Citrus Sinensis ID: 014406

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-----
Protein Sequence
MKDAPRKHKHKHKHPAVLAAQVQVLPLRFLLACAVLALRAPIAHHPILRTPCRSSTYNLNIITDTIAATTVVYEGAIIDKIEERNLAEIPLPAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAESSRTRA
Secondary Structure (PSIPRED)
ccccccccccccccccHHHHHHccccHHHHHHHHHHHHcccccccccccccccccccccccccccccccccccccccccHHHHHcccccccccccccccccccccccccccccccccEEEccccccccEEEEEEccccccEEEEEEcccccEEEEEEcccccHHHHHHHHHHHHHccccccEEEEcEEEEcccccccEEEEEccccccHHHHcccccHHHHHHHHHHHHHHHHHHHHccccccccccccEEEccccccEEEEEcccccccccccccEEEEEccccccHHHHcccccccccccHHHHHHHHHHHHHcccccccccccHHHHHHHHHHcccccHHHHHHHccccccHHHHHHcccccccccccccccccccccccHHHHHHHHHccccccccccHHHHHcccccccccccccccccc
Secondary Structure Prediction (SSPRO)
ccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccccccccccccccccHcHHHHccccccccccccccccccccHHHHccHHHHcHHHcccccccHHHEEEEEEEEEcccEEEEEEEEccccEEEEEEEEccccHHHHHHHHHHHHHHcccccEccEEEEEEccccccEEEEEEccccccHHHHHHHccHHHHHHHHHHHHHHHHHHHHccEEcccccHHHEEEEccccEEEEccccccEEcccccccccccccHHHccHHHHccccccccHHHHHHHHHHHHHHHHccccccccccHHHHHHHHHHHHcHHHHHHHHHHccccccHHHHHHHcccccccHHHHcccccHHHccHHHHHHHHHHccccHHHcccHHHHHccHHHHHHHHHHcccccc
Coil and Loop (DISEMBL)
mkdaprkhkhkhkhpAVLAAQVQVLPLRFLLACAVLALRapiahhpilrtpcrsstynlNIITDTIAATTVVYEGAIIDKIeernlaeiplpamskarvytdvnvlrpkeywdyesltvqwgdqddyEVVRKVGRGKYSEVFEGinvntnerCIIKILKPVKKKKIKREIKILQNlcggpnvvKLLDIVRdqhsktpsLIFEYVNstdfkvlyptltdyDIRYYIYELLKALDYchsqgimhrdvkphnvmiDHELRKLRLIDwglaefyhpgkeyNVRVASryfkgpellvDLQDYDYSLDMWSLGCMFAgmifrkepffyghdnHDQLVKIAKVLGTDELNAYLNKYHLeldpqldalvgrhsrkpwskfinadnqhlvspeAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAESSRTRA
Flexible Loop (DISEMBL)
mkdaprkhkhkhkhpavlAAQVQVLPLRFLLACAVLALRAPIahhpilrtpcrssTYNLNIITDTIAATTVVYEGAIIDKIEernlaeiplpamskarvyTDVNVLRPKEYWdyesltvqwgdqddYEVVRKVGRGKYSevfeginvntnerciikilkpvkkkkiKREIKIlqnlcggpnvVKLLDIVRDQHSKTPSLifeyvnstdfkvLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKfinadnqhlvsPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQvraaessrtra
Low Complexity Region (SEG)
MKDAPRkhkhkhkhPAVLAAQVQVLPLRFLLACAVLALRAPIAHHPILRTPCRSSTYNLNiitdtiaattVVYEGAIIDKIEERNLAEIPLPAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCiikilkpvkkkkikreikiLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAESSRTRA
Disordered region (IsUnstruct)
***************AVLAAQVQVLPLRFLLACAVLALRAPIAHHPILRTPCRSSTYNLNIITDTIAATTVVYEGAIIDKIEERNLAEIPLPAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA************
Disordered Region (DISOPRED)
****************VLAAQVQVLPLRFLLACAVLA*************************************************************VYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV**********
Disordered Region (DISEMBL)
***************AVLAAQVQVLPLRFLLACAVLALRAPIAHHPILRTPCRSSTYNLNIITDTIAATTVVYEGAIIDKIEERNLAEIPLPAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ***********
Disordered Region (DISPRO)
************KHPAVLAAQVQVLPLRFLLACAVLALRAPIAHHPILRTPCRSSTYNLNIITDTIAATTVVYEGAII*******************RVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAES*****
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
iiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
SSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MKDAPRKHKHKHKHPAVLAAQVQVLPLRFLLACAVLALRAPIAHHPILRTPCRSSTYNLNIITDTIAATTVVYEGAIIDKIEERNLAEIPLPAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAESSRTRA
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	425	2.2.26 [Sep-21-2011]
Q08467	409	Casein kinase II subunit	yes	no	0.875	0.909	0.843	0.0
Q08466	403	Casein kinase II subunit	no	no	0.884	0.933	0.840	1e-180
P28523	332	Casein kinase II subunit	N/A	no	0.781	1.0	0.942	1e-176
O64817	333	Probable casein kinase II	no	no	0.781	0.996	0.921	1e-173
O64816	432	Casein kinase II subunit	no	no	0.778	0.766	0.867	1e-164
P19139	391	Casein kinase II subunit	yes	no	0.785	0.854	0.745	1e-141
Q60737	391	Casein kinase II subunit	yes	no	0.762	0.828	0.765	1e-141
P68400	391	Casein kinase II subunit	yes	no	0.776	0.843	0.749	1e-141
P68399	391	Casein kinase II subunit	yes	no	0.776	0.843	0.749	1e-141
P21868	391	Casein kinase II subunit	yes	no	0.755	0.820	0.769	1e-141

>sp|Q08467|CSK21_ARATH Casein kinase II subunit alpha-1 OS=Arabidopsis thaliana GN=CKA1 PE=1 SV=3

 Score =  637 bits (1642), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 329/390 (84%), Positives = 349/390 (89%), Gaps = 18/390 (4%)

Query: 41  PIAHHPILRTPCRSSTYNLNIITDTIAATTVVYEGAIID-----KIEERNLAEIPLPAMS 95
           P AH PILR+         +I+T T  A + V     ID     +I + N       AMS
Sbjct: 32  PTAHSPILRS---------SIVTPTARAVSEVSGCTTIDPDFLVEISDSNQTR----AMS 78

Query: 96  KARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCII 155
           KARVYT+VNV+RPK+YWDYESL VQWG+QDDYEVVRKVGRGKYSEVFEGINVN+ E+CII
Sbjct: 79  KARVYTEVNVIRPKDYWDYESLIVQWGEQDDYEVVRKVGRGKYSEVFEGINVNSKEKCII 138

Query: 156 KILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPT 215
           KILKPVKKKKI+REIKILQNLCGGPN+VKLLD+VRDQHSKTPSLIFEYVNSTDFKVLYPT
Sbjct: 139 KILKPVKKKKIRREIKILQNLCGGPNIVKLLDVVRDQHSKTPSLIFEYVNSTDFKVLYPT 198

Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 275
           LTDYDIRYYIYELLKALD+CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE
Sbjct: 199 LTDYDIRYYIYELLKALDFCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 258

Query: 276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
           YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN DQLVKIAK
Sbjct: 259 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQLVKIAK 318

Query: 336 VLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRY 395
           VLGTDELNAYLNKY LELDPQL+ALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRY
Sbjct: 319 VLGTDELNAYLNKYQLELDPQLEALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRY 378

Query: 396 DHQDRLTAREAMAHPYFAQVRAAESSRTRA 425
           DHQDRLTA+EAMAH YFAQVRAAE+SR R+
Sbjct: 379 DHQDRLTAKEAMAHAYFAQVRAAETSRMRS 408

Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. The alpha chain contains the catalytic site. May act as an ectokinase that phosphorylates several extracellular proteins.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q08466|CSK22_ARATH Casein kinase II subunit alpha-2 OS=Arabidopsis thaliana GN=CKA2 PE=2 SV=3

 Score =  630 bits (1624), Expect = e-180,   Method: Compositional matrix adjust.
 Identities = 327/389 (84%), Positives = 349/389 (89%), Gaps = 13/389 (3%)

Query: 39  RAPIAHHPILRTPCRSSTYNLNIITDTIAATTVVYEGAIIDK-IEERNLAEIPLPA-MSK 96
           RAP+AH  I    C        + T T+ +      G   D+ ++  +LA+I L   MSK
Sbjct: 25  RAPLAHSLIPPLTC--------VNTGTVESDVT---GIRFDRCLDTDSLAKISLSTVMSK 73

Query: 97  ARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIK 156
           ARVYTDVNV+RPK+YWDYESL VQWG+QDDYEVVRKVGRGKYSEVFEGIN+N NE+CIIK
Sbjct: 74  ARVYTDVNVIRPKDYWDYESLNVQWGEQDDYEVVRKVGRGKYSEVFEGINMNNNEKCIIK 133

Query: 157 ILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTL 216
           ILKPVKKKKI+REIKILQNLCGGPN+VKLLD+VRDQHSKTPSLIFEYVNSTDFKVLYPTL
Sbjct: 134 ILKPVKKKKIRREIKILQNLCGGPNIVKLLDVVRDQHSKTPSLIFEYVNSTDFKVLYPTL 193

Query: 217 TDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY 276
           TDYDIRYYIYELLKALD+CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY
Sbjct: 194 TDYDIRYYIYELLKALDFCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY 253

Query: 277 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 336
           NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN DQLVKIAKV
Sbjct: 254 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQLVKIAKV 313

Query: 337 LGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYD 396
           LGTDELNAYLNKY LELD QL+ALVGRHSRKPWSKFINADN+HLVSPEAID+LDKLLRYD
Sbjct: 314 LGTDELNAYLNKYQLELDTQLEALVGRHSRKPWSKFINADNRHLVSPEAIDYLDKLLRYD 373

Query: 397 HQDRLTAREAMAHPYFAQVRAAESSRTRA 425
           HQDRLTA+EAMAHPYFAQVRAAESSR R 
Sbjct: 374 HQDRLTAKEAMAHPYFAQVRAAESSRMRT 402

Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. The alpha chain contains the catalytic site. May act as an ectokinase that phosphorylates several extracellular proteins.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P28523|CSK2A_MAIZE Casein kinase II subunit alpha OS=Zea mays GN=ACK2 PE=1 SV=1

 Score =  619 bits (1595), Expect = e-176,   Method: Compositional matrix adjust.
 Identities = 313/332 (94%), Positives = 323/332 (97%)

Query: 94  MSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERC 153
           MSKARVY DVNVLRPKEYWDYE+LTVQWG+QDDYEVVRKVGRGKYSEVFEGINVN NE+C
Sbjct: 1   MSKARVYADVNVLRPKEYWDYEALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKC 60

Query: 154 IIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY 213
           IIKILKPVKKKKIKREIKILQNLCGGPN+VKLLDIVRDQHSKTPSLIFEYVN+TDFKVLY
Sbjct: 61  IIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLY 120

Query: 214 PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 273
           PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG
Sbjct: 121 PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 180

Query: 274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333
           KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI
Sbjct: 181 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 240

Query: 334 AKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLL 393
           AKVLGTD LN YLNKY +ELDPQL+ALVGRHSRKPW KF+NADNQHLVSPEAIDFLDKLL
Sbjct: 241 AKVLGTDGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLL 300

Query: 394 RYDHQDRLTAREAMAHPYFAQVRAAESSRTRA 425
           RYDHQ+RLTA EAM HPYF QVRAAE+SRTRA
Sbjct: 301 RYDHQERLTALEAMTHPYFQQVRAAENSRTRA 332

Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. The alpha chain contains the catalytic site.

Zea mays (taxid: 4577)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O64817|CSK23_ARATH Probable casein kinase II subunit alpha OS=Arabidopsis thaliana GN=At2g23080 PE=1 SV=1

 Score =  607 bits (1565), Expect = e-173,   Method: Compositional matrix adjust.
 Identities = 306/332 (92%), Positives = 320/332 (96%)

Query: 94  MSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERC 153
           MSKARVYTDVNV+RPKEYWDYESL VQWG QDDYEVVRKVGRGKYSEVFEG NVNTNERC
Sbjct: 1   MSKARVYTDVNVVRPKEYWDYESLVVQWGHQDDYEVVRKVGRGKYSEVFEGKNVNTNERC 60

Query: 154 IIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY 213
           +IKILKPVKKKKIKREIKILQNLCGGPN+VKL DIVRD+HSKTPSL+FE+VNS DFKVLY
Sbjct: 61  VIKILKPVKKKKIKREIKILQNLCGGPNIVKLYDIVRDEHSKTPSLVFEFVNSVDFKVLY 120

Query: 214 PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 273
           PTLTDYDIRYYIYELLKALD+CHSQGIMHRDVKPHNVMIDH+LRKLRLIDWGLAEFYHPG
Sbjct: 121 PTLTDYDIRYYIYELLKALDFCHSQGIMHRDVKPHNVMIDHQLRKLRLIDWGLAEFYHPG 180

Query: 274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333
           KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI
Sbjct: 181 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 240

Query: 334 AKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLL 393
           AKVLGT+EL+ YLNKY L+LDPQL+ALVGRH  KPWSKFINADNQHLVSPEAIDFLDKLL
Sbjct: 241 AKVLGTNELDHYLNKYQLDLDPQLEALVGRHVPKPWSKFINADNQHLVSPEAIDFLDKLL 300

Query: 394 RYDHQDRLTAREAMAHPYFAQVRAAESSRTRA 425
           +YDHQDRLTAREAM HPYFAQV+AAESSR R 
Sbjct: 301 QYDHQDRLTAREAMDHPYFAQVKAAESSRLRT 332

Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. The alpha chain contains the catalytic site. May act as an ectokinase that phosphorylates several extracellular proteins.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O64816|CSK2P_ARATH Casein kinase II subunit alpha, chloroplastic OS=Arabidopsis thaliana GN=At2g23070 PE=2 SV=1

 Score =  578 bits (1491), Expect = e-164,   Method: Compositional matrix adjust.
 Identities = 287/331 (86%), Positives = 312/331 (94%)

Query: 93  AMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNER 152
           A SKARVY DVNV+RPK+YWDYESL VQWG QDDYEVVRKVGRGKYSEVFEGI+   NE+
Sbjct: 98  APSKARVYADVNVVRPKDYWDYESLAVQWGVQDDYEVVRKVGRGKYSEVFEGIHATDNEK 157

Query: 153 CIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL 212
           C+IKILKPVKKKKIKREIKILQNLCGGPN+VKLLDIVRDQ SKTPSLIFE+VN+ DFKVL
Sbjct: 158 CVIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNKDFKVL 217

Query: 213 YPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 272
           YPTL+DYD+RYYI+ELLKALD+CHS+GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYHP
Sbjct: 218 YPTLSDYDVRYYIFELLKALDFCHSRGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 277

Query: 273 GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVK 332
           GKEYNVRVASRYFKGPELLVDLQDYDYSLD+WSLGCMFAGMIFRKEPFFYGHDN+DQLVK
Sbjct: 278 GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVK 337

Query: 333 IAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKL 392
           IAKVLGTDELNAYLNKY +ELDP L +LVGRHSRKPW+KFIN++NQHL  PEA+DF+DKL
Sbjct: 338 IAKVLGTDELNAYLNKYRIELDPNLTSLVGRHSRKPWTKFINSENQHLAVPEAVDFVDKL 397

Query: 393 LRYDHQDRLTAREAMAHPYFAQVRAAESSRT 423
           LRYDHQ+R TA+EAMAHPYF  +R AESSRT
Sbjct: 398 LRYDHQERPTAKEAMAHPYFYPIRNAESSRT 428

Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. The alpha chain contains the catalytic site. May act as an ectokinase that phosphorylates several extracellular proteins.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P19139|CSK21_RAT Casein kinase II subunit alpha OS=Rattus norvegicus GN=Csnk2a1 PE=1 SV=2

 Score =  501 bits (1290), Expect = e-141,   Method: Compositional matrix adjust.
 Identities = 249/334 (74%), Positives = 295/334 (88%)

Query: 92  PAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNE 151
           P  S+ARVYTDVN  RP+EYWDYES  V+WG+QDDY++VRK+GRGKYSEVFE IN+  NE
Sbjct: 4   PVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNE 63

Query: 152 RCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV 211
           + ++KILKPVKKKKIKREIKIL+NL GGPN++ L DIV+D  S+TP+L+FE+VN+TDFK 
Sbjct: 64  KVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ 123

Query: 212 LYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271
           LY TLTDYDIR+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYH
Sbjct: 124 LYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 183

Query: 272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
           PG+EYNVRVASRYFKGPELLVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHDN+DQLV
Sbjct: 184 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 243

Query: 332 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDK 391
           +IAKVLGT++L  Y++KY++ELDP+ + ++GRHSRK W +F++++NQHLVSPEA+DFLDK
Sbjct: 244 RIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDK 303

Query: 392 LLRYDHQDRLTAREAMAHPYFAQVRAAESSRTRA 425
           LLRYDHQ RLTAREAM HPYF  V   ++  + A
Sbjct: 304 LLRYDHQSRLTAREAMEHPYFYTVVKDQARMSSA 337

Catalytic subunit of a constitutively active serine/threonine-protein kinase complex that phosphorylates a large number of substrates containing acidic residues C-terminal to the phosphorylated serine or threonine. Regulates numerous cellular processes, such as cell cycle progression, apoptosis and transcription, as well as viral infection. May act as a regulatory node which integrates and coordinates numerous signals leading to an appropriate cellular response. During mitosis, functions as a component of the p53/TP53-dependent spindle assembly checkpoint (SAC) that maintains cyclin-B-CDK1 activity and G2 arrest in response to spindle damage. Also required for p53/TP53-mediated apoptosis, phosphorylating 'Ser-392' of p53/TP53 following UV irradiation. Can also negatively regulate apoptosis. Phosphorylates the caspases CASP9 and CASP2 and the apoptotic regulator NOL3. Phosphorylation protects CASP9 from cleavage and activation by CASP8, and inhibits the dimerization of CASP2 and activation of CASP8. Regulates transcription by direct phosphorylation of RNA polymerases I, II, III and IV. Also phosphorylates and regulates numerous transcription factors including NF-kappa-B, STAT1, CREB1, IRF1, IRF2, ATF1, SRF, MAX, JUN, FOS, MYC and MYB. Phosphorylates Hsp90 and its co-chaperones FKBP4 and CDC37, which is essential for chaperone function. Regulates Wnt signaling by phosphorylating CTNNB1 and the transcription factor LEF1. Acts as an ectokinase that phosphorylates several extracellular proteins.

Rattus norvegicus (taxid: 10116)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q60737|CSK21_MOUSE Casein kinase II subunit alpha OS=Mus musculus GN=Csnk2a1 PE=1 SV=2

 Score =  501 bits (1290), Expect = e-141,   Method: Compositional matrix adjust.
 Identities = 248/324 (76%), Positives = 291/324 (89%)

Query: 92  PAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNE 151
           P  S+ARVYTDVN  RP+EYWDYES  V+WG+QDDY++VRK+GRGKYSEVFE IN+  NE
Sbjct: 4   PVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNE 63

Query: 152 RCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV 211
           + ++KILKPVKKKKIKREIKIL+NL GGPN++ L DIV+D  S+TP+L+FE+VN+TDFK 
Sbjct: 64  KVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ 123

Query: 212 LYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271
           LY TLTDYDIR+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYH
Sbjct: 124 LYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 183

Query: 272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
           PG+EYNVRVASRYFKGPELLVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHDN+DQLV
Sbjct: 184 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 243

Query: 332 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDK 391
           +IAKVLGT++L  Y++KY++ELDP+ + ++GRHSRK W +F++++NQHLVSPEA+DFLDK
Sbjct: 244 RIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDK 303

Query: 392 LLRYDHQDRLTAREAMAHPYFAQV 415
           LLRYDHQ RLTAREAM HPYF  V
Sbjct: 304 LLRYDHQSRLTAREAMEHPYFYTV 327

Catalytic subunit of a constitutively active serine/threonine-protein kinase complex that phosphorylates a large number of substrates containing acidic residues C-terminal to the phosphorylated serine or threonine. Regulates numerous cellular processes, such as cell cycle progression, apoptosis and transcription, as well as viral infection. May act as a regulatory node which integrates and coordinates numerous signals leading to an appropriate cellular response. During mitosis, functions as a component of the p53/TP53-dependent spindle assembly checkpoint (SAC) that maintains cyclin-B-CDK1 activity and G2 arrest in response to spindle damage. Also required for p53/TP53-mediated apoptosis, phosphorylating 'Ser-392' of p53/TP53 following UV irradiation. Can also negatively regulate apoptosis. Phosphorylates the caspases CASP9 and CASP2 and the apoptotic regulator NOL3. Phosphorylation protects CASP9 from cleavage and activation by CASP8, and inhibits the dimerization of CASP2 and activation of CASP8. Regulates transcription by direct phosphorylation of RNA polymerases I, II, III and IV. Also phosphorylates and regulates numerous transcription factors including NF-kappa-B, STAT1, CREB1, IRF1, IRF2, ATF1, SRF, MAX, JUN, FOS, MYC and MYB. Phosphorylates Hsp90 and its co-chaperones FKBP4 and CDC37, which is essential for chaperone function. Regulates Wnt signaling by phosphorylating CTNNB1 and the transcription factor LEF1. Acts as an ectokinase that phosphorylates several extracellular proteins.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P68400|CSK21_HUMAN Casein kinase II subunit alpha OS=Homo sapiens GN=CSNK2A1 PE=1 SV=1

 Score =  500 bits (1288), Expect = e-141,   Method: Compositional matrix adjust.
 Identities = 251/335 (74%), Positives = 294/335 (87%), Gaps = 5/335 (1%)

Query: 92  PAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNE 151
           P  S+ARVYTDVN  RP+EYWDYES  V+WG+QDDY++VRK+GRGKYSEVFE IN+  NE
Sbjct: 4   PVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNE 63

Query: 152 RCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV 211
           + ++KILKPVKKKKIKREIKIL+NL GGPN++ L DIV+D  S+TP+L+FE+VN+TDFK 
Sbjct: 64  KVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ 123

Query: 212 LYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271
           LY TLTDYDIR+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYH
Sbjct: 124 LYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 183

Query: 272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
           PG+EYNVRVASRYFKGPELLVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHDN+DQLV
Sbjct: 184 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 243

Query: 332 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDK 391
           +IAKVLGT++L  Y++KY++ELDP+ + ++GRHSRK W +F++++NQHLVSPEA+DFLDK
Sbjct: 244 RIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDK 303

Query: 392 LLRYDHQDRLTAREAMAHPYF-----AQVRAAESS 421
           LLRYDHQ RLTAREAM HPYF      Q R   SS
Sbjct: 304 LLRYDHQSRLTAREAMEHPYFYTVVKDQARMGSSS 338

Catalytic subunit of a constitutively active serine/threonine-protein kinase complex that phosphorylates a large number of substrates containing acidic residues C-terminal to the phosphorylated serine or threonine. Regulates numerous cellular processes, such as cell cycle progression, apoptosis and transcription, as well as viral infection. May act as a regulatory node which integrates and coordinates numerous signals leading to an appropriate cellular response. During mitosis, functions as a component of the p53/TP53-dependent spindle assembly checkpoint (SAC) that maintains cyclin-B-CDK1 activity and G2 arrest in response to spindle damage. Also required for p53/TP53-mediated apoptosis, phosphorylating 'Ser-392' of p53/TP53 following UV irradiation. Can also negatively regulate apoptosis. Phosphorylates the caspases CASP9 and CASP2 and the apoptotic regulator NOL3. Phosphorylation protects CASP9 from cleavage and activation by CASP8, and inhibits the dimerization of CASP2 and activation of CASP8. Regulates transcription by direct phosphorylation of RNA polymerases I, II, III and IV. Also phosphorylates and regulates numerous transcription factors including NF-kappa-B, STAT1, CREB1, IRF1, IRF2, ATF1, SRF, MAX, JUN, FOS, MYC and MYB. Phosphorylates Hsp90 and its co-chaperones FKBP4 and CDC37, which is essential for chaperone function. Regulates Wnt signaling by phosphorylating CTNNB1 and the transcription factor LEF1. Acts as an ectokinase that phosphorylates several extracellular proteins. During viral infection, phosphorylates various proteins involved in the viral life cycles of EBV, HSV, HBV, HCV, HIV, CMV and HPV.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P68399|CSK21_BOVIN Casein kinase II subunit alpha OS=Bos taurus GN=CSNK2A1 PE=1 SV=1

 Score =  500 bits (1288), Expect = e-141,   Method: Compositional matrix adjust.
 Identities = 251/335 (74%), Positives = 294/335 (87%), Gaps = 5/335 (1%)

Query: 92  PAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNE 151
           P  S+ARVYTDVN  RP+EYWDYES  V+WG+QDDY++VRK+GRGKYSEVFE IN+  NE
Sbjct: 4   PVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNE 63

Query: 152 RCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV 211
           + ++KILKPVKKKKIKREIKIL+NL GGPN++ L DIV+D  S+TP+L+FE+VN+TDFK 
Sbjct: 64  KVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ 123

Query: 212 LYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271
           LY TLTDYDIR+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYH
Sbjct: 124 LYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 183

Query: 272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
           PG+EYNVRVASRYFKGPELLVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHDN+DQLV
Sbjct: 184 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 243

Query: 332 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDK 391
           +IAKVLGT++L  Y++KY++ELDP+ + ++GRHSRK W +F++++NQHLVSPEA+DFLDK
Sbjct: 244 RIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDK 303

Query: 392 LLRYDHQDRLTAREAMAHPYF-----AQVRAAESS 421
           LLRYDHQ RLTAREAM HPYF      Q R   SS
Sbjct: 304 LLRYDHQSRLTAREAMEHPYFYTVVKDQARMGSSS 338

Catalytic subunit of a constitutively active serine/threonine-protein kinase complex that phosphorylates a large number of substrates containing acidic residues C-terminal to the phosphorylated serine or threonine. Regulates numerous cellular processes, such as cell cycle progression, apoptosis and transcription, as well as viral infection. May act as a regulatory node which integrates and coordinates numerous signals leading to an appropriate cellular response. During mitosis, functions as a component of the p53/TP53-dependent spindle assembly checkpoint (SAC) that maintains cyclin-B-CDK1 activity and G2 arrest in response to spindle damage. Also required for p53/TP53-mediated apoptosis, phosphorylating 'Ser-392' of p53/TP53 following UV irradiation. Can also negatively regulate apoptosis. Phosphorylates the caspases CASP9 and CASP2 and the apoptotic regulator NOL3. Phosphorylation protects CASP9 from cleavage and activation by CASP8, and inhibits the dimerization of CASP2 and activation of CASP8. Regulates transcription by direct phosphorylation of RNA polymerases I, II, III and IV. Also phosphorylates and regulates numerous transcription factors including NF-kappa-B, STAT1, CREB1, IRF1, IRF2, ATF1, SRF, MAX, JUN, FOS, MYC and MYB. Phosphorylates Hsp90 and its co-chaperones FKBP4 and CDC37, which is essential for chaperone function. Regulates Wnt signaling by phosphorylating CTNNB1 and the transcription factor LEF1. Acts as an ectokinase that phosphorylates several extracellular proteins.

Bos taurus (taxid: 9913)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P21868|CSK21_CHICK Casein kinase II subunit alpha OS=Gallus gallus GN=CSNK2A1 PE=2 SV=1

 Score =  500 bits (1287), Expect = e-141,   Method: Compositional matrix adjust.
 Identities = 247/321 (76%), Positives = 290/321 (90%)

Query: 92  PAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNE 151
           P  S+ARVYTDVN  RP+EYWDYES  V+WG+QDDY++VRK+GRGKYSEVFE IN+  NE
Sbjct: 4   PVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNE 63

Query: 152 RCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV 211
           + ++KILKPVKKKKIKREIKIL+NL GGPN++ L DIV+D  S+TP+L+FE+VN+TDFK 
Sbjct: 64  KVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ 123

Query: 212 LYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271
           LY TLTDYDIR+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYH
Sbjct: 124 LYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 183

Query: 272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
           PG+EYNVRVASRYFKGPELLVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHDN+DQLV
Sbjct: 184 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 243

Query: 332 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDK 391
           +IAKVLGT++L  Y++KY++ELDP+ + ++GRHSRK W +F++++NQHLVSPEA+DFLDK
Sbjct: 244 RIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDK 303

Query: 392 LLRYDHQDRLTAREAMAHPYF 412
           LLRYDHQ RLTAREAM HPYF
Sbjct: 304 LLRYDHQSRLTAREAMEHPYF 324

Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. The alpha and alpha' chains contain the catalytic site. Participates in Wnt signaling.

Gallus gallus (taxid: 9031)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	425
224074233	333	predicted protein [Populus trichocarpa]	0.781	0.996	0.978	0.0
356541665	333	PREDICTED: casein kinase II subunit alph	0.781	0.996	0.978	0.0
356511951	411	PREDICTED: casein kinase II subunit alph	0.915	0.946	0.875	0.0
363814459	398	uncharacterized protein LOC100820471 pre	0.924	0.987	0.845	0.0
357476359	388	Casein kinase 2 alpha subunit [Medicago	0.896	0.981	0.851	0.0
391605	333	casein kinase II catalytic subunit [Arab	0.781	0.996	0.933	0.0
297816254	405	hypothetical protein ARALYDRAFT_485358 [	0.910	0.955	0.836	0.0
449448246	397	PREDICTED: casein kinase II subunit alph	0.92	0.984	0.852	0.0
388510076	333	unknown [Medicago truncatula]	0.781	0.996	0.966	0.0
225438950	405	PREDICTED: casein kinase II subunit alph	0.896	0.940	0.875	0.0

>gi|224074233|ref|XP_002304312.1| predicted protein [Populus trichocarpa] gi|222841744|gb|EEE79291.1| predicted protein [Populus trichocarpa]

 Score =  684 bits (1766), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 325/332 (97%), Positives = 330/332 (99%)

Query: 94  MSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERC 153
           MSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVN+NERC
Sbjct: 1   MSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNSNERC 60

Query: 154 IIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY 213
           +IKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY
Sbjct: 61  VIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY 120

Query: 214 PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 273
           PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG
Sbjct: 121 PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 180

Query: 274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333
           KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI
Sbjct: 181 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 240

Query: 334 AKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLL 393
           AKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFIN+DNQHLVSPEA+DFLDKLL
Sbjct: 241 AKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINSDNQHLVSPEALDFLDKLL 300

Query: 394 RYDHQDRLTAREAMAHPYFAQVRAAESSRTRA 425
           RYDHQDRLTAREAMAHPYF+QVRAAESSR R 
Sbjct: 301 RYDHQDRLTAREAMAHPYFSQVRAAESSRMRT 332

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356541665|ref|XP_003539294.1| PREDICTED: casein kinase II subunit alpha-2-like [Glycine max]

 Score =  684 bits (1765), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 325/332 (97%), Positives = 330/332 (99%)

Query: 94  MSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERC 153
           MSKARVYTDVNVLRPKEYWDYESLT+QWGDQDDYEVVRKVGRGKYSEVFEGINVN+NERC
Sbjct: 1   MSKARVYTDVNVLRPKEYWDYESLTLQWGDQDDYEVVRKVGRGKYSEVFEGINVNSNERC 60

Query: 154 IIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY 213
           IIKILKPVKKKKIKREIKILQN+CGGPN+VKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY
Sbjct: 61  IIKILKPVKKKKIKREIKILQNICGGPNIVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY 120

Query: 214 PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 273
           PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG
Sbjct: 121 PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 180

Query: 274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333
           KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI
Sbjct: 181 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 240

Query: 334 AKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLL 393
           AKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLL
Sbjct: 241 AKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLL 300

Query: 394 RYDHQDRLTAREAMAHPYFAQVRAAESSRTRA 425
           RYDHQDRLTAREAMAHPYF+QVRAAESSR R 
Sbjct: 301 RYDHQDRLTAREAMAHPYFSQVRAAESSRMRT 332

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356511951|ref|XP_003524685.1| PREDICTED: casein kinase II subunit alpha-2-like [Glycine max]

 Score =  677 bits (1747), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 351/401 (87%), Positives = 366/401 (91%), Gaps = 12/401 (2%)

Query: 25  LPLRFLLACAVLALRAPIAHHPILRTPCRSSTYNLNIITDTIAATTVVYEGAIIDKIEER 84
           L LRFLL C ++ALRAP+A  PI+R P        N +T+T    TV+    I+ +    
Sbjct: 22  LLLRFLLVCTLVALRAPVAQPPIVRIPP-------NHLTET--TNTVI---TIVHQRHRT 69

Query: 85  NLAEIPLPAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEG 144
            ++    PAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEG
Sbjct: 70  QISGSTRPAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEG 129

Query: 145 INVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV 204
           INVN+NERCIIKILKPVKKKKIKREIKILQNLCGGPN+VKLLDIVRDQHSKTPSLIFEYV
Sbjct: 130 INVNSNERCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEYV 189

Query: 205 NSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDW 264
           NSTDFKVLYPTLTDYDIRYYIYELLKA+DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDW
Sbjct: 190 NSTDFKVLYPTLTDYDIRYYIYELLKAIDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDW 249

Query: 265 GLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH 324
           GLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH
Sbjct: 250 GLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH 309

Query: 325 DNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPE 384
           DNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPE
Sbjct: 310 DNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPE 369

Query: 385 AIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAESSRTRA 425
           AIDFLDKLLRYDHQDRLTAREAMAHPYF+QVRAAESSR R 
Sbjct: 370 AIDFLDKLLRYDHQDRLTAREAMAHPYFSQVRAAESSRMRT 410

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|363814459|ref|NP_001242864.1| uncharacterized protein LOC100820471 precursor [Glycine max] gi|255638871|gb|ACU19738.1| unknown [Glycine max]

 Score =  674 bits (1738), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 350/414 (84%), Positives = 365/414 (88%), Gaps = 21/414 (5%)

Query: 12  HKHPAVLAAQVQVLPLRFLLACAVLALRAPIAHHPILRTPCRSSTYNLNIITDTIAATTV 71
           H+ PA L        LRFLL C ++ALRAP+A  PILR P        N + +T    T+
Sbjct: 5   HEAPAALL-------LRFLLVCTIVALRAPVAQPPILRIP--------NHLIETTNTFTI 49

Query: 72  VYEGAIIDKIEERNLAEIPLPAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVR 131
           V++           ++     AMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVR
Sbjct: 50  VHQRY------RTQISGSNRRAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVR 103

Query: 132 KVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRD 191
           KVGRGKYSEVFEGINVN+NERC+IKILKPVKKKKIKREIKILQNLCGGPN+VKLLDIVRD
Sbjct: 104 KVGRGKYSEVFEGINVNSNERCVIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRD 163

Query: 192 QHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM 251
           QHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQ IMHRDVKPHNVM
Sbjct: 164 QHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQSIMHRDVKPHNVM 223

Query: 252 IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFA 311
           IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY KGPELLVDLQDYDYSLDMWSLGCMFA
Sbjct: 224 IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYIKGPELLVDLQDYDYSLDMWSLGCMFA 283

Query: 312 GMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSK 371
           GMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSK
Sbjct: 284 GMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSK 343

Query: 372 FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAESSRTRA 425
           FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF+QVRAAESSR R 
Sbjct: 344 FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFSQVRAAESSRMRT 397

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357476359|ref|XP_003608465.1| Casein kinase 2 alpha subunit [Medicago truncatula] gi|355509520|gb|AES90662.1| Casein kinase 2 alpha subunit [Medicago truncatula]

 Score =  669 bits (1725), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 343/403 (85%), Positives = 360/403 (89%), Gaps = 22/403 (5%)

Query: 23  QVLPLRFLLACAVLALRAPIAHHPILRTPCRSSTYNLNIITDTIAATTVVYEGAIIDKIE 82
           Q   LR LL C +++LRAP+A  P +R P +S+  N          TT+     I+ +I 
Sbjct: 7   QAPQLRLLLVCTLISLRAPVAQPPNVRIPTQSNESN--------TTTTI-----IVSQIS 53

Query: 83  ERNLAEIPLPAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVF 142
                      MSKARVYTDVNV+RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVF
Sbjct: 54  S---------TMSKARVYTDVNVIRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVF 104

Query: 143 EGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE 202
           EGINVN++ERC+IKILKPVKKKKIKREIKILQNLCGGPN+VKLLDIVRDQHSKTPSLIFE
Sbjct: 105 EGINVNSSERCVIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFE 164

Query: 203 YVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLI 262
           YVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLI
Sbjct: 165 YVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLI 224

Query: 263 DWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 322
           DWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY
Sbjct: 225 DWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 284

Query: 323 GHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVS 382
           GHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVS
Sbjct: 285 GHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVS 344

Query: 383 PEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAESSRTRA 425
           PEAID+LDKLLRYDHQDRLTAREAMAHPYF+QVRAAESSR R 
Sbjct: 345 PEAIDYLDKLLRYDHQDRLTAREAMAHPYFSQVRAAESSRMRT 387

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|391605|dbj|BAA01091.1| casein kinase II catalytic subunit [Arabidopsis thaliana]

 Score =  658 bits (1698), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 310/332 (93%), Positives = 324/332 (97%)

Query: 94  MSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERC 153
           MSKARVYTDVNV+RPK+YWDYESL VQWG+QDDYEVVRKVGRGKYSEVFEGIN+N NE+C
Sbjct: 1   MSKARVYTDVNVIRPKDYWDYESLNVQWGEQDDYEVVRKVGRGKYSEVFEGINMNNNEKC 60

Query: 154 IIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY 213
           IIKILKPVKKK+I+REIKILQNLCGGPN+VKLLD+VRDQHSKTPSLIFEYVNSTDFKVLY
Sbjct: 61  IIKILKPVKKKEIRREIKILQNLCGGPNIVKLLDVVRDQHSKTPSLIFEYVNSTDFKVLY 120

Query: 214 PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 273
           PTLTDYDIRYYIYELLKALD+CHSQGIMHRDVKPHNVMIDH LRKLRLIDWGLAEFYHPG
Sbjct: 121 PTLTDYDIRYYIYELLKALDFCHSQGIMHRDVKPHNVMIDHGLRKLRLIDWGLAEFYHPG 180

Query: 274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333
           KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN DQLVKI
Sbjct: 181 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQLVKI 240

Query: 334 AKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLL 393
           AKVLGTDELNAYLNKY LELD QL+ALVGRHSRKPWSKFINADN+HLVSPEAID+LDKLL
Sbjct: 241 AKVLGTDELNAYLNKYQLELDTQLEALVGRHSRKPWSKFINADNRHLVSPEAIDYLDKLL 300

Query: 394 RYDHQDRLTAREAMAHPYFAQVRAAESSRTRA 425
           RYDHQDRLTA+EAMAHPYFAQVRAAESSR R 
Sbjct: 301 RYDHQDRLTAKEAMAHPYFAQVRAAESSRMRT 332

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297816254|ref|XP_002876010.1| hypothetical protein ARALYDRAFT_485358 [Arabidopsis lyrata subsp. lyrata] gi|297321848|gb|EFH52269.1| hypothetical protein ARALYDRAFT_485358 [Arabidopsis lyrata subsp. lyrata]

 Score =  652 bits (1683), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 337/403 (83%), Positives = 360/403 (89%), Gaps = 16/403 (3%)

Query: 28  RFLLACAVLALRAPIAHHPILRTPCRSSTYNLNIITDTIAATTVVYEGAIIDK-IEERNL 86
           RFLL CA+L LRAP AH PI    C        + T T+ +      G   ++ ++  +L
Sbjct: 13  RFLLLCAILILRAPTAHSPIPPLTC--------VATGTVESDV---SGISFNRCLDSDSL 61

Query: 87  AEIPLP----AMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVF 142
           AEI L     AMSKARVYTDVNV+RPK+YWDYESL VQWG+QDDYEVVRKVGRGKYSEVF
Sbjct: 62  AEISLSSVTGAMSKARVYTDVNVIRPKDYWDYESLNVQWGEQDDYEVVRKVGRGKYSEVF 121

Query: 143 EGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE 202
           EGIN+N+NE+CIIKILKPVKKKKI+REIKILQNLCGGPN+VKLLD+VRDQHSKTPSLIFE
Sbjct: 122 EGINMNSNEKCIIKILKPVKKKKIRREIKILQNLCGGPNIVKLLDVVRDQHSKTPSLIFE 181

Query: 203 YVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLI 262
           YVNSTDFKVLYPTLTDYDIRYYIYELLKALD+CHSQGIMHRDVKPHNVMIDHELRKLRLI
Sbjct: 182 YVNSTDFKVLYPTLTDYDIRYYIYELLKALDFCHSQGIMHRDVKPHNVMIDHELRKLRLI 241

Query: 263 DWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 322
           DWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY
Sbjct: 242 DWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 301

Query: 323 GHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVS 382
           GHDN DQLVKIAKVLGTDELNAYLNKY LELD QL+ALVGRHSRKPWSKFINADN+HLVS
Sbjct: 302 GHDNQDQLVKIAKVLGTDELNAYLNKYQLELDAQLEALVGRHSRKPWSKFINADNRHLVS 361

Query: 383 PEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAESSRTRA 425
           PEAID+LDKLLRYDHQDRLTA+EAMAHPYFAQVRAAESSR R 
Sbjct: 362 PEAIDYLDKLLRYDHQDRLTAKEAMAHPYFAQVRAAESSRMRT 404

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449448246|ref|XP_004141877.1| PREDICTED: casein kinase II subunit alpha-1-like [Cucumis sativus] gi|449510998|ref|XP_004163833.1| PREDICTED: casein kinase II subunit alpha-1-like [Cucumis sativus]

 Score =  649 bits (1674), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 340/399 (85%), Positives = 352/399 (88%), Gaps = 8/399 (2%)

Query: 27  LRFLLACAVLALRAPIAHHPILRTPCRSSTYNLNIITDTIAATTVVYEGAIIDKIEERNL 86
           LR LL   V  L  P++H P LR+P    + + +  +  + A          DKI    L
Sbjct: 6   LRLLLVFTVFFL-LPVSHPPTLRSPPLPPSSDASFFSSAVGAVHG-------DKITPIGL 57

Query: 87  AEIPLPAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGIN 146
                P MSKARVY DVNVLRPK+YWDYESL VQWGDQDDYEVVRKVGRGKYSEVFEGIN
Sbjct: 58  LGSSYPLMSKARVYADVNVLRPKDYWDYESLAVQWGDQDDYEVVRKVGRGKYSEVFEGIN 117

Query: 147 VNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNS 206
           VN NERCIIKILKPVKKKKIKREIKILQNLCGGPN+VKL DIVRDQHSKTPSLIFEYVNS
Sbjct: 118 VNNNERCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLFDIVRDQHSKTPSLIFEYVNS 177

Query: 207 TDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL 266
           TDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL
Sbjct: 178 TDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL 237

Query: 267 AEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN 326
           AEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN
Sbjct: 238 AEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN 297

Query: 327 HDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAI 386
           HDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAI
Sbjct: 298 HDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAI 357

Query: 387 DFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAESSRTRA 425
           DFLDKLLRYDHQDRLTAREAMAHPYF+QVRAAE+SR R 
Sbjct: 358 DFLDKLLRYDHQDRLTAREAMAHPYFSQVRAAENSRMRT 396

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|388510076|gb|AFK43104.1| unknown [Medicago truncatula]

 Score =  649 bits (1674), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 321/332 (96%), Positives = 329/332 (99%)

Query: 94  MSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERC 153
           MSKARVYTDVNV+RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVN++ERC
Sbjct: 1   MSKARVYTDVNVIRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNSSERC 60

Query: 154 IIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY 213
           +IKILKPVKKKKIKRE+KILQNLCGGPN+VKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY
Sbjct: 61  VIKILKPVKKKKIKREMKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY 120

Query: 214 PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 273
           PTLTDYDIRY IYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG
Sbjct: 121 PTLTDYDIRYCIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 180

Query: 274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333
           KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI
Sbjct: 181 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 240

Query: 334 AKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLL 393
           AKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAID+LDKLL
Sbjct: 241 AKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDYLDKLL 300

Query: 394 RYDHQDRLTAREAMAHPYFAQVRAAESSRTRA 425
           RYDHQDRLTAREAMAHPYF+QVRAAESSR R 
Sbjct: 301 RYDHQDRLTAREAMAHPYFSQVRAAESSRMRT 332

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225438950|ref|XP_002284196.1| PREDICTED: casein kinase II subunit alpha-2 isoform 1 [Vitis vinifera]

 Score =  642 bits (1657), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 339/387 (87%), Positives = 348/387 (89%), Gaps = 6/387 (1%)

Query: 39  RAPIAHHPILRTPCRSSTYNLNIITDTIAATTVVYEGAIIDKIEERNLAEIPLPAMSKAR 98
           RAP+A  P LR P  S     N I   I  T+       + +I   ++A      MSKAR
Sbjct: 24  RAPLALPPNLR-PHSSPPIPDNKIITPIVDTSKARLKLQLSEISSSDVA-----PMSKAR 77

Query: 99  VYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL 158
           VY DVNVLRPK+YWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVN+NERCIIKIL
Sbjct: 78  VYADVNVLRPKDYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNSNERCIIKIL 137

Query: 159 KPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTD 218
           KPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTD
Sbjct: 138 KPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTD 197

Query: 219 YDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV 278
           YDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV
Sbjct: 198 YDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV 257

Query: 279 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLG 338
           RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLG
Sbjct: 258 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLG 317

Query: 339 TDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQ 398
           TDELNAYLNKY LELDPQLDALVGRHSRKPWSKFI+ADNQHLVSPEAIDFLDKLLRYDHQ
Sbjct: 318 TDELNAYLNKYRLELDPQLDALVGRHSRKPWSKFIHADNQHLVSPEAIDFLDKLLRYDHQ 377

Query: 399 DRLTAREAMAHPYFAQVRAAESSRTRA 425
           DRLTAREAMAHPYF QVRAAESSR R 
Sbjct: 378 DRLTAREAMAHPYFFQVRAAESSRMRT 404

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	425
UNIPROTKB|Q9AR27	333	OSCKA2 "Casein kinase II alpha	0.778	0.993	0.897	3.8e-165
TAIR|locus:2045349	333	CKA3 "casein kinase II, alpha	0.778	0.993	0.870	4.1e-159
TAIR|locus:2045339	432	AT2G23070 [Arabidopsis thalian	0.778	0.766	0.812	2.6e-150
UNIPROTKB|P68399	391	CSNK2A1 "Casein kinase II subu	0.762	0.828	0.712	3.9e-131
UNIPROTKB|E2RHZ1	391	CSNK2A1 "Uncharacterized prote	0.762	0.828	0.712	3.9e-131
UNIPROTKB|E7EU96	385	CSNK2A1 "Casein kinase II subu	0.762	0.841	0.712	3.9e-131
UNIPROTKB|P68400	391	CSNK2A1 "Casein kinase II subu	0.762	0.828	0.712	3.9e-131
UNIPROTKB|F2Z5I5	391	CSNK2A1 "Uncharacterized prote	0.762	0.828	0.712	3.9e-131
MGI|MGI:88543	391	Csnk2a1 "casein kinase 2, alph	0.762	0.828	0.712	3.9e-131
RGD|621663	391	Csnk2a1 "casein kinase 2, alph	0.762	0.828	0.712	3.9e-131

UNIPROTKB|Q9AR27 OSCKA2 "Casein kinase II alpha subunit" [Oryza sativa Indica Group (taxid:39946)]

 Score = 1607 (570.8 bits), Expect = 3.8e-165, P = 3.8e-165
 Identities = 297/331 (89%), Positives = 307/331 (92%)

Query:    94 MSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERC 153
             MSKARVY DVNVLRPKEYWDYE+LTVQWG+QDDYEVVRKVGRGKYSEVFEGINVN NE+C
Sbjct:     1 MSKARVYADVNVLRPKEYWDYEALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKC 60

Query:   154 XXXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY 213
                                LQNLCGGPN+VKLLDIVRDQHSKTPSLIFEYVN+TDFKVLY
Sbjct:    61 IIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLY 120

Query:   214 PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 273
             PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG
Sbjct:   121 PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 180

Query:   274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333
             KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI
Sbjct:   181 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 240

Query:   334 AKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLL 393
             AKVLGT+ LNAYLNKYH+ELDPQL+ALVGRHSRKPWSKFINADNQHLVSPEA+DFLDKLL
Sbjct:   241 AKVLGTEALNAYLNKYHIELDPQLEALVGRHSRKPWSKFINADNQHLVSPEAVDFLDKLL 300

Query:   394 RYDHQDRLTAREAMAHPYFAQVRAAESSRTR 424
             RYDHQDRLTAREAMAHPYF QVRAAE+SR R
Sbjct:   301 RYDHQDRLTAREAMAHPYFLQVRAAENSRAR 331

GO:0009648 "photoperiodism" evidence=IGI

GO:0010229 "inflorescence development" evidence=IMP

TAIR|locus:2045349 CKA3 "casein kinase II, alpha chain 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 1550 (550.7 bits), Expect = 4.1e-159, P = 4.1e-159
 Identities = 288/331 (87%), Positives = 301/331 (90%)

Query:    94 MSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERC 153
             MSKARVYTDVNV+RPKEYWDYESL VQWG QDDYEVVRKVGRGKYSEVFEG NVNTNERC
Sbjct:     1 MSKARVYTDVNVVRPKEYWDYESLVVQWGHQDDYEVVRKVGRGKYSEVFEGKNVNTNERC 60

Query:   154 XXXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY 213
                                LQNLCGGPN+VKL DIVRD+HSKTPSL+FE+VNS DFKVLY
Sbjct:    61 VIKILKPVKKKKIKREIKILQNLCGGPNIVKLYDIVRDEHSKTPSLVFEFVNSVDFKVLY 120

Query:   214 PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 273
             PTLTDYDIRYYIYELLKALD+CHSQGIMHRDVKPHNVMIDH+LRKLRLIDWGLAEFYHPG
Sbjct:   121 PTLTDYDIRYYIYELLKALDFCHSQGIMHRDVKPHNVMIDHQLRKLRLIDWGLAEFYHPG 180

Query:   274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333
             KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI
Sbjct:   181 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 240

Query:   334 AKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLL 393
             AKVLGT+EL+ YLNKY L+LDPQL+ALVGRH  KPWSKFINADNQHLVSPEAIDFLDKLL
Sbjct:   241 AKVLGTNELDHYLNKYQLDLDPQLEALVGRHVPKPWSKFINADNQHLVSPEAIDFLDKLL 300

Query:   394 RYDHQDRLTAREAMAHPYFAQVRAAESSRTR 424
             +YDHQDRLTAREAM HPYFAQV+AAESSR R
Sbjct:   301 QYDHQDRLTAREAMDHPYFAQVKAAESSRLR 331

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0007623 "circadian rhythm" evidence=IGI

GO:0006281 "DNA repair" evidence=IDA

GO:0006325 "chromatin organization" evidence=IEP;IDA

GO:0010225 "response to UV-C" evidence=IMP

GO:0010332 "response to gamma radiation" evidence=IMP

GO:0051726 "regulation of cell cycle" evidence=IEP

GO:2001020 "regulation of response to DNA damage stimulus" evidence=IEP

GO:0009612 "response to mechanical stimulus" evidence=RCA

GO:0019722 "calcium-mediated signaling" evidence=RCA

TAIR|locus:2045339 AT2G23070 [Arabidopsis thaliana (taxid:3702)]

 Score = 1467 (521.5 bits), Expect = 2.6e-150, P = 2.6e-150
 Identities = 269/331 (81%), Positives = 293/331 (88%)

Query:    93 AMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNER 152
             A SKARVY DVNV+RPK+YWDYESL VQWG QDDYEVVRKVGRGKYSEVFEGI+   NE+
Sbjct:    98 APSKARVYADVNVVRPKDYWDYESLAVQWGVQDDYEVVRKVGRGKYSEVFEGIHATDNEK 157

Query:   153 CXXXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL 212
             C                   LQNLCGGPN+VKLLDIVRDQ SKTPSLIFE+VN+ DFKVL
Sbjct:   158 CVIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNKDFKVL 217

Query:   213 YPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 272
             YPTL+DYD+RYYI+ELLKALD+CHS+GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYHP
Sbjct:   218 YPTLSDYDVRYYIFELLKALDFCHSRGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 277

Query:   273 GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVK 332
             GKEYNVRVASRYFKGPELLVDLQDYDYSLD+WSLGCMFAGMIFRKEPFFYGHDN+DQLVK
Sbjct:   278 GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVK 337

Query:   333 IAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKL 392
             IAKVLGTDELNAYLNKY +ELDP L +LVGRHSRKPW+KFIN++NQHL  PEA+DF+DKL
Sbjct:   338 IAKVLGTDELNAYLNKYRIELDPNLTSLVGRHSRKPWTKFINSENQHLAVPEAVDFVDKL 397

Query:   393 LRYDHQDRLTAREAMAHPYFAQVRAAESSRT 423
             LRYDHQ+R TA+EAMAHPYF  +R AESSRT
Sbjct:   398 LRYDHQERPTAKEAMAHPYFYPIRNAESSRT 428

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005829 "cytosol" evidence=IDA

UNIPROTKB|P68399 CSNK2A1 "Casein kinase II subunit alpha" [Bos taurus (taxid:9913)]

 Score = 1286 (457.8 bits), Expect = 3.9e-131, P = 3.9e-131
 Identities = 231/324 (71%), Positives = 272/324 (83%)

Query:    92 PAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNE 151
             P  S+ARVYTDVN  RP+EYWDYES  V+WG+QDDY++VRK+GRGKYSEVFE IN+  NE
Sbjct:     4 PVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNE 63

Query:   152 RCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV 211
             +                    L+NL GGPN++ L DIV+D  S+TP+L+FE+VN+TDFK 
Sbjct:    64 KVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ 123

Query:   212 LYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271
             LY TLTDYDIR+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYH
Sbjct:   124 LYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 183

Query:   272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
             PG+EYNVRVASRYFKGPELLVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHDN+DQLV
Sbjct:   184 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 243

Query:   332 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDK 391
             +IAKVLGT++L  Y++KY++ELDP+ + ++GRHSRK W +F++++NQHLVSPEA+DFLDK
Sbjct:   244 RIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDK 303

Query:   392 LLRYDHQDRLTAREAMAHPYFAQV 415
             LLRYDHQ RLTAREAM HPYF  V
Sbjct:   304 LLRYDHQSRLTAREAMEHPYFYTV 327

GO:0047485 "protein N-terminus binding" evidence=ISS

GO:0030177 "positive regulation of Wnt receptor signaling pathway" evidence=ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0071174 "mitotic spindle checkpoint" evidence=ISS

GO:0043154 "negative regulation of cysteine-type endopeptidase activity involved in apoptotic process" evidence=ISS

GO:0031519 "PcG protein complex" evidence=ISS

GO:0016055 "Wnt receptor signaling pathway" evidence=IEA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=IEA

GO:0006351 "transcription, DNA-dependent" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

UNIPROTKB|E2RHZ1 CSNK2A1 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)]

 Score = 1286 (457.8 bits), Expect = 3.9e-131, P = 3.9e-131
 Identities = 231/324 (71%), Positives = 272/324 (83%)

Query:    92 PAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNE 151
             P  S+ARVYTDVN  RP+EYWDYES  V+WG+QDDY++VRK+GRGKYSEVFE IN+  NE
Sbjct:     4 PVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNE 63

Query:   152 RCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV 211
             +                    L+NL GGPN++ L DIV+D  S+TP+L+FE+VN+TDFK 
Sbjct:    64 KVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ 123

Query:   212 LYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271
             LY TLTDYDIR+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYH
Sbjct:   124 LYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 183

Query:   272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
             PG+EYNVRVASRYFKGPELLVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHDN+DQLV
Sbjct:   184 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 243

Query:   332 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDK 391
             +IAKVLGT++L  Y++KY++ELDP+ + ++GRHSRK W +F++++NQHLVSPEA+DFLDK
Sbjct:   244 RIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDK 303

Query:   392 LLRYDHQDRLTAREAMAHPYFAQV 415
             LLRYDHQ RLTAREAM HPYF  V
Sbjct:   304 LLRYDHQSRLTAREAMEHPYFYTV 327

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0071174 "mitotic spindle checkpoint" evidence=IEA

GO:0047485 "protein N-terminus binding" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=IEA

GO:0043154 "negative regulation of cysteine-type endopeptidase activity involved in apoptotic process" evidence=IEA

GO:0031519 "PcG protein complex" evidence=IEA

GO:0030177 "positive regulation of Wnt receptor signaling pathway" evidence=IEA

GO:0019888 "protein phosphatase regulator activity" evidence=IEA

GO:0016581 "NuRD complex" evidence=IEA

GO:0016580 "Sin3 complex" evidence=IEA

GO:0008013 "beta-catenin binding" evidence=IEA

UNIPROTKB|E7EU96 CSNK2A1 "Casein kinase II subunit alpha" [Homo sapiens (taxid:9606)]

 Score = 1286 (457.8 bits), Expect = 3.9e-131, P = 3.9e-131
 Identities = 231/324 (71%), Positives = 272/324 (83%)

Query:    92 PAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNE 151
             P  S+ARVYTDVN  RP+EYWDYES  V+WG+QDDY++VRK+GRGKYSEVFE IN+  NE
Sbjct:     4 PVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNE 63

Query:   152 RCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV 211
             +                    L+NL GGPN++ L DIV+D  S+TP+L+FE+VN+TDFK 
Sbjct:    64 KVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ 123

Query:   212 LYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271
             LY TLTDYDIR+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYH
Sbjct:   124 LYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 183

Query:   272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
             PG+EYNVRVASRYFKGPELLVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHDN+DQLV
Sbjct:   184 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 243

Query:   332 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDK 391
             +IAKVLGT++L  Y++KY++ELDP+ + ++GRHSRK W +F++++NQHLVSPEA+DFLDK
Sbjct:   244 RIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDK 303

Query:   392 LLRYDHQDRLTAREAMAHPYFAQV 415
             LLRYDHQ RLTAREAM HPYF  V
Sbjct:   304 LLRYDHQSRLTAREAMEHPYFYTV 327

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

UNIPROTKB|P68400 CSNK2A1 "Casein kinase II subunit alpha" [Homo sapiens (taxid:9606)]

 Score = 1286 (457.8 bits), Expect = 3.9e-131, P = 3.9e-131
 Identities = 231/324 (71%), Positives = 272/324 (83%)

Query:    92 PAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNE 151
             P  S+ARVYTDVN  RP+EYWDYES  V+WG+QDDY++VRK+GRGKYSEVFE IN+  NE
Sbjct:     4 PVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNE 63

Query:   152 RCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV 211
             +                    L+NL GGPN++ L DIV+D  S+TP+L+FE+VN+TDFK 
Sbjct:    64 KVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ 123

Query:   212 LYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271
             LY TLTDYDIR+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYH
Sbjct:   124 LYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 183

Query:   272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
             PG+EYNVRVASRYFKGPELLVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHDN+DQLV
Sbjct:   184 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 243

Query:   332 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDK 391
             +IAKVLGT++L  Y++KY++ELDP+ + ++GRHSRK W +F++++NQHLVSPEA+DFLDK
Sbjct:   244 RIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDK 303

Query:   392 LLRYDHQDRLTAREAMAHPYFAQV 415
             LLRYDHQ RLTAREAM HPYF  V
Sbjct:   304 LLRYDHQSRLTAREAMEHPYFYTV 327

GO:0005524 "ATP binding" evidence=IEA

GO:0006351 "transcription, DNA-dependent" evidence=IEA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=IEA

GO:0016055 "Wnt receptor signaling pathway" evidence=IEA

GO:0008013 "beta-catenin binding" evidence=IEA

GO:0019888 "protein phosphatase regulator activity" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IDA;TAS

GO:0047485 "protein N-terminus binding" evidence=IPI

GO:0005515 "protein binding" evidence=IPI

GO:0045732 "positive regulation of protein catabolic process" evidence=IDA

GO:0006468 "protein phosphorylation" evidence=IDA

GO:0030307 "positive regulation of cell growth" evidence=IDA

GO:0008284 "positive regulation of cell proliferation" evidence=IDA

GO:0031519 "PcG protein complex" evidence=IDA

GO:0071174 "mitotic spindle checkpoint" evidence=IMP

GO:0043154 "negative regulation of cysteine-type endopeptidase activity involved in apoptotic process" evidence=IMP

GO:0030177 "positive regulation of Wnt receptor signaling pathway" evidence=IMP

GO:0051879 "Hsp90 protein binding" evidence=TAS

GO:0061077 "chaperone-mediated protein folding" evidence=TAS

GO:0005634 "nucleus" evidence=IDA

GO:0005886 "plasma membrane" evidence=TAS

GO:0007165 "signal transduction" evidence=TAS

GO:0005829 "cytosol" evidence=TAS

GO:0007411 "axon guidance" evidence=TAS

GO:0016581 "NuRD complex" evidence=IDA

GO:0016580 "Sin3 complex" evidence=IDA

UNIPROTKB|F2Z5I5 CSNK2A1 "Uncharacterized protein" [Sus scrofa (taxid:9823)]

 Score = 1286 (457.8 bits), Expect = 3.9e-131, P = 3.9e-131
 Identities = 231/324 (71%), Positives = 272/324 (83%)

Query:    92 PAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNE 151
             P  S+ARVYTDVN  RP+EYWDYES  V+WG+QDDY++VRK+GRGKYSEVFE IN+  NE
Sbjct:     4 PVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNE 63

Query:   152 RCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV 211
             +                    L+NL GGPN++ L DIV+D  S+TP+L+FE+VN+TDFK 
Sbjct:    64 KVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ 123

Query:   212 LYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271
             LY TLTDYDIR+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYH
Sbjct:   124 LYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 183

Query:   272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
             PG+EYNVRVASRYFKGPELLVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHDN+DQLV
Sbjct:   184 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 243

Query:   332 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDK 391
             +IAKVLGT++L  Y++KY++ELDP+ + ++GRHSRK W +F++++NQHLVSPEA+DFLDK
Sbjct:   244 RIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDK 303

Query:   392 LLRYDHQDRLTAREAMAHPYFAQV 415
             LLRYDHQ RLTAREAM HPYF  V
Sbjct:   304 LLRYDHQSRLTAREAMEHPYFYTV 327

GO:0071174 "mitotic spindle checkpoint" evidence=IEA

GO:0047485 "protein N-terminus binding" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=IEA

GO:0043154 "negative regulation of cysteine-type endopeptidase activity involved in apoptotic process" evidence=IEA

GO:0031519 "PcG protein complex" evidence=IEA

GO:0030177 "positive regulation of Wnt receptor signaling pathway" evidence=IEA

GO:0019888 "protein phosphatase regulator activity" evidence=IEA

GO:0016581 "NuRD complex" evidence=IEA

GO:0016580 "Sin3 complex" evidence=IEA

GO:0008013 "beta-catenin binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

MGI|MGI:88543 Csnk2a1 "casein kinase 2, alpha 1 polypeptide" [Mus musculus (taxid:10090)]

 Score = 1286 (457.8 bits), Expect = 3.9e-131, P = 3.9e-131
 Identities = 231/324 (71%), Positives = 272/324 (83%)

Query:    92 PAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNE 151
             P  S+ARVYTDVN  RP+EYWDYES  V+WG+QDDY++VRK+GRGKYSEVFE IN+  NE
Sbjct:     4 PVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNE 63

Query:   152 RCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV 211
             +                    L+NL GGPN++ L DIV+D  S+TP+L+FE+VN+TDFK 
Sbjct:    64 KVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ 123

Query:   212 LYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271
             LY TLTDYDIR+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYH
Sbjct:   124 LYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 183

Query:   272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
             PG+EYNVRVASRYFKGPELLVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHDN+DQLV
Sbjct:   184 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 243

Query:   332 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDK 391
             +IAKVLGT++L  Y++KY++ELDP+ + ++GRHSRK W +F++++NQHLVSPEA+DFLDK
Sbjct:   244 RIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDK 303

Query:   392 LLRYDHQDRLTAREAMAHPYFAQV 415
             LLRYDHQ RLTAREAM HPYF  V
Sbjct:   304 LLRYDHQSRLTAREAMEHPYFYTV 327

GO:0000166 "nucleotide binding" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISO

GO:0005515 "protein binding" evidence=IPI

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISO

GO:0005956 "protein kinase CK2 complex" evidence=TAS

GO:0006351 "transcription, DNA-dependent" evidence=IEA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;ISO;IDA

GO:0006915 "apoptotic process" evidence=IEA

GO:0007049 "cell cycle" evidence=IEA

GO:0008013 "beta-catenin binding" evidence=IDA

GO:0008284 "positive regulation of cell proliferation" evidence=ISO

GO:0016055 "Wnt receptor signaling pathway" evidence=IEA

GO:0016301 "kinase activity" evidence=IDA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016580 "Sin3 complex" evidence=ISO

GO:0016581 "NuRD complex" evidence=ISO

GO:0016740 "transferase activity" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0019888 "protein phosphatase regulator activity" evidence=IDA

GO:0030177 "positive regulation of Wnt receptor signaling pathway" evidence=ISO

GO:0030307 "positive regulation of cell growth" evidence=ISO

GO:0043154 "negative regulation of cysteine-type endopeptidase activity involved in apoptotic process" evidence=ISO

GO:0045732 "positive regulation of protein catabolic process" evidence=ISO

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0047485 "protein N-terminus binding" evidence=ISO

GO:0050790 "regulation of catalytic activity" evidence=IDA

GO:0071174 "mitotic spindle checkpoint" evidence=ISO

RGD|621663 Csnk2a1 "casein kinase 2, alpha 1 polypeptide" [Rattus norvegicus (taxid:10116)]

 Score = 1286 (457.8 bits), Expect = 3.9e-131, P = 3.9e-131
 Identities = 231/324 (71%), Positives = 272/324 (83%)

Query:    92 PAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNE 151
             P  S+ARVYTDVN  RP+EYWDYES  V+WG+QDDY++VRK+GRGKYSEVFE IN+  NE
Sbjct:     4 PVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNE 63

Query:   152 RCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV 211
             +                    L+NL GGPN++ L DIV+D  S+TP+L+FE+VN+TDFK 
Sbjct:    64 KVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ 123

Query:   212 LYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271
             LY TLTDYDIR+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYH
Sbjct:   124 LYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 183

Query:   272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
             PG+EYNVRVASRYFKGPELLVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHDN+DQLV
Sbjct:   184 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 243

Query:   332 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDK 391
             +IAKVLGT++L  Y++KY++ELDP+ + ++GRHSRK W +F++++NQHLVSPEA+DFLDK
Sbjct:   244 RIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDK 303

Query:   392 LLRYDHQDRLTAREAMAHPYFAQV 415
             LLRYDHQ RLTAREAM HPYF  V
Sbjct:   304 LLRYDHQSRLTAREAMEHPYFYTV 327

GO:0001558 "regulation of cell growth" evidence=NAS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISO;ISS

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISO

GO:0005956 "protein kinase CK2 complex" evidence=TAS

GO:0006351 "transcription, DNA-dependent" evidence=IEA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=ISO

GO:0008013 "beta-catenin binding" evidence=IEA;ISO

GO:0008284 "positive regulation of cell proliferation" evidence=ISO

GO:0016055 "Wnt receptor signaling pathway" evidence=IEA

GO:0016301 "kinase activity" evidence=ISO

GO:0016580 "Sin3 complex" evidence=IEA;ISO

GO:0016581 "NuRD complex" evidence=IEA;ISO

GO:0019888 "protein phosphatase regulator activity" evidence=IEA;ISO

GO:0030177 "positive regulation of Wnt receptor signaling pathway" evidence=ISO;ISS

GO:0030307 "positive regulation of cell growth" evidence=ISO

GO:0031519 "PcG protein complex" evidence=ISO;ISS

GO:0042127 "regulation of cell proliferation" evidence=NAS

GO:0043154 "negative regulation of cysteine-type endopeptidase activity involved in apoptotic process" evidence=ISO;ISS

GO:0045732 "positive regulation of protein catabolic process" evidence=ISO

GO:0046777 "protein autophosphorylation" evidence=IEA;ISO

GO:0047485 "protein N-terminus binding" evidence=IEA;ISO

GO:0050790 "regulation of catalytic activity" evidence=ISO

GO:0071174 "mitotic spindle checkpoint" evidence=ISO;ISS

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
P19454	CSK22_YEAST	2, ., 7, ., 1, 1, ., 1	0.6206	0.7458	0.9351	yes	no
O64817	CSK23_ARATH	2, ., 7, ., 1, 1, ., 1	0.9216	0.7811	0.9969	no	no
P21868	CSK21_CHICK	2, ., 7, ., 1, 1, ., 1	0.7694	0.7552	0.8209	yes	no
Q8TG13	CSK2A_NEUCR	2, ., 7, ., 1, 1, ., 1	0.7621	0.7694	0.9732	N/A	no
P68399	CSK21_BOVIN	2, ., 7, ., 1, 1, ., 1	0.7492	0.7764	0.8439	yes	no
P28523	CSK2A_MAIZE	2, ., 7, ., 1, 1, ., 1	0.9427	0.7811	1.0	N/A	no
P18334	CSK2A_CAEEL	2, ., 7, ., 1, 1, ., 1	0.7220	0.7741	0.9138	yes	no
P08181	CSK2A_DROME	2, ., 7, ., 1, 1, ., 1	0.7767	0.7482	0.9464	yes	no
P19139	CSK21_RAT	2, ., 7, ., 1, 1, ., 1	0.7455	0.7858	0.8542	yes	no
O76484	CSK2A_SPOFR	2, ., 7, ., 1, 1, ., 1	0.7610	0.7482	0.9008	N/A	no
P28547	CSK2A_THEPA	2, ., 7, ., 1, 1, ., 1	0.6865	0.7505	0.9166	yes	no
P68400	CSK21_HUMAN	2, ., 7, ., 1, 1, ., 1	0.7492	0.7764	0.8439	yes	no
P40231	CSK2A_SCHPO	2, ., 7, ., 1, 1, ., 1	0.7102	0.7552	0.9668	yes	no
Q02720	CSK2A_DICDI	2, ., 7, ., 1, 1, ., 1	0.7264	0.7482	0.9436	yes	no
P33674	CSK21_RABIT	2, ., 7, ., 1, 1, ., 1	0.7462	0.7764	0.8439	yes	no
P28020	CSK21_XENLA	2, ., 7, ., 1, 1, ., 1	0.7507	0.7741	0.8392	N/A	no
Q60737	CSK21_MOUSE	2, ., 7, ., 1, 1, ., 1	0.7654	0.7623	0.8286	yes	no
Q08467	CSK21_ARATH	2, ., 7, ., 1, 1, ., 1	0.8435	0.8752	0.9095	yes	no
Q08466	CSK22_ARATH	2, ., 7, ., 1, 1, ., 1	0.8406	0.8847	0.9330	no	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.979
3rd Layer	2.7.11	0.983

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	425
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	5e-73
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	5e-72
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	6e-66
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	5e-63
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	7e-62
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	3e-57
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	3e-57
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	6e-57
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	9e-56
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	2e-49
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	6e-49
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-48
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	2e-48
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	3e-47
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	3e-47
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	4e-47
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	3e-46
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	1e-45
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-45
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	6e-45
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	7e-45
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	8e-45
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	1e-43
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	2e-43
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	4e-43
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	5e-43
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	1e-42
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	2e-42
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	4e-42
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	4e-42
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	4e-42
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	6e-42
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	2e-41
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	3e-40
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	1e-39
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	3e-39
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	1e-38
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	2e-38
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	8e-38
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	1e-37
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	2e-35
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	4e-35
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	5e-35
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	2e-34
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	9e-34
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	2e-33
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	4e-33
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	1e-32
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	2e-32
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	2e-32
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	5e-32
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	2e-31
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	3e-31
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	7e-31
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	4e-30
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	5e-30
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	1e-29
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	5e-29
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	2e-28
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	1e-27
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	3e-27
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	2e-25
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	3e-25
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	3e-25
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	3e-24
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	7e-24
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	1e-23
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	5e-23
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	9e-23
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	9e-23
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	2e-22
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	2e-22
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	1e-21
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	1e-21
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	2e-21
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	2e-21
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-21
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	2e-19
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	8e-19
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	6e-18
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	1e-17
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	1e-17
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	2e-17
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	3e-17
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	4e-17
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	5e-17
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	7e-17
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	7e-17
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	8e-17
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	2e-16
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	2e-16
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	2e-16
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	3e-16
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	4e-16
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	7e-16
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	1e-15
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	1e-15
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	2e-15
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	3e-15
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	3e-15
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	3e-15
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	3e-15
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	9e-15
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	2e-14
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	3e-14
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	3e-14
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	4e-14
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	4e-14
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	4e-14
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	4e-14
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	5e-14
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	5e-14
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	6e-14
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	9e-14
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	1e-13
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	1e-13
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-13
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	2e-13
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-13
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	2e-13
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	3e-13
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	3e-13
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	3e-13
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	4e-13
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	4e-13
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	5e-13
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	7e-13
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	8e-13
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	1e-12
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	2e-12
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	3e-12
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	3e-12
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	5e-12
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	6e-12
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	8e-12
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	1e-11
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	1e-11
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	1e-11
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	1e-11
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	2e-11
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	2e-11
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	2e-11
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	2e-11
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	2e-11
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	3e-11
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	3e-11
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	4e-11
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	5e-11
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	5e-11
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	6e-11
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	6e-11
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	9e-11
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	9e-11
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	1e-10
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	1e-10
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	1e-10
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	1e-10
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	1e-10
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	1e-10
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	2e-10
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	2e-10
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	2e-10
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	3e-10
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	3e-10
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	4e-10
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	4e-10
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	5e-10
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	5e-10
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	6e-10
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	8e-10
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	8e-10
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	8e-10
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	1e-09
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	1e-09
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	1e-09
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	1e-09
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	1e-09
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	2e-09
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	3e-09
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	3e-09
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	4e-09
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	5e-09
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	6e-09
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	9e-09
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	9e-09
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	1e-08
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	1e-08
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	1e-08
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	1e-08
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	1e-08
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	1e-08
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	2e-08
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	2e-08
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	3e-08
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	4e-08
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	7e-08
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	8e-08
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	8e-08
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	9e-08
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	1e-07
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	2e-07
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-07
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	2e-07
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	3e-07
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	8e-07
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	9e-07
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	1e-06
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	2e-06
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	2e-06
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	2e-06
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	3e-06
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	3e-06
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	3e-06
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	4e-06
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	5e-06
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	5e-06
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	6e-06
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	7e-06
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	1e-05
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	2e-05
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	2e-05
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	3e-05
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	4e-05
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	4e-05
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	5e-05
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	9e-05
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	9e-05
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	2e-04
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	2e-04
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	2e-04
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	3e-04
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	3e-04
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	3e-04
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	3e-04
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	3e-04
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	3e-04
PRK09605	535	PRK09605, PRK09605, bifunctional UGMP family prote	3e-04
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	4e-04
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	5e-04
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	6e-04
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	9e-04
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	9e-04
pfam01636	238	pfam01636, APH, Phosphotransferase enzyme family	0.001
PRK14879	211	PRK14879, PRK14879, serine/threonine protein kinas	0.001
TIGR03724	199	TIGR03724, arch_bud32, Kae1-associated kinase Bud3	0.002
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	0.002
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	0.003
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	0.003
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	0.003
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	0.004
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	0.004

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  229 bits (585), Expect = 5e-73
 Identities = 86/295 (29%), Positives = 136/295 (46%), Gaps = 44/295 (14%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK-----REIKILQNLCGGPN 181
           YE++RK+G G +  V++  +  T +   +KILK   +K  K     REI+IL+ L   PN
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRL-SHPN 59

Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTDFK---VLYPTLTDYDIRYYIYELLKALDYCHSQ 238
           +V+L+D   D       L+ EY    D          L++ + +    ++L+ L+Y HS 
Sbjct: 60  IVRLIDAFED--KDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSN 117

Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQDY 297
           GI+HRD+KP N+++D     +++ D+GLA+            V + ++  PE+L+    Y
Sbjct: 118 GIIHRDLKPENILLDENGV-VKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGY 176

Query: 298 DYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQL 357
              +D+WSLG +   ++  K PF  G +  DQL  I ++LG            LE D   
Sbjct: 177 GPKVDVWSLGVILYELLTGKPPF-SGENILDQLQLIRRILGPP----------LEFDEPK 225

Query: 358 DALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 412
                                   S EA D + K L  D   R TA E + HP+F
Sbjct: 226 W--------------------SSGSEEAKDLIKKCLNKDPSKRPTAEEILQHPWF 260

Length = 260

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  226 bits (579), Expect = 5e-72
 Identities = 94/293 (32%), Positives = 151/293 (51%), Gaps = 46/293 (15%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK----IKREIKILQNLCGGPNV 182
           YE++ K+G G + +V+   +  T +   IK++K  K KK    I REIKIL+ L   PN+
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKL-KHPNI 59

Query: 183 VKLLDIVRDQHSKTPSLIFEYVNSTD-FKVL--YPTLTDYDIRYYIYELLKALDYCHSQG 239
           V+L D+  D+      L+ EY    D F +L     L++ + R+Y+ ++L AL+Y HS+G
Sbjct: 60  VRLYDVFEDEDK--LYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKG 117

Query: 240 IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDY 299
           I+HRD+KP N+++D +   ++L D+GLA    PG++    V +  +  PE+L+  + Y  
Sbjct: 118 IVHRDLKPENILLDED-GHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLG-KGYGK 175

Query: 300 SLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDA 359
           ++D+WSLG +   ++  K P F G D   +L K                           
Sbjct: 176 AVDIWSLGVILYELLTGK-PPFPGDDQLLELFKK-------------------------- 208

Query: 360 LVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 412
            +G+          +      +SPEA D + KLL  D + RLTA EA+ HP+F
Sbjct: 209 -IGKPKPPFPPPEWD------ISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  211 bits (540), Expect = 6e-66
 Identities = 101/296 (34%), Positives = 161/296 (54%), Gaps = 24/296 (8%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK-IK----REIKILQNLCGGPN 181
           YE + K+G G Y  V++  +  T E   +K ++   +++ I     REI +L+ L   PN
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKEL-KHPN 59

Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL----YPTLTDYDIRYYIYELLKALDYCHS 237
           +VKLLD++     +   L+FEY +  D K         L+   I+  +Y+LL+ L YCHS
Sbjct: 60  IVKLLDVIH--TERKLYLVFEYCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHS 116

Query: 238 QGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQD 296
             I+HRD+KP N++I+ +   L+L D+GLA  F  P + Y   V + +++ PE+L+  + 
Sbjct: 117 HRILHRDLKPQNILINRD-GVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSKH 175

Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ 356
           Y  ++D+WS+GC+FA MI   +P F G    DQL KI ++LGT    ++     L   P 
Sbjct: 176 YSTAVDIWSVGCIFAEMI-TGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKL---PD 231

Query: 357 LDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 412
                 +   K   K +       + PE ID L K+L+Y+   R++A+EA+ HPYF
Sbjct: 232 YKPTFPKFPPKDLEKVLPR-----LDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  205 bits (525), Expect = 5e-63
 Identities = 112/315 (35%), Positives = 177/315 (56%), Gaps = 45/315 (14%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIK-ILKPVKK----KKIKREIKILQNLCGGPN 181
           YE+++ +G G Y  V   ++  T  +  IK I          K+I REIK+L++L    N
Sbjct: 2   YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHL-RHEN 60

Query: 182 VVKLLDIVRDQHSKTPS---LIFEYVNSTDF-KVLY--PTLTDYDIRYYIYELLKALDYC 235
           ++ LLDI+R    +  +   ++ E +  TD  KV+     LTD  I+Y++Y++L+ L Y 
Sbjct: 61  IIGLLDILRPPSPEDFNDVYIVTELM-ETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYL 119

Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-----EFYHPGK--EYNVRVASRYFKGP 288
           HS  ++HRD+KP N++++     L++ D+GLA     +    G   EY   V +R+++ P
Sbjct: 120 HSANVIHRDLKPSNILVNSNC-DLKICDFGLARGVDPDEDEKGFLTEY---VVTRWYRAP 175

Query: 289 ELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT---DELNAY 345
           ELL+    Y  ++D+WS+GC+FA ++ RK P F G D  DQL  I +VLGT   ++L   
Sbjct: 176 ELLLSSSRYTKAIDIWSVGCIFAELLTRK-PLFPGRDYIDQLNLIVEVLGTPSEEDLKFI 234

Query: 346 LN---KYHLELDPQLDALVGRHSRKPWSK-FINADNQHLVSPEAIDFLDKLLRYDHQDRL 401
            +   + +L+  P+         +KP SK F  A      SPEAID L+K+L +D + R+
Sbjct: 235 TSEKARNYLKSLPK-------KPKKPLSKLFPGA------SPEAIDLLEKMLVFDPKKRI 281

Query: 402 TAREAMAHPYFAQVR 416
           TA EA+AHPY AQ+ 
Sbjct: 282 TADEALAHPYLAQLH 296

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  201 bits (513), Expect = 7e-62
 Identities = 96/301 (31%), Positives = 158/301 (52%), Gaps = 29/301 (9%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK-----IKREIKILQNLCGGPN 181
           YE + ++G G Y +V++  N  T E   +K ++   +K+       REIK+LQ L   PN
Sbjct: 1   YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRH-PN 59

Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL----YPTLTDYDIRYYIYELLKALDYCHS 237
           +V+L +IV  +   +  ++FEY+   D   L        T+  I+ Y+ +LL+ L Y HS
Sbjct: 60  IVRLKEIVTSKGKGSIYMVFEYM-DHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHS 118

Query: 238 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP--GKEYNVRVASRYFKGPELLVDLQ 295
            GI+HRD+K  N++I+++   L+L D+GLA  Y      +Y  RV + +++ PELL+   
Sbjct: 119 NGILHRDIKGSNILINNDGV-LKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGAT 177

Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP 355
            Y   +DMWS+GC+ A + F  +P F G    +QL KI ++ G+     +         P
Sbjct: 178 RYGPEVDMWSVGCILAEL-FLGKPIFQGSTELEQLEKIFELCGSPTDENW---------P 227

Query: 356 QLDALVG----RHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 411
            +  L      +  +    +      +HL+ P A+D LDKLL  D + R++A +A+ H Y
Sbjct: 228 GVSKLPWFENLKPKKPYKRRLREFF-KHLIDPSALDLLDKLLTLDPKKRISADQALQHEY 286

Query: 412 F 412
           F
Sbjct: 287 F 287

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  189 bits (482), Expect = 3e-57
 Identities = 104/300 (34%), Positives = 163/300 (54%), Gaps = 31/300 (10%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-----PVKKKKIKREIKILQNLCGGPN 181
           Y+ + K+G G Y  V++  +  T E   IK +K         K   REIK+L+ L   PN
Sbjct: 1   YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKEL-NHPN 59

Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL----YPTLTDYDIRYYIYELLKALDYCHS 237
           ++KLLD+ R +      L+FE++++  +K++       L +  I+ Y+Y+LL+ L +CHS
Sbjct: 60  IIKLLDVFRHK--GDLYLVFEFMDTDLYKLIKDRQRG-LPESLIKSYLYQLLQGLAFCHS 116

Query: 238 QGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQD 296
            GI+HRD+KP N++I+ E   L+L D+GLA  F  P + Y   V +R+++ PELL+  + 
Sbjct: 117 HGILHRDLKPENLLINTE-GVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKG 175

Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL-ELDP 355
           Y   +D+WS+GC+FA ++ R+ P F G    DQL KI + LGT       +     +   
Sbjct: 176 YSTPVDIWSVGCIFAELLSRR-PLFPGKSEIDQLFKIFRTLGT------PDPEVWPKFTS 228

Query: 356 QLDALVGRHSRK---PWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 412
                     +K   P  K          SP+A+D L ++L YD   R+TA +A+AHPYF
Sbjct: 229 LARNYKFSFPKKAGMPLPKLFPN-----ASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  189 bits (482), Expect = 3e-57
 Identities = 104/304 (34%), Positives = 144/304 (47%), Gaps = 36/304 (11%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-----PVKKKKIKREIKILQNLCGGPN 181
           YEV+  VG G Y  V +  N  T E   IK  K        KK   RE+K+L+ L    N
Sbjct: 3   YEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQL-RHEN 61

Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL--YPTLTDYD-IRYYIYELLKALDYCHSQ 238
           +V L +  R        L+FEYV  T  ++L   P     D +R YI++LL+A+ YCHS 
Sbjct: 62  IVNLKEAFR--RKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSH 119

Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH--PGKEYNVRVASRYFKGPELLVDLQD 296
            I+HRD+KP N+++      L+L D+G A      P       VA+R+++ PELLV   +
Sbjct: 120 NIIHRDIKPENILVSES-GVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTN 178

Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ 356
           Y   +D+W++GC+ A ++   EP F G  + DQL  I K LG              L P 
Sbjct: 179 YGKPVDVWAIGCIMAELL-DGEPLFPGDSDIDQLYLIQKCLGP-------------LPPS 224

Query: 357 LDALVGRHSRKPWSKFINADNQH--------LVSPEAIDFLDKLLRYDHQDRLTAREAMA 408
              L   + R     F                VS  A+DFL   LR D ++RLT  E + 
Sbjct: 225 HQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284

Query: 409 HPYF 412
           HPYF
Sbjct: 285 HPYF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  188 bits (480), Expect = 6e-57
 Identities = 100/299 (33%), Positives = 155/299 (51%), Gaps = 26/299 (8%)

Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIK-ILKPVKKKKIK----REIKILQNLCGGP 180
            Y+++ ++G G +  VF+  +  T E   +K +     +  I     REIK LQ  C  P
Sbjct: 1   RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQA-CQHP 59

Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL----YPTLTDYDIRYYIYELLKALDYCH 236
            VVKLLD+    H     L+ EY+ S   +VL     P L +  ++ Y+  LLK + Y H
Sbjct: 60  YVVKLLDVFP--HGSGFVLVMEYMPSDLSEVLRDEERP-LPEAQVKSYMRMLLKGVAYMH 116

Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE--YNVRVASRYFKGPELLVDL 294
           + GIMHRD+KP N++I      L++ D+GLA  +   +   Y+ +VA+R+++ PELL   
Sbjct: 117 ANGIMHRDLKPANLLIS-ADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGA 175

Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 354
           + YD  +D+W++GC+FA ++    P F G ++ +QL  + + LGT     +     L   
Sbjct: 176 RKYDPGVDLWAVGCIFAELL-NGSPLFPGENDIEQLAIVFRTLGTPNEETWPG---LTSL 231

Query: 355 PQLDALVGRHS-RKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 412
           P  + +    S   P  +          SPEA+D L  LL YD   RL+A EA+ HPYF
Sbjct: 232 PDYNKITFPESKPIPLEEIFPD-----ASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  185 bits (473), Expect = 9e-56
 Identities = 102/305 (33%), Positives = 162/305 (53%), Gaps = 38/305 (12%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK--------REIKILQNLCG 178
           YE  +K+G G Y+ V++  +  T     IK +K  ++K+ K        REIK+LQ L  
Sbjct: 2   YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQEL-K 60

Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDY 234
            PN++ LLD+    H    +L+FE++  TD + +       LT  DI+ Y+   L+ L+Y
Sbjct: 61  HPNIIGLLDVF--GHKSNINLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEY 117

Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY-HPGKEYNVRVASRYFKGPELLVD 293
            HS  I+HRD+KP+N++I  +   L+L D+GLA  +  P ++   +V +R+++ PELL  
Sbjct: 118 LHSNWILHRDLKPNNLLIASD-GVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFG 176

Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELN----AYLNKY 349
            + Y   +DMWS+GC+FA ++ R  PF  G  + DQL KI + LGT              
Sbjct: 177 ARHYGVGVDMWSVGCIFAELLLRV-PFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPD 235

Query: 350 HLELDPQLDALVGRHSRKPWSK-FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 408
           ++E  P            P  + F  A +      +A+D L +LL  +   R+TAR+A+ 
Sbjct: 236 YVEFKPF--------PPTPLKQIFPAASD------DALDLLQRLLTLNPNKRITARQALE 281

Query: 409 HPYFA 413
           HPYF+
Sbjct: 282 HPYFS 286

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score =  170 bits (433), Expect = 2e-49
 Identities = 105/311 (33%), Positives = 164/311 (52%), Gaps = 42/311 (13%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKI-------------KREIKIL 173
           YE+++K+G+G Y  V++ I+  T E         V  KKI              REI  L
Sbjct: 9   YEILQKLGKGAYGIVWKAIDRRTKEV--------VALKKIFDAFRNATDAQRTFREIMFL 60

Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPT-LTDYDIRYYIYELLKAL 232
           Q L   PN+VKLL++++ ++ K   L+FEY+ +    V+    L D   RY +Y+LLKAL
Sbjct: 61  QELGDHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANILEDVHKRYIMYQLLKAL 120

Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR------VASRYFK 286
            Y HS  ++HRD+KP N++++ + R ++L D+GLA      +E          VA+R+++
Sbjct: 121 KYIHSGNVIHRDLKPSNILLNSDCR-VKLADFGLARSLSELEENPENPVLTDYVATRWYR 179

Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLG---TDELN 343
            PE+L+    Y   +DMWS+GC+   M+  K P F G    +QL KI +V+G    +++ 
Sbjct: 180 APEILLGSTRYTKGVDMWSVGCILGEMLLGK-PLFPGTSTLNQLEKIIEVIGPPSAEDIE 238

Query: 344 AYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA 403
           +  + +       LD+L  R  +        A      S +A+D L KLL ++   RLTA
Sbjct: 239 SIKSPF---AATMLDSLPSRPRKPLDELLPKA------SDDALDLLKKLLVFNPNKRLTA 289

Query: 404 REAMAHPYFAQ 414
            EA+ HPY AQ
Sbjct: 290 EEALEHPYVAQ 300

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score =  168 bits (426), Expect = 6e-49
 Identities = 103/317 (32%), Positives = 162/317 (51%), Gaps = 52/317 (16%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK-----------REIKIL 173
           D YE + K+G G Y +V++  + NT +      L  +KK +++           REI +L
Sbjct: 1   DAYEKLEKIGEGTYGKVYKARDKNTGK------LVALKKTRLEMDEEGIPPTALREISLL 54

Query: 174 QNLCGGPNVVKLLDIVR-DQHSKTPSL--IFEYVNSTDFKVLYPT--------LTDYDIR 222
           Q L     +V+LLD+   ++ +  PSL  +FEY+  +D K    +        L    I+
Sbjct: 55  QMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIK 113

Query: 223 YYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVA 281
            ++Y+LLK + +CH  G+MHRD+KP N+++D +   L++ D GL   F  P K Y   + 
Sbjct: 114 SFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV 173

Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDE 341
           + +++ PE+L+    Y   +D+WS+GC+FA M  RK+P F G     QL+ I K+LGT  
Sbjct: 174 TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMS-RKQPLFPGDSELQQLLHIFKLLGT-- 230

Query: 342 LNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHL------VSPEAIDFLDKLLRY 395
                        P      G    + W +F     Q L      +SPE +D L K+LRY
Sbjct: 231 -------------PTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRY 277

Query: 396 DHQDRLTAREAMAHPYF 412
           D   R++A+ A+ HPYF
Sbjct: 278 DPAKRISAKAALTHPYF 294

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score =  167 bits (424), Expect = 1e-48
 Identities = 100/305 (32%), Positives = 160/305 (52%), Gaps = 41/305 (13%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK-------------REIKIL 173
           Y+ V K+G G Y  V++  +  T E         V  KKI+             REI +L
Sbjct: 1   YQKVEKIGEGTYGVVYKARDKLTGEI--------VALKKIRLETEDEGVPSTAIREISLL 52

Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFK-----VLYPTLTDYDIRYYIYEL 228
           + L   PN+V+LLD+V  ++     L+FE+++  D K          L    I+ Y+Y+L
Sbjct: 53  KEL-NHPNIVRLLDVVHSENKLY--LVFEFLDL-DLKKYMDSSPLTGLDPPLIKSYLYQL 108

Query: 229 LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKG 287
           L+ + YCHS  ++HRD+KP N++ID E   L+L D+GLA  F  P + Y   V + +++ 
Sbjct: 109 LQGIAYCHSHRVLHRDLKPQNLLIDRE-GALKLADFGLARAFGVPVRTYTHEVVTLWYRA 167

Query: 288 PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLN 347
           PE+L+  + Y   +D+WS+GC+FA M+ R+ P F G    DQL +I + LGT + + +  
Sbjct: 168 PEILLGSRQYSTPVDIWSIGCIFAEMVNRR-PLFPGDSEIDQLFRIFRTLGTPDEDVWPG 226

Query: 348 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
              L   P       + +R+  SK +       +  + +D L K+L YD   R++A+ A+
Sbjct: 227 VTSL---PDYKPTFPKWARQDLSKVVPN-----LDEDGLDLLSKMLVYDPAKRISAKAAL 278

Query: 408 AHPYF 412
            HPYF
Sbjct: 279 QHPYF 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  166 bits (422), Expect = 2e-48
 Identities = 96/305 (31%), Positives = 149/305 (48%), Gaps = 41/305 (13%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK--------REIKILQNLCG 178
           Y+V++++G G +  V+   N  T E   IK +K    KK          RE+K L+ L  
Sbjct: 1   YKVIKQLGDGTFGSVYLARNKETGELVAIKKMK----KKFYSWEECMNLREVKSLRKLNE 56

Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD--------IRYYIYELLK 230
            PN+VKL ++ R+  +     +FEY+       LY  + D          IR  IY++L+
Sbjct: 57  HPNIVKLKEVFRE--NDELYFVFEYMEGN----LYQLMKDRKGKPFSESVIRSIIYQILQ 110

Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 290
            L + H  G  HRD+KP N+++      +++ D+GLA        Y   V++R+++ PE+
Sbjct: 111 GLAHIHKHGFFHRDLKPENLLVS-GPEVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEI 169

Query: 291 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH 350
           L+    Y   +D+W+LGC+ A + +   P F G    DQL KI  VLGT     +   Y 
Sbjct: 170 LLRSTSYSSPVDIWALGCIMAEL-YTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYK 228

Query: 351 L--ELDPQLDALVGRHSRKPWSKFI-NADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
           L  +L  +              + I NA      SPEAID +  +LR+D + R TA +A+
Sbjct: 229 LASKLGFRFPQFAP----TSLHQLIPNA------SPEAIDLIKDMLRWDPKKRPTASQAL 278

Query: 408 AHPYF 412
            HPYF
Sbjct: 279 QHPYF 283

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score =  164 bits (418), Expect = 3e-47
 Identities = 97/316 (30%), Positives = 168/316 (53%), Gaps = 29/316 (9%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL-----KPVKKKKIKREIKILQNLCGG 179
             Y+ +  +G G Y  V   I+  + ++  IK +      P   K+  RE+KIL++    
Sbjct: 5   SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHF-KH 63

Query: 180 PNVVKLLDIVR--DQHSKTPSLIFEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYC 235
            N++ + DI+R      K   ++ + + S    +++    LT+  IRY++Y+LL+ L Y 
Sbjct: 64  DNIIAIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYI 123

Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY------HPG--KEYNVRVASRYFKG 287
           HS  ++HRD+KP N++++ +  +LR+ D+G+A         H     EY   VA+R+++ 
Sbjct: 124 HSANVIHRDLKPSNLLVNEDC-ELRIGDFGMARGLSSSPTEHKYFMTEY---VATRWYRA 179

Query: 288 PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLN 347
           PELL+ L +Y  ++DMWS+GC+FA M+ R++  F G +   QL  I  VLG+      LN
Sbjct: 180 PELLLSLPEYTTAIDMWSVGCIFAEMLGRRQ-LFPGKNYVHQLKLILSVLGSPS-EEVLN 237

Query: 348 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
           +   +   +    + R    PWSK          SPEA+D L ++L++D ++R+T  +A+
Sbjct: 238 RIGSDRVRKYIQNLPRKQPVPWSKIFPK-----ASPEALDLLSQMLQFDPEERITVEQAL 292

Query: 408 AHPYFAQVRAAESSRT 423
            HP+ AQ    +   T
Sbjct: 293 QHPFLAQYHDPDDEPT 308

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score =  164 bits (417), Expect = 3e-47
 Identities = 98/310 (31%), Positives = 164/310 (52%), Gaps = 32/310 (10%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTN--ERCIIKILKPVKKKKIK-----REIKILQNLCGG 179
           YE+++++G+G Y  V    N  T+  E   IK +  V  KKI      RE+K+L++  G 
Sbjct: 2   YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGH 61

Query: 180 PNVVKL--LDIVRDQHSKTPSLIFEYVNSTDFKVLYPT--LTDYDIRYYIYELLKALDYC 235
            N+  L  +DIV   +     L  E + +   +++     LTD   + +IY++L  L Y 
Sbjct: 62  KNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYI 121

Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR-----VASRYFKGPEL 290
           HS  ++HRD+KP N++++ +  +L++ D+GLA  +      N       VA+R+++ PE+
Sbjct: 122 HSANVLHRDLKPGNLLVNADC-ELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEI 180

Query: 291 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT---DELNAYLN 347
           ++  Q Y  ++D+WS+GC+ A ++ RK P F G D  DQL +I +VLGT   + L+   +
Sbjct: 181 MLSFQSYTKAIDVWSVGCILAELLGRK-PVFKGKDYVDQLNQILQVLGTPDEETLSRIGS 239

Query: 348 KYHLELDPQLDALVGRHSRKPWSK-FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA 406
                    L  +     +KP+   F NA      +P A+D L+KLL +D   R++  EA
Sbjct: 240 PKAQNYIRSLPNIP----KKPFESIFPNA------NPLALDLLEKLLAFDPTKRISVEEA 289

Query: 407 MAHPYFAQVR 416
           + HPY A   
Sbjct: 290 LEHPYLAIWH 299

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score =  162 bits (413), Expect = 4e-47
 Identities = 93/303 (30%), Positives = 163/303 (53%), Gaps = 38/303 (12%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK--------REIKILQNLCG 178
           Y+++ K+G G +SEV +  +  T +   IK +K    K  K        REI+ L+ L  
Sbjct: 1   YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMK----KHFKSLEQVNNLREIQALRRLSP 56

Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL----YPTLTDYDIRYYIYELLKALDY 234
            PN+++L++++ D+ +   +L+FE ++   ++++     P L +  ++ Y+Y+LLK+LD+
Sbjct: 57  HPNILRLIEVLFDRKTGRLALVFELMDMNLYELIKGRKRP-LPEKRVKSYMYQLLKSLDH 115

Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 294
            H  GI HRD+KP N++I  ++  L+L D+G     +    Y   +++R+++ PE L+  
Sbjct: 116 MHRNGIFHRDIKPENILIKDDI--LKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTD 173

Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT--DELNAYLNKY-HL 351
             Y   +D+W++GC+F  ++    P F G +  DQ+ KI  VLGT   E+     K  H+
Sbjct: 174 GYYGPKMDIWAVGCVFFEILSLF-PLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHM 232

Query: 352 ELDPQLDALVGRHSRKP--WSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 409
             +          S+K     K +        S E +D L KLL YD  +R+TA++A+ H
Sbjct: 233 NYNFP--------SKKGTGLRKLL-----PNASAEGLDLLKKLLAYDPDERITAKQALRH 279

Query: 410 PYF 412
           PYF
Sbjct: 280 PYF 282

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score =  161 bits (408), Expect = 3e-46
 Identities = 104/309 (33%), Positives = 164/309 (53%), Gaps = 32/309 (10%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK------PVKKKKIKREIKILQNLCG 178
           D YE V K+G G Y  V++  +  TNE   +K ++       V    I REI +L+ +  
Sbjct: 2   DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAI-REISLLKEMQH 60

Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD-----IRYYIYELLKALD 233
           G N+V+L D+V  +  K   L+FEY++  D K    +  D+      I+ Y+Y++L+ + 
Sbjct: 61  G-NIVRLQDVVHSE--KRLYLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIA 116

Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLV 292
           YCHS  ++HRD+KP N++ID     L+L D+GLA  F  P + +   V + +++ PE+L+
Sbjct: 117 YCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILL 176

Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE 352
             + Y   +D+WS+GC+FA M+ +K P F G    D+L KI ++LGT     +       
Sbjct: 177 GSRHYSTPVDIWSVGCIFAEMVNQK-PLFPGDSEIDELFKIFRILGTPNEETW------- 228

Query: 353 LDPQLDALVGRHSRKPWSKFINADNQHLV---SPEAIDFLDKLLRYDHQDRLTAREAMAH 409
             P + +L    S  P  K+   D   +V    P  +D L K+LR D   R+TAR A+ H
Sbjct: 229 --PGVTSLPDYKSAFP--KWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284

Query: 410 PYFAQVRAA 418
            YF  +  A
Sbjct: 285 EYFKDLGDA 293

Length = 294

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score =  160 bits (406), Expect = 1e-45
 Identities = 97/309 (31%), Positives = 171/309 (55%), Gaps = 35/309 (11%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKK----KIKREIKILQNLCGGP 180
             Y+ +  +G G Y  V    +  T  +  IK + P + +    +  REIKIL+      
Sbjct: 5   PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRF-KHE 63

Query: 181 NVVKLLDIVRDQHSKTPS---LIFEYVNSTDFKVLYP-TLTDYDIRYYIYELLKALDYCH 236
           N++ +LDI+R    ++ +   ++ E + +  +K++    L++  I+Y++Y++L+ L Y H
Sbjct: 64  NIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQILRGLKYIH 123

Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-----EFYHPGK--EYNVRVASRYFKGPE 289
           S  ++HRD+KP N++++     L++ D+GLA     E  H G   EY   VA+R+++ PE
Sbjct: 124 SANVLHRDLKPSNLLLNTNC-DLKICDFGLARIADPEHDHTGFLTEY---VATRWYRAPE 179

Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT---DELNAYL 346
           ++++ + Y  ++D+WS+GC+ A M+  + P F G D   QL  I  VLGT   ++LN  +
Sbjct: 180 IMLNSKGYTKAIDIWSVGCILAEMLSNR-PLFPGKDYLHQLNLILGVLGTPSQEDLNCII 238

Query: 347 NKYHLELDPQLDALVGRHSRKPWSK-FINADNQHLVSPEAIDFLDKLLRYDHQDRLTARE 405
           +         + +L  +  + PW+K F NAD      P+A+D LDK+L ++   R+T  E
Sbjct: 239 SLRARNY---IKSLPFK-PKVPWNKLFPNAD------PKALDLLDKMLTFNPHKRITVEE 288

Query: 406 AMAHPYFAQ 414
           A+AHPY  Q
Sbjct: 289 ALAHPYLEQ 297

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  155 bits (395), Expect = 2e-45
 Identities = 56/190 (29%), Positives = 96/190 (50%), Gaps = 12/190 (6%)

Query: 133 VGRGKYSEVFEGINVNTNERCIIKILKPVKKKK----IKREIKILQNLCGGPNVVKLLDI 188
           +G G +  V+   +  T ++  IKI+K          + REI+IL+ L   PN+VKL  +
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKL-NHPNIVKLYGV 59

Query: 189 VRDQHSKTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRD 244
             D+      L+ EY      K L       L++ +I   + ++L+ L+Y HS GI+HRD
Sbjct: 60  FEDE--NHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRD 117

Query: 245 VKPHNVMIDHELRKLRLIDWGLAEFY-HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDM 303
           +KP N+++D +  K++L D+GL++            V +  +  PE+L+    Y    D+
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDI 177

Query: 304 WSLGCMFAGM 313
           WSLG +   +
Sbjct: 178 WSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  157 bits (398), Expect = 6e-45
 Identities = 92/318 (28%), Positives = 157/318 (49%), Gaps = 63/318 (19%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK-------------REIKIL 173
           YE + ++G G Y  V++  ++NT         + V  KK++             REI +L
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTG--------RFVALKKVRVPLSEEGIPLSTLREIALL 52

Query: 174 QNL--CGGPNVVKLLDI---VRDQHSKTPSLIFEYVNS--TDF--KVLYPTLTDYDIRYY 224
           + L     PN+V+LLD+    R       +L+FE+V+     +  K   P L    I+  
Sbjct: 53  KQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDL 112

Query: 225 IYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR----V 280
           + +LL+ +D+ HS  I+HRD+KP N+++  + + +++ D+GLA  Y     + +     V
Sbjct: 113 MRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQ-VKIADFGLARIY----SFEMALTSVV 167

Query: 281 ASRYFKGPELLVDLQD-YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT 339
            + +++ PE+L  LQ  Y   +DMWS+GC+FA + FR+ P F G    DQL KI  V+G 
Sbjct: 168 VTLWYRAPEVL--LQSSYATPVDMWSVGCIFAEL-FRRRPLFRGTSEADQLDKIFDVIGL 224

Query: 340 ---DE--LNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLR 394
              +E   N  L +               ++ + +  F+       +  E +D L K+L 
Sbjct: 225 PSEEEWPRNVSLPRSSFP----------SYTPRSFKSFVPE-----ICEEGLDLLKKMLT 269

Query: 395 YDHQDRLTAREAMAHPYF 412
           ++   R++A EA+ HPYF
Sbjct: 270 FNPHKRISAFEALQHPYF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score =  158 bits (402), Expect = 7e-45
 Identities = 98/315 (31%), Positives = 166/315 (52%), Gaps = 43/315 (13%)

Query: 121 WGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL-----KPVKKKKIKREIKILQN 175
           W   D Y+ +  VG G Y +V    +  T  +  IK L       +  K+  RE+++L++
Sbjct: 11  WEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKH 70

Query: 176 LCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP-------------TLTDYDIR 222
           +    NV+ LLD+       TP+   E  +  D  ++                L+D  I+
Sbjct: 71  MDH-ENVIGLLDVF------TPASSLE--DFQDVYLVTHLMGADLNNIVKCQKLSDDHIQ 121

Query: 223 YYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVAS 282
           + +Y++L+ L Y HS GI+HRD+KP N+ ++ E  +L+++D+GLA   H   E    VA+
Sbjct: 122 FLVYQILRGLKYIHSAGIIHRDLKPSNIAVN-EDCELKILDFGLAR--HTDDEMTGYVAT 178

Query: 283 RYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT--D 340
           R+++ PE++++   Y+ ++D+WS+GC+ A ++  K   F G D+ DQL +I  ++GT  +
Sbjct: 179 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK-TLFPGSDHIDQLKRIMNLVGTPDE 237

Query: 341 ELNAYLNKYHLELDPQLDALVGRHSRKPWSK-FINADNQHLVSPEAIDFLDKLLRYDHQD 399
           EL   L K   E        + +  +K + + F  A      +P AID L+K+L  D   
Sbjct: 238 EL---LQKISSESARNYIQSLPQMPKKDFKEVFSGA------NPLAIDLLEKMLVLDPDK 288

Query: 400 RLTAREAMAHPYFAQ 414
           R+TA EA+AHPY A+
Sbjct: 289 RITAAEALAHPYLAE 303

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score =  156 bits (397), Expect = 8e-45
 Identities = 91/299 (30%), Positives = 149/299 (49%), Gaps = 29/299 (9%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--------KKKIKREIKILQNLCG 178
           YE + K+G G Y  VF+  N  T+E   I  LK V+             REI +L+ L  
Sbjct: 2   YEKLEKIGEGTYGTVFKAKNRETHE---IVALKRVRLDDDDEGVPSSALREICLLKEL-K 57

Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDY----DIRYYIYELLKALDY 234
             N+V+L D++      T  L+FEY +  D K  + +         ++ ++++LLK L +
Sbjct: 58  HKNIVRLYDVLHSDKKLT--LVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAF 114

Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELLVD 293
           CHS  ++HRD+KP N++I+    +L+L D+GLA  +  P + Y+  V + +++ P++L  
Sbjct: 115 CHSHNVLHRDLKPQNLLINKN-GELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG 173

Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 353
            + Y  S+DMWS GC+FA +     P F G+D  DQL +I ++LGT    ++     L  
Sbjct: 174 AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKL-- 231

Query: 354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 412
            P         +       +       ++    D L  LL  +   R++A EA+ HPYF
Sbjct: 232 -PDYKPYPMYPATTSLVNVVPK-----LNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  156 bits (394), Expect = 1e-43
 Identities = 87/319 (27%), Positives = 143/319 (44%), Gaps = 55/319 (17%)

Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK------IKREIKILQNLCGG 179
            Y ++RK+G G + EV+   +    +   +K+L    + K        REI+IL +L   
Sbjct: 1   SYRILRKLGEGSFGEVYLARD---RKLVALKVLAKKLESKSKEVERFLREIQILASLNHP 57

Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY------PTLTDYDIRYYIYELLKALD 233
           PN+VKL D    Q   +  L+ EYV+    + L         L++ +  + + ++L AL+
Sbjct: 58  PNIVKLYDFF--QDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALE 115

Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY-------HPGKEYNVRVASRYFK 286
           Y HS+GI+HRD+KP N+++D + R ++LID+GLA+               +  V +  + 
Sbjct: 116 YLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175

Query: 287 GPELLVD--LQDYDYSLDMWSLGCMFAGMIFRKEPF--FYGHDNHDQLVKIAKVLGTDEL 342
            PE+L+   L     S D+WSLG     ++    PF          Q +KI   L T  L
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSL 235

Query: 343 NAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT 402
            + L+                             N  L+S  A D L KLL  D ++RL+
Sbjct: 236 ASPLSP---------------------------SNPELISKAASDLLKKLLAKDPKNRLS 268

Query: 403 AREAMAHPYFAQVRAAESS 421
           +   ++H   A ++  ES 
Sbjct: 269 SSSDLSHDLLAHLKLKESD 287

Length = 384

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score =  153 bits (387), Expect = 2e-43
 Identities = 92/297 (30%), Positives = 160/297 (53%), Gaps = 25/297 (8%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILK------PVKKKKIKREIKILQNLCGGP 180
           ++ V K+G G Y  V++  N  T E   +K ++       V    I REI +L+ L   P
Sbjct: 2   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKEL-NHP 59

Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPT----LTDYDIRYYIYELLKALDYCH 236
           N+VKLLD++  +      L+FE+++    K +  +    +    I+ Y+++LL+ L +CH
Sbjct: 60  NIVKLLDVIHTE--NKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH 117

Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQ 295
           S  ++HRD+KP N++I+     ++L D+GLA  F  P + Y   V + +++ PE+L+  +
Sbjct: 118 SHRVLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 176

Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP 355
            Y  ++D+WSLGC+FA M+ R+   F G    DQL +I + LGT +   +     L   P
Sbjct: 177 YYSTAVDIWSLGCIFAEMVTRR-ALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSL---P 232

Query: 356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 412
                  + +R+ +SK +       +  +  D L ++L YD   R++A+ A+AHP+F
Sbjct: 233 DYKPSFPKWARQDFSKVVP-----PLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score =  153 bits (388), Expect = 4e-43
 Identities = 98/317 (30%), Positives = 158/317 (49%), Gaps = 40/317 (12%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIK-ILKPVKKKKIK----REIKILQNLCG 178
             DYE++ K+G G + EV++   + T     +K IL   +K        REIKIL+ L  
Sbjct: 7   LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKL-K 65

Query: 179 GPNVVKLLDIV---RDQHSKTPS---LIFEYVNSTDFKVLYP---TLTDYDIRYYIYELL 229
            PNVV L+D+     D+  +      ++  Y++     +L      LT+  I+ Y+ +LL
Sbjct: 66  HPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLL 125

Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-----PGK-------EYN 277
           + ++Y H   I+HRD+K  N++ID++   L++ D+GLA  Y      P         +Y 
Sbjct: 126 EGINYLHENHILHRDIKAANILIDNQ-GILKIADFGLARPYDGPPPNPKGGGGGGTRKYT 184

Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             V +R+++ PELL+  + Y  ++D+W +GC+FA M  R+ P   G  + DQL  I K+ 
Sbjct: 185 NLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR-PILQGKSDIDQLHLIFKLC 243

Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHL--VSPEAIDFLDKLLRY 395
           GT        +   E  P   +L G      ++ +     +    + PE +D L KLL  
Sbjct: 244 GT------PTE---ETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSL 294

Query: 396 DHQDRLTAREAMAHPYF 412
           D   RLTA +A+ HPYF
Sbjct: 295 DPYKRLTASDALEHPYF 311

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score =  152 bits (385), Expect = 5e-43
 Identities = 97/308 (31%), Positives = 162/308 (52%), Gaps = 44/308 (14%)

Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK-------------REIKI 172
           DY  + K+G G Y  V++G N  T         + V  KKI+             REI +
Sbjct: 1   DYTKIEKIGEGTYGVVYKGRNKKTG--------QIVAMKKIRLESEEEGVPSTAIREISL 52

Query: 173 LQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD------IRYYIY 226
           L+ L   PN+V L D++  Q S+   LIFE++ S D K    +L          ++ Y+Y
Sbjct: 53  LKEL-QHPNIVCLQDVLM-QESRL-YLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLY 108

Query: 227 ELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYF 285
           ++L+ + +CHS+ ++HRD+KP N++ID++   ++L D+GLA  F  P + Y   V + ++
Sbjct: 109 QILQGILFCHSRRVLHRDLKPQNLLIDNK-GVIKLADFGLARAFGIPVRVYTHEVVTLWY 167

Query: 286 KGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAY 345
           + PE+L+    Y   +D+WS+G +FA M  +K P F+G    DQL +I ++LGT   + +
Sbjct: 168 RAPEVLLGSPRYSTPVDIWSIGTIFAEMATKK-PLFHGDSEIDQLFRIFRILGTPTEDVW 226

Query: 346 LNKYHLELDPQLDALVGRHSRKP-WSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAR 404
                    P + +L    +  P W K         +  + +D L+K+L YD   R++A+
Sbjct: 227 ---------PGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAK 277

Query: 405 EAMAHPYF 412
           +A+ HPYF
Sbjct: 278 KALNHPYF 285

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  150 bits (380), Expect = 1e-42
 Identities = 83/293 (28%), Positives = 132/293 (45%), Gaps = 47/293 (16%)

Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK---IKREIKILQNLCGGPNV 182
            +E++ K+G+G + EV++  +  T +   IK++K   K+K   I  EI+IL+  C  PN+
Sbjct: 1   LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILK-KCKHPNI 59

Query: 183 VKLLDIVRDQHSKTPSLIFEYVN----STDFKVLYPTLTDYDIRYYIYELLKALDYCHSQ 238
           VK              ++ E+ +        K    TLT+  I Y   ELLK L+Y HS 
Sbjct: 60  VKYYGSY--LKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN 117

Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYD 298
           GI+HRD+K  N+++  +  +++LID+GL+      K  N  V + Y+  PE++   + YD
Sbjct: 118 GIIHRDIKAANILLTSD-GEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVING-KPYD 175

Query: 299 YSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLD 358
           Y  D+WSLG     +   K P+                               EL P   
Sbjct: 176 YKADIWSLGITAIELAEGKPPYS------------------------------ELPPMK- 204

Query: 359 ALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 411
           AL  + +           N    S E  DFL K L+ + + R TA + + HP+
Sbjct: 205 ALF-KIATNGPPGL---RNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score =  150 bits (382), Expect = 2e-42
 Identities = 103/311 (33%), Positives = 164/311 (52%), Gaps = 48/311 (15%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-------PVKKKKIKREIKILQNLC 177
           + YE + K+G G Y  VF+  N  T +  I+ I K       PV KK   REI++L+ L 
Sbjct: 1   EKYEKLSKIGEGSYGVVFKCRNRETGQ--IVAIKKFVESEDDPVIKKIALREIRMLKQL- 57

Query: 178 GGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL--YPT-LTDYDIRYYIYELLKALDY 234
             PN+V L+++ R    +   L+FEY + T    L   P  + ++ I+  I++ L+A+++
Sbjct: 58  KHPNLVNLIEVFR--RKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNF 115

Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELLV- 292
           CH    +HRDVKP N++I  +  +++L D+G A     PG +Y   VA+R+++ PELLV 
Sbjct: 116 CHKHNCIHRDVKPENILITKQ-GQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVG 174

Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDEL---------- 342
           D Q Y   +D+W++GC+FA ++   +P + G  + DQL  I K LG  +L          
Sbjct: 175 DTQ-YGPPVDVWAIGCVFAELL-TGQPLWPGKSDVDQLYLIRKTLG--DLIPRHQQIFST 230

Query: 343 NAYLNKYHLELDPQLDALVGRHSRKPW-SKFINADNQHLVSPEAIDFLDKLLRYDHQDRL 401
           N +     +  +P+        +R+P  SKF N       S  A+ FL   L+ D  +RL
Sbjct: 231 NQFFKGLSIP-EPE--------TREPLESKFPNI------SSPALSFLKGCLQMDPTERL 275

Query: 402 TAREAMAHPYF 412
           +  E + HPYF
Sbjct: 276 SCEELLEHPYF 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score =  149 bits (379), Expect = 4e-42
 Identities = 86/300 (28%), Positives = 156/300 (52%), Gaps = 31/300 (10%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-------KKKIKREIKILQNLCGG 179
           ++ + K+G G Y+ V++G N  T E   I  LK +             REI +++ L   
Sbjct: 2   FKQLEKLGEGTYATVYKGRNRTTGE---IVALKEIHLDAEEGTPSTAIREISLMKEL-KH 57

Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDY------DIRYYIYELLKALD 233
            N+V+L D++  ++     L+FEY++  D K    T           ++ + Y+LLK + 
Sbjct: 58  ENIVRLHDVIHTENKLM--LVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIA 114

Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLV 292
           +CH   ++HRD+KP N++I+     L+L D+GLA  F  P   ++  V + +++ P++L+
Sbjct: 115 FCHENRVLHRDLKPQNLLINKRGE-LKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLL 173

Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE 352
             + Y  S+D+WS+GC+ A MI  + P F G +N DQL+KI +++GT   + +     + 
Sbjct: 174 GSRTYSTSIDIWSVGCIMAEMITGR-PLFPGTNNEDQLLKIFRIMGTPTESTWPG---IS 229

Query: 353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 412
             P+      R+  +   +           P  ID L +LL+ + + R++A +A+ HP+F
Sbjct: 230 QLPEYKPTFPRYPPQDLQQLFPH-----ADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score =  151 bits (382), Expect = 4e-42
 Identities = 101/315 (32%), Positives = 169/315 (53%), Gaps = 34/315 (10%)

Query: 121 WGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL-KPVKK----KKIKREIKILQN 175
           W   + Y  +++VG G Y  V   I+  T E+  IK L +P +     K+  RE+ +L++
Sbjct: 11  WELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKH 70

Query: 176 LCGGPNVVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKA 231
           +    NV+ LLD+     S    +   L+  Y+ +   K++   L++  ++Y +Y++L  
Sbjct: 71  M-QHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCG 129

Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 291
           L Y HS GI+HRD+KP N+ ++ +  +L+++D+GLA   H   E    V +R+++ PE++
Sbjct: 130 LKYIHSAGIIHRDLKPGNLAVNEDC-ELKILDFGLAR--HADAEMTGYVVTRWYRAPEVI 186

Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLG------TDELNAY 345
           ++   Y+ ++D+WS+GC+ A M+  K   F G D  DQL +I KV G        +L   
Sbjct: 187 LNWMHYNQTVDIWSVGCIMAEMLTGKT-LFKGKDYLDQLTQILKVTGVPGPEFVQKLEDK 245

Query: 346 LNKYHLELDPQLDALVGRHSRKPWSK-FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAR 404
             K +++  P+         RK +S  F  A      SP+A+D L+K+L  D   RLTA 
Sbjct: 246 AAKSYIKSLPKY-------PRKDFSTLFPKA------SPQAVDLLEKMLELDVDKRLTAT 292

Query: 405 EAMAHPYFAQVRAAE 419
           EA+ HPYF   R A+
Sbjct: 293 EALEHPYFDSFRDAD 307

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score =  150 bits (380), Expect = 4e-42
 Identities = 85/314 (27%), Positives = 163/314 (51%), Gaps = 36/314 (11%)

Query: 121 WGDQ--DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK-----IKREIKIL 173
           WG +  D ++++ ++G G Y +V++  + +T E   +K ++   +K+       REIKIL
Sbjct: 1   WGKRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKIL 60

Query: 174 QNLCGGPNVVKLLDIVRDQHSKTP--------SLIFEYVNSTDFKVLYPTLTDYD---IR 222
           + L    N+V L +IV D+              L+FEY++     +L   L  +    I+
Sbjct: 61  RQL-NHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIK 119

Query: 223 YYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG--KEYNVRV 280
            ++ +LL+ L+YCH +  +HRD+K  N++++++  +++L D+GLA  Y+    + Y  +V
Sbjct: 120 SFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNK-GQIKLADFGLARLYNSEESRPYTNKV 178

Query: 281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTD 340
            + +++ PELL+  + Y  ++D+WS GC+  G +F K+P F  +    QL  I+++ G+ 
Sbjct: 179 ITLWYRPPELLLGEERYGPAIDVWSCGCIL-GELFTKKPIFQANQELAQLELISRLCGSP 237

Query: 341 ELNAYLNKYHLELDPQLDALVGRHSRKP---WSKFINADNQHLVSPEAIDFLDKLLRYDH 397
               +         P +  L   ++ KP   + + +  +   +    A+D LD +L  D 
Sbjct: 238 CPAVW---------PDVIKLPYFNTMKPKKQYRRRLREEFSFI-PTPALDLLDHMLTLDP 287

Query: 398 QDRLTAREAMAHPY 411
             R TA EA+  P+
Sbjct: 288 SKRCTAEEALNSPW 301

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score =  149 bits (378), Expect = 6e-42
 Identities = 98/318 (30%), Positives = 158/318 (49%), Gaps = 53/318 (16%)

Query: 121 WGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK------------R 168
           +G  + Y+ + K+G G Y+ V++G +  T +         V  K+I+            R
Sbjct: 1   FGKLETYKKLDKLGEGSYATVYKGRSKLTGQL--------VALKEIRLEHEEGAPFTAIR 52

Query: 169 EIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL---YPTLTD-YDIRYY 224
           E  +L++L    N+V L DI+  +  KT +L+FEY++ TD K            +++R +
Sbjct: 53  EASLLKDL-KHANIVTLHDIIHTK--KTLTLVFEYLD-TDLKQYMDDCGGGLSMHNVRLF 108

Query: 225 IYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKEYNVRVASR 283
           +++LL+ L YCH + ++HRD+KP N++I  E  +L+L D+GLA     P K Y+  V + 
Sbjct: 109 LFQLLRGLAYCHQRRVLHRDLKPQNLLIS-ERGELKLADFGLARAKSVPSKTYSNEVVTL 167

Query: 284 YFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH-DNHDQLVKIAKVLGTD-- 340
           +++ P++L+   +Y  SLDMW +GC+F  M     P F G  D  DQL KI +VLGT   
Sbjct: 168 WYRPPDVLLGSTEYSTSLDMWGVGCIFYEMA-TGRPLFPGSTDVEDQLHKIFRVLGTPTE 226

Query: 341 ------ELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLR 394
                   N     Y              +  +P    IN   +    P   +   K L+
Sbjct: 227 ETWPGVSSNPEFKPYSF----------PFYPPRP---LINHAPRLDRIPHGEELALKFLQ 273

Query: 395 YDHQDRLTAREAMAHPYF 412
           Y+ + R++A EAM HPYF
Sbjct: 274 YEPKKRISAAEAMKHPYF 291

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score =  149 bits (377), Expect = 2e-41
 Identities = 101/330 (30%), Positives = 174/330 (52%), Gaps = 43/330 (13%)

Query: 111 YWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL-KPVKK----KK 165
           Y+  E     W   D Y  +++VG G Y  V   ++  T  +  IK L +P +     K+
Sbjct: 1   YYRQEVNKTIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKR 60

Query: 166 IKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP----------- 214
             RE+++L+++    NV+ LLD+       TP L  +  +  DF ++ P           
Sbjct: 61  AYRELRLLKHM-KHENVIGLLDVF------TPDLSLDRFH--DFYLVMPFMGTDLGKLMK 111

Query: 215 --TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 272
              L++  I++ +Y++LK L Y H+ GI+HRD+KP N+ ++ +  +L+++D+GLA     
Sbjct: 112 HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDC-ELKILDFGLAR--QT 168

Query: 273 GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVK 332
             E    V +R+++ PE++++   Y  ++D+WS+GC+ A M+  K P F GHD+ DQL++
Sbjct: 169 DSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK-PLFKGHDHLDQLME 227

Query: 333 IAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHL---VSPEAIDFL 389
           I KV GT            E   +L +   ++  K   +F   D + L    +P A++ L
Sbjct: 228 IMKVTGTPS---------KEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVL 278

Query: 390 DKLLRYDHQDRLTAREAMAHPYFAQVRAAE 419
           +K+L  D + R+TA EA+AHPYF +    E
Sbjct: 279 EKMLVLDAESRITAAEALAHPYFEEFHDPE 308

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score =  144 bits (366), Expect = 3e-40
 Identities = 95/298 (31%), Positives = 151/298 (50%), Gaps = 26/298 (8%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKIL------KPVKKKKIKREIKILQNLCGGP 180
           YE +  VG G Y  V +  +  T +   IK        K VKK  + REI++L+ L    
Sbjct: 3   YENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAM-REIRMLKQL-RHE 60

Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL--YPTLTDYD-IRYYIYELLKALDYCHS 237
           N+V L+++ R +  K   L+FE+V+ T    L  YP   D   +R Y++++L+ +++CHS
Sbjct: 61  NLVNLIEVFRRK--KRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHS 118

Query: 238 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELLVDLQD 296
             I+HRD+KP N+++      ++L D+G A     PG+ Y   VA+R+++ PELLV    
Sbjct: 119 HNIIHRDIKPENILVSQS-GVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTK 177

Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ 356
           Y  ++D+W++GC+   M    EP F G  + DQL  I K LG       L   H E+  +
Sbjct: 178 YGRAVDIWAVGCLVTEM-LTGEPLFPGDSDIDQLYHIIKCLGN------LIPRHQEIFQK 230

Query: 357 LDALVGRHSRKPWSKFINADNQHL--VSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 412
                G   R P  K I    +    +S   +D   + LR D  DR ++ + + H +F
Sbjct: 231 NPLFAG--MRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score =  144 bits (364), Expect = 1e-39
 Identities = 105/301 (34%), Positives = 162/301 (53%), Gaps = 34/301 (11%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIK-ILKP----VKKKKIKREIKILQNLCGGPN 181
           Y  ++ VG G +  V    +  T +   IK I+KP    V  K+  RE+K+L++L    N
Sbjct: 12  YVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHL-RHEN 70

Query: 182 VVKLLDIVRDQHSKTPSLIFEYVN---STDFKVLYPT--LTDYDIRYYIYELLKALDYCH 236
           ++ L DI       +P     +V     TD   L  +  L    I+Y++Y++L+ L Y H
Sbjct: 71  IISLSDIF-----ISPLEDIYFVTELLGTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVH 125

Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
           S G++HRD+KP N++I+ E   L++ D+GLA    P  +    V++RY++ PE+++  Q 
Sbjct: 126 SAGVVHRDLKPSNILIN-ENCDLKICDFGLARIQDP--QMTGYVSTRYYRAPEIMLTWQK 182

Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT---DELNAYLNKYHLEL 353
           YD  +D+WS GC+FA M    +P F G D+ +Q   I  +LGT   D +N   ++  L  
Sbjct: 183 YDVEVDIWSAGCIFAEM-LEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRF 241

Query: 354 DPQLDALVGRHSRKPWS-KFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 412
              L     +    P+S KF NAD      P AID L+K+L +D Q R++A EA+AHPY 
Sbjct: 242 VQSLP----KREPVPFSEKFKNAD------PSAIDLLEKMLVFDPQKRISAAEALAHPYL 291

Query: 413 A 413
           A
Sbjct: 292 A 292

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  141 bits (357), Expect = 3e-39
 Identities = 79/299 (26%), Positives = 132/299 (44%), Gaps = 51/299 (17%)

Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIK--ILKPVKKKK---IKREIKILQNLCGGP 180
           ++     +GRG +  V+  ++ +T E   +K   L    +++   ++REI+IL +L   P
Sbjct: 1   EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSL-QHP 59

Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNS---TDFKVLYPTLTDYDIRYYIYELLKALDYCHS 237
           N+V+     RD+   T ++  EYV+    +     +  L +  IR Y  ++L+ L Y HS
Sbjct: 60  NIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHS 119

Query: 238 QGIMHRDVKPHNVMIDHELRKLRLIDWGLA---EFYHPGKEYNVRVASRYFKGPELLVDL 294
            GI+HRD+K  N+++D +   ++L D+G A        G+       + Y+  PE++   
Sbjct: 120 NGIVHRDIKGANILVDSDGV-VKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG- 177

Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV-KIAKVLGTDELNAYLNKYHLEL 353
           ++Y  + D+WSLGC    M   K P +    N    + KI       E+  +L       
Sbjct: 178 EEYGRAADIWSLGCTVIEMATGKPP-WSELGNPMAALYKIGSSGEPPEIPEHL------- 229

Query: 354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 412
                                       S EA DFL K LR D + R TA E + HP+ 
Sbjct: 230 ----------------------------SEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score =  141 bits (358), Expect = 1e-38
 Identities = 100/309 (32%), Positives = 168/309 (54%), Gaps = 42/309 (13%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKIL-----KPVKKKKIKREIKILQNLCGGPN 181
           Y  ++ +GRG Y  V    N  TNE+  IK +       +  K+  REIK+L++L    N
Sbjct: 7   YVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHL-DHEN 65

Query: 182 VVKLLDIVRDQHSKTPS---LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYC 235
           V+ + DI+   H +  +   +++E ++ TD   +     TL+D   +Y++Y+LL+ L Y 
Sbjct: 66  VIAIKDIMPPPHREAFNDVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYI 124

Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-------EFYHPGKEYNVRVASRYFKGP 288
           HS  ++HRD+KP N++++     L++ D+GLA       +F     EY   V +R+++ P
Sbjct: 125 HSANVLHRDLKPSNLLLNANC-DLKICDFGLARTTSEKGDFM---TEY---VVTRWYRAP 177

Query: 289 ELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT---DELNAY 345
           ELL++  +Y  ++D+WS+GC+FA ++ RK P F G D   QL  I ++LG+   ++L   
Sbjct: 178 ELLLNCSEYTTAIDVWSVGCIFAELLGRK-PLFPGKDYVHQLKLITELLGSPSEEDLGFI 236

Query: 346 LNKYHLELDPQLDALVGRHSRKPWS-KFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAR 404
            N+        L        R+ ++  F +A      +P AID L+K+L +D   R+T  
Sbjct: 237 RNEKARRYIRSL----PYTPRQSFARLFPHA------NPLAIDLLEKMLVFDPSKRITVE 286

Query: 405 EAMAHPYFA 413
           EA+AHPY A
Sbjct: 287 EALAHPYLA 295

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score =  140 bits (355), Expect = 2e-38
 Identities = 94/302 (31%), Positives = 157/302 (51%), Gaps = 27/302 (8%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK---IK--REIKILQNLCGG 179
           D+YE + ++  G Y  V+   +  T E   +K LK  K+K+   I   REI IL  L   
Sbjct: 5   DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKL-QH 63

Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDY----DIRYYIYELLKALDYC 235
           PN+V + ++V   +     ++ EYV   D K L  T+       +++  + +LL  + + 
Sbjct: 64  PNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHL 122

Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDL 294
           H   I+HRD+K  N+++++    L++ D+GLA E+  P K Y   V + +++ PELL+  
Sbjct: 123 HDNWILHRDLKTSNLLLNNRGI-LKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGA 181

Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 354
           ++Y  ++DMWS+GC+FA ++  K+P F G    DQL KI K+LGT     +         
Sbjct: 182 KEYSTAIDMWSVGCIFAELL-TKKPLFPGKSEIDQLNKIFKLLGTPTEKIW--------- 231

Query: 355 PQLDALVG----RHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHP 410
           P    L G      ++ P+++         +S    D L++LL YD   R++A +A+ HP
Sbjct: 232 PGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHP 291

Query: 411 YF 412
           YF
Sbjct: 292 YF 293

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score =  139 bits (352), Expect = 8e-38
 Identities = 96/316 (30%), Positives = 163/316 (51%), Gaps = 45/316 (14%)

Query: 121 WGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL-KP----VKKKKIKREIKILQN 175
           W   + Y+ +  VG G Y  V    +    ++  +K L +P    +  ++  RE+++L++
Sbjct: 11  WEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKH 70

Query: 176 LCGGPNVVKLLDIVRDQHSKTPSLIFEYVNS---------TDFK--VLYPTLTDYDIRYY 224
           +    NV+ LLD+       TP+   E  N           D    V    L+D  +++ 
Sbjct: 71  M-KHENVIGLLDVF------TPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFL 123

Query: 225 IYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY 284
           IY+LL+ L Y HS GI+HRD+KP NV ++ +  +LR++D+GLA       E    VA+R+
Sbjct: 124 IYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDC-ELRILDFGLAR--QADDEMTGYVATRW 180

Query: 285 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA 344
           ++ PE++++   Y+ ++D+WS+GC+ A ++ + +  F G+D  DQL +I +V+GT     
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELL-KGKALFPGNDYIDQLKRIMEVVGTPSPEV 239

Query: 345 YLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHL------VSPEAIDFLDKLLRYDHQ 398
                       L  +   H+RK      +   Q L       +P AID L+K+L  D  
Sbjct: 240 ------------LKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSD 287

Query: 399 DRLTAREAMAHPYFAQ 414
            R++A EA+AHPYF+Q
Sbjct: 288 KRISASEALAHPYFSQ 303

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score =  139 bits (351), Expect = 1e-37
 Identities = 93/310 (30%), Positives = 158/310 (50%), Gaps = 33/310 (10%)

Query: 121 WGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL-KP----VKKKKIKREIKILQN 175
           W   + Y+ +  VG G Y  V    +  T  R  +K L +P    +  K+  RE+++L++
Sbjct: 13  WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKH 72

Query: 176 LCGGPNVVKLLDIVRDQHSKTPSLIFEYVNS---------TDFK--VLYPTLTDYDIRYY 224
           +    NV+ LLD+       TP+   E  N           D    V    LTD  +++ 
Sbjct: 73  M-KHENVIGLLDVF------TPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 125

Query: 225 IYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY 284
           IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E    VA+R+
Sbjct: 126 IYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMTGYVATRW 182

Query: 285 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA 344
           ++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++GT     
Sbjct: 183 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGTPGAEL 241

Query: 345 YLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAR 404
                       + +L         + FI A+      P A+D L+K+L  D   R+TA 
Sbjct: 242 LKKISSESARNYIQSLTQMPKMNFANVFIGAN------PLAVDLLEKMLVLDSDKRITAA 295

Query: 405 EAMAHPYFAQ 414
           +A+AH YFAQ
Sbjct: 296 QALAHAYFAQ 305

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score =  133 bits (337), Expect = 2e-35
 Identities = 91/311 (29%), Positives = 158/311 (50%), Gaps = 37/311 (11%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK---REIKILQNLCGGPNVV 183
           Y  +R +G G    VF  ++ + ++R  +K +     + +K   REIKI++ L    N+V
Sbjct: 7   YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRL-DHDNIV 65

Query: 184 KLLDIVRDQHSKTPS------------LIFEYVNSTDFKVL--YPTLTDYDIRYYIYELL 229
           K+ +++    S                ++ EY+  TD   +     L++   R ++Y+LL
Sbjct: 66  KVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYME-TDLANVLEQGPLSEEHARLFMYQLL 124

Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY----NVRVASRYF 285
           + L Y HS  ++HRD+KP NV I+ E   L++ D+GLA    P   +    +  + ++++
Sbjct: 125 RGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWY 184

Query: 286 KGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK---VLGTDEL 342
           + P LL+   +Y  ++DMW+ GC+FA M+  K P F G    +Q+  I +   V+  ++ 
Sbjct: 185 RSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK-PLFAGAHELEQMQLILESVPVVREEDR 243

Query: 343 NAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT 402
           N  LN       P      G   R+P    +       V+PEA+DFL+++L ++  DRLT
Sbjct: 244 NELLNV-----IPSFVRNDGGEPRRPLRDLLPG-----VNPEALDFLEQILTFNPMDRLT 293

Query: 403 AREAMAHPYFA 413
           A EA+ HPY +
Sbjct: 294 AEEALMHPYMS 304

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  130 bits (330), Expect = 4e-35
 Identities = 91/326 (27%), Positives = 140/326 (42%), Gaps = 84/326 (25%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP---VKKKK---IKREIKILQNLCG 178
           DD++  + +G G +S V       TN+   IKIL     +K+KK   +K E ++L  L G
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60

Query: 179 GPNVVKLLDIVRDQHSKTPSLIF--EYVNSTDFKVL---YPTLTDYDIRYYIYELLKALD 233
            P ++KL    +D+ +    L F  EY  + +       Y +L +   R+Y  E+L AL+
Sbjct: 61  HPGIIKLYYTFQDEEN----LYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALE 116

Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK---------------EYNV 278
           Y HS+GI+HRD+KP N+++D ++  +++ D+G A+   P                     
Sbjct: 117 YLHSKGIIHRDLKPENILLDKDMH-IKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKN 175

Query: 279 RVASRYFKG------PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV- 331
           R     F G      PELL + +    S D+W+LGC+   M+  K PF     +++ L  
Sbjct: 176 RRRFASFVGTAEYVSPELLNE-KPAGKSSDLWALGCIIYQMLTGKPPF---RGSNEYLTF 231

Query: 332 -KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLD 390
            KI K               LE                +      D        A D ++
Sbjct: 232 QKILK---------------LEYS--------------FPPNFPPD--------AKDLIE 254

Query: 391 KLLRYDHQDRLTA----REAMAHPYF 412
           KLL  D QDRL       E  AHP+F
Sbjct: 255 KLLVLDPQDRLGVNEGYDELKAHPFF 280

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score =  130 bits (329), Expect = 5e-35
 Identities = 89/306 (29%), Positives = 160/306 (52%), Gaps = 29/306 (9%)

Query: 121 WGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK----REIKILQNL 176
           +G    Y  + K+G G Y+ V++GI+    +   +K++    ++ +     RE  +L+ L
Sbjct: 1   FGAATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGL 60

Query: 177 CGGPNVVKLLDIVRDQHSKTPSLIFEYVNS--TDFKVLYPT-LTDYDIRYYIYELLKALD 233
               N+V L DI+  + + T   +FEY+++    + + +P  L  Y++R ++++LL+ L 
Sbjct: 61  -KHANIVLLHDIIHTKETLT--FVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLA 117

Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELLV 292
           Y H Q I+HRD+KP N++I + L +L+L D+GLA     P + Y+  V + +++ P++L+
Sbjct: 118 YIHGQHILHRDLKPQNLLISY-LGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLL 176

Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN-HDQLVKIAKVLGTDELNAY-----L 346
              DY  +LD+W  GC+F  M  + +P F G  +  +QL KI  VLG    + +     L
Sbjct: 177 GATDYSSALDIWGAGCIFIEM-LQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKL 235

Query: 347 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA 406
             Y  E          +  R  W +           P+A D   ++L    +DR++A++A
Sbjct: 236 PNYKPEWFLPCKP---QQLRVVWKRLSRP-------PKAEDLASQMLMMFPKDRISAQDA 285

Query: 407 MAHPYF 412
           + HPYF
Sbjct: 286 LLHPYF 291

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score =  132 bits (333), Expect = 2e-34
 Identities = 93/306 (30%), Positives = 161/306 (52%), Gaps = 31/306 (10%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIK-ILKPVKKKKIKREIKILQNLCGGPNVVKL 185
           Y++   +G G +  V+E I ++T+E+  IK +L+  + K   RE+ I++NL    N++ L
Sbjct: 68  YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKN--RELLIMKNL-NHINIIFL 124

Query: 186 LD------IVRDQHSKTPSLIFEYVNSTDFKVLY------PTLTDYDIRYYIYELLKALD 233
            D        +++ +   +++ E++  T  K +         L  + ++ Y Y+L +AL 
Sbjct: 125 KDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALA 184

Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           Y HS+ I HRD+KP N++ID     L+L D+G A+    G+     + SR+++ PEL++ 
Sbjct: 185 YIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLG 244

Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT---DELNAYLNKYH 350
             +Y   +D+WSLGC+ A MI    P F G  + DQLV+I +VLGT   D+L      Y 
Sbjct: 245 ATNYTTHIDLWSLGCIIAEMIL-GYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNY- 302

Query: 351 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHP 410
              D +   +  +  +K + K            +AI+F+ + L+Y+   RL   EA+A P
Sbjct: 303 --ADIKFPDVKPKDLKKVFPKG--------TPDDAINFISQFLKYEPLKRLNPIEALADP 352

Query: 411 YFAQVR 416
           +F  +R
Sbjct: 353 FFDDLR 358

Length = 440

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score =  127 bits (322), Expect = 9e-34
 Identities = 85/309 (27%), Positives = 144/309 (46%), Gaps = 45/309 (14%)

Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK--------REIKILQNLC 177
           ++E + ++G G Y  V+   +  + E   I  LK V+    +        REI +L N  
Sbjct: 8   EFEKLNRIGEGTYGIVYRARDTTSGE---IVALKKVRMDNERDGIPISSLREITLLLN-L 63

Query: 178 GGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDY 234
             PN+V+L ++V  +H  +  L+ EY       +L       ++  ++  + +LL+ L Y
Sbjct: 64  RHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQY 123

Query: 235 CHSQGIMHRDVKPHNV-MIDHELRKLRLIDWGLAEFY-HPGKEYNVRVASRYFKGPELLV 292
            H   I+HRD+K  N+ + D     L++ D+GLA  Y  P K    +V + +++ PELL+
Sbjct: 124 LHENFIIHRDLKVSNLLLTDKGC--LKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLL 181

Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT---------DELN 343
               Y  ++DMW++GC+ A +    +P   G    +QL  I ++LGT          +L 
Sbjct: 182 GCTTYTTAIDMWAVGCILAEL-LAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLP 240

Query: 344 AYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA 403
               K+ L   P  +    +H + PW           +S   +  L+ LL YD + R TA
Sbjct: 241 LV-GKFTLPKQPYNNL---KH-KFPW-----------LSEAGLRLLNFLLMYDPKKRATA 284

Query: 404 REAMAHPYF 412
            EA+   YF
Sbjct: 285 EEALESSYF 293

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score =  127 bits (319), Expect = 2e-33
 Identities = 92/312 (29%), Positives = 166/312 (53%), Gaps = 44/312 (14%)

Query: 121 WGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK----REIKILQNL 176
           +G  + Y  + K+G G Y+ V++G +  T+    +K ++   ++       RE+ +L++L
Sbjct: 2   FGKLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDL 61

Query: 177 CGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTD-------YDIRYYIYELL 229
               N+V L DI+  +  K+ +L+FEY++    K L   L D       ++++ ++++LL
Sbjct: 62  -KHANIVTLHDIIHTE--KSLTLVFEYLD----KDLKQYLDDCGNSINMHNVKLFLFQLL 114

Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGP 288
           + L+YCH + ++HRD+KP N++I+ E  +L+L D+GLA     P K Y+  V + +++ P
Sbjct: 115 RGLNYCHRRKVLHRDLKPQNLLIN-ERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPP 173

Query: 289 ELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK 348
           ++L+   DY   +DMW +GC+F  M   + P F G    +QL  I ++LGT         
Sbjct: 174 DILLGSTDYSTQIDMWGVGCIFYEMSTGR-PLFPGSTVEEQLHFIFRILGT--------- 223

Query: 349 YHLELDPQLDALVGRHSRKPWSKF----INADNQHLVSP----EAIDFLDKLLRYDHQDR 400
                 P  +   G  S + +  +      AD  H  +P    +  + L KLL+++ + R
Sbjct: 224 ------PTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKR 277

Query: 401 LTAREAMAHPYF 412
           ++A EAM HPYF
Sbjct: 278 ISAEEAMKHPYF 289

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score =  125 bits (316), Expect = 4e-33
 Identities = 92/306 (30%), Positives = 167/306 (54%), Gaps = 23/306 (7%)

Query: 121 WGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK----REIKILQNL 176
           +G  D YE + K+G G Y+ V++G +    +   +K+++  +++       RE  +L+ L
Sbjct: 1   FGKADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGL 60

Query: 177 CGGPNVVKLLDIVRDQHSK-TPSLIFEYVNSTDFKVL--YPT-LTDYDIRYYIYELLKAL 232
               N+V L DI+   H+K T +L+FEYV++   + +  +P  L   +++ ++++LL+ L
Sbjct: 61  -KHANIVLLHDII---HTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGL 116

Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELL 291
            Y H + I+HRD+KP N++I  +  +L+L D+GLA     P   Y+  V + +++ P++L
Sbjct: 117 SYIHQRYILHRDLKPQNLLIS-DTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVL 175

Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL 351
           +   +Y   LDMW +GC+F  MI     F    D  DQL +I  VLGT   + +   + L
Sbjct: 176 LGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSL 235

Query: 352 -ELDPQLDALV-GRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 409
               P+   L   ++ R+ W+K    ++       A D   KLL+   ++RL+A+ A++H
Sbjct: 236 PHFKPERFTLYSPKNLRQAWNKLSYVNH-------AEDLASKLLQCFPKNRLSAQAALSH 288

Query: 410 PYFAQV 415
            YF+ +
Sbjct: 289 EYFSDL 294

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score =  125 bits (316), Expect = 1e-32
 Identities = 94/314 (29%), Positives = 156/314 (49%), Gaps = 36/314 (11%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPN 181
           Y++   +G+G Y  V   I+ +T E+  IK +  V        +I REIK+L+       
Sbjct: 2   YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLR------- 54

Query: 182 VVKLLDIVRDQHSKTPS---------LIFEYVNSTDFKVLYPT--LTDYDIRYYIYELLK 230
           +++  DIV  +H   P          ++FE + S   +V+     LT    ++++Y+LL+
Sbjct: 55  LLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLR 114

Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV----RVASRYFK 286
           AL Y H+  + HRD+KP N++ + +  KL++ D+GLA          +     VA+R+++
Sbjct: 115 ALKYIHTANVFHRDLKPKNILANADC-KLKICDFGLARVAFNDTPTAIFWTDYVATRWYR 173

Query: 287 GPELLVDL-QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAY 345
            PEL       Y  ++D+WS+GC+FA ++  K P F G +   QL  I  +LGT      
Sbjct: 174 APELCGSFFSKYTPAIDIWSIGCIFAEVLTGK-PLFPGKNVVHQLDLITDLLGTPSPETI 232

Query: 346 LNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTARE 405
               + +    L ++  +       KF NAD      P A+  L++LL +D +DR TA E
Sbjct: 233 SRVRNEKARRYLSSMRKKQPVPFSQKFPNAD------PLALRLLERLLAFDPKDRPTAEE 286

Query: 406 AMAHPYFAQVRAAE 419
           A+A PYF  +   E
Sbjct: 287 ALADPYFKGLAKVE 300

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score =  123 bits (310), Expect = 2e-32
 Identities = 94/303 (31%), Positives = 158/303 (52%), Gaps = 32/303 (10%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK--------REIKILQNLCG 178
           YE V ++G G Y +VF+  ++    R +   LK V+ +  +        RE+ +L++L  
Sbjct: 3   YECVAEIGEGAYGKVFKARDLKNGGRFVA--LKRVRVQTGEEGMPLSTIREVAVLRHLET 60

Query: 179 --GPNVVKLLDIV---RDQHSKTPSLIFEYVNS--TDF--KVLYPTLTDYDIRYYIYELL 229
              PNVV+L D+    R       +L+FE+V+   T +  KV  P +    I+  +++LL
Sbjct: 61  FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 120

Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
           + LD+ HS  ++HRD+KP N+++     +++L D+GLA  Y         V + +++ PE
Sbjct: 121 RGLDFLHSHRVVHRDLKPQNILVTSS-GQIKLADFGLARIYSFQMALTSVVVTLWYRAPE 179

Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY 349
           +L+    Y   +D+WS+GC+FA M FR++P F G  + DQL KI  V+G      +    
Sbjct: 180 VLLQ-SSYATPVDLWSVGCIFAEM-FRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 237

Query: 350 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 409
            L   P+  A   + + +P  KF+  D   L      D L K L ++   R++A  A++H
Sbjct: 238 AL---PR-QAFHSKSA-QPIEKFV-TDIDEL----GKDLLLKCLTFNPAKRISAYSALSH 287

Query: 410 PYF 412
           PYF
Sbjct: 288 PYF 290

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score =  124 bits (312), Expect = 2e-32
 Identities = 95/314 (30%), Positives = 160/314 (50%), Gaps = 48/314 (15%)

Query: 121 WGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK----REIKILQNL 176
           +G  + Y  + K+G G Y+ VF+G +  T     +K ++   ++       RE+ +L++L
Sbjct: 2   FGKMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDL 61

Query: 177 CGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKAL 232
               N+V L DIV    S T  L+FEY++  D K         ++ ++++ ++Y++L+ L
Sbjct: 62  -KHANIVTLHDIVHTDKSLT--LVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGL 117

Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELL 291
            YCH + ++HRD+KP N++I+ E  +L+L D+GLA     P K Y+  V + +++ P++L
Sbjct: 118 AYCHRRKVLHRDLKPQNLLIN-ERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVL 176

Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT------------ 339
           +   +Y   +DMW +GC+F  M   + P F G    D+L  I ++LGT            
Sbjct: 177 LGSSEYSTQIDMWGVGCIFFEMASGR-PLFPGSTVEDELHLIFRLLGTPTEETWPGISSN 235

Query: 340 DELNAY-LNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQ 398
           DE   Y   KY     PQ                IN   +  +  E I+ L K L+Y+ +
Sbjct: 236 DEFKNYNFPKY----KPQ--------------PLINHAPR--LDTEGIELLTKFLQYESK 275

Query: 399 DRLTAREAMAHPYF 412
            R++A EAM H YF
Sbjct: 276 KRISAEEAMKHAYF 289

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score =  122 bits (308), Expect = 5e-32
 Identities = 93/301 (30%), Positives = 149/301 (49%), Gaps = 27/301 (8%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGG 179
           + +EV+  VG G Y  V +  +  T E   IK  K  +     K+   RE+K+L+ L   
Sbjct: 1   NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTL-KQ 59

Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL--YPTLTDYD-IRYYIYELLKALDYCH 236
            N+V+L +  R +      L+FEYV     ++L   P     + +R YIY+L+KA+ +CH
Sbjct: 60  ENIVELKEAFRRRGKLY--LVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCH 117

Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE--YNVRVASRYFKGPELLVDL 294
              I+HRD+KP N++I H    L+L D+G A     G    Y   VA+R+++ PELL+  
Sbjct: 118 KNDIVHRDIKPENLLISHN-DVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLG- 175

Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLG---TDELNAYLNKYHL 351
             Y  ++DMWS+GC+  G +   +P F G    DQL  I KVLG    +++  + +    
Sbjct: 176 APYGKAVDMWSVGCIL-GELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYS---- 230

Query: 352 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 411
             +P+   L       P S  +      ++S   +D +  LL+ +  DR    + + HP 
Sbjct: 231 --NPRFHGLRFPAVNHPQS--LERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPA 286

Query: 412 F 412
           F
Sbjct: 287 F 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score =  122 bits (307), Expect = 2e-31
 Identities = 92/325 (28%), Positives = 155/325 (47%), Gaps = 49/325 (15%)

Query: 127 YEVVRKVGRGKYSEVFE--GINVNTNERCIIKILKPVKKKKIK------REIKILQNLCG 178
           YE+   +GRG Y  V++    N    +   IK  K  K++         REI +L+ L  
Sbjct: 2   YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLREL-K 60

Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYV----------NSTDFKVLYPTLTDYDIRYYIYEL 228
             NVV L+++  +   K+  L+F+Y           +    +V  P      ++  ++++
Sbjct: 61  HENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSM---VKSLLWQI 117

Query: 229 LKALDYCHSQGIMHRDVKPHN--VMIDHELR-KLRLIDWGLAEFYH----PGKEYNVRVA 281
           L  + Y HS  ++HRD+KP N  VM +   R  +++ D GLA  ++    P  + +  V 
Sbjct: 118 LNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVV 177

Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD---------NHDQLVK 332
           + +++ PELL+  + Y  ++D+W++GC+FA ++   EP F G +           DQL +
Sbjct: 178 TIWYRAPELLLGARHYTKAIDIWAIGCIFAELL-TLEPIFKGREAKIKKSNPFQRDQLER 236

Query: 333 IAKVLG--TDELNAYLNKYHLELDPQLDALVGRHSRK--PWSKFINADNQHL-VSPEAID 387
           I +VLG  T++    + K      P+ D L+     K  P +       +H     +  D
Sbjct: 237 IFEVLGTPTEKDWPDIKKM-----PEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFD 291

Query: 388 FLDKLLRYDHQDRLTAREAMAHPYF 412
            L KLL YD   R+TA EA+ HPYF
Sbjct: 292 LLRKLLEYDPTKRITAEEALEHPYF 316

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score =  120 bits (303), Expect = 3e-31
 Identities = 89/309 (28%), Positives = 158/309 (51%), Gaps = 38/309 (12%)

Query: 121 WGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK----REIKILQNL 176
           +G  + Y  + K+G G Y+ VF+G +  T     +K ++   ++       RE+ +L+NL
Sbjct: 1   FGKLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNL 60

Query: 177 CGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPT----LTDYDIRYYIYELLKAL 232
               N+V L DI+  +   T  L+FEY++S D K         ++ ++++ ++++LL+ L
Sbjct: 61  -KHANIVTLHDIIHTERCLT--LVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGL 116

Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELL 291
            YCH + I+HRD+KP N++I+ E  +L+L D+GLA     P K Y+  V + +++ P++L
Sbjct: 117 SYCHKRKILHRDLKPQNLLIN-EKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVL 175

Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL 351
           +   +Y   +DMW +GC+   M   + P F G    ++L  I ++LGT            
Sbjct: 176 LGSTEYSTPIDMWGVGCILYEMATGR-PMFPGSTVKEELHLIFRLLGT------------ 222

Query: 352 ELDPQLDALVGRHSRKPWSK--FINADNQHLVS------PEAIDFLDKLLRYDHQDRLTA 403
              P  +   G  S + +    F     Q L++       + ID L  LL Y+ + R++A
Sbjct: 223 ---PTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISA 279

Query: 404 REAMAHPYF 412
             A+ H YF
Sbjct: 280 EAALRHSYF 288

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score =  120 bits (302), Expect = 7e-31
 Identities = 93/311 (29%), Positives = 148/311 (47%), Gaps = 31/311 (9%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIK-ILKPVKKKKIK----REIKILQNLC 177
           +   YE + K+G+G + EVF+  +  T +   +K +L   +K+       REIKILQ L 
Sbjct: 10  EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLL- 68

Query: 178 GGPNVVKLLDIVRDQHSK------TPSLIFEYVNSTDFKVL----YPTLTDYDIRYYIYE 227
              NVV L++I R + +       +  L+FE+    D   L        T  +I+  +  
Sbjct: 69  KHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKM 127

Query: 228 LLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-----YNVRVAS 282
           LL  L Y H   I+HRD+K  N++I  +   L+L D+GLA  +   K      Y  RV +
Sbjct: 128 LLNGLYYIHRNKILHRDMKAANILITKD-GILKLADFGLARAFSLSKNSKPNRYTNRVVT 186

Query: 283 RYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDEL 342
            +++ PELL+  +DY   +DMW  GC+ A M  R  P   G+    QL  I+++ G+   
Sbjct: 187 LWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTR-SPIMQGNTEQHQLTLISQLCGSITP 245

Query: 343 NAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVS-PEAIDFLDKLLRYDHQDRL 401
             +     LEL  +++   G+  +           +  V  P A+D +DKLL  D   R+
Sbjct: 246 EVWPGVDKLELFKKMELPQGQKRKVK------ERLKPYVKDPHALDLIDKLLVLDPAKRI 299

Query: 402 TAREAMAHPYF 412
            A  A+ H +F
Sbjct: 300 DADTALNHDFF 310

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score =  117 bits (294), Expect = 4e-30
 Identities = 84/302 (27%), Positives = 149/302 (49%), Gaps = 31/302 (10%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-PVKKKKIK----REIKILQNL--CGG 179
           YE V ++G G Y  V++  + ++     +K ++    +  +     RE+ +L+ L     
Sbjct: 2   YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDH 61

Query: 180 PNVVKLLDIV----RDQHSKTPSLIFEYVNSTDF-----KVLYPTLTDYDIRYYIYELLK 230
           PN+V+L+D+      D+ +K  +L+FE+V+  D      KV  P L    I+  + + L+
Sbjct: 62  PNIVRLMDVCATSRTDRETKV-TLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLR 119

Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 290
            LD+ H+  I+HRD+KP N+++     +++L D+GLA  Y         V + +++ PE+
Sbjct: 120 GLDFLHANCIVHRDLKPENILVTSG-GQVKLADFGLARIYSCQMALTPVVVTLWYRAPEV 178

Query: 291 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH 350
           L+    Y   +DMWS+GC+FA M FR++P F G+   DQL KI  ++G            
Sbjct: 179 LLQ-STYATPVDMWSVGCIFAEM-FRRKPLFCGNSEADQLGKIFDLIGLPP--------- 227

Query: 351 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHP 410
            E D   D  + R +  P            +       L ++L ++   R++A  A+ HP
Sbjct: 228 -EDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHP 286

Query: 411 YF 412
           +F
Sbjct: 287 FF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score =  119 bits (299), Expect = 5e-30
 Identities = 89/307 (28%), Positives = 154/307 (50%), Gaps = 28/307 (9%)

Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGP 180
           D E  R +G G +  V+   +    +R  +K +  V       K++ RE+K+L       
Sbjct: 1   DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKML-CFFKHD 59

Query: 181 NVVKLLDIVRDQHSKTPSLIF---EYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYC 235
           NV+  LDI++  H      I+   E + S   K++     L+   ++ ++Y++L+ L Y 
Sbjct: 60  NVLSALDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYL 119

Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP--GKEYNVRVASRYFKGPELLVD 293
           HS GI+HRD+KP N++++     L++ D+GLA    P   K     V ++Y++ PE+L+ 
Sbjct: 120 HSAGILHRDIKPGNLLVNSNCV-LKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMG 178

Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 353
            + Y  ++D+WS+GC+FA ++ R+   F       QL  I  +LGT  L A   +   E 
Sbjct: 179 SRHYTSAVDIWSVGCIFAELLGRR-ILFQAQSPIQQLDLITDLLGTPSLEAM--RSACE- 234

Query: 354 DPQLDALVGRHSRKPWSK----FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 409
                A + R   KP S      +++   H    EA+  L ++L +D   R++A +A+AH
Sbjct: 235 --GARAHILRGPHKPPSLPVLYTLSSQATH----EAVHLLCRMLVFDPDKRISAADALAH 288

Query: 410 PYFAQVR 416
           PY  + R
Sbjct: 289 PYLDEGR 295

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  115 bits (290), Expect = 1e-29
 Identities = 78/301 (25%), Positives = 129/301 (42%), Gaps = 72/301 (23%)

Query: 133 VGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR---------EIKILQNLCGGPNVV 183
           +G+G + +V      +T +   +K+LK   KKKI +         E  IL  +   P +V
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLK---KKKIIKRKEVEHTLTERNILSRINH-PFIV 56

Query: 184 KLLDIVRDQHS--KTPS---LIFEYVNSTD-FKVLY--PTLTDYDIRYYIYELLKALDYC 235
           KL       H   +T     L+ EY    + F  L      ++   R+Y  E++ AL+Y 
Sbjct: 57  KL-------HYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYL 109

Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDL 294
           HS GI++RD+KP N+++D +   ++L D+GLA E    G   N    +  +  PE+L   
Sbjct: 110 HSLGIIYRDLKPENILLDAD-GHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVL-LG 167

Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 354
           + Y  ++D WSLG +   M+  K PF+   ++  ++                 +  L+  
Sbjct: 168 KGYGKAVDWWSLGVLLYEMLTGKPPFY--AEDRKEIY----------------EKILKDP 209

Query: 355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA---MAHPY 411
            +                        +SPEA D +  LL+ D   RL +  A    AHP+
Sbjct: 210 LRFPE--------------------FLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPF 249

Query: 412 F 412
           F
Sbjct: 250 F 250

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  113 bits (285), Expect = 5e-29
 Identities = 75/290 (25%), Positives = 121/290 (41%), Gaps = 51/290 (17%)

Query: 133 VGRGKYSEVFEGINVNTNERCIIKILKPVKK--------KKIKREIKILQNLCGGPNVVK 184
           +G G +  V+EG+N++  +   +K +             K++++EI +L  L   PN+V+
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQH-PNIVQ 66

Query: 185 LLDIVRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALDYCHSQGIM 241
            L   R+       +  E V       L   Y +  +  IR Y  ++L  L+Y H +  +
Sbjct: 67  YLGTERE--EDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTV 124

Query: 242 HRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSL 301
           HRD+K  N+++D     ++L D+G+A+             S Y+  PE++     Y  + 
Sbjct: 125 HRDIKGANILVDTN-GVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAA 183

Query: 302 DMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALV 361
           D+WSLGC    M   K P+        QL  +A V                        +
Sbjct: 184 DIWSLGCTVLEMATGKPPW-------SQLEGVAAVFK----------------------I 214

Query: 362 GRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 411
           GR    P          HL S EA DF+ K L+ D   R TA E + HP+
Sbjct: 215 GRSKELP------PIPDHL-SDEAKDFILKCLQRDPSLRPTAAELLEHPF 257

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  112 bits (283), Expect = 2e-28
 Identities = 84/312 (26%), Positives = 136/312 (43%), Gaps = 52/312 (16%)

Query: 119 VQWGDQDD-YEVVRKVGRGKYSEVFEGINVNTNERCIIK--ILKPVKKKKIKREIKILQN 175
           V  GD  + Y+ + K+G G   EV++  +  T +   IK   L+   K+ I  EI I+++
Sbjct: 12  VSEGDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKD 71

Query: 176 LCGGPNVVKLLDIVRDQHSKTPSLIFEYVNS---TDFKVLYPT---LTDYDIRYYIYELL 229
            C  PN+V   D           ++ EY++    TD  ++      + +  I Y   E+L
Sbjct: 72  -CKHPNIVDYYDSYLVG--DELWVVMEYMDGGSLTD--IITQNFVRMNEPQIAYVCREVL 126

Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGP 288
           + L+Y HSQ ++HRD+K  N+++  +   ++L D+G  A+      + N  V + Y+  P
Sbjct: 127 QGLEYLHSQNVIHRDIKSDNILLSKDGS-VKLADFGFAAQLTKEKSKRNSVVGTPYWMAP 185

Query: 289 ELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK 348
           E++   +DY   +D+WSLG M   M    EP                         YL  
Sbjct: 186 EVIKR-KDYGPKVDIWSLGIMCIEMA-EGEP------------------------PYLR- 218

Query: 349 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 408
                +P L AL    + K         N    SPE  DFL+K L  D + R +A E + 
Sbjct: 219 -----EPPLRALF-LITTKGIPPL---KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269

Query: 409 HPYFAQVRAAES 420
           HP+  +    E 
Sbjct: 270 HPFLKKACPKEE 281

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score =  111 bits (280), Expect = 1e-27
 Identities = 81/321 (25%), Positives = 146/321 (45%), Gaps = 58/321 (18%)

Query: 133 VGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK-----------------REIKILQN 175
           +G G Y +V +  +  T +   IK +K ++                      RE+KI+  
Sbjct: 17  LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76

Query: 176 LCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPT--LTDYDIRYYIYELLKALD 233
           +    N++ L+D+  +      +L+ + + S   KV+     LT+  ++  + ++L  L+
Sbjct: 77  I-KHENIMGLVDVYVEG--DFINLVMDIMASDLKKVVDRKIRLTESQVKCILLQILNGLN 133

Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA---------------EFYHPGKEYNV 278
             H    MHRD+ P N+ I+ +    ++ D+GLA               E     +E   
Sbjct: 134 VLHKWYFMHRDLSPANIFINSK-GICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTS 192

Query: 279 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLG 338
           +V + +++ PELL+  + Y +++DMWS+GC+FA ++  K P F G +  DQL +I ++LG
Sbjct: 193 KVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK-PLFPGENEIDQLGRIFELLG 251

Query: 339 TDELNAYLNKYHLELDPQLDALVGRHSRKPWS-----KFINADNQHLVSPEAIDFLDKLL 393
           T   + +     L L  +         RKP          + D        AID L  LL
Sbjct: 252 TPNEDNWPQAKKLPLYTEFTP------RKPKDLKTIFPNASDD--------AIDLLQSLL 297

Query: 394 RYDHQDRLTAREAMAHPYFAQ 414
           + +  +R++A+EA+ H YF  
Sbjct: 298 KLNPLERISAKEALKHEYFKS 318

Length = 335

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  108 bits (273), Expect = 3e-27
 Identities = 83/306 (27%), Positives = 129/306 (42%), Gaps = 66/306 (21%)

Query: 133 VGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR--------EIKILQNLCGGPNVVK 184
           + +G Y  VF     +T +   IK++K  K   I++        E  IL      P VVK
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIK--KADMIRKNQVDQVLTERDILSQ-AQSPYVVK 57

Query: 185 LLDIVRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALDYCHSQGIM 241
           L      Q  K   L+ EY+   D   L     +L +   R YI E++ AL+Y HS GI+
Sbjct: 58  LYYSF--QGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGII 115

Query: 242 HRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASR---------YFKGPELLV 292
           HRD+KP N++ID     L+L D+GL++     ++ N+    +          +  PE+++
Sbjct: 116 HRDLKPDNILIDSN-GHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVIL 174

Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE 352
             Q +  ++D WSLGC+    +    PF   H    + +    +L          K    
Sbjct: 175 -GQGHSKTVDWWSLGCILYEFLVGIPPF---HGETPEEI-FQNILN--------GKI--- 218

Query: 353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAR---EAMAH 409
                           W + +       VS EAID + KLL  D + RL A+   E   H
Sbjct: 219 ---------------EWPEDVE------VSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH 257

Query: 410 PYFAQV 415
           P+F  +
Sbjct: 258 PFFKGI 263

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score =  105 bits (264), Expect = 2e-25
 Identities = 83/324 (25%), Positives = 158/324 (48%), Gaps = 35/324 (10%)

Query: 113 DYESLTVQWGDQ-----DDYEVVRKVGRGKYSEVFE------GINVNTNERCIIKILKPV 161
           D +  +VQ  D        Y+ ++ +G G    V        GINV      + K+ +P 
Sbjct: 4   DSQFYSVQVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINV-----AVKKLSRPF 58

Query: 162 KK----KKIKREIKILQNLCGGPNVVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLY 213
           +     K+  RE+ +L+ +    N++ LL++   Q S    +   L+ E +++   +V++
Sbjct: 59  QNQTHAKRAYRELVLLKCV-NHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIH 117

Query: 214 PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 273
             L    + Y +Y++L  + + HS GI+HRD+KP N+++  +   L+++D+GLA      
Sbjct: 118 MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTACTN 176

Query: 274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333
                 V +RY++ PE+++ +  Y  ++D+WS+GC+   ++ +    F G D+ DQ  K+
Sbjct: 177 FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELV-KGSVIFQGTDHIDQWNKV 234

Query: 334 AKVLGTDELNAYLN------KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAID 387
            + LGT     ++N      + ++E  PQ   +        W     ++   L + +A D
Sbjct: 235 IEQLGTPSAE-FMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARD 293

Query: 388 FLDKLLRYDHQDRLTAREAMAHPY 411
            L K+L  D   R++  EA+ HPY
Sbjct: 294 LLSKMLVIDPDKRISVDEALRHPY 317

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score =  105 bits (263), Expect = 3e-25
 Identities = 82/301 (27%), Positives = 131/301 (43%), Gaps = 50/301 (16%)

Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGG 179
           D++++ +VG+G Y +VF     +T E   +K +K        + + +  E  IL      
Sbjct: 2   DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTT-TKS 60

Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCH 236
             +VKLL   +D   +   L  EYV   DF+ L      L++   R+Y+ E+ +A+D  H
Sbjct: 61  EWLVKLLYAFQD--DEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALH 118

Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY-NVRVASRYFKGPELLVDLQ 295
             G +HRD+KP N +ID     ++L D+GL++       Y N  V S  +  PE+L   +
Sbjct: 119 ELGYIHRDLKPENFLID-ASGHIKLTDFGLSK---GIVTYANSVVGSPDYMAPEVLRG-K 173

Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP 355
            YD+++D WSLGCM    +    PF                   +E    L  +   L  
Sbjct: 174 GYDFTVDYWSLGCMLYEFLCGFPPF--SGST------------PNETWENLKYWKETLQ- 218

Query: 356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTARE-AMAHPYFAQ 414
                     R  +      D +  +S EA D + KL+  D   R  + E    HP+F +
Sbjct: 219 ----------RPVYD-----DPRFNLSDEAWDLITKLIN-DPSRRFGSLEDIKNHPFFKE 262

Query: 415 V 415
           V
Sbjct: 263 V 263

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score =  105 bits (263), Expect = 3e-25
 Identities = 78/305 (25%), Positives = 151/305 (49%), Gaps = 29/305 (9%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-----PVKKKKIKREIKILQNLCGGPN 181
           Y+ ++ +G G    V    +  T +   IK L          K+  RE+ +++ L    N
Sbjct: 18  YQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMK-LVNHKN 76

Query: 182 VVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHS 237
           ++ LL++   Q S    +   L+ E +++   +V+   L    + Y +Y++L  + + HS
Sbjct: 77  IIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHS 136

Query: 238 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDY 297
            GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  Y
Sbjct: 137 AGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-GY 194

Query: 298 DYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQL 357
             ++D+WS+GC+   MI R    F G D+ DQ  KI + LGT   + ++++    L P +
Sbjct: 195 KENVDIWSVGCIMGEMI-RGTVLFPGTDHIDQWNKIIEQLGTPS-DEFMSR----LQPTV 248

Query: 358 DALV---GRHSRKPWSKFI--------NADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA 406
              V    +++   + +          +  +  L + +A D L K+L  D + R++  +A
Sbjct: 249 RNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDA 308

Query: 407 MAHPY 411
           + HPY
Sbjct: 309 LQHPY 313

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score =  100 bits (251), Expect = 3e-24
 Identities = 78/298 (26%), Positives = 127/298 (42%), Gaps = 53/298 (17%)

Query: 130 VRKVGRGKYSEVFEGINVNTNERCIIKILKP---VKKKKI---KREIKILQNLCGGPNVV 183
           ++ + +G +  V+     +T +   IK+LK    + K ++   K E  I+      P V 
Sbjct: 1   LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVA 60

Query: 184 KLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIYELLKALDYCHSQGI 240
           KL      Q      L+ EY+N  D   L  TL        + YI E++  ++  H +GI
Sbjct: 61  KLYYSF--QSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGI 118

Query: 241 MHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYS 300
           +HRD+KP N++ID +   L+L D+GL+      K++   V +  +  PE ++ + D D  
Sbjct: 119 IHRDIKPENLLID-QTGHLKLTDFGLSRNGLENKKF---VGTPDYLAPETILGVGD-DKM 173

Query: 301 LDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDAL 360
            D WSLGC+    +F   PF   H      V    +L                       
Sbjct: 174 SDWWSLGCVIFEFLFGYPPF---HAETPDAV-FDNIL----------------------- 206

Query: 361 VGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA---REAMAHPYFAQV 415
                R  W + +        SPEA+D +++LL  D   RL A   +E  +HP+F  +
Sbjct: 207 ---SRRINWPEEVK----EFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSI 257

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 99.7 bits (249), Expect = 7e-24
 Identities = 85/303 (28%), Positives = 137/303 (45%), Gaps = 67/303 (22%)

Query: 131 RKVGRGKYSEVFEGINVNTNERCIIKILK-----PVKKKKIKREIKILQNLCGGPNVVKL 185
            K+G G + +V+  +N++T E   +K ++     P   K+I  E+K+L+ L   PN+VK 
Sbjct: 6   NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELL-KHPNLVKY 64

Query: 186 --LDIVRDQHSKTPSLIF-EYVN-STDFKVL-YPTLTDYD-IRYYIYELLKALDYCHSQG 239
             +++ R++       IF EY +  T  ++L +  + D   IR Y  +LL+ L Y HS G
Sbjct: 65  YGVEVHREK-----VYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHG 119

Query: 240 IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG---------PEL 290
           I+HRD+KP N+ +DH    ++L D+G A                  +          PE+
Sbjct: 120 IVHRDIKPANIFLDHN-GVIKLGDFGCAVKLKNNT----TTMGEEVQSLAGTPAYMAPEV 174

Query: 291 LV--DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK 348
           +     + +  + D+WSLGC+   M   K P +   DN  Q++                 
Sbjct: 175 ITGGKGKGHGRAADIWSLGCVVLEMATGKRP-WSELDNEFQIM----------------- 216

Query: 349 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 408
           +H          VG   + P    I    Q  +SPE  DFLD+ L  D + R TA E + 
Sbjct: 217 FH----------VGAGHKPP----IPDSLQ--LSPEGKDFLDRCLESDPKKRPTASELLQ 260

Query: 409 HPY 411
           HP+
Sbjct: 261 HPF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 98.7 bits (247), Expect = 1e-23
 Identities = 51/209 (24%), Positives = 99/209 (47%), Gaps = 20/209 (9%)

Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKI-----LKPVKKKKIKREIKILQNLCGGP 180
            YE+++++G+G + +V+     +  +  ++K      +   +++    E+KIL+ L   P
Sbjct: 1   KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKL-NHP 59

Query: 181 NVVKLLD-IVRDQHSKTPSLIFEYVNSTD-------FKVLYPTLTDYDIRYYIYELLKAL 232
           N++K  +            ++ EY +  D        K       +  I  +  +L  AL
Sbjct: 60  NIIKYYESFEEKGKL---CIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLAL 116

Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY-NVRVASRYFKGPELL 291
            Y HS+ I+HRD+KP N+ +      ++L D+G+++      +     V + Y+  PEL 
Sbjct: 117 KYLHSRKILHRDIKPQNIFLTSN-GLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELC 175

Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
            + + Y+Y  D+WSLGC+   +   K PF
Sbjct: 176 QN-KPYNYKSDIWSLGCVLYELCTLKHPF 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 99.3 bits (247), Expect = 5e-23
 Identities = 80/304 (26%), Positives = 146/304 (48%), Gaps = 28/304 (9%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKIL-KPVKK----KKIKREIKILQNLCGGPN 181
           Y+ ++ +G G    V    +        IK L +P +     K+  RE+ +L       N
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYREL-VLMKCVNHKN 84

Query: 182 VVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHS 237
           ++ LL++   Q S    +   ++ E +++   +V+   L    + Y +Y++L  + + HS
Sbjct: 85  IIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS 144

Query: 238 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDY 297
            GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  Y
Sbjct: 145 AGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-GY 202

Query: 298 DYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQL 357
             ++D+WS+GC+   MI      F G D+ DQ  K+ + LGT        ++  +L P +
Sbjct: 203 KENVDIWSVGCIMGEMIKGG-VLFPGTDHIDQWNKVIEQLGTP-----CPEFMKKLQPTV 256

Query: 358 DALVGRHSRKPWSKF--------INADNQH--LVSPEAIDFLDKLLRYDHQDRLTAREAM 407
              V    +     F          AD++H  L + +A D L K+L  D   R++  EA+
Sbjct: 257 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL 316

Query: 408 AHPY 411
            HPY
Sbjct: 317 QHPY 320

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 97.0 bits (242), Expect = 9e-23
 Identities = 51/201 (25%), Positives = 91/201 (45%), Gaps = 19/201 (9%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--KKKIKREIKILQNLCGGPNV 182
             +E+V  +G G Y +V++  +  T +   IKI+  ++  +++IK E  IL+     PN+
Sbjct: 6   GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNI 65

Query: 183 VKLLDIVRDQHSKTPS----LIFEYVNS---TD----FKVLYPTLTDYDIRYYIYELLKA 231
                    ++         L+ E       TD     +     L +  I Y + E L+ 
Sbjct: 66  ATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRG 125

Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPE- 289
           L Y H   ++HRD+K  N+++      ++L+D+G+ A+        N  + + Y+  PE 
Sbjct: 126 LAYLHENKVIHRDIKGQNILLTKNAE-VKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEV 184

Query: 290 LLVDLQD---YDYSLDMWSLG 307
           +  D Q    YD   D+WSLG
Sbjct: 185 IACDEQPDASYDARSDVWSLG 205

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 98.2 bits (244), Expect = 9e-23
 Identities = 81/304 (26%), Positives = 148/304 (48%), Gaps = 28/304 (9%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKIL-KPVKK----KKIKREIKILQNLCGGPN 181
           Y+ ++ +G G    V    +   +    IK L +P +     K+  RE+ +L       N
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYREL-VLMKCVNHKN 77

Query: 182 VVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHS 237
           ++ LL++   Q S    +   L+ E +++   +V+   L    + Y +Y++L  + + HS
Sbjct: 78  IISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS 137

Query: 238 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDY 297
            GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  Y
Sbjct: 138 AGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-GY 195

Query: 298 DYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQL 357
             ++D+WS+GC+   M+ R +  F G D  DQ  K+ + LGT        ++  +L P +
Sbjct: 196 KENVDIWSVGCIMGEMV-RHKILFPGRDYIDQWNKVIEQLGTP-----CPEFMKKLQPTV 249

Query: 358 DALVGRHSRKPWSKF--------INADNQH--LVSPEAIDFLDKLLRYDHQDRLTAREAM 407
              V    +     F          AD++H  L + +A D L K+L  D   R++  EA+
Sbjct: 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEAL 309

Query: 408 AHPY 411
            HPY
Sbjct: 310 QHPY 313

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 95.4 bits (238), Expect = 2e-22
 Identities = 73/299 (24%), Positives = 135/299 (45%), Gaps = 57/299 (19%)

Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK-----IKREIKILQNLCGGP 180
           +Y++   +GRG +  V++G+N+ T +   IK +   K K+     I +EI +L+NL   P
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNL-KHP 59

Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD------IRYYIYELLKALDY 234
           N+VK +  +    S +  +I EY    +   L   +  +       +  Y+Y++L+ L Y
Sbjct: 60  NIVKYIGSIET--SDSLYIILEYA---ENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAY 114

Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVD 293
            H QG++HRD+K  N++   +   ++L D+G+A +     K+    V + Y+  PE +++
Sbjct: 115 LHEQGVIHRDIKAANILTTKD-GVVKLADFGVATKLNDVSKDDASVVGTPYWMAPE-VIE 172

Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 353
           +     + D+WSLGC    ++    P++                   +LN     + +  
Sbjct: 173 MSGASTASDIWSLGCTVIELLTGNPPYY-------------------DLNPMAALFRIVQ 213

Query: 354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 412
           D         H   P            +SPE  DFL +  + D   R TA++ + HP+ 
Sbjct: 214 DD--------HPPLPEG----------ISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 95.4 bits (238), Expect = 2e-22
 Identities = 71/297 (23%), Positives = 134/297 (45%), Gaps = 50/297 (16%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK--KKIKREIKILQNLCGGPN 181
           ++ ++++ K+G G Y  V++ I+  T +   IK++ PV++  ++I +EI IL+  C  P 
Sbjct: 2   EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVV-PVEEDLQEIIKEISILKQ-CDSPY 59

Query: 182 VVKLL-DIVRDQHSKTPSLIFEYVNSTDF----KVLYPTLTDYDIRYYIYELLKALDYCH 236
           +VK      ++       ++ EY  +       K+   TLT+ +I   +Y+ LK L+Y H
Sbjct: 60  IVKYYGSYFKNTDL---WIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLH 116

Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQ 295
           S   +HRD+K  N++++ E  + +L D+G++ +      + N  + + ++  PE++ +  
Sbjct: 117 SNKKIHRDIKAGNILLNEE-GQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQE-I 174

Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP 355
            Y+   D+WSLG     M   K P+   H     +  I                      
Sbjct: 175 GYNNKADIWSLGITAIEMAEGKPPYSDIHPMR-AIFMIPN-------------------- 213

Query: 356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 412
                      KP     +       SPE  DF+ K L  D ++R +A + + HP+ 
Sbjct: 214 -----------KPPPTLSD---PEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 93.1 bits (232), Expect = 1e-21
 Identities = 77/299 (25%), Positives = 130/299 (43%), Gaps = 55/299 (18%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKIL---KPVKKKKIK---REIKILQNLCGGP 180
           +E++R +G+G + +V      +T +   +K +   K V+K  ++    E +ILQ L   P
Sbjct: 2   FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQEL-NHP 60

Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYC 235
            +V L    +D   +   L+ + +   D +  Y        ++  ++++I E++ AL+Y 
Sbjct: 61  FLVNLWYSFQD--EENMYLVVDLLLGGDLR--YHLSQKVKFSEEQVKFWICEIVLALEYL 116

Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 295
           HS+GI+HRD+KP N+++D E   + + D+ +A    P         +  +  PE+L   Q
Sbjct: 117 HSKGIIHRDIKPDNILLD-EQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCR-Q 174

Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP 355
            Y  ++D WSLG      +  K P + GH    +    AK    D L             
Sbjct: 175 GYSVAVDWWSLGVTAYECLRGKRP-YRGHSRTIRDQIRAKQETADVL------------- 220

Query: 356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL--TAREAMAHPYF 412
                        WS             EAID ++KLL  D Q RL    ++   HPYF
Sbjct: 221 ---------YPATWST------------EAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 94.7 bits (236), Expect = 1e-21
 Identities = 89/334 (26%), Positives = 136/334 (40%), Gaps = 92/334 (27%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP---VKKKKI-----KREIKILQNL 176
           DD+EV++ +GRG + EV+   + +T +   +K+L+    +K+ +I     +R+I    + 
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADAD- 59

Query: 177 CGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALD 233
              P +VKL    +D+      L+ EY+   D   L        +   R+YI EL+ ALD
Sbjct: 60  --SPWIVKLYYSFQDEEHLY--LVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALD 115

Query: 234 YCHSQGIMHRDVKPHNVMID---HELRKLRLIDWGLA----------------------- 267
             H  G +HRD+KP N++ID   H    ++L D+GL                        
Sbjct: 116 SVHKLGFIHRDIKPDNILIDADGH----IKLADFGLCKKMNKAKDREYYLNDSHNLLFRD 171

Query: 268 ---EFYHPGKEYNVR----VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
                    K+  VR    V +  +  PE+L     Y    D WSLG +   M++   P 
Sbjct: 172 NVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG-TPYGLECDWWSLGVILYEMLYGFPP- 229

Query: 321 FYGHDNHDQLVKIAKVLGTDELNAYLN-KYHLELDPQLDALVGRHSRKPWSKFINADNQH 379
           FY     +   KI            +N K  L   P                        
Sbjct: 230 FYSDTLQETYNKI------------INWKESLRFPP----------------------DP 255

Query: 380 LVSPEAIDFLDKLLRYDHQDRLT-AREAMAHPYF 412
            VSPEAID + +LL  D +DRL    E  +HP+F
Sbjct: 256 PVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFF 288

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 94.0 bits (233), Expect = 2e-21
 Identities = 80/314 (25%), Positives = 146/314 (46%), Gaps = 37/314 (11%)

Query: 132 KVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK----REIKILQNLCGGPNVVKLLD 187
           KVGRG Y  V++    +  +      LK ++   I     REI +L+ L   PNV+ L  
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDEKEYA-LKQIEGTGISMSACREIALLREL-KHPNVIALQK 65

Query: 188 IVRDQHSKTPSLIFEYVNSTDFKVLY-----------PTLTDYDIRYYIYELLKALDYCH 236
           +      +   L+F+Y     + ++              L    ++  +Y++L  + Y H
Sbjct: 66  VFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH 125

Query: 237 SQGIMHRDVKPHNVMI---DHELRKLRLIDWGLAEFYH----PGKEYNVRVASRYFKGPE 289
           +  ++HRD+KP N+++     E  ++++ D G A  ++    P  + +  V + +++ PE
Sbjct: 126 ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 185

Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD---------NHDQLVKIAKVLGTD 340
           LL+  + Y  ++D+W++GC+FA ++   EP F+            +HDQL +I  V+G  
Sbjct: 186 LLLGARHYTKAIDIWAIGCIFAELL-TSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFP 244

Query: 341 ELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDF--LDKLLRYDHQ 398
               + +   +   P L     R +    S  I    +H V P++  F  L KLL  D  
Sbjct: 245 ADKDWEDIRKMPEYPTLQKDF-RRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPT 303

Query: 399 DRLTAREAMAHPYF 412
            R+T+ +A+  PYF
Sbjct: 304 KRITSEQALQDPYF 317

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 94.0 bits (233), Expect = 2e-21
 Identities = 81/316 (25%), Positives = 148/316 (46%), Gaps = 41/316 (12%)

Query: 132 KVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK----REIKILQNLCGGPNVVKLLD 187
           KVGRG Y  V++    +  +      LK ++   I     REI +L+ L   PNV+ L  
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDDRDYA-LKQIEGTGISMSACREIALLREL-KHPNVISLQK 65

Query: 188 IVRDQHSKTPSLIFEYVNSTDFKVLY-----------PTLTDYDIRYYIYELLKALDYCH 236
           +      +   L+F+Y     + ++              L    ++  +Y++L  + Y H
Sbjct: 66  VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 125

Query: 237 SQGIMHRDVKPHNVMI---DHELRKLRLIDWGLAEFYH----PGKEYNVRVASRYFKGPE 289
           +  ++HRD+KP N+++     E  ++++ D G A  ++    P  + +  V + +++ PE
Sbjct: 126 ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 185

Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD---------NHDQLVKIAKVLGTD 340
           LL+  + Y  ++D+W++GC+FA ++   EP F+            +HDQL +I  V+G  
Sbjct: 186 LLLGARHYTKAIDIWAIGCIFAELL-TSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMG-- 242

Query: 341 ELNAYLNKYHLELDPQLDALVGRHSRKPWSK--FINADNQHLVSPE--AIDFLDKLLRYD 396
              A  +   ++  P+   L+    R  ++    I    +H V P+  A   L KLL  D
Sbjct: 243 -FPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMD 301

Query: 397 HQDRLTAREAMAHPYF 412
              R+T+ +AM  PYF
Sbjct: 302 PIKRITSEQAMQDPYF 317

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 92.9 bits (231), Expect = 2e-21
 Identities = 56/211 (26%), Positives = 104/211 (49%), Gaps = 19/211 (9%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK------PVKKKKIKREIKILQNLCG 178
            ++++ +K+G+G++S V++ I +       +K ++         ++   +EI +L+ L  
Sbjct: 2   GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQL-D 60

Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTD-------FKVLYPTLTDYDIRYYIYELLKA 231
            PNV+K L    + +     ++ E  ++ D       FK     + +  I  Y  +L  A
Sbjct: 61  HPNVIKYLASFIENNELN--IVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSA 118

Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPEL 290
           L++ HS+ IMHRD+KP NV I      ++L D GL  F+       +  V + Y+  PE 
Sbjct: 119 LEHMHSKRIMHRDIKPANVFITAT-GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPER 177

Query: 291 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
           + +   Y++  D+WSLGC+   M   + PF+
Sbjct: 178 IHE-NGYNFKSDIWSLGCLLYEMAALQSPFY 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 87.2 bits (216), Expect = 2e-19
 Identities = 75/305 (24%), Positives = 134/305 (43%), Gaps = 68/305 (22%)

Query: 133 VGRGKYSEVFEGINVNTNERCIIKILKPVKK-------------KKIKREIKILQNLCGG 179
           +G+G Y  V+  +NV T E   +K ++                 K ++ EI+ L++L   
Sbjct: 9   IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL-DH 67

Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIYELLKALDYCH 236
            N+V+ L     +  +  S+  EYV          T   ++   +R++  ++L+ L Y H
Sbjct: 68  LNIVQYLGFETTE--EYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLH 125

Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGL----AEFYHPGKEYNVRVASRYFKGPELLV 292
           S+GI+HRD+K  N+++D +    ++ D+G+     + Y   +  +++  S ++  PE ++
Sbjct: 126 SKGILHRDLKADNLLVDAD-GICKISDFGISKKSDDIYDNDQNMSMQ-GSVFWMAPE-VI 182

Query: 293 DLQDYDYS--LDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYL 346
                 YS  +D+WSLGC    MFAG    + P+                   +E  A +
Sbjct: 183 HSYSQGYSAKVDIWSLGCVVLEMFAG----RRPW-----------------SDEEAIAAM 221

Query: 347 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA 406
            K            +G     P    I  D    +SP A+DFL+     +  +R TARE 
Sbjct: 222 FK------------LGNKRSAP---PIPPDVSMNLSPVALDFLNACFTINPDNRPTAREL 266

Query: 407 MAHPY 411
           + HP+
Sbjct: 267 LQHPF 271

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 85.3 bits (211), Expect = 8e-19
 Identities = 73/301 (24%), Positives = 128/301 (42%), Gaps = 64/301 (21%)

Query: 133 VGRGKYSEVFEGINVNTNERCIIKIL-------KPVKKKK-----IKREIKILQNLCGGP 180
           +G G +  V+ G+N ++ E   +K +           +K+     + REI +L+ L    
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL-QHE 66

Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALDYCHS 237
           N+V+ L    D       +  EYV       L   Y    +  +R ++ ++LK L+Y H+
Sbjct: 67  NIVQYLGSSLDADHLN--IFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHN 124

Query: 238 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASR-------YFKGPEL 290
           +GI+HRD+K  N+++D++   +++ D+G+++             +R       ++  PE 
Sbjct: 125 RGIIHRDIKGANILVDNK-GGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPE- 182

Query: 291 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH 350
           +V    Y    D+WSLGC+   M+  K PF     +  QL  I K+              
Sbjct: 183 VVKQTSYTRKADIWSLGCLVVEMLTGKHPF----PDCTQLQAIFKI-------------- 224

Query: 351 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHP 410
                               +  + +    +S EAIDFL+K    DH  R TA E + HP
Sbjct: 225 -------------------GENASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHP 265

Query: 411 Y 411
           +
Sbjct: 266 F 266

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 83.3 bits (206), Expect = 6e-18
 Identities = 75/297 (25%), Positives = 122/297 (41%), Gaps = 57/297 (19%)

Query: 133 VGRGKYSEVFEGINVNTNERCIIKIL--KPVKKKKIKR----EIKILQNLCGGPNVVKLL 186
           +G+G + EV       T +    K L  K +KK+K ++    E KIL+       +V L 
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILE-KVSSRFIVSL- 58

Query: 187 DIVRDQHSKTP-SLIFEYVNSTDFK-----VLYPTLTDYDIRYYIYELLKALDYCHSQGI 240
                  +K    L+   +N  D K     V  P   +    +Y  +++  L++ H + I
Sbjct: 59  --AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRI 116

Query: 241 MHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYS 300
           ++RD+KP NV++D +   +R+ D GLA     GK+   R  +  +  PE+L   + YD+S
Sbjct: 117 VYRDLKPENVLLD-DHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQG-EVYDFS 174

Query: 301 LDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDAL 360
           +D ++LGC    MI  + PF                           K            
Sbjct: 175 VDWFALGCTLYEMIAGRSPF----------------------RQRKEK------------ 200

Query: 361 VGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYF 412
           V +   K  +  +  +     SPEA D  + LL+ D + RL     +A E   HP F
Sbjct: 201 VEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLF 257

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 82.3 bits (204), Expect = 1e-17
 Identities = 70/295 (23%), Positives = 123/295 (41%), Gaps = 47/295 (15%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK----PVKKKKIKREIKILQNLCGGP 180
            D E V+ +G+G    V++  +  T +   +K +        +K++ RE+K L++ C  P
Sbjct: 1   SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRS-CESP 59

Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNS---TDFKVLYPTLTDYDIRYYIYELLKALDYCHS 237
            VVK             S++ EY++     D       + +  + Y   ++LK LDY H+
Sbjct: 60  YVVKCYGAF--YKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHT 117

Query: 238 Q-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY-NVRVASRYFKGPELLVDLQ 295
           +  I+HRD+KP N++I+ +  ++++ D+G+++      +  N  V +  +  PE +   +
Sbjct: 118 KRHIIHRDIKPSNLLINSK-GEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERI-QGE 175

Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP 355
            Y Y+ D+WSLG         K PF                    EL   +        P
Sbjct: 176 SYSYAADIWSLGLTLLECALGKFPF-----------LPPGQPSFFELMQAICD---GPPP 221

Query: 356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHP 410
            L A                      SPE  DF+   L+ D + R +A E + HP
Sbjct: 222 SLPA-------------------EEFSPEFRDFISACLQKDPKKRPSAAELLQHP 257

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 82.4 bits (203), Expect = 1e-17
 Identities = 60/200 (30%), Positives = 98/200 (49%), Gaps = 18/200 (9%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK--KKIKREIKILQNLCGGPNV 182
           D +E++  +G+G Y +V++  N        +KIL P+    ++I+ E  ILQ+L   PNV
Sbjct: 22  DTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNV 81

Query: 183 VKLLDIV--RDQHSKTPS-LIFEYVNSTDFKVLYP-------TLTDYDIRYYIYELLKAL 232
           VK   +    D+       L+ E  N      L          L +  I Y +Y  L  L
Sbjct: 82  VKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGL 141

Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELL 291
            + H+  I+HRDVK +N+++  E   ++L+D+G+ A+        N  V + ++  PE++
Sbjct: 142 QHLHNNRIIHRDVKGNNILLTTE-GGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVI 200

Query: 292 VDLQDYDYSL----DMWSLG 307
              Q YDYS     D+WSLG
Sbjct: 201 ACEQQYDYSYDARCDVWSLG 220

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 81.6 bits (202), Expect = 2e-17
 Identities = 67/305 (21%), Positives = 124/305 (40%), Gaps = 54/305 (17%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKI----LKPVKKKKIKREIKILQNLCGGP 180
           DD E + ++G G    V + ++  T +   +K     +    +K+I RE+ IL   C  P
Sbjct: 1   DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHK-CNSP 59

Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCH 236
            +V       +      S+  EY++      +       + +  +      +LK L Y H
Sbjct: 60  YIVGFYGAFYNNG--DISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLH 117

Query: 237 SQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN----VRVASRYFKGPELL 291
            +  I+HRDVKP N++++    +++L D+G++     G+  N      V +  +  PE +
Sbjct: 118 EKHKIIHRDVKPSNILVNS-RGQIKLCDFGVS-----GQLVNSLAKTFVGTSSYMAPERI 171

Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL 351
               DY    D+WSLG     +   + P+       +       +   + L   +N    
Sbjct: 172 QGN-DYSVKSDIWSLGLSLIELATGRFPY----PPENDPPD--GIF--ELLQYIVN---- 218

Query: 352 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 411
           E  P+L          P  KF         SP+  DF++  L  D ++R + +E + HP+
Sbjct: 219 EPPPRL----------PSGKF---------SPDFQDFVNLCLIKDPRERPSYKELLEHPF 259

Query: 412 FAQVR 416
             +  
Sbjct: 260 IKKYE 264

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 80.8 bits (199), Expect = 3e-17
 Identities = 55/210 (26%), Positives = 106/210 (50%), Gaps = 19/210 (9%)

Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERC------IIKILKPVKKKKIKREIKILQNLCGG 179
           ++++ +K+GRG++SEV+    +   +        I +++    ++   +EI +L+ L   
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQL-NH 61

Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTD-------FKVLYPTLTDYDIRYYIYELLKAL 232
           PNV+K LD   + +    +++ E  ++ D       FK     + +  +  Y  +L  A+
Sbjct: 62  PNVIKYLDSFIEDNEL--NIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAV 119

Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP-GKEYNVRVASRYFKGPELL 291
           ++ HS+ +MHRD+KP NV I      ++L D GL  F+       +  V + Y+  PE +
Sbjct: 120 EHMHSRRVMHRDIKPANVFITAT-GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI 178

Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
            +   Y++  D+WSLGC+   M   + PF+
Sbjct: 179 HE-NGYNFKSDIWSLGCLLYEMAALQSPFY 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 80.9 bits (200), Expect = 4e-17
 Identities = 57/209 (27%), Positives = 93/209 (44%), Gaps = 20/209 (9%)

Query: 133 VGRGKYSEVFEGINVNTNERCIIKILK----PVKKKKIKREIKILQNLCGG--PNVVKLL 186
           +GRG Y  V+ G +V T     +KI+           I+RE+ +L  L     PN+ K  
Sbjct: 9   IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68

Query: 187 DIVRDQHSKTPSL--IFEYVNSTDFKVLYPT--LTDYDIRYYIYELLKALDYCHSQGIMH 242
                 + K P L  I EY      + L     + +  I   I E+L AL Y H  G++H
Sbjct: 69  G----SYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKVGVIH 124

Query: 243 RDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSL 301
           RD+K  N+++ +    ++L D+G+ A       + +  V + Y+  PE++ + + YD   
Sbjct: 125 RDIKAANILVTNT-GNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKA 183

Query: 302 DMWSLGCMFAGMIFRKEPFFYGHDNHDQL 330
           D+WSLG     M     P    + + D  
Sbjct: 184 DIWSLGITIYEMATGNPP----YSDVDAF 208

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 80.4 bits (199), Expect = 5e-17
 Identities = 68/300 (22%), Positives = 123/300 (41%), Gaps = 60/300 (20%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK----IKREIKILQNLCGGP 180
           + + ++  +G+G + EV++ I+  TN+   IK++   + +     I++EI+ L   C  P
Sbjct: 1   ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQ-CRSP 59

Query: 181 NVVKLLDIVRDQHSKTPSL--IFEYV-NSTDFKVLYP-TLTDYDIRYYIYELLKALDYCH 236
            + K          K   L  I EY    +   +L P  L +  I + + E+L  L+Y H
Sbjct: 60  YITKYYGSF----LKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLH 115

Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQ 295
            +G +HRD+K  N+++  E   ++L D+G++ +      + N  V + ++  PE++    
Sbjct: 116 EEGKIHRDIKAANILLSEE-GDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQ-S 173

Query: 296 DYDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL 351
            YD   D+WSLG     +  G     EP          L  I K                
Sbjct: 174 GYDEKADIWSLGITAIELAKG-----EPPLSDLHPMRVLFLIPK---------------- 212

Query: 352 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 411
              P L+                    +  S    DF+   L  D ++R +A+E + H +
Sbjct: 213 NNPPSLEG-------------------NKFSKPFKDFVSLCLNKDPKERPSAKELLKHKF 253

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 79.7 bits (197), Expect = 7e-17
 Identities = 54/214 (25%), Positives = 93/214 (43%), Gaps = 51/214 (23%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK----PVKKKKIKREIKILQNLCGGP 180
           DDYE++  +G G  + V+  I +  NE+  IK +          ++++E++ + + C  P
Sbjct: 1   DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAM-SQCNHP 59

Query: 181 NVVK----------------------LLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTD 218
           NVVK                      LLDI++   S  P    +                
Sbjct: 60  NVVKYYTSFVVGDELWLVMPYLSGGSLLDIMK---SSYPRGGLDEAI------------- 103

Query: 219 YDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPG---- 273
             I   + E+LK L+Y HS G +HRD+K  N+++  E   +++ D+G+ A     G    
Sbjct: 104 --IATVLKEVLKGLEYLHSNGQIHRDIKAGNILLG-EDGSVKIADFGVSASLADGGDRTR 160

Query: 274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLG 307
           K     V +  +  PE++  +  YD+  D+WS G
Sbjct: 161 KVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFG 194

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 79.6 bits (197), Expect = 7e-17
 Identities = 61/225 (27%), Positives = 102/225 (45%), Gaps = 23/225 (10%)

Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIK-----ILKPVKKKKIKREIKILQNLCGGP 180
           DYEV+  +G+G +  V +    +  +  + K      +   +K+++  E+ IL+ L   P
Sbjct: 1   DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILREL-KHP 59

Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIY----ELLKALD 233
           N+V+  D + D+ ++T  ++ EY    D   L         Y    +I+    +LL AL 
Sbjct: 60  NIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALY 119

Query: 234 YCH-----SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY-NVRVASRYFKG 287
            CH        ++HRD+KP N+ +D     ++L D+GLA+       +    V + Y+  
Sbjct: 120 ECHNRSDPGNTVLHRDLKPANIFLD-ANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMS 178

Query: 288 PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVK 332
           PE L     YD   D+WSLGC+   +     P F    N  QL  
Sbjct: 179 PEQLNH-MSYDEKSDIWSLGCLIYELCALSPP-FTAR-NQLQLAS 220

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 79.6 bits (197), Expect = 8e-17
 Identities = 72/298 (24%), Positives = 129/298 (43%), Gaps = 47/298 (15%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK---KKIKREIKILQNLCGGP 180
           Q+DYE+++++G G Y +V++  ++ T E   IK++K       + I++EI +L+  C  P
Sbjct: 2   QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKE-CRHP 60

Query: 181 NVVKLLDIVRDQHSKTPSLIFEYV--NSTD--FKVLYPTLTDYDIRYYIYELLKALDYCH 236
           N+V        +      ++ EY    S    ++V    L++  I Y   E LK L Y H
Sbjct: 61  NIVAYFGSYLRRD--KLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLH 118

Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLVDLQ 295
             G +HRD+K  N+++  E   ++L D+G+ A+      +    + + Y+  PE+    +
Sbjct: 119 ETGKIHRDIKGANILLT-EDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVER 177

Query: 296 --DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 353
              YD   D+W+LG     +   + P F  H          + L                
Sbjct: 178 KGGYDGKCDIWALGITAIELAELQPPMFDLH--------PMRAL---------------- 213

Query: 354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 411
                 L+ + +  P        ++   SP   DF+ K L  D + R TA + + HP+
Sbjct: 214 -----FLISKSNFPPPK----LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 79.1 bits (196), Expect = 2e-16
 Identities = 61/223 (27%), Positives = 106/223 (47%), Gaps = 34/223 (15%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL---KPVKKKK---IKREIKILQNLCG 178
           DD+E ++ +G G +  V    +  + +   +KIL   K VK K+   +  E +ILQ++  
Sbjct: 1   DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60

Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVL--YPTLTDYDIRYYIYELLKALDYC 235
            P +V L      Q      L+ EYV   + F  L       +   R+Y  +++ AL+Y 
Sbjct: 61  -PFLVNLYG--SFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYL 117

Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK--------G 287
           HS  I++RD+KP N+++D +   +++ D+G A           RV  R +          
Sbjct: 118 HSLDIVYRDLKPENLLLDSD-GYIKITDFGFA----------KRVKGRTYTLCGTPEYLA 166

Query: 288 PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL 330
           PE+++  + Y  ++D W+LG +   M+    PFF   DN  Q+
Sbjct: 167 PEIIL-SKGYGKAVDWWALGILIYEMLAGYPPFF--DDNPIQI 206

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 79.0 bits (194), Expect = 2e-16
 Identities = 80/311 (25%), Positives = 137/311 (44%), Gaps = 51/311 (16%)

Query: 119 VQWGD-QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIK---ILKPVKKKKIKREIKILQ 174
           V  GD +  Y    K+G+G    VF  I+V T +   IK   + K  KK+ I  EI +++
Sbjct: 12  VSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMK 71

Query: 175 NLCGGPNVVKLLD--IVRDQHSKTPSLIFEYVNSTDFK--VLYPTLTDYDIRYYIYELLK 230
            L   PN+V  LD  +V D+      ++ EY+        V    + +  I     E L+
Sbjct: 72  EL-KNPNIVNFLDSFLVGDELF----VVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQ 126

Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPE 289
           AL++ H+  ++HRD+K  NV++  +   ++L D+G      P + + +  V + Y+  PE
Sbjct: 127 ALEFLHANQVIHRDIKSDNVLLGMD-GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE 185

Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY 349
            +V  + Y   +D+WSLG M   M+  + P+   ++N  + + +    GT EL       
Sbjct: 186 -VVTRKAYGPKVDIWSLGIMAIEMVEGEPPYL--NENPLRALYLIATNGTPELQ------ 236

Query: 350 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 409
                                      N   +SP   DFL++ L  D + R +A+E + H
Sbjct: 237 ---------------------------NPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269

Query: 410 PYFAQVRAAES 420
           P+    +   S
Sbjct: 270 PFLKLAKPLSS 280

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 78.4 bits (194), Expect = 2e-16
 Identities = 69/294 (23%), Positives = 135/294 (45%), Gaps = 53/294 (18%)

Query: 133 VGRGKYSEVFEGINVNTNE----RCIIK--ILKPVKKKKIKREIKILQNLCGGPNVVKLL 186
           +G G +  V      + N     +C+ K  I++  +++ I  E +IL+  C  P +VKL 
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEE-CNHPFIVKLY 59

Query: 187 DIVRDQHSKTPSLIFEYVNSTD-FKVLYP--TLTDYDIRYYIYELLKALDYCHSQGIMHR 243
              +D+  K   ++ EY    + + +L       +Y  R+YI  ++ A +Y H++GI++R
Sbjct: 60  RTFKDK--KYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYR 117

Query: 244 DVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDM 303
           D+KP N+++D     ++L+D+G A+    G++      +  +  PE++++ + YD+S+D 
Sbjct: 118 DLKPENLLLDSNGY-VKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILN-KGYDFSVDY 175

Query: 304 WSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGR 363
           WSLG +   ++  + PF  G D+ D +     +L             LE           
Sbjct: 176 WSLGILLYELLTGRPPF--GEDDEDPMEIYNDILK--------GNGKLE----------- 214

Query: 364 HSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYF 412
                +  +I           A D + +LLR + ++RL       ++   H +F
Sbjct: 215 -----FPNYI--------DKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWF 255

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 78.0 bits (192), Expect = 3e-16
 Identities = 71/299 (23%), Positives = 120/299 (40%), Gaps = 58/299 (19%)

Query: 133 VGRGKYSEVFEGINVNTNERCIIKILKPVKKKK---------IKREIKILQNLCGGPNVV 183
           +G G +S  ++  +V T     +K +  V+            +++EI+++  L   P+++
Sbjct: 8   LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL-NHPHII 66

Query: 184 KLLDIVRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALDYCHSQGI 240
           ++L           +L  E++       L   Y    +  I  Y  +LL+ L Y H   I
Sbjct: 67  RMLGAT--CEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQI 124

Query: 241 MHRDVKPHNVMIDHELRKLRLIDWGLA-----EFYHPGKEYNVRVASRYFKGPELLVDLQ 295
           +HRDVK  N++ID   ++LR+ D+G A     +    G+     + +  F  PE+L   +
Sbjct: 125 IHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRG-E 183

Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPF-FYGHDNHDQLV-KIAKVLGTDELNAYLNKYHLEL 353
            Y  S D+WS+GC+   M   K P+    H NH  L+ KIA       +  +L       
Sbjct: 184 QYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHL------- 236

Query: 354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 412
                                       SP   D   + L    +DR  +RE + HP F
Sbjct: 237 ----------------------------SPGLRDVTLRCLELQPEDRPPSRELLKHPVF 267

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 77.7 bits (191), Expect = 4e-16
 Identities = 56/200 (28%), Positives = 96/200 (48%), Gaps = 18/200 (9%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--KKKIKREIKILQNLCGGPNV 182
           D +E++  +G+G Y +VF+ +N     +  +KIL P+    ++I+ E  IL+ L   PNV
Sbjct: 18  DTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNV 77

Query: 183 VKLLDIVRDQHSKTPS---LIFEYVNSTDFKVLYP-------TLTDYDIRYYIYELLKAL 232
           VK   +   +  K      L+ E  N      L          + +  I Y ++E L  L
Sbjct: 78  VKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGL 137

Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELL 291
            + H    +HRDVK +N+++  E   ++L+D+G+ A+        N  V + ++  PE++
Sbjct: 138 QHLHVNKTIHRDVKGNNILLTTE-GGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVI 196

Query: 292 VDLQD----YDYSLDMWSLG 307
              Q     YD   D+WSLG
Sbjct: 197 ACEQQLDSTYDARCDVWSLG 216

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 77.1 bits (190), Expect = 7e-16
 Identities = 48/207 (23%), Positives = 92/207 (44%), Gaps = 19/207 (9%)

Query: 130 VRKVGRGKYSEV----FEGINVNTNERCIIKILK----PVKKKKIKREIKILQNLCGGPN 181
           ++++G G + +V    ++ +  NT E+  +K L        +   +REI+IL+ L    N
Sbjct: 9   IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTL-DHEN 67

Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIR----YYIYELLKALDYCHS 237
           +VK   +      ++  LI EY+ S   +       D         +  ++ K +DY  S
Sbjct: 68  IVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGS 127

Query: 238 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY----NVRVASRYFKGPELLVD 293
           Q  +HRD+   N++++ E   +++ D+GLA+     K+Y        +  ++  PE L  
Sbjct: 128 QRYIHRDLAARNILVESE-DLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRT 186

Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPF 320
            +    S D+WS G     +    +P 
Sbjct: 187 SKFSSAS-DVWSFGVTLYELFTYGDPS 212

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 76.3 bits (188), Expect = 1e-15
 Identities = 67/250 (26%), Positives = 110/250 (44%), Gaps = 54/250 (21%)

Query: 180 PNVVKLLD--IVRDQHSKTPSLIFEYVNS---TDFKVLYPTLTDYDIRYYIYELLKALDY 234
           PN+V++    +V D+      ++ E++     TD  V +  + +  I      +LKAL +
Sbjct: 76  PNIVEMYSSYLVGDELW----VVMEFLEGGALTDI-VTHTRMNEEQIATVCLAVLKALSF 130

Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR---VASRYFKGPELL 291
            H+QG++HRD+K  ++++  + R ++L D+G        KE   R   V + Y+  PE++
Sbjct: 131 LHAQGVIHRDIKSDSILLTSDGR-VKLSDFGFCA--QVSKEVPRRKSLVGTPYWMAPEVI 187

Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL 351
             L  Y   +D+WSLG M   M+  + P+F                              
Sbjct: 188 SRLP-YGTEVDIWSLGIMVIEMVDGEPPYFN----------------------------- 217

Query: 352 ELDPQLDALVG-RHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHP 410
             +P L A+   R +  P  K     N H VSP    FLD++L  D   R TA E + HP
Sbjct: 218 --EPPLQAMKRIRDNLPPKLK-----NLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHP 270

Query: 411 YFAQVRAAES 420
           + A+     S
Sbjct: 271 FLAKAGPPSS 280

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 77.2 bits (190), Expect = 1e-15
 Identities = 61/215 (28%), Positives = 97/215 (45%), Gaps = 25/215 (11%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--------VKKKKIKREIKILQNL 176
            D++V   VGRG + EV       T +   +K++K         V   + +R+I  + N 
Sbjct: 1   KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISN- 59

Query: 177 CGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYD-IRYYIYELLKAL 232
              P + +L    +D+ +    L+ EY    D   L   Y    D D  ++Y+ EL+ A+
Sbjct: 60  --SPWIPQLQYAFQDKDNLY--LVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAI 115

Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR--VASRYFKGPEL 290
              H  G +HRD+KP NV+ID     ++L D+G A      K  N +  V +  +  PE+
Sbjct: 116 HSVHQMGYVHRDIKPENVLID-RTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEV 174

Query: 291 LVDLQD-----YDYSLDMWSLGCMFAGMIFRKEPF 320
           L  +       Y    D WSLG +   MI+ + PF
Sbjct: 175 LTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPF 209

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 76.1 bits (187), Expect = 2e-15
 Identities = 81/314 (25%), Positives = 137/314 (43%), Gaps = 57/314 (18%)

Query: 119 VQWGDQD-DYEVVRKVGRGKYSEVFEGINVNTNERCIIK---ILKPVKKKKIKREIKILQ 174
           V  GD    Y    K+G+G    V+  I+V T +   IK   + +  KK+ I  EI +++
Sbjct: 12  VSVGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMR 71

Query: 175 NLCGGPNVVKLLD--IVRDQHSKTPSLIFEYV---NSTDFKVLYPTLTDYDIRYYIYELL 229
                PN+V  LD  +V D+      ++ EY+   + TD  V    + +  I     E L
Sbjct: 72  EN-KHPNIVNYLDSYLVGDELW----VVMEYLAGGSLTDV-VTETCMDEGQIAAVCRECL 125

Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR---VASRYFK 286
           +AL++ HS  ++HRD+K  N+++  +   ++L D+G      P  E + R   V + Y+ 
Sbjct: 126 QALEFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITP--EQSKRSTMVGTPYWM 182

Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYL 346
            PE +V  + Y   +D+WSLG M   M+  + P  Y ++N  + + +    GT EL    
Sbjct: 183 APE-VVTRKAYGPKVDIWSLGIMAIEMVEGEPP--YLNENPLRALYLIATNGTPEL---- 235

Query: 347 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA 406
                      + L                     S    DFL++ L  D + R +A+E 
Sbjct: 236 --------QNPEKL---------------------SAIFRDFLNRCLEMDVEKRGSAKEL 266

Query: 407 MAHPYFAQVRAAES 420
           + HP+    +   S
Sbjct: 267 LQHPFLKIAKPLSS 280

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 75.9 bits (186), Expect = 3e-15
 Identities = 76/300 (25%), Positives = 132/300 (44%), Gaps = 58/300 (19%)

Query: 130 VRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK------IKREIKILQNLCGGPNVV 183
           +R++G G +  V+   +V TNE   IK +    K+       I +E+K LQ +   PN +
Sbjct: 30  LREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRI-KHPNSI 88

Query: 184 KLLDIVRDQHSKTPSLIFEYV--NSTDF-KVLYPTLTDYDIRYYIYELLKALDYCHSQGI 240
           +       +H  T  L+ EY   +++D  +V    L + +I    +  L+ L Y HS  +
Sbjct: 89  EYKGCYLREH--TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNM 146

Query: 241 MHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD--YD 298
           +HRD+K  N+++  E  +++L D+G A    P   +   V + Y+  PE+++ + +  YD
Sbjct: 147 IHRDIKAGNILLT-EPGQVKLADFGSASIASPANSF---VGTPYWMAPEVILAMDEGQYD 202

Query: 299 YSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD--PQ 356
             +D+WSLG     +  RK P F                    +NA    YH+  +  P 
Sbjct: 203 GKVDVWSLGITCIELAERKPPLF-------------------NMNAMSALYHIAQNESPT 243

Query: 357 LDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR 416
           L +         WS +              +F+D  L+   QDR T+ E + H +  + R
Sbjct: 244 LQS-------NEWSDYFR------------NFVDSCLQKIPQDRPTSEELLKHMFVLRER 284

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 77.9 bits (191), Expect = 3e-15
 Identities = 65/260 (25%), Positives = 125/260 (48%), Gaps = 44/260 (16%)

Query: 108 PKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKI-----LKPVK 162
           P +Y D ES        ++YEV++K+G G++ EVF   +  T E    K      LK  +
Sbjct: 2   PGKYDDGESRL------NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKERE 55

Query: 163 KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFK-------VLYPT 215
           K ++  E+ +++ L    N+V+ +D   ++ ++   ++ E+ ++ D          ++  
Sbjct: 56  KSQLVIEVNVMREL-KHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGK 114

Query: 216 LTDYDIRYYIYELLKALDYCHS-------QGIMHRDVKPHNVMIDHELRKL--------- 259
           + ++ I     +LL AL YCH+       + ++HRD+KP N+ +   +R +         
Sbjct: 115 IEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANN 174

Query: 260 -------RLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV-DLQDYDYSLDMWSLGCMFA 311
                  ++ D+GL++        +  V + Y+  PELL+ + + YD   DMW+LGC+  
Sbjct: 175 LNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIY 234

Query: 312 GMIFRKEPFFYGHDNHDQLV 331
            +   K P F+  +N  QL+
Sbjct: 235 ELCSGKTP-FHKANNFSQLI 253

Length = 1021

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 76.0 bits (187), Expect = 3e-15
 Identities = 78/304 (25%), Positives = 126/304 (41%), Gaps = 60/304 (19%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK------IKREIKILQNLCGGP 180
           +  +R++G G +  V+   +V TNE   IK +    K+       I +E++ LQ     P
Sbjct: 17  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQ-LRHP 75

Query: 181 NVVKLLDIVRDQHSKTPSLIFEYV--NSTD-FKVLYPTLTDYDIRYYIYELLKALDYCHS 237
           N ++       +H  T  L+ EY   +++D  +V    L + +I    +  L+ L Y HS
Sbjct: 76  NTIEYKGCYLREH--TAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHS 133

Query: 238 QGIMHRDVKPHNVMI-DHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE--LLVDL 294
              +HRD+K  N+++ +    KL   D+G A    P    N  V + Y+  PE  L +D 
Sbjct: 134 HERIHRDIKAGNILLTEPGTVKLA--DFGSASLVSPA---NSFVGTPYWMAPEVILAMDE 188

Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 354
             YD  +D+WSLG     +  RK P F                    +NA    YH+  +
Sbjct: 189 GQYDGKVDVWSLGITCIELAERKPPLF-------------------NMNAMSALYHIAQN 229

Query: 355 --PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 412
             P L       S   WS                +F+D  L+   QDR ++ E + H + 
Sbjct: 230 DSPTL-------SSNDWSD------------YFRNFVDSCLQKIPQDRPSSEELLKHRFV 270

Query: 413 AQVR 416
            + R
Sbjct: 271 LRER 274

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 75.1 bits (184), Expect = 3e-15
 Identities = 56/210 (26%), Positives = 104/210 (49%), Gaps = 19/210 (9%)

Query: 126 DYEVVRKVGRGKYSEVF------EGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGG 179
           ++ + +K+GRG++SEV+      +G+ V   +  I  ++    +    +EI +L+ L   
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-NH 61

Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTD-------FKVLYPTLTDYDIRYYIYELLKAL 232
           PNV+K      + +    +++ E  ++ D       FK     + +  +  Y  +L  AL
Sbjct: 62  PNVIKYYASFIEDNEL--NIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSAL 119

Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-KEYNVRVASRYFKGPELL 291
           ++ HS+ +MHRD+KP NV I      ++L D GL  F+       +  V + Y+  PE +
Sbjct: 120 EHMHSRRVMHRDIKPANVFIT-ATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI 178

Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
            +   Y++  D+WSLGC+   M   + PF+
Sbjct: 179 HE-NGYNFKSDIWSLGCLLYEMAALQSPFY 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score = 73.3 bits (181), Expect = 9e-15
 Identities = 47/207 (22%), Positives = 90/207 (43%), Gaps = 41/207 (19%)

Query: 131 RKVGRGKYSEVFEGI---NVNTNERCIIKILK----PVKKKKIKREIKILQNLCGGPNVV 183
           +K+G G + EV++G             +K LK      ++K   +E ++++ L G PNVV
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKL-GHPNVV 59

Query: 184 KLLDIVRDQHSKTPSLIFEYVNSTDFK------------VLYPTLTDYDIRYYIYELLKA 231
           +LL +  ++      L+ EY+   D                  TL+  D+  +  ++ K 
Sbjct: 60  RLLGVCTEEEP--LYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKG 117

Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG---- 287
           ++Y  S+  +HRD+   N ++  +L  +++ D+GL+   +    Y  +       G    
Sbjct: 118 MEYLASKKFVHRDLAARNCLVGEDLV-VKISDFGLSRDVYDDDYYRKKT-----GGKLPI 171

Query: 288 ----PELLVDLQDYDYSL--DMWSLGC 308
               PE    L+D  ++   D+WS G 
Sbjct: 172 RWMAPES---LKDGIFTSKSDVWSFGV 195

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 73.5 bits (180), Expect = 2e-14
 Identities = 59/211 (27%), Positives = 103/211 (48%), Gaps = 20/211 (9%)

Query: 131 RKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKI---------KREIKILQNLCGGPN 181
           R +GRG Y++V   + +  N++  I  +K VKK+ +         + E  + +     P 
Sbjct: 1   RVIGRGSYAKVLL-VRLKKNDQ--IYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPF 57

Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQ 238
           +V L      Q +    L+ EYVN  D          L +   R+Y  E+  AL++ H +
Sbjct: 58  LVGLHSCF--QTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHER 115

Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDY 297
           GI++RD+K  NV++D +   ++L D+G+  E   PG   +    +  +  PE+L   ++Y
Sbjct: 116 GIIYRDLKLDNVLLDAD-GHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRG-EEY 173

Query: 298 DYSLDMWSLGCMFAGMIFRKEPFFYGHDNHD 328
            +S+D W+LG +   M+  + PF    DN D
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFDIITDNPD 204

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 72.8 bits (178), Expect = 3e-14
 Identities = 77/311 (24%), Positives = 137/311 (44%), Gaps = 51/311 (16%)

Query: 119 VQWGD-QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIK---ILKPVKKKKIKREIKILQ 174
           V  GD +  Y    K+G+G    V+  I++ T +   IK   + +  KK+ I  EI +++
Sbjct: 12  VSVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMR 71

Query: 175 NLCGGPNVVKLLD--IVRDQHSKTPSLIFEYVNSTDFK--VLYPTLTDYDIRYYIYELLK 230
                PN+V  LD  +V D+      ++ EY+        V    + +  I     E L+
Sbjct: 72  E-NKNPNIVNYLDSYLVGDELW----VVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQ 126

Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPE 289
           ALD+ HS  ++HRD+K  N+++  +   ++L D+G      P + + +  V + Y+  PE
Sbjct: 127 ALDFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE 185

Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY 349
            +V  + Y   +D+WSLG M   M+  + P+   ++N  + + +    GT EL       
Sbjct: 186 -VVTRKAYGPKVDIWSLGIMAIEMVEGEPPYL--NENPLRALYLIATNGTPELQ------ 236

Query: 350 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 409
               +P+  + V R                       DFL++ L  D   R +A+E + H
Sbjct: 237 ----NPERLSAVFR-----------------------DFLNRCLEMDVDRRGSAKELLQH 269

Query: 410 PYFAQVRAAES 420
           P+    +   S
Sbjct: 270 PFLKLAKPLSS 280

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 72.4 bits (177), Expect = 3e-14
 Identities = 61/198 (30%), Positives = 104/198 (52%), Gaps = 15/198 (7%)

Query: 130 VRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK----IKREIKILQNLCGGPNVVKL 185
           + K+G+G + EVF+GI+  T +   IKI+   + +     I++EI +L   C  P V K 
Sbjct: 9   LEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQ-CDSPYVTKY 67

Query: 186 L-DIVRDQHSKTPSLIFEYVNS-TDFKVLYP-TLTDYDIRYYIYELLKALDYCHSQGIMH 242
               ++D       +I EY+   +   +L P  L +  I   + E+LK LDY HS+  +H
Sbjct: 68  YGSYLKDTKL---WIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIH 124

Query: 243 RDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSL 301
           RD+K  NV++  E  +++L D+G+A +      + N  V + ++  PE ++    YD   
Sbjct: 125 RDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE-VIKQSAYDSKA 182

Query: 302 DMWSLGCMFAGMIFRKEP 319
           D+WSLG + A  + + EP
Sbjct: 183 DIWSLG-ITAIELAKGEP 199

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 72.8 bits (178), Expect = 4e-14
 Identities = 67/219 (30%), Positives = 106/219 (48%), Gaps = 32/219 (14%)

Query: 131 RKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKI---------KREIKILQNLCGGPN 181
           R +GRG Y++V   + +   ER  I  +K VKK+ +         + E  + +     P 
Sbjct: 1   RVIGRGSYAKVLL-VRLKKTER--IYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPF 57

Query: 182 VVKLLDIVRDQHS--KTPSLIF---EYVNSTDFKVLYP---TLTDYDIRYYIYELLKALD 233
           +V L       HS  +T S +F   EYVN  D          L +   R+Y  E+  AL+
Sbjct: 58  LVGL-------HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALN 110

Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLV 292
           Y H +GI++RD+K  NV++D E   ++L D+G+  E   PG   +    +  +  PE+L 
Sbjct: 111 YLHERGIIYRDLKLDNVLLDSE-GHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILR 169

Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPF--FYGHDNHDQ 329
             +DY +S+D W+LG +   M+  + PF      DN DQ
Sbjct: 170 G-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ 207

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 72.4 bits (177), Expect = 4e-14
 Identities = 57/205 (27%), Positives = 92/205 (44%), Gaps = 38/205 (18%)

Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGK 274
           L +  I      +L+AL Y HSQG++HRD+K  ++++  + R ++L D+G  A+      
Sbjct: 114 LNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGR-VKLSDFGFCAQISKDVP 172

Query: 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 334
           +    V + Y+  PE ++    Y   +D+WSLG M   M+  + P+F      D  V+  
Sbjct: 173 KRKSLVGTPYWMAPE-VISRTPYGTEVDIWSLGIMVIEMVDGEPPYF-----SDSPVQAM 226

Query: 335 KVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLR 394
           K L                         R S  P        N H +SP   DFL+++L 
Sbjct: 227 KRL-------------------------RDSPPP-----KLKNAHKISPVLRDFLERMLT 256

Query: 395 YDHQDRLTAREAMAHPYFAQVRAAE 419
            + Q+R TA+E + HP+  Q    E
Sbjct: 257 REPQERATAQELLDHPFLLQTGLPE 281

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 72.4 bits (177), Expect = 4e-14
 Identities = 57/203 (28%), Positives = 100/203 (49%), Gaps = 18/203 (8%)

Query: 130 VRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK------IKREIKILQNLCGGPNVV 183
           +R++G G +  V+   +V  +E   IK +    K+       I +E++ LQ L   PN +
Sbjct: 20  LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTI 78

Query: 184 KLLDIVRDQHSKTPSLIFEYV--NSTDF-KVLYPTLTDYDIRYYIYELLKALDYCHSQGI 240
           +       +H  T  L+ EY   +++D  +V    L + +I    +  L+ L Y HS  +
Sbjct: 79  QYRGCYLREH--TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNM 136

Query: 241 MHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD--YD 298
           +HRDVK  N+++  E   ++L D+G A    P   +   V + Y+  PE+++ + +  YD
Sbjct: 137 IHRDVKAGNILLS-EPGLVKLGDFGSASIMAPANXF---VGTPYWMAPEVILAMDEGQYD 192

Query: 299 YSLDMWSLGCMFAGMIFRKEPFF 321
             +D+WSLG     +  RK P F
Sbjct: 193 GKVDVWSLGITCIELAERKPPLF 215

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 72.1 bits (177), Expect = 4e-14
 Identities = 73/304 (24%), Positives = 138/304 (45%), Gaps = 53/304 (17%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR---EIKILQNLCGGPN 181
           D +E++ ++G G + +V++  +  T      KI++   +++++    EI IL   C  PN
Sbjct: 5   DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSE-CKHPN 63

Query: 182 VVKLLDIVRDQHSKTPSLIFEY-----VNSTDFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           +V L +     +     ++ E+     ++S   ++    LT+  IRY   ++L+AL++ H
Sbjct: 64  IVGLYEAY--FYENKLWILIEFCDGGALDSIMLELERG-LTEPQIRYVCRQMLEALNFLH 120

Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLV--- 292
           S  ++HRD+K  N+++  +   ++L D+G+ A+     ++ +  + + Y+  PE++    
Sbjct: 121 SHKVIHRDLKAGNILLTLD-GDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACET 179

Query: 293 -DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL 351
                YDY  D+WSLG     +   + P    H+ +   V + K+L ++           
Sbjct: 180 FKDNPYDYKADIWSLGITLIELAQMEPP---HHELNPMRV-LLKILKSEP---------- 225

Query: 352 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 411
              P LD        K WS   N            DFL   L  D  DR TA E + HP+
Sbjct: 226 ---PTLDQ-----PSK-WSSSFN------------DFLKSCLVKDPDDRPTAAELLKHPF 264

Query: 412 FAQV 415
            +  
Sbjct: 265 VSDQ 268

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 72.4 bits (177), Expect = 5e-14
 Identities = 57/203 (28%), Positives = 101/203 (49%), Gaps = 18/203 (8%)

Query: 130 VRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKK------KIKREIKILQNLCGGPNVV 183
           + ++G G +  V+   N +TNE   +K +    K+       I +E+K LQ L   PN +
Sbjct: 26  LHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQL-KHPNTI 84

Query: 184 KLLDIVRDQHSKTPSLIFEYV--NSTD-FKVLYPTLTDYDIRYYIYELLKALDYCHSQGI 240
           +       +H  T  L+ EY   +++D  +V    L + +I    +  L+ L Y HS  +
Sbjct: 85  EYKGCYLKEH--TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNM 142

Query: 241 MHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD--YD 298
           +HRD+K  N+++  E  +++L D+G A    P   +   V + Y+  PE+++ + +  YD
Sbjct: 143 IHRDIKAGNILLT-EPGQVKLADFGSASKSSPANSF---VGTPYWMAPEVILAMDEGQYD 198

Query: 299 YSLDMWSLGCMFAGMIFRKEPFF 321
             +D+WSLG     +  RK P F
Sbjct: 199 GKVDVWSLGITCIELAERKPPLF 221

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 71.6 bits (175), Expect = 5e-14
 Identities = 58/190 (30%), Positives = 90/190 (47%), Gaps = 42/190 (22%)

Query: 228 LLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR---VASRY 284
           +LKAL   H+QG++HRD+K  ++++ H+ R ++L D+G        KE   R   V + Y
Sbjct: 125 VLKALSVLHAQGVIHRDIKSDSILLTHDGR-VKLSDFGFCA--QVSKEVPRRKSLVGTPY 181

Query: 285 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA 344
           +  PEL+  L  Y   +D+WSLG M   M+  + P+F     ++  +K  K++  +    
Sbjct: 182 WMAPELISRLP-YGPEVDIWSLGIMVIEMVDGEPPYF-----NEPPLKAMKMIRDN---- 231

Query: 345 YLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAR 404
                   L P+L                   N H VSP    FLD+LL  D   R TA 
Sbjct: 232 --------LPPKL------------------KNLHKVSPSLKGFLDRLLVRDPAQRATAA 265

Query: 405 EAMAHPYFAQ 414
           E + HP+ A+
Sbjct: 266 ELLKHPFLAK 275

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 72.2 bits (177), Expect = 6e-14
 Identities = 58/208 (27%), Positives = 101/208 (48%), Gaps = 30/208 (14%)

Query: 131 RKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK---------IKREIKILQNLCGGPN 181
           R +GRG Y++V   + +    R  I  +K +KK+          ++ E  + +     P 
Sbjct: 1   RVIGRGSYAKVLL-VELKKTRR--IYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPF 57

Query: 182 VVKLLDIVRDQHS--KTPSLIF---EYVNSTDFKVLYP---TLTDYDIRYYIYELLKALD 233
           +V L       HS  +T S +F   E+V+  D          L +   R+Y  E+  AL+
Sbjct: 58  LVGL-------HSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALN 110

Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLV 292
           + H +GI++RD+K  NV++D E   ++L D+G+  E   PG   +    +  +  PE+L 
Sbjct: 111 FLHERGIIYRDLKLDNVLLDAE-GHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILR 169

Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
             +DY +S+D W+LG +   M+  + PF
Sbjct: 170 G-EDYGFSVDWWALGVLMFEMMAGRSPF 196

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score = 70.6 bits (174), Expect = 9e-14
 Identities = 39/162 (24%), Positives = 75/162 (46%), Gaps = 18/162 (11%)

Query: 131 RKVGRGKYSEVFEGI----NVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNV 182
           +K+G G + EV++G              +K LK        ++  RE +I++ L   PNV
Sbjct: 5   KKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKL-DHPNV 63

Query: 183 VKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHS 237
           VKLL +  ++      ++ EY+   D    Y     P L+  D+  +  ++ + ++Y  S
Sbjct: 64  VKLLGVCTEEEP--LYIVMEYMEGGDLL-SYLRKNRPKLSLSDLLSFALQIARGMEYLES 120

Query: 238 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR 279
           +  +HRD+   N ++   L  +++ D+GL+   +    Y  R
Sbjct: 121 KNFIHRDLAARNCLVGENLV-VKISDFGLSRDLYDDDYYRKR 161

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 70.5 bits (172), Expect = 1e-13
 Identities = 56/185 (30%), Positives = 96/185 (51%), Gaps = 16/185 (8%)

Query: 132 KVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK----IKREIKILQNLCGGPNVVKLLD 187
           ++G+G + EV++GI+  T E   IKI+   + +     I++EI +L   C  P + +   
Sbjct: 11  RIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQ-CDSPYITRYYG 69

Query: 188 IVRDQHSKTPSL--IFEYVNS-TDFKVLYP-TLTDYDIRYYIYELLKALDYCHSQGIMHR 243
                + K   L  I EY+   +   +L P  L +  I   + E+LK LDY HS+  +HR
Sbjct: 70  ----SYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKIHR 125

Query: 244 DVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLD 302
           D+K  NV++  E   ++L D+G+A +      + N  V + ++  PE ++    YD+  D
Sbjct: 126 DIKAANVLLS-EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE-VIKQSAYDFKAD 183

Query: 303 MWSLG 307
           +WSLG
Sbjct: 184 IWSLG 188

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 70.8 bits (173), Expect = 1e-13
 Identities = 79/307 (25%), Positives = 140/307 (45%), Gaps = 57/307 (18%)

Query: 126 DYEVVRKVGRGKYSEVFEGINV---NTNERCIIKILKP---VKKKKI----KREIKILQN 175
           ++E+++ +G G Y +VF    V   +T +   +K+L+    V+K K     + E  +L++
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60

Query: 176 LCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLYP--TLTDYDIRYYIYELLKAL 232
           +   P +V L      Q      LI +YV+  + F  LY     ++ ++R+Y  E++ AL
Sbjct: 61  VRQSPFLVTLHYAF--QTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILAL 118

Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVR-VASRYFKGPEL 290
           ++ H  GI++RD+K  N+++D E   + L D+GL+ EF    KE       +  +  PE+
Sbjct: 119 EHLHKLGIVYRDIKLENILLDSE-GHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEI 177

Query: 291 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH 350
           +     +  ++D WSLG +   ++    PF    + + Q              + +++  
Sbjct: 178 IRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ--------------SEVSRRI 223

Query: 351 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TARE 405
           L+ DP   + +G                    PEA D L KLLR D + RL      A E
Sbjct: 224 LKCDPPFPSFIG--------------------PEAQDLLHKLLRKDPKKRLGAGPQGASE 263

Query: 406 AMAHPYF 412
              HP+F
Sbjct: 264 IKEHPFF 270

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 70.2 bits (172), Expect = 2e-13
 Identities = 80/309 (25%), Positives = 136/309 (44%), Gaps = 62/309 (20%)

Query: 126 DYEVVRKVGRGKYSEVF---EGINVNTNERCIIKILKP---VKKKKI----KREIKILQN 175
           ++E++R +G G Y +VF   +    +  +   +K+LK    V+K K     + E ++L+ 
Sbjct: 1   NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60

Query: 176 LCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLYPT--LTDYDIRYYIYELLKAL 232
           +   P +V L      Q      LI +YVN  + F  LY     T+ ++R YI E++ AL
Sbjct: 61  VRRCPFLVTLHYAF--QTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLAL 118

Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY--NVRVASRYFKGPEL 290
           D+ H  GI++RD+K  N+++D E   + L D+GL++ +   +E        +  +  PE+
Sbjct: 119 DHLHQLGIIYRDIKLENILLDSE-GHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEV 177

Query: 291 LVDLQD-YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY 349
           +      +D ++D WSLG +   ++    PF               V G           
Sbjct: 178 IRGGSGGHDKAVDWWSLGVLTFELLTGASPF--------------TVDG----------- 212

Query: 350 HLELDPQLDALVGRHSRKPWSKFINADN---QHLVSPEAIDFLDKLLRYDHQDRL---TA 403
                        ++S+   S+ I          +S EA DF+ KLL  D + RL    A
Sbjct: 213 ------------EQNSQSEISRRILKSKPPFPKTMSAEARDFIQKLLEKDPKKRLGANGA 260

Query: 404 REAMAHPYF 412
            E   HP+F
Sbjct: 261 DEIKNHPFF 269

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 69.7 bits (170), Expect = 2e-13
 Identities = 54/211 (25%), Positives = 103/211 (48%), Gaps = 15/211 (7%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK--PVKKKKIKREIKILQNLCGGPN 181
           Q+D+E+++++G G Y +V++  NVNT E   IK++K  P +   + ++  I+   C   N
Sbjct: 8   QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSN 67

Query: 182 VVKLLD--IVRDQHSKTPSLIFEYVNSTDFKVLYPT---LTDYDIRYYIYELLKALDYCH 236
           +V      + RD+      +  E+      + +Y     L++  I Y   E L+ L Y H
Sbjct: 68  IVAYFGSYLRRDKL----WICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLH 123

Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLVDLQ 295
           S+G MHRD+K  N+++      ++L D+G+ A+      +    + + Y+  PE+    +
Sbjct: 124 SKGKMHRDIKGANILLTDN-GHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVER 182

Query: 296 D--YDYSLDMWSLGCMFAGMIFRKEPFFYGH 324
              Y+   D+W++G     +   + P F  H
Sbjct: 183 KGGYNQLCDIWAVGITAIELAELQPPMFDLH 213

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 70.1 bits (171), Expect = 2e-13
 Identities = 77/322 (23%), Positives = 141/322 (43%), Gaps = 53/322 (16%)

Query: 114 YESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR---EI 170
           YE +       + +E++ ++G G + +V++  N  T      K+++   +++++    EI
Sbjct: 1   YEHVRRDLDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEI 60

Query: 171 KILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEY-----VNSTDFKVLYPTLTDYDIRYYI 225
           +IL   C  P +VKLL            ++ E+     V++   + L   LT+  I+   
Sbjct: 61  EILAT-CNHPYIVKLLGAF--YWDGKLWIMIEFCPGGAVDAIMLE-LDRGLTEPQIQVIC 116

Query: 226 YELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGKEYNVRVASRY 284
            ++L+AL Y HS  I+HRD+K  NV++  +   ++L D+G+ A+     +  +  + + Y
Sbjct: 117 RQMLEALQYLHSMKIIHRDLKAGNVLLTLD-GDIKLADFGVSAKNVKTLQRRDSFIGTPY 175

Query: 285 FKGPELLV--DLQD--YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTD 340
           +  PE+++   ++D  YDY  D+WSLG     M  + EP  +  +    L+KIAK     
Sbjct: 176 WMAPEVVMCETMKDTPYDYKADIWSLGITLIEMA-QIEPPHHELNPMRVLLKIAK----- 229

Query: 341 ELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDR 400
                         P L           W            S E  DFL   L    + R
Sbjct: 230 -----------SEPPTLS------QPSKW------------SMEFRDFLKTALDKHPETR 260

Query: 401 LTAREAMAHPYFAQVRAAESSR 422
            +A + + HP+ + V +    R
Sbjct: 261 PSAAQLLEHPFVSSVTSNRPLR 282

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 70.8 bits (173), Expect = 2e-13
 Identities = 66/216 (30%), Positives = 104/216 (48%), Gaps = 29/216 (13%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR-------EIKILQNLC 177
           +DYEVV+ +GRG + EV    + +T +   +K+L   K + IKR       E + +    
Sbjct: 43  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLS--KFEMIKRSDSAFFWEERDIMAFA 100

Query: 178 GGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDI-----RYYIYELLKAL 232
             P VV+L    +D   +   ++ EY+   D   L   +++YD+     R+Y  E++ AL
Sbjct: 101 NSPWVVQLFYAFQD--DRYLYMVMEYMPGGD---LVNLMSNYDVPEKWARFYTAEVVLAL 155

Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR----VASRYFKGP 288
           D  HS G +HRDVKP N+++D +   L+L D+G        KE  VR    V +  +  P
Sbjct: 156 DAIHSMGFIHRDVKPDNMLLD-KSGHLKLADFGTC--MKMNKEGMVRCDTAVGTPDYISP 212

Query: 289 ELLVDLQD---YDYSLDMWSLGCMFAGMIFRKEPFF 321
           E+L        Y    D WS+G     M+    PF+
Sbjct: 213 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY 248

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 69.2 bits (169), Expect = 3e-13
 Identities = 56/222 (25%), Positives = 107/222 (48%), Gaps = 20/222 (9%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILK----PVKKKKIKREIKILQNLCGGPNV 182
           YE+++K+G G + +++     + +E C+IK +     PVK+K+  ++  IL      PN+
Sbjct: 2   YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNI 61

Query: 183 VKLLDIVRDQHSKTPSLIFEYVNSTDFK--------VLYPTLTDYDIRYYIYELLKALDY 234
           V        Q +    ++ EY +  D          VL+   ++  I  +  ++   L +
Sbjct: 62  VTFFASF--QENGRLFIVMEYCDGGDLMKRINRQRGVLF---SEDQILSWFVQISLGLKH 116

Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY-NVRVASRYFKGPELLVD 293
            H + I+HRD+K  N+ +       +L D+G+A   +   E     V + Y+  PE+  +
Sbjct: 117 IHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQN 176

Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
            + Y+   D+WSLGC+   +   K P F G++ H  ++KI +
Sbjct: 177 -RPYNNKTDIWSLGCVLYELCTLKHP-FEGNNLHQLVLKICQ 216

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 69.3 bits (169), Expect = 3e-13
 Identities = 75/298 (25%), Positives = 128/298 (42%), Gaps = 56/298 (18%)

Query: 133 VGRGKYSEVFEGINVNTNERCIIKILK-----PVKKKKIKR---EIKILQNLCGGPNVVK 184
           +G+G +  V+   +V+T      K ++     P   K++     EI++L+NL     +V+
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNL-QHERIVQ 68

Query: 185 LLDIVRDQHSKTPSLIFEYVNSTDFK---VLYPTLTDYDIRYYIYELLKALDYCHSQGIM 241
               +RD+  KT ++  EY+     K     Y  LT+   R Y  ++L+ + Y HS  I+
Sbjct: 69  YYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIV 128

Query: 242 HRDVKPHNVMIDHELRKLRLIDWG----LAEFYHPGKEYNVRVASRYFKGPELLVDLQDY 297
           HRD+K  N++ D     ++L D+G    L      G        + Y+  PE ++  + Y
Sbjct: 129 HRDIKGANILRD-SAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPE-VISGEGY 186

Query: 298 DYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQL 357
               D+WSLGC    M+  K P+      ++ +  I K+  T   N           PQL
Sbjct: 187 GRKADVWSLGCTVVEMLTEKPPW----AEYEAMAAIFKI-ATQPTN-----------PQL 230

Query: 358 DALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV 415
            + +  H+R                    DFL  +   + + R +A E + HP FAQ+
Sbjct: 231 PSHISEHAR--------------------DFLGCIF-VEARHRPSAEELLRHP-FAQL 266

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score = 68.7 bits (169), Expect = 3e-13
 Identities = 37/162 (22%), Positives = 75/162 (46%), Gaps = 17/162 (10%)

Query: 131 RKVGRGKYSEVFEGI----NVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNV 182
           +K+G G + EV++G              +K LK        ++  RE +I++ L   PN+
Sbjct: 5   KKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKL-DHPNI 63

Query: 183 VKLLDIVRDQHSKTPSLIFEYVNSTDFK-VL----YPTLTDYDIRYYIYELLKALDYCHS 237
           VKLL +  ++      ++ EY+   D    L       L+  D+  +  ++ + ++Y  S
Sbjct: 64  VKLLGVCTEEEP--LMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES 121

Query: 238 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR 279
           +  +HRD+   N ++   L  +++ D+GL+   +    Y V+
Sbjct: 122 KNFIHRDLAARNCLVGENLV-VKISDFGLSRDLYDDDYYKVK 162

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 69.0 bits (168), Expect = 4e-13
 Identities = 51/197 (25%), Positives = 98/197 (49%), Gaps = 17/197 (8%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVK 184
           +E+V  VG G Y +V++G +V T +   IK++     ++++IK+EI +L+      N+  
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67

Query: 185 LLDIVRDQHSKTPS----LIFEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYC 235
                  ++         L+ E+  +     L       TL +  I Y   E+L+ L + 
Sbjct: 68  YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHL 127

Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLVDL 294
           H   ++HRD+K  NV++  E  +++L+D+G+ A+        N  + + Y+  PE++   
Sbjct: 128 HQHKVIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACD 186

Query: 295 QD----YDYSLDMWSLG 307
           ++    YD+  D+WSLG
Sbjct: 187 ENPDATYDFKSDLWSLG 203

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 68.8 bits (168), Expect = 4e-13
 Identities = 72/304 (23%), Positives = 124/304 (40%), Gaps = 65/304 (21%)

Query: 133 VGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQ 192
           +GRG + EV+     +T +   +K L        K+ IK+ Q      N   +L +V   
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLD-------KKRIKMKQGETLALNERIMLSLVSTG 54

Query: 193 HS----------KTP---SLIFEYVNSTDFKV---LYPTLTDYDIRYYIYELLKALDYCH 236
                        TP   S I + +N  D       +   ++ ++R+Y  E++  L++ H
Sbjct: 55  DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMH 114

Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
           ++ +++RD+KP N+++D E   +R+ D GLA  +   K +   V +  +  PE+L     
Sbjct: 115 NRFVVYRDLKPANILLD-EHGHVRISDLGLACDFSKKKPH-ASVGTHGYMAPEVLQKGVA 172

Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ 356
           YD S D +SLGCM   ++    P F  H   D+                +++  L +  +
Sbjct: 173 YDSSADWFSLGCMLFKLLRGHSP-FRQHKTKDKHE--------------IDRMTLTMAVE 217

Query: 357 LDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPY 411
           L                        SPE    L+ LL+ D   RL      A+E   HP+
Sbjct: 218 LP--------------------DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPF 257

Query: 412 FAQV 415
           F  +
Sbjct: 258 FRSL 261

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 68.5 bits (167), Expect = 5e-13
 Identities = 57/186 (30%), Positives = 95/186 (51%), Gaps = 18/186 (9%)

Query: 132 KVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK----IKREIKILQNLCGGPNVVKLLD 187
           ++G+G + EVF+GI+  T +   IKI+   + +     I++EI +L   C  P V K   
Sbjct: 11  RIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQ-CDSPYVTKYYG 69

Query: 188 IVRDQHSKTPSL--IFEYV---NSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMH 242
                + K   L  I EY+   ++ D     P   ++ I   + E+LK LDY HS+  +H
Sbjct: 70  ----SYLKGTKLWIIMEYLGGGSALDLLRAGP-FDEFQIATMLKEILKGLDYLHSEKKIH 124

Query: 243 RDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSL 301
           RD+K  NV++  E   ++L D+G+A +      + N  V + ++  PE ++    YD   
Sbjct: 125 RDIKAANVLLS-EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE-VIQQSAYDSKA 182

Query: 302 DMWSLG 307
           D+WSLG
Sbjct: 183 DIWSLG 188

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 68.5 bits (167), Expect = 7e-13
 Identities = 79/316 (25%), Positives = 137/316 (43%), Gaps = 62/316 (19%)

Query: 106 LRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK 165
           L P+E+W               E++ ++G G + +V++  N  T      K++    +++
Sbjct: 1   LNPEEFW---------------EIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEE 45

Query: 166 IKR---EIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY--PTLTDYD 220
           ++    EI IL + C  PN+VKLLD    +++    + F    + D  +L     LT+  
Sbjct: 46  LEDYMVEIDILAS-CDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQ 104

Query: 221 IRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGKEYNVR 279
           IR    + L+AL+Y H   I+HRD+K  N++   +   ++L D+G+ A+     +  +  
Sbjct: 105 IRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLD-GDIKLADFGVSAKNTRTIQRRDSF 163

Query: 280 VASRYFKGPELLV----DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
           + + Y+  PE+++      + YDY  D+WSLG     M  + EP  +  +    L+KIAK
Sbjct: 164 IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMA-QIEPPHHELNPMRVLLKIAK 222

Query: 336 VLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRY 395
                             +P   A   R     W            S E  DFL K L  
Sbjct: 223 S-----------------EPPTLAQPSR-----W------------SSEFKDFLKKCLEK 248

Query: 396 DHQDRLTAREAMAHPY 411
           +   R T  + + HP+
Sbjct: 249 NVDARWTTTQLLQHPF 264

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 68.1 bits (166), Expect = 8e-13
 Identities = 53/197 (26%), Positives = 98/197 (49%), Gaps = 17/197 (8%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--KKKIKREIKILQNLCGGPNVVK 184
           +E+V  VG G Y +V++G +V T +   IK++   +  +++IK EI +L+      N+  
Sbjct: 18  FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIAT 77

Query: 185 LLDIVRDQ----HSKTPSLIFEYVNS---TDF--KVLYPTLTDYDIRYYIYELLKALDYC 235
                  +    H     L+ E+  +   TD         L +  I Y   E+L+ L + 
Sbjct: 78  YYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHL 137

Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLVDL 294
           H+  ++HRD+K  NV++  E  +++L+D+G+ A+        N  + + Y+  PE++   
Sbjct: 138 HAHKVIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACD 196

Query: 295 QD----YDYSLDMWSLG 307
           ++    YDY  D+WSLG
Sbjct: 197 ENPDATYDYRSDIWSLG 213

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 67.8 bits (165), Expect = 1e-12
 Identities = 52/203 (25%), Positives = 95/203 (46%), Gaps = 18/203 (8%)

Query: 133 VGRGKYSEVFEGINVNTNERCIIKILK-----PVKKKKIKR---EIKILQNLCGGPNVVK 184
           +G+G +  V+   + +T     +K ++     P   K++     EI++L+NL     +V+
Sbjct: 10  LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLH-ERIVQ 68

Query: 185 LLDIVRDQHSKTPSLIFEYVNSTDFK---VLYPTLTDYDIRYYIYELLKALDYCHSQGIM 241
               +RD   +T S+  E++     K     Y  LT+   R Y  ++L+ + Y HS  I+
Sbjct: 69  YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIV 128

Query: 242 HRDVKPHNVMIDHELRKLRLIDWG----LAEFYHPGKEYNVRVASRYFKGPELLVDLQDY 297
           HRD+K  N++ D  +  ++L D+G    L      G        + Y+  PE ++  + Y
Sbjct: 129 HRDIKGANILRD-SVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPE-VISGEGY 186

Query: 298 DYSLDMWSLGCMFAGMIFRKEPF 320
               D+WS+GC    M+  K P+
Sbjct: 187 GRKADIWSVGCTVVEMLTEKPPW 209

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 67.1 bits (164), Expect = 2e-12
 Identities = 59/207 (28%), Positives = 92/207 (44%), Gaps = 50/207 (24%)

Query: 217 TDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE--FYHPGK 274
           T+ D+++Y+ EL  ALD+ HS GI++RD+KP N+++D E   ++L D+GL++    H  K
Sbjct: 96  TEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEE-GHIKLTDFGLSKESIDHEKK 154

Query: 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 334
            Y+      Y   PE +V+ + +  S D WS G +   M+    P F G D  + +  I 
Sbjct: 155 AYSFCGTVEYM-APE-VVNRRGHTQSADWWSFGVLMFEMLTGSLP-FQGKDRKETMTMIL 211

Query: 335 KV-LGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLL 393
           K  LG                PQ                        +SPEA   L  L 
Sbjct: 212 KAKLGM---------------PQ-----------------------FLSPEAQSLLRALF 233

Query: 394 RYDHQDRLTA-----REAMAHPYFAQV 415
           + +  +RL A      E   HP+F+ +
Sbjct: 234 KRNPANRLGAGPDGVEEIKRHPFFSTI 260

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 66.3 bits (161), Expect = 3e-12
 Identities = 75/303 (24%), Positives = 136/303 (44%), Gaps = 51/303 (16%)

Query: 119 VQWGD-QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIK---ILKPVKKKKIKREIKILQ 174
           V  GD +  Y    K+G+G    V+  ++V T +   I+   + +  KK+ I  EI +++
Sbjct: 13  VSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMR 72

Query: 175 NLCGGPNVVKLLD--IVRDQHSKTPSLIFEYVNSTDFK-VLYPTLTDY-DIRYYIYELLK 230
                PN+V  LD  +V D+      ++ EY+       V+  T  D   I     E L+
Sbjct: 73  E-NKNPNIVNYLDSYLVGDELW----VVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQ 127

Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPE 289
           AL++ HS  ++HRD+K  N+++  +   ++L D+G      P + + +  V + Y+  PE
Sbjct: 128 ALEFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE 186

Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY 349
            +V  + Y   +D+WSLG M   MI  + P+   ++N  + + +    GT EL       
Sbjct: 187 -VVTRKAYGPKVDIWSLGIMAIEMIEGEPPYL--NENPLRALYLIATNGTPELQ------ 237

Query: 350 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 409
               +P+  + + R                       DFL++ L  D + R +A+E + H
Sbjct: 238 ----NPEKLSAIFR-----------------------DFLNRCLDMDVEKRGSAKELLQH 270

Query: 410 PYF 412
            + 
Sbjct: 271 QFL 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 66.2 bits (161), Expect = 3e-12
 Identities = 56/213 (26%), Positives = 106/213 (49%), Gaps = 19/213 (8%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK---IKREIKILQNLCGGP 180
           Q DYE++++VG G Y +V++  N++T E   +KI+K         I++EI +++  C   
Sbjct: 8   QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKE-CKHC 66

Query: 181 NVVKLLD--IVRDQHSKTPSLIFEYVNSTDFKVLYPT---LTDYDIRYYIYELLKALDYC 235
           N+V      + R++      +  EY      + +Y     L++  I Y   E L+ L Y 
Sbjct: 67  NIVAYFGSYLSREKL----WICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYL 122

Query: 236 HSQGIMHRDVKPHNVMI-DHELRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLVD 293
           HS+G MHRD+K  N+++ D+    ++L D+G+ A+      +    + + Y+  PE+   
Sbjct: 123 HSKGKMHRDIKGANILLTDNG--DVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAV 180

Query: 294 LQD--YDYSLDMWSLGCMFAGMIFRKEPFFYGH 324
            ++  Y+   D+W++G     +   + P F  H
Sbjct: 181 EKNGGYNQLCDIWAVGITAIELAELQPPMFDLH 213

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 66.6 bits (162), Expect = 5e-12
 Identities = 61/214 (28%), Positives = 104/214 (48%), Gaps = 25/214 (11%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR-------EIKILQNLC 177
           +DY+VV+ +GRG + EV    + ++ +   +K+L   K + IKR       E + +    
Sbjct: 43  EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLS--KFEMIKRSDSAFFWEERDIMAFA 100

Query: 178 GGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDI-----RYYIYELLKAL 232
             P VV+L    +D   K   ++ EY+   D   L   +++YD+     ++Y  E++ AL
Sbjct: 101 NSPWVVQLFCAFQDD--KYLYMVMEYMPGGD---LVNLMSNYDVPEKWAKFYTAEVVLAL 155

Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEY-NVRVASRYFKGPEL 290
           D  HS G++HRDVKP N+++D +   L+L D+G   +    G    +  V +  +  PE+
Sbjct: 156 DAIHSMGLIHRDVKPDNMLLD-KHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEV 214

Query: 291 LVDLQD---YDYSLDMWSLGCMFAGMIFRKEPFF 321
           L        Y    D WS+G     M+    PF+
Sbjct: 215 LKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFY 248

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score = 65.2 bits (160), Expect = 6e-12
 Identities = 47/199 (23%), Positives = 87/199 (43%), Gaps = 34/199 (17%)

Query: 131 RKVGRGKYSEVFEGI----NVNTNERCIIKILKP----VKKKKIKREIKILQNLCGGPNV 182
           +K+G G + EV++G        T  +  +K LK      ++++   E  I++ L   PN+
Sbjct: 5   KKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKL-SHPNI 63

Query: 183 VKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHS 237
           V+LL +      +   ++ EY+   D    +       LT  D+     ++ K ++Y  S
Sbjct: 64  VRLLGVCT--QGEPLYIVTEYMPGGDLL-DFLRKHGEKLTLKDLLQMALQIAKGMEYLES 120

Query: 238 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR---------VASRYFKGP 288
           +  +HRD+   N ++   L  +++ D+GL+   +    Y  R         +A      P
Sbjct: 121 KNFVHRDLAARNCLVTENL-VVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMA------P 173

Query: 289 ELLVDLQDYDYSLDMWSLG 307
           E L D +    S D+WS G
Sbjct: 174 ESLKDGKFTSKS-DVWSFG 191

Length = 258

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 65.0 bits (158), Expect = 8e-12
 Identities = 40/127 (31%), Positives = 64/127 (50%), Gaps = 7/127 (5%)

Query: 199 LIFEYVNSTDFKV-LY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMID 253
           L+   +N  D K  +Y    P   +    +Y  E+L  L+  H +  ++RD+KP N+++D
Sbjct: 77  LVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLD 136

Query: 254 HELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGM 313
            +   +R+ D GLA     G+    RV +  +  PE+L + Q Y  S D W LGC+   M
Sbjct: 137 -DYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNN-QRYTLSPDYWGLGCLIYEM 194

Query: 314 IFRKEPF 320
           I  + PF
Sbjct: 195 IEGQSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 64.8 bits (158), Expect = 1e-11
 Identities = 84/308 (27%), Positives = 133/308 (43%), Gaps = 68/308 (22%)

Query: 130 VRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIK----------ILQNLCGG 179
           ++ +G+G Y +VF+   V   +   I  +K +KK  I R  K          IL+ +   
Sbjct: 1   LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAV-KH 59

Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDI------RYYIYELLKALD 233
           P +V L  I   Q      LI EY++  +   L+  L    I       +Y+ E+  AL+
Sbjct: 60  PFIVDL--IYAFQTGGKLYLILEYLSGGE---LFMHLEREGIFMEDTACFYLSEISLALE 114

Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLV 292
           + H QGI++RD+KP N+++D +   ++L D+GL  E  H G   +    +  +  PE+L+
Sbjct: 115 HLHQQGIIYRDLKPENILLDAQ-GHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILM 173

Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE 352
               +  ++D WSLG +   M+    PF    +N  +   I K+L          K  L 
Sbjct: 174 R-SGHGKAVDWWSLGALMYDMLTGAPPF--TAENRKK--TIDKIL----------KGKLN 218

Query: 353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAM 407
           L P L                        +PEA D L KLL+ +   RL      A E  
Sbjct: 219 LPPYL------------------------TPEARDLLKKLLKRNPSSRLGAGPGDAAEVQ 254

Query: 408 AHPYFAQV 415
           +HP+F  V
Sbjct: 255 SHPFFRHV 262

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 64.5 bits (157), Expect = 1e-11
 Identities = 57/210 (27%), Positives = 95/210 (45%), Gaps = 34/210 (16%)

Query: 131 RKVGRGKYSEVFEGINVNTNERCIIKI------LKPVKKKKIKR---------EIKILQN 175
           R +G+G + EV           C ++        K ++KK+IK+         E +IL+ 
Sbjct: 6   RVLGKGGFGEVCA---------CQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEK 56

Query: 176 LCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV-LY----PTLTDYDIRYYIYELLK 230
           +     VV L      + +    L+   +N  D K  +Y    P   +    +Y  E+  
Sbjct: 57  V-NSRFVVSLAYAYETKDALC--LVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITC 113

Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 290
            L+  H + I++RD+KP N+++D +   +R+ D GLA     G+    RV +  +  PE 
Sbjct: 114 GLEDLHRERIVYRDLKPENILLD-DYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPE- 171

Query: 291 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
           +V  + Y +S D W LGC+   MI  K PF
Sbjct: 172 VVKNERYTFSPDWWGLGCLIYEMIEGKSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 64.1 bits (156), Expect = 1e-11
 Identities = 62/215 (28%), Positives = 100/215 (46%), Gaps = 36/215 (16%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLL 186
           YE +R VGRG +  V         +  IIK + PV++   K E    QN C    V+KLL
Sbjct: 2   YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQI-PVEQMT-KDERLAAQNEC---QVLKLL 56

Query: 187 DIVRDQHSKTPSLIFEYVNSTDFKVL-----YP---TLTDY------------DIRYYIY 226
                 H   P++I  Y N  + K L     Y    TL +Y             I ++  
Sbjct: 57  -----SH---PNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFV 108

Query: 227 ELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYF 285
           ++L AL + H++ I+HRD+K  N+++D     +++ D+G++       K Y V V +  +
Sbjct: 109 QILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTV-VGTPCY 167

Query: 286 KGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
             PE L + + Y+   D+W+LGC+   +   K  F
Sbjct: 168 ISPE-LCEGKPYNQKSDIWALGCVLYELASLKRAF 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 64.5 bits (157), Expect = 1e-11
 Identities = 41/143 (28%), Positives = 72/143 (50%), Gaps = 22/143 (15%)

Query: 198 SLIFEYVNSTDFKVLYPTLTDYDIRYYIY-------------------ELLKALDYCHSQ 238
           SL + +   TD  ++   +   D+RY+IY                   +++  L++ H +
Sbjct: 57  SLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR 116

Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA-SRYFKGPELLVDLQDY 297
            I++RD+KP NV++D++   +R+ D GLA     G+      A +  F  PELL   ++Y
Sbjct: 117 RIIYRDLKPENVLLDND-GNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQG-EEY 174

Query: 298 DYSLDMWSLGCMFAGMIFRKEPF 320
           D+S+D ++LG     MI  + PF
Sbjct: 175 DFSVDYFALGVTLYEMIAARGPF 197

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 65.4 bits (159), Expect = 2e-11
 Identities = 83/337 (24%), Positives = 145/337 (43%), Gaps = 79/337 (23%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLL 186
           ++++  +G G + +V E  +    E C +KI++ V K    R+ KI          ++ +
Sbjct: 131 FKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK--YTRDAKI---------EIQFM 179

Query: 187 DIVR--DQHSKTPSLIFE--YVNSTDFKVLY-----PTLTDYDIRY----------YIYE 227
           + VR  D   + P +  +  + N T    +      P L D+ +++           I++
Sbjct: 180 EKVRQADPADRFPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQ 239

Query: 228 LLKALDYCHSQ-GIMHRDVKPHNVM-------IDHELRK--------LRLIDWGLAEFYH 271
              ALDY H++  +MH D+KP N++       +D    +        +R+ D G      
Sbjct: 240 TGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGC---- 295

Query: 272 PGKEYNVR---VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHD 328
              E + R   V++R+++ PE+++ L  + YS DMWS+GC+   + +  +  +  HDN +
Sbjct: 296 -CDERHSRTAIVSTRHYRSPEVVLGL-GWMYSTDMWSMGCIIYEL-YTGKLLYDTHDNLE 352

Query: 329 QLVKIAKVL-----------GTDELNAYLNKY-HLE--LDPQLDALVGRHSRKPWSKFIN 374
            L  + K L           GT+E     N    L    DP+  A + R   +P  + I 
Sbjct: 353 HLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIAR--ARPVREVIR 410

Query: 375 ADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 411
                       D +  LL YD Q RL AR+   HPY
Sbjct: 411 -------DDLLCDLIYGLLHYDRQKRLNARQMTTHPY 440

Length = 467

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 63.8 bits (155), Expect = 2e-11
 Identities = 54/194 (27%), Positives = 92/194 (47%), Gaps = 19/194 (9%)

Query: 130 VRKVGRGKYSEV----FEGINVNTNERCIIKILKPVKKKK----IKREIKILQNLCGGPN 181
           +R +G G + +V    ++    NT E+  +K LKP         +K+EI+IL+NL    N
Sbjct: 9   IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYH-EN 67

Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDY----DIRYYIYELLKALDYCHS 237
           +VK   I  +       LI E++ S   K   P   +         Y  ++ K +DY  S
Sbjct: 68  IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGS 127

Query: 238 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV----RVASRYFKGPELLVD 293
           +  +HRD+   NV+++ E  ++++ D+GL +     KEY        +  ++  PE L+ 
Sbjct: 128 RQYVHRDLAARNVLVESE-HQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQ 186

Query: 294 LQDYDYSLDMWSLG 307
            + Y  S D+WS G
Sbjct: 187 SKFYIAS-DVWSFG 199

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 64.2 bits (156), Expect = 2e-11
 Identities = 54/212 (25%), Positives = 100/212 (47%), Gaps = 37/212 (17%)

Query: 133 VGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQ 192
           +G+G + +V++   V   +   I  +K + KK+I  + ++   + G  N+     +VR  
Sbjct: 1   IGKGTFGQVYQ---VRKKDTRRIYAMKVLSKKEIVAKKEVAHTI-GERNI-----LVRTL 51

Query: 193 HSKTPSLI---FEYVNSTDFKVLYPTLTDY-------------------DIRYYIYELLK 230
             ++P ++   F +   +D   LY  +TDY                     ++YI EL+ 
Sbjct: 52  LDESPFIVGLKFSFQTDSD---LY-LVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVL 107

Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF-YHPGKEYNVRVASRYFKGPE 289
           AL++ H   I++RD+KP N+++D     + L D+GL++      K  N    +  +  PE
Sbjct: 108 ALEHLHKYDIVYRDLKPENILLDAT-GHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPE 166

Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
           +L+D + Y   +D WSLG +   M     PF+
Sbjct: 167 VLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFY 198

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 63.8 bits (155), Expect = 2e-11
 Identities = 52/214 (24%), Positives = 96/214 (44%), Gaps = 46/214 (21%)

Query: 133 VGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR---------EIKILQNLCGGPNVV 183
           +G+G + EV   + V    +  +   K + KK++K+         E +IL+ +   P +V
Sbjct: 1   LGKGGFGEVC-AVQVKNTGK--MYACKKLDKKRLKKKSGEKMALLEKEILEKV-NSPFIV 56

Query: 184 KLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIY-------ELLKALDYC- 235
                         +L + + + T   ++   +   D++Y+IY       E+ + + Y  
Sbjct: 57  --------------NLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSA 102

Query: 236 ---------HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 286
                    HS  I++RD+KP NV++D +    RL D GLA     GK    R  +  + 
Sbjct: 103 QITCGILHLHSMDIVYRDMKPENVLLD-DQGNCRLSDLGLAVELKDGKTITQRAGTNGYM 161

Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
            PE+L + + Y Y +D +++GC    M+  + PF
Sbjct: 162 APEILKE-EPYSYPVDWFAMGCSIYEMVAGRTPF 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 63.5 bits (154), Expect = 2e-11
 Identities = 53/204 (25%), Positives = 94/204 (46%), Gaps = 25/204 (12%)

Query: 133 VGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQ 192
           +GRG + EV+     +T +   +K L        K+ IK+ Q      N   +L +V   
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLD-------KKRIKMKQGETLALNERIMLSLVSTG 54

Query: 193 HS----------KTPS---LIFEYVNSTDFKV---LYPTLTDYDIRYYIYELLKALDYCH 236
                        TP     I + +N  D       +   ++ ++R+Y  E++  L++ H
Sbjct: 55  DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMH 114

Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
           ++ +++RD+KP N+++D E   +R+ D GLA  +   K +   V +  +  PE+L     
Sbjct: 115 NRFVVYRDLKPANILLD-EHGHVRISDLGLACDFSKKKPH-ASVGTHGYMAPEVLQKGTA 172

Query: 297 YDYSLDMWSLGCMFAGMIFRKEPF 320
           YD S D +SLGCM   ++    PF
Sbjct: 173 YDSSADWFSLGCMLFKLLRGHSPF 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 63.1 bits (153), Expect = 3e-11
 Identities = 53/203 (26%), Positives = 93/203 (45%), Gaps = 18/203 (8%)

Query: 133 VGRGKYSEVFEGINVNTNERCIIKIL--KPVKKKKIKR------EIKILQNLCGGPNVVK 184
           +GRG + EV+   + +T     +K +   P  ++  K       EI++L+NL     +V+
Sbjct: 10  LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNL-RHDRIVQ 68

Query: 185 LLDIVRDQHSKTPSLIFEYVNSTDFK---VLYPTLTDYDIRYYIYELLKALDYCHSQGIM 241
               +RD   K  S+  EY+     K     Y  LT+   R Y  ++L+ + Y HS  I+
Sbjct: 69  YYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIV 128

Query: 242 HRDVKPHNVMIDHELRKLRLIDWGLAE----FYHPGKEYNVRVASRYFKGPELLVDLQDY 297
           HRD+K  N++ D     ++L D+G ++        G        + Y+  PE ++  + Y
Sbjct: 129 HRDIKGANILRDSA-GNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPE-VISGEGY 186

Query: 298 DYSLDMWSLGCMFAGMIFRKEPF 320
               D+WS+ C    M+  K P+
Sbjct: 187 GRKADVWSVACTVVEMLTEKPPW 209

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 63.2 bits (154), Expect = 3e-11
 Identities = 54/236 (22%), Positives = 103/236 (43%), Gaps = 39/236 (16%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCI---IKILK----PVKKKKIKREIKILQN 175
            ++D  + R +G G++ +V++G+ ++     I   +K  K    P  ++K  +E  I++ 
Sbjct: 4   QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQ 63

Query: 176 LCGGPNVVKLLDIVRDQHSKTPSLI------------FEYVNSTDFKVLYPTLTDYDIRY 223
               P++VKL+ ++ +     P  I            +  VN     +    L       
Sbjct: 64  F-DHPHIVKLIGVITEN----PVWIVMELAPLGELRSYLQVNKYSLDLASLIL------- 111

Query: 224 YIYELLKALDYCHSQGIMHRDVKPHNVMI-DHELRKLRLIDWGLAEFYHPGKEYNVRVAS 282
           Y Y+L  AL Y  S+  +HRD+   NV++   +  KL   D+GL+ +      Y      
Sbjct: 112 YSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLG--DFGLSRYLEDESYYKASKGK 169

Query: 283 RYFK--GPELLVDLQDYDYSLDMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
              K   PE  ++ + +  + D+W  G CM+  ++   +PF  G  N+D + +I  
Sbjct: 170 LPIKWMAPE-SINFRRFTSASDVWMFGVCMWEILMLGVKPFQ-GVKNNDVIGRIEN 223

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 63.9 bits (156), Expect = 4e-11
 Identities = 47/160 (29%), Positives = 79/160 (49%), Gaps = 21/160 (13%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKRE----IKILQNLCG-- 178
           DD+E ++ +GRG + EV      +T     +K L+  K + +++E    ++  +++    
Sbjct: 1   DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLR--KSEMLEKEQVAHVRAERDILAEA 58

Query: 179 -GPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALDY 234
             P VVKL    +D       LI EY+   D   L     T T+ + R+YI E + A+D 
Sbjct: 59  DNPWVVKLYYSFQD--ENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDS 116

Query: 235 CHSQGIMHRDVKPHNVMID---HELRKLRLIDWGLAEFYH 271
            H  G +HRD+KP N+++D   H    ++L D+GL     
Sbjct: 117 IHKLGYIHRDIKPDNLLLDAKGH----IKLSDFGLCTGLK 152

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 63.3 bits (154), Expect = 5e-11
 Identities = 55/199 (27%), Positives = 83/199 (41%), Gaps = 45/199 (22%)

Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRV 280
           R+Y  E+  AL Y HS  I++RD+KP N+++D +   + L D+GL  E     K  +   
Sbjct: 99  RFYAAEIASALGYLHSLNIIYRDLKPENILLDSQ-GHVVLTDFGLCKEGIEHSKTTSTFC 157

Query: 281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTD 340
            +  +  PE+L   Q YD ++D W LG +   M++   P FY  D  +    I       
Sbjct: 158 GTPEYLAPEVLRK-QPYDRTVDWWCLGAVLYEMLYGLPP-FYSRDTAEMYDNI------- 208

Query: 341 ELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDR 400
                LNK  L L P                         +S  A   L+ LL+ D   R
Sbjct: 209 -----LNK-PLRLKPN------------------------ISVSARHLLEGLLQKDRTKR 238

Query: 401 LTAR----EAMAHPYFAQV 415
           L A+    E   H +F+ +
Sbjct: 239 LGAKDDFLEIKNHVFFSSI 257

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 63.1 bits (153), Expect = 5e-11
 Identities = 51/200 (25%), Positives = 91/200 (45%), Gaps = 46/200 (23%)

Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRV 280
           R+Y  E++ AL+Y HS+ +++RD+K  N+M+D +   +++ D+GL  E    G       
Sbjct: 98  RFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKD-GHIKITDFGLCKEGISDGATMKTFC 156

Query: 281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTD 340
            +  +  PE+L D  DY  ++D W LG +   M+  + PF+  + +H++L ++       
Sbjct: 157 GTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY--NQDHERLFEL------- 206

Query: 341 ELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDR 400
                              ++    R P +          +SPEA   L  LL+ D + R
Sbjct: 207 -------------------ILMEEIRFPRT----------LSPEAKSLLAGLLKKDPKQR 237

Query: 401 L-----TAREAMAHPYFAQV 415
           L      A+E M H +F  +
Sbjct: 238 LGGGPSDAKEVMEHRFFLSI 257

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 62.5 bits (152), Expect = 6e-11
 Identities = 73/295 (24%), Positives = 125/295 (42%), Gaps = 56/295 (18%)

Query: 133 VGRGKYSEVFEGINVNTNERCIIKILK-----PVKKKKIKR---EIKILQNLCGGPNVVK 184
           +G+G +  V+   +V+T     +K +      P  KK++     EI++L+NL     +V+
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL-QHERIVQ 68

Query: 185 LLDIVRDQHSKTPSLIFEYVNSTDFK---VLYPTLTDYDIRYYIYELLKALDYCHSQGIM 241
               +RD   +T S+  EY+     K     Y  LT+   R Y  ++L+ ++Y HS  I+
Sbjct: 69  YYGCLRDD--ETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIV 126

Query: 242 HRDVKPHNVMIDHELRKLRLIDWG----LAEFYHPGKEYNVRVASRYFKGPELLVDLQDY 297
           HRD+K  N++ D     ++L D+G    L      G        + Y+  PE ++  + Y
Sbjct: 127 HRDIKGANILRDSA-GNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPE-VISGEGY 184

Query: 298 DYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQL 357
               D+WS+GC    M+  K P+       + +  I K+  T   N           PQL
Sbjct: 185 GRKADVWSVGCTVVEMLTEKPPW----AEFEAMAAIFKI-ATQPTN-----------PQL 228

Query: 358 DALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 412
                     P            VSP+A +FL +    + + R +A E + H + 
Sbjct: 229 ----------PSH----------VSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 63.1 bits (153), Expect = 6e-11
 Identities = 61/214 (28%), Positives = 98/214 (45%), Gaps = 22/214 (10%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL------KPVKKKKIKREIKILQNLCG 178
           DD+E+++ +GRG + EV      +T     +KIL      K  +    + E  +L N  G
Sbjct: 1   DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVN--G 58

Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDY---DI-RYYIYELLKALDY 234
               +  L     Q      L+ +Y    D   L     D    D+ R+YI E++ A+  
Sbjct: 59  DCQWITTLHYAF-QDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHS 117

Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWG--LAEFYHPGKEYNVRVASRYFKGPELLV 292
            H    +HRD+KP NV++D     +RL D+G  L        + +V V +  +  PE+L 
Sbjct: 118 IHQLHYVHRDIKPDNVLLDMN-GHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQ 176

Query: 293 DLQD----YDYSLDMWSLG-CMFAGMIFRKEPFF 321
            ++D    Y    D WSLG CM+  M++ + PF+
Sbjct: 177 AMEDGMGKYGPECDWWSLGVCMYE-MLYGETPFY 209

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 62.3 bits (151), Expect = 9e-11
 Identities = 36/134 (26%), Positives = 71/134 (52%), Gaps = 7/134 (5%)

Query: 199 LIFEYVNSTDFKVLYPTLTDYDI---RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE 255
            + EY+N  D      +   +D+    +Y  E++  L + HS+GI++RD+K  N+++D +
Sbjct: 73  FVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTD 132

Query: 256 LRKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI 314
              +++ D+G+ +    G  +      +  +  PE+L+  Q Y+ S+D WS G +   M+
Sbjct: 133 -GHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLG-QKYNTSVDWWSFGVLLYEML 190

Query: 315 FRKEPFFYGHDNHD 328
             + P F+GHD  +
Sbjct: 191 IGQSP-FHGHDEEE 203

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 61.7 bits (150), Expect = 9e-11
 Identities = 52/212 (24%), Positives = 95/212 (44%), Gaps = 28/212 (13%)

Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--------KKKIKREIKILQNLC 177
           D++V++K+G+G Y  V++   V          LK V         ++    EI+IL ++ 
Sbjct: 1   DFKVLKKLGKGSYGSVYK---VKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASV- 56

Query: 178 GGPNVVK----LLDIVR----DQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELL 229
             PN++      LD  +     +++    L          + L P    +  R +I +LL
Sbjct: 57  NHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIW--RIFI-QLL 113

Query: 230 KALDYCHSQGIMHRDVKPHNVMI-DHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 288
           + L   H Q I+HRD+K  N+++  ++L K+   D G+++           + + ++  P
Sbjct: 114 RGLQALHEQKILHRDLKSANILLVANDLVKIG--DLGISKVLKKNMAKTQ-IGTPHYMAP 170

Query: 289 ELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
           E+    + Y Y  D+WSLGC+   M     PF
Sbjct: 171 EVWKG-RPYSYKSDIWSLGCLLYEMATFAPPF 201

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 62.3 bits (151), Expect = 1e-10
 Identities = 54/199 (27%), Positives = 80/199 (40%), Gaps = 45/199 (22%)

Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRV 280
           R+Y  E+  AL Y HS  I++RD+KP N+++D     + L D+GL  E            
Sbjct: 99  RFYAAEIASALGYLHSINIVYRDLKPENILLD-SQGHVVLTDFGLCKEGIAQSDTTTTFC 157

Query: 281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTD 340
            +  +  PE++   Q YD ++D W LG +   M++   P FY  D  +            
Sbjct: 158 GTPEYLAPEVIRK-QPYDNTVDWWCLGAVLYEMLYGLPP-FYCRDVAEM----------- 204

Query: 341 ELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDR 400
               Y N  H  L  +  A     S   WS                  L++LL  D Q R
Sbjct: 205 ----YDNILHKPLVLRPGA-----SLTAWS-----------------ILEELLEKDRQRR 238

Query: 401 LTAR----EAMAHPYFAQV 415
           L A+    E   HP+F  +
Sbjct: 239 LGAKEDFLEIQEHPFFESL 257

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 62.5 bits (152), Expect = 1e-10
 Identities = 71/236 (30%), Positives = 108/236 (45%), Gaps = 37/236 (15%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR--------EIKILQNL 176
           DD+E+++ +GRG + EV      NT +   +KIL   K + +KR        E  +L N 
Sbjct: 1   DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILN--KWEMLKRAETACFREERDVLVN- 57

Query: 177 CGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDY---DI-RYYIYELLKAL 232
            G    +  L     Q      L+ +Y    D   L     D    D+ R+Y+ E++ A+
Sbjct: 58  -GDRRWITNLHYAF-QDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAI 115

Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWG--LAEFYHPGKEYNVRVASRYFKGPEL 290
           D  H  G +HRD+KP NV++D     +RL D+G  L        + NV V +  +  PE+
Sbjct: 116 DSVHQLGYVHRDIKPDNVLLDKN-GHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEI 174

Query: 291 LVDLQD----YDYSLDMWSLG-CMFAGMIFRKEPFF-------YG----HDNHDQL 330
           L  ++D    Y    D WSLG CM+  M++ + PF+       YG    H  H Q 
Sbjct: 175 LQAMEDGKGRYGPECDWWSLGVCMYE-MLYGETPFYAESLVETYGKIMNHKEHFQF 229

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 62.1 bits (151), Expect = 1e-10
 Identities = 55/200 (27%), Positives = 90/200 (45%), Gaps = 46/200 (23%)

Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRV 280
           R+Y  E++ AL Y HS  +++RD+K  N+M+D +   +++ D+GL  E    G       
Sbjct: 98  RFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKD-GHIKITDFGLCKEGISDGATMKTFC 156

Query: 281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTD 340
            +  +  PE+L D  DY  ++D W LG +   M+  + P FY  D H++L ++  +   +
Sbjct: 157 GTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLP-FYNQD-HEKLFELILM---E 210

Query: 341 ELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDR 400
           E+                    R  R              +SPEA   L  LL+ D + R
Sbjct: 211 EI--------------------RFPRT-------------LSPEAKSLLAGLLKKDPKQR 237

Query: 401 L-----TAREAMAHPYFAQV 415
           L      A+E M H +FA +
Sbjct: 238 LGGGPEDAKEIMEHRFFASI 257

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 61.5 bits (149), Expect = 1e-10
 Identities = 55/206 (26%), Positives = 93/206 (45%), Gaps = 19/206 (9%)

Query: 130 VRKVGRGKYSEV----FEGINVNTNERCIIKILK----PVKKKKIKREIKILQNLCGGPN 181
           +R +G G + +V    ++  N  T E   +K LK           K+EI IL+ L    N
Sbjct: 9   IRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTL-YHEN 67

Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQG 239
           +VK      +Q  K   LI EYV     +   P   L    +  +  ++ + + Y HSQ 
Sbjct: 68  IVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQH 127

Query: 240 IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASR-----YFKGPELLVDL 294
            +HRD+   NV++D++ R +++ D+GLA+    G EY  RV        ++   E L + 
Sbjct: 128 YIHRDLAARNVLLDND-RLVKIGDFGLAKAVPEGHEY-YRVREDGDSPVFWYAVECLKEN 185

Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPF 320
           +   Y+ D+WS G     ++   +  
Sbjct: 186 KFS-YASDVWSFGVTLYELLTHCDSK 210

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 62.1 bits (151), Expect = 1e-10
 Identities = 60/216 (27%), Positives = 100/216 (46%), Gaps = 29/216 (13%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR-------EIKILQNLC 177
           +D++V++ +GRG + EV    + ++ +   +K+L   K + IKR       E + +    
Sbjct: 43  EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLS--KFEMIKRSDSAFFWEERDIMAHA 100

Query: 178 GGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDI-----RYYIYELLKAL 232
               +V+L    +D   K   ++ EY+   D   L   +++YDI     R+Y  E++ AL
Sbjct: 101 NSEWIVQLHYAFQDD--KYLYMVMEYMPGGDLVNL---MSNYDIPEKWARFYTAEVVLAL 155

Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR----VASRYFKGP 288
           D  HS G +HRDVKP N+++D     L+L D+G            VR    V +  +  P
Sbjct: 156 DAIHSMGFIHRDVKPDNMLLDKS-GHLKLADFGTC--MKMDANGMVRCDTAVGTPDYISP 212

Query: 289 ELLVDLQ---DYDYSLDMWSLGCMFAGMIFRKEPFF 321
           E+L        Y    D WS+G     M+    PF+
Sbjct: 213 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY 248

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 61.6 bits (149), Expect = 1e-10
 Identities = 54/198 (27%), Positives = 85/198 (42%), Gaps = 41/198 (20%)

Query: 223 YYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVAS 282
           +Y  E+   L+  H + I++RD+KP N+++D     +R+ D GLA     G+    RV +
Sbjct: 106 FYAAEICCGLEDLHQERIVYRDLKPENILLDDH-GHIRISDLGLAVHVPEGQTIKGRVGT 164

Query: 283 RYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDEL 342
             +  PE +V  + Y +S D W+LGC+   MI  + PF        +  KI +       
Sbjct: 165 VGYMAPE-VVKNERYTFSPDWWALGCLLYEMIAGQSPF------QQRKKKIKR------- 210

Query: 343 NAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL- 401
                        +++ LV     +   KF         SP+A      LL  D ++RL 
Sbjct: 211 ------------EEVERLVKEVQEEYSEKF---------SPDARSLCKMLLCKDPKERLG 249

Query: 402 ----TAREAMAHPYFAQV 415
                ARE   HP F Q+
Sbjct: 250 CQGGGAREVKEHPLFKQI 267

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 61.6 bits (149), Expect = 2e-10
 Identities = 57/213 (26%), Positives = 97/213 (45%), Gaps = 20/213 (9%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL------KPVKKKKIKREIKILQNLCG 178
           +D+E+++ +GRG + EV      N ++   +KIL      K  +    + E  +L N  G
Sbjct: 1   EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVN--G 58

Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDY---DI-RYYIYELLKALDY 234
               +  L     Q      L+ +Y    D   L     D    D+ R+Y+ E++ A+D 
Sbjct: 59  DNQWITTLHYAF-QDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDS 117

Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWG--LAEFYHPGKEYNVRVASRYFKGPELLV 292
            H    +HRD+KP N+++D     +RL D+G  L        + +V V +  +  PE+L 
Sbjct: 118 VHQLHYVHRDIKPDNILMDMN-GHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQ 176

Query: 293 DLQD----YDYSLDMWSLGCMFAGMIFRKEPFF 321
            ++D    Y    D WSLG     M++ + PF+
Sbjct: 177 AMEDGKGKYGPECDWWSLGVCMYEMLYGETPFY 209

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 61.2 bits (149), Expect = 2e-10
 Identities = 56/217 (25%), Positives = 100/217 (46%), Gaps = 30/217 (13%)

Query: 131 RKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR--------EIKILQNLCGGPNV 182
           + +G+G + +V       T+E   +K+LK  K   ++         E ++L      P +
Sbjct: 1   KVLGKGSFGKVLLAELKGTDELYAVKVLK--KDVILQDDDVECTMTEKRVLALAGKHPFL 58

Query: 183 VKLLDIVRDQHS--KTPSLIF---EYVNSTDFKVLYPTLTDYD---IRYYIYELLKALDY 234
            +L       HS  +T   +F   EYVN  D          +D    R+Y  E++  L +
Sbjct: 59  TQL-------HSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQF 111

Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVD 293
            H +GI++RD+K  NV++D E   +++ D+G+  E    G   +    +  +  PE+L  
Sbjct: 112 LHERGIIYRDLKLDNVLLDSE-GHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSY 170

Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL 330
            Q Y  ++D W+LG +   M+  + PF    D+ D+L
Sbjct: 171 -QPYGPAVDWWALGVLLYEMLAGQSPF--EGDDEDEL 204

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 62.5 bits (152), Expect = 2e-10
 Identities = 52/237 (21%), Positives = 88/237 (37%), Gaps = 85/237 (35%)

Query: 221 IRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRV 280
           I+  + ++L ALD  HS GI+HRDVKP N++        ++ID G A         ++RV
Sbjct: 257 IQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAA--------DLRV 308

Query: 281 ASRY----------FKGPELLV------------------------DLQDYDYSLDMWSL 306
              Y          +  PE  +                        +L D     D++S 
Sbjct: 309 GINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPD---RFDIYSA 365

Query: 307 GCMFAGMIF---RKEPFFYGHDNHDQLVKIAKVLGTDELNAY-LNKYHLELDPQLDALVG 362
           G +F  M F   R +           L++  + L   + N Y L  +   ++P+    + 
Sbjct: 366 GLIFLQMAFPNLRSD---------SNLIQFNRQL---KRNDYDLVAWRKLVEPRASPDLR 413

Query: 363 R-------HSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 412
           R            W                 + L  ++R+  + R++A+ A+AHPYF
Sbjct: 414 RGFEVLDLDGGAGW-----------------ELLKSMMRFKGRQRISAKAALAHPYF 453

Length = 566

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 61.0 bits (148), Expect = 3e-10
 Identities = 59/216 (27%), Positives = 94/216 (43%), Gaps = 32/216 (14%)

Query: 133 VGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR---------EIKILQNLCGGPNVV 183
           +G+G + +V       T+E   IK+LK   K  I +         E +IL      P + 
Sbjct: 3   LGKGSFGKVMLAELKGTDEVYAIKVLK---KDVILQDDDVDCTMTEKRILALAAKHPFLT 59

Query: 184 KLLDIVRDQHS--KTPSLIF---EYVNSTDFKVLYPTLTDYD---IRYYIYELLKALDYC 235
            L       H   +T   +F   EYVN  D          +D    R+Y  E+  AL + 
Sbjct: 60  AL-------HCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFL 112

Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDL 294
           H  G+++RD+K  N+++D E    +L D+G+  E    G        +  +  PE+L + 
Sbjct: 113 HRHGVIYRDLKLDNILLDAE-GHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQE- 170

Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL 330
            +Y  S+D W+LG +   M+  + PF    DN D L
Sbjct: 171 LEYGPSVDWWALGVLMYEMMAGQPPF--EADNEDDL 204

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 60.1 bits (146), Expect = 3e-10
 Identities = 64/261 (24%), Positives = 114/261 (43%), Gaps = 51/261 (19%)

Query: 127 YEVVRKVGRGKYSE-------------VFEGINVNTNERCIIKILKPVKKKKIKREIKIL 173
           Y  +R +G+G + E             V++ +N        +  L   +++    EI IL
Sbjct: 2   YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVN--------LTRLSEKERRDALNEIVIL 53

Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDF--KVLYPTLTDYDIRY---YIYEL 228
             L   PN++   +   D    T  +  EY N      K++      ++      Y++++
Sbjct: 54  SLL-QHPNIIAYYNHFMD--DNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQI 110

Query: 229 LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLI---DWGLAEFYHPGKEYNVR---VAS 282
           + A+ Y H  GI+HRD+K  N+     L K  LI   D+G+++    G EY++    V +
Sbjct: 111 VSAVSYIHKAGILHRDIKTLNIF----LTKAGLIKLGDFGISKIL--GSEYSMAETVVGT 164

Query: 283 RYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV-KIAKVLGTDE 341
            Y+  PE L     Y++  D+W+LGC+   ++  K  F     N   LV KI +   T  
Sbjct: 165 PYYMSPE-LCQGVKYNFKSDIWALGCVLYELLTLKRTF--DATNPLNLVVKIVQGNYTPV 221

Query: 342 LNAYLNKYH------LELDPQ 356
           ++ Y ++        L+ DP+
Sbjct: 222 VSVYSSELISLVHSLLQQDPE 242

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 60.6 bits (147), Expect = 4e-10
 Identities = 75/347 (21%), Positives = 126/347 (36%), Gaps = 100/347 (28%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR--------EIKILQNLCG 178
           +  ++ +G G + EV     V+TN    +K L+  K   + R        E  IL     
Sbjct: 3   FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLR--KADVLMRNQAAHVKAERDILAE-AD 59

Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIYELLKALDYC 235
              VVKL    +D+ +     + +Y+   D   L   L  ++    R+YI EL  A++  
Sbjct: 60  NEWVVKLYYSFQDKDNLY--FVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESV 117

Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGL---------AEFYHPG------------- 273
           H  G +HRD+KP N++ID +   ++L D+GL         +++Y  G             
Sbjct: 118 HKMGFIHRDIKPDNILIDRD-GHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEE 176

Query: 274 ------------KEYNVR----------VASRYFKGPELLVDLQDYDYSLDMWSLGCMFA 311
                       +    R          V +  +  PE+L+    Y    D WS+G +  
Sbjct: 177 WSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR-TGYTQLCDWWSVGVILY 235

Query: 312 GMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSK 371
            M+  + PF     +            T                       +     W  
Sbjct: 236 EMLVGQPPF---LAD--------TPAET-----------------------QLKVINWET 261

Query: 372 FINADNQHLVSPEAIDFLDKLLRYDHQDRL---TAREAMAHPYFAQV 415
            ++  +Q  +S EA D + +L     +DRL    A E  AHP+F  +
Sbjct: 262 TLHIPSQAKLSREASDLILRLCC-GAEDRLGKNGADEIKAHPFFKGI 307

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 60.8 bits (147), Expect = 4e-10
 Identities = 63/241 (26%), Positives = 109/241 (45%), Gaps = 50/241 (20%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP---VKKKK---IKREIKILQNLCG 178
           DD+E ++ +GRG + EV      +T     +KIL+    ++K++   I+ E  IL     
Sbjct: 1   DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVE-AD 59

Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYC 235
           G  VVK+    +D+  +   LI E++   D   L     TL++   ++YI E + A+D  
Sbjct: 60  GAWVVKMFYSFQDK--RNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAI 117

Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGL---------AEFY-----HPGKEYNVR-- 279
           H  G +HRD+KP N+++D +   ++L D+GL          EFY     +P  +++ +  
Sbjct: 118 HQLGFIHRDIKPDNLLLDAK-GHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNM 176

Query: 280 --------------------VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEP 319
                               V +  +  PE+ +    Y+   D WSLG +   M+    P
Sbjct: 177 NSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEMLIGYPP 235

Query: 320 F 320
           F
Sbjct: 236 F 236

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 59.4 bits (144), Expect = 5e-10
 Identities = 57/227 (25%), Positives = 107/227 (47%), Gaps = 28/227 (12%)

Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR--------EIKILQNLC 177
           D+E++ K+G+G +  VF+ +    ++R  +  +K +   K+ R        E ++L  L 
Sbjct: 1   DFEILNKIGKGSFGVVFKVVR-KADKR--VYAMKQIDLSKMNRREREEAIDEARVLAKL- 56

Query: 178 GGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY------PTLTDYDIRYYIYELLKA 231
               +++  +   D+     +++ EY  + D   L       P   D   R++I  LL  
Sbjct: 57  DSSYIIRYYESFLDK--GKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILL-G 113

Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY-NVRVASRYFKGPEL 290
           L + HS+ I+HRD+K  N+ +D     +++ D G+A+       + N  V + Y+  PEL
Sbjct: 114 LAHLHSKKILHRDIKSLNLFLDAYD-NVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPEL 172

Query: 291 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             D + Y+   D+W+LG +       K PF    D ++Q   I K++
Sbjct: 173 CED-KPYNEKSDVWALGVVLYECCTGKHPF----DANNQGALILKII 214

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 59.8 bits (145), Expect = 5e-10
 Identities = 50/206 (24%), Positives = 102/206 (49%), Gaps = 16/206 (7%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK---PVKKKK---IKREIKILQNLCG 178
           DD E ++ VG G +  V    +  +     +K++     ++ K+   +  E ++L+ +  
Sbjct: 1   DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEV-S 59

Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLYP--TLTDYDIRYYIYELLKALDYC 235
            P +++L     DQ      ++ EYV   + F  L      ++    +Y  E++ AL+Y 
Sbjct: 60  HPFIIRLFWTEHDQRFLY--MLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYL 117

Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 295
           HS+ I++RD+KP N+++D E   ++L D+G A+     + + +     Y   PE++   +
Sbjct: 118 HSKEIVYRDLKPENILLDKE-GHIKLTDFGFAKKLR-DRTWTLCGTPEYL-APEVIQS-K 173

Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFF 321
            ++ ++D W+LG +   M+    PFF
Sbjct: 174 GHNKAVDWWALGILIYEMLVGYPPFF 199

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 59.7 bits (144), Expect = 6e-10
 Identities = 53/204 (25%), Positives = 89/204 (43%), Gaps = 40/204 (19%)

Query: 211 VLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEF 269
           V +  + +  I      +L+AL Y H+QG++HRD+K  ++++  + R ++L D+G  A+ 
Sbjct: 110 VTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGR-IKLSDFGFCAQV 168

Query: 270 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQ 329
                +    V + Y+  PE++  L  Y   +D+WSLG M   MI  + P+F        
Sbjct: 169 SKEVPKRKSLVGTPYWMAPEVISRLP-YGTEVDIWSLGIMVIEMIDGEPPYFN------- 220

Query: 330 LVKIAKVLGTDELNAYLNKYHLELDPQLDALVG-RHSRKPWSKFINADNQHLVSPEAIDF 388
                                   +P L A+   R +  P  K     + H VS     F
Sbjct: 221 ------------------------EPPLQAMRRIRDNLPPRVK-----DSHKVSSVLRGF 251

Query: 389 LDKLLRYDHQDRLTAREAMAHPYF 412
           LD +L  +   R TA+E + HP+ 
Sbjct: 252 LDLMLVREPSQRATAQELLQHPFL 275

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 59.7 bits (144), Expect = 8e-10
 Identities = 53/201 (26%), Positives = 92/201 (45%), Gaps = 47/201 (23%)

Query: 222 RYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVR 279
           R+Y  E++ ALDY HS+  +++RD+K  N+M+D +   +++ D+GL  E    G      
Sbjct: 98  RFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKD-GHIKITDFGLCKEGIKDGATMKTF 156

Query: 280 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT 339
             +  +  PE+L D  DY  ++D W LG +   M+  + PF+  + +H++L ++      
Sbjct: 157 CGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY--NQDHEKLFEL------ 207

Query: 340 DELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQD 399
                               ++    R P +          +SPEA   L  LL+ D + 
Sbjct: 208 --------------------ILMEEIRFPRT----------LSPEAKSLLSGLLKKDPKQ 237

Query: 400 RL-----TAREAMAHPYFAQV 415
           RL      A+E M H +FA +
Sbjct: 238 RLGGGPDDAKEIMQHKFFAGI 258

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 59.6 bits (145), Expect = 8e-10
 Identities = 74/337 (21%), Positives = 119/337 (35%), Gaps = 86/337 (25%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP---VKKKKIKR---EIKILQNLCG 178
             ++ ++ +G+G    VF      T +   +K+L     +K+ K+KR   E +IL  L  
Sbjct: 1   KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATL-D 59

Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPT-----LTDYDIRYYIYELLKALD 233
            P +  L      Q      L+ +Y    +   L        L++   R+Y  E+L AL+
Sbjct: 60  HPFLPTLY--ASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALE 117

Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL---------AEFYHPGKEYNVRVASRY 284
           Y H  GI++RD+KP N+++ HE   + L D+ L                K       +  
Sbjct: 118 YLHLLGIVYRDLKPENILL-HESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSI 176

Query: 285 ---------------FKG------PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG 323
                          F G      PE++     +  ++D W+LG +   M++   PF  G
Sbjct: 177 PSETFSEEPSFRSNSFVGTEEYIAPEVISG-DGHGSAVDWWTLGILLYEMLYGTTPFK-G 234

Query: 324 HDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSP 383
            +  +    I K                                   K +       VS 
Sbjct: 235 SNRDETFSNILK-----------------------------------KEVTFPGSPPVSS 259

Query: 384 EAIDFLDKLLRYDHQDRL----TAREAMAHPYFAQVR 416
            A D + KLL  D   RL     A E   HP+F  V 
Sbjct: 260 SARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVN 296

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 59.6 bits (144), Expect = 8e-10
 Identities = 32/101 (31%), Positives = 56/101 (55%), Gaps = 3/101 (2%)

Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRV 280
           R+Y  E+  A+ Y HS  I++RD+KP N+++D +   + L D+GL  E   P +  +   
Sbjct: 99  RFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQ-GHVVLTDFGLCKEGVEPEETTSTFC 157

Query: 281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
            +  +  PE+L   + YD ++D W LG +   M++   PF+
Sbjct: 158 GTPEYLAPEVLRK-EPYDRTVDWWCLGAVLYEMLYGLPPFY 197

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 59.1 bits (143), Expect = 1e-09
 Identities = 44/143 (30%), Positives = 72/143 (50%), Gaps = 11/143 (7%)

Query: 195 KTPSLIF---EYVNSTDFKVLYPTLTDYD---IRYYIYELLKALDYCHSQGIMHRDVKPH 248
           +TP  +F   E+VN  D          +D    R+Y  E+  AL + H +GI++RD+K  
Sbjct: 66  QTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLD 125

Query: 249 NVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLG 307
           NV++DHE    +L D+G+  E    GK  +    +  +  PE+L ++  Y  S+D W++G
Sbjct: 126 NVLLDHE-GHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEML-YGPSVDWWAMG 183

Query: 308 CMFAGMIFRKEPFFYGHDNHDQL 330
            +   M+    PF    +N D L
Sbjct: 184 VLLYEMLCGHAPF--EAENEDDL 204

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 59.1 bits (143), Expect = 1e-09
 Identities = 71/319 (22%), Positives = 133/319 (41%), Gaps = 76/319 (23%)

Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL----KPVKKKKIKREIKILQNLCGGPN 181
           + E V ++G G    V++ I+  T     +K++    +   +++I REI+IL+++   PN
Sbjct: 75  ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDV-NHPN 133

Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHS 237
           VVK  D+    H+    ++ E+++    +  +      L D        ++L  + Y H 
Sbjct: 134 VVKCHDMF--DHNGEIQVLLEFMDGGSLEGTHIADEQFLADVA-----RQILSGIAYLHR 186

Query: 238 QGIMHRDVKPHNVMIDHELRKLRLIDWG----LAEFYHPGKEYNVRVASRYFKGPELL-V 292
           + I+HRD+KP N++I+   + +++ D+G    LA+   P    N  V +  +  PE +  
Sbjct: 187 RHIVHRDIKPSNLLINSA-KNVKIADFGVSRILAQTMDP---CNSSVGTIAYMSPERINT 242

Query: 293 DLQD--YD-YSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY 349
           DL    YD Y+ D+WSLG                       V I        L  YL ++
Sbjct: 243 DLNHGAYDGYAGDIWSLG-----------------------VSI--------LEFYLGRF 271

Query: 350 HLELDPQLDALVGRHSRKPWSKFINA-------DNQHLVSPEAIDFLDKLLRYDHQDRLT 402
              +  Q D          W+  + A       +     S E   F+   L+ +   R +
Sbjct: 272 PFGVGRQGD----------WASLMCAICMSQPPEAPATASREFRHFISCCLQREPAKRWS 321

Query: 403 AREAMAHPYFAQVRAAESS 421
           A + + HP+  + +  +  
Sbjct: 322 AMQLLQHPFILRAQPGQGQ 340

Length = 353

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 58.6 bits (142), Expect = 1e-09
 Identities = 49/191 (25%), Positives = 87/191 (45%), Gaps = 40/191 (20%)

Query: 228 LLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 286
           ++KAL+Y HS+  ++HRDVKP NV+I+    +++L D+G++ +        +    + + 
Sbjct: 112 IVKALEYLHSKLSVIHRDVKPSNVLINRN-GQVKLCDFGISGYLVDSVAKTIDAGCKPYM 170

Query: 287 GPELL---VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELN 343
            PE +   ++ + YD   D+WSLG     +   + P+        QL ++ +        
Sbjct: 171 APERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVE-------- 222

Query: 344 AYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA 403
                   E  PQL          P  KF         SPE  DF++K L+ ++++R   
Sbjct: 223 --------EPSPQL----------PAEKF---------SPEFQDFVNKCLKKNYKERPNY 255

Query: 404 REAMAHPYFAQ 414
            E + HP+F  
Sbjct: 256 PELLQHPFFEL 266

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 58.5 bits (141), Expect = 1e-09
 Identities = 32/98 (32%), Positives = 54/98 (55%), Gaps = 2/98 (2%)

Query: 223 YYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVAS 282
           +Y  EL   L+    + I++RD+KP N+++D +   +R+ D GLA     G+    RV +
Sbjct: 106 FYAAELCCGLEDLQRERIVYRDLKPENILLD-DRGHIRISDLGLAVQIPEGETVRGRVGT 164

Query: 283 RYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
             +  PE++ + + Y +S D W LGC+   MI  + PF
Sbjct: 165 VGYMAPEVINN-EKYTFSPDWWGLGCLIYEMIQGQSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 58.9 bits (142), Expect = 1e-09
 Identities = 33/101 (32%), Positives = 54/101 (53%), Gaps = 3/101 (2%)

Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRV 280
           R+Y  E+  AL Y HS  I++RD+KP N+++D +   + L D+GL  E        +   
Sbjct: 99  RFYAAEIASALGYLHSLNIVYRDLKPENILLDSQ-GHIVLTDFGLCKENIEHNGTTSTFC 157

Query: 281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
            +  +  PE+L   Q YD ++D W LG +   M++   PF+
Sbjct: 158 GTPEYLAPEVL-HKQPYDRTVDWWCLGAVLYEMLYGLPPFY 197

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 58.2 bits (141), Expect = 2e-09
 Identities = 60/260 (23%), Positives = 108/260 (41%), Gaps = 39/260 (15%)

Query: 160 PVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDY 219
           P  +K+I RE++I ++ C  P +VK      D+ S +  +  EY        +Y  +   
Sbjct: 40  PDLQKQILRELEINKS-CKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKR 98

Query: 220 DIRYYIYEL-------LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYH 271
             R     L       LK L Y HS+ I+HRD+KP N+++  +  +++L D+G++ E  +
Sbjct: 99  GGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRK-GQVKLCDFGVSGELVN 157

Query: 272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
                     + ++  PE +   + Y  + D+WSLG     +   + PF    +    L 
Sbjct: 158 SLA--GTFTGTSFYMAPERIQG-KPYSITSDVWSLGLTLLEVAQNRFPF--PPEGEPPLG 212

Query: 332 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDK 391
            I      + L+  +N  + EL  +    +       WS+               DF+ +
Sbjct: 213 PI------ELLSYIVNMPNPELKDEPGNGIK------WSEEFK------------DFIKQ 248

Query: 392 LLRYDHQDRLTAREAMAHPY 411
            L  D   R T  + + HP+
Sbjct: 249 CLEKDPTRRPTPWDMLEHPW 268

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 57.9 bits (140), Expect = 3e-09
 Identities = 56/216 (25%), Positives = 101/216 (46%), Gaps = 38/216 (17%)

Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR------EIKILQNLCGG 179
           D+E+   +G G +  V    +  T E   IK LK  +  K+K+      E  IL  L   
Sbjct: 19  DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSH- 77

Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVL-----YPTLTDYDI-RYYIYELLKAL 232
           P +V ++   +D+       + E+V   + F  L     +P     D+ ++Y  EL+ A 
Sbjct: 78  PFIVNMMCSFQDE--NRVYFLLEFVVGGELFTHLRKAGRFPN----DVAKFYHAELVLAF 131

Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK---GPE 289
           +Y HS+ I++RD+KP N+++D++   +++ D+G A+          +V  R F     PE
Sbjct: 132 EYLHSKDIIYRDLKPENLLLDNK-GHVKVTDFGFAK----------KVPDRTFTLCGTPE 180

Query: 290 LL----VDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
            L    +  + +  ++D W++G +    I    PFF
Sbjct: 181 YLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFF 216

Length = 329

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 57.3 bits (138), Expect = 3e-09
 Identities = 52/208 (25%), Positives = 96/208 (46%), Gaps = 21/208 (10%)

Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-PVKKKKIK--REIKILQNLCGGPNV 182
            Y V+R VG G +       +VN++++  +K ++ P     ++  R+  +L      PN+
Sbjct: 1   QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNI 60

Query: 183 VKLLDIVR-DQHSKTPSLIFEYVNSTDF--KV------LYPTLTDYDIRYYIYELLKALD 233
           V   +    D H     ++ EY +  D   K+      L+P  T   I  +  ++   + 
Sbjct: 61  VAFKESFEADGHL---YIVMEYCDGGDLMQKIKLQRGKLFPEDT---ILQWFVQMCLGVQ 114

Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY-HPGKEYNVRVASRYFKGPELLV 292
           + H + ++HRD+K  N+ +     K++L D+G A     PG      V + Y+  PE+  
Sbjct: 115 HIHEKRVLHRDIKSKNIFLTQNG-KVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWE 173

Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
           ++  Y+   D+WSLGC+   +   K PF
Sbjct: 174 NMP-YNNKSDIWSLGCILYELCTLKHPF 200

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 57.4 bits (138), Expect = 4e-09
 Identities = 41/139 (29%), Positives = 73/139 (52%), Gaps = 8/139 (5%)

Query: 199 LIFEYVNSTD--FKVLYPTLTDYD-IRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE 255
            + EYVN  +  F +    +   D  R+Y  E++ ALDY HS  I++RD+K  N+M+D +
Sbjct: 72  FVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKD 131

Query: 256 LRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI 314
              +++ D+GL  E             +  +  PE+L D  DY  ++D W LG +   M+
Sbjct: 132 -GHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMM 189

Query: 315 FRKEPFFYGHDNHDQLVKI 333
             + PF+  + +H++L ++
Sbjct: 190 CGRLPFY--NQDHEKLFEL 206

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 56.9 bits (137), Expect = 5e-09
 Identities = 36/119 (30%), Positives = 66/119 (55%), Gaps = 5/119 (4%)

Query: 219 YDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYN 277
           Y   +Y  E++  L + HS+GI++RD+K  NVM+D +   +++ D+G+  E        +
Sbjct: 96  YRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGH-IKIADFGMCKENVFGDNRAS 154

Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 336
               +  +  PE+L  L+ Y +S+D WS G +   M+  + P F+G D+ D+L +  +V
Sbjct: 155 TFCGTPDYIAPEILQGLK-YTFSVDWWSFGVLLYEMLIGQSP-FHG-DDEDELFESIRV 210

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 56.8 bits (137), Expect = 6e-09
 Identities = 75/316 (23%), Positives = 127/316 (40%), Gaps = 53/316 (16%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLL 186
           Y V++ +  G    VF        +  ++KI    +K     E  +LQN+   P+V+++ 
Sbjct: 68  YTVIKTLTPGSEGRVFVATKPGQPDPVVLKI---GQKGTTLIEAMLLQNV-NHPSVIRMK 123

Query: 187 DIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIR---YYIYELLKALDYCHSQGIMHR 243
           D +         ++  + +S  +  L        I        ++L+ L Y H+Q I+HR
Sbjct: 124 DTL--VSGAITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHR 181

Query: 244 DVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG---------PELLVDL 294
           DVK  N+ I+    ++ + D G A+F          V +  F G         PE+L   
Sbjct: 182 DVKTENIFINDV-DQVCIGDLGAAQF---------PVVAPAFLGLAGTVETNAPEVLAR- 230

Query: 295 QDYDYSLDMWSLGCMFAGM------IFRKEPFF---YGHDNHDQLVKIAKVLGTDELNAY 345
             Y+   D+WS G +   M      IF   P     Y    H  L+KI   L        
Sbjct: 231 DKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLK------- 283

Query: 346 LNKYHLELDPQLDALVG-----RHSRKPWSKFINADNQHLVSPEAIDFL-DKLLRYDHQD 399
           ++      DP    + G        R+P++++     Q +  P   +FL  K+L +D   
Sbjct: 284 VHPEEFPRDPGSRLVRGFIEYASLERQPYTRY--PCFQRVNLPIDGEFLVHKMLTFDAAM 341

Query: 400 RLTAREAMAHPYFAQV 415
           R +A E + +P FAQ+
Sbjct: 342 RPSAEEILNYPMFAQL 357

Length = 357

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 56.2 bits (135), Expect = 9e-09
 Identities = 67/312 (21%), Positives = 135/312 (43%), Gaps = 60/312 (19%)

Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKI----------KREIKILQN 175
           ++E+++ +G G Y +VF    V+ ++   +  +K +KK  I          + E ++L++
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60

Query: 176 LCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDF---KVLYPTLTDYDIRYYIYELLKAL 232
           +   P +V L      Q      LI +Y+N  +            + +++ Y  E++ AL
Sbjct: 61  IRQSPFLVTLHYAF--QTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLAL 118

Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG---KEYNVRVASRYFKGPE 289
           ++ H  GI++RD+K  N+++D     + L D+GL++ +H     + Y+      Y   P+
Sbjct: 119 EHLHKLGIIYRDIKLENILLDSN-GHVVLTDFGLSKEFHEDEVERAYSFCGTIEYM-APD 176

Query: 290 LLVDLQD-YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK 348
           ++      +D ++D WS+G +   ++    PF               V G     A +++
Sbjct: 177 IVRGGDGGHDKAVDWWSMGVLMYELLTGASPF--------------TVDGEKNSQAEISR 222

Query: 349 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TA 403
             L+ +P            P+ + +        S  A D + +LL  D + RL      A
Sbjct: 223 RILKSEP------------PYPQEM--------SALAKDIIQRLLMKDPKKRLGCGPSDA 262

Query: 404 REAMAHPYFAQV 415
            E   HP+F ++
Sbjct: 263 DEIKKHPFFQKI 274

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 56.2 bits (136), Expect = 9e-09
 Identities = 53/222 (23%), Positives = 86/222 (38%), Gaps = 38/222 (17%)

Query: 221 IRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE-------LRKLRLID----WGLAEF 269
           I + + ++L ALDY HS+G +HR VK  ++++  +       LR    +           
Sbjct: 103 IAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVH 162

Query: 270 YHP-GKEYNVRVASRYFKGPELL-VDLQDYDYSLDMWSLG---CMFAGMIFRKEPFFYGH 324
             P     N+   S     PE+L  +LQ Y+   D++S+G   C  A       PF    
Sbjct: 163 DFPKSSVKNLPWLS-----PEVLQQNLQGYNEKSDIYSVGITACELANGH---VPFK--- 211

Query: 325 DNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLV--- 381
           D     + + KV GT       + Y L  D          SR       N D+       
Sbjct: 212 DMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQ------SRSSNEHPNNRDSVDHPYTR 265

Query: 382 --SPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAESS 421
             S     F++  L+ D + R +A + + H +F Q +   +S
Sbjct: 266 TFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCKRRNTS 307

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 56.2 bits (136), Expect = 1e-08
 Identities = 48/197 (24%), Positives = 80/197 (40%), Gaps = 46/197 (23%)

Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRV 280
            +Y   ++  L Y H   I++RD+K  N+++D E   +++ D+GL  E    G   +   
Sbjct: 104 VFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTE-GFVKIADFGLCKEGMGFGDRTSTFC 162

Query: 281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTD 340
            +  F  PE+L +   Y  ++D W LG +   M+  + PF                 G D
Sbjct: 163 GTPEFLAPEVLTE-TSYTRAVDWWGLGVLIYEMLVGESPF----------------PGDD 205

Query: 341 ELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDR 400
           E            +   D++V    R P         + L S EAI  + +LLR + + R
Sbjct: 206 E------------EEVFDSIVNDEVRYP---------RFL-SREAISIMRRLLRRNPERR 243

Query: 401 L-----TAREAMAHPYF 412
           L      A +    P+F
Sbjct: 244 LGSGEKDAEDVKKQPFF 260

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 56.4 bits (136), Expect = 1e-08
 Identities = 85/361 (23%), Positives = 136/361 (37%), Gaps = 100/361 (27%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIK-ILKPVKKKK-----IKREIKILQNLCG 178
           +D+  V+ +G+G + EV      +T +   +K +LK    KK     +K E  +L     
Sbjct: 1   EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAE-SD 59

Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALDYC 235
            P VV L    +D  ++   LI E++   D   +   Y T ++   R+Y+ E + A++  
Sbjct: 60  SPWVVSLYYSFQD--AQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAV 117

Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP------------GKEYNVRVASR 283
           H  G +HRD+KP N++ID     ++L D+GL+  +H             GK    R+ +R
Sbjct: 118 HKLGFIHRDIKPDNILIDRG-GHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNR 176

Query: 284 Y------------------------------------FKGPELLVDLQDYDYSLDMWSLG 307
                                                +  PE+ +  Q Y    D WSLG
Sbjct: 177 NSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ-QGYGQECDWWSLG 235

Query: 308 C-MFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSR 366
             MF  +I    P F   ++H+   KI            +N       P           
Sbjct: 236 AIMFECLI--GWPPFCSENSHETYRKI------------INWRETLYFP----------- 270

Query: 367 KPWSKFINADNQHLVSPEAIDFLDKLLRYDHQ--DRLTAREAMAHPYFAQVRAAESSRTR 424
                    D+ HL S EA D + +L+        R  A E  +HP+F  V      + R
Sbjct: 271 ---------DDIHL-SVEAEDLIRRLITNAENRLGRGGAHEIKSHPFFRGVDWDTIRQIR 320

Query: 425 A 425
           A
Sbjct: 321 A 321

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 56.8 bits (137), Expect = 1e-08
 Identities = 43/151 (28%), Positives = 79/151 (52%), Gaps = 11/151 (7%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--KKKIKREIKILQN---LCGG 179
           +++ +V+ + RG + +V+ G   N ++   +K++K      K +  +++  ++   L   
Sbjct: 4   EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKS 63

Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIYELLKALDYCH 236
           P +V L   +  Q +    L+ EY+   D K L      +D      YI E+  ALDY H
Sbjct: 64  PFIVHLYYSL--QSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLH 121

Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 267
             GI+HRD+KP N++I +E   ++L D+GL+
Sbjct: 122 RHGIIHRDLKPDNMLISNE-GHIKLTDFGLS 151

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 55.6 bits (134), Expect = 1e-08
 Identities = 51/205 (24%), Positives = 90/205 (43%), Gaps = 26/205 (12%)

Query: 133 VGRGKYSEVFEGINVNTNERCIIKILKPVKKKK----IKREIKILQNLCGGPNVVKLLDI 188
           +G+G Y  V+   +++T  R  IK + P +  +    +  EI +   L    N+V+ L  
Sbjct: 16  LGKGTYGIVYAARDLSTQVRIAIKEI-PERDSRYVQPLHEEIALHSYLKHR-NIVQYLG- 72

Query: 189 VRDQHSKTPSLIFEYVNSTDFKVLYPT----LTDYD--IRYYIYELLKALDYCHSQGIMH 242
             D  +    +  E V       L  +    L D +  I +Y  ++L+ L Y H   I+H
Sbjct: 73  -SDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVH 131

Query: 243 RDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG------PELL-VDLQ 295
           RD+K  NV+++     +++ D+G ++     +   +   +  F G      PE++    +
Sbjct: 132 RDIKGDNVLVNTYSGVVKISDFGTSK-----RLAGINPCTETFTGTLQYMAPEVIDKGPR 186

Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPF 320
            Y    D+WSLGC    M   K PF
Sbjct: 187 GYGAPADIWSLGCTIVEMATGKPPF 211

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 56.0 bits (135), Expect = 1e-08
 Identities = 39/136 (28%), Positives = 70/136 (51%), Gaps = 10/136 (7%)

Query: 200 IFEYVNSTDFKVLYPTLTDYDI---RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEL 256
           + EY+N  D      +   +D    R+Y  E++  L + H +GI++RD+K  NV++D + 
Sbjct: 74  VMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDG 133

Query: 257 RKLRLIDWGLA--EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI 314
             +++ D+G+        GK  +    +  +  PE+L   Q Y+ S+D WS G +   M+
Sbjct: 134 H-IKIADFGMCKENMNGEGKA-STFCGTPDYIAPEILKG-QKYNESVDWWSFGVLLYEML 190

Query: 315 FRKEPFFYGHDNHDQL 330
             + P F+G D  D+L
Sbjct: 191 IGQSP-FHGED-EDEL 204

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 55.5 bits (134), Expect = 1e-08
 Identities = 48/203 (23%), Positives = 77/203 (37%), Gaps = 44/203 (21%)

Query: 226 YELLKALDYC-HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY 284
             ++KAL Y     G++HRDVKP N+++D     ++L D+G++      K          
Sbjct: 121 VAIVKALHYLKEKHGVIHRDVKPSNILLD-ASGNVKLCDFGISGRLVDSKAKTRSAGCAA 179

Query: 285 FKGPELLVDLQD----YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTD 340
           +  PE + D  D    YD   D+WSLG     +   + P+       + L KI       
Sbjct: 180 YMAPERI-DPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKI------- 231

Query: 341 ELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDR 400
                     L+ +P                          SP+   F+D  L  DH+ R
Sbjct: 232 ----------LQEEPPS-----------------LPPNEGFSPDFCSFVDLCLTKDHRKR 264

Query: 401 LTAREAMAHPYFAQVRAAESSRT 423
              RE + HP+   +R  E++  
Sbjct: 265 PKYRELLQHPF---IRRYETAEV 284

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 55.2 bits (133), Expect = 2e-08
 Identities = 70/327 (21%), Positives = 125/327 (38%), Gaps = 90/327 (27%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQN--------- 175
           +D+E ++ +  G Y  V+   +  T +R  +K        KI ++  IL+N         
Sbjct: 1   EDFETIKLISNGAYGAVYLVRHKETRQRFAMK--------KINKQNLILRNQIQQVFVER 52

Query: 176 ----LCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDI---RYYIYEL 228
                   P VV +      +  +   ++ EYV   D   L   +    +   R Y  E 
Sbjct: 53  DILTFAENPFVVSMF--CSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAET 110

Query: 229 LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE---------FYHPGKEYNVR 279
           + AL+Y H+ GI+HRD+KP N++I   +  ++L D+GL++          Y    E ++ 
Sbjct: 111 VLALEYLHNYGIVHRDLKPDNLLIT-SMGHIKLTDFGLSKIGLMSLTTNLY----EGHIE 165

Query: 280 VASRYFK-----------GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHD 328
             +R F             PE+++  Q Y   +D W++G +    +    PFF   D  +
Sbjct: 166 KDTREFLDKQVCGTPEYIAPEVIL-RQGYGKPVDWWAMGIILYEFLVGCVPFF--GDTPE 222

Query: 329 QLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDF 388
           +L    +V+  D                                   +    +  +A D 
Sbjct: 223 EL--FGQVISDD-------------------------------IEWPEGDEALPADAQDL 249

Query: 389 LDKLLRYDHQDRL---TAREAMAHPYF 412
           + +LLR +  +RL    A E   H +F
Sbjct: 250 ISRLLRQNPLERLGTGGAFEVKQHRFF 276

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 54.9 bits (132), Expect = 2e-08
 Identities = 31/104 (29%), Positives = 55/104 (52%), Gaps = 3/104 (2%)

Query: 219 YDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-YN 277
              R+Y  ELL AL+  H   +++RD+KP N+++D++   + L D+GL +      +  N
Sbjct: 93  SRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQ-GHIALCDFGLCKLNMKDDDKTN 151

Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
               +  +  PELL+    Y  ++D W+LG +   M+    PF+
Sbjct: 152 TFCGTPEYLAPELLLGH-GYTKAVDWWTLGVLLYEMLTGLPPFY 194

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 54.4 bits (131), Expect = 3e-08
 Identities = 72/333 (21%), Positives = 123/333 (36%), Gaps = 74/333 (22%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTN---ERCIIKI-LKPVKKKKIKREIKILQNLCGGP 180
           DD+E + ++G G    V + ++  +     R +I + +KP  + +I RE+K+L   C  P
Sbjct: 1   DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHE-CNSP 59

Query: 181 NVVKL---------------------LDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDY 219
            +V                       LD V  +  + P  I   ++              
Sbjct: 60  YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKIS-------------- 105

Query: 220 DIRYYIYELLKALDYC---HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY 276
                   +L+ L Y    H   IMHRDVKP N++++    +++L D+G++         
Sbjct: 106 ------IAVLRGLTYLREKHK--IMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDSMA- 155

Query: 277 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 336
           N  V +R +  PE L     Y    D+WSLG     M   + P        D   ++  +
Sbjct: 156 NSFVGTRSYMSPERLQG-THYTVQSDIWSLGLSLVEMAIGRYPI----PPPDAK-ELEAM 209

Query: 337 LGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADN----------QHLVSPEAI 386
            G         + H  +           S +P + F   D               S E  
Sbjct: 210 FGRPVSEGEAKESHRPVSGH-----PPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQ 264

Query: 387 DFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE 419
           DF+DK L+ + ++R   +E   HP+  +    E
Sbjct: 265 DFVDKCLKKNPKERADLKELTKHPFIKRAELEE 297

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 53.7 bits (129), Expect = 4e-08
 Identities = 48/212 (22%), Positives = 103/212 (48%), Gaps = 22/212 (10%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIK-----ILKPVKKKKIKREIKILQNLCGGPN 181
           Y  V+K+G G + +     +    ++ +IK      + P ++++ ++E+ +L N+   PN
Sbjct: 2   YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNM-KHPN 60

Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTD-FK-------VLYPTLTDYDIRYYIYELLKALD 233
           +V+  +    + +    ++ +Y    D +K       VL+P   +  I  +  ++  AL 
Sbjct: 61  IVQYQESF--EENGNLYIVMDYCEGGDLYKKINAQRGVLFP---EDQILDWFVQICLALK 115

Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY-NVRVASRYFKGPELLV 292
           + H + I+HRD+K  N+ +  +   ++L D+G+A   +   E     + + Y+  PE + 
Sbjct: 116 HVHDRKILHRDIKSQNIFLTKD-GTIKLGDFGIARVLNSTVELARTCIGTPYYLSPE-IC 173

Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH 324
           + + Y+   D+W+LGC+   M   K  F  G+
Sbjct: 174 ENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 52.9 bits (128), Expect = 7e-08
 Identities = 52/189 (27%), Positives = 82/189 (43%), Gaps = 39/189 (20%)

Query: 225 IYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY 284
           I +L++AL+  H   I+H D+K  NV+ D    ++ L D+GL +       Y+  +   Y
Sbjct: 115 IRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYDGTLD--Y 172

Query: 285 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA 344
           F  PE +    +YD S D W++G +   ++  K PF    D                   
Sbjct: 173 FS-PEKIKG-HNYDVSFDWWAVGVLTYELLTGKHPFKEDEDE------------------ 212

Query: 345 YLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA- 403
                  ELD   ++L+ R  +K    FI       VS  A DF+  +L+Y+   RLT  
Sbjct: 213 -------ELDL--ESLLKRQQKKL--PFIKN-----VSKNANDFVQSMLKYNINYRLTNY 256

Query: 404 REAMAHPYF 412
            E + HP+ 
Sbjct: 257 NEIIKHPFL 265

Length = 267

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 52.6 bits (126), Expect = 8e-08
 Identities = 48/203 (23%), Positives = 91/203 (44%), Gaps = 22/203 (10%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK--------REIKILQNLCG 178
           Y + +++G+G +  V+   +        +K+LK +   ++         +E ++L  L  
Sbjct: 2   YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKL-D 60

Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTD-------FKVLYPTLTDYDIRYYIYELLKA 231
            P +VK      ++ +    +I EY    D        K    TL++  +  +  +LL  
Sbjct: 61  HPAIVKFHASFLERDAFC--IITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLG 118

Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY-NVRVASRYFKGPEL 290
           + Y H + I+HRD+K  N+ + + L  L++ D+G++       +       + Y+  PE 
Sbjct: 119 VHYMHQRRILHRDLKAKNIFLKNNL--LKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEA 176

Query: 291 LVDLQDYDYSLDMWSLGCMFAGM 313
           L   Q YD   D+WSLGC+   M
Sbjct: 177 LKH-QGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 53.7 bits (129), Expect = 8e-08
 Identities = 72/309 (23%), Positives = 117/309 (37%), Gaps = 47/309 (15%)

Query: 127 YEVVRKVGRGKYSEVFEGINV--NTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVK 184
           Y ++  +  G   EVF          ++ I+K +     K   REI IL+ +     ++ 
Sbjct: 94  YNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAV--TGGKTPGREIDILKTI-SHRAIIN 150

Query: 185 LLDIVRDQHSKTPSL------IFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQ 238
           L+   R + +    +      +F YV+ +        L           LL+AL Y H +
Sbjct: 151 LIHAYRWKSTVCMVMPKYKCDLFTYVDRSG------PLPLEQAITIQRRLLEALAYLHGR 204

Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLA-----EFYHPGKEYNVRVASRYFKGPELLVD 293
           GI+HRDVK  N+ +D E     L D+G A         P + Y     +     PELL  
Sbjct: 205 GIIHRDVKTENIFLD-EPENAVLGDFGAACKLDAHPDTP-QCYG-WSGTLETNSPELLA- 260

Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHD--QLVKIAKVLGTDEL------NAY 345
           L  Y    D+WS G +   M  +    F         QL  I + +    L      +  
Sbjct: 261 LDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTN 320

Query: 346 LNKYHLELDPQLDALVGRHSRKPWS--KFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA 403
           L K+  +    L        R P++    I     H+     I    K+L +D + R +A
Sbjct: 321 LCKHFKQYAIVL--------RPPYTIPPVIRKYGMHMDVEYLIA---KMLTFDQEFRPSA 369

Query: 404 REAMAHPYF 412
           ++ ++ P F
Sbjct: 370 QDILSLPLF 378

Length = 392

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 53.5 bits (128), Expect = 9e-08
 Identities = 46/151 (30%), Positives = 81/151 (53%), Gaps = 13/151 (8%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP---VKKKK---IKREIKILQNLCG 178
           +D+E ++ +GRG + EV      +T     +KIL+    ++K++   I+ E  IL     
Sbjct: 1   EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVE-AD 59

Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYC 235
              VVK+    +D+ +    LI E++   D   L     TLT+ + ++YI E + A+D  
Sbjct: 60  SLWVVKMFYSFQDKLNLY--LIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSI 117

Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGL 266
           H  G +HRD+KP N+++D +   ++L D+GL
Sbjct: 118 HQLGFIHRDIKPDNLLLDSK-GHVKLSDFGL 147

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 52.5 bits (126), Expect = 1e-07
 Identities = 71/309 (22%), Positives = 128/309 (41%), Gaps = 49/309 (15%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL----KPVKKKKIKREIKILQNLCG 178
             +D E +  +G G    V +  ++ T      K++    K   +K+I RE++I+   C 
Sbjct: 3   RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHE-CR 61

Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTD--FKVLYPTLTDYDIRYYIYELLKALDYCH 236
            P +V       ++++    + F    S D  +K   P   +  +      +++ L Y +
Sbjct: 62  SPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEI-LGKIAVAVVEGLTYLY 120

Query: 237 S-QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN----VRVASRYFKGPELL 291
           +   IMHRD+KP N++++    +++L D+G++     G+  N      V +  +  PE  
Sbjct: 121 NVHRIMHRDIKPSNILVNSR-GQIKLCDFGVS-----GELINSIADTFVGTSTYMSPE-- 172

Query: 292 VDLQDYDYSL--DMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY 349
             +Q   Y++  D+WSLG     +   K PF + + + D       +L  D L   +   
Sbjct: 173 -RIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGIL--DLLQQIVQ-- 227

Query: 350 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 409
             E  P+L          P S F           +  DF+D  L  D  +R T ++  A 
Sbjct: 228 --EPPPRL----------PSSDF---------PEDLRDFVDACLLKDPTERPTPQQLCAM 266

Query: 410 PYFAQVRAA 418
           P F Q   A
Sbjct: 267 PPFIQALRA 275

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 51.7 bits (124), Expect = 2e-07
 Identities = 46/167 (27%), Positives = 78/167 (46%), Gaps = 16/167 (9%)

Query: 165 KIKREIKILQNLCGGPNVVKL---------LDIVRDQHSKTPSLIFEYVNSTDFKVLYPT 215
            I  E+ I++     PN+V+          L IV D     P  + E+ NS   K     
Sbjct: 54  DIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAP--LGEHFNS--LKEKKQR 109

Query: 216 LTDYDIRYYIYELLKALDYCHSQG-IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 274
            T+  I     +++ AL Y H +  I+HRD+ P+N+M+  E  K+ + D+GLA+   P  
Sbjct: 110 FTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLG-EDDKVTITDFGLAKQKQPES 168

Query: 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
           +    V +  +  PE++ +   Y    D+W+ GC+   M   + PF+
Sbjct: 169 KLTSVVGTILYSCPEIVKNEP-YGEKADVWAFGCILYQMCTLQPPFY 214

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 51.8 bits (124), Expect = 2e-07
 Identities = 67/295 (22%), Positives = 116/295 (39%), Gaps = 54/295 (18%)

Query: 133 VGRGKYSEVFEGINVNTNERCIIK--ILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVR 190
           +G+G Y  V+ G+  N  +   +K   L        ++E + LQ        +K ++IV+
Sbjct: 8   LGKGAYGTVYCGL-TNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66

Query: 191 D----QHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALDYCHSQGIMHR 243
                    T S+  E+V       +   +  L +     Y  ++L  + Y H+  ++HR
Sbjct: 67  YLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHR 126

Query: 244 DVKPHNVMIDHELRKLRLIDWG----LAEFYHPGKEYNVRVASR---YFKGPELLVDLQD 296
           D+K +NVM+      ++LID+G    LA     G   N+  +     Y+  PE++ +   
Sbjct: 127 DIKGNNVML-MPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINE-SG 184

Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ 356
           Y    D+WS+GC    M   K P      + D+L  +  +             H  L P+
Sbjct: 185 YGRKSDIWSIGCTVFEMATGKPPL----ASMDRLAAMFYI-----------GAHRGLMPR 229

Query: 357 LDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 411
           L              F         S  AIDF+   L  D  +R +A + + H +
Sbjct: 230 LP-----------DSF---------SAAAIDFVTSCLTRDQHERPSALQLLRHDF 264

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 52.1 bits (125), Expect = 2e-07
 Identities = 31/99 (31%), Positives = 53/99 (53%), Gaps = 3/99 (3%)

Query: 223 YYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVA 281
           +Y  E+   L + HS+GI++RD+K  NVM+D E   +++ D+G+  E    GK       
Sbjct: 105 FYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAE-GHIKIADFGMCKENIFGGKTTRTFCG 163

Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
           +  +  PE ++  Q Y  S+D W+ G +   M+  + PF
Sbjct: 164 TPDYIAPE-IIAYQPYGKSVDWWAFGVLLYEMLAGQPPF 201

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 51.9 bits (124), Expect = 3e-07
 Identities = 79/356 (22%), Positives = 136/356 (38%), Gaps = 102/356 (28%)

Query: 130 VRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR----EIKILQNLCGGPN---V 182
           ++ +G G + EV     V+T+    +K L+  KK  + R     +K  +++    +   V
Sbjct: 6   IKTLGIGAFGEVCLACKVDTHALYAMKTLR--KKDVLNRNQVAHVKAERDILAEADNEWV 63

Query: 183 VKLLDIVRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALDYCHSQG 239
           VKL    +D+ +     + +Y+   D   L        +   R+YI EL  A++  H  G
Sbjct: 64  VKLYYSFQDKDNLY--FVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMG 121

Query: 240 IMHRDVKPHNVMIDHELRKLRLIDWGL---------AEFYHPGKEY-------------- 276
            +HRD+KP N++ID +   ++L D+GL         +++Y  G                 
Sbjct: 122 FIHRDIKPDNILIDLD-GHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDV 180

Query: 277 -NVRVASRY------------------------FKGPELLVDLQDYDYSLDMWSLGCMFA 311
            N R   R                         +  PE+L+  + Y    D WS+G +  
Sbjct: 181 SNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR-KGYTQLCDWWSVGVILF 239

Query: 312 GMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSK 371
            M+  + PF        QL    KV+                               W  
Sbjct: 240 EMLVGQPPFLAPTPTETQL----KVIN------------------------------WEN 265

Query: 372 FINADNQHLVSPEAIDFLDKLLRYDHQDRL---TAREAMAHPYFAQVRAAESSRTR 424
            ++   Q  +SPEA+D + KL     ++RL    A +  AHP+F++V  +   RT+
Sbjct: 266 TLHIPPQVKLSPEAVDLITKLC-CSAEERLGRNGADDIKAHPFFSEVDFSSDIRTQ 320

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 50.0 bits (120), Expect = 8e-07
 Identities = 44/214 (20%), Positives = 88/214 (41%), Gaps = 38/214 (17%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGI--NVNTNE---RCIIKILKPV----KKKKIKREIKIL 173
            ++   ++R++G+G +  V+EG+   V   E   R  IK +       ++ +   E  ++
Sbjct: 4   PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVM 63

Query: 174 QNL-CGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV-------------LYPTLTDY 219
           +   C   +VV+LL +V     +   ++ E +   D K                   T  
Sbjct: 64  KEFNC--HHVVRLLGVVSTG--QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQ 119

Query: 220 DIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA------EFYHPG 273
                  E+   + Y  ++  +HRD+   N M+  +L  +++ D+G+       ++Y  G
Sbjct: 120 KFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDL-TVKIGDFGMTRDIYETDYYRKG 178

Query: 274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLG 307
            +  + V  R+   PE L D   +    D+WS G
Sbjct: 179 GKGLLPV--RWM-APESLKD-GVFTTKSDVWSFG 208

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 49.6 bits (118), Expect = 9e-07
 Identities = 53/228 (23%), Positives = 107/228 (46%), Gaps = 29/228 (12%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGPN 181
           ++  ++V+K+G G++ EV+ G   N + +  +K LKP  +  +    E  +++ L     
Sbjct: 5   RESIKLVKKLGAGQFGEVWMGY-YNNSTKVAVKTLKPGTMSVQAFLEEANLMKTL-QHDK 62

Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNS---TDF-------KVLYPTLTDYDIRYYIYELLKA 231
           +V+L  +V  +  +   +I EY+      DF       KVL P L D+       ++ + 
Sbjct: 63  LVRLYAVVTKE--EPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSA-----QIAEG 115

Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY---FKGP 288
           + Y   +  +HRD++  NV++  E    ++ D+GLA       EY  R  +++   +  P
Sbjct: 116 MAYIERKNYIHRDLRAANVLVS-ESLMCKIADFGLARVIE-DNEYTAREGAKFPIKWTAP 173

Query: 289 ELLVDLQDYDYSLDMWSLGCMFAGMI-FRKEPFFYGHDNHDQLVKIAK 335
           E  ++   +    D+WS G +   ++ + K P + G  N D +  + +
Sbjct: 174 E-AINFGSFTIKSDVWSFGILLYEIVTYGKIP-YPGMSNSDVMSALQR 219

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 50.0 bits (119), Expect = 1e-06
 Identities = 54/201 (26%), Positives = 89/201 (44%), Gaps = 28/201 (13%)

Query: 228 LLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRV-ASRYF- 285
           +L+A+ Y H   I+HRD+K  N+ I+H    + L D+G A        + V + A++Y+ 
Sbjct: 191 VLRAIQYLHENRIIHRDIKAENIFINHP-GDVCLGDFGAA-------CFPVDINANKYYG 242

Query: 286 -------KGPELLVDLQDYDYSLDMWSLGCMFAGM------IFRKEPFFYGHDNHDQLVK 332
                    PELL     Y  ++D+WS G +   M      +F K+      D+  Q+  
Sbjct: 243 WAGTIATNAPELLAR-DPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKL 301

Query: 333 IAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLD-K 391
           I +  GT   N +       LD     L  + SRKP S+ +  +   L  P  +++L  K
Sbjct: 302 IIRRSGTHP-NEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYEL--PIDLEYLICK 358

Query: 392 LLRYDHQDRLTAREAMAHPYF 412
           +L +D   R +A   +    F
Sbjct: 359 MLAFDAHHRPSAEALLDFAAF 379

Length = 391

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 49.2 bits (117), Expect = 2e-06
 Identities = 39/132 (29%), Positives = 64/132 (48%), Gaps = 18/132 (13%)

Query: 199 LIFEYVNSTDFKVLYPTLTDY---DIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE 255
            + EYVN  D       +  +      +Y  E+   L + H +GI++RD+K  NVM+D E
Sbjct: 78  FVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSE 137

Query: 256 LRKLRLIDWGLAEFYHPGKEYNVR-VASRYFKG------PELLVDLQDYDYSLDMWSLGC 308
              +++ D+G+       KE+ V  V +R F G      PE++   Q Y  S+D W+ G 
Sbjct: 138 -GHIKIADFGMC------KEHMVDGVTTRTFCGTPDYIAPEIIA-YQPYGKSVDWWAYGV 189

Query: 309 MFAGMIFRKEPF 320
           +   M+  + PF
Sbjct: 190 LLYEMLAGQPPF 201

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 48.7 bits (116), Expect = 2e-06
 Identities = 60/290 (20%), Positives = 116/290 (40%), Gaps = 48/290 (16%)

Query: 133 VGRGKYSEVFEGINVNTNERCIIKIL----KPVKKKKIKREIKILQNLCGGPNVVKLLD- 187
           +G G    V++  ++ T     +K++        +K+I  E++IL   C  P ++     
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYK-CDSPYIIGFYGA 67

Query: 188 -IVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVK 246
             V ++     S+  E+++     V Y  + ++ +      ++K L Y  S  I+HRDVK
Sbjct: 68  FFVENR----ISICTEFMDGGSLDV-YRKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVK 122

Query: 247 PHNVMIDHELRKLRLIDWGLAE--FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMW 304
           P N++++    +++L D+G++        K Y   V +  +  PE +   Q Y    D+W
Sbjct: 123 PSNMLVNTR-GQVKLCDFGVSTQLVNSIAKTY---VGTNAYMAPERISGEQ-YGIHSDVW 177

Query: 305 SLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRH 364
           SLG  F  +   + P+     N   L+ +        L   ++    E  P L       
Sbjct: 178 SLGISFMELALGRFPYPQIQKNQGSLMPL------QLLQCIVD----EDPPVLPV----- 222

Query: 365 SRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 414
                            S + + F+ + +R   ++R      M HP+  Q
Sbjct: 223 --------------GQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQ 258

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 49.4 bits (118), Expect = 2e-06
 Identities = 39/163 (23%), Positives = 72/163 (44%), Gaps = 24/163 (14%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILK------PVKKKKIKREIKILQNLCGGP 180
           Y+++R +G+G   EV+   +   + R  +K ++      P+ KK+  RE KI  +L   P
Sbjct: 4   YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIH-P 62

Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTL-------TDYDIRYYIYELLKALD 233
            +V +  I  D           Y+     K L  ++        +   +  +   L    
Sbjct: 63  GIVPVYSICSD--GDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFH 120

Query: 234 -------YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 269
                  Y HS+G++HRD+KP N+++     ++ ++DWG A F
Sbjct: 121 KICATIEYVHSKGVLHRDLKPDNILLG-LFGEVVILDWGAAIF 162

Length = 932

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 48.1 bits (114), Expect = 3e-06
 Identities = 47/193 (24%), Positives = 82/193 (42%), Gaps = 22/193 (11%)

Query: 132 KVGRGKYSEVFEGINVNTNERCIIK----ILKPVKKKKIKREIKILQNLCGGPNVVKLLD 187
           ++GRG + EVF G     N    +K     L P  K K  +E +IL+     PN+V+L+ 
Sbjct: 2   RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQY-SHPNIVRLIG 60

Query: 188 IVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLK-------ALDYCHSQGI 240
           +   +      ++ E V   DF      L     R  + EL++        ++Y  S+  
Sbjct: 61  VCTQKQPIY--IVMELVQGGDFLTF---LRTEGPRLKVKELIQMVENAAAGMEYLESKHC 115

Query: 241 MHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG---KEYNVRVASRYFKGPELLVDLQDY 297
           +HRD+   N ++  E   L++ D+G++     G       ++     +  PE L +   Y
Sbjct: 116 IHRDLAARNCLVT-EKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEAL-NYGRY 173

Query: 298 DYSLDMWSLGCMF 310
               D+WS G + 
Sbjct: 174 SSESDVWSFGILL 186

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 48.8 bits (116), Expect = 3e-06
 Identities = 54/210 (25%), Positives = 95/210 (45%), Gaps = 24/210 (11%)

Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP---VKKKKIK---REIKILQNLCGG 179
           D+  +  +G+G + +V       T+E   IKILK    ++   ++    E ++L  L G 
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLA-LSGK 59

Query: 180 PNVVKLLDIVRDQHSKTPSL-----IFEYVNSTDFKVLYPTLTDYD---IRYYIYELLKA 231
           P  +  L      HS   ++     + EYVN  D       +  +      +Y  E+   
Sbjct: 60  PPFLTQL------HSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIG 113

Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPEL 290
           L + HS+GI++RD+K  NVM+D E   +++ D+G+  E    G        +  +  PE+
Sbjct: 114 LFFLHSKGIIYRDLKLDNVMLDSE-GHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEI 172

Query: 291 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
           +   Q Y  S+D W+ G +   M+  + PF
Sbjct: 173 IA-YQPYGKSVDWWAFGVLLYEMLAGQAPF 201

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 48.0 bits (114), Expect = 3e-06
 Identities = 52/208 (25%), Positives = 92/208 (44%), Gaps = 21/208 (10%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-----PVKKKKIKREIKILQNLCGGPN 181
           Y  VR VG+G Y EV    +    ++ +IK L        ++K  ++E ++L  L   PN
Sbjct: 2   YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQL-KHPN 60

Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY--------PTLTDYDIRYYIYELLKALD 233
           +V      R+       L++  +   +   LY          L +  +  +  ++  AL 
Sbjct: 61  IV----AYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQ 116

Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY-NVRVASRYFKGPELLV 292
           Y H + I+HRD+K  NV +      +++ D G+A       +  +  + + Y+  PEL  
Sbjct: 117 YLHEKHILHRDLKTQNVFLTRT-NIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFS 175

Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
           + + Y+Y  D+W+LGC    M   K  F
Sbjct: 176 N-KPYNYKSDVWALGCCVYEMATLKHAF 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 48.9 bits (116), Expect = 4e-06
 Identities = 31/106 (29%), Positives = 56/106 (52%), Gaps = 5/106 (4%)

Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           +Y++    Y+++ ALD  HS+ +MHRD+K  N+ +      ++L D+G ++ Y      +
Sbjct: 168 EYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFL-MPTGIIKLGDFGFSKQYSDSVSLD 226

Query: 278 VRVA---SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
           V  +   + Y+  PEL  + + Y    DMWSLG +   ++    PF
Sbjct: 227 VASSFCGTPYYLAPELW-ERKRYSKKADMWSLGVILYELLTLHRPF 271

Length = 478

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 47.6 bits (113), Expect = 5e-06
 Identities = 56/229 (24%), Positives = 97/229 (42%), Gaps = 30/229 (13%)

Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE-------LRK-LRLIDWGL- 266
           +++  I Y +  +LKALDY H  G +HR VK  +++I  +       LR  L +I+ G  
Sbjct: 98  MSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157

Query: 267 AEFYHPGKEYNVRVASRYFKGPELL-VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD 325
               H   +Y+V+V    +  PE+L  +LQ YD   D++S+G     +     PF    D
Sbjct: 158 LRVVHDFPKYSVKVLP--WLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPF---KD 212

Query: 326 NHDQLVKIAKVLGT------------DELNAYLNKYHLELDPQLDALVGRHSRKPWSKFI 373
                + + K+ GT            +EL    ++            V            
Sbjct: 213 MPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSS 272

Query: 374 NADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV--RAAES 420
           +  N+   SP    F+++ L+ +   R +A   + H +F Q+  RA+E+
Sbjct: 273 HPYNRTF-SPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKRRASEA 320

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 47.7 bits (113), Expect = 5e-06
 Identities = 54/223 (24%), Positives = 92/223 (41%), Gaps = 54/223 (24%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTN---ERCIIKI-LKPVKKKKIKREIKILQNLCGGP 180
           DD+E + ++G G    VF+  +  +     R +I + +KP  + +I RE+++L   C  P
Sbjct: 5   DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHE-CNSP 63

Query: 181 NVVKL---------------------LDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDY 219
            +V                       LD V  +  + P  I   V+              
Sbjct: 64  YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVS-------------- 109

Query: 220 DIRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV 278
                   ++K L Y   +  IMHRDVKP N++++    +++L D+G++         N 
Sbjct: 110 ------IAVIKGLTYLREKHKIMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDSMA-NS 161

Query: 279 RVASRYFKGPELLVDLQDYDYSL--DMWSLGCMFAGMIFRKEP 319
            V +R +  PE    LQ   YS+  D+WS+G     M   + P
Sbjct: 162 FVGTRSYMSPE---RLQGTHYSVQSDIWSMGLSLVEMAIGRYP 201

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 47.5 bits (113), Expect = 6e-06
 Identities = 49/200 (24%), Positives = 96/200 (48%), Gaps = 32/200 (16%)

Query: 130 VRKVGRGKYSEV----FEGINVNTNERCIIKILKPVKKKKI---KREIKILQNLCGGPNV 182
           ++++G+G +  V    ++ +  NT E   +K L+    + +   +REI+IL++L    N+
Sbjct: 9   IQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSL-QHDNI 67

Query: 183 VKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRY-----------YIYELLKA 231
           VK   +      +   L+ EY+        Y +L DY  ++           Y  ++ K 
Sbjct: 68  VKYKGVCYSAGRRNLRLVMEYLP-------YGSLRDYLQKHRERLDHRKLLLYASQICKG 120

Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-YNVRVASR---YFKG 287
           ++Y  S+  +HRD+   N++++ E R +++ D+GL +     KE Y VR       ++  
Sbjct: 121 MEYLGSKRYVHRDLATRNILVESENR-VKIGDFGLTKVLPQDKEYYKVREPGESPIFWYA 179

Query: 288 PELLVDLQDYDYSLDMWSLG 307
           PE L +   +  + D+WS G
Sbjct: 180 PESLTE-SKFSVASDVWSFG 198

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 48.3 bits (115), Expect = 7e-06
 Identities = 33/117 (28%), Positives = 54/117 (46%), Gaps = 19/117 (16%)

Query: 149 TNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS---- 198
           T     IK+L+        ++ + +RE  +   L   PN+V LLD       + P     
Sbjct: 2   TGHEVAIKLLRTDAPEEEHQRARFRRETALCARL-YHPNIVALLD-----SGEAPPGLLF 55

Query: 199 LIFEYVNSTDFKVLYPT---LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI 252
            +FEYV     + +      L   +    + ++L AL   H+QGI+HRD+KP N+M+
Sbjct: 56  AVFEYVPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMV 112

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 46.9 bits (111), Expect = 1e-05
 Identities = 59/245 (24%), Positives = 89/245 (36%), Gaps = 88/245 (35%)

Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL---------AEFY-- 270
           R+YI EL  A++  H  G +HRD+KP N++ID +   ++L D+GL         +++Y  
Sbjct: 104 RFYIAELTCAVESVHKMGFIHRDIKPDNILIDRD-GHIKLTDFGLCTGFRWTHDSKYYQS 162

Query: 271 --HP-----------GKEYNVRVASRY------------------------FKGPELLVD 293
             H            G   N R   R                         +  PE+L+ 
Sbjct: 163 GDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR 222

Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 353
              Y    D WS+G +   M+  + PF        Q+    KV+                
Sbjct: 223 -TGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQM----KVIN--------------- 262

Query: 354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL---TAREAMAHP 410
                          W   ++   Q  +SPEA D + KL R   +DRL    A E  AHP
Sbjct: 263 ---------------WQTSLHIPPQAKLSPEASDLIIKLCR-GPEDRLGKNGADEIKAHP 306

Query: 411 YFAQV 415
           +F  +
Sbjct: 307 FFKTI 311

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 45.7 bits (108), Expect = 2e-05
 Identities = 48/209 (22%), Positives = 95/209 (45%), Gaps = 21/209 (10%)

Query: 125 DDYEVVRKVGRGKYSEV---------FEGINVNTNERCIIKILKPVKKKKIKREIKILQN 175
           +D+  +R +G G +  V         F  + +   E+   KI+K  +   +  E KIL N
Sbjct: 30  EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKS--KIIKQKQVDHVFSERKIL-N 86

Query: 176 LCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDY--DIR-YYIYELLKAL 232
               P  V L    +D+      L+ E+V   +F         +  D+  +Y  +++   
Sbjct: 87  YINHPFCVNLYGSFKDE--SYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIF 144

Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 292
           +Y  S  I++RD+KP N+++D +   +++ D+G A+     + Y +     Y   PE+L+
Sbjct: 145 EYLQSLNIVYRDLKPENLLLDKD-GFIKMTDFGFAKVVDT-RTYTLCGTPEYI-APEILL 201

Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
           ++  +  + D W+LG     ++    PF+
Sbjct: 202 NV-GHGKAADWWTLGIFIYEILVGCPPFY 229

Length = 340

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 45.6 bits (108), Expect = 2e-05
 Identities = 52/226 (23%), Positives = 97/226 (42%), Gaps = 29/226 (12%)

Query: 99  VYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEG-----INVNTNERC 153
           VY D   L     W++    + +G        + +G G + +V E         +   + 
Sbjct: 17  VYIDPTQLPYDLKWEFPRNNLSFG--------KTLGAGAFGKVVEATAYGLSKSDAVMKV 68

Query: 154 IIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDF 209
            +K+LKP     +++ +  E+KI+ +L    N+V LL            +I EY    D 
Sbjct: 69  AVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGAC--TIGGPILVITEYCCYGDL 126

Query: 210 -----KVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDW 264
                +     LT  D+  + Y++ K + +  S+  +HRD+   NV++ H  + +++ D+
Sbjct: 127 LNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHG-KIVKICDF 185

Query: 265 GLAEFYHPGKEYNVRVASRY---FKGPELLVDLQDYDYSLDMWSLG 307
           GLA        Y V+  +R    +  PE + +   Y +  D+WS G
Sbjct: 186 GLARDIMNDSNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYG 230

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 45.3 bits (107), Expect = 3e-05
 Identities = 19/50 (38%), Positives = 31/50 (62%), Gaps = 1/50 (2%)

Query: 221 IRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 270
           I+  + ++L  L+Y H  GI H D+KP N+M+D   R   +ID+G+A  +
Sbjct: 128 IKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGY-IIDYGIASHF 176

Length = 294

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 45.5 bits (107), Expect = 4e-05
 Identities = 76/310 (24%), Positives = 119/310 (38%), Gaps = 65/310 (20%)

Query: 147 VNTNERCIIKILKPVKKKKI--KREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV 204
               ER I K +K   +  I  + EI  L  L    N++K+ +I+R     + +  +   
Sbjct: 189 KPKCERLIAKRVKAGSRAAIQLENEILALGRL-NHENILKIEEILR-----SEANTYMIT 242

Query: 205 NSTDFKVLYPTLTDYDI-----------RYYIYELLKALDYCHSQGIMHRDVKPHNVMID 253
              DF  LY  + D              R  + +LL A++Y H + ++HRD+K  N+ ++
Sbjct: 243 QKYDFD-LYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLN 301

Query: 254 HELRKLRLIDWGLAEFYHPGKEYNVRVASRY-------FKGPELLVDLQDYDYSLDMWSL 306
            +  K+ L D+G A  +        R A  Y          PE+L     Y    D+WS 
Sbjct: 302 CD-GKIVLGDFGTAMPFE-----KEREAFDYGWVGTVATNSPEILAG-DGYCEITDIWSC 354

Query: 307 GCMFAGMIFRKE-PFFYGHDN-HDQLVKIAKVLGT-DE--------LNAYLNKYHLELDP 355
           G +   M+     P   G      QL+KI   L   DE        L  Y++   ++   
Sbjct: 355 GLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAG 414

Query: 356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDF-LDKLLRYDHQDRLTAREAMAHPYFAQ 414
                   HS  P  +     N  L  P   ++ L K+L +D   R  A E +A P F  
Sbjct: 415 --------HSVPPLIR-----NLGL--PADFEYPLVKMLTFDWHLRPGAAELLALPLF-- 457

Query: 415 VRAAESSRTR 424
             +AE     
Sbjct: 458 --SAEEEEEI 465

Length = 501

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 44.6 bits (105), Expect = 4e-05
 Identities = 48/226 (21%), Positives = 103/226 (45%), Gaps = 26/226 (11%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGPN 181
           ++  ++++K+G G++ EV+ G   N N +  +K LKP  +  +    E +I++ L     
Sbjct: 5   RESLQLIKKLGNGQFGEVWMGT-WNGNTKVAVKTLKPGTMSPESFLEEAQIMKKL-RHDK 62

Query: 182 VVKLLDIVRDQHSKTP-SLIFEYVNSTDFKVLYPTLTDYDIRY--------YIYELLKAL 232
           +V+L  +V    S+ P  ++ EY++      L   L D + R            ++   +
Sbjct: 63  LVQLYAVV----SEEPIYIVTEYMSKGS---LLDFLKDGEGRALKLPNLVDMAAQVAAGM 115

Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY---FKGPE 289
            Y      +HRD++  N+++   L   ++ D+GLA       EY  R  +++   +  PE
Sbjct: 116 AYIERMNYIHRDLRSANILVGDGL-VCKIADFGLARLIE-DNEYTARQGAKFPIKWTAPE 173

Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
             +    +    D+WS G +   ++ +    + G +N + L ++ +
Sbjct: 174 AAL-YGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVER 218

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 44.4 bits (105), Expect = 5e-05
 Identities = 47/210 (22%), Positives = 96/210 (45%), Gaps = 30/210 (14%)

Query: 131 RKVGRGKYSEVFEGINVNTNER---CIIKILKPVKK----KKIKREIKILQNLCGGPNVV 183
           R +G+G +  V+ G  ++++ +   C +K L  +      ++  +E  I+++    PNV+
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDF-SHPNVL 59

Query: 184 KLLDIVRDQHSKTPSLIFEYVNSTDFKVLY------PTLTDYDIRYYIYELLKALDYCHS 237
            LL I       +P ++  Y+   D +         PT+ D  +  +  ++ K ++Y  S
Sbjct: 60  SLLGICLPSEG-SPLVVLPYMKHGDLRNFIRSETHNPTVKD--LIGFGLQVAKGMEYLAS 116

Query: 238 QGIMHRDVKPHNVMIDHELRKLRLIDWGLA------EFYHPGKEYNVRVASRYFKGPELL 291
           +  +HRD+   N M+D E   +++ D+GLA      E+Y        ++  ++      L
Sbjct: 117 KKFVHRDLAARNCMLD-ESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMA----L 171

Query: 292 VDLQDYDYSL--DMWSLGCMFAGMIFRKEP 319
             LQ   ++   D+WS G +   ++ R  P
Sbjct: 172 ESLQTQKFTTKSDVWSFGVLLWELMTRGAP 201

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 43.6 bits (103), Expect = 9e-05
 Identities = 30/109 (27%), Positives = 54/109 (49%), Gaps = 5/109 (4%)

Query: 202 EYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRL 261
           EY +  D +    TLT  D+  + Y++ + +++  S+  +HRD+   NV++  +   +++
Sbjct: 115 EYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDH-VMKI 173

Query: 262 IDWGLAEFYHPGKEYNVRVASRY---FKGPELLVDLQDYDYSLDMWSLG 307
            D+GLA   H    Y      R    +  PE L D + Y +  D+WS G
Sbjct: 174 ADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFG 221

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 42.4 bits (100), Expect = 9e-05
 Identities = 30/126 (23%), Positives = 52/126 (41%), Gaps = 4/126 (3%)

Query: 148 NTNERCIIKILKP-VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNS 206
             +E  ++KI     K    +RE+ ILQ L      V  + +   +      L+ E++  
Sbjct: 19  TKDEDYVLKINPSREKGADREREVAILQLLARKGLPVPKV-LASGESDGWSYLLMEWIEG 77

Query: 207 TDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL 266
                +       DI   + ELL  L       + H D+ P N+++D + + L +IDW  
Sbjct: 78  ETLDEV-SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVD-DGKILGIIDWEY 135

Query: 267 AEFYHP 272
           A +  P
Sbjct: 136 AGYGPP 141

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 43.1 bits (101), Expect = 2e-04
 Identities = 29/100 (29%), Positives = 51/100 (51%), Gaps = 7/100 (7%)

Query: 215 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP-- 272
            LT  D+    Y++ + ++Y  SQ  +HRD+   NV++  +   +++ D+GLA   H   
Sbjct: 130 QLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTED-NVMKIADFGLARDVHNID 188

Query: 273 --GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMF 310
              K  N R+  ++   PE L D + Y +  D+WS G + 
Sbjct: 189 YYKKTTNGRLPVKWM-APEALFD-RVYTHQSDVWSFGVLL 226

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 42.8 bits (101), Expect = 2e-04
 Identities = 51/227 (22%), Positives = 101/227 (44%), Gaps = 33/227 (14%)

Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP---VKKKKIKREIKILQNLCGGPNV 182
           ++ + RK+G G + EV+EG+  N   R  IKILK    +K++  ++E++ L+ L    ++
Sbjct: 7   EFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRL-RHKHL 64

Query: 183 VKLLDIVRDQHSKTPSLIF----------EYVNSTDFKVLYPTLTDYDIRYYIYELLKAL 232
           + L  +        P  I            ++ S + +VL P  +  D+   + E    +
Sbjct: 65  ISLFAVCS---VGEPVYIITELMEKGSLLAFLRSPEGQVL-PVASLIDMACQVAE---GM 117

Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-----EFYHPGKEYNVRVASRYFKG 287
            Y   Q  +HRD+   N+++  +L   ++ D+GLA     + Y      + ++  ++   
Sbjct: 118 AYLEEQNSIHRDLAARNILVGEDL-VCKVADFGLARLIKEDVYLS---SDKKIPYKW-TA 172

Query: 288 PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 334
           PE       +    D+WS G +   M    +  + G +NH+   +I 
Sbjct: 173 PEAA-SHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT 218

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 42.6 bits (100), Expect = 2e-04
 Identities = 48/233 (20%), Positives = 94/233 (40%), Gaps = 32/233 (13%)

Query: 209 FKVLYPT-LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE-LRKLRLIDWGL 266
            K  +P  +++  I   ++  L+ L+Y H  G +HR++K  +++I  + L  L     GL
Sbjct: 90  LKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLS----GL 145

Query: 267 AEFY---HPGKEYNVRVASRYFK-------GPELL-VDLQDYDYSLDMWSLGCMFAGMIF 315
           +  Y     G++  V      F         PELL  DL  Y+   D++S+G     +  
Sbjct: 146 SHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELAT 205

Query: 316 RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHS-------RKP 368
            + PF    D     + + K+ G       +  +  E     ++  G  S          
Sbjct: 206 GRVPF---QDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAG 262

Query: 369 WSKFINADNQH-----LVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR 416
            ++ + ++          SP   + ++  L+ D + R +A   ++H +F QV+
Sbjct: 263 MTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVK 315

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 42.6 bits (100), Expect = 3e-04
 Identities = 31/89 (34%), Positives = 45/89 (50%), Gaps = 15/89 (16%)

Query: 227 ELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF--------YHPGKEYNV 278
           +LL A+DY H +GI+HRD+K  NV+++     + L D+G A F        +H G    V
Sbjct: 268 QLLSAIDYIHGEGIIHRDIKTENVLVNGP-EDICLGDFGAACFARGSWSTPFHYGIAGTV 326

Query: 279 RVASRYFKGPELLVDLQDYDYSLDMWSLG 307
                    PE+L     Y  S+D+WS G
Sbjct: 327 DT-----NAPEVLAG-DPYTPSVDIWSAG 349

Length = 461

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 42.1 bits (99), Expect = 3e-04
 Identities = 46/207 (22%), Positives = 96/207 (46%), Gaps = 30/207 (14%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGPN 181
           ++  ++V+K+G G++ EV+ G   N + +  IK LK   +  +    E  +++ L   P 
Sbjct: 5   RETLKLVKKLGAGQFGEVWMGY-YNGHTKVAIKSLKQGSMSPEAFLAEANLMKQL-QHPR 62

Query: 182 VVKLLDIVRDQHSKTPSLIF-EYVNS---TDFKVLYPTLTDYDIRYYIYELL-------K 230
           +V+L  +V    ++ P  I  EY+ +    DF       T   I+  I +L+       +
Sbjct: 63  LVRLYAVV----TQEPIYIITEYMENGSLVDF-----LKTPEGIKLTINKLIDMAAQIAE 113

Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY---FKG 287
            + +   +  +HRD++  N+++   L   ++ D+GLA       EY  R  +++   +  
Sbjct: 114 GMAFIERKNYIHRDLRAANILVSETL-CCKIADFGLARLIED-NEYTAREGAKFPIKWTA 171

Query: 288 PELLVDLQDYDYSLDMWSLGCMFAGMI 314
           PE  ++   +    D+WS G +   ++
Sbjct: 172 PE-AINYGTFTIKSDVWSFGILLTEIV 197

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 42.0 bits (99), Expect = 3e-04
 Identities = 40/209 (19%), Positives = 82/209 (39%), Gaps = 29/209 (13%)

Query: 132 KVGRGKYSEVFEGINVNTNERCI---IKILKPVKKKKIK----REIKILQNLCGGPNVVK 184
           K+G G +  V  G    +  + I   +K LK  K   I     +E  I+ +L    N+++
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSL-DHENLIR 60

Query: 185 LLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELL--------KALDYCH 236
           L  +V         ++ E         L   L    + +++   L          + Y  
Sbjct: 61  LYGVVLTHPLM---MVTEL---APLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE 114

Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK----GPELLV 292
           S+  +HRD+   N+++  +  K+++ D+GL       +++ V             PE L 
Sbjct: 115 SKRFIHRDLAARNILLASD-DKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLR 173

Query: 293 DLQDYDYSLDMWSLG-CMFAGMIFRKEPF 320
               + ++ D+W  G  ++    + +EP+
Sbjct: 174 TRT-FSHASDVWMFGVTLWEMFTYGEEPW 201

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 42.3 bits (99), Expect = 3e-04
 Identities = 28/98 (28%), Positives = 51/98 (52%), Gaps = 7/98 (7%)

Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP--- 272
           +T  D+    Y++ + ++Y  SQ  +HRD+   NV++  E   +++ D+GLA   +    
Sbjct: 134 MTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVT-ENNVMKIADFGLARDVNNIDY 192

Query: 273 -GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCM 309
             K  N R+  ++   PE L D + Y +  D+WS G +
Sbjct: 193 YKKTTNGRLPVKWM-APEALFD-RVYTHQSDVWSFGVL 228

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 42.1 bits (99), Expect = 3e-04
 Identities = 39/204 (19%), Positives = 94/204 (46%), Gaps = 30/204 (14%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGP 180
           ++ D  +  K+G G+Y EV+EG+    +    +K LK   ++ ++  +E  +++ +   P
Sbjct: 4   ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHP 62

Query: 181 NVVKLLDIVRDQHSKTPSL-----------IFEYVNSTDFKVLYPTLTDYDIRYYIYELL 229
           N+V+LL +     ++ P             + +Y+   + + +   +    + Y   ++ 
Sbjct: 63  NLVQLLGVC----TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVV----LLYMATQIS 114

Query: 230 KALDYCHSQGIMHRDVKPHNVMI-DHELRKLRLIDWGLAEFYHPGKEYNVRVASRY---F 285
            A++Y   +  +HRD+   N ++ ++ L  +++ D+GL+     G  Y     +++   +
Sbjct: 115 SAMEYLEKKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMT-GDTYTAHAGAKFPIKW 171

Query: 286 KGPELLVDLQDYDYSLDMWSLGCM 309
             PE L     +    D+W+ G +
Sbjct: 172 TAPESLA-YNKFSIKSDVWAFGVL 194

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 42.1 bits (99), Expect = 3e-04
 Identities = 46/190 (24%), Positives = 80/190 (42%), Gaps = 21/190 (11%)

Query: 131 RKVGRGKYSEVFEGINVNTNERCIIKI----LKPVKKKKIKREIKILQNLCGGPNVVKLL 186
            K+G+G + +V++G+ +  N    +K     L P  K+K  +E +IL+     PN+VKL+
Sbjct: 1   EKIGKGNFGDVYKGV-LKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQY-DHPNIVKLI 58

Query: 187 DIVRDQHSKTPSLI-FEYVNSTDFKVLYPT----LTDYDIRYYIYELLKALDYCHSQGIM 241
            +      K P  I  E V               LT   +     +    ++Y  S+  +
Sbjct: 59  GVCVQ---KQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCI 115

Query: 242 HRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY----FKGPELLVDLQDY 297
           HRD+   N ++      L++ D+G++     G  Y V    +     +  PE L +   Y
Sbjct: 116 HRDLAARNCLVGEN-NVLKISDFGMSREEEGG-IYTVSDGLKQIPIKWTAPEAL-NYGRY 172

Query: 298 DYSLDMWSLG 307
               D+WS G
Sbjct: 173 TSESDVWSYG 182

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated

 Score = 42.6 bits (101), Expect = 3e-04
 Identities = 19/83 (22%), Positives = 40/83 (48%), Gaps = 9/83 (10%)

Query: 188 IVRDQHSKTPSLIFEYVNSTDFK-VLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVK 246
           ++ D   +  +++ EY+   D K VL            + ++ + +   H  GI+H D+ 
Sbjct: 402 VIYDVDPEEKTIVMEYIGGKDLKDVLEGNPE------LVRKVGEIVAKLHKAGIVHGDLT 455

Query: 247 PHNVMIDHELRKLRLIDWGLAEF 269
             N ++  +  +L LID+GL ++
Sbjct: 456 TSNFIVRDD--RLYLIDFGLGKY 476

Length = 535

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 41.3 bits (97), Expect = 4e-04
 Identities = 50/200 (25%), Positives = 91/200 (45%), Gaps = 27/200 (13%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGP 180
           D+   +++RK+G G++ EV+EG+  NT     +K LKP  +  K    E +I++ L   P
Sbjct: 4   DRTSIQLLRKLGAGQFGEVWEGLWNNTTP-VAVKTLKPGTMDPKDFLAEAQIMKKL-RHP 61

Query: 181 NVVKLLDIVRDQHS--------KTPSLIFEYVNSTDFKVL-YPTLTDYDIRYYIYELLKA 231
            +++L  +   +          K  SL+ EY+     + L  P L D        ++   
Sbjct: 62  KLIQLYAVCTLEEPIYIVTELMKYGSLL-EYLQGGAGRALKLPQLIDMAA-----QVASG 115

Query: 232 LDYCHSQGIMHRDVKPHNVMI-DHELRKLRLIDWGLAEFYHPGKEYNVRVASRY---FKG 287
           + Y  +Q  +HRD+   NV++ ++ + K  + D+GLA        Y  R  +++   +  
Sbjct: 116 MAYLEAQNYIHRDLAARNVLVGENNICK--VADFGLARVIKE-DIYEAREGAKFPIKWTA 172

Query: 288 PELLVDLQDYDYSLDMWSLG 307
           PE       +    D+WS G
Sbjct: 173 PE-AALYNRFSIKSDVWSFG 191

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 41.5 bits (97), Expect = 5e-04
 Identities = 30/129 (23%), Positives = 60/129 (46%), Gaps = 12/129 (9%)

Query: 185 LLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRD 244
           L + +R +    P   F+     + ++ +  L         Y++ + ++Y  S+  +HRD
Sbjct: 105 LREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC-----AYQVARGMEYLESRRCIHRD 159

Query: 245 VKPHNVMIDHELRKLRLIDWGLAEFYHP----GKEYNVRVASRYFKGPELLVDLQDYDYS 300
           +   NV++  +   +++ D+GLA   H      K  N R+  ++   PE L D + Y + 
Sbjct: 160 LAARNVLVTED-NVMKIADFGLARGVHDIDYYKKTSNGRLPVKWM-APEALFD-RVYTHQ 216

Query: 301 LDMWSLGCM 309
            D+WS G +
Sbjct: 217 SDVWSFGIL 225

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 40.9 bits (96), Expect = 6e-04
 Identities = 49/216 (22%), Positives = 99/216 (45%), Gaps = 36/216 (16%)

Query: 128 EVVRKVGRGKYSEVFEGINVNTNER-CI---IKILK----PVKKKKIKREIKILQNLCGG 179
           E ++ +G G +  V++G+ +   E+  I   IK+L+    P   K+I  E  ++ +    
Sbjct: 10  EKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMAS-VDH 68

Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYV----------NSTDFKVLYPTLTDYDIRYYIYELL 229
           P+VV+LL I     S    LI + +          N  D       +    +  +  ++ 
Sbjct: 69  PHVVRLLGICL---SSQVQLITQLMPLGCLLDYVRNHKD------NIGSQYLLNWCVQIA 119

Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-KEYNV---RVASRYF 285
           K + Y   + ++HRD+   NV++    + +++ D+GLA+      KEY+    +V  ++ 
Sbjct: 120 KGMSYLEEKRLVHRDLAARNVLV-KTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWM 178

Query: 286 KGPELLVDLQDYDYSLDMWSLGC-MFAGMIFRKEPF 320
              E ++  + Y +  D+WS G  ++  M F  +P+
Sbjct: 179 -ALESIL-HRIYTHKSDVWSYGVTVWELMTFGAKPY 212

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 40.8 bits (95), Expect = 9e-04
 Identities = 26/89 (29%), Positives = 47/89 (52%), Gaps = 7/89 (7%)

Query: 226 YELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP----GKEYNVRVA 281
           Y++ + ++Y  S+  +HRD+   NV++  E   +++ D+GLA   H      K  N R+ 
Sbjct: 147 YQVARGMEYLASKKCIHRDLAARNVLVT-EDNVMKIADFGLARDIHHIDYYKKTTNGRLP 205

Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMF 310
            ++   PE L D + Y +  D+WS G + 
Sbjct: 206 VKWM-APEALFD-RIYTHQSDVWSFGVLL 232

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 40.6 bits (95), Expect = 9e-04
 Identities = 51/227 (22%), Positives = 95/227 (41%), Gaps = 35/227 (15%)

Query: 133 VGRGKYSEVFEG-----INVNTNE-RCIIKILK----PVKKKKIKREIKILQNLCGGPNV 182
           +G G + EV+EG     +   +   R  +K L+      +KK+  +E  ++ N    PN+
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNF-NHPNI 61

Query: 183 VKLLDIVRDQHSKTPSLIFEYVNSTDF----------KVLYPTLTDYDIRYYIYELLKAL 232
           VKLL +      +   +I E +   D           +   P LT  ++     ++ K  
Sbjct: 62  VKLLGVCLLNEPQ--YIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGC 119

Query: 233 DYCHSQGIMHRDVKPHNVMIDHEL----RKLRLIDWGLAEFYHPGKEYNVR----VASRY 284
            Y      +HRD+   N ++  +     R +++ D+GLA   +    Y       +  R+
Sbjct: 120 VYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRW 179

Query: 285 FKGPELLVDLQDYDYSLDMWSLGC-MFAGMIFRKEPFFYGHDNHDQL 330
              PE L+D +    S D+WS G  M+  +   ++P +   +N + L
Sbjct: 180 M-APESLLDGKFTTQS-DVWSFGVLMWEILTLGQQP-YPALNNQEVL 223

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|216618 pfam01636, APH, Phosphotransferase enzyme family

 Score = 40.2 bits (94), Expect = 0.001
 Identities = 13/53 (24%), Positives = 24/53 (45%)

Query: 220 DIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 272
           ++   +   L AL       ++H D+ P N+++D   R   +ID+  A    P
Sbjct: 147 ELWERLLAALLALLPALPLVLVHGDLHPGNLLVDPGGRVTGVIDFEDAGLGDP 199

This family consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include: aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation. This family also includes homoserine kinase. This family is related to fructosamine kinase pfam03881. Length = 238

>gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional

 Score = 39.5 bits (93), Expect = 0.001
 Identities = 36/151 (23%), Positives = 69/151 (45%), Gaps = 25/151 (16%)

Query: 133 VGRGKYSEVFEGINVNTNERCIIKILKP-----------VKKKKIKREIKIL-QNLCGGP 180
           + RG  +E++ G  +    + +IK   P           +++++ +RE +I+ +    G 
Sbjct: 4   IKRGAEAEIYLGDFLG--IKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGV 61

Query: 181 NV--VKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQ 238
           NV  V  +D           ++ EY+     K L  +    ++     E+ + +   HS 
Sbjct: 62  NVPAVYFVDPENF------IIVMEYIEGEPLKDLINSNGMEELELS-REIGRLVGKLHSA 114

Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 269
           GI+H D+   N+++     K+ LID+GLAEF
Sbjct: 115 GIIHGDLTTSNMILSG--GKIYLIDFGLAEF 143

Length = 211

>gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32

 Score = 38.7 bits (91), Expect = 0.002
 Identities = 26/104 (25%), Positives = 49/104 (47%), Gaps = 11/104 (10%)

Query: 167 KREIKILQNLC-GGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYI 225
           + E ++L      G N   + D+  D  +KT  ++ EY+     K +     D      +
Sbjct: 45  RNEARLLSRARKAGVNTPVVYDV--DPDNKT--IVMEYIEGKPLKDVIEEGNDE----LL 96

Query: 226 YELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 269
            E+ + +   H  GI+H D+   N+++  +  KL LID+GL ++
Sbjct: 97  REIGRLVGKLHKAGIVHGDLTTSNIIVRDD--KLYLIDFGLGKY 138

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 39.2 bits (91), Expect = 0.002
 Identities = 44/216 (20%), Positives = 81/216 (37%), Gaps = 44/216 (20%)

Query: 133 VGRGKYSEVFEGINVNTNER-----CIIKILK----PVKKKKIKREIKILQNLCGGPNVV 183
           +G G++ +V +        R       +K+LK      + + +  E  +L+ +   P+V+
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV-NHPHVI 66

Query: 184 KLLDIVRDQHSKTPSLIFEYV---------------------------NSTDFKVLYPTL 216
           KL             LI EY                            +S         L
Sbjct: 67  KLYGAC--SQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERAL 124

Query: 217 TDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY 276
           T  D+  + +++ + + Y     ++HRD+   NV++  E RK+++ D+GL+   +    Y
Sbjct: 125 TMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLV-AEGRKMKISDFGLSRDVYEEDSY 183

Query: 277 NVRVASRY---FKGPELLVDLQDYDYSLDMWSLGCM 309
             R   R    +   E L D   Y    D+WS G +
Sbjct: 184 VKRSKGRIPVKWMAIESLFD-HIYTTQSDVWSFGVL 218

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 38.9 bits (90), Expect = 0.003
 Identities = 51/224 (22%), Positives = 100/224 (44%), Gaps = 32/224 (14%)

Query: 131 RKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKI----KREIK--ILQNLC----GGP 180
           + +G G++  V EG      +  I+K+   VK  KI    + E++  + + +C      P
Sbjct: 5   KTLGEGEFGSVMEGQL--NQDDSILKV--AVKTMKIAICTRSEMEDFLSEAVCMKEFDHP 60

Query: 181 NVVKLLDI----VRDQHSKTPSLIFEYVNSTDFK--VLYPTLTDYDIRY-------YIYE 227
           NV++L+ +    V  +   +P +I  ++   D    +LY  L D            ++ +
Sbjct: 61  NVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTD 120

Query: 228 LLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV-RVASRYFK 286
           +   ++Y  S+  +HRD+   N M++  +  + + D+GL++  + G  Y   R+A    K
Sbjct: 121 IASGMEYLSSKSFIHRDLAARNCMLNENM-NVCVADFGLSKKIYNGDYYRQGRIAKMPVK 179

Query: 287 --GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHD 328
               E L D + Y    D+WS G     +  R +  + G +N +
Sbjct: 180 WIAIESLAD-RVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE 222

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 38.5 bits (90), Expect = 0.003
 Identities = 38/193 (19%), Positives = 83/193 (43%), Gaps = 24/193 (12%)

Query: 131 RKVGRGKYSEVFEGINVNTNER---CIIKILKPVK----KKKIKREIKILQNLCGGPNVV 183
           +++G G +  V +G+ +  + +     +K LK       KK+  RE  ++  L   P +V
Sbjct: 1   KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQL-DHPCIV 59

Query: 184 KLLDIVRDQHSKTPS--LIFEYVNS---TDFKVLYPTLTDYDIRYYIYELLKALDYCHSQ 238
           +L+ +      K     L+ E         +      +   D++   +++   + Y  S+
Sbjct: 60  RLIGV-----CKGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESK 114

Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-YNVRVASRY---FKGPELLVDL 294
             +HRD+   NV++ +   + ++ D+G++     G + Y    A R+   +  PE  ++ 
Sbjct: 115 HFVHRDLAARNVLLVNR-HQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPE-CINY 172

Query: 295 QDYDYSLDMWSLG 307
             +    D+WS G
Sbjct: 173 GKFSSKSDVWSYG 185

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 38.9 bits (90), Expect = 0.003
 Identities = 29/95 (30%), Positives = 49/95 (51%), Gaps = 8/95 (8%)

Query: 228 LLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 286
           +L+ L Y   +  IMHRDVKP N++++    +++L D+G++         N  V +R + 
Sbjct: 112 VLRGLAYLREKHQIMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDSMA-NSFVGTRSYM 169

Query: 287 GPELLVDLQDYDYSL--DMWSLGCMFAGMIFRKEP 319
            PE    LQ   YS+  D+WS+G     +   + P
Sbjct: 170 SPE---RLQGTHYSVQSDIWSMGLSLVELAIGRYP 201

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 38.5 bits (90), Expect = 0.004
 Identities = 44/212 (20%), Positives = 82/212 (38%), Gaps = 50/212 (23%)

Query: 133 VGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCG---------GPNVV 183
           +G+G++ +V  G              + V  K +K +    Q              PN+V
Sbjct: 14  IGKGEFGDVMLGDYRG----------QKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLV 63

Query: 184 KLLDIVRD--------QHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYC 235
           +LL +V          ++    SL+ +Y+ S    V+    T      +  ++ + ++Y 
Sbjct: 64  QLLGVVLQGNPLYIVTEYMAKGSLV-DYLRSRGRAVI----TLAQQLGFALDVCEGMEYL 118

Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYF----KGPELL 291
             +  +HRD+   NV++  +L   ++ D+GLA      KE +    S         PE L
Sbjct: 119 EEKNFVHRDLAARNVLVSEDLVA-KVSDFGLA------KEASQGQDSGKLPVKWTAPEAL 171

Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG 323
              + +    D+WS G      I   E + +G
Sbjct: 172 -REKKFSTKSDVWSFG------ILLWEIYSFG 196

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 38.5 bits (90), Expect = 0.004
 Identities = 27/87 (31%), Positives = 42/87 (48%), Gaps = 8/87 (9%)

Query: 226 YELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRK--LRLIDWGLAEFYHPGKEYNVRVAS 282
              +KAL+Y   +  I+HRDVKP N+++D   R   ++L D+G++               
Sbjct: 114 VATVKALNYLKEELKIIHRDVKPSNILLD---RNGNIKLCDFGISGQLVDSIAKTRDAGC 170

Query: 283 RYFKGPELLV--DLQDYDYSLDMWSLG 307
           R +  PE +       YD   D+WSLG
Sbjct: 171 RPYMAPERIDPSARDGYDVRSDVWSLG 197

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	425
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
KOG1167	418	consensus Serine/threonine protein kinase of the C	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0576	829	consensus Mitogen-activated protein kinase kinase	100.0
KOG1152	772	consensus Signal transduction serine/threonine kin	99.97
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.97
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.97
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
PLN00181	793	protein SPA1-RELATED; Provisional	99.96
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.95
PRK09188	365	serine/threonine protein kinase; Provisional	99.93
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.92
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.92
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.92
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.91
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.91
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.9
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.9
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.9
PRK12274	218	serine/threonine protein kinase; Provisional	99.88
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.88
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.88
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.87
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.86
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.85
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.84
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.84
PRK10345	210	hypothetical protein; Provisional	99.83
smart00090	237	RIO RIO-like kinase.	99.81
PRK14879	211	serine/threonine protein kinase; Provisional	99.78
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.77
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.76
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.75
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.74
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.74
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.71
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.7
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.68
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.67
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.55
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.51
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.48
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.47
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.41
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.39
KOG1243	690	consensus Protein kinase [General function predict	99.37
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.37
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.32
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.23
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.23
KOG3087	229	consensus Serine/threonine protein kinase [General	99.2
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.18
KOG2137	700	consensus Protein kinase [Signal transduction mech	99.04
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.03
COG4248	637	Uncharacterized protein with protein kinase and he	99.0
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.95
PRK09902	216	hypothetical protein; Provisional	98.83
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.83
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.74
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.58
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.56
PF01636	239	APH: Phosphotransferase enzyme family This family	98.51
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.51
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.5
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.49
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.44
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.4
PLN02876	822	acyl-CoA dehydrogenase	98.34
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.27
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.22
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.16
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.13
PRK10593	297	hypothetical protein; Provisional	98.07
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.03
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	98.02
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.95
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.88
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.87
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.8
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.69
PRK05231	319	homoserine kinase; Provisional	97.66
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.49
PLN02236	344	choline kinase	97.38
KOG1093	725	consensus Predicted protein kinase (contains TBC a	97.29
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	97.23
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.11
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.09
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.07
COG2334	331	Putative homoserine kinase type II (protein kinase	97.04
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	97.0
KOG2270	520	consensus Serine/threonine protein kinase involved	96.96
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	96.84
PTZ00384	383	choline kinase; Provisional	96.71
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.44
KOG1236	565	consensus Predicted unusual protein kinase [Genera	96.39
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.33
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.27
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.06
PRK06148	1013	hypothetical protein; Provisional	95.88
PTZ00296	442	choline kinase; Provisional	95.79
PRK11768	325	serine/threonine protein kinase; Provisional	95.65
PLN02756	418	S-methyl-5-thioribose kinase	95.61
PRK12396	409	5-methylribose kinase; Reviewed	95.15
PRK06149	972	hypothetical protein; Provisional	94.67
PF03109	119	ABC1: ABC1 family; InterPro: IPR004147 This entry	94.07

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=1.4e-68  Score=455.38  Aligned_cols=332  Identities=85%  Similarity=1.387  Sum_probs=324.3

Q ss_pred             CCccCccccccccCCCCccCCcCCcccccCCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcchHHHHHHHHH
Q 014406           93 AMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKI  172 (425)
Q Consensus        93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~  172 (425)
                      ..+.++++++++..++.++|+|+...+.|+..++|++.+++|+|.+++||.|.+..+++.++||++++...+.+.+|+.|
T Consensus         6 v~s~ARvya~vn~~rp~eYWdYE~~~i~wg~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkkkKIkREikI   85 (338)
T KOG0668|consen    6 VPSVARVYADVNEERPREYWDYESLVIDWGNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKKKKIKREIKI   85 (338)
T ss_pred             cchhhhhhhhccccCchhhcchhheeeeccccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHHHHHHHHHHH
Confidence            56788999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHhcCCCCeeeEEeEEEcCCCCccEEEEEeecCCChhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEe
Q 014406          173 LQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI  252 (425)
Q Consensus       173 l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll  252 (425)
                      |..|++||||++++++..++.++.+.||+||+++.++..+.+.++..+++.++.+++.||.|+|++||+|||+||.|+++
T Consensus        86 L~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmI  165 (338)
T KOG0668|consen   86 LQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNTDFKQLYPTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMI  165 (338)
T ss_pred             HHhccCCCCeeehhhhhcCccccCchhHhhhhccccHHHHhhhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeee
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cCCCCcEEEEeccccccccCCCcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHH
Q 014406          253 DHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVK  332 (425)
Q Consensus       253 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~  332 (425)
                      |.....++|+|+|+|.++.++..++..+.++.|..||.+.+...|+.+.|+|||||++..|++.+.|||.|.++.+|+..
T Consensus       166 dh~~rkLrlIDWGLAEFYHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVk  245 (338)
T KOG0668|consen  166 DHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVK  245 (338)
T ss_pred             chhhceeeeeecchHhhcCCCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHH
Confidence            99988999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHhCCchhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCC
Q 014406          333 IAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF  412 (425)
Q Consensus       333 ~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~  412 (425)
                      |.+++|+.++..++.++.+.+++.++.+.+..++.+|..|+..+++...++++.||+.++|++|.++|+||.|+|.||||
T Consensus       246 IakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF  325 (338)
T KOG0668|consen  246 IAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYF  325 (338)
T ss_pred             HHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchH
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cccccchhcccc
Q 014406          413 AQVRAAESSRTR  424 (425)
Q Consensus       413 ~~~~~~~~~~~~  424 (425)
                      ..+..++.++.+
T Consensus       326 ~~~~~~~~~~~~  337 (338)
T KOG0668|consen  326 APVREAESSRMR  337 (338)
T ss_pred             HHHHHHhhcccC
Confidence            999999887765

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.2e-56  Score=410.15  Aligned_cols=259  Identities=28%  Similarity=0.468  Sum_probs=214.4

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc----------hHHHHHHHHHHHHhcCCCCeeeEEeEEEcC
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----------KKKIKREIKILQNLCGGPNVVKLLDIVRDQ  192 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~----------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  192 (425)
                      ..+.|.+.+.||+|+||.|-+|..+.+|+.||||++++..          .....+|+++|++| +|||||+++++|..+
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL-~HP~IV~~~d~f~~~  248 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKL-SHPNIVRIKDFFEVP  248 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhc-CCCCEEEEeeeeecC
Confidence            4677999999999999999999999999999999997432          12356999999999 999999999999765


Q ss_pred             CCCccEEEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCC--CCcEEEEecccc
Q 014406          193 HSKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--LRKLRLIDWGLA  267 (425)
Q Consensus       193 ~~~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~--~~~~kl~Dfg~a  267 (425)
                        ...|+||||++||+|.+.+   ..+.+...+.++.|++.|+.|||++||+||||||+|||+..+  .-.+||+|||+|
T Consensus       249 --ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlA  326 (475)
T KOG0615|consen  249 --DSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLA  326 (475)
T ss_pred             --CceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchh
Confidence              5668999999999998876   458888889999999999999999999999999999999765  236899999999


Q ss_pred             ccccCCCcceeeccCCCccCcccccCCC--CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHH
Q 014406          268 EFYHPGKEYNVRVASRYFKGPELLVDLQ--DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAY  345 (425)
Q Consensus       268 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~--~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~  345 (425)
                      +.........+.+||+.|.|||++.+.+  .+..++|+||+||+||-+++|..||.....+......|            
T Consensus       327 K~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI------------  394 (475)
T KOG0615|consen  327 KVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQI------------  394 (475)
T ss_pred             hccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHH------------
Confidence            9988777888999999999999997622  23458899999999999999999994333322122222            


Q ss_pred             HhhccCCCC-hhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccc
Q 014406          346 LNKYHLELD-PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA  418 (425)
Q Consensus       346 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~  418 (425)
                       .++...+. +.|+                     .+++++++||.+||..||++|||++|+|+||||+.+...
T Consensus       395 -~~G~y~f~p~~w~---------------------~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~~~  446 (475)
T KOG0615|consen  395 -LKGRYAFGPLQWD---------------------RISEEALDLINWMLVVDPENRPSADEALNHPWFKDAPCL  446 (475)
T ss_pred             -hcCcccccChhhh---------------------hhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccccc
Confidence             12222221 1222                     279999999999999999999999999999999987643

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-55  Score=402.28  Aligned_cols=256  Identities=21%  Similarity=0.399  Sum_probs=217.1

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEec----CcchHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEE
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK----PVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~----~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (425)
                      .++.+.++.||+|..|+||++.++.|++.+|+|++.    +...+++.+|+++++.. +|||||.+||.|..+.. .+++
T Consensus        78 ~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~-~spyIV~~ygaF~~~~~-~isI  155 (364)
T KOG0581|consen   78 LSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSC-QSPYIVGFYGAFYSNGE-EISI  155 (364)
T ss_pred             HHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhC-CCCCeeeEeEEEEeCCc-eEEe
Confidence            346777889999999999999999999999999993    44568899999999998 99999999999987643 6889


Q ss_pred             EEEeecCCChhhhcC---CCCHHHHHHHHHHHHHHHHHHHH-CCceeecCCCCceEecCCCCcEEEEeccccccccCCCc
Q 014406          200 IFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (425)
Q Consensus       200 v~e~~~~~~l~~~~~---~l~~~~~~~i~~~i~~~L~~LH~-~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~  275 (425)
                      +||||++|+|+.++.   .+++..+..++.++++||.|||+ .+||||||||+|||++.. |.+||||||.++..... .
T Consensus       156 ~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNsk-GeVKicDFGVS~~lvnS-~  233 (364)
T KOG0581|consen  156 CMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSK-GEVKICDFGVSGILVNS-I  233 (364)
T ss_pred             ehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccC-CCEEeccccccHHhhhh-h
Confidence            999999999999885   49999999999999999999996 899999999999999998 89999999999877654 6


Q ss_pred             ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCC-CHHHHHHHHHHhCCchhHHHHhhccCCCC
Q 014406          276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD-NHDQLVKIAKVLGTDELNAYLNKYHLELD  354 (425)
Q Consensus       276 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~-~~~~~~~~~~~lg~~~~~~~~~~~~~~~~  354 (425)
                      .++.+||..|||||-+.+ ..|+.++||||||++++|+.+|+.||..... ....+..+......++             
T Consensus       234 a~tfvGT~~YMsPERi~g-~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~pp-------------  299 (364)
T KOG0581|consen  234 ANTFVGTSAYMSPERISG-ESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPP-------------  299 (364)
T ss_pred             cccccccccccChhhhcC-CcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCC-------------
Confidence            678899999999999988 7899999999999999999999999965422 2222222222211111             


Q ss_pred             hhhHHHhcccCCCCccccccccCCC-CCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCccccc
Q 014406          355 PQLDALVGRHSRKPWSKFINADNQH-LVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA  417 (425)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~  417 (425)
                                          ...+. .+|+++++|+..||++||.+|||+.|+++|||+++...
T Consensus       300 --------------------P~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~  343 (364)
T KOG0581|consen  300 --------------------PRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFED  343 (364)
T ss_pred             --------------------CCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhccc
Confidence                                00011 27999999999999999999999999999999986644

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=2.3e-56  Score=395.03  Aligned_cols=275  Identities=33%  Similarity=0.604  Sum_probs=231.0

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc-----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEE
Q 014406          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (425)
Q Consensus       125 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (425)
                      +.|+.+.++|+|+||.||+|+++.||+.||||.+....     ++-..+||.+|+++ .|+|+|.++++|+..  +.++|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqL-kH~NLVnLiEVFrrk--rklhL   78 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQL-KHENLVNLIEVFRRK--RKLHL   78 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhc-ccchHHHHHHHHHhc--ceeEE
Confidence            56888899999999999999999999999999986433     34567999999999 999999999999654  67889


Q ss_pred             EEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEecccccccc-CCCc
Q 014406          200 IFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKE  275 (425)
Q Consensus       200 v~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~-~~~~  275 (425)
                      |+||++..-|..+-   ..++...++.++.|++.|+.|+|++++|||||||+|||++.+ +.+||||||+|+... +++.
T Consensus        79 VFE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~-gvvKLCDFGFAR~L~~pgd~  157 (396)
T KOG0593|consen   79 VFEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQN-GVVKLCDFGFARTLSAPGDN  157 (396)
T ss_pred             EeeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecC-CcEEeccchhhHhhcCCcch
Confidence            99999998776553   569999999999999999999999999999999999999999 899999999999887 7778


Q ss_pred             ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhH--HHHhhcc---
Q 014406          276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELN--AYLNKYH---  350 (425)
Q Consensus       276 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~--~~~~~~~---  350 (425)
                      ++..+.|++|+|||.+.+...|+.++||||+||++.||++|. |+++|.++-+++..|.+.+|.-...  .......   
T Consensus       158 YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~-pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~  236 (396)
T KOG0593|consen  158 YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGE-PLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFH  236 (396)
T ss_pred             hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCC-cCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCcee
Confidence            888999999999999999899999999999999999999997 5669999999999999999973322  1111110   


Q ss_pred             ---CCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccc
Q 014406          351 ---LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA  418 (425)
Q Consensus       351 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~  418 (425)
                         ++.++....+.              .....++.-+.||+++||..||.+|++.+|+|.||||.+....
T Consensus       237 Gv~lP~~~~~epLe--------------~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~~er  293 (396)
T KOG0593|consen  237 GVRLPEPEHPEPLE--------------RKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGFIER  293 (396)
T ss_pred             eeecCCCCCccchh--------------hhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHHHHH
Confidence               00111111111              1112367788999999999999999999999999999776543

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-56  Score=418.40  Aligned_cols=288  Identities=31%  Similarity=0.575  Sum_probs=238.5

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc--hH--HHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccE
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--KK--KIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~--~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (425)
                      ..++|.++++||.|.||+||+|+...+++.||||.++..-  .+  .-.+|+..|++|..||||+++.+++.+.+. .++
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~-~L~   86 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDR-ILY   86 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCc-eEe
Confidence            4678999999999999999999999999999999987532  22  346899999999449999999999987643 899


Q ss_pred             EEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCc
Q 014406          199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (425)
Q Consensus       199 lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~  275 (425)
                      +|||||+....+.+.   ..|++..++.|+.||++||+|+|++|+.|||+||+|||+... ..+||+|||+|+.......
T Consensus        87 fVfE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~-~~iKiaDFGLARev~SkpP  165 (538)
T KOG0661|consen   87 FVFEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGN-DVIKIADFGLAREVRSKPP  165 (538)
T ss_pred             eeHHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEeccc-ceeEecccccccccccCCC
Confidence            999999987554333   449999999999999999999999999999999999999976 6899999999999999999


Q ss_pred             ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCCh
Q 014406          276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP  355 (425)
Q Consensus       276 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~  355 (425)
                      ++..+.|++|+|||+++....|+.++|||++||+++|+.+-+ |.|+|.++.|++.+|.+++|++....+.+.+.+.  .
T Consensus       166 YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLr-PLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La--~  242 (538)
T KOG0661|consen  166 YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLR-PLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLA--S  242 (538)
T ss_pred             cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhc-ccCCCCcHHHHHHHHHHHhCCCccccchhHHHHH--H
Confidence            999999999999999999899999999999999999999987 5569999999999999999998877665432110  0


Q ss_pred             hhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccchh
Q 014406          356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAES  420 (425)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~~~  420 (425)
                      .+.-........+...+     -...+.++.++|.+||.|||.+||||.|+|+||||+.....+.
T Consensus       243 ~mnf~~P~~~~~~l~~L-----~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~~~~  302 (538)
T KOG0661|consen  243 AMNFRFPQVKPSPLKDL-----LPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRASGS  302 (538)
T ss_pred             HhccCCCcCCCCChHHh-----CcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccccccc
Confidence            00000000001111111     1227899999999999999999999999999999998766543

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=5.8e-55  Score=379.89  Aligned_cols=279  Identities=36%  Similarity=0.705  Sum_probs=231.7

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcch-----HHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEE
Q 014406          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK-----KKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (425)
Q Consensus       125 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (425)
                      ++|..++.||+|.||.||+|++..+|+.||||.++..+.     -...+||+.|+.+ +|+||+.++++|  .+...+.|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel-~h~nIi~LiD~F--~~~~~l~l   78 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQEL-KHPNIIELIDVF--PHKSNLSL   78 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHc-cCcchhhhhhhc--cCCCceEE
Confidence            467788899999999999999999999999999975432     3577999999999 899999999999  55677889


Q ss_pred             EEEeecCCChhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCc
Q 014406          200 IFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (425)
Q Consensus       200 v~e~~~~~~l~~~~~----~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~  275 (425)
                      |+|||+. +|+..++    -++..+++.++.++++||+|||++.|+||||||.|+|++++ +.+||+|||+|+.+.+...
T Consensus        79 VfEfm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~-g~lKiADFGLAr~f~~p~~  156 (318)
T KOG0659|consen   79 VFEFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSD-GQLKIADFGLARFFGSPNR  156 (318)
T ss_pred             EEEeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCC-CcEEeecccchhccCCCCc
Confidence            9999985 5555553    38999999999999999999999999999999999999999 8999999999998865433


Q ss_pred             -ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCC
Q 014406          276 -YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD  354 (425)
Q Consensus       276 -~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~  354 (425)
                       ....+.|++|+|||.+.+...|+..+||||.||++.||+.| .||++|.++-+|+..+.+.+|++..+.|.+-..+...
T Consensus       157 ~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr-~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY  235 (318)
T KOG0659|consen  157 IQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLR-VPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDY  235 (318)
T ss_pred             ccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHcc-CCCCCCCchHHHHHHHHHHcCCCCcccCccccccccH
Confidence             34458999999999999999999999999999999999976 4899999999999999999999988776433222211


Q ss_pred             hhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccc
Q 014406          355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA  418 (425)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~  418 (425)
                      -.+.    .....+...++     ...++++.||+.+||.+||.+|+|+.|+|+|+||+....+
T Consensus       236 ~~~~----~~P~~~~~~lf-----~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~p  290 (318)
T KOG0659|consen  236 VKIQ----QFPKPPLNNLF-----PAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLP  290 (318)
T ss_pred             HHHh----cCCCCcccccc-----ccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCC
Confidence            1111    11111111111     1267888999999999999999999999999999975543

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.2e-54  Score=408.08  Aligned_cols=281  Identities=33%  Similarity=0.625  Sum_probs=238.1

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc-----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccE
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (425)
                      .+.|+.+++||+|.||.||+|++..+|+.||+|.+.-+.     .....+||.||++| +||||++|.+...+...+.+|
T Consensus       116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l-~HpNIikL~eivt~~~~~siY  194 (560)
T KOG0600|consen  116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRL-DHPNIIKLEEIVTSKLSGSIY  194 (560)
T ss_pred             hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhc-CCCcccceeeEEEecCCceEE
Confidence            467999999999999999999999999999999986443     34567999999999 999999999999887678999


Q ss_pred             EEEEeecCCChhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCC-
Q 014406          199 LIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-  274 (425)
Q Consensus       199 lv~e~~~~~~l~~~~~---~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~-  274 (425)
                      ||+|||+.........   .|++.+++.++.||+.||+|||++||+|||||.+|||||.+ |.+||+|||||+++.... 
T Consensus       195 lVFeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~-G~LKiaDFGLAr~y~~~~~  273 (560)
T KOG0600|consen  195 LVFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNN-GVLKIADFGLARFYTPSGS  273 (560)
T ss_pred             EEEecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCC-CCEEeccccceeeccCCCC
Confidence            9999999876555443   59999999999999999999999999999999999999998 899999999999776554 


Q ss_pred             -cceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCC
Q 014406          275 -EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL  353 (425)
Q Consensus       275 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~  353 (425)
                       .++..+.|.+|+|||++++...|+.++|+||.||+|.||+.|+ |.+.|.++.+|+..|.+..|.+....|. ...+..
T Consensus       274 ~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gk-PI~~G~tEveQl~kIfklcGSP~e~~W~-~~kLP~  351 (560)
T KOG0600|consen  274 APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGK-PILQGRTEVEQLHKIFKLCGSPTEDYWP-VSKLPH  351 (560)
T ss_pred             cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCC-CCcCCccHHHHHHHHHHHhCCCChhccc-cccCCc
Confidence             5677899999999999999999999999999999999999998 5569999999999999999998877665 333332


Q ss_pred             ChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCccc
Q 014406          354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV  415 (425)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~  415 (425)
                      ...+..      ..+....+.+ .-..++..+.+|+..||..||.+|.||.++|+|+||...
T Consensus       352 ~~~~kp------~~~y~r~l~E-~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~  406 (560)
T KOG0600|consen  352 ATIFKP------QQPYKRRLRE-TFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTTE  406 (560)
T ss_pred             ccccCC------CCcccchHHH-HhccCCHHHHHHHHHHhccCccccccHHHHhcCcccccC
Confidence            222111      1111111211 134589999999999999999999999999999999543

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.2e-53  Score=408.83  Aligned_cols=247  Identities=26%  Similarity=0.515  Sum_probs=216.4

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecC------cchHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccE
Q 014406          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP------VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (425)
Q Consensus       125 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~------~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (425)
                      .+|+..+.||+|||++||.+++..+|+.||+|++.+      ..++++.+||+|.++| +|||||+++++|++.  .++|
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L-~HpnIV~f~~~FEDs--~nVY   94 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSL-KHPNIVQFYHFFEDS--NNVY   94 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhc-CCCcEEeeeeEeecC--CceE
Confidence            679999999999999999999999999999999864      3567899999999999 999999999999664  8899


Q ss_pred             EEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCC-C
Q 014406          199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-K  274 (425)
Q Consensus       199 lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~-~  274 (425)
                      +|+|+|..++|..++   ..++|.+++.++.||+.||.|||+.+|+|||||..|++++++ ..+||+|||||...... +
T Consensus        95 ivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~-~~VKIgDFGLAt~le~~~E  173 (592)
T KOG0575|consen   95 IVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNEN-MNVKIGDFGLATQLEYDGE  173 (592)
T ss_pred             EEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCc-CcEEecccceeeeecCccc
Confidence            999999999998887   469999999999999999999999999999999999999999 68999999999888744 6


Q ss_pred             cceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCC
Q 014406          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD  354 (425)
Q Consensus       275 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~  354 (425)
                      ...+.+||+.|.|||++.. ...+..+||||+||+||-||.|+.||. ..+-.+.+..|...                  
T Consensus       174 rk~TlCGTPNYIAPEVl~k-~gHsfEvDiWSlGcvmYtLL~G~PPFe-tk~vkety~~Ik~~------------------  233 (592)
T KOG0575|consen  174 RKKTLCGTPNYIAPEVLNK-SGHSFEVDIWSLGCVMYTLLVGRPPFE-TKTVKETYNKIKLN------------------  233 (592)
T ss_pred             ccceecCCCcccChhHhcc-CCCCCchhhhhhhhHHHhhhhCCCCcc-cchHHHHHHHHHhc------------------
Confidence            6678899999999999987 788999999999999999999999982 22233444433220                  


Q ss_pred             hhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcc
Q 014406          355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ  414 (425)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~  414 (425)
                                         +...+..+|.++++||++||+.||.+|||++++|.|+||+.
T Consensus       234 -------------------~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~  274 (592)
T KOG0575|consen  234 -------------------EYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKS  274 (592)
T ss_pred             -------------------CcccccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhC
Confidence                               11112248999999999999999999999999999999943

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=4.5e-54  Score=391.24  Aligned_cols=283  Identities=34%  Similarity=0.620  Sum_probs=236.7

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcchHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCC---ccEEEE
Q 014406          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK---TPSLIF  201 (425)
Q Consensus       125 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~---~~~lv~  201 (425)
                      -.|+..+.+|.|+||.||+|....+++.||||..-++.+ --.+|+++|+.+ .|||||+|+-+|....+.   +..|||
T Consensus        24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-~knrEl~im~~l-~HpNIV~L~~~f~~~~~~d~~~lnlVl  101 (364)
T KOG0658|consen   24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-YKNRELQIMRKL-DHPNIVRLLYFFSSSTESDEVYLNLVL  101 (364)
T ss_pred             EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-cCcHHHHHHHhc-CCcCeeeEEEEEEecCCCchhHHHHHH
Confidence            357888999999999999999999999999998864433 224799999998 999999999998865444   677999


Q ss_pred             EeecCCChhhhc------CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCc
Q 014406          202 EYVNSTDFKVLY------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (425)
Q Consensus       202 e~~~~~~l~~~~------~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~  275 (425)
                      |||+....+...      ..++...++-+..||++||.|||+.||+||||||.|+|+|.+++.+||||||.|+....++.
T Consensus       102 eymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~ep  181 (364)
T KOG0658|consen  102 EYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEP  181 (364)
T ss_pred             HhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeeccCCC
Confidence            999987655443      56888899999999999999999999999999999999999999999999999999998888


Q ss_pred             ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCCh
Q 014406          276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP  355 (425)
Q Consensus       276 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~  355 (425)
                      ......|+.|+|||.+.+...|+.+.||||.||++.||+-|+ |.|+|.+..+|+.+|.+++|++..++...-.......
T Consensus       182 niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~-plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~  260 (364)
T KOG0658|consen  182 NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQ-PLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEF  260 (364)
T ss_pred             ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCC-cccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccc
Confidence            888999999999999999999999999999999999999998 5568999999999999999998876543211111000


Q ss_pred             hhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccc
Q 014406          356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA  418 (425)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~  418 (425)
                      .    ........|..    -.....++++.+|+.++|+++|.+|.++.|+|.||||...+..
T Consensus       261 ~----~p~ik~~~~~~----~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~  315 (364)
T KOG0658|consen  261 K----FPQIKAHPWHK----VFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP  315 (364)
T ss_pred             c----Cccccccccee----ecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence            0    01111222222    1334478999999999999999999999999999999998775

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-53  Score=388.99  Aligned_cols=257  Identities=30%  Similarity=0.534  Sum_probs=222.7

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCc
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (425)
                      ..++|++++.||+|+||+||.++...+++.+|+|++++.      ..+....|..+|..+ +||.||.++-.|+  +...
T Consensus        23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v-~hPFiv~l~ysFQ--t~~k   99 (357)
T KOG0598|consen   23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKI-KHPFIVKLIYSFQ--TEEK   99 (357)
T ss_pred             ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhC-CCCcEeeeEEecc--cCCe
Confidence            478999999999999999999999999999999999753      245678999999998 9999999999995  4588


Q ss_pred             cEEEEEeecCCChhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccc-cC
Q 014406          197 PSLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY-HP  272 (425)
Q Consensus       197 ~~lv~e~~~~~~l~~~~~---~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~-~~  272 (425)
                      +|||+||++||.|..+++   .|++..++.++.+|+.||.|||+.|||||||||+|||+|.+ |.++|+|||+|+.. ..
T Consensus       100 LylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~-GHi~LtDFgL~k~~~~~  178 (357)
T KOG0598|consen  100 LYLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQ-GHIKLTDFGLCKEDLKD  178 (357)
T ss_pred             EEEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCC-CcEEEeccccchhcccC
Confidence            999999999999999986   59999999999999999999999999999999999999999 89999999999854 34


Q ss_pred             CCcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCC
Q 014406          273 GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE  352 (425)
Q Consensus       273 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~  352 (425)
                      +..+.+.+||+.|||||++.+ ..|+..+|+||+|+++|||++|..||. +.+.......+.+.-               
T Consensus       179 ~~~t~tfcGT~eYmAPEil~~-~gy~~~vDWWsLGillYeML~G~pPF~-~~~~~~~~~~I~~~k---------------  241 (357)
T KOG0598|consen  179 GDATRTFCGTPEYMAPEILLG-KGYDKAVDWWSLGILLYEMLTGKPPFY-AEDVKKMYDKILKGK---------------  241 (357)
T ss_pred             CCccccccCCccccChHHHhc-CCCCcccchHhHHHHHHHHhhCCCCCc-CccHHHHHHHHhcCc---------------
Confidence            456667799999999999998 789999999999999999999999983 444444444443210               


Q ss_pred             CChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCc----CHHHHhcCCCCcccccchhc
Q 014406          353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL----TAREAMAHPYFAQVRAAESS  421 (425)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rp----ta~elL~hp~~~~~~~~~~~  421 (425)
                                           ....+..++.++++|++++|+.||++|.    ++.++-+||||+.++|....
T Consensus       242 ---------------------~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~l~  293 (357)
T KOG0598|consen  242 ---------------------LPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEKLL  293 (357)
T ss_pred             ---------------------CCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHHHHH
Confidence                                 0011223789999999999999999996    78999999999999997653

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=2.6e-53  Score=380.24  Aligned_cols=287  Identities=30%  Similarity=0.549  Sum_probs=234.6

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcchH-----HHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccE
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKK-----KIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (425)
                      -++|+.++.|++|+||.||+|+++.|++.||+|.++.+..+     ...+||.+|.++ +|||||.+-.+..+.+-..+|
T Consensus        75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~-~H~NIV~vkEVVvG~~~d~iy  153 (419)
T KOG0663|consen   75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKA-RHPNIVEVKEVVVGSNMDKIY  153 (419)
T ss_pred             HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhc-CCCCeeeeEEEEeccccceee
Confidence            46799999999999999999999999999999999865433     357999999999 899999999999988778899


Q ss_pred             EEEEeecCCC---hhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCC-C
Q 014406          199 LIFEYVNSTD---FKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-K  274 (425)
Q Consensus       199 lv~e~~~~~~---l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~-~  274 (425)
                      +||||++...   ++..-++|...+++-++.|++.|++|||.+.|+|||||++|+|++.. |.+||+|||+|+.+... .
T Consensus       154 ~VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~-G~lKiaDFGLAR~ygsp~k  232 (419)
T KOG0663|consen  154 IVMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHK-GILKIADFGLAREYGSPLK  232 (419)
T ss_pred             eeHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccC-CcEEecccchhhhhcCCcc
Confidence            9999998642   22333579999999999999999999999999999999999999998 89999999999987644 4


Q ss_pred             cceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCC
Q 014406          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD  354 (425)
Q Consensus       275 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~  354 (425)
                      .++..+.|.+|+|||.+++...|+.++||||+||++.||++++ |.++|.+..+|+..|++.+|.+.-..|..-....  
T Consensus       233 ~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~k-Plf~G~sE~dQl~~If~llGtPte~iwpg~~~lp--  309 (419)
T KOG0663|consen  233 PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQK-PLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELP--  309 (419)
T ss_pred             cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcC-CCCCCCchHHHHHHHHHHhCCCccccCCCccccc--
Confidence            5677899999999999999999999999999999999999987 5569999999999999999998765543211111  


Q ss_pred             hhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccc
Q 014406          355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA  418 (425)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~  418 (425)
                       .+...  .....+...+-..-....+++...+|+..+|.+||.+|.||+|.|+|+||.+...+
T Consensus       310 -~~k~~--~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p  370 (419)
T KOG0663|consen  310 -AVKKM--TFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLP  370 (419)
T ss_pred             -hhhcc--ccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCC
Confidence             11000  00011111111000011167999999999999999999999999999999986544

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-52  Score=381.43  Aligned_cols=292  Identities=33%  Similarity=0.592  Sum_probs=240.8

Q ss_pred             ccccCCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecC-----cchHHHHHHHHHHHHhcCCCCeeeEEeEEEc-
Q 014406          118 TVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-----VKKKKIKREIKILQNLCGGPNVVKLLDIVRD-  191 (425)
Q Consensus       118 ~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~-  191 (425)
                      ...+.....|..++.||+|+||.|+.+.+..+|+.||||.+..     ...++..+|+.+|+++ +|+||+.+++++.. 
T Consensus        15 ~~~~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~-~HeNIi~l~di~~p~   93 (359)
T KOG0660|consen   15 GELFEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHL-RHENIIGLLDIFRPP   93 (359)
T ss_pred             eeEEeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHh-cCCCcceEEeecccc
Confidence            3445566778878999999999999999999999999998862     2356788999999999 79999999999975 


Q ss_pred             --CCCCccEEEEEeecCCChhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccc
Q 014406          192 --QHSKTPSLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL  266 (425)
Q Consensus       192 --~~~~~~~lv~e~~~~~~l~~~~~---~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~  266 (425)
                        ...+.+|+|+|+| +.+|...++   .+++..+..++.||+.||.|+|+.+|+||||||+|+|++.+ ..+||||||+
T Consensus        94 ~~~~f~DvYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~-c~lKI~DFGL  171 (359)
T KOG0660|consen   94 SRDKFNDVYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNAD-CDLKICDFGL  171 (359)
T ss_pred             cccccceeEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccC-CCEEeccccc
Confidence              3456799999999 567777662   38999999999999999999999999999999999999999 6889999999


Q ss_pred             cccccC---CCcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhH
Q 014406          267 AEFYHP---GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELN  343 (425)
Q Consensus       267 a~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~  343 (425)
                      |+....   ....+..+.|.+|+|||++.+...|+.++||||+||++.||++|+.. |+|.+..+|+..|.+.+|++..+
T Consensus       172 AR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkpl-FpG~d~v~Ql~lI~~~lGtP~~e  250 (359)
T KOG0660|consen  172 ARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPL-FPGKDYVHQLQLILELLGTPSEE  250 (359)
T ss_pred             eeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCC-CCCCchHHHHHHHHHhcCCCCHH
Confidence            998764   34446679999999999999989999999999999999999999855 59999999999999999998655


Q ss_pred             HHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccch
Q 014406          344 AYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE  419 (425)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~~  419 (425)
                      ... .........+-.......+.++...+.     ..++.+.+|+.+||..||.+|+|++|+|+||||.....++
T Consensus       251 ~l~-~i~s~~ar~yi~slp~~p~~~f~~~fp-----~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~  320 (359)
T KOG0660|consen  251 DLQ-KIRSEKARPYIKSLPQIPKQPFSSIFP-----NANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPE  320 (359)
T ss_pred             HHH-HhccHHHHHHHHhCCCCCCCCHHHHcC-----CCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCc
Confidence            432 222111111222223333444444443     3789999999999999999999999999999999876544

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=1.5e-51  Score=390.31  Aligned_cols=262  Identities=31%  Similarity=0.523  Sum_probs=223.3

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCc
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (425)
                      ..++|+++..||+|+||.||+|+.+.||+.+|+|++++.      +.+.++.|..+|... ++++||+|+-.|.+  ..+
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~-ds~~vVKLyYsFQD--~~~  215 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEV-DSPWVVKLYYSFQD--KEY  215 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhc-CCCcEEEEEEEecC--CCe
Confidence            578999999999999999999999999999999999754      346678899999996 99999999999955  589


Q ss_pred             cEEEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccC-
Q 014406          197 PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP-  272 (425)
Q Consensus       197 ~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~-  272 (425)
                      +||||||++||++..++   ..|++...+.++.+++.|++-||+.|+|||||||+|+|||.. |++||+||||+..... 
T Consensus       216 LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~-GHiKLSDFGLs~gl~~~  294 (550)
T KOG0605|consen  216 LYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAK-GHIKLSDFGLSTGLDKK  294 (550)
T ss_pred             eEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCC-CCEeeccccccchhhhh
Confidence            99999999999999887   459999999999999999999999999999999999999998 8999999999853311 


Q ss_pred             ---------------------CC-c-------------------------ceeeccCCCccCcccccCCCCCCCcccHHH
Q 014406          273 ---------------------GK-E-------------------------YNVRVASRYFKGPELLVDLQDYDYSLDMWS  305 (425)
Q Consensus       273 ---------------------~~-~-------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~Dvws  305 (425)
                                           .. .                         ....+|||.|+|||++.+ ..|+..+|+||
T Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~-kgY~~~cDwWS  373 (550)
T KOG0605|consen  295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLG-KGYGKECDWWS  373 (550)
T ss_pred             hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhc-CCCCccccHHH
Confidence                                 00 0                         011479999999999998 78999999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHH
Q 014406          306 LGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEA  385 (425)
Q Consensus       306 lG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  385 (425)
                      |||++||||.|..|| .+.+..++..+|..                                 |...+.......+++++
T Consensus       374 LG~ImyEmLvGyPPF-~s~tp~~T~rkI~n---------------------------------wr~~l~fP~~~~~s~eA  419 (550)
T KOG0605|consen  374 LGCIMYEMLVGYPPF-CSETPQETYRKIVN---------------------------------WRETLKFPEEVDLSDEA  419 (550)
T ss_pred             HHHHHHHHHhCCCCC-CCCCHHHHHHHHHH---------------------------------HhhhccCCCcCcccHHH
Confidence            999999999999998 56666777776644                                 22222222333478999


Q ss_pred             HHHHHHcccCCcCCCcC---HHHHhcCCCCcccccchhcccc
Q 014406          386 IDFLDKLLRYDHQDRLT---AREAMAHPYFAQVRAAESSRTR  424 (425)
Q Consensus       386 ~~ll~~~L~~dP~~Rpt---a~elL~hp~~~~~~~~~~~~~~  424 (425)
                      +|||.+||+ ||++|..   ++|+.+||||+++.|.....+-
T Consensus       420 ~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~W~~l~~~~  460 (550)
T KOG0605|consen  420 KDLITRLLC-DPENRLGSKGAEEIKKHPFFKGVDWDHLREMP  460 (550)
T ss_pred             HHHHHHHhc-CHHHhcCcccHHHHhcCCccccCCcchhhcCC
Confidence            999999999 9999995   8999999999999998765543

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-51  Score=389.71  Aligned_cols=256  Identities=31%  Similarity=0.531  Sum_probs=222.3

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCc
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (425)
                      ...+|...+.||.|+|++|++|++..+++.+|||++.+.      ..+-+..|-.+|.+|.+||.|++|+-.|.|+  ..
T Consensus        71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~--~s  148 (604)
T KOG0592|consen   71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDE--ES  148 (604)
T ss_pred             ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecc--cc
Confidence            357888999999999999999999999999999998642      3455778999999998999999999999665  78


Q ss_pred             cEEEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCC
Q 014406          197 PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (425)
Q Consensus       197 ~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~  273 (425)
                      +|.|+||+++|+|..++   +.|++...+.++.+|+.||+|||++|||||||||+|||||.| +++||+|||.|+.+.+.
T Consensus       149 LYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~d-mhikITDFGsAK~l~~~  227 (604)
T KOG0592|consen  149 LYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKD-GHIKITDFGSAKILSPS  227 (604)
T ss_pred             eEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCC-CcEEEeeccccccCChh
Confidence            89999999999998887   569999999999999999999999999999999999999999 89999999999877542


Q ss_pred             Cc--------------ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCC
Q 014406          274 KE--------------YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT  339 (425)
Q Consensus       274 ~~--------------~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~  339 (425)
                      ..              ....+||-.|.+||++.+ ...+..+|+|+|||+||.|+.|..|| .+.++.-.+++|.+.-  
T Consensus       228 ~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~-~~~~~~sDiWAlGCilyQmlaG~PPF-ra~NeyliFqkI~~l~--  303 (604)
T KOG0592|consen  228 QKSQENPVDPNQASSRRSSFVGTAEYVSPELLND-SPAGPSSDLWALGCILYQMLAGQPPF-RAANEYLIFQKIQALD--  303 (604)
T ss_pred             hccccCccCcccccCcccceeeeecccCHHHhcC-CCCCcccchHHHHHHHHHHhcCCCCC-ccccHHHHHHHHHHhc--
Confidence            21              134789999999999987 78999999999999999999999998 5556666677665521  


Q ss_pred             chhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccch
Q 014406          340 DELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE  419 (425)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~~  419 (425)
                                                         .+-...+++.++||++++|..||.+|+|++|+.+||||.++.|.-
T Consensus       304 -----------------------------------y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~n  348 (604)
T KOG0592|consen  304 -----------------------------------YEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWEN  348 (604)
T ss_pred             -----------------------------------ccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChhh
Confidence                                               111223689999999999999999999999999999999999865


Q ss_pred             h
Q 014406          420 S  420 (425)
Q Consensus       420 ~  420 (425)
                      .
T Consensus       349 l  349 (604)
T KOG0592|consen  349 L  349 (604)
T ss_pred             h
Confidence            3

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-51  Score=373.93  Aligned_cols=254  Identities=30%  Similarity=0.529  Sum_probs=213.3

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccE
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (425)
                      ..+|++.+.||+|+||+||+|+++.++..||||.+...     ..+.+..|+.+|+.+ +|||||.++++++.+  +.+|
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel-~H~nIV~l~d~~~~~--~~i~   85 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKEL-KHPNIVRLLDCIEDD--DFIY   85 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhc-CCcceeeEEEEEecC--CeEE
Confidence            56799999999999999999999999999999998755     345678899999999 899999999999765  6899


Q ss_pred             EEEEeecCCChhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCC--C---CcEEEEeccccccc
Q 014406          199 LIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--L---RKLRLIDWGLAEFY  270 (425)
Q Consensus       199 lv~e~~~~~~l~~~~~---~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~--~---~~~kl~Dfg~a~~~  270 (425)
                      ||||||+||+|..++.   .+++..++.++.||+.||++||+++||||||||.||||+..  .   -.+||+|||+|+..
T Consensus        86 lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L  165 (429)
T KOG0595|consen   86 LVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL  165 (429)
T ss_pred             EEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence            9999999999999983   59999999999999999999999999999999999999874  1   35899999999999


Q ss_pred             cCCCcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhcc
Q 014406          271 HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH  350 (425)
Q Consensus       271 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~  350 (425)
                      .++....+.+|++.|||||++.. +.|+.|+|+||+|+++|+|++|+.|| ...+..+.+..+.+.  .           
T Consensus       166 ~~~~~a~tlcGSplYMAPEV~~~-~~YdAKADLWSiG~Ilyq~l~g~~Pf-~a~t~~eL~~~~~k~--~-----------  230 (429)
T KOG0595|consen  166 QPGSMAETLCGSPLYMAPEVIMS-QQYDAKADLWSIGTILYQCLTGKPPF-DAETPKELLLYIKKG--N-----------  230 (429)
T ss_pred             CchhHHHHhhCCccccCHHHHHh-ccccchhhHHHHHHHHHHHHhCCCCc-cccCHHHHHHHHhcc--c-----------
Confidence            98888888999999999999986 78999999999999999999999998 333333333322110  0           


Q ss_pred             CCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccc
Q 014406          351 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR  416 (425)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~  416 (425)
                       .                    .....+..++....+++...|+.+|..|.+..+-+.|+|+..-.
T Consensus       231 -~--------------------~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p  275 (429)
T KOG0595|consen  231 -E--------------------IVPVLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAANP  275 (429)
T ss_pred             -c--------------------ccCchhhhccCchhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence             0                    00111112566777899999999999999999999999876543

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=1.3e-50  Score=393.81  Aligned_cols=285  Identities=28%  Similarity=0.514  Sum_probs=222.0

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc--hHHHHHHHHHHHHhcCC-----CCeeeEEeEEEcCCCCcc
Q 014406          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--KKKIKREIKILQNLCGG-----PNVVKLLDIVRDQHSKTP  197 (425)
Q Consensus       125 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~~h-----~niv~l~~~~~~~~~~~~  197 (425)
                      -+|++++.||+|+||.|.+|.+..|++.||||++++..  ..+...|+.+|..|.+|     -|+|+++++|  ...+|+
T Consensus       186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F--~fr~Hl  263 (586)
T KOG0667|consen  186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYF--YFRNHL  263 (586)
T ss_pred             EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecc--ccccce
Confidence            37899999999999999999999999999999998654  36677899999999423     4999999999  456899


Q ss_pred             EEEEEeecCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecC-CCCcEEEEeccccccccC
Q 014406          198 SLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH-ELRKLRLIDWGLAEFYHP  272 (425)
Q Consensus       198 ~lv~e~~~~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~-~~~~~kl~Dfg~a~~~~~  272 (425)
                      |||+|.++....+.+.    ..++...++.++.||+.||.+||+.+|||+||||+||||.. +...+||+|||+|+....
T Consensus       264 ciVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q  343 (586)
T KOG0667|consen  264 CIVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQ  343 (586)
T ss_pred             eeeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccccCC
Confidence            9999998765443332    45899999999999999999999999999999999999964 345799999999987543


Q ss_pred             CCcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCC
Q 014406          273 GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE  352 (425)
Q Consensus       273 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~  352 (425)
                        ...+.++++.|+|||++++ .+|+.+.|||||||+++||++| .|+|+|.++.++++.|.+++|.++....-......
T Consensus       344 --~vytYiQSRfYRAPEVILG-lpY~~~IDmWSLGCIlAEL~tG-~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~  419 (586)
T KOG0667|consen  344 --RVYTYIQSRFYRAPEVILG-LPYDTAIDMWSLGCILAELFTG-EPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAH  419 (586)
T ss_pred             --cceeeeeccccccchhhcc-CCCCCccceeehhhhHHhHhcC-ccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccc
Confidence              2237899999999999999 8999999999999999999999 57889999999999999999987655432111110


Q ss_pred             --CCh---hhH-----H---------------HhcccCCCC-ccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHH
Q 014406          353 --LDP---QLD-----A---------------LVGRHSRKP-WSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA  406 (425)
Q Consensus       353 --~~~---~~~-----~---------------~~~~~~~~~-~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~el  406 (425)
                        +..   .+.     .               ......+.+ -..-........-...+.|||++||.|||.+|+|+.|+
T Consensus       420 kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qa  499 (586)
T KOG0667|consen  420 KFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQA  499 (586)
T ss_pred             eehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHH
Confidence              000   000     0               000000011 00000111111234567999999999999999999999


Q ss_pred             hcCCCCccc
Q 014406          407 MAHPYFAQV  415 (425)
Q Consensus       407 L~hp~~~~~  415 (425)
                      |+||||...
T Consensus       500 l~Hpfl~~~  508 (586)
T KOG0667|consen  500 LNHPFLTGT  508 (586)
T ss_pred             hcCcccccc
Confidence            999999944

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.6e-51  Score=388.71  Aligned_cols=255  Identities=27%  Similarity=0.506  Sum_probs=218.7

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc---chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEE
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (425)
                      ...|....+||+|+.|.||.|....+++.||||.++..   .++-+.+|+.+|+.. +|+|||.+++.|...  ..+|.|
T Consensus       272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~-~H~NiVnfl~Sylv~--deLWVV  348 (550)
T KOG0578|consen  272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDL-HHPNIVNFLDSYLVG--DELWVV  348 (550)
T ss_pred             hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhc-cchHHHHHHHHhccc--ceeEEE
Confidence            45688889999999999999999999999999998643   345688999999999 999999999988654  678999


Q ss_pred             EEeecCCChhhhcCC--CCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCC-cce
Q 014406          201 FEYVNSTDFKVLYPT--LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EYN  277 (425)
Q Consensus       201 ~e~~~~~~l~~~~~~--l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~-~~~  277 (425)
                      ||||+||+|.+....  +++.++..|+++++.||+|||.+||+|||||.+|||++.+ +.+||+|||++..+.... ...
T Consensus       349 MEym~ggsLTDvVt~~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~-g~vKltDFGFcaqi~~~~~KR~  427 (550)
T KOG0578|consen  349 MEYMEGGSLTDVVTKTRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMD-GSVKLTDFGFCAQISEEQSKRS  427 (550)
T ss_pred             EeecCCCchhhhhhcccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccC-CcEEEeeeeeeeccccccCccc
Confidence            999999999988753  8999999999999999999999999999999999999999 789999999998776554 456


Q ss_pred             eeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCChhh
Q 014406          278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQL  357 (425)
Q Consensus       278 ~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~  357 (425)
                      +.+||++|||||++.. ..|+.++||||||++++||+.|..||+. .+....+..| ..-|++.+.              
T Consensus       428 TmVGTPYWMAPEVvtr-k~YG~KVDIWSLGIMaIEMveGEPPYln-E~PlrAlyLI-a~ng~P~lk--------------  490 (550)
T KOG0578|consen  428 TMVGTPYWMAPEVVTR-KPYGPKVDIWSLGIMAIEMVEGEPPYLN-ENPLRALYLI-ATNGTPKLK--------------  490 (550)
T ss_pred             cccCCCCccchhhhhh-cccCccccchhhhhHHHHHhcCCCCccC-CChHHHHHHH-hhcCCCCcC--------------
Confidence            7799999999999987 7899999999999999999999999975 2223333333 333443322              


Q ss_pred             HHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccc
Q 014406          358 DALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA  418 (425)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~  418 (425)
                                         .++.+|++++||+.+||+.|+++|++|.|||+||||+.....
T Consensus       491 -------------------~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~a~p~  532 (550)
T KOG0578|consen  491 -------------------NPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKMAKPE  532 (550)
T ss_pred             -------------------CccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhhcCCH
Confidence                               233489999999999999999999999999999999765443

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-50  Score=354.26  Aligned_cols=256  Identities=24%  Similarity=0.452  Sum_probs=221.5

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc------hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCc
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (425)
                      ..++|+.++.||.|+||+|.+++.+.+|..+|+|++++..      .+...+|..+|+.+ .||+++++++.|.+  ...
T Consensus        42 ~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v-~~PFlv~l~~t~~d--~~~  118 (355)
T KOG0616|consen   42 SLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAV-SHPFLVKLYGTFKD--NSN  118 (355)
T ss_pred             chhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhc-cCceeEEEEEeecc--CCe
Confidence            4678999999999999999999999999999999998643      35567899999999 89999999999955  488


Q ss_pred             cEEEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCC
Q 014406          197 PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (425)
Q Consensus       197 ~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~  273 (425)
                      +++||||.+||.|..++   ++|++...+.++.||+.||+|||+++|++|||||+|||+|.+ |.+||+|||+|+.... 
T Consensus       119 lymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~-G~iKitDFGFAK~v~~-  196 (355)
T KOG0616|consen  119 LYMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQN-GHIKITDFGFAKRVSG-  196 (355)
T ss_pred             EEEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccC-CcEEEEeccceEEecC-
Confidence            99999999999999887   469999999999999999999999999999999999999999 8999999999998753 


Q ss_pred             CcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCC
Q 014406          274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL  353 (425)
Q Consensus       274 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~  353 (425)
                       .+-+.+||+.|+|||++.. .+|+.++|.|||||++|||+.|..||+.. +.......|.+             ....+
T Consensus       197 -rT~TlCGTPeYLAPEii~s-k~ynkavDWWalGVLIYEMlaG~pPF~~~-~~~~iY~KI~~-------------~~v~f  260 (355)
T KOG0616|consen  197 -RTWTLCGTPEYLAPEIIQS-KGYNKAVDWWALGVLIYEMLAGYPPFYDD-NPIQIYEKILE-------------GKVKF  260 (355)
T ss_pred             -cEEEecCCccccChHHhhc-CCCCcchhHHHHHHHHHHHHcCCCCCcCC-ChHHHHHHHHh-------------CcccC
Confidence             3667899999999999988 89999999999999999999999999533 33444444432             11111


Q ss_pred             ChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCc-----CHHHHhcCCCCcccccchhccc
Q 014406          354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYFAQVRAAESSRT  423 (425)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rp-----ta~elL~hp~~~~~~~~~~~~~  423 (425)
                                              +..++.++++|++++|+.|-.+|.     ...++..||||+.+.|.+....
T Consensus       261 ------------------------P~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~i~~r  311 (355)
T KOG0616|consen  261 ------------------------PSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEAILQR  311 (355)
T ss_pred             ------------------------CcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccHHHHhhc
Confidence                                    223789999999999999999994     5789999999999999776543

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-49  Score=387.06  Aligned_cols=259  Identities=27%  Similarity=0.466  Sum_probs=228.2

Q ss_pred             CCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCC
Q 014406          122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (425)
Q Consensus       122 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (425)
                      ...++|.+++.||+|+||+|+++..+.+++.+|||++++.      ..+....|..|+....+||.++.++..|  +...
T Consensus       365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~f--QT~~  442 (694)
T KOG0694|consen  365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCF--QTKE  442 (694)
T ss_pred             ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccc--ccCC
Confidence            3468999999999999999999999999999999999854      4567888999999887899999999999  5558


Q ss_pred             ccEEEEEeecCCChhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEecccccccc-C
Q 014406          196 TPSLIFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-P  272 (425)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~-~  272 (425)
                      ++|.||||+.||++..+.  ..|++..++.|+..++.||.|||++||||||||.+|||||.+ |.+||+|||+++... .
T Consensus       443 ~l~fvmey~~Ggdm~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~e-Gh~kiADFGlcKe~m~~  521 (694)
T KOG0694|consen  443 HLFFVMEYVAGGDLMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTE-GHVKIADFGLCKEGMGQ  521 (694)
T ss_pred             eEEEEEEecCCCcEEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEccc-CcEEecccccccccCCC
Confidence            999999999999966555  469999999999999999999999999999999999999999 899999999998654 4


Q ss_pred             CCcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCC
Q 014406          273 GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE  352 (425)
Q Consensus       273 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~  352 (425)
                      +..+.+.+||+.|||||++.+ ..|+.++|.|||||+|||||.|..|| .++++++.+..|...                
T Consensus       522 g~~TsTfCGTpey~aPEil~e-~~Yt~aVDWW~lGVLlyeML~Gq~PF-~gddEee~FdsI~~d----------------  583 (694)
T KOG0694|consen  522 GDRTSTFCGTPEFLAPEVLTE-QSYTRAVDWWGLGVLLYEMLVGESPF-PGDDEEEVFDSIVND----------------  583 (694)
T ss_pred             CCccccccCChhhcChhhhcc-CcccchhhHHHHHHHHHHHHcCCCCC-CCCCHHHHHHHHhcC----------------
Confidence            567788899999999999988 88999999999999999999999998 777888877776431                


Q ss_pred             CChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcC-----HHHHhcCCCCcccccchhcc
Q 014406          353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT-----AREAMAHPYFAQVRAAESSR  422 (425)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpt-----a~elL~hp~~~~~~~~~~~~  422 (425)
                                           +...+..+|.++.++++++|+.||++|..     +.++.+||||+.+.|.....
T Consensus       584 ---------------------~~~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~  637 (694)
T KOG0694|consen  584 ---------------------EVRYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLLN  637 (694)
T ss_pred             ---------------------CCCCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHHHhh
Confidence                                 11123348999999999999999999995     58999999999999976543

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=2.8e-49  Score=360.46  Aligned_cols=284  Identities=32%  Similarity=0.603  Sum_probs=229.1

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcch-----HHHHHHHHHHHHhcCCCC-eeeEEeEEEcCC----
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK-----KKIKREIKILQNLCGGPN-VVKLLDIVRDQH----  193 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~E~~~l~~l~~h~n-iv~l~~~~~~~~----  193 (425)
                      .+.|+.+++||+|+||+||+|+.+.+|+.||+|.+.-...     ....+|+.+++++ +|+| |+++++++...+    
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L-~~~~~iv~L~dv~~~~~~~~~   88 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRL-SHANHIVRLHDVIHTSNNHRG   88 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHh-CCCcceEEEEeeeeecccccc
Confidence            4457777889999999999999999999999999874432     4568999999999 8999 999999997653    


Q ss_pred             CCccEEEEEeecCCChhhhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccc
Q 014406          194 SKTPSLIFEYVNSTDFKVLYP-------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL  266 (425)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~~-------~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~  266 (425)
                      ...+++|+||++. +|..++.       .++...++.++.||+.||+|||+++|+||||||.|||++++ +.+||+|||+
T Consensus        89 ~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~-G~lKlaDFGl  166 (323)
T KOG0594|consen   89 IGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSS-GVLKLADFGL  166 (323)
T ss_pred             cceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCC-CcEeeeccch
Confidence            1368899999875 4444442       36667899999999999999999999999999999999997 8999999999


Q ss_pred             ccccc-CCCcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHH
Q 014406          267 AEFYH-PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAY  345 (425)
Q Consensus       267 a~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~  345 (425)
                      |+... +...++..++|.+|+|||++.+...|+..+||||+||+++||++++ |.|++..+.+++..|.+.+|++....|
T Consensus       167 Ara~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~-~LFpG~se~~ql~~If~~lGtP~e~~W  245 (323)
T KOG0594|consen  167 ARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRR-PLFPGDSEIDQLFRIFRLLGTPNEKDW  245 (323)
T ss_pred             HHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCC-CCCCCCcHHHHHHHHHHHcCCCCccCC
Confidence            99776 5556788899999999999999889999999999999999999966 666999999999999999999877655


Q ss_pred             HhhccCCCChhhHHHhcccCCCCcc-ccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccch
Q 014406          346 LNKYHLELDPQLDALVGRHSRKPWS-KFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE  419 (425)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~~  419 (425)
                      ...........        ....|. ...........+++..+++.+||+++|.+|.||+.+|+||||.......
T Consensus       246 p~v~~~~~~k~--------~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~~~  312 (323)
T KOG0594|consen  246 PGVSSLPDYKA--------PFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPEKS  312 (323)
T ss_pred             CCccccccccc--------cCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccccch
Confidence            32221111100        011111 0011111222457899999999999999999999999999999885543

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.5e-49  Score=363.17  Aligned_cols=265  Identities=24%  Similarity=0.401  Sum_probs=216.1

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccE
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (425)
                      ..+.|++.+.||.|..++||+|+...+++.||||+++-+.    .+.+.+|+..|..+ +||||++++..|..+  ..+|
T Consensus        24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~-~HPNIv~~~~sFvv~--~~LW  100 (516)
T KOG0582|consen   24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLI-DHPNIVTYHCSFVVD--SELW  100 (516)
T ss_pred             CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhc-CCCCcceEEEEEEec--ceeE
Confidence            4678999999999999999999999999999999998443    46789999999998 999999999999765  7889


Q ss_pred             EEEEeecCCChhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCC
Q 014406          199 LIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (425)
Q Consensus       199 lv~e~~~~~~l~~~~-----~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~  273 (425)
                      +||.||.+|++.+++     ..+++..+..|++++++||.|||++|.||||||+.||||+.+ |.|||+|||.+-.+...
T Consensus       101 vVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~d-G~VkLadFgvsa~l~~~  179 (516)
T KOG0582|consen  101 VVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSD-GTVKLADFGVSASLFDS  179 (516)
T ss_pred             EeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCC-CcEEEcCceeeeeeccc
Confidence            999999999988876     359999999999999999999999999999999999999999 89999999976544332


Q ss_pred             -Ccc----eeeccCCCccCccc-ccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHh
Q 014406          274 -KEY----NVRVASRYFKGPEL-LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLN  347 (425)
Q Consensus       274 -~~~----~~~~~t~~y~aPE~-~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~  347 (425)
                       ...    ++.+||++|||||+ ......|+.|+||||||++..||.+|..||. .......+  +.+.-+.++...   
T Consensus       180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~-k~pPmkvL--l~tLqn~pp~~~---  253 (516)
T KOG0582|consen  180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFS-KYPPMKVL--LLTLQNDPPTLL---  253 (516)
T ss_pred             CceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcc-cCChHHHH--HHHhcCCCCCcc---
Confidence             222    44589999999999 5666789999999999999999999999993 22222222  222222222110   


Q ss_pred             hccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccch
Q 014406          348 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE  419 (425)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~~  419 (425)
                                            ......+....++..+++++..||++||++||||+++|+|+||+......
T Consensus       254 ----------------------t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~~  303 (516)
T KOG0582|consen  254 ----------------------TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSKE  303 (516)
T ss_pred             ----------------------cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccchh
Confidence                                  01111222233678999999999999999999999999999999886543

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-49  Score=368.27  Aligned_cols=258  Identities=26%  Similarity=0.436  Sum_probs=206.7

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc---hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEE
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (425)
                      ..++...+.||+|+||+||++.+.++|...|||.+....   .+.+.+|+.+|.++ +|||||+++|.........++++
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l-~~p~IV~~~G~~~~~~~~~~~i~   94 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRL-NHPNIVQYYGSSSSRENDEYNIF   94 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhC-CCCCEEeeCCccccccCeeeEee
Confidence            345666788999999999999999999999999987655   45689999999999 69999999997543322368899


Q ss_pred             EEeecCCChhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccC----
Q 014406          201 FEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP----  272 (425)
Q Consensus       201 ~e~~~~~~l~~~~~----~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~----  272 (425)
                      |||+.+|+|.+++.    .+++..++.+.+||++||+|||++|||||||||+|||++...+.+||+|||+++....    
T Consensus        95 mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~  174 (313)
T KOG0198|consen   95 MEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTK  174 (313)
T ss_pred             eeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccccc
Confidence            99999999999873    5899999999999999999999999999999999999999337999999999986653    


Q ss_pred             CCcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCC
Q 014406          273 GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE  352 (425)
Q Consensus       273 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~  352 (425)
                      ........||+.|||||++.+....+.++||||+||++.||+||..||..-   .+....+.......            
T Consensus       175 ~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~---~~~~~~~~~ig~~~------------  239 (313)
T KOG0198|consen  175 SDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF---FEEAEALLLIGRED------------  239 (313)
T ss_pred             ccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh---cchHHHHHHHhccC------------
Confidence            122334689999999999986233345999999999999999999998321   11111111111000            


Q ss_pred             CChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCccccc
Q 014406          353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA  417 (425)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~  417 (425)
                                          ..+..+..+|+++++|+++||+.||++||||+++|+|||.++...
T Consensus       240 --------------------~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~  284 (313)
T KOG0198|consen  240 --------------------SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI  284 (313)
T ss_pred             --------------------CCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence                                001223348999999999999999999999999999999977543

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=4.7e-48  Score=367.57  Aligned_cols=288  Identities=30%  Similarity=0.511  Sum_probs=220.3

Q ss_pred             cCCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCc
Q 014406          121 WGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (425)
Q Consensus       121 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (425)
                      |+..++|++.+.||+|+||+||+|.+..+++.||+|++....    ...+.+|+.+++.+ +||||+++++++.+.  ..
T Consensus         1 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~--~~   77 (303)
T cd07869           1 FGKADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGL-KHANIVLLHDIIHTK--ET   77 (303)
T ss_pred             CCccccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhC-CCCCcCeEEEEEecC--Ce
Confidence            456789999999999999999999999999999999986432    34577899999999 999999999999654  67


Q ss_pred             cEEEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCC
Q 014406          197 PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (425)
Q Consensus       197 ~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~  273 (425)
                      .++||||+.++.+....   ..+++..++.++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||+++.....
T Consensus        78 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~  156 (303)
T cd07869          78 LTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDT-GELKLADFGLARAKSVP  156 (303)
T ss_pred             EEEEEECCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC-CCEEECCCCcceeccCC
Confidence            89999999765444333   348899999999999999999999999999999999999988 78999999998754322


Q ss_pred             -CcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCC
Q 014406          274 -KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE  352 (425)
Q Consensus       274 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~  352 (425)
                       .......++..|+|||++.+...++.++||||+||++|+|++|..||....+..+.+..+...++.+....+.......
T Consensus       157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (303)
T cd07869         157 SHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLP  236 (303)
T ss_pred             CccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcc
Confidence             2334457789999999987656789999999999999999999999965555556777777777665433322111100


Q ss_pred             CChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCccccc
Q 014406          353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA  417 (425)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~  417 (425)
                      ...  ...........+.   ........++++.+|+++||++||++|||++|+++||||+++..
T Consensus       237 ~~~--~~~~~~~~~~~~~---~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~~  296 (303)
T cd07869         237 HFK--PERFTLYSPKNLR---QAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLPP  296 (303)
T ss_pred             ccc--cccccccCCccHH---HHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCCh
Confidence            000  0000000000000   00111125678999999999999999999999999999998864

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-48  Score=372.43  Aligned_cols=252  Identities=31%  Similarity=0.521  Sum_probs=212.9

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc--------chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCC
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS  194 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~--------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  194 (425)
                      ...+|.+.+.||+|+||+|+.|.+..++..||+|+++..        ..+.+.+|+.+++.+..||||+++++++...  
T Consensus        15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~--   92 (370)
T KOG0583|consen   15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP--   92 (370)
T ss_pred             ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC--
Confidence            467899999999999999999999999999999987653        2346678999999994499999999999765  


Q ss_pred             CccEEEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccc-
Q 014406          195 KTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY-  270 (425)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~-  270 (425)
                      ..+++||||+.||+|.+++   ..+.+.+.+.++.|++.|++|||++||+||||||+|||+|.+.+.+||+|||++... 
T Consensus        93 ~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~  172 (370)
T KOG0583|consen   93 TKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP  172 (370)
T ss_pred             CeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccC
Confidence            5589999999999998887   468999999999999999999999999999999999999987568999999999988 


Q ss_pred             cCCCcceeeccCCCccCcccccCCCCCC-CcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhc
Q 014406          271 HPGKEYNVRVASRYFKGPELLVDLQDYD-YSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY  349 (425)
Q Consensus       271 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~-~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~  349 (425)
                      .......+.+||+.|+|||++.+...|+ .++||||+||+||.|++|+.||.. .+.......+.+    .         
T Consensus       173 ~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d-~~~~~l~~ki~~----~---------  238 (370)
T KOG0583|consen  173 GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD-SNVPNLYRKIRK----G---------  238 (370)
T ss_pred             CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC-ccHHHHHHHHhc----C---------
Confidence            4566778899999999999998844264 899999999999999999999932 111112221110    0         


Q ss_pred             cCCCChhhHHHhcccCCCCccccccccCCCCC-CHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcc
Q 014406          350 HLELDPQLDALVGRHSRKPWSKFINADNQHLV-SPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ  414 (425)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~  414 (425)
                                              ....+..+ |.++++|+++||..||.+|+|+.++++||||+.
T Consensus       239 ------------------------~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  239 ------------------------EFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK  280 (370)
T ss_pred             ------------------------CccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence                                    00112225 899999999999999999999999999999996

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-50  Score=349.03  Aligned_cols=256  Identities=27%  Similarity=0.505  Sum_probs=216.1

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecC-----cchHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCcc
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (425)
                      ..++|++.+.||+|.|+.||++.+..+|+.+|+|+++.     ...+++.+|+.|.+.| +||||+++.+.+.+.  ...
T Consensus         9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~L-qHP~IvrL~~ti~~~--~~~   85 (355)
T KOG0033|consen    9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQEE--SFH   85 (355)
T ss_pred             cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhc-CCCcEeehhhhhccc--cee
Confidence            46789999999999999999999999999999998763     3557899999999999 999999999999554  678


Q ss_pred             EEEEEeecCCChhhhc-C--CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCC--CCcEEEEeccccccccC
Q 014406          198 SLIFEYVNSTDFKVLY-P--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--LRKLRLIDWGLAEFYHP  272 (425)
Q Consensus       198 ~lv~e~~~~~~l~~~~-~--~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~--~~~~kl~Dfg~a~~~~~  272 (425)
                      ++|+|+|.|++|..-+ .  -+++..+..+++||+.+|.|+|.+||||||+||+|+|+-+.  ...+||+|||+|.....
T Consensus        86 ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~  165 (355)
T KOG0033|consen   86 YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVND  165 (355)
T ss_pred             EEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCC
Confidence            8999999999886433 2  26888889999999999999999999999999999999643  34689999999998886


Q ss_pred             CCcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCC
Q 014406          273 GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE  352 (425)
Q Consensus       273 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~  352 (425)
                      +......+||+.|||||++.. .+|+..+|||+.||+||-|+.|+.||+ +.+..+..+.|.+             ....
T Consensus       166 g~~~~G~~GtP~fmaPEvvrk-dpy~kpvDiW~cGViLfiLL~G~~PF~-~~~~~rlye~I~~-------------g~yd  230 (355)
T KOG0033|consen  166 GEAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFW-DEDQHRLYEQIKA-------------GAYD  230 (355)
T ss_pred             ccccccccCCCcccCHHHhhc-CCCCCcchhhhhhHHHHHHHhCCCCCC-CccHHHHHHHHhc-------------cccC
Confidence            677778899999999999987 789999999999999999999999984 4444555555433             1111


Q ss_pred             CChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccc
Q 014406          353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR  416 (425)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~  416 (425)
                      .+                    .....++++++++|+++||..||.+|+|+.|+|+|||+.+-.
T Consensus       231 ~~--------------------~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r~  274 (355)
T KOG0033|consen  231 YP--------------------SPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICNRE  274 (355)
T ss_pred             CC--------------------CcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcchH
Confidence            11                    111234899999999999999999999999999999998643

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.5e-48  Score=377.10  Aligned_cols=255  Identities=26%  Similarity=0.476  Sum_probs=221.3

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccE
Q 014406          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (425)
Q Consensus       125 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (425)
                      .-|++.+.||.|+-|.|-+|++..||+.+|||++.+.      ....+.+||-||+-+ .||||+++++++++  ..++|
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi-~HpnVl~LydVwe~--~~~ly   88 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLI-EHPNVLRLYDVWEN--KQHLY   88 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHh-cCCCeeeeeeeecc--CceEE
Confidence            4578888999999999999999999999999999754      245689999999999 99999999999954  58899


Q ss_pred             EEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCc
Q 014406          199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (425)
Q Consensus       199 lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~  275 (425)
                      ||+||+++|.|.+++   +.+++.+...++.||+.|+.|+|..+|+||||||+|+|||.+ +.+||+|||+|..-.++.-
T Consensus        89 lvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~-~nIKIADFGMAsLe~~gkl  167 (786)
T KOG0588|consen   89 LVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVK-NNIKIADFGMASLEVPGKL  167 (786)
T ss_pred             EEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcc-cCEeeeccceeecccCCcc
Confidence            999999999998887   569999999999999999999999999999999999999998 5699999999998887888


Q ss_pred             ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCCh
Q 014406          276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP  355 (425)
Q Consensus       276 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~  355 (425)
                      ..+.+|++.|.+||++.+...-+.++||||+||+||.||+|+.||  +++|...+..-++            ++..    
T Consensus       168 LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPF--dDdNir~LLlKV~------------~G~f----  229 (786)
T KOG0588|consen  168 LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPF--DDDNIRVLLLKVQ------------RGVF----  229 (786)
T ss_pred             ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCC--CCccHHHHHHHHH------------cCcc----
Confidence            889999999999999999544568999999999999999999999  3555554443222            1111    


Q ss_pred             hhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccchhc
Q 014406          356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAESS  421 (425)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~~~~  421 (425)
                                          +.+..++.++.+||++||.+||++|+|.+|+++|||++.-.....+
T Consensus       230 --------------------~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~~~~  275 (786)
T KOG0588|consen  230 --------------------EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSLPSS  275 (786)
T ss_pred             --------------------cCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCCChh
Confidence                                1224589999999999999999999999999999999987765544

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=2.1e-47  Score=360.44  Aligned_cols=277  Identities=29%  Similarity=0.590  Sum_probs=218.5

Q ss_pred             CCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCcc
Q 014406          122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (425)
Q Consensus       122 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (425)
                      +..++|++.+.||.|+||+||+|.+..++..||+|+++..    ....+.+|+.+++.+ +||||+++++++..  ....
T Consensus         2 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~--~~~~   78 (288)
T cd07871           2 GKLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNL-KHANIVTLHDIIHT--ERCL   78 (288)
T ss_pred             CccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhC-CCCCEeeEEEEEcC--CCeE
Confidence            4578899999999999999999999999999999998632    234677999999999 99999999999965  3678


Q ss_pred             EEEEEeecCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCC
Q 014406          198 SLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (425)
Q Consensus       198 ~lv~e~~~~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~  273 (425)
                      ++||||+.+ +|..++    ..+++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++.....
T Consensus        79 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~-~~~kl~DfG~~~~~~~~  156 (288)
T cd07871          79 TLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEK-GELKLADFGLARAKSVP  156 (288)
T ss_pred             EEEEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCC-CCEEECcCcceeeccCC
Confidence            999999986 666554    237889999999999999999999999999999999999988 78999999999764322


Q ss_pred             -CcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCC
Q 014406          274 -KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE  352 (425)
Q Consensus       274 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~  352 (425)
                       .......++..|+|||++.+...++.++||||+||++|+|++|+.|| .+.+..+.+..+.+.++.+....+..-.   
T Consensus       157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~---  232 (288)
T cd07871         157 TKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMF-PGSTVKEELHLIFRLLGTPTEETWPGIT---  232 (288)
T ss_pred             CccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCChHHhhccc---
Confidence             22334577899999999876567899999999999999999999887 5566677788888888776554432110   


Q ss_pred             CChhhHHHh-cccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCC
Q 014406          353 LDPQLDALV-GRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF  412 (425)
Q Consensus       353 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~  412 (425)
                      ....+.... ......+     .......+++++++||++||++||.+|||++|+|+||||
T Consensus       233 ~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f  288 (288)
T cd07871         233 SNEEFRSYLFPQYRAQP-----LINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF  288 (288)
T ss_pred             cchhhhccccCccCCCc-----hHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence            000110000 0000000     011123478899999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.3e-47  Score=381.76  Aligned_cols=283  Identities=31%  Similarity=0.540  Sum_probs=222.0

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcchHHHHHHHHHHHHhcCCCCeeeEEeEEEcC------CCCc
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQ------HSKT  196 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~------~~~~  196 (425)
                      ...+|++.+.||+|+||+||+|.+..+++.||||.+.... ....+|+.+++.+ +|+||+++++++...      ....
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-~~~~~Ei~il~~l-~h~niv~l~~~~~~~~~~~~~~~~~  141 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-QYKNRELLIMKNL-NHINIIFLKDYYYTECFKKNEKNIF  141 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-chHHHHHHHHHhc-CCCCCcceeeeEeecccccCCCceE
Confidence            4578999999999999999999999999999999886432 3456799999999 999999999987532      1235


Q ss_pred             cEEEEEeecCCChhhhc------CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccc
Q 014406          197 PSLIFEYVNSTDFKVLY------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  270 (425)
Q Consensus       197 ~~lv~e~~~~~~l~~~~------~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~  270 (425)
                      +++||||++++......      ..+++..++.++.||+.||.|||+.||+||||||+|||++.+.+.+||+|||+|+..
T Consensus       142 l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~  221 (440)
T PTZ00036        142 LNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNL  221 (440)
T ss_pred             EEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccchhc
Confidence            67999999975433221      358899999999999999999999999999999999999977567999999999876


Q ss_pred             cCCCcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhcc
Q 014406          271 HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH  350 (425)
Q Consensus       271 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~  350 (425)
                      ..........+|+.|+|||++.+...++.++|||||||++|+|++|..|| .+.+..+++..+.+.+|.+......... 
T Consensus       222 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf-~~~~~~~~~~~i~~~~~~p~~~~~~~~~-  299 (440)
T PTZ00036        222 LAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIF-SGQSSVDQLVRIIQVLGTPTEDQLKEMN-  299 (440)
T ss_pred             cCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHhCCCCHHHHHHhc-
Confidence            65555555678999999999877567999999999999999999999887 6677788888999988887655432110 


Q ss_pred             CCCChhhHHHh-cccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCccccc
Q 014406          351 LELDPQLDALV-GRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA  417 (425)
Q Consensus       351 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~  417 (425)
                          +.+.... .......+..    ..+...++++++||.+||++||++|||+.|+|+||||.+++.
T Consensus       300 ----~~~~~~~~~~~~~~~l~~----~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~  359 (440)
T PTZ00036        300 ----PNYADIKFPDVKPKDLKK----VFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRD  359 (440)
T ss_pred             ----hhhhcccCCccCchhHHH----HhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhc
Confidence                0000000 0000001111    112236889999999999999999999999999999988765

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-48  Score=361.63  Aligned_cols=254  Identities=29%  Similarity=0.552  Sum_probs=209.8

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc-----------------hHHHHHHHHHHHHhcCCCCeeeEE
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----------------KKKIKREIKILQNLCGGPNVVKLL  186 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----------------~~~~~~E~~~l~~l~~h~niv~l~  186 (425)
                      .++|+++..||+|.||.|-+|.+..+++.||||++.+..                 .++..+||.||+++ .|+|||+|+
T Consensus        96 lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl-~H~nVV~Li  174 (576)
T KOG0585|consen   96 LNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKL-HHPNVVKLI  174 (576)
T ss_pred             hhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhc-CCcCeeEEE
Confidence            578999999999999999999999999999999996421                 24678999999999 999999999


Q ss_pred             eEEEcCCCCccEEEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEe
Q 014406          187 DIVRDQHSKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLID  263 (425)
Q Consensus       187 ~~~~~~~~~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~D  263 (425)
                      ++..++....+|||+|||..|.+...-   ..+++.+.+.|++++..||+|||.+|||||||||+|+|++++ +++||+|
T Consensus       175 EvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~-g~VKIsD  253 (576)
T KOG0585|consen  175 EVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSD-GTVKISD  253 (576)
T ss_pred             EeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCC-CcEEeec
Confidence            999999999999999999988775443   238999999999999999999999999999999999999999 8999999


Q ss_pred             ccccccccCC------CcceeeccCCCccCcccccCC---CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHH
Q 014406          264 WGLAEFYHPG------KEYNVRVASRYFKGPELLVDL---QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA  334 (425)
Q Consensus       264 fg~a~~~~~~------~~~~~~~~t~~y~aPE~~~~~---~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~  334 (425)
                      ||.+.....+      ......+||+.|+|||.+.+.   ...+.+.||||+||+||.|+.|+.||+. ....+.+..|+
T Consensus       254 FGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~-~~~~~l~~KIv  332 (576)
T KOG0585|consen  254 FGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFD-DFELELFDKIV  332 (576)
T ss_pred             cceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCccc-chHHHHHHHHh
Confidence            9998765222      223447999999999999772   2346799999999999999999999942 22223333332


Q ss_pred             HHhCCchhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcc
Q 014406          335 KVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ  414 (425)
Q Consensus       335 ~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~  414 (425)
                      .    .++                               .......+.++++|||.+||.+||++|+|..++..|||...
T Consensus       333 n----~pL-------------------------------~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~  377 (576)
T KOG0585|consen  333 N----DPL-------------------------------EFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTR  377 (576)
T ss_pred             c----Ccc-------------------------------cCCCcccccHHHHHHHHHHhhcChhheeehhhheecceecc
Confidence            1    000                               00111136789999999999999999999999999999764


Q ss_pred             c
Q 014406          415 V  415 (425)
Q Consensus       415 ~  415 (425)
                      -
T Consensus       378 ~  378 (576)
T KOG0585|consen  378 D  378 (576)
T ss_pred             C
Confidence            3

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=7.5e-49  Score=372.36  Aligned_cols=246  Identities=28%  Similarity=0.559  Sum_probs=210.7

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcchH-----HHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEE
Q 014406          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKK-----KIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (425)
Q Consensus       125 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (425)
                      ++|.+.+.||+|+||+||||+.+.+.+.||+|.+.+..+.     .+.+|++|++.+ +||||+.++++|+.  ..++|+
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~l-kHpniv~m~esfEt--~~~~~v   78 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSL-KHPNIVEMLESFET--SAHLWV   78 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhc-CCcchhhHHHhhcc--cceEEE
Confidence            5788889999999999999999999999999999876543     488999999999 99999999999954  589999


Q ss_pred             EEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCcc
Q 014406          200 IFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY  276 (425)
Q Consensus       200 v~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~~  276 (425)
                      |.||+.| +|..++   ..++++.++.++.++..||.|||+++|+|||+||.|||++.+ +.+|+||||+|+.+..+...
T Consensus        79 Vte~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~-~~~KlcdFg~Ar~m~~~t~v  156 (808)
T KOG0597|consen   79 VTEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKG-GTLKLCDFGLARAMSTNTSV  156 (808)
T ss_pred             Eehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCC-CceeechhhhhhhcccCcee
Confidence            9999998 888777   469999999999999999999999999999999999999998 89999999999987655433


Q ss_pred             -eeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHH-HhCCchhHHHHhhccCCCC
Q 014406          277 -NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK-VLGTDELNAYLNKYHLELD  354 (425)
Q Consensus       277 -~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~-~lg~~~~~~~~~~~~~~~~  354 (425)
                       +...||+.|||||++.+ .+|+..+|+||+||++||+++|+.||+..     .+..+.+ .+..+.             
T Consensus       157 ltsikGtPlYmAPElv~e-~pyd~~sDlWslGcilYE~~~G~PPF~a~-----si~~Lv~~I~~d~v-------------  217 (808)
T KOG0597|consen  157 LTSIKGTPLYMAPELVEE-QPYDHTSDLWSLGCILYELYVGQPPFYAR-----SITQLVKSILKDPV-------------  217 (808)
T ss_pred             eeeccCcccccCHHHHcC-CCccchhhHHHHHHHHHHHhcCCCCchHH-----HHHHHHHHHhcCCC-------------
Confidence             44579999999999987 89999999999999999999999999532     1222211 111110             


Q ss_pred             hhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCccc
Q 014406          355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV  415 (425)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~  415 (425)
                                   .        .+..++..++.|+..+|++||.+|.|-.+++.|||.++.
T Consensus       218 -------------~--------~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~  257 (808)
T KOG0597|consen  218 -------------K--------PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGK  257 (808)
T ss_pred             -------------C--------CcccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhh
Confidence                         0        011378999999999999999999999999999998853

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.1e-49  Score=349.28  Aligned_cols=250  Identities=24%  Similarity=0.518  Sum_probs=204.4

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEec-----CcchHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccE
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-----PVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~-----~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (425)
                      ..+|+++++||+|+||+||++++..+|..+|.|.++     ...++....|+.+|++| +|||||++++.-...+..-++
T Consensus        18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL-~HpNIVqYy~~~f~~~~evln   96 (375)
T KOG0591|consen   18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQL-NHPNIVQYYAHSFIEDNEVLN   96 (375)
T ss_pred             HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhc-CCchHHHHHHHhhhccchhhH
Confidence            467999999999999999999999999999999875     23456788999999999 999999999933333345588


Q ss_pred             EEEEeecCCChhhhc-------CCCCHHHHHHHHHHHHHHHHHHHH--CC--ceeecCCCCceEecCCCCcEEEEecccc
Q 014406          199 LIFEYVNSTDFKVLY-------PTLTDYDIRYYIYELLKALDYCHS--QG--IMHRDVKPHNVMIDHELRKLRLIDWGLA  267 (425)
Q Consensus       199 lv~e~~~~~~l~~~~-------~~l~~~~~~~i~~~i~~~L~~LH~--~~--ivH~Dlk~~NIll~~~~~~~kl~Dfg~a  267 (425)
                      +||||+..|+|..++       +.+++..+++++.|++.||.++|+  .+  |+||||||.||+++.+ |.+||+|||++
T Consensus        97 ivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~-gvvKLGDfGL~  175 (375)
T KOG0591|consen   97 IVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTAN-GVVKLGDFGLG  175 (375)
T ss_pred             HHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCC-CceeeccchhH
Confidence            999999999999887       348999999999999999999998  45  9999999999999988 89999999999


Q ss_pred             ccccCCCcc-eeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHH
Q 014406          268 EFYHPGKEY-NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYL  346 (425)
Q Consensus       268 ~~~~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~  346 (425)
                      +........ ...+||+.||+||.+.+ .+|+.++||||+||++|||+.-..||+ +. +...+.+-++           
T Consensus       176 r~l~s~~tfA~S~VGTPyYMSPE~i~~-~~Y~~kSDiWslGCllyEMcaL~~PF~-g~-n~~~L~~KI~-----------  241 (375)
T KOG0591|consen  176 RFLSSKTTFAHSLVGTPYYMSPERIHE-SGYNFKSDIWSLGCLLYEMCALQSPFY-GD-NLLSLCKKIE-----------  241 (375)
T ss_pred             hHhcchhHHHHhhcCCCcccCHHHHhc-CCCCcchhHHHHHHHHHHHHhcCCCcc-cc-cHHHHHHHHH-----------
Confidence            988765443 45799999999999988 899999999999999999999999984 33 3333332221           


Q ss_pred             hhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCccccc
Q 014406          347 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA  417 (425)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~  417 (425)
                       ++...  +..                    ...+|.++..++..|+..||+.||+.     +|++.++..
T Consensus       242 -qgd~~--~~p--------------------~~~YS~~l~~li~~ci~vd~~~RP~t-----~~~v~di~~  284 (375)
T KOG0591|consen  242 -QGDYP--PLP--------------------DEHYSTDLRELINMCIAVDPEQRPDT-----VPYVQDIQS  284 (375)
T ss_pred             -cCCCC--CCc--------------------HHHhhhHHHHHHHHHccCCcccCCCc-----chHHHHHHH
Confidence             11110  000                    01268899999999999999999986     555555443

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.4e-48  Score=340.98  Aligned_cols=260  Identities=25%  Similarity=0.511  Sum_probs=216.5

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-------c----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcC
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-------K----KKKIKREIKILQNLCGGPNVVKLLDIVRDQ  192 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-------~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  192 (425)
                      -+.|+..+.||.|..++|.++....+|..+|+|++...       .    .+.-.+|+.||+++.+||||+.+.++|+. 
T Consensus        16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes-   94 (411)
T KOG0599|consen   16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES-   94 (411)
T ss_pred             HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC-
Confidence            45677788999999999999999999999999998521       1    24456899999999999999999999955 


Q ss_pred             CCCccEEEEEeecCCChhhhcCC---CCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEecccccc
Q 014406          193 HSKTPSLIFEYVNSTDFKVLYPT---LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (425)
Q Consensus       193 ~~~~~~lv~e~~~~~~l~~~~~~---l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~  269 (425)
                       +..+++|+|.|+.|.|.+++..   +++.+.+.|++|++.|++|||.++||||||||+|||+|++ .++||+|||+|+.
T Consensus        95 -~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn-~~i~isDFGFa~~  172 (411)
T KOG0599|consen   95 -DAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDN-MNIKISDFGFACQ  172 (411)
T ss_pred             -cchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccc-cceEEeccceeec
Confidence             4788899999999999999853   8999999999999999999999999999999999999999 7899999999999


Q ss_pred             ccCCCcceeeccCCCccCcccccC-----CCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHH
Q 014406          270 YHPGKEYNVRVASRYFKGPELLVD-----LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA  344 (425)
Q Consensus       270 ~~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~  344 (425)
                      +.++......+||++|.|||.+..     ...|+..+|+|++||+||-|+.|..||+    ...++. |.+.+..+.   
T Consensus       173 l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFw----HRkQml-MLR~ImeGk---  244 (411)
T KOG0599|consen  173 LEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFW----HRKQML-MLRMIMEGK---  244 (411)
T ss_pred             cCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchh----HHHHHH-HHHHHHhcc---
Confidence            999999999999999999999853     3468889999999999999999999994    122221 222111111   


Q ss_pred             HHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccchh
Q 014406          345 YLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAES  420 (425)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~~~  420 (425)
                          +.. -.+.                     ..++|...+|||++||+.||++|.|++|+|+||||.++...+.
T Consensus       245 ----yqF-~spe---------------------Wadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~~~~  294 (411)
T KOG0599|consen  245 ----YQF-RSPE---------------------WADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQQQA  294 (411)
T ss_pred             ----ccc-CCcc---------------------hhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHHhcc
Confidence                000 0111                     2237899999999999999999999999999999987755443

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=8.9e-47  Score=355.78  Aligned_cols=277  Identities=32%  Similarity=0.581  Sum_probs=215.2

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEE
Q 014406          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (425)
Q Consensus       125 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (425)
                      ++|++.+.||+|+||+||+|++..+++.+|+|+++..     ..+.+.+|+.+++.+ +|+||+++++++..  ....++
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~~~l   77 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTL-KQENIVELKEAFRR--RGKLYL   77 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhC-CCccccchhhhEec--CCEEEE
Confidence            4799999999999999999999999999999998643     235678999999999 99999999999965  367899


Q ss_pred             EEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCC--
Q 014406          200 IFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK--  274 (425)
Q Consensus       200 v~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~--  274 (425)
                      ||||++++++..+.   ..+++..++.++.|++.||.|||+.+|+|+||||+||+++.+ +.+||+|||++.......  
T Consensus        78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~~~  156 (287)
T cd07848          78 VFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHN-DVLKLCDFGFARNLSEGSNA  156 (287)
T ss_pred             EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCC-CcEEEeeccCcccccccccc
Confidence            99999998877654   358899999999999999999999999999999999999988 789999999998764322  


Q ss_pred             cceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCC
Q 014406          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD  354 (425)
Q Consensus       275 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~  354 (425)
                      ......++..|+|||++.+ ..++.++|||||||++|+|++|+.|| .+.+..+.+..+....+..+..........   
T Consensus       157 ~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslGvil~el~~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---  231 (287)
T cd07848         157 NYTEYVATRWYRSPELLLG-APYGKAVDMWSVGCILGELSDGQPLF-PGESEIDQLFTIQKVLGPLPAEQMKLFYSN---  231 (287)
T ss_pred             cccccccccccCCcHHHcC-CCCCCchhHHhHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHhhCCCCHHHHHhhhcc---
Confidence            2233568899999999987 67899999999999999999999887 455566666666666665443322111000   


Q ss_pred             hhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCC
Q 014406          355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF  412 (425)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~  412 (425)
                      +.....  .........-........++.++.+|+++||++||++|||++|+|+||||
T Consensus       232 ~~~~~~--~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f  287 (287)
T cd07848         232 PRFHGL--RFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF  287 (287)
T ss_pred             chhccc--ccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            000000  00000000000011122378899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=8.6e-47  Score=355.77  Aligned_cols=256  Identities=24%  Similarity=0.395  Sum_probs=209.5

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc------hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEE
Q 014406          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (425)
Q Consensus       126 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (425)
                      .|+..+.||+|+||+||+|.+..+++.||+|.+....      ...+.+|+.+++++ +|+||+++++++.+.  ...++
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~iv~~~~~~~~~--~~~~l   77 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKV-NSRFVVSLAYAYETK--DALCL   77 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhc-CCCcEEEEEEEEccC--CeEEE
Confidence            3788899999999999999999999999999986432      23567899999999 999999999999654  67899


Q ss_pred             EEEeecCCChhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCC
Q 014406          200 IFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (425)
Q Consensus       200 v~e~~~~~~l~~~~-----~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~  274 (425)
                      ||||+.+++|..++     ..+++..+..++.|++.||+|||+.+|+||||||+|||++.+ +.++|+|||++.......
T Consensus        78 v~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~-~~~kl~Dfg~~~~~~~~~  156 (285)
T cd05631          78 VLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDR-GHIRISDLGLAVQIPEGE  156 (285)
T ss_pred             EEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCC-CCEEEeeCCCcEEcCCCC
Confidence            99999999997664     248899999999999999999999999999999999999987 789999999998765444


Q ss_pred             cceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCC
Q 014406          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD  354 (425)
Q Consensus       275 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~  354 (425)
                      ......|+..|+|||++.+ ..++.++|||||||++|+|++|+.||..... ......+...+...              
T Consensus       157 ~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~~g~~pf~~~~~-~~~~~~~~~~~~~~--------------  220 (285)
T cd05631         157 TVRGRVGTVGYMAPEVINN-EKYTFSPDWWGLGCLIYEMIQGQSPFRKRKE-RVKREEVDRRVKED--------------  220 (285)
T ss_pred             eecCCCCCCCccCHhhhcC-CCCCcccCchhHHHHHHHHHhCCCCCCCCCc-chhHHHHHHHhhcc--------------
Confidence            4455678999999999987 7899999999999999999999999853322 11111111111000              


Q ss_pred             hhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcC-----HHHHhcCCCCcccccchh
Q 014406          355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT-----AREAMAHPYFAQVRAAES  420 (425)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpt-----a~elL~hp~~~~~~~~~~  420 (425)
                                         .......+++++.+|+++||+.||++|||     ++++++||||+++++...
T Consensus       221 -------------------~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~~~~  272 (285)
T cd05631         221 -------------------QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFKRL  272 (285)
T ss_pred             -------------------cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCHHHH
Confidence                               00112236889999999999999999997     899999999999977543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1.5e-46  Score=365.82  Aligned_cols=287  Identities=25%  Similarity=0.441  Sum_probs=221.3

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCC---
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS---  194 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~---  194 (425)
                      ..++|++.+.||+|+||.||+|.+..++..||+|++...     ....+.+|+.+++.+ +||||+++++++.....   
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~   97 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCV-NHKNIISLLNVFTPQKSLEE   97 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhC-CCCCEeeeeeeeccCCCccc
Confidence            468999999999999999999999999999999998632     245677899999999 99999999999864422   


Q ss_pred             -CccEEEEEeecCCChhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCC
Q 014406          195 -KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (425)
Q Consensus       195 -~~~~lv~e~~~~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~  273 (425)
                       ...++||||++++.+......+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++.....
T Consensus        98 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~-~~~kl~Dfg~a~~~~~~  176 (359)
T cd07876          98 FQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-CTLKILDFGLARTACTN  176 (359)
T ss_pred             cceeEEEEeCCCcCHHHHHhccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCC-CCEEEecCCCccccccC
Confidence             3578999999987666655678999999999999999999999999999999999999988 79999999999765444


Q ss_pred             CcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCC
Q 014406          274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL  353 (425)
Q Consensus       274 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~  353 (425)
                      .......+|..|+|||++.+ ..++.++|||||||++|+|++|+.||. +.+..+.+..+.+.++.+....... .... 
T Consensus       177 ~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf~-~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~-  252 (359)
T cd07876         177 FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGELVKGSVIFQ-GTDHIDQWNKVIEQLGTPSAEFMNR-LQPT-  252 (359)
T ss_pred             ccCCCCcccCCCCCchhccC-CCCCcchhhHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHHhcCCCcHHHHHH-HHHH-
Confidence            44445678999999999987 779999999999999999999999984 5566677777777777654322110 0000 


Q ss_pred             ChhhHHHhcccC-------CCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCccc
Q 014406          354 DPQLDALVGRHS-------RKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV  415 (425)
Q Consensus       354 ~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~  415 (425)
                      ...+........       ...|............++++++||.+||++||++|||+.|+|+||||...
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~  321 (359)
T cd07876         253 VRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVW  321 (359)
T ss_pred             HHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhh
Confidence            000000000000       00111001111223357889999999999999999999999999999753

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.6e-46  Score=360.88  Aligned_cols=285  Identities=31%  Similarity=0.575  Sum_probs=218.3

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCC---Ccc
Q 014406          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS---KTP  197 (425)
Q Consensus       126 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~---~~~  197 (425)
                      +|++.+.||+|+||.||+|.+..++..||||.+...     ....+.+|+.+++++ +||||+++++++.....   ...
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~~~   79 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREFKDI   79 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhC-CCCCEeeecceEeccCCCCCceE
Confidence            589999999999999999999999999999998632     234678999999999 99999999998864322   357


Q ss_pred             EEEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCC
Q 014406          198 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (425)
Q Consensus       198 ~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~  274 (425)
                      ++||||+++ +|..++   ..+++..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++......
T Consensus        80 ~lv~e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~-~~~kL~Dfg~~~~~~~~~  157 (338)
T cd07859          80 YVVFELMES-DLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANAD-CKLKICDFGLARVAFNDT  157 (338)
T ss_pred             EEEEecCCC-CHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCC-CcEEEccCcccccccccc
Confidence            999999964 666555   358999999999999999999999999999999999999988 789999999997543221


Q ss_pred             ----cceeeccCCCccCcccccCC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhc
Q 014406          275 ----EYNVRVASRYFKGPELLVDL-QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY  349 (425)
Q Consensus       275 ----~~~~~~~t~~y~aPE~~~~~-~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~  349 (425)
                          ......++..|+|||++.+. ..++.++|||||||++|+|++|+.|| .+.+...++..+.+.+|.+.......-.
T Consensus       158 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~i~  236 (338)
T cd07859         158 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLF-PGKNVVHQLDLITDLLGTPSPETISRVR  236 (338)
T ss_pred             CccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCC-CCCChHHHHHHHHHHhCCCCHHHHHHhh
Confidence                11335789999999998642 46889999999999999999999887 5556666777777777766544322111


Q ss_pred             cCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccchh
Q 014406          350 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAES  420 (425)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~~~  420 (425)
                      ............... ..+.     ......+++++.+|+.+||+.||++|||++|+++||||+++.....
T Consensus       237 ~~~~~~~~~~~~~~~-~~~~-----~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~~~~  301 (338)
T cd07859         237 NEKARRYLSSMRKKQ-PVPF-----SQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKVER  301 (338)
T ss_pred             hhhHHHHHHhhcccC-CCch-----HHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCcccc
Confidence            110001111110000 0000     0111236788999999999999999999999999999998877554

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-46  Score=356.28  Aligned_cols=252  Identities=24%  Similarity=0.422  Sum_probs=209.6

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccE
Q 014406          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (425)
Q Consensus       125 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (425)
                      ++|++.+.||+|+||+||+|.+..+++.||+|++...      ..+.+.+|+.+++++ +||||+++++++.+  ....+
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~--~~~~~   77 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEV-SHPFIIRLFWTEHD--QRFLY   77 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhC-CCCcHhhhHhhhcc--CCeEE
Confidence            4789999999999999999999999999999998642      234578899999999 99999999999865  46889


Q ss_pred             EEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCc
Q 014406          199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (425)
Q Consensus       199 lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~  275 (425)
                      +||||+.+++|.+++   ..+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++....  .
T Consensus        78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~-~~~kl~Dfg~~~~~~~--~  154 (291)
T cd05612          78 MLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKE-GHIKLTDFGFAKKLRD--R  154 (291)
T ss_pred             EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCC-CCEEEEecCcchhccC--C
Confidence            999999999998876   358899999999999999999999999999999999999987 7899999999986543  2


Q ss_pred             ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCCh
Q 014406          276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP  355 (425)
Q Consensus       276 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~  355 (425)
                      .....|++.|+|||++.+ ..++.++|||||||++|+|++|+.||.. .+..+....+..             ...    
T Consensus       155 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~~l~~g~~pf~~-~~~~~~~~~i~~-------------~~~----  215 (291)
T cd05612         155 TWTLCGTPEYLAPEVIQS-KGHNKAVDWWALGILIYEMLVGYPPFFD-DNPFGIYEKILA-------------GKL----  215 (291)
T ss_pred             cccccCChhhcCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHh-------------CCc----
Confidence            234578999999999977 6789999999999999999999999843 222222222211             000    


Q ss_pred             hhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcC-----HHHHhcCCCCcccccchhc
Q 014406          356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT-----AREAMAHPYFAQVRAAESS  421 (425)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpt-----a~elL~hp~~~~~~~~~~~  421 (425)
                                          .....++..+++|+++||+.||.+|++     ++|+++||||+.+.+....
T Consensus       216 --------------------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~~~~  266 (291)
T cd05612         216 --------------------EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDWDDVP  266 (291)
T ss_pred             --------------------CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCCCHHHHh
Confidence                                011235889999999999999999995     9999999999988776543

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.5e-47  Score=348.75  Aligned_cols=258  Identities=27%  Similarity=0.422  Sum_probs=219.4

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc------hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCc
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (425)
                      ..+.|++++.||.|.-|+||++....++..+|+|++.+..      ..+.+.|-+||+.+ +||.+..||..|+.  .+.
T Consensus        75 ~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~l-DHPFlPTLYa~fet--~~~  151 (459)
T KOG0610|consen   75 GLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLL-DHPFLPTLYASFET--DKY  151 (459)
T ss_pred             CHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhc-CCCccchhhheeec--cce
Confidence            4577899999999999999999999999999999997542      34567899999999 99999999999955  488


Q ss_pred             cEEEEEeecCCChhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEecccccccc
Q 014406          197 PSLIFEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (425)
Q Consensus       197 ~~lv~e~~~~~~l~~~~~-----~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~  271 (425)
                      .||+||||.||+|..+.+     .|++..++.++.+++.||+|||-.|||+|||||+|||+-++ |.+.|+||.|+....
T Consensus       152 ~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvred-GHIMLsDFDLS~~~~  230 (459)
T KOG0610|consen  152 SCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVRED-GHIMLSDFDLSLRCP  230 (459)
T ss_pred             eEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecC-CcEEeeeccccccCC
Confidence            999999999999988874     39999999999999999999999999999999999999999 899999999984321


Q ss_pred             C---------------------------------C-C-----------------------cceeeccCCCccCcccccCC
Q 014406          272 P---------------------------------G-K-----------------------EYNVRVASRYFKGPELLVDL  294 (425)
Q Consensus       272 ~---------------------------------~-~-----------------------~~~~~~~t~~y~aPE~~~~~  294 (425)
                      -                                 . .                       .....+||..|.|||++.+ 
T Consensus       231 ~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G-  309 (459)
T KOG0610|consen  231 VSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG-  309 (459)
T ss_pred             CCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec-
Confidence            0                                 0 0                       0122478889999999998 


Q ss_pred             CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCChhhHHHhcccCCCCcccccc
Q 014406          295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFIN  374 (425)
Q Consensus       295 ~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  374 (425)
                      ..-+.++|+|+|||++|||+.|.-|| .|.++.+++.++...   +.                                .
T Consensus       310 ~GHgsAVDWWtfGIflYEmLyG~TPF-KG~~~~~Tl~NIv~~---~l--------------------------------~  353 (459)
T KOG0610|consen  310 EGHGSAVDWWTFGIFLYEMLYGTTPF-KGSNNKETLRNIVGQ---PL--------------------------------K  353 (459)
T ss_pred             CCCCchhhHHHHHHHHHHHHhCCCCc-CCCCchhhHHHHhcC---CC--------------------------------c
Confidence            67899999999999999999999998 788888888876431   10                                0


Q ss_pred             ccCCCCCCHHHHHHHHHcccCCcCCCcC----HHHHhcCCCCcccccchhc
Q 014406          375 ADNQHLVSPEAIDFLDKLLRYDHQDRLT----AREAMAHPYFAQVRAAESS  421 (425)
Q Consensus       375 ~~~~~~~s~~~~~ll~~~L~~dP~~Rpt----a~elL~hp~~~~~~~~~~~  421 (425)
                      ......++..++|||+++|.+||++|..    |+|+-+||||++++|+-.+
T Consensus       354 Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWaLir  404 (459)
T KOG0610|consen  354 FPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWALIR  404 (459)
T ss_pred             CCCCCcchhHHHHHHHHHhccChhhhhccccchHHhhcCccccCCChhhee
Confidence            0011136889999999999999999998    9999999999999998544

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=4e-46  Score=358.60  Aligned_cols=259  Identities=30%  Similarity=0.574  Sum_probs=220.2

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc------hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCc
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (425)
                      ..+.|++.+.||+|.||.||+|+.+.+|+.+|+|++.+..      ...+.+|+.+|+++.+||||+.+.+.|++.  ..
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~--~~  110 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDP--DS  110 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcC--Ce
Confidence            4678999999999999999999999999999999997543      357899999999995599999999999765  57


Q ss_pred             cEEEEEeecCCChhhhcCC--CCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCC---CcEEEEecccccccc
Q 014406          197 PSLIFEYVNSTDFKVLYPT--LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEL---RKLRLIDWGLAEFYH  271 (425)
Q Consensus       197 ~~lv~e~~~~~~l~~~~~~--l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~---~~~kl~Dfg~a~~~~  271 (425)
                      +++|||++.||.|.+.+..  +++.....++.|++.++.|||+.||+||||||+|+|+....   +.+|++|||++....
T Consensus       111 ~~lvmEL~~GGeLfd~i~~~~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~  190 (382)
T KOG0032|consen  111 VYLVMELCEGGELFDRIVKKHYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIK  190 (382)
T ss_pred             EEEEEEecCCchHHHHHHHccCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEcc
Confidence            8899999999999887744  99999999999999999999999999999999999997652   379999999999988


Q ss_pred             CCCcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccC
Q 014406          272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL  351 (425)
Q Consensus       272 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~  351 (425)
                      ++......+||+.|+|||++.. ..|+..+||||+||++|.|++|..||. +.+..+....+..  |..           
T Consensus       191 ~~~~~~~~~Gtp~y~APEvl~~-~~y~~~~DiWS~Gvi~yiLL~G~~PF~-~~~~~~~~~~i~~--~~~-----------  255 (382)
T KOG0032|consen  191 PGERLHTIVGTPEYVAPEVLGG-RPYGDEVDVWSIGVILYILLSGVPPFW-GETEFEIFLAILR--GDF-----------  255 (382)
T ss_pred             CCceEeeecCCccccCchhhcC-CCCCcccchhHHHHHHHHHhhCCCCCc-CCChhHHHHHHHc--CCC-----------
Confidence            7667788999999999999976 789999999999999999999999984 3333333332221  100           


Q ss_pred             CCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccc
Q 014406          352 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA  418 (425)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~  418 (425)
                                 .         +..+....++..+++|+++||..||.+|+|+.++|+|||+++...+
T Consensus       256 -----------~---------f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~~~  302 (382)
T KOG0032|consen  256 -----------D---------FTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIGEA  302 (382)
T ss_pred             -----------C---------CCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCCccc
Confidence                       1         1122233479999999999999999999999999999999987443

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.5e-46  Score=367.05  Aligned_cols=284  Identities=24%  Similarity=0.326  Sum_probs=215.5

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcchHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEEEe
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEY  203 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~  203 (425)
                      .++|++++.||+|+||.||+|.+..+++.||+|...   ...+.+|+.+++++ +||||++++++|...  ...++|+|+
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~---~~~~~~E~~il~~l-~HpnIv~~~~~~~~~--~~~~lv~e~  164 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ---RGGTATEAHILRAI-NHPSIIQLKGTFTYN--KFTCLILPR  164 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh---hhhhHHHHHHHHhC-CCCCCCCEeEEEEEC--CeeEEEEec
Confidence            468999999999999999999999999999999754   34678999999999 999999999999653  678899999


Q ss_pred             ecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCC--Cccee
Q 014406          204 VNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG--KEYNV  278 (425)
Q Consensus       204 ~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~--~~~~~  278 (425)
                      +.+ +|..++   ..+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++.....  .....
T Consensus       165 ~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~-~~vkL~DFG~a~~~~~~~~~~~~~  242 (391)
T PHA03212        165 YKT-DLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHP-GDVCLGDFGAACFPVDINANKYYG  242 (391)
T ss_pred             CCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCC-CCEEEEeCCccccccccccccccc
Confidence            974 554443   358899999999999999999999999999999999999988 78999999999754321  22334


Q ss_pred             eccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCC------CCHHHHHHHHHHhCCchhHHHHhhccCC
Q 014406          279 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH------DNHDQLVKIAKVLGTDELNAYLNKYHLE  352 (425)
Q Consensus       279 ~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~------~~~~~~~~~~~~lg~~~~~~~~~~~~~~  352 (425)
                      ..||+.|+|||++.+ ..++.++|||||||++|||++|..||+...      +...++..+...+|..+..... .....
T Consensus       243 ~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~-~~~~~  320 (391)
T PHA03212        243 WAGTIATNAPELLAR-DPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPI-DAQAN  320 (391)
T ss_pred             ccCccCCCChhhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCc-chhHH
Confidence            578999999999977 679999999999999999999999987543      2345677777777754321100 00000


Q ss_pred             CChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccc
Q 014406          353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA  418 (425)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~  418 (425)
                      ....+..........+.. .........++.++.+||.+||++||++|||++|+|+||||+.+...
T Consensus       321 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~  385 (391)
T PHA03212        321 LDEIYIGLAKKSSRKPGS-RPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPDP  385 (391)
T ss_pred             HHHHHHHHHhccCCCCCC-CCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCCCC
Confidence            000000111111111100 00111112257789999999999999999999999999999987554

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=2e-46  Score=357.81  Aligned_cols=245  Identities=20%  Similarity=0.342  Sum_probs=198.3

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcE-EEEEEecCcc-----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCcc
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNER-CIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~-vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (425)
                      .++..+.+.||+|+||+||+|.+.  |+. ||||++....     .+.|.+|+.+|.++ +|||||+++|+|.++.. ..
T Consensus        40 ~~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l-~HpNIV~f~G~~~~~~~-~~  115 (362)
T KOG0192|consen   40 PDELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRL-RHPNIVQFYGACTSPPG-SL  115 (362)
T ss_pred             hHHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhC-CCCCeeeEEEEEcCCCC-ce
Confidence            344455566999999999999775  444 9999998543     45899999999999 99999999999976532 68


Q ss_pred             EEEEEeecCCChhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC-ceeecCCCCceEecCCCCcEEEEecccccccc
Q 014406          198 SLIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQG-IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (425)
Q Consensus       198 ~lv~e~~~~~~l~~~~-----~~l~~~~~~~i~~~i~~~L~~LH~~~-ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~  271 (425)
                      ++|||||++|+|..++     ..+++..+..++.||+.||+|||+++ |||||||++|||++.+..++||+|||+++...
T Consensus       116 ~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~  195 (362)
T KOG0192|consen  116 CIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKV  195 (362)
T ss_pred             EEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeec
Confidence            8999999999999887     35899999999999999999999999 99999999999999983399999999998766


Q ss_pred             CC-CcceeeccCCCccCcccccC-CCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhc
Q 014406          272 PG-KEYNVRVASRYFKGPELLVD-LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY  349 (425)
Q Consensus       272 ~~-~~~~~~~~t~~y~aPE~~~~-~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~  349 (425)
                      .. ...+...||..|||||++.+ ...|+.++||||||+++|||+||+.||.. ....+....+.. -+.          
T Consensus       196 ~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~-~~~~~~~~~v~~-~~~----------  263 (362)
T KOG0192|consen  196 ISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFED-LAPVQVASAVVV-GGL----------  263 (362)
T ss_pred             cccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCC-CCHHHHHHHHHh-cCC----------
Confidence            44 33344789999999999985 26899999999999999999999999933 222222222211 110          


Q ss_pred             cCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhc
Q 014406          350 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  408 (425)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~  408 (425)
                                              +...+..+++.+.+++.+||..||++||+..+++.
T Consensus       264 ------------------------Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~  298 (362)
T KOG0192|consen  264 ------------------------RPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVS  298 (362)
T ss_pred             ------------------------CCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence                                    11112226889999999999999999999988753

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=4.1e-46  Score=358.29  Aligned_cols=251  Identities=25%  Similarity=0.428  Sum_probs=209.1

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCcc
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (425)
                      .++|++.+.||+|+||+||+|.+..+++.||+|++...      ..+.+.+|+.+++++ +||||+++++++.+.  ...
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~--~~~   93 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMEL-SHPFIVNMMCSFQDE--NRV   93 (329)
T ss_pred             chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCCCcEEEEEEcC--CEE
Confidence            57899999999999999999999999999999998643      235678999999999 999999999999654  678


Q ss_pred             EEEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCC
Q 014406          198 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (425)
Q Consensus       198 ~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~  274 (425)
                      ++||||+.+++|..++   ..+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++..... 
T Consensus        94 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~-~~~kl~Dfg~~~~~~~~-  171 (329)
T PTZ00263         94 YFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNK-GHVKVTDFGFAKKVPDR-  171 (329)
T ss_pred             EEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCC-CCEEEeeccCceEcCCC-
Confidence            9999999999998776   358899999999999999999999999999999999999988 78999999999865432 


Q ss_pred             cceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCC
Q 014406          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD  354 (425)
Q Consensus       275 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~  354 (425)
                       .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.. .+..+....+..  +           ..   
T Consensus       172 -~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~-~~~~~~~~~i~~--~-----------~~---  232 (329)
T PTZ00263        172 -TFTLCGTPEYLAPEVIQS-KGHGKAVDWWTMGVLLYEFIAGYPPFFD-DTPFRIYEKILA--G-----------RL---  232 (329)
T ss_pred             -cceecCChhhcCHHHHcC-CCCCCcceeechHHHHHHHHcCCCCCCC-CCHHHHHHHHhc--C-----------Cc---
Confidence             234578999999999987 6789999999999999999999999843 222222221110  0           00   


Q ss_pred             hhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcC-----HHHHhcCCCCcccccch
Q 014406          355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT-----AREAMAHPYFAQVRAAE  419 (425)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpt-----a~elL~hp~~~~~~~~~  419 (425)
                                           ..+..++..+++|+++||+.||++|++     ++++++||||++..+..
T Consensus       233 ---------------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~~~~  281 (329)
T PTZ00263        233 ---------------------KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANWDK  281 (329)
T ss_pred             ---------------------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCCCHHH
Confidence                                 011226889999999999999999997     79999999999876543

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1.2e-45  Score=348.51  Aligned_cols=274  Identities=30%  Similarity=0.568  Sum_probs=210.8

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcC-CCcEEEEEEecCc-----chHHHHHHHHHHHHhc--CCCCeeeEEeEEEc---CC
Q 014406          125 DDYEVVRKVGRGKYSEVFEGINVN-TNERCIIKILKPV-----KKKKIKREIKILQNLC--GGPNVVKLLDIVRD---QH  193 (425)
Q Consensus       125 ~~y~~~~~LG~G~fg~V~~~~~~~-~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~--~h~niv~l~~~~~~---~~  193 (425)
                      ++|++.+.||+|+||+||+|.+.. ++..||+|.++..     ....+.+|+.+++.+.  +||||++++++|..   ..
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            478999999999999999999854 5788999998632     2245667888887763  69999999999863   23


Q ss_pred             CCccEEEEEeecCCChhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccc
Q 014406          194 SKTPSLIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE  268 (425)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~-----~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~  268 (425)
                      ...+++||||+++ +|..++     ..+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++
T Consensus        81 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~-~~~kl~Dfg~~~  158 (290)
T cd07862          81 ETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSS-GQIKLADFGLAR  158 (290)
T ss_pred             CCcEEEEEccCCC-CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCC-CCEEEccccceE
Confidence            4568999999975 666554     237889999999999999999999999999999999999988 789999999998


Q ss_pred             cccCCCcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhh
Q 014406          269 FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK  348 (425)
Q Consensus       269 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~  348 (425)
                      ............++..|+|||.+.+ ..++.++|||||||++|+|++|+.|| .+.++.+.+..+.+..+.+....+...
T Consensus       159 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~~f-~~~~~~~~~~~i~~~~~~~~~~~~~~~  236 (290)
T cd07862         159 IYSFQMALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLF-RGSSDVDQLGKILDVIGLPGEEDWPRD  236 (290)
T ss_pred             eccCCcccccccccccccChHHHhC-CCCCCccchHHHHHHHHHHHcCCCCc-CCCCHHHHHHHHHHHhCCCChhhchhh
Confidence            7654444455678999999999977 67899999999999999999998887 555667777777777665443332111


Q ss_pred             ccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCC
Q 014406          349 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF  412 (425)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~  412 (425)
                      ....  ..   ........+..     .....+++.+.+|+.+||+.||++|||+.|+|+||||
T Consensus       237 ~~~~--~~---~~~~~~~~~~~-----~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         237 VALP--RQ---AFHSKSAQPIE-----KFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             hccc--ch---hccCCCCCCHH-----HHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence            1100  00   00000000011     1112368899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.7e-47  Score=327.41  Aligned_cols=249  Identities=26%  Similarity=0.456  Sum_probs=216.5

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCc
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (425)
                      ..++|++.+.||+|.||.||.|+.++++..||+|++.+.      ...++.+|++|-.+| +||||++++++|-+.  ..
T Consensus        20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L-~hpnilrlY~~fhd~--~r   96 (281)
T KOG0580|consen   20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHL-RHPNILRLYGYFHDS--KR   96 (281)
T ss_pred             chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeeccc-CCccHHhhhhheecc--ce
Confidence            468899999999999999999999999999999998643      346789999999999 999999999999764  78


Q ss_pred             cEEEEEeecCCChhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEecccccccc
Q 014406          197 PSLIFEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (425)
Q Consensus       197 ~~lv~e~~~~~~l~~~~~-----~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~  271 (425)
                      +||++||...|.+...+.     .+++.....++.|++.||.|+|..+++||||||+|+|++.+ +.+||+|||.+...+
T Consensus        97 iyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~-~~lkiAdfGwsV~~p  175 (281)
T KOG0580|consen   97 IYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSA-GELKIADFGWSVHAP  175 (281)
T ss_pred             eEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCC-CCeeccCCCceeecC
Confidence            999999999998876663     48999999999999999999999999999999999999998 899999999986544


Q ss_pred             CCCcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccC
Q 014406          272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL  351 (425)
Q Consensus       272 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~  351 (425)
                       .....+.+||..|.+||+..+ ...+..+|+|++|++.||++.|..||.... ..+...+|.+.-              
T Consensus       176 -~~kR~tlcgt~dyl~pEmv~~-~~hd~~Vd~w~lgvl~yeflvg~ppFes~~-~~etYkrI~k~~--------------  238 (281)
T KOG0580|consen  176 -SNKRKTLCGTLDYLPPEMVEG-RGHDKFVDLWSLGVLCYEFLVGLPPFESQS-HSETYKRIRKVD--------------  238 (281)
T ss_pred             -CCCceeeecccccCCHhhcCC-CCccchhhHHHHHHHHHHHHhcCCchhhhh-hHHHHHHHHHcc--------------
Confidence             556677899999999999988 789999999999999999999999995433 555555554421              


Q ss_pred             CCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCccc
Q 014406          352 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV  415 (425)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~  415 (425)
                                             ...+..++.++.|+|.+||.++|.+|.+..|+++|||..+.
T Consensus       239 -----------------------~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a~  279 (281)
T KOG0580|consen  239 -----------------------LKFPSTISGGAADLISRLLVKNPIERLALTEVMDHPWIVAN  279 (281)
T ss_pred             -----------------------ccCCcccChhHHHHHHHHhccCccccccHHHHhhhHHHHhc
Confidence                                   11123489999999999999999999999999999997653

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=3.4e-46  Score=357.94  Aligned_cols=247  Identities=27%  Similarity=0.449  Sum_probs=203.4

Q ss_pred             eeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEEEee
Q 014406          131 RKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV  204 (425)
Q Consensus       131 ~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~  204 (425)
                      +.||+|+||+||+|.+..+++.||+|+++..      ....+.+|+.+++++ +||||+++++++...  ...++||||+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~i~~~~~~~~~~--~~~~lv~e~~   77 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNT-RHPFLTALKYSFQTH--DRLCFVMEYA   77 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-CCCCCCCEEEEEEcC--CEEEEEEeCC
Confidence            3699999999999999999999999998743      224577899999999 999999999999654  6789999999


Q ss_pred             cCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccC-CCcceeec
Q 014406          205 NSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP-GKEYNVRV  280 (425)
Q Consensus       205 ~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~-~~~~~~~~  280 (425)
                      ++++|..++   ..+++..++.++.||+.||+|||+.||+||||||+|||++.+ +.+||+|||+++.... ........
T Consensus        78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~-~~~kl~DfG~a~~~~~~~~~~~~~~  156 (323)
T cd05571          78 NGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKD-GHIKITDFGLCKEGISDGATMKTFC  156 (323)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCC-CCEEEeeCCCCcccccCCCccccee
Confidence            999998776   358999999999999999999999999999999999999988 7899999999875422 22334567


Q ss_pred             cCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCChhhHHH
Q 014406          281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDAL  360 (425)
Q Consensus       281 ~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~  360 (425)
                      ||+.|+|||++.+ ..++.++|||||||++|||++|+.||... +.......+..  +           .          
T Consensus       157 gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~-~~~~~~~~~~~--~-----------~----------  211 (323)
T cd05571         157 GTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQ-DHEKLFELILM--E-----------E----------  211 (323)
T ss_pred             cCccccChhhhcC-CCCCccccCcccchhhhhhhcCCCCCCCC-CHHHHHHHHHc--C-----------C----------
Confidence            8999999999977 77999999999999999999999999532 21111111100  0           0          


Q ss_pred             hcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCc-----CHHHHhcCCCCcccccchh
Q 014406          361 VGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYFAQVRAAES  420 (425)
Q Consensus       361 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rp-----ta~elL~hp~~~~~~~~~~  420 (425)
                                    ......+++++.+||++||+.||++||     ++.++++||||+++.+...
T Consensus       212 --------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~~~~~~  262 (323)
T cd05571         212 --------------IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINWQDV  262 (323)
T ss_pred             --------------CCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCCCHHHH
Confidence                          001123689999999999999999999     8999999999998766543

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=1.1e-45  Score=360.15  Aligned_cols=256  Identities=26%  Similarity=0.423  Sum_probs=206.3

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccE
Q 014406          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (425)
Q Consensus       125 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (425)
                      ++|++.+.||+|+||+||+|.+..+++.||+|++...      ....+.+|+.++..+ +|+||+++++.+.+.  ..++
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~-~~~~iv~~~~~~~~~--~~~~   77 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEA-DSLWVVKMFYSFQDK--LNLY   77 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhC-CCCCcceEEEEEecC--CeEE
Confidence            5799999999999999999999999999999999742      234577899999999 999999999999654  6789


Q ss_pred             EEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCC-
Q 014406          199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-  274 (425)
Q Consensus       199 lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~-  274 (425)
                      +||||+++++|..++   ..+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++...... 
T Consensus        78 lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~-~~vkL~DFGla~~~~~~~~  156 (363)
T cd05628          78 LIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSK-GHVKLSDFGLCTGLKKAHR  156 (363)
T ss_pred             EEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCC-CCEEEeeccCccccccccc
Confidence            999999999998876   358999999999999999999999999999999999999988 799999999987543211 


Q ss_pred             -----------------------------------cceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCC
Q 014406          275 -----------------------------------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEP  319 (425)
Q Consensus       275 -----------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~p  319 (425)
                                                         .....+||+.|+|||++.+ ..++.++|||||||++|||++|+.|
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~~P  235 (363)
T cd05628         157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEMLIGYPP  235 (363)
T ss_pred             ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcC-CCCCCchhhhhhHHHHHHHHhCCCC
Confidence                                               0123478999999999987 6799999999999999999999999


Q ss_pred             CCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcC-
Q 014406          320 FFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQ-  398 (425)
Q Consensus       320 f~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~-  398 (425)
                      |. +.+..+....+......           .                      .......+++++++|+.+|+. +|+ 
T Consensus       236 f~-~~~~~~~~~~i~~~~~~-----------~----------------------~~p~~~~~s~~~~~li~~l~~-~~~~  280 (363)
T cd05628         236 FC-SETPQETYKKVMNWKET-----------L----------------------IFPPEVPISEKAKDLILRFCC-EWEH  280 (363)
T ss_pred             CC-CCCHHHHHHHHHcCcCc-----------c----------------------cCCCcCCCCHHHHHHHHHHcC-Chhh
Confidence            84 33333333332211000           0                      000011268899999999775 454 


Q ss_pred             --CCcCHHHHhcCCCCcccccchh
Q 014406          399 --DRLTAREAMAHPYFAQVRAAES  420 (425)
Q Consensus       399 --~Rpta~elL~hp~~~~~~~~~~  420 (425)
                        .||+++|+++||||+++.+...
T Consensus       281 r~~r~~~~ei~~hp~f~~~~~~~~  304 (363)
T cd05628         281 RIGAPGVEEIKTNPFFEGVDWEHI  304 (363)
T ss_pred             cCCCCCHHHHhCCCCCCCCCHHHH
Confidence              4589999999999999877654

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=2.2e-45  Score=351.47  Aligned_cols=279  Identities=25%  Similarity=0.511  Sum_probs=207.9

Q ss_pred             eeeeeeCceEEEEEEEc--CCCcEEEEEEecCcc-hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEEEeecCC
Q 014406          131 RKVGRGKYSEVFEGINV--NTNERCIIKILKPVK-KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST  207 (425)
Q Consensus       131 ~~LG~G~fg~V~~~~~~--~~~~~vavK~~~~~~-~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~  207 (425)
                      ++||+|+||+||+|.+.  .+++.+|+|.+.... ...+.+|+.+++++ +||||+++++++........+++|||+++.
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~lv~e~~~~~   85 (317)
T cd07868           7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLREL-KHPNVISLQKVFLSHADRKVWLLFDYAEHD   85 (317)
T ss_pred             cccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhc-CCCCCcceeeeEecCCCcEEEEEEeccCCC
Confidence            57999999999999865  467899999987543 45678999999999 999999999999876667889999998764


Q ss_pred             Chhhhc------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEec---CCCCcEEEEeccccccccC
Q 014406          208 DFKVLY------------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMID---HELRKLRLIDWGLAEFYHP  272 (425)
Q Consensus       208 ~l~~~~------------~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~---~~~~~~kl~Dfg~a~~~~~  272 (425)
                       +..++            ..+++..++.++.||+.||.|||++||+||||||+|||++   ...+.+||+|||+++....
T Consensus        86 -l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~  164 (317)
T cd07868          86 -LWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS  164 (317)
T ss_pred             -HHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCC
Confidence             43332            1488899999999999999999999999999999999994   2336899999999986543


Q ss_pred             CC----cceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCC--------CHHHHHHHHHHhCCc
Q 014406          273 GK----EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD--------NHDQLVKIAKVLGTD  340 (425)
Q Consensus       273 ~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~--------~~~~~~~~~~~lg~~  340 (425)
                      ..    ......+|+.|+|||++.+...++.++||||+||++|+|++|+.||.....        ..+++..+...+|.+
T Consensus       165 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (317)
T cd07868         165 PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFP  244 (317)
T ss_pred             CCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhcCCC
Confidence            21    223457889999999998756789999999999999999999999854332        245677777888766


Q ss_pred             hhHHHHhhccCCCChhh-HHHhccc-CCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCC
Q 014406          341 ELNAYLNKYHLELDPQL-DALVGRH-SRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF  412 (425)
Q Consensus       341 ~~~~~~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~  412 (425)
                      ....+............ ....... ........+ .......+.++.+||++||++||++|||++|+|+||||
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07868         245 ADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYM-EKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF  317 (317)
T ss_pred             ChHHhHHHhhccchhhhhhhhhccccCcccccchH-HhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            55444322221111111 1100000 000000111 11112246779999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.2e-46  Score=357.28  Aligned_cols=259  Identities=31%  Similarity=0.507  Sum_probs=211.5

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccE
Q 014406          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (425)
Q Consensus       125 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (425)
                      ++|++.+.||+|+||.||+|.+..+++.||+|+++..      ....+.+|+.++..+ +||||+++++++.+  ....+
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~iv~~~~~~~~--~~~~~   77 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTT-KSEWLVKLLYAFQD--DEYLY   77 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhC-CCCCCccEEEEEEc--CCEEE
Confidence            4699999999999999999999999999999999743      234678899999999 89999999999965  46789


Q ss_pred             EEEEeecCCChhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCc
Q 014406          199 LIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (425)
Q Consensus       199 lv~e~~~~~~l~~~~~---~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~  275 (425)
                      +||||+++++|..++.   .+++..++.++.|++.||.|||+.||+||||||+|||++.+ +.+||+|||++.....  .
T Consensus        78 lv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~-~~~kL~Dfg~a~~~~~--~  154 (333)
T cd05600          78 LAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDAS-GHIKLTDFGLSKGIVT--Y  154 (333)
T ss_pred             EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCC-CCEEEEeCcCCccccc--c
Confidence            9999999999998873   48899999999999999999999999999999999999988 7899999999976543  3


Q ss_pred             ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCCh
Q 014406          276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP  355 (425)
Q Consensus       276 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~  355 (425)
                      .....||+.|+|||++.+ ..++.++|||||||++|||++|..||. +.+..+....+......           ..   
T Consensus       155 ~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~-~~~~~~~~~~i~~~~~~-----------~~---  218 (333)
T cd05600         155 ANSVVGSPDYMAPEVLRG-KGYDFTVDYWSLGCMLYEFLCGFPPFS-GSTPNETWENLKYWKET-----------LQ---  218 (333)
T ss_pred             cCCcccCccccChhHhcC-CCCCCccceecchHHHhhhhhCCCCCC-CCCHHHHHHHHHhcccc-----------cc---
Confidence            344578999999999987 689999999999999999999999983 33333333322211000           00   


Q ss_pred             hhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccchh
Q 014406          356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAES  420 (425)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~~~  420 (425)
                                ...     .......+++++.+|+.+||+.+|++|||++++++||||+++.+...
T Consensus       219 ----------~~~-----~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~~~~~~  268 (333)
T cd05600         219 ----------RPV-----YDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEVDWNEL  268 (333)
T ss_pred             ----------CCC-----CCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCCCHHHH
Confidence                      000     00001236899999999999999999999999999999998866543

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.8e-46  Score=363.95  Aligned_cols=256  Identities=27%  Similarity=0.459  Sum_probs=205.4

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccE
Q 014406          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (425)
Q Consensus       125 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (425)
                      ++|++++.||+|+||+||++.+..+++.||||++...      ..+.+.+|+++++++ +||||++++++|.+.  .+.|
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~~~~~~~~~--~~~~   77 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAES-DSPWVVSLYYSFQDA--QYLY   77 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhC-CCCCcceEEEEEEcC--CeeE
Confidence            4789999999999999999999999999999998642      235678899999999 999999999999654  6789


Q ss_pred             EEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCc
Q 014406          199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (425)
Q Consensus       199 lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~  275 (425)
                      +||||+++++|..++   ..+++..++.++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||+++.......
T Consensus        78 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~-~~~kl~DfGla~~~~~~~~  156 (377)
T cd05629          78 LIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRG-GHIKLSDFGLSTGFHKQHD  156 (377)
T ss_pred             EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCC-CCEEEeecccccccccccc
Confidence            999999999998876   458899999999999999999999999999999999999988 7999999999863221000


Q ss_pred             ------------------------------------------------ceeeccCCCccCcccccCCCCCCCcccHHHHH
Q 014406          276 ------------------------------------------------YNVRVASRYFKGPELLVDLQDYDYSLDMWSLG  307 (425)
Q Consensus       276 ------------------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG  307 (425)
                                                                      ....+||+.|+|||++.+ ..++.++||||||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG  235 (377)
T cd05629         157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ-QGYGQECDWWSLG  235 (377)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHcc-CCCCCceeeEecc
Confidence                                                            012468999999999977 6799999999999


Q ss_pred             HHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHH
Q 014406          308 CMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAID  387 (425)
Q Consensus       308 ~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  387 (425)
                      |++|||++|..||.. .+..+.+..+.....                                 .........++.++.+
T Consensus       236 vil~elltG~~Pf~~-~~~~~~~~~i~~~~~---------------------------------~~~~p~~~~~s~~~~d  281 (377)
T cd05629         236 AIMFECLIGWPPFCS-ENSHETYRKIINWRE---------------------------------TLYFPDDIHLSVEAED  281 (377)
T ss_pred             hhhhhhhcCCCCCCC-CCHHHHHHHHHccCC---------------------------------ccCCCCCCCCCHHHHH
Confidence            999999999999842 233333332221000                                 0000111236889999


Q ss_pred             HHHHcccCCcCCC---cCHHHHhcCCCCcccccchh
Q 014406          388 FLDKLLRYDHQDR---LTAREAMAHPYFAQVRAAES  420 (425)
Q Consensus       388 ll~~~L~~dP~~R---pta~elL~hp~~~~~~~~~~  420 (425)
                      ||++||+ +|.+|   +|+.|+++||||+++.+...
T Consensus       282 li~~lL~-~~~~r~~r~~~~~~l~hp~~~~~~~~~~  316 (377)
T cd05629         282 LIRRLIT-NAENRLGRGGAHEIKSHPFFRGVDWDTI  316 (377)
T ss_pred             HHHHHhc-CHhhcCCCCCHHHHhcCCCcCCCCHHHH
Confidence            9999998 77765   59999999999998876544

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=1.1e-45  Score=360.25  Aligned_cols=289  Identities=25%  Similarity=0.457  Sum_probs=221.1

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCC----
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH----  193 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~----  193 (425)
                      ..++|++.+.||+|+||.||+|.+..+++.||||++...     ....+.+|+.+++.+ +||||+++++++....    
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~ii~~~~~~~~~~~~~~  100 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIIGLLNVFTPQKSLEE  100 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhc-CCCCccccceeecccccccc
Confidence            468899999999999999999999999999999998642     235677899999999 9999999999886432    


Q ss_pred             CCccEEEEEeecCCChhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCC
Q 014406          194 SKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (425)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~  273 (425)
                      ....++||||++++........+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++.....
T Consensus       101 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-~~~kL~DfG~a~~~~~~  179 (364)
T cd07875         101 FQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-CTLKILDFGLARTAGTS  179 (364)
T ss_pred             cCeEEEEEeCCCCCHHHHHHhcCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCC-CcEEEEeCCCccccCCC
Confidence            24579999999886655555678999999999999999999999999999999999999988 78999999999876544


Q ss_pred             CcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCC
Q 014406          274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL  353 (425)
Q Consensus       274 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~  353 (425)
                      .......+|..|+|||++.+ ..++.++|||||||++|+|++|+.|| .+.+..+.+..+.+.++.+..... .......
T Consensus       180 ~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~  256 (364)
T cd07875         180 FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLF-PGTDHIDQWNKVIEQLGTPCPEFM-KKLQPTV  256 (364)
T ss_pred             CcccCCcccCCcCCHHHHhC-CCCCchhhHHhHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHhcCCCCHHHH-HhhhHHH
Confidence            44455678999999999987 77999999999999999999999998 556666777777777776543211 1100000


Q ss_pred             ChhhHHHhcccCCCCcccc-------ccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCccccc
Q 014406          354 DPQLDALVGRHSRKPWSKF-------INADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA  417 (425)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~  417 (425)
                      ...... ........+...       .........+.++++||.+||+.||++|||+.|+|+||||+....
T Consensus       257 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~~  326 (364)
T cd07875         257 RTYVEN-RPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYD  326 (364)
T ss_pred             HHHHhh-CCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccccC
Confidence            000000 000000000000       011112224678999999999999999999999999999986443

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=2.5e-45  Score=349.80  Aligned_cols=283  Identities=29%  Similarity=0.598  Sum_probs=220.9

Q ss_pred             cCCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCc
Q 014406          121 WGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (425)
Q Consensus       121 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (425)
                      |+..++|++.++||+|+||+||+|.+..+++.+|+|.++..    ....+.+|+.+++++ +|+||+++++++...  ..
T Consensus         2 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~--~~   78 (309)
T cd07872           2 FGKMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDL-KHANIVTLHDIVHTD--KS   78 (309)
T ss_pred             CCCCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhC-CCCCcceEEEEEeeC--Ce
Confidence            45678899999999999999999999999999999998643    234577899999999 999999999999654  67


Q ss_pred             cEEEEEeecCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccC
Q 014406          197 PSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (425)
Q Consensus       197 ~~lv~e~~~~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~  272 (425)
                      .++||||+++ ++..++    ..+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++....
T Consensus        79 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~  156 (309)
T cd07872          79 LTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINER-GELKLADFGLARAKSV  156 (309)
T ss_pred             EEEEEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC-CCEEECccccceecCC
Confidence            8999999987 454443    237889999999999999999999999999999999999988 7899999999875432


Q ss_pred             C-CcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccC
Q 014406          273 G-KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL  351 (425)
Q Consensus       273 ~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~  351 (425)
                      . .......++..|+|||.+.+...++.++|||||||++|+|++|+.|| .+.+..+.+..+.+.++.+....+..-...
T Consensus       157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (309)
T cd07872         157 PTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLF-PGSTVEDELHLIFRLLGTPTEETWPGISSN  235 (309)
T ss_pred             CccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHhCCCCHHHHhhhcch
Confidence            2 22234567889999999876567899999999999999999999887 455666777778888877655443211000


Q ss_pred             CCChhhHHH-hcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCccccc
Q 014406          352 ELDPQLDAL-VGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA  417 (425)
Q Consensus       352 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~  417 (425)
                         ...... ........+     ......+++++++||++||+.||.+|||++|+++||||+.+..
T Consensus       236 ---~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~  294 (309)
T cd07872         236 ---DEFKNYNFPKYKPQPL-----INHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLGT  294 (309)
T ss_pred             ---hhhhhhhcCccCCCch-----hhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhccc
Confidence               000000 000000000     0111247889999999999999999999999999999998653

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7e-46  Score=361.76  Aligned_cols=256  Identities=29%  Similarity=0.490  Sum_probs=207.4

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccE
Q 014406          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (425)
Q Consensus       125 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (425)
                      ++|++.+.||+|+||+||+|.+..+++.||||++...      ....+.+|+.++..+ +|+||++++++|.+  ....+
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~~~~~~~~--~~~~~   77 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEA-DNPWVVKLYYSFQD--ENYLY   77 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCcceEEEEEc--CCeEE
Confidence            4799999999999999999999999999999999742      224577899999999 89999999999965  47889


Q ss_pred             EEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCc
Q 014406          199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (425)
Q Consensus       199 lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~  275 (425)
                      +||||+.+++|..++   ..+++..++.++.|++.||+|||+.||+||||||+|||++.+ +.++|+|||+++.......
T Consensus        78 lv~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~-~~~kl~Dfg~~~~~~~~~~  156 (364)
T cd05599          78 LIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAK-GHIKLSDFGLCTGLKKSHR  156 (364)
T ss_pred             EEECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCC-CCEEEeecccceecccccc
Confidence            999999999998876   348999999999999999999999999999999999999988 7899999999865432110


Q ss_pred             ---------------------------------------ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhC
Q 014406          276 ---------------------------------------YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFR  316 (425)
Q Consensus       276 ---------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg  316 (425)
                                                             ....+||+.|+|||++.+ ..++.++|||||||++|+|++|
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~G  235 (364)
T cd05599         157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ-TGYNKECDWWSLGVIMYEMLVG  235 (364)
T ss_pred             ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcC-CCCCCeeeeecchhHHHHhhcC
Confidence                                                   012368999999999977 7799999999999999999999


Q ss_pred             CCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCC
Q 014406          317 KEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYD  396 (425)
Q Consensus       317 ~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~d  396 (425)
                      ..||.. .+..+....+...                                 ...........+++++++||++||. +
T Consensus       236 ~~Pf~~-~~~~~~~~~i~~~---------------------------------~~~~~~~~~~~~s~~~~~li~~ll~-~  280 (364)
T cd05599         236 YPPFCS-DNPQETYRKIINW---------------------------------KETLQFPDEVPLSPEAKDLIKRLCC-E  280 (364)
T ss_pred             CCCCCC-CCHHHHHHHHHcC---------------------------------CCccCCCCCCCCCHHHHHHHHHHcc-C
Confidence            999842 2222222222110                                 0000000111368999999999997 9


Q ss_pred             cCCCcC---HHHHhcCCCCcccccchh
Q 014406          397 HQDRLT---AREAMAHPYFAQVRAAES  420 (425)
Q Consensus       397 P~~Rpt---a~elL~hp~~~~~~~~~~  420 (425)
                      |.+|++   ++|+++||||+++.+...
T Consensus       281 p~~R~~~~~~~~ll~h~~~~~~~~~~~  307 (364)
T cd05599         281 AERRLGNNGVNEIKSHPFFKGVDWEHI  307 (364)
T ss_pred             HhhcCCCCCHHHHhcCCCcCCCCHHHH
Confidence            999998   999999999999876543

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1.1e-45  Score=359.01  Aligned_cols=285  Identities=26%  Similarity=0.477  Sum_probs=219.9

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCC----
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH----  193 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~----  193 (425)
                      ..++|++.+.||+|+||.||+|.+..+++.+|+|.+...     ....+.+|+.+++.+ +|+||+++++++....    
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~   93 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIISLLNVFTPQKSLEE   93 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHh-CCCchhceeeeeeccccccc
Confidence            468999999999999999999999999999999998642     235677899999999 9999999999986432    


Q ss_pred             CCccEEEEEeecCCChhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCC
Q 014406          194 SKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (425)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~  273 (425)
                      ....++||||++++........+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++.....
T Consensus        94 ~~~~~lv~e~~~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~-~~~kl~Dfg~~~~~~~~  172 (355)
T cd07874          94 FQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-CTLKILDFGLARTAGTS  172 (355)
T ss_pred             cceeEEEhhhhcccHHHHHhhcCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCC-CCEEEeeCcccccCCCc
Confidence            23578999999887666555678999999999999999999999999999999999999988 78999999999876544


Q ss_pred             CcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCC
Q 014406          274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL  353 (425)
Q Consensus       274 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~  353 (425)
                      .......+|..|+|||++.+ ..++.++|||||||++|+|++|+.|| .+.+..+.+..+.+.++.+...... ..    
T Consensus       173 ~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~-~~----  245 (355)
T cd07874         173 FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILF-PGRDYIDQWNKVIEQLGTPCPEFMK-KL----  245 (355)
T ss_pred             cccCCccccCCccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCCHHHHH-hh----
Confidence            44455678999999999987 67999999999999999999999998 4555566677777766654332211 00    


Q ss_pred             ChhhHHHhcc---cCCCCc-----ccc--ccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccc
Q 014406          354 DPQLDALVGR---HSRKPW-----SKF--INADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR  416 (425)
Q Consensus       354 ~~~~~~~~~~---~~~~~~-----~~~--~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~  416 (425)
                      .+........   ......     ...  .........+.++++||.+||+.||++|||+.|+|+||||+...
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~  318 (355)
T cd07874         246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWY  318 (355)
T ss_pred             cHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhccc
Confidence            0000000000   000000     000  01112223567899999999999999999999999999998553

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1.3e-45  Score=356.00  Aligned_cols=252  Identities=21%  Similarity=0.388  Sum_probs=208.7

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCC-cEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCC
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTN-ERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~-~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (425)
                      ..++|++.+.||+|+||.||+|.+..++ ..||+|.+...      ..+.+.+|+.+++.+ +||||+++++++.+.  .
T Consensus        28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~~~~~~~~~--~  104 (340)
T PTZ00426         28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYI-NHPFCVNLYGSFKDE--S  104 (340)
T ss_pred             ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-CCCCCcceEEEEEeC--C
Confidence            4678999999999999999999876654 68999998532      235678899999999 999999999999654  6


Q ss_pred             ccEEEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccC
Q 014406          196 TPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (425)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~  272 (425)
                      ..++||||+.+++|..++   ..+++..+..++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||+++....
T Consensus       105 ~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~-~~ikL~DFG~a~~~~~  183 (340)
T PTZ00426        105 YLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKD-GFIKMTDFGFAKVVDT  183 (340)
T ss_pred             EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCC-CCEEEecCCCCeecCC
Confidence            789999999999998877   358899999999999999999999999999999999999988 7999999999986543


Q ss_pred             CCcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCC
Q 014406          273 GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE  352 (425)
Q Consensus       273 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~  352 (425)
                        ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.. .+.......+...             .  
T Consensus       184 --~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~G~~Pf~~-~~~~~~~~~i~~~-------------~--  244 (340)
T PTZ00426        184 --RTYTLCGTPEYIAPEILLN-VGHGKAADWWTLGIFIYEILVGCPPFYA-NEPLLIYQKILEG-------------I--  244 (340)
T ss_pred             --CcceecCChhhcCHHHHhC-CCCCccccccchhhHHHHHhcCCCCCCC-CCHHHHHHHHhcC-------------C--
Confidence              2334578999999999987 6789999999999999999999999953 2222222222110             0  


Q ss_pred             CChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCc-----CHHHHhcCCCCcccccch
Q 014406          353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYFAQVRAAE  419 (425)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rp-----ta~elL~hp~~~~~~~~~  419 (425)
                                            ...+..+++.+.+++++||+.||++|+     |++++++||||+++.+..
T Consensus       245 ----------------------~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~~  294 (340)
T PTZ00426        245 ----------------------IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWVS  294 (340)
T ss_pred             ----------------------CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCHHH
Confidence                                  001123688999999999999999995     899999999999987654

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=4.2e-45  Score=367.37  Aligned_cols=289  Identities=23%  Similarity=0.408  Sum_probs=211.8

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc--chHHHHHHHHHHHHhc-----CCCCeeeEEeEEEcCCCC
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLC-----GGPNVVKLLDIVRDQHSK  195 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~-----~h~niv~l~~~~~~~~~~  195 (425)
                      ..++|++.++||+|+||+||+|.+..+++.||||+++..  .......|+.+++.+.     +|.++++++++|... ..
T Consensus       127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~-~~  205 (467)
T PTZ00284        127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE-TG  205 (467)
T ss_pred             CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC-Cc
Confidence            357899999999999999999999999999999999643  2345677888888772     244689999998754 35


Q ss_pred             ccEEEEEeecCCChhhhc--CCCCHHHHHHHHHHHHHHHHHHHH-CCceeecCCCCceEecCCCC---------------
Q 014406          196 TPSLIFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHELR---------------  257 (425)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~LH~-~~ivH~Dlk~~NIll~~~~~---------------  257 (425)
                      +.|+|||++.+..+..+.  ..+++..+..++.||+.||+|||+ .|||||||||+|||++.+..               
T Consensus       206 ~~~iv~~~~g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~  285 (467)
T PTZ00284        206 HMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPC  285 (467)
T ss_pred             eEEEEEeccCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCCc
Confidence            789999998554443332  358999999999999999999998 59999999999999986521               


Q ss_pred             cEEEEeccccccccCCCcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh
Q 014406          258 KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL  337 (425)
Q Consensus       258 ~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~l  337 (425)
                      .+||+|||.+....  ......+||..|+|||++.+ ..|+.++|||||||++|||++|+.|| .+.++.+++..+.+.+
T Consensus       286 ~vkl~DfG~~~~~~--~~~~~~~gt~~Y~APE~~~~-~~~~~~~DiwSlGvil~elltG~~pf-~~~~~~~~~~~i~~~~  361 (467)
T PTZ00284        286 RVRICDLGGCCDER--HSRTAIVSTRHYRSPEVVLG-LGWMYSTDMWSMGCIIYELYTGKLLY-DTHDNLEHLHLMEKTL  361 (467)
T ss_pred             eEEECCCCccccCc--cccccccCCccccCcHHhhc-CCCCcHHHHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHc
Confidence            48999999886432  23345688999999999987 78999999999999999999999887 5667778888888888


Q ss_pred             CCchhHHHHhhccCCCChhhHHHhccc----CCCCccccccc--cCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCC
Q 014406          338 GTDELNAYLNKYHLELDPQLDALVGRH----SRKPWSKFINA--DNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY  411 (425)
Q Consensus       338 g~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~--~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~  411 (425)
                      |..+.. +...+.......+.......    ....+......  ......++.+.|||++||++||++|||++|+|+|||
T Consensus       362 g~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~  440 (467)
T PTZ00284        362 GRLPSE-WAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPY  440 (467)
T ss_pred             CCCCHH-HHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCcc
Confidence            865432 21111110000000000000    00000000000  000012467889999999999999999999999999


Q ss_pred             Cccccc
Q 014406          412 FAQVRA  417 (425)
Q Consensus       412 ~~~~~~  417 (425)
                      |.+...
T Consensus       441 ~~~~~~  446 (467)
T PTZ00284        441 VLKYYP  446 (467)
T ss_pred             ccccCC
Confidence            998654

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=2.2e-45  Score=359.29  Aligned_cols=282  Identities=28%  Similarity=0.533  Sum_probs=219.3

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCC---Ccc
Q 014406          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS---KTP  197 (425)
Q Consensus       126 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~---~~~  197 (425)
                      +|++.+.||+|+||+||+|.+..+++.||+|.+...     ..+.+.+|+.+++.+ +|+||+++++++.....   ...
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~   79 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFF-KHDNVLSALDILQPPHIDPFEEI   79 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhC-CCCCcCCHhheecCCCccccceE
Confidence            477889999999999999999999999999998642     235678999999999 99999999999975431   268


Q ss_pred             EEEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCC
Q 014406          198 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (425)
Q Consensus       198 ~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~  274 (425)
                      ++|+||+.++ |...+   ..+++..++.++.||+.||.|||+.||+||||||+|||++.+ +.+||+|||+++......
T Consensus        80 ~lv~e~~~~~-l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~-~~~kL~Dfg~a~~~~~~~  157 (372)
T cd07853          80 YVVTELMQSD-LHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSN-CVLKICDFGLARVEEPDE  157 (372)
T ss_pred             EEEeeccccC-HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCC-CCEEeccccceeecccCc
Confidence            8999999864 44443   358999999999999999999999999999999999999988 799999999997654322


Q ss_pred             --cceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCC
Q 014406          275 --EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE  352 (425)
Q Consensus       275 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~  352 (425)
                        ......++..|+|||++.+...++.++||||+||++|||++|+.|| .+.+..+++..+.+.+|.+..........  
T Consensus       158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf-~~~~~~~~~~~i~~~~g~~~~~~~~~~~~--  234 (372)
T cd07853         158 SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILF-QAQSPIQQLDLITDLLGTPSLEAMRSACE--  234 (372)
T ss_pred             cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCC-CCCCHHHHHHHHHHHcCCCCHHHHHHhhH--
Confidence              2233467889999999987566899999999999999999999987 56667788888999999877654322110  


Q ss_pred             CChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccc
Q 014406          353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR  416 (425)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~  416 (425)
                        .............+... .........++++.+||.+||++||++|||+.|+|+||||++.+
T Consensus       235 --~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~  295 (372)
T cd07853         235 --GARAHILRGPHKPPSLP-VLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGR  295 (372)
T ss_pred             --HHHHHHHhCCCCCCchH-HhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCc
Confidence              00011111111110000 00111223588999999999999999999999999999999854

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=2.4e-45  Score=359.99  Aligned_cols=255  Identities=27%  Similarity=0.459  Sum_probs=203.8

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEE
Q 014406          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (425)
Q Consensus       126 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (425)
                      .|++++.||+|+||+||+|.+..+++.+|+|++...      ....+.+|+.+++.+ +|+||+++++++.+.  ..+++
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~~--~~~~l   78 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEA-DNEWVVKLYYSFQDK--DNLYF   78 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhc-CCCCeeeeEEEEecC--CEEEE
Confidence            688999999999999999999999999999998642      234578899999999 999999999999654  67899


Q ss_pred             EEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCC--
Q 014406          200 IFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK--  274 (425)
Q Consensus       200 v~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~--  274 (425)
                      ||||+++++|..++   ..+++..++.++.||+.||+|||+.||+||||||+|||++.+ +.+||+|||+++......  
T Consensus        79 v~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~-~~~kL~DFGl~~~~~~~~~~  157 (381)
T cd05626          79 VMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLD-GHIKLTDFGLCTGFRWTHNS  157 (381)
T ss_pred             EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCC-CCEEEeeCcCCccccccccc
Confidence            99999999998876   458899999999999999999999999999999999999988 799999999975321000  


Q ss_pred             ----------------------------------------------cceeeccCCCccCcccccCCCCCCCcccHHHHHH
Q 014406          275 ----------------------------------------------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGC  308 (425)
Q Consensus       275 ----------------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~  308 (425)
                                                                    .....+||..|+|||++.+ ..++.++|||||||
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlG~  236 (381)
T cd05626         158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR-KGYTQLCDWWSVGV  236 (381)
T ss_pred             ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcC-CCCCCccceeehhh
Confidence                                                          0112468999999999987 67999999999999


Q ss_pred             HHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHH
Q 014406          309 MFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDF  388 (425)
Q Consensus       309 ~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  388 (425)
                      ++|||++|..||.... ..+....+.....                                 .........+++++++|
T Consensus       237 il~elltG~~Pf~~~~-~~~~~~~i~~~~~---------------------------------~~~~~~~~~~s~~~~dl  282 (381)
T cd05626         237 ILFEMLVGQPPFLAPT-PTETQLKVINWEN---------------------------------TLHIPPQVKLSPEAVDL  282 (381)
T ss_pred             HHHHHHhCCCCCcCCC-HHHHHHHHHcccc---------------------------------ccCCCCCCCCCHHHHHH
Confidence            9999999999995432 2222222211000                                 00011112378999999


Q ss_pred             HHHcccC--CcCCCcCHHHHhcCCCCcccccch
Q 014406          389 LDKLLRY--DHQDRLTAREAMAHPYFAQVRAAE  419 (425)
Q Consensus       389 l~~~L~~--dP~~Rpta~elL~hp~~~~~~~~~  419 (425)
                      |.+|+..  +|..|+|++|+++||||+++.+..
T Consensus       283 i~~ll~~~~~~~~R~~~~~~l~hp~f~~~~~~~  315 (381)
T cd05626         283 ITKLCCSAEERLGRNGADDIKAHPFFSEVDFSS  315 (381)
T ss_pred             HHHHccCcccccCCCCHHHHhcCcccCCCChhH
Confidence            9996654  555599999999999999887644

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-45  Score=358.40  Aligned_cols=257  Identities=32%  Similarity=0.544  Sum_probs=211.4

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccE
Q 014406          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (425)
Q Consensus       125 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (425)
                      ++|++.+.||+|+||+||+|.+..+++.||+|+++..      ....+.+|+.++..+ +|+||+++++++.+  +...+
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~--~~~~~   77 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADA-DSPWIVKLYYSFQD--EEHLY   77 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhc-CCCCccchhhheec--CCeEE
Confidence            4799999999999999999999999999999998642      335678899999999 89999999999965  46789


Q ss_pred             EEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCC-
Q 014406          199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-  274 (425)
Q Consensus       199 lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~-  274 (425)
                      +||||+.+++|..++   ..+++..++.++.||+.||+|||+.||+||||||+|||++.+ +.+||+|||++....... 
T Consensus        78 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~-~~~kL~Dfg~~~~~~~~~~  156 (350)
T cd05573          78 LVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDAD-GHIKLADFGLCKKMNKAKD  156 (350)
T ss_pred             EEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCC-CCEEeecCCCCccCcccCc
Confidence            999999999998876   358999999999999999999999999999999999999988 789999999997654332 


Q ss_pred             -----------------------------cceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCC
Q 014406          275 -----------------------------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD  325 (425)
Q Consensus       275 -----------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~  325 (425)
                                                   ......||..|+|||++.+ ..++.++|||||||++|+|++|+.||... +
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~Pf~~~-~  234 (350)
T cd05573         157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG-TPYGLECDWWSLGVILYEMLYGFPPFYSD-T  234 (350)
T ss_pred             ccccccccccccccccccccccccccccccccccccCccccCHHHHcC-CCCCCceeeEecchhhhhhccCCCCCCCC-C
Confidence                                         2234578999999999987 68999999999999999999999998433 2


Q ss_pred             CHHHHHHHHHHhCCchhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcC-HH
Q 014406          326 NHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT-AR  404 (425)
Q Consensus       326 ~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpt-a~  404 (425)
                      ..+....+.....                                 .........+++++.+||.+||+ ||.+|++ ++
T Consensus       235 ~~~~~~~i~~~~~---------------------------------~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~  280 (350)
T cd05573         235 LQETYNKIINWKE---------------------------------SLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFE  280 (350)
T ss_pred             HHHHHHHHhccCC---------------------------------cccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHH
Confidence            2222222211000                                 00001111268999999999998 9999999 99


Q ss_pred             HHhcCCCCcccccchhc
Q 014406          405 EAMAHPYFAQVRAAESS  421 (425)
Q Consensus       405 elL~hp~~~~~~~~~~~  421 (425)
                      |+++||||+++.+....
T Consensus       281 ~ll~hp~~~~~~~~~~~  297 (350)
T cd05573         281 EIKSHPFFKGIDWENLR  297 (350)
T ss_pred             HHhcCCCcCCCCHHHHh
Confidence            99999999998775543

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=6.5e-45  Score=343.16  Aligned_cols=273  Identities=28%  Similarity=0.544  Sum_probs=211.2

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc-----hHHHHHHHHHHHHhc--CCCCeeeEEeEEEcC---CCC
Q 014406          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLC--GGPNVVKLLDIVRDQ---HSK  195 (425)
Q Consensus       126 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~--~h~niv~l~~~~~~~---~~~  195 (425)
                      +|++.+.||+|+||+||+|.+..+++.||+|.++...     ...+.+|+.+++.+.  +||||+++++++...   ...
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            5889999999999999999999999999999986421     235667888877663  699999999988643   234


Q ss_pred             ccEEEEEeecCCChhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccc
Q 014406          196 TPSLIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  270 (425)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~-----~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~  270 (425)
                      ..+++|||+.+ ++..++     ..+++..++.++.|++.||.|||+.||+|+||||+|||++.+ +.+||+|||+++..
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~-~~~kl~dfg~~~~~  158 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSG-GQVKLADFGLARIY  158 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC-CCEEECccCccccc
Confidence            68899999986 555544     238899999999999999999999999999999999999988 78999999999876


Q ss_pred             cCCCcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhcc
Q 014406          271 HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH  350 (425)
Q Consensus       271 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~  350 (425)
                      ..........++..|+|||++.+ ..++.++||||+||++|+|++|+.|| .+....+.+..+....+.+....+.....
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~~f-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (288)
T cd07863         159 SCQMALTPVVVTLWYRAPEVLLQ-STYATPVDMWSVGCIFAEMFRRKPLF-CGNSEADQLGKIFDLIGLPPEDDWPRDVT  236 (288)
T ss_pred             cCcccCCCccccccccCchHhhC-CCCCCcchhhhHHHHHHHHHhCCcCc-CCCCHHHHHHHHHHHhCCCChhhCccccc
Confidence            54444445578899999999977 67999999999999999999998776 55566677777777766554333221110


Q ss_pred             CCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCC
Q 014406          351 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF  412 (425)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~  412 (425)
                      ....        ...  +............+++.+.+|+.+||++||++|||+.|+++||||
T Consensus       237 ~~~~--------~~~--~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         237 LPRG--------AFS--PRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             cccc--------ccC--CCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            0000        000  000000011122368889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=7e-45  Score=349.05  Aligned_cols=252  Identities=25%  Similarity=0.409  Sum_probs=206.2

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEE
Q 014406          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (425)
Q Consensus       126 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (425)
                      +|++++.||+|+||+||+|.+..+++.||+|++...      ..+.+..|+.++..+.+|++|+++++++.+.  ...++
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~--~~~~l   78 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM--DRLYF   78 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcC--CEEEE
Confidence            588999999999999999999999999999998642      2355778999999985556788999998654  67899


Q ss_pred             EEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEecccccccc-CCCc
Q 014406          200 IFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKE  275 (425)
Q Consensus       200 v~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~-~~~~  275 (425)
                      ||||+++++|..++   ..+++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++... ....
T Consensus        79 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~-~~~kL~Dfg~~~~~~~~~~~  157 (324)
T cd05587          79 VMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAE-GHIKIADFGMCKENIFGGKT  157 (324)
T ss_pred             EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCC-CCEEEeecCcceecCCCCCc
Confidence            99999999998776   358899999999999999999999999999999999999988 789999999986432 2233


Q ss_pred             ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCCh
Q 014406          276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP  355 (425)
Q Consensus       276 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~  355 (425)
                      .....||..|+|||++.+ ..++.++||||+||++|+|++|+.||. +.+..+.+..+...             .     
T Consensus       158 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~pf~-~~~~~~~~~~i~~~-------------~-----  217 (324)
T cd05587         158 TRTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQPPFD-GEDEDELFQSIMEH-------------N-----  217 (324)
T ss_pred             eeeecCCccccChhhhcC-CCCCcccchhhhHHHHHHHHhCCCCCC-CCCHHHHHHHHHcC-------------C-----
Confidence            345678999999999987 678999999999999999999999984 33322222222110             0     


Q ss_pred             hhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCH-----HHHhcCCCCcccccch
Q 014406          356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA-----REAMAHPYFAQVRAAE  419 (425)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta-----~elL~hp~~~~~~~~~  419 (425)
                                         ...+..+++++.+|+++||+.||++|++.     +++++||||+.+.+..
T Consensus       218 -------------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~~~  267 (324)
T cd05587         218 -------------------VSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDWEK  267 (324)
T ss_pred             -------------------CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCHHH
Confidence                               00112368899999999999999999976     8999999999887643

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=3.4e-45  Score=359.15  Aligned_cols=255  Identities=27%  Similarity=0.451  Sum_probs=205.3

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccE
Q 014406          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (425)
Q Consensus       125 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (425)
                      .+|++++.||+|+||+||+|.+..+++.+|+|++...      ....+.+|+.+++.+ +|+||+++++.|.+.  ..++
T Consensus         1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~-~h~~iv~~~~~~~~~--~~~~   77 (382)
T cd05625           1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEA-DNEWVVRLYYSFQDK--DNLY   77 (382)
T ss_pred             CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhC-CCCcCCeEEEEEEeC--CEEE
Confidence            3689999999999999999999999999999998743      234678899999999 999999999999654  6789


Q ss_pred             EEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCC--
Q 014406          199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG--  273 (425)
Q Consensus       199 lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~--  273 (425)
                      +||||+++|+|..++   ..+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||++......  
T Consensus        78 lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~-g~~kL~DFGla~~~~~~~~  156 (382)
T cd05625          78 FVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRD-GHIKLTDFGLCTGFRWTHD  156 (382)
T ss_pred             EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC-CCEEEeECCCCcccccccc
Confidence            999999999998876   347899999999999999999999999999999999999988 79999999997532100  


Q ss_pred             ----------------------------------------------CcceeeccCCCccCcccccCCCCCCCcccHHHHH
Q 014406          274 ----------------------------------------------KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLG  307 (425)
Q Consensus       274 ----------------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG  307 (425)
                                                                    ......+||+.|+|||++.+ ..++.++||||||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlG  235 (382)
T cd05625         157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR-TGYTQLCDWWSVG  235 (382)
T ss_pred             ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcC-CCCCCeeeEEech
Confidence                                                          00112368999999999987 6799999999999


Q ss_pred             HHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHH
Q 014406          308 CMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAID  387 (425)
Q Consensus       308 ~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  387 (425)
                      |++|||++|+.||.. .+..+....+.....                                 .........+++++.+
T Consensus       236 vil~elltG~~Pf~~-~~~~~~~~~i~~~~~---------------------------------~~~~p~~~~~s~~~~~  281 (382)
T cd05625         236 VILYEMLVGQPPFLA-QTPLETQMKVINWQT---------------------------------SLHIPPQAKLSPEASD  281 (382)
T ss_pred             HHHHHHHhCCCCCCC-CCHHHHHHHHHccCC---------------------------------CcCCCCcccCCHHHHH
Confidence            999999999999843 332222222211000                                 0001112237899999


Q ss_pred             HHHHcccCCcCCCcC---HHHHhcCCCCcccccch
Q 014406          388 FLDKLLRYDHQDRLT---AREAMAHPYFAQVRAAE  419 (425)
Q Consensus       388 ll~~~L~~dP~~Rpt---a~elL~hp~~~~~~~~~  419 (425)
                      +|.+|+ .||++|++   ++++++||||+.+.+..
T Consensus       282 li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~~~~~  315 (382)
T cd05625         282 LIIKLC-RGPEDRLGKNGADEIKAHPFFKTIDFSS  315 (382)
T ss_pred             HHHHHc-cCHhHcCCCCCHHHHhcCCCcCCcChHH
Confidence            999987 59999997   99999999999887654

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=3.9e-45  Score=350.59  Aligned_cols=246  Identities=26%  Similarity=0.460  Sum_probs=202.4

Q ss_pred             eeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEEEee
Q 014406          131 RKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV  204 (425)
Q Consensus       131 ~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~  204 (425)
                      +.||+|+||+||++.+..+++.||+|++...      ....+.+|+.+++.+ +||||++++++|...  ...++||||+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i~~~~~~~~~~--~~~~lv~E~~   77 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHPFLTALKYAFQTH--DRLCFVMEYA   77 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-CCCCCcceeeEEecC--CEEEEEEeCC
Confidence            3699999999999999999999999998642      234567899999999 999999999999654  6789999999


Q ss_pred             cCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccC-CCcceeec
Q 014406          205 NSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP-GKEYNVRV  280 (425)
Q Consensus       205 ~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~-~~~~~~~~  280 (425)
                      ++++|..++   ..+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++.... ........
T Consensus        78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~  156 (323)
T cd05595          78 NGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKD-GHIKITDFGLCKEGISDGATMKTFC  156 (323)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCC-CCEEecccHHhccccCCCCcccccc
Confidence            999998766   348999999999999999999999999999999999999988 7899999999875322 22233457


Q ss_pred             cCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCChhhHHH
Q 014406          281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDAL  360 (425)
Q Consensus       281 ~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~  360 (425)
                      ||..|+|||++.+ ..++.++|||||||++|+|++|+.||... +..+....+..  +           .          
T Consensus       157 gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~g~~Pf~~~-~~~~~~~~~~~--~-----------~----------  211 (323)
T cd05595         157 GTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQ-DHERLFELILM--E-----------E----------  211 (323)
T ss_pred             CCcCcCCcccccC-CCCCchhchhhhHHHHHHHHhCCCCCCCC-CHHHHHHHHhc--C-----------C----------
Confidence            8999999999977 67899999999999999999999998432 22222221110  0           0          


Q ss_pred             hcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCc-----CHHHHhcCCCCcccccch
Q 014406          361 VGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYFAQVRAAE  419 (425)
Q Consensus       361 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rp-----ta~elL~hp~~~~~~~~~  419 (425)
                                    ...+..+++++.+||.+||+.||++|+     ++.++++||||.+..+..
T Consensus       212 --------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~~~~  261 (323)
T cd05595         212 --------------IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQD  261 (323)
T ss_pred             --------------CCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCCCHHH
Confidence                          001123789999999999999999998     899999999999877644

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=2.7e-45  Score=351.19  Aligned_cols=248  Identities=24%  Similarity=0.404  Sum_probs=203.3

Q ss_pred             eeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEEEee
Q 014406          131 RKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV  204 (425)
Q Consensus       131 ~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~  204 (425)
                      +.||+|+||+||+|.+..+++.||+|++...      ....+..|..++..+.+||||+++++++.+.  ...++||||+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~--~~~~iv~Ey~   78 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTP--DRLFFVMEFV   78 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcC--CEEEEEEcCC
Confidence            3699999999999999999999999998642      2345678888888776899999999999654  6789999999


Q ss_pred             cCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccC-CCcceeec
Q 014406          205 NSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP-GKEYNVRV  280 (425)
Q Consensus       205 ~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~-~~~~~~~~  280 (425)
                      ++++|..++   ..+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++.... ........
T Consensus        79 ~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~-~~~kL~DfG~~~~~~~~~~~~~~~~  157 (320)
T cd05590          79 NGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHE-GHCKLADFGMCKEGIFNGKTTSTFC  157 (320)
T ss_pred             CCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCC-CcEEEeeCCCCeecCcCCCcccccc
Confidence            999998766   458999999999999999999999999999999999999988 7899999999875422 22334457


Q ss_pred             cCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCChhhHHH
Q 014406          281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDAL  360 (425)
Q Consensus       281 ~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~  360 (425)
                      ||+.|+|||++.+ ..++.++|||||||++|+|++|+.||. +.+..+....+..   .          .          
T Consensus       158 gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~Pf~-~~~~~~~~~~i~~---~----------~----------  212 (320)
T cd05590         158 GTPDYIAPEILQE-MLYGPSVDWWAMGVLLYEMLCGHAPFE-AENEDDLFEAILN---D----------E----------  212 (320)
T ss_pred             cCccccCHHHHcC-CCCCCccchhhhHHHHHHHhhCCCCCC-CCCHHHHHHHHhc---C----------C----------
Confidence            8999999999977 678999999999999999999999983 3232222222211   0          0          


Q ss_pred             hcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCH------HHHhcCCCCcccccchh
Q 014406          361 VGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA------REAMAHPYFAQVRAAES  420 (425)
Q Consensus       361 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta------~elL~hp~~~~~~~~~~  420 (425)
                                    ......+++++.+|+++||+.||++|+++      +++++||||+++.+...
T Consensus       213 --------------~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~~~~  264 (320)
T cd05590         213 --------------VVYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDWEKL  264 (320)
T ss_pred             --------------CCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCCCHHHH
Confidence                          00112268899999999999999999998      99999999999877553

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-47  Score=352.33  Aligned_cols=251  Identities=25%  Similarity=0.419  Sum_probs=209.6

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEE
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (425)
                      ...|..++.||+|+||.||+|.+..+++.||+|++.-+    ..+.+++|+.+|.++ +++||.++|+.+...  ..+++
T Consensus        12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~-~~~~it~yygsyl~g--~~Lwi   88 (467)
T KOG0201|consen   12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQC-DSPNITEYYGSYLKG--TKLWI   88 (467)
T ss_pred             ccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhc-CcchHHhhhhheeec--ccHHH
Confidence            45577778999999999999999999999999999743    446788999999998 899999999988654  67889


Q ss_pred             EEEeecCCChhhhcCC---CCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCC-c
Q 014406          200 IFEYVNSTDFKVLYPT---LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-E  275 (425)
Q Consensus       200 v~e~~~~~~l~~~~~~---l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~-~  275 (425)
                      +|||+.||++.+.+..   +.+..+..++++++.||.|||.++.+|||||+.|||+..+ +.+|++|||.+-...... .
T Consensus        89 iMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~-g~vkl~DfgVa~ql~~~~~r  167 (467)
T KOG0201|consen   89 IMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSES-GDVKLADFGVAGQLTNTVKR  167 (467)
T ss_pred             HHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEecc-CcEEEEecceeeeeechhhc
Confidence            9999999999888743   4888889999999999999999999999999999999999 899999999987665432 2


Q ss_pred             ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCCh
Q 014406          276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP  355 (425)
Q Consensus       276 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~  355 (425)
                      ..+.+||+.|||||++.. ..|+.++||||||++.+||.+|..|+. .......+..|-                     
T Consensus       168 r~tfvGTPfwMAPEVI~~-~~Y~~KADIWSLGITaiEla~GePP~s-~~hPmrvlflIp---------------------  224 (467)
T KOG0201|consen  168 RKTFVGTPFWMAPEVIKQ-SGYDTKADIWSLGITAIELAKGEPPHS-KLHPMRVLFLIP---------------------  224 (467)
T ss_pred             cccccccccccchhhhcc-ccccchhhhhhhhHHHHHHhcCCCCCc-ccCcceEEEecc---------------------
Confidence            367899999999999985 789999999999999999999999982 221111111110                     


Q ss_pred             hhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccc
Q 014406          356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR  416 (425)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~  416 (425)
                                     .-..+..+..+++.+++|+..||++||+.||+|.+||+|+|+++..
T Consensus       225 ---------------k~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~a~  270 (467)
T KOG0201|consen  225 ---------------KSAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKRAK  270 (467)
T ss_pred             ---------------CCCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHhcC
Confidence                           0001112235899999999999999999999999999999999854

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=4.5e-45  Score=350.86  Aligned_cols=245  Identities=26%  Similarity=0.435  Sum_probs=201.7

Q ss_pred             eeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEEEeec
Q 014406          132 KVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVN  205 (425)
Q Consensus       132 ~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~  205 (425)
                      .||+|+||+||++.+..+++.||+|++...      ....+.+|+.+++.+ +||||+++++++.+.  ...++||||++
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~--~~~~lv~Ey~~   78 (328)
T cd05593           2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNT-RHPFLTSLKYSFQTK--DRLCFVMEYVN   78 (328)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCcceEEEEEcC--CEEEEEEeCCC
Confidence            699999999999999999999999999742      234677899999999 999999999999654  67899999999


Q ss_pred             CCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccC-CCcceeecc
Q 014406          206 STDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP-GKEYNVRVA  281 (425)
Q Consensus       206 ~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~-~~~~~~~~~  281 (425)
                      +++|..++   ..+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++.... ........|
T Consensus        79 ~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~-~~~kL~DfG~~~~~~~~~~~~~~~~g  157 (328)
T cd05593          79 GGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKD-GHIKITDFGLCKEGITDAATMKTFCG  157 (328)
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCC-CcEEEecCcCCccCCCcccccccccC
Confidence            99998776   358999999999999999999999999999999999999988 7899999999875432 222334578


Q ss_pred             CCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCChhhHHHh
Q 014406          282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALV  361 (425)
Q Consensus       282 t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~  361 (425)
                      |+.|+|||++.+ ..++.++|||||||++|+|++|+.||.. .+..+....+..  +           .           
T Consensus       158 t~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~Pf~~-~~~~~~~~~~~~--~-----------~-----------  211 (328)
T cd05593         158 TPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILM--E-----------D-----------  211 (328)
T ss_pred             CcCccChhhhcC-CCCCccCCccccchHHHHHhhCCCCCCC-CCHHHHHHHhcc--C-----------C-----------
Confidence            999999999977 6789999999999999999999999843 222222111100  0           0           


Q ss_pred             cccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCc-----CHHHHhcCCCCcccccch
Q 014406          362 GRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYFAQVRAAE  419 (425)
Q Consensus       362 ~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rp-----ta~elL~hp~~~~~~~~~  419 (425)
                                   ...+..+++++.+|+++||+.||++|+     ++.|+++||||.++.+..
T Consensus       212 -------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~~  261 (328)
T cd05593         212 -------------IKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNWQD  261 (328)
T ss_pred             -------------ccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCCCHHH
Confidence                         001123688999999999999999997     899999999999876643

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-44  Score=340.86  Aligned_cols=257  Identities=26%  Similarity=0.396  Sum_probs=210.0

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc------hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEE
Q 014406          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (425)
Q Consensus       126 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (425)
                      +|++.+.||+|+||+||++.+..+++.||+|++....      ...+.+|+.+++.+ +|+||+++++.+...  ...++
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~--~~~~l   77 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-NSRFVVSLAYAYETK--DALCL   77 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhc-CCCCEeeeeeeecCC--CeEEE
Confidence            4888999999999999999999999999999986432      23467899999999 999999999999654  67899


Q ss_pred             EEEeecCCChhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCC
Q 014406          200 IFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (425)
Q Consensus       200 v~e~~~~~~l~~~~-----~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~  274 (425)
                      ||||+.+++|..++     ..+++..+..++.|++.||.|||+.||+|+||||+||+++.+ +.++|+|||++.......
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~-~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05605          78 VLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDY-GHIRISDLGLAVEIPEGE  156 (285)
T ss_pred             EEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCC-CCEEEeeCCCceecCCCC
Confidence            99999999998665     248899999999999999999999999999999999999988 789999999998765444


Q ss_pred             cceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCC
Q 014406          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD  354 (425)
Q Consensus       275 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~  354 (425)
                      ......++..|+|||++.+ ..++.++||||+||++|+|++|+.||.. .+.......+...+....             
T Consensus       157 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Diws~G~~l~el~~g~~pf~~-~~~~~~~~~~~~~~~~~~-------------  221 (285)
T cd05605         157 TIRGRVGTVGYMAPEVVKN-ERYTFSPDWWGLGCLIYEMIEGKSPFRQ-RKEKVKREEVERRVKEDQ-------------  221 (285)
T ss_pred             ccccccCCCCccCcHHhcC-CCCCccccchhHHHHHHHHHHCCCCCCC-CchhhHHHHHHHHhhhcc-------------
Confidence            4445678999999999977 6789999999999999999999999843 222222222211110000             


Q ss_pred             hhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCc-----CHHHHhcCCCCcccccchhc
Q 014406          355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYFAQVRAAESS  421 (425)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rp-----ta~elL~hp~~~~~~~~~~~  421 (425)
                                          ......+++.+.+|+.+||+.||++||     +++++++||||.+..+....
T Consensus       222 --------------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~~~  273 (285)
T cd05605         222 --------------------EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKRLE  273 (285)
T ss_pred             --------------------cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCHHHHh
Confidence                                001122688999999999999999999     99999999999987766543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-45  Score=348.37  Aligned_cols=243  Identities=24%  Similarity=0.413  Sum_probs=199.9

Q ss_pred             eeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEEEeecC
Q 014406          133 VGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNS  206 (425)
Q Consensus       133 LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~  206 (425)
                      ||+|+||+||+|.+..+++.||+|+++..      ....+.+|+.+++++ +||||+++++++.+.  ...++||||+++
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~--~~~~lv~e~~~~   77 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQV-NCPFIVPLKFSFQSP--EKLYLVLAFING   77 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCcEeceeeEEecC--CeEEEEEcCCCC
Confidence            79999999999999999999999998642      234577899999999 999999999999654  678999999999


Q ss_pred             CChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCC-CcceeeccC
Q 014406          207 TDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-KEYNVRVAS  282 (425)
Q Consensus       207 ~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~~t  282 (425)
                      ++|..++   ..+++..+..++.|++.||.|||++||+||||||+|||++.+ +.++|+|||+++..... .......||
T Consensus        78 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~gt  156 (312)
T cd05585          78 GELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQ-GHIALCDFGLCKLNMKDDDKTNTFCGT  156 (312)
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCC-CcEEEEECcccccCccCCCccccccCC
Confidence            9998776   358999999999999999999999999999999999999988 78999999999754322 223445789


Q ss_pred             CCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCChhhHHHhc
Q 014406          283 RYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVG  362 (425)
Q Consensus       283 ~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~  362 (425)
                      +.|+|||++.+ ..++.++|||||||++|+|++|+.||.. .+..+....+..   .          .            
T Consensus       157 ~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~~-~~~~~~~~~~~~---~----------~------------  209 (312)
T cd05585         157 PEYLAPELLLG-HGYTKAVDWWTLGVLLYEMLTGLPPFYD-ENVNEMYRKILQ---E----------P------------  209 (312)
T ss_pred             cccCCHHHHcC-CCCCCccceechhHHHHHHHhCCCCcCC-CCHHHHHHHHHc---C----------C------------
Confidence            99999999987 7799999999999999999999999842 222222211110   0          0            


Q ss_pred             ccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCc---CHHHHhcCCCCcccccc
Q 014406          363 RHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL---TAREAMAHPYFAQVRAA  418 (425)
Q Consensus       363 ~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rp---ta~elL~hp~~~~~~~~  418 (425)
                                  ......+++++.+|+.+||+.||++||   ++.|+++||||.+..+.
T Consensus       210 ------------~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~~~~  256 (312)
T cd05585         210 ------------LRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLSWK  256 (312)
T ss_pred             ------------CCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCCCHH
Confidence                        001123688999999999999999997   58999999999987543

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=5.7e-45  Score=356.85  Aligned_cols=256  Identities=27%  Similarity=0.450  Sum_probs=205.4

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccE
Q 014406          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (425)
Q Consensus       125 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (425)
                      ++|++++.||+|+||+||+|.+..+++.||+|++...      ....+.+|+.+++.+ +|+||+++++.+.+.  ..++
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~~~~~~~~~--~~~~   77 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEA-DNEWVVKLYYSFQDK--DNLY   77 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhC-CCCCcceEEEEEEcC--CEEE
Confidence            4799999999999999999999999999999998642      235678899999999 999999999999654  6889


Q ss_pred             EEEEeecCCChhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCC--
Q 014406          199 LIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG--  273 (425)
Q Consensus       199 lv~e~~~~~~l~~~~~---~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~--  273 (425)
                      +||||+++++|..++.   .+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|......  
T Consensus        78 lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~-~~ikL~DFG~a~~~~~~~~  156 (376)
T cd05598          78 FVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRD-GHIKLTDFGLCTGFRWTHD  156 (376)
T ss_pred             EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCC-CCEEEEeCCCCcccccccc
Confidence            9999999999998863   47889999999999999999999999999999999999988 78999999997532100  


Q ss_pred             ------------------------------------------CcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHH
Q 014406          274 ------------------------------------------KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFA  311 (425)
Q Consensus       274 ------------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~  311 (425)
                                                                ......+||+.|+|||++.+ ..++.++|||||||++|
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvily  235 (376)
T cd05598         157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR-TGYTQLCDWWSVGVILY  235 (376)
T ss_pred             ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcC-CCCCcceeeeeccceee
Confidence                                                      00112468999999999977 77899999999999999


Q ss_pred             HHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHH
Q 014406          312 GMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDK  391 (425)
Q Consensus       312 elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~  391 (425)
                      +|++|+.||... +..+....+...                                 ...........+++++.+||.+
T Consensus       236 ell~G~~Pf~~~-~~~~~~~~i~~~---------------------------------~~~~~~~~~~~~s~~~~~li~~  281 (376)
T cd05598         236 EMLVGQPPFLAD-TPAETQLKVINW---------------------------------ETTLHIPSQAKLSREASDLILR  281 (376)
T ss_pred             ehhhCCCCCCCC-CHHHHHHHHhcc---------------------------------CccccCCCCCCCCHHHHHHHHH
Confidence            999999998432 222222211110                                 0000011112378999999999


Q ss_pred             cccCCcCCCc---CHHHHhcCCCCcccccchh
Q 014406          392 LLRYDHQDRL---TAREAMAHPYFAQVRAAES  420 (425)
Q Consensus       392 ~L~~dP~~Rp---ta~elL~hp~~~~~~~~~~  420 (425)
                      |+ .+|++|+   |+.|+++||||+.+.+...
T Consensus       282 l~-~~p~~R~~~~t~~ell~h~~~~~~~~~~~  312 (376)
T cd05598         282 LC-CGAEDRLGKNGADEIKAHPFFKGIDFASL  312 (376)
T ss_pred             Hh-cCHhhcCCCCCHHHHhCCCCcCCCCHHHH
Confidence            77 5999999   9999999999998765443

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-45  Score=351.60  Aligned_cols=241  Identities=20%  Similarity=0.358  Sum_probs=202.1

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc--chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEE
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (425)
                      .+.+.+++.||+|.||+||.|.+. ....||+|.++..  ..+.|.+|+++|++| +|+|||+++++|..+  ..++|||
T Consensus       205 r~~l~l~~~LG~G~FG~V~~g~~~-~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L-~H~~lV~l~gV~~~~--~piyIVt  280 (468)
T KOG0197|consen  205 REELKLIRELGSGQFGEVWLGKWN-GSTKVAVKTIKEGSMSPEAFLREAQIMKKL-RHEKLVKLYGVCTKQ--EPIYIVT  280 (468)
T ss_pred             HHHHHHHHHhcCCccceEEEEEEc-CCCcccceEEeccccChhHHHHHHHHHHhC-cccCeEEEEEEEecC--CceEEEE
Confidence            344667788999999999999764 4558999999863  457899999999999 999999999999764  4789999


Q ss_pred             EeecCCChhhhcCC-----CCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCcc
Q 014406          202 EYVNSTDFKVLYPT-----LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY  276 (425)
Q Consensus       202 e~~~~~~l~~~~~~-----l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~~  276 (425)
                      |||..|+|.++++.     +...++..++.|||+||+||+++++|||||.++|||++++ ..+||+|||+|+... ++.+
T Consensus       281 E~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~-~~vKIsDFGLAr~~~-d~~Y  358 (468)
T KOG0197|consen  281 EYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDED-LVVKISDFGLARLIG-DDEY  358 (468)
T ss_pred             EecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccC-ceEEEcccccccccC-CCce
Confidence            99999999999853     8888999999999999999999999999999999999999 799999999999544 3344


Q ss_pred             eeecc---CCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCC
Q 014406          277 NVRVA---SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL  353 (425)
Q Consensus       277 ~~~~~---t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~  353 (425)
                      ....+   +..|.|||.+.. ..++.+||||||||+||||+|-...++.+.++.+.+..+.+-.                
T Consensus       359 ~~~~~~kfPIkWtAPEa~~~-~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~Gy----------------  421 (468)
T KOG0197|consen  359 TASEGGKFPIKWTAPEALNY-GKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGY----------------  421 (468)
T ss_pred             eecCCCCCCceecCHHHHhh-CCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccC----------------
Confidence            43333   345999999977 7899999999999999999985555558888888887664311                


Q ss_pred             ChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHh
Q 014406          354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM  407 (425)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL  407 (425)
                                          +...+..+++++.++|..||+.+|++|||.+.+.
T Consensus       422 --------------------Rlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~  455 (468)
T KOG0197|consen  422 --------------------RLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLR  455 (468)
T ss_pred             --------------------cCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence                                2223345899999999999999999999998664

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=6.3e-45  Score=354.45  Aligned_cols=256  Identities=27%  Similarity=0.460  Sum_probs=207.0

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccE
Q 014406          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (425)
Q Consensus       125 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (425)
                      ++|++.+.||+|+||+||+|.+..+++.||+|+++..      ....+.+|+.++..+ +|+||+++++.+.+  ....+
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~--~~~~~   77 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEA-DGAWVVKMFYSFQD--KRNLY   77 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCEeeEEEEEEc--CCEEE
Confidence            4789999999999999999999999999999998632      235678899999999 99999999999965  46889


Q ss_pred             EEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCC-
Q 014406          199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-  274 (425)
Q Consensus       199 lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~-  274 (425)
                      +||||+++++|..++   ..+++..++.++.|++.||+|||+.||+||||||+|||++.+ +.++|+|||+++...... 
T Consensus        78 lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~-~~vkL~DfG~~~~~~~~~~  156 (360)
T cd05627          78 LIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAK-GHVKLSDFGLCTGLKKAHR  156 (360)
T ss_pred             EEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCC-CCEEEeeccCCcccccccc
Confidence            999999999998876   358999999999999999999999999999999999999988 799999999986542111 


Q ss_pred             -----------------------------------cceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCC
Q 014406          275 -----------------------------------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEP  319 (425)
Q Consensus       275 -----------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~p  319 (425)
                                                         .....+||+.|+|||++.+ ..++.++|||||||++|||++|+.|
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyel~tG~~P  235 (360)
T cd05627         157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEMLIGYPP  235 (360)
T ss_pred             cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcC-CCCCCcceeccccceeeecccCCCC
Confidence                                               0113468999999999987 7899999999999999999999999


Q ss_pred             CCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCC
Q 014406          320 FFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQD  399 (425)
Q Consensus       320 f~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~  399 (425)
                      |. +.+..+....+.....                                 .........+++++++||.+|+. ||++
T Consensus       236 f~-~~~~~~~~~~i~~~~~---------------------------------~~~~p~~~~~s~~~~~li~~l~~-~p~~  280 (360)
T cd05627         236 FC-SETPQETYRKVMNWKE---------------------------------TLVFPPEVPISEKAKDLILRFCT-DSEN  280 (360)
T ss_pred             CC-CCCHHHHHHHHHcCCC---------------------------------ceecCCCCCCCHHHHHHHHHhcc-Chhh
Confidence            84 2232222222211000                                 00000111268899999999874 9999


Q ss_pred             Cc---CHHHHhcCCCCcccccchh
Q 014406          400 RL---TAREAMAHPYFAQVRAAES  420 (425)
Q Consensus       400 Rp---ta~elL~hp~~~~~~~~~~  420 (425)
                      |+   +++|+++||||+++.+.+.
T Consensus       281 R~~~~~~~ei~~hp~f~~~~~~~~  304 (360)
T cd05627         281 RIGSNGVEEIKSHPFFEGVDWGHI  304 (360)
T ss_pred             cCCCCCHHHHhcCCCCCCCCHHHH
Confidence            98   4899999999999887654

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=2e-44  Score=349.93  Aligned_cols=254  Identities=22%  Similarity=0.394  Sum_probs=202.2

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEE
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (425)
                      .++|+.+++||+|+||+||+|.+..+++.||||++....    ...+.+|+++++.+ +|+||+++++++..  ....++
T Consensus        73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~~~l  149 (353)
T PLN00034         73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDV-NHPNVVKCHDMFDH--NGEIQV  149 (353)
T ss_pred             HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhC-CCCCcceeeeEecc--CCeEEE
Confidence            467888899999999999999999999999999986432    35688999999999 89999999999954  467889


Q ss_pred             EEEeecCCChhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCC-ccee
Q 014406          200 IFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EYNV  278 (425)
Q Consensus       200 v~e~~~~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~-~~~~  278 (425)
                      ||||+.+++|.... ...+..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++...... ....
T Consensus       150 v~e~~~~~~L~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~-~~~kL~DfG~~~~~~~~~~~~~~  227 (353)
T PLN00034        150 LLEFMDGGSLEGTH-IADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSA-KNVKIADFGVSRILAQTMDPCNS  227 (353)
T ss_pred             EEecCCCCcccccc-cCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCC-CCEEEcccccceecccccccccc
Confidence            99999999987542 35677888999999999999999999999999999999988 789999999998664322 2344


Q ss_pred             eccCCCccCcccccCC----CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCC
Q 014406          279 RVASRYFKGPELLVDL----QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD  354 (425)
Q Consensus       279 ~~~t~~y~aPE~~~~~----~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~  354 (425)
                      ..||..|+|||++...    ...+.++|||||||++|||++|+.||......  .+..........              
T Consensus       228 ~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~--~~~~~~~~~~~~--------------  291 (353)
T PLN00034        228 SVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG--DWASLMCAICMS--------------  291 (353)
T ss_pred             cccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc--cHHHHHHHHhcc--------------
Confidence            6789999999987431    23456899999999999999999999522211  111111100000              


Q ss_pred             hhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccc
Q 014406          355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR  416 (425)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~  416 (425)
                                        ........++.++++||.+||+.||++|||+.|+++||||.+..
T Consensus       292 ------------------~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~  335 (353)
T PLN00034        292 ------------------QPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQ  335 (353)
T ss_pred             ------------------CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccCC
Confidence                              00011223688999999999999999999999999999999763

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=3.7e-45  Score=351.91  Aligned_cols=257  Identities=27%  Similarity=0.460  Sum_probs=209.4

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccE
Q 014406          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (425)
Q Consensus       125 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (425)
                      ++|++.+.||+|+||+||+|.+..+++.||+|+++..      ..+.+.+|+.+++.+ +|+||+++++++.+.  ...+
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~-~~~~i~~~~~~~~~~--~~~~   77 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSIS-NSPWIPQLQYAFQDK--DNLY   77 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCcceeeEEecC--CeEE
Confidence            4789999999999999999999999999999999743      234578899999998 999999999999654  6789


Q ss_pred             EEEEeecCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCC
Q 014406          199 LIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (425)
Q Consensus       199 lv~e~~~~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~  274 (425)
                      +||||+++++|..++    ..+++..++.++.|++.||.|||+.+|+||||||+|||++.+ +.+||+|||++.......
T Consensus        78 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~-~~~kL~Dfg~a~~~~~~~  156 (330)
T cd05601          78 LVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRT-GHIKLADFGSAARLTANK  156 (330)
T ss_pred             EEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCC-CCEEeccCCCCeECCCCC
Confidence            999999999998887    358999999999999999999999999999999999999988 799999999998665433


Q ss_pred             cc--eeeccCCCccCcccccC-----CCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHh
Q 014406          275 EY--NVRVASRYFKGPELLVD-----LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLN  347 (425)
Q Consensus       275 ~~--~~~~~t~~y~aPE~~~~-----~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~  347 (425)
                      ..  ....+|+.|+|||++..     ...++.++|||||||++|+|++|..||... +..+.+..+....          
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~-~~~~~~~~i~~~~----------  225 (330)
T cd05601         157 MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEG-TSAKTYNNIMNFQ----------  225 (330)
T ss_pred             ceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCC-CHHHHHHHHHcCC----------
Confidence            22  23468999999999863     256789999999999999999999998432 2222222221100          


Q ss_pred             hccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccchh
Q 014406          348 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAES  420 (425)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~~~  420 (425)
                                             ..........+++++.+|+.+||+ ||.+|||++++++||||+.+.+...
T Consensus       226 -----------------------~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~~~~~  274 (330)
T cd05601         226 -----------------------RFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKIDWNNI  274 (330)
T ss_pred             -----------------------CccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCCHHHH
Confidence                                   000001112368999999999998 9999999999999999998876554

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=4.7e-45  Score=356.23  Aligned_cols=258  Identities=24%  Similarity=0.403  Sum_probs=209.1

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCc
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (425)
                      ..++|++.+.||+|+||+||+|.+..+++.||+|+++..      ....+.+|+.+++.+ +||||+++++++.+  +..
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~-~h~~iv~~~~~~~~--~~~  117 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHA-NSEWIVQLHYAFQD--DKY  117 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-CCCCcceEEEEEec--CCE
Confidence            467899999999999999999999999999999998642      224477899999999 99999999999965  467


Q ss_pred             cEEEEEeecCCChhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCC
Q 014406          197 PSLIFEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (425)
Q Consensus       197 ~~lv~e~~~~~~l~~~~~--~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~  274 (425)
                      .++||||+++|+|..++.  .+++..+..++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||++.......
T Consensus       118 ~~lv~Ey~~gg~L~~~l~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~-~~~kL~DfG~~~~~~~~~  196 (370)
T cd05596         118 LYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKS-GHLKLADFGTCMKMDANG  196 (370)
T ss_pred             EEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCC-CCEEEEeccceeeccCCC
Confidence            899999999999998874  47888899999999999999999999999999999999988 799999999997654332


Q ss_pred             --cceeeccCCCccCcccccCC---CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhc
Q 014406          275 --EYNVRVASRYFKGPELLVDL---QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY  349 (425)
Q Consensus       275 --~~~~~~~t~~y~aPE~~~~~---~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~  349 (425)
                        ......||+.|+|||++.+.   ..++.++|||||||++|||++|+.||.. .+.......+.....           
T Consensus       197 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~-~~~~~~~~~i~~~~~-----------  264 (370)
T cd05596         197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA-DSLVGTYSKIMDHKN-----------  264 (370)
T ss_pred             cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCC-CCHHHHHHHHHcCCC-----------
Confidence              22345789999999998652   2478999999999999999999999843 222222222211000           


Q ss_pred             cCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCC--CcCHHHHhcCCCCcccccc
Q 014406          350 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQD--RLTAREAMAHPYFAQVRAA  418 (425)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~--Rpta~elL~hp~~~~~~~~  418 (425)
                      .                      ........++.++++||++||+.+|++  |+|++|+++||||++..+.
T Consensus       265 ~----------------------~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~~~  313 (370)
T cd05596         265 S----------------------LTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQWT  313 (370)
T ss_pred             c----------------------CCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCCChh
Confidence            0                      000111236899999999999999988  9999999999999986543

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=9e-45  Score=348.14  Aligned_cols=254  Identities=24%  Similarity=0.384  Sum_probs=207.7

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc------hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEE
Q 014406          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (425)
Q Consensus       126 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (425)
                      +|++.+.||+|+||+||+|.+..+++.||+|+++...      ...+..|..++..+.+|++|+++++++.+.  ...++
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~--~~~~l   78 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTM--DRLYF   78 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecC--CEEEE
Confidence            5888999999999999999999999999999987432      234667888888876789999999999654  67899


Q ss_pred             EEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccC-CCc
Q 014406          200 IFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP-GKE  275 (425)
Q Consensus       200 v~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~-~~~  275 (425)
                      ||||+++++|...+   ..+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++.... ...
T Consensus        79 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~-~~~kL~DfG~~~~~~~~~~~  157 (323)
T cd05616          79 VMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSE-GHIKIADFGMCKENMWDGVT  157 (323)
T ss_pred             EEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCC-CcEEEccCCCceecCCCCCc
Confidence            99999999998776   458999999999999999999999999999999999999998 7899999999875432 223


Q ss_pred             ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCCh
Q 014406          276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP  355 (425)
Q Consensus       276 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~  355 (425)
                      .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||. +.+..+....+...             .     
T Consensus       158 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~Pf~-~~~~~~~~~~i~~~-------------~-----  217 (323)
T cd05616         158 TKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFE-GEDEDELFQSIMEH-------------N-----  217 (323)
T ss_pred             cccCCCChhhcCHHHhcC-CCCCCccchhchhHHHHHHHhCCCCCC-CCCHHHHHHHHHhC-------------C-----
Confidence            344578999999999987 779999999999999999999999984 32323333222110             0     


Q ss_pred             hhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcC-----HHHHhcCCCCcccccchhc
Q 014406          356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT-----AREAMAHPYFAQVRAAESS  421 (425)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpt-----a~elL~hp~~~~~~~~~~~  421 (425)
                                         ...+..++.++.+++.+||+.||++|++     ..++++||||+.+.+....
T Consensus       218 -------------------~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~~~~~  269 (323)
T cd05616         218 -------------------VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLE  269 (323)
T ss_pred             -------------------CCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCCHHHHH
Confidence                               0011236889999999999999999997     4899999999988765543

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=8.9e-45  Score=348.34  Aligned_cols=250  Identities=24%  Similarity=0.440  Sum_probs=203.8

Q ss_pred             EEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHH---HhcCCCCeeeEEeEEEcCCCCcc
Q 014406          127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQ---NLCGGPNVVKLLDIVRDQHSKTP  197 (425)
Q Consensus       127 y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~---~l~~h~niv~l~~~~~~~~~~~~  197 (425)
                      |++++.||+|+||+||+|.+..+++.||||+++..      ..+.+.+|+.++.   .+ +||||+++++++..  +...
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l-~hp~i~~~~~~~~~--~~~~   77 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSE-RHPFLVNLFACFQT--EDHV   77 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcccc-CCCChhceeeEEEc--CCEE
Confidence            67889999999999999999999999999999743      2345667776654   44 79999999999965  4688


Q ss_pred             EEEEEeecCCChhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccC-CC
Q 014406          198 SLIFEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP-GK  274 (425)
Q Consensus       198 ~lv~e~~~~~~l~~~~~--~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~-~~  274 (425)
                      |+||||+++++|...+.  .+++..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++.... ..
T Consensus        78 ~lv~E~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~-~~~kL~Dfg~~~~~~~~~~  156 (324)
T cd05589          78 CFVMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTE-GFVKIADFGLCKEGMGFGD  156 (324)
T ss_pred             EEEEcCCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCC-CcEEeCcccCCccCCCCCC
Confidence            99999999999987763  58999999999999999999999999999999999999988 7999999999875432 22


Q ss_pred             cceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCC
Q 014406          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD  354 (425)
Q Consensus       275 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~  354 (425)
                      ......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||. +.+..+.+..+...             .    
T Consensus       157 ~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~G~~pf~-~~~~~~~~~~i~~~-------------~----  217 (324)
T cd05589         157 RTSTFCGTPEFLAPEVLTE-TSYTRAVDWWGLGVLIYEMLVGESPFP-GDDEEEVFDSIVND-------------E----  217 (324)
T ss_pred             cccccccCccccCHhHhcC-CCCCcccchhhHHHHHHHHHhCCCCCC-CCCHHHHHHHHHhC-------------C----
Confidence            2344578999999999987 678999999999999999999999983 22222222222110             0    


Q ss_pred             hhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCc-----CHHHHhcCCCCcccccch
Q 014406          355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYFAQVRAAE  419 (425)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rp-----ta~elL~hp~~~~~~~~~  419 (425)
                                          ...+..+++++.+|+++||+.||++||     ++.++++||||+++.+..
T Consensus       218 --------------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~~~~  267 (324)
T cd05589         218 --------------------VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINWDD  267 (324)
T ss_pred             --------------------CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCCHHH
Confidence                                001123688999999999999999999     799999999999876544

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=7.6e-45  Score=351.58  Aligned_cols=285  Identities=31%  Similarity=0.561  Sum_probs=218.2

Q ss_pred             CCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCC---
Q 014406          122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH---  193 (425)
Q Consensus       122 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~---  193 (425)
                      ...++|++++.||+|+||+||+|.+..+++.||||.+...     ....+.+|+.+++++ +|+||+++++++....   
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~   90 (343)
T cd07878          12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHM-KHENVIGLLDVFTPATSIE   90 (343)
T ss_pred             hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhc-CCCchhhhhhhhccccccc
Confidence            3468899999999999999999999999999999998743     234577899999999 9999999999885321   


Q ss_pred             -CCccEEEEEeecCCChhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccc
Q 014406          194 -SKTPSLIFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  270 (425)
Q Consensus       194 -~~~~~lv~e~~~~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~  270 (425)
                       ....++++|++ +++|..++  ..+++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++..
T Consensus        91 ~~~~~~~~~~~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~-~~~kl~Dfg~~~~~  168 (343)
T cd07878          91 NFNEVYLVTNLM-GADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNED-CELRILDFGLARQA  168 (343)
T ss_pred             ccCcEEEEeecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCC-CCEEEcCCccceec
Confidence             24568999987 56776665  359999999999999999999999999999999999999988 78999999999865


Q ss_pred             cCCCcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhcc
Q 014406          271 HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH  350 (425)
Q Consensus       271 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~  350 (425)
                      ..  ......+|..|+|||++.+...++.++|||||||++|+|++|+.|| .+.+..+.+..+.+..+.+...... ...
T Consensus       169 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~-~~~  244 (343)
T cd07878         169 DD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALF-PGNDYIDQLKRIMEVVGTPSPEVLK-KIS  244 (343)
T ss_pred             CC--CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCC-CCCCHHHHHHHHHHHhCCCCHHHHH-hcc
Confidence            43  2344578999999999977567899999999999999999999988 4555566777777766665433221 100


Q ss_pred             CCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccc
Q 014406          351 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA  418 (425)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~  418 (425)
                      ..................+.     ......++.+.+|+.+||+.||++|||+.|+|+||||.+....
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~~  307 (343)
T cd07878         245 SEHARKYIQSLPHMPQQDLK-----KIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDP  307 (343)
T ss_pred             hhhHHHHhhccccccchhHH-----HhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCCC
Confidence            00000000000000000000     0111256789999999999999999999999999999986543

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=8.6e-45  Score=349.63  Aligned_cols=257  Identities=25%  Similarity=0.455  Sum_probs=204.9

Q ss_pred             CEEEEeeeeeeCceEEEEEEEc---CCCcEEEEEEecCc-------chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCC
Q 014406          126 DYEVVRKVGRGKYSEVFEGINV---NTNERCIIKILKPV-------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (425)
Q Consensus       126 ~y~~~~~LG~G~fg~V~~~~~~---~~~~~vavK~~~~~-------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (425)
                      +|++.+.||+|+||+||++.+.   .+++.||+|++...       ..+.+.+|+.++..+.+|+||+++++++...  .
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~--~   78 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTE--A   78 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecC--C
Confidence            5889999999999999998764   57899999998642       1245778999999997799999999999653  6


Q ss_pred             ccEEEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccC
Q 014406          196 TPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (425)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~  272 (425)
                      ..++||||+.+++|..++   ..+++..++.++.||+.||+|||+.||+||||||+|||++.+ +.+||+|||+++....
T Consensus        79 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~-~~~kl~DfG~~~~~~~  157 (332)
T cd05614          79 KLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSE-GHVVLTDFGLSKEFLS  157 (332)
T ss_pred             EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCC-CCEEEeeCcCCccccc
Confidence            788999999999998876   458999999999999999999999999999999999999988 7999999999976533


Q ss_pred             CC--cceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhcc
Q 014406          273 GK--EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH  350 (425)
Q Consensus       273 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~  350 (425)
                      ..  ......||..|+|||++.+...++.++|||||||++|+|++|..||........ ...+...+         ... 
T Consensus       158 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-~~~~~~~~---------~~~-  226 (332)
T cd05614         158 EEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT-QSEVSRRI---------LKC-  226 (332)
T ss_pred             cCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC-HHHHHHHH---------hcC-
Confidence            22  223457899999999998745688999999999999999999999843211111 11111100         000 


Q ss_pred             CCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCc-----CHHHHhcCCCCcccccch
Q 014406          351 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYFAQVRAAE  419 (425)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rp-----ta~elL~hp~~~~~~~~~  419 (425)
                                             .......+++.+.+|+.+||+.||++||     +++++++||||++..+..
T Consensus       227 -----------------------~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~~  277 (332)
T cd05614         227 -----------------------DPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWEA  277 (332)
T ss_pred             -----------------------CCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCCHHH
Confidence                                   0011223688999999999999999999     889999999999876533

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-45  Score=340.85  Aligned_cols=311  Identities=25%  Similarity=0.401  Sum_probs=246.1

Q ss_pred             ccCCCCccCCcCCcccccCCC-CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc--hHHHHHHHHHHHHhcC--
Q 014406          104 NVLRPKEYWDYESLTVQWGDQ-DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--KKKIKREIKILQNLCG--  178 (425)
Q Consensus       104 ~~~~~~~~~~~~~~~~~~~~~-~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~~--  178 (425)
                      +....+....|..+.++..+. .+|.+.++||.|.|+|||+|.|..+.+.||+|+.+...  .+....||++|+++..  
T Consensus        56 E~~~dY~kGGYHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~D  135 (590)
T KOG1290|consen   56 EDPEDYRKGGYHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGD  135 (590)
T ss_pred             cChhhhhcCCCceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcC
Confidence            344556677889999988887 89999999999999999999999999999999998543  4667899999999843  


Q ss_pred             -----CCCeeeEEeEEE--cCCCCccEEEEEeecCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHH-CCceeecCC
Q 014406          179 -----GPNVVKLLDIVR--DQHSKTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHS-QGIMHRDVK  246 (425)
Q Consensus       179 -----h~niv~l~~~~~--~~~~~~~~lv~e~~~~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~LH~-~~ivH~Dlk  246 (425)
                           ..+||+|++.|.  +.++.|+|+|+|++....|....    +.++...++.|++||+.||.|||. +||||.|||
T Consensus       136 p~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlK  215 (590)
T KOG1290|consen  136 PNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLK  215 (590)
T ss_pred             CCCCCCceeeeeeccceecCCCCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCC
Confidence                 248999999997  56888999999999988877654    569999999999999999999996 599999999


Q ss_pred             CCceEec-------------------------------------------------------------------------
Q 014406          247 PHNVMID-------------------------------------------------------------------------  253 (425)
Q Consensus       247 ~~NIll~-------------------------------------------------------------------------  253 (425)
                      |+|||+.                                                                         
T Consensus       216 PENvLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~  295 (590)
T KOG1290|consen  216 PENVLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIE  295 (590)
T ss_pred             cceeeeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhccccccc
Confidence            9999983                                                                         


Q ss_pred             -----------------------------------------CC-------------------------------------
Q 014406          254 -----------------------------------------HE-------------------------------------  255 (425)
Q Consensus       254 -----------------------------------------~~-------------------------------------  255 (425)
                                                               ..                                     
T Consensus       296 ~~~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~  375 (590)
T KOG1290|consen  296 EEPNQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIA  375 (590)
T ss_pred             ccccccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccc
Confidence                                                     00                                     


Q ss_pred             --------------CCcEEEEeccccccccCCCcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 014406          256 --------------LRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF  321 (425)
Q Consensus       256 --------------~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~  321 (425)
                                    .-++||+|||-|+...  ..++...+|+.|+|||++++ ..|++.+||||++|++|||.||...|.
T Consensus       376 ~n~~v~p~~~~~~~di~vKIaDlGNACW~~--khFT~DIQTRQYRapEVllG-sgY~~~ADiWS~AC~~FELaTGDyLFe  452 (590)
T KOG1290|consen  376 SNPLVNPDIPLPECDIRVKIADLGNACWVH--KHFTEDIQTRQYRAPEVLLG-SGYSTSADIWSTACMAFELATGDYLFE  452 (590)
T ss_pred             cccccCCCCCCCccceeEEEeeccchhhhh--hhhchhhhhhhccCcceeec-CCCCCchhHHHHHHHHHHhhcCceeec
Confidence                          0147999999998754  45666789999999999999 789999999999999999999999986


Q ss_pred             CCC-----CCHHHHHHHHHHhCCchhHHHH-hhccCCCChhhHHHhcccCCCCccccccccCC----CCCCHHHHHHHHH
Q 014406          322 YGH-----DNHDQLVKIAKVLGTDELNAYL-NKYHLELDPQLDALVGRHSRKPWSKFINADNQ----HLVSPEAIDFLDK  391 (425)
Q Consensus       322 ~~~-----~~~~~~~~~~~~lg~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~s~~~~~ll~~  391 (425)
                      +..     .++++++.|++.+|.-+....+ .++...+...-..+......++|...-.....    ..-..++.+|+.-
T Consensus       453 PhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~P  532 (590)
T KOG1290|consen  453 PHSGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSP  532 (590)
T ss_pred             CCCCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHH
Confidence            533     3578999999999976554333 22322222222223333334555533211111    1123457899999


Q ss_pred             cccCCcCCCcCHHHHhcCCCCccccc
Q 014406          392 LLRYDHQDRLTAREAMAHPYFAQVRA  417 (425)
Q Consensus       392 ~L~~dP~~Rpta~elL~hp~~~~~~~  417 (425)
                      ||+.+|++|+||.++|+||||+.+..
T Consensus       533 mLef~PeKR~tA~~cl~hPwLn~~~~  558 (590)
T KOG1290|consen  533 MLEFDPEKRPTAAQCLKHPWLNPVAG  558 (590)
T ss_pred             HHhcCccccccHHHHhcCccccCCCC
Confidence            99999999999999999999997755

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-46  Score=345.66  Aligned_cols=269  Identities=26%  Similarity=0.399  Sum_probs=224.2

Q ss_pred             CCcCCcccccCCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc------hHHHHHHHHHHHHhcCCCCeeeE
Q 014406          112 WDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKL  185 (425)
Q Consensus       112 ~~~~~~~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l  185 (425)
                      .+|+.+..+....+.|..-+.||+||||.||-++...||+.+|.|.+.+..      .....+|-.||.++ +.+.||.+
T Consensus       172 lQWK~lE~qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV-~s~FiVsl  250 (591)
T KOG0986|consen  172 LQWKWLELQPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKV-SSPFIVSL  250 (591)
T ss_pred             HHHHHHHhhhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHh-ccCcEEEE
Confidence            345556666667788999999999999999999999999999999886432      23467899999999 89999999


Q ss_pred             EeEEEcCCCCccEEEEEeecCCChhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEE
Q 014406          186 LDIVRDQHSKTPSLIFEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLR  260 (425)
Q Consensus       186 ~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-----~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~k  260 (425)
                      --.|+.  ...+|||+..|+||+|..++.     .|++..++.++.+|+.||++||+.+||+||+||+|||+|+. |+++
T Consensus       251 aYAfeT--kd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~-GhvR  327 (591)
T KOG0986|consen  251 AYAFET--KDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDH-GHVR  327 (591)
T ss_pred             eeeecC--CCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccC-CCeE
Confidence            888844  478999999999999998873     58999999999999999999999999999999999999988 8999


Q ss_pred             EEeccccccccCCCcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCc
Q 014406          261 LIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTD  340 (425)
Q Consensus       261 l~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~  340 (425)
                      |+|+|+|..+..+......+||.+|||||++.+ ..|+.+.|.||+||++|||+.|+.||-. ........++-+..-. 
T Consensus       328 ISDLGLAvei~~g~~~~~rvGT~GYMAPEvl~n-e~Y~~s~Dwf~lGCllYemi~G~sPFr~-~KeKvk~eEvdrr~~~-  404 (591)
T KOG0986|consen  328 ISDLGLAVEIPEGKPIRGRVGTVGYMAPEVLQN-EVYDFSPDWFSLGCLLYEMIAGHSPFRQ-RKEKVKREEVDRRTLE-  404 (591)
T ss_pred             eeccceEEecCCCCccccccCcccccCHHHHcC-CcccCCccHHHHHhHHHHHHcccCchhh-hhhhhhHHHHHHHHhc-
Confidence            999999999988888888899999999999998 6699999999999999999999999932 1111111111110000 


Q ss_pred             hhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCc-----CHHHHhcCCCCccc
Q 014406          341 ELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYFAQV  415 (425)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rp-----ta~elL~hp~~~~~  415 (425)
                                                      ...+....+|++++++++.+|+.||++|.     +++++.+||||+.+
T Consensus       405 --------------------------------~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~l  452 (591)
T KOG0986|consen  405 --------------------------------DPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDL  452 (591)
T ss_pred             --------------------------------chhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccC
Confidence                                            01122334899999999999999999998     57899999999999


Q ss_pred             ccch
Q 014406          416 RAAE  419 (425)
Q Consensus       416 ~~~~  419 (425)
                      +|..
T Consensus       453 nw~r  456 (591)
T KOG0986|consen  453 NWRR  456 (591)
T ss_pred             CHhH
Confidence            8854

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=1.2e-44  Score=348.33  Aligned_cols=281  Identities=19%  Similarity=0.321  Sum_probs=211.7

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccE
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (425)
                      ..++|++.+.||+|+||.||++.+..++..+|+|++....    .+.+.+|+++++++ +||||+++++++.+.  ...+
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~--~~~~   79 (331)
T cd06649           3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYSD--GEIS   79 (331)
T ss_pred             CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHC-CCCCCCeEEEEEEEC--CEEE
Confidence            3688999999999999999999999999999999987532    35688999999999 999999999999654  6788


Q ss_pred             EEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHC-CceeecCCCCceEecCCCCcEEEEeccccccccCCC
Q 014406          199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (425)
Q Consensus       199 lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~-~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~  274 (425)
                      +||||+++++|.+++   ..+++..+..++.|++.||.|||+. +|+|+||||+|||++.+ +.+||+|||++...... 
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~-  157 (331)
T cd06649          80 ICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDS-  157 (331)
T ss_pred             EEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCC-CcEEEccCccccccccc-
Confidence            999999999999887   3488999999999999999999986 69999999999999988 78999999998765432 


Q ss_pred             cceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhc-----
Q 014406          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY-----  349 (425)
Q Consensus       275 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~-----  349 (425)
                      ......++..|+|||++.+ ..++.++|||||||++|+|++|+.||... +. ..+.   ..++.+.........     
T Consensus       158 ~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~-~~-~~~~---~~~~~~~~~~~~~~~~~~~~  231 (331)
T cd06649         158 MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVELAIGRYPIPPP-DA-KELE---AIFGRPVVDGEEGEPHSISP  231 (331)
T ss_pred             ccccCCCCcCcCCHhHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCC-CH-HHHH---HHhcccccccccCCccccCc
Confidence            2334578999999999987 67999999999999999999999998432 22 2222   222221110000000     


Q ss_pred             -cCC-----------CCh--hhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCccc
Q 014406          350 -HLE-----------LDP--QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV  415 (425)
Q Consensus       350 -~~~-----------~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~  415 (425)
                       ...           ..+  ...........    ..........+++++++||++||++||++|||+.|+++||||+..
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~  307 (331)
T cd06649         232 RPRPPGRPVSGHGMDSRPAMAIFELLDYIVN----EPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRS  307 (331)
T ss_pred             ccccccccccccccccccchhHHHHHHHHHh----CCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhc
Confidence             000           000  00000000000    000011112368899999999999999999999999999999876


Q ss_pred             ccc
Q 014406          416 RAA  418 (425)
Q Consensus       416 ~~~  418 (425)
                      ...
T Consensus       308 ~~~  310 (331)
T cd06649         308 EVE  310 (331)
T ss_pred             ccc
Confidence            543

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=1.1e-44  Score=348.36  Aligned_cols=252  Identities=25%  Similarity=0.438  Sum_probs=202.1

Q ss_pred             eeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEEEee
Q 014406          131 RKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV  204 (425)
Q Consensus       131 ~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~  204 (425)
                      +.||+|+||+||+|.+..+++.||+|+++..      ..+.+.+|..++..+.+||||++++++|.+.  ...++||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~--~~~~lv~e~~   78 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTE--SRLFFVIEFV   78 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcC--CEEEEEEeCC
Confidence            3699999999999999999999999999742      2345778999999887899999999999654  6789999999


Q ss_pred             cCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccc-cCCCcceeec
Q 014406          205 NSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY-HPGKEYNVRV  280 (425)
Q Consensus       205 ~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~-~~~~~~~~~~  280 (425)
                      ++++|..++   ..+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++.. ..........
T Consensus        79 ~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~  157 (329)
T cd05588          79 SGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAE-GHIKLTDYGMCKEGIRPGDTTSTFC  157 (329)
T ss_pred             CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCC-CCEEECcCccccccccCCCcccccc
Confidence            999998765   458999999999999999999999999999999999999988 78999999998753 2233344567


Q ss_pred             cCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCH--H--HHHHHHHHhCCchhHHHHhhccCCCChh
Q 014406          281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNH--D--QLVKIAKVLGTDELNAYLNKYHLELDPQ  356 (425)
Q Consensus       281 ~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~--~--~~~~~~~~lg~~~~~~~~~~~~~~~~~~  356 (425)
                      ||..|+|||++.+ ..++.++|||||||++|+|++|+.||.......  .  ....+.+.                    
T Consensus       158 gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~--------------------  216 (329)
T cd05588         158 GTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQV--------------------  216 (329)
T ss_pred             CCccccCHHHHcC-CCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHH--------------------
Confidence            8999999999987 778999999999999999999999984211000  0  00000000                    


Q ss_pred             hHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcC------HHHHhcCCCCcccccch
Q 014406          357 LDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT------AREAMAHPYFAQVRAAE  419 (425)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpt------a~elL~hp~~~~~~~~~  419 (425)
                         .....          ...+..++.++.+++++||+.||++|+|      ++|+++||||+++.+..
T Consensus       217 ---~~~~~----------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~~~  272 (329)
T cd05588         217 ---ILEKQ----------IRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWDL  272 (329)
T ss_pred             ---HHcCC----------CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCHHH
Confidence               00000          0012237889999999999999999997      78999999999876643

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.3e-44  Score=351.51  Aligned_cols=280  Identities=22%  Similarity=0.346  Sum_probs=207.7

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcchHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEEE
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE  202 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e  202 (425)
                      ...+|++++.||+|+||.||+|.+..+++.||+|+...   .....|+.+++++ +|+||+++++++...  ...++|+|
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~---~~~~~E~~~l~~l-~h~~iv~~~~~~~~~--~~~~lv~e  137 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK---GTTLIEAMLLQNV-NHPSVIRMKDTLVSG--AITCMVLP  137 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc---cccHHHHHHHHhC-CCCCCcChhheEEeC--CeeEEEEE
Confidence            35679999999999999999999999999999998543   2345799999999 999999999999654  67889999


Q ss_pred             eecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCcceee
Q 014406          203 YVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR  279 (425)
Q Consensus       203 ~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~~~~~  279 (425)
                      |+.+..+..+.   ..+++..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++...........
T Consensus       138 ~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~-~~~kl~DfG~a~~~~~~~~~~~~  216 (357)
T PHA03209        138 HYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDV-DQVCIGDLGAAQFPVVAPAFLGL  216 (357)
T ss_pred             ccCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC-CCEEEecCccccccccCcccccc
Confidence            99764443332   348999999999999999999999999999999999999988 78999999999754433344456


Q ss_pred             ccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCC---------HHHHHHHHHHhCCchhHHHHhhcc
Q 014406          280 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN---------HDQLVKIAKVLGTDELNAYLNKYH  350 (425)
Q Consensus       280 ~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~---------~~~~~~~~~~lg~~~~~~~~~~~~  350 (425)
                      .||..|+|||++.+ ..++.++|||||||++|||+++..+++.....         ..++..+...++..+.. +...  
T Consensus       217 ~gt~~y~aPE~~~~-~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~-~~~~--  292 (357)
T PHA03209        217 AGTVETNAPEVLAR-DKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEE-FPRD--  292 (357)
T ss_pred             cccccccCCeecCC-CCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhh-cCCC--
Confidence            78999999999987 67999999999999999999987777654322         22333344444432111 0000  


Q ss_pred             CCCChhhHHHhc--ccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCccc
Q 014406          351 LELDPQLDALVG--RHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV  415 (425)
Q Consensus       351 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~  415 (425)
                       ...........  ...+.++... .......++.++.+||.+||+.||++|||+.|+|+||||+++
T Consensus       293 -~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~~  357 (357)
T PHA03209        293 -PGSRLVRGFIEYASLERQPYTRY-PCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQL  357 (357)
T ss_pred             -CccHHHHHHHhhcccCCCccccc-HHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhccC
Confidence             00000000000  0111111111 011122467888999999999999999999999999999874

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=8.4e-45  Score=348.04  Aligned_cols=247  Identities=24%  Similarity=0.379  Sum_probs=202.9

Q ss_pred             eeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEEEeec
Q 014406          132 KVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVN  205 (425)
Q Consensus       132 ~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~  205 (425)
                      .||+|+||+||+|.+..+++.||+|+++..      ....+..|..++..+.+||||+++++++.+.  ...++||||++
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~--~~~~lv~E~~~   79 (321)
T cd05591           2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTK--DRLFFVMEYVN   79 (321)
T ss_pred             ccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcC--CeEEEEEeCCC
Confidence            699999999999999999999999998742      2345678899998776899999999999654  67899999999


Q ss_pred             CCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccC-CCcceeecc
Q 014406          206 STDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP-GKEYNVRVA  281 (425)
Q Consensus       206 ~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~-~~~~~~~~~  281 (425)
                      +++|...+   ..+++..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++..... ........|
T Consensus        80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~g  158 (321)
T cd05591          80 GGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAE-GHCKLADFGMCKEGILNGVTTTTFCG  158 (321)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCC-CCEEEeecccceecccCCcccccccc
Confidence            99998766   458899999999999999999999999999999999999988 7899999999875432 222344578


Q ss_pred             CCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCChhhHHHh
Q 014406          282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALV  361 (425)
Q Consensus       282 t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~  361 (425)
                      +..|+|||++.+ ..++.++|||||||++|+|++|+.||. +.+..+.+..+..  +           .           
T Consensus       159 t~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~Pf~-~~~~~~~~~~i~~--~-----------~-----------  212 (321)
T cd05591         159 TPDYIAPEILQE-LEYGPSVDWWALGVLMYEMMAGQPPFE-ADNEDDLFESILH--D-----------D-----------  212 (321)
T ss_pred             CccccCHHHHcC-CCCCCccceechhHHHHHHhcCCCCCC-CCCHHHHHHHHHc--C-----------C-----------
Confidence            999999999877 679999999999999999999999983 3333333322211  0           0           


Q ss_pred             cccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCc-------CHHHHhcCCCCcccccchh
Q 014406          362 GRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-------TAREAMAHPYFAQVRAAES  420 (425)
Q Consensus       362 ~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rp-------ta~elL~hp~~~~~~~~~~  420 (425)
                                   ...+..++.++.+|+++||+.||++|+       +++++++||||..+.+...
T Consensus       213 -------------~~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~~~~~  265 (321)
T cd05591         213 -------------VLYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDWVLL  265 (321)
T ss_pred             -------------CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCCCHHHH
Confidence                         001112688999999999999999999       9999999999998876543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=7.9e-44  Score=340.51  Aligned_cols=280  Identities=25%  Similarity=0.512  Sum_probs=205.1

Q ss_pred             eeeeeeCceEEEEEEEcC--CCcEEEEEEecCcc-hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEEEeecCC
Q 014406          131 RKVGRGKYSEVFEGINVN--TNERCIIKILKPVK-KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST  207 (425)
Q Consensus       131 ~~LG~G~fg~V~~~~~~~--~~~~vavK~~~~~~-~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~  207 (425)
                      .+||+|+||+||+|.+..  ++..+|+|.+.... ...+.+|+.+++.+ +||||+++++++........++|+||++++
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~lv~e~~~~~   85 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLREL-KHPNVIALQKVFLSHSDRKVWLLFDYAEHD   85 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhC-CCCCeeeEEEEEeccCCCeEEEEEeeeCCc
Confidence            579999999999998654  56889999987543 35678999999999 999999999999766667889999999875


Q ss_pred             Chhhhc-----------CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecC---CCCcEEEEeccccccccCC
Q 014406          208 DFKVLY-----------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH---ELRKLRLIDWGLAEFYHPG  273 (425)
Q Consensus       208 ~l~~~~-----------~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~---~~~~~kl~Dfg~a~~~~~~  273 (425)
                      .+....           ..+++..++.++.|++.||.|||+.+|+||||||+|||++.   +.+.+||+|||+++.....
T Consensus        86 l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~  165 (317)
T cd07867          86 LWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP  165 (317)
T ss_pred             HHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCC
Confidence            433221           13788899999999999999999999999999999999942   2368999999999865432


Q ss_pred             C----cceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCC--------CHHHHHHHHHHhCCch
Q 014406          274 K----EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD--------NHDQLVKIAKVLGTDE  341 (425)
Q Consensus       274 ~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~--------~~~~~~~~~~~lg~~~  341 (425)
                      .    ......+|..|+|||++.+...++.++|||||||++|||++|..||.....        ...++..+...+|.+.
T Consensus       166 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (317)
T cd07867         166 LKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPA  245 (317)
T ss_pred             cccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcCCCC
Confidence            2    223456788999999997756689999999999999999999999854332        2345666777777554


Q ss_pred             hHHHHhhccCCCChhhHHHhcccCC--CCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCC
Q 014406          342 LNAYLNKYHLELDPQLDALVGRHSR--KPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF  412 (425)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~  412 (425)
                      ...+..-......+...........  ...... ........+..+++|+.+||+.||++|||++|+|+||||
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07867         246 DKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKY-MEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF  317 (317)
T ss_pred             hhhhhhhhhcccchhhhhhhcccccCCchhhhh-hhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            4433221111111111110000000  000000 011122346779999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=2.3e-44  Score=344.23  Aligned_cols=247  Identities=23%  Similarity=0.434  Sum_probs=201.0

Q ss_pred             eeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEEEee
Q 014406          131 RKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV  204 (425)
Q Consensus       131 ~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~  204 (425)
                      +.||+|+||.||+|.+..+++.||+|+++..      .......|..++....+|+||+++++++.+.  .+.++||||+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~--~~~~lv~E~~   78 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTK--EHLFFVMEFL   78 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeC--CEEEEEECCC
Confidence            3699999999999999999999999999742      2345677888887666899999999999654  6889999999


Q ss_pred             cCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccC-CCcceeec
Q 014406          205 NSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP-GKEYNVRV  280 (425)
Q Consensus       205 ~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~-~~~~~~~~  280 (425)
                      .+++|..++   ..+++..+..++.|++.||+|||++||+||||||+|||++.+ +.++|+|||+++.... ........
T Consensus        79 ~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~  157 (316)
T cd05620          79 NGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRD-GHIKIADFGMCKENVFGDNRASTFC  157 (316)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCC-CCEEeCccCCCeecccCCCceeccC
Confidence            999998776   358899999999999999999999999999999999999988 7899999999874322 22334467


Q ss_pred             cCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCChhhHHH
Q 014406          281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDAL  360 (425)
Q Consensus       281 ~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~  360 (425)
                      ||..|+|||++.+ ..++.++|||||||++|+|++|+.||. +.+..+....+..  +.                     
T Consensus       158 gt~~y~aPE~~~~-~~~~~~~DiwslGvil~el~~g~~Pf~-~~~~~~~~~~~~~--~~---------------------  212 (316)
T cd05620         158 GTPDYIAPEILQG-LKYTFSVDWWSFGVLLYEMLIGQSPFH-GDDEDELFESIRV--DT---------------------  212 (316)
T ss_pred             CCcCccCHHHHcC-CCCCcccchhhhHHHHHHHHhCCCCCC-CCCHHHHHHHHHh--CC---------------------
Confidence            8999999999987 679999999999999999999999984 2222222221110  00                     


Q ss_pred             hcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCH-HHHhcCCCCcccccch
Q 014406          361 VGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA-REAMAHPYFAQVRAAE  419 (425)
Q Consensus       361 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta-~elL~hp~~~~~~~~~  419 (425)
                                    ......++.++++|+++||+.||++|+++ +++++||||+++.+..
T Consensus       213 --------------~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~~~~~  258 (316)
T cd05620         213 --------------PHYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTINWTA  258 (316)
T ss_pred             --------------CCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCCCHHH
Confidence                          00112268899999999999999999997 5899999999987653

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=1.6e-44  Score=345.19  Aligned_cols=246  Identities=26%  Similarity=0.444  Sum_probs=200.2

Q ss_pred             eeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEEEeec
Q 014406          132 KVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVN  205 (425)
Q Consensus       132 ~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~  205 (425)
                      .||+|+||+||+|.+..+++.||+|+++..      ..+.+..|..++..+.+||||+++++++...  ...++||||++
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~--~~~~lv~e~~~   79 (316)
T cd05592           2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTK--EHLFFVMEYLN   79 (316)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcC--CEEEEEEcCCC
Confidence            699999999999999999999999998742      2344566777777665899999999999653  67899999999


Q ss_pred             CCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCC-Ccceeecc
Q 014406          206 STDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-KEYNVRVA  281 (425)
Q Consensus       206 ~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~~  281 (425)
                      +++|..++   ..+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++..... .......|
T Consensus        80 gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~-~~~kL~Dfg~a~~~~~~~~~~~~~~g  158 (316)
T cd05592          80 GGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKD-GHIKIADFGMCKENMNGEGKASTFCG  158 (316)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCC-CCEEEccCcCCeECCCCCCccccccC
Confidence            99998776   458999999999999999999999999999999999999988 78999999999754322 23344578


Q ss_pred             CCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCChhhHHHh
Q 014406          282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALV  361 (425)
Q Consensus       282 t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~  361 (425)
                      |..|+|||++.+ ..++.++|||||||++|+|++|+.||. +.+..+.+..+..   .                      
T Consensus       159 t~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~G~~Pf~-~~~~~~~~~~i~~---~----------------------  211 (316)
T cd05592         159 TPDYIAPEILKG-QKYNESVDWWSFGVLLYEMLIGQSPFH-GEDEDELFDSILN---D----------------------  211 (316)
T ss_pred             CccccCHHHHcC-CCCCCcccchhHHHHHHHHHhCCCCCC-CCCHHHHHHHHHc---C----------------------
Confidence            999999999987 678999999999999999999999984 3332222222211   0                      


Q ss_pred             cccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCH-HHHhcCCCCcccccch
Q 014406          362 GRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA-REAMAHPYFAQVRAAE  419 (425)
Q Consensus       362 ~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta-~elL~hp~~~~~~~~~  419 (425)
                                  ....+..++.++.+|+++||+.||++||++ .++++||||+.+.+..
T Consensus       212 ------------~~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~~~~~  258 (316)
T cd05592         212 ------------RPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGIDWER  258 (316)
T ss_pred             ------------CCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCCCCHHH
Confidence                        000112368899999999999999999986 5899999999887643

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=3.2e-44  Score=337.77  Aligned_cols=275  Identities=31%  Similarity=0.562  Sum_probs=216.7

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEE
Q 014406          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (425)
Q Consensus       126 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (425)
                      +|++.+.||+|+||+||+|.+..+|+.+|+|.++..     ....+.+|+.+++++ +|+||+++++++.+.  ...+++
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l-~h~~i~~~~~~~~~~--~~~~lv   77 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-KHKNIVRLYDVLHSD--KKLTLV   77 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhc-CCCCeeeHHHHhccC--CceEEE
Confidence            588899999999999999999999999999998642     234577899999999 999999999999654  678999


Q ss_pred             EEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCC-Ccc
Q 014406          201 FEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-KEY  276 (425)
Q Consensus       201 ~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~-~~~  276 (425)
                      +||++++.+..+.   ..+++..++.++.||+.||.|||+++|+|+||||+||+++.+ +.++|+|||+++..... ...
T Consensus        78 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~-~~~~l~dfg~~~~~~~~~~~~  156 (284)
T cd07839          78 FEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKN-GELKLADFGLARAFGIPVRCY  156 (284)
T ss_pred             EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCC-CcEEECccchhhccCCCCCCc
Confidence            9999865433332   348999999999999999999999999999999999999988 78999999999765432 222


Q ss_pred             eeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCChh
Q 014406          277 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ  356 (425)
Q Consensus       277 ~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~  356 (425)
                      ....++..|+|||.+.+...++.++|||||||++|+|++|+.||+.+.+..+.+..+.+.++..+...+.......... 
T Consensus       157 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  235 (284)
T cd07839         157 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYK-  235 (284)
T ss_pred             CCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccccc-
Confidence            3456788899999987755689999999999999999999999988888788888888877766544332111110000 


Q ss_pred             hHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCC
Q 014406          357 LDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF  412 (425)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~  412 (425)
                        ..........     .......+++++++|+.+||+.||.+|||++|+++||||
T Consensus       236 --~~~~~~~~~~-----~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f  284 (284)
T cd07839         236 --PYPMYPATTS-----LVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF  284 (284)
T ss_pred             --ccCCCCCcch-----hhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence              0000000000     011223478999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=7.4e-44  Score=338.38  Aligned_cols=283  Identities=28%  Similarity=0.580  Sum_probs=217.2

Q ss_pred             cCCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCc
Q 014406          121 WGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (425)
Q Consensus       121 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (425)
                      ++..++|++.+.||.|+||.||+|.+..+++.||+|.+...    ....+.+|+.+++.+ +|+||+++++++...  ..
T Consensus         2 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nI~~~~~~~~~~--~~   78 (301)
T cd07873           2 FGKLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDL-KHANIVTLHDIIHTE--KS   78 (301)
T ss_pred             CccccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhc-CCCCcceEEEEEecC--Ce
Confidence            34568899999999999999999999999999999998633    234677899999999 999999999999654  67


Q ss_pred             cEEEEEeecCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccC
Q 014406          197 PSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (425)
Q Consensus       197 ~~lv~e~~~~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~  272 (425)
                      .++||||+++ +|..++    ..+++..+..++.|++.||+|||+.||+|+||||+||+++.+ +.++|+|||++.....
T Consensus        79 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~-~~~kl~dfg~~~~~~~  156 (301)
T cd07873          79 LTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINER-GELKLADFGLARAKSI  156 (301)
T ss_pred             EEEEEecccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCC-CcEEECcCcchhccCC
Confidence            8999999985 555544    347889999999999999999999999999999999999988 7899999999875432


Q ss_pred             C-CcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccC
Q 014406          273 G-KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL  351 (425)
Q Consensus       273 ~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~  351 (425)
                      . .......++..|+|||.+.+...++.++|||||||++|+|++|+.|| .+.+..+++..+...++.+....+..-...
T Consensus       157 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (301)
T cd07873         157 PTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLF-PGSTVEEQLHFIFRILGTPTEETWPGILSN  235 (301)
T ss_pred             CCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHcCCCChhhchhhhcc
Confidence            2 22233466889999999877566889999999999999999999887 445556667777776665443322110000


Q ss_pred             CCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccc
Q 014406          352 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR  416 (425)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~  416 (425)
                        .. +    .......+...........+++.+++||.+||+.||.+|||++|+|+||||+...
T Consensus       236 --~~-~----~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~  293 (301)
T cd07873         236 --EE-F----KSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG  293 (301)
T ss_pred             --cc-c----cccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence              00 0    0000000000000111234788999999999999999999999999999998764

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1.2e-44  Score=353.06  Aligned_cols=256  Identities=26%  Similarity=0.417  Sum_probs=206.4

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCc
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (425)
                      ..++|++.+.||+|+||.||++.+..+++.+|+|++...      ....+.+|+.+++.+ +||||+++++++.+  +..
T Consensus        41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~-~hp~iv~~~~~~~~--~~~  117 (370)
T cd05621          41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLFCAFQD--DKY  117 (370)
T ss_pred             CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-CCCCEeeEEEEEEc--CCE
Confidence            467899999999999999999999999999999998632      234577899999998 99999999999965  478


Q ss_pred             cEEEEEeecCCChhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCC
Q 014406          197 PSLIFEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (425)
Q Consensus       197 ~~lv~e~~~~~~l~~~~~--~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~  274 (425)
                      .++||||+++++|..++.  .+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||++.......
T Consensus       118 ~~lv~Ey~~gg~L~~~l~~~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~-~~~kL~DFG~a~~~~~~~  196 (370)
T cd05621         118 LYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKH-GHLKLADFGTCMKMDETG  196 (370)
T ss_pred             EEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCC-CCEEEEecccceecccCC
Confidence            899999999999998874  47888999999999999999999999999999999999988 799999999998664332


Q ss_pred             c--ceeeccCCCccCcccccCC---CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhc
Q 014406          275 E--YNVRVASRYFKGPELLVDL---QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY  349 (425)
Q Consensus       275 ~--~~~~~~t~~y~aPE~~~~~---~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~  349 (425)
                      .  .....||+.|+|||++.+.   ..++.++||||+||++|+|++|+.||.. .+.......+......          
T Consensus       197 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~-~~~~~~~~~i~~~~~~----------  265 (370)
T cd05621         197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYA-DSLVGTYSKIMDHKNS----------  265 (370)
T ss_pred             ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCcc----------
Confidence            2  2355789999999998652   2378999999999999999999999943 2323333322211000          


Q ss_pred             cCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCC--CcCHHHHhcCCCCcccc
Q 014406          350 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQD--RLTAREAMAHPYFAQVR  416 (425)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~--Rpta~elL~hp~~~~~~  416 (425)
                       .                      .......++..+++++.+||+.++.+  |+|++|+++||||++..
T Consensus       266 -~----------------------~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~~  311 (370)
T cd05621         266 -L----------------------NFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQ  311 (370)
T ss_pred             -c----------------------CCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCCC
Confidence             0                      00011236889999999999865544  88999999999998754

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=2.1e-44  Score=346.37  Aligned_cols=251  Identities=26%  Similarity=0.442  Sum_probs=201.0

Q ss_pred             eeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEEEee
Q 014406          131 RKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV  204 (425)
Q Consensus       131 ~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~  204 (425)
                      +.||+|+||+||+|.+..+++.+|+|+++..      ..+.+.+|+.++.++.+||||+++++++...  ...++||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~--~~~~lv~E~~   78 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE--SRLFFVIEYV   78 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeC--CEEEEEEeCC
Confidence            3699999999999999999999999998743      2245678999888876899999999999654  6789999999


Q ss_pred             cCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccC-CCcceeec
Q 014406          205 NSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP-GKEYNVRV  280 (425)
Q Consensus       205 ~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~-~~~~~~~~  280 (425)
                      ++++|..++   ..+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++.... ........
T Consensus        79 ~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~-~~~kL~DfG~~~~~~~~~~~~~~~~  157 (329)
T cd05618          79 NGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE-GHIKLTDYGMCKEGLRPGDTTSTFC  157 (329)
T ss_pred             CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCC-CCEEEeeCCccccccCCCCcccccc
Confidence            999998765   458999999999999999999999999999999999999988 7899999999875322 23334457


Q ss_pred             cCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCC--C--HHHHHHHHHHhCCchhHHHHhhccCCCChh
Q 014406          281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD--N--HDQLVKIAKVLGTDELNAYLNKYHLELDPQ  356 (425)
Q Consensus       281 ~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~--~--~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~  356 (425)
                      ||..|+|||++.+ ..++.++|||||||++|+|++|+.||.....  .  ......+.+..                   
T Consensus       158 gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i-------------------  217 (329)
T cd05618         158 GTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI-------------------  217 (329)
T ss_pred             CCccccCHHHHcC-CCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHH-------------------
Confidence            8999999999987 7789999999999999999999999842110  0  00000000000                   


Q ss_pred             hHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcC------HHHHhcCCCCcccccc
Q 014406          357 LDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT------AREAMAHPYFAQVRAA  418 (425)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpt------a~elL~hp~~~~~~~~  418 (425)
                          ...          ....+..++.++.+|+++||+.||++|+|      ++++++||||+++.+.
T Consensus       218 ----~~~----------~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~~  271 (329)
T cd05618         218 ----LEK----------QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWD  271 (329)
T ss_pred             ----hcC----------CCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCHH
Confidence                000          00112236889999999999999999998      5899999999988764

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=3e-44  Score=337.54  Aligned_cols=249  Identities=24%  Similarity=0.389  Sum_probs=200.6

Q ss_pred             eeeeCceEEEEEEEcCCCcEEEEEEecCcc------hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEEEeecC
Q 014406          133 VGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNS  206 (425)
Q Consensus       133 LG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~  206 (425)
                      ||+|+||+||++.+..+++.+|+|.+....      .+.+..|+.+++.+ +|+||+++.+++...  ...++||||+++
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~i~~~~~~~~~~--~~~~lv~e~~~~   77 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV-HSRFIVSLAYAFQTK--TDLCLVMTIMNG   77 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhC-CCCcEeeeeEEEcCC--CeEEEEEeCCCC
Confidence            699999999999999999999999986432      24567899999999 999999999998653  678999999999


Q ss_pred             CChhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCc-cee
Q 014406          207 TDFKVLY-------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-YNV  278 (425)
Q Consensus       207 ~~l~~~~-------~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~-~~~  278 (425)
                      ++|..++       ..+++..+..++.||+.||+|||+.+|+||||||+||+++.+ +.++|+|||++........ ...
T Consensus        78 g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~-~~~~l~dfg~~~~~~~~~~~~~~  156 (280)
T cd05608          78 GDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDND-GNVRISDLGLAVELKDGQSKTKG  156 (280)
T ss_pred             CCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC-CCEEEeeCccceecCCCCccccc
Confidence            9997654       248899999999999999999999999999999999999987 7899999999976543322 233


Q ss_pred             eccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCChhhH
Q 014406          279 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLD  358 (425)
Q Consensus       279 ~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~  358 (425)
                      ..++..|+|||++.+ ..++.++|||||||++|+|++|+.||........ ...+....-..                  
T Consensus       157 ~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~------------------  216 (280)
T cd05608         157 YAGTPGFMAPELLQG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE-NKELKQRILND------------------  216 (280)
T ss_pred             cCCCcCccCHHHhcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh-HHHHHHhhccc------------------
Confidence            578899999999987 6889999999999999999999999843222111 11111000000                  


Q ss_pred             HHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCc-----CHHHHhcCCCCcccccchh
Q 014406          359 ALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYFAQVRAAES  420 (425)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rp-----ta~elL~hp~~~~~~~~~~  420 (425)
                                     .......+++++.+|+.+||+.||++||     |++++++||||+++.+...
T Consensus       217 ---------------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~~~~  268 (280)
T cd05608         217 ---------------SVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWRQL  268 (280)
T ss_pred             ---------------CCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCCHhHH
Confidence                           0001123788999999999999999999     8999999999999876543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=1e-44  Score=347.98  Aligned_cols=246  Identities=27%  Similarity=0.453  Sum_probs=201.1

Q ss_pred             eeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEEEee
Q 014406          131 RKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV  204 (425)
Q Consensus       131 ~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~  204 (425)
                      +.||+|+||+||++.+..+++.||+|+++..      ....+.+|+.++..+ +||||+++++++...  ...++||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~-~hp~i~~~~~~~~~~--~~~~lv~E~~   77 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS-RHPFLTALKYSFQTH--DRLCFVMEYA   77 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCCceEEEEEcC--CEEEEEEeCC
Confidence            3699999999999999999999999999743      234567899999998 999999999999654  6789999999


Q ss_pred             cCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHH-CCceeecCCCCceEecCCCCcEEEEeccccccccC-CCcceee
Q 014406          205 NSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP-GKEYNVR  279 (425)
Q Consensus       205 ~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~-~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~-~~~~~~~  279 (425)
                      ++++|..++   ..+++..+..++.||+.||+|||+ .||+||||||+|||++.+ +.+||+|||+++.... .......
T Consensus        78 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~-~~~kL~Dfg~~~~~~~~~~~~~~~  156 (325)
T cd05594          78 NGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKD-GHIKITDFGLCKEGIKDGATMKTF  156 (325)
T ss_pred             CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCC-CCEEEecCCCCeecCCCCcccccc
Confidence            999998776   348999999999999999999997 799999999999999988 7899999999875332 2233445


Q ss_pred             ccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCChhhHH
Q 014406          280 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDA  359 (425)
Q Consensus       280 ~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~  359 (425)
                      .||..|+|||++.+ ..++.++|||||||++|+|++|+.||... +..+....+..             ..         
T Consensus       157 ~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tG~~Pf~~~-~~~~~~~~i~~-------------~~---------  212 (325)
T cd05594         157 CGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQ-DHEKLFELILM-------------EE---------  212 (325)
T ss_pred             cCCcccCCHHHHcc-CCCCCccccccccceeeeeccCCCCCCCC-CHHHHHHHHhc-------------CC---------
Confidence            78999999999977 67899999999999999999999998432 22222111100             00         


Q ss_pred             HhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCc-----CHHHHhcCCCCcccccch
Q 014406          360 LVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYFAQVRAAE  419 (425)
Q Consensus       360 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rp-----ta~elL~hp~~~~~~~~~  419 (425)
                                     ...+..+++++.+|+++||+.||++|+     ++.++++||||.++.+..
T Consensus       213 ---------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~~  262 (325)
T cd05594         213 ---------------IRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQD  262 (325)
T ss_pred             ---------------CCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCCCHHH
Confidence                           001123688999999999999999997     999999999999876543

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=3.1e-44  Score=343.60  Aligned_cols=247  Identities=24%  Similarity=0.423  Sum_probs=202.6

Q ss_pred             eeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEEEee
Q 014406          131 RKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV  204 (425)
Q Consensus       131 ~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~  204 (425)
                      +.||+|+||+||+|.+..+++.||+|+++..      ....+.+|+.++..+.+||||+++++++.+.  ...++||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~--~~~~lv~e~~   78 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTK--DRLFFVMEYV   78 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcC--CEEEEEEcCC
Confidence            3699999999999999999999999998742      2345678999998886799999999999654  6789999999


Q ss_pred             cCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccC-CCcceeec
Q 014406          205 NSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP-GKEYNVRV  280 (425)
Q Consensus       205 ~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~-~~~~~~~~  280 (425)
                      ++++|..++   ..+++..+..++.|++.||.|||+.+|+|+||||+|||++.+ +.+||+|||+++.... ........
T Consensus        79 ~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~  157 (318)
T cd05570          79 NGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSE-GHIKIADFGMCKEGILGGVTTSTFC  157 (318)
T ss_pred             CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCC-CcEEecccCCCeecCcCCCccccee
Confidence            999998776   358999999999999999999999999999999999999988 7899999999865322 22233457


Q ss_pred             cCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCChhhHHH
Q 014406          281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDAL  360 (425)
Q Consensus       281 ~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~  360 (425)
                      ++..|+|||++.+ ..++.++|||||||++|+|++|+.||. +.+..+....+..             ..          
T Consensus       158 g~~~y~aPE~~~~-~~~~~~~DiwslGvil~~l~~G~~pf~-~~~~~~~~~~i~~-------------~~----------  212 (318)
T cd05570         158 GTPDYIAPEILSY-QPYGPAVDWWALGVLLYEMLAGQSPFE-GDDEDELFQSILE-------------DE----------  212 (318)
T ss_pred             cCccccCHHHhcC-CCCCcchhhhhHHHHHHHHhhCCCCCC-CCCHHHHHHHHHc-------------CC----------
Confidence            8999999999987 789999999999999999999999984 2222222221110             00          


Q ss_pred             hcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCH-----HHHhcCCCCcccccch
Q 014406          361 VGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA-----REAMAHPYFAQVRAAE  419 (425)
Q Consensus       361 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta-----~elL~hp~~~~~~~~~  419 (425)
                                    ...+..+++++.+|+++||+.||++|||+     .++++||||+++.+..
T Consensus       213 --------------~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~~~~~  262 (318)
T cd05570         213 --------------VRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREIDWDK  262 (318)
T ss_pred             --------------CCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCCCHHH
Confidence                          00112368899999999999999999999     9999999999987643

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=5e-44  Score=341.76  Aligned_cols=248  Identities=24%  Similarity=0.415  Sum_probs=201.7

Q ss_pred             eeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEEEee
Q 014406          131 RKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV  204 (425)
Q Consensus       131 ~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~  204 (425)
                      +.||+|+||+||+|.+..+++.||+|+++..      .......|..++..+.+||||+++++++.+.  ...++||||+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~--~~~~lv~ey~   78 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTK--ENLFFVMEYL   78 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeC--CEEEEEEeCC
Confidence            3699999999999999999999999998743      2345667888887655899999999999654  6789999999


Q ss_pred             cCCChhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccC-CCcceeec
Q 014406          205 NSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP-GKEYNVRV  280 (425)
Q Consensus       205 ~~~~l~~~~~---~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~-~~~~~~~~  280 (425)
                      ++++|..++.   .+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++.... ........
T Consensus        79 ~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~  157 (316)
T cd05619          79 NGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTD-GHIKIADFGMCKENMLGDAKTCTFC  157 (316)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCC-CCEEEccCCcceECCCCCCceeeec
Confidence            9999988763   58899999999999999999999999999999999999988 7899999999875322 22334457


Q ss_pred             cCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCChhhHHH
Q 014406          281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDAL  360 (425)
Q Consensus       281 ~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~  360 (425)
                      ||..|+|||++.+ ..++.++|||||||++|+|++|..||.. .+..+.+..+..  +.                     
T Consensus       158 gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~G~~pf~~-~~~~~~~~~i~~--~~---------------------  212 (316)
T cd05619         158 GTPDYIAPEILLG-QKYNTSVDWWSFGVLLYEMLIGQSPFHG-HDEEELFQSIRM--DN---------------------  212 (316)
T ss_pred             CCccccCHHHHcC-CCCCchhhhhhHHHHHHHHHhCCCCCCC-CCHHHHHHHHHh--CC---------------------
Confidence            8999999999987 6799999999999999999999999842 222222222110  00                     


Q ss_pred             hcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHH-HHhcCCCCcccccchh
Q 014406          361 VGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAR-EAMAHPYFAQVRAAES  420 (425)
Q Consensus       361 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~-elL~hp~~~~~~~~~~  420 (425)
                                    ...+..++.++++|+.+||+.||++|+++. ++++||||+.+.+...
T Consensus       213 --------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~~~~~~  259 (316)
T cd05619         213 --------------PCYPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREIDWSAL  259 (316)
T ss_pred             --------------CCCCccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCCCHHHH
Confidence                          000112688999999999999999999996 9999999999876543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=6.6e-44  Score=336.09  Aligned_cols=254  Identities=26%  Similarity=0.433  Sum_probs=207.6

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc------hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEE
Q 014406          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (425)
Q Consensus       126 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (425)
                      .|+..+.||+|+||+||++.+..+++.+|+|.+....      ...+.+|+.+++++ +|+|++.+++.+.+.  ...++
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~i~~~~~~~~~~--~~~~l   77 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKV-NSRFVVSLAYAYETK--DALCL   77 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhC-CCCCeeeeeEEEecC--CEEEE
Confidence            3677889999999999999999999999999986421      23467899999999 999999999999654  67899


Q ss_pred             EEEeecCCChhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCC
Q 014406          200 IFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (425)
Q Consensus       200 v~e~~~~~~l~~~~-----~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~  274 (425)
                      ||||+++++|..++     ..+++..+..++.|++.||.|||+.+|+|+||||+||+++.+ +.++|+|||++.......
T Consensus        78 v~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~-~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05630          78 VLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDH-GHIRISDLGLAVHVPEGQ  156 (285)
T ss_pred             EEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCC-CCEEEeeccceeecCCCc
Confidence            99999999998776     248889999999999999999999999999999999999987 789999999997655444


Q ss_pred             cceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCH--HHHHHHHHHhCCchhHHHHhhccCC
Q 014406          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNH--DQLVKIAKVLGTDELNAYLNKYHLE  352 (425)
Q Consensus       275 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~--~~~~~~~~~lg~~~~~~~~~~~~~~  352 (425)
                      ......++..|+|||++.+ ..++.++|||||||++|+|++|+.||.......  +....+.+..               
T Consensus       157 ~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~---------------  220 (285)
T cd05630         157 TIKGRVGTVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV---------------  220 (285)
T ss_pred             cccCCCCCccccChHHHcC-CCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhh---------------
Confidence            4444578999999999977 679999999999999999999999995322211  1111110000               


Q ss_pred             CChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcC-----HHHHhcCCCCcccccchh
Q 014406          353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT-----AREAMAHPYFAQVRAAES  420 (425)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpt-----a~elL~hp~~~~~~~~~~  420 (425)
                                           .......+++++.+|+++||+.||++|||     ++|+++||||+++.+...
T Consensus       221 ---------------------~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~~~~~  272 (285)
T cd05630         221 ---------------------QEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINFKRL  272 (285)
T ss_pred             ---------------------hhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhccCHHHH
Confidence                                 00011236889999999999999999999     999999999998766543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.8e-44  Score=344.20  Aligned_cols=259  Identities=27%  Similarity=0.413  Sum_probs=205.6

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccE
Q 014406          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (425)
Q Consensus       125 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (425)
                      ++|++.+.||+|+||+||++.+..+++.||+|++...      ..+.+.+|+.++..+ +|+||+++++++.+.  .+.+
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~--~~~~   77 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNG-DRRWITNLHYAFQDE--NNLY   77 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCCCceEEEEecC--CeEE
Confidence            5799999999999999999999999999999998642      234578899999998 999999999999654  7889


Q ss_pred             EEEEeecCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCC
Q 014406          199 LIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (425)
Q Consensus       199 lv~e~~~~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~  274 (425)
                      +||||+.+++|..++    ..+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||++.......
T Consensus        78 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~  156 (331)
T cd05597          78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKN-GHIRLADFGSCLRLLADG  156 (331)
T ss_pred             EEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCC-CCEEEEECCceeecCCCC
Confidence            999999999998876    348899999999999999999999999999999999999988 789999999987654332


Q ss_pred             cc--eeeccCCCccCcccccC----CCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhh
Q 014406          275 EY--NVRVASRYFKGPELLVD----LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK  348 (425)
Q Consensus       275 ~~--~~~~~t~~y~aPE~~~~----~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~  348 (425)
                      ..  ....||+.|+|||++..    ...++.++|||||||++|+|++|+.||.. .+..+....+.....          
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~-~~~~~~~~~i~~~~~----------  225 (331)
T cd05597         157 TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA-ESLVETYGKIMNHKE----------  225 (331)
T ss_pred             CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCC-CCHHHHHHHHHcCCC----------
Confidence            22  23468999999999863    24578899999999999999999999842 222222222211000          


Q ss_pred             ccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCC--CcCHHHHhcCCCCcccccchh
Q 014406          349 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQD--RLTAREAMAHPYFAQVRAAES  420 (425)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~--Rpta~elL~hp~~~~~~~~~~  420 (425)
                                       ...     .......+++++++|+++||..++++  |++++++++||||.++++...
T Consensus       226 -----------------~~~-----~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~~~~~  277 (331)
T cd05597         226 -----------------HFQ-----FPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDWDNI  277 (331)
T ss_pred             -----------------ccc-----CCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCCHHHH
Confidence                             000     00011227899999999999765444  789999999999998876544

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=1.6e-45  Score=327.20  Aligned_cols=290  Identities=29%  Similarity=0.540  Sum_probs=225.5

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCc----EEEEEEecCcc-----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCC
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNE----RCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHS  194 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~----~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  194 (425)
                      ...|+.+..||+|.||.||+|...+++.    .+|||.++.+.     ....-+|+..++.+ +|+|++++..+|... +
T Consensus        23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl-~h~nvi~Lv~Vfl~~-d  100 (438)
T KOG0666|consen   23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLREL-KHPNVISLVKVFLSH-D  100 (438)
T ss_pred             HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHh-cCCcchhHHHHHhcc-C
Confidence            4578899999999999999997665543    68999987542     24567999999999 999999999999764 5


Q ss_pred             CccEEEEEeecCCChhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCC---CCcEEEEec
Q 014406          195 KTPSLIFEYVNSTDFKVLY-------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE---LRKLRLIDW  264 (425)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~-------~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~---~~~~kl~Df  264 (425)
                      +.++|++||.+...+.-..       ..++...++.|+.||+.|+.|||++.|+||||||.|||+..+   .|.|||+||
T Consensus       101 ~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDl  180 (438)
T KOG0666|consen  101 KKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADL  180 (438)
T ss_pred             ceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecc
Confidence            7899999999987665432       348899999999999999999999999999999999999754   478999999


Q ss_pred             cccccccCCC----cceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCC--------CCHHHHHH
Q 014406          265 GLAEFYHPGK----EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH--------DNHDQLVK  332 (425)
Q Consensus       265 g~a~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~--------~~~~~~~~  332 (425)
                      |+++.+...-    .....+.|.+|+|||.+++...|+.+.|||+.||++.||++-...|....        -..+++.+
T Consensus       181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~r  260 (438)
T KOG0666|consen  181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDR  260 (438)
T ss_pred             cHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHH
Confidence            9999875431    23456889999999999999999999999999999999999887664322        12578899


Q ss_pred             HHHHhCCchhHHHHhhccCCCChhhHHHhcccCCCCcccc--c-cccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcC
Q 014406          333 IAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKF--I-NADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  409 (425)
Q Consensus       333 ~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~-~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~h  409 (425)
                      |.+++|.+....|..-..++.....-.   .+....+...  . .....+.-++...+|+.+||++||.+|+|++++|+|
T Consensus       261 If~vLG~Pt~~~Wp~lkk~Pe~q~~ls---~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh  337 (438)
T KOG0666|consen  261 IFEVLGTPTDKDWPDLKKMPEYQTLLS---DFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH  337 (438)
T ss_pred             HHHHcCCCccccchhhhhCcchHHHHH---HhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence            999999988777754444443321111   1111111110  0 011111235669999999999999999999999999


Q ss_pred             CCCcccccc
Q 014406          410 PYFAQVRAA  418 (425)
Q Consensus       410 p~~~~~~~~  418 (425)
                      +||..-...
T Consensus       338 ~yF~~d~lp  346 (438)
T KOG0666|consen  338 PYFTEDPLP  346 (438)
T ss_pred             cccccCCCC
Confidence            999977554

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=5.3e-44  Score=342.75  Aligned_cols=245  Identities=28%  Similarity=0.472  Sum_probs=199.1

Q ss_pred             eeeeeeCceEEEEEEEc---CCCcEEEEEEecCc-------chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEE
Q 014406          131 RKVGRGKYSEVFEGINV---NTNERCIIKILKPV-------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (425)
Q Consensus       131 ~~LG~G~fg~V~~~~~~---~~~~~vavK~~~~~-------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (425)
                      +.||+|+||.||++.+.   .+++.||+|+++..       ....+.+|+.+++.+ +||||++++++|...  ...++|
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~~~~~~~~~--~~~~lv   78 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAV-KHPFIVDLIYAFQTG--GKLYLI   78 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhC-CCCchhceeeEEecC--CeEEEE
Confidence            57999999999999864   47889999998642       124567899999999 999999999999654  678999


Q ss_pred             EEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCC-Ccc
Q 014406          201 FEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-KEY  276 (425)
Q Consensus       201 ~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~-~~~  276 (425)
                      |||+.+++|..++   ..+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++..... ...
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~  157 (323)
T cd05584          79 LEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQ-GHVKLTDFGLCKESIHEGTVT  157 (323)
T ss_pred             EeCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCC-CCEEEeeCcCCeecccCCCcc
Confidence            9999999998876   347888999999999999999999999999999999999988 79999999998754322 223


Q ss_pred             eeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCChh
Q 014406          277 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ  356 (425)
Q Consensus       277 ~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~  356 (425)
                      ....|+..|+|||++.+ ..++.++|||||||++|||++|+.||.. .+.......+..             ..      
T Consensus       158 ~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~pf~~-~~~~~~~~~~~~-------------~~------  216 (323)
T cd05584         158 HTFCGTIEYMAPEILMR-SGHGKAVDWWSLGALMYDMLTGAPPFTA-ENRKKTIDKILK-------------GK------  216 (323)
T ss_pred             cccCCCccccChhhccC-CCCCCcceecccHHHHHHHhcCCCCCCC-CCHHHHHHHHHc-------------CC------
Confidence            34578999999999977 6789999999999999999999999842 222222222111             00      


Q ss_pred             hHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCc-----CHHHHhcCCCCcccccc
Q 014406          357 LDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYFAQVRAA  418 (425)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rp-----ta~elL~hp~~~~~~~~  418 (425)
                                        ...+..+++++.+|+++||+.||++||     +++++++||||....+.
T Consensus       217 ------------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~~~  265 (323)
T cd05584         217 ------------------LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNWD  265 (323)
T ss_pred             ------------------CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCCCHH
Confidence                              001123688999999999999999999     89999999999877553

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=1.3e-43  Score=339.99  Aligned_cols=252  Identities=23%  Similarity=0.386  Sum_probs=205.4

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEE
Q 014406          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (425)
Q Consensus       126 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (425)
                      +|+..+.||+|+||+||+|.+..+++.||+|++...      ..+.+..|..++..+.+|++|+++++++.+.  ...++
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~--~~~~l   78 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTV--DRLYF   78 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecC--CEEEE
Confidence            477889999999999999999999999999998742      2245678889998885678888999998654  67899


Q ss_pred             EEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCC-c
Q 014406          200 IFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-E  275 (425)
Q Consensus       200 v~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~-~  275 (425)
                      ||||+++++|..++   ..+++.++..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++...... .
T Consensus        79 v~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~-~~ikL~Dfg~~~~~~~~~~~  157 (323)
T cd05615          79 VMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSE-GHIKIADFGMCKEHMVDGVT  157 (323)
T ss_pred             EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCC-CCEEEeccccccccCCCCcc
Confidence            99999999998876   458999999999999999999999999999999999999988 789999999987543222 2


Q ss_pred             ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCCh
Q 014406          276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP  355 (425)
Q Consensus       276 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~  355 (425)
                      .....||..|+|||++.+ ..++.++||||+||++|+|++|+.||. +.+.......+...             .     
T Consensus       158 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~pf~-~~~~~~~~~~i~~~-------------~-----  217 (323)
T cd05615         158 TRTFCGTPDYIAPEIIAY-QPYGKSVDWWAYGVLLYEMLAGQPPFD-GEDEDELFQSIMEH-------------N-----  217 (323)
T ss_pred             ccCccCCccccCHHHHcC-CCCCCccchhhhHHHHHHHHhCCCCCC-CCCHHHHHHHHHhC-------------C-----
Confidence            334568999999999977 678999999999999999999999984 22222222222110             0     


Q ss_pred             hhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcC-----HHHHhcCCCCcccccch
Q 014406          356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT-----AREAMAHPYFAQVRAAE  419 (425)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpt-----a~elL~hp~~~~~~~~~  419 (425)
                                         ...+..++.++.+++.+||+.||++|++     .+++++||||+.+.+..
T Consensus       218 -------------------~~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~~~  267 (323)
T cd05615         218 -------------------VSYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDWDK  267 (323)
T ss_pred             -------------------CCCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCCHHH
Confidence                               0011236889999999999999999997     57999999999987644

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=1.3e-43  Score=341.36  Aligned_cols=283  Identities=20%  Similarity=0.325  Sum_probs=209.5

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccE
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (425)
                      ..++|++.++||+|+||+||++.+..++..+|+|++....    ...+.+|+++++.+ +|+||++++++|.+.  ...+
T Consensus         3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~--~~~~   79 (333)
T cd06650           3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYSD--GEIS   79 (333)
T ss_pred             chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHC-CCCcccceeEEEEEC--CEEE
Confidence            4678999999999999999999999999999999986432    35688999999999 899999999999764  6789


Q ss_pred             EEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHC-CceeecCCCCceEecCCCCcEEEEeccccccccCCC
Q 014406          199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (425)
Q Consensus       199 lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~-~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~  274 (425)
                      +||||+.+++|.+++   ..+++..+..++.|++.||.|||+. +|+|+||||+|||++.+ +.+||+|||++...... 
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~-~~~kL~Dfg~~~~~~~~-  157 (333)
T cd06650          80 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDS-  157 (333)
T ss_pred             EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCC-CCEEEeeCCcchhhhhh-
Confidence            999999999999887   3488889999999999999999985 79999999999999988 78999999998765322 


Q ss_pred             cceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHH--hCCchhHHHHh-----
Q 014406          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV--LGTDELNAYLN-----  347 (425)
Q Consensus       275 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~--lg~~~~~~~~~-----  347 (425)
                      ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.....  ..+..+...  .+.........     
T Consensus       158 ~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (333)
T cd06650         158 MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAIGRYPIPPPDA--KELELMFGCPVEGDPAESETSPRPRPP  234 (333)
T ss_pred             ccccCCCCccccCHHHhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcch--hHHHHHhcCcccCCccccccCcccCCc
Confidence            2234578899999999977 6789999999999999999999999843322  122111110  00000000000     


Q ss_pred             -----hccCCCChh--hHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCccccc
Q 014406          348 -----KYHLELDPQ--LDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA  417 (425)
Q Consensus       348 -----~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~  417 (425)
                           .+.....+.  ...........    .........++.++++|+.+||++||++|||++|+++||||+....
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~~  307 (333)
T cd06650         235 GRPLSSYGPDSRPPMAIFELLDYIVNE----PPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSEA  307 (333)
T ss_pred             cchhhhhcccccccccHHHHHHHHhcC----CCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCcc
Confidence                 000000000  00000000000    0000011236788999999999999999999999999999987643

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=9.2e-44  Score=341.66  Aligned_cols=250  Identities=25%  Similarity=0.447  Sum_probs=203.6

Q ss_pred             eeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEEEee
Q 014406          131 RKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV  204 (425)
Q Consensus       131 ~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~  204 (425)
                      +.||+|+||+||+|.+..+++.+|+|++...      ..+.+.+|+.++.++.+|+||+.+++++.+.  ..+++||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--~~~~lv~e~~   78 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTT--SRLFLVIEYV   78 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeC--CEEEEEEeCC
Confidence            3699999999999999999999999999743      2345778999999887799999999999654  6789999999


Q ss_pred             cCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEecccccccc-CCCcceeec
Q 014406          205 NSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKEYNVRV  280 (425)
Q Consensus       205 ~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~-~~~~~~~~~  280 (425)
                      ++++|..++   ..+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++... .........
T Consensus        79 ~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~  157 (327)
T cd05617          79 NGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDAD-GHIKLTDYGMCKEGLGPGDTTSTFC  157 (327)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCC-CCEEEeccccceeccCCCCceeccc
Confidence            999998765   459999999999999999999999999999999999999988 789999999987532 233344567


Q ss_pred             cCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCC-----HHHHHHHHHHhCCchhHHHHhhccCCCCh
Q 014406          281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN-----HDQLVKIAKVLGTDELNAYLNKYHLELDP  355 (425)
Q Consensus       281 ~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~-----~~~~~~~~~~lg~~~~~~~~~~~~~~~~~  355 (425)
                      ||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....++     .+.+.....                    
T Consensus       158 gt~~y~aPE~~~~-~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~--------------------  216 (327)
T cd05617         158 GTPNYIAPEILRG-EEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVIL--------------------  216 (327)
T ss_pred             CCcccCCHHHHCC-CCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHH--------------------
Confidence            8999999999987 78999999999999999999999999432211     111111100                    


Q ss_pred             hhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcC------HHHHhcCCCCcccccchh
Q 014406          356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT------AREAMAHPYFAQVRAAES  420 (425)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpt------a~elL~hp~~~~~~~~~~  420 (425)
                            ..          ....+..++..+.+++++||+.||++|++      .+++++||||+.+.+...
T Consensus       217 ------~~----------~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~~~~  271 (327)
T cd05617         217 ------EK----------PIRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWDLL  271 (327)
T ss_pred             ------hC----------CCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCHHHH
Confidence                  00          00112236889999999999999999998      579999999999876543

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.1e-43  Score=352.83  Aligned_cols=280  Identities=22%  Similarity=0.298  Sum_probs=206.3

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcchHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEEEe
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEY  203 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~  203 (425)
                      ..+|.+.+.||+|+||.||+|.+..+++.||||...   ...+.+|+.+++++ +|+||+++++++...  ...++|||+
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~---~~~~~~E~~iL~~L-~HpnIv~l~~~~~~~--~~~~lv~e~  241 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW---YASSVHEARLLRRL-SHPAVLALLDVRVVG--GLTCLVLPK  241 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc---ccCHHHHHHHHHHC-CCCCCCcEEEEEEEC--CEEEEEEEc
Confidence            457999999999999999999999999999999643   34567899999999 999999999998654  678899999


Q ss_pred             ecCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCc---c
Q 014406          204 VNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE---Y  276 (425)
Q Consensus       204 ~~~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~---~  276 (425)
                      +.+ +|..++    ..+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||+++.......   .
T Consensus       242 ~~~-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~-~~vkL~DFGla~~~~~~~~~~~~  319 (461)
T PHA03211        242 YRS-DLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGP-EDICLGDFGAACFARGSWSTPFH  319 (461)
T ss_pred             cCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCC-CCEEEcccCCceecccccccccc
Confidence            975 444443    348999999999999999999999999999999999999988 7899999999976543221   1


Q ss_pred             eeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCC------HHHHHHHHHHhCCchhHHHHhhcc
Q 014406          277 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN------HDQLVKIAKVLGTDELNAYLNKYH  350 (425)
Q Consensus       277 ~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~------~~~~~~~~~~lg~~~~~~~~~~~~  350 (425)
                      ....||..|+|||++.+ ..++.++|||||||++|||++|..++|.....      ..++.++++..+..... +.....
T Consensus       320 ~~~~GT~~Y~APE~~~~-~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~-~~~~~~  397 (461)
T PHA03211        320 YGIAGTVDTNAPEVLAG-DPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDE-FPQHAG  397 (461)
T ss_pred             cccCCCcCCcCHHHHcC-CCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhcccccc-CCCCcc
Confidence            23468999999999987 67999999999999999999999887654322      33455554433321100 000000


Q ss_pred             CCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcc
Q 014406          351 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ  414 (425)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~  414 (425)
                      ..+...+....... ..+......+.....++.++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus       398 ~~l~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~  460 (461)
T PHA03211        398 SRLVSQYRHRAARN-RRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS  460 (461)
T ss_pred             hHHHHHHHhhhhcc-cCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence            00000000000000 0111111111111235678999999999999999999999999999975

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.1e-43  Score=341.98  Aligned_cols=259  Identities=24%  Similarity=0.400  Sum_probs=205.8

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccE
Q 014406          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (425)
Q Consensus       125 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (425)
                      ++|++.+.||+|+||+||++.+..+++.+|+|++.+.      ....+.+|+.++..+ +|+||+++++.+.+.  ...+
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~--~~~~   77 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNG-DNQWITTLHYAFQDE--NNLY   77 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhC-CCCCEeeEEEEEecC--CEEE
Confidence            4799999999999999999999999999999998632      223477899999998 999999999999654  6789


Q ss_pred             EEEEeecCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCC
Q 014406          199 LIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (425)
Q Consensus       199 lv~e~~~~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~  274 (425)
                      +||||+.+|+|..++    ..+++..++.++.||+.||+|||+.||+||||||+|||++.+ +.+||+|||++.......
T Consensus        78 lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~-~~~kL~DfG~a~~~~~~~  156 (332)
T cd05623          78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMN-GHIRLADFGSCLKLMEDG  156 (332)
T ss_pred             EEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCC-CCEEEeecchheecccCC
Confidence            999999999998887    347889999999999999999999999999999999999987 789999999987653332


Q ss_pred             c--ceeeccCCCccCcccccC----CCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhh
Q 014406          275 E--YNVRVASRYFKGPELLVD----LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK  348 (425)
Q Consensus       275 ~--~~~~~~t~~y~aPE~~~~----~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~  348 (425)
                      .  .....||+.|+|||++..    ...++.++|||||||++|||++|+.||.. .+..+....+..   ..        
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~-~~~~~~~~~i~~---~~--------  224 (332)
T cd05623         157 TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYA-ESLVETYGKIMN---HK--------  224 (332)
T ss_pred             cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCC-CCHHHHHHHHhC---CC--------
Confidence            2  223578999999999862    24688999999999999999999999842 222222222211   00        


Q ss_pred             ccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCC--CcCHHHHhcCCCCcccccchh
Q 014406          349 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQD--RLTAREAMAHPYFAQVRAAES  420 (425)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~--Rpta~elL~hp~~~~~~~~~~  420 (425)
                                      .+..     .......+++++++|+++||+.++.+  |+|++|+++||||+++.+...
T Consensus       225 ----------------~~~~-----~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~~~~~  277 (332)
T cd05623         225 ----------------ERFQ-----FPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDWDNI  277 (332)
T ss_pred             ----------------cccc-----CCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCCHHHH
Confidence                            0000     00111236899999999999765554  789999999999999876543

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=1.5e-43  Score=332.21  Aligned_cols=250  Identities=24%  Similarity=0.363  Sum_probs=200.6

Q ss_pred             eeeeCceEEEEEEEcCCCcEEEEEEecCcc------hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEEEeecC
Q 014406          133 VGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNS  206 (425)
Q Consensus       133 LG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~  206 (425)
                      ||+|+||+||++.+..+++.+|+|.+....      ...+..|+++++++ +||||+++++++..  ..+.++||||+++
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~i~~~~~~~~~--~~~~~lv~e~~~g   77 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKV-NSPFIVNLAYAFES--KTHLCLVMSLMNG   77 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhc-CCCcEEEEEEEEec--CCeEEEEEecCCC
Confidence            799999999999999999999999986321      23456799999999 99999999999965  4678999999999


Q ss_pred             CChhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCcceeecc
Q 014406          207 TDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA  281 (425)
Q Consensus       207 ~~l~~~~-----~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  281 (425)
                      ++|..++     ..+++..+..++.|++.||+|||+.||+|+||||+||+++.+ +.++|+|||++.............+
T Consensus        78 ~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~-~~~~l~Dfg~~~~~~~~~~~~~~~~  156 (277)
T cd05607          78 GDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQ-GNCRLSDLGLAVELKDGKTITQRAG  156 (277)
T ss_pred             CCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCC-CCEEEeeceeeeecCCCceeeccCC
Confidence            9998765     247888889999999999999999999999999999999988 7899999999987655444455678


Q ss_pred             CCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCChhhHHHh
Q 014406          282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALV  361 (425)
Q Consensus       282 t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~  361 (425)
                      +..|+|||++.+ ..++.++||||+||++|+|++|+.||........ ...+....        . ...           
T Consensus       157 ~~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~-~~~~~~~~--------~-~~~-----------  214 (277)
T cd05607         157 TNGYMAPEILKE-EPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA-KEELKRRT--------L-EDE-----------  214 (277)
T ss_pred             CCCccCHHHHcc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh-HHHHHHHh--------h-ccc-----------
Confidence            899999999987 5699999999999999999999999843222111 11110000        0 000           


Q ss_pred             cccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCH----HHHhcCCCCcccccchh
Q 014406          362 GRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA----REAMAHPYFAQVRAAES  420 (425)
Q Consensus       362 ~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta----~elL~hp~~~~~~~~~~  420 (425)
                                 . ......+++++++|+++||+.||++|||+    +++++||||+.+.+...
T Consensus       215 -----------~-~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~~~~~  265 (277)
T cd05607         215 -----------V-KFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINFPRL  265 (277)
T ss_pred             -----------c-ccccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCCCHHHH
Confidence                       0 00011368899999999999999999999    77889999999876544

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-44  Score=338.96  Aligned_cols=254  Identities=24%  Similarity=0.447  Sum_probs=222.9

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc-----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEE
Q 014406          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (425)
Q Consensus       125 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (425)
                      .=|.+.+.||+|.|..|-+|++.-+|+.||||++++..     ...+.+|+..|+.+ +|||||++|++...+  ..+||
T Consensus        18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLV-QHpNiVRLYEViDTQ--TKlyL   94 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLV-QHPNIVRLYEVIDTQ--TKLYL   94 (864)
T ss_pred             eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHh-cCcCeeeeeehhccc--ceEEE
Confidence            34777889999999999999999999999999998654     35688999999998 999999999999544  67899


Q ss_pred             EEEeecCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCc
Q 014406          200 IFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (425)
Q Consensus       200 v~e~~~~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~  275 (425)
                      |+|.-.+|+|.+++    ..+.+...++++.||+.|+.|+|+..+|||||||+|+.+-+..|-+||.|||++..+.++..
T Consensus        95 iLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~k  174 (864)
T KOG4717|consen   95 ILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKK  174 (864)
T ss_pred             EEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcch
Confidence            99999999999988    45999999999999999999999999999999999999998889999999999999999999


Q ss_pred             ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCCh
Q 014406          276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP  355 (425)
Q Consensus       276 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~  355 (425)
                      .++.+|+..|.|||++++...-..++|||||||+||.|++|+.|| ...++.+.+..|.++-                  
T Consensus       175 L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PF-qeANDSETLTmImDCK------------------  235 (864)
T KOG4717|consen  175 LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPF-QEANDSETLTMIMDCK------------------  235 (864)
T ss_pred             hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCcc-ccccchhhhhhhhccc------------------
Confidence            999999999999999999544457899999999999999999998 4555666666654421                  


Q ss_pred             hhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccch
Q 014406          356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE  419 (425)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~~  419 (425)
                                         ...+..++.++++||..||+.||++|.+.+++..|+|++.+....
T Consensus       236 -------------------YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~~  280 (864)
T KOG4717|consen  236 -------------------YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRGL  280 (864)
T ss_pred             -------------------ccCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCCCc
Confidence                               111223789999999999999999999999999999999987643

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=3e-43  Score=341.74  Aligned_cols=289  Identities=25%  Similarity=0.461  Sum_probs=219.3

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCC----
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH----  193 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~----  193 (425)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|.+...     ....+.+|+.+++.+ +|+||++++++|....    
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~   92 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLV-NHKNIIGLLNVFTPQKSLEE   92 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhc-CCCCCcceeeeeccCCCccc
Confidence            468899999999999999999999999999999998632     234677899999999 9999999999986432    


Q ss_pred             CCccEEEEEeecCCChhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCC
Q 014406          194 SKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (425)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~  273 (425)
                      ....++||||+.+.........+++..+..++.|++.||+|||++||+|+||||+||+++.+ +.+||+|||+++.....
T Consensus        93 ~~~~~lv~e~~~~~l~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~-~~~kL~Dfg~~~~~~~~  171 (353)
T cd07850          93 FQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-CTLKILDFGLARTAGTS  171 (353)
T ss_pred             cCcEEEEEeccCCCHHHHHhhcCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCC-CCEEEccCccceeCCCC
Confidence            24579999999875444444458999999999999999999999999999999999999998 78999999999876544


Q ss_pred             CcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCC
Q 014406          274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL  353 (425)
Q Consensus       274 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~  353 (425)
                      .......++..|+|||.+.+ ..++.++|||||||++|+|++|+.|| .+.+..+.+..+.+.+|.+..... .......
T Consensus       172 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~  248 (353)
T cd07850         172 FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGTVLF-PGTDHIDQWNKIIEQLGTPSDEFM-SRLQPTV  248 (353)
T ss_pred             CCCCCCcccccccCHHHHhC-CCCCCchhhHhHHHHHHHHHHCCCCC-CCCCHHHHHHHHHHhcCCCCHHHH-HHhhhhh
Confidence            33344567889999999987 78999999999999999999999988 455666777778777776543211 1111000


Q ss_pred             ChhhHHHhcccCCCCccccc--------cccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCccccc
Q 014406          354 DPQLDALVGRHSRKPWSKFI--------NADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA  417 (425)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~  417 (425)
                      ...... ........+....        ........++++++||.+||++||++|||+.|+|+||||+....
T Consensus       249 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~  319 (353)
T cd07850         249 RNYVEN-RPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYD  319 (353)
T ss_pred             hHHhhc-CCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccC
Confidence            000000 0000000010100        01112235678999999999999999999999999999985443

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=8.4e-45  Score=299.28  Aligned_cols=277  Identities=31%  Similarity=0.618  Sum_probs=225.4

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc-----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEE
Q 014406          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (425)
Q Consensus       126 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (425)
                      +|.-.++||+|.||+||+|++..+++.||+|.+.-+.     .....+||.+++.+ .|+|||+++++.-.+  +.+.||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkel-khknivrl~dvlhsd--kkltlv   79 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-KHKNIVRLHDVLHSD--KKLTLV   79 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHh-hhcceeehhhhhccC--ceeEEe
Confidence            4555679999999999999999999999999986432     35678999999999 999999999988544  677899


Q ss_pred             EEeecCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCC-Cc
Q 014406          201 FEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-KE  275 (425)
Q Consensus       201 ~e~~~~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~-~~  275 (425)
                      +||+... |..+.    ..++.+.++.++.|+++||.++|++++.|||+||.|.|++.+ +.+|++|||+++.+.-. .-
T Consensus        80 fe~cdqd-lkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~n-gelkladfglarafgipvrc  157 (292)
T KOG0662|consen   80 FEFCDQD-LKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRN-GELKLADFGLARAFGIPVRC  157 (292)
T ss_pred             HHHhhHH-HHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccC-CcEEecccchhhhcCCceEe
Confidence            9999643 33333    458889999999999999999999999999999999999999 89999999999876533 34


Q ss_pred             ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCCh
Q 014406          276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP  355 (425)
Q Consensus       276 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~  355 (425)
                      ++..+.|.+|++|.++.+...|+.+.|+||-||++.|+.....|.|++.+-.+++.+|...+|.+....|..-....   
T Consensus       158 ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lp---  234 (292)
T KOG0662|consen  158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLP---  234 (292)
T ss_pred             eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCC---
Confidence            56678899999999999988899999999999999999988889999999999999999999988765553211111   


Q ss_pred             hhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCccc
Q 014406          356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV  415 (425)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~  415 (425)
                      .+...-.......|.++.     ..+....+|++.++|..+|.+|++|+++|+||||.+-
T Consensus       235 dyk~yp~ypattswsqiv-----p~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~  289 (292)
T KOG0662|consen  235 DYKPYPIYPATTSWSQIV-----PKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF  289 (292)
T ss_pred             CCcccCCccccchHHHHh-----hhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence            111110111112232222     2255667899999999999999999999999999875

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=1.3e-43  Score=340.20  Aligned_cols=246  Identities=26%  Similarity=0.443  Sum_probs=197.7

Q ss_pred             eeeeeeCceEEEEEEEcCCCcEEEEEEecCcc------hHHHHHHHHH-HHHhcCCCCeeeEEeEEEcCCCCccEEEEEe
Q 014406          131 RKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKI-LQNLCGGPNVVKLLDIVRDQHSKTPSLIFEY  203 (425)
Q Consensus       131 ~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~-l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~  203 (425)
                      +.||+|+||+||+|.+..+++.||+|++....      ...+..|..+ ++.+ +||||+++++++.+.  ...++||||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l-~hp~iv~~~~~~~~~--~~~~lv~e~   77 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNV-KHPFLVGLHYSFQTA--DKLYFVLDY   77 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhC-CCCCCCCeeEEEEeC--CEEEEEEcC
Confidence            36999999999999999999999999986431      2344555554 5667 999999999999654  678999999


Q ss_pred             ecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccC-CCcceee
Q 014406          204 VNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP-GKEYNVR  279 (425)
Q Consensus       204 ~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~-~~~~~~~  279 (425)
                      +++++|..++   ..+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++.... .......
T Consensus        78 ~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~-~~~kl~Dfg~~~~~~~~~~~~~~~  156 (323)
T cd05575          78 VNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQ-GHVVLTDFGLCKEGIEHSKTTSTF  156 (323)
T ss_pred             CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCC-CcEEEeccCCCcccccCCCccccc
Confidence            9999998776   358899999999999999999999999999999999999988 7899999999875422 2233445


Q ss_pred             ccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCChhhHH
Q 014406          280 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDA  359 (425)
Q Consensus       280 ~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~  359 (425)
                      .||+.|+|||++.+ ..++.++|||||||++|+|++|..||.. .+..+....+..   .          .         
T Consensus       157 ~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~-~~~~~~~~~i~~---~----------~---------  212 (323)
T cd05575         157 CGTPEYLAPEVLRK-QPYDRTVDWWCLGAVLYEMLYGLPPFYS-RDTAEMYDNILN---K----------P---------  212 (323)
T ss_pred             cCChhhcChhhhcC-CCCCccccccccchhhhhhhcCCCCCCC-CCHHHHHHHHHc---C----------C---------
Confidence            78999999999977 7799999999999999999999999843 222222222110   0          0         


Q ss_pred             HhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCH----HHHhcCCCCcccccch
Q 014406          360 LVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA----REAMAHPYFAQVRAAE  419 (425)
Q Consensus       360 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta----~elL~hp~~~~~~~~~  419 (425)
                                     ......++.++.++|++||+.||++||++    .|+++||||..+.+..
T Consensus       213 ---------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~~~~~  261 (323)
T cd05575         213 ---------------LRLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINWDD  261 (323)
T ss_pred             ---------------CCCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCCCHHH
Confidence                           00112368899999999999999999987    6999999999877644

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=6.2e-43  Score=329.07  Aligned_cols=273  Identities=31%  Similarity=0.616  Sum_probs=207.9

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEE
Q 014406          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (425)
Q Consensus       126 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (425)
                      +|++.+.||+|+||+||+|.+..++..||+|.+...     ..+.+.+|+.+++.+ +||||+++++++.++  ...++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~~v   77 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKEL-QHPNIVCLQDVLMQE--SRLYLI   77 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhc-CCCCEeeeEEEEeeC--CeEEEE
Confidence            588999999999999999999999999999998632     235688999999999 899999999999654  678999


Q ss_pred             EEeecCCChhhhc------CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCC-
Q 014406          201 FEYVNSTDFKVLY------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-  273 (425)
Q Consensus       201 ~e~~~~~~l~~~~------~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~-  273 (425)
                      |||+++ ++..++      ..+++..++.++.|++.||.|||+.|++|+||||+||+++.+ +.++|+|||++...... 
T Consensus        78 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~~  155 (285)
T cd07861          78 FEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNK-GVIKLADFGLARAFGIPV  155 (285)
T ss_pred             EecCCC-CHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCC-CcEEECcccceeecCCCc
Confidence            999985 555544      348899999999999999999999999999999999999988 78999999998755322 


Q ss_pred             CcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCC
Q 014406          274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL  353 (425)
Q Consensus       274 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~  353 (425)
                      .......++..|+|||.+.+...++.++|||||||++|+|++|+.||. +.+..+....+...++......+...   ..
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~---~~  231 (285)
T cd07861         156 RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFH-GDSEIDQLFRIFRILGTPTEDVWPGV---TS  231 (285)
T ss_pred             ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCC-CCCHHHHHHHHHHHhCCCChhhhhcc---hh
Confidence            222334668889999998765668899999999999999999998874 44444555555555544322211000   00


Q ss_pred             ChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCC
Q 014406          354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF  412 (425)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~  412 (425)
                      ...+....     ..+...........+++++++||++||+.||++|||+.++++||||
T Consensus       232 ~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~  285 (285)
T cd07861         232 LPDYKNTF-----PKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF  285 (285)
T ss_pred             hHHHHhhc-----cccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence            00010000     0111111111223378999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-43  Score=340.74  Aligned_cols=254  Identities=20%  Similarity=0.325  Sum_probs=197.1

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc---hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEE
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (425)
                      ++++|...+.||+|+||+||+|.. .++..||||.++...   ..+|.+|+.++.++ +|||+|+|+|||.+... ..+|
T Consensus        73 AT~~Fs~~~~ig~Ggfg~VYkG~l-~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l-~H~Nlv~LlGyC~e~~~-~~~L  149 (361)
T KOG1187|consen   73 ATNNFSESNLIGEGGFGTVYKGVL-SDGTVVAVKRLSSNSGQGEREFLNEVEILSRL-RHPNLVKLLGYCLEGGE-HRLL  149 (361)
T ss_pred             HHhCCchhcceecCCCeEEEEEEE-CCCCEEEEEEecCCCCcchhHHHHHHHHHhcC-CCcCcccEEEEEecCCc-eEEE
Confidence            568888889999999999999965 455899999987643   56799999999999 79999999999976532 5889


Q ss_pred             EEEeecCCChhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ceeecCCCCceEecCCCCcEEEEecccccccc
Q 014406          200 IFEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (425)
Q Consensus       200 v~e~~~~~~l~~~~~-----~l~~~~~~~i~~~i~~~L~~LH~~~---ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~  271 (425)
                      |||||.+|+|++++.     .++|..+.+|+.++|.||+|||+..   |||||||++|||||.+ ..+||+|||+|+...
T Consensus       150 VYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~-~~aKlsDFGLa~~~~  228 (361)
T KOG1187|consen  150 VYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDED-FNAKLSDFGLAKLGP  228 (361)
T ss_pred             EEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCC-CCEEccCccCcccCC
Confidence            999999999998872     5799999999999999999999853   9999999999999988 689999999997665


Q ss_pred             C-CCcceee-ccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCC-CCHHHHHHHH-HHhCCchhHHHHh
Q 014406          272 P-GKEYNVR-VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH-DNHDQLVKIA-KVLGTDELNAYLN  347 (425)
Q Consensus       272 ~-~~~~~~~-~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~-~~~~~~~~~~-~~lg~~~~~~~~~  347 (425)
                      . ....... .||.+|+|||++.. +..+.++|||||||+|+|++||+.+..... .....+..+. ..+......++  
T Consensus       229 ~~~~~~~~~~~gt~gY~~PEy~~~-g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~ei--  305 (361)
T KOG1187|consen  229 EGDTSVSTTVMGTFGYLAPEYAST-GKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREI--  305 (361)
T ss_pred             ccccceeeecCCCCccCChhhhcc-CCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhhe--
Confidence            4 3333333 89999999999977 789999999999999999999998874332 1111122221 11111111111  


Q ss_pred             hccCCCChhhHHHhcccCCCCccccccccCC-CCCC-----HHHHHHHHHcccCCcCCCcCHHHHhc
Q 014406          348 KYHLELDPQLDALVGRHSRKPWSKFINADNQ-HLVS-----PEAIDFLDKLLRYDHQDRLTAREAMA  408 (425)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~s-----~~~~~ll~~~L~~dP~~Rpta~elL~  408 (425)
                                               ++.... ...+     ..+..+..+|++.+|++||++.|+++
T Consensus       306 -------------------------iD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~  347 (361)
T KOG1187|consen  306 -------------------------VDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK  347 (361)
T ss_pred             -------------------------eCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence                                     111100 1111     23568888999999999999999743

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.1e-44  Score=331.84  Aligned_cols=247  Identities=21%  Similarity=0.486  Sum_probs=212.1

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcch------HHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCcc
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK------KKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~------~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (425)
                      ..+|++.+.||+|.||.|-+|.....|+.||||.++++..      -.+.+||+||..| +||||+.++.+|+.  ...+
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsL-NHPhII~IyEVFEN--kdKI  128 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSL-NHPHIIQIYEVFEN--KDKI  128 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhc-CCCceeehhhhhcC--CceE
Confidence            5689999999999999999999999999999999875432      3478999999999 99999999999954  4678


Q ss_pred             EEEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCC
Q 014406          198 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (425)
Q Consensus       198 ~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~  274 (425)
                      .+||||..+|.|.+|+   +.+++.+.+.+++||..|+.|+|+++++|||||.+|||+|.+ +++||+|||++..+....
T Consensus       129 vivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N-~NiKIADFGLSNly~~~k  207 (668)
T KOG0611|consen  129 VIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQN-NNIKIADFGLSNLYADKK  207 (668)
T ss_pred             EEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCC-CCeeeeccchhhhhcccc
Confidence            8999999999999998   469999999999999999999999999999999999999999 789999999999998888


Q ss_pred             cceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCC
Q 014406          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD  354 (425)
Q Consensus       275 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~  354 (425)
                      ..++.+|++.|.+||++.+...-+..+|-|||||+||-|+.|..|| .|.|....+..|..    ..         ..  
T Consensus       208 fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPF-DG~Dhk~lvrQIs~----Ga---------Yr--  271 (668)
T KOG0611|consen  208 FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPF-DGRDHKRLVRQISR----GA---------YR--  271 (668)
T ss_pred             HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhccccc-CCchHHHHHHHhhc----cc---------cc--
Confidence            8899999999999999988444468999999999999999999998 34433322222211    10         00  


Q ss_pred             hhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCc
Q 014406          355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA  413 (425)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~  413 (425)
                                             ...-+.++.-||+.||..||++|.|++++..|=|.+
T Consensus       272 -----------------------EP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvN  307 (668)
T KOG0611|consen  272 -----------------------EPETPSDASGLIRWMLMVNPERRATIEDIASHWWVN  307 (668)
T ss_pred             -----------------------CCCCCchHHHHHHHHHhcCcccchhHHHHhhhheee
Confidence                                   011366788999999999999999999999998864

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-44  Score=329.37  Aligned_cols=291  Identities=26%  Similarity=0.467  Sum_probs=223.9

Q ss_pred             ccccCCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc--hHHHHHHHHHHHHhcCC-C----CeeeEEeEEE
Q 014406          118 TVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--KKKIKREIKILQNLCGG-P----NVVKLLDIVR  190 (425)
Q Consensus       118 ~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~~h-~----niv~l~~~~~  190 (425)
                      .......++|+++.++|+|.||.|-.+.+..++..||||+++...  ++...-|+++|+++..+ |    -++.+.++| 
T Consensus        82 ~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF-  160 (415)
T KOG0671|consen   82 QVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWF-  160 (415)
T ss_pred             EeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh-
Confidence            334445789999999999999999999999999999999998543  45677899999999322 2    467888888 


Q ss_pred             cCCCCccEEEEEeecCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCC-----------
Q 014406          191 DQHSKTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE-----------  255 (425)
Q Consensus       191 ~~~~~~~~lv~e~~~~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~-----------  255 (425)
                       +..++.|+|+|.++....+.+-    .+++...++.+..|++.+++|||+.+++|.||||+|||+.+.           
T Consensus       161 -dyrghiCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~  239 (415)
T KOG0671|consen  161 -DYRGHICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKK  239 (415)
T ss_pred             -hccCceEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCc
Confidence             5568999999998755544433    249999999999999999999999999999999999998421           


Q ss_pred             --------CCcEEEEeccccccccCCCcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCH
Q 014406          256 --------LRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNH  327 (425)
Q Consensus       256 --------~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~  327 (425)
                              ...++|+|||.|+...  ......+.|..|+|||++++ -+|+.++||||+||+|+|+++|...| .++++.
T Consensus       240 ~~~~r~~ks~~I~vIDFGsAtf~~--e~hs~iVsTRHYRAPEViLg-LGwS~pCDvWSiGCIL~ElytG~~LF-qtHen~  315 (415)
T KOG0671|consen  240 VCFIRPLKSTAIKVIDFGSATFDH--EHHSTIVSTRHYRAPEVILG-LGWSQPCDVWSIGCILVELYTGETLF-QTHENL  315 (415)
T ss_pred             cceeccCCCcceEEEecCCcceec--cCcceeeeccccCCchheec-cCcCCccCceeeeeEEEEeeccceec-ccCCcH
Confidence                    2358999999998754  34467789999999999999 78999999999999999999999887 778899


Q ss_pred             HHHHHHHHHhCCchhHHHHhh--------ccCCCChhhHHHh-cc--cCCCCccccccccCCCCCCHHHHHHHHHcccCC
Q 014406          328 DQLVKIAKVLGTDELNAYLNK--------YHLELDPQLDALV-GR--HSRKPWSKFINADNQHLVSPEAIDFLDKLLRYD  396 (425)
Q Consensus       328 ~~~~~~~~~lg~~~~~~~~~~--------~~~~~~~~~~~~~-~~--~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~d  396 (425)
                      |+++.|..++|+.+.......        ..+.++.....-. ..  ..-.+....+.....  .-.++.|||++||.+|
T Consensus       316 EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~--e~~~LfDLl~~mL~fD  393 (415)
T KOG0671|consen  316 EHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDL--EHVQLFDLLRRMLEFD  393 (415)
T ss_pred             HHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcH--HHhHHHHHHHHHHccC
Confidence            999999999997654443222        2222222111100 00  001122222222111  2345889999999999


Q ss_pred             cCCCcCHHHHhcCCCCcccc
Q 014406          397 HQDRLTAREAMAHPYFAQVR  416 (425)
Q Consensus       397 P~~Rpta~elL~hp~~~~~~  416 (425)
                      |.+|+|+.|+|+||||+...
T Consensus       394 P~~RiTl~EAL~HpFF~~~~  413 (415)
T KOG0671|consen  394 PARRITLREALSHPFFARLT  413 (415)
T ss_pred             ccccccHHHHhcCHHhhcCC
Confidence            99999999999999999764

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5e-43  Score=344.67  Aligned_cols=285  Identities=21%  Similarity=0.293  Sum_probs=213.6

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEc--CCCcEEEEEEecCcchHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEE
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINV--NTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~--~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (425)
                      ..+|++++.||+|+||+||+|...  .++..||+|.+...  ....+|+.+++++ +|+||+++++++...  ...|++|
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--~~~~~E~~il~~l-~h~~iv~~~~~~~~~--~~~~lv~  165 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--KTPGREIDILKTI-SHRAIINLIHAYRWK--STVCMVM  165 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--ccHHHHHHHHHhc-CCCCccceeeeEeeC--CEEEEEe
Confidence            467999999999999999999754  45678999988743  3457899999999 999999999999653  6789999


Q ss_pred             EeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCc---
Q 014406          202 EYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE---  275 (425)
Q Consensus       202 e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~---  275 (425)
                      |++.+. +..++   ..+++..+..++.||+.||.|||++||+||||||+|||++.+ +.++|+|||+++.......   
T Consensus       166 e~~~~~-l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~-~~~~l~DfG~a~~~~~~~~~~~  243 (392)
T PHA03207        166 PKYKCD-LFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEP-ENAVLGDFGAACKLDAHPDTPQ  243 (392)
T ss_pred             hhcCCC-HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCC-CCEEEccCccccccCccccccc
Confidence            999754 44443   458999999999999999999999999999999999999988 7899999999976543322   


Q ss_pred             ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCC--CCHHHHHHHHHHhCCchhHHHHhhccCCC
Q 014406          276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH--DNHDQLVKIAKVLGTDELNAYLNKYHLEL  353 (425)
Q Consensus       276 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~--~~~~~~~~~~~~lg~~~~~~~~~~~~~~~  353 (425)
                      .....||..|+|||++.+ ..++.++|||||||++|||++|+.||+...  ....++..+.+.++..+.... .......
T Consensus       244 ~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~-~~~~~~~  321 (392)
T PHA03207        244 CYGWSGTLETNSPELLAL-DPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFP-QNGSTNL  321 (392)
T ss_pred             ccccccccCccCHhHhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccC-CccchhH
Confidence            223578999999999977 679999999999999999999999996543  245667777777665432210 0000000


Q ss_pred             ChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccch
Q 014406          354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE  419 (425)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~~  419 (425)
                      ...+..... ..+.++. .........++.++.+||++||++||++|||+.|+|+||||++..+..
T Consensus       322 ~~~~~~~~~-~~~~~~~-~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~~~~  385 (392)
T PHA03207        322 CKHFKQYAI-VLRPPYT-IPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEPINL  385 (392)
T ss_pred             HHHHHhhcc-cccCCcc-ccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccchhh
Confidence            000110000 0000000 000011123577899999999999999999999999999999876543

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-45  Score=352.28  Aligned_cols=257  Identities=26%  Similarity=0.438  Sum_probs=212.0

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc---hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEE
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (425)
                      ..+.|+++..||.|+||.||+|.++.++-..|-|++....   .+.+.-||+||..+ +||+||+|++.|.-  .+.+++
T Consensus        30 P~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~C-dHP~ivkLl~ayy~--enkLwi  106 (1187)
T KOG0579|consen   30 PRDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAEC-DHPVIVKLLSAYYF--ENKLWI  106 (1187)
T ss_pred             HHHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcC-CChHHHHHHHHHhc--cCceEE
Confidence            3456788899999999999999999999999999987544   35677899999998 89999999997743  367899


Q ss_pred             EEEeecCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccc-cCCC
Q 014406          200 IFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY-HPGK  274 (425)
Q Consensus       200 v~e~~~~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~-~~~~  274 (425)
                      +.|||.||-.+..+    ..+++.++..++.|++.||.|||+++|||||||+.|||++-+ |.++|+|||.+... ....
T Consensus       107 liEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~Tld-GdirLADFGVSAKn~~t~q  185 (1187)
T KOG0579|consen  107 LIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLD-GDIRLADFGVSAKNKSTRQ  185 (1187)
T ss_pred             EEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEec-CcEeeecccccccchhHHh
Confidence            99999999888765    569999999999999999999999999999999999999999 89999999986432 2223


Q ss_pred             cceeeccCCCccCcccccC----CCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhcc
Q 014406          275 EYNVRVASRYFKGPELLVD----LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH  350 (425)
Q Consensus       275 ~~~~~~~t~~y~aPE~~~~----~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~  350 (425)
                      ......||++|||||++..    ..+|++++||||||++|.||..+..|- ...+....+..+.+.-.+           
T Consensus       186 kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPH-helnpMRVllKiaKSePP-----------  253 (1187)
T KOG0579|consen  186 KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPH-HELNPMRVLLKIAKSEPP-----------  253 (1187)
T ss_pred             hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCc-cccchHHHHHHHhhcCCC-----------
Confidence            4466799999999999753    367999999999999999999998775 444455555555432111           


Q ss_pred             CCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccc
Q 014406          351 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA  418 (425)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~  418 (425)
                                             ..-.+..++..+.||+++||.+||..||+++++|+|||++++.+.
T Consensus       254 -----------------------TLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~Sn  298 (1187)
T KOG0579|consen  254 -----------------------TLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAPSN  298 (1187)
T ss_pred             -----------------------cccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccCCcc
Confidence                                   011122368899999999999999999999999999999988654

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=2e-43  Score=344.81  Aligned_cols=257  Identities=26%  Similarity=0.406  Sum_probs=205.5

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCc
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (425)
                      ..++|++.+.||+|+||+||+|.+..+++.+|+|++...      ....+.+|+.+++.+ +||||+++++.+.+  +..
T Consensus        41 ~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~-~hp~iv~~~~~~~~--~~~  117 (371)
T cd05622          41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLFYAFQD--DRY  117 (371)
T ss_pred             chhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEc--CCE
Confidence            468999999999999999999999999999999998632      224467899999998 99999999999965  478


Q ss_pred             cEEEEEeecCCChhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCC
Q 014406          197 PSLIFEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (425)
Q Consensus       197 ~~lv~e~~~~~~l~~~~~--~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~  274 (425)
                      .++||||+++++|..++.  .+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++......
T Consensus       118 ~~lv~Ey~~gg~L~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~-~~ikL~DfG~a~~~~~~~  196 (371)
T cd05622         118 LYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKS-GHLKLADFGTCMKMNKEG  196 (371)
T ss_pred             EEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCC-CCEEEEeCCceeEcCcCC
Confidence            899999999999988773  47888899999999999999999999999999999999988 799999999998664332


Q ss_pred             --cceeeccCCCccCcccccCCC---CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhc
Q 014406          275 --EYNVRVASRYFKGPELLVDLQ---DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY  349 (425)
Q Consensus       275 --~~~~~~~t~~y~aPE~~~~~~---~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~  349 (425)
                        ......||+.|+|||++.+..   .++.++|||||||++|+|++|..||.. .+.......+......          
T Consensus       197 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~-~~~~~~~~~i~~~~~~----------  265 (371)
T cd05622         197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA-DSLVGTYSKIMNHKNS----------  265 (371)
T ss_pred             cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCCc----------
Confidence              223457899999999987522   378999999999999999999999842 2222222222110000          


Q ss_pred             cCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCC--CcCHHHHhcCCCCccccc
Q 014406          350 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQD--RLTAREAMAHPYFAQVRA  417 (425)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~--Rpta~elL~hp~~~~~~~  417 (425)
                                             ........++.++++|+.+||+.++.+  |++++|+++||||++..+
T Consensus       266 -----------------------~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~~  312 (371)
T cd05622         266 -----------------------LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQW  312 (371)
T ss_pred             -----------------------ccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCCh
Confidence                                   000111237899999999999844433  789999999999988543

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=8.7e-45  Score=321.02  Aligned_cols=260  Identities=26%  Similarity=0.448  Sum_probs=210.4

Q ss_pred             CCCEEEE-eeeeeeCceEEEEEEEcCCCcEEEEEEecCcchHHHHHHHHHHHHhcCCCCeeeEEeEEEcC--CCCccEEE
Q 014406          124 QDDYEVV-RKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQ--HSKTPSLI  200 (425)
Q Consensus       124 ~~~y~~~-~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~--~~~~~~lv  200 (425)
                      +++|.+. ++||-|-.|.|-.+.++.+++.+|+|++.  +..+.++|++..-...+|||||+++++|+..  ..+.+.+|
T Consensus        60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~--Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiV  137 (400)
T KOG0604|consen   60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLL--DSPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIV  137 (400)
T ss_pred             hhhheehhhhhccccCCceEEEEeccchhhhHHHHHh--cCHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEee
Confidence            5556544 46999999999999999999999999998  4456678888777667999999999999754  23567789


Q ss_pred             EEeecCCChhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCC--CCcEEEEeccccccccCC
Q 014406          201 FEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--LRKLRLIDWGLAEFYHPG  273 (425)
Q Consensus       201 ~e~~~~~~l~~~~~-----~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~--~~~~kl~Dfg~a~~~~~~  273 (425)
                      ||.|+||.|...++     .|++.++..|+.||+.|+.|||+.+|.||||||+|+|....  ...+||+|||+|+.....
T Consensus       138 mE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~  217 (400)
T KOG0604|consen  138 MECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEP  217 (400)
T ss_pred             eecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccccCCC
Confidence            99999999988773     39999999999999999999999999999999999999753  246899999999987766


Q ss_pred             CcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCC
Q 014406          274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL  353 (425)
Q Consensus       274 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~  353 (425)
                      ....+.+.|++|.|||++-. .+|+..+|+||+||++|-|++|..||+..+.-. .         .+.+...+......+
T Consensus       218 ~~L~TPc~TPyYvaPevlg~-eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a-i---------spgMk~rI~~gqy~F  286 (400)
T KOG0604|consen  218 GDLMTPCFTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA-I---------SPGMKRRIRTGQYEF  286 (400)
T ss_pred             ccccCCcccccccCHHHhCc-hhcCCCCCccchhHHHHHhhcCCCcccccCCcc-C---------ChhHHhHhhccCccC
Confidence            77788899999999999865 789999999999999999999999997655411 0         011111111111111


Q ss_pred             ChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccc
Q 014406          354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR  416 (425)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~  416 (425)
                                          ..+.+..+|+.++|+|+++|+.+|++|.|+.|++.|||+.+-.
T Consensus       287 --------------------P~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~  329 (400)
T KOG0604|consen  287 --------------------PEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYE  329 (400)
T ss_pred             --------------------CChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccc
Confidence                                1112233799999999999999999999999999999998644

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.8e-43  Score=366.87  Aligned_cols=259  Identities=25%  Similarity=0.428  Sum_probs=210.4

Q ss_pred             CCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCc
Q 014406          122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (425)
Q Consensus       122 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (425)
                      ...++|++++.||+|+||+||+|.+..++..+|+|++...     ....+..|+.+++.| +||||++++++|.+.....
T Consensus        10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L-~HPNIVrl~d~f~de~~~~   88 (1021)
T PTZ00266         10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMREL-KHKNIVRYIDRFLNKANQK   88 (1021)
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHc-CCCCcCeEEEEEEecCCCE
Confidence            3567999999999999999999999999999999998642     235688999999999 9999999999997766677


Q ss_pred             cEEEEEeecCCChhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHC-------CceeecCCCCceEecCC-------
Q 014406          197 PSLIFEYVNSTDFKVLY-------PTLTDYDIRYYIYELLKALDYCHSQ-------GIMHRDVKPHNVMIDHE-------  255 (425)
Q Consensus       197 ~~lv~e~~~~~~l~~~~-------~~l~~~~~~~i~~~i~~~L~~LH~~-------~ivH~Dlk~~NIll~~~-------  255 (425)
                      +++||||+.+++|..++       ..+++..++.|+.||+.||.|||+.       +|||+||||+||||+.+       
T Consensus        89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i  168 (1021)
T PTZ00266         89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI  168 (1021)
T ss_pred             EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence            89999999999998776       3589999999999999999999984       49999999999999642       


Q ss_pred             ---------CCcEEEEeccccccccCCCcceeeccCCCccCcccccCC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCC
Q 014406          256 ---------LRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL-QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD  325 (425)
Q Consensus       256 ---------~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DvwslG~~l~elltg~~pf~~~~~  325 (425)
                               ...+||+|||++.............+|+.|+|||++.+. ..++.++|||||||+||+|++|..||... +
T Consensus       169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~-~  247 (1021)
T PTZ00266        169 TAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA-N  247 (1021)
T ss_pred             cccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC-C
Confidence                     134899999999876544444456789999999998642 45889999999999999999999998433 2


Q ss_pred             CHHHHHHHHHHhCCchhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHH
Q 014406          326 NHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTARE  405 (425)
Q Consensus       326 ~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~e  405 (425)
                      +...+......  .+.                                  ......+.++.+||..||+.+|.+|||+.|
T Consensus       248 ~~~qli~~lk~--~p~----------------------------------lpi~~~S~eL~dLI~~~L~~dPeeRPSa~Q  291 (1021)
T PTZ00266        248 NFSQLISELKR--GPD----------------------------------LPIKGKSKELNILIKNLLNLSAKERPSALQ  291 (1021)
T ss_pred             cHHHHHHHHhc--CCC----------------------------------CCcCCCCHHHHHHHHHHhcCChhHCcCHHH
Confidence            22222211110  000                                  000125789999999999999999999999


Q ss_pred             HhcCCCCcccccc
Q 014406          406 AMAHPYFAQVRAA  418 (425)
Q Consensus       406 lL~hp~~~~~~~~  418 (425)
                      +|+|||++.+..+
T Consensus       292 lL~h~~ik~i~~p  304 (1021)
T PTZ00266        292 CLGYQIIKNVGPP  304 (1021)
T ss_pred             HhccHHHhhcCCC
Confidence            9999999877543

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=6.7e-43  Score=329.24  Aligned_cols=255  Identities=26%  Similarity=0.388  Sum_probs=207.7

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc------hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEE
Q 014406          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (425)
Q Consensus       126 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (425)
                      .|+..+.||+|+||+||+|.+..+++.+|+|.+....      ...+.+|+++++.+ +|+|++.+.+.+..  +...++
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~i~~~~~~~~~--~~~~~l   77 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKV-NSQFVVNLAYAYET--KDALCL   77 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCcCceeEEEEEec--CCEEEE
Confidence            3677889999999999999999999999999986432      23467899999999 99999999999865  367899


Q ss_pred             EEEeecCCChhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCC
Q 014406          200 IFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (425)
Q Consensus       200 v~e~~~~~~l~~~~-----~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~  274 (425)
                      +|||+.+++|..++     ..+++..+..++.|++.||.|||+.||+|+||||+||+++.+ +.++|+|||++.......
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~-~~~kl~Dfg~~~~~~~~~  156 (285)
T cd05632          78 VLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDY-GHIRISDLGLAVKIPEGE  156 (285)
T ss_pred             EEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCC-CCEEEecCCcceecCCCC
Confidence            99999999997665     248999999999999999999999999999999999999988 789999999997654444


Q ss_pred             cceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCC
Q 014406          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD  354 (425)
Q Consensus       275 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~  354 (425)
                      ......++..|+|||.+.+ ..++.++|+|||||++|+|++|..||... .+......+........             
T Consensus       157 ~~~~~~g~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~P~~~~-~~~~~~~~~~~~~~~~~-------------  221 (285)
T cd05632         157 SIRGRVGTVGYMAPEVLNN-QRYTLSPDYWGLGCLIYEMIEGQSPFRGR-KEKVKREEVDRRVLETE-------------  221 (285)
T ss_pred             cccCCCCCcCccChHHhcC-CCCCcccchHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHHhhhccc-------------
Confidence            4445578999999999977 67999999999999999999999998432 22222222211110000             


Q ss_pred             hhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcC-----HHHHhcCCCCcccccch
Q 014406          355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT-----AREAMAHPYFAQVRAAE  419 (425)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpt-----a~elL~hp~~~~~~~~~  419 (425)
                                          ......++.++.+|+.+||+.||++|||     +.++++||||+.+.+..
T Consensus       222 --------------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~  271 (285)
T cd05632         222 --------------------EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFKR  271 (285)
T ss_pred             --------------------cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCCHHH
Confidence                                0011236788999999999999999999     89999999999986653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.5e-44  Score=343.24  Aligned_cols=247  Identities=26%  Similarity=0.439  Sum_probs=197.3

Q ss_pred             eeeeCceEEEEEEEcCCCcEEEEEEecCcc------hHHHHHHHHHHHHhc--CCCCeeeEEeEEEcCCCCccEEEEEee
Q 014406          133 VGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLC--GGPNVVKLLDIVRDQHSKTPSLIFEYV  204 (425)
Q Consensus       133 LG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~--~h~niv~l~~~~~~~~~~~~~lv~e~~  204 (425)
                      ||+|+||+||+|.+..+++.||+|++....      ......|..++....  +||||+++++++.+.  ...++||||+
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~--~~~~lv~e~~   78 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTD--SDLYLVTDYM   78 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecC--CeEEEEEcCC
Confidence            799999999999999999999999986421      123445677776654  799999999999654  6789999999


Q ss_pred             cCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccC-CCcceeec
Q 014406          205 NSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP-GKEYNVRV  280 (425)
Q Consensus       205 ~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~-~~~~~~~~  280 (425)
                      .+++|..++   ..+++..++.++.||+.||+|||++||+||||||+|||++.+ +.++|+|||+++.... ........
T Consensus        79 ~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~  157 (330)
T cd05586          79 SGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDAT-GHIALCDFGLSKANLTDNKTTNTFC  157 (330)
T ss_pred             CCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCC-CCEEEecCCcCcCCCCCCCCccCcc
Confidence            999998766   358999999999999999999999999999999999999988 7899999999875432 22334567


Q ss_pred             cCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCChhhHHH
Q 014406          281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDAL  360 (425)
Q Consensus       281 ~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~  360 (425)
                      ||..|+|||++.+...++.++|||||||++|+|++|+.||... +..+....+..  +.           ..+       
T Consensus       158 gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~-~~~~~~~~i~~--~~-----------~~~-------  216 (330)
T cd05586         158 GTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAE-DTQQMYRNIAF--GK-----------VRF-------  216 (330)
T ss_pred             CCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCC-CHHHHHHHHHc--CC-----------CCC-------
Confidence            8999999999976556899999999999999999999998432 22222221110  00           000       


Q ss_pred             hcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCc----CHHHHhcCCCCcccccch
Q 014406          361 VGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL----TAREAMAHPYFAQVRAAE  419 (425)
Q Consensus       361 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rp----ta~elL~hp~~~~~~~~~  419 (425)
                                      ....+++++.+|+++||+.||++||    ++.++++||||++..+..
T Consensus       217 ----------------~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~~~~~  263 (330)
T cd05586         217 ----------------PKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADIDWDL  263 (330)
T ss_pred             ----------------CCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCCCHHH
Confidence                            0112688999999999999999998    799999999999876544

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=7.8e-43  Score=332.62  Aligned_cols=285  Identities=27%  Similarity=0.514  Sum_probs=218.7

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc-----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCcc
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (425)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|.++...     ...+.+|+.+++++ +|+|++++++++.+......
T Consensus         5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~   83 (309)
T cd07845           5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNL-RHPNIVELKEVVVGKHLDSI   83 (309)
T ss_pred             cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhC-CCCCCcceEEEEecCCCCeE
Confidence            4578999999999999999999999999999999986332     23466899999999 99999999999987655678


Q ss_pred             EEEEEeecCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCC
Q 014406          198 SLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (425)
Q Consensus       198 ~lv~e~~~~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~  273 (425)
                      ++||||+++ +|..++    ..+++..+..++.|++.||.|||+.|++|+||||+||+++.+ +.+||+|||++......
T Consensus        84 ~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~-~~~kL~dfg~~~~~~~~  161 (309)
T cd07845          84 FLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDK-GCLKIADFGLARTYGLP  161 (309)
T ss_pred             EEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC-CCEEECccceeeecCCc
Confidence            999999986 454443    348999999999999999999999999999999999999988 78999999999866533


Q ss_pred             C-cceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCC
Q 014406          274 K-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE  352 (425)
Q Consensus       274 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~  352 (425)
                      . ......++..|+|||.+.+...++.++||||+||++|+|++|+.|| .+.+..+.+..+...++.+....+..-....
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (309)
T cd07845         162 AKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLL-PGKSEIEQLDLIIQLLGTPNESIWPGFSDLP  240 (309)
T ss_pred             cCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHhcCCCChhhchhhhccc
Confidence            2 2233345778999999876567899999999999999999999887 4566677778787777765433221100000


Q ss_pred             CChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccc
Q 014406          353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA  418 (425)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~  418 (425)
                      ......     .....+...  .......++++.+||.+||++||++|||+.|+++||||++...+
T Consensus       241 ~~~~~~-----~~~~~~~~~--~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~  299 (309)
T cd07845         241 LVGKFT-----LPKQPYNNL--KHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLP  299 (309)
T ss_pred             cccccc-----ccCCCCCch--HHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCCC
Confidence            000000     000000000  00112258899999999999999999999999999999876544

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-42  Score=331.77  Aligned_cols=282  Identities=28%  Similarity=0.531  Sum_probs=211.4

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcC--CCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCcc
Q 014406          126 DYEVVRKVGRGKYSEVFEGINVN--TNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (425)
Q Consensus       126 ~y~~~~~LG~G~fg~V~~~~~~~--~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (425)
                      +|++.+.||+|+||.||+|.+..  ++..||+|.+...      ....+.+|+.+++.+ +||||+++++++.+......
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~   79 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLREL-KHENVVSLVEVFLEHADKSV   79 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhc-CCCCccceEEEEeCCCCceE
Confidence            48889999999999999999988  8999999998752      235678899999999 99999999999987656789


Q ss_pred             EEEEEeecCCChhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecC----CCCcEEEEeccc
Q 014406          198 SLIFEYVNSTDFKVLY-------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH----ELRKLRLIDWGL  266 (425)
Q Consensus       198 ~lv~e~~~~~~l~~~~-------~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~----~~~~~kl~Dfg~  266 (425)
                      ++||||++++.+....       ..+++..++.++.|++.||.|||+.+|+|+||||+||+++.    + +.+||+|||+
T Consensus        80 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~-~~~kl~Dfg~  158 (316)
T cd07842          80 YLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPER-GVVKIGDLGL  158 (316)
T ss_pred             EEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCcc-ceEEECCCcc
Confidence            9999999875443221       25788999999999999999999999999999999999998    6 7899999999


Q ss_pred             cccccCCCc----ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCC--------HHHHHHHH
Q 014406          267 AEFYHPGKE----YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN--------HDQLVKIA  334 (425)
Q Consensus       267 a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~--------~~~~~~~~  334 (425)
                      +........    .....++..|+|||++.+...++.++|||||||++++|++|+.||......        ...+..+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (316)
T cd07842         159 ARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIF  238 (316)
T ss_pred             ccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHH
Confidence            986543222    223467888999999877566899999999999999999999998533222        23455566


Q ss_pred             HHhCCchhHHHHhhccCCCChhhHHHhcccCCCCcc---ccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCC
Q 014406          335 KVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWS---KFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY  411 (425)
Q Consensus       335 ~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~  411 (425)
                      ..++.+....+........   +.............   .....+.....+.++.+++.+||++||++|||+.|+++|||
T Consensus       239 ~~l~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~  315 (316)
T cd07842         239 EVLGTPTEKDWPDIKKMPE---YDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPY  315 (316)
T ss_pred             HHhCCCchhHHHHHhhccc---chhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCC
Confidence            6666544333321111110   01100000000000   00001111246889999999999999999999999999999


Q ss_pred             C
Q 014406          412 F  412 (425)
Q Consensus       412 ~  412 (425)
                      |
T Consensus       316 f  316 (316)
T cd07842         316 F  316 (316)
T ss_pred             C
Confidence            8

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=7.8e-44  Score=340.91  Aligned_cols=245  Identities=28%  Similarity=0.480  Sum_probs=200.2

Q ss_pred             eeeeeeCceEEEEEEE---cCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEEE
Q 014406          131 RKVGRGKYSEVFEGIN---VNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE  202 (425)
Q Consensus       131 ~~LG~G~fg~V~~~~~---~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e  202 (425)
                      +.||+|+||+||++.+   ..+++.+|+|++...     ....+.+|+++++++ +||||+++++++.+.  ...++|||
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~--~~~~lv~e   78 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEV-NHPFIVKLHYAFQTE--GKLYLILD   78 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhC-CCCCcccEEEEEEcC--CEEEEEEc
Confidence            5799999999999876   357899999999743     234567899999999 999999999999654  67899999


Q ss_pred             eecCCChhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCC-Cccee
Q 014406          203 YVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-KEYNV  278 (425)
Q Consensus       203 ~~~~~~l~~~~~---~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~-~~~~~  278 (425)
                      |+++++|..++.   .+++..++.++.||+.||.|||+.||+||||||+|||++.+ +.+||+|||+++..... .....
T Consensus        79 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~-~~~kL~Dfg~~~~~~~~~~~~~~  157 (318)
T cd05582          79 FLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEE-GHIKLTDFGLSKESIDHEKKAYS  157 (318)
T ss_pred             CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCC-CcEEEeeccCCcccCCCCCceec
Confidence            999999987763   48999999999999999999999999999999999999988 78999999998765433 22334


Q ss_pred             eccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCChhhH
Q 014406          279 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLD  358 (425)
Q Consensus       279 ~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~  358 (425)
                      ..|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||. +.+..+....+.+.             .        
T Consensus       158 ~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~-~~~~~~~~~~i~~~-------------~--------  214 (318)
T cd05582         158 FCGTVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGSLPFQ-GKDRKETMTMILKA-------------K--------  214 (318)
T ss_pred             ccCChhhcCHHHHcC-CCCCCccceeccceEeeeeccCCCCCC-CCCHHHHHHHHHcC-------------C--------
Confidence            578999999999977 678999999999999999999999984 22222222222110             0        


Q ss_pred             HHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcC-----HHHHhcCCCCcccccc
Q 014406          359 ALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT-----AREAMAHPYFAQVRAA  418 (425)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpt-----a~elL~hp~~~~~~~~  418 (425)
                                      ...+..+++++.+|+++||+.||++|||     ++++++||||+.+.+.
T Consensus       215 ----------------~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~~~  263 (318)
T cd05582         215 ----------------LGMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTIDWN  263 (318)
T ss_pred             ----------------CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCCCHH
Confidence                            0011236889999999999999999999     7889999999987654

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-42  Score=327.00  Aligned_cols=279  Identities=31%  Similarity=0.559  Sum_probs=212.4

Q ss_pred             CCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCcc
Q 014406          122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (425)
Q Consensus       122 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (425)
                      +..++|++.+.||+|++|+||+|.+..+++.||+|.+....    ...+.+|+++++.+ +|+||+++++++.+  ....
T Consensus         2 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~--~~~~   78 (291)
T cd07844           2 GKLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDL-KHANIVTLHDIIHT--KKTL   78 (291)
T ss_pred             CCccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhC-CCcceeeEEEEEec--CCeE
Confidence            45688999999999999999999999899999999986432    24567899999999 99999999999965  4688


Q ss_pred             EEEEEeecCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCC
Q 014406          198 SLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (425)
Q Consensus       198 ~lv~e~~~~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~  273 (425)
                      ++||||+.+ +|..++    ..+++..++.++.|++.||.|||+.+|+|+||||+||+++.+ +.+||+|||+++.....
T Consensus        79 ~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~-~~~kl~dfg~~~~~~~~  156 (291)
T cd07844          79 TLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISER-GELKLADFGLARAKSVP  156 (291)
T ss_pred             EEEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCC-CCEEECccccccccCCC
Confidence            999999986 676654    247889999999999999999999999999999999999988 78999999998654321


Q ss_pred             -CcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCC
Q 014406          274 -KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE  352 (425)
Q Consensus       274 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~  352 (425)
                       .......++..|+|||++.+...++.++||||+||++|+|++|+.||....+..+++..+.+.++.+....+.......
T Consensus       157 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (291)
T cd07844         157 SKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNP  236 (291)
T ss_pred             CccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcc
Confidence             1222335678899999987656689999999999999999999999854444566677777776665433321111100


Q ss_pred             CChhhHHHhcccCCCCccccccccCCCCCC--HHHHHHHHHcccCCcCCCcCHHHHhcCCCC
Q 014406          353 LDPQLDALVGRHSRKPWSKFINADNQHLVS--PEAIDFLDKLLRYDHQDRLTAREAMAHPYF  412 (425)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s--~~~~~ll~~~L~~dP~~Rpta~elL~hp~~  412 (425)
                      ......  .....   ...  .......++  .++.+++.+||++||++|||+.|+++||||
T Consensus       237 ~~~~~~--~~~~~---~~~--~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f  291 (291)
T cd07844         237 EFKPYS--FPFYP---PRP--LINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF  291 (291)
T ss_pred             cccccc--ccccC---Chh--HHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            000000  00000   000  000111233  788999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=3.1e-43  Score=338.61  Aligned_cols=259  Identities=25%  Similarity=0.398  Sum_probs=205.4

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccE
Q 014406          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (425)
Q Consensus       125 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (425)
                      ++|++.+.||+|+||+||++.+..+++.+|+|++...      ....+.+|+.++..+ +|+||+++++++.+.  ...+
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~l~~~~~~~--~~~~   77 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNG-DCQWITTLHYAFQDE--NYLY   77 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEcC--CEEE
Confidence            5799999999999999999999999999999998642      223477889999988 999999999999654  7889


Q ss_pred             EEEEeecCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCC
Q 014406          199 LIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (425)
Q Consensus       199 lv~e~~~~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~  274 (425)
                      +||||+.+|+|..++    ..+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||++.......
T Consensus        78 lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~-~~~kl~DfG~a~~~~~~~  156 (331)
T cd05624          78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMN-GHIRLADFGSCLKMNQDG  156 (331)
T ss_pred             EEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCC-CCEEEEeccceeeccCCC
Confidence            999999999999876    347899999999999999999999999999999999999988 789999999997664433


Q ss_pred             cc--eeeccCCCccCcccccCC----CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhh
Q 014406          275 EY--NVRVASRYFKGPELLVDL----QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK  348 (425)
Q Consensus       275 ~~--~~~~~t~~y~aPE~~~~~----~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~  348 (425)
                      ..  ....|+..|+|||++.+.    ..++.++|||||||++|+|++|+.||.. .+..+....+....           
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~-~~~~~~~~~i~~~~-----------  224 (331)
T cd05624         157 TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA-ESLVETYGKIMNHE-----------  224 (331)
T ss_pred             ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccC-CCHHHHHHHHHcCC-----------
Confidence            22  234689999999998642    3578899999999999999999999842 22222222221100           


Q ss_pred             ccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCC--CcCHHHHhcCCCCcccccchh
Q 014406          349 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQD--RLTAREAMAHPYFAQVRAAES  420 (425)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~--Rpta~elL~hp~~~~~~~~~~  420 (425)
                                      .+..+     ......+++++++|+.+||..++.+  |++++++++||||+.+.+...
T Consensus       225 ----------------~~~~~-----p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~~~~~  277 (331)
T cd05624         225 ----------------ERFQF-----PSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDWENI  277 (331)
T ss_pred             ----------------CcccC-----CCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCCHHHH
Confidence                            00000     0011236899999999999876654  569999999999998876543

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=2.2e-43  Score=338.82  Aligned_cols=246  Identities=25%  Similarity=0.436  Sum_probs=197.3

Q ss_pred             eeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHH-HHHhcCCCCeeeEEeEEEcCCCCccEEEEEe
Q 014406          131 RKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKI-LQNLCGGPNVVKLLDIVRDQHSKTPSLIFEY  203 (425)
Q Consensus       131 ~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~-l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~  203 (425)
                      +.||+|+||+||+|.+..+++.+|+|++...      ....+..|..+ ++.+ +||||+++++++...  ...++||||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-~hp~iv~~~~~~~~~--~~~~lv~e~   77 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNV-KHPFLVGLHYSFQTT--EKLYFVLDF   77 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhC-CCCCCccEEEEEecC--CEEEEEEcC
Confidence            3699999999999999999999999998642      22345556554 5566 999999999999654  678999999


Q ss_pred             ecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccC-CCcceee
Q 014406          204 VNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP-GKEYNVR  279 (425)
Q Consensus       204 ~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~-~~~~~~~  279 (425)
                      +.+++|..++   ..+++..+..++.||+.||+|||+.||+||||||+|||++.+ +.+||+|||+++.... .......
T Consensus        78 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~-~~~kL~DfG~~~~~~~~~~~~~~~  156 (325)
T cd05604          78 VNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQ-GHVVLTDFGLCKEGIAQSDTTTTF  156 (325)
T ss_pred             CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCC-CCEEEeecCCcccCCCCCCCcccc
Confidence            9999997766   458999999999999999999999999999999999999988 7899999999875322 2233445


Q ss_pred             ccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCChhhHH
Q 014406          280 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDA  359 (425)
Q Consensus       280 ~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~  359 (425)
                      .|+..|+|||++.+ ..++.++|||||||++|+|++|..||.. .+..+....+..   .          .         
T Consensus       157 ~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~G~~pf~~-~~~~~~~~~~~~---~----------~---------  212 (325)
T cd05604         157 CGTPEYLAPEVIRK-QPYDNTVDWWCLGAVLYEMLYGLPPFYC-RDVAEMYDNILH---K----------P---------  212 (325)
T ss_pred             cCChhhCCHHHHcC-CCCCCcCccccccceehhhhcCCCCCCC-CCHHHHHHHHHc---C----------C---------
Confidence            78999999999987 7789999999999999999999999853 222222222111   0          0         


Q ss_pred             HhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCH----HHHhcCCCCcccccch
Q 014406          360 LVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA----REAMAHPYFAQVRAAE  419 (425)
Q Consensus       360 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta----~elL~hp~~~~~~~~~  419 (425)
                                     ......++..+.+++++||+.||++||++    .++++||||+...+..
T Consensus       213 ---------------~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~~~~~  261 (325)
T cd05604         213 ---------------LVLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLSWTD  261 (325)
T ss_pred             ---------------ccCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCCCHHH
Confidence                           00011268889999999999999999976    5999999999876543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=1.6e-42  Score=326.25  Aligned_cols=277  Identities=31%  Similarity=0.567  Sum_probs=211.6

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEE
Q 014406          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (425)
Q Consensus       125 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (425)
                      ++|++.+.||+|+||.||+|.+..+++.+|+|.+...     ..+.+.+|+.+++++ +|+|++++++++...  ...++
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~--~~~~~   77 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQL-KHPNLVNLIEVFRRK--RKLHL   77 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhC-CCCCEeeeeeEEeeC--CEEEE
Confidence            5799999999999999999999999999999988532     234578999999999 899999999999654  67889


Q ss_pred             EEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCC-c
Q 014406          200 IFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-E  275 (425)
Q Consensus       200 v~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~-~  275 (425)
                      ||||++++++..+.   ..+++..+..++.|++.||+|||+.|++|+||||+||+++.+ +.++|+|||++....... .
T Consensus        78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~~~~  156 (286)
T cd07847          78 VFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQ-GQIKLCDFGFARILTGPGDD  156 (286)
T ss_pred             EEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCC-CcEEECccccceecCCCccc
Confidence            99999999988775   358999999999999999999999999999999999999988 789999999998765433 2


Q ss_pred             ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCCh
Q 014406          276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP  355 (425)
Q Consensus       276 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~  355 (425)
                      .....++..|+|||.+.+...++.++|||||||++|+|++|+.|| .+.++.+.+..+...++........ ....  ..
T Consensus       157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~--~~  232 (286)
T cd07847         157 YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLW-PGKSDVDQLYLIRKTLGDLIPRHQQ-IFST--NQ  232 (286)
T ss_pred             ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHhCCCChHHhh-hccc--cc
Confidence            334467788999999876566889999999999999999999887 4555556666655554432211000 0000  00


Q ss_pred             hhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCC
Q 014406          356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF  412 (425)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~  412 (425)
                      .....   .................++..+.+|+.+||+.||++|||+.|+++||||
T Consensus       233 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f  286 (286)
T cd07847         233 FFKGL---SIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF  286 (286)
T ss_pred             ccccc---cCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence            00000   0000000000000112368899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=8e-43  Score=323.52  Aligned_cols=251  Identities=31%  Similarity=0.561  Sum_probs=204.8

Q ss_pred             EEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcchH-----HHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEE
Q 014406          127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKK-----KIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (425)
Q Consensus       127 y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (425)
                      |++.+.||+|+||+||++.+..+++.+|+|++......     ...+|+.+++++ +|+||+++++++..  ....++||
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~--~~~~~~v~   77 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRL-RHPNIVQILDVFQD--DNYLYIVM   77 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHH-TBTTBCHEEEEEEE--SSEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccc-cccccccccccccc--cccccccc
Confidence            78999999999999999999999999999999865432     234599999999 99999999999976  47788999


Q ss_pred             EeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccc-cCCCcce
Q 014406          202 EYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY-HPGKEYN  277 (425)
Q Consensus       202 e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~-~~~~~~~  277 (425)
                      ||+.+++|..++   ..+++..+..++.|++.||++||+.+|+|+||||+||+++.+ +.++|+|||.+... .......
T Consensus        78 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~-~~~~l~Dfg~~~~~~~~~~~~~  156 (260)
T PF00069_consen   78 EYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDEN-GEVKLIDFGSSVKLSENNENFN  156 (260)
T ss_dssp             EEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTT-SEEEESSGTTTEESTSTTSEBS
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-cccccccccccccccccccccc
Confidence            999999998766   468999999999999999999999999999999999999977 78999999998753 2334445


Q ss_pred             eeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCChhh
Q 014406          278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQL  357 (425)
Q Consensus       278 ~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~  357 (425)
                      ...++..|+|||++.....++.++||||+|+++++|++|..||... ...+....+.+.+.........           
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~-----------  224 (260)
T PF00069_consen  157 PFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES-NSDDQLEIIEKILKRPLPSSSQ-----------  224 (260)
T ss_dssp             SSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS-SHHHHHHHHHHHHHTHHHHHTT-----------
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccc-cchhhhhhhhhccccccccccc-----------
Confidence            5678889999999873378999999999999999999999998533 2233333333333221111100           


Q ss_pred             HHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCC
Q 014406          358 DALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF  412 (425)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~  412 (425)
                                         .....+.++.+++.+||+.||++|||+.++++||||
T Consensus       225 -------------------~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~  260 (260)
T PF00069_consen  225 -------------------QSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF  260 (260)
T ss_dssp             -------------------SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred             -------------------ccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence                               000013789999999999999999999999999997

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=3.7e-42  Score=325.05  Aligned_cols=282  Identities=29%  Similarity=0.512  Sum_probs=211.9

Q ss_pred             CCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCcc
Q 014406          122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (425)
Q Consensus       122 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (425)
                      +..++|++.+.||+|+||.||+|.+..++..+|+|++....    ...+.+|+.+++.+ +|+||+++++++.+.  ...
T Consensus         2 ~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~--~~~   78 (291)
T cd07870           2 GAATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGL-KHANIVLLHDIIHTK--ETL   78 (291)
T ss_pred             CccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhc-CCCCEeEEEEEEecC--CeE
Confidence            45688999999999999999999999999999999986432    23577899999999 899999999999654  678


Q ss_pred             EEEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCC-
Q 014406          198 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-  273 (425)
Q Consensus       198 ~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~-  273 (425)
                      ++|+||+.++.+....   ..+++..+..++.|++.||.|||+.||+|+||||+||+++.+ +.++|+|||+++..... 
T Consensus        79 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~-~~~~l~Dfg~~~~~~~~~  157 (291)
T cd07870          79 TFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYL-GELKLADFGLARAKSIPS  157 (291)
T ss_pred             EEEEecccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCC-CcEEEeccccccccCCCC
Confidence            8999999755444433   247788899999999999999999999999999999999988 78999999998754322 


Q ss_pred             CcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCC
Q 014406          274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL  353 (425)
Q Consensus       274 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~  353 (425)
                      .......++..|+|||.+.+...++.++|||||||++|+|++|..||....+..+.+..+...+|.+....+..-...  
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  235 (291)
T cd07870         158 QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKL--  235 (291)
T ss_pred             CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhc--
Confidence            222334578889999998764568899999999999999999999986555556667777666665433221110000  


Q ss_pred             ChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCC
Q 014406          354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF  412 (425)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~  412 (425)
                      +................   ........+.++.+++.+||+.||++|||+.|++.||||
T Consensus       236 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~  291 (291)
T cd07870         236 PNYKPEWFLPCKPQQLR---VVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF  291 (291)
T ss_pred             ccccchhccccCCcchh---hhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence            00000000000000000   000011136789999999999999999999999999998

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=1e-42  Score=329.85  Aligned_cols=279  Identities=35%  Similarity=0.605  Sum_probs=216.9

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc--------hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCcc
Q 014406          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (425)
Q Consensus       126 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~--------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (425)
                      +|++.+.||+|+||.||+|.+..+++.||+|.+....        ...+..|+++++.+ +|+||+++++++.+  ....
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~--~~~~   77 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQEL-KHPNIIGLLDVFGH--KSNI   77 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhc-CCCCChhhhheeec--CCEE
Confidence            4788899999999999999999999999999987432        23467899999999 89999999999976  4678


Q ss_pred             EEEEEeecCCChhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCC
Q 014406          198 SLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (425)
Q Consensus       198 ~lv~e~~~~~~l~~~~~----~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~  273 (425)
                      ++||||+ +++|..++.    .+++..+..++.||+.||.|||++||+|+||+|+||+++.+ +.++|+|||+++.....
T Consensus        78 ~lv~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~-~~~~l~dfg~~~~~~~~  155 (298)
T cd07841          78 NLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASD-GVLKLADFGLARSFGSP  155 (298)
T ss_pred             EEEEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCC-CCEEEccceeeeeccCC
Confidence            9999999 888888763    48899999999999999999999999999999999999988 78999999999766433


Q ss_pred             -CcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCC
Q 014406          274 -KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE  352 (425)
Q Consensus       274 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~  352 (425)
                       .......++..|+|||.+.+...++.++|||||||++++|++|. |++.+.++.+.+..+...++.+....+.......
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (298)
T cd07841         156 NRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRV-PFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLP  234 (298)
T ss_pred             CccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCC-ccccCCccHHHHHHHHHHcCCCchhhhhhccccc
Confidence             22233456778999999866567899999999999999999995 5556666666677666666554433322111110


Q ss_pred             CChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccch
Q 014406          353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE  419 (425)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~~  419 (425)
                      .         ...................+.++.+|+.+||++||++|||+.|+++||||++.....
T Consensus       235 ~---------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~  292 (298)
T cd07841         235 D---------YVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPT  292 (298)
T ss_pred             c---------cccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCC
Confidence            0         000000000001111233678999999999999999999999999999999876544

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=5.1e-43  Score=338.15  Aligned_cols=247  Identities=20%  Similarity=0.347  Sum_probs=193.3

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEc-----CCCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCC
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINV-----NTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQH  193 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~-----~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  193 (425)
                      ..++|++.+.||+|+||.||+|.+.     .++..||+|+++...    .+.+.+|+.++.++.+||||++++++|... 
T Consensus         5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~-   83 (338)
T cd05102           5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP-   83 (338)
T ss_pred             chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC-
Confidence            3578999999999999999999752     345789999987432    356889999999997899999999998654 


Q ss_pred             CCccEEEEEeecCCChhhhcC-----------------------------------------------------------
Q 014406          194 SKTPSLIFEYVNSTDFKVLYP-----------------------------------------------------------  214 (425)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~~-----------------------------------------------------------  214 (425)
                      ...+++||||+++|+|.+++.                                                           
T Consensus        84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (338)
T cd05102          84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET  163 (338)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence            346789999999999977652                                                           


Q ss_pred             ------CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCcc---eeeccCCCc
Q 014406          215 ------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY---NVRVASRYF  285 (425)
Q Consensus       215 ------~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~t~~y  285 (425)
                            .+++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++........   ....++..|
T Consensus       164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~-~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y  242 (338)
T cd05102         164 DDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSEN-NVVKICDFGLARDIYKDPDYVRKGSARLPLKW  242 (338)
T ss_pred             cccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCC-CcEEEeecccccccccCcchhcccCCCCCccc
Confidence                  26677888899999999999999999999999999999988 78999999999765332211   223456789


Q ss_pred             cCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCChhhHHHhccc
Q 014406          286 KGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRH  364 (425)
Q Consensus       286 ~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~  364 (425)
                      +|||++.+ ..++.++|||||||++|||++ |..||.. ....+.+.....   ...                       
T Consensus       243 ~aPE~~~~-~~~~~~sDiwslG~il~el~~~g~~pf~~-~~~~~~~~~~~~---~~~-----------------------  294 (338)
T cd05102         243 MAPESIFD-KVYTTQSDVWSFGVLLWEIFSLGASPYPG-VQINEEFCQRLK---DGT-----------------------  294 (338)
T ss_pred             cCcHHhhc-CCCCcccCHHHHHHHHHHHHhCCCCCCCC-CCccHHHHHHHh---cCC-----------------------
Confidence            99999977 678999999999999999997 8888733 222222111100   000                       


Q ss_pred             CCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhc
Q 014406          365 SRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  408 (425)
Q Consensus       365 ~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~  408 (425)
                               .......+++++.+++.+||+.||++|||+.|+++
T Consensus       295 ---------~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~  329 (338)
T cd05102         295 ---------RMRAPENATPEIYRIMLACWQGDPKERPTFSALVE  329 (338)
T ss_pred             ---------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                     00011236889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=9.6e-43  Score=327.11  Aligned_cols=257  Identities=20%  Similarity=0.369  Sum_probs=206.4

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEE
Q 014406          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (425)
Q Consensus       125 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (425)
                      ++|++.+.||+|+||.||+|.+..+++.+|+|.+...    ....+.+|+.+++++ +||||+++++++...  ...++|
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~--~~~~lv   77 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKC-DSPYIIGFYGAFFVE--NRISIC   77 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEEC--CEEEEE
Confidence            4678889999999999999999999999999998643    235688999999999 999999999999764  677899


Q ss_pred             EEeecCCChhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCcceeec
Q 014406          201 FEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRV  280 (425)
Q Consensus       201 ~e~~~~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~~~~~~  280 (425)
                      |||++++++..+ ..+++..+..++.|++.||.|||+.||+|+||||+|||++.+ +.++|+|||++...... ......
T Consensus        78 ~e~~~~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~-~~~~l~dfg~~~~~~~~-~~~~~~  154 (279)
T cd06619          78 TEFMDGGSLDVY-RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTR-GQVKLCDFGVSTQLVNS-IAKTYV  154 (279)
T ss_pred             EecCCCCChHHh-hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCC-CCEEEeeCCcceecccc-cccCCC
Confidence            999999998655 457888999999999999999999999999999999999998 78999999999765432 334457


Q ss_pred             cCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHH--HHHHHHhCCchhHHHHhhccCCCChhhH
Q 014406          281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL--VKIAKVLGTDELNAYLNKYHLELDPQLD  358 (425)
Q Consensus       281 ~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~--~~~~~~lg~~~~~~~~~~~~~~~~~~~~  358 (425)
                      ++..|+|||.+.+ ..++.++|+|||||++|+|++|..||..........  ....+.....                  
T Consensus       155 ~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~------------------  215 (279)
T cd06619         155 GTNAYMAPERISG-EQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDE------------------  215 (279)
T ss_pred             CChhhcCceeecC-CCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhcc------------------
Confidence            8899999999987 678999999999999999999999985322211110  0000000000                  


Q ss_pred             HHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccch
Q 014406          359 ALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE  419 (425)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~~  419 (425)
                            ...       .......++++.+|+.+||+.||++||+++|+++||||.......
T Consensus       216 ------~~~-------~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~~~~  263 (279)
T cd06619         216 ------DPP-------VLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQYNDGN  263 (279)
T ss_pred             ------CCC-------CCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccccccCcc
Confidence                  000       001122578899999999999999999999999999999775544

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=2e-42  Score=327.22  Aligned_cols=279  Identities=32%  Similarity=0.573  Sum_probs=216.0

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc-----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccE
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (425)
                      .++|++.+.||.|+||.||+|.+..+++.+++|.++...     ...+.+|+.+++++ +||||+++++++.+.+....+
T Consensus         4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~~~   82 (293)
T cd07843           4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKL-QHPNIVTVKEVVVGSNLDKIY   82 (293)
T ss_pred             hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhc-CCCCEEEEEEEEEecCCCcEE
Confidence            357888999999999999999999999999999986432     23467899999999 899999999999876667899


Q ss_pred             EEEEeecCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCC-
Q 014406          199 LIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-  273 (425)
Q Consensus       199 lv~e~~~~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~-  273 (425)
                      +||||+++ +|..++    ..+++..+..++.|++.||+|||+.|++|+||||+||+++.+ +.++|+|||++...... 
T Consensus        83 lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~-~~~~l~d~g~~~~~~~~~  160 (293)
T cd07843          83 MVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNR-GILKICDFGLAREYGSPL  160 (293)
T ss_pred             EEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCC-CcEEEeecCceeeccCCc
Confidence            99999986 665554    248999999999999999999999999999999999999988 78999999998866543 


Q ss_pred             CcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCC
Q 014406          274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL  353 (425)
Q Consensus       274 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~  353 (425)
                      .......++..|+|||.+.+...++.++|+||||+++|+|++|..|| .+.+..+.+..+...++.+....+........
T Consensus       161 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (293)
T cd07843         161 KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLF-PGKSEIDQLNKIFKLLGTPTEKIWPGFSELPG  239 (293)
T ss_pred             cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHhCCCchHHHHHhhccch
Confidence            23344567888999999876555789999999999999999999887 45555666777777776654443322111111


Q ss_pred             ChhhHHHhcccCCCCccccccccCCCC-CCHHHHHHHHHcccCCcCCCcCHHHHhcCCCC
Q 014406          354 DPQLDALVGRHSRKPWSKFINADNQHL-VSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF  412 (425)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~  412 (425)
                      ...     ........ .......... +++.+.+||++||+.||++|||+.|+++||||
T Consensus       240 ~~~-----~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f  293 (293)
T cd07843         240 AKK-----KTFTKYPY-NQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF  293 (293)
T ss_pred             hcc-----cccccccc-hhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence            100     00000000 0001111111 58889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=1.7e-42  Score=326.13  Aligned_cols=274  Identities=34%  Similarity=0.629  Sum_probs=217.1

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc-----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEE
Q 014406          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (425)
Q Consensus       126 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (425)
                      +|++.+.||.|+||.||+|.+..+++.+|+|++....     ...+.+|+.+++++ +|+||+++++++..  +...++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~--~~~~~~v   77 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQAC-QHPYVVKLLDVFPH--GSGFVLV   77 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhC-CCCCCcceeeEEec--CCeeEEE
Confidence            5889999999999999999999999999999987432     35788999999999 89999999999965  4678999


Q ss_pred             EEeecCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCC--
Q 014406          201 FEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK--  274 (425)
Q Consensus       201 ~e~~~~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~--  274 (425)
                      +||+ +++|..++    ..+++.+++.++.|++.||+|||+.|++|+||||+||+++.+ +.++|+|||++.......  
T Consensus        78 ~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~-~~~~l~dfg~~~~~~~~~~~  155 (286)
T cd07832          78 MEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISAD-GVLKIADFGLARLFSEEEPR  155 (286)
T ss_pred             eccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCC-CcEEEeeeeecccccCCCCC
Confidence            9999 89888775    348999999999999999999999999999999999999987 789999999988665432  


Q ss_pred             cceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCC
Q 014406          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD  354 (425)
Q Consensus       275 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~  354 (425)
                      ......++..|+|||.+.+...++.++||||+||++++|++|. |++.+.++.+.+..+.+.++.+....+..-..+   
T Consensus       156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---  231 (286)
T cd07832         156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGS-PLFPGENDIEQLAIVFRTLGTPNEETWPGLTSL---  231 (286)
T ss_pred             ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCC-cCcCCCCHHHHHHHHHHHcCCCChHHHhhccCc---
Confidence            2344578889999999876566789999999999999999995 555677777778877777776554433221111   


Q ss_pred             hhhHHHhcc-cCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCc
Q 014406          355 PQLDALVGR-HSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA  413 (425)
Q Consensus       355 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~  413 (425)
                      ..+...... .....+     .......+.++.+|+.+||+.||++|||++++++||||.
T Consensus       232 ~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~  286 (286)
T cd07832         232 PDYNKITFPESKPIPL-----EEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT  286 (286)
T ss_pred             chhhcccCCCCCcchH-----HHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence            000000000 000001     111123578999999999999999999999999999984

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.1e-44  Score=340.20  Aligned_cols=252  Identities=26%  Similarity=0.476  Sum_probs=217.0

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccE
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (425)
                      .++|+.++.+|+|+||.++.++++.+++.+|+|.+.-.     .+....+|+.+++++ .|||||.+.+.|... +..++
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~-~hP~iv~y~ds~~~~-~~~l~   80 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKL-LHPNIVEYKDSFEED-GQLLC   80 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhc-cCCCeeeeccchhcC-CceEE
Confidence            46889999999999999999999999999999998632     234678999999998 999999999999754 34599


Q ss_pred             EEEEeecCCChhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCC
Q 014406          199 LIFEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (425)
Q Consensus       199 lv~e~~~~~~l~~~~~-----~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~  273 (425)
                      +||+|++||++.+.+.     .|+++.+..|+.|++.|+.|||+++|+|||||+.||+++.+ +.++|+|||+|+...+.
T Consensus        81 Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~-~~VkLgDfGlaK~l~~~  159 (426)
T KOG0589|consen   81 IVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKD-KKVKLGDFGLAKILNPE  159 (426)
T ss_pred             EEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhcccc-CceeecchhhhhhcCCc
Confidence            9999999999998873     38999999999999999999999999999999999999999 67899999999998877


Q ss_pred             C-cceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCC
Q 014406          274 K-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE  352 (425)
Q Consensus       274 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~  352 (425)
                      . ...+.+||+.|+.||.+.+ .+|+.++|||||||++|||++-+.+| .+.+......++.+....+            
T Consensus       160 ~~~a~tvvGTp~YmcPEil~d-~pYn~KSDiWsLGC~~yEm~~lk~aF-~a~~m~~Li~ki~~~~~~P------------  225 (426)
T KOG0589|consen  160 DSLASTVVGTPYYMCPEILSD-IPYNEKSDIWSLGCCLYEMCTLKPAF-KASNMSELILKINRGLYSP------------  225 (426)
T ss_pred             hhhhheecCCCcccCHHHhCC-CCCCccCcchhhcchHHHHHhccccc-CccchHHHHHHHhhccCCC------------
Confidence            6 5567899999999999998 89999999999999999999999888 4444444445554432111            


Q ss_pred             CChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccc
Q 014406          353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR  416 (425)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~  416 (425)
                                              .+..++.+++.+++.||+.+|+.||++.++|.+|.+....
T Consensus       226 ------------------------lp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~~~~  265 (426)
T KOG0589|consen  226 ------------------------LPSMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLLRYL  265 (426)
T ss_pred             ------------------------CCccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhhhHH
Confidence                                    1223689999999999999999999999999999887543

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=2.2e-42  Score=326.83  Aligned_cols=262  Identities=25%  Similarity=0.406  Sum_probs=210.0

Q ss_pred             cccCCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc---hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCC
Q 014406          119 VQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (425)
Q Consensus       119 ~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (425)
                      ......+.|+++++||.|+||.||+|.+..+++.+++|.+....   .+.+.+|+.+++.+ +|+||+++++.+..+  .
T Consensus         6 ~~~~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~   82 (292)
T cd06644           6 RDLDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATC-NHPYIVKLLGAFYWD--G   82 (292)
T ss_pred             cccCcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhC-CCCcEeeeEEEEEeC--C
Confidence            33445678999999999999999999999999999999997544   34677899999999 899999999998654  6


Q ss_pred             ccEEEEEeecCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEecccccccc
Q 014406          196 TPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (425)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~  271 (425)
                      ..++||||++++++..++    ..+++..+..++.|++.||.|||+.+++|+||||+||+++.+ +.++|+|||++....
T Consensus        83 ~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~-~~~kl~dfg~~~~~~  161 (292)
T cd06644          83 KLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLD-GDIKLADFGVSAKNV  161 (292)
T ss_pred             eEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCC-CCEEEccCccceecc
Confidence            789999999999987664    348999999999999999999999999999999999999987 789999999986543


Q ss_pred             CC-CcceeeccCCCccCcccccC----CCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHH
Q 014406          272 PG-KEYNVRVASRYFKGPELLVD----LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYL  346 (425)
Q Consensus       272 ~~-~~~~~~~~t~~y~aPE~~~~----~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~  346 (425)
                      .. .......++..|+|||++.+    ...++.++|||||||++|+|++|..||... +.......+..   ...     
T Consensus       162 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~-~~~~~~~~~~~---~~~-----  232 (292)
T cd06644         162 KTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL-NPMRVLLKIAK---SEP-----  232 (292)
T ss_pred             ccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccc-cHHHHHHHHhc---CCC-----
Confidence            22 22344567889999999852    245788999999999999999999998422 22121111110   000     


Q ss_pred             hhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccch
Q 014406          347 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE  419 (425)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~~  419 (425)
                                                ........++.++.+|+++||+.||++||+++|+++||||..+.+..
T Consensus       233 --------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~  279 (292)
T cd06644         233 --------------------------PTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSNR  279 (292)
T ss_pred             --------------------------ccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccccch
Confidence                                      00001123678899999999999999999999999999999887765

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=7.1e-43  Score=352.01  Aligned_cols=253  Identities=22%  Similarity=0.359  Sum_probs=205.5

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCC---
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS---  194 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~---  194 (425)
                      ..++|++.+.||+|+||+||+|.+..+++.||||++...     ....+.+|+.++..+ +|+|++++++.+.....   
T Consensus        30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~-~h~~iv~~~~~~~~~~~~~~  108 (496)
T PTZ00283         30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNC-DFFSIVKCHEDFAKKDPRNP  108 (496)
T ss_pred             cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcC-CCCcEEEeecceecccccCc
Confidence            357999999999999999999999999999999998643     234577899999998 99999999987754321   


Q ss_pred             ---CccEEEEEeecCCChhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEec
Q 014406          195 ---KTPSLIFEYVNSTDFKVLY-------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDW  264 (425)
Q Consensus       195 ---~~~~lv~e~~~~~~l~~~~-------~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Df  264 (425)
                         ..+++||||+++|+|.+++       ..+++..+..++.|++.||+|||+.+|+||||||+|||++.+ +.+||+||
T Consensus       109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~-~~vkL~DF  187 (496)
T PTZ00283        109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSN-GLVKLGDF  187 (496)
T ss_pred             ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCC-CCEEEEec
Confidence               1367999999999998776       248899999999999999999999999999999999999988 78999999


Q ss_pred             cccccccCC---CcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCch
Q 014406          265 GLAEFYHPG---KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDE  341 (425)
Q Consensus       265 g~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~  341 (425)
                      |+++.....   .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||. +.+..+.+..+..  +.  
T Consensus       188 Gls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~k~DVwSlGvilyeLltG~~Pf~-~~~~~~~~~~~~~--~~--  261 (496)
T PTZ00283        188 GFSKMYAATVSDDVGRTFCGTPYYVAPEIWRR-KPYSKKADMFSLGVLLYELLTLKRPFD-GENMEEVMHKTLA--GR--  261 (496)
T ss_pred             ccCeeccccccccccccccCCcceeCHHHhCC-CCCCcHHHHHHHHHHHHHHHHCCCCCC-CCCHHHHHHHHhc--CC--
Confidence            999765432   12234578999999999987 679999999999999999999999983 2222222221110  00  


Q ss_pred             hHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCccc
Q 014406          342 LNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV  415 (425)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~  415 (425)
                                              .        ......+++++.+++.+||+.||++|||+.++++|||++..
T Consensus       262 ------------------------~--------~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~  303 (496)
T PTZ00283        262 ------------------------Y--------DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLF  303 (496)
T ss_pred             ------------------------C--------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHh
Confidence                                    0        00122368899999999999999999999999999998754

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=6.7e-43  Score=335.44  Aligned_cols=245  Identities=24%  Similarity=0.435  Sum_probs=197.0

Q ss_pred             eeeeeCceEEEEEEEcCCCcEEEEEEecCcc------hHHHHHHHH-HHHHhcCCCCeeeEEeEEEcCCCCccEEEEEee
Q 014406          132 KVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIK-ILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV  204 (425)
Q Consensus       132 ~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~-~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~  204 (425)
                      .||+|+||+||+|.+..+++.+|+|++....      ...+..|.. +++.+ +|+||+++++++...  ...++||||+
T Consensus         2 ~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-~h~~Iv~~~~~~~~~--~~~~lv~e~~   78 (325)
T cd05602           2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNV-KHPFLVGLHFSFQTA--DKLYFVLDYI   78 (325)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhC-CCCCCCceeEEEEcC--CeEEEEEeCC
Confidence            6999999999999999999999999986422      223444544 45666 999999999999654  6789999999


Q ss_pred             cCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccC-CCcceeec
Q 014406          205 NSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP-GKEYNVRV  280 (425)
Q Consensus       205 ~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~-~~~~~~~~  280 (425)
                      ++++|..++   ..+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++.... ........
T Consensus        79 ~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~-~~~kl~DfG~a~~~~~~~~~~~~~~  157 (325)
T cd05602          79 NGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQ-GHIVLTDFGLCKENIEHNGTTSTFC  157 (325)
T ss_pred             CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCC-CCEEEccCCCCcccccCCCCccccc
Confidence            999998876   347889999999999999999999999999999999999988 7899999999875422 22334557


Q ss_pred             cCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCChhhHHH
Q 014406          281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDAL  360 (425)
Q Consensus       281 ~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~  360 (425)
                      ||+.|+|||++.+ ..++.++|||||||++|+|++|..||. +.+..+.+..+...             .          
T Consensus       158 gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~-~~~~~~~~~~i~~~-------------~----------  212 (325)
T cd05602         158 GTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFY-SRNTAEMYDNILNK-------------P----------  212 (325)
T ss_pred             CCccccCHHHHcC-CCCCCccccccccHHHHHHhcCCCCCC-CCCHHHHHHHHHhC-------------C----------
Confidence            8999999999987 789999999999999999999999984 22322222222110             0          


Q ss_pred             hcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHH----HHhcCCCCcccccch
Q 014406          361 VGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAR----EAMAHPYFAQVRAAE  419 (425)
Q Consensus       361 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~----elL~hp~~~~~~~~~  419 (425)
                                    ......+++.+.+++++||+.||.+|+++.    ++++|+||....+..
T Consensus       213 --------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~~~~~  261 (325)
T cd05602         213 --------------LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPINWDD  261 (325)
T ss_pred             --------------cCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCCCHHH
Confidence                          001123688999999999999999999876    899999998876543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-42  Score=321.37  Aligned_cols=247  Identities=26%  Similarity=0.434  Sum_probs=201.6

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc--------chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCc
Q 014406          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (425)
Q Consensus       125 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~--------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (425)
                      ++|++.+.||+|++|.||+|.+..+++.+|+|.+...        ..+.+.+|+.+++++ +||||+++++++.+.  ..
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~--~~   78 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL-QHERIVQYYGCLRDD--ET   78 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhC-CCCCeeeeEEEEccC--Ce
Confidence            5688899999999999999999999999999998532        124678899999999 999999999999654  58


Q ss_pred             cEEEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCC
Q 014406          197 PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (425)
Q Consensus       197 ~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~  273 (425)
                      .++|+||+++++|.+++   ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.+ +.++|+|||+++.....
T Consensus        79 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~-~~~~l~dfg~~~~~~~~  157 (263)
T cd06625          79 LSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSA-GNVKLGDFGASKRLQTI  157 (263)
T ss_pred             EEEEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC-CCEEEeecccceecccc
Confidence            89999999999998776   357889999999999999999999999999999999999987 78999999998765432


Q ss_pred             Ccc----eeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhc
Q 014406          274 KEY----NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY  349 (425)
Q Consensus       274 ~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~  349 (425)
                      ...    ....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||... +..+....+....            
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~-~~~~~~~~~~~~~------------  223 (263)
T cd06625         158 CSSGTGMKSVTGTPYWMSPEVISG-EGYGRKADVWSVGCTVVEMLTEKPPWAEF-EAMAAIFKIATQP------------  223 (263)
T ss_pred             ccccccccCCCcCccccCcceecc-CCCCchhhhHHHHHHHHHHHhCCCCcccc-chHHHHHHHhccC------------
Confidence            111    23456788999999987 66899999999999999999999998432 2211111111000            


Q ss_pred             cCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCC
Q 014406          350 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF  412 (425)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~  412 (425)
                                             .....+..++..+.+|+++||+.+|++|||+.|+++||||
T Consensus       224 -----------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  263 (263)
T cd06625         224 -----------------------TNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV  263 (263)
T ss_pred             -----------------------CCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence                                   0011122368899999999999999999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-42  Score=333.06  Aligned_cols=286  Identities=30%  Similarity=0.574  Sum_probs=216.9

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCC---CC
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH---SK  195 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~---~~  195 (425)
                      ..++|++.+.||+|+||+||+|.+..+++.||+|.++..    ....+.+|+.+++++ +|+||+++++++....   ..
T Consensus         3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~   81 (336)
T cd07849           3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRF-KHENIIGILDIIRPPSFESFN   81 (336)
T ss_pred             cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhC-CCCCcCchhheeecccccccc
Confidence            457899999999999999999999999999999998642    234577899999999 8999999999876432   24


Q ss_pred             ccEEEEEeecCCChhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCC
Q 014406          196 TPSLIFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (425)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~  273 (425)
                      ..++++||+.+ ++..++  ..+++..++.++.|++.||.|||+.||+|+||||+||+++.+ +.++|+|||++......
T Consensus        82 ~~~lv~e~~~~-~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~-~~~kl~dfg~~~~~~~~  159 (336)
T cd07849          82 DVYIVQELMET-DLYKLIKTQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTN-CDLKICDFGLARIADPE  159 (336)
T ss_pred             eEEEEehhccc-CHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCC-CCEEECcccceeecccc
Confidence            57899999986 554444  358999999999999999999999999999999999999988 78999999998765432


Q ss_pred             Cc----ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhc
Q 014406          274 KE----YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY  349 (425)
Q Consensus       274 ~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~  349 (425)
                      ..    .....++..|+|||.+.+...++.++||||+||++|+|++|+.|| .+.+...++..+...++.+..+....-.
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (336)
T cd07849         160 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLF-PGKDYLHQLNLILGVLGTPSQEDLNCII  238 (336)
T ss_pred             ccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHcCCCCHHHHHHhh
Confidence            21    122467888999998766567899999999999999999999888 4555566677777777765443321100


Q ss_pred             cCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccc
Q 014406          350 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA  418 (425)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~  418 (425)
                      .. ...............++..     ....+++++.+|+.+||+.||++|||+.|+++||||++....
T Consensus       239 ~~-~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~  301 (336)
T cd07849         239 SL-RARNYIKSLPFKPKVPWNK-----LFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDP  301 (336)
T ss_pred             ch-hhhhHHhhcCcCCcccHHH-----HhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCC
Confidence            00 0000000000000001110     112257889999999999999999999999999999987643

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9e-44  Score=317.72  Aligned_cols=255  Identities=27%  Similarity=0.457  Sum_probs=216.2

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCc
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (425)
                      -.++|+.++.||+|.||.|-+++.+.+++.+|+|++++.      ....-..|-.+|+.. +||.+..+--.|+  ....
T Consensus       166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~-~HPFLt~LKYsFQ--t~dr  242 (516)
T KOG0690|consen  166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNC-RHPFLTSLKYSFQ--TQDR  242 (516)
T ss_pred             ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhc-cCcHHHHhhhhhc--cCce
Confidence            357899999999999999999999999999999999753      234456788999997 9999999988884  4578


Q ss_pred             cEEEEEeecCCChhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccc-cC
Q 014406          197 PSLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY-HP  272 (425)
Q Consensus       197 ~~lv~e~~~~~~l~~~~~---~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~-~~  272 (425)
                      +|.||||.+||.|..+++   .|++...+.+-.+|..||.|||+++||+||||.+|.|+|.+ |.+||+|||+++.. ..
T Consensus       243 lCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkD-GHIKitDFGLCKE~I~~  321 (516)
T KOG0690|consen  243 LCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKD-GHIKITDFGLCKEEIKY  321 (516)
T ss_pred             EEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccC-CceEeeecccchhcccc
Confidence            999999999999988874   49999999999999999999999999999999999999999 89999999999753 33


Q ss_pred             CCcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCC
Q 014406          273 GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE  352 (425)
Q Consensus       273 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~  352 (425)
                      +....+.+||+.|.|||++.+ ..|+.++|.|.+||++|||++|+.||++. +....+..|.-             ..  
T Consensus       322 g~t~kTFCGTPEYLAPEVleD-nDYgraVDWWG~GVVMYEMmCGRLPFyn~-dh~kLFeLIl~-------------ed--  384 (516)
T KOG0690|consen  322 GDTTKTFCGTPEYLAPEVLED-NDYGRAVDWWGVGVVMYEMMCGRLPFYNK-DHEKLFELILM-------------ED--  384 (516)
T ss_pred             cceeccccCChhhcCchhhcc-ccccceeehhhhhHHHHHHHhccCccccc-chhHHHHHHHh-------------hh--
Confidence            456677899999999999987 89999999999999999999999999643 33222322211             00  


Q ss_pred             CChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCc-----CHHHHhcCCCCcccccchh
Q 014406          353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYFAQVRAAES  420 (425)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rp-----ta~elL~hp~~~~~~~~~~  420 (425)
                                            ...+..++++++.|+..+|.+||.+|.     .|.|+++|+||..+.|...
T Consensus       385 ----------------------~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~  435 (516)
T KOG0690|consen  385 ----------------------LKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEAT  435 (516)
T ss_pred             ----------------------ccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHH
Confidence                                  011234799999999999999999998     5899999999999998754

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=3.6e-42  Score=325.64  Aligned_cols=278  Identities=33%  Similarity=0.616  Sum_probs=210.4

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc-----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCC---Cc
Q 014406          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHS---KT  196 (425)
Q Consensus       125 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~---~~  196 (425)
                      ++|++.+.||+|+||+||+|.+..+++.||+|.+....     ...+.+|+.+++.+.+|+||+++++++.....   ..
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            47899999999999999999999999999999986432     35678899999999667999999998865422   23


Q ss_pred             cEEEEEeecCCChhhhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccc
Q 014406          197 PSLIFEYVNSTDFKVLY--------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE  268 (425)
Q Consensus       197 ~~lv~e~~~~~~l~~~~--------~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~  268 (425)
                      .++||||+++ ++..++        ..+++..++.++.||+.||.|||+.||+|+||+|+||+++.+.+.+||+|||++.
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~  159 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR  159 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccce
Confidence            7899999997 555543        2378999999999999999999999999999999999999844899999999987


Q ss_pred             cccCC-CcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHh
Q 014406          269 FYHPG-KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLN  347 (425)
Q Consensus       269 ~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~  347 (425)
                      ..... .......+++.|+|||.+.+...++.++||||||+++|+|++|..|| .+.++.+.+..+.+.++.+....+..
T Consensus       160 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (295)
T cd07837         160 AFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLF-PGDSELQQLLHIFKLLGTPTEQVWPG  238 (295)
T ss_pred             ecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCC-CCCCHHHHHHHHHHHhCCCChhhCcc
Confidence            55322 22233456788999999876556899999999999999999999887 45555666666666665443322110


Q ss_pred             hccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCc
Q 014406          348 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA  413 (425)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~  413 (425)
                      ......         ......+...........+++++.+||.+||+.||.+|||+.|+++||||+
T Consensus       239 ~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~  295 (295)
T cd07837         239 VSKLRD---------WHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD  295 (295)
T ss_pred             hhhccc---------hhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence            000000         000000000001111223788999999999999999999999999999985

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.3e-42  Score=349.69  Aligned_cols=249  Identities=23%  Similarity=0.384  Sum_probs=203.5

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCC-CcEEEEEEecCcc---hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEE
Q 014406          125 DDYEVVRKVGRGKYSEVFEGINVNT-NERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (425)
Q Consensus       125 ~~y~~~~~LG~G~fg~V~~~~~~~~-~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (425)
                      ..|.+.+.||+|+||.||+|.+..+ +..||+|.+....   ...+.+|+.+++.+ +||||++++++|...  ...++|
T Consensus        67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~--~~~~lv  143 (478)
T PTZ00267         67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAAC-DHFGIVKHFDDFKSD--DKLLLI  143 (478)
T ss_pred             eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCCCEeEEEEEEEEC--CEEEEE
Confidence            4599999999999999999998877 7889999775333   24567899999999 999999999999654  688999


Q ss_pred             EEeecCCChhhhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCC
Q 014406          201 FEYVNSTDFKVLYP-------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (425)
Q Consensus       201 ~e~~~~~~l~~~~~-------~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~  273 (425)
                      |||+++++|..++.       .+++.++..++.|++.||+|||+++|+||||||+|||++.+ +.+||+|||+++.....
T Consensus       144 ~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~-~~~kL~DFgla~~~~~~  222 (478)
T PTZ00267        144 MEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPT-GIIKLGDFGFSKQYSDS  222 (478)
T ss_pred             EECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCC-CcEEEEeCcCceecCCc
Confidence            99999999987542       37889999999999999999999999999999999999988 78999999999876433


Q ss_pred             Cc---ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhcc
Q 014406          274 KE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH  350 (425)
Q Consensus       274 ~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~  350 (425)
                      ..   ....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||. +.+..+.+..+..  +.           
T Consensus       223 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~Pf~-~~~~~~~~~~~~~--~~-----------  287 (478)
T PTZ00267        223 VSLDVASSFCGTPYYLAPELWER-KRYSKKADMWSLGVILYELLTLHRPFK-GPSQREIMQQVLY--GK-----------  287 (478)
T ss_pred             cccccccccCCCccccCHhHhCC-CCCCcHHhHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHh--CC-----------
Confidence            22   234568999999999977 679999999999999999999999984 2222222222111  00           


Q ss_pred             CCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCccc
Q 014406          351 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV  415 (425)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~  415 (425)
                                   .  .        ..+..++.++.+||.+||+.||++|||++++++|||++..
T Consensus       288 -------------~--~--------~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~~  329 (478)
T PTZ00267        288 -------------Y--D--------PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYV  329 (478)
T ss_pred             -------------C--C--------CCCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHHH
Confidence                         0  0        0012368899999999999999999999999999998754

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=9e-43  Score=334.00  Aligned_cols=246  Identities=24%  Similarity=0.412  Sum_probs=196.2

Q ss_pred             eeeeeeCceEEEEEEEcCCCcEEEEEEecCcc------hHHHHHHHH-HHHHhcCCCCeeeEEeEEEcCCCCccEEEEEe
Q 014406          131 RKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIK-ILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEY  203 (425)
Q Consensus       131 ~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~-~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~  203 (425)
                      +.||+|+||+||+|.+..+++.||+|++....      ...+..|.. +++.+ +||||+++++++.+.  ...++||||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-~h~~iv~~~~~~~~~--~~~~lv~e~   77 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNL-KHPFLVGLHYSFQTA--EKLYFVLDY   77 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhC-CCCCccceeeEEEcC--CEEEEEEcC
Confidence            36999999999999999999999999986422      234555554 56677 999999999999654  678999999


Q ss_pred             ecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccC-CCcceee
Q 014406          204 VNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP-GKEYNVR  279 (425)
Q Consensus       204 ~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~-~~~~~~~  279 (425)
                      +++++|...+   ..+++..++.++.||+.||.|||+.||+||||||+|||++.+ +.+||+|||+++.... .......
T Consensus        78 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~-~~~kl~Dfg~~~~~~~~~~~~~~~  156 (321)
T cd05603          78 VNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQ-GHVVLTDFGLCKEGVEPEETTSTF  156 (321)
T ss_pred             CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCC-CCEEEccCCCCccCCCCCCccccc
Confidence            9999997765   348899999999999999999999999999999999999988 7999999999875322 2233445


Q ss_pred             ccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCChhhHH
Q 014406          280 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDA  359 (425)
Q Consensus       280 ~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~  359 (425)
                      .+|+.|+|||++.+ ..++.++|||||||++|+|++|..||... +..+....+..   .          .         
T Consensus       157 ~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~-~~~~~~~~i~~---~----------~---------  212 (321)
T cd05603         157 CGTPEYLAPEVLRK-EPYDRTVDWWCLGAVLYEMLYGLPPFYSR-DVSQMYDNILH---K----------P---------  212 (321)
T ss_pred             cCCcccCCHHHhcC-CCCCCcCcccccchhhhhhhcCCCCCCCC-CHHHHHHHHhc---C----------C---------
Confidence            78999999999977 67999999999999999999999998432 22222221110   0          0         


Q ss_pred             HhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCH----HHHhcCCCCcccccch
Q 014406          360 LVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA----REAMAHPYFAQVRAAE  419 (425)
Q Consensus       360 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta----~elL~hp~~~~~~~~~  419 (425)
                                     .......+.++.+++.+||+.||.+|+++    .++++|+||..+.+..
T Consensus       213 ---------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~~~~~  261 (321)
T cd05603         213 ---------------LQLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPINWDD  261 (321)
T ss_pred             ---------------CCCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCCCHHH
Confidence                           00112257889999999999999999975    5999999999876643

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=3.8e-42  Score=323.08  Aligned_cols=275  Identities=31%  Similarity=0.573  Sum_probs=210.4

Q ss_pred             EEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEEE
Q 014406          127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE  202 (425)
Q Consensus       127 y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e  202 (425)
                      |++.+.||+|+||.||+|.+..+++.+|+|.++...    .....+|+.++.++.+|+|++++++++.+......++|+|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            677899999999999999999999999999987432    2234578999999866999999999998765578899999


Q ss_pred             eecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCcceee
Q 014406          203 YVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR  279 (425)
Q Consensus       203 ~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~~~~~  279 (425)
                      |++++.+....   ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.  +.+||+|||+++...........
T Consensus        81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~--~~~kl~dfg~~~~~~~~~~~~~~  158 (282)
T cd07831          81 LMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD--DILKLADFGSCRGIYSKPPYTEY  158 (282)
T ss_pred             cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC--CCeEEEecccccccccCCCcCCC
Confidence            99865444433   24899999999999999999999999999999999999998  78999999999876544444445


Q ss_pred             ccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCChhhHH
Q 014406          280 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDA  359 (425)
Q Consensus       280 ~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~  359 (425)
                      .++..|+|||.+.....++.++|||||||++|+|++|..|| .+.+..+.+..+.+.++.+..... ..........+  
T Consensus       159 ~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~-~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~--  234 (282)
T cd07831         159 ISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLF-PGTNELDQIAKIHDVLGTPDAEVL-KKFRKSRHMNY--  234 (282)
T ss_pred             CCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCC-CCCCHHHHHHHHHHHcCCCCHHHH-Hhhcccccccc--
Confidence            67889999998765456789999999999999999998887 555566667777777765443221 11000000000  


Q ss_pred             HhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCC
Q 014406          360 LVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF  412 (425)
Q Consensus       360 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~  412 (425)
                         .........  .......++.++++|+.+||+.||++|||++++++||||
T Consensus       235 ---~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~  282 (282)
T cd07831         235 ---NFPSKKGTG--LRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF  282 (282)
T ss_pred             ---cCccccccc--HHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence               000000000  001112368999999999999999999999999999998

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=9e-43  Score=334.86  Aligned_cols=282  Identities=20%  Similarity=0.244  Sum_probs=199.8

Q ss_pred             EEeeeeee--CceEEEEEEEcCCCcEEEEEEecCcc-----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEE
Q 014406          129 VVRKVGRG--KYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (425)
Q Consensus       129 ~~~~LG~G--~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (425)
                      ++++||+|  +||+||++.+..+++.||+|.++...     .+.+.+|+.+++.+ +||||++++++|..+  ...++||
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~--~~~~lv~   78 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLF-NHPNIVPYRATFIAD--NELWVVT   78 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEEC--CEEEEEE
Confidence            45689999  78999999999999999999997432     24577899999999 999999999999764  6788999


Q ss_pred             EeecCCChhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCC--
Q 014406          202 EYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK--  274 (425)
Q Consensus       202 e~~~~~~l~~~~-----~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~--  274 (425)
                      ||++++++.+++     ..+++..++.++.|++.||+|||+++|+||||||+|||++.+ +.++++|||.+.......  
T Consensus        79 e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~-~~~~l~~~~~~~~~~~~~~~  157 (327)
T cd08227          79 SFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVD-GKVYLSGLRSNLSMINHGQR  157 (327)
T ss_pred             eccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecC-CcEEEcccchhhcccccccc
Confidence            999999998876     248899999999999999999999999999999999999988 789999998654322111  


Q ss_pred             ------cceeeccCCCccCcccccCC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCch------
Q 014406          275 ------EYNVRVASRYFKGPELLVDL-QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDE------  341 (425)
Q Consensus       275 ------~~~~~~~t~~y~aPE~~~~~-~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~------  341 (425)
                            ......++..|+|||++.+. ..++.++|||||||++|+|++|+.||..... .......  ..+..+      
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-~~~~~~~--~~~~~~~~~~~~  234 (327)
T cd08227         158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPA-TQMLLEK--LNGTVPCLLDTT  234 (327)
T ss_pred             ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcch-hHHHHHH--hcCCcccccccc
Confidence                  11223456779999998753 3588999999999999999999999843222 2211111  111100      


Q ss_pred             ---hHHHHhhc-cCCCChhhHHHhc-ccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccc
Q 014406          342 ---LNAYLNKY-HLELDPQLDALVG-RHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR  416 (425)
Q Consensus       342 ---~~~~~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~  416 (425)
                         ........ ............. ..................+++++.+|+++||++||++|||++|+++||||+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~~  314 (327)
T cd08227         235 TIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK  314 (327)
T ss_pred             chhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhcc
Confidence               00000000 0000000000000 000000000011112334688999999999999999999999999999999875


Q ss_pred             c
Q 014406          417 A  417 (425)
Q Consensus       417 ~  417 (425)
                      .
T Consensus       315 ~  315 (327)
T cd08227         315 R  315 (327)
T ss_pred             h
Confidence            3

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=1.9e-42  Score=323.56  Aligned_cols=253  Identities=25%  Similarity=0.433  Sum_probs=202.9

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc--chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCC----CCc
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH----SKT  196 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~----~~~  196 (425)
                      ..+.|++.+.||+|+||+||+|.+..+++.+|+|.+...  ....+.+|+.++.++.+|+||++++++|....    ...
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~   83 (272)
T cd06637           4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ   83 (272)
T ss_pred             hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcE
Confidence            356788889999999999999999999999999998643  34578899999999867999999999987532    245


Q ss_pred             cEEEEEeecCCChhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEecccccccc
Q 014406          197 PSLIFEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (425)
Q Consensus       197 ~~lv~e~~~~~~l~~~~~-----~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~  271 (425)
                      .+++|||+.+++|..++.     .+++..+..++.|++.||.|||+++|+|+||||+||+++.+ +.++|+|||++....
T Consensus        84 ~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~-~~~~l~Dfg~~~~~~  162 (272)
T cd06637          84 LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTEN-AEVKLVDFGVSAQLD  162 (272)
T ss_pred             EEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCC-CCEEEccCCCceecc
Confidence            789999999999988763     37889999999999999999999999999999999999988 789999999987654


Q ss_pred             CC-CcceeeccCCCccCcccccC----CCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHH
Q 014406          272 PG-KEYNVRVASRYFKGPELLVD----LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYL  346 (425)
Q Consensus       272 ~~-~~~~~~~~t~~y~aPE~~~~----~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~  346 (425)
                      .. .......++..|+|||++.+    ...++.++|||||||++|+|++|..||.... ..........           
T Consensus       163 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~-~~~~~~~~~~-----------  230 (272)
T cd06637         163 RTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH-PMRALFLIPR-----------  230 (272)
T ss_pred             cccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccC-HHHHHHHHhc-----------
Confidence            32 22334567889999999863    2358889999999999999999999984221 1111110000           


Q ss_pred             hhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCC
Q 014406          347 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF  412 (425)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~  412 (425)
                                       .       .........++.++.+|+.+||+.||++|||+.|++.||||
T Consensus       231 -----------------~-------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~  272 (272)
T cd06637         231 -----------------N-------PAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI  272 (272)
T ss_pred             -----------------C-------CCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence                             0       00001112367899999999999999999999999999997

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=5.7e-42  Score=324.21  Aligned_cols=281  Identities=33%  Similarity=0.635  Sum_probs=212.5

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEE
Q 014406          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (425)
Q Consensus       125 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (425)
                      ++|++.+.||+|++|+||+|.+..+++.+|+|.+...     ..+.+.+|+++++++ +|+||+++++++.+.  ...++
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~l   78 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEM-QHGNIVRLQDVVHSE--KRLYL   78 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhc-cCCCEeeEEEEEecC--CeEEE
Confidence            5799999999999999999999999999999998642     235688999999999 999999999999654  68899


Q ss_pred             EEEeecCCChhhhc-C----CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCC-
Q 014406          200 IFEYVNSTDFKVLY-P----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-  273 (425)
Q Consensus       200 v~e~~~~~~l~~~~-~----~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~-  273 (425)
                      ||||+++ ++...+ .    .+++..+..++.||+.||+|||+++++|+||+|+||+++.+.+.+||+|||++...... 
T Consensus        79 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~  157 (294)
T PLN00009         79 VFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV  157 (294)
T ss_pred             EEecccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence            9999976 444443 1    25778888999999999999999999999999999999876568999999999755322 


Q ss_pred             CcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCC
Q 014406          274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL  353 (425)
Q Consensus       274 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~  353 (425)
                      .......++..|+|||.+.+...++.++||||+||++|+|++|+.||. ..+..+.+..+...++.+....+...  ...
T Consensus       158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~-~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~  234 (294)
T PLN00009        158 RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFP-GDSEIDELFKIFRILGTPNEETWPGV--TSL  234 (294)
T ss_pred             cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHHHhCCCChhhcccc--ccc
Confidence            222334668889999998765568899999999999999999998884 34445555566666555432221100  000


Q ss_pred             ChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccc
Q 014406          354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA  418 (425)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~  418 (425)
                       +.+..   ..  ..+...........+++++.+|+.+||+.||++||++.++++||||.++..+
T Consensus       235 -~~~~~---~~--~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~~~  293 (294)
T PLN00009        235 -PDYKS---AF--PKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLGDA  293 (294)
T ss_pred             -hhhhh---hc--ccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHhcC
Confidence             00000   00  0011001111123468899999999999999999999999999999988654

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=7e-43  Score=348.50  Aligned_cols=242  Identities=21%  Similarity=0.398  Sum_probs=207.6

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEc-----CCCcEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCC
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINV-----NTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH  193 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~-----~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  193 (425)
                      ...+.+..+.||+|+||.||+|...     .....||||.++..    .+.+|++|++.+..+ +|||||+|+|+|..  
T Consensus       484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l-~H~nIVrLlGVC~~--  560 (774)
T KOG1026|consen  484 PRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAEL-QHPNIVRLLGVCRE--  560 (774)
T ss_pred             chhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhc-cCCCeEEEEEEEcc--
Confidence            4567888999999999999999754     34468999999854    346899999999999 99999999999965  


Q ss_pred             CCccEEEEEeecCCChhhhc-------------CC----CCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCC
Q 014406          194 SKTPSLIFEYVNSTDFKVLY-------------PT----LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEL  256 (425)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~-------------~~----l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~  256 (425)
                      ++.+|+|+|||..|||..++             ..    ++..+...|+.|||.||+||-++.+|||||..+|+|+.++ 
T Consensus       561 ~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~-  639 (774)
T KOG1026|consen  561 GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGEN-  639 (774)
T ss_pred             CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccc-
Confidence            47789999999999999987             12    7888999999999999999999999999999999999998 


Q ss_pred             CcEEEEeccccccccCCCcceee---ccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHH
Q 014406          257 RKLRLIDWGLAEFYHPGKEYNVR---VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVK  332 (425)
Q Consensus       257 ~~~kl~Dfg~a~~~~~~~~~~~~---~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~  332 (425)
                      ..|||+|||+++.+...+.+...   .-...||+||.++. .+|+.+||||||||+|||+++ |+.|+ .+..+.+.++.
T Consensus       640 l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly-~kFTteSDVWs~GVvLWEIFsyG~QPy-~glSn~EVIe~  717 (774)
T KOG1026|consen  640 LVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILY-GKFTTESDVWSFGVVLWEIFSYGKQPY-YGLSNQEVIEC  717 (774)
T ss_pred             eEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhc-CcccchhhhhhhhhhhhhhhccccCcc-cccchHHHHHH
Confidence            69999999999988766666543   33567999999997 899999999999999999996 77776 67888888876


Q ss_pred             HHHHhCCchhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHH
Q 014406          333 IAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA  406 (425)
Q Consensus       333 ~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~el  406 (425)
                      +.+-                                    -..+.++.++.++.+||..||+.+|++||+++|+
T Consensus       718 i~~g------------------------------------~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI  755 (774)
T KOG1026|consen  718 IRAG------------------------------------QLLSCPENCPTEVYSLMLECWNENPKRRPSFKEI  755 (774)
T ss_pred             HHcC------------------------------------CcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence            6430                                    0133455689999999999999999999999887

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=7.2e-42  Score=321.74  Aligned_cols=273  Identities=32%  Similarity=0.647  Sum_probs=209.4

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEE
Q 014406          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (425)
Q Consensus       126 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (425)
                      +|++++.||.|+||.||+|.+..+++.+|||.+...     ....+.+|+++++++ +||||+++++++.+  ....++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~--~~~~~~v   77 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-NHPNIVKLLDVIHT--ENKLYLV   77 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhc-CCCCCcchhhhccc--CCcEEEE
Confidence            488899999999999999999999999999988642     235688999999999 99999999999964  4678999


Q ss_pred             EEeecCCChhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCC-
Q 014406          201 FEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-  274 (425)
Q Consensus       201 ~e~~~~~~l~~~~-----~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~-  274 (425)
                      |||+.+ ++..++     ..+++..+..++.|++.||+|||+.+++|+||+|+||+++.+ +.++|+|||++....... 
T Consensus        78 ~e~~~~-~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~-~~~~l~dfg~~~~~~~~~~  155 (284)
T cd07860          78 FEFLHQ-DLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVR  155 (284)
T ss_pred             eecccc-CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC-CCEEEeeccchhhcccCcc
Confidence            999974 566554     347899999999999999999999999999999999999988 789999999987654322 


Q ss_pred             cceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCC
Q 014406          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD  354 (425)
Q Consensus       275 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~  354 (425)
                      ......++..|+|||.+.+...++.++|||||||++|+|+||+.||. +.+..+.+..+.+.++.+....+.....  . 
T Consensus       156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~-  231 (284)
T cd07860         156 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFP-GDSEIDQLFRIFRTLGTPDEVVWPGVTS--L-  231 (284)
T ss_pred             ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCC-CCCHHHHHHHHHHHhCCCChhhhhhhhH--H-
Confidence            22334567889999998764557889999999999999999999984 4455566666666666554322110000  0 


Q ss_pred             hhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCC
Q 014406          355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF  412 (425)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~  412 (425)
                      +....   ....  +...........++.+++++|.+||+.||++|||++++++||||
T Consensus       232 ~~~~~---~~~~--~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         232 PDYKP---SFPK--WARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF  284 (284)
T ss_pred             HHHHh---hccc--ccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence            00000   0000  00000001112368899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=8.3e-42  Score=322.57  Aligned_cols=251  Identities=26%  Similarity=0.471  Sum_probs=209.2

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccE
Q 014406          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (425)
Q Consensus       125 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (425)
                      ++|++.+.||+|+||.||++.+..+++.+|+|++...      ..+.+.+|+++++++ +||||+++++++.+  +...+
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~   77 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSI-RHPFLVNLYGSFQD--DSNLY   77 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCccceeeEEEc--CCeEE
Confidence            4799999999999999999999999999999998642      235688899999999 89999999999965  46789


Q ss_pred             EEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCc
Q 014406          199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (425)
Q Consensus       199 lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~  275 (425)
                      +||||+++++|..++   ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.+ +.+||+|||++......  
T Consensus        78 ~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~-~~~kl~dfg~~~~~~~~--  154 (290)
T cd05580          78 LVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSD-GYIKITDFGFAKRVKGR--  154 (290)
T ss_pred             EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCC-CCEEEeeCCCccccCCC--
Confidence            999999999998876   458999999999999999999999999999999999999988 78999999999876543  


Q ss_pred             ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCCh
Q 014406          276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP  355 (425)
Q Consensus       276 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~  355 (425)
                      .....++..|+|||.+.+ ..++.++||||||+++|+|++|..||.... ..+....+..  +..               
T Consensus       155 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~-~~~~~~~~~~--~~~---------------  215 (290)
T cd05580         155 TYTLCGTPEYLAPEIILS-KGYGKAVDWWALGILIYEMLAGYPPFFDDN-PIQIYEKILE--GKV---------------  215 (290)
T ss_pred             CCCCCCCccccChhhhcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHhc--CCc---------------
Confidence            334467889999999877 678899999999999999999999984322 1212222110  000               


Q ss_pred             hhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCc-----CHHHHhcCCCCcccccchh
Q 014406          356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYFAQVRAAES  420 (425)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rp-----ta~elL~hp~~~~~~~~~~  420 (425)
                                          .....++..+++++.+||+.||.+|+     +++|+++||||+.+.+...
T Consensus       216 --------------------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~~  265 (290)
T cd05580         216 --------------------RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWIAL  265 (290)
T ss_pred             --------------------cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCCHHHH
Confidence                                01122578999999999999999999     9999999999999887554

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=3e-42  Score=328.41  Aligned_cols=282  Identities=21%  Similarity=0.314  Sum_probs=208.4

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEE
Q 014406          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (425)
Q Consensus       125 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (425)
                      ++|++.+.||+|+||.||++.+..++..+|+|.+....    ..++.+|++++.++ +||||++++++|.++  ...++|
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~--~~~~lv   77 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHEC-NSPYIVGFYGAFYSD--GEISIC   77 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEeeC--CEEEEE
Confidence            47899999999999999999999999999999986432    34578899999999 999999999999654  688999


Q ss_pred             EEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHH-CCceeecCCCCceEecCCCCcEEEEeccccccccCCCcc
Q 014406          201 FEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY  276 (425)
Q Consensus       201 ~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~-~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~~  276 (425)
                      |||+++++|..++   ..+++..+..++.|++.||.|||+ .+++|+||||+|||++.+ +.++|+|||++...... ..
T Consensus        78 ~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~-~~  155 (308)
T cd06615          78 MEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDS-MA  155 (308)
T ss_pred             eeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecC-CcEEEccCCCccccccc-cc
Confidence            9999999999887   347899999999999999999997 599999999999999988 78999999998765332 22


Q ss_pred             eeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCC-chhHHHHhh---ccCC
Q 014406          277 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT-DELNAYLNK---YHLE  352 (425)
Q Consensus       277 ~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~-~~~~~~~~~---~~~~  352 (425)
                      ....++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||....  ......+...... .........   ....
T Consensus       156 ~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (308)
T cd06615         156 NSFVGTRSYMSPERLQG-THYTVQSDIWSLGLSLVEMAIGRYPIPPPD--AKELEAMFGRPVSEGEAKESHRPVSGHPPD  232 (308)
T ss_pred             ccCCCCcCccChhHhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCcc--hhhHHHhhcCccccccccCCcccccCCCCC
Confidence            34577889999999876 678999999999999999999999984332  2222221111000 000000000   0000


Q ss_pred             CC--hhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccc
Q 014406          353 LD--PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA  418 (425)
Q Consensus       353 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~  418 (425)
                      ..  ...............    .......++.++++|+.+||+.||++|||+.|+++||||.+....
T Consensus       233 ~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~  296 (308)
T cd06615         233 SPRPMAIFELLDYIVNEPP----PKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAELE  296 (308)
T ss_pred             ccchhhHHHHHHHHhcCCC----ccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhcccc
Confidence            00  000000000000000    000111268889999999999999999999999999999886444

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-45  Score=323.05  Aligned_cols=256  Identities=23%  Similarity=0.382  Sum_probs=211.6

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecC-cchHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEEE
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE  202 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~-~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e  202 (425)
                      .+-|.++++||+|+||.||+|.++.+|..+|||.+.. .+.+++..|+.|+++. ..|++|++||.+-.  ...+++|||
T Consensus        32 EEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC-~S~yVVKYYGSYFK--~sDLWIVME  108 (502)
T KOG0574|consen   32 EEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQC-KSKYVVKYYGSYFK--HSDLWIVME  108 (502)
T ss_pred             HHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHc-CCchhhhhhhhhcc--CCceEeehh
Confidence            4568889999999999999999999999999999875 4568899999999998 99999999997743  356899999


Q ss_pred             eecCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCC-Ccce
Q 014406          203 YVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-KEYN  277 (425)
Q Consensus       203 ~~~~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~-~~~~  277 (425)
                      ||..|+..+.+    ..+++.++..+++..+.||+|||...-||||||+.|||++.+ |.+||+|||.|-..... ...+
T Consensus       109 YCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~-G~AKLADFGVAGQLTDTMAKRN  187 (502)
T KOG0574|consen  109 YCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTD-GIAKLADFGVAGQLTDTMAKRN  187 (502)
T ss_pred             hcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEccc-chhhhhhccccchhhhhHHhhC
Confidence            99999998876    469999999999999999999999999999999999999999 89999999999665432 2346


Q ss_pred             eeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCChhh
Q 014406          278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQL  357 (425)
Q Consensus       278 ~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~  357 (425)
                      +..||+.|||||++.. -.|+.++||||||++..||..|+.||. .......+-                          
T Consensus       188 TVIGTPFWMAPEVI~E-IGY~~~ADIWSLGITaIEMAEG~PPYs-DIHPMRAIF--------------------------  239 (502)
T KOG0574|consen  188 TVIGTPFWMAPEVIEE-IGYDTKADIWSLGITAIEMAEGRPPYS-DIHPMRAIF--------------------------  239 (502)
T ss_pred             ccccCcccccHHHHHH-hccchhhhHhhhcchhhhhhcCCCCcc-cccccceeE--------------------------
Confidence            6799999999999987 789999999999999999999999982 111100000                          


Q ss_pred             HHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccch
Q 014406          358 DALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE  419 (425)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~~  419 (425)
                          .. ...+...|-   .+...|.++.||+++||.++|++|.||.++++|||.++.....
T Consensus       240 ----MI-PT~PPPTF~---KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~g~~  293 (502)
T KOG0574|consen  240 ----MI-PTKPPPTFK---KPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNAPGCD  293 (502)
T ss_pred             ----ec-cCCCCCCCC---ChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCCCccc
Confidence                00 001111111   1223688999999999999999999999999999999876543

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=8.5e-42  Score=329.47  Aligned_cols=287  Identities=32%  Similarity=0.585  Sum_probs=218.6

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCC---
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS---  194 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~---  194 (425)
                      ..++|.+.+.||+|+||+||+|.+..+++.||||.+...     ....+.+|+.+++.+ +|+||+++++++.....   
T Consensus         3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~~~~~~~~~~~~~~   81 (337)
T cd07858           3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHL-DHENVIAIKDIMPPPHREAF   81 (337)
T ss_pred             cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhc-CCCCccchHHheeccccccc
Confidence            356899999999999999999999999999999998642     234677899999999 99999999998864422   


Q ss_pred             CccEEEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEecccccccc
Q 014406          195 KTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (425)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~  271 (425)
                      ...++|+||+.+ +|..++   ..+++..+..++.|++.||.|||+++++|+||||+||+++.+ +.+||+|||++....
T Consensus        82 ~~~~lv~e~~~~-~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~-~~~kL~Dfg~~~~~~  159 (337)
T cd07858          82 NDVYIVYELMDT-DLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDFGLARTTS  159 (337)
T ss_pred             CcEEEEEeCCCC-CHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCC-CCEEECcCccccccC
Confidence            458999999974 565554   458999999999999999999999999999999999999988 789999999998654


Q ss_pred             CC-CcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhcc
Q 014406          272 PG-KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH  350 (425)
Q Consensus       272 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~  350 (425)
                      .. .......++..|+|||.+.+...++.++|||||||++|+|++|+.|| .+.+....+..+.+.+|.+.......   
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~---  235 (337)
T cd07858         160 EKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLF-PGKDYVHQLKLITELLGSPSEEDLGF---  235 (337)
T ss_pred             CCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCC-CCCChHHHHHHHHHHhCCCChHHhhh---
Confidence            33 22234467888999999876456899999999999999999999887 45555566666777776644332210   


Q ss_pred             CCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccch
Q 014406          351 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE  419 (425)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~~  419 (425)
                       ....................+  ......+++++.+|+++||+.||++|||++|+++||||+.+....
T Consensus       236 -~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~  301 (337)
T cd07858         236 -IRNEKARRYIRSLPYTPRQSF--ARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPS  301 (337)
T ss_pred             -cCchhhhHHHHhcCcccccCH--HHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCcc
Confidence             000011100111111100000  011224789999999999999999999999999999998875543

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.4e-42  Score=328.42  Aligned_cols=256  Identities=26%  Similarity=0.429  Sum_probs=209.0

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc------hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccE
Q 014406          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (425)
Q Consensus       125 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (425)
                      ++|++.+.||+|+||+||+|.+..+++.+|+|.+....      .+.+.+|+++++.+ +|+||+++++.+.+  +...+
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~~~   77 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATL-DHPFLPTLYASFQT--ETYLC   77 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhC-CCCCchhheeeeec--CCEEE
Confidence            47899999999999999999999999999999987532      34578899999999 89999999999965  46789


Q ss_pred             EEEEeecCCChhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCC
Q 014406          199 LIFEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (425)
Q Consensus       199 lv~e~~~~~~l~~~~~-----~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~  273 (425)
                      +||||+.+++|..++.     .+++..+..++.|++.||+|||+.|++|+||||+||+++.+ +.++|+|||++......
T Consensus        78 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~-~~~~l~dfg~~~~~~~~  156 (316)
T cd05574          78 LVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHES-GHIMLSDFDLSKQSDVE  156 (316)
T ss_pred             EEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCC-CCEEEeecchhhccccc
Confidence            9999999999988763     48889999999999999999999999999999999999988 78999999998654322


Q ss_pred             Cc------------------------------ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Q 014406          274 KE------------------------------YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG  323 (425)
Q Consensus       274 ~~------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~  323 (425)
                      ..                              .....|+..|+|||++.+ ..++.++||||||+++|+|++|..||. +
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~ll~~l~~g~~pf~-~  234 (316)
T cd05574         157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISG-DGHGSAVDWWTLGILLYEMLYGTTPFK-G  234 (316)
T ss_pred             ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcC-CCCCchHHHHHHHHHHHHHhhCCCCCC-C
Confidence            11                              112357888999999987 678999999999999999999999984 3


Q ss_pred             CCCHHHHHHHHHHhCCchhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcC-
Q 014406          324 HDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT-  402 (425)
Q Consensus       324 ~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpt-  402 (425)
                      .+..+.+..+..   ..          .                .      ......+++++++|+.+||..||++||| 
T Consensus       235 ~~~~~~~~~~~~---~~----------~----------------~------~~~~~~~~~~~~~li~~~l~~~p~~R~s~  279 (316)
T cd05574         235 SNRDETFSNILK---KE----------V----------------T------FPGSPPVSSSARDLIRKLLVKDPSKRLGS  279 (316)
T ss_pred             CchHHHHHHHhc---CC----------c----------------c------CCCccccCHHHHHHHHHHccCCHhHCCCc
Confidence            333333322211   00          0                0      0001116889999999999999999999 


Q ss_pred             ---HHHHhcCCCCcccccchhc
Q 014406          403 ---AREAMAHPYFAQVRAAESS  421 (425)
Q Consensus       403 ---a~elL~hp~~~~~~~~~~~  421 (425)
                         ++|+|+||||+++.++..+
T Consensus       280 ~~~~~~ll~~~~~~~~~~~~~~  301 (316)
T cd05574         280 KRGAAEIKQHPFFRGVNWALIR  301 (316)
T ss_pred             hhhHHHHHcCchhhcCChhhcc
Confidence               9999999999998876643

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=7.6e-42  Score=318.65  Aligned_cols=249  Identities=25%  Similarity=0.423  Sum_probs=199.5

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc--------chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCc
Q 014406          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (425)
Q Consensus       125 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~--------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (425)
                      .+|+..+.||+|+||.||+|.+..++..+++|.+...        ....+.+|+.+++.+ +|+||+++++++.+.....
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~   80 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNL-QHERIVQYYGCLRDRAEKT   80 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHc-CCCCeeeEEEEEEcCCCCE
Confidence            4688889999999999999999999999999988532        124578899999999 8999999999987655567


Q ss_pred             cEEEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCC
Q 014406          197 PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (425)
Q Consensus       197 ~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~  273 (425)
                      .++++||+++++|..++   ..+++..+..++.|++.||+|||+.+|+|+||+|+||+++.+ +.++|+|||+++.....
T Consensus        81 ~~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~-~~~~l~dfg~~~~~~~~  159 (266)
T cd06651          81 LTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSA-GNVKLGDFGASKRLQTI  159 (266)
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCC-CCEEEccCCCccccccc
Confidence            88999999999998776   347889999999999999999999999999999999999987 78999999998754321


Q ss_pred             ----CcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhc
Q 014406          274 ----KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY  349 (425)
Q Consensus       274 ----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~  349 (425)
                          .......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||... +...   .+........        
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~i~~el~~g~~pf~~~-~~~~---~~~~~~~~~~--------  226 (266)
T cd06651         160 CMSGTGIRSVTGTPYWMSPEVISG-EGYGRKADVWSLGCTVVEMLTEKPPWAEY-EAMA---AIFKIATQPT--------  226 (266)
T ss_pred             cccCCccccCCccccccCHHHhCC-CCCCchhhhHHHHHHHHHHHHCCCCcccc-chHH---HHHHHhcCCC--------
Confidence                11123457788999999977 67899999999999999999999998422 1111   1111100000        


Q ss_pred             cCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCc
Q 014406          350 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA  413 (425)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~  413 (425)
                                              ....+..+++.+.+|+ +||..+|++|||++|+++||||+
T Consensus       227 ------------------------~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~  265 (266)
T cd06651         227 ------------------------NPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ  265 (266)
T ss_pred             ------------------------CCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence                                    0011123678889999 57778999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=2.5e-41  Score=319.32  Aligned_cols=255  Identities=26%  Similarity=0.451  Sum_probs=204.4

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc--chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCC---CCcc
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH---SKTP  197 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~---~~~~  197 (425)
                      ..++|++.+.||+|+||.||++.+..+++.+|+|++...  ....+.+|+.+++++.+|+|++++++++...+   +...
T Consensus        20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~   99 (291)
T cd06639          20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQL   99 (291)
T ss_pred             CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCee
Confidence            468899999999999999999999999999999998753  34567889999999878999999999987542   2468


Q ss_pred             EEEEEeecCCChhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccc
Q 014406          198 SLIFEYVNSTDFKVLY-------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  270 (425)
Q Consensus       198 ~lv~e~~~~~~l~~~~-------~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~  270 (425)
                      ++|+||+++++|..++       ..+++..++.++.|++.||+|||+.+++|+||||+||+++.+ +.++|+|||++...
T Consensus       100 ~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~-~~~kl~dfg~~~~~  178 (291)
T cd06639         100 WLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTE-GGVKLVDFGVSAQL  178 (291)
T ss_pred             EEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCC-CCEEEeecccchhc
Confidence            9999999999998765       348899999999999999999999999999999999999988 78999999998765


Q ss_pred             cCCC-cceeeccCCCccCcccccCCC----CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHH
Q 014406          271 HPGK-EYNVRVASRYFKGPELLVDLQ----DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAY  345 (425)
Q Consensus       271 ~~~~-~~~~~~~t~~y~aPE~~~~~~----~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~  345 (425)
                      .... ......++..|+|||.+....    .++.++|||||||++|+|++|+.||... +..+.+..+.+   ...    
T Consensus       179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~-~~~~~~~~~~~---~~~----  250 (291)
T cd06639         179 TSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDM-HPVKTLFKIPR---NPP----  250 (291)
T ss_pred             ccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCC-cHHHHHHHHhc---CCC----
Confidence            4322 223456788899999975422    3688999999999999999999998432 22222221110   000    


Q ss_pred             HhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCc
Q 014406          346 LNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA  413 (425)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~  413 (425)
                                              .   .......++..+.+|+.+||+.||++||++.|+++||||+
T Consensus       251 ------------------------~---~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~  291 (291)
T cd06639         251 ------------------------P---TLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK  291 (291)
T ss_pred             ------------------------C---CCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence                                    0   0001112567899999999999999999999999999995

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=8.2e-42  Score=321.10  Aligned_cols=254  Identities=24%  Similarity=0.413  Sum_probs=199.9

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEE
Q 014406          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (425)
Q Consensus       125 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (425)
                      ++|++.+.||+|+||.||+|.+..+++.||+|.++...    ..++..|+.++.+..+|+||+++++++...  ...+++
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~--~~~~lv   78 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFRE--GDVWIC   78 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecC--CcEEEE
Confidence            47899999999999999999999999999999987432    245566777644444899999999999654  678999


Q ss_pred             EEeecCCChhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHC-CceeecCCCCceEecCCCCcEEEEeccccccccC
Q 014406          201 FEYVNSTDFKVLY-------PTLTDYDIRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (425)
Q Consensus       201 ~e~~~~~~l~~~~-------~~l~~~~~~~i~~~i~~~L~~LH~~-~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~  272 (425)
                      |||+++ +|..++       ..+++..+..++.|++.||+|||++ +++|+||||+||+++.+ +.+||+|||++.....
T Consensus        79 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~-~~~kl~dfg~~~~~~~  156 (283)
T cd06617          79 MEVMDT-SLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRN-GQVKLCDFGISGYLVD  156 (283)
T ss_pred             hhhhcc-cHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCC-CCEEEeeccccccccc
Confidence            999985 444332       2488999999999999999999997 99999999999999988 7899999999986644


Q ss_pred             CCcceeeccCCCccCcccccCC---CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhc
Q 014406          273 GKEYNVRVASRYFKGPELLVDL---QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY  349 (425)
Q Consensus       273 ~~~~~~~~~t~~y~aPE~~~~~---~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~  349 (425)
                      ........++..|+|||.+.+.   ..++.++|+|||||++|+|++|+.||.......+.+.........          
T Consensus       157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----------  226 (283)
T cd06617         157 SVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSP----------  226 (283)
T ss_pred             ccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCC----------
Confidence            3333445678889999988542   346889999999999999999999985433333332222110000          


Q ss_pred             cCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCccccc
Q 014406          350 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA  417 (425)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~  417 (425)
                                               ......+++++.+|+.+||+.+|++|||+.++++||||.+...
T Consensus       227 -------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~  269 (283)
T cd06617         227 -------------------------QLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHLS  269 (283)
T ss_pred             -------------------------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhccc
Confidence                                     0001126889999999999999999999999999999998753

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=8.8e-42  Score=323.38  Aligned_cols=256  Identities=28%  Similarity=0.497  Sum_probs=209.3

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc---chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEE
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (425)
                      ..+|++.+.||.|+||+||+|.+..+++.|++|.+...   ..+.+.+|+.+++.+ +|+|++++++++...  ...++|
T Consensus        18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~--~~~~lv   94 (296)
T cd06655          18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKEL-KNPNIVNFLDSFLVG--DELFVV   94 (296)
T ss_pred             cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhc-CCCceeeeeeeEecC--ceEEEE
Confidence            46799999999999999999999999999999988643   345678899999999 999999999999653  678999


Q ss_pred             EEeecCCChhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCc-ce
Q 014406          201 FEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-YN  277 (425)
Q Consensus       201 ~e~~~~~~l~~~~~--~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~-~~  277 (425)
                      +||+.+++|..++.  .+++.++..++.|++.||+|||+.|++|+||||+||+++.+ +.++|+|||++........ ..
T Consensus        95 ~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~-~~~kl~dfg~~~~~~~~~~~~~  173 (296)
T cd06655          95 MEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMD-GSVKLTDFGFCAQITPEQSKRS  173 (296)
T ss_pred             EEecCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC-CCEEEccCccchhcccccccCC
Confidence            99999999988774  48999999999999999999999999999999999999987 7899999999876543322 23


Q ss_pred             eeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCChhh
Q 014406          278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQL  357 (425)
Q Consensus       278 ~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~  357 (425)
                      ...++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.... ..+....+.. .+.+.                
T Consensus       174 ~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvil~~lltg~~pf~~~~-~~~~~~~~~~-~~~~~----------------  234 (296)
T cd06655         174 TMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNEN-PLRALYLIAT-NGTPE----------------  234 (296)
T ss_pred             CcCCCccccCcchhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHh-cCCcc----------------
Confidence            3467888999999876 678999999999999999999999984322 2222211110 00000                


Q ss_pred             HHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccch
Q 014406          358 DALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE  419 (425)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~~  419 (425)
                                       ......+++.+.+|+++||..||++|||+.++++||||+..+...
T Consensus       235 -----------------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~~~~  279 (296)
T cd06655         235 -----------------LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAKPLS  279 (296)
T ss_pred             -----------------cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhccccc
Confidence                             001123688999999999999999999999999999999776533

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=6.8e-42  Score=324.14  Aligned_cols=256  Identities=26%  Similarity=0.456  Sum_probs=208.9

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc---chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEE
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (425)
                      ..+|++.+.||+|+||.||+|.+..++..+++|.+...   ..+.+.+|+.+++.+ +|+||+++++.+...  ...++|
T Consensus        19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~-~h~~v~~~~~~~~~~--~~~~lv   95 (296)
T cd06654          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN-KNPNIVNYLDSYLVG--DELWVV   95 (296)
T ss_pred             ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhC-CCCCEeeEEEEEEeC--CEEEEe
Confidence            46899999999999999999999999999999998643   235678899999998 999999999999653  678999


Q ss_pred             EEeecCCChhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCc-ce
Q 014406          201 FEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-YN  277 (425)
Q Consensus       201 ~e~~~~~~l~~~~~--~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~-~~  277 (425)
                      |||+.+++|..++.  .+++.++..++.|++.||+|||+.||+|+||||+||+++.+ +.++|+|||++........ ..
T Consensus        96 ~e~~~~~~L~~~~~~~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~-~~~kl~dfg~~~~~~~~~~~~~  174 (296)
T cd06654          96 MEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRS  174 (296)
T ss_pred             ecccCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCC-CCEEECccccchhccccccccC
Confidence            99999999998874  47899999999999999999999999999999999999988 7899999999876543322 23


Q ss_pred             eeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCChhh
Q 014406          278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQL  357 (425)
Q Consensus       278 ~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~  357 (425)
                      ...++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.... ..+.+..+.. .+.+                 
T Consensus       175 ~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~-~~~~~~~~~~-~~~~-----------------  234 (296)
T cd06654         175 TMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNEN-PLRALYLIAT-NGTP-----------------  234 (296)
T ss_pred             cccCCccccCHHHHcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCC-HHHhHHHHhc-CCCC-----------------
Confidence            3467889999999877 678999999999999999999999984322 1111111100 0000                 


Q ss_pred             HHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccch
Q 014406          358 DALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE  419 (425)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~~  419 (425)
                                      .......++..+.+++.+||..||++|||+.++++||||...+...
T Consensus       235 ----------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~~~  280 (296)
T cd06654         235 ----------------ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLS  280 (296)
T ss_pred             ----------------CCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhccCCcc
Confidence                            0001123678899999999999999999999999999998776543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=4.5e-42  Score=323.35  Aligned_cols=277  Identities=29%  Similarity=0.527  Sum_probs=211.5

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEE
Q 014406          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (425)
Q Consensus       125 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (425)
                      ++|++.+.||+|+||.||+|.+..+++.+|+|.+...     ..+.+.+|+++++.+ +|+||+++++++.+  ....++
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~l   77 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQL-RHENLVNLIEVFRR--KKRLYL   77 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhc-CCcchhhHHHhccc--CCeEEE
Confidence            4799999999999999999999989999999987532     234678999999999 99999999999954  478899


Q ss_pred             EEEeecCCChhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCC-Cc
Q 014406          200 IFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-KE  275 (425)
Q Consensus       200 v~e~~~~~~l~~~~~---~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~-~~  275 (425)
                      |+||++++++..+..   .+++..+..++.|++.||.|||+.|++|+||+|+||+++.+ +.++|+|||++...... ..
T Consensus        78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~-~~~~l~dfg~~~~~~~~~~~  156 (286)
T cd07846          78 VFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQS-GVVKLCDFGFARTLAAPGEV  156 (286)
T ss_pred             EEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCC-CcEEEEeeeeeeeccCCccc
Confidence            999999999887653   48899999999999999999999999999999999999988 78999999998765432 22


Q ss_pred             ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCCh
Q 014406          276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP  355 (425)
Q Consensus       276 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~  355 (425)
                      .....++..|+|||++.+...++.++|||||||++|+|++|+.|| .+.+..+....+....+........ .  ....+
T Consensus       157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~-~--~~~~~  232 (286)
T cd07846         157 YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLF-PGDSDIDQLYHIIKCLGNLIPRHQE-I--FQKNP  232 (286)
T ss_pred             cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCC-CCCchHHHHHHHHHHhCCCchhhHH-H--hccch
Confidence            234567888999999876556788999999999999999998776 4455556666666555542211100 0  00000


Q ss_pred             hhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCC
Q 014406          356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF  412 (425)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~  412 (425)
                      .....  ...... ...........++..+.+|+.+||+.||++|||+.++++||||
T Consensus       233 ~~~~~--~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  286 (286)
T cd07846         233 LFAGM--RLPEVK-EIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF  286 (286)
T ss_pred             Hhhcc--cccccc-CcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence            00000  000000 0000001123478899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=5.6e-42  Score=322.23  Aligned_cols=253  Identities=25%  Similarity=0.431  Sum_probs=202.7

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc--chHHHHHHHHHHHHhcCCCCeeeEEeEEEcC----CCCc
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQ----HSKT  196 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~----~~~~  196 (425)
                      ..+.|++.+.||.|+||+||+|.+..+++.+|+|++...  ....+..|+.++.++.+|+||+++++++...    ....
T Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~   93 (282)
T cd06636          14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQ   93 (282)
T ss_pred             hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCE
Confidence            457888999999999999999999999999999998643  3456888999999987799999999998532    2457


Q ss_pred             cEEEEEeecCCChhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEecccccccc
Q 014406          197 PSLIFEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (425)
Q Consensus       197 ~~lv~e~~~~~~l~~~~~-----~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~  271 (425)
                      .+++|||+++++|..++.     .+++..+..++.|++.||.|||+.||+|+||+|+||+++.+ +.++|+|||++....
T Consensus        94 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~-~~~~l~dfg~~~~~~  172 (282)
T cd06636          94 LWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTEN-AEVKLVDFGVSAQLD  172 (282)
T ss_pred             EEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC-CCEEEeeCcchhhhh
Confidence            899999999999987763     37888889999999999999999999999999999999988 789999999987553


Q ss_pred             CC-CcceeeccCCCccCcccccC----CCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHH
Q 014406          272 PG-KEYNVRVASRYFKGPELLVD----LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYL  346 (425)
Q Consensus       272 ~~-~~~~~~~~t~~y~aPE~~~~----~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~  346 (425)
                      .. .......++..|+|||.+..    ...++.++|||||||++|+|++|..||.... ..+....+..   ..      
T Consensus       173 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~-~~~~~~~~~~---~~------  242 (282)
T cd06636         173 RTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMH-PMRALFLIPR---NP------  242 (282)
T ss_pred             ccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccC-HHhhhhhHhh---CC------
Confidence            22 22334568889999999853    2457889999999999999999999984322 1111111000   00      


Q ss_pred             hhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCC
Q 014406          347 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF  412 (425)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~  412 (425)
                                                ........++.++.+||++||+.||.+|||+.|+|+||||
T Consensus       243 --------------------------~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~  282 (282)
T cd06636         243 --------------------------PPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI  282 (282)
T ss_pred             --------------------------CCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence                                      0000112368899999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=7.3e-42  Score=329.52  Aligned_cols=286  Identities=32%  Similarity=0.615  Sum_probs=219.8

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcC--CCCc
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQ--HSKT  196 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~--~~~~  196 (425)
                      .++|++.+.||+|+||.||+|.+..+++.||+|.+...     ..+.+.+|+.+++.+ +|+||+++++++...  ....
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~   82 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHF-KHDNIIAIRDILRPPGADFKD   82 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhc-CCCCccCHHHhccccCCCCce
Confidence            47899999999999999999999999999999998643     235677899999999 899999999988643  3357


Q ss_pred             cEEEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCC
Q 014406          197 PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (425)
Q Consensus       197 ~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~  273 (425)
                      .++||||+.+ +|..++   ..+++..++.++.|++.||.|||+.||+|+||||+||+++.+ +.+||+|||++......
T Consensus        83 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~-~~~kl~dfg~~~~~~~~  160 (334)
T cd07855          83 VYVVMDLMES-DLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNED-CELRIGDFGMARGLSSS  160 (334)
T ss_pred             EEEEEehhhh-hHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCC-CcEEecccccceeeccc
Confidence            8999999975 666665   348999999999999999999999999999999999999988 78999999998765332


Q ss_pred             Cc-----ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhh
Q 014406          274 KE-----YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK  348 (425)
Q Consensus       274 ~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~  348 (425)
                      ..     .....++..|+|||.+.+...++.++|||||||++|+|++|+.|| .+.+...++..+...+|.+........
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf-~~~~~~~~~~~~~~~~g~~~~~~~~~~  239 (334)
T cd07855         161 PTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLF-PGKNYVHQLKLILSVLGSPSEEVLNRI  239 (334)
T ss_pred             CcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCcc-CCCChHHHHHHHHHHhCCChhHhhhhh
Confidence            21     123467888999999876556899999999999999999999988 555666677777777776554332111


Q ss_pred             ccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccch
Q 014406          349 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE  419 (425)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~~  419 (425)
                      ........+.. ........|..     .....++++.+||.+||+.||++|||++++++||||++....+
T Consensus       240 ~~~~~~~~~~~-~~~~~~~~~~~-----~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~~  304 (334)
T cd07855         240 GSDRVRKYIQN-LPRKQPVPWSK-----IFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPD  304 (334)
T ss_pred             chhhHHHHHhh-cccCCCCCHHH-----HcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCCc
Confidence            10000000000 00000011111     1123588999999999999999999999999999998776554

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1.3e-41  Score=314.68  Aligned_cols=246  Identities=23%  Similarity=0.386  Sum_probs=203.7

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEE
Q 014406          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (425)
Q Consensus       126 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (425)
                      +|++.+.||+|+||.||++.+..+++.+|+|.+...     ....+.+|+.+++.+ +|+|++++++.+..  ....++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~--~~~~~lv   77 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLL-SHPNIIEYYENFLE--DKALMIV   77 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhC-CCCchhheeeeEec--CCEEEEE
Confidence            588999999999999999999999999999998643     245688999999999 89999999999864  4678999


Q ss_pred             EEeecCCChhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCc
Q 014406          201 FEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (425)
Q Consensus       201 ~e~~~~~~l~~~~~-----~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~  275 (425)
                      |||+++++|.+++.     .+++..+..++.+++.||+|||++|++|+||+|+||+++.+.+.++|+|||++........
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~  157 (256)
T cd08220          78 MEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK  157 (256)
T ss_pred             EecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence            99999999988763     3788999999999999999999999999999999999987656789999999987654444


Q ss_pred             ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCCh
Q 014406          276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP  355 (425)
Q Consensus       276 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~  355 (425)
                      .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||. +.+.......+....                  
T Consensus       158 ~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~-~~~~~~~~~~~~~~~------------------  217 (256)
T cd08220         158 AYTVVGTPCYISPELCEG-KPYNQKSDIWALGCVLYELASLKRAFE-AANLPALVLKIMSGT------------------  217 (256)
T ss_pred             ccccccCCcccCchhccC-CCCCcccchHHHHHHHHHHHhCCCCcc-cCchHHHHHHHHhcC------------------
Confidence            444577889999999977 678999999999999999999999983 222222222211100                  


Q ss_pred             hhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCC
Q 014406          356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF  412 (425)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~  412 (425)
                                        .......++.++.+++.+||+.||++|||+.|+++||||
T Consensus       218 ------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~  256 (256)
T cd08220         218 ------------------FAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC  256 (256)
T ss_pred             ------------------CCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence                              000112268899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.6e-42  Score=319.31  Aligned_cols=253  Identities=24%  Similarity=0.416  Sum_probs=207.8

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEE
Q 014406          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (425)
Q Consensus       125 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (425)
                      ++|++.+.||.|+||.||+|.+..+++.+|+|.+....    ...+.+|+.+++.+ +|+|++++++++.+.  ...++|
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~~v   77 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQC-RSPYITKYYGSFLKG--SKLWII   77 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHc-CCCCeeeeeEEEEEC--CeEEEE
Confidence            46888899999999999999999999999999986432    35678999999999 899999999999654  678999


Q ss_pred             EEeecCCChhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCC-Ccce
Q 014406          201 FEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-KEYN  277 (425)
Q Consensus       201 ~e~~~~~~l~~~~~--~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~-~~~~  277 (425)
                      +||+.+++|..++.  .+++..+..++.|++.||.|||+.+++|+||+|+||+++.+ +.++|+|||+++..... ....
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~-~~~~l~d~g~~~~~~~~~~~~~  156 (274)
T cd06609          78 MEYCGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEE-GDVKLADFGVSGQLTSTMSKRN  156 (274)
T ss_pred             EEeeCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCC-CCEEEcccccceeecccccccc
Confidence            99999999988875  48999999999999999999999999999999999999998 78999999999876543 2233


Q ss_pred             eeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCChhh
Q 014406          278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQL  357 (425)
Q Consensus       278 ~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~  357 (425)
                      ...++..|+|||.+.+ ..++.++|||||||++|+|++|..||... +.......+....                    
T Consensus       157 ~~~~~~~y~~PE~~~~-~~~~~~sDv~slG~il~~l~tg~~p~~~~-~~~~~~~~~~~~~--------------------  214 (274)
T cd06609         157 TFVGTPFWMAPEVIKQ-SGYDEKADIWSLGITAIELAKGEPPLSDL-HPMRVLFLIPKNN--------------------  214 (274)
T ss_pred             cccCCccccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCcccC-chHHHHHHhhhcC--------------------
Confidence            4567888999999987 56999999999999999999999998422 2211111111000                    


Q ss_pred             HHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccc
Q 014406          358 DALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA  418 (425)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~  418 (425)
                                  .   .......++.++.+++.+||..||++|||++++++||||++....
T Consensus       215 ------------~---~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~~~~  260 (274)
T cd06609         215 ------------P---PSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKAKKT  260 (274)
T ss_pred             ------------C---CCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCCCcc
Confidence                        0   000001167889999999999999999999999999999986543

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=8e-42  Score=316.20  Aligned_cols=249  Identities=26%  Similarity=0.461  Sum_probs=205.0

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc-hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEEE
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE  202 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~-~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e  202 (425)
                      .++|++.+.||+|+||.||+|.+..++..+++|.+.... .+.+.+|+++++.+ +|+||+++++++.+.  ...++++|
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~--~~~~l~~e   78 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQC-DSPYIVKYYGSYFKN--TDLWIVME   78 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhC-CCCcEeeeeeeeecC--CcEEEEEe
Confidence            467899999999999999999998889999999987543 57899999999999 999999999999654  78899999


Q ss_pred             eecCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCC-cce
Q 014406          203 YVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EYN  277 (425)
Q Consensus       203 ~~~~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~-~~~  277 (425)
                      |+++++|.+++    ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.+ +.++|+|||++....... ...
T Consensus        79 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~-~~~~l~dfg~~~~~~~~~~~~~  157 (256)
T cd06612          79 YCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEE-GQAKLADFGVSGQLTDTMAKRN  157 (256)
T ss_pred             cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCC-CcEEEcccccchhcccCccccc
Confidence            99999998876    347899999999999999999999999999999999999988 789999999998665433 223


Q ss_pred             eeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCChhh
Q 014406          278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQL  357 (425)
Q Consensus       278 ~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~  357 (425)
                      ...++..|+|||.+.+ ..++.++||||||+++|+|++|+.||... +..+....+..   .                  
T Consensus       158 ~~~~~~~y~~PE~~~~-~~~~~~~Di~s~G~il~~l~~g~~p~~~~-~~~~~~~~~~~---~------------------  214 (256)
T cd06612         158 TVIGTPFWMAPEVIQE-IGYNNKADIWSLGITAIEMAEGKPPYSDI-HPMRAIFMIPN---K------------------  214 (256)
T ss_pred             cccCCccccCHHHHhc-CCCCchhhHHHHHHHHHHHHhCCCCCCCc-chhhhhhhhcc---C------------------
Confidence            4457888999999877 67899999999999999999999998422 11111100000   0                  


Q ss_pred             HHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCC
Q 014406          358 DALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF  412 (425)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~  412 (425)
                                   ..........++.++.+|+.+||+.||++|||+.|+|+||||
T Consensus       215 -------------~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~  256 (256)
T cd06612         215 -------------PPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI  256 (256)
T ss_pred             -------------CCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence                         000001112367899999999999999999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=6.4e-42  Score=324.48  Aligned_cols=256  Identities=27%  Similarity=0.471  Sum_probs=208.7

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc---chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEE
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (425)
                      ..+|++.+.||+|+||.||+|.+..+++.||+|.+...   ..+.+.+|+.+++.+ +|+||++++++|..  +...++|
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~--~~~~~lv   94 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMREN-KNPNIVNYLDSYLV--GDELWVV   94 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhC-CCCCEeeEEEEEec--CCEEEEe
Confidence            47899999999999999999999999999999998643   235678899999998 99999999999965  4678999


Q ss_pred             EEeecCCChhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCc-ce
Q 014406          201 FEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-YN  277 (425)
Q Consensus       201 ~e~~~~~~l~~~~~--~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~-~~  277 (425)
                      |||+++++|..++.  .+++.++..++.|++.||.|||+.|++|+||||+|||++.+ +.++|+|||++........ ..
T Consensus        95 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~-~~~~l~Dfg~~~~~~~~~~~~~  173 (297)
T cd06656          95 MEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRS  173 (297)
T ss_pred             ecccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC-CCEEECcCccceEccCCccCcC
Confidence            99999999998863  47889999999999999999999999999999999999988 7899999999876543322 23


Q ss_pred             eeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCChhh
Q 014406          278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQL  357 (425)
Q Consensus       278 ~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~  357 (425)
                      ...++..|+|||.+.+ ..++.++|+|||||++|++++|..||..... ...+..+.. .+.+                 
T Consensus       174 ~~~~~~~y~aPE~~~~-~~~~~~~Di~slGvil~~l~tg~~pf~~~~~-~~~~~~~~~-~~~~-----------------  233 (297)
T cd06656         174 TMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENP-LRALYLIAT-NGTP-----------------  233 (297)
T ss_pred             cccCCccccCHHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCc-chheeeecc-CCCC-----------------
Confidence            3467888999999977 7789999999999999999999999843221 111110000 0000                 


Q ss_pred             HHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccch
Q 014406          358 DALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE  419 (425)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~~  419 (425)
                                      .......++..+++|+.+||+.||++|||++++++||||+..+...
T Consensus       234 ----------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~  279 (297)
T cd06656         234 ----------------ELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKPLS  279 (297)
T ss_pred             ----------------CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhccccccc
Confidence                            0011123678899999999999999999999999999998776543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=2.1e-41  Score=315.50  Aligned_cols=249  Identities=23%  Similarity=0.400  Sum_probs=200.9

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc--------chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCc
Q 014406          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (425)
Q Consensus       125 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~--------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (425)
                      ++|++.+.||+|+||.||+|.+..++..||+|.+...        ..+.+.+|+.+++++ +|+||+++++++.+.....
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~   80 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNL-LHERIVQYYGCLRDPMERT   80 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhc-CCCCeeeEEeEeccCCCce
Confidence            5789999999999999999999999999999987521        124678899999999 9999999999987655567


Q ss_pred             cEEEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCC
Q 014406          197 PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (425)
Q Consensus       197 ~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~  273 (425)
                      ++++|||+++++|.+++   ..+++..+..++.|++.||+|||+.+++|+||||+||+++.+ +.++|+|||+++.....
T Consensus        81 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~-~~~~l~Dfg~~~~~~~~  159 (265)
T cd06652          81 LSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSV-GNVKLGDFGASKRLQTI  159 (265)
T ss_pred             EEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCC-CCEEECcCccccccccc
Confidence            88999999999998876   457888899999999999999999999999999999999988 78999999998754321


Q ss_pred             ----CcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhc
Q 014406          274 ----KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY  349 (425)
Q Consensus       274 ----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~  349 (425)
                          .......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||... +.....   .+....+.        
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~p~~~~-~~~~~~---~~~~~~~~--------  226 (265)
T cd06652         160 CLSGTGMKSVTGTPYWMSPEVISG-EGYGRKADIWSVGCTVVEMLTEKPPWAEF-EAMAAI---FKIATQPT--------  226 (265)
T ss_pred             cccccccccCCCCccccChhhhcC-CCCCcchhHHHHHHHHHHHhhCCCCCCcc-chHHHH---HHHhcCCC--------
Confidence                12223457888999999977 67899999999999999999999998421 111111   11111000        


Q ss_pred             cCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCc
Q 014406          350 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA  413 (425)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~  413 (425)
                                              ....+..++..+.+++++|+. +|++|||++|+++|||+.
T Consensus       227 ------------------------~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~  265 (265)
T cd06652         227 ------------------------NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH  265 (265)
T ss_pred             ------------------------CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence                                    000112357889999999994 999999999999999974

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.2e-41  Score=318.10  Aligned_cols=264  Identities=21%  Similarity=0.328  Sum_probs=207.0

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEE
Q 014406          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (425)
Q Consensus       125 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (425)
                      ++|+..+.||.|++|.||+|.+..+++.+|+|.+...    ....+.+|+++++++ +|+||++++++|.+.....+++|
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~lv   79 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSC-KSPYIVKYYGAFLDESSSSIGIA   79 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEccCCCeEEEE
Confidence            4789999999999999999999999999999998743    235688999999999 89999999999977666778999


Q ss_pred             EEeecCCChhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCC
Q 014406          201 FEYVNSTDFKVLY-------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (425)
Q Consensus       201 ~e~~~~~~l~~~~-------~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~  273 (425)
                      |||+++++|.+++       ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.+ +.++|+|||++......
T Consensus        80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~-~~~~l~dfg~~~~~~~~  158 (287)
T cd06621          80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRK-GQVKLCDFGVSGELVNS  158 (287)
T ss_pred             EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecC-CeEEEeecccccccccc
Confidence            9999999997764       237888999999999999999999999999999999999988 78999999998754322


Q ss_pred             CcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCC
Q 014406          274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL  353 (425)
Q Consensus       274 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~  353 (425)
                      .. ....++..|+|||.+.+ ..++.++|||||||++|+|++|..||................+......          
T Consensus       159 ~~-~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~----------  226 (287)
T cd06621         159 LA-GTFTGTSFYMAPERIQG-KPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNP----------  226 (287)
T ss_pred             cc-ccccCCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCch----------
Confidence            21 23456788999999876 6789999999999999999999999854321100001111110000000          


Q ss_pred             ChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccc
Q 014406          354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA  418 (425)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~  418 (425)
                                    ...  .........++++.+|+.+||+.||++|||+.|+++||||++....
T Consensus       227 --------------~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~~  275 (287)
T cd06621         227 --------------ELK--DEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKK  275 (287)
T ss_pred             --------------hhc--cCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccccc
Confidence                          000  0001111256789999999999999999999999999999776543

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=2.2e-41  Score=313.24  Aligned_cols=245  Identities=22%  Similarity=0.443  Sum_probs=202.0

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecC-----cchHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEE
Q 014406          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (425)
Q Consensus       126 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (425)
                      +|++.+.||+|+||.||+|.+..+++.+++|.+..     .....+.+|+++++.+ +|||++++++++.+.  ...++|
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~lv   77 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKL-DSSYIIRYYESFLDK--GKLNIV   77 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhc-CCCCeehheeeeccC--CEEEEE
Confidence            57889999999999999999999999999999863     2346688999999999 999999999999654  678999


Q ss_pred             EEeecCCChhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCc
Q 014406          201 FEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (425)
Q Consensus       201 ~e~~~~~~l~~~~-----~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~  275 (425)
                      |||+++++|..++     ..+++..+..++.|++.||.|||+.|++|+||||+||+++.+ +.++|+|||+++.......
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~-~~~~l~df~~~~~~~~~~~  156 (256)
T cd08529          78 MEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAY-DNVKIGDLGVAKLLSDNTN  156 (256)
T ss_pred             EEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCC-CCEEEcccccceeccCccc
Confidence            9999999998876     347888999999999999999999999999999999999988 7899999999886654322


Q ss_pred             -ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCC
Q 014406          276 -YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD  354 (425)
Q Consensus       276 -~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~  354 (425)
                       .....++..|+|||++.+ ..++.++|+|||||++++|++|+.||... +..+....+.+  +.               
T Consensus       157 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~--~~---------------  217 (256)
T cd08529         157 FANTIVGTPYYLSPELCED-KPYNEKSDVWALGVVLYECCTGKHPFDAN-NQGALILKIIR--GV---------------  217 (256)
T ss_pred             hhhccccCccccCHHHhcC-CCCCCccchHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHc--CC---------------
Confidence             233467888999999987 67899999999999999999999998432 22222221111  00               


Q ss_pred             hhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCC
Q 014406          355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF  412 (425)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~  412 (425)
                                         .......++.++.+++++||+.+|++||++.++++|||+
T Consensus       218 -------------------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~  256 (256)
T cd08529         218 -------------------FPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL  256 (256)
T ss_pred             -------------------CCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence                               000011268899999999999999999999999999996

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=3.6e-41  Score=320.57  Aligned_cols=258  Identities=24%  Similarity=0.419  Sum_probs=207.5

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc------hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccE
Q 014406          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (425)
Q Consensus       125 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (425)
                      ++|++.+.||+|+||.||++.+..+++.|++|.+....      .+.+.+|+.+++.+ +|+||+++++.+..  +...+
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~--~~~~~   77 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFA-ENPFVVSMFCSFET--KRHLC   77 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhC-CCCCeeeeEEEEec--CCEEE
Confidence            47899999999999999999999999999999987432      34577899999998 99999999999965  46789


Q ss_pred             EEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCC-
Q 014406          199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-  274 (425)
Q Consensus       199 lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~-  274 (425)
                      +||||+++++|..++   ..+++..+..++.|++.||.|||+.+++|+||||+||+++.+ +.++|+|||+++...... 
T Consensus        78 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~-~~~~l~dfg~~~~~~~~~~  156 (305)
T cd05609          78 MVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSM-GHIKLTDFGLSKIGLMSLT  156 (305)
T ss_pred             EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCC-CCEEEeeCCCccccCcCcc
Confidence            999999999999887   348899999999999999999999999999999999999987 789999999986421110 


Q ss_pred             ---------------cceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCC
Q 014406          275 ---------------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT  339 (425)
Q Consensus       275 ---------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~  339 (425)
                                     ......++..|+|||.+.+ ..++.++|+|||||++|+|++|..||. +.+..+.+.......  
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~vl~el~~g~~pf~-~~~~~~~~~~~~~~~--  232 (305)
T cd05609         157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCVPFF-GDTPEELFGQVISDD--  232 (305)
T ss_pred             ccccccccccchhhccccCCccCccccCchhccC-CCCCchhhHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHhcc--
Confidence                           0012346778999999877 678999999999999999999999984 323222222211100  


Q ss_pred             chhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcC---HHHHhcCCCCcccc
Q 014406          340 DELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT---AREAMAHPYFAQVR  416 (425)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpt---a~elL~hp~~~~~~  416 (425)
                                 .                     ........++.++.+++++||+.||++|||   +.++|+||||...+
T Consensus       233 -----------~---------------------~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~  280 (305)
T cd05609         233 -----------I---------------------EWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLD  280 (305)
T ss_pred             -----------c---------------------CCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCC
Confidence                       0                     000011136889999999999999999997   79999999999888


Q ss_pred             cchhcc
Q 014406          417 AAESSR  422 (425)
Q Consensus       417 ~~~~~~  422 (425)
                      ++..-+
T Consensus       281 ~~~~~~  286 (305)
T cd05609         281 WNGLLR  286 (305)
T ss_pred             HHHHhh
Confidence            877544

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=2.8e-41  Score=312.82  Aligned_cols=246  Identities=24%  Similarity=0.419  Sum_probs=200.6

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEE
Q 014406          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (425)
Q Consensus       126 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (425)
                      +|++.+.||+|++|.||++.+..+++.+|+|.+...     ..+.+.+|+++++++ +|+|++++++.+... ....+++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~-~~~~~lv   78 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQL-KHPNIVAYRESWEGE-DGLLYIV   78 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhC-CCCCeeeeeeeecCC-CCEEEEE
Confidence            589999999999999999999999999999998632     234678899999999 899999999987533 3467899


Q ss_pred             EEeecCCChhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCC-
Q 014406          201 FEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-  274 (425)
Q Consensus       201 ~e~~~~~~l~~~~-----~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~-  274 (425)
                      |||++++++.+++     ..+++.++..++.|++.||+|||+.|++|+||||+||+++.+ +.++|+|||++....... 
T Consensus        79 ~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~-~~~~l~df~~~~~~~~~~~  157 (257)
T cd08223          79 MGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRT-NIIKVGDLGIARVLENQCD  157 (257)
T ss_pred             ecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecC-CcEEEecccceEEecccCC
Confidence            9999999998776     238899999999999999999999999999999999999987 789999999997664322 


Q ss_pred             cceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCC
Q 014406          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD  354 (425)
Q Consensus       275 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~  354 (425)
                      ......++..|+|||++.+ ..++.++|||||||++++|++|+.||. +.+.......+...  .               
T Consensus       158 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~~~~-~~~~~~~~~~~~~~--~---------------  218 (257)
T cd08223         158 MASTLIGTPYYMSPELFSN-KPYNYKSDVWALGCCVYEMATLKHAFN-AKDMNSLVYRIIEG--K---------------  218 (257)
T ss_pred             ccccccCCcCccChhHhcC-CCCCchhhhHHHHHHHHHHHcCCCCCC-CCCHHHHHHHHHhc--C---------------
Confidence            2233467888999999887 678999999999999999999999984 22222221111110  0               


Q ss_pred             hhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCC
Q 014406          355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF  412 (425)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~  412 (425)
                                         .......+++++.+|+.+||+.||++|||+.++++||||
T Consensus       219 -------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~  257 (257)
T cd08223         219 -------------------LPPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI  257 (257)
T ss_pred             -------------------CCCCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence                               000112368899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.5e-42  Score=320.34  Aligned_cols=255  Identities=25%  Similarity=0.440  Sum_probs=206.4

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc---hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEE
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (425)
                      .++|++.+.||.|+||+||+|.+..++..+|+|++....   .+.+.+|+++++++ +|+||+++++++...  ...++|
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~lv   80 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSEC-KHPNIVGLYEAYFYE--NKLWIL   80 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhC-CCCceeEEEEEEecC--CeEEEE
Confidence            467899999999999999999998899999999987543   34678899999999 899999999999654  678999


Q ss_pred             EEeecCCChhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCC-Cc
Q 014406          201 FEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-KE  275 (425)
Q Consensus       201 ~e~~~~~~l~~~~~----~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~-~~  275 (425)
                      |||+++++|..++.    .+++..++.++.|++.||.|||+.||+|+||+|+||+++.+ +.++|+|||++...... ..
T Consensus        81 ~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~-~~~~l~d~g~~~~~~~~~~~  159 (280)
T cd06611          81 IEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLD-GDVKLADFGVSAKNKSTLQK  159 (280)
T ss_pred             eeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCC-CCEEEccCccchhhcccccc
Confidence            99999999988863    48999999999999999999999999999999999999988 78999999988654332 22


Q ss_pred             ceeeccCCCccCcccccC----CCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccC
Q 014406          276 YNVRVASRYFKGPELLVD----LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL  351 (425)
Q Consensus       276 ~~~~~~t~~y~aPE~~~~----~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~  351 (425)
                      .....++..|+|||.+..    ...++.++|+|||||++|+|++|+.||. +.+..+....+..  +..           
T Consensus       160 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~-~~~~~~~~~~~~~--~~~-----------  225 (280)
T cd06611         160 RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHH-ELNPMRVLLKILK--SEP-----------  225 (280)
T ss_pred             cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcc-cCCHHHHHHHHhc--CCC-----------
Confidence            234568889999999752    2457889999999999999999999983 2222222221110  000           


Q ss_pred             CCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCccccc
Q 014406          352 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA  417 (425)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~  417 (425)
                                           ........++.++.+|+.+||+.||.+|||+.++++||||.+...
T Consensus       226 ---------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~  270 (280)
T cd06611         226 ---------------------PTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQSD  270 (280)
T ss_pred             ---------------------CCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhcccch
Confidence                                 000111236889999999999999999999999999999998743

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=3.5e-41  Score=320.95  Aligned_cols=280  Identities=31%  Similarity=0.513  Sum_probs=205.6

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc-----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCC-----
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQH-----  193 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~-----  193 (425)
                      -++|++.++||+|+||.||+|.+..+++.||+|.+....     ...+.+|+.+++++ +||||+++++++....     
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~   89 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLL-KHENVVNLIEICRTKATPYNR   89 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhC-CCCCccceEEEEecccccccC
Confidence            467999999999999999999999999999999885322     23457899999999 9999999999986542     


Q ss_pred             -CCccEEEEEeecCCChhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccc
Q 014406          194 -SKTPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE  268 (425)
Q Consensus       194 -~~~~~lv~e~~~~~~l~~~~~----~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~  268 (425)
                       ....++||||+.+ ++...+.    .+++.+++.++.|++.||.|||++|++|+||||+||+++.+ +.+||+|||++.
T Consensus        90 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~-~~~kl~dfg~~~  167 (310)
T cd07865          90 YKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKD-GILKLADFGLAR  167 (310)
T ss_pred             CCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCC-CcEEECcCCCcc
Confidence             2356899999986 4444432    48999999999999999999999999999999999999988 789999999997


Q ss_pred             cccCCCc-----ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhH
Q 014406          269 FYHPGKE-----YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELN  343 (425)
Q Consensus       269 ~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~  343 (425)
                      .......     .....++..|+|||.+.+...++.++||||||+++|+|++|+.|| .+.+....+..+....|..+..
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~-~~~~~~~~~~~~~~~~~~~~~~  246 (310)
T cd07865         168 AFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIM-QGNTEQHQLTLISQLCGSITPE  246 (310)
T ss_pred             cccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCChh
Confidence            6543221     123456788999999876556789999999999999999999887 4445555555555555543222


Q ss_pred             HHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCC
Q 014406          344 AYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF  412 (425)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~  412 (425)
                      .+.......   .++...  ..................+..+++||.+||+.||++|||++|+|+||||
T Consensus       247 ~~~~~~~~~---~~~~~~--~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f  310 (310)
T cd07865         247 VWPGVDKLE---LFKKME--LPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF  310 (310)
T ss_pred             hcccccchh---hhhhcc--CCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence            110000000   000000  0000000000000011146788999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3e-41  Score=326.32  Aligned_cols=285  Identities=33%  Similarity=0.592  Sum_probs=215.1

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCC----
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH----  193 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~----  193 (425)
                      ..++|.+.+.||+|+||.||+|.+..+++.+|+|.+...     ....+.+|+.+++.+ +|+||+++++++....    
T Consensus        13 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~   91 (342)
T cd07879          13 LPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHM-QHENVIGLLDVFTSAVSGDE   91 (342)
T ss_pred             cccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhc-CCCCccchhheecccccCCC
Confidence            357899999999999999999999999999999998642     234578899999999 9999999999986432    


Q ss_pred             CCccEEEEEeecCCChhhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccC
Q 014406          194 SKTPSLIFEYVNSTDFKVLYP-TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (425)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~~-~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~  272 (425)
                      ....++|+||+.. ++..+.. .+++..+..++.|++.||+|||+.|++||||||+||+++.+ +.++|+|||+++....
T Consensus        92 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~-~~~kL~dfg~~~~~~~  169 (342)
T cd07879          92 FQDFYLVMPYMQT-DLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNED-CELKILDFGLARHADA  169 (342)
T ss_pred             CceEEEEeccccc-CHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC-CCEEEeeCCCCcCCCC
Confidence            1346899999975 5655544 68999999999999999999999999999999999999988 7899999999876432


Q ss_pred             CCcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCC
Q 014406          273 GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE  352 (425)
Q Consensus       273 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~  352 (425)
                        ......++..|+|||.+.+...++.++|||||||++|+|++|+.||. +.+....+..+....|.+.... .......
T Consensus       170 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~-~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~  245 (342)
T cd07879         170 --EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFK-GKDYLDQLTQILKVTGVPGPEF-VQKLEDK  245 (342)
T ss_pred             --CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHHhcCCCCHHH-HHHhccc
Confidence              22334668889999998764568899999999999999999999984 4444555666666555433221 1111110


Q ss_pred             CChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccch
Q 014406          353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE  419 (425)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~~  419 (425)
                      ................+..     .....+.++.+|+++||+.||++|||++|+++||||+.++...
T Consensus       246 ~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~  307 (342)
T cd07879         246 AAKSYIKSLPKYPRKDFST-----LFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDAD  307 (342)
T ss_pred             chHHHHhhcCCcccchHHH-----HhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccccc
Confidence            0000000000000111100     0113578899999999999999999999999999999987653

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-41  Score=318.74  Aligned_cols=278  Identities=35%  Similarity=0.573  Sum_probs=213.5

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEE
Q 014406          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (425)
Q Consensus       125 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (425)
                      ++|++.+.||+|+||.||+|.+..+++.||+|.++..     ..+.+.+|+++++++ +|+||+++++++.+  ....++
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~~~i   77 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQL-RHENIVNLKEAFRR--KGRLYL   77 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhc-CCCCeeehhheEEE--CCEEEE
Confidence            4799999999999999999999999999999998632     246788999999999 89999999999966  467899


Q ss_pred             EEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCC--
Q 014406          200 IFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK--  274 (425)
Q Consensus       200 v~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~--  274 (425)
                      +|||++++++..+.   ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.+ +.+||+|||++.......  
T Consensus        78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~-~~~kl~d~g~~~~~~~~~~~  156 (288)
T cd07833          78 VFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSES-GVLKLCDFGFARALRARPAS  156 (288)
T ss_pred             EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCC-CCEEEEeeecccccCCCccc
Confidence            99999998887655   348899999999999999999999999999999999999987 789999999998765443  


Q ss_pred             cceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCC
Q 014406          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD  354 (425)
Q Consensus       275 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~  354 (425)
                      ......++..|+|||++.+...++.++||||||+++|+|++|..|| .+.+..+.+..+...++............   .
T Consensus       157 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~  232 (288)
T cd07833         157 PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLF-PGDSDIDQLYLIQKCLGPLPPSHQELFSS---N  232 (288)
T ss_pred             cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCCHHHhhhccc---C
Confidence            3334567888999999987447899999999999999999999877 44455555655555555433221110000   0


Q ss_pred             hhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCC
Q 014406          355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF  412 (425)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~  412 (425)
                      ..+...  ..................++.++++|+++||..||++|||++++++||||
T Consensus       233 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f  288 (288)
T cd07833         233 PRFAGV--AFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF  288 (288)
T ss_pred             cccccc--ccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence            000000  00000000000111122358899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=3.8e-41  Score=317.18  Aligned_cols=254  Identities=28%  Similarity=0.463  Sum_probs=203.0

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc--hHHHHHHHHHHHHhcCCCCeeeEEeEEEc---CCCCcc
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--KKKIKREIKILQNLCGGPNVVKLLDIVRD---QHSKTP  197 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~~h~niv~l~~~~~~---~~~~~~  197 (425)
                      ..++|++.+.||+|+||+||+|.+..+++.+|+|+++...  ...+.+|+.+++.+.+|+||+++++++..   ..+...
T Consensus        16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~   95 (286)
T cd06638          16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQL   95 (286)
T ss_pred             cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeE
Confidence            4689999999999999999999999999999999987532  35688899999998679999999998853   234678


Q ss_pred             EEEEEeecCCChhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccc
Q 014406          198 SLIFEYVNSTDFKVLY-------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  270 (425)
Q Consensus       198 ~lv~e~~~~~~l~~~~-------~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~  270 (425)
                      ++||||+++++|..++       ..+++..+..++.|++.||.|||+.+++|+||||+||+++.+ +.++|+|||++...
T Consensus        96 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~-~~~kl~dfg~~~~~  174 (286)
T cd06638          96 WLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTE-GGVKLVDFGVSAQL  174 (286)
T ss_pred             EEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCC-CCEEEccCCceeec
Confidence            9999999999998754       347888899999999999999999999999999999999988 78999999998765


Q ss_pred             cCCC-cceeeccCCCccCcccccC----CCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHH
Q 014406          271 HPGK-EYNVRVASRYFKGPELLVD----LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAY  345 (425)
Q Consensus       271 ~~~~-~~~~~~~t~~y~aPE~~~~----~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~  345 (425)
                      .... ......++..|+|||++..    ...++.++||||+||++|+|++|+.||.... ....+..+..   .      
T Consensus       175 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~-~~~~~~~~~~---~------  244 (286)
T cd06638         175 TSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLH-PMRALFKIPR---N------  244 (286)
T ss_pred             ccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCc-hhHHHhhccc---c------
Confidence            4322 2234568899999999753    1447889999999999999999999984321 1111111000   0      


Q ss_pred             HhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCC
Q 014406          346 LNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF  412 (425)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~  412 (425)
                                            ..   ........++..+.+|+.+||+.||++|||+.|+++|+||
T Consensus       245 ----------------------~~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~  286 (286)
T cd06638         245 ----------------------PP---PTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI  286 (286)
T ss_pred             ----------------------CC---CcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence                                  00   0000112257789999999999999999999999999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=9.1e-43  Score=334.28  Aligned_cols=244  Identities=16%  Similarity=0.355  Sum_probs=198.1

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccE
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (425)
                      .++..+...||+|.||+||+|.+..   .||||+++..     ..+.|++|+.++++- +|.||+-+.|+|..+  .. .
T Consensus       391 ~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkT-RH~NIlLFMG~~~~p--~~-A  463 (678)
T KOG0193|consen  391 PEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKT-RHENILLFMGACMNP--PL-A  463 (678)
T ss_pred             HHHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhc-chhhheeeehhhcCC--ce-e
Confidence            4567788999999999999998743   6999999743     457899999999998 999999999999764  33 7


Q ss_pred             EEEEeecCCChhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccc---c
Q 014406          199 LIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY---H  271 (425)
Q Consensus       199 lv~e~~~~~~l~~~~~----~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~---~  271 (425)
                      +|..+|+|.+|..++.    +|.....+.|++||++||.|||.++|||||||..||++.++ ++|||+|||++..-   .
T Consensus       464 IiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~-~kVkIgDFGLatvk~~w~  542 (678)
T KOG0193|consen  464 IITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHED-LKVKIGDFGLATVKTRWS  542 (678)
T ss_pred             eeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccC-CcEEEecccceeeeeeec
Confidence            9999999999998884    48888899999999999999999999999999999999998 89999999998532   3


Q ss_pred             CCCcceeeccCCCccCcccccC--CCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhc
Q 014406          272 PGKEYNVRVASRYFKGPELLVD--LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY  349 (425)
Q Consensus       272 ~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~  349 (425)
                      .........+...|||||++..  ..+|++.+||||||+++|||++|..||.  ..+.+++.-++   |.+-.       
T Consensus       543 g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys--i~~~dqIifmV---GrG~l-------  610 (678)
T KOG0193|consen  543 GEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS--IQNRDQIIFMV---GRGYL-------  610 (678)
T ss_pred             cccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC--CCChhheEEEe---ccccc-------
Confidence            3445556678889999999854  3468999999999999999999999984  44555443221   11100       


Q ss_pred             cCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhc
Q 014406          350 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  408 (425)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~  408 (425)
                       +   ++                 .......+++++++|+..||.+++++||+..++|.
T Consensus       611 -~---pd-----------------~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~  648 (678)
T KOG0193|consen  611 -M---PD-----------------LSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS  648 (678)
T ss_pred             -C---cc-----------------chhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence             0   00                 00112336789999999999999999999998876

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=3e-41  Score=326.23  Aligned_cols=286  Identities=29%  Similarity=0.528  Sum_probs=210.4

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc---chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCC-----
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS-----  194 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~-----  194 (425)
                      ...+|++.+.||.|+||+||+|.+..+++.||+|.+...   ..+.+.+|+++++.+ +||||+++++++.....     
T Consensus         3 ~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l-~h~~i~~~~~~~~~~~~~~~~~   81 (342)
T cd07854           3 LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRL-DHDNIVKVYEVLGPSGSDLTED   81 (342)
T ss_pred             cCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhc-CCCcchhhHhhhcccccccccc
Confidence            357899999999999999999999999999999998643   345688999999999 99999999987764322     


Q ss_pred             -------CccEEEEEeecCCChhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEecc
Q 014406          195 -------KTPSLIFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWG  265 (425)
Q Consensus       195 -------~~~~lv~e~~~~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg  265 (425)
                             ...++||||+++ +|..++  ..+++..++.++.||+.||.|||+.||+|+||||+||+++.+.+.++|+|||
T Consensus        82 ~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~dfg  160 (342)
T cd07854          82 VGSLTELNSVYIVQEYMET-DLANVLEQGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFG  160 (342)
T ss_pred             cccccccceEEEEeecccc-cHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCcc
Confidence                   346899999985 666655  3589999999999999999999999999999999999998765688999999


Q ss_pred             ccccccCCC----cceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCch
Q 014406          266 LAEFYHPGK----EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDE  341 (425)
Q Consensus       266 ~a~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~  341 (425)
                      +++......    ......++..|+|||.+.+...++.++|||||||++|+|++|+.||. +.+..+....+.+......
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~-~~~~~~~~~~~~~~~~~~~  239 (342)
T cd07854         161 LARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFA-GAHELEQMQLILESVPVVR  239 (342)
T ss_pred             cceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHHhcCCCC
Confidence            997653221    11234578889999987665678899999999999999999999984 3333344443333332221


Q ss_pred             hHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccc
Q 014406          342 LNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA  418 (425)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~  418 (425)
                      ........ ......... .......+...     ....++.++++|+++||+.||++|||+.|+++||||+....+
T Consensus       240 ~~~~~~~~-~~~~~~~~~-~~~~~~~~~~~-----~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~~~  309 (342)
T cd07854         240 EEDRNELL-NVIPSFVRN-DGGEPRRPLRD-----LLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYSCP  309 (342)
T ss_pred             hHHhhhhh-hhhhhhhhh-cccccCCCHHH-----HccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccccCC
Confidence            11110000 000000000 00001111111     112378899999999999999999999999999999865443

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-41  Score=317.11  Aligned_cols=276  Identities=34%  Similarity=0.641  Sum_probs=211.0

Q ss_pred             EEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEE
Q 014406          127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (425)
Q Consensus       127 y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (425)
                      |++.+.||.|+||.||+|.+..+++.+|+|.+...     ....+.+|+.+++.+ +|+|++++++++.+......++|+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~lv~   79 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKL-RHPNIVRLKEIVTSKGKGSIYMVF   79 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhc-cCCCeeeheeeEecCCCCcEEEEe
Confidence            67889999999999999999999999999999754     234678899999999 899999999999765446889999


Q ss_pred             EeecCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCC--c
Q 014406          202 EYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK--E  275 (425)
Q Consensus       202 e~~~~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~--~  275 (425)
                      ||+++ ++..++    ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.+ +.++|+|||++.......  .
T Consensus        80 e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~-~~~~l~d~g~~~~~~~~~~~~  157 (287)
T cd07840          80 EYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINND-GVLKLADFGLARPYTKRNSAD  157 (287)
T ss_pred             ccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCC-CCEEEccccceeeccCCCccc
Confidence            99986 555554    258899999999999999999999999999999999999998 799999999998665433  2


Q ss_pred             ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCCh
Q 014406          276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP  355 (425)
Q Consensus       276 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~  355 (425)
                      .....++..|+|||.+.+...++.++||||||+++|+|++|+.||. ..+..+.+..+.+..+......+........  
T Consensus       158 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  234 (287)
T cd07840         158 YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQ-GSTELEQLEKIFELCGSPTDENWPGVSKLPW--  234 (287)
T ss_pred             ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCC-CCChHHHHHHHHHHhCCCchhhccccccchh--
Confidence            3344667889999988765668999999999999999999998874 4445556666666555544332211100000  


Q ss_pred             hhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCC
Q 014406          356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF  412 (425)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~  412 (425)
                       ..   ...................++.++.+++++||+.||++|||++++++||||
T Consensus       235 -~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~  287 (287)
T cd07840         235 -FE---NLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF  287 (287)
T ss_pred             -hh---hccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence             00   000000001111111111248899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.5e-41  Score=343.39  Aligned_cols=285  Identities=20%  Similarity=0.248  Sum_probs=199.4

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCC-cEEEEE------------------EecC--cchHHHHHHHHHHHHhcCCCC
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTN-ERCIIK------------------ILKP--VKKKKIKREIKILQNLCGGPN  181 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~-~~vavK------------------~~~~--~~~~~~~~E~~~l~~l~~h~n  181 (425)
                      ..++|++++.||+|+||+||+|...... ...+.|                  .+..  .....+.+|+.+++++ +|+|
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l-~Hpn  224 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRL-NHEN  224 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhC-CCCC
Confidence            3578999999999999999998754322 222222                  1111  1234578999999999 9999


Q ss_pred             eeeEEeEEEcCCCCccEEEEEeecCCChhhhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecC
Q 014406          182 VVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP-------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH  254 (425)
Q Consensus       182 iv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-------~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~  254 (425)
                      |+++++++...  ...++|+|++.+..+.....       ......++.++.||+.||+|||++|||||||||+|||++.
T Consensus       225 Iv~l~~~~~~~--~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~  302 (501)
T PHA03210        225 ILKIEEILRSE--ANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNC  302 (501)
T ss_pred             cCcEeEEEEEC--CeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECC
Confidence            99999999765  56789999987655544321       2345667889999999999999999999999999999998


Q ss_pred             CCCcEEEEeccccccccCCCc--ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCC--CCHHHH
Q 014406          255 ELRKLRLIDWGLAEFYHPGKE--YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH--DNHDQL  330 (425)
Q Consensus       255 ~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~--~~~~~~  330 (425)
                      + +.+||+|||+++.......  .....||..|+|||++.+ ..++.++|||||||++|||++|..+++...  +...++
T Consensus       303 ~-~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~  380 (501)
T PHA03210        303 D-GKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAG-DGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL  380 (501)
T ss_pred             C-CCEEEEeCCCceecCcccccccccccCCcCCCCchhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHH
Confidence            8 7899999999987653322  223578999999999987 679999999999999999999987654432  234556


Q ss_pred             HHHHHHhCCchhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCC
Q 014406          331 VKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHP  410 (425)
Q Consensus       331 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp  410 (425)
                      ..+...++..... +.    ......++.+...........+...-....++.++.+++.+||++||++|||+.|+|+||
T Consensus       381 ~~~~~~~~~~~~~-~p----~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp  455 (501)
T PHA03210        381 LKIIDSLSVCDEE-FP----DPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALP  455 (501)
T ss_pred             HHHHHhcccChhh-cC----CcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhCh
Confidence            6665555432111 00    000000000000000000000001111123677889999999999999999999999999


Q ss_pred             CCccccc
Q 014406          411 YFAQVRA  417 (425)
Q Consensus       411 ~~~~~~~  417 (425)
                      ||+....
T Consensus       456 ~f~~~~~  462 (501)
T PHA03210        456 LFSAEEE  462 (501)
T ss_pred             hhhcCCc
Confidence            9987643

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.2e-41  Score=315.60  Aligned_cols=251  Identities=25%  Similarity=0.446  Sum_probs=201.7

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc---------hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCc
Q 014406          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK---------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (425)
Q Consensus       126 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~---------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (425)
                      +|+..+.||+|+||.||+|.+..+++.+|+|++....         .+.+.+|+.+++++ +|+||+++++++.+  ...
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~--~~~   77 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL-NHPHIIRMLGATCE--DSH   77 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHc-CCCceehhhceecc--CCe
Confidence            4677889999999999999999999999999986422         35688999999999 99999999999954  467


Q ss_pred             cEEEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCC
Q 014406          197 PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (425)
Q Consensus       197 ~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~  273 (425)
                      .++|+||+.+++|.+++   ..+++..+..++.|++.||.|||++|++|+||+|+||+++.+...++|+|||++......
T Consensus        78 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~  157 (268)
T cd06630          78 FNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAK  157 (268)
T ss_pred             EEEEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccccc
Confidence            88999999999998876   358889999999999999999999999999999999999877457999999998765432


Q ss_pred             C-----cceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhh
Q 014406          274 K-----EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK  348 (425)
Q Consensus       274 ~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~  348 (425)
                      .     ......++..|+|||.+.+ ..++.++|+||+||++++|++|..||..... ......+.+....         
T Consensus       158 ~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-~~~~~~~~~~~~~---------  226 (268)
T cd06630         158 GTGAGEFQGQLLGTIAFMAPEVLRG-EQYGRSCDVWSVGCVIIEMATAKPPWNAEKH-SNHLALIFKIASA---------  226 (268)
T ss_pred             cccCCccccccccccceeCHhHhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCC-cchHHHHHHHhcc---------
Confidence            1     1123467888999999876 6789999999999999999999999843221 1111111110000         


Q ss_pred             ccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCc
Q 014406          349 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA  413 (425)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~  413 (425)
                                             ......+..+++++.+++.+||+.||++|||+.++++||||+
T Consensus       227 -----------------------~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~  268 (268)
T cd06630         227 -----------------------TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR  268 (268)
T ss_pred             -----------------------CCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence                                   000111223688999999999999999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=3.1e-41  Score=314.45  Aligned_cols=245  Identities=28%  Similarity=0.526  Sum_probs=198.5

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc------------hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCC
Q 014406          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------------KKKIKREIKILQNLCGGPNVVKLLDIVRDQH  193 (425)
Q Consensus       126 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~------------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  193 (425)
                      +|.+...||+|+||.||+|.+..+++.+|+|.+....            .+.+.+|+.+++++ +||||+++++++.+. 
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~-   78 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL-QHENIVQYLGSSLDA-   78 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeC-
Confidence            3566789999999999999999999999999885321            14577899999999 999999999999654 


Q ss_pred             CCccEEEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccc
Q 014406          194 SKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  270 (425)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~  270 (425)
                       ...++++||+++++|..++   ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.+ +.++|+|||+++..
T Consensus        79 -~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~-~~~~l~dfg~~~~~  156 (267)
T cd06628          79 -DHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNK-GGIKISDFGISKKL  156 (267)
T ss_pred             -CccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCC-CCEEecccCCCccc
Confidence             6788999999999998887   348889999999999999999999999999999999999988 78999999998766


Q ss_pred             cCCCc-------ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhH
Q 014406          271 HPGKE-------YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELN  343 (425)
Q Consensus       271 ~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~  343 (425)
                      .....       .....++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||... +.......+...       
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~-------  227 (267)
T cd06628         157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQ-TSYTRKADIWSLGCLVVEMLTGKHPFPDC-TQLQAIFKIGEN-------  227 (267)
T ss_pred             ccccccCCccccccccCCCcCccChhHhcc-CCCCchhhhHHHHHHHHHHhhCCCCCCCc-cHHHHHHHHhcc-------
Confidence            42211       112346788999999877 67889999999999999999999998432 211111111000       


Q ss_pred             HHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCC
Q 014406          344 AYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF  412 (425)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~  412 (425)
                                                   ........++.++.+++++||+.||++||++.|+++||||
T Consensus       228 -----------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  267 (267)
T cd06628         228 -----------------------------ASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL  267 (267)
T ss_pred             -----------------------------CCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence                                         0001112368899999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=3.2e-41  Score=317.16  Aligned_cols=253  Identities=26%  Similarity=0.429  Sum_probs=203.2

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc---hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEE
Q 014406          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (425)
Q Consensus       125 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (425)
                      +.|++.+.||+|+||.||+|.+..++..+++|.+....   .+.+.+|+++++.+ +|+|++++++++...  ...++|+
T Consensus         5 ~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~h~~ii~~~~~~~~~--~~~~~v~   81 (282)
T cd06643           5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASC-DHPNIVKLLDAFYYE--NNLWILI   81 (282)
T ss_pred             HHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHC-CCCCeeeEEEEEeeC--CEEEEEE
Confidence            34677889999999999999999999999999987543   34678899999999 899999999999654  6788999


Q ss_pred             EeecCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCC-Ccc
Q 014406          202 EYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-KEY  276 (425)
Q Consensus       202 e~~~~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~-~~~  276 (425)
                      ||++++++..++    ..+++..+..++.|++.||.|||+.|++|+||||+||+++.+ +.++|+|||++...... ...
T Consensus        82 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~-~~~kl~dfg~~~~~~~~~~~~  160 (282)
T cd06643          82 EFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLD-GDIKLADFGVSAKNTRTIQRR  160 (282)
T ss_pred             EecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccC-CCEEEcccccccccccccccc
Confidence            999999998765    348999999999999999999999999999999999999988 78999999998654322 222


Q ss_pred             eeeccCCCccCcccccC----CCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCC
Q 014406          277 NVRVASRYFKGPELLVD----LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE  352 (425)
Q Consensus       277 ~~~~~t~~y~aPE~~~~----~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~  352 (425)
                      ....++..|+|||++..    ...++.++|||||||++|+|++|+.||.. .+..+....+......             
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~-~~~~~~~~~~~~~~~~-------------  226 (282)
T cd06643         161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHE-LNPMRVLLKIAKSEPP-------------  226 (282)
T ss_pred             ccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccc-cCHHHHHHHHhhcCCC-------------
Confidence            34567889999999842    24578899999999999999999998732 2222222222110000             


Q ss_pred             CChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccc
Q 014406          353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR  416 (425)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~  416 (425)
                                           ....+..++.++.+|+.+||+.||++|||++++++||||+...
T Consensus       227 ---------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  269 (282)
T cd06643         227 ---------------------TLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNS  269 (282)
T ss_pred             ---------------------CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEeccC
Confidence                                 0001123688999999999999999999999999999998653

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=9.8e-42  Score=317.94  Aligned_cols=252  Identities=25%  Similarity=0.420  Sum_probs=201.5

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc---chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEE
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (425)
                      ..++|++.+.||+|+||.||+|.+..+++.+|+|++...   ....+.+|+.+++.+ +|+||+++++++...  ...++
T Consensus         7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~-~h~~ii~~~~~~~~~--~~~~i   83 (267)
T cd06646           7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKEC-KHCNIVAYFGSYLSR--EKLWI   83 (267)
T ss_pred             chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhc-CCCCeeeeeEEEEeC--CEEEE
Confidence            467899999999999999999999999999999998743   234678899999999 999999999999654  67889


Q ss_pred             EEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCC-c
Q 014406          200 IFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-E  275 (425)
Q Consensus       200 v~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~-~  275 (425)
                      ||||+++++|..++   ..+++..+..++.|++.||.|||+.||+|+||+|+||+++.+ +.++|+|||++....... .
T Consensus        84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~-~~~~l~dfg~~~~~~~~~~~  162 (267)
T cd06646          84 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDN-GDVKLADFGVAAKITATIAK  162 (267)
T ss_pred             EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCC-CCEEECcCccceeecccccc
Confidence            99999999998876   358899999999999999999999999999999999999987 789999999997654322 2


Q ss_pred             ceeeccCCCccCcccccC--CCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCC
Q 014406          276 YNVRVASRYFKGPELLVD--LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL  353 (425)
Q Consensus       276 ~~~~~~t~~y~aPE~~~~--~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~  353 (425)
                      .....++..|+|||.+..  ...++.++|||||||++|+|++|+.||+..... +....+..             .... 
T Consensus       163 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~-~~~~~~~~-------------~~~~-  227 (267)
T cd06646         163 RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPM-RALFLMSK-------------SNFQ-  227 (267)
T ss_pred             cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchh-hhheeeec-------------CCCC-
Confidence            234567889999998742  245788999999999999999999998432211 11100000             0000 


Q ss_pred             ChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCC
Q 014406          354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY  411 (425)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~  411 (425)
                                  .      ........++..+.+|+++||+.||++|||++++++|+|
T Consensus       228 ------------~------~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         228 ------------P------PKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             ------------C------CCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence                        0      000011236889999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-43  Score=336.30  Aligned_cols=250  Identities=27%  Similarity=0.423  Sum_probs=207.3

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccE
Q 014406          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (425)
Q Consensus       125 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (425)
                      ..|+.++.||.|+||.||.|++..+.+.||||.++-.      ....+..|+.+|+++ .|||++.+-|+|..+  ...|
T Consensus        26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l-~HPntieYkgCyLre--~TaW  102 (948)
T KOG0577|consen   26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQL-RHPNTIEYKGCYLRE--HTAW  102 (948)
T ss_pred             HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhc-cCCCcccccceeecc--chHH
Confidence            3467788999999999999999999999999998632      346788999999999 999999999999765  4566


Q ss_pred             EEEEeecCC--C-hhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCc
Q 014406          199 LIFEYVNST--D-FKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (425)
Q Consensus       199 lv~e~~~~~--~-l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~  275 (425)
                      ||||||-|.  + ++.+..++.+.++..|..+.+.||+|||+.+.||||||+.|||+++. +.|||+|||.|....   .
T Consensus       103 LVMEYClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~-g~VKLaDFGSAsi~~---P  178 (948)
T KOG0577|consen  103 LVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEP-GLVKLADFGSASIMA---P  178 (948)
T ss_pred             HHHHHHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCC-CeeeeccccchhhcC---c
Confidence            999999775  2 34445779999999999999999999999999999999999999988 899999999998765   4


Q ss_pred             ceeeccCCCccCcccccC--CCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCC
Q 014406          276 YNVRVASRYFKGPELLVD--LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL  353 (425)
Q Consensus       276 ~~~~~~t~~y~aPE~~~~--~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~  353 (425)
                      .+..+||++|||||+++.  .+.|+-++||||||++..||...+.|+|+. +-...+.-|.+.-. +.+.          
T Consensus       179 AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnM-NAMSALYHIAQNes-PtLq----------  246 (948)
T KOG0577|consen  179 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-NAMSALYHIAQNES-PTLQ----------  246 (948)
T ss_pred             hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCc-hHHHHHHHHHhcCC-CCCC----------
Confidence            456899999999999853  467999999999999999999999998643 33333333332111 0000          


Q ss_pred             ChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCccccc
Q 014406          354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA  417 (425)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~  417 (425)
                                              ...+|+.++.|+..||++-|.+|||.+++|.|+|...-+.
T Consensus       247 ------------------------s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~Rp  286 (948)
T KOG0577|consen  247 ------------------------SNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRERP  286 (948)
T ss_pred             ------------------------CchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccCCC
Confidence                                    1226889999999999999999999999999999876554

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=8.3e-42  Score=318.43  Aligned_cols=251  Identities=24%  Similarity=0.439  Sum_probs=201.2

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc---hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEE
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (425)
                      .++|++.+.||+|+||.||+|.+..+++.+|+|+++...   ...+.+|+.+++.+ +||||+++++++.+.  ...++|
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l-~h~~ii~~~~~~~~~--~~~~lv   84 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDC-KHSNIVAYFGSYLRR--DKLWIC   84 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhC-CCCCeeeEEEEEEeC--CEEEEE
Confidence            467888899999999999999999999999999987543   24577899999999 999999999999654  678899


Q ss_pred             EEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCC-cc
Q 014406          201 FEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EY  276 (425)
Q Consensus       201 ~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~-~~  276 (425)
                      +||+++++|.+++   ..+++.++..++.|++.||.|||+.|++|+||||+||+++.+ +.++|+|||++....... ..
T Consensus        85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~-~~~~l~dfg~~~~~~~~~~~~  163 (267)
T cd06645          85 MEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDN-GHVKLADFGVSAQITATIAKR  163 (267)
T ss_pred             EeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC-CCEEECcceeeeEccCccccc
Confidence            9999999999876   458999999999999999999999999999999999999988 789999999987553221 22


Q ss_pred             eeeccCCCccCcccccC--CCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCC
Q 014406          277 NVRVASRYFKGPELLVD--LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD  354 (425)
Q Consensus       277 ~~~~~t~~y~aPE~~~~--~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~  354 (425)
                      ....++..|+|||.+..  ...++.++|+|||||++|+|++|..||+...... .......  .           ...  
T Consensus       164 ~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~-~~~~~~~--~-----------~~~--  227 (267)
T cd06645         164 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR-ALFLMTK--S-----------NFQ--  227 (267)
T ss_pred             ccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh-hHHhhhc--c-----------CCC--
Confidence            34578889999999742  2458899999999999999999999985432211 1111100  0           000  


Q ss_pred             hhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCC
Q 014406          355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY  411 (425)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~  411 (425)
                                 ..      .......++..+.+|+++||+.||++|||++++++|||
T Consensus       228 -----------~~------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~  267 (267)
T cd06645         228 -----------PP------KLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF  267 (267)
T ss_pred             -----------CC------cccccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence                       00      00011126788999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=2.4e-41  Score=326.37  Aligned_cols=287  Identities=33%  Similarity=0.606  Sum_probs=219.2

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecC-----cchHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCcc
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (425)
                      ..++|++.+.||+|+||.||+|.+..+++.+|+|.+..     .....+.+|+.+++++.+|+||++++++|...+....
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~   84 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI   84 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence            35788999999999999999999998999999998743     2234577899999998789999999999976666678


Q ss_pred             EEEEEeecCCChhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCC-
Q 014406          198 SLIFEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-  274 (425)
Q Consensus       198 ~lv~e~~~~~~l~~~~~--~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~-  274 (425)
                      ++||||+++ +|..++.  .+++..+..++.|++.||+|||+.||+|+||||+||+++.+ +.+||+|||++....... 
T Consensus        85 ~lv~e~~~~-~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~-~~~kl~d~g~~~~~~~~~~  162 (337)
T cd07852          85 YLVFEYMET-DLHAVIRANILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSD-CRVKLADFGLARSLSELEE  162 (337)
T ss_pred             EEEeccccc-CHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCC-CcEEEeeccchhccccccc
Confidence            999999985 6766653  47888889999999999999999999999999999999988 799999999997654322 


Q ss_pred             -----cceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhc
Q 014406          275 -----EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY  349 (425)
Q Consensus       275 -----~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~  349 (425)
                           ......++..|+|||.+.+...++.++|||||||++|+|++|+.|| .+.+..+....+....+........ ..
T Consensus       163 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~-~~  240 (337)
T cd07852         163 NPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLF-PGTSTLNQLEKIIEVIGPPSAEDIE-SI  240 (337)
T ss_pred             cccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHhCCCCHHHHH-HH
Confidence                 1223467889999999876567889999999999999999999987 4556666777776666654322211 00


Q ss_pred             cCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccc
Q 014406          350 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA  418 (425)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~  418 (425)
                      .....   ...............  ......++.++.+|+.+||+.||++|||+.++++||||++....
T Consensus       241 ~~~~~---~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~~  304 (337)
T cd07852         241 KSPFA---ATMLDSLPSRPRKPL--DELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNP  304 (337)
T ss_pred             HhhhH---HHhhhhcccccccch--hhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhccC
Confidence            00000   000110000000000  11112268999999999999999999999999999999988554

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=4.3e-41  Score=312.48  Aligned_cols=247  Identities=27%  Similarity=0.456  Sum_probs=204.1

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEE
Q 014406          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (425)
Q Consensus       126 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (425)
                      +|++.+.||.|+||+||++.+..++..+|+|.+...     ..+.+.+|+++++.+ +|+||+++++++....+...+++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~   79 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILREL-KHPNIVRYYDRIIDRSNQTLYIV   79 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhc-CCCccceeeeeeecCCCCEEEEE
Confidence            588899999999999999999999999999998632     235678899999999 99999999998876666778999


Q ss_pred             EEeecCCChhhhc-------CCCCHHHHHHHHHHHHHHHHHHH-----HCCceeecCCCCceEecCCCCcEEEEeccccc
Q 014406          201 FEYVNSTDFKVLY-------PTLTDYDIRYYIYELLKALDYCH-----SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE  268 (425)
Q Consensus       201 ~e~~~~~~l~~~~-------~~l~~~~~~~i~~~i~~~L~~LH-----~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~  268 (425)
                      |||+++++|..++       ..+++..+..++.|++.||.|||     +.+++|+||+|+||+++.+ +.+||+|||++.
T Consensus        80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~-~~~kl~d~g~~~  158 (265)
T cd08217          80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDAN-NNVKLGDFGLAK  158 (265)
T ss_pred             ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecC-CCEEEecccccc
Confidence            9999999998776       34788999999999999999999     8999999999999999987 799999999998


Q ss_pred             cccCCCc-ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHh
Q 014406          269 FYHPGKE-YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLN  347 (425)
Q Consensus       269 ~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~  347 (425)
                      ....... .....++..|+|||.+.+ ..++.++|+||||+++++|++|..||... + .+.+.....   ...      
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~-~-~~~~~~~~~---~~~------  226 (265)
T cd08217         159 ILGHDSSFAKTYVGTPYYMSPEQLNH-MSYDEKSDIWSLGCLIYELCALSPPFTAR-N-QLQLASKIK---EGK------  226 (265)
T ss_pred             cccCCcccccccccCCCccChhhhcC-CCCCchhHHHHHHHHHHHHHHCCCcccCc-C-HHHHHHHHh---cCC------
Confidence            7654433 344578889999999977 66899999999999999999999998422 2 222111110   000      


Q ss_pred             hccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCC
Q 014406          348 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF  412 (425)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~  412 (425)
                                                .......++.++.+++.+||+.+|++|||+.++++|||+
T Consensus       227 --------------------------~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~  265 (265)
T cd08217         227 --------------------------FRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI  265 (265)
T ss_pred             --------------------------CCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence                                      001112367899999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=8.6e-41  Score=311.10  Aligned_cols=252  Identities=23%  Similarity=0.419  Sum_probs=204.1

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEE
Q 014406          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (425)
Q Consensus       125 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (425)
                      ++|++.+.||.|+||+||+|....++..+++|++...    ..+.+.+|+.+++.+ +|+|++++++.+...  ...+++
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~--~~~~iv   77 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQC-NHPNVVKYYTSFVVG--DELWLV   77 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhc-CCCCEEEEEEEEeeC--CEEEEE
Confidence            4789999999999999999998889999999998643    246788999999999 999999999998654  678899


Q ss_pred             EEeecCCChhhhcC------CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCC
Q 014406          201 FEYVNSTDFKVLYP------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (425)
Q Consensus       201 ~e~~~~~~l~~~~~------~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~  274 (425)
                      +||+.+++|..++.      .+++..+..++.|++.||+|||+.|++|+||+|+||+++++ +.++|+|||++.......
T Consensus        78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~-~~~~l~df~~~~~~~~~~  156 (267)
T cd06610          78 MPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGED-GSVKIADFGVSASLADGG  156 (267)
T ss_pred             EeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCC-CCEEEcccchHHHhccCc
Confidence            99999999988762      37889999999999999999999999999999999999988 789999999987665432


Q ss_pred             cc-----eeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhc
Q 014406          275 EY-----NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY  349 (425)
Q Consensus       275 ~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~  349 (425)
                      ..     ....++..|+|||.+.....++.++|+|||||++++|++|+.||... +....+.....   ...        
T Consensus       157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~-~~~~~~~~~~~---~~~--------  224 (267)
T cd06610         157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKY-PPMKVLMLTLQ---NDP--------  224 (267)
T ss_pred             cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCcccc-ChhhhHHHHhc---CCC--------
Confidence            22     23467888999999877447899999999999999999999998422 22222221111   000        


Q ss_pred             cCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCC
Q 014406          350 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF  412 (425)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~  412 (425)
                                          ..+........+++++.+|+.+||+.||++|||++++++||||
T Consensus       225 --------------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~  267 (267)
T cd06610         225 --------------------PSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF  267 (267)
T ss_pred             --------------------CCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence                                0000001123478899999999999999999999999999998

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=6.9e-41  Score=314.97  Aligned_cols=273  Identities=30%  Similarity=0.626  Sum_probs=208.7

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEE
Q 014406          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (425)
Q Consensus       126 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (425)
                      +|++.+.||.|++|+||+|.+..+++.||+|.++..    ..+.+.+|+.+++.+ +|+||+++++++.+.  ...++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~--~~~~lv~   77 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKEL-KHENIVRLHDVIHTE--NKLMLVF   77 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhh-cCCCEeeeeeeEeeC--CcEEEEE
Confidence            588999999999999999999999999999998743    245677899999999 899999999999764  6788999


Q ss_pred             EeecCCChhhhc------CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCC-C
Q 014406          202 EYVNSTDFKVLY------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-K  274 (425)
Q Consensus       202 e~~~~~~l~~~~------~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~-~  274 (425)
                      ||+.+ ++..++      ..+++..+..++.|++.||.|||+.|++|+||||+||+++.+ +.++|+|||++...... .
T Consensus        78 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~-~~~~l~d~g~~~~~~~~~~  155 (284)
T cd07836          78 EYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKR-GELKLADFGLARAFGIPVN  155 (284)
T ss_pred             ecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCC-CcEEEeecchhhhhcCCcc
Confidence            99996 555443      247899999999999999999999999999999999999987 78999999999755332 1


Q ss_pred             cceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCC
Q 014406          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD  354 (425)
Q Consensus       275 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~  354 (425)
                      ......++..|++||.+.+...++.++|||||||++|+|++|..|| .+.+..+....+.+..+.+....+. ... .. 
T Consensus       156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~-~~~-~~-  231 (284)
T cd07836         156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLF-PGTNNEDQLLKIFRIMGTPTESTWP-GIS-QL-  231 (284)
T ss_pred             ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCC-CCCCcHHHHHHHHHHhCCCChhhHH-HHh-cC-
Confidence            2233466888999999876556789999999999999999999887 4455666666666655544322211 000 00 


Q ss_pred             hhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCC
Q 014406          355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF  412 (425)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~  412 (425)
                      +.+.   ..........  .......++..+++++.+||+.||.+|||+.|+++||||
T Consensus       232 ~~~~---~~~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f  284 (284)
T cd07836         232 PEYK---PTFPRYPPQD--LQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF  284 (284)
T ss_pred             chhc---ccccCCChHH--HHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            0000   0000000000  000112357889999999999999999999999999998

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.8e-41  Score=311.53  Aligned_cols=250  Identities=27%  Similarity=0.493  Sum_probs=203.1

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc---chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEE
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (425)
                      .++|++.+.||.|+||.||+|.+..+++.+++|++...   ..+.+.+|+++++.+ +||||+++++++.+.  ..++++
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~--~~~~l~   78 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKEC-RHPNIVAYFGSYLRR--DKLWIV   78 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhC-CCCChhceEEEEEeC--CEEEEE
Confidence            46899999999999999999999999999999998744   346788999999999 999999999998654  678999


Q ss_pred             EEeecCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCC-c
Q 014406          201 FEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-E  275 (425)
Q Consensus       201 ~e~~~~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~-~  275 (425)
                      |||+++++|..++    ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.+ +.++|+|||++....... .
T Consensus        79 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~-~~~~l~d~g~~~~~~~~~~~  157 (262)
T cd06613          79 MEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTED-GDVKLADFGVSAQLTATIAK  157 (262)
T ss_pred             EeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCC-CCEEECccccchhhhhhhhc
Confidence            9999999998876    458999999999999999999999999999999999999988 789999999987654322 2


Q ss_pred             ceeeccCCCccCcccccCC--CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHH-hCCchhHHHHhhccCC
Q 014406          276 YNVRVASRYFKGPELLVDL--QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV-LGTDELNAYLNKYHLE  352 (425)
Q Consensus       276 ~~~~~~t~~y~aPE~~~~~--~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~-lg~~~~~~~~~~~~~~  352 (425)
                      .....++..|+|||.+.+.  ..++.++|+|||||++|+|++|..||.... ..+....+... +...            
T Consensus       158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~-~~~~~~~~~~~~~~~~------------  224 (262)
T cd06613         158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLH-PMRALFLISKSNFPPP------------  224 (262)
T ss_pred             cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhccCCCc------------
Confidence            2344678889999998762  268899999999999999999999985322 22222111110 0000            


Q ss_pred             CChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCC
Q 014406          353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY  411 (425)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~  411 (425)
                                           .......++.++.+|+++||+.||.+|||+.+++.|+|
T Consensus       225 ---------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~  262 (262)
T cd06613         225 ---------------------KLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF  262 (262)
T ss_pred             ---------------------cccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence                                 00001125678999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=4.2e-41  Score=316.04  Aligned_cols=248  Identities=24%  Similarity=0.416  Sum_probs=194.8

Q ss_pred             eeeeeCceEEEEEEEcCCCcEEEEEEecCcc------hHHHHHHHHHHHHh--cCCCCeeeEEeEEEcCCCCccEEEEEe
Q 014406          132 KVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNL--CGGPNVVKLLDIVRDQHSKTPSLIFEY  203 (425)
Q Consensus       132 ~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l--~~h~niv~l~~~~~~~~~~~~~lv~e~  203 (425)
                      .||+|+||.||++.+..+++.+|+|.+....      ...+.+|..+++.+  .+|+|++.+++++...  +..++||||
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~--~~~~lv~e~   78 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTP--DKLCFILDL   78 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecC--CeEEEEEec
Confidence            3899999999999999999999999986421      12234454444433  2789999999999654  678899999


Q ss_pred             ecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCcceeec
Q 014406          204 VNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRV  280 (425)
Q Consensus       204 ~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~~~~~~  280 (425)
                      +.+++|..++   ..+++..+..++.|++.||+|||+.+|+|+||||+|||++.+ +.++|+|||++...... ......
T Consensus        79 ~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~-~~~~l~dfg~~~~~~~~-~~~~~~  156 (279)
T cd05633          79 MNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEH-GHVRISDLGLACDFSKK-KPHASV  156 (279)
T ss_pred             CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCC-CCEEEccCCcceecccc-CccCcC
Confidence            9999998776   458999999999999999999999999999999999999988 78999999998755432 223356


Q ss_pred             cCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCC-HHHHHHHHHHhCCchhHHHHhhccCCCChhhHH
Q 014406          281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN-HDQLVKIAKVLGTDELNAYLNKYHLELDPQLDA  359 (425)
Q Consensus       281 ~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~-~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~  359 (425)
                      ++..|+|||.+.+...++.++||||+||++|+|++|..||...... ...+......                       
T Consensus       157 ~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~-----------------------  213 (279)
T cd05633         157 GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT-----------------------  213 (279)
T ss_pred             CCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhc-----------------------
Confidence            8899999999865456899999999999999999999998532221 1111111000                       


Q ss_pred             HhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCc-----CHHHHhcCCCCcccccch
Q 014406          360 LVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYFAQVRAAE  419 (425)
Q Consensus       360 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rp-----ta~elL~hp~~~~~~~~~  419 (425)
                                   ........++.++.+|+++||+.||++|+     |++|+++||||+++.+.+
T Consensus       214 -------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~~~  265 (279)
T cd05633         214 -------------VNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQQ  265 (279)
T ss_pred             -------------CCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCCHhH
Confidence                         00011223688999999999999999999     699999999999987654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.3e-41  Score=324.39  Aligned_cols=286  Identities=36%  Similarity=0.631  Sum_probs=222.2

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCC---CCcc
Q 014406          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH---SKTP  197 (425)
Q Consensus       126 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~---~~~~  197 (425)
                      +|++.+.||.|+||.||+|.+..+++.+|+|.+...     ..+.+.+|+.+++.+ +|+||+++++++....   ....
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~   79 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHL-RHENIIGLLDILRPPSPEDFNDV   79 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhc-CCcchhhhhhhhcccCcccccce
Confidence            588999999999999999999999999999998643     235788999999999 8999999999987542   2468


Q ss_pred             EEEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCC
Q 014406          198 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (425)
Q Consensus       198 ~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~  274 (425)
                      +++|||+++ ++..++   ..+++..+..++.|++.||+|||+.||+|+||||+|||++.+ +.++|+|||++.......
T Consensus        80 ~lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~-~~~~L~dfg~~~~~~~~~  157 (330)
T cd07834          80 YIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSN-CDLKICDFGLARGVDPDE  157 (330)
T ss_pred             EEEecchhh-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC-CCEEEcccCceEeecccc
Confidence            999999985 565554   258899999999999999999999999999999999999998 899999999998765442


Q ss_pred             ----cceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhcc
Q 014406          275 ----EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH  350 (425)
Q Consensus       275 ----~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~  350 (425)
                          ......++..|+|||.+.+...++.++|+||||+++|+|++|..|| .+.+..+.+..+...+|.+....+.. ..
T Consensus       158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~-~~  235 (330)
T cd07834         158 DEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLF-PGRDYIDQLNLIVEVLGTPSEEDLKF-IT  235 (330)
T ss_pred             cccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCc-CCCCHHHHHHHHHHhcCCCChhHhhh-cc
Confidence                2334567888999999988447899999999999999999999887 55556677777777777655433221 11


Q ss_pred             CCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccchhc
Q 014406          351 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAESS  421 (425)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~~~~  421 (425)
                      .......-..........+..     ....++.++.+|+++||++||++|||++++++||||+++...+..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~~~  301 (330)
T cd07834         236 SEKARNYLKSLPKKPKKPLSK-----LFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPEDE  301 (330)
T ss_pred             ccchhhHHhhcccCCcchhHH-----hcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcccccC
Confidence            100000000001111111111     112268899999999999999999999999999999998776543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.8e-41  Score=318.20  Aligned_cols=256  Identities=23%  Similarity=0.408  Sum_probs=205.2

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEE
Q 014406          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (425)
Q Consensus       125 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (425)
                      ++|++++.||+|+||+||++.+..++..+|+|.+...    ....+.+|+.+++++ +|+||+++++.+..  ....++|
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~--~~~~~lv   77 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKA-VSPYIVDFYGAFFI--EGAVYMC   77 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhc-CCCcHHhhhhheec--CCeEEEE
Confidence            4688899999999999999999999999999988642    235688999999999 99999999999865  3678999


Q ss_pred             EEeecCCChhhhcC------CCCHHHHHHHHHHHHHHHHHHHH-CCceeecCCCCceEecCCCCcEEEEeccccccccCC
Q 014406          201 FEYVNSTDFKVLYP------TLTDYDIRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (425)
Q Consensus       201 ~e~~~~~~l~~~~~------~l~~~~~~~i~~~i~~~L~~LH~-~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~  273 (425)
                      |||+++++|..++.      .+++..+..++.|++.||.|||+ .+|+|+||||+||+++.+ +.++|+|||++......
T Consensus        78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~  156 (286)
T cd06622          78 MEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGN-GQVKLCDFGVSGNLVAS  156 (286)
T ss_pred             EeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCC-CCEEEeecCCcccccCC
Confidence            99999999987762      58899999999999999999997 599999999999999987 78999999998765322


Q ss_pred             CcceeeccCCCccCcccccCC-----CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhh
Q 014406          274 KEYNVRVASRYFKGPELLVDL-----QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK  348 (425)
Q Consensus       274 ~~~~~~~~t~~y~aPE~~~~~-----~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~  348 (425)
                       ......++..|+|||.+.+.     ..++.++|+|||||++|+|++|+.||.... .......+.......        
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~--------  226 (286)
T cd06622         157 -LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPET-YANIFAQLSAIVDGD--------  226 (286)
T ss_pred             -ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcc-hhhHHHHHHHHhhcC--------
Confidence             23345678889999998542     235789999999999999999999984322 111122111111000        


Q ss_pred             ccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccch
Q 014406          349 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE  419 (425)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~~  419 (425)
                                               .......+++++.+|+.+||+.+|++||+++++++||||...+...
T Consensus       227 -------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~~~  272 (286)
T cd06622         227 -------------------------PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNAD  272 (286)
T ss_pred             -------------------------CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhccCCc
Confidence                                     0001122688999999999999999999999999999998876553

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.9e-41  Score=313.98  Aligned_cols=254  Identities=24%  Similarity=0.408  Sum_probs=204.4

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc--hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCC----CCc
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--KKKIKREIKILQNLCGGPNVVKLLDIVRDQH----SKT  196 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~----~~~  196 (425)
                      ..++|++.+.||+|+||+||+|.+..+++.+++|++....  .+.+.+|+.+++++.+|+||+++++++....    +..
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~   83 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQ   83 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceE
Confidence            4688999999999999999999999899999999987543  4678899999999867999999999997543    456


Q ss_pred             cEEEEEeecCCChhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEecccccc
Q 014406          197 PSLIFEYVNSTDFKVLY-------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (425)
Q Consensus       197 ~~lv~e~~~~~~l~~~~-------~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~  269 (425)
                      .++||||+++++|.+++       ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.+ +.++|+|||++..
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~-~~~~l~d~~~~~~  162 (275)
T cd06608          84 LWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKN-AEVKLVDFGVSAQ  162 (275)
T ss_pred             EEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccC-CeEEECCCcccee
Confidence            89999999999988765       247899999999999999999999999999999999999988 7899999999876


Q ss_pred             ccCCC-cceeeccCCCccCcccccCC----CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHH
Q 014406          270 YHPGK-EYNVRVASRYFKGPELLVDL----QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA  344 (425)
Q Consensus       270 ~~~~~-~~~~~~~t~~y~aPE~~~~~----~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~  344 (425)
                      ..... ......++..|+|||++...    ..++.++|||||||++++|++|..||.. .+....+..+....       
T Consensus       163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~-~~~~~~~~~~~~~~-------  234 (275)
T cd06608         163 LDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCD-MHPMRALFKIPRNP-------  234 (275)
T ss_pred             cccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccc-cchHHHHHHhhccC-------
Confidence            54322 22345678899999987531    3477899999999999999999999842 22222222111100       


Q ss_pred             HHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCC
Q 014406          345 YLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF  412 (425)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~  412 (425)
                                              ..   .......+++++++|+.+||+.||++|||+.|+++|||+
T Consensus       235 ------------------------~~---~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~  275 (275)
T cd06608         235 ------------------------PP---TLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI  275 (275)
T ss_pred             ------------------------CC---CCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence                                    00   000111257899999999999999999999999999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=7.3e-41  Score=318.87  Aligned_cols=280  Identities=33%  Similarity=0.570  Sum_probs=209.4

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc-----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCC----
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQH----  193 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~----  193 (425)
                      ..++|++.+.||.|+||.||+|.+..+++.+|+|.+....     ...+.+|+++++.+ +|+||+++++++.+..    
T Consensus         6 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~   84 (311)
T cd07866           6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKL-KHPNVVPLIDMAVERPDKSK   84 (311)
T ss_pred             ccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhc-CCCCccchhhheeccccccc
Confidence            3689999999999999999999999999999999885322     24577899999999 8999999999876533    


Q ss_pred             --CCccEEEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccc
Q 014406          194 --SKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE  268 (425)
Q Consensus       194 --~~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~  268 (425)
                        ...+++|+||+.+..+..+.   ..+++..+..++.|++.||.|||+.||+|+||||+||+++.+ +.++|+|||++.
T Consensus        85 ~~~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~-~~~~l~dfg~~~  163 (311)
T cd07866          85 RKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQ-GILKIADFGLAR  163 (311)
T ss_pred             ccCceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC-CCEEECcCccch
Confidence              23578999999875444333   358999999999999999999999999999999999999998 789999999997


Q ss_pred             cccCCCc------------ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHH
Q 014406          269 FYHPGKE------------YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV  336 (425)
Q Consensus       269 ~~~~~~~------------~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~  336 (425)
                      .......            .....++..|+|||.+.+...++.++|||||||++|+|++|+.|| .+.+.......+...
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~-~~~~~~~~~~~~~~~  242 (311)
T cd07866         164 PYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPIL-QGKSDIDQLHLIFKL  242 (311)
T ss_pred             hccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHH
Confidence            6543221            122355778999999876556899999999999999999999877 455556666666665


Q ss_pred             hCCchhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCC
Q 014406          337 LGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF  412 (425)
Q Consensus       337 lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~  412 (425)
                      .+......+...........      ........... ......+++.+.+|+.+||+.||++|||+.|+++||||
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f  311 (311)
T cd07866         243 CGTPTEETWPGWRSLPGCEG------VHSFTNYPRTL-EERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF  311 (311)
T ss_pred             hCCCChhhchhhhhcccccc------cccCCCCCccH-HHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence            55443222211100000000      00000000000 00112356789999999999999999999999999998

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.8e-42  Score=324.29  Aligned_cols=254  Identities=25%  Similarity=0.468  Sum_probs=194.6

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEec-----CcchHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCcc
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-----PVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~-----~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (425)
                      ....|+++++||+||.+.||++... +...+|+|.+.     ......+.+|+..|.+|.+|.+|+++++|-..  +..+
T Consensus       359 kg~~Yeilk~iG~GGSSkV~kV~~s-~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~--d~~l  435 (677)
T KOG0596|consen  359 KGREYEILKQIGSGGSSKVFKVLNS-DKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVT--DGYL  435 (677)
T ss_pred             CcchhhHHHhhcCCCcceeeeeecC-CCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeecc--CceE
Confidence            4567999999999999999999654 34455555442     33456799999999999999999999999866  4789


Q ss_pred             EEEEEeecCCChhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCC
Q 014406          198 SLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (425)
Q Consensus       198 ~lv~e~~~~~~l~~~~~----~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~  273 (425)
                      |+||||-+ .+|..++.    ..+...++.+..|++.|+.+.|+.||||.||||.|+|+-.  |.+||+|||.|..+...
T Consensus       436 YmvmE~Gd-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVk--G~LKLIDFGIA~aI~~D  512 (677)
T KOG0596|consen  436 YMVMECGD-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVK--GRLKLIDFGIANAIQPD  512 (677)
T ss_pred             EEEeeccc-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEe--eeEEeeeechhcccCcc
Confidence            99999854 46666663    2555688999999999999999999999999999999986  58999999999988755


Q ss_pred             Ccc---eeeccCCCccCcccccCCC----------CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCc
Q 014406          274 KEY---NVRVASRYFKGPELLVDLQ----------DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTD  340 (425)
Q Consensus       274 ~~~---~~~~~t~~y~aPE~~~~~~----------~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~  340 (425)
                      ...   ...+||..||+||.+....          +.+.++||||+||+||+|+.|+.||.   +-...++++.....+.
T Consensus       513 TTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~---~~~n~~aKl~aI~~P~  589 (677)
T KOG0596|consen  513 TTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFG---QIINQIAKLHAITDPN  589 (677)
T ss_pred             ccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchH---HHHHHHHHHHhhcCCC
Confidence            432   4579999999999986411          24579999999999999999999992   1111223332222111


Q ss_pred             hhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccc
Q 014406          341 ELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR  416 (425)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~  416 (425)
                      ...+                           +.    ...-..++.++++.||.+||++|||+.+||+|||++...
T Consensus       590 ~~Ie---------------------------fp----~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~~  634 (677)
T KOG0596|consen  590 HEIE---------------------------FP----DIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQP  634 (677)
T ss_pred             cccc---------------------------cc----CCCCchHHHHHHHHHHhcCcccCCCcHHHhcCccccccc
Confidence            1000                           00    000123489999999999999999999999999999744

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=8.5e-41  Score=311.87  Aligned_cols=250  Identities=23%  Similarity=0.399  Sum_probs=197.3

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc---hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEE
Q 014406          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (425)
Q Consensus       125 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (425)
                      +.+.....||+|+||.||+|.+..++..|++|.+....   .+.+.+|+.+++.+ +|+||+++++++...  ...++|+
T Consensus         8 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~--~~~~lv~   84 (268)
T cd06624           8 DENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYL-KHRNIVQYLGSDSEN--GFFKIFM   84 (268)
T ss_pred             ccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhc-CCCCeeeeeeeeccC--CEEEEEE
Confidence            33434468999999999999999999999999987543   35688999999999 999999999999654  6789999


Q ss_pred             EeecCCChhhhcC----CC--CHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCc
Q 014406          202 EYVNSTDFKVLYP----TL--TDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (425)
Q Consensus       202 e~~~~~~l~~~~~----~l--~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~  275 (425)
                      ||+.+++|..++.    .+  ++..+..++.|++.||+|||+.||+|+||||+||+++.+.+.++|+|||++........
T Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~  164 (268)
T cd06624          85 EQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP  164 (268)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCC
Confidence            9999999988763    24  77888889999999999999999999999999999987547899999999876543222


Q ss_pred             -ceeeccCCCccCcccccCC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCC
Q 014406          276 -YNVRVASRYFKGPELLVDL-QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL  353 (425)
Q Consensus       276 -~~~~~~t~~y~aPE~~~~~-~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~  353 (425)
                       .....++..|+|||.+.+. ..++.++||||||+++|+|++|+.||............. ...+               
T Consensus       165 ~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~-~~~~---------------  228 (268)
T cd06624         165 CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKV-GMFK---------------  228 (268)
T ss_pred             ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhh-hhhc---------------
Confidence             2234578899999998652 247899999999999999999999984322211111000 0000               


Q ss_pred             ChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCC
Q 014406          354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF  412 (425)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~  412 (425)
                                         .....+..+++++++|+++||+.+|++|||+.|+++||||
T Consensus       229 -------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  268 (268)
T cd06624         229 -------------------IHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL  268 (268)
T ss_pred             -------------------cCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence                               0001122368899999999999999999999999999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2e-40  Score=320.81  Aligned_cols=287  Identities=30%  Similarity=0.561  Sum_probs=215.8

Q ss_pred             cCCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc-----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCC--
Q 014406          121 WGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQH--  193 (425)
Q Consensus       121 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~--  193 (425)
                      +...++|++.+.||+|+||.||+|.+..+++.||+|.+....     .+.+.+|+.+++++ +|+||+++++++....  
T Consensus        13 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~~iv~~~~~~~~~~~~   91 (345)
T cd07877          13 WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLDVFTPARSL   91 (345)
T ss_pred             hhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHc-CCCcccceeeeeeecccc
Confidence            445789999999999999999999999999999999986432     35677899999999 9999999999886432  


Q ss_pred             --CCccEEEEEeecCCChhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEecccccc
Q 014406          194 --SKTPSLIFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (425)
Q Consensus       194 --~~~~~lv~e~~~~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~  269 (425)
                        ....+++++++ +++|..++  ..+++..++.++.|++.||.|||+.||+|+||||+||+++.+ +.++|+|||++..
T Consensus        92 ~~~~~~~lv~~~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~-~~~kl~dfg~~~~  169 (345)
T cd07877          92 EEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED-CELKILDFGLARH  169 (345)
T ss_pred             cccccEEEEehhc-ccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCC-CCEEEeccccccc
Confidence              23467888876 56777665  358999999999999999999999999999999999999988 7899999999876


Q ss_pred             ccCCCcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhc
Q 014406          270 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY  349 (425)
Q Consensus       270 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~  349 (425)
                      ...  ......++..|+|||.+.+...++.++|||||||++|+|++|+.|| ...+....+..+.+..+....... ...
T Consensus       170 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~-~~~  245 (345)
T cd07877         170 TDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF-PGTDHIDQLKLILRLVGTPGAELL-KKI  245 (345)
T ss_pred             ccc--cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCCHHHH-hhc
Confidence            432  2334567888999999876567889999999999999999999987 444555556666665554332221 111


Q ss_pred             cCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccch
Q 014406          350 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE  419 (425)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~~  419 (425)
                      .......+.............     ......++++++||.+||+.||++|||+.++++||||++....+
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~~  310 (345)
T cd07877         246 SSESARNYIQSLTQMPKMNFA-----NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD  310 (345)
T ss_pred             ccHhHHHHHHHhcccCCcchh-----hhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCCC
Confidence            100000000000000000000     01112578899999999999999999999999999999765544

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=9.3e-41  Score=310.46  Aligned_cols=246  Identities=25%  Similarity=0.480  Sum_probs=201.9

Q ss_pred             eeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEEEeecC
Q 014406          133 VGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNS  206 (425)
Q Consensus       133 LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~  206 (425)
                      ||.|+||+||+|.+..+++.+|+|++...      ..+.+.+|+.+++.+ +|+||+++++.+.+.  ...++++||+++
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~lv~e~~~~   77 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEEC-NHPFIVKLYRTFKDK--KYIYMLMEYCLG   77 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhC-CCCCEeeeeeeEEcC--CccEEEEecCCC
Confidence            69999999999999999999999998642      235688999999999 999999999998654  678999999999


Q ss_pred             CChhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCcceeeccCC
Q 014406          207 TDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASR  283 (425)
Q Consensus       207 ~~l~~~~~---~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~  283 (425)
                      ++|.+++.   .+++..+..++.|++.||.|||+++++|+||+|+||+++.+ +.++|+|||++.............++.
T Consensus        78 ~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~-~~~~l~df~~~~~~~~~~~~~~~~~~~  156 (262)
T cd05572          78 GELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSN-GYVKLVDFGFAKKLKSGQKTWTFCGTP  156 (262)
T ss_pred             CcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCC-CCEEEeeCCcccccCcccccccccCCc
Confidence            99998863   47899999999999999999999999999999999999988 789999999998765443334456788


Q ss_pred             CccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHH-HHHHHHHHhCCchhHHHHhhccCCCChhhHHHhc
Q 014406          284 YFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHD-QLVKIAKVLGTDELNAYLNKYHLELDPQLDALVG  362 (425)
Q Consensus       284 ~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~-~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~  362 (425)
                      .|++||.+.+ ..++.++|+||+|+++|+|++|..||.....+.. ....+..  +..                      
T Consensus       157 ~~~~PE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~----------------------  211 (262)
T cd05572         157 EYVAPEIILN-KGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILK--GNG----------------------  211 (262)
T ss_pred             CccChhHhcC-CCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhc--cCC----------------------
Confidence            9999999876 6789999999999999999999999854432221 1111110  000                      


Q ss_pred             ccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcC-----HHHHhcCCCCcccccc
Q 014406          363 RHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT-----AREAMAHPYFAQVRAA  418 (425)
Q Consensus       363 ~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpt-----a~elL~hp~~~~~~~~  418 (425)
                                 ....+...++++.+|+.+||+.||++|+|     ++|+++||||++..+.
T Consensus       212 -----------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~  261 (262)
T cd05572         212 -----------KLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFDWE  261 (262)
T ss_pred             -----------CCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCCCCC
Confidence                       00011224789999999999999999999     9999999999987653

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=1.2e-41  Score=316.76  Aligned_cols=253  Identities=23%  Similarity=0.414  Sum_probs=205.2

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEE
Q 014406          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (425)
Q Consensus       125 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (425)
                      ++|+..+.||.|+||.||++.+..+++.+++|.+...    ..+++.+|+++++++ +|+||+++++.+...  ...+++
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~--~~~~lv   77 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKC-NSPYIVGFYGAFYNN--GDISIC   77 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHC-CCCchhhhheeeecC--CEEEEE
Confidence            4677888999999999999999999999999998653    235688999999999 799999999999654  778999


Q ss_pred             EEeecCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHH-CCceeecCCCCceEecCCCCcEEEEeccccccccCCCc
Q 014406          201 FEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (425)
Q Consensus       201 ~e~~~~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~LH~-~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~  275 (425)
                      +||+++++|..++    ..+++..+..++.|++.||+|||+ .|++|+||||+||+++.+ +.++|+|||.+........
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~-~~~~l~d~g~~~~~~~~~~  156 (265)
T cd06605          78 MEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSR-GQIKLCDFGVSGQLVNSLA  156 (265)
T ss_pred             EEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCC-CCEEEeecccchhhHHHHh
Confidence            9999999998877    457889999999999999999999 999999999999999997 7899999999876543222


Q ss_pred             ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHH-HhCCchhHHHHhhccCCCC
Q 014406          276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK-VLGTDELNAYLNKYHLELD  354 (425)
Q Consensus       276 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~-~lg~~~~~~~~~~~~~~~~  354 (425)
                      . ...++..|+|||.+.+ ..++.++||||||+++++|++|..||.......+......+ ......             
T Consensus       157 ~-~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-------------  221 (265)
T cd06605         157 K-TFVGTSSYMAPERIQG-NDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPP-------------  221 (265)
T ss_pred             h-cccCChhccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCC-------------
Confidence            2 2677888999999977 68899999999999999999999998544322221111111 110000             


Q ss_pred             hhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCccc
Q 014406          355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV  415 (425)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~  415 (425)
                                     ..    .....++.++++||.+||..||++|||+.|++.||||++-
T Consensus       222 ---------------~~----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~  263 (265)
T cd06605         222 ---------------PR----LPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKY  263 (265)
T ss_pred             ---------------CC----CChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence                           00    0001168889999999999999999999999999999764

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.1e-40  Score=322.37  Aligned_cols=287  Identities=33%  Similarity=0.615  Sum_probs=215.9

Q ss_pred             cCCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCC-
Q 014406          121 WGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS-  194 (425)
Q Consensus       121 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~-  194 (425)
                      +...++|++.+.||+|+||+||+|.+..++..||+|.+...     ....+.+|+.+++.+ +|+||+++++++..... 
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~   89 (343)
T cd07880          11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-KHENVIGLLDVFTPDLSL   89 (343)
T ss_pred             hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhc-CCCCccceeeeecCCccc
Confidence            34578899999999999999999999999999999998532     124577899999999 99999999999864321 


Q ss_pred             ---CccEEEEEeecCCChhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEecccccc
Q 014406          195 ---KTPSLIFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (425)
Q Consensus       195 ---~~~~lv~e~~~~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~  269 (425)
                         ...++||||+ ++++..++  ..+++..++.++.|++.||+|||+.||+|+||||+||+++.+ +.++|+|||++..
T Consensus        90 ~~~~~~~lv~e~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~-~~~kl~dfg~~~~  167 (343)
T cd07880          90 DRFHDFYLVMPFM-GTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNED-CELKILDFGLARQ  167 (343)
T ss_pred             cccceEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC-CCEEEeecccccc
Confidence               2458999998 56777665  468999999999999999999999999999999999999987 7899999999976


Q ss_pred             ccCCCcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhc
Q 014406          270 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY  349 (425)
Q Consensus       270 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~  349 (425)
                      ...  ......++..|+|||.+.+...++.++|+|||||++|++++|..||. +.+.......+.+..+..... +....
T Consensus       168 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~-~~~~~~~~~~~~~~~~~~~~~-~~~~~  243 (343)
T cd07880         168 TDS--EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFK-GHDHLDQLMEIMKVTGTPSKE-FVQKL  243 (343)
T ss_pred             ccc--CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHHhcCCCCHH-HHHhh
Confidence            532  22334668889999998764568899999999999999999999984 444445555555544433221 11111


Q ss_pred             cCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccch
Q 014406          350 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE  419 (425)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~~  419 (425)
                      ...................   +  ......++.++.+++.+||+.||++|||+.++++||||+..+..+
T Consensus       244 ~~~~~~~~~~~~~~~~~~~---~--~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~~  308 (343)
T cd07880         244 QSEDAKNYVKKLPRFRKKD---F--RSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPE  308 (343)
T ss_pred             cchhHHHHHHhccccCcch---H--HHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCcc
Confidence            1110000000000000000   0  011234688899999999999999999999999999999876543

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-42  Score=335.13  Aligned_cols=247  Identities=22%  Similarity=0.405  Sum_probs=203.3

Q ss_pred             eeeeeCceEEEEEEEcCCCcEEEEEEecCcc---hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEEEeecCCC
Q 014406          132 KVGRGKYSEVFEGINVNTNERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTD  208 (425)
Q Consensus       132 ~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~  208 (425)
                      .||+|.||+||-|+|..+...+|||-+....   .+-+..||...++| .|.|||+++|.|.  .++++-+.||-++||+
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~L-rHkNIVrYLGs~s--enGf~kIFMEqVPGGS  658 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTL-RHKNIVRYLGSVS--ENGFFKIFMEQVPGGS  658 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHH-hhHhHHHHhhccC--CCCeEEEEeecCCCCc
Confidence            5999999999999999999999999987433   35578999999999 8999999999984  4578889999999999


Q ss_pred             hhhhcC----CC--CHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCc-ceeecc
Q 014406          209 FKVLYP----TL--TDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-YNVRVA  281 (425)
Q Consensus       209 l~~~~~----~l--~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~  281 (425)
                      |..+++    ++  ++..+..+.+||+.||.|||++.|||||||-+|+|++.-.|.+||+|||-++....-.. +.+..|
T Consensus       659 LSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFTG  738 (1226)
T KOG4279|consen  659 LSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFTG  738 (1226)
T ss_pred             HHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCcccccccc
Confidence            998874    35  78889999999999999999999999999999999998889999999999887754433 356789


Q ss_pred             CCCccCccccc-CCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCChhhHHH
Q 014406          282 SRYFKGPELLV-DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDAL  360 (425)
Q Consensus       282 t~~y~aPE~~~-~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~  360 (425)
                      |..|||||++. +...|+.++|||||||++.||.||+.||..-              |.+...++- -+....       
T Consensus       739 TLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~El--------------gspqAAMFk-VGmyKv-------  796 (1226)
T KOG4279|consen  739 TLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVEL--------------GSPQAAMFK-VGMYKV-------  796 (1226)
T ss_pred             chhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeec--------------CChhHhhhh-hcceec-------
Confidence            99999999994 3456999999999999999999999999432              222111110 000000       


Q ss_pred             hcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccc
Q 014406          361 VGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR  416 (425)
Q Consensus       361 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~  416 (425)
                                   -++.+..++.+++.||.+|+.+||.+||+|.++|++||++.-+
T Consensus       797 -------------HP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~~  839 (1226)
T KOG4279|consen  797 -------------HPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHNN  839 (1226)
T ss_pred             -------------CCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccCC
Confidence                         0112233688999999999999999999999999999998663

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.5e-41  Score=324.57  Aligned_cols=285  Identities=32%  Similarity=0.598  Sum_probs=217.3

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCC---
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS---  194 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~---  194 (425)
                      ..++|++.+.||+|+||+||+|.+..+++.||+|++...     ..+.+.+|+.+++.+ +|+|++++++++.....   
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHM-DHENVIGLLDVFTPASSLED   91 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhc-cCCCHHHHHHHhhccccccc
Confidence            467899999999999999999999999999999998642     235577899999999 99999999998754322   


Q ss_pred             -CccEEEEEeecCCChhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEecccccccc
Q 014406          195 -KTPSLIFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (425)
Q Consensus       195 -~~~~lv~e~~~~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~  271 (425)
                       ...++|+||++ ++|..++  ..+++..+..++.|++.||.|||+.||+|+||||+||+++.+ +.++|+|||++....
T Consensus        92 ~~~~~lv~e~~~-~~L~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~-~~~kL~dfg~~~~~~  169 (343)
T cd07851          92 FQDVYLVTHLMG-ADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNED-CELKILDFGLARHTD  169 (343)
T ss_pred             cccEEEEEecCC-CCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCC-CCEEEcccccccccc
Confidence             35889999984 5777665  358999999999999999999999999999999999999988 789999999997654


Q ss_pred             CCCcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccC
Q 014406          272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL  351 (425)
Q Consensus       272 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~  351 (425)
                      ..  .....++..|+|||.+.+...++.++|||||||++|+|++|+.||. +.+..+.+..+.+..+.+.... ..+...
T Consensus       170 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~-~~~~~~~~~~i~~~~~~~~~~~-~~~~~~  245 (343)
T cd07851         170 DE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFP-GSDHIDQLKRIMNLVGTPDEEL-LQKISS  245 (343)
T ss_pred             cc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCC-CCChHHHHHHHHHhcCCCCHHH-Hhhccc
Confidence            32  3344678889999998764568899999999999999999999884 4455666666666666544221 111111


Q ss_pred             CCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccch
Q 014406          352 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE  419 (425)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~~  419 (425)
                         .................+  ......+++++.+|+++||+.||++|||+.|+++||||++....+
T Consensus       246 ---~~~~~~~~~~~~~~~~~~--~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~~  308 (343)
T cd07851         246 ---ESARNYIQSLPQMPKKDF--KEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPE  308 (343)
T ss_pred             ---hhHHHHHHhccccCCCCH--HHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCCc
Confidence               111111111111000000  011123588999999999999999999999999999999876554

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=2.3e-41  Score=313.85  Aligned_cols=247  Identities=27%  Similarity=0.470  Sum_probs=205.1

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEE
Q 014406          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (425)
Q Consensus       126 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (425)
                      +|++.+.||.|+||.||+|.+..+++.+|+|++...      ..+.+.+|+++++++ +||||+++++.+.+  +...++
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~l   77 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQEL-NHPFLVNLWYSFQD--EENMYL   77 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhC-CCCChHHHHHhhcC--CCeEEE
Confidence            588999999999999999999999999999998642      246788999999999 99999999999954  477899


Q ss_pred             EEEeecCCChhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCcc
Q 014406          200 IFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY  276 (425)
Q Consensus       200 v~e~~~~~~l~~~~~---~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~~  276 (425)
                      |+||+.+++|..++.   .+++..+..++.|++.||.|||+++++|+||+|+||+++.+ +.++|+|||++.........
T Consensus        78 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~-~~~~l~d~~~~~~~~~~~~~  156 (258)
T cd05578          78 VVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQ-GHVHITDFNIATKVTPDTLT  156 (258)
T ss_pred             EEeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCC-CCEEEeecccccccCCCccc
Confidence            999999999988763   58899999999999999999999999999999999999988 78999999999876554444


Q ss_pred             eeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCChh
Q 014406          277 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ  356 (425)
Q Consensus       277 ~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~  356 (425)
                      ....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||......  ....+......                 
T Consensus       157 ~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~-----------------  216 (258)
T cd05578         157 TSTSGTPGYMAPEVLCR-QGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT--IRDQIRAKQET-----------------  216 (258)
T ss_pred             cccCCChhhcCHHHHcc-cCCCCcccchhhHHHHHHHHhCCCCCCCCCcc--HHHHHHHHhcc-----------------
Confidence            55677888999999877 66899999999999999999999998543321  11111111000                 


Q ss_pred             hHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCH--HHHhcCCCC
Q 014406          357 LDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA--REAMAHPYF  412 (425)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta--~elL~hp~~  412 (425)
                                      ........++.++.++|++||+.||.+||++  +|+++||||
T Consensus       217 ----------------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~  258 (258)
T cd05578         217 ----------------ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF  258 (258)
T ss_pred             ----------------ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence                            0001112267899999999999999999999  999999998

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-42  Score=332.20  Aligned_cols=245  Identities=29%  Similarity=0.421  Sum_probs=206.3

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcchHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEEE
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE  202 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e  202 (425)
                      +.+.|++...+|.|+||.|-.+.+..+++..++|++... ..+..+|+.++....+|+||+++.+.+.+  +.+.++|||
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~-~~~~~~e~~~~~~~~~h~niv~~~~v~~~--~~~~~~v~e  396 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR-ADDNQDEIPISLLVRDHPNIVKSHDVYED--GKEIYLVME  396 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheecccc-ccccccccchhhhhcCCCcceeecceecC--Cceeeeeeh
Confidence            467899999999999999999999999999999999865 44566788888888899999999999955  588999999


Q ss_pred             eecCCChhhhcCC--CCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCcceeec
Q 014406          203 YVNSTDFKVLYPT--LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRV  280 (425)
Q Consensus       203 ~~~~~~l~~~~~~--l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~~~~~~  280 (425)
                      .+.++.+.+.+..  ....++..|+.+|+.++.|||++|+|||||||+|||++.+.++++|+|||.++.....  ..+.+
T Consensus       397 ~l~g~ell~ri~~~~~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~--~~tp~  474 (612)
T KOG0603|consen  397 LLDGGELLRRIRSKPEFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS--CDTPA  474 (612)
T ss_pred             hccccHHHHHHHhcchhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh--hcccc
Confidence            9999987666533  2225777899999999999999999999999999999533388999999999876544  55567


Q ss_pred             cCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCChhhHHH
Q 014406          281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDAL  360 (425)
Q Consensus       281 ~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~  360 (425)
                      .|..|.|||++.. ..|+.++|+||||++||+||+|+.||....+.    .++...++.+.+.                 
T Consensus       475 ~t~~y~APEvl~~-~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~----~ei~~~i~~~~~s-----------------  532 (612)
T KOG0603|consen  475 LTLQYVAPEVLAI-QEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG----IEIHTRIQMPKFS-----------------  532 (612)
T ss_pred             hhhcccChhhhcc-CCCCcchhhHHHHHHHHHHHhCCCccccCCch----HHHHHhhcCCccc-----------------
Confidence            8889999999985 88999999999999999999999999554444    2222333333222                 


Q ss_pred             hcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCC
Q 014406          361 VGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF  412 (425)
Q Consensus       361 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~  412 (425)
                                        ..+|+++++|+++||+.||.+|+|+.+++.||||
T Consensus       533 ------------------~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  533 ------------------ECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF  566 (612)
T ss_pred             ------------------cccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence                              2379999999999999999999999999999999

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-42  Score=300.16  Aligned_cols=261  Identities=21%  Similarity=0.357  Sum_probs=213.8

Q ss_pred             CCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCcc
Q 014406          122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (425)
Q Consensus       122 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (425)
                      .+.++.+.+..||.|+.|+||+++.+.+|...|||.+...    ..+++...+.++..-.+.|+||+.+|+|...  ..+
T Consensus        89 ~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n--~dV  166 (391)
T KOG0983|consen   89 ADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITN--TDV  166 (391)
T ss_pred             cChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeC--chH
Confidence            3456677788999999999999999999999999998643    2355667777776654689999999999754  456


Q ss_pred             EEEEEeecCC---ChhhhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeecCCCCceEecCCCCcEEEEeccccccccCC
Q 014406          198 SLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (425)
Q Consensus       198 ~lv~e~~~~~---~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~  273 (425)
                      ++-||.|...   .|....+.+++..+-++...+.+||.||-+ ++|+|||+||+|||+|.. |.+|+||||.+-.+-++
T Consensus       167 ~IcMelMs~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~-GniKlCDFGIsGrlvdS  245 (391)
T KOG0983|consen  167 FICMELMSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDER-GNIKLCDFGISGRLVDS  245 (391)
T ss_pred             HHHHHHHHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccC-CCEEeecccccceeecc
Confidence            6778887543   444555779999999999999999999986 589999999999999988 89999999999888777


Q ss_pred             CcceeeccCCCccCcccccC--CCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccC
Q 014406          274 KEYNVRVASRYFKGPELLVD--LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL  351 (425)
Q Consensus       274 ~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~  351 (425)
                      ...+...|-+.|||||-+.-  ...|+.++||||||++++||.||..||.....+.+.+..+....- +-          
T Consensus       246 kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~eP-P~----------  314 (391)
T KOG0983|consen  246 KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEP-PL----------  314 (391)
T ss_pred             cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCC-CC----------
Confidence            77888899999999999853  246899999999999999999999999777777777776654211 00          


Q ss_pred             CCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccch
Q 014406          352 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE  419 (425)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~~  419 (425)
                                           +.  ....+|+++++|+..||++|+.+||...++|+|||+..-..++
T Consensus       315 ---------------------L~--~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye~a~  359 (391)
T KOG0983|consen  315 ---------------------LP--GHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYETAE  359 (391)
T ss_pred             ---------------------CC--cccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecchhh
Confidence                                 00  0112799999999999999999999999999999988765544

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=4.9e-41  Score=316.17  Aligned_cols=236  Identities=18%  Similarity=0.210  Sum_probs=190.5

Q ss_pred             eeeeeeCceEEEEEEEcCCCcEEEEEEecCcc------hHHHHHHHHHHHHhcCCCCeeeEEeEEEc--CCCCccEEEEE
Q 014406          131 RKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRD--QHSKTPSLIFE  202 (425)
Q Consensus       131 ~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~--~~~~~~~lv~e  202 (425)
                      ..||+|++|.||+|..  +|+.||||.++...      .+.+.+|+.+|+++ +||||+++++++.+  +.....++|||
T Consensus        26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~g~~~~~~~~~~~~~lv~E  102 (283)
T PHA02988         26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRI-DSNNILKIYGFIIDIVDDLPRLSLILE  102 (283)
T ss_pred             eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhc-CCCCEEEEeeeEEecccCCCceEEEEE
Confidence            4699999999999976  68999999987432      25677999999999 99999999999976  44467899999


Q ss_pred             eecCCChhhhcC---CCCHHHHHHHHHHHHHHHHHHHH-CCceeecCCCCceEecCCCCcEEEEeccccccccCCCccee
Q 014406          203 YVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV  278 (425)
Q Consensus       203 ~~~~~~l~~~~~---~l~~~~~~~i~~~i~~~L~~LH~-~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~~~~  278 (425)
                      |+++|+|..++.   .+++.....++.|++.||.|||+ .+++||||||+|||++.+ +.+||+|||+++.....  ...
T Consensus       103 y~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~-~~~kl~dfg~~~~~~~~--~~~  179 (283)
T PHA02988        103 YCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTEN-YKLKIICHGLEKILSSP--PFK  179 (283)
T ss_pred             eCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCC-CcEEEcccchHhhhccc--ccc
Confidence            999999998873   48888899999999999999998 499999999999999988 78999999999865432  233


Q ss_pred             eccCCCccCcccccCC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCChhh
Q 014406          279 RVASRYFKGPELLVDL-QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQL  357 (425)
Q Consensus       279 ~~~t~~y~aPE~~~~~-~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~  357 (425)
                      ..++..|+|||++.+. ..++.++|||||||++|||++|+.||. +.+..+....+...-..                  
T Consensus       180 ~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~-~~~~~~~~~~i~~~~~~------------------  240 (283)
T PHA02988        180 NVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFE-NLTTKEIYDLIINKNNS------------------  240 (283)
T ss_pred             ccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCC-CCCHHHHHHHHHhcCCC------------------
Confidence            5678899999998652 468999999999999999999999984 22222222222110000                  


Q ss_pred             HHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhc
Q 014406          358 DALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  408 (425)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~  408 (425)
                                       ...+..+++++.+|+.+||+.||++|||++|+++
T Consensus       241 -----------------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  274 (283)
T PHA02988        241 -----------------LKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILY  274 (283)
T ss_pred             -----------------CCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence                             0001126889999999999999999999999985

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-42  Score=307.93  Aligned_cols=257  Identities=24%  Similarity=0.416  Sum_probs=204.4

Q ss_pred             eeeeeeCceEEEEEEEcCCCcEEEEEEecCc---chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEEEeecCC
Q 014406          131 RKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST  207 (425)
Q Consensus       131 ~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~  207 (425)
                      +.||+|+|+.|-.+....++..+|||++.+.   .+.++.+|++++.+.++|+||+.++++|+++  ...|||||-|.||
T Consensus        84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd--~~FYLVfEKm~GG  161 (463)
T KOG0607|consen   84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD--TRFYLVFEKMRGG  161 (463)
T ss_pred             HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc--ceEEEEEecccCc
Confidence            4699999999999999999999999999864   4678899999999999999999999999765  6788999999999


Q ss_pred             ChhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCC--CCcEEEEeccccccccCCC--------
Q 014406          208 DFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--LRKLRLIDWGLAEFYHPGK--------  274 (425)
Q Consensus       208 ~l~~~~~---~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~--~~~~kl~Dfg~a~~~~~~~--------  274 (425)
                      .|-..+.   -|++.+...++.+|+.||+|||++||.||||||+|||....  ...+|||||.+...+....        
T Consensus       162 plLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP  241 (463)
T KOG0607|consen  162 PLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTP  241 (463)
T ss_pred             hHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCc
Confidence            9887764   39999999999999999999999999999999999998653  2358999999986543222        


Q ss_pred             cceeeccCCCccCcccccC----CCCCCCcccHHHHHHHHHHHHhCCCCCCCCC------C----CHHHHHHHHHHhCCc
Q 014406          275 EYNVRVASRYFKGPELLVD----LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH------D----NHDQLVKIAKVLGTD  340 (425)
Q Consensus       275 ~~~~~~~t~~y~aPE~~~~----~~~~~~~~DvwslG~~l~elltg~~pf~~~~------~----~~~~~~~~~~~lg~~  340 (425)
                      ...+.+|+-.|||||++.-    ...|+.++|.|||||++|-||+|..||...-      +    -..-...+.+.+...
T Consensus       242 ~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEG  321 (463)
T KOG0607|consen  242 ELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEG  321 (463)
T ss_pred             cccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhcc
Confidence            2344678888999999732    2468999999999999999999999984211      1    111112222211111


Q ss_pred             hhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccc
Q 014406          341 ELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA  418 (425)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~  418 (425)
                               ...+                    ....+..+|.+++|+++.+|..|+.+|.++.++++|||++.+...
T Consensus       322 ---------kYeF--------------------PdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~e  370 (463)
T KOG0607|consen  322 ---------KYEF--------------------PDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPE  370 (463)
T ss_pred             ---------CCcC--------------------ChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchh
Confidence                     1111                    111223489999999999999999999999999999999988653

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=3.4e-41  Score=329.43  Aligned_cols=245  Identities=23%  Similarity=0.351  Sum_probs=192.2

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCC-----CcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCC
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNT-----NERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHS  194 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~-----~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  194 (425)
                      .++|++.+.||+|+||.||+|.+...     +..||+|+++...    ...+.+|+.+++.+.+|+||++++++|...  
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~--  114 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHG--  114 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC--
Confidence            56899999999999999999986443     3579999997432    345788999999987799999999999654  


Q ss_pred             CccEEEEEeecCCChhhhcC------------------------------------------------------------
Q 014406          195 KTPSLIFEYVNSTDFKVLYP------------------------------------------------------------  214 (425)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~~------------------------------------------------------------  214 (425)
                      ...++||||+.+|+|.+++.                                                            
T Consensus       115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (374)
T cd05106         115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS  194 (374)
T ss_pred             CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence            67899999999999877642                                                            


Q ss_pred             -------------CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCcce---e
Q 014406          215 -------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN---V  278 (425)
Q Consensus       215 -------------~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~~~---~  278 (425)
                                   .+++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++.........   .
T Consensus       195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~-~~~kL~DfGla~~~~~~~~~~~~~~  273 (374)
T cd05106         195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDG-RVAKICDFGLARDIMNDSNYVVKGN  273 (374)
T ss_pred             ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCC-CeEEEeeceeeeeccCCcceeeccC
Confidence                         25777889999999999999999999999999999999987 789999999997654332211   1


Q ss_pred             eccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCChhh
Q 014406          279 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQL  357 (425)
Q Consensus       279 ~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~  357 (425)
                      ..++..|+|||++.+ ..++.++|||||||++|+|++ |+.||...... ..+..+... +                   
T Consensus       274 ~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~-~~~~~~~~~-~-------------------  331 (374)
T cd05106         274 ARLPVKWMAPESIFD-CVYTVQSDVWSYGILLWEIFSLGKSPYPGILVN-SKFYKMVKR-G-------------------  331 (374)
T ss_pred             CCCccceeCHHHhcC-CCCCccccHHHHHHHHHHHHhCCCCCCcccccc-HHHHHHHHc-c-------------------
Confidence            234567999999977 679999999999999999997 99898432221 111111110 0                   


Q ss_pred             HHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhc
Q 014406          358 DALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  408 (425)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~  408 (425)
                                     ........+++++.+++.+||+.||++|||+.++++
T Consensus       332 ---------------~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~  367 (374)
T cd05106         332 ---------------YQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQ  367 (374)
T ss_pred             ---------------cCccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                           000011225789999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=9.7e-41  Score=313.90  Aligned_cols=272  Identities=34%  Similarity=0.673  Sum_probs=207.5

Q ss_pred             EEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc-----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEE
Q 014406          127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (425)
Q Consensus       127 y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (425)
                      |++.+.||.|++|+||+|.+..+|..||+|++....     ...+.+|+++++.+ +|+|++++++++.+.  ...+++|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~iv~~~~~~~~~--~~~~iv~   77 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKEL-NHPNIVRLLDVVHSE--NKLYLVF   77 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhc-CCCCccCHhheeccC--CeEEEEE
Confidence            567889999999999999999999999999986432     35688899999999 899999999999654  7889999


Q ss_pred             EeecCCChhhhc---C--CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCC-Cc
Q 014406          202 EYVNSTDFKVLY---P--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-KE  275 (425)
Q Consensus       202 e~~~~~~l~~~~---~--~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~-~~  275 (425)
                      ||++ +++..++   .  .+++..+..++.|++.||+|||+.+++|+||+|+||+++.+ +.++|+|||++...... ..
T Consensus        78 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~-~~~~l~df~~~~~~~~~~~~  155 (283)
T cd07835          78 EFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDRE-GALKLADFGLARAFGVPVRT  155 (283)
T ss_pred             eccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCC-CcEEEeecccccccCCCccc
Confidence            9996 4666655   2  47899999999999999999999999999999999999987 79999999998755322 22


Q ss_pred             ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCCh
Q 014406          276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP  355 (425)
Q Consensus       276 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~  355 (425)
                      .....++..|+|||++.+...++.++||||||+++|+|++|..||. +.++.+.+..+.+..+.+....+...  ...+ 
T Consensus       156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~-~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~-  231 (283)
T cd07835         156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFP-GDSEIDQLFRIFRTLGTPDEDVWPGV--TSLP-  231 (283)
T ss_pred             cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHHHhCCCChHHhhhh--hhch-
Confidence            2334567889999988764567899999999999999999998884 34444555556665555433221100  0000 


Q ss_pred             hhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCC
Q 014406          356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF  412 (425)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~  412 (425)
                      .....   .  ..+...........++.++.+++.+||+.||++|||++|+++||||
T Consensus       232 ~~~~~---~--~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~  283 (283)
T cd07835         232 DYKPT---F--PKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF  283 (283)
T ss_pred             hhhhh---c--ccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence            00000   0  0000001111233478899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=9.1e-41  Score=311.71  Aligned_cols=248  Identities=27%  Similarity=0.417  Sum_probs=194.2

Q ss_pred             CCEEEEeee--eeeCceEEEEEEEcCCCcEEEEEEecCcchHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEEE
Q 014406          125 DDYEVVRKV--GRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE  202 (425)
Q Consensus       125 ~~y~~~~~L--G~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e  202 (425)
                      ++|++.+.+  |+|+||+||++.+..++..+|+|.+........  |+.....+.+|+|+++++++|...  ...++|||
T Consensus        14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--e~~~~~~~~~h~~iv~~~~~~~~~--~~~~iv~e   89 (267)
T PHA03390         14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI--EPMVHQLMKDNPNFIKLYYSVTTL--KGHVLIMD   89 (267)
T ss_pred             HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh--hHHHHHHhhcCCCEEEEEEEEecC--CeeEEEEE
Confidence            345555555  999999999999999999999999875433322  333333334799999999999764  57899999


Q ss_pred             eecCCChhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCcceee
Q 014406          203 YVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR  279 (425)
Q Consensus       203 ~~~~~~l~~~~~---~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~~~~~  279 (425)
                      |+++++|..++.   .+++..+..++.|++.||.|||+.|++|+||||+||+++.+.+.++|+|||++......   ...
T Consensus        90 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~---~~~  166 (267)
T PHA03390         90 YIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP---SCY  166 (267)
T ss_pred             cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC---ccC
Confidence            999999988762   58999999999999999999999999999999999999988448999999998765422   234


Q ss_pred             ccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCChhhHH
Q 014406          280 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDA  359 (425)
Q Consensus       280 ~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~  359 (425)
                      .++..|+|||++.+ ..++.++||||||+++|+|++|+.||.......-....+..... .                   
T Consensus       167 ~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~-------------------  225 (267)
T PHA03390        167 DGTLDYFSPEKIKG-HNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQ-K-------------------  225 (267)
T ss_pred             CCCCcccChhhhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhc-c-------------------
Confidence            67889999999977 67899999999999999999999998532222111111111000 0                   


Q ss_pred             HhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcC-HHHHhcCCCCcc
Q 014406          360 LVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT-AREAMAHPYFAQ  414 (425)
Q Consensus       360 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpt-a~elL~hp~~~~  414 (425)
                                    .......+++.+.+||.+||+.||.+|++ .+|+|+||||++
T Consensus       226 --------------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~  267 (267)
T PHA03390        226 --------------KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI  267 (267)
T ss_pred             --------------cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence                          00011137899999999999999999996 599999999974

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=8.5e-41  Score=317.27  Aligned_cols=280  Identities=27%  Similarity=0.571  Sum_probs=210.8

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCC----
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH----  193 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~----  193 (425)
                      ..++|++.+.||+|+||+||+|.+..+++.||+|.++..     ....+.+|+++++.+ +|||++++++++.+..    
T Consensus         5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQL-NHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhC-CCCCeeeeeheecCcchhhh
Confidence            357899999999999999999999999999999998642     224577899999999 8999999999987543    


Q ss_pred             ----CCccEEEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccc
Q 014406          194 ----SKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL  266 (425)
Q Consensus       194 ----~~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~  266 (425)
                          ....++|+||++++.+....   ..+++..+..++.|++.||.|||+.||+|+||||+||+++.+ +.+||+|||+
T Consensus        84 ~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~-~~~kl~dfg~  162 (302)
T cd07864          84 FKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNK-GQIKLADFGL  162 (302)
T ss_pred             ccccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC-CcEEeCcccc
Confidence                23789999999985444333   358999999999999999999999999999999999999988 7899999999


Q ss_pred             cccccCCC--cceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHH
Q 014406          267 AEFYHPGK--EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA  344 (425)
Q Consensus       267 a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~  344 (425)
                      +.......  ......++..|+|||.+.+...++.++|||||||++++|++|+.||. ..+..+.+..+.+..+.+....
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~-~~~~~~~~~~~~~~~~~~~~~~  241 (302)
T cd07864         163 ARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQ-ANQELAQLELISRLCGSPCPAV  241 (302)
T ss_pred             cccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCC-CCChHHHHHHHHHHhCCCChhh
Confidence            97654332  22233557789999998764567899999999999999999998874 4455666666666665543322


Q ss_pred             HHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCC
Q 014406          345 YLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF  412 (425)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~  412 (425)
                      +..-.....   +...   .......... ......++..+.+++.+||+.||++|||+.++++||||
T Consensus       242 ~~~~~~~~~---~~~~---~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  302 (302)
T cd07864         242 WPDVIKLPY---FNTM---KPKKQYRRRL-REEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL  302 (302)
T ss_pred             ccccccccc---cccc---ccccccccch-hhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence            110000000   0000   0000000000 01112368899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=7.7e-41  Score=309.85  Aligned_cols=245  Identities=20%  Similarity=0.444  Sum_probs=201.2

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEE
Q 014406          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (425)
Q Consensus       126 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (425)
                      +|++.+.||+|+||+||++.+..+++.+|+|.+...     ..+++.+|+.+++++ +|+||+++++++.+  ....++|
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~~~lv   77 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNM-KHPNIVQYQESFEE--NGNLYIV   77 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhC-CCCCeeeeEeeecC--CCeEEEE
Confidence            588999999999999999999999999999998632     235788999999999 99999999999965  4688999


Q ss_pred             EEeecCCChhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCc
Q 014406          201 FEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (425)
Q Consensus       201 ~e~~~~~~l~~~~~-----~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~  275 (425)
                      +||+.+++|..++.     .+++..+..++.|++.||.|||+++++|+||+|+||+++.+ +.++|+|||++........
T Consensus        78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~-~~~~l~d~~~~~~~~~~~~  156 (256)
T cd08218          78 MDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKD-GTIKLGDFGIARVLNSTVE  156 (256)
T ss_pred             EecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCC-CCEEEeeccceeecCcchh
Confidence            99999999887762     37888999999999999999999999999999999999987 7899999999976543222


Q ss_pred             -ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCC
Q 014406          276 -YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD  354 (425)
Q Consensus       276 -~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~  354 (425)
                       .....++..|+|||++.+ ..++.++|+|||||++++|++|..||..+ +..+....+..  +..              
T Consensus       157 ~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~i~~~l~~g~~~~~~~-~~~~~~~~~~~--~~~--------------  218 (256)
T cd08218         157 LARTCIGTPYYLSPEICEN-RPYNNKSDIWALGCVLYEMCTLKHAFEAG-NMKNLVLKIIR--GSY--------------  218 (256)
T ss_pred             hhhhccCCccccCHHHhCC-CCCCCccchhHHHHHHHHHHcCCCCccCC-CHHHHHHHHhc--CCC--------------
Confidence             123457788999999877 67899999999999999999999998533 22222211110  000              


Q ss_pred             hhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCC
Q 014406          355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF  412 (425)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~  412 (425)
                                          ......++.++.+++.+||+.+|++||++.|+++||||
T Consensus       219 --------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~  256 (256)
T cd08218         219 --------------------PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI  256 (256)
T ss_pred             --------------------CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence                                00112368899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=7.4e-41  Score=311.66  Aligned_cols=246  Identities=25%  Similarity=0.423  Sum_probs=197.8

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc---------hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCc
Q 014406          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK---------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (425)
Q Consensus       126 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~---------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (425)
                      +|++.+.||+|+||+||+|.+ .+++.+|+|.+....         ...+.+|+++++++ +|+||+++++++.+.  ..
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~--~~   76 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSL-KHVNIVQYLGTCLDD--NT   76 (265)
T ss_pred             CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhc-CCCCEeeEeeEeecC--Ce
Confidence            467788999999999999975 578899999886321         24578899999999 899999999999654  78


Q ss_pred             cEEEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCC
Q 014406          197 PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (425)
Q Consensus       197 ~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~  273 (425)
                      .++++||+.+++|..++   ..+++..+..++.|++.||+|||+.+|+|+||+|+||+++.+ +.++|+|||++......
T Consensus        77 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~  155 (265)
T cd06631          77 ISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPN-GIIKLIDFGCARRLAWV  155 (265)
T ss_pred             EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCC-CeEEeccchhhHhhhhc
Confidence            89999999999999886   348899999999999999999999999999999999999987 78999999998754211


Q ss_pred             -------CcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHH
Q 014406          274 -------KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYL  346 (425)
Q Consensus       274 -------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~  346 (425)
                             .......++..|+|||++.+ ..++.++|||||||++|+|++|..||... +.......+....+.       
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~-~~~~~~~~~~~~~~~-------  226 (265)
T cd06631         156 GLHGTHSNMLKSMHGTPYWMAPEVINE-SGYGRKSDIWSIGCTVFEMATGKPPLASM-DRLAAMFYIGAHRGL-------  226 (265)
T ss_pred             cccccccccccccCCCccccChhhhcC-CCCcchhhHHHHHHHHHHHHhCCCccccC-ChHHHHHHhhhccCC-------
Confidence                   11223457888999999877 67899999999999999999999998432 211111111100000       


Q ss_pred             hhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCC
Q 014406          347 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF  412 (425)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~  412 (425)
                                                 .......++.++.+|+++||+.+|++|||+.|+++||||
T Consensus       227 ---------------------------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~  265 (265)
T cd06631         227 ---------------------------MPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL  265 (265)
T ss_pred             ---------------------------CCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence                                       001122368899999999999999999999999999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=5.1e-41  Score=323.76  Aligned_cols=281  Identities=28%  Similarity=0.485  Sum_probs=212.5

Q ss_pred             CCCCEEE-EeeeeeeCceEEEEEEEcCCCcEEEEEEecCcch-----------------HHHHHHHHHHHHhcCCCCeee
Q 014406          123 DQDDYEV-VRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK-----------------KKIKREIKILQNLCGGPNVVK  184 (425)
Q Consensus       123 ~~~~y~~-~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~-----------------~~~~~E~~~l~~l~~h~niv~  184 (425)
                      ..++|.. .+.||.|+||+||+|.+..+++.||+|.+.....                 ..+.+|+++++.+ +|+||++
T Consensus         6 ~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~   84 (335)
T PTZ00024          6 ISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEI-KHENIMG   84 (335)
T ss_pred             cccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhC-CCcceee
Confidence            3566654 4679999999999999999999999999864321                 1467899999999 9999999


Q ss_pred             EEeEEEcCCCCccEEEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEE
Q 014406          185 LLDIVRDQHSKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRL  261 (425)
Q Consensus       185 l~~~~~~~~~~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl  261 (425)
                      +++++...  ...++||||+.+ ++..++   ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.+ +.++|
T Consensus        85 ~~~~~~~~--~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~-~~~kl  160 (335)
T PTZ00024         85 LVDVYVEG--DFINLVMDIMAS-DLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSK-GICKI  160 (335)
T ss_pred             eeEEEecC--CcEEEEEecccc-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCC-CCEEE
Confidence            99999654  688999999985 666655   348999999999999999999999999999999999999988 78999


Q ss_pred             EeccccccccCC---------------CcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCC
Q 014406          262 IDWGLAEFYHPG---------------KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN  326 (425)
Q Consensus       262 ~Dfg~a~~~~~~---------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~  326 (425)
                      +|||++......               .......++..|+|||.+.+...++.++|||||||++|+|++|..|| .+.++
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~-~~~~~  239 (335)
T PTZ00024        161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLF-PGENE  239 (335)
T ss_pred             CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCC-CCCCH
Confidence            999998765411               11122345778999999877556799999999999999999998887 45566


Q ss_pred             HHHHHHHHHHhCCchhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHH
Q 014406          327 HDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA  406 (425)
Q Consensus       327 ~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~el  406 (425)
                      .+.+..+...++.+....+............         ...............++++.+|+.+||+.||++|||++|+
T Consensus       240 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~  310 (335)
T PTZ00024        240 IDQLGRIFELLGTPNEDNWPQAKKLPLYTEF---------TPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEA  310 (335)
T ss_pred             HHHHHHHHHHhCCCchhhCcchhhccccccc---------CcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHH
Confidence            6777777777765543322111100000000         0000000001112357889999999999999999999999


Q ss_pred             hcCCCCcccccc
Q 014406          407 MAHPYFAQVRAA  418 (425)
Q Consensus       407 L~hp~~~~~~~~  418 (425)
                      |.||||+.-...
T Consensus       311 l~~~~~~~~~~~  322 (335)
T PTZ00024        311 LKHEYFKSDPLP  322 (335)
T ss_pred             hcCcccCCCCCC
Confidence            999999876544

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=5.3e-41  Score=314.92  Aligned_cols=249  Identities=26%  Similarity=0.411  Sum_probs=201.1

Q ss_pred             eeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEEEeecC
Q 014406          133 VGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNS  206 (425)
Q Consensus       133 LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~  206 (425)
                      ||+|+||+||+|.+..+++.+|+|.+...      ....+.+|+++++.+ +||||+++++++...  ...|+||||+++
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~--~~~~lv~e~~~~   77 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKV-SSRFIVSLAYAFETK--DDLCLVMTLMNG   77 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhC-CCCCEeeeeeEEecC--CeEEEEEecCCC
Confidence            69999999999999999999999998632      234567899999999 899999999999654  678999999999


Q ss_pred             CChhhhc---C--CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCcceeecc
Q 014406          207 TDFKVLY---P--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA  281 (425)
Q Consensus       207 ~~l~~~~---~--~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  281 (425)
                      ++|..++   .  .+++..+..++.|++.||.|||+.|++|+||+|+||+++.+ +.++|+|||.+.............+
T Consensus        78 ~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~  156 (277)
T cd05577          78 GDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDH-GNVRISDLGLAVELKGGKKIKGRAG  156 (277)
T ss_pred             CcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCC-CCEEEccCcchhhhccCCccccccC
Confidence            9998775   2  48899999999999999999999999999999999999988 7899999999876654334444567


Q ss_pred             CCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCChhhHHHh
Q 014406          282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALV  361 (425)
Q Consensus       282 t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~  361 (425)
                      +..|+|||.+.+ ..++.++|||||||++++|++|+.||........ ...+....-                       
T Consensus       157 ~~~y~~PE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~-----------------------  211 (277)
T cd05577         157 TPGYMAPEVLQG-EVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE-KEELKRRTL-----------------------  211 (277)
T ss_pred             CCCcCCHHHhcC-CCCCchhhhHHHHHHHHHHhhCCCCCCCCccccc-HHHHHhccc-----------------------
Confidence            788999999877 5689999999999999999999999843222110 111100000                       


Q ss_pred             cccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCc-----CHHHHhcCCCCcccccchh
Q 014406          362 GRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYFAQVRAAES  420 (425)
Q Consensus       362 ~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rp-----ta~elL~hp~~~~~~~~~~  420 (425)
                          .      ........+++++.+||++||+.||++||     ++.++++||||.++++...
T Consensus       212 ----~------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~~~~  265 (277)
T cd05577         212 ----E------MAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNWRRL  265 (277)
T ss_pred             ----c------ccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCChhhh
Confidence                0      00011223688999999999999999999     9999999999999887554

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=1.9e-41  Score=320.45  Aligned_cols=255  Identities=23%  Similarity=0.415  Sum_probs=205.5

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc---hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEE
Q 014406          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (425)
Q Consensus       125 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (425)
                      +.|.....||+|+||.||++.+..++..||||.+....   .+.+.+|+.+++.+ +|+|++++++.+..  +...++||
T Consensus        22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~ii~~~~~~~~--~~~~~lv~   98 (292)
T cd06658          22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDY-HHENVVDMYNSYLV--GDELWVVM   98 (292)
T ss_pred             HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhC-CCCcHHHHHHheec--CCeEEEEE
Confidence            34444567999999999999999999999999986432   35678999999999 99999999999865  36789999


Q ss_pred             EeecCCChhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCC-ccee
Q 014406          202 EYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EYNV  278 (425)
Q Consensus       202 e~~~~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~-~~~~  278 (425)
                      ||+++++|..++  ..+++..+..++.||+.||+|||+.+|+|+||||+||+++.+ +.++|+|||++....... ....
T Consensus        99 e~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~-~~~kL~dfg~~~~~~~~~~~~~~  177 (292)
T cd06658          99 EFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSD-GRIKLSDFGFCAQVSKEVPKRKS  177 (292)
T ss_pred             eCCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCC-CCEEEccCcchhhcccccccCce
Confidence            999999998876  458899999999999999999999999999999999999988 789999999987553322 2234


Q ss_pred             eccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCChhhH
Q 014406          279 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLD  358 (425)
Q Consensus       279 ~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~  358 (425)
                      ..++..|+|||.+.+ ..++.++||||||+++|||++|+.||... +..+.+..+...+...                  
T Consensus       178 ~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvil~el~~g~~p~~~~-~~~~~~~~~~~~~~~~------------------  237 (292)
T cd06658         178 LVGTPYWMAPEVISR-LPYGTEVDIWSLGIMVIEMIDGEPPYFNE-PPLQAMRRIRDNLPPR------------------  237 (292)
T ss_pred             eecCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhcCCCc------------------
Confidence            568889999999876 67899999999999999999999998532 2222222111110000                  


Q ss_pred             HHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccch
Q 014406          359 ALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE  419 (425)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~~  419 (425)
                                      ......++..+.+|+.+||+.||++|||++|+++||||+.....+
T Consensus       238 ----------------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~~~  282 (292)
T cd06658         238 ----------------VKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGPPS  282 (292)
T ss_pred             ----------------cccccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccCCcc
Confidence                            000112678899999999999999999999999999999776544

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=8.2e-41  Score=309.64  Aligned_cols=247  Identities=27%  Similarity=0.454  Sum_probs=201.0

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc--------chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCcc
Q 014406          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (425)
Q Consensus       126 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~--------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (425)
                      +|+..+.||+|+||+||+|.+..+++.+++|.+...        ..+.+.+|+.+++.+ +|+||+++++++.+.  ...
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~--~~~   77 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKL-QHPNIVQYLGTEREE--DNL   77 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhc-CCCCchheeeeEecC--CeE
Confidence            466678899999999999999889999999998642        235688999999999 999999999999654  678


Q ss_pred             EEEEEeecCCChhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCC
Q 014406          198 SLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (425)
Q Consensus       198 ~lv~e~~~~~~l~~~~~---~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~  274 (425)
                      ++++||+++++|..++.   .+++..+..++.|++.||.|||+.|++|+||+|+||+++.+ +.+||+|||++.......
T Consensus        78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~-~~~kl~d~~~~~~~~~~~  156 (258)
T cd06632          78 YIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTN-GVVKLADFGMAKQVVEFS  156 (258)
T ss_pred             EEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC-CCEEEccCccceeccccc
Confidence            89999999999988873   37889999999999999999999999999999999999988 789999999987665444


Q ss_pred             cceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCC
Q 014406          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD  354 (425)
Q Consensus       275 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~  354 (425)
                      ......++..|++||.+.....++.++|+|||||++|+|++|+.||.... ..+....+.....                
T Consensus       157 ~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~-~~~~~~~~~~~~~----------------  219 (258)
T cd06632         157 FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE-GVAAVFKIGRSKE----------------  219 (258)
T ss_pred             cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc-HHHHHHHHHhccc----------------
Confidence            34455678889999998763338999999999999999999999984322 1111111110000                


Q ss_pred             hhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCC
Q 014406          355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF  412 (425)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~  412 (425)
                                         .......+++.+.+|+++||+.+|++|||+.++++|||+
T Consensus       220 -------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~  258 (258)
T cd06632         220 -------------------LPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV  258 (258)
T ss_pred             -------------------CCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence                               000112368899999999999999999999999999996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=4e-41  Score=329.14  Aligned_cols=246  Identities=22%  Similarity=0.366  Sum_probs=192.2

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEE-----cCCCcEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCC
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGIN-----VNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS  194 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~-----~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  194 (425)
                      .++|++.+.||+|+||+||+|.+     ..++..||||+++..    ..+.+.+|+.++..+.+||||++++++|.+.  
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~--  111 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVG--  111 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC--
Confidence            45899999999999999999974     345678999998743    2356789999999987799999999999654  


Q ss_pred             CccEEEEEeecCCChhhhcC------------------------------------------------------------
Q 014406          195 KTPSLIFEYVNSTDFKVLYP------------------------------------------------------------  214 (425)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~~------------------------------------------------------------  214 (425)
                      ...++||||+++|+|..++.                                                            
T Consensus       112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (375)
T cd05104         112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS  191 (375)
T ss_pred             CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence            67889999999999876652                                                            


Q ss_pred             ------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCcc
Q 014406          215 ------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY  276 (425)
Q Consensus       215 ------------------~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~~  276 (425)
                                        .+++..+..++.||+.||+|||+.||+||||||+|||++.+ +.+||+|||+++........
T Consensus       192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~-~~~kl~DfG~a~~~~~~~~~  270 (375)
T cd05104         192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHG-RITKICDFGLARDIRNDSNY  270 (375)
T ss_pred             ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECC-CcEEEecCccceeccCcccc
Confidence                              25677888999999999999999999999999999999987 78999999999765433221


Q ss_pred             e---eeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCC
Q 014406          277 N---VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE  352 (425)
Q Consensus       277 ~---~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~  352 (425)
                      .   ...++..|+|||++.+ ..++.++|||||||++|+|++ |..||. +......+.....            ..   
T Consensus       271 ~~~~~~~~~~~y~aPE~~~~-~~~~~~sDi~slG~~l~ellt~g~~p~~-~~~~~~~~~~~~~------------~~---  333 (375)
T cd05104         271 VVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGILLWEIFSLGSSPYP-GMPVDSKFYKMIK------------EG---  333 (375)
T ss_pred             cccCCCCCCcceeChhHhcC-CCCCCCCCHHHHHHHHHHHHhcCCCCCC-CCCchHHHHHHHH------------hC---
Confidence            1   1234567999999977 679999999999999999998 777763 2222222211111            00   


Q ss_pred             CChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcC
Q 014406          353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  409 (425)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~h  409 (425)
                                  .+        .......+.++.+|+.+||+.||++|||+.|+++.
T Consensus       334 ------------~~--------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  370 (375)
T cd05104         334 ------------YR--------MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQL  370 (375)
T ss_pred             ------------cc--------CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence                        00        00011257889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=8e-41  Score=311.85  Aligned_cols=244  Identities=14%  Similarity=0.267  Sum_probs=194.2

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEc---CCCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCC
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINV---NTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~---~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (425)
                      +.++|++.+.||+|+||.||+|.+.   ..+..||+|.++...    ...+.+|+.+++++ +||||+++++++..  +.
T Consensus         3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~--~~   79 (266)
T cd05064           3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQF-DHSNIVRLEGVITR--GN   79 (266)
T ss_pred             chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcC-CCCCcCeEEEEEec--CC
Confidence            4678999999999999999999765   456789999987542    24678899999999 99999999999965  46


Q ss_pred             ccEEEEEeecCCChhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEecccccccc
Q 014406          196 TPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (425)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~~----~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~  271 (425)
                      ..++||||+++++|..++.    .+++..++.++.|++.||+|||++|++|+||||+|||++.+ +.++++|||.+....
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~-~~~~l~dfg~~~~~~  158 (266)
T cd05064          80 TMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSD-LVCKISGFRRLQEDK  158 (266)
T ss_pred             CcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCC-CcEEECCCccccccc
Confidence            7899999999999998762    47899999999999999999999999999999999999988 789999999876543


Q ss_pred             CCCcce--eeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhh
Q 014406          272 PGKEYN--VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK  348 (425)
Q Consensus       272 ~~~~~~--~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~  348 (425)
                      ......  ...++..|+|||.+.+ ..++.++|||||||++||+++ |..||. +.+..+.+..+.+..           
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~ell~~g~~p~~-~~~~~~~~~~~~~~~-----------  225 (266)
T cd05064         159 SEAIYTTMSGKSPVLWAAPEAIQY-HHFSSASDVWSFGIVMWEVMSYGERPYW-DMSGQDVIKAVEDGF-----------  225 (266)
T ss_pred             ccchhcccCCCCceeecCHHHHhh-CCccchhHHHHHHHHHHHHhcCCCCCcC-cCCHHHHHHHHHCCC-----------
Confidence            222111  1234567999999877 789999999999999999775 888883 222222222221100           


Q ss_pred             ccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhc
Q 014406          349 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  408 (425)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~  408 (425)
                                               .......++..+.+++.+||+.+|++|||++++++
T Consensus       226 -------------------------~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~  260 (266)
T cd05064         226 -------------------------RLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHS  260 (266)
T ss_pred             -------------------------CCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence                                     00112236889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-42  Score=326.72  Aligned_cols=245  Identities=26%  Similarity=0.509  Sum_probs=213.0

Q ss_pred             eeeeeeCceEEEEEEEcCCCcEEEEEEecC-----cchHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEEEeec
Q 014406          131 RKVGRGKYSEVFEGINVNTNERCIIKILKP-----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVN  205 (425)
Q Consensus       131 ~~LG~G~fg~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~  205 (425)
                      +.||+|.||+||-|.++++|+.||||++++     ...+++++|+.||+++ .||.||.+...|+.  ...+++|||-+.
T Consensus       570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l-~HPGiV~le~M~ET--~ervFVVMEKl~  646 (888)
T KOG4236|consen  570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNL-HHPGIVNLECMFET--PERVFVVMEKLH  646 (888)
T ss_pred             hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhc-CCCCeeEEEEeecC--CceEEEEehhhc
Confidence            579999999999999999999999999974     3457899999999999 99999999999955  477889999999


Q ss_pred             CCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecC--CCCcEEEEeccccccccCCCcceee
Q 014406          206 STDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGKEYNVR  279 (425)
Q Consensus       206 ~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~--~~~~~kl~Dfg~a~~~~~~~~~~~~  279 (425)
                      |.-|+..+    .++++...+.++.||+.||.|||-++|+|+||||+|||+.+  +...+||||||+|+.+.........
T Consensus       647 GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRrsV  726 (888)
T KOG4236|consen  647 GDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRRSV  726 (888)
T ss_pred             chHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhhhhhh
Confidence            98888776    45899989999999999999999999999999999999965  3468999999999999877777788


Q ss_pred             ccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCChhhHH
Q 014406          280 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDA  359 (425)
Q Consensus       280 ~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~  359 (425)
                      +||+.|.|||++.+ +.|+...|+||+||++|.-++|..||..+.+-.+++++-.=               +..      
T Consensus       727 VGTPAYLaPEVLrn-kGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaF---------------MyP------  784 (888)
T KOG4236|consen  727 VGTPAYLAPEVLRN-KGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAF---------------MYP------  784 (888)
T ss_pred             cCCccccCHHHHhh-ccccccccceeeeEEEEEEecccccCCCccchhHHhhcccc---------------ccC------
Confidence            99999999999998 88999999999999999999999999666555555543211               111      


Q ss_pred             HhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCccc
Q 014406          360 LVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV  415 (425)
Q Consensus       360 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~  415 (425)
                            ..+|         ..++.++.|||..+|+..-.+|.|.++.|.|||+++-
T Consensus       785 ------p~PW---------~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~y  825 (888)
T KOG4236|consen  785 ------PNPW---------SEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDY  825 (888)
T ss_pred             ------CCch---------hhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcc
Confidence                  1122         2379999999999999999999999999999999874

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=2.1e-40  Score=306.86  Aligned_cols=245  Identities=24%  Similarity=0.453  Sum_probs=202.7

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEE
Q 014406          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (425)
Q Consensus       126 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (425)
                      +|+.++.||.|+||.||.+.+..+++.+++|.+...     ....+.+|+.+++++ +|+||+++++++.+.  ...+++
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~--~~~~~~   77 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLL-QHPNIIAYYNHFMDD--NTLLIE   77 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhC-CCCCeeEEEeEEecC--CeEEEE
Confidence            589999999999999999999999999999987632     235688999999999 999999999999664  678999


Q ss_pred             EEeecCCChhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCC-
Q 014406          201 FEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-  274 (425)
Q Consensus       201 ~e~~~~~~l~~~~~-----~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~-  274 (425)
                      |||+++++|..++.     .+++..+..++.|++.||.|||+.|++|+||+|+||+++.+ +.+||+|||++....... 
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~-~~~kl~d~~~~~~~~~~~~  156 (256)
T cd08221          78 MEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKA-GLIKLGDFGISKILGSEYS  156 (256)
T ss_pred             EEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCC-CCEEECcCcceEEcccccc
Confidence            99999999988773     37889999999999999999999999999999999999988 789999999997664333 


Q ss_pred             cceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCC
Q 014406          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD  354 (425)
Q Consensus       275 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~  354 (425)
                      ......++..|+|||.+.+ ..++.++||||||+++|+|++|..||.. .+..+....+..  +..              
T Consensus       157 ~~~~~~~~~~y~ape~~~~-~~~~~~~Dv~slG~i~~~l~~g~~~~~~-~~~~~~~~~~~~--~~~--------------  218 (256)
T cd08221         157 MAETVVGTPYYMSPELCQG-VKYNFKSDIWALGCVLYELLTLKRTFDA-TNPLNLVVKIVQ--GNY--------------  218 (256)
T ss_pred             cccccCCCccccCHhhcCC-CCCCCcchhHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHc--CCC--------------
Confidence            2234567889999999887 5689999999999999999999998832 222222222211  000              


Q ss_pred             hhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCC
Q 014406          355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF  412 (425)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~  412 (425)
                                          ......++.++.+++.+||+.||++|||+.|+|+|||+
T Consensus       219 --------------------~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l  256 (256)
T cd08221         219 --------------------TPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL  256 (256)
T ss_pred             --------------------CCCccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence                                00012368899999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=2e-40  Score=315.25  Aligned_cols=249  Identities=17%  Similarity=0.342  Sum_probs=191.7

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcC----------------CCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCee
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVN----------------TNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVV  183 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~----------------~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv  183 (425)
                      .++|++.++||+|+||.||+|.+..                ++..||+|++....    ...+.+|+.++.++ +||||+
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv   82 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRL-KDPNII   82 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhc-CCCCee
Confidence            4688999999999999999997532                34579999987532    34688999999999 999999


Q ss_pred             eEEeEEEcCCCCccEEEEEeecCCChhhhcC----------------------CCCHHHHHHHHHHHHHHHHHHHHCCce
Q 014406          184 KLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP----------------------TLTDYDIRYYIYELLKALDYCHSQGIM  241 (425)
Q Consensus       184 ~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~----------------------~l~~~~~~~i~~~i~~~L~~LH~~~iv  241 (425)
                      ++++++.+.  ...++||||+.+++|..++.                      .+++..+..++.||+.||.|||+.||+
T Consensus        83 ~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv  160 (304)
T cd05096          83 RLLGVCVDE--DPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV  160 (304)
T ss_pred             EEEEEEecC--CceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            999999654  56899999999999987652                      256778899999999999999999999


Q ss_pred             eecCCCCceEecCCCCcEEEEeccccccccCCCcc---eeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh--C
Q 014406          242 HRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF--R  316 (425)
Q Consensus       242 H~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt--g  316 (425)
                      |+||||+|||++.+ +.+||+|||+++........   ....++..|+|||++.+ ..++.++|||||||++|+|++  +
T Consensus       161 H~dlkp~Nill~~~-~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~~~  238 (304)
T cd05096         161 HRDLATRNCLVGEN-LTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILM-GKFTTASDVWAFGVTLWEILMLCK  238 (304)
T ss_pred             ccCcchhheEEcCC-ccEEECCCccceecccCceeEecCcCCCCccccCHHHHhc-CCCCchhhhHHHHHHHHHHHHccC
Confidence            99999999999988 78999999999765433221   12344678999999876 679999999999999999987  4


Q ss_pred             CCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCC
Q 014406          317 KEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYD  396 (425)
Q Consensus       317 ~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~d  396 (425)
                      ..||. +.+..+.+......+.....                        .     ........++..+.+|+.+||+.|
T Consensus       239 ~~p~~-~~~~~~~~~~~~~~~~~~~~------------------------~-----~~~~~~~~~~~~~~~li~~cl~~~  288 (304)
T cd05096         239 EQPYG-ELTDEQVIENAGEFFRDQGR------------------------Q-----VYLFRPPPCPQGLYELMLQCWSRD  288 (304)
T ss_pred             CCCCC-cCCHHHHHHHHHHHhhhccc------------------------c-----ccccCCCCCCHHHHHHHHHHccCC
Confidence            45653 33333333322221100000                        0     000011236889999999999999


Q ss_pred             cCCCcCHHHHh
Q 014406          397 HQDRLTAREAM  407 (425)
Q Consensus       397 P~~Rpta~elL  407 (425)
                      |++|||+.|+.
T Consensus       289 p~~RPs~~~i~  299 (304)
T cd05096         289 CRERPSFSDIH  299 (304)
T ss_pred             chhCcCHHHHH
Confidence            99999999994

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.1e-42  Score=330.52  Aligned_cols=248  Identities=24%  Similarity=0.452  Sum_probs=206.6

Q ss_pred             EEEeeeeeeCceEEEEEEEcCCCcEEE---EEEec----CcchHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEE
Q 014406          128 EVVRKVGRGKYSEVFEGINVNTNERCI---IKILK----PVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (425)
Q Consensus       128 ~~~~~LG~G~fg~V~~~~~~~~~~~va---vK~~~----~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (425)
                      .....||+|+|-+||+|.|..+|..||   ||+-+    +...++|..|+.+|+.| +|+||+++++++.+.+.+.+.+|
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL-~H~NIirfy~SW~d~~n~~in~i  121 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSL-KHPNIIRFYDSWVDTDNKTINFI  121 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccC-CCCceeeeeeheecCCCceeeee
Confidence            445679999999999999999998887   33321    23347899999999999 99999999999998888889999


Q ss_pred             EEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHC--CceeecCCCCceEecCCCCcEEEEeccccccccCCCc
Q 014406          201 FEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQ--GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (425)
Q Consensus       201 ~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~--~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~  275 (425)
                      +|.|..|+|..|.   +.++...++.|++||++||.|||++  -|||||||=+||+|+.+.|.|||+|+|||....... 
T Consensus       122 TEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~-  200 (632)
T KOG0584|consen  122 TELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH-  200 (632)
T ss_pred             eecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhccc-
Confidence            9999999999997   4588889999999999999999987  499999999999999999999999999998876443 


Q ss_pred             ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCCh
Q 014406          276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP  355 (425)
Q Consensus       276 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~  355 (425)
                      ....+|||.|||||++.  ..|++.+||||||+.|+||.|+..||....+..+...++..  |..+.. + .        
T Consensus       201 aksvIGTPEFMAPEmYE--E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~S--GiKP~s-l-~--------  266 (632)
T KOG0584|consen  201 AKSVIGTPEFMAPEMYE--ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTS--GIKPAA-L-S--------  266 (632)
T ss_pred             cceeccCccccChHHHh--hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHc--CCCHHH-h-h--------
Confidence            33479999999999986  58999999999999999999999998555444444443332  111111 0 0        


Q ss_pred             hhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCccc
Q 014406          356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV  415 (425)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~  415 (425)
                                             .--.+++++||.+||.. .++|+|+.|||+||||..-
T Consensus       267 -----------------------kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d  302 (632)
T KOG0584|consen  267 -----------------------KVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED  302 (632)
T ss_pred             -----------------------ccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence                                   00267899999999999 9999999999999999864

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=8.1e-41  Score=314.82  Aligned_cols=262  Identities=22%  Similarity=0.379  Sum_probs=206.1

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEE
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (425)
                      .++|++.+.||+|+||+||++.+..+++.+|+|++...    ..+.+.+|+++++.+ +|+||+++++++...  ...++
T Consensus         4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~--~~~~l   80 (284)
T cd06620           4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHEC-RSPYIVSFYGAFLNE--NNICM   80 (284)
T ss_pred             HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHc-CCCCcceEeeeEecC--CEEEE
Confidence            56788899999999999999999999999999987643    235788999999999 899999999999664  67899


Q ss_pred             EEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHH-CCceeecCCCCceEecCCCCcEEEEeccccccccCCCc
Q 014406          200 IFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (425)
Q Consensus       200 v~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~-~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~  275 (425)
                      ||||+++++|..++   ..+++..+..++.+++.||.|||+ .+++|+||+|+||+++.+ +.++|+|||++...... .
T Consensus        81 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~-~~~~l~d~gl~~~~~~~-~  158 (284)
T cd06620          81 CMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSR-GQIKLCDFGVSGELINS-I  158 (284)
T ss_pred             EEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCC-CcEEEccCCcccchhhh-c
Confidence            99999999998776   347899999999999999999997 689999999999999988 78999999998654322 2


Q ss_pred             ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHH---HHHHHHHHhCCchhHHHHhhccCC
Q 014406          276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHD---QLVKIAKVLGTDELNAYLNKYHLE  352 (425)
Q Consensus       276 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~---~~~~~~~~lg~~~~~~~~~~~~~~  352 (425)
                      .....++..|+|||++.+ ..++.++|||||||++|++++|+.||.......+   ....+.+.         .      
T Consensus       159 ~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~---------~------  222 (284)
T cd06620         159 ADTFVGTSTYMSPERIQG-GKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDL---------L------  222 (284)
T ss_pred             cCccccCcccCCHHHHcc-CCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHH---------H------
Confidence            234578899999999877 6789999999999999999999999853322111   00000000         0      


Q ss_pred             CChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccch
Q 014406          353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE  419 (425)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~~  419 (425)
                           ........    ..+    ....++.++.+|+.+||+.||++|||+.|+++|+||.+...+.
T Consensus       223 -----~~~~~~~~----~~~----~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~~~~  276 (284)
T cd06620         223 -----QQIVQEPP----PRL----PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALRAS  276 (284)
T ss_pred             -----HHHhhccC----CCC----CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccccc
Confidence                 00000000    000    0011577899999999999999999999999999997754443

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=5.3e-41  Score=316.59  Aligned_cols=257  Identities=20%  Similarity=0.370  Sum_probs=200.1

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEE
Q 014406          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (425)
Q Consensus       125 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (425)
                      ++|+..+.||+|+||+||++.+..+++.+|+|.+...    ....+.+|+.++.++.+|+||+++++++..+  ...+++
T Consensus         4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~--~~~~~~   81 (288)
T cd06616           4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFRE--GDCWIC   81 (288)
T ss_pred             HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecC--CcEEEE
Confidence            4566678899999999999999999999999998643    2356788999999995599999999998654  567899


Q ss_pred             EEeecCCC--hhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHC-CceeecCCCCceEecCCCCcEEEEeccccccccC
Q 014406          201 FEYVNSTD--FKVLY-----PTLTDYDIRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (425)
Q Consensus       201 ~e~~~~~~--l~~~~-----~~l~~~~~~~i~~~i~~~L~~LH~~-~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~  272 (425)
                      |||+....  +...+     ..+++..+..++.|++.||+|||+. +++||||||+||+++.+ +.++|+|||+++....
T Consensus        82 ~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~-~~~kl~dfg~~~~~~~  160 (288)
T cd06616          82 MELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRN-GNIKLCDFGISGQLVD  160 (288)
T ss_pred             EecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccC-CcEEEeecchhHHhcc
Confidence            99987532  22221     4588999999999999999999975 99999999999999987 7899999999976554


Q ss_pred             CCcceeeccCCCccCcccccCC--CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhcc
Q 014406          273 GKEYNVRVASRYFKGPELLVDL--QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH  350 (425)
Q Consensus       273 ~~~~~~~~~t~~y~aPE~~~~~--~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~  350 (425)
                      ........++..|+|||.+.+.  ..++.++|||||||++|+|++|+.||....   .....+.+......         
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~---~~~~~~~~~~~~~~---------  228 (288)
T cd06616         161 SIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN---SVFDQLTQVVKGDP---------  228 (288)
T ss_pred             CCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc---hHHHHHhhhcCCCC---------
Confidence            4444445678899999998764  368999999999999999999999984322   11111111111000         


Q ss_pred             CCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccc
Q 014406          351 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR  416 (425)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~  416 (425)
                                          ..........++.++.+|+++||+.||++|||++++++||||+...
T Consensus       229 --------------------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~  274 (288)
T cd06616         229 --------------------PILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYE  274 (288)
T ss_pred             --------------------CcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchh
Confidence                                0000111123788999999999999999999999999999998754

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=4.2e-40  Score=317.01  Aligned_cols=283  Identities=31%  Similarity=0.552  Sum_probs=214.3

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcCC--CcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcC--CCCc
Q 014406          126 DYEVVRKVGRGKYSEVFEGINVNT--NERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQ--HSKT  196 (425)
Q Consensus       126 ~y~~~~~LG~G~fg~V~~~~~~~~--~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~--~~~~  196 (425)
                      +|++.+.||+|+||.||++.+..+  +..+|+|.+...     ..+.+.+|+.+++++.+|+||+++++.+...  ....
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            588899999999999999999888  899999998642     2356788999999996799999999976432  2345


Q ss_pred             cEEEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCC
Q 014406          197 PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (425)
Q Consensus       197 ~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~  273 (425)
                      .++++||+++ +|..++   ..+++..++.++.||+.||+|||+.||+|+||||+||+++.+ +.++|+|||+++.....
T Consensus        81 ~~~~~e~~~~-~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~-~~~kl~Dfg~a~~~~~~  158 (332)
T cd07857          81 LYLYEELMEA-DLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNAD-CELKICDFGLARGFSEN  158 (332)
T ss_pred             EEEEEecccC-CHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCC-CCEEeCcCCCceecccc
Confidence            7888898874 566554   458899999999999999999999999999999999999988 78999999999765432


Q ss_pred             Cc-----ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhh
Q 014406          274 KE-----YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK  348 (425)
Q Consensus       274 ~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~  348 (425)
                      ..     .....++..|+|||.+.+...++.++||||+||++|+|++|..|| .+.+....+..+...+|.++..... .
T Consensus       159 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~-~  236 (332)
T cd07857         159 PGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVF-KGKDYVDQLNQILQVLGTPDEETLS-R  236 (332)
T ss_pred             cccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCC-CCCCHHHHHHHHHHHhCCCCHHHHH-h
Confidence            21     123467889999998876567899999999999999999998876 5555667788888888876543321 1


Q ss_pred             ccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCccccc
Q 014406          349 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA  417 (425)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~  417 (425)
                      ......................     .....++..+.+|+.+||+.||++|||+.|+++||||...+.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~  300 (332)
T cd07857         237 IGSPKAQNYIRSLPNIPKKPFE-----SIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHD  300 (332)
T ss_pred             hhhhhHHHHHHhccccCCcchH-----hhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcC
Confidence            1111000000000000000100     111225788999999999999999999999999999987654

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=8.1e-41  Score=313.65  Aligned_cols=252  Identities=26%  Similarity=0.412  Sum_probs=204.9

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEE
Q 014406          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (425)
Q Consensus       125 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (425)
                      ..|+..+.||.|+||.||+|.+..++..+|+|++....    ...+.+|+.+++++ +|+||+++++.+.+.  ...++|
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~lv   80 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQC-DSPYVTKYYGSYLKG--TKLWII   80 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEEC--CEEEEE
Confidence            45777889999999999999999999999999987432    35688899999999 999999999999664  678999


Q ss_pred             EEeecCCChhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCc-ce
Q 014406          201 FEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-YN  277 (425)
Q Consensus       201 ~e~~~~~~l~~~~~--~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~-~~  277 (425)
                      |||+++++|.+++.  .+++.++..++.|++.||+|||+.+++|+||+|+||+++.+ +.++|+|||++........ ..
T Consensus        81 ~e~~~~~~L~~~i~~~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~-~~~~l~dfg~~~~~~~~~~~~~  159 (277)
T cd06640          81 MEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQ-GDVKLADFGVAGQLTDTQIKRN  159 (277)
T ss_pred             EecCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCC-CCEEEcccccceeccCCccccc
Confidence            99999999988774  48889999999999999999999999999999999999988 7899999999976543322 23


Q ss_pred             eeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCChhh
Q 014406          278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQL  357 (425)
Q Consensus       278 ~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~  357 (425)
                      ...++..|+|||++.+ ..++.++|+|||||++|+|++|..||... +.......+.. ..                   
T Consensus       160 ~~~~~~~y~apE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~-~~~~~~~~~~~-~~-------------------  217 (277)
T cd06640         160 TFVGTPFWMAPEVIQQ-SAYDSKADIWSLGITAIELAKGEPPNSDM-HPMRVLFLIPK-NN-------------------  217 (277)
T ss_pred             cccCcccccCHhHhcc-CCCccHHHHHHHHHHHHHHHHCCCCCCCc-ChHhHhhhhhc-CC-------------------
Confidence            3457788999999876 67899999999999999999999998422 21111111000 00                   


Q ss_pred             HHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccc
Q 014406          358 DALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA  418 (425)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~  418 (425)
                                      .......++..+.+++.+||+.+|++|||+.++++||||.+....
T Consensus       218 ----------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~  262 (277)
T cd06640         218 ----------------PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNAKK  262 (277)
T ss_pred             ----------------CCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhcchh
Confidence                            000111257789999999999999999999999999999887653

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=7.3e-40  Score=314.67  Aligned_cols=285  Identities=33%  Similarity=0.576  Sum_probs=216.4

Q ss_pred             CCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecC-----cchHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCc
Q 014406          122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (425)
Q Consensus       122 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (425)
                      ...++|++.+.||.|+||.||+|.+..+++.+|+|.+..     ...+.+.+|+.+++.+ +||||++++++|... +..
T Consensus         7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~-~~~   84 (328)
T cd07856           7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHL-RHENIISLSDIFISP-LED   84 (328)
T ss_pred             ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhc-CCCCeeeEeeeEecC-CCc
Confidence            457889999999999999999999999999999998753     2345688999999999 999999999998653 356


Q ss_pred             cEEEEEeecCCChhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCC
Q 014406          197 PSLIFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (425)
Q Consensus       197 ~~lv~e~~~~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~  274 (425)
                      .++++||++ ++|..++  ..+++..+..++.|++.||.|||+.+|+|+||+|+||+++.+ +.++|+|||++.....  
T Consensus        85 ~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~-~~~~l~dfg~~~~~~~--  160 (328)
T cd07856          85 IYFVTELLG-TDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINEN-CDLKICDFGLARIQDP--  160 (328)
T ss_pred             EEEEeehhc-cCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCC-CCEEeCccccccccCC--
Confidence            789999985 4677665  357888889999999999999999999999999999999987 7899999999875432  


Q ss_pred             cceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCC
Q 014406          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD  354 (425)
Q Consensus       275 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~  354 (425)
                      ......++..|+|||.+.+...++.++|||||||++|+|++|+.|| .+.+.......+.+.+|.+..... ......  
T Consensus       161 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f-~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~--  236 (328)
T cd07856         161 QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLF-PGKDHVNQFSIITDLLGTPPDDVI-NTICSE--  236 (328)
T ss_pred             CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCCHHHH-Hhccch--
Confidence            2233466788999999866467899999999999999999999887 444445556666677766442211 110000  


Q ss_pred             hhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccch
Q 014406          355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE  419 (425)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~~  419 (425)
                      ... ..........  .....+....+++++.+++++||+.+|++|||+++++.||||.......
T Consensus       237 ~~~-~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~~  298 (328)
T cd07856         237 NTL-RFVQSLPKRE--PVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPT  298 (328)
T ss_pred             hhH-HHHhhccccC--CCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCCc
Confidence            000 0000000000  0000111123678999999999999999999999999999998766543

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.3e-41  Score=313.03  Aligned_cols=254  Identities=25%  Similarity=0.441  Sum_probs=204.0

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc----chHHHHHHHHHHHHhc--CCCCeeeEEeEEEcCCCCccEE
Q 014406          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLC--GGPNVVKLLDIVRDQHSKTPSL  199 (425)
Q Consensus       126 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~--~h~niv~l~~~~~~~~~~~~~l  199 (425)
                      .|++.+.||+|+||.||+|.+..+++.+|+|.++..    ..+.+.+|+.+++.+.  .|+|++++++++.+  +...++
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~--~~~~~l   79 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLK--GPRLWI   79 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeee--CCEEEE
Confidence            477788999999999999999999999999998642    2456888999999983  39999999999865  367899


Q ss_pred             EEEeecCCChhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCc-c
Q 014406          200 IFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-Y  276 (425)
Q Consensus       200 v~e~~~~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~-~  276 (425)
                      ||||+++++|..++  ..+++..+..++.|++.||.|||+.||+|+||+|+||+++.+ +.++|+|||++........ .
T Consensus        80 v~e~~~~~~L~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~-~~~~l~dfg~~~~~~~~~~~~  158 (277)
T cd06917          80 IMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNT-GNVKLCDFGVAALLNQNSSKR  158 (277)
T ss_pred             EEecCCCCcHHHHHHccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCC-CCEEEccCCceeecCCCcccc
Confidence            99999999998876  357889999999999999999999999999999999999987 7999999999976654322 2


Q ss_pred             eeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCChh
Q 014406          277 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ  356 (425)
Q Consensus       277 ~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~  356 (425)
                      ....++..|+|||.+.+...++.++|+|||||++|+|++|..||.. .+.......    +...                
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~-~~~~~~~~~----~~~~----------------  217 (277)
T cd06917         159 STFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSD-VDAFRAMML----IPKS----------------  217 (277)
T ss_pred             ccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCC-CChhhhhhc----cccC----------------
Confidence            3346788899999987655678999999999999999999999832 111110000    0000                


Q ss_pred             hHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccc
Q 014406          357 LDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA  418 (425)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~  418 (425)
                                .. .    ......++.++.+|+.+||+.||++|||+.|+++||||++....
T Consensus       218 ----------~~-~----~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~~~  264 (277)
T cd06917         218 ----------KP-P----RLEDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHSKT  264 (277)
T ss_pred             ----------CC-C----CCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhccccC
Confidence                      00 0    00011157889999999999999999999999999999887643

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=8.3e-41  Score=316.27  Aligned_cols=257  Identities=27%  Similarity=0.468  Sum_probs=208.5

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc---chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEE
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (425)
                      .++|++.+.||+|+||.||++.+..++..+++|.+...   ..+.+.+|+.+++.+ +|||++++++++...  ...++|
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~hp~i~~~~~~~~~~--~~~~lv   94 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMREN-KHPNIVNYLDSYLVG--DELWVV   94 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhc-CCCCeeehhheeeeC--CcEEEE
Confidence            47899999999999999999999889999999998632   345688899999999 899999999999654  678899


Q ss_pred             EEeecCCChhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCc-ce
Q 014406          201 FEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-YN  277 (425)
Q Consensus       201 ~e~~~~~~l~~~~~--~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~-~~  277 (425)
                      +||+++++|..++.  .+++.++..++.|++.||.|||++|++|+||+|+||+++.+ +.++|+|||++........ ..
T Consensus        95 ~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~-~~~kL~dfg~~~~~~~~~~~~~  173 (293)
T cd06647          95 MEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRS  173 (293)
T ss_pred             EecCCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCC-CCEEEccCcceecccccccccc
Confidence            99999999998874  47889999999999999999999999999999999999988 7899999998875543322 23


Q ss_pred             eeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCChhh
Q 014406          278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQL  357 (425)
Q Consensus       278 ~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~  357 (425)
                      ...++..|++||.+.+ ..++.++|+|||||++|++++|+.||... +..+.+..+.. -+.+                 
T Consensus       174 ~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~ll~~ll~g~~pf~~~-~~~~~~~~~~~-~~~~-----------------  233 (293)
T cd06647         174 TMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNE-NPLRALYLIAT-NGTP-----------------  233 (293)
T ss_pred             cccCChhhcCchhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCC-Chhhheeehhc-CCCC-----------------
Confidence            3467888999999877 67899999999999999999999998432 21111111000 0000                 


Q ss_pred             HHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccchh
Q 014406          358 DALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAES  420 (425)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~~~  420 (425)
                                      .......++..+.+|+++||+.+|++||++.+++.||||+..+...+
T Consensus       234 ----------------~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~~~~~  280 (293)
T cd06647         234 ----------------ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAKPLSS  280 (293)
T ss_pred             ----------------CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCccccc
Confidence                            00011235788999999999999999999999999999998875443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=2.9e-40  Score=307.19  Aligned_cols=249  Identities=29%  Similarity=0.512  Sum_probs=201.4

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEE
Q 014406          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (425)
Q Consensus       126 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (425)
                      +|++.+.||+|+||.||+|.+..++..+++|.++..     ..+.+.+|+++++.+ +|+||+++++.+.+  ....++|
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~--~~~~~lv   77 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELL-KHPNLVKYYGVEVH--REKVYIF   77 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhC-CCCChhheeeeEec--CCEEEEE
Confidence            588899999999999999999999999999998743     345788999999999 99999999999854  4678899


Q ss_pred             EEeecCCChhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCcc-
Q 014406          201 FEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY-  276 (425)
Q Consensus       201 ~e~~~~~~l~~~~~---~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~~-  276 (425)
                      +||+.+++|.+++.   .+++..+..++.|++.||.|||+.|++|+||+|+||+++.+ +.+||+|||++......... 
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~-~~~kl~d~g~~~~~~~~~~~~  156 (264)
T cd06626          78 MEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHN-GVIKLGDFGCAVKLKNNTTTM  156 (264)
T ss_pred             EecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC-CCEEEcccccccccCCCCCcc
Confidence            99999999998873   37888999999999999999999999999999999999987 78999999998766433221 


Q ss_pred             ----eeeccCCCccCcccccCCC--CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhcc
Q 014406          277 ----NVRVASRYFKGPELLVDLQ--DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH  350 (425)
Q Consensus       277 ----~~~~~t~~y~aPE~~~~~~--~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~  350 (425)
                          ....++..|+|||.+.+..  .++.++||||||+++|++++|+.||....+.......+..  +...         
T Consensus       157 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~--~~~~---------  225 (264)
T cd06626         157 GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA--GHKP---------  225 (264)
T ss_pred             cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc--CCCC---------
Confidence                1245678899999987632  2789999999999999999999998543322222111110  0000         


Q ss_pred             CCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCC
Q 014406          351 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF  412 (425)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~  412 (425)
                                             .......+++.+.+|+.+||+.||++|||+.|+++|||+
T Consensus       226 -----------------------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~  264 (264)
T cd06626         226 -----------------------PIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV  264 (264)
T ss_pred             -----------------------CCCcccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence                                   000011257889999999999999999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=2e-40  Score=309.07  Aligned_cols=246  Identities=24%  Similarity=0.440  Sum_probs=199.3

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccE
Q 014406          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (425)
Q Consensus       125 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (425)
                      ++|++.+.||+|+||.||+|.+..+++.||||.+...      ....+.+|+.+++.+ +||||+++++++.+.  ...+
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~   78 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQL-NHPNVIKYLDSFIED--NELN   78 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCcceeeeeeeEEEC--CeEE
Confidence            5799999999999999999999999999999987531      234578899999999 999999999999754  6778


Q ss_pred             EEEEeecCCChhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEecccccccc
Q 014406          199 LIFEYVNSTDFKVLY-------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (425)
Q Consensus       199 lv~e~~~~~~l~~~~-------~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~  271 (425)
                      +++||+++++|..++       ..+++..+..++.|++.||.|||+++++|+||||+||+++.+ +.++|+|||++....
T Consensus        79 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~-~~~~l~d~g~~~~~~  157 (267)
T cd08228          79 IVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITAT-GVVKLGDLGLGRFFS  157 (267)
T ss_pred             EEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCC-CCEEECccccceecc
Confidence            999999999998765       237888999999999999999999999999999999999988 789999999987654


Q ss_pred             CCCc-ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhcc
Q 014406          272 PGKE-YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH  350 (425)
Q Consensus       272 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~  350 (425)
                      .... .....++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||+....+...+.......+.++         
T Consensus       158 ~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------  227 (267)
T cd08228         158 SKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPP---------  227 (267)
T ss_pred             chhHHHhcCCCCccccChhhhcc-CCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCC---------
Confidence            3222 223467888999999877 67899999999999999999999999654433322222211111100         


Q ss_pred             CCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcC
Q 014406          351 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  409 (425)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~h  409 (425)
                                               .....++..+.+++.+||+.+|++|||+.++++.
T Consensus       228 -------------------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~  261 (267)
T cd08228         228 -------------------------LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQI  261 (267)
T ss_pred             -------------------------CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHH
Confidence                                     0011257889999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=2.8e-40  Score=307.10  Aligned_cols=251  Identities=26%  Similarity=0.461  Sum_probs=207.8

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEE
Q 014406          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (425)
Q Consensus       125 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (425)
                      ++|++.+.||+|++|.||+|.+..+++.+++|.+....    .+.+.+|+.++.++ +|+|++++++++...  ...++|
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~--~~~~lv   77 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSC-ESPYVVKCYGAFYKE--GEISIV   77 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhc-CCCCeeeEEEEEccC--CeEEEE
Confidence            46889999999999999999999999999999987543    46788999999999 899999999999654  778999


Q ss_pred             EEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHH-CCceeecCCCCceEecCCCCcEEEEeccccccccCCCcc
Q 014406          201 FEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY  276 (425)
Q Consensus       201 ~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~-~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~~  276 (425)
                      +||+++++|..++   ..+++..+..++.|++.||.|||+ .+++|+||+|+||+++.+ +.++|+|||++.........
T Consensus        78 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~-~~~~l~df~~~~~~~~~~~~  156 (264)
T cd06623          78 LEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSK-GEVKIADFGISKVLENTLDQ  156 (264)
T ss_pred             EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCC-CCEEEccCccceecccCCCc
Confidence            9999999999887   458999999999999999999999 999999999999999988 78999999999876543332


Q ss_pred             -eeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCC-CH-HHHHHHHHHhCCchhHHHHhhccCCC
Q 014406          277 -NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD-NH-DQLVKIAKVLGTDELNAYLNKYHLEL  353 (425)
Q Consensus       277 -~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~-~~-~~~~~~~~~lg~~~~~~~~~~~~~~~  353 (425)
                       ....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||..... .. +....+.   ...             
T Consensus       157 ~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~---~~~-------------  219 (264)
T cd06623         157 CNTFVGTVTYMSPERIQG-ESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC---DGP-------------  219 (264)
T ss_pred             ccceeecccccCHhhhCC-CCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh---cCC-------------
Confidence             24567888999999877 6789999999999999999999999843321 11 1111110   000             


Q ss_pred             ChhhHHHhcccCCCCccccccccCCCC-CCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccc
Q 014406          354 DPQLDALVGRHSRKPWSKFINADNQHL-VSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR  416 (425)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~  416 (425)
                                          ....... ++..+.+++.+||..+|++|||+.|+++|||++.++
T Consensus       220 --------------------~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~~  263 (264)
T cd06623         220 --------------------PPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKAD  263 (264)
T ss_pred             --------------------CCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHhcc
Confidence                                0001112 688999999999999999999999999999998764

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=1.6e-40  Score=307.68  Aligned_cols=246  Identities=23%  Similarity=0.472  Sum_probs=201.2

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEE
Q 014406          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (425)
Q Consensus       126 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (425)
                      +|++.+.||+|+||.||+|.+..++..+|+|.+...     ..+.+.+|+.+++.+ +|+||+++++.+..  ....++|
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~-~h~~i~~~~~~~~~--~~~~~lv   77 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKM-KHPNIVTFFASFQE--NGRLFIV   77 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhC-CCCChhhhhheecc--CCeEEEE
Confidence            588999999999999999999999999999998642     345788999999999 89999999999854  4678999


Q ss_pred             EEeecCCChhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCc
Q 014406          201 FEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (425)
Q Consensus       201 ~e~~~~~~l~~~~~-----~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~  275 (425)
                      +||+.+++|..++.     .+++..+..++.|++.||.|||+.+++|+||||+||+++.+...++|+|||.+........
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~  157 (257)
T cd08225          78 MEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME  157 (257)
T ss_pred             EecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence            99999999988763     3688999999999999999999999999999999999998755679999999876654322


Q ss_pred             c-eeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCC
Q 014406          276 Y-NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD  354 (425)
Q Consensus       276 ~-~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~  354 (425)
                      . ....++..|+|||.+.+ ..++.++|+||||+++++|++|..||... +..+....+..   .            .. 
T Consensus       158 ~~~~~~~~~~~~ape~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~---~------------~~-  219 (257)
T cd08225         158 LAYTCVGTPYYLSPEICQN-RPYNNKTDIWSLGCVLYELCTLKHPFEGN-NLHQLVLKICQ---G------------YF-  219 (257)
T ss_pred             cccccCCCccccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCc-cHHHHHHHHhc---c------------cC-
Confidence            2 23467888999999876 67899999999999999999999998422 21221111110   0            00 


Q ss_pred             hhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCC
Q 014406          355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF  412 (425)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~  412 (425)
                                          ......++.++.+++.+||+.+|++|||+.|+++||||
T Consensus       220 --------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~  257 (257)
T cd08225         220 --------------------APISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL  257 (257)
T ss_pred             --------------------CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence                                00112367899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=4.8e-40  Score=303.98  Aligned_cols=249  Identities=31%  Similarity=0.512  Sum_probs=205.9

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc-----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEE
Q 014406          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (425)
Q Consensus       126 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (425)
                      +|+..+.||+|++|.||+|.+..+++.+++|++....     .+.+.+|+.+++++ +|+||+++++.+.+......+++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~lv   79 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSL-QHPNIVRYYGSERDEEKNTLNIF   79 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHc-CCCCEeeEEEEEecCCCCeEEEE
Confidence            4778899999999999999999999999999987544     56788999999999 89999999999976533678899


Q ss_pred             EEeecCCChhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCc--
Q 014406          201 FEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE--  275 (425)
Q Consensus       201 ~e~~~~~~l~~~~~---~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~--  275 (425)
                      +||+++++|.+++.   .+++..+..++.|++.||+|||+.+++|+||+|+||+++.+ +.++|+|||.+........  
T Consensus        80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~-~~~~l~d~~~~~~~~~~~~~~  158 (260)
T cd06606          80 LEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSD-GVVKLADFGCAKRLGDIETGE  158 (260)
T ss_pred             EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCC-CCEEEcccccEEecccccccc
Confidence            99999999988763   58999999999999999999999999999999999999987 7899999999987765443  


Q ss_pred             -ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCC
Q 014406          276 -YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD  354 (425)
Q Consensus       276 -~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~  354 (425)
                       .....++..|++||.+.+ ..++.++||||||+++++|++|..||....+.......+   ....              
T Consensus       159 ~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~---~~~~--------------  220 (260)
T cd06606         159 GTGSVRGTPYWMAPEVIRG-EEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKI---GSSG--------------  220 (260)
T ss_pred             cccCCCCCccccCHhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhc---cccC--------------
Confidence             345678889999999877 568999999999999999999999984433111111111   0000              


Q ss_pred             hhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCC
Q 014406          355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF  412 (425)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~  412 (425)
                                        ........++..+.+|+.+||+.||++|||+.|+++||||
T Consensus       221 ------------------~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~  260 (260)
T cd06606         221 ------------------EPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL  260 (260)
T ss_pred             ------------------CCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence                              0001112358899999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-41  Score=292.22  Aligned_cols=252  Identities=22%  Similarity=0.322  Sum_probs=198.7

Q ss_pred             CCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEec---CcchHHHHHHHHHHHHhcCCCCeeeEEeEEEcC---CCC
Q 014406          122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK---PVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQ---HSK  195 (425)
Q Consensus       122 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~---~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~---~~~  195 (425)
                      .++++|.+.+.||+|||+-||.++...++..+|+|.+.   .+..+...+|++..+++ +|||+++++++...+   ...
T Consensus        18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf-~s~~vl~l~dh~l~~~~D~~~   96 (302)
T KOG2345|consen   18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKF-NSPNVLRLVDHQLREEKDGKH   96 (302)
T ss_pred             EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhh-CCcchHHHHHHHHHhhccCce
Confidence            36789999999999999999999999999999999885   24456788999999999 999999999977533   234


Q ss_pred             ccEEEEEeecCCChhhhcC-------CCCHHHHHHHHHHHHHHHHHHHHCC--ceeecCCCCceEecCCCCcEEEEeccc
Q 014406          196 TPSLIFEYVNSTDFKVLYP-------TLTDYDIRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHELRKLRLIDWGL  266 (425)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~~-------~l~~~~~~~i~~~i~~~L~~LH~~~--ivH~Dlk~~NIll~~~~~~~kl~Dfg~  266 (425)
                      ..||+++|...|+|.+.+.       .+++.++..|+.++++||++||+..  +.||||||.|||++++ +.+++.|||.
T Consensus        97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~-~~~vl~D~GS  175 (302)
T KOG2345|consen   97 EAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDS-GLPVLMDLGS  175 (302)
T ss_pred             eEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCC-CceEEEeccC
Confidence            5899999999999887762       4899999999999999999999998  9999999999999987 7899999999


Q ss_pred             cccccCC----------CcceeeccCCCccCcccccCC--CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHH
Q 014406          267 AEFYHPG----------KEYNVRVASRYFKGPELLVDL--QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA  334 (425)
Q Consensus       267 a~~~~~~----------~~~~~~~~t~~y~aPE~~~~~--~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~  334 (425)
                      ++...-.          ........|..|+|||.+.-.  ...++++|||||||+||.|+.|..||.....         
T Consensus       176 ~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~---------  246 (302)
T KOG2345|consen  176 ATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ---------  246 (302)
T ss_pred             ccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh---------
Confidence            8754311          111224568889999998431  3467999999999999999999999921100         


Q ss_pred             HHhCCchhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcC
Q 014406          335 KVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  409 (425)
Q Consensus       335 ~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~h  409 (425)
                        -|..          ..+.-             ...-+...+...+|+.+.+|++.||+.||.+||++.+++.+
T Consensus       247 --~GgS----------laLAv-------------~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~  296 (302)
T KOG2345|consen  247 --QGGS----------LALAV-------------QNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK  296 (302)
T ss_pred             --cCCe----------EEEee-------------eccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence              0100          00000             00011112223389999999999999999999999999864

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=1.6e-40  Score=314.87  Aligned_cols=251  Identities=24%  Similarity=0.439  Sum_probs=203.4

Q ss_pred             EEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc---chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEEEe
Q 014406          127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEY  203 (425)
Q Consensus       127 y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~  203 (425)
                      |+....||+|+||.||+|.+..+++.||+|.+...   ..+.+.+|+.+++.+ +|||++++++++...  ...++++||
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~hp~i~~~~~~~~~~--~~~~iv~e~   99 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDY-QHQNVVEMYKSYLVG--EELWVLMEF   99 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhC-CCCchhhhhhheeeC--CeEEEEEec
Confidence            33445799999999999999999999999998632   345688999999999 899999999998654  678999999


Q ss_pred             ecCCChhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCC-cceeec
Q 014406          204 VNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EYNVRV  280 (425)
Q Consensus       204 ~~~~~l~~~~~--~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~  280 (425)
                      +++++|..++.  .+++..+..++.|++.||.|||+.|++|+||||+||+++.+ +.++|+|||++....... ......
T Consensus       100 ~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~-~~~kL~dfg~~~~~~~~~~~~~~~~  178 (297)
T cd06659         100 LQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLD-GRVKLSDFGFCAQISKDVPKRKSLV  178 (297)
T ss_pred             CCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccC-CcEEEeechhHhhccccccccccee
Confidence            99999988763  58899999999999999999999999999999999999988 789999999987554322 223456


Q ss_pred             cCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCChhhHHH
Q 014406          281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDAL  360 (425)
Q Consensus       281 ~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~  360 (425)
                      ++..|+|||++.+ ..++.++|||||||++++|++|+.||+.. +..+.+..+..   ...                   
T Consensus       179 ~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~p~~~~-~~~~~~~~~~~---~~~-------------------  234 (297)
T cd06659         179 GTPYWMAPEVISR-TPYGTEVDIWSLGIMVIEMVDGEPPYFSD-SPVQAMKRLRD---SPP-------------------  234 (297)
T ss_pred             cCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHhc---cCC-------------------
Confidence            8889999999977 67899999999999999999999998532 22222211110   000                   


Q ss_pred             hcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCccccc
Q 014406          361 VGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA  417 (425)
Q Consensus       361 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~  417 (425)
                                  ........++..+.+|+++||+.+|++|||++++++||||.+...
T Consensus       235 ------------~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~~  279 (297)
T cd06659         235 ------------PKLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTGL  279 (297)
T ss_pred             ------------CCccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCCC
Confidence                        000011236788999999999999999999999999999998753

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=3.8e-40  Score=309.09  Aligned_cols=251  Identities=26%  Similarity=0.416  Sum_probs=204.0

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEE
Q 014406          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (425)
Q Consensus       126 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (425)
                      -|++.+.||+|+||.||+|.+..++..+|+|++....    .+.+.+|+.++.++ +|+||+++++++.+.  ...++||
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~--~~~~lv~   81 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC-DSPYVTKYYGSYLKD--TKLWIIM   81 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhc-CCCCEeEEEEEEEeC--CeEEEEE
Confidence            4667889999999999999998999999999986432    35688899999999 999999999999654  6788999


Q ss_pred             EeecCCChhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCC-ccee
Q 014406          202 EYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EYNV  278 (425)
Q Consensus       202 e~~~~~~l~~~~~--~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~-~~~~  278 (425)
                      ||+++++|..++.  .+++..+..++.|++.|+.|||+.|++|+||+|+||+++.+ +.++|+|||++....... ....
T Consensus        82 e~~~~~~l~~~i~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~-~~~~l~dfg~~~~~~~~~~~~~~  160 (277)
T cd06641          82 EYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEH-GEVKLADFGVAGQLTDTQIKRNT  160 (277)
T ss_pred             EeCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCC-CCEEEeecccceecccchhhhcc
Confidence            9999999988874  48899999999999999999999999999999999999988 789999999987654322 1233


Q ss_pred             eccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCChhhH
Q 014406          279 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLD  358 (425)
Q Consensus       279 ~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~  358 (425)
                      ..++..|+|||.+.+ ..++.++|+|||||++|+|++|..||.. .........+.. .+                    
T Consensus       161 ~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~-~~~~~~~~~~~~-~~--------------------  217 (277)
T cd06641         161 FVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELAKGEPPHSE-LHPMKVLFLIPK-NN--------------------  217 (277)
T ss_pred             ccCCccccChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCc-cchHHHHHHHhc-CC--------------------
Confidence            467888999999876 6788999999999999999999999832 221111111100 00                    


Q ss_pred             HHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccc
Q 014406          359 ALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA  418 (425)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~  418 (425)
                                     .......++.++.+++.+||+.+|++||++.++++||||.+....
T Consensus       218 ---------------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~~~~  262 (277)
T cd06641         218 ---------------PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRFAKK  262 (277)
T ss_pred             ---------------CCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhhhhc
Confidence                           000112367899999999999999999999999999999986543

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=2.7e-40  Score=313.13  Aligned_cols=260  Identities=23%  Similarity=0.388  Sum_probs=203.8

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccE
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (425)
                      ..++|++.+.||+|+||+||+|.+..+++.+|||.++..    ....+..|+.++....+|+||+++++++.+.  ...+
T Consensus        13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--~~~~   90 (296)
T cd06618          13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITD--SDVF   90 (296)
T ss_pred             CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecC--CeEE
Confidence            457899999999999999999999988999999998743    2345667887777775699999999999654  6789


Q ss_pred             EEEEeecCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHH-CCceeecCCCCceEecCCCCcEEEEeccccccccCC
Q 014406          199 LIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (425)
Q Consensus       199 lv~e~~~~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~LH~-~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~  273 (425)
                      ++|||+.+ ++..+.    ..+++..+..++.|++.||.|||+ .||+|+||+|+||+++.+ +.+||+|||++......
T Consensus        91 ~v~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~-~~~kL~dfg~~~~~~~~  168 (296)
T cd06618          91 ICMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDAS-GNVKLCDFGISGRLVDS  168 (296)
T ss_pred             EEeeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCC-CCEEECccccchhccCC
Confidence            99999865 444433    348899999999999999999997 599999999999999987 79999999999766544


Q ss_pred             CcceeeccCCCccCcccccCC---CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhcc
Q 014406          274 KEYNVRVASRYFKGPELLVDL---QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH  350 (425)
Q Consensus       274 ~~~~~~~~t~~y~aPE~~~~~---~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~  350 (425)
                      .......++..|+|||.+.+.   ..++.++||||||+++|+|++|+.||.....+.+.+..+..   ...         
T Consensus       169 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~---~~~---------  236 (296)
T cd06618         169 KAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQ---EEP---------  236 (296)
T ss_pred             CcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhc---CCC---------
Confidence            334445677889999998753   23788999999999999999999998543222222222111   000         


Q ss_pred             CCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccchh
Q 014406          351 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAES  420 (425)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~~~  420 (425)
                                      .      .......+++++.+|+.+||+.||++|||++++++||||.......+
T Consensus       237 ----------------~------~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~~  284 (296)
T cd06618         237 ----------------P------SLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYETAEV  284 (296)
T ss_pred             ----------------C------CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccchhHH
Confidence                            0      00001136789999999999999999999999999999998765543

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=2.8e-41  Score=316.78  Aligned_cols=251  Identities=26%  Similarity=0.418  Sum_probs=203.0

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEE
Q 014406          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (425)
Q Consensus       126 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (425)
                      .|+..+.||+|+||.||+|.+..++..||+|.++...    .+.+.+|+.+++++ +|+||+++++++.+.  ...++||
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~lv~   81 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQC-DSPYITRYYGSYLKG--TKLWIIM   81 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcC-CCCccHhhhcccccC--CceEEEE
Confidence            4566778999999999999999999999999987432    34688999999999 899999999999654  6789999


Q ss_pred             EeecCCChhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCc-cee
Q 014406          202 EYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-YNV  278 (425)
Q Consensus       202 e~~~~~~l~~~~~--~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~-~~~  278 (425)
                      ||+++++|..++.  .+++..+..++.|++.||.|||++|++|+||+|+||+++.+ +.++|+|||++........ ...
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~-~~~~l~dfg~~~~~~~~~~~~~~  160 (277)
T cd06642          82 EYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQ-GDVKLADFGVAGQLTDTQIKRNT  160 (277)
T ss_pred             EccCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCC-CCEEEccccccccccCcchhhhc
Confidence            9999999988773  47899999999999999999999999999999999999987 7899999999976543321 223


Q ss_pred             eccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCChhhH
Q 014406          279 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLD  358 (425)
Q Consensus       279 ~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~  358 (425)
                      ..++..|+|||.+.+ ..++.++|||||||++|+|++|..||... ........+..    .                  
T Consensus       161 ~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~-~~~~~~~~~~~----~------------------  216 (277)
T cd06642         161 FVGTPFWMAPEVIKQ-SAYDFKADIWSLGITAIELAKGEPPNSDL-HPMRVLFLIPK----N------------------  216 (277)
T ss_pred             ccCcccccCHHHhCc-CCCchhhhHHHHHHHHHHHHhCCCCCccc-chhhHHhhhhc----C------------------
Confidence            457888999999977 67899999999999999999999998321 11111111000    0                  


Q ss_pred             HHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccc
Q 014406          359 ALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA  418 (425)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~  418 (425)
                            .        .......++.++.+++.+||+.+|++|||+.++++||||.+....
T Consensus       217 ------~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~  262 (277)
T cd06642         217 ------S--------PPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRYTKK  262 (277)
T ss_pred             ------C--------CCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHHHhhh
Confidence                  0        000112367889999999999999999999999999999876543

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-40  Score=310.54  Aligned_cols=273  Identities=37%  Similarity=0.671  Sum_probs=209.8

Q ss_pred             EEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc-----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEE
Q 014406          127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (425)
Q Consensus       127 y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (425)
                      |++.+.||.|++|.||+|.+..+++.+++|.+....     ...+.+|+.+++.+ +|+||+++++++.+.  ...++|+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~--~~~~~v~   77 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKEL-NHPNIIKLLDVFRHK--GDLYLVF   77 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHh-cCCCcchHHHhhccC--CCEEEEE
Confidence            566788999999999999999999999999986432     35678899999999 899999999999654  7788999


Q ss_pred             EeecCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCC-cc
Q 014406          202 EYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EY  276 (425)
Q Consensus       202 e~~~~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~-~~  276 (425)
                      ||+++ ++...+    ..+++..+..++.|++.||.|||+.+|+|+||+|+||+++.+ +.++|+|||.+....... ..
T Consensus        78 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~-~~~~l~df~~~~~~~~~~~~~  155 (283)
T cd05118          78 EFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTE-GVLKLADFGLARSFGSPVRPY  155 (283)
T ss_pred             eccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCC-CcEEEeeeeeeEecCCCcccc
Confidence            99987 444443    258899999999999999999999999999999999999987 789999999997765443 23


Q ss_pred             eeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCChh
Q 014406          277 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ  356 (425)
Q Consensus       277 ~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~  356 (425)
                      ....++..|+|||.+.+...++.++|+||||+++|+|++|+.|| .+.+..+.+..+...++.+....+......  ...
T Consensus       156 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~  232 (283)
T cd05118         156 THYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLF-PGKSEIDQLFKIFRTLGTPDPEVWPKFTSL--ARN  232 (283)
T ss_pred             cCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHcCCCchHhcccchhh--hhh
Confidence            33467788999999987447899999999999999999999877 555666777777666665433222111000  000


Q ss_pred             hHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCC
Q 014406          357 LDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF  412 (425)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~  412 (425)
                      ............     .......++.++++|+.+||++||.+||+++++++||||
T Consensus       233 ~~~~~~~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~  283 (283)
T cd05118         233 YKFSFPKKAGMP-----LPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF  283 (283)
T ss_pred             hhhhhccccccC-----HHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence            000000000000     011122368899999999999999999999999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=4.8e-40  Score=309.10  Aligned_cols=274  Identities=32%  Similarity=0.574  Sum_probs=211.4

Q ss_pred             EEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEEE
Q 014406          127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE  202 (425)
Q Consensus       127 y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e  202 (425)
                      |++.+.||+|+||+||+|.+..+++.++||.+....    .....+|+..++++.+|+|++++++++.+  ....++|||
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~--~~~~~lv~e   78 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRE--NDELYFVFE   78 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhc--CCcEEEEEe
Confidence            567889999999999999998899999999986432    23456799999999349999999999966  477899999


Q ss_pred             eecCCChhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCcce
Q 014406          203 YVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN  277 (425)
Q Consensus       203 ~~~~~~l~~~~-----~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~~~  277 (425)
                      |+ ++++...+     ..+++..+..++.|++.+|.|||++|++|+||+|+||+++.+ +.++|+|||++..........
T Consensus        79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~-~~~~l~d~~~~~~~~~~~~~~  156 (283)
T cd07830          79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGP-EVVKIADFGLAREIRSRPPYT  156 (283)
T ss_pred             cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCC-CCEEEeecccceeccCCCCcC
Confidence            99 66666554     247899999999999999999999999999999999999987 789999999998765544445


Q ss_pred             eeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCChhh
Q 014406          278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQL  357 (425)
Q Consensus       278 ~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~  357 (425)
                      ...++..|+|||++.+...++.++|+||||+++++|++|+.|| ......+....+...++.+....+........  ..
T Consensus       157 ~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~  233 (283)
T cd07830         157 DYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLF-PGSSEIDQLYKICSVLGTPTKQDWPEGYKLAS--KL  233 (283)
T ss_pred             CCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCcc-CCCChHHHHHHHHHhcCCCChhhhhhHhhhhc--cc
Confidence            5677889999999866566899999999999999999999886 55566777777777777655443322111100  00


Q ss_pred             HHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCC
Q 014406          358 DALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF  412 (425)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~  412 (425)
                      .....     ..............+..+.+|+++||+.||++|||+.|++.||||
T Consensus       234 ~~~~~-----~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~  283 (283)
T cd07830         234 GFRFP-----QFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF  283 (283)
T ss_pred             ccccc-----ccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence            00000     000000000111236889999999999999999999999999997

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=4.5e-40  Score=307.55  Aligned_cols=251  Identities=26%  Similarity=0.484  Sum_probs=198.3

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----c--------hHHHHHHHHHHHHhcCCCCeeeEEeEEEcC
Q 014406          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----K--------KKKIKREIKILQNLCGGPNVVKLLDIVRDQ  192 (425)
Q Consensus       126 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~--------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  192 (425)
                      +|.+.+.||.|+||.||+|.+..+++.+|+|.++..     .        .+.+.+|+.+++.+ +|+|++++++++...
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~   80 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL-DHLNIVQYLGFETTE   80 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhc-CCCCcceEEEEeccC
Confidence            577888999999999999999989999999987521     1        13577899999999 899999999999654


Q ss_pred             CCCccEEEEEeecCCChhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEecccccc
Q 014406          193 HSKTPSLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (425)
Q Consensus       193 ~~~~~~lv~e~~~~~~l~~~~~---~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~  269 (425)
                        ...++||||+.+++|..++.   .+++..++.++.|++.||.|||+.+++|+||+|+||+++.+ +.++|+|||+++.
T Consensus        81 --~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~-~~~~l~d~~~~~~  157 (272)
T cd06629          81 --EYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDAD-GICKISDFGISKK  157 (272)
T ss_pred             --CceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCC-CeEEEeecccccc
Confidence              67889999999999988763   48889999999999999999999999999999999999987 7999999999875


Q ss_pred             ccCCC---cceeeccCCCccCcccccCCC-CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHH
Q 014406          270 YHPGK---EYNVRVASRYFKGPELLVDLQ-DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAY  345 (425)
Q Consensus       270 ~~~~~---~~~~~~~t~~y~aPE~~~~~~-~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~  345 (425)
                      .....   ......++..|+|||.+.+.. .++.++|+||||+++|++++|..||... +   ....+.+.....     
T Consensus       158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~-~---~~~~~~~~~~~~-----  228 (272)
T cd06629         158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDE-E---AIAAMFKLGNKR-----  228 (272)
T ss_pred             ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCc-c---hHHHHHHhhccc-----
Confidence            43211   122345778899999987633 4789999999999999999999998321 1   111111110000     


Q ss_pred             HhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCC
Q 014406          346 LNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF  412 (425)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~  412 (425)
                                         ..    ..........++.++.+|+.+||+.+|++|||++++++||||
T Consensus       229 -------------------~~----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~  272 (272)
T cd06629         229 -------------------SA----PPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI  272 (272)
T ss_pred             -------------------cC----CcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence                               00    000011122368899999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=4.5e-40  Score=308.84  Aligned_cols=250  Identities=24%  Similarity=0.406  Sum_probs=196.2

Q ss_pred             eeeeeCceEEEEEEEcCCCcEEEEEEecCcc------hHHHHHHHHHHHHh--cCCCCeeeEEeEEEcCCCCccEEEEEe
Q 014406          132 KVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNL--CGGPNVVKLLDIVRDQHSKTPSLIFEY  203 (425)
Q Consensus       132 ~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l--~~h~niv~l~~~~~~~~~~~~~lv~e~  203 (425)
                      .||+|+||.||+|.+..+++.||+|.+....      ...+..|..+++.+  .+|+||+++++++.+.  ...++||||
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~--~~~~~v~e~   78 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP--DKLSFILDL   78 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecC--CEEEEEEec
Confidence            3899999999999999999999999986432      11233444433332  2799999999999654  678899999


Q ss_pred             ecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCcceeec
Q 014406          204 VNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRV  280 (425)
Q Consensus       204 ~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~~~~~~  280 (425)
                      +.+++|..++   ..+++..++.++.|++.||+|||+.+|+|+||||+||+++.+ +.++|+|||++...... ......
T Consensus        79 ~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~-~~~kl~dfg~~~~~~~~-~~~~~~  156 (278)
T cd05606          79 MNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEH-GHVRISDLGLACDFSKK-KPHASV  156 (278)
T ss_pred             CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCC-CCEEEccCcCccccCcc-CCcCcC
Confidence            9999998776   348999999999999999999999999999999999999988 78999999998755432 223457


Q ss_pred             cCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCC-HHHHHHHHHHhCCchhHHHHhhccCCCChhhHH
Q 014406          281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN-HDQLVKIAKVLGTDELNAYLNKYHLELDPQLDA  359 (425)
Q Consensus       281 ~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~-~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~  359 (425)
                      ++..|+|||.+.+...++.++||||+||++|+|++|+.||...... .........  .                     
T Consensus       157 ~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--~---------------------  213 (278)
T cd05606         157 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL--T---------------------  213 (278)
T ss_pred             CCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhh--c---------------------
Confidence            8899999999976456899999999999999999999998533211 111110000  0                     


Q ss_pred             HhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCc-----CHHHHhcCCCCcccccchhc
Q 014406          360 LVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYFAQVRAAESS  421 (425)
Q Consensus       360 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rp-----ta~elL~hp~~~~~~~~~~~  421 (425)
                                   .....+..++.++.+++++||..||.+|+     ++.++++||||+...+.+..
T Consensus       214 -------------~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~~~~~  267 (278)
T cd05606         214 -------------MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQMVF  267 (278)
T ss_pred             -------------cCCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCCchHhh
Confidence                         00111223688999999999999999999     99999999999998876543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=5.9e-40  Score=309.60  Aligned_cols=253  Identities=21%  Similarity=0.386  Sum_probs=198.4

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcC-----CCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCC
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVN-----TNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQH  193 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~-----~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  193 (425)
                      ..++|++.+.||+|+||.||+|....     .+..||+|.++...    ...+.+|+.+++.+ +|+||+++++++.+. 
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~-   81 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGF-TCHHVVRLLGVVSKG-   81 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEcCC-
Confidence            46889999999999999999997542     34589999886432    23577899999999 899999999998654 


Q ss_pred             CCccEEEEEeecCCChhhhcCC-------------CCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEE
Q 014406          194 SKTPSLIFEYVNSTDFKVLYPT-------------LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLR  260 (425)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~~~-------------l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~k  260 (425)
                       ...++||||+.+++|..++..             .+...+..++.|++.||.|||+++|+|+||||+||+++.+ +.++
T Consensus        82 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~-~~~~  159 (288)
T cd05061          82 -QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHD-FTVK  159 (288)
T ss_pred             -CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCC-CcEE
Confidence             578999999999999988732             3456788899999999999999999999999999999988 7899


Q ss_pred             EEeccccccccCCCcc---eeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHH
Q 014406          261 LIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKV  336 (425)
Q Consensus       261 l~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~  336 (425)
                      |+|||+++........   ....++..|+|||.+.+ ..++.++|||||||++|||++ |..|| .+.+..+....+.. 
T Consensus       160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~DvwslG~~l~el~~~~~~p~-~~~~~~~~~~~~~~-  236 (288)
T cd05061         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD-GVFTTSSDMWSFGVVLWEITSLAEQPY-QGLSNEQVLKFVMD-  236 (288)
T ss_pred             ECcCCccccccccccccccCCCcccccccCHHHhcc-CCCChHhHHHHHHHHHHHHHhCCCCCC-CCCCHHHHHHHHHc-
Confidence            9999998755332211   12234567999999877 678999999999999999998 66676 33332222221110 


Q ss_pred             hCCchhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhc------CC
Q 014406          337 LGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA------HP  410 (425)
Q Consensus       337 lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~------hp  410 (425)
                       +  .                      .          ......+++.+.+++.+||+.||++|||+.++++      ||
T Consensus       237 -~--~----------------------~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~  281 (288)
T cd05061         237 -G--G----------------------Y----------LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHP  281 (288)
T ss_pred             -C--C----------------------C----------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCC
Confidence             0  0                      0          0011225789999999999999999999999987      99


Q ss_pred             CCccccc
Q 014406          411 YFAQVRA  417 (425)
Q Consensus       411 ~~~~~~~  417 (425)
                      ||.++.+
T Consensus       282 ~~~~~~~  288 (288)
T cd05061         282 SFPEVSF  288 (288)
T ss_pred             CCCCCCC
Confidence            9998864

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=3e-42  Score=327.44  Aligned_cols=235  Identities=19%  Similarity=0.308  Sum_probs=195.3

Q ss_pred             EEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcchHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEEEeecCC
Q 014406          128 EVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST  207 (425)
Q Consensus       128 ~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~  207 (425)
                      ..++-||.|+.|.||+|+.  .++.||||.++    +.-..+|+-|++| +|+||+.+.|+|..  .-.+|+|||||..|
T Consensus       127 sELeWlGSGaQGAVF~Grl--~netVAVKKV~----elkETdIKHLRkL-kH~NII~FkGVCtq--sPcyCIiMEfCa~G  197 (904)
T KOG4721|consen  127 SELEWLGSGAQGAVFLGRL--HNETVAVKKVR----ELKETDIKHLRKL-KHPNIITFKGVCTQ--SPCYCIIMEFCAQG  197 (904)
T ss_pred             hhhhhhccCcccceeeeec--cCceehhHHHh----hhhhhhHHHHHhc-cCcceeeEeeeecC--CceeEEeeeccccc
Confidence            3456799999999999964  47889999876    3334688999999 99999999999954  47889999999999


Q ss_pred             Chhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCcceeeccCCC
Q 014406          208 DFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY  284 (425)
Q Consensus       208 ~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~  284 (425)
                      -|...+   +.++...+..|..+|+.||.|||.+.|||||||.-||||..+ ..|||+|||-++........-...||..
T Consensus       198 qL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~-d~VKIsDFGTS~e~~~~STkMSFaGTVa  276 (904)
T KOG4721|consen  198 QLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYD-DVVKISDFGTSKELSDKSTKMSFAGTVA  276 (904)
T ss_pred             cHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeecc-ceEEeccccchHhhhhhhhhhhhhhhHh
Confidence            999887   358888999999999999999999999999999999999998 7999999999987766555566799999


Q ss_pred             ccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCChhhHHHhccc
Q 014406          285 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRH  364 (425)
Q Consensus       285 y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~  364 (425)
                      |||||++.+ .+.++|+|||||||+|||||||..||..    -+.-+.|   .|...                       
T Consensus       277 WMAPEvIrn-ePcsEKVDIwSfGVVLWEmLT~EiPYkd----VdssAII---wGVGs-----------------------  325 (904)
T KOG4721|consen  277 WMAPEVIRN-EPCSEKVDIWSFGVVLWEMLTGEIPYKD----VDSSAII---WGVGS-----------------------  325 (904)
T ss_pred             hhCHHHhhc-CCcccccceehhHHHHHHHHhcCCCccc----cchheeE---EeccC-----------------------
Confidence            999999998 8999999999999999999999999821    1111111   11000                       


Q ss_pred             CCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcC
Q 014406          365 SRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  409 (425)
Q Consensus       365 ~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~h  409 (425)
                            ..+....+..+++.++=||+.||+-.|..||++.++|+|
T Consensus       326 ------NsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~H  364 (904)
T KOG4721|consen  326 ------NSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLH  364 (904)
T ss_pred             ------CcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHH
Confidence                  011122334478999999999999999999999999999

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=2.1e-40  Score=311.57  Aligned_cols=244  Identities=17%  Similarity=0.332  Sum_probs=195.7

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCC-----cEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCC
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTN-----ERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHS  194 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~-----~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  194 (425)
                      .++|++.+.||+|+||.||+|.+...+     ..+++|.++...    ...+.+|+.++..+ +||||+++++++.+.  
T Consensus         4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l-~h~~i~~~~~~~~~~--   80 (283)
T cd05048           4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDL-QHPNIVCLLGVCTKE--   80 (283)
T ss_pred             hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhc-CCcccceEEEEEcCC--
Confidence            357888999999999999999876555     689999987432    35688999999999 999999999999653  


Q ss_pred             CccEEEEEeecCCChhhhc-------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCC
Q 014406          195 KTPSLIFEYVNSTDFKVLY-------------------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE  255 (425)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~-------------------~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~  255 (425)
                      ...+++|||+++++|.+++                   ..+++..+..++.|++.||.|||+.|++|+||||+||+++.+
T Consensus        81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~  160 (283)
T cd05048          81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEG  160 (283)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCC
Confidence            6788999999999998776                   236778899999999999999999999999999999999988


Q ss_pred             CCcEEEEeccccccccCCCc---ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHH
Q 014406          256 LRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLV  331 (425)
Q Consensus       256 ~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~  331 (425)
                       +.++|+|||+++.......   .....++..|+|||.+.+ ..++.++|||||||++|||++ |..||+. .+..+...
T Consensus       161 -~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDv~slG~il~el~~~g~~p~~~-~~~~~~~~  237 (283)
T cd05048         161 -LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILY-GKFTTESDIWSFGVVLWEIFSYGLQPYYG-FSNQEVIE  237 (283)
T ss_pred             -CcEEECCCcceeeccccccccccCCCcccccccCHHHhcc-CcCchhhhHHHHHHHHHHHHcCCCCCCCC-CCHHHHHH
Confidence             7899999999976543322   223455778999999877 678999999999999999998 9989843 23222222


Q ss_pred             HHHHHhCCchhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcC
Q 014406          332 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  409 (425)
Q Consensus       332 ~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~h  409 (425)
                      .+...    .                                .......+++++.+|+++||+.||.+|||+.|++++
T Consensus       238 ~i~~~----~--------------------------------~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~  279 (283)
T cd05048         238 MIRSR----Q--------------------------------LLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR  279 (283)
T ss_pred             HHHcC----C--------------------------------cCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            11110    0                                001122378999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-42  Score=349.06  Aligned_cols=261  Identities=28%  Similarity=0.453  Sum_probs=214.9

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecC------cchHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCc
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP------VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~------~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (425)
                      ..++|++++.||+|+||.|..++.+.+++.+|+|++++      ....-|..|-.+|..- +.+-|+.++-.|.+  .++
T Consensus        73 ~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~-ns~Wiv~LhyAFQD--~~~  149 (1317)
T KOG0612|consen   73 KAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFG-NSEWIVQLHYAFQD--ERY  149 (1317)
T ss_pred             CHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcC-CcHHHHHHHHHhcC--ccc
Confidence            46889999999999999999999999999999999975      2335588899999986 89999999999955  589


Q ss_pred             cEEEEEeecCCChhhhcCC---CCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCC
Q 014406          197 PSLIFEYVNSTDFKVLYPT---LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (425)
Q Consensus       197 ~~lv~e~~~~~~l~~~~~~---l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~  273 (425)
                      +|+|||||+||+|-.++.+   +++..++.|+..|..||+-||+.|+|||||||+|||+|.. |++||+|||.+-.+...
T Consensus       150 LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~-GHikLADFGsClkm~~d  228 (1317)
T KOG0612|consen  150 LYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKS-GHIKLADFGSCLKMDAD  228 (1317)
T ss_pred             eEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEeccc-CcEeeccchhHHhcCCC
Confidence            9999999999999888754   7889999999999999999999999999999999999998 89999999998776644


Q ss_pred             Cc--ceeeccCCCccCcccccCC----CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHh
Q 014406          274 KE--YNVRVASRYFKGPELLVDL----QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLN  347 (425)
Q Consensus       274 ~~--~~~~~~t~~y~aPE~~~~~----~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~  347 (425)
                      +.  ....+|||.|.+||++...    +.|+..+|+||+||++|||+.|.-|||.. +-.++...|..   .        
T Consensus       229 G~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad-slveTY~KIm~---h--------  296 (1317)
T KOG0612|consen  229 GTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD-SLVETYGKIMN---H--------  296 (1317)
T ss_pred             CcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH-HHHHHHHHHhc---h--------
Confidence            33  3567999999999998542    45889999999999999999999999532 22222222221   1        


Q ss_pred             hccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcC---HHHHhcCCCCcccccchhcc
Q 014406          348 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT---AREAMAHPYFAQVRAAESSR  422 (425)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpt---a~elL~hp~~~~~~~~~~~~  422 (425)
                                         +....|.   ....+|+++++||.++++ +|+.|..   ++++.+||||.++.|...+.
T Consensus       297 -------------------k~~l~FP---~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~iR~  351 (1317)
T KOG0612|consen  297 -------------------KESLSFP---DETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDNIRE  351 (1317)
T ss_pred             -------------------hhhcCCC---cccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhhhhh
Confidence                               0011111   112289999999999885 8889998   99999999999999965543

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=5.1e-40  Score=309.61  Aligned_cols=253  Identities=23%  Similarity=0.428  Sum_probs=203.6

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc---chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEEE
Q 014406          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE  202 (425)
Q Consensus       126 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e  202 (425)
                      .|...+.||+|++|.||++.+..+++.+++|.++..   ..+.+.+|+.+++.+ +|+||+++++++...  ...++++|
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~-~h~~vv~~~~~~~~~--~~~~~v~e   96 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDY-QHPNIVEMYSSYLVG--DELWVVME   96 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHc-CCCChheEEEEEEcC--CeEEEEEe
Confidence            344456899999999999999999999999998633   235678999999999 999999999998653  67899999


Q ss_pred             eecCCChhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCC-cceee
Q 014406          203 YVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EYNVR  279 (425)
Q Consensus       203 ~~~~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~-~~~~~  279 (425)
                      |+.+++|.+++  ..+++..+..++.|++.||+|||++|++|+||+|+||+++.+ +.++|+|||.+....... .....
T Consensus        97 ~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~-~~~~l~d~g~~~~~~~~~~~~~~~  175 (285)
T cd06648          97 FLEGGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSD-GRVKLSDFGFCAQVSKEVPRRKSL  175 (285)
T ss_pred             ccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCC-CcEEEcccccchhhccCCcccccc
Confidence            99999998876  358889999999999999999999999999999999999988 799999999887544322 12334


Q ss_pred             ccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCChhhHH
Q 014406          280 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDA  359 (425)
Q Consensus       280 ~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~  359 (425)
                      .++..|+|||.+.+ ..++.++|||||||++|+|++|+.||+.. +.......+... ..                    
T Consensus       176 ~~~~~y~aPE~~~~-~~~~~~~Dv~slGv~l~ell~g~~p~~~~-~~~~~~~~~~~~-~~--------------------  232 (285)
T cd06648         176 VGTPYWMAPEVISR-LPYGTEVDIWSLGIMVIEMVDGEPPYFNE-PPLQAMKRIRDN-LP--------------------  232 (285)
T ss_pred             cCCccccCHHHhcC-CCCCCcccHHHHHHHHHHHHhCCCCCcCC-CHHHHHHHHHhc-CC--------------------
Confidence            67889999999876 67899999999999999999999998532 211122111110 00                    


Q ss_pred             HhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccc
Q 014406          360 LVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA  418 (425)
Q Consensus       360 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~  418 (425)
                                   ........++..+.+|+.+||+.||++|||+.++++||||++.+..
T Consensus       233 -------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~  278 (285)
T cd06648         233 -------------PKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGPP  278 (285)
T ss_pred             -------------CCCcccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCCCc
Confidence                         0000111267899999999999999999999999999999987753

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=2.6e-40  Score=314.39  Aligned_cols=245  Identities=18%  Similarity=0.298  Sum_probs=192.4

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcE--EEEEEecCc----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCcc
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNER--CIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~--vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (425)
                      .++|++.+.||+|+||.||+|.+..++..  +++|.++..    ....+.+|+.++.++.+|+||+++++++..  ....
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~--~~~~   83 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH--RGYL   83 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECC--CCCc
Confidence            46889999999999999999998777754  577776532    234678899999999789999999999954  4678


Q ss_pred             EEEEEeecCCChhhhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCc
Q 014406          198 SLIFEYVNSTDFKVLYP-------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRK  258 (425)
Q Consensus       198 ~lv~e~~~~~~l~~~~~-------------------~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~  258 (425)
                      ++||||+++++|..++.                   .+++..++.++.|++.||+|||++|++||||||+|||++.+ +.
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~-~~  162 (303)
T cd05088          84 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN-YV  162 (303)
T ss_pred             eEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCC-Cc
Confidence            99999999999988762                   36788999999999999999999999999999999999988 78


Q ss_pred             EEEEeccccccccCCCcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHh
Q 014406          259 LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVL  337 (425)
Q Consensus       259 ~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~l  337 (425)
                      +||+|||++..............+..|+|||.+.+ ..++.++|||||||++|+|++ |..||. +.+..+....+... 
T Consensus       163 ~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~-~~~~~~~~~~~~~~-  239 (303)
T cd05088         163 AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYC-GMTCAELYEKLPQG-  239 (303)
T ss_pred             EEeCccccCcccchhhhcccCCCcccccCHHHHhc-cCCcccccchhhhhHHHHHHhcCCCCcc-cCChHHHHHHHhcC-
Confidence            99999999864322111222234567999999876 678999999999999999998 888873 22222222111000 


Q ss_pred             CCchhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcC
Q 014406          338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  409 (425)
Q Consensus       338 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~h  409 (425)
                                                         ........+++++.+|+.+||+.+|++|||+++++++
T Consensus       240 -----------------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  276 (303)
T cd05088         240 -----------------------------------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  276 (303)
T ss_pred             -----------------------------------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                               0000112267889999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.7e-40  Score=305.18  Aligned_cols=248  Identities=25%  Similarity=0.426  Sum_probs=200.9

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc--------chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCc
Q 014406          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (425)
Q Consensus       125 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~--------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (425)
                      ++|++.+.||+|+||.||+|.+..+++.+|+|.+...        ....+.+|+.+++++ +|+||+++++++.+.....
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l-~h~~i~~~~~~~~~~~~~~   80 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNL-RHDRIVQYYGCLRDPEEKK   80 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHc-CCCCcceEEEEEEcCCCCE
Confidence            5799999999999999999999999999999987421        124678899999999 8999999999997765567


Q ss_pred             cEEEEEeecCCChhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCC
Q 014406          197 PSLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (425)
Q Consensus       197 ~~lv~e~~~~~~l~~~~~---~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~  273 (425)
                      .++++||+++++|..++.   .+++..+..++.|++.||.|||+.|++|+||||+||+++.+ +.++|+|||+++.....
T Consensus        81 ~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~-~~~~l~dfg~~~~~~~~  159 (264)
T cd06653          81 LSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSA-GNVKLGDFGASKRIQTI  159 (264)
T ss_pred             EEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCC-CCEEECccccccccccc
Confidence            889999999999987763   47889999999999999999999999999999999999987 78999999999765321


Q ss_pred             ----CcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhc
Q 014406          274 ----KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY  349 (425)
Q Consensus       274 ----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~  349 (425)
                          .......++..|+|||.+.+ ..++.++|+|||||++++|++|+.||.. ..   ....+.+....+.        
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~-~~---~~~~~~~~~~~~~--------  226 (264)
T cd06653         160 CMSGTGIKSVTGTPYWMSPEVISG-EGYGRKADVWSVACTVVEMLTEKPPWAE-YE---AMAAIFKIATQPT--------  226 (264)
T ss_pred             cccCccccccCCcccccCHhhhcC-CCCCccccHHHHHHHHHHHHhCCCCCCc-cC---HHHHHHHHHcCCC--------
Confidence                11223457888999999977 6789999999999999999999999832 11   1222222111100        


Q ss_pred             cCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCC
Q 014406          350 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF  412 (425)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~  412 (425)
                                              ....+..+++++.+|+.+||+ +|.+|||+.++++|||.
T Consensus       227 ------------------------~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~  264 (264)
T cd06653         227 ------------------------KPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV  264 (264)
T ss_pred             ------------------------CCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence                                    011122378899999999999 57999999999999983

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=4.3e-40  Score=314.73  Aligned_cols=244  Identities=18%  Similarity=0.338  Sum_probs=193.6

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcE----EEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCC
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNER----CIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHS  194 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~----vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  194 (425)
                      ...+|++.+.||+|+||+||+|.+..+++.    ||+|.++...    .+.+.+|+.+++.+ +|+||++++++|..   
T Consensus         5 ~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~g~~~~---   80 (316)
T cd05108           5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DNPHVCRLLGICLT---   80 (316)
T ss_pred             chhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEcC---
Confidence            356799999999999999999987766654    8999986432    35688899999999 99999999999965   


Q ss_pred             CccEEEEEeecCCChhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccc
Q 014406          195 KTPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  270 (425)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~~----~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~  270 (425)
                      ...++++||+.+|+|.+++.    .+++..+..++.||+.||+|||+.||+||||||+|||++.+ +.+||+|||+++..
T Consensus        81 ~~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~-~~~kl~DfG~a~~~  159 (316)
T cd05108          81 STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTP-QHVKITDFGLAKLL  159 (316)
T ss_pred             CCceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCC-CcEEEccccccccc
Confidence            34679999999999988763    37888899999999999999999999999999999999988 78999999999876


Q ss_pred             cCCCcce---eeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCCchhHHHH
Q 014406          271 HPGKEYN---VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYL  346 (425)
Q Consensus       271 ~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~  346 (425)
                      .......   ...++..|+|||.+.+ ..++.++|||||||++|||++ |..||. +. ....+..+....         
T Consensus       160 ~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slGv~l~el~t~g~~p~~-~~-~~~~~~~~~~~~---------  227 (316)
T cd05108         160 GADEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYD-GI-PASEISSILEKG---------  227 (316)
T ss_pred             cCCCcceeccCCccceeecChHHhcc-CCCCchhhhHHHHHHHHHHHcCCCCCCC-CC-CHHHHHHHHhCC---------
Confidence            5332221   1233567999999977 788999999999999999997 888873 22 222222211100         


Q ss_pred             hhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcC
Q 014406          347 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  409 (425)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~h  409 (425)
                                        ..        ......++.++.+++.+||..||++|||+.+++++
T Consensus       228 ------------------~~--------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~  264 (316)
T cd05108         228 ------------------ER--------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  264 (316)
T ss_pred             ------------------CC--------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                              00        00012257889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=1.9e-40  Score=319.79  Aligned_cols=247  Identities=20%  Similarity=0.337  Sum_probs=194.0

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcC-----CCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCC
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVN-----TNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHS  194 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~-----~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  194 (425)
                      .++|++.+.||+|+||.||+|.+..     +++.||+|+++...    .+.+.+|+.++.++.+|+||++++++|... +
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~-~   84 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKP-G   84 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecC-C
Confidence            5689999999999999999997443     45789999986432    245778999999997799999999988654 3


Q ss_pred             CccEEEEEeecCCChhhhcC------------------------------------------------------------
Q 014406          195 KTPSLIFEYVNSTDFKVLYP------------------------------------------------------------  214 (425)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~~------------------------------------------------------------  214 (425)
                      ..++++|||+++++|..++.                                                            
T Consensus        85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (337)
T cd05054          85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE  164 (337)
T ss_pred             CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence            57889999999999987652                                                            


Q ss_pred             ----CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCc---ceeeccCCCccC
Q 014406          215 ----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKG  287 (425)
Q Consensus       215 ----~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~a  287 (425)
                          .+++..+..++.||+.||+|||++||+||||||+|||++.+ +.++|+|||+++.......   .....++..|+|
T Consensus       165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~-~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a  243 (337)
T cd05054         165 LYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSEN-NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA  243 (337)
T ss_pred             HhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCC-CcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence                46788899999999999999999999999999999999987 7899999999986543221   122344667999


Q ss_pred             cccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCChhhHHHhcccCC
Q 014406          288 PELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSR  366 (425)
Q Consensus       288 PE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~  366 (425)
                      ||++.+ ..++.++|||||||++|+|++ |..||.. ....+.+.....            ..               . 
T Consensus       244 PE~~~~-~~~~~~~Di~SlGv~l~el~t~g~~p~~~-~~~~~~~~~~~~------------~~---------------~-  293 (337)
T cd05054         244 PESIFD-KVYTTQSDVWSFGVLLWEIFSLGASPYPG-VQIDEEFCRRLK------------EG---------------T-  293 (337)
T ss_pred             cHHhcC-CCCCccccHHHHHHHHHHHHHcCCCCCCC-CCccHHHHHHHh------------cc---------------C-
Confidence            999987 789999999999999999998 8888732 222222211110            00               0 


Q ss_pred             CCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcC
Q 014406          367 KPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  409 (425)
Q Consensus       367 ~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~h  409 (425)
                             ........++++.+++.+||+.+|++|||+.|+++|
T Consensus       294 -------~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~  329 (337)
T cd05054         294 -------RMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEI  329 (337)
T ss_pred             -------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                   000112357899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=7.7e-40  Score=311.69  Aligned_cols=252  Identities=27%  Similarity=0.432  Sum_probs=200.1

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCc
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (425)
                      ....|++.+.||+|+||+||+|.+..+++.||+|.+...      ..+.+.+|+++++.+ +||||++++++|.+.  ..
T Consensus        13 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~~~~~~~~~--~~   89 (307)
T cd06607          13 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQL-RHPNTIEYKGCYLRE--HT   89 (307)
T ss_pred             cchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEEeC--Ce
Confidence            356688899999999999999999999999999998632      124678999999999 899999999999764  56


Q ss_pred             cEEEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCC
Q 014406          197 PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (425)
Q Consensus       197 ~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~  273 (425)
                      .++|+||+.++.+....   ..+++..+..++.|++.||.|||+.||+|+||+|+||+++.+ +.++|+|||++......
T Consensus        90 ~~lv~e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~-~~~kL~dfg~~~~~~~~  168 (307)
T cd06607          90 AWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEP-GTVKLADFGSASLVSPA  168 (307)
T ss_pred             EEEEHHhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCC-CCEEEeecCcceecCCC
Confidence            78999999865433332   458999999999999999999999999999999999999988 78999999998765432


Q ss_pred             CcceeeccCCCccCcccccC--CCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccC
Q 014406          274 KEYNVRVASRYFKGPELLVD--LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL  351 (425)
Q Consensus       274 ~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~  351 (425)
                         ....++..|+|||++.+  ...++.++||||||+++|+|++|..||... +.......+... ..+           
T Consensus       169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~-~~~~~~~~~~~~-~~~-----------  232 (307)
T cd06607         169 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-NAMSALYHIAQN-DSP-----------  232 (307)
T ss_pred             ---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCc-cHHHHHHHHhcC-CCC-----------
Confidence               23467888999999852  256889999999999999999999998432 211111111000 000           


Q ss_pred             CCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCccccc
Q 014406          352 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA  417 (425)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~  417 (425)
                                             ......++.++++++.+||+.||++|||+.++++||||.....
T Consensus       233 -----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~  275 (307)
T cd06607         233 -----------------------TLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRERP  275 (307)
T ss_pred             -----------------------CCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcccCC
Confidence                                   0001125788999999999999999999999999999987654

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=1e-40  Score=320.68  Aligned_cols=283  Identities=17%  Similarity=0.241  Sum_probs=196.9

Q ss_pred             eeeeee--CceEEEEEEEcCCCcEEEEEEecCcc-----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEEEe
Q 014406          131 RKVGRG--KYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEY  203 (425)
Q Consensus       131 ~~LG~G--~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~  203 (425)
                      ..||+|  +||+||++.+..+++.||+|++....     .+.+.+|+.+++.+ +||||++++++|...  ...++|+||
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~~--~~~~~v~e~   80 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFF-RHPNIMTSWTVFTTG--SWLWVISPF   80 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCcceEeeeEecC--CceEEEEec
Confidence            356666  99999999999999999999986432     35678899999988 899999999999654  678999999


Q ss_pred             ecCCChhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCc---
Q 014406          204 VNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE---  275 (425)
Q Consensus       204 ~~~~~l~~~~~-----~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~---  275 (425)
                      +.++++..++.     .+++..+..++.|++.||+|||++||+||||||+|||++.+ +.++++||+.+........   
T Consensus        81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~-~~~~~~~~~~~~~~~~~~~~~~  159 (328)
T cd08226          81 MAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGD-GLVSLSGLSHLYSLVRNGQKAK  159 (328)
T ss_pred             ccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCC-CcEEEechHHHhhhhccCcccc
Confidence            99999888763     37889999999999999999999999999999999999988 7899999986533221110   


Q ss_pred             -----ceeeccCCCccCcccccCC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHH-Hhh
Q 014406          276 -----YNVRVASRYFKGPELLVDL-QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAY-LNK  348 (425)
Q Consensus       276 -----~~~~~~t~~y~aPE~~~~~-~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~-~~~  348 (425)
                           .....++..|+|||++.+. ..++.++|||||||++|+|++|..||... ...+............+.... ...
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  238 (328)
T cd08226         160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDM-LRTQMLLQKLKGPPYSPLDITTFPC  238 (328)
T ss_pred             ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCc-ChHHHHHHHhcCCCCCCccccccch
Confidence                 0112345569999998753 34789999999999999999999998433 222222222111000000000 000


Q ss_pred             ccCC-C--ChhhHH-HhcccCCCCcc-----ccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccc
Q 014406          349 YHLE-L--DPQLDA-LVGRHSRKPWS-----KFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA  418 (425)
Q Consensus       349 ~~~~-~--~~~~~~-~~~~~~~~~~~-----~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~  418 (425)
                      .... .  ...... .........+.     ..........+++.+++|+++||++||++|||+.|+|+||||+++...
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~~  317 (328)
T cd08226         239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKEQ  317 (328)
T ss_pred             hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHHh
Confidence            0000 0  000000 00000000000     001111223367889999999999999999999999999999988764

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=4.9e-40  Score=322.88  Aligned_cols=246  Identities=22%  Similarity=0.342  Sum_probs=192.2

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCC-----CcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCC
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNT-----NERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQH  193 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~-----~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  193 (425)
                      ..++|++.+.||+|+||.||+|.+...     +..||||+++...    .+.+.+|+.+++++..||||++++++|.+  
T Consensus        35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~--  112 (400)
T cd05105          35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTK--  112 (400)
T ss_pred             cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc--
Confidence            467899999999999999999986433     3579999997432    35688999999999459999999999954  


Q ss_pred             CCccEEEEEeecCCChhhhcC-----------------------------------------------------------
Q 014406          194 SKTPSLIFEYVNSTDFKVLYP-----------------------------------------------------------  214 (425)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~~-----------------------------------------------------------  214 (425)
                      ....++||||+++|+|.+++.                                                           
T Consensus       113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (400)
T cd05105         113 SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPML  192 (400)
T ss_pred             CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhh
Confidence            467899999999999876541                                                           


Q ss_pred             ----------------------------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecC
Q 014406          215 ----------------------------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH  254 (425)
Q Consensus       215 ----------------------------------------~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~  254 (425)
                                                              .+++..+..++.|++.||+|||+.+|+|+||||+|||++.
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~  272 (400)
T cd05105         193 EIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQ  272 (400)
T ss_pred             hhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeC
Confidence                                                    2567778889999999999999999999999999999998


Q ss_pred             CCCcEEEEeccccccccCCCcc---eeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHH
Q 014406          255 ELRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQL  330 (425)
Q Consensus       255 ~~~~~kl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~  330 (425)
                      + +.+||+|||+++........   ....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.....+....
T Consensus       273 ~-~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~  350 (400)
T cd05105         273 G-KIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFD-NLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFY  350 (400)
T ss_pred             C-CEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHH
Confidence            8 78999999999765432221   22345678999999977 678999999999999999997 888874322211111


Q ss_pred             HHHHHHhCCchhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhc
Q 014406          331 VKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  408 (425)
Q Consensus       331 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~  408 (425)
                      ..+..              ..                      .......++.++.+++.+||+.||++|||+.++.+
T Consensus       351 ~~~~~--------------~~----------------------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  392 (400)
T cd05105         351 NKIKS--------------GY----------------------RMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD  392 (400)
T ss_pred             HHHhc--------------CC----------------------CCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence            11100              00                      00011236889999999999999999999988865

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-39  Score=305.10  Aligned_cols=272  Identities=30%  Similarity=0.578  Sum_probs=206.1

Q ss_pred             EEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhc--CCCCeeeEEeEEEcCCC---Cc
Q 014406          127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLC--GGPNVVKLLDIVRDQHS---KT  196 (425)
Q Consensus       127 y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~--~h~niv~l~~~~~~~~~---~~  196 (425)
                      |++.+.||+|+||.||+|.+..+++.+|+|.++..     ....+.+|+.+++++.  +|+|++++++++.+...   ..
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            67889999999999999999888999999999632     1235667888887773  59999999999976432   24


Q ss_pred             cEEEEEeecCCChhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEecccccccc
Q 014406          197 PSLIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (425)
Q Consensus       197 ~~lv~e~~~~~~l~~~~-----~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~  271 (425)
                      .+++|||+.+ ++..++     ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.+ +.++|+|||++....
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~-~~~~l~dfg~~~~~~  158 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSD-GQVKIADFGLARIYS  158 (287)
T ss_pred             eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccC-CCEEEeccCcceecc
Confidence            8899999986 565543     248999999999999999999999999999999999999998 899999999998765


Q ss_pred             CCCcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccC
Q 014406          272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL  351 (425)
Q Consensus       272 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~  351 (425)
                      .........++..|+|||.+.+ ..++.++|+|||||++|+|++|..|| .+....+.+..+.+..+.+....+..... 
T Consensus       159 ~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~s~G~~l~~l~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  235 (287)
T cd07838         159 FEMALTSVVVTLWYRAPEVLLQ-SSYATPVDMWSVGCIFAELFRRRPLF-RGTSEADQLDKIFDVIGLPSEEEWPRNVS-  235 (287)
T ss_pred             CCcccccccccccccChHHhcc-CCCCCcchhhhHHHHHHHHHhCCCcc-cCCChHHHHHHHHHHcCCCChHhcCCCcc-
Confidence            4444444567888999999987 67899999999999999999997776 55666666776666554432211100000 


Q ss_pred             CCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCC
Q 014406          352 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF  412 (425)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~  412 (425)
                         ..... .........     ......+++.+.+|+.+||+.||++||++.|+++||||
T Consensus       236 ---~~~~~-~~~~~~~~~-----~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~  287 (287)
T cd07838         236 ---LPRSS-FPSYTPRSF-----KSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF  287 (287)
T ss_pred             ---cchhh-cccccccch-----hhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence               00000 000000000     11112357888999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=6e-40  Score=310.98  Aligned_cols=244  Identities=17%  Similarity=0.301  Sum_probs=191.7

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCc--EEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccE
Q 014406          125 DDYEVVRKVGRGKYSEVFEGINVNTNE--RCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (425)
Q Consensus       125 ~~y~~~~~LG~G~fg~V~~~~~~~~~~--~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (425)
                      ++|++.+.||+|+||.||+|.+..++.  .+++|.++..    ..+.+.+|+.++.++.+||||+++++++...  ...+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~--~~~~   79 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENR--GYLY   79 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccC--Ccce
Confidence            578999999999999999998877664  4688887642    2356888999999986799999999999653  5688


Q ss_pred             EEEEeecCCChhhhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcE
Q 014406          199 LIFEYVNSTDFKVLYP-------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKL  259 (425)
Q Consensus       199 lv~e~~~~~~l~~~~~-------------------~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~  259 (425)
                      +++||+++++|.+++.                   .+++..+..++.|++.||+|||+.||+|+||||+|||++.+ +.+
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~-~~~  158 (297)
T cd05089          80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGEN-LAS  158 (297)
T ss_pred             EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCC-CeE
Confidence            9999999999987762                   37788999999999999999999999999999999999988 789


Q ss_pred             EEEeccccccccCCCcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhC
Q 014406          260 RLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLG  338 (425)
Q Consensus       260 kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~lg  338 (425)
                      ||+|||++..............+..|+|||.+.+ ..++.++|||||||++|+|++ |..||. +.+..+....+...  
T Consensus       159 kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~il~el~t~g~~pf~-~~~~~~~~~~~~~~--  234 (297)
T cd05089         159 KIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNY-SVYTTKSDVWSFGVLLWEIVSLGGTPYC-GMTCAELYEKLPQG--  234 (297)
T ss_pred             EECCcCCCccccceeccCCCCcCccccCchhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCC-CCCHHHHHHHHhcC--
Confidence            9999999864322111122233456999999876 678999999999999999997 888883 22222222211100  


Q ss_pred             CchhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcC
Q 014406          339 TDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  409 (425)
Q Consensus       339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~h  409 (425)
                                                        ........++.++.+|+.+||+.||.+|||++++++.
T Consensus       235 ----------------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~  271 (297)
T cd05089         235 ----------------------------------YRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ  271 (297)
T ss_pred             ----------------------------------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                              0001112368899999999999999999999999765

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=5.3e-40  Score=308.06  Aligned_cols=245  Identities=19%  Similarity=0.357  Sum_probs=192.4

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEc-----CCCcEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCC
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINV-----NTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH  193 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~-----~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  193 (425)
                      ..++|++.+.||+|+||.||+|.+.     .++..+|+|.++..    ...++.+|+.+++.+ +|+||+++++++..  
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~--   80 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF-NCHHVVRLLGVVSQ--   80 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEcC--
Confidence            4678999999999999999999764     24567999998642    234578999999999 99999999999954  


Q ss_pred             CCccEEEEEeecCCChhhhcCC-------------CCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEE
Q 014406          194 SKTPSLIFEYVNSTDFKVLYPT-------------LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLR  260 (425)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~~~-------------l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~k  260 (425)
                      +...++||||+.+++|..++..             +++..+..++.|++.||+|||+.|++|+||||+||+++.+ +.++
T Consensus        81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~-~~~~  159 (277)
T cd05062          81 GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED-FTVK  159 (277)
T ss_pred             CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCC-CCEE
Confidence            4678999999999999887632             4567788899999999999999999999999999999988 7899


Q ss_pred             EEeccccccccCCCcc---eeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHH
Q 014406          261 LIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKV  336 (425)
Q Consensus       261 l~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~  336 (425)
                      |+|||+++........   ....++..|+|||.+.+ ..++.++|||||||++|+|++ |..|| .+....+....+...
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~p~-~~~~~~~~~~~~~~~  237 (277)
T cd05062         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPY-QGMSNEQVLRFVMEG  237 (277)
T ss_pred             ECCCCCccccCCcceeecCCCCccCHhhcChhHhhc-CCcCchhHHHHHHHHHHHHHcCCCCCC-CCCCHHHHHHHHHcC
Confidence            9999998755432221   12244667999999877 678999999999999999999 56666 333333222211110


Q ss_pred             hCCchhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcC
Q 014406          337 LGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  409 (425)
Q Consensus       337 lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~h  409 (425)
                       +.                                   ......+++.+.+++.+||+.||++|||+.|++++
T Consensus       238 -~~-----------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  274 (277)
T cd05062         238 -GL-----------------------------------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  274 (277)
T ss_pred             -Cc-----------------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence             00                                   00112367889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=9.5e-40  Score=306.69  Aligned_cols=272  Identities=35%  Similarity=0.644  Sum_probs=212.6

Q ss_pred             EEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc-----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEE
Q 014406          127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (425)
Q Consensus       127 y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (425)
                      |+..+.||+|+||.||+|.+..+++.+|+|++....     .+.+.+|+.+++.+ +|+|++++++++.+.  ...++|+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~--~~~~~v~   77 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKEL-KHPNIVKLLDVIHTE--RKLYLVF   77 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhc-CCCCHHHHHhhhhcC--CceEEEe
Confidence            566788999999999999999999999999987532     35677899999999 899999999999654  6788999


Q ss_pred             EeecCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCC-cc
Q 014406          202 EYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EY  276 (425)
Q Consensus       202 e~~~~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~-~~  276 (425)
                      ||+++ +|..++    ..+++..+..++.|++.||.|||++||+|+||+|+||+++.+ +.++|+|||+++...... ..
T Consensus        78 e~~~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~-~~~~l~d~g~~~~~~~~~~~~  155 (282)
T cd07829          78 EYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRD-GVLKLADFGLARAFGIPLRTY  155 (282)
T ss_pred             cCcCc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCC-CCEEEecCCcccccCCCcccc
Confidence            99985 677666    258899999999999999999999999999999999999998 789999999987654332 23


Q ss_pred             eeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCChh
Q 014406          277 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ  356 (425)
Q Consensus       277 ~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~  356 (425)
                      .....+..|+|||.+.+...++.++|||||||++++|++|+.|| .+.+..+.+..+.+.++.+....+..-....   .
T Consensus       156 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~  231 (282)
T cd07829         156 THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLF-PGDSEIDQLFKIFQILGTPTEESWPGVTKLP---D  231 (282)
T ss_pred             CccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCC-CCccHHHHHHHHHHHhCCCcHHHHHhhcccc---c
Confidence            34456778999999877447899999999999999999998776 5556667777777777765544432221111   0


Q ss_pred             hHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCC
Q 014406          357 LDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF  412 (425)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~  412 (425)
                      ....     ...+...........++..+.+|+++||+.||++|||++++++||||
T Consensus       232 ~~~~-----~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~  282 (282)
T cd07829         232 YKPT-----FPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF  282 (282)
T ss_pred             cccc-----ccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence            0000     00010000111112247889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=9.5e-41  Score=334.64  Aligned_cols=247  Identities=20%  Similarity=0.332  Sum_probs=194.7

Q ss_pred             CCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc---chHHHHHHHHHHHHhcCCCCeeeEEeEE-E---cCC-
Q 014406          122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIV-R---DQH-  193 (425)
Q Consensus       122 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~-~---~~~-  193 (425)
                      ....++++.+.|.+|||+.||.|++...+..||+|.+-..   ..+.+.+||++|+.|.+|+|||.+++.. .   ... 
T Consensus        34 Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~  113 (738)
T KOG1989|consen   34 VGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNG  113 (738)
T ss_pred             ECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCc
Confidence            3567899999999999999999999988899999987433   3456889999999998999999999932 2   122 


Q ss_pred             CCccEEEEEeecCCChhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC--ceeecCCCCceEecCCCCcEEEEeccc
Q 014406          194 SKTPSLIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHELRKLRLIDWGL  266 (425)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~-----~~l~~~~~~~i~~~i~~~L~~LH~~~--ivH~Dlk~~NIll~~~~~~~kl~Dfg~  266 (425)
                      ...+.|+||||.||.|-+++     ..|++.++.+|+.|+++|+.+||...  |||||||-+||||+.+ +..||||||.
T Consensus       114 ~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~-g~~KLCDFGS  192 (738)
T KOG1989|consen  114 VWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSAD-GNYKLCDFGS  192 (738)
T ss_pred             eeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCC-CCEEeCcccc
Confidence            24578999999988776665     35999999999999999999999987  9999999999999999 7999999999


Q ss_pred             cccccCCCcc----------eeeccCCCccCcccccC--CCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHH
Q 014406          267 AEFYHPGKEY----------NVRVASRYFKGPELLVD--LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA  334 (425)
Q Consensus       267 a~~~~~~~~~----------~~~~~t~~y~aPE~~~~--~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~  334 (425)
                      |.........          -....|+.|+|||++.-  ....++|+|||+|||+||-|+....||..+.    .++.+.
T Consensus       193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg----~laIln  268 (738)
T KOG1989|consen  193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG----KLAILN  268 (738)
T ss_pred             cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc----ceeEEe
Confidence            8643222111          11356889999999732  2567899999999999999999999993211    111000


Q ss_pred             HHhCCchhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcC
Q 014406          335 KVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  409 (425)
Q Consensus       335 ~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~h  409 (425)
                                  .+|..+.                        ...++..+++||+.||+.||.+||++-|++.+
T Consensus       269 ------------g~Y~~P~------------------------~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~  307 (738)
T KOG1989|consen  269 ------------GNYSFPP------------------------FPNYSDRLKDLIRTMLQPNPDERPNIYQVLEE  307 (738)
T ss_pred             ------------ccccCCC------------------------CccHHHHHHHHHHHHhccCcccCCCHHHHHHH
Confidence                        0111110                        12368899999999999999999999998865

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1.1e-39  Score=303.09  Aligned_cols=243  Identities=19%  Similarity=0.338  Sum_probs=194.7

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc--chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEE
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (425)
                      ..++|++.++||+|+||+||+|.+ .++..+|+|.+...  ..+.+.+|+.+++.+ +|+||+++++++.+  ....+++
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~-~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv   79 (261)
T cd05072           4 PRESIKLVKKLGAGQFGEVWMGYY-NNSTKVAVKTLKPGTMSVQAFLEEANLMKTL-QHDKLVRLYAVVTK--EEPIYII   79 (261)
T ss_pred             chHHeEEeeecCCcCCceEEEEEe-cCCceEEEEEccCCchhHHHHHHHHHHHHhC-CCCCeeeEEEEEcC--CCCcEEE
Confidence            357899999999999999999975 45678999988743  346788999999999 99999999999854  4678899


Q ss_pred             EEeecCCChhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCc
Q 014406          201 FEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (425)
Q Consensus       201 ~e~~~~~~l~~~~-----~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~  275 (425)
                      |||+.+++|..++     ..+++..+..++.|++.||+|||+.+++|+||||+||+++.+ +.++|+|||++........
T Consensus        80 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~-~~~~l~dfg~~~~~~~~~~  158 (261)
T cd05072          80 TEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSES-LMCKIADFGLARVIEDNEY  158 (261)
T ss_pred             EecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCC-CcEEECCCccceecCCCce
Confidence            9999999998876     237888899999999999999999999999999999999988 7899999999986543221


Q ss_pred             c--eeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCC
Q 014406          276 Y--NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE  352 (425)
Q Consensus       276 ~--~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~  352 (425)
                      .  ....++..|+|||.+.+ ..++.++|||||||++|+|++ |..|| .+.+..+....+....               
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~t~g~~p~-~~~~~~~~~~~~~~~~---------------  221 (261)
T cd05072         159 TAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLYEIVTYGKIPY-PGMSNSDVMSALQRGY---------------  221 (261)
T ss_pred             eccCCCccceecCCHHHhcc-CCCChhhhhhhhHHHHHHHHccCCCCC-CCCCHHHHHHHHHcCC---------------
Confidence            1  12234567999999876 678999999999999999998 88887 3333333222221100               


Q ss_pred             CChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhc
Q 014406          353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  408 (425)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~  408 (425)
                                           .......++.++.+++.+||+.||++|||++++++
T Consensus       222 ---------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  256 (261)
T cd05072         222 ---------------------RMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQS  256 (261)
T ss_pred             ---------------------CCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence                                 00011236889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1.5e-39  Score=302.61  Aligned_cols=243  Identities=18%  Similarity=0.351  Sum_probs=196.5

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc--hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEE
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (425)
                      ..+|++.+.||+|+||.||+|.+..+++.+|+|.+....  .+.+.+|+.+++.+ +|+||+++++++...  ...+++|
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~lv~   81 (263)
T cd05052           5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTRE--PPFYIIT   81 (263)
T ss_pred             hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhC-CCCChhheEEEEcCC--CCcEEEE
Confidence            456899999999999999999999999999999987543  35788999999999 999999999999654  6788999


Q ss_pred             EeecCCChhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCcc
Q 014406          202 EYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY  276 (425)
Q Consensus       202 e~~~~~~l~~~~~-----~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~~  276 (425)
                      ||+++++|.+++.     .+++..+..++.|++.||+|||++|++|+||||+||+++.+ +.+||+|||++.........
T Consensus        82 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~-~~~kl~df~~~~~~~~~~~~  160 (263)
T cd05052          82 EFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGEN-HLVKVADFGLSRLMTGDTYT  160 (263)
T ss_pred             EeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCC-CcEEeCCCccccccccceee
Confidence            9999999988762     37888999999999999999999999999999999999988 78999999999765432211


Q ss_pred             e--eeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCC
Q 014406          277 N--VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL  353 (425)
Q Consensus       277 ~--~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~  353 (425)
                      .  ....+..|+|||.+.+ ..++.++|||||||++|+|++ |..|| .+.+..+....+....                
T Consensus       161 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~t~g~~p~-~~~~~~~~~~~~~~~~----------------  222 (263)
T cd05052         161 AHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPY-PGIDLSQVYELLEKGY----------------  222 (263)
T ss_pred             ccCCCCCccccCCHHHhcc-CCCCchhHHHHHHHHHHHHHcCCCCCC-CCCCHHHHHHHHHCCC----------------
Confidence            1  1223457999999876 678999999999999999998 77776 3333222222111000                


Q ss_pred             ChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhc
Q 014406          354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  408 (425)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~  408 (425)
                                          .......++.++.+++.+||+.||++|||+.++++
T Consensus       223 --------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~  257 (263)
T cd05052         223 --------------------RMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQ  257 (263)
T ss_pred             --------------------CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence                                00112236889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=1.5e-39  Score=302.69  Aligned_cols=242  Identities=19%  Similarity=0.312  Sum_probs=192.8

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc--chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEE
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (425)
                      ..++|++.++||+|+||+||+|.+..+ ..||+|.++..  ..+.+.+|+++++.+ +|+||+++++.+.+   ...++|
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~---~~~~lv   78 (262)
T cd05071           4 PRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYAVVSE---EPIYIV   78 (262)
T ss_pred             ChHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccCHHHHHHHHHHHHhC-CCCCcceEEEEECC---CCcEEE
Confidence            356799999999999999999987655 46999999753  346789999999999 89999999998743   457899


Q ss_pred             EEeecCCChhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCc
Q 014406          201 FEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (425)
Q Consensus       201 ~e~~~~~~l~~~~~-----~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~  275 (425)
                      |||+++++|.+++.     .+++..+..++.|++.||+|||+.+++|+||||+||+++.+ +.++|+|||.++.......
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~-~~~~L~dfg~~~~~~~~~~  157 (262)
T cd05071          79 TEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN-LVCKVADFGLARLIEDNEY  157 (262)
T ss_pred             EEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCC-CcEEeccCCceeecccccc
Confidence            99999999988874     37888999999999999999999999999999999999988 7899999999976543322


Q ss_pred             c--eeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCC
Q 014406          276 Y--NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE  352 (425)
Q Consensus       276 ~--~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~  352 (425)
                      .  ....++..|+|||...+ ..++.++|||||||++|+|++ |..|| .+....+....+....               
T Consensus       158 ~~~~~~~~~~~y~~PE~~~~-~~~~~~~DvwslG~~l~ellt~g~~p~-~~~~~~~~~~~~~~~~---------------  220 (262)
T cd05071         158 TARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPY-PGMVNREVLDQVERGY---------------  220 (262)
T ss_pred             ccccCCcccceecCHhHhcc-CCCCchhhHHHHHHHHHHHHcCCCCCC-CCCChHHHHHHHhcCC---------------
Confidence            1  12345567999999876 678999999999999999999 66666 3333333222211100               


Q ss_pred             CChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhc
Q 014406          353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  408 (425)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~  408 (425)
                                           .......++..+.+++.+||+.||++|||+.++++
T Consensus       221 ---------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~  255 (262)
T cd05071         221 ---------------------RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQA  255 (262)
T ss_pred             ---------------------CCCCccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence                                 00001226888999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=100.00  E-value=5.2e-41  Score=310.49  Aligned_cols=294  Identities=28%  Similarity=0.516  Sum_probs=237.1

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcC---CCcEEEEEEecC-cchHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEE
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVN---TNERCIIKILKP-VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~---~~~~vavK~~~~-~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (425)
                      .+.|.++++||.|.|++||++.+..   ..+.||+|.+.. .....+.+|+++|..+.++.||+++.+.+..  +..+++
T Consensus        35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rn--nd~v~i  112 (418)
T KOG1167|consen   35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCFRN--NDQVAI  112 (418)
T ss_pred             hhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhhcc--CCeeEE
Confidence            5678899999999999999999887   789999999875 4567899999999999999999999999954  478889


Q ss_pred             EEEeecCCChhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEecccccccc--------
Q 014406          200 IFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH--------  271 (425)
Q Consensus       200 v~e~~~~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~--------  271 (425)
                      |+||++.....+++..++..+++.++..++.||.++|.+|||||||||+|+|.+...+.-.|+|||+|....        
T Consensus       113 vlp~~~H~~f~~l~~~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s  192 (418)
T KOG1167|consen  113 VLPYFEHDRFRDLYRSLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHS  192 (418)
T ss_pred             EecccCccCHHHHHhcCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHhhhhhhhh
Confidence            999999999999999999999999999999999999999999999999999999988899999999996210        


Q ss_pred             ---------C-----------------CCc-----------ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHH
Q 014406          272 ---------P-----------------GKE-----------YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI  314 (425)
Q Consensus       272 ---------~-----------------~~~-----------~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ell  314 (425)
                               +                 ...           .-...||++|+|||++......+.++||||.||+++.++
T Consensus       193 ~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lsll  272 (418)
T KOG1167|consen  193 RSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLL  272 (418)
T ss_pred             hhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeehhh
Confidence                     0                 000           011368999999999999888999999999999999999


Q ss_pred             hCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccC--CCCh-h---hHHHhccc-C-----CCCccc--cccccCCCC
Q 014406          315 FRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL--ELDP-Q---LDALVGRH-S-----RKPWSK--FINADNQHL  380 (425)
Q Consensus       315 tg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~--~~~~-~---~~~~~~~~-~-----~~~~~~--~~~~~~~~~  380 (425)
                      +++.|||...++.+.++++...+|...+.....-.+.  .+.. +   .......+ .     ....++  .....-...
T Consensus       273 s~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~  352 (418)
T KOG1167|consen  273 SRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGSDV  352 (418)
T ss_pred             ccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeecccccc
Confidence            9999999999999999999999999877665333332  1110 0   00000000 0     000001  111222233


Q ss_pred             CCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccch
Q 014406          381 VSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE  419 (425)
Q Consensus       381 ~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~~  419 (425)
                      .+..+.+|+++||..||.+|.||+++|+||||.++...+
T Consensus       353 ~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~~~~  391 (418)
T KOG1167|consen  353 FPALLLDLLDKCLELNPQKRITAEDALKHPFFDEADRTE  391 (418)
T ss_pred             ccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchhhhh
Confidence            566889999999999999999999999999999776543

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=9.7e-40  Score=302.39  Aligned_cols=243  Identities=20%  Similarity=0.407  Sum_probs=197.3

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEE
Q 014406          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (425)
Q Consensus       126 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (425)
                      +|++.+.||+|+||.||++.+..++..+|+|.++..    ..+.+.+|+.+++.+ +|+||+++++.+.+.  ..++++|
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~lv~   77 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKM-KHPNIVAFKESFEAD--GHLYIVM   77 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhC-CCCCcceEEEEEEEC--CEEEEEE
Confidence            588999999999999999999999999999998532    235678899999999 999999999999654  6889999


Q ss_pred             EeecCCChhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCc-
Q 014406          202 EYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-  275 (425)
Q Consensus       202 e~~~~~~l~~~~~-----~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~-  275 (425)
                      ||++++++..++.     .+++..+..++.|++.||.|||++||+|+||||+||+++.+ +.++++|||++........ 
T Consensus        78 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~-~~~~l~dfg~~~~~~~~~~~  156 (255)
T cd08219          78 EYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQN-GKVKLGDFGSARLLTSPGAY  156 (255)
T ss_pred             eeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCC-CcEEEcccCcceeecccccc
Confidence            9999999877652     37889999999999999999999999999999999999988 7899999999876543322 


Q ss_pred             ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCCh
Q 014406          276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP  355 (425)
Q Consensus       276 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~  355 (425)
                      .....++..|+|||++.+ ..++.++|+||||+++|+|++|..||.. .+.......+..  +.                
T Consensus       157 ~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~g~~p~~~-~~~~~~~~~~~~--~~----------------  216 (255)
T cd08219         157 ACTYVGTPYYVPPEIWEN-MPYNNKSDIWSLGCILYELCTLKHPFQA-NSWKNLILKVCQ--GS----------------  216 (255)
T ss_pred             cccccCCccccCHHHHcc-CCcCchhhhhhhchhheehhhccCCCCC-CCHHHHHHHHhc--CC----------------
Confidence            233567888999999877 6789999999999999999999999842 221111111100  00                


Q ss_pred             hhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCC
Q 014406          356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHP  410 (425)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp  410 (425)
                                .        ......++..+.+|+++||+.||++|||+.++++--
T Consensus       217 ----------~--------~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~  253 (255)
T cd08219         217 ----------Y--------KPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSRG  253 (255)
T ss_pred             ----------C--------CCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhcc
Confidence                      0        001122678899999999999999999999998643

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.5e-40  Score=304.00  Aligned_cols=246  Identities=28%  Similarity=0.483  Sum_probs=194.5

Q ss_pred             eeeeeeCceEEEEEEEcCCCcEEEEEEecCcch------HHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEEEee
Q 014406          131 RKVGRGKYSEVFEGINVNTNERCIIKILKPVKK------KKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV  204 (425)
Q Consensus       131 ~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~------~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~  204 (425)
                      +.||.|+||.||+|.+..+++.+|+|++.....      ..+..|..++....+|+|++++++++..  +...++|+||+
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~   79 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQS--KDYLYLVMEYL   79 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEc--CCeEEEEEecc
Confidence            468999999999999999999999999864321      2344555555544489999999999965  46789999999


Q ss_pred             cCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCcceeecc
Q 014406          205 NSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA  281 (425)
Q Consensus       205 ~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  281 (425)
                      ++++|..++   ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.+ +.++|+|||++.....   .....+
T Consensus        80 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~---~~~~~~  155 (260)
T cd05611          80 NGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQT-GHLKLTDFGLSRNGLE---NKKFVG  155 (260)
T ss_pred             CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCC-CcEEEeecccceeccc---cccCCC
Confidence            999999887   458899999999999999999999999999999999999987 7899999999875432   233467


Q ss_pred             CCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCChhhHHHh
Q 014406          282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALV  361 (425)
Q Consensus       282 t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~  361 (425)
                      +..|+|||.+.+ ..++.++||||||+++|+|++|..||.. .+..+....+...             ..          
T Consensus       156 ~~~y~~pe~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~-~~~~~~~~~~~~~-------------~~----------  210 (260)
T cd05611         156 TPDYLAPETILG-VGDDKMSDWWSLGCVIFEFLFGYPPFHA-ETPDAVFDNILSR-------------RI----------  210 (260)
T ss_pred             CcCccChhhhcC-CCCcchhhhHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhc-------------cc----------
Confidence            788999999987 5589999999999999999999999842 2222222221110             00          


Q ss_pred             cccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcC---HHHHhcCCCCccccc
Q 014406          362 GRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT---AREAMAHPYFAQVRA  417 (425)
Q Consensus       362 ~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpt---a~elL~hp~~~~~~~  417 (425)
                            .+    .......+++++.+++.+||+.||++|||   ++|++.||||+++.|
T Consensus       211 ------~~----~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~~~  259 (260)
T cd05611         211 ------NW----PEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSINW  259 (260)
T ss_pred             ------CC----CCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcCCC
Confidence                  00    00011136899999999999999999995   479999999998765

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-40  Score=322.14  Aligned_cols=244  Identities=23%  Similarity=0.381  Sum_probs=195.6

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCc---E-EEEEEecC------cchHHHHHHHHHHHHhcCCCCeeeEEeEEEcCC
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNE---R-CIIKILKP------VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQH  193 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~---~-vavK~~~~------~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  193 (425)
                      .++..+.++||+|+||.||+|.....+.   . ||||..+.      ....++.+|.++|+++ +|||||+++|++..+ 
T Consensus       156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l-~H~NVVr~yGVa~~~-  233 (474)
T KOG0194|consen  156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQL-NHPNVVRFYGVAVLE-  233 (474)
T ss_pred             ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEcCC-
Confidence            4556667899999999999999765422   3 89998873      2346789999999999 999999999999665 


Q ss_pred             CCccEEEEEeecCCChhhhcCC----CCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEecccccc
Q 014406          194 SKTPSLIFEYVNSTDFKVLYPT----LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (425)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~~~----l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~  269 (425)
                       ..+++|||+|+||+|.+++.+    ++..+...++.+.+.||+|||++++|||||.++|+|++.+ +.+||+|||+++.
T Consensus       234 -~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~-~~vKISDFGLs~~  311 (474)
T KOG0194|consen  234 -EPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKK-GVVKISDFGLSRA  311 (474)
T ss_pred             -CccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCC-CeEEeCccccccC
Confidence             678899999999999999853    8899999999999999999999999999999999999997 6789999999976


Q ss_pred             ccCCCcce-eeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCCchhHHHHh
Q 014406          270 YHPGKEYN-VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLN  347 (425)
Q Consensus       270 ~~~~~~~~-~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~  347 (425)
                      ........ ....+..|+|||.+.. ..|+.++|||||||++||+++ |..|| .+..+.+..+.+...           
T Consensus       312 ~~~~~~~~~~~klPirWLAPEtl~~-~~~s~kTDV~sfGV~~~Eif~~g~~Py-~g~~~~~v~~kI~~~-----------  378 (474)
T KOG0194|consen  312 GSQYVMKKFLKKLPIRWLAPETLNT-GIFSFKTDVWSFGVLLWEIFENGAEPY-PGMKNYEVKAKIVKN-----------  378 (474)
T ss_pred             CcceeeccccccCcceecChhhhcc-CccccccchhheeeeEEeeeccCCCCC-CCCCHHHHHHHHHhc-----------
Confidence            53111111 1234577999999988 689999999999999999998 77776 566655555544221           


Q ss_pred             hccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhc
Q 014406          348 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  408 (425)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~  408 (425)
                      .+.+.                        .+...+.++..++.+|+..||++|||+.++.+
T Consensus       379 ~~r~~------------------------~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~  415 (474)
T KOG0194|consen  379 GYRMP------------------------IPSKTPKELAKVMKQCWKKDPEDRPTMSTIKK  415 (474)
T ss_pred             CccCC------------------------CCCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence            11111                        11125788899999999999999999987753

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=1.7e-39  Score=306.68  Aligned_cols=258  Identities=22%  Similarity=0.431  Sum_probs=204.2

Q ss_pred             CEEEEeeeeeeCceEEEEEEEc---CCCcEEEEEEecCc-------chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCC
Q 014406          126 DYEVVRKVGRGKYSEVFEGINV---NTNERCIIKILKPV-------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (425)
Q Consensus       126 ~y~~~~~LG~G~fg~V~~~~~~---~~~~~vavK~~~~~-------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (425)
                      +|++.+.||.|+||.||++.+.   .+|..||+|++...       ..+.+.+|+.++..+.+|+||+++++.+..  +.
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~--~~   78 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT--DT   78 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeec--CC
Confidence            4788999999999999999874   47899999998642       235678899999999779999999999965  36


Q ss_pred             ccEEEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccC
Q 014406          196 TPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (425)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~  272 (425)
                      ..++|+||+++++|.+++   ..+++..+..++.|++.||.|||+.|++|+||+|+|||++.+ +.++|+|||++.....
T Consensus        79 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~-~~~kl~dfg~~~~~~~  157 (290)
T cd05613          79 KLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSN-GHVVLTDFGLSKEFHE  157 (290)
T ss_pred             eEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCC-CCEEEeeCccceeccc
Confidence            788999999999998876   348889999999999999999999999999999999999988 7899999999976543


Q ss_pred             CC--cceeeccCCCccCcccccCC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhc
Q 014406          273 GK--EYNVRVASRYFKGPELLVDL-QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY  349 (425)
Q Consensus       273 ~~--~~~~~~~t~~y~aPE~~~~~-~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~  349 (425)
                      ..  ......++..|+|||.+.+. ..++.++||||||+++|+|++|..||... ........+.+.....         
T Consensus       158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~-~~~~~~~~~~~~~~~~---------  227 (290)
T cd05613         158 DEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVD-GEKNSQAEISRRILKS---------  227 (290)
T ss_pred             ccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcC-CccccHHHHHHHhhcc---------
Confidence            22  12234678899999998652 24678999999999999999999998421 1111112221111000         


Q ss_pred             cCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCc-----CHHHHhcCCCCcccccchh
Q 014406          350 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYFAQVRAAES  420 (425)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rp-----ta~elL~hp~~~~~~~~~~  420 (425)
                                              .......++..+.+|+++||+.||++|+     ++++++.||||+++.+...
T Consensus       228 ------------------------~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~~  279 (290)
T cd05613         228 ------------------------EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWDDL  279 (290)
T ss_pred             ------------------------CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCHHHH
Confidence                                    0001123678899999999999999997     8999999999999987543

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=1.6e-39  Score=301.11  Aligned_cols=242  Identities=17%  Similarity=0.298  Sum_probs=193.2

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc--chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEE
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (425)
                      .++|++.+.||+|+||.||++... ++..+|+|.+...  ..+.+.+|+.+++.+ +||||+++++++...  ...++||
T Consensus         3 ~~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~iv~   78 (256)
T cd05114           3 PSELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMSEEDFIEEAKVMMKL-SHPKLVQLYGVCTQQ--KPLYIVT   78 (256)
T ss_pred             HHHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCccHHHHHHHHHHHHHC-CCCCceeEEEEEccC--CCEEEEE
Confidence            467889999999999999999764 4568999988743  346788999999999 899999999999654  6789999


Q ss_pred             EeecCCChhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCcce
Q 014406          202 EYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN  277 (425)
Q Consensus       202 e~~~~~~l~~~~~----~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~~~  277 (425)
                      ||+++++|.+++.    .+++..+..++.|++.||+|||+.||+|+||||+||+++.+ +.+||+|||.++.........
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~-~~~kl~d~g~~~~~~~~~~~~  157 (256)
T cd05114          79 EFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSST-GVVKVSDFGMTRYVLDDEYTS  157 (256)
T ss_pred             EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCC-CeEEECCCCCccccCCCceec
Confidence            9999999988763    37889999999999999999999999999999999999987 789999999987653322211


Q ss_pred             --eeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCC
Q 014406          278 --VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD  354 (425)
Q Consensus       278 --~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~  354 (425)
                        ...++..|+|||.+.+ ..++.++||||||+++|+|++ |+.|| ...+..+.+..+.+..                 
T Consensus       158 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~s~G~~l~el~~~g~~p~-~~~~~~~~~~~i~~~~-----------------  218 (256)
T cd05114         158 SSGAKFPVKWSPPEVFNF-SKYSSKSDVWSFGVLMWEVFTEGKMPF-EKKSNYEVVEMISRGF-----------------  218 (256)
T ss_pred             cCCCCCchhhCChhhccc-CccchhhhhHHHHHHHHHHHcCCCCCC-CCCCHHHHHHHHHCCC-----------------
Confidence              2234557999999876 678999999999999999999 78787 3333333333221100                 


Q ss_pred             hhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhc
Q 014406          355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  408 (425)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~  408 (425)
                                 .        .......+.++.+++.+||+.||++|||++++++
T Consensus       219 -----------~--------~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~  253 (256)
T cd05114         219 -----------R--------LYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLR  253 (256)
T ss_pred             -----------C--------CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence                       0        0001125778999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.5e-39  Score=306.00  Aligned_cols=258  Identities=24%  Similarity=0.357  Sum_probs=196.3

Q ss_pred             CCE-EEEeeeeeeCceEEEEEE----EcCCCcEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCC
Q 014406          125 DDY-EVVRKVGRGKYSEVFEGI----NVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (425)
Q Consensus       125 ~~y-~~~~~LG~G~fg~V~~~~----~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (425)
                      ++| ++.+.||+|+||+||++.    ...++..+|+|+++..    ....+.+|+++++++ +||||+++++++......
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~   81 (283)
T cd05080           3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTL-YHENIVKYKGCCSEQGGK   81 (283)
T ss_pred             hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhC-CCCCEeeEEEEEecCCCc
Confidence            445 889999999999998764    3457889999998753    245678999999999 999999999998766556


Q ss_pred             ccEEEEEeecCCChhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCC
Q 014406          196 TPSLIFEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (425)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~~--~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~  273 (425)
                      ..+++|||+++++|..++.  .+++.+++.++.|++.||+|||++||+|+||||+|||++.+ +.++|+|||+++.....
T Consensus        82 ~~~lv~e~~~~~~l~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~-~~~~l~dfg~~~~~~~~  160 (283)
T cd05080          82 GLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDND-RLVKIGDFGLAKAVPEG  160 (283)
T ss_pred             eEEEEecCCCCCCHHHHHHHcCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCC-CcEEEeecccccccCCc
Confidence            7899999999999988863  58999999999999999999999999999999999999988 78999999999866432


Q ss_pred             Ccc----eeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHH-hCCchhHHHHhh
Q 014406          274 KEY----NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV-LGTDELNAYLNK  348 (425)
Q Consensus       274 ~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~-lg~~~~~~~~~~  348 (425)
                      ...    ....++..|+|||.+.+ ..++.++||||||+++|+|++|..||......   +..+... .+...       
T Consensus       161 ~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~---~~~~~~~~~~~~~-------  229 (283)
T cd05080         161 HEYYRVREDGDSPVFWYAVECLKE-NKFSYASDVWSFGVTLYELLTHCDSKQSPPKK---FEEMIGPKQGQMT-------  229 (283)
T ss_pred             chhhccCCCCCCCceeeCHhHhcc-cCCCcccccHHHHHHHHHHHhCCCCCCCCcch---hhhhhcccccccc-------
Confidence            221    12234566999999876 67899999999999999999999998432221   1111100 00000       


Q ss_pred             ccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhc
Q 014406          349 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  408 (425)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~  408 (425)
                           ...........        ........++.++.+++.+||+.||++|||++++++
T Consensus       230 -----~~~~~~~~~~~--------~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~  276 (283)
T cd05080         230 -----VVRLIELLERG--------MRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP  276 (283)
T ss_pred             -----hhhhhhhhhcC--------CCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence                 00000000000        001112346889999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5e-40  Score=339.18  Aligned_cols=245  Identities=21%  Similarity=0.403  Sum_probs=203.6

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCC-----cEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCC
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTN-----ERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH  193 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~-----~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  193 (425)
                      ..++.+..+.||+|+||.||.|......     ..||||.++..    ...+|.+|..+|+++ +|||||+++|++-+  
T Consensus       690 ~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f-~HpNiv~liGv~l~--  766 (1025)
T KOG1095|consen  690 PRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKF-DHPNIVSLIGVCLD--  766 (1025)
T ss_pred             ChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcC-CCcceeeEEEeecC--
Confidence            4567888999999999999999865433     34899998754    456799999999999 99999999999976  


Q ss_pred             CCccEEEEEeecCCChhhhcC----------CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEe
Q 014406          194 SKTPSLIFEYVNSTDFKVLYP----------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLID  263 (425)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~~----------~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~D  263 (425)
                      ....++++|||.+|+|..+++          .++..++..++.|||+|+.||+++++|||||..+|+||+.. ..+||+|
T Consensus       767 ~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~-r~VKIaD  845 (1025)
T KOG1095|consen  767 SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDER-RVVKIAD  845 (1025)
T ss_pred             CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeeccc-CcEEEcc
Confidence            467789999999999999883          37889999999999999999999999999999999999998 8999999


Q ss_pred             ccccccccCCCcceee---ccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCc
Q 014406          264 WGLAEFYHPGKEYNVR---VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTD  340 (425)
Q Consensus       264 fg~a~~~~~~~~~~~~---~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~  340 (425)
                      ||+|+-+...+.+...   .-...|||||.+.+ ..++.++|||||||+|||++|...+.|.+.++.+.+....+     
T Consensus       846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d-~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~-----  919 (1025)
T KOG1095|consen  846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKD-GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLE-----  919 (1025)
T ss_pred             cchhHhhhhchheeccCccccceecCCHHHHhh-cccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHh-----
Confidence            9999966544444322   22346999999998 78999999999999999999865555677777776664322     


Q ss_pred             hhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhc
Q 014406          341 ELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  408 (425)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~  408 (425)
                             ..                        +.+.+..+++.+.++|..||+.+|++||+...+++
T Consensus       920 -------gg------------------------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~  956 (1025)
T KOG1095|consen  920 -------GG------------------------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE  956 (1025)
T ss_pred             -------CC------------------------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence                   11                        11223348999999999999999999999999886

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=2.2e-39  Score=299.58  Aligned_cols=245  Identities=24%  Similarity=0.497  Sum_probs=202.2

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEE
Q 014406          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (425)
Q Consensus       126 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (425)
                      +|++.+.||.|+||.||++.+..++..+++|.+...     ..+.+.+|+++++.+ +|+|++++.+.+...  ...++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~~~~~~~~~~~~--~~~~lv   77 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKL-NHPNIIKYYESFEEK--GKLCIV   77 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhc-CCCChhheEEEEecC--CEEEEE
Confidence            588899999999999999999999999999998743     345688999999999 899999999999654  788999


Q ss_pred             EEeecCCChhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCC
Q 014406          201 FEYVNSTDFKVLY-------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (425)
Q Consensus       201 ~e~~~~~~l~~~~-------~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~  273 (425)
                      +||+++++|..++       ..+++..+..++.+++.||.|||+.|++|+||+|+||+++.+ +.++|+|||++......
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~-~~~~l~d~~~~~~~~~~  156 (258)
T cd08215          78 MEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSN-GLVKLGDFGISKVLSST  156 (258)
T ss_pred             EEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCC-CcEEECCccceeecccC
Confidence            9999999998776       348899999999999999999999999999999999999987 78999999999765443


Q ss_pred             C-cceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCC
Q 014406          274 K-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE  352 (425)
Q Consensus       274 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~  352 (425)
                      . ......++..|+|||.+.+ ..++.++|+||+|+++++|++|..||... +..+........    .           
T Consensus       157 ~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~-~~~~~~~~~~~~----~-----------  219 (258)
T cd08215         157 VDLAKTVVGTPYYLSPELCQN-KPYNYKSDIWSLGCVLYELCTLKHPFEGE-NLLELALKILKG----Q-----------  219 (258)
T ss_pred             cceecceeeeecccChhHhcc-CCCCccccHHHHHHHHHHHHcCCCCCCCC-cHHHHHHHHhcC----C-----------
Confidence            3 2233567888999999877 67899999999999999999999998322 211111111000    0           


Q ss_pred             CChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCC
Q 014406          353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF  412 (425)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~  412 (425)
                                      .     ......++.++.+++.+||..+|++|||+.|+|+||||
T Consensus       220 ----------------~-----~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~  258 (258)
T cd08215         220 ----------------Y-----PPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI  258 (258)
T ss_pred             ----------------C-----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence                            0     00011368899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=4.3e-40  Score=314.34  Aligned_cols=273  Identities=20%  Similarity=0.247  Sum_probs=194.1

Q ss_pred             CceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEEEeecCCChhh
Q 014406          137 KYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV  211 (425)
Q Consensus       137 ~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~  211 (425)
                      ++|.||.++...+++.||+|+++..     ..+.+.+|+.+++.+ +|+||+++++++.+.  ...+++|||++++++..
T Consensus        12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~~i~~~~~~~~~~--~~~~~~~e~~~~~~l~~   88 (314)
T cd08216          12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQL-QHPNILPYVTSFIVD--SELYVVSPLMAYGSCED   88 (314)
T ss_pred             CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhc-CCcchhhhhheeecC--CeEEEEEeccCCCCHHH
Confidence            4455666666779999999998643     235788999999999 899999999999654  67889999999999988


Q ss_pred             hcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCc--------cee
Q 014406          212 LYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE--------YNV  278 (425)
Q Consensus       212 ~~~-----~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~--------~~~  278 (425)
                      ++.     .+++..+..++.|++.||+|||+.+|+|+||||+||+++.+ +.++|+|||.+........        ...
T Consensus        89 ~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~-~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~  167 (314)
T cd08216          89 LLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGD-GKVVLSGLRYSVSMIKHGKRQRVVHDFPKS  167 (314)
T ss_pred             HHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecC-CceEEecCccceeecccccccccccccccc
Confidence            763     47889999999999999999999999999999999999987 7899999998865432211        123


Q ss_pred             eccCCCccCcccccCC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCChhh
Q 014406          279 RVASRYFKGPELLVDL-QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQL  357 (425)
Q Consensus       279 ~~~t~~y~aPE~~~~~-~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~  357 (425)
                      ..++..|+|||++... ..++.++|||||||++|+|++|..||.........+..+   .+....  ......  .....
T Consensus       168 ~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~---~~~~~~--~~~~~~--~~~~~  240 (314)
T cd08216         168 SVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKV---RGTVPC--LLDKST--YPLYE  240 (314)
T ss_pred             ccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---hccCcc--ccccCc--hhhhc
Confidence            4566789999998652 358899999999999999999999985433222222221   111000  000000  00000


Q ss_pred             HHHhc---ccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccchh
Q 014406          358 DALVG---RHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAES  420 (425)
Q Consensus       358 ~~~~~---~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~~~  420 (425)
                      .....   ..................++.++.+|+++||++||++|||++|+|+||||++++..+.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~~~~~  306 (314)
T cd08216         241 DSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCKRRNT  306 (314)
T ss_pred             CCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhcccch
Confidence            00000   0000000000111112235678999999999999999999999999999999976554

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=3.1e-39  Score=297.38  Aligned_cols=246  Identities=34%  Similarity=0.555  Sum_probs=202.8

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc---chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEEE
Q 014406          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE  202 (425)
Q Consensus       126 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e  202 (425)
                      +|++.+.||+|++|.||++.+..+++.+++|++...   ..+.+.+|+.+++.+ +|+|++++++.+...  ...++++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~--~~~~l~~e   77 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKC-KHPNIVKYYGSYLKK--DELWIVME   77 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhC-CCCCEeEEEEEEecC--CeEEEEEe
Confidence            478889999999999999999989999999999754   346788999999999 899999999999654  67889999


Q ss_pred             eecCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCccee
Q 014406          203 YVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV  278 (425)
Q Consensus       203 ~~~~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~~~~  278 (425)
                      |+++++|.+++    ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.+ +.++|+|||.+...........
T Consensus        78 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~-~~~~l~d~~~~~~~~~~~~~~~  156 (253)
T cd05122          78 FCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSD-GEVKLIDFGLSAQLSDTKARNT  156 (253)
T ss_pred             cCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccC-CeEEEeeccccccccccccccc
Confidence            99999998876    357999999999999999999999999999999999999987 7899999999987655433445


Q ss_pred             eccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCChhhH
Q 014406          279 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLD  358 (425)
Q Consensus       279 ~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~  358 (425)
                      ..++..|++||.+.+ ..++.++||||||+++++|++|+.||.... ..+....... .....                 
T Consensus       157 ~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-~~~~~~~~~~-~~~~~-----------------  216 (253)
T cd05122         157 MVGTPYWMAPEVING-KPYDYKADIWSLGITAIELAEGKPPYSELP-PMKALFKIAT-NGPPG-----------------  216 (253)
T ss_pred             eecCCcccCHHHHcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCc-hHHHHHHHHh-cCCCC-----------------
Confidence            678889999999877 568999999999999999999999984322 1111111111 00000                 


Q ss_pred             HHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCC
Q 014406          359 ALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY  411 (425)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~  411 (425)
                                      ......++..+.+++.+||+.||++|||+.|+++|||
T Consensus       217 ----------------~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~  253 (253)
T cd05122         217 ----------------LRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF  253 (253)
T ss_pred             ----------------cCcccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence                            0001114788999999999999999999999999998

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-41  Score=307.12  Aligned_cols=257  Identities=25%  Similarity=0.407  Sum_probs=218.9

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCcc
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (425)
                      ..+|..+..||+|+||.|-+|..+.+.+.+|||+++++      +.+--..|-.+|.....-|.+++++..|+.  -..+
T Consensus       348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQT--mDRL  425 (683)
T KOG0696|consen  348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQT--MDRL  425 (683)
T ss_pred             ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhh--hhhe
Confidence            45788999999999999999999999999999999753      223345677777766567899999999954  4778


Q ss_pred             EEEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccc-cCC
Q 014406          198 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY-HPG  273 (425)
Q Consensus       198 ~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~-~~~  273 (425)
                      |.||||++||+|...+   .++.+.....++.+|+-||-+||++|||+||||.+|||+|.+ +.+||+|||+++.. -.+
T Consensus       426 yFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~e-GHiKi~DFGmcKEni~~~  504 (683)
T KOG0696|consen  426 YFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSE-GHIKIADFGMCKENIFDG  504 (683)
T ss_pred             eeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccC-CceEeeecccccccccCC
Confidence            9999999999998876   468888999999999999999999999999999999999999 89999999999743 334


Q ss_pred             CcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCC
Q 014406          274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL  353 (425)
Q Consensus       274 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~  353 (425)
                      ..+.+.+||+.|+|||++.. .+|+.++|.|||||+||||+.|..|| .+.++.+.++.|.+.-                
T Consensus       505 ~TTkTFCGTPdYiAPEIi~Y-qPYgksvDWWa~GVLLyEmlaGQpPF-dGeDE~elF~aI~ehn----------------  566 (683)
T KOG0696|consen  505 VTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQPPF-DGEDEDELFQAIMEHN----------------  566 (683)
T ss_pred             cceeeecCCCcccccceEEe-cccccchhHHHHHHHHHHHHcCCCCC-CCCCHHHHHHHHHHcc----------------
Confidence            56677899999999999987 89999999999999999999999987 6777777777765421                


Q ss_pred             ChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCH-----HHHhcCCCCcccccchhcc
Q 014406          354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA-----REAMAHPYFAQVRAAESSR  422 (425)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta-----~elL~hp~~~~~~~~~~~~  422 (425)
                                           -..++.+|.++.++++..|++.|.+|..+     +++-.||||+.+.|....+
T Consensus       567 ---------------------vsyPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~E~  619 (683)
T KOG0696|consen  567 ---------------------VSYPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEKLER  619 (683)
T ss_pred             ---------------------CcCcccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccHHHHhh
Confidence                                 11234489999999999999999999954     7899999999999876543

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.5e-43  Score=301.25  Aligned_cols=289  Identities=29%  Similarity=0.498  Sum_probs=222.6

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcC------
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQ------  192 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~------  192 (425)
                      .+.|+-..+||+|.||.||+|+..++++.||+|+.--+     -.....+|+++|..+ .|+|++.+++.|...      
T Consensus        16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~l-kHenv~nliEic~tk~Tp~~r   94 (376)
T KOG0669|consen   16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLL-KHENVVNLIEICRTKATPTNR   94 (376)
T ss_pred             chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHh-cchhHHHHHHHHhhccCCccc
Confidence            45677788999999999999999999999998765321     224567999999999 999999999988632      


Q ss_pred             CCCccEEEEEeecCCC---hhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEecccccc
Q 014406          193 HSKTPSLIFEYVNSTD---FKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (425)
Q Consensus       193 ~~~~~~lv~e~~~~~~---l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~  269 (425)
                      ....+||||++++...   |.....+++..++..++.++..||.|+|...|+|||+|+.|+||+.+ +.+||+|||+++.
T Consensus        95 ~r~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~d-gilklADFGlar~  173 (376)
T KOG0669|consen   95 DRATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKD-GILKLADFGLARA  173 (376)
T ss_pred             ccceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCC-ceEEeeccccccc
Confidence            2234889999998643   44444569999999999999999999999999999999999999998 8999999999976


Q ss_pred             ccCCC-----cceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHH
Q 014406          270 YHPGK-----EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA  344 (425)
Q Consensus       270 ~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~  344 (425)
                      +...+     .++..+.|.+|++||.+++...|+.+.|||.-||++.||.||. |.+.+..+..++..|....|....+.
T Consensus       174 fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrs-pimqgnteqqql~~Is~LcGs~tkev  252 (376)
T KOG0669|consen  174 FSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRS-PIMQGNTEQQQLHLISQLCGSITKEV  252 (376)
T ss_pred             eecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccC-ccccCChHHHHHHHHHHHhccCCccc
Confidence            64332     3445677999999999999999999999999999999999986 55688888999999999999866555


Q ss_pred             HHhhccCCCChhhHHH-hcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccc
Q 014406          345 YLNKYHLELDPQLDAL-VGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA  418 (425)
Q Consensus       345 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~  418 (425)
                      |.+--.+++...+... ............+..   ---++++.+|+.++|..||.+|++++++|+|.||..=..+
T Consensus       253 WP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp---~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~p  324 (376)
T KOG0669|consen  253 WPNVDNLPLYQSIELEPLPKGQKRKVKNRLKP---YVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPMP  324 (376)
T ss_pred             CCCcccchHHHhccCCCCCcchhhhhhhhccc---ccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCcc
Confidence            4332222222111000 000000000111110   0125789999999999999999999999999999865544

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.4e-40  Score=319.32  Aligned_cols=273  Identities=27%  Similarity=0.467  Sum_probs=226.4

Q ss_pred             CcCCcccccCCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc------hHHHHHHHHHHHHhcCCCCeeeEE
Q 014406          113 DYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLL  186 (425)
Q Consensus       113 ~~~~~~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~  186 (425)
                      .|..+....-+..-|..++.||-|+||+|.++....|...+|+|.+.+.+      ....+.|.+||... +.+-||+|+
T Consensus       617 nYiRLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEA-Dn~WVVrLy  695 (1034)
T KOG0608|consen  617 NYIRLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEA-DNEWVVRLY  695 (1034)
T ss_pred             hHHHHHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhc-CCcceEEEE
Confidence            34444444456678999999999999999999999999999999987533      35578899999998 899999999


Q ss_pred             eEEEcCCCCccEEEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEe
Q 014406          187 DIVRDQHSKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLID  263 (425)
Q Consensus       187 ~~~~~~~~~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~D  263 (425)
                      -.|.+  ...+|+||||++||++..++   .-|.+...+.++.++..|+++.|+.|+|||||||+|||||.+ |.+||.|
T Consensus       696 ySFQD--kdnLYFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrd-GHIKLTD  772 (1034)
T KOG0608|consen  696 YSFQD--KDNLYFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRD-GHIKLTD  772 (1034)
T ss_pred             EEecc--CCceEEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccC-Cceeeee
Confidence            99965  47899999999999988776   458899999999999999999999999999999999999999 8999999


Q ss_pred             cccccccc---------CCC----------------------------------cceeeccCCCccCcccccCCCCCCCc
Q 014406          264 WGLAEFYH---------PGK----------------------------------EYNVRVASRYFKGPELLVDLQDYDYS  300 (425)
Q Consensus       264 fg~a~~~~---------~~~----------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~  300 (425)
                      |||+..+.         .++                                  .....+||+.|+|||++.. ..|+..
T Consensus       773 FGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r-~g~~q~  851 (1034)
T KOG0608|consen  773 FGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLAR-TGYTQL  851 (1034)
T ss_pred             ccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcc-cCcccc
Confidence            99995431         000                                  0012478999999999988 789999


Q ss_pred             ccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCC
Q 014406          301 LDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHL  380 (425)
Q Consensus       301 ~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  380 (425)
                      +|.||.||+||||+.|+.||..... .+                                 -......|+.++.......
T Consensus       852 cdwws~gvil~em~~g~~pf~~~tp-~~---------------------------------tq~kv~nw~~~l~~~~~~~  897 (1034)
T KOG0608|consen  852 CDWWSVGVILYEMLVGQPPFLADTP-GE---------------------------------TQYKVINWRNFLHIPYQGN  897 (1034)
T ss_pred             chhhHhhHHHHHHhhCCCCccCCCC-Cc---------------------------------ceeeeeehhhccccccccc
Confidence            9999999999999999999943221 11                                 1122356777777777888


Q ss_pred             CCHHHHHHHHHcccCCcCCCc---CHHHHhcCCCCcccccchhccccC
Q 014406          381 VSPEAIDFLDKLLRYDHQDRL---TAREAMAHPYFAQVRAAESSRTRA  425 (425)
Q Consensus       381 ~s~~~~~ll~~~L~~dP~~Rp---ta~elL~hp~~~~~~~~~~~~~~~  425 (425)
                      +|.++.++|.++. .+++.|.   .++|+..||||+.|.+...++++|
T Consensus       898 ls~e~~~li~kLc-~sad~RLGkng~d~vKaHpfFkgIDfsslRkq~A  944 (1034)
T KOG0608|consen  898 LSKEALDLIQKLC-CSADSRLGKNGADQVKAHPFFKGIDFSSLRKQRA  944 (1034)
T ss_pred             cCHHHHHHHHHHh-cChhhhhcccchhhhhcCccccccchHhhhhccC
Confidence            9999999999865 5788888   578899999999999999988887

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=7.7e-40  Score=307.22  Aligned_cols=243  Identities=21%  Similarity=0.377  Sum_probs=195.0

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcC-----CCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCC
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVN-----TNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHS  194 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~-----~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  194 (425)
                      .++|.+.+.||+|+||.||+|.+..     ++..||+|.++...    .+.+.+|+++++.+ +|+||+++++++...  
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~--   80 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNF-QHENIVKFYGVCTEG--   80 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhc-CCCCchheeeEEecC--
Confidence            4568889999999999999998653     46789999987532    35788999999999 899999999999654  


Q ss_pred             CccEEEEEeecCCChhhhcC-----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCC
Q 014406          195 KTPSLIFEYVNSTDFKVLYP-----------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELR  257 (425)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~~-----------------~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~  257 (425)
                      ...++||||+++++|..++.                 .+++..+..++.|++.||.|||+.|++|+||||+||+++.+ +
T Consensus        81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~-~  159 (280)
T cd05049          81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYD-L  159 (280)
T ss_pred             CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCC-C
Confidence            67899999999999988762                 26788899999999999999999999999999999999988 8


Q ss_pred             cEEEEeccccccccCCCc---ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHH
Q 014406          258 KLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKI  333 (425)
Q Consensus       258 ~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~  333 (425)
                      .++|+|||+++.......   .....++..|+|||++.+ ..++.++|||||||++|+|++ |..||+.. +..+....+
T Consensus       160 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~e~~~~g~~p~~~~-~~~~~~~~~  237 (280)
T cd05049         160 VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSFGVVLWEIFTYGKQPWYGL-SNEEVIECI  237 (280)
T ss_pred             eEEECCcccceecccCcceecCCCCcccceecChhhhcc-CCcchhhhHHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHH
Confidence            999999999976533221   122345678999999987 679999999999999999998 99998432 222222221


Q ss_pred             HHHhCCchhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhc
Q 014406          334 AKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  408 (425)
Q Consensus       334 ~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~  408 (425)
                      ..  +.                                  .......++..+.+++++||+.||++|||+.|+++
T Consensus       238 ~~--~~----------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  276 (280)
T cd05049         238 TQ--GR----------------------------------LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE  276 (280)
T ss_pred             Hc--CC----------------------------------cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            10  00                                  00011236889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-39  Score=303.49  Aligned_cols=243  Identities=19%  Similarity=0.354  Sum_probs=191.1

Q ss_pred             EEEEeeeeeeCceEEEEEEEcCC---CcEEEEEEecCcc-----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCC----
Q 014406          127 YEVVRKVGRGKYSEVFEGINVNT---NERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHS----  194 (425)
Q Consensus       127 y~~~~~LG~G~fg~V~~~~~~~~---~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~----  194 (425)
                      |++.+.||+|+||.||+|....+   +..+|+|.++...     ...+.+|+..++.+ +|+||+++++++.....    
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~   79 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDF-DHPNVMKLIGVCFEASSLQKI   79 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhC-CCCCeeeEEeeeccCCccccC
Confidence            45678899999999999987653   4789999987432     24688999999999 99999999998864322    


Q ss_pred             CccEEEEEeecCCChhhhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEecc
Q 014406          195 KTPSLIFEYVNSTDFKVLY---------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWG  265 (425)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~---------~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg  265 (425)
                      ...++++||+.+++|..++         ..+++..+..++.|++.||+|||+.+++|+||||+||+++.+ +.+||+|||
T Consensus        80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~-~~~kl~dfg  158 (273)
T cd05035          80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLRED-MTVCVADFG  158 (273)
T ss_pred             cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCC-CeEEECCcc
Confidence            3478999999999998765         247889999999999999999999999999999999999988 789999999


Q ss_pred             ccccccCCCcc---eeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCCch
Q 014406          266 LAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDE  341 (425)
Q Consensus       266 ~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~lg~~~  341 (425)
                      +++........   ....++..|+|||.+.+ ..++.++|||||||++|||++ |..|| .+.++.+....+..   .. 
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~SlG~il~el~~~g~~p~-~~~~~~~~~~~~~~---~~-  232 (273)
T cd05035         159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIATRGQTPY-PGVENHEIYDYLRH---GN-  232 (273)
T ss_pred             ceeeccccccccccccccCCccccCHhhccc-CCCCcccchHHHHHHHHHHHhCCCCCC-CCCCHHHHHHHHHc---CC-
Confidence            99866433222   12234567999999876 678999999999999999999 66665 44443333222211   00 


Q ss_pred             hHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcC
Q 014406          342 LNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  409 (425)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~h  409 (425)
                                                      .......+++++.+++.+||+.||++|||+.|++++
T Consensus       233 --------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~  268 (273)
T cd05035         233 --------------------------------RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV  268 (273)
T ss_pred             --------------------------------CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                            000112368899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.6e-40  Score=318.82  Aligned_cols=253  Identities=23%  Similarity=0.455  Sum_probs=214.7

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc-----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccE
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (425)
                      ...|.+...||+|.|+.|.+|.+..++..||||++++..     ...+.+|+++|+.+ +|||||+++.+...+  ..+|
T Consensus        55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l-~HPnIvkl~~v~~t~--~~ly  131 (596)
T KOG0586|consen   55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSL-NHPNIVKLFSVIETE--ATLY  131 (596)
T ss_pred             ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhc-CCcceeeeeeeeeec--ceeE
Confidence            467999999999999999999999999999999997643     34578999999999 999999999999654  7899


Q ss_pred             EEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCc
Q 014406          199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (425)
Q Consensus       199 lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~  275 (425)
                      +||||..+|.+.+++   ....+...+.++.|+.+|++|||+++|||||||++||||+.+ ..+||+|||++..+..+..
T Consensus       132 lV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~-mnikIaDfgfS~~~~~~~~  210 (596)
T KOG0586|consen  132 LVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDEN-MNIKIADFGFSTFFDYGLM  210 (596)
T ss_pred             EEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccc-cceeeeccccceeeccccc
Confidence            999999999999988   446778889999999999999999999999999999999999 5789999999999988888


Q ss_pred             ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCCh
Q 014406          276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP  355 (425)
Q Consensus       276 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~  355 (425)
                      ..+.+|++.|.|||++.+....+..+|+||+|+++|-|+.|..||. +.+-.+.-.             ....+.+    
T Consensus       211 lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFD-G~~lk~Lr~-------------rvl~gk~----  272 (596)
T KOG0586|consen  211 LQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFD-GQNLKELRP-------------RVLRGKY----  272 (596)
T ss_pred             ccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccC-Ccccccccc-------------hheeeee----
Confidence            8899999999999999996666789999999999999999999992 211110000             0000000    


Q ss_pred             hhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccc
Q 014406          356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA  418 (425)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~  418 (425)
                                          ..+..++-++.++|+++|..+|.+|++.++++.|.|.......
T Consensus       273 --------------------rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~~  315 (596)
T KOG0586|consen  273 --------------------RIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLEA  315 (596)
T ss_pred             --------------------cccceeechhHHHHHHhhccCccccCCHHHhhhhcccchhhhh
Confidence                                1112268899999999999999999999999999998876554

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=7e-40  Score=304.34  Aligned_cols=244  Identities=33%  Similarity=0.549  Sum_probs=198.0

Q ss_pred             eeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEEEeecC
Q 014406          133 VGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNS  206 (425)
Q Consensus       133 LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~  206 (425)
                      ||.|+||.||++.+..+++.+++|++...      ..+.+.+|+.+++++ +|+||+++++.+..  +...++++||+.+
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~--~~~~~lv~e~~~~   77 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQA-QSPYVVKLYYSFQG--KKNLYLVMEYLPG   77 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhC-CCcchhHHHHheec--CcEEEEEEecCCC
Confidence            68999999999999999999999998643      235688899999999 89999999999854  4778999999999


Q ss_pred             CChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCC---------
Q 014406          207 TDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK---------  274 (425)
Q Consensus       207 ~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~---------  274 (425)
                      ++|..++   ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.+ +.++|+|||++.......         
T Consensus        78 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~  156 (265)
T cd05579          78 GDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSN-GHLKLTDFGLSKVGLVRRQINLNDDEK  156 (265)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCC-CCEEEEecccchhcccCcccccccccc
Confidence            9998776   358999999999999999999999999999999999999998 799999999987553321         


Q ss_pred             cceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCC
Q 014406          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD  354 (425)
Q Consensus       275 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~  354 (425)
                      ......++..|++||...+ ..++.++||||||++++++++|..||... +..+....+..  +.               
T Consensus       157 ~~~~~~~~~~~~~Pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~-~~~~~~~~~~~--~~---------------  217 (265)
T cd05579         157 EDKRIVGTPDYIAPEVILG-QGHSKTVDWWSLGCILYEFLVGIPPFHGE-TPEEIFQNILN--GK---------------  217 (265)
T ss_pred             cccCcccCccccCHHHhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHhc--CC---------------
Confidence            1223456788999999877 56889999999999999999999998432 22222211111  00               


Q ss_pred             hhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCH---HHHhcCCCCccccc
Q 014406          355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA---REAMAHPYFAQVRA  417 (425)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta---~elL~hp~~~~~~~  417 (425)
                                  ..+.      ....++..+.+|+++||+.+|++|||+   .++|+||||+++.|
T Consensus       218 ------------~~~~------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~~  265 (265)
T cd05579         218 ------------IEWP------EDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGIDW  265 (265)
T ss_pred             ------------cCCC------ccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCCCC
Confidence                        0000      001148899999999999999999999   99999999998864

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=2.5e-39  Score=300.01  Aligned_cols=243  Identities=17%  Similarity=0.313  Sum_probs=193.1

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc--hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEE
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (425)
                      .++|++.+.||+|+||+||+|.+. .+..+|+|.+....  .+.+.+|+.+++++ +||||+++++++...  ...+++|
T Consensus         3 ~~~~~~~~~lg~G~~~~vy~~~~~-~~~~~aik~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~lv~   78 (256)
T cd05113           3 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMKL-SHEKLVQLYGVCTKQ--RPIYIVT   78 (256)
T ss_pred             hHHeEEeeEecCcccceEEEEEec-CCCcEEEEEcCCCcccHHHHHHHHHHHhcC-CCCCeeeEEEEEccC--CCcEEEE
Confidence            467999999999999999999654 35569999887533  46789999999999 899999999999654  5678999


Q ss_pred             EeecCCChhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCcce
Q 014406          202 EYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN  277 (425)
Q Consensus       202 e~~~~~~l~~~~~----~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~~~  277 (425)
                      ||+.+++|.+++.    .+++..+..++.|++.||.|||+.|++|+||||+||+++.+ +.+||+|||+++.........
T Consensus        79 e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~-~~~kl~d~g~~~~~~~~~~~~  157 (256)
T cd05113          79 EYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQ-GCVKVSDFGLSRYVLDDEYTS  157 (256)
T ss_pred             EcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCC-CCEEECCCccceecCCCceee
Confidence            9999999988762    48899999999999999999999999999999999999988 789999999987654332211


Q ss_pred             --eeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCC
Q 014406          278 --VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD  354 (425)
Q Consensus       278 --~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~  354 (425)
                        ...++..|++||.+.+ ..++.++|||||||++|+|++ |..||. ..+..+....+.....                
T Consensus       158 ~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slG~~l~~l~~~g~~p~~-~~~~~~~~~~~~~~~~----------------  219 (256)
T cd05113         158 SVGSKFPVRWSPPEVLLY-SKFSSKSDVWAFGVLMWEVYSLGKMPYE-RFNNSETVEKVSQGLR----------------  219 (256)
T ss_pred             cCCCccChhhCCHHHHhc-CcccchhHHHHHHHHHHHHhcCCCCCcC-cCCHHHHHHHHhcCCC----------------
Confidence              1234567999999976 678999999999999999998 888873 2222222222111000                


Q ss_pred             hhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcC
Q 014406          355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  409 (425)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~h  409 (425)
                                          .......+..+++++.+||+.||++|||+.+++++
T Consensus       220 --------------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~  254 (256)
T cd05113         220 --------------------LYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSS  254 (256)
T ss_pred             --------------------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence                                00011257899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=2.3e-39  Score=304.65  Aligned_cols=244  Identities=17%  Similarity=0.342  Sum_probs=193.3

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEc----CCCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCC
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINV----NTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~----~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (425)
                      .++|++.+.||+|+||+||+|.+.    .++..+++|.+....    ...+.+|+.+++.+ +|+||+++++++...  .
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~--~   80 (283)
T cd05090           4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAEL-HHPNIVCLLGVVTQE--Q   80 (283)
T ss_pred             hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhC-CCCCeeeEEEEEecC--C
Confidence            467899999999999999999853    456789999987422    24688899999999 999999999998654  6


Q ss_pred             ccEEEEEeecCCChhhhcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCC
Q 014406          196 TPSLIFEYVNSTDFKVLYP--------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE  255 (425)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~~--------------------~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~  255 (425)
                      ..+++|||+.+++|..++.                    .+++..+..++.|++.||+|||++|++|+||||+|||++.+
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~  160 (283)
T cd05090          81 PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQ  160 (283)
T ss_pred             ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCC
Confidence            7889999999999988761                    36788889999999999999999999999999999999988


Q ss_pred             CCcEEEEeccccccccCCCc---ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHH
Q 014406          256 LRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLV  331 (425)
Q Consensus       256 ~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~  331 (425)
                       +.+||+|||+++.......   .....++..|+|||.+.+ ..++.++|||||||++|||++ |..||. +.+..+...
T Consensus       161 -~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~~g~~p~~-~~~~~~~~~  237 (283)
T cd05090         161 -LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMY-GKFSSDSDIWSFGVVLWEIFSFGLQPYY-GFSNQEVIE  237 (283)
T ss_pred             -CcEEeccccccccccCCcceecccCCCccceecChHHhcc-CCCCchhhhHHHHHHHHHHHcCCCCCCC-CCCHHHHHH
Confidence             7899999999976543321   122344567999999876 678999999999999999998 877873 333222222


Q ss_pred             HHHHHhCCchhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcC
Q 014406          332 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  409 (425)
Q Consensus       332 ~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~h  409 (425)
                      .+ ....                                   .......+++.+.+++.+||+.||++||++.+++++
T Consensus       238 ~~-~~~~-----------------------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~  279 (283)
T cd05090         238 MV-RKRQ-----------------------------------LLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR  279 (283)
T ss_pred             HH-HcCC-----------------------------------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            11 1000                                   000112368899999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=2.4e-39  Score=305.39  Aligned_cols=259  Identities=27%  Similarity=0.455  Sum_probs=202.7

Q ss_pred             CEEEEeeeeeeCceEEEEEEEc---CCCcEEEEEEecCc-------chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCC
Q 014406          126 DYEVVRKVGRGKYSEVFEGINV---NTNERCIIKILKPV-------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (425)
Q Consensus       126 ~y~~~~~LG~G~fg~V~~~~~~---~~~~~vavK~~~~~-------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (425)
                      +|++.+.||+|+||.||++.+.   .+++.+|||+++..       ..+.+.+|+.++.++.+|+||+++++.+..  +.
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~--~~   78 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQT--DT   78 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeec--CC
Confidence            4788999999999999999854   46788999998632       224577899999999779999999999854  46


Q ss_pred             ccEEEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccC
Q 014406          196 TPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (425)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~  272 (425)
                      ..++||||+.+++|..++   ..+++..++.++.|++.||.|||+.+++|+||+|+||+++.+ +.++|+|||+++....
T Consensus        79 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~  157 (288)
T cd05583          79 KLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSE-GHVVLTDFGLSKEFLA  157 (288)
T ss_pred             EEEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCC-CCEEEEECcccccccc
Confidence            788999999999998776   347889999999999999999999999999999999999988 7899999999876543


Q ss_pred             CCcc--eeeccCCCccCcccccCCC-CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhc
Q 014406          273 GKEY--NVRVASRYFKGPELLVDLQ-DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY  349 (425)
Q Consensus       273 ~~~~--~~~~~t~~y~aPE~~~~~~-~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~  349 (425)
                      ....  ....++..|+|||.+.+.. ..+.++||||||+++|+|++|..||..... ......+.+..-         . 
T Consensus       158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~-~~~~~~~~~~~~---------~-  226 (288)
T cd05583         158 EEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGE-QNSQSEISRRIL---------K-  226 (288)
T ss_pred             ccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcc-cchHHHHHHHHH---------c-
Confidence            3221  2245788999999986622 368899999999999999999999843211 111111111000         0 


Q ss_pred             cCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcC---HHHHhcCCCCcccccchhc
Q 014406          350 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT---AREAMAHPYFAQVRAAESS  421 (425)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpt---a~elL~hp~~~~~~~~~~~  421 (425)
                                   .          ....+..++.++.+|+.+||+.||++|||   +.++|+||||+++.+.+..
T Consensus       227 -------------~----------~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~~~~~  278 (288)
T cd05583         227 -------------S----------KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWDDLA  278 (288)
T ss_pred             -------------c----------CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCHHHHh
Confidence                         0          00112236788999999999999999998   5678999999999886543

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=2e-39  Score=306.58  Aligned_cols=246  Identities=18%  Similarity=0.355  Sum_probs=194.7

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCC-----CcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCC
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNT-----NERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQH  193 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~-----~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  193 (425)
                      ..++|++.+.||+|+||.||++.....     ...+|+|.+....    ...+.+|+++++++.+|+||+++++++..  
T Consensus        10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~--   87 (293)
T cd05053          10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ--   87 (293)
T ss_pred             CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC--
Confidence            467899999999999999999987643     3789999987532    24577899999998679999999999964  


Q ss_pred             CCccEEEEEeecCCChhhhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecC
Q 014406          194 SKTPSLIFEYVNSTDFKVLYP-------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH  254 (425)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~~-------------------~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~  254 (425)
                      ....+++|||+.+++|..++.                   .+++..+..++.|++.||.|||+.+|+|+||||+||+++.
T Consensus        88 ~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~  167 (293)
T cd05053          88 EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTE  167 (293)
T ss_pred             CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcC
Confidence            467899999999999987762                   3788889999999999999999999999999999999998


Q ss_pred             CCCcEEEEeccccccccCCCcc---eeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHH
Q 014406          255 ELRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQL  330 (425)
Q Consensus       255 ~~~~~kl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~  330 (425)
                      + +.+||+|||+++........   ....++..|+|||++.+ ..++.++|||||||++|+|++ |..||. +....+..
T Consensus       168 ~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~-~~~~~~~~  244 (293)
T cd05053         168 D-HVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGSPYP-GIPVEELF  244 (293)
T ss_pred             C-CeEEeCccccccccccccceeccCCCCCCccccCHHHhcc-CCcCcccceeehhhHHHHHhcCCCCCCC-CCCHHHHH
Confidence            8 79999999999866433221   11234567999999876 678999999999999999997 888873 32222222


Q ss_pred             HHHHHHhCCchhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcC
Q 014406          331 VKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  409 (425)
Q Consensus       331 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~h  409 (425)
                      ..+....                                    .......++.++.+|+.+||..||++|||+.|++++
T Consensus       245 ~~~~~~~------------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~  287 (293)
T cd05053         245 KLLKEGY------------------------------------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED  287 (293)
T ss_pred             HHHHcCC------------------------------------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            2111000                                    000112357899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=2.5e-39  Score=304.88  Aligned_cols=255  Identities=29%  Similarity=0.492  Sum_probs=208.2

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc--hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEE
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (425)
                      ..+.|++.+.||+|+||.||+|.+..++..+++|++....  .+.+.+|+++++.+ +|+|++++++++...  ...+++
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~--~~~~lv   93 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDC-KHPNIVDYYDSYLVG--DELWVV   93 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHC-CCCCeeEEEEEEEEC--CEEEEE
Confidence            4677888999999999999999998899999999998654  56788999999999 899999999999765  678899


Q ss_pred             EEeecCCChhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCC-c
Q 014406          201 FEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-E  275 (425)
Q Consensus       201 ~e~~~~~~l~~~~~----~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~-~  275 (425)
                      +||+++++|.+++.    .+++..+..++.|++.||.|||+.|++|+||+|+||+++.+ +.++|+|||++....... .
T Consensus        94 ~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~-~~~~l~d~~~~~~~~~~~~~  172 (286)
T cd06614          94 MEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKD-GSVKLADFGFAAQLTKEKSK  172 (286)
T ss_pred             EeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCC-CCEEECccchhhhhccchhh
Confidence            99999999998873    68999999999999999999999999999999999999987 789999999886544322 2


Q ss_pred             ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCCh
Q 014406          276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP  355 (425)
Q Consensus       276 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~  355 (425)
                      .....++..|++||.+.+ ..++.++|+|||||++|+|++|..||.. .+.......+.. .+..               
T Consensus       173 ~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slGvil~~l~~g~~p~~~-~~~~~~~~~~~~-~~~~---------------  234 (286)
T cd06614         173 RNSVVGTPYWMAPEVIKR-KDYGPKVDIWSLGIMCIEMAEGEPPYLR-EPPLRALFLITT-KGIP---------------  234 (286)
T ss_pred             hccccCCcccCCHhHhcC-CCCCCccccHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHh-cCCC---------------
Confidence            233456788999999877 6789999999999999999999999832 222221111110 0000               


Q ss_pred             hhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCccccc
Q 014406          356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA  417 (425)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~  417 (425)
                                        .......++.++.+|+++||+.+|.+|||+.++++||||++..+
T Consensus       235 ------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~  278 (286)
T cd06614         235 ------------------PLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKACP  278 (286)
T ss_pred             ------------------CCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhccCc
Confidence                              00011126788999999999999999999999999999998544

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=2.7e-39  Score=301.38  Aligned_cols=244  Identities=17%  Similarity=0.306  Sum_probs=194.4

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCC---CcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCc
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNT---NERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~---~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (425)
                      .++|++.+.||+|+||+||+|.+..+   ...+|+|.++...    ...+.+|+.+++.+ +|+||+++++++..  ...
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~   79 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQF-DHPNIIRLEGVVTK--SRP   79 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhC-CCCCcceEeEEEec--CCc
Confidence            46799999999999999999987644   4589999986432    34678899999999 89999999999965  367


Q ss_pred             cEEEEEeecCCChhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccC
Q 014406          197 PSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (425)
Q Consensus       197 ~~lv~e~~~~~~l~~~~~----~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~  272 (425)
                      .+++|||+.+++|..++.    .+++..+..++.|++.||+|||+++|+|+||||+||+++.+ +.++|+|||+++....
T Consensus        80 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~-~~~~l~dfg~~~~~~~  158 (266)
T cd05033          80 VMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSN-LVCKVSDFGLSRRLED  158 (266)
T ss_pred             eEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCC-CCEEECccchhhcccc
Confidence            889999999999998862    48899999999999999999999999999999999999988 7899999999987642


Q ss_pred             CC-cce--eeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhh
Q 014406          273 GK-EYN--VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK  348 (425)
Q Consensus       273 ~~-~~~--~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~  348 (425)
                      .. ...  ...++..|+|||.+.+ ..++.++||||||+++|+|++ |..||.. ..+.+....+.+..           
T Consensus       159 ~~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Dv~slG~~l~~l~~~g~~p~~~-~~~~~~~~~~~~~~-----------  225 (266)
T cd05033         159 SEATYTTKGGKIPIRWTAPEAIAY-RKFTSASDVWSFGIVMWEVMSYGERPYWD-MSNQDVIKAVEDGY-----------  225 (266)
T ss_pred             cccceeccCCCCCccccChhhhcc-CCCccccchHHHHHHHHHHHccCCCCCCC-CCHHHHHHHHHcCC-----------
Confidence            21 111  1234567999999876 678999999999999999998 8888732 22222222111100           


Q ss_pred             ccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcC
Q 014406          349 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  409 (425)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~h  409 (425)
                                               .......+++.+.+|+.+||+.+|++||++.|++++
T Consensus       226 -------------------------~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~  261 (266)
T cd05033         226 -------------------------RLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVST  261 (266)
T ss_pred             -------------------------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence                                     000012368899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=9.8e-39  Score=297.39  Aligned_cols=245  Identities=25%  Similarity=0.469  Sum_probs=197.7

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecC------cchHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccE
Q 014406          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP------VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (425)
Q Consensus       125 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~------~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (425)
                      ++|++.+.||+|+||.||+|.+..+++.||+|.++.      ...+.+.+|+++++++ +|+|++++++++.+.  ...+
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~-~~~~i~~~~~~~~~~--~~~~   78 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQL-DHPNVIKYLASFIEN--NELN   78 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCeeeeeeeeecC--CeEE
Confidence            579999999999999999999998999999998753      1245788999999999 999999999999654  6788


Q ss_pred             EEEEeecCCChhhhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEecccccccc
Q 014406          199 LIFEYVNSTDFKVLYP-------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (425)
Q Consensus       199 lv~e~~~~~~l~~~~~-------~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~  271 (425)
                      +||||+++++|..++.       .+++..+..++.+++.||.|||+.|++|+||+|+||+++.+ +.++|+|||++....
T Consensus        79 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~-~~~~l~d~~~~~~~~  157 (267)
T cd08224          79 IVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITAT-GVVKLGDLGLGRFFS  157 (267)
T ss_pred             EEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCC-CcEEEeccceeeecc
Confidence            9999999999987752       37889999999999999999999999999999999999988 789999999987654


Q ss_pred             CCC-cceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhcc
Q 014406          272 PGK-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH  350 (425)
Q Consensus       272 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~  350 (425)
                      ... ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.....+...+   .+.+....         
T Consensus       158 ~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~---~~~~~~~~---------  224 (267)
T cd08224         158 SKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSL---CKKIEKCD---------  224 (267)
T ss_pred             CCCcccceecCCccccCHHHhcc-CCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHH---HhhhhcCC---------
Confidence            322 2233567888999999876 678999999999999999999999985433221111   11000000         


Q ss_pred             CCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhc
Q 014406          351 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  408 (425)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~  408 (425)
                                            ........++..+.+++.+||..+|++|||+.++++
T Consensus       225 ----------------------~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~  260 (267)
T cd08224         225 ----------------------YPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQ  260 (267)
T ss_pred             ----------------------CCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence                                  000001136788999999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=5e-39  Score=301.75  Aligned_cols=243  Identities=19%  Similarity=0.326  Sum_probs=192.4

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCc----EEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCC
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNE----RCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHS  194 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~----~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  194 (425)
                      ..++|++.+.||+|+||+||+|.+..++.    .||+|+++...    ...+.+|+.++..+ +|+||+++++++..   
T Consensus         5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~---   80 (279)
T cd05109           5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGV-GSPYVCRLLGICLT---   80 (279)
T ss_pred             chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhc-CCCCCceEEEEEcC---
Confidence            46789999999999999999998777766    48999986432    35678899999998 99999999999964   


Q ss_pred             CccEEEEEeecCCChhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccc
Q 014406          195 KTPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  270 (425)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~~----~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~  270 (425)
                      ...++++||+++|++.+++.    .+++..+..++.|++.||+|||+++|+|+||||+|||++.+ +.+||+|||+++..
T Consensus        81 ~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~-~~~kL~dfG~~~~~  159 (279)
T cd05109          81 STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSP-NHVKITDFGLARLL  159 (279)
T ss_pred             CCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCC-CcEEECCCCceeec
Confidence            34679999999999987763    47899999999999999999999999999999999999887 78999999999866


Q ss_pred             cCCCcc---eeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCCchhHHHH
Q 014406          271 HPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYL  346 (425)
Q Consensus       271 ~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~  346 (425)
                      ......   ....++..|+|||.+.+ ..++.++|||||||++|||++ |..||. ... .+.+.........       
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~-~~~-~~~~~~~~~~~~~-------  229 (279)
T cd05109         160 DIDETEYHADGGKVPIKWMALESILH-RRFTHQSDVWSYGVTVWELMTFGAKPYD-GIP-AREIPDLLEKGER-------  229 (279)
T ss_pred             ccccceeecCCCccchhhCCHHHhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCC-CCC-HHHHHHHHHCCCc-------
Confidence            433221   11234567999999977 679999999999999999998 777762 222 2222211110000       


Q ss_pred             hhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhc
Q 014406          347 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  408 (425)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~  408 (425)
                                                  ......++.++.+++.+||+.||++|||+.++++
T Consensus       230 ----------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~  263 (279)
T cd05109         230 ----------------------------LPQPPICTIDVYMIMVKCWMIDSECRPRFRELVD  263 (279)
T ss_pred             ----------------------------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                                        0001226789999999999999999999999984

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1.4e-39  Score=303.26  Aligned_cols=245  Identities=24%  Similarity=0.441  Sum_probs=196.4

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccE
Q 014406          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (425)
Q Consensus       125 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (425)
                      ++|++.+.||+|+||.||+|.+..++..+|||.+...      ....+.+|+.+++.+ +|+||+++++++.+.  ...+
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~--~~~~   78 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-NHPNVIKYYASFIED--NELN   78 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHc-cCCchhhhhheeEeC--CeEE
Confidence            4688889999999999999999999999999987532      235678899999999 999999999999654  6788


Q ss_pred             EEEEeecCCChhhhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEecccccccc
Q 014406          199 LIFEYVNSTDFKVLYP-------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (425)
Q Consensus       199 lv~e~~~~~~l~~~~~-------~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~  271 (425)
                      ++|||+++++|..++.       .+++..+..++.|++.||.|||++|++|+||||+||+++.+ +.++|+|||++....
T Consensus        79 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~-~~~~l~dfg~~~~~~  157 (267)
T cd08229          79 IVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITAT-GVVKLGDLGLGRFFS  157 (267)
T ss_pred             EEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCC-CCEEECcchhhhccc
Confidence            9999999999987652       37889999999999999999999999999999999999987 789999999987654


Q ss_pred             CCCc-ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhcc
Q 014406          272 PGKE-YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH  350 (425)
Q Consensus       272 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~  350 (425)
                      .... .....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.....+.............           
T Consensus       158 ~~~~~~~~~~~~~~~~ape~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-----------  225 (267)
T cd08229         158 SKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDY-----------  225 (267)
T ss_pred             cCCcccccccCCcCccCHHHhcC-CCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCC-----------
Confidence            3322 233467889999999876 678999999999999999999999985332221111111000000           


Q ss_pred             CCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhc
Q 014406          351 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  408 (425)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~  408 (425)
                                             .......+++++.+|+.+||+.||++|||+.++++
T Consensus       226 -----------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~  260 (267)
T cd08229         226 -----------------------PPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYD  260 (267)
T ss_pred             -----------------------CCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence                                   00011236889999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=1.7e-39  Score=304.55  Aligned_cols=246  Identities=33%  Similarity=0.575  Sum_probs=201.2

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccE
Q 014406          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (425)
Q Consensus       125 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (425)
                      ++|++.+.||+|+||.||+|.+..+++.+|+|++...      ..+.+.+|+.++.++.+|+||+++++++.+  ....+
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~--~~~~~   78 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQD--EENLY   78 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcC--CceEE
Confidence            4799999999999999999999999999999998642      235678899999999339999999999855  46789


Q ss_pred             EEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCC-
Q 014406          199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-  274 (425)
Q Consensus       199 lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~-  274 (425)
                      +||||+.+++|.+++   ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.+ +.++++|||++....... 
T Consensus        79 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~-~~~~l~df~~~~~~~~~~~  157 (280)
T cd05581          79 FVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKD-MHIKITDFGTAKVLDPNSS  157 (280)
T ss_pred             EEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCC-CCEEecCCccccccCCccc
Confidence            999999999998877   358999999999999999999999999999999999999988 789999999987654322 


Q ss_pred             --------------------cceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHH
Q 014406          275 --------------------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA  334 (425)
Q Consensus       275 --------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~  334 (425)
                                          ......++..|+|||.+.+ ..++.++|+||||++++++++|+.||... +....+..+.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~-~~~~~~~~~~  235 (280)
T cd05581         158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE-KPAGKSSDLWALGCIIYQMLTGKPPFRGS-NEYLTFQKIL  235 (280)
T ss_pred             cccCCCCCccccccccccccccccccCCccccCHHHhCC-CCCChhhhHHHHHHHHHHHHhCCCCCCCc-cHHHHHHHHH
Confidence                                1122356788999999877 66899999999999999999999998432 2111122111


Q ss_pred             HHhCCchhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCH----HHHhcCC
Q 014406          335 KVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA----REAMAHP  410 (425)
Q Consensus       335 ~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta----~elL~hp  410 (425)
                      .             .                        .......+++.+.+|+.+||+.||++|||+    +|+++||
T Consensus       236 ~-------------~------------------------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~  278 (280)
T cd05581         236 K-------------L------------------------EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHP  278 (280)
T ss_pred             h-------------c------------------------CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCC
Confidence            0             0                        000112258899999999999999999999    9999999


Q ss_pred             CC
Q 014406          411 YF  412 (425)
Q Consensus       411 ~~  412 (425)
                      ||
T Consensus       279 ~~  280 (280)
T cd05581         279 FF  280 (280)
T ss_pred             CC
Confidence            98

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=4.2e-39  Score=302.03  Aligned_cols=246  Identities=18%  Similarity=0.334  Sum_probs=194.4

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcC-----CCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCC
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVN-----TNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQH  193 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~-----~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  193 (425)
                      ..++|++.+.||+|+||.||+|.+..     ++..|++|.+....    ...+.+|+.+++.+ +|+||+++++++.+. 
T Consensus         4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~-   81 (277)
T cd05036           4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKF-NHQNIVRLIGVSFER-   81 (277)
T ss_pred             CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEccC-
Confidence            35779999999999999999999877     77899999886432    34588899999999 999999999988654 


Q ss_pred             CCccEEEEEeecCCChhhhcC----------CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCC--CcEEE
Q 014406          194 SKTPSLIFEYVNSTDFKVLYP----------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEL--RKLRL  261 (425)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~~----------~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~--~~~kl  261 (425)
                       ...++||||+.+++|..++.          .+++..+..++.||+.||+|||+++++|+||||+||+++.+.  ..+||
T Consensus        82 -~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl  160 (277)
T cd05036          82 -LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKI  160 (277)
T ss_pred             -CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEe
Confidence             56789999999999998762          378899999999999999999999999999999999998652  36899


Q ss_pred             EeccccccccCCCcc---eeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHh
Q 014406          262 IDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVL  337 (425)
Q Consensus       262 ~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~l  337 (425)
                      +|||+++........   .....+..|+|||++.+ ..++.++|||||||++|+|++ |..||. +.+..+....+..  
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~~g~~pf~-~~~~~~~~~~~~~--  236 (277)
T cd05036         161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLD-GIFTSKTDVWSFGVLLWEIFSLGYMPYP-GRTNQEVMEFVTG--  236 (277)
T ss_pred             ccCccccccCCccceecCCCCCccHhhCCHHHHhc-CCcCchhHHHHHHHHHHHHHcCCCCCCC-CCCHHHHHHHHHc--
Confidence            999999865322211   11223457999999977 679999999999999999997 888873 3332222211110  


Q ss_pred             CCchhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcC
Q 014406          338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  409 (425)
Q Consensus       338 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~h  409 (425)
                       ..                                 .......++..+.+|+.+||+.||++|||+.++++|
T Consensus       237 -~~---------------------------------~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~  274 (277)
T cd05036         237 -GG---------------------------------RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER  274 (277)
T ss_pred             -CC---------------------------------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence             00                                 000112368899999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=2.9e-39  Score=298.87  Aligned_cols=244  Identities=22%  Similarity=0.439  Sum_probs=201.2

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEE
Q 014406          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (425)
Q Consensus       126 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (425)
                      +|++.+.||.|+||.||++.+..+++.+++|.+...     ....+.+|+++++.+ +|+||+++++++.+.  ...++|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~--~~~~~v   77 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASV-NHPNIISYKEAFLDG--NKLCIV   77 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhC-CCCCchhhhhhhccC--CEEEEE
Confidence            588999999999999999999999999999998642     234677899999999 899999999998654  778999


Q ss_pred             EEeecCCChhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCC
Q 014406          201 FEYVNSTDFKVLY-------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (425)
Q Consensus       201 ~e~~~~~~l~~~~-------~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~  273 (425)
                      +||+++++|..++       ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.+ +.+||+|||++......
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~-~~~kl~d~g~~~~~~~~  156 (256)
T cd08530          78 MEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVAN-DLVKIGDLGISKVLKKN  156 (256)
T ss_pred             ehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecC-CcEEEeeccchhhhccC
Confidence            9999999998876       348889999999999999999999999999999999999987 78999999999876544


Q ss_pred             CcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCC
Q 014406          274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL  353 (425)
Q Consensus       274 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~  353 (425)
                       ......++..|++||.+.+ ..++.++|+||+|+++++|++|+.||.. .+..+....+..    ..            
T Consensus       157 -~~~~~~~~~~~~~Pe~~~~-~~~~~~~D~~slG~~~~~l~~g~~p~~~-~~~~~~~~~~~~----~~------------  217 (256)
T cd08530         157 -MAKTQIGTPHYMAPEVWKG-RPYSYKSDIWSLGCLLYEMATFAPPFEA-RSMQDLRYKVQR----GK------------  217 (256)
T ss_pred             -CcccccCCccccCHHHHCC-CCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhc----CC------------
Confidence             3334567889999999977 7789999999999999999999999832 222211111100    00            


Q ss_pred             ChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCC
Q 014406          354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF  412 (425)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~  412 (425)
                                     .     ......++.++++++.+||+.+|++|||+.|+++||++
T Consensus       218 ---------------~-----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~  256 (256)
T cd08530         218 ---------------Y-----PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV  256 (256)
T ss_pred             ---------------C-----CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence                           0     00011267889999999999999999999999999985

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=3e-39  Score=298.58  Aligned_cols=236  Identities=20%  Similarity=0.373  Sum_probs=186.5

Q ss_pred             eeeeeeCceEEEEEEEcCCCcEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEEEeecC
Q 014406          131 RKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNS  206 (425)
Q Consensus       131 ~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~  206 (425)
                      +.||+|+||+||+|.+..+++.+|+|.+...    ....+.+|+++++.+ +|+||+++++++...  ...++||||+.+
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~lv~e~~~~   77 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQY-SHPNIVRLIGVCTQK--QPIYIVMELVQG   77 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEcCC--CCeEEEEeeccC
Confidence            3699999999999999999999999987643    235688999999999 999999999999654  678899999999


Q ss_pred             CChhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCcce---ee
Q 014406          207 TDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN---VR  279 (425)
Q Consensus       207 ~~l~~~~~----~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~~~---~~  279 (425)
                      ++|.+++.    .+++..+..++.|++.||.|||++|++|+||||+||+++.+ +.+||+|||++..........   ..
T Consensus        78 ~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~  156 (252)
T cd05084          78 GDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEK-NVLKISDFGMSREEEDGVYASTGGMK  156 (252)
T ss_pred             CcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCC-CcEEECccccCcccccccccccCCCC
Confidence            99998863    37899999999999999999999999999999999999988 789999999987543221111   11


Q ss_pred             ccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCChhhH
Q 014406          280 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLD  358 (425)
Q Consensus       280 ~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~  358 (425)
                      ..+..|+|||.+.+ ..++.++|||||||++|+|++ |..||. .....+....+...                      
T Consensus       157 ~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~e~~~~~~~p~~-~~~~~~~~~~~~~~----------------------  212 (252)
T cd05084         157 QIPVKWTAPEALNY-GRYSSESDVWSFGILLWEAFSLGAVPYA-NLSNQQTREAIEQG----------------------  212 (252)
T ss_pred             CCceeecCchhhcC-CCCChHHHHHHHHHHHHHHHhCCCCCcc-ccCHHHHHHHHHcC----------------------
Confidence            22346999999877 678999999999999999998 777762 22211111111000                      


Q ss_pred             HHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhc
Q 014406          359 ALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  408 (425)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~  408 (425)
                                    ........++..+.+|+.+||+.||++|||+.++++
T Consensus       213 --------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  248 (252)
T cd05084         213 --------------VRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ  248 (252)
T ss_pred             --------------CCCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                          000111236889999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.1e-39  Score=297.71  Aligned_cols=243  Identities=20%  Similarity=0.325  Sum_probs=194.4

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc--chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEE
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (425)
                      ..++|++.+.||+|+||.||+|.+. +++.||+|.++..  ..+++.+|+.+++++ +|+||+++++++...  ...+++
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~lv   79 (261)
T cd05068           4 DRTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTMDPKDFLAEAQIMKKL-RHPKLIQLYAVCTLE--EPIYIV   79 (261)
T ss_pred             chhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcccHHHHHHHHHHHHHC-CCCCccceeEEEecC--CCeeee
Confidence            4577999999999999999999864 4578999998754  346788999999999 899999999998654  678899


Q ss_pred             EEeecCCChhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCc
Q 014406          201 FEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (425)
Q Consensus       201 ~e~~~~~~l~~~~~-----~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~  275 (425)
                      |||+.+++|.+++.     .+++..+..++.|++.||.|||+.|++|+||||+||+++.+ +.++|+|||+++.......
T Consensus        80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~-~~~~l~dfg~~~~~~~~~~  158 (261)
T cd05068          80 TELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGEN-NICKVADFGLARVIKEDIY  158 (261)
T ss_pred             eecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCC-CCEEECCcceEEEccCCcc
Confidence            99999999988863     47899999999999999999999999999999999999988 7899999999987653221


Q ss_pred             ce--eeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCC
Q 014406          276 YN--VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE  352 (425)
Q Consensus       276 ~~--~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~  352 (425)
                      ..  ....+..|+|||.+.+ ..++.++||||||+++|+|++ |+.|| .+.+..+.+..+.....              
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~-~~~~~~~~~~~~~~~~~--------------  222 (261)
T cd05068         159 EAREGAKFPIKWTAPEAALY-NRFSIKSDVWSFGILLTEIVTYGRMPY-PGMTNAEVLQQVDQGYR--------------  222 (261)
T ss_pred             cccCCCcCceeccCcccccc-CCCCchhhHHHHHHHHHHHHhcCCCCC-CCCCHHHHHHHHHcCCC--------------
Confidence            11  1122357999999877 678999999999999999999 88777 33333332222211000              


Q ss_pred             CChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhc
Q 014406          353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  408 (425)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~  408 (425)
                                            ......+++.+.+++.+||+.+|++|||+.++++
T Consensus       223 ----------------------~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~  256 (261)
T cd05068         223 ----------------------MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQW  256 (261)
T ss_pred             ----------------------CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence                                  0011236789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=3.3e-39  Score=305.14  Aligned_cols=250  Identities=25%  Similarity=0.427  Sum_probs=202.4

Q ss_pred             EeeeeeeCceEEEEEEEcCCCcEEEEEEecCc---chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEEEeecC
Q 014406          130 VRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNS  206 (425)
Q Consensus       130 ~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~  206 (425)
                      ..+||+|+||.||++....+++.||+|.+...   ....+.+|+.+++.+ +|+|++++++++...  ...+++|||+++
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~--~~~~lv~e~~~~  101 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY-QHENVVEMYNSYLVG--DELWVVMEFLEG  101 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhc-CCcchhheeeEEEeC--CEEEEEEecCCC
Confidence            35799999999999999999999999998632   235688899999999 899999999999654  678999999999


Q ss_pred             CChhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCC-cceeeccCC
Q 014406          207 TDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EYNVRVASR  283 (425)
Q Consensus       207 ~~l~~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~t~  283 (425)
                      ++|..++  ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.+ +.++|+|||++....... ......++.
T Consensus       102 ~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~  180 (292)
T cd06657         102 GALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHD-GRVKLSDFGFCAQVSKEVPRRKSLVGTP  180 (292)
T ss_pred             CcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC-CCEEEcccccceecccccccccccccCc
Confidence            9998876  358899999999999999999999999999999999999988 789999999987554322 223356788


Q ss_pred             CccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCChhhHHHhcc
Q 014406          284 YFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGR  363 (425)
Q Consensus       284 ~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~  363 (425)
                      .|+|||.+.+ ..++.++|+||+|+++|+|++|..||.. .+..+....+...+..                        
T Consensus       181 ~y~~pE~~~~-~~~~~~~Dv~slGvil~el~tg~~p~~~-~~~~~~~~~~~~~~~~------------------------  234 (292)
T cd06657         181 YWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFN-EPPLKAMKMIRDNLPP------------------------  234 (292)
T ss_pred             cccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhhCCc------------------------
Confidence            8999999876 6789999999999999999999999843 2222222211110000                        


Q ss_pred             cCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccch
Q 014406          364 HSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE  419 (425)
Q Consensus       364 ~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~~  419 (425)
                                .......++..+.+++.+||+.||.+||++.++++||||.....+.
T Consensus       235 ----------~~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~~~~  280 (292)
T cd06657         235 ----------KLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPS  280 (292)
T ss_pred             ----------ccCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccCCCc
Confidence                      0000122678899999999999999999999999999999887543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=7.1e-41  Score=315.24  Aligned_cols=294  Identities=27%  Similarity=0.445  Sum_probs=227.9

Q ss_pred             CcCCcccccCCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc--hHHHHHHHHHHHHhc-----CCCCeeeE
Q 014406          113 DYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--KKKIKREIKILQNLC-----GGPNVVKL  185 (425)
Q Consensus       113 ~~~~~~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~-----~h~niv~l  185 (425)
                      .|+.+.++..-..+|.+....|+|-||+|.+|.+...|..||||++.+..  .+.-..|++||++|.     +.-|++++
T Consensus       420 GYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl  499 (752)
T KOG0670|consen  420 GYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRL  499 (752)
T ss_pred             ceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHH
Confidence            46677777777899999999999999999999999999999999998643  466788999999993     23488999


Q ss_pred             EeEEEcCCCCccEEEEEeecCCChhhhcC------CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcE
Q 014406          186 LDIVRDQHSKTPSLIFEYVNSTDFKVLYP------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKL  259 (425)
Q Consensus       186 ~~~~~~~~~~~~~lv~e~~~~~~l~~~~~------~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~  259 (425)
                      +..|  .+.+|+|||+|-+.... ...+.      .|....++.|+.|++.||..|-++||+|.||||+|||++.....+
T Consensus       500 ~r~F--~hknHLClVFE~LslNL-RevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iL  576 (752)
T KOG0670|consen  500 FRHF--KHKNHLCLVFEPLSLNL-REVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNIL  576 (752)
T ss_pred             HHHh--hhcceeEEEehhhhchH-HHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCccee
Confidence            9988  55689999999886543 33332      377788999999999999999999999999999999999988899


Q ss_pred             EEEeccccccccCCCcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCC
Q 014406          260 RLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT  339 (425)
Q Consensus       260 kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~  339 (425)
                      ||||||.|.....+ ..+....+..|+|||++++ ..|++..|+||+||+||||.||+..| +|..+.+.+..+.++-|.
T Consensus       577 KLCDfGSA~~~~en-eitPYLVSRFYRaPEIiLG-~~yd~~iD~WSvgctLYElYtGkIlF-pG~TNN~MLrl~me~KGk  653 (752)
T KOG0670|consen  577 KLCDFGSASFASEN-EITPYLVSRFYRAPEIILG-LPYDYPIDTWSVGCTLYELYTGKILF-PGRTNNQMLRLFMELKGK  653 (752)
T ss_pred             eeccCccccccccc-cccHHHHHHhccCcceeec-CcccCCccceeeceeeEEeeccceec-CCCCcHHHHHHHHHhcCC
Confidence            99999999876543 3445567788999999999 78999999999999999999999886 899999999998888887


Q ss_pred             chhHHHHhhccCCCChhhHHH-----------hcccCC------CC---cccccc-----ccCCCCCCHHHHHHHHHccc
Q 014406          340 DELNAYLNKYHLELDPQLDAL-----------VGRHSR------KP---WSKFIN-----ADNQHLVSPEAIDFLDKLLR  394 (425)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~------~~---~~~~~~-----~~~~~~~s~~~~~ll~~~L~  394 (425)
                      -+-... .+ +...++.++..           ......      ++   ....+.     ...+..+-.++++|+.+||.
T Consensus       654 ~p~Kml-RK-gqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~  731 (752)
T KOG0670|consen  654 FPNKML-RK-GQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLI  731 (752)
T ss_pred             CcHHHh-hh-cchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhc
Confidence            543332 11 11111211111           111000      01   000000     11111233457899999999


Q ss_pred             CCcCCCcCHHHHhcCCCCcc
Q 014406          395 YDHQDRLTAREAMAHPYFAQ  414 (425)
Q Consensus       395 ~dP~~Rpta~elL~hp~~~~  414 (425)
                      .||++|.|..|+|+||||..
T Consensus       732 LdP~KRit~nqAL~HpFi~~  751 (752)
T KOG0670|consen  732 LDPEKRITVNQALKHPFITE  751 (752)
T ss_pred             cChhhcCCHHHHhcCCcccC
Confidence            99999999999999999974

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.9e-39  Score=301.31  Aligned_cols=244  Identities=19%  Similarity=0.339  Sum_probs=194.4

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCC-----CcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCC
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNT-----NERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQH  193 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~-----~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  193 (425)
                      ..++|++.+.||+|+||.||+|.+...     +..||+|.+....    ...+.+|+.+++.+ +|+||+++++++... 
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~-   81 (277)
T cd05032           4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEF-NCHHVVRLLGVVSTG-   81 (277)
T ss_pred             chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhC-CCCceeEEEEEEcCC-
Confidence            467899999999999999999987644     3789999986432    34678999999999 999999999999654 


Q ss_pred             CCccEEEEEeecCCChhhhcC-------------CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEE
Q 014406          194 SKTPSLIFEYVNSTDFKVLYP-------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLR  260 (425)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~~-------------~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~k  260 (425)
                       ...++||||+++++|..++.             .+++..+..++.|++.||.|||+.+++|+||||+||+++.+ +.+|
T Consensus        82 -~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~-~~~k  159 (277)
T cd05032          82 -QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAED-LTVK  159 (277)
T ss_pred             -CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCC-CCEE
Confidence             77899999999999988763             25677889999999999999999999999999999999998 7899


Q ss_pred             EEeccccccccCCCc---ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHH
Q 014406          261 LIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKV  336 (425)
Q Consensus       261 l~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~  336 (425)
                      |+|||+++.......   .....++..|+|||.+.+ ..++.++|||||||++|++++ |..|| .+.+..+....+ ..
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~-~~~~~~~~~~~~-~~  236 (277)
T cd05032         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD-GVFTTKSDVWSFGVVLWEMATLAEQPY-QGLSNEEVLKFV-ID  236 (277)
T ss_pred             ECCcccchhhccCcccccCCCCCccccccCHHHHhc-CCCCcccchHHHHHHHHHhhccCCCCC-ccCCHHHHHHHH-hc
Confidence            999999876543322   123345678999999876 678999999999999999998 77777 333322222211 10


Q ss_pred             hCCchhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhc
Q 014406          337 LGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  408 (425)
Q Consensus       337 lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~  408 (425)
                      -+                                   ....+..++.++.+++.+||+.+|++|||+.++++
T Consensus       237 ~~-----------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  273 (277)
T cd05032         237 GG-----------------------------------HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS  273 (277)
T ss_pred             CC-----------------------------------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            00                                   00011225789999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=4.6e-39  Score=334.11  Aligned_cols=244  Identities=22%  Similarity=0.360  Sum_probs=192.6

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccE
Q 014406          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (425)
Q Consensus       125 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (425)
                      ++|++.++||+|+||+||+|.+..+++.||+|++...      ..+.+.+|+.+++++ +||||+++++++.+.  ...+
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L-~HPNIVkl~~v~~d~--~~ly   78 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADL-IHPGIVPVYSICSDG--DPVY   78 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhC-CCcCcCeEEEEEeeC--CEEE
Confidence            5799999999999999999999999999999998642      135688999999999 999999999999654  6789


Q ss_pred             EEEEeecCCChhhhcC--------------CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEec
Q 014406          199 LIFEYVNSTDFKVLYP--------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDW  264 (425)
Q Consensus       199 lv~e~~~~~~l~~~~~--------------~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Df  264 (425)
                      ++|||++|++|..++.              .++...+..++.||+.||+|||+.||+||||||+|||++.+ +.++|+||
T Consensus        79 LVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~d-g~vKLiDF  157 (932)
T PRK13184         79 YTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLF-GEVVILDW  157 (932)
T ss_pred             EEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCC-CCEEEEec
Confidence            9999999999987652              23456678899999999999999999999999999999988 78999999


Q ss_pred             cccccccCCC-------------------cceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCC
Q 014406          265 GLAEFYHPGK-------------------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD  325 (425)
Q Consensus       265 g~a~~~~~~~-------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~  325 (425)
                      |+++......                   .....+||+.|+|||.+.+ ..++.++|||||||++|||++|+.||.... 
T Consensus       158 GLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g-~~~S~kSDIWSLGVILyELLTG~~PF~~~~-  235 (932)
T PRK13184        158 GAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG-VPASESTDIYALGVILYQMLTLSFPYRRKK-  235 (932)
T ss_pred             CcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcC-CCCCcHhHHHHHHHHHHHHHHCCCCCCCcc-
Confidence            9997652110                   0112368999999999987 678999999999999999999999984311 


Q ss_pred             CHHHHHHHHHHhCCchhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHH
Q 014406          326 NHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTARE  405 (425)
Q Consensus       326 ~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~e  405 (425)
                      ..+....  ..+..+.                                .......+++.+.+++.+||+.||++|++..+
T Consensus       236 ~~ki~~~--~~i~~P~--------------------------------~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~e  281 (932)
T PRK13184        236 GRKISYR--DVILSPI--------------------------------EVAPYREIPPFLSQIAMKALAVDPAERYSSVQ  281 (932)
T ss_pred             hhhhhhh--hhccChh--------------------------------hccccccCCHHHHHHHHHHccCChhhCcCHHH
Confidence            1111000  0000000                                00001236889999999999999999987665


Q ss_pred             Hhc
Q 014406          406 AMA  408 (425)
Q Consensus       406 lL~  408 (425)
                      .+.
T Consensus       282 eLl  284 (932)
T PRK13184        282 ELK  284 (932)
T ss_pred             HHH
Confidence            553

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1.4e-39  Score=306.04  Aligned_cols=244  Identities=19%  Similarity=0.334  Sum_probs=192.8

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCC-----CcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCC
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNT-----NERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHS  194 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~-----~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  194 (425)
                      ..+|++.+.||+|+||+||+|.+..+     +..||+|+++...    ...+.+|+.++..+ +||||+++++++...  
T Consensus         4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~~~--   80 (283)
T cd05091           4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRL-QHPNIVCLLGVVTKE--   80 (283)
T ss_pred             HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcC-CCCCcCeEEEEEcCC--
Confidence            34577788999999999999987543     5789999997543    24578899999999 899999999999654  


Q ss_pred             CccEEEEEeecCCChhhhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCC
Q 014406          195 KTPSLIFEYVNSTDFKVLYP-------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE  255 (425)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~~-------------------~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~  255 (425)
                      ...++++||+.+++|..++.                   .+++..+..++.|++.||.|||++||+||||||+||+++.+
T Consensus        81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~  160 (283)
T cd05091          81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDK  160 (283)
T ss_pred             CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCC
Confidence            56789999999999887751                   36788889999999999999999999999999999999987


Q ss_pred             CCcEEEEeccccccccCCCcc---eeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHH
Q 014406          256 LRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLV  331 (425)
Q Consensus       256 ~~~~kl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~  331 (425)
                       +.+||+|||+++........   ....++..|+|||.+.+ ..++.++|||||||++|||++ |..|| .+.+..+...
T Consensus       161 -~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~-~~~~~~~~~~  237 (283)
T cd05091         161 -LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMY-GKFSIDSDIWSYGVVLWEVFSYGLQPY-CGYSNQDVIE  237 (283)
T ss_pred             -CceEecccccccccccchheeeccCccCCccccCHHHHhc-CCCCcchhHHHHHHHHHHHHcCCCCCC-CCCCHHHHHH
Confidence             78999999998765433221   22345678999999876 678999999999999999998 66665 4433333333


Q ss_pred             HHHHHhCCchhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcC
Q 014406          332 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  409 (425)
Q Consensus       332 ~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~h  409 (425)
                      .+.+.    ..                                ......++..+.+|+.+||+.+|++||++.++++.
T Consensus       238 ~i~~~----~~--------------------------------~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~  279 (283)
T cd05091         238 MIRNR----QV--------------------------------LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR  279 (283)
T ss_pred             HHHcC----Cc--------------------------------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence            22110    00                                00112368899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=2.3e-39  Score=313.14  Aligned_cols=247  Identities=21%  Similarity=0.356  Sum_probs=191.8

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEE-----cCCCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCC
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGIN-----VNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHS  194 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~-----~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  194 (425)
                      .++|++.+.||+|+||+||+|.+     ..+++.||||+++...    ...+.+|+.++.++.+|+||+++++++... +
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~-~   84 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP-G   84 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecC-C
Confidence            57899999999999999999974     3567899999997432    245778999999997789999999988654 3


Q ss_pred             CccEEEEEeecCCChhhhcC------------------------------------------------------------
Q 014406          195 KTPSLIFEYVNSTDFKVLYP------------------------------------------------------------  214 (425)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~~------------------------------------------------------------  214 (425)
                      ...+++|||+++|+|.+++.                                                            
T Consensus        85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (343)
T cd05103          85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE  164 (343)
T ss_pred             CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence            56789999999999987652                                                            


Q ss_pred             ----------CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCcc---eeecc
Q 014406          215 ----------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY---NVRVA  281 (425)
Q Consensus       215 ----------~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~  281 (425)
                                .+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||++.........   ....+
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~  243 (343)
T cd05103         165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEN-NVVKICDFGLARDIYKDPDYVRKGDARL  243 (343)
T ss_pred             hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCC-CcEEEEecccccccccCcchhhcCCCCC
Confidence                      25667788899999999999999999999999999999987 78999999998765322211   12234


Q ss_pred             CCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCChhhHHH
Q 014406          282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDAL  360 (425)
Q Consensus       282 t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~  360 (425)
                      +..|+|||.+.+ ..++.++||||||+++|+|++ |..||... .....+.....            ..           
T Consensus       244 ~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~-~~~~~~~~~~~------------~~-----------  298 (343)
T cd05103         244 PLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGV-KIDEEFCRRLK------------EG-----------  298 (343)
T ss_pred             CcceECcHHhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCc-cccHHHHHHHh------------cc-----------
Confidence            567999999877 678999999999999999997 88887322 21111111100            00           


Q ss_pred             hcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcC
Q 014406          361 VGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  409 (425)
Q Consensus       361 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~h  409 (425)
                          ..        ...+..+++++.+++.+||+.||++|||+.|+++|
T Consensus       299 ----~~--------~~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~  335 (343)
T cd05103         299 ----TR--------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  335 (343)
T ss_pred             ----CC--------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                00        00011257789999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=4.8e-39  Score=303.39  Aligned_cols=243  Identities=20%  Similarity=0.367  Sum_probs=193.5

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEc-----CCCcEEEEEEecCcc---hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCC
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINV-----NTNERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~-----~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (425)
                      .++|.+.+.||+|+||+||++.+.     .++..+|+|.+....   .+.+.+|+++++++ +|+||+++++++..  ..
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~   80 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL-QHEHIVKFYGVCVE--GD   80 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEec--CC
Confidence            567899999999999999999752     345678999987543   35688999999999 89999999999965  46


Q ss_pred             ccEEEEEeecCCChhhhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcE
Q 014406          196 TPSLIFEYVNSTDFKVLYP----------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKL  259 (425)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~~----------------~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~  259 (425)
                      ..++||||+++++|..++.                .+++..+..++.|++.||+|||++|++||||||+||+++.+ +.+
T Consensus        81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~-~~~  159 (288)
T cd05093          81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGEN-LLV  159 (288)
T ss_pred             ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccC-CcE
Confidence            7899999999999987762                37899999999999999999999999999999999999988 789


Q ss_pred             EEEeccccccccCCCcc---eeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHH
Q 014406          260 RLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAK  335 (425)
Q Consensus       260 kl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~  335 (425)
                      +|+|||+++........   ....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||. +....+.+..+..
T Consensus       160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~t~g~~p~~-~~~~~~~~~~i~~  237 (288)
T cd05093         160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSLGVVLWEIFTYGKQPWY-QLSNNEVIECITQ  237 (288)
T ss_pred             EeccCCccccccCCceeecCCCCCccccccCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCC-CCCHHHHHHHHHc
Confidence            99999999765432211   22334667999999877 678999999999999999998 777773 3333322222211


Q ss_pred             HhCCchhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhc
Q 014406          336 VLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  408 (425)
Q Consensus       336 ~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~  408 (425)
                        +.                                  .......++.++.+|+.+||+.||.+|||+.++++
T Consensus       238 --~~----------------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~  274 (288)
T cd05093         238 --GR----------------------------------VLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS  274 (288)
T ss_pred             --CC----------------------------------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence              00                                  00001236789999999999999999999999854

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=8.7e-39  Score=305.32  Aligned_cols=250  Identities=26%  Similarity=0.402  Sum_probs=198.0

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc------hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccE
Q 014406          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (425)
Q Consensus       125 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (425)
                      +.|...++||+|+||+||+|.+..++..+++|.+....      ...+.+|+++++.+ +|+|++++++++.+.  ...+
T Consensus        21 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~--~~~~   97 (313)
T cd06633          21 EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQL-KHPNTIEYKGCYLKE--HTAW   97 (313)
T ss_pred             HHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhC-CCCCCccEEEEEEeC--CEEE
Confidence            34666788999999999999999999999999986321      24578899999999 899999999999764  6788


Q ss_pred             EEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCc
Q 014406          199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (425)
Q Consensus       199 lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~  275 (425)
                      +||||+.+..+..+.   ..+++.++..++.|++.||.|||+.|++|+||+|+||+++.+ +.++|+|||++....   .
T Consensus        98 lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~-~~~kL~dfg~~~~~~---~  173 (313)
T cd06633          98 LVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEP-GQVKLADFGSASKSS---P  173 (313)
T ss_pred             EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCC-CCEEEeecCCCcccC---C
Confidence            999999765443332   348899999999999999999999999999999999999988 789999999986432   2


Q ss_pred             ceeeccCCCccCcccccC--CCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCC
Q 014406          276 YNVRVASRYFKGPELLVD--LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL  353 (425)
Q Consensus       276 ~~~~~~t~~y~aPE~~~~--~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~  353 (425)
                      .....++..|+|||.+..  ...++.++|||||||++|+|++|..||+.. +.......+... ..              
T Consensus       174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~-~~~~~~~~~~~~-~~--------------  237 (313)
T cd06633         174 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-NAMSALYHIAQN-DS--------------  237 (313)
T ss_pred             CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHhc-CC--------------
Confidence            234567889999999842  256888999999999999999999998543 222222221110 00              


Q ss_pred             ChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCccccc
Q 014406          354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA  417 (425)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~  417 (425)
                                          .......++..+++|+.+||+.+|++|||+.++++||||...+.
T Consensus       238 --------------------~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~~~  281 (313)
T cd06633         238 --------------------PTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRDRP  281 (313)
T ss_pred             --------------------CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCch
Confidence                                00001125778999999999999999999999999999987654

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=9.1e-39  Score=300.73  Aligned_cols=261  Identities=20%  Similarity=0.354  Sum_probs=196.6

Q ss_pred             CCCEEEEeeeeeeCceEEEEEE----EcCCCcEEEEEEecCcc---hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCc
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGI----NVNTNERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~----~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (425)
                      ..+|++.+.||+|+||+||+|.    +..++..||+|.+....   .+.+.+|+++++.+ +||||+++++++.......
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~   81 (284)
T cd05081           3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSL-QHDNIVKYKGVCYSAGRRN   81 (284)
T ss_pred             cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhC-CCCCeeEEEEEEccCCCCc
Confidence            4578999999999999999997    44678899999987544   34678999999999 9999999999887655567


Q ss_pred             cEEEEEeecCCChhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccC
Q 014406          197 PSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (425)
Q Consensus       197 ~~lv~e~~~~~~l~~~~~----~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~  272 (425)
                      .++|+||+++++|..++.    .+++..+..++.|++.||+|||++|++|+||||+||+++.+ +.++|+|||+++....
T Consensus        82 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~-~~~~l~dfg~~~~~~~  160 (284)
T cd05081          82 LRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESE-NRVKIGDFGLTKVLPQ  160 (284)
T ss_pred             eEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCC-CeEEECCCcccccccC
Confidence            899999999999998763    37899999999999999999999999999999999999988 7899999999987643


Q ss_pred             CCcce----eeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhh
Q 014406          273 GKEYN----VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK  348 (425)
Q Consensus       273 ~~~~~----~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~  348 (425)
                      .....    ...++..|+|||.+.+ ..++.++|||||||+++||++|..++....   ..   ..+.++.....     
T Consensus       161 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~~~~~~---~~---~~~~~~~~~~~-----  228 (284)
T cd05081         161 DKEYYKVREPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYSDKSCSPP---AE---FMRMMGNDKQG-----  228 (284)
T ss_pred             CCcceeecCCCCCceEeeCHHHhcc-CCcChHHHHHHHHHHHHHHhhcCCcCCCcc---hh---hhhhccccccc-----
Confidence            32211    1123445999999877 678999999999999999999887653211   11   11111111000     


Q ss_pred             ccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhc
Q 014406          349 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  408 (425)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~  408 (425)
                        ...............        .......++.++.+|+.+||..+|++|||+.|+++
T Consensus       229 --~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05081         229 --QMIVYHLIELLKNNG--------RLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL  278 (284)
T ss_pred             --ccchHHHHHHHhcCC--------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence              000000000000000        01112347889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=3.8e-39  Score=301.19  Aligned_cols=242  Identities=17%  Similarity=0.334  Sum_probs=188.6

Q ss_pred             EEEeeeeeeCceEEEEEEEcCCCc--EEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcC----CCCc
Q 014406          128 EVVRKVGRGKYSEVFEGINVNTNE--RCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQ----HSKT  196 (425)
Q Consensus       128 ~~~~~LG~G~fg~V~~~~~~~~~~--~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~----~~~~  196 (425)
                      .+.+.||+|+||.||+|.+..++.  .+|+|.++..     ..+.+.+|+.+++.+ +|+||+++++++...    ....
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEF-DHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEccCCcccCCCC
Confidence            456789999999999999877765  6899988643     235678899999999 999999999987532    1235


Q ss_pred             cEEEEEeecCCChhhhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEecccc
Q 014406          197 PSLIFEYVNSTDFKVLY---------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA  267 (425)
Q Consensus       197 ~~lv~e~~~~~~l~~~~---------~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a  267 (425)
                      .+++|||+.+++|..++         ..+++..+..++.|++.||+|||+++|+|+||||+|||++.+ +.++|+|||++
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~-~~~kl~Dfg~~  159 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNEN-MNVCVADFGLS  159 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCC-CCEEECCCCcc
Confidence            78999999999987764         237889999999999999999999999999999999999987 78999999999


Q ss_pred             ccccCCCcc---eeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCCchhH
Q 014406          268 EFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELN  343 (425)
Q Consensus       268 ~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~lg~~~~~  343 (425)
                      +........   ....++..|++||.+.+ ..++.++|||||||++|+|++ |..|| .+.+..+....+..        
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slG~il~el~~~g~~p~-~~~~~~~~~~~~~~--------  229 (272)
T cd05075         160 KKIYNGDYYRQGRIAKMPVKWIAIESLAD-RVYTTKSDVWSFGVTMWEIATRGQTPY-PGVENSEIYDYLRQ--------  229 (272)
T ss_pred             cccCcccceecCCcccCCcccCCHHHccC-CCcChHHHHHHHHHHHHHHHcCCCCCC-CCCCHHHHHHHHHc--------
Confidence            876433221   22245667999999877 678999999999999999999 67776 33333222221110        


Q ss_pred             HHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcC
Q 014406          344 AYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  409 (425)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~h  409 (425)
                           ..              .         ......++..+.+++.+||+.||++|||+.+++++
T Consensus       230 -----~~--------------~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  267 (272)
T cd05075         230 -----GN--------------R---------LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE  267 (272)
T ss_pred             -----CC--------------C---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence                 00              0         00112367889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=4.8e-39  Score=298.67  Aligned_cols=241  Identities=17%  Similarity=0.336  Sum_probs=192.7

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc--chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEE
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (425)
                      ..++|++.++||+|+||+||+|.+. ++..+|+|.+...  ..+.+.+|+.+++++ +|+|++++++++..   ...+++
T Consensus         4 ~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~---~~~~lv   78 (260)
T cd05070           4 PRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMSPESFLEEAQIMKKL-RHDKLVQLYAVVSE---EPIYIV   78 (260)
T ss_pred             chHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCCHHHHHHHHHHHHhc-CCCceEEEEeEECC---CCcEEE
Confidence            4568999999999999999999654 5677999998753  346789999999999 99999999998843   457899


Q ss_pred             EEeecCCChhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCc
Q 014406          201 FEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (425)
Q Consensus       201 ~e~~~~~~l~~~~~-----~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~  275 (425)
                      |||+.+++|.+++.     .+++..+..++.|++.||.|||+.+++|+||||+||+++.+ +.++|+|||++........
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~-~~~~l~dfg~~~~~~~~~~  157 (260)
T cd05070          79 TEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDG-LVCKIADFGLARLIEDNEY  157 (260)
T ss_pred             EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCC-ceEEeCCceeeeeccCccc
Confidence            99999999988763     37889999999999999999999999999999999999987 7899999999976543221


Q ss_pred             c--eeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCC
Q 014406          276 Y--NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE  352 (425)
Q Consensus       276 ~--~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~  352 (425)
                      .  ....++..|+|||.+.+ ..++.++||||||+++|+|++ |..|| .+.+..+....+....               
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~g~~p~-~~~~~~~~~~~~~~~~---------------  220 (260)
T cd05070         158 TARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVPY-PGMNNREVLEQVERGY---------------  220 (260)
T ss_pred             ccccCCCCCccccChHHHhc-CCCcchhhhHHHHHHHHHHHhcCCCCC-CCCCHHHHHHHHHcCC---------------
Confidence            1  11234567999999876 678999999999999999999 77776 3333333333221100               


Q ss_pred             CChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHh
Q 014406          353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM  407 (425)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL  407 (425)
                                           ........+..+.+|+.+||+.||++|||++++.
T Consensus       221 ---------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~  254 (260)
T cd05070         221 ---------------------RMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQ  254 (260)
T ss_pred             ---------------------CCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHH
Confidence                                 0001123678899999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=7.4e-39  Score=297.43  Aligned_cols=242  Identities=18%  Similarity=0.338  Sum_probs=194.5

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc--chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEE
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (425)
                      ..++|++.++||+|+||.||+|.. .+++.+|+|.+...  ....+.+|+.+++++ +|+|++++++++..   ...+++
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~-~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~---~~~~~v   78 (260)
T cd05067           4 PRETLKLVKKLGAGQFGEVWMGYY-NGHTKVAIKSLKQGSMSPEAFLAEANLMKQL-QHPRLVRLYAVVTQ---EPIYII   78 (260)
T ss_pred             chHHceeeeeeccCccceEEeeec-CCCceEEEEEecCCCCcHHHHHHHHHHHHhc-CCcCeeeEEEEEcc---CCcEEE
Confidence            367899999999999999999974 46788999998753  346789999999999 89999999998743   468899


Q ss_pred             EEeecCCChhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCc
Q 014406          201 FEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (425)
Q Consensus       201 ~e~~~~~~l~~~~~-----~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~  275 (425)
                      |||+.+++|.+++.     .+++.++..++.|++.||+|||+.|++|+||||+||+++.+ +.++|+|||++........
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~-~~~~l~dfg~~~~~~~~~~  157 (260)
T cd05067          79 TEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSET-LCCKIADFGLARLIEDNEY  157 (260)
T ss_pred             EEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCC-CCEEEccCcceeecCCCCc
Confidence            99999999988762     47888999999999999999999999999999999999988 7899999999976542221


Q ss_pred             c--eeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCC
Q 014406          276 Y--NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE  352 (425)
Q Consensus       276 ~--~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~  352 (425)
                      .  ....++..|+|||++.. ..++.++||||||+++|++++ |+.||. +.+..+....+.....              
T Consensus       158 ~~~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~-~~~~~~~~~~~~~~~~--------------  221 (260)
T cd05067         158 TAREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTYGRIPYP-GMTNPEVIQNLERGYR--------------  221 (260)
T ss_pred             ccccCCcccccccCHHHhcc-CCcCcccchHHHHHHHHHHHhCCCCCCC-CCChHHHHHHHHcCCC--------------
Confidence            1  12344567999999876 678999999999999999998 888873 3333333222211000              


Q ss_pred             CChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhc
Q 014406          353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  408 (425)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~  408 (425)
                                            ......++.++.+++.+||+.||++|||++++++
T Consensus       222 ----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05067         222 ----------------------MPRPDNCPEELYELMRLCWKEKPEERPTFEYLRS  255 (260)
T ss_pred             ----------------------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence                                  0111236789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=4.9e-39  Score=305.45  Aligned_cols=246  Identities=22%  Similarity=0.365  Sum_probs=194.2

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEc-----CCCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCC
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINV-----NTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQH  193 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~-----~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  193 (425)
                      ..++|++.+.||+|+||.||+|.+.     .++..+|+|.++...    .+.+.+|+.+++++.+|+||+++++++... 
T Consensus        33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-  111 (302)
T cd05055          33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIG-  111 (302)
T ss_pred             cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC-
Confidence            3568999999999999999999753     345689999987432    246889999999996799999999999654 


Q ss_pred             CCccEEEEEeecCCChhhhcCC-----CCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccc
Q 014406          194 SKTPSLIFEYVNSTDFKVLYPT-----LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE  268 (425)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~~~-----l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~  268 (425)
                       ...+++|||+.+++|..++..     +++.++..++.|++.||.|||+++|+|+||||+|||++.+ +.++++|||+++
T Consensus       112 -~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~-~~~~l~dfg~~~  189 (302)
T cd05055         112 -GPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHG-KIVKICDFGLAR  189 (302)
T ss_pred             -CceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCC-CeEEECCCcccc
Confidence             678999999999999887632     7899999999999999999999999999999999999987 789999999997


Q ss_pred             cccCCCcc---eeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCCchhHH
Q 014406          269 FYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNA  344 (425)
Q Consensus       269 ~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~lg~~~~~~  344 (425)
                      ........   ....++..|+|||.+.+ ..++.++||||+||++|+|++ |..||... ...+.+...... +      
T Consensus       190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslGvil~el~t~g~~p~~~~-~~~~~~~~~~~~-~------  260 (302)
T cd05055         190 DIMNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGILLWEIFSLGSNPYPGM-PVDSKFYKLIKE-G------  260 (302)
T ss_pred             cccCCCceeecCCCCcccccCCHhhhcc-CCCCcHhHHHHHHHHHHHHHhCCCCCcCCC-CchHHHHHHHHc-C------
Confidence            65433221   12244677999999877 678999999999999999998 88887432 222222111110 0      


Q ss_pred             HHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhc
Q 014406          345 YLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  408 (425)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~  408 (425)
                                                  .........++++.+|+.+||+.+|++|||+.|+++
T Consensus       261 ----------------------------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~  296 (302)
T cd05055         261 ----------------------------YRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ  296 (302)
T ss_pred             ----------------------------CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence                                        000011235789999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-38  Score=294.48  Aligned_cols=245  Identities=27%  Similarity=0.533  Sum_probs=202.6

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc-----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEE
Q 014406          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (425)
Q Consensus       126 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (425)
                      +|++.+.||+|++|.||++.+..+++.+++|.+....     .+.+.+|++++.++ +|+|++++++++.+.  ...+++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~--~~~~~v   77 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNL-KHPNIVKYIGSIETS--DSLYII   77 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhC-CCCCccEEEEEEEeC--CEEEEE
Confidence            5888999999999999999999999999999987543     35688999999999 899999999999654  678899


Q ss_pred             EEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCc-c
Q 014406          201 FEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-Y  276 (425)
Q Consensus       201 ~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~-~  276 (425)
                      +||+++++|.+++   ..+++..+..++.|++.||.|||+.||+|+||+|+||+++.+ +.++|+|||++........ .
T Consensus        78 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~-~~~~l~d~~~~~~~~~~~~~~  156 (254)
T cd06627          78 LEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKD-GVVKLADFGVATKLNDVSKDD  156 (254)
T ss_pred             EecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCC-CCEEEeccccceecCCCcccc
Confidence            9999999998876   358999999999999999999999999999999999999987 7899999999987654332 2


Q ss_pred             eeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCChh
Q 014406          277 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ  356 (425)
Q Consensus       277 ~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~  356 (425)
                      ....++..|+|||.+.+ ..++.++||||+|+++++|++|..||.... .......+..   .                 
T Consensus       157 ~~~~~~~~y~~pe~~~~-~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~-~~~~~~~~~~---~-----------------  214 (254)
T cd06627         157 ASVVGTPYWMAPEVIEM-SGASTASDIWSLGCTVIELLTGNPPYYDLN-PMAALFRIVQ---D-----------------  214 (254)
T ss_pred             cccccchhhcCHhhhcC-CCCCcchhHHHHHHHHHHHHhCCCCCCCcc-HHHHHHHHhc---c-----------------
Confidence            33467888999999877 558899999999999999999999984322 1111111100   0                 


Q ss_pred             hHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCC
Q 014406          357 LDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF  412 (425)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~  412 (425)
                              .        .......+++.+.+++.+||+.+|++|||+.+++.||||
T Consensus       215 --------~--------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~  254 (254)
T cd06627         215 --------D--------HPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI  254 (254)
T ss_pred             --------C--------CCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence                    0        001122368899999999999999999999999999997

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=8.7e-39  Score=297.01  Aligned_cols=241  Identities=17%  Similarity=0.303  Sum_probs=191.3

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc--chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEE
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (425)
                      .++|++.+.||+|+||+||+|.+..+ ..+|+|.+...  ..+.+.+|+.+++.+ +|+|++++++++..   ...+++|
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~---~~~~~v~   79 (260)
T cd05069           5 RESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMMPEAFLQEAQIMKKL-RHDKLVPLYAVVSE---EPIYIVT   79 (260)
T ss_pred             hHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCccHHHHHHHHHHHHhC-CCCCeeeEEEEEcC---CCcEEEE
Confidence            46799999999999999999977554 46899988643  346788999999999 99999999998843   4578999


Q ss_pred             EeecCCChhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCcc
Q 014406          202 EYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY  276 (425)
Q Consensus       202 e~~~~~~l~~~~~-----~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~~  276 (425)
                      ||+.+++|.+++.     .+++..+..++.|++.||.|||+.|++|+||||+||+++.+ +.++|+|||++.........
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~-~~~~l~dfg~~~~~~~~~~~  158 (260)
T cd05069          80 EFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDN-LVCKIADFGLARLIEDNEYT  158 (260)
T ss_pred             EcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCC-CeEEECCCccceEccCCccc
Confidence            9999999988763     27888999999999999999999999999999999999988 78999999999765432211


Q ss_pred             --eeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCC
Q 014406          277 --NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL  353 (425)
Q Consensus       277 --~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~  353 (425)
                        ....++..|+|||...+ ..++.++||||||+++|+|++ |..||. +..+.+....+.....               
T Consensus       159 ~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~-~~~~~~~~~~~~~~~~---------------  221 (260)
T cd05069         159 ARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVPYP-GMVNREVLEQVERGYR---------------  221 (260)
T ss_pred             ccCCCccchhhCCHHHhcc-CCcChHHHHHHHHHHHHHHHhCCCCCCC-CCCHHHHHHHHHcCCC---------------
Confidence              12244567999999876 678999999999999999999 777773 3333332222211000               


Q ss_pred             ChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhc
Q 014406          354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  408 (425)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~  408 (425)
                                           ......++..+.+++++||+.||++|||++++++
T Consensus       222 ---------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  255 (260)
T cd05069         222 ---------------------MPCPQGCPESLHELMKLCWKKDPDERPTFEYIQS  255 (260)
T ss_pred             ---------------------CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence                                 0011236789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=5.2e-39  Score=303.44  Aligned_cols=241  Identities=19%  Similarity=0.341  Sum_probs=189.7

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcC-----CCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCc
Q 014406          126 DYEVVRKVGRGKYSEVFEGINVN-----TNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (425)
Q Consensus       126 ~y~~~~~LG~G~fg~V~~~~~~~-----~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (425)
                      +|++.+.||+|+||+||+|.+..     ....+++|.+....    ...+.+|+.+++.+ +||||+++++.+...  ..
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~--~~   77 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV-NHPHVIKLYGACSQD--GP   77 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhC-CCCCEeeEEEEEecC--CC
Confidence            47788999999999999998653     33578999886432    34688899999999 999999999999654  56


Q ss_pred             cEEEEEeecCCChhhhcC---------------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCc
Q 014406          197 PSLIFEYVNSTDFKVLYP---------------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHN  249 (425)
Q Consensus       197 ~~lv~e~~~~~~l~~~~~---------------------------~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~N  249 (425)
                      .++++||+.+++|..++.                           .+++..+..++.|++.||+|||+.+++|+||||+|
T Consensus        78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~n  157 (290)
T cd05045          78 LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARN  157 (290)
T ss_pred             cEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhhe
Confidence            889999999999987752                           26788889999999999999999999999999999


Q ss_pred             eEecCCCCcEEEEeccccccccCCCcc---eeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCC
Q 014406          250 VMIDHELRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHD  325 (425)
Q Consensus       250 Ill~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~  325 (425)
                      ||++++ +.+||+|||+++........   ....++..|+|||.+.+ ..++.++||||||+++++|++ |..|| .+..
T Consensus       158 ill~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~-~~~~  234 (290)
T cd05045         158 VLVAEG-RKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFD-HIYTTQSDVWSFGVLLWEIVTLGGNPY-PGIA  234 (290)
T ss_pred             EEEcCC-CcEEeccccccccccCccchhcccCCCCCccccCHHHHcc-CCcchHhHHHHHHHHHHHHHhcCCCCC-CCCC
Confidence            999988 78999999999765433221   22344667999999876 678999999999999999998 88877 3332


Q ss_pred             CHHHHHHHHHHhCCchhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHH
Q 014406          326 NHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTARE  405 (425)
Q Consensus       326 ~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~e  405 (425)
                      ..+....+.+.                                    ........++.++.+|+.+||+.||++|||++|
T Consensus       235 ~~~~~~~~~~~------------------------------------~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~  278 (290)
T cd05045         235 PERLFNLLKTG------------------------------------YRMERPENCSEEMYNLMLTCWKQEPDKRPTFAD  278 (290)
T ss_pred             HHHHHHHHhCC------------------------------------CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHH
Confidence            22212111000                                    000112236889999999999999999999999


Q ss_pred             Hhc
Q 014406          406 AMA  408 (425)
Q Consensus       406 lL~  408 (425)
                      +++
T Consensus       279 i~~  281 (290)
T cd05045         279 ISK  281 (290)
T ss_pred             HHH
Confidence            874

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=8.9e-39  Score=325.22  Aligned_cols=276  Identities=22%  Similarity=0.331  Sum_probs=184.1

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCC----CcEEEEEEecCcchHHHHHHHHHHHHhcCCCCeeeEEeEE----EcCCC
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNT----NERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIV----RDQHS  194 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~----~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~----~~~~~  194 (425)
                      ..++|++.+.||+|+||+||+|.+..+    +..||+|.+......+...+. .+.+. .+.++..+...+    ....+
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~~~~e-~l~~~-~~~~~~~~~~~~~~~~~~~~~  207 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNE-RVRRA-CPNSCADFVYGFLEPVSSKKE  207 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHHHHHH-HHHhh-chhhHHHHHHhhhcccccccC
Confidence            467899999999999999999999988    899999998754322221111 11222 222222222211    11344


Q ss_pred             CccEEEEEeecCCChhhhcCCC-----------------------CHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceE
Q 014406          195 KTPSLIFEYVNSTDFKVLYPTL-----------------------TDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM  251 (425)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~~~l-----------------------~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIl  251 (425)
                      ...++|+||+++++|.+++..-                       ....+..++.||+.||+|||+++|+||||||+|||
T Consensus       208 ~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NIL  287 (566)
T PLN03225        208 DEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNII  287 (566)
T ss_pred             CceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHHEE
Confidence            6789999999999988776321                       12345679999999999999999999999999999


Q ss_pred             ecCCCCcEEEEeccccccccCCCc--ceeeccCCCccCcccccCCC---------------------CCCCcccHHHHHH
Q 014406          252 IDHELRKLRLIDWGLAEFYHPGKE--YNVRVASRYFKGPELLVDLQ---------------------DYDYSLDMWSLGC  308 (425)
Q Consensus       252 l~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~---------------------~~~~~~DvwslG~  308 (425)
                      ++.+.+.+||+|||+|+.......  .....+++.|+|||.+....                     .++.++|||||||
T Consensus       288 l~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGv  367 (566)
T PLN03225        288 FSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGL  367 (566)
T ss_pred             EeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHH
Confidence            997557899999999976543222  23457889999999764311                     2345679999999


Q ss_pred             HHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHH
Q 014406          309 MFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDF  388 (425)
Q Consensus       309 ~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  388 (425)
                      ++|||+++..++   .++...+.......+.. ...+.........+..            ....  +..........+|
T Consensus       368 iL~el~~~~~~~---~~~~~~~~~~l~~~~~~-~~~~~~~~~~~~~~~~------------~~~~--~~~d~~~~~~~dL  429 (566)
T PLN03225        368 IFLQMAFPNLRS---DSNLIQFNRQLKRNDYD-LVAWRKLVEPRASPDL------------RRGF--EVLDLDGGAGWEL  429 (566)
T ss_pred             HHHHHHhCcCCC---chHHHHHHHHHHhcCCc-HHHHHHhhccccchhh------------hhhh--hhccccchHHHHH
Confidence            999999876543   33333444443333322 1111111000000000            0000  0011134567799


Q ss_pred             HHHcccCCcCCCcCHHHHhcCCCCcccccc
Q 014406          389 LDKLLRYDHQDRLTAREAMAHPYFAQVRAA  418 (425)
Q Consensus       389 l~~~L~~dP~~Rpta~elL~hp~~~~~~~~  418 (425)
                      |++||++||++|||+.|+|+||||++....
T Consensus       430 i~~mL~~dP~kR~ta~e~L~Hpff~~~~~~  459 (566)
T PLN03225        430 LKSMMRFKGRQRISAKAALAHPYFDREGLL  459 (566)
T ss_pred             HHHHccCCcccCCCHHHHhCCcCcCCCCcc
Confidence            999999999999999999999999987665

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.9e-39  Score=297.47  Aligned_cols=243  Identities=17%  Similarity=0.310  Sum_probs=193.0

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc--chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEE
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (425)
                      ..+|++.+.||+|+||.||+|.+. ++..+|+|++...  ....+.+|+++++.+ +|+||+++++++...  ...++||
T Consensus         3 ~~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~--~~~~lv~   78 (256)
T cd05059           3 PSELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSEDDFIEEAKVMMKL-SHPNLVQLYGVCTKQ--RPIFIVT   78 (256)
T ss_pred             hHHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCCHHHHHHHHHHHHhC-CCCCEEEEEEEEcCC--CceEEEE
Confidence            346788899999999999999765 5678999998743  345788999999999 899999999998544  6789999


Q ss_pred             EeecCCChhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCcc-
Q 014406          202 EYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY-  276 (425)
Q Consensus       202 e~~~~~~l~~~~~----~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~~-  276 (425)
                      ||+++++|.+++.    .+++..+..++.|++.||+|||+.|++|+||||+||+++.+ +.+||+|||+++........ 
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~-~~~kl~dfg~~~~~~~~~~~~  157 (256)
T cd05059          79 EYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGED-NVVKVSDFGLARYVLDDQYTS  157 (256)
T ss_pred             ecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCC-CcEEECCcccceecccccccc
Confidence            9999999988762    47899999999999999999999999999999999999988 78999999998765432211 


Q ss_pred             -eeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCC
Q 014406          277 -NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD  354 (425)
Q Consensus       277 -~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~  354 (425)
                       ....++..|+|||.+.+ ..++.++||||||+++|+|++ |..||. ..++.+....+....                 
T Consensus       158 ~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~-~~~~~~~~~~~~~~~-----------------  218 (256)
T cd05059         158 SQGTKFPVKWAPPEVFDY-SRFSSKSDVWSFGVLMWEVFSEGKMPYE-RFSNSEVVESVSAGY-----------------  218 (256)
T ss_pred             cCCCCCCccccCHHHhcc-CCCCchhhHHHHHHHHHHHhccCCCCCC-CCCHHHHHHHHHcCC-----------------
Confidence             11123356999999887 678999999999999999999 777773 333332222211100                 


Q ss_pred             hhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcC
Q 014406          355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  409 (425)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~h  409 (425)
                                         .......++.++.+++.+||+.+|++|||+.|+++.
T Consensus       219 -------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~  254 (256)
T cd05059         219 -------------------RLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ  254 (256)
T ss_pred             -------------------cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence                               001112368899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=6.9e-39  Score=302.78  Aligned_cols=243  Identities=20%  Similarity=0.339  Sum_probs=193.3

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEc-----CCCcEEEEEEecCcc---hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCC
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINV-----NTNERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~-----~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (425)
                      ..+|.+.+.||+|+||.||+|.+.     .++..+++|.+....   .+.+.+|+.+++++ +|+||+++++++..  ..
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~   80 (291)
T cd05094           4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL-QHEHIVKFYGVCGD--GD   80 (291)
T ss_pred             hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcC-CCCCcceEEEEEcc--CC
Confidence            356889999999999999999754     345678999987543   35688999999999 89999999999965  46


Q ss_pred             ccEEEEEeecCCChhhhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCC
Q 014406          196 TPSLIFEYVNSTDFKVLYP-------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEL  256 (425)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~~-------------------~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~  256 (425)
                      ..++||||+++++|.+++.                   .+++..+..++.||+.||+|||++||+|+||||+||+++.+ 
T Consensus        81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~-  159 (291)
T cd05094          81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN-  159 (291)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccC-
Confidence            7899999999999988762                   26888999999999999999999999999999999999988 


Q ss_pred             CcEEEEeccccccccCCCc---ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHH
Q 014406          257 RKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVK  332 (425)
Q Consensus       257 ~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~  332 (425)
                      +.++|+|||+++.......   .....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||+.. +..+....
T Consensus       160 ~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~-~~~~~~~~  237 (291)
T cd05094         160 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSFGVILWEIFTYGKQPWFQL-SNTEVIEC  237 (291)
T ss_pred             CcEEECCCCcccccCCCceeecCCCCCcceeecChHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHH
Confidence            7999999999976543221   122345678999999877 678999999999999999998 88887432 22222221


Q ss_pred             HHHHhCCchhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhc
Q 014406          333 IAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  408 (425)
Q Consensus       333 ~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~  408 (425)
                      +..    .                           .+.     .....++..+.+++.+||+.||++|||+.++++
T Consensus       238 ~~~----~---------------------------~~~-----~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~  277 (291)
T cd05094         238 ITQ----G---------------------------RVL-----ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK  277 (291)
T ss_pred             HhC----C---------------------------CCC-----CCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence            100    0                           000     001125788999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-40  Score=294.74  Aligned_cols=285  Identities=26%  Similarity=0.463  Sum_probs=224.8

Q ss_pred             CCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecC-----cchHHHHHHHHHHHHhcCCCCeeeEEeEEEcC----
Q 014406          122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQ----  192 (425)
Q Consensus       122 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~----  192 (425)
                      ....+|.-+..+|.|.- .|..+.|.-.+..||+|.+..     ...++..+|...+..+ +|+||++++.+|.-.    
T Consensus        14 tv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v-~~~nii~l~n~ftP~~~l~   91 (369)
T KOG0665|consen   14 TVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCV-NHKNIISLLNVFTPQKTLE   91 (369)
T ss_pred             eeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhh-cccceeeeeeccCccccHH
Confidence            34678888899999998 788888999999999998742     2346678999999999 999999999999633    


Q ss_pred             CCCccEEEEEeecCCChhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccC
Q 014406          193 HSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (425)
Q Consensus       193 ~~~~~~lv~e~~~~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~  272 (425)
                      .....|+|||+|....-...+-.++-..+..+..|++.|+.|||+.||+||||||+||++..+ ..+||.|||+|+....
T Consensus        92 ~~~e~y~v~e~m~~nl~~vi~~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~-~~lKi~dfg~ar~e~~  170 (369)
T KOG0665|consen   92 EFQEVYLVMELMDANLCQVILMELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSD-CTLKILDFGLARTEDT  170 (369)
T ss_pred             HHHhHHHHHHhhhhHHHHHHHHhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecch-hheeeccchhhcccCc
Confidence            223578999999887666666678888999999999999999999999999999999999998 7999999999987665


Q ss_pred             CCcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHH------
Q 014406          273 GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYL------  346 (425)
Q Consensus       273 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~------  346 (425)
                      .-..+..+.++.|+|||++.+ ..+...+||||+||++.||++|...| +|.+..+++.++.+.+|+++...+-      
T Consensus       171 ~~~mtpyVvtRyyrapevil~-~~~ke~vdiwSvGci~gEli~~~Vlf-~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~  248 (369)
T KOG0665|consen  171 DFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGELILGTVLF-PGKDHIDQWNKIIEQLGTPDPSFMKQLQPTV  248 (369)
T ss_pred             ccccCchhheeeccCchheec-cCCcccchhhhhhhHHHHHhhceEEe-cCchHHHHHHHHHHHhcCCCHHHHHHhhHHH
Confidence            544566788999999999999 55999999999999999999999877 6999999999999999997654331      


Q ss_pred             hhccCCCChhhH-HHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCc
Q 014406          347 NKYHLELDPQLD-ALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA  413 (425)
Q Consensus       347 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~  413 (425)
                      ..+....++... ..........|..  ..+..+.-+..+++++.+||..||++|.+++++|+|||++
T Consensus       249 r~yv~~~~~y~~~~f~~~fpD~~f~~--~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~  314 (369)
T KOG0665|consen  249 RNYVENRPQYQAISFSELFPDSLFPV--VLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK  314 (369)
T ss_pred             HHHhhcChHhhccchhhhCCcccccc--cccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence            111111111100 0000011111111  1222233456789999999999999999999999999998

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=6e-39  Score=299.83  Aligned_cols=236  Identities=18%  Similarity=0.316  Sum_probs=184.6

Q ss_pred             eeeeeCceEEEEEEEcCCCc--EEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEEEeec
Q 014406          132 KVGRGKYSEVFEGINVNTNE--RCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVN  205 (425)
Q Consensus       132 ~LG~G~fg~V~~~~~~~~~~--~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~  205 (425)
                      .||+|+||.||+|.+..++.  .+++|.++..    ..+.+.+|+.++.++.+||||+++++++...  ...+++|||++
T Consensus         2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~--~~~~lv~e~~~   79 (270)
T cd05047           2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR--GYLYLAIEYAP   79 (270)
T ss_pred             cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecC--CCceEEEEeCC
Confidence            58999999999999887775  4688888642    2356788999999997899999999999654  56889999999


Q ss_pred             CCChhhhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccc
Q 014406          206 STDFKVLYP-------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL  266 (425)
Q Consensus       206 ~~~l~~~~~-------------------~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~  266 (425)
                      +++|..++.                   .+++..+..++.|++.||+|||+.|++|+||||+||+++.+ +.+||+|||+
T Consensus        80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~-~~~kl~dfgl  158 (270)
T cd05047          80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN-YVAKIADFGL  158 (270)
T ss_pred             CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCC-CeEEECCCCC
Confidence            999987762                   36788999999999999999999999999999999999988 7899999999


Q ss_pred             cccccCCCcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCCchhHHH
Q 014406          267 AEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAY  345 (425)
Q Consensus       267 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~lg~~~~~~~  345 (425)
                      +..............+..|+|||++.+ ..++.++|||||||++|+|++ |..||. +.+..+....+..          
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~-~~~~~~~~~~~~~----------  226 (270)
T cd05047         159 SRGQEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYC-GMTCAELYEKLPQ----------  226 (270)
T ss_pred             ccccchhhhccCCCCccccCChHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCcc-ccCHHHHHHHHhC----------
Confidence            864321111112233556999999876 678999999999999999997 888873 2222222211100          


Q ss_pred             HhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhc
Q 014406          346 LNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  408 (425)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~  408 (425)
                        ..                        ..+....++.++.+++.+||+.||.+|||+.++++
T Consensus       227 --~~------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (270)
T cd05047         227 --GY------------------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV  263 (270)
T ss_pred             --CC------------------------CCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence              00                        00011226788999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1e-38  Score=299.73  Aligned_cols=242  Identities=17%  Similarity=0.305  Sum_probs=189.8

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCc----EEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCC
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNE----RCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~----~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (425)
                      .++|++.+.||+|+||+||+|.+..++.    .+++|.+....    ..++..|+.+++++ +||||+++++++.+   .
T Consensus         6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l-~h~~iv~~~~~~~~---~   81 (279)
T cd05111           6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSL-DHAYIVRLLGICPG---A   81 (279)
T ss_pred             HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcC-CCCCcceEEEEECC---C
Confidence            4678889999999999999999877776    47777775332    24566788888998 99999999998843   4


Q ss_pred             ccEEEEEeecCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEecccccccc
Q 014406          196 TPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (425)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~  271 (425)
                      ..++++||+.+++|.+++    ..+++..+..++.|++.||+|||+.+++|+||||+|||++.+ +.+||+|||+++...
T Consensus        82 ~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~-~~~kl~Dfg~~~~~~  160 (279)
T cd05111          82 SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSD-SIVQIADFGVADLLY  160 (279)
T ss_pred             ccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCC-CcEEEcCCccceecc
Confidence            567999999999998887    247899999999999999999999999999999999999988 789999999998654


Q ss_pred             CCCc---ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCCchhHHHHh
Q 014406          272 PGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLN  347 (425)
Q Consensus       272 ~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~  347 (425)
                      ....   .....++..|+|||.+.+ ..++.++|||||||++||+++ |..||. +... .....+..            
T Consensus       161 ~~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~el~t~g~~p~~-~~~~-~~~~~~~~------------  225 (279)
T cd05111         161 PDDKKYFYSEHKTPIKWMALESILF-GRYTHQSDVWSYGVTVWEMMSYGAEPYA-GMRP-HEVPDLLE------------  225 (279)
T ss_pred             CCCcccccCCCCCcccccCHHHhcc-CCcCchhhHHHHHHHHHHHHcCCCCCCC-CCCH-HHHHHHHH------------
Confidence            3321   223345678999999977 679999999999999999998 888873 2221 11111111            


Q ss_pred             hccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhc
Q 014406          348 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  408 (425)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~  408 (425)
                      ....                       ......++.++.+++.+||..||++|||+.|+++
T Consensus       226 ~~~~-----------------------~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~  263 (279)
T cd05111         226 KGER-----------------------LAQPQICTIDVYMVMVKCWMIDENVRPTFKELAN  263 (279)
T ss_pred             CCCc-----------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            0000                       0001125678899999999999999999999976

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=1e-38  Score=296.06  Aligned_cols=234  Identities=19%  Similarity=0.358  Sum_probs=185.9

Q ss_pred             eeeeeCceEEEEEEE--cCCCcEEEEEEecCcc-----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEEEee
Q 014406          132 KVGRGKYSEVFEGIN--VNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV  204 (425)
Q Consensus       132 ~LG~G~fg~V~~~~~--~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~  204 (425)
                      +||+|+||.||+|.+  ..++..+|+|+++...     .+.+.+|+.+++.+ +|+||+++++++.+   ...++||||+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~---~~~~lv~e~~   77 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQL-DNPYIVRMIGICEA---ESWMLVMELA   77 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhC-CCCCcceEEEEEcC---CCcEEEEecC
Confidence            589999999999964  4678899999986432     35688999999999 99999999999853   4578999999


Q ss_pred             cCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCcc----e
Q 014406          205 NSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY----N  277 (425)
Q Consensus       205 ~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~~----~  277 (425)
                      ++++|..++   ..+++..+..++.|++.||+|||++||+|+||||+||+++.+ +.+||+|||+++........    .
T Consensus        78 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~  156 (257)
T cd05116          78 ELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQ-HYAKISDFGLSKALGADENYYKAKT  156 (257)
T ss_pred             CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCC-CeEEECCCccccccCCCCCeeeecC
Confidence            999998876   358899999999999999999999999999999999999988 78999999999766433221    1


Q ss_pred             eeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCChh
Q 014406          278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ  356 (425)
Q Consensus       278 ~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~  356 (425)
                      ...++..|+|||.+.+ ..++.++|||||||++|||++ |..||. +.+..+....+.+.             .      
T Consensus       157 ~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~-~~~~~~~~~~i~~~-------------~------  215 (257)
T cd05116         157 HGKWPVKWYAPECMNY-YKFSSKSDVWSFGVLMWEAFSYGQKPYK-GMKGNEVTQMIESG-------------E------  215 (257)
T ss_pred             CCCCCccccCHhHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCCC-CCCHHHHHHHHHCC-------------C------
Confidence            1233468999999876 678899999999999999998 888873 22222222221100             0      


Q ss_pred             hHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhc
Q 014406          357 LDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  408 (425)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~  408 (425)
                                       ....+..+++++.++|.+||+.||++||+++++.+
T Consensus       216 -----------------~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~  250 (257)
T cd05116         216 -----------------RMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVEL  250 (257)
T ss_pred             -----------------CCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence                             00011236899999999999999999999998854

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=3.7e-39  Score=299.46  Aligned_cols=242  Identities=19%  Similarity=0.353  Sum_probs=196.4

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc---hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEE
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (425)
                      ..+|++.+.||.|+||+||+|.+.. +..+++|++....   ...+.+|+.+++.+ +|+||+++++++.+.  ...++|
T Consensus         5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~--~~~~lv   80 (261)
T cd05148           5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRL-RHKHLISLFAVCSVG--EPVYII   80 (261)
T ss_pred             HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcC-CCcchhheeeeEecC--CCeEEE
Confidence            4568889999999999999998877 8899999987543   46788999999999 899999999999654  678899


Q ss_pred             EEeecCCChhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCc
Q 014406          201 FEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (425)
Q Consensus       201 ~e~~~~~~l~~~~~-----~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~  275 (425)
                      |||+++++|.+++.     .+++..+..++.|++.||.|||+.|++|+||+|+||+++.+ +.+||+|||.+........
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~-~~~kl~d~g~~~~~~~~~~  159 (261)
T cd05148          81 TELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGED-LVCKVADFGLARLIKEDVY  159 (261)
T ss_pred             EeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCC-ceEEEccccchhhcCCccc
Confidence            99999999998874     37889999999999999999999999999999999999988 7899999999976543221


Q ss_pred             c-eeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCC
Q 014406          276 Y-NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL  353 (425)
Q Consensus       276 ~-~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~  353 (425)
                      . ....++..|+|||.+.+ ..++.++||||||+++|+|++ |+.|| .+.+..+.+..+.....               
T Consensus       160 ~~~~~~~~~~~~~PE~~~~-~~~~~~~DiwslG~~l~~l~~~g~~p~-~~~~~~~~~~~~~~~~~---------------  222 (261)
T cd05148         160 LSSDKKIPYKWTAPEAASH-GTFSTKSDVWSFGILLYEMFTYGQVPY-PGMNNHEVYDQITAGYR---------------  222 (261)
T ss_pred             cccCCCCceEecCHHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCC-CcCCHHHHHHHHHhCCc---------------
Confidence            1 12234567999999876 678999999999999999998 78777 33333333332221000               


Q ss_pred             ChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhc
Q 014406          354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  408 (425)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~  408 (425)
                                           ......+++.+.+++.+||+.||++|||+.++++
T Consensus       223 ---------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~  256 (261)
T cd05148         223 ---------------------MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALRE  256 (261)
T ss_pred             ---------------------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence                                 0011236889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=4.7e-39  Score=302.82  Aligned_cols=261  Identities=23%  Similarity=0.356  Sum_probs=197.4

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEE----cCCCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCC
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGIN----VNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~----~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (425)
                      ...|++++.||+|+||.||++..    ..++..||+|.++...    ...+.+|+.+++.+ +|+|++++++++.+....
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~   81 (284)
T cd05079           3 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL-YHENIVKYKGICTEDGGN   81 (284)
T ss_pred             hhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEecCCCC
Confidence            34578899999999999999974    4578899999987432    35688999999999 999999999999776556


Q ss_pred             ccEEEEEeecCCChhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEecccccccc
Q 014406          196 TPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (425)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~~----~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~  271 (425)
                      ..++||||+++++|..++.    .+++..+..++.|++.||+|||++|++|+||||+||+++.+ +.++|+|||+++...
T Consensus        82 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~-~~~~l~dfg~~~~~~  160 (284)
T cd05079          82 GIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESE-HQVKIGDFGLTKAIE  160 (284)
T ss_pred             ceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCC-CCEEECCCccccccc
Confidence            7899999999999998862    47889999999999999999999999999999999999988 789999999998664


Q ss_pred             CCCcc----eeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHh
Q 014406          272 PGKEY----NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLN  347 (425)
Q Consensus       272 ~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~  347 (425)
                      .....    ....++..|+|||++.+ ..++.++|||||||++|+|++++.|+.....   .   ..+..++....... 
T Consensus       161 ~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~ellt~~~~~~~~~~---~---~~~~~~~~~~~~~~-  232 (284)
T cd05079         161 TDKEYYTVKDDLDSPVFWYAPECLIQ-SKFYIASDVWSFGVTLYELLTYCDSESSPMT---L---FLKMIGPTHGQMTV-  232 (284)
T ss_pred             cCccceeecCCCCCCccccCHHHhcc-CCCCccccchhhhhhhhhhhcCCCCCccccc---h---hhhhcccccccccH-
Confidence            33221    22345667999999877 6789999999999999999998876532211   1   11111111100000 


Q ss_pred             hccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcC
Q 014406          348 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  409 (425)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~h  409 (425)
                            ....... ....        .......++..+.+|+.+||+.||++|||+.++++.
T Consensus       233 ------~~~~~~~-~~~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  279 (284)
T cd05079         233 ------TRLVRVL-EEGK--------RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG  279 (284)
T ss_pred             ------HHHHHHH-HcCc--------cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence                  0000000 0000        001123378999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=1.6e-38  Score=331.01  Aligned_cols=141  Identities=29%  Similarity=0.529  Sum_probs=127.4

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc------hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCcc
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (425)
                      .++|++.++||+|+||+||+|.+..+++.||||++....      ...+.+|+.++..+ +|+||+++++++...  .++
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~~~~~~~~~--~~~   79 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALS-KSPFIVHLYYSLQSA--NNV   79 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhc-CCCCcCeEEEEEEEC--CEE
Confidence            468999999999999999999999999999999997432      25688899999998 999999999988654  678


Q ss_pred             EEEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccc
Q 014406          198 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE  268 (425)
Q Consensus       198 ~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~  268 (425)
                      |+||||+.+++|..++   ..+++..++.++.||+.||+|||+++||||||||+|||++.+ +.+||+|||+++
T Consensus        80 ~lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~-g~vkL~DFGls~  152 (669)
T cd05610          80 YLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNE-GHIKLTDFGLSK  152 (669)
T ss_pred             EEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCC-CCEEEEeCCCCc
Confidence            9999999999998876   347889999999999999999999999999999999999988 789999999885

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=1.8e-38  Score=300.45  Aligned_cols=250  Identities=19%  Similarity=0.343  Sum_probs=195.2

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCC----------------cEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCee
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTN----------------ERCIIKILKPVK----KKKIKREIKILQNLCGGPNVV  183 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~----------------~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv  183 (425)
                      .++|++.+.||+|+||.||+|.+..++                ..||+|.+....    .+.+.+|+.+++++ +|+||+
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~   82 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRL-SDPNIA   82 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhc-CCCCEe
Confidence            568899999999999999999876543                568999987542    45688899999999 899999


Q ss_pred             eEEeEEEcCCCCccEEEEEeecCCChhhhcC--------------CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCc
Q 014406          184 KLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP--------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHN  249 (425)
Q Consensus       184 ~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~--------------~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~N  249 (425)
                      ++++++...  ...++++||+.+++|..++.              .+++..+..++.|++.||+|||+.|++|+||||+|
T Consensus        83 ~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~N  160 (296)
T cd05051          83 RLLGVCTVD--PPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRN  160 (296)
T ss_pred             EEEEEEecC--CCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhc
Confidence            999999654  67899999999999988762              47889999999999999999999999999999999


Q ss_pred             eEecCCCCcEEEEeccccccccCCCc---ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh--CCCCCCCCC
Q 014406          250 VMIDHELRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF--RKEPFFYGH  324 (425)
Q Consensus       250 Ill~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt--g~~pf~~~~  324 (425)
                      |+++.+ +.++|+|||+++.......   .....++..|+|||.+.+ ..++.++|||||||++|+|++  |..|| ...
T Consensus       161 ili~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~~~~~p~-~~~  237 (296)
T cd05051         161 CLVGKN-YTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLL-GKFTTKSDVWAFGVTLWEILTLCREQPY-EHL  237 (296)
T ss_pred             eeecCC-CceEEccccceeecccCcceeecCcCCCCceecCHHHhhc-CCCCccchhhhhHHHHHHHHhcCCCCCC-CCc
Confidence            999988 7999999999876543322   122345678999999877 678999999999999999998  56666 233


Q ss_pred             CCHHHHHHHHHHhCCchhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHH
Q 014406          325 DNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAR  404 (425)
Q Consensus       325 ~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~  404 (425)
                      +..+.+............                             .........++.++.+++.+||+.||++|||+.
T Consensus       238 ~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~  288 (296)
T cd05051         238 TDQQVIENAGHFFRDDGR-----------------------------QIYLPRPPNCPKDIYELMLECWRRDEEDRPTFR  288 (296)
T ss_pred             ChHHHHHHHHhccccccc-----------------------------cccCCCccCCCHHHHHHHHHHhccChhcCCCHH
Confidence            333333332221110000                             000001123678999999999999999999999


Q ss_pred             HHhc
Q 014406          405 EAMA  408 (425)
Q Consensus       405 elL~  408 (425)
                      |+++
T Consensus       289 el~~  292 (296)
T cd05051         289 EIHL  292 (296)
T ss_pred             HHHH
Confidence            9964

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=1.6e-38  Score=304.12  Aligned_cols=250  Identities=28%  Similarity=0.424  Sum_probs=198.3

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc------hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccE
Q 014406          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (425)
Q Consensus       125 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (425)
                      ..|+..+.||+|+||+||+|.+..++..+|+|.+....      ...+.+|+.+++.+ +|+|++++++++.+.  ...+
T Consensus        25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~--~~~~  101 (317)
T cd06635          25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRI-KHPNSIEYKGCYLRE--HTAW  101 (317)
T ss_pred             hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhC-CCCCEEEEEEEEeeC--CeEE
Confidence            44778889999999999999999999999999986321      24678899999999 899999999999654  5678


Q ss_pred             EEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCc
Q 014406          199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (425)
Q Consensus       199 lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~  275 (425)
                      +||||+.+..+....   ..+++.++..++.|++.||.|||+.||+|+||+|+||+++.+ +.++|+|||++.....   
T Consensus       102 lv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~-~~~kl~dfg~~~~~~~---  177 (317)
T cd06635         102 LVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEP-GQVKLADFGSASIASP---  177 (317)
T ss_pred             EEEeCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCC-CCEEEecCCCccccCC---
Confidence            999999864433322   348899999999999999999999999999999999999988 7899999999875432   


Q ss_pred             ceeeccCCCccCcccccC--CCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCC
Q 014406          276 YNVRVASRYFKGPELLVD--LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL  353 (425)
Q Consensus       276 ~~~~~~t~~y~aPE~~~~--~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~  353 (425)
                      .....++..|+|||.+..  ...++.++|||||||++|+|++|+.||+.. +....+..+......              
T Consensus       178 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~-~~~~~~~~~~~~~~~--------------  242 (317)
T cd06635         178 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-NAMSALYHIAQNESP--------------  242 (317)
T ss_pred             cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCc-cHHHHHHHHHhccCC--------------
Confidence            233467888999999742  256889999999999999999999998532 222222222110000              


Q ss_pred             ChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCccccc
Q 014406          354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA  417 (425)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~  417 (425)
                                           ......+++.+++|+.+||+.+|++|||+.++++|+|+.....
T Consensus       243 ---------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~  285 (317)
T cd06635         243 ---------------------TLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERP  285 (317)
T ss_pred             ---------------------CCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCc
Confidence                                 0001125788999999999999999999999999999876543

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=6.6e-39  Score=297.67  Aligned_cols=244  Identities=23%  Similarity=0.447  Sum_probs=195.0

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc--------chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCcc
Q 014406          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (425)
Q Consensus       126 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~--------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (425)
                      +|.+.+.||+|+||+||++.+..++..+++|+++..        ....+..|+.+++.+ +||||+++++++.+.  ...
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~   77 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKL-DHPAIVKFHASFLER--DAF   77 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhC-CCCcHHHHHHHHhcC--Cce
Confidence            588899999999999999998888777777776531        223566799999999 999999999998654  568


Q ss_pred             EEEEEeecCCChhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccc
Q 014406          198 SLIFEYVNSTDFKVLY-------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  270 (425)
Q Consensus       198 ~lv~e~~~~~~l~~~~-------~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~  270 (425)
                      ++|+||+++++|..++       ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.+  .++|+|||++...
T Consensus        78 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~~--~~~l~d~g~~~~~  155 (260)
T cd08222          78 CIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKNN--LLKIGDFGVSRLL  155 (260)
T ss_pred             EEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeecC--CEeecccCceeec
Confidence            8999999999998765       348899999999999999999999999999999999999864  6899999998765


Q ss_pred             cCCCc-ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhc
Q 014406          271 HPGKE-YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY  349 (425)
Q Consensus       271 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~  349 (425)
                      ..... .....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||. +.+.......+   ....         
T Consensus       156 ~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~~~~~~~-~~~~~~~~~~~---~~~~---------  221 (260)
T cd08222         156 MGSCDLATTFTGTPYYMSPEALKH-QGYDSKSDIWSLGCILYEMCCLAHAFE-GQNFLSVVLRI---VEGP---------  221 (260)
T ss_pred             CCCcccccCCCCCcCccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCC-CccHHHHHHHH---HcCC---------
Confidence            43322 233467888999999876 678899999999999999999999983 22211111111   1000         


Q ss_pred             cCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCC
Q 014406          350 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF  412 (425)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~  412 (425)
                                              .......++.++.+++.+||+.||++||++.|+++||||
T Consensus       222 ------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  260 (260)
T cd08222         222 ------------------------TPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI  260 (260)
T ss_pred             ------------------------CCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence                                    000012267899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=4e-39  Score=299.23  Aligned_cols=239  Identities=23%  Similarity=0.434  Sum_probs=185.1

Q ss_pred             EEEeeeeeeCceEEEEEEEc----CCCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEE
Q 014406          128 EVVRKVGRGKYSEVFEGINV----NTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (425)
Q Consensus       128 ~~~~~LG~G~fg~V~~~~~~----~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (425)
                      ++.+.||.|.||.||+|...    ..+..|+||.++...    .+.+.+|++.++++ +||||++++|++..  ....++
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~g~~~~--~~~~~l   78 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKL-RHPNIVKLYGFCIE--NEPLFL   78 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTH-SBTTBE-EEEEEES--SSSEEE
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccc-cccccccccccccc--cccccc
Confidence            46789999999999999987    456789999996432    46789999999999 99999999999974  355889


Q ss_pred             EEEeecCCChhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCC
Q 014406          200 IFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (425)
Q Consensus       200 v~e~~~~~~l~~~~-----~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~  274 (425)
                      |+||+.+|+|.+++     ..+++..+..++.||+.||.|||+++++|+||+++||+++.+ +.+||+|||++.......
T Consensus        79 v~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~-~~~Kl~~f~~~~~~~~~~  157 (259)
T PF07714_consen   79 VMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSN-GQVKLSDFGLSRPISEKS  157 (259)
T ss_dssp             EEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETT-TEEEEESTTTGEETTTSS
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-cccccccccccccccccc
Confidence            99999999998876     258899999999999999999999999999999999999998 799999999998763222


Q ss_pred             cc---eeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhcc
Q 014406          275 EY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH  350 (425)
Q Consensus       275 ~~---~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~  350 (425)
                      ..   ........|+|||.+.+ ..++.++||||||+++|||++ |+.|| ...+..+....+.+..             
T Consensus       158 ~~~~~~~~~~~~~~~aPE~~~~-~~~~~ksDVysfG~~l~ei~~~~~~p~-~~~~~~~~~~~~~~~~-------------  222 (259)
T PF07714_consen  158 KYKNDSSQQLPLRYLAPEVLKD-GEYTKKSDVYSFGMLLYEILTLGKFPF-SDYDNEEIIEKLKQGQ-------------  222 (259)
T ss_dssp             SEEESTTSESGGGGS-HHHHHH-SEESHHHHHHHHHHHHHHHHTTSSGTT-TTSCHHHHHHHHHTTE-------------
T ss_pred             cccccccccccccccccccccc-ccccccccccccccccccccccccccc-cccccccccccccccc-------------
Confidence            22   22345667999999977 568999999999999999999 56776 3333333333321100             


Q ss_pred             CCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhc
Q 014406          351 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  408 (425)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~  408 (425)
                                             .......++..+.+++..||..||++|||++++++
T Consensus       223 -----------------------~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~  257 (259)
T PF07714_consen  223 -----------------------RLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ  257 (259)
T ss_dssp             -----------------------ETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred             -----------------------cceeccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence                                   01112236889999999999999999999999974

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=1.7e-38  Score=296.17  Aligned_cols=243  Identities=17%  Similarity=0.310  Sum_probs=192.9

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCC---cEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCc
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTN---ERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~---~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (425)
                      .++|++.+.||+|+||.||+|.+..++   ..+|+|.++...    .+.+.+|+.+++++ +||||+++++++..  +..
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~   79 (267)
T cd05066           3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQF-DHPNIIHLEGVVTK--SKP   79 (267)
T ss_pred             HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEec--CCc
Confidence            467899999999999999999876544   379999986432    35688999999999 99999999999964  367


Q ss_pred             cEEEEEeecCCChhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccC
Q 014406          197 PSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (425)
Q Consensus       197 ~~lv~e~~~~~~l~~~~~----~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~  272 (425)
                      .++||||+++++|..++.    .+++.++..++.|++.||.|||+.+++|+||||+|||++.+ +.++|+|||++.....
T Consensus        80 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~-~~~~l~dfg~~~~~~~  158 (267)
T cd05066          80 VMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSN-LVCKVSDFGLSRVLED  158 (267)
T ss_pred             cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCC-CeEEeCCCCccccccc
Confidence            899999999999988863    47889999999999999999999999999999999999988 7899999999986643


Q ss_pred             CCcce----eeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCCchhHHHHh
Q 014406          273 GKEYN----VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLN  347 (425)
Q Consensus       273 ~~~~~----~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~  347 (425)
                      .....    ...++..|+|||.+.+ ..++.++|+|||||++|++++ |..||.. .+..+....+.+...         
T Consensus       159 ~~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~l~ell~~g~~p~~~-~~~~~~~~~~~~~~~---------  227 (267)
T cd05066         159 DPEAAYTTRGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWE-MSNQDVIKAIEEGYR---------  227 (267)
T ss_pred             ccceeeecCCCccceeecCHhHhcc-CccCchhhhHHHHHHHHHHhcCCCCCccc-CCHHHHHHHHhCCCc---------
Confidence            32211    1122457999999977 678999999999999999886 9988842 222222222211000         


Q ss_pred             hccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhc
Q 014406          348 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  408 (425)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~  408 (425)
                                                 ......+++.+.+++.+||+.+|++|||+.++++
T Consensus       228 ---------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  261 (267)
T cd05066         228 ---------------------------LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVS  261 (267)
T ss_pred             ---------------------------CCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence                                       0001125789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=1.5e-38  Score=303.74  Aligned_cols=244  Identities=18%  Similarity=0.325  Sum_probs=191.8

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcC-------CCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcC
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVN-------TNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQ  192 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~-------~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  192 (425)
                      .++|.+.+.||+|+||.||+|.+..       ....+|+|.++...    ...+.+|+.+++.+.+||||+++++++.+.
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE   90 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence            4689999999999999999997532       34578999987432    245788999999986699999999999653


Q ss_pred             CCCccEEEEEeecCCChhhhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEec
Q 014406          193 HSKTPSLIFEYVNSTDFKVLYP-------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMID  253 (425)
Q Consensus       193 ~~~~~~lv~e~~~~~~l~~~~~-------------------~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~  253 (425)
                        ...+++|||+.+++|..++.                   .+++.++..++.|++.||.|||++|++|+||||+|||++
T Consensus        91 --~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~  168 (314)
T cd05099          91 --GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVT  168 (314)
T ss_pred             --CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEc
Confidence              67899999999999988762                   277888899999999999999999999999999999999


Q ss_pred             CCCCcEEEEeccccccccCCCcc---eeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHH
Q 014406          254 HELRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQ  329 (425)
Q Consensus       254 ~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~  329 (425)
                      .+ +.+||+|||+++........   ....++..|+|||.+.+ ..++.++|||||||++|+|++ |..|| .+.+..+.
T Consensus       169 ~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~~g~~p~-~~~~~~~~  245 (314)
T cd05099         169 ED-NVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFD-RVYTHQSDVWSFGILMWEIFTLGGSPY-PGIPVEEL  245 (314)
T ss_pred             CC-CcEEEccccccccccccccccccccCCCCccccCHHHHcc-CCcCccchhhHHHHHHHHHHhCCCCCC-CCCCHHHH
Confidence            88 78999999999765432211   11233457999999877 678999999999999999999 77777 33332222


Q ss_pred             HHHHHHHhCCchhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhc
Q 014406          330 LVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  408 (425)
Q Consensus       330 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~  408 (425)
                      +..+...            .                        .......++.++++++.+||+.||++|||+.|+++
T Consensus       246 ~~~~~~~------------~------------------------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~  288 (314)
T cd05099         246 FKLLREG------------H------------------------RMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE  288 (314)
T ss_pred             HHHHHcC------------C------------------------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            2221110            0                        00011236789999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-38  Score=300.43  Aligned_cols=250  Identities=18%  Similarity=0.352  Sum_probs=191.8

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCC--------------CcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeeE
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNT--------------NERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKL  185 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~--------------~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l  185 (425)
                      .++|++.+.||+|+||.||+|.+..+              ...||+|.++...    ...+.+|+++++++ +|+|++++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l-~h~~i~~~   82 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRL-KNPNIIRL   82 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCCcCeE
Confidence            46899999999999999999976543              2358999987532    34688999999999 99999999


Q ss_pred             EeEEEcCCCCccEEEEEeecCCChhhhcC---------------CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCce
Q 014406          186 LDIVRDQHSKTPSLIFEYVNSTDFKVLYP---------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNV  250 (425)
Q Consensus       186 ~~~~~~~~~~~~~lv~e~~~~~~l~~~~~---------------~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NI  250 (425)
                      ++++..  ....++||||+.+++|..++.               .+++..+..++.|++.||.|||+.|++|+||||+||
T Consensus        83 ~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Ni  160 (295)
T cd05097          83 LGVCVS--DDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNC  160 (295)
T ss_pred             EEEEcC--CCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhE
Confidence            999965  467899999999999987762               257788899999999999999999999999999999


Q ss_pred             EecCCCCcEEEEeccccccccCCCcc---eeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh--CCCCCCCCCC
Q 014406          251 MIDHELRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF--RKEPFFYGHD  325 (425)
Q Consensus       251 ll~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt--g~~pf~~~~~  325 (425)
                      +++.+ +.+||+|||++.........   ....++..|+|||.+.+ ..++.++|||||||++++|++  |..||. ..+
T Consensus       161 ll~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~~l~el~~~~~~~p~~-~~~  237 (295)
T cd05097         161 LVGNH-YTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILL-GKFTTASDVWAFGVTLWEMFTLCKEQPYS-LLS  237 (295)
T ss_pred             EEcCC-CcEEecccccccccccCcceeccCcCcCceeecChhhhcc-CCcCchhhHHHHHHHHHHHHHcCCCCCCc-ccC
Confidence            99987 78999999999765433221   12234567999999877 678999999999999999998  555653 223


Q ss_pred             CHHHHHHHHHHhCCchhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHH
Q 014406          326 NHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTARE  405 (425)
Q Consensus       326 ~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~e  405 (425)
                      ..+.+..+.+......                        .     .........+++.+.+|+++||+.||++|||+.+
T Consensus       238 ~~~~~~~~~~~~~~~~------------------------~-----~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~  288 (295)
T cd05097         238 DEQVIENTGEFFRNQG------------------------R-----QIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNK  288 (295)
T ss_pred             hHHHHHHHHHhhhhcc------------------------c-----cccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHH
Confidence            3333332222110000                        0     0000112236789999999999999999999999


Q ss_pred             Hhc
Q 014406          406 AMA  408 (425)
Q Consensus       406 lL~  408 (425)
                      +++
T Consensus       289 i~~  291 (295)
T cd05097         289 IHH  291 (295)
T ss_pred             HHH
Confidence            964

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.8e-38  Score=293.55  Aligned_cols=243  Identities=18%  Similarity=0.328  Sum_probs=196.4

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc--chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEE
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (425)
                      ..++|++.+.||+|+||+||+|.+. ++..+|+|.+...  ..+.+.+|+.+++++ +|+||+++++++...  ...+++
T Consensus         4 ~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~~v   79 (261)
T cd05034           4 PRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMSPEAFLQEAQIMKKL-RHDKLVQLYAVCSEE--EPIYIV   79 (261)
T ss_pred             chhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccCHHHHHHHHHHHhhC-CCCCEeeeeeeeecC--CceEEE
Confidence            4688999999999999999999864 5678999998743  356799999999999 899999999998653  668999


Q ss_pred             EEeecCCChhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCc
Q 014406          201 FEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (425)
Q Consensus       201 ~e~~~~~~l~~~~~-----~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~  275 (425)
                      |||+++++|..++.     .+++..+..++.|++.||.|||++|++|+||||+||+++.+ +.++|+|||++........
T Consensus        80 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~-~~~~l~d~g~~~~~~~~~~  158 (261)
T cd05034          80 TEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGEN-LVCKIADFGLARLIEDDEY  158 (261)
T ss_pred             EeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCC-CCEEECccccceeccchhh
Confidence            99999999988863     47899999999999999999999999999999999999998 7999999999876543211


Q ss_pred             c--eeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCC
Q 014406          276 Y--NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE  352 (425)
Q Consensus       276 ~--~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~  352 (425)
                      .  .....+..|+|||.+.+ ..++.++||||+||+++++++ |+.|| .+.+....+..+.....              
T Consensus       159 ~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~-~~~~~~~~~~~~~~~~~--------------  222 (261)
T cd05034         159 TAREGAKFPIKWTAPEAANY-GRFTIKSDVWSFGILLTEIVTYGRVPY-PGMTNREVLEQVERGYR--------------  222 (261)
T ss_pred             hhhhccCCCccccCHHHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCC-CCCCHHHHHHHHHcCCC--------------
Confidence            1  12234567999999876 678999999999999999998 88887 34443333333221100              


Q ss_pred             CChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhc
Q 014406          353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  408 (425)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~  408 (425)
                                            .......+.++.+++.+||+.||++|||++++.+
T Consensus       223 ----------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~  256 (261)
T cd05034         223 ----------------------MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQS  256 (261)
T ss_pred             ----------------------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence                                  0011225788999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=1.4e-38  Score=300.23  Aligned_cols=244  Identities=18%  Similarity=0.329  Sum_probs=193.1

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcC-----CCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCC
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVN-----TNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQH  193 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~-----~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  193 (425)
                      ..++|++.+.||+|+||.||+|.+..     ++..+|+|.+....    .+.+.+|+.+++.+ +||||+++++++.+  
T Consensus         3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l-~h~~iv~~~~~~~~--   79 (288)
T cd05050           3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF-DHPNIVKLLGVCAV--   79 (288)
T ss_pred             ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhc-CCCchheEEEEEcC--
Confidence            46789999999999999999998643     67899999987432    35688899999999 99999999999965  


Q ss_pred             CCccEEEEEeecCCChhhhcC-------------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCC
Q 014406          194 SKTPSLIFEYVNSTDFKVLYP-------------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPH  248 (425)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~~-------------------------~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~  248 (425)
                      +...+++|||+++++|..++.                         .+++..+..++.|++.||+|||+++++|+||||+
T Consensus        80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~  159 (288)
T cd05050          80 GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATR  159 (288)
T ss_pred             CCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHh
Confidence            467899999999999987763                         2677888999999999999999999999999999


Q ss_pred             ceEecCCCCcEEEEeccccccccCCCcc---eeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCC
Q 014406          249 NVMIDHELRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGH  324 (425)
Q Consensus       249 NIll~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~  324 (425)
                      ||+++.+ +.++|+|||++.........   .....+..|+|||.+.+ ..++.++|||||||++|+|++ |..||+. .
T Consensus       160 nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~~~~~p~~~-~  236 (288)
T cd05050         160 NCLVGEN-MVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGMQPYYG-M  236 (288)
T ss_pred             heEecCC-CceEECccccceecccCccccccCCCccChhhcCHHHHhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCC-C
Confidence            9999988 78999999998765332211   12234567999999877 679999999999999999997 7778742 2


Q ss_pred             CCHHHHHHHHHHhCCchhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHH
Q 014406          325 DNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAR  404 (425)
Q Consensus       325 ~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~  404 (425)
                      +..+....+..             ...                       ......++.++.+|+.+||+.||++|||+.
T Consensus       237 ~~~~~~~~~~~-------------~~~-----------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~  280 (288)
T cd05050         237 AHEEVIYYVRD-------------GNV-----------------------LSCPDNCPLELYNLMRLCWSKLPSDRPSFA  280 (288)
T ss_pred             CHHHHHHHHhc-------------CCC-----------------------CCCCCCCCHHHHHHHHHHcccCcccCCCHH
Confidence            22222211110             000                       001123678999999999999999999999


Q ss_pred             HHhc
Q 014406          405 EAMA  408 (425)
Q Consensus       405 elL~  408 (425)
                      |+++
T Consensus       281 el~~  284 (288)
T cd05050         281 SINR  284 (288)
T ss_pred             HHHH
Confidence            9874

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=2.9e-38  Score=294.66  Aligned_cols=243  Identities=18%  Similarity=0.333  Sum_probs=193.1

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCc---EEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCc
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNE---RCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~---~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (425)
                      .++|+..+.||+|+||.||+|.+..++.   .+++|.+....    .+.+.+|+++++++ +|+|++++.+++.+.  ..
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~   80 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQF-SHHNIIRLEGVVTKF--KP   80 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcC-CCCCeeEEEEEEccC--CC
Confidence            4578889999999999999999876554   79999986432    35688999999999 999999999999654  67


Q ss_pred             cEEEEEeecCCChhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccC
Q 014406          197 PSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (425)
Q Consensus       197 ~~lv~e~~~~~~l~~~~~----~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~  272 (425)
                      .++||||+++++|..++.    .+++..+..++.|++.||+|||+.|++|+||||+||+++.+ +.++|+|||++.....
T Consensus        81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~-~~~kl~dfg~~~~~~~  159 (268)
T cd05063          81 AMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSN-LECKVSDFGLSRVLED  159 (268)
T ss_pred             cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCC-CcEEECCCccceeccc
Confidence            899999999999988862    47899999999999999999999999999999999999987 7899999999876543


Q ss_pred             CCcce----eeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCCchhHHHHh
Q 014406          273 GKEYN----VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLN  347 (425)
Q Consensus       273 ~~~~~----~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~  347 (425)
                      .....    ....+..|+|||++.+ ..++.++|||||||++|+|++ |..||... +..+....+.....         
T Consensus       160 ~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~il~ell~~g~~p~~~~-~~~~~~~~i~~~~~---------  228 (268)
T cd05063         160 DPEGTYTTSGGKIPIRWTAPEAIAY-RKFTSASDVWSFGIVMWEVMSFGERPYWDM-SNHEVMKAINDGFR---------  228 (268)
T ss_pred             ccccceeccCCCcCceecCHHHhhc-CCcChHhHHHHHHHHHHHHHhCCCCCCCcC-CHHHHHHHHhcCCC---------
Confidence            22111    1122346999999877 678999999999999999997 99998432 22222222211000         


Q ss_pred             hccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhc
Q 014406          348 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  408 (425)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~  408 (425)
                                                 ......++.++.+++.+||+.+|++||++.++++
T Consensus       229 ---------------------------~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~  262 (268)
T cd05063         229 ---------------------------LPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVN  262 (268)
T ss_pred             ---------------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence                                       0001125788999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=2.2e-38  Score=297.47  Aligned_cols=245  Identities=18%  Similarity=0.346  Sum_probs=194.4

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcC----CCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCC
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVN----TNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHS  194 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~----~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  194 (425)
                      ..++|++.+.||+|+||.||+|.+..    ++..|++|.+....    ...+.+|+.+++.+ +|+||+++++++... +
T Consensus         4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~-~   81 (280)
T cd05043           4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGL-SHQNILPILHVCIED-G   81 (280)
T ss_pred             chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEecC-C
Confidence            46789999999999999999998775    36889999886432    35578899999999 999999999988654 3


Q ss_pred             CccEEEEEeecCCChhhhcC-----------CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEe
Q 014406          195 KTPSLIFEYVNSTDFKVLYP-----------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLID  263 (425)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~~-----------~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~D  263 (425)
                      ...++++||+.+++|..++.           .+++..+..++.|++.||+|||+++++|+||||+||+++.+ +.+||+|
T Consensus        82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~-~~~kl~d  160 (280)
T cd05043          82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEE-LQVKITD  160 (280)
T ss_pred             CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCC-CcEEECC
Confidence            56789999999999988762           37889999999999999999999999999999999999988 7899999


Q ss_pred             ccccccccCCCcc---eeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCC
Q 014406          264 WGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGT  339 (425)
Q Consensus       264 fg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~lg~  339 (425)
                      ||+++.+......   ....++..|+|||++.+ ..++.++|||||||++|++++ |+.||.. .+..+....+...   
T Consensus       161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~-~~~~~~~~~~~~~---  235 (280)
T cd05043         161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVN-KEYSSASDVWSFGVLLWELMTLGQTPYVE-IDPFEMAAYLKDG---  235 (280)
T ss_pred             CCCcccccCCceEEeCCCCCcchhccCHHHHhc-CCCCchhhHHHhHHHHHHHhcCCCCCcCc-CCHHHHHHHHHcC---
Confidence            9999865433221   12244667999999977 678999999999999999998 8888832 2222211111000   


Q ss_pred             chhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhc
Q 014406          340 DELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  408 (425)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~  408 (425)
                                 .                      .......+++++.+++.+||+.||++|||+.++++
T Consensus       236 -----------~----------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  271 (280)
T cd05043         236 -----------Y----------------------RLAQPINCPDELFAVMACCWALDPEERPSFSQLVQ  271 (280)
T ss_pred             -----------C----------------------CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence                       0                      00001125789999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=1.6e-38  Score=302.16  Aligned_cols=246  Identities=18%  Similarity=0.302  Sum_probs=193.4

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEc-------CCCcEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeeEEeEEEc
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINV-------NTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRD  191 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~-------~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~  191 (425)
                      ..++|++.+.||+|+||.||+|...       .++..+|+|.+...    ..+.+.+|+.+++.+.+|+||+++++++..
T Consensus        13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   92 (304)
T cd05101          13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ   92 (304)
T ss_pred             cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence            4678999999999999999999753       23457999998643    235688999999998779999999999965


Q ss_pred             CCCCccEEEEEeecCCChhhhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEe
Q 014406          192 QHSKTPSLIFEYVNSTDFKVLYP-------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI  252 (425)
Q Consensus       192 ~~~~~~~lv~e~~~~~~l~~~~~-------------------~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll  252 (425)
                      .  ...+++|||+.+++|..++.                   .+++..+..++.||+.||.|||++|++|+||||+||++
T Consensus        93 ~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili  170 (304)
T cd05101          93 D--GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLV  170 (304)
T ss_pred             C--CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEE
Confidence            4  67889999999999987752                   26777889999999999999999999999999999999


Q ss_pred             cCCCCcEEEEeccccccccCCCc---ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHH
Q 014406          253 DHELRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHD  328 (425)
Q Consensus       253 ~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~  328 (425)
                      +.+ +.+||+|||+++.......   .....++..|+|||++.+ ..++.++||||||+++|+|++ |..|| .+.+..+
T Consensus       171 ~~~-~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~-~~~~~~~  247 (304)
T cd05101         171 TEN-NVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPY-PGIPVEE  247 (304)
T ss_pred             cCC-CcEEECCCccceecccccccccccCCCCCceeeCchhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCc-ccCCHHH
Confidence            987 7899999999986643222   122344567999999977 678999999999999999998 66666 3333222


Q ss_pred             HHHHHHHHhCCchhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhc
Q 014406          329 QLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  408 (425)
Q Consensus       329 ~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~  408 (425)
                      ....+...    .                                .......++.++.+|+.+||+.+|++|||+.|+++
T Consensus       248 ~~~~~~~~----~--------------------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~  291 (304)
T cd05101         248 LFKLLKEG----H--------------------------------RMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVE  291 (304)
T ss_pred             HHHHHHcC----C--------------------------------cCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence            22211100    0                                00011236889999999999999999999999986


Q ss_pred             C
Q 014406          409 H  409 (425)
Q Consensus       409 h  409 (425)
                      .
T Consensus       292 ~  292 (304)
T cd05101         292 D  292 (304)
T ss_pred             H
Confidence            4

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=1.1e-38  Score=303.90  Aligned_cols=245  Identities=20%  Similarity=0.343  Sum_probs=192.2

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcC-------CCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcC
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVN-------TNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQ  192 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~-------~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  192 (425)
                      .++|.+.+.||+|+||.||++.+..       +...+|+|.++...    ...+.+|+.+++.+.+|+||+++++++...
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   96 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            4689999999999999999997643       23579999997532    245778999999987799999999999654


Q ss_pred             CCCccEEEEEeecCCChhhhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEec
Q 014406          193 HSKTPSLIFEYVNSTDFKVLYP-------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMID  253 (425)
Q Consensus       193 ~~~~~~lv~e~~~~~~l~~~~~-------------------~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~  253 (425)
                        ...++||||+++++|..++.                   .+++.++..++.|++.||+|||++|++|+||||+||+++
T Consensus        97 --~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~  174 (307)
T cd05098          97 --GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT  174 (307)
T ss_pred             --CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEc
Confidence              57889999999999987763                   267888999999999999999999999999999999999


Q ss_pred             CCCCcEEEEeccccccccCCCcc---eeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHH
Q 014406          254 HELRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQ  329 (425)
Q Consensus       254 ~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~  329 (425)
                      .+ +.++|+|||+++........   ....++..|+|||.+.+ ..++.++|||||||++|+|++ |..|| .+.+ .+.
T Consensus       175 ~~-~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~~g~~p~-~~~~-~~~  250 (307)
T cd05098         175 ED-NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPY-PGVP-VEE  250 (307)
T ss_pred             CC-CcEEECCCcccccccccchhhccccCCCccceeChHHhcc-CCCCcHHHHHHHHHHHHHHHcCCCCCC-CcCC-HHH
Confidence            88 78999999998765432211   11223467999999877 678999999999999999998 77776 3322 222


Q ss_pred             HHHHHHHhCCchhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcC
Q 014406          330 LVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  409 (425)
Q Consensus       330 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~h  409 (425)
                      +......   .                                ...+....++.++.+|+.+||..+|++|||+.+++++
T Consensus       251 ~~~~~~~---~--------------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~  295 (307)
T cd05098         251 LFKLLKE---G--------------------------------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  295 (307)
T ss_pred             HHHHHHc---C--------------------------------CCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            2211110   0                                0001112368899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=2.5e-38  Score=293.56  Aligned_cols=234  Identities=18%  Similarity=0.338  Sum_probs=184.2

Q ss_pred             eeeeeCceEEEEEEEc--CCCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEEEeec
Q 014406          132 KVGRGKYSEVFEGINV--NTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVN  205 (425)
Q Consensus       132 ~LG~G~fg~V~~~~~~--~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~  205 (425)
                      .||+|+||.||+|.+.  .++..||+|++....    .+.+.+|+.+++++ +|+||+++++++..   ...++||||++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l-~h~~ii~~~~~~~~---~~~~lv~e~~~   77 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQL-DNPYIVRMIGVCEA---EALMLVMEMAS   77 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhc-CCCCeEEEEEEEcC---CCeEEEEEeCC
Confidence            3899999999999765  455679999987543    34588999999999 99999999999843   46789999999


Q ss_pred             CCChhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCcc----e
Q 014406          206 STDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY----N  277 (425)
Q Consensus       206 ~~~l~~~~~----~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~~----~  277 (425)
                      +++|.+++.    .+++..+..++.|++.||+|||++|++|+||||+|||++.+ +.+||+|||++.........    .
T Consensus        78 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~  156 (257)
T cd05115          78 GGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQ-HYAKISDFGLSKALGADDSYYKARS  156 (257)
T ss_pred             CCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCC-CcEEeccCCccccccCCccceeccC
Confidence            999998763    48999999999999999999999999999999999999988 78999999999755433221    1


Q ss_pred             eeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCChh
Q 014406          278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ  356 (425)
Q Consensus       278 ~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~  356 (425)
                      ...++..|+|||.+.+ ..++.++|||||||++|++++ |..||.. ....+....+.+             ..      
T Consensus       157 ~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~-~~~~~~~~~~~~-------------~~------  215 (257)
T cd05115         157 AGKWPLKWYAPECINF-RKFSSRSDVWSYGITMWEAFSYGQKPYKK-MKGPEVMSFIEQ-------------GK------  215 (257)
T ss_pred             CCCCCcccCCHHHHcc-CCCCchhhHHHHHHHHHHHhcCCCCCcCc-CCHHHHHHHHHC-------------CC------
Confidence            1223467999999876 678999999999999999996 8888732 222222111110             00      


Q ss_pred             hHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhc
Q 014406          357 LDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  408 (425)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~  408 (425)
                                       ....+..+++++.+++.+||..||++||++.++.+
T Consensus       216 -----------------~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~  250 (257)
T cd05115         216 -----------------RLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEE  250 (257)
T ss_pred             -----------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                             00111236889999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=2.2e-38  Score=293.60  Aligned_cols=240  Identities=17%  Similarity=0.346  Sum_probs=191.3

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc-hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEEE
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE  202 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~-~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e  202 (425)
                      .++|++.+.||+|+||.||++..  .+..+|+|.++... .+.+.+|+.+++.+ +|+|++++++++... +...++++|
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~-~~~~~lv~e   80 (256)
T cd05082           5 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQL-RHSNLVQLLGVIVEE-KGGLYIVTE   80 (256)
T ss_pred             HHhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCchHHHHHHHHHHHHhC-CCCCeeeEEEEEEcC-CCceEEEEE
Confidence            46789999999999999999965  47789999987543 45788999999999 999999999986543 356789999


Q ss_pred             eecCCChhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCcce
Q 014406          203 YVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN  277 (425)
Q Consensus       203 ~~~~~~l~~~~~-----~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~~~  277 (425)
                      |+++++|..++.     .+++..+..++.|++.||+|||++|++|+||||+||+++.+ +.+||+|||+++......  .
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~-~~~kl~dfg~~~~~~~~~--~  157 (256)
T cd05082          81 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSED-NVAKVSDFGLTKEASSTQ--D  157 (256)
T ss_pred             CCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCC-CcEEecCCccceeccccC--C
Confidence            999999988763     27888999999999999999999999999999999999988 789999999987543222  2


Q ss_pred             eeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCChh
Q 014406          278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ  356 (425)
Q Consensus       278 ~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~  356 (425)
                      ....+..|+|||++.+ ..++.++|||||||++|+|++ |+.||. ..+..+....+.+.            .       
T Consensus       158 ~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~~g~~p~~-~~~~~~~~~~~~~~------------~-------  216 (256)
T cd05082         158 TGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYP-RIPLKDVVPRVEKG------------Y-------  216 (256)
T ss_pred             CCccceeecCHHHHcc-CCCCchhhhHHHHHHHHHHHhCCCCCCC-CCCHHHHHHHHhcC------------C-------
Confidence            2344567999999876 678999999999999999997 888873 22211111111100            0       


Q ss_pred             hHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhc
Q 014406          357 LDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  408 (425)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~  408 (425)
                                       .......+++.+.+++.+||+.||++|||+.++++
T Consensus       217 -----------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  251 (256)
T cd05082         217 -----------------KMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE  251 (256)
T ss_pred             -----------------CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence                             00111236889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=6e-39  Score=297.79  Aligned_cols=234  Identities=16%  Similarity=0.265  Sum_probs=184.1

Q ss_pred             eeeeeCceEEEEEEEcCCCc-------EEEEEEecCcc---hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEE
Q 014406          132 KVGRGKYSEVFEGINVNTNE-------RCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (425)
Q Consensus       132 ~LG~G~fg~V~~~~~~~~~~-------~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (425)
                      .||+|+||+||+|.+..++.       .+++|.+....   .+.+.+|+.+++.+ +|||++++++++...  ...++||
T Consensus         2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~-~h~~iv~~~~~~~~~--~~~~lv~   78 (258)
T cd05078           2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQL-SHKHLVLNYGVCVCG--DESIMVQ   78 (258)
T ss_pred             CCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhC-CCCChhheeeEEEeC--CCcEEEE
Confidence            69999999999998765544       38888876433   35678899999998 899999999999764  5678999


Q ss_pred             EeecCCChhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCc-------EEEEeccccccc
Q 014406          202 EYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRK-------LRLIDWGLAEFY  270 (425)
Q Consensus       202 e~~~~~~l~~~~~----~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~-------~kl~Dfg~a~~~  270 (425)
                      ||+++++|..++.    .+++..+..++.||+.||+|||+.||+||||||+||+++.+...       ++++|||++...
T Consensus        79 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~  158 (258)
T cd05078          79 EYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITV  158 (258)
T ss_pred             ecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccccccc
Confidence            9999999988873    37889999999999999999999999999999999999876322       799999998654


Q ss_pred             cCCCcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhcc
Q 014406          271 HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH  350 (425)
Q Consensus       271 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~  350 (425)
                      ..   .....++..|+|||++.+...++.++|||||||++|+|++|..+++...+..........              .
T Consensus       159 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~~--------------~  221 (258)
T cd05078         159 LP---KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYED--------------R  221 (258)
T ss_pred             CC---chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHHc--------------c
Confidence            32   223467788999999987556899999999999999999996555443332221111000              0


Q ss_pred             CCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcC
Q 014406          351 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  409 (425)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~h  409 (425)
                                              ...+...+.++.+|+.+||+.||++|||++++++.
T Consensus       222 ------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  256 (258)
T cd05078         222 ------------------------HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRD  256 (258)
T ss_pred             ------------------------ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence                                    00011245789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3e-38  Score=292.81  Aligned_cols=235  Identities=18%  Similarity=0.330  Sum_probs=186.7

Q ss_pred             eeeeeeCceEEEEEEEcCCC---cEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEEEe
Q 014406          131 RKVGRGKYSEVFEGINVNTN---ERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEY  203 (425)
Q Consensus       131 ~~LG~G~fg~V~~~~~~~~~---~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~  203 (425)
                      ++||+|+||.||+|.+..++   ..+|+|.+....    .+.+.+|+.+++.+ +|+||+++++++..   ...++||||
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~---~~~~~v~e~   76 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQL-DHPCIVRLIGVCKG---EPLMLVMEL   76 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhc-CCCCeeeEEEEEcC---CceEEEEEe
Confidence            36999999999999876655   789999987443    35688999999999 89999999998853   457899999


Q ss_pred             ecCCChhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCcce---
Q 014406          204 VNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN---  277 (425)
Q Consensus       204 ~~~~~l~~~~~---~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~~~---  277 (425)
                      +++++|.+++.   .+++..+..++.|++.||+|||+.+++|+||||+|||++.+ +.+||+|||+++.........   
T Consensus        77 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~-~~~kl~df~~~~~~~~~~~~~~~~  155 (257)
T cd05060          77 APLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNR-HQAKISDFGMSRALGAGSDYYRAT  155 (257)
T ss_pred             CCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCC-CcEEeccccccceeecCCcccccc
Confidence            99999998873   48899999999999999999999999999999999999988 789999999998664333221   


Q ss_pred             -eeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCCh
Q 014406          278 -VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP  355 (425)
Q Consensus       278 -~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~  355 (425)
                       ...++..|+|||.+.+ ..++.++|||||||++|+|++ |..||. ..+..+....+.. ..                 
T Consensus       156 ~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~~~~~g~~p~~-~~~~~~~~~~~~~-~~-----------------  215 (257)
T cd05060         156 TAGRWPLKWYAPECINY-GKFSSKSDVWSYGVTLWEAFSYGAKPYG-EMKGAEVIAMLES-GE-----------------  215 (257)
T ss_pred             cCccccccccCHHHhcC-CCCCccchHHHHHHHHHHHHcCCCCCcc-cCCHHHHHHHHHc-CC-----------------
Confidence             1122356999999876 679999999999999999998 888873 2222222221110 00                 


Q ss_pred             hhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhc
Q 014406          356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  408 (425)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~  408 (425)
                                        .......++..+++++.+||+.||++|||+.++++
T Consensus       216 ------------------~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~  250 (257)
T cd05060         216 ------------------RLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELES  250 (257)
T ss_pred             ------------------cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence                              00112236789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.4e-38  Score=292.18  Aligned_cols=239  Identities=18%  Similarity=0.352  Sum_probs=193.4

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc--hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEE
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (425)
                      .++|++.+.||.|+||.||+|..  .++.+|+|.++...  .+++.+|+.+++.+ +|+||+++++++.+  ....++||
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~~~~v~   79 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDSTAAQAFLAEASVMTTL-RHPNLVQLLGVVLQ--GNPLYIVT   79 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchhHHHHHHHHHHHHHhc-CCcceeeeEEEEcC--CCCeEEEE
Confidence            56788999999999999999975  47889999997553  46788999999999 89999999999965  46788999


Q ss_pred             EeecCCChhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCcc
Q 014406          202 EYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY  276 (425)
Q Consensus       202 e~~~~~~l~~~~~-----~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~~  276 (425)
                      ||+++++|.+++.     .+++..+..++.|++.||.|||+.|++|+||||+||+++.+ +.++|+|||.++......  
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~-~~~~l~d~g~~~~~~~~~--  156 (256)
T cd05039          80 EYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSED-LVAKVSDFGLAKEASQGQ--  156 (256)
T ss_pred             EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCC-CCEEEccccccccccccc--
Confidence            9999999988863     48899999999999999999999999999999999999988 789999999998663222  


Q ss_pred             eeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCCh
Q 014406          277 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP  355 (425)
Q Consensus       277 ~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~  355 (425)
                      .....+..|+|||.+.+ ..++.++||||||++++++++ |..||.. .. .+.+.....   .        ..      
T Consensus       157 ~~~~~~~~~~ape~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~-~~-~~~~~~~~~---~--------~~------  216 (256)
T cd05039         157 DSGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPR-IP-LKDVVPHVE---K--------GY------  216 (256)
T ss_pred             ccCCCcccccCchhhcC-CcCCcHHHHHHHHHHHHHHHhcCCCCCCC-CC-HHHHHHHHh---c--------CC------
Confidence            23344567999999876 678999999999999999997 8888732 22 222111110   0        00      


Q ss_pred             hhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhc
Q 014406          356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  408 (425)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~  408 (425)
                                        .......+++++.+++++||+.+|++|||+.|+++
T Consensus       217 ------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  251 (256)
T cd05039         217 ------------------RMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE  251 (256)
T ss_pred             ------------------CCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence                              00111236889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-39  Score=306.42  Aligned_cols=252  Identities=19%  Similarity=0.333  Sum_probs=203.3

Q ss_pred             cCCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCc
Q 014406          121 WGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (425)
Q Consensus       121 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (425)
                      +...+...+.++||+|.||.|.+|. ...+..||||.++...    +..|.+|+++|.++ +||||++++|+|..+  +.
T Consensus       534 EfPRs~L~~~ekiGeGqFGEVhLCe-veg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqL-khPNIveLvGVC~~D--eP  609 (807)
T KOG1094|consen  534 EFPRSRLRFKEKIGEGQFGEVHLCE-VEGPLKVAVKILRPDATKNARNDFLKEIKILSRL-KHPNIVELLGVCVQD--DP  609 (807)
T ss_pred             hcchhheehhhhhcCcccceeEEEE-ecCceEEEEeecCcccchhHHHHHHHHHHHHhcc-CCCCeeEEEeeeecC--Cc
Confidence            3345678889999999999999995 4557999999998643    46799999999999 999999999999754  67


Q ss_pred             cEEEEEeecCCChhhhcCC-----CCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEecccccccc
Q 014406          197 PSLIFEYVNSTDFKVLYPT-----LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (425)
Q Consensus       197 ~~lv~e~~~~~~l~~~~~~-----l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~  271 (425)
                      +|+|+|||++|+|.+++..     ........|+.||+.||+||.+.++|||||.++|+|+|.+ .++||+|||+++...
T Consensus       610 icmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e-~~iKiadfgmsR~ly  688 (807)
T KOG1094|consen  610 LCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGE-FTIKIADFGMSRNLY  688 (807)
T ss_pred             hHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCc-ccEEecCcccccccc
Confidence            8899999999999998843     2445566799999999999999999999999999999999 799999999999887


Q ss_pred             CCCcceee---ccCCCccCcccccCCCCCCCcccHHHHHHHHHHHH--hCCCCCCCCCCCHHHHHHHHHHhCCchhHHHH
Q 014406          272 PGKEYNVR---VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI--FRKEPFFYGHDNHDQLVKIAKVLGTDELNAYL  346 (425)
Q Consensus       272 ~~~~~~~~---~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ell--tg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~  346 (425)
                      .++.+...   +-+..|||||.++. ++++.++|+|+||+++||++  +...|| ....+++...+.-..+..+....++
T Consensus       689 sg~yy~vqgr~vlpiRwmawEsill-gkFttaSDvWafgvTlwE~~~~C~e~Py-~~lt~e~vven~~~~~~~~~~~~~l  766 (807)
T KOG1094|consen  689 SGDYYRVQGRAVLPIRWMAWESILL-GKFTTASDVWAFGVTLWEVFMLCREQPY-SQLTDEQVVENAGEFFRDQGRQVVL  766 (807)
T ss_pred             cCCceeeecceeeeeeehhHHHHHh-ccccchhhhhhhHHHHHHHHHHHhhCch-hhhhHHHHHHhhhhhcCCCCcceec
Confidence            66665443   55778999999988 78999999999999999986  466777 3334444444443333332222111


Q ss_pred             hhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhc
Q 014406          347 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  408 (425)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~  408 (425)
                                                   ..+..++..+.+++.+||+.|-++||+.+++-.
T Consensus       767 -----------------------------~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~  799 (807)
T KOG1094|consen  767 -----------------------------SRPPACPQGLYELMLRCWRRESEQRPSFEQLHL  799 (807)
T ss_pred             -----------------------------cCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence                                         112337899999999999999999999999843

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=1.3e-38  Score=303.45  Aligned_cols=250  Identities=28%  Similarity=0.427  Sum_probs=198.3

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCcc
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (425)
                      .+.|+..+.||+|+||+||+|.+..+++.+|+|.+...      ....+.+|+++++.+ +|+|++++++++.+.  ...
T Consensus        14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~   90 (308)
T cd06634          14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQYRGCYLRE--HTA   90 (308)
T ss_pred             HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhC-CCCCcccEEEEEEcC--Cee
Confidence            44577788999999999999999999999999998632      124577899999999 999999999999764  677


Q ss_pred             EEEEEeecCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCC
Q 014406          198 SLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (425)
Q Consensus       198 ~lv~e~~~~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~  273 (425)
                      ++||||+.+ ++...+    ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.+ +.++|+|||++......
T Consensus        91 ~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~-~~~kl~dfg~~~~~~~~  168 (308)
T cd06634          91 WLVMEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEP-GLVKLGDFGSASIMAPA  168 (308)
T ss_pred             EEEEEccCC-CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCC-CcEEECCcccceeecCc
Confidence            899999975 444433    348899999999999999999999999999999999999988 78999999998765432


Q ss_pred             CcceeeccCCCccCcccccC--CCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccC
Q 014406          274 KEYNVRVASRYFKGPELLVD--LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL  351 (425)
Q Consensus       274 ~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~  351 (425)
                         ....++..|+|||.+.+  ...++.++|||||||++|+|++|..||.... ..+....+....              
T Consensus       169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-~~~~~~~~~~~~--------------  230 (308)
T cd06634         169 ---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-AMSALYHIAQNE--------------  230 (308)
T ss_pred             ---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCcccc-HHHHHHHHhhcC--------------
Confidence               23467888999999752  2457889999999999999999999984321 111111111100              


Q ss_pred             CCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCccccc
Q 014406          352 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA  417 (425)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~  417 (425)
                                     .+      ......++..+.+||++||+.+|++|||++++++|||+.+...
T Consensus       231 ---------------~~------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~~~  275 (308)
T cd06634         231 ---------------SP------ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERP  275 (308)
T ss_pred             ---------------CC------CcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccccCC
Confidence                           00      0001126788999999999999999999999999999987654

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=3.2e-38  Score=294.62  Aligned_cols=243  Identities=16%  Similarity=0.306  Sum_probs=192.1

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCc---EEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCc
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNE---RCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~---~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (425)
                      ..+|++.+.||+|+||.||+|.+..+++   .||+|.++..    ....+..|+.+++.+ +||||+++++++.+  +..
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~--~~~   79 (269)
T cd05065           3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF-DHPNIIHLEGVVTK--SRP   79 (269)
T ss_pred             hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhC-CCcCcceEEEEECC--CCc
Confidence            3568899999999999999999877664   6999998743    235788999999999 99999999999954  467


Q ss_pred             cEEEEEeecCCChhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccC
Q 014406          197 PSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (425)
Q Consensus       197 ~~lv~e~~~~~~l~~~~~----~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~  272 (425)
                      .++||||+++++|..++.    .+++.++..++.|++.||.|||++|++|+||||+||+++.+ +.++|+|||++.....
T Consensus        80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~-~~~kl~dfg~~~~~~~  158 (269)
T cd05065          80 VMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSN-LVCKVSDFGLSRFLED  158 (269)
T ss_pred             eEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCC-CcEEECCCcccccccc
Confidence            889999999999988763    37889999999999999999999999999999999999987 7899999999876543


Q ss_pred             CCcc---eeec---cCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCCchhHHH
Q 014406          273 GKEY---NVRV---ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAY  345 (425)
Q Consensus       273 ~~~~---~~~~---~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~lg~~~~~~~  345 (425)
                      ....   ....   .+..|+|||.+.+ ..++.++|||||||++||+++ |..||.. .+..+....+....        
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DvwslG~~l~e~l~~g~~p~~~-~~~~~~~~~i~~~~--------  228 (269)
T cd05065         159 DTSDPTYTSSLGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWD-MSNQDVINAIEQDY--------  228 (269)
T ss_pred             CccccccccccCCCcceeecCHhHhcc-CcccchhhhhhhHHHHHHHhcCCCCCCCC-CCHHHHHHHHHcCC--------
Confidence            2211   1111   1346999999876 678999999999999999886 8888843 22222222211000        


Q ss_pred             HhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhc
Q 014406          346 LNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  408 (425)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~  408 (425)
                                                  .......++..+.+++.+||+.+|.+|||+.++++
T Consensus       229 ----------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  263 (269)
T cd05065         229 ----------------------------RLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVS  263 (269)
T ss_pred             ----------------------------cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                                        00001226788999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.7e-38  Score=294.23  Aligned_cols=234  Identities=18%  Similarity=0.259  Sum_probs=180.2

Q ss_pred             eeeeeeCceEEEEEEEcC------------CCcEEEEEEecCcch---HHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCC
Q 014406          131 RKVGRGKYSEVFEGINVN------------TNERCIIKILKPVKK---KKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (425)
Q Consensus       131 ~~LG~G~fg~V~~~~~~~------------~~~~vavK~~~~~~~---~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (425)
                      +.||+|+||.||+|....            ....+++|.+.....   ..+.+|+.+++.+ +||||+++++++.+.  .
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l-~hp~iv~~~~~~~~~--~   77 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQV-SHKHIVLLYGVCVRD--V   77 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhC-CCCCEeeEEEEEecC--C
Confidence            368999999999997432            233688998875433   4677899999999 999999999999654  5


Q ss_pred             ccEEEEEeecCCChhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCC------cEEEEecc
Q 014406          196 TPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELR------KLRLIDWG  265 (425)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~~----~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~------~~kl~Dfg  265 (425)
                      ..++||||+++++|..++.    .+++..+..++.||+.||+|||+++|+||||||+|||++.+..      .++++|||
T Consensus        78 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g  157 (262)
T cd05077          78 ENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG  157 (262)
T ss_pred             CCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence            6789999999999887763    3889999999999999999999999999999999999986521      28999999


Q ss_pred             ccccccCCCcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHH-hCCCCCCCCCCCHHHHHHHHHHhCCchhHH
Q 014406          266 LAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI-FRKEPFFYGHDNHDQLVKIAKVLGTDELNA  344 (425)
Q Consensus       266 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ell-tg~~pf~~~~~~~~~~~~~~~~lg~~~~~~  344 (425)
                      ++.....   .....++..|+|||.+.+...++.++|||||||++|+|+ +|..|| ......+. ..+.   ..     
T Consensus       158 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~-~~~~~~~~-~~~~---~~-----  224 (262)
T cd05077         158 IPITVLS---RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPL-KDKTLAEK-ERFY---EG-----  224 (262)
T ss_pred             CCccccC---cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCC-CCcchhHH-HHHH---hc-----
Confidence            9865432   223467788999999875567899999999999999998 476665 22221111 1000   00     


Q ss_pred             HHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcC
Q 014406          345 YLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  409 (425)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~h  409 (425)
                           ..                        ......++++.+|+.+||+.||++|||+.+++++
T Consensus       225 -----~~------------------------~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~  260 (262)
T cd05077         225 -----QC------------------------MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD  260 (262)
T ss_pred             -----Cc------------------------cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence                 00                        0001135788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=3.1e-38  Score=292.59  Aligned_cols=237  Identities=24%  Similarity=0.421  Sum_probs=193.4

Q ss_pred             eeeeeeCceEEEEEEEcCC---CcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEEEe
Q 014406          131 RKVGRGKYSEVFEGINVNT---NERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEY  203 (425)
Q Consensus       131 ~~LG~G~fg~V~~~~~~~~---~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~  203 (425)
                      +.||+|+||.||+|.+...   +..+++|.+....    .+.+.+|+..+..+ +|+|++++++++..  ....+++|||
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~--~~~~~lv~e~   77 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKL-GHPNVVRLLGVCTE--EEPLYLVLEY   77 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhc-CCCChheeeeeecC--CCceEEEEEe
Confidence            3699999999999998866   8999999997543    46788999999999 79999999999965  5778999999


Q ss_pred             ecCCChhhhcC------------CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEecccccccc
Q 014406          204 VNSTDFKVLYP------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (425)
Q Consensus       204 ~~~~~l~~~~~------------~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~  271 (425)
                      +++++|..++.            .+++..+..++.|++.||+|||+++++|+||+|+||+++.+ +.++|+|||.+....
T Consensus        78 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~-~~~~l~dfg~~~~~~  156 (262)
T cd00192          78 MEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGED-LVVKISDFGLSRDVY  156 (262)
T ss_pred             ccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCC-CcEEEcccccccccc
Confidence            99999988763            36899999999999999999999999999999999999998 799999999998765


Q ss_pred             CCC---cceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCCchhHHHHh
Q 014406          272 PGK---EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLN  347 (425)
Q Consensus       272 ~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~  347 (425)
                      ...   ......++..|+|||.+.. ..++.++||||+||++|+|++ |..||. ..+..+....+..  +         
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~-~~~~~~~~~~~~~--~---------  223 (262)
T cd00192         157 DDDYYRKKTGGKLPIRWMAPESLKD-GIFTSKSDVWSFGVLLWEIFTLGATPYP-GLSNEEVLEYLRK--G---------  223 (262)
T ss_pred             cccccccccCCCcCccccCHHHhcc-CCcchhhccHHHHHHHHHHHhcCCCCCC-CCCHHHHHHHHHc--C---------
Confidence            432   2233456788999999877 578999999999999999999 577773 3332222222211  0         


Q ss_pred             hccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcC
Q 014406          348 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  409 (425)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~h  409 (425)
                                               ........++.++.+++.+||+.||++|||+.|++++
T Consensus       224 -------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  260 (262)
T cd00192         224 -------------------------YRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER  260 (262)
T ss_pred             -------------------------CCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence                                     0011122368899999999999999999999999875

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=3e-38  Score=294.96  Aligned_cols=244  Identities=21%  Similarity=0.408  Sum_probs=193.7

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCC---CcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCC
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNT---NERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~---~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (425)
                      ..++|.+.+.||+|+||.||+|.+...   ...+++|......    .+.+.+|+.+++.+ +|+||+++++++.+   .
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~---~   79 (270)
T cd05056           4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQF-DHPHIVKLIGVITE---N   79 (270)
T ss_pred             chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhC-CCCchhceeEEEcC---C
Confidence            356789999999999999999987644   3568999886432    35688999999999 89999999999864   4


Q ss_pred             ccEEEEEeecCCChhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEecccccccc
Q 014406          196 TPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (425)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~~----~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~  271 (425)
                      ..++||||+.+++|..++.    .+++..+..++.|++.||+|||+.|++|+||||+||+++.+ +.++|+|||+++...
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~-~~~~l~d~g~~~~~~  158 (270)
T cd05056          80 PVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSP-DCVKLGDFGLSRYLE  158 (270)
T ss_pred             CcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecC-CCeEEccCceeeecc
Confidence            5689999999999998873    37899999999999999999999999999999999999988 789999999997664


Q ss_pred             CCCcce--eeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhh
Q 014406          272 PGKEYN--VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK  348 (425)
Q Consensus       272 ~~~~~~--~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~  348 (425)
                      ......  ...++..|+|||.+.. ..++.++|||||||++|++++ |..||. +.+..+....+....           
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~-~~~~~~~~~~~~~~~-----------  225 (270)
T cd05056         159 DESYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMLGVKPFQ-GVKNNDVIGRIENGE-----------  225 (270)
T ss_pred             cccceecCCCCccccccChhhhcc-CCCCchhhhHHHHHHHHHHHHcCCCCCC-CCCHHHHHHHHHcCC-----------
Confidence            432222  1223457999999876 678999999999999999986 998883 333333322221100           


Q ss_pred             ccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcC
Q 014406          349 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  409 (425)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~h  409 (425)
                                               .......++.++.+++.+||..+|++|||+.++++.
T Consensus       226 -------------------------~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~  261 (270)
T cd05056         226 -------------------------RLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQ  261 (270)
T ss_pred             -------------------------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                     000112368899999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=2.4e-38  Score=310.78  Aligned_cols=247  Identities=21%  Similarity=0.327  Sum_probs=192.7

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEc-----CCCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCC
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINV-----NTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQH  193 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~-----~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  193 (425)
                      ..++|.+.+.||+|+||.||+|.+.     .++..||+|+++...    .+.+.+|+.++.++..||||++++++|... 
T Consensus        35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~-  113 (401)
T cd05107          35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG-  113 (401)
T ss_pred             cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC-
Confidence            3567888999999999999999853     355689999997432    246788999999994499999999999654 


Q ss_pred             CCccEEEEEeecCCChhhhcC-----------------------------------------------------------
Q 014406          194 SKTPSLIFEYVNSTDFKVLYP-----------------------------------------------------------  214 (425)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~~-----------------------------------------------------------  214 (425)
                       ...++||||+.+|+|.+++.                                                           
T Consensus       114 -~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (401)
T cd05107         114 -GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPM  192 (401)
T ss_pred             -CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccch
Confidence             67899999999999977652                                                           


Q ss_pred             ------------------------------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEe
Q 014406          215 ------------------------------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI  252 (425)
Q Consensus       215 ------------------------------------------~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll  252 (425)
                                                                .+++..+..++.|++.||+|||+.+++|+||||+|||+
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl  272 (401)
T cd05107         193 QDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLI  272 (401)
T ss_pred             hcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEE
Confidence                                                      24566778899999999999999999999999999999


Q ss_pred             cCCCCcEEEEeccccccccCCCc---ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHH
Q 014406          253 DHELRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHD  328 (425)
Q Consensus       253 ~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~  328 (425)
                      +.+ +.+||+|||+++.......   .....++..|+|||.+.+ ..++.++|||||||++|||++ |+.||. .....+
T Consensus       273 ~~~-~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGvil~e~l~~g~~P~~-~~~~~~  349 (401)
T cd05107         273 CEG-KLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFN-NLYTTLSDVWSFGILLWEIFTLGGTPYP-ELPMNE  349 (401)
T ss_pred             eCC-CEEEEEecCcceecccccccccCCCcCCCCceeChHHhcC-CCCCcHhHHHHHHHHHHHHHHcCCCCCC-CCCchH
Confidence            987 7899999999976532221   122356778999999977 678999999999999999998 788873 222222


Q ss_pred             HHHHHHHHhCCchhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhc
Q 014406          329 QLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  408 (425)
Q Consensus       329 ~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~  408 (425)
                      .+...... +            .                      .......++.++.+|+.+||+.+|++||+++|+++
T Consensus       350 ~~~~~~~~-~------------~----------------------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~  394 (401)
T cd05107         350 QFYNAIKR-G------------Y----------------------RMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVH  394 (401)
T ss_pred             HHHHHHHc-C------------C----------------------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            22211110 0            0                      00011236889999999999999999999999986


Q ss_pred             C
Q 014406          409 H  409 (425)
Q Consensus       409 h  409 (425)
                      .
T Consensus       395 ~  395 (401)
T cd05107         395 L  395 (401)
T ss_pred             H
Confidence            4

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=2.3e-38  Score=297.55  Aligned_cols=243  Identities=17%  Similarity=0.340  Sum_probs=192.3

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEc-----CCCcEEEEEEecCcc---hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCC
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINV-----NTNERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~-----~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (425)
                      ..+|+..++||+|+||+||++...     .++..+++|.+....   ...+.+|+++++.+ +|+||+++++++.+.  .
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~   80 (280)
T cd05092           4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVL-QHQHIVRFYGVCTEG--R   80 (280)
T ss_pred             hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcC-CCCCCceEEEEEecC--C
Confidence            467888999999999999999643     356789999887543   35688999999999 999999999999654  5


Q ss_pred             ccEEEEEeecCCChhhhcC------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCC
Q 014406          196 TPSLIFEYVNSTDFKVLYP------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELR  257 (425)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~~------------------~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~  257 (425)
                      ..+++|||+.+++|..++.                  .+++..+..++.|++.||+|||+.|++|+||||+|||++++ +
T Consensus        81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~-~  159 (280)
T cd05092          81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQG-L  159 (280)
T ss_pred             ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCC-C
Confidence            6889999999999987762                  36788899999999999999999999999999999999987 7


Q ss_pred             cEEEEeccccccccCCCcc---eeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHH
Q 014406          258 KLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKI  333 (425)
Q Consensus       258 ~~kl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~  333 (425)
                      .++|+|||+++........   ....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.. ....+....+
T Consensus       160 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~-~~~~~~~~~~  237 (280)
T cd05092         160 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY-RKFTTESDIWSFGVVLWEIFTYGKQPWYQ-LSNTEAIECI  237 (280)
T ss_pred             CEEECCCCceeEcCCCceeecCCCccccccccCHHHhcc-CCcCchhhHHHHHHHHHHHHcCCCCCCcc-CCHHHHHHHH
Confidence            8999999998755432221   12234677999999877 678999999999999999998 8888732 2222222211


Q ss_pred             HHHhCCchhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhc
Q 014406          334 AKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  408 (425)
Q Consensus       334 ~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~  408 (425)
                      ....                                    .......+++.+.+|+.+||+.||++||++.|+++
T Consensus       238 ~~~~------------------------------------~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~  276 (280)
T cd05092         238 TQGR------------------------------------ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS  276 (280)
T ss_pred             HcCc------------------------------------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            1100                                    00111236889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-40  Score=290.99  Aligned_cols=278  Identities=28%  Similarity=0.532  Sum_probs=220.1

Q ss_pred             eeeeeeCceEEEEEEEcCCCcEEEEEEecC-----cchHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCC---ccEEEEE
Q 014406          131 RKVGRGKYSEVFEGINVNTNERCIIKILKP-----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK---TPSLIFE  202 (425)
Q Consensus       131 ~~LG~G~fg~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~---~~~lv~e  202 (425)
                      +.||.|+||.||.++|..+|+.||+|.+.+     ...+.+.+|+.+|..+ +|.|++..+++..-.+-.   .+|++.|
T Consensus        59 RPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfF-kHdNVLSaLDILQPph~dfFqEiYV~TE  137 (449)
T KOG0664|consen   59 RPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSF-RHDNVLSLLDILQPANPSFFQELYVLTE  137 (449)
T ss_pred             CcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhh-ccccHHHHHHhcCCCCchHHHHHHHHHH
Confidence            569999999999999999999999998864     2457889999999998 999999999987644322   3567788


Q ss_pred             eecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCC--cce
Q 014406          203 YVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK--EYN  277 (425)
Q Consensus       203 ~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~--~~~  277 (425)
                      .|+. +|...+   +.++.+.++.++.||++||.|||+.+|.||||||.|.|++++ ..+||||||+++.....+  ..+
T Consensus       138 LmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSN-CvLKICDFGLARvee~d~~~hMT  215 (449)
T KOG0664|consen  138 LMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSN-CILKICDFGLARTWDQRDRLNMT  215 (449)
T ss_pred             HHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccC-ceEEecccccccccchhhhhhhH
Confidence            8775 344443   458899999999999999999999999999999999999999 789999999999775543  334


Q ss_pred             eeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCChhh
Q 014406          278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQL  357 (425)
Q Consensus       278 ~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~  357 (425)
                      ..+.|.+|+|||++.+...|+.++||||+||++.||+..+..| ...+..+++..|.+.+|++..+.....+.-    ..
T Consensus       216 qEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILF-QAq~PiqQL~lItdLLGTPs~EaMr~ACEG----Ak  290 (449)
T KOG0664|consen  216 HEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILF-QAAGPIEQLQMIIDLLGTPSQEAMKYACEG----AK  290 (449)
T ss_pred             HHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhh-hccChHHHHHHHHHHhCCCcHHHHHHHhhh----hH
Confidence            5688999999999999899999999999999999999777665 788899999999999999987764322111    11


Q ss_pred             HHHhcccCC-CCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccc
Q 014406          358 DALVGRHSR-KPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR  416 (425)
Q Consensus       358 ~~~~~~~~~-~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~  416 (425)
                      ..+.....+ .....+.....+..-.-+..+++.++|..||.+|.+.++++.|+++.+.+
T Consensus       291 ~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R  350 (449)
T KOG0664|consen  291 NHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGR  350 (449)
T ss_pred             HHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccccc
Confidence            111111111 11122222333333456788999999999999999999999999988765

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=3e-38  Score=299.20  Aligned_cols=250  Identities=16%  Similarity=0.340  Sum_probs=190.4

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcC----------------CCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCee
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVN----------------TNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVV  183 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~----------------~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv  183 (425)
                      .++|++.+.||+|+||+||++.+..                ++..+|+|++....    .+.+.+|+.+++.+ +|+||+
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~   82 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRL-KDPNII   82 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCcc
Confidence            4679999999999999999985432                34578999987432    35688999999999 999999


Q ss_pred             eEEeEEEcCCCCccEEEEEeecCCChhhhcCC--------------CCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCc
Q 014406          184 KLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPT--------------LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHN  249 (425)
Q Consensus       184 ~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--------------l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~N  249 (425)
                      ++++++...  ...+++|||+.+++|..++..              +++..+..++.|++.||+|||+.|++|+||||+|
T Consensus        83 ~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~N  160 (296)
T cd05095          83 RLLAVCITS--DPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRN  160 (296)
T ss_pred             eEEEEEecC--CccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChhe
Confidence            999999654  568999999999999887632              5567899999999999999999999999999999


Q ss_pred             eEecCCCCcEEEEeccccccccCCCcc---eeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh--CCCCCCCCC
Q 014406          250 VMIDHELRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF--RKEPFFYGH  324 (425)
Q Consensus       250 Ill~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt--g~~pf~~~~  324 (425)
                      ||++.+ +.++|+|||+++........   ....++..|++||...+ ..++.++|||||||++|||++  |..||. ..
T Consensus       161 ili~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~DiwSlG~~l~el~~~~~~~p~~-~~  237 (296)
T cd05095         161 CLVGKN-YTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILL-GKFTTASDVWAFGVTLWEILTLCKEQPYS-QL  237 (296)
T ss_pred             EEEcCC-CCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhc-CCccchhhhhHHHHHHHHHHHhCCCCCcc-cc
Confidence            999987 78999999999765433211   12233567999998876 679999999999999999998  667773 22


Q ss_pred             CCHHHHHHHHHHhCCchhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHH
Q 014406          325 DNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAR  404 (425)
Q Consensus       325 ~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~  404 (425)
                      +..+...........        . .           .   .      ........+++.+.+|+.+||+.||++|||+.
T Consensus       238 ~~~~~~~~~~~~~~~--------~-~-----------~---~------~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~  288 (296)
T cd05095         238 SDEQVIENTGEFFRD--------Q-G-----------R---Q------VYLPKPALCPDSLYKLMLSCWRRNAKERPSFQ  288 (296)
T ss_pred             ChHHHHHHHHHHHhh--------c-c-----------c---c------ccCCCCCCCCHHHHHHHHHHcCCCcccCCCHH
Confidence            222222211110000        0 0           0   0      00011123678999999999999999999999


Q ss_pred             HHhc
Q 014406          405 EAMA  408 (425)
Q Consensus       405 elL~  408 (425)
                      |+++
T Consensus       289 ~i~~  292 (296)
T cd05095         289 EIHA  292 (296)
T ss_pred             HHHH
Confidence            9864

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-38  Score=292.26  Aligned_cols=237  Identities=30%  Similarity=0.526  Sum_probs=195.6

Q ss_pred             eeeeCceEEEEEEEcCCCcEEEEEEecCcc------hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEEEeecC
Q 014406          133 VGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNS  206 (425)
Q Consensus       133 LG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~  206 (425)
                      ||.|+||.||++.+..+++.+++|++....      ...+..|+.+++.+ +|+|++++++.+..  +...+++|||+.+
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~~v~e~~~~   77 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRI-NHPFIVKLHYAFQT--EEKLYLVLEYAPG   77 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHc-CCCcHHHHHHHeec--CCeeEEEEecCCC
Confidence            699999999999998889999999987432      34688999999999 89999999999854  4788999999999


Q ss_pred             CChhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCC-CcceeeccC
Q 014406          207 TDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-KEYNVRVAS  282 (425)
Q Consensus       207 ~~l~~~~~---~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~~t  282 (425)
                      ++|.+++.   .+++..+..++.|++.||.|||+.+++|+||+|+||+++.+ +.++|+|||++...... .......++
T Consensus        78 ~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~  156 (250)
T cd05123          78 GELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDAD-GHIKLTDFGLAKELSSEGSRTNTFCGT  156 (250)
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCC-CcEEEeecCcceecccCCCcccCCcCC
Confidence            99988763   47899999999999999999999999999999999999988 78999999998765433 233445678


Q ss_pred             CCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCChhhHHHhc
Q 014406          283 RYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVG  362 (425)
Q Consensus       283 ~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~  362 (425)
                      ..|++||...+ ..++.++|+||||+++|++++|..||... +..+....+..  +                        
T Consensus       157 ~~~~~Pe~~~~-~~~~~~~D~~slG~~~~~l~~g~~p~~~~-~~~~~~~~~~~--~------------------------  208 (250)
T cd05123         157 PEYLAPEVLLG-KGYGKAVDWWSLGVLLYEMLTGKPPFYAE-DRKEIYEKILK--D------------------------  208 (250)
T ss_pred             ccccChHHhCC-CCCCchhhHHHHHHHHHHHHHCCCCCCCC-CHHHHHHHHhc--C------------------------
Confidence            88999999877 66889999999999999999999998422 22222221111  0                        


Q ss_pred             ccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCH---HHHhcCCCC
Q 014406          363 RHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA---REAMAHPYF  412 (425)
Q Consensus       363 ~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta---~elL~hp~~  412 (425)
                                 .......++..+.+|+++||..||++|||+   +++++||||
T Consensus       209 -----------~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f  250 (250)
T cd05123         209 -----------PLRFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF  250 (250)
T ss_pred             -----------CCCCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence                       001112257889999999999999999999   999999998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=6.2e-38  Score=290.35  Aligned_cols=243  Identities=16%  Similarity=0.353  Sum_probs=193.3

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc--chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEE
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (425)
                      ..+|++.+.||.|+||.||+|.+. .+..+|+|.+...  ....+.+|+++++.+ +|||++++++++...  ...++||
T Consensus         3 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~--~~~~~v~   78 (256)
T cd05112           3 PSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMSEEDFIEEAQVMMKL-SHPKLVQLYGVCTER--SPICLVF   78 (256)
T ss_pred             hhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCCHHHHHHHHHHHHhC-CCCCeeeEEEEEccC--CceEEEE
Confidence            457899999999999999999775 4678999998743  346789999999999 999999999998654  6788999


Q ss_pred             EeecCCChhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCc--
Q 014406          202 EYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE--  275 (425)
Q Consensus       202 e~~~~~~l~~~~~----~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~--  275 (425)
                      ||+.+++|..++.    .+++..+..++.|++.||+|||+.+++|+||||+||+++.+ +.++|+|||++........  
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~-~~~~l~d~g~~~~~~~~~~~~  157 (256)
T cd05112          79 EFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGEN-QVVKVSDFGMTRFVLDDQYTS  157 (256)
T ss_pred             EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCC-CeEEECCCcceeecccCcccc
Confidence            9999999988763    37889999999999999999999999999999999999987 7899999999875533211  


Q ss_pred             ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCC
Q 014406          276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD  354 (425)
Q Consensus       276 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~  354 (425)
                      .....++..|+|||.+.+ ..++.++||||||+++|+|++ |..||. .....+.+..+.+.                  
T Consensus       158 ~~~~~~~~~~~aPe~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~-~~~~~~~~~~~~~~------------------  217 (256)
T cd05112         158 STGTKFPVKWSSPEVFSF-SKYSSKSDVWSFGVLMWEVFSEGKTPYE-NRSNSEVVETINAG------------------  217 (256)
T ss_pred             cCCCccchhhcCHhHhcc-CCcChHHHHHHHHHHHHHHHcCCCCCCC-cCCHHHHHHHHhCC------------------
Confidence            112234567999999876 678999999999999999998 888873 22222222221100                  


Q ss_pred             hhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcC
Q 014406          355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  409 (425)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~h  409 (425)
                                    +    ........++.+.+|+.+||+.+|++|||+.|+++.
T Consensus       218 --------------~----~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~  254 (256)
T cd05112         218 --------------F----RLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQ  254 (256)
T ss_pred             --------------C----CCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence                          0    000011257889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=4.7e-38  Score=292.21  Aligned_cols=239  Identities=21%  Similarity=0.341  Sum_probs=184.7

Q ss_pred             eeeeeeCceEEEEEEEcC---CCcEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEEEe
Q 014406          131 RKVGRGKYSEVFEGINVN---TNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEY  203 (425)
Q Consensus       131 ~~LG~G~fg~V~~~~~~~---~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~  203 (425)
                      +.||+|+||+||+|.+..   .+..+|+|.+...    ..+.+.+|+.+++.+ +||||+++++++... +...++++||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~-~~~~~lv~e~   78 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDF-SHPNVLSLLGICLPS-EGSPLVVLPY   78 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccC-CCCCcceEEEEeecC-CCCcEEEEec
Confidence            368999999999998653   3457999988542    235678899999998 999999999987643 3457899999


Q ss_pred             ecCCChhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCc----
Q 014406          204 VNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE----  275 (425)
Q Consensus       204 ~~~~~l~~~~~----~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~----  275 (425)
                      +.+++|..++.    ..++..+..++.|++.||.|||+.+++|+||||+|||++.+ +.+||+|||+++.......    
T Consensus        79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~-~~~kl~dfg~~~~~~~~~~~~~~  157 (262)
T cd05058          79 MKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDES-FTVKVADFGLARDIYDKEYYSVH  157 (262)
T ss_pred             CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCC-CcEEECCccccccccCCcceeec
Confidence            99999998863    35677788899999999999999999999999999999988 7899999999975532211    


Q ss_pred             -ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCC
Q 014406          276 -YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD  354 (425)
Q Consensus       276 -~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~  354 (425)
                       .....++..|+|||.+.+ ..++.++|||||||++|||++|+.|++...+..+....+..   .          .    
T Consensus       158 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~---~----------~----  219 (262)
T cd05058         158 NHTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQ---G----------R----  219 (262)
T ss_pred             ccccCcCCccccChhHhcc-CccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc---C----------C----
Confidence             112244667999999876 67899999999999999999976665554433222211100   0          0    


Q ss_pred             hhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcC
Q 014406          355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  409 (425)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~h  409 (425)
                                         .......+++.+.+++.+||+.+|++|||+.|+++.
T Consensus       220 -------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~  255 (262)
T cd05058         220 -------------------RLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSR  255 (262)
T ss_pred             -------------------CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence                               000012257889999999999999999999999853

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=3.7e-38  Score=296.21  Aligned_cols=260  Identities=21%  Similarity=0.363  Sum_probs=197.8

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEc----CCCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCC
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINV----NTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~----~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (425)
                      .++|++.+.||+|+||.||+|...    .+++.+|+|++....    .+.+.+|+++++.+ +|+||+++++++......
T Consensus         3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l-~~~~i~~~~~~~~~~~~~   81 (284)
T cd05038           3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTL-DHENIVKYKGVCEKPGGR   81 (284)
T ss_pred             hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhC-CCCChheEEeeeecCCCC
Confidence            356778899999999999999854    347899999997543    45789999999999 999999999999776567


Q ss_pred             ccEEEEEeecCCChhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEecccccccc
Q 014406          196 TPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (425)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~~----~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~  271 (425)
                      ..+++|||+++++|..++.    .+++..+..++.|++.||+|||+.|++|+||||+||+++.+ +.++|+|||++....
T Consensus        82 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~  160 (284)
T cd05038          82 SLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESE-DLVKISDFGLAKVLP  160 (284)
T ss_pred             ceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCC-CCEEEcccccccccc
Confidence            8899999999999988873    38899999999999999999999999999999999999988 789999999998765


Q ss_pred             CCCcc----eeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHh
Q 014406          272 PGKEY----NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLN  347 (425)
Q Consensus       272 ~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~  347 (425)
                      .....    ....++..|++||.+.+ ..++.++||||||+++++|++|..|+........      ...+....     
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~------~~~~~~~~-----  228 (284)
T cd05038         161 EDKDYYYVKEPGESPIFWYAPECLRT-SKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFL------RMIGIAQG-----  228 (284)
T ss_pred             cCCcceeccCCCCCcccccCcHHHcc-CCCCcccchHHHhhhhheeeccCCCcccccchhc------cccccccc-----
Confidence            33221    11234556999999877 6789999999999999999999999843222110      00110000     


Q ss_pred             hccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhc
Q 014406          348 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  408 (425)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~  408 (425)
                         ...............+        ......++.++.+++.+||+.||++|||+.|+++
T Consensus       229 ---~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05038         229 ---QMIVTRLLELLKEGER--------LPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL  278 (284)
T ss_pred             ---cccHHHHHHHHHcCCc--------CCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence               0000000000000000        0111236788999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-40  Score=341.36  Aligned_cols=255  Identities=25%  Similarity=0.425  Sum_probs=207.5

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEE
Q 014406          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (425)
Q Consensus       125 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (425)
                      -+++-...||.|.||.||.|.+..+|+..|+|-++-.     ..+.+.+|..++..+ +|||+|+++|+-..  ...+++
T Consensus      1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~l-nHpNlV~YyGVEvH--Rekv~I 1311 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGL-NHPNLVRYYGVEVH--REKVYI 1311 (1509)
T ss_pred             eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhc-cCccccccCceeec--HHHHHH
Confidence            3566677899999999999999999999999987632     235678999999999 99999999998854  356779


Q ss_pred             EEEeecCCChhhhcCC---CCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCC--
Q 014406          200 IFEYVNSTDFKVLYPT---LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK--  274 (425)
Q Consensus       200 v~e~~~~~~l~~~~~~---l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~--  274 (425)
                      .||||++|+|.+.+..   .++.-.+.+..|++.|+.|||+.|||||||||.||+++.+ +.+|++|||.|..+....  
T Consensus      1312 FMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~-g~iK~~DFGsa~ki~~~~~~ 1390 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFN-GLIKYGDFGSAVKIKNNAQT 1390 (1509)
T ss_pred             HHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecC-CcEEeecccceeEecCchhc
Confidence            9999999999988742   5666678899999999999999999999999999999999 799999999998775442  


Q ss_pred             ---cceeeccCCCccCcccccCCC--CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhc
Q 014406          275 ---EYNVRVASRYFKGPELLVDLQ--DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY  349 (425)
Q Consensus       275 ---~~~~~~~t~~y~aPE~~~~~~--~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~  349 (425)
                         ..+...||+.|||||++.+..  .-.-+.||||+||++.||+||+.||. ..++..++..-+..-..+.+       
T Consensus      1391 ~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~-~~dne~aIMy~V~~gh~Pq~------- 1462 (1509)
T KOG4645|consen 1391 MPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWA-ELDNEWAIMYHVAAGHKPQI------- 1462 (1509)
T ss_pred             CCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchh-hccchhHHHhHHhccCCCCC-------
Confidence               234568999999999997632  23468999999999999999999984 44444444433332222221       


Q ss_pred             cCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccch
Q 014406          350 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE  419 (425)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~~  419 (425)
                                                  +..+|.+.++||..||..||++|+++.|+++|.|=+..+...
T Consensus      1463 ----------------------------P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~~d~~ 1504 (1509)
T KOG4645|consen 1463 ----------------------------PERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSCTDED 1504 (1509)
T ss_pred             ----------------------------chhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhccccccccc
Confidence                                        122789999999999999999999999999999977655443

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=2.6e-38  Score=289.91  Aligned_cols=226  Identities=21%  Similarity=0.330  Sum_probs=182.8

Q ss_pred             eCceEEEEEEEcCCCcEEEEEEecCcchHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEEEeecCCChhhhc--
Q 014406          136 GKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY--  213 (425)
Q Consensus       136 G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~--  213 (425)
                      |.||.||++.+..+++.+|+|.+....  .+.+|...+... .||||+++++++.+.  ...+++|||+++++|.+++  
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--~~~~~~~~~~~~-~~~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS--EYSRERLTIIPH-CVPNMVCLHKYIVSE--DSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh--hhhhHHHHHHhc-CCCceeehhhheecC--CeEEEEEecCCCCCHHHHHHH
Confidence            889999999999999999999997543  344555555555 799999999999654  6789999999999998776  


Q ss_pred             -CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCcceeeccCCCccCccccc
Q 014406          214 -PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV  292 (425)
Q Consensus       214 -~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~  292 (425)
                       ..+++..+..++.|++.||+|||+.||+|+||||+||+++.+ +.++++|||.+......  .....++..|+|||.+.
T Consensus        79 ~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~-~~~~l~df~~~~~~~~~--~~~~~~~~~y~aPE~~~  155 (237)
T cd05576          79 FLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDR-GHIQLTYFSRWSEVEDS--CDGEAVENMYCAPEVGG  155 (237)
T ss_pred             hcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCC-CCEEEecccchhccccc--cccCCcCccccCCcccC
Confidence             358999999999999999999999999999999999999988 78999999987655432  23345567799999986


Q ss_pred             CCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCChhhHHHhcccCCCCcccc
Q 014406          293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKF  372 (425)
Q Consensus       293 ~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  372 (425)
                      + ..++.++|+||+||++|+|++|..|+......   .            .                           ..
T Consensus       156 ~-~~~~~~~DvwslG~il~el~~g~~~~~~~~~~---~------------~---------------------------~~  192 (237)
T cd05576         156 I-SEETEACDWWSLGAILFELLTGKTLVECHPSG---I------------N---------------------------TH  192 (237)
T ss_pred             C-CCCCchhhHHHHHHHHHHHHHCcchhhcCchh---c------------c---------------------------cc
Confidence            6 67899999999999999999999876211000   0            0                           00


Q ss_pred             ccccCCCCCCHHHHHHHHHcccCCcCCCcCH-----HHHhcCCCC
Q 014406          373 INADNQHLVSPEAIDFLDKLLRYDHQDRLTA-----REAMAHPYF  412 (425)
Q Consensus       373 ~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta-----~elL~hp~~  412 (425)
                      .....+..+++.+++|+++||+.||++|+|+     +|+++||||
T Consensus       193 ~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~  237 (237)
T cd05576         193 TTLNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF  237 (237)
T ss_pred             cccCCcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence            0001122368899999999999999999986     999999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=6.1e-38  Score=290.27  Aligned_cols=239  Identities=23%  Similarity=0.410  Sum_probs=193.5

Q ss_pred             EEEeeeeeeCceEEEEEEEcCCC----cEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEE
Q 014406          128 EVVRKVGRGKYSEVFEGINVNTN----ERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (425)
Q Consensus       128 ~~~~~LG~G~fg~V~~~~~~~~~----~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (425)
                      ++.+.||.|+||.||++.+...+    ..+|+|.+....    .+.+.+|+.++..+ +|+||+++++++.+.  ...++
T Consensus         2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~--~~~~~   78 (258)
T smart00219        2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKL-DHPNIVKLLGVCTEE--EPLMI   78 (258)
T ss_pred             cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhc-CCCchheEEEEEcCC--CeeEE
Confidence            45678999999999999988766    899999997543    45788999999999 999999999999654  67889


Q ss_pred             EEEeecCCChhhhcC---C--CCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCC
Q 014406          200 IFEYVNSTDFKVLYP---T--LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (425)
Q Consensus       200 v~e~~~~~~l~~~~~---~--l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~  274 (425)
                      +|||+++++|..++.   .  +++..+..++.|++.||+|||+.+++|+||||+||+++.+ +.++|+|||++.......
T Consensus        79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~-~~~~l~dfg~~~~~~~~~  157 (258)
T smart00219       79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGEN-LVVKISDFGLSRDLYDDD  157 (258)
T ss_pred             EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccC-CeEEEcccCCceeccccc
Confidence            999999999988763   2  8999999999999999999999999999999999999988 789999999997765442


Q ss_pred             ccee--eccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccC
Q 014406          275 EYNV--RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL  351 (425)
Q Consensus       275 ~~~~--~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~  351 (425)
                      ....  ..++..|+|||.+.+ ..++.++||||+|+++++|++ |..|| ...+..+....+....              
T Consensus       158 ~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~i~~~l~~~g~~p~-~~~~~~~~~~~~~~~~--------------  221 (258)
T smart00219      158 YYKKKGGKLPIRWMAPESLKD-GKFTSKSDVWSFGVLLWEIFTLGESPY-PGMSNEEVLEYLKKGY--------------  221 (258)
T ss_pred             ccccccCCCcccccChHHhcc-CCCCcchhHHHHHHHHHHHHhCCCCCC-CCCCHHHHHHHHhcCC--------------
Confidence            2222  236678999999865 778999999999999999998 66665 3333333222221100              


Q ss_pred             CCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhc
Q 014406          352 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  408 (425)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~  408 (425)
                                            .......++.++.+++.+||+.||++|||+.|+++
T Consensus       222 ----------------------~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  256 (258)
T smart00219      222 ----------------------RLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVE  256 (258)
T ss_pred             ----------------------CCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence                                  00111226889999999999999999999999985

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=8.7e-38  Score=290.28  Aligned_cols=242  Identities=15%  Similarity=0.303  Sum_probs=192.2

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc--hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEE
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (425)
                      ..++|++.++||+|+||.||++.+ ..+..+++|.+....  .+.+.+|+.+++.+ +|+||+++++++.+   ...+++
T Consensus         4 ~~~~~~~~~~lg~g~~~~vy~~~~-~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~---~~~~~v   78 (260)
T cd05073           4 PRESLKLEKKLGAGQFGEVWMATY-NKHTKVAVKTMKPGSMSVEAFLAEANVMKTL-QHDKLVKLHAVVTK---EPIYII   78 (260)
T ss_pred             cccceeEEeEecCccceEEEEEEe-cCCccEEEEecCCChhHHHHHHHHHHHHHhc-CCCCcceEEEEEcC---CCeEEE
Confidence            367899999999999999999964 456679999887543  46788999999999 89999999999855   567899


Q ss_pred             EEeecCCChhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCc
Q 014406          201 FEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (425)
Q Consensus       201 ~e~~~~~~l~~~~~-----~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~  275 (425)
                      |||+++++|.+++.     .+++..+..++.|++.||.|||+.|++|+||||+||+++.+ +.++|+|||++........
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~-~~~~l~d~~~~~~~~~~~~  157 (260)
T cd05073          79 TEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSAS-LVCKIADFGLARVIEDNEY  157 (260)
T ss_pred             EEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCC-CcEEECCCcceeeccCCCc
Confidence            99999999988873     26788889999999999999999999999999999999988 7999999999876543221


Q ss_pred             c--eeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCC
Q 014406          276 Y--NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE  352 (425)
Q Consensus       276 ~--~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~  352 (425)
                      .  ....++..|+|||++.. ..++.++|+|||||++|++++ |..||. +.+..+....+....               
T Consensus       158 ~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~t~g~~p~~-~~~~~~~~~~~~~~~---------------  220 (260)
T cd05073         158 TAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLMEIVTYGRIPYP-GMSNPEVIRALERGY---------------  220 (260)
T ss_pred             ccccCCcccccccCHhHhcc-CCcCccccchHHHHHHHHHHhcCCCCCC-CCCHHHHHHHHhCCC---------------
Confidence            1  12234567999999876 678999999999999999998 787773 333322222211100               


Q ss_pred             CChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhc
Q 014406          353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  408 (425)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~  408 (425)
                                           ........+.++.+++.+||+.||++||++.++++
T Consensus       221 ---------------------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05073         221 ---------------------RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQS  255 (260)
T ss_pred             ---------------------CCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence                                 00011236789999999999999999999988863

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-40  Score=321.41  Aligned_cols=245  Identities=18%  Similarity=0.339  Sum_probs=207.3

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCC---cEEEEEEecC----cchHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCC
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTN---ERCIIKILKP----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~---~~vavK~~~~----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (425)
                      +.+...+.+.||.|.||.|++|+.+..+   ..||||.++.    ..+.+|..|..||.++ +||||++|.|+...  .+
T Consensus       627 d~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQF-dHPNIIrLEGVVTk--s~  703 (996)
T KOG0196|consen  627 DPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQF-DHPNIIRLEGVVTK--SK  703 (996)
T ss_pred             ChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccC-CCCcEEEEEEEEec--Cc
Confidence            3456788999999999999999987665   4799999984    3567899999999999 99999999999954  47


Q ss_pred             ccEEEEEeecCCChhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEecccccccc
Q 014406          196 TPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (425)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~~----~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~  271 (425)
                      .+++|.|||++|+|+.+++    .|+.-++..+++.|+.||.||-+.++|||||.++|||++.+ -.+|++|||+++.+.
T Consensus       704 PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsn-LvCKVsDFGLSRvle  782 (996)
T KOG0196|consen  704 PVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSN-LVCKVSDFGLSRVLE  782 (996)
T ss_pred             eeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccc-eEEEeccccceeecc
Confidence            8899999999999999984    48889999999999999999999999999999999999999 689999999999875


Q ss_pred             CCC--cceeecc--CCCccCcccccCCCCCCCcccHHHHHHHHHHHH-hCCCCCCCCCCCHHHHHHHHHHhCCchhHHHH
Q 014406          272 PGK--EYNVRVA--SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI-FRKEPFFYGHDNHDQLVKIAKVLGTDELNAYL  346 (425)
Q Consensus       272 ~~~--~~~~~~~--t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ell-tg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~  346 (425)
                      ++.  .+++..|  +..|.|||.+.. .+++.++||||||++|||.+ .|..|| -+.+|.+.+..+.+-++.++     
T Consensus       783 dd~~~~ytt~GGKIPiRWTAPEAIa~-RKFTsASDVWSyGIVmWEVmSyGERPY-WdmSNQdVIkaIe~gyRLPp-----  855 (996)
T KOG0196|consen  783 DDPEAAYTTLGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPY-WDMSNQDVIKAIEQGYRLPP-----  855 (996)
T ss_pred             cCCCccccccCCccceeecChhHhhh-cccCchhhccccceEEEEecccCCCcc-cccchHHHHHHHHhccCCCC-----
Confidence            443  2222223  356999999987 89999999999999999987 488887 56778888887765443322     


Q ss_pred             hhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcC
Q 014406          347 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  409 (425)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~h  409 (425)
                               .                      -.++..+.+|+..||++|-.+||+..|++.+
T Consensus       856 ---------P----------------------mDCP~aL~qLMldCWqkdR~~RP~F~qiV~~  887 (996)
T KOG0196|consen  856 ---------P----------------------MDCPAALYQLMLDCWQKDRNRRPKFAQIVST  887 (996)
T ss_pred             ---------C----------------------CCCcHHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence                     1                      1278999999999999999999999998754

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.8e-38  Score=293.33  Aligned_cols=243  Identities=19%  Similarity=0.325  Sum_probs=192.8

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCc----EEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCC
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNE----RCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHS  194 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~----~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  194 (425)
                      ...+|++.+.||+|+||+||+|.+..++.    .+|+|.+....    ...+.+|+.+++.+ +|+||+++++++..   
T Consensus         5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~---   80 (279)
T cd05057           5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASV-DHPHVVRLLGICLS---   80 (279)
T ss_pred             CHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEec---
Confidence            45788999999999999999999876664    58999887543    35678899999999 99999999999965   


Q ss_pred             CccEEEEEeecCCChhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccc
Q 014406          195 KTPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  270 (425)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~~----~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~  270 (425)
                      ...++|+||+.+++|.+++.    .+++..+..++.|++.||+|||+++++|+||||+||+++.+ +.+||+|||+++..
T Consensus        81 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~-~~~kL~dfg~~~~~  159 (279)
T cd05057          81 SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTP-QHVKITDFGLAKLL  159 (279)
T ss_pred             CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCC-CeEEECCCcccccc
Confidence            56789999999999988763    48899999999999999999999999999999999999987 78999999999866


Q ss_pred             cCCCccee---eccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCCchhHHHH
Q 014406          271 HPGKEYNV---RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYL  346 (425)
Q Consensus       271 ~~~~~~~~---~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~  346 (425)
                      ........   ..++..|+|||.+.+ ..++.++|+|||||++||+++ |..||. +... +.+........        
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~-~~~~-~~~~~~~~~~~--------  228 (279)
T cd05057         160 DVDEKEYHAEGGKVPIKWMALESILH-RIYTHKSDVWSYGVTVWELMTFGAKPYE-GIPA-VEIPDLLEKGE--------  228 (279)
T ss_pred             cCcccceecCCCcccccccCHHHhhc-CCcCchhhHHHHHHHHHHHhcCCCCCCC-CCCH-HHHHHHHhCCC--------
Confidence            53322211   123457999999876 678999999999999999998 888873 2222 22221111000        


Q ss_pred             hhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhc
Q 014406          347 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  408 (425)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~  408 (425)
                                                 ....+...+.++.+++.+||..||++|||+.++++
T Consensus       229 ---------------------------~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~  263 (279)
T cd05057         229 ---------------------------RLPQPPICTIDVYMVLVKCWMIDAESRPTFKELIN  263 (279)
T ss_pred             ---------------------------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence                                       00011225778999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=6.3e-38  Score=302.14  Aligned_cols=245  Identities=18%  Similarity=0.314  Sum_probs=192.2

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCC-------CcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcC
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNT-------NERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQ  192 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~-------~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  192 (425)
                      ..+|++.+.||+|+||.||+|.+...       +..+|+|.++...    .+.+.+|+.+++++.+|+||++++++|.. 
T Consensus        11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-   89 (334)
T cd05100          11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ-   89 (334)
T ss_pred             HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc-
Confidence            45799999999999999999986432       2368999887432    35688999999999779999999999965 


Q ss_pred             CCCccEEEEEeecCCChhhhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEec
Q 014406          193 HSKTPSLIFEYVNSTDFKVLYP-------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMID  253 (425)
Q Consensus       193 ~~~~~~lv~e~~~~~~l~~~~~-------------------~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~  253 (425)
                       ....++++||+++++|..++.                   .+++..+..++.|++.||.|||++|++|+||||+|||++
T Consensus        90 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~  168 (334)
T cd05100          90 -DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVT  168 (334)
T ss_pred             -CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEc
Confidence             367889999999999988763                   266778889999999999999999999999999999999


Q ss_pred             CCCCcEEEEeccccccccCCCcc---eeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHH
Q 014406          254 HELRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQ  329 (425)
Q Consensus       254 ~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~  329 (425)
                      .+ +.+||+|||+++........   ....++..|+|||++.+ ..++.++|||||||++|+|++ |..|| .+.+..+.
T Consensus       169 ~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~-~~~~~~~~  245 (334)
T cd05100         169 ED-NVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGSPY-PGIPVEEL  245 (334)
T ss_pred             CC-CcEEECCcccceecccccccccccCCCcCceEcCHHHhcc-CCcCchhhhHHHHHHHHHHHhcCCCCC-CCCCHHHH
Confidence            88 78999999999765432211   12233457999999977 678999999999999999998 77776 33332222


Q ss_pred             HHHHHHHhCCchhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcC
Q 014406          330 LVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  409 (425)
Q Consensus       330 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~h  409 (425)
                      ...+....                                    .......++.++.+|+.+||+.+|++|||+.|++++
T Consensus       246 ~~~~~~~~------------------------------------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~  289 (334)
T cd05100         246 FKLLKEGH------------------------------------RMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED  289 (334)
T ss_pred             HHHHHcCC------------------------------------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            22111000                                    001112367899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=6.7e-38  Score=289.96  Aligned_cols=237  Identities=15%  Similarity=0.305  Sum_probs=189.8

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEEEe
Q 014406          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEY  203 (425)
Q Consensus       125 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~  203 (425)
                      ++|++.+.||+|+||.||++.  .+++.+|+|.++.. ..+.+.+|+.+++++ +|+|++++++++..   ...+++|||
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~---~~~~~v~e~   79 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDVTAQAFLEETAVMTKL-HHKNLVRLLGVILH---NGLYIVMEL   79 (254)
T ss_pred             HHceeeeeeccCCCCceEecc--cCCCceEEEeecCcchHHHHHHHHHHHHhC-CCCCcCeEEEEEcC---CCcEEEEEC
Confidence            568999999999999999985  47888999998754 446788999999999 99999999999854   346899999


Q ss_pred             ecCCChhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCccee
Q 014406          204 VNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV  278 (425)
Q Consensus       204 ~~~~~l~~~~~-----~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~~~~  278 (425)
                      +.+++|..++.     .+++..+..++.|++.||.|||+.|++|+||||+||+++.+ +.++|+|||++......  ...
T Consensus        80 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~-~~~kl~Dfg~~~~~~~~--~~~  156 (254)
T cd05083          80 MSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSED-GVAKVSDFGLARVGSMG--VDN  156 (254)
T ss_pred             CCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCC-CcEEECCCccceecccc--CCC
Confidence            99999988763     37888899999999999999999999999999999999988 78999999998754322  222


Q ss_pred             eccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCChhh
Q 014406          279 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQL  357 (425)
Q Consensus       279 ~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~  357 (425)
                      ...+..|+|||.+.+ ..++.++|+|||||++|+|++ |+.||. ..+..+....+.+            .  .      
T Consensus       157 ~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~-~~~~~~~~~~~~~------------~--~------  214 (254)
T cd05083         157 SKLPVKWTAPEALKH-KKFSSKSDVWSYGVLLWEVFSYGRAPYP-KMSLKEVKECVEK------------G--Y------  214 (254)
T ss_pred             CCCCceecCHHHhcc-CCcCchhhHHHHHHHHHHHHhCCCCCCc-cCCHHHHHHHHhC------------C--C------
Confidence            334567999999876 678999999999999999997 888873 2222221111100            0  0      


Q ss_pred             HHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhc
Q 014406          358 DALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  408 (425)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~  408 (425)
                                      .......+++++.+|+++||+.+|++|||++++++
T Consensus       215 ----------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  249 (254)
T cd05083         215 ----------------RMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLRE  249 (254)
T ss_pred             ----------------CCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                            00011236889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-37  Score=287.40  Aligned_cols=235  Identities=21%  Similarity=0.382  Sum_probs=186.3

Q ss_pred             eeeeeeCceEEEEEEEcCCCcEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEEEeecC
Q 014406          131 RKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNS  206 (425)
Q Consensus       131 ~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~  206 (425)
                      ++||+|+||.||+|.+.. ++.|++|.+...    ....+.+|+++++++ +|+||+++++++.+.  ...++||||+.+
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~--~~~~~v~e~~~~   76 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQY-DHPNIVKLIGVCVQK--QPIYIVMELVPG   76 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCeEEEEEEEecC--CCeEEEEEcCCC
Confidence            369999999999998877 999999998743    235788999999999 999999999999654  678899999999


Q ss_pred             CChhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCcc---eee
Q 014406          207 TDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY---NVR  279 (425)
Q Consensus       207 ~~l~~~~~----~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~~---~~~  279 (425)
                      ++|..++.    .+++..+..++.+++.||+|||+++++|+||+|+||+++.+ +.++|+|||++.........   ...
T Consensus        77 ~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~-~~~~l~d~g~~~~~~~~~~~~~~~~~  155 (251)
T cd05041          77 GSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGEN-NVLKISDFGMSREEEGGIYTVSDGLK  155 (251)
T ss_pred             CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCC-CcEEEeeccccccccCCcceeccccC
Confidence            99988762    37888899999999999999999999999999999999988 78999999999765422111   112


Q ss_pred             ccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCChhhH
Q 014406          280 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLD  358 (425)
Q Consensus       280 ~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~  358 (425)
                      ..+..|+|||.+.+ ..++.++|+|||||++|+|++ |..|| .+.........+....                     
T Consensus       156 ~~~~~y~~PE~~~~-~~~~~~~Di~slG~i~~~l~t~~~~p~-~~~~~~~~~~~~~~~~---------------------  212 (251)
T cd05041         156 QIPIKWTAPEALNY-GRYTSESDVWSYGILLWETFSLGDTPY-PGMSNQQTRERIESGY---------------------  212 (251)
T ss_pred             cceeccCChHhhcc-CCCCcchhHHHHHHHHHHHHhccCCCC-ccCCHHHHHHHHhcCC---------------------
Confidence            23456999999876 678999999999999999999 67666 3322222111111000                     


Q ss_pred             HHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhc
Q 014406          359 ALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  408 (425)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~  408 (425)
                                     .......++.++.+++.+||+.+|++|||+.|+++
T Consensus       213 ---------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~  247 (251)
T cd05041         213 ---------------RMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYN  247 (251)
T ss_pred             ---------------CCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence                           00011236789999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=1.6e-37  Score=290.88  Aligned_cols=245  Identities=19%  Similarity=0.378  Sum_probs=193.7

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcC-----CCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCC
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVN-----TNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHS  194 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~-----~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  194 (425)
                      .++|++...||+|+||+||+|....     +.+.+++|.+....    .+.+.+|+.+++++ +|+||+++++++.+.  
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~--   80 (275)
T cd05046           4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL-SHKNVVRLLGLCREA--   80 (275)
T ss_pred             hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhc-CCcceeeeEEEECCC--
Confidence            4678999999999999999998653     35679999986533    35688999999999 999999999999553  


Q ss_pred             CccEEEEEeecCCChhhhcC------------CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEE
Q 014406          195 KTPSLIFEYVNSTDFKVLYP------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLI  262 (425)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~~------------~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~  262 (425)
                      ...++||||+++++|..++.            .+++..+..++.|++.||.|||+.+|+|+||||+||+++.+ +.++++
T Consensus        81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~-~~~~l~  159 (275)
T cd05046          81 EPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQ-REVKVS  159 (275)
T ss_pred             CcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCC-CcEEEc
Confidence            67889999999999988762            47899999999999999999999999999999999999988 789999


Q ss_pred             eccccccccCCC--cceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCC
Q 014406          263 DWGLAEFYHPGK--EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGT  339 (425)
Q Consensus       263 Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~lg~  339 (425)
                      |||++.......  ......++..|+|||.+.+ ..++.++||||||+++|+|++ |..||. ...+...+..+..  + 
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~~~~~~p~~-~~~~~~~~~~~~~--~-  234 (275)
T cd05046         160 LLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQE-DDFSTKSDVWSFGVLMWEVFTQGELPFY-GLSDEEVLNRLQA--G-  234 (275)
T ss_pred             ccccccccCcccccccCCceeEEeecChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCcc-ccchHHHHHHHHc--C-
Confidence            999986543221  2223355677999999876 568899999999999999998 677773 2222222221110  0 


Q ss_pred             chhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcC
Q 014406          340 DELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  409 (425)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~h  409 (425)
                                                ...|      .....++..+.+++.+||+.||++|||+.|+++.
T Consensus       235 --------------------------~~~~------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~  272 (275)
T cd05046         235 --------------------------KLEL------PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA  272 (275)
T ss_pred             --------------------------CcCC------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence                                      0000      0112368899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=8.7e-38  Score=297.02  Aligned_cols=244  Identities=18%  Similarity=0.304  Sum_probs=192.0

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCc----EEEEEEecCcch----HHHHHHHHHHHHhcCCCCeeeEEeEEEcCCC
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNE----RCIIKILKPVKK----KKIKREIKILQNLCGGPNVVKLLDIVRDQHS  194 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~----~vavK~~~~~~~----~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  194 (425)
                      ..++|+..+.||+|+||.||+|.+..++.    .+|+|.+.....    ..+.+|+.+++.+ +|+||+++++++...  
T Consensus         5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~~--   81 (303)
T cd05110           5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASM-DHPHLVRLLGVCLSP--   81 (303)
T ss_pred             chhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCcccEEEEEcCC--
Confidence            46778899999999999999999887776    468888875432    3578899999999 999999999998643  


Q ss_pred             CccEEEEEeecCCChhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccc
Q 014406          195 KTPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  270 (425)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~~----~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~  270 (425)
                       ..++++||+++|++.+++.    .+++..+..++.|++.||.|||+++|+|+||||+||+++.+ +.+||+|||+++..
T Consensus        82 -~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~-~~~kL~Dfg~~~~~  159 (303)
T cd05110          82 -TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSP-NHVKITDFGLARLL  159 (303)
T ss_pred             -CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCC-CceEEccccccccc
Confidence             4569999999999887763    47888999999999999999999999999999999999887 78999999999865


Q ss_pred             cCCCc---ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCCchhHHHH
Q 014406          271 HPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYL  346 (425)
Q Consensus       271 ~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~  346 (425)
                      .....   .....++..|+|||.+.+ ..++.++|||||||++|||++ |+.||. +.. ......+.....        
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DiwslG~~l~el~t~g~~p~~-~~~-~~~~~~~~~~~~--------  228 (303)
T cd05110         160 EGDEKEYNADGGKMPIKWMALECIHY-RKFTHQSDVWSYGVTIWELMTFGGKPYD-GIP-TREIPDLLEKGE--------  228 (303)
T ss_pred             cCcccccccCCCccccccCCHHHhcc-CCCChHHHHHHHHHHHHHHHhCCCCCCC-CCC-HHHHHHHHHCCC--------
Confidence            43222   122344668999999876 678999999999999999997 888873 221 222222111000        


Q ss_pred             hhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcC
Q 014406          347 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  409 (425)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~h  409 (425)
                                         .        ......++..+.+++.+||..+|++||+++++++.
T Consensus       229 -------------------~--------~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~  264 (303)
T cd05110         229 -------------------R--------LPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAE  264 (303)
T ss_pred             -------------------C--------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                               0        00011257789999999999999999999998774

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=9.8e-38  Score=292.38  Aligned_cols=233  Identities=15%  Similarity=0.217  Sum_probs=179.6

Q ss_pred             eeeeeCceEEEEEEEcCC------------------------CcEEEEEEecCcc---hHHHHHHHHHHHHhcCCCCeee
Q 014406          132 KVGRGKYSEVFEGINVNT------------------------NERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVK  184 (425)
Q Consensus       132 ~LG~G~fg~V~~~~~~~~------------------------~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~  184 (425)
                      .||+|+||.||+|....+                        ...|++|++....   ...+.+|+.+++.+ +|+||++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l-~h~niv~   80 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQV-SHIHLAF   80 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcC-CCCCeee
Confidence            599999999999974321                        2458899887543   24677889999998 9999999


Q ss_pred             EEeEEEcCCCCccEEEEEeecCCChhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCC----
Q 014406          185 LLDIVRDQHSKTPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEL----  256 (425)
Q Consensus       185 l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~----~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~----  256 (425)
                      +++++.+.  ...++||||+++++|..++.    .+++..+..++.|++.||+|||+++|+||||||+|||++...    
T Consensus        81 ~~~~~~~~--~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~  158 (274)
T cd05076          81 VHGVCVRG--SENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEG  158 (274)
T ss_pred             EEEEEEeC--CceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccC
Confidence            99999654  57789999999999988762    478899999999999999999999999999999999997541    


Q ss_pred             --CcEEEEeccccccccCCCcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHH-hCCCCCCCCCCCHHHHHHH
Q 014406          257 --RKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI-FRKEPFFYGHDNHDQLVKI  333 (425)
Q Consensus       257 --~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ell-tg~~pf~~~~~~~~~~~~~  333 (425)
                        ..++++|||++......   ....++..|+|||.+.+...++.++|||||||++|||+ +|..||.. ....+. ...
T Consensus       159 ~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~-~~~~~~-~~~  233 (274)
T cd05076         159 TSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKE-RTPSEK-ERF  233 (274)
T ss_pred             ccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccc-cChHHH-HHH
Confidence              24899999988643221   22456788999999876567899999999999999985 68887732 222111 111


Q ss_pred             HHHhCCchhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcC
Q 014406          334 AKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  409 (425)
Q Consensus       334 ~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~h  409 (425)
                      ..            . ..                        ......++++.+++.+||+.+|++|||+.+++++
T Consensus       234 ~~------------~-~~------------------------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~  272 (274)
T cd05076         234 YE------------K-KH------------------------RLPEPSCKELATLISQCLTYEPTQRPSFRTILRD  272 (274)
T ss_pred             HH------------h-cc------------------------CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence            00            0 00                        0001135679999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=1.5e-37  Score=286.83  Aligned_cols=234  Identities=21%  Similarity=0.373  Sum_probs=185.4

Q ss_pred             eeeeeCceEEEEEEEcCCCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEEEeecCC
Q 014406          132 KVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST  207 (425)
Q Consensus       132 ~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~  207 (425)
                      .||+|+||.||+|.. .++..+|+|.+....    ...+.+|+.+++.+ +|+||+++++++...  ...++||||++++
T Consensus         2 ~ig~g~~g~vy~~~~-~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~lv~e~~~~~   77 (250)
T cd05085           2 LLGKGNFGEVFKGTL-KDKTPVAVKTCKEDLPQELKIKFLSEARILKQY-DHPNIVKLIGVCTQR--QPIYIVMELVPGG   77 (250)
T ss_pred             ccCCCCCceEEEEEe-cCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhC-CCCCcCeEEEEEecC--CccEEEEECCCCC
Confidence            689999999999975 568899999987543    24578899999999 999999999999654  5788999999999


Q ss_pred             ChhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCcc--eeecc
Q 014406          208 DFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY--NVRVA  281 (425)
Q Consensus       208 ~l~~~~~----~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~  281 (425)
                      +|..++.    .+++..+..++.|++.||.|||++|++|+||||+||+++.+ +.++|+|||++.........  ....+
T Consensus        78 ~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~-~~~~l~d~g~~~~~~~~~~~~~~~~~~  156 (250)
T cd05085          78 DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGEN-NVLKISDFGMSRQEDDGIYSSSGLKQI  156 (250)
T ss_pred             cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCC-CeEEECCCccceeccccccccCCCCCC
Confidence            9988763    37889999999999999999999999999999999999988 78999999998754332211  11233


Q ss_pred             CCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCChhhHHH
Q 014406          282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDAL  360 (425)
Q Consensus       282 t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~  360 (425)
                      +..|+|||++.+ ..++.++||||||+++|++++ |..||. +.........+...            .           
T Consensus       157 ~~~y~aPE~~~~-~~~~~~~Di~slG~ll~~~~~~g~~p~~-~~~~~~~~~~~~~~------------~-----------  211 (250)
T cd05085         157 PIKWTAPEALNY-GRYSSESDVWSYGILLWETFSLGVCPYP-GMTNQQAREQVEKG------------Y-----------  211 (250)
T ss_pred             cccccCHHHhcc-CCCCchhHHHHHHHHHHHHhcCCCCCCC-CCCHHHHHHHHHcC------------C-----------
Confidence            567999999876 678999999999999999998 888873 22222211111100            0           


Q ss_pred             hcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhc
Q 014406          361 VGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  408 (425)
Q Consensus       361 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~  408 (425)
                                   .......++..+.+|+.+||+.+|++|||+.|+++
T Consensus       212 -------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  246 (250)
T cd05085         212 -------------RMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQK  246 (250)
T ss_pred             -------------CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence                         00011236889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-39  Score=301.37  Aligned_cols=258  Identities=24%  Similarity=0.470  Sum_probs=208.5

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEec--Ccch--------HHHHHHHHHHHHhcCCCCeeeEEeEEEcC
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK--PVKK--------KKIKREIKILQNLCGGPNVVKLLDIVRDQ  192 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~--~~~~--------~~~~~E~~~l~~l~~h~niv~l~~~~~~~  192 (425)
                      .+++|-++.+||+|||+.||+|.|....++||+|+-.  +..+        +...+|..|.+.| +||.||++|++|.-+
T Consensus       461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeL-DHpRIVKlYDyfslD  539 (775)
T KOG1151|consen  461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKEL-DHPRIVKLYDYFSLD  539 (775)
T ss_pred             hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhcc-Ccceeeeeeeeeeec
Confidence            4678999999999999999999999999999999964  2222        3456899999999 999999999999854


Q ss_pred             CCCccEEEEEeecCCChhhhcC---CCCHHHHHHHHHHHHHHHHHHHHC--CceeecCCCCceEecCC--CCcEEEEecc
Q 014406          193 HSKTPSLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQ--GIMHRDVKPHNVMIDHE--LRKLRLIDWG  265 (425)
Q Consensus       193 ~~~~~~lv~e~~~~~~l~~~~~---~l~~~~~~~i~~~i~~~L~~LH~~--~ivH~Dlk~~NIll~~~--~~~~kl~Dfg  265 (425)
                      . ..+|-|+||++|.+|+.++.   .+++.+.+.|++||..||.||.+.  .|||-||||.|||+-..  .|.+||.|||
T Consensus       540 t-dsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFG  618 (775)
T KOG1151|consen  540 T-DSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFG  618 (775)
T ss_pred             c-ccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecc
Confidence            3 57899999999999999984   489999999999999999999976  59999999999999653  3579999999


Q ss_pred             ccccccCCCc--------ceeeccCCCccCcccccC---CCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHH
Q 014406          266 LAEFYHPGKE--------YNVRVASRYFKGPELLVD---LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA  334 (425)
Q Consensus       266 ~a~~~~~~~~--------~~~~~~t~~y~aPE~~~~---~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~  334 (425)
                      +++.+.....        +....||.+|.+||.+.-   ..+.+.++||||+||++|.++.|+.||.......+.+..- 
T Consensus       619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeN-  697 (775)
T KOG1151|consen  619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQEN-  697 (775)
T ss_pred             hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhh-
Confidence            9998864322        233578999999999853   2457899999999999999999999995444444444321 


Q ss_pred             HHhCCchhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcc
Q 014406          335 KVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ  414 (425)
Q Consensus       335 ~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~  414 (425)
                      ..         ++.....+                      .....++.++++||++||++.-++|....++..||||..
T Consensus       698 TI---------lkAtEVqF----------------------P~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP  746 (775)
T KOG1151|consen  698 TI---------LKATEVQF----------------------PPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP  746 (775)
T ss_pred             ch---------hcceeccC----------------------CCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence            01         11111111                      112237999999999999999999999999999999975

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.3e-37  Score=288.51  Aligned_cols=232  Identities=17%  Similarity=0.250  Sum_probs=182.4

Q ss_pred             eeeeeeCceEEEEEEEcCCC----------cEEEEEEecCcc--hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccE
Q 014406          131 RKVGRGKYSEVFEGINVNTN----------ERCIIKILKPVK--KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (425)
Q Consensus       131 ~~LG~G~fg~V~~~~~~~~~----------~~vavK~~~~~~--~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (425)
                      +.||+|+||.||+|.+..++          ..+++|++....  ...+.+|+.+++.+ +|+||+++++++..   ...+
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~---~~~~   76 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQL-SHKHLVKLYGVCVR---DENI   76 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcC-CCcchhheeeEEec---CCcE
Confidence            36999999999999988776          358888876443  56788999999999 89999999999865   4568


Q ss_pred             EEEEeecCCChhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCC------cEEEEeccccc
Q 014406          199 LIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELR------KLRLIDWGLAE  268 (425)
Q Consensus       199 lv~e~~~~~~l~~~~~----~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~------~~kl~Dfg~a~  268 (425)
                      +||||+.+++|..++.    .+++..+..++.||+.||.|||++||+|+||||+|||++.+..      .+||+|||++.
T Consensus        77 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~  156 (259)
T cd05037          77 MVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI  156 (259)
T ss_pred             EEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCccc
Confidence            9999999999998863    4788999999999999999999999999999999999997721      69999999997


Q ss_pred             cccCCCcceeeccCCCccCcccccCC-CCCCCcccHHHHHHHHHHHHhC-CCCCCCCCCCHHHHHHHHHHhCCchhHHHH
Q 014406          269 FYHPGKEYNVRVASRYFKGPELLVDL-QDYDYSLDMWSLGCMFAGMIFR-KEPFFYGHDNHDQLVKIAKVLGTDELNAYL  346 (425)
Q Consensus       269 ~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DvwslG~~l~elltg-~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~  346 (425)
                      ....   .....++..|+|||++.+. ..++.++|||||||++|+|++| ..||. ..+..+......   .        
T Consensus       157 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~-~~~~~~~~~~~~---~--------  221 (259)
T cd05037         157 TVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLS-TLSSSEKERFYQ---D--------  221 (259)
T ss_pred             cccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcc-cCCchhHHHHHh---c--------
Confidence            6543   2234567789999998773 3689999999999999999995 55552 222111111000   0        


Q ss_pred             hhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhc
Q 014406          347 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  408 (425)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~  408 (425)
                                       ...          ........+.+++.+||+.+|++|||+.++++
T Consensus       222 -----------------~~~----------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  256 (259)
T cd05037         222 -----------------QHR----------LPMPDCAELANLINQCWTYDPTKRPSFRAILR  256 (259)
T ss_pred             -----------------CCC----------CCCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence                             000          00002368899999999999999999999985

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-39  Score=306.56  Aligned_cols=257  Identities=23%  Similarity=0.410  Sum_probs=221.3

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCcc
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (425)
                      ..+++.+..||-|+||.|=++........+|+|++++.      +.+.+..|-.||... ..|.||++|..|.++  +++
T Consensus       419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~-~s~fIvrLYrTfrd~--kyv  495 (732)
T KOG0614|consen  419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMEC-RSDFIVRLYRTFRDS--KYV  495 (732)
T ss_pred             hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhc-CchHHHHHHHHhccc--hhh
Confidence            45677788899999999999876655556899988743      345677899999998 799999999999764  899


Q ss_pred             EEEEEeecCCChhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCC
Q 014406          198 SLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (425)
Q Consensus       198 ~lv~e~~~~~~l~~~~~---~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~  274 (425)
                      |++||-|-||.+...++   .|.+...+.++..++.|++|||.+|||+|||||+|.++|.+ |-+||.|||+|+.+..+.
T Consensus       496 YmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~-Gy~KLVDFGFAKki~~g~  574 (732)
T KOG0614|consen  496 YMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNR-GYLKLVDFGFAKKIGSGR  574 (732)
T ss_pred             hhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccC-CceEEeehhhHHHhccCC
Confidence            99999999999998874   59999999999999999999999999999999999999998 899999999999999999


Q ss_pred             cceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCC
Q 014406          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD  354 (425)
Q Consensus       275 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~  354 (425)
                      .+.+.+||+.|.|||++++ ..-+.++|.||||+++|||++|..|| .+.+.......|.+-+..-              
T Consensus       575 KTwTFcGTpEYVAPEIILn-KGHD~avDyWaLGIli~ELL~G~pPF-s~~dpmktYn~ILkGid~i--------------  638 (732)
T KOG0614|consen  575 KTWTFCGTPEYVAPEIILN-KGHDRAVDYWALGILIYELLTGSPPF-SGVDPMKTYNLILKGIDKI--------------  638 (732)
T ss_pred             ceeeecCCcccccchhhhc-cCcchhhHHHHHHHHHHHHHcCCCCC-CCCchHHHHHHHHhhhhhh--------------
Confidence            9999999999999999999 77899999999999999999999998 5666666666554422111              


Q ss_pred             hhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcC-----HHHHhcCCCCcccccchhc
Q 014406          355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT-----AREAMAHPYFAQVRAAESS  421 (425)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpt-----a~elL~hp~~~~~~~~~~~  421 (425)
                                           +.+..++..+.+|++++.+.+|.+|..     +.|+-.|.||.+.+|....
T Consensus       639 ---------------------~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr  689 (732)
T KOG0614|consen  639 ---------------------EFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLR  689 (732)
T ss_pred             ---------------------hcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhhh
Confidence                                 112237889999999999999999995     8999999999999987653

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=2.7e-37  Score=292.39  Aligned_cols=254  Identities=16%  Similarity=0.191  Sum_probs=180.6

Q ss_pred             CCCCCEEEEeeeeeeCceEEEEEEEcCC---CcEEEEEEecCcchH--------------HHHHHHHHHHHhcCCCCeee
Q 014406          122 GDQDDYEVVRKVGRGKYSEVFEGINVNT---NERCIIKILKPVKKK--------------KIKREIKILQNLCGGPNVVK  184 (425)
Q Consensus       122 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~---~~~vavK~~~~~~~~--------------~~~~E~~~l~~l~~h~niv~  184 (425)
                      ...++|++.+.||+|+||+||+|.+..+   +..+|+|+.......              ....+...+..+ +|+|+++
T Consensus         9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~-~h~~i~~   87 (294)
T PHA02882          9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNI-DHLGIPK   87 (294)
T ss_pred             cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccC-CCCCCCc
Confidence            3467899999999999999999998877   677788865422210              111223334455 8999999


Q ss_pred             EEeEEEcCCC--CccEEEEEeecCCC--hhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEE
Q 014406          185 LLDIVRDQHS--KTPSLIFEYVNSTD--FKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLR  260 (425)
Q Consensus       185 l~~~~~~~~~--~~~~lv~e~~~~~~--l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~k  260 (425)
                      +++.+.....  ...++++|++....  +.......++..+..++.|++.||+|||+.+|+||||||+|||++.+ +.++
T Consensus        88 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~-~~~~  166 (294)
T PHA02882         88 YYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGN-NRGY  166 (294)
T ss_pred             EEEeeeEecCCceEEEEEEehhccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC-CcEE
Confidence            9987654322  23456777664432  22222346788899999999999999999999999999999999987 7899


Q ss_pred             EEeccccccccCCC--------cceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHH
Q 014406          261 LIDWGLAEFYHPGK--------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVK  332 (425)
Q Consensus       261 l~Dfg~a~~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~  332 (425)
                      |+|||+|+......        ......||+.|+|||+..+ ..++.++|||||||++|||++|..||.....+......
T Consensus       167 l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~-~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~  245 (294)
T PHA02882        167 IIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNG-ACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHA  245 (294)
T ss_pred             EEEcCCceeeccCCcccccccccccccCCCccccCHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHH
Confidence            99999997653221        1223468999999999887 77999999999999999999999998433222222211


Q ss_pred             HHHHhCCchhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhc
Q 014406          333 IAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  408 (425)
Q Consensus       333 ~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~  408 (425)
                      ....     ....+....                         .....+++++.++++.|++.+|++||+..++++
T Consensus       246 ~~~~-----~~~~~~~~~-------------------------~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~  291 (294)
T PHA02882        246 AKCD-----FIKRLHEGK-------------------------IKIKNANKFIYDFIECVTKLSYEEKPDYDALIK  291 (294)
T ss_pred             hHHH-----HHHHhhhhh-------------------------hccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            1100     000000000                         001125788999999999999999999999875

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=2e-37  Score=287.15  Aligned_cols=236  Identities=19%  Similarity=0.300  Sum_probs=187.6

Q ss_pred             eeeeeeCceEEEEEEEcC-CCc--EEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEEEe
Q 014406          131 RKVGRGKYSEVFEGINVN-TNE--RCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEY  203 (425)
Q Consensus       131 ~~LG~G~fg~V~~~~~~~-~~~--~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~  203 (425)
                      +.||+|++|.||+|.+.. +++  .+|+|.+....    .+.+.+|+.+++++ +|+||+++++++.+   ...++++||
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~---~~~~~v~e~   76 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSL-DHENLIRLYGVVLT---HPLMMVTEL   76 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhc-CCCCccceeEEEcC---CeEEEEEEe
Confidence            368999999999998765 333  68999987543    35688999999999 99999999999865   678899999


Q ss_pred             ecCCChhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCc---
Q 014406          204 VNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE---  275 (425)
Q Consensus       204 ~~~~~l~~~~~-----~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~---  275 (425)
                      +++++|..++.     .+++..+..++.|++.||+|||+.|++|+||||+||+++.+ +.+||+|||+++.......   
T Consensus        77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~-~~~kl~dfg~~~~~~~~~~~~~  155 (257)
T cd05040          77 APLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASD-DKVKIGDFGLMRALPQNEDHYV  155 (257)
T ss_pred             cCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecC-CEEEecccccccccccccccee
Confidence            99999988762     47889999999999999999999999999999999999998 7999999999987643221   


Q ss_pred             -ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCC
Q 014406          276 -YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL  353 (425)
Q Consensus       276 -~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~  353 (425)
                       .....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||. ..+..+....+.. .+.              
T Consensus       156 ~~~~~~~~~~y~~pE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~-~~~~~~~~~~~~~-~~~--------------  218 (257)
T cd05040         156 MEEHLKVPFAWCAPESLRT-RTFSHASDVWMFGVTLWEMFTYGEEPWA-GLSGSQILKKIDK-EGE--------------  218 (257)
T ss_pred             cccCCCCCceecCHHHhcc-cCcCchhhhHHHHHHHHHHHhCCCCCCC-CCCHHHHHHHHHh-cCC--------------
Confidence             112345678999999876 678999999999999999998 998873 2222222222211 000              


Q ss_pred             ChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhc
Q 014406          354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  408 (425)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~  408 (425)
                                          .......++..+.+++.+||+.+|++|||+.++++
T Consensus       219 --------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  253 (257)
T cd05040         219 --------------------RLERPEACPQDIYNVMLQCWAHNPADRPTFAALRE  253 (257)
T ss_pred             --------------------cCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence                                00001125789999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=3.7e-37  Score=287.45  Aligned_cols=240  Identities=19%  Similarity=0.284  Sum_probs=180.0

Q ss_pred             eeeeeCceEEEEEEEcC--CCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEEEeec
Q 014406          132 KVGRGKYSEVFEGINVN--TNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVN  205 (425)
Q Consensus       132 ~LG~G~fg~V~~~~~~~--~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~  205 (425)
                      .||+|+||+||+|....  ....+++|.+....    ...+.+|+.+++.+ +|+||+++++.+..  ....++||||++
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l-~h~nii~~~~~~~~--~~~~~lv~e~~~   78 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYREL-NHPNVLQCLGQCIE--SIPYLLVLEFCP   78 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhC-CCCCcceEEEEECC--CCceEEEEEeCC
Confidence            59999999999996433  44578888876432    24578899999998 99999999999954  467899999999


Q ss_pred             CCChhhhcCC--------CCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCc--
Q 014406          206 STDFKVLYPT--------LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE--  275 (425)
Q Consensus       206 ~~~l~~~~~~--------l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~--  275 (425)
                      +++|.+++..        .++..+..++.||+.||+|||+++|+||||||+|||++.+ +.+||+|||++........  
T Consensus        79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~-~~~kl~dfg~~~~~~~~~~~~  157 (269)
T cd05042          79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTAD-LSVKIGDYGLALEQYPEDYYI  157 (269)
T ss_pred             CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCC-CcEEEeccccccccccchhee
Confidence            9999887632        3567788999999999999999999999999999999998 7899999999865433221  


Q ss_pred             -ceeeccCCCccCcccccC------CCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCCchhHHHHh
Q 014406          276 -YNVRVASRYFKGPELLVD------LQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLN  347 (425)
Q Consensus       276 -~~~~~~t~~y~aPE~~~~------~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~  347 (425)
                       .....++..|+|||++..      ...++.++|||||||++|+|++ |..|| ....+.+.+.........        
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~-~~~~~~~~~~~~~~~~~~--------  228 (269)
T cd05042         158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPY-PDLSDEQVLKQVVREQDI--------  228 (269)
T ss_pred             ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCC-CcCCHHHHHHHHhhccCc--------
Confidence             122345667999998742      2457889999999999999999 56665 333333333322211000        


Q ss_pred             hccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhc
Q 014406          348 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  408 (425)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~  408 (425)
                                             ..........+++.+.+++..|+ .||++|||++|+++
T Consensus       229 -----------------------~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~  265 (269)
T cd05042         229 -----------------------KLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE  265 (269)
T ss_pred             -----------------------cCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence                                   00001112236888999999998 59999999999875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-38  Score=303.66  Aligned_cols=240  Identities=20%  Similarity=0.396  Sum_probs=198.6

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCC----CcEEEEEEecC----cchHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCC
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNT----NERCIIKILKP----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~----~~~vavK~~~~----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (425)
                      .+..++.++||.|.||.||+|....-    .-.||||..+.    ++.+.|..|..+|+++ +||||++++|+|.+   .
T Consensus       388 Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnf-dHphIikLIGv~~e---~  463 (974)
T KOG4257|consen  388 RELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNF-DHPHIIKLIGVCVE---Q  463 (974)
T ss_pred             hhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhC-CCcchhheeeeeec---c
Confidence            45566778899999999999996533    23588999875    4567899999999999 99999999999976   5


Q ss_pred             ccEEEEEeecCCChhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEecccccccc
Q 014406          196 TPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (425)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~~----~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~  271 (425)
                      ..++|||.++-|.|..+++    .++...+..++.||+.||+|||+.++|||||..+|||+.+. ..+||+|||+++.+.
T Consensus       464 P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp-~CVKLaDFGLSR~~e  542 (974)
T KOG4257|consen  464 PMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSP-QCVKLADFGLSRYLE  542 (974)
T ss_pred             ceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCc-ceeeecccchhhhcc
Confidence            6889999999999999984    48888899999999999999999999999999999999998 799999999999988


Q ss_pred             CCCcceeecc--CCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhh
Q 014406          272 PGKEYNVRVA--SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK  348 (425)
Q Consensus       272 ~~~~~~~~~~--t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~  348 (425)
                      ....+....+  +.-|||||.+.- ..++.++|||-|||.+||++. |..|| .+..|.+.+..+               
T Consensus       543 d~~yYkaS~~kLPIKWmaPESINf-RrFTtASDVWMFgVCmWEIl~lGvkPf-qgvkNsDVI~~i---------------  605 (974)
T KOG4257|consen  543 DDAYYKASRGKLPIKWMAPESINF-RRFTTASDVWMFGVCMWEILSLGVKPF-QGVKNSDVIGHI---------------  605 (974)
T ss_pred             ccchhhccccccceeecCccccch-hcccchhhHHHHHHHHHHHHHhcCCcc-ccccccceEEEe---------------
Confidence            7766655544  345999999865 889999999999999999885 88888 344443333221               


Q ss_pred             ccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHH
Q 014406          349 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA  406 (425)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~el  406 (425)
                                           +.-.+...+.++++.+..++.+||.+||.+||+..++
T Consensus       606 ---------------------EnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei  642 (974)
T KOG4257|consen  606 ---------------------ENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEI  642 (974)
T ss_pred             ---------------------cCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHH
Confidence                                 1112334455699999999999999999999987665

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=3.6e-37  Score=287.62  Aligned_cols=240  Identities=18%  Similarity=0.251  Sum_probs=180.4

Q ss_pred             eeeeeCceEEEEEEEc--CCCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEEEeec
Q 014406          132 KVGRGKYSEVFEGINV--NTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVN  205 (425)
Q Consensus       132 ~LG~G~fg~V~~~~~~--~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~  205 (425)
                      .||+|+||.||+|...  .++..+|+|.++...    ...+.+|+.+++++ +||||+++++++.+.  ...++||||++
T Consensus         2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~--~~~~lv~e~~~   78 (269)
T cd05087           2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSL-QHSNLLQCLGQCTEV--TPYLLVMEFCP   78 (269)
T ss_pred             cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhC-CCCCEeeEEEEEcCC--CCcEEEEECCC
Confidence            5899999999999754  345679999886432    24678899999999 999999999999654  56789999999


Q ss_pred             CCChhhhcC--------CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCcc-
Q 014406          206 STDFKVLYP--------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY-  276 (425)
Q Consensus       206 ~~~l~~~~~--------~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~~-  276 (425)
                      +++|.+++.        ..++..+..++.|++.||+|||+.+++|+||||+||+++.+ +.++|+|||+++........ 
T Consensus        79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~-~~~kL~dfg~~~~~~~~~~~~  157 (269)
T cd05087          79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTAD-LTVKIGDYGLSHNKYKEDYYV  157 (269)
T ss_pred             CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCC-CcEEECCccccccccCcceee
Confidence            999988763        24566778899999999999999999999999999999987 78999999998754332211 


Q ss_pred             --eeeccCCCccCcccccCC------CCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCCchhHHHHh
Q 014406          277 --NVRVASRYFKGPELLVDL------QDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLN  347 (425)
Q Consensus       277 --~~~~~t~~y~aPE~~~~~------~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~  347 (425)
                        ....++..|+|||++.+.      ..++.++|||||||++|||++ |..||.. .++.+.......  +.        
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~-~~~~~~~~~~~~--~~--------  226 (269)
T cd05087         158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRH-LSDEQVLTYTVR--EQ--------  226 (269)
T ss_pred             cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCC-CChHHHHHHHhh--cc--------
Confidence              223456789999998542      135789999999999999996 9988832 222222211110  00        


Q ss_pred             hccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhc
Q 014406          348 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  408 (425)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~  408 (425)
                        ..                   ...........++.+.+++++|+ .+|++|||++|+++
T Consensus       227 --~~-------------------~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~  265 (269)
T cd05087         227 --QL-------------------KLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL  265 (269)
T ss_pred             --cC-------------------CCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence              00                   00001111225778999999998 68999999999974

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=4.6e-39  Score=329.27  Aligned_cols=253  Identities=27%  Similarity=0.443  Sum_probs=193.0

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeeEEeEEEc--------
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRD--------  191 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~--------  191 (425)
                      .++|+.++.||+||||.||+++++-+|..+|||.+.-.    ...++.+|+..|.+| +|||||+++....+        
T Consensus       478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArL-nHpNVVRYysAWVEs~~~~~~~  556 (1351)
T KOG1035|consen  478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARL-NHPNVVRYYSAWVESTAELTVL  556 (1351)
T ss_pred             hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhc-CCcceeeeehhhhccCCccccc
Confidence            35788999999999999999999999999999998633    345688999999999 99999999742211        


Q ss_pred             --------------------------------------------------------------------CC----------
Q 014406          192 --------------------------------------------------------------------QH----------  193 (425)
Q Consensus       192 --------------------------------------------------------------------~~----------  193 (425)
                                                                                          ++          
T Consensus       557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~  636 (1351)
T KOG1035|consen  557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS  636 (1351)
T ss_pred             cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence                                                                                00          


Q ss_pred             -----------------------C--------CccEEEEEeecCCChhhhcCC--C--CHHHHHHHHHHHHHHHHHHHHC
Q 014406          194 -----------------------S--------KTPSLIFEYVNSTDFKVLYPT--L--TDYDIRYYIYELLKALDYCHSQ  238 (425)
Q Consensus       194 -----------------------~--------~~~~lv~e~~~~~~l~~~~~~--l--~~~~~~~i~~~i~~~L~~LH~~  238 (425)
                                             .        ..+|+-||||+..++.+++..  +  .....+.++++|+.||.|+|++
T Consensus       637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~  716 (1351)
T KOG1035|consen  637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQ  716 (1351)
T ss_pred             CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhC
Confidence                                   0        235677888888888877732  3  2667889999999999999999


Q ss_pred             CceeecCCCCceEecCCCCcEEEEecccccccc-------------------CCCcceeeccCCCccCcccccCCC--CC
Q 014406          239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-------------------PGKEYNVRVASRYFKGPELLVDLQ--DY  297 (425)
Q Consensus       239 ~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~-------------------~~~~~~~~~~t~~y~aPE~~~~~~--~~  297 (425)
                      |||||||||.||++|++ +.|||+|||+|+...                   .....+..+||..|+|||++.+..  .|
T Consensus       717 giIHRDLKP~NIFLd~~-~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Y  795 (1351)
T KOG1035|consen  717 GIIHRDLKPRNIFLDSR-NSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKY  795 (1351)
T ss_pred             ceeeccCCcceeEEcCC-CCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccc
Confidence            99999999999999988 799999999997621                   112345678999999999998865  69


Q ss_pred             CCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCChhhHHHhcccCCCCccccccccC
Q 014406          298 DYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADN  377 (425)
Q Consensus       298 ~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  377 (425)
                      +.|+||||+|++++||+.   ||.........+.    .|..+.+         +.+.               .+...  
T Consensus       796 n~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~----~LR~g~i---------P~~~---------------~f~~~--  842 (1351)
T KOG1035|consen  796 NSKIDMYSLGIVLFEMLY---PFGTSMERASILT----NLRKGSI---------PEPA---------------DFFDP--  842 (1351)
T ss_pred             cchhhhHHHHHHHHHHhc---cCCchHHHHHHHH----hcccCCC---------CCCc---------------ccccc--
Confidence            999999999999999984   6633222222222    2221111         1110               00000  


Q ss_pred             CCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcc
Q 014406          378 QHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ  414 (425)
Q Consensus       378 ~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~  414 (425)
                         --+.-..+|+.||+.||.+||||.|||++.||-.
T Consensus       843 ---~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~llpp  876 (1351)
T KOG1035|consen  843 ---EHPEEASLIRWLLSHDPSKRPTATELLNSELLPP  876 (1351)
T ss_pred             ---cchHHHHHHHHHhcCCCccCCCHHHHhhccCCCc
Confidence               1234578999999999999999999999999974

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=2e-38  Score=309.90  Aligned_cols=201  Identities=26%  Similarity=0.468  Sum_probs=178.7

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecC----cchHHHHHHHHHHHHhcCCCCeeeEEeEEEcCC----CCc
Q 014406          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQH----SKT  196 (425)
Q Consensus       125 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~----~~~  196 (425)
                      -.+...+.||+|+||.||+|+++.+|+.||||.+++    ...+..-+|+++|+++ +|+|||++.++-.+..    ...
T Consensus        13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKL-nh~NIVk~f~iee~~~~~~~~~~   91 (732)
T KOG4250|consen   13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKL-NHPNIVKLFDIEETKFLGLVTRL   91 (732)
T ss_pred             cceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHc-CchhhhhhcccCCccccCccccc
Confidence            345566789999999999999999999999999875    3457788999999999 8999999999877665    567


Q ss_pred             cEEEEEeecCCChhhhcC------CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCC---CCcEEEEecccc
Q 014406          197 PSLIFEYVNSTDFKVLYP------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE---LRKLRLIDWGLA  267 (425)
Q Consensus       197 ~~lv~e~~~~~~l~~~~~------~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~---~~~~kl~Dfg~a  267 (425)
                      ..+|||||.+|+|...+.      .+++.++..++.++..||.|||++|||||||||.||++-..   ...-||+|||.|
T Consensus        92 ~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A  171 (732)
T KOG4250|consen   92 PVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA  171 (732)
T ss_pred             ceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence            889999999999999984      39999999999999999999999999999999999998433   124699999999


Q ss_pred             ccccCCCcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCC
Q 014406          268 EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN  326 (425)
Q Consensus       268 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~  326 (425)
                      +..+++......+||..|.+||++.....|+..+|.|||||++|++.||..||.+...+
T Consensus       172 rel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p  230 (732)
T KOG4250|consen  172 RELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP  230 (732)
T ss_pred             ccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence            99998888899999999999999986578999999999999999999999999654443

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=2.1e-37  Score=289.04  Aligned_cols=244  Identities=21%  Similarity=0.406  Sum_probs=193.2

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcC-CCcEEEEEEecCc-------------chHHHHHHHHHHHHhcCCCCeeeEEeEEEc
Q 014406          126 DYEVVRKVGRGKYSEVFEGINVN-TNERCIIKILKPV-------------KKKKIKREIKILQNLCGGPNVVKLLDIVRD  191 (425)
Q Consensus       126 ~y~~~~~LG~G~fg~V~~~~~~~-~~~~vavK~~~~~-------------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~  191 (425)
                      +|++.+.||+|+||.||+|.+.. +++.+|+|.+...             ...++.+|+.++.+..+|+||+++++++.+
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47778899999999999999887 6889999987521             123466788888764499999999999965


Q ss_pred             CCCCccEEEEEeecCCChhhhc-------CCCCHHHHHHHHHHHHHHHHHHHH-CCceeecCCCCceEecCCCCcEEEEe
Q 014406          192 QHSKTPSLIFEYVNSTDFKVLY-------PTLTDYDIRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHELRKLRLID  263 (425)
Q Consensus       192 ~~~~~~~lv~e~~~~~~l~~~~-------~~l~~~~~~~i~~~i~~~L~~LH~-~~ivH~Dlk~~NIll~~~~~~~kl~D  263 (425)
                        ....+++|||+.+++|.+++       ..+++..++.++.|++.||.|||+ .+++|+||+|+||+++.+ +.++|+|
T Consensus        81 --~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~-~~~~l~d  157 (269)
T cd08528          81 --NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGED-DKVTITD  157 (269)
T ss_pred             --CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCC-CcEEEec
Confidence              46889999999999987765       247889999999999999999996 689999999999999988 7899999


Q ss_pred             ccccccccCCCcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhH
Q 014406          264 WGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELN  343 (425)
Q Consensus       264 fg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~  343 (425)
                      ||++.............++..|++||.+.+ ..++.++||||||+++|+|++|+.||... +.......+.....     
T Consensus       158 fg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Dv~slG~ll~~l~~g~~p~~~~-~~~~~~~~~~~~~~-----  230 (269)
T cd08528         158 FGLAKQKQPESKLTSVVGTILYSCPEIVKN-EPYGEKADVWAFGCILYQMCTLQPPFYST-NMLSLATKIVEAVY-----  230 (269)
T ss_pred             ccceeecccccccccccCcccCcChhhhcC-CCCchHHHHHHHHHHHHHHHhCCCccccc-CHHHHHHHHhhccC-----
Confidence            999987654444445678889999999987 67899999999999999999999998422 11111111111000     


Q ss_pred             HHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcC
Q 014406          344 AYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  409 (425)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~h  409 (425)
                                                    .......+++++.+|+++||+.||++|||+.|+..+
T Consensus       231 ------------------------------~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~  266 (269)
T cd08528         231 ------------------------------EPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM  266 (269)
T ss_pred             ------------------------------CcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence                                          000111367899999999999999999999998653

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-38  Score=302.92  Aligned_cols=242  Identities=19%  Similarity=0.381  Sum_probs=200.5

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc--hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEE
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (425)
                      ..+.....+||.|.||.||.|.+++-...||||.++.+.  .++|..|..+|+.+ .|||+|+|+|+|..  .-.+|+|.
T Consensus       266 RtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKei-kHpNLVqLLGVCT~--EpPFYIiT  342 (1157)
T KOG4278|consen  266 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTH--EPPFYIIT  342 (1157)
T ss_pred             chheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhh-cCccHHHHhhhhcc--CCCeEEEE
Confidence            456778899999999999999999999999999998654  57899999999999 99999999999954  46788999


Q ss_pred             EeecCCChhhhcCC-----CCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCcc
Q 014406          202 EYVNSTDFKVLYPT-----LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY  276 (425)
Q Consensus       202 e~~~~~~l~~~~~~-----l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~~  276 (425)
                      |||..|+|-+|++.     ++.-.+.+++.||..||+||..+++|||||.++|+|+.++ ..+|++|||+++.+. ++.+
T Consensus       343 EfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEn-hiVKvADFGLsRlMt-gDTY  420 (1157)
T KOG4278|consen  343 EFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGEN-HIVKVADFGLSRLMT-GDTY  420 (1157)
T ss_pred             ecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhcccccc-ceEEeeccchhhhhc-CCce
Confidence            99999999999854     5556678899999999999999999999999999999998 799999999999876 3444


Q ss_pred             eeecc---CCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCC
Q 014406          277 NVRVA---SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL  353 (425)
Q Consensus       277 ~~~~~---t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~  353 (425)
                      +...|   ...|.|||.+.. ..++.++|||+|||+|||+.|-..-.+++.+-......+.+            .+    
T Consensus       421 TAHAGAKFPIKWTAPEsLAy-NtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEk------------gy----  483 (1157)
T KOG4278|consen  421 TAHAGAKFPIKWTAPESLAY-NTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEK------------GY----  483 (1157)
T ss_pred             ecccCccCcccccCcccccc-cccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhc------------cc----
Confidence            44444   455999999876 78999999999999999999855444466654433332211            11    


Q ss_pred             ChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHh
Q 014406          354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM  407 (425)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL  407 (425)
                                          +.+-+.-|++...+|++.||+|+|.+||+.+|+-
T Consensus       484 --------------------RM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiH  517 (1157)
T KOG4278|consen  484 --------------------RMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIH  517 (1157)
T ss_pred             --------------------cccCCCCCCHHHHHHHHHHhcCCcccCccHHHHH
Confidence                                1222334899999999999999999999988764

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=1.1e-37  Score=290.82  Aligned_cols=235  Identities=21%  Similarity=0.365  Sum_probs=185.4

Q ss_pred             eeeeeCceEEEEEEEcCCC------cEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEE
Q 014406          132 KVGRGKYSEVFEGINVNTN------ERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (425)
Q Consensus       132 ~LG~G~fg~V~~~~~~~~~------~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (425)
                      .||+|+||.||+|.+....      ..+|+|.+...    ....+.+|+.+++.+ +||||+++++++.+.  ...++||
T Consensus         2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~~v~   78 (269)
T cd05044           2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNF-NHPNIVKLLGVCLLN--EPQYIIM   78 (269)
T ss_pred             ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhc-CCCCeeeEeeeecCC--CCeEEEE
Confidence            5899999999999876433      68999987643    345788999999999 999999999999654  5688999


Q ss_pred             EeecCCChhhhcC----------CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCC-----cEEEEeccc
Q 014406          202 EYVNSTDFKVLYP----------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELR-----KLRLIDWGL  266 (425)
Q Consensus       202 e~~~~~~l~~~~~----------~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~-----~~kl~Dfg~  266 (425)
                      ||+++++|..++.          .+++.++..++.|++.||.|||+.+++|+||||+||+++.+ +     .++++|||+
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~-~~~~~~~~~l~dfg~  157 (269)
T cd05044          79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEK-GYDADRVVKIGDFGL  157 (269)
T ss_pred             eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecC-CCCCCcceEECCccc
Confidence            9999999988762          26788899999999999999999999999999999999986 4     799999999


Q ss_pred             cccccCCCcc---eeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCCchh
Q 014406          267 AEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDEL  342 (425)
Q Consensus       267 a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~lg~~~~  342 (425)
                      ++........   ....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||. ..++.+....+.. -+    
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~ellt~g~~p~~-~~~~~~~~~~~~~-~~----  230 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLD-GKFTTQSDVWSFGVLMWEILTLGQQPYP-ALNNQEVLQHVTA-GG----  230 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHcc-CCcccchhHHHHHHHHHHHHHcCCCCCc-ccCHHHHHHHHhc-CC----
Confidence            8765432211   12344678999999977 678999999999999999998 888873 3232222221110 00    


Q ss_pred             HHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhc
Q 014406          343 NAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  408 (425)
Q Consensus       343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~  408 (425)
                                                     .......+++.+.+|+.+||+.+|++|||+.++++
T Consensus       231 -------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  265 (269)
T cd05044         231 -------------------------------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE  265 (269)
T ss_pred             -------------------------------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence                                           00011226788999999999999999999999864

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-38  Score=293.59  Aligned_cols=263  Identities=21%  Similarity=0.286  Sum_probs=196.1

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcchHHHHHHHHHHHHh-cCCCCeeeEEeEEEcCC--CCccEEE
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNL-CGGPNVVKLLDIVRDQH--SKTPSLI  200 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l-~~h~niv~l~~~~~~~~--~~~~~lv  200 (425)
                      ....++++.||+|.||.||+|+.  +++.||||++....++.|.+|-.|+... ..|+||+++++.-+...  ...++||
T Consensus       209 l~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLV  286 (534)
T KOG3653|consen  209 LDPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLV  286 (534)
T ss_pred             CCchhhHHHhhcCccceeehhhc--cCceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEE
Confidence            45566778999999999999955  5699999999999999999999998844 28999999999876432  3468899


Q ss_pred             EEeecCCChhhhcC--CCCHHHHHHHHHHHHHHHHHHHHC---------CceeecCCCCceEecCCCCcEEEEecccccc
Q 014406          201 FEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQ---------GIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (425)
Q Consensus       201 ~e~~~~~~l~~~~~--~l~~~~~~~i~~~i~~~L~~LH~~---------~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~  269 (425)
                      +||.+.|+|.+++.  ..+|.+..+++..+++||+|||+.         .|+|||||++|||+..| .++.|+|||+|..
T Consensus       287 t~fh~kGsL~dyL~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~D-lTccIaDFGLAl~  365 (534)
T KOG3653|consen  287 TEFHPKGSLCDYLKANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKND-LTCCIADFGLALR  365 (534)
T ss_pred             eeeccCCcHHHHHHhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccC-CcEEeeccceeEE
Confidence            99999999999984  599999999999999999999963         59999999999999999 7899999999987


Q ss_pred             ccCCC---cceeeccCCCccCcccccCCCCCC-----CcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCc-
Q 014406          270 YHPGK---EYNVRVASRYFKGPELLVDLQDYD-----YSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTD-  340 (425)
Q Consensus       270 ~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~-----~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~-  340 (425)
                      +.+..   .....+||..|||||++.+...+.     .+.||||+|.+||||++...-++.+...+-++ -....+|.. 
T Consensus       366 ~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yql-pfe~evG~hP  444 (534)
T KOG3653|consen  366 LEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQL-PFEAEVGNHP  444 (534)
T ss_pred             ecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccC-chhHHhcCCC
Confidence            76543   333479999999999998755544     46999999999999999876554332222222 122233321 


Q ss_pred             hhHHHHhhccCCCChhhHHHhcccC-CCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHH
Q 014406          341 ELNAYLNKYHLELDPQLDALVGRHS-RKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTARE  405 (425)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~e  405 (425)
                      .+..            +....-... |..+....   ..+.--.-+++.+..||..||+.|.||.=
T Consensus       445 t~e~------------mq~~VV~kK~RP~~p~~W---~~h~~~~~l~et~EeCWDhDaeARLTA~C  495 (534)
T KOG3653|consen  445 TLEE------------MQELVVRKKQRPKIPDAW---RKHAGMAVLCETIEECWDHDAEARLTAGC  495 (534)
T ss_pred             CHHH------------HHHHHHhhccCCCChhhh---hcCccHHHHHHHHHHHcCCchhhhhhhHH
Confidence            1111            111111111 11111111   11123456889999999999999999853

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-37  Score=308.26  Aligned_cols=257  Identities=25%  Similarity=0.448  Sum_probs=211.6

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc--chHHHHHHHHHHHHhcCCCCeeeEEeEEEc---CCCCcc
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRD---QHSKTP  197 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~---~~~~~~  197 (425)
                      ..+.|++.+.||.|.+|.||+++.+.+++.+|+|+....  ..++++.|.+|++.+++|||++.++|+|..   ..+..+
T Consensus        17 p~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqL   96 (953)
T KOG0587|consen   17 PADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQL   96 (953)
T ss_pred             CCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeE
Confidence            467799999999999999999999999999999998754  457889999999999999999999998863   245679


Q ss_pred             EEEEEeecCCChhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccC
Q 014406          198 SLIFEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (425)
Q Consensus       198 ~lv~e~~~~~~l~~~~~-----~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~  272 (425)
                      |||||||.+|+..++..     .+.|..+..|++.++.||.+||++.++|||||-.|||++.+ +.||++|||.+.....
T Consensus        97 WLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e-~~VKLvDFGvSaQlds  175 (953)
T KOG0587|consen   97 WLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTEN-AEVKLVDFGVSAQLDS  175 (953)
T ss_pred             EEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEecc-CcEEEeeeeeeeeeec
Confidence            99999999999988873     48889999999999999999999999999999999999999 8999999999876543


Q ss_pred             C-CcceeeccCCCccCcccccCCC----CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHh
Q 014406          273 G-KEYNVRVASRYFKGPELLVDLQ----DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLN  347 (425)
Q Consensus       273 ~-~~~~~~~~t~~y~aPE~~~~~~----~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~  347 (425)
                      . ...++.+||++|||||++....    .|+..+|+||||++..||-.|..|+...   +...+. +.            
T Consensus       176 T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~Dm---HPmraL-F~------------  239 (953)
T KOG0587|consen  176 TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDM---HPMRAL-FL------------  239 (953)
T ss_pred             ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCc---chhhhh-cc------------
Confidence            2 4456789999999999996533    4778999999999999999999998322   111111 11            


Q ss_pred             hccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCccc
Q 014406          348 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV  415 (425)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~  415 (425)
                                      ..+.+...+..   +...++++.+||..||.+|-++||+..++|+|||+.+.
T Consensus       240 ----------------IpRNPPPkLkr---p~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~  288 (953)
T KOG0587|consen  240 ----------------IPRNPPPKLKR---PKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQ  288 (953)
T ss_pred             ----------------CCCCCCccccc---hhhHHHHHHHHHHHHHhhccccCcchhhhccCCccccc
Confidence                            11111111111   12258899999999999999999999999999999844

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1.4e-37  Score=339.45  Aligned_cols=253  Identities=19%  Similarity=0.287  Sum_probs=188.9

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcchHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEEEeec
Q 014406          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVN  205 (425)
Q Consensus       126 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~  205 (425)
                      .|...+.||+|+||.||+|.+..++..||||.++.... ....|+++++++ +||||++++++|.+.  ...++||||++
T Consensus       691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~l~~l-~HpnIv~~~~~~~~~--~~~~lv~Ey~~  766 (968)
T PLN00113        691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-IPSSEIADMGKL-QHPNIVKLIGLCRSE--KGAYLIHEYIE  766 (968)
T ss_pred             hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-ccHHHHHHHhhC-CCCCcceEEEEEEcC--CCCEEEEeCCC
Confidence            45566789999999999999989999999999874332 234678999999 999999999999764  56789999999


Q ss_pred             CCChhhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCceeecCCCCceEecCCCCcEEEEeccccccccCCCcceeeccC
Q 014406          206 STDFKVLYPTLTDYDIRYYIYELLKALDYCH---SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVAS  282 (425)
Q Consensus       206 ~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH---~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t  282 (425)
                      +++|.+++..+++..+..++.|++.||+|||   +.+|+||||||+||+++.+ +..++. ||.......   .....++
T Consensus       767 ~g~L~~~l~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~-~~~~~~-~~~~~~~~~---~~~~~~t  841 (968)
T PLN00113        767 GKNLSEVLRNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGK-DEPHLR-LSLPGLLCT---DTKCFIS  841 (968)
T ss_pred             CCcHHHHHhcCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCC-CceEEE-ecccccccc---CCCcccc
Confidence            9999999999999999999999999999999   6699999999999999987 565654 665543321   1223678


Q ss_pred             CCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh-CCchhHHHHhhccCCCChhhHHHh
Q 014406          283 RYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL-GTDELNAYLNKYHLELDPQLDALV  361 (425)
Q Consensus       283 ~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~l-g~~~~~~~~~~~~~~~~~~~~~~~  361 (425)
                      ..|+|||++.+ ..++.++|||||||++|||++|+.||.........+....+.. .......+               .
T Consensus       842 ~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------~  905 (968)
T PLN00113        842 SAYVAPETRET-KDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMW---------------I  905 (968)
T ss_pred             ccccCcccccC-CCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhhe---------------e
Confidence            89999999877 7799999999999999999999999854333222222221110 00000000               0


Q ss_pred             cccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcC
Q 014406          362 GRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  409 (425)
Q Consensus       362 ~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~h  409 (425)
                      .......      .........++.+++.+||+.||++|||++|+++.
T Consensus       906 ~~~~~~~------~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  947 (968)
T PLN00113        906 DPSIRGD------VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT  947 (968)
T ss_pred             CccccCC------CCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence            0000000      00000112457789999999999999999999875

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-37  Score=279.78  Aligned_cols=257  Identities=26%  Similarity=0.479  Sum_probs=213.5

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCcc
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (425)
                      .++|.+++.||+|+|..|..++..++.+.+|+|++++.      ..+=.+.|-.+..+..+||.+|-+..+|..  ...+
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqt--esrl  326 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQT--ESRL  326 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcc--cceE
Confidence            57899999999999999999999999999999998743      223356788888888899999999999954  4788


Q ss_pred             EEEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEecccccc-ccCC
Q 014406          198 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF-YHPG  273 (425)
Q Consensus       198 ~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~-~~~~  273 (425)
                      +.|.||++||+|....   ++++++..+.+..+|+.||.|||++|||+||||.+|+|+|.+ +.+||.|+|+++. +.++
T Consensus       327 ffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldae-ghikltdygmcke~l~~g  405 (593)
T KOG0695|consen  327 FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAE-GHIKLTDYGMCKEGLGPG  405 (593)
T ss_pred             EEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccC-CceeecccchhhcCCCCC
Confidence            9999999999997665   469999999999999999999999999999999999999999 8999999999875 3556


Q ss_pred             CcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCC-CCCCH-----HHHHHHHHHhCCchhHHHHh
Q 014406          274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY-GHDNH-----DQLVKIAKVLGTDELNAYLN  347 (425)
Q Consensus       274 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~-~~~~~-----~~~~~~~~~lg~~~~~~~~~  347 (425)
                      +.+++.+||+.|.|||++.+ ..|.+++|.|++||+++||+.|+.||.- +.++.     +.+-.++             
T Consensus       406 d~tstfcgtpnyiapeilrg-eeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvi-------------  471 (593)
T KOG0695|consen  406 DTTSTFCGTPNYIAPEILRG-EEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVI-------------  471 (593)
T ss_pred             cccccccCCCcccchhhhcc-cccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHH-------------
Confidence            77788999999999999988 7899999999999999999999999931 22222     2121110             


Q ss_pred             hccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCc------CHHHHhcCCCCcccccchh
Q 014406          348 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL------TAREAMAHPYFAQVRAAES  420 (425)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rp------ta~elL~hp~~~~~~~~~~  420 (425)
                                   .....+          .+..+|-.+..+++..|++||.+|.      ..+++-.|+||+.+.|...
T Consensus       472 -------------lekqir----------iprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~l  527 (593)
T KOG0695|consen  472 -------------LEKQIR----------IPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLL  527 (593)
T ss_pred             -------------hhhccc----------ccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHH
Confidence                         000011          1223566778899999999999998      4689999999999998654

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=1.7e-36  Score=283.01  Aligned_cols=241  Identities=16%  Similarity=0.241  Sum_probs=178.6

Q ss_pred             eeeeeCceEEEEEEEcCC--CcEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEEEeec
Q 014406          132 KVGRGKYSEVFEGINVNT--NERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVN  205 (425)
Q Consensus       132 ~LG~G~fg~V~~~~~~~~--~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~  205 (425)
                      +||+|+||+||+|....+  ...+++|.++..    ..+.+.+|+.+++.+ +||||+++++.|.+.  ...++||||++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~~~--~~~~lv~e~~~   78 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRIL-QHPNILQCLGQCVEA--IPYLLVFEYCE   78 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhcc-CCcchhheEEEecCC--CccEEEEecCC
Confidence            599999999999975433  345677776643    235788999999999 999999999999654  67899999999


Q ss_pred             CCChhhhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCC---c
Q 014406          206 STDFKVLYP-------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK---E  275 (425)
Q Consensus       206 ~~~l~~~~~-------~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~---~  275 (425)
                      +++|..++.       ..++..+..++.||+.||+|||+.+++|+||||+|||++.+ +.++|+|||++.......   .
T Consensus        79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~-~~~~l~Dfg~~~~~~~~~~~~~  157 (268)
T cd05086          79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSD-LTVKVGDYGIGPSRYKEDYIET  157 (268)
T ss_pred             CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCC-ccEEecccccccccCcchhhhc
Confidence            999988763       24566778899999999999999999999999999999988 789999999986432211   1


Q ss_pred             ceeeccCCCccCcccccCC------CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhc
Q 014406          276 YNVRVASRYFKGPELLVDL------QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY  349 (425)
Q Consensus       276 ~~~~~~t~~y~aPE~~~~~------~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~  349 (425)
                      .....++..|+|||++...      ..++.++|||||||++|||+++..+++...++.+.+..+...-.           
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~-----------  226 (268)
T cd05086         158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQ-----------  226 (268)
T ss_pred             ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcc-----------
Confidence            1234677889999997431      24578999999999999999765443344444333333211000           


Q ss_pred             cCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhc
Q 014406          350 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  408 (425)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~  408 (425)
                       .                   ..........+++.+.+++..|| .+|++|||++++++
T Consensus       227 -~-------------------~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~  264 (268)
T cd05086         227 -V-------------------KLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHR  264 (268)
T ss_pred             -c-------------------ccCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence             0                   00001111226788999999999 68999999999964

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=6.8e-37  Score=286.12  Aligned_cols=243  Identities=18%  Similarity=0.332  Sum_probs=187.1

Q ss_pred             EEEEeeeeeeCceEEEEEEEc---CCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCC----
Q 014406          127 YEVVRKVGRGKYSEVFEGINV---NTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS----  194 (425)
Q Consensus       127 y~~~~~LG~G~fg~V~~~~~~---~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~----  194 (425)
                      |.+.+.||+|+||+||+|.+.   .++..+|||++...     ..+++.+|+.+++.+ +||||+++++++.....    
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~   79 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEF-DHPNVIKLIGVSLRSRAKGRL   79 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcC-CCCCcceEEEEEccCCCCCcc
Confidence            456778999999999999854   35789999998643     234678899999999 89999999998865322    


Q ss_pred             CccEEEEEeecCCChhhhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEecc
Q 014406          195 KTPSLIFEYVNSTDFKVLY---------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWG  265 (425)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~---------~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg  265 (425)
                      ...++++||+.++++..++         ..+++..+..++.|++.||+|||+.||+|+||||+||+++.+ +.+||+|||
T Consensus        80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~-~~~kl~dfg  158 (273)
T cd05074          80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNEN-MTVCVADFG  158 (273)
T ss_pred             cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCC-CCEEECccc
Confidence            1347889999999987654         136888899999999999999999999999999999999987 789999999


Q ss_pred             ccccccCCCc---ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCCch
Q 014406          266 LAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDE  341 (425)
Q Consensus       266 ~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~lg~~~  341 (425)
                      +++.......   .....++..|++||.+.+ ..++.++|||||||++|+|++ |..|| .+.+..+....+..   ...
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~sDi~slG~il~el~~~g~~p~-~~~~~~~~~~~~~~---~~~  233 (273)
T cd05074         159 LSKKIYSGDYYRQGCASKLPVKWLALESLAD-NVYTTHSDVWAFGVTMWEIMTRGQTPY-AGVENSEIYNYLIK---GNR  233 (273)
T ss_pred             ccccccCCcceecCCCccCchhhcCHhHHhc-CccchhhhhHHHHHHHHHHhhCCCCCC-CCCCHHHHHHHHHc---CCc
Confidence            9986543221   122344567999999876 678999999999999999999 66666 33332222111110   000


Q ss_pred             hHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcC
Q 014406          342 LNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  409 (425)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~h  409 (425)
                                                       ......+++.+.+++.+||+.+|++|||+.++++.
T Consensus       234 ---------------------------------~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~  268 (273)
T cd05074         234 ---------------------------------LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ  268 (273)
T ss_pred             ---------------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                             00011257899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-39  Score=283.39  Aligned_cols=258  Identities=20%  Similarity=0.350  Sum_probs=203.1

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEE
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (425)
                      .++.+.+..||.|+||+|+|-.++.+|+..|||.+...    ..+++..|.+...+-.+.||||+++|.+-.+  +.-|+
T Consensus        63 ~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~E--GdcWi  140 (361)
T KOG1006|consen   63 SDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSE--GDCWI  140 (361)
T ss_pred             cchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcC--Cceee
Confidence            34556677899999999999999999999999998632    3456888888877766899999999987554  44568


Q ss_pred             EEEeecCCChhhhc--------CCCCHHHHHHHHHHHHHHHHHHHH-CCceeecCCCCceEecCCCCcEEEEeccccccc
Q 014406          200 IFEYVNSTDFKVLY--------PTLTDYDIRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  270 (425)
Q Consensus       200 v~e~~~~~~l~~~~--------~~l~~~~~~~i~~~i~~~L~~LH~-~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~  270 (425)
                      -||.|.-. ++.+.        ..+++..+-.|......||+||-+ ..|||||+||+|||+|.. |.+||||||.+-..
T Consensus       141 CMELMd~S-lDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~-G~vKLCDFGIcGqL  218 (361)
T KOG1006|consen  141 CMELMDIS-LDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRH-GDVKLCDFGICGQL  218 (361)
T ss_pred             eHHHHhhh-HHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecC-CCEeeecccchHhH
Confidence            89998754 33322        358888888888999999999986 589999999999999998 89999999999776


Q ss_pred             cCCCcceeeccCCCccCcccccCCCC-CCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhc
Q 014406          271 HPGKEYNVRVASRYFKGPELLVDLQD-YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY  349 (425)
Q Consensus       271 ~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~  349 (425)
                      ..+-..+...|-..|||||-+..... |+.++||||||++|+|+.||..|+..-.+-.+|+..+.  .|.++..      
T Consensus       219 v~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv--~gdpp~l------  290 (361)
T KOG1006|consen  219 VDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVV--IGDPPIL------  290 (361)
T ss_pred             HHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHH--cCCCCee------
Confidence            65555566788899999999976544 99999999999999999999999843333333433332  2222211      


Q ss_pred             cCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccc
Q 014406          350 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR  416 (425)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~  416 (425)
                                             ......-.++..++.|+.-||.+|-+.||...+++.+||++.-.
T Consensus       291 -----------------------~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~  334 (361)
T KOG1006|consen  291 -----------------------LFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYA  334 (361)
T ss_pred             -----------------------cCcccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhh
Confidence                                   11111123788999999999999999999999999999987543

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=2.2e-36  Score=300.63  Aligned_cols=265  Identities=19%  Similarity=0.327  Sum_probs=183.0

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEc----------------CCCcEEEEEEecCcch---H--------------HHHHH
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINV----------------NTNERCIIKILKPVKK---K--------------KIKRE  169 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~----------------~~~~~vavK~~~~~~~---~--------------~~~~E  169 (425)
                      ..++|++.++||+|+||+||+|.+.                ..++.||||.++....   +              ....|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            4678999999999999999999752                2346799999864321   1              23346


Q ss_pred             HHHHHHhcCCCC-----eeeEEeEEEcC------CCCccEEEEEeecCCChhhhcC------------------------
Q 014406          170 IKILQNLCGGPN-----VVKLLDIVRDQ------HSKTPSLIFEYVNSTDFKVLYP------------------------  214 (425)
Q Consensus       170 ~~~l~~l~~h~n-----iv~l~~~~~~~------~~~~~~lv~e~~~~~~l~~~~~------------------------  214 (425)
                      +.++.++ +|.+     +++++++|...      .....+|||||+++++|.+++.                        
T Consensus       223 ~~~l~~l-~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~  301 (507)
T PLN03224        223 AYMCAKI-KRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM  301 (507)
T ss_pred             HHHHHHh-hcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence            7777777 4544     46778877532      1245789999999999877652                        


Q ss_pred             ---CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCccee--eccCCCccCcc
Q 014406          215 ---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV--RVASRYFKGPE  289 (425)
Q Consensus       215 ---~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~~~~--~~~t~~y~aPE  289 (425)
                         .+++..++.++.|++.||.|||+.+|+||||||+|||++.+ +.+||+|||++...........  ..+++.|+|||
T Consensus       302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~-~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE  380 (507)
T PLN03224        302 PQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVD-GQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE  380 (507)
T ss_pred             ccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCC-CcEEEEeCcCccccccCCccCccccCCCcceeChh
Confidence               13456678899999999999999999999999999999988 7899999999976543332222  23478899999


Q ss_pred             cccCCCC-------------------CC--CcccHHHHHHHHHHHHhCCC-CCCCCCCCHHHHHHHHHHhCCchhHHHHh
Q 014406          290 LLVDLQD-------------------YD--YSLDMWSLGCMFAGMIFRKE-PFFYGHDNHDQLVKIAKVLGTDELNAYLN  347 (425)
Q Consensus       290 ~~~~~~~-------------------~~--~~~DvwslG~~l~elltg~~-pf~~~~~~~~~~~~~~~~lg~~~~~~~~~  347 (425)
                      .+.....                   ++  .+.||||+||++++|++|.. ||. +..   .+....+... .....+  
T Consensus       381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~-~~~---~f~~~~~~~~-~~~~~~--  453 (507)
T PLN03224        381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVA-NIR---LFNTELRQYD-NDLNRW--  453 (507)
T ss_pred             hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCcc-chh---hhhhHHhhcc-chHHHH--
Confidence            9854211                   11  24799999999999999886 442 111   1110000000 000000  


Q ss_pred             hccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCc---CCCcCHHHHhcCCCCcc
Q 014406          348 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDH---QDRLTAREAMAHPYFAQ  414 (425)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP---~~Rpta~elL~hp~~~~  414 (425)
                                ...    ...    ..........++.++||+.+||..+|   .+|+|++|+|+||||.+
T Consensus       454 ----------r~~----~~~----~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~  505 (507)
T PLN03224        454 ----------RMY----KGQ----KYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP  505 (507)
T ss_pred             ----------Hhh----ccc----CCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence                      000    000    00111223368999999999999876   68999999999999965

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-37  Score=298.27  Aligned_cols=248  Identities=19%  Similarity=0.309  Sum_probs=201.7

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCC---cEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCc
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTN---ERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~---~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (425)
                      .++..+.++||+|.||.|++|.+...+   -.||||.+....    .+.|.+|+.+|.+| +|+|+++|||+..+   ..
T Consensus       109 ee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L-~H~hliRLyGvVl~---qp  184 (1039)
T KOG0199|consen  109 EEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKL-QHPHLIRLYGVVLD---QP  184 (1039)
T ss_pred             HHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhc-cCcceeEEeeeecc---ch
Confidence            355677789999999999999987533   368999998543    47899999999999 99999999999976   45


Q ss_pred             cEEEEEeecCCChhhhcCC-----CCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEecccccccc
Q 014406          197 PSLIFEYVNSTDFKVLYPT-----LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (425)
Q Consensus       197 ~~lv~e~~~~~~l~~~~~~-----l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~  271 (425)
                      ..+|+|.+..|+|.+.+.+     |....+..++.||+.||.||..+++|||||..+|+|+-.. ..+||||||+.+.+.
T Consensus       185 ~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasp-rtVKI~DFGLmRaLg  263 (1039)
T KOG0199|consen  185 AMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASP-RTVKICDFGLMRALG  263 (1039)
T ss_pred             hhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheeccc-ceeeeecccceeccC
Confidence            6799999999999887743     7778889999999999999999999999999999999887 789999999999887


Q ss_pred             CCCcceeec----cCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCCchhHHHH
Q 014406          272 PGKEYNVRV----ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYL  346 (425)
Q Consensus       272 ~~~~~~~~~----~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~  346 (425)
                      .++.+....    ....|.|||.+.. ..++.++|||+|||++|||+| |..|| .|....+.+..+-+           
T Consensus       264 ~ned~Yvm~p~rkvPfAWCaPEsLrh-~kFShaSDvWmyGVTiWEMFtyGEePW-~G~~g~qIL~~iD~-----------  330 (1039)
T KOG0199|consen  264 ENEDMYVMAPQRKVPFAWCAPESLRH-RKFSHASDVWMYGVTIWEMFTYGEEPW-VGCRGIQILKNIDA-----------  330 (1039)
T ss_pred             CCCcceEecCCCcCcccccCHhHhcc-ccccccchhhhhhhhHHhhhccCCCCC-CCCCHHHHHHhccc-----------
Confidence            665544322    2345999999976 889999999999999999998 45565 56555555554321           


Q ss_pred             hhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcc
Q 014406          347 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ  414 (425)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~  414 (425)
                                               .......+.+++++.+++..||..+|++|||+..+.+.-++.+
T Consensus       331 -------------------------~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l~e  373 (1039)
T KOG0199|consen  331 -------------------------GERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLAE  373 (1039)
T ss_pred             -------------------------cccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHHHh
Confidence                                     0111223448999999999999999999999999876655443

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=3.2e-35  Score=268.69  Aligned_cols=237  Identities=35%  Similarity=0.615  Sum_probs=194.5

Q ss_pred             CceEEEEEEEcCCCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEEEeecCCChhhh
Q 014406          137 KYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL  212 (425)
Q Consensus       137 ~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~  212 (425)
                      +||.||+|.+..+++.+|+|++....    .+.+.+|++.++++ +|+|++++++++...  ...++++||+++++|..+
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~--~~~~l~~e~~~~~~L~~~   77 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKL-KHPNIVRLYDVFEDE--DKLYLVMEYCDGGDLFDL   77 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhC-CCCcHHHHHhheeeC--CEEEEEEeCCCCCCHHHH
Confidence            58999999998889999999997543    57889999999999 999999999999654  678899999999999887


Q ss_pred             cCC---CCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCcceeeccCCCccCcc
Q 014406          213 YPT---LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE  289 (425)
Q Consensus       213 ~~~---l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE  289 (425)
                      +..   +++..+..++.+++.++.|||+.+++|+||+|+||+++.+ +.++|+|||.+.............++..|++||
T Consensus        78 ~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE  156 (244)
T smart00220       78 LKKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDED-GHVKLADFGLARQLDPGGLLTTFVGTPEYMAPE  156 (244)
T ss_pred             HHhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCC-CcEEEccccceeeeccccccccccCCcCCCCHH
Confidence            633   7889999999999999999999999999999999999998 789999999998776544455567888999999


Q ss_pred             cccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCChhhHHHhcccCCCCc
Q 014406          290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPW  369 (425)
Q Consensus       290 ~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (425)
                      .+.+ ..++.++||||||++++++++|..||....+ .+.......   .....                          
T Consensus       157 ~~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~-~~~~~~~~~---~~~~~--------------------------  205 (244)
T smart00220      157 VLLG-KGYGKAVDVWSLGVILYELLTGKPPFPGDDQ-LLELFKKIG---KPKPP--------------------------  205 (244)
T ss_pred             HHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-HHHHHHHHh---ccCCC--------------------------
Confidence            9876 6788999999999999999999999843322 222211111   00000                          


Q ss_pred             cccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCC
Q 014406          370 SKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF  412 (425)
Q Consensus       370 ~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~  412 (425)
                          .......++.++.+++.+||..+|++||++.++++||||
T Consensus       206 ----~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~  244 (244)
T smart00220      206 ----FPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF  244 (244)
T ss_pred             ----CccccccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence                000000157889999999999999999999999999997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-35  Score=275.53  Aligned_cols=262  Identities=19%  Similarity=0.292  Sum_probs=195.4

Q ss_pred             CcccccCCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcchHHHHHHHHHHHHh-cCCCCeeeEEeEEEcCCC
Q 014406          116 SLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNL-CGGPNVVKLLDIVRDQHS  194 (425)
Q Consensus       116 ~~~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l-~~h~niv~l~~~~~~~~~  194 (425)
                      .+-++-....+.++.+.||+|.||+||+|.+  .|+.||||++...+...+.+|.+|++.. .+|+||+.+++.=..+++
T Consensus       202 plLVQRTiarqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~g  279 (513)
T KOG2052|consen  202 PLLVQRTIARQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSRDERSWFRETEIYQTVMLRHENILGFIAADNKDNG  279 (513)
T ss_pred             hhHhHHhhhheeEEEEEecCccccceeeccc--cCCceEEEEecccchhhhhhHHHHHHHHHhccchhhhhhhccccCCC
Confidence            3344444557899999999999999999977  4889999999988889999999998843 389999999986543322


Q ss_pred             --CccEEEEEeecCCChhhhcC--CCCHHHHHHHHHHHHHHHHHHHHC--------CceeecCCCCceEecCCCCcEEEE
Q 014406          195 --KTPSLIFEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQ--------GIMHRDVKPHNVMIDHELRKLRLI  262 (425)
Q Consensus       195 --~~~~lv~e~~~~~~l~~~~~--~l~~~~~~~i~~~i~~~L~~LH~~--------~ivH~Dlk~~NIll~~~~~~~kl~  262 (425)
                        ..++||.+|.+.|+|.+++.  .++.....+++..++.||+|||..        .|.|||||+.|||+..+ +.+.|+
T Consensus       280 s~TQLwLvTdYHe~GSL~DyL~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn-~~C~IA  358 (513)
T KOG2052|consen  280 SWTQLWLVTDYHEHGSLYDYLNRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN-GTCCIA  358 (513)
T ss_pred             ceEEEEEeeecccCCcHHHHHhhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccC-CcEEEe
Confidence              35899999999999999984  588899999999999999999942        49999999999999999 899999


Q ss_pred             eccccccccCCC-----cceeeccCCCccCcccccCCCCCC-----CcccHHHHHHHHHHHHhC----------CCCCCC
Q 014406          263 DWGLAEFYHPGK-----EYNVRVASRYFKGPELLVDLQDYD-----YSLDMWSLGCMFAGMIFR----------KEPFFY  322 (425)
Q Consensus       263 Dfg~a~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~-----~~~DvwslG~~l~elltg----------~~pf~~  322 (425)
                      |+|||-......     ..+..+||..|||||++.......     ..+||||||.++||+...          ..||+.
T Consensus       359 DLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd  438 (513)
T KOG2052|consen  359 DLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYD  438 (513)
T ss_pred             eceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCccc
Confidence            999997654432     335679999999999996532221     369999999999998743          246654


Q ss_pred             CCCCHHHHHHHHHHhCCchhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcC
Q 014406          323 GHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT  402 (425)
Q Consensus       323 ~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpt  402 (425)
                      -..+...++.|.++.-.....       -..+.            .|..       ...-..+-++++.||..||.-|.|
T Consensus       439 ~Vp~DPs~eeMrkVVCv~~~R-------P~ipn------------rW~s-------~~~l~~m~klMkeCW~~Np~aRlt  492 (513)
T KOG2052|consen  439 VVPSDPSFEEMRKVVCVQKLR-------PNIPN------------RWKS-------DPALRVMAKLMKECWYANPAARLT  492 (513)
T ss_pred             CCCCCCCHHHHhcceeecccC-------CCCCc------------cccc-------CHHHHHHHHHHHHhhcCCchhhhH
Confidence            444444444444433221110       00000            1110       001123558899999999999999


Q ss_pred             HHHH
Q 014406          403 AREA  406 (425)
Q Consensus       403 a~el  406 (425)
                      |-.+
T Consensus       493 ALri  496 (513)
T KOG2052|consen  493 ALRI  496 (513)
T ss_pred             HHHH
Confidence            8655

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=1e-35  Score=294.87  Aligned_cols=245  Identities=25%  Similarity=0.383  Sum_probs=188.1

Q ss_pred             EEEEeeeeeeCceE-EEEEEEcCCCcEEEEEEecCcchHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEEEeec
Q 014406          127 YEVVRKVGRGKYSE-VFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVN  205 (425)
Q Consensus       127 y~~~~~LG~G~fg~-V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~  205 (425)
                      |.-.+.+|.|+-|+ ||+|..  .++.||||.+-....+-..+|+..|+.-..||||+++++.-  .+....|+..|.|.
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~E--~d~qF~YIalELC~  586 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVY--EGREVAVKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCSE--QDRQFLYIALELCA  586 (903)
T ss_pred             eccHHHcccCCCCcEEEEEee--CCceehHHHHhhHhHHHHHHHHHHHHhccCCCceEEEEeec--cCCceEEEEehHhh
Confidence            44456689999986 589965  57899999998888888899999999988999999998876  44578899999987


Q ss_pred             CCChhhhcCC-------CCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecC----CCCcEEEEeccccccccCCC
Q 014406          206 STDFKVLYPT-------LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH----ELRKLRLIDWGLAEFYHPGK  274 (425)
Q Consensus       206 ~~~l~~~~~~-------l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~----~~~~~kl~Dfg~a~~~~~~~  274 (425)
                      . +|++++..       ......+..+.|++.||++||+.+||||||||.||||+.    ...+++|+|||+++....+.
T Consensus       587 ~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~  665 (903)
T KOG1027|consen  587 C-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGK  665 (903)
T ss_pred             h-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCc
Confidence            5 45555432       111344678899999999999999999999999999986    23579999999999887553


Q ss_pred             c----ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhC-CCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhc
Q 014406          275 E----YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFR-KEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY  349 (425)
Q Consensus       275 ~----~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg-~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~  349 (425)
                      .    .....||.+|+|||++.. ..-+.++||||+||++|+.++| ..||.   ++.+.-++|..  |...        
T Consensus       666 sS~~r~s~~sGt~GW~APE~L~~-~~~~~avDiFslGCvfyYvltgG~HpFG---d~~~R~~NIl~--~~~~--------  731 (903)
T KOG1027|consen  666 SSFSRLSGGSGTSGWQAPEQLRE-DRKTQAVDIFSLGCVFYYVLTGGSHPFG---DSLERQANILT--GNYT--------  731 (903)
T ss_pred             chhhcccCCCCcccccCHHHHhc-cccCcccchhhcCceEEEEecCCccCCC---chHHhhhhhhc--Cccc--------
Confidence            2    244578999999999987 5567899999999999999987 78882   22222222221  0000        


Q ss_pred             cCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcc
Q 014406          350 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ  414 (425)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~  414 (425)
                                            .......  -..++.|||.+|++.||..||+|.++|.||||=.
T Consensus       732 ----------------------L~~L~~~--~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~  772 (903)
T KOG1027|consen  732 ----------------------LVHLEPL--PDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWD  772 (903)
T ss_pred             ----------------------eeeeccC--chHHHHHHHHHhcCCCcccCCCHHHHhCCCccCC
Confidence                                  0000011  1128999999999999999999999999999943

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.6e-34  Score=291.80  Aligned_cols=245  Identities=22%  Similarity=0.381  Sum_probs=194.5

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEc----C---CCcEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcC
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINV----N---TNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQ  192 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~----~---~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  192 (425)
                      .++.++.+.||+|.||.|++|...    .   ....||||.++..    ..+.+..|+++|..+..|+||+.++|.|.. 
T Consensus       295 ~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~-  373 (609)
T KOG0200|consen  295 RENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ-  373 (609)
T ss_pred             hhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc-
Confidence            344566679999999999999733    1   2567999998742    356789999999999889999999999976 


Q ss_pred             CCCccEEEEEeecCCChhhhc--CC-----------------CCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEec
Q 014406          193 HSKTPSLIFEYVNSTDFKVLY--PT-----------------LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMID  253 (425)
Q Consensus       193 ~~~~~~lv~e~~~~~~l~~~~--~~-----------------l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~  253 (425)
                       ...+++|.||+..|+|..++  .+                 ++..++..++.||+.|++||++.++|||||.++|||+.
T Consensus       374 -~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~  452 (609)
T KOG0200|consen  374 -DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLIT  452 (609)
T ss_pred             -CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEec
Confidence             57889999999999998876  23                 78889999999999999999999999999999999999


Q ss_pred             CCCCcEEEEeccccccccCCCcceee--cc--CCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCC-CHH
Q 014406          254 HELRKLRLIDWGLAEFYHPGKEYNVR--VA--SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD-NHD  328 (425)
Q Consensus       254 ~~~~~~kl~Dfg~a~~~~~~~~~~~~--~~--t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~-~~~  328 (425)
                      .+ ..+||+|||+|+.......+...  .+  ...|||||.+.. ..|+.++||||||++|||++|...+.+++.. ..+
T Consensus       453 ~~-~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~-~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~  530 (609)
T KOG0200|consen  453 KN-KVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD-RVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEE  530 (609)
T ss_pred             CC-CEEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc-CcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHH
Confidence            98 79999999999976655544322  22  344999999988 8899999999999999999985544445543 222


Q ss_pred             HHHHHHHHhCCchhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhc
Q 014406          329 QLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  408 (425)
Q Consensus       329 ~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~  408 (425)
                      .+..+.+                                    -...+.+..+++++.++++.||+.+|++||+..++.+
T Consensus       531 l~~~l~~------------------------------------G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~  574 (609)
T KOG0200|consen  531 LLEFLKE------------------------------------GNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE  574 (609)
T ss_pred             HHHHHhc------------------------------------CCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence            2221111                                    0111223347999999999999999999999988753

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-35  Score=291.14  Aligned_cols=240  Identities=21%  Similarity=0.362  Sum_probs=191.5

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCc----EEEEEEecC----cchHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCc
Q 014406          125 DDYEVVRKVGRGKYSEVFEGINVNTNE----RCIIKILKP----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (425)
Q Consensus       125 ~~y~~~~~LG~G~fg~V~~~~~~~~~~----~vavK~~~~----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (425)
                      ......+.||.|+||+||+|.+...++    +||||++..    ....++.+|..+|.++ +|||+++++++|..+   .
T Consensus       696 telkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masl-dHpnl~RLLgvc~~s---~  771 (1177)
T KOG1025|consen  696 TELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASL-DHPNLLRLLGVCMLS---T  771 (1177)
T ss_pred             hhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcC-CCchHHHHhhhcccc---h
Confidence            344556789999999999999876665    578888753    2356899999999999 999999999999653   3


Q ss_pred             cEEEEEeecCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccC
Q 014406          197 PSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (425)
Q Consensus       197 ~~lv~e~~~~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~  272 (425)
                      +.||++||+.|.|.++.    ..+.......|..||++||.|||++++|||||.++|||+..- ..+||.|||+++...+
T Consensus       772 ~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP-~hvkitdfgla~ll~~  850 (1177)
T KOG1025|consen  772 LQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSP-NHVKITDFGLAKLLAP  850 (1177)
T ss_pred             HHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCC-CeEEEEecchhhccCc
Confidence            77999999999999887    358888999999999999999999999999999999999987 7899999999998765


Q ss_pred             CC-cceee--ccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhh
Q 014406          273 GK-EYNVR--VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK  348 (425)
Q Consensus       273 ~~-~~~~~--~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~  348 (425)
                      .. .+...  ...+.|||=|.+.. ..|+.++|||||||++||++| |..|++ +....+    |.+.+.         +
T Consensus       851 d~~ey~~~~gK~pikwmale~i~~-~~~thqSDVWsfGVtiWElmTFGa~Py~-gi~~~e----I~dlle---------~  915 (1177)
T KOG1025|consen  851 DEKEYSAPGGKVPIKWMALESIRI-RKYTHQSDVWSFGVTIWELMTFGAKPYD-GIPAEE----IPDLLE---------K  915 (1177)
T ss_pred             ccccccccccccCcHHHHHHHhhc-cCCCchhhhhhhhhhHHHHHhcCCCccC-CCCHHH----hhHHHh---------c
Confidence            43 33333  23456999999987 889999999999999999996 778873 322222    111111         1


Q ss_pred             ccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHh
Q 014406          349 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM  407 (425)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL  407 (425)
                      ..                       +...+..++.++.-++.+||-.|+..||+++++-
T Consensus       916 ge-----------------------RLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~  951 (1177)
T KOG1025|consen  916 GE-----------------------RLSQPPICTIDVYMVMVKCWMIDADSRPTFKELA  951 (1177)
T ss_pred             cc-----------------------cCCCCCCccHHHHHHHHHHhccCcccCccHHHHH
Confidence            00                       1112234788999999999999999999998874

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=9.5e-35  Score=244.82  Aligned_cols=209  Identities=20%  Similarity=0.398  Sum_probs=175.0

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecC----cchHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccE
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (425)
                      ..++...+..||+|++|.|-+-++..+|...|+|.+..    +..++..+|+.+..+....|.+|+++|.+.++  ..++
T Consensus        44 ~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~re--gdvw  121 (282)
T KOG0984|consen   44 PADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFRE--GDVW  121 (282)
T ss_pred             chhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcc--ccEE
Confidence            45666777889999999999999999999999999863    34466788999888776899999999977544  6678


Q ss_pred             EEEEeecCCChhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHC-CceeecCCCCceEecCCCCcEEEEeccccccc
Q 014406          199 LIFEYVNSTDFKVLY-------PTLTDYDIRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  270 (425)
Q Consensus       199 lv~e~~~~~~l~~~~-------~~l~~~~~~~i~~~i~~~L~~LH~~-~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~  270 (425)
                      +.||.|... ++.+.       ...++..+-+|+..+..||.|||++ .+||||+||+|||++.+ |++|+||||.+-..
T Consensus       122 IcME~M~tS-ldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~-GqVKiCDFGIsG~L  199 (282)
T KOG0984|consen  122 ICMELMDTS-LDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYD-GQVKICDFGISGYL  199 (282)
T ss_pred             EeHHHhhhh-HHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccC-CcEEEcccccceee
Confidence            999998754 33332       3488999999999999999999976 89999999999999999 89999999999776


Q ss_pred             cCCCcceeeccCCCccCcccccC---CCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHH
Q 014406          271 HPGKEYNVRVASRYFKGPELLVD---LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK  335 (425)
Q Consensus       271 ~~~~~~~~~~~t~~y~aPE~~~~---~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~  335 (425)
                      .++-..+...|-..|||||.+..   ...|+.++||||||+++.||.+++.||.......+++..+.+
T Consensus       200 ~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVe  267 (282)
T KOG0984|consen  200 VDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVE  267 (282)
T ss_pred             hhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhc
Confidence            65555555677888999999853   246899999999999999999999999888888888877654

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-34  Score=280.04  Aligned_cols=256  Identities=25%  Similarity=0.428  Sum_probs=205.7

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecC---cchHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEE
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP---VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (425)
                      ..++|+++..+|.|.||.|||+++..+++..|+|+++-   +..+.+++|+-+++.. +|+||+.++|.+..  ...+++
T Consensus        13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc-~h~nivay~gsylr--~dklwi   89 (829)
T KOG0576|consen   13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDC-RHPNIVAYFGSYLR--RDKLWI   89 (829)
T ss_pred             CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecC-CCcChHHHHhhhhh--hcCcEE
Confidence            46789999999999999999999999999999999974   3456678999999997 99999999998854  356789


Q ss_pred             EEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCC-Cc
Q 014406          200 IFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-KE  275 (425)
Q Consensus       200 v~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~-~~  275 (425)
                      .|||+.+|+|++..   ..+++.++....++.++||+|||+.|-+|||||-.|||+++. +.+|++|||.+-.+... ..
T Consensus        90 cMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~-gDvklaDfgvsaqitati~K  168 (829)
T KOG0576|consen   90 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDE-GDVKLADFGVSAQITATIAK  168 (829)
T ss_pred             EEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeeccc-CceeecccCchhhhhhhhhh
Confidence            99999999999876   469999999999999999999999999999999999999988 89999999987654322 23


Q ss_pred             ceeeccCCCccCccccc--CCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCC
Q 014406          276 YNVRVASRYFKGPELLV--DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL  353 (425)
Q Consensus       276 ~~~~~~t~~y~aPE~~~--~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~  353 (425)
                      .....||++|||||+..  ..+.|...+|||++|++..|+-.-..|.|.-+. ...+..+.+.              .. 
T Consensus       169 rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp-mr~l~LmTkS--------------~~-  232 (829)
T KOG0576|consen  169 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP-MRALFLMTKS--------------GF-  232 (829)
T ss_pred             hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccch-HHHHHHhhcc--------------CC-
Confidence            34568999999999962  225689999999999999999877776642111 1111111110              00 


Q ss_pred             ChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCccc
Q 014406          354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV  415 (425)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~  415 (425)
                                       +-...+.....++.+.+|++.+|.++|++|||++.+|+|||...-
T Consensus       233 -----------------qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~  277 (829)
T KOG0576|consen  233 -----------------QPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT  277 (829)
T ss_pred             -----------------CCCcccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc
Confidence                             011122233468889999999999999999999999999997653

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.97  E-value=2.5e-32  Score=260.63  Aligned_cols=193  Identities=26%  Similarity=0.507  Sum_probs=170.4

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcch-----------HHHHHHHHHHHHhcC---CCCeeeEEeEEE
Q 014406          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK-----------KKIKREIKILQNLCG---GPNVVKLLDIVR  190 (425)
Q Consensus       125 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~-----------~~~~~E~~~l~~l~~---h~niv~l~~~~~  190 (425)
                      .+|..+..||.|+||.|+.|.++.+...|+||.+.++..           -.+-.||+||..+ +   |+||++++++|+
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l-~~~sH~NIlKlLdfFE  639 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATL-NKHSHENILKLLDFFE  639 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHh-hhcCccchhhhhheee
Confidence            569999999999999999999999999999999875421           2345799999999 5   999999999996


Q ss_pred             cCCCCccEEEEEee-cCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccc
Q 014406          191 DQHSKTPSLIFEYV-NSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL  266 (425)
Q Consensus       191 ~~~~~~~~lv~e~~-~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~  266 (425)
                      ++  .+.||+||-- ++.+|.+++   +.+++.+.+.|++|++.|+++||++||||||||-+|+.++.+ |.+||+|||.
T Consensus       640 dd--d~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~-g~~klidfgs  716 (772)
T KOG1152|consen  640 DD--DYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSN-GFVKLIDFGS  716 (772)
T ss_pred             cC--CeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecC-CeEEEeeccc
Confidence            64  7888999986 455787776   569999999999999999999999999999999999999999 8999999999


Q ss_pred             cccccCCCcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCC
Q 014406          267 AEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY  322 (425)
Q Consensus       267 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~  322 (425)
                      |.... +......+||..|.|||++.+....+..-|||++|++||-++....||++
T Consensus       717 aa~~k-sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  717 AAYTK-SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             hhhhc-CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            87654 56778899999999999998866667889999999999999999999863

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.97  E-value=1.1e-31  Score=245.67  Aligned_cols=244  Identities=18%  Similarity=0.306  Sum_probs=194.4

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCC-----CcEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCC
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNT-----NERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS  194 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~-----~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  194 (425)
                      .++++....+-+|.||.||.|.+...     .+.|-+|.++..    +...+..|--.+..+ .|||+..+.+++... .
T Consensus       283 r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~-sH~nll~V~~V~ie~-~  360 (563)
T KOG1024|consen  283 RCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGA-SHPNLLSVLGVSIED-Y  360 (563)
T ss_pred             hhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcC-cCCCccceeEEEeec-c
Confidence            46789999999999999999976543     334556666532    235677888888888 799999999998764 4


Q ss_pred             CccEEEEEeecCCChhhhcC-----------CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEe
Q 014406          195 KTPSLIFEYVNSTDFKVLYP-----------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLID  263 (425)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~~-----------~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~D  263 (425)
                      ..++.+|.+++-|+|..++.           .++..++..++.|++.|++|||+.|+||.||.++|++||+. -++||+|
T Consensus       361 ~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~-LqVkltD  439 (563)
T KOG1024|consen  361 ATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQ-LQVKLTD  439 (563)
T ss_pred             CcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhh-eeEEecc
Confidence            66789999999999998873           36777888999999999999999999999999999999988 6899999


Q ss_pred             ccccccccCCCcce---eeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCC
Q 014406          264 WGLAEFYHPGKEYN---VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGT  339 (425)
Q Consensus       264 fg~a~~~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~lg~  339 (425)
                      =.+++-..+.+...   ....+..||+||.+.+ ..|+.++|+|||||+||||+| |+.|+ ...|..|....+.+    
T Consensus       440 saLSRDLFP~DYhcLGDnEnRPvkWMslEal~n-~~yssasDvWsfGVllWELmtlg~~Py-aeIDPfEm~~ylkd----  513 (563)
T KOG1024|consen  440 SALSRDLFPGDYHCLGDNENRPVKWMSLEALQN-SHYSSASDVWSFGVLLWELMTLGKLPY-AEIDPFEMEHYLKD----  513 (563)
T ss_pred             chhccccCcccccccCCCCCCcccccCHHHHhh-hhhcchhhhHHHHHHHHHHHhcCCCCc-cccCHHHHHHHHhc----
Confidence            99998776554331   2234556999999998 789999999999999999997 66665 55555554443322    


Q ss_pred             chhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhc
Q 014406          340 DELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  408 (425)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~  408 (425)
                              .+..                        .-+.++++++..++-.||..+|++||+.+|+..
T Consensus       514 --------GyRl------------------------aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~  550 (563)
T KOG1024|consen  514 --------GYRL------------------------AQPFNCPDELFTVMACCWALLPEERPSFSQLVI  550 (563)
T ss_pred             --------ccee------------------------cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence                    1111                        112248999999999999999999999999864

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.97  E-value=6.3e-30  Score=227.96  Aligned_cols=205  Identities=33%  Similarity=0.618  Sum_probs=179.5

Q ss_pred             eeeeCceEEEEEEEcCCCcEEEEEEecCcch----HHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEEEeecCCC
Q 014406          133 VGRGKYSEVFEGINVNTNERCIIKILKPVKK----KKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTD  208 (425)
Q Consensus       133 LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~----~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~  208 (425)
                      ||+|++|.||++.+..+++.+++|++.....    +.+.+|+..++.+ .|++++++++++...  ...++++||+.+++
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~--~~~~~~~e~~~~~~   77 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKL-NHPNIVKLYGVFEDE--NHLYLVMEYCEGGS   77 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhc-CCCCeeeEeeeeecC--CeEEEEEecCCCCc
Confidence            6899999999999988899999999986654    6899999999999 899999999999654  67889999999999


Q ss_pred             hhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecC-CCCcEEEEeccccccccCCC-cceeeccC
Q 014406          209 FKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH-ELRKLRLIDWGLAEFYHPGK-EYNVRVAS  282 (425)
Q Consensus       209 l~~~~~----~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~-~~~~~kl~Dfg~a~~~~~~~-~~~~~~~t  282 (425)
                      |..++.    .+++..+..++.+++.++.+||+.|++|+||+|.||+++. + +.++|+|||.+....... ......+.
T Consensus        78 l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~  156 (215)
T cd00180          78 LKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDN-GKVKLADFGLSKLLTSDKSLLKTIVGT  156 (215)
T ss_pred             HHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCC-CcEEEecCCceEEccCCcchhhcccCC
Confidence            998874    4789999999999999999999999999999999999998 5 789999999997654332 13335677


Q ss_pred             CCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCChhhHHHhc
Q 014406          283 RYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVG  362 (425)
Q Consensus       283 ~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~  362 (425)
                      ..|++||.+.....++.+.|+|++|++++++                                                 
T Consensus       157 ~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------------------------  187 (215)
T cd00180         157 PAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------------------------  187 (215)
T ss_pred             CCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------------------
Confidence            8899999987633788999999999999998                                                 


Q ss_pred             ccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCC
Q 014406          363 RHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHP  410 (425)
Q Consensus       363 ~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp  410 (425)
                                          ..+.+++.+|++.||++|||+.++++|+
T Consensus       188 --------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 --------------------PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             --------------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence                                1456899999999999999999999885

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.9e-31  Score=232.37  Aligned_cols=256  Identities=19%  Similarity=0.326  Sum_probs=193.8

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc--chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEE
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (425)
                      .+.|.+.+.||+|.||.+-++.++.+.+.+++|.+...  ...+|.+|..---.|..|.||+.-|+.-- +.....+.++
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaF-qt~d~YvF~q  101 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAF-QTSDAYVFVQ  101 (378)
T ss_pred             hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHh-hcCceEEEee
Confidence            57899999999999999999999999999999998743  45789999877667778999998776432 2335778999


Q ss_pred             EeecCCChhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEe-cCCCCcEEEEeccccccccCCCccee
Q 014406          202 EYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI-DHELRKLRLIDWGLAEFYHPGKEYNV  278 (425)
Q Consensus       202 e~~~~~~l~~~~~--~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll-~~~~~~~kl~Dfg~a~~~~~~~~~~~  278 (425)
                      ||++.|+|..-..  .+.+...+.++.|+++|++|||+.++||||||.+|||+ +.+..++||||||+.+..+  .....
T Consensus       102 E~aP~gdL~snv~~~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g--~tV~~  179 (378)
T KOG1345|consen  102 EFAPRGDLRSNVEAAGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG--TTVKY  179 (378)
T ss_pred             ccCccchhhhhcCcccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccC--ceehh
Confidence            9999999988764  48888899999999999999999999999999999997 5666799999999987533  12222


Q ss_pred             eccCCCccCcccccCC----CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCC
Q 014406          279 RVASRYFKGPELLVDL----QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD  354 (425)
Q Consensus       279 ~~~t~~y~aPE~~~~~----~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~  354 (425)
                      .-.+..|.+||++...    -..+..+|+|.||+++|.++||+.||...........+..+.++..         ....+
T Consensus       180 ~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk---------~~~~P  250 (378)
T KOG1345|consen  180 LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRK---------NPALP  250 (378)
T ss_pred             hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhccc---------CccCc
Confidence            3345568899987431    1246789999999999999999999953333333333333333221         11111


Q ss_pred             hhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCC---cCHHHHhcCCCC
Q 014406          355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDR---LTAREAMAHPYF  412 (425)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R---pta~elL~hp~~  412 (425)
                      ..+                     ..+++.+..+.++-|..++++|   .+++......|-
T Consensus       251 ~~F---------------------~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~  290 (378)
T KOG1345|consen  251 KKF---------------------NPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWK  290 (378)
T ss_pred             hhh---------------------cccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHH
Confidence            111                     1268899999999999999999   566666655553

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=4.6e-29  Score=225.66  Aligned_cols=192  Identities=33%  Similarity=0.649  Sum_probs=167.3

Q ss_pred             EEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEEE
Q 014406          127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE  202 (425)
Q Consensus       127 y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e  202 (425)
                      |.+.+.||.|++|+||++.+..+++.+++|.+...    ..+.+.+|++.++++ +|+|++++++++...  ...++++|
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~-~~~~i~~~~~~~~~~--~~~~~v~e   77 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKL-KHPNIVKLYGVFEDP--EPLYLVME   77 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhC-CCCChhhheeeeecC--CceEEEEe
Confidence            45678999999999999999888999999999764    456788999999999 899999999998654  67789999


Q ss_pred             eecCCChhhhcCC----CCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCC--cc
Q 014406          203 YVNSTDFKVLYPT----LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK--EY  276 (425)
Q Consensus       203 ~~~~~~l~~~~~~----l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~--~~  276 (425)
                      |+.+++|..++..    +++..+..++.+++.++.+||+.+++|+||++.||+++.+ +.++|+|||.+.......  ..
T Consensus        78 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~-~~~~l~d~g~~~~~~~~~~~~~  156 (225)
T smart00221       78 YCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMD-GLVKLADFGLARFIHRDLAALL  156 (225)
T ss_pred             ccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC-CCEEEeeCceeeEecCcccccc
Confidence            9999999888732    7889999999999999999999999999999999999988 789999999998765443  33


Q ss_pred             eeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCC
Q 014406          277 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY  322 (425)
Q Consensus       277 ~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~  322 (425)
                      ....++..|++||.+.+...++.++|+|+||+++++|++|+.||..
T Consensus       157 ~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      157 KTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             cceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            4456778899999984336788899999999999999999999943

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.96  E-value=3.2e-30  Score=274.84  Aligned_cols=198  Identities=14%  Similarity=0.195  Sum_probs=141.8

Q ss_pred             CC-CCeeeEEeEEEcC-----CCCccEEEEEeecCCChhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCC
Q 014406          178 GG-PNVVKLLDIVRDQ-----HSKTPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKP  247 (425)
Q Consensus       178 ~h-~niv~l~~~~~~~-----~~~~~~lv~e~~~~~~l~~~~~----~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~  247 (425)
                      .| .||++++++|...     ....+++++||+. ++|..++.    .+++.++..++.||+.||+|||++||+||||||
T Consensus        30 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP  108 (793)
T PLN00181         30 SHIDYVRSLLGSHKEGNLDGLDDDSIVRALECED-VSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRP  108 (793)
T ss_pred             hHHHHHHHhhcccCCccccccccchhhhhhccCC-ccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCc
Confidence            44 6888888887321     2245778889874 57877773    389999999999999999999999999999999


Q ss_pred             CceEecCC------------------CCcEEEEeccccccccCCC-----------------cceeeccCCCccCccccc
Q 014406          248 HNVMIDHE------------------LRKLRLIDWGLAEFYHPGK-----------------EYNVRVASRYFKGPELLV  292 (425)
Q Consensus       248 ~NIll~~~------------------~~~~kl~Dfg~a~~~~~~~-----------------~~~~~~~t~~y~aPE~~~  292 (425)
                      +||||+..                  .+.+|++|||+++......                 ......+|+.|||||++.
T Consensus       109 ~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~  188 (793)
T PLN00181        109 SCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDN  188 (793)
T ss_pred             hhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhc
Confidence            99999532                  2456777777775421100                 011235788899999998


Q ss_pred             CCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCChhhHHHhcccCCCCcccc
Q 014406          293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKF  372 (425)
Q Consensus       293 ~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  372 (425)
                      + ..++.++|||||||+||||++|..|+..   ....+..+....               .++..               
T Consensus       189 ~-~~~~~~sDVwSlGviL~ELl~~~~~~~~---~~~~~~~~~~~~---------------~~~~~---------------  234 (793)
T PLN00181        189 G-SSSNCASDVYRLGVLLFELFCPVSSREE---KSRTMSSLRHRV---------------LPPQI---------------  234 (793)
T ss_pred             c-CCCCchhhhhhHHHHHHHHhhCCCchhh---HHHHHHHHHHhh---------------cChhh---------------
Confidence            7 6799999999999999999998877521   111111110000               00000               


Q ss_pred             ccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccc
Q 014406          373 INADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR  416 (425)
Q Consensus       373 ~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~  416 (425)
                            ........+++.+||+.||.+|||+.|+++||||.+..
T Consensus       235 ------~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~~~  272 (793)
T PLN00181        235 ------LLNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINEPR  272 (793)
T ss_pred             ------hhcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhhhh
Confidence                  00134567899999999999999999999999998753

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.95  E-value=1.3e-27  Score=208.46  Aligned_cols=165  Identities=23%  Similarity=0.280  Sum_probs=122.7

Q ss_pred             CChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCcceeeccC
Q 014406          207 TDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVAS  282 (425)
Q Consensus       207 ~~l~~~~----~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t  282 (425)
                      |+|.+++    ..+++.+++.++.|++.||.|||+++      ||+|||++.+ +.+|+  ||+++......    ..++
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~-~~~~~--fG~~~~~~~~~----~~g~   67 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWD-GLLKL--DGSVAFKTPEQ----SRVD   67 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCc-cceee--ccceEeecccc----CCCc
Confidence            4555554    24899999999999999999999998      9999999988 78888  99998654322    3678


Q ss_pred             CCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCChhhHHHhc
Q 014406          283 RYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVG  362 (425)
Q Consensus       283 ~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~  362 (425)
                      +.|+|||++.+ ..++.++|||||||++|||++|+.||.........+..+..........                   
T Consensus        68 ~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-------------------  127 (176)
T smart00750       68 PYFMAPEVIQG-QSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPR-------------------  127 (176)
T ss_pred             ccccChHHhcC-CCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCcc-------------------
Confidence            99999999987 7899999999999999999999999853332222232222211100000                   


Q ss_pred             ccCCCCccccccccCCCCCCH--HHHHHHHHcccCCcCCCcCHHHHhcCCCCccc
Q 014406          363 RHSRKPWSKFINADNQHLVSP--EAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV  415 (425)
Q Consensus       363 ~~~~~~~~~~~~~~~~~~~s~--~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~  415 (425)
                        .+         .....+++  ++.+|+++||+.||++|||+.|+++|+|+...
T Consensus       128 --~~---------~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~  171 (176)
T smart00750      128 --DR---------SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA  171 (176)
T ss_pred             --cc---------ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence              00         00001233  68999999999999999999999999997643

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.93  E-value=2.3e-25  Score=213.09  Aligned_cols=159  Identities=19%  Similarity=0.257  Sum_probs=125.7

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcC-CCcEEEEEEecCc--------chHHHHHHHHHHHHhcCCCCeee-EEeEEEcC
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVN-TNERCIIKILKPV--------KKKKIKREIKILQNLCGGPNVVK-LLDIVRDQ  192 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~-~~~~vavK~~~~~--------~~~~~~~E~~~l~~l~~h~niv~-l~~~~~~~  192 (425)
                      ..++|++.+.||+|+||+||+|.+.. +++.+|||.+...        ....+.+|+++|+++ +|+|++. +++ +   
T Consensus        16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L-~h~~iv~~l~~-~---   90 (365)
T PRK09188         16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTV-RGIGVVPQLLA-T---   90 (365)
T ss_pred             ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhc-cCCCCCcEEEE-c---
Confidence            35789999999999999999998876 6788899986522        134688999999999 8999885 443 2   


Q ss_pred             CCCccEEEEEeecCCChhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeecC-CCCceEecCCCCcEEEEecccccccc
Q 014406          193 HSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDV-KPHNVMIDHELRKLRLIDWGLAEFYH  271 (425)
Q Consensus       193 ~~~~~~lv~e~~~~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dl-k~~NIll~~~~~~~kl~Dfg~a~~~~  271 (425)
                        ...++||||+.|++|.... ...   ...++.+++.+|.|||++||+|||| ||+|||++.+ +.+||+|||+|+...
T Consensus        91 --~~~~LVmE~~~G~~L~~~~-~~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~-~~ikLiDFGlA~~~~  163 (365)
T PRK09188         91 --GKDGLVRGWTEGVPLHLAR-PHG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPD-GEAAVIDFQLASVFR  163 (365)
T ss_pred             --CCcEEEEEccCCCCHHHhC-ccc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCC-CCEEEEECccceecc
Confidence              3468999999999997432 111   2467899999999999999999999 9999999877 789999999998665


Q ss_pred             CCCcc---------eeeccCCCccCcccccC
Q 014406          272 PGKEY---------NVRVASRYFKGPELLVD  293 (425)
Q Consensus       272 ~~~~~---------~~~~~t~~y~aPE~~~~  293 (425)
                      .....         ....++..|+|||.+..
T Consensus       164 ~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        164 RRGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             cCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            43211         23356677999998754

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.92  E-value=3.5e-26  Score=232.51  Aligned_cols=258  Identities=24%  Similarity=0.401  Sum_probs=189.6

Q ss_pred             EEEeeeeeeCceEEEEEEEcCCCcEEEEEEec----Cc-ch----HHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccE
Q 014406          128 EVVRKVGRGKYSEVFEGINVNTNERCIIKILK----PV-KK----KKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (425)
Q Consensus       128 ~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~----~~-~~----~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (425)
                      ...+.+|.|++|.|+........+.++.|.+.    .. ..    ..+..|+.+-..+ .|+|++..+..+.+....  .
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l-~h~~~~e~l~~~~~~~~~--~  397 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSL-SHPNIIETLDIVQEIDGI--L  397 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccc-cCCchhhhHHHHhhcccc--h
Confidence            45667999999988888877766666666543    11 11    1144566666677 899998877766543222  2


Q ss_pred             EEEEeecCCChhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCc
Q 014406          199 LIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (425)
Q Consensus       199 lv~e~~~~~~l~~~~~---~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~  275 (425)
                      -.|||+++ +|..++.   .++..++..++.|++.|+.|||+.||.|||+|++|+++..+ +.+||+|||.+....-...
T Consensus       398 ~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~-g~lki~Dfg~~~vf~~~~e  475 (601)
T KOG0590|consen  398 QSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTEN-GILKIIDFGAASVFRYPWE  475 (601)
T ss_pred             hhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecC-CceEEeecCcceeeccCcc
Confidence            34999999 8877663   48899999999999999999999999999999999999998 7999999999876543222


Q ss_pred             -----ceeeccCCCccCcccccCCCCCC-CcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhc
Q 014406          276 -----YNVRVASRYFKGPELLVDLQDYD-YSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY  349 (425)
Q Consensus       276 -----~~~~~~t~~y~aPE~~~~~~~~~-~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~  349 (425)
                           ....+|+..|+|||++.+ ..|+ ...||||.|+++..|++|+.||........++...   .+.....      
T Consensus       476 ~~~~~~~g~~gS~pY~apE~~~~-~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~---~~~~~~~------  545 (601)
T KOG0590|consen  476 KNIHESSGIVGSDPYLAPEVLTG-KEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTN---NYSDQRN------  545 (601)
T ss_pred             hhhhhhcCcccCCcCcCcccccc-cccCcchhhhhhccceEEEEecCCCccccccccccchhhh---ccccccc------
Confidence                 244688999999999987 5565 57999999999999999999996554443332110   0000000      


Q ss_pred             cCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccchh
Q 014406          350 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAES  420 (425)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~~~  420 (425)
                       .             ...+      ......++.+.+.+|.+||++||.+|.|++++++++||+.+..+.-
T Consensus       546 -~-------------~~~~------~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~c~v  596 (601)
T KOG0590|consen  546 -I-------------FEGP------NRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIECCHV  596 (601)
T ss_pred             -c-------------ccCh------HHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcceEEe
Confidence             0             0000      0001126778899999999999999999999999999999987653

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.92  E-value=1.8e-23  Score=198.85  Aligned_cols=259  Identities=33%  Similarity=0.565  Sum_probs=197.7

Q ss_pred             EEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCC-CeeeEEeEEEcCCCCccEE
Q 014406          127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGP-NVVKLLDIVRDQHSKTPSL  199 (425)
Q Consensus       127 y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~-niv~l~~~~~~~~~~~~~l  199 (425)
                      |.+...||.|+||.||++.+.   ..+++|.+...      ....+.+|+.++..+ .|+ +++++.+.+...  ...++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~-~~~~~i~~~~~~~~~~--~~~~~   75 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASL-NHPPNIVKLYDFFQDE--GSLYL   75 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHc-cCCcceeeEEEEEecC--CEEEE
Confidence            678889999999999999876   78899998642      245688999999999 666 899999999443  44789


Q ss_pred             EEEeecCCChhhhcC------CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCC
Q 014406          200 IFEYVNSTDFKVLYP------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (425)
Q Consensus       200 v~e~~~~~~l~~~~~------~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~  273 (425)
                      +++++.++++..+..      .++......++.|++.++.|+|+.+++|||+||+||+++.....++++|||.++.....
T Consensus        76 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~  155 (384)
T COG0515          76 VMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP  155 (384)
T ss_pred             EEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence            999999999986653      68889999999999999999999999999999999999988337999999999755433


Q ss_pred             C-------cceeeccCCCccCcccccCC--CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCC--HHHHHHHHHHhCCchh
Q 014406          274 K-------EYNVRVASRYFKGPELLVDL--QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN--HDQLVKIAKVLGTDEL  342 (425)
Q Consensus       274 ~-------~~~~~~~t~~y~aPE~~~~~--~~~~~~~DvwslG~~l~elltg~~pf~~~~~~--~~~~~~~~~~lg~~~~  342 (425)
                      .       ......++..|++||.+.+.  ..++...|+||+|++++++++|..||......  .............+. 
T Consensus       156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~-  234 (384)
T COG0515         156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPS-  234 (384)
T ss_pred             CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcc-
Confidence            2       24567899999999999763  47889999999999999999999996433321  222222222221110 


Q ss_pred             HHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccc
Q 014406          343 NAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA  418 (425)
Q Consensus       343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~  418 (425)
                                ...            ....    .........+.+++.+|+..+|..|.+..+...++|.......
T Consensus       235 ----------~~~------------~~~~----~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~~~  284 (384)
T COG0515         235 ----------LAS------------PLSP----SNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLK  284 (384)
T ss_pred             ----------ccc------------ccCc----cccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCcccc
Confidence                      000            0000    0001123578899999999999999999999988776655443

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.92  E-value=5.8e-26  Score=220.93  Aligned_cols=235  Identities=26%  Similarity=0.400  Sum_probs=191.3

Q ss_pred             eeeeCceEEEEEE---EcCCCcEEEEEEecCcc-----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEEEee
Q 014406          133 VGRGKYSEVFEGI---NVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV  204 (425)
Q Consensus       133 LG~G~fg~V~~~~---~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~  204 (425)
                      +|+|+||.|+++.   -...+..+|+|++++..     +.....|..++..+++||.++++.-.|+.+  ...++++++.
T Consensus         2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~--~kl~l~ld~~   79 (612)
T KOG0603|consen    2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTD--GKLYLILDFL   79 (612)
T ss_pred             CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccc--cchhHhhhhc
Confidence            7999999998764   23456778899886432     224567888999886799999999999554  5677999999


Q ss_pred             cCCChhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCcceeecc
Q 014406          205 NSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA  281 (425)
Q Consensus       205 ~~~~l~~~~~---~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  281 (425)
                      .+|++...+.   .+.+...+.+...++.+++++|+.+|+|+|+|++||+++.+ |.+++.|||+++..-..+..   +|
T Consensus        80 rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~-Ghi~~tdfglske~v~~~~~---cg  155 (612)
T KOG0603|consen   80 RGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLE-GHIKLTDFGLSKEAVKEKIA---CG  155 (612)
T ss_pred             ccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeeccc-CccccCCchhhhHhHhhhhc---cc
Confidence            9999887764   37778888999999999999999999999999999999999 89999999999876543332   89


Q ss_pred             CCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHH-HhCCchhHHHHhhccCCCChhhHHH
Q 014406          282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK-VLGTDELNAYLNKYHLELDPQLDAL  360 (425)
Q Consensus       282 t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~-~lg~~~~~~~~~~~~~~~~~~~~~~  360 (425)
                      |..|||||++.   ..+..+|.||||+++++|+||..||..     +....|.+ .++                      
T Consensus       156 t~eymApEI~~---gh~~a~D~ws~gvl~felltg~~pf~~-----~~~~~Il~~~~~----------------------  205 (612)
T KOG0603|consen  156 TYEYRAPEIIN---GHLSAADWWSFGVLAFELLTGTLPFGG-----DTMKRILKAELE----------------------  205 (612)
T ss_pred             chhhhhhHhhh---ccCCcccchhhhhhHHHHhhCCCCCch-----HHHHHHhhhccC----------------------
Confidence            99999999986   357899999999999999999999953     33333322 111                      


Q ss_pred             hcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcC-----HHHHhcCCCCcccccch
Q 014406          361 VGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT-----AREAMAHPYFAQVRAAE  419 (425)
Q Consensus       361 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpt-----a~elL~hp~~~~~~~~~  419 (425)
                                      .+..++..+.++++.++..+|.+|..     +.|+++|+||+.+.|.+
T Consensus       206 ----------------~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~~  253 (612)
T KOG0603|consen  206 ----------------MPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWNE  253 (612)
T ss_pred             ----------------CchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHhh
Confidence                            11225778999999999999999995     47999999999999973

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.91  E-value=1.2e-24  Score=221.72  Aligned_cols=229  Identities=28%  Similarity=0.435  Sum_probs=170.1

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcchHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEEE
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE  202 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e  202 (425)
                      ..++|+.++.|..|+||.||..+++.+.+.+|+|+-++.   -+.+-  ++... +.|.+|                   
T Consensus        81 ~e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~---lilRn--ilt~a-~npfvv-------------------  135 (1205)
T KOG0606|consen   81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQN---LILRN--ILTFA-GNPFVV-------------------  135 (1205)
T ss_pred             CccccceeEeeccCCCCceeeeeccccccchhhcccccc---hhhhc--ccccc-CCccee-------------------
Confidence            367899999999999999999999999999999543311   11000  22222 333333                   


Q ss_pred             eecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCc----
Q 014406          203 YVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE----  275 (425)
Q Consensus       203 ~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~----  275 (425)
                          |+....+   ..++...        +.+++|||+.||+|||+||+|.+|+.- +.+|+.|||+++..-....    
T Consensus       136 ----gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~m-GhiKlTDfgLsk~GLms~atnl~  202 (1205)
T KOG0606|consen  136 ----GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSM-GHIKLTDFGLSKKGLMSLATNLK  202 (1205)
T ss_pred             ----chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeec-ccccccchhhhhhhhhhccchhh
Confidence                3333333   3344332        789999999999999999999999987 8999999999975532111    


Q ss_pred             ------------ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhH
Q 014406          276 ------------YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELN  343 (425)
Q Consensus       276 ------------~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~  343 (425)
                                  ....+||+.|+|||++.. ..|+..+|+|++|+++||++-|+.||| ++..++.+...+....     
T Consensus       203 eg~I~k~t~Ef~dKqvcgTPeyiaPeVilr-qgygkpvdwwamGiIlyeFLVgcvpff-Gdtpeelfg~visd~i-----  275 (1205)
T KOG0606|consen  203 EGHIEKDTHEFQDKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCVPFF-GDTPEELFGQVISDDI-----  275 (1205)
T ss_pred             hcchHHHHHHhhhccccCCccccChhhhhh-hccCCCccHHHHHHHHHHHheeeeecc-CCCHHHHHhhhhhhhc-----
Confidence                        122489999999999988 789999999999999999999999995 4444444444332111     


Q ss_pred             HHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCc---CHHHHhcCCCCcccccchh
Q 014406          344 AYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL---TAREAMAHPYFAQVRAAES  420 (425)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rp---ta~elL~hp~~~~~~~~~~  420 (425)
                                                   ...+....+..+++++++++|+.+|..|.   .+-++.+|+||+.+.|...
T Consensus       276 -----------------------------~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~~l  326 (1205)
T KOG0606|consen  276 -----------------------------EWPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWKSL  326 (1205)
T ss_pred             -----------------------------cccccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccchh
Confidence                                         11112334789999999999999999998   5779999999999999988


Q ss_pred             ccccC
Q 014406          421 SRTRA  425 (425)
Q Consensus       421 ~~~~~  425 (425)
                      -|++|
T Consensus       327 lRqka  331 (1205)
T KOG0606|consen  327 LRQKA  331 (1205)
T ss_pred             hhhhc
Confidence            88876

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.91  E-value=7.6e-23  Score=195.72  Aligned_cols=193  Identities=23%  Similarity=0.330  Sum_probs=156.6

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcCCC-cEEEEEEecCcc---hHHHHHHHHHHHHhc---CCCCeeeEEeEEEcCCCCccE
Q 014406          126 DYEVVRKVGRGKYSEVFEGINVNTN-ERCIIKILKPVK---KKKIKREIKILQNLC---GGPNVVKLLDIVRDQHSKTPS  198 (425)
Q Consensus       126 ~y~~~~~LG~G~fg~V~~~~~~~~~-~~vavK~~~~~~---~~~~~~E~~~l~~l~---~h~niv~l~~~~~~~~~~~~~  198 (425)
                      +|.+.++||+|+||.||.+.+..++ ..+|+|+.....   ...+..|+.++..+.   +.+++..+++... ....+-+
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~-~~~~~~~   97 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR-STEDFNF   97 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc-CCCceeE
Confidence            8999999999999999999987775 688999876532   226889999999984   2368888888874 2345678


Q ss_pred             EEEEeecCCChhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCC----CcEEEEeccccc-
Q 014406          199 LIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEL----RKLRLIDWGLAE-  268 (425)
Q Consensus       199 lv~e~~~~~~l~~~~-----~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~----~~~kl~Dfg~a~-  268 (425)
                      +||+.+... |.++.     +.++...+..++.|++.+|++||+.|++||||||.|+++....    ..+.|.|||+++ 
T Consensus        98 iVM~l~G~s-L~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~  176 (322)
T KOG1164|consen   98 IVMSLLGPS-LEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARR  176 (322)
T ss_pred             EEEeccCcc-HHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCcc
Confidence            998887554 44433     4699999999999999999999999999999999999998653    469999999998 


Q ss_pred             -cccCCC--------c-ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 014406          269 -FYHPGK--------E-YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF  321 (425)
Q Consensus       269 -~~~~~~--------~-~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~  321 (425)
                       ......        . .....||..|.++.+..+ ...+.+.|+||++.++.+++.|..|+.
T Consensus       177 ~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~-~e~~r~DDles~~Y~l~el~~g~LPW~  238 (322)
T KOG1164|consen  177 FKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLG-IEQGRRDDLESLFYMLLELLKGSLPWE  238 (322)
T ss_pred             ccccCCCCcccccCCCCccCCCCccccccHHHhCC-CccCCchhhhhHHHHHHHHhcCCCCCc
Confidence             321111        1 123458999999999887 778999999999999999999999983

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.90  E-value=1.1e-22  Score=183.37  Aligned_cols=209  Identities=20%  Similarity=0.352  Sum_probs=171.0

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEec-CcchHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEEE
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-PVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE  202 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~-~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e  202 (425)
                      .-.|.+.++||+|+||..+.|.+.-+++.||||.-. +....++..|...++.|.+.+.|...+-+-  +.+.+-.||+|
T Consensus        27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFG--qeG~~NiLVid  104 (449)
T KOG1165|consen   27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFG--QEGKYNILVID  104 (449)
T ss_pred             cccceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeec--cccchhhhhhh
Confidence            457999999999999999999999999999999975 445678999999999998888988876554  55677789999


Q ss_pred             eecCC--Chhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCC----CCcEEEEeccccccccCCCc
Q 014406          203 YVNST--DFKVLY-PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE----LRKLRLIDWGLAEFYHPGKE  275 (425)
Q Consensus       203 ~~~~~--~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~----~~~~kl~Dfg~a~~~~~~~~  275 (425)
                      .+...  +|.++. +.|+...+..++.|++.-++|+|++..|+|||||+|+||...    -..+.++|||+|+.+.+...
T Consensus       105 LLGPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~T  184 (449)
T KOG1165|consen  105 LLGPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKT  184 (449)
T ss_pred             hhCcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCccc
Confidence            98654  334444 569999999999999999999999999999999999999642    24689999999998764432


Q ss_pred             --------ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCC--CCCCHHHHHHHHH
Q 014406          276 --------YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY--GHDNHDQLVKIAK  335 (425)
Q Consensus       276 --------~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~--~~~~~~~~~~~~~  335 (425)
                              .....||-.||+=...++ ..-+.+-|+-|+|-+++++|-|..||..  ..++.+..++|-+
T Consensus       185 kqHIPYrE~KSLsGTARYMSINTHlG-rEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe  253 (449)
T KOG1165|consen  185 KQHIPYREHKSLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGE  253 (449)
T ss_pred             cccCccccccccccceeeeEeecccc-chhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhcc
Confidence                    234578999999888888 6788999999999999999999999832  2234444454443

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.90  E-value=9.2e-23  Score=176.36  Aligned_cols=195  Identities=22%  Similarity=0.385  Sum_probs=159.8

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecC-cchHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEE
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~-~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (425)
                      ....|.++++||.|+||.+|.|....+|+.||||+-+. ....++..|..+.+.|++...|..+.-+..+  ..+-.|||
T Consensus        13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e--~~ynvlVM   90 (341)
T KOG1163|consen   13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYGTE--KDYNVLVM   90 (341)
T ss_pred             eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhccc--cccceeee
Confidence            46789999999999999999999999999999999864 4557888999999999666777777777744  46677999


Q ss_pred             EeecCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCC--CCcEEEEeccccccccCCCc
Q 014406          202 EYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--LRKLRLIDWGLAEFYHPGKE  275 (425)
Q Consensus       202 e~~~~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~--~~~~kl~Dfg~a~~~~~~~~  275 (425)
                      |.+.. +|++++    +.++...+...+-|++.-++|+|.+++|||||||+|+|..-+  ...+.++|||+|+.+.+...
T Consensus        91 dLLGP-sLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t  169 (341)
T KOG1163|consen   91 DLLGP-SLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRT  169 (341)
T ss_pred             eccCc-cHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhccccc
Confidence            99865 444443    569999999999999999999999999999999999997543  35789999999987754321


Q ss_pred             --------ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 014406          276 --------YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF  321 (425)
Q Consensus       276 --------~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~  321 (425)
                              .....||..|.+=....+ ...+...|+-|+|.+|.++.-|..||.
T Consensus       170 ~~HIpyre~r~ltGTaRYASinAh~g-~eqSRRDDmeSvgYvLmYfnrG~LPWQ  222 (341)
T KOG1163|consen  170 RQHIPYREDRNLTGTARYASINAHLG-IEQSRRDDMESVGYVLMYFNRGSLPWQ  222 (341)
T ss_pred             cccCccccCCccceeeeehhhhhhhh-hhhhhhhhhhhhcceeeeeecCCCccc
Confidence                    122467778877666655 456789999999999999999999983

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.90  E-value=2.9e-23  Score=185.02  Aligned_cols=169  Identities=13%  Similarity=0.185  Sum_probs=131.6

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc--hH----------HHHHHHHHHHHhcCCCCeeeEEeEEEc
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--KK----------KIKREIKILQNLCGGPNVVKLLDIVRD  191 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~----------~~~~E~~~l~~l~~h~niv~l~~~~~~  191 (425)
                      .++|++++.||.|+||.||++.+  ++..+|+|++.+..  .+          .+.+|+..+.++ .|++|....+++..
T Consensus        30 ~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL-~~~GI~~~~d~~~~  106 (232)
T PRK10359         30 SYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRV-RSEGLASLNDFYLL  106 (232)
T ss_pred             hCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHH-HHCCCCcceEeeee
Confidence            68999999999999999999744  46689999997432  11          157899999999 99999999998764


Q ss_pred             CC------CCccEEEEEeecCCChhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEecc
Q 014406          192 QH------SKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWG  265 (425)
Q Consensus       192 ~~------~~~~~lv~e~~~~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg  265 (425)
                      ..      ....+|+|||++|.+|.++. .+++    ....+++.+|..||+.|++|+|++|+||+++++ + ++|+|||
T Consensus       107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~-~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~-g-i~liDfg  179 (232)
T PRK10359        107 AERKTLRYAHTYIMLIEYIEGVELNDMP-EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKN-G-LRIIDLS  179 (232)
T ss_pred             cccccccccCCeEEEEEEECCccHHHhh-hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCC-C-EEEEECC
Confidence            32      23578999999999998773 2333    245699999999999999999999999999987 5 9999999


Q ss_pred             ccccccCCCcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHH
Q 014406          266 LAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI  314 (425)
Q Consensus       266 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ell  314 (425)
                      ..+..........           +++. ..|+.++|+||||+++..+.
T Consensus       180 ~~~~~~e~~a~d~-----------~vle-r~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        180 GKRCTAQRKAKDR-----------IDLE-RHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             CcccccchhhHHH-----------HHHH-hHhcccccccceeEeehHHH
Confidence            8865432221111           2222 56778999999999876554

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.88  E-value=4.5e-22  Score=173.71  Aligned_cols=181  Identities=17%  Similarity=0.157  Sum_probs=137.6

Q ss_pred             EEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcch-------HHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEE
Q 014406          129 VVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK-------KKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (425)
Q Consensus       129 ~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (425)
                      +...|++|+||+||.+..  .+.+++.+.+.....       ..+.+|+++|++|.+++++.+++++.      ..+++|
T Consensus         6 ~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~------~~~lvm   77 (218)
T PRK12274          6 VNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWD------GRHLDR   77 (218)
T ss_pred             cceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc------CEEEEE
Confidence            356799999999998743  778888777764332       25789999999996678899999862      247999


Q ss_pred             EeecCCChhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeecC-CCCceEecCCCCcEEEEeccccccccCCCcc----
Q 014406          202 EYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDV-KPHNVMIDHELRKLRLIDWGLAEFYHPGKEY----  276 (425)
Q Consensus       202 e~~~~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dl-k~~NIll~~~~~~~kl~Dfg~a~~~~~~~~~----  276 (425)
                      ||+.|.+|......    ....++.|++.+|+++|++||+|||| ||.|||++.+ +.++|+|||+|.........    
T Consensus        78 eyI~G~~L~~~~~~----~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~-g~i~LIDFG~A~~~~~~~~~~r~L  152 (218)
T PRK12274         78 SYLAGAAMYQRPPR----GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQED-GSPAVIDFQLAVRGNPRARWMRLL  152 (218)
T ss_pred             eeecCccHHhhhhh----hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCC-CCEEEEECCCceecCCcchHHHHH
Confidence            99999998755322    12357889999999999999999999 7999999987 78999999999865433310    


Q ss_pred             ----------eeeccCCCccCcccccCCCCCC-CcccHHHHHHHHHHHHhCCCCCCC
Q 014406          277 ----------NVRVASRYFKGPELLVDLQDYD-YSLDMWSLGCMFAGMIFRKEPFFY  322 (425)
Q Consensus       277 ----------~~~~~t~~y~aPE~~~~~~~~~-~~~DvwslG~~l~elltg~~pf~~  322 (425)
                                .....++.|++|+...-....+ ...+.++.|+.+|.++|++.+++.
T Consensus       153 ~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~  209 (218)
T PRK12274        153 AREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE  209 (218)
T ss_pred             HHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence                      0123466677777643322334 456778999999999999998753

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.88  E-value=2.1e-22  Score=177.28  Aligned_cols=132  Identities=17%  Similarity=0.262  Sum_probs=104.2

Q ss_pred             eeeeeeCceEEEEEEEcCCCcEEEEEEecCcch------------HH-----------------HHHHHHHHHHhcCCCC
Q 014406          131 RKVGRGKYSEVFEGINVNTNERCIIKILKPVKK------------KK-----------------IKREIKILQNLCGGPN  181 (425)
Q Consensus       131 ~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~------------~~-----------------~~~E~~~l~~l~~h~n  181 (425)
                      +.||+|+||+||+|.+. +|+.||||+++....            ..                 ..+|+.++.++ .+++
T Consensus         3 ~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~   80 (190)
T cd05147           3 GCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRL-VTAG   80 (190)
T ss_pred             CccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHH-HHCC
Confidence            57999999999999876 899999999964321            11                 23499999999 6666


Q ss_pred             eeeEEeEEEcCCCCccEEEEEeecCCChhhh-c--CCCCHHHHHHHHHHHHHHHHHH-HHCCceeecCCCCceEecCCCC
Q 014406          182 VVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-Y--PTLTDYDIRYYIYELLKALDYC-HSQGIMHRDVKPHNVMIDHELR  257 (425)
Q Consensus       182 iv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~-~--~~l~~~~~~~i~~~i~~~L~~L-H~~~ivH~Dlk~~NIll~~~~~  257 (425)
                      +.....+...    ..++||||++++++... +  ..++...+..++.|++.+|.|| |+.||+||||||+|||++.  +
T Consensus        81 v~~p~~~~~~----~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~~--~  154 (190)
T cd05147          81 IPCPEPILLK----SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYHD--G  154 (190)
T ss_pred             CCCCcEEEec----CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEEC--C
Confidence            5433322211    22799999999876543 2  4588899999999999999999 7999999999999999984  5


Q ss_pred             cEEEEeccccccc
Q 014406          258 KLRLIDWGLAEFY  270 (425)
Q Consensus       258 ~~kl~Dfg~a~~~  270 (425)
                      .++|+|||+|...
T Consensus       155 ~v~LiDFG~a~~~  167 (190)
T cd05147         155 KLYIIDVSQSVEH  167 (190)
T ss_pred             cEEEEEccccccC
Confidence            7999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.88  E-value=3.9e-22  Score=183.05  Aligned_cols=229  Identities=21%  Similarity=0.300  Sum_probs=140.7

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecC------cchHHHHHHHHHHHHhcC---------CCCeeeEEeEEE
Q 014406          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP------VKKKKIKREIKILQNLCG---------GPNVVKLLDIVR  190 (425)
Q Consensus       126 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~------~~~~~~~~E~~~l~~l~~---------h~niv~l~~~~~  190 (425)
                      .+...+.||.|++|.||.+++..+++.+|+|++..      ...+++++|.-....+.+         |-.++.-++...
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            45677889999999999999999999999999742      223556666544443311         222333333222


Q ss_pred             cC---------CCC------ccEEEEEeecCCChhhhcC------CC----CHHHHHHHHHHHHHHHHHHHHCCceeecC
Q 014406          191 DQ---------HSK------TPSLIFEYVNSTDFKVLYP------TL----TDYDIRYYIYELLKALDYCHSQGIMHRDV  245 (425)
Q Consensus       191 ~~---------~~~------~~~lv~e~~~~~~l~~~~~------~l----~~~~~~~i~~~i~~~L~~LH~~~ivH~Dl  245 (425)
                      .+         .+.      ..+++|+-+. ++|..++.      ..    .......+..|+++.+++||..|+||+||
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi  171 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI  171 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred             EcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence            11         111      2356666663 45555431      11    11223445689999999999999999999


Q ss_pred             CCCceEecCCCCcEEEEeccccccccCCCcceeeccCCCccCcccccCC-------CCCCCcccHHHHHHHHHHHHhCCC
Q 014406          246 KPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL-------QDYDYSLDMWSLGCMFAGMIFRKE  318 (425)
Q Consensus       246 k~~NIll~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~-------~~~~~~~DvwslG~~l~elltg~~  318 (425)
                      +|+|++++.+ |.+.|+||+......  ........+..|.+||.....       ..++.+.|.|++|+++|.|.+|+.
T Consensus       172 ~~~nfll~~~-G~v~Lg~F~~~~r~g--~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l  248 (288)
T PF14531_consen  172 KPENFLLDQD-GGVFLGDFSSLVRAG--TRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL  248 (288)
T ss_dssp             SGGGEEE-TT-S-EEE--GGGEEETT--EEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred             ceeeEEEcCC-CCEEEcChHHHeecC--ceeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence            9999999998 899999998775433  222224455678899876431       247889999999999999999999


Q ss_pred             CCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcC
Q 014406          319 PFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQ  398 (425)
Q Consensus       319 pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~  398 (425)
                      ||.......           ..+                           +   ....+. .+++.+++||+.+|++||+
T Consensus       249 Pf~~~~~~~-----------~~~---------------------------~---~f~~C~-~~Pe~v~~LI~~lL~~~~~  286 (288)
T PF14531_consen  249 PFGLSSPEA-----------DPE---------------------------W---DFSRCR-DMPEPVQFLIRGLLQRNPE  286 (288)
T ss_dssp             STCCCGGGS-----------TSG---------------------------G---GGTTSS----HHHHHHHHHHT-SSGG
T ss_pred             CCCCCCccc-----------ccc---------------------------c---cchhcC-CcCHHHHHHHHHHccCCcc
Confidence            993211000           000                           0   011222 4799999999999999999


Q ss_pred             CC
Q 014406          399 DR  400 (425)
Q Consensus       399 ~R  400 (425)
                      +|
T Consensus       287 ~R  288 (288)
T PF14531_consen  287 DR  288 (288)
T ss_dssp             GS
T ss_pred             cC
Confidence            88

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.87  E-value=2.4e-21  Score=171.00  Aligned_cols=134  Identities=17%  Similarity=0.205  Sum_probs=106.7

Q ss_pred             EeeeeeeCceEEEEEEEcCCCcEEEEEEecCcch-----------------------------HHHHHHHHHHHHhcCCC
Q 014406          130 VRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK-----------------------------KKIKREIKILQNLCGGP  180 (425)
Q Consensus       130 ~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~-----------------------------~~~~~E~~~l~~l~~h~  180 (425)
                      .+.||+|+||+||+|.+. +|+.||||+++....                             ..+..|...+.++ .++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~   79 (190)
T cd05145           2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRL-YEA   79 (190)
T ss_pred             CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHH-HhC
Confidence            357999999999999876 899999999875321                             1135788999999 788


Q ss_pred             CeeeEEeEEEcCCCCccEEEEEeecCCChhhh-c--CCCCHHHHHHHHHHHHHHHHHHHH-CCceeecCCCCceEecCCC
Q 014406          181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-Y--PTLTDYDIRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHEL  256 (425)
Q Consensus       181 niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~-~--~~l~~~~~~~i~~~i~~~L~~LH~-~~ivH~Dlk~~NIll~~~~  256 (425)
                      ++.....+...    ..+|||||++++++... +  ..++..+...++.|++.++.+||+ .||+||||||+|||++ + 
T Consensus        80 ~i~~p~~~~~~----~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~-  153 (190)
T cd05145          80 GVPVPEPILLK----KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-D-  153 (190)
T ss_pred             CCCCceEEEec----CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-C-
Confidence            87544443322    23799999998854322 2  346778899999999999999999 9999999999999998 5 


Q ss_pred             CcEEEEecccccccc
Q 014406          257 RKLRLIDWGLAEFYH  271 (425)
Q Consensus       257 ~~~kl~Dfg~a~~~~  271 (425)
                      +.++|+|||++....
T Consensus       154 ~~~~liDFG~a~~~~  168 (190)
T cd05145         154 GKPYIIDVSQAVELD  168 (190)
T ss_pred             CCEEEEEcccceecC
Confidence            689999999997654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.86  E-value=5.3e-22  Score=182.96  Aligned_cols=195  Identities=20%  Similarity=0.283  Sum_probs=133.7

Q ss_pred             cCCCCeeeEEeEEEcC-------------------------CCCccEEEEEeecCCChhhhc--CCCCHHHHHHHHHHHH
Q 014406          177 CGGPNVVKLLDIVRDQ-------------------------HSKTPSLIFEYVNSTDFKVLY--PTLTDYDIRYYIYELL  229 (425)
Q Consensus       177 ~~h~niv~l~~~~~~~-------------------------~~~~~~lv~e~~~~~~l~~~~--~~l~~~~~~~i~~~i~  229 (425)
                      ..|||||++.+.|.++                         ++..+||||..+... |..++  +..+....+.++.|++
T Consensus       273 a~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~t-Lr~yl~~~~~s~r~~~~~laQlL  351 (598)
T KOG4158|consen  273 AKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQT-LREYLWTRHRSYRTGRVILAQLL  351 (598)
T ss_pred             CCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhh-HHHHHhcCCCchHHHHHHHHHHH
Confidence            3799999999887652                         345677888776654 44443  4577778888999999


Q ss_pred             HHHHHHHHCCceeecCCCCceEecC---CCCcEEEEeccccccccC-------CCcceeeccCCCccCcccccCCCCC--
Q 014406          230 KALDYCHSQGIMHRDVKPHNVMIDH---ELRKLRLIDWGLAEFYHP-------GKEYNVRVASRYFKGPELLVDLQDY--  297 (425)
Q Consensus       230 ~~L~~LH~~~ivH~Dlk~~NIll~~---~~~~~kl~Dfg~a~~~~~-------~~~~~~~~~t~~y~aPE~~~~~~~~--  297 (425)
                      +|+.|||++||.|||+|++|||+.-   .-..+.|+|||++--...       ........|.-..||||+.......  
T Consensus       352 Eav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~a  431 (598)
T KOG4158|consen  352 EAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNA  431 (598)
T ss_pred             HHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCce
Confidence            9999999999999999999999832   223589999998732211       0111223456678999997542111  


Q ss_pred             ---CCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCChhhHHHhcccCCCCcccccc
Q 014406          298 ---DYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFIN  374 (425)
Q Consensus       298 ---~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  374 (425)
                         -.+.|.|+.|.+.||+++...||+....-.-...                .|...                    -.
T Consensus       432 vvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r----------------~Yqe~--------------------qL  475 (598)
T KOG4158|consen  432 VVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTR----------------TYQES--------------------QL  475 (598)
T ss_pred             eeccchhhhhhhhhhHHHHhccCCcccccchheechh----------------hhhhh--------------------hC
Confidence               1489999999999999999999964110000000                00000                    00


Q ss_pred             ccCCCCCCHHHHHHHHHcccCCcCCCcCH---HHHhc
Q 014406          375 ADNQHLVSPEAIDFLDKLLRYDHQDRLTA---REAMA  408 (425)
Q Consensus       375 ~~~~~~~s~~~~~ll~~~L~~dP~~Rpta---~elL~  408 (425)
                      ......+++.+++++..+|+.||++|+++   +.+|+
T Consensus       476 Palp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~  512 (598)
T KOG4158|consen  476 PALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVLN  512 (598)
T ss_pred             CCCcccCChHHHHHHHHHhcCCccccCCccHHHhHHH
Confidence            11223478999999999999999999984   45554

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.85  E-value=5.1e-22  Score=202.87  Aligned_cols=242  Identities=20%  Similarity=0.372  Sum_probs=167.8

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc----hHHHHHHHHHHH-HhcCCCCeeeEEeEEEcCCCCccEEE
Q 014406          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQ-NLCGGPNVVKLLDIVRDQHSKTPSLI  200 (425)
Q Consensus       126 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~-~l~~h~niv~l~~~~~~~~~~~~~lv  200 (425)
                      +|...+.||++.|=.|.+|++.. | .|+||++-+..    ...+.++++-++ .+.++||++.+..+...  .+..|||
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~e-G-~vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t--~kAAylv   99 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDRE-G-LVVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVT--DKAAYLV   99 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCC-c-eEEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHh--hHHHHHH
Confidence            67778899999999999996543 3 49999985433    233443333222 22389999998877643  4677889


Q ss_pred             EEeecCCChhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEecccccccc--CC--C
Q 014406          201 FEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH--PG--K  274 (425)
Q Consensus       201 ~e~~~~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~--~~--~  274 (425)
                      -+|..+...+.+-  +-+..-+.+.|+.|++.||..+|+.||+|+|||.+|||+++- +-+.|+||..-+...  .+  .
T Consensus       100 RqyvkhnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSW-NW~~LtDFAsFKPtYLPeDNPa  178 (1431)
T KOG1240|consen  100 RQYVKHNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSW-NWLYLTDFASFKPTYLPEDNPA  178 (1431)
T ss_pred             HHHHhhhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeee-chhhhhcccccCCccCCCCCcc
Confidence            8898776544432  226677888999999999999999999999999999999998 678999998665331  11  1


Q ss_pred             cc----eeeccCCCccCcccccCCC----------CCCCcccHHHHHHHHHHHHhC-CCCCCCCCCCHHHHHHHHHHhCC
Q 014406          275 EY----NVRVASRYFKGPELLVDLQ----------DYDYSLDMWSLGCMFAGMIFR-KEPFFYGHDNHDQLVKIAKVLGT  339 (425)
Q Consensus       275 ~~----~~~~~t~~y~aPE~~~~~~----------~~~~~~DvwslG~~l~elltg-~~pf~~~~~~~~~~~~~~~~lg~  339 (425)
                      .+    .+.....+|.|||-+....          ..+.+-||||+||+++||++- +.||     +..++-..... +.
T Consensus       179 df~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF-----~LSQL~aYr~~-~~  252 (1431)
T KOG1240|consen  179 DFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLF-----TLSQLLAYRSG-NA  252 (1431)
T ss_pred             cceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcc-----cHHHHHhHhcc-Cc
Confidence            22    2233445799999986521          146789999999999999874 5555     12222211110 01


Q ss_pred             chhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcC
Q 014406          340 DELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  409 (425)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~h  409 (425)
                      ...+..+++                           -    -+..++.++..|++.||++|.+|++.|+-
T Consensus       253 ~~~e~~Le~---------------------------I----ed~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  253 DDPEQLLEK---------------------------I----EDVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             cCHHHHHHh---------------------------C----cCccHHHHHHHHHccCchhccCHHHHHHh
Confidence            111111110                           0    14578899999999999999999999975

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.84  E-value=9.5e-21  Score=196.81  Aligned_cols=194  Identities=20%  Similarity=0.403  Sum_probs=152.9

Q ss_pred             cCCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcchHHHHHHHHHHHHhc--CCCCeeeEEeEEEcCCCCccE
Q 014406          121 WGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLC--GGPNVVKLLDIVRDQHSKTPS  198 (425)
Q Consensus       121 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~--~h~niv~l~~~~~~~~~~~~~  198 (425)
                      ....+.|.|.+.||+|+||+||+|...+ |+.||+|+-++...-+|--=.+++.+|.  --+-|+.+...+.-.++.  +
T Consensus       694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S--~  770 (974)
T KOG1166|consen  694 EVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICLQVMERLKPQMLPSIMHISSAHVFQNAS--V  770 (974)
T ss_pred             eecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehHHHHHhhchhhhcchHHHHHHHccCCcc--e
Confidence            3446789999999999999999998776 9999999998766544333333344441  113344444433334333  4


Q ss_pred             EEEEeecCCChhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecC------CCCcEEEEeccccc-
Q 014406          199 LIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH------ELRKLRLIDWGLAE-  268 (425)
Q Consensus       199 lv~e~~~~~~l~~~~~---~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~------~~~~~kl~Dfg~a~-  268 (425)
                      ||+||.+.|+|.+++.   .+++..+..++.|++.-+++||..+|||+||||+|+||..      +...++|+|||.+- 
T Consensus       771 lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siD  850 (974)
T KOG1166|consen  771 LVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSID  850 (974)
T ss_pred             eeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEeccccee
Confidence            9999999999998884   4888889999999999999999999999999999999942      23468999999884 


Q ss_pred             --cccCCCcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCC
Q 014406          269 --FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKE  318 (425)
Q Consensus       269 --~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~  318 (425)
                        ...++.......+|-.+--+|+..| ..|++.+|.|.++.+++-||.|+.
T Consensus       851 m~lfp~~~~F~~~~~td~f~C~EM~~g-rpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  851 MKLFPDGTKFKAVWHTDLFDCIEMREG-RPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             eeEcCCCcEEeeeeccccchhHHHhcC-CCCchhhhhHHHHHHHHHHHHHHH
Confidence              3344456677888999999999988 899999999999999999999973

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.84  E-value=2e-21  Score=170.83  Aligned_cols=235  Identities=17%  Similarity=0.239  Sum_probs=173.5

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEE
Q 014406          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (425)
Q Consensus       126 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (425)
                      +..++.+|.+...|+.|+|++.  |..+++|+++..     ....|..|.-.|+-+ .||||+.+++.|..+  -++.++
T Consensus       191 ~lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~risrdfneefp~lrif-shpnilpvlgacnsp--pnlv~i  265 (448)
T KOG0195|consen  191 SLNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTARISRDFNEEFPALRIF-SHPNILPVLGACNSP--PNLVII  265 (448)
T ss_pred             hhhhhhhhccCCCccccccccc--CcchhhhhhhhhhcchhhcchhhhhCcceeee-cCCchhhhhhhccCC--CCceEe
Confidence            4456678999999999999774  556777887643     235788999999988 999999999999654  678899


Q ss_pred             EEeecCCChhhhcCC-----CCHHHHHHHHHHHHHHHHHHHHCC--ceeecCCCCceEecCCCCcEEEEeccccccccCC
Q 014406          201 FEYVNSTDFKVLYPT-----LTDYDIRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (425)
Q Consensus       201 ~e~~~~~~l~~~~~~-----l~~~~~~~i~~~i~~~L~~LH~~~--ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~  273 (425)
                      ..||+-|+|...+..     .+..+...++.++++|++|||+..  |----|.+..+++|++ -+++|+ .+-+++..  
T Consensus       266 sq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmided-ltaris-mad~kfsf--  341 (448)
T KOG0195|consen  266 SQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDED-LTARIS-MADTKFSF--  341 (448)
T ss_pred             eeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecch-hhhhee-cccceeee--
Confidence            999999999988854     566788999999999999999863  4455789999999998 455554 22222211  


Q ss_pred             CcceeeccCCCccCcccccCCCCC---CCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhcc
Q 014406          274 KEYNVRVASRYFKGPELLVDLQDY---DYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH  350 (425)
Q Consensus       274 ~~~~~~~~t~~y~aPE~~~~~~~~---~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~  350 (425)
                       ........+.||+||.+.. .+-   -.++|+|||++++|||.|...|| ....+.+.-.++.           ++.  
T Consensus       342 -qe~gr~y~pawmspealqr-kped~n~raadmwsfaillwel~trevpf-adlspmecgmkia-----------leg--  405 (448)
T KOG0195|consen  342 -QEVGRAYSPAWMSPEALQR-KPEDLNIRAADMWSFAILLWELNTREVPF-ADLSPMECGMKIA-----------LEG--  405 (448)
T ss_pred             -eccccccCcccCCHHHHhc-CchhcchhhhhHHHHHHHHHHhhcccccc-ccCCchhhhhhhh-----------hcc--
Confidence             1223455788999999976 332   25899999999999999999998 3333333222221           000  


Q ss_pred             CCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHh
Q 014406          351 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM  407 (425)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL  407 (425)
                                            ++...+..++..+..|+.-|++.||.+||....++
T Consensus       406 ----------------------lrv~ippgis~hm~klm~icmnedpgkrpkfdmiv  440 (448)
T KOG0195|consen  406 ----------------------LRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIV  440 (448)
T ss_pred             ----------------------ccccCCCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence                                  11122233788999999999999999999876653

>PRK10345 hypothetical protein; Provisional

Probab=99.83  E-value=4.7e-20  Score=163.88  Aligned_cols=133  Identities=19%  Similarity=0.239  Sum_probs=104.4

Q ss_pred             EeeeeeeCceEEEEEEEcCCCcEEEEEEecCc---chHHHHHHHHHHHHhc----CCCCeeeEEeEEEcCCC-Cc-cEEE
Q 014406          130 VRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLC----GGPNVVKLLDIVRDQHS-KT-PSLI  200 (425)
Q Consensus       130 ~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~----~h~niv~l~~~~~~~~~-~~-~~lv  200 (425)
                      .+.||+|+||.||.  +..++.. +||++...   ..+.+.+|+.+++.+.    .||||++++|++.++.+ .. ..+|
T Consensus         7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I   83 (210)
T PRK10345          7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI   83 (210)
T ss_pred             cceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence            35799999999996  6777666 69988654   4567899999999993    47999999999987543 23 3378


Q ss_pred             EEe--ecCCChhhhcCC--CCHHHHHHHHHHHHHHH-HHHHHCCceeecCCCCceEecCC---CCcEEEEecccc
Q 014406          201 FEY--VNSTDFKVLYPT--LTDYDIRYYIYELLKAL-DYCHSQGIMHRDVKPHNVMIDHE---LRKLRLIDWGLA  267 (425)
Q Consensus       201 ~e~--~~~~~l~~~~~~--l~~~~~~~i~~~i~~~L-~~LH~~~ivH~Dlk~~NIll~~~---~~~~kl~Dfg~a  267 (425)
                      +||  +.+++|.+++..  +++.  ..++.+++.++ +|||+++|+||||||+|||++..   ...++|+||+.+
T Consensus        84 ~e~~G~~~~tL~~~l~~~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~  156 (210)
T PRK10345         84 ADFDGKPSITLTEFAEQCRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE  156 (210)
T ss_pred             ecCCCCcchhHHHHHHcccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence            999  447899988853  4444  35678888888 99999999999999999999743   247999995444

>smart00090 RIO RIO-like kinase

Probab=99.81  E-value=2e-19  Score=163.75  Aligned_cols=136  Identities=15%  Similarity=0.199  Sum_probs=107.4

Q ss_pred             CEEEEeeeeeeCceEEEEEE-EcCCCcEEEEEEecCcch---------------------------HHHHHHHHHHHHhc
Q 014406          126 DYEVVRKVGRGKYSEVFEGI-NVNTNERCIIKILKPVKK---------------------------KKIKREIKILQNLC  177 (425)
Q Consensus       126 ~y~~~~~LG~G~fg~V~~~~-~~~~~~~vavK~~~~~~~---------------------------~~~~~E~~~l~~l~  177 (425)
                      -|++.+.||+|+||.||+|. +..+|+.||+|+++....                           ..+.+|+.++.++ 
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L-  107 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL-  107 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH-
Confidence            47778899999999999998 678999999999864310                           1246899999999 


Q ss_pred             CC--CCeeeEEeEEEcCCCCccEEEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCC-ceeecCCCCceE
Q 014406          178 GG--PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQG-IMHRDVKPHNVM  251 (425)
Q Consensus       178 ~h--~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~-ivH~Dlk~~NIl  251 (425)
                      .+  ..+.+++++   .   ..++||||+++.++....   ..+.......++.|++.++.+||+.| |+|+||||+||+
T Consensus       108 ~~~~i~~p~~~~~---~---~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIl  181 (237)
T smart00090      108 YEAGVPVPKPIAW---R---RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNIL  181 (237)
T ss_pred             HhcCCCCCeeeEe---c---CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEE
Confidence            44  223444432   1   237999999998876543   23455567889999999999999999 999999999999


Q ss_pred             ecCCCCcEEEEeccccccc
Q 014406          252 IDHELRKLRLIDWGLAEFY  270 (425)
Q Consensus       252 l~~~~~~~kl~Dfg~a~~~  270 (425)
                      ++ + +.++|+|||.+...
T Consensus       182 i~-~-~~i~LiDFg~a~~~  198 (237)
T smart00090      182 VH-D-GKVVIIDVSQSVEL  198 (237)
T ss_pred             EE-C-CCEEEEEChhhhcc
Confidence            99 4 68999999998743

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.78  E-value=1.9e-18  Score=155.23  Aligned_cols=131  Identities=25%  Similarity=0.380  Sum_probs=109.1

Q ss_pred             eeeeeeCceEEEEEEEcCCCcEEEEEEecCcc-----------hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEE
Q 014406          131 RKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (425)
Q Consensus       131 ~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (425)
                      +.||+|++|.||+|.+  ++..+++|+.....           ...+.+|+.++..+ .|+++.....++.+.  ...++
T Consensus         2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~p~~~~~~~--~~~~l   76 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRA-RKAGVNVPAVYFVDP--ENFII   76 (211)
T ss_pred             cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHH-HHCCCCCCeEEEEeC--CCCEE
Confidence            4799999999999976  67789999865321           13577899999999 788887766666543  45679


Q ss_pred             EEEeecCCChhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEecccccc
Q 014406          200 IFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (425)
Q Consensus       200 v~e~~~~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~  269 (425)
                      +|||++|++|.+.+..... ....++.+++.+|.+||+.+++|+|++|.|||++ + +.++|+|||++..
T Consensus        77 v~e~~~G~~L~~~~~~~~~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~-~~~~liDf~~a~~  143 (211)
T PRK14879         77 VMEYIEGEPLKDLINSNGM-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-G-GKIYLIDFGLAEF  143 (211)
T ss_pred             EEEEeCCcCHHHHHHhccH-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-C-CCEEEEECCcccC
Confidence            9999999999988765555 7788999999999999999999999999999999 4 6899999999865

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.77  E-value=5.3e-18  Score=150.84  Aligned_cols=133  Identities=20%  Similarity=0.349  Sum_probs=105.3

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc-------------------------hHHHHHHHHHHHHhcCCC
Q 014406          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-------------------------KKKIKREIKILQNLCGGP  180 (425)
Q Consensus       126 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~-------------------------~~~~~~E~~~l~~l~~h~  180 (425)
                      .|.+.+.||+|+||.||+|.. .+|+.+|||++....                         ......|+.++..+ .+.
T Consensus        16 ~~~~~~~i~~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~   93 (198)
T cd05144          16 VESLGNQIGVGKESDVYLALD-PDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKAL-YEE   93 (198)
T ss_pred             hhhcCCccccCcceEEEEEEc-CCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHH-HHc
Confidence            367778999999999999976 479999999875321                         11256788889988 666


Q ss_pred             --CeeeEEeEEEcCCCCccEEEEEeecCCChhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCc
Q 014406          181 --NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRK  258 (425)
Q Consensus       181 --niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~  258 (425)
                        .+...++.      ...++||||++++++......   .....++.+++.++.++|+.||+|+||||+||+++.+ +.
T Consensus        94 ~i~v~~~~~~------~~~~lv~e~~~g~~L~~~~~~---~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~-~~  163 (198)
T cd05144          94 GFPVPKPIDW------NRHAVVMEYIDGVELYRVRVL---EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDD-EK  163 (198)
T ss_pred             CCCCCceeec------CCceEEEEEeCCcchhhcccc---ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCC-Cc
Confidence              44444432      234799999999998766431   3456788999999999999999999999999999987 78


Q ss_pred             EEEEeccccccc
Q 014406          259 LRLIDWGLAEFY  270 (425)
Q Consensus       259 ~kl~Dfg~a~~~  270 (425)
                      ++|+|||++...
T Consensus       164 ~~liDfg~~~~~  175 (198)
T cd05144         164 IYIIDWPQMVST  175 (198)
T ss_pred             EEEEECCccccC
Confidence            999999998644

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.76  E-value=3.4e-19  Score=170.81  Aligned_cols=173  Identities=19%  Similarity=0.388  Sum_probs=132.1

Q ss_pred             ccEEEEEeecCCChhhhcC------CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEecccccc
Q 014406          196 TPSLIFEYVNSTDFKVLYP------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (425)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~~------~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~  269 (425)
                      ++++.|+++...+|.+++.      ..+......++.|++.|++|   ++.+|+|+||.||++..+ ..+||+|||+...
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d-~q~kIgDFgl~ts  405 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDD-DQLKIGDFGLVTS  405 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccc-hhhhhhhhhheee
Confidence            5889999999999999983      36677788999999999999   999999999999999888 6899999999876


Q ss_pred             ccCCC-------cceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCCch
Q 014406          270 YHPGK-------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDE  341 (425)
Q Consensus       270 ~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~lg~~~  341 (425)
                      .....       ..+..+||..||+||.+.+ ..|+.++||||||++|+|++. -...|       +....+.+. ....
T Consensus       406 ~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g-~~y~~kvdIyaLGlil~EL~~~f~T~~-------er~~t~~d~-r~g~  476 (516)
T KOG1033|consen  406 QDKDETVAPAAASHTQQVGTLLYMSPEQIRG-QQYSEKVDIYALGLILAELLIQFSTQF-------ERIATLTDI-RDGI  476 (516)
T ss_pred             cccCCcccchhhhhhhcccccccCCHHHHhh-hhhhhhcchhhHHHHHHHHHHHhccHH-------HHHHhhhhh-hcCC
Confidence            65444       4566799999999999998 789999999999999999996 22122       111111110 0000


Q ss_pred             hHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCc
Q 014406          342 LNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA  413 (425)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~  413 (425)
                                 +++.                +..     --++-.+|+.+||...|.+||++.+.-.|+|++
T Consensus       477 -----------ip~~----------------~~~-----d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~~  516 (516)
T KOG1033|consen  477 -----------IPPE----------------FLQ-----DYPEEYTLLQQLLSPSPEERPSAIEVALHEFLQ  516 (516)
T ss_pred             -----------CChH----------------Hhh-----cCcHHHHHHHHhcCCCcccCchHHHHhhhhhcC
Confidence                       0000                000     123456899999999999999988888888763

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.75  E-value=1.6e-17  Score=147.77  Aligned_cols=127  Identities=21%  Similarity=0.390  Sum_probs=99.7

Q ss_pred             eeeeeCceEEEEEEEcCCCcEEEEEEecCcc-----------hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEE
Q 014406          132 KVGRGKYSEVFEGINVNTNERCIIKILKPVK-----------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (425)
Q Consensus       132 ~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (425)
                      .||+|+||+||+|.  .++..+++|......           ..++.+|++++..+ .++++.....++...  ...++|
T Consensus         1 ~ig~G~~~~vy~~~--~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~p~~~~~~~--~~~~lv   75 (199)
T TIGR03724         1 LIAKGAEAIIYLGD--FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRA-RKAGVNTPVVYDVDP--DNKTIV   75 (199)
T ss_pred             CCCCCceEEEEEee--cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHH-HHCCCCCCEEEEEEC--CCCEEE
Confidence            38999999999997  357789999864321           24567899999999 666554433333333  345799


Q ss_pred             EEeecCCChhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEecccccc
Q 014406          201 FEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (425)
Q Consensus       201 ~e~~~~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~  269 (425)
                      |||++|+++...+.....    .++.+++.+|.+||+.|++|+|++|.||+++ + +.++++|||++..
T Consensus        76 ~e~~~g~~l~~~~~~~~~----~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~-~~~~liDfg~a~~  138 (199)
T TIGR03724        76 MEYIEGKPLKDVIEEGND----ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-D-DKLYLIDFGLGKY  138 (199)
T ss_pred             EEEECCccHHHHHhhcHH----HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-C-CcEEEEECCCCcC
Confidence            999999999877543221    7899999999999999999999999999999 4 6899999999865

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.74  E-value=1.5e-17  Score=169.84  Aligned_cols=134  Identities=19%  Similarity=0.351  Sum_probs=105.9

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEe--cCc---------chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCC
Q 014406          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL--KPV---------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH  193 (425)
Q Consensus       125 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~--~~~---------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  193 (425)
                      ..|...+.||+|+||+||+|.+....  +++|..  +..         ..+.+.+|++++..+ +|++++....++.+. 
T Consensus       333 ~~~~~~~~iG~G~~g~Vy~~~~~~~~--~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~p~~~~~~~-  408 (535)
T PRK09605        333 RRKIPDHLIGKGAEADIKKGEYLGRD--AVIKERVPKGYRHPELDERLRTERTRAEARLLSEA-RRAGVPTPVIYDVDP-  408 (535)
T ss_pred             cccCccceeccCCcEEEEEEeecCcc--ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhh-cccCCCeeEEEEEeC-
Confidence            34566789999999999999765443  333332  111         124578899999999 899998877766543 


Q ss_pred             CCccEEEEEeecCCChhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccc
Q 014406          194 SKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  270 (425)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~  270 (425)
                       ...++||||+++++|.+++.     ....++.+++.+|.|||+.|++||||||+|||++ + +.++|+|||+++..
T Consensus       409 -~~~~lv~E~~~g~~L~~~l~-----~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~-~-~~~~liDFGla~~~  477 (535)
T PRK09605        409 -EEKTIVMEYIGGKDLKDVLE-----GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR-D-DRLYLIDFGLGKYS  477 (535)
T ss_pred             -CCCEEEEEecCCCcHHHHHH-----HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE-C-CcEEEEeCcccccC
Confidence             45679999999999988764     4577899999999999999999999999999994 3 57999999999753

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.74  E-value=1.1e-17  Score=163.32  Aligned_cols=200  Identities=22%  Similarity=0.356  Sum_probs=148.2

Q ss_pred             HHhcCCCCeeeEEeEEEcCCCCccEEEEEeecCCChhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCc-eeecCCCC
Q 014406          174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGI-MHRDVKPH  248 (425)
Q Consensus       174 ~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~----~l~~~~~~~i~~~i~~~L~~LH~~~i-vH~Dlk~~  248 (425)
                      +.+ .|.|+.+++|.+.++  ...+.|.+|+..|+|.+.+.    ++++.....++++|+.||.|||+-.| .|+.+++.
T Consensus         2 ~~l-~h~n~~~f~g~~~~~--~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~   78 (484)
T KOG1023|consen    2 RQL-DHDNLNKFIGASVDG--PEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSS   78 (484)
T ss_pred             ccc-chhhhhhheeeEecC--CceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccc
Confidence            456 899999999999776  77889999999999999874    37777788899999999999998755 99999999


Q ss_pred             ceEecCCCCcEEEEeccccccccCC---CcceeeccCCCccCcccccCCCC------CCCcccHHHHHHHHHHHHhCCCC
Q 014406          249 NVMIDHELRKLRLIDWGLAEFYHPG---KEYNVRVASRYFKGPELLVDLQD------YDYSLDMWSLGCMFAGMIFRKEP  319 (425)
Q Consensus       249 NIll~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~------~~~~~DvwslG~~l~elltg~~p  319 (425)
                      |+++|.. ..+||+|||+.......   ...........|.|||.+.+...      .+.+.||||||++++|+++...|
T Consensus        79 nClvd~~-w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~  157 (484)
T KOG1023|consen   79 NCLVDSR-WVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP  157 (484)
T ss_pred             cceeeee-EEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence            9999998 79999999998765321   11122233456999999876211      46679999999999999999999


Q ss_pred             CCCCCCCHHH---HHHHHHHhCCchhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCC
Q 014406          320 FFYGHDNHDQ---LVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYD  396 (425)
Q Consensus       320 f~~~~~~~~~---~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~d  396 (425)
                      |.......+.   ...+.+ .+...           +.+.                +...+  .+.+++..++..||..+
T Consensus       158 ~~~~~~~~~~~eii~~~~~-~~~~~-----------~rP~----------------i~~~~--e~~~~l~~l~~~cw~e~  207 (484)
T KOG1023|consen  158 FDLRNLVEDPDEIILRVKK-GGSNP-----------FRPS----------------IELLN--ELPPELLLLVARCWEEI  207 (484)
T ss_pred             cccccccCChHHHHHHHHh-cCCCC-----------cCcc----------------hhhhh--hcchHHHHHHHHhcccC
Confidence            9664444332   222111 01100           0000                00000  24568999999999999


Q ss_pred             cCCCcCHHHHh
Q 014406          397 HQDRLTAREAM  407 (425)
Q Consensus       397 P~~Rpta~elL  407 (425)
                      |++||+++++-
T Consensus       208 P~~rPs~~~i~  218 (484)
T KOG1023|consen  208 PEKRPSIEQIR  218 (484)
T ss_pred             hhhCccHHHHH
Confidence            99999998773

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.71  E-value=5.9e-19  Score=179.85  Aligned_cols=255  Identities=22%  Similarity=0.368  Sum_probs=192.4

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEc-CCCcEEEEEEecCcc-----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCcc
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINV-NTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~-~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (425)
                      ...|.+.+.||+|+|+.|-..... .....+|+|.+....     ...+..|..+-..+.+|+|++++++...+.  ...
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~--~~~   96 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSP--RSY   96 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCC--ccc
Confidence            445666777999999999887653 344566777665332     234456777777774599999999988554  667


Q ss_pred             EEEEEeecCCChhhhc-C----CCCHHHHHHHHHHHHHHHHHHH-HCCceeecCCCCceEecCCCC-cEEEEeccccccc
Q 014406          198 SLIFEYVNSTDFKVLY-P----TLTDYDIRYYIYELLKALDYCH-SQGIMHRDVKPHNVMIDHELR-KLRLIDWGLAEFY  270 (425)
Q Consensus       198 ~lv~e~~~~~~l~~~~-~----~l~~~~~~~i~~~i~~~L~~LH-~~~ivH~Dlk~~NIll~~~~~-~~kl~Dfg~a~~~  270 (425)
                      +++++|..++++...+ .    ..+......++.|+..++.|+| ..++.|+|+||+|.+++.. + .++++|||+|...
T Consensus        97 ~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s-~~~l~~~df~~At~~  175 (601)
T KOG0590|consen   97 LLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDES-GSALKIADFGLATAY  175 (601)
T ss_pred             ccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccC-CCcccCCCchhhccc
Confidence            7999999999887766 2    3566778889999999999999 9999999999999999988 5 8999999999877


Q ss_pred             cC-CC---cceeecc-CCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHH
Q 014406          271 HP-GK---EYNVRVA-SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAY  345 (425)
Q Consensus       271 ~~-~~---~~~~~~~-t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~  345 (425)
                      .. .+   .....+| ++.|+|||...+........|+||.|+++.-+++|..|+.............            
T Consensus       176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~------------  243 (601)
T KOG0590|consen  176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSW------------  243 (601)
T ss_pred             cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceee------------
Confidence            65 22   2234577 9999999999874456789999999999999999999984332221100000            


Q ss_pred             HhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcc
Q 014406          346 LNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ  414 (425)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~  414 (425)
                      .+.                     ...........++....+++.+++..+|+.|.+.+++..+||+..
T Consensus       244 ~~~---------------------~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  244 KSN---------------------KGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS  291 (601)
T ss_pred             ccc---------------------ccccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence            000                     000111122336888999999999999999999999999999988

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.70  E-value=1.5e-16  Score=140.02  Aligned_cols=133  Identities=20%  Similarity=0.324  Sum_probs=96.5

Q ss_pred             EeeeeeeCceEEEEEEEcCCCcEEEEEEecCcch-----HHH----------------------HHHHHHHHHhcCC-CC
Q 014406          130 VRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK-----KKI----------------------KREIKILQNLCGG-PN  181 (425)
Q Consensus       130 ~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~-----~~~----------------------~~E~~~l~~l~~h-~n  181 (425)
                      .+.||+|+||+||+|.+. +++.||||++.....     ...                      ..|...+.++..+ -.
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   80 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP   80 (187)
T ss_pred             CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence            357999999999999875 889999999874321     111                      3566666666222 22


Q ss_pred             eeeEEeEEEcCCCCccEEEEEeecCCChhh-hcCCCCH-HHHHHHHHHHHHHHHHHHH-CCceeecCCCCceEecCCCCc
Q 014406          182 VVKLLDIVRDQHSKTPSLIFEYVNSTDFKV-LYPTLTD-YDIRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHELRK  258 (425)
Q Consensus       182 iv~l~~~~~~~~~~~~~lv~e~~~~~~l~~-~~~~l~~-~~~~~i~~~i~~~L~~LH~-~~ivH~Dlk~~NIll~~~~~~  258 (425)
                      +.+.++.      ...++||||++++.+.. .+..... .+...++.+++.++.++|. .+|+|+||||+||+++ + +.
T Consensus        81 ~~~~~~~------~~~~lv~e~~~g~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~-~~  152 (187)
T cd05119          81 VPKPIDL------NRHVLVMEFIGGDGIPAPRLKDVRLLEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-D-GK  152 (187)
T ss_pred             CCceEec------CCCEEEEEEeCCCCccChhhhhhhhcccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-C-Cc
Confidence            4444443      23579999999954321 1222222 6678899999999999999 9999999999999999 5 78


Q ss_pred             EEEEecccccccc
Q 014406          259 LRLIDWGLAEFYH  271 (425)
Q Consensus       259 ~kl~Dfg~a~~~~  271 (425)
                      ++|+|||.+....
T Consensus       153 ~~liDfg~a~~~~  165 (187)
T cd05119         153 VYIIDVPQAVEID  165 (187)
T ss_pred             EEEEECccccccc
Confidence            9999999996543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.68  E-value=7.1e-16  Score=130.17  Aligned_cols=132  Identities=22%  Similarity=0.328  Sum_probs=110.3

Q ss_pred             EEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc-hHHHHHHHHHHHHhcCC-CCeeeEEeEEEcCCCCccEEEEEeecC
Q 014406          129 VVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-KKKIKREIKILQNLCGG-PNVVKLLDIVRDQHSKTPSLIFEYVNS  206 (425)
Q Consensus       129 ~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~-~~~~~~E~~~l~~l~~h-~niv~l~~~~~~~~~~~~~lv~e~~~~  206 (425)
                      +.+.||.|.++.||++....  ..+++|...... ...+.+|+.+++.+.++ .++.++++++...  ...+++|||+++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~--~~~~~v~e~~~g   77 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASGESD--GWSYLLMEWIEG   77 (155)
T ss_pred             cceecccccccceEEEEecC--CeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEcCCC--CccEEEEEecCC
Confidence            35689999999999997643  789999987544 36789999999999433 6889998888543  568899999999


Q ss_pred             CChhhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceeecCCCCceEecCCCCcEEEEecccccc
Q 014406          207 TDFKVLYPTLTDYDIRYYIYELLKALDYCHSQ---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (425)
Q Consensus       207 ~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~---~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~  269 (425)
                      +.+..+    +......++.+++.+|++||..   +++|+|++|+||+++.. +.++++|||.+..
T Consensus        78 ~~~~~~----~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~-~~~~l~Df~~~~~  138 (155)
T cd05120          78 ETLDEV----SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDG-KILGIIDWEYAGY  138 (155)
T ss_pred             eecccC----CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECC-cEEEEEecccccC
Confidence            887655    5667778899999999999985   69999999999999986 7899999998864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.67  E-value=6.3e-16  Score=141.02  Aligned_cols=130  Identities=17%  Similarity=0.301  Sum_probs=100.1

Q ss_pred             eee-eeCceEEEEEEEcCCCcEEEEEEecCc----------------chHHHHHHHHHHHHhcCCCCe--eeEEeEEEcC
Q 014406          132 KVG-RGKYSEVFEGINVNTNERCIIKILKPV----------------KKKKIKREIKILQNLCGGPNV--VKLLDIVRDQ  192 (425)
Q Consensus       132 ~LG-~G~fg~V~~~~~~~~~~~vavK~~~~~----------------~~~~~~~E~~~l~~l~~h~ni--v~l~~~~~~~  192 (425)
                      .|| .||.|+||++..  .+..++||.+...                ....+.+|+.++.++ .|+++  +..+++....
T Consensus        38 ~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L-~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         38 VVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQL-YEAGLPVPRPIAARVVR  114 (239)
T ss_pred             eeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHH-HhCCCCCceeEeeeeee
Confidence            577 889999999854  3778899887421                124577899999999 77764  6777765433


Q ss_pred             CCC--ccEEEEEeecC-CChhhhcCC--CCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEecccc
Q 014406          193 HSK--TPSLIFEYVNS-TDFKVLYPT--LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA  267 (425)
Q Consensus       193 ~~~--~~~lv~e~~~~-~~l~~~~~~--l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a  267 (425)
                      .+.  ..++|+|+++| .+|.+++..  +++.    .+.+++.+|.+||+.||+|+||||.|||++.+ +.++|+|||.+
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~-~~v~LIDfg~~  189 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQEAPLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLDPD-GKFWLIDFDRG  189 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhcCCCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEcCC-CCEEEEECCCc
Confidence            222  23599999997 688877643  3433    35789999999999999999999999999987 68999999988


Q ss_pred             cc
Q 014406          268 EF  269 (425)
Q Consensus       268 ~~  269 (425)
                      +.
T Consensus       190 ~~  191 (239)
T PRK01723        190 EL  191 (239)
T ss_pred             cc
Confidence            65

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.55  E-value=7.3e-15  Score=143.73  Aligned_cols=249  Identities=20%  Similarity=0.219  Sum_probs=187.6

Q ss_pred             CCCEEEEeeeee--eCceEEEEEEE--cCCCcEEEEEEecC-----cchHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCC
Q 014406          124 QDDYEVVRKVGR--GKYSEVFEGIN--VNTNERCIIKILKP-----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS  194 (425)
Q Consensus       124 ~~~y~~~~~LG~--G~fg~V~~~~~--~~~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  194 (425)
                      ...+.+...+|.  |.+|.||.+..  ..++..+|+|.-+.     .....-.+|+....++..|+|.++.+..+.+  +
T Consensus       113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~--~  190 (524)
T KOG0601|consen  113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEG--S  190 (524)
T ss_pred             hhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccccc--C
Confidence            455667788999  99999999988  78889999988431     2334445788888888789999998887744  4


Q ss_pred             CccEEEEEeecCCChhhhc----CCCCHHHHHHHHHHHHH----HHHHHHHCCceeecCCCCceEecCCCCcEEEEeccc
Q 014406          195 KTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLK----ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL  266 (425)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~----~~l~~~~~~~i~~~i~~----~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~  266 (425)
                      +..++-+|++. .++..+.    .-+++..++.+..+...    ||.++|+.+++|-|+||.||+...+...++++|||+
T Consensus       191 ~~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~  269 (524)
T KOG0601|consen  191 GILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGL  269 (524)
T ss_pred             Ccceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcce
Confidence            67788889888 4444443    23788888899999998    999999999999999999999998855789999999


Q ss_pred             cccccCCCcce-ee-----ccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHH-HHHHHHHHhCC
Q 014406          267 AEFYHPGKEYN-VR-----VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHD-QLVKIAKVLGT  339 (425)
Q Consensus       267 a~~~~~~~~~~-~~-----~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~-~~~~~~~~lg~  339 (425)
                      ...+..+.-.. ..     .+...|++||...+  .++...|++++|.++.+-.++-.++..+..+.. ++..       
T Consensus       270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~--l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~-------  340 (524)
T KOG0601|consen  270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG--LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ-------  340 (524)
T ss_pred             eEEccCCccccceeeeecCCCCceEeChhhhcc--ccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc-------
Confidence            98876654221 11     45667999999865  688999999999999999988877754422110 0000       


Q ss_pred             chhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCccc
Q 014406          340 DELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV  415 (425)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~  415 (425)
                                                   +  ++..+.-...+.++...+..|++.+|-.|++++.++.|++....
T Consensus       341 -----------------------------~--~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~  385 (524)
T KOG0601|consen  341 -----------------------------G--YIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSK  385 (524)
T ss_pred             -----------------------------c--cCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccch
Confidence                                         0  00111111245666679999999999999999999999997744

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.51  E-value=1.2e-13  Score=136.78  Aligned_cols=137  Identities=18%  Similarity=0.274  Sum_probs=94.8

Q ss_pred             eeeeeeCceEEEEEEEcCCCcEEEEEEecCcchHHHH-------------------------------------------
Q 014406          131 RKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK-------------------------------------------  167 (425)
Q Consensus       131 ~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~-------------------------------------------  167 (425)
                      +.||.|++|.||+|+. .+|+.||||+..+...+.+.                                           
T Consensus       123 ~plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       123 KPLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             cceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            4699999999999975 57899999998765433332                                           


Q ss_pred             HHHHHHHHhc---CCCCeeeEEeEEEcCCCCccEEEEEeecCCChhhhcCC--CCHHHHHHHHHHHHH-HHHHHHHCCce
Q 014406          168 REIKILQNLC---GGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPT--LTDYDIRYYIYELLK-ALDYCHSQGIM  241 (425)
Q Consensus       168 ~E~~~l~~l~---~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--l~~~~~~~i~~~i~~-~L~~LH~~~iv  241 (425)
                      +|...+.++.   .+.+-+.+-.++.+.. ...+|||||++|+++.+....  ... ....++.+++. .+..+|..|++
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~-~~~vLvmE~i~G~~L~~~~~~~~~~~-~~~~ia~~~~~~~l~ql~~~g~~  279 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRT-SERVLTMEWIDGIPLSDIAALDEAGL-DRKALAENLARSFLNQVLRDGFF  279 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhc-CCceEEEEeECCcccccHHHHHhcCC-CHHHHHHHHHHHHHHHHHhCCce
Confidence            3343333331   1223334333443222 345799999999998776421  111 23445666655 47889999999


Q ss_pred             eecCCCCceEecCCCCcEEEEecccccccc
Q 014406          242 HRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (425)
Q Consensus       242 H~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~  271 (425)
                      |+|++|.||+++.+ +.++++|||++....
T Consensus       280 H~D~hPgNilv~~~-g~i~liDfG~~~~l~  308 (437)
T TIGR01982       280 HADLHPGNIFVLKD-GKIIALDFGIVGRLS  308 (437)
T ss_pred             eCCCCcccEEECCC-CcEEEEeCCCeeECC
Confidence            99999999999887 789999999997654

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.48  E-value=9.4e-15  Score=150.14  Aligned_cols=263  Identities=23%  Similarity=0.337  Sum_probs=187.0

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCc
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (425)
                      ..+.+.+.+-+-+|.+|.++.+.-..++...++|+....      ..+....+-.++-.. .+|-+++..-.+  .....
T Consensus       802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p-~~P~v~~~~~s~--~~rsP  878 (1205)
T KOG0606|consen  802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITP-RSPAVVRSFPSF--PCRSP  878 (1205)
T ss_pred             CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccC-CCCceecccCCC--CCCCC
Confidence            457788888999999999999877777766666665421      122222333332222 456555544432  23356


Q ss_pred             cEEEEEeecCCChhhhcCC---CCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccC-
Q 014406          197 PSLIFEYVNSTDFKVLYPT---LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP-  272 (425)
Q Consensus       197 ~~lv~e~~~~~~l~~~~~~---l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~-  272 (425)
                      .+|+++|+++++|...+..   .+.+-.+.++..+..+++|||...++|+|++|.|+|...+ +..++.|||......- 
T Consensus       879 ~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~-gh~~l~~~~t~~~vg~~  957 (1205)
T KOG0606|consen  879 LPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYD-GHRPLTDFGTLSKVGLI  957 (1205)
T ss_pred             cchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhccc-CCcccCccccccccccc
Confidence            7799999999998877643   5556677788889999999999999999999999999988 7889999984322100 


Q ss_pred             --------------------C-----------CcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 014406          273 --------------------G-----------KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF  321 (425)
Q Consensus       273 --------------------~-----------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~  321 (425)
                                          .           .......+|+.|.+||...+ ..-....|+|++|+.++|.++|..||.
T Consensus       958 ~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg-~~hgs~ad~~~~g~~l~e~l~g~pp~n 1036 (1205)
T KOG0606|consen  958 PPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLG-RRHGSAADWWSSGVCLFEVLTGIPPFN 1036 (1205)
T ss_pred             cCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccc-ccCCCcchhhhhhhhhhhhhcCCCCCC
Confidence                                0           00122467888999999998 667789999999999999999999982


Q ss_pred             CCCCCHHHHHHHHHHhCCchhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCc
Q 014406          322 YGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL  401 (425)
Q Consensus       322 ~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rp  401 (425)
                       .......+..+..    .                         ..+|.     .-....+.++.+++.+.|..+|.+|.
T Consensus      1037 -a~tpq~~f~ni~~----~-------------------------~~~~p-----~g~~~~s~~aq~~~~~ll~~~~~qr~ 1081 (1205)
T KOG0606|consen 1037 -AETPQQIFENILN----R-------------------------DIPWP-----EGPEEGSYEAQDLINRLLTEEPTQRL 1081 (1205)
T ss_pred             -Ccchhhhhhcccc----C-------------------------CCCCC-----CCccccChhhhhhhhhhhccCchhcc
Confidence             2222222222211    0                         01111     12233688999999999999999999


Q ss_pred             CHH---HHhcCCCCcccccchhccccC
Q 014406          402 TAR---EAMAHPYFAQVRAAESSRTRA  425 (425)
Q Consensus       402 ta~---elL~hp~~~~~~~~~~~~~~~  425 (425)
                      ++.   ++-.||||+.+.|......+|
T Consensus      1082 ~a~~~~e~k~~~~~~~~~~~~l~~q~~ 1108 (1205)
T KOG0606|consen 1082 GAKGAAEVKGHPFFQDVDWENLALQKA 1108 (1205)
T ss_pred             CcccccccccCCccCCCCccccccccC
Confidence            887   999999999999987766543

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.47  E-value=4.1e-13  Score=116.06  Aligned_cols=126  Identities=20%  Similarity=0.262  Sum_probs=95.8

Q ss_pred             EeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc--hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEEEeecCC
Q 014406          130 VRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST  207 (425)
Q Consensus       130 ~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~  207 (425)
                      ++.|+.|.++.||++..  .+..+++|+.....  ...+.+|+.+++.+.+...+.+++....    ...++||||++|.
T Consensus         3 ~~~l~~G~~~~vy~~~~--~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~~----~~~~lv~e~i~G~   76 (170)
T cd05151           3 ISPLKGGMTNKNYRVEV--ANKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFDP----ETGVLITEFIEGS   76 (170)
T ss_pred             eeecCCcccCceEEEEE--CCeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEeC----CCCeEEEEecCCC
Confidence            45789999999999865  37789999986543  3457889999999843333455665542    2246999999998


Q ss_pred             ChhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCc-----eeecCCCCceEecCCCCcEEEEeccccc
Q 014406          208 DFKVLYPTLTDYDIRYYIYELLKALDYCHSQGI-----MHRDVKPHNVMIDHELRKLRLIDWGLAE  268 (425)
Q Consensus       208 ~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~i-----vH~Dlk~~NIll~~~~~~~kl~Dfg~a~  268 (425)
                      ++...  .   .....++.+++.+|..||+.++     +|+|++|.||+++ + +.++++|||.+.
T Consensus        77 ~l~~~--~---~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~-~~~~liDf~~a~  135 (170)
T cd05151          77 ELLTE--D---FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-D-GRLWLIDWEYAG  135 (170)
T ss_pred             ccccc--c---ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-C-CeEEEEeccccc
Confidence            87653  1   1123456899999999999875     9999999999999 4 578999999875

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.41  E-value=2.4e-13  Score=123.39  Aligned_cols=206  Identities=21%  Similarity=0.251  Sum_probs=142.0

Q ss_pred             HHHHHHhcCCCCeeeEEeEEEcCC---CCccEEEEEeecCCChhhhcC-------CCCHHHHHHHHHHHHHHHHHHHHC-
Q 014406          170 IKILQNLCGGPNVVKLLDIVRDQH---SKTPSLIFEYVNSTDFKVLYP-------TLTDYDIRYYIYELLKALDYCHSQ-  238 (425)
Q Consensus       170 ~~~l~~l~~h~niv~l~~~~~~~~---~~~~~lv~e~~~~~~l~~~~~-------~l~~~~~~~i~~~i~~~L~~LH~~-  238 (425)
                      ..-|-.+ .|.|+|+++.|+.+..   .....++.|||..|++..+++       .+....+++|+-||+.||.|||+. 
T Consensus       118 Fdnllql-vHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~  196 (458)
T KOG1266|consen  118 FDNLLQL-VHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD  196 (458)
T ss_pred             HHHHHHH-HHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC
Confidence            3445555 7899999999887542   234678999999999998874       378888999999999999999987 


Q ss_pred             -CceeecCCCCceEecCCCCcEEEEeccccccccC------CCcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHH
Q 014406          239 -GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP------GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFA  311 (425)
Q Consensus       239 -~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~  311 (425)
                       -|+|+++.-+-|++..+ +-+|++--.-.. ...      ........+-++|.+||.=.. ...+-++|||+||....
T Consensus       197 PpiihgnlTc~tifiq~n-gLIkig~~ap~s-~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~-tn~~~a~dIy~fgmcAl  273 (458)
T KOG1266|consen  197 PPIIHGNLTCDTIFIQHN-GLIKIGSVAPDS-THPSVNSTREAEKSVNTSLPGFSAPESGTT-TNTTGASDIYKFGMCAL  273 (458)
T ss_pred             CccccCCcchhheeecCC-ceEEecccCccc-cchhhhhhhHhhhhccccCCccccCCcCcc-cccccchhhhhhhHHHH
Confidence             49999999999999977 566654321111 110      011223345678999997543 45677999999999889


Q ss_pred             HHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHH
Q 014406          312 GMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDK  391 (425)
Q Consensus       312 elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~  391 (425)
                      +|.-+..--..+.+..+.-..+....                                   +..     -.+.-++++++
T Consensus       274 emailEiq~tnseS~~~~ee~ia~~i-----------------------------------~~l-----en~lqr~~i~k  313 (458)
T KOG1266|consen  274 EMAILEIQSTNSESKVEVEENIANVI-----------------------------------IGL-----ENGLQRGSITK  313 (458)
T ss_pred             HHHHheeccCCCcceeehhhhhhhhe-----------------------------------eec-----cCccccCcCcc
Confidence            99877654322222111111111100                                   000     01223578999


Q ss_pred             cccCCcCCCcCHHHHhcCCCCcccccch
Q 014406          392 LLRYDHQDRLTAREAMAHPYFAQVRAAE  419 (425)
Q Consensus       392 ~L~~dP~~Rpta~elL~hp~~~~~~~~~  419 (425)
                      ||+-.|..||++.+++.||-+-++....
T Consensus       314 cl~~eP~~rp~ar~llfHpllfeVhslk  341 (458)
T KOG1266|consen  314 CLEGEPNGRPDARLLLFHPLLFEVHSLK  341 (458)
T ss_pred             cccCCCCCCcchhhhhcCceeeecchHH
Confidence            9999999999999999999988776543

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.39  E-value=8e-12  Score=109.27  Aligned_cols=132  Identities=17%  Similarity=0.290  Sum_probs=96.9

Q ss_pred             eeeeeeCceEEEEEEEcC------CCcEEEEEEecCc-------------c------------hHHHH----HHHHHHHH
Q 014406          131 RKVGRGKYSEVFEGINVN------TNERCIIKILKPV-------------K------------KKKIK----REIKILQN  175 (425)
Q Consensus       131 ~~LG~G~fg~V~~~~~~~------~~~~vavK~~~~~-------------~------------~~~~~----~E~~~l~~  175 (425)
                      ..||.|.-+.||.|....      .+..+|||+++..             .            .+.+.    +|+..|.+
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            468999999999997543      3579999997411             0            11233    79999998


Q ss_pred             hcCC-CCeeeEEeEEEcCCCCccEEEEEeecCCChhh-hcC--CCCHHHHHHHHHHHHHHHHHH-HHCCceeecCCCCce
Q 014406          176 LCGG-PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV-LYP--TLTDYDIRYYIYELLKALDYC-HSQGIMHRDVKPHNV  250 (425)
Q Consensus       176 l~~h-~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~-~~~--~l~~~~~~~i~~~i~~~L~~L-H~~~ivH~Dlk~~NI  250 (425)
                      +... -++...+++.      .-+|||||++++.+.. .+.  .++..+...+..+++.+|..| |+.|+||+||++.||
T Consensus        83 l~~~Gv~vP~pi~~~------~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NI  156 (197)
T cd05146          83 MQKAGIPCPEVVVLK------KHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNM  156 (197)
T ss_pred             HHHcCCCCCeEEEec------CCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence            8432 4666666642      2359999998764321 122  245556777889999999999 899999999999999


Q ss_pred             EecCCCCcEEEEeccccccc
Q 014406          251 MIDHELRKLRLIDWGLAEFY  270 (425)
Q Consensus       251 ll~~~~~~~kl~Dfg~a~~~  270 (425)
                      |++.  +.+.|+|||.+...
T Consensus       157 L~~~--~~v~iIDF~qav~~  174 (197)
T cd05146         157 LWHD--GKVWFIDVSQSVEP  174 (197)
T ss_pred             EEEC--CcEEEEECCCceeC
Confidence            9985  46899999988654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.37  E-value=6.9e-12  Score=124.29  Aligned_cols=165  Identities=20%  Similarity=0.341  Sum_probs=128.1

Q ss_pred             EEEEcCCCcEEEEEEecCcch---HHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEEEeecCCChhhhcCCCCHH
Q 014406          143 EGINVNTNERCIIKILKPVKK---KKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDY  219 (425)
Q Consensus       143 ~~~~~~~~~~vavK~~~~~~~---~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~l~~~  219 (425)
                      .|..+.++.+|.|..++....   ....+-++.|+.+ +||||+++++.++..  ...|||+|-+..  |..++..++..
T Consensus        30 ~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtl-RHP~Il~yL~t~e~~--~~~ylvTErV~P--l~~~lk~l~~~  104 (690)
T KOG1243|consen   30 DGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTL-RHPNILSYLDTTEEE--GTLYLVTERVRP--LETVLKELGKE  104 (690)
T ss_pred             ccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhc-cCchhhhhhhhhccc--CceEEEeecccc--HHHHHHHhHHH
Confidence            466778888999988876554   5677888999999 999999999999654  688899998754  44555667788


Q ss_pred             HHHHHHHHHHHHHHHHH-HCCceeecCCCCceEecCCCCcEEEEeccccccccCCCc-ceeeccCCCccCcccccCCCCC
Q 014406          220 DIRYYIYELLKALDYCH-SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-YNVRVASRYFKGPELLVDLQDY  297 (425)
Q Consensus       220 ~~~~i~~~i~~~L~~LH-~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~  297 (425)
                      .+...+.||+.||.||| +.+++|++|.-+.|+++.. |..||++|.++........ .....--..|..|+.+..   -
T Consensus       105 ~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~-GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~---s  180 (690)
T KOG1243|consen  105 EVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNES-GEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDP---S  180 (690)
T ss_pred             HHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCC-CcEEEeeeEEEeccccCCcccccchhhhcccChhhcCc---c
Confidence            89999999999999998 5689999999999999998 8999999998864432221 111122223666765533   2


Q ss_pred             CCcccHHHHHHHHHHHHhC
Q 014406          298 DYSLDMWSLGCMFAGMIFR  316 (425)
Q Consensus       298 ~~~~DvwslG~~l~elltg  316 (425)
                      +...|.|-|||++++++.|
T Consensus       181 ~~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  181 EWSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             ccchhhhhHHHHHHHHhCc
Confidence            2567999999999999998

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.37  E-value=3.4e-12  Score=128.11  Aligned_cols=140  Identities=11%  Similarity=0.217  Sum_probs=90.7

Q ss_pred             EEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcchHH-----------------------------------------
Q 014406          127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK-----------------------------------------  165 (425)
Q Consensus       127 y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~-----------------------------------------  165 (425)
                      |+. +.||.|++|+||+|+...+|+.||||+..+.-.+.                                         
T Consensus       122 fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~E  200 (537)
T PRK04750        122 FDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDE  200 (537)
T ss_pred             cCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHh
Confidence            444 57999999999999988889999999997542111                                         


Q ss_pred             --HHHHHHHHHHhc---CCCCeeeEEeEEEcCCCCccEEEEEeecCCChhhhc--C--CCCHHHHHHHHHHHH-HHHHHH
Q 014406          166 --IKREIKILQNLC---GGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY--P--TLTDYDIRYYIYELL-KALDYC  235 (425)
Q Consensus       166 --~~~E~~~l~~l~---~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~--~--~l~~~~~~~i~~~i~-~~L~~L  235 (425)
                        +.+|...+.++.   .+.+.+.+-.++.+- ....+|||||+.|+.+.+..  .  ..+...+   +...+ .-+..+
T Consensus       201 lD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~-st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~l---a~~~v~~~~~Qi  276 (537)
T PRK04750        201 LDLMREAANASQLRRNFEDSDMLYVPEVYWDY-CSETVMVMERMYGIPVSDVAALRAAGTDMKLL---AERGVEVFFTQV  276 (537)
T ss_pred             hCHHHHHHHHHHHHHHccCCCCeecceeeccc-CCCceEEEeeecCccHHhHHHHHhcCCCHHHH---HHHHHHHHHHHH
Confidence              223333333331   233334444444332 23457999999999887632  1  1221111   11111 112334


Q ss_pred             HHCCceeecCCCCceEecCCCC----cEEEEeccccccccC
Q 014406          236 HSQGIMHRDVKPHNVMIDHELR----KLRLIDWGLAEFYHP  272 (425)
Q Consensus       236 H~~~ivH~Dlk~~NIll~~~~~----~~kl~Dfg~a~~~~~  272 (425)
                      ...|++|+|++|.||+++.+ +    .++++|||++....+
T Consensus       277 f~~GffHaDpHPGNIlv~~~-g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        277 FRDGFFHADMHPGNIFVSYD-PPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             HhCCeeeCCCChHHeEEecC-CCCCCeEEEEecceEEECCH
Confidence            46899999999999999987 5    899999999976643

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.32  E-value=2.3e-12  Score=126.43  Aligned_cols=247  Identities=19%  Similarity=0.118  Sum_probs=175.6

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEc-CCCcEEEEEEecCcch-----HHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCcc
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINV-NTNERCIIKILKPVKK-----KKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~-~~~~~vavK~~~~~~~-----~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (425)
                      ..+|..+..||.|.|+.|+..... .++..+++|.+.+...     ..-..|+.+...+..|.+++.....+...  ...
T Consensus       264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~--r~~  341 (524)
T KOG0601|consen  264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQL--RQG  341 (524)
T ss_pred             cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccc--ccc
Confidence            467888999999999999997655 6788899988764322     12235777777776788888876655332  445


Q ss_pred             EEEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCC
Q 014406          198 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (425)
Q Consensus       198 ~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~  274 (425)
                      ++-.||+.+++.....   ..+.+...+.+..|++.++.++|+..++|+|+||+||++..+.+..+++|||.+....  -
T Consensus       342 ~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~--~  419 (524)
T KOG0601|consen  342 YIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLA--F  419 (524)
T ss_pred             cCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccc--e
Confidence            5889999998876554   4478888899999999999999999999999999999999864667999999986421  1


Q ss_pred             cceeeccCCCcc-CcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCC
Q 014406          275 EYNVRVASRYFK-GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL  353 (425)
Q Consensus       275 ~~~~~~~t~~y~-aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~  353 (425)
                      ........-.++ ..|++.....+..+.|++|||..+.+.+++...-..+.    +...+...                 
T Consensus       420 ~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~----~~~~i~~~-----------------  478 (524)
T KOG0601|consen  420 SSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV----QSLTIRSG-----------------  478 (524)
T ss_pred             ecccccccccccccchhhccccccccccccccccccccccccCcccCcccc----cceeeecc-----------------
Confidence            111222333344 35555554678889999999999999998864331111    11111000                 


Q ss_pred             ChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCccc
Q 014406          354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV  415 (425)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~  415 (425)
                                          ....-.....++..+.+.+...++..|+.+.++..|+=|...
T Consensus       479 --------------------~~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~~  520 (524)
T KOG0601|consen  479 --------------------DTPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYRD  520 (524)
T ss_pred             --------------------cccCCCchHHhhhhhhhhhcCCccccchhhhhhcccchhhhh
Confidence                                000011133677888999999999999999999988766543

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.23  E-value=3.4e-10  Score=109.20  Aligned_cols=209  Identities=15%  Similarity=0.234  Sum_probs=149.9

Q ss_pred             CceEEEEEEEcCCCcEEEEEEecC---cchHHHHHHHHHHHHhcCCCCeeeEEeEEEcC--CCCccEEEEEeecCC-Chh
Q 014406          137 KYSEVFEGINVNTNERCIIKILKP---VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQ--HSKTPSLIFEYVNST-DFK  210 (425)
Q Consensus       137 ~fg~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~--~~~~~~lv~e~~~~~-~l~  210 (425)
                      ...+.|++....+|..+++|.+.-   ........-+++++++ .|.|+|.+.++|...  +...+++||+|.++. +|.
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl-~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~  366 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKL-CHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLY  366 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHh-ccCceeehhhhhhhhccCcceEEEEEecCCCCchHH
Confidence            446889999999999999999932   2222334567889999 899999999988622  335789999999765 454


Q ss_pred             hhc------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccC
Q 014406          211 VLY------------------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (425)
Q Consensus       211 ~~~------------------~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~  272 (425)
                      ++.                  .+.++..+|.++.|+..||.++|+.|...+-|.+.+||++.+ .+++|+-.|.......
T Consensus       367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~-~RIriS~C~i~Dvl~~  445 (655)
T KOG3741|consen  367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGK-MRIRISGCGIMDVLQE  445 (655)
T ss_pred             HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCc-ceEEEecccceeeecC
Confidence            432                  126788999999999999999999999999999999999988 5788887776655443


Q ss_pred             CCcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHH-HHHHHHHhCCchhHHHHhhccC
Q 014406          273 GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQ-LVKIAKVLGTDELNAYLNKYHL  351 (425)
Q Consensus       273 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~-~~~~~~~lg~~~~~~~~~~~~~  351 (425)
                      +..             |.+..    -.+-|.=.||.+++.|.||...-...+..... +..+.                 
T Consensus       446 d~~-------------~~le~----~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I~-----------------  491 (655)
T KOG3741|consen  446 DPT-------------EPLES----QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRIT-----------------  491 (655)
T ss_pred             CCC-------------cchhH----HhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHhh-----------------
Confidence            220             11112    23568889999999999997542222211111 11111                 


Q ss_pred             CCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcC
Q 014406          352 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  409 (425)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~h  409 (425)
                                                 ..++.++++++..+...++.+ -++.++|.+
T Consensus       492 ---------------------------~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~  521 (655)
T KOG3741|consen  492 ---------------------------TTYSTDLRNVVEYLESLNFRE-KSIQDLLPM  521 (655)
T ss_pred             ---------------------------hhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence                                       125778888888888888876 577777765

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.23  E-value=1.5e-10  Score=104.36  Aligned_cols=139  Identities=25%  Similarity=0.398  Sum_probs=105.4

Q ss_pred             eeeeeeCceEEEEEEEcCCCcEEEEEEecCcc----hHHHHHHHHHHHHhcC-CCCeeeEEeEEEcCC-CCccEEEEEee
Q 014406          131 RKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCG-GPNVVKLLDIVRDQH-SKTPSLIFEYV  204 (425)
Q Consensus       131 ~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~-h~niv~l~~~~~~~~-~~~~~lv~e~~  204 (425)
                      +.||.|.++.||++... +|+.+++|+.....    ...+.+|..+++.+.. +.++.+++.+..... ....++||||+
T Consensus         4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i   82 (223)
T cd05154           4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV   82 (223)
T ss_pred             eecCCCccceEEEEEec-CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence            46899999999999753 36789999986532    4678999999999943 234667777764321 12568999999


Q ss_pred             cCCChhhhc--CCCCHHHHHHHHHHHHHHHHHHHH---------------------------------------------
Q 014406          205 NSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHS---------------------------------------------  237 (425)
Q Consensus       205 ~~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~LH~---------------------------------------------  237 (425)
                      +|.++....  ..++..+...++.+++.+|..||+                                             
T Consensus        83 ~G~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (223)
T cd05154          83 DGRVLRDRLLRPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLLR  162 (223)
T ss_pred             CCEecCCCCCCCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHHH
Confidence            999887765  357777777788888888888873                                             


Q ss_pred             -----------CCceeecCCCCceEecCC-CCcEEEEeccccccc
Q 014406          238 -----------QGIMHRDVKPHNVMIDHE-LRKLRLIDWGLAEFY  270 (425)
Q Consensus       238 -----------~~ivH~Dlk~~NIll~~~-~~~~kl~Dfg~a~~~  270 (425)
                                 ..++|+|+.+.||+++.+ .+.+.|+||+.+...
T Consensus       163 ~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g  207 (223)
T cd05154         163 WLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLG  207 (223)
T ss_pred             HHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccC
Confidence                       236999999999999983 256799999988643

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.20  E-value=3.9e-10  Score=95.11  Aligned_cols=136  Identities=19%  Similarity=0.286  Sum_probs=96.7

Q ss_pred             EEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----------chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCcc
Q 014406          129 VVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (425)
Q Consensus       129 ~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (425)
                      .+..+-+|+-+.|+++.+  .|+.++||.--..           .+++..+|...|.++ .--.|.--.=+|.+..++  
T Consensus        11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~-~~~GI~~P~l~~~D~~~~--   85 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKC-RALGIPAPRLIFIDTYGG--   85 (229)
T ss_pred             cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHH-HHhCCCCceEEEEecCCC--
Confidence            456799999999999944  6888888753211           235677899999987 222332222234344333  


Q ss_pred             EEEEEeecC-CChhhhc----C-CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcE--EEEecccccc
Q 014406          198 SLIFEYVNS-TDFKVLY----P-TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKL--RLIDWGLAEF  269 (425)
Q Consensus       198 ~lv~e~~~~-~~l~~~~----~-~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~--kl~Dfg~a~~  269 (425)
                      +|+|||++| .++.+++    . .........++..|-..+.-||.++|||+||..+||++.++.+.+  .++|||++..
T Consensus        86 ~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   86 QIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             eEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence            499999988 3555554    2 223333467889999999999999999999999999998775555  8999999864

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.18  E-value=3.5e-10  Score=95.87  Aligned_cols=126  Identities=21%  Similarity=0.357  Sum_probs=91.6

Q ss_pred             eeeeeCceEEEEEEEcCCCcEEEEEEecCc-----------chHHHHHHHHHHHHhcC-CCCeeeEEeEEEcCCCCccEE
Q 014406          132 KVGRGKYSEVFEGINVNTNERCIIKILKPV-----------KKKKIKREIKILQNLCG-GPNVVKLLDIVRDQHSKTPSL  199 (425)
Q Consensus       132 ~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----------~~~~~~~E~~~l~~l~~-h~niv~l~~~~~~~~~~~~~l  199 (425)
                      .+++|+-+.+|.+..  -|..+++|.=-+.           ......+|..++.++.. --++..++++.  +  ....+
T Consensus         3 ~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD--~--~~~~I   76 (204)
T COG3642           3 LIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVD--P--DNGLI   76 (204)
T ss_pred             hhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEc--C--CCCEE
Confidence            578999999999854  2334777753221           12446689999998732 22344444443  4  33459


Q ss_pred             EEEeecCCChhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEecccccc
Q 014406          200 IFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (425)
Q Consensus       200 v~e~~~~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~  269 (425)
                      +|||++|..+.+.+..-.    -.++..+-.-+.-||..||||+||.++||++..+  .+.++|||++..
T Consensus        77 ~me~I~G~~lkd~l~~~~----~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~--~i~~IDfGLg~~  140 (204)
T COG3642          77 VMEYIEGELLKDALEEAR----PDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGG--RIYFIDFGLGEF  140 (204)
T ss_pred             EEEEeCChhHHHHHHhcc----hHHHHHHHHHHHHHHhcCeecCCCccceEEEeCC--cEEEEECCcccc
Confidence            999999999998775442    4456777777888999999999999999999976  489999999974

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.04  E-value=8.5e-11  Score=117.11  Aligned_cols=160  Identities=16%  Similarity=0.230  Sum_probs=114.9

Q ss_pred             HHHHHHHHHHHH-CCceeecCCCCceEecCCCCcEEEEeccccccccCCCcceee----------ccCCCccCcccccCC
Q 014406          226 YELLKALDYCHS-QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR----------VASRYFKGPELLVDL  294 (425)
Q Consensus       226 ~~i~~~L~~LH~-~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~~~~~----------~~t~~y~aPE~~~~~  294 (425)
                      .+++.||.|+|. .++||++|.|++|.++.+ +..||+.|+++....+...+...          .....|.|||++.+ 
T Consensus       106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~na~-~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~-  183 (700)
T KOG2137|consen  106 GNVADGLAFLHRSAKVVHGNIQPEAIVVNAN-GDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG-  183 (700)
T ss_pred             hcccchhhhhccCcceeecccchhheeeccC-cceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc-
Confidence            344499999996 589999999999999998 88999999988655442222111          23345999999987 


Q ss_pred             CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCChhhHHHhcccCCCCcccccc
Q 014406          295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFIN  374 (425)
Q Consensus       295 ~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  374 (425)
                      ...+.++|++|+||++|-+..|+.+.+...+....... ....+...                        .        
T Consensus       184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~-~~~~~~~~------------------------~--------  230 (700)
T KOG2137|consen  184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSF-SRNLLNAG------------------------A--------  230 (700)
T ss_pred             ccccccccceeeeeEEEEEecCCcchhhccCCcchhhh-hhcccccc------------------------c--------
Confidence            77889999999999999988666665443332221111 00000000                        0        


Q ss_pred             ccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccchh
Q 014406          375 ADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAES  420 (425)
Q Consensus       375 ~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~~~  420 (425)
                      ......++.++++=+.++|..++..||++.+++..|||.+......
T Consensus       231 ~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~~~ff~D~~~~aL  276 (700)
T KOG2137|consen  231 FGYSNNLPSELRESLKKLLNGDSAVRPTLDLLLSIPFFSDPGLKAL  276 (700)
T ss_pred             ccccccCcHHHHHHHHHHhcCCcccCcchhhhhcccccCCchhhhh
Confidence            0001347899999999999999999999999999999998765543

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.03  E-value=2.5e-09  Score=93.30  Aligned_cols=122  Identities=25%  Similarity=0.403  Sum_probs=80.0

Q ss_pred             EEEEEEEcCCCcEEEEEEecCcc-----------------------------hHHHHHHHHHHHHhcCC-CCeeeEEeEE
Q 014406          140 EVFEGINVNTNERCIIKILKPVK-----------------------------KKKIKREIKILQNLCGG-PNVVKLLDIV  189 (425)
Q Consensus       140 ~V~~~~~~~~~~~vavK~~~~~~-----------------------------~~~~~~E~~~l~~l~~h-~niv~l~~~~  189 (425)
                      .||.|.. .+|..+|+|+.+...                             .....+|...|.++... -++.+.+++-
T Consensus         1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~   79 (188)
T PF01163_consen    1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN   79 (188)
T ss_dssp             EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred             CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence            3899854 567899999975210                             12356899999999433 2567777553


Q ss_pred             EcCCCCccEEEEEeec--CCChhhhcCC-CCHHHHHHHHHHHHHHHHH-HHHCCceeecCCCCceEecCCCCcEEEEecc
Q 014406          190 RDQHSKTPSLIFEYVN--STDFKVLYPT-LTDYDIRYYIYELLKALDY-CHSQGIMHRDVKPHNVMIDHELRKLRLIDWG  265 (425)
Q Consensus       190 ~~~~~~~~~lv~e~~~--~~~l~~~~~~-l~~~~~~~i~~~i~~~L~~-LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg  265 (425)
                        .    -+|||||++  |..+..+... ++......++.+++..+.. +|..||+|+||.+.|||++.+  .+.|+|||
T Consensus        80 --~----~~ivME~I~~~G~~~~~l~~~~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~--~~~iIDf~  151 (188)
T PF01163_consen   80 --R----NVIVMEYIGEDGVPLPRLKDVDLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG--KVYIIDFG  151 (188)
T ss_dssp             --T----TEEEEE--EETTEEGGCHHHCGGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT--CEEE--GT
T ss_pred             --C----CEEEEEecCCCccchhhHHhccccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc--eEEEEecC
Confidence              1    259999999  6555444322 2245567778888886655 579999999999999999976  78999999


Q ss_pred             ccccc
Q 014406          266 LAEFY  270 (425)
Q Consensus       266 ~a~~~  270 (425)
                      .+...
T Consensus       152 qav~~  156 (188)
T PF01163_consen  152 QAVDS  156 (188)
T ss_dssp             TEEET
T ss_pred             cceec
Confidence            88643

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.00  E-value=7.3e-09  Score=97.82  Aligned_cols=187  Identities=16%  Similarity=0.196  Sum_probs=128.4

Q ss_pred             EeeeeeeCceEEEEEEEcCCCcEEEEEEecCcchHHHHHHHHHHHHhcCCCCeeeEE----eEEEcCCC-CccEEEEEee
Q 014406          130 VRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLL----DIVRDQHS-KTPSLIFEYV  204 (425)
Q Consensus       130 ~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~----~~~~~~~~-~~~~lv~e~~  204 (425)
                      .+.||+|+-+.+|-.-   .-...+.|++..-....-.+.+..|.....||-+-.-+    ....+.+. ....++|..+
T Consensus        16 gr~LgqGgea~ly~l~---e~~d~VAKIYh~Pppa~~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP~v   92 (637)
T COG4248          16 GRPLGQGGEADLYTLG---EVRDQVAKIYHAPPPAAQAQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMPKV   92 (637)
T ss_pred             CccccCCccceeeecc---hhhchhheeecCCCchHHHHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEecccC
Confidence            4579999999999752   22335668876433333333444555554555433211    11112222 2255666666


Q ss_pred             cCCC----------hhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCC
Q 014406          205 NSTD----------FKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (425)
Q Consensus       205 ~~~~----------l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~  274 (425)
                      .+..          .....+.+.|..+.+.++.++.+.+-||+.|.+-+|++++|+|++++ ..+.|.|=..-.....+.
T Consensus        93 ~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~-~~V~LVdsDsfqi~~ng~  171 (637)
T COG4248          93 SGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDD-SKVVLVDSDSFQINANGT  171 (637)
T ss_pred             CCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecC-ceEEEEcccceeeccCCc
Confidence            5541          12222447889999999999999999999999999999999999988 788998866554445556


Q ss_pred             cceeeccCCCccCcccccC----CCCCCCcccHHHHHHHHHHHHhC-CCCC
Q 014406          275 EYNVRVASRYFKGPELLVD----LQDYDYSLDMWSLGCMFAGMIFR-KEPF  320 (425)
Q Consensus       275 ~~~~~~~t~~y~aPE~~~~----~~~~~~~~DvwslG~~l~elltg-~~pf  320 (425)
                      .+...+|...|.+||.-.-    .-.-+...|.|.||+++++++.| +.||
T Consensus       172 ~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPy  222 (637)
T COG4248         172 LHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPY  222 (637)
T ss_pred             eEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCC
Confidence            6677899999999997531    12345789999999999999987 8888

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.95  E-value=2.3e-08  Score=92.36  Aligned_cols=127  Identities=18%  Similarity=0.149  Sum_probs=90.4

Q ss_pred             EEEEEEEcCCCcEEEEEEecCcch--------------HHHHHHHHHHHHhcCCCCe--eeEEeEEEcCC---CCccEEE
Q 014406          140 EVFEGINVNTNERCIIKILKPVKK--------------KKIKREIKILQNLCGGPNV--VKLLDIVRDQH---SKTPSLI  200 (425)
Q Consensus       140 ~V~~~~~~~~~~~vavK~~~~~~~--------------~~~~~E~~~l~~l~~h~ni--v~l~~~~~~~~---~~~~~lv  200 (425)
                      .|++...  .|+.+.||.......              ..+.+|...+..+ ...+|  ...+++.+...   ...-+||
T Consensus        37 rvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L-~~~GIptP~pVa~~e~~~~~~~~~s~LV  113 (268)
T PRK15123         37 RTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRL-HEVGVDTMTGVAFGERGSNPATRTSFII  113 (268)
T ss_pred             eEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHH-HHcCCCCCCeeEEEEecCCCccceeEEE
Confidence            3556532  567888887653321              1377899988887 32222  34444543221   2346799


Q ss_pred             EEeecCC-ChhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecC------CCCcEEEEeccccc
Q 014406          201 FEYVNST-DFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH------ELRKLRLIDWGLAE  268 (425)
Q Consensus       201 ~e~~~~~-~l~~~~~-----~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~------~~~~~kl~Dfg~a~  268 (425)
                      +|++++. ++.+++.     ..+......++.+++..+.-||+.||+|+|++++|||++.      +...+.++||+.++
T Consensus       114 te~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~  193 (268)
T PRK15123        114 TEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ  193 (268)
T ss_pred             EeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence            9999986 7877753     2455667789999999999999999999999999999985      23679999999875


Q ss_pred             c
Q 014406          269 F  269 (425)
Q Consensus       269 ~  269 (425)
                      .
T Consensus       194 ~  194 (268)
T PRK15123        194 I  194 (268)
T ss_pred             c
Confidence            3

>PRK09902 hypothetical protein; Provisional

Probab=98.83  E-value=7.9e-08  Score=84.45  Aligned_cols=133  Identities=17%  Similarity=0.147  Sum_probs=96.0

Q ss_pred             eeeeCceEEEEEEEcCCCcEEEEEEec---------CcchHHHHHHHHHHHHhcCC-CCeeeEEeEEE---cCCCCccEE
Q 014406          133 VGRGKYSEVFEGINVNTNERCIIKILK---------PVKKKKIKREIKILQNLCGG-PNVVKLLDIVR---DQHSKTPSL  199 (425)
Q Consensus       133 LG~G~fg~V~~~~~~~~~~~vavK~~~---------~~~~~~~~~E~~~l~~l~~h-~niv~l~~~~~---~~~~~~~~l  199 (425)
                      -|+||.|.|++...  .|+.+-+|.-.         +.....|.+|+..|.++... -.+.+.. ++.   ......-+|
T Consensus        26 ~~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~L  102 (216)
T PRK09902         26 YRRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALL  102 (216)
T ss_pred             cCCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEE
Confidence            47789999999743  23357777654         34567899999999988321 1233433 332   222234679


Q ss_pred             EEEeecC-CChhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCc--EEEEecccccc
Q 014406          200 IFEYVNS-TDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRK--LRLIDWGLAEF  269 (425)
Q Consensus       200 v~e~~~~-~~l~~~~~-----~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~--~kl~Dfg~a~~  269 (425)
                      |+|-++| .+|.+++.     ..+......++.+++..+.-||+.|+.|+|+.+.||+++.+ +.  ++++||.-++.
T Consensus       103 VTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~-g~~~v~lIDlEk~r~  179 (216)
T PRK09902        103 VTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTE-GKAEAGFLDLEKSRR  179 (216)
T ss_pred             EEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCC-CCeeEEEEEhhccch
Confidence            9997765 47777653     34666778899999999999999999999999999999855 35  99999987653

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.83  E-value=3.4e-08  Score=88.85  Aligned_cols=132  Identities=22%  Similarity=0.372  Sum_probs=94.6

Q ss_pred             EEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-------------------------chHHHHHHHHHHHHhcCC-C
Q 014406          127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-------------------------KKKKIKREIKILQNLCGG-P  180 (425)
Q Consensus       127 y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-------------------------~~~~~~~E~~~l~~l~~h-~  180 (425)
                      +.+...||-|.-|.||.|.+. .|.++|||.-+..                         .+...++|.++|.+|... -
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~  171 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV  171 (304)
T ss_pred             HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence            345678999999999999654 7889999985311                         123357899999999332 2


Q ss_pred             CeeeEEeEEEcCCCCccEEEEEeecCCChhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEE
Q 014406          181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLR  260 (425)
Q Consensus       181 niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~k  260 (425)
                      .+.+-+++      +.-++||||++|..|...-  +.......++..|+.-+.-+=..||||+|+++-||+++.+ +.+.
T Consensus       172 ~VP~P~~~------nRHaVvMe~ieG~eL~~~r--~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~d-g~~~  242 (304)
T COG0478         172 KVPKPIAW------NRHAVVMEYIEGVELYRLR--LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTED-GDIV  242 (304)
T ss_pred             CCCCcccc------ccceeeeehcccceeeccc--CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecC-CCEE
Confidence            55555553      2336999999997776543  1334444455555555555558999999999999999998 7899


Q ss_pred             EEeccccc
Q 014406          261 LIDWGLAE  268 (425)
Q Consensus       261 l~Dfg~a~  268 (425)
                      ++||--+.
T Consensus       243 vIDwPQ~v  250 (304)
T COG0478         243 VIDWPQAV  250 (304)
T ss_pred             EEeCcccc
Confidence            99996553

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.74  E-value=1.2e-07  Score=84.60  Aligned_cols=107  Identities=25%  Similarity=0.355  Sum_probs=81.4

Q ss_pred             hHHHHHHHHHHHHhcC-CCCeeeEEeEEEcCCC--CccEEEEEeecCC-ChhhhcCC---CCHHHHHHHHHHHHHHHHHH
Q 014406          163 KKKIKREIKILQNLCG-GPNVVKLLDIVRDQHS--KTPSLIFEYVNST-DFKVLYPT---LTDYDIRYYIYELLKALDYC  235 (425)
Q Consensus       163 ~~~~~~E~~~l~~l~~-h~niv~l~~~~~~~~~--~~~~lv~e~~~~~-~l~~~~~~---l~~~~~~~i~~~i~~~L~~L  235 (425)
                      .....+|...+..+.. .=.+.+.+++.....+  ..-+||+|++++. +|.+++..   .+......++.+++..+.-|
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~l  134 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKL  134 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHH
Confidence            3567788888887721 1234455555543221  3347999999885 78887754   56777888999999999999


Q ss_pred             HHCCceeecCCCCceEecCCC--CcEEEEecccccc
Q 014406          236 HSQGIMHRDVKPHNVMIDHEL--RKLRLIDWGLAEF  269 (425)
Q Consensus       236 H~~~ivH~Dlk~~NIll~~~~--~~~kl~Dfg~a~~  269 (425)
                      |+.||+|+|+++.|||++.+.  ..+.++||+-++.
T Consensus       135 H~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  135 HDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            999999999999999999872  2789999998764

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.58  E-value=5.4e-07  Score=90.30  Aligned_cols=136  Identities=15%  Similarity=0.344  Sum_probs=88.5

Q ss_pred             eeeeeeCceEEEEEEEcCCCcEEEEEEecCcchHH-------------------------------------------HH
Q 014406          131 RKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK-------------------------------------------IK  167 (425)
Q Consensus       131 ~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~-------------------------------------------~~  167 (425)
                      +-|+.++-|.||+|+. .+|+.||||+..+.-.+.                                           +.
T Consensus       131 ~PiAsASIaQVH~A~L-~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~  209 (517)
T COG0661         131 EPIASASIAQVHRAVL-KSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR  209 (517)
T ss_pred             CchhhhhHhhheeEEe-cCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence            4689999999999975 459999999987543222                                           22


Q ss_pred             HHHHHHHHhc----CCCCeeeEEeEEEcCCCCccEEEEEeecCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCC
Q 014406          168 REIKILQNLC----GGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQG  239 (425)
Q Consensus       168 ~E~~~l~~l~----~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~LH~~~  239 (425)
                      +|...+.++.    +.++ +.+=.+|++-. ..-+|+|||++|.-+.+..    ..++...+.....++  .+..+=..|
T Consensus       210 ~EA~n~~~~~~nf~~~~~-v~VP~V~we~t-~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~--f~~q~~~dg  285 (517)
T COG0661         210 REAANAERFRENFKDDPD-VYVPKVYWEYT-TRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRA--FLRQLLRDG  285 (517)
T ss_pred             HHHHHHHHHHHHcCCCCC-eEeceeehhcc-CCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHH--HHHHHHhcC
Confidence            3444444331    2232 33333443321 3457999999998877663    234433333222222  123333579


Q ss_pred             ceeecCCCCceEecCCCCcEEEEeccccccccC
Q 014406          240 IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (425)
Q Consensus       240 ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~  272 (425)
                      ++|.|..|.||+++.+ +.+.+.|||+...+.+
T Consensus       286 ffHaDpHpGNi~v~~~-g~i~~lDfGi~g~l~~  317 (517)
T COG0661         286 FFHADPHPGNILVRSD-GRIVLLDFGIVGRLDP  317 (517)
T ss_pred             ccccCCCccceEEecC-CcEEEEcCcceecCCH
Confidence            9999999999999999 8999999999876653

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.56  E-value=1.6e-08  Score=100.18  Aligned_cols=241  Identities=16%  Similarity=0.140  Sum_probs=165.8

Q ss_pred             EEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcchHHHHHHHHHHHHhcCCCC-eeeEEeEEEcCCCCccEEEEEeec
Q 014406          127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPN-VVKLLDIVRDQHSKTPSLIFEYVN  205 (425)
Q Consensus       127 y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~n-iv~l~~~~~~~~~~~~~lv~e~~~  205 (425)
                      ++..+.+++|+++.++|.+...+...+ .+++...  ....-++++|.++ +||| .+..++-+  +.+.+.++.++++.
T Consensus       244 s~~fh~fvK~altknpKkRptaeklL~-h~fvs~~--l~~rl~~eLLdK~-n~P~~~v~~~~d~--~~E~~~~i~~~i~s  317 (829)
T KOG0576|consen  244 SEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT--LSRRLAIELLDKV-NNPNPVVRYLEDY--DGEDYLWIPMRICS  317 (829)
T ss_pred             hHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc--hhhHHHHHHHHHc-cCCCCcccccccC--Ccccccchhhhhhc
Confidence            445567899999999999776666555 7776633  4556689999999 9999 55555554  34467889999998


Q ss_pred             CC-Chhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCcceeec
Q 014406          206 ST-DFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRV  280 (425)
Q Consensus       206 ~~-~l~~~~----~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~~~~~~  280 (425)
                      ++ +-....    -.+...+...+.+.-.+++++||+..=+|+|    ||+..++  ..+..||+....+......+...
T Consensus       318 ~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~~--~~~~~~~~v~~~L~~~~~~~t~~  391 (829)
T KOG0576|consen  318 TGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSEE--EVKLLDFAVPPQLTRTMKPRTAI  391 (829)
T ss_pred             CCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----ccccccc--ccccccccCCcccCcccccccCC
Confidence            77 222111    1244455566777788999999998778998    8888875  57999999988776665567778


Q ss_pred             cCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCChhhHHH
Q 014406          281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDAL  360 (425)
Q Consensus       281 ~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~  360 (425)
                      +++.|+|||+... ..++...|.|++|+--.++--|-.|-..   .....    ...|.++                   
T Consensus       392 ~~~~~~~pev~~~-~~~~~~p~~~~~~~~~~~~ap~~pPr~~---P~~~~----~~~g~~p-------------------  444 (829)
T KOG0576|consen  392 GTPEPLAPEVIQE-NTIDGCPDSGSLAVSAIQMAPGLPPRSS---PPAVL----PMIGNGP-------------------  444 (829)
T ss_pred             CCCCCCCchhhcc-cccccCCCccCCCcchhhcCCCCCCCCC---Ccccc----CCCCCCC-------------------
Confidence            9999999999877 6789999999999866666666555311   00000    0011110                   


Q ss_pred             hcccCCCCccccccccCCCCCCHHH-HHHHHHcccCCcCCCcCHHHHhcCCCCcccc
Q 014406          361 VGRHSRKPWSKFINADNQHLVSPEA-IDFLDKLLRYDHQDRLTAREAMAHPYFAQVR  416 (425)
Q Consensus       361 ~~~~~~~~~~~~~~~~~~~~~s~~~-~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~  416 (425)
                          +   .........   .+... .++...|+...|..|++...++-|.+|++..
T Consensus       445 ----~---s~~L~~~~a---w~~~~~~~~~~~~~~g~P~~pkv~mgacfsKvfngCp  491 (829)
T KOG0576|consen  445 ----N---SPMLTDKSA---WSPVFHRDFPAPCLNGLPPTPKVHMGACFSKVFNGCP  491 (829)
T ss_pred             ----C---ccccchhhh---cCcccccCCcccccCCCCCCCcchhhHHHHHHhccCc
Confidence                0   000000000   11111 2588899999999999999999999998764

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.51  E-value=2.6e-06  Score=77.24  Aligned_cols=138  Identities=22%  Similarity=0.434  Sum_probs=83.7

Q ss_pred             EeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-chHHHHHHHHHHHHhcCC-CCeeeEEeEEEcC-CCCccEEEEEeecC
Q 014406          130 VRKVGRGKYSEVFEGINVNTNERCIIKILKPV-KKKKIKREIKILQNLCGG-PNVVKLLDIVRDQ-HSKTPSLIFEYVNS  206 (425)
Q Consensus       130 ~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~~h-~niv~l~~~~~~~-~~~~~~lv~e~~~~  206 (425)
                      ++.|+.|..+.||+.....  ..+++|+.... ....+.+|..+++.+..+ ..+.+++.+.... .....+++|++++|
T Consensus         2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g   79 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPPDAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG   79 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT--SEEEEEEESSHHHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred             CccCCCCCeeeEEEEEECC--cEEEEEEeCCCCCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence            4679999999999996544  48999998765 556788999999988433 2356777655433 22346899999999


Q ss_pred             CChhhh----------------c-------CC---CCHHH------HHH---H------------HHHHHH-HHHHHHH-
Q 014406          207 TDFKVL----------------Y-------PT---LTDYD------IRY---Y------------IYELLK-ALDYCHS-  237 (425)
Q Consensus       207 ~~l~~~----------------~-------~~---l~~~~------~~~---i------------~~~i~~-~L~~LH~-  237 (425)
                      ..+...                +       ..   +....      ...   .            ...+.. .+..+++ 
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (239)
T PF01636_consen   80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL  159 (239)
T ss_dssp             EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence            877760                0       00   00000      000   0            111222 3334432 


Q ss_pred             ------CCceeecCCCCceEecCCCCcEEEEecccccc
Q 014406          238 ------QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (425)
Q Consensus       238 ------~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~  269 (425)
                            ..++|+|+.+.|||++.+.+.+-|+||+.+..
T Consensus       160 ~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~  197 (239)
T PF01636_consen  160 LPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW  197 (239)
T ss_dssp             HHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred             hccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence                  35999999999999994335667999987753

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.51  E-value=2e-06  Score=77.76  Aligned_cols=131  Identities=19%  Similarity=0.241  Sum_probs=81.6

Q ss_pred             eeeeeeCceEEEEEEEcCCCcEEEEEEecCcc-hHHHHHHHHHHHHhcCCC-CeeeEEeEEEcCCCCccEEEEEeecCCC
Q 014406          131 RKVGRGKYSEVFEGINVNTNERCIIKILKPVK-KKKIKREIKILQNLCGGP-NVVKLLDIVRDQHSKTPSLIFEYVNSTD  208 (425)
Q Consensus       131 ~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~-~~~~~~E~~~l~~l~~h~-niv~l~~~~~~~~~~~~~lv~e~~~~~~  208 (425)
                      ..||.|..+.||+.    .+..+++|...... .....+|.++++.+.... -+.+.+++..+.  ....+|||+++|..
T Consensus         7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~--~~~glv~e~i~G~~   80 (226)
T TIGR02172         7 TQTGEGGNGESYTH----KTGKWMLKLYNPGFDKETIKREFDASRKVFSLGIPTPHPFDLVEDG--GRLGLIYELIVGKR   80 (226)
T ss_pred             eeecCCCCcceeEe----cCCCEEEEeCCCCCCHHHHHHHHHHHHHHHHcCCCCCceEEEEecC--CeeeeeeeecCCcc
Confidence            46899999999984    24467899987543 456889999999884222 246677777443  44568999999963


Q ss_pred             -hhhhc---------------------CC-----CCHHH-HHHHHHH----------HHH-HHHHHHH----CCceeecC
Q 014406          209 -FKVLY---------------------PT-----LTDYD-IRYYIYE----------LLK-ALDYCHS----QGIMHRDV  245 (425)
Q Consensus       209 -l~~~~---------------------~~-----l~~~~-~~~i~~~----------i~~-~L~~LH~----~~ivH~Dl  245 (425)
                       +....                     ..     ..... ...+..+          +.. ...+|..    ..++|+|+
T Consensus        81 ~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~  160 (226)
T TIGR02172        81 SFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF  160 (226)
T ss_pred             chhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence             21111                     00     01000 0001000          111 1222221    24789999


Q ss_pred             CCCceEecCCCCcEEEEecccccc
Q 014406          246 KPHNVMIDHELRKLRLIDWGLAEF  269 (425)
Q Consensus       246 k~~NIll~~~~~~~kl~Dfg~a~~  269 (425)
                      .|.||+++.+ + +.|+||+.+..
T Consensus       161 ~~~Nii~~~~-~-~~iIDwe~a~~  182 (226)
T TIGR02172       161 QIGNLITSGK-G-TYWIDLGDFGY  182 (226)
T ss_pred             CCCcEEEcCC-C-cEEEechhcCc
Confidence            9999999987 5 89999998753

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.50  E-value=2.9e-06  Score=74.98  Aligned_cols=136  Identities=15%  Similarity=0.262  Sum_probs=90.1

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcch------------HHHHHHHHHHHHhc--CCCCeeeEEeEE
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK------------KKIKREIKILQNLC--GGPNVVKLLDIV  189 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~------------~~~~~E~~~l~~l~--~h~niv~l~~~~  189 (425)
                      ..+|.+++.+-......|.+-  .-+++.+++|...+...            ....+++..+..+.  +--....++-+.
T Consensus        30 ~~~~~~~kv~k~~~r~~ValI--ei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~  107 (229)
T PF06176_consen   30 DNNYKIIKVFKNTKRNYVALI--EIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA  107 (229)
T ss_pred             hCCceEEEeecCCCccEEEEE--EECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence            567888888888877777775  44678899998875432            11234444444441  222333333322


Q ss_pred             EcCC---CCccEEEEEeecCCChhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccc
Q 014406          190 RDQH---SKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL  266 (425)
Q Consensus       190 ~~~~---~~~~~lv~e~~~~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~  266 (425)
                      ....   ....+|+|||++|..+.+.. .+++    .+...+..++.-||+.|++|+|..|.|++++.+  .++++||+.
T Consensus       108 ekk~~~~~~~~~ll~EYIeG~~l~d~~-~i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~--~i~iID~~~  180 (229)
T PF06176_consen  108 EKKIFRYTSSYVLLMEYIEGVELNDIE-DIDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN--GIRIIDTQG  180 (229)
T ss_pred             eeeeccceeEEEEEEEEecCeecccch-hcCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC--cEEEEECcc
Confidence            2111   12346899999998876653 2332    234567788999999999999999999999965  589999986


Q ss_pred             cc
Q 014406          267 AE  268 (425)
Q Consensus       267 a~  268 (425)
                      .+
T Consensus       181 k~  182 (229)
T PF06176_consen  181 KR  182 (229)
T ss_pred             cc
Confidence            64

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.49  E-value=2.5e-06  Score=76.19  Aligned_cols=133  Identities=16%  Similarity=0.261  Sum_probs=91.8

Q ss_pred             EeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc----------------------hHH-----HHHHHHHHHHhcC-CCC
Q 014406          130 VRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----------------------KKK-----IKREIKILQNLCG-GPN  181 (425)
Q Consensus       130 ~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~----------------------~~~-----~~~E~~~l~~l~~-h~n  181 (425)
                      ...|..|.-+.||+|. ..++..+|+|+++...                      ..+     ...|+..|.++.+ +=.
T Consensus        53 ~g~istGKEA~Vy~a~-~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr  131 (268)
T COG1718          53 VGCISTGKEANVYLAE-TGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR  131 (268)
T ss_pred             EeeecCCcceEEEeec-cCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence            3468888899999995 4678999999986321                      011     2357777777732 234


Q ss_pred             eeeEEeEEEcCCCCccEEEEEeecCCCh-hhhcCC--CCHHHHHHHHHHHHHHHHHHHH-CCceeecCCCCceEecCCCC
Q 014406          182 VVKLLDIVRDQHSKTPSLIFEYVNSTDF-KVLYPT--LTDYDIRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHELR  257 (425)
Q Consensus       182 iv~l~~~~~~~~~~~~~lv~e~~~~~~l-~~~~~~--l~~~~~~~i~~~i~~~L~~LH~-~~ivH~Dlk~~NIll~~~~~  257 (425)
                      +.+-+++.      .-.|||||++.... .-.+..  +...+...+..+++..+.-|=. .++||+||..-|||+. + +
T Consensus       132 vP~Pi~~~------~nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~-~  203 (268)
T COG1718         132 VPEPIAFR------NNVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-D-G  203 (268)
T ss_pred             CCCceeec------CCeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-C-C
Confidence            44445544      23599999976621 112222  2333577778888888888876 8999999999999999 4 5


Q ss_pred             cEEEEecccccccc
Q 014406          258 KLRLIDWGLAEFYH  271 (425)
Q Consensus       258 ~~kl~Dfg~a~~~~  271 (425)
                      .+.|+|||-|....
T Consensus       204 ~p~iID~~QaV~~~  217 (268)
T COG1718         204 EPYIIDVSQAVTID  217 (268)
T ss_pred             eEEEEECccccccC
Confidence            78999999876443

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.44  E-value=3.1e-06  Score=77.67  Aligned_cols=75  Identities=21%  Similarity=0.204  Sum_probs=54.3

Q ss_pred             eeeeCc-eEEEEEEEcCCCcEEEEEEecCcchHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEEEeecCCChhh
Q 014406          133 VGRGKY-SEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV  211 (425)
Q Consensus       133 LG~G~f-g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~  211 (425)
                      |-.|.+ ..||+...  .+..+++|+........+.+|+.+++.+.++--+.+++++....  ...++|||+++|..+..
T Consensus         6 ~~~g~~~~~v~~~~~--~~~~~~vk~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~--~~~~lv~e~i~G~~l~~   81 (244)
T cd05150           6 VTEGQSGATVYRLDG--KNPGLYLKIAPSGPTYELEREAERLRWLAGKLPVPEVIDYGSDD--GRAWLLTSAVPGVPAAA   81 (244)
T ss_pred             cCCCCCcCeEEEEcC--CCCcEEEEecCCCcccchHHHHHHHHHHHhcCCCCeEEEEEecC--CccEEEEEeeCCccHhH
Confidence            444445 78999843  34688899987654566788999999986555566778777543  45679999999987664

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.40  E-value=9.9e-07  Score=93.25  Aligned_cols=204  Identities=18%  Similarity=0.241  Sum_probs=140.4

Q ss_pred             HHHHHHHHHHhcCCCCeeeEEeEEEcCCCC--ccEEEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 014406          166 IKREIKILQNLCGGPNVVKLLDIVRDQHSK--TPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGI  240 (425)
Q Consensus       166 ~~~E~~~l~~l~~h~niv~l~~~~~~~~~~--~~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~i  240 (425)
                      ...|+..+.++ .|+|++.++.|-......  ...+.-+++...++...+   ...+....+.+..++..||.|+|+...
T Consensus       229 ~E~e~~~l~k~-~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~l  307 (1351)
T KOG1035|consen  229 TEIELESLSKI-AHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLSL  307 (1351)
T ss_pred             HHHHHHHHHhh-ccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhcc
Confidence            34567777887 899999999887643222  223445677776666655   457888899999999999999999876


Q ss_pred             eeecCCCC---ceEecCCCCcEEEE--eccccccccCCCcceeeccCCCccCcccccCCCCCC--CcccHHHHHHHHHHH
Q 014406          241 MHRDVKPH---NVMIDHELRKLRLI--DWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYD--YSLDMWSLGCMFAGM  313 (425)
Q Consensus       241 vH~Dlk~~---NIll~~~~~~~kl~--Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~--~~~DvwslG~~l~el  313 (425)
                      .|.-+..+   +-..+.+ +.+.++  ||+.++.............+..+.++|.... ..++  ...|+|.+|.....+
T Consensus       308 ~~v~L~~s~~~~~~~~~e-~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~-~~~~~~r~~dL~~lgll~~~~  385 (1351)
T KOG1035|consen  308 EHVVLSASSSKESTVDGE-GVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKE-NTAKKSRLTDLWCLGLLLLQL  385 (1351)
T ss_pred             ceeEEecccccccccCcc-ceeecchhhhcccccCCCcccchhhcCcccccccccccc-ccchhhhhhHHHHHHHHHhhh
Confidence            66666555   4444555 455666  8888877665555555566677888888754 3343  347999999999999


Q ss_pred             HhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcc
Q 014406          314 IFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLL  393 (425)
Q Consensus       314 ltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L  393 (425)
                      ..|..+-.       ..+.....++.                                        .......+++.+|+
T Consensus       386 ~~~~~i~~-------~~~~~~~~l~~----------------------------------------~~~~~~~d~~~~~~  418 (1351)
T KOG1035|consen  386 SQGEDISE-------KSAVPVSLLDV----------------------------------------LSTSELLDALPKCL  418 (1351)
T ss_pred             hhcCcccc-------cccchhhhhcc----------------------------------------ccchhhhhhhhhhc
Confidence            88765431       11111111100                                        01226778999999


Q ss_pred             cCCcCCCcCHHHHhcCCCCcccccch
Q 014406          394 RYDHQDRLTAREAMAHPYFAQVRAAE  419 (425)
Q Consensus       394 ~~dP~~Rpta~elL~hp~~~~~~~~~  419 (425)
                      .-++++|+++.+++.|+|.+.-...+
T Consensus       419 ~~~~~~Rl~~~~ll~~~f~~~~~~~~  444 (1351)
T KOG1035|consen  419 DEDSEERLSALELLTHPFLRFPTDNE  444 (1351)
T ss_pred             chhhhhccchhhhhhchhcccccccc
Confidence            99999999999999999987654433

>PLN02876 acyl-CoA dehydrogenase

Probab=98.34  E-value=1.1e-05  Score=86.92  Aligned_cols=143  Identities=20%  Similarity=0.349  Sum_probs=92.0

Q ss_pred             EeeeeeeCceEEEEEEEcCCC--cEEEEEEecCc----chHHHHHHHHHHHHhcCCCCe--eeEEeEEEcCC-CCccEEE
Q 014406          130 VRKVGRGKYSEVFEGINVNTN--ERCIIKILKPV----KKKKIKREIKILQNLCGGPNV--VKLLDIVRDQH-SKTPSLI  200 (425)
Q Consensus       130 ~~~LG~G~fg~V~~~~~~~~~--~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~ni--v~l~~~~~~~~-~~~~~lv  200 (425)
                      ++.|+.|.++.+|+.....++  ..+++|+....    ....+.+|..+++.+..|.++  .+++.+|.+.. ....++|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            567899999999998654432  46778876432    235788999999999446654  78888886532 2457899


Q ss_pred             EEeecCCChhhh-----------------------cCCCC----------------HHHHHHHHH---------------
Q 014406          201 FEYVNSTDFKVL-----------------------YPTLT----------------DYDIRYYIY---------------  226 (425)
Q Consensus       201 ~e~~~~~~l~~~-----------------------~~~l~----------------~~~~~~i~~---------------  226 (425)
                      |||++|..+.+.                       +..++                ..++..+..               
T Consensus       123 ME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~  202 (822)
T PLN02876        123 MEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNP  202 (822)
T ss_pred             EEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCCh
Confidence            999998753210                       01111                012221111               


Q ss_pred             HHHHHHHHHHH-----------CCceeecCCCCceEecCCCC-cEEEEeccccccccC
Q 014406          227 ELLKALDYCHS-----------QGIMHRDVKPHNVMIDHELR-KLRLIDWGLAEFYHP  272 (425)
Q Consensus       227 ~i~~~L~~LH~-----------~~ivH~Dlk~~NIll~~~~~-~~kl~Dfg~a~~~~~  272 (425)
                      .+...+++|..           ..+||+|+++.||+++.+.+ .+-|.||+++...++
T Consensus       203 ~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~GdP  260 (822)
T PLN02876        203 KMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLGNQ  260 (822)
T ss_pred             hHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccCCh
Confidence            12233566642           24999999999999986423 357999999876543

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.27  E-value=5.5e-05  Score=66.17  Aligned_cols=125  Identities=23%  Similarity=0.301  Sum_probs=90.7

Q ss_pred             CCEEEEeeeeeeCc-eEEEEEEEcCCCcEEEEEEecC------------------------cchHHHHHHHHHHHHhc--
Q 014406          125 DDYEVVRKVGRGKY-SEVFEGINVNTNERCIIKILKP------------------------VKKKKIKREIKILQNLC--  177 (425)
Q Consensus       125 ~~y~~~~~LG~G~f-g~V~~~~~~~~~~~vavK~~~~------------------------~~~~~~~~E~~~l~~l~--  177 (425)
                      .+++.++.||.|.- |.||++..  +|+.+|+|++..                        ....-|..|.....+|.  
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~  114 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA  114 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence            78999999999999 99999954  677999999421                        00124678988888874  


Q ss_pred             CCCCe--eeEEeEEEcCC----------------CCccEEEEEeecCCChhhhcCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 014406          178 GGPNV--VKLLDIVRDQH----------------SKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQG  239 (425)
Q Consensus       178 ~h~ni--v~l~~~~~~~~----------------~~~~~lv~e~~~~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~  239 (425)
                      ++.++  ++++||..-..                .....+|.||+....      .+...    -+.+|.+-|..+|..|
T Consensus       115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------~~~~~----~~~~~~~dl~~~~k~g  184 (207)
T PF13095_consen  115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------PLQIR----DIPQMLRDLKILHKLG  184 (207)
T ss_pred             cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------ccchh----HHHHHHHHHHHHHHCC
Confidence            33455  99999885220                112357888776554      22333    3467778889999999


Q ss_pred             ceeecCCCCceEecCCCCcEEEEecccc
Q 014406          240 IMHRDVKPHNVMIDHELRKLRLIDWGLA  267 (425)
Q Consensus       240 ivH~Dlk~~NIll~~~~~~~kl~Dfg~a  267 (425)
                      |+-+|+++.|..   +   -+|+|||.+
T Consensus       185 I~~~Dv~~~ny~---~---G~lvDfs~~  206 (207)
T PF13095_consen  185 IVPRDVKPRNYR---G---GKLVDFSSS  206 (207)
T ss_pred             eeeccCcccccc---C---CEEEecccC
Confidence            999999999987   2   289999864

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.22  E-value=1.1e-05  Score=68.30  Aligned_cols=128  Identities=21%  Similarity=0.329  Sum_probs=89.3

Q ss_pred             EEEeeeeeeCceEEEEEEEcCCCcEEEEEEecC-cchHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEEEeecC
Q 014406          128 EVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNS  206 (425)
Q Consensus       128 ~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~-~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~  206 (425)
                      +..+.||+|.+|.||+|.+  .+..+|+|+-.. ..+..+..|.++|..+..-.--.+++.|-.+      ++.|||+.|
T Consensus        25 ~v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr~ds~r~~l~kEakiLeil~g~~~~p~vy~yg~~------~i~me~i~G   96 (201)
T COG2112          25 RVEKELAKGTTSVVYLGEW--RGGEVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYFYGED------FIRMEYIDG   96 (201)
T ss_pred             hhhhhhhcccccEEEEeec--cCceEEEEEecCCcchhhHHHHHHHHHHhhhcCCCceEEEechh------hhhhhhhcC
Confidence            4566799999999999965  355888988764 4567899999999998333333456665432      256999999


Q ss_pred             CChhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCC--CceEecCCCCcEEEEecccccc
Q 014406          207 TDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKP--HNVMIDHELRKLRLIDWGLAEF  269 (425)
Q Consensus       207 ~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~--~NIll~~~~~~~kl~Dfg~a~~  269 (425)
                      -.|.......+...+    ..++..---|-..||-|..|.-  .||++..  +.+.|+||..|+.
T Consensus        97 ~~L~~~~~~~~rk~l----~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~--~~~~iIDFd~At~  155 (201)
T COG2112          97 RPLGKLEIGGDRKHL----LRVLEKAYKLDRLGIEHGELSRPWKNVLVND--RDVYIIDFDSATF  155 (201)
T ss_pred             cchhhhhhcccHHHH----HHHHHHHHHHHHhccchhhhcCCceeEEecC--CcEEEEEccchhh
Confidence            888776544333333    3444444445567999998863  4556554  3789999998863

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.16  E-value=1.9e-05  Score=79.11  Aligned_cols=138  Identities=20%  Similarity=0.260  Sum_probs=86.6

Q ss_pred             eeeeeeCceEEEEEEEcCCCcEEEEEEecCcchH----------------------------------H------HHHHH
Q 014406          131 RKVGRGKYSEVFEGINVNTNERCIIKILKPVKKK----------------------------------K------IKREI  170 (425)
Q Consensus       131 ~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~----------------------------------~------~~~E~  170 (425)
                      +.||..+.|.||+|+.+ +|+.||||+-++.-.+                                  .      |.+|.
T Consensus       167 ~piaaASlaQVhrA~L~-~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLK-NGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             chhhhcchhheEEEEec-CCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            46999999999999755 5999999997643211                                  1      22333


Q ss_pred             HHHHHhc---CCCC---eeeEEeEEEcCCCCccEEEEEeecCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 014406          171 KILQNLC---GGPN---VVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGI  240 (425)
Q Consensus       171 ~~l~~l~---~h~n---iv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~LH~~~i  240 (425)
                      +...++.   .|-+   =|.+=.++++- ....+|+||||+|.-+.+.-    ..++...+..-+.+...  +-+=..|+
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~-st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~--~qIf~~Gf  322 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVYWDL-STKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYL--EQIFKTGF  322 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeehhhc-CcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHH--HHHHhcCC
Confidence            3322221   2333   12233334332 23567999999998666542    34666554433333222  22224689


Q ss_pred             eeecCCCCceEecC---CCCcEEEEeccccccccC
Q 014406          241 MHRDVKPHNVMIDH---ELRKLRLIDWGLAEFYHP  272 (425)
Q Consensus       241 vH~Dlk~~NIll~~---~~~~~kl~Dfg~a~~~~~  272 (425)
                      +|+|-.|.||+++.   ....+.+-|||+...+..
T Consensus       323 fHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  323 FHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             ccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            99999999999994   246899999999876543

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.13  E-value=2.6e-05  Score=71.11  Aligned_cols=75  Identities=12%  Similarity=0.174  Sum_probs=47.6

Q ss_pred             eeeeeeCce-EEEEEEEcCCCcEEEEEEecCc-chHHHHHHHHHHHHhcCCC--CeeeEEeEEEcCCC-CccEEEEEeec
Q 014406          131 RKVGRGKYS-EVFEGINVNTNERCIIKILKPV-KKKKIKREIKILQNLCGGP--NVVKLLDIVRDQHS-KTPSLIFEYVN  205 (425)
Q Consensus       131 ~~LG~G~fg-~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~~h~--niv~l~~~~~~~~~-~~~~lv~e~~~  205 (425)
                      +.|+.|+.. .||+.     +..+++|+.... ....+.+|.+++..+.++-  -+.+.++.....+. ...+++|++++
T Consensus         3 ~~~~~gG~~n~vy~~-----~~~~VlR~~~~~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~   77 (235)
T cd05155           3 EPVDSGGTDNATFRL-----GDDMSVRLPSAAGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLE   77 (235)
T ss_pred             eeccCCCcccceEEc-----CCceEEEcCCccchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeec
Confidence            457777776 58885     235778887653 3457889999999884331  33444443322211 24578999999


Q ss_pred             CCChh
Q 014406          206 STDFK  210 (425)
Q Consensus       206 ~~~l~  210 (425)
                      |.++.
T Consensus        78 G~~l~   82 (235)
T cd05155          78 GETAT   82 (235)
T ss_pred             CCCCC
Confidence            97764

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PRK10593 hypothetical protein; Provisional

Probab=98.07  E-value=9.9e-05  Score=69.72  Aligned_cols=80  Identities=9%  Similarity=0.143  Sum_probs=58.7

Q ss_pred             EEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-chHHHHHHHHHHHHhcCC--CCeeeEEeEEEcC-CCCccEEEEEe
Q 014406          128 EVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-KKKKIKREIKILQNLCGG--PNVVKLLDIVRDQ-HSKTPSLIFEY  203 (425)
Q Consensus       128 ~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~~h--~niv~l~~~~~~~-~~~~~~lv~e~  203 (425)
                      .-.+.||.|..+.||+... .++ .+++|..+.. ....+..|...|+.+.++  -.+.++++++... ..+..+||||+
T Consensus        17 ~~~~~i~~G~~~~vy~~~~-~~~-~~~~k~~~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~   94 (297)
T PRK10593         17 SRVECISEQPYAALWALYD-SQG-NPMPLMARSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLER   94 (297)
T ss_pred             heeeecCCccceeEEEEEc-CCC-CEEEEEecccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEec
Confidence            3356799999999999743 233 5777886653 456899999999999543  3678899887643 23457899999


Q ss_pred             ecCCCh
Q 014406          204 VNSTDF  209 (425)
Q Consensus       204 ~~~~~l  209 (425)
                      +++.++
T Consensus        95 i~G~~~  100 (297)
T PRK10593         95 LRGVSV  100 (297)
T ss_pred             cCCEec
Confidence            998754

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.03  E-value=0.00014  Score=64.07  Aligned_cols=124  Identities=19%  Similarity=0.385  Sum_probs=88.1

Q ss_pred             eeeeeeCceEEEEEEEcCCCcEEEEEEecCcc-------------------hHHHHHHHHHHHHhc-----CCCCeeeEE
Q 014406          131 RKVGRGKYSEVFEGINVNTNERCIIKILKPVK-------------------KKKIKREIKILQNLC-----GGPNVVKLL  186 (425)
Q Consensus       131 ~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~-------------------~~~~~~E~~~l~~l~-----~h~niv~l~  186 (425)
                      ..||+|+.=.||.-   .......||+..+..                   .++..+|+.-...+.     .+.+|.+++
T Consensus         7 ~~i~~G~~R~cy~H---P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~   83 (199)
T PF10707_consen    7 DLIAQGGERDCYQH---PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY   83 (199)
T ss_pred             cccccCCCceEEEC---CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence            36999999999973   344556789988766                   577888888887772     267999999


Q ss_pred             eEEEcCCCCccEEEEEeecCC------ChhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCC--
Q 014406          187 DIVRDQHSKTPSLIFEYVNST------DFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEL--  256 (425)
Q Consensus       187 ~~~~~~~~~~~~lv~e~~~~~------~l~~~~~--~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~--  256 (425)
                      |+.+..  .-+.+|+|.+.+.      +|.+++.  .++. ..   ...+-.-..||-+.+|+.+|++|.||++....  
T Consensus        84 G~veT~--~G~Glv~e~I~d~dG~~s~TL~~~l~~~~~~~-~~---~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~  157 (199)
T PF10707_consen   84 GFVETN--LGLGLVVELIRDADGNISPTLEDYLKEGGLTE-EL---RQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSG  157 (199)
T ss_pred             EEEecC--CceEEEEEEEECCCCCcCccHHHHHHcCCccH-HH---HHHHHHHHHHHHHcCCeecCCCcccEEEEecCCC
Confidence            999655  4456999987443      3555553  2443 33   33334445677889999999999999996431  


Q ss_pred             C-cEEEEe
Q 014406          257 R-KLRLID  263 (425)
Q Consensus       257 ~-~~kl~D  263 (425)
                      . .+.|+|
T Consensus       158 ~~~lvlID  165 (199)
T PF10707_consen  158 EFRLVLID  165 (199)
T ss_pred             ceEEEEEe
Confidence            2 567777

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=98.02  E-value=8.2e-05  Score=67.73  Aligned_cols=74  Identities=15%  Similarity=0.290  Sum_probs=50.6

Q ss_pred             EeeeeeeCceEEEEEEEcC-CCcEEEEEEecCcchH--HHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEEEeecC
Q 014406          130 VRKVGRGKYSEVFEGINVN-TNERCIIKILKPVKKK--KIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNS  206 (425)
Q Consensus       130 ~~~LG~G~fg~V~~~~~~~-~~~~vavK~~~~~~~~--~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~  206 (425)
                      ++.|..|-...+|+..... .++.+++|+.......  ...+|+.+++.+..+.-..++++.+.    .  .++|||++|
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~--~~l~e~i~G   76 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATFQ----N--GLIYEFIPG   76 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEeC----C--cEEEEeeCC
Confidence            3568888889999985432 3578889987654322  33579999998854444566665542    1  289999998


Q ss_pred             CCh
Q 014406          207 TDF  209 (425)
Q Consensus       207 ~~l  209 (425)
                      .++
T Consensus        77 ~~l   79 (235)
T cd05157          77 RTL   79 (235)
T ss_pred             CcC
Confidence            765

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.95  E-value=5e-05  Score=66.52  Aligned_cols=96  Identities=23%  Similarity=0.209  Sum_probs=78.8

Q ss_pred             HHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEEEeecCCChh-------hhcCCCCHHHHHHHHHHHHHHHHHHHH--
Q 014406          167 KREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFK-------VLYPTLTDYDIRYYIYELLKALDYCHS--  237 (425)
Q Consensus       167 ~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~-------~~~~~l~~~~~~~i~~~i~~~L~~LH~--  237 (425)
                      ..|.-+++.+.+.+++.+++|+|  .  .  .++.||...+.+.       .+ ...+|..+.+++.+++..+++|+.  
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~C--G--~--~~v~E~~~~~~~~~~~~~l~~~-~~~~w~~R~~iA~~lL~~l~~l~~~~   79 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSC--G--R--FYVVEYVGAGSLYGIYRPLSQF-LQSPWEQRAKIALQLLELLEELDHGP   79 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeEC--C--C--EEEEEeecCccccccccccccc-cccCHHHHHHHHHHHHHHHHHHhcCC
Confidence            35888899886667999999999  2  2  3799999977553       22 346899999999999999999997  


Q ss_pred             -CCceeecCCCCceEecCCCCcEEEEeccccccc
Q 014406          238 -QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  270 (425)
Q Consensus       238 -~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~  270 (425)
                       ..+.-.|++++|+-++++ +++|++|...+...
T Consensus        80 ~~~~~lcDv~~~nfgv~~~-~~lk~iDld~v~~~  112 (188)
T PF12260_consen   80 LGFFYLCDVSPDNFGVNDD-GRLKLIDLDDVFVE  112 (188)
T ss_pred             CCcEEEeecchHHeEEeCC-CcEEEEechhcchh
Confidence             358889999999999987 78999999876543

Proteins in this uncharacterised family are described as transmembrane proteins.

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.88  E-value=0.00012  Score=67.54  Aligned_cols=128  Identities=22%  Similarity=0.255  Sum_probs=77.6

Q ss_pred             eeeeCceEEEEEEEcCCCcEEEEEEecCcch---HHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEEEeecCCCh
Q 014406          133 VGRGKYSEVFEGINVNTNERCIIKILKPVKK---KKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDF  209 (425)
Q Consensus       133 LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~---~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l  209 (425)
                      +..|-.+.+|+..  .++..+++|+......   -...+|..+++.+..+.-..+++...  .    -++||||++|..+
T Consensus         4 ~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~----~~~v~e~i~G~~~   75 (256)
T TIGR02721         4 LSGGLTNRSWRIE--HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--E----HWLLVEWLEGEVI   75 (256)
T ss_pred             CCCcCcCCeEEEE--eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--C----CEEEEEeccCccc
Confidence            5667788999885  4567888998654322   13578999999984442334455443  2    2499999998765


Q ss_pred             hhh-------c----------CC-------CCH-HHHHHHHHHH---------HHHHHHHHH--------CCceeecCCC
Q 014406          210 KVL-------Y----------PT-------LTD-YDIRYYIYEL---------LKALDYCHS--------QGIMHRDVKP  247 (425)
Q Consensus       210 ~~~-------~----------~~-------l~~-~~~~~i~~~i---------~~~L~~LH~--------~~ivH~Dlk~  247 (425)
                      ...       .          ..       ++. ..+..+..++         ...+..+-.        ..++|+|+.|
T Consensus        76 ~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~  155 (256)
T TIGR02721        76 TLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHA  155 (256)
T ss_pred             ccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCc
Confidence            421       0          00       111 1111221111         111222221        2589999999


Q ss_pred             CceEecCCCCcEEEEeccccccc
Q 014406          248 HNVMIDHELRKLRLIDWGLAEFY  270 (425)
Q Consensus       248 ~NIll~~~~~~~kl~Dfg~a~~~  270 (425)
                      .||+++.+ + +.|+||+.|...
T Consensus       156 ~Nil~~~~-~-~~lIDwE~a~~g  176 (256)
T TIGR02721       156 YNLVVTPQ-G-LKLIDWEYASDG  176 (256)
T ss_pred             CcEEEeCC-C-CEEEeccccCcC
Confidence            99999987 4 689999988643

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.87  E-value=0.00014  Score=68.75  Aligned_cols=137  Identities=14%  Similarity=0.191  Sum_probs=85.3

Q ss_pred             EeeeeeeCceEEEEEEEcCCCcEEEEEEecCcchHHHHHHHHHHHHhcCCC-CeeeEEeEEEc----CCCCccEEEEEee
Q 014406          130 VRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGP-NVVKLLDIVRD----QHSKTPSLIFEYV  204 (425)
Q Consensus       130 ~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~-niv~l~~~~~~----~~~~~~~lv~e~~  204 (425)
                      ++.|..|....+|+...  ++..+++|+........+..|+.++..+.++. .+.+.+....+    ...+..+.|++|+
T Consensus        19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i   96 (296)
T cd05153          19 FEGISAGIENTNYFVTT--DSGRYVLTLFEKVSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFL   96 (296)
T ss_pred             eecccCccccceEEEEe--CCCcEEEEEcCCCChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeC
Confidence            45688888889999743  34478899987655677888999999884331 24454442110    1123467999999


Q ss_pred             cCCChhhh----c--------------CCC----------CHHHH--H--------HHHHHHHHHHHHHHH-------CC
Q 014406          205 NSTDFKVL----Y--------------PTL----------TDYDI--R--------YYIYELLKALDYCHS-------QG  239 (425)
Q Consensus       205 ~~~~l~~~----~--------------~~l----------~~~~~--~--------~i~~~i~~~L~~LH~-------~~  239 (425)
                      +|..+...    .              ..+          .+...  .        .....+..++.++.+       .+
T Consensus        97 ~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~  176 (296)
T cd05153          97 AGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRG  176 (296)
T ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCc
Confidence            98775321    0              011          00000  0        011112334455543       37


Q ss_pred             ceeecCCCCceEecCCCCcEEEEecccccc
Q 014406          240 IMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (425)
Q Consensus       240 ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~  269 (425)
                      ++|+|+.|.||+++.+ +.+.|+||+.+..
T Consensus       177 l~HgD~~~~Nil~~~~-~~~~iIDfe~a~~  205 (296)
T cd05153         177 VIHADLFRDNVLFDGD-ELSGVIDFYFACT  205 (296)
T ss_pred             CCccCcCcccEEEeCC-ceEEEeehhhhcC
Confidence            9999999999999986 5568999998753

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.80  E-value=0.00031  Score=66.62  Aligned_cols=75  Identities=17%  Similarity=0.237  Sum_probs=51.2

Q ss_pred             EeeeeeeCceEEEEEEEcC------CCcEEEEEEecCcc--hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEE
Q 014406          130 VRKVGRGKYSEVFEGINVN------TNERCIIKILKPVK--KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (425)
Q Consensus       130 ~~~LG~G~fg~V~~~~~~~------~~~~vavK~~~~~~--~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (425)
                      ++.|..|-...||+.....      .++.+++|+.....  .....+|..++..+..+.-..++++++.+      .+|+
T Consensus         3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~------~~v~   76 (302)
T cd05156           3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIFPN------GRIE   76 (302)
T ss_pred             EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEeCC------Cchh
Confidence            3456777778999886433      25789999987543  24567899999988544444566766632      2689


Q ss_pred             EeecCCChh
Q 014406          202 EYVNSTDFK  210 (425)
Q Consensus       202 e~~~~~~l~  210 (425)
                      ||++|..+.
T Consensus        77 e~i~G~~l~   85 (302)
T cd05156          77 EFIPSRTLT   85 (302)
T ss_pred             heeCCCcCC
Confidence            999887654

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.69  E-value=0.00051  Score=67.04  Aligned_cols=74  Identities=18%  Similarity=0.239  Sum_probs=53.0

Q ss_pred             EeeeeeeCceEEEEEEEcCCCcEEEEEEecC----------cchHHHHHHHHHHHHhcCC--CCeeeEEeEEEcCCCCcc
Q 014406          130 VRKVGRGKYSEVFEGINVNTNERCIIKILKP----------VKKKKIKREIKILQNLCGG--PNVVKLLDIVRDQHSKTP  197 (425)
Q Consensus       130 ~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~----------~~~~~~~~E~~~l~~l~~h--~niv~l~~~~~~~~~~~~  197 (425)
                      .+.||.|.+..||++.+..+++.++||.-.+          ...++...|.+.|..+...  .++.+++.+-  .  ..-
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D--~--~~~  106 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD--E--ELA  106 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC--C--CCC
Confidence            3579999999999998765446899998431          1345677888888876332  4577777764  2  345


Q ss_pred             EEEEEeecCC
Q 014406          198 SLIFEYVNST  207 (425)
Q Consensus       198 ~lv~e~~~~~  207 (425)
                      ++||||+++.
T Consensus       107 ~lVME~L~~~  116 (401)
T PRK09550        107 VTVMEDLSDH  116 (401)
T ss_pred             EEEEecCCCc
Confidence            6999999864

>PRK05231 homoserine kinase; Provisional

Probab=97.66  E-value=0.0006  Score=65.19  Aligned_cols=137  Identities=13%  Similarity=0.207  Sum_probs=78.1

Q ss_pred             EeeeeeeCceEEEEEEEcCCCcEEEEEEecCcchHHHHHHHHHHHHhcCC-CCeeeEEeEE----EcCCCCccEEEEEee
Q 014406          130 VRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGG-PNVVKLLDIV----RDQHSKTPSLIFEYV  204 (425)
Q Consensus       130 ~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h-~niv~l~~~~----~~~~~~~~~lv~e~~  204 (425)
                      .+.|+.|...++|+... .+| .+++|++.....+.+..|+.++..|..+ -.+.+.+...    .....+..+++++|+
T Consensus        27 ~~~l~~G~~n~~y~v~t-~~g-~~vLK~~~~~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~l  104 (319)
T PRK05231         27 LKGIAEGIENSNFFLTT-TQG-EYVLTLFERLTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTFL  104 (319)
T ss_pred             cchhccccccceEEEEe-CCC-cEEEEEeccCChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEec
Confidence            34577888889999853 333 6889988633455666777888777322 1233333211    001124468999999


Q ss_pred             cCCChhh-----h------c-------CCC--------C--H-HHHHH------------HHHH-HHHHHHHHH------
Q 014406          205 NSTDFKV-----L------Y-------PTL--------T--D-YDIRY------------YIYE-LLKALDYCH------  236 (425)
Q Consensus       205 ~~~~l~~-----~------~-------~~l--------~--~-~~~~~------------i~~~-i~~~L~~LH------  236 (425)
                      +|..+..     .      +       ..+        .  + .....            .+.+ +...++.+.      
T Consensus       105 ~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  184 (319)
T PRK05231        105 EGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWPA  184 (319)
T ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccccc
Confidence            9875421     1      0       111        0  1 01000            1111 111223332      


Q ss_pred             -HCCceeecCCCCceEecCCCCcEEEEecccccc
Q 014406          237 -SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (425)
Q Consensus       237 -~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~  269 (425)
                       ..++||+|+.+.||+++.+ ...-|+||+.+..
T Consensus       185 lp~~liHgD~~~~Nil~~~~-~~~~iIDf~~~~~  217 (319)
T PRK05231        185 LPRGVIHADLFRDNVLFEGD-RLSGFIDFYFACN  217 (319)
T ss_pred             CCcccCCCCCCCCcEEEECC-ceEEEEecccccC
Confidence             1379999999999999965 4457999998854

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.49  E-value=0.0017  Score=61.79  Aligned_cols=138  Identities=18%  Similarity=0.243  Sum_probs=83.2

Q ss_pred             EEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-chHHHHHHHHHHHHhcCC-CCeeeEEeEEEc----CCCCccEEEEE
Q 014406          129 VVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-KKKKIKREIKILQNLCGG-PNVVKLLDIVRD----QHSKTPSLIFE  202 (425)
Q Consensus       129 ~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~~h-~niv~l~~~~~~----~~~~~~~lv~e  202 (425)
                      .+..++.|....+|+... .++ .+++|+.... ..+.+..|..++..|.++ -.+.+.+....+    ...+..+++++
T Consensus        26 ~i~~~~~G~~n~~y~v~t-~~~-~~vLK~~~~~~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e  103 (307)
T TIGR00938        26 SLKGIAEGVENSNYLLTT-DVG-RYILTLYEKRVKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE  103 (307)
T ss_pred             eccccCCccccceEEEEe-CCC-cEEEEEecCCCCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence            355678888889999753 344 5778987653 345677888888888322 124444442211    11245689999


Q ss_pred             eecCCChhhh-----------c-------CCCC--------HHHHH---------------HHHHHHHHHHHHHHH----
Q 014406          203 YVNSTDFKVL-----------Y-------PTLT--------DYDIR---------------YYIYELLKALDYCHS----  237 (425)
Q Consensus       203 ~~~~~~l~~~-----------~-------~~l~--------~~~~~---------------~i~~~i~~~L~~LH~----  237 (425)
                      |++|..+...           +       ..++        .....               .....+...++++..    
T Consensus       104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~  183 (307)
T TIGR00938       104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR  183 (307)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence            9988654211           0       1110        01000               001123344555542    


Q ss_pred             ---CCceeecCCCCceEecCCCCcEEEEecccccc
Q 014406          238 ---QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (425)
Q Consensus       238 ---~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~  269 (425)
                         .+++|+|+.+.||+++.+ +.+.|+||+.+..
T Consensus       184 ~~~~~l~HgD~~~~Nvl~~~~-~~~~vIDfd~~~~  217 (307)
T TIGR00938       184 DLPRGVIHADLFPDNVLFDGD-SVKGVIDFYFACT  217 (307)
T ss_pred             cCCCccCCCCCCcCcEEEECC-ceEEEeecccccC
Confidence               579999999999999987 5568999998753

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PLN02236 choline kinase

Probab=97.38  E-value=0.0043  Score=59.90  Aligned_cols=133  Identities=17%  Similarity=0.265  Sum_probs=81.9

Q ss_pred             eeeeeeCceEEEEEEEcC----CCcEEEEEEecCcchH--HHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEEEee
Q 014406          131 RKVGRGKYSEVFEGINVN----TNERCIIKILKPVKKK--KIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV  204 (425)
Q Consensus       131 ~~LG~G~fg~V~~~~~~~----~~~~vavK~~~~~~~~--~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~  204 (425)
                      ..|-.|-...+|++....    +++.+++|+.......  .-.+|..+++.+..+.--.++++.+  +++    .|.+|+
T Consensus        42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~--~~g----~v~efi  115 (344)
T PLN02236         42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRF--PNG----RVEEFI  115 (344)
T ss_pred             EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEE--CCc----eEEEee
Confidence            356568888999986432    3468999988654321  2367999999885544445677776  322    689999


Q ss_pred             cCCChhhh-------c----------CC--------C-CHHHHHHHHHHH-----------------HHHHHHHH-----
Q 014406          205 NSTDFKVL-------Y----------PT--------L-TDYDIRYYIYEL-----------------LKALDYCH-----  236 (425)
Q Consensus       205 ~~~~l~~~-------~----------~~--------l-~~~~~~~i~~~i-----------------~~~L~~LH-----  236 (425)
                      ++.++...       .          ..        . .+..+..+..++                 ...+..|.     
T Consensus       116 ~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~  195 (344)
T PLN02236        116 HARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSG  195 (344)
T ss_pred             CCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcc
Confidence            87765421       0          00        1 122222332111                 11122222     


Q ss_pred             ---HCCceeecCCCCceEecCCCCcEEEEecccccc
Q 014406          237 ---SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (425)
Q Consensus       237 ---~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~  269 (425)
                         ...++|+|+++.|||++.+.+.+.++||..+..
T Consensus       196 ~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        196 DDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             cCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence               125899999999999987546799999988753

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=97.29  E-value=0.0012  Score=64.95  Aligned_cols=175  Identities=19%  Similarity=0.179  Sum_probs=104.0

Q ss_pred             hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEEEeecCCChhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q 014406          163 KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMH  242 (425)
Q Consensus       163 ~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~ivH  242 (425)
                      ..++.-...+++.+ .|+|....+++-+..... ..+|+|+++..+-+...... . .    ..   +++    .+++.|
T Consensus        26 s~~ilgr~~~lktl-~~~~l~~yl~~~r~~~~r-~IVV~e~~~~Sled~~~~~~-l-~----~~---s~~----~~~~~~   90 (725)
T KOG1093|consen   26 SIQILGRFQYLKSL-QHDNLCQYLDFSRGKHER-VIVVMEHYTMSLEDILKTGN-L-K----DE---SLL----AHGVLH   90 (725)
T ss_pred             HHHHhhhhHHHHhh-cCccceeeEeeecCccce-EEEEehhhccchHHHHHhcc-c-c----hh---hhc----ccccce
Confidence            45666778889998 899999999988766544 78899998754433221111 0 0    00   111    122222


Q ss_pred             ecCCCCceEecCCCCcEEEEeccccccccCCCcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCC
Q 014406          243 RDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY  322 (425)
Q Consensus       243 ~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~  322 (425)
                      -             +..+++| -++..    .             |      .....++||||+|.++.++.-|...+ .
T Consensus        91 ~-------------~~~~~td-~~~t~----~-------------~------~~~~pKsdVwsl~~i~~el~L~~~l~-~  132 (725)
T KOG1093|consen   91 L-------------NIIYITD-HFLTK----Y-------------P------SPIGPKSDVWSLGFIILELYLGISLE-A  132 (725)
T ss_pred             e-------------hhhhccc-ccccc----C-------------C------CCCCcchhhhhHHHHHHHHHHhhHHH-H
Confidence            1             2234444 11100    0             1      11124999999999999999988665 3


Q ss_pred             CCCCHHHHHHHHHHhCCchhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcC
Q 014406          323 GHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT  402 (425)
Q Consensus       323 ~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpt  402 (425)
                      ...+.+++..+.+..-.+.....+....                         .....++...+++..+|+...|..||.
T Consensus       133 ~~~~s~~l~~i~k~~~~d~~~~~~a~e~-------------------------~~~~~~d~~~~~~~~~c~~~~~~ir~l  187 (725)
T KOG1093|consen  133 ELTESEYLEILLKYYTDDQELLSTAMEH-------------------------LIQLLADKKRLPLLKKCLWLEPIIRPL  187 (725)
T ss_pred             HHHHHHHHHHHHHhccCchhHHHHHHHH-------------------------HHHHhhhHhHHHHhccCCccccccccc
Confidence            3444555555544333222111110000                         001115777889999999999999999


Q ss_pred             HHHHhcCCCCccc
Q 014406          403 AREAMAHPYFAQV  415 (425)
Q Consensus       403 a~elL~hp~~~~~  415 (425)
                      ..++++++-|.++
T Consensus       188 ~~~~~k~~i~~ev  200 (725)
T KOG1093|consen  188 PMELSKRCSFTEV  200 (725)
T ss_pred             hhHHhcCccHHHH
Confidence            9999999998776

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=97.23  E-value=0.0034  Score=60.28  Aligned_cols=138  Identities=17%  Similarity=0.244  Sum_probs=81.6

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCC---CcEEEEEEecCcchH--HHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEE
Q 014406          125 DDYEVVRKVGRGKYSEVFEGINVNT---NERCIIKILKPVKKK--KIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (425)
Q Consensus       125 ~~y~~~~~LG~G~fg~V~~~~~~~~---~~~vavK~~~~~~~~--~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (425)
                      +..++. .|..|-...+|+......   +..+++|+.......  .-.+|..+++.+..+.--.++++++  +++    +
T Consensus        15 ~~i~i~-~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~IdR~~E~~il~~l~~~gl~P~~l~~~--~~G----~   87 (330)
T PLN02421         15 SDFSVE-RISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVIDRERELQAIKYLSAAGFGAKLLGVF--GNG----M   87 (330)
T ss_pred             CceEEE-EeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEechHHHHHHHHHHHhcCCCCceeEEe--CCc----E
Confidence            344444 455588888998864432   347899988654321  2357999999884443335677766  222    6


Q ss_pred             EEEeecCCChhhh-------c----------CC--------C-CHHHHHHHHHHH----------------------HHH
Q 014406          200 IFEYVNSTDFKVL-------Y----------PT--------L-TDYDIRYYIYEL----------------------LKA  231 (425)
Q Consensus       200 v~e~~~~~~l~~~-------~----------~~--------l-~~~~~~~i~~~i----------------------~~~  231 (425)
                      |.+|+++..+...       +          ..        . .+..+..+..++                      ..-
T Consensus        88 i~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  167 (330)
T PLN02421         88 IQSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDE  167 (330)
T ss_pred             eehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHH
Confidence            8999987765321       0          00        1 122222222221                      111


Q ss_pred             HHHHH----HC----CceeecCCCCceEecCCCCcEEEEecccccc
Q 014406          232 LDYCH----SQ----GIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (425)
Q Consensus       232 L~~LH----~~----~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~  269 (425)
                      +..+.    ..    -.+|+|+.+.|||++++.+.++++||+.|..
T Consensus       168 ~~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        168 IVELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             HHHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            22221    11    2799999999999986546899999998853

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.11  E-value=0.0099  Score=56.16  Aligned_cols=143  Identities=18%  Similarity=0.323  Sum_probs=83.8

Q ss_pred             EeeeeeeCceEEEEEEEcCCCcEEEEEEec-----CcchHHHHHHHHHHHHhcC-CCCeeeEEeEEEcCCCCccEEEEEe
Q 014406          130 VRKVGRGKYSEVFEGINVNTNERCIIKILK-----PVKKKKIKREIKILQNLCG-GPNVVKLLDIVRDQHSKTPSLIFEY  203 (425)
Q Consensus       130 ~~~LG~G~fg~V~~~~~~~~~~~vavK~~~-----~~~~~~~~~E~~~l~~l~~-h~niv~l~~~~~~~~~~~~~lv~e~  203 (425)
                      .+.+-.|....+|...+.  ++.+++. ..     ........+|..+++.+.. ---+...+++|.+..-...+.||+|
T Consensus        30 v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~  106 (321)
T COG3173          30 VEEISGGWSNDTFRLGDT--GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEW  106 (321)
T ss_pred             eeeccCCcccceEEEecC--CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEE
Confidence            334444444455554333  7778887 22     1233566789999998732 2234456677754432467899999


Q ss_pred             ecCCChhhhcCCCC-----------------------------------HHHHHHHHHHH--------------HHHHHH
Q 014406          204 VNSTDFKVLYPTLT-----------------------------------DYDIRYYIYEL--------------LKALDY  234 (425)
Q Consensus       204 ~~~~~l~~~~~~l~-----------------------------------~~~~~~i~~~i--------------~~~L~~  234 (425)
                      ++|..........+                                   ..++..+..+.              ..-..|
T Consensus       107 veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~W  186 (321)
T COG3173         107 VEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKW  186 (321)
T ss_pred             ecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHH
Confidence            99853332221111                                   01111111111              223455


Q ss_pred             HHHC--------CceeecCCCCceEecCCCCcEEEEeccccccccCCCcc
Q 014406          235 CHSQ--------GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY  276 (425)
Q Consensus       235 LH~~--------~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~~  276 (425)
                      |+.+        .++|+|+.+.|++++++ +.+-|.||+++...++....
T Consensus       187 l~~~~p~~~~~~~lvHGD~~~gNlii~~~-~~~gVlDwe~~~lGDP~~Dl  235 (321)
T COG3173         187 LEANRPPWAGPPVLVHGDYRPGNLIIDPG-RPTGVLDWELATLGDPLEDL  235 (321)
T ss_pred             HHhcCCCcCCCceeeeCCcccCCEEEeCC-CeeEEEeccccccCCcHHHH
Confidence            5532        58999999999999998 55899999999876654443

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.09  E-value=0.00083  Score=62.55  Aligned_cols=131  Identities=18%  Similarity=0.268  Sum_probs=91.5

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecC---------cc----------------hHHHHHHHHHHHHhcCCC
Q 014406          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP---------VK----------------KKKIKREIKILQNLCGGP  180 (425)
Q Consensus       126 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~---------~~----------------~~~~~~E~~~l~~l~~h~  180 (425)
                      -+.+.+.||-|.-+.||.+.+ ..|+..++|+-.-         ..                +-...+|+..|+.|..|.
T Consensus        93 v~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g  171 (465)
T KOG2268|consen   93 VESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG  171 (465)
T ss_pred             hhhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence            467788999999999999964 5678888886421         00                012357888888885443


Q ss_pred             C-eeeEEeEEEcCCCCccEEEEEeecCCChhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcE
Q 014406          181 N-VVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKL  259 (425)
Q Consensus       181 n-iv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~  259 (425)
                      . +.+.+++.      .-|+|||++.+-.|.....-.+...+..-+   ..-+.-|-..|+||+|.+--||+++.+ +.+
T Consensus       172 fpVPkpiD~~------RH~Vvmelv~g~Pl~~v~~v~d~~~ly~~l---m~~Iv~la~~GlIHgDFNEFNimv~dd-~~i  241 (465)
T KOG2268|consen  172 FPVPKPIDHN------RHCVVMELVDGYPLRQVRHVEDPPTLYDDL---MGLIVRLANHGLIHGDFNEFNIMVKDD-DKI  241 (465)
T ss_pred             CCCCCccccc------ceeeHHHhhcccceeeeeecCChHHHHHHH---HHHHHHHHHcCceecccchheeEEecC-CCE
Confidence            2 33344432      347999999998887665444444444333   333455668999999999999999987 789


Q ss_pred             EEEecccc
Q 014406          260 RLIDWGLA  267 (425)
Q Consensus       260 kl~Dfg~a  267 (425)
                      +++||--.
T Consensus       242 ~vIDFPQm  249 (465)
T KOG2268|consen  242 VVIDFPQM  249 (465)
T ss_pred             EEeechHh
Confidence            99999744

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.07  E-value=0.0065  Score=56.71  Aligned_cols=32  Identities=34%  Similarity=0.631  Sum_probs=25.8

Q ss_pred             CceeecCCCCceEecCCCCcEEEEeccccccc
Q 014406          239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  270 (425)
Q Consensus       239 ~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~  270 (425)
                      .++|+|+.+.|||++.+....-|+||+.+...
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG  217 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVG  217 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence            48999999999999975234569999988653

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=97.04  E-value=0.011  Score=56.41  Aligned_cols=133  Identities=25%  Similarity=0.316  Sum_probs=82.4

Q ss_pred             eeeeCceEEEEEEEcCCCcEEEEEEecCc-chHHHHHHHHHHHHhcCCCC-----eeeEEeEEEcCCC--CccEEEEEee
Q 014406          133 VGRGKYSEVFEGINVNTNERCIIKILKPV-KKKKIKREIKILQNLCGGPN-----VVKLLDIVRDQHS--KTPSLIFEYV  204 (425)
Q Consensus       133 LG~G~fg~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~~h~n-----iv~l~~~~~~~~~--~~~~lv~e~~  204 (425)
                      |.+ .-..||+... .+|.. ++|+.... ...++..|+..+..|..+.-     +..+=|-....-.  ....-+++|+
T Consensus        34 l~s-~eN~~f~~~~-~~g~~-iLki~~~~~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l  110 (331)
T COG2334          34 LNS-EENSNFRVQT-EDGRY-ILKIYRPGWTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYL  110 (331)
T ss_pred             ccc-ccCceEEEEe-cCCCe-EEEEecCCCCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEec
Confidence            444 4567888844 33444 99999886 67788899999999843311     2222221111112  3667899999


Q ss_pred             cCCChhh-hc------------------CC-----------CCHH----HH---------HHHHHHHHHHHHHHHHC---
Q 014406          205 NSTDFKV-LY------------------PT-----------LTDY----DI---------RYYIYELLKALDYCHSQ---  238 (425)
Q Consensus       205 ~~~~l~~-~~------------------~~-----------l~~~----~~---------~~i~~~i~~~L~~LH~~---  238 (425)
                      +|..+.. ..                  ..           ..|.    ..         .....++...++.+.+.   
T Consensus       111 ~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~  190 (331)
T COG2334         111 PGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPA  190 (331)
T ss_pred             CCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchh
Confidence            9988772 11                  01           1121    00         11234455555555532   


Q ss_pred             -----C--ceeecCCCCceEecCCCCcEEEEeccccc
Q 014406          239 -----G--IMHRDVKPHNVMIDHELRKLRLIDWGLAE  268 (425)
Q Consensus       239 -----~--ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~  268 (425)
                           +  +||+|+.|.||+++.+...+.++|||.+.
T Consensus       191 ~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         191 HLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             hCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence                 3  99999999999999883347899999875

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=97.00  E-value=0.0022  Score=57.28  Aligned_cols=114  Identities=18%  Similarity=0.272  Sum_probs=60.6

Q ss_pred             CcEEEEEEecCc--chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEEEeecCCChhh--hcC-----------
Q 014406          150 NERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV--LYP-----------  214 (425)
Q Consensus       150 ~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~--~~~-----------  214 (425)
                      ++.|+|++....  ..-.-.+|..+++.+..+..-.++++.+.+  +    .|++|+++..+..  +..           
T Consensus         2 ~~~~~~Ri~g~~t~~~idr~~E~~~~~~l~~~g~~p~~~~~~~~--g----~v~e~i~g~~l~~~~~~~~~~~~~iA~~l   75 (211)
T PF01633_consen    2 PEKYLVRIPGEGTENFIDRENENEALKLLSEAGLGPKIIYFFEN--G----RVEEFIEGRTLSPEDFRNPEILKRIAKLL   75 (211)
T ss_dssp             TSEEEEEEEESCGCSHHHHHHHHHHHHHHHHTTSSS-EEEEETT--E----EEEE--SSEE--CGGGGSHHHHHHHHHHH
T ss_pred             CCEEEEEeCCCCcccccCHHHHHHHHHHHHHcCCCCeEEEEcCC--C----cEEEEecccccChhhccChHHHHHHHHHH
Confidence            457888888765  334556789999988666666788887732  1    7889997766432  110           


Q ss_pred             ----C--C--------CHHHHHHH----------------------HHHHHHHHHHHHH--------CCceeecCCCCce
Q 014406          215 ----T--L--------TDYDIRYY----------------------IYELLKALDYCHS--------QGIMHRDVKPHNV  250 (425)
Q Consensus       215 ----~--l--------~~~~~~~i----------------------~~~i~~~L~~LH~--------~~ivH~Dlk~~NI  250 (425)
                          .  .        .+..+..+                      ...+..-+..+.+        ..++|+|+.+.||
T Consensus        76 ~~lH~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~v~cHnDl~~~Ni  155 (211)
T PF01633_consen   76 AKLHSIPISPNSKKPDLWDRIDKYMNKKSEFLFKRKKKKKSIDKEDLEDLQEELEELEKLLEKSNSPLVFCHNDLNPGNI  155 (211)
T ss_dssp             HHHHTHHHTTSSSS-HHHHHHHHHHHHHHTCCCCHHTTTCHHHHHHHHHHHHHHHHHHHHHHTSCGGEEEE-S--SGGGE
T ss_pred             HHHhhcccccccCcchHHHHhhhhccchhhhhhhhhhhccccccCCHHHHHHHHhhhhhhhhccCCCceEeeccCccccE
Confidence                0  0        01112222                      1112222233221        2589999999999


Q ss_pred             EecCCCCcEEEEecccccc
Q 014406          251 MIDHELRKLRLIDWGLAEF  269 (425)
Q Consensus       251 ll~~~~~~~kl~Dfg~a~~  269 (425)
                      |++...+.++++||..|..
T Consensus       156 l~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  156 LINNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             EETSSSSCEEE--GTT-EE
T ss_pred             EeccCCCeEEEecHHHHhh
Confidence            9933337899999998853

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=96.96  E-value=0.011  Score=56.24  Aligned_cols=134  Identities=19%  Similarity=0.288  Sum_probs=90.7

Q ss_pred             EEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----c--------------------hHH----HHHHHHHHHHhcC
Q 014406          128 EVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----K--------------------KKK----IKREIKILQNLCG  178 (425)
Q Consensus       128 ~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~--------------------~~~----~~~E~~~l~~l~~  178 (425)
                      ++-..|..|.-+.||.|. ..+|..+|||+++..     .                    ++.    ...|+..|.++ +
T Consensus       147 ~inGCiSTGKEANVYHat-~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl-~  224 (520)
T KOG2270|consen  147 EINGCISTGKEANVYHAT-EEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRL-N  224 (520)
T ss_pred             ecccccccCccceeEeee-cCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHH-H
Confidence            344578999999999995 567788999998521     0                    111    24588888888 3


Q ss_pred             CCCeeeEEeEEEcCCCCccEEEEEeecCCChhhh-c--CCCCHHHHHHHHHHHHHHHHHH-HHCCceeecCCCCceEecC
Q 014406          179 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-Y--PTLTDYDIRYYIYELLKALDYC-HSQGIMHRDVKPHNVMIDH  254 (425)
Q Consensus       179 h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~-~--~~l~~~~~~~i~~~i~~~L~~L-H~~~ivH~Dlk~~NIll~~  254 (425)
                      .-.|..---...    +.-+|||++++...+..- +  -.++...+..+-.+++.-|.-| +.++.||.||.--|+|+-.
T Consensus       225 ~aGIP~PePIlL----k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyhd  300 (520)
T KOG2270|consen  225 NAGIPCPEPILL----KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYHD  300 (520)
T ss_pred             hcCCCCCCceee----ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEEC
Confidence            323222111111    233599999985543322 2  2366677777778887777777 4678999999999999976


Q ss_pred             CCCcEEEEecccccc
Q 014406          255 ELRKLRLIDWGLAEF  269 (425)
Q Consensus       255 ~~~~~kl~Dfg~a~~  269 (425)
                        |.+.|+|-+-+.-
T Consensus       301 --G~lyiIDVSQSVE  313 (520)
T KOG2270|consen  301 --GKLYIIDVSQSVE  313 (520)
T ss_pred             --CEEEEEEcccccc
Confidence              5799999876643

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=96.84  E-value=0.00018  Score=78.62  Aligned_cols=151  Identities=11%  Similarity=-0.034  Sum_probs=107.8

Q ss_pred             HHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEEEeecCCChhhhcC-------CCCHHHHHHHHHHHHHHHHHHHHC-
Q 014406          167 KREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP-------TLTDYDIRYYIYELLKALDYCHSQ-  238 (425)
Q Consensus       167 ~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-------~l~~~~~~~i~~~i~~~L~~LH~~-  238 (425)
                      ..|..-++.. .|+++.....-.........+..++|+.+|.+...+-       .+...-+.....+...+..-+|.. 
T Consensus      1277 l~e~de~~~~-~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1277 LSERDELREA-KHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred             hhhhhhhhhh-hceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence            3455555555 7888887766655444556678999999998887661       133333333334435556665543 


Q ss_pred             ----CceeecCCCCceEecCCCCcEEEEeccccccccC-CCcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHH
Q 014406          239 ----GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP-GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGM  313 (425)
Q Consensus       239 ----~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~el  313 (425)
                          -.+|+++|+.|.+|..+ ..++++++|+.+...+ ........+++.|+.|+.... ..++.++|+|+.|+.+|..
T Consensus      1356 nlg~T~v~~~Lkf~lpmIVtn-y~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~-ik~t~rsdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTN-YNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNE-IKFTKRSDILRRSLSLYLR 1433 (2724)
T ss_pred             cCCccchhhhhhhhccceecC-CcccccccccccccCchHhhhhhhhCCHHHHHHHHHHH-HhhhhHHHHHHHHHHHHHH
Confidence                27899999999999988 6889999999983332 233455678888999998766 6788889999999999998


Q ss_pred             HhCCCCC
Q 014406          314 IFRKEPF  320 (425)
Q Consensus       314 ltg~~pf  320 (425)
                      .-|..+|
T Consensus      1434 s~~n~~f 1440 (2724)
T KOG1826|consen 1434 SDGNAYF 1440 (2724)
T ss_pred             hcccHHH
Confidence            8777665

>PTZ00384 choline kinase; Provisional

Probab=96.71  E-value=0.016  Score=56.66  Aligned_cols=78  Identities=18%  Similarity=0.192  Sum_probs=48.8

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcCCC-c-----EEEEEEecCcch--HHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCcc
Q 014406          126 DYEVVRKVGRGKYSEVFEGINVNTN-E-----RCIIKILKPVKK--KKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (425)
Q Consensus       126 ~y~~~~~LG~G~fg~V~~~~~~~~~-~-----~vavK~~~~~~~--~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (425)
                      ..++ +.|..|-...+|++...... .     .|.+++......  -.-.+|+.+++.+..+.--.++++.+.+      
T Consensus        52 ~i~i-~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~------  124 (383)
T PTZ00384         52 FIEI-KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD------  124 (383)
T ss_pred             cEEE-EEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhCCCCCeEEEecCC------
Confidence            3444 35656888899998643321 2     244444322211  1235689999999555566778888732      


Q ss_pred             EEEEEeecCCChh
Q 014406          198 SLIFEYVNSTDFK  210 (425)
Q Consensus       198 ~lv~e~~~~~~l~  210 (425)
                      ++++||++|..+.
T Consensus       125 g~l~efIeGr~l~  137 (383)
T PTZ00384        125 FTIQEWVEGNTMG  137 (383)
T ss_pred             EEEEEEeccccCC
Confidence            3999999988764

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.44  E-value=0.032  Score=53.63  Aligned_cols=72  Identities=18%  Similarity=0.260  Sum_probs=46.8

Q ss_pred             eeeeeCceEEEEEEEcCCCcEEEEEEecC----------cchHHHHHHHHHHHHhcC-CC-CeeeEEeEEEcCCCCccEE
Q 014406          132 KVGRGKYSEVFEGINVNTNERCIIKILKP----------VKKKKIKREIKILQNLCG-GP-NVVKLLDIVRDQHSKTPSL  199 (425)
Q Consensus       132 ~LG~G~fg~V~~~~~~~~~~~vavK~~~~----------~~~~~~~~E~~~l~~l~~-h~-niv~l~~~~~~~~~~~~~l  199 (425)
                      .||.|....||++.+..+++.++||.-.+          -..++..-|...|+.... -| .+.+++.+-  +  ....+
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~D--~--e~~~~   77 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHFD--T--EMAVT   77 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEEc--c--cccee
Confidence            57999999999998754446899997431          123455677788876532 23 455555543  2  33458


Q ss_pred             EEEeecCC
Q 014406          200 IFEYVNST  207 (425)
Q Consensus       200 v~e~~~~~  207 (425)
                      |||+++..
T Consensus        78 vMEdL~~~   85 (370)
T TIGR01767        78 VMEDLSHH   85 (370)
T ss_pred             hHhhCccc
Confidence            99998653

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=96.39  E-value=0.011  Score=57.03  Aligned_cols=124  Identities=19%  Similarity=0.193  Sum_probs=75.7

Q ss_pred             eeeeeCceEEEEEEE---------------cCCCcEEEEEEecCcchHHHHHHHHHHHHhcCCCCeeeE-----------
Q 014406          132 KVGRGKYSEVFEGIN---------------VNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKL-----------  185 (425)
Q Consensus       132 ~LG~G~fg~V~~~~~---------------~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l-----------  185 (425)
                      .||.|+-..||+|..               ..+.+.||+|+..+...+++...+.||+....-.|++.-           
T Consensus       196 PIGsG~IAQVY~atl~~a~lekd~~~~~~~~~~tq~~AiKv~Hp~V~~~ir~Dl~Il~f~Akl~~~vP~l~wL~l~~~vk  275 (565)
T KOG1236|consen  196 PIGSGCIAQVYRATLKTAYLEKDSGKEYVQKLGTQSCAIKVLHPNVEKQIRLDLGILGFGAKLINNVPDLSWLSLPLEVK  275 (565)
T ss_pred             ccccchhhhhhhhhhhHHHhhcccchhhhcCCccceeeeeccCccHHHHHHHHHHHHhhhhhhhhhcCccccccCcchHH
Confidence            599999999999872               223467999999887766666666665533211111111           


Q ss_pred             ----------------------EeEEEc-----------CCCCccEEEEEeecCCChhhhcCC--CCHHHHHHHHHHHHH
Q 014406          186 ----------------------LDIVRD-----------QHSKTPSLIFEYVNSTDFKVLYPT--LTDYDIRYYIYELLK  230 (425)
Q Consensus       186 ----------------------~~~~~~-----------~~~~~~~lv~e~~~~~~l~~~~~~--l~~~~~~~i~~~i~~  230 (425)
                                            ..-|.+           +-.....|+=+|+.|-.+..++..  .++.-.+.++.-...
T Consensus       276 qF~v~ln~QvdL~~EA~hL~rF~~NF~~s~~V~fP~P~~~~~~~~vl~E~~~~Gl~v~~~v~~~~~pe~l~kkva~lg~~  355 (565)
T KOG1236|consen  276 QFSVGLNAQVDLRQEALHLPRFTNNFSGSKKVLFPKPIAPLHTDLVLVETYERGLSVLRFVKWKSQPEALVKKVAKLGVN  355 (565)
T ss_pred             HHHHHHHhhcchhhhhhhhHHHHHhcccceeecCCcccccccccceeeeeccccccHHhhhhcccChHHHHHHHHHHHHH
Confidence                                  111110           001123455567777777777643  444455556655556


Q ss_pred             HHHHHH-HCCceeecCCCCceEecCC
Q 014406          231 ALDYCH-SQGIMHRDVKPHNVMIDHE  255 (425)
Q Consensus       231 ~L~~LH-~~~ivH~Dlk~~NIll~~~  255 (425)
                      |+--+- -.+++|.|+.|.||++..+
T Consensus       356 AllkMl~vDNFvHaDlHPGNVlirf~  381 (565)
T KOG1236|consen  356 ALLKMLIVDNFVHADLHPGNVLIRFN  381 (565)
T ss_pred             HHHHHHHhhcceecccCCCcEEEEec
Confidence            654443 4689999999999999654

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.33  E-value=0.045  Score=51.94  Aligned_cols=30  Identities=23%  Similarity=0.588  Sum_probs=25.4

Q ss_pred             CCceeecCCCCceEecCCCCcEEEEecccccc
Q 014406          238 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (425)
Q Consensus       238 ~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~  269 (425)
                      .+++|+|+.+.||+++.+  .+.|+||+.+..
T Consensus       187 ~~liHgD~~~~Nil~~~~--~i~lIDfd~~~~  216 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKDN--EVYVIDFDYCTI  216 (313)
T ss_pred             CceEcCCCCcccEEEeCC--cEEEEECccccc
Confidence            478999999999999874  578999997653

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.27  E-value=0.037  Score=52.60  Aligned_cols=30  Identities=20%  Similarity=0.338  Sum_probs=26.7

Q ss_pred             CceeecCCCCceEecCCCCcEEEEecccccc
Q 014406          239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (425)
Q Consensus       239 ~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~  269 (425)
                      +++|+|+.++|+|++.+ +.+.++||..+..
T Consensus       197 ~lcHgD~~~~Nvl~~~~-~~~~iIDfd~~~~  226 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDET-RGGYFINFEKASF  226 (309)
T ss_pred             eeeCCCCcHHhEEEcCC-CCEEEEEhhhccc
Confidence            79999999999999887 6789999988764

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.06  E-value=0.044  Score=51.35  Aligned_cols=77  Identities=14%  Similarity=0.190  Sum_probs=50.6

Q ss_pred             EEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcchHHHHHHHHHHHHhc--CCCCeeeEEeEEEcCCCCccEEEEEee
Q 014406          127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLC--GGPNVVKLLDIVRDQHSKTPSLIFEYV  204 (425)
Q Consensus       127 y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~--~h~niv~l~~~~~~~~~~~~~lv~e~~  204 (425)
                      .+-.+.++.|..+.+|+..  .+++.+.||+-.......|..|..-|+.|.  .--.+.+.+++....  ...+||+||+
T Consensus        19 i~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~--~~~fLlle~l   94 (288)
T PF03881_consen   19 ITSIEPVSGGDINEAYRLD--TDGGSYFVKVNSESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYD--DDAFLLLEFL   94 (288)
T ss_dssp             --EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-S--SCCEEEEE--
T ss_pred             eeeeEecCCCChhheEEEE--CCCccEEEEecChhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeec--CCceEEEEee
Confidence            3446679999999999974  778889999988667788999999999883  334567888877554  3347999999


Q ss_pred             cCC
Q 014406          205 NST  207 (425)
Q Consensus       205 ~~~  207 (425)
                      +.+
T Consensus        95 ~~~   97 (288)
T PF03881_consen   95 EMG   97 (288)
T ss_dssp             ---
T ss_pred             cCC
Confidence            877

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PRK06148 hypothetical protein; Provisional

Probab=95.88  E-value=0.12  Score=57.19  Aligned_cols=137  Identities=18%  Similarity=0.289  Sum_probs=77.6

Q ss_pred             eeeeeeCceEEEEEEEcCCCcEEEEEEecCcc-hHHHHHHHHHHHHhcCC-CC--eeeEEe--------EEEcCCC-Ccc
Q 014406          131 RKVGRGKYSEVFEGINVNTNERCIIKILKPVK-KKKIKREIKILQNLCGG-PN--VVKLLD--------IVRDQHS-KTP  197 (425)
Q Consensus       131 ~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~-~~~~~~E~~~l~~l~~h-~n--iv~l~~--------~~~~~~~-~~~  197 (425)
                      +.|+ |..-.+|+.. ..++..+++|+.+... ......|...|..|..+ +.  +.+.+-        .+.+..+ ...
T Consensus        31 ~~L~-s~~d~nf~v~-~~~g~~yVLKi~~~~~~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~~  108 (1013)
T PRK06148         31 TPLD-GERDLNFRLT-TDDGADYILKIVNPSEPRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPRL  108 (1013)
T ss_pred             eecC-CcCCceEEEE-eCCCCeEEEEEcCCccchhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceEE
Confidence            3464 3457788874 4567789999998643 34555677777766332 22  223221        1112122 246


Q ss_pred             EEEEEeecCCChhhhc---------------------CC---------CCHH-----------------HHHHHHHHHHH
Q 014406          198 SLIFEYVNSTDFKVLY---------------------PT---------LTDY-----------------DIRYYIYELLK  230 (425)
Q Consensus       198 ~lv~e~~~~~~l~~~~---------------------~~---------l~~~-----------------~~~~i~~~i~~  230 (425)
                      +-+++|++|..+....                     ..         +.|.                 ..+.++.+++.
T Consensus       109 vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~~  188 (1013)
T PRK06148        109 LRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFLA  188 (1013)
T ss_pred             EEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHHH
Confidence            6789999997665410                     00         1111                 11222333333


Q ss_pred             HHH-----HHHH--CCceeecCCCCceEecCCCC-cE-EEEecccccc
Q 014406          231 ALD-----YCHS--QGIMHRDVKPHNVMIDHELR-KL-RLIDWGLAEF  269 (425)
Q Consensus       231 ~L~-----~LH~--~~ivH~Dlk~~NIll~~~~~-~~-kl~Dfg~a~~  269 (425)
                      ..+     .|.+  .++||+|+.+.|||++.+.. .+ -|+|||.+..
T Consensus       189 ~~~~~v~p~l~~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        189 RFERNVAPRLAALPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             HHHHHHHHHHhcCCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            222     1221  47999999999999997631 34 4999998854

>PTZ00296 choline kinase; Provisional

Probab=95.79  E-value=0.14  Score=51.19  Aligned_cols=78  Identities=17%  Similarity=0.208  Sum_probs=51.0

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCC--------CcEEEEEEecCcchH--HHHHHHHHHHHhcCCCCeeeEEeEEEcCCC
Q 014406          125 DDYEVVRKVGRGKYSEVFEGINVNT--------NERCIIKILKPVKKK--KIKREIKILQNLCGGPNVVKLLDIVRDQHS  194 (425)
Q Consensus       125 ~~y~~~~~LG~G~fg~V~~~~~~~~--------~~~vavK~~~~~~~~--~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  194 (425)
                      ++. .++.|..|-.-.+|++.....        ++.|++++.-.....  .-.+|..+++.+..+.--.++++.+.+   
T Consensus       106 ~~I-~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lIdR~~E~~v~~~ls~~gi~P~l~~~f~g---  181 (442)
T PTZ00296        106 DDV-RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELYNPISEFEVYKTMSKYRIAPQLLNTFSG---  181 (442)
T ss_pred             ccE-EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccceeCHHHHHHHHHHHHHCCCCCceEEEeCC---
Confidence            344 456677788889999864422        568999988654322  235688888888443333467777632   


Q ss_pred             CccEEEEEeecCCCh
Q 014406          195 KTPSLIFEYVNSTDF  209 (425)
Q Consensus       195 ~~~~lv~e~~~~~~l  209 (425)
                         +.|.||++|..+
T Consensus       182 ---g~I~efi~g~~l  193 (442)
T PTZ00296        182 ---GRIEEWLYGDPL  193 (442)
T ss_pred             ---CEEEEeeCCccC
Confidence               268999998744

>PRK11768 serine/threonine protein kinase; Provisional

Probab=95.65  E-value=0.23  Score=47.58  Aligned_cols=72  Identities=17%  Similarity=0.161  Sum_probs=43.9

Q ss_pred             eCceEEEEEEEcCCCcEEEEEEecCc--chHHHHHHHHHHHHhcCCC-CeeeEE---e-EEEcCCCCccEEEEEeecCCC
Q 014406          136 GKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGP-NVVKLL---D-IVRDQHSKTPSLIFEYVNSTD  208 (425)
Q Consensus       136 G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~-niv~l~---~-~~~~~~~~~~~lv~e~~~~~~  208 (425)
                      +.-..||+.. ..++..+++|+..+.  ...++..|+..+..|..+. .++...   | .+. ..++..+.++++++|..
T Consensus        36 s~eN~vy~v~-~~~~~~~vlKv~r~~~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~-~~~g~~~~l~~~~~G~~  113 (325)
T PRK11768         36 SYENRVYQFG-DEDGRRVVAKFYRPERWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLH-EHQGFRFALFPRRGGRA  113 (325)
T ss_pred             cccceEEEEe-cCCCCEEEEEEcCcccCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEE-EECCEEEEEEeeeCCCC
Confidence            3446789874 455678999998754  4567888999988874321 122211   1 111 11245678999998764


Q ss_pred             h
Q 014406          209 F  209 (425)
Q Consensus       209 l  209 (425)
                      .
T Consensus       114 ~  114 (325)
T PRK11768        114 P  114 (325)
T ss_pred             C
Confidence            3

>PLN02756 S-methyl-5-thioribose kinase

Probab=95.61  E-value=0.25  Score=48.51  Aligned_cols=71  Identities=18%  Similarity=0.296  Sum_probs=49.6

Q ss_pred             EeeeeeeCceEEEEEEEcCCCcEEEEEEecC----------cchHHHHHHHHHHHHhcC--CCCeeeEEeEEEcCCCCcc
Q 014406          130 VRKVGRGKYSEVFEGINVNTNERCIIKILKP----------VKKKKIKREIKILQNLCG--GPNVVKLLDIVRDQHSKTP  197 (425)
Q Consensus       130 ~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~----------~~~~~~~~E~~~l~~l~~--h~niv~l~~~~~~~~~~~~  197 (425)
                      .+.||.|....||+..+  .+..++||.-.+          ....+-..|...|+.+..  -.++.+++.++.+    .-
T Consensus        37 ~~eiggGn~N~VyrV~~--~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded----~~  110 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVS--SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT----MA  110 (418)
T ss_pred             EEEcCCCceeeEEEEEc--CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC----CC
Confidence            56799999999999865  345688987541          133445566777776522  2478889988853    34


Q ss_pred             EEEEEeecC
Q 014406          198 SLIFEYVNS  206 (425)
Q Consensus       198 ~lv~e~~~~  206 (425)
                      +++|||+++
T Consensus       111 vlvME~L~~  119 (418)
T PLN02756        111 LIGMRYLEP  119 (418)
T ss_pred             EEEEeecCC
Confidence            689999977

>PRK12396 5-methylribose kinase; Reviewed

Probab=95.15  E-value=0.15  Score=49.77  Aligned_cols=73  Identities=21%  Similarity=0.248  Sum_probs=48.6

Q ss_pred             EeeeeeeCceEEEEEEEcCCCcEEEEEEecC---------cchHHHHHHHHHHHHhcC-CC-CeeeEEeEEEcCCCCccE
Q 014406          130 VRKVGRGKYSEVFEGINVNTNERCIIKILKP---------VKKKKIKREIKILQNLCG-GP-NVVKLLDIVRDQHSKTPS  198 (425)
Q Consensus       130 ~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~---------~~~~~~~~E~~~l~~l~~-h~-niv~l~~~~~~~~~~~~~  198 (425)
                      .+.||.|.-..||++.+..+++.++||.-.+         -..++..-|.++|+.... -| ++.+++.+=.    ..-.
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~D~----e~~~  109 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLFDS----VMNC  109 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEECc----HHhh
Confidence            5679999999999998744456789987431         224566678888886632 23 4556665432    3345


Q ss_pred             EEEEeecC
Q 014406          199 LIFEYVNS  206 (425)
Q Consensus       199 lv~e~~~~  206 (425)
                      +|||+++.
T Consensus       110 ~vMEdL~~  117 (409)
T PRK12396        110 CVMEDLSD  117 (409)
T ss_pred             HHHHhCcc
Confidence            88998854

>PRK06149 hypothetical protein; Provisional

Probab=94.67  E-value=0.5  Score=52.28  Aligned_cols=77  Identities=12%  Similarity=0.179  Sum_probs=44.2

Q ss_pred             eeeeeeCceEEEEEEEcCCCcEEEEEEecCc-chHHHHHHHHHHHHhcCC---CCeeeEEe--------EEEcCCCCccE
Q 014406          131 RKVGRGKYSEVFEGINVNTNERCIIKILKPV-KKKKIKREIKILQNLCGG---PNVVKLLD--------IVRDQHSKTPS  198 (425)
Q Consensus       131 ~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~~h---~niv~l~~--------~~~~~~~~~~~  198 (425)
                      ..|+.+ .-.+|+....  +..+++|+.+.. ....+..|...+.+|...   -.+.+.+-        ..........+
T Consensus        37 ~~L~s~-~d~nf~v~t~--~~~yVLKi~~~~~~~~~l~~e~~~l~hL~~~~~glpvp~pi~t~~G~~~~~~~~~g~~~~v  113 (972)
T PRK06149         37 TELGSQ-QDRNFRVDSD--GGRFVLKICHAAYAAVELEAQHAALRHLAEREPALRVPVVIPALDGEELLTLDVRGQGLRV  113 (972)
T ss_pred             EecCCc-CcceEEEEec--CCcEEEEeCCccCChHHHHHHHHHHHHHHhhCCCCCCceeeECCCCCeEEEEecCCceEEE
Confidence            345533 3467876432  346888998743 445677788888887432   22333332        11112224567


Q ss_pred             EEEEeecCCChh
Q 014406          199 LIFEYVNSTDFK  210 (425)
Q Consensus       199 lv~e~~~~~~l~  210 (425)
                      -+++|++|..+.
T Consensus       114 rL~~~l~G~~~~  125 (972)
T PRK06149        114 RLLDYLPGQPLT  125 (972)
T ss_pred             EEEEecCCcccc
Confidence            789999986553

>PF03109 ABC1: ABC1 family; InterPro: IPR004147 This entry includes ABC1 from yeast [] and AarF from Escherichia coli []

Probab=94.07  E-value=0.025  Score=45.43  Aligned_cols=45  Identities=18%  Similarity=0.379  Sum_probs=39.6

Q ss_pred             eeeeeeCceEEEEEEEcCCCcEEEEEEecCcchHHHHHHHHHHHHh
Q 014406          131 RKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNL  176 (425)
Q Consensus       131 ~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l  176 (425)
                      +-||.|+.|.||+|+. .+|+.||||+..+.-.+.+...+.+++.+
T Consensus        17 ~PlasASiaQVh~a~l-~~g~~VaVKV~rP~i~~~i~~Dl~~l~~~   61 (119)
T PF03109_consen   17 EPLASASIAQVHRARL-KDGEEVAVKVQRPGIEEQIEADLRILRRL   61 (119)
T ss_pred             chhhheehhhheeeee-cccchhhhhhcchHHHHHHHHHHHHHHHH
Confidence            4699999999999965 45999999999999889999888888876

These proteins have a nuclear or mitochondrial subcellular location in eukaryotes. The exact molecular functions of these proteins is not clear, however yeast ABC1 suppresses a cytochrome b mRNA translation defect and is essential for the electron transfer in the bc 1 complex [] and E. coli AarF is required for ubiquinone production []. It has been suggested that members of the ABC1 family are novel chaperonins []. These proteins are unrelated to the ABC transporter proteins.

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	425
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		1e-176
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		1e-176
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		1e-175
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		1e-175
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		1e-174
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		1e-173
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		1e-172
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		1e-172
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		1e-172
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		1e-171
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		1e-141
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		1e-140
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		1e-140
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		1e-140
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		1e-140
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		1e-140
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		1e-140
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		1e-140
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		1e-140
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		1e-140
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		1e-140
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		1e-140
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		1e-140
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		1e-140
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		1e-139
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		1e-135
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		1e-135
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		5e-36
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		6e-36
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		9e-35
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		7e-34
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-32
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		4e-32
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		4e-32
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		4e-32
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		4e-32
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		4e-32
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		5e-32
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		6e-32
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		6e-32
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		7e-32
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		7e-32
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		7e-32
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		7e-32
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		7e-32
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		8e-32
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		8e-32
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		8e-32
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		9e-32
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		9e-32
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		9e-32
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		1e-31
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		1e-31
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		1e-31
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		1e-31
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		1e-31
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		1e-31
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		1e-31
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		1e-31
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		1e-31
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		1e-31
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		1e-31
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		1e-31
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-31
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		1e-31
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		1e-31
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		2e-31
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		2e-31
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		2e-31
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-31
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		2e-31
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		3e-31
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		3e-31
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-31
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		3e-31
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		3e-31
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		3e-31
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		3e-31
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		3e-31
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		3e-31
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		4e-31
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		4e-31
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		4e-31
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		5e-31
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		5e-31
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		1e-30
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		1e-30
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		1e-30
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		1e-30
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		2e-30
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		2e-30
4exu_A	371	Mapk13, Inactive Form Length = 371		3e-30
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		4e-30
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		9e-30
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		6e-29
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		7e-28
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		7e-28
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		1e-27
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		1e-27
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		1e-27
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		2e-27
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		2e-27
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-27
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		2e-27
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-27
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		2e-27
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		3e-27
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		4e-27
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		4e-27
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		5e-27
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		5e-27
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		6e-27
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		6e-27
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		6e-27
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		7e-27
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		7e-27
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		7e-27
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		7e-27
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		7e-27
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		7e-27
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		7e-27
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		7e-27
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		7e-27
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		7e-27
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		7e-27
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		7e-27
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		7e-27
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		8e-27
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		9e-27
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		1e-26
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		1e-26
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		1e-26
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		1e-26
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		1e-26
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		1e-26
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		1e-26
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		2e-26
2oza_B	366	Structure Of P38alpha Complex Length = 366		2e-26
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		2e-26
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		2e-26
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		2e-26
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-26
3hec_A	348	P38 In Complex With Imatinib Length = 348		2e-26
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-26
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		2e-26
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		2e-26
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		2e-26
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		2e-26
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-26
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		2e-26
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		2e-26
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		2e-26
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		2e-26
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		2e-26
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		2e-26
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		2e-26
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		2e-26
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		2e-26
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		2e-26
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		2e-26
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		2e-26
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		2e-26
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		2e-26
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		2e-26
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		2e-26
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		2e-26
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		2e-26
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		3e-26
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		3e-26
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		3e-26
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		3e-26
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		3e-26
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		3e-26
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		3e-26
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		3e-26
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		3e-26
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		3e-26
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		3e-26
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		3e-26
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		3e-26
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		3e-26
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		5e-26
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		5e-26
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		6e-26
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		6e-26
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		6e-26
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		6e-26
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		1e-25
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		2e-25
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		5e-25
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		6e-25
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		9e-25
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		6e-24
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		3e-23
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		4e-23
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		4e-23
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		4e-23
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		5e-23
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		6e-23
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		7e-23
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		8e-23
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		9e-23
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		4e-22
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		6e-22
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		6e-22
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		7e-22
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		9e-22
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		1e-21
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-21
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-21
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		1e-21
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		1e-21
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-21
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		1e-21
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		2e-21
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		2e-21
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		2e-21
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		2e-21
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		4e-21
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		4e-21
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		4e-21
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		4e-21
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		5e-21
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		5e-21
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		5e-21
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		5e-21
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		5e-21
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		5e-21
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		5e-21
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		6e-21
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		6e-21
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		7e-21
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		8e-21
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		8e-21
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		9e-21
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		1e-20
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		1e-20
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-20
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-20
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-20
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		1e-19
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		1e-19
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		1e-18
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		2e-17
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		3e-17
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		1e-16
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		2e-16
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		9e-16
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		1e-15
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		1e-15
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-15
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		2e-15
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		2e-15
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		3e-15
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		4e-15
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		5e-15
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		8e-15
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		8e-15
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		9e-15
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		1e-14
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		1e-14
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		2e-14
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		2e-14
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		3e-14
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		3e-14
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		3e-14
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		3e-14
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		4e-14
4fie_A	423	Full-Length Human Pak4 Length = 423		5e-14
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		8e-14
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		9e-14
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		9e-14
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		9e-14
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		1e-13
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		1e-13
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		1e-13
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		1e-13
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		2e-13
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		2e-13
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		2e-13
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		2e-13
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		2e-13
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		2e-13
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		2e-13
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		3e-13
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		3e-13
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		4e-13
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		4e-13
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-13
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		6e-13
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		6e-13
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		7e-13
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		7e-13
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		9e-13
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		1e-12
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		1e-12
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		1e-12
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		1e-12
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		1e-12
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		1e-12
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		1e-12
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		1e-12
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		1e-12
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-12
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		2e-12
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-12
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-12
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		2e-12
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		2e-12
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		2e-12
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-12
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		2e-12
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		2e-12
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		2e-12
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		3e-12
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		3e-12
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		3e-12
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		3e-12
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		3e-12
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-12
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		3e-12
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		3e-12
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		3e-12
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		3e-12
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		3e-12
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		4e-12
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		4e-12
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		4e-12
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		4e-12
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		4e-12
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		4e-12
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		4e-12
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		4e-12
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		4e-12
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		4e-12
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		4e-12
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		4e-12
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		4e-12
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		4e-12
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		4e-12
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		4e-12
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		4e-12
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		4e-12
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		5e-12
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		5e-12
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		5e-12
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		6e-12
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		6e-12
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		6e-12
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		7e-12
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		7e-12
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		7e-12
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		7e-12
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		7e-12
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		7e-12
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		7e-12
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		7e-12
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		7e-12
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		8e-12
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		8e-12
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		8e-12
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		9e-12
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		9e-12
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		9e-12
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		9e-12
3soa_A	444	Full-Length Human Camkii Length = 444		9e-12
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		1e-11
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		1e-11
3g51_A	325	Structural Diversity Of The Active Conformation Of		1e-11
3kk8_A	284	Camkii Substrate Complex A Length = 284		1e-11
3kk9_A	282	Camkii Substrate Complex B Length = 282		1e-11
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		1e-11
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		1e-11
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		1e-11
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		1e-11
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		1e-11
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		1e-11
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		1e-11
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		1e-11
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		1e-11
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		1e-11
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		1e-11
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		1e-11
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		2e-11
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		2e-11
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		2e-11
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		2e-11
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		2e-11
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		2e-11
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		2e-11
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		2e-11
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-11
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		2e-11
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		2e-11
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		2e-11
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-11
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		2e-11
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-11
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-11
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-11
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		3e-11
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		3e-11
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		4e-11
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		4e-11
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		4e-11
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		5e-11
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		5e-11
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		5e-11
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		5e-11
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		5e-11
2oza_A	356	Structure Of P38alpha Complex Length = 356		5e-11
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		5e-11
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		5e-11
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		5e-11
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		6e-11
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		6e-11
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		6e-11
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		7e-11
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		7e-11
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		7e-11
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		7e-11
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		7e-11
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		8e-11
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		8e-11
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		9e-11
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		9e-11
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		9e-11
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		1e-10
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		1e-10
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		1e-10
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		1e-10
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		1e-10
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-10
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		1e-10
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		1e-10
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		1e-10
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		1e-10
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		1e-10
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		1e-10
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		1e-10
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		1e-10
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		1e-10
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		1e-10
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		2e-10
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-10
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		2e-10
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		2e-10
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		2e-10
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-10
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-10
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		3e-10
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		3e-10
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		3e-10
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		3e-10
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		3e-10
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		3e-10
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		3e-10
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		3e-10
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-10
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		3e-10
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		3e-10
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-10
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		3e-10
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		3e-10
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		3e-10
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		3e-10
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		4e-10
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		4e-10
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		4e-10
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		4e-10
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		4e-10
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		4e-10
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		4e-10
3a7f_A	303	Human Mst3 Kinase Length = 303		4e-10
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		4e-10
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		4e-10
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		4e-10
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		4e-10
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		4e-10
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		4e-10
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		4e-10
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		4e-10
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		4e-10
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		5e-10
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		5e-10
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		5e-10
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		5e-10
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		5e-10
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		5e-10
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		5e-10
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		5e-10
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		5e-10
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		5e-10
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		5e-10
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		5e-10
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		6e-10
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		6e-10
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		6e-10
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		6e-10
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		7e-10
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		7e-10
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		7e-10
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		7e-10
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		7e-10
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		7e-10
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		7e-10
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		8e-10
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		8e-10
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		8e-10
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		8e-10
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		8e-10
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		8e-10
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		8e-10
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		8e-10
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		8e-10
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		9e-10
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		9e-10
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		9e-10
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		9e-10
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		9e-10
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		9e-10
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		9e-10
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		9e-10
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		9e-10
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		1e-09
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		1e-09
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		1e-09
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		1e-09
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		1e-09
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		1e-09
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		1e-09
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		1e-09
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		1e-09
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		1e-09
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		2e-09
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		2e-09
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		2e-09
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		2e-09
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		2e-09
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		2e-09
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		2e-09
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		2e-09
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		3e-09
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		3e-09
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		3e-09
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		3e-09
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		4e-09
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		4e-09
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		4e-09
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		4e-09
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		4e-09
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		4e-09
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		5e-09
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		5e-09
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		5e-09
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		6e-09
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		6e-09
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		6e-09
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		7e-09
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		7e-09
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		9e-09
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		1e-08
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		2e-08
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		2e-08
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		2e-08
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		2e-08
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		2e-08
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		2e-08
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		2e-08
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		2e-08
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		2e-08
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		2e-08
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-08
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		3e-08
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		3e-08
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		4e-08
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		5e-08
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		5e-08
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		6e-08
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		7e-08
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		8e-08
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		8e-08
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		9e-08
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		1e-07
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		1e-07
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		1e-07
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		1e-07
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		1e-07
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		1e-07
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		1e-07
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		1e-07
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		1e-07
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		1e-07
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		1e-07
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-07
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		2e-07
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		2e-07
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		2e-07
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-07
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		2e-07
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		2e-07
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		2e-07
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		2e-07
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		2e-07
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		3e-07
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		4e-07
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		4e-07
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		4e-07
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		4e-07
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		4e-07
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		4e-07
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		5e-07
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		5e-07
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		6e-07
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		6e-07
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		6e-07
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		7e-07
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		7e-07
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		7e-07
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		7e-07
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		7e-07
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		7e-07
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		8e-07
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		9e-07
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		9e-07
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		1e-06
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		1e-06
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		1e-06
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		1e-06
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		1e-06
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		1e-06
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		1e-06
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		1e-06
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		1e-06
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		1e-06
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		1e-06
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		1e-06
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		2e-06
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		2e-06
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-06
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-06
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		2e-06
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		2e-06
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		2e-06
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		2e-06
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		2e-06
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-06
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		2e-06
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		2e-06
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		2e-06
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		2e-06
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-06
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-06
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-06
4ae9_A	343	Structure And Function Of The Human Sperm-specific		2e-06
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		2e-06
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		2e-06
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		2e-06
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		2e-06
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-06
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-06
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		2e-06
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		2e-06
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-06
4ae6_A	343	Structure And Function Of The Human Sperm-specific		2e-06
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		2e-06
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		2e-06
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		2e-06
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		2e-06
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		2e-06
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		2e-06
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-06
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		3e-06
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		4e-06
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		4e-06
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		4e-06
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		5e-06
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		5e-06
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		5e-06
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		6e-06
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		7e-06
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		9e-06
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		1e-05
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		1e-05
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		1e-05
3a4o_X	286	Lyn Kinase Domain Length = 286		1e-05
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		1e-05
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		2e-05
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		2e-05
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		2e-05
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-05
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		3e-05
3sv0_A	483	Crystal Structure Of Casein Kinase-1 Like Protein I		3e-05
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-05
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		4e-05
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		4e-05
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		5e-05
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		5e-05
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		5e-05
2wtk_B	373	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		6e-05
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		8e-05
3gni_B	389	Structure Of Strad And Mo25 Length = 389		8e-05
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		8e-05
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		9e-05
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-05
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		9e-05
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		9e-05
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		1e-04
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		1e-04
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		1e-04
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		1e-04
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		1e-04
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-04
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		1e-04
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		1e-04
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		2e-04
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-04
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		2e-04
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		2e-04
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		2e-04
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		2e-04
2x7g_A	389	Structure Of Human Serine-Arginine-Rich Protein-Spe		2e-04
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		2e-04
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		2e-04
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		2e-04
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		2e-04
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-04
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-04
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		2e-04
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		2e-04
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-04
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		2e-04
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		2e-04
3b2t_A	311	Structure Of Phosphotransferase Length = 311		2e-04
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-04
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-04
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		2e-04
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-04
4h58_A	275	Braf In Complex With Compound 3 Length = 275		2e-04
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		2e-04
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		2e-04
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		3e-04
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		3e-04
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-04
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-04
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		3e-04
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-04
3beg_A	381	Crystal Structure Of Sr Protein Kinase 1 Complexed		3e-04
1wbp_A	397	Srpk1 Bound To 9mer Docking Motif Peptide Length =		3e-04
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		4e-04
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		4e-04
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		4e-04
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		4e-04
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-04
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		4e-04
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		4e-04
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		4e-04
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		4e-04
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		4e-04
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		4e-04
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-04
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		5e-04
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		5e-04
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		5e-04
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-04
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		5e-04
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		5e-04
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		6e-04
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		6e-04
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		6e-04
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		6e-04
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		6e-04
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		8e-04
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-04
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		8e-04
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		8e-04
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-04

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score =  614 bits (1584), Expect = e-176,   Method: Compositional matrix adjust.
 Identities = 294/332 (88%), Positives = 304/332 (91%)
Query: 94  MSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERC 153
           MSKARVY DVNVLRPKEYWDYE+LTVQWG+QDDYEVVRKVGRGKYSEVFEGINVN NE+C
Sbjct: 1   MSKARVYADVNVLRPKEYWDYEALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKC 60
Query: 154 XXXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY 213
                              LQNLCGGPN+VKLLDIVRDQHSKTPSLIFEYVN+TDFKVLY
Sbjct: 61  IIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLY 120
Query: 214 PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 273
           PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG
Sbjct: 121 PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 180
Query: 274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333
           KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI
Sbjct: 181 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 240
Query: 334 AKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLL 393
           AKVLGTD LN YLNKY +ELDPQL+ALVGRHSRKPW KF+NADNQHLVSPEAIDFLDKLL
Sbjct: 241 AKVLGTDGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLL 300
Query: 394 RYDHQDRLTAREAMAHPYFAQVRAAESSRTRA 425
           RYDHQ+RLTA EAM HPYF QVRAAE+SRTRA
Sbjct: 301 RYDHQERLTALEAMTHPYFQQVRAAENSRTRA 332

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score =  613 bits (1580), Expect = e-176,   Method: Compositional matrix adjust.
 Identities = 293/331 (88%), Positives = 303/331 (91%)
Query: 95  SKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCX 154
           SKARVY DVNVLRPKEYWDYE+LTVQWG+QDDYEVVRKVGRGKYSEVFEGINVN NE+C 
Sbjct: 3   SKARVYADVNVLRPKEYWDYEALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCI 62
Query: 155 XXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP 214
                             LQNLCGGPN+VKLLDIVRDQHSKTPSLIFEYVN+TDFKVLYP
Sbjct: 63  IKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYP 122
Query: 215 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 274
           TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK
Sbjct: 123 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 182
Query: 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 334
           EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA
Sbjct: 183 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 242
Query: 335 KVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLR 394
           KVLGTD LN YLNKY +ELDPQL+ALVGRHSRKPW KF+NADNQHLVSPEAIDFLDKLLR
Sbjct: 243 KVLGTDGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLR 302
Query: 395 YDHQDRLTAREAMAHPYFAQVRAAESSRTRA 425
           YDHQ+RLTA EAM HPYF QVRAAE+SRTRA
Sbjct: 303 YDHQERLTALEAMTHPYFQQVRAAENSRTRA 333

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score =  612 bits (1579), Expect = e-175,   Method: Compositional matrix adjust.
 Identities = 294/332 (88%), Positives = 304/332 (91%)
Query: 94  MSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERC 153
           MSKARVY DVNVLRPKEYWDYE+LTVQWG+QDDYEVVRKVGRGKYSEVFEGINVN NE+C
Sbjct: 21  MSKARVYADVNVLRPKEYWDYEALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKC 80
Query: 154 XXXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY 213
                              LQNL GGPN+VKLLDIVRDQHSKTPSLIFEYVN+TDFKVLY
Sbjct: 81  IIKILKPVKKKKIKREIKILQNLXGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLY 140
Query: 214 PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 273
           PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG
Sbjct: 141 PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 200
Query: 274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333
           KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI
Sbjct: 201 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 260
Query: 334 AKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLL 393
           AKVLGTD LNAYLNKY +ELDPQL+ALVGRHSRKPW KF+NADNQHLVSPEAIDFLDKLL
Sbjct: 261 AKVLGTDGLNAYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLL 320
Query: 394 RYDHQDRLTAREAMAHPYFAQVRAAESSRTRA 425
           RYDHQ+RLTA EAM HPYF QVRAAE+SRTRA
Sbjct: 321 RYDHQERLTALEAMTHPYFQQVRAAENSRTRA 352

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score =  611 bits (1575), Expect = e-175,   Method: Compositional matrix adjust.
 Identities = 293/332 (88%), Positives = 303/332 (91%)
Query: 94  MSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERC 153
           MSKARVY DVNVLRPKEYWDYE+LTVQWG+QDDYEVVRKVGRGKYSEVFEGINVN NE+C
Sbjct: 1   MSKARVYADVNVLRPKEYWDYEALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKC 60
Query: 154 XXXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY 213
                              LQNL GGPN+VKLLDIVRDQHSKTPSLIFEYVN+TDFKVLY
Sbjct: 61  IIKILKPVKKKKIKREIKILQNLXGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLY 120
Query: 214 PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 273
           PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG
Sbjct: 121 PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 180
Query: 274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333
           KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI
Sbjct: 181 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 240
Query: 334 AKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLL 393
           AKVLGTD LN YLNKY +ELDPQL+ALVGRHSRKPW KF+NADNQHLVSPEAIDFLDKLL
Sbjct: 241 AKVLGTDGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLL 300
Query: 394 RYDHQDRLTAREAMAHPYFAQVRAAESSRTRA 425
           RYDHQ+RLTA EAM HPYF QVRAAE+SRTRA
Sbjct: 301 RYDHQERLTALEAMTHPYFQQVRAAENSRTRA 332

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score =  608 bits (1568), Expect = e-174,   Method: Compositional matrix adjust.
 Identities = 292/331 (88%), Positives = 302/331 (91%)
Query: 95  SKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCX 154
           SKARVY DVNVLRPKEYWDYE+LTVQWG+QDDYEVVRKVGRGKYSEVFEGINVN NE+C 
Sbjct: 1   SKARVYADVNVLRPKEYWDYEALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCI 60
Query: 155 XXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP 214
                             LQNL GGPN+VKLLDIVRDQHSKTPSLIFEYVN+TDFKVLYP
Sbjct: 61  IKILKPVKKKKIKREIKILQNLXGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYP 120
Query: 215 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 274
           TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK
Sbjct: 121 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 180
Query: 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 334
           EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA
Sbjct: 181 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 240
Query: 335 KVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLR 394
           KVLGTD LN YLNKY +ELDPQL+ALVGRHSRKPW KF+NADNQHLVSPEAIDFLDKLLR
Sbjct: 241 KVLGTDGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLR 300
Query: 395 YDHQDRLTAREAMAHPYFAQVRAAESSRTRA 425
           YDHQ+RLTA EAM HPYF QVRAAE+SRTRA
Sbjct: 301 YDHQERLTALEAMTHPYFQQVRAAENSRTRA 331

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score =  604 bits (1557), Expect = e-173,   Method: Compositional matrix adjust.
 Identities = 289/327 (88%), Positives = 299/327 (91%)
Query: 95  SKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCX 154
           SKARVY DVNVLRPKEYWDYE+LTVQWG+QDDYEVVRKVGRGKYSEVFEGINVN NE+C 
Sbjct: 1   SKARVYADVNVLRPKEYWDYEALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCI 60
Query: 155 XXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP 214
                             LQNLCGGPN+VKLLDIVRDQHSKTPSLIFEYVN+TDFKVLYP
Sbjct: 61  IKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYP 120
Query: 215 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 274
           TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK
Sbjct: 121 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 180
Query: 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 334
           EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA
Sbjct: 181 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 240
Query: 335 KVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLR 394
           KVLGTD LN YLNKY +ELDPQL+ALVGRHSRKPW KF+NADNQHLVSPEAIDFLDKLLR
Sbjct: 241 KVLGTDGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLR 300
Query: 395 YDHQDRLTAREAMAHPYFAQVRAAESS 421
           YDHQ+RLTA EAM HPYF QVRAAE+S
Sbjct: 301 YDHQERLTALEAMTHPYFQQVRAAENS 327

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score =  602 bits (1552), Expect = e-172,   Method: Compositional matrix adjust.
 Identities = 288/325 (88%), Positives = 297/325 (91%)
Query: 95  SKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCX 154
           SKARVY DVNVLRPKEYWDYE+LTVQWG+QDDYEVVRKVGRGKYSEVFEGINVN NE+C 
Sbjct: 1   SKARVYADVNVLRPKEYWDYEALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCI 60
Query: 155 XXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP 214
                             LQNLCGGPN+VKLLDIVRDQHSKTPSLIFEYVN+TDFKVLYP
Sbjct: 61  IKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYP 120
Query: 215 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 274
           TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK
Sbjct: 121 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 180
Query: 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 334
           EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA
Sbjct: 181 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 240
Query: 335 KVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLR 394
           KVLGTD LN YLNKY +ELDPQL+ALVGRHSRKPW KF+NADNQHLVSPEAIDFLDKLLR
Sbjct: 241 KVLGTDGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLR 300
Query: 395 YDHQDRLTAREAMAHPYFAQVRAAE 419
           YDHQ+RLTA EAM HPYF QVRAAE
Sbjct: 301 YDHQERLTALEAMTHPYFQQVRAAE 325

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score =  600 bits (1547), Expect = e-172,   Method: Compositional matrix adjust.
 Identities = 288/327 (88%), Positives = 298/327 (91%)
Query: 95  SKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCX 154
           SKARVY DVNVLRPKEYWDYE+LTVQWG+QDDYEVVRKVGRGKYSEVFEGINVN NE+C 
Sbjct: 1   SKARVYADVNVLRPKEYWDYEALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCI 60
Query: 155 XXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP 214
                             LQNL GGPN+VKLLDIVRDQHSKTPSLIFEYVN+TDFKVLYP
Sbjct: 61  IKILKPVKKKKIKREIKILQNLXGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYP 120
Query: 215 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 274
           TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK
Sbjct: 121 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 180
Query: 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 334
           EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA
Sbjct: 181 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 240
Query: 335 KVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLR 394
           KVLGTD LN YLNKY +ELDPQL+ALVGRHSRKPW KF+NADNQHLVSPEAIDFLDKLLR
Sbjct: 241 KVLGTDGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLR 300
Query: 395 YDHQDRLTAREAMAHPYFAQVRAAESS 421
           YDHQ+RLTA EAM HPYF QVRAAE+S
Sbjct: 301 YDHQERLTALEAMTHPYFQQVRAAENS 327

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score =  599 bits (1544), Expect = e-172,   Method: Compositional matrix adjust.
 Identities = 287/326 (88%), Positives = 297/326 (91%)
Query: 95  SKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCX 154
           SKARVY DVNVLRPKEYWDYE+LTVQWG+QDDYEVVRKVGRGKYSEVFEGINVN NE+C 
Sbjct: 1   SKARVYADVNVLRPKEYWDYEALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCI 60
Query: 155 XXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP 214
                             LQNL GGPN+VKLLDIVRDQHSKTPSLIFEYVN+TDFKVLYP
Sbjct: 61  IKILKPVKKKKIKREIKILQNLMGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYP 120
Query: 215 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 274
           TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK
Sbjct: 121 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 180
Query: 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 334
           EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA
Sbjct: 181 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 240
Query: 335 KVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLR 394
           KVLGTD LN YLNKY +ELDPQL+ALVGRHSRKPW KF+NADNQHLVSPEAIDFLDKLLR
Sbjct: 241 KVLGTDGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLR 300
Query: 395 YDHQDRLTAREAMAHPYFAQVRAAES 420
           YDHQ+RLTA EAM HPYF QVRAAE+
Sbjct: 301 YDHQERLTALEAMTHPYFQQVRAAEN 326

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score =  598 bits (1543), Expect = e-171,   Method: Compositional matrix adjust.
 Identities = 287/326 (88%), Positives = 297/326 (91%)
Query: 95  SKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCX 154
           SKARVY DVNVLRPKEYWDYE+LTVQWG+QDDYEVVRKVGRGKYSEVFEGINVN NE+C 
Sbjct: 1   SKARVYADVNVLRPKEYWDYEALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCI 60
Query: 155 XXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP 214
                             LQNL GGPN+VKLLDIVRDQHSKTPSLIFEYVN+TDFKVLYP
Sbjct: 61  IKILKPVKKKKIKREIKILQNLXGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYP 120
Query: 215 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 274
           TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK
Sbjct: 121 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 180
Query: 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 334
           EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA
Sbjct: 181 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 240
Query: 335 KVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLR 394
           KVLGTD LN YLNKY +ELDPQL+ALVGRHSRKPW KF+NADNQHLVSPEAIDFLDKLLR
Sbjct: 241 KVLGTDGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLR 300
Query: 395 YDHQDRLTAREAMAHPYFAQVRAAES 420
           YDHQ+RLTA EAM HPYF QVRAAE+
Sbjct: 301 YDHQERLTALEAMTHPYFQQVRAAEN 326

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score =  496 bits (1278), Expect = e-141,   Method: Compositional matrix adjust.
 Identities = 230/324 (70%), Positives = 271/324 (83%)
Query: 92  PAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNE 151
           P  S+ARVYTDVN  RP+EYWDY S  V+WG+QDDY++VRK+GRGKYSEVFE IN+  NE
Sbjct: 4   PVPSRARVYTDVNTHRPREYWDYASHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNE 63
Query: 152 RCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV 211
           +                    L+NL GGPN++ L DIV+D  S+TP+L+FE+VN+TDFK 
Sbjct: 64  KVVVKILKPVKKNKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ 123
Query: 212 LYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271
           LY TLTDYDIR+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYH
Sbjct: 124 LYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 183
Query: 272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
           PG+EYNVRVASRYFKGPELLVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHDN+DQLV
Sbjct: 184 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 243
Query: 332 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDK 391
           +IAKVLGT++L  Y++KY++ELDP+ + ++GRHSRK W +F++++NQHLVSPEA+DFLDK
Sbjct: 244 RIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDK 303
Query: 392 LLRYDHQDRLTAREAMAHPYFAQV 415
           LLRYDHQ RLTAREAM HPYF  V
Sbjct: 304 LLRYDHQSRLTAREAMEHPYFYTV 327

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score =  496 bits (1277), Expect = e-140,   Method: Compositional matrix adjust.
 Identities = 232/330 (70%), Positives = 274/330 (83%)
Query: 86  LAEIPLPAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGI 145
           L  +  P  S+ARVYTDVN  RP+EYWDYES  V+WG+QDDY++VRK+GRGKYSEVFE I
Sbjct: 3   LGSMSGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAI 62
Query: 146 NVNTNERCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVN 205
           N+  NE+                    L+NL GGPN++ L DIV+D  S+TP+L+FE+VN
Sbjct: 63  NITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVN 122
Query: 206 STDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWG 265
           +TDFK LY TLTDYDIR+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWG
Sbjct: 123 NTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWG 182
Query: 266 LAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD 325
           LAEFYHPG+EYNVRVASRYFKGPELLVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHD
Sbjct: 183 LAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 242
Query: 326 NHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEA 385
           N+DQLV+IAKVLGT++L  Y++KY++ELDP+ + ++GRHSRK W +F++++NQHLVSPEA
Sbjct: 243 NYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEA 302
Query: 386 IDFLDKLLRYDHQDRLTAREAMAHPYFAQV 415
           +DFLDKLLRYDHQ RLTAREAM HPYF  V
Sbjct: 303 LDFLDKLLRYDHQSRLTAREAMEHPYFYTV 332

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score =  496 bits (1276), Expect = e-140,   Method: Compositional matrix adjust.
 Identities = 230/324 (70%), Positives = 272/324 (83%)
Query: 92  PAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNE 151
           P  S+ARVYTDVN  RP+EYWDYES  V+WG+QDDY++VRK+GRGKYSEVFE IN+  NE
Sbjct: 4   PVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNE 63
Query: 152 RCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV 211
           +                    L+NL GGPN++ L DIV+D  S+TP+L+FE+VN+TDFK 
Sbjct: 64  KVAVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ 123
Query: 212 LYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271
           LY TLTDYDIR+Y+YE+LKALDYCHS GIMHRDVKPHNV+IDHE RKLRLIDWGLAEFYH
Sbjct: 124 LYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVLIDHEHRKLRLIDWGLAEFYH 183
Query: 272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
           PG+EYNVRVASRYFKGPELLVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHDN+DQLV
Sbjct: 184 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 243
Query: 332 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDK 391
           +IAKVLGT++L  Y++KY++ELDP+ + ++GRHSRK W +F++++NQHLVSPEA+DFLDK
Sbjct: 244 RIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDK 303
Query: 392 LLRYDHQDRLTAREAMAHPYFAQV 415
           LLRYDHQ RLTAREAM HPYF  V
Sbjct: 304 LLRYDHQSRLTAREAMEHPYFYTV 327

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score =  496 bits (1276), Expect = e-140,   Method: Compositional matrix adjust.
 Identities = 232/330 (70%), Positives = 274/330 (83%)
Query: 92  PAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNE 151
           P  S+ARVYTDVN  RP+EYWDYES  V+WG+QDDY++VRK+GRGKYSEVFE IN+  NE
Sbjct: 4   PVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNE 63
Query: 152 RCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV 211
           +                    L+NL GGPN++ L DIV+D  S+TP+L+FE+VN+TDFK 
Sbjct: 64  KVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ 123
Query: 212 LYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271
           LY TLTDYDIR+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYH
Sbjct: 124 LYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 183
Query: 272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
           PG+EYNVRVASRYFKGPELLVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHDN+DQLV
Sbjct: 184 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 243
Query: 332 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDK 391
           +IAKVLGT++L  Y++KY++ELDP+ + ++GRHSRK W +F++++NQHLVSPEA+DFLDK
Sbjct: 244 RIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDK 303
Query: 392 LLRYDHQDRLTAREAMAHPYFAQVRAAESS 421
           LLRYDHQ RLTAREAM HPYF  V   +S 
Sbjct: 304 LLRYDHQSRLTAREAMEHPYFYPVVKEQSQ 333

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score =  496 bits (1276), Expect = e-140,   Method: Compositional matrix adjust.
 Identities = 231/324 (71%), Positives = 272/324 (83%)
Query: 92  PAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNE 151
           P  S+ARVYTDVN  RP+EYWDYES  V+WG+QDDY++VRK+GRGKYSEVFE IN+  NE
Sbjct: 4   PVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNE 63
Query: 152 RCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV 211
           +                    L+NL GGPN++ L DIV+D  S+TP+L+FE+VN+TDFK 
Sbjct: 64  KVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ 123
Query: 212 LYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271
           LY TLTDYDIR+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYH
Sbjct: 124 LYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 183
Query: 272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
           PG+EYNVRVASRYFKGPELLVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHDN+DQLV
Sbjct: 184 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 243
Query: 332 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDK 391
           +IAKVLGT++L  Y++KY++ELDP+ + ++GRHSRK W +F++++NQHLVSPEA+DFLDK
Sbjct: 244 RIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDK 303
Query: 392 LLRYDHQDRLTAREAMAHPYFAQV 415
           LLRYDHQ RLTAREAM HPYF  V
Sbjct: 304 LLRYDHQSRLTAREAMEHPYFYTV 327

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score =  495 bits (1275), Expect = e-140,   Method: Compositional matrix adjust.
 Identities = 231/324 (71%), Positives = 272/324 (83%)
Query: 92  PAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNE 151
           P  S+ARVYTDVN  RP+EYWDYES  V+WG+QDDY++VRK+GRGKYSEVFE IN+  NE
Sbjct: 4   PVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNE 63
Query: 152 RCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV 211
           +                    L+NL GGPN++ L DIV+D  S+TP+L+FE+VN+TDFK 
Sbjct: 64  KVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ 123
Query: 212 LYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271
           LY TLTDYDIR+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYH
Sbjct: 124 LYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 183
Query: 272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
           PG+EYNVRVASRYFKGPELLVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHDN+DQLV
Sbjct: 184 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 243
Query: 332 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDK 391
           +IAKVLGT++L  Y++KY++ELDP+ + ++GRHSRK W +F++++NQHLVSPEA+DFLDK
Sbjct: 244 RIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDK 303
Query: 392 LLRYDHQDRLTAREAMAHPYFAQV 415
           LLRYDHQ RLTAREAM HPYF  V
Sbjct: 304 LLRYDHQSRLTAREAMEHPYFYTV 327

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score =  495 bits (1275), Expect = e-140,   Method: Compositional matrix adjust.
 Identities = 231/324 (71%), Positives = 272/324 (83%)
Query: 92  PAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNE 151
           P  S+ARVYTDVN  RP+EYWDYES  V+WG+QDDY++VRK+GRGKYSEVFE IN+  NE
Sbjct: 4   PVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNE 63
Query: 152 RCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV 211
           +                    L+NL GGPN++ L DIV+D  S+TP+L+FE+VN+TDFK 
Sbjct: 64  KVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ 123
Query: 212 LYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271
           LY TLTDYDIR+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYH
Sbjct: 124 LYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 183
Query: 272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
           PG+EYNVRVASRYFKGPELLVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHDN+DQLV
Sbjct: 184 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 243
Query: 332 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDK 391
           +IAKVLGT++L  Y++KY++ELDP+ + ++GRHSRK W +F++++NQHLVSPEA+DFLDK
Sbjct: 244 RIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDK 303
Query: 392 LLRYDHQDRLTAREAMAHPYFAQV 415
           LLRYDHQ RLTAREAM HPYF  V
Sbjct: 304 LLRYDHQSRLTAREAMEHPYFYTV 327

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score =  495 bits (1274), Expect = e-140,   Method: Compositional matrix adjust.
 Identities = 231/324 (71%), Positives = 272/324 (83%)
Query: 92  PAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNE 151
           P  S+ARVYTDVN  RP+EYWDYES  V+WG+QDDY++VRK+GRGKYSEVFE IN+  NE
Sbjct: 4   PVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNE 63
Query: 152 RCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV 211
           +                    L+NL GGPN++ L DIV+D  S+TP+L+FE+VN+TDFK 
Sbjct: 64  KVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ 123
Query: 212 LYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271
           LY TLTDYDIR+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYH
Sbjct: 124 LYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 183
Query: 272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
           PG+EYNVRVASRYFKGPELLVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHDN+DQLV
Sbjct: 184 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 243
Query: 332 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDK 391
           +IAKVLGT++L  Y++KY++ELDP+ + ++GRHSRK W +F++++NQHLVSPEA+DFLDK
Sbjct: 244 RIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDK 303
Query: 392 LLRYDHQDRLTAREAMAHPYFAQV 415
           LLRYDHQ RLTAREAM HPYF  V
Sbjct: 304 LLRYDHQSRLTAREAMEHPYFYTV 327

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score =  495 bits (1274), Expect = e-140,   Method: Compositional matrix adjust.
 Identities = 231/324 (71%), Positives = 272/324 (83%)
Query: 92  PAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNE 151
           P  S+ARVYTDVN  RP+EYWDYES  V+WG+QDDY++VRK+GRGKYSEVFE IN+  NE
Sbjct: 4   PVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNE 63
Query: 152 RCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV 211
           +                    L+NL GGPN++ L DIV+D  S+TP+L+FE+VN+TDFK 
Sbjct: 64  KVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ 123
Query: 212 LYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271
           LY TLTDYDIR+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYH
Sbjct: 124 LYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 183
Query: 272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
           PG+EYNVRVASRYFKGPELLVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHDN+DQLV
Sbjct: 184 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 243
Query: 332 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDK 391
           +IAKVLGT++L  Y++KY++ELDP+ + ++GRHSRK W +F++++NQHLVSPEA+DFLDK
Sbjct: 244 RIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDK 303
Query: 392 LLRYDHQDRLTAREAMAHPYFAQV 415
           LLRYDHQ RLTAREAM HPYF  V
Sbjct: 304 LLRYDHQSRLTAREAMEHPYFYTV 327

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score =  495 bits (1274), Expect = e-140,   Method: Compositional matrix adjust.
 Identities = 231/324 (71%), Positives = 272/324 (83%)
Query: 92  PAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNE 151
           P  S+ARVYTDVN  RP+EYWDYES  V+WG+QDDY++VRK+GRGKYSEVFE IN+  NE
Sbjct: 4   PVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNE 63
Query: 152 RCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV 211
           +                    L+NL GGPN++ L DIV+D  S+TP+L+FE+VN+TDFK 
Sbjct: 64  KVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ 123
Query: 212 LYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271
           LY TLTDYDIR+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYH
Sbjct: 124 LYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 183
Query: 272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
           PG+EYNVRVASRYFKGPELLVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHDN+DQLV
Sbjct: 184 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 243
Query: 332 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDK 391
           +IAKVLGT++L  Y++KY++ELDP+ + ++GRHSRK W +F++++NQHLVSPEA+DFLDK
Sbjct: 244 RIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDK 303
Query: 392 LLRYDHQDRLTAREAMAHPYFAQV 415
           LLRYDHQ RLTAREAM HPYF  V
Sbjct: 304 LLRYDHQSRLTAREAMEHPYFYTV 327

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score =  495 bits (1274), Expect = e-140,   Method: Compositional matrix adjust.
 Identities = 231/324 (71%), Positives = 272/324 (83%)
Query: 92  PAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNE 151
           P  S+ARVYTDVN  RP+EYWDYES  V+WG+QDDY++VRK+GRGKYSEVFE IN+  NE
Sbjct: 4   PVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNE 63
Query: 152 RCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV 211
           +                    L+NL GGPN++ L DIV+D  S+TP+L+FE+VN+TDFK 
Sbjct: 64  KVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ 123
Query: 212 LYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271
           LY TLTDYDIR+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYH
Sbjct: 124 LYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 183
Query: 272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
           PG+EYNVRVASRYFKGPELLVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHDN+DQLV
Sbjct: 184 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 243
Query: 332 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDK 391
           +IAKVLGT++L  Y++KY++ELDP+ + ++GRHSRK W +F++++NQHLVSPEA+DFLDK
Sbjct: 244 RIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDK 303
Query: 392 LLRYDHQDRLTAREAMAHPYFAQV 415
           LLRYDHQ RLTAREAM HPYF  V
Sbjct: 304 LLRYDHQSRLTAREAMEHPYFYTV 327

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score =  495 bits (1274), Expect = e-140,   Method: Compositional matrix adjust.
 Identities = 231/324 (71%), Positives = 272/324 (83%)
Query: 92  PAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNE 151
           P  S+ARVYTDVN  RP+EYWDYES  V+WG+QDDY++VRK+GRGKYSEVFE IN+  NE
Sbjct: 3   PVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNE 62
Query: 152 RCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV 211
           +                    L+NL GGPN++ L DIV+D  S+TP+L+FE+VN+TDFK 
Sbjct: 63  KVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ 122
Query: 212 LYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271
           LY TLTDYDIR+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYH
Sbjct: 123 LYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182
Query: 272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
           PG+EYNVRVASRYFKGPELLVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHDN+DQLV
Sbjct: 183 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 242
Query: 332 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDK 391
           +IAKVLGT++L  Y++KY++ELDP+ + ++GRHSRK W +F++++NQHLVSPEA+DFLDK
Sbjct: 243 RIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDK 302
Query: 392 LLRYDHQDRLTAREAMAHPYFAQV 415
           LLRYDHQ RLTAREAM HPYF  V
Sbjct: 303 LLRYDHQSRLTAREAMEHPYFYTV 326

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score =  495 bits (1274), Expect = e-140,   Method: Compositional matrix adjust.
 Identities = 231/324 (71%), Positives = 272/324 (83%)
Query: 92  PAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNE 151
           P  S+ARVYTDVN  RP+EYWDYES  V+WG+QDDY++VRK+GRGKYSEVFE IN+  NE
Sbjct: 3   PVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNE 62
Query: 152 RCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV 211
           +                    L+NL GGPN++ L DIV+D  S+TP+L+FE+VN+TDFK 
Sbjct: 63  KVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ 122
Query: 212 LYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271
           LY TLTDYDIR+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYH
Sbjct: 123 LYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182
Query: 272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
           PG+EYNVRVASRYFKGPELLVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHDN+DQLV
Sbjct: 183 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 242
Query: 332 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDK 391
           +IAKVLGT++L  Y++KY++ELDP+ + ++GRHSRK W +F++++NQHLVSPEA+DFLDK
Sbjct: 243 RIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDK 302
Query: 392 LLRYDHQDRLTAREAMAHPYFAQV 415
           LLRYDHQ RLTAREAM HPYF  V
Sbjct: 303 LLRYDHQSRLTAREAMEHPYFYTV 326

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score =  494 bits (1273), Expect = e-140,   Method: Compositional matrix adjust.
 Identities = 231/324 (71%), Positives = 272/324 (83%)
Query: 92  PAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNE 151
           P  S+ARVYTDVN  RP+EYWDYES  V+WG+QDDY++VRK+GRGKYSEVFE IN+  NE
Sbjct: 2   PVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNE 61
Query: 152 RCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV 211
           +                    L+NL GGPN++ L DIV+D  S+TP+L+FE+VN+TDFK 
Sbjct: 62  KVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ 121
Query: 212 LYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271
           LY TLTDYDIR+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYH
Sbjct: 122 LYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 181
Query: 272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
           PG+EYNVRVASRYFKGPELLVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHDN+DQLV
Sbjct: 182 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 241
Query: 332 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDK 391
           +IAKVLGT++L  Y++KY++ELDP+ + ++GRHSRK W +F++++NQHLVSPEA+DFLDK
Sbjct: 242 RIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDK 301
Query: 392 LLRYDHQDRLTAREAMAHPYFAQV 415
           LLRYDHQ RLTAREAM HPYF  V
Sbjct: 302 LLRYDHQSRLTAREAMEHPYFYTV 325

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score =  492 bits (1266), Expect = e-139,   Method: Compositional matrix adjust.
 Identities = 230/324 (70%), Positives = 271/324 (83%)
Query: 92  PAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNE 151
           P  S+ARVYTDVN  RP+EYWDYES  V+WG+QDDY++VRK+GRGKYSEVFE IN+  NE
Sbjct: 4   PVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNE 63
Query: 152 RCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV 211
           +                    L+NL GGPN++ L DIV+D  S+TP+L+FE+VN+TDFK 
Sbjct: 64  KVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ 123
Query: 212 LYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271
           L  TLTDYDIR+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYH
Sbjct: 124 LRQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 183
Query: 272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
           PG+EYNVRVASRYFKGPELLVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHDN+DQLV
Sbjct: 184 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 243
Query: 332 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDK 391
           +IAKVLGT++L  Y++KY++ELDP+ + ++GRHSRK W +F++++NQHLVSPEA+DFLDK
Sbjct: 244 RIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDK 303
Query: 392 LLRYDHQDRLTAREAMAHPYFAQV 415
           LLRYDHQ RLTAREAM HPYF  V
Sbjct: 304 LLRYDHQSRLTAREAMEHPYFYTV 327

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score =  479 bits (1233), Expect = e-135,   Method: Compositional matrix adjust.
 Identities = 225/337 (66%), Positives = 269/337 (79%), Gaps = 1/337 (0%)
Query: 86  LAEIPLPAM-SKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEG 144
           L  +P PA  S+ARVY +VN LR +EYWDYE+    WG+QDDY++VRK+GRGKYSEVFE 
Sbjct: 3   LGSMPGPAAGSRARVYAEVNSLRSREYWDYEAHVPSWGNQDDYQLVRKLGRGKYSEVFEA 62
Query: 145 INVNTNERCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV 204
           IN+  NER                    L+NL GG N++KL+D V+D  SKTP+L+FEY+
Sbjct: 63  INITNNERVVVKILKPVKKKKIKREVKILENLRGGTNIIKLIDTVKDPVSKTPALVFEYI 122
Query: 205 NSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDW 264
           N+TDFK LY  LTD+DIR+Y+YELLKALDYCHS+GIMHRDVKPHNVMIDH+ +KLRLIDW
Sbjct: 123 NNTDFKQLYQILTDFDIRFYMYELLKALDYCHSKGIMHRDVKPHNVMIDHQQKKLRLIDW 182
Query: 265 GLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH 324
           GLAEFYHP +EYNVRVASRYFKGPELLVD Q YDYSLDMWSLGCM A MIFR+EPFF+G 
Sbjct: 183 GLAEFYHPAQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRREPFFHGQ 242
Query: 325 DNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPE 384
           DN+DQLV+IAKVLGT+EL  YL KYH++LDP  + ++G+HSRK W  FI+++N+HLVSPE
Sbjct: 243 DNYDQLVRIAKVLGTEELYGYLKKYHIDLDPHFNDILGQHSRKRWENFIHSENRHLVSPE 302
Query: 385 AIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAESS 421
           A+D LDKLLRYDHQ RLTA+EAM HPYF  V   +S 
Sbjct: 303 ALDLLDKLLRYDHQQRLTAKEAMEHPYFYPVVKEQSQ 339

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score =  479 bits (1232), Expect = e-135,   Method: Compositional matrix adjust.
 Identities = 224/334 (67%), Positives = 268/334 (80%), Gaps = 1/334 (0%)
Query: 89  IPLPAM-SKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINV 147
           +P PA  S+ARVY +VN LR +EYWDYE+    WG+QDDY++VRK+GRGKYSEVFE IN+
Sbjct: 1   MPGPAAGSRARVYAEVNSLRSREYWDYEAHVPSWGNQDDYQLVRKLGRGKYSEVFEAINI 60
Query: 148 NTNERCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST 207
             NER                    L+NL GG N++KL+D V+D  SKTP+L+FEY+N+T
Sbjct: 61  TNNERVVVKILKPVKKKKIKREVKILENLRGGTNIIKLIDTVKDPVSKTPALVFEYINNT 120
Query: 208 DFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 267
           DFK LY  LTD+DIR+Y+YELLKALDYCHS+GIMHRDVKPHNVMIDH+ +KLRLIDWGLA
Sbjct: 121 DFKQLYQILTDFDIRFYMYELLKALDYCHSKGIMHRDVKPHNVMIDHQQKKLRLIDWGLA 180
Query: 268 EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNH 327
           EFYHP +EYNVRVASRYFKGPELLVD Q YDYSLDMWSLGCM A MIFR+EPFF+G DN+
Sbjct: 181 EFYHPAQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRREPFFHGQDNY 240
Query: 328 DQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAID 387
           DQLV+IAKVLGT+EL  YL KYH++LDP  + ++G+HSRK W  FI+++N+HLVSPEA+D
Sbjct: 241 DQLVRIAKVLGTEELYGYLKKYHIDLDPHFNDILGQHSRKRWENFIHSENRHLVSPEALD 300
Query: 388 FLDKLLRYDHQDRLTAREAMAHPYFAQVRAAESS 421
            LDKLLRYDHQ RLTA+EAM HPYF  V   +S 
Sbjct: 301 LLDKLLRYDHQQRLTAKEAMEHPYFYPVVKEQSQ 334

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score =  148 bits (374), Expect = 5e-36,   Method: Compositional matrix adjust.
 Identities = 100/299 (33%), Positives = 152/299 (50%), Gaps = 20/299 (6%)
Query: 122 GDQDDYEVVRKVGRGKYSEVFEGINVNTN----ERCXXXXXXXXXXXXXXXXXXXLQNLC 177
           G  + Y+ + KVG G Y  V++  +        +R                    L+ L 
Sbjct: 18  GLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKEL- 76
Query: 178 GGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALDY 234
             PN+V L+D++  +   T  L+FE++     KVL      L D  I+ Y+Y+LL+ + +
Sbjct: 77  HHPNIVSLIDVIHSERCLT--LVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAH 134
Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVD 293
           CH   I+HRD+KP N++I+ +   L+L D+GLA  F  P + Y   V + +++ P++L+ 
Sbjct: 135 CHQHRILHRDLKPQNLLINSD-GALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMG 193
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 353
            + Y  S+D+WS+GC+FA MI  K P F G  + DQL KI  +LGT     +     L L
Sbjct: 194 SKKYSTSVDIWSIGCIFAEMITGK-PLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPL 252
Query: 354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 412
             Q    V    +KPWS  I    Q     E ID L  +L +D   R++AR+AM HPYF
Sbjct: 253 WKQRTFQV--FEKKPWSSIIPGFCQ-----EGIDLLSNMLCFDPNKRISARDAMNHPYF 304

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score =  148 bits (374), Expect = 6e-36,   Method: Compositional matrix adjust.
 Identities = 100/299 (33%), Positives = 152/299 (50%), Gaps = 20/299 (6%)
Query: 122 GDQDDYEVVRKVGRGKYSEVFEGINVNTN----ERCXXXXXXXXXXXXXXXXXXXLQNLC 177
           G  + Y+ + KVG G Y  V++  +        +R                    L+ L 
Sbjct: 18  GLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKEL- 76
Query: 178 GGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALDY 234
             PN+V L+D++  +   T  L+FE++     KVL      L D  I+ Y+Y+LL+ + +
Sbjct: 77  HHPNIVSLIDVIHSERCLT--LVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAH 134
Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVD 293
           CH   I+HRD+KP N++I+ +   L+L D+GLA  F  P + Y   V + +++ P++L+ 
Sbjct: 135 CHQHRILHRDLKPQNLLINSD-GALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMG 193
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 353
            + Y  S+D+WS+GC+FA MI  K P F G  + DQL KI  +LGT     +     L L
Sbjct: 194 SKKYSTSVDIWSIGCIFAEMITGK-PLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPL 252
Query: 354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 412
             Q    V    +KPWS  I    Q     E ID L  +L +D   R++AR+AM HPYF
Sbjct: 253 WKQRTFQV--FEKKPWSSIIPGFCQ-----EGIDLLSNMLCFDPNKRISARDAMNHPYF 304

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score =  144 bits (363), Expect = 9e-35,   Method: Compositional matrix adjust.
 Identities = 99/316 (31%), Positives = 155/316 (49%), Gaps = 30/316 (9%)
Query: 120 QWGDQDD--YEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLC 177
           + G+Q +  Y   + +G G +  VF+   V ++E                     +  + 
Sbjct: 33  KTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDE---VAIKKVLQDKRFKNRELQIMRIV 89
Query: 178 GGPNVVKLLDIVRDQHSKTP----SLIFEYVNSTDFKV------LYPTLTDYDIRYYIYE 227
             PNVV L         K      +L+ EYV  T ++       L  T+    I+ Y+Y+
Sbjct: 90  KHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQ 149
Query: 228 LLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG 287
           LL++L Y HS GI HRD+KP N+++D     L+LID+G A+    G+     + SRY++ 
Sbjct: 150 LLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXICSRYYRA 209
Query: 288 PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTD--ELNAY 345
           PEL+    +Y  ++D+WS GC+ A ++ + +P F G    DQLV+I KVLGT   E    
Sbjct: 210 PELIFGATNYTTNIDIWSTGCVMAELM-QGQPLFPGESGIDQLVEIIKVLGTPSREQIKT 268
Query: 346 LNKYHLELD-PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAR 404
           +N  ++E   PQ+          P+SK           P+AID + +LL Y    RLTA 
Sbjct: 269 MNPNYMEHKFPQIRP-------HPFSKVFRPRT----PPDAIDLISRLLEYTPSARLTAI 317
Query: 405 EAMAHPYFAQVRAAES 420
           EA+ HP+F ++R  E+
Sbjct: 318 EALCHPFFDELRTGEA 333

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score =  141 bits (356), Expect = 7e-34,   Method: Compositional matrix adjust.
 Identities = 85/246 (34%), Positives = 134/246 (54%), Gaps = 21/246 (8%)
Query: 188 IVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD------IRYYIYELLKALDYCHSQGIM 241
           IV    +K  ++I EYV  T  KVL   +          I  YIY+L +A+ + HS GI 
Sbjct: 104 IVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGIC 163
Query: 242 HRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSL 301
           HRD+KP N++++ +   L+L D+G A+   P +     + SR+++ PEL++   +Y  S+
Sbjct: 164 HRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAXICSRFYRAPELMLGATEYTPSI 223
Query: 302 DMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLG--TDELNAYLNKYHLELD-PQLD 358
           D+WS+GC+F  +I  K P F G  + DQLV+I +++G  T E    +N ++ E+  P L 
Sbjct: 224 DLWSIGCVFGELILGK-PLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLK 282
Query: 359 ALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA 418
           A       K W K +      L    AID L+++LRY+   R+   EAMAHP+F  +R +
Sbjct: 283 A-------KDWRKILPEGTPSL----AIDLLEQILRYEPDLRINPYEAMAHPFFDHLRNS 331
Query: 419 ESSRTR 424
             S  +
Sbjct: 332 YESEVK 337

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  135 bits (341), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 91/305 (29%), Positives = 157/305 (51%), Gaps = 25/305 (8%)
Query: 122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNE-----RCXXXXXXXXXXXXXXXXXXXLQNL 176
           G  ++++ V K+G G Y  V++  N  T E     +                    L+ L
Sbjct: 3   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 177 CGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY--PTLTDYD---IRYYIYELLKA 231
              PN+VKLLD++  ++     L+FE++ S D K       LT      I+ Y+++LL+ 
Sbjct: 63  -NHPNIVKLLDVIHTENKL--YLVFEFL-SMDLKKFMDASALTGIPLPLIKSYLFQLLQG 118
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPEL 290
           L +CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+
Sbjct: 119 LAFCHSHRVLHRDLKPENLLINTE-GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 177
Query: 291 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH 350
           L+  + Y  ++D+WSLGC+FA M+ R+   F G    DQL +I + LGT +   +     
Sbjct: 178 LLGCKYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 236
Query: 351 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHP 410
           +   P       + +R+ +SK +   ++     +    L ++L YD   R++A+ A+AHP
Sbjct: 237 M---PDYKPSFPKWARQDFSKVVPPLDE-----DGRSLLSQMLHYDPNKRISAKAALAHP 288
Query: 411 YFAQV 415
           +F  V
Sbjct: 289 FFQDV 293

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  135 bits (340), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 90/305 (29%), Positives = 157/305 (51%), Gaps = 25/305 (8%)
Query: 122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNE-----RCXXXXXXXXXXXXXXXXXXXLQNL 176
           G  ++++ V K+G G Y  V++  N  T E     +                    L+ L
Sbjct: 3   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 177 CGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY--PTLTDYD---IRYYIYELLKA 231
              PN+VKLLD++  ++     L+FE+++  D K       LT      I+ Y+++LL+ 
Sbjct: 63  -NHPNIVKLLDVIHTENKL--YLVFEFLHQ-DLKTFMDASALTGIPLPLIKSYLFQLLQG 118
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPEL 290
           L +CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+
Sbjct: 119 LAFCHSHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 177
Query: 291 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH 350
           L+  + Y  ++D+WSLGC+FA M+ R+   F G    DQL +I + LGT +   +     
Sbjct: 178 LLGCKYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 236
Query: 351 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHP 410
           +   P       + +R+ +SK +   ++     +    L ++L YD   R++A+ A+AHP
Sbjct: 237 M---PDYKPSFPKWARQDFSKVVPPLDE-----DGRSLLSQMLHYDPNKRISAKAALAHP 288
Query: 411 YFAQV 415
           +F  V
Sbjct: 289 FFQDV 293

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  135 bits (340), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 91/305 (29%), Positives = 157/305 (51%), Gaps = 25/305 (8%)
Query: 122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNE-----RCXXXXXXXXXXXXXXXXXXXLQNL 176
           G  ++++ V K+G G Y  V++  N  T E     +                    L+ L
Sbjct: 1   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 177 CGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY--PTLTDYD---IRYYIYELLKA 231
              PN+VKLLD++  ++     L+FE++ S D K       LT      I+ Y+++LL+ 
Sbjct: 61  -NHPNIVKLLDVIHTENKL--YLVFEFL-SMDLKKFMDASALTGIPLPLIKSYLFQLLQG 116
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPEL 290
           L +CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+
Sbjct: 117 LAFCHSHRVLHRDLKPENLLINTE-GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 175
Query: 291 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH 350
           L+  + Y  ++D+WSLGC+FA M+ R+   F G    DQL +I + LGT +   +     
Sbjct: 176 LLGCKYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 234
Query: 351 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHP 410
           +   P       + +R+ +SK +   ++     +    L ++L YD   R++A+ A+AHP
Sbjct: 235 M---PDYKPSFPKWARQDFSKVVPPLDE-----DGRSLLSQMLHYDPNKRISAKAALAHP 286
Query: 411 YFAQV 415
           +F  V
Sbjct: 287 FFQDV 291

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score =  135 bits (340), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 91/305 (29%), Positives = 157/305 (51%), Gaps = 25/305 (8%)
Query: 122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNE-----RCXXXXXXXXXXXXXXXXXXXLQNL 176
           G  ++++ V K+G G Y  V++  N  T E     +                    L+ L
Sbjct: 3   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 177 CGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY--PTLTDYD---IRYYIYELLKA 231
              PN+VKLLD++  ++     L+FE++ S D K       LT      I+ Y+++LL+ 
Sbjct: 63  -NHPNIVKLLDVIHTENKL--YLVFEFL-SMDLKDFMDASALTGIPLPLIKSYLFQLLQG 118
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPEL 290
           L +CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+
Sbjct: 119 LAFCHSHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 177
Query: 291 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH 350
           L+  + Y  ++D+WSLGC+FA M+ R+   F G    DQL +I + LGT +   +     
Sbjct: 178 LLGCKYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 236
Query: 351 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHP 410
           +   P       + +R+ +SK +   ++     +    L ++L YD   R++A+ A+AHP
Sbjct: 237 M---PDYKPSFPKWARQDFSKVVPPLDE-----DGRSLLSQMLHYDPNKRISAKAALAHP 288
Query: 411 YFAQV 415
           +F  V
Sbjct: 289 FFQDV 293

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score =  135 bits (340), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 90/304 (29%), Positives = 157/304 (51%), Gaps = 23/304 (7%)
Query: 122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNE-----RCXXXXXXXXXXXXXXXXXXXLQNL 176
           G  ++++ V K+G G Y  V++  N  T E     +                    L+ L
Sbjct: 3   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 177 CGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-YPTLTDYD---IRYYIYELLKAL 232
              PN+VKLLD++  ++     L+FE+V+    K +    LT      I+ Y+++LL+ L
Sbjct: 63  -NHPNIVKLLDVIHTENKL--YLVFEHVDQDLKKFMDASALTGIPLPLIKSYLFQLLQGL 119
Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELL 291
            +CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L
Sbjct: 120 AFCHSHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 178
Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL 351
           +  + Y  ++D+WSLGC+FA M+ R+   F G    DQL +I + LGT +   +     +
Sbjct: 179 LGCKYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 237
Query: 352 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 411
              P       + +R+ +SK +   ++     +    L ++L YD   R++A+ A+AHP+
Sbjct: 238 ---PDYKPSFPKWARQDFSKVVPPLDE-----DGRSLLSQMLHYDPNKRISAKAALAHPF 289
Query: 412 FAQV 415
           F  V
Sbjct: 290 FQDV 293

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score =  135 bits (340), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 89/304 (29%), Positives = 157/304 (51%), Gaps = 23/304 (7%)
Query: 122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNE-----RCXXXXXXXXXXXXXXXXXXXLQNL 176
           G  ++++ V K+G G Y  V++  N  T E     +                    L+ L
Sbjct: 1   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 177 CGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-YPTLTDYD---IRYYIYELLKAL 232
              PN+VKLLD++  ++     L+FE+++    K +    LT      I+ Y+++LL+ L
Sbjct: 61  -NHPNIVKLLDVIHTENKL--YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGL 117
Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELL 291
            +CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L
Sbjct: 118 AFCHSHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 176
Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL 351
           +  + Y  ++D+WSLGC+FA M+ R+   F G    DQL +I + LGT +   +     +
Sbjct: 177 LGCKYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 235
Query: 352 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 411
              P       + +R+ +SK +   ++     +    L ++L YD   R++A+ A+AHP+
Sbjct: 236 ---PDYKPSFPKWARQDFSKVVPPLDE-----DGRSLLSQMLHYDPNKRISAKAALAHPF 287
Query: 412 FAQV 415
           F  V
Sbjct: 288 FQDV 291

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score =  135 bits (339), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 91/305 (29%), Positives = 157/305 (51%), Gaps = 25/305 (8%)
Query: 122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNE-----RCXXXXXXXXXXXXXXXXXXXLQNL 176
           G  ++++ V K+G G Y  V++  N  T E     +                    L+ L
Sbjct: 2   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 61
Query: 177 CGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY--PTLTDYD---IRYYIYELLKA 231
              PN+VKLLD++  ++     L+FE++ S D K       LT      I+ Y+++LL+ 
Sbjct: 62  -NHPNIVKLLDVIHTENKL--YLVFEFL-SMDLKDFMDASALTGIPLPLIKSYLFQLLQG 117
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPEL 290
           L +CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+
Sbjct: 118 LAFCHSHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 176
Query: 291 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH 350
           L+  + Y  ++D+WSLGC+FA M+ R+   F G    DQL +I + LGT +   +     
Sbjct: 177 LLGCKYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 235
Query: 351 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHP 410
           +   P       + +R+ +SK +   ++     +    L ++L YD   R++A+ A+AHP
Sbjct: 236 M---PDYKPSFPKWARQDFSKVVPPLDE-----DGRSLLSQMLHYDPNKRISAKAALAHP 287
Query: 411 YFAQV 415
           +F  V
Sbjct: 288 FFQDV 292

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  134 bits (338), Expect = 6e-32,   Method: Compositional matrix adjust.
 Identities = 89/304 (29%), Positives = 157/304 (51%), Gaps = 23/304 (7%)
Query: 122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNE-----RCXXXXXXXXXXXXXXXXXXXLQNL 176
           G  ++++ V K+G G Y  V++  N  T E     +                    L+ L
Sbjct: 3   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 177 CGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-YPTLTDYD---IRYYIYELLKAL 232
              PN+VKLLD++  ++     L+FE+++    K +    LT      I+ Y+++LL+ L
Sbjct: 63  -NHPNIVKLLDVIHTENKL--YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGL 119
Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELL 291
            +CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L
Sbjct: 120 AFCHSHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 178
Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL 351
           +  + Y  ++D+WSLGC+FA M+ R+   F G    DQL +I + LGT +   +     +
Sbjct: 179 LGCKYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 237
Query: 352 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 411
              P       + +R+ +SK +   ++     +    L ++L YD   R++A+ A+AHP+
Sbjct: 238 ---PDYKPSFPKWARQDFSKVVPPLDE-----DGRSLLSQMLHYDPNKRISAKAALAHPF 289
Query: 412 FAQV 415
           F  V
Sbjct: 290 FQDV 293

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score =  134 bits (338), Expect = 6e-32,   Method: Compositional matrix adjust.
 Identities = 89/304 (29%), Positives = 157/304 (51%), Gaps = 23/304 (7%)
Query: 122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNE-----RCXXXXXXXXXXXXXXXXXXXLQNL 176
           G  ++++ V K+G G Y  V++  N  T E     +                    L+ L
Sbjct: 2   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 61
Query: 177 CGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-YPTLTDYD---IRYYIYELLKAL 232
              PN+VKLLD++  ++     L+FE+++    K +    LT      I+ Y+++LL+ L
Sbjct: 62  -NHPNIVKLLDVIHTENKL--YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGL 118
Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELL 291
            +CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L
Sbjct: 119 AFCHSHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 177
Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL 351
           +  + Y  ++D+WSLGC+FA M+ R+   F G    DQL +I + LGT +   +     +
Sbjct: 178 LGCKYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 236
Query: 352 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 411
              P       + +R+ +SK +   ++     +    L ++L YD   R++A+ A+AHP+
Sbjct: 237 ---PDYKPSFPKWARQDFSKVVPPLDE-----DGRSLLSQMLHYDPNKRISAKAALAHPF 288
Query: 412 FAQV 415
           F  V
Sbjct: 289 FQDV 292

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score =  134 bits (338), Expect = 7e-32,   Method: Compositional matrix adjust.
 Identities = 88/302 (29%), Positives = 155/302 (51%), Gaps = 21/302 (6%)
Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQNLCG 178
           D ++++ V K+G G Y  V++  N  T E    +                    L     
Sbjct: 5   DMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 64
Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-YPTLTDYD---IRYYIYELLKALDY 234
            PN+VKLLD++  ++     L+FE+++    K +    LT      I+ Y+++LL+ L +
Sbjct: 65  HPNIVKLLDVIHTENKL--YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 122
Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVD 293
           CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L+ 
Sbjct: 123 CHSHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 181
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 353
            + Y  ++D+WSLGC+FA M+ R+   F G    DQL +I + LGT +   +     +  
Sbjct: 182 CKYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM-- 238
Query: 354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA 413
            P       + +R+ +SK +   ++     +    L ++L YD   R++A+ A+AHP+F 
Sbjct: 239 -PDYKPSFPKWARQDFSKVVPPLDE-----DGRSLLSQMLHYDPNKRISAKAALAHPFFQ 292
Query: 414 QV 415
            V
Sbjct: 293 DV 294

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  134 bits (338), Expect = 7e-32,   Method: Compositional matrix adjust.
 Identities = 89/304 (29%), Positives = 157/304 (51%), Gaps = 23/304 (7%)
Query: 122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNE-----RCXXXXXXXXXXXXXXXXXXXLQNL 176
           G  ++++ V K+G G Y  V++  N  T E     +                    L+ L
Sbjct: 2   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 61
Query: 177 CGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-YPTLTDYD---IRYYIYELLKAL 232
              PN+VKLLD++  ++     L+FE+++    K +    LT      I+ Y+++LL+ L
Sbjct: 62  -NHPNIVKLLDVIHTENKL--YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGL 118
Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELL 291
            +CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L
Sbjct: 119 AFCHSHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 177
Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL 351
           +  + Y  ++D+WSLGC+FA M+ R+   F G    DQL +I + LGT +   +     +
Sbjct: 178 LGCKYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 236
Query: 352 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 411
              P       + +R+ +SK +   ++     +    L ++L YD   R++A+ A+AHP+
Sbjct: 237 ---PDYKPSFPKWARQDFSKVVPPLDE-----DGRSLLSQMLHYDPNKRISAKAALAHPF 288
Query: 412 FAQV 415
           F  V
Sbjct: 289 FQDV 292

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  134 bits (338), Expect = 7e-32,   Method: Compositional matrix adjust.
 Identities = 88/303 (29%), Positives = 155/303 (51%), Gaps = 21/303 (6%)
Query: 122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQNLC 177
           G  ++++ V K+G G Y  V++  N  T E    +                    L    
Sbjct: 3   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 178 GGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-YPTLTDYD---IRYYIYELLKALD 233
             PN+VKLLD++  ++     L+FE+++    K +    LT      I+ Y+++LL+ L 
Sbjct: 63  NHPNIVKLLDVIHTENKL--YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 120
Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLV 292
           +CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L+
Sbjct: 121 FCHSHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILL 179
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE 352
             + Y  ++D+WSLGC+FA M+ R+   F G    DQL +I + LGT +   +     + 
Sbjct: 180 GCKYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM- 237
Query: 353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 412
             P       + +R+ +SK +   ++     +    L ++L YD   R++A+ A+AHP+F
Sbjct: 238 --PDYKPSFPKWARQDFSKVVPPLDE-----DGRSLLSQMLHYDPNKRISAKAALAHPFF 290
Query: 413 AQV 415
             V
Sbjct: 291 QDV 293

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score =  134 bits (338), Expect = 7e-32,   Method: Compositional matrix adjust.
 Identities = 89/304 (29%), Positives = 157/304 (51%), Gaps = 23/304 (7%)
Query: 122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNE-----RCXXXXXXXXXXXXXXXXXXXLQNL 176
           G  ++++ V K+G G Y  V++  N  T E     +                    L+ L
Sbjct: 1   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 177 CGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-YPTLTDYD---IRYYIYELLKAL 232
              PN+VKLLD++  ++     L+FE+++    K +    LT      I+ Y+++LL+ L
Sbjct: 61  -NHPNIVKLLDVIHTENKL--YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGL 117
Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELL 291
            +CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L
Sbjct: 118 AFCHSHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 176
Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL 351
           +  + Y  ++D+WSLGC+FA M+ R+   F G    DQL +I + LGT +   +     +
Sbjct: 177 LGCKYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 235
Query: 352 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 411
              P       + +R+ +SK +   ++     +    L ++L YD   R++A+ A+AHP+
Sbjct: 236 ---PDYKPSFPKWARQDFSKVVPPLDE-----DGRSLLSQMLHYDPNKRISAKAALAHPF 287
Query: 412 FAQV 415
           F  V
Sbjct: 288 FQDV 291

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score =  134 bits (338), Expect = 7e-32,   Method: Compositional matrix adjust.
 Identities = 88/303 (29%), Positives = 155/303 (51%), Gaps = 21/303 (6%)
Query: 122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQNLC 177
           G  ++++ V K+G G Y  V++  N  T E    +                    L    
Sbjct: 4   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 63
Query: 178 GGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-YPTLTDYD---IRYYIYELLKALD 233
             PN+VKLLD++  ++     L+FE+++    K +    LT      I+ Y+++LL+ L 
Sbjct: 64  NHPNIVKLLDVIHTENKL--YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 121
Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLV 292
           +CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L+
Sbjct: 122 FCHSHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILL 180
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE 352
             + Y  ++D+WSLGC+FA M+ R+   F G    DQL +I + LGT +   +     + 
Sbjct: 181 GCKYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM- 238
Query: 353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 412
             P       + +R+ +SK +   ++     +    L ++L YD   R++A+ A+AHP+F
Sbjct: 239 --PDYKPSFPKWARQDFSKVVPPLDE-----DGRSLLSQMLHYDPNKRISAKAALAHPFF 291
Query: 413 AQV 415
             V
Sbjct: 292 QDV 294

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score =  134 bits (338), Expect = 8e-32,   Method: Compositional matrix adjust.
 Identities = 81/231 (35%), Positives = 121/231 (52%), Gaps = 27/231 (11%)
Query: 198 SLIFEYVNSTDFKVL------YPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM 251
           +L+ +YV  T ++V         TL    ++ Y+Y+L ++L Y HS GI HRD+KP N++
Sbjct: 129 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLL 188
Query: 252 IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFA 311
           +D +   L+L D+G A+    G+     + SRY++ PEL+    DY  S+D+WS GC+ A
Sbjct: 189 LDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLA 248
Query: 312 GMIFRKEPFFYGHDNHDQLVKIAKVLGTD------ELNAYLNKYHLELDPQLDALVGRHS 365
            ++   +P F G    DQLV+I KVLGT       E+N    ++     PQ+ A      
Sbjct: 249 ELLL-GQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF---PQIKA------ 298
Query: 366 RKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR 416
             PW+K           PEAI    +LL Y    RLT  EA AH +F ++R
Sbjct: 299 -HPWTKVFRPRT----PPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 344

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  134 bits (338), Expect = 8e-32,   Method: Compositional matrix adjust.
 Identities = 89/304 (29%), Positives = 157/304 (51%), Gaps = 23/304 (7%)
Query: 122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNE-----RCXXXXXXXXXXXXXXXXXXXLQNL 176
           G  ++++ V K+G G Y  V++  N  T E     +                    L+ L
Sbjct: 2   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 61
Query: 177 CGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-YPTLTDYD---IRYYIYELLKAL 232
              PN+VKLLD++  ++     L+FE+++    K +    LT      I+ Y+++LL+ L
Sbjct: 62  -NHPNIVKLLDVIHTENKL--YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGL 118
Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELL 291
            +CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L
Sbjct: 119 AFCHSHRVLHRDLKPENLLINTE-GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 177
Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL 351
           +  + Y  ++D+WSLGC+FA M+ R+   F G    DQL +I + LGT +   +     +
Sbjct: 178 LGCKYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 236
Query: 352 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 411
              P       + +R+ +SK +   ++     +    L ++L YD   R++A+ A+AHP+
Sbjct: 237 ---PDYKPSFPKWARQDFSKVVPPLDE-----DGRSLLSQMLHYDPNKRISAKAALAHPF 288
Query: 412 FAQV 415
           F  V
Sbjct: 289 FQDV 292

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score =  134 bits (338), Expect = 8e-32,   Method: Compositional matrix adjust.
 Identities = 81/231 (35%), Positives = 122/231 (52%), Gaps = 27/231 (11%)
Query: 198 SLIFEYVNSTDFKVL------YPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM 251
           +L+ +YV +T ++V         TL    ++ Y+Y+L ++L Y HS GI HRD+KP N++
Sbjct: 95  NLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLL 154
Query: 252 IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFA 311
           +D +   L+L D+G A+    G+     + SRY++ PEL+    DY  S+D+WS GC+ A
Sbjct: 155 LDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLA 214
Query: 312 GMIFRKEPFFYGHDNHDQLVKIAKVLGTD------ELNAYLNKYHLELDPQLDALVGRHS 365
            ++   +P F G    DQLV+I KVLGT       E+N    ++     PQ+ A      
Sbjct: 215 ELLL-GQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFAF---PQIKA------ 264
Query: 366 RKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR 416
             PW+K           PEAI    +LL Y    RLT  EA AH +F ++R
Sbjct: 265 -HPWTKVFRPRT----PPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score =  134 bits (337), Expect = 9e-32,   Method: Compositional matrix adjust.
 Identities = 81/231 (35%), Positives = 121/231 (52%), Gaps = 27/231 (11%)
Query: 198 SLIFEYVNSTDFKVL------YPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM 251
           +L+ +YV  T ++V         TL    ++ Y+Y+L ++L Y HS GI HRD+KP N++
Sbjct: 107 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLL 166
Query: 252 IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFA 311
           +D +   L+L D+G A+    G+     + SRY++ PEL+    DY  S+D+WS GC+ A
Sbjct: 167 LDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLA 226
Query: 312 GMIFRKEPFFYGHDNHDQLVKIAKVLGTD------ELNAYLNKYHLELDPQLDALVGRHS 365
            ++   +P F G    DQLV+I KVLGT       E+N    ++     PQ+ A      
Sbjct: 227 ELLL-GQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF---PQIKA------ 276
Query: 366 RKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR 416
             PW+K           PEAI    +LL Y    RLT  EA AH +F ++R
Sbjct: 277 -HPWTKVFRPRT----PPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 322

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score =  134 bits (337), Expect = 9e-32,   Method: Compositional matrix adjust.
 Identities = 88/303 (29%), Positives = 155/303 (51%), Gaps = 21/303 (6%)
Query: 122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQNLC 177
           G  ++++ V K+G G Y  V++  N  T E    +                    L    
Sbjct: 1   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 178 GGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-YPTLTDYD---IRYYIYELLKALD 233
             PN+VKLLD++  ++     L+FE+++    K +    LT      I+ Y+++LL+ L 
Sbjct: 61  NHPNIVKLLDVIHTENKL--YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 118
Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLV 292
           +CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L+
Sbjct: 119 FCHSHRVLHRDLKPENLLINTE-GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILL 177
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE 352
             + Y  ++D+WSLGC+FA M+ R+   F G    DQL +I + LGT +   +     + 
Sbjct: 178 GCKYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM- 235
Query: 353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 412
             P       + +R+ +SK +   ++     +    L ++L YD   R++A+ A+AHP+F
Sbjct: 236 --PDYKPSFPKWARQDFSKVVPPLDE-----DGRSLLSQMLHYDPNKRISAKAALAHPFF 288
Query: 413 AQV 415
             V
Sbjct: 289 QDV 291

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score =  134 bits (337), Expect = 9e-32,   Method: Compositional matrix adjust.
 Identities = 81/231 (35%), Positives = 121/231 (52%), Gaps = 27/231 (11%)
Query: 198 SLIFEYVNSTDFKVL------YPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM 251
           +L+ +YV  T ++V         TL    ++ Y+Y+L ++L Y HS GI HRD+KP N++
Sbjct: 114 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLL 173
Query: 252 IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFA 311
           +D +   L+L D+G A+    G+     + SRY++ PEL+    DY  S+D+WS GC+ A
Sbjct: 174 LDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLA 233
Query: 312 GMIFRKEPFFYGHDNHDQLVKIAKVLGTD------ELNAYLNKYHLELDPQLDALVGRHS 365
            ++   +P F G    DQLV+I KVLGT       E+N    ++     PQ+ A      
Sbjct: 234 ELLL-GQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF---PQIKA------ 283
Query: 366 RKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR 416
             PW+K           PEAI    +LL Y    RLT  EA AH +F ++R
Sbjct: 284 -HPWTKVFRPRT----PPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 329

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score =  134 bits (337), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 81/231 (35%), Positives = 121/231 (52%), Gaps = 27/231 (11%)
Query: 198 SLIFEYVNSTDFKVL------YPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM 251
           +L+ +YV  T ++V         TL    ++ Y+Y+L ++L Y HS GI HRD+KP N++
Sbjct: 107 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLL 166
Query: 252 IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFA 311
           +D +   L+L D+G A+    G+     + SRY++ PEL+    DY  S+D+WS GC+ A
Sbjct: 167 LDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLA 226
Query: 312 GMIFRKEPFFYGHDNHDQLVKIAKVLGTD------ELNAYLNKYHLELDPQLDALVGRHS 365
            ++   +P F G    DQLV+I KVLGT       E+N    ++     PQ+ A      
Sbjct: 227 ELLL-GQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF---PQIKA------ 276
Query: 366 RKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR 416
             PW+K           PEAI    +LL Y    RLT  EA AH +F ++R
Sbjct: 277 -HPWTKVFRPRT----PPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 322

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score =  134 bits (337), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 81/231 (35%), Positives = 121/231 (52%), Gaps = 27/231 (11%)
Query: 198 SLIFEYVNSTDFKVL------YPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM 251
           +L+ +YV  T ++V         TL    ++ Y+Y+L ++L Y HS GI HRD+KP N++
Sbjct: 174 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLL 233
Query: 252 IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFA 311
           +D +   L+L D+G A+    G+     + SRY++ PEL+    DY  S+D+WS GC+ A
Sbjct: 234 LDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLA 293
Query: 312 GMIFRKEPFFYGHDNHDQLVKIAKVLGTD------ELNAYLNKYHLELDPQLDALVGRHS 365
            ++   +P F G    DQLV+I KVLGT       E+N    ++     PQ+ A      
Sbjct: 294 ELLL-GQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF---PQIKA------ 343
Query: 366 RKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR 416
             PW+K           PEAI    +LL Y    RLT  EA AH +F ++R
Sbjct: 344 -HPWTKVFRPRT----PPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 389

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 81/231 (35%), Positives = 121/231 (52%), Gaps = 27/231 (11%)
Query: 198 SLIFEYVNSTDFKVL------YPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM 251
           +L+ +YV  T ++V         TL    ++ Y+Y+L ++L Y HS GI HRD+KP N++
Sbjct: 131 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLL 190
Query: 252 IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFA 311
           +D +   L+L D+G A+    G+     + SRY++ PEL+    DY  S+D+WS GC+ A
Sbjct: 191 LDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLA 250
Query: 312 GMIFRKEPFFYGHDNHDQLVKIAKVLGTD------ELNAYLNKYHLELDPQLDALVGRHS 365
            ++   +P F G    DQLV+I KVLGT       E+N    ++     PQ+ A      
Sbjct: 251 ELLL-GQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF---PQIKA------ 300
Query: 366 RKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR 416
             PW+K           PEAI    +LL Y    RLT  EA AH +F ++R
Sbjct: 301 -HPWTKVFRPRT----PPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 346

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 81/231 (35%), Positives = 121/231 (52%), Gaps = 27/231 (11%)
Query: 198 SLIFEYVNSTDFKVL------YPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM 251
           +L+ +YV  T ++V         TL    ++ Y+Y+L ++L Y HS GI HRD+KP N++
Sbjct: 103 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLL 162
Query: 252 IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFA 311
           +D +   L+L D+G A+    G+     + SRY++ PEL+    DY  S+D+WS GC+ A
Sbjct: 163 LDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLA 222
Query: 312 GMIFRKEPFFYGHDNHDQLVKIAKVLGTD------ELNAYLNKYHLELDPQLDALVGRHS 365
            ++   +P F G    DQLV+I KVLGT       E+N    ++     PQ+ A      
Sbjct: 223 ELLL-GQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF---PQIKA------ 272
Query: 366 RKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR 416
             PW+K           PEAI    +LL Y    RLT  EA AH +F ++R
Sbjct: 273 -HPWTKVFRPRT----PPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 318

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 90/302 (29%), Positives = 156/302 (51%), Gaps = 25/302 (8%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNE-----RCXXXXXXXXXXXXXXXXXXXLQNLCGG 179
           ++++ V K+G G Y  V++  N  T E     +                    L+ L   
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-NH 60
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY--PTLTDYD---IRYYIYELLKALDY 234
           PN+VKLLD++  ++     L+FE+V+  D K       LT      I+ Y+++LL+ L +
Sbjct: 61  PNIVKLLDVIHTENKL--YLVFEHVHQ-DLKTFMDASALTGIPLPLIKSYLFQLLQGLAF 117
Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVD 293
           CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L+ 
Sbjct: 118 CHSHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 176
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 353
            + Y  ++D+WSLGC+FA M+ R+   F G    DQL +I + LGT +   +     +  
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM-- 233
Query: 354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA 413
            P       + +R+ +SK +   ++     +    L ++L YD   R++A+ A+AHP+F 
Sbjct: 234 -PDYKPSFPKWARQDFSKVVPPLDE-----DGRSLLSQMLHYDPNKRISAKAALAHPFFQ 287
Query: 414 QV 415
            V
Sbjct: 288 DV 289

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 81/231 (35%), Positives = 121/231 (52%), Gaps = 27/231 (11%)
Query: 198 SLIFEYVNSTDFKVL------YPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM 251
           +L+ +YV  T ++V         TL    ++ Y+Y+L ++L Y HS GI HRD+KP N++
Sbjct: 129 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLL 188
Query: 252 IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFA 311
           +D +   L+L D+G A+    G+     + SRY++ PEL+    DY  S+D+WS GC+ A
Sbjct: 189 LDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLA 248
Query: 312 GMIFRKEPFFYGHDNHDQLVKIAKVLGTD------ELNAYLNKYHLELDPQLDALVGRHS 365
            ++   +P F G    DQLV+I KVLGT       E+N    ++     PQ+ A      
Sbjct: 249 ELLL-GQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF---PQIKA------ 298
Query: 366 RKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR 416
             PW+K           PEAI    +LL Y    RLT  EA AH +F ++R
Sbjct: 299 -HPWTKVFRPRT----PPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 344

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 81/231 (35%), Positives = 121/231 (52%), Gaps = 27/231 (11%)
Query: 198 SLIFEYVNSTDFKVL------YPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM 251
           +L+ +YV  T ++V         TL    ++ Y+Y+L ++L Y HS GI HRD+KP N++
Sbjct: 133 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLL 192
Query: 252 IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFA 311
           +D +   L+L D+G A+    G+     + SRY++ PEL+    DY  S+D+WS GC+ A
Sbjct: 193 LDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLA 252
Query: 312 GMIFRKEPFFYGHDNHDQLVKIAKVLGTD------ELNAYLNKYHLELDPQLDALVGRHS 365
            ++   +P F G    DQLV+I KVLGT       E+N    ++     PQ+ A      
Sbjct: 253 ELLL-GQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF---PQIKA------ 302
Query: 366 RKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR 416
             PW+K           PEAI    +LL Y    RLT  EA AH +F ++R
Sbjct: 303 -HPWTKVFRPRT----PPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 348

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 81/231 (35%), Positives = 121/231 (52%), Gaps = 27/231 (11%)
Query: 198 SLIFEYVNSTDFKVL------YPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM 251
           +L+ +YV  T ++V         TL    ++ Y+Y+L ++L Y HS GI HRD+KP N++
Sbjct: 123 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLL 182
Query: 252 IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFA 311
           +D +   L+L D+G A+    G+     + SRY++ PEL+    DY  S+D+WS GC+ A
Sbjct: 183 LDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLA 242
Query: 312 GMIFRKEPFFYGHDNHDQLVKIAKVLGTD------ELNAYLNKYHLELDPQLDALVGRHS 365
            ++   +P F G    DQLV+I KVLGT       E+N    ++     PQ+ A      
Sbjct: 243 ELLL-GQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF---PQIKA------ 292
Query: 366 RKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR 416
             PW+K           PEAI    +LL Y    RLT  EA AH +F ++R
Sbjct: 293 -HPWTKVFRPRT----PPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 338

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 81/231 (35%), Positives = 121/231 (52%), Gaps = 27/231 (11%)
Query: 198 SLIFEYVNSTDFKVL------YPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM 251
           +L+ +YV  T ++V         TL    ++ Y+Y+L ++L Y HS GI HRD+KP N++
Sbjct: 95  NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLL 154
Query: 252 IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFA 311
           +D +   L+L D+G A+    G+     + SRY++ PEL+    DY  S+D+WS GC+ A
Sbjct: 155 LDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLA 214
Query: 312 GMIFRKEPFFYGHDNHDQLVKIAKVLGTD------ELNAYLNKYHLELDPQLDALVGRHS 365
            ++   +P F G    DQLV+I KVLGT       E+N    ++     PQ+ A      
Sbjct: 215 ELLL-GQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF---PQIKA------ 264
Query: 366 RKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR 416
             PW+K           PEAI    +LL Y    RLT  EA AH +F ++R
Sbjct: 265 -HPWTKVFRPRT----PPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 81/231 (35%), Positives = 121/231 (52%), Gaps = 27/231 (11%)
Query: 198 SLIFEYVNSTDFKVL------YPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM 251
           +L+ +YV  T ++V         TL    ++ Y+Y+L ++L Y HS GI HRD+KP N++
Sbjct: 95  NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLL 154
Query: 252 IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFA 311
           +D +   L+L D+G A+    G+     + SRY++ PEL+    DY  S+D+WS GC+ A
Sbjct: 155 LDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLA 214
Query: 312 GMIFRKEPFFYGHDNHDQLVKIAKVLGTD------ELNAYLNKYHLELDPQLDALVGRHS 365
            ++   +P F G    DQLV+I KVLGT       E+N    ++     PQ+ A      
Sbjct: 215 ELLL-GQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF---PQIKA------ 264
Query: 366 RKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR 416
             PW+K           PEAI    +LL Y    RLT  EA AH +F ++R
Sbjct: 265 -HPWTKVFRPRT----PPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 81/231 (35%), Positives = 121/231 (52%), Gaps = 27/231 (11%)
Query: 198 SLIFEYVNSTDFKVL------YPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM 251
           +L+ +YV  T ++V         TL    ++ Y+Y+L ++L Y HS GI HRD+KP N++
Sbjct: 96  NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLL 155
Query: 252 IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFA 311
           +D +   L+L D+G A+    G+     + SRY++ PEL+    DY  S+D+WS GC+ A
Sbjct: 156 LDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLA 215
Query: 312 GMIFRKEPFFYGHDNHDQLVKIAKVLGTD------ELNAYLNKYHLELDPQLDALVGRHS 365
            ++   +P F G    DQLV+I KVLGT       E+N    ++     PQ+ A      
Sbjct: 216 ELLL-GQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF---PQIKA------ 265
Query: 366 RKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR 416
             PW+K           PEAI    +LL Y    RLT  EA AH +F ++R
Sbjct: 266 -HPWTKVFRPRT----PPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 311

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 81/231 (35%), Positives = 121/231 (52%), Gaps = 27/231 (11%)
Query: 198 SLIFEYVNSTDFKVL------YPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM 251
           +L+ +YV  T ++V         TL    ++ Y+Y+L ++L Y HS GI HRD+KP N++
Sbjct: 100 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLL 159
Query: 252 IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFA 311
           +D +   L+L D+G A+    G+     + SRY++ PEL+    DY  S+D+WS GC+ A
Sbjct: 160 LDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLA 219
Query: 312 GMIFRKEPFFYGHDNHDQLVKIAKVLGTD------ELNAYLNKYHLELDPQLDALVGRHS 365
            ++   +P F G    DQLV+I KVLGT       E+N    ++     PQ+ A      
Sbjct: 220 ELLL-GQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF---PQIKA------ 269
Query: 366 RKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR 416
             PW+K           PEAI    +LL Y    RLT  EA AH +F ++R
Sbjct: 270 -HPWTKVFRPRT----PPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 315

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 81/231 (35%), Positives = 121/231 (52%), Gaps = 27/231 (11%)
Query: 198 SLIFEYVNSTDFKVL------YPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM 251
           +L+ +YV  T ++V         TL    ++ Y+Y+L ++L Y HS GI HRD+KP N++
Sbjct: 95  NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLL 154
Query: 252 IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFA 311
           +D +   L+L D+G A+    G+     + SRY++ PEL+    DY  S+D+WS GC+ A
Sbjct: 155 LDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLA 214
Query: 312 GMIFRKEPFFYGHDNHDQLVKIAKVLGTD------ELNAYLNKYHLELDPQLDALVGRHS 365
            ++   +P F G    DQLV+I KVLGT       E+N    ++     PQ+ A      
Sbjct: 215 ELLL-GQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF---PQIKA------ 264
Query: 366 RKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR 416
             PW+K           PEAI    +LL Y    RLT  EA AH +F ++R
Sbjct: 265 -HPWTKVFRPRT----PPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 81/231 (35%), Positives = 121/231 (52%), Gaps = 27/231 (11%)
Query: 198 SLIFEYVNSTDFKVL------YPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM 251
           +L+ +YV  T ++V         TL    ++ Y+Y+L ++L Y HS GI HRD+KP N++
Sbjct: 99  NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLL 158
Query: 252 IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFA 311
           +D +   L+L D+G A+    G+     + SRY++ PEL+    DY  S+D+WS GC+ A
Sbjct: 159 LDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLA 218
Query: 312 GMIFRKEPFFYGHDNHDQLVKIAKVLGTD------ELNAYLNKYHLELDPQLDALVGRHS 365
            ++   +P F G    DQLV+I KVLGT       E+N    ++     PQ+ A      
Sbjct: 219 ELLL-GQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF---PQIKA------ 268
Query: 366 RKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR 416
             PW+K           PEAI    +LL Y    RLT  EA AH +F ++R
Sbjct: 269 -HPWTKVFRPRT----PPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 314

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 89/304 (29%), Positives = 157/304 (51%), Gaps = 23/304 (7%)
Query: 122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNE-----RCXXXXXXXXXXXXXXXXXXXLQNL 176
           G  ++++ V K+G G Y  V++  N  T E     +                    L+ L
Sbjct: 1   GHMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 177 CGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-YPTLTDYD---IRYYIYELLKAL 232
              PN+VKLLD++  ++     L+FE+++    K +    LT      I+ Y+++LL+ L
Sbjct: 61  -NHPNIVKLLDVIHTENKL--YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGL 117
Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELL 291
            +CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L
Sbjct: 118 AFCHSHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 176
Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL 351
           +  + Y  ++D+WSLGC+FA M+ R+   F G    DQL +I + LGT +   +     +
Sbjct: 177 LGCKYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 235
Query: 352 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 411
              P       + +R+ +SK +   ++     +    L ++L YD   R++A+ A+AHP+
Sbjct: 236 ---PDYKPSFPKWARQDFSKVVPPLDE-----DGRSLLSQMLHYDPNKRISAKAALAHPF 287
Query: 412 FAQV 415
           F  V
Sbjct: 288 FQDV 291

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 81/231 (35%), Positives = 121/231 (52%), Gaps = 27/231 (11%)
Query: 198 SLIFEYVNSTDFKVL------YPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM 251
           +L+ +YV  T ++V         TL    ++ Y+Y+L ++L Y HS GI HRD+KP N++
Sbjct: 95  NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLL 154
Query: 252 IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFA 311
           +D +   L+L D+G A+    G+     + SRY++ PEL+    DY  S+D+WS GC+ A
Sbjct: 155 LDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLA 214
Query: 312 GMIFRKEPFFYGHDNHDQLVKIAKVLGTD------ELNAYLNKYHLELDPQLDALVGRHS 365
            ++   +P F G    DQLV+I KVLGT       E+N    ++     PQ+ A      
Sbjct: 215 ELLL-GQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF---PQIKA------ 264
Query: 366 RKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR 416
             PW+K           PEAI    +LL Y    RLT  EA AH +F ++R
Sbjct: 265 -HPWTKVFRPRT----PPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 81/231 (35%), Positives = 121/231 (52%), Gaps = 27/231 (11%)
Query: 198 SLIFEYVNSTDFKVL------YPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM 251
           +L+ +YV  T ++V         TL    ++ Y+Y+L ++L Y HS GI HRD+KP N++
Sbjct: 108 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLL 167
Query: 252 IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFA 311
           +D +   L+L D+G A+    G+     + SRY++ PEL+    DY  S+D+WS GC+ A
Sbjct: 168 LDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLA 227
Query: 312 GMIFRKEPFFYGHDNHDQLVKIAKVLGTD------ELNAYLNKYHLELDPQLDALVGRHS 365
            ++   +P F G    DQLV+I KVLGT       E+N    ++     PQ+ A      
Sbjct: 228 ELLL-GQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF---PQIKA------ 277
Query: 366 RKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR 416
             PW+K           PEAI    +LL Y    RLT  EA AH +F ++R
Sbjct: 278 -HPWTKVFRPRT----PPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 323

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 81/231 (35%), Positives = 121/231 (52%), Gaps = 27/231 (11%)
Query: 198 SLIFEYVNSTDFKVL------YPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM 251
           +L+ +YV  T ++V         TL    ++ Y+Y+L ++L Y HS GI HRD+KP N++
Sbjct: 95  NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLL 154
Query: 252 IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFA 311
           +D +   L+L D+G A+    G+     + SRY++ PEL+    DY  S+D+WS GC+ A
Sbjct: 155 LDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLA 214
Query: 312 GMIFRKEPFFYGHDNHDQLVKIAKVLGTD------ELNAYLNKYHLELDPQLDALVGRHS 365
            ++   +P F G    DQLV+I KVLGT       E+N    ++     PQ+ A      
Sbjct: 215 ELLL-GQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFAF---PQIKA------ 264
Query: 366 RKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR 416
             PW+K           PEAI    +LL Y    RLT  EA AH +F ++R
Sbjct: 265 -HPWTKVFRPRT----PPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 88/301 (29%), Positives = 156/301 (51%), Gaps = 23/301 (7%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNE-----RCXXXXXXXXXXXXXXXXXXXLQNLCGG 179
           ++++ V K+G G Y  V++  N  T E     +                    L+ L   
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-NH 61
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-YPTLTDYD---IRYYIYELLKALDYC 235
           PN+VKLLD++  ++     L+FE+++    K +    LT      I+ Y+++LL+ L +C
Sbjct: 62  PNIVKLLDVIHTENKL--YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLSFC 119
Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDL 294
           HS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L+  
Sbjct: 120 HSHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 178
Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 354
           + Y  ++D+WSLGC+FA M+ R+   F G    DQL +I + LGT +   +     +   
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM--- 234
Query: 355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 414
           P       + +R+ +SK +   ++     +    L ++L YD   R++A+ A+AHP+F  
Sbjct: 235 PDYKPSFPKWARQDFSKVVPPLDE-----DGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289
Query: 415 V 415
           V
Sbjct: 290 V 290

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 81/231 (35%), Positives = 121/231 (52%), Gaps = 27/231 (11%)
Query: 198 SLIFEYVNSTDFKVL------YPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM 251
           +L+ +YV  T ++V         TL    ++ Y+Y+L ++L Y HS GI HRD+KP N++
Sbjct: 95  NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLL 154
Query: 252 IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFA 311
           +D +   L+L D+G A+    G+     + SRY++ PEL+    DY  S+D+WS GC+ A
Sbjct: 155 LDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLA 214
Query: 312 GMIFRKEPFFYGHDNHDQLVKIAKVLGTD------ELNAYLNKYHLELDPQLDALVGRHS 365
            ++   +P F G    DQLV+I KVLGT       E+N    ++     PQ+ A      
Sbjct: 215 ELLL-GQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF---PQIKA------ 264
Query: 366 RKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR 416
             PW+K           PEAI    +LL Y    RLT  EA AH +F ++R
Sbjct: 265 -HPWTKVFRPRT----PPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score =  132 bits (333), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 87/300 (29%), Positives = 154/300 (51%), Gaps = 21/300 (7%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQNLCGGP 180
           ++++ V K+G G Y  V++  N  T E    +                    L      P
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-YPTLTDYD---IRYYIYELLKALDYCH 236
           N+VKLLD++  ++     L+FE+++    K +    LT      I+ Y+++LL+ L +CH
Sbjct: 70  NIVKLLDVIHTENKL--YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 127
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQ 295
           S  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L+  +
Sbjct: 128 SHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXK 186
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP 355
            Y  ++D+WSLGC+FA M+ R+   F G    DQL +I + LGT +   +     +   P
Sbjct: 187 YYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM---P 242
Query: 356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV 415
                  + +R+ +SK +   ++     +    L ++L YD   R++A+ A+AHP+F  V
Sbjct: 243 DYKPSFPKWARQDFSKVVPPLDE-----DGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 297

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score =  132 bits (333), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 88/301 (29%), Positives = 156/301 (51%), Gaps = 23/301 (7%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNE-----RCXXXXXXXXXXXXXXXXXXXLQNLCGG 179
           ++++ V K+G G Y  V++  N  T E     +                    L+ L   
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-NH 68
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-YPTLTDYD---IRYYIYELLKALDYC 235
           PN+VKLLD++  ++     L+FE+++    K +    LT      I+ Y+++LL+ L +C
Sbjct: 69  PNIVKLLDVIHTENKL--YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 126
Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDL 294
           HS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L+  
Sbjct: 127 HSHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 185
Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 354
           + Y  ++D+WSLGC+FA M+ R+   F G    DQL +I + LGT +   +     +   
Sbjct: 186 KYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM--- 241
Query: 355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 414
           P       + +R+ +SK +   ++     +    L ++L YD   R++A+ A+AHP+F  
Sbjct: 242 PDYKPSFPKWARQDFSKVVPPLDE-----DGRSLLSQMLHYDPNKRISAKAALAHPFFQD 296
Query: 415 V 415
           V
Sbjct: 297 V 297

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score =  132 bits (333), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 88/301 (29%), Positives = 156/301 (51%), Gaps = 23/301 (7%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNE-----RCXXXXXXXXXXXXXXXXXXXLQNLCGG 179
           ++++ V K+G G Y  V++  N  T E     +                    L+ L   
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKEL-NH 61
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-YPTLTDYD---IRYYIYELLKALDYC 235
           PN+VKLLD++  ++     L+FE+++    K +    LT      I+ Y+++LL+ L +C
Sbjct: 62  PNIVKLLDVIHTENKL--YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDL 294
           HS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L+  
Sbjct: 120 HSHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 178
Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 354
           + Y  ++D+WSLGC+FA M+ R+   F G    DQL +I + LGT +   +     +   
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM--- 234
Query: 355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 414
           P       + +R+ +SK +   ++     +    L ++L YD   R++A+ A+AHP+F  
Sbjct: 235 PDYKPSFPKWARQDFSKVVPPLDE-----DGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289
Query: 415 V 415
           V
Sbjct: 290 V 290

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  132 bits (333), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 88/301 (29%), Positives = 156/301 (51%), Gaps = 23/301 (7%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNE-----RCXXXXXXXXXXXXXXXXXXXLQNLCGG 179
           ++++ V K+G G Y  V++  N  T E     +                    L+ L   
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKEL-NH 60
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-YPTLTDYD---IRYYIYELLKALDYC 235
           PN+VKLLD++  ++     L+FE+++    K +    LT      I+ Y+++LL+ L +C
Sbjct: 61  PNIVKLLDVIHTENKL--YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDL 294
           HS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L+  
Sbjct: 119 HSHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 177
Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 354
           + Y  ++D+WSLGC+FA M+ R+   F G    DQL +I + LGT +   +     +   
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM--- 233
Query: 355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 414
           P       + +R+ +SK +   ++     +    L ++L YD   R++A+ A+AHP+F  
Sbjct: 234 PDYKPSFPKWARQDFSKVVPPLDE-----DGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288
Query: 415 V 415
           V
Sbjct: 289 V 289

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score =  132 bits (333), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 87/300 (29%), Positives = 154/300 (51%), Gaps = 21/300 (7%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQNLCGGP 180
           ++++ V K+G G Y  V++  N  T E    +                    L      P
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-YPTLTDYD---IRYYIYELLKALDYCH 236
           N+VKLLD++  ++     L+FE+++    K +    LT      I+ Y+++LL+ L +CH
Sbjct: 63  NIVKLLDVIHTENKL--YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQ 295
           S  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L+  +
Sbjct: 121 SHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXK 179
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP 355
            Y  ++D+WSLGC+FA M+ R+   F G    DQL +I + LGT +   +     +   P
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM---P 235
Query: 356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV 415
                  + +R+ +SK +   ++     +    L ++L YD   R++A+ A+AHP+F  V
Sbjct: 236 DYKPSFPKWARQDFSKVVPPLDE-----DGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 290

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score =  132 bits (333), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 88/301 (29%), Positives = 156/301 (51%), Gaps = 23/301 (7%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNE-----RCXXXXXXXXXXXXXXXXXXXLQNLCGG 179
           ++++ V K+G G Y  V++  N  T E     +                    L+ L   
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-NH 61
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-YPTLTDYD---IRYYIYELLKALDYC 235
           PN+VKLLD++  ++     L+FE+++    K +    LT      I+ Y+++LL+ L +C
Sbjct: 62  PNIVKLLDVIHTENKL--YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDL 294
           HS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L+  
Sbjct: 120 HSHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 178
Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 354
           + Y  ++D+WSLGC+FA M+ R+   F G    DQL +I + LGT +   +     +   
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM--- 234
Query: 355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 414
           P       + +R+ +SK +   ++     +    L ++L YD   R++A+ A+AHP+F  
Sbjct: 235 PDYKPSFPKWARQDFSKVVPPLDE-----DGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289
Query: 415 V 415
           V
Sbjct: 290 V 290

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score =  132 bits (333), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 88/301 (29%), Positives = 156/301 (51%), Gaps = 23/301 (7%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNE-----RCXXXXXXXXXXXXXXXXXXXLQNLCGG 179
           ++++ V K+G G Y  V++  N  T E     +                    L+ L   
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-NH 60
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-YPTLTDYD---IRYYIYELLKALDYC 235
           PN+VKLLD++  ++     L+FE+++    K +    LT      I+ Y+++LL+ L +C
Sbjct: 61  PNIVKLLDVIHTENKL--YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDL 294
           HS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L+  
Sbjct: 119 HSHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 177
Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 354
           + Y  ++D+WSLGC+FA M+ R+   F G    DQL +I + LGT +   +     +   
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM--- 233
Query: 355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 414
           P       + +R+ +SK +   ++     +    L ++L YD   R++A+ A+AHP+F  
Sbjct: 234 PDYKPSFPKWARQDFSKVVPPLDE-----DGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288
Query: 415 V 415
           V
Sbjct: 289 V 289

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score =  132 bits (333), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 88/301 (29%), Positives = 156/301 (51%), Gaps = 23/301 (7%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNE-----RCXXXXXXXXXXXXXXXXXXXLQNLCGG 179
           ++++ V K+G G Y  V++  N  T E     +                    L+ L   
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-NH 60
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-YPTLTDYD---IRYYIYELLKALDYC 235
           PN+VKLLD++  ++     L+FE+++    K +    LT      I+ Y+++LL+ L +C
Sbjct: 61  PNIVKLLDVIHTENKL--YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDL 294
           HS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L+  
Sbjct: 119 HSHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 177
Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 354
           + Y  ++D+WSLGC+FA M+ R+   F G    DQL +I + LGT +   +     +   
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM--- 233
Query: 355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 414
           P       + +R+ +SK +   ++     +    L ++L YD   R++A+ A+AHP+F  
Sbjct: 234 PDYKPSFPKWARQDFSKVVPPLDE-----DGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288
Query: 415 V 415
           V
Sbjct: 289 V 289

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score =  132 bits (332), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 88/301 (29%), Positives = 156/301 (51%), Gaps = 23/301 (7%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNE-----RCXXXXXXXXXXXXXXXXXXXLQNLCGG 179
           ++++ V K+G G Y  V++  N  T E     +                    L+ L   
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-NH 61
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-YPTLTDYD---IRYYIYELLKALDYC 235
           PN+VKLLD++  ++     L+FE+++    K +    LT      I+ Y+++LL+ L +C
Sbjct: 62  PNIVKLLDVIHTENKL--YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDL 294
           HS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L+  
Sbjct: 120 HSHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 178
Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 354
           + Y  ++D+WSLGC+FA M+ R+   F G    DQL +I + LGT +   +     +   
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM--- 234
Query: 355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 414
           P       + +R+ +SK +   ++     +    L ++L YD   R++A+ A+AHP+F  
Sbjct: 235 PDYKPSFPKWARQDFSKVVPPLDE-----DGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289
Query: 415 V 415
           V
Sbjct: 290 V 290

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score =  132 bits (331), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 88/301 (29%), Positives = 156/301 (51%), Gaps = 23/301 (7%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNE-----RCXXXXXXXXXXXXXXXXXXXLQNLCGG 179
           ++++ V K+G G Y  V++  N  T E     +                    L+ L   
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-NH 61
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-YPTLTDYD---IRYYIYELLKALDYC 235
           PN+VKLLD++  ++     L+FE+++    K +    LT      I+ Y+++LL+ L +C
Sbjct: 62  PNIVKLLDVIHTENKL--YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDL 294
           HS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L+  
Sbjct: 120 HSHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC 178
Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 354
           + Y  ++D+WSLGC+FA M+ R+   F G    DQL +I + LGT +   +     +   
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM--- 234
Query: 355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 414
           P       + +R+ +SK +   ++     +    L ++L YD   R++A+ A+AHP+F  
Sbjct: 235 PDYKPSFPKWARQDFSKVVPPLDE-----DGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289
Query: 415 V 415
           V
Sbjct: 290 V 290

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score =  132 bits (331), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 88/301 (29%), Positives = 156/301 (51%), Gaps = 23/301 (7%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNE-----RCXXXXXXXXXXXXXXXXXXXLQNLCGG 179
           ++++ V K+G G Y  V++  N  T E     +                    L+ L   
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-NH 61
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-YPTLTDYD---IRYYIYELLKALDYC 235
           PN+VKLLD++  ++     L+FE+++    K +    LT      I+ Y+++LL+ L +C
Sbjct: 62  PNIVKLLDVIHTENKL--YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDL 294
           HS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L+  
Sbjct: 120 HSHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC 178
Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 354
           + Y  ++D+WSLGC+FA M+ R+   F G    DQL +I + LGT +   +     +   
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM--- 234
Query: 355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 414
           P       + +R+ +SK +   ++     +    L ++L YD   R++A+ A+AHP+F  
Sbjct: 235 PDYKPSFPKWARQDFSKVVPPLDE-----DGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289
Query: 415 V 415
           V
Sbjct: 290 V 290

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score =  132 bits (331), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 88/301 (29%), Positives = 156/301 (51%), Gaps = 23/301 (7%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNE-----RCXXXXXXXXXXXXXXXXXXXLQNLCGG 179
           ++++ V K+G G Y  V++  N  T E     +                    L+ L   
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-NH 60
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-YPTLTDYD---IRYYIYELLKALDYC 235
           PN+VKLLD++  ++     L+FE+++    K +    LT      I+ Y+++LL+ L +C
Sbjct: 61  PNIVKLLDVIHTENKL--YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDL 294
           HS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L+  
Sbjct: 119 HSHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC 177
Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 354
           + Y  ++D+WSLGC+FA M+ R+   F G    DQL +I + LGT +   +     +   
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM--- 233
Query: 355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 414
           P       + +R+ +SK +   ++     +    L ++L YD   R++A+ A+AHP+F  
Sbjct: 234 PDYKPSFPKWARQDFSKVVPPLDE-----DGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288
Query: 415 V 415
           V
Sbjct: 289 V 289

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score =  132 bits (331), Expect = 5e-31,   Method: Compositional matrix adjust.
 Identities = 88/301 (29%), Positives = 156/301 (51%), Gaps = 23/301 (7%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNE-----RCXXXXXXXXXXXXXXXXXXXLQNLCGG 179
           ++++ V K+G G Y  V++  N  T E     +                    L+ L   
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-NH 61
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-YPTLTDYD---IRYYIYELLKALDYC 235
           PN+VKLLD++  ++     L+FE+++    K +    LT      I+ Y+++LL+ L +C
Sbjct: 62  PNIVKLLDVIHTENKL--YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDL 294
           HS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L+  
Sbjct: 120 HSHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC 178
Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 354
           + Y  ++D+WSLGC+FA M+ R+   F G    DQL +I + LGT +   +     +   
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM--- 234
Query: 355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 414
           P       + +R+ +SK +   ++     +    L ++L YD   R++A+ A+AHP+F  
Sbjct: 235 PDYKPSFPKWARQDFSKVVPPLDE-----DGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289
Query: 415 V 415
           V
Sbjct: 290 V 290

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score =  132 bits (331), Expect = 5e-31,   Method: Compositional matrix adjust.
 Identities = 88/301 (29%), Positives = 156/301 (51%), Gaps = 23/301 (7%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNE-----RCXXXXXXXXXXXXXXXXXXXLQNLCGG 179
           ++++ V K+G G Y  V++  N  T E     +                    L+ L   
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-NH 60
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-YPTLTDYD---IRYYIYELLKALDYC 235
           PN+VKLLD++  ++     L+FE+++    K +    LT      I+ Y+++LL+ L +C
Sbjct: 61  PNIVKLLDVIHTENKL--YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDL 294
           HS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L+  
Sbjct: 119 HSHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC 177
Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 354
           + Y  ++D+WSLGC+FA M+ R+   F G    DQL +I + LGT +   +     +   
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM--- 233
Query: 355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 414
           P       + +R+ +SK +   ++     +    L ++L YD   R++A+ A+AHP+F  
Sbjct: 234 PDYKPSFPKWARQDFSKVVPPLDE-----DGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288
Query: 415 V 415
           V
Sbjct: 289 V 289

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score =  130 bits (328), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 88/301 (29%), Positives = 154/301 (51%), Gaps = 23/301 (7%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQNLCGGP 180
           ++++ V K+G G Y  V++  N  T E    +                    L      P
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY--PTLTDYD---IRYYIYELLKALDYC 235
           N+VKLLD++  ++     L+FE+++  D K       LT      I+ Y+++LL+ L +C
Sbjct: 63  NIVKLLDVIHTENKL--YLVFEFLHQ-DLKDFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDL 294
           HS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L+  
Sbjct: 120 HSHRVLHRDLKPENLLINTE-GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC 178
Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 354
           + Y  ++D+WSLGC+FA M+ R+   F G    DQL +I + LGT +   +     +   
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM--- 234
Query: 355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 414
           P       + +R+ +SK +   ++     +    L ++L YD   R++A+ A+AHP+F  
Sbjct: 235 PDYKPSFPKWARQDFSKVVPPLDE-----DGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289
Query: 415 V 415
           V
Sbjct: 290 V 290

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score =  130 bits (328), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 87/298 (29%), Positives = 155/298 (52%), Gaps = 23/298 (7%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNE-----RCXXXXXXXXXXXXXXXXXXXLQNLCGG 179
           ++++ V K+G G Y  V++  N  T E     +                    L+ L   
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-NH 61
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-YPTLTDYD---IRYYIYELLKALDYC 235
           PN+VKLLD++  ++     L+FE+++    K +    LT      I+ Y+++LL+ L +C
Sbjct: 62  PNIVKLLDVIHTENKL--YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDL 294
           HS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L+  
Sbjct: 120 HSHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC 178
Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 354
           + Y  ++D+WSLGC+FA M+ R+   F G    DQL +I + LGT +   +     +   
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM--- 234
Query: 355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 412
           P       + +R+ +SK +   ++     +    L ++L YD   R++A+ A+AHP+F
Sbjct: 235 PDYKPSFPKWARQDFSKVVPPLDE-----DGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score =  130 bits (328), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 75/238 (31%), Positives = 132/238 (55%), Gaps = 16/238 (6%)
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALDYCHS 237
           N+VKL D++  +  K   L+FE+++    K+L      L     + ++ +LL  + YCH 
Sbjct: 61  NIVKLYDVIHTK--KRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 238 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQD 296
           + ++HRD+KP N++I+ E  +L++ D+GLA  F  P ++Y   V + +++ P++L+  + 
Sbjct: 119 RRVLHRDLKPQNLLINRE-GELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKK 177
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ 356
           Y  ++D+WS+GC+FA M+    P F G    DQL++I ++LGT     + N   L   P+
Sbjct: 178 YSTTIDIWSVGCIFAEMV-NGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL---PK 233
Query: 357 LDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 414
            D     +   PW  F+       +    ID L K+L+ D   R+TA++A+ H YF +
Sbjct: 234 YDPNFTVYEPLPWESFLKG-----LDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score =  130 bits (327), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 75/238 (31%), Positives = 132/238 (55%), Gaps = 16/238 (6%)
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALDYCHS 237
           N+VKL D++  +  K   L+FE+++    K+L      L     + ++ +LL  + YCH 
Sbjct: 61  NIVKLYDVIHTK--KRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 238 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQD 296
           + ++HRD+KP N++I+ E  +L++ D+GLA  F  P ++Y   V + +++ P++L+  + 
Sbjct: 119 RRVLHRDLKPQNLLINRE-GELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKK 177
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ 356
           Y  ++D+WS+GC+FA M+    P F G    DQL++I ++LGT     + N   L   P+
Sbjct: 178 YSTTIDIWSVGCIFAEMV-NGAPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL---PK 233
Query: 357 LDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 414
            D     +   PW  F+       +    ID L K+L+ D   R+TA++A+ H YF +
Sbjct: 234 YDPNFTVYEPLPWESFLKG-----LDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score =  130 bits (326), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 74/238 (31%), Positives = 132/238 (55%), Gaps = 16/238 (6%)
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALDYCHS 237
           N+VKL D++  +  K   L+FE+++    K+L      L     + ++ +LL  + YCH 
Sbjct: 61  NIVKLYDVIHTK--KRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 238 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQD 296
           + ++HRD+KP N++I+ E  +L++ D+GLA  F  P ++Y   + + +++ P++L+  + 
Sbjct: 119 RRVLHRDLKPQNLLINRE-GELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKK 177
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ 356
           Y  ++D+WS+GC+FA M+    P F G    DQL++I ++LGT     + N   L   P+
Sbjct: 178 YSTTIDIWSVGCIFAEMV-NGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL---PK 233
Query: 357 LDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 414
            D     +   PW  F+       +    ID L K+L+ D   R+TA++A+ H YF +
Sbjct: 234 YDPNFTVYEPLPWESFLKG-----LDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score =  129 bits (325), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 88/300 (29%), Positives = 148/300 (49%), Gaps = 29/300 (9%)
Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLC-----GGPN 181
           YE + K+G G Y  VF+  N  T+E                     L+ +C        N
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHE-IVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62
Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIYELLKALDYCHSQ 238
           +V+L D++     K  +L+FE+ +    K       D D   ++ ++++LLK L +CHS+
Sbjct: 63  IVRLHDVL--HSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR 120
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQDY 297
            ++HRD+KP N++I+    +L+L D+GLA  F  P + Y+  V + +++ P++L   + Y
Sbjct: 121 NVLHRDLKPQNLLINRN-GELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLY 179
Query: 298 DYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQL 357
             S+DMWS GC+FA +     P F G+D  DQL +I ++LGT              + Q 
Sbjct: 180 STSIDMWSAGCIFAELANAARPLFPGNDVDDQLKRIFRLLGT------------PTEEQW 227
Query: 358 DALVGRHSRKPWSKFINADNQHLVSPE----AIDFLDKLLRYDHQDRLTAREAMAHPYFA 413
            ++      KP+  +    +   V P+      D L  LL+ +   R++A EA+ HPYF+
Sbjct: 228 PSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFS 287

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score =  129 bits (324), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 91/331 (27%), Positives = 156/331 (47%), Gaps = 30/331 (9%)
Query: 103 VNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXX 162
           ++++R K ++  +     W     Y     VG G Y  V   I+  + E+          
Sbjct: 20  MSLIRKKGFYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF 79
Query: 163 XXXXXXXXXXLQNLC----GGPNVVKLLDIVRDQHSKTPS----LIFEYVNSTDFKVLYP 214
                      + L        NV+ LLD+     S        L+  ++ +   K++  
Sbjct: 80  QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGM 139
Query: 215 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 274
             ++  I+Y +Y++LK L Y HS G++HRD+KP N+ ++ +  +L+++D+GLA   H   
Sbjct: 140 EFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDC-ELKILDFGLAR--HADA 196
Query: 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 334
           E    V +R+++ PE+++    Y+ ++D+WS+GC+ A M+  K   F G D  DQL +I 
Sbjct: 197 EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKT-LFKGKDYLDQLTQIL 255
Query: 335 KVLG------TDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDF 388
           KV G        +LN    K +++  PQ         RK +++          SP+A D 
Sbjct: 256 KVTGVPGTEFVQKLNDKAAKSYIQSLPQT-------PRKDFTQLFPR-----ASPQAADL 303
Query: 389 LDKLLRYDHQDRLTAREAMAHPYFAQVRAAE 419
           L+K+L  D   RLTA +A+ HP+F   R  E
Sbjct: 304 LEKMLELDVDKRLTAAQALTHPFFEPFRDPE 334

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score =  129 bits (323), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 91/331 (27%), Positives = 156/331 (47%), Gaps = 30/331 (9%)
Query: 103 VNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXX 162
           ++++R K ++  +     W     Y     VG G Y  V   I+  + E+          
Sbjct: 2   LSLIRKKGFYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF 61
Query: 163 XXXXXXXXXXLQNLC----GGPNVVKLLDIVRDQHSKTPS----LIFEYVNSTDFKVLYP 214
                      + L        NV+ LLD+     S        L+  ++ +   K++  
Sbjct: 62  QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGL 121
Query: 215 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 274
             ++  I+Y +Y++LK L Y HS G++HRD+KP N+ ++ +  +L+++D+GLA   H   
Sbjct: 122 KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDC-ELKILDFGLAR--HADA 178
Query: 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 334
           E    V +R+++ PE+++    Y+ ++D+WS+GC+ A M+  K   F G D  DQL +I 
Sbjct: 179 EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKT-LFKGKDYLDQLTQIL 237
Query: 335 KVLG------TDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDF 388
           KV G        +LN    K +++  PQ         RK +++          SP+A D 
Sbjct: 238 KVTGVPGTEFVQKLNDKAAKSYIQSLPQT-------PRKDFTQLFPR-----ASPQAADL 285
Query: 389 LDKLLRYDHQDRLTAREAMAHPYFAQVRAAE 419
           L+K+L  D   RLTA +A+ HP+F   R  E
Sbjct: 286 LEKMLELDVDKRLTAAQALTHPFFEPFRDPE 316

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score =  127 bits (320), Expect = 9e-30,   Method: Compositional matrix adjust.
 Identities = 87/300 (29%), Positives = 148/300 (49%), Gaps = 29/300 (9%)
Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLC-----GGPN 181
           YE + K+G G Y  VF+  N  T+E                     L+ +C        N
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHE-IVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62
Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIYELLKALDYCHSQ 238
           +V+L D++     K  +L+FE+ +    K       D D   ++ ++++LLK L +CHS+
Sbjct: 63  IVRLHDVL--HSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR 120
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQDY 297
            ++HRD+KP N++I+    +L+L ++GLA  F  P + Y+  V + +++ P++L   + Y
Sbjct: 121 NVLHRDLKPQNLLINRN-GELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLY 179
Query: 298 DYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQL 357
             S+DMWS GC+FA +     P F G+D  DQL +I ++LGT              + Q 
Sbjct: 180 STSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGT------------PTEEQW 227
Query: 358 DALVGRHSRKPWSKFINADNQHLVSPE----AIDFLDKLLRYDHQDRLTAREAMAHPYFA 413
            ++      KP+  +    +   V P+      D L  LL+ +   R++A EA+ HPYF+
Sbjct: 228 PSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFS 287

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score =  125 bits (313), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 96/337 (28%), Positives = 159/337 (47%), Gaps = 32/337 (9%)
Query: 93  AMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNER 152
           A S A  +T  +  RP  Y    + T+ W   + Y+ +  VG G Y  V    +V +  +
Sbjct: 20  AGSAAAPFTMSHKERPTFYRQELNKTI-WEVPERYQTLSPVGSGAYGSVCSSYDVKSGLK 78
Query: 153 CXXXXXX----XXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVN--- 205
                                   L       NV+ LLD+       TP+   E  N   
Sbjct: 79  IAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVF------TPATSLEEFNDVY 132
Query: 206 ------STDFK--VLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELR 257
                   D    V    LTD  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  
Sbjct: 133 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC- 191
Query: 258 KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRK 317
           +L+++D+GLA   H   E    VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +
Sbjct: 192 ELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTGR 249
Query: 318 EPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADN 377
              F G D+ +QL +I ++ GT   +        E    +++L     R     FI A+ 
Sbjct: 250 T-LFPGTDHINQLQQIMRLTGTPPASVISRMPSHEARNYINSLPQMPKRNFADVFIGAN- 307
Query: 378 QHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 414
                P A+D L+K+L  D   R+TA EA+AHPYF+Q
Sbjct: 308 -----PLAVDLLEKMLVLDTDKRITASEALAHPYFSQ 339

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score =  121 bits (304), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 81/258 (31%), Positives = 138/258 (53%), Gaps = 43/258 (16%)
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP-------------TLTDYDIRYYIYE 227
           NV+ LLD+       TP    +  + TDF ++ P              L +  I++ +Y+
Sbjct: 85  NVIGLLDVF------TPDETLD--DFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQ 136
Query: 228 LLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG 287
           +LK L Y H+ GI+HRD+KP N+ ++ +  +L+++D+GLA       E    V +R+++ 
Sbjct: 137 MLKGLRYIHAAGIIHRDLKPGNLAVNEDC-ELKILDFGLAR--QADSEMXGXVVTRWYRA 193
Query: 288 PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT------DE 341
           PE++++   Y  ++D+WS+GC+ A MI  K   F G D+ DQL +I KV GT        
Sbjct: 194 PEVILNWMRYTQTVDIWSVGCIMAEMITGKT-LFKGSDHLDQLKEIMKVTGTPPAEFVQR 252
Query: 342 LNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL 401
           L +   K +++  P+L+       +K ++  +        SP A++ L+K+L  D + R+
Sbjct: 253 LQSDEAKNYMKGLPELE-------KKDFASILTN-----ASPLAVNLLEKMLVLDAEQRV 300
Query: 402 TAREAMAHPYFAQVRAAE 419
           TA EA+AHPYF  +   E
Sbjct: 301 TAGEALAHPYFESLHDTE 318

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score =  121 bits (304), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 84/330 (25%), Positives = 159/330 (48%), Gaps = 50/330 (15%)
Query: 127 YEVVRKVGRGKYSEVFEGINVNTNE-----RCXXXXXXXXXXXXXXXXXXXLQNLCGGPN 181
           YE+V+K+G+G Y  V++ I+  T E     +                    L  L G  N
Sbjct: 11  YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHEN 70
Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTD-YDIRYYIYELLKALDYCHSQGI 240
           +V LL+++R  + +   L+F+Y+ +    V+   + +    +Y +Y+L+K + Y HS G+
Sbjct: 71  IVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVYQLIKVIKYLHSGGL 130
Query: 241 MHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR--------------------- 279
           +HRD+KP N++++ E   +++ D+GL+  +      N+R                     
Sbjct: 131 LHRDMKPSNILLNAECH-VKVADFGLSRSF-----VNIRRVTNNIPLSINENTENFDDDQ 184
Query: 280 ------VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333
                 VA+R+++ PE+L+    Y   +DMWSLGC+  G I   +P F G    +QL +I
Sbjct: 185 PILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCIL-GEILCGKPIFPGSSTMNQLERI 243
Query: 334 AKVL------GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFIN----ADNQHLVSP 383
             V+        + + +   K  +E   +   +   + R  ++K+ N     + +   + 
Sbjct: 244 IGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNE 303
Query: 384 EAIDFLDKLLRYDHQDRLTAREAMAHPYFA 413
           EA+D LDKLL+++   R++A +A+ HP+ +
Sbjct: 304 EALDLLDKLLQFNPNKRISANDALKHPFVS 333

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score =  120 bits (302), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 87/306 (28%), Positives = 144/306 (47%), Gaps = 38/306 (12%)
Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLC--------G 178
           YE V ++G G Y +VF+  ++    R                    ++ +          
Sbjct: 13  YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 72
Query: 179 GPNVVKLLDIV---RDQHSKTPSLIFEYVNS--TDF--KVLYPTLTDYDIRYYIYELLKA 231
            PNVV+L D+    R       +L+FE+V+   T +  KV  P +    I+  +++LL+ 
Sbjct: 73  HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRG 132
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 291
           LD+ HS  ++HRD+KP N+++     +++L D+GLA  Y         V + +++ PE+L
Sbjct: 133 LDFLHSHRVVHRDLKPQNILVTSS-GQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVL 191
Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL 351
           +    Y   +D+WS+GC+FA M FR++P F G  + DQL KI  V+G             
Sbjct: 192 LQ-SSYATPVDLWSVGCIFAEM-FRRKPLFRGSSDVDQLGKILDVIGLPG---------- 239
Query: 352 ELDPQLDALVGRH-----SRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA 406
           E D   D  + R      S +P  KF+       +     D L K L ++   R++A  A
Sbjct: 240 EEDWPRDVALPRQAFHSKSAQPIEKFVTD-----IDELGKDLLLKCLTFNPAKRISAYSA 294
Query: 407 MAHPYF 412
           ++HPYF
Sbjct: 295 LSHPYF 300

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score =  120 bits (301), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 81/252 (32%), Positives = 136/252 (53%), Gaps = 41/252 (16%)
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY----------------PTLTDYDIRYY 224
           NV+ LLD+       TP+   E     DF  +Y                  L+D  +++ 
Sbjct: 88  NVIGLLDVF------TPATSIE-----DFSEVYLVTTLMGADLNNIVKSQALSDEHVQFL 136
Query: 225 IYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY 284
           +Y+LL+ L Y HS GI+HRD+KP NV ++ +  +LR++D+GLA      +E    VA+R+
Sbjct: 137 VYQLLRGLKYIHSAGIIHRDLKPSNVAVNED-SELRILDFGLAR--QADEEMTGYVATRW 193
Query: 285 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT--DEL 342
           ++ PE++++   Y+ ++D+WS+GC+ A ++ + +  F G D  DQL +I +V+GT   E+
Sbjct: 194 YRAPEIMLNWMHYNQTVDIWSVGCIMAELL-QGKALFPGSDYIDQLKRIMEVVGTPSPEV 252
Query: 343 NAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT 402
            A ++  H      + +L     +   S F  A+      P AID L ++L  D   R++
Sbjct: 253 LAKISSEHAR--TYIQSLPPMPQKDLSSIFRGAN------PLAIDLLGRMLVLDSDQRVS 304
Query: 403 AREAMAHPYFAQ 414
           A EA+AH YF+Q
Sbjct: 305 AAEALAHAYFSQ 316

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score =  120 bits (301), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 87/306 (28%), Positives = 144/306 (47%), Gaps = 38/306 (12%)
Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLC--------G 178
           YE V ++G G Y +VF+  ++    R                    ++ +          
Sbjct: 13  YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 72
Query: 179 GPNVVKLLDIV---RDQHSKTPSLIFEYVNS--TDF--KVLYPTLTDYDIRYYIYELLKA 231
            PNVV+L D+    R       +L+FE+V+   T +  KV  P +    I+  +++LL+ 
Sbjct: 73  HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRG 132
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 291
           LD+ HS  ++HRD+KP N+++     +++L D+GLA  Y         V + +++ PE+L
Sbjct: 133 LDFLHSHRVVHRDLKPQNILVTSS-GQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVL 191
Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL 351
           +    Y   +D+WS+GC+FA M FR++P F G  + DQL KI  V+G             
Sbjct: 192 LQ-SSYATPVDLWSVGCIFAEM-FRRKPLFRGSSDVDQLGKILDVIGLPG---------- 239
Query: 352 ELDPQLDALVGRH-----SRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA 406
           E D   D  + R      S +P  KF+       +     D L K L ++   R++A  A
Sbjct: 240 EEDWPRDVALPRQAFHSKSAQPIEKFVTD-----IDELGKDLLLKCLTFNPAKRISAYSA 294
Query: 407 MAHPYF 412
           ++HPYF
Sbjct: 295 LSHPYF 300

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score =  120 bits (301), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 87/306 (28%), Positives = 144/306 (47%), Gaps = 38/306 (12%)
Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLC--------G 178
           YE V ++G G Y +VF+  ++    R                    ++ +          
Sbjct: 13  YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 72
Query: 179 GPNVVKLLDIV---RDQHSKTPSLIFEYVNS--TDF--KVLYPTLTDYDIRYYIYELLKA 231
            PNVV+L D+    R       +L+FE+V+   T +  KV  P +    I+  +++LL+ 
Sbjct: 73  HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRG 132
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 291
           LD+ HS  ++HRD+KP N+++     +++L D+GLA  Y         V + +++ PE+L
Sbjct: 133 LDFLHSHRVVHRDLKPQNILVTSS-GQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVL 191
Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL 351
           +    Y   +D+WS+GC+FA M FR++P F G  + DQL KI  V+G             
Sbjct: 192 LQ-SSYATPVDLWSVGCIFAEM-FRRKPLFRGSSDVDQLGKILDVIGLPG---------- 239
Query: 352 ELDPQLDALVGRH-----SRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA 406
           E D   D  + R      S +P  KF+       +     D L K L ++   R++A  A
Sbjct: 240 EEDWPRDVALPRQAFHSKSAQPIEKFVTD-----IDELGKDLLLKCLTFNPAKRISAYSA 294
Query: 407 MAHPYF 412
           ++HPYF
Sbjct: 295 LSHPYF 300

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score =  120 bits (301), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 81/252 (32%), Positives = 136/252 (53%), Gaps = 41/252 (16%)
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY----------------PTLTDYDIRYY 224
           NV+ LLD+       TP+   E     DF  +Y                  L+D  +++ 
Sbjct: 88  NVIGLLDVF------TPATSIE-----DFSEVYLVTTLMGADLNNIVKCQALSDEHVQFL 136
Query: 225 IYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY 284
           +Y+LL+ L Y HS GI+HRD+KP NV ++ +  +LR++D+GLA      +E    VA+R+
Sbjct: 137 VYQLLRGLKYIHSAGIIHRDLKPSNVAVNED-SELRILDFGLAR--QADEEMTGYVATRW 193
Query: 285 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT--DEL 342
           ++ PE++++   Y+ ++D+WS+GC+ A ++ + +  F G D  DQL +I +V+GT   E+
Sbjct: 194 YRAPEIMLNWMHYNQTVDIWSVGCIMAELL-QGKALFPGSDYIDQLKRIMEVVGTPSPEV 252
Query: 343 NAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT 402
            A ++  H      + +L     +   S F  A+      P AID L ++L  D   R++
Sbjct: 253 LAKISSEHAR--TYIQSLPPMPQKDLSSIFRGAN------PLAIDLLGRMLVLDSDQRVS 304
Query: 403 AREAMAHPYFAQ 414
           A EA+AH YF+Q
Sbjct: 305 AAEALAHAYFSQ 316

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  120 bits (301), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 77/246 (31%), Positives = 144/246 (58%), Gaps = 24/246 (9%)
Query: 181 NVVKLLDIVRD---QHSKTPSLIFEYVNSTDFKVLYPT-LTDYDIRYYIYELLKALDYCH 236
           N++ + DI+R    +  K   ++ + + +  +K+L    L++  I Y++Y++L+ L Y H
Sbjct: 84  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 143
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY----NVRVASRYFKGPELLV 292
           S  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE+++
Sbjct: 144 SANVLHRDLKPSNLLLNTTC-DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 202
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT---DELNAYLNKY 349
           + + Y  S+D+WS+GC+ A M+  + P F G    DQL  I  +LG+   ++LN  +N  
Sbjct: 203 NSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIIN-- 259
Query: 350 HLELDPQLDALVGRHSRKPWSK-FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 408
            L+    L +L  + ++ PW++ F NAD++      A+D LDK+L ++   R+   +A+A
Sbjct: 260 -LKARNYLLSLPHK-NKVPWNRLFPNADSK------ALDLLDKMLTFNPHKRIEVEQALA 311
Query: 409 HPYFAQ 414
           HPY AQ
Sbjct: 312 HPYLAQ 317

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score =  120 bits (300), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 70/202 (34%), Positives = 121/202 (59%), Gaps = 14/202 (6%)
Query: 215 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 274
            L+D  +++ +Y+LL+ L Y HS GI+HRD+KP NV ++ +  +LR++D+GLA      +
Sbjct: 119 ALSDEHVQFLVYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDC-ELRILDFGLAR--QADE 175
Query: 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 334
           E    VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++ + +  F G D  DQL +I 
Sbjct: 176 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL-QGKALFPGSDYIDQLKRIM 234
Query: 335 KVLGT--DELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKL 392
           +V+GT   E+ A ++  H      + +L     +   S F  A+      P AID L ++
Sbjct: 235 EVVGTPSPEVLAKISSEHAR--TYIQSLPPMPQKDLSSIFRGAN------PLAIDLLGRM 286
Query: 393 LRYDHQDRLTAREAMAHPYFAQ 414
           L  D   R++A EA+AH YF+Q
Sbjct: 287 LVLDSDQRVSAAEALAHAYFSQ 308

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  120 bits (300), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 77/246 (31%), Positives = 144/246 (58%), Gaps = 24/246 (9%)
Query: 181 NVVKLLDIVRD---QHSKTPSLIFEYVNSTDFKVLYPT-LTDYDIRYYIYELLKALDYCH 236
           N++ + DI+R    +  K   ++ + + +  +K+L    L++  I Y++Y++L+ L Y H
Sbjct: 84  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 143
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY----NVRVASRYFKGPELLV 292
           S  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE+++
Sbjct: 144 SANVLHRDLKPSNLLLN-TTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 202
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT---DELNAYLNKY 349
           + + Y  S+D+WS+GC+ A M+  + P F G    DQL  I  +LG+   ++LN  +N  
Sbjct: 203 NSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCGIN-- 259
Query: 350 HLELDPQLDALVGRHSRKPWSK-FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 408
            L+    L +L  + ++ PW++ F NAD++      A+D LDK+L ++   R+   +A+A
Sbjct: 260 -LKARNYLLSLPHK-NKVPWNRLFPNADSK------ALDLLDKMLTFNPHKRIEVEQALA 311
Query: 409 HPYFAQ 414
           HPY AQ
Sbjct: 312 HPYLAQ 317

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score =  119 bits (299), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 79/301 (26%), Positives = 154/301 (51%), Gaps = 21/301 (6%)
Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCXXXXX---XXXXXXXXXXXXXXLQNLCGGPNVV 183
           ++ + K+G G Y+ V++G+N  T                          L       N+V
Sbjct: 7   FKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIV 66
Query: 184 KLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---------IRYYIYELLKALDY 234
           +L D++  ++  T  L+FE++++ D K    + T  +         ++Y+ ++LL+ L +
Sbjct: 67  RLYDVIHTENKLT--LVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAF 123
Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVD 293
           CH   I+HRD+KP N++I+    +L+L D+GLA  F  P   ++  V + +++ P++L+ 
Sbjct: 124 CHENKILHRDLKPQNLLINKR-GQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMG 182
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 353
            + Y  S+D+WS GC+ A MI  K P F G ++ +QL  I  ++GT   + + +   L  
Sbjct: 183 SRTYSTSIDIWSCGCILAEMITGK-PLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKL-- 239
Query: 354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA 413
            P+ +  + +   +   + +    +  +    +DFL  LL+ +   RL+A++A+ HP+FA
Sbjct: 240 -PKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFA 298
Query: 414 Q 414
           +
Sbjct: 299 E 299

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score =  119 bits (298), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 77/246 (31%), Positives = 139/246 (56%), Gaps = 24/246 (9%)
Query: 181 NVVKLLDIVRDQ--HSKTPSLIFEYVNSTDFKVLYPT--LTDYDIRYYIYELLKALDYCH 236
           NV+ + DI+R     +     I + +  TD   L  +  L++  I Y++Y++L+ L Y H
Sbjct: 102 NVIGIRDILRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICYFLYQILRGLKYIH 161
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY----NVRVASRYFKGPELLV 292
           S  ++HRD+KP N++I+     L++ D+GLA    P  ++       VA+R+++ PE+++
Sbjct: 162 SANVLHRDLKPSNLLINTTC-DLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEIML 220
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT---DELNAYLNKY 349
           + + Y  S+D+WS+GC+ A M+  + P F G    DQL  I  +LG+   ++LN  +N  
Sbjct: 221 NSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIIN-- 277
Query: 350 HLELDPQLDALVGRHSRKPWSK-FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 408
            ++    L +L  + ++  W+K F  +D++      A+D LD++L ++   R+T  EA+A
Sbjct: 278 -MKARNYLQSLPSK-TKVAWAKLFPKSDSK------ALDLLDRMLTFNPNKRITVEEALA 329
Query: 409 HPYFAQ 414
           HPY  Q
Sbjct: 330 HPYLEQ 335

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score =  119 bits (298), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 77/246 (31%), Positives = 142/246 (57%), Gaps = 24/246 (9%)
Query: 181 NVVKLLDIVRD---QHSKTPSLIFEYVNSTDFKVLYPT-LTDYDIRYYIYELLKALDYCH 236
           N++ + DI+R    +  K   L+   + +  +K+L    L++  I Y++Y++L+ L Y H
Sbjct: 102 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 161
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY----NVRVASRYFKGPELLV 292
           S  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE+++
Sbjct: 162 SANVLHRDLKPSNLLLN-TTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 220
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT---DELNAYLNKY 349
           + + Y  S+D+WS+GC+ A M+  + P F G    DQL  I  +LG+   ++LN  +N  
Sbjct: 221 NSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIIN-- 277
Query: 350 HLELDPQLDALVGRHSRKPWSK-FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 408
            L+    L +L  + ++ PW++ F NAD++      A+D LDK+L ++   R+   +A+A
Sbjct: 278 -LKARNYLLSLPHK-NKVPWNRLFPNADSK------ALDLLDKMLTFNPHKRIEVEQALA 329
Query: 409 HPYFAQ 414
           HPY  Q
Sbjct: 330 HPYLEQ 335

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score =  119 bits (297), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 67/199 (33%), Positives = 115/199 (57%), Gaps = 12/199 (6%)
Query: 221 IRYYIYELLKALDYCH--SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV 278
           I+ ++++L++++   H  S  + HRD+KPHNV+++     L+L D+G A+   P +    
Sbjct: 131 IKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVA 190
Query: 279 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLG 338
            + SRY++ PEL+   Q Y  ++D+WS+GC+FA M+   EP F G ++  QL +I +VLG
Sbjct: 191 YICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMML-GEPIFRGDNSAGQLHEIVRVLG 249
Query: 339 --TDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYD 396
             + E+   LN  H ++D      +      PWS  + +D+    + EA D L  LL+Y 
Sbjct: 250 CPSREVLRKLNPSHTDVD------LYNSKGIPWSN-VFSDHSLKDAKEAYDLLSALLQYL 302
Query: 397 HQDRLTAREAMAHPYFAQV 415
            ++R+   EA+ HPYF ++
Sbjct: 303 PEERMKPYEALCHPYFDEL 321

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score =  118 bits (296), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 76/246 (30%), Positives = 143/246 (58%), Gaps = 24/246 (9%)
Query: 181 NVVKLLDIVRD---QHSKTPSLIFEYVNSTDFKVLYPT-LTDYDIRYYIYELLKALDYCH 236
           N++ + DI+R    +  K   ++ + + +  +K+L    L++  I Y++Y++L+ L Y H
Sbjct: 86  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 145
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN----VRVASRYFKGPELLV 292
           S  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE+++
Sbjct: 146 SANVLHRDLKPSNLLLNTTC-DLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIML 204
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT---DELNAYLNKY 349
           + + Y  S+D+WS+GC+ A M+  + P F G    DQL  I  +LG+   ++LN  +N  
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIIN-- 261
Query: 350 HLELDPQLDALVGRHSRKPWSK-FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 408
            L+    L +L  + ++ PW++ F NAD++      A+D LDK+L ++   R+   +A+A
Sbjct: 262 -LKARNYLLSLPHK-NKVPWNRLFPNADSK------ALDLLDKMLTFNPHKRIEVEQALA 313
Query: 409 HPYFAQ 414
           HPY  Q
Sbjct: 314 HPYLEQ 319

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score =  118 bits (296), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 76/246 (30%), Positives = 143/246 (58%), Gaps = 24/246 (9%)
Query: 181 NVVKLLDIVRD---QHSKTPSLIFEYVNSTDFKVLYPT-LTDYDIRYYIYELLKALDYCH 236
           N++ + DI+R    +  K   ++ + + +  +K+L    L++  I Y++Y++L+ L Y H
Sbjct: 87  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 146
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN----VRVASRYFKGPELLV 292
           S  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE+++
Sbjct: 147 SANVLHRDLKPSNLLLNTTC-DLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIML 205
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT---DELNAYLNKY 349
           + + Y  S+D+WS+GC+ A M+  + P F G    DQL  I  +LG+   ++LN  +N  
Sbjct: 206 NSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIIN-- 262
Query: 350 HLELDPQLDALVGRHSRKPWSK-FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 408
            L+    L +L  + ++ PW++ F NAD++      A+D LDK+L ++   R+   +A+A
Sbjct: 263 -LKARNYLLSLPHK-NKVPWNRLFPNADSK------ALDLLDKMLTFNPHKRIEVEQALA 314
Query: 409 HPYFAQ 414
           HPY  Q
Sbjct: 315 HPYLEQ 320

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score =  118 bits (296), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 77/246 (31%), Positives = 142/246 (57%), Gaps = 24/246 (9%)
Query: 181 NVVKLLDIVRD---QHSKTPSLIFEYVNSTDFKVLYPT-LTDYDIRYYIYELLKALDYCH 236
           N++ + DI+R    +  K   ++ + + +  +K+L    L++  I Y++Y++L+ L Y H
Sbjct: 80  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 139
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY----NVRVASRYFKGPELLV 292
           S  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE+++
Sbjct: 140 SANVLHRDLKPSNLLLNTTC-DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 198
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDE---LNAYLNKY 349
           + + Y  S+D+WS+GC+ A M+  + P F G    DQL  I  +LG+ E   LN  +N  
Sbjct: 199 NSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPEQEDLNCIIN-- 255
Query: 350 HLELDPQLDALVGRHSRKPWSK-FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 408
            L+    L +L  + ++ PW++ F NAD++      A+D LDK+L ++   R+   +A+A
Sbjct: 256 -LKARNYLLSLPHK-NKVPWNRLFPNADSK------ALDLLDKMLTFNPHKRIEVEQALA 307
Query: 409 HPYFAQ 414
           HPY  Q
Sbjct: 308 HPYLEQ 313

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score =  118 bits (295), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 76/246 (30%), Positives = 143/246 (58%), Gaps = 24/246 (9%)
Query: 181 NVVKLLDIVRD---QHSKTPSLIFEYVNSTDFKVLYPT-LTDYDIRYYIYELLKALDYCH 236
           N++ + DI+R    +  K   ++ + + +  +K+L    L++  I Y++Y++L+ L Y H
Sbjct: 82  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 141
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY----NVRVASRYFKGPELLV 292
           S  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE+++
Sbjct: 142 SANVLHRDLKPSNLLLN-TTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT---DELNAYLNKY 349
           + + Y  S+D+WS+GC+ A M+  + P F G    DQL  I  +LG+   ++LN  +N  
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIIN-- 257
Query: 350 HLELDPQLDALVGRHSRKPWSK-FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 408
            L+    L +L  + ++ PW++ F NAD++      A+D LDK+L ++   R+   +A+A
Sbjct: 258 -LKARNYLLSLPHK-NKVPWNRLFPNADSK------ALDLLDKMLTFNPHKRIEVEQALA 309
Query: 409 HPYFAQ 414
           HPY  Q
Sbjct: 310 HPYLEQ 315

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score =  118 bits (295), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 76/246 (30%), Positives = 143/246 (58%), Gaps = 24/246 (9%)
Query: 181 NVVKLLDIVRD---QHSKTPSLIFEYVNSTDFKVLYPT-LTDYDIRYYIYELLKALDYCH 236
           N++ + DI+R    +  K   ++ + + +  +K+L    L++  I Y++Y++L+ L Y H
Sbjct: 102 NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 161
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY----NVRVASRYFKGPELLV 292
           S  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE+++
Sbjct: 162 SANVLHRDLKPSNLLLNTTC-DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 220
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT---DELNAYLNKY 349
           + + Y  S+D+WS+GC+ A M+  + P F G    DQL  I  +LG+   ++LN  +N  
Sbjct: 221 NSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIIN-- 277
Query: 350 HLELDPQLDALVGRHSRKPWSK-FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 408
            L+    L +L  + ++ PW++ F NAD++      A+D LDK+L ++   R+   +A+A
Sbjct: 278 -LKARNYLLSLPHK-NKVPWNRLFPNADSK------ALDLLDKMLTFNPHKRIEVEQALA 329
Query: 409 HPYFAQ 414
           HPY  Q
Sbjct: 330 HPYLEQ 335

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score =  118 bits (295), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 76/246 (30%), Positives = 143/246 (58%), Gaps = 24/246 (9%)
Query: 181 NVVKLLDIVRD---QHSKTPSLIFEYVNSTDFKVLYPT-LTDYDIRYYIYELLKALDYCH 236
           N++ + DI+R    +  K   ++ + + +  +K+L    L++  I Y++Y++L+ L Y H
Sbjct: 86  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 145
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY----NVRVASRYFKGPELLV 292
           S  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE+++
Sbjct: 146 SANVLHRDLKPSNLLLN-TTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT---DELNAYLNKY 349
           + + Y  S+D+WS+GC+ A M+  + P F G    DQL  I  +LG+   ++LN  +N  
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIIN-- 261
Query: 350 HLELDPQLDALVGRHSRKPWSK-FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 408
            L+    L +L  + ++ PW++ F NAD++      A+D LDK+L ++   R+   +A+A
Sbjct: 262 -LKARNYLLSLPHK-NKVPWNRLFPNADSK------ALDLLDKMLTFNPHKRIEVEQALA 313
Query: 409 HPYFAQ 414
           HPY  Q
Sbjct: 314 HPYLEQ 319

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score =  118 bits (295), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 76/246 (30%), Positives = 143/246 (58%), Gaps = 24/246 (9%)
Query: 181 NVVKLLDIVRD---QHSKTPSLIFEYVNSTDFKVLYPT-LTDYDIRYYIYELLKALDYCH 236
           N++ + DI+R    +  K   ++ + + +  +K+L    L++  I Y++Y++L+ L Y H
Sbjct: 80  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 139
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY----NVRVASRYFKGPELLV 292
           S  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE+++
Sbjct: 140 SANVLHRDLKPSNLLLNTTC-DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 198
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT---DELNAYLNKY 349
           + + Y  S+D+WS+GC+ A M+  + P F G    DQL  I  +LG+   ++LN  +N  
Sbjct: 199 NSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIIN-- 255
Query: 350 HLELDPQLDALVGRHSRKPWSK-FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 408
            L+    L +L  + ++ PW++ F NAD++      A+D LDK+L ++   R+   +A+A
Sbjct: 256 -LKARNYLLSLPHK-NKVPWNRLFPNADSK------ALDLLDKMLTFNPHKRIEVEQALA 307
Query: 409 HPYFAQ 414
           HPY  Q
Sbjct: 308 HPYLEQ 313

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score =  118 bits (295), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 76/246 (30%), Positives = 143/246 (58%), Gaps = 24/246 (9%)
Query: 181 NVVKLLDIVRD---QHSKTPSLIFEYVNSTDFKVLYPT-LTDYDIRYYIYELLKALDYCH 236
           N++ + DI+R    +  K   ++ + + +  +K+L    L++  I Y++Y++L+ L Y H
Sbjct: 87  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 146
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY----NVRVASRYFKGPELLV 292
           S  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE+++
Sbjct: 147 SANVLHRDLKPSNLLLNTTC-DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 205
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT---DELNAYLNKY 349
           + + Y  S+D+WS+GC+ A M+  + P F G    DQL  I  +LG+   ++LN  +N  
Sbjct: 206 NSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIIN-- 262
Query: 350 HLELDPQLDALVGRHSRKPWSK-FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 408
            L+    L +L  + ++ PW++ F NAD++      A+D LDK+L ++   R+   +A+A
Sbjct: 263 -LKARNYLLSLPHK-NKVPWNRLFPNADSK------ALDLLDKMLTFNPHKRIEVEQALA 314
Query: 409 HPYFAQ 414
           HPY  Q
Sbjct: 315 HPYLEQ 320

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score =  118 bits (295), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 76/246 (30%), Positives = 143/246 (58%), Gaps = 24/246 (9%)
Query: 181 NVVKLLDIVRD---QHSKTPSLIFEYVNSTDFKVLYPT-LTDYDIRYYIYELLKALDYCH 236
           N++ + DI+R    +  K   ++ + + +  +K+L    L++  I Y++Y++L+ L Y H
Sbjct: 88  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 147
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY----NVRVASRYFKGPELLV 292
           S  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE+++
Sbjct: 148 SANVLHRDLKPSNLLLNTTC-DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 206
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT---DELNAYLNKY 349
           + + Y  S+D+WS+GC+ A M+  + P F G    DQL  I  +LG+   ++LN  +N  
Sbjct: 207 NSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIIN-- 263
Query: 350 HLELDPQLDALVGRHSRKPWSK-FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 408
            L+    L +L  + ++ PW++ F NAD++      A+D LDK+L ++   R+   +A+A
Sbjct: 264 -LKARNYLLSLPHK-NKVPWNRLFPNADSK------ALDLLDKMLTFNPHKRIEVEQALA 315
Query: 409 HPYFAQ 414
           HPY  Q
Sbjct: 316 HPYLEQ 321

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score =  118 bits (295), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 76/246 (30%), Positives = 143/246 (58%), Gaps = 24/246 (9%)
Query: 181 NVVKLLDIVRD---QHSKTPSLIFEYVNSTDFKVLYPT-LTDYDIRYYIYELLKALDYCH 236
           N++ + DI+R    +  K   ++ + + +  +K+L    L++  I Y++Y++L+ L Y H
Sbjct: 79  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 138
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY----NVRVASRYFKGPELLV 292
           S  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE+++
Sbjct: 139 SANVLHRDLKPSNLLLNTTC-DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 197
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT---DELNAYLNKY 349
           + + Y  S+D+WS+GC+ A M+  + P F G    DQL  I  +LG+   ++LN  +N  
Sbjct: 198 NSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIIN-- 254
Query: 350 HLELDPQLDALVGRHSRKPWSK-FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 408
            L+    L +L  + ++ PW++ F NAD++      A+D LDK+L ++   R+   +A+A
Sbjct: 255 -LKARNYLLSLPHK-NKVPWNRLFPNADSK------ALDLLDKMLTFNPHKRIEVEQALA 306
Query: 409 HPYFAQ 414
           HPY  Q
Sbjct: 307 HPYLEQ 312

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score =  118 bits (295), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 76/246 (30%), Positives = 143/246 (58%), Gaps = 24/246 (9%)
Query: 181 NVVKLLDIVRD---QHSKTPSLIFEYVNSTDFKVLYPT-LTDYDIRYYIYELLKALDYCH 236
           N++ + DI+R    +  K   ++ + + +  +K+L    L++  I Y++Y++L+ L Y H
Sbjct: 86  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 145
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY----NVRVASRYFKGPELLV 292
           S  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE+++
Sbjct: 146 SANVLHRDLKPSNLLLNTTC-DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT---DELNAYLNKY 349
           + + Y  S+D+WS+GC+ A M+  + P F G    DQL  I  +LG+   ++LN  +N  
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIIN-- 261
Query: 350 HLELDPQLDALVGRHSRKPWSK-FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 408
            L+    L +L  + ++ PW++ F NAD++      A+D LDK+L ++   R+   +A+A
Sbjct: 262 -LKARNYLLSLPHK-NKVPWNRLFPNADSK------ALDLLDKMLTFNPHKRIEVEQALA 313
Query: 409 HPYFAQ 414
           HPY  Q
Sbjct: 314 HPYLEQ 319

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score =  118 bits (295), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 76/246 (30%), Positives = 143/246 (58%), Gaps = 24/246 (9%)
Query: 181 NVVKLLDIVRD---QHSKTPSLIFEYVNSTDFKVLYPT-LTDYDIRYYIYELLKALDYCH 236
           N++ + DI+R    +  K   ++ + + +  +K+L    L++  I Y++Y++L+ L Y H
Sbjct: 82  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 141
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY----NVRVASRYFKGPELLV 292
           S  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE+++
Sbjct: 142 SANVLHRDLKPSNLLLNTTC-DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT---DELNAYLNKY 349
           + + Y  S+D+WS+GC+ A M+  + P F G    DQL  I  +LG+   ++LN  +N  
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIIN-- 257
Query: 350 HLELDPQLDALVGRHSRKPWSK-FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 408
            L+    L +L  + ++ PW++ F NAD++      A+D LDK+L ++   R+   +A+A
Sbjct: 258 -LKARNYLLSLPHK-NKVPWNRLFPNADSK------ALDLLDKMLTFNPHKRIEVEQALA 309
Query: 409 HPYFAQ 414
           HPY  Q
Sbjct: 310 HPYLEQ 315

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  118 bits (295), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 76/246 (30%), Positives = 143/246 (58%), Gaps = 24/246 (9%)
Query: 181 NVVKLLDIVRD---QHSKTPSLIFEYVNSTDFKVLYPT-LTDYDIRYYIYELLKALDYCH 236
           N++ + DI+R    +  K   ++ + + +  +K+L    L++  I Y++Y++L+ L Y H
Sbjct: 84  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 143
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY----NVRVASRYFKGPELLV 292
           S  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE+++
Sbjct: 144 SANVLHRDLKPSNLLLNTTC-DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 202
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT---DELNAYLNKY 349
           + + Y  S+D+WS+GC+ A M+  + P F G    DQL  I  +LG+   ++LN  +N  
Sbjct: 203 NSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIIN-- 259
Query: 350 HLELDPQLDALVGRHSRKPWSK-FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 408
            L+    L +L  + ++ PW++ F NAD++      A+D LDK+L ++   R+   +A+A
Sbjct: 260 -LKARNYLLSLPHK-NKVPWNRLFPNADSK------ALDLLDKMLTFNPHKRIEVEQALA 311
Query: 409 HPYFAQ 414
           HPY  Q
Sbjct: 312 HPYLEQ 317

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score =  118 bits (295), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 76/246 (30%), Positives = 143/246 (58%), Gaps = 24/246 (9%)
Query: 181 NVVKLLDIVRD---QHSKTPSLIFEYVNSTDFKVLYPT-LTDYDIRYYIYELLKALDYCH 236
           N++ + DI+R    +  K   ++ + + +  +K+L    L++  I Y++Y++L+ L Y H
Sbjct: 86  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 145
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY----NVRVASRYFKGPELLV 292
           S  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE+++
Sbjct: 146 SANVLHRDLKPSNLLLNTTC-DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT---DELNAYLNKY 349
           + + Y  S+D+WS+GC+ A M+  + P F G    DQL  I  +LG+   ++LN  +N  
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIIN-- 261
Query: 350 HLELDPQLDALVGRHSRKPWSK-FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 408
            L+    L +L  + ++ PW++ F NAD++      A+D LDK+L ++   R+   +A+A
Sbjct: 262 -LKARNYLLSLPHK-NKVPWNRLFPNADSK------ALDLLDKMLTFNPHKRIEVEQALA 313
Query: 409 HPYFAQ 414
           HPY  Q
Sbjct: 314 HPYLEQ 319

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score =  118 bits (295), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 76/246 (30%), Positives = 143/246 (58%), Gaps = 24/246 (9%)
Query: 181 NVVKLLDIVRD---QHSKTPSLIFEYVNSTDFKVLYPT-LTDYDIRYYIYELLKALDYCH 236
           N++ + DI+R    +  K   ++ + + +  +K+L    L++  I Y++Y++L+ L Y H
Sbjct: 90  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 149
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY----NVRVASRYFKGPELLV 292
           S  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE+++
Sbjct: 150 SANVLHRDLKPSNLLLNTTC-DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 208
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT---DELNAYLNKY 349
           + + Y  S+D+WS+GC+ A M+  + P F G    DQL  I  +LG+   ++LN  +N  
Sbjct: 209 NSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIIN-- 265
Query: 350 HLELDPQLDALVGRHSRKPWSK-FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 408
            L+    L +L  + ++ PW++ F NAD++      A+D LDK+L ++   R+   +A+A
Sbjct: 266 -LKARNYLLSLPHK-NKVPWNRLFPNADSK------ALDLLDKMLTFNPHKRIEVEQALA 317
Query: 409 HPYFAQ 414
           HPY  Q
Sbjct: 318 HPYLEQ 323

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score =  118 bits (295), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 76/246 (30%), Positives = 143/246 (58%), Gaps = 24/246 (9%)
Query: 181 NVVKLLDIVRD---QHSKTPSLIFEYVNSTDFKVLYPT-LTDYDIRYYIYELLKALDYCH 236
           N++ + DI+R    +  K   ++ + + +  +K+L    L++  I Y++Y++L+ L Y H
Sbjct: 82  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 141
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY----NVRVASRYFKGPELLV 292
           S  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE+++
Sbjct: 142 SANVLHRDLKPSNLLLNTTC-DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT---DELNAYLNKY 349
           + + Y  S+D+WS+GC+ A M+  + P F G    DQL  I  +LG+   ++LN  +N  
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIIN-- 257
Query: 350 HLELDPQLDALVGRHSRKPWSK-FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 408
            L+    L +L  + ++ PW++ F NAD++      A+D LDK+L ++   R+   +A+A
Sbjct: 258 -LKARNYLLSLPHK-NKVPWNRLFPNADSK------ALDLLDKMLTFNPHKRIEVEQALA 309
Query: 409 HPYFAQ 414
           HPY  Q
Sbjct: 310 HPYLEQ 315

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score =  118 bits (295), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 76/246 (30%), Positives = 143/246 (58%), Gaps = 24/246 (9%)
Query: 181 NVVKLLDIVRD---QHSKTPSLIFEYVNSTDFKVLYPT-LTDYDIRYYIYELLKALDYCH 236
           N++ + DI+R    +  K   ++ + + +  +K+L    L++  I Y++Y++L+ L Y H
Sbjct: 86  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 145
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY----NVRVASRYFKGPELLV 292
           S  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE+++
Sbjct: 146 SANVLHRDLKPSNLLLN-TTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT---DELNAYLNKY 349
           + + Y  S+D+WS+GC+ A M+  + P F G    DQL  I  +LG+   ++LN  +N  
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIIN-- 261
Query: 350 HLELDPQLDALVGRHSRKPWSK-FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 408
            L+    L +L  + ++ PW++ F NAD++      A+D LDK+L ++   R+   +A+A
Sbjct: 262 -LKARNYLLSLPHK-NKVPWNRLFPNADSK------ALDLLDKMLTFNPHKRIEVEQALA 313
Query: 409 HPYFAQ 414
           HPY  Q
Sbjct: 314 HPYLEQ 319

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score =  118 bits (295), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 89/320 (27%), Positives = 154/320 (48%), Gaps = 26/320 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 1   RPTFYRQELAKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSII 59
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 60  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCAKLT 119
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 120 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMT 176
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++
Sbjct: 177 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 235
Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKF--INADNQHL-VSPEAIDFLDKLLR 394
           GT            EL  ++ +   R+  +  ++   +N  N  +  +P A+D L+K+L 
Sbjct: 236 GTPG---------AELLKKISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLV 286
Query: 395 YDHQDRLTAREAMAHPYFAQ 414
            D   R+TA +A+AH YFAQ
Sbjct: 287 LDSDKRITAAQALAHAYFAQ 306

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score =  117 bits (294), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 76/246 (30%), Positives = 143/246 (58%), Gaps = 24/246 (9%)
Query: 181 NVVKLLDIVRD---QHSKTPSLIFEYVNSTDFKVLYPT-LTDYDIRYYIYELLKALDYCH 236
           N++ + DI+R    +  K   ++ + + +  +K+L    L++  I Y++Y++L+ L Y H
Sbjct: 82  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 141
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY----NVRVASRYFKGPELLV 292
           S  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE+++
Sbjct: 142 SANVLHRDLKPSNLLLN-TTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT---DELNAYLNKY 349
           + + Y  S+D+WS+GC+ A M+  + P F G    DQL  I  +LG+   ++LN  +N  
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNXIIN-- 257
Query: 350 HLELDPQLDALVGRHSRKPWSK-FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 408
            L+    L +L  + ++ PW++ F NAD++      A+D LDK+L ++   R+   +A+A
Sbjct: 258 -LKARNYLLSLPHK-NKVPWNRLFPNADSK------ALDLLDKMLTFNPHKRIEVEQALA 309
Query: 409 HPYFAQ 414
           HPY  Q
Sbjct: 310 HPYLEQ 315

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score =  117 bits (294), Expect = 9e-27,   Method: Compositional matrix adjust.
 Identities = 76/246 (30%), Positives = 143/246 (58%), Gaps = 24/246 (9%)
Query: 181 NVVKLLDIVRD---QHSKTPSLIFEYVNSTDFKVLYPT-LTDYDIRYYIYELLKALDYCH 236
           N++ + DI+R    +  K   ++ + + +  +K+L    L++  I Y++Y++L+ L Y H
Sbjct: 86  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYFLYQILRGLKYIH 145
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY----NVRVASRYFKGPELLV 292
           S  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE+++
Sbjct: 146 SANVLHRDLKPSNLLLNTTC-DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT---DELNAYLNKY 349
           + + Y  S+D+WS+GC+ A M+  + P F G    DQL  I  +LG+   ++LN  +N  
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIIN-- 261
Query: 350 HLELDPQLDALVGRHSRKPWSK-FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 408
            L+    L +L  + ++ PW++ F NAD++      A+D LDK+L ++   R+   +A+A
Sbjct: 262 -LKARNYLLSLPHK-NKVPWNRLFPNADSK------ALDLLDKMLTFNPHKRIEVEQALA 313
Query: 409 HPYFAQ 414
           HPY  Q
Sbjct: 314 HPYLEQ 319

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score =  117 bits (294), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 89/320 (27%), Positives = 154/320 (48%), Gaps = 26/320 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 12  RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 70
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 71  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 130
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 131 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTADEMT 187
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++
Sbjct: 188 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 246
Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKF--INADNQHL-VSPEAIDFLDKLLR 394
           GT            EL  ++ +   R+  +  ++   +N  N  +  +P A+D L+K+L 
Sbjct: 247 GTP---------GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLV 297
Query: 395 YDHQDRLTAREAMAHPYFAQ 414
            D   R+TA +A+AH YFAQ
Sbjct: 298 LDSDKRITAAQALAHAYFAQ 317

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score =  117 bits (294), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 89/320 (27%), Positives = 154/320 (48%), Gaps = 26/320 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 12  RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 70
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 71  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 130
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 131 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTADEMT 187
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++
Sbjct: 188 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 246
Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKF--INADNQHL-VSPEAIDFLDKLLR 394
           GT            EL  ++ +   R+  +  ++   +N  N  +  +P A+D L+K+L 
Sbjct: 247 GTP---------GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLV 297
Query: 395 YDHQDRLTAREAMAHPYFAQ 414
            D   R+TA +A+AH YFAQ
Sbjct: 298 LDSDKRITAAQALAHAYFAQ 317

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score =  117 bits (294), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 89/320 (27%), Positives = 154/320 (48%), Gaps = 26/320 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 12  RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 70
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 71  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 130
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 131 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTADEMT 187
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++
Sbjct: 188 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 246
Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKF--INADNQHL-VSPEAIDFLDKLLR 394
           GT            EL  ++ +   R+  +  ++   +N  N  +  +P A+D L+K+L 
Sbjct: 247 GTP---------GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLV 297
Query: 395 YDHQDRLTAREAMAHPYFAQ 414
            D   R+TA +A+AH YFAQ
Sbjct: 298 LDSDKRITAAQALAHAYFAQ 317

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score =  117 bits (294), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 76/246 (30%), Positives = 143/246 (58%), Gaps = 24/246 (9%)
Query: 181 NVVKLLDIVRD---QHSKTPSLIFEYVNSTDFKVLYPT-LTDYDIRYYIYELLKALDYCH 236
           N++ + DI+R    +  K   ++ + + +  +K+L    L++  I Y++Y++L+ L Y H
Sbjct: 82  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 141
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY----NVRVASRYFKGPELLV 292
           S  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE+++
Sbjct: 142 SANVLHRDLKPSNLLLN-TTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT---DELNAYLNKY 349
           + + Y  S+D+WS+GC+ A M+  + P F G    DQL  I  +LG+   ++LN  +N  
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNXIIN-- 257
Query: 350 HLELDPQLDALVGRHSRKPWSK-FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 408
            L+    L +L  + ++ PW++ F NAD++      A+D LDK+L ++   R+   +A+A
Sbjct: 258 -LKARNYLLSLPHK-NKVPWNRLFPNADSK------ALDLLDKMLTFNPHKRIEVEQALA 309
Query: 409 HPYFAQ 414
           HPY  Q
Sbjct: 310 HPYLEQ 315

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score =  117 bits (293), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 89/320 (27%), Positives = 154/320 (48%), Gaps = 26/320 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 1   RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSII 59
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 60  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 119
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 120 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMT 176
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++
Sbjct: 177 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 235
Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKF--INADNQHL-VSPEAIDFLDKLLR 394
           GT            EL  ++ +   R+  +  ++   +N  N  +  +P A+D L+K+L 
Sbjct: 236 GTPG---------AELLKKISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLV 286
Query: 395 YDHQDRLTAREAMAHPYFAQ 414
            D   R+TA +A+AH YFAQ
Sbjct: 287 LDSDKRITAAQALAHAYFAQ 306

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score =  117 bits (292), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 88/317 (27%), Positives = 147/317 (46%), Gaps = 20/317 (6%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 25  RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSII 83
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 84  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 143
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 144 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMX 200
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++
Sbjct: 201 GXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 259
Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDH 397
           GT                 + +L         + FI A+      P A+D L+K+L  D 
Sbjct: 260 GTPGAELLKKISSESARNYIQSLAQMPKMNFANVFIGAN------PLAVDLLEKMLVLDS 313
Query: 398 QDRLTAREAMAHPYFAQ 414
             R+TA +A+AH YFAQ
Sbjct: 314 DKRITAAQALAHAYFAQ 330

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score =  117 bits (292), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 88/317 (27%), Positives = 147/317 (46%), Gaps = 20/317 (6%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 24  RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSII 82
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 83  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 142
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 143 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMT 199
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++
Sbjct: 200 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 258
Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDH 397
           GT                 + +L         + FI A+      P A+D L+K+L  D 
Sbjct: 259 GTPGAELLKKISSESARNYIQSLAQMPKMNFANVFIGAN------PLAVDLLEKMLVLDS 312
Query: 398 QDRLTAREAMAHPYFAQ 414
             R+TA +A+AH YFAQ
Sbjct: 313 DKRITAAQALAHAYFAQ 329

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score =  117 bits (292), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 89/320 (27%), Positives = 154/320 (48%), Gaps = 26/320 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 5   RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 63
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMT 180
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++
Sbjct: 181 GXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 239
Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKF--INADNQHL-VSPEAIDFLDKLLR 394
           GT            EL  ++ +   R+  +  ++   +N  N  +  +P A+D L+K+L 
Sbjct: 240 GTP---------GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLV 290
Query: 395 YDHQDRLTAREAMAHPYFAQ 414
            D   R+TA +A+AH YFAQ
Sbjct: 291 LDSDKRITAAQALAHAYFAQ 310

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score =  117 bits (292), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 89/320 (27%), Positives = 154/320 (48%), Gaps = 26/320 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 11  RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSII 69
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 70  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 129
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 130 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMT 186
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++
Sbjct: 187 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 245
Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKF--INADNQHL-VSPEAIDFLDKLLR 394
           GT            EL  ++ +   R+  +  ++   +N  N  +  +P A+D L+K+L 
Sbjct: 246 GTPG---------AELLKKISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLV 296
Query: 395 YDHQDRLTAREAMAHPYFAQ 414
            D   R+TA +A+AH YFAQ
Sbjct: 297 LDSDKRITAAQALAHAYFAQ 316

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score =  117 bits (292), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 89/320 (27%), Positives = 154/320 (48%), Gaps = 26/320 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 5   RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 63
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMT 180
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++
Sbjct: 181 GYVATRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 239
Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKF--INADNQHL-VSPEAIDFLDKLLR 394
           GT            EL  ++ +   R+  +  ++   +N  N  +  +P A+D L+K+L 
Sbjct: 240 GTP---------GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLV 290
Query: 395 YDHQDRLTAREAMAHPYFAQ 414
            D   R+TA +A+AH YFAQ
Sbjct: 291 LDSDKRITAAQALAHAYFAQ 310

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score =  117 bits (292), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 89/320 (27%), Positives = 154/320 (48%), Gaps = 26/320 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 5   RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSII 63
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMT 180
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 239
Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKF--INADNQHL-VSPEAIDFLDKLLR 394
           GT            EL  ++ +   R+  +  ++   +N  N  +  +P A+D L+K+L 
Sbjct: 240 GTP---------GAELLKKISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLV 290
Query: 395 YDHQDRLTAREAMAHPYFAQ 414
            D   R+TA +A+AH YFAQ
Sbjct: 291 LDSDKRITAAQALAHAYFAQ 310

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score =  117 bits (292), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 88/317 (27%), Positives = 147/317 (46%), Gaps = 20/317 (6%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 25  RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSII 83
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 84  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 143
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 144 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMT 200
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++
Sbjct: 201 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 259
Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDH 397
           GT                 + +L         + FI A+      P A+D L+K+L  D 
Sbjct: 260 GTPGAELLKKISSESARNYIQSLAQMPKMNFANVFIGAN------PLAVDLLEKMLVLDS 313
Query: 398 QDRLTAREAMAHPYFAQ 414
             R+TA +A+AH YFAQ
Sbjct: 314 DKRITAAQALAHAYFAQ 330

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  117 bits (292), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 89/320 (27%), Positives = 154/320 (48%), Gaps = 26/320 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 5   RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 63
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLT 123
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMT 180
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 239
Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKF--INADNQHL-VSPEAIDFLDKLLR 394
           GT            EL  ++ +   R+  +  ++   +N  N  +  +P A+D L+K+L 
Sbjct: 240 GTP---------GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLV 290
Query: 395 YDHQDRLTAREAMAHPYFAQ 414
            D   R+TA +A+AH YFAQ
Sbjct: 291 LDSDKRITAAQALAHAYFAQ 310

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score =  117 bits (292), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 89/320 (27%), Positives = 154/320 (48%), Gaps = 26/320 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 1   RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 59
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 60  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 119
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 120 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMT 176
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++
Sbjct: 177 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 235
Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKF--INADNQHL-VSPEAIDFLDKLLR 394
           GT            EL  ++ +   R+  +  ++   +N  N  +  +P A+D L+K+L 
Sbjct: 236 GTP---------GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLV 286
Query: 395 YDHQDRLTAREAMAHPYFAQ 414
            D   R+TA +A+AH YFAQ
Sbjct: 287 LDSDKRITAAQALAHAYFAQ 306

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  117 bits (292), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 89/320 (27%), Positives = 154/320 (48%), Gaps = 26/320 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 5   RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 63
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLT 123
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED-XELKILDFGLAR--HTDDEMT 180
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 239
Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKF--INADNQHL-VSPEAIDFLDKLLR 394
           GT            EL  ++ +   R+  +  ++   +N  N  +  +P A+D L+K+L 
Sbjct: 240 GTP---------GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLV 290
Query: 395 YDHQDRLTAREAMAHPYFAQ 414
            D   R+TA +A+AH YFAQ
Sbjct: 291 LDSDKRITAAQALAHAYFAQ 310

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score =  117 bits (292), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 89/320 (27%), Positives = 154/320 (48%), Gaps = 26/320 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 1   RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSII 59
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 60  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 119
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 120 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMA 176
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++
Sbjct: 177 GFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 235
Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKF--INADNQHL-VSPEAIDFLDKLLR 394
           GT            EL  ++ +   R+  +  ++   +N  N  +  +P A+D L+K+L 
Sbjct: 236 GTPG---------AELLKKISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLV 286
Query: 395 YDHQDRLTAREAMAHPYFAQ 414
            D   R+TA +A+AH YFAQ
Sbjct: 287 LDSDKRITAAQALAHAYFAQ 306

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 89/320 (27%), Positives = 154/320 (48%), Gaps = 26/320 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 15  RPTFYRQELNKTI-WEVPERYQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSII 73
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 74  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 133
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 134 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMT 190
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++
Sbjct: 191 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 249
Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKF--INADNQHL-VSPEAIDFLDKLLR 394
           GT            EL  ++ +   R+  +  ++   +N  N  +  +P A+D L+K+L 
Sbjct: 250 GTP---------GAELLKKISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLV 300
Query: 395 YDHQDRLTAREAMAHPYFAQ 414
            D   R+TA +A+AH YFAQ
Sbjct: 301 LDSDKRITAAQALAHAYFAQ 320

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 89/320 (27%), Positives = 154/320 (48%), Gaps = 26/320 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 2   RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 60
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 61  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 120
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 121 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMT 177
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++
Sbjct: 178 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 236
Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKF--INADNQHL-VSPEAIDFLDKLLR 394
           GT            EL  ++ +   R+  +  ++   +N  N  +  +P A+D L+K+L 
Sbjct: 237 GTP---------GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLV 287
Query: 395 YDHQDRLTAREAMAHPYFAQ 414
            D   R+TA +A+AH YFAQ
Sbjct: 288 LDSDKRITAAQALAHAYFAQ 307

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 89/320 (27%), Positives = 154/320 (48%), Gaps = 26/320 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 5   RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 63
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMT 180
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 239
Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKF--INADNQHL-VSPEAIDFLDKLLR 394
           GT            EL  ++ +   R+  +  ++   +N  N  +  +P A+D L+K+L 
Sbjct: 240 GTP---------GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLV 290
Query: 395 YDHQDRLTAREAMAHPYFAQ 414
            D   R+TA +A+AH YFAQ
Sbjct: 291 LDSDKRITAAQALAHAYFAQ 310

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 89/320 (27%), Positives = 154/320 (48%), Gaps = 26/320 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 5   RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 63
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDYGLAR--HTDDEMT 180
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 239
Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKF--INADNQHL-VSPEAIDFLDKLLR 394
           GT            EL  ++ +   R+  +  ++   +N  N  +  +P A+D L+K+L 
Sbjct: 240 GTP---------GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLV 290
Query: 395 YDHQDRLTAREAMAHPYFAQ 414
            D   R+TA +A+AH YFAQ
Sbjct: 291 LDSDKRITAAQALAHAYFAQ 310

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 89/320 (27%), Positives = 154/320 (48%), Gaps = 26/320 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 10  RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 68
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 69  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 128
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 129 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMT 185
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++
Sbjct: 186 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 244
Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKF--INADNQHL-VSPEAIDFLDKLLR 394
           GT            EL  ++ +   R+  +  ++   +N  N  +  +P A+D L+K+L 
Sbjct: 245 GTP---------GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLV 295
Query: 395 YDHQDRLTAREAMAHPYFAQ 414
            D   R+TA +A+AH YFAQ
Sbjct: 296 LDSDKRITAAQALAHAYFAQ 315

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 89/320 (27%), Positives = 154/320 (48%), Gaps = 26/320 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 5   RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 63
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMT 180
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 239
Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKF--INADNQHL-VSPEAIDFLDKLLR 394
           GT            EL  ++ +   R+  +  ++   +N  N  +  +P A+D L+K+L 
Sbjct: 240 GTP---------GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLV 290
Query: 395 YDHQDRLTAREAMAHPYFAQ 414
            D   R+TA +A+AH YFAQ
Sbjct: 291 LDSDKRITAAQALAHAYFAQ 310

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 89/320 (27%), Positives = 154/320 (48%), Gaps = 26/320 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 3   RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 61
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 62  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 121
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 122 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMT 178
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++
Sbjct: 179 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 237
Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKF--INADNQHL-VSPEAIDFLDKLLR 394
           GT            EL  ++ +   R+  +  ++   +N  N  +  +P A+D L+K+L 
Sbjct: 238 GTP---------GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLV 288
Query: 395 YDHQDRLTAREAMAHPYFAQ 414
            D   R+TA +A+AH YFAQ
Sbjct: 289 LDSDKRITAAQALAHAYFAQ 308

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 89/320 (27%), Positives = 154/320 (48%), Gaps = 26/320 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 7   RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 65
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 66  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 125
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 126 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED-SELKILDFGLAR--HTDDEMT 182
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++
Sbjct: 183 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 241
Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKF--INADNQHL-VSPEAIDFLDKLLR 394
           GT            EL  ++ +   R+  +  ++   +N  N  +  +P A+D L+K+L 
Sbjct: 242 GTP---------GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLV 292
Query: 395 YDHQDRLTAREAMAHPYFAQ 414
            D   R+TA +A+AH YFAQ
Sbjct: 293 LDSDKRITAAQALAHAYFAQ 312

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 89/320 (27%), Positives = 154/320 (48%), Gaps = 26/320 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 12  RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 70
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 71  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 130
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 131 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMT 187
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++
Sbjct: 188 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 246
Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKF--INADNQHL-VSPEAIDFLDKLLR 394
           GT            EL  ++ +   R+  +  ++   +N  N  +  +P A+D L+K+L 
Sbjct: 247 GTP---------GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLV 297
Query: 395 YDHQDRLTAREAMAHPYFAQ 414
            D   R+TA +A+AH YFAQ
Sbjct: 298 LDSDKRITAAQALAHAYFAQ 317

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 89/320 (27%), Positives = 154/320 (48%), Gaps = 26/320 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXX 166
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 17  RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSII 75
Query: 167 XXXXX----XLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 76  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 135
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 136 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMT 192
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++
Sbjct: 193 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 251
Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKF--INADNQHL-VSPEAIDFLDKLLR 394
           GT            EL  ++ +   R+  +  ++   +N  N  +  +P A+D L+K+L 
Sbjct: 252 GTP---------GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLV 302
Query: 395 YDHQDRLTAREAMAHPYFAQ 414
            D   R+TA +A+AH YFAQ
Sbjct: 303 LDSDKRITAAQALAHAYFAQ 322

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 89/320 (27%), Positives = 154/320 (48%), Gaps = 26/320 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 5   RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 63
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMT 180
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 239
Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKF--INADNQHL-VSPEAIDFLDKLLR 394
           GT            EL  ++ +   R+  +  ++   +N  N  +  +P A+D L+K+L 
Sbjct: 240 GTP---------GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLV 290
Query: 395 YDHQDRLTAREAMAHPYFAQ 414
            D   R+TA +A+AH YFAQ
Sbjct: 291 LDSDKRITAAQALAHAYFAQ 310

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 89/320 (27%), Positives = 154/320 (48%), Gaps = 26/320 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 5   RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 63
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMT 180
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 239
Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKF--INADNQHL-VSPEAIDFLDKLLR 394
           GT            EL  ++ +   R+  +  ++   +N  N  +  +P A+D L+K+L 
Sbjct: 240 GTP---------GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLV 290
Query: 395 YDHQDRLTAREAMAHPYFAQ 414
            D   R+TA +A+AH YFAQ
Sbjct: 291 LDSDKRITAAQALAHAYFAQ 310

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 89/320 (27%), Positives = 154/320 (48%), Gaps = 26/320 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 11  RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 69
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 70  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 129
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 130 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED-SELKILDFGLAR--HTDDEMT 186
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++
Sbjct: 187 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 245
Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKF--INADNQHL-VSPEAIDFLDKLLR 394
           GT            EL  ++ +   R+  +  ++   +N  N  +  +P A+D L+K+L 
Sbjct: 246 GTP---------GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLV 296
Query: 395 YDHQDRLTAREAMAHPYFAQ 414
            D   R+TA +A+AH YFAQ
Sbjct: 297 LDSDKRITAAQALAHAYFAQ 316

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 89/320 (27%), Positives = 154/320 (48%), Gaps = 26/320 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 2   RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 60
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 61  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 120
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 121 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMT 177
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++
Sbjct: 178 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 236
Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKF--INADNQHL-VSPEAIDFLDKLLR 394
           GT            EL  ++ +   R+  +  ++   +N  N  +  +P A+D L+K+L 
Sbjct: 237 GTP---------GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLV 287
Query: 395 YDHQDRLTAREAMAHPYFAQ 414
            D   R+TA +A+AH YFAQ
Sbjct: 288 LDSDKRITAAQALAHAYFAQ 307

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 89/320 (27%), Positives = 154/320 (48%), Gaps = 26/320 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 17  RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 75
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 76  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 135
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 136 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMT 192
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++
Sbjct: 193 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 251
Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKF--INADNQHL-VSPEAIDFLDKLLR 394
           GT            EL  ++ +   R+  +  ++   +N  N  +  +P A+D L+K+L 
Sbjct: 252 GTP---------GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLV 302
Query: 395 YDHQDRLTAREAMAHPYFAQ 414
            D   R+TA +A+AH YFAQ
Sbjct: 303 LDSDKRITAAQALAHAYFAQ 322

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 89/320 (27%), Positives = 154/320 (48%), Gaps = 26/320 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 7   RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 65
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 66  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 125
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 126 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMT 182
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++
Sbjct: 183 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 241
Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKF--INADNQHL-VSPEAIDFLDKLLR 394
           GT            EL  ++ +   R+  +  ++   +N  N  +  +P A+D L+K+L 
Sbjct: 242 GTP---------GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLV 292
Query: 395 YDHQDRLTAREAMAHPYFAQ 414
            D   R+TA +A+AH YFAQ
Sbjct: 293 LDSDKRITAAQALAHAYFAQ 312

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 89/320 (27%), Positives = 154/320 (48%), Gaps = 26/320 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 17  RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 75
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 76  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 135
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 136 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMT 192
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++
Sbjct: 193 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 251
Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKF--INADNQHL-VSPEAIDFLDKLLR 394
           GT            EL  ++ +   R+  +  ++   +N  N  +  +P A+D L+K+L 
Sbjct: 252 GTP---------GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLV 302
Query: 395 YDHQDRLTAREAMAHPYFAQ 414
            D   R+TA +A+AH YFAQ
Sbjct: 303 LDSDKRITAAQALAHAYFAQ 322

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 88/317 (27%), Positives = 147/317 (46%), Gaps = 20/317 (6%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 24  RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 82
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 83  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 142
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 143 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMT 199
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++
Sbjct: 200 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 258
Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDH 397
           GT                 + +L         + FI A+      P A+D L+K+L  D 
Sbjct: 259 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGAN------PLAVDLLEKMLVLDS 312
Query: 398 QDRLTAREAMAHPYFAQ 414
             R+TA +A+AH YFAQ
Sbjct: 313 DKRITAAQALAHAYFAQ 329

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score =  116 bits (290), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 89/320 (27%), Positives = 154/320 (48%), Gaps = 26/320 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 10  RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 68
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 69  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 128
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 129 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMT 185
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++
Sbjct: 186 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 244
Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKF--INADNQHL-VSPEAIDFLDKLLR 394
           GT            EL  ++ +   R+  +  ++   +N  N  +  +P A+D L+K+L 
Sbjct: 245 GTP---------GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLV 295
Query: 395 YDHQDRLTAREAMAHPYFAQ 414
            D   R+TA +A+AH YFAQ
Sbjct: 296 LDSDKRITAAQALAHAYFAQ 315

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score =  116 bits (290), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 89/320 (27%), Positives = 154/320 (48%), Gaps = 26/320 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 4   RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 62
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 63  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 122
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 123 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMT 179
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++
Sbjct: 180 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 238
Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKF--INADNQHL-VSPEAIDFLDKLLR 394
           GT            EL  ++ +   R+  +  ++   +N  N  +  +P A+D L+K+L 
Sbjct: 239 GTP---------GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLV 289
Query: 395 YDHQDRLTAREAMAHPYFAQ 414
            D   R+TA +A+AH YFAQ
Sbjct: 290 LDSDKRITAAQALAHAYFAQ 309

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score =  116 bits (290), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 89/320 (27%), Positives = 154/320 (48%), Gaps = 26/320 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 5   RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 63
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMT 180
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 239
Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKF--INADNQHL-VSPEAIDFLDKLLR 394
           GT            EL  ++ +   R+  +  ++   +N  N  +  +P A+D L+K+L 
Sbjct: 240 GTP---------GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLV 290
Query: 395 YDHQDRLTAREAMAHPYFAQ 414
            D   R+TA +A+AH YFAQ
Sbjct: 291 LDSDKRITAAQALAHAYFAQ 310

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score =  116 bits (290), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 89/320 (27%), Positives = 154/320 (48%), Gaps = 26/320 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 16  RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 74
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 75  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 134
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 135 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED-XELKILDFGLAR--HTDDEMT 191
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++
Sbjct: 192 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 250
Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKF--INADNQHL-VSPEAIDFLDKLLR 394
           GT            EL  ++ +   R+  +  ++   +N  N  +  +P A+D L+K+L 
Sbjct: 251 GTP---------GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLV 301
Query: 395 YDHQDRLTAREAMAHPYFAQ 414
            D   R+TA +A+AH YFAQ
Sbjct: 302 LDSDKRITAAQALAHAYFAQ 321

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score =  116 bits (290), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 89/320 (27%), Positives = 154/320 (48%), Gaps = 26/320 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 7   RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 65
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 66  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 125
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 126 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMT 182
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++
Sbjct: 183 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 241
Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKF--INADNQHL-VSPEAIDFLDKLLR 394
           GT            EL  ++ +   R+  +  ++   +N  N  +  +P A+D L+K+L 
Sbjct: 242 GTP---------GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLV 292
Query: 395 YDHQDRLTAREAMAHPYFAQ 414
            D   R+TA +A+AH YFAQ
Sbjct: 293 LDSDKRITAAQALAHAYFAQ 312

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score =  116 bits (290), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 89/320 (27%), Positives = 154/320 (48%), Gaps = 26/320 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 7   RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 65
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 66  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 125
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 126 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMT 182
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++
Sbjct: 183 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 241
Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKF--INADNQHL-VSPEAIDFLDKLLR 394
           GT            EL  ++ +   R+  +  ++   +N  N  +  +P A+D L+K+L 
Sbjct: 242 GTP---------GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLV 292
Query: 395 YDHQDRLTAREAMAHPYFAQ 414
            D   R+TA +A+AH YFAQ
Sbjct: 293 LDSDKRITAAQALAHAYFAQ 312

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score =  116 bits (290), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 88/317 (27%), Positives = 147/317 (46%), Gaps = 20/317 (6%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 25  RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 83
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 84  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 143
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 144 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMT 200
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++
Sbjct: 201 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 259
Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDH 397
           GT                 + +L         + FI A+      P A+D L+K+L  D 
Sbjct: 260 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGAN------PLAVDLLEKMLVLDS 313
Query: 398 QDRLTAREAMAHPYFAQ 414
             R+TA +A+AH YFAQ
Sbjct: 314 DKRITAAQALAHAYFAQ 330

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score =  116 bits (290), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 89/320 (27%), Positives = 154/320 (48%), Gaps = 26/320 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 5   RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 63
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMT 180
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 239
Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKF--INADNQHL-VSPEAIDFLDKLLR 394
           GT            EL  ++ +   R+  +  ++   +N  N  +  +P A+D L+K+L 
Sbjct: 240 GTP---------GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLV 290
Query: 395 YDHQDRLTAREAMAHPYFAQ 414
            D   R+TA +A+AH YFAQ
Sbjct: 291 LDSDKRITAAQALAHAYFAQ 310

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score =  116 bits (290), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 89/320 (27%), Positives = 154/320 (48%), Gaps = 26/320 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 10  RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 68
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 69  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 128
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 129 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED-XELKILDFGLAR--HTDDEMT 185
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++
Sbjct: 186 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 244
Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKF--INADNQHL-VSPEAIDFLDKLLR 394
           GT            EL  ++ +   R+  +  ++   +N  N  +  +P A+D L+K+L 
Sbjct: 245 GTP---------GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLV 295
Query: 395 YDHQDRLTAREAMAHPYFAQ 414
            D   R+TA +A+AH YFAQ
Sbjct: 296 LDSDKRITAAQALAHAYFAQ 315

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score =  116 bits (290), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 89/320 (27%), Positives = 154/320 (48%), Gaps = 26/320 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 5   RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSII 63
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMA 180
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++
Sbjct: 181 GFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 239
Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKF--INADNQHL-VSPEAIDFLDKLLR 394
           GT            EL  ++ +   R+  +  ++   +N  N  +  +P A+D L+K+L 
Sbjct: 240 GTP---------GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLV 290
Query: 395 YDHQDRLTAREAMAHPYFAQ 414
            D   R+TA +A+AH YFAQ
Sbjct: 291 LDSDKRITAAQALAHAYFAQ 310

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score =  116 bits (290), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 88/317 (27%), Positives = 147/317 (46%), Gaps = 20/317 (6%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 5   RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSII 63
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMA 180
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++
Sbjct: 181 GFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 239
Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDH 397
           GT                 + +L         + FI A+      P A+D L+K+L  D 
Sbjct: 240 GTPGAELLKKISSESARNYIQSLAQMPKMNFANVFIGAN------PLAVDLLEKMLVLDS 293
Query: 398 QDRLTAREAMAHPYFAQ 414
             R+TA +A+AH YFAQ
Sbjct: 294 DKRITAAQALAHAYFAQ 310

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score =  116 bits (290), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 89/320 (27%), Positives = 154/320 (48%), Gaps = 26/320 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 28  RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 86
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 87  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 146
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 147 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMT 203
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++
Sbjct: 204 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 262
Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKF--INADNQHL-VSPEAIDFLDKLLR 394
           GT            EL  ++ +   R+  +  ++   +N  N  +  +P A+D L+K+L 
Sbjct: 263 GTP---------GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLV 313
Query: 395 YDHQDRLTAREAMAHPYFAQ 414
            D   R+TA +A+AH YFAQ
Sbjct: 314 LDSDKRITAAQALAHAYFAQ 333

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score =  116 bits (290), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 89/320 (27%), Positives = 154/320 (48%), Gaps = 26/320 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 5   RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 63
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMT 180
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 239
Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKF--INADNQHL-VSPEAIDFLDKLLR 394
           GT            EL  ++ +   R+  +  ++   +N  N  +  +P A+D L+K+L 
Sbjct: 240 GTP---------GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLV 290
Query: 395 YDHQDRLTAREAMAHPYFAQ 414
            D   R+TA +A+AH YFAQ
Sbjct: 291 LDSDKRITAAQALAHAYFAQ 310

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score =  116 bits (290), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 89/320 (27%), Positives = 154/320 (48%), Gaps = 26/320 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 16  RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 74
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 75  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 134
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 135 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMT 191
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++
Sbjct: 192 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 250
Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKF--INADNQHL-VSPEAIDFLDKLLR 394
           GT            EL  ++ +   R+  +  ++   +N  N  +  +P A+D L+K+L 
Sbjct: 251 GTP---------GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLV 301
Query: 395 YDHQDRLTAREAMAHPYFAQ 414
            D   R+TA +A+AH YFAQ
Sbjct: 302 LDSDKRITAAQALAHAYFAQ 321

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score =  116 bits (290), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 89/320 (27%), Positives = 154/320 (48%), Gaps = 26/320 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 11  RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 69
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 70  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 129
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 130 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMT 186
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++
Sbjct: 187 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 245
Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKF--INADNQHL-VSPEAIDFLDKLLR 394
           GT            EL  ++ +   R+  +  ++   +N  N  +  +P A+D L+K+L 
Sbjct: 246 GTP---------GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLV 296
Query: 395 YDHQDRLTAREAMAHPYFAQ 414
            D   R+TA +A+AH YFAQ
Sbjct: 297 LDSDKRITAAQALAHAYFAQ 316

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score =  116 bits (290), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 89/320 (27%), Positives = 154/320 (48%), Gaps = 26/320 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 11  RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 69
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 70  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 129
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 130 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMT 186
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++
Sbjct: 187 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 245
Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKF--INADNQHL-VSPEAIDFLDKLLR 394
           GT            EL  ++ +   R+  +  ++   +N  N  +  +P A+D L+K+L 
Sbjct: 246 GTPG---------AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLV 296
Query: 395 YDHQDRLTAREAMAHPYFAQ 414
            D   R+TA +A+AH YFAQ
Sbjct: 297 LDSDKRITAAQALAHAYFAQ 316

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score =  116 bits (290), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 89/320 (27%), Positives = 154/320 (48%), Gaps = 26/320 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 28  RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 86
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 87  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 146
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 147 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMX 203
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++
Sbjct: 204 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 262
Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKF--INADNQHL-VSPEAIDFLDKLLR 394
           GT            EL  ++ +   R+  +  ++   +N  N  +  +P A+D L+K+L 
Sbjct: 263 GTP---------GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLV 313
Query: 395 YDHQDRLTAREAMAHPYFAQ 414
            D   R+TA +A+AH YFAQ
Sbjct: 314 LDSDKRITAAQALAHAYFAQ 333

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score =  115 bits (289), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 88/320 (27%), Positives = 154/320 (48%), Gaps = 26/320 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  +G G Y  V    +  T  R              
Sbjct: 10  RPTFYRQELNKTI-WEVPERYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 68
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 69  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 128
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 129 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED-XELKILDFGLAR--HTDDEMT 185
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++
Sbjct: 186 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 244
Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKF--INADNQHL-VSPEAIDFLDKLLR 394
           GT            EL  ++ +   R+  +  ++   +N  N  +  +P A+D L+K+L 
Sbjct: 245 GTP---------GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLV 295
Query: 395 YDHQDRLTAREAMAHPYFAQ 414
            D   R+TA +A+AH YFAQ
Sbjct: 296 LDSDKRITAAQALAHAYFAQ 315

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  115 bits (288), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 89/320 (27%), Positives = 153/320 (47%), Gaps = 26/320 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 5   RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 63
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D GLA   H   E  
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDAGLAR--HTDDEMT 180
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 239
Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKF--INADNQHL-VSPEAIDFLDKLLR 394
           GT            EL  ++ +   R+  +  ++   +N  N  +  +P A+D L+K+L 
Sbjct: 240 GTP---------GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLV 290
Query: 395 YDHQDRLTAREAMAHPYFAQ 414
            D   R+TA +A+AH YFAQ
Sbjct: 291 LDSDKRITAAQALAHAYFAQ 310

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  115 bits (288), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 89/320 (27%), Positives = 153/320 (47%), Gaps = 26/320 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 5   RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 63
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D GLA   H   E  
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDGGLAR--HTDDEMT 180
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 239
Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKF--INADNQHL-VSPEAIDFLDKLLR 394
           GT            EL  ++ +   R+  +  ++   +N  N  +  +P A+D L+K+L 
Sbjct: 240 GTP---------GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLV 290
Query: 395 YDHQDRLTAREAMAHPYFAQ 414
            D   R+TA +A+AH YFAQ
Sbjct: 291 LDSDKRITAAQALAHAYFAQ 310

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score =  115 bits (287), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 87/320 (27%), Positives = 154/320 (48%), Gaps = 26/320 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 5   RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 63
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFKVLYPT--LT 217
                     L       NV+ LLD+    R         +  ++   D   +  +  LT
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKSQKLT 123
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GL    H   E  
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED-SELKILDFGLCR--HTDDEMT 180
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 239
Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKF--INADNQHL-VSPEAIDFLDKLLR 394
           GT            EL  ++ +   R+  +  ++   +N  N  +  +P A+D L+K+L 
Sbjct: 240 GTP---------GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLV 290
Query: 395 YDHQDRLTAREAMAHPYFAQ 414
            D   R+TA +A+AH YFAQ
Sbjct: 291 LDSDKRITAAQALAHAYFAQ 310

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score =  115 bits (287), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 80/253 (31%), Positives = 132/253 (52%), Gaps = 49/253 (19%)
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTD-------YDIRYYIYELLKALD 233
           N+V L DI+  + S T  L+FEY++    K L   L D       ++++ ++++LL+ L 
Sbjct: 61  NIVTLHDIIHTEKSLT--LVFEYLD----KDLKQYLDDCGNIINMHNVKLFLFQLLRGLA 114
Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELLV 292
           YCH Q ++HRD+KP N++I+ E  +L+L D+GLA     P K Y+  V + +++ P++L+
Sbjct: 115 YCHRQKVLHRDLKPQNLLIN-ERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILL 173
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT------------D 340
              DY   +DMW +GC+F  M   + P F G    +QL  I ++LGT            +
Sbjct: 174 GSTDYSTQIDMWGVGCIFYEMATGR-PLFPGSTVEEQLHFIFRILGTPTEETWPGILSNE 232
Query: 341 ELNAY-LNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQD 399
           E   Y   KY  E      AL+    R              +  +  D L KLL+++ ++
Sbjct: 233 EFKTYNYPKYRAE------ALLSHAPR--------------LDSDGADLLTKLLQFEGRN 272
Query: 400 RLTAREAMAHPYF 412
           R++A +AM HP+F
Sbjct: 273 RISAEDAMKHPFF 285

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  115 bits (287), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 89/320 (27%), Positives = 153/320 (47%), Gaps = 26/320 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 5   RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 63
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D GLA   H   E  
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDRGLAR--HTDDEMT 180
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 239
Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKF--INADNQHL-VSPEAIDFLDKLLR 394
           GT            EL  ++ +   R+  +  ++   +N  N  +  +P A+D L+K+L 
Sbjct: 240 GTP---------GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLV 290
Query: 395 YDHQDRLTAREAMAHPYFAQ 414
            D   R+TA +A+AH YFAQ
Sbjct: 291 LDSDKRITAAQALAHAYFAQ 310

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score =  115 bits (287), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 87/302 (28%), Positives = 145/302 (48%), Gaps = 32/302 (10%)
Query: 127 YEVVRKVGRGKYSEVFEGINVNTNE-------RCXXXXXXXXXXXXXXXXXXXLQNLCGG 179
           YE +  +G G+++ V++  + NTN+       +                    L      
Sbjct: 12  YEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSH 71
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYC 235
           PN++ LLD     H    SL+F+++  TD +V+       LT   I+ Y+   L+ L+Y 
Sbjct: 72  PNIIGLLDAF--GHKSNISLVFDFM-ETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYL 128
Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDL 294
           H   I+HRD+KP+N+++D E   L+L D+GLA+ F  P + Y  +V +R+++ PELL   
Sbjct: 129 HQHWILHRDLKPNNLLLD-ENGVLKLADFGLAKSFGSPNRAYXHQVVTRWYRAPELLFGA 187
Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 354
           + Y   +DMW++GC+ A ++ R  PF  G  + DQL +I + LGT     +         
Sbjct: 188 RMYGVGVDMWAVGCILAELLLRV-PFLPGDSDLDQLTRIFETLGTPTEEQW--------- 237
Query: 355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLD---KLLRYDHQDRLTAREAMAHPY 411
           P + +L    + K    F      H+ S    D LD    L  ++   R+TA +A+   Y
Sbjct: 238 PDMCSLPDYVTFK---SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKY 294
Query: 412 FA 413
           F+
Sbjct: 295 FS 296

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 88/320 (27%), Positives = 153/320 (47%), Gaps = 26/320 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 5   RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 63
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++ +GLA   H   E  
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILGFGLAR--HTDDEMT 180
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 239
Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKF--INADNQHL-VSPEAIDFLDKLLR 394
           GT            EL  ++ +   R+  +  ++   +N  N  +  +P A+D L+K+L 
Sbjct: 240 GTP---------GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLV 290
Query: 395 YDHQDRLTAREAMAHPYFAQ 414
            D   R+TA +A+AH YFAQ
Sbjct: 291 LDSDKRITAAQALAHAYFAQ 310

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 88/320 (27%), Positives = 153/320 (47%), Gaps = 26/320 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 5   RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSII 63
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+ LA   H   E  
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFYLAR--HTDDEMT 180
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 239
Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKF--INADNQHL-VSPEAIDFLDKLLR 394
           GT            EL  ++ +   R+  +  ++   +N  N  +  +P A+D L+K+L 
Sbjct: 240 GTP---------GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLV 290
Query: 395 YDHQDRLTAREAMAHPYFAQ 414
            D   R+TA +A+AH YFAQ
Sbjct: 291 LDSDKRITAAQALAHAYFAQ 310

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score =  112 bits (279), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 82/318 (25%), Positives = 153/318 (48%), Gaps = 31/318 (9%)
Query: 116 SLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXX----XXXXXXXXXX 171
           S  V +   D+YE++  +G G Y  V       T ++                       
Sbjct: 45  SFDVTFDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLREL 104
Query: 172 XLQNLCGGPNVVKLLDIVRDQ----HSKTPSLIFEYVNSTDFKVLYPT--LTDYDIRYYI 225
            +       N++ + DI+R        K+  ++ + + S   ++++ +  LT   +RY++
Sbjct: 105 KILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFL 164
Query: 226 YELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA--------EFYHPGKEYN 277
           Y+LL+ L Y HS  ++HRD+KP N++++    +L++ D+G+A        E  +   EY 
Sbjct: 165 YQLLRGLKYMHSAQVIHRDLKPSNLLVNENC-ELKIGDFGMARGLCTSPAEHQYFMTEY- 222
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             VA+R+++ PEL++ L +Y  ++D+WS+GC+F  M+ R++  F G +   QL  I  VL
Sbjct: 223 --VATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ-LFPGKNYVHQLQLIMMVL 279
Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPW-SKFINADNQHLVSPEAIDFLDKLLRYD 396
           GT             +   + +L  R    PW + +  AD Q      A+  L ++LR++
Sbjct: 280 GTPSPAVIQAVGAERVRAYIQSLPPRQP-VPWETVYPGADRQ------ALSLLGRMLRFE 332
Query: 397 HQDRLTAREAMAHPYFAQ 414
              R++A  A+ HP+ A+
Sbjct: 333 PSARISAAAALRHPFLAK 350

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score =  111 bits (278), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 82/318 (25%), Positives = 153/318 (48%), Gaps = 31/318 (9%)
Query: 116 SLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXX----XXXXXXXXXX 171
           S  V +   D+YE++  +G G Y  V       T ++                       
Sbjct: 46  SFDVTFDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLREL 105
Query: 172 XLQNLCGGPNVVKLLDIVRDQ----HSKTPSLIFEYVNSTDFKVLYPT--LTDYDIRYYI 225
            +       N++ + DI+R        K+  ++ + + S   ++++ +  LT   +RY++
Sbjct: 106 KILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFL 165
Query: 226 YELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA--------EFYHPGKEYN 277
           Y+LL+ L Y HS  ++HRD+KP N++++    +L++ D+G+A        E  +   EY 
Sbjct: 166 YQLLRGLKYMHSAQVIHRDLKPSNLLVNENC-ELKIGDFGMARGLCTSPAEHQYFMTEY- 223
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             VA+R+++ PEL++ L +Y  ++D+WS+GC+F  M+ R++  F G +   QL  I  VL
Sbjct: 224 --VATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ-LFPGKNYVHQLQLIMMVL 280
Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPW-SKFINADNQHLVSPEAIDFLDKLLRYD 396
           GT             +   + +L  R    PW + +  AD Q      A+  L ++LR++
Sbjct: 281 GTPSPAVIQAVGAERVRAYIQSLPPRQP-VPWETVYPGADRQ------ALSLLGRMLRFE 333
Query: 397 HQDRLTAREAMAHPYFAQ 414
              R++A  A+ HP+ A+
Sbjct: 334 PSARISAAAALRHPFLAK 351

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score =  111 bits (277), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 81/302 (26%), Positives = 143/302 (47%), Gaps = 23/302 (7%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNE-----RCXXXXXXXXXXXXXXXXXXXLQNLCGG 179
           D Y  + K+G G Y EV++ I+  TNE     R                    L+ L   
Sbjct: 34  DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHR 93
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL--YPTLTDYDIRYYIYELLKALDYCHS 237
            N+++L  ++   H+    LIFEY  +   K +   P ++   I+ ++Y+L+  +++CHS
Sbjct: 94  -NIIELKSVI--HHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHS 150
Query: 238 QGIMHRDVKPHNVMID----HELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLV 292
           +  +HRD+KP N+++      E   L++ D+GLA  F  P +++   + + +++ PE+L+
Sbjct: 151 RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILL 210
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE 352
             + Y  S+D+WS+ C++A M+  K P F G    DQL KI +VLG  +   +     L 
Sbjct: 211 GSRHYSTSVDIWSIACIWAEMLM-KTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTAL- 268
Query: 353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 412
             P       +   K   + + A                +L  D   R++A+ A+ HPYF
Sbjct: 269 --PDWKQSFPKFRGKTLKRVLGALLDDEGLDLLT----AMLEMDPVKRISAKNALEHPYF 322
Query: 413 AQ 414
           + 
Sbjct: 323 SH 324

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score =  108 bits (270), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 88/313 (28%), Positives = 144/313 (46%), Gaps = 38/313 (12%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNE-----RCXXXXXXXXXXXXXXXXXXXLQNLCGG 179
           + YE + K+G G Y  VF+  N +T +     +                    L+ L   
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQL-KH 61
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALDYCH 236
           PN+V LL++ R +  +   L+FEY + T    L      + ++ ++   ++ L+A+++CH
Sbjct: 62  PNLVNLLEVFRRK--RRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH 119
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY-HPGKEYNVRVASRYFKGPELLVDLQ 295
               +HRDVKP N++I      ++L D+G A     P   Y+  VA+R+++ PELLV   
Sbjct: 120 KHNCIHRDVKPENILITKH-SVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDT 178
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLG--------TDELNAYLN 347
            Y   +D+W++GC+FA ++    P + G  + DQL  I K LG            N Y +
Sbjct: 179 QYGPPVDVWAIGCVFAELL-SGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFS 237
Query: 348 KYHLELDPQLDALVGRHSRKPWS-KFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA 406
              +  DP+          +P   KF N      +S  A+  L   L  D  +RLT  + 
Sbjct: 238 GVKIP-DPE--------DMEPLELKFPN------ISYPALGLLKGCLHMDPTERLTCEQL 282
Query: 407 MAHPYFAQVRAAE 419
           + HPYF  +R  E
Sbjct: 283 LHHPYFENIREIE 295

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 86/318 (27%), Positives = 148/318 (46%), Gaps = 26/318 (8%)
Query: 114 YESLTVQWGDQ-DDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXX----XXX 168
           Y+S+   + D+   YE + K+G+G + EVF+  +  T ++                    
Sbjct: 6   YDSVECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITAL 65
Query: 169 XXXXLQNLCGGPNVVKLLDIVRDQHS------KTPSLIFEYVNSTDFKVLYPTLTDY--- 219
               +  L    NVV L++I R + S       +  L+F++       +L   L  +   
Sbjct: 66  REIKILQLLKHENVVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLS 125
Query: 220 DIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE---- 275
           +I+  +  LL  L Y H   I+HRD+K  NV+I  +   L+L D+GLA  +   K     
Sbjct: 126 EIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRD-GVLKLADFGLARAFSLAKNSQPN 184
Query: 276 -YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 334
            Y  RV + +++ PELL+  +DY   +D+W  GC+ A M + + P   G+    QL  I+
Sbjct: 185 RYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEM-WTRSPIMQGNTEQHQLALIS 243
Query: 335 KVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLR 394
           ++ G+     + N  + EL  +L+ LV    RK   +       ++  P A+D +DKLL 
Sbjct: 244 QLCGSITPEVWPNVDNYELYEKLE-LVKGQKRKVKDRL----KAYVRDPYALDLIDKLLV 298
Query: 395 YDHQDRLTAREAMAHPYF 412
            D   R+ + +A+ H +F
Sbjct: 299 LDPAQRIDSDDALNHDFF 316

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score =  105 bits (263), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 86/318 (27%), Positives = 148/318 (46%), Gaps = 26/318 (8%)
Query: 114 YESLTVQWGDQ-DDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXX----XXX 168
           Y+S+   + D+   YE + K+G+G + EVF+  +  T ++                    
Sbjct: 6   YDSVECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITAL 65
Query: 169 XXXXLQNLCGGPNVVKLLDIVRDQHS------KTPSLIFEYVNSTDFKVLYPTLTDY--- 219
               +  L    NVV L++I R + S       +  L+F++       +L   L  +   
Sbjct: 66  REIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLS 125
Query: 220 DIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE---- 275
           +I+  +  LL  L Y H   I+HRD+K  NV+I  +   L+L D+GLA  +   K     
Sbjct: 126 EIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRD-GVLKLADFGLARAFSLAKNSQPN 184
Query: 276 -YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 334
            Y  RV + +++ PELL+  +DY   +D+W  GC+ A M + + P   G+    QL  I+
Sbjct: 185 RYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEM-WTRSPIMQGNTEQHQLALIS 243
Query: 335 KVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLR 394
           ++ G+     + N  + EL  +L+ LV    RK   +       ++  P A+D +DKLL 
Sbjct: 244 QLCGSITPEVWPNVDNYELYEKLE-LVKGQKRKVKDRL----KAYVRDPYALDLIDKLLV 298
Query: 395 YDHQDRLTAREAMAHPYF 412
            D   R+ + +A+ H +F
Sbjct: 299 LDPAQRIDSDDALNHDFF 316

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 86/318 (27%), Positives = 148/318 (46%), Gaps = 26/318 (8%)
Query: 114 YESLTVQWGDQ-DDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXX----XXX 168
           Y+S+   + D+   YE + K+G+G + EVF+  +  T ++                    
Sbjct: 5   YDSVECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITAL 64
Query: 169 XXXXLQNLCGGPNVVKLLDIVRDQHS------KTPSLIFEYVNSTDFKVLYPTLTDY--- 219
               +  L    NVV L++I R + S       +  L+F++       +L   L  +   
Sbjct: 65  REIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLS 124
Query: 220 DIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE---- 275
           +I+  +  LL  L Y H   I+HRD+K  NV+I  +   L+L D+GLA  +   K     
Sbjct: 125 EIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRD-GVLKLADFGLARAFSLAKNSQPN 183
Query: 276 -YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 334
            Y  RV + +++ PELL+  +DY   +D+W  GC+ A M + + P   G+    QL  I+
Sbjct: 184 RYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEM-WTRSPIMQGNTEQHQLALIS 242
Query: 335 KVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLR 394
           ++ G+     + N  + EL  +L+ LV    RK   +       ++  P A+D +DKLL 
Sbjct: 243 QLCGSITPEVWPNVDNYELYEKLE-LVKGQKRKVKDRL----KAYVRDPYALDLIDKLLV 297
Query: 395 YDHQDRLTAREAMAHPYF 412
            D   R+ + +A+ H +F
Sbjct: 298 LDPAQRIDSDDALNHDFF 315

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 86/318 (27%), Positives = 148/318 (46%), Gaps = 26/318 (8%)
Query: 114 YESLTVQWGDQ-DDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXX----XXX 168
           Y+S+   + D+   YE + K+G+G + EVF+  +  T ++                    
Sbjct: 6   YDSVECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITAL 65
Query: 169 XXXXLQNLCGGPNVVKLLDIVRDQHS------KTPSLIFEYVNSTDFKVLYPTLTDY--- 219
               +  L    NVV L++I R + S       +  L+F++       +L   L  +   
Sbjct: 66  REIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLS 125
Query: 220 DIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE---- 275
           +I+  +  LL  L Y H   I+HRD+K  NV+I  +   L+L D+GLA  +   K     
Sbjct: 126 EIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRD-GVLKLADFGLARAFSLAKNSQPN 184
Query: 276 -YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 334
            Y  RV + +++ PELL+  +DY   +D+W  GC+ A M + + P   G+    QL  I+
Sbjct: 185 RYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEM-WTRSPIMQGNTEQHQLALIS 243
Query: 335 KVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLR 394
           ++ G+     + N  + EL  +L+ LV    RK   +       ++  P A+D +DKLL 
Sbjct: 244 QLCGSITPEVWPNVDNYELYEKLE-LVKGQKRKVKDRL----KAYVRDPYALDLIDKLLV 298
Query: 395 YDHQDRLTAREAMAHPYF 412
            D   R+ + +A+ H +F
Sbjct: 299 LDPAQRIDSDDALNHDFF 316

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score =  105 bits (262), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 77/248 (31%), Positives = 122/248 (49%), Gaps = 24/248 (9%)
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNST--DFKVLYPTLTDYDI-RYYIYELLKALDYCHS 237
           N+V LL++ + +  K   L+FE+V+ T  D   L+P   DY + + Y+++++  + +CHS
Sbjct: 85  NLVNLLEVCKKK--KRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHS 142
Query: 238 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQD 296
             I+HRD+KP N+++      ++L D+G A     PG+ Y+  VA+R+++ PELLV    
Sbjct: 143 HNIIHRDIKPENILVSQS-GVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVK 201
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ 356
           Y  ++D+W++GC+   M F  EP F G  + DQL  I   LG       L   H EL  +
Sbjct: 202 YGKAVDVWAIGCLVTEM-FMGEPLFPGDSDIDQLYHIMMCLGN------LIPRHQELFNK 254
Query: 357 LDALVGRH-----SRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 411
                G        R+P  +         +S   ID   K L  D   R    E + H +
Sbjct: 255 NPVFAGVRLPEIKEREPLER-----RYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDF 309
Query: 412 FAQVRAAE 419
           F     AE
Sbjct: 310 FQMDGFAE 317

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score =  105 bits (261), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 112/226 (49%), Gaps = 20/226 (8%)
Query: 200 IFEYVNSTDFKVLYPT--LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELR 257
           I + +  TD   +  T  L+D  I+Y+IY+ L+A+   H   ++HRD+KP N++I+    
Sbjct: 91  IIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNC- 149
Query: 258 KLRLIDWGLAEFYHPGKEYNVR-----------VASRYFKGPELLVDLQDYDYSLDMWSL 306
            L++ D+GLA         N             VA+R+++ PE+++    Y  ++D+WS 
Sbjct: 150 DLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVATRWYRAPEVMLTSAKYSRAMDVWSC 209
Query: 307 GCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSR 366
           GC+ A +  R+ P F G D   QL+ I  ++GT   +  L         +    +  +  
Sbjct: 210 GCILAELFLRR-PIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPA 268
Query: 367 KPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 412
            P  K         V+P+ ID L ++L +D   R+TA+EA+ HPY 
Sbjct: 269 APLEKMFPR-----VNPKGIDLLQRMLVFDPAKRITAKEALEHPYL 309

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score =  105 bits (261), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 112/226 (49%), Gaps = 20/226 (8%)
Query: 200 IFEYVNSTDFKVLYPT--LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELR 257
           I + +  TD   +  T  L+D  I+Y+IY+ L+A+   H   ++HRD+KP N++I+    
Sbjct: 91  IIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNC- 149
Query: 258 KLRLIDWGLAEFYHPGKEYNVR-----------VASRYFKGPELLVDLQDYDYSLDMWSL 306
            L++ D+GLA         N             VA+R+++ PE+++    Y  ++D+WS 
Sbjct: 150 DLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSC 209
Query: 307 GCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSR 366
           GC+ A +  R+ P F G D   QL+ I  ++GT   +  L         +    +  +  
Sbjct: 210 GCILAELFLRR-PIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPA 268
Query: 367 KPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 412
            P  K         V+P+ ID L ++L +D   R+TA+EA+ HPY 
Sbjct: 269 APLEKMFPR-----VNPKGIDLLQRMLVFDPAKRITAKEALEHPYL 309

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score =  104 bits (260), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 112/226 (49%), Gaps = 20/226 (8%)
Query: 200 IFEYVNSTDFKVLYPT--LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELR 257
           I + +  TD   +  T  L+D  I+Y+IY+ L+A+   H   ++HRD+KP N++I+    
Sbjct: 91  IIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNC- 149
Query: 258 KLRLIDWGLAEFYHPGKEYNVR-----------VASRYFKGPELLVDLQDYDYSLDMWSL 306
            L++ D+GLA         N             VA+R+++ PE+++    Y  ++D+WS 
Sbjct: 150 DLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVATRWYRAPEVMLTSAKYSRAMDVWSC 209
Query: 307 GCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSR 366
           GC+ A +  R+ P F G D   QL+ I  ++GT   +  L         +    +  +  
Sbjct: 210 GCILAELFLRR-PIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPA 268
Query: 367 KPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 412
            P  K         V+P+ ID L ++L +D   R+TA+EA+ HPY 
Sbjct: 269 APLEKMFPR-----VNPKGIDLLQRMLVFDPAKRITAKEALEHPYL 309

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score =  104 bits (260), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 112/203 (55%), Gaps = 26/203 (12%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R ++Y+LL+ L Y HS  ++HRD+KP N+ I+ E   L++ D+GLA    P   +   ++
Sbjct: 123 RLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLS 182
Query: 282 ----SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
               +++++ P LL+   +Y  ++DMW+ GC+FA M+  K  F   H    +L ++  +L
Sbjct: 183 EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAH----ELEQMQLIL 238
Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSR-------KPWSKFINADNQHLVSPEAIDFLD 390
            +      +   H E   +L +++  + R       KP ++ +       +S EA+DFL+
Sbjct: 239 ES------IPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPG-----ISREAVDFLE 287
Query: 391 KLLRYDHQDRLTAREAMAHPYFA 413
           ++L +   DRLTA EA++HPY +
Sbjct: 288 QILTFSPMDRLTAEEALSHPYMS 310

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 68/246 (27%), Positives = 125/246 (50%), Gaps = 22/246 (8%)
Query: 181 NVVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           N++ LL++   Q S    +   ++ E +++   +V+   L    + Y +Y++L  + + H
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
           S GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  
Sbjct: 144 SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPEVVTRYYRAPEVILGM-G 201
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ 356
           Y  ++D+WS+GC+   MI +    F G D+ DQ  K+ + LGT        ++  +L P 
Sbjct: 202 YKENVDIWSVGCIMGEMI-KGGVLFPGTDHIDQWNKVIEQLGTP-----CPEFMKKLQPT 255
Query: 357 LDALVGRHSRKPWSKF--------INADNQH--LVSPEAIDFLDKLLRYDHQDRLTAREA 406
           +   V    +     F          AD++H  L + +A D L K+L  D   R++  EA
Sbjct: 256 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNALKASQARDLLSKMLVIDASKRISVDEA 315
Query: 407 MAHPYF 412
           + HPY 
Sbjct: 316 LQHPYI 321

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score =  102 bits (253), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 70/246 (28%), Positives = 125/246 (50%), Gaps = 22/246 (8%)
Query: 181 NVVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           N++ LL++   Q S    +   ++ E +++   +V+   L    + Y +Y++L  + + H
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
           S GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  
Sbjct: 144 SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMEPEVVTRYYRAPEVILGM-G 201
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ 356
           Y  ++D+WS+GC+   M+  K   F G D  DQ  K+ + LGT    A++ K    L P 
Sbjct: 202 YKENVDIWSVGCIMGEMVCHK-ILFPGRDYIDQWNKVIEQLGT-PCPAFMKK----LQPT 255
Query: 357 LDALVGRHSRKPWSKF--------INADNQH--LVSPEAIDFLDKLLRYDHQDRLTAREA 406
           +   V    +     F          AD++H  L + +A D L K+L  D   R++  EA
Sbjct: 256 VRNYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 315
Query: 407 MAHPYF 412
           + HPY 
Sbjct: 316 LQHPYI 321

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 68/246 (27%), Positives = 124/246 (50%), Gaps = 22/246 (8%)
Query: 181 NVVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           N++ LL++   Q S    +   ++ E +++   +V+   L    + Y +Y++L  + + H
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
           S GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  
Sbjct: 144 SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMEPEVVTRYYRAPEVILGM-G 201
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ 356
           Y  ++D+WS+GC+   M+  K   F G D  DQ  K+ + LGT        ++  +L P 
Sbjct: 202 YKENVDLWSVGCIMGEMVCHK-ILFPGRDYIDQWNKVIEQLGTP-----CPEFMKKLQPT 255
Query: 357 LDALVGRHSRKPWSKF--------INADNQH--LVSPEAIDFLDKLLRYDHQDRLTAREA 406
           +   V    +     F          AD++H  L + +A D L K+L  D   R++  EA
Sbjct: 256 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 315
Query: 407 MAHPYF 412
           + HPY 
Sbjct: 316 LQHPYI 321

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score =  101 bits (252), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 65/242 (26%), Positives = 124/242 (51%), Gaps = 12/242 (4%)
Query: 181 NVVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           N++ LL++   Q +    +   L+ E +++   +V++  L    + Y +Y++L  + + H
Sbjct: 82  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLH 141
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
           S GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  
Sbjct: 142 SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTASTNFMMTPYVVTRYYRAPEVILGM-G 199
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT--DELNAYLN---KYHL 351
           Y  ++D+WS+GC+  G + +    F G D+ DQ  K+ + LGT   E  A L    + ++
Sbjct: 200 YKENVDIWSVGCIM-GELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQPTVRNYV 258
Query: 352 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 411
           E  P    +        W     ++   + + +A D L K+L  D   R++  EA+ HPY
Sbjct: 259 ENRPAYPGIAFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDEALRHPY 318
Query: 412 FA 413
Sbjct: 319 IT 320

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  101 bits (251), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 69/254 (27%), Positives = 127/254 (50%), Gaps = 22/254 (8%)
Query: 173 LQNLCGGPNVVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYEL 228
           L  +    N++ LL++   Q S    +   ++ E +++   +V+   L    + Y +Y++
Sbjct: 76  LMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQM 135
Query: 229 LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 288
           L  + + HS GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ P
Sbjct: 136 LVGIKHLHSAGIIHRDLKPSNIVVKSD-ATLKILDFGLARTAGTSFMMTPYVVTRYYRAP 194
Query: 289 ELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK 348
           E+++ +  Y  ++D+WS+GC+   MI +    F G D+ DQ  K+ + LGT        +
Sbjct: 195 EVILGM-GYKENVDIWSVGCIMGEMI-KGGVLFPGTDHIDQWNKVIEQLGTPS-----PE 247
Query: 349 YHLELDPQLDALVGRHSRKPWSKF--------INADNQH--LVSPEAIDFLDKLLRYDHQ 398
           +  +L P +   V    +     F          AD++H  L + +A D L K+L  D  
Sbjct: 248 FMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDAS 307
Query: 399 DRLTAREAMAHPYF 412
            R++  EA+ HPY 
Sbjct: 308 KRISVDEALQHPYI 321

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 68/246 (27%), Positives = 125/246 (50%), Gaps = 22/246 (8%)
Query: 181 NVVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           N++ LL++   Q S    +   ++ E +++   +V+   L    + Y +Y++L  + + H
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
           S GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  
Sbjct: 144 SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-G 201
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ 356
           Y  ++D+WS+GC+   MI +    F G D+ DQ  K+ + LGT        ++  +L P 
Sbjct: 202 YKENVDIWSVGCIMGEMI-KGGVLFPGTDHIDQWNKVIEQLGTP-----CPEFMKKLQPT 255
Query: 357 LDALVGRHSRKPWSKF--------INADNQH--LVSPEAIDFLDKLLRYDHQDRLTAREA 406
           +   V    +     F          AD++H  L + +A D L K+L  D   R++  EA
Sbjct: 256 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 315
Query: 407 MAHPYF 412
           + HPY 
Sbjct: 316 LQHPYI 321

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 69/254 (27%), Positives = 127/254 (50%), Gaps = 22/254 (8%)
Query: 173 LQNLCGGPNVVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYEL 228
           L  +    N++ LL++   Q S    +   ++ E +++   +V+   L    + Y +Y++
Sbjct: 76  LMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQM 135
Query: 229 LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 288
           L  + + HS GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ P
Sbjct: 136 LCGIKHLHSAGIIHRDLKPSNIVVKSD-ATLKILDFGLARTAGTSFMMTPYVVTRYYRAP 194
Query: 289 ELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK 348
           E+++ +  Y  ++D+WS+GC+   MI +    F G D+ DQ  K+ + LGT        +
Sbjct: 195 EVILGM-GYKENVDIWSVGCIMGEMI-KGGVLFPGTDHIDQWNKVIEQLGTPS-----PE 247
Query: 349 YHLELDPQLDALVGRHSRKPWSKF--------INADNQH--LVSPEAIDFLDKLLRYDHQ 398
           +  +L P +   V    +     F          AD++H  L + +A D L K+L  D  
Sbjct: 248 FMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDAS 307
Query: 399 DRLTAREAMAHPYF 412
            R++  EA+ HPY 
Sbjct: 308 KRISVDEALQHPYI 321

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 68/246 (27%), Positives = 125/246 (50%), Gaps = 22/246 (8%)
Query: 181 NVVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           N++ LL++   Q S    +   ++ E +++   +V+   L    + Y +Y++L  + + H
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
           S GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  
Sbjct: 144 SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-G 201
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ 356
           Y  ++D+WS+GC+   MI +    F G D+ DQ  K+ + LGT        ++  +L P 
Sbjct: 202 YKENVDIWSVGCIMGEMI-KGGVLFPGTDHIDQWNKVIEQLGTPS-----PEFMKKLQPT 255
Query: 357 LDALVGRHSRKPWSKF--------INADNQH--LVSPEAIDFLDKLLRYDHQDRLTAREA 406
           +   V    +     F          AD++H  L + +A D L K+L  D   R++  EA
Sbjct: 256 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 315
Query: 407 MAHPYF 412
           + HPY 
Sbjct: 316 LQHPYI 321

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 68/246 (27%), Positives = 125/246 (50%), Gaps = 22/246 (8%)
Query: 181 NVVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           N++ LL++   Q S    +   ++ E +++   +V+   L    + Y +Y++L  + + H
Sbjct: 85  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 144
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
           S GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  
Sbjct: 145 SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-G 202
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ 356
           Y  ++D+WS+GC+   MI +    F G D+ DQ  K+ + LGT        ++  +L P 
Sbjct: 203 YKENVDIWSVGCIMGEMI-KGGVLFPGTDHIDQWNKVIEQLGTP-----CPEFMKKLQPT 256
Query: 357 LDALVGRHSRKPWSKF--------INADNQH--LVSPEAIDFLDKLLRYDHQDRLTAREA 406
           +   V    +     F          AD++H  L + +A D L K+L  D   R++  EA
Sbjct: 257 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 316
Query: 407 MAHPYF 412
           + HPY 
Sbjct: 317 LQHPYI 322

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 68/246 (27%), Positives = 124/246 (50%), Gaps = 22/246 (8%)
Query: 181 NVVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           N++ LL++   Q S    +   ++ E +++   +V+   L    + Y +Y++L  + + H
Sbjct: 89  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 148
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
           S GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  
Sbjct: 149 SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-G 206
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ 356
           Y  ++D+WS+GC+   M+  K   F G D  DQ  K+ + LGT        ++  +L P 
Sbjct: 207 YKENVDLWSVGCIMGEMVCHK-ILFPGRDYIDQWNKVIEQLGTP-----CPEFMKKLQPT 260
Query: 357 LDALVGRHSRKPWSKF--------INADNQH--LVSPEAIDFLDKLLRYDHQDRLTAREA 406
           +   V    +     F          AD++H  L + +A D L K+L  D   R++  EA
Sbjct: 261 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 320
Query: 407 MAHPYF 412
           + HPY 
Sbjct: 321 LQHPYI 326

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 68/246 (27%), Positives = 125/246 (50%), Gaps = 22/246 (8%)
Query: 181 NVVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           N++ LL++   Q S    +   ++ E +++   +V+   L    + Y +Y++L  + + H
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
           S GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  
Sbjct: 144 SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-G 201
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ 356
           Y  ++D+WS+GC+   MI +    F G D+ DQ  K+ + LGT        ++  +L P 
Sbjct: 202 YKENVDIWSVGCIMGEMI-KGGVLFPGTDHIDQWNKVIEQLGTPS-----PEFMKKLQPT 255
Query: 357 LDALVGRHSRKPWSKF--------INADNQH--LVSPEAIDFLDKLLRYDHQDRLTAREA 406
           +   V    +     F          AD++H  L + +A D L K+L  D   R++  EA
Sbjct: 256 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 315
Query: 407 MAHPYF 412
           + HPY 
Sbjct: 316 LQHPYI 321

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 68/246 (27%), Positives = 124/246 (50%), Gaps = 22/246 (8%)
Query: 181 NVVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           N++ LL++   Q S    +   ++ E +++   +V+   L    + Y +Y++L  + + H
Sbjct: 78  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 137
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
           S GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  
Sbjct: 138 SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-G 195
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ 356
           Y  ++D+WS+GC+   M+  K   F G D  DQ  K+ + LGT        ++  +L P 
Sbjct: 196 YKENVDLWSVGCIMGEMVCHK-ILFPGRDYIDQWNKVIEQLGTP-----CPEFMKKLQPT 249
Query: 357 LDALVGRHSRKPWSKF--------INADNQH--LVSPEAIDFLDKLLRYDHQDRLTAREA 406
           +   V    +     F          AD++H  L + +A D L K+L  D   R++  EA
Sbjct: 250 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 309
Query: 407 MAHPYF 412
           + HPY 
Sbjct: 310 LQHPYI 315

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 68/246 (27%), Positives = 125/246 (50%), Gaps = 22/246 (8%)
Query: 181 NVVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           N++ LL++   Q S    +   ++ E +++   +V+   L    + Y +Y++L  + + H
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
           S GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  
Sbjct: 144 SAGIIHRDLKPSNIVVKSD-ATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-G 201
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ 356
           Y  ++D+WS+GC+   MI +    F G D+ DQ  K+ + LGT        ++  +L P 
Sbjct: 202 YKENVDIWSVGCIMGEMI-KGGVLFPGTDHIDQWNKVIEQLGTPS-----PEFMKKLQPT 255
Query: 357 LDALVGRHSRKPWSKF--------INADNQH--LVSPEAIDFLDKLLRYDHQDRLTAREA 406
           +   V    +     F          AD++H  L + +A D L K+L  D   R++  EA
Sbjct: 256 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 315
Query: 407 MAHPYF 412
           + HPY 
Sbjct: 316 LQHPYI 321

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 65/247 (26%), Positives = 124/247 (50%), Gaps = 22/247 (8%)
Query: 181 NVVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           N++ LL++   Q +    +   L+ E +++   +V++  L    + Y +Y++L  + + H
Sbjct: 84  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLH 143
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
           S GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  
Sbjct: 144 SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGM-G 201
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ 356
           Y  ++D+WS+GC+  G + +    F G D+ DQ  K+ + LGT        ++   L P 
Sbjct: 202 YAANVDIWSVGCIM-GELVKGCVIFQGTDHIDQWNKVIEQLGTPS-----AEFMAALQPT 255
Query: 357 LDALVGRHSRKPWSKF----------INADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA 406
           +   V    + P  KF            ++   + + +A D L K+L  D   R++  EA
Sbjct: 256 VRNYVENRPKYPGIKFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDEA 315
Query: 407 MAHPYFA 413
           + HPY  
Sbjct: 316 LRHPYIT 322

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 68/246 (27%), Positives = 125/246 (50%), Gaps = 22/246 (8%)
Query: 181 NVVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           N++ LL++   Q S    +   ++ E +++   +V+   L    + Y +Y++L  + + H
Sbjct: 86  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 145
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
           S GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  
Sbjct: 146 SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMVPFVVTRYYRAPEVILGM-G 203
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ 356
           Y  ++D+WS+GC+   MI +    F G D+ DQ  K+ + LGT        ++  +L P 
Sbjct: 204 YKENVDIWSVGCIMGEMI-KGGVLFPGTDHIDQWNKVIEQLGTP-----CPEFMKKLQPT 257
Query: 357 LDALVGRHSRKPWSKF--------INADNQH--LVSPEAIDFLDKLLRYDHQDRLTAREA 406
           +   V    +     F          AD++H  L + +A D L K+L  D   R++  EA
Sbjct: 258 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 317
Query: 407 MAHPYF 412
           + HPY 
Sbjct: 318 LQHPYI 323

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 91/361 (25%), Positives = 153/361 (42%), Gaps = 64/361 (17%)
Query: 121 WGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQ-----N 175
           W   D YE+   +G G Y  V E  +    +R                    L+     N
Sbjct: 49  WQIPDRYEIRHLIGTGSYGHVCEAYD-KLEKRVVAIKKILRVFEDLIDCKRILREIAILN 107
Query: 176 LCGGPNVVKLLDIV--RDQHSKTPSLIFEYVNSTDFKVLYPT---LTDYDIRYYIYELLK 230
                +VVK+LDIV  +D        +   +  +DFK L+ T   LT+  I+  +Y LL 
Sbjct: 108 RLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLV 167
Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE---------------------- 268
            + Y HS GI+HRD+KP N +++ +   +++ D+GLA                       
Sbjct: 168 GVKYVHSAGILHRDLKPANCLVNQDC-SVKVCDFGLARTVDYPENGNSQLPISPREDDMN 226
Query: 269 ---FYHP---GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI-------- 314
              F H     ++    V +R+++ PEL++  ++Y  ++D+WS+GC+FA ++        
Sbjct: 227 LVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVA 286
Query: 315 --FRKEPFFYGHD----NHDQLV----KIAKVLGTDELNAYLNKYHLELDPQLDALVGRH 364
               + P F G      + DQ      K       D+LN   N      +  ++AL    
Sbjct: 287 YHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKED 346
Query: 365 SRKPWSKFINADNQHLV------SPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA 418
           +++    F   +   L       S +AI  L ++L ++   R+T  E +AHP+F +VR A
Sbjct: 347 AKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIA 406
Query: 419 E 419
           E
Sbjct: 407 E 407

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 67/246 (27%), Positives = 125/246 (50%), Gaps = 22/246 (8%)
Query: 181 NVVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           N++ LL++   Q +    +   L+ E +++   +V+   L    + Y +Y++L  + + H
Sbjct: 84  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGIKHLH 143
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
           S GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  
Sbjct: 144 SAGIIHRDLKPSNIVVKSD-XTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-G 201
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ 356
           Y  ++D+WS+GC+   M+ R +  F G D  DQ  K+ + LGT        ++  +L P 
Sbjct: 202 YKENVDIWSVGCIMGEMV-RHKILFPGRDYIDQWNKVIEQLGTP-----CPEFMKKLQPT 255
Query: 357 LDALVGRHSRKPWSKF--------INADNQH--LVSPEAIDFLDKLLRYDHQDRLTAREA 406
           +   V    +     F          AD++H  L + +A D L K+L  D   R++  +A
Sbjct: 256 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 315
Query: 407 MAHPYF 412
           + HPY 
Sbjct: 316 LQHPYI 321

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 67/246 (27%), Positives = 125/246 (50%), Gaps = 22/246 (8%)
Query: 181 NVVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           N++ LL++   Q +    +   L+ E +++   +V+   L    + Y +Y++L  + + H
Sbjct: 77  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGIKHLH 136
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
           S GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  
Sbjct: 137 SAGIIHRDLKPSNIVVKSD-XTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-G 194
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ 356
           Y  ++D+WS+GC+   M+ R +  F G D  DQ  K+ + LGT        ++  +L P 
Sbjct: 195 YKENVDIWSVGCIMGEMV-RHKILFPGRDYIDQWNKVIEQLGTP-----CPEFMKKLQPT 248
Query: 357 LDALVGRHSRKPWSKF--------INADNQH--LVSPEAIDFLDKLLRYDHQDRLTAREA 406
           +   V    +     F          AD++H  L + +A D L K+L  D   R++  +A
Sbjct: 249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 308
Query: 407 MAHPYF 412
           + HPY 
Sbjct: 309 LQHPYI 314

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 67/246 (27%), Positives = 125/246 (50%), Gaps = 22/246 (8%)
Query: 181 NVVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           N++ LL++   Q +    +   L+ E +++   +V+   L    + Y +Y++L  + + H
Sbjct: 84  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGIKHLH 143
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
           S GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  
Sbjct: 144 SAGIIHRDLKPSNIVVKSD-XTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-G 201
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ 356
           Y  ++D+WS+GC+   M+ R +  F G D  DQ  K+ + LGT        ++  +L P 
Sbjct: 202 YKENVDIWSVGCIMGEMV-RHKILFPGRDYIDQWNKVIEQLGTP-----CPEFMKKLQPT 255
Query: 357 LDALVGRHSRKPWSKF--------INADNQH--LVSPEAIDFLDKLLRYDHQDRLTAREA 406
           +   V    +     F          AD++H  L + +A D L K+L  D   R++  +A
Sbjct: 256 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 315
Query: 407 MAHPYF 412
           + HPY 
Sbjct: 316 LQHPYI 321

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 67/246 (27%), Positives = 125/246 (50%), Gaps = 22/246 (8%)
Query: 181 NVVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           N++ LL++   Q +    +   L+ E +++   +V+   L    + Y +Y++L  + + H
Sbjct: 122 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 181
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
           S GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  
Sbjct: 182 SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-G 239
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ 356
           Y  ++D+WS+GC+   M+ R +  F G D  DQ  K+ + LGT        ++  +L P 
Sbjct: 240 YKENVDIWSVGCIMGEMV-RHKILFPGRDYIDQWNKVIEQLGTP-----CPEFMKKLQPT 293
Query: 357 LDALVGRHSRKPWSKF--------INADNQH--LVSPEAIDFLDKLLRYDHQDRLTAREA 406
           +   V    +     F          AD++H  L + +A D L K+L  D   R++  +A
Sbjct: 294 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 353
Query: 407 MAHPYF 412
           + HPY 
Sbjct: 354 LQHPYI 359

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 99.0 bits (245), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 67/246 (27%), Positives = 125/246 (50%), Gaps = 22/246 (8%)
Query: 181 NVVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           N++ LL++   Q +    +   L+ E +++   +V+   L    + Y +Y++L  + + H
Sbjct: 85  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 144
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
           S GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  
Sbjct: 145 SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-G 202
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ 356
           Y  ++D+WS+GC+   M+ R +  F G D  DQ  K+ + LGT        ++  +L P 
Sbjct: 203 YKENVDIWSVGCIMGEMV-RHKILFPGRDYIDQWNKVIEQLGTP-----CPEFMKKLQPT 256
Query: 357 LDALVGRHSRKPWSKF--------INADNQH--LVSPEAIDFLDKLLRYDHQDRLTAREA 406
           +   V    +     F          AD++H  L + +A D L K+L  D   R++  +A
Sbjct: 257 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 316
Query: 407 MAHPYF 412
           + HPY 
Sbjct: 317 LQHPYI 322

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 99.0 bits (245), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 67/246 (27%), Positives = 125/246 (50%), Gaps = 22/246 (8%)
Query: 181 NVVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           N++ LL++   Q +    +   L+ E +++   +V+   L    + Y +Y++L  + + H
Sbjct: 84  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
           S GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  
Sbjct: 144 SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-G 201
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ 356
           Y  ++D+WS+GC+   M+ R +  F G D  DQ  K+ + LGT        ++  +L P 
Sbjct: 202 YKENVDIWSVGCIMGEMV-RHKILFPGRDYIDQWNKVIEQLGTP-----CPEFMKKLQPT 255
Query: 357 LDALVGRHSRKPWSKF--------INADNQH--LVSPEAIDFLDKLLRYDHQDRLTAREA 406
           +   V    +     F          AD++H  L + +A D L K+L  D   R++  +A
Sbjct: 256 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 315
Query: 407 MAHPYF 412
           + HPY 
Sbjct: 316 LQHPYI 321

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 99.0 bits (245), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 67/246 (27%), Positives = 125/246 (50%), Gaps = 22/246 (8%)
Query: 181 NVVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           N++ LL++   Q +    +   L+ E +++   +V+   L    + Y +Y++L  + + H
Sbjct: 78  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 137
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
           S GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  
Sbjct: 138 SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-G 195
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ 356
           Y  ++D+WS+GC+   M+ R +  F G D  DQ  K+ + LGT        ++  +L P 
Sbjct: 196 YKENVDIWSVGCIMGEMV-RHKILFPGRDYIDQWNKVIEQLGTP-----CPEFMKKLQPT 249
Query: 357 LDALVGRHSRKPWSKF--------INADNQH--LVSPEAIDFLDKLLRYDHQDRLTAREA 406
           +   V    +     F          AD++H  L + +A D L K+L  D   R++  +A
Sbjct: 250 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 309
Query: 407 MAHPYF 412
           + HPY 
Sbjct: 310 LQHPYI 315

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 67/246 (27%), Positives = 125/246 (50%), Gaps = 22/246 (8%)
Query: 181 NVVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           N++ LL++   Q +    +   L+ E +++   +V+   L    + Y +Y++L  + + H
Sbjct: 85  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 144
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
           S GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  
Sbjct: 145 SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-G 202
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ 356
           Y  ++D+WS+GC+   M+ R +  F G D  DQ  K+ + LGT        ++  +L P 
Sbjct: 203 YKENVDIWSVGCIMGEMV-RHKILFPGRDYIDQWNKVIEQLGTP-----CPEFMKKLQPT 256
Query: 357 LDALVGRHSRKPWSKF--------INADNQH--LVSPEAIDFLDKLLRYDHQDRLTAREA 406
           +   V    +     F          AD++H  L + +A D L K+L  D   R++  +A
Sbjct: 257 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 316
Query: 407 MAHPYF 412
           + HPY 
Sbjct: 317 LQHPYI 322

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 67/246 (27%), Positives = 125/246 (50%), Gaps = 22/246 (8%)
Query: 181 NVVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           N++ LL++   Q +    +   L+ E +++   +V+   L    + Y +Y++L  + + H
Sbjct: 77  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 136
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
           S GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  
Sbjct: 137 SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-G 194
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ 356
           Y  ++D+WS+GC+   M+ R +  F G D  DQ  K+ + LGT        ++  +L P 
Sbjct: 195 YKENVDIWSVGCIMGEMV-RHKILFPGRDYIDQWNKVIEQLGTP-----CPEFMKKLQPT 248
Query: 357 LDALVGRHSRKPWSKF--------INADNQH--LVSPEAIDFLDKLLRYDHQDRLTAREA 406
           +   V    +     F          AD++H  L + +A D L K+L  D   R++  +A
Sbjct: 249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 308
Query: 407 MAHPYF 412
           + HPY 
Sbjct: 309 LQHPYI 314

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 67/246 (27%), Positives = 125/246 (50%), Gaps = 22/246 (8%)
Query: 181 NVVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           N++ LL++   Q +    +   L+ E +++   +V+   L    + Y +Y++L  + + H
Sbjct: 84  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
           S GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  
Sbjct: 144 SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-G 201
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ 356
           Y  ++D+WS+GC+   M+ R +  F G D  DQ  K+ + LGT        ++  +L P 
Sbjct: 202 YKENVDIWSVGCIMGEMV-RHKILFPGRDYIDQWNKVIEQLGTP-----CPEFMKKLQPT 255
Query: 357 LDALVGRHSRKPWSKF--------INADNQH--LVSPEAIDFLDKLLRYDHQDRLTAREA 406
           +   V    +     F          AD++H  L + +A D L K+L  D   R++  +A
Sbjct: 256 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 315
Query: 407 MAHPYF 412
           + HPY 
Sbjct: 316 LQHPYI 321

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 67/246 (27%), Positives = 125/246 (50%), Gaps = 22/246 (8%)
Query: 181 NVVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           N++ LL++   Q +    +   L+ E +++   +V+   L    + Y +Y++L  + + H
Sbjct: 78  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 137
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
           S GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  
Sbjct: 138 SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-G 195
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ 356
           Y  ++D+WS+GC+   M+ R +  F G D  DQ  K+ + LGT        ++  +L P 
Sbjct: 196 YKENVDIWSVGCIMGEMV-RHKILFPGRDYIDQWNKVIEQLGTP-----CPEFMKKLQPT 249
Query: 357 LDALVGRHSRKPWSKF--------INADNQH--LVSPEAIDFLDKLLRYDHQDRLTAREA 406
           +   V    +     F          AD++H  L + +A D L K+L  D   R++  +A
Sbjct: 250 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 309
Query: 407 MAHPYF 412
           + HPY 
Sbjct: 310 LQHPYI 315

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 98.6 bits (244), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 67/246 (27%), Positives = 125/246 (50%), Gaps = 22/246 (8%)
Query: 181 NVVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           N++ LL++   Q +    +   L+ E +++   +V+   L    + Y +Y++L  + + H
Sbjct: 122 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 181
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
           S GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  
Sbjct: 182 SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-G 239
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ 356
           Y  ++D+WS+GC+   M+ R +  F G D  DQ  K+ + LGT        ++  +L P 
Sbjct: 240 YKENVDIWSVGCIMGEMV-RHKILFPGRDYIDQWNKVIEQLGTP-----CPEFMKKLQPT 293
Query: 357 LDALVGRHSRKPWSKF--------INADNQH--LVSPEAIDFLDKLLRYDHQDRLTAREA 406
           +   V    +     F          AD++H  L + +A D L K+L  D   R++  +A
Sbjct: 294 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 353
Query: 407 MAHPYF 412
           + HPY 
Sbjct: 354 LQHPYI 359

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 98.6 bits (244), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 67/246 (27%), Positives = 125/246 (50%), Gaps = 22/246 (8%)
Query: 181 NVVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           N++ LL++   Q +    +   L+ E +++   +V+   L    + Y +Y++L  + + H
Sbjct: 83  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 142
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
           S GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  
Sbjct: 143 SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-G 200
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ 356
           Y  ++D+WS+GC+   M+ R +  F G D  DQ  K+ + LGT        ++  +L P 
Sbjct: 201 YKENVDIWSVGCIMGEMV-RHKILFPGRDYIDQWNKVIEQLGTP-----CPEFMKKLQPT 254
Query: 357 LDALVGRHSRKPWSKF--------INADNQH--LVSPEAIDFLDKLLRYDHQDRLTAREA 406
           +   V    +     F          AD++H  L + +A D L K+L  D   R++  +A
Sbjct: 255 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 314
Query: 407 MAHPYF 412
           + HPY 
Sbjct: 315 LQHPYI 320

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 98.2 bits (243), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 57/167 (34%), Positives = 94/167 (56%), Gaps = 12/167 (7%)
Query: 180 PNVVKLLDIV---RDQHSKTPSLIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKA 231
           PNVV+L+D+    R       +L+FE+V+  D +        P L    I+  + + L+ 
Sbjct: 66  PNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRG 124
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 291
           LD+ H+  I+HRD+KP N+++      ++L D+GLA  Y      +  V + +++ PE+L
Sbjct: 125 LDFLHANCIVHRDLKPENILVTSG-GTVKLADFGLARIYSYQMALDPVVVTLWYRAPEVL 183
Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLG 338
           +    Y   +DMWS+GC+FA M FR++P F G+   DQL KI  ++G
Sbjct: 184 LQ-STYATPVDMWSVGCIFAEM-FRRKPLFCGNSEADQLGKIFDLIG 228

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 98.2 bits (243), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 67/246 (27%), Positives = 125/246 (50%), Gaps = 22/246 (8%)
Query: 181 NVVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           N++ LL++   Q +    +   L+ E +++   +V+   L    + Y +Y++L  + + H
Sbjct: 84  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
           S GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  
Sbjct: 144 SAGIIHRDLKPSNIVVKSD-XTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-G 201
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ 356
           Y  ++D+WS+GC+   M+ R +  F G D  DQ  K+ + LGT        ++  +L P 
Sbjct: 202 YKENVDIWSVGCIMGEMV-RHKILFPGRDYIDQWNKVIEQLGTP-----CPEFMKKLQPT 255
Query: 357 LDALVGRHSRKPWSKF--------INADNQH--LVSPEAIDFLDKLLRYDHQDRLTAREA 406
           +   V    +     F          AD++H  L + +A D L K+L  D   R++  +A
Sbjct: 256 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 315
Query: 407 MAHPYF 412
           + HPY 
Sbjct: 316 LQHPYI 321

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 98.2 bits (243), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 58/167 (34%), Positives = 93/167 (55%), Gaps = 12/167 (7%)
Query: 180 PNVVKLLDIV---RDQHSKTPSLIFEYVNSTDF-----KVLYPTLTDYDIRYYIYELLKA 231
           PNVV+L+D+    R       +L+FE+V+  D      K   P L    I+  + + L+ 
Sbjct: 74  PNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRG 132
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 291
           LD+ H+  I+HRD+KP N+++      ++L D+GLA  Y         V + +++ PE+L
Sbjct: 133 LDFLHANCIVHRDLKPENILVTSG-GTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVL 191
Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLG 338
           +    Y   +DMWS+GC+FA M FR++P F G+   DQL KI  ++G
Sbjct: 192 LQ-STYATPVDMWSVGCIFAEM-FRRKPLFCGNSEADQLGKIFDLIG 236

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 98.2 bits (243), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 67/246 (27%), Positives = 125/246 (50%), Gaps = 22/246 (8%)
Query: 181 NVVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           N++ LL++   Q +    +   L+ E +++   +V+   L    + Y +Y++L  + + H
Sbjct: 84  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
           S GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  
Sbjct: 144 SAGIIHRDLKPSNIVVKSD-XTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-G 201
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ 356
           Y  ++D+WS+GC+   M+ R +  F G D  DQ  K+ + LGT        ++  +L P 
Sbjct: 202 YKENVDIWSVGCIMGEMV-RHKILFPGRDYIDQWNKVIEQLGTP-----CPEFMKKLQPT 255
Query: 357 LDALVGRHSRKPWSKF--------INADNQH--LVSPEAIDFLDKLLRYDHQDRLTAREA 406
           +   V    +     F          AD++H  L + +A D L K+L  D   R++  +A
Sbjct: 256 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 315
Query: 407 MAHPYF 412
           + HPY 
Sbjct: 316 LQHPYI 321

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 84/349 (24%), Positives = 147/349 (42%), Gaps = 59/349 (16%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXX----XXXXXXXXLQNLCGGP 180
           D+YE+   +GRG Y  V+   + N N+                         + N     
Sbjct: 28  DNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNRLKSD 87
Query: 181 NVVKLLDIV--RDQHSKTPSLIFEYVNSTDFKVLYPT---LTDYDIRYYIYELLKALDYC 235
            +++L D++   D        I   +  +D K L+ T   LT+  ++  +Y LL    + 
Sbjct: 88  YIIRLHDLIIPEDLLKFDELYIVLEIADSDLKKLFKTPIFLTEQHVKTILYNLLLGEKFI 147
Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-------------------PG--- 273
           H  GI+HRD+KP N +++ +   +++ D+GLA   +                   PG   
Sbjct: 148 HESGIIHRDLKPANCLLNQDC-SVKICDFGLARTINSDKDIHIVNDLEEKEENEEPGPHN 206
Query: 274 ----KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI----------FRKEP 319
               K+    V +R+++ PEL++  ++Y  S+D+WS GC+FA ++            + P
Sbjct: 207 KNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELLNMMKSHINNPTNRFP 266
Query: 320 FFYGHD------NHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFI 373
            F G        +H+   K+ +    D+LN   N      +  L  +  +   K    F 
Sbjct: 267 LFPGSSCFPLSPDHNS-KKVHEKSNRDQLNIIFNVIGTPPEEDLKCITKQEVIKYIKLFP 325
Query: 374 NADNQHL------VSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR 416
             D   L      +S E ID L+ +LR++ Q R+T  +A++HPY   VR
Sbjct: 326 TRDGIDLSKKYSSISKEGIDLLESMLRFNAQKRITIDKALSHPYLKDVR 374

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 68/254 (26%), Positives = 126/254 (49%), Gaps = 22/254 (8%)
Query: 173 LQNLCGGPNVVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYEL 228
           L  +    N++ LL++   Q S    +   ++ E +++   +V+   L    + Y +Y++
Sbjct: 76  LMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQM 135
Query: 229 LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 288
           L  + + HS GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ P
Sbjct: 136 LVGIKHLHSAGIIHRDLKPSNIVVKSD-ATLKILDFGLARTAGTSFMMTPYVVTRYYRAP 194
Query: 289 ELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK 348
           E+++ +  Y  ++D+WS+G +   MI +    F G D+ DQ  K+ + LGT        +
Sbjct: 195 EVILGM-GYKENVDIWSVGVIMGEMI-KGGVLFPGTDHIDQWNKVIEQLGTPS-----PE 247
Query: 349 YHLELDPQLDALVGRHSRKPWSKF--------INADNQH--LVSPEAIDFLDKLLRYDHQ 398
           +  +L P +   V    +     F          AD++H  L + +A D L K+L  D  
Sbjct: 248 FMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDAS 307
Query: 399 DRLTAREAMAHPYF 412
            R++  EA+ HPY 
Sbjct: 308 KRISVDEALQHPYI 321

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 58/167 (34%), Positives = 93/167 (55%), Gaps = 12/167 (7%)
Query: 180 PNVVKLLDIV---RDQHSKTPSLIFEYVNSTDF-----KVLYPTLTDYDIRYYIYELLKA 231
           PNVV+L+D+    R       +L+FE+V+  D      K   P L    I+  + + L+ 
Sbjct: 66  PNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRG 124
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 291
           LD+ H+  I+HRD+KP N+++      ++L D+GLA  Y         V + +++ PE+L
Sbjct: 125 LDFLHANCIVHRDLKPENILVTSG-GTVKLADFGLARIYSYQMALAPVVVTLWYRAPEVL 183
Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLG 338
           +    Y   +DMWS+GC+FA M FR++P F G+   DQL KI  ++G
Sbjct: 184 LQ-STYATPVDMWSVGCIFAEM-FRRKPLFCGNSEADQLGKIFDLIG 228

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 68/254 (26%), Positives = 126/254 (49%), Gaps = 22/254 (8%)
Query: 173 LQNLCGGPNVVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYEL 228
           L  +    N++ LL++   Q S    +   ++ E +++   +V+   L    + Y +Y++
Sbjct: 76  LMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQM 135
Query: 229 LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 288
           L  + + HS GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ P
Sbjct: 136 LVGIKHLHSAGIIHRDLKPSNIVVKSD-ATLKILDFGLARTAGTSFMMTPYVVTRYYRAP 194
Query: 289 ELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK 348
           E+++ +  Y  ++D+WS+G +   MI +    F G D+ DQ  K+ + LGT        +
Sbjct: 195 EVILGM-GYKENVDIWSVGVIMGEMI-KGGVLFPGTDHIDQWNKVIEQLGTPS-----PE 247
Query: 349 YHLELDPQLDALVGRHSRKPWSKF--------INADNQH--LVSPEAIDFLDKLLRYDHQ 398
           +  +L P +   V    +     F          AD++H  L + +A D L K+L  D  
Sbjct: 248 FMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDAS 307
Query: 399 DRLTAREAMAHPYF 412
            R++  EA+ HPY 
Sbjct: 308 KRISVDEALQHPYI 321

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 57/167 (34%), Positives = 93/167 (55%), Gaps = 12/167 (7%)
Query: 180 PNVVKLLDIV---RDQHSKTPSLIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKA 231
           PNVV+L+D+    R       +L+FE+V+  D +        P L    I+  + + L+ 
Sbjct: 66  PNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRG 124
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 291
           LD+ H+  I+HRD+KP N+++      ++L D+GLA  Y         V + +++ PE+L
Sbjct: 125 LDFLHANCIVHRDLKPENILVTSG-GTVKLADFGLARIYSYQMALFPVVVTLWYRAPEVL 183
Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLG 338
           +    Y   +DMWS+GC+FA M FR++P F G+   DQL KI  ++G
Sbjct: 184 LQ-STYATPVDMWSVGCIFAEM-FRRKPLFCGNSEADQLGKIFDLIG 228

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 64/242 (26%), Positives = 120/242 (49%), Gaps = 19/242 (7%)
Query: 180 PNVVKLLDIVRDQHSKTPS-----LIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKA 231
           PN++ L DI    H + P+     L+ E + +   +V++     ++   I+Y++Y +L  
Sbjct: 89  PNILGLRDIF--VHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLG 146
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 291
           L   H  G++HRD+ P N+++      + + D+ LA            V  R+++ PEL+
Sbjct: 147 LHVLHEAGVVHRDLHPGNILLADN-NDITICDFNLAREDTADANKTHYVTHRWYRAPELV 205
Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL 351
           +  + +   +DMWS GC+ A M F ++  F G   ++QL KI +V+GT ++   +     
Sbjct: 206 MQFKGFTKLVDMWSAGCVMAEM-FNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSP 264
Query: 352 ELDPQLDALVGRHSRKPWSKFI-NADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHP 410
                L   +     + W+  +  AD      P A+D + K+L ++ Q R++  +A+ HP
Sbjct: 265 SARDYLRNSLSNVPARAWTAVVPTAD------PVALDLIAKMLEFNPQRRISTEQALRHP 318
Query: 411 YF 412
           YF
Sbjct: 319 YF 320

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 64/242 (26%), Positives = 120/242 (49%), Gaps = 19/242 (7%)
Query: 180 PNVVKLLDIVRDQHSKTPS-----LIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKA 231
           PN++ L DI    H + P+     L+ E + +   +V++     ++   I+Y++Y +L  
Sbjct: 89  PNILGLRDIF--VHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLG 146
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 291
           L   H  G++HRD+ P N+++      + + D+ LA            V  R+++ PEL+
Sbjct: 147 LHVLHEAGVVHRDLHPGNILLADN-NDITICDFNLAREDTADANKTHYVTHRWYRAPELV 205
Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL 351
           +  + +   +DMWS GC+ A M F ++  F G   ++QL KI +V+GT ++   +     
Sbjct: 206 MQFKGFTKLVDMWSAGCVMAEM-FNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSP 264
Query: 352 ELDPQLDALVGRHSRKPWSKFI-NADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHP 410
                L   +     + W+  +  AD      P A+D + K+L ++ Q R++  +A+ HP
Sbjct: 265 SARDYLRNSLSNVPARAWTAVVPTAD------PVALDLIAKMLEFNPQRRISTEQALRHP 318
Query: 411 YF 412
           YF
Sbjct: 319 YF 320

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 87/358 (24%), Positives = 154/358 (43%), Gaps = 74/358 (20%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXX----XXXXXXXXLQNLCGGP 180
           D+Y +   +GRG Y  V+   + NT +                         + N     
Sbjct: 26  DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSD 85
Query: 181 NVVKLLD-IVRDQHSKTPSL-IFEYVNSTDFKVLYPT---LTDYDIRYYIYELLKALDYC 235
            +++L D I+ D   K   L I   +  +D K L+ T   LT+  I+  +Y LL   ++ 
Sbjct: 86  YIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFI 145
Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV----------------- 278
           H  GI+HRD+KP N +++ +   +++ D+GLA   +  K+ N+                 
Sbjct: 146 HESGIIHRDLKPANCLLNQDC-SVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNL 204
Query: 279 ------RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI----------FRKEPFFY 322
                  V +R+++ PEL++  ++Y  S+D+WS GC+FA ++            + P F 
Sbjct: 205 KKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFP 264
Query: 323 G-----------------HDNHDQLVKIAKVLGT---DELNAYLNKYHLELDPQLDALVG 362
           G                   N DQL  I  ++GT   D+L   +NK      P++   + 
Sbjct: 265 GSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKN-INK------PEVIKYIK 317
Query: 363 RHSRKPWSKFINADNQH-LVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE 419
                P  K IN   ++  +S + I+ L+ +L+++   R+T  +A+ HPY   VR  +
Sbjct: 318 LF---PHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKK 372

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/266 (24%), Positives = 127/266 (47%), Gaps = 35/266 (13%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY-----------PTLTDYDIRYYIYEL 228
           PNV+ L  +      +   L+F+Y     + ++              L    ++  +Y++
Sbjct: 78  PNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQI 137
Query: 229 LKALDYCHSQGIMHRDVKPHNVMI---DHELRKLRLIDWGLAEFYH----PGKEYNVRVA 281
           L  + Y H+  ++HRD+KP N+++     E  ++++ D G A  ++    P  + +  V 
Sbjct: 138 LDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 197
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD---------NHDQLVK 332
           + +++ PELL+  + Y  ++D+W++GC+FA ++   EP F+            +HDQL +
Sbjct: 198 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELL-TSEPIFHCRQEDIKTSNPYHHDQLDR 256
Query: 333 IAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWS--KFINADNQHLVSPEAIDF-- 388
           I  V+G     A  +   ++  P+   L+    R  ++    I    +H V P++  F  
Sbjct: 257 IFNVMG---FPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHL 313
Query: 389 LDKLLRYDHQDRLTAREAMAHPYFAQ 414
           L KLL  D   R+T+ +AM  PYF +
Sbjct: 314 LQKLLTMDPIKRITSEQAMQDPYFLE 339

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 72/284 (25%), Positives = 134/284 (47%), Gaps = 62/284 (21%)
Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-------YPTLTDYDIRYYIY 226
           +NLC     V++ D   D H     + FE +  + F  L       YP    + +R+  +
Sbjct: 95  KNLC-----VQMFDWF-DYHGHM-CISFELLGLSTFDFLKDNNYLPYPI---HQVRHMAF 144
Query: 227 ELLKALDYCHSQGIMHRDVKPHNVMI---DHELR---------------KLRLIDWGLAE 268
           +L +A+ + H   + H D+KP N++    D+EL                 +R++D+G A 
Sbjct: 145 QLCQAVKFLHDNKLTHTDLKPENILFVNSDYELTYNLEKKRDERSVKSTAVRVVDFGSAT 204
Query: 269 FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCM----FAGMIFRKEPFFYGH 324
           F H  + ++  V++R+++ PE++++L  +    D+WS+GC+    + G        F  H
Sbjct: 205 FDH--EHHSTIVSTRHYRAPEVILEL-GWSQPCDVWSIGCIIFEYYVGFTL-----FQTH 256
Query: 325 DNHDQLVKIAKVLG--------TDELNAYLNKYHLELDPQLDALVGRHSR---KPWSKFI 373
           DN + L  + ++LG              Y  +  L+ D    A  GR+ R   KP  +++
Sbjct: 257 DNREHLAMMERILGPIPSRMIRKTRKQKYFYRGRLDWDENTSA--GRYVRENCKPLRRYL 314
Query: 374 NADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA 417
            ++ +     +  D ++ +L Y+   RLT  EA+ HP+FA++RA
Sbjct: 315 TSEAEE--HHQLFDLIESMLEYEPAKRLTLGEALQHPFFARLRA 356

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 69/256 (26%), Positives = 108/256 (42%), Gaps = 46/256 (17%)
Query: 203 YVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLI 262
           Y+    F  +  +L+  ++R Y+  L KAL   H  GI+HRDVKP N + +  L+K  L+
Sbjct: 101 YLEHESFLDILNSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALV 160
Query: 263 DWGLAEFYHPGK-----------------------------EYNVRVASRYFKGPELLVD 293
           D+GLA+  H  K                             +   R  +  F+ PE+L  
Sbjct: 161 DFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTK 220
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH--- 350
             +   ++DMWS G +F  ++  + PF+   D+   L +I  + G+ E       +    
Sbjct: 221 CPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSI 280
Query: 351 --------LELDPQLDALVGRHSRKP------WSKFINADNQHLVSPEAIDFLDKLLRYD 396
                    +L    + L G  S  P           N +  + V  EA D LDKLL  +
Sbjct: 281 LCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLLDLN 340
Query: 397 HQDRLTAREAMAHPYF 412
              R+TA EA+ HP+F
Sbjct: 341 PASRITAEEALLHPFF 356

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 70/309 (22%), Positives = 133/309 (43%), Gaps = 57/309 (18%)
Query: 127 YEVVRKVGRGKYSEVF----EGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLCGGPNV 182
           Y+ V+K+G G Y EV     +  +V    +                    +  L   PN+
Sbjct: 39  YQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNI 98
Query: 183 VKLLDIVRDQHS--------KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDY 234
           +KL D   D+ +        K   L  E ++   F        + D    I ++L  + Y
Sbjct: 99  MKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKF-------NEVDAAVIIKQVLSGVTY 151
Query: 235 CHSQGIMHRDVKPHNVMIDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 292
            H   I+HRD+KP N++++ + +   ++++D+GL+  +   K+   R+ + Y+  PE+L 
Sbjct: 152 LHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVL- 210
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE 352
             + YD   D+WS+G +   ++    P F G  + + L K+ K            KY  +
Sbjct: 211 -RKKYDEKCDVWSIGVILF-ILLAGYPPFGGQTDQEILRKVEK-----------GKYTFD 257
Query: 353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 412
             P+            W           VS  A D + ++L++D Q R++A++A+ HP+ 
Sbjct: 258 -SPE------------WKN---------VSEGAKDLIKQMLQFDSQRRISAQQALEHPWI 295
Query: 413 AQVRAAESS 421
            ++ + + S
Sbjct: 296 KEMCSKKES 304

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 66/248 (26%), Positives = 115/248 (46%), Gaps = 37/248 (14%)
Query: 201 FEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM-IDHELRKL 259
           FE++   +F+  YP      +R+  Y+L  AL + H   + H D+KP N++ ++ E   L
Sbjct: 109 FEFLKENNFQP-YPLP---HVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETL 164
Query: 260 -----------------RLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLD 302
                            R+ D+G A F H  + +   VA+R+++ PE++++L  +    D
Sbjct: 165 YNEHKSCEEKSVKNTSIRVADFGSATFDH--EHHTTIVATRHYRPPEVILEL-GWAQPCD 221
Query: 303 MWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLG--------TDELNAYLNKYHLELD 354
           +WS+GC+     +R    F  H+N + LV + K+LG              Y  K  L  D
Sbjct: 222 VWSIGCILFEY-YRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWD 280
Query: 355 PQL-DALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA 413
               D    + + KP   ++  D+  L   +  D + ++L +D   R+T  EA+ HP+FA
Sbjct: 281 ENSSDGRYVKENCKPLKSYMLQDS--LEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFA 338
Query: 414 QVRAAESS 421
            +   E S
Sbjct: 339 GLTPEERS 346

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/248 (26%), Positives = 115/248 (46%), Gaps = 37/248 (14%)
Query: 201 FEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM-IDHELRKL 259
           FE++   +F+  YP      +R+  Y+L  AL + H   + H D+KP N++ ++ E   L
Sbjct: 118 FEFLKENNFQP-YPLP---HVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETL 173
Query: 260 -----------------RLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLD 302
                            R+ D+G A F H  + +   VA+R+++ PE++++L  +    D
Sbjct: 174 YNEHKSCEEKSVKNTSIRVADFGSATFDH--EHHTTIVATRHYRPPEVILEL-GWAQPCD 230
Query: 303 MWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLG--------TDELNAYLNKYHLELD 354
           +WS+GC+     +R    F  H+N + LV + K+LG              Y  K  L  D
Sbjct: 231 VWSIGCILFEY-YRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWD 289
Query: 355 PQL-DALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA 413
               D    + + KP   ++  D+  L   +  D + ++L +D   R+T  EA+ HP+FA
Sbjct: 290 ENSSDGRYVKENCKPLKSYMLQDS--LEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFA 347
Query: 414 QVRAAESS 421
            +   E S
Sbjct: 348 GLTPEERS 355

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/248 (26%), Positives = 115/248 (46%), Gaps = 37/248 (14%)
Query: 201 FEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM-IDHELRKL 259
           FE++   +F+  YP      +R+  Y+L  AL + H   + H D+KP N++ ++ E   L
Sbjct: 141 FEFLKENNFQP-YPLP---HVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETL 196
Query: 260 -----------------RLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLD 302
                            R+ D+G A F H  + +   VA+R+++ PE++++L  +    D
Sbjct: 197 YNEHKSCEEKSVKNTSIRVADFGSATFDH--EHHTTIVATRHYRPPEVILEL-GWAQPCD 253
Query: 303 MWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLG--------TDELNAYLNKYHLELD 354
           +WS+GC+     +R    F  H+N + LV + K+LG              Y  K  L  D
Sbjct: 254 VWSIGCILFEY-YRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWD 312
Query: 355 PQL-DALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA 413
               D    + + KP   ++  D+  L   +  D + ++L +D   R+T  EA+ HP+FA
Sbjct: 313 ENSSDGRYVKENCKPLKSYMLQDS--LEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFA 370
Query: 414 QVRAAESS 421
            +   E S
Sbjct: 371 GLTPEERS 378

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 73/302 (24%), Positives = 126/302 (41%), Gaps = 56/302 (18%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNL-----CGG 179
           D Y+  R +G+G + EV    +  T + C                   L+ +        
Sbjct: 26  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 85
Query: 180 PNVVKLLDIVRDQ-------HSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKAL 232
           PN++KL +   D+          T   +F+ + S          ++ D    I ++L  +
Sbjct: 86  PNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISR------KRFSEVDAARIIRQVLSGI 139
Query: 233 DYCHSQGIMHRDVKPHNVMIDHELR--KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 290
            Y H   I+HRD+KP N++++ + +   +R+ID+GL+  +   K+   ++ + Y+  PE+
Sbjct: 140 TYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEV 199
Query: 291 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH 350
           L     YD   D+WS G +   ++    P F G + +D L K+ K            KY 
Sbjct: 200 LHGT--YDEKCDVWSTGVILY-ILLSGCPPFNGANEYDILKKVEK-----------GKYT 245
Query: 351 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHP 410
            EL PQ            W K         VS  A D + K+L Y    R++AR+A+ H 
Sbjct: 246 FEL-PQ------------WKK---------VSESAKDLIRKMLTYVPSMRISARDALDHE 283
Query: 411 YF 412
           + 
Sbjct: 284 WI 285

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 73/302 (24%), Positives = 126/302 (41%), Gaps = 56/302 (18%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNL-----CGG 179
           D Y+  R +G+G + EV    +  T + C                   L+ +        
Sbjct: 49  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 108
Query: 180 PNVVKLLDIVRDQ-------HSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKAL 232
           PN++KL +   D+          T   +F+ + S          ++ D    I ++L  +
Sbjct: 109 PNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISR------KRFSEVDAARIIRQVLSGI 162
Query: 233 DYCHSQGIMHRDVKPHNVMIDHELR--KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 290
            Y H   I+HRD+KP N++++ + +   +R+ID+GL+  +   K+   ++ + Y+  PE+
Sbjct: 163 TYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEV 222
Query: 291 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH 350
           L     YD   D+WS G +   ++    P F G + +D L K+ K            KY 
Sbjct: 223 LHGT--YDEKCDVWSTGVILY-ILLSGCPPFNGANEYDILKKVEK-----------GKYT 268
Query: 351 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHP 410
            EL PQ            W K         VS  A D + K+L Y    R++AR+A+ H 
Sbjct: 269 FEL-PQ------------WKK---------VSESAKDLIRKMLTYVPSMRISARDALDHE 306
Query: 411 YF 412
           + 
Sbjct: 307 WI 308

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 73/302 (24%), Positives = 126/302 (41%), Gaps = 56/302 (18%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNL-----CGG 179
           D Y+  R +G+G + EV    +  T + C                   L+ +        
Sbjct: 50  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 109
Query: 180 PNVVKLLDIVRDQ-------HSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKAL 232
           PN++KL +   D+          T   +F+ + S          ++ D    I ++L  +
Sbjct: 110 PNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISR------KRFSEVDAARIIRQVLSGI 163
Query: 233 DYCHSQGIMHRDVKPHNVMIDHELR--KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 290
            Y H   I+HRD+KP N++++ + +   +R+ID+GL+  +   K+   ++ + Y+  PE+
Sbjct: 164 TYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEV 223
Query: 291 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH 350
           L     YD   D+WS G +   ++    P F G + +D L K+ K            KY 
Sbjct: 224 LHGT--YDEKCDVWSTGVILY-ILLSGCPPFNGANEYDILKKVEK-----------GKYT 269
Query: 351 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHP 410
            EL PQ            W K         VS  A D + K+L Y    R++AR+A+ H 
Sbjct: 270 FEL-PQ------------WKK---------VSESAKDLIRKMLTYVPSMRISARDALDHE 307
Query: 411 YF 412
           + 
Sbjct: 308 WI 309

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 73/301 (24%), Positives = 126/301 (41%), Gaps = 56/301 (18%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNL-----CGG 179
           D Y+  R +G+G + EV    +  T + C                   L+ +        
Sbjct: 32  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 91
Query: 180 PNVVKLLDIVRDQ-------HSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKAL 232
           PN++KL +   D+          T   +F+ + S          ++ D    I ++L  +
Sbjct: 92  PNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISR------KRFSEVDAARIIRQVLSGI 145
Query: 233 DYCHSQGIMHRDVKPHNVMIDHELR--KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 290
            Y H   I+HRD+KP N++++ + +   +R+ID+GL+  +   K+   ++ + Y+  PE+
Sbjct: 146 TYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEV 205
Query: 291 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH 350
           L     YD   D+WS G +   ++    P F G + +D L K+ K            KY 
Sbjct: 206 LHGT--YDEKCDVWSTGVILY-ILLSGCPPFNGANEYDILKKVEK-----------GKYT 251
Query: 351 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHP 410
            EL PQ            W K         VS  A D + K+L Y    R++AR+A+ H 
Sbjct: 252 FEL-PQ------------WKK---------VSESAKDLIRKMLTYVPSMRISARDALDHE 289
Query: 411 Y 411
           +
Sbjct: 290 W 290

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 69/318 (21%), Positives = 132/318 (41%), Gaps = 55/318 (17%)
Query: 115 ESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXX 170
           E+L  Q    + Y +V  +G+G + EV +  +  T +    +                  
Sbjct: 12  ENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILRE 71
Query: 171 XXLQNLCGGPNVVKLLDIVRDQHS-------KTPSLIFEYVNSTDFKVLYPTLTDYDIRY 223
             L      PN++KL +I+ D  S        T   +F+ +      +     +++D   
Sbjct: 72  VELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEI------IKRKRFSEHDAAR 125
Query: 224 YIYELLKALDYCHSQGIMHRDVKPHNVMIDHELR--KLRLIDWGLAEFYHPGKEYNVRVA 281
            I ++   + Y H   I+HRD+KP N++++ + +   +++ID+GL+  +    +   R+ 
Sbjct: 126 IIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIG 185
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDE 341
           + Y+  PE+L     YD   D+WS G +   ++    P FYG + +D L ++        
Sbjct: 186 TAYYIAPEVLRGT--YDEKCDVWSAGVILY-ILLSGTPPFYGKNEYDILKRVE------- 235
Query: 342 LNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL 401
                 KY  +L PQ            W           +S +A D + K+L +    R+
Sbjct: 236 ----TGKYAFDL-PQ------------W---------RTISDDAKDLIRKMLTFHPSLRI 269
Query: 402 TAREAMAHPYFAQVRAAE 419
           TA + + HP+  +  + E
Sbjct: 270 TATQCLEHPWIQKYSSEE 287

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 73/302 (24%), Positives = 124/302 (41%), Gaps = 56/302 (18%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNL-----CGG 179
           D Y+  R +G+G + EV    +  T + C                   L+ +        
Sbjct: 26  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 85
Query: 180 PNVVKLLDIVRDQ-------HSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKAL 232
           PN+ KL +   D+          T   +F+ + S          ++ D    I ++L  +
Sbjct: 86  PNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISR------KRFSEVDAARIIRQVLSGI 139
Query: 233 DYCHSQGIMHRDVKPHNVMIDHELR--KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 290
            Y H   I+HRD+KP N++++ + +   +R+ID+GL+  +   K+   ++ + Y+  PE+
Sbjct: 140 TYXHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDKIGTAYYIAPEV 199
Query: 291 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH 350
           L     YD   D+WS G +   ++    P F G + +D L K+ K            KY 
Sbjct: 200 LHGT--YDEKCDVWSTGVILY-ILLSGCPPFNGANEYDILKKVEK-----------GKYT 245
Query: 351 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHP 410
            EL PQ            W K         VS  A D + K L Y    R++AR+A+ H 
Sbjct: 246 FEL-PQ------------WKK---------VSESAKDLIRKXLTYVPSXRISARDALDHE 283
Query: 411 YF 412
           + 
Sbjct: 284 WI 285

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 68/313 (21%), Positives = 130/313 (41%), Gaps = 55/313 (17%)
Query: 115 ESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXX 170
           E+L  Q    + Y +V  +G+G + EV +  +  T +    +                  
Sbjct: 12  ENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILRE 71
Query: 171 XXLQNLCGGPNVVKLLDIVRDQHS-------KTPSLIFEYVNSTDFKVLYPTLTDYDIRY 223
             L      PN++KL +I+ D  S        T   +F+ +      +     +++D   
Sbjct: 72  VELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEI------IKRKRFSEHDAAR 125
Query: 224 YIYELLKALDYCHSQGIMHRDVKPHNVMIDHELR--KLRLIDWGLAEFYHPGKEYNVRVA 281
            I ++   + Y H   I+HRD+KP N++++ + +   +++ID+GL+  +    +   R+ 
Sbjct: 126 IIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIG 185
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDE 341
           + Y+  PE+L     YD   D+WS G +   ++    P FYG + +D L ++        
Sbjct: 186 TAYYIAPEVLRGT--YDEKCDVWSAGVILY-ILLSGTPPFYGKNEYDILKRVET------ 236
Query: 342 LNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL 401
                 KY  +L PQ            W           +S +A D + K+L +    R+
Sbjct: 237 -----GKYAFDL-PQ------------W---------RTISDDAKDLIRKMLTFHPSLRI 269
Query: 402 TAREAMAHPYFAQ 414
           TA + + HP+  +
Sbjct: 270 TATQCLEHPWIQK 282

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 82/345 (23%), Positives = 152/345 (44%), Gaps = 53/345 (15%)
Query: 117 LTVQWGD--QDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQ 174
           L  Q GD     YE+V  +G G + +V E I+     R                    +Q
Sbjct: 4   LICQSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQ 63
Query: 175 NL----CGGPN----VVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-----YPTLTDYDI 221
            L       PN     V++L+    +H     ++FE +  + +  +      P   D+ I
Sbjct: 64  VLEHLNTTDPNSTFRCVQMLEWF--EHHGHICIVFELLGLSTYDFIKENGFLPFRLDH-I 120
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVM-------------IDHELRKL-----RLID 263
           R   Y++ K++++ HS  + H D+KP N++             I  + R L     +++D
Sbjct: 121 RKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVD 180
Query: 264 WGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG 323
           +G A +    + ++  V++R+++ PE+++ L  +    D+WS+GC+     +     F  
Sbjct: 181 FGSATY--DDEHHSTLVSTRHYRAPEVILAL-GWSQPCDVWSIGCILIEY-YLGFTVFPT 236
Query: 324 HDNHDQLVKIAKVLG------TDELNAYLNKYHLELDPQLDALVGRH-SR--KPWSKF-I 373
           HD+ + L  + ++LG        +       +H  LD    +  GR+ SR  KP  +F +
Sbjct: 237 HDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFML 296
Query: 374 NADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA 418
           + D +H       D + K+L YD   R+T REA+ HP+F  ++ +
Sbjct: 297 SQDVEH---ERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKKS 338

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 68/313 (21%), Positives = 130/313 (41%), Gaps = 55/313 (17%)
Query: 115 ESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXX 170
           E+L  Q    + Y +V  +G+G + EV +  +  T +    +                  
Sbjct: 12  ENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILRE 71
Query: 171 XXLQNLCGGPNVVKLLDIVRDQHS-------KTPSLIFEYVNSTDFKVLYPTLTDYDIRY 223
             L      PN++KL +I+ D  S        T   +F+ +      +     +++D   
Sbjct: 72  VELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEI------IKRKRFSEHDAAR 125
Query: 224 YIYELLKALDYCHSQGIMHRDVKPHNVMIDHELR--KLRLIDWGLAEFYHPGKEYNVRVA 281
            I ++   + Y H   I+HRD+KP N++++ + +   +++ID+GL+  +    +   R+ 
Sbjct: 126 IIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIG 185
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDE 341
           + Y+  PE+L     YD   D+WS G +   ++    P FYG + +D L ++        
Sbjct: 186 TAYYIAPEVLRGT--YDEKCDVWSAGVILY-ILLSGTPPFYGKNEYDILKRVET------ 236
Query: 342 LNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL 401
                 KY  +L PQ            W           +S +A D + K+L +    R+
Sbjct: 237 -----GKYAFDL-PQ------------W---------RTISDDAKDLIRKMLTFHPSLRI 269
Query: 402 TAREAMAHPYFAQ 414
           TA + + HP+  +
Sbjct: 270 TATQCLEHPWIQK 282

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 74/299 (24%), Positives = 123/299 (41%), Gaps = 46/299 (15%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVVK 184
           D Y V   +G G YSE    ++  TN                      L+     PN++ 
Sbjct: 27  DGYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIEILLR-YGQHPNIIT 85
Query: 185 LLDIVRDQHSKTPSLIFEYVNSTDF--KVLYPTL-TDYDIRYYIYELLKALDYCHSQGIM 241
           L D+  D   K   L+ E +   +   K+L     ++ +  + ++ + K ++Y HSQG++
Sbjct: 86  LKDVYDD--GKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHSQGVV 143
Query: 242 HRDVKPHNVMIDHELRK---LRLIDWGLAEFYHPGKEYNVRVASRY---FKGPELLVDLQ 295
           HRD+KP N++   E      LR+ D+G A+      E  + +   Y   F  PE+L   Q
Sbjct: 144 HRDLKPSNILYVDESGNPECLRICDFGFAKQLR--AENGLLMTPCYTANFVAPEVL-KRQ 200
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP 355
            YD   D+WSLG +   M+    PF  G  +  +  +I   +G+ +              
Sbjct: 201 GYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPE--EILTRIGSGKFT------------ 246
Query: 356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 414
                            ++  N + VS  A D + K+L  D   RLTA++ + HP+  Q
Sbjct: 247 -----------------LSGGNWNTVSETAKDLVSKMLHVDPHQRLTAKQVLQHPWVTQ 288

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/305 (22%), Positives = 125/305 (40%), Gaps = 52/305 (17%)
Query: 122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLC---- 177
           G  D Y+ V+K+G G Y EV    +  T                       L  +     
Sbjct: 18  GLSDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQ 77
Query: 178 -GGPNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALD 233
              PN++KL +   D+  +   L+ E        D  +L    ++ D    + ++L    
Sbjct: 78  LDHPNIMKLYEFFEDK--RNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTT 135
Query: 234 YCHSQGIMHRDVKPHNVMIDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 291
           Y H   I+HRD+KP N++++ + R   ++++D+GL+  +  G +   R+ + Y+  PE+L
Sbjct: 136 YLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVL 195
Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL 351
              + YD   D+WS G +   ++    P F G  + + L ++ K                
Sbjct: 196 --RKKYDEKCDVWSCGVILY-ILLCGYPPFGGQTDQEILKRVEK---------------- 236
Query: 352 ELDPQLDALVGRHSRKP--WSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 409
                     G+ S  P  W++         VS EA   +  +L Y+   R++A EA+ H
Sbjct: 237 ----------GKFSFDPPDWTQ---------VSDEAKQLVKLMLTYEPSKRISAEEALNH 277
Query: 410 PYFAQ 414
           P+  +
Sbjct: 278 PWIVK 282

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 109/236 (46%), Gaps = 31/236 (13%)
Query: 200 IFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRK- 258
           ++E +    F+     L    +R + + +L+ LD  H   I+H D+KP N+++  + R  
Sbjct: 185 LYELIKKNKFQGFSLPL----VRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSG 240
Query: 259 LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKE 318
           +++ID+G + + H  +     + SR+++ PE+++  + Y   +DMWSLGC+ A ++    
Sbjct: 241 IKVIDFGSSCYEH--QRVYTXIQSRFYRAPEVILGAR-YGMPIDMWSLGCILAELL-TGY 296
Query: 319 PFFYGHDNHDQLVKIAKVLGTDE---LNAYLNKYHL-------------ELDPQLDALVG 362
           P   G D  DQL  + ++LG      L+A     +               L      L G
Sbjct: 297 PLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSXKGYPRYCTVTTLSDGSVVLNG 356
Query: 363 RHSRK------PWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 412
             SR+      P S+      +    P  +DFL + L +D   R+T  +A+ HP+ 
Sbjct: 357 GRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWL 412

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 74/299 (24%), Positives = 123/299 (41%), Gaps = 46/299 (15%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVVK 184
           D Y V   +G G YSE    ++  TN                      L+     PN++ 
Sbjct: 27  DGYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIEILLR-YGQHPNIIT 85
Query: 185 LLDIVRDQHSKTPSLIFEYVNSTDF--KVLYPTL-TDYDIRYYIYELLKALDYCHSQGIM 241
           L D+  D   K   L+ E +   +   K+L     ++ +  + ++ + K ++Y HSQG++
Sbjct: 86  LKDVYDD--GKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHSQGVV 143
Query: 242 HRDVKPHNVMIDHELRK---LRLIDWGLAEFYHPGKEYNVRVASRY---FKGPELLVDLQ 295
           HRD+KP N++   E      LR+ D+G A+      E  + +   Y   F  PE+L   Q
Sbjct: 144 HRDLKPSNILYVDESGNPECLRICDFGFAKQLR--AENGLLMTPCYTANFVAPEVL-KRQ 200
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP 355
            YD   D+WSLG +   M+    PF  G  +  +  +I   +G+ +              
Sbjct: 201 GYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPE--EILTRIGSGKFT------------ 246
Query: 356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 414
                            ++  N + VS  A D + K+L  D   RLTA++ + HP+  Q
Sbjct: 247 -----------------LSGGNWNTVSETAKDLVSKMLHVDPHQRLTAKQVLQHPWVTQ 288

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/258 (23%), Positives = 112/258 (43%), Gaps = 48/258 (18%)
Query: 173 LQNLCGGPNVVKLLDIVRDQHSKTPSL-------IFEYVNSTDFKVLYPTLTDYDIRYYI 225
           + N    P ++ L D   D++     L       +F+ + + D+K     +++ ++  Y+
Sbjct: 101 IMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK-----MSEAEVINYM 155
Query: 226 YELLKALDYCHSQGIMHRDVKPHNVMID-HELRKLRLIDWGLAEFYHPGKEYNVRVASRY 284
            +  + L + H   I+H D+KP N+M +  +   +++ID+GLA   +P +   V  A+  
Sbjct: 156 RQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAE 215
Query: 285 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA 344
           F  PE +VD +   +  DMW++G +   ++    PF                 G D+L  
Sbjct: 216 FAAPE-IVDREPVGFYTDMWAIGVLGYVLLSGLSPF----------------AGEDDLET 258
Query: 345 YLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAR 404
             N    + +   DA                     VSPEA DF+  LL+ + + RLT  
Sbjct: 259 LQNVKRCDWEFDEDAFSS------------------VSPEAKDFIKNLLQKEPRKRLTVH 300
Query: 405 EAMAHPYFAQVRAAESSR 422
           +A+ HP+     +  +SR
Sbjct: 301 DALEHPWLKGDHSNLTSR 318

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 109/236 (46%), Gaps = 31/236 (13%)
Query: 200 IFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRK- 258
           ++E +    F+     L    +R + + +L+ LD  H   I+H D+KP N+++  + R  
Sbjct: 185 LYELIKKNKFQGFSLPL----VRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSG 240
Query: 259 LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKE 318
           +++ID+G + + H  +     + SR+++ PE+++  + Y   +DMWSLGC+ A ++    
Sbjct: 241 IKVIDFGSSCYEH--QRVYTXIQSRFYRAPEVILGAR-YGMPIDMWSLGCILAELL-TGY 296
Query: 319 PFFYGHDNHDQLVKIAKVLGTDE---LNAYLNKYHL-------------ELDPQLDALVG 362
           P   G D  DQL  + ++LG      L+A     +               L      L G
Sbjct: 297 PLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSXKGYPRYCTVTTLSDGSVVLNG 356
Query: 363 RHSRK------PWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 412
             SR+      P S+      +    P  +DFL + L +D   R+T  +A+ HP+ 
Sbjct: 357 GRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWL 412

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 69/305 (22%), Positives = 125/305 (40%), Gaps = 52/305 (17%)
Query: 122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLC---- 177
           G  D Y+ V+K+G G Y EV    +  T                       L  +     
Sbjct: 1   GLSDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQ 60
Query: 178 -GGPNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALD 233
              PN++KL +   D+  +   L+ E        D  +L    ++ D    + ++L    
Sbjct: 61  LDHPNIMKLYEFFEDK--RNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTT 118
Query: 234 YCHSQGIMHRDVKPHNVMIDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 291
           Y H   I+HRD+KP N++++ + R   ++++D+GL+  +  G +   R+ + Y+  PE+L
Sbjct: 119 YLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVL 178
Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL 351
              + YD   D+WS G +   ++    P F G  + + L ++ K                
Sbjct: 179 --RKKYDEKCDVWSCGVILY-ILLCGYPPFGGQTDQEILKRVEK---------------- 219
Query: 352 ELDPQLDALVGRHSRKP--WSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 409
                     G+ S  P  W++         VS EA   +  +L Y+   R++A EA+ H
Sbjct: 220 ----------GKFSFDPPDWTQ---------VSDEAKQLVKLMLTYEPSKRISAEEALNH 260
Query: 410 PYFAQ 414
           P+  +
Sbjct: 261 PWIVK 265

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 82/345 (23%), Positives = 150/345 (43%), Gaps = 53/345 (15%)
Query: 117 LTVQWGD--QDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQ 174
           L  Q GD     YE+V  +G G + +V E I+     R                    +Q
Sbjct: 4   LICQSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQ 63
Query: 175 NL----CGGPN----VVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-----YPTLTDYDI 221
            L       PN     V++L+    +H     ++FE +  + +  +      P   D+ I
Sbjct: 64  VLEHLNTTDPNSTFRCVQMLEWF--EHHGHICIVFELLGLSTYDFIKENGFLPFRLDH-I 120
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVM-------------IDHELRKL-----RLID 263
           R   Y++ K++++ HS  + H D+KP N++             I  + R L     +++D
Sbjct: 121 RKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVD 180
Query: 264 WGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG 323
           +G A +    + ++  V  R+++ PE+++ L  +    D+WS+GC+     +     F  
Sbjct: 181 FGSATY--DDEHHSTLVXXRHYRAPEVILAL-GWSQPCDVWSIGCILIEY-YLGFTVFPT 236
Query: 324 HDNHDQLVKIAKVLG------TDELNAYLNKYHLELDPQLDALVGRH-SR--KPWSKF-I 373
           HD+ + L  + ++LG        +       +H  LD    +  GR+ SR  KP  +F +
Sbjct: 237 HDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFML 296
Query: 374 NADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA 418
           + D +H       D + K+L YD   R+T REA+ HP+F  ++ +
Sbjct: 297 SQDVEH---ERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKKS 338

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 109/236 (46%), Gaps = 31/236 (13%)
Query: 200 IFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRK- 258
           ++E +    F+     L    +R + + +L+ LD  H   I+H D+KP N+++  + R  
Sbjct: 185 LYELIKKNKFQGFSLPL----VRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSG 240
Query: 259 LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKE 318
           +++ID+G + + H  +     + SR+++ PE+++  + Y   +DMWSLGC+ A ++    
Sbjct: 241 IKVIDFGSSCYEH--QRVYXXIQSRFYRAPEVILGAR-YGMPIDMWSLGCILAELL-TGY 296
Query: 319 PFFYGHDNHDQLVKIAKVLGTDE---LNAYLNKYHL-------------ELDPQLDALVG 362
           P   G D  DQL  + ++LG      L+A     +               L      L G
Sbjct: 297 PLLPGEDEGDQLACMIELLGMPXQKLLDASKRAKNFVSXKGYPRYCTVTTLSDGSVVLNG 356
Query: 363 RHSRK------PWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 412
             SR+      P S+      +    P  +DFL + L +D   R+T  +A+ HP+ 
Sbjct: 357 GRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWL 412

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 101/220 (45%), Gaps = 42/220 (19%)
Query: 199 LIFEYVNS---TDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE 255
           ++ E++     TD  V +  + +  I      +L+AL   H+QG++HRD+K  ++++ H+
Sbjct: 225 VVMEFLEGGALTDI-VTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHD 283
Query: 256 LRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI 314
            R ++L D+G  A+           V + Y+  PEL+  L  Y   +D+WSLG M   M+
Sbjct: 284 GR-VKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRL-PYGPEVDIWSLGIMVIEMV 341
Query: 315 FRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFIN 374
             + P+F     ++  +K  K++  +            L P+L                 
Sbjct: 342 DGEPPYF-----NEPPLKAMKMIRDN------------LPPRL----------------- 367
Query: 375 ADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 414
             N H VSP    FLD+LL  D   R TA E + HP+ A+
Sbjct: 368 -KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAK 406

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 44/202 (21%), Positives = 94/202 (46%), Gaps = 10/202 (4%)
Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQN-----LCGGP 180
           +Y++V+ +G G + +V    +  T ++                     +      L   P
Sbjct: 15  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 74
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNST--DFKVLYPTLTDYDIRYYIYELLKALDYCHSQ 238
           +++KL D+++ +      ++ EY  +   D+ V    +++ + R +  +++ A++YCH  
Sbjct: 75  HIIKLYDVIKSKDEII--MVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRH 132
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYD 298
            I+HRD+KP N+++D  L  +++ D+GL+     G        S  +  PE++       
Sbjct: 133 KIVHRDLKPENLLLDEHL-NVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAG 191
Query: 299 YSLDMWSLGCMFAGMIFRKEPF 320
             +D+WS G +   M+ R+ PF
Sbjct: 192 PEVDVWSCGVILYVMLCRRLPF 213

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 44/202 (21%), Positives = 94/202 (46%), Gaps = 10/202 (4%)
Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQN-----LCGGP 180
           +Y++V+ +G G + +V    +  T ++                     +      L   P
Sbjct: 9   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 68
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNST--DFKVLYPTLTDYDIRYYIYELLKALDYCHSQ 238
           +++KL D+++ +      ++ EY  +   D+ V    +++ + R +  +++ A++YCH  
Sbjct: 69  HIIKLYDVIKSKDEII--MVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRH 126
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYD 298
            I+HRD+KP N+++D  L  +++ D+GL+     G        S  +  PE++       
Sbjct: 127 KIVHRDLKPENLLLDEHL-NVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAG 185
Query: 299 YSLDMWSLGCMFAGMIFRKEPF 320
             +D+WS G +   M+ R+ PF
Sbjct: 186 PEVDVWSCGVILYVMLCRRLPF 207

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 44/202 (21%), Positives = 94/202 (46%), Gaps = 10/202 (4%)
Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQN-----LCGGP 180
           +Y++V+ +G G + +V    +  T ++                     +      L   P
Sbjct: 14  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 73
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNST--DFKVLYPTLTDYDIRYYIYELLKALDYCHSQ 238
           +++KL D+++ +      ++ EY  +   D+ V    +++ + R +  +++ A++YCH  
Sbjct: 74  HIIKLYDVIKSKDEII--MVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRH 131
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYD 298
            I+HRD+KP N+++D  L  +++ D+GL+     G        S  +  PE++       
Sbjct: 132 KIVHRDLKPENLLLDEHL-NVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAG 190
Query: 299 YSLDMWSLGCMFAGMIFRKEPF 320
             +D+WS G +   M+ R+ PF
Sbjct: 191 PEVDVWSCGVILYVMLCRRLPF 212

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 44/202 (21%), Positives = 94/202 (46%), Gaps = 10/202 (4%)
Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQN-----LCGGP 180
           +Y++V+ +G G + +V    +  T ++                     +      L   P
Sbjct: 5   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 64
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNST--DFKVLYPTLTDYDIRYYIYELLKALDYCHSQ 238
           +++KL D+++ +      ++ EY  +   D+ V    +++ + R +  +++ A++YCH  
Sbjct: 65  HIIKLYDVIKSKDEII--MVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRH 122
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYD 298
            I+HRD+KP N+++D  L  +++ D+GL+     G        S  +  PE++       
Sbjct: 123 KIVHRDLKPENLLLDEHL-NVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAG 181
Query: 299 YSLDMWSLGCMFAGMIFRKEPF 320
             +D+WS G +   M+ R+ PF
Sbjct: 182 PEVDVWSCGVILYVMLCRRLPF 203

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 101/220 (45%), Gaps = 42/220 (19%)
Query: 199 LIFEYVNS---TDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE 255
           ++ E++     TD  V +  + +  I      +L+AL   H+QG++HRD+K  ++++ H+
Sbjct: 148 VVMEFLEGGALTDI-VTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHD 206
Query: 256 LRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI 314
            R ++L D+G  A+           V + Y+  PEL+  L  Y   +D+WSLG M   M+
Sbjct: 207 GR-VKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRL-PYGPEVDIWSLGIMVIEMV 264
Query: 315 FRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFIN 374
             + P+F     ++  +K  K++  +            L P+L                 
Sbjct: 265 DGEPPYF-----NEPPLKAMKMIRDN------------LPPRL----------------- 290
Query: 375 ADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 414
             N H VSP    FLD+LL  D   R TA E + HP+ A+
Sbjct: 291 -KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAK 329

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 72/336 (21%), Positives = 146/336 (43%), Gaps = 53/336 (15%)
Query: 91  LPAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRK---VGRGKYSEVFEGINV 147
           +P  SK      V++  P   +D+  +T + G  + +  V K   +G G++ +V +    
Sbjct: 52  MPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEET 111
Query: 148 NTNERCXXXXXXXXXXXXXXXXXXXLQ--NLCGGPNVVKLLDIVRDQHSKTPSLIFEYVN 205
            T  +                    +   N     N+++L D    ++     L+ EYV+
Sbjct: 112 ATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIV--LVMEYVD 169
Query: 206 STDF--KVLYPT--LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM-IDHELRKLR 260
             +   +++  +  LT+ D   ++ ++ + + + H   I+H D+KP N++ ++ + ++++
Sbjct: 170 GGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIK 229
Query: 261 LIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYD---YSLDMWSLGCMFAGMIFRK 317
           +ID+GLA  Y P ++  V   +  F  PE++    +YD   +  DMWS+G +   ++   
Sbjct: 230 IIDFGLARRYKPREKLKVNFGTPEFLAPEVV----NYDFVSFPTDMWSVGVIAYMLLSGL 285
Query: 318 EPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADN 377
            PF   +D        A+ L     N    ++ LE +   D                   
Sbjct: 286 SPFLGDND--------AETLN----NILACRWDLEDEEFQD------------------- 314
Query: 378 QHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA 413
              +S EA +F+ KLL  +   R++A EA+ HP+ +
Sbjct: 315 ---ISEEAKEFISKLLIKEKSWRISASEALKHPWLS 347

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 94/205 (45%), Gaps = 38/205 (18%)
Query: 211 VLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEF 269
           V +  + +  I      +L+AL   H+QG++HRD+K  ++++ H+ R ++L D+G  A+ 
Sbjct: 119 VTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGR-VKLSDFGFCAQV 177
Query: 270 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQ 329
                     V + Y+  PEL+  L  Y   +D+WSLG M   M+  + P+F     ++ 
Sbjct: 178 SKEVPRRKXLVGTPYWMAPELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYF-----NEP 231
Query: 330 LVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFL 389
            +K  K++  +            L P+L                   N H VSP    FL
Sbjct: 232 PLKAMKMIRDN------------LPPRL------------------KNLHKVSPSLKGFL 261
Query: 390 DKLLRYDHQDRLTAREAMAHPYFAQ 414
           D+LL  D   R TA E + HP+ A+
Sbjct: 262 DRLLVRDPAQRATAAELLKHPFLAK 286

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 94/205 (45%), Gaps = 38/205 (18%)
Query: 211 VLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEF 269
           V +  + +  I      +L+AL   H+QG++HRD+K  ++++ H+ R ++L D+G  A+ 
Sbjct: 117 VTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGR-VKLSDFGFCAQV 175
Query: 270 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQ 329
                     V + Y+  PEL+  L  Y   +D+WSLG M   M+  + P+F     ++ 
Sbjct: 176 SKEVPRRKXLVGTPYWMAPELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYF-----NEP 229
Query: 330 LVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFL 389
            +K  K++  +            L P+L                   N H VSP    FL
Sbjct: 230 PLKAMKMIRDN------------LPPRL------------------KNLHKVSPSLKGFL 259
Query: 390 DKLLRYDHQDRLTAREAMAHPYFAQ 414
           D+LL  D   R TA E + HP+ A+
Sbjct: 260 DRLLVRDPAQRATAAELLKHPFLAK 284

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 94/205 (45%), Gaps = 38/205 (18%)
Query: 211 VLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEF 269
           V +  + +  I      +L+AL   H+QG++HRD+K  ++++ H+ R ++L D+G  A+ 
Sbjct: 108 VTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGR-VKLSDFGFCAQV 166
Query: 270 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQ 329
                     V + Y+  PEL+  L  Y   +D+WSLG M   M+  + P+F     ++ 
Sbjct: 167 SKEVPRRKXLVGTPYWMAPELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYF-----NEP 220
Query: 330 LVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFL 389
            +K  K++  +            L P+L                   N H VSP    FL
Sbjct: 221 PLKAMKMIRDN------------LPPRL------------------KNLHKVSPSLKGFL 250
Query: 390 DKLLRYDHQDRLTAREAMAHPYFAQ 414
           D+LL  D   R TA E + HP+ A+
Sbjct: 251 DRLLVRDPAQRATAAELLKHPFLAK 275

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 94/205 (45%), Gaps = 38/205 (18%)
Query: 211 VLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEF 269
           V +  + +  I      +L+AL   H+QG++HRD+K  ++++ H+ R ++L D+G  A+ 
Sbjct: 112 VTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGR-VKLSDFGFCAQV 170
Query: 270 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQ 329
                     V + Y+  PEL+  L  Y   +D+WSLG M   M+  + P+F     ++ 
Sbjct: 171 SKEVPRRKXLVGTPYWMAPELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYF-----NEP 224
Query: 330 LVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFL 389
            +K  K++  +            L P+L                   N H VSP    FL
Sbjct: 225 PLKAMKMIRDN------------LPPRL------------------KNLHKVSPSLKGFL 254
Query: 390 DKLLRYDHQDRLTAREAMAHPYFAQ 414
           D+LL  D   R TA E + HP+ A+
Sbjct: 255 DRLLVRDPAQRATAAELLKHPFLAK 279

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 81/148 (54%), Gaps = 8/148 (5%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNS---TDFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           PNVVKL++++ D +     ++FE VN     +   L P L++   R+Y  +L+K ++Y H
Sbjct: 96  PNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKP-LSEDQARFYFQDLIKGIEYLH 154
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQ 295
            Q I+HRD+KP N+++  +   +++ D+G++ EF       +  V +  F  PE L + +
Sbjct: 155 YQKIIHRDIKPSNLLVGED-GHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETR 213
Query: 296 DY--DYSLDMWSLGCMFAGMIFRKEPFF 321
                 +LD+W++G      +F + PF 
Sbjct: 214 KIFSGKALDVWAMGVTLYCFVFGQCPFM 241

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/248 (22%), Positives = 113/248 (45%), Gaps = 45/248 (18%)
Query: 173 LQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELL 229
           L+ + G P+++ L+D    + S    L+F+ +      D+      L++ + R  +  LL
Sbjct: 153 LRQVAGHPHIITLIDSY--ESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLL 210
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
           +A+ + H+  I+HRD+KP N+++D  + ++RL D+G +    PG++      +  +  PE
Sbjct: 211 EAVSFLHANNIVHRDLKPENILLDDNM-QIRLSDFGFSCHLEPGEKLRELCGTPGYLAPE 269
Query: 290 LLVDLQD-----YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA 344
           +L    D     Y   +D+W+ G +   ++    PF++      Q++ +  ++       
Sbjct: 270 ILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWH----RRQILMLRMIME------ 319
Query: 345 YLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAR 404
              +Y     P+ D                 D    V     D + +LL+ D + RLTA 
Sbjct: 320 --GQYQFS-SPEWD-----------------DRSSTVK----DLISRLLQVDPEARLTAE 355
Query: 405 EAMAHPYF 412
           +A+ HP+F
Sbjct: 356 QALQHPFF 363

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 109/233 (46%), Gaps = 43/233 (18%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLYP--TLTDYDIRYYIYELLKALDYCH 236
           PN++KL D+  D+  K   L+ E+    + F+ +       + D    + ++L  + Y H
Sbjct: 106 PNIIKLFDVFEDK--KYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLH 163
Query: 237 SQGIMHRDVKPHNVMIDHE--LRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 294
              I+HRD+KP N++++++  L  ++++D+GL+ F+    +   R+ + Y+  PE+L   
Sbjct: 164 KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLK-- 221
Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 354
           + Y+   D+WS G +   ++    P F G ++ D + K+ K            KY+ + +
Sbjct: 222 KKYNEKCDVWSCGVIMY-ILLCGYPPFGGQNDQDIIKKVEK-----------GKYYFDFN 269
Query: 355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
                         W           +S EA + +  +L YD+  R TA EA+
Sbjct: 270 -------------DWKN---------ISDEAKELIKLMLTYDYNKRCTAEEAL 300

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/300 (22%), Positives = 127/300 (42%), Gaps = 47/300 (15%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQNLCGGP 180
           D+Y++  ++G+G +S V   + + T +    +                    +  L   P
Sbjct: 4   DEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHP 63
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDF---KVLYPTLTDYDIRYYIYELLKALDYCHS 237
           N+V+L D + ++      L+F+ V   +     V     ++ D  + I ++L+++++CH 
Sbjct: 64  NIVRLHDSISEEGFHY--LVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHL 121
Query: 238 QGIMHRDVKPHNVMIDHELR--KLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDL 294
            GI+HRD+KP N+++  + +   ++L D+GLA E     + +     +  +  PE+L   
Sbjct: 122 NGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRK- 180
Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 354
             Y   +DMW+ G +   ++    P F+  D H                         L 
Sbjct: 181 DPYGKPVDMWACGVILY-ILLVGYPPFWDEDQH------------------------RLY 215
Query: 355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 414
            Q+ A         W           V+PEA D ++K+L  +   R+TA EA+ HP+  Q
Sbjct: 216 QQIKAGAYDFPSPEWDT---------VTPEAKDLINKMLTINPAKRITASEALKHPWICQ 266

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 69/310 (22%), Positives = 129/310 (41%), Gaps = 47/310 (15%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQNLCGGP 180
           D+Y++  ++G+G +S V   + + T +    +                    +  L   P
Sbjct: 4   DEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHP 63
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDF---KVLYPTLTDYDIRYYIYELLKALDYCHS 237
           N+V+L D + ++      L+F+ V   +     V     ++ D  + I ++L+++++CH 
Sbjct: 64  NIVRLHDSISEEGFHY--LVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHL 121
Query: 238 QGIMHRDVKPHNVMIDHELR--KLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDL 294
            GI+HRD+KP N+++  + +   ++L D+GLA E     + +     +  +  PE+L   
Sbjct: 122 NGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRK- 180
Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 354
             Y   +DMW+ G +   ++    P F+  D H                         L 
Sbjct: 181 DPYGKPVDMWACGVILY-ILLVGYPPFWDEDQH------------------------RLY 215
Query: 355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 414
            Q+ A         W           V+PEA D ++K+L  +   R+TA EA+ HP+  Q
Sbjct: 216 QQIKAGAYDFPSPEWDT---------VTPEAKDLINKMLTINPAKRITASEALKHPWICQ 266
Query: 415 VRAAESSRTR 424
                S   R
Sbjct: 267 RSTVASMMHR 276

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 72/310 (23%), Positives = 128/310 (41%), Gaps = 59/310 (19%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNER-------CXXXXXXXXXXXXXXXXXXXLQNL 176
           +D YE+   +G+G +S V   IN  T ++                           + ++
Sbjct: 23  EDVYELCEVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82
Query: 177 CGGPNVVKLLDIVRD--------QHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYEL 228
              P++V+LL+            +      L FE V   D   +Y   ++    +Y+ ++
Sbjct: 83  LKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVY---SEAVASHYMRQI 139
Query: 229 LKALDYCHSQGIMHRDVKPHNVMIDHELRK--LRLIDWGLA-EFYHPGKEYNVRVASRYF 285
           L+AL YCH   I+HRDVKP NV++  +     ++L D+G+A +    G     RV + +F
Sbjct: 140 LEALRYCHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGRVGTPHF 199
Query: 286 KGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDE-LNA 344
             PE +V  + Y   +D+W  G +   ++    PF+                GT E L  
Sbjct: 200 MAPE-VVKREPYGKPVDVWGCGVILFILLSGCLPFY----------------GTKERLFE 242
Query: 345 YLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAR 404
            + K   +++P           + WS          +S  A D + ++L  D  +R+T  
Sbjct: 243 GIIKGKYKMNP-----------RQWSH---------ISESAKDLVRRMLMLDPAERITVY 282
Query: 405 EAMAHPYFAQ 414
           EA+ HP+  +
Sbjct: 283 EALNHPWLKE 292

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 93/205 (45%), Gaps = 38/205 (18%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGK 274
           L +  I      +L+AL Y H+QG++HRD+K  ++++  + R ++L D+G  A+      
Sbjct: 138 LNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGR-VKLSDFGFCAQISKDVP 196
Query: 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 334
           +    V + Y+  PE ++    Y   +D+WSLG M   M+  + P+F      D  V+  
Sbjct: 197 KRKXLVGTPYWMAPE-VISRSLYATEVDIWSLGIMVIEMVDGEPPYF-----SDSPVQAM 250
Query: 335 KVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLR 394
           K L                         R S  P  K     N H VSP   DFL+++L 
Sbjct: 251 KRL-------------------------RDSPPPKLK-----NSHKVSPVLRDFLERMLV 280
Query: 395 YDHQDRLTAREAMAHPYFAQVRAAE 419
            D Q+R TA+E + HP+  Q    E
Sbjct: 281 RDPQERATAQELLDHPFLLQTGLPE 305

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 95/204 (46%), Gaps = 51/204 (25%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY---NV 278
           R+Y  E++ AL+Y H +GI+HRD+KP N++++ ++  +++ D+G A+   P  +    N 
Sbjct: 135 RFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANX 193
Query: 279 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLG 338
            V +  +  PELL + +    S D+W+LGC+   ++    PF  G++     +  AK++ 
Sbjct: 194 FVGTAQYVSPELLTE-KSAXKSSDLWALGCIIYQLVAGLPPFRAGNEG----LIFAKII- 247
Query: 339 TDELNAYLNKYHLELD-PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDH 397
                       LE D P+              KF          P+A D ++KLL  D 
Sbjct: 248 -----------KLEYDFPE--------------KFF---------PKARDLVEKLLVLDA 273
Query: 398 QDRLTAREA------MAHPYFAQV 415
             RL   E        AHP+F  V
Sbjct: 274 TKRLGCEEMEGYGPLKAHPFFESV 297

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/242 (26%), Positives = 106/242 (43%), Gaps = 43/242 (17%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           PN++ L D+  ++      LI E V+     DF     +L++ +   +I ++L  ++Y H
Sbjct: 75  PNIITLHDVYENRTDVV--LILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH 132
Query: 237 SQGIMHRDVKPHNVMI---DHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           ++ I H D+KP N+M+   +  +  ++LID+GLA     G E+     +  F  PE +V+
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE-IVN 191
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 353
            +      DMWS+G +   ++    PF  G    + L  I  V       +Y   +  E 
Sbjct: 192 YEPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANITAV-------SY--DFDEEF 241
Query: 354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA 413
             Q   L                        A DF+ KLL  + + RLT +EA+ HP+  
Sbjct: 242 FSQTSEL------------------------AKDFIRKLLVKETRKRLTIQEALRHPWIT 277
Query: 414 QV 415
            V
Sbjct: 278 PV 279

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 44/202 (21%), Positives = 97/202 (48%), Gaps = 10/202 (4%)
Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQNLCGGPN 181
           +Y +++ +G+G +++V    ++ T +    R                    +  +   PN
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCHSQ 238
           +VKL +++  +  KT  L+ EY +     D+ V +  + + + R    +++ A+ YCH +
Sbjct: 75  IVKLFEVIETE--KTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQK 132
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYD 298
            I+HRD+K  N+++D ++  +++ D+G +  +  G + +    S  +  PEL    +   
Sbjct: 133 FIVHRDLKAENLLLDADM-NIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDG 191
Query: 299 YSLDMWSLGCMFAGMIFRKEPF 320
             +D+WSLG +   ++    PF
Sbjct: 192 PEVDVWSLGVILYTLVSGSLPF 213

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 95/204 (46%), Gaps = 51/204 (25%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY---NV 278
           R+Y  E++ AL+Y H +GI+HRD+KP N++++ ++  +++ D+G A+   P  +    N 
Sbjct: 135 RFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANX 193
Query: 279 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLG 338
            V +  +  PELL + +    S D+W+LGC+   ++    PF  G++     +  AK++ 
Sbjct: 194 FVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEG----LIFAKII- 247
Query: 339 TDELNAYLNKYHLELD-PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDH 397
                       LE D P+              KF          P+A D ++KLL  D 
Sbjct: 248 -----------KLEYDFPE--------------KFF---------PKARDLVEKLLVLDA 273
Query: 398 QDRLTAREA------MAHPYFAQV 415
             RL   E        AHP+F  V
Sbjct: 274 TKRLGCEEMEGYGPLKAHPFFESV 297

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 107/219 (48%), Gaps = 47/219 (21%)
Query: 200 IFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRK- 258
           IFE +N++ F+     L + +I  Y++++ +AL + HS  I H D++P N++  ++ R+ 
Sbjct: 88  IFERINTSAFE-----LNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENII--YQTRRS 140
Query: 259 --LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD-YDYSLDMWSLGCMFAGMIF 315
             +++I++G A    PG  + +   +  +  PE  V   D    + DMWSLG +   ++ 
Sbjct: 141 STIKIIEFGQARQLKPGDNFRLLFTAPEYYAPE--VHQHDVVSTATDMWSLGTLVYVLLS 198
Query: 316 RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINA 375
              PF    + + Q+++       + +NA   +Y  + +   +                 
Sbjct: 199 GINPFLA--ETNQQIIE-------NIMNA---EYTFDEEAFKE----------------- 229
Query: 376 DNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 414
                +S EA+DF+D+LL  + + R+TA EA+ HP+  Q
Sbjct: 230 -----ISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 39/144 (27%), Positives = 77/144 (53%), Gaps = 6/144 (4%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           PN+VKL +++  +  KT  LI EY +     D+ V +  + + + R    +++ A+ YCH
Sbjct: 71  PNIVKLFEVIETE--KTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCH 128
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
            + I+HRD+K  N+++D ++  +++ D+G +  +  G + +    S  +  PEL    + 
Sbjct: 129 QKRIVHRDLKAENLLLDADM-NIKIADFGFSNEFTVGGKLDTFCGSPPYAAPELFQGKKY 187
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPF 320
               +D+WSLG +   ++    PF
Sbjct: 188 DGPEVDVWSLGVILYTLVSGSLPF 211

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 72/302 (23%), Positives = 122/302 (40%), Gaps = 52/302 (17%)
Query: 120 QWGDQDDYEVVRKVGRGKYSEVFEGINVNTN-----ERCXXXXXXXXXXXXXXXXXXXLQ 174
           QW   +D+E+ R +G+GK+  V+     N+      +                     +Q
Sbjct: 4   QWA-LEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 62
Query: 175 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIYELLKA 231
           +    PN+++L     D  S    LI EY            L+ +D      YI EL  A
Sbjct: 63  SHLRHPNILRLYGYFHD--STRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 120
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 291
           L YCHS+ ++HRD+KP N+++     +L++ D+G +  + P         +  +  PE +
Sbjct: 121 LSYCHSKKVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRAALCGTLDYLPPE-M 177
Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL 351
           ++ + +D  +D+WSLG +    +  K PF                    E N Y + Y  
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPPF--------------------EANTYQDTYK- 216
Query: 352 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 411
                      R SR    +F   D    V+  A D + +LL+++   R   RE + HP+
Sbjct: 217 -----------RISR---VEFTFPD---FVTEGARDLISRLLKHNPSQRPMLREVLEHPW 259
Query: 412 FA 413
Sbjct: 260 IT 261

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 72/307 (23%), Positives = 123/307 (40%), Gaps = 52/307 (16%)
Query: 115 ESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTN-----ERCXXXXXXXXXXXXXXXX 169
           ES   QW   +D+E+ R +G+GK+  V+      +      +                  
Sbjct: 4   ESKKRQWA-LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 62
Query: 170 XXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIY 226
              +Q+    PN+++L     D  +    LI EY    +       L+ +D      YI 
Sbjct: 63  EVEIQSHLRHPNILRLYGYFHD--ATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYIT 120
Query: 227 ELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 286
           EL  AL YCHS+ ++HRD+KP N+++     +L++ D+G +  + P         +  + 
Sbjct: 121 ELANALSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRTTLCGTLDYL 178
Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYL 346
            PE +++ + +D  +D+WSLG +    +  K PF                    E N Y 
Sbjct: 179 PPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPF--------------------EANTYQ 217
Query: 347 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA 406
             Y             R SR    +F   D    V+  A D + +LL+++   R   RE 
Sbjct: 218 ETYK------------RISR---VEFTFPD---FVTEGARDLISRLLKHNPSQRPMLREV 259
Query: 407 MAHPYFA 413
           + HP+  
Sbjct: 260 LEHPWIT 266

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 71/310 (22%), Positives = 127/310 (40%), Gaps = 59/310 (19%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNER-------CXXXXXXXXXXXXXXXXXXXLQNL 176
           +D YE+   +G+G +S V   IN  T ++                           + ++
Sbjct: 25  EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 84
Query: 177 CGGPNVVKLLDIVRD--------QHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYEL 228
              P++V+LL+            +      L FE V   D   +Y   ++    +Y+ ++
Sbjct: 85  LKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVY---SEAVASHYMRQI 141
Query: 229 LKALDYCHSQGIMHRDVKPHNVMIDHELRK--LRLIDWGLA-EFYHPGKEYNVRVASRYF 285
           L+AL YCH   I+HRDVKPH V++  +     ++L  +G+A +    G     RV + +F
Sbjct: 142 LEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHF 201
Query: 286 KGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDE-LNA 344
             PE +V  + Y   +D+W  G +   ++    PF+                GT E L  
Sbjct: 202 MAPE-VVKREPYGKPVDVWGCGVILFILLSGCLPFY----------------GTKERLFE 244
Query: 345 YLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAR 404
            + K   +++P           + WS          +S  A D + ++L  D  +R+T  
Sbjct: 245 GIIKGKYKMNP-----------RQWSH---------ISESAKDLVRRMLMLDPAERITVY 284
Query: 405 EAMAHPYFAQ 414
           EA+ HP+  +
Sbjct: 285 EALNHPWLKE 294

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/240 (25%), Positives = 102/240 (42%), Gaps = 43/240 (17%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDF--KVLYP-TLTDYDIRYYIYELLKALDYCH 236
           PN+++L +   D       L+ E     +   +V++     + D    + ++L A+ YCH
Sbjct: 66  PNIIRLYETFEDNTDIY--LVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCH 123
Query: 237 SQGIMHRDVKPHNVMI--DHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 294
              + HRD+KP N +   D     L+LID+GLA  + PGK    +V + Y+  P++L  L
Sbjct: 124 KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGL 183
Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 354
             Y    D WS G M   ++    PF    D  + ++KI +   T     +LN       
Sbjct: 184 --YGPECDEWSAGVMMYVLLCGYPPFSAPTD-XEVMLKIREGTFTFPEKDWLN------- 233
Query: 355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 414
                                     VSP+A   + +LL    + R+T+ +A+ H +F +
Sbjct: 234 --------------------------VSPQAESLIRRLLTKSPKQRITSLQALEHEWFEK 267

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/240 (25%), Positives = 102/240 (42%), Gaps = 43/240 (17%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDF--KVLYP-TLTDYDIRYYIYELLKALDYCH 236
           PN+++L +   D       L+ E     +   +V++     + D    + ++L A+ YCH
Sbjct: 83  PNIIRLYETFEDNTDIY--LVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCH 140
Query: 237 SQGIMHRDVKPHNVMI--DHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 294
              + HRD+KP N +   D     L+LID+GLA  + PGK    +V + Y+  P++L  L
Sbjct: 141 KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGL 200
Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 354
             Y    D WS G M   ++    PF    D  + ++KI +   T     +LN       
Sbjct: 201 --YGPECDEWSAGVMMYVLLCGYPPFSAPTD-XEVMLKIREGTFTFPEKDWLN------- 250
Query: 355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 414
                                     VSP+A   + +LL    + R+T+ +A+ H +F +
Sbjct: 251 --------------------------VSPQAESLIRRLLTKSPKQRITSLQALEHEWFEK 284

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 38/144 (26%), Positives = 77/144 (53%), Gaps = 6/144 (4%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           PN+VKL +++  +  KT  L+ EY +     D+ V +  + + + R    +++ A+ YCH
Sbjct: 74  PNIVKLFEVIETE--KTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCH 131
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
            + I+HRD+K  N+++D ++  +++ D+G +  +  G + +    S  +  PEL    + 
Sbjct: 132 QKYIVHRDLKAENLLLDGDM-NIKIADFGFSNEFTVGNKLDTFCGSPPYAAPELFQGKKY 190
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPF 320
               +D+WSLG +   ++    PF
Sbjct: 191 DGPEVDVWSLGVILYTLVSGSLPF 214

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 44/202 (21%), Positives = 97/202 (48%), Gaps = 10/202 (4%)
Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQNLCGGPN 181
           +Y +++ +G+G +++V    ++ T +    R                    +  +   PN
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCHSQ 238
           +VKL +++  +  KT  L+ EY +     D+ V +  + + + R    +++ A+ YCH +
Sbjct: 75  IVKLFEVIETE--KTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQK 132
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYD 298
            I+HRD+K  N+++D ++  +++ D+G +  +  G + +    S  +  PEL    +   
Sbjct: 133 FIVHRDLKAENLLLDADM-NIKIADFGFSNEFTFGNKLDEFCGSPPYAAPELFQGKKYDG 191
Query: 299 YSLDMWSLGCMFAGMIFRKEPF 320
             +D+WSLG +   ++    PF
Sbjct: 192 PEVDVWSLGVILYTLVSGSLPF 213

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 71/310 (22%), Positives = 127/310 (40%), Gaps = 59/310 (19%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNER-------CXXXXXXXXXXXXXXXXXXXLQNL 176
           +D YE+   +G+G +S V   IN  T ++                           + ++
Sbjct: 23  EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82
Query: 177 CGGPNVVKLLDIVRD--------QHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYEL 228
              P++V+LL+            +      L FE V   D   +Y   ++    +Y+ ++
Sbjct: 83  LKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVY---SEAVASHYMRQI 139
Query: 229 LKALDYCHSQGIMHRDVKPHNVMIDHELRK--LRLIDWGLA-EFYHPGKEYNVRVASRYF 285
           L+AL YCH   I+HRDVKPH V++  +     ++L  +G+A +    G     RV + +F
Sbjct: 140 LEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHF 199
Query: 286 KGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDE-LNA 344
             PE +V  + Y   +D+W  G +   ++    PF+                GT E L  
Sbjct: 200 MAPE-VVKREPYGKPVDVWGCGVILFILLSGCLPFY----------------GTKERLFE 242
Query: 345 YLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAR 404
            + K   +++P           + WS          +S  A D + ++L  D  +R+T  
Sbjct: 243 GIIKGKYKMNP-----------RQWSH---------ISESAKDLVRRMLMLDPAERITVY 282
Query: 405 EAMAHPYFAQ 414
           EA+ HP+  +
Sbjct: 283 EALNHPWLKE 292

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 43/202 (21%), Positives = 97/202 (48%), Gaps = 10/202 (4%)
Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQNLCGGPN 181
           +Y +++ +G+G +++V    ++ T +    +                    +  +   PN
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCHSQ 238
           +VKL +++  +  KT  L+ EY +     D+ V +  + + + R    +++ A+ YCH +
Sbjct: 75  IVKLFEVIETE--KTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQK 132
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYD 298
            I+HRD+K  N+++D ++  +++ D+G +  +  G + +    S  +  PEL    +   
Sbjct: 133 FIVHRDLKAENLLLDADM-NIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDG 191
Query: 299 YSLDMWSLGCMFAGMIFRKEPF 320
             +D+WSLG +   ++    PF
Sbjct: 192 PEVDVWSLGVILYTLVSGSLPF 213

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 74/297 (24%), Positives = 124/297 (41%), Gaps = 46/297 (15%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVVK 184
           D YEV   +G G YS     I+  TN                      L+     PN++ 
Sbjct: 22  DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLR-YGQHPNIIT 80
Query: 185 LLDIVRDQHSKTPSLIFEYVNSTDF--KVLYPTL-TDYDIRYYIYELLKALDYCHSQGIM 241
           L D+  D   K   ++ E +   +   K+L     ++ +    ++ + K ++Y H+QG++
Sbjct: 81  LKDVYDD--GKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVV 138
Query: 242 HRDVKPHNVMIDHEL---RKLRLIDWGLAEFYHPGKEYNVRVASRY---FKGPELLVDLQ 295
           HRD+KP N++   E      +R+ D+G A+      E  + +   Y   F  PE+L + Q
Sbjct: 139 HRDLKPSNILYVDESGNPESIRICDFGFAKQLR--AENGLLMTPCYTANFVAPEVL-ERQ 195
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP 355
            YD + D+WSLG +   M+    PF  G D+  +  +I   +G+ +              
Sbjct: 196 GYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPE--EILARIGSGKF------------- 240
Query: 356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 412
              +L G +    W+          VS  A D + K+L  D   RLTA   + HP+ 
Sbjct: 241 ---SLSGGY----WNS---------VSDTAKDLVSKMLHVDPHQRLTAALVLRHPWI 281

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 38/144 (26%), Positives = 77/144 (53%), Gaps = 6/144 (4%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           PN+VKL +++  +  KT  LI EY +     D+ V +  + + + R    +++ A+ YCH
Sbjct: 74  PNIVKLFEVIETE--KTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCH 131
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
            + I+HRD+K  N+++D ++  +++ D+G +  +  G + +    +  +  PEL    + 
Sbjct: 132 QKRIVHRDLKAENLLLDADM-NIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKY 190
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPF 320
               +D+WSLG +   ++    PF
Sbjct: 191 DGPEVDVWSLGVILYTLVSGSLPF 214

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 43/202 (21%), Positives = 97/202 (48%), Gaps = 10/202 (4%)
Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQNLCGGPN 181
           +Y +++ +G+G +++V    ++ T +    +                    +  +   PN
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCHSQ 238
           +VKL +++  +  KT  L+ EY +     D+ V +  + + + R    +++ A+ YCH +
Sbjct: 75  IVKLFEVIETE--KTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQK 132
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYD 298
            I+HRD+K  N+++D ++  +++ D+G +  +  G + +    S  +  PEL    +   
Sbjct: 133 FIVHRDLKAENLLLDADM-NIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDG 191
Query: 299 YSLDMWSLGCMFAGMIFRKEPF 320
             +D+WSLG +   ++    PF
Sbjct: 192 PEVDVWSLGVILYTLVSGSLPF 213

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 34/107 (31%), Positives = 64/107 (59%), Gaps = 5/107 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY---NV 278
           R+Y  E++ AL+Y H +GI+HRD+KP N++++ ++  +++ D+G A+   P  +    N 
Sbjct: 135 RFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANS 193
Query: 279 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD 325
            V +  +  PELL + +    S D+W+LGC+   ++    PF  G++
Sbjct: 194 FVGTAQYVSPELLTE-KSASKSSDLWALGCIIYQLVAGLPPFRAGNE 239

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 44/125 (35%), Positives = 68/125 (54%), Gaps = 19/125 (15%)
Query: 227 ELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-------------PG 273
           ++L+AL Y HSQGI+HRD+KP N+ ID E R +++ D+GLA+  H             PG
Sbjct: 124 QILEALSYIHSQGIIHRDLKPMNIFID-ESRNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182
Query: 274 KEYNVR--VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
              N+   + +  +   E+L     Y+  +DM+SLG +F  MI+   PF  G +  + L 
Sbjct: 183 SSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILK 239
Query: 332 KIAKV 336
           K+  V
Sbjct: 240 KLRSV 244

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 44/125 (35%), Positives = 68/125 (54%), Gaps = 19/125 (15%)
Query: 227 ELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-------------PG 273
           ++L+AL Y HSQGI+HRD+KP N+ ID E R +++ D+GLA+  H             PG
Sbjct: 124 QILEALSYIHSQGIIHRDLKPMNIFID-ESRNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182
Query: 274 KEYNVR--VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
              N+   + +  +   E+L     Y+  +DM+SLG +F  MI+   PF  G +  + L 
Sbjct: 183 SSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILK 239
Query: 332 KIAKV 336
           K+  V
Sbjct: 240 KLRSV 244

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 43/142 (30%), Positives = 82/142 (57%), Gaps = 11/142 (7%)
Query: 200 IFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQ--GIMHRDVKPHNVMIDHELR 257
           +++ + +T+F+ +   LT    R +  ++  AL +  +    I+H D+KP N+++ +  R
Sbjct: 123 LYDLLRNTNFRGVSLNLT----RKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKR 178
Query: 258 K-LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFR 316
             ++++D+G +     G+     + SR+++ PE+L+ +  YD ++DMWSLGC+   M   
Sbjct: 179 SAIKIVDFGSS--CQLGQRIYQXIQSRFYRSPEVLLGM-PYDLAIDMWSLGCILVEM-HT 234
Query: 317 KEPFFYGHDNHDQLVKIAKVLG 338
            EP F G +  DQ+ KI +VLG
Sbjct: 235 GEPLFSGANEVDQMNKIVEVLG 256

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/311 (22%), Positives = 127/311 (40%), Gaps = 47/311 (15%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQNLCGG 179
           Q  Y++  ++G+G +S V   + V   +    +                    +  L   
Sbjct: 21  QSMYQLFEELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 80
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDF---KVLYPTLTDYDIRYYIYELLKALDYCH 236
           PN+V+L D + ++      LIF+ V   +     V     ++ D  + I ++L+A+ +CH
Sbjct: 81  PNIVRLHDSISEEGHHY--LIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCH 138
Query: 237 SQGIMHRDVKPHNVMIDHELR--KLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVD 293
             G++HRD+KP N+++  +L+   ++L D+GLA E     + +     +  +  PE+L  
Sbjct: 139 QMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRK 198
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 353
              Y   +D+W+ G +   ++    P F+  D H                         L
Sbjct: 199 -DPYGKPVDLWACGVILY-ILLVGYPPFWDEDQH------------------------RL 232
Query: 354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA 413
             Q+ A         W           V+PEA D ++K+L  +   R+TA EA+ HP+ +
Sbjct: 233 YQQIKAGAYDFPSPEWDT---------VTPEAKDLINKMLTINPSKRITAAEALKHPWIS 283
Query: 414 QVRAAESSRTR 424
                 S   R
Sbjct: 284 HRSTVASCMHR 294

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 43/142 (30%), Positives = 82/142 (57%), Gaps = 11/142 (7%)
Query: 200 IFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQ--GIMHRDVKPHNVMIDHELR 257
           +++ + +T+F+ +   LT    R +  ++  AL +  +    I+H D+KP N+++ +  R
Sbjct: 142 LYDLLRNTNFRGVSLNLT----RKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKR 197
Query: 258 K-LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFR 316
             ++++D+G +     G+     + SR+++ PE+L+ +  YD ++DMWSLGC+   M   
Sbjct: 198 SAIKIVDFGSS--CQLGQRIYQXIQSRFYRSPEVLLGM-PYDLAIDMWSLGCILVEM-HT 253
Query: 317 KEPFFYGHDNHDQLVKIAKVLG 338
            EP F G +  DQ+ KI +VLG
Sbjct: 254 GEPLFSGANEVDQMNKIVEVLG 275

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 72/307 (23%), Positives = 122/307 (39%), Gaps = 52/307 (16%)
Query: 115 ESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTN-----ERCXXXXXXXXXXXXXXXX 169
           ES   QW   +D+E+ R +G+GK+  V+      +      +                  
Sbjct: 25  ESKKRQWA-LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 83
Query: 170 XXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIY 226
              +Q+    PN+++L     D  +    LI EY            L+ +D      YI 
Sbjct: 84  EVEIQSHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT 141
Query: 227 ELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 286
           EL  AL YCHS+ ++HRD+KP N+++     +L++ D+G +  + P         +  + 
Sbjct: 142 ELANALSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRTTLCGTLDYL 199
Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYL 346
            PE +++ + +D  +D+WSLG +    +  K PF                    E N Y 
Sbjct: 200 PPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPF--------------------EANTYQ 238
Query: 347 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA 406
             Y             R SR    +F   D    V+  A D + +LL+++   R   RE 
Sbjct: 239 ETYK------------RISR---VEFTFPD---FVTEGARDLISRLLKHNPSQRPMLREV 280
Query: 407 MAHPYFA 413
           + HP+  
Sbjct: 281 LEHPWIT 287

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 72/307 (23%), Positives = 123/307 (40%), Gaps = 52/307 (16%)
Query: 115 ESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTN-----ERCXXXXXXXXXXXXXXXX 169
           ES   QW   +D+E+ R +G+GK+  V+      +      +                  
Sbjct: 4   ESKKRQWA-LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 62
Query: 170 XXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIY 226
              +Q+    PN+++L     D  +    LI EY    +       L+ +D      YI 
Sbjct: 63  EVEIQSHLRHPNILRLYGYFHD--ATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYIT 120
Query: 227 ELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 286
           EL  AL YCHS+ ++HRD+KP N+++     +L++ D+G +  + P         +  + 
Sbjct: 121 ELANALSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRXXLXGTLDYL 178
Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYL 346
            PE +++ + +D  +D+WSLG +    +  K PF                    E N Y 
Sbjct: 179 PPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPF--------------------EANTYQ 217
Query: 347 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA 406
             Y             R SR    +F   D    V+  A D + +LL+++   R   RE 
Sbjct: 218 ETYK------------RISR---VEFTFPD---FVTEGARDLISRLLKHNPSQRPMLREV 259
Query: 407 MAHPYFA 413
           + HP+  
Sbjct: 260 LEHPWIT 266

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 72/307 (23%), Positives = 122/307 (39%), Gaps = 52/307 (16%)
Query: 115 ESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTN-----ERCXXXXXXXXXXXXXXXX 169
           ES   QW   +D+E+ R +G+GK+  V+      +      +                  
Sbjct: 4   ESKKRQWA-LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 62
Query: 170 XXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIY 226
              +Q+    PN+++L     D  +    LI EY            L+ +D      YI 
Sbjct: 63  EVEIQSHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT 120
Query: 227 ELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 286
           EL  AL YCHS+ ++HRD+KP N+++     +L++ D+G +  + P         +  + 
Sbjct: 121 ELANALSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRTTLCGTLDYL 178
Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYL 346
            PE +++ + +D  +D+WSLG +    +  K PF                    E N Y 
Sbjct: 179 PPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPF--------------------EANTYQ 217
Query: 347 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA 406
             Y             R SR    +F   D    V+  A D + +LL+++   R   RE 
Sbjct: 218 ETYK------------RISR---VEFTFPD---FVTEGARDLISRLLKHNPSQRPMLREV 259
Query: 407 MAHPYFA 413
           + HP+  
Sbjct: 260 LEHPWIT 266

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 43/202 (21%), Positives = 97/202 (48%), Gaps = 10/202 (4%)
Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQNLCGGPN 181
           +Y +++ +G+G +++V    ++ T +    +                    +  +   PN
Sbjct: 8   NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 67
Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCHSQ 238
           +VKL +++  +  KT  L+ EY +     D+ V +  + + + R    +++ A+ YCH +
Sbjct: 68  IVKLFEVIETE--KTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVSAVQYCHQK 125
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYD 298
            I+HRD+K  N+++D ++  +++ D+G +  +  G + +    S  +  PEL    +   
Sbjct: 126 FIVHRDLKAENLLLDADM-NIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDG 184
Query: 299 YSLDMWSLGCMFAGMIFRKEPF 320
             +D+WSLG +   ++    PF
Sbjct: 185 PEVDVWSLGVILYTLVSGSLPF 206

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 34/107 (31%), Positives = 64/107 (59%), Gaps = 5/107 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY---NV 278
           R+Y  E++ AL+Y H +GI+HRD+KP N++++ ++  +++ D+G A+   P  +    N 
Sbjct: 133 RFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANA 191
Query: 279 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD 325
            V +  +  PELL + +    S D+W+LGC+   ++    PF  G++
Sbjct: 192 FVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNE 237

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 72/307 (23%), Positives = 122/307 (39%), Gaps = 52/307 (16%)
Query: 115 ESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTN-----ERCXXXXXXXXXXXXXXXX 169
           ES   QW   +D+E+ R +G+GK+  V+      +      +                  
Sbjct: 2   ESKKRQWA-LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 60
Query: 170 XXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIY 226
              +Q+    PN+++L     D  +    LI EY            L+ +D      YI 
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT 118
Query: 227 ELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 286
           EL  AL YCHS+ ++HRD+KP N+++     +L++ D+G +  + P         +  + 
Sbjct: 119 ELANALSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRTTLCGTLDYL 176
Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYL 346
            PE +++ + +D  +D+WSLG +    +  K PF                    E N Y 
Sbjct: 177 PPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPF--------------------EANTYQ 215
Query: 347 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA 406
             Y             R SR    +F   D    V+  A D + +LL+++   R   RE 
Sbjct: 216 ETYK------------RISR---VEFTFPD---FVTEGARDLISRLLKHNPSQRPMLREV 257
Query: 407 MAHPYFA 413
           + HP+  
Sbjct: 258 LEHPWIT 264

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 72/307 (23%), Positives = 122/307 (39%), Gaps = 52/307 (16%)
Query: 115 ESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTN-----ERCXXXXXXXXXXXXXXXX 169
           ES   QW   +D+E+ R +G+GK+  V+      +      +                  
Sbjct: 16  ESKKRQWA-LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 74
Query: 170 XXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIY 226
              +Q+    PN+++L     D  +    LI EY            L+ +D      YI 
Sbjct: 75  EVEIQSHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT 132
Query: 227 ELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 286
           EL  AL YCHS+ ++HRD+KP N+++     +L++ D+G +  + P         +  + 
Sbjct: 133 ELANALSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRTTLCGTLDYL 190
Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYL 346
            PE +++ + +D  +D+WSLG +    +  K PF                    E N Y 
Sbjct: 191 PPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPF--------------------EANTYQ 229
Query: 347 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA 406
             Y             R SR    +F   D    V+  A D + +LL+++   R   RE 
Sbjct: 230 ETYK------------RISR---VEFTFPD---FVTEGARDLISRLLKHNPSQRPMLREV 271
Query: 407 MAHPYFA 413
           + HP+  
Sbjct: 272 LEHPWIT 278

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 43/142 (30%), Positives = 82/142 (57%), Gaps = 11/142 (7%)
Query: 200 IFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQ--GIMHRDVKPHNVMIDHELR 257
           +++ + +T+F+ +   LT    R +  ++  AL +  +    I+H D+KP N+++ +  R
Sbjct: 142 LYDLLRNTNFRGVSLNLT----RKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKR 197
Query: 258 K-LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFR 316
             ++++D+G +     G+     + SR+++ PE+L+ +  YD ++DMWSLGC+   M   
Sbjct: 198 XAIKIVDFGSS--CQLGQRIYQXIQSRFYRSPEVLLGM-PYDLAIDMWSLGCILVEM-HT 253
Query: 317 KEPFFYGHDNHDQLVKIAKVLG 338
            EP F G +  DQ+ KI +VLG
Sbjct: 254 GEPLFSGANEVDQMNKIVEVLG 275

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 34/107 (31%), Positives = 64/107 (59%), Gaps = 5/107 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY---NV 278
           R+Y  E++ AL+Y H +GI+HRD+KP N++++ ++  +++ D+G A+   P  +    N 
Sbjct: 138 RFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANX 196
Query: 279 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD 325
            V +  +  PELL + +    S D+W+LGC+   ++    PF  G++
Sbjct: 197 FVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNE 242

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 42/202 (20%), Positives = 97/202 (48%), Gaps = 10/202 (4%)
Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQNLCGGPN 181
           +Y +++ +G+G +++V    ++ T +    +                    +  +   PN
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCHSQ 238
           +VKL +++  +  KT  L+ EY +     D+ V +  + + + R    +++ A+ YCH +
Sbjct: 75  IVKLFEVIETE--KTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQK 132
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYD 298
            I+HRD+K  N+++D ++  +++ D+G +  +  G + +    +  +  PEL    +   
Sbjct: 133 FIVHRDLKAENLLLDADM-NIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKYDG 191
Query: 299 YSLDMWSLGCMFAGMIFRKEPF 320
             +D+WSLG +   ++    PF
Sbjct: 192 PEVDVWSLGVILYTLVSGSLPF 213

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/241 (26%), Positives = 105/241 (43%), Gaps = 43/241 (17%)
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCHS 237
           NV+ L D+  ++      LI E V+     DF     +L++ +   +I ++L  ++Y H+
Sbjct: 76  NVITLHDVYENRTDVV--LILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 238 QGIMHRDVKPHNVMI---DHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 294
           + I H D+KP N+M+   +  +  ++LID+GLA     G E+     +  F  PE +V+ 
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE-IVNY 192
Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 354
           +      DMWS+G +   ++    PF  G    + L  I  V       +Y         
Sbjct: 193 EPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANITSV-------SY--------- 235
Query: 355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 414
              D     H+                S  A DF+ KLL  + + RLT +EA+ HP+   
Sbjct: 236 -DFDEEFFSHT----------------SELAKDFIRKLLVKETRKRLTIQEALRHPWITP 278
Query: 415 V 415
           V
Sbjct: 279 V 279

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/241 (26%), Positives = 105/241 (43%), Gaps = 43/241 (17%)
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCHS 237
           NV+ L D+  ++      LI E V+     DF     +L++ +   +I ++L  ++Y H+
Sbjct: 76  NVITLHDVYENRTDVV--LILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 238 QGIMHRDVKPHNVMI---DHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 294
           + I H D+KP N+M+   +  +  ++LID+GLA     G E+     +  F  PE +V+ 
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE-IVNY 192
Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 354
           +      DMWS+G +   ++    PF  G    + L  I  V       +Y   +  E  
Sbjct: 193 EPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANITAV-------SY--DFDEEFF 242
Query: 355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 414
            Q   L                        A DF+ KLL  + + RLT +EA+ HP+   
Sbjct: 243 SQTSEL------------------------AKDFIRKLLVKETRKRLTIQEALRHPWITP 278
Query: 415 V 415
           V
Sbjct: 279 V 279

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 94/197 (47%), Gaps = 11/197 (5%)
Query: 131 RKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVR 190
           + +G G +S   + ++  +N+                     L+   G PN+VKL ++  
Sbjct: 17  KPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFH 76
Query: 191 DQ-HSKTPSLIFEYVNSTD-FKVLYPT--LTDYDIRYYIYELLKALDYCHSQGIMHRDVK 246
           DQ H+    L+ E +N  + F+ +      ++ +  Y + +L+ A+ + H  G++HRD+K
Sbjct: 77  DQLHT---FLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLK 133
Query: 247 PHNVMIDHELRKL--RLIDWGLAEFYHPGKE-YNVRVASRYFKGPELLVDLQDYDYSLDM 303
           P N++   E   L  ++ID+G A    P  +       + ++  PELL +   YD S D+
Sbjct: 134 PENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELL-NQNGYDESCDL 192
Query: 304 WSLGCMFAGMIFRKEPF 320
           WSLG +   M+  + PF
Sbjct: 193 WSLGVILYTMLSGQVPF 209

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/241 (26%), Positives = 105/241 (43%), Gaps = 43/241 (17%)
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCHS 237
           NV+ L D+  ++      LI E V+     DF     +L++ +   +I ++L  ++Y H+
Sbjct: 76  NVITLHDVYENRTDVV--LILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 238 QGIMHRDVKPHNVMI---DHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 294
           + I H D+KP N+M+   +  +  ++LID+GLA     G E+     +  F  PE +V+ 
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE-IVNY 192
Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 354
           +      DMWS+G +   ++    PF  G    + L  I  V       +Y         
Sbjct: 193 EPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANITSV-------SY--------- 235
Query: 355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 414
              D     H+                S  A DF+ KLL  + + RLT +EA+ HP+   
Sbjct: 236 -DFDEEFFSHT----------------SELAKDFIRKLLVKETRKRLTIQEALRHPWITP 278
Query: 415 V 415
           V
Sbjct: 279 V 279

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 72/307 (23%), Positives = 122/307 (39%), Gaps = 52/307 (16%)
Query: 115 ESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTN-----ERCXXXXXXXXXXXXXXXX 169
           ES   QW   +D+E+ R +G+GK+  V+      +      +                  
Sbjct: 2   ESKKRQWA-LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 60
Query: 170 XXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIY 226
              +Q+    PN+++L     D  +    LI EY            L+ +D      YI 
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT 118
Query: 227 ELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 286
           EL  AL YCHS+ ++HRD+KP N+++     +L++ D+G +  + P         +  + 
Sbjct: 119 ELANALSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRTTLCGTLDYL 176
Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYL 346
            PE +++ + +D  +D+WSLG +    +  K PF                    E N Y 
Sbjct: 177 PPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPF--------------------EANTYQ 215
Query: 347 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA 406
             Y             R SR    +F   D    V+  A D + +LL+++   R   RE 
Sbjct: 216 ETYK------------RISR---VEFTFPD---FVTEGARDLISRLLKHNPSQRPMLREV 257
Query: 407 MAHPYFA 413
           + HP+  
Sbjct: 258 LEHPWIT 264

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 34/107 (31%), Positives = 64/107 (59%), Gaps = 5/107 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY---NV 278
           R+Y  E++ AL+Y H +GI+HRD+KP N++++ ++  +++ D+G A+   P  +    N 
Sbjct: 136 RFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANX 194
Query: 279 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD 325
            V +  +  PELL + +    S D+W+LGC+   ++    PF  G++
Sbjct: 195 FVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNE 240

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 34/107 (31%), Positives = 64/107 (59%), Gaps = 5/107 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY---NV 278
           R+Y  E++ AL+Y H +GI+HRD+KP N++++ ++  +++ D+G A+   P  +    N 
Sbjct: 135 RFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANX 193
Query: 279 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD 325
            V +  +  PELL + +    S D+W+LGC+   ++    PF  G++
Sbjct: 194 FVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNE 239

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 95/213 (44%), Gaps = 19/213 (8%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           PN++ L DI  ++      LI E V+     DF     +LT+ +   ++ ++L  + Y H
Sbjct: 68  PNIITLHDIFENKTDVV--LILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLH 125
Query: 237 SQGIMHRDVKPHNVM-IDHEL--RKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           S+ I H D+KP N+M +D  +   +++LID+G+A     G E+     +  F  PE +V+
Sbjct: 126 SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPE-IVN 184
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV---------LGTDELNA 344
            +      DMWS+G +   ++    PF  G    + L  I+ V           T EL  
Sbjct: 185 YEPLGLEADMWSIGVITYILLSGASPFL-GETKQETLTNISAVNYDFDEEYFSNTSELAK 243
Query: 345 YLNKYHLELDPQLDALVGRHSRKPWSKFINADN 377
              +  L  DP+    + +     W K I   N
Sbjct: 244 DFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRN 276

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/241 (26%), Positives = 105/241 (43%), Gaps = 43/241 (17%)
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCHS 237
           NV+ L D+  ++      LI E V+     DF     +L++ +   +I ++L  ++Y H+
Sbjct: 76  NVITLHDVYENRTDVV--LILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 238 QGIMHRDVKPHNVMI---DHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 294
           + I H D+KP N+M+   +  +  ++LID+GLA     G E+     +  F  PE +V+ 
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE-IVNY 192
Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 354
           +      DMWS+G +   ++    PF  G    + L  I  V       +Y   +  E  
Sbjct: 193 EPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANITAV-------SY--DFDEEFF 242
Query: 355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 414
            Q   L                        A DF+ KLL  + + RLT +EA+ HP+   
Sbjct: 243 SQTSEL------------------------AKDFIRKLLVKETRKRLTIQEALRHPWITP 278
Query: 415 V 415
           V
Sbjct: 279 V 279

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 34/107 (31%), Positives = 64/107 (59%), Gaps = 5/107 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY---NV 278
           R+Y  E++ AL+Y H +GI+HRD+KP N++++ ++  +++ D+G A+   P  +    N 
Sbjct: 133 RFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANX 191
Query: 279 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD 325
            V +  +  PELL + +    S D+W+LGC+   ++    PF  G++
Sbjct: 192 FVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNE 237

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/241 (26%), Positives = 105/241 (43%), Gaps = 43/241 (17%)
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCHS 237
           NV+ L D+  ++      LI E V+     DF     +L++ +   +I ++L  ++Y H+
Sbjct: 76  NVITLHDVYENRTDVV--LILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 238 QGIMHRDVKPHNVMI---DHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 294
           + I H D+KP N+M+   +  +  ++LID+GLA     G E+     +  F  PE +V+ 
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE-IVNY 192
Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 354
           +      DMWS+G +   ++    PF  G    + L  I  V       +Y         
Sbjct: 193 EPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANITSV-------SY--------- 235
Query: 355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 414
              D     H+                S  A DF+ KLL  + + RLT +EA+ HP+   
Sbjct: 236 -DFDEEFFSHT----------------SELAKDFIRKLLVKETRKRLTIQEALRHPWITP 278
Query: 415 V 415
           V
Sbjct: 279 V 279

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 34/107 (31%), Positives = 64/107 (59%), Gaps = 5/107 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY---NV 278
           R+Y  E++ AL+Y H +GI+HRD+KP N++++ ++  +++ D+G A+   P  +    N 
Sbjct: 133 RFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANX 191
Query: 279 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD 325
            V +  +  PELL + +    S D+W+LGC+   ++    PF  G++
Sbjct: 192 FVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNE 237

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 34/107 (31%), Positives = 64/107 (59%), Gaps = 5/107 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY---NV 278
           R+Y  E++ AL+Y H +GI+HRD+KP N++++ ++  +++ D+G A+   P  +    N 
Sbjct: 136 RFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANS 194
Query: 279 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD 325
            V +  +  PELL + +    S D+W+LGC+   ++    PF  G++
Sbjct: 195 FVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNE 240

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 34/107 (31%), Positives = 64/107 (59%), Gaps = 5/107 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY---NV 278
           R+Y  E++ AL+Y H +GI+HRD+KP N++++ ++  +++ D+G A+   P  +    N 
Sbjct: 113 RFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANX 171
Query: 279 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD 325
            V +  +  PELL + +    S D+W+LGC+   ++    PF  G++
Sbjct: 172 FVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNE 217

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 34/107 (31%), Positives = 64/107 (59%), Gaps = 5/107 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY---NV 278
           R+Y  E++ AL+Y H +GI+HRD+KP N++++ ++  +++ D+G A+   P  +    N 
Sbjct: 135 RFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANX 193
Query: 279 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD 325
            V +  +  PELL + +    S D+W+LGC+   ++    PF  G++
Sbjct: 194 FVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNE 239

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 72/307 (23%), Positives = 121/307 (39%), Gaps = 52/307 (16%)
Query: 115 ESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTN-----ERCXXXXXXXXXXXXXXXX 169
           ES   QW   +D+E+ R +G+GK+  V+      +      +                  
Sbjct: 4   ESKKRQWA-LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 62
Query: 170 XXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIY 226
              +Q+    PN+++L     D  +    LI EY            L+ +D      YI 
Sbjct: 63  EVEIQSHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT 120
Query: 227 ELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 286
           EL  AL YCHS+ ++HRD+KP N+++     +L++ D+G +  + P         +  + 
Sbjct: 121 ELANALSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRTTLCGTLDYL 178
Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYL 346
            PE  ++ + +D  +D+WSLG +    +  K PF                    E N Y 
Sbjct: 179 PPE-XIEGRXHDEKVDLWSLGVLCYEFLVGKPPF--------------------EANTYQ 217
Query: 347 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA 406
             Y             R SR    +F   D    V+  A D + +LL+++   R   RE 
Sbjct: 218 ETYK------------RISR---VEFTFPD---FVTEGARDLISRLLKHNPSQRPXLREV 259
Query: 407 MAHPYFA 413
           + HP+  
Sbjct: 260 LEHPWIT 266

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 45/137 (32%), Positives = 71/137 (51%), Gaps = 8/137 (5%)
Query: 199 LIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE 255
            + EYVN  D          L +   R+Y  E+  AL+Y H +GI++RD+K  NV++D E
Sbjct: 130 FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE 189
Query: 256 LRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI 314
              ++L D+G+  E   PG   +    +  +  PE+L   +DY +S+D W+LG +   M+
Sbjct: 190 -GHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMM 247
Query: 315 FRKEPF--FYGHDNHDQ 329
             + PF      DN DQ
Sbjct: 248 AGRSPFDIVGSSDNPDQ 264

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 34/107 (31%), Positives = 64/107 (59%), Gaps = 5/107 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY---NV 278
           R+Y  E++ AL+Y H +GI+HRD+KP N++++ ++  +++ D+G A+   P  +    N 
Sbjct: 133 RFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANX 191
Query: 279 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD 325
            V +  +  PELL + +    S D+W+LGC+   ++    PF  G++
Sbjct: 192 FVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNE 237

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 34/107 (31%), Positives = 64/107 (59%), Gaps = 5/107 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY---NV 278
           R+Y  E++ AL+Y H +GI+HRD+KP N++++ ++  +++ D+G A+   P  +    N 
Sbjct: 135 RFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANX 193
Query: 279 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD 325
            V +  +  PELL + +    S D+W+LGC+   ++    PF  G++
Sbjct: 194 FVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNE 239

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 34/107 (31%), Positives = 64/107 (59%), Gaps = 5/107 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY---NV 278
           R+Y  E++ AL+Y H +GI+HRD+KP N++++ ++  +++ D+G A+   P  +    N 
Sbjct: 110 RFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANX 168
Query: 279 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD 325
            V +  +  PELL + +    S D+W+LGC+   ++    PF  G++
Sbjct: 169 FVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNE 214

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 34/107 (31%), Positives = 64/107 (59%), Gaps = 5/107 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY---NV 278
           R+Y  E++ AL+Y H +GI+HRD+KP N++++ ++  +++ D+G A+   P  +    N 
Sbjct: 112 RFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANX 170
Query: 279 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD 325
            V +  +  PELL + +    S D+W+LGC+   ++    PF  G++
Sbjct: 171 FVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNE 216

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 34/107 (31%), Positives = 64/107 (59%), Gaps = 5/107 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY---NV 278
           R+Y  E++ AL+Y H +GI+HRD+KP N++++ ++  +++ D+G A+   P  +    N 
Sbjct: 140 RFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANX 198
Query: 279 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD 325
            V +  +  PELL + +    S D+W+LGC+   ++    PF  G++
Sbjct: 199 FVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNE 244

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 34/107 (31%), Positives = 64/107 (59%), Gaps = 5/107 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY---NV 278
           R+Y  E++ AL+Y H +GI+HRD+KP N++++ ++  +++ D+G A+   P  +    N 
Sbjct: 111 RFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANX 169
Query: 279 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD 325
            V +  +  PELL + +    S D+W+LGC+   ++    PF  G++
Sbjct: 170 FVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNE 215

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 95/213 (44%), Gaps = 19/213 (8%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           PN++ L DI  ++      LI E V+     DF     +LT+ +   ++ ++L  + Y H
Sbjct: 89  PNIITLHDIFENKTDVV--LILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLH 146
Query: 237 SQGIMHRDVKPHNVM-IDHEL--RKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           S+ I H D+KP N+M +D  +   +++LID+G+A     G E+     +  F  PE +V+
Sbjct: 147 SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPE-IVN 205
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV---------LGTDELNA 344
            +      DMWS+G +   ++    PF  G    + L  I+ V           T EL  
Sbjct: 206 YEPLGLEADMWSIGVITYILLSGASPFL-GETKQETLTNISAVNYDFDEEYFSNTSELAK 264
Query: 345 YLNKYHLELDPQLDALVGRHSRKPWSKFINADN 377
              +  L  DP+    + +     W K I   N
Sbjct: 265 DFIRRLLVKDPKRRMXIAQSLEHSWIKAIRRRN 297

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 34/107 (31%), Positives = 64/107 (59%), Gaps = 5/107 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY---NV 278
           R+Y  E++ AL+Y H +GI+HRD+KP N++++ ++  +++ D+G A+   P  +    N 
Sbjct: 117 RFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANX 175
Query: 279 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD 325
            V +  +  PELL + +    S D+W+LGC+   ++    PF  G++
Sbjct: 176 FVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNE 221

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 72/307 (23%), Positives = 123/307 (40%), Gaps = 52/307 (16%)
Query: 115 ESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTN-----ERCXXXXXXXXXXXXXXXX 169
           ES   QW   +D+E+ R +G+GK+  V+      +      +                  
Sbjct: 25  ESKKRQWA-LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 83
Query: 170 XXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIY 226
              +Q+    PN+++L     D  +    LI EY            L+ +D      YI 
Sbjct: 84  EVEIQSHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT 141
Query: 227 ELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 286
           EL  AL YCHS+ ++HRD+KP N+++     +L++ D+G +  + P    +    +  + 
Sbjct: 142 ELANALSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRDDLCGTLDYL 199
Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYL 346
            PE +++ + +D  +D+WSLG +    +  K PF                    E N Y 
Sbjct: 200 PPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPF--------------------EANTYQ 238
Query: 347 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA 406
             Y             R SR    +F   D    V+  A D + +LL+++   R   RE 
Sbjct: 239 ETYK------------RISR---VEFTFPD---FVTEGARDLISRLLKHNPSQRPMLREV 280
Query: 407 MAHPYFA 413
           + HP+  
Sbjct: 281 LEHPWIT 287

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 72/307 (23%), Positives = 122/307 (39%), Gaps = 52/307 (16%)
Query: 115 ESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTN-----ERCXXXXXXXXXXXXXXXX 169
           ES   QW   +D+E+ R +G+GK+  V+      +      +                  
Sbjct: 1   ESKKRQWA-LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 59
Query: 170 XXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIY 226
              +Q+    PN+++L     D  +    LI EY            L+ +D      YI 
Sbjct: 60  EVEIQSHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT 117
Query: 227 ELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 286
           EL  AL YCHS+ ++HRD+KP N+++     +L++ D+G +  + P         +  + 
Sbjct: 118 ELANALSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRXXLCGTLDYL 175
Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYL 346
            PE +++ + +D  +D+WSLG +    +  K PF                    E N Y 
Sbjct: 176 PPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPF--------------------EANTYQ 214
Query: 347 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA 406
             Y             R SR    +F   D    V+  A D + +LL+++   R   RE 
Sbjct: 215 ETYK------------RISR---VEFTFPD---FVTEGARDLISRLLKHNPSQRPMLREV 256
Query: 407 MAHPYFA 413
           + HP+  
Sbjct: 257 LEHPWIT 263

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 66/244 (27%), Positives = 105/244 (43%), Gaps = 54/244 (22%)
Query: 186 LDIVRDQHSKTPSLIFEYVN--------STDFKVLYPTLTDYDIRYYIYELLKALDYCHS 237
           +D+V+ Q    P    E +N        S DF V    L    +R    ++  AL Y H+
Sbjct: 132 MDVVKTQICPCPECNEEAINGSIHGFRESLDF-VQREKLISNIMR----QIFSALHYLHN 186
Query: 238 QGIMHRDVKPHNVMID-HELRKLRLIDWGLA-EFY--HPGKEYNV--RVASRYFKGPELL 291
           QGI HRD+KP N +   ++  +++L+D+GL+ EFY  + G+ Y +  +  + YF  PE+L
Sbjct: 187 QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVL 246
Query: 292 -VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH 350
               + Y    D WS G +   ++    PF               V   D ++  LNK  
Sbjct: 247 NTTNESYGPKCDAWSAGVLLHLLLMGAVPF-------------PGVNDADTISQVLNKKL 293
Query: 351 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHP 410
              +P                     N +++SP A D L  LL  +  +R  A  A+ HP
Sbjct: 294 CFENP---------------------NYNVLSPLARDLLSNLLNRNVDERFDAMRALQHP 332
Query: 411 YFAQ 414
           + +Q
Sbjct: 333 WISQ 336

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 70/302 (23%), Positives = 120/302 (39%), Gaps = 52/302 (17%)
Query: 120 QWGDQDDYEVVRKVGRGKYSEVFEGINVNTN-----ERCXXXXXXXXXXXXXXXXXXXLQ 174
           QW   +D+E+ R +G+GK+  V+      +      +                     +Q
Sbjct: 8   QWA-LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 66
Query: 175 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIYELLKA 231
           +    PN+++L     D  +    LI EY            L+ +D      YI EL  A
Sbjct: 67  SHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 124
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 291
           L YCHS+ ++HRD+KP N+++     +L++ D+G +  + P         +  +  PE +
Sbjct: 125 LSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPE-M 181
Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL 351
           ++ + +D  +D+WSLG +    +  K PF                    E N Y   Y  
Sbjct: 182 IEGRMHDEKVDLWSLGVLCYEFLVGKPPF--------------------EANTYQETYK- 220
Query: 352 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 411
                      R SR    +F   D    V+  A D + +LL+++   R   RE + HP+
Sbjct: 221 -----------RISR---VEFTFPD---FVTEGARDLISRLLKHNPSQRPMLREVLEHPW 263
Query: 412 FA 413
Sbjct: 264 IT 265

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 70/302 (23%), Positives = 121/302 (40%), Gaps = 52/302 (17%)
Query: 120 QWGDQDDYEVVRKVGRGKYSEVFEGINVNTN-----ERCXXXXXXXXXXXXXXXXXXXLQ 174
           QW   +D+E+ R +G+GK+  V+      +      +                     +Q
Sbjct: 5   QWA-LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 63
Query: 175 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIYELLKA 231
           +    PN+++L     D  +    LI EY            L+ +D      YI EL  A
Sbjct: 64  SHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 121
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 291
           L YCHS+ ++HRD+KP N+++     +L++ D+G +  + P    +    +  +  PE +
Sbjct: 122 LSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRDTLCGTLDYLPPE-M 178
Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL 351
           ++ + +D  +D+WSLG +    +  K PF                    E N Y   Y  
Sbjct: 179 IEGRMHDEKVDLWSLGVLCYEFLVGKPPF--------------------EANTYQETYK- 217
Query: 352 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 411
                      R SR    +F   D    V+  A D + +LL+++   R   RE + HP+
Sbjct: 218 -----------RISR---VEFTFPD---FVTEGARDLISRLLKHNPSQRPMLREVLEHPW 260
Query: 412 FA 413
Sbjct: 261 IT 262

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 34/107 (31%), Positives = 64/107 (59%), Gaps = 5/107 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY---NV 278
           R+Y  E++ AL+Y H +GI+HRD+KP N++++ ++  +++ D+G A+   P  +    N 
Sbjct: 132 RFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANX 190
Query: 279 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD 325
            V +  +  PELL + +    S D+W+LGC+   ++    PF  G++
Sbjct: 191 FVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNE 236

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 45/137 (32%), Positives = 71/137 (51%), Gaps = 8/137 (5%)
Query: 199 LIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE 255
            + EYVN  D          L +   R+Y  E+  AL+Y H +GI++RD+K  NV++D E
Sbjct: 98  FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE 157
Query: 256 LRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI 314
              ++L D+G+  E   PG   +    +  +  PE+L   +DY +S+D W+LG +   M+
Sbjct: 158 -GHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMM 215
Query: 315 FRKEPF--FYGHDNHDQ 329
             + PF      DN DQ
Sbjct: 216 AGRSPFDIVGSSDNPDQ 232

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 72/307 (23%), Positives = 122/307 (39%), Gaps = 52/307 (16%)
Query: 115 ESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTN-----ERCXXXXXXXXXXXXXXXX 169
           ES   QW   +D+E+ R +G+GK+  V+      +      +                  
Sbjct: 2   ESKKRQWA-LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 60
Query: 170 XXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIY 226
              +Q+    PN+++L     D  +    LI EY            L+ +D      YI 
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT 118
Query: 227 ELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 286
           EL  AL YCHS+ ++HRD+KP N+++     +L++ D+G +  + P         +  + 
Sbjct: 119 ELANALSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRXXLCGTLDYL 176
Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYL 346
            PE +++ + +D  +D+WSLG +    +  K PF                    E N Y 
Sbjct: 177 PPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPF--------------------EANTYQ 215
Query: 347 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA 406
             Y             R SR    +F   D    V+  A D + +LL+++   R   RE 
Sbjct: 216 ETYK------------RISR---VEFTFPD---FVTEGARDLISRLLKHNPSQRPMLREV 257
Query: 407 MAHPYFA 413
           + HP+  
Sbjct: 258 LEHPWIT 264

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 70/302 (23%), Positives = 120/302 (39%), Gaps = 52/302 (17%)
Query: 120 QWGDQDDYEVVRKVGRGKYSEVFEGINVNTN-----ERCXXXXXXXXXXXXXXXXXXXLQ 174
           QW   +D+E+ R +G+GK+  V+      +      +                     +Q
Sbjct: 3   QWA-LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 61
Query: 175 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIYELLKA 231
           +    PN+++L     D  +    LI EY            L+ +D      YI EL  A
Sbjct: 62  SHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 119
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 291
           L YCHS+ ++HRD+KP N+++     +L++ D+G +  + P         +  +  PE +
Sbjct: 120 LSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPE-M 176
Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL 351
           ++ + +D  +D+WSLG +    +  K PF                    E N Y   Y  
Sbjct: 177 IEGRMHDEKVDLWSLGVLCYEFLVGKPPF--------------------EANTYQETYK- 215
Query: 352 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 411
                      R SR    +F   D    V+  A D + +LL+++   R   RE + HP+
Sbjct: 216 -----------RISR---VEFTFPD---FVTEGARDLISRLLKHNPSQRPMLREVLEHPW 258
Query: 412 FA 413
Sbjct: 259 IT 260

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 99/222 (44%), Gaps = 21/222 (9%)
Query: 126 DYEVVRKVGRGKYSEVF------EGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLCGG 179
           ++ + +K+GRG++SEV+      +G+ V   +                     L+ L   
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-NH 91
Query: 180 PNVVKL-LDIVRDQHSKTPSLIFEYVNSTD-------FKVLYPTLTDYDIRYYIYELLKA 231
           PNV+K     + D      +++ E  ++ D       FK     + +  +  Y  +L  A
Sbjct: 92  PNVIKYYASFIEDNEL---NIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSA 148
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP-GKEYNVRVASRYFKGPEL 290
           L++ HS+ +MHRD+KP NV I      ++L D GL  F+       +  V + Y+  PE 
Sbjct: 149 LEHMHSRRVMHRDIKPANVFIT-ATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPER 207
Query: 291 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVK 332
           + +   Y++  D+WSLGC+   M   + PF+    N   L K
Sbjct: 208 IHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK 248

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 34/107 (31%), Positives = 64/107 (59%), Gaps = 5/107 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY---NV 278
           R+Y  E++ AL+Y H +GI+HRD+KP N++++ ++  +++ D+G A+   P  +    N 
Sbjct: 132 RFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANS 190
Query: 279 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD 325
            V +  +  PELL + +    S D+W+LGC+   ++    PF  G++
Sbjct: 191 FVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNE 236

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 42/123 (34%), Positives = 68/123 (55%), Gaps = 6/123 (4%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE--FYHPG 273
            T+ D+++Y+ EL   LD+ HS GI++RD+KP N+++D E   ++L D+GL++    H  
Sbjct: 127 FTEEDVKFYLAELALGLDHLHSLGIIYRDLKPENILLDEE-GHIKLTDFGLSKEAIDHEK 185
Query: 274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333
           K Y+      Y   PE +V+ Q + +S D WS G +   M+    P F G D  + +  I
Sbjct: 186 KAYSFCGTVEYM-APE-VVNRQGHSHSADWWSYGVLMFEMLTGSLP-FQGKDRKETMTLI 242
Query: 334 AKV 336
            K 
Sbjct: 243 LKA 245

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 70/302 (23%), Positives = 120/302 (39%), Gaps = 52/302 (17%)
Query: 120 QWGDQDDYEVVRKVGRGKYSEVFEGINVNTN-----ERCXXXXXXXXXXXXXXXXXXXLQ 174
           QW   +D+E+ R +G+GK+  V+      +      +                     +Q
Sbjct: 4   QWA-LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 62
Query: 175 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIYELLKA 231
           +    PN+++L     D  +    LI EY            L+ +D      YI EL  A
Sbjct: 63  SHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 120
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 291
           L YCHS+ ++HRD+KP N+++     +L++ D+G +  + P         +  +  PE +
Sbjct: 121 LSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPE-M 177
Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL 351
           ++ + +D  +D+WSLG +    +  K PF                    E N Y   Y  
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPPF--------------------EANTYQETYK- 216
Query: 352 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 411
                      R SR    +F   D    V+  A D + +LL+++   R   RE + HP+
Sbjct: 217 -----------RISR---VEFTFPD---FVTEGARDLISRLLKHNPSQRPMLREVLEHPW 259
Query: 412 FA 413
Sbjct: 260 IT 261

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 89/203 (43%), Gaps = 46/203 (22%)
Query: 223 YYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVA 281
           +Y+ E+  AL + H +GI++RD+KP N+M++H+   ++L D+GL  E  H G   +    
Sbjct: 125 FYLAEISMALGHLHQKGIIYRDLKPENIMLNHQ-GHVKLTDFGLCKESIHDGTVTHTFCG 183
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDE 341
           +  +  PE+L+    ++ ++D WSLG +   M+    P F G +    + KI K      
Sbjct: 184 TIEYMAPEILMR-SGHNRAVDWWSLGALMYDMLTGAPP-FTGENRKKTIDKILKC----- 236
Query: 342 LNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL 401
                    L L P L                        + EA D L KLL+ +   RL
Sbjct: 237 --------KLNLPPYL------------------------TQEARDLLKKLLKRNAASRL 264
Query: 402 T-----AREAMAHPYFAQVRAAE 419
                 A E  AHP+F  +   E
Sbjct: 265 GAGPGDAGEVQAHPFFRHINWEE 287

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 73/300 (24%), Positives = 125/300 (41%), Gaps = 49/300 (16%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQNLCGG 179
           +D Y+    +G G +SEV    +  T +    +C                   L  +   
Sbjct: 17  RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKI-KH 75
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           PN+V L DI   +      LI + V+     D  V     T+ D    I+++L A+ Y H
Sbjct: 76  PNIVALDDIY--ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLH 133
Query: 237 SQGIMHRDVKPHNVM---IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
             GI+HRD+KP N++   +D E  K+ + D+GL++   PG   +    +  +  PE+L  
Sbjct: 134 DLGIVHRDLKPENLLYYSLD-EDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQ 192
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 353
            + Y  ++D WS+G +   ++    PF+                  DE +A L +  L+ 
Sbjct: 193 -KPYSKAVDCWSIGVIAYILLCGYPPFY------------------DENDAKLFEQILKA 233
Query: 354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA 413
           + + D+         W           +S  A DF+  L+  D + R T  +A+ HP+ A
Sbjct: 234 EYEFDSPY-------WDD---------ISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIA 277

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 47/163 (28%), Positives = 81/163 (49%), Gaps = 10/163 (6%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           PN++ L DI  ++      LI E V+     DF     +LT+ +   ++ ++L  + Y H
Sbjct: 75  PNIITLHDIFENKTDVV--LILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLH 132
Query: 237 SQGIMHRDVKPHNVM-IDHEL--RKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           S+ I H D+KP N+M +D  +   +++LID+G+A     G E+     +  F  PE +V+
Sbjct: 133 SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPE-IVN 191
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 336
            +      DMWS+G +   ++    PF  G    + L  I+ V
Sbjct: 192 YEPLGLEADMWSIGVITYILLSGASPFL-GETKQETLTNISAV 233

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 71/307 (23%), Positives = 122/307 (39%), Gaps = 52/307 (16%)
Query: 115 ESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTN-----ERCXXXXXXXXXXXXXXXX 169
           ES   QW   +D+E+ R +G+GK+  V+      +      +                  
Sbjct: 2   ESKKRQWA-LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 60
Query: 170 XXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIY 226
              +Q+    PN+++L     D  +    LI EY            L+ +D      YI 
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT 118
Query: 227 ELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 286
           EL  AL YCHS+ ++HRD+KP N+++     +L++ ++G +  + P         +  + 
Sbjct: 119 ELANALSYCHSKRVIHRDIKPENLLLG-SAGELKIANFGWS-VHAPSSRRTTLCGTLDYL 176
Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYL 346
            PE +++ + +D  +D+WSLG +    +  K PF                    E N Y 
Sbjct: 177 PPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPF--------------------EANTYQ 215
Query: 347 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA 406
             Y             R SR    +F   D    V+  A D + +LL+++   R   RE 
Sbjct: 216 ETYK------------RISR---VEFTFPD---FVTEGARDLISRLLKHNPSQRPMLREV 257
Query: 407 MAHPYFA 413
           + HP+  
Sbjct: 258 LEHPWIT 264

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 45/137 (32%), Positives = 71/137 (51%), Gaps = 8/137 (5%)
Query: 199 LIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE 255
            + EYVN  D          L +   R+Y  E+  AL+Y H +GI++RD+K  NV++D E
Sbjct: 83  FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE 142
Query: 256 LRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI 314
              ++L D+G+  E   PG   +    +  +  PE+L   +DY +S+D W+LG +   M+
Sbjct: 143 -GHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMM 200
Query: 315 FRKEPF--FYGHDNHDQ 329
             + PF      DN DQ
Sbjct: 201 AGRSPFDIVGSSDNPDQ 217

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 71/307 (23%), Positives = 122/307 (39%), Gaps = 52/307 (16%)
Query: 115 ESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTN-----ERCXXXXXXXXXXXXXXXX 169
           ES   QW   +D+E+ R +G+GK+  V+      +      +                  
Sbjct: 1   ESKKRQWA-LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 59
Query: 170 XXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIY 226
              +Q+    PN+++L     D  +    LI EY            L+ +D      YI 
Sbjct: 60  EVEIQSHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT 117
Query: 227 ELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 286
           EL  AL YCHS+ ++HRD+KP N+++     +L++ ++G +  + P         +  + 
Sbjct: 118 ELANALSYCHSKRVIHRDIKPENLLLG-SAGELKIANFGWS-VHAPSSRRTTLCGTLDYL 175
Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYL 346
            PE +++ + +D  +D+WSLG +    +  K PF                    E N Y 
Sbjct: 176 PPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPF--------------------EANTYQ 214
Query: 347 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA 406
             Y             R SR    +F   D    V+  A D + +LL+++   R   RE 
Sbjct: 215 ETYK------------RISR---VEFTFPD---FVTEGARDLISRLLKHNPSQRPMLREV 256
Query: 407 MAHPYFA 413
           + HP+  
Sbjct: 257 LEHPWIT 263

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 67/310 (21%), Positives = 127/310 (40%), Gaps = 47/310 (15%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNER----CXXXXXXXXXXXXXXXXXXXLQNLCGGP 180
           ++Y++  ++G+G +S V   + V   +                         +  L   P
Sbjct: 11  EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHP 70
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDF---KVLYPTLTDYDIRYYIYELLKALDYCHS 237
           N+V+L D + ++      LIF+ V   +     V     ++ D  + I ++L+A+ +CH 
Sbjct: 71  NIVRLHDSISEEGHHY--LIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQ 128
Query: 238 QGIMHRDVKPHNVMIDHELR--KLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDL 294
            G++HR++KP N+++  +L+   ++L D+GLA E     + +     +  +  PE+L   
Sbjct: 129 MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRK- 187
Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 354
             Y   +D+W+ G +   ++    P F+  D H                         L 
Sbjct: 188 DPYGKPVDLWACGVILYILLVGYPP-FWDEDQH------------------------RLY 222
Query: 355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 414
            Q+ A         W           V+PEA D ++K+L  +   R+TA EA+ HP+ + 
Sbjct: 223 QQIKAGAYDFPSPEWDT---------VTPEAKDLINKMLTINPSKRITAAEALKHPWISH 273
Query: 415 VRAAESSRTR 424
                S   R
Sbjct: 274 RSTVASCMHR 283

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 72/300 (24%), Positives = 125/300 (41%), Gaps = 49/300 (16%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQNLCGG 179
           +D Y+    +G G +SEV    +  T +    +C                   L  +   
Sbjct: 17  RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKI-KH 75
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           PN+V L DI   +      LI + V+     D  V     T+ D    I+++L A+ Y H
Sbjct: 76  PNIVALDDIY--ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLH 133
Query: 237 SQGIMHRDVKPHNVM---IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
             GI+HRD+KP N++   +D +  K+ + D+GL++   PG   +    +  +  PE+L  
Sbjct: 134 DLGIVHRDLKPENLLYYSLDED-SKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQ 192
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 353
            + Y  ++D WS+G +   ++    PF+                  DE +A L +  L+ 
Sbjct: 193 -KPYSKAVDCWSIGVIAYILLCGYPPFY------------------DENDAKLFEQILKA 233
Query: 354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA 413
           + + D+         W           +S  A DF+  L+  D + R T  +A+ HP+ A
Sbjct: 234 EYEFDSPY-------WDD---------ISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIA 277

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 45/137 (32%), Positives = 71/137 (51%), Gaps = 8/137 (5%)
Query: 199 LIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE 255
            + EYVN  D          L +   R+Y  E+  AL+Y H +GI++RD+K  NV++D E
Sbjct: 87  FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE 146
Query: 256 LRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI 314
              ++L D+G+  E   PG   +    +  +  PE+L   +DY +S+D W+LG +   M+
Sbjct: 147 -GHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMM 204
Query: 315 FRKEPF--FYGHDNHDQ 329
             + PF      DN DQ
Sbjct: 205 AGRSPFDIVGSSDNPDQ 221

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 42/123 (34%), Positives = 68/123 (55%), Gaps = 6/123 (4%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE--FYHPG 273
            T+ D+++Y+ EL  ALD+ HS GI++RD+KP N+++D E   ++L D+GL++    H  
Sbjct: 123 FTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEE-GHIKLTDFGLSKESIDHEK 181
Query: 274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333
           K Y+      Y   PE +V+ + +  S D WS G +   M+    P F G D  + +  I
Sbjct: 182 KAYSFCGTVEYM-APE-VVNRRGHTQSADWWSFGVLMFEMLTGTLP-FQGKDRKETMTMI 238
Query: 334 AKV 336
            K 
Sbjct: 239 LKA 241

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/299 (21%), Positives = 126/299 (42%), Gaps = 46/299 (15%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTN-ERCXXXXXXXXXXXXXXXXXXXLQNLCGG--- 179
            D+Y+V  ++G+G +S V   ++  T  E                        +C     
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDF---KVLYPTLTDYDIRYYIYELLKALDYCH 236
           PN+V+L D ++++      L+F+ V   +     V     ++ D  + I ++L+++ YCH
Sbjct: 65  PNIVRLHDSIQEESFHY--LVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCH 122
Query: 237 SQGIMHRDVKPHNVMIDHELR--KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 294
           S GI+HR++KP N+++  + +   ++L D+GLA   +  + ++    +  +  PE+L   
Sbjct: 123 SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKK- 181
Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 354
             Y   +D+W+ G +   ++    P F+  D H                         L 
Sbjct: 182 DPYSKPVDIWACGVILYILLVGYPP-FWDEDQH------------------------RLY 216
Query: 355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA 413
            Q+ A    +    W           V+PEA   +D +L  + + R+TA +A+  P+  
Sbjct: 217 AQIKAGAYDYPSPEWDT---------VTPEAKSLIDSMLTVNPKKRITADQALKVPWIC 266

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/299 (21%), Positives = 124/299 (41%), Gaps = 46/299 (15%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTN-ERCXXXXXXXXXXXXXXXXXXXLQNLCGG--- 179
            D+Y+V  ++G+G +S V   ++  T  E                        +C     
Sbjct: 4   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 63
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDF---KVLYPTLTDYDIRYYIYELLKALDYCH 236
           PN+V+L D +  Q      L+F+ V   +     V     ++ D  + I ++L+++ YCH
Sbjct: 64  PNIVRLHDSI--QEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCH 121
Query: 237 SQGIMHRDVKPHNVMIDHELR--KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 294
           S GI+HR++KP N+++  + +   ++L D+GLA   +  + ++    +  +  PE+L   
Sbjct: 122 SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVL-KK 180
Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 354
             Y   +D+W+ G +   ++    P F+  D H                         L 
Sbjct: 181 DPYSKPVDIWACGVILYILLVGYPP-FWDEDQH------------------------RLY 215
Query: 355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA 413
            Q+ A    +    W           V+PEA   +D +L  + + R+TA +A+  P+  
Sbjct: 216 AQIKAGAYDYPSPEWDT---------VTPEAKSLIDSMLTVNPKKRITADQALKVPWIC 265

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 72/300 (24%), Positives = 125/300 (41%), Gaps = 49/300 (16%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQNLCGG 179
           +D Y+    +G G +SEV    +  T +    +C                   L  +   
Sbjct: 17  RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKI-KH 75
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           PN+V L DI   +      LI + V+     D  V     T+ D    I+++L A+ Y H
Sbjct: 76  PNIVALDDIY--ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLH 133
Query: 237 SQGIMHRDVKPHNVM---IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
             GI+HRD+KP N++   +D +  K+ + D+GL++   PG   +    +  +  PE+L  
Sbjct: 134 DLGIVHRDLKPENLLYYSLDED-SKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQ 192
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 353
            + Y  ++D WS+G +   ++    PF+                  DE +A L +  L+ 
Sbjct: 193 -KPYSKAVDCWSIGVIAYILLCGYPPFY------------------DENDAKLFEQILKA 233
Query: 354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA 413
           + + D+         W           +S  A DF+  L+  D + R T  +A+ HP+ A
Sbjct: 234 EYEFDSPY-------WDD---------ISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIA 277

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 42/123 (34%), Positives = 68/123 (55%), Gaps = 6/123 (4%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE--FYHPG 273
            T+ D+++Y+ EL  ALD+ HS GI++RD+KP N+++D E   ++L D+GL++    H  
Sbjct: 124 FTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEE-GHIKLTDFGLSKESIDHEK 182
Query: 274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333
           K Y+      Y   PE +V+ + +  S D WS G +   M+    P F G D  + +  I
Sbjct: 183 KAYSFCGTVEYM-APE-VVNRRGHTQSADWWSFGVLMFEMLTGTLP-FQGKDRKETMTMI 239
Query: 334 AKV 336
            K 
Sbjct: 240 LKA 242

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 70/302 (23%), Positives = 120/302 (39%), Gaps = 52/302 (17%)
Query: 120 QWGDQDDYEVVRKVGRGKYSEVFEGINVNTN-----ERCXXXXXXXXXXXXXXXXXXXLQ 174
           QW   +D+E+ R +G+GK+  V+      +      +                     +Q
Sbjct: 4   QWA-LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 62
Query: 175 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIYELLKA 231
           +    PN+++L     D  +    LI EY            L+ +D      YI EL  A
Sbjct: 63  SHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 120
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 291
           L YCHS+ ++HRD+KP N+++     +L++ D+G +  + P         +  +  PE +
Sbjct: 121 LSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRAALCGTLDYLPPE-M 177
Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL 351
           ++ + +D  +D+WSLG +    +  K PF                    E N Y   Y  
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPPF--------------------EANTYQETYK- 216
Query: 352 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 411
                      R SR    +F   D    V+  A D + +LL+++   R   RE + HP+
Sbjct: 217 -----------RISR---VEFTFPD---FVTEGARDLISRLLKHNPSQRPMLREVLEHPW 259
Query: 412 FA 413
Sbjct: 260 IT 261

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 42/123 (34%), Positives = 68/123 (55%), Gaps = 6/123 (4%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE--FYHPG 273
            T+ D+++Y+ EL  ALD+ HS GI++RD+KP N+++D E   ++L D+GL++    H  
Sbjct: 123 FTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEE-GHIKLTDFGLSKESIDHEK 181
Query: 274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333
           K Y+      Y   PE +V+ + +  S D WS G +   M+    P F G D  + +  I
Sbjct: 182 KAYSFCGTVEYM-APE-VVNRRGHTQSADWWSFGVLMFEMLTGTLP-FQGKDRKETMTMI 238
Query: 334 AKV 336
            K 
Sbjct: 239 LKA 241

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/299 (21%), Positives = 126/299 (42%), Gaps = 46/299 (15%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTN-ERCXXXXXXXXXXXXXXXXXXXLQNLCGG--- 179
            D+Y+V  ++G+G +S V   ++  T  E                        +C     
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDF---KVLYPTLTDYDIRYYIYELLKALDYCH 236
           PN+V+L D ++++      L+F+ V   +     V     ++ D  + I ++L+++ YCH
Sbjct: 65  PNIVRLHDSIQEESFHY--LVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCH 122
Query: 237 SQGIMHRDVKPHNVMIDHELR--KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 294
           S GI+HR++KP N+++  + +   ++L D+GLA   +  + ++    +  +  PE+L   
Sbjct: 123 SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKK- 181
Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 354
             Y   +D+W+ G +   ++    P F+  D H                         L 
Sbjct: 182 DPYSKPVDIWACGVILYILLVGYPP-FWDEDQH------------------------RLY 216
Query: 355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA 413
            Q+ A    +    W           V+PEA   +D +L  + + R+TA +A+  P+  
Sbjct: 217 AQIKAGAYDYPSPEWDT---------VTPEAKSLIDSMLTVNPKKRITADQALKVPWIC 266

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/297 (21%), Positives = 126/297 (42%), Gaps = 46/297 (15%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTN-ERCXXXXXXXXXXXXXXXXXXXLQNLCGG---P 180
           D+Y+V  ++G+G +S V   ++  T  E                        +C     P
Sbjct: 29  DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHP 88
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDF---KVLYPTLTDYDIRYYIYELLKALDYCHS 237
           N+V+L D ++++      L+F+ V   +     V     ++ D  + I ++L+++ YCHS
Sbjct: 89  NIVRLHDSIQEESFHY--LVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHS 146
Query: 238 QGIMHRDVKPHNVMIDHELR--KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 295
            GI+HR++KP N+++  + +   ++L D+GLA   +  + ++    +  +  PE+L    
Sbjct: 147 NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKK-D 205
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP 355
            Y   +D+W+ G +   ++    P F+  D H                         L  
Sbjct: 206 PYSKPVDIWACGVILY-ILLVGYPPFWDEDQH------------------------RLYA 240
Query: 356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 412
           Q+ A    +    W           V+PEA   +D +L  + + R+TA +A+  P+ 
Sbjct: 241 QIKAGAYDYPSPEWD---------TVTPEAKSLIDSMLTVNPKKRITADQALKVPWI 288

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 72/300 (24%), Positives = 125/300 (41%), Gaps = 49/300 (16%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQNLCGG 179
           +D Y+    +G G +SEV    +  T +    +C                   L  +   
Sbjct: 17  RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKI-KH 75
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           PN+V L DI   +      LI + V+     D  V     T+ D    I+++L A+ Y H
Sbjct: 76  PNIVALDDIY--ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLH 133
Query: 237 SQGIMHRDVKPHNVM---IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
             GI+HRD+KP N++   +D +  K+ + D+GL++   PG   +    +  +  PE+L  
Sbjct: 134 DLGIVHRDLKPENLLYYSLDED-SKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQ 192
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 353
            + Y  ++D WS+G +   ++    PF+                  DE +A L +  L+ 
Sbjct: 193 -KPYSKAVDCWSIGVIAYILLCGYPPFY------------------DENDAKLFEQILKA 233
Query: 354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA 413
           + + D+         W           +S  A DF+  L+  D + R T  +A+ HP+ A
Sbjct: 234 EYEFDSPY-------WDD---------ISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIA 277

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 70/302 (23%), Positives = 120/302 (39%), Gaps = 52/302 (17%)
Query: 120 QWGDQDDYEVVRKVGRGKYSEVFEGINVNTN-----ERCXXXXXXXXXXXXXXXXXXXLQ 174
           QW   +D+E+ R +G+GK+  V+      +      +                     +Q
Sbjct: 4   QWA-LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 62
Query: 175 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIYELLKA 231
           +    PN+++L     D  +    LI EY            L+ +D      YI EL  A
Sbjct: 63  SHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 120
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 291
           L YCHS+ ++HRD+KP N+++     +L++ D+G +  + P         +  +  PE +
Sbjct: 121 LSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRTXLCGTLDYLPPE-M 177
Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL 351
           ++ + +D  +D+WSLG +    +  K PF                    E N Y   Y  
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPPF--------------------EANTYQETYK- 216
Query: 352 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 411
                      R SR    +F   D    V+  A D + +LL+++   R   RE + HP+
Sbjct: 217 -----------RISR---VEFTFPD---FVTEGARDLISRLLKHNPSQRPMLREVLEHPW 259
Query: 412 FA 413
Sbjct: 260 IT 261

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 70/302 (23%), Positives = 120/302 (39%), Gaps = 52/302 (17%)
Query: 120 QWGDQDDYEVVRKVGRGKYSEVFEGINVNTN-----ERCXXXXXXXXXXXXXXXXXXXLQ 174
           QW   +D+E+ R +G+GK+  V+      +      +                     +Q
Sbjct: 7   QWA-LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 65
Query: 175 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIYELLKA 231
           +    PN+++L     D  +    LI EY            L+ +D      YI EL  A
Sbjct: 66  SHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 123
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 291
           L YCHS+ ++HRD+KP N+++     +L++ D+G +  + P         +  +  PE +
Sbjct: 124 LSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRAALCGTLDYLPPE-M 180
Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL 351
           ++ + +D  +D+WSLG +    +  K PF                    E N Y   Y  
Sbjct: 181 IEGRMHDEKVDLWSLGVLCYEFLVGKPPF--------------------EANTYQETYK- 219
Query: 352 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 411
                      R SR    +F   D    V+  A D + +LL+++   R   RE + HP+
Sbjct: 220 -----------RISR---VEFTFPD---FVTEGARDLISRLLKHNPSQRPMLREVLEHPW 262
Query: 412 FA 413
Sbjct: 263 IT 264

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 39/146 (26%), Positives = 75/146 (51%), Gaps = 11/146 (7%)
Query: 180 PNVVKLLDIVRDQHSKTPS---LIFEYVNST--DFKVLYPTLTDYDIRYYIYELLKALDY 234
           P+++KL D++      TP+   ++ EY      D+ V    +T+ + R +  +++ A++Y
Sbjct: 69  PHIIKLYDVI-----TTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEY 123
Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 294
           CH   I+HRD+KP N+++D  L  +++ D+GL+     G        S  +  PE++   
Sbjct: 124 CHRHKIVHRDLKPENLLLDDNL-NVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGK 182
Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPF 320
                 +D+WS G +   M+  + PF
Sbjct: 183 LYAGPEVDVWSCGIVLYVMLVGRLPF 208

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/257 (22%), Positives = 109/257 (42%), Gaps = 59/257 (22%)
Query: 173 LQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELL 229
           L+ + G PN+++L D    + +    L+F+ +      D+     TL++ + R  +  LL
Sbjct: 77  LRKVSGHPNIIQLKDTY--ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALL 134
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
           + +   H   I+HRD+KP N+++D ++  ++L D+G +    PG++      +  +  PE
Sbjct: 135 EVICALHKLNIVHRDLKPENILLDDDM-NIKLTDFGFSCQLDPGEKLRSVCGTPSYLAPE 193
Query: 290 LL-VDLQD----YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA 344
           ++   + D    Y   +DMWS G +   ++    PF++      Q++ +           
Sbjct: 194 IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH----RKQMLML----------- 238
Query: 345 YLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLD-------KLLRYDH 397
                                     + I + N    SPE  D+ D       + L    
Sbjct: 239 --------------------------RMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQP 272
Query: 398 QDRLTAREAMAHPYFAQ 414
           Q R TA EA+AHP+F Q
Sbjct: 273 QKRYTAEEALAHPFFQQ 289

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 89/203 (43%), Gaps = 46/203 (22%)
Query: 223 YYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVA 281
           +Y+ E+  AL + H +GI++RD+KP N+M++H+   ++L D+GL  E  H G   +    
Sbjct: 125 FYLAEISMALGHLHQKGIIYRDLKPENIMLNHQ-GHVKLTDFGLCKESIHDGTVTHXFCG 183
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDE 341
           +  +  PE+L+    ++ ++D WSLG +   M+    P F G +    + KI K      
Sbjct: 184 TIEYMAPEILMR-SGHNRAVDWWSLGALMYDMLTGAPP-FTGENRKKTIDKILKC----- 236
Query: 342 LNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL 401
                    L L P L                        + EA D L KLL+ +   RL
Sbjct: 237 --------KLNLPPYL------------------------TQEARDLLKKLLKRNAASRL 264
Query: 402 T-----AREAMAHPYFAQVRAAE 419
                 A E  AHP+F  +   E
Sbjct: 265 GAGPGDAGEVQAHPFFRHINWEE 287

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 70/302 (23%), Positives = 120/302 (39%), Gaps = 52/302 (17%)
Query: 120 QWGDQDDYEVVRKVGRGKYSEVFEGINVNTN-----ERCXXXXXXXXXXXXXXXXXXXLQ 174
           QW   +D+E+ R +G+GK+  V+      +      +                     +Q
Sbjct: 4   QWA-LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 62
Query: 175 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIYELLKA 231
           +    PN+++L     D  +    LI EY            L+ +D      YI EL  A
Sbjct: 63  SHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 120
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 291
           L YCHS+ ++HRD+KP N+++     +L++ D+G +  + P         +  +  PE +
Sbjct: 121 LSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRTELCGTLDYLPPE-M 177
Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL 351
           ++ + +D  +D+WSLG +    +  K PF                    E N Y   Y  
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPPF--------------------EANTYQETYK- 216
Query: 352 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 411
                      R SR    +F   D    V+  A D + +LL+++   R   RE + HP+
Sbjct: 217 -----------RISR---VEFTFPD---FVTEGARDLISRLLKHNPSQRPMLREVLEHPW 259
Query: 412 FA 413
Sbjct: 260 IT 261

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 70/302 (23%), Positives = 120/302 (39%), Gaps = 52/302 (17%)
Query: 120 QWGDQDDYEVVRKVGRGKYSEVFEGINVNTN-----ERCXXXXXXXXXXXXXXXXXXXLQ 174
           QW   +D+E+ R +G+GK+  V+      +      +                     +Q
Sbjct: 4   QWA-LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 62
Query: 175 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIYELLKA 231
           +    PN+++L     D  +    LI EY            L+ +D      YI EL  A
Sbjct: 63  SHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 120
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 291
           L YCHS+ ++HRD+KP N+++     +L++ D+G +  + P         +  +  PE +
Sbjct: 121 LSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRXXLCGTLDYLPPE-M 177
Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL 351
           ++ + +D  +D+WSLG +    +  K PF                    E N Y   Y  
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPPF--------------------EANTYQETYK- 216
Query: 352 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 411
                      R SR    +F   D    V+  A D + +LL+++   R   RE + HP+
Sbjct: 217 -----------RISR---VEFTFPD---FVTEGARDLISRLLKHNPSQRPMLREVLEHPW 259
Query: 412 FA 413
Sbjct: 260 IT 261

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 70/302 (23%), Positives = 120/302 (39%), Gaps = 52/302 (17%)
Query: 120 QWGDQDDYEVVRKVGRGKYSEVFEGINVNTN-----ERCXXXXXXXXXXXXXXXXXXXLQ 174
           QW   +D+E+ R +G+GK+  V+      +      +                     +Q
Sbjct: 5   QWA-LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 63
Query: 175 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIYELLKA 231
           +    PN+++L     D  +    LI EY            L+ +D      YI EL  A
Sbjct: 64  SHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 121
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 291
           L YCHS+ ++HRD+KP N+++     +L++ D+G +  + P         +  +  PE +
Sbjct: 122 LSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-CHAPSSRRTTLSGTLDYLPPE-M 178
Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL 351
           ++ + +D  +D+WSLG +    +  K PF                    E N Y   Y  
Sbjct: 179 IEGRMHDEKVDLWSLGVLCYEFLVGKPPF--------------------EANTYQETYK- 217
Query: 352 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 411
                      R SR    +F   D    V+  A D + +LL+++   R   RE + HP+
Sbjct: 218 -----------RISR---VEFTFPD---FVTEGARDLISRLLKHNPSQRPMLREVLEHPW 260
Query: 412 FA 413
Sbjct: 261 IT 262

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/257 (22%), Positives = 109/257 (42%), Gaps = 59/257 (22%)
Query: 173 LQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELL 229
           L+ + G PN+++L D    + +    L+F+ +      D+     TL++ + R  +  LL
Sbjct: 77  LRKVSGHPNIIQLKDTY--ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALL 134
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
           + +   H   I+HRD+KP N+++D ++  ++L D+G +    PG++      +  +  PE
Sbjct: 135 EVICALHKLNIVHRDLKPENILLDDDM-NIKLTDFGFSCQLDPGEKLREVCGTPSYLAPE 193
Query: 290 LL-VDLQD----YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA 344
           ++   + D    Y   +DMWS G +   ++    PF++      Q++ +           
Sbjct: 194 IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH----RKQMLML----------- 238
Query: 345 YLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLD-------KLLRYDH 397
                                     + I + N    SPE  D+ D       + L    
Sbjct: 239 --------------------------RMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQP 272
Query: 398 QDRLTAREAMAHPYFAQ 414
           Q R TA EA+AHP+F Q
Sbjct: 273 QKRYTAEEALAHPFFQQ 289

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 70/302 (23%), Positives = 121/302 (40%), Gaps = 52/302 (17%)
Query: 120 QWGDQDDYEVVRKVGRGKYSEVFEGINVNTN-----ERCXXXXXXXXXXXXXXXXXXXLQ 174
           QW   +D+E+ R +G+GK+  V+      +      +                     +Q
Sbjct: 7   QWA-LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 65
Query: 175 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIYELLKA 231
           +    PN+++L     D  +    LI EY            L+ +D      YI EL  A
Sbjct: 66  SHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 123
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 291
           L YCHS+ ++HRD+KP N+++     +L++ D+G +  + P    +    +  +  PE +
Sbjct: 124 LSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRDDLCGTLDYLPPE-M 180
Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL 351
           ++ + +D  +D+WSLG +    +  K PF                    E N Y   Y  
Sbjct: 181 IEGRMHDEKVDLWSLGVLCYEFLVGKPPF--------------------EANTYQETYK- 219
Query: 352 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 411
                      R SR    +F   D    V+  A D + +LL+++   R   RE + HP+
Sbjct: 220 -----------RISR---VEFTFPD---FVTEGARDLISRLLKHNPSQRPMLREVLEHPW 262
Query: 412 FA 413
Sbjct: 263 IT 264

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 70/302 (23%), Positives = 119/302 (39%), Gaps = 52/302 (17%)
Query: 120 QWGDQDDYEVVRKVGRGKYSEVFEGINVNTN-----ERCXXXXXXXXXXXXXXXXXXXLQ 174
           QW   +D+E+ R +G+GK+  V+             +                     +Q
Sbjct: 1   QWA-LEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQ 59
Query: 175 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIYELLKA 231
           +    PN+++L     D  +    LI EY            L+ +D      YI EL  A
Sbjct: 60  SHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 117
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 291
           L YCHS+ ++HRD+KP N+++     +L++ D+G +  + P         +  +  PE +
Sbjct: 118 LSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPE-M 174
Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL 351
           ++ + +D  +D+WSLG +    +  K PF                    E N Y   Y  
Sbjct: 175 IEGRMHDEKVDLWSLGVLCYEFLVGKPPF--------------------EANTYQETYK- 213
Query: 352 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 411
                      R SR    +F   D    V+  A D + +LL+++   R   RE + HP+
Sbjct: 214 -----------RISR---VEFTFPD---FVTEGARDLISRLLKHNPSQRPMLREVLEHPW 256
Query: 412 FA 413
Sbjct: 257 IT 258

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 70/302 (23%), Positives = 120/302 (39%), Gaps = 52/302 (17%)
Query: 120 QWGDQDDYEVVRKVGRGKYSEVFEGINVNTN-----ERCXXXXXXXXXXXXXXXXXXXLQ 174
           QW   +D+E+ R +G+GK+  V+      +      +                     +Q
Sbjct: 4   QWA-LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 62
Query: 175 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIYELLKA 231
           +    PN+++L     D  +    LI EY            L+ +D      YI EL  A
Sbjct: 63  SHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 120
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 291
           L YCHS+ ++HRD+KP N+++     +L++ D+G +  + P         +  +  PE +
Sbjct: 121 LSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPE-M 177
Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL 351
           ++ + +D  +D+WSLG +    +  K PF                    E N Y   Y  
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPPF--------------------EANTYQETYK- 216
Query: 352 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 411
                      R SR    +F   D    V+  A D + +LL+++   R   RE + HP+
Sbjct: 217 -----------RISR---VEFTFPD---FVTEGARDLISRLLKHNPSQRPMLREVLEHPW 259
Query: 412 FA 413
Sbjct: 260 IT 261

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/257 (22%), Positives = 109/257 (42%), Gaps = 59/257 (22%)
Query: 173 LQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELL 229
           L+ + G PN+++L D    + +    L+F+ +      D+     TL++ + R  +  LL
Sbjct: 64  LRKVSGHPNIIQLKDTY--ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALL 121
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
           + +   H   I+HRD+KP N+++D ++  ++L D+G +    PG++      +  +  PE
Sbjct: 122 EVICALHKLNIVHRDLKPENILLDDDM-NIKLTDFGFSCQLDPGEKLREVCGTPSYLAPE 180
Query: 290 LL-VDLQD----YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA 344
           ++   + D    Y   +DMWS G +   ++    PF++      Q++ +           
Sbjct: 181 IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH----RKQMLML----------- 225
Query: 345 YLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLD-------KLLRYDH 397
                                     + I + N    SPE  D+ D       + L    
Sbjct: 226 --------------------------RMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQP 259
Query: 398 QDRLTAREAMAHPYFAQ 414
           Q R TA EA+AHP+F Q
Sbjct: 260 QKRYTAEEALAHPFFQQ 276

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 90/201 (44%), Gaps = 37/201 (18%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRK--LRLIDWGLAEFYHPG 273
           L +   + Y Y++L A+ Y H  GI+HRD+KP NV++  +     +++ D+G ++     
Sbjct: 111 LKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET 170
Query: 274 KEYNVRVASRYFKGPELLVDL--QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
                   +  +  PE+LV +    Y+ ++D WSLG +   +     P F  H     L 
Sbjct: 171 SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILF-ICLSGYPPFSEHRTQVSL- 228
Query: 332 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDK 391
                   D++ +   KY+    P++           W++         VS +A+D + K
Sbjct: 229 -------KDQITS--GKYN--FIPEV-----------WAE---------VSEKALDLVKK 257
Query: 392 LLRYDHQDRLTAREAMAHPYF 412
           LL  D + R T  EA+ HP+ 
Sbjct: 258 LLVVDPKARFTTEEALRHPWL 278

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/201 (24%), Positives = 88/201 (43%), Gaps = 37/201 (18%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRK--LRLIDWGLAEFYHPG 273
           L +   + Y Y++L A+ Y H  GI+HRD+KP NV++  +     +++ D+G ++     
Sbjct: 111 LKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET 170
Query: 274 KEYNVRVASRYFKGPELLVDL--QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
                   +  +  PE+LV +    Y+ ++D WSLG +    +    PF      H   V
Sbjct: 171 SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF----SEHRTQV 226
Query: 332 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDK 391
            +   + + + N           P++           W++         VS +A+D + K
Sbjct: 227 SLKDQITSGKYN---------FIPEV-----------WAE---------VSEKALDLVKK 257
Query: 392 LLRYDHQDRLTAREAMAHPYF 412
           LL  D + R T  EA+ HP+ 
Sbjct: 258 LLVVDPKARFTTEEALRHPWL 278

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/201 (24%), Positives = 88/201 (43%), Gaps = 37/201 (18%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRK--LRLIDWGLAEFYHPG 273
           L +   + Y Y++L A+ Y H  GI+HRD+KP NV++  +     +++ D+G ++     
Sbjct: 110 LKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET 169
Query: 274 KEYNVRVASRYFKGPELLVDL--QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
                   +  +  PE+LV +    Y+ ++D WSLG +    +    PF      H   V
Sbjct: 170 SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF----SEHRTQV 225
Query: 332 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDK 391
            +   + + + N           P++           W++         VS +A+D + K
Sbjct: 226 SLKDQITSGKYN---------FIPEV-----------WAE---------VSEKALDLVKK 256
Query: 392 LLRYDHQDRLTAREAMAHPYF 412
           LL  D + R T  EA+ HP+ 
Sbjct: 257 LLVVDPKARFTTEEALRHPWL 277

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/201 (24%), Positives = 88/201 (43%), Gaps = 37/201 (18%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRK--LRLIDWGLAEFYHPG 273
           L +   + Y Y++L A+ Y H  GI+HRD+KP NV++  +     +++ D+G ++     
Sbjct: 117 LKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET 176
Query: 274 KEYNVRVASRYFKGPELLVDL--QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
                   +  +  PE+LV +    Y+ ++D WSLG +    +    PF      H   V
Sbjct: 177 SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF----SEHRTQV 232
Query: 332 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDK 391
            +   + + + N           P++           W++         VS +A+D + K
Sbjct: 233 SLKDQITSGKYN---------FIPEV-----------WAE---------VSEKALDLVKK 263
Query: 392 LLRYDHQDRLTAREAMAHPYF 412
           LL  D + R T  EA+ HP+ 
Sbjct: 264 LLVVDPKARFTTEEALRHPWL 284

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/201 (24%), Positives = 88/201 (43%), Gaps = 37/201 (18%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRK--LRLIDWGLAEFYHPG 273
           L +   + Y Y++L A+ Y H  GI+HRD+KP NV++  +     +++ D+G ++     
Sbjct: 111 LKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET 170
Query: 274 KEYNVRVASRYFKGPELLVDL--QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
                   +  +  PE+LV +    Y+ ++D WSLG +    +    PF      H   V
Sbjct: 171 SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF----SEHRTQV 226
Query: 332 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDK 391
            +   + + + N           P++           W++         VS +A+D + K
Sbjct: 227 SLKDQITSGKYN---------FIPEV-----------WAE---------VSEKALDLVKK 257
Query: 392 LLRYDHQDRLTAREAMAHPYF 412
           LL  D + R T  EA+ HP+ 
Sbjct: 258 LLVVDPKARFTTEEALRHPWL 278

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 70/302 (23%), Positives = 120/302 (39%), Gaps = 52/302 (17%)
Query: 120 QWGDQDDYEVVRKVGRGKYSEVFEGINVNTN-----ERCXXXXXXXXXXXXXXXXXXXLQ 174
           QW   +D+E+ R +G+GK+  V+      +      +                     +Q
Sbjct: 5   QWA-LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 63
Query: 175 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIYELLKA 231
           +    PN+++L     D  +    LI EY            L+ +D      YI EL  A
Sbjct: 64  SHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 121
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 291
           L YCHS+ ++HRD+KP N+++     +L++ D+G +  + P         +  +  PE +
Sbjct: 122 LSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPE-M 178
Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL 351
           ++ + +D  +D+WSLG +    +  K PF                    E N Y   Y  
Sbjct: 179 IEGRMHDEKVDLWSLGVLCYEFLVGKPPF--------------------EANTYQETYK- 217
Query: 352 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 411
                      R SR    +F   D    V+  A D + +LL+++   R   RE + HP+
Sbjct: 218 -----------RISR---VEFTFPD---FVTEGARDLISRLLKHNPSQRPMLREVLEHPW 260
Query: 412 FA 413
Sbjct: 261 IT 262

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 70/302 (23%), Positives = 120/302 (39%), Gaps = 52/302 (17%)
Query: 120 QWGDQDDYEVVRKVGRGKYSEVFEGINVNTN-----ERCXXXXXXXXXXXXXXXXXXXLQ 174
           QW   +D+E+ R +G+GK+  V+      +      +                     +Q
Sbjct: 9   QWA-LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 67
Query: 175 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIYELLKA 231
           +    PN+++L     D  +    LI EY            L+ +D      YI EL  A
Sbjct: 68  SHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 125
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 291
           L YCHS+ ++HRD+KP N+++     +L++ D+G +  + P         +  +  PE +
Sbjct: 126 LSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPE-M 182
Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL 351
           ++ + +D  +D+WSLG +    +  K PF                    E N Y   Y  
Sbjct: 183 IEGRMHDEKVDLWSLGVLCYEFLVGKPPF--------------------EANTYQETYK- 221
Query: 352 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 411
                      R SR    +F   D    V+  A D + +LL+++   R   RE + HP+
Sbjct: 222 -----------RISR---VEFTFPD---FVTEGARDLISRLLKHNPSQRPMLREVLEHPW 264
Query: 412 FA 413
Sbjct: 265 IT 266

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 70/302 (23%), Positives = 120/302 (39%), Gaps = 52/302 (17%)
Query: 120 QWGDQDDYEVVRKVGRGKYSEVFEGINVNTN-----ERCXXXXXXXXXXXXXXXXXXXLQ 174
           QW   +D+E+ R +G+GK+  V+      +      +                     +Q
Sbjct: 4   QWA-LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 62
Query: 175 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIYELLKA 231
           +    PN+++L     D  +    LI EY            L+ +D      YI EL  A
Sbjct: 63  SHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 120
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 291
           L YCHS+ ++HRD+KP N+++     +L++ D+G +  + P         +  +  PE +
Sbjct: 121 LSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPE-M 177
Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL 351
           ++ + +D  +D+WSLG +    +  K PF                    E N Y   Y  
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPPF--------------------EANTYQETYK- 216
Query: 352 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 411
                      R SR    +F   D    V+  A D + +LL+++   R   RE + HP+
Sbjct: 217 -----------RISR---VEFTFPD---FVTEGARDLISRLLKHNPSQRPMLREVLEHPW 259
Query: 412 FA 413
Sbjct: 260 IT 261

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 37/144 (25%), Positives = 75/144 (52%), Gaps = 6/144 (4%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           PN+VKL +++  +  KT  L+ EY +     D+ V +    + + R    +++ A+ YCH
Sbjct: 73  PNIVKLFEVIETE--KTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSAVQYCH 130
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
            + I+HRD+K  N+++D +   +++ D+G +  +  G + +    +  +  PEL    + 
Sbjct: 131 QKFIVHRDLKAENLLLDAD-XNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKY 189
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPF 320
               +D+WSLG +   ++    PF
Sbjct: 190 DGPEVDVWSLGVILYTLVSGSLPF 213

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/206 (22%), Positives = 95/206 (46%), Gaps = 41/206 (19%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGK 274
            ++ + R+++++++  + Y HS GI+HRD+   N+++   +  +++ D+GLA +   P +
Sbjct: 109 FSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNM-NIKIADFGLATQLKMPHE 167
Query: 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 334
           ++     +  +  PE+      +    D+WSLGCMF  ++  + PF              
Sbjct: 168 KHYTLCGTPNYISPEIATR-SAHGLESDVWSLGCMFYTLLIGRPPF-------------- 212
Query: 335 KVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLR 394
               TD +   LNK  L  D ++ +                     +S EA D + +LLR
Sbjct: 213 ---DTDTVKNTLNKVVLA-DYEMPS--------------------FLSIEAKDLIHQLLR 248
Query: 395 YDHQDRLTAREAMAHPYFAQVRAAES 420
            +  DRL+    + HP+ ++  + +S
Sbjct: 249 RNPADRLSLSSVLDHPFMSRNSSTKS 274

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 71/295 (24%), Positives = 118/295 (40%), Gaps = 42/295 (14%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVVK 184
           D YEV   +G G YS     I+  TN                      L+     PN++ 
Sbjct: 22  DGYEVKEDIGVGSYSVCKRCIHKATNXEFAVKIIDKSKRDPTEEIEILLR-YGQHPNIIT 80
Query: 185 LLDIVRDQHSKTPSLIFEYVNSTDF--KVLYPTL-TDYDIRYYIYELLKALDYCHSQGIM 241
           L D+  D   K   ++ E     +   K+L     ++ +    ++ + K ++Y H+QG++
Sbjct: 81  LKDVYDD--GKYVYVVTELXKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVV 138
Query: 242 HRDVKPHNVMIDHEL---RKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDY 297
           HRD+KP N++   E      +R+ D+G A +             +  F  PE+L + Q Y
Sbjct: 139 HRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTPCYTANFVAPEVL-ERQGY 197
Query: 298 DYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQL 357
           D + D+WSLG +    +    PF  G D+  +  +I   +G+ +                
Sbjct: 198 DAACDIWSLGVLLYTXLTGYTPFANGPDDTPE--EILARIGSGKF--------------- 240
Query: 358 DALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 412
            +L G +    W+          VS  A D + K L  D   RLTA   + HP+ 
Sbjct: 241 -SLSGGY----WNS---------VSDTAKDLVSKXLHVDPHQRLTAALVLRHPWI 281

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 49/201 (24%), Positives = 88/201 (43%), Gaps = 37/201 (18%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRK--LRLIDWGLAEFYHPG 273
           L +   + Y Y++L A+ Y H  GI+HRD+KP NV++  +     +++ D+G ++     
Sbjct: 250 LKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET 309
Query: 274 KEYNVRVASRYFKGPELLVDL--QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
                   +  +  PE+LV +    Y+ ++D WSLG +    +    PF      H   V
Sbjct: 310 SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF----SEHRTQV 365
Query: 332 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDK 391
            +   + + + N           P++           W++         VS +A+D + K
Sbjct: 366 SLKDQITSGKYN---------FIPEV-----------WAE---------VSEKALDLVKK 396
Query: 392 LLRYDHQDRLTAREAMAHPYF 412
           LL  D + R T  EA+ HP+ 
Sbjct: 397 LLVVDPKARFTTEEALRHPWL 417

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 71/301 (23%), Positives = 119/301 (39%), Gaps = 45/301 (14%)
Query: 125 DDYEVVRKV-GRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVV 183
           DDY+V  +V G G   +V +  N  T E+                      + C  P++V
Sbjct: 15  DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC--PHIV 72
Query: 184 KLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYI----YELLK----ALDYC 235
           +++D+  + ++    L+   +   D   L+  + D   + +      E++K    A+ Y 
Sbjct: 73  RIVDVYENLYAGRKCLLI-VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 131
Query: 236 HSQGIMHRDVKPHNVMIDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           HS  I HRDVKP N++   +     L+L D+G A+             + Y+  PE+L  
Sbjct: 132 HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL-G 190
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 353
            + YD S DMWSLG +   ++    PF+  H                          L +
Sbjct: 191 PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG-------------------------LAI 225
Query: 354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA 413
            P +   +    R    +F N +    VS E    +  LL+ +   R+T  E M HP+  
Sbjct: 226 SPGMKTRI----RMGQYEFPNPEWSE-VSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM 280
Query: 414 Q 414
           Q
Sbjct: 281 Q 281

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 71/301 (23%), Positives = 119/301 (39%), Gaps = 45/301 (14%)
Query: 125 DDYEVVRKV-GRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVV 183
           DDY+V  +V G G   +V +  N  T E+                      + C  P++V
Sbjct: 21  DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC--PHIV 78
Query: 184 KLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYI----YELLK----ALDYC 235
           +++D+  + ++    L+   +   D   L+  + D   + +      E++K    A+ Y 
Sbjct: 79  RIVDVYENLYAGRKCLLI-VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 137
Query: 236 HSQGIMHRDVKPHNVMIDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           HS  I HRDVKP N++   +     L+L D+G A+             + Y+  PE+L  
Sbjct: 138 HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL-G 196
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 353
            + YD S DMWSLG +   ++    PF+  H                          L +
Sbjct: 197 PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG-------------------------LAI 231
Query: 354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA 413
            P +   +    R    +F N +    VS E    +  LL+ +   R+T  E M HP+  
Sbjct: 232 SPGMKTRI----RMGQYEFPNPEWSE-VSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM 286
Query: 414 Q 414
           Q
Sbjct: 287 Q 287

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 71/301 (23%), Positives = 119/301 (39%), Gaps = 45/301 (14%)
Query: 125 DDYEVVRKV-GRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVV 183
           DDY+V  +V G G   +V +  N  T E+                      + C  P++V
Sbjct: 31  DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC--PHIV 88
Query: 184 KLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYI----YELLK----ALDYC 235
           +++D+  + ++    L+   +   D   L+  + D   + +      E++K    A+ Y 
Sbjct: 89  RIVDVYENLYAGRKCLLI-VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 147
Query: 236 HSQGIMHRDVKPHNVMIDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           HS  I HRDVKP N++   +     L+L D+G A+             + Y+  PE+L  
Sbjct: 148 HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL-G 206
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 353
            + YD S DMWSLG +   ++    PF+  H                          L +
Sbjct: 207 PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG-------------------------LAI 241
Query: 354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA 413
            P +   +    R    +F N +    VS E    +  LL+ +   R+T  E M HP+  
Sbjct: 242 SPGMKTRI----RMGQYEFPNPEWSE-VSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM 296
Query: 414 Q 414
           Q
Sbjct: 297 Q 297

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 71/301 (23%), Positives = 119/301 (39%), Gaps = 45/301 (14%)
Query: 125 DDYEVVRKV-GRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVV 183
           DDY+V  +V G G   +V +  N  T E+                      + C  P++V
Sbjct: 16  DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC--PHIV 73
Query: 184 KLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYI----YELLK----ALDYC 235
           +++D+  + ++    L+   +   D   L+  + D   + +      E++K    A+ Y 
Sbjct: 74  RIVDVYENLYAGRKCLLI-VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 132
Query: 236 HSQGIMHRDVKPHNVMIDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           HS  I HRDVKP N++   +     L+L D+G A+             + Y+  PE+L  
Sbjct: 133 HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL-G 191
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 353
            + YD S DMWSLG +   ++    PF+  H                          L +
Sbjct: 192 PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG-------------------------LAI 226
Query: 354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA 413
            P +   +    R    +F N +    VS E    +  LL+ +   R+T  E M HP+  
Sbjct: 227 SPGMKTRI----RMGQYEFPNPEWSE-VSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM 281
Query: 414 Q 414
           Q
Sbjct: 282 Q 282

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 71/301 (23%), Positives = 119/301 (39%), Gaps = 45/301 (14%)
Query: 125 DDYEVVRKV-GRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVV 183
           DDY+V  +V G G   +V +  N  T E+                      + C  P++V
Sbjct: 22  DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC--PHIV 79
Query: 184 KLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYI----YELLK----ALDYC 235
           +++D+  + ++    L+   +   D   L+  + D   + +      E++K    A+ Y 
Sbjct: 80  RIVDVYENLYAGRKCLLI-VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 138
Query: 236 HSQGIMHRDVKPHNVMIDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           HS  I HRDVKP N++   +     L+L D+G A+             + Y+  PE+L  
Sbjct: 139 HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL-G 197
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 353
            + YD S DMWSLG +   ++    PF+  H                          L +
Sbjct: 198 PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG-------------------------LAI 232
Query: 354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA 413
            P +   +    R    +F N +    VS E    +  LL+ +   R+T  E M HP+  
Sbjct: 233 SPGMKTRI----RMGQYEFPNPEWSE-VSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM 287
Query: 414 Q 414
           Q
Sbjct: 288 Q 288

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 71/301 (23%), Positives = 119/301 (39%), Gaps = 45/301 (14%)
Query: 125 DDYEVVRKV-GRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVV 183
           DDY+V  +V G G   +V +  N  T E+                      + C  P++V
Sbjct: 23  DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC--PHIV 80
Query: 184 KLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYI----YELLK----ALDYC 235
           +++D+  + ++    L+   +   D   L+  + D   + +      E++K    A+ Y 
Sbjct: 81  RIVDVYENLYAGRKCLLI-VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 139
Query: 236 HSQGIMHRDVKPHNVMIDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           HS  I HRDVKP N++   +     L+L D+G A+             + Y+  PE+L  
Sbjct: 140 HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL-G 198
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 353
            + YD S DMWSLG +   ++    PF+  H                          L +
Sbjct: 199 PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG-------------------------LAI 233
Query: 354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA 413
            P +   +    R    +F N +    VS E    +  LL+ +   R+T  E M HP+  
Sbjct: 234 SPGMKTRI----RMGQYEFPNPEWSE-VSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM 288
Query: 414 Q 414
           Q
Sbjct: 289 Q 289

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 49/201 (24%), Positives = 88/201 (43%), Gaps = 37/201 (18%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRK--LRLIDWGLAEFYHPG 273
           L +   + Y Y++L A+ Y H  GI+HRD+KP NV++  +     +++ D+G ++     
Sbjct: 236 LKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET 295
Query: 274 KEYNVRVASRYFKGPELLVDL--QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
                   +  +  PE+LV +    Y+ ++D WSLG +    +    PF      H   V
Sbjct: 296 SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF----SEHRTQV 351
Query: 332 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDK 391
            +   + + + N           P++           W++         VS +A+D + K
Sbjct: 352 SLKDQITSGKYN---------FIPEV-----------WAE---------VSEKALDLVKK 382
Query: 392 LLRYDHQDRLTAREAMAHPYF 412
           LL  D + R T  EA+ HP+ 
Sbjct: 383 LLVVDPKARFTTEEALRHPWL 403

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 71/301 (23%), Positives = 119/301 (39%), Gaps = 45/301 (14%)
Query: 125 DDYEVVRKV-GRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVV 183
           DDY+V  +V G G   +V +  N  T E+                      + C  P++V
Sbjct: 17  DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC--PHIV 74
Query: 184 KLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYI----YELLK----ALDYC 235
           +++D+  + ++    L+   +   D   L+  + D   + +      E++K    A+ Y 
Sbjct: 75  RIVDVYENLYAGRKCLLI-VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 133
Query: 236 HSQGIMHRDVKPHNVMIDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           HS  I HRDVKP N++   +     L+L D+G A+             + Y+  PE+L  
Sbjct: 134 HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL-G 192
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 353
            + YD S DMWSLG +   ++    PF+  H                          L +
Sbjct: 193 PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG-------------------------LAI 227
Query: 354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA 413
            P +   +    R    +F N +    VS E    +  LL+ +   R+T  E M HP+  
Sbjct: 228 SPGMKTRI----RMGQYEFPNPEWSE-VSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM 282
Query: 414 Q 414
           Q
Sbjct: 283 Q 283

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 71/301 (23%), Positives = 119/301 (39%), Gaps = 45/301 (14%)
Query: 125 DDYEVVRKV-GRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVV 183
           DDY+V  +V G G   +V +  N  T E+                      + C  P++V
Sbjct: 17  DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC--PHIV 74
Query: 184 KLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYI----YELLK----ALDYC 235
           +++D+  + ++    L+   +   D   L+  + D   + +      E++K    A+ Y 
Sbjct: 75  RIVDVYENLYAGRKCLLI-VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 133
Query: 236 HSQGIMHRDVKPHNVMIDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           HS  I HRDVKP N++   +     L+L D+G A+             + Y+  PE+L  
Sbjct: 134 HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL-G 192
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 353
            + YD S DMWSLG +   ++    PF+  H                          L +
Sbjct: 193 PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG-------------------------LAI 227
Query: 354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA 413
            P +   +    R    +F N +    VS E    +  LL+ +   R+T  E M HP+  
Sbjct: 228 SPGMKTRI----RMGQYEFPNPEWSE-VSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM 282
Query: 414 Q 414
           Q
Sbjct: 283 Q 283

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 71/301 (23%), Positives = 119/301 (39%), Gaps = 45/301 (14%)
Query: 125 DDYEVVRKV-GRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVV 183
           DDY+V  +V G G   +V +  N  T E+                      + C  P++V
Sbjct: 61  DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC--PHIV 118
Query: 184 KLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYI----YELLK----ALDYC 235
           +++D+  + ++    L+   +   D   L+  + D   + +      E++K    A+ Y 
Sbjct: 119 RIVDVYENLYAGRKCLLI-VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 177
Query: 236 HSQGIMHRDVKPHNVMIDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           HS  I HRDVKP N++   +     L+L D+G A+             + Y+  PE+L  
Sbjct: 178 HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL-G 236
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 353
            + YD S DMWSLG +   ++    PF+  H                          L +
Sbjct: 237 PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG-------------------------LAI 271
Query: 354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA 413
            P +   +    R    +F N +    VS E    +  LL+ +   R+T  E M HP+  
Sbjct: 272 SPGMKTRI----RMGQYEFPNPEWSE-VSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM 326
Query: 414 Q 414
           Q
Sbjct: 327 Q 327

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 71/301 (23%), Positives = 119/301 (39%), Gaps = 45/301 (14%)
Query: 125 DDYEVVRKV-GRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVV 183
           DDY+V  +V G G   +V +  N  T E+                      + C  P++V
Sbjct: 67  DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC--PHIV 124
Query: 184 KLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYI----YELLK----ALDYC 235
           +++D+  + ++    L+   +   D   L+  + D   + +      E++K    A+ Y 
Sbjct: 125 RIVDVYENLYAGRKCLLI-VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 183
Query: 236 HSQGIMHRDVKPHNVMIDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           HS  I HRDVKP N++   +     L+L D+G A+             + Y+  PE+L  
Sbjct: 184 HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL-G 242
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 353
            + YD S DMWSLG +   ++    PF+  H                          L +
Sbjct: 243 PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG-------------------------LAI 277
Query: 354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA 413
            P +   +    R    +F N +    VS E    +  LL+ +   R+T  E M HP+  
Sbjct: 278 SPGMKTRI----RMGQYEFPNPEWSE-VSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM 332
Query: 414 Q 414
           Q
Sbjct: 333 Q 333

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 37/147 (25%), Positives = 73/147 (49%), Gaps = 12/147 (8%)
Query: 180 PNVVKLLDIVRDQHSKTPS---LIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALD 233
           P+++KL  ++      TP+   ++ EYV+     D+   +  + + + R    ++L A+D
Sbjct: 71  PHIIKLYQVI-----STPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVD 125
Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           YCH   ++HRD+KP NV++D  +   ++ D+GL+     G+       S  +  PE++  
Sbjct: 126 YCHRHMVVHRDLKPENVLLDAHMNA-KIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISG 184
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPF 320
                  +D+WS G +   ++    PF
Sbjct: 185 RLYAGPEVDIWSCGVILYALLCGTLPF 211

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 97/215 (45%), Gaps = 15/215 (6%)
Query: 113 DYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXX 172
           D +SLT Q   ++ ++V+ K+G G Y  V++ I+  T +                     
Sbjct: 19  DEDSLTKQ--PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEIS 76
Query: 173 LQNLCGGPNVVKLLDIVRDQHSKTPSL--IFEYVNSTD----FKVLYPTLTDYDIRYYIY 226
           +   C  P+VVK        + K   L  + EY  +       ++   TLT+ +I   + 
Sbjct: 77  IMQQCDSPHVVKYYG----SYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQ 132
Query: 227 ELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYF 285
             LK L+Y H    +HRD+K  N++++ E    +L D+G+A +      + N  + + ++
Sbjct: 133 STLKGLEYLHFMRKIHRDIKAGNILLNTE-GHAKLADFGVAGQLTDXMAKRNXVIGTPFW 191
Query: 286 KGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
             PE++ ++  Y+   D+WSLG     M   K P+
Sbjct: 192 MAPEVIQEI-GYNCVADIWSLGITAIEMAEGKPPY 225

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 73/300 (24%), Positives = 123/300 (41%), Gaps = 44/300 (14%)
Query: 125 DDYEVVRKV-GRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVV 183
           DDY++ ++V G G   +V E  +  T ++C                        GGP++V
Sbjct: 9   DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHW--QASGGPHIV 66
Query: 184 KLLDIVRDQHSKTPSL--IFEYVNSTD-FKVLYP----TLTDYDIRYYIYELLKALDYCH 236
            +LD+  + H     L  I E +   + F  +        T+ +    + ++  A+ + H
Sbjct: 67  CILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH 126
Query: 237 SQGIMHRDVKPHNVMIDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 294
           S  I HRDVKP N++   + +   L+L D+G A+             + Y+  PE+L   
Sbjct: 127 SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK-ETTQNALQTPCYTPYYVAPEVL-GP 184
Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 354
           + YD S DMWSLG +   ++    PF+    N  Q +         +    L +Y    +
Sbjct: 185 EKYDKSCDMWSLGVIMYILLCGFPPFY---SNTGQAISPGM-----KRRIRLGQYGFP-N 235
Query: 355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 414
           P+            WS+         VS +A   +  LL+ D  +RLT  + M HP+  Q
Sbjct: 236 PE------------WSE---------VSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQ 274

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 65/310 (20%), Positives = 127/310 (40%), Gaps = 47/310 (15%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQNLCGGP 180
           D+Y++   +G+G +S V   + + T      +                    +  L    
Sbjct: 4   DEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKHS 63
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDF---KVLYPTLTDYDIRYYIYELLKALDYCHS 237
           N+V+L D + ++      L+F+ V   +     V     ++ D  + I ++L+A+ +CH 
Sbjct: 64  NIVRLHDSISEEGFHY--LVFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQ 121
Query: 238 QGIMHRDVKPHNVMIDHELR--KLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDL 294
            G++HRD+KP N+++  + +   ++L D+GLA E     + +     +  +  PE+L   
Sbjct: 122 MGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRK- 180
Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 354
           + Y   +D+W+ G +   ++    P F+  D H                        +L 
Sbjct: 181 EAYGKPVDIWACGVILY-ILLVGYPPFWDEDQH------------------------KLY 215
Query: 355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 414
            Q+ A         W           V+PEA + ++++L  +   R+TA EA+ HP+  Q
Sbjct: 216 QQIKAGAYDFPSPEWDT---------VTPEAKNLINQMLTINPAKRITAHEALKHPWVCQ 266
Query: 415 VRAAESSRTR 424
                S   R
Sbjct: 267 RSTVASMMHR 276

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 104/238 (43%), Gaps = 43/238 (18%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           PNV+ L ++  ++      LI E V      DF     +LT+ +   ++ ++L  + Y H
Sbjct: 74  PNVITLHEVYENKTDVI--LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 237 SQGIMHRDVKPHNVM-IDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           S  I H D+KP N+M +D  + K  +++ID+GLA     G E+     +  F  PE +V+
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPAFVAPE-IVN 190
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 353
            +      DMWS+G +   ++    PF  G    + L  ++ V            Y  E 
Sbjct: 191 YEPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANVSAV-----------NYEFED 238
Query: 354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 411
           +                 F N       S  A DF+ +LL  D + R+T ++++ HP+
Sbjct: 239 E----------------YFSN------TSALAKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 73/300 (24%), Positives = 123/300 (41%), Gaps = 44/300 (14%)
Query: 125 DDYEVVRKV-GRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVV 183
           DDY++ ++V G G   +V E  +  T ++C                        GGP++V
Sbjct: 28  DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHW--QASGGPHIV 85
Query: 184 KLLDIVRDQHSKTPSL--IFEYVNSTD-FKVLYP----TLTDYDIRYYIYELLKALDYCH 236
            +LD+  + H     L  I E +   + F  +        T+ +    + ++  A+ + H
Sbjct: 86  CILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH 145
Query: 237 SQGIMHRDVKPHNVMIDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 294
           S  I HRDVKP N++   + +   L+L D+G A+             + Y+  PE+L   
Sbjct: 146 SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK-ETTQNALQTPCYTPYYVAPEVL-GP 203
Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 354
           + YD S DMWSLG +   ++    PF+    N  Q +         +    L +Y    +
Sbjct: 204 EKYDKSCDMWSLGVIMYILLCGFPPFY---SNTGQAISPGM-----KRRIRLGQYGFP-N 254
Query: 355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 414
           P+            WS+         VS +A   +  LL+ D  +RLT  + M HP+  Q
Sbjct: 255 PE------------WSE---------VSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQ 293

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 67/304 (22%), Positives = 122/304 (40%), Gaps = 60/304 (19%)
Query: 120 QWGDQDDYEVVRKVGRGKYSEVFEGINVNTN-----ERCXXXXXXXXXXXXXXXXXXXLQ 174
           QW   +D+++ R +G+GK+  V+      +      +                     +Q
Sbjct: 8   QW-TLEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQ 66
Query: 175 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIYELLKA 231
           +    PN+++L     D  +    LI EY            L+ +D      YI EL  A
Sbjct: 67  SHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANA 124
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 291
           L YCHS+ ++HRD+KP N+++     +L++ D+G +  + P    +    +  +  PE +
Sbjct: 125 LSYCHSKRVIHRDIKPENLLLGSN-GELKIADFGWS-VHAPSSRRDTLCGTLDYLPPE-M 181
Query: 292 VDLQDYDYSLDMWSLGCM----FAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLN 347
           ++ + +D  +D+WSLG +      GM     P F  H   +   +I++V           
Sbjct: 182 IEGRMHDEKVDLWSLGVLCYEFLVGM-----PPFEAHTYQETYRRISRV----------- 225
Query: 348 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
                                  +F   D    V+  A D + +LL+++   RLT  E +
Sbjct: 226 -----------------------EFTFPD---FVTEGARDLISRLLKHNASQRLTLAEVL 259
Query: 408 AHPY 411
            HP+
Sbjct: 260 EHPW 263

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 67/304 (22%), Positives = 121/304 (39%), Gaps = 60/304 (19%)
Query: 120 QWGDQDDYEVVRKVGRGKYSEVFEGINVNTN-----ERCXXXXXXXXXXXXXXXXXXXLQ 174
           QW   +D+++ R +G+GK+  V+      +      +                     +Q
Sbjct: 8   QW-TLEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQ 66
Query: 175 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIYELLKA 231
           +    PN+++L     D  +    LI EY            L+ +D      YI EL  A
Sbjct: 67  SHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANA 124
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 291
           L YCHS+ ++HRD+KP N+++     +L++ D+G +  + P         +  +  PE +
Sbjct: 125 LSYCHSKRVIHRDIKPENLLLGSN-GELKIADFGWS-VHAPSSRRTTLCGTLDYLPPE-M 181
Query: 292 VDLQDYDYSLDMWSLGCM----FAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLN 347
           ++ + +D  +D+WSLG +      GM     P F  H   +   +I++V           
Sbjct: 182 IEGRMHDEKVDLWSLGVLCYEFLVGM-----PPFEAHTYQETYRRISRV----------- 225
Query: 348 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
                                  +F   D    V+  A D + +LL+++   RLT  E +
Sbjct: 226 -----------------------EFTFPD---FVTEGARDLISRLLKHNASQRLTLAEVL 259
Query: 408 AHPY 411
            HP+
Sbjct: 260 EHPW 263

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 90/205 (43%), Gaps = 22/205 (10%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIF---EYVNST---DFKVLYPTLTDYDIRYYIYELLKALD 233
           P+++KL  ++      TPS IF   EYV+     D+      L + + R    ++L  +D
Sbjct: 76  PHIIKLYQVI-----STPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVD 130
Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           YCH   ++HRD+KP NV++D  +   ++ D+GL+     G+       S  +  PE++  
Sbjct: 131 YCHRHMVVHRDLKPENVLLDAHMNA-KIADFGLSNMMSDGEFLRXSCGSPNYAAPEVISG 189
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLN------ 347
                  +D+WS G +   ++    PF    D+H   +      G      YLN      
Sbjct: 190 RLYAGPEVDIWSSGVILYALLCGTLPF---DDDHVPTLFKKICDGIFYTPQYLNPSVISL 246
Query: 348 -KYHLELDPQLDALVGRHSRKPWSK 371
            K+ L++DP   A +       W K
Sbjct: 247 LKHMLQVDPMKRATIKDIREHEWFK 271

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 104/238 (43%), Gaps = 43/238 (18%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           PNV+ L ++  ++      LI E V      DF     +LT+ +   ++ ++L  + Y H
Sbjct: 74  PNVITLHEVYENKTDVI--LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 237 SQGIMHRDVKPHNVM-IDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           S  I H D+KP N+M +D  + K  +++ID+GLA     G E+     +  F  PE +V+
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE-IVN 190
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 353
            +      DMWS+G +   ++    PF  G    + L  ++ V            Y  E 
Sbjct: 191 YEPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANVSAV-----------NYEFED 238
Query: 354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 411
           +                 F N       S  A DF+ +LL  D + R+T ++++ HP+
Sbjct: 239 E----------------YFSN------TSALAKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 104/238 (43%), Gaps = 43/238 (18%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           PNV+ L ++  ++      LI E V      DF     +LT+ +   ++ ++L  + Y H
Sbjct: 74  PNVITLHEVYENKTDVI--LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 237 SQGIMHRDVKPHNVM-IDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           S  I H D+KP N+M +D  + K  +++ID+GLA     G E+     +  F  PE +V+
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE-IVN 190
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 353
            +      DMWS+G +   ++    PF  G    + L  ++ V            Y  E 
Sbjct: 191 YEPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANVSAV-----------NYEFED 238
Query: 354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 411
           +                 F N       S  A DF+ +LL  D + R+T ++++ HP+
Sbjct: 239 E----------------YFSNT------SALAKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 104/238 (43%), Gaps = 43/238 (18%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           PNV+ L ++  ++      LI E V      DF     +LT+ +   ++ ++L  + Y H
Sbjct: 74  PNVITLHEVYENKTDVI--LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 237 SQGIMHRDVKPHNVM-IDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           S  I H D+KP N+M +D  + K  +++ID+GLA     G E+     +  F  PE +V+
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE-IVN 190
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 353
            +      DMWS+G +   ++    PF  G    + L  ++ V            Y  E 
Sbjct: 191 YEPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANVSAV-----------NYEFED 238
Query: 354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 411
           +                 F N       S  A DF+ +LL  D + R+T ++++ HP+
Sbjct: 239 E----------------YFSNT------SALAKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 71/301 (23%), Positives = 119/301 (39%), Gaps = 45/301 (14%)
Query: 125 DDYEVVRKV-GRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVV 183
           DDY+V  +V G G   +V +  N  T E+                      + C  P++V
Sbjct: 15  DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC--PHIV 72
Query: 184 KLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYI----YELLK----ALDYC 235
           +++D+  + ++    L+   +   D   L+  + D   + +      E++K    A+ Y 
Sbjct: 73  RIVDVYENLYAGRKCLLI-VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 131
Query: 236 HSQGIMHRDVKPHNVMIDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           HS  I HRDVKP N++   +     L+L D+G A+             + Y+  PE+L  
Sbjct: 132 HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTEPCYTPYYVAPEVL-G 190
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 353
            + YD S DMWSLG +   ++    PF+  H                          L +
Sbjct: 191 PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG-------------------------LAI 225
Query: 354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA 413
            P +   +    R    +F N +    VS E    +  LL+ +   R+T  E M HP+  
Sbjct: 226 SPGMKTRI----RMGQYEFPNPEWSE-VSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM 280
Query: 414 Q 414
           Q
Sbjct: 281 Q 281

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 104/238 (43%), Gaps = 43/238 (18%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           PNV+ L ++  ++      LI E V      DF     +LT+ +   ++ ++L  + Y H
Sbjct: 73  PNVITLHEVYENKTDVI--LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 130
Query: 237 SQGIMHRDVKPHNVM-IDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           S  I H D+KP N+M +D  + K  +++ID+GLA     G E+     +  F  PE +V+
Sbjct: 131 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE-IVN 189
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 353
            +      DMWS+G +   ++    PF  G    + L  ++ V            Y  E 
Sbjct: 190 YEPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANVSAV-----------NYEFED 237
Query: 354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 411
           +                 F N       S  A DF+ +LL  D + R+T ++++ HP+
Sbjct: 238 E----------------YFSNT------SALAKDFIRRLLVKDPKKRMTIQDSLQHPW 273

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 104/238 (43%), Gaps = 43/238 (18%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           PNV+ L ++  ++      LI E V      DF     +LT+ +   ++ ++L  + Y H
Sbjct: 73  PNVITLHEVYENKTDVI--LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 130
Query: 237 SQGIMHRDVKPHNVM-IDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           S  I H D+KP N+M +D  + K  +++ID+GLA     G E+     +  F  PE +V+
Sbjct: 131 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE-IVN 189
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 353
            +      DMWS+G +   ++    PF  G    + L  ++ V            Y  E 
Sbjct: 190 YEPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANVSAV-----------NYEFED 237
Query: 354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 411
           +                 F N       S  A DF+ +LL  D + R+T ++++ HP+
Sbjct: 238 E----------------YFSNT------SALAKDFIRRLLVKDPKKRMTIQDSLQHPW 273

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 104/238 (43%), Gaps = 43/238 (18%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           PNV+ L ++  ++      LI E V      DF     +LT+ +   ++ ++L  + Y H
Sbjct: 74  PNVITLHEVYENKTDVI--LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 237 SQGIMHRDVKPHNVM-IDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           S  I H D+KP N+M +D  + K  +++ID+GLA     G E+     +  F  PE +V+
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE-IVN 190
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 353
            +      DMWS+G +   ++    PF  G    + L  ++ V            Y  E 
Sbjct: 191 YEPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANVSAV-----------NYEFED 238
Query: 354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 411
           +                 F N       S  A DF+ +LL  D + R+T ++++ HP+
Sbjct: 239 E----------------YFSNT------SALAKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 104/238 (43%), Gaps = 43/238 (18%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           PNV+ L ++  ++      LI E V      DF     +LT+ +   ++ ++L  + Y H
Sbjct: 74  PNVITLHEVYENKTDVI--LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 237 SQGIMHRDVKPHNVM-IDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           S  I H D+KP N+M +D  + K  +++ID+GLA     G E+     +  F  PE +V+
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE-IVN 190
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 353
            +      DMWS+G +   ++    PF  G    + L  ++ V            Y  E 
Sbjct: 191 YEPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANVSAV-----------NYEFED 238
Query: 354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 411
           +                 F N       S  A DF+ +LL  D + R+T ++++ HP+
Sbjct: 239 E----------------YFSNT------SALAKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 104/238 (43%), Gaps = 43/238 (18%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           PNV+ L ++  ++      LI E V      DF     +LT+ +   ++ ++L  + Y H
Sbjct: 74  PNVITLHEVYENKTDVI--LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 237 SQGIMHRDVKPHNVM-IDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           S  I H D+KP N+M +D  + K  +++ID+GLA     G E+     +  F  PE +V+
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE-IVN 190
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 353
            +      DMWS+G +   ++    PF  G    + L  ++ V            Y  E 
Sbjct: 191 YEPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANVSAV-----------NYEFED 238
Query: 354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 411
           +                 F N       S  A DF+ +LL  D + R+T ++++ HP+
Sbjct: 239 E----------------YFSNT------SALAKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 41/125 (32%), Positives = 66/125 (52%), Gaps = 19/125 (15%)
Query: 227 ELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-------------PG 273
           ++L+AL Y HSQGI+HR++KP N+ ID E R +++ D+GLA+  H             PG
Sbjct: 124 QILEALSYIHSQGIIHRNLKPXNIFID-ESRNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182
Query: 274 KEYNVR--VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
              N+   + +  +   E+L     Y+  +D +SLG +F   I+   PF  G +  + L 
Sbjct: 183 SSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXIY---PFSTGXERVNILK 239
Query: 332 KIAKV 336
           K+  V
Sbjct: 240 KLRSV 244

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 104/238 (43%), Gaps = 43/238 (18%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           PNV+ L ++  ++      LI E V      DF     +LT+ +   ++ ++L  + Y H
Sbjct: 74  PNVITLHEVYENKTDVI--LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 237 SQGIMHRDVKPHNVM-IDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           S  I H D+KP N+M +D  + K  +++ID+GLA     G E+     +  F  PE +V+
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE-IVN 190
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 353
            +      DMWS+G +   ++    PF  G    + L  ++ V            Y  E 
Sbjct: 191 YEPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANVSAV-----------NYEFED 238
Query: 354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 411
           +                 F N       S  A DF+ +LL  D + R+T ++++ HP+
Sbjct: 239 E----------------YFSNT------SALAKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 96/217 (44%), Gaps = 54/217 (24%)
Query: 199 LIFEYVNSTDFKVL----YPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH 254
           LIFE +  + ++++    Y      DI+ Y  E+LKAL+Y     + H D+KP N+++D 
Sbjct: 113 LIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDD 172
Query: 255 --------ELRK----------------LRLIDWGLAEF---YHPGKEYNVRVASRYFKG 287
                    +R+                ++LID+G A F   YH        + +R ++ 
Sbjct: 173 PYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGS-----IINTRQYRA 227
Query: 288 PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLN 347
           PE++++L  +D S DMWS GC+ A + +     F  H++ + L  +  +           
Sbjct: 228 PEVILNL-GWDVSSDMWSFGCVLAEL-YTGSLLFRTHEHMEHLAMMESI----------- 274
Query: 348 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPE 384
                + P    ++   ++   SK++N D   L  PE
Sbjct: 275 -----IQPIPKNMLYEATKTNGSKYVNKDELKLAWPE 306

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 104/238 (43%), Gaps = 43/238 (18%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           PNV+ L ++  ++      LI E V      DF     +LT+ +   ++ ++L  + Y H
Sbjct: 74  PNVITLHEVYENKTDVI--LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 237 SQGIMHRDVKPHNVM-IDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           S  I H D+KP N+M +D  + K  +++ID+GLA     G E+     +  F  PE +V+
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE-IVN 190
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 353
            +      DMWS+G +   ++    PF  G    + L  ++ V            Y  E 
Sbjct: 191 YEPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANVSAV-----------NYEFED 238
Query: 354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 411
           +                 F N       S  A DF+ +LL  D + R+T ++++ HP+
Sbjct: 239 E----------------YFSNT------SALAKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 104/238 (43%), Gaps = 43/238 (18%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           PNV+ L ++  ++      LI E V      DF     +LT+ +   ++ ++L  + Y H
Sbjct: 74  PNVITLHEVYENKTDVI--LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 237 SQGIMHRDVKPHNVM-IDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           S  I H D+KP N+M +D  + K  +++ID+GLA     G E+     +  F  PE +V+
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE-IVN 190
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 353
            +      DMWS+G +   ++    PF  G    + L  ++ V            Y  E 
Sbjct: 191 YEPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANVSAV-----------NYEFED 238
Query: 354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 411
           +                 F N       S  A DF+ +LL  D + R+T ++++ HP+
Sbjct: 239 E----------------YFSN------TSALAKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 104/238 (43%), Gaps = 43/238 (18%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           PNV+ L ++  ++      LI E V      DF     +LT+ +   ++ ++L  + Y H
Sbjct: 74  PNVITLHEVYENKTDVI--LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 237 SQGIMHRDVKPHNVM-IDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           S  I H D+KP N+M +D  + K  +++ID+GLA     G E+     +  F  PE +V+
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE-IVN 190
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 353
            +      DMWS+G +   ++    PF  G    + L  ++ V            Y  E 
Sbjct: 191 YEPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANVSAV-----------NYEFED 238
Query: 354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 411
           +                 F N       S  A DF+ +LL  D + R+T ++++ HP+
Sbjct: 239 E----------------YFSNT------SALAKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/243 (24%), Positives = 104/243 (42%), Gaps = 42/243 (17%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDF--KVL--YPTLTDYDIRYYIYELLKALDYC 235
           P +V L D   D +     +I+E+++  +   KV   +  +++ +   Y+ ++ K L + 
Sbjct: 214 PTLVNLHDAFEDDNEMV--MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHM 271
Query: 236 HSQGIMHRDVKPHNVMIDHE-LRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 294
           H    +H D+KP N+M   +   +L+LID+GL     P +   V   +  F  PE + + 
Sbjct: 272 HENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPE-VAEG 330
Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 354
           +   Y  DMWS+G +   ++    PF  G +N D+ ++  K                  D
Sbjct: 331 KPVGYYTDMWSVGVLSYILLSGLSPF--GGENDDETLRNVK----------------SCD 372
Query: 355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 414
             +D           S F        +S +  DF+ KLL  D   R+T  +A+ HP+   
Sbjct: 373 WNMDD----------SAFSG------ISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTP 416
Query: 415 VRA 417
             A
Sbjct: 417 GNA 419

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/205 (24%), Positives = 95/205 (46%), Gaps = 11/205 (5%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQ-NLCGG 179
           +D+ V R +GRG + EV+     +T +    +C                   +  +L   
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 180 PNVVKLLDIVRDQHSKTP-SLIFEYVNSTDFK---VLYPTLTDYDIRYYIYELLKALDYC 235
            +   ++ +    H+    S I + +N  D       +   ++ D+R+Y  E++  L++ 
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHM 308
Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 295
           H++ +++RD+KP N+++D E   +R+ D GLA  +   K +   V +  +  PE+L    
Sbjct: 309 HNRFVVYRDLKPANILLD-EHGHVRISDLGLACDFSKKKPH-ASVGTHGYMAPEVLQKGV 366
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPF 320
            YD S D +SLGCM   ++    PF
Sbjct: 367 AYDSSADWFSLGCMLFKLLRGHSPF 391

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/205 (24%), Positives = 95/205 (46%), Gaps = 11/205 (5%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQ-NLCGG 179
           +D+ V R +GRG + EV+     +T +    +C                   +  +L   
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 180 PNVVKLLDIVRDQHSKTP-SLIFEYVNSTDFK---VLYPTLTDYDIRYYIYELLKALDYC 235
            +   ++ +    H+    S I + +N  D       +   ++ D+R+Y  E++  L++ 
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHM 308
Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 295
           H++ +++RD+KP N+++D E   +R+ D GLA  +   K +   V +  +  PE+L    
Sbjct: 309 HNRFVVYRDLKPANILLD-EHGHVRISDLGLACDFSKKKPH-ASVGTHGYMAPEVLQKGV 366
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPF 320
            YD S D +SLGCM   ++    PF
Sbjct: 367 AYDSSADWFSLGCMLFKLLRGHSPF 391

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/205 (24%), Positives = 95/205 (46%), Gaps = 11/205 (5%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQ-NLCGG 179
           +D+ V R +GRG + EV+     +T +    +C                   +  +L   
Sbjct: 188 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 247
Query: 180 PNVVKLLDIVRDQHSKTP-SLIFEYVNSTDFK---VLYPTLTDYDIRYYIYELLKALDYC 235
            +   ++ +    H+    S I + +N  D       +   ++ D+R+Y  E++  L++ 
Sbjct: 248 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHM 307
Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 295
           H++ +++RD+KP N+++D E   +R+ D GLA  +   K +   V +  +  PE+L    
Sbjct: 308 HNRFVVYRDLKPANILLD-EHGHVRISDLGLACDFSKKKPH-ASVGTHGYMAPEVLQKGV 365
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPF 320
            YD S D +SLGCM   ++    PF
Sbjct: 366 AYDSSADWFSLGCMLFKLLRGHSPF 390

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/205 (24%), Positives = 95/205 (46%), Gaps = 11/205 (5%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQ-NLCGG 179
           +D+ V R +GRG + EV+     +T +    +C                   +  +L   
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 180 PNVVKLLDIVRDQHSKTP-SLIFEYVNSTDFK---VLYPTLTDYDIRYYIYELLKALDYC 235
            +   ++ +    H+    S I + +N  D       +   ++ D+R+Y  E++  L++ 
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHM 308
Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 295
           H++ +++RD+KP N+++D E   +R+ D GLA  +   K +   V +  +  PE+L    
Sbjct: 309 HNRFVVYRDLKPANILLD-EHGHVRISDLGLACDFSKKKPH-ASVGTHGYMAPEVLQKGV 366
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPF 320
            YD S D +SLGCM   ++    PF
Sbjct: 367 AYDSSADWFSLGCMLFKLLRGHSPF 391

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/151 (27%), Positives = 69/151 (45%), Gaps = 15/151 (9%)
Query: 178 GGPNVVKLLDIVRDQHSKTPSL--------IFEYVNSTDFKVLYPTLTDYDIRYYIYELL 229
           G P V++LLD    Q      L        +F+Y+           L +   R +  +++
Sbjct: 96  GHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKG------PLGEGPSRCFFGQVV 149
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
            A+ +CHS+G++HRD+K  N++ID      +LID+G     H  + Y     +R +  PE
Sbjct: 150 AAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLH-DEPYTDFDGTRVYSPPE 208
Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
            +   Q +     +WSLG +   M+    PF
Sbjct: 209 WISRHQYHALPATVWSLGILLYDMVCGDIPF 239

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 37/147 (25%), Positives = 73/147 (49%), Gaps = 12/147 (8%)
Query: 180 PNVVKLLDIVRDQHSKTPS---LIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALD 233
           P+++KL  ++      TP+   ++ EYV+     D+   +  + + + R    ++L A+D
Sbjct: 71  PHIIKLYQVI-----STPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVD 125
Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           YCH   ++HRD+KP NV++D  +   ++ D+GL+     G+       S  +  PE++  
Sbjct: 126 YCHRHMVVHRDLKPENVLLDAHMNA-KIADFGLSNMMSDGEFLRDSCGSPNYAAPEVISG 184
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPF 320
                  +D+WS G +   ++    PF
Sbjct: 185 RLYAGPEVDIWSCGVILYALLCGTLPF 211

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/255 (25%), Positives = 114/255 (44%), Gaps = 31/255 (12%)
Query: 93  AMSKARVYTDVNV-LRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNE 151
           +M K+R Y  V   L P E W               E+V ++G G + +V++  N  T  
Sbjct: 1   SMRKSREYEHVRRDLDPNEVW---------------EIVGELGDGAFGKVYKAKNKETGA 45
Query: 152 RCXXXXXXXXXXXXXXXXXXXLQNL--CGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDF 209
                                ++ L  C  P +VKLL      H     ++ E+      
Sbjct: 46  LAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY--YHDGKLWIMIEFCPGGAV 103
Query: 210 KVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWG 265
             +       LT+  I+    ++L+AL++ HS+ I+HRD+K  NV++  E   +RL D+G
Sbjct: 104 DAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLE-GDIRLADFG 162
Query: 266 L-AEFYHPGKEYNVRVASRYFKGPELLV--DLQD--YDYSLDMWSLGCMFAGMIFRKEPF 320
           + A+     ++ +  + + Y+  PE+++   ++D  YDY  D+WSLG     M  + EP 
Sbjct: 163 VSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMA-QIEPP 221
Query: 321 FYGHDNHDQLVKIAK 335
            +  +    L+KIAK
Sbjct: 222 HHELNPMRVLLKIAK 236

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/245 (24%), Positives = 104/245 (42%), Gaps = 46/245 (18%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDF--KVL--YPTLTDYDIRYYIYELLKALDYC 235
           P +V L D   D +     +I+E+++  +   KV   +  +++ +   Y+ ++ K L + 
Sbjct: 108 PTLVNLHDAFEDDNEMV--MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHM 165
Query: 236 HSQGIMHRDVKPHNVMIDHE-LRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 294
           H    +H D+KP N+M   +   +L+LID+GL     P +   V   +  F  PE + + 
Sbjct: 166 HENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPE-VAEG 224
Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 354
           +   Y  DMWS+G +   ++    PF  G +N D+ ++  K                  D
Sbjct: 225 KPVGYYTDMWSVGVLSYILLSGLSPF--GGENDDETLRNVK----------------SCD 266
Query: 355 PQLD--ALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 412
             +D  A  G                  +S +  DF+ KLL  D   R+T  +A+ HP+ 
Sbjct: 267 WNMDDSAFSG------------------ISEDGKDFIRKLLLADPNTRMTIHQALEHPWL 308
Query: 413 AQVRA 417
               A
Sbjct: 309 TPGNA 313

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 89/203 (43%), Gaps = 38/203 (18%)
Query: 211 VLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEF 269
           V +  + +  I      +L+AL Y H+QG++HRD+K  ++++  + R ++L D+G  A+ 
Sbjct: 133 VTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGR-IKLSDFGFCAQV 191
Query: 270 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQ 329
                +    V + Y+  PE++  L  Y   +D+WSLG M   MI  + P+F    N   
Sbjct: 192 SKEVPKRKXLVGTPYWMAPEVISRL-PYGTEVDIWSLGIMVIEMIDGEPPYF----NEPP 246
Query: 330 LVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFL 389
           L  + ++                          R S  P  K     + H VS     FL
Sbjct: 247 LQAMRRI--------------------------RDSLPPRVK-----DLHKVSSVLRGFL 275
Query: 390 DKLLRYDHQDRLTAREAMAHPYF 412
           D +L  +   R TA+E + HP+ 
Sbjct: 276 DLMLVREPSQRATAQELLGHPFL 298

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 42/143 (29%), Positives = 71/143 (49%), Gaps = 22/143 (15%)
Query: 198 SLIFEYVNSTDFKVLYPTLTDYDIRYYIY-------------------ELLKALDYCHSQ 238
           SL + +   TD  ++   +   DIRY+IY                   +++  L++ H +
Sbjct: 249 SLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR 308
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASR-YFKGPELLVDLQDY 297
            I++RD+KP NV++D +   +R+ D GLA     G+      A    F  PELL+  ++Y
Sbjct: 309 NIIYRDLKPENVLLDDD-GNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLG-EEY 366
Query: 298 DYSLDMWSLGCMFAGMIFRKEPF 320
           D+S+D ++LG     MI  + PF
Sbjct: 367 DFSVDYFALGVTLYEMIAARGPF 389

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 42/143 (29%), Positives = 71/143 (49%), Gaps = 22/143 (15%)
Query: 198 SLIFEYVNSTDFKVLYPTLTDYDIRYYIY-------------------ELLKALDYCHSQ 238
           SL + +   TD  ++   +   DIRY+IY                   +++  L++ H +
Sbjct: 249 SLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR 308
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASR-YFKGPELLVDLQDY 297
            I++RD+KP NV++D +   +R+ D GLA     G+      A    F  PELL+  ++Y
Sbjct: 309 NIIYRDLKPENVLLDDD-GNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLG-EEY 366
Query: 298 DYSLDMWSLGCMFAGMIFRKEPF 320
           D+S+D ++LG     MI  + PF
Sbjct: 367 DFSVDYFALGVTLYEMIAARGPF 389

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 42/143 (29%), Positives = 71/143 (49%), Gaps = 22/143 (15%)
Query: 198 SLIFEYVNSTDFKVLYPTLTDYDIRYYIY-------------------ELLKALDYCHSQ 238
           SL + +   TD  ++   +   DIRY+IY                   +++  L++ H +
Sbjct: 249 SLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR 308
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASR-YFKGPELLVDLQDY 297
            I++RD+KP NV++D +   +R+ D GLA     G+      A    F  PELL+  ++Y
Sbjct: 309 NIIYRDLKPENVLLDDD-GNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLG-EEY 366
Query: 298 DYSLDMWSLGCMFAGMIFRKEPF 320
           D+S+D ++LG     MI  + PF
Sbjct: 367 DFSVDYFALGVTLYEMIAARGPF 389

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 93/201 (46%), Gaps = 22/201 (10%)
Query: 221 IRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR 279
           I+  I  +L +  Y H++  I HRDVKP N+++D   R ++L D+G +E Y   K+    
Sbjct: 153 IKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGR-VKLSDFGESE-YMVDKKIKGS 210
Query: 280 VASRYFKGPELLVDLQDYDYS-LDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLG 338
             +  F  PE   +   Y+ + +D+WSLG     M +   PF          +KI+ V  
Sbjct: 211 RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPF---------SLKISLVEL 261
Query: 339 TDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQ 398
            + +     +Y L+ +  L  L  + S           + + +S E IDFL   LR +  
Sbjct: 262 FNNIRTKNIEYPLDRNHFLYPLTNKKS---------TCSNNFLSNEDIDFLKLFLRKNPA 312
Query: 399 DRLTAREAMAHPYFAQVRAAE 419
           +R+T+ +A+ H + A     +
Sbjct: 313 ERITSEDALKHEWLADTNIED 333

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 101/213 (47%), Gaps = 14/213 (6%)
Query: 115 ESLTVQWGDQDD-YEVVRKVGRGKYSEVFEGINVNTNERCXXXX---XXXXXXXXXXXXX 170
           E+L  Q  D ++ +  + K+G+G + EVF+GI+  T +                      
Sbjct: 16  ENLYFQSMDPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQE 75
Query: 171 XXLQNLCGGPNVVKLL-DIVRDQHSKTPSLIFEYVNS-TDFKVLYPT-LTDYDIRYYIYE 227
             + + C  P V K     ++D       +I EY+   +   +L P  L +  I   + E
Sbjct: 76  ITVLSQCDSPYVTKYYGSYLKDTKL---WIIMEYLGGGSALDLLEPGPLDETQIATILRE 132
Query: 228 LLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFK 286
           +LK LDY HS+  +HRD+K  NV++  E  +++L D+G+A +      + N  V + ++ 
Sbjct: 133 ILKGLDYLHSEKKIHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWM 191
Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEP 319
            PE ++    YD   D+WSLG + A  + R EP
Sbjct: 192 APE-VIKQSAYDSKADIWSLG-ITAIELARGEP 222

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 42/143 (29%), Positives = 71/143 (49%), Gaps = 22/143 (15%)
Query: 198 SLIFEYVNSTDFKVLYPTLTDYDIRYYIY-------------------ELLKALDYCHSQ 238
           SL + +   TD  ++   +   DIRY+IY                   +++  L++ H +
Sbjct: 249 SLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR 308
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASR-YFKGPELLVDLQDY 297
            I++RD+KP NV++D +   +R+ D GLA     G+      A    F  PELL+  ++Y
Sbjct: 309 NIIYRDLKPENVLLDDD-GNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLG-EEY 366
Query: 298 DYSLDMWSLGCMFAGMIFRKEPF 320
           D+S+D ++LG     MI  + PF
Sbjct: 367 DFSVDYFALGVTLYEMIAARGPF 389

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 104/238 (43%), Gaps = 43/238 (18%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           PNV+ L ++  ++      LI E V      DF     +LT+ +   ++ ++L  + Y H
Sbjct: 74  PNVITLHEVYENKTDVI--LIGELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 237 SQGIMHRDVKPHNVM-IDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           S  I H D+KP N+M +D  + K  +++ID+GLA     G E+     +  F  PE +V+
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE-IVN 190
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 353
            +      DMWS+G +   ++    PF  G    + L  ++ V            Y  E 
Sbjct: 191 YEPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANVSAV-----------NYEFED 238
Query: 354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 411
           +                 F N       S  A DF+ +LL  D + R+T ++++ HP+
Sbjct: 239 E----------------YFSN------TSALAKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 95/205 (46%), Gaps = 12/205 (5%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXX---XXXXXXXXLQNLCGGPN 181
           +D+++V+ +G G Y EV   +N  T E                        +  +    N
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHEN 65
Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLYP--TLTDYDIRYYIYELLKALDYCHSQ 238
           VVK     R+ + +   L  EY +  + F  + P   + + D + + ++L+  + Y H  
Sbjct: 66  VVKFYGHRREGNIQY--LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKE--YNVRVASRYFKGPELLVDLQ 295
           GI HRD+KP N+++D E   L++ D+GLA  F +  +E   N    +  +  PELL   +
Sbjct: 124 GITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPF 320
            +   +D+WS G +   M+  + P+
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 104/220 (47%), Gaps = 15/220 (6%)
Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNL--CGGPNVVK 184
           +E+V ++G G + +V++  N  T                       ++ L  C  P +VK
Sbjct: 13  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 72
Query: 185 LLDIVRDQHSKTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGI 240
           LL      H     ++ E+        +       LT+  I+    ++L+AL++ HS+ I
Sbjct: 73  LLGAY--YHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRI 130
Query: 241 MHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLV--DLQD- 296
           +HRD+K  NV++  E   +RL D+G+ A+     ++ +  + + Y+  PE+++   ++D 
Sbjct: 131 IHRDLKAGNVLMTLE-GDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDT 189
Query: 297 -YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
            YDY  D+WSLG     M  + EP  +  +    L+KIAK
Sbjct: 190 PYDYKADIWSLGITLIEMA-QIEPPHHELNPMRVLLKIAK 228

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 94/205 (45%), Gaps = 12/205 (5%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXX---XXXXXXXXLQNLCGGPN 181
           +D+++V+ +G G Y EV   +N  T E                        +  +    N
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLYP--TLTDYDIRYYIYELLKALDYCHSQ 238
           VVK     R+ + +   L  EY +  + F  + P   + + D + + ++L+  + Y H  
Sbjct: 67  VVKFYGHRREGNIQY--LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKE--YNVRVASRYFKGPELLVDLQ 295
           GI HRD+KP N+++D E   L++ D+GLA  F +  +E   N    +  +  PELL   +
Sbjct: 125 GITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPF 320
            +   +D+WS G +   M+  + P+
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 94/200 (47%), Gaps = 13/200 (6%)
Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCXXXX---XXXXXXXXXXXXXXXLQNLCGGPNVV 183
           +  + K+G+G + EVF+GI+  T +                        + + C  P V 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 184 KLL-DIVRDQHSKTPSLIFEYVNS-TDFKVLYPT-LTDYDIRYYIYELLKALDYCHSQGI 240
           K     ++D       +I EY+   +   +L P  L +  I   + E+LK LDY HS+  
Sbjct: 69  KYYGSYLKDTKL---WIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKK 125
Query: 241 MHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDY 299
           +HRD+K  NV++  E  +++L D+G+A +      + N  V + ++  PE ++    YD 
Sbjct: 126 IHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE-VIKQSAYDS 183
Query: 300 SLDMWSLGCMFAGMIFRKEP 319
             D+WSLG + A  + R EP
Sbjct: 184 KADIWSLG-ITAIELARGEP 202

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 95/205 (46%), Gaps = 12/205 (5%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXX---XXXXXXXXLQNLCGGPN 181
           +D+++V+ +G G Y EV   +N  T E                        +  +    N
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHEN 65
Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLYP--TLTDYDIRYYIYELLKALDYCHSQ 238
           VVK     R+ + +   L  EY +  + F  + P   + + D + + ++L+  + Y H  
Sbjct: 66  VVKFYGHRREGNIQY--LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKE--YNVRVASRYFKGPELLVDLQ 295
           GI HRD+KP N+++D E   L++ D+GLA  F +  +E   N    +  +  PELL   +
Sbjct: 124 GITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 182
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPF 320
            +   +D+WS G +   M+  + P+
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 94/205 (45%), Gaps = 12/205 (5%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXX---XXXXXXXXLQNLCGGPN 181
           +D+++V+ +G G Y EV   +N  T E                        +  +    N
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLYP--TLTDYDIRYYIYELLKALDYCHSQ 238
           VVK     R+ + +   L  EY +  + F  + P   + + D + + ++L+  + Y H  
Sbjct: 66  VVKFYGHRREGNIQY--LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKE--YNVRVASRYFKGPELLVDLQ 295
           GI HRD+KP N+++D E   L++ D+GLA  F +  +E   N    +  +  PELL   +
Sbjct: 124 GITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPF 320
            +   +D+WS G +   M+  + P+
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 106/231 (45%), Gaps = 11/231 (4%)
Query: 114 YESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXL 173
           YE +T     +D +E++ ++G G + +V++  N  T+                      +
Sbjct: 26  YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEI 85
Query: 174 QNL--CGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPT--LTDYDIRYYIYELL 229
             L  C  PN+VKLLD    +++    + F    + D  +L     LT+  I+    + L
Sbjct: 86  DILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTL 145
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGP 288
            AL+Y H   I+HRD+K  N++   +   ++L D+G+ A+     +  +  + + Y+  P
Sbjct: 146 DALNYLHDNKIIHRDLKAGNILFTLD-GDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAP 204
Query: 289 ELLV----DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
           E+++      + YDY  D+WSLG     M    EP  +  +    L+KIAK
Sbjct: 205 EVVMCETSKDRPYDYKADVWSLGITLIEMA-EIEPPHHELNPMRVLLKIAK 254

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 106/231 (45%), Gaps = 11/231 (4%)
Query: 114 YESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXL 173
           YE +T     +D +E++ ++G G + +V++  N  T+                      +
Sbjct: 26  YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEI 85
Query: 174 QNL--CGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPT--LTDYDIRYYIYELL 229
             L  C  PN+VKLLD    +++    + F    + D  +L     LT+  I+    + L
Sbjct: 86  DILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTL 145
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGP 288
            AL+Y H   I+HRD+K  N++   +   ++L D+G+ A+     +  +  + + Y+  P
Sbjct: 146 DALNYLHDNKIIHRDLKAGNILFTLD-GDIKLADFGVSAKNTRXIQRRDXFIGTPYWMAP 204
Query: 289 ELLV----DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
           E+++      + YDY  D+WSLG     M    EP  +  +    L+KIAK
Sbjct: 205 EVVMCETSKDRPYDYKADVWSLGITLIEMA-EIEPPHHELNPMRVLLKIAK 254

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 95/205 (46%), Gaps = 12/205 (5%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXX---XXXXXXXXLQNLCGGPN 181
           +D+++V+ +G G Y EV   +N  T E                        +  +    N
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHEN 66
Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLYP--TLTDYDIRYYIYELLKALDYCHSQ 238
           VVK     R+ + +   L  EY +  + F  + P   + + D + + ++L+  + Y H  
Sbjct: 67  VVKFYGHRREGNIQY--LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKE--YNVRVASRYFKGPELLVDLQ 295
           GI HRD+KP N+++D E   L++ D+GLA  F +  +E   N    +  +  PELL   +
Sbjct: 125 GITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 183
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPF 320
            +   +D+WS G +   M+  + P+
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 94/205 (45%), Gaps = 12/205 (5%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXX---XXXXXXXXLQNLCGGPN 181
           +D+++V+ +G G Y EV   +N  T E                        +  +    N
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLYP--TLTDYDIRYYIYELLKALDYCHSQ 238
           VVK     R+ + +   L  EY +  + F  + P   + + D + + ++L+  + Y H  
Sbjct: 66  VVKFYGHRREGNIQY--LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKE--YNVRVASRYFKGPELLVDLQ 295
           GI HRD+KP N+++D E   L++ D+GLA  F +  +E   N    +  +  PELL   +
Sbjct: 124 GITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPF 320
            +   +D+WS G +   M+  + P+
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 94/205 (45%), Gaps = 12/205 (5%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXX---XXXXXXXXLQNLCGGPN 181
           +D+++V+ +G G Y EV   +N  T E                        +  +    N
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLYP--TLTDYDIRYYIYELLKALDYCHSQ 238
           VVK     R+ + +   L  EY +  + F  + P   + + D + + ++L+  + Y H  
Sbjct: 65  VVKFYGHRREGNIQY--LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 122
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKE--YNVRVASRYFKGPELLVDLQ 295
           GI HRD+KP N+++D E   L++ D+GLA  F +  +E   N    +  +  PELL   +
Sbjct: 123 GITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 181
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPF 320
            +   +D+WS G +   M+  + P+
Sbjct: 182 FHAEPVDVWSCGIVLTAMLAGELPW 206

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 94/205 (45%), Gaps = 12/205 (5%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXX---XXXXXXXXLQNLCGGPN 181
           +D+++V+ +G G Y EV   +N  T E                        +  +    N
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLYP--TLTDYDIRYYIYELLKALDYCHSQ 238
           VVK     R+ + +   L  EY +  + F  + P   + + D + + ++L+  + Y H  
Sbjct: 67  VVKFYGHRREGNIQY--LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKE--YNVRVASRYFKGPELLVDLQ 295
           GI HRD+KP N+++D E   L++ D+GLA  F +  +E   N    +  +  PELL   +
Sbjct: 125 GITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPF 320
            +   +D+WS G +   M+  + P+
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 94/205 (45%), Gaps = 12/205 (5%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXX---XXXXXXXXLQNLCGGPN 181
           +D+++V+ +G G Y EV   +N  T E                        +  +    N
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLYP--TLTDYDIRYYIYELLKALDYCHSQ 238
           VVK     R+ + +   L  EY +  + F  + P   + + D + + ++L+  + Y H  
Sbjct: 67  VVKFYGHRREGNIQY--LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKE--YNVRVASRYFKGPELLVDLQ 295
           GI HRD+KP N+++D E   L++ D+GLA  F +  +E   N    +  +  PELL   +
Sbjct: 125 GITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPF 320
            +   +D+WS G +   M+  + P+
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 94/205 (45%), Gaps = 12/205 (5%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXX---XXXXXXXXLQNLCGGPN 181
           +D+++V+ +G G Y EV   +N  T E                        +  +    N
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLYP--TLTDYDIRYYIYELLKALDYCHSQ 238
           VVK     R+ + +   L  EY +  + F  + P   + + D + + ++L+  + Y H  
Sbjct: 66  VVKFYGHRREGNIQY--LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKE--YNVRVASRYFKGPELLVDLQ 295
           GI HRD+KP N+++D E   L++ D+GLA  F +  +E   N    +  +  PELL   +
Sbjct: 124 GITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPF 320
            +   +D+WS G +   M+  + P+
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 94/205 (45%), Gaps = 12/205 (5%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXX---XXXXXXXXLQNLCGGPN 181
           +D+++V+ +G G Y EV   +N  T E                        +  +    N
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLYP--TLTDYDIRYYIYELLKALDYCHSQ 238
           VVK     R+ + +   L  EY +  + F  + P   + + D + + ++L+  + Y H  
Sbjct: 67  VVKFYGHRREGNIQY--LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKE--YNVRVASRYFKGPELLVDLQ 295
           GI HRD+KP N+++D E   L++ D+GLA  F +  +E   N    +  +  PELL   +
Sbjct: 125 GITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPF 320
            +   +D+WS G +   M+  + P+
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 94/205 (45%), Gaps = 12/205 (5%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXX---XXXXXXXXLQNLCGGPN 181
           +D+++V+ +G G Y EV   +N  T E                        +  +    N
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLYP--TLTDYDIRYYIYELLKALDYCHSQ 238
           VVK     R+ + +   L  EY +  + F  + P   + + D + + ++L+  + Y H  
Sbjct: 66  VVKFYGHRREGNIQY--LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKE--YNVRVASRYFKGPELLVDLQ 295
           GI HRD+KP N+++D E   L++ D+GLA  F +  +E   N    +  +  PELL   +
Sbjct: 124 GITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 182
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPF 320
            +   +D+WS G +   M+  + P+
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 94/205 (45%), Gaps = 12/205 (5%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXX---XXXXXXXXLQNLCGGPN 181
           +D+++V+ +G G Y EV   +N  T E                        +  +    N
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLYP--TLTDYDIRYYIYELLKALDYCHSQ 238
           VVK     R+ + +   L  EY +  + F  + P   + + D + + ++L+  + Y H  
Sbjct: 67  VVKFYGHRREGNIQY--LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKE--YNVRVASRYFKGPELLVDLQ 295
           GI HRD+KP N+++D E   L++ D+GLA  F +  +E   N    +  +  PELL   +
Sbjct: 125 GITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPF 320
            +   +D+WS G +   M+  + P+
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/265 (23%), Positives = 107/265 (40%), Gaps = 25/265 (9%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTN----------ERCXXXXXXXXXXXXXXXXXXXL 173
           +  Y+V   +G G +  V+ GI V+ N          +R                     
Sbjct: 7   ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 66
Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST----DFKVLYPTLTDYDIRYYIYELL 229
           +   G   V++LLD      S    LI E +       DF      L +   R + +++L
Sbjct: 67  KVSSGFSGVIRLLDWFERPDSFV--LILERMEPVQDLFDFITERGALQEELARSFFWQVL 124
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
           +A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  PE
Sbjct: 125 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPE 183
Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA---YL 346
            +   + +  S  +WSLG +   M+    PF      HD+ +   +V     +++   +L
Sbjct: 184 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIRGQVFFRQRVSSECQHL 238
Query: 347 NKYHLELDPQLDALVGRHSRKPWSK 371
            ++ L L P            PW +
Sbjct: 239 IRWCLALRPSDRPTFEEIQNHPWMQ 263

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 94/200 (47%), Gaps = 13/200 (6%)
Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCXXXX---XXXXXXXXXXXXXXXLQNLCGGPNVV 183
           +  + K+G+G + EVF+GI+  T +                        + + C  P V 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 184 KLL-DIVRDQHSKTPSLIFEYVNS-TDFKVLYPT-LTDYDIRYYIYELLKALDYCHSQGI 240
           K     ++D       +I EY+   +   +L P  L +  I   + E+LK LDY HS+  
Sbjct: 84  KYYGSYLKDTKL---WIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKK 140
Query: 241 MHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDY 299
           +HRD+K  NV++  E  +++L D+G+A +      + N  V + ++  PE ++    YD 
Sbjct: 141 IHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPE-VIKQSAYDS 198
Query: 300 SLDMWSLGCMFAGMIFRKEP 319
             D+WSLG + A  + R EP
Sbjct: 199 KADIWSLG-ITAIELARGEP 217

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 42/144 (29%), Positives = 71/144 (49%), Gaps = 7/144 (4%)
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNST----DFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           N++K+LDI  +Q      L+ E   S      F   +P L +    Y   +L+ A+ Y  
Sbjct: 90  NIIKVLDIFENQGFF--QLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLR 147
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
            + I+HRD+K  N++I  +   ++LID+G A +   GK +     +  +  PE+L+    
Sbjct: 148 LKDIIHRDIKDENIVIAEDF-TIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPY 206
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPF 320
               L+MWSLG     ++F + PF
Sbjct: 207 RGPELEMWSLGVTLYTLVFEENPF 230

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 94/205 (45%), Gaps = 12/205 (5%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXX---XXXXXXXXLQNLCGGPN 181
           +D+++V+ +G G Y EV   +N  T E                        +  +    N
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLYP--TLTDYDIRYYIYELLKALDYCHSQ 238
           VVK     R+ + +   L  EY +  + F  + P   + + D + + ++L+  + Y H  
Sbjct: 66  VVKFYGHRREGNIQY--LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKE--YNVRVASRYFKGPELLVDLQ 295
           GI HRD+KP N+++D E   L++ D+GLA  F +  +E   N    +  +  PELL   +
Sbjct: 124 GITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 182
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPF 320
            +   +D+WS G +   M+  + P+
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 106/231 (45%), Gaps = 11/231 (4%)
Query: 114 YESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXL 173
           YE +T     +D +E++ ++G G + +V++  N  T+                      +
Sbjct: 26  YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEI 85
Query: 174 QNL--CGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPT--LTDYDIRYYIYELL 229
             L  C  PN+VKLLD    +++    + F    + D  +L     LT+  I+    + L
Sbjct: 86  DILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTL 145
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGP 288
            AL+Y H   I+HRD+K  N++   +   ++L D+G+ A+     +  +  + + Y+  P
Sbjct: 146 DALNYLHDNKIIHRDLKAGNILFTLD-GDIKLADFGVSAKNTRXIQRRDSFIGTPYWMAP 204
Query: 289 ELLV----DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
           E+++      + YDY  D+WSLG     M    EP  +  +    L+KIAK
Sbjct: 205 EVVMCETSKDRPYDYKADVWSLGITLIEMA-EIEPPHHELNPMRVLLKIAK 254

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 94/205 (45%), Gaps = 12/205 (5%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXX---XXXXXXXXLQNLCGGPN 181
           +D+++V+ +G G Y EV   +N  T E                        +  +    N
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLYP--TLTDYDIRYYIYELLKALDYCHSQ 238
           VVK     R+ + +   L  EY +  + F  + P   + + D + + ++L+  + Y H  
Sbjct: 66  VVKFYGHRREGNIQY--LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKE--YNVRVASRYFKGPELLVDLQ 295
           GI HRD+KP N+++D E   L++ D+GLA  F +  +E   N    +  +  PELL   +
Sbjct: 124 GITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPF 320
            +   +D+WS G +   M+  + P+
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 94/205 (45%), Gaps = 12/205 (5%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXX---XXXXXXXXLQNLCGGPN 181
           +D+++V+ +G G Y EV   +N  T E                        +  +    N
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLYP--TLTDYDIRYYIYELLKALDYCHSQ 238
           VVK     R+ + +   L  EY +  + F  + P   + + D + + ++L+  + Y H  
Sbjct: 66  VVKFYGHRREGNIQY--LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKE--YNVRVASRYFKGPELLVDLQ 295
           GI HRD+KP N+++D E   L++ D+GLA  F +  +E   N    +  +  PELL   +
Sbjct: 124 GITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPF 320
            +   +D+WS G +   M+  + P+
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 94/205 (45%), Gaps = 12/205 (5%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXX---XXXXXXXXLQNLCGGPN 181
           +D+++V+ +G G Y EV   +N  T E                        +  +    N
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLYP--TLTDYDIRYYIYELLKALDYCHSQ 238
           VVK     R+ + +   L  EY +  + F  + P   + + D + + ++L+  + Y H  
Sbjct: 66  VVKFYGHRREGNIQY--LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKE--YNVRVASRYFKGPELLVDLQ 295
           GI HRD+KP N+++D E   L++ D+GLA  F +  +E   N    +  +  PELL   +
Sbjct: 124 GITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPF 320
            +   +D+WS G +   M+  + P+
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 94/205 (45%), Gaps = 12/205 (5%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXX---XXXXXXXXLQNLCGGPN 181
           +D+++V+ +G G Y EV   +N  T E                        +  +    N
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLYP--TLTDYDIRYYIYELLKALDYCHSQ 238
           VVK     R+ + +   L  EY +  + F  + P   + + D + + ++L+  + Y H  
Sbjct: 67  VVKFYGHRREGNIQY--LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKE--YNVRVASRYFKGPELLVDLQ 295
           GI HRD+KP N+++D E   L++ D+GLA  F +  +E   N    +  +  PELL   +
Sbjct: 125 GITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPF 320
            +   +D+WS G +   M+  + P+
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 78/337 (23%), Positives = 133/337 (39%), Gaps = 61/337 (18%)
Query: 90  PLPAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNT 149
           P+PA  +A    D +V       D E L         +  +R++G G +  V+   +V  
Sbjct: 28  PMPAGGRAGSLKDPDVAELFFKDDPEKL---------FSDLREIGHGSFGAVYFARDVRN 78
Query: 150 NERCXXXXXXXXXXXXXXXXXXXLQNL-----CGGPNVVKLLDIVRDQHSKTPSLIFEYV 204
           +E                     ++ +        PN ++       +H  T  L+ EY 
Sbjct: 79  SEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH--TAWLVMEYC 136
Query: 205 --NSTDF-KVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRL 261
             +++D  +V    L + +I    +  L+ L Y HS  ++HRDVK  N+++  E   ++L
Sbjct: 137 LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS-EPGLVKL 195
Query: 262 IDWGLAEFYHPGKEYNVRVASRYFKGPELL--VDLQDYDYSLDMWSLGCMFAGMIFRKEP 319
            D+G A    P    N  V + Y+  PE++  +D   YD  +D+WSLG     +  RK P
Sbjct: 196 GDFGSASIMAPA---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 252
Query: 320 FFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQH 379
            F                    +NA    YH+  + +  AL   H    WS++       
Sbjct: 253 LF-------------------NMNAMSALYHIAQN-ESPALQSGH----WSEYFR----- 283
Query: 380 LVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR 416
                  +F+D  L+   QDR T+   + H +  + R
Sbjct: 284 -------NFVDSCLQKIPQDRPTSEVLLKHRFVLRER 313

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 93/206 (45%), Gaps = 46/206 (22%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGK 274
            T+   R+Y  E++ AL+Y HS+ +++RD+K  N+M+D +   +++ D+GL  E    G 
Sbjct: 102 FTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKD-GHIKITDFGLCKEGISDGA 160
Query: 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 334
                  +  +  PE+L D  DY  ++D W LG +   M+  + PF+  + +H++L ++ 
Sbjct: 161 TMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY--NQDHERLFEL- 216
Query: 335 KVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLR 394
                                    ++    R P +          +SPEA   L  LL+
Sbjct: 217 -------------------------ILMEEIRFPRT----------LSPEAKSLLAGLLK 241
Query: 395 YDHQDRLT-----AREAMAHPYFAQV 415
            D + RL      A+E M H +F  +
Sbjct: 242 KDPKQRLGGGPSDAKEVMEHRFFLSI 267

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 94/200 (47%), Gaps = 13/200 (6%)
Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCXXXX---XXXXXXXXXXXXXXXLQNLCGGPNVV 183
           +  + K+G+G + EVF+GI+  T +                        + + C  P V 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 184 KLL-DIVRDQHSKTPSLIFEYVNS-TDFKVLYPT-LTDYDIRYYIYELLKALDYCHSQGI 240
           K     ++D       +I EY+   +   +L P  L +  I   + E+LK LDY HS+  
Sbjct: 69  KYYGSYLKDTKL---WIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKK 125
Query: 241 MHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDY 299
           +HRD+K  NV++  E  +++L D+G+A +      + N  V + ++  PE ++    YD 
Sbjct: 126 IHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPE-VIKQSAYDS 183
Query: 300 SLDMWSLGCMFAGMIFRKEP 319
             D+WSLG + A  + R EP
Sbjct: 184 KADIWSLG-ITAIELARGEP 202

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 93/206 (45%), Gaps = 46/206 (22%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGK 274
            T+   R+Y  E++ AL+Y HS+ +++RD+K  N+M+D +   +++ D+GL  E    G 
Sbjct: 102 FTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKD-GHIKITDFGLCKEGISDGA 160
Query: 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 334
                  +  +  PE+L D  DY  ++D W LG +   M+  + PF+  + +H++L ++ 
Sbjct: 161 TMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY--NQDHERLFEL- 216
Query: 335 KVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLR 394
                                    ++    R P +          +SPEA   L  LL+
Sbjct: 217 -------------------------ILMEEIRFPRT----------LSPEAKSLLAGLLK 241
Query: 395 YDHQDRLT-----AREAMAHPYFAQV 415
            D + RL      A+E M H +F  +
Sbjct: 242 KDPKQRLGGGPSDAKEVMEHRFFLSI 267

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 94/205 (45%), Gaps = 12/205 (5%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXX---XXXXXXXXLQNLCGGPN 181
           +D+++V+ +G G Y EV   +N  T E                        +  +    N
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLYP--TLTDYDIRYYIYELLKALDYCHSQ 238
           VVK     R+ + +   L  EY +  + F  + P   + + D + + ++L+  + Y H  
Sbjct: 66  VVKFYGHRREGNIQY--LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKE--YNVRVASRYFKGPELLVDLQ 295
           GI HRD+KP N+++D E   L++ D+GLA  F +  +E   N    +  +  PELL   +
Sbjct: 124 GITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 182
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPF 320
            +   +D+WS G +   M+  + P+
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/263 (23%), Positives = 105/263 (39%), Gaps = 25/263 (9%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTN----------ERCXXXXXXXXXXXXXXXXXXXL 173
           +  Y+V   +G G +  V+ GI V+ N          +R                     
Sbjct: 36  ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 95
Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST----DFKVLYPTLTDYDIRYYIYELL 229
           +   G   V++LLD      S    LI E         DF      L +   R + +++L
Sbjct: 96  KVSSGFSGVIRLLDWFERPDSFV--LILERPEPVQDLFDFITERGALQEELARSFFWQVL 153
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
           +A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  PE
Sbjct: 154 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPE 212
Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA---YL 346
            +   + +  S  +WSLG +   M+    PF      HD+ +   +V     +++   +L
Sbjct: 213 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIGGQVFFRQRVSSECQHL 267
Query: 347 NKYHLELDPQLDALVGRHSRKPW 369
            ++ L L P            PW
Sbjct: 268 IRWCLALRPSDRPTFEEIQNHPW 290

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 93/206 (45%), Gaps = 46/206 (22%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGK 274
            T+   R+Y  E++ AL+Y HS+ +++RD+K  N+M+D +   +++ D+GL  E    G 
Sbjct: 105 FTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKD-GHIKITDFGLCKEGISDGA 163
Query: 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 334
                  +  +  PE+L D  DY  ++D W LG +   M+  + PF+  + +H++L ++ 
Sbjct: 164 TMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY--NQDHERLFEL- 219
Query: 335 KVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLR 394
                                    ++    R P +          +SPEA   L  LL+
Sbjct: 220 -------------------------ILMEEIRFPRT----------LSPEAKSLLAGLLK 244
Query: 395 YDHQDRLT-----AREAMAHPYFAQV 415
            D + RL      A+E M H +F  +
Sbjct: 245 KDPKQRLGGGPSDAKEVMEHRFFLSI 270

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 94/205 (45%), Gaps = 12/205 (5%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXX---XXXXXXXXLQNLCGGPN 181
           +D+++V+ +G G Y EV   +N  T E                        +  +    N
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHEN 66
Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLYP--TLTDYDIRYYIYELLKALDYCHSQ 238
           VVK     R+ + +   L  EY +  + F  + P   + + D + + ++L+  + Y H  
Sbjct: 67  VVKFYGHRREGNIQY--LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKE--YNVRVASRYFKGPELLVDLQ 295
           GI HRD+KP N+++D E   L++ D+GLA  F +  +E   N    +  +  PELL   +
Sbjct: 125 GITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPF 320
            +   +D+WS G +   M+  + P+
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/263 (23%), Positives = 105/263 (39%), Gaps = 25/263 (9%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTN----------ERCXXXXXXXXXXXXXXXXXXXL 173
           +  Y+V   +G G +  V+ GI V+ N          +R                     
Sbjct: 35  ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 94
Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST----DFKVLYPTLTDYDIRYYIYELL 229
           +   G   V++LLD      S    LI E         DF      L +   R + +++L
Sbjct: 95  KVSSGFSGVIRLLDWFERPDSFV--LILERPEPVQDLFDFITERGALQEELARSFFWQVL 152
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
           +A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  PE
Sbjct: 153 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPE 211
Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA---YL 346
            +   + +  S  +WSLG +   M+    PF      HD+ +   +V     +++   +L
Sbjct: 212 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIGGQVFFRQRVSSECQHL 266
Query: 347 NKYHLELDPQLDALVGRHSRKPW 369
            ++ L L P            PW
Sbjct: 267 IRWCLALRPSDRPTFEEIQNHPW 289

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/263 (23%), Positives = 105/263 (39%), Gaps = 25/263 (9%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTN----------ERCXXXXXXXXXXXXXXXXXXXL 173
           +  Y+V   +G G +  V+ GI V+ N          +R                     
Sbjct: 36  ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 95
Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST----DFKVLYPTLTDYDIRYYIYELL 229
           +   G   V++LLD      S    LI E         DF      L +   R + +++L
Sbjct: 96  KVSSGFSGVIRLLDWFERPDSFV--LILERPEPVQDLFDFITERGALQEELARSFFWQVL 153
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
           +A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  PE
Sbjct: 154 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPE 212
Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA---YL 346
            +   + +  S  +WSLG +   M+    PF      HD+ +   +V     +++   +L
Sbjct: 213 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIGGQVFFRQRVSSECQHL 267
Query: 347 NKYHLELDPQLDALVGRHSRKPW 369
            ++ L L P            PW
Sbjct: 268 IRWCLALRPSDRPTFEEIQNHPW 290

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 50/244 (20%), Positives = 103/244 (42%), Gaps = 48/244 (19%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDF-------KVLYPTLTDYDIRYYIYELLKAL 232
           PN++K+ ++  D H+    ++ E     +        +     L++  +   + +++ AL
Sbjct: 80  PNIIKIFEVFEDYHNMY--IVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNAL 137
Query: 233 DYCHSQGIMHRDVKPHNVMIDHEL--RKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 290
            Y HSQ ++H+D+KP N++         +++ID+GLAE +   +       +  +  PE+
Sbjct: 138 AYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEV 197
Query: 291 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH 350
               +D  +  D+WS G +   ++    PF         L ++ +     E N     Y 
Sbjct: 198 FK--RDVTFKCDIWSAGVVMYFLLTGCLPF-----TGTSLEEVQQKATYKEPN-----YA 245
Query: 351 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHP 410
           +E  P                         ++P+A+D L ++L  D + R +A + + H 
Sbjct: 246 VECRP-------------------------LTPQAVDLLKQMLTKDPERRPSAAQVLHHE 280
Query: 411 YFAQ 414
           +F Q
Sbjct: 281 WFKQ 284

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/263 (23%), Positives = 105/263 (39%), Gaps = 25/263 (9%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTN----------ERCXXXXXXXXXXXXXXXXXXXL 173
           +  Y+V   +G G +  V+ GI V+ N          +R                     
Sbjct: 22  ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 81
Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST----DFKVLYPTLTDYDIRYYIYELL 229
           +   G   V++LLD      S    LI E         DF      L +   R + +++L
Sbjct: 82  KVSSGFSGVIRLLDWFERPDSFV--LILERPEPVQDLFDFITERGALQEELARSFFWQVL 139
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
           +A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  PE
Sbjct: 140 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPE 198
Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA---YL 346
            +   + +  S  +WSLG +   M+    PF      HD+ +   +V     +++   +L
Sbjct: 199 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIRGQVFFRQRVSSECQHL 253
Query: 347 NKYHLELDPQLDALVGRHSRKPW 369
            ++ L L P            PW
Sbjct: 254 IRWCLALRPSDRPTFEEIQNHPW 276

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/263 (23%), Positives = 105/263 (39%), Gaps = 25/263 (9%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTN----------ERCXXXXXXXXXXXXXXXXXXXL 173
           +  Y+V   +G G +  V+ GI V+ N          +R                     
Sbjct: 42  ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 101
Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST----DFKVLYPTLTDYDIRYYIYELL 229
           +   G   V++LLD      S    LI E         DF      L +   R + +++L
Sbjct: 102 KVSSGFSGVIRLLDWFERPDSFV--LILERPEPVQDLFDFITERGALQEELARSFFWQVL 159
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
           +A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  PE
Sbjct: 160 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPE 218
Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA---YL 346
            +   + +  S  +WSLG +   M+    PF      HD+ +   +V     +++   +L
Sbjct: 219 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIRGQVFFRQRVSSECQHL 273
Query: 347 NKYHLELDPQLDALVGRHSRKPW 369
            ++ L L P            PW
Sbjct: 274 IRWCLALRPSDRPTFEEIQNHPW 296

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/263 (23%), Positives = 105/263 (39%), Gaps = 25/263 (9%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTN----------ERCXXXXXXXXXXXXXXXXXXXL 173
           +  Y+V   +G G +  V+ GI V+ N          +R                     
Sbjct: 35  ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 94
Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST----DFKVLYPTLTDYDIRYYIYELL 229
           +   G   V++LLD      S    LI E         DF      L +   R + +++L
Sbjct: 95  KVSSGFSGVIRLLDWFERPDSFV--LILERPEPVQDLFDFITERGALQEELARSFFWQVL 152
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
           +A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  PE
Sbjct: 153 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPE 211
Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA---YL 346
            +   + +  S  +WSLG +   M+    PF      HD+ +   +V     +++   +L
Sbjct: 212 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIRGQVFFRQRVSSECQHL 266
Query: 347 NKYHLELDPQLDALVGRHSRKPW 369
            ++ L L P            PW
Sbjct: 267 IRWCLALRPSDRPTFEEIQNHPW 289

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 61/263 (23%), Positives = 105/263 (39%), Gaps = 25/263 (9%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTN----------ERCXXXXXXXXXXXXXXXXXXXL 173
           +  Y+V   +G G +  V+ GI V+ N          +R                     
Sbjct: 35  ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 94
Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST----DFKVLYPTLTDYDIRYYIYELL 229
           +   G   V++LLD      S    LI E         DF      L +   R + +++L
Sbjct: 95  KVSSGFSGVIRLLDWFERPDSFV--LILERPEPVQDLFDFITERGALQEELARSFFWQVL 152
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
           +A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  PE
Sbjct: 153 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPE 211
Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA---YL 346
            +   + +  S  +WSLG +   M+    PF      HD+ +   +V     +++   +L
Sbjct: 212 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIGGQVFFRQRVSSECQHL 266
Query: 347 NKYHLELDPQLDALVGRHSRKPW 369
            ++ L L P            PW
Sbjct: 267 IRWCLALRPSDRPTFEEIQNHPW 289

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 61/263 (23%), Positives = 105/263 (39%), Gaps = 25/263 (9%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTN----------ERCXXXXXXXXXXXXXXXXXXXL 173
           +  Y+V   +G G +  V+ GI V+ N          +R                     
Sbjct: 23  ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 82
Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST----DFKVLYPTLTDYDIRYYIYELL 229
           +   G   V++LLD      S    LI E         DF      L +   R + +++L
Sbjct: 83  KVSSGFSGVIRLLDWFERPDSFV--LILERPEPVQDLFDFITERGALQEELARSFFWQVL 140
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
           +A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  PE
Sbjct: 141 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPE 199
Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA---YL 346
            +   + +  S  +WSLG +   M+    PF      HD+ +   +V     +++   +L
Sbjct: 200 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIRGQVFFRQRVSSECQHL 254
Query: 347 NKYHLELDPQLDALVGRHSRKPW 369
            ++ L L P            PW
Sbjct: 255 IRWCLALRPSDRPTFEEIQNHPW 277

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 61/263 (23%), Positives = 105/263 (39%), Gaps = 25/263 (9%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTN----------ERCXXXXXXXXXXXXXXXXXXXL 173
           +  Y+V   +G G +  V+ GI V+ N          +R                     
Sbjct: 8   ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 67
Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST----DFKVLYPTLTDYDIRYYIYELL 229
           +   G   V++LLD      S    LI E         DF      L +   R + +++L
Sbjct: 68  KVSSGFSGVIRLLDWFERPDSFV--LILERPEPVQDLFDFITERGALQEELARSFFWQVL 125
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
           +A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  PE
Sbjct: 126 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPE 184
Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA---YL 346
            +   + +  S  +WSLG +   M+    PF      HD+ +   +V     +++   +L
Sbjct: 185 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIRGQVFFRQRVSSECQHL 239
Query: 347 NKYHLELDPQLDALVGRHSRKPW 369
            ++ L L P            PW
Sbjct: 240 IRWCLALRPSDRPTFEEIQNHPW 262

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 67/302 (22%), Positives = 124/302 (41%), Gaps = 49/302 (16%)
Query: 119 VQWGD-QDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNL- 176
           V  GD +  Y    K+G+G    V+  ++V T +                     +  + 
Sbjct: 13  VSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMR 72
Query: 177 -CGGPNVVKLLD--IVRDQHSKTPSLIFEYVNSTDFK--VLYPTLTDYDIRYYIYELLKA 231
               PN+V  LD  +V D+      ++ EY+        V    + +  I     E L+A
Sbjct: 73  ENKNPNIVNYLDSYLVGDELW----VVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQA 128
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPEL 290
           L++ HS  ++HRD+K  N+++  +   ++L D+G      P + + +  V + Y+  PE 
Sbjct: 129 LEFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPE- 186
Query: 291 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH 350
           +V  + Y   +D+WSLG M   MI  + P+   ++N  + + +    GT EL        
Sbjct: 187 VVTRKAYGPKVDIWSLGIMAIEMIEGEPPYL--NENPLRALYLIATNGTPELQ------- 237
Query: 351 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHP 410
              +P+  + + R                       DFL++ L  D + R +A+E + H 
Sbjct: 238 ---NPEKLSAIFR-----------------------DFLNRCLEMDVEKRGSAKELLQHQ 271
Query: 411 YF 412
           + 
Sbjct: 272 FL 273

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/263 (23%), Positives = 105/263 (39%), Gaps = 25/263 (9%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTN----------ERCXXXXXXXXXXXXXXXXXXXL 173
           +  Y+V   +G G +  V+ GI V+ N          +R                     
Sbjct: 50  ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 109
Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST----DFKVLYPTLTDYDIRYYIYELL 229
           +   G   V++LLD      S    LI E         DF      L +   R + +++L
Sbjct: 110 KVSSGFSGVIRLLDWFERPDSFV--LILERPEPVQDLFDFITERGALQEELARSFFWQVL 167
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
           +A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  PE
Sbjct: 168 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPE 226
Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA---YL 346
            +   + +  S  +WSLG +   M+    PF      HD+ +   +V     +++   +L
Sbjct: 227 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIRGQVFFRQRVSSECQHL 281
Query: 347 NKYHLELDPQLDALVGRHSRKPW 369
            ++ L L P            PW
Sbjct: 282 IRWCLALRPSDRPTFEEIQNHPW 304

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/263 (23%), Positives = 105/263 (39%), Gaps = 25/263 (9%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTN----------ERCXXXXXXXXXXXXXXXXXXXL 173
           +  Y+V   +G G +  V+ GI V+ N          +R                     
Sbjct: 7   ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 66
Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST----DFKVLYPTLTDYDIRYYIYELL 229
           +   G   V++LLD      S    LI E         DF      L +   R + +++L
Sbjct: 67  KVSSGFSGVIRLLDWFERPDSFV--LILERPEPVQDLFDFITERGALQEELARSFFWQVL 124
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
           +A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  PE
Sbjct: 125 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPE 183
Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA---YL 346
            +   + +  S  +WSLG +   M+    PF      HD+ +   +V     +++   +L
Sbjct: 184 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIRGQVFFRQRVSSECQHL 238
Query: 347 NKYHLELDPQLDALVGRHSRKPW 369
            ++ L L P            PW
Sbjct: 239 IRWCLALRPSDRPTFEEIQNHPW 261

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 93/206 (45%), Gaps = 46/206 (22%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGK 274
            T+   R+Y  E++ AL+Y HS+ +++RD+K  N+M+D +   +++ D+GL  E    G 
Sbjct: 102 FTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKD-GHIKITDFGLCKEGISDGA 160
Query: 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 334
                  +  +  PE+L D  DY  ++D W LG +   M+  + PF+  + +H++L ++ 
Sbjct: 161 TMKXFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY--NQDHERLFEL- 216
Query: 335 KVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLR 394
                                    ++    R P +          +SPEA   L  LL+
Sbjct: 217 -------------------------ILMEEIRFPRT----------LSPEAKSLLAGLLK 241
Query: 395 YDHQDRLT-----AREAMAHPYFAQV 415
            D + RL      A+E M H +F  +
Sbjct: 242 KDPKQRLGGGPSDAKEVMEHRFFLSI 267

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/265 (23%), Positives = 106/265 (40%), Gaps = 25/265 (9%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTN----------ERCXXXXXXXXXXXXXXXXXXXL 173
           +  Y+V   +G G +  V+ GI V+ N          +R                     
Sbjct: 8   ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 67
Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST----DFKVLYPTLTDYDIRYYIYELL 229
           +   G   V++LLD      S    LI E         DF      L +   R + +++L
Sbjct: 68  KVSSGFSGVIRLLDWFERPDSFV--LILERPEPVQDLFDFITERGALQEELARSFFWQVL 125
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
           +A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  PE
Sbjct: 126 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPE 184
Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA---YL 346
            +   + +  S  +WSLG +   M+    PF      HD+ +   +V     +++   +L
Sbjct: 185 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIRGQVFFRQRVSSECQHL 239
Query: 347 NKYHLELDPQLDALVGRHSRKPWSK 371
            ++ L L P            PW +
Sbjct: 240 IRWCLALRPSDRPTFEEIQNHPWMQ 264

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/263 (23%), Positives = 105/263 (39%), Gaps = 25/263 (9%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTN----------ERCXXXXXXXXXXXXXXXXXXXL 173
           +  Y+V   +G G +  V+ GI V+ N          +R                     
Sbjct: 8   ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 67
Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST----DFKVLYPTLTDYDIRYYIYELL 229
           +   G   V++LLD      S    LI E         DF      L +   R + +++L
Sbjct: 68  KVSSGFSGVIRLLDWFERPDSFV--LILERPEPVQDLFDFITERGALQEELARSFFWQVL 125
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
           +A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  PE
Sbjct: 126 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPE 184
Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA---YL 346
            +   + +  S  +WSLG +   M+    PF      HD+ +   +V     +++   +L
Sbjct: 185 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIRGQVFFRQRVSSECQHL 239
Query: 347 NKYHLELDPQLDALVGRHSRKPW 369
            ++ L L P            PW
Sbjct: 240 IRWCLALRPSDRPTFEEIQNHPW 262

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/265 (23%), Positives = 106/265 (40%), Gaps = 25/265 (9%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTN----------ERCXXXXXXXXXXXXXXXXXXXL 173
           +  Y+V   +G G +  V+ GI V+ N          +R                     
Sbjct: 3   ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 62
Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST----DFKVLYPTLTDYDIRYYIYELL 229
           +   G   V++LLD      S    LI E         DF      L +   R + +++L
Sbjct: 63  KVSSGFSGVIRLLDWFERPDSFV--LILERPEPVQDLFDFITERGALQEELARSFFWQVL 120
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
           +A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  PE
Sbjct: 121 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPE 179
Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA---YL 346
            +   + +  S  +WSLG +   M+    PF      HD+ +   +V     +++   +L
Sbjct: 180 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIGGQVFFRQRVSSECQHL 234
Query: 347 NKYHLELDPQLDALVGRHSRKPWSK 371
            ++ L L P            PW +
Sbjct: 235 IRWCLALRPSDRPTFEEIQNHPWMQ 259

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 62/242 (25%), Positives = 105/242 (43%), Gaps = 47/242 (19%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYV--NSTDF-KVLYPTLTDYDIRYYIYELLKALDYCH 236
           PN ++       +H  T  L+ EY   +++D  +V    L + +I    +  L+ L Y H
Sbjct: 75  PNTIQYRGCYLREH--TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH 132
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
           S  ++HRDVK  N+++  E   ++L D+G A    P    N  V + Y+  PE+++ + +
Sbjct: 133 SHNMIHRDVKAGNILLS-EPGLVKLGDFGSASIMAPA---NXFVGTPYWMAPEVILAMDE 188
Query: 297 --YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 354
             YD  +D+WSLG     +  RK P F                    +NA    YH+  +
Sbjct: 189 GQYDGKVDVWSLGITCIELAERKPPLF-------------------NMNAMSALYHIAQN 229
Query: 355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 414
            +  AL   H    WS++              +F+D  L+   QDR T+   + H +  +
Sbjct: 230 -ESPALQSGH----WSEYFR------------NFVDSCLQKIPQDRPTSEVLLKHRFVLR 272
Query: 415 VR 416
            R
Sbjct: 273 ER 274

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 61/265 (23%), Positives = 106/265 (40%), Gaps = 25/265 (9%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTN----------ERCXXXXXXXXXXXXXXXXXXXL 173
           +  Y+V   +G G +  V+ GI V+ N          +R                     
Sbjct: 3   ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 62
Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST----DFKVLYPTLTDYDIRYYIYELL 229
           +   G   V++LLD      S    LI E         DF      L +   R + +++L
Sbjct: 63  KVSSGFSGVIRLLDWFERPDSFV--LILERPEPVQDLFDFITERGALQEELARSFFWQVL 120
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
           +A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  PE
Sbjct: 121 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPE 179
Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA---YL 346
            +   + +  S  +WSLG +   M+    PF      HD+ +   +V     +++   +L
Sbjct: 180 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIRGQVFFRQRVSSECQHL 234
Query: 347 NKYHLELDPQLDALVGRHSRKPWSK 371
            ++ L L P            PW +
Sbjct: 235 IRWCLALRPSDRPTFEEIQNHPWMQ 259

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 82/198 (41%), Gaps = 41/198 (20%)
Query: 223 YYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVAS 282
           +Y  E+   L+  H + I++RD+KP N+++D     +R+ D GLA     G+    RV +
Sbjct: 290 FYAAEICCGLEDLHRERIVYRDLKPENILLDDH-GHIRISDLGLAVHVPEGQTIKGRVGT 348
Query: 283 RYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDEL 342
             +  PE++ + + Y +S D W+LGC+   MI  + PF                      
Sbjct: 349 VGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPF---------------------- 385
Query: 343 NAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL- 401
                        Q    + R   +   K +  +     SP+A     +LL  D  +RL 
Sbjct: 386 ------------QQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQLLCKDPAERLG 433
Query: 402 ----TAREAMAHPYFAQV 415
               +ARE   HP F ++
Sbjct: 434 CRGGSAREVKEHPLFKKL 451

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 93/206 (45%), Gaps = 46/206 (22%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGK 274
            T+   R+Y  E++ AL+Y HS+ +++RD+K  N+M+D +   +++ D+GL  E    G 
Sbjct: 102 FTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKD-GHIKITDFGLCKEGISDGA 160
Query: 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 334
                  +  +  PE+L D  DY  ++D W LG +   M+  + PF+  + +H++L ++ 
Sbjct: 161 TMKXFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY--NQDHERLFEL- 216
Query: 335 KVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLR 394
                                    ++    R P +          +SPEA   L  LL+
Sbjct: 217 -------------------------ILMEEIRFPRT----------LSPEAKSLLAGLLK 241
Query: 395 YDHQDRLT-----AREAMAHPYFAQV 415
            D + RL      A+E M H +F  +
Sbjct: 242 KDPKQRLGGGPSDAKEVMEHRFFLSI 267

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 82/198 (41%), Gaps = 41/198 (20%)
Query: 223 YYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVAS 282
           +Y  E+   L+  H + I++RD+KP N+++D     +R+ D GLA     G+    RV +
Sbjct: 290 FYAAEICCGLEDLHRERIVYRDLKPENILLDDH-GHIRISDLGLAVHVPEGQTIKGRVGT 348
Query: 283 RYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDEL 342
             +  PE++ + + Y +S D W+LGC+   MI  + PF                      
Sbjct: 349 VGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPF---------------------- 385
Query: 343 NAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL- 401
                        Q    + R   +   K +  +     SP+A     +LL  D  +RL 
Sbjct: 386 ------------QQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQLLCKDPAERLG 433
Query: 402 ----TAREAMAHPYFAQV 415
               +ARE   HP F ++
Sbjct: 434 CRGGSAREVKEHPLFKKL 451

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 67/302 (22%), Positives = 124/302 (41%), Gaps = 49/302 (16%)
Query: 119 VQWGD-QDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNL- 176
           V  GD +  Y    K+G+G    V+  ++V T +                     +  + 
Sbjct: 13  VSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMR 72
Query: 177 -CGGPNVVKLLD--IVRDQHSKTPSLIFEYVNSTDFK--VLYPTLTDYDIRYYIYELLKA 231
               PN+V  LD  +V D+      ++ EY+        V    + +  I     E L+A
Sbjct: 73  ENKNPNIVNYLDSYLVGDELW----VVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQA 128
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPEL 290
           L++ HS  ++HRD+K  N+++  +   ++L D+G      P + + +  V + Y+  PE 
Sbjct: 129 LEFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE- 186
Query: 291 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH 350
           +V  + Y   +D+WSLG M   MI  + P+   ++N  + + +    GT EL        
Sbjct: 187 VVTRKAYGPKVDIWSLGIMAIEMIEGEPPYL--NENPLRALYLIATNGTPELQ------- 237
Query: 351 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHP 410
              +P+  + + R                       DFL++ L  D + R +A+E + H 
Sbjct: 238 ---NPEKLSAIFR-----------------------DFLNRCLDMDVEKRGSAKELLQHQ 271
Query: 411 YF 412
           + 
Sbjct: 272 FL 273

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 67/302 (22%), Positives = 124/302 (41%), Gaps = 49/302 (16%)
Query: 119 VQWGD-QDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNL- 176
           V  GD +  Y    K+G+G    V+  ++V T +                     +  + 
Sbjct: 14  VSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMR 73
Query: 177 -CGGPNVVKLLD--IVRDQHSKTPSLIFEYVNSTDFK--VLYPTLTDYDIRYYIYELLKA 231
               PN+V  LD  +V D+      ++ EY+        V    + +  I     E L+A
Sbjct: 74  ENKNPNIVNYLDSYLVGDELW----VVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQA 129
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPEL 290
           L++ HS  ++HRD+K  N+++  +   ++L D+G      P + + +  V + Y+  PE 
Sbjct: 130 LEFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPE- 187
Query: 291 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH 350
           +V  + Y   +D+WSLG M   MI  + P+   ++N  + + +    GT EL        
Sbjct: 188 VVTRKAYGPKVDIWSLGIMAIEMIEGEPPYL--NENPLRALYLIATNGTPELQ------- 238
Query: 351 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHP 410
              +P+  + + R                       DFL++ L  D + R +A+E + H 
Sbjct: 239 ---NPEKLSAIFR-----------------------DFLNRCLEMDVEKRGSAKELIQHQ 272
Query: 411 YF 412
           + 
Sbjct: 273 FL 274

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 61/263 (23%), Positives = 104/263 (39%), Gaps = 25/263 (9%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTN----------ERCXXXXXXXXXXXXXXXXXXXL 173
           +  Y+V   +G G +  V+ GI V+ N          +R                     
Sbjct: 22  ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 81
Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST----DFKVLYPTLTDYDIRYYIYELL 229
           +   G   V++LLD      S    LI E         DF      L +   R + +++L
Sbjct: 82  KVSSGFSGVIRLLDWFERPDSFV--LILERPEPVQDLFDFITERGALQEELARSFFWQVL 139
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
           +A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  PE
Sbjct: 140 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPE 198
Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA---YL 346
            +   + +  S  +WSLG +   M+    PF      HD+ +   +V     ++    +L
Sbjct: 199 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIRGQVFFRQRVSXECQHL 253
Query: 347 NKYHLELDPQLDALVGRHSRKPW 369
            ++ L L P            PW
Sbjct: 254 IRWCLALRPSDRPTFEEIQNHPW 276

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 61/265 (23%), Positives = 105/265 (39%), Gaps = 25/265 (9%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTN----------ERCXXXXXXXXXXXXXXXXXXXL 173
           +  Y+V   +G G +  V+ GI V+ N          +R                     
Sbjct: 3   ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 62
Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST----DFKVLYPTLTDYDIRYYIYELL 229
           +   G   V++LLD      S    LI E         DF      L +   R + +++L
Sbjct: 63  KVSSGFSGVIRLLDWFERPDSFV--LILERPEPVQDLFDFITERGALQEELARSFFWQVL 120
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
           +A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  PE
Sbjct: 121 EAVRHCHNXGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPE 179
Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA---YL 346
            +   + +  S  +WSLG +   M+    PF      HD+ +   +V     ++    +L
Sbjct: 180 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIRGQVFFRQRVSXECQHL 234
Query: 347 NKYHLELDPQLDALVGRHSRKPWSK 371
            ++ L L P            PW +
Sbjct: 235 IRWCLALRPSDRPTFEEIQNHPWMQ 259

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 61/265 (23%), Positives = 106/265 (40%), Gaps = 25/265 (9%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTN----------ERCXXXXXXXXXXXXXXXXXXXL 173
           +  Y+V   +G G +  V+ GI V+ N          +R                     
Sbjct: 6   ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 65
Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST----DFKVLYPTLTDYDIRYYIYELL 229
           +   G   V++LLD      S    LI E         DF      L +   R + +++L
Sbjct: 66  KVSSGFSGVIRLLDWFERPDSFV--LILERPEPVQDLFDFITERGALQEELARSFFWQVL 123
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
           +A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  PE
Sbjct: 124 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPE 182
Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA---YL 346
            +   + +  S  +WSLG +   M+    PF      HD+ +   +V     +++   +L
Sbjct: 183 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIRGQVFFRQRVSSECQHL 237
Query: 347 NKYHLELDPQLDALVGRHSRKPWSK 371
            ++ L L P            PW +
Sbjct: 238 IRWCLALRPSDRPTFEEIQNHPWMQ 262

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 61/263 (23%), Positives = 104/263 (39%), Gaps = 25/263 (9%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTN----------ERCXXXXXXXXXXXXXXXXXXXL 173
           +  Y+V   +G G +  V+ GI V+ N          +R                     
Sbjct: 36  ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 95
Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST----DFKVLYPTLTDYDIRYYIYELL 229
           +   G   V++LLD      S    LI E         DF      L +   R + +++L
Sbjct: 96  KVSSGFSGVIRLLDWFERPDSFV--LILERPEPVQDLFDFITERGALQEELARSFFWQVL 153
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
           +A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  PE
Sbjct: 154 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPE 212
Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA---YL 346
            +   + +  S  +WSLG +   M+    PF      HD+ +   +V     ++    +L
Sbjct: 213 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIGGQVFFRQRVSXECQHL 267
Query: 347 NKYHLELDPQLDALVGRHSRKPW 369
            ++ L L P            PW
Sbjct: 268 IRWCLALRPSDRPTFEEIQNHPW 290

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 61/263 (23%), Positives = 104/263 (39%), Gaps = 25/263 (9%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTN----------ERCXXXXXXXXXXXXXXXXXXXL 173
           +  Y+V   +G G +  V+ GI V+ N          +R                     
Sbjct: 35  ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 94
Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST----DFKVLYPTLTDYDIRYYIYELL 229
           +   G   V++LLD      S    LI E         DF      L +   R + +++L
Sbjct: 95  KVSSGFSGVIRLLDWFERPDSFV--LILERPEPVQDLFDFITERGALQEELARSFFWQVL 152
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
           +A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  PE
Sbjct: 153 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPE 211
Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA---YL 346
            +   + +  S  +WSLG +   M+    PF      HD+ +   +V     ++    +L
Sbjct: 212 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIGGQVFFRQRVSXECQHL 266
Query: 347 NKYHLELDPQLDALVGRHSRKPW 369
            ++ L L P            PW
Sbjct: 267 IRWCLALRPSDRPTFEEIQNHPW 289

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 87/201 (43%), Gaps = 33/201 (16%)
Query: 225 IYELLKALDYCHSQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYH--------PGK 274
           + ++  ALD+ H++GI HRD+KP N++ +H  ++  +++ D+GL                
Sbjct: 117 VQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTP 176
Query: 275 EYNVRVASRYFKGPELLVDLQD----YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL 330
           E      S  +  PE++    +    YD   D+WSLG +   ++    P F G    D  
Sbjct: 177 ELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILY-ILLSGYPPFVGRCGSD-- 233
Query: 331 VKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLD 390
                  G D   A          P    ++    ++   +F + D  H +S  A D + 
Sbjct: 234 ------CGWDRGEAC---------PACQNMLFESIQEGKYEFPDKDWAH-ISCAAKDLIS 277
Query: 391 KLLRYDHQDRLTAREAMAHPY 411
           KLL  D + RL+A + + HP+
Sbjct: 278 KLLVRDAKQRLSAAQVLQHPW 298

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 93/206 (45%), Gaps = 46/206 (22%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGK 274
            T+   R+Y  E++ AL+Y HS+ +++RD+K  N+M+D +   +++ D+GL  E    G 
Sbjct: 102 FTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKD-GHIKITDFGLCKEGISDGA 160
Query: 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 334
                  +  +  PE+L D  DY  ++D W LG +   M+  + PF+  + +H++L ++ 
Sbjct: 161 TMKXFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY--NQDHERLFEL- 216
Query: 335 KVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLR 394
                                    ++    R P +          +SPEA   L  LL+
Sbjct: 217 -------------------------ILMEEIRFPRT----------LSPEAKSLLAGLLK 241
Query: 395 YDHQDRLT-----AREAMAHPYFAQV 415
            D + RL      A+E M H +F  +
Sbjct: 242 KDPKQRLGGGPSDAKEVMEHRFFLSI 267

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 61/263 (23%), Positives = 104/263 (39%), Gaps = 25/263 (9%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTN----------ERCXXXXXXXXXXXXXXXXXXXL 173
           +  Y+V   +G G +  V+ GI V+ N          +R                     
Sbjct: 50  ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 109
Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST----DFKVLYPTLTDYDIRYYIYELL 229
           +   G   V++LLD      S    LI E         DF      L +   R + +++L
Sbjct: 110 KVSSGFSGVIRLLDWFERPDSFV--LILERPEPVQDLFDFITERGALQEELARSFFWQVL 167
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
           +A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  PE
Sbjct: 168 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPE 226
Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA---YL 346
            +   + +  S  +WSLG +   M+    PF      HD+ +   +V     ++    +L
Sbjct: 227 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIRGQVFFRQRVSXECQHL 281
Query: 347 NKYHLELDPQLDALVGRHSRKPW 369
            ++ L L P            PW
Sbjct: 282 IRWCLALRPSDRPTFEEIQNHPW 304

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 93/206 (45%), Gaps = 46/206 (22%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGK 274
            T+   R+Y  E++ AL+Y HS+ +++RD+K  N+M+D +   +++ D+GL  E    G 
Sbjct: 107 FTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKD-GHIKITDFGLCKEGISDGA 165
Query: 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 334
                  +  +  PE+L D  DY  ++D W LG +   M+  + PF+  + +H++L ++ 
Sbjct: 166 TMKXFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY--NQDHERLFEL- 221
Query: 335 KVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLR 394
                                    ++    R P +          +SPEA   L  LL+
Sbjct: 222 -------------------------ILMEEIRFPRT----------LSPEAKSLLAGLLK 246
Query: 395 YDHQDRLT-----AREAMAHPYFAQV 415
            D + RL      A+E M H +F  +
Sbjct: 247 KDPKQRLGGGPSDAKEVMEHRFFLSI 272

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 90/214 (42%), Gaps = 25/214 (11%)
Query: 125 DDYEVVRKVGRGKYSEV-----FEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLCGG 179
           +DYEVV+ +GRG + EV          V   +                     +      
Sbjct: 74  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 133
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDI-----RYYIYELLKALDY 234
           P VV+L    +D   +   ++ EY+   D   L   +++YD+     R+Y  E++ ALD 
Sbjct: 134 PWVVQLFYAFQDD--RYLYMVMEYMPGGD---LVNLMSNYDVPEKWARFYTAEVVLALDA 188
Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR----VASRYFKGPEL 290
            HS G +HRDVKP N+++D     L+L D+G        KE  VR    V +  +  PE+
Sbjct: 189 IHSMGFIHRDVKPDNMLLDKS-GHLKLADFGTC--MKMNKEGMVRCDTAVGTPDYISPEV 245
Query: 291 LVDLQD---YDYSLDMWSLGCMFAGMIFRKEPFF 321
           L        Y    D WS+G     M+    PF+
Sbjct: 246 LKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY 279

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 61/263 (23%), Positives = 104/263 (39%), Gaps = 25/263 (9%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTN----------ERCXXXXXXXXXXXXXXXXXXXL 173
           +  Y+V   +G G +  V+ GI V+ N          +R                     
Sbjct: 23  ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 82
Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST----DFKVLYPTLTDYDIRYYIYELL 229
           +   G   V++LLD      S    LI E         DF      L +   R + +++L
Sbjct: 83  KVSSGFSGVIRLLDWFERPDSFV--LILERPEPVQDLFDFITERGALQEELARSFFWQVL 140
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
           +A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  PE
Sbjct: 141 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPE 199
Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA---YL 346
            +   + +  S  +WSLG +   M+    PF      HD+ +   +V     ++    +L
Sbjct: 200 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIRGQVFFRQRVSXECQHL 254
Query: 347 NKYHLELDPQLDALVGRHSRKPW 369
            ++ L L P            PW
Sbjct: 255 IRWCLALRPSDRPTFEEIQNHPW 277

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 61/263 (23%), Positives = 104/263 (39%), Gaps = 25/263 (9%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTN----------ERCXXXXXXXXXXXXXXXXXXXL 173
           +  Y+V   +G G +  V+ GI V+ N          +R                     
Sbjct: 36  ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 95
Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST----DFKVLYPTLTDYDIRYYIYELL 229
           +   G   V++LLD      S    LI E         DF      L +   R + +++L
Sbjct: 96  KVSSGFSGVIRLLDWFERPDSFV--LILERPEPVQDLFDFITERGALQEELARSFFWQVL 153
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
           +A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  PE
Sbjct: 154 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPE 212
Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA---YL 346
            +   + +  S  +WSLG +   M+    PF      HD+ +   +V     ++    +L
Sbjct: 213 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIGGQVFFRQRVSXECQHL 267
Query: 347 NKYHLELDPQLDALVGRHSRKPW 369
            ++ L L P            PW
Sbjct: 268 IRWCLALRPSDRPTFEEIQNHPW 290

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 90/214 (42%), Gaps = 25/214 (11%)
Query: 125 DDYEVVRKVGRGKYSEV-----FEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLCGG 179
           +DYEVV+ +GRG + EV          V   +                     +      
Sbjct: 69  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 128
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDI-----RYYIYELLKALDY 234
           P VV+L    +D   +   ++ EY+   D   L   +++YD+     R+Y  E++ ALD 
Sbjct: 129 PWVVQLFYAFQDD--RYLYMVMEYMPGGD---LVNLMSNYDVPEKWARFYTAEVVLALDA 183
Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR----VASRYFKGPEL 290
            HS G +HRDVKP N+++D     L+L D+G        KE  VR    V +  +  PE+
Sbjct: 184 IHSMGFIHRDVKPDNMLLDKS-GHLKLADFGTC--MKMNKEGMVRCDTAVGTPDYISPEV 240
Query: 291 LVDLQD---YDYSLDMWSLGCMFAGMIFRKEPFF 321
           L        Y    D WS+G     M+    PF+
Sbjct: 241 LKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY 274

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/263 (23%), Positives = 104/263 (39%), Gaps = 25/263 (9%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTN----------ERCXXXXXXXXXXXXXXXXXXXL 173
           +  Y+V   +G G +  V+ GI V+ N          +R                     
Sbjct: 55  ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 114
Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST----DFKVLYPTLTDYDIRYYIYELL 229
           +   G   V++LLD      S    LI E         DF      L +   R + +++L
Sbjct: 115 KVSSGFSGVIRLLDWFERPDSFV--LILERPEPVQDLFDFITERGALQEELARSFFWQVL 172
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
           +A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  PE
Sbjct: 173 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPE 231
Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA---YL 346
            +   + +  S  +WSLG +   M+    PF      HD+ +   +V     ++    +L
Sbjct: 232 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIRGQVFFRQRVSXECQHL 286
Query: 347 NKYHLELDPQLDALVGRHSRKPW 369
            ++ L L P            PW
Sbjct: 287 IRWCLALRPSDRPTFEEIQNHPW 309

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/190 (24%), Positives = 85/190 (44%), Gaps = 40/190 (21%)
Query: 228 LLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 286
           ++KAL++ HS+  ++HRDVKP NV+I+  L ++++ D+G++ +        +    + + 
Sbjct: 162 IVKALEHLHSKLSVIHRDVKPSNVLIN-ALGQVKMCDFGISGYLVDSVAKTIDAGCKPYM 220
Query: 287 GPELL---VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELN 343
            PE +   ++ + Y    D+WSLG     +   + P+        QL ++ +        
Sbjct: 221 APERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVE-------- 272
Query: 344 AYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA 403
                   E  PQL          P  KF         S E +DF  + L+ + ++R T 
Sbjct: 273 --------EPSPQL----------PADKF---------SAEFVDFTSQCLKKNSKERPTY 305
Query: 404 REAMAHPYFA 413
            E M HP+F 
Sbjct: 306 PELMQHPFFT 315

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 65/310 (20%), Positives = 127/310 (40%), Gaps = 47/310 (15%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVN-TNERCXXXXXXXXXXXXXXXXXXXLQNLC---GGP 180
           DDY++  ++G+G +S V   +    T E                        +C     P
Sbjct: 31  DDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARICRLLKHP 90
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDF---KVLYPTLTDYDIRYYIYELLKALDYCHS 237
           N+V+L D + ++      L+F+ V   +     V     ++ D  + I+++L+++++ H 
Sbjct: 91  NIVRLHDSISEEGFHY--LVFDLVTGGELFEDIVAREYYSEADASHCIHQILESVNHIHQ 148
Query: 238 QGIMHRDVKPHNVMIDHELR--KLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDL 294
             I+HRD+KP N+++  + +   ++L D+GLA E     + +     +  +  PE+L   
Sbjct: 149 HDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFAGTPGYLSPEVLRK- 207
Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 354
             Y   +D+W+ G +   ++    P F+  D H                        +L 
Sbjct: 208 DPYGKPVDIWACGVILYILLVGYPP-FWDEDQH------------------------KLY 242
Query: 355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 414
            Q+ A         W           V+PEA + ++++L  +   R+TA +A+ HP+  Q
Sbjct: 243 QQIKAGAYDFPSPEWDT---------VTPEAKNLINQMLTINPAKRITADQALKHPWVCQ 293
Query: 415 VRAAESSRTR 424
                S   R
Sbjct: 294 RSTVASMMHR 303

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 90/214 (42%), Gaps = 25/214 (11%)
Query: 125 DDYEVVRKVGRGKYSEV-----FEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLCGG 179
           +DYEVV+ +GRG + EV          V   +                     +      
Sbjct: 74  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 133
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDI-----RYYIYELLKALDY 234
           P VV+L    +D   +   ++ EY+   D   L   +++YD+     R+Y  E++ ALD 
Sbjct: 134 PWVVQLFYAFQDD--RYLYMVMEYMPGGD---LVNLMSNYDVPEKWARFYTAEVVLALDA 188
Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR----VASRYFKGPEL 290
            HS G +HRDVKP N+++D     L+L D+G        KE  VR    V +  +  PE+
Sbjct: 189 IHSMGFIHRDVKPDNMLLDKS-GHLKLADFGTC--MKMNKEGMVRCDTAVGTPDYISPEV 245
Query: 291 LVDLQD---YDYSLDMWSLGCMFAGMIFRKEPFF 321
           L        Y    D WS+G     M+    PF+
Sbjct: 246 LKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY 279

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/263 (23%), Positives = 104/263 (39%), Gaps = 25/263 (9%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTN----------ERCXXXXXXXXXXXXXXXXXXXL 173
           +  Y+V   +G G +  V+ GI V+ N          +R                     
Sbjct: 23  ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 82
Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST----DFKVLYPTLTDYDIRYYIYELL 229
           +   G   V++LLD      S    LI E         DF      L +   R + +++L
Sbjct: 83  KVSSGFSGVIRLLDWFERPDSFV--LILERPEPVQDLFDFITERGALQEELARSFFWQVL 140
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
           +A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  PE
Sbjct: 141 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPE 199
Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA---YL 346
            +   + +  S  +WSLG +   M+    PF      HD+ +   +V     ++    +L
Sbjct: 200 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIRGQVFFRQRVSXECQHL 254
Query: 347 NKYHLELDPQLDALVGRHSRKPW 369
            ++ L L P            PW
Sbjct: 255 IRWCLALRPXDRPTFEEIQNHPW 277

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 108/245 (44%), Gaps = 50/245 (20%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLYPTL----TDYDIRYYIYELLKALDY 234
           P V+ L ++   +++    LI EY    + F +  P L    ++ D+   I ++L+ + Y
Sbjct: 89  PRVINLHEVY--ENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYY 146
Query: 235 CHSQGIMHRDVKPHNVMID--HELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 292
            H   I+H D+KP N+++   + L  ++++D+G++       E    + +  +  PE+L 
Sbjct: 147 LHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEIL- 205
Query: 293 DLQDYD---YSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY 349
              +YD    + DMW++G + A M+      F G DN +                YLN  
Sbjct: 206 ---NYDPITTATDMWNIG-IIAYMLLTHTSPFVGEDNQE---------------TYLNIS 246
Query: 350 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 409
            + +D         +S + +S          VS  A DF+  LL  + + R TA   ++H
Sbjct: 247 QVNVD---------YSEETFSS---------VSQLATDFIQSLLVKNPEKRPTAEICLSH 288
Query: 410 PYFAQ 414
            +  Q
Sbjct: 289 SWLQQ 293

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 66/304 (21%), Positives = 125/304 (41%), Gaps = 49/304 (16%)
Query: 117 LTVQWGD-QDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQN 175
           + V  GD +  Y    K+G+G    V+  ++V T +                     +  
Sbjct: 12  IIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV 71
Query: 176 L--CGGPNVVKLLD--IVRDQHSKTPSLIFEYVNSTDFK--VLYPTLTDYDIRYYIYELL 229
           +     PN+V  LD  +V D+      ++ EY+        V    + +  I     E L
Sbjct: 72  MRENKNPNIVNYLDSYLVGDELW----VVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL 127
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGP 288
           +AL++ HS  ++HR++K  N+++  +   ++L D+G      P + + +  V + Y+  P
Sbjct: 128 QALEFLHSNQVIHRNIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 186
Query: 289 ELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK 348
           E +V  + Y   +D+WSLG M   MI  + P+   ++N  + + +    GT EL      
Sbjct: 187 E-VVTRKAYGPKVDIWSLGIMAIEMIEGEPPYL--NENPLRALYLIATNGTPELQ----- 238
Query: 349 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 408
                +P+  + + R                       DFL++ L  D + R +A+E + 
Sbjct: 239 -----NPEKLSAIFR-----------------------DFLNRCLEMDVEKRGSAKELIQ 270
Query: 409 HPYF 412
           H + 
Sbjct: 271 HQFL 274

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/265 (23%), Positives = 105/265 (39%), Gaps = 25/265 (9%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTN----------ERCXXXXXXXXXXXXXXXXXXXL 173
           +  Y+V   +G G +  V+ GI V+ N          +R                     
Sbjct: 30  ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 89
Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST----DFKVLYPTLTDYDIRYYIYELL 229
           +   G   V++LLD      S    LI E         DF      L +   R + +++L
Sbjct: 90  KVSSGFSGVIRLLDWFERPDSFV--LILERPEPVQDLFDFITERGALQEELARSFFWQVL 147
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
           +A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  PE
Sbjct: 148 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPE 206
Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA---YL 346
            +   + +  S  +WSLG +   M+    PF      HD+ +   +V     ++    +L
Sbjct: 207 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIRGQVFFRQRVSXECQHL 261
Query: 347 NKYHLELDPQLDALVGRHSRKPWSK 371
            ++ L L P            PW +
Sbjct: 262 IRWCLALRPSDRPTFEEIQNHPWMQ 286

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 30/107 (28%), Positives = 63/107 (58%), Gaps = 3/107 (2%)
Query: 215 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPG 273
            LT+ + RYY+ +++    Y H   ++HRD+K  N+ ++ +L ++++ D+GLA +  + G
Sbjct: 135 ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDL-EVKIGDFGLATKVEYDG 193
Query: 274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
           +   V   +  +  PE+L   + + + +D+WS+GC+   ++  K PF
Sbjct: 194 ERKKVLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPF 239

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 30/107 (28%), Positives = 63/107 (58%), Gaps = 3/107 (2%)
Query: 215 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPG 273
            LT+ + RYY+ +++    Y H   ++HRD+K  N+ ++ +L ++++ D+GLA +  + G
Sbjct: 137 ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDL-EVKIGDFGLATKVEYDG 195
Query: 274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
           +   V   +  +  PE+L   + + + +D+WS+GC+   ++  K PF
Sbjct: 196 ERKKVLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPF 241

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 37/141 (26%), Positives = 74/141 (52%), Gaps = 7/141 (4%)
Query: 192 QHSKTPSLIFEYVNSTDFKVLYPTLTDYDIR---YYIYELLKALDYCHSQGIMHRDVKPH 248
           Q  +    + EY+N  D      +   +D+    +Y  E++  L + HS+GI++RD+K  
Sbjct: 88  QTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLD 147
Query: 249 NVMIDHELRKLRLIDWGLAEFYHPG-KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLG 307
           N+++D +   +++ D+G+ +    G  + N    +  +  PE+L+  Q Y++S+D WS G
Sbjct: 148 NILLDKD-GHIKIADFGMCKENMLGDAKTNXFCGTPDYIAPEILLG-QKYNHSVDWWSFG 205
Query: 308 CMFAGMIFRKEPFFYGHDNHD 328
            +   M+  + P F+G D  +
Sbjct: 206 VLLYEMLIGQSP-FHGQDEEE 225

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 67/302 (22%), Positives = 122/302 (40%), Gaps = 49/302 (16%)
Query: 119 VQWGD-QDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNL- 176
           V  GD +  Y    K+G+G    V+  ++V T +                     +  + 
Sbjct: 13  VSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMR 72
Query: 177 -CGGPNVVKLLD--IVRDQHSKTPSLIFEYVNSTDFK--VLYPTLTDYDIRYYIYELLKA 231
               PN+V  LD  +V D+      ++ EY+        V    + +  I     E L+A
Sbjct: 73  ENKNPNIVNYLDSYLVGDELW----VVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQA 128
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR-VASRYFKGPEL 290
           L++ HS  ++HRD+K  N+++  +   ++L D+G      P +      V + Y+  PE 
Sbjct: 129 LEFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRSEMVGTPYWMAPE- 186
Query: 291 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH 350
           +V  + Y   +D+WSLG M   MI  + P+   ++N  + + +    GT EL        
Sbjct: 187 VVTRKAYGPKVDIWSLGIMAIEMIEGEPPYL--NENPLRALYLIATNGTPELQ------- 237
Query: 351 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHP 410
              +P+  + + R                       DFL++ L  D + R +A+E + H 
Sbjct: 238 ---NPEKLSAIFR-----------------------DFLNRCLDMDVEKRGSAKELLQHQ 271
Query: 411 YF 412
           + 
Sbjct: 272 FL 273

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/185 (26%), Positives = 87/185 (47%), Gaps = 14/185 (7%)
Query: 132 KVGRGKYSEVFEGINVNTNERCXXXX---XXXXXXXXXXXXXXXLQNLCGGPNVVKLLDI 188
           ++G+G + EV++GI+ +T E                        + + C  P + +    
Sbjct: 26  RIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYFG- 84
Query: 189 VRDQHSKTPSL--IFEYVNS-TDFKVLYPT-LTDYDIRYYIYELLKALDYCHSQGIMHRD 244
               + K+  L  I EY+   +   +L P  L +  I   + E+LK LDY HS+  +HRD
Sbjct: 85  ---SYLKSTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKIHRD 141
Query: 245 VKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDM 303
           +K  NV++  E   ++L D+G+A +      + N  V + ++  PE ++    YD+  D+
Sbjct: 142 IKAANVLLS-EQGDVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPE-VIKQSAYDFKADI 199
Query: 304 WSLGC 308
           WSLG 
Sbjct: 200 WSLGI 204

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 30/107 (28%), Positives = 63/107 (58%), Gaps = 3/107 (2%)
Query: 215 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPG 273
            LT+ + RYY+ +++    Y H   ++HRD+K  N+ ++ +L ++++ D+GLA +  + G
Sbjct: 111 ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDL-EVKIGDFGLATKVEYDG 169
Query: 274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
           +   V   +  +  PE+L   + + + +D+WS+GC+   ++  K PF
Sbjct: 170 ERKKVLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPF 215

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 70/296 (23%), Positives = 116/296 (39%), Gaps = 47/296 (15%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVV 183
            D +EV  ++GRG  S V+      T +                     +      PN++
Sbjct: 52  SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNII 111
Query: 184 KLLDIVRDQHSKTP---SLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCHS 237
           KL +I      +TP   SL+ E V      D  V     ++ D    + ++L+A+ Y H 
Sbjct: 112 KLKEIF-----ETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHE 166
Query: 238 QGIMHRDVKPHNVMIDHEL--RKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 295
            GI+HRD+KP N++         L++ D+GL++             +  +  PE+L    
Sbjct: 167 NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCA 226
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP 355
            Y   +DMWS+G +   ++   EPF+   +  DQ +              LN  +  + P
Sbjct: 227 -YGPEVDMWSVGIITYILLCGFEPFY--DERGDQFM----------FRRILNCEYYFISP 273
Query: 356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 411
             D                      VS  A D + KL+  D + RLT  +A+ HP+
Sbjct: 274 WWDE---------------------VSLNAKDLVRKLIVLDPKKRLTTFQALQHPW 308

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/190 (24%), Positives = 86/190 (45%), Gaps = 40/190 (21%)
Query: 228 LLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 286
           ++KAL++ HS+  ++HRDVKP NV+I+  L ++++ D+G++ +       ++    + + 
Sbjct: 118 IVKALEHLHSKLSVIHRDVKPSNVLIN-ALGQVKMCDFGISGYLVDDVAKDIDAGCKPYM 176
Query: 287 GPELL---VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELN 343
            PE +   ++ + Y    D+WSLG     +   + P+        QL ++ +        
Sbjct: 177 APERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVE-------- 228
Query: 344 AYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA 403
                   E  PQL          P  KF         S E +DF  + L+ + ++R T 
Sbjct: 229 --------EPSPQL----------PADKF---------SAEFVDFTSQCLKKNSKERPTY 261
Query: 404 REAMAHPYFA 413
            E M HP+F 
Sbjct: 262 PELMQHPFFT 271

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 93/205 (45%), Gaps = 12/205 (5%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXX---XXXXXXXXLQNLCGGPN 181
           +D+++V+ +G G   EV   +N  T E                        +  +    N
Sbjct: 6   EDWDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLYP--TLTDYDIRYYIYELLKALDYCHSQ 238
           VVK     R+ + +   L  EY +  + F  + P   + + D + + ++L+  + Y H  
Sbjct: 66  VVKFYGHRREGNIQY--LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKE--YNVRVASRYFKGPELLVDLQ 295
           GI HRD+KP N+++D E   L++ D+GLA  F +  +E   N    +  +  PELL   +
Sbjct: 124 GITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPF 320
            +   +D+WS G +   M+  + P+
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 37/141 (26%), Positives = 74/141 (52%), Gaps = 7/141 (4%)
Query: 192 QHSKTPSLIFEYVNSTDFKVLYPTLTDYDIR---YYIYELLKALDYCHSQGIMHRDVKPH 248
           Q  +    + EY+N  D      +   +D+    +Y  E++  L + HS+GI++RD+K  
Sbjct: 89  QTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLD 148
Query: 249 NVMIDHELRKLRLIDWGLAEFYHPG-KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLG 307
           N+++D +   +++ D+G+ +    G  + N    +  +  PE+L+  Q Y++S+D WS G
Sbjct: 149 NILLDKD-GHIKIADFGMCKENMLGDAKTNEFCGTPDYIAPEILLG-QKYNHSVDWWSFG 206
Query: 308 CMFAGMIFRKEPFFYGHDNHD 328
            +   M+  + P F+G D  +
Sbjct: 207 VLLYEMLIGQSP-FHGQDEEE 226

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 90/201 (44%), Gaps = 47/201 (23%)
Query: 222 RYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVR 279
           R+Y  E++ ALDY HS+  +++RD+K  N+M+D +   +++ D+GL  E    G      
Sbjct: 251 RFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKD-GHIKITDFGLCKEGIKDGATMKTF 309
Query: 280 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT 339
             +  +  PE+L D  DY  ++D W LG +   M+  + PF+  + +H++L ++      
Sbjct: 310 CGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY--NQDHEKLFEL------ 360
Query: 340 DELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQD 399
                               ++    R P            + PEA   L  LL+ D + 
Sbjct: 361 --------------------ILMEEIRFP----------RTLGPEAKSLLSGLLKKDPKQ 390
Query: 400 RLT-----AREAMAHPYFAQV 415
           RL      A+E M H +FA +
Sbjct: 391 RLGGGSEDAKEIMQHRFFAGI 411

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 90/201 (44%), Gaps = 47/201 (23%)
Query: 222 RYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVR 279
           R+Y  E++ ALDY HS+  +++RD+K  N+M+D +   +++ D+GL  E    G      
Sbjct: 254 RFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKD-GHIKITDFGLCKEGIKDGATMKTF 312
Query: 280 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT 339
             +  +  PE+L D  DY  ++D W LG +   M+  + PF+  + +H++L ++      
Sbjct: 313 CGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY--NQDHEKLFEL------ 363
Query: 340 DELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQD 399
                               ++    R P            + PEA   L  LL+ D + 
Sbjct: 364 --------------------ILMEEIRFP----------RTLGPEAKSLLSGLLKKDPKQ 393
Query: 400 RLT-----AREAMAHPYFAQV 415
           RL      A+E M H +FA +
Sbjct: 394 RLGGGSEDAKEIMQHRFFAGI 414

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 77/155 (49%), Gaps = 17/155 (10%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLT--------DYDIRYYIYELLKA 231
           PN+V+  D + D+ + T  ++ EY    D   +    T        ++ +R  + +L  A
Sbjct: 65  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRV-MTQLTLA 123
Query: 232 LDYCHSQG-----IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR-VASRYF 285
           L  CH +      ++HRD+KP NV +D + + ++L D+GLA   +  +++    V + Y+
Sbjct: 124 LKECHRRSDGGHTVLHRDLKPANVFLDGK-QNVKLGDFGLARILNHDEDFAKEFVGTPYY 182
Query: 286 KGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
             PE + +   Y+   D+WSLGC+   +     PF
Sbjct: 183 MSPEQM-NRMSYNEKSDIWSLGCLLYELCALMPPF 216

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 29/106 (27%), Positives = 62/106 (58%), Gaps = 3/106 (2%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGK 274
           LT+ + RYY+ +++    Y H   ++HRD+K  N+ ++ +L ++++ D+GLA +  + G+
Sbjct: 118 LTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDL-EVKIGDFGLATKVEYDGE 176
Query: 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
                  +  +  PE+L   + + + +D+WS+GC+   ++  K PF
Sbjct: 177 RKKTLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPF 221

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 88/201 (43%), Gaps = 15/201 (7%)
Query: 178 GGPNVVKLLDIVRDQHSKTPSLIFEYVNST----DFKVLYPTLTDYDIRYYIYELLKALD 233
           G   V++LLD      S    LI E         DF      L +   R + +++L+A+ 
Sbjct: 114 GFSGVIRLLDWFERPDSFV--LILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 171
Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  PE +  
Sbjct: 172 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRY 230
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA---YLNKYH 350
            + +  S  +WSLG +   M+    PF      HD+ +   +V     +++   +L ++ 
Sbjct: 231 HRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIRGQVFFRQRVSSECQHLIRWC 285
Query: 351 LELDPQLDALVGRHSRKPWSK 371
           L L P            PW +
Sbjct: 286 LALRPSDRPTFEEIQNHPWMQ 306

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 91/212 (42%), Gaps = 21/212 (9%)
Query: 125 DDYEVVRKVGRGKYSEV-----FEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLCGG 179
           +DY+VV+ +GRG + EV          V   +                     +      
Sbjct: 75  EDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 134
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDI-----RYYIYELLKALDY 234
           P VV+L    +D   K   ++ EY+   D   L   +++YD+     ++Y  E++ ALD 
Sbjct: 135 PWVVQLFCAFQDD--KYLYMVMEYMPGGD---LVNLMSNYDVPEKWAKFYTAEVVLALDA 189
Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEY-NVRVASRYFKGPELLV 292
            HS G++HRDVKP N+++D     L+L D+G   +    G  + +  V +  +  PE+L 
Sbjct: 190 IHSMGLIHRDVKPDNMLLDKH-GHLKLADFGTCMKMDETGMVHCDTAVGTPDYISPEVLK 248
Query: 293 DLQD---YDYSLDMWSLGCMFAGMIFRKEPFF 321
                  Y    D WS+G     M+    PF+
Sbjct: 249 SQGGDGYYGRECDWWSVGVFLFEMLVGDTPFY 280

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 74/155 (47%), Gaps = 17/155 (10%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLT--------DYDIRYYIYELLKA 231
           PN+V+  D + D+ + T  ++ EY    D   +    T        ++ +R  + +L  A
Sbjct: 65  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRV-MTQLTLA 123
Query: 232 LDYCHSQG-----IMHRDVKPHNVMIDHELRKLRLIDWGLAEFY-HPGKEYNVRVASRYF 285
           L  CH +      ++HRD+KP NV +D + + ++L D+GLA    H        V + Y+
Sbjct: 124 LKECHRRSDGGHTVLHRDLKPANVFLDGK-QNVKLGDFGLARILNHDTSFAKTFVGTPYY 182
Query: 286 KGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
             PE + +   Y+   D+WSLGC+   +     PF
Sbjct: 183 MSPEQM-NRMSYNEKSDIWSLGCLLYELCALMPPF 216

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 29/106 (27%), Positives = 62/106 (58%), Gaps = 3/106 (2%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGK 274
           LT+ + RYY+ +++    Y H   ++HRD+K  N+ ++ +L ++++ D+GLA +  + G+
Sbjct: 114 LTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDL-EVKIGDFGLATKVEYDGE 172
Query: 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
                  +  +  PE+L   + + + +D+WS+GC+   ++  K PF
Sbjct: 173 RKKTLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPF 217

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 29/106 (27%), Positives = 62/106 (58%), Gaps = 3/106 (2%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGK 274
           LT+ + RYY+ +++    Y H   ++HRD+K  N+ ++ +L ++++ D+GLA +  + G+
Sbjct: 114 LTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDL-EVKIGDFGLATKVEYDGE 172
Query: 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
                  +  +  PE+L   + + + +D+WS+GC+   ++  K PF
Sbjct: 173 RKKTLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPF 217

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 74/155 (47%), Gaps = 17/155 (10%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLT--------DYDIRYYIYELLKA 231
           PN+V+  D + D+ + T  ++ EY    D   +    T        ++ +R  + +L  A
Sbjct: 65  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRV-MTQLTLA 123
Query: 232 LDYCHSQG-----IMHRDVKPHNVMIDHELRKLRLIDWGLAEFY-HPGKEYNVRVASRYF 285
           L  CH +      ++HRD+KP NV +D + + ++L D+GLA    H        V + Y+
Sbjct: 124 LKECHRRSDGGHTVLHRDLKPANVFLDGK-QNVKLGDFGLARILNHDTSFAKAFVGTPYY 182
Query: 286 KGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
             PE + +   Y+   D+WSLGC+   +     PF
Sbjct: 183 MSPEQM-NRMSYNEKSDIWSLGCLLYELCALMPPF 216

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 91/201 (45%), Gaps = 47/201 (23%)
Query: 222 RYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVR 279
           R+Y  E++ ALDY HS+  +++RD+K  N+M+D +   +++ D+GL  E    G      
Sbjct: 112 RFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKD-GHIKITDFGLCKEGIKDGATMKXF 170
Query: 280 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT 339
             +  +  PE+L D  DY  ++D W LG +   M+  + PF+  + +H++L ++      
Sbjct: 171 CGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY--NQDHEKLFEL------ 221
Query: 340 DELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQD 399
                               ++    R P +          + PEA   L  LL+ D + 
Sbjct: 222 --------------------ILMEEIRFPRT----------LGPEAKSLLSGLLKKDPKQ 251
Query: 400 RLT-----AREAMAHPYFAQV 415
           RL      A+E M H +FA +
Sbjct: 252 RLGGGSEDAKEIMQHRFFAGI 272

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/243 (22%), Positives = 99/243 (40%), Gaps = 53/243 (21%)
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-------YPTLTDYDIRYYIYELLKALD 233
           NV++L+D++ ++  +   ++ EY      ++L       +P    +    Y  +L+  L+
Sbjct: 67  NVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHG---YFCQLIDGLE 123
Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP-GKEYNVRVA--SRYFKGPEL 290
           Y HSQGI+H+D+KP N+++      L++   G+AE  HP   +   R +  S  F+ PE+
Sbjct: 124 YLHSQGIVHKDIKPGNLLLTTG-GTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEI 182
Query: 291 LVDLQDYD-YSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY 349
              L  +  + +D+WS G     +     PF       D + K+ + +G          Y
Sbjct: 183 ANGLDTFSGFKVDIWSAGVTLYNITTGLYPF-----EGDNIYKLFENIGK-------GSY 230
Query: 350 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 409
            +  D                            P   D L  +L Y+   R + R+   H
Sbjct: 231 AIPGD--------------------------CGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264
Query: 410 PYF 412
            +F
Sbjct: 265 SWF 267

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 91/201 (45%), Gaps = 47/201 (23%)
Query: 222 RYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVR 279
           R+Y  E++ ALDY HS+  +++RD+K  N+M+D +   +++ D+GL  E    G      
Sbjct: 113 RFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKD-GHIKITDFGLCKEGIKDGATMKXF 171
Query: 280 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT 339
             +  +  PE+L D  DY  ++D W LG +   M+  + PF+  + +H++L ++      
Sbjct: 172 CGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY--NQDHEKLFEL------ 222
Query: 340 DELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQD 399
                               ++    R P +          + PEA   L  LL+ D + 
Sbjct: 223 --------------------ILMEEIRFPRT----------LGPEAKSLLSGLLKKDPKQ 252
Query: 400 RLT-----AREAMAHPYFAQV 415
           RL      A+E M H +FA +
Sbjct: 253 RLGGGSEDAKEIMQHRFFAGI 273

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 86/199 (43%), Gaps = 37/199 (18%)
Query: 217 TDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI--DHELRKLRLIDWGLAEFYHPGK 274
           T+ D    I ++L A+ Y H  GI+HRD+KP N++     E  K+ + D+GL++    G 
Sbjct: 118 TEKDASTLIRQVLDAVYYLHRMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGD 177
Query: 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 334
             +    +  +  PE+L   + Y  ++D WS+G +   ++    PF+             
Sbjct: 178 VMSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVIAYILLCGYPPFY------------- 223
Query: 335 KVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLR 394
                DE ++ L +  L+ + + D+         W           +S  A DF+  L+ 
Sbjct: 224 -----DENDSKLFEQILKAEYEFDSPY-------WDD---------ISDSAKDFIRNLME 262
Query: 395 YDHQDRLTAREAMAHPYFA 413
            D   R T  +A  HP+ A
Sbjct: 263 KDPNKRYTCEQAARHPWIA 281

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 91/201 (45%), Gaps = 47/201 (23%)
Query: 222 RYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVR 279
           R+Y  E++ ALDY HS+  +++RD+K  N+M+D +   +++ D+GL  E    G      
Sbjct: 111 RFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKD-GHIKITDFGLCKEGIKDGATMKXF 169
Query: 280 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT 339
             +  +  PE+L D  DY  ++D W LG +   M+  + PF+  + +H++L ++      
Sbjct: 170 CGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY--NQDHEKLFEL------ 220
Query: 340 DELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQD 399
                               ++    R P +          + PEA   L  LL+ D + 
Sbjct: 221 --------------------ILMEEIRFPRT----------LGPEAKSLLSGLLKKDPKQ 250
Query: 400 RLT-----AREAMAHPYFAQV 415
           RL      A+E M H +FA +
Sbjct: 251 RLGGGSEDAKEIMQHRFFAGI 271

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 60/251 (23%), Positives = 104/251 (41%), Gaps = 38/251 (15%)
Query: 178 GGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIR---YYIYELLKALDY 234
           G  N+++L++   D       L+FE +              ++ R     + ++  ALD+
Sbjct: 69  GNKNILELIEFFED--DTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDF 126
Query: 235 CHSQGIMHRDVKPHNVMID--HELRKLRLIDWGLAEFYH--------PGKEYNVRVASRY 284
            H++GI HRD+KP N++ +   ++  +++ D+ L                E      S  
Sbjct: 127 LHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAE 186
Query: 285 FKGPELLVDLQD----YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTD 340
           +  PE++    D    YD   D+WSLG +   M+    PF  GH   D      +V    
Sbjct: 187 YMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFV-GHCGADCGWDRGEV---- 241
Query: 341 ELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDR 400
                 NK    +        G++      +F + D  H +S EA D + KLL  D + R
Sbjct: 242 -CRVCQNKLFESIQE------GKY------EFPDKDWAH-ISSEAKDLISKLLVRDAKQR 287
Query: 401 LTAREAMAHPY 411
           L+A + + HP+
Sbjct: 288 LSAAQVLQHPW 298

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 55/244 (22%), Positives = 102/244 (41%), Gaps = 52/244 (21%)
Query: 180 PNVVKLLDIVRDQHSKTPS---LIFEYVNSTDFKVLYPTL------TDYDIRYYIYELLK 230
           PN+V+  +++      TP+   +I EY +  +   LY  +      ++ + R++  +LL 
Sbjct: 76  PNIVRFKEVIL-----TPTHLAIIMEYASGGE---LYERICNAGRFSEDEARFFFQQLLS 127
Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHE-LRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
            + YCHS  I HRD+K  N ++D     +L++ D+G ++      +    V +  +  PE
Sbjct: 128 GVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPE 187
Query: 290 LLVDLQDYDYSL-DMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK 348
           +L+  Q+YD  + D+WS G     M+    PF    +  D    I ++L          K
Sbjct: 188 VLLR-QEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSV--------K 238
Query: 349 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 408
           Y +  D +                        +SPE    + ++   D   R++  E   
Sbjct: 239 YSIPDDIR------------------------ISPECCHLISRIFVADPATRISIPEIKT 274
Query: 409 HPYF 412
           H +F
Sbjct: 275 HSWF 278

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 49/201 (24%), Positives = 86/201 (42%), Gaps = 33/201 (16%)
Query: 225 IYELLKALDYCHSQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYH--------PGK 274
           + ++  ALD+ H++GI HRD+KP N++ +H  ++  +++ D+ L                
Sbjct: 117 VQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTP 176
Query: 275 EYNVRVASRYFKGPELLVDLQD----YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL 330
           E      S  +  PE++    +    YD   D+WSLG +   ++    P F G    D  
Sbjct: 177 ELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILY-ILLSGYPPFVGRCGSD-- 233
Query: 331 VKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLD 390
                  G D   A          P    ++    ++   +F + D  H +S  A D + 
Sbjct: 234 ------CGWDRGEAC---------PACQNMLFESIQEGKYEFPDKDWAH-ISCAAKDLIS 277
Query: 391 KLLRYDHQDRLTAREAMAHPY 411
           KLL  D + RL+A + + HP+
Sbjct: 278 KLLVRDAKQRLSAAQVLQHPW 298

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 27/106 (25%), Positives = 62/106 (58%), Gaps = 3/106 (2%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGK 274
           +T+ + RY++ + ++ + Y H+  ++HRD+K  N+ ++ ++  +++ D+GLA +    G+
Sbjct: 139 VTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDM-DVKIGDFGLATKIEFDGE 197
Query: 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
                  +  +  PE+L   + + + +D+WSLGC+   ++  K PF
Sbjct: 198 RKKTLCGTPNYIAPEVLCK-KGHSFEVDIWSLGCILYTLLVGKPPF 242

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 56/104 (53%), Gaps = 9/104 (8%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  E+  AL Y HS  I++RD+KP N+++D +   + L D+GL +      E+N    
Sbjct: 142 RFYAAEIASALGYLHSLNIVYRDLKPENILLDSQ-GHIVLTDFGLCK---ENIEHN-STT 196
Query: 282 SRYFKGPELL----VDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
           S +   PE L    +  Q YD ++D W LG +   M++   PF+
Sbjct: 197 STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFY 240

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 28/98 (28%), Positives = 52/98 (53%), Gaps = 7/98 (7%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 275
           L +  I   + E+L+ L+Y H  G +HRDVK  N+++  +   +++ D+G++ F   G +
Sbjct: 118 LDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGED-GSVQIADFGVSAFLATGGD 176
Query: 276 YNVRVASRYFKG------PELLVDLQDYDYSLDMWSLG 307
                  + F G      PE++  ++ YD+  D+WS G
Sbjct: 177 ITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFG 214

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 28/98 (28%), Positives = 52/98 (53%), Gaps = 7/98 (7%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 275
           L +  I   + E+L+ L+Y H  G +HRDVK  N+++  +   +++ D+G++ F   G +
Sbjct: 113 LDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGED-GSVQIADFGVSAFLATGGD 171
Query: 276 YNVRVASRYFKG------PELLVDLQDYDYSLDMWSLG 307
                  + F G      PE++  ++ YD+  D+WS G
Sbjct: 172 ITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFG 209

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 90/211 (42%), Gaps = 15/211 (7%)
Query: 125 DDYEVVRKV-GRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVV 183
           DDY+V  +V G G   +V +  N  T E+                      + C  P++V
Sbjct: 61  DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKXLQDCPKARREVELHWRASQC--PHIV 118
Query: 184 KLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYI----YELLK----ALDYC 235
           +++D+  + ++    L+       D   L+  + D   + +      E+ K    A+ Y 
Sbjct: 119 RIVDVYENLYAGRKCLLI-VXECLDGGELFSRIQDRGDQAFTEREASEIXKSIGEAIQYL 177
Query: 236 HSQGIMHRDVKPHNVMIDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           HS  I HRDVKP N++   +     L+L D+G A+             + Y+  PE+L  
Sbjct: 178 HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL-G 236
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH 324
            + YD S D WSLG +   ++    PF+  H
Sbjct: 237 PEKYDKSCDXWSLGVIXYILLCGYPPFYSNH 267

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           ++Y  E+  AL+Y HS+ I++RD+KP N+++D     +++ D+G A+ Y P   Y +   
Sbjct: 109 KFYAAEVCLALEYLHSKDIIYRDLKPENILLDKN-GHIKITDFGFAK-YVPDVTYXLCGT 166
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE +V  + Y+ S+D WS G +   M+    PF+
Sbjct: 167 PDYI-APE-VVSTKPYNKSIDWWSFGILIYEMLAGYTPFY 204

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 99/219 (45%), Gaps = 31/219 (14%)
Query: 227 ELLKALDYCHSQ-GIMHRDVKPHNVMID-----HELRKLRLIDWGLAEFYHPGKEYNVRV 280
           +LL  LDY H + GI+H D+KP NV+++       L ++++ D G A +Y   + Y   +
Sbjct: 139 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD--EHYTNSI 196
Query: 281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI---FRKEPFFYGHD---NHDQLVKIA 334
            +R ++ PE+L+    +    D+WS  C+   +I   F  EP   GH    + D + +I 
Sbjct: 197 QTREYRSPEVLLG-APWGCGADIWSTACLIFELITGDFLFEP-DEGHSYTKDDDHIAQII 254
Query: 335 KVLGTDELNAYL---NKYHLELDPQLDALVGRHSRKPW-------SKFINADNQHLVSPE 384
           ++LG  EL +YL    KY          L      K W        K+  + ++   + E
Sbjct: 255 ELLG--ELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDE---AKE 309
Query: 385 AIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAESSRT 423
             DFL  +L+ D + R  A   + HP+       E  R 
Sbjct: 310 ISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRV 348

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/190 (24%), Positives = 84/190 (44%), Gaps = 40/190 (21%)
Query: 228 LLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 286
           ++KAL++ HS+  ++HRDVKP NV+I+  L +++  D+G++ +       ++    + + 
Sbjct: 145 IVKALEHLHSKLSVIHRDVKPSNVLIN-ALGQVKXCDFGISGYLVDDVAKDIDAGCKPYX 203
Query: 287 GPELL---VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELN 343
            PE +   ++ + Y    D+WSLG     +   + P+        QL ++ +        
Sbjct: 204 APERINPELNQKGYSVKSDIWSLGITXIELAILRFPYDSWGTPFQQLKQVVE-------- 255
Query: 344 AYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA 403
                   E  PQL          P  KF         S E +DF  + L+ + ++R T 
Sbjct: 256 --------EPSPQL----------PADKF---------SAEFVDFTSQCLKKNSKERPTY 288
Query: 404 REAMAHPYFA 413
            E   HP+F 
Sbjct: 289 PELXQHPFFT 298

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 99/219 (45%), Gaps = 31/219 (14%)
Query: 227 ELLKALDYCHSQ-GIMHRDVKPHNVMID-----HELRKLRLIDWGLAEFYHPGKEYNVRV 280
           +LL  LDY H + GI+H D+KP NV+++       L ++++ D G A +Y   + Y   +
Sbjct: 139 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD--EHYTNSI 196
Query: 281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI---FRKEPFFYGHD---NHDQLVKIA 334
            +R ++ PE+L+    +    D+WS  C+   +I   F  EP   GH    + D + +I 
Sbjct: 197 QTREYRSPEVLLG-APWGCGADIWSTACLIFELITGDFLFEP-DEGHSYTKDDDHIAQII 254
Query: 335 KVLGTDELNAYL---NKYHLELDPQLDALVGRHSRKPW-------SKFINADNQHLVSPE 384
           ++LG  EL +YL    KY          L      K W        K+  + ++   + E
Sbjct: 255 ELLG--ELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDE---AKE 309
Query: 385 AIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAESSRT 423
             DFL  +L+ D + R  A   + HP+       E  R 
Sbjct: 310 ISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRV 348

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 27/106 (25%), Positives = 62/106 (58%), Gaps = 3/106 (2%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGK 274
           +T+ + RY++ + ++ + Y H+  ++HRD+K  N+ ++ ++  +++ D+GLA +    G+
Sbjct: 139 VTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDM-DVKIGDFGLATKIEFDGE 197
Query: 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
                  +  +  PE+L   + + + +D+WSLGC+   ++  K PF
Sbjct: 198 RKKXLCGTPNYIAPEVLCK-KGHSFEVDIWSLGCILYTLLVGKPPF 242

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/158 (25%), Positives = 75/158 (47%), Gaps = 19/158 (12%)
Query: 181 NVVKLLDIVRD-QHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRY---------------Y 224
           NV K L I++  +H    +L + + +  D  ++   L   D+RY               +
Sbjct: 61  NVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLF 120
Query: 225 IYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY 284
           I EL+ ALDY  +Q I+HRD+KP N+++D E   + + D+ +A       +      ++ 
Sbjct: 121 ICELVMALDYLQNQRIIHRDMKPDNILLD-EHGHVHITDFNIAAMLPRETQITTMAGTKP 179
Query: 285 FKGPELLVDLQ--DYDYSLDMWSLGCMFAGMIFRKEPF 320
           +  PE+    +   Y +++D WSLG     ++  + P+
Sbjct: 180 YMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPY 217

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 84/197 (42%), Gaps = 38/197 (19%)
Query: 217 TDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNV--MIDHELRKLRLIDWGLAEFYHPGK 274
           T+ D    I ++L A+ Y H  GI+HRD+KP N+  +   E  K+ + D+GL++    G 
Sbjct: 104 TEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI 163
Query: 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 334
             +    +  +  PE+L   + Y  ++D WS+G +   ++    PF+   +   +L +  
Sbjct: 164 -MSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVITYILLCGYPPFY--EETESKLFEKI 219
Query: 335 KVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLR 394
           K             Y+    P  D                      +S  A DF+  LL 
Sbjct: 220 K-----------EGYYEFESPFWDD---------------------ISESAKDFICHLLE 247
Query: 395 YDHQDRLTAREAMAHPY 411
            D  +R T  +A++HP+
Sbjct: 248 KDPNERYTCEKALSHPW 264

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/190 (25%), Positives = 85/190 (44%), Gaps = 16/190 (8%)
Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCXXXX---XXXXXXXXXXXXXXXLQNLCGGPNVV 183
           +  + ++G+G + EVF+GI+  T +                        + + C    V 
Sbjct: 25  FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVT 84
Query: 184 KLLDIVRDQHSKTPSL--IFEYV---NSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQ 238
           K        + K   L  I EY+   ++ D     P   ++ I   + E+LK LDY HS+
Sbjct: 85  KYYG----SYLKGSKLWIIMEYLGGGSALDLLRAGP-FDEFQIATMLKEILKGLDYLHSE 139
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDY 297
             +HRD+K  NV++  E   ++L D+G+A +      + N  V + ++  PE ++    Y
Sbjct: 140 KKIHRDIKAANVLLS-EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE-VIQQSAY 197
Query: 298 DYSLDMWSLG 307
           D   D+WSLG
Sbjct: 198 DSKADIWSLG 207

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 67/133 (50%), Gaps = 9/133 (6%)
Query: 195 KTPSLIF---EYVNSTDFKVLYPTLTDYD---IRYYIYELLKALDYCHSQGIMHRDVKPH 248
           +TP  +F   E+VN  D          +D    R+Y  E++ AL + H +GI++RD+K  
Sbjct: 94  QTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLD 153
Query: 249 NVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLG 307
           NV++DHE    +L D+G+  E    G        +  +  PE+L ++  Y  ++D W++G
Sbjct: 154 NVLLDHE-GHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEML-YGPAVDWWAMG 211
Query: 308 CMFAGMIFRKEPF 320
            +   M+    PF
Sbjct: 212 VLLYEMLCGHAPF 224

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 27/106 (25%), Positives = 62/106 (58%), Gaps = 3/106 (2%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGK 274
           +T+ + RY++ + ++ + Y H+  ++HRD+K  N+ ++ ++  +++ D+GLA +    G+
Sbjct: 139 VTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDM-DVKIGDFGLATKIEFDGE 197
Query: 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
                  +  +  PE+L   + + + +D+WSLGC+   ++  K PF
Sbjct: 198 RKKDLCGTPNYIAPEVLCK-KGHSFEVDIWSLGCILYTLLVGKPPF 242

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 27/106 (25%), Positives = 62/106 (58%), Gaps = 3/106 (2%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGK 274
           +T+ + RY++ + ++ + Y H+  ++HRD+K  N+ ++ ++  +++ D+GLA +    G+
Sbjct: 123 VTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDM-DVKIGDFGLATKIEFDGE 181
Query: 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
                  +  +  PE+L   + + + +D+WSLGC+   ++  K PF
Sbjct: 182 RKKDLCGTPNYIAPEVLCK-KGHSFEVDIWSLGCILYTLLVGKPPF 226

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 87/210 (41%), Gaps = 50/210 (23%)
Query: 215 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 274
           ++  ++ + Y   +L+A+   H  GI+H D+KP N +I   +  L+LID+G+A    P  
Sbjct: 107 SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGM--LKLIDFGIANQMQPDT 164
Query: 275 EYNVR---VASRYFKGPELLVDLQD----------YDYSLDMWSLGCMFAGMIFRKEPFF 321
              V+   V +  +  PE + D+                 D+WSLGC+   M + K PF 
Sbjct: 165 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF- 223
Query: 322 YGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLV 381
                              ++   ++K H  +DP  +            +F +   + L 
Sbjct: 224 ------------------QQIINQISKLHAIIDPNHEI-----------EFPDIPEKDLQ 254
Query: 382 SPEAIDFLDKLLRYDHQDRLTAREAMAHPY 411
                D L   L+ D + R++  E +AHPY
Sbjct: 255 -----DVLKCCLKRDPKQRISIPELLAHPY 279

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 87/210 (41%), Gaps = 50/210 (23%)
Query: 215 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 274
           ++  ++ + Y   +L+A+   H  GI+H D+KP N +I   +  L+LID+G+A    P  
Sbjct: 103 SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGM--LKLIDFGIANQMQPDT 160
Query: 275 EYNVR---VASRYFKGPELLVDLQD----------YDYSLDMWSLGCMFAGMIFRKEPFF 321
              V+   V +  +  PE + D+                 D+WSLGC+   M + K PF 
Sbjct: 161 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF- 219
Query: 322 YGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLV 381
                              ++   ++K H  +DP  +            +F +   + L 
Sbjct: 220 ------------------QQIINQISKLHAIIDPNHEI-----------EFPDIPEKDLQ 250
Query: 382 SPEAIDFLDKLLRYDHQDRLTAREAMAHPY 411
                D L   L+ D + R++  E +AHPY
Sbjct: 251 -----DVLKCCLKRDPKQRISIPELLAHPY 275

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 87/210 (41%), Gaps = 50/210 (23%)
Query: 215 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 274
           ++  ++ + Y   +L+A+   H  GI+H D+KP N +I   +  L+LID+G+A    P  
Sbjct: 151 SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGM--LKLIDFGIANQMQPDT 208
Query: 275 EYNVR---VASRYFKGPELLVDLQD----------YDYSLDMWSLGCMFAGMIFRKEPFF 321
              V+   V +  +  PE + D+                 D+WSLGC+   M + K PF 
Sbjct: 209 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF- 267
Query: 322 YGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLV 381
                              ++   ++K H  +DP  +            +F +   + L 
Sbjct: 268 ------------------QQIINQISKLHAIIDPNHEI-----------EFPDIPEKDLQ 298
Query: 382 SPEAIDFLDKLLRYDHQDRLTAREAMAHPY 411
                D L   L+ D + R++  E +AHPY
Sbjct: 299 -----DVLKCCLKRDPKQRISIPELLAHPY 323

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 87/210 (41%), Gaps = 50/210 (23%)
Query: 215 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 274
           ++  ++ + Y   +L+A+   H  GI+H D+KP N +I   +  L+LID+G+A    P  
Sbjct: 104 SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGM--LKLIDFGIANQMQPDT 161
Query: 275 EYNVR---VASRYFKGPELLVDLQD----------YDYSLDMWSLGCMFAGMIFRKEPFF 321
              V+   V +  +  PE + D+                 D+WSLGC+   M + K PF 
Sbjct: 162 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF- 220
Query: 322 YGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLV 381
                              ++   ++K H  +DP  +            +F +   + L 
Sbjct: 221 ------------------QQIINQISKLHAIIDPNHEI-----------EFPDIPEKDLQ 251
Query: 382 SPEAIDFLDKLLRYDHQDRLTAREAMAHPY 411
                D L   L+ D + R++  E +AHPY
Sbjct: 252 -----DVLKCCLKRDPKQRISIPELLAHPY 276

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 32/105 (30%), Positives = 54/105 (51%), Gaps = 6/105 (5%)
Query: 221 IRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE---FYHPGKEYN 277
           I +Y  ++L+ L Y H   I+HRD+K  NV+I+     L++ D+G ++     +P  E  
Sbjct: 124 IGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTE-- 181
Query: 278 VRVASRYFKGPELL-VDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
               +  +  PE++    + Y  + D+WSLGC    M   K PF+
Sbjct: 182 TFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFY 226

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 88/210 (41%), Gaps = 50/210 (23%)
Query: 215 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 274
           ++  ++ + Y   +L+A+   H  GI+H D+KP N +I   +  L+LID+G+A    P  
Sbjct: 151 SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGM--LKLIDFGIANQMQPDT 208
Query: 275 EYNVR---VASRYFKGPELLVDLQD----------YDYSLDMWSLGCMFAGMIFRKEPFF 321
              V+   V +  +  PE + D+                 D+WSLGC+   M + K PF 
Sbjct: 209 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF- 267
Query: 322 YGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLV 381
                  Q++              ++K H  +DP  +            +F +   + L 
Sbjct: 268 ------QQIIN------------QISKLHAIIDPNHEI-----------EFPDIPEKDLQ 298
Query: 382 SPEAIDFLDKLLRYDHQDRLTAREAMAHPY 411
                D L   L+ D + R++  E +AHPY
Sbjct: 299 -----DVLKCCLKRDPKQRISIPELLAHPY 323

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 88/210 (41%), Gaps = 50/210 (23%)
Query: 215 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 274
           ++  ++ + Y   +L+A+   H  GI+H D+KP N +I   +  L+LID+G+A    P  
Sbjct: 151 SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGM--LKLIDFGIANQMQPDT 208
Query: 275 EYNVR---VASRYFKGPELLVDLQD----------YDYSLDMWSLGCMFAGMIFRKEPFF 321
              V+   V +  +  PE + D+                 D+WSLGC+   M + K PF 
Sbjct: 209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF- 267
Query: 322 YGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLV 381
                  Q++              ++K H  +DP  +            +F +   + L 
Sbjct: 268 ------QQIIN------------QISKLHAIIDPNHEI-----------EFPDIPEKDLQ 298
Query: 382 SPEAIDFLDKLLRYDHQDRLTAREAMAHPY 411
                D L   L+ D + R++  E +AHPY
Sbjct: 299 -----DVLKCCLKRDPKQRISIPELLAHPY 323

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 83/203 (40%), Gaps = 50/203 (24%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR-- 279
           + Y   +L+A+   H  GI+H D+KP N +I   +  L+LID+G+A    P     V+  
Sbjct: 130 KSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGM--LKLIDFGIANQMQPDTTSVVKDS 187
Query: 280 -VASRYFKGPELLVDLQD----------YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHD 328
            V +  +  PE + D+                 D+WSLGC+   M + K PF        
Sbjct: 188 QVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF-------- 239
Query: 329 QLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDF 388
                       ++   ++K H  +DP  +            +F +   + L      D 
Sbjct: 240 -----------QQIINQISKLHAIIDPNHEI-----------EFPDIPEKDLQ-----DV 272
Query: 389 LDKLLRYDHQDRLTAREAMAHPY 411
           L   L+ D + R++  E +AHPY
Sbjct: 273 LKCCLKRDPKQRISIPELLAHPY 295

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 38/133 (28%), Positives = 61/133 (45%), Gaps = 9/133 (6%)
Query: 197 PSLIFEYVNSTDFKVLYPT------LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNV 250
           P L  EY    D +           L +  IR  + ++  AL Y H   I+HRD+KP N+
Sbjct: 94  PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENI 153
Query: 251 MIDHELRKL--RLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGC 308
           ++    ++L  ++ID G A+    G+     V +  +  PELL + + Y  ++D WS G 
Sbjct: 154 VLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELL-EQKKYTVTVDYWSFGT 212
Query: 309 MFAGMIFRKEPFF 321
           +    I    PF 
Sbjct: 213 LAFECITGFRPFL 225

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 32/108 (29%), Positives = 54/108 (50%), Gaps = 12/108 (11%)
Query: 221 IRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRV 280
           I +Y  ++L+ L Y H   I+HRD+K  NV+I+     L++ D+G ++     +   +  
Sbjct: 110 IGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSK-----RLAGINP 164
Query: 281 ASRYFKG------PELL-VDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
            +  F G      PE++    + Y  + D+WSLGC    M   K PF+
Sbjct: 165 CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFY 212

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 38/133 (28%), Positives = 61/133 (45%), Gaps = 9/133 (6%)
Query: 197 PSLIFEYVNSTDFKVLYPT------LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNV 250
           P L  EY    D +           L +  IR  + ++  AL Y H   I+HRD+KP N+
Sbjct: 93  PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENI 152
Query: 251 MIDHELRKL--RLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGC 308
           ++    ++L  ++ID G A+    G+     V +  +  PELL + + Y  ++D WS G 
Sbjct: 153 VLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELL-EQKKYTVTVDYWSFGT 211
Query: 309 MFAGMIFRKEPFF 321
           +    I    PF 
Sbjct: 212 LAFECITGFRPFL 224

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/299 (20%), Positives = 121/299 (40%), Gaps = 59/299 (19%)
Query: 125 DDYEVVRKVGRGKYSEVF-----EGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLCGG 179
           DD+++VR +G+GK+  V+     +   +   +                     +Q+    
Sbjct: 14  DDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRY-------YIYELLKAL 232
           PN++++ +   D+  K   L+ E+    +   LY  L  +  R+       ++ EL  AL
Sbjct: 74  PNILRMYNYFHDR--KRIYLMLEFAPRGE---LYKELQKHG-RFDEQRSATFMEELADAL 127
Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 292
            YCH + ++HRD+KP N+++ ++  +L++ D+G +  + P         +  +  PE ++
Sbjct: 128 HYCHERKVIHRDIKPENLLMGYK-GELKIADFGWS-VHAPSLRRRXMCGTLDYLPPE-MI 184
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE 352
           + + +D  +D+W  G +    +    PF    D+        +++  D          L+
Sbjct: 185 EGKTHDEKVDLWCAGVLCYEFLVGMPPF----DSPSHTETHRRIVNVD----------LK 230
Query: 353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 411
             P                         +S  + D + KLLRY    RL  +  M HP+
Sbjct: 231 FPP------------------------FLSDGSKDLISKLLRYHPPQRLPLKGVMEHPW 265

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 63/132 (47%), Gaps = 11/132 (8%)
Query: 197 PSLIFEYVNSTDFKVLYPT---LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMID 253
           P ++ EYV+    + +  T   +T       I +  +AL++ H  GI+HRDVKP N+MI 
Sbjct: 91  PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMIS 150
Query: 254 HELRKLRLIDWGLAEFYHPGKEYNVRVA-----SRYFKGPELLVDLQDYDYSLDMWSLGC 308
                ++++D+G+A           + A     ++Y    +   D    D   D++SLGC
Sbjct: 151 -ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD--SVDARSDVYSLGC 207
Query: 309 MFAGMIFRKEPF 320
           +   ++  + PF
Sbjct: 208 VLYEVLTGEPPF 219

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 63/132 (47%), Gaps = 11/132 (8%)
Query: 197 PSLIFEYVNSTDFKVLYPT---LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMID 253
           P ++ EYV+    + +  T   +T       I +  +AL++ H  GI+HRDVKP N+MI 
Sbjct: 91  PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMIS 150
Query: 254 HELRKLRLIDWGLAEFYHPGKEYNVRVA-----SRYFKGPELLVDLQDYDYSLDMWSLGC 308
                ++++D+G+A           + A     ++Y    +   D    D   D++SLGC
Sbjct: 151 -ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD--SVDARSDVYSLGC 207
Query: 309 MFAGMIFRKEPF 320
           +   ++  + PF
Sbjct: 208 VLYEVLTGEPPF 219

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 63/132 (47%), Gaps = 11/132 (8%)
Query: 197 PSLIFEYVNSTDFKVLYPT---LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMID 253
           P ++ EYV+    + +  T   +T       I +  +AL++ H  GI+HRDVKP N+MI 
Sbjct: 91  PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMIS 150
Query: 254 HELRKLRLIDWGLAEFYHPGKEYNVRVA-----SRYFKGPELLVDLQDYDYSLDMWSLGC 308
                ++++D+G+A           + A     ++Y    +   D    D   D++SLGC
Sbjct: 151 -ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD--SVDARSDVYSLGC 207
Query: 309 MFAGMIFRKEPF 320
           +   ++  + PF
Sbjct: 208 VLYEVLTGEPPF 219

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 87/210 (41%), Gaps = 50/210 (23%)
Query: 215 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 274
           ++  ++ + Y   +L+A+   H  GI+H D+KP N +I   +  L+LID+G+A    P  
Sbjct: 123 SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGM--LKLIDFGIANQMQPDX 180
Query: 275 EYNVR---VASRYFKGPELLVDLQD----------YDYSLDMWSLGCMFAGMIFRKEPFF 321
              V+   V +  +  PE + D+                 D+WSLGC+   M + K PF 
Sbjct: 181 XXVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF- 239
Query: 322 YGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLV 381
                              ++   ++K H  +DP  +            +F +   + L 
Sbjct: 240 ------------------QQIINQISKLHAIIDPNHEI-----------EFPDIPEKDLQ 270
Query: 382 SPEAIDFLDKLLRYDHQDRLTAREAMAHPY 411
                D L   L+ D + R++  E +AHPY
Sbjct: 271 -----DVLKCCLKRDPKQRISIPELLAHPY 295

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 63/132 (47%), Gaps = 11/132 (8%)
Query: 197 PSLIFEYVNSTDFKVLYPT---LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMID 253
           P ++ EYV+    + +  T   +T       I +  +AL++ H  GI+HRDVKP N+MI 
Sbjct: 91  PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMIS 150
Query: 254 HELRKLRLIDWGLAEFYHPGKEYNVRVA-----SRYFKGPELLVDLQDYDYSLDMWSLGC 308
                ++++D+G+A           + A     ++Y    +   D    D   D++SLGC
Sbjct: 151 -ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD--SVDARSDVYSLGC 207
Query: 309 MFAGMIFRKEPF 320
           +   ++  + PF
Sbjct: 208 VLYEVLTGEPPF 219

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/98 (30%), Positives = 55/98 (56%), Gaps = 6/98 (6%)
Query: 215 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPG 273
           TL +  I Y   E+L+ L + H   ++HRD+K  NV++  E  +++L+D+G+ A+     
Sbjct: 125 TLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLDRTV 183
Query: 274 KEYNVRVASRYFKGPELLVDLQD----YDYSLDMWSLG 307
              N  + + Y+  PE++   ++    YD+  D+WSLG
Sbjct: 184 GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLG 221

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 91/213 (42%), Gaps = 18/213 (8%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQN-----LCG 178
           ++D+E+++ +GRG + EV   + +   ER                     +      + G
Sbjct: 73  REDFEIIKVIGRGAFGEV-AVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNG 131
Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDY---DI-RYYIYELLKALDY 234
               +  L     Q      L+ +Y    D   L     D    D+ R+YI E++ A+D 
Sbjct: 132 DCQWITALHYAF-QDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDS 190
Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGK-EYNVRVASRYFKGPELLV 292
            H    +HRD+KP NV++D     +RL D+G   +    G  + +V V +  +  PE+L 
Sbjct: 191 IHQLHYVHRDIKPDNVLLDVN-GHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQ 249
Query: 293 DLQD----YDYSLDMWSLGCMFAGMIFRKEPFF 321
            ++D    Y    D WSLG     M++ + PF+
Sbjct: 250 AMEDGMGKYGPECDWWSLGVCMYEMLYGETPFY 282

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 63/132 (47%), Gaps = 11/132 (8%)
Query: 197 PSLIFEYVNSTDFKVLYPT---LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMID 253
           P ++ EYV+    + +  T   +T       I +  +AL++ H  GI+HRDVKP N+MI 
Sbjct: 108 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMIS 167
Query: 254 HELRKLRLIDWGLAEFYHPGKEYNVRVA-----SRYFKGPELLVDLQDYDYSLDMWSLGC 308
                ++++D+G+A           + A     ++Y    +   D    D   D++SLGC
Sbjct: 168 -ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD--SVDARSDVYSLGC 224
Query: 309 MFAGMIFRKEPF 320
           +   ++  + PF
Sbjct: 225 VLYEVLTGEPPF 236

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/100 (30%), Positives = 58/100 (58%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N+MID +   +++ D+GLA+    G+ + +   
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQ-GYIKVTDFGLAKRVK-GRTWXLCGT 201
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 202 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 91/213 (42%), Gaps = 18/213 (8%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQN-----LCG 178
           ++D+E+++ +GRG + EV   + +   ER                     +      + G
Sbjct: 89  REDFEIIKVIGRGAFGEV-AVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNG 147
Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDY---DI-RYYIYELLKALDY 234
               +  L     Q      L+ +Y    D   L     D    D+ R+YI E++ A+D 
Sbjct: 148 DCQWITALHYAF-QDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDS 206
Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGK-EYNVRVASRYFKGPELLV 292
            H    +HRD+KP NV++D     +RL D+G   +    G  + +V V +  +  PE+L 
Sbjct: 207 IHQLHYVHRDIKPDNVLLDVN-GHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQ 265
Query: 293 DLQD----YDYSLDMWSLGCMFAGMIFRKEPFF 321
            ++D    Y    D WSLG     M++ + PF+
Sbjct: 266 AMEDGMGKYGPECDWWSLGVCMYEMLYGETPFY 298

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/207 (21%), Positives = 93/207 (44%), Gaps = 15/207 (7%)
Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLC-GGPN 181
           D D YE+V+ +G G +       +  +NE                     + +     PN
Sbjct: 17  DSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIAANVKREIINHRSLRHPN 76
Query: 182 VVKLLDIVRDQHSKTPS---LIFEYVNSTD-FKVLYPT--LTDYDIRYYIYELLKALDYC 235
           +V+  +++      TP+   ++ EY +  + F+ +      ++ + R++  +L+  + YC
Sbjct: 77  IVRFKEVIL-----TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 131
Query: 236 HSQGIMHRDVKPHNVMIDHE-LRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 294
           H+  + HRD+K  N ++D     +L++ D+G ++      +    V +  +  PE+L+  
Sbjct: 132 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK- 190
Query: 295 QDYDYSL-DMWSLGCMFAGMIFRKEPF 320
           ++YD  + D+WS G     M+    PF
Sbjct: 191 KEYDGKVADVWSCGVTLYVMLVGAYPF 217

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 69/301 (22%), Positives = 113/301 (37%), Gaps = 66/301 (21%)
Query: 125 DDYEVVRKV-GRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVV 183
           DDY+V  +V G G   +V +  N  T E+                      + C  P++V
Sbjct: 17  DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC--PHIV 74
Query: 184 KLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYI----YELLK----ALDYC 235
           +++D+  + ++    L+   +   D   L+  + D   + +      E++K    A+ Y 
Sbjct: 75  RIVDVYENLYAGRKCLLI-VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 133
Query: 236 HSQGIMHRDVKPHNVMIDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           HS  I HRDVKP N++   +     L+L D+G A      KE                  
Sbjct: 134 HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA------KETTG--------------- 172
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 353
            + YD S DMWSLG +   ++    PF+  H                          L +
Sbjct: 173 -EKYDKSCDMWSLGVIMYILLCGYPPFYSNHG-------------------------LAI 206
Query: 354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA 413
            P +   +    R    +F N +    VS E    +  LL+ +   R+T  E M HP+  
Sbjct: 207 SPGMKTRI----RMGQYEFPNPEWSE-VSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM 261
Query: 414 Q 414
           Q
Sbjct: 262 Q 262

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/207 (21%), Positives = 93/207 (44%), Gaps = 15/207 (7%)
Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLC-GGPN 181
           D D YE+V+ +G G +       +  +NE                     + +     PN
Sbjct: 16  DSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPN 75
Query: 182 VVKLLDIVRDQHSKTPS---LIFEYVNSTD-FKVLYPT--LTDYDIRYYIYELLKALDYC 235
           +V+  +++      TP+   ++ EY +  + F+ +      ++ + R++  +L+  + YC
Sbjct: 76  IVRFKEVIL-----TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 130
Query: 236 HSQGIMHRDVKPHNVMIDHE-LRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 294
           H+  + HRD+K  N ++D     +L++ D+G ++      +    V +  +  PE+L+  
Sbjct: 131 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK- 189
Query: 295 QDYDYSL-DMWSLGCMFAGMIFRKEPF 320
           ++YD  + D+WS G     M+    PF
Sbjct: 190 KEYDGKVADVWSCGVTLYVMLVGAYPF 216

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/100 (30%), Positives = 58/100 (58%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N+MID +   +++ D+GLA+    G+ + +   
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQ-GYIQVTDFGLAKRVK-GRTWXLCGT 201
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 202 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 33/131 (25%), Positives = 64/131 (48%), Gaps = 9/131 (6%)
Query: 197 PSLIFEYVNSTDFKVLYPT---LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMID 253
           P ++ EYV+    + +  T   +T       I +  +AL++ H  GI+HRDVKP N++I 
Sbjct: 91  PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANILIS 150
Query: 254 HELRKLRLIDWG----LAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCM 309
                ++++D+G    +A+  +   +    + +  +  PE        D   D++SLGC+
Sbjct: 151 -ATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQARG-DSVDARSDVYSLGCV 208
Query: 310 FAGMIFRKEPF 320
              ++  + PF
Sbjct: 209 LYEVLTGEPPF 219

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 29/100 (29%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N+MID +   +++ D+G A+    G+ + +   
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQ-GYIKVTDFGFAKRVK-GRTWXLCGT 201
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 202 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 29/100 (29%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N+MID +   +++ D+G A+    G+ + +   
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQ-GYIKVTDFGFAKRVK-GRTWXLCGT 201
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 202 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 29/100 (29%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N+MID +   +++ D+G A+    G+ + +   
Sbjct: 145 RFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQ-GYIKVTDFGFAKRVK-GRTWXLCGT 202
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 203 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 240

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 29/100 (29%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N+MID +   +++ D+G A+    G+ + +   
Sbjct: 145 RFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQ-GYIKVTDFGFAKRVK-GRTWXLCGT 202
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 203 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 240

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 29/100 (29%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N+MID +   +++ D+G A+    G+ + +   
Sbjct: 145 RFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQ-GYIKVTDFGFAKRVK-GRTWXLCGT 202
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 203 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 240

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 29/100 (29%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N+MID +   +++ D+G A+    G+ + +   
Sbjct: 145 RFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQ-GYIKVTDFGFAKRVK-GRTWXLCGT 202
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 203 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 240

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 37/133 (27%), Positives = 70/133 (52%), Gaps = 8/133 (6%)
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQ 238
           +++K      DQ  K+  L+ EYV     +   P  ++    +  +  ++ + + Y HSQ
Sbjct: 77  HIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHSQ 136
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-YNVRV---ASRYFKGPELLVDL 294
             +HR++   NV++D++ R +++ D+GLA+    G E Y VR    +  ++  PE L + 
Sbjct: 137 HYIHRNLAARNVLLDND-RLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEY 195
Query: 295 QDYDYSLDMWSLG 307
           + Y Y+ D+WS G
Sbjct: 196 KFY-YASDVWSFG 207

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 55/106 (51%), Gaps = 7/106 (6%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWG--LAEFYHPGKEYNVR 279
           R+Y+ E++ A+D  H    +HRD+KP N+++D     +RL D+G  L        + +V 
Sbjct: 178 RFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMN-GHIRLADFGSCLKLMEDGTVQSSVA 236
Query: 280 VASRYFKGPELLVDLQD----YDYSLDMWSLGCMFAGMIFRKEPFF 321
           V +  +  PE+L  ++     Y    D WSLG     M++ + PF+
Sbjct: 237 VGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFY 282

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 29/100 (29%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N+MID +   +++ D+G A+    G+ + +   
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQ-GYIQVTDFGFAKRVK-GRTWXLCGT 201
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 202 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 80/207 (38%), Gaps = 24/207 (11%)
Query: 132 KVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLCGG---PNVVKLLDI 188
           ++GRG + EV    +  T  +C                       C G   P +V L   
Sbjct: 100 RLGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRAEELMA------CAGLTSPRIVPLYGA 153
Query: 189 VRDQHSKTPSLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDV 245
           VR+      ++  E +       L      L +    YY+ + L+ L+Y HS+ I+H DV
Sbjct: 154 VRE--GPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGDV 211
Query: 246 KPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG------PELLVDLQDYDY 299
           K  NV++  +     L D+G A    P       +   Y  G      PE+++  +  D 
Sbjct: 212 KADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLG-RSCDA 270
Query: 300 SLDMWSLGCMFAGMIFRKEP---FFYG 323
            +D+WS  CM   M+    P   FF G
Sbjct: 271 KVDVWSSCCMMLHMLNGCHPWTQFFRG 297

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 59/299 (19%), Positives = 120/299 (40%), Gaps = 59/299 (19%)
Query: 125 DDYEVVRKVGRGKYSEVF-----EGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLCGG 179
           DD+++ R +G+GK+  V+     +   +   +                     +Q+    
Sbjct: 15  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 74
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRY-------YIYELLKAL 232
           PN++++ +   D+  K   L+ E+    +   LY  L  +  R+       ++ EL  AL
Sbjct: 75  PNILRMYNYFHDR--KRIYLMLEFAPRGE---LYKELQKHG-RFDEQRSATFMEELADAL 128
Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 292
            YCH + ++HRD+KP N+++ ++  +L++ D+G +  + P         +  +  PE ++
Sbjct: 129 HYCHERKVIHRDIKPENLLMGYK-GELKIADFGWS-VHAPSLRRRXMCGTLDYLPPE-MI 185
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE 352
           + + +D  +D+W  G +    +    PF    D+        +++  D          L+
Sbjct: 186 EGKTHDEKVDLWCAGVLCYEFLVGMPPF----DSPSHTETHRRIVNVD----------LK 231
Query: 353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 411
             P                         +S  + D + KLLRY    RL  +  M HP+
Sbjct: 232 FPP------------------------FLSDGSKDLISKLLRYHPPQRLPLKGVMEHPW 266

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 77/200 (38%), Gaps = 19/200 (9%)
Query: 132 KVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLCGG---PNVVKLLDI 188
           +VGRG + EV    +  T  +C                       C G   P +V L   
Sbjct: 81  RVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELVA------CAGLSSPRIVPLYGA 134
Query: 189 VRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALDYCHSQGIMHRDV 245
           VR+      ++  E +       L      L +    YY+ + L+ L+Y H++ I+H DV
Sbjct: 135 VRE--GPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDV 192
Query: 246 KPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL-----LVDLQDYDYS 300
           K  NV++  +  +  L D+G A    P       +   Y  G E      +V  +  D  
Sbjct: 193 KADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAK 252
Query: 301 LDMWSLGCMFAGMIFRKEPF 320
           +D+WS  CM   M+    P+
Sbjct: 253 VDIWSSCCMMLHMLNGCHPW 272

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 50/217 (23%), Positives = 94/217 (43%), Gaps = 28/217 (12%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGI-------NVNTNERCXXXXXXXXXXXXXXXXXXXLQNL 176
           ++D  + R +G G + EV+EG+        +N   +                    ++NL
Sbjct: 7   REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNL 66
Query: 177 CGGPNVVKLLDIVRDQHSKTPSLIFEYV--------NSTDFKVLYPTLTDYDIRYYIYEL 228
              P++VKL+ I+ ++ +     ++ Y         N    KVL  TL  Y +     ++
Sbjct: 67  -DHPHIVKLIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVL--TLVLYSL-----QI 118
Query: 229 LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK-- 286
            KA+ Y  S   +HRD+   N+++      ++L D+GL+ +      Y   V     K  
Sbjct: 119 CKAMAYLESINCVHRDIAVRNILVASP-ECVKLGDFGLSRYIEDEDYYKASVTRLPIKWM 177
Query: 287 GPELLVDLQDYDYSLDMWSLG-CMFAGMIFRKEPFFY 322
            PE  ++ + +  + D+W    CM+  + F K+PFF+
Sbjct: 178 SPE-SINFRRFTTASDVWMFAVCMWEILSFGKQPFFW 213

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 50/217 (23%), Positives = 94/217 (43%), Gaps = 28/217 (12%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGI-------NVNTNERCXXXXXXXXXXXXXXXXXXXLQNL 176
           ++D  + R +G G + EV+EG+        +N   +                    ++NL
Sbjct: 23  REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNL 82
Query: 177 CGGPNVVKLLDIVRDQHSKTPSLIFEYV--------NSTDFKVLYPTLTDYDIRYYIYEL 228
              P++VKL+ I+ ++ +     ++ Y         N    KVL  TL  Y +     ++
Sbjct: 83  -DHPHIVKLIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVL--TLVLYSL-----QI 134
Query: 229 LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK-- 286
            KA+ Y  S   +HRD+   N+++      ++L D+GL+ +      Y   V     K  
Sbjct: 135 CKAMAYLESINCVHRDIAVRNILVASP-ECVKLGDFGLSRYIEDEDYYKASVTRLPIKWM 193
Query: 287 GPELLVDLQDYDYSLDMWSLG-CMFAGMIFRKEPFFY 322
            PE  ++ + +  + D+W    CM+  + F K+PFF+
Sbjct: 194 SPE-SINFRRFTTASDVWMFAVCMWEILSFGKQPFFW 229

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVK-GRTWXLXGT 201
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 202 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVK-GRTWXLAGT 201
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 202 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 50/217 (23%), Positives = 94/217 (43%), Gaps = 28/217 (12%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGI-------NVNTNERCXXXXXXXXXXXXXXXXXXXLQNL 176
           ++D  + R +G G + EV+EG+        +N   +                    ++NL
Sbjct: 11  REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNL 70
Query: 177 CGGPNVVKLLDIVRDQHSKTPSLIFEYV--------NSTDFKVLYPTLTDYDIRYYIYEL 228
              P++VKL+ I+ ++ +     ++ Y         N    KVL  TL  Y +     ++
Sbjct: 71  -DHPHIVKLIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVL--TLVLYSL-----QI 122
Query: 229 LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK-- 286
            KA+ Y  S   +HRD+   N+++      ++L D+GL+ +      Y   V     K  
Sbjct: 123 CKAMAYLESINCVHRDIAVRNILVASP-ECVKLGDFGLSRYIEDEDYYKASVTRLPIKWM 181
Query: 287 GPELLVDLQDYDYSLDMWSLG-CMFAGMIFRKEPFFY 322
            PE  ++ + +  + D+W    CM+  + F K+PFF+
Sbjct: 182 SPE-SINFRRFTTASDVWMFAVCMWEILSFGKQPFFW 217

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 30/102 (29%), Positives = 56/102 (54%), Gaps = 10/102 (9%)
Query: 227 ELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGKEYNVRVASRYF 285
           ++ K +DY HS+ ++HRD+KP N+ +  + +++++ D+GL     + GK    +   RY 
Sbjct: 144 QITKGVDYIHSKKLIHRDLKPSNIFL-VDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYM 202
Query: 286 KGPELLVDLQDYDYSLDMWSLGCMFAGMI------FRKEPFF 321
             PE  +  QDY   +D+++LG + A ++      F    FF
Sbjct: 203 -SPE-QISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFF 242

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 77/200 (38%), Gaps = 19/200 (9%)
Query: 132 KVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLCGG---PNVVKLLDI 188
           +VGRG + EV    +  T  +C                       C G   P +V L   
Sbjct: 65  RVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELVA------CAGLSSPRIVPLYGA 118
Query: 189 VRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALDYCHSQGIMHRDV 245
           VR+      ++  E +       L      L +    YY+ + L+ L+Y H++ I+H DV
Sbjct: 119 VRE--GPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDV 176
Query: 246 KPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL-----LVDLQDYDYS 300
           K  NV++  +  +  L D+G A    P       +   Y  G E      +V  +  D  
Sbjct: 177 KADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAK 236
Query: 301 LDMWSLGCMFAGMIFRKEPF 320
           +D+WS  CM   M+    P+
Sbjct: 237 VDIWSSCCMMLHMLNGCHPW 256

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLIIDQQ-GYIQVTDFGFAKRVK-GRTWXLCGT 201
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 202 PEYL-APEIIIS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 80/207 (38%), Gaps = 24/207 (11%)
Query: 132 KVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLCGG---PNVVKLLDI 188
           ++GRG + EV    +  T  +C                       C G   P +V L   
Sbjct: 81  RLGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRAEELMA------CAGLTSPRIVPLYGA 134
Query: 189 VRDQHSKTPSLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDV 245
           VR+      ++  E +       L      L +    YY+ + L+ L+Y HS+ I+H DV
Sbjct: 135 VRE--GPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGDV 192
Query: 246 KPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG------PELLVDLQDYDY 299
           K  NV++  +     L D+G A    P       +   Y  G      PE+++  +  D 
Sbjct: 193 KADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLG-RSCDA 251
Query: 300 SLDMWSLGCMFAGMIFRKEP---FFYG 323
            +D+WS  CM   M+    P   FF G
Sbjct: 252 KVDVWSSCCMMLHMLNGCHPWTQFFRG 278

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 36/133 (27%), Positives = 70/133 (52%), Gaps = 8/133 (6%)
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQ 238
           +++K      DQ  K+  L+ EYV     +   P  ++    +  +  ++ + + Y H+Q
Sbjct: 77  HIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQ 136
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-YNVRV---ASRYFKGPELLVDL 294
             +HR++   NV++D++ R +++ D+GLA+    G E Y VR    +  ++  PE L + 
Sbjct: 137 HYIHRNLAARNVLLDND-RLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEY 195
Query: 295 QDYDYSLDMWSLG 307
           + Y Y+ D+WS G
Sbjct: 196 KFY-YASDVWSFG 207

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 40/166 (24%), Positives = 77/166 (46%), Gaps = 28/166 (16%)
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRY----------YIYELLK 230
           N+V ++D+  D+      L+ EY+         PTL++Y   +          +  ++L 
Sbjct: 72  NIVSMIDV--DEEDDCYYLVMEYIEG-------PTLSEYIESHGPLSVDTAINFTNQILD 122
Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK--EYNVRVASRYFKGP 288
            + + H   I+HRD+KP N++ID   + L++ D+G+A+        + N  + +  +  P
Sbjct: 123 GIKHAHDMRIVHRDIKPQNILIDSN-KTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSP 181
Query: 289 ELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 334
           E     +  D   D++S+G +   M+  + PF     N +  V IA
Sbjct: 182 E-QAKGEATDECTDIYSIGIVLYEMLVGEPPF-----NGETAVSIA 221

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 145 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVK-GRTWTLCGT 202
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 203 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 240

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 130 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVK-GRTWTLCGT 187
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 188 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 225

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVK-GRTWXLCGT 201
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 202 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIKVADFGFAKRVK-GRTWXLCGT 201
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 202 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVK-GRTWXLCGT 201
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 202 PEYL-APEIILS-KGYNKAVDWWALGVLIYQMAAGYPPFF 239

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVK-GRTWXLCGT 201
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 202 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 145 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIKVADFGFAKRVK-GRTWXLCGT 202
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 203 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 240

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 145 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVK-GRTWXLCGT 202
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 203 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 240

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVK-GRTWXLCGT 201
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 202 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/100 (29%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID E   +++ D+G A+    G+ + +   
Sbjct: 131 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLID-EQGYIQVTDFGFAKRVK-GRTWXLCGT 188
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 189 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 226

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIKVADFGFAKRVK-GRTWXLCGT 201
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 202 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIKVADFGFAKRVK-GRTWXLCGT 201
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 202 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 165 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVK-GRTWXLCGT 222
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 223 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 260

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVK-GRTWXLCGT 201
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 202 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVK-GRTWXLCGT 201
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 202 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 145 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVK-GRTWXLCGT 202
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 203 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 240

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVK-GRTWXLCGT 201
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 202 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 145 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVK-GRTWXLCGT 202
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 203 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 240

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 165 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVK-GRTWXLCGT 222
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 223 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 260

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVK-GRTWXLCGT 201
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 202 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVK-GRTWXLCGT 201
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 202 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVK-GRTWXLCGT 201
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 202 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 145 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVK-GRTWXLCGT 202
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 203 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 240

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 145 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVK-GRTWXLCGT 202
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 203 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 240

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 145 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVK-GRTWXLCGT 202
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 203 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 240

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 137 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVK-GRTWXLCGT 194
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 195 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 232

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVK-GRTWXLCGT 201
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 202 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVK-GRTWXLCGT 201
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 202 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVK-GRTWXLCGT 201
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 202 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVK-GRTWXLCGT 201
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 202 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVK-GRTWXLCGT 201
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 202 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/133 (27%), Positives = 68/133 (51%), Gaps = 8/133 (6%)
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQ 238
           ++VK      DQ  K+  L+ EYV     +   P   +    +  +  ++ + + Y H+Q
Sbjct: 72  HIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLLLFAQQICEGMAYLHAQ 131
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-YNVRV---ASRYFKGPELLVDL 294
             +HR +   NV++D++ R +++ D+GLA+    G E Y VR    +  ++  PE L + 
Sbjct: 132 HYIHRALAARNVLLDND-RLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEC 190
Query: 295 QDYDYSLDMWSLG 307
           + Y Y+ D+WS G
Sbjct: 191 KFY-YASDVWSFG 202

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVK-GRTWXLCGT 201
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 202 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVK-GRTWXLCGT 201
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 202 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/133 (27%), Positives = 68/133 (51%), Gaps = 8/133 (6%)
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQ 238
           ++VK      DQ  K+  L+ EYV     +   P   +    +  +  ++ + + Y H+Q
Sbjct: 71  HIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLLLFAQQICEGMAYLHAQ 130
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-YNVRV---ASRYFKGPELLVDL 294
             +HR +   NV++D++ R +++ D+GLA+    G E Y VR    +  ++  PE L + 
Sbjct: 131 HYIHRALAARNVLLDND-RLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEC 189
Query: 295 QDYDYSLDMWSLG 307
           + Y Y+ D+WS G
Sbjct: 190 KFY-YASDVWSFG 201

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 137 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVK-GRTWXLCGT 194
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 195 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 232

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVK-GRTWXLCGT 201
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 202 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 139 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVK-GRTWXLCGT 196
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 197 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 234

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVK-GRTWXLCGT 201
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 202 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/137 (23%), Positives = 67/137 (48%), Gaps = 7/137 (5%)
Query: 199 LIFEYVNSTDFKVLYPT---LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE 255
           LI +Y+N  +           T+++++ Y+ E++ AL++ H  GI++RD+K  N+++D  
Sbjct: 136 LILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSN 195
Query: 256 LRKLRLIDWGLAEFY---HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAG 312
              + L D+GL++ +      + Y+      Y     +      +D ++D WSLG +   
Sbjct: 196 -GHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYE 254
Query: 313 MIFRKEPFFYGHDNHDQ 329
           ++    PF    + + Q
Sbjct: 255 LLTGASPFTVDGEKNSQ 271

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/207 (20%), Positives = 92/207 (44%), Gaps = 15/207 (7%)
Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLC-GGPN 181
           D D YE+V+ +G G +       +  +NE                     + +     PN
Sbjct: 17  DSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPN 76
Query: 182 VVKLLDIVRDQHSKTPS---LIFEYVNSTD-FKVLYPT--LTDYDIRYYIYELLKALDYC 235
           +V+  +++      TP+   ++ EY +  + F+ +      ++ + R++  +L+  + YC
Sbjct: 77  IVRFKEVIL-----TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 131
Query: 236 HSQGIMHRDVKPHNVMIDHE-LRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 294
           H+  + HRD+K  N ++D     +L++  +G ++      +    V +  +  PE+L+  
Sbjct: 132 HAMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK- 190
Query: 295 QDYDYSL-DMWSLGCMFAGMIFRKEPF 320
           ++YD  + D+WS G     M+    PF
Sbjct: 191 KEYDGKVADVWSCGVTLYVMLVGAYPF 217

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 56/100 (56%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G  + +   
Sbjct: 165 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVK-GATWTLCGT 222
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 223 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 260

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 77/200 (38%), Gaps = 19/200 (9%)
Query: 132 KVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLCGG---PNVVKLLDI 188
           ++GRG + EV    +  T  +C                       C G   P +V L   
Sbjct: 79  RLGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELVA------CAGLSSPRIVPLYGA 132
Query: 189 VRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALDYCHSQGIMHRDV 245
           VR+      ++  E +       L      L +    YY+ + L+ L+Y H++ I+H DV
Sbjct: 133 VRE--GPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDV 190
Query: 246 KPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL-----LVDLQDYDYS 300
           K  NV++  +  +  L D+G A    P       +   Y  G E      +V  +  D  
Sbjct: 191 KADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAK 250
Query: 301 LDMWSLGCMFAGMIFRKEPF 320
           +D+WS  CM   M+    P+
Sbjct: 251 VDIWSSCCMMLHMLNGCHPW 270

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 35/133 (26%), Positives = 69/133 (51%), Gaps = 8/133 (6%)
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQ 238
           +++K      D  + +  L+ EYV     +   P  ++    +  +  ++ + + Y H+Q
Sbjct: 94  HIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQ 153
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-YNVRV---ASRYFKGPELLVDL 294
             +HRD+   NV++D++ R +++ D+GLA+    G E Y VR    +  ++  PE L + 
Sbjct: 154 HYIHRDLAARNVLLDND-RLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECLKEY 212
Query: 295 QDYDYSLDMWSLG 307
           + Y Y+ D+WS G
Sbjct: 213 KFY-YASDVWSFG 224

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 43/207 (20%), Positives = 92/207 (44%), Gaps = 15/207 (7%)
Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLC-GGPN 181
           D D YE+V+ +G G +       +  +NE                     + +     PN
Sbjct: 17  DSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPN 76
Query: 182 VVKLLDIVRDQHSKTPS---LIFEYVNSTD-FKVLYPT--LTDYDIRYYIYELLKALDYC 235
           +V+  +++      TP+   ++ EY +  + F+ +      ++ + R++  +L+  + YC
Sbjct: 77  IVRFKEVIL-----TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 131
Query: 236 HSQGIMHRDVKPHNVMIDHE-LRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 294
           H+  + HRD+K  N ++D     +L++  +G ++      +    V +  +  PE+L+  
Sbjct: 132 HAMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDTVGTPAYIAPEVLLK- 190
Query: 295 QDYDYSL-DMWSLGCMFAGMIFRKEPF 320
           ++YD  + D+WS G     M+    PF
Sbjct: 191 KEYDGKVADVWSCGVTLYVMLVGAYPF 217

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 36/140 (25%), Positives = 67/140 (47%), Gaps = 11/140 (7%)
Query: 180 PNVVKLLDIVR--DQHSKTPS-LIFEYVNSTDFK-VLYPTLTDYDIRYYIYELLKALDYC 235
           P++V++ + V   D+H      ++ EYV     K      L   +   Y+ E+L AL Y 
Sbjct: 139 PSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEAIAYLLEILPALSYL 198
Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 295
           HS G+++ D+KP N+M+  E  +L+LID G     +    +     +  F+ PE++    
Sbjct: 199 HSIGLVYNDLKPENIMLTEE--QLKLIDLGAVSRIN---SFGYLYGTPGFQAPEIV--RT 251
Query: 296 DYDYSLDMWSLGCMFAGMIF 315
               + D++++G   A +  
Sbjct: 252 GPTVATDIYTVGRTLAALTL 271

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 43/207 (20%), Positives = 91/207 (43%), Gaps = 15/207 (7%)
Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLC-GGPN 181
           D D YE+V+ +G G +       +   NE                     + +     PN
Sbjct: 17  DSDRYELVKDIGAGNFGVARLMRDKQANELVAVKYIERGEKIDENVKREIINHRSLRHPN 76
Query: 182 VVKLLDIVRDQHSKTPS---LIFEYVNSTD-FKVLYPT--LTDYDIRYYIYELLKALDYC 235
           +V+  +++      TP+   ++ EY +  + F+ +      ++ + R++  +L+  + Y 
Sbjct: 77  IVRFKEVIL-----TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYA 131
Query: 236 HSQGIMHRDVKPHNVMIDHE-LRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 294
           H+  + HRD+K  N ++D     +L++ D+G ++      +    V +  +  PE+L+  
Sbjct: 132 HAMQVAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSAVGTPAYIAPEVLLK- 190
Query: 295 QDYDYSL-DMWSLGCMFAGMIFRKEPF 320
           ++YD  + D+WS G     M+    PF
Sbjct: 191 KEYDGKVADVWSCGVTLYVMLVGAYPF 217

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 38/132 (28%), Positives = 64/132 (48%), Gaps = 18/132 (13%)
Query: 199 LIFEYVNSTDFKVLYPTLTDY---DIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE 255
            + EYVN  D       +  +      +Y  E+   L + H +GI++RD+K  NVM+D E
Sbjct: 97  FVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISIGLFFLHKRGIIYRDLKLDNVMLDSE 156
Query: 256 LRKLRLIDWGLAEFYHPGKEYNV-RVASRYFKG------PELLVDLQDYDYSLDMWSLGC 308
              +++ D+G+       KE+ +  V +R F G      PE++   Q Y  S+D W+ G 
Sbjct: 157 -GHIKIADFGMC------KEHMMDGVTTREFCGTPDYIAPEIIA-YQPYGKSVDWWAYGV 208
Query: 309 MFAGMIFRKEPF 320
           +   M+  + PF
Sbjct: 209 LLYEMLAGQPPF 220

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 61/279 (21%), Positives = 125/279 (44%), Gaps = 28/279 (10%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTN-----ERCXXXXXXXXXXXXXXXXXXXLQNLCGG 179
           DD+E+ R +G+GK+  V+      ++     +                     +Q     
Sbjct: 23  DDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHH 82
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLYPTLTDYDIRY--YIYELLKALDYCH 236
           PN+++L +   D+  +   LI EY    + +K L  + T  + R    + EL  AL YCH
Sbjct: 83  PNILRLYNYFYDR--RRIYLILEYAPRGELYKELQKSCTFDEQRTATIMEELADALMYCH 140
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
            + ++HRD+KP N+++     +L++ D+G +  + P         +  +  PE +++ + 
Sbjct: 141 GKKVIHRDIKPENLLLG-LKGELKIADFGWS-VHAPSLRRKTMCGTLDYLPPE-MIEGRM 197
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDN--HDQLVKI-----AKV-LGTDELNAYLNK 348
           ++  +D+W +G +   ++    PF     N  + ++VK+     A V  G  +L + L  
Sbjct: 198 HNEKVDLWCIGVLCYELLVGNPPFESASHNETYRRIVKVDLKFPASVPTGAQDLISKL-- 255
Query: 349 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAID 387
             L  +P     + + S  PW   + A+++ ++ P A+ 
Sbjct: 256 --LRHNPSERLPLAQVSAHPW---VRANSRRVLPPSALQ 289

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 29/102 (28%), Positives = 56/102 (54%), Gaps = 10/102 (9%)
Query: 227 ELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGKEYNVRVASRYF 285
           ++ K +DY HS+ +++RD+KP N+ +  + +++++ D+GL     + GK    +   RY 
Sbjct: 130 QITKGVDYIHSKKLINRDLKPSNIFL-VDTKQVKIGDFGLVTSLKNDGKRXRSKGTLRYM 188
Query: 286 KGPELLVDLQDYDYSLDMWSLGCMFAGMI------FRKEPFF 321
             PE  +  QDY   +D+++LG + A ++      F    FF
Sbjct: 189 -SPE-QISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFF 228

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 29/108 (26%), Positives = 56/108 (51%), Gaps = 20/108 (18%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+          RV 
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAK----------RVK 192
Query: 282 SRYFK--------GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
            R +          PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 193 GRTWXLCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 27/100 (27%), Positives = 56/100 (56%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVK-GRTWXLCGT 201
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   P +++  + Y+ ++D W+LG +   M     PFF
Sbjct: 202 PEYL-APAIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 34/126 (26%), Positives = 59/126 (46%), Gaps = 6/126 (4%)
Query: 199 LIFEYVNSTDFKVLYPTLTDYD---IRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE 255
            + EYVN  D       +  +      +Y  E+   L +  S+GI++RD+K  NVM+D E
Sbjct: 419 FVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSE 478
Query: 256 LRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI 314
              +++ D+G+  E    G        +  +  PE++   Q Y  S+D W+ G +   M+
Sbjct: 479 -GHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIA-YQPYGKSVDWWAFGVLLYEML 536
Query: 315 FRKEPF 320
             + PF
Sbjct: 537 AGQAPF 542

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/118 (27%), Positives = 62/118 (52%), Gaps = 15/118 (12%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWG---LAEFYHP 272
           LT+  I + +  + + L+  H++G  HRD+KP N+++  E + + L+D G    A  +  
Sbjct: 131 LTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPV-LMDLGSMNQACIHVE 189
Query: 273 G-------KEYNVRVASRYFKGPELLVDLQDY---DYSLDMWSLGCMFAGMIFRKEPF 320
           G       +++  +  +  ++ PEL   +Q +   D   D+WSLGC+   M+F + P+
Sbjct: 190 GSRQALTLQDWAAQRCTISYRAPELF-SVQSHCVIDERTDVWSLGCVLYAMMFGEGPY 246

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 34/126 (26%), Positives = 59/126 (46%), Gaps = 6/126 (4%)
Query: 199 LIFEYVNSTDFKVLYPTLTDYD---IRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE 255
            + EYVN  D       +  +      +Y  E+   L +  S+GI++RD+K  NVM+D E
Sbjct: 98  FVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSE 157
Query: 256 LRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI 314
              +++ D+G+  E    G        +  +  PE++   Q Y  S+D W+ G +   M+
Sbjct: 158 -GHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIA-YQPYGKSVDWWAFGVLLYEML 215
Query: 315 FRKEPF 320
             + PF
Sbjct: 216 AGQAPF 221

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 60/249 (24%), Positives = 106/249 (42%), Gaps = 55/249 (22%)
Query: 180 PNVVKLLDIVRDQHSK------TPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALD 233
           PNV++     +D+  +        + + EYV   DF  L       +    + +    L 
Sbjct: 78  PNVIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHL-----GLEPITLLQQTTSGLA 132
Query: 234 YCHSQGIMHRDVKPHNVMID----HELRKLRLIDWGLAEFYHPGKEYNVRVA----SRYF 285
           + HS  I+HRD+KPHN++I     H   K  + D+GL +    G+    R +    +  +
Sbjct: 133 HLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGW 192
Query: 286 KGPELLVD--LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELN 343
             PE+L +   ++  Y++D++S GC+F  +I         H     L + A +L    L 
Sbjct: 193 IAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEG-----SHPFGKSLQRQANIL----LG 243
Query: 344 AYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA 403
           A            LD L   H  K         ++ +++ E I   +K++  D Q R +A
Sbjct: 244 AC----------SLDCL---HPEK---------HEDVIARELI---EKMIAMDPQKRPSA 278
Query: 404 REAMAHPYF 412
           +  + HP+F
Sbjct: 279 KHVLKHPFF 287

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 47/237 (19%), Positives = 99/237 (41%), Gaps = 26/237 (10%)
Query: 112 WDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXX 171
           WD ++  +    ++  ++V+++G G++ EV+ G   N+ +                    
Sbjct: 3   WDKDAWEIP---RESIKLVKRLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEA 59
Query: 172 XLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST---DF-------KVLYPTLTDYDI 221
            L        +V+L  +V  +      +I EY+      DF       KVL P L D+  
Sbjct: 60  NLMKTLQHDKLVRLYAVVTREEP--IYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSA 117
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
                ++ + + Y   +  +HRD++  NV++   L   ++ D+GLA       EY  R  
Sbjct: 118 -----QIAEGMAYIERKNYIHRDLRAANVLVSESLM-CKIADFGLARVIE-DNEYTAREG 170
Query: 282 SRY---FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
           +++   +  PE  ++   +    D+WS G +   ++   +  + G  N D +  +++
Sbjct: 171 AKFPIKWTAPE-AINFGCFTIKSDVWSFGILLYEIVTYGKIPYPGRTNADVMTALSQ 226

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/188 (23%), Positives = 76/188 (40%), Gaps = 37/188 (19%)
Query: 229 LKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG 287
           +KAL++      I+HRD+KP N+++D     ++L D+G++               R +  
Sbjct: 135 VKALNHLKENLKIIHRDIKPSNILLDRS-GNIKLCDFGISGQLVDSIAKTRDAGCRPYMA 193
Query: 288 PELL---VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA 344
           PE +      Q YD   D+WSLG     +   + P+   +   DQL ++ K  G      
Sbjct: 194 PERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVK--GD----- 246
Query: 345 YLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAR 404
                     PQL                N++ +   SP  I+F++  L  D   R   +
Sbjct: 247 ---------PPQLS---------------NSEEREF-SPSFINFVNLCLTKDESKRPKYK 281
Query: 405 EAMAHPYF 412
           E + HP+ 
Sbjct: 282 ELLKHPFI 289

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/145 (22%), Positives = 76/145 (52%), Gaps = 13/145 (8%)
Query: 212 LYPTLTDYDIRYYI---YELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE 268
           L+ + T ++++  I    +  + +DY H++ I+HRD+K +N+ + HE   +++ D+GLA 
Sbjct: 98  LHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFL-HEDNTVKIGDFGLAT 156
Query: 269 F---YHPGKEYNVRVASRYFKGPEL--LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG 323
               +    ++     S  +  PE+  + D   Y +  D+++ G +   ++  + P +  
Sbjct: 157 VKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP-YSN 215
Query: 324 HDNHDQLVKIAKVLGTDELNAYLNK 348
            +N DQ++++   +G   L+  L+K
Sbjct: 216 INNRDQIIEM---VGRGSLSPDLSK 237

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 36/136 (26%), Positives = 65/136 (47%), Gaps = 12/136 (8%)
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTD-----YDIRYYIYELLKALDYC 235
           N+VK   I  +       LI E++ S   K   P   +       ++Y + ++ K +DY 
Sbjct: 84  NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAV-QICKGMDYL 142
Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV----RVASRYFKGPELL 291
            S+  +HRD+   NV+++ E  ++++ D+GL +     KE       R +  ++  PE L
Sbjct: 143 GSRQYVHRDLAARNVLVESE-HQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECL 201
Query: 292 VDLQDYDYSLDMWSLG 307
           +  + Y  S D+WS G
Sbjct: 202 MQSKFYIAS-DVWSFG 216

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 36/136 (26%), Positives = 65/136 (47%), Gaps = 12/136 (8%)
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTD-----YDIRYYIYELLKALDYC 235
           N+VK   I  +       LI E++ S   K   P   +       ++Y + ++ K +DY 
Sbjct: 72  NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAV-QICKGMDYL 130
Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV----RVASRYFKGPELL 291
            S+  +HRD+   NV+++ E  ++++ D+GL +     KE       R +  ++  PE L
Sbjct: 131 GSRQYVHRDLAARNVLVESE-HQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECL 189
Query: 292 VDLQDYDYSLDMWSLG 307
           +  + Y  S D+WS G
Sbjct: 190 MQSKFYIAS-DVWSFG 204

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 33/145 (22%), Positives = 76/145 (52%), Gaps = 13/145 (8%)
Query: 212 LYPTLTDYDIRYYI---YELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA- 267
           L+ + T ++++  I    +  + +DY H++ I+HRD+K +N+ + HE   +++ D+GLA 
Sbjct: 110 LHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFL-HEDNTVKIGDFGLAT 168
Query: 268 --EFYHPGKEYNVRVASRYFKGPEL--LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG 323
               +    ++     S  +  PE+  + D   Y +  D+++ G +   ++  + P +  
Sbjct: 169 EKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP-YSN 227
Query: 324 HDNHDQLVKIAKVLGTDELNAYLNK 348
            +N DQ++++   +G   L+  L+K
Sbjct: 228 INNRDQIIEM---VGRGSLSPDLSK 249

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 31/111 (27%), Positives = 55/111 (49%), Gaps = 6/111 (5%)
Query: 228 LLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 286
           ++KAL Y   + G++HRDVKP N+++D E  +++L D+G++      K  +       + 
Sbjct: 133 IVKALYYLKEKHGVIHRDVKPSNILLD-ERGQIKLCDFGISGRLVDDKAKDRSAGCAAYM 191
Query: 287 GPELL----VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333
            PE +        DYD   D+WSLG     +   + P+     + + L K+
Sbjct: 192 APERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKV 242

>pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 35/152 (23%), Positives = 67/152 (44%), Gaps = 8/152 (5%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQNLCGGP 180
           + + + RK+G G + E++ G N+ TNE    +                    LQ   G P
Sbjct: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIP 66
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGI 240
           NV +   +  D +     L+   +    F      L+   +     +++  +++ HS+  
Sbjct: 67  NV-RWFGVEGDYNVLVMDLLGPSLEDL-FNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 124
Query: 241 MHRDVKPHNVMIDHELR--KLRLIDWGLAEFY 270
           +HRD+KP N ++    R  ++ +ID+GLA+ Y
Sbjct: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 33/145 (22%), Positives = 76/145 (52%), Gaps = 13/145 (8%)
Query: 212 LYPTLTDYDIRYYI---YELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA- 267
           L+ + T ++++  I    +  + +DY H++ I+HRD+K +N+ + HE   +++ D+GLA 
Sbjct: 110 LHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFL-HEDNTVKIGDFGLAT 168
Query: 268 --EFYHPGKEYNVRVASRYFKGPEL--LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG 323
               +    ++     S  +  PE+  + D   Y +  D+++ G +   ++  + P +  
Sbjct: 169 EKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP-YSN 227
Query: 324 HDNHDQLVKIAKVLGTDELNAYLNK 348
            +N DQ++++   +G   L+  L+K
Sbjct: 228 INNRDQIIEM---VGRGSLSPDLSK 249

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 31/108 (28%), Positives = 53/108 (49%), Gaps = 9/108 (8%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYN-VR 279
           R+Y+ E++ A+D  H  G +HRD+KP N+++D     +RL D+G   +    G   + V 
Sbjct: 165 RFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDR-CGHIRLADFGSCLKLRADGTVRSLVA 223
Query: 280 VASRYFKGPELLVDLQDYDY------SLDMWSLGCMFAGMIFRKEPFF 321
           V +  +  PE+L  +             D W+LG     M + + PF+
Sbjct: 224 VGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFY 271

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 33/134 (24%), Positives = 71/134 (52%), Gaps = 18/134 (13%)
Query: 212 LYPTLTDYDIRYYIYELL-------KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDW 264
           LY  L   + ++ +++L+       + +DY H++ I+HRD+K +N+ + HE   +++ D+
Sbjct: 118 LYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFL-HEGLTVKIGDF 176
Query: 265 GLAEF---YHPGKEYNVRVASRYFKGPELLVDLQD---YDYSLDMWSLGCMFAGMIFRKE 318
           GLA     +   ++      S  +  PE ++ +QD   + +  D++S G +   ++  + 
Sbjct: 177 GLATVKSRWSGSQQVEQPTGSVLWMAPE-VIRMQDNNPFSFQSDVYSYGIVLYELMTGEL 235
Query: 319 PFFYGH-DNHDQLV 331
           P  Y H +N DQ++
Sbjct: 236 P--YSHINNRDQII 247

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 30/93 (32%), Positives = 47/93 (50%), Gaps = 3/93 (3%)
Query: 215 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 274
           +L +  +  Y+ + L AL + HSQG++H DVKP N+ +    R  +L D+GL        
Sbjct: 153 SLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGR-CKLGDFGLLVELGTAG 211
Query: 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLG 307
              V+     +  PELL     Y  + D++SLG
Sbjct: 212 AGEVQEGDPRYMAPELLQG--SYGTAADVFSLG 242

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 41/223 (18%), Positives = 93/223 (41%), Gaps = 19/223 (8%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVV 183
           ++  ++V+K+G G++ EV+ G   N+ +                     L        +V
Sbjct: 11  RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLV 70
Query: 184 KLLDIVRDQHS-------KTPSLIFEYVNSTDF-KVLYPTLTDYDIRYYIYELLKALDYC 235
           +L  +V  +              + +++ S +  KVL P L D+       ++ + + Y 
Sbjct: 71  RLYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSA-----QIAEGMAYI 125
Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY---FKGPELLV 292
             +  +HRD++  NV++   L   ++ D+GLA       EY  R  +++   +  PE  +
Sbjct: 126 ERKNYIHRDLRAANVLVSESLM-CKIADFGLARVIE-DNEYTAREGAKFPIKWTAPE-AI 182
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
           +   +    ++WS G +   ++   +  + G  N D +  +++
Sbjct: 183 NFGCFTIKSNVWSFGILLYEIVTYGKIPYPGRTNADVMSALSQ 225

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 26/101 (25%), Positives = 52/101 (51%), Gaps = 3/101 (2%)
Query: 224 YIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY-NVRVAS 282
           +  ++  AL + H + I+HRD+K  N+ +  +   ++L D+G+A   +   E     + +
Sbjct: 130 WFVQICLALKHVHDRKILHRDIKSQNIFLTKD-GTVQLGDFGIARVLNSTVELARACIGT 188
Query: 283 RYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG 323
            Y+  PE+  + + Y+   D+W+LGC+   +   K  F  G
Sbjct: 189 PYYLSPEICEN-KPYNNKSDIWALGCVLYELCTLKHAFEAG 228

>pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 55/228 (24%), Positives = 96/228 (42%), Gaps = 28/228 (12%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELR--------KLRLIDWGLA 267
           + +  I Y +  +LKALDY H  G +HR VK  +++I  + +         L +I  G  
Sbjct: 109 MNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQR 168
Query: 268 E-FYHPGKEYNVRVASRYFKGPELL-VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD 325
           +   H   +Y+V+V    +  PE+L  +LQ YD   D++S+G     +     PF    D
Sbjct: 169 QRVVHDFPKYSVKVLP--WLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPF---KD 223
Query: 326 NHDQLVKIAKVLGTDEL---NAYLNKYHLELDPQ--------LDALVGRHSRKPWSKFIN 374
                + + K+ GT       + +    L + P          D+L     R       +
Sbjct: 224 MPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPS 283
Query: 375 ADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV--RAAES 420
                  SP    F+++ L+ +   R +A   + H +F Q+  RA+E+
Sbjct: 284 HPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKRRASEA 331

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 52/233 (22%), Positives = 97/233 (41%), Gaps = 28/233 (12%)
Query: 122 GDQDDYEVVRK-------VGRGKYSEVFEGINVN-TNERCXXXXXXXXXXXXXXXXXXXL 173
           G   DYE+ R+       +G G++ +V +GI ++  N                      L
Sbjct: 3   GSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFL 62
Query: 174 QNLCGG-----PNVVKLLDIVRDQHSKTPS-LIFEYVNSTDFKVLYP----TLTDYDIRY 223
           Q          P++VKL+ ++    ++ P  +I E     + +        +L    +  
Sbjct: 63  QEALTMRQFDHPHIVKLIGVI----TENPVWIIMELCTLGELRSFLQVRKYSLDLASLIL 118
Query: 224 YIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASR 283
           Y Y+L  AL Y  S+  +HRD+   NV++      ++L D+GL+ +      Y       
Sbjct: 119 YAYQLSTALAYLESKRFVHRDIAARNVLVSSN-DCVKLGDFGLSRYMEDSTYYKASKGKL 177
Query: 284 YFK--GPELLVDLQDYDYSLDMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKI 333
             K   PE  ++ + +  + D+W  G CM+  ++   +P F G  N+D + +I
Sbjct: 178 PIKWMAPE-SINFRRFTSASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGRI 228

>pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 55/228 (24%), Positives = 96/228 (42%), Gaps = 28/228 (12%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELR--------KLRLIDWGLA 267
           + +  I Y +  +LKALDY H  G +HR VK  +++I  + +         L +I  G  
Sbjct: 125 MNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQR 184
Query: 268 E-FYHPGKEYNVRVASRYFKGPELL-VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD 325
           +   H   +Y+V+V    +  PE+L  +LQ YD   D++S+G     +     PF    D
Sbjct: 185 QRVVHDFPKYSVKVLP--WLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPF---KD 239
Query: 326 NHDQLVKIAKVLGTDEL---NAYLNKYHLELDPQ--------LDALVGRHSRKPWSKFIN 374
                + + K+ GT       + +    L + P          D+L     R       +
Sbjct: 240 MPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPS 299
Query: 375 ADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV--RAAES 420
                  SP    F+++ L+ +   R +A   + H +F Q+  RA+E+
Sbjct: 300 HPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKRRASEA 347

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 40/160 (25%), Positives = 74/160 (46%), Gaps = 31/160 (19%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRY-------YIYELLKAL 232
           PNV+K + ++     K  + I EY+     + +  ++   D +Y       +  ++   +
Sbjct: 67  PNVLKFIGVL--YKDKRLNFITEYIKGGTLRGIIKSM---DSQYPWSQRVSFAKDIASGM 121
Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-----EFYHP-----------GKEY 276
            Y HS  I+HRD+  HN ++  E + + + D+GLA     E   P            K Y
Sbjct: 122 AYLHSMNIIHRDLNSHNCLV-RENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRY 180
Query: 277 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFR 316
            V V + Y+  PE +++ + YD  +D++S G +   +I R
Sbjct: 181 TV-VGNPYWMAPE-MINGRSYDEKVDVFSFGIVLCEIIGR 218

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 37/153 (24%), Positives = 70/153 (45%), Gaps = 20/153 (13%)
Query: 180 PNVVKLLDI-VRDQHSKTPSLIFEYVNSTDFKVLY------PTLTDYDIRYYIYELLKAL 232
           PNV+ LL I +R + S  P ++  Y+   D +         PT+ D  +  +  ++ K +
Sbjct: 83  PNVLSLLGICLRSEGS--PLVVLPYMKHGDLRNFIRNETHNPTVKD--LIGFGLQVAKGM 138
Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA------EFYHPGKEYNVRVASRYFK 286
            Y  S+  +HRD+   N M+D +   +++ D+GLA      E+Y    +   ++  ++  
Sbjct: 139 KYLASKKFVHRDLAARNCMLDEKF-TVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 197
Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEP 319
              L    Q +    D+WS G +   ++ R  P
Sbjct: 198 LESL--QTQKFTTKSDVWSFGVLLWELMTRGAP 228

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 31/101 (30%), Positives = 53/101 (52%), Gaps = 11/101 (10%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA------EF 269
           +T  D+    Y+L + ++Y  SQ  +HRD+   NV++  E   +R+ D+GLA      ++
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV-TENNVMRIADFGLARDINNIDY 212
Query: 270 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMF 310
           Y   K  N R+  ++   PE L D + Y +  D+WS G + 
Sbjct: 213 YK--KTTNGRLPVKWM-APEALFD-RVYTHQSDVWSFGVLM 249

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 37/153 (24%), Positives = 70/153 (45%), Gaps = 20/153 (13%)
Query: 180 PNVVKLLDI-VRDQHSKTPSLIFEYVNSTDFKVLY------PTLTDYDIRYYIYELLKAL 232
           PNV+ LL I +R + S  P ++  Y+   D +         PT+ D  +  +  ++ K +
Sbjct: 91  PNVLSLLGICLRSEGS--PLVVLPYMKHGDLRNFIRNETHNPTVKD--LIGFGLQVAKGM 146
Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA------EFYHPGKEYNVRVASRYFK 286
            Y  S+  +HRD+   N M+D +   +++ D+GLA      E+Y    +   ++  ++  
Sbjct: 147 KYLASKKFVHRDLAARNCMLDEKF-TVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 205
Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEP 319
              L    Q +    D+WS G +   ++ R  P
Sbjct: 206 LESL--QTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 35/152 (23%), Positives = 68/152 (44%), Gaps = 18/152 (11%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY------PTLTDYDIRYYIYELLKALD 233
           PNV+ LL I   +   +P ++  Y+   D +         PT+ D  +  +  ++ K + 
Sbjct: 109 PNVLSLLGICL-RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD--LIGFGLQVAKGMK 165
Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA------EFYHPGKEYNVRVASRYFKG 287
           Y  S+  +HRD+   N M+D +   +++ D+GLA      E+Y    +   ++  ++   
Sbjct: 166 YLASKKFVHRDLAARNCMLDEKF-TVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL 224
Query: 288 PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEP 319
             L    Q +    D+WS G +   ++ R  P
Sbjct: 225 ESL--QTQKFTTKSDVWSFGVLLWELMTRGAP 254

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 37/153 (24%), Positives = 70/153 (45%), Gaps = 20/153 (13%)
Query: 180 PNVVKLLDI-VRDQHSKTPSLIFEYVNSTDFKVLY------PTLTDYDIRYYIYELLKAL 232
           PNV+ LL I +R + S  P ++  Y+   D +         PT+ D  +  +  ++ K +
Sbjct: 110 PNVLSLLGICLRSEGS--PLVVLPYMKHGDLRNFIRNETHNPTVKD--LIGFGLQVAKGM 165
Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA------EFYHPGKEYNVRVASRYFK 286
            Y  S+  +HRD+   N M+D +   +++ D+GLA      E+Y    +   ++  ++  
Sbjct: 166 KYLASKKFVHRDLAARNCMLDEKF-TVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 224
Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEP 319
              L    Q +    D+WS G +   ++ R  P
Sbjct: 225 LESL--QTQKFTTKSDVWSFGVLLWELMTRGAP 255

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 35/152 (23%), Positives = 68/152 (44%), Gaps = 18/152 (11%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY------PTLTDYDIRYYIYELLKALD 233
           PNV+ LL I   +   +P ++  Y+   D +         PT+ D  +  +  ++ K + 
Sbjct: 91  PNVLSLLGICL-RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD--LIGFGLQVAKGMK 147
Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA------EFYHPGKEYNVRVASRYFKG 287
           Y  S+  +HRD+   N M+D +   +++ D+GLA      E+Y    +   ++  ++   
Sbjct: 148 YLASKKFVHRDLAARNCMLDEKF-TVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL 206
Query: 288 PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEP 319
             L    Q +    D+WS G +   ++ R  P
Sbjct: 207 ESL--QTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 35/152 (23%), Positives = 68/152 (44%), Gaps = 18/152 (11%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY------PTLTDYDIRYYIYELLKALD 233
           PNV+ LL I   +   +P ++  Y+   D +         PT+ D  +  +  ++ K + 
Sbjct: 90  PNVLSLLGICL-RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD--LIGFGLQVAKGMK 146
Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA------EFYHPGKEYNVRVASRYFKG 287
           Y  S+  +HRD+   N M+D +   +++ D+GLA      E+Y    +   ++  ++   
Sbjct: 147 YLASKKFVHRDLAARNCMLDEKF-TVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL 205
Query: 288 PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEP 319
             L    Q +    D+WS G +   ++ R  P
Sbjct: 206 ESL--QTQKFTTKSDVWSFGVLLWELMTRGAP 235

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 37/153 (24%), Positives = 70/153 (45%), Gaps = 20/153 (13%)
Query: 180 PNVVKLLDI-VRDQHSKTPSLIFEYVNSTDFKVLY------PTLTDYDIRYYIYELLKAL 232
           PNV+ LL I +R + S  P ++  Y+   D +         PT+ D  +  +  ++ K +
Sbjct: 88  PNVLSLLGICLRSEGS--PLVVLPYMKHGDLRNFIRNETHNPTVKD--LIGFGLQVAKGM 143
Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA------EFYHPGKEYNVRVASRYFK 286
            Y  S+  +HRD+   N M+D +   +++ D+GLA      E+Y    +   ++  ++  
Sbjct: 144 KYLASKKFVHRDLAARNCMLDEKF-TVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 202
Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEP 319
              L    Q +    D+WS G +   ++ R  P
Sbjct: 203 LESL--QTQKFTTKSDVWSFGVLLWELMTRGAP 233

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 35/152 (23%), Positives = 68/152 (44%), Gaps = 18/152 (11%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY------PTLTDYDIRYYIYELLKALD 233
           PNV+ LL I   +   +P ++  Y+   D +         PT+ D  +  +  ++ K + 
Sbjct: 89  PNVLSLLGICL-RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD--LIGFGLQVAKGMK 145
Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA------EFYHPGKEYNVRVASRYFKG 287
           Y  S+  +HRD+   N M+D +   +++ D+GLA      E+Y    +   ++  ++   
Sbjct: 146 YLASKKFVHRDLAARNCMLDEKF-TVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL 204
Query: 288 PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEP 319
             L    Q +    D+WS G +   ++ R  P
Sbjct: 205 ESL--QTQKFTTKSDVWSFGVLLWELMTRGAP 234

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 89/205 (43%), Gaps = 22/205 (10%)
Query: 228 LLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 286
           ++K L Y   +  IMHRDVKP N++++    +++L D+G++         N  V +R + 
Sbjct: 140 VIKGLTYLREKHKIMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDSM-ANSFVGTRSYM 197
Query: 287 GPELLVDLQDYDYSL--DMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLG------ 338
            PE    LQ   YS+  D+WS+G     M   + P         +L+   +V G      
Sbjct: 198 SPE---RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETP 254
Query: 339 --TDELNAYLNKYHLELDPQLD--ALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLR 394
                    LNK+ ++  P +    L+     +P  K  +     + S E  DF++K L 
Sbjct: 255 PRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSG----VFSLEFQDFVNKCLI 310
Query: 395 YDHQDRLTAREAMAHPYFAQVRAAE 419
            +  +R   ++ M H +  +  A E
Sbjct: 311 KNPAERADLKQLMVHAFIKRSDAEE 335

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 35/152 (23%), Positives = 68/152 (44%), Gaps = 18/152 (11%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY------PTLTDYDIRYYIYELLKALD 233
           PNV+ LL I   +   +P ++  Y+   D +         PT+ D  +  +  ++ K + 
Sbjct: 86  PNVLSLLGICL-RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD--LIGFGLQVAKGMK 142
Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA------EFYHPGKEYNVRVASRYFKG 287
           Y  S+  +HRD+   N M+D +   +++ D+GLA      E+Y    +   ++  ++   
Sbjct: 143 YLASKKFVHRDLAARNCMLDEKF-TVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL 201
Query: 288 PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEP 319
             L    Q +    D+WS G +   ++ R  P
Sbjct: 202 ESL--QTQKFTTKSDVWSFGVLLWELMTRGAP 231

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/101 (29%), Positives = 53/101 (52%), Gaps = 11/101 (10%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA------EF 269
           +T  D+    Y+L + ++Y  SQ  +HRD+   NV++  E   +++ D+GLA      ++
Sbjct: 200 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV-TENNVMKIADFGLARDINNIDY 258
Query: 270 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMF 310
           Y   K  N R+  ++   PE L D + Y +  D+WS G + 
Sbjct: 259 YK--KTTNGRLPVKWM-APEALFD-RVYTHQSDVWSFGVLM 295

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 89/205 (43%), Gaps = 22/205 (10%)
Query: 228 LLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 286
           ++K L Y   +  IMHRDVKP N++++    +++L D+G++         N  V +R + 
Sbjct: 175 VIKGLTYLREKHKIMHRDVKPSNILVNSR-GEIKLCDFGVSGQLI-DSMANSFVGTRSYM 232
Query: 287 GPELLVDLQDYDYSL--DMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLG------ 338
            PE    LQ   YS+  D+WS+G     M   + P         +L+   +V G      
Sbjct: 233 SPE---RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETP 289
Query: 339 --TDELNAYLNKYHLELDPQLD--ALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLR 394
                    L+ Y ++  P +    L+     +P  K  +A    + S E  DF++K L 
Sbjct: 290 PRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSA----VFSLEFQDFVNKCLI 345
Query: 395 YDHQDRLTAREAMAHPYFAQVRAAE 419
            +  +R   ++ M H +  +  A E
Sbjct: 346 KNPAERADLKQLMVHAFIKRSDAEE 370

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 32/123 (26%), Positives = 60/123 (48%), Gaps = 10/123 (8%)
Query: 192 QHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM 251
           Q  + P L F +  S + +     L+  D+    Y++ + ++Y  S+  +HRD+   NV+
Sbjct: 126 QARRPPGLEFSFNPSHNPE---EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 182
Query: 252 IDHELRKLRLIDWGLAEFYH----PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLG 307
           +  +   +++ D+GLA   H      K  N R+  ++   PE L D + Y +  D+WS G
Sbjct: 183 VTED-NVMKIADFGLARDIHHIDXXKKTTNGRLPVKWM-APEALFD-RIYTHQSDVWSFG 239
Query: 308 CMF 310
            + 
Sbjct: 240 VLL 242

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 45/215 (20%), Positives = 89/215 (41%), Gaps = 53/215 (24%)
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELR----------KLRLI--DWG 265
           +Y+    + ++   + + HS  I+HRD+KP N+++    R           LR++  D+G
Sbjct: 132 EYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFG 191
Query: 266 LAEFYHPGK-----EYNVRVASRYFKGPELLVDL--QDYDYSLDMWSLGCMFAGMIFR-K 317
           L +    G+       N    +  ++ PELL +   +    S+D++S+GC+F  ++ + K
Sbjct: 192 LCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGK 251
Query: 318 EPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADN 377
            PF   +     +++   +   DE+                     H R           
Sbjct: 252 HPFGDKYSRESNIIR--GIFSLDEMKCL------------------HDRS---------- 281
Query: 378 QHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 412
              +  EA D + +++ +D   R TA + + HP F
Sbjct: 282 ---LIAEATDLISQMIDHDPLKRPTAMKVLRHPLF 313

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/210 (20%), Positives = 85/210 (40%), Gaps = 57/210 (27%)
Query: 227 ELLKALDYCHSQGIMHRDVKPHNVMIDHELR----------KLRLI--DWGLAEFYHPGK 274
           ++   + + HS  I+HRD+KP N+++    R           LR++  D+GL +    G+
Sbjct: 123 QIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQ 182
Query: 275 E-----YNVRVASRYFKGPELLVDLQDYDY------SLDMWSLGCMFAGMIFR-KEPFFY 322
                  N    +  ++ PELL +  +         S+D++S+GC+F  ++ + K PF  
Sbjct: 183 SSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD 242
Query: 323 GHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVS 382
            +     +++   +   DE+                     H R              + 
Sbjct: 243 KYSRESNIIR--GIFSLDEMKCL------------------HDRS-------------LI 269
Query: 383 PEAIDFLDKLLRYDHQDRLTAREAMAHPYF 412
            EA D + +++ +D   R TA + + HP F
Sbjct: 270 AEATDLISQMIDHDPLKRPTAMKVLRHPLF 299

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 39/162 (24%), Positives = 75/162 (46%), Gaps = 15/162 (9%)
Query: 180 PNVVKLLDIVRDQHSKTPS-LIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDY 234
           P++VKL+ ++    ++ P  +I E     + +        +L    +  Y Y+L  AL Y
Sbjct: 76  PHIVKLIGVI----TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAY 131
Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK--GPELLV 292
             S+  +HRD+   NV++      ++L D+GL+ +      Y         K   PE  +
Sbjct: 132 LESKRFVHRDIAARNVLVSSN-DCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE-SI 189
Query: 293 DLQDYDYSLDMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKI 333
           + + +  + D+W  G CM+  ++   +P F G  N+D + +I
Sbjct: 190 NFRRFTSASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGRI 230

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/210 (20%), Positives = 85/210 (40%), Gaps = 57/210 (27%)
Query: 227 ELLKALDYCHSQGIMHRDVKPHNVMIDHELR----------KLRLI--DWGLAEFYHPGK 274
           ++   + + HS  I+HRD+KP N+++    R           LR++  D+GL +    G+
Sbjct: 123 QIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQ 182
Query: 275 -----EYNVRVASRYFKGPELLVDLQDYDY------SLDMWSLGCMFAGMIFR-KEPFFY 322
                  N    +  ++ PELL +  +         S+D++S+GC+F  ++ + K PF  
Sbjct: 183 XXFRXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD 242
Query: 323 GHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVS 382
            +     +++   +   DE+                     H R              + 
Sbjct: 243 KYSRESNIIR--GIFSLDEMKCL------------------HDRS-------------LI 269
Query: 383 PEAIDFLDKLLRYDHQDRLTAREAMAHPYF 412
            EA D + +++ +D   R TA + + HP F
Sbjct: 270 AEATDLISQMIDHDPLKRPTAMKVLRHPLF 299

>pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 58/250 (23%), Positives = 99/250 (39%), Gaps = 62/250 (24%)
Query: 221 IRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMI---DHELRKL----------------- 259
           ++  I ++L+ LDY HS+  I+H D+KP N+++   D  +R++                 
Sbjct: 142 VKSIIRQVLQGLDYLHSKCKIIHTDIKPENILMCVDDAYVRRMAAEATEWQKAGAPPPSG 201
Query: 260 --------------------------RLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
                                     ++ D G A + H  K +   + +R ++  E+L+ 
Sbjct: 202 SAVSTAPAADLLVNPLDPRNADKIRVKIADLGNACWVH--KHFTEDIQTRQYRSIEVLIG 259
Query: 294 LQDYDYSLDMWSLGCM---FAGMIFRKEPFFYGHD---NHDQLVKIAKVLGTDELN-AYL 346
              Y    D+WS  CM    A   +  EP   G D   + D +  I ++LG+   + A  
Sbjct: 260 -AGYSTPADIWSTACMAFELATGDYLFEPH-SGEDYSRDEDHIAHIIELLGSIPRHFALS 317
Query: 347 NKYHLELDPQLDALVGRHSRKPWSKFINADNQ----HLVSPEAIDFLDKLLRYDHQDRLT 402
            KY  E   +   L      KPWS F     +    H  + +  DFL  +L    + R +
Sbjct: 318 GKYSREFFNRRGELRHITKLKPWSLFDVLVEKYGWPHEDAAQFTDFLIPMLEMVPEKRAS 377
Query: 403 AREAMAHPYF 412
           A E + HP+ 
Sbjct: 378 AGECLRHPWL 387

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 45/215 (20%), Positives = 89/215 (41%), Gaps = 53/215 (24%)
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELR----------KLRLI--DWG 265
           +Y+    + ++   + + HS  I+HRD+KP N+++    R           LR++  D+G
Sbjct: 132 EYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFG 191
Query: 266 LAEFYHPGK-----EYNVRVASRYFKGPELLVDL--QDYDYSLDMWSLGCMFAGMIFR-K 317
           L +    G+       N    +  ++ PELL +   +    S+D++S+GC+F  ++ + K
Sbjct: 192 LCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGK 251
Query: 318 EPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADN 377
            PF   +     +++   +   DE+                     H R           
Sbjct: 252 HPFGDKYSRESNIIR--GIFSLDEMKCL------------------HDRS---------- 281
Query: 378 QHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 412
              +  EA D + +++ +D   R TA + + HP F
Sbjct: 282 ---LIAEATDLISQMIDHDPLKRPTAMKVLRHPLF 313

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 49/220 (22%), Positives = 93/220 (42%), Gaps = 21/220 (9%)
Query: 128 EVVRKVGRGKYSEVFEGINVN-TNERCXXXXXXXXXXXXXXXXXXXLQNLCGG-----PN 181
           E+ R +G G++ +V +GI ++  N                      LQ          P+
Sbjct: 13  ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPH 72
Query: 182 VVKLLDIVRDQHSKTPS-LIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCH 236
           +VKL+ ++    ++ P  +I E     + +        +L    +  Y Y+L  AL Y  
Sbjct: 73  IVKLIGVI----TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 128
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK--GPELLVDL 294
           S+  +HRD+   NV++      ++L D+GL+ +      Y         K   PE  ++ 
Sbjct: 129 SKRFVHRDIAARNVLVSSN-DCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE-SINF 186
Query: 295 QDYDYSLDMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKI 333
           + +  + D+W  G CM+  ++   +P F G  N+D + +I
Sbjct: 187 RRFTSASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGRI 225

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 49/220 (22%), Positives = 93/220 (42%), Gaps = 21/220 (9%)
Query: 128 EVVRKVGRGKYSEVFEGINVN-TNERCXXXXXXXXXXXXXXXXXXXLQNLCGG-----PN 181
           E+ R +G G++ +V +GI ++  N                      LQ          P+
Sbjct: 41  ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPH 100
Query: 182 VVKLLDIVRDQHSKTPS-LIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCH 236
           +VKL+ ++    ++ P  +I E     + +        +L    +  Y Y+L  AL Y  
Sbjct: 101 IVKLIGVI----TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 156
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK--GPELLVDL 294
           S+  +HRD+   NV++      ++L D+GL+ +      Y         K   PE  ++ 
Sbjct: 157 SKRFVHRDIAARNVLVSSN-DCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE-SINF 214
Query: 295 QDYDYSLDMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKI 333
           + +  + D+W  G CM+  ++   +P F G  N+D + +I
Sbjct: 215 RRFTSASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGRI 253

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 39/162 (24%), Positives = 75/162 (46%), Gaps = 15/162 (9%)
Query: 180 PNVVKLLDIVRDQHSKTPS-LIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDY 234
           P++VKL+ ++    ++ P  +I E     + +        +L    +  Y Y+L  AL Y
Sbjct: 73  PHIVKLIGVI----TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAY 128
Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK--GPELLV 292
             S+  +HRD+   NV++      ++L D+GL+ +      Y         K   PE  +
Sbjct: 129 LESKRFVHRDIAARNVLVSSN-DCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE-SI 186
Query: 293 DLQDYDYSLDMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKI 333
           + + +  + D+W  G CM+  ++   +P F G  N+D + +I
Sbjct: 187 NFRRFTSASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGRI 227

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 30/101 (29%), Positives = 53/101 (52%), Gaps = 11/101 (10%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA------EF 269
           +T  D+    Y+L + ++Y  SQ  +HRD+   NV++  E   +++ D+GLA      ++
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV-TENNVMKIADFGLARDINNIDY 212
Query: 270 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMF 310
           Y   K  N R+  ++   PE L D + Y +  D+WS G + 
Sbjct: 213 YK--KTTNGRLPVKWM-APEALFD-RVYTHQSDVWSFGVLM 249

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 49/220 (22%), Positives = 93/220 (42%), Gaps = 21/220 (9%)
Query: 128 EVVRKVGRGKYSEVFEGINVN-TNERCXXXXXXXXXXXXXXXXXXXLQNLCGG-----PN 181
           E+ R +G G++ +V +GI ++  N                      LQ          P+
Sbjct: 13  ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPH 72
Query: 182 VVKLLDIVRDQHSKTPS-LIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCH 236
           +VKL+ ++    ++ P  +I E     + +        +L    +  Y Y+L  AL Y  
Sbjct: 73  IVKLIGVI----TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 128
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK--GPELLVDL 294
           S+  +HRD+   NV++      ++L D+GL+ +      Y         K   PE  ++ 
Sbjct: 129 SKRFVHRDIAARNVLVSSN-DCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE-SINF 186
Query: 295 QDYDYSLDMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKI 333
           + +  + D+W  G CM+  ++   +P F G  N+D + +I
Sbjct: 187 RRFTSASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGRI 225

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 49/220 (22%), Positives = 93/220 (42%), Gaps = 21/220 (9%)
Query: 128 EVVRKVGRGKYSEVFEGINVN-TNERCXXXXXXXXXXXXXXXXXXXLQNLCGG-----PN 181
           E+ R +G G++ +V +GI ++  N                      LQ          P+
Sbjct: 10  ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPH 69
Query: 182 VVKLLDIVRDQHSKTPS-LIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCH 236
           +VKL+ ++    ++ P  +I E     + +        +L    +  Y Y+L  AL Y  
Sbjct: 70  IVKLIGVI----TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 125
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK--GPELLVDL 294
           S+  +HRD+   NV++      ++L D+GL+ +      Y         K   PE  ++ 
Sbjct: 126 SKRFVHRDIAARNVLVSSN-DCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE-SINF 183
Query: 295 QDYDYSLDMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKI 333
           + +  + D+W  G CM+  ++   +P F G  N+D + +I
Sbjct: 184 RRFTSASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGRI 222

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/108 (25%), Positives = 59/108 (54%), Gaps = 9/108 (8%)
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF---YHPGKEYNVRVASRYFK 286
           + +DY H++ I+HRD+K +N+ + HE   +++ D+GLA     +    ++     S  + 
Sbjct: 117 QGMDYLHAKSIIHRDLKSNNIFL-HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM 175
Query: 287 GPELLVDLQD---YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
            PE ++ +QD   Y +  D+++ G +   ++  + P +   +N DQ++
Sbjct: 176 APE-VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP-YSNINNRDQII 221

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 30/101 (29%), Positives = 53/101 (52%), Gaps = 11/101 (10%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA------EF 269
           +T  D+    Y+L + ++Y  SQ  +HRD+   NV++  E   +++ D+GLA      ++
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV-TENNVMKIADFGLARDINNIDY 212
Query: 270 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMF 310
           Y   K  N R+  ++   PE L D + Y +  D+WS G + 
Sbjct: 213 YK--KTTNGRLPVKWM-APEALFD-RVYTHQSDVWSFGVLM 249

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/108 (25%), Positives = 59/108 (54%), Gaps = 9/108 (8%)
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF---YHPGKEYNVRVASRYFK 286
           + +DY H++ I+HRD+K +N+ + HE   +++ D+GLA     +    ++     S  + 
Sbjct: 120 QGMDYLHAKSIIHRDLKSNNIFL-HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM 178
Query: 287 GPELLVDLQD---YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
            PE ++ +QD   Y +  D+++ G +   ++  + P +   +N DQ++
Sbjct: 179 APE-VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP-YSNINNRDQII 224

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 30/101 (29%), Positives = 53/101 (52%), Gaps = 11/101 (10%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA------EF 269
           +T  D+    Y+L + ++Y  SQ  +HRD+   NV++  E   +++ D+GLA      ++
Sbjct: 146 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV-TENNVMKIADFGLARDINNIDY 204
Query: 270 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMF 310
           Y   K  N R+  ++   PE L D + Y +  D+WS G + 
Sbjct: 205 YK--KTTNGRLPVKWM-APEALFD-RVYTHQSDVWSFGVLM 241

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 30/101 (29%), Positives = 53/101 (52%), Gaps = 11/101 (10%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA------EF 269
           +T  D+    Y+L + ++Y  SQ  +HRD+   NV++  E   +++ D+GLA      ++
Sbjct: 141 MTFKDLVSCTYQLARGMEYLASQKCIHRDLTARNVLV-TENNVMKIADFGLARDINNIDY 199
Query: 270 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMF 310
           Y   K  N R+  ++   PE L D + Y +  D+WS G + 
Sbjct: 200 YK--KTTNGRLPVKWM-APEALFD-RVYTHQSDVWSFGVLM 236

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 30/101 (29%), Positives = 53/101 (52%), Gaps = 11/101 (10%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA------EF 269
           +T  D+    Y+L + ++Y  SQ  +HRD+   NV++  E   +++ D+GLA      ++
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV-TENNVMKIADFGLARDINNIDY 212
Query: 270 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMF 310
           Y   K  N R+  ++   PE L D + Y +  D+WS G + 
Sbjct: 213 YK--KTTNGRLPVKWM-APEALFD-RVYTHQSDVWSFGVLM 249

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 30/101 (29%), Positives = 53/101 (52%), Gaps = 11/101 (10%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA------EF 269
           +T  D+    Y+L + ++Y  SQ  +HRD+   NV++  E   +++ D+GLA      ++
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV-TENNVMKIADFGLARDINNIDY 212
Query: 270 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMF 310
           Y   K  N R+  ++   PE L D + Y +  D+WS G + 
Sbjct: 213 YK--KTTNGRLPVKWM-APEALFD-RVYTHQSDVWSFGVLM 249

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/108 (25%), Positives = 59/108 (54%), Gaps = 9/108 (8%)
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF---YHPGKEYNVRVASRYFK 286
           + +DY H++ I+HRD+K +N+ + HE   +++ D+GLA     +    ++     S  + 
Sbjct: 115 QGMDYLHAKSIIHRDLKSNNIFL-HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM 173
Query: 287 GPELLVDLQD---YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
            PE ++ +QD   Y +  D+++ G +   ++  + P +   +N DQ++
Sbjct: 174 APE-VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP-YSNINNRDQII 219

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/229 (22%), Positives = 96/229 (41%), Gaps = 28/229 (12%)
Query: 126 DYEVVRK-------VGRGKYSEVFEGINVN-TNERCXXXXXXXXXXXXXXXXXXXLQNLC 177
           DYE+ R+       +G G++ +V +GI ++  N                      LQ   
Sbjct: 384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEAL 443
Query: 178 GG-----PNVVKLLDIVRDQHSKTPS-LIFEYVNSTDFKVLYP----TLTDYDIRYYIYE 227
                  P++VKL+ ++    ++ P  +I E     + +        +L    +  Y Y+
Sbjct: 444 TMRQFDHPHIVKLIGVI----TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQ 499
Query: 228 LLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK- 286
           L  AL Y  S+  +HRD+   NV++      ++L D+GL+ +      Y         K 
Sbjct: 500 LSTALAYLESKRFVHRDIAARNVLVSSN-DCVKLGDFGLSRYMEDSTYYKASKGKLPIKW 558
Query: 287 -GPELLVDLQDYDYSLDMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKI 333
             PE  ++ + +  + D+W  G CM+  ++   +P F G  N+D + +I
Sbjct: 559 MAPE-SINFRRFTSASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGRI 605

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/108 (25%), Positives = 59/108 (54%), Gaps = 9/108 (8%)
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF---YHPGKEYNVRVASRYFK 286
           + +DY H++ I+HRD+K +N+ + HE   +++ D+GLA     +    ++     S  + 
Sbjct: 115 QGMDYLHAKSIIHRDLKSNNIFL-HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM 173
Query: 287 GPELLVDLQD---YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
            PE ++ +QD   Y +  D+++ G +   ++  + P +   +N DQ++
Sbjct: 174 APE-VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP-YSNINNRDQII 219

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 30/101 (29%), Positives = 53/101 (52%), Gaps = 11/101 (10%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA------EF 269
           +T  D+    Y+L + ++Y  SQ  +HRD+   NV++  E   +++ D+GLA      ++
Sbjct: 143 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV-TENNVMKIADFGLARDINNIDY 201
Query: 270 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMF 310
           Y   K  N R+  ++   PE L D + Y +  D+WS G + 
Sbjct: 202 YK--KTTNGRLPVKWM-APEALFD-RVYTHQSDVWSFGVLM 238

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/108 (25%), Positives = 59/108 (54%), Gaps = 9/108 (8%)
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF---YHPGKEYNVRVASRYFK 286
           + +DY H++ I+HRD+K +N+ + HE   +++ D+GLA     +    ++     S  + 
Sbjct: 120 QGMDYLHAKSIIHRDLKSNNIFL-HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM 178
Query: 287 GPELLVDLQD---YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
            PE ++ +QD   Y +  D+++ G +   ++  + P +   +N DQ++
Sbjct: 179 APE-VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP-YSNINNRDQII 224

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 27/108 (25%), Positives = 59/108 (54%), Gaps = 9/108 (8%)
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF---YHPGKEYNVRVASRYFK 286
           + +DY H++ I+HRD+K +N+ + HE   +++ D+GLA     +    ++     S  + 
Sbjct: 142 QGMDYLHAKSIIHRDLKSNNIFL-HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM 200
Query: 287 GPELLVDLQD---YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
            PE ++ +QD   Y +  D+++ G +   ++  + P +   +N DQ++
Sbjct: 201 APE-VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP-YSNINNRDQII 246

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 31/102 (30%), Positives = 51/102 (50%), Gaps = 8/102 (7%)
Query: 228 LLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 286
           ++K L Y   +  IMHRDVKP N++++    +++L D+G++         N  V +R + 
Sbjct: 132 VIKGLTYLREKHKIMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDSMA-NSFVGTRSYM 189
Query: 287 GPELLVDLQDYDYSL--DMWSLGCMFAGMIFRKEPFFYGHDN 326
            PE    LQ   YS+  D+WS+G     M   + P   G  +
Sbjct: 190 SPE---RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIGSGSGS 228

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 30/101 (29%), Positives = 53/101 (52%), Gaps = 11/101 (10%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA------EF 269
           +T  D+    Y+L + ++Y  SQ  +HRD+   NV++  E   +++ D+GLA      ++
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV-TENNVMKIADFGLARDINNIDY 212
Query: 270 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMF 310
           Y   K  N R+  ++   PE L D + Y +  D+WS G + 
Sbjct: 213 YK--KTTNGRLPVKWM-APEALFD-RVYTHQSDVWSFGVLM 249

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 49/220 (22%), Positives = 93/220 (42%), Gaps = 21/220 (9%)
Query: 128 EVVRKVGRGKYSEVFEGINVN-TNERCXXXXXXXXXXXXXXXXXXXLQNLCGG-----PN 181
           E+ R +G G++ +V +GI ++  N                      LQ          P+
Sbjct: 13  ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPH 72
Query: 182 VVKLLDIVRDQHSKTPS-LIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCH 236
           +VKL+ ++    ++ P  +I E     + +        +L    +  Y Y+L  AL Y  
Sbjct: 73  IVKLIGVI----TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE 128
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK--GPELLVDL 294
           S+  +HRD+   NV++      ++L D+GL+ +      Y         K   PE  ++ 
Sbjct: 129 SKRFVHRDIAARNVLVSAT-DCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE-SINF 186
Query: 295 QDYDYSLDMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKI 333
           + +  + D+W  G CM+  ++   +P F G  N+D + +I
Sbjct: 187 RRFTSASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGRI 225

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 27/108 (25%), Positives = 59/108 (54%), Gaps = 9/108 (8%)
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF---YHPGKEYNVRVASRYFK 286
           + +DY H++ I+HRD+K +N+ + HE   +++ D+GLA     +    ++     S  + 
Sbjct: 143 QGMDYLHAKSIIHRDLKSNNIFL-HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM 201
Query: 287 GPELLVDLQD---YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
            PE ++ +QD   Y +  D+++ G +   ++  + P +   +N DQ++
Sbjct: 202 APE-VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP-YSNINNRDQII 247

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 51/229 (22%), Positives = 96/229 (41%), Gaps = 28/229 (12%)
Query: 126 DYEVVRK-------VGRGKYSEVFEGINVN-TNERCXXXXXXXXXXXXXXXXXXXLQNLC 177
           DYE+ R+       +G G++ +V +GI ++  N                      LQ   
Sbjct: 384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEAL 443
Query: 178 GG-----PNVVKLLDIVRDQHSKTPS-LIFEYVNSTDFKVLYP----TLTDYDIRYYIYE 227
                  P++VKL+ ++    ++ P  +I E     + +        +L    +  Y Y+
Sbjct: 444 TMRQFDHPHIVKLIGVI----TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQ 499
Query: 228 LLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK- 286
           L  AL Y  S+  +HRD+   NV++      ++L D+GL+ +      Y         K 
Sbjct: 500 LSTALAYLESKRFVHRDIAARNVLVS-ATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKW 558
Query: 287 -GPELLVDLQDYDYSLDMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKI 333
             PE  ++ + +  + D+W  G CM+  ++   +P F G  N+D + +I
Sbjct: 559 MAPE-SINFRRFTSASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGRI 605

>pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 55/252 (21%), Positives = 95/252 (37%), Gaps = 64/252 (25%)
Query: 221 IRYYIYELLKALDYCHSQG-IMHRDVKPHNVMI--------------------------- 252
           ++  I ++L+ LDY H++  I+H D+KP N+++                           
Sbjct: 132 VKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSG 191
Query: 253 ---------------------DHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 291
                                + E  K+++ D G A + H  K +   + +R ++  E+L
Sbjct: 192 SAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVH--KHFTEDIQTRQYRSLEVL 249
Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD------NHDQLVKIAKVLGTDELNAY 345
           +    Y+   D+WS  CM A  +   +  F  H       + D +  I ++LG       
Sbjct: 250 IG-SGYNTPADIWSTACM-AFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLI 307
Query: 346 L-NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEA----IDFLDKLLRYDHQDR 400
           +  KY  E   +   L      KPW  F     ++  S E      DFL  +L    + R
Sbjct: 308 VAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKR 367
Query: 401 LTAREAMAHPYF 412
            TA E + HP+ 
Sbjct: 368 ATAAECLRHPWL 379

>pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 55/252 (21%), Positives = 95/252 (37%), Gaps = 64/252 (25%)
Query: 221 IRYYIYELLKALDYCHSQG-IMHRDVKPHNVMI--------------------------- 252
           ++  I ++L+ LDY H++  I+H D+KP N+++                           
Sbjct: 148 VKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSG 207
Query: 253 ---------------------DHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 291
                                + E  K+++ D G A + H  K +   + +R ++  E+L
Sbjct: 208 SAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVH--KHFTEDIQTRQYRSLEVL 265
Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD------NHDQLVKIAKVLGTDELNAY 345
           +    Y+   D+WS  CM A  +   +  F  H       + D +  I ++LG       
Sbjct: 266 IG-SGYNTPADIWSTACM-AFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLI 323
Query: 346 L-NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEA----IDFLDKLLRYDHQDR 400
           +  KY  E   +   L      KPW  F     ++  S E      DFL  +L    + R
Sbjct: 324 VAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKR 383
Query: 401 LTAREAMAHPYF 412
            TA E + HP+ 
Sbjct: 384 ATAAECLRHPWL 395

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 29/99 (29%), Positives = 51/99 (51%), Gaps = 7/99 (7%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH---- 271
           +T  D+    Y+L + ++Y  SQ  +HRD+   NV++  E   +++ D+GLA   +    
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV-TENNVMKIADFGLARDINNIDX 212
Query: 272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMF 310
             K  N R+  ++   PE L D + Y +  D+WS G + 
Sbjct: 213 XKKTTNGRLPVKWM-APEALFD-RVYTHQSDVWSFGVLM 249

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 32/123 (26%), Positives = 60/123 (48%), Gaps = 10/123 (8%)
Query: 192 QHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM 251
           Q  + P L + Y  S + +     L+  D+    Y++ + ++Y  S+  +HRD+   NV+
Sbjct: 118 QARRPPGLEYSYNPSHNPE---EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 174
Query: 252 IDHELRKLRLIDWGLAEFYHP----GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLG 307
           +  +   +++ D+GLA   H      K  N R+  ++   PE L D + Y +  D+WS G
Sbjct: 175 VTED-NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWM-APEALFD-RIYTHQSDVWSFG 231
Query: 308 CMF 310
            + 
Sbjct: 232 VLL 234

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 27/108 (25%), Positives = 59/108 (54%), Gaps = 9/108 (8%)
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA---EFYHPGKEYNVRVASRYFK 286
           + +DY H++ I+HRD+K +N+ + HE   +++ D+GLA     +    ++     S  + 
Sbjct: 115 QGMDYLHAKSIIHRDLKSNNIFL-HEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWM 173
Query: 287 GPELLVDLQD---YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
            PE ++ +QD   Y +  D+++ G +   ++  + P +   +N DQ++
Sbjct: 174 APE-VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP-YSNINNRDQII 219

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 32/123 (26%), Positives = 60/123 (48%), Gaps = 10/123 (8%)
Query: 192 QHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM 251
           Q  + P L + Y  S + +     L+  D+    Y++ + ++Y  S+  +HRD+   NV+
Sbjct: 126 QARRPPGLEYSYNPSHNPE---EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 182
Query: 252 IDHELRKLRLIDWGLAEFYHP----GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLG 307
           +  +   +++ D+GLA   H      K  N R+  ++   PE L D + Y +  D+WS G
Sbjct: 183 VTED-NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWM-APEALFD-RIYTHQSDVWSFG 239
Query: 308 CMF 310
            + 
Sbjct: 240 VLL 242

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 32/123 (26%), Positives = 60/123 (48%), Gaps = 10/123 (8%)
Query: 192 QHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM 251
           Q  + P L + Y  S + +     L+  D+    Y++ + ++Y  S+  +HRD+   NV+
Sbjct: 119 QARRPPGLEYSYNPSHNPE---EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 175
Query: 252 IDHELRKLRLIDWGLAEFYHP----GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLG 307
           +  +   +++ D+GLA   H      K  N R+  ++   PE L D + Y +  D+WS G
Sbjct: 176 VTED-NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWM-APEALFD-RIYTHQSDVWSFG 232
Query: 308 CMF 310
            + 
Sbjct: 233 VLL 235

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 52/94 (55%), Gaps = 12/94 (12%)
Query: 234 YCHSQG----IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK---EYNVRVASRYFK 286
           +C  +G    I HRD K  NV++  +L  + L D+GLA  + PGK   + + +V +R + 
Sbjct: 134 WCRGEGHKPSIAHRDFKSKNVLLKSDLTAV-LADFGLAVRFEPGKPPGDTHGQVGTRRYM 192
Query: 287 GPELL---VDLQ-DYDYSLDMWSLGCMFAGMIFR 316
            PE+L   ++ Q D    +DM+++G +   ++ R
Sbjct: 193 APEVLEGAINFQRDAFLRIDMYAMGLVLWELVSR 226

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 27/108 (25%), Positives = 59/108 (54%), Gaps = 9/108 (8%)
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA---EFYHPGKEYNVRVASRYFK 286
           + +DY H++ I+HRD+K +N+ + HE   +++ D+GLA     +    ++     S  + 
Sbjct: 135 QGMDYLHAKSIIHRDLKSNNIFL-HEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWM 193
Query: 287 GPELLVDLQD---YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
            PE ++ +QD   Y +  D+++ G +   ++  + P +   +N DQ++
Sbjct: 194 APE-VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP-YSNINNRDQII 239

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 32/123 (26%), Positives = 60/123 (48%), Gaps = 10/123 (8%)
Query: 192 QHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM 251
           Q  + P L + Y  S + +     L+  D+    Y++ + ++Y  S+  +HRD+   NV+
Sbjct: 115 QARRPPGLEYSYNPSHNPE---EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 171
Query: 252 IDHELRKLRLIDWGLAEFYHP----GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLG 307
           +  +   +++ D+GLA   H      K  N R+  ++   PE L D + Y +  D+WS G
Sbjct: 172 VTED-NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWM-APEALFD-RIYTHQSDVWSFG 228
Query: 308 CMF 310
            + 
Sbjct: 229 VLL 231

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 27/108 (25%), Positives = 59/108 (54%), Gaps = 9/108 (8%)
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA---EFYHPGKEYNVRVASRYFK 286
           + +DY H++ I+HRD+K +N+ + HE   +++ D+GLA     +    ++     S  + 
Sbjct: 143 QGMDYLHAKSIIHRDLKSNNIFL-HEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWM 201
Query: 287 GPELLVDLQD---YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
            PE ++ +QD   Y +  D+++ G +   ++  + P +   +N DQ++
Sbjct: 202 APE-VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP-YSNINNRDQII 247

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 29/99 (29%), Positives = 51/99 (51%), Gaps = 7/99 (7%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH---- 271
           +T  D+    Y+L + ++Y  SQ  +HRD+   NV++  E   +++ D+GLA   +    
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV-TENNVMKIADFGLARDINNIDX 212
Query: 272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMF 310
             K  N R+  ++   PE L D + Y +  D+WS G + 
Sbjct: 213 XKKTTNGRLPVKWM-APEALFD-RVYTHQSDVWSFGVLM 249

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 46/218 (21%), Positives = 88/218 (40%), Gaps = 28/218 (12%)
Query: 131 RKVGRGKYSEVFEGINVNTNE---RCXXXXXXXXXXXXXXXXXXXLQNLCGG---PNVVK 184
           R +G+G +  V+ G  ++  +   +C                      L  G   PNV+ 
Sbjct: 27  RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 185 LLDIVRDQHSKTPSLIFEYVNSTDFKVLY------PTLTDYDIRYYIYELLKALDYCHSQ 238
           L+ I+       P ++  Y+   D           PT+ D  +  +  ++ + ++Y   Q
Sbjct: 87  LIGIMLPPEG-LPHVLLPYMCHGDLLQFIRSPQRNPTVKD--LISFGLQVARGMEYLAEQ 143
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLA------EFYHPGKEYNVRVASRYFKGPELLV 292
             +HRD+   N M+D     +++ D+GLA      E+Y   +  + R+  ++      L 
Sbjct: 144 KFVHRDLAARNCMLDESF-TVKVADFGLARDILDREYYSVQQHRHARLPVKWTA----LE 198
Query: 293 DLQDYDYSL--DMWSLGCMFAGMIFRKEPFFYGHDNHD 328
            LQ Y ++   D+WS G +   ++ R  P +   D  D
Sbjct: 199 SLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD 236

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 87/209 (41%), Gaps = 30/209 (14%)
Query: 228 LLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 286
           ++K L Y   +  IMHRDVKP N++++    +++L D+G++         N  V +R + 
Sbjct: 113 VIKGLTYLREKHKIMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDSMA-NSFVGTRSYM 170
Query: 287 GPELLVDLQDYDYSL--DMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLG------ 338
            PE    LQ   YS+  D+WS+G     M   + P         +L+   +V G      
Sbjct: 171 SPE---RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETP 227
Query: 339 --TDELNAYLNKYHLELDPQ------LDALVGRHSRKPWSKFINADNQHLVSPEAIDFLD 390
                    L+ Y ++  P       LD +V     K  S   + + Q        DF++
Sbjct: 228 PRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQ--------DFVN 279
Query: 391 KLLRYDHQDRLTAREAMAHPYFAQVRAAE 419
           K L  +  +R   ++ M H +  +  A E
Sbjct: 280 KCLIKNPAERADLKQLMVHAFIKRSDAEE 308

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 32/123 (26%), Positives = 60/123 (48%), Gaps = 10/123 (8%)
Query: 192 QHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM 251
           Q  + P L + Y  S + +     L+  D+    Y++ + ++Y  S+  +HRD+   NV+
Sbjct: 167 QARRPPGLEYSYNPSHNPE---EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 223
Query: 252 IDHELRKLRLIDWGLAEFYHP----GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLG 307
           +  +   +++ D+GLA   H      K  N R+  ++   PE L D + Y +  D+WS G
Sbjct: 224 VTED-NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWM-APEALFD-RIYTHQSDVWSFG 280
Query: 308 CMF 310
            + 
Sbjct: 281 VLL 283

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 43/187 (22%), Positives = 74/187 (39%), Gaps = 14/187 (7%)
Query: 132 KVGRGKYSEVFEGINVNTNERCX--XXXXXXXXXXXXXXXXXXLQNLCG--GPNVVKLLD 187
           ++GRG +  V++G++  T                          + L G   PN+V+  D
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYD 92
Query: 188 IVRD--QHSKTPSLIFEYVNSTDFKVLYPTLTDYDI---RYYIYELLKALDYCHSQG--I 240
                 +  K   L+ E   S   K          I   R +  ++LK L + H++   I
Sbjct: 93  SWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQILKGLQFLHTRTPPI 152
Query: 241 MHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYS 300
           +HRD+K  N+ I      +++ D GLA          V + +  F  PE     + YD S
Sbjct: 153 IHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAV-IGTPEFXAPEXYE--EKYDES 209
Query: 301 LDMWSLG 307
           +D+++ G
Sbjct: 210 VDVYAFG 216

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 27/99 (27%), Positives = 51/99 (51%), Gaps = 7/99 (7%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP--- 272
           L+  D+    Y++ + ++Y  S+  +HRD+   NV++  +   +++ D+GLA   H    
Sbjct: 132 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTED-NVMKIADFGLARDIHHIDY 190
Query: 273 -GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMF 310
             K  N R+  ++   PE L D + Y +  D+WS G + 
Sbjct: 191 YKKTTNGRLPVKWM-APEALFD-RIYTHQSDVWSFGVLL 227

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 87/209 (41%), Gaps = 30/209 (14%)
Query: 228 LLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 286
           ++K L Y   +  IMHRDVKP N++++    +++L D+G++         N  V +R + 
Sbjct: 113 VIKGLTYLREKHKIMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDSMA-NSFVGTRSYM 170
Query: 287 GPELLVDLQDYDYSL--DMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLG------ 338
            PE    LQ   YS+  D+WS+G     M   + P         +L+   +V G      
Sbjct: 171 SPE---RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETP 227
Query: 339 --TDELNAYLNKYHLELDPQ------LDALVGRHSRKPWSKFINADNQHLVSPEAIDFLD 390
                    L+ Y ++  P       LD +V     K  S   + + Q        DF++
Sbjct: 228 PRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQ--------DFVN 279
Query: 391 KLLRYDHQDRLTAREAMAHPYFAQVRAAE 419
           K L  +  +R   ++ M H +  +  A E
Sbjct: 280 KCLIKNPAERADLKQLMVHAFIKRSDAEE 308

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 56/250 (22%), Positives = 100/250 (40%), Gaps = 45/250 (18%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDF---KVLYPTLTDYDIRYYIYELL------- 229
           PN+++L  +V +     P +I      T+F     L   L   D ++ + +L+       
Sbjct: 77  PNIIRLEGVVTNS---MPVMIL-----TEFMENGALDSFLRLNDGQFTVIQLVGMLRGIA 128
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK--- 286
             + Y      +HRD+   N++++  L   ++ D+GL+ F           +S   K   
Sbjct: 129 SGMRYLAEMSYVHRDLAARNILVNSNL-VCKVSDFGLSRFLEENSSDPTETSSLGGKIPI 187
Query: 287 ---GPELLVDLQDYDYSLDMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDEL 342
               PE +   + +  + D WS G  M+  M F + P++   D  +Q          D +
Sbjct: 188 RWTAPEAIA-FRKFTSASDAWSYGIVMWEVMSFGERPYW---DMSNQ----------DVI 233
Query: 343 NAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT 402
           NA    Y L   P     + +     W K  NA  +    P+ +  LDK++R     ++ 
Sbjct: 234 NAIEQDYRLPPPPDCPTSLHQLMLDCWQKDRNARPRF---PQVVSALDKMIRNPASLKIV 290
Query: 403 ARE--AMAHP 410
           ARE    +HP
Sbjct: 291 ARENGGASHP 300

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 32/123 (26%), Positives = 60/123 (48%), Gaps = 10/123 (8%)
Query: 192 QHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM 251
           Q  + P L + Y  S + +     L+  D+    Y++ + ++Y  S+  +HRD+   NV+
Sbjct: 126 QAREPPGLEYSYNPSHNPE---EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 182
Query: 252 IDHELRKLRLIDWGLAEFYHP----GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLG 307
           +  +   +++ D+GLA   H      K  N R+  ++   PE L D + Y +  D+WS G
Sbjct: 183 VTED-NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWM-APEALFD-RIYTHQSDVWSFG 239
Query: 308 CMF 310
            + 
Sbjct: 240 VLL 242

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 86/205 (41%), Gaps = 22/205 (10%)
Query: 228 LLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 286
           ++K L Y   +  IMHRDVKP N++++    +++L D+G++         N  V +R + 
Sbjct: 113 VIKGLTYLREKHKIMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDSMA-NSFVGTRSYM 170
Query: 287 GPELLVDLQDYDYSL--DMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA 344
            PE    LQ   YS+  D+WS+G     M   + P         +L+   +V G    +A
Sbjct: 171 SPE---RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEG----DA 223
Query: 345 YLNKYHLELDPQLDALVGRHSRKPWSKFINAD----------NQHLVSPEAIDFLDKLLR 394
                      +  +  G  SR P + F   D             + S E  DF++K L 
Sbjct: 224 AETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLI 283
Query: 395 YDHQDRLTAREAMAHPYFAQVRAAE 419
            +  +R   ++ M H +  +  A E
Sbjct: 284 KNPAERADLKQLMVHAFIKRSDAEE 308

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 86/205 (41%), Gaps = 22/205 (10%)
Query: 228 LLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 286
           ++K L Y   +  IMHRDVKP N++++    +++L D+G++         N  V +R + 
Sbjct: 113 VIKGLTYLREKHKIMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDSMA-NSFVGTRSYM 170
Query: 287 GPELLVDLQDYDYSL--DMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA 344
            PE    LQ   YS+  D+WS+G     M   + P         +L+   +V G    +A
Sbjct: 171 SPE---RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEG----DA 223
Query: 345 YLNKYHLELDPQLDALVGRHSRKPWSKFINAD----------NQHLVSPEAIDFLDKLLR 394
                      +  +  G  SR P + F   D             + S E  DF++K L 
Sbjct: 224 AETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLI 283
Query: 395 YDHQDRLTAREAMAHPYFAQVRAAE 419
            +  +R   ++ M H +  +  A E
Sbjct: 284 KNPAERADLKQLMVHAFIKRSDAEE 308

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 36/134 (26%), Positives = 61/134 (45%), Gaps = 15/134 (11%)
Query: 185 LLDIVRDQHSKTPSLIFEYVNST------DFKVLYPTLTDYDIRYYIYELLKALDYCHSQ 238
           LL+ +R +  K      EY N        D  VL    T  D+  + Y++ K +++   +
Sbjct: 136 LLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL----TFEDLLCFAYQVAKGMEFLEFK 191
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY---FKGPELLVDLQ 295
             +HRD+   NV++ H  + +++ D+GLA        Y VR  +R    +  PE L +  
Sbjct: 192 SCVHRDLAARNVLVTHG-KVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE-G 249
Query: 296 DYDYSLDMWSLGCM 309
            Y    D+WS G +
Sbjct: 250 IYTIKSDVWSYGIL 263

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 49/96 (51%), Gaps = 8/96 (8%)
Query: 228 LLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 286
           ++K L Y   +  IMHRDVKP N++++    +++L D+G++         N  V +R + 
Sbjct: 113 VIKGLTYLREKHKIMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDSMA-NSFVGTRSYM 170
Query: 287 GPELLVDLQDYDYSL--DMWSLGCMFAGMIFRKEPF 320
            PE    LQ   YS+  D+WS+G     M   + P 
Sbjct: 171 SPE---RLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 27/99 (27%), Positives = 51/99 (51%), Gaps = 7/99 (7%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP--- 272
           L+  D+    Y++ + ++Y  S+  +HRD+   NV++  +   +++ D+GLA   H    
Sbjct: 147 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTED-NVMKIADFGLARDIHHIDY 205
Query: 273 -GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMF 310
             K  N R+  ++   PE L D + Y +  D+WS G + 
Sbjct: 206 YKKTTNGRLPVKWM-APEALFD-RIYTHQSDVWSFGVLL 242

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 48/224 (21%), Positives = 94/224 (41%), Gaps = 21/224 (9%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVN-TNERCXXXXXXXXXXXXXXXXXXXLQNLCGG--- 179
           ++  E+ R +G G++ +V +GI ++  N                      LQ        
Sbjct: 9   RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQF 68
Query: 180 --PNVVKLLDIVRDQHSKTPS-LIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKAL 232
             P++VKL+ ++    ++ P  +I E     + +        +L    +  Y Y+L  AL
Sbjct: 69  DHPHIVKLIGVI----TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTAL 124
Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK--GPEL 290
            Y  S+  +HRD+   NV++      ++L D+GL+ +                K   PE 
Sbjct: 125 AYLESKRFVHRDIAARNVLVSSN-DCVKLGDFGLSRYMEDSTXXKASKGKLPIKWMAPE- 182
Query: 291 LVDLQDYDYSLDMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKI 333
            ++ + +  + D+W  G CM+  ++   +P F G  N+D + +I
Sbjct: 183 SINFRRFTSASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGRI 225

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 36/153 (23%), Positives = 69/153 (45%), Gaps = 20/153 (13%)
Query: 180 PNVVKLLDI-VRDQHSKTPSLIFEYVNSTDFKVLY------PTLTDYDIRYYIYELLKAL 232
           PNV+ LL I +R + S  P ++  Y+   D +         PT+ D  +  +  ++ K +
Sbjct: 150 PNVLSLLGICLRSEGS--PLVVLPYMKHGDLRNFIRNETHNPTVKD--LIGFGLQVAKGM 205
Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA------EFYHPGKEYNVRVASRYFK 286
            +  S+  +HRD+   N M+D +   +++ D+GLA      EF     +   ++  ++  
Sbjct: 206 KFLASKKFVHRDLAARNCMLDEKF-TVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 264
Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEP 319
              L    Q +    D+WS G +   ++ R  P
Sbjct: 265 LESL--QTQKFTTKSDVWSFGVLLWELMTRGAP 295

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 30/95 (31%), Positives = 50/95 (52%), Gaps = 8/95 (8%)
Query: 228 LLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 286
           ++K L Y   +  IMHRDVKP N++++    +++L D+G++      +  N  V +R + 
Sbjct: 116 VIKGLTYLREKHKIMHRDVKPSNILVNSR-GEIKLCDFGVSGQLID-EMANEFVGTRSYM 173
Query: 287 GPELLVDLQDYDYSL--DMWSLGCMFAGMIFRKEP 319
            PE    LQ   YS+  D+WS+G     M   + P
Sbjct: 174 SPE---RLQGTHYSVQSDIWSMGLSLVEMAVGRYP 205

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 36/177 (20%), Positives = 78/177 (44%), Gaps = 31/177 (17%)
Query: 173 LQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDF------------KVLYPTLTDYD 220
           ++ L G PN+V+          ++ +   E++  T+             +   P   D  
Sbjct: 79  MKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTV 138
Query: 221 IRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN- 277
           ++ + Y+  +A+ + H Q   I+HRD+K  N+++ ++   ++L D+G A       +Y+ 
Sbjct: 139 LKIF-YQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQ-GTIKLCDFGSATTISHYPDYSW 196
Query: 278 ------------VRVASRYFKGPELLVDLQDYDYS--LDMWSLGCMFAGMIFRKEPF 320
                        R  +  ++ PE++    ++      D+W+LGC+   + FR+ PF
Sbjct: 197 SAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF 253

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 29/101 (28%), Positives = 52/101 (51%), Gaps = 11/101 (10%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA------EF 269
           +T  D+    Y+L + ++Y  SQ  +HRD+   NV++  E   +++ D+GLA      ++
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV-TENNVMKIADFGLARDINNIDY 212
Query: 270 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMF 310
           Y      N R+  ++   PE L D + Y +  D+WS G + 
Sbjct: 213 YK--NTTNGRLPVKWM-APEALFD-RVYTHQSDVWSFGVLM 249

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	425
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	0.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	6e-77
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	2e-75
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	5e-74
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	7e-71
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	6e-68
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	7e-66
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	2e-64
3o0g_A	292	Cell division protein kinase 5; kinase activator c	3e-64
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	6e-64
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	8e-64
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	1e-63
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	1e-63
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	1e-62
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	2e-62
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	3e-62
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	3e-62
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	4e-62
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	4e-62
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	4e-62
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	6e-62
3niz_A	311	Rhodanese family protein; structural genomics, str	6e-62
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	2e-61
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	4e-61
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	4e-61
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	8e-60
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	2e-59
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	2e-58
3rp9_A	458	Mitogen-activated protein kinase; structural genom	6e-56
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	6e-54
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	6e-53
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	1e-48
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	1e-47
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	2e-47
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	2e-47
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-47
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	5e-47
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	5e-47
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	5e-47
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	8e-47
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	1e-46
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	2e-46
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	2e-46
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	3e-46
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	3e-46
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	7e-46
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	7e-46
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	2e-45
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	2e-45
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	3e-45
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	4e-45
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	6e-45
3bhy_A	283	Death-associated protein kinase 3; death associate	7e-45
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	8e-45
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	9e-45
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	1e-44
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-44
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	2e-44
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	2e-44
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	4e-44
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	6e-44
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	2e-43
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	3e-43
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	9e-43
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	2e-42
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	2e-42
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	3e-42
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	4e-42
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	3e-41
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	3e-41
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	4e-41
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	4e-41
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	5e-41
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	5e-41
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	7e-41
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	8e-41
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	9e-41
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	1e-40
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	3e-40
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	4e-40
2a19_B	284	Interferon-induced, double-stranded RNA-activated	1e-39
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	2e-38
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	2e-37
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	4e-37
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	4e-37
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	8e-37
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	2e-36
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	3e-36
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	3e-35
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	7e-35
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	7e-35
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	8e-35
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	8e-35
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	9e-35
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	1e-34
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	1e-34
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	1e-33
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	2e-33
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	3e-33
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	1e-32
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-32
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	2e-32
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	3e-31
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	4e-31
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	8e-31
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	1e-30
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	6e-30
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	1e-29
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	4e-29
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	1e-28
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	4e-28
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	5e-28
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	7e-28
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	9e-28
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	1e-27
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	3e-27
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	6e-27
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	7e-27
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	8e-27
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	9e-27
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	1e-26
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	1e-26
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	2e-26
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	2e-26
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	3e-26
2dyl_A	318	Dual specificity mitogen-activated protein kinase	2e-25
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	3e-25
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	3e-25
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	9e-25
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	2e-24
3aln_A	327	Dual specificity mitogen-activated protein kinase;	6e-24
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	7e-24
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	1e-22
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	8e-22
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	1e-21
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	2e-21
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	4e-21
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	6e-21
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	1e-20
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	1e-20
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	2e-20
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	3e-20
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	3e-20
3fme_A	290	Dual specificity mitogen-activated protein kinase;	4e-20
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	4e-20
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	5e-20
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	5e-20
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	5e-20
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	7e-20
3an0_A	340	Dual specificity mitogen-activated protein kinase;	1e-19
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	1e-19
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	2e-19
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	2e-18
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	4e-17
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	1e-16
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	2e-16
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	3e-16
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	4e-16
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	5e-16
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	2e-15
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	3e-15
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	6e-15
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	6e-15
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	1e-14
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	1e-14
3ork_A	311	Serine/threonine protein kinase; structural genomi	3e-14
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	1e-13
3uqc_A	286	Probable conserved transmembrane protein; structur	2e-13
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	7e-13
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-12
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	3e-12
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	3e-12
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-11
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	4e-11
3q4u_A	301	Activin receptor type-1; structural genomics conso	4e-11
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	4e-11
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	1e-10
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	5e-10
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	6e-10
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	7e-10
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	4e-06
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	5e-06
3soc_A	322	Activin receptor type-2A; structural genomics cons	2e-09
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-09
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	5e-09
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	9e-09
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	1e-08
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	2e-08
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-08
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	4e-08
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	1e-07
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	1e-07
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	2e-07
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	2e-07
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	3e-07
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	3e-07
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	3e-07
3pls_A	298	Macrophage-stimulating protein receptor; protein k	5e-07
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	7e-07
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	1e-06
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	1e-06
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	2e-06
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	2e-06
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	3e-06
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	3e-06
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	4e-06
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	7e-06
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	1e-05
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	1e-05
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	1e-05
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	1e-05
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	1e-05
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	2e-05
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	3e-05
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	3e-05
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	4e-05
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	4e-05
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	5e-05
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	5e-05
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	6e-05
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	9e-05
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	9e-05
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	1e-04
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-04
4aoj_A	329	High affinity nerve growth factor receptor; transf	4e-04
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	4e-04
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	5e-04
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	6e-04
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	6e-04
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	7e-04
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	8e-04

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  568 bits (1465), Expect = 0.0
 Identities = 248/328 (75%), Positives = 292/328 (89%)

Query: 92  PAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNE 151
           P  S+ARVYTDVN  RP+EYWDYES  V+WG+QDDY++VRK+GRGKYSEVFE IN+  NE
Sbjct: 3   PVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNE 62

Query: 152 RCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV 211
           + ++KILKPVKKKKIKREIKIL+NL GGPN++ L DIV+D  S+TP+L+FE+VN+TDFK 
Sbjct: 63  KVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ 122

Query: 212 LYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271
           LY TLTDYDIR+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYH
Sbjct: 123 LYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182

Query: 272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
           PG+EYNVRVASRYFKGPELLVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHDN+DQLV
Sbjct: 183 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 242

Query: 332 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDK 391
           +IAKVLGT++L  Y++KY++ELDP+ + ++GRHSRK W +F++++NQHLVSPEA+DFLDK
Sbjct: 243 RIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDK 302

Query: 392 LLRYDHQDRLTAREAMAHPYFAQVRAAE 419
           LLRYDHQ RLTAREAM HPYF  V   +
Sbjct: 303 LLRYDHQSRLTAREAMEHPYFYTVVKDQ 330

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  244 bits (624), Expect = 6e-77
 Identities = 96/303 (31%), Positives = 150/303 (49%), Gaps = 27/303 (8%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLL 186
           Y   + +G G +  V++    ++ E   IK +   K+ K  RE++I++ L    N+V+L 
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-RELQIMRKL-DHCNIVRLR 113

Query: 187 DIVRDQHSKTPS----LIFEYVNSTDFKVLYP------TLTDYDIRYYIYELLKALDYCH 236
                   K       L+ +YV  T ++V         TL    ++ Y+Y+L ++L Y H
Sbjct: 114 YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 173

Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
           S GI HRD+KP N+++D +   L+L D+G A+    G+     + SRY++ PEL+    D
Sbjct: 174 SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATD 233

Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT---DELNAYLNKYHLEL 353
           Y  S+D+WS GC+ A ++  + P F G    DQLV+I KVLGT   +++      Y    
Sbjct: 234 YTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 292

Query: 354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA 413
            PQ+          PW+K           PEAI    +LL Y    RLT  EA AH +F 
Sbjct: 293 FPQI-------KAHPWTKVFRPR----TPPEAIALCSRLLEYTPTARLTPLEACAHSFFD 341

Query: 414 QVR 416
           ++R
Sbjct: 342 ELR 344

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  239 bits (612), Expect = 2e-75
 Identities = 101/306 (33%), Positives = 158/306 (51%), Gaps = 28/306 (9%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVV 183
           +  Y   + +G G +  VF+   V ++E  I K+L+   K+   RE++I++ +   PNVV
Sbjct: 39  EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQD--KRFKNRELQIMRIV-KHPNVV 95

Query: 184 KLLDIVRDQHSKTPS----LIFEYVNSTDFKVL--YP----TLTDYDIRYYIYELLKALD 233
            L         K       L+ EYV  T ++    Y     T+    I+ Y+Y+LL++L 
Sbjct: 96  DLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLA 155

Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           Y HS GI HRD+KP N+++D     L+LID+G A+    G+     + SRY++ PEL+  
Sbjct: 156 YIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFG 215

Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT---DELNAYLNKYH 350
             +Y  ++D+WS GC+ A ++  + P F G    DQLV+I KVLGT   +++      Y 
Sbjct: 216 ATNYTTNIDIWSTGCVMAELMQGQ-PLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYM 274

Query: 351 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHP 410
               PQ+          P+SK           P+AID + +LL Y    RLTA EA+ HP
Sbjct: 275 EHKFPQI-------RPHPFSKVFRPR----TPPDAIDLISRLLEYTPSARLTAIEALCHP 323

Query: 411 YFAQVR 416
           +F ++R
Sbjct: 324 FFDELR 329

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  234 bits (600), Expect = 5e-74
 Identities = 84/310 (27%), Positives = 145/310 (46%), Gaps = 28/310 (9%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIK--ILKPVKKKKIKREIKILQNLCGGPNV 182
           D ++V R  G+G +  V  G   +T     IK  I  P  + +  + ++ L  L   PN+
Sbjct: 23  DRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVL-HHPNI 81

Query: 183 VKLLDIVRDQHSKTPS-----LIFEYVNSTDFKVL--YP----TLTDYDIRYYIYELLKA 231
           V+L         +        ++ EYV  T  +    Y           I+ ++++L+++
Sbjct: 82  VQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRS 141

Query: 232 LDYCH--SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
           +   H  S  + HRD+KPHNV+++     L+L D+G A+   P +     + SRY++ PE
Sbjct: 142 IGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPE 201

Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT---DELNAYL 346
           L+   Q Y  ++D+WS+GC+FA M+  + P F G ++  QL +I +VLG    + L    
Sbjct: 202 LIFGNQHYTTAVDIWSVGCIFAEMMLGE-PIFRGDNSAGQLHEIVRVLGCPSREVLRKLN 260

Query: 347 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA 406
             +                  PWS   +  +    + EA D L  LL+Y  ++R+   EA
Sbjct: 261 PSHTDVDLYNS-------KGIPWSNVFSDHSLKD-AKEAYDLLSALLQYLPEERMKPYEA 312

Query: 407 MAHPYFAQVR 416
           + HPYF ++ 
Sbjct: 313 LCHPYFDELH 322

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  227 bits (580), Expect = 7e-71
 Identities = 94/336 (27%), Positives = 156/336 (46%), Gaps = 61/336 (18%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLL 186
           Y + + +G G +  V E  ++ + +R  +K +    + K  RE+ I++ L    N++KL+
Sbjct: 9   YSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKN-RELDIMKVLDH-VNIIKLV 66

Query: 187 DIVRDQHSKTPS------------------------------------LIFEYVNSTDFK 210
           D       + P                                     +I EYV  T  K
Sbjct: 67  DYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHK 126

Query: 211 VLYP------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDW 264
           VL        ++    I  YIY+L +A+ + HS GI HRD+KP N++++ +   L+L D+
Sbjct: 127 VLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDF 186

Query: 265 GLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH 324
           G A+   P +     + SR+++ PEL++   +Y  S+D+WS+GC+F  +I  K P F G 
Sbjct: 187 GSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGK-PLFSGE 245

Query: 325 DNHDQLVKIAKVLGT---DELNAYLNKYHLELDPQLDALVGRHSRKPWSK-FINADNQHL 380
            + DQLV+I +++GT   +++      Y     P L         K W K          
Sbjct: 246 TSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTL-------KAKDWRKILPEGTP--- 295

Query: 381 VSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR 416
               AID L+++LRY+   R+   EAMAHP+F  +R
Sbjct: 296 --SLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLR 329

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  217 bits (555), Expect = 6e-68
 Identities = 91/312 (29%), Positives = 145/312 (46%), Gaps = 36/312 (11%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK-------------REIK 171
           + YE + K+G G Y  VF+  N +T +   IK        K               REI+
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIK--------KFLESEDDPVIKKIALREIR 54

Query: 172 ILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL--YPT-LTDYDIRYYIYEL 228
           +L+ L   PN+V LL++ R    +   L+FEY + T    L  Y   + ++ ++   ++ 
Sbjct: 55  MLKQLKH-PNLVNLLEVFR--RKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQT 111

Query: 229 LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKG 287
           L+A+++CH    +HRDVKP N++I      ++L D+G A     P   Y+  VA+R+++ 
Sbjct: 112 LQAVNFCHKHNCIHRDVKPENILITKH-SVIKLCDFGFARLLTGPSDYYDDEVATRWYRS 170

Query: 288 PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLN 347
           PELLV    Y   +D+W++GC+FA ++    P + G  + DQL  I K LG       L 
Sbjct: 171 PELLVGDTQYGPPVDVWAIGCVFAELL-SGVPLWPGKSDVDQLYLIRKTLGD------LI 223

Query: 348 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
             H ++        G     P            +S  A+  L   L  D  +RLT  + +
Sbjct: 224 PRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLL 283

Query: 408 AHPYFAQVRAAE 419
            HPYF  +R  E
Sbjct: 284 HHPYFENIREIE 295

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  212 bits (543), Expect = 7e-66
 Identities = 90/313 (28%), Positives = 144/313 (46%), Gaps = 30/313 (9%)

Query: 121 WGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK-IK----REIKILQN 175
           +   + YE +  VG G Y  V +  N +T     IK        K +K    REIK+L+ 
Sbjct: 21  FQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQ 80

Query: 176 LCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL--YPT-LTDYDIRYYIYELLKAL 232
           L    N+V LL++ +    K   L+FE+V+ T    L  +P  L    ++ Y+++++  +
Sbjct: 81  LRH-ENLVNLLEVCK--KKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGI 137

Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELL 291
            +CHS  I+HRD+KP N+++      ++L D+G A     PG+ Y+  VA+R+++ PELL
Sbjct: 138 GFCHSHNIIHRDIKPENILVSQS-GVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELL 196

Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT-DELN----AYL 346
           V    Y  ++D+W++GC+   M F  EP F G  + DQL  I   LG     +       
Sbjct: 197 VGDVKYGKAVDVWAIGCLVTEM-FMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKN 255

Query: 347 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA 406
             +     P+         R+P  +         +S   ID   K L  D   R    E 
Sbjct: 256 PVFAGVRLPE------IKEREPLERRYPK-----LSEVVIDLAKKCLHIDPDKRPFCAEL 304

Query: 407 MAHPYFAQVRAAE 419
           + H +F     AE
Sbjct: 305 LHHDFFQMDGFAE 317

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  209 bits (535), Expect = 2e-64
 Identities = 93/327 (28%), Positives = 165/327 (50%), Gaps = 30/327 (9%)

Query: 104 NVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIK-ILKPVK 162
           +++R K ++  +     W     Y     VG G Y  V   I+  + E+  IK + +P +
Sbjct: 3   SLIRKKGFYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQ 62

Query: 163 K----KKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS----LIFEYVNSTDFKVLYP 214
                K+  RE+ +L+++    NV+ LLD+     S        L+  ++ +   K++  
Sbjct: 63  SEIFAKRAYRELLLLKHMQH-ENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGL 121

Query: 215 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 274
             ++  I+Y +Y++LK L Y HS G++HRD+KP N+ ++ +  +L+++D+GLA       
Sbjct: 122 KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDC-ELKILDFGLARHADAEM 180

Query: 275 -EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333
             Y   V +R+++ PE+++    Y+ ++D+WS+GC+ A M+  K   F G D  DQL +I
Sbjct: 181 TGY---VVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK-TLFKGKDYLDQLTQI 236

Query: 334 AKVLGT---DELNAYLNKYHLELDPQLDALVGRHSRKPWSK-FINADNQHLVSPEAIDFL 389
            KV G    + +    +K        L     +  RK +++ F  A       P+A D L
Sbjct: 237 LKVTGVPGTEFVQKLNDKAAKSYIQSL----PQTPRKDFTQLFPRAS------PQAADLL 286

Query: 390 DKLLRYDHQDRLTAREAMAHPYFAQVR 416
           +K+L  D   RLTA +A+ HP+F   R
Sbjct: 287 EKMLELDVDKRLTAAQALTHPFFEPFR 313

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  207 bits (529), Expect = 3e-64
 Identities = 91/311 (29%), Positives = 152/311 (48%), Gaps = 43/311 (13%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK-------------REIK 171
             YE + K+G G Y  VF+  N  T+E         V  K+++             REI 
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEI--------VALKRVRLDDDDEGVPSSALREIC 53

Query: 172 ILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL----YPTLTDYDIRYYIYE 227
           +L+ L    N+V+L D++      T  L+FE+    D K         L    ++ ++++
Sbjct: 54  LLKELKH-KNIVRLHDVLHSDKKLT--LVFEFC-DQDLKKYFDSCNGDLDPEIVKSFLFQ 109

Query: 228 LLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKEYNVRVASRYFK 286
           LLK L +CHS+ ++HRD+KP N++I+    +L+L ++GLA  +  P + Y+  V + +++
Sbjct: 110 LLKGLGFCHSRNVLHRDLKPQNLLINRN-GELKLANFGLARAFGIPVRCYSAEVVTLWYR 168

Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT-DELNAY 345
            P++L   + Y  S+DMWS GC+FA +     P F G+D  DQL +I ++LGT  E    
Sbjct: 169 PPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTE---- 224

Query: 346 LNKYHLELDPQLDALVGRHSRKPWSKFINADNQ-HLVSPEAIDFLDKLLRYDHQDRLTAR 404
                 E  P +  L        +    +  N    ++    D L  LL+ +   R++A 
Sbjct: 225 ------EQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAE 278

Query: 405 EAMAHPYFAQV 415
           EA+ HPYF+  
Sbjct: 279 EALQHPYFSDF 289

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  207 bits (529), Expect = 8e-64
 Identities = 90/319 (28%), Positives = 155/319 (48%), Gaps = 51/319 (15%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK-------------RE 169
             D Y  + K+G G Y EV++ I+  TNE         V  K+I+             RE
Sbjct: 32  SIDRYRRITKLGEGTYGEVYKAIDTVTNET--------VAIKRIRLEHEEEGVPGTAIRE 83

Query: 170 IKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIY 226
           + +L+ L    N+++L  ++   H     LIFEY    D K      P ++   I+ ++Y
Sbjct: 84  VSLLKELQH-RNIIELKSVIHHNHRLH--LIFEYA-ENDLKKYMDKNPDVSMRVIKSFLY 139

Query: 227 ELLKALDYCHSQGIMHRDVKPHNVMIDHELRK----LRLIDWGLAEFYH-PGKEYNVRVA 281
           +L+  +++CHS+  +HRD+KP N+++          L++ D+GLA  +  P +++   + 
Sbjct: 140 QLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII 199

Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT-D 340
           + +++ PE+L+  + Y  S+D+WS+ C++A M+  K P F G    DQL KI +VLG  D
Sbjct: 200 TLWYRPPEILLGSRHYSTSVDIWSIACIWAEML-MKTPLFPGDSEIDQLFKIFEVLGLPD 258

Query: 341 ELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLV----SPEAIDFLDKLLRYD 396
           +             P + AL       P  KF     + ++      E +D L  +L  D
Sbjct: 259 D----------TTWPGVTALPDWKQSFP--KFRGKTLKRVLGALLDDEGLDLLTAMLEMD 306

Query: 397 HQDRLTAREAMAHPYFAQV 415
              R++A+ A+ HPYF+  
Sbjct: 307 PVKRISAKNALEHPYFSHN 325

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  206 bits (527), Expect = 1e-63
 Identities = 80/312 (25%), Positives = 145/312 (46%), Gaps = 37/312 (11%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKIL---KPVKKKKIKREIKILQNLCGGPNVV 183
           Y  ++ +G G    VF  ++ + ++R  IK +    P   K   REIKI++ L    N+V
Sbjct: 13  YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRL-DHDNIV 71

Query: 184 KLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP-------------TLTDYDIRYYIYELLK 230
           K+ +I+    S+    +          ++                L +   R ++Y+LL+
Sbjct: 72  KVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLLR 131

Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR----VASRYFK 286
            L Y HS  ++HRD+KP N+ I+ E   L++ D+GLA    P   +       + +++++
Sbjct: 132 GLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYR 191

Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT---DELN 343
            P LL+   +Y  ++DMW+ GC+FA M+  K   F G    +Q+  I + +     ++  
Sbjct: 192 SPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK-TLFAGAHELEQMQLILESIPVVHEEDRQ 250

Query: 344 AYLNKYHLELDPQLDALVGRHSRKPWSK-FINADNQHLVSPEAIDFLDKLLRYDHQDRLT 402
             L+   + +             KP ++             EA+DFL+++L +   DRLT
Sbjct: 251 ELLSVIPVYIRND-----MTEPHKPLTQLLPGIS------REAVDFLEQILTFSPMDRLT 299

Query: 403 AREAMAHPYFAQ 414
           A EA++HPY + 
Sbjct: 300 AEEALSHPYMSI 311

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  206 bits (526), Expect = 1e-63
 Identities = 84/317 (26%), Positives = 160/317 (50%), Gaps = 47/317 (14%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK------------REIKI 172
             ++ + K+G G Y+ V++G+N  T           V  K++K            REI +
Sbjct: 5   SQFKQLEKLGNGTYATVYKGLNKTTGVY--------VALKEVKLDSEEGTPSTAIREISL 56

Query: 173 LQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV--------NSTDFKVLYPTLTDYDIRYY 224
           ++ L    N+V+L D++  ++  T  L+FE++        +S         L    ++Y+
Sbjct: 57  MKELKH-ENIVRLYDVIHTENKLT--LVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYF 113

Query: 225 IYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKEYNVRVASR 283
            ++LL+ L +CH   I+HRD+KP N++I+   + L+L D+GLA  +  P   ++  V + 
Sbjct: 114 QWQLLQGLAFCHENKILHRDLKPQNLLINKRGQ-LKLGDFGLARAFGIPVNTFSSEVVTL 172

Query: 284 YFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT-DEL 342
           +++ P++L+  + Y  S+D+WS GC+ A MI   +P F G ++ +QL  I  ++GT +E 
Sbjct: 173 WYRAPDVLMGSRTYSTSIDIWSCGCILAEMI-TGKPLFPGTNDEEQLKLIFDIMGTPNES 231

Query: 343 N----AYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQ 398
                  L KY+  +  +          +   + +    +  +    +DFL  LL+ +  
Sbjct: 232 LWPSVTKLPKYNPNIQQR--------PPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPD 283

Query: 399 DRLTAREAMAHPYFAQV 415
            RL+A++A+ HP+FA+ 
Sbjct: 284 MRLSAKQALHHPWFAEY 300

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  203 bits (519), Expect = 1e-62
 Identities = 81/323 (25%), Positives = 140/323 (43%), Gaps = 60/323 (18%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK----------------R 168
             YE V ++G G Y  V++  + ++           V  K ++                R
Sbjct: 9   SRYEPVAEIGVGAYGTVYKARDPHSGHF--------VALKSVRVPNGGGGGGGLPISTVR 60

Query: 169 EIKILQNLCGG--PNVVKLLDIVRDQHSKTPS---LIFEYVNSTDFKVL-----YPTLTD 218
           E+ +L+ L     PNVV+L+D+     +       L+FE+V   D +        P L  
Sbjct: 61  EVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPA 119

Query: 219 YDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV 278
             I+  + + L+ LD+ H+  I+HRD+KP N+++      ++L D+GLA  Y        
Sbjct: 120 ETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSG-GTVKLADFGLARIYSYQMALTP 178

Query: 279 RVASRYFKGPELLVDLQD-YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
            V + +++ PE+L  LQ  Y   +DMWS+GC+FA M FR++P F G+   DQL KI  ++
Sbjct: 179 VVVTLWYRAPEVL--LQSTYATPVDMWSVGCIFAEM-FRRKPLFCGNSEADQLGKIFDLI 235

Query: 338 GT-DELN----AYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKL 392
           G   E +      L +                  +P    +       +       L ++
Sbjct: 236 GLPPEDDWPRDVSLPRGAFP----------PRGPRPVQSVVPE-----MEESGAQLLLEM 280

Query: 393 LRYDHQDRLTAREAMAHPYFAQV 415
           L ++   R++A  A+ H Y  + 
Sbjct: 281 LTFNPHKRISAFRALQHSYLHKD 303

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  202 bits (517), Expect = 2e-62
 Identities = 91/314 (28%), Positives = 154/314 (49%), Gaps = 51/314 (16%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK-------------REIK 171
           + Y  + K+G G Y  V++  N N  E            KKI+             REI 
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQN-NYGET--------FALKKIRLEKEDEGIPSTTIREIS 52

Query: 172 ILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL----YPTLTDYDIRYYIYE 227
           IL+ L    N+VKL D++  +      L+FE++   D K L       L     + ++ +
Sbjct: 53  ILKELKH-SNIVKLYDVIHTKKRLV--LVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQ 108

Query: 228 LLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKEYNVRVASRYFK 286
           LL  + YCH + ++HRD+KP N++I+ E  +L++ D+GLA  +  P ++Y   + + +++
Sbjct: 109 LLNGIAYCHDRRVLHRDLKPQNLLINRE-GELKIADFGLARAFGIPVRKYTHEIVTLWYR 167

Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT-DELN-- 343
            P++L+  + Y  ++D+WS+GC+FA M+    P F G    DQL++I ++LGT +  N  
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMV-NGTPLFPGVSEADQLMRIFRILGTPNSKNWP 226

Query: 344 --AYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL 401
               L KY              +   PW  F+       +    ID L K+L+ D   R+
Sbjct: 227 NVTELPKYDPNFT--------VYEPLPWESFLKG-----LDESGIDLLSKMLKLDPNQRI 273

Query: 402 TAREAMAHPYFAQV 415
           TA++A+ H YF + 
Sbjct: 274 TAKQALEHAYFKEN 287

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  204 bits (521), Expect = 3e-62
 Identities = 89/307 (28%), Positives = 160/307 (52%), Gaps = 31/307 (10%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIK-ILKPVKK----KKIKREIKILQNLCGG 179
             Y  ++ VG G Y  V   ++  T  +  IK + +P +     K+  RE+++L+++   
Sbjct: 25  AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRH- 83

Query: 180 PNVVKLLDIVRDQHSKTPS----LIFEYVNSTDFKVLYP-TLTDYDIRYYIYELLKALDY 234
            NV+ LLD+     +        L+  ++ +   K++    L +  I++ +Y++LK L Y
Sbjct: 84  ENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRY 143

Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVD 293
            H+ GI+HRD+KP N+ ++ +  +L+++D+GLA         Y   V +R+++ PE++++
Sbjct: 144 IHAAGIIHRDLKPGNLAVNEDC-ELKILDFGLARQADSEMTGY---VVTRWYRAPEVILN 199

Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT---DELNAYLNKYH 350
              Y  ++D+WS+GC+ A MI  K   F G D+ DQL +I KV GT   + +    +   
Sbjct: 200 WMRYTQTVDIWSVGCIMAEMITGK-TLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEA 258

Query: 351 LELDPQLDALVGRHSRKPWSK-FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 409
                 L        +K ++    NA      SP A++ L+K+L  D + R+TA EA+AH
Sbjct: 259 KNYMKGL----PELEKKDFASILTNA------SPLAVNLLEKMLVLDAEQRVTAGEALAH 308

Query: 410 PYFAQVR 416
           PYF  + 
Sbjct: 309 PYFESLH 315

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  203 bits (518), Expect = 3e-62
 Identities = 86/313 (27%), Positives = 157/313 (50%), Gaps = 48/313 (15%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK------------REIKI 172
           + Y  + K+G G Y+ V++G +  T+          V  K+I+            RE+ +
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNL--------VALKEIRLEHEEGAPCTAIREVSL 53

Query: 173 LQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL----YPTLTDYDIRYYIYEL 228
           L++L    N+V L DI+  + S T  L+FEY++  D K         +  ++++ ++++L
Sbjct: 54  LKDLKH-ANIVTLHDIIHTEKSLT--LVFEYLD-KDLKQYLDDCGNIINMHNVKLFLFQL 109

Query: 229 LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKG 287
           L+ L YCH Q ++HRD+KP N++I+    +L+L D+GLA     P K Y+  V + +++ 
Sbjct: 110 LRGLAYCHRQKVLHRDLKPQNLLINER-GELKLADFGLARAKSIPTKTYDNEVVTLWYRP 168

Query: 288 PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT-DELN--- 343
           P++L+   DY   +DMW +GC+F  M   + P F G    +QL  I ++LGT  E     
Sbjct: 169 PDILLGSTDYSTQIDMWGVGCIFYEMATGR-PLFPGSTVEEQLHFIFRILGTPTEETWPG 227

Query: 344 -AYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT 402
                ++     P+       +  +             +  +  D L KLL+++ ++R++
Sbjct: 228 ILSNEEFKTYNYPK-------YRAEALLSHAPR-----LDSDGADLLTKLLQFEGRNRIS 275

Query: 403 AREAMAHPYFAQV 415
           A +AM HP+F  +
Sbjct: 276 AEDAMKHPFFLSL 288

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  203 bits (519), Expect = 4e-62
 Identities = 87/322 (27%), Positives = 153/322 (47%), Gaps = 37/322 (11%)

Query: 119 VQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK----KKIKREIKILQ 174
           + +    D+++   +G G Y  V    +  T E   IK ++P  K     +  REIKIL+
Sbjct: 5   IVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILK 64

Query: 175 NLCGGPNVVKLLDIVRDQHSKTPS---LIFEYVNSTDFKVLYP-TLTDYDIRYYIYELLK 230
           +     N++ + +I R    +  +   +I E + +   +V+    L+D  I+Y+IY+ L+
Sbjct: 65  HF-KHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLR 123

Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR----------- 279
           A+   H   ++HRD+KP N++I+     L++ D+GLA         N             
Sbjct: 124 AVKVLHGSNVIHRDLKPSNLLINSNC-DLKVCDFGLARIIDESAADNSEPTGQQSGMVEF 182

Query: 280 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT 339
           VA+R+++ PE+++    Y  ++D+WS GC+ A +  R+ P F G D   QL+ I  ++GT
Sbjct: 183 VATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR-PIFPGRDYRHQLLLIFGIIGT 241

Query: 340 ----DELNAYLNKYHLELDPQLDALVGRHSRKPWSK-FINADNQHLVSPEAIDFLDKLLR 394
               ++L    +    E    L      +   P  K F   +      P+ ID L ++L 
Sbjct: 242 PHSDNDLRCIESPRAREYIKSL----PMYPAAPLEKMFPRVN------PKGIDLLQRMLV 291

Query: 395 YDHQDRLTAREAMAHPYFAQVR 416
           +D   R+TA+EA+ HPY     
Sbjct: 292 FDPAKRITAKEALEHPYLQTYH 313

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  204 bits (520), Expect = 4e-62
 Identities = 80/334 (23%), Positives = 147/334 (44%), Gaps = 37/334 (11%)

Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIK-ILKPVKK-- 163
              E    + +      Q  Y V R +  G Y  V  G++ +      IK +   V    
Sbjct: 4   AKGEAAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVD-SEGIPVAIKRVFNTVSDGR 62

Query: 164 -----------KKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS---LIFEYVNSTDF 209
                      K++ REI++L +    PN++ L DI             L+ E + +   
Sbjct: 63  TVNILSDSFLCKRVLREIRLLNHF-HHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLA 121

Query: 210 KVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL 266
           +V++     ++   I+Y++Y +L  L   H  G++HRD+ P N+++      + + D+ L
Sbjct: 122 QVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNN-DITICDFNL 180

Query: 267 AEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN 326
           A            V  R+++ PEL++  + +   +DMWS GC+ A M  RK   F G   
Sbjct: 181 AREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK-ALFRGSTF 239

Query: 327 HDQLVKIAKVLGT---DELNAYLNKYHLELDPQLDALVGRHSRKPWSK-FINADNQHLVS 382
           ++QL KI +V+GT   +++  + +    +    L   +     + W+     AD      
Sbjct: 240 YNQLNKIVEVVGTPKIEDVVMFSSPSARDY---LRNSLSNVPARAWTAVVPTAD------ 290

Query: 383 PEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR 416
           P A+D + K+L ++ Q R++  +A+ HPYF  + 
Sbjct: 291 PVALDLIAKMLEFNPQRRISTEQALRHPYFESLF 324

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  204 bits (520), Expect = 4e-62
 Identities = 89/323 (27%), Positives = 163/323 (50%), Gaps = 31/323 (9%)

Query: 109 KEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL-----KPVKK 163
             ++  E     W   + Y+ +  VG G Y  V    +  T  R  +K L       +  
Sbjct: 13  PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA 72

Query: 164 KKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS----LIFEYVNSTDFKVLYP-TLTD 218
           K+  RE+++L+++    NV+ LLD+     S        L+   + +    ++    LTD
Sbjct: 73  KRTYRELRLLKHMKH-ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD 131

Query: 219 YDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EYN 277
             +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA         Y 
Sbjct: 132 DHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLARHTADEMTGY- 189

Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++
Sbjct: 190 --VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR-TLFPGTDHIDQLKLILRLV 246

Query: 338 GT---DELNAYLNKYHLELDPQLDALVGRHSRKPWSK-FINADNQHLVSPEAIDFLDKLL 393
           GT   + L    ++        L     +  +  ++  FI A+      P A+D L+K+L
Sbjct: 247 GTPGAELLKKISSESARNYIQSL----TQMPKMNFANVFIGAN------PLAVDLLEKML 296

Query: 394 RYDHQDRLTAREAMAHPYFAQVR 416
             D   R+TA +A+AH YFAQ  
Sbjct: 297 VLDSDKRITAAQALAHAYFAQYH 319

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  202 bits (517), Expect = 6e-62
 Identities = 93/302 (30%), Positives = 154/302 (50%), Gaps = 30/302 (9%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK--------REIKILQNL 176
             YE +  +G G+++ V++  + NTN+   IK +K   + + K        REIK+LQ L
Sbjct: 10  KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 69

Query: 177 CGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL----YPTLTDYDIRYYIYELLKAL 232
              PN++ LLD     H    SL+F+++  TD +V+       LT   I+ Y+   L+ L
Sbjct: 70  SH-PNIIGLLDAF--GHKSNISLVFDFME-TDLEVIIKDNSLVLTPSHIKAYMLMTLQGL 125

Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELL 291
           +Y H   I+HRD+KP+N+++D     L+L D+GLA  F  P + Y  +V +R+++ PELL
Sbjct: 126 EYLHQHWILHRDLKPNNLLLDEN-GVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELL 184

Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT-DELNAYLNKYH 350
              + Y   +DMW++GC+ A ++ R  PF  G  + DQL +I + LGT  E         
Sbjct: 185 FGARMYGVGVDMWAVGCILAELLLRV-PFLPGDSDLDQLTRIFETLGTPTE--------- 234

Query: 351 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHP 410
            E  P + +L    + K +              + +D +  L  ++   R+TA +A+   
Sbjct: 235 -EQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK 293

Query: 411 YF 412
           YF
Sbjct: 294 YF 295

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  201 bits (514), Expect = 6e-62
 Identities = 99/317 (31%), Positives = 158/317 (49%), Gaps = 50/317 (15%)

Query: 122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK-------------R 168
           G  + Y+ + KVG G Y  V++  + +            V  K+I+             R
Sbjct: 18  GLMEKYQKLEKVGEGTYGVVYKAKD-SQGRI--------VALKRIRLDAEDEGIPSTAIR 68

Query: 169 EIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL----YPTLTDYDIRYY 224
           EI +L+ L   PN+V L+D++  +   T  L+FE++   D K +       L D  I+ Y
Sbjct: 69  EISLLKELHH-PNIVSLIDVIHSERCLT--LVFEFM-EKDLKKVLDENKTGLQDSQIKIY 124

Query: 225 IYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKEYNVRVASR 283
           +Y+LL+ + +CH   I+HRD+KP N++I+ +   L+L D+GLA  +  P + Y   V + 
Sbjct: 125 LYQLLRGVAHCHQHRILHRDLKPQNLLINSDGA-LKLADFGLARAFGIPVRSYTHEVVTL 183

Query: 284 YFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT-DEL 342
           +++ P++L+  + Y  S+D+WS+GC+FA MI  K P F G  + DQL KI  +LGT +  
Sbjct: 184 WYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK-PLFPGVTDDDQLPKIFSILGTPNPR 242

Query: 343 N----AYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQ 398
                  L  +                +KPWS  I          E ID L  +L +D  
Sbjct: 243 EWPQVQELPLWKQRTFQV-------FEKKPWSSIIPG-----FCQEGIDLLSNMLCFDPN 290

Query: 399 DRLTAREAMAHPYFAQV 415
            R++AR+AM HPYF  +
Sbjct: 291 KRISARDAMNHPYFKDL 307

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  202 bits (515), Expect = 2e-61
 Identities = 88/308 (28%), Positives = 158/308 (51%), Gaps = 29/308 (9%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK----KKIKREIKILQNLCGGP 180
             Y  +  +G G Y  V    +     R  IK + P +     ++  REIKIL       
Sbjct: 27  PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRF-RHE 85

Query: 181 NVVKLLDIVRDQHSKTPS---LIFEYVNSTDFKVLY-PTLTDYDIRYYIYELLKALDYCH 236
           N++ + DI+R    +      ++ + + +  +K+L    L++  I Y++Y++L+ L Y H
Sbjct: 86  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 145

Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR----VASRYFKGPELLV 292
           S  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE+++
Sbjct: 146 SANVLHRDLKPSNLLLNTTC-DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204

Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT---DELNAYLNKY 349
           + + Y  S+D+WS+GC+ A M+  + P F G    DQL  I  +LG+   ++LN  +N  
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 263

Query: 350 HLELDPQLDALVGRHSRKPWSK-FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 408
                  L       ++ PW++ F NAD       +A+D LDK+L ++   R+   +A+A
Sbjct: 264 ARNYLLSL----PHKNKVPWNRLFPNAD------SKALDLLDKMLTFNPHKRIEVEQALA 313

Query: 409 HPYFAQVR 416
           HPY  Q  
Sbjct: 314 HPYLEQYY 321

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  200 bits (510), Expect = 4e-61
 Identities = 92/322 (28%), Positives = 152/322 (47%), Gaps = 60/322 (18%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK-------------REIK 171
             YE V ++G G Y +VF+  ++    R        V  K+++             RE+ 
Sbjct: 11  QQYECVAEIGEGAYGKVFKARDLKNGGRF-------VALKRVRVQTGEEGMPLSTIREVA 63

Query: 172 ILQNLCGG--PNVVKLLDIVRDQHSKTPS---LIFEYVNSTDFKVL-----YPTLTDYDI 221
           +L++L     PNVV+L D+     +   +   L+FE+V   D          P +    I
Sbjct: 64  VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETI 122

Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           +  +++LL+ LD+ HS  ++HRD+KP N+++     +++L D+GLA  Y         V 
Sbjct: 123 KDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSS-GQIKLADFGLARIYSFQMALTSVVV 181

Query: 282 SRYFKGPELLVDLQD-YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT- 339
           + +++ PE+L  LQ  Y   +D+WS+GC+FA M FR++P F G  + DQL KI  V+G  
Sbjct: 182 TLWYRAPEVL--LQSSYATPVDLWSVGCIFAEM-FRRKPLFRGSSDVDQLGKILDVIGLP 238

Query: 340 DELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHL------VSPEAIDFLDKLL 393
            E          E  P+  AL       P   F +   Q +      +     D L K L
Sbjct: 239 GE----------EDWPRDVAL-------PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCL 281

Query: 394 RYDHQDRLTAREAMAHPYFAQV 415
            ++   R++A  A++HPYF  +
Sbjct: 282 TFNPAKRISAYSALSHPYFQDL 303

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  202 bits (515), Expect = 4e-61
 Identities = 86/330 (26%), Positives = 163/330 (49%), Gaps = 40/330 (12%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIK-ILKPVKK----KKIKREIKILQNLCGG 179
             YE+V+K+G+G Y  V++ I+  T E   +K I    +     ++  REI IL  L G 
Sbjct: 9   RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGH 68

Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY-PTLTDYDIRYYIYELLKALDYCHSQ 238
            N+V LL+++R  + +   L+F+Y+ +    V+    L     +Y +Y+L+K + Y HS 
Sbjct: 69  ENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVYQLIKVIKYLHSG 128

Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR------------------- 279
           G++HRD+KP N++++ E   +++ D+GL+  +   +                        
Sbjct: 129 GLLHRDMKPSNILLNAEC-HVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPIL 187

Query: 280 ---VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 336
              VA+R+++ PE+L+    Y   +DMWSLGC+   ++  K P F G    +QL +I  V
Sbjct: 188 TDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK-PIFPGSSTMNQLERIIGV 246

Query: 337 LGT---DELNAYLNKY------HLELDPQLDALVGRHSRKPWSK-FINADNQHLVSPEAI 386
           +     +++ +  + +       L+   ++     R     W    +  + +   + EA+
Sbjct: 247 IDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEAL 306

Query: 387 DFLDKLLRYDHQDRLTAREAMAHPYFAQVR 416
           D LDKLL+++   R++A +A+ HP+ +   
Sbjct: 307 DLLDKLLQFNPNKRISANDALKHPFVSIFH 336

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  198 bits (505), Expect = 8e-60
 Identities = 77/326 (23%), Positives = 146/326 (44%), Gaps = 26/326 (7%)

Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIK-ILKPVKK-- 163
           R   ++  E     +     Y+ ++ +G G    V    +        IK + +P +   
Sbjct: 7   RDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQT 66

Query: 164 --KKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS----LIFEYVNSTDFKVLYPTLT 217
             K+  RE+ +++ +    N++ LL++   Q S        ++ E +++   +V+   L 
Sbjct: 67  HAKRAYRELVLMKCV-NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELD 125

Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
              + Y +Y++L  + + HS GI+HRD+KP N+++  +   L+++D+GLA          
Sbjct: 126 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMT 184

Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             V +RY++ PE+++    Y  ++D+WS+GC+   MI      F G D+ DQ  K+ + L
Sbjct: 185 PYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGG-VLFPGTDHIDQWNKVIEQL 242

Query: 338 GT--DELNAYLNKYHLELDPQLDALVGRHSRKPWSK-FINADN------QHLVSPEAIDF 388
           GT   E    L                +++   + K F +           L + +A D 
Sbjct: 243 GTPCPEFMKKLQPTVRTYVENR----PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDL 298

Query: 389 LDKLLRYDHQDRLTAREAMAHPYFAQ 414
           L K+L  D   R++  EA+ HPY   
Sbjct: 299 LSKMLVIDASKRISVDEALQHPYINV 324

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  196 bits (501), Expect = 2e-59
 Identities = 89/321 (27%), Positives = 143/321 (44%), Gaps = 55/321 (17%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK-------------REIK 171
             YE + K+G+G + EVF+  +  T ++        V  KK+              REIK
Sbjct: 17  SKYEKLAKIGQGTFGEVFKARHRKTGQK--------VALKKVLMENEKEGFPITALREIK 68

Query: 172 ILQNLCGGPNVVKLLDIVRDQHSKTPS------LIFEYVNSTDFKVL----YPTLTDYDI 221
           ILQ L    NVV L++I R + S          L+F++    D   L        T  +I
Sbjct: 69  ILQLL-KHENVVNLIEICRTKASPYNRCKGSIYLVFDFC-EHDLAGLLSNVLVKFTLSEI 126

Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-----PGKEY 276
           +  +  LL  L Y H   I+HRD+K  NV+I  +   L+L D+GLA  +          Y
Sbjct: 127 KRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGV-LKLADFGLARAFSLAKNSQPNRY 185

Query: 277 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 336
             RV + +++ PELL+  +DY   +D+W  GC+ A M + + P   G+    QL  I+++
Sbjct: 186 TNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEM-WTRSPIMQGNTEQHQLALISQL 244

Query: 337 LGT-DELNAYLNKYHLELDPQLDALVGRHSRKPW----SKFINADNQHLVSPEAIDFLDK 391
            G+             E+ P +D        +       K  +    ++  P A+D +DK
Sbjct: 245 CGSITP----------EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDK 294

Query: 392 LLRYDHQDRLTAREAMAHPYF 412
           LL  D   R+ + +A+ H +F
Sbjct: 295 LLVLDPAQRIDSDDALNHDFF 315

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  197 bits (502), Expect = 2e-58
 Identities = 76/328 (23%), Positives = 150/328 (45%), Gaps = 32/328 (9%)

Query: 108 PKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIK-ILKPVKK--- 163
             +++  E     +     Y+ ++ +G G    V    +   +    IK + +P +    
Sbjct: 45  DNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTH 104

Query: 164 -KKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS----LIFEYVNSTDFKVLYPTLTD 218
            K+  RE+ +++ +    N++ LL++   Q +        L+ E +++   +V+   L  
Sbjct: 105 AKRAYRELVLMKCV-NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDH 163

Query: 219 YDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK---E 275
             + Y +Y++L  + + HS GI+HRD+KP N+++  +   L+++D+GLA           
Sbjct: 164 ERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTP 222

Query: 276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
           Y   V +RY++ PE+++    Y  ++D+WS+GC+   M+  K   F G D  DQ  K+ +
Sbjct: 223 Y---VVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHK-ILFPGRDYIDQWNKVIE 277

Query: 336 VLGT--DELNAYLNKYHLELDPQLDALVGRHSRKPWSK-FINAD------NQHLVSPEAI 386
            LGT   E    L                +++   + K F ++       +  L + +A 
Sbjct: 278 QLGTPCPEFMKKLQPTVRNYVENR----PKYAGLTFPKLFPDSLFPADSEHNKLKASQAR 333

Query: 387 DFLDKLLRYDHQDRLTAREAMAHPYFAQ 414
           D L K+L  D   R++  +A+ HPY   
Sbjct: 334 DLLSKMLVIDPAKRISVDDALQHPYINV 361

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  190 bits (484), Expect = 6e-56
 Identities = 94/382 (24%), Positives = 159/382 (41%), Gaps = 86/382 (22%)

Query: 108 PKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIK-ILKPVKK--- 163
            K           W   D YE+   +G G Y  V E  +        IK IL+  +    
Sbjct: 36  SKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLID 95

Query: 164 -KKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS---LIFEYVNSTDF-KVLY--PTL 216
            K+I REI IL  L    +VVK+LDIV  +  +      ++ E  + +DF K+      L
Sbjct: 96  CKRILREIAILNRL-NHDHVVKVLDIVIPKDVEKFDELYVVLEIAD-SDFKKLFRTPVYL 153

Query: 217 TDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY 276
           T+  I+  +Y LL  + Y HS GI+HRD+KP N +++ +   +++ D+GLA      +  
Sbjct: 154 TELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDC-SVKVCDFGLARTVDYPENG 212

Query: 277 NVR----------------------------VASRYFKGPELLVDLQDYDYSLDMWSLGC 308
           N +                            V +R+++ PEL++  ++Y  ++D+WS+GC
Sbjct: 213 NSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGC 272

Query: 309 MFAGMI----------FRKEPFFYGHD--------------------NHDQLVKIAKVLG 338
           +FA ++            + P F G                      N DQL  I  +LG
Sbjct: 273 IFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILG 332

Query: 339 T---DELNAYLNKYHLELDPQLDALVGRHSRKPWSK-FINADNQHLVSPEAIDFLDKLLR 394
           T   +++ A   +              +      ++ F  +        +AI  L ++L 
Sbjct: 333 TPSEEDIEALEKEDAKRYIRIF----PKREGTDLAERFPASS------ADAIHLLKRMLV 382

Query: 395 YDHQDRLTAREAMAHPYFAQVR 416
           ++   R+T  E +AHP+F +VR
Sbjct: 383 FNPNKRITINECLAHPFFKEVR 404

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score =  184 bits (469), Expect = 6e-54
 Identities = 83/357 (23%), Positives = 153/357 (42%), Gaps = 78/357 (21%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIK-ILKPVKK----KKIKREIKILQNLCGG 179
           D+Y +   +GRG Y  V+   + NT +   IK + +  +     K+I REI IL  L   
Sbjct: 26  DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRL-KS 84

Query: 180 PNVVKLLDIVRDQHSKTPS---LIFEYVNSTDF-KVLYP--TLTDYDIRYYIYELLKALD 233
             +++L D++            ++ E  + +D  K+      LT+  I+  +Y LL   +
Sbjct: 85  DYIIRLYDLIIPDDLLKFDELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGEN 143

Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR-------------- 279
           + H  GI+HRD+KP N +++ +   +++ D+GLA   +  K+ N+               
Sbjct: 144 FIHESGIIHRDLKPANCLLNQDC-SVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNK 202

Query: 280 ---------VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI----------FRKEPF 320
                    V +R+++ PEL++  ++Y  S+D+WS GC+FA ++            + P 
Sbjct: 203 NLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPL 262

Query: 321 FYG-----------------HDNHDQLVKIAKVLGT---DELNAYLNKYHLELDPQLDAL 360
           F G                   N DQL  I  ++GT   D+L        ++        
Sbjct: 263 FPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLF--- 319

Query: 361 VGRHSRKPWSK-FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR 416
                     + + +       S + I+ L+ +L+++   R+T  +A+ HPY   VR
Sbjct: 320 -PHRKPINLKQKYPSI------SDDGINLLESMLKFNPNKRITIDQALDHPYLKDVR 369

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  181 bits (460), Expect = 6e-53
 Identities = 80/333 (24%), Positives = 145/333 (43%), Gaps = 54/333 (16%)

Query: 124 QDDYEVVR-KVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK---------REIKIL 173
           +D +E    KVGRG Y  V++    +  +     +      K+I+         REI +L
Sbjct: 19  EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYAL------KQIEGTGISMSACREIALL 72

Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL------------YPTLTDYDI 221
           + L   PNV+ L  +      +   L+F+Y    D   +               L    +
Sbjct: 73  RELKH-PNVISLQKVFLSHADRKVWLLFDYA-EHDLWHIIKFHRASKANKKPVQLPRGMV 130

Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRK---LRLIDWGLA-EFYHPGKEY- 276
           +  +Y++L  + Y H+  ++HRD+KP N+++  E  +   +++ D G A  F  P K   
Sbjct: 131 KSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLA 190

Query: 277 --NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD--------- 325
             +  V + +++ PELL+  + Y  ++D+W++GC+FA ++   EP F+            
Sbjct: 191 DLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL-TSEPIFHCRQEDIKTSNPY 249

Query: 326 NHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLV---- 381
           +HDQL +I  V+G      + +   +   P+   L+    R  ++               
Sbjct: 250 HHDQLDRIFNVMGFPADKDWEDIKKM---PEHSTLMKDFRRNTYTNCSLIKYMEKHKVKP 306

Query: 382 SPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 414
             +A   L KLL  D   R+T+ +AM  PYF +
Sbjct: 307 DSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLE 339

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  171 bits (436), Expect = 1e-48
 Identities = 74/308 (24%), Positives = 139/308 (45%), Gaps = 49/308 (15%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKI-----LKPVKKKKIKREIKILQNLCG 178
            + Y+ V+K+G G Y EV    +  T+    IKI     +      K+  E+ +L+ L  
Sbjct: 36  SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLL-D 94

Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYC 235
            PN++KL D   D+ +    L+ E        D  +      + D    I ++L  + Y 
Sbjct: 95  HPNIMKLYDFFEDKRNY--YLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYL 152

Query: 236 HSQGIMHRDVKPHNVMID--HELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           H   I+HRD+KP N++++   +   ++++D+GL+  +   K+   R+ + Y+  PE+L  
Sbjct: 153 HKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVL-- 210

Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 353
            + YD   D+WS+G +   ++    P F G  + + L K+ K            KY  + 
Sbjct: 211 RKKYDEKCDVWSIGVILFILLAGYPP-FGGQTDQEILRKVEK-----------GKYTFD- 257

Query: 354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA 413
                          W           VS  A D + ++L++D Q R++A++A+ HP+  
Sbjct: 258 ------------SPEWKN---------VSEGAKDLIKQMLQFDSQRRISAQQALEHPWIK 296

Query: 414 QVRAAESS 421
           ++ + + S
Sbjct: 297 EMCSKKES 304

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  164 bits (417), Expect = 1e-47
 Identities = 65/308 (21%), Positives = 113/308 (36%), Gaps = 61/308 (19%)

Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKI-----LKPVKKKKIKREIKILQNLCGG- 179
            Y +++++G G  S+VF+ +N    +   IK               + EI  L  L    
Sbjct: 29  IYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 87

Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL--YPTLTDYDIRYYIYELLKALDYCHS 237
             +++L D       +   ++ E  N      L    ++  ++ + Y   +L+A+   H 
Sbjct: 88  DKIIRLYDYEIT--DQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 145

Query: 238 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR---VASRYFKGPELLVDL 294
            GI+H D+KP N +I      L+LID+G+A    P     V+   V +  +  PE + D+
Sbjct: 146 HGIVHSDLKPANFLIVD--GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 203

Query: 295 ----------QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA 344
                            D+WSLGC+   M + K PF    +   +L  I           
Sbjct: 204 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID--------- 254

Query: 345 YLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAR 404
               + +E                               +  D L   L+ D + R++  
Sbjct: 255 --PNHEIEFPDI------------------------PEKDLQDVLKCCLKRDPKQRISIP 288

Query: 405 EAMAHPYF 412
           E +AHPY 
Sbjct: 289 ELLAHPYV 296

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  168 bits (428), Expect = 2e-47
 Identities = 73/309 (23%), Positives = 133/309 (43%), Gaps = 50/309 (16%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK------PVKKKKIKREIKILQNLC 177
            D Y+  R +G+G + EV    +  T + C +K++          K+ + RE+++L+ L 
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL- 83

Query: 178 GGPNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDY 234
             PN++KL +   D+      L+ E        D  +     ++ D    I ++L  + Y
Sbjct: 84  DHPNIMKLYEFFEDKGYF--YLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITY 141

Query: 235 CHSQGIMHRDVKPHNVMID--HELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 292
            H   I+HRD+KP N++++   +   +R+ID+GL+  +   K+   ++ + Y+  PE+L 
Sbjct: 142 MHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVL- 200

Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE 352
               YD   D+WS G +   ++    P F G + +D L K+              K    
Sbjct: 201 -HGTYDEKCDVWSTGVILYILLSGCPP-FNGANEYDILKKV-------------EKGKYT 245

Query: 353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 412
            +              W K         VS  A D + K+L Y    R++AR+A+ H + 
Sbjct: 246 FE-----------LPQWKK---------VSESAKDLIRKMLTYVPSMRISARDALDHEWI 285

Query: 413 AQVRAAESS 421
                 + S
Sbjct: 286 QTYTKEQIS 294

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  163 bits (414), Expect = 2e-47
 Identities = 60/308 (19%), Positives = 123/308 (39%), Gaps = 61/308 (19%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK----PVKKKKIKREIKILQNLCGG 179
            D +   RK+G G + +V      ++    +IK +      V  ++I+ EI++L++L   
Sbjct: 21  DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSL-DH 79

Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNS-------TDFKVLYPTLTDYDIRYYIYELLKAL 232
           PN++K+ ++  D H+    ++ E              +     L++  +   + +++ AL
Sbjct: 80  PNIIKIFEVFEDYHNM--YIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNAL 137

Query: 233 DYCHSQGIMHRDVKPHNVMID--HELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 290
            Y HSQ ++H+D+KP N++         +++ID+GLAE +   +       +  +  PE+
Sbjct: 138 AYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEV 197

Query: 291 LVDLQDYDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYL 346
               +D  +  D+WS G     +  G        F G    +   K              
Sbjct: 198 F--KRDVTFKCDIWSAGVVMYFLLTGC-----LPFTGTSLEEVQQKATYK---------- 240

Query: 347 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA 406
                    +                        ++P+A+D L ++L  D + R +A + 
Sbjct: 241 ---EPNYAVE-----------CRP----------LTPQAVDLLKQMLTKDPERRPSAAQV 276

Query: 407 MAHPYFAQ 414
           + H +F Q
Sbjct: 277 LHHEWFKQ 284

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  164 bits (418), Expect = 2e-47
 Identities = 65/308 (21%), Positives = 112/308 (36%), Gaps = 61/308 (19%)

Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKI-----LKPVKKKKIKREIKILQNLCGG- 179
            Y +++++G G  S+VF+ +N    +   IK               + EI  L  L    
Sbjct: 10  IYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68

Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL--YPTLTDYDIRYYIYELLKALDYCHS 237
             +++L D       +   ++ E  N      L    ++  ++ + Y   +L+A+   H 
Sbjct: 69  DKIIRLYDYEIT--DQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 126

Query: 238 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR---VASRYFKGPELLVD- 293
            GI+H D+KP N +I      L+LID+G+A    P     V+   V +  +  PE + D 
Sbjct: 127 HGIVHSDLKPANFLIVD--GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 184

Query: 294 ---------LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA 344
                            D+WSLGC+   M + K PF    +   +L  I           
Sbjct: 185 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID--------- 235

Query: 345 YLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAR 404
               + +E                               +  D L   L+ D + R++  
Sbjct: 236 --PNHEIEFPDI------------------------PEKDLQDVLKCCLKRDPKQRISIP 269

Query: 405 EAMAHPYF 412
           E +AHPY 
Sbjct: 270 ELLAHPYV 277

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  166 bits (421), Expect = 5e-47
 Identities = 58/301 (19%), Positives = 112/301 (37%), Gaps = 52/301 (17%)

Query: 126 DYEVVRKVGRGKYSE-VFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVK 184
            +     +G G     V+ G+    N    +K + P       RE+++L+     PNV++
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMF--DNRDVAVKRILPECFSFADREVQLLRESDEHPNVIR 82

Query: 185 LLDIVRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALDYCHSQGIM 241
                +D+  +   +  E   +T  + +          +    + +    L + HS  I+
Sbjct: 83  YFCTEKDRQFQ--YIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIV 140

Query: 242 HRDVKPHNVMIDHE----LRKLRLIDWGLAEFYHPGKEYNVR----VASRYFKGPELLVD 293
           HRD+KPHN++I         K  + D+GL +    G+    R      +  +  PE+L +
Sbjct: 141 HRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSE 200

Query: 294 L--QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL 351
              ++  Y++D++S GC+F  +I      F         + +                  
Sbjct: 201 DCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGA---------------- 244

Query: 352 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 411
                LD L       P                A + ++K++  D Q R +A+  + HP+
Sbjct: 245 ---CSLDCL------HPEKH---------EDVIARELIEKMIAMDPQKRPSAKHVLKHPF 286

Query: 412 F 412
           F
Sbjct: 287 F 287

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  163 bits (414), Expect = 5e-47
 Identities = 65/315 (20%), Positives = 130/315 (41%), Gaps = 63/315 (20%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL--KPVKKKKIKREIKILQNLCGGPN 181
            + Y +   +GRG++  V   +  ++ +  + K +  K   +  +K+EI IL       N
Sbjct: 4   YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIA-RHRN 62

Query: 182 VVKLLDIVRDQHSKTPSLIFEYVN---------STDFKVLYPTLTDYDIRYYIYELLKAL 232
           ++ L +           +IFE+++         ++ F+     L + +I  Y++++ +AL
Sbjct: 63  ILHLHESFESMEELV--MIFEFISGLDIFERINTSAFE-----LNEREIVSYVHQVCEAL 115

Query: 233 DYCHSQGIMHRDVKPHNVM-IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 291
            + HS  I H D++P N++        +++I++G A    PG  + +   +  +  PE+ 
Sbjct: 116 QFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVH 175

Query: 292 VDLQDYDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLN 347
                   + DMWSLG     + +G+       F    N   +  I              
Sbjct: 176 -QHDVVSTATDMWSLGTLVYVLLSGI-----NPFLAETNQQIIENIMNA----------- 218

Query: 348 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
                 D +            + +         +S EA+DF+D+LL  + + R+TA EA+
Sbjct: 219 --EYTFDEE-----------AFKE---------ISIEAMDFVDRLLVKERKSRMTASEAL 256

Query: 408 AHPYFAQVRAAESSR 422
            HP+  Q     S++
Sbjct: 257 QHPWLKQKIERVSTK 271

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  167 bits (424), Expect = 5e-47
 Identities = 69/315 (21%), Positives = 135/315 (42%), Gaps = 63/315 (20%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKI-----LKPVKKKKIKREIKILQNLCG 178
            + Y +V  +G+G + EV +  +  T +   +K+      K      I RE+++L+ L  
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL-D 79

Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY------PTLTDYDIRYYIYELLKAL 232
            PN++KL +I+ D  S    ++ E     +   L+         +++D    I ++   +
Sbjct: 80  HPNIMKLFEILEDSSSF--YIVGELYTGGE---LFDEIIKRKRFSEHDAARIIKQVFSGI 134

Query: 233 DYCHSQGIMHRDVKPHNVMID--HELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 290
            Y H   I+HRD+KP N++++   +   +++ID+GL+  +    +   R+ + Y+  PE+
Sbjct: 135 TYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEV 194

Query: 291 LVDLQDYDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYL 346
           L     YD   D+WS G     + +G      P FYG + +D L ++             
Sbjct: 195 L--RGTYDEKCDVWSAGVILYILLSG-----TPPFYGKNEYDILKRVET----------- 236

Query: 347 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA 406
            KY  +                W           +S +A D + K+L +    R+TA + 
Sbjct: 237 GKYAFD-------------LPQWRT---------ISDDAKDLIRKMLTFHPSLRITATQC 274

Query: 407 MAHPYFAQVRAAESS 421
           + HP+  +  +   +
Sbjct: 275 LEHPWIQKYSSETPT 289

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  164 bits (417), Expect = 8e-47
 Identities = 74/316 (23%), Positives = 136/316 (43%), Gaps = 64/316 (20%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERC---IIKILKPVKKKKIKREIKILQNLCGGP 180
            D Y+++ ++G G +  V   +   T        I    P+ K  +K EI I+  L   P
Sbjct: 50  YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHH-P 108

Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVN---------STDFKVLYPTLTDYDIRYYIYELLKA 231
            ++ L D   D++     LI E+++         + D+K     +++ ++  Y+ +  + 
Sbjct: 109 KLINLHDAFEDKYEMV--LILEFLSGGELFDRIAAEDYK-----MSEAEVINYMRQACEG 161

Query: 232 LDYCHSQGIMHRDVKPHNVMI-DHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 290
           L + H   I+H D+KP N+M    +   +++ID+GLA   +P +   V  A+  F  PE+
Sbjct: 162 LKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEI 221

Query: 291 LVDLQDYDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYL 346
           + D +   +  DMW++G     + +G+       F G D+ + L  + +           
Sbjct: 222 V-DREPVGFYTDMWAIGVLGYVLLSGL-----SPFAGEDDLETLQNVKRC---------- 265

Query: 347 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA 406
                E D              +S          VSPEA DF+  LL+ + + RLT  +A
Sbjct: 266 ---DWEFDED-----------AFSS---------VSPEAKDFIKNLLQKEPRKRLTVHDA 302

Query: 407 MAHPYFAQVRAAESSR 422
           + HP+     +  +SR
Sbjct: 303 LEHPWLKGDHSNLTSR 318

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  162 bits (413), Expect = 1e-46
 Identities = 72/309 (23%), Positives = 123/309 (39%), Gaps = 52/309 (16%)

Query: 124 QDDYEVVRKV-GRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNV 182
            DDY++ ++V G G   +V E  +  T ++C +K+L      K ++E+       GGP++
Sbjct: 27  TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLY--DSPKARQEVDHHWQASGGPHI 84

Query: 183 VKLLDIVRDQHSKTPS--LIFEYVNSTD-----FKVLYPTLTDYDIRYYIYELLKALDYC 235
           V +LD+  + H       +I E +   +      +      T+ +    + ++  A+ + 
Sbjct: 85  VCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFL 144

Query: 236 HSQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           HS  I HRDVKP N++     +   L+L D+G A+             + Y+  PE+L  
Sbjct: 145 HSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTP-CYTPYYVAPEVL-G 202

Query: 294 LQDYDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY 349
            + YD S DMWSLG     +  G      P FY +        + + +            
Sbjct: 203 PEKYDKSCDMWSLGVIMYILLCGF-----PPFYSNTGQAISPGMKRRIR---------LG 248

Query: 350 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 409
                              WS+         VS +A   +  LL+ D  +RLT  + M H
Sbjct: 249 QYGFP-----------NPEWSE---------VSEDAKQLIRLLLKTDPTERLTITQFMNH 288

Query: 410 PYFAQVRAA 418
           P+  Q    
Sbjct: 289 PWINQSMVV 297

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  161 bits (410), Expect = 2e-46
 Identities = 64/316 (20%), Positives = 126/316 (39%), Gaps = 58/316 (18%)

Query: 124 QDDYEVVRKV-GRGKYSEVFEGINVNTNERCIIKI-----LKPVKKKKIKREIKILQNLC 177
            + Y +  K  GRGK++ V + I+ +T +    K           + +I  EI +L+   
Sbjct: 27  NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAK 86

Query: 178 GGPNVVKLLDIVRDQHSKTPSLIFEYVNSTD-F----KVLYPTLTDYDIRYYIYELLKAL 232
             P V+ L ++  +       LI EY    + F      L   +++ D+   I ++L+ +
Sbjct: 87  SCPRVINLHEVYENTSEII--LILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGV 144

Query: 233 DYCHSQGIMHRDVKPHNVMID--HELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 290
            Y H   I+H D+KP N+++   + L  ++++D+G++       E    + +  +  PE+
Sbjct: 145 YYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEI 204

Query: 291 LVDLQDYDYSLDMWSLG----CMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYL 346
           L +      + DMW++G     +           F G DN +  + I++V          
Sbjct: 205 L-NYDPITTATDMWNIGIIAYMLLTHT-----SPFVGEDNQETYLNISQV---------- 248

Query: 347 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA 406
              +++              + +S          VS  A DF+  LL  + + R TA   
Sbjct: 249 ---NVDYS-----------EETFSS---------VSQLATDFIQSLLVKNPEKRPTAEIC 285

Query: 407 MAHPYFAQVRAAESSR 422
           ++H +  Q        
Sbjct: 286 LSHSWLQQWDFENLFH 301

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  161 bits (409), Expect = 2e-46
 Identities = 76/321 (23%), Positives = 139/321 (43%), Gaps = 61/321 (19%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK---------PVKKKKIKREIKILQ 174
           +D Y++  ++G G+++ V +    +T      K +K          V +++I+RE+ IL+
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70

Query: 175 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKA 231
            +    NV+ L D+  ++      LI E V+     DF     +L++ +   +I ++L  
Sbjct: 71  QV-LHHNVITLHDVYENRTDVV--LILELVSGGELFDFLAQKESLSEEEATSFIKQILDG 127

Query: 232 LDYCHSQGIMHRDVKPHNVMI---DHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 288
           ++Y H++ I H D+KP N+M+   +  +  ++LID+GLA     G E+     +  F  P
Sbjct: 128 VNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAP 187

Query: 289 ELLVDLQDYDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA 344
           E++ + +      DMWS+G     + +G        F G    + L  I  V        
Sbjct: 188 EIV-NYEPLGLEADMWSIGVITYILLSGA-----SPFLGDTKQETLANITSV-------- 233

Query: 345 YLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAR 404
                  + D +            +S           S  A DF+ KLL  + + RLT +
Sbjct: 234 -----SYDFDEE-----------FFSH---------TSELAKDFIRKLLVKETRKRLTIQ 268

Query: 405 EAMAHPYFAQVRAAESSRTRA 425
           EA+ HP+   V   ++   R 
Sbjct: 269 EALRHPWITPVDNQQAMVRRE 289

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  166 bits (423), Expect = 3e-46
 Identities = 66/372 (17%), Positives = 133/372 (35%), Gaps = 65/372 (17%)

Query: 69  TTVVYEGAIIDKIEERNLAEIPLPAMSKARVYTDVNVLRPKEYWDYESLTVQWGD-QDDY 127
             +  +     +  + +     +          D  V    + +  + + ++     D Y
Sbjct: 100 VLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHY 159

Query: 128 EVVRKVGRGKYSEVFEGINVNTNERC---IIKILKPVKKKKIKREIKILQNLCGGPNVVK 184
           ++  ++G G +  V       T        +       K+ +++EI+ +  L   P +V 
Sbjct: 160 DIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVL-RHPTLVN 218

Query: 185 LLDIVRDQHSKTPSLIFEYVN---------STDFKVLYPTLTDYDIRYYIYELLKALDYC 235
           L D   D +     +I+E+++             K     +++ +   Y+ ++ K L + 
Sbjct: 219 LHDAFEDDNEMV--MIYEFMSGGELFEKVADEHNK-----MSEDEAVEYMRQVCKGLCHM 271

Query: 236 HSQGIMHRDVKPHNVMI-DHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 294
           H    +H D+KP N+M       +L+LID+GL     P +   V   +  F  PE+  + 
Sbjct: 272 HENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVA-EG 330

Query: 295 QDYDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH 350
           +   Y  DMWS+G     + +G+       F G ++ + L  +                 
Sbjct: 331 KPVGYYTDMWSVGVLSYILLSGL-----SPFGGENDDETLRNVKSC-------------D 372

Query: 351 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHP 410
             +D              +S          +S +  DF+ KLL  D   R+T  +A+ HP
Sbjct: 373 WNMD-----------DSAFSG---------ISEDGKDFIRKLLLADPNTRMTIHQALEHP 412

Query: 411 YFAQVRAAESSR 422
           +     A     
Sbjct: 413 WLTPGNAPGRDS 424

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  163 bits (414), Expect = 3e-46
 Identities = 70/311 (22%), Positives = 122/311 (39%), Gaps = 53/311 (17%)

Query: 123 DQDDYEVVRKV-GRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPN 181
             DDY+V  +V G G   +V +  N  T E+  +K+L+     K +RE+++       P+
Sbjct: 59  IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ--DCPKARREVELHWRASQCPH 116

Query: 182 VVKLLDIVRDQHSKTPS--LIFEYVNSTD-----FKVLYPTLTDYDIRYYIYELLKALDY 234
           +V+++D+  + ++      ++ E ++  +             T+ +    +  + +A+ Y
Sbjct: 117 IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQY 176

Query: 235 CHSQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 292
            HS  I HRDVKP N++         L+L D+G A+             + Y+  PE+L 
Sbjct: 177 LHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL- 235

Query: 293 DLQDYDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVKI-AKVLGTDELNAYLN 347
             + YD S DMWSLG     +  G      P FY +        +  ++           
Sbjct: 236 GPEKYDKSCDMWSLGVIMYILLCGY-----PPFYSNHGLAISPGMKTRIR---------- 280

Query: 348 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
               E                WS+         VS E    +  LL+ +   R+T  E M
Sbjct: 281 MGQYEFP-----------NPEWSE---------VSEEVKMLIRNLLKTEPTQRMTITEFM 320

Query: 408 AHPYFAQVRAA 418
            HP+  Q    
Sbjct: 321 NHPWIMQSTKV 331

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  161 bits (410), Expect = 7e-46
 Identities = 65/308 (21%), Positives = 112/308 (36%), Gaps = 61/308 (19%)

Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKI-----LKPVKKKKIKREIKILQNLCG-G 179
            Y +++++G G  S+VF+ +N    +   IK               + EI  L  L    
Sbjct: 57  IYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 115

Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL--YPTLTDYDIRYYIYELLKALDYCHS 237
             +++L D       +   ++ E  N      L    ++  ++ + Y   +L+A+   H 
Sbjct: 116 DKIIRLYDYEIT--DQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 173

Query: 238 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR---VASRYFKGPELLVD- 293
            GI+H D+KP N +I      L+LID+G+A    P     V+   V +  +  PE + D 
Sbjct: 174 HGIVHSDLKPANFLIVD--GMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDM 231

Query: 294 ---------LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA 344
                            D+WSLGC+   M + K PF    +   +L  I           
Sbjct: 232 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID--------- 282

Query: 345 YLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAR 404
               + +E                               +  D L   L+ D + R++  
Sbjct: 283 --PNHEIEFPDI------------------------PEKDLQDVLKCCLKRDPKQRISIP 316

Query: 405 EAMAHPYF 412
           E +AHPY 
Sbjct: 317 ELLAHPYV 324

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  164 bits (417), Expect = 7e-46
 Identities = 73/311 (23%), Positives = 136/311 (43%), Gaps = 60/311 (19%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK----------------PVKKKKIKR 168
           + Y  VRK+G G Y EV      N +    IK++K                    ++I  
Sbjct: 36  ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYN 95

Query: 169 EIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTD-FK--VLYPTLTDYDIRYYI 225
           EI +L++L   PN++KL D+  D+      L+ E+    + F+  +      + D    +
Sbjct: 96  EISLLKSL-DHPNIIKLFDVFEDKKYF--YLVTEFYEGGELFEQIINRHKFDECDAANIM 152

Query: 226 YELLKALDYCHSQGIMHRDVKPHNVMID--HELRKLRLIDWGLAEFYHPGKEYNVRVASR 283
            ++L  + Y H   I+HRD+KP N++++  + L  ++++D+GL+ F+    +   R+ + 
Sbjct: 153 KQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTA 212

Query: 284 YFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELN 343
           Y+  PE+L   + Y+   D+WS G +   ++    P F G ++ D + K+ K        
Sbjct: 213 YYIAPEVL--KKKYNEKCDVWSCGVIMYILLCGYPP-FGGQNDQDIIKKVEK-------- 261

Query: 344 AYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA 403
               KY+ +                W           +S EA + +  +L YD+  R TA
Sbjct: 262 ---GKYYFD-------------FNDWKN---------ISDEAKELIKLMLTYDYNKRCTA 296

Query: 404 REAMAHPYFAQ 414
            EA+   +  +
Sbjct: 297 EEALNSRWIKK 307

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  157 bits (400), Expect = 2e-45
 Identities = 70/303 (23%), Positives = 120/303 (39%), Gaps = 55/303 (18%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL---KPVKKKKIKREIKILQNLCGGP 180
              Y +   +GRG + EV   +   T  R   K +         + K+EI+I+++L   P
Sbjct: 8   NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSL-DHP 66

Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCHS 237
           N+++L +   D       L+ E        +  V      + D    + ++L A+ YCH 
Sbjct: 67  NIIRLYETFEDNTDI--YLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHK 124

Query: 238 QGIMHRDVKPHNVMID--HELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 295
             + HRD+KP N +         L+LID+GLA  + PGK    +V + Y+  P++L    
Sbjct: 125 LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVL--EG 182

Query: 296 DYDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL 351
            Y    D WS G     +  G      P F    + + ++KI +             +  
Sbjct: 183 LYGPECDEWSAGVMMYVLLCGY-----PPFSAPTDSEVMLKIRE-----------GTFTF 226

Query: 352 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 411
                          K W           VSP+A   + +LL    + R+T+ +A+ H +
Sbjct: 227 P-------------EKDWLN---------VSPQAESLIRRLLTKSPKQRITSLQALEHEW 264

Query: 412 FAQ 414
           F +
Sbjct: 265 FEK 267

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  158 bits (401), Expect = 2e-45
 Identities = 72/320 (22%), Positives = 123/320 (38%), Gaps = 65/320 (20%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK------------PVKKKKIKREIK 171
            ++YE    +GRG  S V   I+  T +   +KI+                ++   +E+ 
Sbjct: 16  YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75

Query: 172 ILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYEL 228
           IL+ + G PN+++L D           L+F+ +      D+     TL++ + R  +  L
Sbjct: 76  ILRKVSGHPNIIQLKDTYETNTFF--FLVFDLMKKGELFDYLTEKVTLSEKETRKIMRAL 133

Query: 229 LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 288
           L+ +   H   I+HRD+KP N+++D ++  ++L D+G +    PG++      +  +  P
Sbjct: 134 LEVICALHKLNIVHRDLKPENILLDDDM-NIKLTDFGFSCQLDPGEKLREVCGTPSYLAP 192

Query: 289 ELL-----VDLQDYDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT 339
           E++      +   Y   +DMWS G     + AG      P F+       L  I      
Sbjct: 193 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS-----PPFWHRKQMLMLRMIMS---- 243

Query: 340 DELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQD 399
                    Y                   W            S    D + + L    Q 
Sbjct: 244 -------GNYQFG-------------SPEWDD---------YSDTVKDLVSRFLVVQPQK 274

Query: 400 RLTAREAMAHPYFAQVRAAE 419
           R TA EA+AHP+F Q    E
Sbjct: 275 RYTAEEALAHPFFQQYVVEE 294

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  157 bits (400), Expect = 3e-45
 Identities = 70/310 (22%), Positives = 134/310 (43%), Gaps = 57/310 (18%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKI-----LKPVKKKKIKREIKILQNLCG 178
            + Y +V  +G+G + EV +  +  T +   +K+      K      I RE+++L+ L  
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL-D 79

Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYC 235
            PN++KL +I+ D  S    ++ E        D  +     +++D    I ++   + Y 
Sbjct: 80  HPNIMKLFEILEDSSSF--YIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYM 137

Query: 236 HSQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           H   I+HRD+KP N++++   +   +++ID+GL+  +    +   R+ + Y+  PE+L  
Sbjct: 138 HKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL-- 195

Query: 294 LQDYDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY 349
              YD   D+WS G     + +G      P FYG + +D L ++              KY
Sbjct: 196 RGTYDEKCDVWSAGVILYILLSGT-----PPFYGKNEYDILKRVET-----------GKY 239

Query: 350 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 409
             +                W           +S +A D + K+L +    R+TA + + H
Sbjct: 240 AFD-------------LPQWRT---------ISDDAKDLIRKMLTFHPSLRITATQCLEH 277

Query: 410 PYFAQVRAAE 419
           P+  +  + E
Sbjct: 278 PWIQKYSSEE 287

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  157 bits (400), Expect = 4e-45
 Identities = 54/308 (17%), Positives = 110/308 (35%), Gaps = 30/308 (9%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK----IKREIKILQNLCGGP 180
             + +   +G+G  + VF G +  T +   IK+   +   +      RE ++L+ L    
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNH-K 67

Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVL-----YPTLTDYDIRYYIYELLKALDY 234
           N+VKL  I  +  ++   LI E+      + VL        L + +    + +++  +++
Sbjct: 68  NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127

Query: 235 CHSQGIMHRDVKPHNVMIDHELRK---LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 291
               GI+HR++KP N+M           +L D+G A      +++     +  +  P++ 
Sbjct: 128 LRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMY 187

Query: 292 -------VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA 344
                     + Y  ++D+WS+G  F        PF            + K++      A
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGA 247

Query: 345 YLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAR 404
                  E  P     +      P S  ++      +       L  +L  D +      
Sbjct: 248 ISGVQKAENGP-----IDWSGDMPVSCSLSRG----LQVLLTPVLANILEADQEKCWGFD 298

Query: 405 EAMAHPYF 412
           +  A    
Sbjct: 299 QFFAETSD 306

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score =  160 bits (406), Expect = 6e-45
 Identities = 74/338 (21%), Positives = 154/338 (45%), Gaps = 50/338 (14%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK--KKIKREIKILQNLC-----GG 179
           YEV++ +G+G + +V +  +   ++   +K+++  K+  ++   EI+IL++L        
Sbjct: 99  YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNT 158

Query: 180 PNVVKLLD---------IVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLK 230
            NV+ +L+         +  +  S   +L +E +    F+     L    +R + + +L+
Sbjct: 159 MNVIHMLENFTFRNHICMTFELLS--MNL-YELIKKNKFQGFSLPL----VRKFAHSILQ 211

Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHELR-KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
            LD  H   I+H D+KP N+++  + R  +++ID+G + + H  + Y   + SR+++ PE
Sbjct: 212 CLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH-QRVYTY-IQSRFYRAPE 269

Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLG----------- 338
           +++    Y   +DMWSLGC+ A +     P   G D  DQL  + ++LG           
Sbjct: 270 VILGA-RYGMPIDMWSLGCILAEL-LTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASK 327

Query: 339 --TDELNAYLNKYHLELDPQLDALVGRHSRK---------PWSKFINADNQHLVSPEAID 387
              + +++     +  +    D  V  +  +         P S+      +    P  +D
Sbjct: 328 RAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLD 387

Query: 388 FLDKLLRYDHQDRLTAREAMAHPYFAQVRAAESSRTRA 425
           FL + L +D   R+T  +A+ HP+  +      +  + 
Sbjct: 388 FLKQCLEWDPAVRMTPGQALRHPWLRRRLPKPPTGEKT 425

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  156 bits (396), Expect = 7e-45
 Identities = 73/316 (23%), Positives = 137/316 (43%), Gaps = 65/316 (20%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK---------PVKKKKIKREIKILQ 174
           +D YE+  ++G G+++ V +     T +    K +K          V +++I+RE+ IL+
Sbjct: 4   EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63

Query: 175 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST-----DFKVLYPTLTDYDIRYYIYELL 229
            +   PN++ L DI  ++      LI E V  +     DF     +LT+ +   ++ ++L
Sbjct: 64  EI-RHPNIITLHDIFENKTDVV--LILELV--SGGELFDFLAEKESLTEDEATQFLKQIL 118

Query: 230 KALDYCHSQGIMHRDVKPHNVMI---DHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 286
             + Y HS+ I H D+KP N+M+   +    +++LID+G+A     G E+     +  F 
Sbjct: 119 DGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFV 178

Query: 287 GPELLVDLQDYDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDEL 342
            PE++ + +      DMWS+G     + +G        F G    + L  I+ V      
Sbjct: 179 APEIV-NYEPLGLEADMWSIGVITYILLSGA-----SPFLGETKQETLTNISAV------ 226

Query: 343 NAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT 402
                  + + D +            +S           S  A DF+ +LL  D + R+T
Sbjct: 227 -------NYDFDEE-----------YFSN---------TSELAKDFIRRLLVKDPKRRMT 259

Query: 403 AREAMAHPYFAQVRAA 418
             +++ H +   +R  
Sbjct: 260 IAQSLEHSWIKAIRRR 275

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  158 bits (402), Expect = 8e-45
 Identities = 76/320 (23%), Positives = 141/320 (44%), Gaps = 61/320 (19%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK---------PVKKKKIKREIKILQ 174
           +D Y++  ++G G+++ V +    +T      K +K          V +++I+RE+ IL+
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70

Query: 175 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKA 231
            +   PN++ L D+  ++      LI E V+     DF     +L++ +   +I ++L  
Sbjct: 71  QV-LHPNIITLHDVYENRTDVV--LILELVSGGELFDFLAQKESLSEEEATSFIKQILDG 127

Query: 232 LDYCHSQGIMHRDVKPHNVMI---DHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 288
           ++Y H++ I H D+KP N+M+   +  +  ++LID+GLA     G E+     +  F  P
Sbjct: 128 VNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAP 187

Query: 289 ELLVDLQDYDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA 344
           E++ + +      DMWS+G     + +G        F G    + L  I  V        
Sbjct: 188 EIV-NYEPLGLEADMWSIGVITYILLSGA-----SPFLGDTKQETLANITAV-------- 233

Query: 345 YLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAR 404
                  + D +            +S+          S  A DF+ KLL  + + RLT +
Sbjct: 234 -----SYDFDEE-----------FFSQ---------TSELAKDFIRKLLVKETRKRLTIQ 268

Query: 405 EAMAHPYFAQVRAAESSRTR 424
           EA+ HP+   V   ++   R
Sbjct: 269 EALRHPWITPVDTQQAMVRR 288

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  156 bits (397), Expect = 9e-45
 Identities = 62/299 (20%), Positives = 101/299 (33%), Gaps = 52/299 (17%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-----PVKKKKIKREIKILQNLCG 178
           Q  ++ + ++G G Y EVF+  +        +K        P  + +   E+   + +  
Sbjct: 56  QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQ 115

Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYC 235
            P  V+L      +      L  E    +  +       +L +  +  Y+ + L AL + 
Sbjct: 116 HPCCVRLEQ--AWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHL 173

Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 295
           HSQG++H DVKP N+ +    R  +L D+GL           V+     +  PELL    
Sbjct: 174 HSQGLVHLDVKPANIFLGPRGR-CKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQG-- 230

Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP 355
            Y  + D++SLG     +    E    G     QL +                   E   
Sbjct: 231 SYGTAADVFSLGLTILEVACNMELPHGGEGWQ-QLRQ--------------GYLPPEFTA 275

Query: 356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 414
            L                        S E    L  +L  D + R TA   +A P   Q
Sbjct: 276 GL------------------------SSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  156 bits (396), Expect = 1e-44
 Identities = 65/321 (20%), Positives = 111/321 (34%), Gaps = 70/321 (21%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK--PVKKKKIKREIKILQNLCGGPN 181
             D+E +  +G+G + +V +  N   +    IK ++    K   I  E+ +L +L     
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASL-NHQY 63

Query: 182 VVKLLDIVRDQHSKTPS-----------LIFEYVNS---TDFKVLYPTLTDYD-IRYYIY 226
           VV+      ++ +               +  EY  +    D           D       
Sbjct: 64  VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR 123

Query: 227 ELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 286
           ++L+AL Y HSQGI+HRD+KP N+ ID   R +++ D+GLA+  H   +     +     
Sbjct: 124 QILEALSYIHSQGIIHRDLKPMNIFIDES-RNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182

Query: 287 G---------------PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
                            E+L     Y+  +DM+SLG +F  MI+   PF  G      ++
Sbjct: 183 SSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM-ERVNIL 238

Query: 332 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDK 391
           K             L    +E  P                                 +  
Sbjct: 239 KK------------LRSVSIEFPPDF-----------DDNK---------MKVEKKIIRL 266

Query: 392 LLRYDHQDRLTAREAMAHPYF 412
           L+ +D   R  AR  +   + 
Sbjct: 267 LIDHDPNKRPGARTLLNSGWL 287

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  157 bits (398), Expect = 1e-44
 Identities = 70/316 (22%), Positives = 135/316 (42%), Gaps = 61/316 (19%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK---------PVKKKKIKREIKILQ 174
            D Y+   ++G G+++ V +    +T  +   K +K          V ++ I+RE+ IL+
Sbjct: 10  DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69

Query: 175 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKA 231
            +   PNV+ L ++  ++      LI E V      DF     +LT+ +   ++ ++L  
Sbjct: 70  EI-QHPNVITLHEVYENKTDVI--LILELVAGGELFDFLAEKESLTEEEATEFLKQILNG 126

Query: 232 LDYCHSQGIMHRDVKPHNVMI---DHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 288
           + Y HS  I H D+KP N+M+   +    ++++ID+GLA     G E+     +  F  P
Sbjct: 127 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186

Query: 289 ELLVDLQDYDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA 344
           E++ + +      DMWS+G     + +G        F G    + L  ++ V        
Sbjct: 187 EIV-NYEPLGLEADMWSIGVITYILLSGA-----SPFLGDTKQETLANVSAV-------- 232

Query: 345 YLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAR 404
                + E + +            +S           S  A DF+ +LL  D + R+T +
Sbjct: 233 -----NYEFEDE-----------YFSN---------TSALAKDFIRRLLVKDPKKRMTIQ 267

Query: 405 EAMAHPYFAQVRAAES 420
           +++ HP+       ++
Sbjct: 268 DSLQHPWIKPKDTQQA 283

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  157 bits (400), Expect = 2e-44
 Identities = 74/353 (20%), Positives = 150/353 (42%), Gaps = 63/353 (17%)

Query: 90  PLPAMSKARVYTDVNVLRPKEYWDYESLTVQWGD-QDDYEVVRK--VGRGKYSEVFEGIN 146
            +P  SK      V++  P   +D+  +T + G     Y V +   +G G++ +V +   
Sbjct: 51  RMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEE 110

Query: 147 VNTNERC---IIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEY 203
             T  +    IIK      K+++K EI ++  L    N+++L D    ++     L+ EY
Sbjct: 111 TATGLKLAAKIIKTRGMKDKEEVKNEISVMNQL-DHANLIQLYDAFESKNDIV--LVMEY 167

Query: 204 VNS-------TDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM-IDHE 255
           V+         D        T+ D   ++ ++ + + + H   I+H D+KP N++ ++ +
Sbjct: 168 VDGGELFDRIIDESYNL---TELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRD 224

Query: 256 LRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLG----CMFA 311
            +++++ID+GLA  Y P ++  V   +  F  PE++ +     +  DMWS+G     + +
Sbjct: 225 AKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVV-NYDFVSFPTDMWSVGVIAYMLLS 283

Query: 312 GMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSK 371
           G+       F G ++ + L  I                  +L+ +            +  
Sbjct: 284 GL-----SPFLGDNDAETLNNILAC-------------RWDLEDE-----------EFQD 314

Query: 372 FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAESSRTR 424
                    +S EA +F+ KLL  +   R++A EA+ HP+ +  +       +
Sbjct: 315 ---------ISEEAKEFISKLLIKEKSWRISASEALKHPWLSDHKLHSRLSAQ 358

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  157 bits (398), Expect = 2e-44
 Identities = 71/311 (22%), Positives = 134/311 (43%), Gaps = 56/311 (18%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKI-----LKPVKKKKIKREIKILQNLCG 178
            D+Y+V  ++G+G +S V   ++  T      KI     L     +K++RE +I + L  
Sbjct: 28  SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87

Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYC 235
            PN+V+L D ++++      L+F+ V      +  V     ++ D  + I ++L+++ YC
Sbjct: 88  -PNIVRLHDSIQEESFH--YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYC 144

Query: 236 HSQGIMHRDVKPHNVMIDHELR--KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           HS GI+HR++KP N+++  + +   ++L D+GLA   +  + ++    +  +  PE+L  
Sbjct: 145 HSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVL-K 203

Query: 294 LQDYDYSLDMWSLGCMF----AGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY 349
              Y   +D+W+ G +      G      P F+  D H    +I               Y
Sbjct: 204 KDPYSKPVDIWACGVILYILLVGY-----PPFWDEDQHRLYAQIKA-----------GAY 247

Query: 350 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 409
                              W           V+PEA   +D +L  + + R+TA +A+  
Sbjct: 248 DYP-------------SPEWDT---------VTPEAKSLIDSMLTVNPKKRITADQALKV 285

Query: 410 PYFAQVRAAES 420
           P+        S
Sbjct: 286 PWICNRERVAS 296

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  158 bits (401), Expect = 4e-44
 Identities = 55/322 (17%), Positives = 111/322 (34%), Gaps = 69/322 (21%)

Query: 124 QDDYEVVRKVGRGKYSEV-FEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNV 182
           ++     + +G G    V F+G          +K +          EIK+L      PNV
Sbjct: 14  KNLVVSEKILGYGSSGTVVFQGSF--QGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNV 71

Query: 183 VKLLDIVRDQHSKTPSLIFEYVNST---------DFKVLYPTLTDYDIRYYIYELLKALD 233
           ++              +  E  N                     +Y+    + ++   + 
Sbjct: 72  IRYYCSETTDRFL--YIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 129

Query: 234 YCHSQGIMHRDVKPHNVMID------------HELRKLRLIDWGLAEFYHPGKEY----- 276
           + HS  I+HRD+KP N+++              E  ++ + D+GL +    G+       
Sbjct: 130 HLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNL 189

Query: 277 NVRVASRYFKGPELLVDLQD------YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL 330
           N    +  ++ PELL +  +         S+D++S+GC+F  ++ + +  F   D + + 
Sbjct: 190 NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG--DKYSRE 247

Query: 331 VKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLD 390
             I +             + L+                            +  EA D + 
Sbjct: 248 SNIIR-----------GIFSLDEMK----------CLHDRS---------LIAEATDLIS 277

Query: 391 KLLRYDHQDRLTAREAMAHPYF 412
           +++ +D   R TA + + HP F
Sbjct: 278 QMIDHDPLKRPTAMKVLRHPLF 299

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  153 bits (390), Expect = 6e-44
 Identities = 71/311 (22%), Positives = 134/311 (43%), Gaps = 56/311 (18%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKI-----LKPVKKKKIKREIKILQNLCG 178
            D+Y+V  ++G+G +S V   ++  T      KI     L     +K++RE +I + L  
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64

Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYC 235
            PN+V+L D ++++      L+F+ V      +  V     ++ D  + I ++L+++ YC
Sbjct: 65  -PNIVRLHDSIQEESFH--YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYC 121

Query: 236 HSQGIMHRDVKPHNVMIDHELR--KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           HS GI+HR++KP N+++  + +   ++L D+GLA   +  + ++    +  +  PE+L  
Sbjct: 122 HSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVL-K 180

Query: 294 LQDYDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY 349
              Y   +D+W+ G     +  G      P F+  D H    +I               Y
Sbjct: 181 KDPYSKPVDIWACGVILYILLVGY-----PPFWDEDQHRLYAQIKA-----------GAY 224

Query: 350 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 409
                              W           V+PEA   +D +L  + + R+TA +A+  
Sbjct: 225 DYP-------------SPEWDT---------VTPEAKSLIDSMLTVNPKKRITADQALKV 262

Query: 410 PYFAQVRAAES 420
           P+        S
Sbjct: 263 PWICNRERVAS 273

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  154 bits (392), Expect = 2e-43
 Identities = 68/313 (21%), Positives = 126/313 (40%), Gaps = 64/313 (20%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKK-----------KIKREIKIL 173
             Y+    +GRG  S V   ++  T     +KI++   ++             +RE  IL
Sbjct: 94  QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHIL 153

Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLK 230
           + + G P+++ L+D           L+F+ +      D+      L++ + R  +  LL+
Sbjct: 154 RQVAGHPHIITLIDSYESSSFM--FLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLE 211

Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 290
           A+ + H+  I+HRD+KP N+++D  + ++RL D+G +    PG++      +  +  PE+
Sbjct: 212 AVSFLHANNIVHRDLKPENILLDDNM-QIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEI 270

Query: 291 L-----VDLQDYDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDE 341
           L          Y   +D+W+ G     + AG      P F+       L  I +      
Sbjct: 271 LKCSMDETHPGYGKEVDLWACGVILFTLLAGS-----PPFWHRRQILMLRMIME------ 319

Query: 342 LNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL 401
                 +Y                   W            S    D + +LL+ D + RL
Sbjct: 320 -----GQYQFS-------------SPEWDD---------RSSTVKDLISRLLQVDPEARL 352

Query: 402 TAREAMAHPYFAQ 414
           TA +A+ HP+F +
Sbjct: 353 TAEQALQHPFFER 365

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  154 bits (390), Expect = 3e-43
 Identities = 71/349 (20%), Positives = 124/349 (35%), Gaps = 95/349 (27%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK--------PVKKKKIKREIKILQN 175
           Q  Y +   +G+G Y  V   I   T     IKI+         P   ++IK E+++++ 
Sbjct: 25  QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84

Query: 176 LCGGPNVVKLLDIVRDQHSKTPSLIFEYV------------------------------- 204
           L   PN+ +L ++  D+      L+ E                                 
Sbjct: 85  LHH-PNIARLYEVYEDEQYI--CLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICP 141

Query: 205 ------------NSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI 252
                            + L     +  I   + ++  AL Y H+QGI HRD+KP N + 
Sbjct: 142 CPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLF 201

Query: 253 DH-ELRKLRLIDWGLAEFYHPGKE-----YNVRVASRYFKGPELL-VDLQDYDYSLDMWS 305
              +  +++L+D+GL++ ++            +  + YF  PE+L    + Y    D WS
Sbjct: 202 STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261

Query: 306 LGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHS 365
            G +   ++    PF     N      I++VL             L  +           
Sbjct: 262 AGVLLHLLLMGAVPFP--GVNDADT--ISQVL----------NKKLCFE----------- 296

Query: 366 RKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 414
              ++          +SP A D L  LL  +  +R  A  A+ HP+ +Q
Sbjct: 297 NPNYNV---------LSPLARDLLSNLLNRNVDERFDAMRALQHPWISQ 336

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  152 bits (385), Expect = 9e-43
 Identities = 69/315 (21%), Positives = 128/315 (40%), Gaps = 53/315 (16%)

Query: 124 QDDYEV---VRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGP 180
              Y++    + +G G +S   + ++  +N+   +KI+    +   ++EI  L+   G P
Sbjct: 7   YQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHP 66

Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTD-F-----KVLYPTLTDYDIRYYIYELLKALDY 234
           N+VKL ++  DQ      L+ E +N  + F     K  +   ++ +  Y + +L+ A+ +
Sbjct: 67  NIVKLHEVFHDQLHT--FLVMELLNGGELFERIKKKKHF---SETEASYIMRKLVSAVSH 121

Query: 235 CHSQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHP-GKEYNVRVASRYFKGPELL 291
            H  G++HRD+KP N++     +  ++++ID+G A    P  +       + ++  PELL
Sbjct: 122 MHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELL 181

Query: 292 VDLQDYDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLN 347
            +   YD S D+WSLG     M +G        F  HD         +++        + 
Sbjct: 182 -NQNGYDESCDLWSLGVILYTMLSGQ-----VPFQSHDRSLTCTSAVEIM------KKIK 229

Query: 348 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
           K     +            + W           VS EA D +  LL  D   RL      
Sbjct: 230 KGDFSFEG-----------EAWKN---------VSQEAKDLIQGLLTVDPNKRLKMSGLR 269

Query: 408 AHPYFAQVRAAESSR 422
            + +        S+ 
Sbjct: 270 YNEWLQDGSQLSSNP 284

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  153 bits (389), Expect = 2e-42
 Identities = 69/319 (21%), Positives = 125/319 (39%), Gaps = 63/319 (19%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL-----------KPVKKKKIKREIKI 172
           +D+Y + + +G G   EV       T ++  I+I+           +      ++ EI+I
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193

Query: 173 LQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNS---TDFKVLYPTLTDYDIRYYIYELL 229
           L+ L   P ++K+ +    +      ++ E +      D  V    L +   + Y Y++L
Sbjct: 194 LKKL-NHPCIIKIKNFFDAEDY---YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML 249

Query: 230 KALDYCHSQGIMHRDVKPHNVMID--HELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG 287
            A+ Y H  GI+HRD+KP NV++    E   +++ D+G ++             +  +  
Sbjct: 250 LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLA 309

Query: 288 PELLVDLQD--YDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDE 341
           PE+LV +    Y+ ++D WSLG       +G      PF           +I        
Sbjct: 310 PEVLVSVGTAGYNRAVDCWSLGVILFICLSGY----PPFSEHRTQVSLKDQITS------ 359

Query: 342 LNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL 401
                 KY+   +              W++         VS +A+D + KLL  D + R 
Sbjct: 360 -----GKYNFIPE-------------VWAE---------VSEKALDLVKKLLVVDPKARF 392

Query: 402 TAREAMAHPYFAQVRAAES 420
           T  EA+ HP+         
Sbjct: 393 TTEEALRHPWLQDEDMKRK 411

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  151 bits (384), Expect = 2e-42
 Identities = 71/319 (22%), Positives = 135/319 (42%), Gaps = 65/319 (20%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK--------PVKKKKIKREIKILQN 175
           +D YE+   +G+G +S V   IN  T ++  +KI+          +  + +KRE  I   
Sbjct: 23  EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82

Query: 176 LCGGPNVVKLLDIVRDQHSKTPSLIFEYVNS-------TDFKVLYPTLTDYDIRYYIYEL 228
           L   P++V+LL+           ++FE+++                  ++    +Y+ ++
Sbjct: 83  L-KHPHIVELLETYSSDGML--YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQI 139

Query: 229 LKALDYCHSQGIMHRDVKPHNVMID--HELRKLRLIDWGLA-EFYHPGKEYNVRVASRYF 285
           L+AL YCH   I+HRDVKPH V++        ++L  +G+A +    G     RV + +F
Sbjct: 140 LEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHF 199

Query: 286 KGPELLVDLQDYDYSLDMWSLG----CMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDE 341
             PE++   + Y   +D+W  G     + +G      PF   +   ++L +   ++    
Sbjct: 200 MAPEVV-KREPYGKPVDVWGCGVILFILLSGC----LPF---YGTKERLFE--GII---- 245

Query: 342 LNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL 401
                 K   +++P           + WS          +S  A D + ++L  D  +R+
Sbjct: 246 ------KGKYKMNP-----------RQWSH---------ISESAKDLVRRMLMLDPAERI 279

Query: 402 TAREAMAHPYFAQVRAAES 420
           T  EA+ HP+  +      
Sbjct: 280 TVYEALNHPWLKERDRYAY 298

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  151 bits (383), Expect = 3e-42
 Identities = 49/336 (14%), Positives = 87/336 (25%), Gaps = 71/336 (21%)

Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL------KPVKKKKIKREIKILQNL--- 176
             ++V  +  G  S VF   +V   E   +K+          + +++         L   
Sbjct: 63  KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122

Query: 177 --------------------CGGPNVVKLLDIVRDQHSKTPSLIFEYVNST--------- 207
                                  P   +L     D       L+    +           
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182

Query: 208 DFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 267
              V         +     +L++      S+G++H    P N+ I  + R L L D    
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGR-LMLGDVSAL 241

Query: 268 EFYHPGKEYNVRVASRYFKGPELL-VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN 326
             +  G           +   E L      + ++L+ W LG     +     PF      
Sbjct: 242 --WKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPG 299

Query: 327 HDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAI 386
                K   +                          R        F +      +     
Sbjct: 300 IKGSWKRPSL--------------------------RVPGTDSLAFGSCTP---LPDFVK 330

Query: 387 DFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAESSR 422
             + + L +D + RL   EAM  P F Q++   SS 
Sbjct: 331 TLIGRFLNFDRRRRLLPLEAMETPEFLQLQNEISSS 366

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  150 bits (382), Expect = 4e-42
 Identities = 75/306 (24%), Positives = 121/306 (39%), Gaps = 55/306 (17%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIK-ILKPVKKKKIKREIKILQNLCGGPNV 182
            D +EV  ++GRG  S V+      T +   +K + K V KK ++ EI +L  L   PN+
Sbjct: 52  SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSH-PNI 110

Query: 183 VKLLDIVRDQHSKTPSLIFEYVNST-----DFKVLYPTLTDYDIRYYIYELLKALDYCHS 237
           +KL +I         SL+ E V  T     D  V     ++ D    + ++L+A+ Y H 
Sbjct: 111 IKLKEIFETPTEI--SLVLELV--TGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHE 166

Query: 238 QGIMHRDVKPHNVMIDHELR--KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 295
            GI+HRD+KP N++         L++ D+GL++             +  +  PE+L    
Sbjct: 167 NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRG-C 225

Query: 296 DYDYSLDMWSLGCMF----AGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL 351
            Y   +DMWS+G +      G        FY       +    ++L              
Sbjct: 226 AYGPEVDMWSVGIITYILLCGF-----EPFYDERGDQFM--FRRIL----------NCEY 268

Query: 352 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 411
                            W +         VS  A D + KL+  D + RLT  +A+ HP+
Sbjct: 269 YFIS-----------PWWDE---------VSLNAKDLVRKLIVLDPKKRLTTFQALQHPW 308

Query: 412 FAQVRA 417
                A
Sbjct: 309 VTGKAA 314

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  149 bits (379), Expect = 3e-41
 Identities = 54/307 (17%), Positives = 107/307 (34%), Gaps = 34/307 (11%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGP 180
             + +   +G+G  + VF G +  T +   IK+   +          RE ++L+ L    
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNH-K 67

Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVL-----YPTLTDYDIRYYIYELLKALDY 234
           N+VKL  I  +  ++   LI E+      + VL        L + +    + +++  +++
Sbjct: 68  NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127

Query: 235 CHSQGIMHRDVKPHNVMIDHELRK---LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 291
               GI+HR++KP N+M           +L D+G A      +++     +  +  P++ 
Sbjct: 128 LRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMY 187

Query: 292 -------VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA 344
                     + Y  ++D+WS+G  F        PF            + K++      A
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGA 247

Query: 345 YLNKYHLELDPQLDALVGRHSRKPWSKFINADNQ--HLVSPEAIDFLDKLLRYDHQDRLT 402
                  E  P             WS  +         +       L  +L  D +    
Sbjct: 248 ISGVQKAENGP-----------IDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWG 296

Query: 403 AREAMAH 409
             +  A 
Sbjct: 297 FDQFFAE 303

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  148 bits (376), Expect = 3e-41
 Identities = 71/305 (23%), Positives = 116/305 (38%), Gaps = 50/305 (16%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVK 184
           D YEV   +G G YS     I+  TN    +KI+    K+    EI+IL      PN++ 
Sbjct: 22  DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIID-KSKRDPTEEIEILLRYGQHPNIIT 80

Query: 185 LLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIM 241
           L D+  D       ++ E +      D  +     ++ +    ++ + K ++Y H+QG++
Sbjct: 81  LKDVYDDGKYV--YVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVV 138

Query: 242 HRDVKPHNVMI---DHELRKLRLIDWGLAEFYHPGKE-YNVRVASRYFKGPELLVDLQDY 297
           HRD+KP N++          +R+ D+G A+              +  F  PE+L + Q Y
Sbjct: 139 HRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVL-ERQGY 197

Query: 298 DYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 353
           D + D+WSLG     M  G        F    +      +A++                L
Sbjct: 198 DAACDIWSLGVLLYTMLTGY-----TPFANGPDDTPEEILARIG----------SGKFSL 242

Query: 354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA 413
                          W+          VS  A D + K+L  D   RLTA   + HP+  
Sbjct: 243 S-----------GGYWNS---------VSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIV 282

Query: 414 QVRAA 418
                
Sbjct: 283 HWDQL 287

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  146 bits (372), Expect = 4e-41
 Identities = 70/311 (22%), Positives = 119/311 (38%), Gaps = 59/311 (18%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL---KPVKKKKIKREIKILQNLCGGP 180
           +  +  +  +G G +SEVF      T +   +K +      +   ++ EI +L+ +    
Sbjct: 8   RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKH-E 66

Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNST-----DFKVLYPTLTDYDIRYYIYELLKALDYC 235
           N+V L DI          L+ + V  +     D  +     T+ D    I ++L A+ Y 
Sbjct: 67  NIVTLEDIYESTTHY--YLVMQLV--SGGELFDRILERGVYTEKDASLVIQQVLSAVKYL 122

Query: 236 HSQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           H  GI+HRD+KP N++     E  K+ + D+GL++    G   +    +  +  PE+L  
Sbjct: 123 HENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI-MSTACGTPGYVAPEVLAQ 181

Query: 294 LQDYDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY 349
            + Y  ++D WS+G     +  G      P FY         KI +             Y
Sbjct: 182 -KPYSKAVDCWSIGVITYILLCGY-----PPFYEETESKLFEKIKE-----------GYY 224

Query: 350 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 409
             E                W           +S  A DF+  LL  D  +R T  +A++H
Sbjct: 225 EFE-------------SPFWDD---------ISESAKDFICHLLEKDPNERYTCEKALSH 262

Query: 410 PYFAQVRAAES 420
           P+     A   
Sbjct: 263 PWIDGNTALHR 273

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  147 bits (372), Expect = 4e-41
 Identities = 66/321 (20%), Positives = 132/321 (41%), Gaps = 60/321 (18%)

Query: 124 QDDYEVVRKV-GRGKYSEVFEGINVNTNERCIIKIL---KPVKKKKIKREIKILQNLCGG 179
           +D Y++   V G G ++ V   IN+ T++   +KI+       + ++ RE+++L    G 
Sbjct: 11  EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGH 70

Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTD-F-----KVLYPTLTDYDIRYYIYELLKALD 233
            NV++L++   ++      L+FE +           +  +    + +    + ++  ALD
Sbjct: 71  RNVLELIEFFEEEDRF--YLVFEKMRGGSILSHIHKRRHF---NELEASVVVQDVASALD 125

Query: 234 YCHSQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGKEYNV--------RVASR 283
           + H++GI HRD+KP N++ +H  ++  +++ D+ L        + +            S 
Sbjct: 126 FLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSA 185

Query: 284 YFKGPELL----VDLQDYDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVKIAK 335
            +  PE++     +   YD   D+WSLG     + +G      P F G    D      +
Sbjct: 186 EYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGY-----PPFVGRCGSDCGWDRGE 240

Query: 336 VLGTDELNAYLN--KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLL 393
                +   + +  +   E              K W+          +S  A D + KLL
Sbjct: 241 ACPACQNMLFESIQEGKYEFP-----------DKDWAH---------ISCAAKDLISKLL 280

Query: 394 RYDHQDRLTAREAMAHPYFAQ 414
             D + RL+A + + HP+   
Sbjct: 281 VRDAKQRLSAAQVLQHPWVQG 301

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score =  148 bits (375), Expect = 5e-41
 Identities = 77/347 (22%), Positives = 150/347 (43%), Gaps = 61/347 (17%)

Query: 127 YEVVRKVGRGKYSEVFEGI-NVNTNERCIIKILKPVKK--KKIKREIKILQNLC-----G 178
           YE+V  +G G + +V E + +     +  +KI++ V K  +  + EI +L+ +       
Sbjct: 21  YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKEN 80

Query: 179 GPNVVKLLD---------IVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELL 229
               V + D         I  +      +  FE++   +F+          +R+  Y+L 
Sbjct: 81  KFLCVLMSDWFNFHGHMCIAFELLG--KNT-FEFLKENNFQPYPLPH----VRHMAYQLC 133

Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRK------------------LRLIDWGLAEFYH 271
            AL + H   + H D+KP N++  +   +                  +R+ D+G A F H
Sbjct: 134 HALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDH 193

Query: 272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
                 + VA+R+++ PE++++L  +    D+WS+GC+     +R    F  H+N + LV
Sbjct: 194 E-HHTTI-VATRHYRPPEVILELG-WAQPCDVWSIGCILFEY-YRGFTLFQTHENREHLV 249

Query: 332 KIAKVLGT--DEL--NAYLNKYHLE-----LDPQLDALVGRHSRKPWSKFINADNQHLVS 382
            + K+LG     +       KY  +      +   D    + + KP   ++  D+     
Sbjct: 250 MMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEH-- 307

Query: 383 PEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV----RAAESSRTRA 425
            +  D + ++L +D   R+T  EA+ HP+FA +    R+  +SR  +
Sbjct: 308 VQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEERSFHTSRNPS 354

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  147 bits (372), Expect = 5e-41
 Identities = 71/313 (22%), Positives = 125/313 (39%), Gaps = 63/313 (20%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----------KKKIKREIKI 172
           +D+Y + + +G G   EV       T ++  IKI+   K              ++ EI+I
Sbjct: 9   RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68

Query: 173 LQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELL 229
           L+ L   P ++K+ +    +      ++ E +      D  V    L +   + Y Y++L
Sbjct: 69  LKKL-NHPCIIKIKNFFDAEDY---YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML 124

Query: 230 KALDYCHSQGIMHRDVKPHNVMID--HELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG 287
            A+ Y H  GI+HRD+KP NV++    E   +++ D+G ++             +  +  
Sbjct: 125 LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLA 184

Query: 288 PELLVDLQD--YDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDE 341
           PE+LV +    Y+ ++D WSLG       +G      PF           +I        
Sbjct: 185 PEVLVSVGTAGYNRAVDCWSLGVILFICLSGY----PPFSEHRTQVSLKDQITS------ 234

Query: 342 LNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL 401
                 KY+   +              W++         VS +A+D + KLL  D + R 
Sbjct: 235 -----GKYNFIPE-------------VWAE---------VSEKALDLVKKLLVVDPKARF 267

Query: 402 TAREAMAHPYFAQ 414
           T  EA+ HP+   
Sbjct: 268 TTEEALRHPWLQD 280

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score =  147 bits (373), Expect = 7e-41
 Identities = 75/338 (22%), Positives = 145/338 (42%), Gaps = 65/338 (19%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTN-ERCIIKILKPVKK--KKIKREIKILQNLC-----G 178
           YE+V  +G G + +V E I+         +KI+K V +  +  + EI++L++L       
Sbjct: 16  YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNS 75

Query: 179 GPNVVKLLD---------IVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELL 229
               V++L+         IV +      S  ++++    F           IR   Y++ 
Sbjct: 76  TFRCVQMLEWFEHHGHICIVFELLG--LST-YDFIKENGFLPFRLDH----IRKMAYQIC 128

Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELR------------------KLRLIDWGLAEFYH 271
           K++++ HS  + H D+KP N++                         ++++D+G A +  
Sbjct: 129 KSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDD 188

Query: 272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNH 327
                 + V++R+++ PE+++ L  +    D+WS+GC     + G        F  HD+ 
Sbjct: 189 E-HHSTL-VSTRHYRAPEVILALG-WSQPCDVWSIGCILIEYYLG-----FTVFPTHDSK 240

Query: 328 DQLVKIAKVLGT--DEL--NAYLNKYH--LELDPQLDALVGRHSR---KPWSKFINADNQ 378
           + L  + ++LG     +       KY     LD    +  GR+     KP  +F+ + + 
Sbjct: 241 EHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDV 300

Query: 379 HLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR 416
                   D + K+L YD   R+T REA+ HP+F  ++
Sbjct: 301 EH--ERLFDLIQKMLEYDPAKRITLREALKHPFFDLLK 336

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  147 bits (374), Expect = 8e-41
 Identities = 71/332 (21%), Positives = 138/332 (41%), Gaps = 39/332 (11%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK--KKIKREIKILQNLC------- 177
           Y +VRK+G G +S V+   ++  N    +KI++  K   +  + EIK+LQ +        
Sbjct: 21  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 80

Query: 178 ---GGPNVVKLLD--IVRDQHSKTPSLIFEYVNSTDFKVL----YPTLTDYDIRYYIYEL 228
              G  +++KLLD    +  +     ++FE +      ++    +  +    ++    +L
Sbjct: 81  DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQL 140

Query: 229 LKALDYCHSQ-GIMHRDVKPHNVMIDHELR-----KLRLIDWGLAEFYHPGKEYNVRVAS 282
           L  LDY H + GI+H D+KP NV+++         ++++ D G A +Y   + Y   + +
Sbjct: 141 LLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD--EHYTNSIQT 198

Query: 283 RYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD------NHDQLVKIAKV 336
           R ++ PE+L+    +    D+WS  C+   +I      F   +      + D + +I ++
Sbjct: 199 REYRSPEVLLGAP-WGCGADIWSTACLIFELITGD-FLFEPDEGHSYTKDDDHIAQIIEL 256

Query: 337 LG--TDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEA---IDFLDK 391
           LG     L           + +         +    + +  +       EA    DFL  
Sbjct: 257 LGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSP 316

Query: 392 LLRYDHQDRLTAREAMAHPYFAQVRAAESSRT 423
           +L+ D + R  A   + HP+       E  R 
Sbjct: 317 MLQLDPRKRADAGGLVNHPWLKDTLGMEEIRV 348

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  149 bits (378), Expect = 9e-41
 Identities = 72/313 (23%), Positives = 134/313 (42%), Gaps = 61/313 (19%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKI-----LKPVKKKKIKREIKILQNLCGG 179
           ++Y++  ++G+G +S V   + V   +     I     L     +K++RE +I + L   
Sbjct: 11  EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLL-KH 69

Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNST-----DFKVLYPTLTDYDIRYYIYELLKALDY 234
           PN+V+L D + ++      LIF+ V  T     +  V     ++ D  + I ++L+A+ +
Sbjct: 70  PNIVRLHDSISEEGHH--YLIFDLV--TGGELFEDIVAREYYSEADASHCIQQILEAVLH 125

Query: 235 CHSQGIMHRDVKPHNVMIDHELR--KLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELL 291
           CH  G++HR++KP N+++  +L+   ++L D+GLA       + +     +  +  PE+L
Sbjct: 126 CHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVL 185

Query: 292 VDLQDYDYSLDMWSLGCMF----AGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLN 347
                Y   +D+W+ G +      G      P F+  D H    +I              
Sbjct: 186 -RKDPYGKPVDLWACGVILYILLVGY-----PPFWDEDQHRLYQQIKA-----------G 228

Query: 348 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
            Y                   W           V+PEA D ++K+L  +   R+TA EA+
Sbjct: 229 AYDFP-------------SPEWDT---------VTPEAKDLINKMLTINPSKRITAAEAL 266

Query: 408 AHPYFAQVRAAES 420
            HP+ +      S
Sbjct: 267 KHPWISHRSTVAS 279

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score =  147 bits (374), Expect = 1e-40
 Identities = 71/334 (21%), Positives = 144/334 (43%), Gaps = 57/334 (17%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK--KKIKREIKILQNLC-----GG 179
           YE+   +G+G + +V +  +    E   IKI+K  K    + + E+++L+ +        
Sbjct: 56  YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMK 115

Query: 180 PNVVKLLD---------IVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLK 230
             +V L           +V +  S   +L ++ + +T+F+ +   L     R +  ++  
Sbjct: 116 YYIVHLKRHFMFRNHLCLVFEMLS--YNL-YDLLRNTNFRGVSLNL----TRKFAQQMCT 168

Query: 231 ALDYCHSQ--GIMHRDVKPHNVMIDHELR-KLRLIDWGLAEFYHPGKEYNVRVASRYFKG 287
           AL +  +    I+H D+KP N+++ +  R  ++++D+G +      +     + SR+++ 
Sbjct: 169 ALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG--QRIYQYIQSRFYRS 226

Query: 288 PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLG--------- 338
           PE+L+ +  YD ++DMWSLGC+   M    EP F G +  DQ+ KI +VLG         
Sbjct: 227 PEVLLGM-PYDLAIDMWSLGCILVEM-HTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQ 284

Query: 339 -----------------TDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLV 381
                              +      +Y      +L  ++G  +  P  +        + 
Sbjct: 285 APKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVA 344

Query: 382 SPEA-IDFLDKLLRYDHQDRLTAREAMAHPYFAQ 414
                 D + ++L YD + R+    A+ H +F +
Sbjct: 345 DYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKK 378

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  144 bits (365), Expect = 3e-40
 Identities = 67/312 (21%), Positives = 115/312 (36%), Gaps = 74/312 (23%)

Query: 122 GDQDDYEVVRKV-GRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGP 180
              DDY+V  +V G G   +V +  N  T E+  +K+L+     K +RE+++       P
Sbjct: 14  AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ--DCPKARREVELHWRASQCP 71

Query: 181 NVVKLLDIVRDQHSKTPS--LIFEYVNSTD-----FKVLYPTLTDYDIRYYIYELLKALD 233
           ++V+++D+  + ++      ++ E ++  +             T+ +    +  + +A+ 
Sbjct: 72  HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 131

Query: 234 YCHSQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 291
           Y HS  I HRDVKP N++         L+L D+G A                     E  
Sbjct: 132 YLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA--------------------KETT 171

Query: 292 VDLQDYDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVKI-AKVLGTDELNAYL 346
              + YD S DMWSLG     +  G      P FY +        +  ++          
Sbjct: 172 --GEKYDKSCDMWSLGVIMYILLCGY-----PPFYSNHGLAISPGMKTRIR--------- 215

Query: 347 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA 406
                E                WS+         VS E    +  LL+ +   R+T  E 
Sbjct: 216 -MGQYEFP-----------NPEWSE---------VSEEVKMLIRNLLKTEPTQRMTITEF 254

Query: 407 MAHPYFAQVRAA 418
           M HP+  Q    
Sbjct: 255 MNHPWIMQSTKV 266

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score =  145 bits (369), Expect = 4e-40
 Identities = 68/334 (20%), Positives = 137/334 (41%), Gaps = 59/334 (17%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK--KKIKREIKILQNL----CGGP 180
           + V+RK+G G +  V    +++  +   +K+++ +KK  +  K E  IL+ +        
Sbjct: 37  FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNN 96

Query: 181 NVVKLLD---------IVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKA 231
           N+VK            ++ +     PSL +E +   ++   +       I+ Y  E+LKA
Sbjct: 97  NIVKYHGKFMYYDHMCLIFEPLG--PSL-YEIITRNNYNGFHIED----IKLYCIEILKA 149

Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRK------------------------LRLIDWGLA 267
           L+Y     + H D+KP N+++D    +                        ++LID+G A
Sbjct: 150 LNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCA 209

Query: 268 EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNH 327
            F       ++ + +R ++ PE++++L  +D S DMWS GC+ A + +     F  H++ 
Sbjct: 210 TFKSD-YHGSI-INTRQYRAPEVILNLG-WDVSSDMWSFGCVLAEL-YTGSLLFRTHEHM 265

Query: 328 DQLVKIAKVLGT--DEL-----NAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHL 380
           + L  +  ++      +         +KY  + + +L       S             + 
Sbjct: 266 EHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYK 325

Query: 381 VS--PEAIDFLDKLLRYDHQDRLTAREAMAHPYF 412
           +       DFL  +L+ D   R +  E + H + 
Sbjct: 326 IIKHELFCDFLYSILQIDPTLRPSPAELLKHKFL 359

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  142 bits (360), Expect = 1e-39
 Identities = 53/322 (16%), Positives = 105/322 (32%), Gaps = 67/322 (20%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVV 183
             D++ +  +G G + +VF+  +    +  +IK +K    +K +RE+K L  L    N+V
Sbjct: 10  GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVK-YNNEKAEREVKALAKLDH-VNIV 67

Query: 184 KLLDIVRDQHSKTPSLIFEYVNSTDFKVLY--------------------PTLTDYDIRY 223
                         +       S   K L+                      L       
Sbjct: 68  HYNGCWDGFDYDPETSSKNSSRSKT-KCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALE 126

Query: 224 YIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASR 283
              ++ K +DY HS+ +++RD+KP N+ +    +++++ D+GL        +      + 
Sbjct: 127 LFEQITKGVDYIHSKKLINRDLKPSNIFLVDT-KQVKIGDFGLVTSLKNDGKRTRSKGTL 185

Query: 284 YFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELN 343
            +  PE +   QDY   +D+++LG + A ++   +  F        L             
Sbjct: 186 RYMSPEQISS-QDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDG---------- 234

Query: 344 AYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA 403
                    +                              +    L KLL    +DR   
Sbjct: 235 --------IISDI------------------------FDKKEKTLLQKLLSKKPEDRPNT 262

Query: 404 REAMAHPYFAQVRAAESSRTRA 425
            E +      +    ++ R  A
Sbjct: 263 SEILRTLTVWKKSPEKNERHTA 284

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  145 bits (368), Expect = 2e-38
 Identities = 68/307 (22%), Positives = 120/307 (39%), Gaps = 32/307 (10%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK----PVKKKKIKREIKILQNLCGGP 180
             +E+  ++G G +  V   I+ +T E+  IK  +    P  +++   EI+I++ L   P
Sbjct: 14  GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKL-NHP 72

Query: 181 NVVKLLDIVRDQHSKTPS----LIFEYVNSTD-FKVL-----YPTLTDYDIRYYIYELLK 230
           NVV   ++        P+    L  EY    D  K L        L +  IR  + ++  
Sbjct: 73  NVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS 132

Query: 231 ALDYCHSQGIMHRDVKPHNVMID--HELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 288
           AL Y H   I+HRD+KP N+++    +    ++ID G A+    G+     V +  +  P
Sbjct: 133 ALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAP 192

Query: 289 ELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK 348
           ELL + + Y  ++D WS G +    I    P F  +    Q     +    + +  Y   
Sbjct: 193 ELL-EQKKYTVTVDYWSFGTLAFECITGFRP-FLPNWQPVQWHGKVREKSNEHIVVY--- 247

Query: 349 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 408
                   L   V   S  P    ++      +      +L  +L +  + R T  +   
Sbjct: 248 ------DDLTGAVKFSSVLPTPNHLSGILAGKLER----WLQCMLMWHQRQRGTDPQNPN 297

Query: 409 HPYFAQV 415
              F  +
Sbjct: 298 VGCFQAL 304

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  136 bits (344), Expect = 2e-37
 Identities = 53/321 (16%), Positives = 100/321 (31%), Gaps = 71/321 (22%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-----PVKKKKIKREIKILQNLCG 178
             ++  + K+G G++  VF+ +         IK  K      V ++   RE+     L  
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69

Query: 179 GPNVVKLLDIVRDQHSKTPSLIF-EYVNS-------TDFKVLYPTLTDYDIRYYIYELLK 230
             +VV+      +       LI  EY N        ++   +     + +++  + ++ +
Sbjct: 70  HSHVVRYFSAWAEDDH---MLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 126

Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY-------------- 276
            L Y HS  ++H D+KP N+ I          + G  + +   K                
Sbjct: 127 GLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS 186

Query: 277 -NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
             V      F   E+L +   +    D+++L          +     G   H    +I +
Sbjct: 187 PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWH----EIRQ 242

Query: 336 VLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRY 395
                                     GR  R P         Q L S E  + L  ++  
Sbjct: 243 --------------------------GRLPRIP---------QVL-SQEFTELLKVMIHP 266

Query: 396 DHQDRLTAREAMAHPYFAQVR 416
           D + R +A   + H       
Sbjct: 267 DPERRPSAMALVKHSVLLSAS 287

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  136 bits (344), Expect = 4e-37
 Identities = 54/337 (16%), Positives = 113/337 (33%), Gaps = 79/337 (23%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK----PVKKKKIKREIKILQNLCGGP 180
            D+E ++ +GRG +  VFE  N   +    IK ++     + ++K+ RE+K L  L   P
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEH-P 63

Query: 181 NVVKLLDIVRDQHSKTPS----------LIFEYVNSTDFKVL------YPTLTDYDIRYY 224
            +V+  +   ++++              +  +     + K                  + 
Sbjct: 64  GIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI 123

Query: 225 IYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-------EFYHPGKEYN 277
             ++ +A+++ HS+G+MHRD+KP N+    +   +++ D+GL        E         
Sbjct: 124 FLQIAEAVEFLHSKGLMHRDLKPSNIFFTMD-DVVKVGDFGLVTAMDQDEEEQTVLTPMP 182

Query: 278 VRVASRYFKG------PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
                    G      PE +     Y + +D++SLG +   +++   PF    +    L 
Sbjct: 183 AYARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLT 238

Query: 332 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDK 391
            +                             +       K           P     +  
Sbjct: 239 DVRN--------------------------LKFPPLFTQK----------YPCEYVMVQD 262

Query: 392 LLRYDHQDRLTAREAMAHPYFAQV----RAAESSRTR 424
           +L     +R  A   + +  F  +    +     R+R
Sbjct: 263 MLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSR 299

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  135 bits (342), Expect = 4e-37
 Identities = 60/308 (19%), Positives = 116/308 (37%), Gaps = 58/308 (18%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKI-----LKPVKKKKIKREIKILQNLCGG 179
           +DYEV+  +G G Y    +    +  +  + K      +   +K+ +  E+ +L+ L   
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK-H 64

Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTD-------FKVLYPTLTDYDIRYYIYELLKAL 232
           PN+V+  D + D+ + T  ++ EY    D              L +  +   + +L  AL
Sbjct: 65  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124

Query: 233 DYCHSQG-----IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY-NVRVASRYFK 286
             CH +      ++HRD+KP NV +D + + ++L D+GLA   +    +    V + Y+ 
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGK-QNVKLGDFGLARILNHDTSFAKTFVGTPYYM 183

Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYL 346
            PE +     Y+   D+WSLGC+   +     PF     +  +L                
Sbjct: 184 SPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFT--AFSQKELAG-------------- 226

Query: 347 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA 406
                         +     +              S E  + + ++L      R +  E 
Sbjct: 227 -------------KIREGKFRRIPYRY--------SDELNEIITRMLNLKDYHRPSVEEI 265

Query: 407 MAHPYFAQ 414
           + +P   +
Sbjct: 266 LENPLILE 273

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  134 bits (340), Expect = 8e-37
 Identities = 67/308 (21%), Positives = 130/308 (42%), Gaps = 75/308 (24%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKK--------KIKREIKILQNL 176
           +D+E+ R +G+GK+  V+      +     +K+L   K +        +++RE++I  +L
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLF--KAQLEKAGVEHQLRREVEIQSHL 66

Query: 177 CGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLYPT--LTDYDIRYYIYELLKALD 233
              PN+++L     D  +    LI EY      ++ L       +     YI EL  AL 
Sbjct: 67  RH-PNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 123

Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK--------EYNVRVASRYF 285
           YCHS+ ++HRD+KP N+++      L++ D+G +      +        +Y   +     
Sbjct: 124 YCHSKRVIHRDIKPENLLLGSAGE-LKIADFGWSVHAPSSRRTDLCGTLDY---LP---- 175

Query: 286 KGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV-KIAKVLGTDELNA 344
             PE++   + +D  +D+WSLG +    +  K PF    + + +   +I++V        
Sbjct: 176 --PEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFE--ANTYQETYKRISRV-------- 222

Query: 345 YLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAR 404
              ++     P             +           V+  A D + +LL+++   R   R
Sbjct: 223 ---EFTF---P------------DF-----------VTEGARDLISRLLKHNPSQRPMLR 253

Query: 405 EAMAHPYF 412
           E + HP+ 
Sbjct: 254 EVLEHPWI 261

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  135 bits (342), Expect = 2e-36
 Identities = 59/304 (19%), Positives = 101/304 (33%), Gaps = 58/304 (19%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNV 182
           +        +VGRG + EV    +  T  +C +K ++   +     E+     L   P +
Sbjct: 56  EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR--LEVFRVEELVACAGLSS-PRI 112

Query: 183 VKLLDIVRDQHSKTPSLIFEYVNS---TDFKVLYPTLTDYDIRYYIYELLKALDYCHSQG 239
           V L   VR+      ++  E +              L +    YY+ + L+ L+Y H++ 
Sbjct: 113 VPLYGAVREGP--WVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR 170

Query: 240 IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG------PELLVD 293
           I+H DVK  NV++  +  +  L D+G A    P       +   Y  G      PE +V 
Sbjct: 171 ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE-VVM 229

Query: 294 LQDYDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY 349
            +  D  +D+WS  C    M  G        +  +      +KIA               
Sbjct: 230 GKPCDAKVDIWSSCCMMLHMLNG-----CHPWTQYFRGPLCLKIAS-------------- 270

Query: 350 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 409
                             P       +     +P     + + LR +   R +A E    
Sbjct: 271 ---------------EPPP-----IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRK 310

Query: 410 PYFA 413
              A
Sbjct: 311 VGKA 314

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  134 bits (339), Expect = 3e-36
 Identities = 57/346 (16%), Positives = 122/346 (35%), Gaps = 66/346 (19%)

Query: 94  MSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERC 153
           M  +  +   +  R   Y  ++   V   ++  Y  ++K+G G +S V     ++     
Sbjct: 1   MGSSHHHHHHSSGRENLY--FQGHMVIIDNKH-YLFIQKLGEGGFSYVDLVEGLHDGHFY 57

Query: 154 IIKIL---KPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS--LIFEYVNSTD 208
            +K +   +   +++ +RE  + +     PN+++L+     +        L+  +     
Sbjct: 58  ALKRILCHEQQDREEAQREADMHRLF-NHPNILRLVAYCLRERGAKHEAWLLLPFFKRGT 116

Query: 209 -------FKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRL 261
                   K     LT+  I + +  + + L+  H++G  HRD+KP N+++  E  +  L
Sbjct: 117 LWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDE-GQPVL 175

Query: 262 IDWGLAEFYHPGKEYNVRVASR----------YFKGPELLVDLQDY---DYSLDMWSLGC 308
           +D G         E + +  +            ++ PE L  +Q +   D   D+WSLGC
Sbjct: 176 MDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPE-LFSVQSHCVIDERTDVWSLGC 234

Query: 309 MFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKP 368
           +   M+F + P+       D +    +           N+  +   P+            
Sbjct: 235 VLYAMMFGEGPYDMVFQKGDSVALAVQ-----------NQLSIPQSPR------------ 271

Query: 369 WSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 414
                        S      L+ ++  D   R      ++     Q
Sbjct: 272 ------------HSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  130 bits (330), Expect = 3e-35
 Identities = 64/311 (20%), Positives = 134/311 (43%), Gaps = 74/311 (23%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL------KPVKKKKIKREIKILQNLCG 178
           +D++V   +G+G ++ V+   +++T     IK++      K    ++++ E+KI   L  
Sbjct: 11  EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70

Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLYP---TLTDYDIRYYIYELLKALDY 234
            P++++L +   D  S    L+ E  ++ +  + L       ++ + R+++++++  + Y
Sbjct: 71  -PSILELYNYFED--SNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLY 127

Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE----------YNVRVASRY 284
            HS GI+HRD+   N+++   +  +++ D+GLA       E          Y   ++   
Sbjct: 128 LHSHGILHRDLTLSNLLLTRNMN-IKIADFGLATQLKMPHEKHYTLCGTPNY---IS--- 180

Query: 285 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV-KIAKVLGTDELN 343
              PE+      +    D+WSLGCMF  ++  + PF    D     + K+          
Sbjct: 181 ---PEIATR-SAHGLESDVWSLGCMFYTLLIGRPPFD--TDTVKNTLNKVVL-------- 226

Query: 344 AYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA 403
                Y +   P             +           +S EA D + +LLR +  DRL+ 
Sbjct: 227 ---ADYEM---P------------SF-----------LSIEAKDLIHQLLRRNPADRLSL 257

Query: 404 REAMAHPYFAQ 414
              + HP+ ++
Sbjct: 258 SSVLDHPFMSR 268

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  130 bits (328), Expect = 7e-35
 Identities = 66/308 (21%), Positives = 125/308 (40%), Gaps = 73/308 (23%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL------KPVKKKKIKREIKILQNLCG 178
             Y   R +G+G +++ FE  + +T E    KI+      KP +++K+  EI I ++L  
Sbjct: 15  RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 74

Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNS---TDFKVLYPTLTDYDIRYYIYELLKALDYC 235
             +VV       D  +    ++ E        +       LT+ + RYY+ +++    Y 
Sbjct: 75  -QHVVGFHGFFED--NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYL 131

Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE----------YNVRVASRYF 285
           H   ++HRD+K  N+ ++ +L  +++ D+GLA       E          Y   +A    
Sbjct: 132 HRNRVIHRDLKLGNLFLNEDLE-VKIGDFGLATKVEYDGERKKVLCGTPNY---IA---- 183

Query: 286 KGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL-VKIAKVLGTDELNA 344
             PE+L   + + + +D+WS+GC+   ++  K PF        +  ++I K         
Sbjct: 184 --PEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFE--TSCLKETYLRIKK--------- 229

Query: 345 YLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAR 404
             N+Y +   P                         ++P A   + K+L+ D   R T  
Sbjct: 230 --NEYSI---P------------KH-----------INPVAASLIQKMLQTDPTARPTIN 261

Query: 405 EAMAHPYF 412
           E +   +F
Sbjct: 262 ELLNDEFF 269

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  130 bits (329), Expect = 7e-35
 Identities = 69/309 (22%), Positives = 115/309 (37%), Gaps = 69/309 (22%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL---------KPVKKKKIKREIKILQN 175
             Y+V   +G G +  V+ GI V+ N    IK +         +     ++  E+ +L+ 
Sbjct: 43  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 102

Query: 176 LC-GGPNVVKLLDIVRDQHSKTPS---LIFEYVNST----DFKVLYPTLTDYDIRYYIYE 227
           +  G   V++LLD       + P    LI E         DF      L +   R + ++
Sbjct: 103 VSSGFSGVIRLLDWF-----ERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQ 157

Query: 228 LLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG 287
           +L+A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  
Sbjct: 158 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV-YTDFDGTRVYSP 216

Query: 288 PELLVDLQDYD-YSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYL 346
           PE +     Y   S  +WSLG +   M+    PF     +     +I +           
Sbjct: 217 PEWIRY-HRYHGRSAAVWSLGILLYDMVCGDIPF---EHDE----EIIR----------- 257

Query: 347 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA 406
                          G+   +             VS E    +   L     DR T  E 
Sbjct: 258 ---------------GQVFFRQR-----------VSSECQHLIRWCLALRPSDRPTFEEI 291

Query: 407 MAHPYFAQV 415
             HP+   V
Sbjct: 292 QNHPWMQDV 300

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  129 bits (327), Expect = 8e-35
 Identities = 56/295 (18%), Positives = 113/295 (38%), Gaps = 51/295 (17%)

Query: 132 KVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK-----IKREIKILQNLCGGPNVVKLL 186
           ++GRG +  V++G++  T        L+  K  K      K E ++L+ L   PN+V+  
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQH-PNIVRFY 91

Query: 187 DIVRDQHSKTPSLIF--EYVNS---TDFKVLYPTLTDYDIRYYIYELLKALDYCHSQG-- 239
           D           ++   E + S     +   +  +    +R +  ++LK L + H++   
Sbjct: 92  DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPP 151

Query: 240 IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDY 299
           I+HRD+K  N+ I      +++ D GLA          V + +  F  PE+    + YD 
Sbjct: 152 IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAV-IGTPEFMAPEMY--EEKYDE 208

Query: 300 SLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDA 359
           S+D+++ G     M   + P +    N  Q+ +                           
Sbjct: 209 SVDVYAFGMCMLEMATSEYP-YSECQNAAQIYRRVT------------------------ 243

Query: 360 LVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 414
                     S    A    +  PE  + ++  +R +  +R + ++ + H +F +
Sbjct: 244 ----------SGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  130 bits (330), Expect = 8e-35
 Identities = 66/308 (21%), Positives = 125/308 (40%), Gaps = 73/308 (23%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL------KPVKKKKIKREIKILQNLCG 178
             Y   R +G+G +++ FE  + +T E    KI+      KP +++K+  EI I ++L  
Sbjct: 41  RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 100

Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNS---TDFKVLYPTLTDYDIRYYIYELLKALDYC 235
             +VV       D  +    ++ E        +       LT+ + RYY+ +++    Y 
Sbjct: 101 -QHVVGFHGFFED--NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYL 157

Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE----------YNVRVASRYF 285
           H   ++HRD+K  N+ ++ +L  +++ D+GLA       E          Y   +A    
Sbjct: 158 HRNRVIHRDLKLGNLFLNEDLE-VKIGDFGLATKVEYDGERKKVLCGTPNY---IA---- 209

Query: 286 KGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL-VKIAKVLGTDELNA 344
             PE+L   + + + +D+WS+GC+   ++  K PF        +  ++I K         
Sbjct: 210 --PEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFE--TSCLKETYLRIKK--------- 255

Query: 345 YLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAR 404
             N+Y +   P                         ++P A   + K+L+ D   R T  
Sbjct: 256 --NEYSI---P------------KH-----------INPVAASLIQKMLQTDPTARPTIN 287

Query: 405 EAMAHPYF 412
           E +   +F
Sbjct: 288 ELLNDEFF 295

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  130 bits (330), Expect = 9e-35
 Identities = 55/302 (18%), Positives = 121/302 (40%), Gaps = 55/302 (18%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKI-----LKPVKKKKIKREIKILQNLCGG 179
           + Y  ++K+G G + +     +     + +IK      +   ++++ +RE+ +L N+   
Sbjct: 24  EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKH- 82

Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVL----YPTLTDYDIRYYIYELLKALDY 234
           PN+V+  +   +  + +  ++ +Y    D FK +         +  I  +  ++  AL +
Sbjct: 83  PNIVQYRESFEE--NGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKH 140

Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY-NVRVASRYFKGPELLVD 293
            H + I+HRD+K  N+ +  +   ++L D+G+A   +   E     + + Y+  PE+  +
Sbjct: 141 VHDRKILHRDIKSQNIFLTKD-GTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICEN 199

Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV-KIAKVLGTDELNAYLNKYHLE 352
            + Y+   D+W+LGC+   +   K  F     +   LV KI                   
Sbjct: 200 -KPYNNKSDIWALGCVLYELCTLKHAFE--AGSMKNLVLKIIS----------------- 239

Query: 353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 412
                    G     P S           S +    + +L + + +DR +    +   + 
Sbjct: 240 ---------GSF--PPVSLHY--------SYDLRSLVSQLFKRNPRDRPSVNSILEKGFI 280

Query: 413 AQ 414
           A+
Sbjct: 281 AK 282

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  129 bits (326), Expect = 1e-34
 Identities = 66/309 (21%), Positives = 127/309 (41%), Gaps = 77/309 (24%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKK--------KIKREIKILQNL 176
           DD+++ R +G+GK+  V+            +K+L   K +        +++REI+I  +L
Sbjct: 14  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLF--KSQLEKEGVEHQLRREIEIQSHL 71

Query: 177 CGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVL--YPTLTDYDIRYYIYELLKALD 233
              PN++++ +   D   K   L+ E+    + +K L  +    +     ++ EL  AL 
Sbjct: 72  RH-PNILRMYNYFHD--RKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALH 128

Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK---------EYNVRVASRY 284
           YCH + ++HRD+KP N+++ ++   L++ D+G +  + P           +Y   +    
Sbjct: 129 YCHERKVIHRDIKPENLLMGYKGE-LKIADFGWS-VHAPSLRRRTMCGTLDY---LP--- 180

Query: 285 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV-KIAKVLGTDELN 343
              PE++   + +D  +D+W  G +    +    PF     +H +   +I  V       
Sbjct: 181 ---PEMIEG-KTHDEKVDLWCAGVLCYEFLVGMPPFD--SPSHTETHRRIVNV------- 227

Query: 344 AYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA 403
                      P            P+           +S  + D + KLLRY    RL  
Sbjct: 228 ----DLKF---P------------PF-----------LSDGSKDLISKLLRYHPPQRLPL 257

Query: 404 REAMAHPYF 412
           +  M HP+ 
Sbjct: 258 KGVMEHPWV 266

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  129 bits (327), Expect = 1e-34
 Identities = 65/313 (20%), Positives = 119/313 (38%), Gaps = 55/313 (17%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIK------ILKPVKKKKIKREIKILQNLCG 178
            ++ + +K+GRG++SEV+    +       +K      ++    +    +EI +L+ L  
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91

Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTD-------FKVLYPTLTDYDIRYYIYELLKA 231
            PNV+K      + +    +++ E  ++ D       FK     + +  +  Y  +L  A
Sbjct: 92  -PNVIKYYASFIEDN--ELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSA 148

Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY-NVRVASRYFKGPEL 290
           L++ HS+ +MHRD+KP NV I      ++L D GL  F+       +  V + Y+  PE 
Sbjct: 149 LEHMHSRRVMHRDIKPANVFITAT-GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPER 207

Query: 291 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV-KIAKVLGTDELNAYLNKY 349
           + +   Y++  D+WSLGC+   M   + PF+    N   L  KI +              
Sbjct: 208 IHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQ-------------- 252

Query: 350 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 409
                         +   P   +         S E    ++  +  D + R         
Sbjct: 253 ------------CDYPPLPSDHY---------SEELRQLVNMCINPDPEKRPDVTYVYDV 291

Query: 410 PYFAQVRAAESSR 422
                   A S  
Sbjct: 292 AKRMHACTASSLE 304

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  128 bits (324), Expect = 1e-33
 Identities = 47/348 (13%), Positives = 99/348 (28%), Gaps = 95/348 (27%)

Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK------KKIKREIKILQNL--- 176
                  +G+       E  +  T E   + +    ++      K++K E+  L+ L   
Sbjct: 74  TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133

Query: 177 ---------------------CGGPNVVKLLDIVRDQHSKTPSLIFEYVNST-------- 207
                                     ++++    RD    +   ++  + S         
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193

Query: 208 -DFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL 266
                 + +L  +       ++++ L   H  G++H  ++P ++++D     + L  +  
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGG-VFLTGFEH 252

Query: 267 AEFYHPGKEYNVRVASRYFKGPELLVDLQD----------YDYSLDMWSLGCMFAGMIFR 316
                      V   SR F+ PEL                  +S D W+LG +   +   
Sbjct: 253 L---VRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCA 309

Query: 317 KEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINAD 376
             P                   T +     +++                           
Sbjct: 310 DLPI------------------TKDAALGGSEWIFRSCKN-------------------- 331

Query: 377 NQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAESSRTR 424
               +       L+  LRY  +DRL   +AM  P + Q+R   S+   
Sbjct: 332 ----IPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTELSAALP 375

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  125 bits (317), Expect = 2e-33
 Identities = 64/313 (20%), Positives = 115/313 (36%), Gaps = 69/313 (22%)

Query: 133 VGRGKYSEVFEGINVNTNERCIIKILKPVKK---KKIKREIKILQNLCGGPNVVKLLDIV 189
           +G+G Y  V+ G +++   R  IK +        + +  EI + ++L    N+V+ L   
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKH-KNIVQYLGSF 88

Query: 190 RDQHSKTPSLIFEYVN----STDFKVLYPTLTDYD--IRYYIYELLKALDYCHSQGIMHR 243
            +       +  E V     S   +  +  L D +  I +Y  ++L+ L Y H   I+HR
Sbjct: 89  SENG--FIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHR 146

Query: 244 DVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG------PE-LLVDLQD 296
           D+K  NV+I+     L++ D+G +      +   +   +  F G      PE +    + 
Sbjct: 147 DIKGDNVLINTYSGVLKISDFGTS-----KRLAGINPCTETFTGTLQYMAPEIIDKGPRG 201

Query: 297 YDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQ-LVKIAKVLGTDELNAYLNKYHL 351
           Y  + D+WSLGC    M  G     +P FY        + K+              K H 
Sbjct: 202 YGKAADIWSLGCTIIEMATG-----KPPFYELGEPQAAMFKVGM-----------FKVHP 245

Query: 352 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 411
           E+   +                        S EA  F+ K    D   R  A + +   +
Sbjct: 246 EIPESM------------------------SAEAKAFILKCFEPDPDKRACANDLLVDEF 281

Query: 412 FAQVRAAESSRTR 424
                  + ++ +
Sbjct: 282 LKVSSKKKKTQPK 294

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  127 bits (320), Expect = 3e-33
 Identities = 68/325 (20%), Positives = 125/325 (38%), Gaps = 60/325 (18%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK--------------------PVKKK 164
           +DY ++R + +GK++++        N+   +K  +                      K  
Sbjct: 31  NDYRIIRTLNQGKFNKIILC--EKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYD 88

Query: 165 KIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV-----------NSTDFKVLY 213
             K E++I+ ++      +    I+ +       +I+EY+                K   
Sbjct: 89  DFKNELQIITDIKN-EYCLTCEGIITN--YDEVYIIYEYMENDSILKFDEYFFVLDKNYT 145

Query: 214 PTLTDYDIRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 272
             +    I+  I  +L +  Y H++  I HRDVKP N+++D   R ++L D+G +E Y  
Sbjct: 146 CFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGR-VKLSDFGESE-YMV 203

Query: 273 GKEYNVRVASRYFKGPELLVDLQDYD-YSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
            K+      +  F  PE   +   Y+   +D+WSLG     M +   PF     +  +L 
Sbjct: 204 DKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPF-SLKISLVELF 262

Query: 332 -KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLD 390
             I                   LD         H   P +   +  + + +S E IDFL 
Sbjct: 263 NNIRTK-----------NIEYPLDRN-------HFLYPLTNKKSTCSNNFLSNEDIDFLK 304

Query: 391 KLLRYDHQDRLTAREAMAHPYFAQV 415
             LR +  +R+T+ +A+ H + A  
Sbjct: 305 LFLRKNPAERITSEDALKHEWLADT 329

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  124 bits (314), Expect = 1e-32
 Identities = 69/305 (22%), Positives = 121/305 (39%), Gaps = 65/305 (21%)

Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-----------PVKKKKIKREIKILQ 174
            Y  +  +G G +  V+  ++   N+  ++K +K             K  K+  EI IL 
Sbjct: 25  KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84

Query: 175 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST----DFKVLYPTLTDYDIRYYIYELLK 230
            +    N++K+LDI  +Q      L+ E   S      F   +P L +    Y   +L+ 
Sbjct: 85  RVEH-ANIIKVLDIFENQ--GFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVS 141

Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 290
           A+ Y   + I+HRD+K  N++I  +   ++LID+G A +   GK +     +  +  PE+
Sbjct: 142 AVGYLRLKDIIHRDIKDENIVIAEDFT-IKLIDFGSAAYLERGKLFYTFCGTIEYCAPEV 200

Query: 291 LVDLQDYD-YSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY 349
           L+    Y    L+MWSLG     ++F + PF        +L +  +              
Sbjct: 201 LMG-NPYRGPELEMWSLGVTLYTLVFEENPF-------CELEETVE-----------AAI 241

Query: 350 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 409
           H    P                       +LVS E +  +  LL+   + R T  + +  
Sbjct: 242 HP---P-----------------------YLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275

Query: 410 PYFAQ 414
           P+  Q
Sbjct: 276 PWVTQ 280

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  124 bits (313), Expect = 1e-32
 Identities = 61/312 (19%), Positives = 107/312 (34%), Gaps = 79/312 (25%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL---------KPVKKKKIKREIKILQN 175
            +Y +   +G+G +  VF G  +    +  IK++                   E+ +L  
Sbjct: 31  AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWK 90

Query: 176 LCGG---PNVVKLLDIVRDQHSKTPS---LIFEYVNST----DFKVLYPTLTDYDIRYYI 225
           +  G   P V++LLD       +T     L+ E         D+      L +   R + 
Sbjct: 91  VGAGGGHPGVIRLLDWF-----ETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFF 145

Query: 226 YELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYF 285
            +++ A+ +CHS+G++HRD+K  N++ID      +LID+G     H    Y     +R +
Sbjct: 146 GQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEP-YTDFDGTRVY 204

Query: 286 KGPELLVDLQDYD-YSLDMWSLG----CMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTD 340
             PE +     Y      +WSLG     M  G I    PF       ++  +I +     
Sbjct: 205 SPPEWISR-HQYHALPATVWSLGILLYDMVCGDI----PF-------ERDQEILE----- 247

Query: 341 ELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDR 400
                                                   VSP+    + + L      R
Sbjct: 248 ---------------------AELHFPAH-----------VSPDCCALIRRCLAPKPSSR 275

Query: 401 LTAREAMAHPYF 412
            +  E +  P+ 
Sbjct: 276 PSLEEILLDPWM 287

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  124 bits (312), Expect = 2e-32
 Identities = 60/316 (18%), Positives = 119/316 (37%), Gaps = 74/316 (23%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKIL---KPVKKKKIKREIKILQNLCGGPNVV 183
             V R +  G ++ V+E  +V +     +K L   +  K + I +E+  ++ L G PN+V
Sbjct: 30  LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIV 89

Query: 184 KLLD--IVRDQHSKTPSLIF----EYVNSTDFKVLYPT-----LTDYDIRYYIYELLKAL 232
           +      +  + S T    F    E       + L        L+   +    Y+  +A+
Sbjct: 90  QFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAV 149

Query: 233 DYCHSQG--IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASR------- 283
            + H Q   I+HRD+K  N+++ ++   ++L D+G A       +Y+     R       
Sbjct: 150 QHMHRQKPPIIHRDLKVENLLLSNQ-GTIKLCDFGSATTISHYPDYSWSAQRRALVEEEI 208

Query: 284 ------YFKGPELLVDL---QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 334
                  ++ PE ++DL          D+W+LGC+   + FR+ PF    ++  +L +I 
Sbjct: 209 TRNTTPMYRTPE-IIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF----EDGAKL-RIV 262

Query: 335 KVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLR 394
                                      G++S  P                    +  +L+
Sbjct: 263 N--------------------------GKYSIPPHDTQ---------YTVFHSLIRAMLQ 287

Query: 395 YDHQDRLTAREAMAHP 410
            + ++RL+  E +   
Sbjct: 288 VNPEERLSIAEVVHQL 303

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  121 bits (305), Expect = 3e-31
 Identities = 43/280 (15%), Positives = 96/280 (34%), Gaps = 38/280 (13%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTN-----ERCIIKILKPVKKKKIKREIKILQNLC 177
                 V   +G G +++V+E    + N     ++ ++K+ KP    +     ++++ L 
Sbjct: 63  GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLK 122

Query: 178 GG--PNVVKLLDIVRDQHSKTPSLIFEYVNSTDF--------KVLYPTLTDYDIRYYIYE 227
                  +K       Q+     L+ E  +                  +    +  +   
Sbjct: 123 PSMQHMFMKFYSAHLFQNGS--VLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMR 180

Query: 228 LLKALDYCHSQGIMHRDVKPHNVMIDHELR----------KLRLIDWGLA---EFYHPGK 274
           +L  ++  H   I+H D+KP N ++ +              L LID G +   + +  G 
Sbjct: 181 MLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGT 240

Query: 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 334
            +  +  +  F+  E+L + + ++Y +D + +      M+F             +   + 
Sbjct: 241 IFTAKCETSGFQCVEMLSN-KPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLF 299

Query: 335 KV-----LGTDELNAYLNKYHLELDPQLDALVGRHSRKPW 369
           +      +  +  +  LN       P LD L  R   K  
Sbjct: 300 RRLPHLDMWNEFFHVMLNIPDCHHLPSLDLL--RQKLKKV 337

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  120 bits (303), Expect = 4e-31
 Identities = 65/299 (21%), Positives = 134/299 (44%), Gaps = 58/299 (19%)

Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKI-----LKPVKKKKIKREIKILQNLCGGP 180
           +Y +++ +G+G +++V    ++ T     IKI     L P   +K+ RE++I++ L   P
Sbjct: 16  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNH-P 74

Query: 181 NVVKLLDIVRDQHSKTPS---LIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDY 234
           N+VKL +++     +T     LI EY +     D+ V +  + + + R    +++ A+ Y
Sbjct: 75  NIVKLFEVI-----ETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQY 129

Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 294
           CH + I+HRD+K  N+++D ++  +++ D+G +  +  G + +    +  +  PEL    
Sbjct: 130 CHQKRIVHRDLKAENLLLDADM-NIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQG- 187

Query: 295 QDYD-YSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 353
           + YD   +D+WSLG +   ++    PF     N  +L +  +VL                
Sbjct: 188 KKYDGPEVDVWSLGVILYTLVSGSLPF--DGQNLKELRE--RVLR--------------- 228

Query: 354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 412
                   G++    +           +S +  + L + L  +   R T  + M   + 
Sbjct: 229 --------GKYRIPFY-----------MSTDCENLLKRFLVLNPIKRGTLEQIMKDRWI 268

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  118 bits (298), Expect = 8e-31
 Identities = 64/306 (20%), Positives = 119/306 (38%), Gaps = 65/306 (21%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK----KKIKREIKILQNLCGGP 180
           +D+++V+ +G G Y EV   +N  T E   +KI+   +     + IK+EI I + L    
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH-E 65

Query: 181 NVVKLLDIVRDQHSKTPSLIF---EYVNST---DFKVLYPTLTDYDIRYYIYELLKALDY 234
           NVVK          +  ++ +   EY +     D       + + D + + ++L+  + Y
Sbjct: 66  NVVKFYGHR-----REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 120

Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV---RVASRYFKGPELL 291
            H  GI HRD+KP N+++D     L++ D+GLA  +       +      +  +  PELL
Sbjct: 121 LHGIGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179

Query: 292 VDLQDYD-YSLDMWSLG----CMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYL 346
              +++    +D+WS G     M AG +    P+    D+  +     +           
Sbjct: 180 KR-REFHAEPVDVWSCGIVLTAMLAGEL----PWDQPSDSCQEYSDWKE----------- 223

Query: 347 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA 406
                           +    PW K              +  L K+L  +   R+T  + 
Sbjct: 224 ---------------KKTYLNPWKKI---------DSAPLALLHKILVENPSARITIPDI 259

Query: 407 MAHPYF 412
               ++
Sbjct: 260 KKDRWY 265

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  118 bits (299), Expect = 1e-30
 Identities = 70/301 (23%), Positives = 121/301 (40%), Gaps = 55/301 (18%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-------PVKKKKIKREIKILQNLCGG 179
           Y +   +G G Y +V E ++  T  R  +KILK       P  +  +K+EI++L+ L   
Sbjct: 7   YLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRH- 65

Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDF----KVLYPTLTDYDIRYYIYELLKALDYC 235
            NV++L+D++ ++  +   ++ EY           V            Y  +L+  L+Y 
Sbjct: 66  KNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYL 125

Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV---RVASRYFKGPELLV 292
           HSQGI+H+D+KP N+++      L++   G+AE  HP    +       S  F+ PE+  
Sbjct: 126 HSQGIVHKDIKPGNLLLTTGGT-LKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIAN 184

Query: 293 DLQDYD-YSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL 351
            L  +  + +D+WS G     +     PF    DN  +L +   +            Y +
Sbjct: 185 GLDTFSGFKVDIWSAGVTLYNITTGLYPFE--GDNIYKLFE--NIGKGS--------YAI 232

Query: 352 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 411
              P                           P   D L  +L Y+   R + R+   H +
Sbjct: 233 ---P------------GD-----------CGPPLSDLLKGMLEYEPAKRFSIRQIRQHSW 266

Query: 412 F 412
           F
Sbjct: 267 F 267

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  117 bits (295), Expect = 6e-30
 Identities = 71/322 (22%), Positives = 127/322 (39%), Gaps = 65/322 (20%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKI--LKPVKKKKIKREIKILQNLCGGPN 181
              +E+V  VG G Y +V++G +V T +   IK+  +   ++++IK+EI +L+      N
Sbjct: 23  AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRN 82

Query: 182 VVKLLDIVRDQHSKTPS----LIFEY---------VNSTDFKVLYPTLTDYDIRYYIYEL 228
           +         ++         L+ E+         + +T       TL +  I Y   E+
Sbjct: 83  IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGN----TLKEEWIAYICREI 138

Query: 229 LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKG 287
           L+ L + H   ++HRD+K  NV++     +++L+D+G+ A+        N  + + Y+  
Sbjct: 139 LRGLSHLHQHKVIHRDIKGQNVLLTEN-AEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMA 197

Query: 288 PELLVDLQD----YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNH--DQLVKIAKVLGTDE 341
           PE++   ++    YD+  D+WSLG     M     P     D H    L  I +      
Sbjct: 198 PEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLC---DMHPMRALFLIPR------ 248

Query: 342 LNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL 401
                N       P+L +       K WSK                F++  L  +H  R 
Sbjct: 249 -----NP-----APRLKS-------KKWSKKFQ------------SFIESCLVKNHSQRP 279

Query: 402 TAREAMAHPYFAQVRAAESSRT 423
              + M HP+          R 
Sbjct: 280 ATEQLMKHPFIRDQPNERQVRI 301

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  116 bits (293), Expect = 1e-29
 Identities = 64/306 (20%), Positives = 119/306 (38%), Gaps = 65/306 (21%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK----KKIKREIKILQNLCGGP 180
           +D+++V+ +G G Y EV   +N  T E   +KI+   +     + IK+EI I + L    
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH-E 65

Query: 181 NVVKLLDIVRDQHSKTPSLIF---EYVNST---DFKVLYPTLTDYDIRYYIYELLKALDY 234
           NVVK          +  ++ +   EY +     D       + + D + + ++L+  + Y
Sbjct: 66  NVVKFYGHR-----REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 120

Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV---RVASRYFKGPELL 291
            H  GI HRD+KP N+++D     L++ D+GLA  +       +      +  +  PELL
Sbjct: 121 LHGIGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179

Query: 292 VDLQDYD-YSLDMWSLG----CMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYL 346
              +++    +D+WS G     M AG +    P+    D+  +     +           
Sbjct: 180 KR-REFHAEPVDVWSCGIVLTAMLAGEL----PWDQPSDSCQEYSDWKE----------- 223

Query: 347 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA 406
                           +    PW K              +  L K+L  +   R+T  + 
Sbjct: 224 ---------------KKTYLNPWKKI---------DSAPLALLHKILVENPSARITIPDI 259

Query: 407 MAHPYF 412
               ++
Sbjct: 260 KKDRWY 265

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  116 bits (291), Expect = 4e-29
 Identities = 63/335 (18%), Positives = 117/335 (34%), Gaps = 47/335 (14%)

Query: 123 DQDDYEVVRKVGRG--KYSEVFEGINVNTNERCIIKILKPVKKKK-----IKREIKILQN 175
           +   YE++  +G+G      V       T E   ++ +            ++ E+ + + 
Sbjct: 23  EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSK- 81

Query: 176 LCGGPNVVKLLD--IVRDQHSKTPSL--IFEYVNS---TDF-KVLYP-TLTDYDIRYYIY 226
           L   PN+V      I  ++      L  +  ++      D     +   + +  I Y + 
Sbjct: 82  LFNHPNIVPYRATFIADNE------LWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQ 135

Query: 227 ELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE--FYHPGKEYNVRVASRY 284
            +LKALDY H  G +HR VK  +++I  +  K+ L           H  ++  V    +Y
Sbjct: 136 GVLKALDYIHHMGYVHRSVKASHILISVD-GKVYLSGLRSNLSMISHGQRQRVVHDFPKY 194

Query: 285 FKG------PELLV-DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQ--LVKIAK 335
                    PE+L  +LQ YD   D++S+G     +     PF    D      L++   
Sbjct: 195 SVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPF---KDMPATQMLLEKLN 251

Query: 336 ---------VLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAI 386
                         E         +      D+L     R       +       SP   
Sbjct: 252 GTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFH 311

Query: 387 DFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAESS 421
            F+++ L+ +   R +A   + H +F Q++   S 
Sbjct: 312 HFVEQCLQRNPDARPSASTLLNHSFFKQIKRRASE 346

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  113 bits (284), Expect = 1e-28
 Identities = 66/341 (19%), Positives = 122/341 (35%), Gaps = 80/341 (23%)

Query: 115 ESLTVQW-GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK----PVKKKKIKRE 169
           +S  + W  ++DDYE+   +G G  + V         E+  IK +          ++ +E
Sbjct: 4   DSSALPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKE 63

Query: 170 IKILQNLCGGPNVVK----------------------LLDIVRDQHSKTPSLIFEYVNST 207
           I+ +   C  PN+V                       +LDI++   +K            
Sbjct: 64  IQAMS-QCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHK-------- 114

Query: 208 DFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 267
                   L +  I   + E+L+ L+Y H  G +HRDVK  N+++  +   +++ D+G++
Sbjct: 115 -----SGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDG-SVQIADFGVS 168

Query: 268 EFYHPGKEYNVRVASRYFKG------PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
            F   G +       + F G      PE++  ++ YD+  D+WS G     +     P+ 
Sbjct: 169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPY- 227

Query: 322 YGHDNH--DQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQH 379
             H       L+   +                   P L+  V         K+       
Sbjct: 228 --HKYPPMKVLMLTLQ----------------NDPPSLETGVQDKEML--KKY------- 260

Query: 380 LVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAES 420
                    +   L+ D + R TA E + H +F + +  E 
Sbjct: 261 --GKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNKEF 299

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  113 bits (284), Expect = 4e-28
 Identities = 64/298 (21%), Positives = 119/298 (39%), Gaps = 49/298 (16%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL--KPVKKKKIKREIKILQNLCGGPNV 182
           D Y+ V+ +G G +       +  T E   +K +       + ++REI   ++L   PN+
Sbjct: 20  DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRH-PNI 78

Query: 183 VKLLDIVRDQHSKTPSLIF---EYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           V+  +++      TP+ +    EY +     +        ++ + R++  +LL  + YCH
Sbjct: 79  VRFKEVI-----LTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCH 133

Query: 237 SQGIMHRDVKPHNVMID-HELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 295
           S  I HRD+K  N ++D     +L++ D+G ++      +    V +  +  PE+L+  Q
Sbjct: 134 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLR-Q 192

Query: 296 DYD-YSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 354
           +YD    D+WS G     M+    PF    +  D    I ++L           Y +   
Sbjct: 193 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVK--------YSI--- 241

Query: 355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 412
                        P    I        SPE    + ++   D   R++  E   H +F
Sbjct: 242 -------------PDDIRI--------SPECCHLISRIFVADPATRISIPEIKTHSWF 278

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  110 bits (278), Expect = 5e-28
 Identities = 68/299 (22%), Positives = 123/299 (41%), Gaps = 59/299 (19%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGP 180
           Y +   +G G + +V  G +  T  +  +KIL   K        KIKREI+ L+     P
Sbjct: 13  YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRH-P 71

Query: 181 NVVKLLDIVRDQHSKTPSLIF---EYVNST---DFKVLYPTLTDYDIRYYIYELLKALDY 234
           +++KL  ++      TP+  F   EYV+     D+   +  + + + R    ++L A+DY
Sbjct: 72  HIIKLYQVI-----STPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDY 126

Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 294
           CH   ++HRD+KP NV++D  +   ++ D+GL+     G+       S  +  PE++   
Sbjct: 127 CHRHMVVHRDLKPENVLLDAHM-NAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISG- 184

Query: 295 QDYD-YSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 353
           + Y    +D+WS G +   ++    PF    ++   L K  K+ G               
Sbjct: 185 RLYAGPEVDIWSCGVILYALLCGTLPF--DDEHVPTLFK--KIRG--------------- 225

Query: 354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 412
                   G      +           ++      L  +L+ D   R T ++   H +F
Sbjct: 226 --------GVFYIPEY-----------LNRSVATLLMHMLQVDPLKRATIKDIREHEWF 265

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  111 bits (279), Expect = 7e-28
 Identities = 66/322 (20%), Positives = 131/322 (40%), Gaps = 76/322 (23%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKIL---KPVKKK------------------- 164
           Y +  ++G+G Y  V    N N N    +K+L   K +++                    
Sbjct: 15  YTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCI 74

Query: 165 -------KIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLYPT- 215
                  ++ +EI IL+     PNVVKL++++ D +     ++FE VN     +V     
Sbjct: 75  QPRGPIEQVYQEIAILK-KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKP 133

Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 275
           L++   R+Y  +L+K ++Y H Q I+HRD+KP N+++  +   +++ D+G++  +     
Sbjct: 134 LSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGH-IKIADFGVSNEFKGSDA 192

Query: 276 Y-NVRVASRYFKGPELLVDL-QDYD-YSLDMWSLGC-MFAGMIFRKEPFFYGHDNHDQL- 330
             +  V +  F  PE L +  + +   +LD+W++G  ++   +F + PF    +    L 
Sbjct: 193 LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYC-FVFGQCPFM--DERIMCLH 249

Query: 331 VKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLD 390
            KI                     P +                        + +  D + 
Sbjct: 250 SKIKS-----------QALEFPDQPDI------------------------AEDLKDLIT 274

Query: 391 KLLRYDHQDRLTAREAMAHPYF 412
           ++L  + + R+   E   HP+ 
Sbjct: 275 RMLDKNPESRIVVPEIKLHPWV 296

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  110 bits (277), Expect = 1e-27
 Identities = 69/307 (22%), Positives = 124/307 (40%), Gaps = 54/307 (17%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK-KKIKREIKILQNLCGGPNV 182
           ++ ++V+ K+G G Y  V++ I+  T +   IK +      ++I +EI I+Q  C  P+V
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQ-CDSPHV 86

Query: 183 VKLLDIVRDQHSKTPSL--IFEYVNS---TD-FKVLYPTLTDYDIRYYIYELLKALDYCH 236
           VK        + K   L  + EY  +   +D  ++   TLT+ +I   +   LK L+Y H
Sbjct: 87  VKYYG----SYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLH 142

Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLVDLQ 295
               +HRD+K  N++++ E    +L D+G+  +      + N  + + ++  PE++ +  
Sbjct: 143 FMRKIHRDIKAGNILLNTE-GHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE-I 200

Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNH--DQLVKIAKVLGTDELNAYLNKYHLEL 353
            Y+   D+WSLG     M   K P+    D H    +  I                    
Sbjct: 201 GYNCVADIWSLGITAIEMAEGKPPYA---DIHPMRAIFMIPT----------------NP 241

Query: 354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA 413
            P                        L S    DF+ + L    + R TA + + HP+  
Sbjct: 242 PPTF------------------RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVR 283

Query: 414 QVRAAES 420
             +    
Sbjct: 284 SAKGVSI 290

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  110 bits (276), Expect = 3e-27
 Identities = 65/298 (21%), Positives = 124/298 (41%), Gaps = 58/298 (19%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKIL------KPVKKKKIKREIKILQNLCGGP 180
           Y +   +G G + +V    +  T ++  +K +      K     +++REI  L+ L   P
Sbjct: 11  YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRH-P 69

Query: 181 NVVKLLDIVRDQHSKTPSLIF---EYVNST--DFKVLYPTLTDYDIRYYIYELLKALDYC 235
           +++KL D++      TP+ I    EY      D+ V    +T+ + R +  +++ A++YC
Sbjct: 70  HIIKLYDVI-----TTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYC 124

Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 295
           H   I+HRD+KP N+++D  L  +++ D+GL+     G        S  +  PE++   +
Sbjct: 125 HRHKIVHRDLKPENLLLDDNL-NVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVING-K 182

Query: 296 DYD-YSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 354
            Y    +D+WS G +   M+  + PF    D+        KV                  
Sbjct: 183 LYAGPEVDVWSCGIVLYVMLVGRLPF----DDEFIPNLFKKVNS---------------- 222

Query: 355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 412
                    +    +           +SP A   + +++  D   R+T +E    P+F
Sbjct: 223 -------CVYVMPDF-----------LSPGAQSLIRRMIVADPMQRITIQEIRRDPWF 262

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  108 bits (273), Expect = 6e-27
 Identities = 69/310 (22%), Positives = 133/310 (42%), Gaps = 60/310 (19%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL---KPVKKKKIKREIKILQNLCGGP 180
           +   +   K+G G    V      ++  +  +K++   K  +++ +  E+ I+++     
Sbjct: 44  RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRD-YQHF 102

Query: 181 NVVKLLD--IVRDQHSKTPSL--IFEYVNS---TDFKVLYPTLTDYDIRYYIYELLKALD 233
           NVV++    +V ++      L  + E++     TD  V    L +  I      +L+AL 
Sbjct: 103 NVVEMYKSYLVGEE------LWVLMEFLQGGALTDI-VSQVRLNEEQIATVCEAVLQALA 155

Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLV 292
           Y H+QG++HRD+K  ++++  +  +++L D+G  A+      +    V + Y+  PE++ 
Sbjct: 156 YLHAQGVIHRDIKSDSILLTLD-GRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVIS 214

Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNH--DQLVKIAKVLGTDELNAYLNKYH 350
               Y   +D+WSLG M   M+  + P+F    +     + ++                 
Sbjct: 215 R-SLYATEVDIWSLGIMVIEMVDGEPPYF---SDSPVQAMKRLRD--------------- 255

Query: 351 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHP 410
               P+L                   N H VSP   DFL+++L  D Q+R TA+E + HP
Sbjct: 256 -SPPPKL------------------KNSHKVSPVLRDFLERMLVRDPQERATAQELLDHP 296

Query: 411 YFAQVRAAES 420
           +  Q    E 
Sbjct: 297 FLLQTGLPEC 306

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  108 bits (271), Expect = 7e-27
 Identities = 72/308 (23%), Positives = 128/308 (41%), Gaps = 56/308 (18%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL---KPVKKKKIKREIKILQNLCGGP 180
           +  Y    K+G+G    V+  ++V T +   I+ +   +  KK+ I  EI +++     P
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE-NKNP 77

Query: 181 NVVKLLDIVRDQHSKTPSL--IFEYVNS---TDFKVLYPTLTDYDIRYYIYELLKALDYC 235
           N+V  LD     +     L  + EY+     TD  V    + +  I     E L+AL++ 
Sbjct: 78  NIVNYLD----SYLVGDELWVVMEYLAGGSLTDV-VTETCMDEGQIAAVCRECLQALEFL 132

Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLVDL 294
           HS  ++HRD+K  N+++  +   ++L D+G  A+      + +  V + Y+  PE +V  
Sbjct: 133 HSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE-VVTR 190

Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNH--DQLVKIAKVLGTDELNAYLNKYHLE 352
           + Y   +D+WSLG M   MI  + P+    + +    L  IA                  
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIEGEPPYL---NENPLRALYLIAT----------------N 231

Query: 353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 412
             P+L                   N   +S    DFL++ L  D + R +A+E + H + 
Sbjct: 232 GTPEL------------------QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFL 273

Query: 413 AQVRAAES 420
              +   S
Sbjct: 274 KIAKPLSS 281

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  110 bits (275), Expect = 8e-27
 Identities = 47/346 (13%), Positives = 99/346 (28%), Gaps = 92/346 (26%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK------KKIKREIKILQNLCGGP 180
                 +G+       E  +  T E   + +    ++      K++K E+  L+ L G  
Sbjct: 80  LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139

Query: 181 NVVKLLDIVRD-------QHSKTPSLIFEYVNSTDFKVLY-------------------- 213
           N  +    +R        +  +   +I   ++  D  VL                     
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199

Query: 214 ------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 267
                  +L  +       ++++ L   H  G++H  ++P ++++D     + L  +   
Sbjct: 200 SHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGG-VFLTGFEHL 258

Query: 268 EFYHPGKEYNVRVASRY----FKGPELLVDLQD----YDYSLDMWSLGCMFAGMIFRKEP 319
                G      +   +         +L   Q       ++ D W+LG     +     P
Sbjct: 259 V--RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316

Query: 320 FFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQH 379
                              TD+     +++                              
Sbjct: 317 N------------------TDDAALGGSEWIFRSCKN----------------------- 335

Query: 380 LVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAESSRTRA 425
            +       L+  LRY  +DRL   +AM  P + Q+R   S+    
Sbjct: 336 -IPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTELSAALPL 380

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  108 bits (272), Expect = 9e-27
 Identities = 56/370 (15%), Positives = 117/370 (31%), Gaps = 120/370 (32%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL----KPVKKKKIKREIKILQNLCGG 179
             D+E ++ +GRG +  VFE  N   +    IK +    + + ++K+ RE+K L  L   
Sbjct: 5   LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL-EH 63

Query: 180 PNVVKLLD----------------------------------------IVRDQHSKTPSL 199
           P +V+  +                                        I R     T + 
Sbjct: 64  PGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNT 123

Query: 200 IFEYVNSTDFKVLY--------PTLTDY-------------DIRYYIYELLKALDYCHSQ 238
           + +   S+    LY          L D+                +   ++ +A+++ HS+
Sbjct: 124 VGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSK 183

Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG----------- 287
           G+MHRD+KP N+    +   +++ D+GL       +E    +                  
Sbjct: 184 GLMHRDLKPSNIFFTMD-DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242

Query: 288 --PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAY 345
             PE +    +Y + +D++SLG +   +++    F    +    +  +            
Sbjct: 243 MSPEQIHG-NNYSHKVDIFSLGLILFELLY---SFSTQMERVRIITDVRN---------- 288

Query: 346 LNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTARE 405
                            +       K           P+    +  +L     +R  A +
Sbjct: 289 ----------------LKFPLLFTQK----------YPQEHMMVQDMLSPSPTERPEATD 322

Query: 406 AMAHPYFAQV 415
            + +  F  +
Sbjct: 323 IIENAIFENL 332

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  107 bits (269), Expect = 1e-26
 Identities = 73/302 (24%), Positives = 127/302 (42%), Gaps = 57/302 (18%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK----PVKKKKIKREIKILQNLCGG 179
           ++ +  + K+G+G + EVF+GI+  T +   IKI+       + + I++EI +L   C  
Sbjct: 21  EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQ-CDS 79

Query: 180 PNVVKLLDIVRDQHSKTPSL--IFEYVN--STDFKVLYPTLTDYDIRYYIYELLKALDYC 235
           P V K        + K   L  I EY+   S    +    L +  I   + E+LK LDY 
Sbjct: 80  PYVTKYYG----SYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYL 135

Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLVDL 294
           HS+  +HRD+K  NV++     +++L D+G+  +      + N  V + ++  PE++   
Sbjct: 136 HSEKKIHRDIKAANVLLSEH-GEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQ- 193

Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNH--DQLVKIAKVLGTDELNAYLNKYHLE 352
             YD   D+WSLG     +   + P     + H    L  I K           N     
Sbjct: 194 SAYDSKADIWSLGITAIELARGEPPHS---ELHPMKVLFLIPK-----------NN---- 235

Query: 353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 412
             P L+          +SK +             +F++  L  +   R TA+E + H + 
Sbjct: 236 -PPTLE--------GNYSKPLK------------EFVEACLNKEPSFRPTAKELLKHKFI 274

Query: 413 AQ 414
            +
Sbjct: 275 LR 276

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  111 bits (278), Expect = 1e-26
 Identities = 75/368 (20%), Positives = 136/368 (36%), Gaps = 78/368 (21%)

Query: 79  DKIEERNLAEIPLPAMSKARVYTDVNVLRPKEYWDYESLTVQWG-------DQDDYEVVR 131
            ++E+    ++          Y  V          Y +  +QW         ++ +   R
Sbjct: 131 QRLEQGPCKDLFQELTRLTHEYLSVAPFADYLDSIYFNRFLQWKWLERQPVTKNTFRQYR 190

Query: 132 KVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR---------EIKILQNLCGGPNV 182
            +G+G + EV       T +    K L+   KK+IK+         E +IL+       V
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLE---KKRIKKRKGEAMALNEKQILE-KVNSRFV 246

Query: 183 VKLLDIVRDQHS--KTPS---LIFEYVNSTD-----FKVLYPTLTDYDIRYYIYELLKAL 232
           V L           +T     L+   +N  D     + +      +    +Y  E+   L
Sbjct: 247 VSL-------AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGL 299

Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 292
           +  H + I++RD+KP N+++D     +R+ D GLA     G+    RV +  +  PE++ 
Sbjct: 300 EDLHRERIVYRDLKPENILLDDH-GHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVK 358

Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE 352
           + + Y +S D W+LGC+   MI  + P F       +  ++ +++          +Y   
Sbjct: 359 N-ERYTFSPDWWALGCLLYEMIAGQSP-FQQRKKKIKREEVERLVKEVPE-----EYSER 411

Query: 353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAM 407
                                        SP+A     +LL  D  +RL     +ARE  
Sbjct: 412 F----------------------------SPQARSLCSQLLCKDPAERLGCRGGSAREVK 443

Query: 408 AHPYFAQV 415
            HP F ++
Sbjct: 444 EHPLFKKL 451

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  107 bits (269), Expect = 2e-26
 Identities = 72/313 (23%), Positives = 133/313 (42%), Gaps = 59/313 (18%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGP 180
            + +E+V ++G G + +V++  N  T      K+++     + +    EI+IL   C  P
Sbjct: 18  NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILAT-CDHP 76

Query: 181 NVVKLLDIVRDQHSKTPSL--IFEYVNS---TD-FKVLYPTLTDYDIRYYIYELLKALDY 234
            +VKLL      +     L  + E+            L   LT+  I+    ++L+AL++
Sbjct: 77  YIVKLLG----AYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNF 132

Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLVD 293
            HS+ I+HRD+K  NV++  E   +RL D+G+ A+     ++ +  + + Y+  PE+++ 
Sbjct: 133 LHSKRIIHRDLKAGNVLMTLE-GDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMC 191

Query: 294 LQ----DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNH--DQLVKIAKVLGTDELNAYLN 347
                  YDY  D+WSLG     M   + P     + +    L+KIAK           +
Sbjct: 192 ETMKDTPYDYKADIWSLGITLIEMAQIEPPHH---ELNPMRVLLKIAK-----------S 237

Query: 348 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
                  P L                        S E  DFL   L  + + R +A + +
Sbjct: 238 D-----PPTL------------------LTPSKWSVEFRDFLKIALDKNPETRPSAAQLL 274

Query: 408 AHPYFAQVRAAES 420
            HP+ + + + ++
Sbjct: 275 EHPFVSSITSNKA 287

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  109 bits (275), Expect = 2e-26
 Identities = 71/299 (23%), Positives = 123/299 (41%), Gaps = 59/299 (19%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGP 180
           Y +   +G G + +V  G +  T  +  +KIL   K        KI+REI+ L+     P
Sbjct: 18  YILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRH-P 76

Query: 181 NVVKLLDIVRDQHSKTPSLIF---EYVNST---DFKVLYPTLTDYDIRYYIYELLKALDY 234
           +++KL  ++      TPS IF   EYV+     D+      L + + R    ++L  +DY
Sbjct: 77  HIIKLYQVI-----STPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDY 131

Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 294
           CH   ++HRD+KP NV++D  +   ++ D+GL+     G+       S  +  PE++   
Sbjct: 132 CHRHMVVHRDLKPENVLLDAHM-NAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISG- 189

Query: 295 QDYD-YSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 353
           + Y    +D+WS G +   ++    PF    D+   L K  K+                 
Sbjct: 190 RLYAGPEVDIWSSGVILYALLCGTLPF--DDDHVPTLFK--KICD--------------- 230

Query: 354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 412
                   G      +           ++P  I  L  +L+ D   R T ++   H +F
Sbjct: 231 --------GIFYTPQY-----------LNPSVISLLKHMLQVDPMKRATIKDIREHEWF 270

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  107 bits (269), Expect = 3e-26
 Identities = 68/312 (21%), Positives = 125/312 (40%), Gaps = 62/312 (19%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK------IKREIKILQNLC 177
           +  +  +R++G G +  V+   +V  +E   IK +    K+       I +E++ LQ   
Sbjct: 53  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQK-L 111

Query: 178 GGPNVVKLLDIVRDQHSKTPSL--IFEYVN---STDFKVLYPTLTDYDIRYYIYELLKAL 232
             PN ++        + +  +   + EY     S   +V    L + +I    +  L+ L
Sbjct: 112 RHPNTIQYRG----CYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGL 167

Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 292
            Y HS  ++HRDVK  N+++      ++L D+G A    P   +   V + Y+  PE+++
Sbjct: 168 AYLHSHNMIHRDVKAGNILLSEP-GLVKLGDFGSASIMAPANSF---VGTPYWMAPEVIL 223

Query: 293 DLQD--YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNH--DQLVKIAKVLGTDELNAYLNK 348
            + +  YD  +D+WSLG     +  RK P F   + +    L  IA+           N+
Sbjct: 224 AMDEGQYDGKVDVWSLGITCIELAERKPPLF---NMNAMSALYHIAQ-----------NE 269

Query: 349 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 408
                 P L +            +         S    +F+D  L+   QDR T+   + 
Sbjct: 270 -----SPALQS----------GHW---------SEYFRNFVDSCLQKIPQDRPTSEVLLK 305

Query: 409 HPYFAQVRAAES 420
           H +  + R    
Sbjct: 306 HRFVLRERPPTV 317

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  104 bits (262), Expect = 2e-25
 Identities = 54/309 (17%), Positives = 110/309 (35%), Gaps = 49/309 (15%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL----KPVKKKKIKREIKILQNLCG 178
           + +D E + ++G G   +V++     T     +K +       + K+I  ++ ++     
Sbjct: 23  EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHD 82

Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVN--STDFKVLYP-TLTDYDIRYYIYELLKALDYC 235
            P +V+              +  E +   +   K      + +  +      ++KAL Y 
Sbjct: 83  CPYIVQCFGTFITNTDV--FIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYL 140

Query: 236 HSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE----L 290
             + G++HRDVKP N+++D    +++L D+G++      K  +       +  PE     
Sbjct: 141 KEKHGVIHRDVKPSNILLDER-GQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPP 199

Query: 291 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH 350
                DYD   D+WSLG     +   + P+     + + L K+ +               
Sbjct: 200 DPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQ--------------- 244

Query: 351 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHP 410
            E  P L           +            S +   F+   L  DH+ R    + + H 
Sbjct: 245 -EEPPLLP------GHMGF------------SGDFQSFVKDCLTKDHRKRPKYNKLLEHS 285

Query: 411 YFAQVRAAE 419
           +  +    E
Sbjct: 286 FIKRYETLE 294

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  107 bits (269), Expect = 3e-25
 Identities = 74/315 (23%), Positives = 122/315 (38%), Gaps = 71/315 (22%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR---------EIKILQ- 174
           +D+ V R +GRG + EV+     +T +   +K L    KK+IK          E  +L  
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLD---KKRIKMKQGETLALNERIMLSL 245

Query: 175 -NLCGGPNVVKLLDIVRDQHS--KTPS---LIFEYVNSTD-FKVLY--PTLTDYDIRYYI 225
            +    P +V +            TP     I + +N  D    L      ++ D+R+Y 
Sbjct: 246 VSTGDCPFIVCM-------SYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYA 298

Query: 226 YELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYF 285
            E++  L++ H++ +++RD+KP N+++D     +R+ D GLA      K+ +  V +  +
Sbjct: 299 AEIILGLEHMHNRFVVYRDLKPANILLDEH-GHVRISDLGLAC-DFSKKKPHASVGTHGY 356

Query: 286 KGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAY 345
             PE+L     YD S D +SLGCM   ++    P F  H   D+       L        
Sbjct: 357 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP-FRQHKTKDKHEIDRMTL-------- 407

Query: 346 LNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL---- 401
                                               SPE    L+ LL+ D   RL    
Sbjct: 408 ------------------TMAVELPDSF--------SPELRSLLEGLLQRDVNRRLGCLG 441

Query: 402 -TAREAMAHPYFAQV 415
             A+E    P+F  +
Sbjct: 442 RGAQEVKESPFFRSL 456

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  106 bits (267), Expect = 3e-25
 Identities = 75/377 (19%), Positives = 135/377 (35%), Gaps = 81/377 (21%)

Query: 73  YEGAIIDKIEERNLAEIPLPAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQ-------D 125
            +   + +        +  P +     +      +      Y    +QW          D
Sbjct: 126 LDAETVARARAGAGDGLFQPLLRAVLAHLGQAPFQEFLDSLYFLRFLQWKWLEAQPMGED 185

Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR---------EIKILQNL 176
            +   R +GRG + EVF      T +    K L    KK++K+         E KIL   
Sbjct: 186 WFLDFRVLGRGGFGEVFACQMKATGKLYACKKLN---KKRLKKRKGYQGAMVEKKILA-K 241

Query: 177 CGGPNVVKLLDIVRDQHS--KTPS---LIFEYVNSTDFKV-LYPTLTDYDI------RYY 224
                +V L           +T +   L+   +N  D +  +Y    D          +Y
Sbjct: 242 VHSRFIVSL-------AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294

Query: 225 IYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASR 283
             +++  L++ H + I++RD+KP NV++D +   +R+ D GLA E      +      + 
Sbjct: 295 TAQIVSGLEHLHQRNIIYRDLKPENVLLDDD-GNVRISDLGLAVELKAGQTKTKGYAGTP 353

Query: 284 YFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELN 343
            F  PELL+  ++YD+S+D ++LG     MI  + P F       +  ++ + +    + 
Sbjct: 354 GFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGP-FRARGEKVENKELKQRVLEQAV- 410

Query: 344 AYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-- 401
                Y  +                             SP + DF + LL+ D + RL  
Sbjct: 411 ----TYPDKF----------------------------SPASKDFCEALLQKDPEKRLGF 438

Query: 402 ---TAREAMAHPYFAQV 415
              +      HP F  +
Sbjct: 439 RDGSCDGLRTHPLFRDI 455

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  103 bits (258), Expect = 9e-25
 Identities = 63/314 (20%), Positives = 119/314 (37%), Gaps = 30/314 (9%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKI----LKPVKKKKIKREIKILQNLCGGP 180
           DD+E + ++G G    VF+  +  +      K+    +KP  + +I RE+++L   C  P
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE-CNSP 91

Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIYELLKALDYCHS 237
            +V              S+  E+++      +           +      ++K L Y   
Sbjct: 92  YIVGFYGAF--YSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 149

Query: 238 QG-IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK----EYNVRVASRYFKGPELLV 292
           +  IMHRDVKP N++++    +++L D+G++     G+      N  V +R +  PE L 
Sbjct: 150 KHKIMHRDVKPSNILVNSR-GEIKLCDFGVS-----GQLIDSMANSFVGTRSYMSPERL- 202

Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE 352
               Y    D+WS+G     M   + P     D  +  +     +  D            
Sbjct: 203 QGTHYSVQSDIWSMGLSLVEMAVGRYPIP-PPDAKELELMFGCQVEGDAAETPPRPRTPG 261

Query: 353 LDPQLDALVGRHSRKPWS--KFINADN-----QHLVSPEAIDFLDKLLRYDHQDRLTARE 405
                  +  R     +    +I  +        + S E  DF++K L  +  +R   ++
Sbjct: 262 RPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQ 321

Query: 406 AMAHPYFAQVRAAE 419
            M H +  +  A E
Sbjct: 322 LMVHAFIKRSDAEE 335

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score =  103 bits (258), Expect = 2e-24
 Identities = 79/389 (20%), Positives = 144/389 (37%), Gaps = 83/389 (21%)

Query: 102 DVNVLRPKEYWDYESLTVQWGD--QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK 159
           D     P +Y       V+ GD     Y V+RK+G G +S V+   ++   +   +K++K
Sbjct: 12  DDEQEDPNDYCKGGYHLVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVK 71

Query: 160 PVKK--KKIKREIKILQNLC-------GGPNVVKLLDI--VRDQHSKTPSLIFEY--VNS 206
             +   +    EI++L+++            VV+LLD   +   +     ++FE    + 
Sbjct: 72  SAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHL 131

Query: 207 TDFKVLYPT--LTDYDIRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMI----------- 252
             + +      L    ++  I ++L+ LDY H++  I+H D+KP N+++           
Sbjct: 132 LKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLA 191

Query: 253 -------------------------------------DHELRKLRLIDWGLAEFYHPGKE 275
                                                + E  K+++ D G A      K 
Sbjct: 192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNA--CWVHKH 249

Query: 276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNH------DQ 329
           +   + +R ++  E+L+    Y+   D+WS  CM    +   +  F  H         D 
Sbjct: 250 FTEDIQTRQYRSLEVLIGS-GYNTPADIWSTACMAFE-LATGDYLFEPHSGEEYTRDEDH 307

Query: 330 LVKIAKVLGT--DELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPE--- 384
           +  I ++LG    +L             + D L      KPW  F     ++  S E   
Sbjct: 308 IALIIELLGKVPRKLIVAGKYSKEFFTKKGD-LKHITKLKPWGLFEVLVEKYEWSQEEAA 366

Query: 385 -AIDFLDKLLRYDHQDRLTAREAMAHPYF 412
              DFL  +L    + R TA E + HP+ 
Sbjct: 367 GFTDFLLPMLELIPEKRATAAECLRHPWL 395

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  100 bits (251), Expect = 6e-24
 Identities = 58/330 (17%), Positives = 115/330 (34%), Gaps = 90/330 (27%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL----KPVKKKKIKREIKILQNLCGGP 180
           +D + + ++GRG Y  V + ++  + +   +K +       ++K++  ++ ++      P
Sbjct: 22  EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCP 81

Query: 181 NVVK---------------------LLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDY 219
            +V+                          +  +S    +I E +               
Sbjct: 82  YIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEI--------------- 126

Query: 220 DIRYYIYELLKALDYCHSQG-IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV 278
            +       +KAL++      I+HRD+KP N+++D     ++L D+G++       +   
Sbjct: 127 -LGKITLATVKALNHLKENLKIIHRDIKPSNILLDRS-GNIKLCDFGIS------GQLVD 178

Query: 279 RVASRYFKG------PELL---VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQ 329
            +A     G      PE +      Q YD   D+WSLG     +   + P+   +   DQ
Sbjct: 179 SIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ 238

Query: 330 LVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFL 389
           L ++ K                   PQL             +F         SP  I+F+
Sbjct: 239 LTQVVK----------------GDPPQLSN-------SEEREF---------SPSFINFV 266

Query: 390 DKLLRYDHQDRLTAREAMAHPYFAQVRAAE 419
           +  L  D   R   +E + HP+        
Sbjct: 267 NLCLTKDESKRPKYKELLKHPFILMYEERA 296

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =   99 bits (250), Expect = 7e-24
 Identities = 75/317 (23%), Positives = 129/317 (40%), Gaps = 77/317 (24%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP---VKKKKI---KREIKILQNLCG 178
           +D++  + +G G +S V     + T+    IKIL+    +K+ K+    RE  ++  L  
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-D 88

Query: 179 GPNVVKLLDIVRDQHS-KTPS---LIFEYVNSTD-FKVLYP--TLTDYDIRYYIYELLKA 231
            P  VKL        + +          Y  + +  K +    +  +   R+Y  E++ A
Sbjct: 89  HPFFVKLY------FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA 142

Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG---- 287
           L+Y H +GI+HRD+KP N++++ ++  +++ D+G A+     +    R  S  F G    
Sbjct: 143 LEYLHGKGIIHRDLKPENILLNEDMH-IQITDFGTAK-VLSPESKQARANS--FVGTAQY 198

Query: 288 --PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV-KIAKVLGTDELNA 344
             PELL + +    S D+W+LGC+   ++    PF     N   +  KI K         
Sbjct: 199 VSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFR--AGNEYLIFQKIIK--------- 246

Query: 345 YLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT-- 402
              +Y     P+                          P+A D ++KLL  D   RL   
Sbjct: 247 --LEYDF---PE-----------------------KFFPKARDLVEKLLVLDATKRLGCE 278

Query: 403 ----AREAMAHPYFAQV 415
                    AHP+F  V
Sbjct: 279 EMEGYGPLKAHPFFESV 295

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 98.2 bits (245), Expect = 1e-22
 Identities = 72/325 (22%), Positives = 120/325 (36%), Gaps = 85/325 (26%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR--------EIKILQNL 176
           DD+E+++ +GRG +SEV       T +   +KI+   K   +KR        E  +L N 
Sbjct: 61  DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMN--KWDMLKRGEVSCFREERDVLVN- 117

Query: 177 CGGPNVVKLLDIVRDQHS-KTPS---LIFEYVNSTD-FKVLY---PTLTDYDIRYYIYEL 228
                + +L        + +  +   L+ EY    D   +L      +     R+Y+ E+
Sbjct: 118 GDRRWITQL------HFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEI 171

Query: 229 LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV--RVASRYFK 286
           + A+D  H  G +HRD+KP N+++D     +RL D+G         +      V S    
Sbjct: 172 VMAIDSVHRLGYVHRDIKPDNILLDRC-GHIRLADFGSC------LKLRADGTVRSLVAV 224

Query: 287 G------PELL------VDLQDYDYSLDMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKI 333
           G      PE+L           Y    D W+LG   +  M + + PF+   D+  +    
Sbjct: 225 GTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYE-MFYGQTPFY--ADSTAET--Y 279

Query: 334 AKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLL 393
            K++   E                                       V  EA DF+ +LL
Sbjct: 280 GKIVHYKE-----------------------------HLSLPLVDEGVPEEARDFIQRLL 310

Query: 394 RYDHQDRLT---AREAMAHPYFAQV 415
               + RL    A +   HP+F  +
Sbjct: 311 C-PPETRLGRGGAGDFRTHPFFFGL 334

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 95.5 bits (238), Expect = 8e-22
 Identities = 54/314 (17%), Positives = 110/314 (35%), Gaps = 73/314 (23%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK--PVKKKK----IKREIKILQNLCG 178
           D +E++R +G+G + +V      +T +   +K +      ++     + +E++I+Q L  
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGL-E 73

Query: 179 GPNVVKLLDIVRDQHS--KTPS---LIFEYVNSTD-FKVLY--PTLTDYDIRYYIYELLK 230
            P +V L           +      ++ + +   D    L       +  ++ +I EL+ 
Sbjct: 74  HPFLVNL-------WYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVM 126

Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG--- 287
           ALDY  +Q I+HRD+KP N+++D     + + D+ +A                   G   
Sbjct: 127 ALDYLQNQRIIHRDMKPDNILLDEH-GHVHITDFNIA------AMLPRETQITTMAGTKP 179

Query: 288 ---PELLVD--LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDEL 342
              PE+        Y +++D WSLG     ++  + P ++   +      +         
Sbjct: 180 YMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP-YHIRSSTSSKEIVHTFE----- 233

Query: 343 NAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL- 401
                                 +   +            S E +  L KLL  +   R  
Sbjct: 234 ---------------------TTVVTYPSAW--------SQEMVSLLKKLLEPNPDQRFS 264

Query: 402 TAREAMAHPYFAQV 415
              +    PY   +
Sbjct: 265 QLSDVQNFPYMNDI 278

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 95.6 bits (238), Expect = 1e-21
 Identities = 69/323 (21%), Positives = 126/323 (39%), Gaps = 83/323 (25%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR--------EIKILQNL 176
           +D+E+++ +GRG + EV      N ++   +KIL   K + +KR        E  +L N 
Sbjct: 74  EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILN--KWEMLKRAETACFREERDVLVN- 130

Query: 177 CGGPNVVKLLDIVRDQHS--KTPS---LIFEYVNSTD-FKVLY---PTLTDYDIRYYIYE 227
                +  L       H   +  +   L+ +Y    D   +L      L +   R+Y+ E
Sbjct: 131 GDSKWITTL-------HYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAE 183

Query: 228 LLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE--YNVRVASRYF 285
           ++ A+D  H    +HRD+KP N+++D     +RL D+G         +   +  V S   
Sbjct: 184 MVIAIDSVHQLHYVHRDIKPDNILMDMN-GHIRLADFGSC------LKLMEDGTVQSSVA 236

Query: 286 KG------PELLVDLQD----YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
            G      PE+L  ++     Y    D WSLG     M++ + PF+   ++  +     K
Sbjct: 237 VGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFY--AESLVET--YGK 292

Query: 336 VLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRY 395
           ++         +K   +   Q+                       VS  A D + +L+  
Sbjct: 293 IMN--------HKERFQFPTQVTD---------------------VSENAKDLIRRLIC- 322

Query: 396 DHQDRLT---AREAMAHPYFAQV 415
             + RL      +   HP+F+ +
Sbjct: 323 SREHRLGQNGIEDFKKHPFFSGI 345

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 94.8 bits (236), Expect = 2e-21
 Identities = 75/321 (23%), Positives = 124/321 (38%), Gaps = 83/321 (25%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP---VKKKKIKR---EIKILQNLCG 178
           +DYEVV+ +GRG + EV    + +T +   +K+L     +K+        E  I+     
Sbjct: 69  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF-AN 127

Query: 179 GPNVVKLLDIVRDQHS-KTPS---LIFEYVNSTDFKVLYPTLTDYDI-----RYYIYELL 229
            P VV+L       ++ +      ++ EY+   D   L   +++YD+     R+Y  E++
Sbjct: 128 SPWVVQL------FYAFQDDRYLYMVMEYMPGGD---LVNLMSNYDVPEKWARFYTAEVV 178

Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV--RVASRYFKG 287
            ALD  HS G +HRDVKP N+++D     L+L D+G         + N    V      G
Sbjct: 179 LALDAIHSMGFIHRDVKPDNMLLDKS-GHLKLADFGTC------MKMNKEGMVRCDTAVG 231

Query: 288 ------PELLVD---LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL- 337
                 PE+L        Y    D WS+G     M+    PF+   D+       +K++ 
Sbjct: 232 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY--ADSLVGT--YSKIMN 287

Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDH 397
             + L      +  + D                          +S EA + +   L  D 
Sbjct: 288 HKNSL-----TFPDDND--------------------------ISKEAKNLICAFLT-DR 315

Query: 398 QDRLT---AREAMAHPYFAQV 415
           + RL      E   H +F   
Sbjct: 316 EVRLGRNGVEEIKRHLFFKND 336

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 93.1 bits (232), Expect = 4e-21
 Identities = 73/322 (22%), Positives = 123/322 (38%), Gaps = 90/322 (27%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR--------EIKILQNL 176
            D+  ++ +G+G + +V    +        +K+L+  KK  +K+        E  +L   
Sbjct: 38  SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQ--KKAILKKKEEKHIMSERNVLLKN 95

Query: 177 CGGPNVVKLLDIVRDQHS--KTPS---LIFEYVNSTD-FKVLY--PTLTDYDIRYYIYEL 228
              P +V L       H   +T      + +Y+N  + F  L       +   R+Y  E+
Sbjct: 96  VKHPFLVGL-------HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEI 148

Query: 229 LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGK---------EYNV 278
             AL Y HS  I++RD+KP N+++D +   + L D+GL  E               EY  
Sbjct: 149 ASALGYLHSLNIVYRDLKPENILLDSQ-GHIVLTDFGLCKENIEHNSTTSTFCGTPEY-- 205

Query: 279 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV-KIAKVL 337
            +A      PE+L   Q YD ++D W LG +   M++   PF+    N  ++   I    
Sbjct: 206 -LA------PEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFY--SRNTAEMYDNI---- 251

Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDH 397
                        L    QL         KP            ++  A   L+ LL+ D 
Sbjct: 252 -------------LNKPLQL---------KPN-----------ITNSARHLLEGLLQKDR 278

Query: 398 QDRL----TAREAMAHPYFAQV 415
             RL       E  +H +F+ +
Sbjct: 279 TKRLGAKDDFMEIKSHVFFSLI 300

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 92.3 bits (230), Expect = 6e-21
 Identities = 78/321 (24%), Positives = 132/321 (41%), Gaps = 77/321 (23%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK--PVKKKK----IKREIKILQNLCG 178
            D++++R +GRG Y++V       T+    +K++K   V   +    ++ E  + +    
Sbjct: 9   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 68

Query: 179 GPNVVKLLDIVRDQHS--KTPS---LIFEYVNSTD-FKVLY--PTLTDYDIRYYIYELLK 230
            P +V L       HS  +T S    + EYVN  D    +     L +   R+Y  E+  
Sbjct: 69  HPFLVGL-------HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISL 121

Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGK---------EYNVRV 280
           AL+Y H +GI++RD+K  NV++D E   ++L D+G+  E   PG           Y   +
Sbjct: 122 ALNYLHERGIIYRDLKLDNVLLDSE-GHIKLTDYGMCKEGLRPGDTTSTFCGTPNY---I 177

Query: 281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTD 340
           A      PE+L   +DY +S+D W+LG +   M+  + PF                   D
Sbjct: 178 A------PEILRG-EDYGFSVDWWALGVLMFEMMAGRSPF-------------------D 211

Query: 341 ELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDR 400
            + +  N      D     ++ +  R P            +S +A   L   L  D ++R
Sbjct: 212 IVGSSDNPDQNTEDYLFQVILEKQIRIP----------RSLSVKAASVLKSFLNKDPKER 261

Query: 401 L------TAREAMAHPYFAQV 415
           L         +   HP+F  V
Sbjct: 262 LGCHPQTGFADIQGHPFFRNV 282

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 91.5 bits (228), Expect = 1e-20
 Identities = 79/321 (24%), Positives = 136/321 (42%), Gaps = 88/321 (27%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR--------EIKILQNL 176
           +D++ ++ +G+G + +V       T     +KIL+  K+  I +        E ++LQN 
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILR--KEVIIAKDEVAHTVTESRVLQN- 61

Query: 177 CGGPNVVKLLDIVRDQHS--KTPS---LIFEYVNSTD-FKVLY--PTLTDYDIRYYIYEL 228
              P +  L           +T      + EY N  + F  L      T+   R+Y  E+
Sbjct: 62  TRHPFLTAL-------KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEI 114

Query: 229 LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE---YNVRVASRYF 285
           + AL+Y HS+ +++RD+K  N+M+D +   +++ D+GL       KE       + +  F
Sbjct: 115 VSALEYLHSRDVVYRDIKLENLMLDKD-GHIKITDFGLC------KEGISDGATMKT--F 165

Query: 286 KG------PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT 339
            G      PE+L D  DY  ++D W LG +   M+  + P FY   +H++L +   +L  
Sbjct: 166 CGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLP-FYN-QDHERLFE--LIL-M 219

Query: 340 DELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQD 399
           +E+                       R P            +SPEA   L  LL+ D + 
Sbjct: 220 EEI-----------------------RFP----------RTLSPEAKSLLAGLLKKDPKQ 246

Query: 400 RL-----TAREAMAHPYFAQV 415
           RL      A+E M H +F  +
Sbjct: 247 RLGGGPSDAKEVMEHRFFLSI 267

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 91.6 bits (228), Expect = 1e-20
 Identities = 67/314 (21%), Positives = 119/314 (37%), Gaps = 77/314 (24%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK--PVKKKK----IKREIKILQNLCG 178
           D ++ ++ +G G +  V    +  +     +KIL    V K K       E +ILQ    
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-VN 99

Query: 179 GPNVVKLLDIVRDQHSKTPS---LIFEYVNSTD-FKVLY--PTLTDYDIRYYIYELLKAL 232
            P +VKL     +   K  S   ++ EYV   + F  L      ++   R+Y  +++   
Sbjct: 100 FPFLVKL-----EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154

Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG----- 287
           +Y HS  +++RD+KP N++ID +   +++ D+G A      K    R  +    G     
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFA------KRVKGRTWT--LCGTPEAL 205

Query: 288 -PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYL 346
            PE+++  + Y+ ++D W+LG +   M     PFF   D   Q+                
Sbjct: 206 APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF--ADQPIQI---------------- 246

Query: 347 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL----- 401
             Y   +  ++           +            S +  D L  LL+ D   R      
Sbjct: 247 --YEKIVSGKVR----------FPSHF--------SSDLKDLLRNLLQVDLTKRFGNLKN 286

Query: 402 TAREAMAHPYFAQV 415
              +   H +FA  
Sbjct: 287 GVNDIKNHKWFATT 300

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 91.1 bits (227), Expect = 2e-20
 Identities = 68/327 (20%), Positives = 118/327 (36%), Gaps = 99/327 (30%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKI---------KREIKILQN 175
            D+  +  +G+G + +V       T+E   +KILK   K  +           E ++L  
Sbjct: 20  TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILK---KDVVIQDDDVECTMVEKRVLAL 76

Query: 176 LCGGPNVVKLLDIVRDQHS--KTPS---LIFEYVNSTD-FKVLYPT--LTDYDIRYYIYE 227
               P + +L       HS  +T      + EYVN  D    +       +    +Y  E
Sbjct: 77  PGKPPFLTQL-------HSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAE 129

Query: 228 LLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGK---------EYN 277
           +   L +  S+GI++RD+K  NVM+D E   +++ D+G+  E    G          +Y 
Sbjct: 130 IAIGLFFLQSKGIIYRDLKLDNVMLDSE-GHIKIADFGMCKENIWDGVTTKTFCGTPDY- 187

Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVKI 333
             +A      PE++   Q Y  S+D W+ G     M AG     +  F G ++ D+L   
Sbjct: 188 --IA------PEIIAY-QPYGKSVDWWAFGVLLYEMLAG-----QAPFEG-EDEDEL--- 229

Query: 334 AKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLL 393
                                    +++  +   P            +S EA+     L+
Sbjct: 230 -----------------------FQSIMEHNVAYP----------KSMSKEAVAICKGLM 256

Query: 394 RYDHQDRL-----TAREAMAHPYFAQV 415
                 RL       R+   H +F  +
Sbjct: 257 TKHPGKRLGCGPEGERDIKEHAFFRYI 283

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 91.3 bits (227), Expect = 3e-20
 Identities = 77/321 (23%), Positives = 132/321 (41%), Gaps = 77/321 (23%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK--PVKKKK----IKREIKILQNLCG 178
            D++++R +GRG Y++V       T+    ++++K   V   +    ++ E  + +    
Sbjct: 52  QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASN 111

Query: 179 GPNVVKLLDIVRDQHS--KTPS---LIFEYVNSTD-FKVLY--PTLTDYDIRYYIYELLK 230
            P +V L       HS  +T S    + EYVN  D    +     L +   R+Y  E+  
Sbjct: 112 HPFLVGL-------HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISL 164

Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGK---------EYNVRV 280
           AL+Y H +GI++RD+K  NV++D E   ++L D+G+  E   PG           Y   +
Sbjct: 165 ALNYLHERGIIYRDLKLDNVLLDSE-GHIKLTDYGMCKEGLRPGDTTSTFCGTPNY---I 220

Query: 281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTD 340
           A      PE+L   +DY +S+D W+LG +   M+  + PF                   D
Sbjct: 221 A------PEILRG-EDYGFSVDWWALGVLMFEMMAGRSPF-------------------D 254

Query: 341 ELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDR 400
            + +  N      D     ++ +  R P            +S +A   L   L  D ++R
Sbjct: 255 IVGSSDNPDQNTEDYLFQVILEKQIRIP----------RSLSVKAASVLKSFLNKDPKER 304

Query: 401 L------TAREAMAHPYFAQV 415
           L         +   HP+F  V
Sbjct: 305 LGCHPQTGFADIQGHPFFRNV 325

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 90.4 bits (225), Expect = 3e-20
 Identities = 69/324 (21%), Positives = 120/324 (37%), Gaps = 92/324 (28%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKI---------KREIKILQN 175
           D++E +R +G+G + +V       T +   +K+LK   K  I           E +IL  
Sbjct: 23  DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLK---KDVILQDDDVECTMTEKRILSL 79

Query: 176 LCGGPNVVKLLDIVRDQHS--KTPS---LIFEYVNSTD-FKVLYPT--LTDYDIRYYIYE 227
               P + +L           +TP     + E+VN  D    +  +    +   R+Y  E
Sbjct: 80  ARNHPFLTQL-------FCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAE 132

Query: 228 LLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGK---------EYN 277
           ++ AL + H +GI++RD+K  NV++DHE    +L D+G+  E    G          +Y 
Sbjct: 133 IISALMFLHDKGIIYRDLKLDNVLLDHE-GHCKLADFGMCKEGICNGVTTATFCGTPDY- 190

Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             +A      PE+L +   Y  ++D W++G +   M+    P F   +  D    I    
Sbjct: 191 --IA------PEILQE-MLYGPAVDWWAMGVLLYEMLCGHAP-FEAENEDDLFEAILN-- 238

Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDH 397
             DE+      Y   L                              +A   L   +  + 
Sbjct: 239 --DEV-----VYPTWL----------------------------HEDATGILKSFMTKNP 263

Query: 398 QDRL------TAREAMAHPYFAQV 415
             RL           + HP+F ++
Sbjct: 264 TMRLGSLTQGGEHAILRHPFFKEI 287

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 88.8 bits (221), Expect = 4e-20
 Identities = 65/311 (20%), Positives = 126/311 (40%), Gaps = 56/311 (18%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKI----LKPVKKKKIKREIKILQNLCGGP 180
           DD E + ++GRG Y  V +  +V + +   +K     +   ++K++  ++ I       P
Sbjct: 7   DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66

Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVN-STD-----FKVLYPTLTDYDIRYYIYELLKALDY 234
             V     +  +      +  E ++ S D           T+ +  +      ++KAL++
Sbjct: 67  FTVTFYGALFREG--DVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEH 124

Query: 235 CHSQG-IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE---L 290
            HS+  ++HRDVKP NV+I+    ++++ D+G++ +       ++    + +  PE    
Sbjct: 125 LHSKLSVIHRDVKPSNVLINAL-GQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINP 183

Query: 291 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNH--DQLVKIAKVLGTDELNAYLNK 348
            ++ + Y    D+WSLG     +   + P  Y        QL ++ +             
Sbjct: 184 ELNQKGYSVKSDIWSLGITMIELAILRFP--YDSWGTPFQQLKQVVE------------- 228

Query: 349 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 408
              E  PQL          P  KF         S E +DF  + L+ + ++R T  E M 
Sbjct: 229 ---EPSPQL----------PADKF---------SAEFVDFTSQCLKKNSKERPTYPELMQ 266

Query: 409 HPYFAQVRAAE 419
           HP+F    +  
Sbjct: 267 HPFFTLHESKG 277

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 90.0 bits (224), Expect = 4e-20
 Identities = 65/316 (20%), Positives = 121/316 (38%), Gaps = 81/316 (25%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK--PVKKKK----IKREIKILQNLCG 178
           +D+ + + +G+G + +VF      TN+   IK LK   V           E ++L     
Sbjct: 17  EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 76

Query: 179 GPNVVKLLDIVRDQHS--KTPS---LIFEYVNSTD-FKVLYP--TLTDYDIRYYIYELLK 230
            P +  +           +T      + EY+N  D    +            +Y  E++ 
Sbjct: 77  HPFLTHM-------FCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIIL 129

Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGK---------EYNVRV 280
            L + HS+GI++RD+K  N+++D +   +++ D+G+  E               +Y   +
Sbjct: 130 GLQFLHSKGIVYRDLKLDNILLDKD-GHIKIADFGMCKENMLGDAKTNTFCGTPDY---I 185

Query: 281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTD 340
           A      PE+L+  Q Y++S+D WS G +   M+  + P F+G  + ++L          
Sbjct: 186 A------PEILLG-QKYNHSVDWWSFGVLLYEMLIGQSP-FHG-QDEEEL---------- 226

Query: 341 ELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDR 400
                             ++   +   P            +  EA D L KL   + + R
Sbjct: 227 ----------------FHSIRMDNPFYP----------RWLEKEAKDLLVKLFVREPEKR 260

Query: 401 LTAREA-MAHPYFAQV 415
           L  R     HP F ++
Sbjct: 261 LGVRGDIRQHPLFREI 276

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 91.6 bits (227), Expect = 5e-20
 Identities = 69/321 (21%), Positives = 116/321 (36%), Gaps = 87/321 (27%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR--------EIKILQNL 176
            D+  +  +G+G + +V       T+E   +KILK  K   I+         E ++L   
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILK--KDVVIQDDDVECTMVEKRVLALP 398

Query: 177 CGGPNVVKLLDIVRDQHS--KTPS---LIFEYVNSTD-FKVLYPT--LTDYDIRYYIYEL 228
              P + +L       HS  +T      + EYVN  D    +       +    +Y  E+
Sbjct: 399 GKPPFLTQL-------HSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEI 451

Query: 229 LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE---YNVRVASRYF 285
              L +  S+GI++RD+K  NVM+D E   +++ D+G+       KE     V   +  F
Sbjct: 452 AIGLFFLQSKGIIYRDLKLDNVMLDSE-GHIKIADFGMC------KENIWDGVTTKT--F 502

Query: 286 KG------PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT 339
            G      PE++   Q Y  S+D W+ G +   M+  + P F G D  +    I +    
Sbjct: 503 CGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAP-FEGEDEDELFQSIME---- 556

Query: 340 DELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQD 399
             +                         P            +S EA+     L+      
Sbjct: 557 HNV-----------------------AYP----------KSMSKEAVAICKGLMTKHPGK 583

Query: 400 RL-----TAREAMAHPYFAQV 415
           RL       R+   H +F  +
Sbjct: 584 RLGCGPEGERDIKEHAFFRYI 604

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 89.1 bits (222), Expect = 5e-20
 Identities = 77/325 (23%), Positives = 131/325 (40%), Gaps = 94/325 (28%)

Query: 125 DDYEVVRKVGRGKYSEVF---EGINVNTNERCIIKILKPVKKKKIKR--------EIKIL 173
             +E+++ +G+G + +VF   +    +  +   +K+LK   K  +K         E  IL
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLK---KATLKVRDRVRTKMERDIL 80

Query: 174 QNLCGGPNVVKLLDIVRDQHS--KTPS---LIFEYVNSTD-FKVLY--PTLTDYDIRYYI 225
                 P +VKL       H   +T     LI +++   D F  L      T+ D+++Y+
Sbjct: 81  VE-VNHPFIVKL-------HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYL 132

Query: 226 YELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGK---------E 275
            EL  ALD+ HS GI++RD+KP N+++D E   ++L D+GL+ E     K         E
Sbjct: 133 AELALALDHLHSLGIIYRDLKPENILLDEE-GHIKLTDFGLSKESIDHEKKAYSFCGTVE 191

Query: 276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
           Y   +A      PE++   + +  S D WS G +   M+    P F G D  + +  I  
Sbjct: 192 Y---MA------PEVVNR-RGHTQSADWWSFGVLMFEMLTGTLP-FQGKDRKETMTMI-- 238

Query: 336 VLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRY 395
                          L+    +           +           +SPEA   L  L + 
Sbjct: 239 ---------------LKAKLGM---------PQF-----------LSPEAQSLLRMLFKR 263

Query: 396 DHQDRL-----TAREAMAHPYFAQV 415
           +  +RL        E   H +F+ +
Sbjct: 264 NPANRLGAGPDGVEEIKRHSFFSTI 288

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 89.7 bits (223), Expect = 5e-20
 Identities = 72/329 (21%), Positives = 138/329 (41%), Gaps = 92/329 (27%)

Query: 125 DDYEVVRKVGRGKYSEVF---EGINVNTNERCIIKILKP---VKKKK----IKREIKILQ 174
           +++E+++ +G G Y +VF   +    +T +   +K+LK    V+K K     + E ++L+
Sbjct: 54  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113

Query: 175 NLCGGPNVVKLLDIVRDQHS--KTPS---LIFEYVNSTD-FKVLY--PTLTDYDIRYYIY 226
           ++   P +V L       H   +T +   LI +Y+N  + F  L      T+++++ Y+ 
Sbjct: 114 HIRQSPFLVTL-------HYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVG 166

Query: 227 ELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE----YNVRVAS 282
           E++ AL++ H  GI++RD+K  N+++D     + L D+GL+      KE       R   
Sbjct: 167 EIVLALEHLHKLGIIYRDIKLENILLDSN-GHVVLTDFGLS------KEFVADETERAYD 219

Query: 283 RYFKG------PELLVDL-QDYDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLV 331
             F G      P+++      +D ++D WSLG     +  G        F      +   
Sbjct: 220 --FCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA-----SPFTVDGEKNSQA 272

Query: 332 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDK 391
           +I++ +   E                          P+ + +        S  A D + +
Sbjct: 273 EISRRILKSEP-------------------------PYPQEM--------SALAKDLIQR 299

Query: 392 LLRYDHQDRL-----TAREAMAHPYFAQV 415
           LL  D + RL      A E   H +F ++
Sbjct: 300 LLMKDPKKRLGCGPRDADEIKEHLFFQKI 328

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 88.8 bits (221), Expect = 7e-20
 Identities = 85/328 (25%), Positives = 136/328 (41%), Gaps = 98/328 (29%)

Query: 125 DDYEVVRKVGRGKYSEVF---EGINVNTNERCIIKILKP---VKKKK----IKREIKILQ 174
           + +E++R +G+G Y +VF   +    NT +   +K+LK    V+  K     K E  IL+
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76

Query: 175 NLCGGPNVVKLLDIVRDQHS--KTPS---LIFEYVNSTD-FKVLY--PTLTDYDIRYYIY 226
                P +V L           +T     LI EY++  + F  L       +    +Y+ 
Sbjct: 77  E-VKHPFIVDL-------IYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLA 128

Query: 227 ELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGK---------EY 276
           E+  AL + H +GI++RD+KP N+M++H+   ++L D+GL  E  H G          EY
Sbjct: 129 EISMALGHLHQKGIIYRDLKPENIMLNHQ-GHVKLTDFGLCKESIHDGTVTHTFCGTIEY 187

Query: 277 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVK 332
              +A      PE+L+    ++ ++D WSLG     M  G      P F G +    + K
Sbjct: 188 ---MA------PEILMR-SGHNRAVDWWSLGALMYDMLTG-----APPFTGENRKKTIDK 232

Query: 333 IAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKL 392
           I K     +L                         P+           ++ EA D L KL
Sbjct: 233 ILK----CKL-----NL-----------------PPY-----------LTQEARDLLKKL 255

Query: 393 LRYDHQDRL-----TAREAMAHPYFAQV 415
           L+ +   RL      A E  AHP+F  +
Sbjct: 256 LKRNAASRLGAGPGDAGEVQAHPFFRHI 283

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 89.4 bits (222), Expect = 1e-19
 Identities = 76/314 (24%), Positives = 135/314 (42%), Gaps = 73/314 (23%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR--------EIKILQNL 176
           +++E ++ +G+G + +V       T     +KILK  K+  + +        E ++LQN 
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILK--KEVIVAKDEVAHTLTENRVLQN- 204

Query: 177 CGGPNVVKLLDIVRDQHS--KTPS---LIFEYVNSTD-FKVLY--PTLTDYDIRYYIYEL 228
              P +  L           +T      + EY N  + F  L      ++   R+Y  E+
Sbjct: 205 SRHPFLTAL-------KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEI 257

Query: 229 LKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFK 286
           + ALDY HS+  +++RD+K  N+M+D +   +++ D+GL  E    G        +  + 
Sbjct: 258 VSALDYLHSEKNVVYRDLKLENLMLDKD-GHIKITDFGLCKEGIKDGATMKTFCGTPEYL 316

Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYL 346
            PE+L D  DY  ++D W LG +   M+  + PF+  + +H++L +   +L  +E+    
Sbjct: 317 APEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY--NQDHEKLFE--LIL-MEEI---- 366

Query: 347 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL----- 401
                              R P            + PEA   L  LL+ D + RL     
Sbjct: 367 -------------------RFP----------RTLGPEAKSLLSGLLKKDPKQRLGGGSE 397

Query: 402 TAREAMAHPYFAQV 415
            A+E M H +FA +
Sbjct: 398 DAKEIMQHRFFAGI 411

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 87.2 bits (217), Expect = 2e-19
 Identities = 61/316 (19%), Positives = 122/316 (38%), Gaps = 81/316 (25%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK--PVKKKK----IKREIKILQNLCG 178
            D++++R +G G +  V    + +      +K+LK   V + K       E  +L  +  
Sbjct: 6   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-T 64

Query: 179 GPNVVKLLDIVRDQHS--KTPS---LIFEYVNSTD-FKVLY--PTLTDYDIRYYIYELLK 230
            P ++++           +      +I +Y+   + F +L       +   ++Y  E+  
Sbjct: 65  HPFIIRM-------WGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCL 117

Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG--- 287
           AL+Y HS+ I++RD+KP N+++D     +++ D+G A      K       +    G   
Sbjct: 118 ALEYLHSKDIIYRDLKPENILLDKN-GHIKITDFGFA------KYVPDVTYT--LCGTPD 168

Query: 288 ---PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA 344
              PE++   + Y+ S+D WS G +   M+    PF+    N  +  +  K+L       
Sbjct: 169 YIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFY--DSNTMKTYE--KIL------- 216

Query: 345 YLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL--- 401
                              ++   +  F         + +  D L +L+  D   RL   
Sbjct: 217 -------------------NAELRFPPFF--------NEDVKDLLSRLITRDLSQRLGNL 249

Query: 402 --TAREAMAHPYFAQV 415
                +   HP+F +V
Sbjct: 250 QNGTEDVKNHPWFKEV 265

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 86.8 bits (215), Expect = 2e-18
 Identities = 45/212 (21%), Positives = 86/212 (40%), Gaps = 17/212 (8%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCI-IKILKPVK----KKKIKREIKILQNLCGGPN 181
           YEV   +  G    ++  ++ N N R + +K L        +     E + L  +   P+
Sbjct: 82  YEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEV-VHPS 140

Query: 182 VVKLLDIVRDQHSKTPSLIF---EYVNSTDFK-VLYPTLTDYDIRYYIYELLKALDYCHS 237
           +V++ + V         + +   EYV     K      L   +   Y+ E+L AL Y HS
Sbjct: 141 IVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEAIAYLLEILPALSYLHS 200

Query: 238 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDY 297
            G+++ D+KP N+M+  E  +L+LID G          +     +  F+ PE++      
Sbjct: 201 IGLVYNDLKPENIMLTEE--QLKLIDLGAV---SRINSFGYLYGTPGFQAPEIVRTGPT- 254

Query: 298 DYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQ 329
             + D++++G   A +          + +   
Sbjct: 255 VAT-DIYTVGRTLAALTLDLPTRNGRYVDGLP 285

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 80.9 bits (200), Expect = 4e-17
 Identities = 37/156 (23%), Positives = 71/156 (45%), Gaps = 18/156 (11%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-PVKKKKIKREIKILQNLCGGPNVVKL 185
           + V +K+G G + E+  G N+ TNE   IK+     +  ++  E +  + L  G  + ++
Sbjct: 11  FRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQV 70

Query: 186 LDIVRDQHSKT-------PSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQ 238
                             PSL  E +    F +   T +   +     +L+  ++Y HS+
Sbjct: 71  YYFGPCGKYNAMVLELLGPSL--EDL----FDLCDRTFSLKTVLMIAIQLISRMEYVHSK 124

Query: 239 GIMHRDVKPHNVMI----DHELRKLRLIDWGLAEFY 270
            +++RDVKP N +I    +   + + +ID+ LA+ Y
Sbjct: 125 NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 79.0 bits (195), Expect = 1e-16
 Identities = 36/154 (23%), Positives = 69/154 (44%), Gaps = 16/154 (10%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-VKKKKIKREIKILQNLCGGPNVVKL 185
           Y + RK+G G + +++ G ++   E   IK+     K  ++  E KI + + GG  +  +
Sbjct: 11  YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTI 70

Query: 186 LDIVRDQHSKT-------PSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQ 238
                +            PSL  E +    F       +   +     +++  ++Y HS+
Sbjct: 71  RWCGAEGDYNVMVMELLGPSL--EDL----FNFCSRKFSLKTVLLLADQMISRIEYIHSK 124

Query: 239 GIMHRDVKPHNVMI--DHELRKLRLIDWGLAEFY 270
             +HRDVKP N ++    +   + +ID+GLA+ Y
Sbjct: 125 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 78.6 bits (194), Expect = 2e-16
 Identities = 31/156 (19%), Positives = 67/156 (42%), Gaps = 18/156 (11%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-VKKKKIKREIKILQNLCGGPNVVKL 185
           Y+V R++G G +  +FEG N+  N++  IK         +++ E +  + L G   +  +
Sbjct: 12  YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNV 71

Query: 186 LDIVRDQHSKT-------PSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQ 238
               ++            PSL  E +      +     +   +     ++L  +   H +
Sbjct: 72  YYFGQEGLHNVLVIDLLGPSL--EDL----LDLCGRKFSVKTVAMAAKQMLARVQSIHEK 125

Query: 239 GIMHRDVKPHNVMI----DHELRKLRLIDWGLAEFY 270
            +++RD+KP N +I          + ++D+G+ +FY
Sbjct: 126 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 78.6 bits (194), Expect = 3e-16
 Identities = 27/169 (15%), Positives = 63/169 (37%), Gaps = 21/169 (12%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILK--PVKKKKIKREIKILQNLCGGPNVVK 184
           + + +K+G G +  ++     N  E+    ++K    +   +  E+K  Q +     + K
Sbjct: 39  WVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKK 98

Query: 185 LLDIVRDQHSKTPSLIF---EYVNSTDFKV-----LYPTLTDYDIRYYIY---------- 226
            ++  +  +   P              ++      L   L     +   +          
Sbjct: 99  WIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGI 158

Query: 227 ELLKALDYCHSQGIMHRDVKPHNVMIDHE-LRKLRLIDWGLAEFYHPGK 274
            +L  L+Y H    +H D+K  N+++ ++   ++ L D+GL+  Y P  
Sbjct: 159 RMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNG 207

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 77.3 bits (191), Expect = 4e-16
 Identities = 36/150 (24%), Positives = 68/150 (45%), Gaps = 13/150 (8%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILK------PVKKKKIKREIKILQNLCGGP 180
           Y++V K+G G  S V+   +   N +  IK +           K+ +RE+     L    
Sbjct: 13  YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQL-SHQ 71

Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALDYCHS 237
           N+V ++D+  +       L+ EY+           +  L+      +  ++L  + + H 
Sbjct: 72  NIVSMIDVDEEDD--CYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHD 129

Query: 238 QGIMHRDVKPHNVMIDHELRKLRLIDWGLA 267
             I+HRD+KP N++ID     L++ D+G+A
Sbjct: 130 MRIVHRDIKPQNILIDSNKT-LKIFDFGIA 158

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score = 77.4 bits (191), Expect = 5e-16
 Identities = 48/217 (22%), Positives = 86/217 (39%), Gaps = 38/217 (17%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-KKKIKREIKILQNLCGGPN 181
           D  + EV   VGRG +  V +       +   IK ++    +K    E++ L  +   PN
Sbjct: 6   DYKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESESERKAFIVELRQLSRVNH-PN 62

Query: 182 VVKLLDIVRDQHSKTPSLIFEYV-NSTDFKVLY-----PTLTDYDIRYYIYELLKALDYC 235
           +VKL             L+ EY    + + VL+     P  T      +  +  + + Y 
Sbjct: 63  IVKLYGACL----NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYL 118

Query: 236 HS---QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG----- 287
           HS   + ++HRD+KP N+++      L++ D+G A                +        
Sbjct: 119 HSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA-----------CDIQTHMTNNKGSA 167

Query: 288 ----PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
               PE+     +Y    D++S G +   +I R++PF
Sbjct: 168 AWMAPEVFEG-SNYSEKCDVFSWGIILWEVITRRKPF 203

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 77.0 bits (189), Expect = 2e-15
 Identities = 39/154 (25%), Positives = 72/154 (46%), Gaps = 16/154 (10%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-VKKKKIKREIKILQNLCGGPNVVKL 185
           + + RK+G G + E++ G N+ TNE   IK+     K  ++  E KI + L GG  +  +
Sbjct: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNV 68

Query: 186 LDIVRDQHSKT-------PSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQ 238
                +            PSL  E +    F      L+   +     +++  +++ HS+
Sbjct: 69  RWFGVEGDYNVLVMDLLGPSL--EDL----FNFCSRKLSLKTVLMLADQMINRVEFVHSK 122

Query: 239 GIMHRDVKPHNVMI--DHELRKLRLIDWGLAEFY 270
             +HRD+KP N ++       ++ +ID+GLA+ Y
Sbjct: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score = 75.1 bits (185), Expect = 3e-15
 Identities = 47/225 (20%), Positives = 88/225 (39%), Gaps = 33/225 (14%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGG 179
              D      +G+G + +  +  +  T E  ++K L       ++   +E+K+++ L   
Sbjct: 8   RPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEH- 66

Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLK-ALD----- 233
           PNV+K + ++     K  + I EY+       L   +   D +Y   + +  A D     
Sbjct: 67  PNVLKFIGVLY--KDKRLNFITEYIKGGT---LRGIIKSMDSQYPWSQRVSFAKDIASGM 121

Query: 234 -YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF---------YHPGKEYNVRVASR 283
            Y HS  I+HRD+  HN ++      + + D+GLA                +   R    
Sbjct: 122 AYLHSMNIIHRDLNSHNCLVRENKN-VVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRY 180

Query: 284 YFKG------PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 322
              G      PE++   + YD  +D++S G +   +I R      
Sbjct: 181 TVVGNPYWMAPEMING-RSYDEKVDVFSFGIVLCEIIGRVNADPD 224

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score = 73.9 bits (182), Expect = 6e-15
 Identities = 49/231 (21%), Positives = 90/231 (38%), Gaps = 52/231 (22%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----------KKKKIKREIKI 172
             ++ E  +++G+G +  V +G  V       IK L             K ++ +RE+ I
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76

Query: 173 LQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLK-A 231
           + NL   PN+VKL  ++ +     P ++ E+V   D   LY  L D          L+  
Sbjct: 77  MSNLN-HPNIVKLYGLMHNP----PRMVMEFVPCGD---LYHRLLDKAHPIKWSVKLRLM 128

Query: 232 LD------YCHSQG--IMHRDVKPHNVMIDHELRK----LRLIDWGLAEFYHPGKEYNVR 279
           LD      Y  +Q   I+HRD++  N+ +           ++ D+GL+           +
Sbjct: 129 LDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS-----------Q 177

Query: 280 VASRYFKG---------PELLVDLQD-YDYSLDMWSLGCMFAGMIFRKEPF 320
            +     G         PE +   ++ Y    D +S   +   ++  + PF
Sbjct: 178 QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPF 228

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 74.2 bits (183), Expect = 6e-15
 Identities = 38/153 (24%), Positives = 67/153 (43%), Gaps = 19/153 (12%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILK------PVKKKKIKREIKI---LQNLC 177
           Y + R VGRG   +V+E  +        +K++       PV + +++RE +    LQ   
Sbjct: 36  YRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQE-- 93

Query: 178 GGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALDY 234
             P+VV + D    +      +    +N  D   +      L        + ++  ALD 
Sbjct: 94  --PHVVPIHD--FGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDA 149

Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 267
            H+ G  HRDVKP N+++  +     L+D+G+A
Sbjct: 150 AHAAGATHRDVKPENILVSAD-DFAYLVDFGIA 181

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score = 73.0 bits (180), Expect = 1e-14
 Identities = 41/208 (19%), Positives = 78/208 (37%), Gaps = 27/208 (12%)

Query: 117 LTVQWG-DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREI 170
           +    G D      + K+      E+++G     +   ++K+LK       K +    E 
Sbjct: 1   MNKHSGIDFKQLNFLTKLNENHSGELWKGRWQGND--IVVKVLKVRDWSTRKSRDFNEEC 58

Query: 171 KILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV-NSTDFKVLY---PTLTDYDIRYYI- 225
             L+     PNV+ +L   +   +  P+LI  ++   + + VL+     + D        
Sbjct: 59  PRLRIFSH-PNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFA 117

Query: 226 YELLKALDYCHSQG--IMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVR-VA 281
            ++ + + + H+    I    +   +VMID ++   R+    +   F  PG+ Y    VA
Sbjct: 118 LDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMT-ARISMADVKFSFQSPGRMYAPAWVA 176

Query: 282 SRYFKGPELLVDLQDYDYSL--DMWSLG 307
                 PE L    +       DMWS  
Sbjct: 177 ------PEALQKKPEDTNRRSADMWSFA 198

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 73.4 bits (179), Expect = 1e-14
 Identities = 45/344 (13%), Positives = 95/344 (27%), Gaps = 75/344 (21%)

Query: 120 QWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL-----------KPVKKKKIKR 168
                +  +   K+G G + EVF+ I    +    IKI+                ++I  
Sbjct: 15  HCLPTEKLQRCEKIGEGVFGEVFQTI--ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILP 72

Query: 169 EIKILQNLCG--------GPNVVKLLD--IVRDQHSK----------------------- 195
           EI I + L              + L     V+  +                         
Sbjct: 73  EIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFF 132

Query: 196 ---TPSLIFEYVNSTD--FKVLYPTLTDYDIRYYIYELLKALDYCHSQ-GIMHRDVKPHN 249
                 ++ E+        ++     +    +  +++L  +L    +     HRD+   N
Sbjct: 133 KDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGN 192

Query: 250 VMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCM 309
           V++               +       Y +   S       L V + DY  S        +
Sbjct: 193 VLLK--------------KTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVV 238

Query: 310 FAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGR-HSRKP 368
           F  +    E  F G    D    I +++  +  N +   +       L  L  +   +  
Sbjct: 239 FCDV-SMDEDLFTGD--GDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMT 295

Query: 369 WSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 412
           +    N      +  +  +F   +L +      +A + +     
Sbjct: 296 FKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSL 334

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 72.3 bits (178), Expect = 3e-14
 Identities = 39/152 (25%), Positives = 70/152 (46%), Gaps = 13/152 (8%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILK------PVKKKKIKREIKILQNLCGGP 180
           YE+   +G G  SEV    ++  +    +K+L+      P    + +RE +    L   P
Sbjct: 14  YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-NHP 72

Query: 181 NVVKLLDI--VRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALDYC 235
            +V + D           P ++ EYV+    + +      +T       I +  +AL++ 
Sbjct: 73  AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFS 132

Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 267
           H  GI+HRDVKP N+MI      ++++D+G+A
Sbjct: 133 HQNGIIHRDVKPANIMISATNA-VKVMDFGIA 163

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 70.6 bits (173), Expect = 1e-13
 Identities = 29/173 (16%), Positives = 69/173 (39%), Gaps = 26/173 (15%)

Query: 127 YEVVRKVGRGKYSEVFEGI-----NVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPN 181
           ++V   +G+G +  ++        +V ++  C++K+ +P     +  E+K  Q       
Sbjct: 37  WKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKV-EPSDNGPLFTELKFYQRAAKPEQ 95

Query: 182 VVKLLDIVRDQHSKTPSLIF---EYVNSTDFKVLYPTLTDYDIRYYI------------- 225
           + K +   + ++   P          N   ++ +       D++                
Sbjct: 96  IQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVL 155

Query: 226 ---YELLKALDYCHSQGIMHRDVKPHNVMIDHE-LRKLRLIDWGLAEFYHPGK 274
                +L  L+Y H    +H D+K  N++++++   ++ L+D+GLA  Y P  
Sbjct: 156 QLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEG 208

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 69.4 bits (170), Expect = 2e-13
 Identities = 28/244 (11%), Positives = 72/244 (29%), Gaps = 41/244 (16%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP------VKKKKIKREIKILQNLCGGP 180
           Y ++   G     + ++ ++   + +  +  + P         ++       L  +   P
Sbjct: 33  YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRI-DKP 91

Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFK-VLYPTLTDYDIRYYIYELLKALDYCHSQG 239
            V ++LD+V  +      ++ E++     + V   + +       +  L  A D  H  G
Sbjct: 92  GVARVLDVVHTRA--GGLVVAEWIRGGSLQEVADTSPSPVGAIRAMQSLAAAADAAHRAG 149

Query: 240 IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDY 299
           +      P  V +  +         G           +V +A                + 
Sbjct: 150 VALSIDHPSRVRVSID---------G-----------DVVLAYPATMPDA--------NP 181

Query: 300 SLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDA 359
             D+  +G     ++  + P           +  A+     +          ++  Q+ A
Sbjct: 182 QDDIRGIGASLYALLVNRWPL--PEAGVRSGLAPAERDTAGQPIE-PADIDRDIPFQISA 238

Query: 360 LVGR 363
           +  R
Sbjct: 239 VAAR 242

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score = 68.2 bits (167), Expect = 7e-13
 Identities = 46/223 (20%), Positives = 88/223 (39%), Gaps = 35/223 (15%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-----PVKKKKIKREIKILQNLC 177
             +  E+   +G+G++ +V+ G     +    I+++        + K  KRE+   +   
Sbjct: 31  PFEQLEIGELIGKGRFGQVYHGR---WHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTR 87

Query: 178 GGPNVVKLLDIVRDQHSKTPSL--IFEYV-NSTDFKVLYPTLTDYDIRYYI---YELLKA 231
              NVV  +          P L  I       T + V+       D+        E++K 
Sbjct: 88  H-ENVVLFMGAC----MSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKG 142

Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG---- 287
           + Y H++GI+H+D+K  NV  D+   K+ + D+GL       +        R   G    
Sbjct: 143 MGYLHAKGILHKDLKSKNVFYDN--GKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCH 200

Query: 288 --PELL--------VDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
             PE++         D   +    D+++LG ++  +  R+ PF
Sbjct: 201 LAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPF 243

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score = 67.1 bits (164), Expect = 2e-12
 Identities = 37/214 (17%), Positives = 83/214 (38%), Gaps = 30/214 (14%)

Query: 119 VQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCI-IKILKPVKKKKIKREIKILQ-NL 176
           VQ        +   +G+G++ EV+ G         + +KI    +++   RE +I Q  +
Sbjct: 36  VQRTIARTIVLQESIGKGRFGEVWRGK---WRGEEVAVKIFSSREERSWFREAEIYQTVM 92

Query: 177 CGGPNVVKLLDIVRDQHSKTP--SLIFEYV-NSTDFKVLYPTLTDYDIRYYI-YELLKAL 232
               N++  +      +       L+ +Y  + + F  L       +    +       L
Sbjct: 93  LRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGL 152

Query: 233 DYCHSQ--------GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY 284
            + H +         I HRD+K  N+++        + D GLA  +    +  + +A  +
Sbjct: 153 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT-CCIADLGLAVRHDSATDT-IDIAPNH 210

Query: 285 FKG------PELL---VDLQDYDYSL--DMWSLG 307
             G      PE+L   ++++ ++     D++++G
Sbjct: 211 RVGTKRYMAPEVLDDSINMKHFESFKRADIYAMG 244

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score = 66.2 bits (162), Expect = 3e-12
 Identities = 41/230 (17%), Positives = 96/230 (41%), Gaps = 37/230 (16%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-----PVKKKKIKREIKILQNLC 177
                 V +++G G +  V++G     +    +K+L      P + +  K E+ +L+   
Sbjct: 22  PDGQITVGQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR 78

Query: 178 GGPNVVKLLDIVRDQHSKTPSLIFEYV-NSTDFKVLYPTLTDYDIRYYIYELLK-ALD-- 233
              N++  +           +++ ++   S+    LY  L   + ++ + +L+  A    
Sbjct: 79  H-VNILLFMGYSTAPQ---LAIVTQWCEGSS----LYHHLHASETKFEMKKLIDIARQTA 130

Query: 234 ----YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG-- 287
               Y H++ I+HRD+K +N+ +  +   +++ D+GLA         +         G  
Sbjct: 131 RGMDYLHAKSIIHRDLKSNNIFLHEDN-TVKIGDFGLATEKSRWSGSHQFEQL---SGSI 186

Query: 288 ----PELLVDLQDYDYSL--DMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
               PE++       YS   D+++ G +   ++  + P+    +N DQ++
Sbjct: 187 LWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQII 235

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score = 66.3 bits (162), Expect = 3e-12
 Identities = 47/216 (21%), Positives = 85/216 (39%), Gaps = 28/216 (12%)

Query: 116 SLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQ- 174
            L VQ       ++V+++G+G+Y EV+ G      E+  +K+    ++    RE +I Q 
Sbjct: 28  PLLVQRTIAKQIQMVKQIGKGRYGEVWMGKW--RGEKVAVKVFFTTEEASWFRETEIYQT 85

Query: 175 NLCGGPNVVKLLDIVRDQHSKTP--SLIFEYV-NSTDFKVLYPTLTDYDIRYYI-YELLK 230
            L    N++  +              LI +Y  N + +  L  T  D      + Y  + 
Sbjct: 86  VLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVS 145

Query: 231 ALDYCHSQ--------GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVAS 282
            L + H++         I HRD+K  N+++        + D GLA  +       V +  
Sbjct: 146 GLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGT-CCIADLGLAVKFISDTN-EVDIPP 203

Query: 283 RYFKG------PELL---VDLQDYDYSL--DMWSLG 307
               G      PE+L   ++   +   +  DM+S G
Sbjct: 204 NTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFG 239

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score = 64.3 bits (157), Expect = 1e-11
 Identities = 43/204 (21%), Positives = 92/204 (45%), Gaps = 31/204 (15%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLC 177
              D  +  K+G G +  V       ++    +KIL           +  RE+ I++ L 
Sbjct: 35  PWCDLNIKEKIGAGSFGTVHRAEWHGSD--VAVKILMEQDFHAERVNEFLREVAIMKRLR 92

Query: 178 GGPNVVKLLDIVRDQHSKTPSLIFEYV-NSTDFKVLY-----PTLTDYDIRYYIYELLKA 231
             PN+V  +  V        S++ EY+   + +++L+       L +       Y++ K 
Sbjct: 93  H-PNIVLFMGAVTQP--PNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKG 149

Query: 232 LDYCHSQG--IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG-- 287
           ++Y H++   I+HR++K  N+++D +   +++ D+GL+       + +  ++S+   G  
Sbjct: 150 MNYLHNRNPPIVHRNLKSPNLLVDKKYT-VKVCDFGLSRL-----KASTFLSSKSAAGTP 203

Query: 288 ----PELLVDLQDYDYSLDMWSLG 307
               PE+L D +  +   D++S G
Sbjct: 204 EWMAPEVLRD-EPSNEKSDVYSFG 226

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score = 62.8 bits (153), Expect = 4e-11
 Identities = 46/204 (22%), Positives = 78/204 (38%), Gaps = 28/204 (13%)

Query: 128 EVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQ-NLCGGPNVVKLL 186
            ++  VG+G+Y EV+ G     N    +KI     +K   RE ++    +    N++  +
Sbjct: 11  TLLECVGKGRYGEVWRGSWQGEN--VAVKIFSSRDEKSWFRETELYNTVMLRHENILGFI 68

Query: 187 --DIVRDQHSKTPSLIFEYV-NSTDFKVLYPTLTDYDIRYYI-YELLKALDYCHSQ---- 238
             D+     S    LI  Y    + +  L  T  D      I   +   L + H +    
Sbjct: 69  ASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGT 128

Query: 239 ----GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG------P 288
                I HRD+K  N+++    +   + D GLA  +       + V +    G      P
Sbjct: 129 QGKPAIAHRDLKSKNILVKKNGQ-CCIADLGLAVMHSQSTNQ-LDVGNNPRVGTKRYMAP 186

Query: 289 ELL-----VDLQDYDYSLDMWSLG 307
           E+L     VD  D    +D+W+ G
Sbjct: 187 EVLDETIQVDCFDSYKRVDIWAFG 210

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 62.8 bits (153), Expect = 4e-11
 Identities = 28/176 (15%), Positives = 58/176 (32%), Gaps = 30/176 (17%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNT--------NERCIIKILKPVKKKKIKREIKILQNLCG 178
           +++     R     ++E    +T         ++  +K+    K  ++  E    Q    
Sbjct: 44  WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDA--KDGRLFNEQNFFQRAAK 101

Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV-----LYPTLTDYDIRYY--------- 224
              V K   +        P+ +   V+   ++      L  +L    +            
Sbjct: 102 PLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSA-LDVSPKHVLSERS 160

Query: 225 ----IYELLKALDYCHSQGIMHRDVKPHNVMIDHE-LRKLRLIDWGLAEFYHPGKE 275
                  LL AL++ H    +H +V   N+ +D E   ++ L  +G A  Y P  +
Sbjct: 161 VLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGK 216

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score = 61.1 bits (149), Expect = 1e-10
 Identities = 41/223 (18%), Positives = 88/223 (39%), Gaps = 38/223 (17%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-------KKKIKREIKILQN 175
           D  +  +   +G G + +V+    +       +K  +           + +++E K+   
Sbjct: 5   DFAELTLEEIIGIGGFGKVYRAFWIGDE--VAVKAARHDPDEDISQTIENVRQEAKLFAM 62

Query: 176 LCGGPNVVKLLDIVRDQHSKTPSLIFEYV-NSTDFKVLYPTLTDYDIRYYI-YELLKALD 233
           L   PN++ L  +   +      L+ E+       +VL       DI      ++ + ++
Sbjct: 63  LKH-PNIIALRGVCLKE--PNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMN 119

Query: 234 YCHSQG---IMHRDVKPHNVMIDHELRK-------LRLIDWGLAEFYHPGKEYNVRVASR 283
           Y H +    I+HRD+K  N++I  ++         L++ D+GLA  +H   + +      
Sbjct: 120 YLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMS------ 173

Query: 284 YFKG------PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
              G      PE++     +    D+WS G +   ++  + PF
Sbjct: 174 -AAGAYAWMAPEVIRA-SMFSKGSDVWSYGVLLWELLTGEVPF 214

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score = 59.5 bits (144), Expect = 6e-10
 Identities = 41/230 (17%), Positives = 88/230 (38%), Gaps = 46/230 (20%)

Query: 113 DYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCI-IKILKPVKKKKIKREIK 171
                ++     D+ +++  +GRG+Y  V++G     +ER + +K+     ++    E  
Sbjct: 4   AASEPSLDL---DNLKLLELIGRGRYGAVYKGS---LDERPVAVKVFSFANRQNFINEKN 57

Query: 172 I-----LQNLCGGPNVVKLL--DIVRDQHSKTP-SLIFEYV-NSTDFKVLYPTLTDYDIR 222
           I     +++     N+ + +  D       +    L+ EY  N +  K L    +D+   
Sbjct: 58  IYRVPLMEH----DNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSS 113

Query: 223 YYI-YELLKALDYCHSQ---------GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 272
             + + + + L Y H++          I HRD+   NV++ ++     + D+GL+     
Sbjct: 114 CRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGT-CVISDFGLSMRLTG 172

Query: 273 GKEYNVRVASRYFKG---------PELL------VDLQDYDYSLDMWSLG 307
            +                      PE+L       D +     +DM++LG
Sbjct: 173 NRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALG 222

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 60.3 bits (145), Expect = 7e-10
 Identities = 61/383 (15%), Positives = 119/383 (31%), Gaps = 117/383 (30%)

Query: 72  VYEGAIIDKIEERNLAEIPLPAMSKA-------------RVYTDVNVLRPKEYWDYESLT 118
           V+E A +D  + +++ ++P   +SK                      L  K+    +   
Sbjct: 24  VFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKF- 82

Query: 119 VQWGDQDDY----EVVRKVGRGK------YSEVFEGINVNTNERCIIKILKPVKKKKIKR 168
           V+   + +Y      ++   R        Y E  + +  N N+    K    V + +   
Sbjct: 83  VEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLY-NDNQV-FAK--YNVSRLQPYL 138

Query: 169 EIKI-LQNLCGGPNVV--------K--L-LDIVRDQHSKTPSLIFEYVNSTDFKVLYPTL 216
           +++  L  L    NV+        K  + LD+            ++     DFK+ +  L
Sbjct: 139 KLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLS---------YKVQCKMDFKIFWLNL 189

Query: 217 TDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY 276
            + +    + E+L+ L        +++         DH       I    AE        
Sbjct: 190 KNCNSPETVLEMLQKL--------LYQIDPNWTSRSDHSSNIKLRIHSIQAEL------- 234

Query: 277 NVRVASRYFKGPE----LLV--DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL 330
                 R  K       LLV  ++Q+   + + ++L C                      
Sbjct: 235 -----RRLLKSKPYENCLLVLLNVQNAK-AWNAFNLSC---------------------- 266

Query: 331 VKIAKVLGT-------DELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHL--- 380
               K+L T       D L+A     H+ LD     L     +    K+++   Q L   
Sbjct: 267 ----KILLTTRFKQVTDFLSA-ATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPRE 321

Query: 381 ---VSPEAIDFLDKLLRYDHQDR 400
               +P  +  + + +R D    
Sbjct: 322 VLTTNPRRLSIIAESIR-DGLAT 343

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 48.3 bits (114), Expect = 4e-06
 Identities = 41/332 (12%), Positives = 102/332 (30%), Gaps = 87/332 (26%)

Query: 126 DYEVVRKVGRGKYSEVF-----EGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGP 180
             +V   +     + +        +  +  +  ++K L   + + + RE+         P
Sbjct: 274 FKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLD-CRPQDLPREVLT-----TNP 327

Query: 181 NVVKLL---------------DIVRDQHSKTPSLIFEYVNSTDFKVLYPTLT----DYDI 221
             + ++                +  D+ +         +   +++ ++  L+       I
Sbjct: 328 RRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHI 387

Query: 222 RYYIYELL----------KALDYCHSQGIMHRDVKP-----HNVMID--------HELRK 258
              +  L+            ++  H   ++ +  K       ++ ++        + L +
Sbjct: 388 PTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHR 447

Query: 259 LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD-YDYS--------LDMWSLGCM 309
             ++D            YN+    + F   +L+    D Y YS        ++      +
Sbjct: 448 -SIVD-----------HYNIP---KTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTL 492

Query: 310 FAGMIFRKEPFFYGHDNHDQLVKIAKVLGTD---ELNAYLNKYHLELDPQLDALVGRHSR 366
           F  M+F    F      HD     A     +   +L  Y   Y  + DP+ + LV     
Sbjct: 493 FR-MVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFY-KPYICDNDPKYERLV----- 545

Query: 367 KPWSKFINADNQHLVSPEAIDFLDKLLRYDHQ 398
                F+    ++L+  +  D L   L  + +
Sbjct: 546 NAILDFLPKIEENLICSKYTDLLRIALMAEDE 577

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 47.9 bits (113), Expect = 5e-06
 Identities = 56/374 (14%), Positives = 111/374 (29%), Gaps = 83/374 (22%)

Query: 57  YNLNIITDTIAATTVVYEGAIIDKIEERNLAEIPLPAMSKARVYTDVNVLRPKEYWDYES 116
            N   +   I              IE+R+         +  +V+   NV R + Y     
Sbjct: 89  INYKFLMSPIKTEQRQPSMMTRMYIEQRD------RLYNDNQVFAKYNVSRLQPYLKLRQ 142

Query: 117 LTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCI-IKI--LKPVKKKKIKREIKIL 173
             ++     +  +   +G GK     +       +  +  KI  L        +  +++L
Sbjct: 143 ALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEML 202

Query: 174 QNLCG--GPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKA 231
           Q L     PN     D     HS    L                     I+  +  LLK+
Sbjct: 203 QKLLYQIDPNWTSRSD-----HSSNIKLRIH-----------------SIQAELRRLLKS 240

Query: 232 LDYCHSQGIMHRDVKPHNV--MIDHELRKL---RLIDWGLAEFYHPGKEYNVRV--ASRY 284
             Y +   ++  +V+        +   + L   R     + +F       ++ +   S  
Sbjct: 241 KPYENCLLVL-LNVQNAKAWNAFNLSCKILLTTR--FKQVTDFLSAATTTHISLDHHSMT 297

Query: 285 FKGPELL------VDLQDYDYSLDMWSLGCMFAGMI---FRKEPF---FYGHDNHDQLVK 332
               E+       +D +  D   ++ +       +I    R        + H N D+L  
Sbjct: 298 LTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTT 357

Query: 333 IAK----VLGTDELNAYLNKYHLELDPQLDALVGRHSRKP-------WSKFINADNQHLV 381
           I +    VL   E     ++  L + P   A +      P       W          ++
Sbjct: 358 IIESSLNVLEPAEYRKMFDR--LSVFPP-SAHI------PTILLSLIWFD--------VI 400

Query: 382 SPEAIDFLDKLLRY 395
             + +  ++KL +Y
Sbjct: 401 KSDVMVVVNKLHKY 414

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score = 57.8 bits (140), Expect = 2e-09
 Identities = 44/220 (20%), Positives = 84/220 (38%), Gaps = 32/220 (14%)

Query: 112 WDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKK--KIKRE 169
              E+L  Q       +++    RG++  V++      NE   +KI     K+  + + E
Sbjct: 14  LGTENLYFQS---MPLQLLEVKARGRFGCVWKA--QLLNEYVAVKIFPIQDKQSWQNEYE 68

Query: 170 IKILQNLCGGPNVVKLL--DIVRDQHSKTPSLIFEYV-NSTDFKVLYPTLTDYDIRYYI- 225
           +  L  +    N+++ +  +           LI  +    +    L   +  ++   +I 
Sbjct: 69  VYSLPGMKH-ENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIA 127

Query: 226 YELLKALDYCHSQ----------GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 275
             + + L Y H             I HRD+K  NV++ + L    + D+GLA  +  GK 
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLT-ACIADFGLALKFEAGKS 186

Query: 276 YNVRVAS----RYFKGPELLVD----LQDYDYSLDMWSLG 307
                      RY   PE+L       +D    +DM+++G
Sbjct: 187 AGDTHGQVGTRRYM-APEVLEGAINFQRDAFLRIDMYAMG 225

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 57.3 bits (139), Expect = 2e-09
 Identities = 45/167 (26%), Positives = 78/167 (46%), Gaps = 16/167 (9%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGI----NVNTNERCIIKILKP----VKKKKIKREIKILQ 174
           ++   + +R +G G + +V          NT E+  +K LKP         +K+EI+IL+
Sbjct: 19  EKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILR 78

Query: 175 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELL 229
           NL    N+VK   I  +       LI E++ S   K  Y       +       Y  ++ 
Sbjct: 79  NLYH-ENIVKYKGICTEDGGNGIKLIMEFLPSGSLKE-YLPKNKNKINLKQQLKYAVQIC 136

Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY 276
           K +DY  S+  +HRD+   NV+++ E + +++ D+GL +     KEY
Sbjct: 137 KGMDYLGSRQYVHRDLAARNVLVESEHQ-VKIGDFGLTKAIETDKEY 182

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 56.6 bits (137), Expect = 5e-09
 Identities = 47/192 (24%), Positives = 88/192 (45%), Gaps = 17/192 (8%)

Query: 130 VRKVGRGKYSEVFEGI----NVNTNERCIIKILK----PVKKKKIKREIKILQNLCGGPN 181
           +R +G G + +V        N  T E   +K LK    P  +   K+EI IL+ L    +
Sbjct: 36  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYH-EH 94

Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTDFK--VLYPTLTDYDIRYYIYELLKALDYCHSQG 239
           ++K      D  + +  L+ EYV     +  +   ++    +  +  ++ + + Y H+Q 
Sbjct: 95  IIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQH 154

Query: 240 IMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRY-FK--GPELLVDLQ 295
            +HRD+   NV++D++   +++ D+GLA       + Y VR           PE L + +
Sbjct: 155 YIHRDLAARNVLLDNDR-LVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYK 213

Query: 296 DYDYSLDMWSLG 307
            + Y+ D+WS G
Sbjct: 214 -FYYASDVWSFG 224

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 55.7 bits (135), Expect = 9e-09
 Identities = 51/230 (22%), Positives = 90/230 (39%), Gaps = 28/230 (12%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP----VKKKKIKREIKILQNLCG 178
           + +D  +  ++GRG + EVF G     N    +K  +       K K  +E +IL+    
Sbjct: 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYS- 170

Query: 179 GPNVVKLLDIVRDQHSKTPSLI-FEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKAL 232
            PN+V+L+ +   +    P  I  E V   DF   +       L    +   + +    +
Sbjct: 171 HPNIVRLIGVCTQKQ---PIYIVMELVQGGDFLT-FLRTEGARLRVKTLLQMVGDAAAGM 226

Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYF--K--GP 288
           +Y  S+  +HRD+   N ++  +   L++ D+G++     G  Y      R    K   P
Sbjct: 227 EYLESKCCIHRDLAARNCLVTEKNV-LKISDFGMSREEADG-VYAASGGLRQVPVKWTAP 284

Query: 289 ELLVDLQDYDYSL--DMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
           E L   +   YS   D+WS G  ++        P +    N      + K
Sbjct: 285 EALNYGR---YSSESDVWSFGILLWETFSLGASP-YPNLSNQQTREFVEK 330

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 55.5 bits (134), Expect = 1e-08
 Identities = 54/310 (17%), Positives = 113/310 (36%), Gaps = 31/310 (10%)

Query: 40  APIAHHPILRTPCRSSTYNLNIITDTIAATTVVYEGAIIDKIEERNLAEIPLPAMSKARV 99
            P+ HH       R+S     ++         +     +     +      L       V
Sbjct: 5   DPMGHHHHHHGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTV 64

Query: 100 YTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCI---IK 156
           + D++ L P+     + + +             +GRG +  V+ G  ++ + + I   +K
Sbjct: 65  HIDLSALNPELVQAVQHVVIG-PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVK 123

Query: 157 ILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL 212
            L  +    +  +   E  I+++    PNV+ LL I        P ++  Y+   D +  
Sbjct: 124 SLNRITDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEGS-PLVVLPYMKHGDLRN- 180

Query: 213 Y-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 267
           +        T  D+  +  ++ K + +  S+  +HRD+   N M+D +   +++ D+GLA
Sbjct: 181 FIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKF-TVKVADFGLA 239

Query: 268 EFYHPGKEYNVRVASRYFKG--------PELLVDLQDYDYSLDMWSLG-CMFAGMIFRKE 318
              +  +  +V   +              E L   Q +    D+WS G  ++  M     
Sbjct: 240 RDMYDKEFDSVHNKT---GAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAP 295

Query: 319 PFFYGHDNHD 328
           P +   +  D
Sbjct: 296 P-YPDVNTFD 304

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 55.5 bits (134), Expect = 2e-08
 Identities = 43/225 (19%), Positives = 99/225 (44%), Gaps = 20/225 (8%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGP 180
           ++ D  +  K+G G+Y EV+EG+    +    +K LK   ++ ++  +E  +++ +   P
Sbjct: 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK-HP 276

Query: 181 NVVKLLDIVRDQHSKTPSLI-FEYVNS---TDF--KVLYPTLTDYDIRYYIYELLKALDY 234
           N+V+LL +   +    P  I  E++      D+  +     ++   + Y   ++  A++Y
Sbjct: 277 NLVQLLGVCTREP---PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEY 333

Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY---FKGPELL 291
              +  +HR++   N ++      +++ D+GL+     G  Y     +++   +  PE L
Sbjct: 334 LEKKNFIHRNLAARNCLVGENH-LVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESL 391

Query: 292 VDLQDYDYSLDMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
                +    D+W+ G  ++    +   P + G D       + K
Sbjct: 392 AY-NKFSIKSDVWAFGVLLWEIATYGMSP-YPGIDLSQVYELLEK 434

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 54.3 bits (131), Expect = 2e-08
 Identities = 48/200 (24%), Positives = 92/200 (46%), Gaps = 18/200 (9%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGI----NVNTNERCIIKILK---PVKKKKIKREIKILQN 175
           ++   + + ++G+G +  V          NT     +K L+   P +++  +REI+IL+ 
Sbjct: 21  EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKA 80

Query: 176 LCGGPNVVKLLDIVRDQHSKTPSLIFEYVNS---TDF-KVLYPTLTDYDIRYYIYELLKA 231
           L     +VK   +      ++  L+ EY+ S    DF +     L    +  Y  ++ K 
Sbjct: 81  L-HSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKG 139

Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-YNVRVASRY-FK--G 287
           ++Y  S+  +HRD+   N++++ E   +++ D+GLA+     K+ Y VR   +       
Sbjct: 140 MEYLGSRRCVHRDLAARNILVESEAH-VKIADFGLAKLLPLDKDYYVVREPGQSPIFWYA 198

Query: 288 PELLVDLQDYDYSLDMWSLG 307
           PE L D   +    D+WS G
Sbjct: 199 PESLSDNI-FSRQSDVWSFG 217

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 53.5 bits (129), Expect = 4e-08
 Identities = 50/262 (19%), Positives = 115/262 (43%), Gaps = 33/262 (12%)

Query: 100 YTDVNVLRPKEYWDYESLTVQWGDQDDYEV-------VRKVGRGKYSEVFEG----INVN 148
           + D ++   +  +   ++   + D+D  +        ++++G+G +  V       +  N
Sbjct: 9   HHDYDIPTTENLYFQGAMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDN 68

Query: 149 TNERCIIKILKPVKKKKIK---REIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVN 205
           T E   +K L+   ++ ++   REI+IL++L    N+VK   +      +   LI EY+ 
Sbjct: 69  TGEVVAVKKLQHSTEEHLRDFEREIEILKSLQH-DNIVKYKGVCYSAGRRNLKLIMEYLP 127

Query: 206 S---TDF-KVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRL 261
                D+ +     +    +  Y  ++ K ++Y  ++  +HRD+   N+++++E R +++
Sbjct: 128 YGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENR-VKI 186

Query: 262 IDWGLA-EFYHPGKEYNVRVASRY-FK--GPELLVDLQDYDYSLDMWSLG-CMFAGMIFR 316
            D+GL        + Y V+           PE L + + +  + D+WS G  ++      
Sbjct: 187 GDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESK-FSVASDVWSFGVVLY------ 239

Query: 317 KEPFFYGHDNHDQLVKIAKVLG 338
            E F Y   +     +  +++G
Sbjct: 240 -ELFTYIEKSKSPPAEFMRMIG 260

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 52.3 bits (126), Expect = 1e-07
 Identities = 46/225 (20%), Positives = 93/225 (41%), Gaps = 26/225 (11%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCI---IKILKPV----KKKKIKREIKILQN 175
                     +GRG +  V+ G  ++ + + I   +K L  +    +  +   E  I+++
Sbjct: 23  SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKD 82

Query: 176 LCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLK 230
               PNV+ LL I       +P ++  Y+   D +  +        T  D+  +  ++ K
Sbjct: 83  FS-HPNVLSLLGICLRSEG-SPLVVLPYMKHGDLRN-FIRNETHNPTVKDLIGFGLQVAK 139

Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA------EFYHPGKEYNVRVASRY 284
            + Y  S+  +HRD+   N M+D +   +++ D+GLA      E+Y    +   ++  ++
Sbjct: 140 GMKYLASKKFVHRDLAARNCMLDEKF-TVKVADFGLARDMYDKEYYSVHNKTGAKLPVKW 198

Query: 285 FKGPELLVDLQDYDYSLDMWSLG-CMFAGMIFRKEPFFYGHDNHD 328
               E L   Q +    D+WS G  ++  M     P +   +  D
Sbjct: 199 M-ALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPP-YPDVNTFD 240

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 52.3 bits (126), Expect = 1e-07
 Identities = 46/232 (19%), Positives = 105/232 (45%), Gaps = 26/232 (11%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEG----INVNTNERCIIKILKPVKKKKIK---REIKILQN 175
           ++   + ++++G+G +  V       +  NT E   +K L+   ++ ++   REI+IL++
Sbjct: 8   EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKS 67

Query: 176 LCGGPNVVKLLDIVRDQHSKTPSLIFEYVNS---TDF-KVLYPTLTDYDIRYYIYELLKA 231
           L    N+VK   +      +   LI EY+      D+ +     +    +  Y  ++ K 
Sbjct: 68  LQH-DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 126

Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRY-FK--G 287
           ++Y  ++  +HRD+   N+++++E R +++ D+GL        + + V+           
Sbjct: 127 MEYLGTKRYIHRDLATRNILVENENR-VKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYA 185

Query: 288 PELLVDLQDYDYSLDMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKIAKVLG 338
           PE L + + +  + D+WS G  ++       E F Y   +     +  +++G
Sbjct: 186 PESLTESK-FSVASDVWSFGVVLY-------ELFTYIEKSKSPPAEFMRMIG 229

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 52.2 bits (125), Expect = 2e-07
 Identities = 48/225 (21%), Positives = 94/225 (41%), Gaps = 22/225 (9%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGP 180
            ++   +  K+G+G + EV+ G   N   R  IK LKP  +  +   +E ++++ L    
Sbjct: 265 PRESLRLEVKLGQGCFGEVWMGT-WNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLR-HE 322

Query: 181 NVVKLLDIVRDQHSKTPSLI-FEYVNSTDF-----KVLYPTLTDYDIRYYIYELLKALDY 234
            +V+L  +V    S+ P  I  EY++               L    +     ++   + Y
Sbjct: 323 KLVQLYAVV----SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAY 378

Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY-FK--GPELL 291
                 +HRD++  N+++   L   ++ D+GLA       EY  R  +++  K   PE  
Sbjct: 379 VERMNYVHRDLRAANILVGENL-VCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAA 436

Query: 292 VDLQDYDYSLDMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
           +    +    D+WS G  +       + P + G  N + L ++ +
Sbjct: 437 LY-GRFTIKSDVWSFGILLTELTTKGRVP-YPGMVNREVLDQVER 479

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 52.2 bits (125), Expect = 2e-07
 Identities = 53/233 (22%), Positives = 102/233 (43%), Gaps = 32/233 (13%)

Query: 124 QDDYEV-------VRKVGRGKYSEVFEGINVNTNERCI---IKILKP----VKKKKIKRE 169
             DYE+        R +G G++ +V +GI ++     +   IK  K       ++K  +E
Sbjct: 382 TRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQE 441

Query: 170 IKILQNLCGGPNVVKLLDIVRDQHSKTPSLI-FEYVNSTDFKVLY-----PTLTDYDIRY 223
              ++     P++VKL+ ++    ++ P  I  E     + +  +      +L    +  
Sbjct: 442 ALTMRQFDH-PHIVKLIGVI----TENPVWIIMELCTLGELRS-FLQVRKFSLDLASLIL 495

Query: 224 YIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASR 283
           Y Y+L  AL Y  S+  +HRD+   NV++      ++L D+GL+ +      Y       
Sbjct: 496 YAYQLSTALAYLESKRFVHRDIAARNVLVSSND-CVKLGDFGLSRYMEDSTYYKASKGKL 554

Query: 284 YFKG--PELLVDLQDYDYSLDMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKI 333
             K   PE +   + +  + D+W  G CM+  ++   +P F G  N+D + +I
Sbjct: 555 PIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGRI 605

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 50.7 bits (122), Expect = 3e-07
 Identities = 39/163 (23%), Positives = 74/163 (45%), Gaps = 25/163 (15%)

Query: 124 QDDYEV-------VRKVGRGKYSEVFEGINVNTNERCI---IKILKP----VKKKKIKRE 169
             DYE+        R +G G++ +V +GI ++     +   IK  K       ++K  +E
Sbjct: 7   TRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQE 66

Query: 170 IKILQNLCGGPNVVKLLDIVRDQHSKTPSLI-FEYVNSTDF----KVLYPTLTDYDIRYY 224
              ++     P++VKL+ ++    ++ P  I  E     +     +V   +L    +  Y
Sbjct: 67  ALTMRQFD-HPHIVKLIGVI----TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILY 121

Query: 225 IYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 267
            Y+L  AL Y  S+  +HRD+   NV++      ++L D+GL+
Sbjct: 122 AYQLSTALAYLESKRFVHRDIAARNVLVSSND-CVKLGDFGLS 163

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 50.7 bits (122), Expect = 3e-07
 Identities = 40/163 (24%), Positives = 71/163 (43%), Gaps = 25/163 (15%)

Query: 124 QDDYEV-------VRKVGRGKYSEVFEGINVNTNERCI---IKILKP----VKKKKIKRE 169
              Y +        R +G G + EV+EG+  N     I   +K  K       K+K   E
Sbjct: 4   GPQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSE 63

Query: 170 IKILQNLCGGPNVVKLLDIVRDQHSKTPSLI-FEYVNSTDF----KVLYPTLTDYDIRYY 224
             I++NL   P++VKL+ I+     + P+ I  E     +     +    +L    +  Y
Sbjct: 64  AVIMKNLD-HPHIVKLIGII----EEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLY 118

Query: 225 IYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 267
             ++ KA+ Y  S   +HRD+   N+++      ++L D+GL+
Sbjct: 119 SLQICKAMAYLESINCVHRDIAVRNILVASPE-CVKLGDFGLS 160

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 51.3 bits (123), Expect = 3e-07
 Identities = 47/225 (20%), Positives = 94/225 (41%), Gaps = 22/225 (9%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGP 180
            ++   +  K+G+G + EV+ G   N   R  IK LKP  +  +   +E ++++ L    
Sbjct: 182 PRESLRLEVKLGQGCFGEVWMGT-WNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLR-HE 239

Query: 181 NVVKLLDIVRDQHSKTPSLI-FEYVNSTDF-----KVLYPTLTDYDIRYYIYELLKALDY 234
            +V+L  +V    S+ P  I  EY++               L    +     ++   + Y
Sbjct: 240 KLVQLYAVV----SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAY 295

Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY---FKGPELL 291
                 +HRD++  N+++   L   ++ D+GLA       EY  R  +++   +  PE  
Sbjct: 296 VERMNYVHRDLRAANILVGENL-VCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAA 353

Query: 292 VDLQDYDYSLDMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
           +    +    D+WS G  +       + P + G  N + L ++ +
Sbjct: 354 LY-GRFTIKSDVWSFGILLTELTTKGRVP-YPGMVNREVLDQVER 396

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 50.0 bits (120), Expect = 5e-07
 Identities = 45/226 (19%), Positives = 87/226 (38%), Gaps = 28/226 (12%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGI---NVNTNERCIIKILKPV----KKKKIKREIKILQN 175
           ++      R +G+G +  V+ G          +C IK L  +    + +   RE  +++ 
Sbjct: 19  ERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRG 78

Query: 176 LCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFK----VLYPTLTDYDIRYYIYELLKA 231
           L   PNV+ L+ I+       P ++  Y+   D            T  D+  +  ++ + 
Sbjct: 79  LNH-PNVLALIGIMLPPEG-LPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARG 136

Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG---- 287
           ++Y   Q  +HRD+   N M+D     +++ D+GLA      + Y+V+            
Sbjct: 137 MEYLAEQKFVHRDLAARNCMLDESF-TVKVADFGLARDILDREYYSVQQHR---HARLPV 192

Query: 288 ----PELLVDLQDYDYSLDMWSLG-CMFAGMIFRKEPFFYGHDNHD 328
                E L     +    D+WS G  ++  +     P +   D  D
Sbjct: 193 KWTALESLQT-YRFTTKSDVWSFGVLLWELLTRGAPP-YRHIDPFD 236

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 49.6 bits (119), Expect = 7e-07
 Identities = 31/238 (13%), Positives = 78/238 (32%), Gaps = 39/238 (16%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCI-------IKILKPV---KKKKIKREIKI 172
             +D      +G+G ++++F+G+     +          +K+L        +       +
Sbjct: 6   RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASM 65

Query: 173 LQNLCGGPNVVKLLDIVRDQHSKTPSLI-FEYVNSTDFKVLY-----PTLTDYDIRYYIY 226
           +  L    ++V    +         +++  E+V        Y       +          
Sbjct: 66  MSKLS-HKHLVLNYGVCVCGD---ENILVQEFVKFGSLD-TYLKKNKNCINILWKLEVAK 120

Query: 227 ELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLI-------DWGLAEFYHPGKEYNVR 279
           +L  A+ +     ++H +V   N+++  E  +           D G++    P      R
Sbjct: 121 QLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQER 180

Query: 280 V---ASRYFKGPELLVDLQDYDYSLDMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKI 333
           +          PE + + ++ + + D WS G  ++       +P     D+  +L   
Sbjct: 181 IPWVP------PECIENPKNLNLATDKWSFGTTLWEICSGGDKP-LSALDSQRKLQFY 231

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 49.3 bits (118), Expect = 1e-06
 Identities = 46/236 (19%), Positives = 92/236 (38%), Gaps = 36/236 (15%)

Query: 125 DDYEV-------VRKVGRGKYSEVFEGINVNTNERCI---IKILKP-----VKKKKIKRE 169
           +D  +        R +G+G++  V E      +   +   +K+LK         ++  RE
Sbjct: 16  EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLRE 75

Query: 170 IKILQNLCGGPNVVKLLDIVRDQHSKTPS----LIFEYVNSTDFK---------VLYPTL 216
              ++     P+V KL+ +     +K       +I  ++   D                L
Sbjct: 76  AACMKEFDH-PHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNL 134

Query: 217 TDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY 276
               +  ++ ++   ++Y  S+  +HRD+   N M+  +   + + D+GL+   + G  Y
Sbjct: 135 PLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAED-MTVCVADFGLSRKIYSGDYY 193

Query: 277 NVRVASRY-FK--GPELLVDLQDYDYSLDMWSLG-CMFAGMIFRKEPFFYGHDNHD 328
               AS+   K    E L D   Y    D+W+ G  M+  M   + P + G +N +
Sbjct: 194 RQGCASKLPVKWLALESLAD-NLYTVHSDVWAFGVTMWEIMTRGQTP-YAGIENAE 247

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 48.8 bits (117), Expect = 1e-06
 Identities = 46/228 (20%), Positives = 100/228 (43%), Gaps = 26/228 (11%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGP 180
           ++ D  +  K+G G+Y EV+EG+    +    +K LK   ++ ++  +E  +++ +   P
Sbjct: 11  ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK-HP 69

Query: 181 NVVKLLDIVRDQHSKTPSLI-FEYVNSTDFKVLY------PTLTDYDIRYYIYELLKALD 233
           N+V+LL +   +    P  I  E++   +    Y        ++   + Y   ++  A++
Sbjct: 70  NLVQLLGVCTREP---PFYIITEFMTYGNLLD-YLRECNRQEVSAVVLLYMATQISSAME 125

Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY-FK--GPEL 290
           Y   +  +HRD+   N ++      +++ D+GL+     G  Y     +++  K   PE 
Sbjct: 126 YLEKKNFIHRDLAARNCLVGENH-LVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPES 183

Query: 291 LVDLQDYDYSL--DMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
              L    +S+  D+W+ G  ++    +   P + G D       + K
Sbjct: 184 ---LAYNKFSIKSDVWAFGVLLWEIATYGMSP-YPGIDLSQVYELLEK 227

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 48.8 bits (117), Expect = 2e-06
 Identities = 37/213 (17%), Positives = 86/213 (40%), Gaps = 33/213 (15%)

Query: 125 DDYEV-------VRKVGRGKYSEVFEGINVNTNERCI---IKILKP-----VKKKKIKRE 169
           +D  +        + +G G++  V EG     +   +   +K +K       + ++   E
Sbjct: 27  EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSE 86

Query: 170 IKILQNLCGGPNVVKLLDIVRD---QHSKTPSLIFEYVNSTDFK---------VLYPTLT 217
              +++    PNV++LL +  +   Q    P +I  ++   D                + 
Sbjct: 87  AACMKDFS-HPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIP 145

Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
              +  ++ ++   ++Y  ++  +HRD+   N M+  ++  + + D+GL++  + G  Y 
Sbjct: 146 LQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDM-TVCVADFGLSKKIYSGDYYR 204

Query: 278 VRVASRY-FK--GPELLVDLQDYDYSLDMWSLG 307
               ++   K    E L D + Y    D+W+ G
Sbjct: 205 QGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFG 236

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 48.4 bits (116), Expect = 2e-06
 Identities = 46/223 (20%), Positives = 88/223 (39%), Gaps = 41/223 (18%)

Query: 123 DQDDYEV-------VRKVGRGKYSEVFEGI-----NVNTNERCIIKILKP----VKKKKI 166
           D   +E         + +GRG + +V E          T     +K+LK      + + +
Sbjct: 18  DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRAL 77

Query: 167 KREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV-------------------NST 207
             E+KIL ++    NVV LL     +      +I E+                       
Sbjct: 78  MSELKILIHIGHHLNVVNLLGAC-TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA 136

Query: 208 DFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 267
              +    LT   +  Y +++ K +++  S+  +HRD+   N+++  +   +++ D+GLA
Sbjct: 137 PEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK-NVVKICDFGLA 195

Query: 268 EFYHPGKEYNVRVASRY-FK--GPELLVDLQDYDYSLDMWSLG 307
              +   +Y  +  +R   K   PE + D + Y    D+WS G
Sbjct: 196 RDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFG 237

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 48.1 bits (115), Expect = 3e-06
 Identities = 23/147 (15%), Positives = 59/147 (40%), Gaps = 17/147 (11%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGI-NVNTNERCI---IKILKP----VKKKKIKREIKILQ 174
                   + +G G++ EV++G+   ++ ++ +   IK LK      ++     E  I+ 
Sbjct: 42  HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMG 101

Query: 175 NLCGGPNVVKLLDIVRDQHSKTPSLI-FEYVNSTDF----KVLYPTLTDYDIRYYIYELL 229
                 N+++L  ++       P +I  EY+ +       +      +   +   +  + 
Sbjct: 102 QFS-HHNIIRLEGVISKYK---PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIA 157

Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHEL 256
             + Y  +   +HRD+   N++++  L
Sbjct: 158 AGMKYLANMNYVHRDLAARNILVNSNL 184

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 47.7 bits (114), Expect = 3e-06
 Identities = 31/146 (21%), Positives = 60/146 (41%), Gaps = 16/146 (10%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCI---IKILKP----VKKKKIKREIKILQN 175
           D  +  + + VG G++ EV  G     +++ I   IK LK      +++    E  I+  
Sbjct: 43  DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQ 102

Query: 176 LCGGPNVVKLLDIVRDQHSKTPSLI-FEYVNSTDF----KVLYPTLTDYDIRYYIYELLK 230
               PN+++L  +V       P +I  EY+ +       +      T   +   +  +  
Sbjct: 103 FD-HPNIIRLEGVVTKSK---PVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIAS 158

Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHEL 256
            + Y    G +HRD+   N++I+  L
Sbjct: 159 GMKYLSDMGYVHRDLAARNILINSNL 184

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 47.3 bits (113), Expect = 4e-06
 Identities = 29/172 (16%), Positives = 67/172 (38%), Gaps = 33/172 (19%)

Query: 125 DDYEV-------VRKVGRGKYSEVFEGINVNTNE-----RCIIKILKP----VKKKKIKR 168
           D++EV        R++G+G +  V+EG+     +     R  IK +       ++ +   
Sbjct: 18  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 77

Query: 169 EIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV-------------NSTDFKVLYPT 215
           E  +++      +VV+LL +V         +I E +              +     +   
Sbjct: 78  EASVMKEF-NCHHVVRLLGVVSQGQP--TLVIMELMTRGDLKSYLRSLRPAMANNPVLAP 134

Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 267
            +   +     E+   + Y ++   +HRD+   N M+  +   +++ D+G+ 
Sbjct: 135 PSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED-FTVKIGDFGMT 185

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 46.5 bits (111), Expect = 7e-06
 Identities = 44/229 (19%), Positives = 100/229 (43%), Gaps = 23/229 (10%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCI----IKILK----PVKKKKIKREIKILQ 174
            + +++ ++ +G G +  V++G+ +   E+      IK L+    P   K+I  E  ++ 
Sbjct: 13  KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA 72

Query: 175 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYV---NSTDF-KVLYPTLTDYDIRYYIYELLK 230
           ++   P+V +LL I       T  LI + +      D+ +     +    +  +  ++ K
Sbjct: 73  SVD-NPHVCRLLGICLTS---TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 128

Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY-FK--G 287
            ++Y   + ++HRD+   NV++      +++ D+GLA+     ++       +   K   
Sbjct: 129 GMNYLEDRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187

Query: 288 PELLVDLQDYDYSLDMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
            E ++    Y +  D+WS G  ++  M F  +P+  G    +    + K
Sbjct: 188 LESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSILEK 234

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 46.0 bits (110), Expect = 1e-05
 Identities = 40/199 (20%), Positives = 88/199 (44%), Gaps = 26/199 (13%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGP 180
            ++  ++V ++G G++ EV+ G   N + +  +K LK   +       E  +++ L    
Sbjct: 11  PRETLKLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQ-HQ 68

Query: 181 NVVKLLDIVRDQHSKTPSLI-FEYVNSTDFKVLY------PTLTDYDIRYYIYELLKALD 233
            +V+L  +V    ++ P  I  EY+ +      +        LT   +     ++ + + 
Sbjct: 69  RLVRLYAVV----TQEPIYIITEYMENGSLVD-FLKTPSGIKLTINKLLDMAAQIAEGMA 123

Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY-FK--GPEL 290
           +   +  +HRD++  N+++   L   ++ D+GLA       EY  R  +++  K   PE 
Sbjct: 124 FIEERNYIHRDLRAANILVSDTL-SCKIADFGLARLIE-DNEYTAREGAKFPIKWTAPEA 181

Query: 291 LVDLQDYDYSL--DMWSLG 307
           +       +++  D+WS G
Sbjct: 182 INYGT---FTIKSDVWSFG 197

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 46.1 bits (110), Expect = 1e-05
 Identities = 29/146 (19%), Positives = 56/146 (38%), Gaps = 16/146 (10%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCI---IKILKP----VKKKKIKREIKILQN 175
           +     + + +G G   EV  G      +R +   IK LK      +++    E  I+  
Sbjct: 47  EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQ 106

Query: 176 LCGGPNVVKLLDIVRDQHSKTPSLI-FEYVNSTDF----KVLYPTLTDYDIRYYIYELLK 230
               PN+++L  +V        ++I  EY+ +       +      T   +   +  +  
Sbjct: 107 FDH-PNIIRLEGVVTRGR---LAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGA 162

Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHEL 256
            + Y    G +HRD+   NV++D  L
Sbjct: 163 GMRYLSDLGYVHRDLAARNVLVDSNL 188

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 46.2 bits (110), Expect = 1e-05
 Identities = 38/231 (16%), Positives = 95/231 (41%), Gaps = 27/231 (11%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGI----NVNTNERCIIKILK----PVKKKKIKREIKILQ 174
            + +   ++ +G G +  V +G+      +      IK+++        + +   +  + 
Sbjct: 11  KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIG 70

Query: 175 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYV---NSTDF-KVLYPTLTDYDIRYYIYELLK 230
           +L    ++V+LL +       +  L+ +Y+   +  D  +     L    +  +  ++ K
Sbjct: 71  SLDH-AHIVRLLGLCPGS---SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAK 126

Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY-FK--G 287
            + Y    G++HR++   NV++     ++++ D+G+A+   P  +  +   ++   K   
Sbjct: 127 GMYYLEEHGMVHRNLAARNVLLKSPS-QVQVADFGVADLLPPDDKQLLYSEAKTPIKWMA 185

Query: 288 PELLVDLQDYDYSL--DMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
            E    +    Y+   D+WS G  ++  M F  EP+  G    +    + K
Sbjct: 186 LE---SIHFGKYTHQSDVWSYGVTVWELMTFGAEPYA-GLRLAEVPDLLEK 232

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 45.6 bits (109), Expect = 1e-05
 Identities = 27/153 (17%), Positives = 69/153 (45%), Gaps = 15/153 (9%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGP 180
            +++  +++++G G++  V  G          +K++K   + + +  +E + +  L   P
Sbjct: 6   KREEITLLKELGSGQFGVVKLGK-WKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLS-HP 63

Query: 181 NVVKLLDIVRDQHSKTPSLI-FEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDY 234
            +VK   +   ++   P  I  EY+++      Y       L    +    Y++ + + +
Sbjct: 64  KLVKFYGVCSKEY---PIYIVTEYISNGCLLN-YLRSHGKGLEPSQLLEMCYDVCEGMAF 119

Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 267
             S   +HRD+   N ++D +L  +++ D+G+ 
Sbjct: 120 LESHQFIHRDLAARNCLVDRDL-CVKVSDFGMT 151

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 45.3 bits (108), Expect = 1e-05
 Identities = 30/152 (19%), Positives = 68/152 (44%), Gaps = 13/152 (8%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGP 180
           D  D   ++++G G++  V  G          IK++K   + + +   E K++ NL    
Sbjct: 22  DPKDLTFLKELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLS-HE 79

Query: 181 NVVKLLDIVRDQHSKTPSLI-FEYVNSTDF----KVLYPTLTDYDIRYYIYELLKALDYC 235
            +V+L  +   Q    P  I  EY+ +       + +        +     ++ +A++Y 
Sbjct: 80  KLVQLYGVCTKQR---PIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL 136

Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 267
            S+  +HRD+   N +++ +   +++ D+GL+
Sbjct: 137 ESKQFLHRDLAARNCLVNDQG-VVKVSDFGLS 167

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540

 Score = 45.8 bits (109), Expect = 2e-05
 Identities = 31/193 (16%), Positives = 71/193 (36%), Gaps = 32/193 (16%)

Query: 94  MSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVR----KVGRGKYSEVFEGINVNT 149
           M K   +  ++  +    +  + + V W  +   +  +     +G+G  +++     ++ 
Sbjct: 301 MHKNGRWMSLDETKIIPNYRTDMVEVNWIKEIKGKKRKIPEHLIGKGAEADIKRDSYLDF 360

Query: 150 NERCIIKILKP-----------VKKKKIKREIKILQNL--CGGPNVVKLLDIVRDQHSKT 196
           +   IIK               ++K +  RE + L  +   G P        + D     
Sbjct: 361 D--VIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPA-----PYIFDVDLDN 413

Query: 197 PSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEL 256
             ++  Y+N    K +     D       Y++ + +   H   ++H D+   N + D   
Sbjct: 414 KRIMMSYINGKLAKDVIEDNLDI-----AYKIGEIVGKLHKNDVIHNDLTTSNFIFD--- 465

Query: 257 RKLRLIDWGLAEF 269
           + L +ID+GL + 
Sbjct: 466 KDLYIIDFGLGKI 478

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 45.1 bits (107), Expect = 3e-05
 Identities = 43/227 (18%), Positives = 101/227 (44%), Gaps = 26/227 (11%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGP 180
            ++  ++ +K+G G++ EV+     N + +  +K +KP  +  +    E  +++ L    
Sbjct: 186 PRESLKLEKKLGAGQFGEVWMAT-YNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQ-HD 243

Query: 181 NVVKLLDIVRDQHSKTPSLI-FEYV---NSTDF--KVLYPTLTDYDIRYYIYELLKALDY 234
            +VKL  +V    +K P  I  E++   +  DF             +  +  ++ + + +
Sbjct: 244 KLVKLHAVV----TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAF 299

Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY-FK--GPELL 291
              +  +HRD++  N+++   L   ++ D+GLA       EY  R  +++  K   PE +
Sbjct: 300 IEQRNYIHRDLRAANILVSASL-VCKIADFGLARVIE-DNEYTAREGAKFPIKWTAPEAI 357

Query: 292 VDLQDYDYSL--DMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
                  +++  D+WS G  +   + + + P + G  N + +  + +
Sbjct: 358 NFGS---FTIKSDVWSFGILLMEIVTYGRIP-YPGMSNPEVIRALER 400

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 44.5 bits (106), Expect = 3e-05
 Identities = 46/221 (20%), Positives = 84/221 (38%), Gaps = 40/221 (18%)

Query: 125 DDYEV-------VRKVGRGKYSEVFEG-----INVNTNERCIIKILKP----VKKKKIKR 168
             +E         + +G G + +V E      I  +      +K+LKP     +++ +  
Sbjct: 16  HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMS 75

Query: 169 EIKILQNLCGGPNVVKLLDIVRDQH-------------------SKTPSLIFEYVNSTDF 209
           E+K+L  L    N+V LL                           K  S I    +    
Sbjct: 76  ELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIM 135

Query: 210 KVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 269
           +     L   D+  + Y++ K + +  S+  +HRD+   N+++    R  ++ D+GLA  
Sbjct: 136 EDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT-HGRITKICDFGLARD 194

Query: 270 YHPGKEYNVRVASRY-FK--GPELLVDLQDYDYSLDMWSLG 307
                 Y V+  +R   K   PE + +   Y +  D+WS G
Sbjct: 195 IKNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYG 234

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 44.6 bits (106), Expect = 4e-05
 Identities = 31/173 (17%), Positives = 64/173 (36%), Gaps = 33/173 (19%)

Query: 125 DDYEVVRKVGRGKYSEVFEGI-------NVNTNERCIIKILKP----VKKKKIKREIKIL 173
           D   + + +G G + +V                    +K+LK          +  E++++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94

Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV-------------------NSTDFKVLYP 214
           + +    N++ LL            +I EY                    +    +V   
Sbjct: 95  KMIGKHKNIINLLGACTQDGP--LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 152

Query: 215 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 267
            +T  D+    Y+L + ++Y  SQ  +HRD+   NV++      +++ D+GLA
Sbjct: 153 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTEN-NVMKIADFGLA 204

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 44.2 bits (105), Expect = 4e-05
 Identities = 44/229 (19%), Positives = 100/229 (43%), Gaps = 23/229 (10%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCI----IKILK----PVKKKKIKREIKILQ 174
            + +++ ++ +G G +  V++G+ +   E+      IK L+    P   K+I  E  ++ 
Sbjct: 13  KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA 72

Query: 175 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYV---NSTDF-KVLYPTLTDYDIRYYIYELLK 230
           ++   P+V +LL I       T  LI + +      D+ +     +    +  +  ++ K
Sbjct: 73  SVD-NPHVCRLLGICLTS---TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 128

Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY-FK--G 287
            ++Y   + ++HRD+   NV++      +++ D+GLA+     ++       +   K   
Sbjct: 129 GMNYLEDRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187

Query: 288 PELLVDLQDYDYSLDMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
            E ++    Y +  D+WS G  ++  M F  +P+  G    +    + K
Sbjct: 188 LESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSILEK 234

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 43.7 bits (104), Expect = 5e-05
 Identities = 39/226 (17%), Positives = 89/226 (39%), Gaps = 24/226 (10%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGP 180
           D  +   V+++G G++  V  G      ++  IK ++   + ++    E +++  L   P
Sbjct: 6   DPSELTFVQEIGSGQFGLVHLGY-WLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLS-HP 63

Query: 181 NVVKLLDIVRDQHSKTPSLI-FEYVNSTDF----KVLYPTLTDYDIRYYIYELLKALDYC 235
            +V+L  +  +Q    P  +  E++         +          +     ++ + + Y 
Sbjct: 64  KLVQLYGVCLEQA---PICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL 120

Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY-FK--GPELLV 292
               ++HRD+   N ++      +++ D+G+  F     +Y     +++  K   PE+  
Sbjct: 121 EEACVIHRDLAARNCLVGENQ-VIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEV-- 176

Query: 293 DLQDYDYSL--DMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
                 YS   D+WS G  M+      K P +    N + +  I+ 
Sbjct: 177 -FSFSRYSSKSDVWSFGVLMWEVFSEGKIP-YENRSNSEVVEDIST 220

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 43.8 bits (104), Expect = 5e-05
 Identities = 47/213 (22%), Positives = 87/213 (40%), Gaps = 35/213 (16%)

Query: 125 DDYEVVRKVGRGKYSEVFEGI-----NVNTNERCIIKILKP----VKKKKIKREIKILQN 175
           ++ +  + +G G + +V E         +   +  +K+LK      +K+ +  E+KI+ +
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105

Query: 176 LCGGPNVVKLLDIVRDQHSKTPSL-IFEYV-----------------NSTDFKVLYPTLT 217
           L    N+V LL          P L I EY                      F +   T +
Sbjct: 106 LGQHENIVNLLGACTHGG---PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTAS 162

Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
             D+ ++  ++ + + +  S+  +HRDV   NV++ +     ++ D+GLA        Y 
Sbjct: 163 TRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNG-HVAKIGDFGLARDIMNDSNYI 221

Query: 278 VRVASRY-FK--GPELLVDLQDYDYSLDMWSLG 307
           V+  +R   K   PE + D   Y    D+WS G
Sbjct: 222 VKGNARLPVKWMAPESIFD-CVYTVQSDVWSYG 253

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 43.4 bits (103), Expect = 6e-05
 Identities = 27/153 (17%), Positives = 69/153 (45%), Gaps = 15/153 (9%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-VKKKKIKREIKILQNLCGGPN 181
           +  + ++++ +G+G++ +V  G       +  +K +K     +    E  ++  L    N
Sbjct: 19  NMKELKLLQTIGKGEFGDVMLGDYRGN--KVAVKCIKNDATAQAFLAEASVMTQLR-HSN 75

Query: 182 VVKLLDIVRDQHSKTPSL--IFEYV---NSTDF--KVLYPTLTDYDIRYYIYELLKALDY 234
           +V+LL ++ ++      L  + EY+   +  D+        L    +  +  ++ +A++Y
Sbjct: 76  LVQLLGVIVEEK---GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 132

Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 267
                 +HRD+   NV++  +    ++ D+GL 
Sbjct: 133 LEGNNFVHRDLAARNVLVSEDN-VAKVSDFGLT 164

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 43.0 bits (102), Expect = 9e-05
 Identities = 31/187 (16%), Positives = 63/187 (33%), Gaps = 40/187 (21%)

Query: 108 PKEYW--DYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGI--NVNTNERCIIKILKP--- 160
           P  Y   D+  +  Q            +G G + +V +             IK +K    
Sbjct: 16  PTIYPVLDWNDIKFQ----------DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS 65

Query: 161 -VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV--------------- 204
               +    E+++L  L   PN++ LL     +      L  EY                
Sbjct: 66  KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY--LYLAIEYAPHGNLLDFLRKSRVL 123

Query: 205 ----NSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLR 260
                         TL+   + ++  ++ + +DY   +  +HRD+   N+++       +
Sbjct: 124 ETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY-VAK 182

Query: 261 LIDWGLA 267
           + D+GL+
Sbjct: 183 IADFGLS 189

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 43.0 bits (102), Expect = 9e-05
 Identities = 46/239 (19%), Positives = 90/239 (37%), Gaps = 41/239 (17%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCI---IKILKP------VKKKKIKREIKIL 173
            + D  ++ K+G G +  V  G     + + +   +K LKP             RE+  +
Sbjct: 16  GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAM 75

Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLI----------FEYVNSTDFKVLYPTLTDYDIRY 223
            +L    N+++L  +V       P  +           + +       L  TL+      
Sbjct: 76  HSLD-HRNLIRLYGVV----LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSR----- 125

Query: 224 YIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVAS 282
           Y  ++ + + Y  S+  +HRD+   N+++      +++ D+GL          Y ++   
Sbjct: 126 YAVQVAEGMGYLESKRFIHRDLAARNLLLATRD-LVKIGDFGLMRALPQNDDHYVMQEHR 184

Query: 283 RY-FK--GPELLVDLQDYDYSL--DMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
           +  F    PE L       +S   D W  G  ++    + +EP + G +    L KI K
Sbjct: 185 KVPFAWCAPESLKTRT---FSHASDTWMFGVTLWEMFTYGQEP-WIGLNGSQILHKIDK 239

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 43.1 bits (102), Expect = 1e-04
 Identities = 31/173 (17%), Positives = 64/173 (36%), Gaps = 33/173 (19%)

Query: 125 DDYEVVRKVGRGKYSEVFEGI-------NVNTNERCIIKILKP----VKKKKIKREIKIL 173
           D   + + +G G + +V                    +K+LK          +  E++++
Sbjct: 81  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140

Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV-------------------NSTDFKVLYP 214
           + +    N++ LL            +I EY                    +    +V   
Sbjct: 141 KMIGKHKNIINLLGACTQDGP--LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 198

Query: 215 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 267
            +T  D+    Y+L + ++Y  SQ  +HRD+   NV++      +++ D+GLA
Sbjct: 199 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTEN-NVMKIADFGLA 250

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 42.4 bits (100), Expect = 2e-04
 Identities = 29/173 (16%), Positives = 65/173 (37%), Gaps = 33/173 (19%)

Query: 125 DDYEVVRKVGRGKYSEVFEGI-------NVNTNERCIIKILKP----VKKKKIKREIKIL 173
           D   + + +G G + +V             N   +  +K+LK          +  E++++
Sbjct: 69  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 128

Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV-------------------NSTDFKVLYP 214
           + +    N++ LL            +I EY                    +         
Sbjct: 129 KMIGKHKNIINLLGACTQDGP--LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 186

Query: 215 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 267
            L+  D+    Y++ + ++Y  S+  +HRD+   NV++  +   +++ D+GLA
Sbjct: 187 QLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTED-NVMKIADFGLA 238

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 41.5 bits (98), Expect = 4e-04
 Identities = 28/182 (15%), Positives = 63/182 (34%), Gaps = 32/182 (17%)

Query: 104 NVLRPKEYWD--YESLTVQWG-DQDDYEVVRKVGRGKYSEVFEGI--NVNTNERCI---I 155
           + L+     +  Y S        + D  +  ++G G + +VF     N+   +  +   +
Sbjct: 17  SGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAV 76

Query: 156 KILKPVKKKKIK---REIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV-------- 204
           K LK   +   +   RE ++L  L    ++V+   +  +   +   ++FEY+        
Sbjct: 77  KALKEASESARQDFQREAELLTMLQ-HQHIVRFFGVCTE--GRPLLMVFEYMRHGDLNRF 133

Query: 205 ----------NSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH 254
                      +    V    L    +     ++   + Y      +HRD+   N ++  
Sbjct: 134 LRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQ 193

Query: 255 EL 256
            L
Sbjct: 194 GL 195

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 41.2 bits (97), Expect = 4e-04
 Identities = 27/162 (16%), Positives = 72/162 (44%), Gaps = 15/162 (9%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-VKKKKIKREIKILQNLCGGPN 181
           +  + ++++ +G+G++ +V  G       +  +K +K     +    E  ++  L    N
Sbjct: 191 NMKELKLLQTIGKGEFGDVMLGDYRGN--KVAVKCIKNDATAQAFLAEASVMTQLR-HSN 247

Query: 182 VVKLLDIVRDQHSKTPSL--IFEYV---NSTDF--KVLYPTLTDYDIRYYIYELLKALDY 234
           +V+LL ++ ++      L  + EY+   +  D+        L    +  +  ++ +A++Y
Sbjct: 248 LVQLLGVIVEEK---GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 304

Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY 276
                 +HRD+   NV++  +    ++ D+GL +     ++ 
Sbjct: 305 LEGNNFVHRDLAARNVLVSEDN-VAKVSDFGLTKEASSTQDT 345

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 40.7 bits (96), Expect = 5e-04
 Identities = 46/221 (20%), Positives = 86/221 (38%), Gaps = 42/221 (19%)

Query: 125 DDYEVVRKVGRGKYSEVFEGI-----NVNTNERCIIKILKP----VKKKKIKREIKILQN 175
           ++ E  + +G G + +V             + +  +K+LK      +++ +  E+K++  
Sbjct: 45  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 104

Query: 176 LCGGPNVVKLLDIVRDQHSKTPSLIFEYV--------------------------NSTDF 209
           L    N+V LL            LIFEY                              + 
Sbjct: 105 LGSHENIVNLLGACTLSGP--IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEE 162

Query: 210 KVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 269
           +     LT  D+  + Y++ K +++   +  +HRD+   NV++    + +++ D+GLA  
Sbjct: 163 EEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVT-HGKVVKICDFGLARD 221

Query: 270 YHPGKEYNVRVASRY-FK--GPELLVDLQDYDYSLDMWSLG 307
                 Y VR  +R   K   PE L +   Y    D+WS G
Sbjct: 222 IMSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYG 261

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282

 Score = 40.7 bits (95), Expect = 6e-04
 Identities = 28/168 (16%), Positives = 64/168 (38%), Gaps = 36/168 (21%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP---------------------VKKKK 165
             + + +G GK S VF   +      C++K  K                      +  + 
Sbjct: 92  DAIGKLMGEGKESAVFNCYSEK-FGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 150

Query: 166 IKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYI 225
            + E + LQ L G   V K+     +      +++ E +++ +       +   +    +
Sbjct: 151 ARNEFRALQKLQGLA-VPKVYAWEGN------AVLMELIDAKEL----YRVRVENPDEVL 199

Query: 226 YELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHP 272
             +L+ +   + +GI+H D+  +NV++  E   + +ID+  + E    
Sbjct: 200 DMILEEVAKFYHRGIVHGDLSQYNVLVSEE--GIWIIDFPQSVEVGEE 245

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 40.3 bits (95), Expect = 6e-04
 Identities = 39/240 (16%), Positives = 95/240 (39%), Gaps = 46/240 (19%)

Query: 125 DDYEVVR--------KVGRGKYSEVFEGI-NVNTNERCI-IKILKP----VKKKKIKREI 170
               + R        ++G G +  V +G+  +   +  + IK+LK        +++ RE 
Sbjct: 2   KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 61

Query: 171 KILQNLCGGPNVVKLLDIVRDQHSKTPSLI----------FEYVNSTDFKVLYPTLTDYD 220
           +I+  L   P +V+L+ +          ++           +++     ++    + +  
Sbjct: 62  QIMHQLD-NPYIVRLIGVC----QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAE-- 114

Query: 221 IRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVR 279
               ++++   + Y   +  +HRD+   NV++ +     ++ D+GL+         Y  R
Sbjct: 115 ---LLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRH-YAKISDFGLSKALGADDSYYTAR 170

Query: 280 VASRY-FK--GPELLVDLQDYDYSL--DMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKI 333
            A ++  K   PE    +    +S   D+WS G  M+  + + ++P +      + +  I
Sbjct: 171 SAGKWPLKWYAPE---CINFRKFSSRSDVWSYGVTMWEALSYGQKP-YKKMKGPEVMAFI 226

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 40.3 bits (95), Expect = 7e-04
 Identities = 43/224 (19%), Positives = 89/224 (39%), Gaps = 30/224 (13%)

Query: 131 RKVGRGKYSEVFEGINVNTNERCI---IKILK-----PVKKKKIKREIKILQNLCGGPNV 182
           +++G G +  V +G      +      +KILK     P  K ++  E  ++Q L   P +
Sbjct: 23  KELGSGNFGTVKKGY-YQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD-NPYI 80

Query: 183 VKLLDIVRDQHSKTPS-LIFEYVNS---TDFKVLYPTLTDYDIRYYIYELLKALDYCHSQ 238
           V+++ I           L+ E         +      + D +I   ++++   + Y    
Sbjct: 81  VRMIGIC----EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES 136

Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRY-FK--GPELLVDL 294
             +HRD+   NV++  +    ++ D+GL+         Y  +   ++  K   PE    +
Sbjct: 137 NFVHRDLAARNVLLVTQH-YAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC---I 192

Query: 295 QDYDYSL--DMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
             Y +S   D+WS G  M+    + ++P + G    +    + K
Sbjct: 193 NYYKFSSKSDVWSFGVLMWEAFSYGQKP-YRGMKGSEVTAMLEK 235

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 40.3 bits (94), Expect = 8e-04
 Identities = 26/121 (21%), Positives = 53/121 (43%), Gaps = 5/121 (4%)

Query: 190 RDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHN 249
                +  SL           +    LT   +  Y +++ K +++  S+  +HRD+   N
Sbjct: 164 SSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN 223

Query: 250 VMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY-FK--GPELLVDLQDYDYSLDMWSL 306
           +++  +   +++ D+GLA   +   +Y  +  +R   K   PE + D + Y    D+WS 
Sbjct: 224 ILLSEK-NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSF 281

Query: 307 G 307
           G
Sbjct: 282 G 282

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	425
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.97
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.95
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.92
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.87
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.73
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.45
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.35
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.26
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.13
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.95
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.78
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.73
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.57
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.48
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.46
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.2
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.02
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.93
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.81
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.71
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.7
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.68
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.65
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.52
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.49
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.49
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.42
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.24
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.8
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.8
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	96.56
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.41
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.21

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=8.8e-62  Score=456.25  Aligned_cols=257  Identities=28%  Similarity=0.494  Sum_probs=220.8

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecC------cchHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCcc
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP------VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~------~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (425)
                      .++|++++.||+|+||+||+|++..+++.||||++++      ...+.+.+|+++|+++ +|||||+++++|.++  ..+
T Consensus        31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~--~~~  107 (311)
T 4aw0_A           31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVKLYFTFQDD--EKL  107 (311)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-CCTTBCCEEEEEECS--SEE
T ss_pred             ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEeC--CEE
Confidence            4679999999999999999999999999999999963      3346789999999999 999999999999764  789


Q ss_pred             EEEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCC
Q 014406          198 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (425)
Q Consensus       198 ~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~  274 (425)
                      |+||||++||+|.+++   ..+++.+++.++.||+.||+|||++|||||||||+|||++.+ +.+||+|||+|+......
T Consensus       108 yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~-g~vKl~DFGla~~~~~~~  186 (311)
T 4aw0_A          108 YFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNED-MHIQITDFGTAKVLSPES  186 (311)
T ss_dssp             EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-SCEEECCCTTCEECCTTT
T ss_pred             EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCC-CCEEEEEcCCceecCCCC
Confidence            9999999999999887   469999999999999999999999999999999999999988 799999999998765332


Q ss_pred             ---cceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccC
Q 014406          275 ---EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL  351 (425)
Q Consensus       275 ---~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~  351 (425)
                         .....+||+.|||||++.+ ..|+.++||||+||++|+|++|+.||. +.+..+.+..+.+.             ..
T Consensus       187 ~~~~~~~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~-~~~~~~~~~~i~~~-------------~~  251 (311)
T 4aw0_A          187 KQARANSFVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFR-AGNEGLIFAKIIKL-------------EY  251 (311)
T ss_dssp             TCCCBCCCCSCGGGCCHHHHHH-SCBCHHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHT-------------CC
T ss_pred             CcccccCcccCcccCCHHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHcC-------------CC
Confidence               3455689999999999987 789999999999999999999999983 33444444443320             00


Q ss_pred             CCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHH------HhcCCCCcccccchhccc
Q 014406          352 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTARE------AMAHPYFAQVRAAESSRT  423 (425)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~e------lL~hp~~~~~~~~~~~~~  423 (425)
                                              ..+..+++++++||++||+.||++|||++|      +++||||++++|....++
T Consensus       252 ------------------------~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~l~~~  305 (311)
T 4aw0_A          252 ------------------------DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQ  305 (311)
T ss_dssp             ------------------------CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGGGS
T ss_pred             ------------------------CCCcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHHhcCC
Confidence                                    011237999999999999999999999987      689999999998876543

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=2.6e-61  Score=459.66  Aligned_cols=254  Identities=24%  Similarity=0.421  Sum_probs=217.1

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecC---cchHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEE
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP---VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (425)
                      .+.|+++++||+|+||+||+|.+..+|+.||||+++.   ...+.+.+|+.+|+++ +|||||+++++|.+.  ..+|||
T Consensus        73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~~--~~~~iv  149 (346)
T 4fih_A           73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY-QHENVVEMYNSYLVG--DELWVV  149 (346)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHC-CCTTBCCEEEEEEET--TEEEEE
T ss_pred             hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhC-CCCCCCcEEEEEEEC--CEEEEE
Confidence            3569999999999999999999999999999999963   3456789999999999 999999999999764  689999


Q ss_pred             EEeecCCChhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCC-Ccce
Q 014406          201 FEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-KEYN  277 (425)
Q Consensus       201 ~e~~~~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~-~~~~  277 (425)
                      |||++||+|.+++  ..+++.+++.++.||+.||+|||++|||||||||+|||++.+ +.+||+|||+|+..... ....
T Consensus       150 mEy~~gg~L~~~l~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~-g~vKl~DFGla~~~~~~~~~~~  228 (346)
T 4fih_A          150 MEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHD-GRVKLSDFGFCAQVSKEVPRRK  228 (346)
T ss_dssp             ECCCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-CCEEECCCTTCEECCSSSCCBC
T ss_pred             EeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCC-CCEEEecCcCceecCCCCCccc
Confidence            9999999999887  569999999999999999999999999999999999999988 79999999999876543 3445


Q ss_pred             eeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCChhh
Q 014406          278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQL  357 (425)
Q Consensus       278 ~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~  357 (425)
                      ..+||+.|||||++.+ ..|+.++|||||||++|||++|+.||. +.+..+.+..+.+....                  
T Consensus       229 ~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~-~~~~~~~~~~i~~~~~~------------------  288 (346)
T 4fih_A          229 SLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYF-NEPPLKAMKMIRDNLPP------------------  288 (346)
T ss_dssp             CCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTT-TSCHHHHHHHHHHSSCC------------------
T ss_pred             ccccCcCcCCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCC-CcCHHHHHHHHHcCCCC------------------
Confidence            6799999999999977 789999999999999999999999984 33434444433221100                  


Q ss_pred             HHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCccccc
Q 014406          358 DALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA  417 (425)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~  417 (425)
                                      .......+|+++++||.+||+.||++|||++|+|+||||++...
T Consensus       289 ----------------~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~~  332 (346)
T 4fih_A          289 ----------------RLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP  332 (346)
T ss_dssp             ----------------CCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred             ----------------CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCCC
Confidence                            00111237999999999999999999999999999999997654

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=1.7e-60  Score=460.42  Aligned_cols=291  Identities=29%  Similarity=0.487  Sum_probs=232.6

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEc---CCCcEEEEEEecCc-chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEE
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINV---NTNERCIIKILKPV-KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~---~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (425)
                      .++|++.++||+|+||+||+|++.   .+++.||+|.+... ...++.+|+++|+.+.+||||++++++|.+.  .++|+
T Consensus        20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~--~~~~l   97 (361)
T 4f9c_A           20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRKN--DHVVI   97 (361)
T ss_dssp             GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEEET--TEEEE
T ss_pred             cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEEEC--CEEEE
Confidence            578999999999999999999875   46789999988654 4567889999999987899999999999764  78999


Q ss_pred             EEEeecCCChhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCC-----
Q 014406          200 IFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-----  274 (425)
Q Consensus       200 v~e~~~~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~-----  274 (425)
                      ||||+++++|.+++..+++.+++.++.||+.||+|||++|||||||||+|||++.+.+.+||+|||+|+......     
T Consensus        98 vmE~~~g~~L~~~~~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~~  177 (361)
T 4f9c_A           98 AMPYLEHESFLDILNSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLK  177 (361)
T ss_dssp             EEECCCCCCHHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCGGGG
T ss_pred             EEeCCCcccHHHHHcCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCccccccc
Confidence            999999999999999999999999999999999999999999999999999999876799999999997553321     


Q ss_pred             ------------------------cceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHH
Q 014406          275 ------------------------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL  330 (425)
Q Consensus       275 ------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~  330 (425)
                                              .....+||+.|+|||++.+...|+.++||||+||++|||++|+.||+.+.++.+++
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~~~l  257 (361)
T 4f9c_A          178 FVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLTAL  257 (361)
T ss_dssp             GC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHH
T ss_pred             cccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCHHHHH
Confidence                                    12345799999999999886679999999999999999999999999999999999


Q ss_pred             HHHHHHhCCchhHHHHhhccCCC-------ChhhHHHhccc----------CCCCccccccccCCCCCCHHHHHHHHHcc
Q 014406          331 VKIAKVLGTDELNAYLNKYHLEL-------DPQLDALVGRH----------SRKPWSKFINADNQHLVSPEAIDFLDKLL  393 (425)
Q Consensus       331 ~~~~~~lg~~~~~~~~~~~~~~~-------~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~s~~~~~ll~~~L  393 (425)
                      ..+.+.+|+++............       ...........          ...........+....+|++++|||++||
T Consensus       258 ~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~~lL  337 (361)
T 4f9c_A          258 AQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLL  337 (361)
T ss_dssp             HHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHHHHHHT
T ss_pred             HHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHHHHHHC
Confidence            99999999866554433221110       00011100000          00000111122334458999999999999


Q ss_pred             cCCcCCCcCHHHHhcCCCCcccc
Q 014406          394 RYDHQDRLTAREAMAHPYFAQVR  416 (425)
Q Consensus       394 ~~dP~~Rpta~elL~hp~~~~~~  416 (425)
                      ++||++|+||+|+|+||||++++
T Consensus       338 ~~dP~~R~ta~eaL~Hp~f~~i~  360 (361)
T 4f9c_A          338 DLNPASRITAEEALLHPFFKDMS  360 (361)
T ss_dssp             CSCTTTSCCHHHHHTSGGGTTC-
T ss_pred             cCChhHCcCHHHHhcCcccCCCC
Confidence            99999999999999999999875

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=3.9e-60  Score=442.76  Aligned_cols=253  Identities=22%  Similarity=0.430  Sum_probs=208.3

Q ss_pred             CCCCE-EEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcC--CC
Q 014406          123 DQDDY-EVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQ--HS  194 (425)
Q Consensus       123 ~~~~y-~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~--~~  194 (425)
                      ...+| ++.++||+|+||+||+|.+..++..||+|++...     ..+.+.+|+.+++++ +|||||+++++|.+.  ..
T Consensus        23 ~~gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIV~~~~~~~~~~~~~  101 (290)
T 3fpq_A           23 NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-QHPNIVRFYDSWESTVKGK  101 (290)
T ss_dssp             TTSSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEEEETTE
T ss_pred             CCCceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEeeccCCC
Confidence            34455 7778899999999999999999999999998643     235689999999999 999999999999753  23


Q ss_pred             CccEEEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--ceeecCCCCceEecCCCCcEEEEecccccc
Q 014406          195 KTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (425)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~--ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~  269 (425)
                      ..++|||||+++|+|.+++   ..+++..++.++.||+.||+|||++|  ||||||||+|||++...+.+||+|||+|+.
T Consensus       102 ~~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~  181 (290)
T 3fpq_A          102 KCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL  181 (290)
T ss_dssp             EEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred             cEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEe
Confidence            5689999999999999887   46999999999999999999999998  999999999999986447899999999986


Q ss_pred             ccCCCcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhc
Q 014406          270 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY  349 (425)
Q Consensus       270 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~  349 (425)
                      .. .......+||+.|||||++.+  .|+.++|||||||++|||+||+.||.. .++...+...... +..+        
T Consensus       182 ~~-~~~~~~~~GTp~YmAPE~~~~--~y~~~~DiwSlGvilyelltg~~Pf~~-~~~~~~~~~~i~~-~~~~--------  248 (290)
T 3fpq_A          182 KR-ASFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSE-CQNAAQIYRRVTS-GVKP--------  248 (290)
T ss_dssp             CC-TTSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTT-CSSHHHHHHHHTT-TCCC--------
T ss_pred             CC-CCccCCcccCccccCHHHcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCC-CCcHHHHHHHHHc-CCCC--------
Confidence            44 344566789999999999864  699999999999999999999999843 3333333222110 0000        


Q ss_pred             cCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcc
Q 014406          350 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ  414 (425)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~  414 (425)
                                               ...+..+++++++||.+||+.||++|||++|+|+||||++
T Consensus       249 -------------------------~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~  288 (290)
T 3fpq_A          249 -------------------------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             -------------------------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             -------------------------CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence                                     0011236889999999999999999999999999999985

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=5.6e-60  Score=461.24  Aligned_cols=254  Identities=24%  Similarity=0.417  Sum_probs=217.7

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecC---cchHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEE
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP---VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (425)
                      .+.|+++++||+|+||+||+|.+..+|+.||||+++.   ...+.+.+|+.+|+.+ +|||||+++++|.+.  ..+|||
T Consensus       150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~~--~~~~iV  226 (423)
T 4fie_A          150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY-QHENVVEMYNSYLVG--DELWVV  226 (423)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHC-CCTTBCCEEEEEEET--TEEEEE
T ss_pred             hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhC-CCCCCCceEEEEEEC--CEEEEE
Confidence            3679999999999999999999999999999999963   3456789999999999 999999999999764  689999


Q ss_pred             EEeecCCChhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCC-Ccce
Q 014406          201 FEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-KEYN  277 (425)
Q Consensus       201 ~e~~~~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~-~~~~  277 (425)
                      ||||+||+|.+++  ..+++.+++.++.||+.||+|||++|||||||||+||||+.+ +.+||+|||+|+..... ....
T Consensus       227 mEy~~gG~L~~~i~~~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~-g~vKl~DFGla~~~~~~~~~~~  305 (423)
T 4fie_A          227 MEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHD-GRVKLSDFGFCAQVSKEVPRRK  305 (423)
T ss_dssp             EECCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTT-CCEEECCCTTCEECCSSCCCBC
T ss_pred             EeCCCCCcHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCC-CCEEEecCccceECCCCCcccc
Confidence            9999999999887  569999999999999999999999999999999999999988 79999999999876543 3445


Q ss_pred             eeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCChhh
Q 014406          278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQL  357 (425)
Q Consensus       278 ~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~  357 (425)
                      ..+||+.|||||++.+ ..|+.++|||||||++|||++|+.||. +.+..+.+..+.....                   
T Consensus       306 ~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~-~~~~~~~~~~i~~~~~-------------------  364 (423)
T 4fie_A          306 SLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYF-NEPPLKAMKMIRDNLP-------------------  364 (423)
T ss_dssp             CCEECTTTCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTT-TSCHHHHHHHHHHSCC-------------------
T ss_pred             ccccCcCcCCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCC-CcCHHHHHHHHHcCCC-------------------
Confidence            6799999999999987 789999999999999999999999984 3333444443322100                   


Q ss_pred             HHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCccccc
Q 014406          358 DALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA  417 (425)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~  417 (425)
                                     ........+|+++++||.+||+.||++|||++|+|+||||++...
T Consensus       365 ---------------~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~~~  409 (423)
T 4fie_A          365 ---------------PRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP  409 (423)
T ss_dssp             ---------------CCCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred             ---------------CCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCCCC
Confidence                           001112347999999999999999999999999999999997644

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.1e-60  Score=456.17  Aligned_cols=251  Identities=19%  Similarity=0.394  Sum_probs=208.2

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCcc
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (425)
                      ..++|++++.||+|+||+||+|++..+|+.||||+++..     ..+.+.+|+.+|+++ +|||||+++++|.+.  ..+
T Consensus        22 sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIV~~~~~~~~~--~~~   98 (350)
T 4b9d_A           22 SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANM-KHPNIVQYRESFEEN--GSL   98 (350)
T ss_dssp             CCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEET--TEE
T ss_pred             cccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHC-CCCCCCcEEEEEEEC--CEE
Confidence            457999999999999999999999999999999999643     245788999999999 999999999999764  788


Q ss_pred             EEEEEeecCCChhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccC
Q 014406          198 SLIFEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (425)
Q Consensus       198 ~lv~e~~~~~~l~~~~~-----~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~  272 (425)
                      |+||||++||+|.+++.     .+++.+++.|+.||+.||+|||++|||||||||+|||++.+ +.+||+|||+|+....
T Consensus        99 yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~-g~vKl~DFGla~~~~~  177 (350)
T 4b9d_A           99 YIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKD-GTVQLGDFGIARVLNS  177 (350)
T ss_dssp             EEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTT-CCEEECSTTEESCCCH
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCC-CCEEEcccccceeecC
Confidence            99999999999998872     36899999999999999999999999999999999999988 7999999999987653


Q ss_pred             CC-cceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccC
Q 014406          273 GK-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL  351 (425)
Q Consensus       273 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~  351 (425)
                      .. .....+||+.|||||++.+ ..|+.++|||||||++|||++|+.||. +.+..+.+..+...-             .
T Consensus       178 ~~~~~~~~~GT~~YmAPE~l~~-~~y~~~~DiwSlGvilyemltG~~PF~-~~~~~~~~~~i~~~~-------------~  242 (350)
T 4b9d_A          178 TVELARACIGTPYYLSPEICEN-KPYNNKSDIWALGCVLYELCTLKHAFE-AGSMKNLVLKIISGS-------------F  242 (350)
T ss_dssp             HHHHHHHHHSCCTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCC-CSSHHHHHHHHHHTC-------------C
T ss_pred             CcccccccCCCccccCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCC-CcCHHHHHHHHHcCC-------------C
Confidence            32 2345689999999999987 789999999999999999999999983 444444444432210             0


Q ss_pred             CCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCccc
Q 014406          352 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV  415 (425)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~  415 (425)
                                             ......+|+++++||.+||+.||++|||++|+|+||||++-
T Consensus       243 -----------------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~  283 (350)
T 4b9d_A          243 -----------------------PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKR  283 (350)
T ss_dssp             -----------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHTT
T ss_pred             -----------------------CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhcC
Confidence                                   00122379999999999999999999999999999999753

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=3.3e-60  Score=439.55  Aligned_cols=247  Identities=23%  Similarity=0.499  Sum_probs=194.5

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccE
Q 014406          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (425)
Q Consensus       125 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (425)
                      ++|++.+.||+|+||+||+|.+..+++.||||++++.      ..+.+.+|+.+++++ +||||+++++++.++  ..+|
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~--~~~~   89 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLL-RHPHIIKLYDVIKSK--DEII   89 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHC-CCTTBCCEEEEEECS--SEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHC-CCCCCCeEEEEEEEC--CEEE
Confidence            5899999999999999999999999999999998643      245689999999999 999999999999664  7789


Q ss_pred             EEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCc
Q 014406          199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (425)
Q Consensus       199 lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~  275 (425)
                      +||||++ |+|.+++   ..+++.+++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+.......
T Consensus        90 ivmEy~~-g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~-~~vkl~DFGla~~~~~~~~  167 (275)
T 3hyh_A           90 MVIEYAG-NELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEH-LNVKIADFGLSNIMTDGNF  167 (275)
T ss_dssp             EEEECCC-EEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTT-CCEEECCSSCC--------
T ss_pred             EEEeCCC-CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCC-CCEEEeecCCCeecCCCCc
Confidence            9999995 5666655   469999999999999999999999999999999999999988 7999999999988766666


Q ss_pred             ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCCh
Q 014406          276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP  355 (425)
Q Consensus       276 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~  355 (425)
                      ....+||+.|||||++.+...++.++||||+||++|+|++|+.||. +.+..+.+..+..             ...    
T Consensus       168 ~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~-~~~~~~~~~~i~~-------------~~~----  229 (275)
T 3hyh_A          168 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFD-DESIPVLFKNISN-------------GVY----  229 (275)
T ss_dssp             -------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHH-------------TCC----
T ss_pred             cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCC-CCCHHHHHHHHHc-------------CCC----
Confidence            6678999999999999884445689999999999999999999983 3332222332221             000    


Q ss_pred             hhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcc
Q 014406          356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ  414 (425)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~  414 (425)
                                          ..+..+|+++++||++||+.||++|||++|+|+||||+.
T Consensus       230 --------------------~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~  268 (275)
T 3hyh_A          230 --------------------TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV  268 (275)
T ss_dssp             --------------------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred             --------------------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence                                011237999999999999999999999999999999973

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=2.8e-60  Score=445.87  Aligned_cols=256  Identities=27%  Similarity=0.478  Sum_probs=210.4

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEc---CCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCC
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINV---NTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS  194 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~---~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  194 (425)
                      +.++|++++.||+|+||+||+|++.   .+++.||||+++..     ....+.+|+.+|+++ +|||||+++++|.++  
T Consensus        22 ~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~--   98 (304)
T 3ubd_A           22 DPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV-NHPFIVKLHYAFQTE--   98 (304)
T ss_dssp             CGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCC-CCTTEECEEEEEEET--
T ss_pred             CccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHC-CCCCCCeEEEEEEEC--
Confidence            3578999999999999999999874   46789999998643     234688999999999 999999999999764  


Q ss_pred             CccEEEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEecccccccc
Q 014406          195 KTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (425)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~  271 (425)
                      ..+|+||||++||+|.+++   ..+++.+++.++.||+.||+|||++|||||||||+|||++.+ +.+||+|||+|+...
T Consensus        99 ~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~-g~vKl~DFGla~~~~  177 (304)
T 3ubd_A           99 GKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEE-GHIKLTDFGLSKESI  177 (304)
T ss_dssp             TEEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTT-SCEEEESSEEEEC--
T ss_pred             CEEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCC-CCEEecccccceecc
Confidence            7889999999999999887   469999999999999999999999999999999999999998 799999999998654


Q ss_pred             CC-CcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhcc
Q 014406          272 PG-KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH  350 (425)
Q Consensus       272 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~  350 (425)
                      .. ......+||+.|||||++.+ ..|+.++||||+||++|||++|+.|| .+.+..+.+..+.+.  .           
T Consensus       178 ~~~~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyemltG~~PF-~~~~~~~~~~~i~~~--~-----------  242 (304)
T 3ubd_A          178 DHEKKAYSFCGTVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGTLPF-QGKDRKETMTMILKA--K-----------  242 (304)
T ss_dssp             ---CCCCSCCCCGGGCCHHHHHT-SCCCTHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHC--C-----------
T ss_pred             CCCccccccccCcccCCHHHhcc-CCCCCCCcccchHHHHHHHHhCCCCC-CCcCHHHHHHHHHcC--C-----------
Confidence            33 34456789999999999987 78999999999999999999999998 344444444444320  0           


Q ss_pred             CCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcC-----HHHHhcCCCCcccccchhc
Q 014406          351 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT-----AREAMAHPYFAQVRAAESS  421 (425)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpt-----a~elL~hp~~~~~~~~~~~  421 (425)
                      .                        ..+..+|+++++||++||+.||++|||     ++|+++||||++++|....
T Consensus       243 ~------------------------~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw~~l~  294 (304)
T 3ubd_A          243 L------------------------GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNKLY  294 (304)
T ss_dssp             C------------------------CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCHHHHH
T ss_pred             C------------------------CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCCHHHHH
Confidence            0                        011237999999999999999999998     5799999999999886553

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.8e-59  Score=455.85  Aligned_cols=288  Identities=28%  Similarity=0.547  Sum_probs=228.5

Q ss_pred             cCCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcC---
Q 014406          121 WGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQ---  192 (425)
Q Consensus       121 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~---  192 (425)
                      +...++|++++.||+|+||+||+|.+..+|+.||||+++..     ..+.+.+|+.+|+++ +|||||++++++...   
T Consensus        50 ~~i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~  128 (398)
T 4b99_A           50 FDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHF-KHDNIIAIKDILRPTVPY  128 (398)
T ss_dssp             CCCCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSSCT
T ss_pred             CCCCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhc-CCCCcceEeeeeeccccc
Confidence            33467899999999999999999999999999999999743     235678999999999 999999999998643   


Q ss_pred             -CCCccEEEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccc
Q 014406          193 -HSKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE  268 (425)
Q Consensus       193 -~~~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~  268 (425)
                       +...+|+||||++| +|..++   ..+++..++.++.||+.||+|||++|||||||||+|||++.+ +.+||+|||+|+
T Consensus       129 ~~~~~~~ivmE~~~g-~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~-~~~Ki~DFGla~  206 (398)
T 4b99_A          129 GEFKSVYVVLDLMES-DLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNEN-CELKIGDFGMAR  206 (398)
T ss_dssp             TTCCCEEEEEECCSE-EHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT-CCEEECCCTTCB
T ss_pred             ccCCEEEEEEeCCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCC-CCEEEeecceee
Confidence             33678999999975 566665   459999999999999999999999999999999999999988 799999999998


Q ss_pred             cccCC-----CcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhH
Q 014406          269 FYHPG-----KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELN  343 (425)
Q Consensus       269 ~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~  343 (425)
                      .....     ......+||+.|||||++.+...++.++||||+||++|||++|+.|| .+.+..+++..|.+..|.+...
T Consensus       207 ~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF-~g~~~~~~l~~I~~~~g~p~~~  285 (398)
T 4b99_A          207 GLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLF-PGKNYVHQLQLIMMVLGTPSPA  285 (398)
T ss_dssp             CC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSS-CCSSHHHHHHHHHHHHCCCCGG
T ss_pred             ecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCC-CCCCHHHHHHHHHHhcCCCChH
Confidence            65432     23345689999999999988667899999999999999999999987 6778889999999999987644


Q ss_pred             HHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccc
Q 014406          344 AYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA  418 (425)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~  418 (425)
                      .+........ .............+|...     ...++++++|||++||++||++|||++|+|+||||++...+
T Consensus       286 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~-----~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~p  354 (398)
T 4b99_A          286 VIQAVGAERV-RAYIQSLPPRQPVPWETV-----YPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDP  354 (398)
T ss_dssp             GTC-----CH-HHHHHSSCCCCCCCHHHH-----STTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCCG
T ss_pred             Hhhhhhhhhh-hhhhhcCCCcCCCCHHHh-----CCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCCC
Confidence            3211100000 000000000111122211     22478999999999999999999999999999999987543

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=5.2e-59  Score=442.50  Aligned_cols=256  Identities=22%  Similarity=0.335  Sum_probs=212.0

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcchHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEEEe
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEY  203 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~  203 (425)
                      .+.|++.++||+|+||+||+|++..+|+.||||+++...  ...+|+.+++.+ +|||||+++++|.+.  ..+||||||
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~--~~~~E~~il~~l-~HpnIV~l~~~~~~~--~~~~ivmEy  131 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV--FRVEELVACAGL-SSPRIVPLYGAVREG--PWVNIFMEL  131 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT--CCTHHHHTTTTC-CCTTBCCEEEEEEET--TEEEEEECC
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH--hHHHHHHHHHhC-CCCCCCcEEEEEEEC--CEEEEEEec
Confidence            467999999999999999999999999999999997543  235799999999 999999999999764  678999999


Q ss_pred             ecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCc-----
Q 014406          204 VNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-----  275 (425)
Q Consensus       204 ~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~-----  275 (425)
                      ++||+|.+++   ..+++.+++.++.||+.||+|||++|||||||||+|||++.+...+||+|||+|+.......     
T Consensus       132 ~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~  211 (336)
T 4g3f_A          132 LEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLL  211 (336)
T ss_dssp             CTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC----------
T ss_pred             cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccccee
Confidence            9999999987   46999999999999999999999999999999999999998844699999999987654321     


Q ss_pred             -ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCC
Q 014406          276 -YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD  354 (425)
Q Consensus       276 -~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~  354 (425)
                       ....+||+.|||||++.+ ..|+.++|||||||++|||++|+.||. +.+..+.+..+..  +..+.            
T Consensus       212 ~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyemltG~~Pf~-~~~~~~~~~~i~~--~~~~~------------  275 (336)
T 4g3f_A          212 TGDYIPGTETHMAPEVVMG-KPCDAKVDIWSSCCMMLHMLNGCHPWT-QYFRGPLCLKIAS--EPPPI------------  275 (336)
T ss_dssp             --CCCCCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSST-TTCCSCCHHHHHH--SCCGG------------
T ss_pred             cCCccccCccccCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCcCCCC-CCCHHHHHHHHHc--CCCCc------------
Confidence             123479999999999988 789999999999999999999999984 3333333333322  01000            


Q ss_pred             hhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHH-------------hcCCCCcccccchh
Q 014406          355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA-------------MAHPYFAQVRAAES  420 (425)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~el-------------L~hp~~~~~~~~~~  420 (425)
                                          ...+..+++++.+||.+||+.||++|||+.|+             |+|||+++...+..
T Consensus       276 --------------------~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~Pr~  334 (336)
T 4g3f_A          276 --------------------REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKEPRG  334 (336)
T ss_dssp             --------------------GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCCCCC
T ss_pred             --------------------hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCCCCC
Confidence                                01123479999999999999999999999997             68999998876544

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=1.9e-57  Score=435.52  Aligned_cols=327  Identities=76%  Similarity=1.297  Sum_probs=299.6

Q ss_pred             CCCccCccccccccCCCCccCCcCCcccccCCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcchHHHHHHHH
Q 014406           92 PAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIK  171 (425)
Q Consensus        92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~  171 (425)
                      |..+.++...+.+...+..++++......++..++|++.+.||+|+||+||+|.+..+++.||+|+++....+.+.+|+.
T Consensus         3 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~   82 (330)
T 3nsz_A            3 PVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIK   82 (330)
T ss_dssp             SCCCCCSSSTTTTTTSCHHHHCGGGCCCCCEEGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCCHHHHHHHHH
T ss_pred             CCCCceeEeccccccCchhHHHhhhhhhcccCCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccchHHHHHHHH
Confidence            34456777788888888889998888888888999999999999999999999999999999999999888899999999


Q ss_pred             HHHHhcCCCCeeeEEeEEEcCCCCccEEEEEeecCCChhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceE
Q 014406          172 ILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM  251 (425)
Q Consensus       172 ~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIl  251 (425)
                      +++++.+||||+++++++.+......++||||+.+++|..++..+++..++.++.|++.||+|||++||+||||||+|||
T Consensus        83 ~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil  162 (330)
T 3nsz_A           83 ILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVM  162 (330)
T ss_dssp             HHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCCCCHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred             HHHHcCCCCCEEEeeeeeccCCCCceEEEEeccCchhHHHHHHhCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEE
Confidence            99999559999999999987667889999999999999999999999999999999999999999999999999999999


Q ss_pred             ecCCCCcEEEEeccccccccCCCcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHH
Q 014406          252 IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV  331 (425)
Q Consensus       252 l~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~  331 (425)
                      ++.+...+||+|||+++............++..|+|||++.+...++.++|||||||++|+|++|+.||+.+.++.+.+.
T Consensus       163 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~  242 (330)
T 3nsz_A          163 IDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV  242 (330)
T ss_dssp             EETTTTEEEECCCTTCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHH
T ss_pred             EcCCCCEEEEEeCCCceEcCCCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHH
Confidence            99874589999999998877666666778999999999998767799999999999999999999999999999999999


Q ss_pred             HHHHHhCCchhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCC
Q 014406          332 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY  411 (425)
Q Consensus       332 ~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~  411 (425)
                      .+.+.++.+....+.........+.............|..+........+++++.+||++||++||++|||++|+|+|||
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~  322 (330)
T 3nsz_A          243 RIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY  322 (330)
T ss_dssp             HHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGG
T ss_pred             HHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCcc
Confidence            99999999999888889999999999988888888888888888877889999999999999999999999999999999


Q ss_pred             Ccccccc
Q 014406          412 FAQVRAA  418 (425)
Q Consensus       412 ~~~~~~~  418 (425)
                      |+++.+.
T Consensus       323 f~~~~~~  329 (330)
T 3nsz_A          323 FYTVVKD  329 (330)
T ss_dssp             GTTCC--
T ss_pred             HhhhccC
Confidence            9998653

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=7.7e-58  Score=430.61  Aligned_cols=253  Identities=21%  Similarity=0.396  Sum_probs=194.5

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCC------
Q 014406          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHS------  194 (425)
Q Consensus       125 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~------  194 (425)
                      ++|++++.||+|+||+||+|++..+++.||||+++...    .+.+.+|+.+|+++ +|||||+++++|.+.+.      
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l-~HpnIV~~~~~~~~~~~~~~~~~   83 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL-EHPGIVRYFNAWLEKNTTEKLQP   83 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEEEC-------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEecCccccccc
Confidence            46999999999999999999999999999999986432    35688999999999 99999999999875432      


Q ss_pred             ----CccEEEEEeecCCChhhhcCC------CCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEec
Q 014406          195 ----KTPSLIFEYVNSTDFKVLYPT------LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDW  264 (425)
Q Consensus       195 ----~~~~lv~e~~~~~~l~~~~~~------l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Df  264 (425)
                          .++|+||||+++|+|.+++..      ..+..++.++.||+.||+|||++|||||||||+|||++.+ +.+||+||
T Consensus        84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~-~~vKl~DF  162 (299)
T 4g31_A           84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMD-DVVKVGDF  162 (299)
T ss_dssp             ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-CCEEECCC
T ss_pred             cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCC-CcEEEccC
Confidence                247899999999999988732      4556688999999999999999999999999999999988 79999999


Q ss_pred             cccccccCCCc-------------ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHH
Q 014406          265 GLAEFYHPGKE-------------YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV  331 (425)
Q Consensus       265 g~a~~~~~~~~-------------~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~  331 (425)
                      |+|+.......             ....+||+.|||||++.+ ..|+.++|||||||++|||++   ||.   +..+...
T Consensus       163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyell~---Pf~---~~~~~~~  235 (299)
T 4g31_A          163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELLY---PFS---TQMERVR  235 (299)
T ss_dssp             CCC--------------------------CCCTTSCHHHHTT-CCCCTHHHHHHHHHHHHHHHS---CCS---SHHHHHH
T ss_pred             ccceecCCCccccccccccccccccCCcccCccccCHHHHcC-CCCCCHHHHHHHHHHHHHHcc---CCC---CccHHHH
Confidence            99987654321             233579999999999987 789999999999999999996   773   2222222


Q ss_pred             HHHHHhCCchhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCC
Q 014406          332 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY  411 (425)
Q Consensus       332 ~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~  411 (425)
                      .+......            ..++.+..                     .++.+.+||++||+.||++|||+.|+|+|||
T Consensus       236 ~~~~~~~~------------~~p~~~~~---------------------~~~~~~~li~~~L~~dP~~Rps~~eil~h~~  282 (299)
T 4g31_A          236 TLTDVRNL------------KFPPLFTQ---------------------KYPCEYVMVQDMLSPSPMERPEAINIIENAV  282 (299)
T ss_dssp             HHHHHHTT------------CCCHHHHH---------------------HCHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred             HHHHHhcC------------CCCCCCcc---------------------cCHHHHHHHHHHcCCChhHCcCHHHHhcCHh
Confidence            22221111            11111111                     3677889999999999999999999999999


Q ss_pred             Ccccccch
Q 014406          412 FAQVRAAE  419 (425)
Q Consensus       412 ~~~~~~~~  419 (425)
                      |+++.++.
T Consensus       283 ~~~~~~p~  290 (299)
T 4g31_A          283 FEDLDFPG  290 (299)
T ss_dssp             GCCC----
T ss_pred             hCCCCCCC
Confidence            99988743

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.1e-56  Score=422.25  Aligned_cols=251  Identities=18%  Similarity=0.337  Sum_probs=205.5

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEc-----CCCcEEEEEEecCcc---hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCC
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINV-----NTNERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRDQHS  194 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~-----~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  194 (425)
                      ..++|.+.++||+|+||+||+|++.     .++..||||+++...   .++|.+|+++|+++ +|||||+++|+|.+  +
T Consensus        11 ~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l-~HpnIV~l~g~~~~--~   87 (299)
T 4asz_A           11 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL-QHEHIVKFYGVCVE--G   87 (299)
T ss_dssp             CGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECS--S
T ss_pred             CHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhC-CCCCCccEEEEEee--C
Confidence            4678999999999999999999865     367899999997543   46789999999999 99999999999965  4


Q ss_pred             CccEEEEEeecCCChhhhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCc
Q 014406          195 KTPSLIFEYVNSTDFKVLYP----------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRK  258 (425)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~~----------------~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~  258 (425)
                      ..++|||||+++|+|.+++.                .+++.++..++.||+.||+|||+++||||||||+|||++.+ +.
T Consensus        88 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~-~~  166 (299)
T 4asz_A           88 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGEN-LL  166 (299)
T ss_dssp             SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG-GC
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCC-Cc
Confidence            67899999999999998872                48999999999999999999999999999999999999998 78


Q ss_pred             EEEEeccccccccCCCcc---eeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHH
Q 014406          259 LRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIA  334 (425)
Q Consensus       259 ~kl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~  334 (425)
                      +||+|||+|+........   ....||+.|||||++.+ ..|+.++|||||||++|||+| |+.||. +.++.+.+..+.
T Consensus       167 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~-~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~-~~~~~~~~~~i~  244 (299)
T 4asz_A          167 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSLGVVLWEIFTYGKQPWY-QLSNNEVIECIT  244 (299)
T ss_dssp             EEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTT-TSCHHHHHHHHH
T ss_pred             EEECCcccceecCCCCceeecCceecChhhcCHHHHcC-CCCCchhhHHHHHHHHHHHHcCCCCCCC-CCCHHHHHHHHH
Confidence            999999999876543322   23468999999999987 789999999999999999998 898883 444444333332


Q ss_pred             HHhCCchhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcc
Q 014406          335 KVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ  414 (425)
Q Consensus       335 ~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~  414 (425)
                      +..                                    ....+..+++++.+|+.+||+.||++|||++|+  ++||++
T Consensus       245 ~~~------------------------------------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~~  286 (299)
T 4asz_A          245 QGR------------------------------------VLQRPRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQN  286 (299)
T ss_dssp             HTC------------------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHHH
T ss_pred             cCC------------------------------------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHHH
Confidence            200                                    001123479999999999999999999999999  457776


Q ss_pred             ccc
Q 014406          415 VRA  417 (425)
Q Consensus       415 ~~~  417 (425)
                      +..
T Consensus       287 ~~~  289 (299)
T 4asz_A          287 LAK  289 (299)
T ss_dssp             HHH
T ss_pred             HHh
Confidence            543

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.6e-55  Score=415.98  Aligned_cols=245  Identities=18%  Similarity=0.306  Sum_probs=202.2

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEc-----CCCcEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCC
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINV-----NTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH  193 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~-----~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  193 (425)
                      ..+++++.++||+|+||+||+|...     .+++.||||+++..    ..++|.+|+.+++++ +|||||+++|+|.+  
T Consensus        24 ~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l-~HpNIV~l~g~~~~--  100 (308)
T 4gt4_A           24 SLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARL-QHPNVVCLLGVVTK--  100 (308)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHC-CCTTBCCEEEEECS--
T ss_pred             CHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhC-CCCCCCCcceEEEE--
Confidence            4567889999999999999999853     46789999999643    346899999999999 99999999999965  


Q ss_pred             CCccEEEEEeecCCChhhhc-------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecC
Q 014406          194 SKTPSLIFEYVNSTDFKVLY-------------------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH  254 (425)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~-------------------~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~  254 (425)
                      ...++||||||++|+|.+++                   ..+++.++..++.||+.||+|||+++||||||||+|||++.
T Consensus       101 ~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~  180 (308)
T 4gt4_A          101 DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYD  180 (308)
T ss_dssp             SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECC
Confidence            46789999999999999887                   23889999999999999999999999999999999999998


Q ss_pred             CCCcEEEEeccccccccCCC---cceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHH
Q 014406          255 ELRKLRLIDWGLAEFYHPGK---EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQL  330 (425)
Q Consensus       255 ~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~  330 (425)
                      + +.+||+|||+|+......   ......||+.|||||++.+ ..|+.++|||||||++|||+| |..|| .+.++.+.+
T Consensus       181 ~-~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~-~~~s~ksDVwSfGvvl~El~t~g~~Pf-~~~~~~~~~  257 (308)
T 4gt4_A          181 K-LNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMY-GKFSIDSDIWSYGVVLWEVFSYGLQPY-CGYSNQDVV  257 (308)
T ss_dssp             G-GCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTT-TTCCHHHHH
T ss_pred             C-CCEEECCcccceeccCCCceeEecccccCCcccCHHHHhC-CCCCccchhhhHHHHHHHHHhCCCCCC-CCCCHHHHH
Confidence            8 789999999998664332   2234578999999999987 789999999999999999998 78887 444444433


Q ss_pred             HHHHHHhCCchhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcC
Q 014406          331 VKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  409 (425)
Q Consensus       331 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~h  409 (425)
                      ..+...            .                        ....+..+++++.+|+.+||+.||++|||++|++++
T Consensus       258 ~~i~~~------------~------------------------~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~  300 (308)
T 4gt4_A          258 EMIRNR------------Q------------------------VLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR  300 (308)
T ss_dssp             HHHHTT------------C------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHcC------------C------------------------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            332110            0                        001123478999999999999999999999999875

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=3.1e-55  Score=417.88  Aligned_cols=245  Identities=16%  Similarity=0.313  Sum_probs=196.9

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEc-----CCCcEEEEEEecCcc---hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCC
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINV-----NTNERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRDQHS  194 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~-----~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  194 (425)
                      ..++|.+.++||+|+||+||+|++.     .+++.||||+++...   .++|.+|+++|+++ +|||||+++|+|.+  .
T Consensus        39 ~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l-~HpnIV~l~g~~~~--~  115 (329)
T 4aoj_A           39 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTML-QHQHIVRFFGVCTE--G  115 (329)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECS--S
T ss_pred             CHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEE--C
Confidence            4578999999999999999999865     368899999997543   46789999999999 99999999999965  4


Q ss_pred             CccEEEEEeecCCChhhhcC------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCC
Q 014406          195 KTPSLIFEYVNSTDFKVLYP------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEL  256 (425)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~~------------------~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~  256 (425)
                      ..++|||||+++|+|.+++.                  .+++.++..|+.||+.||+|||+++||||||||+|||++.+ 
T Consensus       116 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~-  194 (329)
T 4aoj_A          116 RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQG-  194 (329)
T ss_dssp             SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETT-
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCC-
Confidence            67899999999999998762                  38899999999999999999999999999999999999998 


Q ss_pred             CcEEEEeccccccccCCCc---ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHH
Q 014406          257 RKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVK  332 (425)
Q Consensus       257 ~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~  332 (425)
                      +.+||+|||+|+.......   .....||+.|||||++.+ ..|+.++|||||||++|||+| |+.||. +.++.+.+..
T Consensus       195 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~-~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~-~~~~~~~~~~  272 (329)
T 4aoj_A          195 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY-RKFTTESDVWSFGVVLWEIFTYGKQPWY-QLSNTEAIDC  272 (329)
T ss_dssp             TEEEECCCC----------------CCCCGGGCCHHHHTT-CCCCHHHHHHHHHHHHHHHHTTSCCTTC-SSCHHHHHHH
T ss_pred             CcEEEcccccceeccCCCcceecCcccccccccChhhhcC-CCCCccccccchHHHHHHHHcCCCCCCC-CCCHHHHHHH
Confidence            7999999999987644332   234578999999999987 789999999999999999999 899984 3344443333


Q ss_pred             HHHHhCCchhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcC
Q 014406          333 IAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  409 (425)
Q Consensus       333 ~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~h  409 (425)
                      +.+..                                    ..+.+..+++++.+|+.+||+.||++|||++|++++
T Consensus       273 i~~g~------------------------------------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~  313 (329)
T 4aoj_A          273 ITQGR------------------------------------ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR  313 (329)
T ss_dssp             HHHTC------------------------------------CCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred             HHcCC------------------------------------CCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            32200                                    001123479999999999999999999999999864

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.4e-55  Score=414.84  Aligned_cols=248  Identities=15%  Similarity=0.314  Sum_probs=197.6

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCcc
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (425)
                      ..+++++.++||+|+||+||+|++.   ..||||+++..     ..+.|.+|+.+++++ +|||||+++|++.+   ..+
T Consensus        34 ~~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l-~HpNIV~l~g~~~~---~~~  106 (307)
T 3omv_A           34 EASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKT-RHVNILLFMGYMTK---DNL  106 (307)
T ss_dssp             CTTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECS---SSC
T ss_pred             cHHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEC---CeE
Confidence            4678889999999999999999753   35999998632     236789999999999 99999999999854   457


Q ss_pred             EEEEEeecCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCC
Q 014406          198 SLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (425)
Q Consensus       198 ~lv~e~~~~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~  273 (425)
                      +|||||+++|+|.+++    ..+++.++..|+.||+.||+|||+++||||||||+|||++.+ +.+||+|||+|+.....
T Consensus       107 ~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~-~~~Ki~DFGla~~~~~~  185 (307)
T 3omv_A          107 AIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEG-LTVKIGDFGLATVKSRW  185 (307)
T ss_dssp             EEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETT-EEEEECCCSSCBC----
T ss_pred             EEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCC-CcEEEeeccCceecccC
Confidence            8999999999999887    359999999999999999999999999999999999999988 79999999999865432


Q ss_pred             ---CcceeeccCCCccCcccccCC--CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh-CCchhHHHHh
Q 014406          274 ---KEYNVRVASRYFKGPELLVDL--QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL-GTDELNAYLN  347 (425)
Q Consensus       274 ---~~~~~~~~t~~y~aPE~~~~~--~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~l-g~~~~~~~~~  347 (425)
                         ......+||+.|||||++.+.  ..|+.++|||||||++|||+||+.||. +.++.+.+..+...- ..+.      
T Consensus       186 ~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~-~~~~~~~~~~~~~~~~~~p~------  258 (307)
T 3omv_A          186 SGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYS-HINNRDQIIFMVGRGYASPD------  258 (307)
T ss_dssp             --------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTT-TCCCHHHHHHHHHTTCCCCC------
T ss_pred             CcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCC-CCChHHHHHHHHhcCCCCCC------
Confidence               223456899999999998642  468999999999999999999999983 444444444332210 0000      


Q ss_pred             hccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHH------hcCCC
Q 014406          348 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA------MAHPY  411 (425)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~el------L~hp~  411 (425)
                                                .......+++++.+|+.+||+.||++|||++|+      |+|++
T Consensus       259 --------------------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~l  302 (307)
T 3omv_A          259 --------------------------LSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSL  302 (307)
T ss_dssp             --------------------------STTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTC
T ss_pred             --------------------------cccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccC
Confidence                                      011123478999999999999999999999876      56665

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=9e-55  Score=444.70  Aligned_cols=258  Identities=24%  Similarity=0.440  Sum_probs=221.3

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc---hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEE
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (425)
                      .++|++++.||+|+||+||+|.++.+|+.||+|++....   .+.+.+|+.+|+.+ +||||++++++|.+.  ..+|+|
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~--~~~~iv  232 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVL-RHPTLVNLHDAFEDD--NEMVMI  232 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHT-CCTTBCCEEEEEECS--SEEEEE
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhC-CCCCCCeEEEEEEEC--CEEEEE
Confidence            368999999999999999999999999999999987543   45688999999999 999999999999654  789999


Q ss_pred             EEeecCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCC-CCcEEEEeccccccccCCCc
Q 014406          201 FEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE-LRKLRLIDWGLAEFYHPGKE  275 (425)
Q Consensus       201 ~e~~~~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~-~~~~kl~Dfg~a~~~~~~~~  275 (425)
                      ||||+||+|.+++    ..+++.+++.++.||+.||+|||++||+||||||+|||++.+ .+.+||+|||+|+.......
T Consensus       233 ~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~  312 (573)
T 3uto_A          233 YEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS  312 (573)
T ss_dssp             EECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSE
T ss_pred             EeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCc
Confidence            9999999998876    248999999999999999999999999999999999999864 36899999999998887777


Q ss_pred             ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCCh
Q 014406          276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP  355 (425)
Q Consensus       276 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~  355 (425)
                      ....+||+.|||||++.+ ..|+.++||||+||++|+|++|..|| .+.+..+.+..+......             +  
T Consensus       313 ~~~~~GT~~y~APEv~~~-~~y~~~~DiWSlGvilyeml~G~~Pf-~~~~~~~~~~~i~~~~~~-------------~--  375 (573)
T 3uto_A          313 VKVTTGTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPF-GGENDDETLRNVKSCDWN-------------M--  375 (573)
T ss_dssp             EEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSS-CCSSHHHHHHHHHTTCCC-------------C--
T ss_pred             eeeeEECccccCHHHhCC-CCCCcHHHHHHHHHHHHHHHHCCCCC-CCcCHHHHHHHHHhCCCC-------------C--
Confidence            778899999999999988 78999999999999999999999998 444444555444321100             0  


Q ss_pred             hhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccch
Q 014406          356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE  419 (425)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~~  419 (425)
                                        .......+|+++++||++||++||++|||++|+|+||||+...+..
T Consensus       376 ------------------~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~~  421 (573)
T 3uto_A          376 ------------------DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPG  421 (573)
T ss_dssp             ------------------CSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCCTT
T ss_pred             ------------------CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCCCC
Confidence                              0111123799999999999999999999999999999999876654

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1e-54  Score=442.79  Aligned_cols=259  Identities=25%  Similarity=0.398  Sum_probs=212.4

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHH---HHHHHHhcCCCCeeeEEeEEEcCC
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKRE---IKILQNLCGGPNVVKLLDIVRDQH  193 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E---~~~l~~l~~h~niv~l~~~~~~~~  193 (425)
                      ..++|++++.||+|+||+||+|++..+|+.||||++++.      ......+|   +.+++.+ +|||||+++++|.+. 
T Consensus       187 slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~-~HP~IV~l~~~f~~~-  264 (689)
T 3v5w_A          187 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG-DCPFIVCMSYAFHTP-  264 (689)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSS-CCTTBCCEEEEEECS-
T ss_pred             chHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhC-CCCCEeEEEEEEEEC-
Confidence            357899999999999999999999999999999999642      22334455   4445555 899999999999664 


Q ss_pred             CCccEEEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccc
Q 014406          194 SKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  270 (425)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~  270 (425)
                       ..+|+||||++||+|..++   ..+++..++.|+.||+.||+|||++|||||||||+||||+.+ +.+||+|||+|+..
T Consensus       265 -~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~-G~vKL~DFGlA~~~  342 (689)
T 3v5w_A          265 -DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEH-GHVRISDLGLACDF  342 (689)
T ss_dssp             -SEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTT-SCEEECCCTTCEEC
T ss_pred             -CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCC-CCEEecccceeeec
Confidence             7899999999999999887   469999999999999999999999999999999999999998 89999999999876


Q ss_pred             cCCCcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhcc
Q 014406          271 HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH  350 (425)
Q Consensus       271 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~  350 (425)
                      ... ...+.+||+.|||||++.+...|+.++||||+||++|||++|+.||..... .+........+          .. 
T Consensus       343 ~~~-~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~-~~~~~i~~~i~----------~~-  409 (689)
T 3v5w_A          343 SKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT-KDKHEIDRMTL----------TM-  409 (689)
T ss_dssp             SSC-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGC-CCHHHHHHHHH----------HC-
T ss_pred             CCC-CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHhhc----------CC-
Confidence            543 345579999999999997546799999999999999999999999953221 11111111100          00 


Q ss_pred             CCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcC-----HHHHhcCCCCcccccchhc
Q 014406          351 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT-----AREAMAHPYFAQVRAAESS  421 (425)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpt-----a~elL~hp~~~~~~~~~~~  421 (425)
                                             ....+..+|+++++||++||+.||++|++     ++|+++||||++++|....
T Consensus       410 -----------------------~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~~l~  462 (689)
T 3v5w_A          410 -----------------------AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVF  462 (689)
T ss_dssp             -----------------------CCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHHHHH
T ss_pred             -----------------------CCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCHHHHH
Confidence                                   00112337999999999999999999998     7999999999999987653

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=3e-54  Score=414.34  Aligned_cols=248  Identities=21%  Similarity=0.361  Sum_probs=203.9

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCC-----CcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCC
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNT-----NERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQH  193 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~-----~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  193 (425)
                      ..++|++.+.||+|+||+||+|.+..+     ++.||||.++...    .+.+.+|+.+|.++.+|||||+++|+|..+ 
T Consensus        62 ~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~-  140 (353)
T 4ase_A           62 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP-  140 (353)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT-
T ss_pred             cHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec-
Confidence            468899999999999999999987654     3689999997532    356889999999996569999999999643 


Q ss_pred             CCccEEEEEeecCCChhhhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecC
Q 014406          194 SKTPSLIFEYVNSTDFKVLYP-------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH  254 (425)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~~-------------------~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~  254 (425)
                      +..+++|||||++|+|.+++.                   .+++.++..++.||+.||+|||+++||||||||+|||++.
T Consensus       141 ~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~  220 (353)
T 4ase_A          141 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE  220 (353)
T ss_dssp             TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred             CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCC
Confidence            356899999999999998872                   2789999999999999999999999999999999999998


Q ss_pred             CCCcEEEEeccccccccCCCcc---eeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHH
Q 014406          255 ELRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQL  330 (425)
Q Consensus       255 ~~~~~kl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~  330 (425)
                      + +.+||+|||+|+........   ....||+.|||||++.+ ..|+.++|||||||++|||+| |+.||. +.+..+.+
T Consensus       221 ~-~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~-~~y~~ksDVwS~Gv~l~El~t~G~~Pf~-~~~~~~~~  297 (353)
T 4ase_A          221 K-NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYP-GVKIDEEF  297 (353)
T ss_dssp             G-GCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSST-TCCCSHHH
T ss_pred             C-CCEEECcchhhhhcccCCCceeeccccccccccCHHHHhc-CCCCCcccEeehHHHHHHHHhCCCCCCC-CCCHHHHH
Confidence            8 79999999999876544332   33578999999999987 789999999999999999998 888884 33333333


Q ss_pred             HHHHHHhCCchhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcC
Q 014406          331 VKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  409 (425)
Q Consensus       331 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~h  409 (425)
                      ...... |          .                        ....+..+++++.+|+.+||+.||++|||++|+++|
T Consensus       298 ~~~i~~-g----------~------------------------~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~  341 (353)
T 4ase_A          298 CRRLKE-G----------T------------------------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  341 (353)
T ss_dssp             HHHHHH-T----------C------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHc-C----------C------------------------CCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            322210 0          0                        011123378999999999999999999999999998

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=3.2e-51  Score=385.68  Aligned_cols=279  Identities=30%  Similarity=0.563  Sum_probs=226.7

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc-----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEE
Q 014406          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (425)
Q Consensus       125 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (425)
                      ++|++.+.||+|+||+||+|.+..+++.||+|++....     ...+.+|+.+++++ +||||+++++++.+.  ...++
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~--~~~~l   78 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-KHKNIVRLHDVLHSD--KKLTL   78 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTC-CCTTBCCEEEEEEET--TEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcC-CCCCEeeEEeEEEeC--CEEEE
Confidence            58999999999999999999999999999999996432     36688999999999 899999999999754  67899


Q ss_pred             EEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCC-Cc
Q 014406          200 IFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-KE  275 (425)
Q Consensus       200 v~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~-~~  275 (425)
                      ||||++++.+..+.   ..+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++..... ..
T Consensus        79 v~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~  157 (292)
T 3o0g_A           79 VFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRN-GELKLANFGLARAFGIPVRC  157 (292)
T ss_dssp             EEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-SCEEECCCTTCEECCSCCSC
T ss_pred             EEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC-CCEEEeecccceecCCcccc
Confidence            99999987665553   469999999999999999999999999999999999999988 79999999999876432 33


Q ss_pred             ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCCh
Q 014406          276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP  355 (425)
Q Consensus       276 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~  355 (425)
                      .....+|..|+|||++.+...++.++|||||||++|+|++|..||+.+.+..+.+..+.+.++.+....+........  
T Consensus       158 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~--  235 (292)
T 3o0g_A          158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD--  235 (292)
T ss_dssp             CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT--
T ss_pred             ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccc--
Confidence            345678999999999987555899999999999999999999999998888888999888888765433211111000  


Q ss_pred             hhHHHhcccCCCCc-cccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccc
Q 014406          356 QLDALVGRHSRKPW-SKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR  416 (425)
Q Consensus       356 ~~~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~  416 (425)
                             ....... ...........+++++++|+++||++||++|||++|+|+||||++..
T Consensus       236 -------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  290 (292)
T 3o0g_A          236 -------YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC  290 (292)
T ss_dssp             -------CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC-
T ss_pred             -------ccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCC
Confidence                   0000000 00011122234789999999999999999999999999999999864

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=3.2e-51  Score=409.80  Aligned_cols=286  Identities=26%  Similarity=0.478  Sum_probs=224.6

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCC----
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH----  193 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~----  193 (425)
                      ..++|++++.||+|+||+||+|.+..+++.||||++...     ..+.+.+|+.+++.+ +||||+++++++....    
T Consensus        60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~~  138 (464)
T 3ttj_A           60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIISLLNVFTPQKTLEE  138 (464)
T ss_dssp             EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCCSTTT
T ss_pred             ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhC-CCCCCCcEEEEEccCCcccc
Confidence            468999999999999999999999999999999999643     245688999999999 9999999999996542    


Q ss_pred             CCccEEEEEeecCCChhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCC
Q 014406          194 SKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (425)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~  273 (425)
                      ...+++||||++++.+..+...+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++.....
T Consensus       139 ~~~~~lv~E~~~~~l~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~-~~~kl~DFG~a~~~~~~  217 (464)
T 3ttj_A          139 FQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-CTLKILDFGLARTAGTS  217 (464)
T ss_dssp             CCEEEEEEECCSEEHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-SCEEECCCCCC-----C
T ss_pred             CCeEEEEEeCCCCCHHHHHhhcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCC-CCEEEEEEEeeeecCCC
Confidence            24579999999998777777789999999999999999999999999999999999999998 79999999999887665


Q ss_pred             CcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCC
Q 014406          274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL  353 (425)
Q Consensus       274 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~  353 (425)
                      ......+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.|| .+.+..+++..+.+.+|.+....+. .    .
T Consensus       218 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pF-~g~~~~~~~~~i~~~lg~p~~~~~~-~----~  290 (464)
T 3ttj_A          218 FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILF-PGRDYIDQWNKVIEQLGTPCPEFMK-K----L  290 (464)
T ss_dssp             CCC----CCCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCSCCHHHHT-T----S
T ss_pred             cccCCCcccccccCHHHHcC-CCCCHHHHHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHhcCCCCHHHHH-H----c
Confidence            55667789999999999988 68999999999999999999999987 6778888999999999987554321 1    1


Q ss_pred             ChhhHHHhcccC---CCCcccccccc-------CCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCccccc
Q 014406          354 DPQLDALVGRHS---RKPWSKFINAD-------NQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA  417 (425)
Q Consensus       354 ~~~~~~~~~~~~---~~~~~~~~~~~-------~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~  417 (425)
                      ............   ...+.......       .....++++++||++||++||++|||++|+|+||||+....
T Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~~  364 (464)
T 3ttj_A          291 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYD  364 (464)
T ss_dssp             CHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCC
T ss_pred             chhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhccC
Confidence            111111111110   01111111000       00012567999999999999999999999999999986543

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1.2e-51  Score=389.96  Aligned_cols=265  Identities=18%  Similarity=0.196  Sum_probs=190.8

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcchHHHHHHH--HHHHHhcCCCCeeeEEeEEEcCCC--CccEEE
Q 014406          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREI--KILQNLCGGPNVVKLLDIVRDQHS--KTPSLI  200 (425)
Q Consensus       125 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~--~~l~~l~~h~niv~l~~~~~~~~~--~~~~lv  200 (425)
                      .+|.+.++||+|+||+||+|++  +|+.||||+++....+.+..|.  ..+.++ +|||||+++++|.+++.  ..++||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l-~HpNIv~l~g~~~~~~~~~~~~~lV   79 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVML-RHENILGFIAADNKDNGTWTQLWLV   79 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhhHHHHHHHHHHhcC-CCCCCCcEEEEEEecCCCceEEEEE
Confidence            4688999999999999999976  5899999999877666655554  445577 89999999999986543  357999


Q ss_pred             EEeecCCChhhhc--CCCCHHHHHHHHHHHHHHHHHHHHC--------CceeecCCCCceEecCCCCcEEEEeccccccc
Q 014406          201 FEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQ--------GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  270 (425)
Q Consensus       201 ~e~~~~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~LH~~--------~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~  270 (425)
                      |||+++|+|.+++  ..+++..+..++.|++.||+|||++        +||||||||+|||++.+ +.+||+|||+|+..
T Consensus        80 ~Ey~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~-~~~Ki~DFGla~~~  158 (303)
T 3hmm_A           80 SDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN-GTCCIADLGLAVRH  158 (303)
T ss_dssp             EECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTT-SCEEECCCTTCEEE
T ss_pred             ecCCCCCcHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCC-CCEEEEeCCCCccc
Confidence            9999999999987  5689999999999999999999987        99999999999999998 79999999999876


Q ss_pred             cCCCcc-----eeeccCCCccCcccccCCC-----CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCc
Q 014406          271 HPGKEY-----NVRVASRYFKGPELLVDLQ-----DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTD  340 (425)
Q Consensus       271 ~~~~~~-----~~~~~t~~y~aPE~~~~~~-----~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~  340 (425)
                      ......     ...+||+.|||||++.+..     .++.++|||||||++|||+||..||....+.......+  ....+
T Consensus       159 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~--~~~~~  236 (303)
T 3hmm_A          159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL--VPSDP  236 (303)
T ss_dssp             ETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTT--SCSSC
T ss_pred             cCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhc--ccccc
Confidence            544322     2357999999999997632     36779999999999999999987763221110000000  00000


Q ss_pred             hhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcC
Q 014406          341 ELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  409 (425)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~h  409 (425)
                      ......           ........+....   ........++.+.+|+.+||+.||++|||+.|+++.
T Consensus       237 ~~~~~~-----------~~~~~~~~rp~~p---~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  291 (303)
T 3hmm_A          237 SVEEMR-----------KVVCEQKLRPNIP---NRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             CHHHHH-----------HHHTTSCCCCCCC---GGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             hHHHHH-----------HHHhcccCCCCCC---ccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence            000000           0000000000000   000011134578899999999999999999999875

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1e-50  Score=397.79  Aligned_cols=291  Identities=28%  Similarity=0.564  Sum_probs=220.0

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccE
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (425)
                      .++|++++.||+|+||+||+|.+..+++.||||++...     ....+.+|+.++.++.+||||+++++++...+...+|
T Consensus         8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~   87 (388)
T 3oz6_A            8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY   87 (388)
T ss_dssp             HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred             cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence            47899999999999999999999999999999998532     2356779999999995599999999999876667899


Q ss_pred             EEEEeecCCChhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCC---
Q 014406          199 LIFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG---  273 (425)
Q Consensus       199 lv~e~~~~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~---  273 (425)
                      +||||+++ +|..++  ..+++..+..++.||+.||+|||+.||+||||||+|||++.+ +.+||+|||+|+.....   
T Consensus        88 lv~e~~~~-~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~-~~~kl~DFG~a~~~~~~~~~  165 (388)
T 3oz6_A           88 LVFDYMET-DLHAVIRANILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAE-CHVKVADFGLSRSFVNIRRV  165 (388)
T ss_dssp             EEEECCSE-EHHHHHHHTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-CCEEECCCTTCEESSSCCCC
T ss_pred             EEecccCc-CHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCC-CCEEecCCcccccccccccc
Confidence            99999985 666655  458999999999999999999999999999999999999998 79999999999765321   


Q ss_pred             -------------------CcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHH
Q 014406          274 -------------------KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA  334 (425)
Q Consensus       274 -------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~  334 (425)
                                         ......+||+.|+|||++.+...++.++|||||||++|||++|+.|| .+.+..+++..+.
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf-~~~~~~~~~~~i~  244 (388)
T 3oz6_A          166 TNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIF-PGSSTMNQLERII  244 (388)
T ss_dssp             CCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHH
T ss_pred             cccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHH
Confidence                               11234578999999999987678999999999999999999999887 6777888999999


Q ss_pred             HHhCCchhHHHHhhccCCCChhh-HHHhccc--CCCCccccc--------cccCCCCCCHHHHHHHHHcccCCcCCCcCH
Q 014406          335 KVLGTDELNAYLNKYHLELDPQL-DALVGRH--SRKPWSKFI--------NADNQHLVSPEAIDFLDKLLRYDHQDRLTA  403 (425)
Q Consensus       335 ~~lg~~~~~~~~~~~~~~~~~~~-~~~~~~~--~~~~~~~~~--------~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta  403 (425)
                      ..+|.+....... ........+ ..+....  ....+....        .......+++++.+||++||++||++|||+
T Consensus       245 ~~~~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~  323 (388)
T 3oz6_A          245 GVIDFPSNEDVES-IQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISA  323 (388)
T ss_dssp             HHHCCCCHHHHHT-SCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred             HhcCCCCHHHHHh-ccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCH
Confidence            9998876554321 111111111 1100000  000011000        111223478999999999999999999999


Q ss_pred             HHHhcCCCCcccccc
Q 014406          404 REAMAHPYFAQVRAA  418 (425)
Q Consensus       404 ~elL~hp~~~~~~~~  418 (425)
                      +|+|+||||+.....
T Consensus       324 ~e~l~Hp~~~~~~~~  338 (388)
T 3oz6_A          324 NDALKHPFVSIFHNP  338 (388)
T ss_dssp             HHHTTSTTTTTTCCG
T ss_pred             HHHhCCHHHHHhcCC
Confidence            999999999876543

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1.9e-50  Score=391.32  Aligned_cols=258  Identities=28%  Similarity=0.487  Sum_probs=217.6

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc---------hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCC
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK---------KKKIKREIKILQNLCGGPNVVKLLDIVRDQH  193 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~---------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  193 (425)
                      ..++|++.+.||+|+||+||+|.+..+|+.||+|+++...         .+.+.+|+.+++++ +||||++++++|.+. 
T Consensus        10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~-   87 (361)
T 2yab_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQV-LHPNIITLHDVYENR-   87 (361)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTC-CCTTBCCEEEEEECS-
T ss_pred             hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhC-CCcCCCcEEEEEEeC-
Confidence            3678999999999999999999999999999999996432         36789999999999 899999999999654 


Q ss_pred             CCccEEEEEeecCCChhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCC---cEEEEecccc
Q 014406          194 SKTPSLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELR---KLRLIDWGLA  267 (425)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~~---~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~---~~kl~Dfg~a  267 (425)
                       ...++||||+.+++|.+++.   .+++..+..++.||+.||.|||++||+||||||+|||++.+..   .+||+|||++
T Consensus        88 -~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a  166 (361)
T 2yab_A           88 -TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA  166 (361)
T ss_dssp             -SEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred             -CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence             67899999999999998873   4899999999999999999999999999999999999987632   7999999999


Q ss_pred             ccccCCCcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHh
Q 014406          268 EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLN  347 (425)
Q Consensus       268 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~  347 (425)
                      +............||+.|+|||++.+ ..++.++|||||||++|+|++|..||. +.+..+.+..+....          
T Consensus       167 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~~ll~g~~Pf~-~~~~~~~~~~i~~~~----------  234 (361)
T 2yab_A          167 HEIEDGVEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANITAVS----------  234 (361)
T ss_dssp             EECCTTCCCCCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSC-CSSHHHHHHHHHTTC----------
T ss_pred             eEcCCCCccccCCCCccEECchHHcC-CCCCccccHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHhcC----------
Confidence            88766655666789999999999977 789999999999999999999999984 333344444332211          


Q ss_pred             hccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccc
Q 014406          348 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA  418 (425)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~  418 (425)
                         ..+...                    ....+++++++||++||+.||++|||++|+|+||||+.+.+.
T Consensus       235 ---~~~~~~--------------------~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~  282 (361)
T 2yab_A          235 ---YDFDEE--------------------FFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQ  282 (361)
T ss_dssp             ---CCCCHH--------------------HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCSSHH
T ss_pred             ---CCCCch--------------------hccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCCchh
Confidence               001100                    012368999999999999999999999999999999987653

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1.5e-50  Score=387.42  Aligned_cols=252  Identities=22%  Similarity=0.453  Sum_probs=213.6

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccE
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (425)
                      .++|++.+.||+|+||+||+|.+..+++.||||++...     ..+.+.+|+.+++.+ +||||+++++++...  ...+
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~--~~~~   90 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKIL-NHPNIVKLFEVIETE--KTLY   90 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEECS--SEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEEC--CEEE
Confidence            56899999999999999999999999999999998643     235678999999999 899999999999654  6789


Q ss_pred             EEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCc
Q 014406          199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (425)
Q Consensus       199 lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~  275 (425)
                      +||||+++++|.+++   ..+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++.......
T Consensus        91 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~-~~~kl~DFG~a~~~~~~~~  169 (328)
T 3fe3_A           91 LIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDAD-MNIKIADFGFSNEFTVGGK  169 (328)
T ss_dssp             EEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-SCEEECSTTCCGGGSSSCG
T ss_pred             EEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCC-CCEEEeeccCceecCCCCc
Confidence            999999999998876   569999999999999999999999999999999999999988 7899999999987766666


Q ss_pred             ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCCh
Q 014406          276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP  355 (425)
Q Consensus       276 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~  355 (425)
                      ....+||+.|+|||++.+....+.++||||+||++|+|++|+.||. +.+..+....+..             ...    
T Consensus       170 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~-~~~~~~~~~~i~~-------------~~~----  231 (328)
T 3fe3_A          170 LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD-GQNLKELRERVLR-------------GKY----  231 (328)
T ss_dssp             GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHH-------------CCC----
T ss_pred             cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCC-CCCHHHHHHHHHh-------------CCC----
Confidence            6677899999999999884334589999999999999999999983 3332222222211             000    


Q ss_pred             hhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCccccc
Q 014406          356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA  417 (425)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~  417 (425)
                                          ..+..+++++.+|+++||+.||++|||++|+++||||+....
T Consensus       232 --------------------~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~  273 (328)
T 3fe3_A          232 --------------------RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHE  273 (328)
T ss_dssp             --------------------CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTCT
T ss_pred             --------------------CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCCc
Confidence                                011236899999999999999999999999999999987543

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=2.5e-50  Score=383.29  Aligned_cols=283  Identities=34%  Similarity=0.642  Sum_probs=221.5

Q ss_pred             cCCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc-----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCC
Q 014406          121 WGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (425)
Q Consensus       121 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (425)
                      .+..++|++++.||+|+||+||+|.+. +++.||+|++....     .+.+.+|+.+++++ +||||+++++++.+  ..
T Consensus        17 q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~--~~   92 (311)
T 3niz_A           17 QGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKEL-HHPNIVSLIDVIHS--ER   92 (311)
T ss_dssp             ECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHC-CCTTBCCEEEEECC--SS
T ss_pred             cchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHc-CCCCEeeeeeEEcc--CC
Confidence            345789999999999999999999874 58999999986432     35688999999999 99999999999954  47


Q ss_pred             ccEEEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccC
Q 014406          196 TPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (425)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~  272 (425)
                      ..++||||++++.+..+.   ..+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++....
T Consensus        93 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~-~~~kl~Dfg~a~~~~~  171 (311)
T 3niz_A           93 CLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSD-GALKLADFGLARAFGI  171 (311)
T ss_dssp             CEEEEEECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-CCEEECCCTTCEETTS
T ss_pred             EEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCC-CCEEEccCcCceecCC
Confidence            889999999975444333   248999999999999999999999999999999999999988 7899999999987643


Q ss_pred             C-CcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccC
Q 014406          273 G-KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL  351 (425)
Q Consensus       273 ~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~  351 (425)
                      . .......+|+.|+|||++.+...++.++|||||||++|+|++|+.|| .+.++.+.+..+...++.+....+......
T Consensus       172 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  250 (311)
T 3niz_A          172 PVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLF-PGVTDDDQLPKIFSILGTPNPREWPQVQEL  250 (311)
T ss_dssp             CCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSC-CCSSTTTHHHHHHHHHCCCCTTTSGGGTTS
T ss_pred             CcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHHCCCChHHhhhhhcc
Confidence            2 33445678999999999987567899999999999999999999887 566777788888888887654332111000


Q ss_pred             CCChhhHH-HhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCccccc
Q 014406          352 ELDPQLDA-LVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA  417 (425)
Q Consensus       352 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~  417 (425)
                         +.+.. ........++.     .....+++++++||++||++||++|||++|+|+||||+++..
T Consensus       251 ---~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  309 (311)
T 3niz_A          251 ---PLWKQRTFQVFEKKPWS-----SIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLDP  309 (311)
T ss_dssp             ---HHHHSCCCCCCCCCCHH-----HHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSCT
T ss_pred             ---chhhhcccccccCCcHH-----HhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCCc
Confidence               00000 00000111111     112347899999999999999999999999999999999864

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.3e-50  Score=391.56  Aligned_cols=257  Identities=23%  Similarity=0.408  Sum_probs=213.0

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCc
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (425)
                      ..++|++++.||+|+||+||+|++..+++.||||+++..      ....+.+|..++..+.+||||+++++++.+.  ..
T Consensus        21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~--~~   98 (353)
T 3txo_A           21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTP--DR   98 (353)
T ss_dssp             --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--SE
T ss_pred             chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeC--CE
Confidence            357899999999999999999999999999999999743      3456788999999887899999999999654  67


Q ss_pred             cEEEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccC-
Q 014406          197 PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP-  272 (425)
Q Consensus       197 ~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~-  272 (425)
                      +++||||+++++|..++   ..+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+.... 
T Consensus        99 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~-g~ikL~DFG~a~~~~~~  177 (353)
T 3txo_A           99 LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHE-GHCKLADFGMCKEGICN  177 (353)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT-SCEEECCCTTCBCSCC-
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCC-CCEEEccccceeecccC
Confidence            89999999999998877   569999999999999999999999999999999999999988 7999999999986432 


Q ss_pred             CCcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCC
Q 014406          273 GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE  352 (425)
Q Consensus       273 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~  352 (425)
                      .......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||. +.+..+.+..+...             .. 
T Consensus       178 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~-~~~~~~~~~~i~~~-------------~~-  241 (353)
T 3txo_A          178 GVTTATFCGTPDYIAPEILQE-MLYGPAVDWWAMGVLLYEMLCGHAPFE-AENEDDLFEAILND-------------EV-  241 (353)
T ss_dssp             --------CCGGGCCHHHHHH-HHCTTHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHC-------------CC-
T ss_pred             CccccccCCCcCeEChhhcCC-CCcCCccCCCcchHHHHHHHhCCCCCC-CCCHHHHHHHHHcC-------------CC-
Confidence            233455689999999999987 679999999999999999999999983 33444444443220             00 


Q ss_pred             CChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCH------HHHhcCCCCcccccchhc
Q 014406          353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA------REAMAHPYFAQVRAAESS  421 (425)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta------~elL~hp~~~~~~~~~~~  421 (425)
                                             ..+..+++++.+||++||+.||++||++      +|+++||||+++.|....
T Consensus       242 -----------------------~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w~~l~  293 (353)
T 3txo_A          242 -----------------------VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQLN  293 (353)
T ss_dssp             -----------------------CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCHHHHH
T ss_pred             -----------------------CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCHHHHh
Confidence                                   0112268999999999999999999998      899999999999886643

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=8.7e-50  Score=383.30  Aligned_cols=254  Identities=26%  Similarity=0.465  Sum_probs=215.4

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecC------cchHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCcc
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP------VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~------~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (425)
                      .++|++++.||+|+||+||+|.+..+++.||+|++++      .....+.+|+.+++.+ +||||+++++++.+.  ...
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~--~~~   80 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHPFLTALKYAFQTH--DRL   80 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CCTTBCCEEEEEECS--SEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhC-CCCcCcceEEEEEeC--CEE
Confidence            4789999999999999999999999999999999964      2346788999999999 899999999999654  678


Q ss_pred             EEEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEecccccccc-CC
Q 014406          198 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PG  273 (425)
Q Consensus       198 ~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~-~~  273 (425)
                      ++||||+++++|..++   ..+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++... ..
T Consensus        81 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~-g~vkL~DFG~a~~~~~~~  159 (337)
T 1o6l_A           81 CFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKD-GHIKITDFGLCKEGISDG  159 (337)
T ss_dssp             EEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT-SCEEECCCTTCBCSCCTT
T ss_pred             EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCC-CCEEEeeccchhhcccCC
Confidence            9999999999998776   468999999999999999999999999999999999999988 799999999998643 23


Q ss_pred             CcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCC
Q 014406          274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL  353 (425)
Q Consensus       274 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~  353 (425)
                      ......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.. .+..+....+..             ...  
T Consensus       160 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~-~~~~~~~~~i~~-------------~~~--  222 (337)
T 1o6l_A          160 ATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELILM-------------EEI--  222 (337)
T ss_dssp             CCBCCCEECGGGCCGGGGSS-SCBCTTHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHH-------------CCC--
T ss_pred             CcccccccChhhCChhhhcC-CCCCchhhcccchhHHHHHhcCCCCCCC-CCHHHHHHHHHc-------------CCC--
Confidence            34456789999999999987 7899999999999999999999999843 222222222211             000  


Q ss_pred             ChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCc-----CHHHHhcCCCCcccccchh
Q 014406          354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYFAQVRAAES  420 (425)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rp-----ta~elL~hp~~~~~~~~~~  420 (425)
                                            ..+..+++++.+||.+||+.||++||     +++|+++||||+++.|...
T Consensus       223 ----------------------~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~~~~  272 (337)
T 1o6l_A          223 ----------------------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDV  272 (337)
T ss_dssp             ----------------------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHH
T ss_pred             ----------------------CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCCHHHH
Confidence                                  01123789999999999999999999     9999999999999987654

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=1.5e-49  Score=394.71  Aligned_cols=292  Identities=29%  Similarity=0.544  Sum_probs=227.8

Q ss_pred             ccCCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCC
Q 014406          120 QWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS  194 (425)
Q Consensus       120 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  194 (425)
                      .+...++|++.+.||+|+||+||+|.+..+++.||||++...     ..+.+.+|+.+++++ +|+||+++++++.....
T Consensus        21 ~~~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~   99 (432)
T 3n9x_A           21 NVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRL-KSDYIIRLYDLIIPDDL   99 (432)
T ss_dssp             GCCCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSCT
T ss_pred             cceecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHc-CCCCcceEEEEEecCCC
Confidence            344578999999999999999999999999999999999743     235788999999999 89999999999965432


Q ss_pred             ---CccEEEEEeecCCChhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccc
Q 014406          195 ---KTPSLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE  268 (425)
Q Consensus       195 ---~~~~lv~e~~~~~~l~~~~~---~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~  268 (425)
                         ...|+||||+++ +|..++.   .+++..++.++.||+.||+|||+.||+||||||+|||++.+ +.+||+|||+++
T Consensus       100 ~~~~~~~lv~e~~~~-~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~-~~~kL~DFGla~  177 (432)
T 3n9x_A          100 LKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQD-CSVKVCDFGLAR  177 (432)
T ss_dssp             TTCCCEEEEEECCSE-EHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-CCEEECCCTTCE
T ss_pred             CcCCeEEEEEecCCc-CHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCC-CCEEEccCCCcc
Confidence               568999999885 7776653   48999999999999999999999999999999999999988 799999999998


Q ss_pred             cccCCC-----------------------cceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhC---------
Q 014406          269 FYHPGK-----------------------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFR---------  316 (425)
Q Consensus       269 ~~~~~~-----------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg---------  316 (425)
                      ......                       .....++|+.|+|||++.....++.++|||||||++|||++|         
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~  257 (432)
T 3n9x_A          178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPT  257 (432)
T ss_dssp             EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGG
T ss_pred             cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccc
Confidence            764332                       125568899999999976657899999999999999999974         


Q ss_pred             -CCCCCCCCC-----------------CHHHHHHHHHHhCCchhHHHHhhccCCCChhhHHHhcccCCCCccccccccCC
Q 014406          317 -KEPFFYGHD-----------------NHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQ  378 (425)
Q Consensus       317 -~~pf~~~~~-----------------~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  378 (425)
                       +.|+|.+.+                 ..+++..+.+.+|.+.......-    ..................  ......
T Consensus       258 ~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~----~~~~~~~~~~~~~~~~~~--~~~~~~  331 (432)
T 3n9x_A          258 NRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNI----NKPEVIKYIKLFPHRKPI--NLKQKY  331 (432)
T ss_dssp             GCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTC----CCHHHHHHHHTSCCCCCC--CHHHHS
T ss_pred             cccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhc----cCHHHHHHHHhCCCCCCC--CHHHHC
Confidence             556666654                 36788889999998776543211    111111111111111000  001111


Q ss_pred             CCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccchh
Q 014406          379 HLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAES  420 (425)
Q Consensus       379 ~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~~~  420 (425)
                      ..+++++++||++||++||++|||++|+|+||||+++++...
T Consensus       332 ~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~  373 (432)
T 3n9x_A          332 PSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKKL  373 (432)
T ss_dssp             TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCCTTT
T ss_pred             CCCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhccCccc
Confidence            347999999999999999999999999999999999877654

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=3.5e-50  Score=383.26  Aligned_cols=286  Identities=28%  Similarity=0.572  Sum_probs=212.1

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEE
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (425)
                      .++|++++.||+|+||+||+|.+..+++.||+|+++..    ..+.+.+|+.+++++ +||||+++++++.+  ....++
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~--~~~~~l   80 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKEL-KHENIVRLYDVIHT--ENKLTL   80 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTC-CBTTBCCEEEEECC--TTEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhc-CCCCcceEEEEEEE--CCeEEE
Confidence            56899999999999999999999999999999998643    236788999999999 99999999999955  467899


Q ss_pred             EEEeecCCChhhhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccc
Q 014406          200 IFEYVNSTDFKVLY---------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  270 (425)
Q Consensus       200 v~e~~~~~~l~~~~---------~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~  270 (425)
                      ||||+++ +|..++         ..+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++..
T Consensus        81 v~e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~-~~~kl~Dfg~~~~~  158 (317)
T 2pmi_A           81 VFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKR-GQLKLGDFGLARAF  158 (317)
T ss_dssp             EEECCCC-BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-CCEEECCCSSCEET
T ss_pred             EEEecCC-CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCC-CCEEECcCccceec
Confidence            9999995 666654         248999999999999999999999999999999999999988 79999999999876


Q ss_pred             cCC-CcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhc
Q 014406          271 HPG-KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY  349 (425)
Q Consensus       271 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~  349 (425)
                      ... .......+|+.|+|||++.+...++.++|||||||++|+|++|+.|| .+.+..+.+..+.+.+|.+....+....
T Consensus       159 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~  237 (317)
T 2pmi_A          159 GIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLF-PGTNDEEQLKLIFDIMGTPNESLWPSVT  237 (317)
T ss_dssp             TSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCSCCTTTCGGGG
T ss_pred             CCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHhCCCChhHhhhhh
Confidence            432 23345678999999999987567899999999999999999999998 5566677788888887765433221111


Q ss_pred             cCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccc
Q 014406          350 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA  418 (425)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~  418 (425)
                      ....   +.......................+++++.+||++||+.||++|||++|+|+||||++....
T Consensus       238 ~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~  303 (317)
T 2pmi_A          238 KLPK---YNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHH  303 (317)
T ss_dssp             GCTT---CCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC-
T ss_pred             hhhh---cccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccch
Confidence            0000   00000000111112222333344589999999999999999999999999999999987664

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=8.2e-50  Score=390.69  Aligned_cols=259  Identities=25%  Similarity=0.461  Sum_probs=215.4

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCc
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (425)
                      ..++|++++.||+|+||+||+|++..+++.||+|++++.      ..+.+.+|..++.++.+||||++++++|.+.  ..
T Consensus        50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~--~~  127 (396)
T 4dc2_A           50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE--SR  127 (396)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECS--SE
T ss_pred             ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEEC--CE
Confidence            357899999999999999999999999999999999743      2345789999999887899999999999654  68


Q ss_pred             cEEEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccc-cC
Q 014406          197 PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY-HP  272 (425)
Q Consensus       197 ~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~-~~  272 (425)
                      +++||||+++|+|..++   ..+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+.. ..
T Consensus       128 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~-g~ikL~DFGla~~~~~~  206 (396)
T 4dc2_A          128 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE-GHIKLTDYGMCKEGLRP  206 (396)
T ss_dssp             EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT-SCEEECCCTTCBCCCCT
T ss_pred             EEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCC-CCEEEeecceeeecccC
Confidence            89999999999998776   569999999999999999999999999999999999999998 79999999999863 33


Q ss_pred             CCcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCC-------HHHHHHHHHHhCCchhHHH
Q 014406          273 GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN-------HDQLVKIAKVLGTDELNAY  345 (425)
Q Consensus       273 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~-------~~~~~~~~~~lg~~~~~~~  345 (425)
                      .......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||......       .+.+.....          
T Consensus       207 ~~~~~~~~gt~~Y~aPE~l~~-~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~----------  275 (396)
T 4dc2_A          207 GDTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL----------  275 (396)
T ss_dssp             TCCBCCCCBCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHH----------
T ss_pred             CCccccccCCcccCCchhhcC-CCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHh----------
Confidence            445566789999999999987 78999999999999999999999999432111       111111100          


Q ss_pred             HhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCH------HHHhcCCCCcccccch
Q 014406          346 LNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA------REAMAHPYFAQVRAAE  419 (425)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta------~elL~hp~~~~~~~~~  419 (425)
                        ...                        ...+..+++++++||++||+.||++||++      +|+++||||++++|..
T Consensus       276 --~~~------------------------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w~~  329 (396)
T 4dc2_A          276 --EKQ------------------------IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDM  329 (396)
T ss_dssp             --HCC------------------------CCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCHHH
T ss_pred             --ccc------------------------cCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCHHH
Confidence              000                        01122378999999999999999999985      8999999999998865


Q ss_pred             hc
Q 014406          420 SS  421 (425)
Q Consensus       420 ~~  421 (425)
                      ..
T Consensus       330 l~  331 (396)
T 4dc2_A          330 ME  331 (396)
T ss_dssp             HH
T ss_pred             HH
Confidence            43

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=8.3e-50  Score=377.18  Aligned_cols=256  Identities=26%  Similarity=0.464  Sum_probs=214.4

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecC---cchHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEE
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP---VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (425)
                      .++|++.+.||+|+||+||+|.+..+++.||+|++..   ...+.+.+|+.+++.+ +||||+++++++...  ...++|
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~--~~~~lv   95 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN-KNPNIVNYLDSYLVG--DELWVV   95 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHC-CCTTBCCEEEEEEET--TEEEEE
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcC-CCCCCCeEeEEEEEC--CEEEEE
Confidence            5679999999999999999999999999999999863   3456788999999999 999999999999754  678999


Q ss_pred             EEeecCCChhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCC-cce
Q 014406          201 FEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EYN  277 (425)
Q Consensus       201 ~e~~~~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~-~~~  277 (425)
                      |||+.+++|.+++  ..+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||++....... ...
T Consensus        96 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~  174 (297)
T 3fxz_A           96 MEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRS  174 (297)
T ss_dssp             EECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-CCEEECCCTTCEECCSTTCCBC
T ss_pred             EECCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCC-CCEEEeeCCCceecCCcccccC
Confidence            9999999999887  458999999999999999999999999999999999999988 789999999998765433 334


Q ss_pred             eeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCChhh
Q 014406          278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQL  357 (425)
Q Consensus       278 ~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~  357 (425)
                      ...||+.|+|||++.+ ..++.++|||||||++|+|++|+.||. +.+..+....+... +..                 
T Consensus       175 ~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~-~~~~~~~~~~~~~~-~~~-----------------  234 (297)
T 3fxz_A          175 TMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYL-NENPLRALYLIATN-GTP-----------------  234 (297)
T ss_dssp             CCCSCGGGCCHHHHHC-SCBCTHHHHHHHHHHHHHHHHSSCTTT-TSCHHHHHHHHHHH-CSC-----------------
T ss_pred             CccCCcCccChhhhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHhC-CCC-----------------
Confidence            5689999999999987 789999999999999999999999984 23323333222211 000                 


Q ss_pred             HHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccch
Q 014406          358 DALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE  419 (425)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~~  419 (425)
                                      .......+++.+.+|+.+||+.||++|||++|+++||||+......
T Consensus       235 ----------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~~  280 (297)
T 3fxz_A          235 ----------------ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAKPLS  280 (297)
T ss_dssp             ----------------CCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCCGG
T ss_pred             ----------------CCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhcccCccc
Confidence                            0011123789999999999999999999999999999999876544

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=1.3e-49  Score=398.47  Aligned_cols=289  Identities=32%  Similarity=0.566  Sum_probs=212.5

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcC---CC
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQ---HS  194 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~---~~  194 (425)
                      ..++|++++.||+|+||+||+|.+..+++.||||++...     ..+.+.+|+.+|+++ +||||+++++++...   ..
T Consensus        51 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~  129 (458)
T 3rp9_A           51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRL-NHDHVVKVLDIVIPKDVEKF  129 (458)
T ss_dssp             SCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSCTTTC
T ss_pred             cCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhC-CCCCCCceEEEEecCCcccC
Confidence            468999999999999999999999999999999998642     235688999999999 999999999999643   22


Q ss_pred             CccEEEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEecccccccc
Q 014406          195 KTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (425)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~  271 (425)
                      ..+|+||||++ ++|..++   ..+++..++.++.||+.||+|||+.||+||||||+|||++.+ +.+||+|||+|+...
T Consensus       130 ~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~-~~~kl~DFGla~~~~  207 (458)
T 3rp9_A          130 DELYVVLEIAD-SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQD-CSVKVCDFGLARTVD  207 (458)
T ss_dssp             CCEEEEECCCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT-CCEEECCCTTCBCTT
T ss_pred             ceEEEEEeccc-cchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCC-CCEeecccccchhcc
Confidence            57899999986 4566555   348999999999999999999999999999999999999998 799999999998654


Q ss_pred             CCC----------------------------cceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhC-------
Q 014406          272 PGK----------------------------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFR-------  316 (425)
Q Consensus       272 ~~~----------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg-------  316 (425)
                      ...                            .....+||+.|+|||++.....++.++|||||||++|||++|       
T Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~  287 (458)
T 3rp9_A          208 YPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAY  287 (458)
T ss_dssp             SCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSS
T ss_pred             CccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccc
Confidence            221                            223457899999999876657799999999999999999984       


Q ss_pred             ---CCCCCCCCC--------------------CHHHHHHHHHHhCCchhHHHHhhccCCCChhhHHHhcccCCCCccccc
Q 014406          317 ---KEPFFYGHD--------------------NHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFI  373 (425)
Q Consensus       317 ---~~pf~~~~~--------------------~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  373 (425)
                         +.|+|.+.+                    +.+++..+.+.+|.+.......-.    ..................  
T Consensus       288 ~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~----~~~~~~~~~~~~~~~~~~--  361 (458)
T 3rp9_A          288 HADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALE----KEDAKRYIRIFPKREGTD--  361 (458)
T ss_dssp             GGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSS----CHHHHHHHTTSCCCCCCC--
T ss_pred             cccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcC----CHHHHHHHHhcCCCCCCC--
Confidence               344445543                    257788888999987655432110    111111111111111111  


Q ss_pred             cccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccchh
Q 014406          374 NADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAES  420 (425)
Q Consensus       374 ~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~~~  420 (425)
                      ..+....+++++++||++||++||++|||++|+|+||||+++.+...
T Consensus       362 ~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~~~  408 (458)
T 3rp9_A          362 LAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAEV  408 (458)
T ss_dssp             GGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCGGG
T ss_pred             HHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCCcc
Confidence            11122346899999999999999999999999999999999977654

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.1e-50  Score=381.36  Aligned_cols=257  Identities=25%  Similarity=0.451  Sum_probs=217.1

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc--hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEE
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (425)
                      ..++|++.+.||+|+||+||+|.+..+++.+|+|++....  ...+.+|+.+++.+ +||||+++++++.+.  ...++|
T Consensus         3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~--~~~~lv   79 (321)
T 1tki_A            3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIA-RHRNILHLHESFESM--EELVMI   79 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHS-CCTTBCCEEEEEEET--TEEEEE
T ss_pred             hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhC-CCCCCCeEeEEEecC--CEEEEE
Confidence            3678999999999999999999999999999999997543  35688999999999 999999999999664  678999


Q ss_pred             EEeecCCChhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCC-CCcEEEEeccccccccCCCc
Q 014406          201 FEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE-LRKLRLIDWGLAEFYHPGKE  275 (425)
Q Consensus       201 ~e~~~~~~l~~~~~----~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~-~~~~kl~Dfg~a~~~~~~~~  275 (425)
                      |||+++++|.+++.    .+++..+..++.|++.||.|||++||+||||||+|||++.+ .+.+||+|||+++.......
T Consensus        80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~  159 (321)
T 1tki_A           80 FEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN  159 (321)
T ss_dssp             ECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE
T ss_pred             EEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCc
Confidence            99999999988773    48999999999999999999999999999999999999872 37899999999998876666


Q ss_pred             ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCCh
Q 014406          276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP  355 (425)
Q Consensus       276 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~  355 (425)
                      .....+|+.|+|||++.+ ..++.++|||||||++|+|++|..||. +.++.+.+..+.......+.             
T Consensus       160 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~-~~~~~~~~~~i~~~~~~~~~-------------  224 (321)
T 1tki_A          160 FRLLFTAPEYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGINPFL-AETNQQIIENIMNAEYTFDE-------------  224 (321)
T ss_dssp             EEEEESCGGGSCHHHHTT-CEECHHHHHHHHHHHHHHHHHSSCTTC-CSSHHHHHHHHHHTCCCCCH-------------
T ss_pred             cccccCChhhcCcHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCc-CCCHHHHHHHHHcCCCCCCh-------------
Confidence            677789999999999977 678999999999999999999999984 33334444433321111000             


Q ss_pred             hhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCccccc
Q 014406          356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA  417 (425)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~  417 (425)
                                          .....+++++.+|+++||+.||++|||+.|+|+||||++...
T Consensus       225 --------------------~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~  266 (321)
T 1tki_A          225 --------------------EAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIE  266 (321)
T ss_dssp             --------------------HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSCGG
T ss_pred             --------------------hhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccCcc
Confidence                                001237899999999999999999999999999999987643

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=1.5e-49  Score=382.74  Aligned_cols=257  Identities=24%  Similarity=0.423  Sum_probs=217.1

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCc
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (425)
                      ..++|++.+.||+|+||+||+|++..+++.||+|+++..      ....+..|..++..+.+||||+++++++.+.  ..
T Consensus        15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~--~~   92 (345)
T 1xjd_A           15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK--EN   92 (345)
T ss_dssp             -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS--SE
T ss_pred             ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeC--CE
Confidence            468899999999999999999999999999999999742      3456788999999876899999999999654  67


Q ss_pred             cEEEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccC-
Q 014406          197 PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP-  272 (425)
Q Consensus       197 ~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~-  272 (425)
                      .++||||+++|+|..++   ..+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++.... 
T Consensus        93 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~-g~vkL~DFG~a~~~~~~  171 (345)
T 1xjd_A           93 LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKD-GHIKIADFGMCKENMLG  171 (345)
T ss_dssp             EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT-SCEEECCCTTCBCCCCT
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCC-CCEEEeEChhhhhcccC
Confidence            89999999999998887   469999999999999999999999999999999999999988 7999999999986432 


Q ss_pred             CCcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCC
Q 014406          273 GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE  352 (425)
Q Consensus       273 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~  352 (425)
                      .......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||. +.+..+.+..+..  +.           . 
T Consensus       172 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~-~~~~~~~~~~i~~--~~-----------~-  235 (345)
T 1xjd_A          172 DAKTNTFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFH-GQDEEELFHSIRM--DN-----------P-  235 (345)
T ss_dssp             TCCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHH--CC-----------C-
T ss_pred             CCcccCCCCCcccCChhhhcC-CCCCChhhhHHHHHHHHHHhcCCCCCC-CCCHHHHHHHHHh--CC-----------C-
Confidence            234456689999999999987 679999999999999999999999984 3333333333321  00           0 


Q ss_pred             CChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHH-HHhcCCCCcccccchhc
Q 014406          353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAR-EAMAHPYFAQVRAAESS  421 (425)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~-elL~hp~~~~~~~~~~~  421 (425)
                                             ..+..+++++.+||++||+.||++|||+. |+++||||+++.|....
T Consensus       236 -----------------------~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~w~~l~  282 (345)
T 1xjd_A          236 -----------------------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWEELE  282 (345)
T ss_dssp             -----------------------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCHHHHH
T ss_pred             -----------------------CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCCCHHHHh
Confidence                                   01123789999999999999999999998 99999999999876553

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=8.3e-50  Score=378.95  Aligned_cols=281  Identities=27%  Similarity=0.500  Sum_probs=219.2

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc--------hHHHHHHHHHHHHhc--CCCCeeeEEeEEEcC
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--------KKKIKREIKILQNLC--GGPNVVKLLDIVRDQ  192 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~--------~~~~~~E~~~l~~l~--~h~niv~l~~~~~~~  192 (425)
                      ..++|++.+.||+|+||+||+|.+..+++.||+|++....        ...+.+|+.+++.+.  +||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            4689999999999999999999999999999999986322        356778888888773  499999999999764


Q ss_pred             CCC---ccEEEEEeecCCChhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEec
Q 014406          193 HSK---TPSLIFEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDW  264 (425)
Q Consensus       193 ~~~---~~~lv~e~~~~~~l~~~~~-----~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Df  264 (425)
                      ...   ..++||||+.+ +|..++.     .+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+||
T Consensus        87 ~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~-~~~kl~Df  164 (308)
T 3g33_A           87 RTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSG-GTVKLADF  164 (308)
T ss_dssp             CSSSEEEEEEEEECCCC-BHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTT-SCEEECSC
T ss_pred             CCCCceeEEEEehhhhc-CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCC-CCEEEeeC
Confidence            322   57899999985 7766652     28999999999999999999999999999999999999988 79999999


Q ss_pred             cccccccCCCcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHH
Q 014406          265 GLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA  344 (425)
Q Consensus       265 g~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~  344 (425)
                      |+++............+|+.|+|||++.+ ..++.++|||||||++|+|++|+.|| .+.+..+.+..+.+.++.+....
T Consensus       165 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~  242 (308)
T 3g33_A          165 GLARIYSYQMALTPVVVTLWYRAPEVLLQ-STYATPVDMWSVGCIFAEMFRRKPLF-CGNSEADQLGKIFDLIGLPPEDD  242 (308)
T ss_dssp             SCTTTSTTCCCSGGGGCCCSSCCHHHHHT-SCCCSTHHHHHHHHHHHHTTTSSCSC-CCSSHHHHHHHHHHHHCCCCTTT
T ss_pred             ccccccCCCcccCCccccccccCchHHcC-CCCCchHHHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCChhh
Confidence            99987765556666789999999999987 67999999999999999999999887 56666777888888777655432


Q ss_pred             HHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCccccc
Q 014406          345 YLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA  417 (425)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~  417 (425)
                      +.......  .      .....  ............+++++.+||.+||++||++|||++|+|+||||++...
T Consensus       243 ~~~~~~~~--~------~~~~~--~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~~  305 (308)
T 3g33_A          243 WPRDVSLP--R------GAFPP--RGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDEG  305 (308)
T ss_dssp             SCSSCSSC--G------GGSCC--CCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC-----
T ss_pred             ccchhhcc--c------cccCC--CCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCCC
Confidence            21111000  0      00000  0000011122347899999999999999999999999999999997643

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=2.6e-49  Score=372.03  Aligned_cols=276  Identities=32%  Similarity=0.630  Sum_probs=214.4

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc-----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEE
Q 014406          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (425)
Q Consensus       125 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (425)
                      ++|++++.||+|+||+||+|.+ .+++.||+|++....     .+.+.+|+.+++++ +||||+++++++.+.  ...++
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~--~~~~l   77 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKEL-KHSNIVKLYDVIHTK--KRLVL   77 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGC-CCTTBCCEEEEEECS--SCEEE
T ss_pred             ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhc-CCCCEeeeeeEEccC--CeEEE
Confidence            5899999999999999999988 678999999986432     35788999999999 899999999999654  67899


Q ss_pred             EEEeecCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCC-C
Q 014406          200 IFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-K  274 (425)
Q Consensus       200 v~e~~~~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~-~  274 (425)
                      ||||+++ +|..++    ..+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++..... .
T Consensus        78 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~  155 (288)
T 1ob3_A           78 VFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINRE-GELKIADFGLARAFGIPVR  155 (288)
T ss_dssp             EEECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-SCEEECCTTHHHHHCC---
T ss_pred             EEEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCC-CCEEEeECccccccCcccc
Confidence            9999997 555544    458999999999999999999999999999999999999988 78999999999866432 2


Q ss_pred             cceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCC
Q 014406          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD  354 (425)
Q Consensus       275 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~  354 (425)
                      ......+|+.|+|||++.+...++.++|||||||++|+|++|+.|| .+.+..+.+..+.+.++.+....+.......  
T Consensus       156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  232 (288)
T 1ob3_A          156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLF-PGVSEADQLMRIFRILGTPNSKNWPNVTELP--  232 (288)
T ss_dssp             ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCCCCTTTSTTGGGST--
T ss_pred             ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHHCCCChhhchhhhccc--
Confidence            3345578999999999977567899999999999999999999987 4556667777787777765433221110000  


Q ss_pred             hhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCccc
Q 014406          355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV  415 (425)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~  415 (425)
                       .++.........+|     ......+++++.+||++||+.||++|||++|+|+||||++.
T Consensus       233 -~~~~~~~~~~~~~~-----~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  287 (288)
T 1ob3_A          233 -KYDPNFTVYEPLPW-----ESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN  287 (288)
T ss_dssp             -TCCTTCCCCCCCCG-----GGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred             -ccccccccccCccH-----HHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence             00000000001111     12223478999999999999999999999999999999874

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2e-49  Score=385.66  Aligned_cols=284  Identities=32%  Similarity=0.589  Sum_probs=222.7

Q ss_pred             cCCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCC-
Q 014406          121 WGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS-  194 (425)
Q Consensus       121 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~-  194 (425)
                      +...++|++++.||+|+||+||+|.+..+|+.||||++...     ..+.+.+|+.+++++ +||||+++++++..... 
T Consensus        21 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~   99 (367)
T 1cm8_A           21 WEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-RHENVIGLLDVFTPDETL   99 (367)
T ss_dssp             ECCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHC-CBTTBCCCSEEECSCSST
T ss_pred             eeecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhC-CCcCCCCceeeEecCCcc
Confidence            44578999999999999999999999999999999998542     235678999999999 89999999999975422 


Q ss_pred             ---CccEEEEEeecCCChhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEecccccc
Q 014406          195 ---KTPSLIFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (425)
Q Consensus       195 ---~~~~lv~e~~~~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~  269 (425)
                         ...++||||+ +++|..++  ..+++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++.
T Consensus       100 ~~~~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~-~~~kl~Dfg~a~~  177 (367)
T 1cm8_A          100 DDFTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNED-CELKILDFGLARQ  177 (367)
T ss_dssp             TTCCCCEEEEECC-SEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-CCEEECCCTTCEE
T ss_pred             ccCceEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCC-CCEEEEeeecccc
Confidence               4569999999 77888776  569999999999999999999999999999999999999988 7899999999987


Q ss_pred             ccCCCcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhc
Q 014406          270 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY  349 (425)
Q Consensus       270 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~  349 (425)
                      ...  .....++|+.|+|||++.+...++.++||||+||++|+|++|+.|| .+.+..+++..+.+.+|.++..... ..
T Consensus       178 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf-~~~~~~~~l~~i~~~~g~~~~~~~~-~~  253 (367)
T 1cm8_A          178 ADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLF-KGSDHLDQLKEIMKVTGTPPAEFVQ-RL  253 (367)
T ss_dssp             CCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCCCCHHHHH-TC
T ss_pred             ccc--ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHhcCCCCHHHHH-Hh
Confidence            543  3345678999999999987667999999999999999999999987 5667788899999999887654321 11


Q ss_pred             cCCCChhhHHHhc---ccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccch
Q 014406          350 HLELDPQLDALVG---RHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE  419 (425)
Q Consensus       350 ~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~~  419 (425)
                      .   .........   ......+..     ....+++++.+|+++||+.||++|||++|+|+||||++....+
T Consensus       254 ~---~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~~  318 (367)
T 1cm8_A          254 Q---SDEAKNYMKGLPELEKKDFAS-----ILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTE  318 (367)
T ss_dssp             S---CHHHHHHHHHSCCCCCCCGGG-----TCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC---
T ss_pred             h---hHHHHHHHHhCCCCCCCCHHH-----HCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCCc
Confidence            0   011111111   111112211     1234789999999999999999999999999999999876543

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=3e-49  Score=378.28  Aligned_cols=257  Identities=25%  Similarity=0.460  Sum_probs=215.8

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc---------chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCC
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS  194 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~---------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  194 (425)
                      .++|++.+.||+|+||+||+|.+..+++.||+|++...         ..+.+.+|+.+++++ +||||+++++++.+.  
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~--   86 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI-QHPNVITLHEVYENK--   86 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEEECS--
T ss_pred             ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhC-CCCCCCcEEEEEEeC--
Confidence            46799999999999999999999999999999998642         246789999999999 899999999999654  


Q ss_pred             CccEEEEEeecCCChhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCC---CcEEEEeccccc
Q 014406          195 KTPSLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEL---RKLRLIDWGLAE  268 (425)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~~---~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~---~~~kl~Dfg~a~  268 (425)
                      ...++||||+.+++|.+++.   .+++..+..++.|++.||.|||+.||+||||||+|||++.+.   ..+||+|||+++
T Consensus        87 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~  166 (326)
T 2y0a_A           87 TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH  166 (326)
T ss_dssp             SEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred             CEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCe
Confidence            67899999999999998874   489999999999999999999999999999999999998762   179999999998


Q ss_pred             cccCCCcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhh
Q 014406          269 FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK  348 (425)
Q Consensus       269 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~  348 (425)
                      ............+|+.|+|||++.+ ..++.++|||||||++|+|++|..||. +.+..+.+..+......         
T Consensus       167 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~-~~~~~~~~~~~~~~~~~---------  235 (326)
T 2y0a_A          167 KIDFGNEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANVSAVNYE---------  235 (326)
T ss_dssp             ECCTTSCCCCCCSCTTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSC-CSSHHHHHHHHHHTCCC---------
T ss_pred             ECCCCCccccccCCcCcCCceeecC-CCCCcHHHHHHHHHHHHHHHHCcCCCC-CCCHHHHHHHHHhcCCC---------
Confidence            8765555566789999999999976 779999999999999999999999984 33333344333221110         


Q ss_pred             ccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccc
Q 014406          349 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA  418 (425)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~  418 (425)
                          ...                    .....+++.+.+||++||+.||++|||++|+|+||||++....
T Consensus       236 ----~~~--------------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~  281 (326)
T 2y0a_A          236 ----FED--------------------EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQ  281 (326)
T ss_dssp             ----CCH--------------------HHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCCSHH
T ss_pred             ----cCc--------------------cccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCCcch
Confidence                000                    0011268899999999999999999999999999999987653

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.1e-49  Score=394.35  Aligned_cols=285  Identities=32%  Similarity=0.547  Sum_probs=227.0

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcchHHHHHHHHHHHHhcCCCCeeeEEeEEEcC----CCCccEE
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQ----HSKTPSL  199 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~----~~~~~~l  199 (425)
                      ..+|++.+.||+|+||+||+|.+..+++.||||++.... ....+|+++++.+ +|+||++++++|...    +..++++
T Consensus        53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~E~~il~~l-~hpniv~l~~~~~~~~~~~~~~~~~l  130 (420)
T 1j1b_A           53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-RFKNRELQIMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNL  130 (420)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT-TSCCHHHHHHHTC-CCTTBCCEEEEEEEEETTTTEEEEEE
T ss_pred             cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc-hhHHHHHHHHHHc-CCCCccceeeEEeccCCCCcceeEEe
Confidence            457999999999999999999999999999999986432 3345799999999 999999999998642    2234779


Q ss_pred             EEEeecCCChhhh------cCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCC
Q 014406          200 IFEYVNSTDFKVL------YPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (425)
Q Consensus       200 v~e~~~~~~l~~~------~~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~  273 (425)
                      ||||++++.+...      ...+++..++.++.||+.||+|||++||+||||||+|||++.+.+.+||+|||+++.....
T Consensus       131 v~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~  210 (420)
T 1j1b_A          131 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG  210 (420)
T ss_dssp             EEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred             ehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhcccC
Confidence            9999997544332      1458999999999999999999999999999999999999977567899999999877655


Q ss_pred             CcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCC
Q 014406          274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL  353 (425)
Q Consensus       274 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~  353 (425)
                      .......+|+.|+|||++.+...++.++|||||||++|||++|+.|| .+.+..+++..+.+.+|.+....+........
T Consensus       211 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf-~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~  289 (420)
T 1j1b_A          211 EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF-PGDSGVDQLVEIIKVLGTPTREQIREMNPNYT  289 (420)
T ss_dssp             CCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCC
T ss_pred             CCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCCHHHHHhhChhhh
Confidence            55556788999999999987567999999999999999999999887 56677888999999999877655432111000


Q ss_pred             ChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccch
Q 014406          354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE  419 (425)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~~  419 (425)
                      ...    .......+|...    ....+++++++||++||++||++|||+.|+++||||++++...
T Consensus       290 ~~~----~p~~~~~~~~~~----~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~  347 (420)
T 1j1b_A          290 EFK----FPQIKAHPWTKV----FRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN  347 (420)
T ss_dssp             CCC----CCCCCCCCHHHH----SCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTT
T ss_pred             hhc----cCccCCCCHHHh----cCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccccccc
Confidence            000    000111122211    1234689999999999999999999999999999999876543

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=3.7e-49  Score=372.73  Aligned_cols=253  Identities=26%  Similarity=0.494  Sum_probs=206.5

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc-----------------------------hHHHHHHHHHHH
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----------------------------KKKIKREIKILQ  174 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----------------------------~~~~~~E~~~l~  174 (425)
                      .++|++.+.||+|+||+||+|.+..+++.||||++....                             .+.+.+|+.+++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            578999999999999999999999999999999986432                             246889999999


Q ss_pred             HhcCCCCeeeEEeEEEcCCCCccEEEEEeecCCChhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEe
Q 014406          175 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI  252 (425)
Q Consensus       175 ~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll  252 (425)
                      ++ +||||+++++++.+......++||||+++++|..+.  ..+++..++.++.|++.||+|||++||+||||||+|||+
T Consensus        92 ~l-~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~  170 (298)
T 2zv2_A           92 KL-DHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLV  170 (298)
T ss_dssp             TC-CCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred             hC-CCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE
Confidence            99 999999999999876667899999999999998775  358999999999999999999999999999999999999


Q ss_pred             cCCCCcEEEEeccccccccCCC-cceeeccCCCccCcccccCCCC--CCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHH
Q 014406          253 DHELRKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVDLQD--YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQ  329 (425)
Q Consensus       253 ~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~--~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~  329 (425)
                      +.+ +.+||+|||+++...... ......+|+.|+|||.+.+...  ++.++|||||||++|+|++|+.||... +....
T Consensus       171 ~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~-~~~~~  248 (298)
T 2zv2_A          171 GED-GHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE-RIMCL  248 (298)
T ss_dssp             CTT-SCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS-SHHHH
T ss_pred             CCC-CCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc-cHHHH
Confidence            988 789999999998765432 2344678999999999976332  477899999999999999999998422 11111


Q ss_pred             HHHHHHHhCCchhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcC
Q 014406          330 LVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  409 (425)
Q Consensus       330 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~h  409 (425)
                      ...+..             ...                      .......+++++.+||.+||+.||++|||++|+++|
T Consensus       249 ~~~~~~-------------~~~----------------------~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h  293 (298)
T 2zv2_A          249 HSKIKS-------------QAL----------------------EFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH  293 (298)
T ss_dssp             HHHHHH-------------CCC----------------------CCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred             HHHHhc-------------ccC----------------------CCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence            111110             000                      001122478999999999999999999999999999


Q ss_pred             CCCcc
Q 014406          410 PYFAQ  414 (425)
Q Consensus       410 p~~~~  414 (425)
                      |||++
T Consensus       294 p~~~~  298 (298)
T 2zv2_A          294 PWVTR  298 (298)
T ss_dssp             HHHHC
T ss_pred             ccccC
Confidence            99864

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=3.6e-49  Score=377.26  Aligned_cols=256  Identities=24%  Similarity=0.386  Sum_probs=210.3

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccE
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (425)
                      ..++|++.+.||+|+||+||+|.+..+++.||+|++....    .+.+.+|+.+++.+ +||||+++++++.+  +...+
T Consensus         5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~--~~~~~   81 (323)
T 3tki_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-NHENVVKFYGHRRE--GNIQY   81 (323)
T ss_dssp             TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHC-CCTTBCCEEEEEEC--SSEEE
T ss_pred             HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhC-CCCCCCeEEEEEec--CCeEE
Confidence            4689999999999999999999999999999999986432    35688999999999 99999999999965  46789


Q ss_pred             EEEEeecCCChhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCC-
Q 014406          199 LIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-  274 (425)
Q Consensus       199 lv~e~~~~~~l~~~~~---~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~-  274 (425)
                      +||||+++++|.+++.   .+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++...... 
T Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~-~~~kl~Dfg~a~~~~~~~~  160 (323)
T 3tki_A           82 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNR  160 (323)
T ss_dssp             EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-CCEEECCCTTCEECEETTE
T ss_pred             EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCC-CCEEEEEeeccceeccCCc
Confidence            9999999999998874   48999999999999999999999999999999999999988 789999999997653222 


Q ss_pred             --cceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCC
Q 014406          275 --EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE  352 (425)
Q Consensus       275 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~  352 (425)
                        ......||+.|+|||++.+...++.++|||||||++|+|++|+.||............+....             ..
T Consensus       161 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~-------------~~  227 (323)
T 3tki_A          161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK-------------TY  227 (323)
T ss_dssp             ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTC-------------TT
T ss_pred             ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhccc-------------cc
Confidence              223467899999999998744457899999999999999999999954333322222211100             00


Q ss_pred             CChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCccccc
Q 014406          353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA  417 (425)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~  417 (425)
                                   ..         ....+++++.+|+.+||+.||++|||++|+++||||++...
T Consensus       228 -------------~~---------~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~  270 (323)
T 3tki_A          228 -------------LN---------PWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLK  270 (323)
T ss_dssp             -------------ST---------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred             -------------CC---------ccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhccccc
Confidence                         00         01226899999999999999999999999999999987543

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=5.2e-49  Score=375.07  Aligned_cols=252  Identities=22%  Similarity=0.452  Sum_probs=214.9

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCcc
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (425)
                      .++|++.+.||+|+||+||+|++..+++.||+|+++..      ..+.+.+|+.+++.+ +||||+++++++.+.  ...
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~~~~~~~~~--~~~   81 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-THPFIIRMWGTFQDA--QQI   81 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CBTTBCCEEEEEECS--SEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhC-CCCCCceEeEEEEeC--CEE
Confidence            47899999999999999999999999999999999642      346678899999999 999999999999654  678


Q ss_pred             EEEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCC
Q 014406          198 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (425)
Q Consensus       198 ~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~  274 (425)
                      ++||||+++++|..++   ..+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++....  
T Consensus        82 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~-g~~kL~Dfg~a~~~~~--  158 (318)
T 1fot_A           82 FMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKN-GHIKITDFGFAKYVPD--  158 (318)
T ss_dssp             EEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTT-SCEEECCCSSCEECSS--
T ss_pred             EEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCC-CCEEEeecCcceecCC--
Confidence            9999999999999887   458999999999999999999999999999999999999988 7999999999986543  


Q ss_pred             cceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCC
Q 014406          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD  354 (425)
Q Consensus       275 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~  354 (425)
                      .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.. .+..+....+...             ...  
T Consensus       159 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~-~~~~~~~~~i~~~-------------~~~--  221 (318)
T 1fot_A          159 VTYTLCGTPDYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYD-SNTMKTYEKILNA-------------ELR--  221 (318)
T ss_dssp             CBCCCCSCTTTCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHHC-------------CCC--
T ss_pred             ccccccCCccccCHhHhcC-CCCCcccchhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHhC-------------CCC--
Confidence            3345689999999999987 7899999999999999999999999843 3333333333210             000  


Q ss_pred             hhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCc-----CHHHHhcCCCCcccccchh
Q 014406          355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYFAQVRAAES  420 (425)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rp-----ta~elL~hp~~~~~~~~~~  420 (425)
                                            .+..+++++.+||++||+.||++||     +++|+++||||+++.+...
T Consensus       222 ----------------------~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~~~~  270 (318)
T 1fot_A          222 ----------------------FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKL  270 (318)
T ss_dssp             ----------------------CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHHH
T ss_pred             ----------------------CCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCCHHHH
Confidence                                  1123689999999999999999999     9999999999999887654

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=4.6e-49  Score=380.50  Aligned_cols=257  Identities=23%  Similarity=0.380  Sum_probs=216.7

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCc
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (425)
                      ..++|++++.||+|+||+||+|.+..+++.||+|+++..      ..+.+.+|..++..+.+||||+++++++.+.  ..
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~--~~   95 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM--DR   95 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECS--SE
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcC--CE
Confidence            357899999999999999999999999999999999642      3456788999999876899999999999654  68


Q ss_pred             cEEEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEecccccccc-C
Q 014406          197 PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-P  272 (425)
Q Consensus       197 ~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~-~  272 (425)
                      .|+||||+++|+|..++   ..+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++... .
T Consensus        96 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~-g~vkL~DFG~a~~~~~~  174 (353)
T 2i0e_A           96 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSE-GHIKIADFGMCKENIWD  174 (353)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT-SCEEECCCTTCBCCCCT
T ss_pred             EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCC-CcEEEEeCCcccccccC
Confidence            89999999999998887   469999999999999999999999999999999999999988 799999999998643 2


Q ss_pred             CCcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCC
Q 014406          273 GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE  352 (425)
Q Consensus       273 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~  352 (425)
                      .......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||. +.+..+....+...             .. 
T Consensus       175 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~-~~~~~~~~~~i~~~-------------~~-  238 (353)
T 2i0e_A          175 GVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFE-GEDEDELFQSIMEH-------------NV-  238 (353)
T ss_dssp             TCCBCCCCSCGGGCCHHHHTT-CCBSTHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHC-------------CC-
T ss_pred             CcccccccCCccccChhhhcC-CCcCCcccccchHHHHHHHHcCCCCCC-CCCHHHHHHHHHhC-------------CC-
Confidence            334456689999999999987 789999999999999999999999984 33333333333220             00 


Q ss_pred             CChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCc-----CHHHHhcCCCCcccccchhc
Q 014406          353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYFAQVRAAESS  421 (425)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rp-----ta~elL~hp~~~~~~~~~~~  421 (425)
                                             ..+..+++++.+||++||+.||++||     +++|+++||||+.+.|....
T Consensus       239 -----------------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w~~l~  289 (353)
T 2i0e_A          239 -----------------------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLE  289 (353)
T ss_dssp             -----------------------CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCHHHHH
T ss_pred             -----------------------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCHHHHH
Confidence                                   01123789999999999999999999     47999999999999886653

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.9e-49  Score=386.83  Aligned_cols=283  Identities=30%  Similarity=0.566  Sum_probs=227.1

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcchHHHHHHHHHHHHhcCCCCeeeEEeEEEcC----------
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQ----------  192 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~----------  192 (425)
                      ..++|++.+.||+|+||+||+|.+..+++.||||++.... ....+|+.+++.+ +||||++++++|...          
T Consensus         5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~   82 (383)
T 3eb0_A            5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP-RYKNRELDIMKVL-DHVNIIKLVDYFYTTGDEEPKPPQP   82 (383)
T ss_dssp             -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT-TSCCHHHHHHTTC-CCTTBCCEEEEEEEC----------
T ss_pred             ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc-chHHHHHHHHHHc-CCCCccchhheeeecCccccccccc
Confidence            4678999999999999999999999999999999986432 3345899999999 999999999998642          


Q ss_pred             --------------------------CCCccEEEEEeecCCChhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC
Q 014406          193 --------------------------HSKTPSLIFEYVNSTDFKVLY-------PTLTDYDIRYYIYELLKALDYCHSQG  239 (425)
Q Consensus       193 --------------------------~~~~~~lv~e~~~~~~l~~~~-------~~l~~~~~~~i~~~i~~~L~~LH~~~  239 (425)
                                                ...+.++||||+++ +|...+       ..+++..++.++.||+.||+|||+.|
T Consensus        83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g  161 (383)
T 3eb0_A           83 PDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG  161 (383)
T ss_dssp             ---------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT
T ss_pred             ccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCc
Confidence                                      23458899999996 444332       45999999999999999999999999


Q ss_pred             ceeecCCCCceEecCCCCcEEEEeccccccccCCCcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCC
Q 014406          240 IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEP  319 (425)
Q Consensus       240 ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~p  319 (425)
                      |+||||||+|||++.+.+.+||+|||+++............+|+.|+|||++.+...++.++||||+||++|+|++|+.|
T Consensus       162 i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~p  241 (383)
T 3eb0_A          162 ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPL  241 (383)
T ss_dssp             EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCC
Confidence            99999999999998544799999999998876666666778899999999998756699999999999999999999988


Q ss_pred             CCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCC
Q 014406          320 FFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQD  399 (425)
Q Consensus       320 f~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~  399 (425)
                      | .+.+..+++..+.+.+|.+................    ........|..    .....+++++.+||++||++||++
T Consensus       242 f-~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~----~~~~~~~~~~~----~~~~~~~~~~~~li~~~L~~dP~~  312 (383)
T 3eb0_A          242 F-SGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVR----FPTLKAKDWRK----ILPEGTPSLAIDLLEQILRYEPDL  312 (383)
T ss_dssp             S-CCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CC----CCCCCCCCHHH----HSCTTCCHHHHHHHHHHCCSSGGG
T ss_pred             C-CCCChHHHHHHHHHHhCCCCHHHHHHhCccccccc----CCccCcccHHh----hCCCCCCHHHHHHHHHHccCChhh
Confidence            7 56777889999999999887665433211100000    00001111221    123347899999999999999999


Q ss_pred             CcCHHHHhcCCCCccccc
Q 014406          400 RLTAREAMAHPYFAQVRA  417 (425)
Q Consensus       400 Rpta~elL~hp~~~~~~~  417 (425)
                      |||+.|+|+||||++++.
T Consensus       313 R~t~~e~l~hp~f~~~~~  330 (383)
T 3eb0_A          313 RINPYEAMAHPFFDHLRN  330 (383)
T ss_dssp             SCCHHHHHTSGGGHHHHH
T ss_pred             CCCHHHHhcCHHHHHHHh
Confidence            999999999999998765

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=5.2e-49  Score=383.71  Aligned_cols=258  Identities=21%  Similarity=0.444  Sum_probs=217.8

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCc
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (425)
                      ..++|++++.||+|+||+||+|.+..+++.||+|++...      ....+.+|+.+++.+ +||||++++++|.+.  ..
T Consensus        13 ~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~--~~   89 (384)
T 4fr4_A           13 NFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGL-EHPFLVNLWYSFQDE--ED   89 (384)
T ss_dssp             CGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEECS--SE
T ss_pred             ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEeC--CE
Confidence            357899999999999999999999999999999998632      346788999999999 999999999999654  67


Q ss_pred             cEEEEEeecCCChhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCC
Q 014406          197 PSLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (425)
Q Consensus       197 ~~lv~e~~~~~~l~~~~~---~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~  273 (425)
                      .++||||+.+++|..++.   .+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++.....
T Consensus        90 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~-g~vkL~DFG~a~~~~~~  168 (384)
T 4fr4_A           90 MFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEH-GHVHITDFNIAAMLPRE  168 (384)
T ss_dssp             EEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-SCEEECCCTTCEECCTT
T ss_pred             EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCC-CCEEEeccceeeeccCC
Confidence            899999999999988873   58999999999999999999999999999999999999988 79999999999887666


Q ss_pred             CcceeeccCCCccCcccccCC--CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCC-HHHHHHHHHHhCCchhHHHHhhcc
Q 014406          274 KEYNVRVASRYFKGPELLVDL--QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN-HDQLVKIAKVLGTDELNAYLNKYH  350 (425)
Q Consensus       274 ~~~~~~~~t~~y~aPE~~~~~--~~~~~~~DvwslG~~l~elltg~~pf~~~~~~-~~~~~~~~~~lg~~~~~~~~~~~~  350 (425)
                      ......+||+.|+|||++.+.  ..++.++|||||||++|+|++|+.||...... ...+.....            ...
T Consensus       169 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~------------~~~  236 (384)
T 4fr4_A          169 TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFE------------TTV  236 (384)
T ss_dssp             CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHH------------HCC
T ss_pred             CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHh------------hcc
Confidence            666778899999999998642  45899999999999999999999999543222 111111110            000


Q ss_pred             CCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcC-HHHHhcCCCCcccccchh
Q 014406          351 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT-AREAMAHPYFAQVRAAES  420 (425)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpt-a~elL~hp~~~~~~~~~~  420 (425)
                                              ...+..+++++.+||++||+.||++||+ ++++++||||+++.|...
T Consensus       237 ------------------------~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~w~~~  283 (384)
T 4fr4_A          237 ------------------------VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINWDAV  283 (384)
T ss_dssp             ------------------------CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCCHHHH
T ss_pred             ------------------------cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCCHHHH
Confidence                                    0111237899999999999999999998 999999999999988654

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.3e-48  Score=371.05  Aligned_cols=286  Identities=30%  Similarity=0.512  Sum_probs=217.1

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc-----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccE
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (425)
                      .++|++++.||+|+||+||+|.+..+++.||+|++....     .+.+.+|+.+++++ +||||+++++++.+.  ...+
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~--~~~~   78 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQL-KHPNLVNLLEVFRRK--RRLH   78 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEET--TEEE
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhC-CCCCccchhheeecC--CeEE
Confidence            368999999999999999999999999999999986432     35577899999999 899999999999754  6788


Q ss_pred             EEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCC-C
Q 014406          199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-K  274 (425)
Q Consensus       199 lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~-~  274 (425)
                      +||||++++++..+.   ..+++..+..++.|++.||+|||+.||+|+||||+||+++.+ +.+||+|||++...... .
T Consensus        79 lv~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~  157 (311)
T 4agu_A           79 LVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKH-SVIKLCDFGFARLLTGPSD  157 (311)
T ss_dssp             EEEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-SCEEECCCTTCEECC----
T ss_pred             EEEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCC-CCEEEeeCCCchhccCccc
Confidence            999999999988775   458999999999999999999999999999999999999988 79999999999876533 2


Q ss_pred             cceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCC
Q 014406          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD  354 (425)
Q Consensus       275 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~  354 (425)
                      ......+|..|+|||++.+...++.++|||||||++|+|++|..|| .+.+..+....+.+.++.............   
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---  233 (311)
T 4agu_A          158 YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLW-PGKSDVDQLYLIRKTLGDLIPRHQQVFSTN---  233 (311)
T ss_dssp             --------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCSCCHHHHHHHHTC---
T ss_pred             ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhcccccccccccccc---
Confidence            3345678999999999987677899999999999999999999887 556666777777777765332211100000   


Q ss_pred             hhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccchh
Q 014406          355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAES  420 (425)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~~~  420 (425)
                      ...   .......+............+++++.+|+++||++||++|||++|+|+||||+++++.+.
T Consensus       234 ~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~  296 (311)
T 4agu_A          234 QYF---SGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIED  296 (311)
T ss_dssp             GGG---TTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC----
T ss_pred             ccc---ccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCHHH
Confidence            000   000000000000000111347899999999999999999999999999999999987654

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=2.4e-49  Score=389.36  Aligned_cols=258  Identities=27%  Similarity=0.406  Sum_probs=215.4

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecC------cchHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCc
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP------VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~------~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (425)
                      ..++|++++.||+|+||+||+|++..+++.||+|++++      .....+.+|+.+++.+ +||||++++++|.+  ...
T Consensus        67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~--~~~  143 (410)
T 3v8s_A           67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLFYAFQD--DRY  143 (410)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHC-CCTTBCCEEEEEEC--SSE
T ss_pred             CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEE--CCE
Confidence            56889999999999999999999999999999999864      2334588999999999 99999999999965  478


Q ss_pred             cEEEEEeecCCChhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCC
Q 014406          197 PSLIFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (425)
Q Consensus       197 ~~lv~e~~~~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~  274 (425)
                      +++||||+++|+|..++  ..+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+......
T Consensus       144 ~~lV~E~~~gg~L~~~l~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~-g~ikL~DFG~a~~~~~~~  222 (410)
T 3v8s_A          144 LYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKS-GHLKLADFGTCMKMNKEG  222 (410)
T ss_dssp             EEEEECCCTTEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-SCEEECCCTTCEECCTTS
T ss_pred             EEEEEeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCC-CCEEEeccceeEeeccCC
Confidence            89999999999998887  458999999999999999999999999999999999999988 799999999998765443


Q ss_pred             c--ceeeccCCCccCcccccCCCC---CCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhc
Q 014406          275 E--YNVRVASRYFKGPELLVDLQD---YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY  349 (425)
Q Consensus       275 ~--~~~~~~t~~y~aPE~~~~~~~---~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~  349 (425)
                      .  ....+||+.|+|||++.+...   ++.++|||||||++|||++|+.||. +.+..+....+.....           
T Consensus       223 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~-~~~~~~~~~~i~~~~~-----------  290 (410)
T 3v8s_A          223 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY-ADSLVGTYSKIMNHKN-----------  290 (410)
T ss_dssp             EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTC-CSSHHHHHHHHHTHHH-----------
T ss_pred             cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCC-CCChhhHHHHHHhccc-----------
Confidence            2  235689999999999976321   7899999999999999999999984 3343444444322100           


Q ss_pred             cCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCC--CcCHHHHhcCCCCcccccc
Q 014406          350 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQD--RLTAREAMAHPYFAQVRAA  418 (425)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~--Rpta~elL~hp~~~~~~~~  418 (425)
                      ..                      .......+++++++||++||+.+|++  |++++|+++||||+++.|.
T Consensus       291 ~~----------------------~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w~  339 (410)
T 3v8s_A          291 SL----------------------TFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWA  339 (410)
T ss_dssp             HC----------------------CCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSCC
T ss_pred             cc----------------------cCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCHH
Confidence            00                      00011237999999999999999998  9999999999999998764

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1e-49  Score=394.90  Aligned_cols=263  Identities=24%  Similarity=0.401  Sum_probs=218.1

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCc
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (425)
                      ..++|++++.||+|+||+||+|++..+++.||+|++++.      ....+.+|+.++..+ +||||++++++|.+.  ..
T Consensus        72 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~-~hp~Iv~l~~~~~~~--~~  148 (437)
T 4aw2_A           72 HREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNG-DSKWITTLHYAFQDD--NN  148 (437)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHS-CTTTBCCEEEEEECS--SE
T ss_pred             ChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEeeC--CE
Confidence            468899999999999999999999999999999999642      233488999999998 999999999999654  77


Q ss_pred             cEEEEEeecCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccC
Q 014406          197 PSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (425)
Q Consensus       197 ~~lv~e~~~~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~  272 (425)
                      +++||||+.+|+|..++    ..+++..++.++.||+.||+|||+.||+||||||+|||++.+ +.+||+|||+|+....
T Consensus       149 ~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~-g~vkL~DFGla~~~~~  227 (437)
T 4aw2_A          149 LYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMN-GHIRLADFGSCLKLME  227 (437)
T ss_dssp             EEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-SCEEECCCTTCEECCT
T ss_pred             EEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCC-CCEEEcchhhhhhccc
Confidence            89999999999999887    358999999999999999999999999999999999999988 7999999999977654


Q ss_pred             CCcc--eeeccCCCccCccccc----CCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHH
Q 014406          273 GKEY--NVRVASRYFKGPELLV----DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYL  346 (425)
Q Consensus       273 ~~~~--~~~~~t~~y~aPE~~~----~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~  346 (425)
                      ....  ...+||+.|+|||++.    +...++.++|||||||++|||++|+.||. +.+..+....+.....        
T Consensus       228 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~-~~~~~~~~~~i~~~~~--------  298 (437)
T 4aw2_A          228 DGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFY-AESLVETYGKIMNHKE--------  298 (437)
T ss_dssp             TSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTC-CSSHHHHHHHHHTHHH--------
T ss_pred             CCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCC-CCChhHHHHhhhhccc--------
Confidence            4332  3358999999999986    23568999999999999999999999984 3444444444422100        


Q ss_pred             hhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCC--CcCHHHHhcCCCCcccccchhcc
Q 014406          347 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQD--RLTAREAMAHPYFAQVRAAESSR  422 (425)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~--Rpta~elL~hp~~~~~~~~~~~~  422 (425)
                         ...+                     ......+++++++||++||+.+|++  |++++|+++||||+++.|....+
T Consensus       299 ---~~~~---------------------p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~~l~~  352 (437)
T 4aw2_A          299 ---RFQF---------------------PTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDNIRN  352 (437)
T ss_dssp             ---HCCC---------------------CSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTTTGGG
T ss_pred             ---cccC---------------------CcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHHHHhh
Confidence               0000                     0111237999999999999999998  99999999999999998876643

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=8.6e-49  Score=377.81  Aligned_cols=258  Identities=26%  Similarity=0.460  Sum_probs=213.8

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc------hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCc
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (425)
                      ..++|++++.||+|+||+||+|++..+++.||+|+++...      .+.+.+|+.++.++.+||||+++++++.+.  ..
T Consensus         7 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~--~~   84 (345)
T 3a8x_A            7 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE--SR   84 (345)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--SE
T ss_pred             chhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeC--CE
Confidence            3578999999999999999999999999999999997432      345788999999876899999999999654  68


Q ss_pred             cEEEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEecccccccc-C
Q 014406          197 PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-P  272 (425)
Q Consensus       197 ~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~-~  272 (425)
                      .++||||+++++|..++   ..+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++... .
T Consensus        85 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~-g~~kL~DFG~a~~~~~~  163 (345)
T 3a8x_A           85 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE-GHIKLTDYGMCKEGLRP  163 (345)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT-SCEEECCGGGCBCSCCT
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCC-CCEEEEeccccccccCC
Confidence            89999999999998876   469999999999999999999999999999999999999988 799999999998643 2


Q ss_pred             CCcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCC-------HHHHHHHHHHhCCchhHHH
Q 014406          273 GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN-------HDQLVKIAKVLGTDELNAY  345 (425)
Q Consensus       273 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~-------~~~~~~~~~~lg~~~~~~~  345 (425)
                      .......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||......       .+.+....           
T Consensus       164 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i-----------  231 (345)
T 3a8x_A          164 GDTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI-----------  231 (345)
T ss_dssp             TCCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHH-----------
T ss_pred             CCcccccCCCccccCccccCC-CCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHH-----------
Confidence            334456689999999999987 78999999999999999999999999532111       11111100           


Q ss_pred             HhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCH------HHHhcCCCCcccccch
Q 014406          346 LNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA------REAMAHPYFAQVRAAE  419 (425)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta------~elL~hp~~~~~~~~~  419 (425)
                       .....                        ..+..++.++++||++||+.||++|||+      +|+++||||+++.|..
T Consensus       232 -~~~~~------------------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w~~  286 (345)
T 3a8x_A          232 -LEKQI------------------------RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDM  286 (345)
T ss_dssp             -HHCCC------------------------CCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCHHH
T ss_pred             -HcCCC------------------------CCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCHHH
Confidence             00000                        0112378999999999999999999995      8999999999998755


Q ss_pred             h
Q 014406          420 S  420 (425)
Q Consensus       420 ~  420 (425)
                      .
T Consensus       287 ~  287 (345)
T 3a8x_A          287 M  287 (345)
T ss_dssp             H
T ss_pred             H
Confidence            4

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.8e-49  Score=379.47  Aligned_cols=281  Identities=28%  Similarity=0.584  Sum_probs=216.5

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcch----HHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEE
Q 014406          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK----KKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (425)
Q Consensus       125 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~----~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (425)
                      ++|++++.||+|+||+||+|.+..+++.||+|++.....    ..+.+|+.+++++ +||||+++++++.+.  ...++|
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~--~~~~lv   78 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDL-KHANIVTLHDIIHTE--KSLTLV   78 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCC-CCTTBCCEEEEEECS--SCEEEE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhc-CCCCCCeeeeEEeeC--CEEEEE
Confidence            689999999999999999999999999999999974432    2455799999999 899999999999654  678999


Q ss_pred             EEeecCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCC-Cc
Q 014406          201 FEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-KE  275 (425)
Q Consensus       201 ~e~~~~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~-~~  275 (425)
                      |||+++ +|..++    ..+++..++.++.|++.||.|||+.||+||||||+|||++.+ +.+||+|||+++..... ..
T Consensus        79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~-~~~kl~Dfg~a~~~~~~~~~  156 (324)
T 3mtl_A           79 FEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINER-GELKLADFGLARAKSIPTKT  156 (324)
T ss_dssp             EECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTT-CCEEECSSSEEECC------
T ss_pred             eccccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCC-CCEEEccCcccccccCCccc
Confidence            999986 555544    348999999999999999999999999999999999999988 79999999999765432 23


Q ss_pred             ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCCh
Q 014406          276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP  355 (425)
Q Consensus       276 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~  355 (425)
                      .....+|..|+|||++.+...++.++|||||||++|+|++|+.|| .+.+..+++..+.+.+|.+....+.....   ..
T Consensus       157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~~---~~  232 (324)
T 3mtl_A          157 YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLF-PGSTVEEQLHFIFRILGTPTEETWPGILS---NE  232 (324)
T ss_dssp             ------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCCCCTTTSTTGGG---CH
T ss_pred             cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCChHhchhhhc---ch
Confidence            344578999999999987667899999999999999999999887 56677788888888888765433211100   00


Q ss_pred             hhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccc
Q 014406          356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA  418 (425)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~  418 (425)
                      .+..    .................+++++.+||++||++||++|||++|+|+||||.++...
T Consensus       233 ~~~~----~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  291 (324)
T 3mtl_A          233 EFKT----YNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGER  291 (324)
T ss_dssp             HHHH----TCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCST
T ss_pred             hhcc----cccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccc
Confidence            0000    0000000001111223478999999999999999999999999999999988654

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-48  Score=381.21  Aligned_cols=256  Identities=26%  Similarity=0.505  Sum_probs=215.4

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc---chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEE
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (425)
                      .++|++.+.||+|+||+||+|.+..+++.+|+|++...   ....+.+|+.+++.+ +||||+++++++.+.  ...++|
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~--~~~~lv  126 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQL-HHPKLINLHDAFEDK--YEMVLI  126 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTC-CSTTBCCEEEEEECS--SEEEEE
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhC-CCcCCCeEEEEEEeC--CEEEEE
Confidence            46899999999999999999999999999999999754   345688999999999 999999999999654  678999


Q ss_pred             EEeecCCChhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCC-CCcEEEEeccccccccCCCc
Q 014406          201 FEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE-LRKLRLIDWGLAEFYHPGKE  275 (425)
Q Consensus       201 ~e~~~~~~l~~~~~----~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~-~~~~kl~Dfg~a~~~~~~~~  275 (425)
                      |||+.+++|.+++.    .+++..+..++.||+.||+|||++||+||||||+|||++.+ .+.+||+|||+++.......
T Consensus       127 ~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~  206 (387)
T 1kob_A          127 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI  206 (387)
T ss_dssp             EECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred             EEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCcc
Confidence            99999999988773    48999999999999999999999999999999999999853 36799999999988766666


Q ss_pred             ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCCh
Q 014406          276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP  355 (425)
Q Consensus       276 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~  355 (425)
                      .....+|+.|+|||++.+ ..++.++|||||||++|+|++|..||. +.+..+.+..+...             ...   
T Consensus       207 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~Pf~-~~~~~~~~~~i~~~-------------~~~---  268 (387)
T 1kob_A          207 VKVTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFA-GEDDLETLQNVKRC-------------DWE---  268 (387)
T ss_dssp             EEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSC-CSSHHHHHHHHHHC-------------CCC---
T ss_pred             eeeeccCCCccCchhccC-CCCCCcccEeeHhHHHHHHHhCCCCCC-CCCHHHHHHHHHhC-------------CCC---
Confidence            666789999999999987 779999999999999999999999984 33333333333211             000   


Q ss_pred             hhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCccccc
Q 014406          356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA  417 (425)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~  417 (425)
                                       ........+++++++||++||+.||++|||++|+|+||||++...
T Consensus       269 -----------------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  313 (387)
T 1kob_A          269 -----------------FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHS  313 (387)
T ss_dssp             -----------------CCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCCT
T ss_pred             -----------------CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCCcc
Confidence                             001112237899999999999999999999999999999987543

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=7.6e-49  Score=380.75  Aligned_cols=254  Identities=26%  Similarity=0.500  Sum_probs=211.9

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc-----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccE
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (425)
                      .++|++.+.||+|+||+||+|.+..+++.||+|++....     .+.+.+|+.+++.+ +||||+++++++.+.  ...+
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~--~~~~  104 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQEE--SFHY  104 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEECS--SEEE
T ss_pred             ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEeC--CEEE
Confidence            468999999999999999999999999999999996432     35688999999999 999999999999654  6789


Q ss_pred             EEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCC--CcEEEEeccccccccCC
Q 014406          199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEL--RKLRLIDWGLAEFYHPG  273 (425)
Q Consensus       199 lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~--~~~kl~Dfg~a~~~~~~  273 (425)
                      +||||+.+++|.+.+   ..+++..+..++.||+.||.|||++||+||||||+|||++.+.  +.+||+|||++......
T Consensus       105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~  184 (362)
T 2bdw_A          105 LVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS  184 (362)
T ss_dssp             EEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC
T ss_pred             EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCC
Confidence            999999999998776   3489999999999999999999999999999999999998652  35999999999877655


Q ss_pred             CcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCC
Q 014406          274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL  353 (425)
Q Consensus       274 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~  353 (425)
                      .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||. +.+..+....+....             ...
T Consensus       185 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~Pf~-~~~~~~~~~~i~~~~-------------~~~  249 (362)
T 2bdw_A          185 EAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFW-DEDQHRLYAQIKAGA-------------YDY  249 (362)
T ss_dssp             CSCCCSCSCTTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHTC-------------CCC
T ss_pred             cccccCCCCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHHCCCCCC-CCCHHHHHHHHHhCC-------------CCC
Confidence            55566789999999999977 689999999999999999999999984 333333333322210             000


Q ss_pred             ChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCccc
Q 014406          354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV  415 (425)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~  415 (425)
                      +                    ......+++++++||.+||+.||++|||++|+|+||||++.
T Consensus       250 ~--------------------~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~  291 (362)
T 2bdw_A          250 P--------------------SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNR  291 (362)
T ss_dssp             C--------------------TTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHTH
T ss_pred             C--------------------cccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCCC
Confidence            0                    00012368999999999999999999999999999999764

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=1.7e-48  Score=376.33  Aligned_cols=253  Identities=23%  Similarity=0.398  Sum_probs=215.8

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCc
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (425)
                      ..++|++++.||+|+||+||+|.+..+++.||+|+++..      ..+.+.+|+.+++.+ +||||+++++++.+.  ..
T Consensus        39 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~--~~  115 (350)
T 1rdq_E           39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLEFSFKDN--SN  115 (350)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-CCTTBCCEEEEEECS--SE
T ss_pred             CHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEcC--CE
Confidence            457899999999999999999999999999999998642      346788999999999 999999999999654  67


Q ss_pred             cEEEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCC
Q 014406          197 PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (425)
Q Consensus       197 ~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~  273 (425)
                      .++||||+++++|..++   ..+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++.... 
T Consensus       116 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~-g~~kL~DFg~a~~~~~-  193 (350)
T 1rdq_E          116 LYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVKG-  193 (350)
T ss_dssp             EEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-SCEEECCCTTCEECSS-
T ss_pred             EEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCC-CCEEEcccccceeccC-
Confidence            89999999999998887   469999999999999999999999999999999999999988 7999999999987643 


Q ss_pred             CcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCC
Q 014406          274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL  353 (425)
Q Consensus       274 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~  353 (425)
                       .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||. +.+..+....+...             ... 
T Consensus       194 -~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~-~~~~~~~~~~i~~~-------------~~~-  256 (350)
T 1rdq_E          194 -RTWTLCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF-ADQPIQIYEKIVSG-------------KVR-  256 (350)
T ss_dssp             -CBCCCEECGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHC-------------CCC-
T ss_pred             -CcccccCCccccCHHHhcC-CCCCCcCCEecccHhHhHHhhCCCCCC-CCCHHHHHHHHHcC-------------CCC-
Confidence             2345689999999999987 679999999999999999999999984 33333333333210             000 


Q ss_pred             ChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcC-----HHHHhcCCCCcccccchh
Q 014406          354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT-----AREAMAHPYFAQVRAAES  420 (425)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpt-----a~elL~hp~~~~~~~~~~  420 (425)
                                             .+..+++++.+||++||+.||++||+     ++|+++||||+++.|...
T Consensus       257 -----------------------~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w~~~  305 (350)
T 1rdq_E          257 -----------------------FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAI  305 (350)
T ss_dssp             -----------------------CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHH
T ss_pred             -----------------------CCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCCHHHH
Confidence                                   11237899999999999999999998     999999999999988654

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=1e-48  Score=375.03  Aligned_cols=284  Identities=29%  Similarity=0.575  Sum_probs=215.7

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc-----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCcc
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (425)
                      ..++|++.+.||+|+||+||+|.+..+++.||||+++...     .+.+.+|+.+++++ +||||+++++++.+.  ...
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~--~~~  108 (329)
T 3gbz_A           32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKEL-QHRNIIELKSVIHHN--HRL  108 (329)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGC-CCTTBCCEEEEEEET--TEE
T ss_pred             chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHc-CCCCcceEEEEEecC--CEE
Confidence            3578999999999999999999999999999999997433     34567999999999 999999999999764  678


Q ss_pred             EEEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCC----CCcEEEEeccccccc
Q 014406          198 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE----LRKLRLIDWGLAEFY  270 (425)
Q Consensus       198 ~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~----~~~~kl~Dfg~a~~~  270 (425)
                      ++||||+++ +|..++   ..+++..++.++.||+.||+|||++||+||||||+|||++.+    .+.+||+|||+++..
T Consensus       109 ~lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~  187 (329)
T 3gbz_A          109 HLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF  187 (329)
T ss_dssp             EEEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHH
T ss_pred             EEEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCcccc
Confidence            999999996 666665   458999999999999999999999999999999999999533    246999999999866


Q ss_pred             cCC-CcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhc
Q 014406          271 HPG-KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY  349 (425)
Q Consensus       271 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~  349 (425)
                      ... .......+|..|+|||++.+...++.++|||||||++|+|++|..|| .+.+..+.+..+.+.++.+....+....
T Consensus       188 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (329)
T 3gbz_A          188 GIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLF-PGDSEIDQLFKIFEVLGLPDDTTWPGVT  266 (329)
T ss_dssp             C-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred             CCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCc-CCCCHHHHHHHHHHHhCCCchhhhhhhh
Confidence            432 33345678999999999987566899999999999999999999987 5566677788888777765433221110


Q ss_pred             cCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccc
Q 014406          350 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA  418 (425)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~  418 (425)
                      ...   .+...........    ........+++++++||++||++||++|||++|+|+||||++..+.
T Consensus       267 ~~~---~~~~~~~~~~~~~----~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  328 (329)
T 3gbz_A          267 ALP---DWKQSFPKFRGKT----LKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDFD  328 (329)
T ss_dssp             GST---TCCTTCCCCCCCC----HHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSCSC
T ss_pred             hhh---hhhhhhhhhcccc----HhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCCCC
Confidence            000   0000000000000    0111122368999999999999999999999999999999988653

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1.8e-48  Score=370.46  Aligned_cols=247  Identities=23%  Similarity=0.297  Sum_probs=198.7

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc-----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCcc
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (425)
                      ..++|++.++||+|+||+||+|.+..+++.||||++....     ......|+..+.++.+|+||++++++|.+  +...
T Consensus        55 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~--~~~~  132 (311)
T 3p1a_A           55 FQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEE--GGIL  132 (311)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEE
T ss_pred             hhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEe--CCEE
Confidence            3478999999999999999999999999999999986422     23455667677666689999999999965  4788


Q ss_pred             EEEEEeecCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCC
Q 014406          198 SLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (425)
Q Consensus       198 ~lv~e~~~~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~  273 (425)
                      ++||||+++ +|..++    ..+++..++.++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||++......
T Consensus       133 ~lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~-~~~kl~DFG~a~~~~~~  210 (311)
T 3p1a_A          133 YLQTELCGP-SLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPR-GRCKLGDFGLLVELGTA  210 (311)
T ss_dssp             EEEEECCCC-BHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGG-GCEEECCCTTCEECC--
T ss_pred             EEEEeccCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCC-CCEEEccceeeeecccC
Confidence            999999954 665554    359999999999999999999999999999999999999988 78999999999877655


Q ss_pred             CcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCC
Q 014406          274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL  353 (425)
Q Consensus       274 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~  353 (425)
                      .......||+.|+|||++.+  .++.++|||||||++|||++|..||+..    +....+....               .
T Consensus       211 ~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~el~~g~~~~~~~----~~~~~~~~~~---------------~  269 (311)
T 3p1a_A          211 GAGEVQEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELPHGG----EGWQQLRQGY---------------L  269 (311)
T ss_dssp             ----CCCCCGGGCCGGGGGT--CCSTHHHHHHHHHHHHHHHHTCCCCSSH----HHHHHHTTTC---------------C
T ss_pred             CCCcccCCCccccCHhHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCc----cHHHHHhccC---------------C
Confidence            55566679999999999875  6899999999999999999998777421    2221111100               0


Q ss_pred             ChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcc
Q 014406          354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ  414 (425)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~  414 (425)
                      .+                    .....+++++.+|+.+||++||++|||++|+|+||||++
T Consensus       270 ~~--------------------~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~  310 (311)
T 3p1a_A          270 PP--------------------EFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ  310 (311)
T ss_dssp             CH--------------------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred             Cc--------------------ccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence            00                    011236899999999999999999999999999999986

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=1e-48  Score=379.80  Aligned_cols=257  Identities=24%  Similarity=0.444  Sum_probs=199.9

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc--chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEE
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (425)
                      ..++|++++.||+|+||+||+|.+..+++.||+|++...  ..+.+.+|+.+++.+ +||||+++++++.+.  ...++|
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~--~~~~lv   94 (361)
T 3uc3_A           18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSL-RHPNIVRFKEVILTP--THLAII   94 (361)
T ss_dssp             CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHC-CCTTBCCEEEEEECS--SEEEEE
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhC-CCCCCCcEEEEEeeC--CEEEEE
Confidence            468999999999999999999999999999999999753  346788999999999 899999999999654  678999


Q ss_pred             EEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCC-CcEEEEeccccccccCCCcc
Q 014406          201 FEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEL-RKLRLIDWGLAEFYHPGKEY  276 (425)
Q Consensus       201 ~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~-~~~kl~Dfg~a~~~~~~~~~  276 (425)
                      |||+.+++|..++   ..+++..++.++.|++.||+|||++||+||||||+|||++.+. +.+||+|||+++........
T Consensus        95 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~~  174 (361)
T 3uc3_A           95 MEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP  174 (361)
T ss_dssp             EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC---------
T ss_pred             EEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccCCC
Confidence            9999999998876   5699999999999999999999999999999999999998762 24999999999865544455


Q ss_pred             eeeccCCCccCcccccCCCCCC-CcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCCh
Q 014406          277 NVRVASRYFKGPELLVDLQDYD-YSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP  355 (425)
Q Consensus       277 ~~~~~t~~y~aPE~~~~~~~~~-~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~  355 (425)
                      ....||+.|+|||++.+ ..++ .++|||||||++|+|++|+.||............+...+...          .    
T Consensus       175 ~~~~gt~~y~aPE~~~~-~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~----------~----  239 (361)
T 3uc3_A          175 KSTVGTPAYIAPEVLLR-QEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVK----------Y----  239 (361)
T ss_dssp             ------CTTSCHHHHHC-SSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTC----------C----
T ss_pred             CCCcCCCCcCChhhhcC-CCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCC----------C----
Confidence            56789999999999987 4554 449999999999999999999954332222222221111100          0    


Q ss_pred             hhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCccc
Q 014406          356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV  415 (425)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~  415 (425)
                                        .......+++++++||++||+.||++|||++|+++||||.+.
T Consensus       240 ------------------~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~  281 (361)
T 3uc3_A          240 ------------------SIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKN  281 (361)
T ss_dssp             ------------------CCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred             ------------------CCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence                              001112378999999999999999999999999999999643

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=2.2e-48  Score=378.03  Aligned_cols=283  Identities=29%  Similarity=0.557  Sum_probs=212.5

Q ss_pred             CCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcC----
Q 014406          122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQ----  192 (425)
Q Consensus       122 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~----  192 (425)
                      ...++|++++.||+|+||+||+|.+..+++.||||++...     ..+.+.+|+.+++.+ +||||+++++++...    
T Consensus        26 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~  104 (367)
T 2fst_X           26 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLDVFTPARSLE  104 (367)
T ss_dssp             EEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSSGG
T ss_pred             CCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEecCCccc
Confidence            3468999999999999999999999999999999998642     235678999999999 899999999999643    


Q ss_pred             CCCccEEEEEeecCCChhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccc
Q 014406          193 HSKTPSLIFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  270 (425)
Q Consensus       193 ~~~~~~lv~e~~~~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~  270 (425)
                      .....++|+||+ +++|..++  ..+++..++.++.||+.||+|||+.||+||||||+|||++.+ +.+||+|||+++..
T Consensus       105 ~~~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~-~~~kL~DFG~a~~~  182 (367)
T 2fst_X          105 EFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED-CELKILDFGLARHT  182 (367)
T ss_dssp             GCCCCEEEEECC-CEECC-----CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-CCEEECC-------
T ss_pred             cCCeEEEEeccc-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCC-CCEEEeeccccccc
Confidence            225679999999 57777766  459999999999999999999999999999999999999988 79999999999865


Q ss_pred             cCCCcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhcc
Q 014406          271 HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH  350 (425)
Q Consensus       271 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~  350 (425)
                      ..  ......+|+.|+|||++.+...++.++|||||||++|+|++|+.|| .+.+..+++..+.+.+|.+...... .. 
T Consensus       183 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf-~~~~~~~~l~~i~~~~g~p~~~~~~-~~-  257 (367)
T 2fst_X          183 AD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF-PGTDHIDQLKLILRLVGTPGAELLK-KI-  257 (367)
T ss_dssp             ----------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCSCCHHHHT-TC-
T ss_pred             cc--cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCCHHHHH-Hh-
Confidence            42  3345688999999999987667999999999999999999999987 6677788899999999987644321 10 


Q ss_pred             CCCChhhHHHhcccC---CCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccch
Q 014406          351 LELDPQLDALVGRHS---RKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE  419 (425)
Q Consensus       351 ~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~~  419 (425)
                        .............   ...+...     ...+++++.+||++||++||++|||++|+|+||||++.....
T Consensus       258 --~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~  322 (367)
T 2fst_X          258 --SSESARNYIQSLTQMPKMNFANV-----FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD  322 (367)
T ss_dssp             --CCHHHHHHHHTSCCCCCCCHHHH-----TTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCGG
T ss_pred             --hhHHHHHHHhccCCCCCCCHHHH-----CCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccCCC
Confidence              0111111111111   1111111     123689999999999999999999999999999999876544

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=1.4e-48  Score=374.57  Aligned_cols=249  Identities=22%  Similarity=0.429  Sum_probs=207.7

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCcc
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (425)
                      .++|++.+.||+|+||+||+|.+..+++.||+|++...      ....+.+|+.+++.+ +||||+++++++...  ...
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~--~~~   84 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLL-RHPHIIKLYDVITTP--TDI   84 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTC-CCTTBCCEEEEEECS--SEE
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhC-CCCCCCeEEEEEEeC--CEE
Confidence            47899999999999999999999999999999998632      245788999999999 899999999999764  678


Q ss_pred             EEEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCC
Q 014406          198 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (425)
Q Consensus       198 ~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~  274 (425)
                      ++||||+ +|++.+++   ..+++.+++.++.|++.||.|||+.||+||||||+|||++.+ +.+||+|||++.......
T Consensus        85 ~lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~-~~~kl~DFG~s~~~~~~~  162 (336)
T 3h4j_B           85 VMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDN-LNVKIADFGLSNIMTDGN  162 (336)
T ss_dssp             EEEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTT-CCEEECCSSCTBTTTTSB
T ss_pred             EEEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCC-CCEEEEEeccceeccCCc
Confidence            9999999 45665554   569999999999999999999999999999999999999988 789999999998877666


Q ss_pred             cceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCC
Q 014406          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD  354 (425)
Q Consensus       275 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~  354 (425)
                      .....+||+.|+|||++.+....+.++|||||||++|+|++|+.||..... .+..                        
T Consensus       163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~-~~~~------------------------  217 (336)
T 3h4j_B          163 FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFI-PNLF------------------------  217 (336)
T ss_dssp             TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSS-TTCB------------------------
T ss_pred             ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccH-HHHH------------------------
Confidence            667778999999999998743347899999999999999999999932110 0000                        


Q ss_pred             hhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCccc
Q 014406          355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV  415 (425)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~  415 (425)
                             .....      .....+..+++++.+||++||+.||++|||++|+++||||+.-
T Consensus       218 -------~~i~~------~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~  265 (336)
T 3h4j_B          218 -------KKVNS------CVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVN  265 (336)
T ss_dssp             -------CCCCS------SCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred             -------HHHHc------CCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhccC
Confidence                   00000      0011223478999999999999999999999999999999853

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=1.5e-48  Score=377.31  Aligned_cols=254  Identities=27%  Similarity=0.478  Sum_probs=209.7

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc--------chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCC
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~--------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (425)
                      .++|++.+.||+|+||+||+|.+..+++.||||++...        ..+.+.+|+.+++.+ +||||+++++++.+.  .
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~--~   99 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML-KHPHIVELLETYSSD--G   99 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHC-CCTTBCCEEEEEEET--T
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhC-CCCCCCcEEEEEEeC--C
Confidence            56899999999999999999999999999999998532        356789999999999 999999999999764  6


Q ss_pred             ccEEEEEeecCCChhhhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCC--CcEEEEeccc
Q 014406          196 TPSLIFEYVNSTDFKVLYP-------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEL--RKLRLIDWGL  266 (425)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~~-------~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~--~~~kl~Dfg~  266 (425)
                      ..++||||+++++|...+.       .+++..+..++.||+.||+|||++||+||||||+|||++.+.  ..+||+|||+
T Consensus       100 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~  179 (351)
T 3c0i_A          100 MLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGV  179 (351)
T ss_dssp             EEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred             EEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcc
Confidence            7899999999999976551       389999999999999999999999999999999999998652  3499999999


Q ss_pred             cccccCCCc-ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHH
Q 014406          267 AEFYHPGKE-YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAY  345 (425)
Q Consensus       267 a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~  345 (425)
                      ++....... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...  +.+....+...         
T Consensus       180 a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~--~~~~~~~i~~~---------  247 (351)
T 3c0i_A          180 AIQLGESGLVAGGRVGTPHFMAPEVVKR-EPYGKPVDVWGCGVILFILLSGCLPFYGT--KERLFEGIIKG---------  247 (351)
T ss_dssp             CEECCTTSCBCCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCSS--HHHHHHHHHHT---------
T ss_pred             eeEecCCCeeecCCcCCcCccCHHHHcC-CCCCchHhhHHHHHHHHHHHHCCCCCCCc--HHHHHHHHHcC---------
Confidence            987654432 345689999999999987 67899999999999999999999999431  22222222211         


Q ss_pred             HhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccc
Q 014406          346 LNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR  416 (425)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~  416 (425)
                          .....+                    .....+++++++||++||+.||++|||+.|+|+||||++..
T Consensus       248 ----~~~~~~--------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~~  294 (351)
T 3c0i_A          248 ----KYKMNP--------------------RQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERD  294 (351)
T ss_dssp             ----CCCCCH--------------------HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTHH
T ss_pred             ----CCCCCc--------------------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCCc
Confidence                000000                    00123789999999999999999999999999999998754

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=9.6e-49  Score=378.27  Aligned_cols=258  Identities=28%  Similarity=0.417  Sum_probs=198.1

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEEE
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE  202 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e  202 (425)
                      .++|++.+.||+|+||+||+|.+..+++.||||+++.. ..+.+.+|+.+++++ +||||+++++++.+.  ...++|||
T Consensus        52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~--~~~~lv~e  128 (349)
T 2w4o_A           52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRL-SHPNIIKLKEIFETP--TEISLVLE  128 (349)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHC-CCTTBCCEEEEEECS--SEEEEEEC
T ss_pred             cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhC-CCCCCcceeeeEecC--CeEEEEEE
Confidence            57899999999999999999999999999999999754 346688999999999 899999999999654  67899999


Q ss_pred             eecCCChhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecC--CCCcEEEEeccccccccCCCcce
Q 014406          203 YVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGKEYN  277 (425)
Q Consensus       203 ~~~~~~l~~~~~---~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~--~~~~~kl~Dfg~a~~~~~~~~~~  277 (425)
                      |+.+++|.+++.   .+++.++..++.|++.||.|||+.||+||||||+|||++.  +.+.+||+|||+++.........
T Consensus       129 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~  208 (349)
T 2w4o_A          129 LVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMK  208 (349)
T ss_dssp             CCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC------------
T ss_pred             eCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcccccc
Confidence            999999988773   4899999999999999999999999999999999999975  23789999999998765554455


Q ss_pred             eeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCChhh
Q 014406          278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQL  357 (425)
Q Consensus       278 ~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~  357 (425)
                      ...||+.|+|||++.+ ..++.++|||||||++|+|++|..||.........+..+....             ...    
T Consensus       209 ~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~-------------~~~----  270 (349)
T 2w4o_A          209 TVCGTPGYCAPEILRG-CAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCE-------------YYF----  270 (349)
T ss_dssp             ----CGGGSCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTC-------------CCC----
T ss_pred             cccCCCCccCHHHhcC-CCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCC-------------Ccc----
Confidence            6788999999999987 6799999999999999999999999964433332333222100             000    


Q ss_pred             HHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccc
Q 014406          358 DALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA  418 (425)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~  418 (425)
                                      .......++.++.+||++||+.||++|||+.|+|+||||++....
T Consensus       271 ----------------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~  315 (349)
T 2w4o_A          271 ----------------ISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAAN  315 (349)
T ss_dssp             ----------------CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTTCC
T ss_pred             ----------------CCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCccc
Confidence                            001112378999999999999999999999999999999976543

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=2.2e-48  Score=381.81  Aligned_cols=284  Identities=33%  Similarity=0.571  Sum_probs=224.8

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcchHHHHHHHHHHHHhcCCCCeeeEEeEEEcCC----CCccEE
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQH----SKTPSL  199 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~----~~~~~l  199 (425)
                      ..+|++.+.||+|+||+||+|.+..+++ +|+|.+.... ....+|+.+++.+ +||||++++++|....    ....++
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~-~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~~l  115 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDK-RFKNRELQIMRIV-KHPNVVDLKAFFYSNGDKKDEVFLNL  115 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCT-TSCCHHHHHHHTC-CCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCc-chHHHHHHHHHhC-CCCCcceEEEEEEecCCCCCceEEEE
Confidence            4579999999999999999999877776 7777664322 2334799999999 9999999999996532    224789


Q ss_pred             EEEeecCCChhhhc------CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCC
Q 014406          200 IFEYVNSTDFKVLY------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (425)
Q Consensus       200 v~e~~~~~~l~~~~------~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~  273 (425)
                      ||||++++.+....      ..+++..++.++.||+.||+|||++||+||||||+|||++.+.+.+||+|||+++.....
T Consensus       116 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~  195 (394)
T 4e7w_A          116 VLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG  195 (394)
T ss_dssp             EEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred             EeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCC
Confidence            99999987655432      569999999999999999999999999999999999999944489999999999887666


Q ss_pred             CcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCC
Q 014406          274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL  353 (425)
Q Consensus       274 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~  353 (425)
                      .......+|+.|+|||++.+...++.++|||||||++|+|++|+.|| .+.+..+++..+.+.+|.+.............
T Consensus       196 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf-~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~  274 (394)
T 4e7w_A          196 EPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLF-PGESGIDQLVEIIKVLGTPSREQIKTMNPNYM  274 (394)
T ss_dssp             CCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGS
T ss_pred             CCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCCHHHHHhhChhhh
Confidence            66666788999999999987567999999999999999999999987 66777889999999999877655432111000


Q ss_pred             ChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccch
Q 014406          354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE  419 (425)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~~  419 (425)
                      ...    .......++.    ......+++++.+||.+||++||++|||+.|+++||||++++...
T Consensus       275 ~~~----~~~~~~~~~~----~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~  332 (394)
T 4e7w_A          275 EHK----FPQIRPHPFS----KVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTGE  332 (394)
T ss_dssp             SSC----CCCCCCCCHH----HHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTSSC
T ss_pred             hhc----cccccCCcHH----HhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcccc
Confidence            000    0000111111    112234789999999999999999999999999999999887654

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=1.7e-48  Score=387.44  Aligned_cols=254  Identities=26%  Similarity=0.479  Sum_probs=209.7

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc-----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccE
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (425)
                      .++|++.+.||+|+||+||+|.+..+++.+|+|++....     .+.+.+|+.+++.+ +||||+++++++.+.  ...+
T Consensus        10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~--~~~~   86 (444)
T 3soa_A           10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLL-KHPNIVRLHDSISEE--GHHY   86 (444)
T ss_dssp             HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHC-CBTTBCCEEEEEECS--SEEE
T ss_pred             cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCcCCCeEEEEEEEC--CEEE
Confidence            568999999999999999999999999999999987533     35688999999999 999999999999654  7889


Q ss_pred             EEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCC--CCcEEEEeccccccccCC
Q 014406          199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--LRKLRLIDWGLAEFYHPG  273 (425)
Q Consensus       199 lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~--~~~~kl~Dfg~a~~~~~~  273 (425)
                      +||||+.+++|.+.+   ..+++..+..++.||+.||.|||++||+||||||+|||++.+  .+.+||+|||++......
T Consensus        87 lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~  166 (444)
T 3soa_A           87 LIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE  166 (444)
T ss_dssp             EEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTT
T ss_pred             EEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCC
Confidence            999999999998776   569999999999999999999999999999999999999852  367999999999876543


Q ss_pred             C-cceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCC
Q 014406          274 K-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE  352 (425)
Q Consensus       274 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~  352 (425)
                      . ......||+.|+|||++.+ ..++.++||||+||++|+|++|..||. +.+..+.+..+....             ..
T Consensus       167 ~~~~~~~~gt~~Y~APE~l~~-~~~~~~~DIwSlGvilyell~G~~Pf~-~~~~~~~~~~i~~~~-------------~~  231 (444)
T 3soa_A          167 QQAWFGFAGTPGYLSPEVLRK-DPYGKPVDLWACGVILYILLVGYPPFW-DEDQHRLYQQIKAGA-------------YD  231 (444)
T ss_dssp             CCBCCCSCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSCC-CSSHHHHHHHHHHTC-------------CC
T ss_pred             CceeecccCCcccCCHHHhcC-CCCCCccccHHHHHHHHHHHhCCCCCC-CccHHHHHHHHHhCC-------------CC
Confidence            3 2345689999999999977 689999999999999999999999984 333333333332210             00


Q ss_pred             CChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCccc
Q 014406          353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV  415 (425)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~  415 (425)
                      .                    .......+++++++||.+||+.||++|||++|+|+||||++.
T Consensus       232 ~--------------------~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~  274 (444)
T 3soa_A          232 F--------------------PSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHR  274 (444)
T ss_dssp             C--------------------CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred             C--------------------CccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence            0                    001112378999999999999999999999999999999764

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=7.3e-49  Score=386.17  Aligned_cols=262  Identities=27%  Similarity=0.416  Sum_probs=215.9

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCc
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (425)
                      ..++|++++.||+|+||+||+|++..+++.||+|++++.      ..+.+.+|..++..+ +||||++++++|.+.  ..
T Consensus        59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~-~hp~Iv~l~~~~~~~--~~  135 (412)
T 2vd5_A           59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNG-DRRWITQLHFAFQDE--NY  135 (412)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHS-CTTTBCCEEEEEECS--SE
T ss_pred             ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhc-CCCCeeeEEEEEeeC--CE
Confidence            468899999999999999999999999999999999642      234588999999998 999999999999654  78


Q ss_pred             cEEEEEeecCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccC
Q 014406          197 PSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (425)
Q Consensus       197 ~~lv~e~~~~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~  272 (425)
                      +|+||||+++|+|..++    ..+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++....
T Consensus       136 ~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~-g~vkL~DFGla~~~~~  214 (412)
T 2vd5_A          136 LYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRC-GHIRLADFGSCLKLRA  214 (412)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-SCEEECCCTTCEECCT
T ss_pred             EEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCC-CCEEEeechhheeccC
Confidence            89999999999999887    369999999999999999999999999999999999999988 7999999999987654


Q ss_pred             CCcc--eeeccCCCccCcccccC------CCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHH
Q 014406          273 GKEY--NVRVASRYFKGPELLVD------LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA  344 (425)
Q Consensus       273 ~~~~--~~~~~t~~y~aPE~~~~------~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~  344 (425)
                      ....  ...+||+.|+|||++..      ...++.++|||||||++|||++|+.||. +.+..+....+...-       
T Consensus       215 ~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~-~~~~~~~~~~i~~~~-------  286 (412)
T 2vd5_A          215 DGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFY-ADSTAETYGKIVHYK-------  286 (412)
T ss_dssp             TSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTC-CSSHHHHHHHHHTHH-------
T ss_pred             CCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCC-CCCHHHHHHHHHhcc-------
Confidence            4332  34589999999999973      2468999999999999999999999984 334344444432210       


Q ss_pred             HHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCC---cCHHHHhcCCCCcccccchhc
Q 014406          345 YLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDR---LTAREAMAHPYFAQVRAAESS  421 (425)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R---pta~elL~hp~~~~~~~~~~~  421 (425)
                          ....+                     ......+++++++||++||+ +|++|   ++++|+++||||+++.|....
T Consensus       287 ----~~~~~---------------------p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~~l~  340 (412)
T 2vd5_A          287 ----EHLSL---------------------PLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDGLR  340 (412)
T ss_dssp             ----HHCCC---------------------C----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCSTTST
T ss_pred             ----cCcCC---------------------CccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHHHHh
Confidence                00000                     00012379999999999999 99998   599999999999999887654


Q ss_pred             c
Q 014406          422 R  422 (425)
Q Consensus       422 ~  422 (425)
                      +
T Consensus       341 ~  341 (412)
T 2vd5_A          341 D  341 (412)
T ss_dssp             T
T ss_pred             h
Confidence            3

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=2.2e-48  Score=381.36  Aligned_cols=291  Identities=19%  Similarity=0.256  Sum_probs=208.8

Q ss_pred             CCCCEEEEeeeeee--CceEEEEEEEcCCCcEEEEEEecCcc-----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCC
Q 014406          123 DQDDYEVVRKVGRG--KYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (425)
Q Consensus       123 ~~~~y~~~~~LG~G--~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (425)
                      ..++|++.+.||+|  +||+||+|.+..+++.||||+++...     .+.+.+|+.+++.+ +||||+++++++.+.  .
T Consensus        23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~--~   99 (389)
T 3gni_B           23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF-NHPNIVPYRATFIAD--N   99 (389)
T ss_dssp             CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEET--T
T ss_pred             CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhC-CCCCCCcEeEEEEEC--C
Confidence            56789999999999  99999999999999999999997432     35678899999999 899999999999764  6


Q ss_pred             ccEEEEEeecCCChhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccc
Q 014406          196 TPSLIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  270 (425)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~-----~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~  270 (425)
                      ..++||||+.+++|.+++     ..+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||++...
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~-~~~kl~dfg~~~~~  178 (389)
T 3gni_B          100 ELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVD-GKVYLSGLRSNLSM  178 (389)
T ss_dssp             EEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-CCEEECCGGGCEEC
T ss_pred             EEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC-CCEEEcccccceee
Confidence            789999999999998876     458999999999999999999999999999999999999988 79999999988644


Q ss_pred             cCC--------CcceeeccCCCccCcccccCC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHH-HhC--
Q 014406          271 HPG--------KEYNVRVASRYFKGPELLVDL-QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK-VLG--  338 (425)
Q Consensus       271 ~~~--------~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~-~lg--  338 (425)
                      ...        .......+|..|+|||++.+. ..++.++|||||||++|+|++|+.||.. .+..+.+..+.. ...  
T Consensus       179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~-~~~~~~~~~~~~~~~~~~  257 (389)
T 3gni_B          179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD-MPATQMLLEKLNGTVPCL  257 (389)
T ss_dssp             EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTT-CCSTTHHHHC--------
T ss_pred             ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHhcCCCCcc
Confidence            221        112234788899999999763 4689999999999999999999999843 333333322211 000  


Q ss_pred             --CchhH--HHH-hhccCCCChh-hHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCC
Q 014406          339 --TDELN--AYL-NKYHLELDPQ-LDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF  412 (425)
Q Consensus       339 --~~~~~--~~~-~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~  412 (425)
                        .....  ... .......... .+......................+++++++||++||++||++|||++|+|+||||
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f  337 (389)
T 3gni_B          258 LDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFF  337 (389)
T ss_dssp             ------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGG
T ss_pred             ccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHH
Confidence              00000  000 0000000000 00000000001111111222334578999999999999999999999999999999


Q ss_pred             cccccc
Q 014406          413 AQVRAA  418 (425)
Q Consensus       413 ~~~~~~  418 (425)
                      +++...
T Consensus       338 ~~~~~~  343 (389)
T 3gni_B          338 KQIKRR  343 (389)
T ss_dssp             GGC---
T ss_pred             HHHhhc
Confidence            988653

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=3.7e-48  Score=370.86  Aligned_cols=255  Identities=29%  Similarity=0.501  Sum_probs=205.3

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEc---CCCcEEEEEEecCc-------chHHHHHHHHHHHHhcCCCCeeeEEeEEEcC
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINV---NTNERCIIKILKPV-------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQ  192 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~---~~~~~vavK~~~~~-------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  192 (425)
                      ..++|++.+.||+|+||+||+|.+.   .+++.||+|+++..       ....+.+|+.+++.+ +||||+++++++.. 
T Consensus        15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~-   92 (327)
T 3a62_A           15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV-KHPFIVDLIYAFQT-   92 (327)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHC-CCTTBCCEEEEEEC-
T ss_pred             CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhC-CCCCccceeEEEEc-
Confidence            3578999999999999999999875   68999999999753       234577899999999 89999999999965 


Q ss_pred             CCCccEEEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEecccccc
Q 014406          193 HSKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (425)
Q Consensus       193 ~~~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~  269 (425)
                       ....++||||+.+++|..++   ..+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++.
T Consensus        93 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~-~~~kl~Dfg~~~~  170 (327)
T 3a62_A           93 -GGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQ-GHVKLTDFGLCKE  170 (327)
T ss_dssp             -SSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTT-SCEEECCCSCC--
T ss_pred             -CCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCC-CcEEEEeCCcccc
Confidence             46789999999999998876   458999999999999999999999999999999999999988 7999999999975


Q ss_pred             ccCC-CcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhh
Q 014406          270 YHPG-KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK  348 (425)
Q Consensus       270 ~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~  348 (425)
                      .... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||. +.+..+.+..+.+.            
T Consensus       171 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~-~~~~~~~~~~i~~~------------  236 (327)
T 3a62_A          171 SIHDGTVTHTFCGTIEYMAPEILMR-SGHNRAVDWWSLGALMYDMLTGAPPFT-GENRKKTIDKILKC------------  236 (327)
T ss_dssp             --------CTTSSCCTTSCHHHHTT-SCCCTHHHHHHHHHHHHHHHHSSCSCC-CSSHHHHHHHHHHT------------
T ss_pred             cccCCccccccCCCcCccCHhhCcC-CCCCCcccchhHHHHHHHHHHCCCCCC-CCCHHHHHHHHHhC------------
Confidence            4322 23344578999999999987 678999999999999999999999984 33333333333221            


Q ss_pred             ccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCc-----CHHHHhcCCCCcccccchh
Q 014406          349 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYFAQVRAAES  420 (425)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rp-----ta~elL~hp~~~~~~~~~~  420 (425)
                       ..                        ..+..+++++.+||.+||+.||++||     +++|+++||||+++.+.+.
T Consensus       237 -~~------------------------~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~~~~  288 (327)
T 3a62_A          237 -KL------------------------NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEEL  288 (327)
T ss_dssp             -CC------------------------CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCHHHH
T ss_pred             -CC------------------------CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCCHHHH
Confidence             00                        01123689999999999999999999     8999999999999877554

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=6e-48  Score=374.20  Aligned_cols=282  Identities=23%  Similarity=0.398  Sum_probs=218.6

Q ss_pred             CCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc--chHHHHHHHHHHHHhc----CCCCeeeEEeEEEcCCCC
Q 014406          122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLC----GGPNVVKLLDIVRDQHSK  195 (425)
Q Consensus       122 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~----~h~niv~l~~~~~~~~~~  195 (425)
                      ...++|++.++||+|+||+||+|.+..+++.||||+++..  ....+..|+.+++.+.    +||||+++++++...  .
T Consensus        32 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~--~  109 (360)
T 3llt_A           32 LLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYY--D  109 (360)
T ss_dssp             EETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEET--T
T ss_pred             EecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeEC--C
Confidence            3468999999999999999999999999999999999743  3456788999999983    399999999999764  6


Q ss_pred             ccEEEEEeecCCChhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecC----------------
Q 014406          196 TPSLIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH----------------  254 (425)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~-----~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~----------------  254 (425)
                      ..++||||+ +++|.+++     ..+++..++.++.||+.||+|||++||+||||||+|||++.                
T Consensus       110 ~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~  188 (360)
T 3llt_A          110 HMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDG  188 (360)
T ss_dssp             EEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTC
T ss_pred             eeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhccccc
Confidence            789999999 88887776     24899999999999999999999999999999999999975                


Q ss_pred             --------CCCcEEEEeccccccccCCCcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCC
Q 014406          255 --------ELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN  326 (425)
Q Consensus       255 --------~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~  326 (425)
                              +.+.+||+|||+++....  ......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.|| .+.+.
T Consensus       189 ~~~~~~~~~~~~~kl~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf-~~~~~  264 (360)
T 3llt_A          189 KKIQIYRTKSTGIKLIDFGCATFKSD--YHGSIINTRQYRAPEVILN-LGWDVSSDMWSFGCVLAELYTGSLLF-RTHEH  264 (360)
T ss_dssp             CEEEEEEESCCCEEECCCTTCEETTS--CCCSCCSCGGGCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSC-CCSSH
T ss_pred             ccccccccCCCCEEEEeccCceecCC--CCcCccCcccccCcHHHcC-CCCCCccchHHHHHHHHHHHHCCCCC-CCCcH
Confidence                    237899999999986442  3345678999999999987 68999999999999999999999998 45566


Q ss_pred             HHHHHHHHHHhCCchhHHHHhhccCCCChhhHHHhcccCCCCccccc------------cccCCCCCCHHHHHHHHHccc
Q 014406          327 HDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFI------------NADNQHLVSPEAIDFLDKLLR  394 (425)
Q Consensus       327 ~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~s~~~~~ll~~~L~  394 (425)
                      .+.+..+....+..+..................   ......|....            ........++.+.+||++||+
T Consensus       265 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~---~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~  341 (360)
T 3llt_A          265 MEHLAMMESIIQPIPKNMLYEATKTNGSKYVNK---DELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQ  341 (360)
T ss_dssp             HHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEET---TTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCC
T ss_pred             HHHHHHHHHhcCCCCHHHHhhhhhccCccccCc---ccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhc
Confidence            677777877777655443322111110000000   00000000000            000011135788999999999


Q ss_pred             CCcCCCcCHHHHhcCCCCc
Q 014406          395 YDHQDRLTAREAMAHPYFA  413 (425)
Q Consensus       395 ~dP~~Rpta~elL~hp~~~  413 (425)
                      +||++|||++|+|+||||+
T Consensus       342 ~dP~~Rpta~elL~hp~f~  360 (360)
T 3llt_A          342 IDPTLRPSPAELLKHKFLE  360 (360)
T ss_dssp             SSGGGSCCHHHHTTSGGGC
T ss_pred             CChhhCCCHHHHhcCcccC
Confidence            9999999999999999996

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=7.4e-49  Score=382.26  Aligned_cols=254  Identities=25%  Similarity=0.455  Sum_probs=207.2

Q ss_pred             EEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc---chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEEEee
Q 014406          128 EVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV  204 (425)
Q Consensus       128 ~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~  204 (425)
                      ...+.||+|+||+||+|.+..+++.||+|+++..   ..+.+.+|+.+++++ +||||+++++++.+.  ...++||||+
T Consensus        92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~--~~~~lv~E~~  168 (373)
T 2x4f_A           92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQL-DHANLIQLYDAFESK--NDIVLVMEYV  168 (373)
T ss_dssp             EEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEECS--SEEEEEEECC
T ss_pred             ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhC-CCCCCCeEEEEEEEC--CEEEEEEeCC
Confidence            3367899999999999999999999999999764   346788999999999 999999999999654  6789999999


Q ss_pred             cCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecC-CCCcEEEEeccccccccCCCcceee
Q 014406          205 NSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH-ELRKLRLIDWGLAEFYHPGKEYNVR  279 (425)
Q Consensus       205 ~~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~-~~~~~kl~Dfg~a~~~~~~~~~~~~  279 (425)
                      ++++|.+++    ..+++..+..++.||+.||+|||+.||+||||||+|||++. +.+.+||+|||+++...........
T Consensus       169 ~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~~~  248 (373)
T 2x4f_A          169 DGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVN  248 (373)
T ss_dssp             TTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCCCC
T ss_pred             CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccccccc
Confidence            999987765    24899999999999999999999999999999999999942 2368999999999987766666667


Q ss_pred             ccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCChhhHH
Q 014406          280 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDA  359 (425)
Q Consensus       280 ~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~  359 (425)
                      .||+.|+|||++.+ ..++.++|||||||++|+|++|..||. +.+..+.+..+.......                   
T Consensus       249 ~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~-~~~~~~~~~~i~~~~~~~-------------------  307 (373)
T 2x4f_A          249 FGTPEFLAPEVVNY-DFVSFPTDMWSVGVIAYMLLSGLSPFL-GDNDAETLNNILACRWDL-------------------  307 (373)
T ss_dssp             CSSCTTCCHHHHTT-CBCCHHHHHHHHHHHHHHHHHSSCTTC-CSSHHHHHHHHHHTCCCS-------------------
T ss_pred             cCCCcEeChhhccC-CCCCcHHhHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHhccCCC-------------------
Confidence            89999999999876 678999999999999999999999984 444444444443211000                   


Q ss_pred             HhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccch
Q 014406          360 LVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE  419 (425)
Q Consensus       360 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~~  419 (425)
                                    .......+++++++||.+||+.||++|||++|+|+||||++.....
T Consensus       308 --------------~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~~~~~  353 (373)
T 2x4f_A          308 --------------EDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDHKLHS  353 (373)
T ss_dssp             --------------CSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCHHHHH
T ss_pred             --------------ChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCCchhh
Confidence                          0011123789999999999999999999999999999999886543

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=4.3e-48  Score=369.45  Aligned_cols=258  Identities=28%  Similarity=0.473  Sum_probs=216.0

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc---------chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCC
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS  194 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~---------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  194 (425)
                      .++|++.+.||+|+||+||+|.+..+++.||+|++...         ..+.+.+|+.+++++ +||||+++++++.+.  
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~--   87 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQV-LHHNVITLHDVYENR--   87 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEEECS--
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhC-CCCCcceEEEEEecC--
Confidence            56799999999999999999999999999999998643         246789999999999 899999999999654  


Q ss_pred             CccEEEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCC---cEEEEeccccc
Q 014406          195 KTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELR---KLRLIDWGLAE  268 (425)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~---~~kl~Dfg~a~  268 (425)
                      ...++||||+++++|.+++   ..+++..+..++.|++.||+|||+.||+|+||||+|||++.+..   .+||+|||+++
T Consensus        88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~  167 (321)
T 2a2a_A           88 TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH  167 (321)
T ss_dssp             SEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCE
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccce
Confidence            6789999999999999887   34889999999999999999999999999999999999998732   79999999998


Q ss_pred             cccCCCcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhh
Q 014406          269 FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK  348 (425)
Q Consensus       269 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~  348 (425)
                      ............+|+.|+|||++.+ ..++.++|||||||++|+|++|..||. +.+..+.+..+.....          
T Consensus       168 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~-~~~~~~~~~~i~~~~~----------  235 (321)
T 2a2a_A          168 EIEDGVEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANITSVSY----------  235 (321)
T ss_dssp             ECCTTCCCCCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSC-CSSHHHHHHHHHTTCC----------
T ss_pred             ecCccccccccCCCCCccCcccccC-CCCCCccccHHHHHHHHHHHHCCCCCC-CCCHHHHHHHHHhccc----------
Confidence            7766555566689999999999977 789999999999999999999999984 3333333333322110          


Q ss_pred             ccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccch
Q 014406          349 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE  419 (425)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~~  419 (425)
                         ...+.                    ....+++.+.+||++||+.||++|||++|+++||||+++.+.+
T Consensus       236 ---~~~~~--------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~~~~  283 (321)
T 2a2a_A          236 ---DFDEE--------------------FFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQ  283 (321)
T ss_dssp             ---CCCHH--------------------HHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSSHHH
T ss_pred             ---ccChh--------------------hhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCCCccc
Confidence               00000                    0123688999999999999999999999999999999876544

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=2.5e-48  Score=377.97  Aligned_cols=255  Identities=24%  Similarity=0.434  Sum_probs=207.5

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc------hHHHHHHHHHH-HHhcCCCCeeeEEeEEEcCCCC
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKIL-QNLCGGPNVVKLLDIVRDQHSK  195 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l-~~l~~h~niv~l~~~~~~~~~~  195 (425)
                      ..++|++++.||+|+||+||+|++..+++.||+|++++..      ...+.+|..++ +.+ +||||++++++|.+.  .
T Consensus        36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~-~hp~Iv~l~~~~~~~--~  112 (373)
T 2r5t_A           36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNV-KHPFLVGLHFSFQTA--D  112 (373)
T ss_dssp             CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCC-CCTTBCCEEEEEECS--S
T ss_pred             ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhC-CCCCCCCEEEEEEeC--C
Confidence            4678999999999999999999999999999999996432      23456677664 555 899999999999654  6


Q ss_pred             ccEEEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEecccccccc-
Q 014406          196 TPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-  271 (425)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~-  271 (425)
                      .+|+||||+++++|..++   ..+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++... 
T Consensus       113 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~-g~ikL~DFG~a~~~~~  191 (373)
T 2r5t_A          113 KLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQ-GHIVLTDFGLCKENIE  191 (373)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-SCEEECCCCBCGGGBC
T ss_pred             EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCC-CCEEEeeCcccccccc
Confidence            889999999999998876   458999999999999999999999999999999999999988 799999999998643 


Q ss_pred             CCCcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccC
Q 014406          272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL  351 (425)
Q Consensus       272 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~  351 (425)
                      ........+||+.|+|||++.+ ..++.++|||||||++|||++|..||. +.+..+....+...             ..
T Consensus       192 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~-~~~~~~~~~~i~~~-------------~~  256 (373)
T 2r5t_A          192 HNSTTSTFCGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFY-SRNTAEMYDNILNK-------------PL  256 (373)
T ss_dssp             CCCCCCSBSCCCCCCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTC-CSBHHHHHHHHHHS-------------CC
T ss_pred             CCCccccccCCccccCHHHhCC-CCCCchhhhHHHHHHHHHHHcCCCCCC-CCCHHHHHHHHHhc-------------cc
Confidence            3334456789999999999987 789999999999999999999999984 33333333333220             00


Q ss_pred             CCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCH----HHHhcCCCCcccccchh
Q 014406          352 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA----REAMAHPYFAQVRAAES  420 (425)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta----~elL~hp~~~~~~~~~~  420 (425)
                                              .....++.++++||++||+.||++||++    +++++||||+.+.|...
T Consensus       257 ------------------------~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w~~l  305 (373)
T 2r5t_A          257 ------------------------QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWDDL  305 (373)
T ss_dssp             ------------------------CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCHHHH
T ss_pred             ------------------------CCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCCHHHH
Confidence                                    0112378999999999999999999986    69999999999988665

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=6.1e-48  Score=374.89  Aligned_cols=283  Identities=28%  Similarity=0.561  Sum_probs=226.8

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCC---CC
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQH---SK  195 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~---~~  195 (425)
                      ..++|++++.||+|+||+||+|.+..+++.||||++....    .+.+.+|+.+++++ +||||+++++++....   ..
T Consensus        25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~  103 (364)
T 3qyz_A           25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRF-RHENIIGINDIIRAPTIEQMK  103 (364)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHC-CCTTBCCCCEEECCSSTTTCC
T ss_pred             ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhc-CCCCCccceeEEecCCccccc
Confidence            3579999999999999999999999999999999997432    35688999999999 8999999999996542   24


Q ss_pred             ccEEEEEeecCCChhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCC
Q 014406          196 TPSLIFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (425)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~  273 (425)
                      ..++||||+++ +|..++  ..+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++.....
T Consensus       104 ~~~iv~e~~~~-~L~~~l~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~-~~~kl~Dfg~a~~~~~~  181 (364)
T 3qyz_A          104 DVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTT-CDLKICDFGLARVADPD  181 (364)
T ss_dssp             CEEEEEECCSE-EHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-CCEEECCCTTCEECCGG
T ss_pred             eEEEEEcccCc-CHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCC-CCEEEEeCcceEecCCC
Confidence            68999999986 666655  469999999999999999999999999999999999999988 78999999999866433


Q ss_pred             Cc----ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhc
Q 014406          274 KE----YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY  349 (425)
Q Consensus       274 ~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~  349 (425)
                      ..    .....+|+.|+|||++.+...++.++|||||||++|+|++|+.|| .+.+..+.+..+...+|.+....+....
T Consensus       182 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~  260 (364)
T 3qyz_A          182 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF-PGKHYLDQLNHILGILGSPSQEDLNCII  260 (364)
T ss_dssp             GCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSS-CCSSGGGHHHHHHHHHCSCCHHHHHTCC
T ss_pred             CCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCC-CCCChHHHHHHHHHHhCCCCHHHHHHhh
Confidence            22    234578999999999877567899999999999999999999887 6677788889998888887654432110


Q ss_pred             cCCCChhhHHHhc---ccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccc
Q 014406          350 HLELDPQLDALVG---RHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA  418 (425)
Q Consensus       350 ~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~  418 (425)
                          .........   .....+|..     ....+++++.+||++||++||++|||++|+|+||||++....
T Consensus       261 ----~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~  323 (364)
T 3qyz_A          261 ----NLKARNYLLSLPHKNKVPWNR-----LFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP  323 (364)
T ss_dssp             ----CHHHHHHHHTSCCCCCCCHHH-----HCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCCG
T ss_pred             ----hhhHHHHHHhcCCccCCCHHH-----hCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccCc
Confidence                000000000   011111111     123378999999999999999999999999999999987543

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=6.8e-48  Score=361.18  Aligned_cols=260  Identities=26%  Similarity=0.473  Sum_probs=215.8

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc-----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCcc
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (425)
                      ..++|++.+.||+|+||+||+|.+..+++.||+|++....     .+.+.+|+.+++++ +||||+++++++.+.  ...
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~   80 (284)
T 3kk8_A            4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQEE--SFH   80 (284)
T ss_dssp             TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEECS--SEE
T ss_pred             hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHc-CCCCcCeEEEEEEcC--CEE
Confidence            4689999999999999999999999999999999986432     35678999999999 899999999999654  678


Q ss_pred             EEEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCC--CcEEEEeccccccccC
Q 014406          198 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEL--RKLRLIDWGLAEFYHP  272 (425)
Q Consensus       198 ~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~--~~~kl~Dfg~a~~~~~  272 (425)
                      ++||||+.+++|...+   ..+++..+..++.|++.||.|||++||+|+||||+||+++.+.  +.+||+|||++.....
T Consensus        81 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~  160 (284)
T 3kk8_A           81 YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND  160 (284)
T ss_dssp             EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred             EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence            8999999999987765   4589999999999999999999999999999999999998652  3499999999987766


Q ss_pred             CCcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCC
Q 014406          273 GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE  352 (425)
Q Consensus       273 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~  352 (425)
                      ........+|+.|+|||++.+ ..++.++||||||+++|+|++|+.||.. .+..+....+......             
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~-~~~~~~~~~~~~~~~~-------------  225 (284)
T 3kk8_A          161 SEAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWD-EDQHRLYAQIKAGAYD-------------  225 (284)
T ss_dssp             SCBCCCSCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCC-------------
T ss_pred             CccccCCCCCcCCcCchhhcC-CCCCcccchHHHHHHHHHHHHCCCCCCC-CchhHHHHHHHhcccc-------------
Confidence            555566789999999999987 6789999999999999999999999843 3333333322211000             


Q ss_pred             CChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccchh
Q 014406          353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAES  420 (425)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~~~  420 (425)
                      .                    .......+++++.+|+++||+.||++|||++|+++||||++......
T Consensus       226 ~--------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~~  273 (284)
T 3kk8_A          226 Y--------------------PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVAS  273 (284)
T ss_dssp             C--------------------CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCCGGG
T ss_pred             C--------------------CchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCChhHHh
Confidence            0                    00111237899999999999999999999999999999998766554

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=5.8e-48  Score=362.29  Aligned_cols=252  Identities=23%  Similarity=0.453  Sum_probs=202.2

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEE
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (425)
                      .++|++.+.||+|+||+||+|.+..++..+|+|++...    ..+.+.+|+.+++++ +||||+++++++.+.  ...++
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~--~~~~l   97 (285)
T 3is5_A           21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSL-DHPNIIKIFEVFEDY--HNMYI   97 (285)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTC-CCTTBCCEEEEEECS--SEEEE
T ss_pred             hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhC-CCchHHhHHHheecC--CeEEE
Confidence            57899999999999999999999999999999998643    347789999999999 999999999999654  67899


Q ss_pred             EEEeecCCChhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCC--CCcEEEEeccccccc
Q 014406          200 IFEYVNSTDFKVLY-------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--LRKLRLIDWGLAEFY  270 (425)
Q Consensus       200 v~e~~~~~~l~~~~-------~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~--~~~~kl~Dfg~a~~~  270 (425)
                      ||||+++++|.+.+       ..+++..+..++.|++.||+|||+.||+|+||||+|||++.+  .+.+||+|||+++..
T Consensus        98 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~  177 (285)
T 3is5_A           98 VMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF  177 (285)
T ss_dssp             EECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred             EEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence            99999999998776       569999999999999999999999999999999999999542  267999999999876


Q ss_pred             cCCCcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhcc
Q 014406          271 HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH  350 (425)
Q Consensus       271 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~  350 (425)
                      ..........+|..|+|||++.  ..++.++|||||||++|+|++|+.||. +.+..+....... . ...         
T Consensus       178 ~~~~~~~~~~~t~~y~aPE~~~--~~~~~~~Di~slG~il~~ll~g~~pf~-~~~~~~~~~~~~~-~-~~~---------  243 (285)
T 3is5_A          178 KSDEHSTNAAGTALYMAPEVFK--RDVTFKCDIWSAGVVMYFLLTGCLPFT-GTSLEEVQQKATY-K-EPN---------  243 (285)
T ss_dssp             ---------CTTGGGCCHHHHT--TCCCHHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHH-C-CCC---------
T ss_pred             CCcccCcCcccccCcCChHHhc--cCCCcccCeehHHHHHHHHHhCCCCCC-CCCHHHHHhhhcc-C-Ccc---------
Confidence            6555556678999999999985  468999999999999999999999984 2222222111110 0 000         


Q ss_pred             CCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCccc
Q 014406          351 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV  415 (425)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~  415 (425)
                                             .......+++++.+|+++||+.||++|||++|+|+||||+++
T Consensus       244 -----------------------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~a  285 (285)
T 3is5_A          244 -----------------------YAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQA  285 (285)
T ss_dssp             -----------------------CCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC-
T ss_pred             -----------------------cccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhcC
Confidence                                   000112268999999999999999999999999999999874

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=2.9e-48  Score=378.15  Aligned_cols=286  Identities=26%  Similarity=0.467  Sum_probs=211.8

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCC----
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH----  193 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~----  193 (425)
                      ..++|++.+.||+|+||+||+|.+..+++.||||++...     ..+.+.+|+.+++.+ +||||+++++++....    
T Consensus        23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~  101 (371)
T 2xrw_A           23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIIGLLNVFTPQKSLEE  101 (371)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSCCSTTT
T ss_pred             hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhc-CCCCccceEEeecccccccc
Confidence            357899999999999999999999999999999998642     235678999999999 9999999999997543    


Q ss_pred             CCccEEEEEeecCCChhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCC
Q 014406          194 SKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (425)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~  273 (425)
                      ....++||||++++.+..+...+++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++.....
T Consensus       102 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~-~~~kl~Dfg~a~~~~~~  180 (371)
T 2xrw_A          102 FQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-CTLKILDFGLARTAGTS  180 (371)
T ss_dssp             CCEEEEEEECCSEEHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-SCEEECCCCC-------
T ss_pred             ccceEEEEEcCCCCHHHHHhhccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCC-CCEEEEEeecccccccc
Confidence            13679999999976555555679999999999999999999999999999999999999988 78999999999876554


Q ss_pred             CcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCC
Q 014406          274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL  353 (425)
Q Consensus       274 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~  353 (425)
                      .......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.|| .+.+..+++..+.+.+|.+......     ..
T Consensus       181 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~-----~~  253 (371)
T 2xrw_A          181 FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLF-PGTDHIDQWNKVIEQLGTPCPEFMK-----KL  253 (371)
T ss_dssp             ---------CTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHC-CCCCCHHHHT-----TS
T ss_pred             cccCCceecCCccCHHHhcC-CCCCchHhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCCHHHHH-----Hh
Confidence            44556689999999999987 67999999999999999999999998 5566677778787777765433211     01


Q ss_pred             ChhhHHHhcccC---CCCcccccccc-------CCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCccccc
Q 014406          354 DPQLDALVGRHS---RKPWSKFINAD-------NQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA  417 (425)
Q Consensus       354 ~~~~~~~~~~~~---~~~~~~~~~~~-------~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~  417 (425)
                      .+..........   ...+.......       .....++++++||++||++||++|||++|+|+||||+....
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~  327 (371)
T 2xrw_A          254 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYD  327 (371)
T ss_dssp             CHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTCC
T ss_pred             hhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhcC
Confidence            111111111000   00000000000       00112567999999999999999999999999999986544

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=3.6e-48  Score=374.52  Aligned_cols=290  Identities=30%  Similarity=0.478  Sum_probs=220.4

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCC----
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH----  193 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~----  193 (425)
                      ..++|++.+.||+|+||+||+|.+..+++.||+|++...     ....+.+|+.+++.+ +||||+++++++....    
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~   93 (351)
T 3mi9_A           15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL-KHENVVNLIEICRTKASPYN   93 (351)
T ss_dssp             BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHC-CCTTBCCEEEEEEEC-----
T ss_pred             cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhc-cCCCcccHhheeeccccccc
Confidence            357899999999999999999999999999999998533     235688999999999 8999999999997643    


Q ss_pred             --CCccEEEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccc
Q 014406          194 --SKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE  268 (425)
Q Consensus       194 --~~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~  268 (425)
                        ....++||||++++.+..+.   ..+++.+++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++
T Consensus        94 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~-~~~kl~Dfg~a~  172 (351)
T 3mi9_A           94 RCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRD-GVLKLADFGLAR  172 (351)
T ss_dssp             ---CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-SCEEECCCTTCE
T ss_pred             cCCceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCC-CCEEEccchhcc
Confidence              35689999999975444433   458999999999999999999999999999999999999988 799999999998


Q ss_pred             cccCC-----CcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhH
Q 014406          269 FYHPG-----KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELN  343 (425)
Q Consensus       269 ~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~  343 (425)
                      .....     .......+|+.|+|||++.+...++.++|||||||++|+|++|..|| .+.+..+.+..+.+..+.....
T Consensus       173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf-~~~~~~~~~~~i~~~~~~~~~~  251 (351)
T 3mi9_A          173 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIM-QGNTEQHQLALISQLCGSITPE  251 (351)
T ss_dssp             ECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCCCCTT
T ss_pred             cccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHhCCCChh
Confidence            65422     22344578999999999987567899999999999999999999887 5566677777787777754432


Q ss_pred             HHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccchh
Q 014406          344 AYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAES  420 (425)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~~~  420 (425)
                      .+...........   . . ..................++++.+||.+||++||++|||++|+|+||||+....+..
T Consensus       252 ~~~~~~~~~~~~~---~-~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~  323 (351)
T 3mi9_A          252 VWPNVDNYELYEK---L-E-LVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPSD  323 (351)
T ss_dssp             TSTTGGGCGGGTS---S-C-CCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCCCC
T ss_pred             hccccccchhhcc---c-c-cccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCccc
Confidence            2111000000000   0 0 000000000000000013778999999999999999999999999999987665443

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=2.2e-48  Score=377.53  Aligned_cols=288  Identities=26%  Similarity=0.462  Sum_probs=217.1

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc--------------hHHHHHHHHHHHHhcCCCCeeeEEeE
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--------------KKKIKREIKILQNLCGGPNVVKLLDI  188 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~--------------~~~~~~E~~~l~~l~~h~niv~l~~~  188 (425)
                      ..++|++.+.||+|+||+||+|.+.. +..||||++....              .+.+.+|+.+++++ +||||++++++
T Consensus        20 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~   97 (362)
T 3pg1_A           20 MQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHF-HHPNILGLRDI   97 (362)
T ss_dssp             TTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHC-CCTTBCCCSEE
T ss_pred             hccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhC-CCcCccceeee
Confidence            46889999999999999999998754 8999999985321              26788999999999 89999999999


Q ss_pred             EEcC---CCCccEEEEEeecCCChhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEE
Q 014406          189 VRDQ---HSKTPSLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLI  262 (425)
Q Consensus       189 ~~~~---~~~~~~lv~e~~~~~~l~~~~~---~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~  262 (425)
                      +...   .....++||||++++.+..+..   .+++..+..++.||+.||.|||++||+|+||||+|||++.+ +.+||+
T Consensus        98 ~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~-~~~kl~  176 (362)
T 3pg1_A           98 FVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADN-NDITIC  176 (362)
T ss_dssp             EEECCTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-CCEEEC
T ss_pred             EEeccCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCC-CCEEEE
Confidence            8642   3346899999999654444432   48999999999999999999999999999999999999988 789999


Q ss_pred             eccccccccCCCcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchh
Q 014406          263 DWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDEL  342 (425)
Q Consensus       263 Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~  342 (425)
                      |||+++............+|+.|+|||++.+...++.++|||||||++|+|++|+.|| .+.+..+.+..+.+..+.+..
T Consensus       177 Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf-~~~~~~~~~~~i~~~~~~~~~  255 (362)
T 3pg1_A          177 DFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALF-RGSTFYNQLNKIVEVVGTPKI  255 (362)
T ss_dssp             CTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCCCCH
T ss_pred             ecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHcCCCCh
Confidence            9999986655555566788999999999987567999999999999999999999998 556667788888888888766


Q ss_pred             HHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccch
Q 014406          343 NAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE  419 (425)
Q Consensus       343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~~  419 (425)
                      .......    .+........... .............+++.+.+||.+||++||++|||++|+|+||||+++....
T Consensus       256 ~~~~~~~----~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~  327 (362)
T 3pg1_A          256 EDVVMFS----SPSARDYLRNSLS-NVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDPL  327 (362)
T ss_dssp             HHHHHTS----CHHHHHHTTTCCC-CCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCCGG
T ss_pred             HHhhhcc----chhhhHHHHhhcc-cCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccCcc
Confidence            5433211    1111111111100 0000011112234688999999999999999999999999999999886543

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=4.1e-48  Score=392.92  Aligned_cols=258  Identities=25%  Similarity=0.421  Sum_probs=218.2

Q ss_pred             CCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCC
Q 014406          122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (425)
Q Consensus       122 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (425)
                      ...++|++.+.||+|+||+||+|.+..+++.||+|++...      ....+.+|+.+++.+ +||||+++++++.+.  .
T Consensus       181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~--~  257 (576)
T 2acx_A          181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-NSRFVVSLAYAYETK--D  257 (576)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-CCTTBCCEEEEEECS--S
T ss_pred             ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHc-CCCCEeeEEEEEeeC--C
Confidence            4568899999999999999999999999999999998642      345678999999999 999999999999654  6


Q ss_pred             ccEEEEEeecCCChhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccc
Q 014406          196 TPSLIFEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  270 (425)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~~-----~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~  270 (425)
                      .+++||||++||+|..++.     .+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++..
T Consensus       258 ~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~-g~vKL~DFGla~~~  336 (576)
T 2acx_A          258 ALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDH-GHIRISDLGLAVHV  336 (576)
T ss_dssp             EEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-SCEEECCCTTCEEC
T ss_pred             EEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCC-CCeEEEecccceec
Confidence            8899999999999988762     38999999999999999999999999999999999999988 79999999999887


Q ss_pred             cCCCcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCC--CHHHHHHHHHHhCCchhHHHHhh
Q 014406          271 HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD--NHDQLVKIAKVLGTDELNAYLNK  348 (425)
Q Consensus       271 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~--~~~~~~~~~~~lg~~~~~~~~~~  348 (425)
                      .........+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.....  ..+.+.......           
T Consensus       337 ~~~~~~~~~~GT~~Y~APEvl~~-~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~-----------  404 (576)
T 2acx_A          337 PEGQTIKGRVGTVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV-----------  404 (576)
T ss_dssp             CTTCCEECCCSCGGGCCHHHHTT-CEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHC-----------
T ss_pred             ccCccccccCCCccccCHHHHcC-CCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcc-----------
Confidence            66655566789999999999987 6799999999999999999999999954322  122222211100           


Q ss_pred             ccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCc-----CHHHHhcCCCCcccccchh
Q 014406          349 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYFAQVRAAES  420 (425)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rp-----ta~elL~hp~~~~~~~~~~  420 (425)
                       .                        ......+++++++||++||+.||++||     |++|+++||||+++.|...
T Consensus       405 -~------------------------~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w~~l  456 (576)
T 2acx_A          405 -P------------------------EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKRL  456 (576)
T ss_dssp             -C------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCHHHH
T ss_pred             -c------------------------ccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCCHHHH
Confidence             0                        001123789999999999999999999     8999999999999887544

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=2e-48  Score=388.35  Aligned_cols=255  Identities=26%  Similarity=0.456  Sum_probs=206.1

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCc
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (425)
                      ..++|++.+.||+|+||+||+|.+..+++.||||+++..      ....+.+|+.+++.+ +||||++++++|.+.  ..
T Consensus       146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~--~~  222 (446)
T 4ejn_A          146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS-RHPFLTALKYSFQTH--DR  222 (446)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCC-SCTTSCCEEEEEEET--TE
T ss_pred             ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhC-CCCeEeeEEEEEeeC--CE
Confidence            357899999999999999999999999999999998642      235577899999998 899999999999754  67


Q ss_pred             cEEEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHH-CCceeecCCCCceEecCCCCcEEEEeccccccccC
Q 014406          197 PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (425)
Q Consensus       197 ~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~-~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~  272 (425)
                      +++||||+++++|..++   ..+++..++.++.||+.||+|||+ .||+||||||+|||++.+ +.+||+|||+++....
T Consensus       223 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~-~~~kl~DFG~a~~~~~  301 (446)
T 4ejn_A          223 LCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKD-GHIKITDFGLCKEGIK  301 (446)
T ss_dssp             EEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSS-SCEEECCCCCCCTTCC
T ss_pred             EEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCC-CCEEEccCCCceeccC
Confidence            89999999999998876   468999999999999999999998 999999999999999988 7999999999976432


Q ss_pred             -CCcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccC
Q 014406          273 -GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL  351 (425)
Q Consensus       273 -~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~  351 (425)
                       .......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.. .+..+....+...             ..
T Consensus       302 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~-~~~~~~~~~i~~~-------------~~  366 (446)
T 4ejn_A          302 DGATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILME-------------EI  366 (446)
T ss_dssp             -----CCSSSCGGGCCHHHHHT-SCCCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHC-------------CC
T ss_pred             CCcccccccCCccccCHhhcCC-CCCCCccchhhhHHHHHHHhhCCCCCCC-CCHHHHHHHHHhC-------------CC
Confidence             233455689999999999987 7899999999999999999999999842 2322222222110             00


Q ss_pred             CCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCc-----CHHHHhcCCCCcccccchh
Q 014406          352 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYFAQVRAAES  420 (425)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rp-----ta~elL~hp~~~~~~~~~~  420 (425)
                                              ..+..+++++.+||.+||+.||++||     |++|+++||||+++.+...
T Consensus       367 ------------------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~~~~  416 (446)
T 4ejn_A          367 ------------------------RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHV  416 (446)
T ss_dssp             ------------------------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHH
T ss_pred             ------------------------CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCCHHHH
Confidence                                    01123689999999999999999999     9999999999999987554

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=1.2e-47  Score=373.76  Aligned_cols=288  Identities=32%  Similarity=0.591  Sum_probs=223.2

Q ss_pred             cCCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc-----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCC
Q 014406          121 WGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (425)
Q Consensus       121 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (425)
                      +...++|++.+.||+|+||+||+|.+..+++.||||++....     .+.+.+|+.+++.+ +||||+++++++......
T Consensus        38 ~~l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~  116 (371)
T 4exu_A           38 WELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHM-QHENVIGLLDVFTPASSL  116 (371)
T ss_dssp             EEEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSSS
T ss_pred             ecccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhc-CCCCchhhhhheeccCCc
Confidence            334689999999999999999999999999999999997532     35678999999999 899999999999754322


Q ss_pred             ----ccEEEEEeecCCChhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccc
Q 014406          196 ----TPSLIFEYVNSTDFKVLY-PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  270 (425)
Q Consensus       196 ----~~~lv~e~~~~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~  270 (425)
                          ..++||||+.+ +|...+ ..+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++..
T Consensus       117 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~-~~~kL~Dfg~a~~~  194 (371)
T 4exu_A          117 RNFYDFYLVMPFMQT-DLQKIMGMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNED-CELKILDFGLARHA  194 (371)
T ss_dssp             TTCCCCEEEEECCCE-EHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-CCEEECSTTCC---
T ss_pred             ccceeEEEEEccccc-cHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCC-CCEEEEecCccccc
Confidence                24899999995 555554 569999999999999999999999999999999999999988 78999999999865


Q ss_pred             cCCCcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhcc
Q 014406          271 HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH  350 (425)
Q Consensus       271 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~  350 (425)
                      ..  ......+|+.|+|||++.+...++.++|||||||++|+|++|+.|| .+.+..+.+..+.+..|.+...... ...
T Consensus       195 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~-~~~  270 (371)
T 4exu_A          195 DA--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLF-KGKDYLDQLTQILKVTGVPGTEFVQ-KLN  270 (371)
T ss_dssp             -------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCCCCHHHHT-TCS
T ss_pred             cc--CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHhCCCcHHHHH-Hhh
Confidence            42  3344678999999999987667999999999999999999999998 5666677888888888876543221 110


Q ss_pred             CCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccchh
Q 014406          351 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAES  420 (425)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~~~  420 (425)
                         ..................+.  .....+++++.+||++||++||++|||++|+|+||||++......
T Consensus       271 ---~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~  335 (371)
T 4exu_A          271 ---DKAAKSYIQSLPQTPRKDFT--QLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEE  335 (371)
T ss_dssp             ---CHHHHHHHHHSCCCCCCCHH--HHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGGG
T ss_pred             ---hhhhhhhhhccCCCcchhHH--HhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCCccc
Confidence               11111111111111111111  112337899999999999999999999999999999998866543

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=2e-48  Score=372.48  Aligned_cols=260  Identities=26%  Similarity=0.446  Sum_probs=191.3

Q ss_pred             CEEEE---eeeeeeCceEEEEEEEcCCCcEEEEEEecCcchHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEEE
Q 014406          126 DYEVV---RKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE  202 (425)
Q Consensus       126 ~y~~~---~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e  202 (425)
                      +|++.   +.||+|+||+||+|.+..+++.||||++.......+.+|+.+++.+.+||||+++++++.+.  ...++|||
T Consensus         9 ~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~--~~~~lv~e   86 (325)
T 3kn6_A            9 HYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQ--LHTFLVME   86 (325)
T ss_dssp             HEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGGHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--SEEEEEEC
T ss_pred             ccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcC--CEEEEEEE
Confidence            45554   67999999999999999999999999998877888999999999995699999999999654  67899999


Q ss_pred             eecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCC--CcEEEEeccccccccCC-Ccc
Q 014406          203 YVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEL--RKLRLIDWGLAEFYHPG-KEY  276 (425)
Q Consensus       203 ~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~--~~~kl~Dfg~a~~~~~~-~~~  276 (425)
                      |+++++|.+++   ..+++.+++.++.|++.||+|||++||+||||||+|||++.+.  ..+||+|||+++..... ...
T Consensus        87 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~  166 (325)
T 3kn6_A           87 LLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPL  166 (325)
T ss_dssp             CCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred             ccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCcc
Confidence            99999998876   4589999999999999999999999999999999999998652  27999999999865443 233


Q ss_pred             eeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCH--HHHHHHHHHhCCchhHHHHhhccCCCC
Q 014406          277 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNH--DQLVKIAKVLGTDELNAYLNKYHLELD  354 (425)
Q Consensus       277 ~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~--~~~~~~~~~lg~~~~~~~~~~~~~~~~  354 (425)
                      ....+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.......  .....+.+.+.         .......
T Consensus       167 ~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~---------~~~~~~~  236 (325)
T 3kn6_A          167 KTPCFTLHYAAPELLNQ-NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIK---------KGDFSFE  236 (325)
T ss_dssp             ------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHT---------TTCCCCC
T ss_pred             cccCCCcCccCHHHhcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHH---------cCCCCCC
Confidence            45678999999999977 789999999999999999999999994322110  00011111110         0000000


Q ss_pred             hhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCccccc
Q 014406          355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA  417 (425)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~  417 (425)
                                          .+....+++++++||++||+.||++|||++|+++||||++...
T Consensus       237 --------------------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~~  279 (325)
T 3kn6_A          237 --------------------GEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQ  279 (325)
T ss_dssp             --------------------SHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTCC
T ss_pred             --------------------cccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCcc
Confidence                                0001237899999999999999999999999999999987643

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=2.6e-48  Score=381.96  Aligned_cols=257  Identities=26%  Similarity=0.435  Sum_probs=202.6

Q ss_pred             CCCEEEE-eeeeeeCceEEEEEEEcCCCcEEEEEEecCcchHHHHHHHHHHHHhcCCCCeeeEEeEEEc--CCCCccEEE
Q 014406          124 QDDYEVV-RKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRD--QHSKTPSLI  200 (425)
Q Consensus       124 ~~~y~~~-~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~--~~~~~~~lv  200 (425)
                      .++|.+. +.||+|+||+||+|.+..+++.||||+++  ....+.+|+.++.++.+||||++++++|..  .....+++|
T Consensus        60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~--~~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv  137 (400)
T 1nxk_A           60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ--DCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIV  137 (400)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEE--CSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred             cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeC--cchhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEE
Confidence            4678777 68999999999999999999999999997  345778999998776699999999999864  234678999


Q ss_pred             EEeecCCChhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCC--CCcEEEEeccccccccCC
Q 014406          201 FEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--LRKLRLIDWGLAEFYHPG  273 (425)
Q Consensus       201 ~e~~~~~~l~~~~~-----~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~--~~~~kl~Dfg~a~~~~~~  273 (425)
                      |||+.+++|.+++.     .+++..++.++.||+.||+|||++||+||||||+|||++.+  .+.+||+|||+++.....
T Consensus       138 ~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~  217 (400)
T 1nxk_A          138 MECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH  217 (400)
T ss_dssp             EECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC--
T ss_pred             EEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccccCCC
Confidence            99999999988873     38999999999999999999999999999999999999973  378999999999876655


Q ss_pred             CcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCH---HHHHHHHHHhCCchhHHHHhhcc
Q 014406          274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNH---DQLVKIAKVLGTDELNAYLNKYH  350 (425)
Q Consensus       274 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~---~~~~~~~~~lg~~~~~~~~~~~~  350 (425)
                      ......++|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.......   .....+.             ...
T Consensus       218 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~-------------~~~  283 (400)
T 1nxk_A          218 NSLTTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR-------------MGQ  283 (400)
T ss_dssp             ---------CTTCCGGGSCC-CCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHH-------------HTC
T ss_pred             CccccCCCCCCccCHhhcCC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHH-------------cCc
Confidence            55566789999999999976 789999999999999999999999995433211   0111111             000


Q ss_pred             CCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccc
Q 014406          351 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR  416 (425)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~  416 (425)
                      ...                    .......+++++++||++||+.||++|||++|+++||||.+..
T Consensus       284 ~~~--------------------~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~  329 (400)
T 1nxk_A          284 YEF--------------------PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST  329 (400)
T ss_dssp             CCC--------------------CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTT
T ss_pred             ccC--------------------CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCC
Confidence            000                    0011123789999999999999999999999999999998643

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=5.5e-48  Score=369.71  Aligned_cols=260  Identities=25%  Similarity=0.423  Sum_probs=211.6

Q ss_pred             CCCCEEEE-eeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCc
Q 014406          123 DQDDYEVV-RKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (425)
Q Consensus       123 ~~~~y~~~-~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (425)
                      ..++|.+. +.||+|+||+||+|.+..+++.||+|++...     ....+.+|+.++..+.+||||+++++++.+  ...
T Consensus        26 ~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~--~~~  103 (327)
T 3lm5_A           26 FNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYEN--TSE  103 (327)
T ss_dssp             HHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSE
T ss_pred             hhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEe--CCe
Confidence            35678887 8899999999999999999999999998742     346789999999999778999999999965  467


Q ss_pred             cEEEEEeecCCChhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecC--CCCcEEEEecccccc
Q 014406          197 PSLIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEF  269 (425)
Q Consensus       197 ~~lv~e~~~~~~l~~~~-----~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~--~~~~~kl~Dfg~a~~  269 (425)
                      .++||||+.+++|..++     ..+++..++.++.|++.||+|||++||+||||||+|||++.  +.+.+||+|||+++.
T Consensus       104 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~  183 (327)
T 3lm5_A          104 IILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK  183 (327)
T ss_dssp             EEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEE
T ss_pred             EEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccc
Confidence            89999999999998886     34899999999999999999999999999999999999987  127899999999987


Q ss_pred             ccCCCcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhc
Q 014406          270 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY  349 (425)
Q Consensus       270 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~  349 (425)
                      ...........+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||. +.+..+....+.......         
T Consensus       184 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~-~~~~~~~~~~i~~~~~~~---------  252 (327)
T 3lm5_A          184 IGHACELREIMGTPEYLAPEILNY-DPITTATDMWNIGIIAYMLLTHTSPFV-GEDNQETYLNISQVNVDY---------  252 (327)
T ss_dssp             C---------CCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHTCCCC---------
T ss_pred             cCCccccccccCCcCccCCeeecC-CCCCchhhHHHHHHHHHHHHhCCCCCC-CCCchHHHHHHHhccccc---------
Confidence            765555566789999999999977 789999999999999999999999983 333333333332211110         


Q ss_pred             cCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccch
Q 014406          350 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE  419 (425)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~~  419 (425)
                                              .......+++.+.+||.+||+.||++|||++|+|+||||+++.+..
T Consensus       253 ------------------------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~~  298 (327)
T 3lm5_A          253 ------------------------SEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFEN  298 (327)
T ss_dssp             ------------------------CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTTC
T ss_pred             ------------------------CchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhccccccc
Confidence                                    0111123789999999999999999999999999999999886643

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=9.1e-48  Score=359.14  Aligned_cols=256  Identities=27%  Similarity=0.474  Sum_probs=214.6

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecC---cchHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEE
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP---VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (425)
                      .++|++.+.||+|+||+||+|.+..++..+|+|.+..   ...+.+.+|+.+++++ +||||+++++++.+  ....++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv   84 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSL-DHPNIIRLYETFED--NTDIYLV   84 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTC-CCTTBCCEEEEEEC--SSEEEEE
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhC-CCCCEeeEEEEEec--CCeEEEE
Confidence            4679999999999999999999999999999999864   3457889999999999 99999999999965  4678999


Q ss_pred             EEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEe---cCCCCcEEEEeccccccccCCC
Q 014406          201 FEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI---DHELRKLRLIDWGLAEFYHPGK  274 (425)
Q Consensus       201 ~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll---~~~~~~~kl~Dfg~a~~~~~~~  274 (425)
                      |||+++++|.+++   ..+++..+..++.|++.||+|||++||+|+||||+|||+   +.+ +.+||+|||++.......
T Consensus        85 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~-~~~~l~Dfg~~~~~~~~~  163 (277)
T 3f3z_A           85 MELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPD-SPLKLIDFGLAARFKPGK  163 (277)
T ss_dssp             EECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTT-CCEEECCCTTCEECCTTS
T ss_pred             EeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCC-CcEEEEecccceeccCcc
Confidence            9999999998765   458999999999999999999999999999999999999   555 789999999998877666


Q ss_pred             cceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCC
Q 014406          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD  354 (425)
Q Consensus       275 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~  354 (425)
                      ......+|+.|+|||++.+  .++.++||||||+++|+|++|+.||. +.+..+....+.+.....+..           
T Consensus       164 ~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~-~~~~~~~~~~~~~~~~~~~~~-----------  229 (277)
T 3f3z_A          164 MMRTKVGTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFS-APTDSEVMLKIREGTFTFPEK-----------  229 (277)
T ss_dssp             CBCCCCSCTTTCCHHHHTT--CBCTTHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHCCCCCCHH-----------
T ss_pred             chhccCCCCCccChHHhcc--cCCchhhehhHHHHHHHHHHCCCCCC-CCCHHHHHHHHHhCCCCCCch-----------
Confidence            6667789999999999865  48999999999999999999999984 333333333332211111000           


Q ss_pred             hhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccch
Q 014406          355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE  419 (425)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~~  419 (425)
                                            ....+++++.+|+++||+.||++|||+.|+|+||||++.....
T Consensus       230 ----------------------~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~~~  272 (277)
T 3f3z_A          230 ----------------------DWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQLSSS  272 (277)
T ss_dssp             ----------------------HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHHCCS
T ss_pred             ----------------------hhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcccccc
Confidence                                  0012689999999999999999999999999999998765443

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=1.3e-47  Score=380.45  Aligned_cols=281  Identities=25%  Similarity=0.484  Sum_probs=218.7

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc--hHHHHHHHHHHHHhc-----CCCCeeeEEeEEEcCCCCc
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--KKKIKREIKILQNLC-----GGPNVVKLLDIVRDQHSKT  196 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~-----~h~niv~l~~~~~~~~~~~  196 (425)
                      ..+|++.+.||+|+||+||+|.+..+++.||||++....  ...+.+|+.+++.+.     +|+||+++++++...  ..
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~--~~  173 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR--NH  173 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET--TE
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC--Ce
Confidence            578999999999999999999999999999999997653  356788999998873     567999999999654  78


Q ss_pred             cEEEEEeecCCChhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCc--EEEEecccccc
Q 014406          197 PSLIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRK--LRLIDWGLAEF  269 (425)
Q Consensus       197 ~~lv~e~~~~~~l~~~~-----~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~--~kl~Dfg~a~~  269 (425)
                      .++||||+.+ +|.+++     ..+++..++.++.||+.||+|||++||+||||||+|||++.+ +.  +||+|||+++.
T Consensus       174 ~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~-~~~~vkL~DFG~a~~  251 (429)
T 3kvw_A          174 ICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQ-GRSGIKVIDFGSSCY  251 (429)
T ss_dssp             EEEEECCCCC-BHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESST-TSCCEEECCCTTCEE
T ss_pred             EEEEEeccCC-CHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccC-CCcceEEeeccccee
Confidence            8999999975 555544     348999999999999999999999999999999999999987 44  99999999976


Q ss_pred             ccCCCcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhc
Q 014406          270 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY  349 (425)
Q Consensus       270 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~  349 (425)
                      ..  .......+|+.|+|||++.+ ..++.++|||||||++|+|++|..|| .+.+..+++..+.+.+|.+........ 
T Consensus       252 ~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~pf-~~~~~~~~l~~i~~~~~~p~~~~~~~~-  326 (429)
T 3kvw_A          252 EH--QRVYTYIQSRFYRAPEVILG-ARYGMPIDMWSLGCILAELLTGYPLL-PGEDEGDQLACMIELLGMPSQKLLDAS-  326 (429)
T ss_dssp             TT--CCCCSSCSCGGGCCHHHHHT-BCCCTHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCCCCHHHHHTB-
T ss_pred             cC--CcccccCCCCCccChHHHhC-CCCCchHHHHhHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHcCCCCHHHHHhh-
Confidence            54  23345688999999999988 67999999999999999999998887 677778889999999887665432110 


Q ss_pred             cCCCChhhHHHhccc-----------------------CC-----CCccccccccCCCCCCHHHHHHHHHcccCCcCCCc
Q 014406          350 HLELDPQLDALVGRH-----------------------SR-----KPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL  401 (425)
Q Consensus       350 ~~~~~~~~~~~~~~~-----------------------~~-----~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rp  401 (425)
                      .     .........                       .+     .+.............++++++||++||++||++||
T Consensus       327 ~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rp  401 (429)
T 3kvw_A          327 K-----RAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRM  401 (429)
T ss_dssp             T-----THHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSC
T ss_pred             h-----hhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCC
Confidence            0     000000000                       00     00000001111223578899999999999999999


Q ss_pred             CHHHHhcCCCCcccccc
Q 014406          402 TAREAMAHPYFAQVRAA  418 (425)
Q Consensus       402 ta~elL~hp~~~~~~~~  418 (425)
                      |++|+|+||||++....
T Consensus       402 ta~e~L~Hpw~~~~~~~  418 (429)
T 3kvw_A          402 TPGQALRHPWLRRRLPK  418 (429)
T ss_dssp             CHHHHHTSTTTC-----
T ss_pred             CHHHHhCChhhccCCCC
Confidence            99999999999986543

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=4.9e-48  Score=382.33  Aligned_cols=259  Identities=25%  Similarity=0.442  Sum_probs=202.8

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc-----------hHHHHHHHHHHHHhcCCCCeeeEEeEEEcC
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----------KKKIKREIKILQNLCGGPNVVKLLDIVRDQ  192 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  192 (425)
                      .++|++.+.||+|+||+||+|.+..+++.||||++....           ...+.+|+.+++++ +||||+++++++.. 
T Consensus       134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~-  211 (419)
T 3i6u_A          134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKL-NHPCIIKIKNFFDA-  211 (419)
T ss_dssp             HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHC-CCTTBCCCCEEEES-
T ss_pred             hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhC-CCCCEeeEEEEEec-
Confidence            478999999999999999999999999999999986432           12478999999999 99999999999854 


Q ss_pred             CCCccEEEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCC--CcEEEEecccc
Q 014406          193 HSKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEL--RKLRLIDWGLA  267 (425)
Q Consensus       193 ~~~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~--~~~kl~Dfg~a  267 (425)
                        ...++||||+.+++|.+++   ..+++..++.++.|++.||+|||++||+||||||+|||++.+.  ..+||+|||++
T Consensus       212 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a  289 (419)
T 3i6u_A          212 --EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS  289 (419)
T ss_dssp             --SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTT
T ss_pred             --CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccc
Confidence              3478999999999998876   3589999999999999999999999999999999999997541  35999999999


Q ss_pred             ccccCCCcceeeccCCCccCcccccC--CCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHH
Q 014406          268 EFYHPGKEYNVRVASRYFKGPELLVD--LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAY  345 (425)
Q Consensus       268 ~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~  345 (425)
                      +............||+.|+|||++.+  ...++.++|||||||++|+|++|+.||............+..          
T Consensus       290 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~----------  359 (419)
T 3i6u_A          290 KILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITS----------  359 (419)
T ss_dssp             TSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHT----------
T ss_pred             eecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhc----------
Confidence            88765555566789999999999853  356788999999999999999999998543322222222111          


Q ss_pred             HhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccch
Q 014406          346 LNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE  419 (425)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~~  419 (425)
                         ......+                    .....+++++.+|+++||+.||++|||++|+|+||||++.....
T Consensus       360 ---~~~~~~~--------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~~~  410 (419)
T 3i6u_A          360 ---GKYNFIP--------------------EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKR  410 (419)
T ss_dssp             ---TCCCCCH--------------------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCHHHHH
T ss_pred             ---CCCCCCc--------------------hhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCChhHHH
Confidence               0000000                    00123689999999999999999999999999999999875543

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=3.8e-48  Score=370.70  Aligned_cols=250  Identities=20%  Similarity=0.361  Sum_probs=201.0

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCC-----
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS-----  194 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~-----  194 (425)
                      .++|++.+.||+|+||+||+|.+..+++.||||+++..    ..+.+.+|+.+++++ +||||++++++|.+...     
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~~   83 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL-EHPGIVRYFNAWLETPPEKWQE   83 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSC-CCTTBCCEEEEEEECCSCHHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhC-CCCCEeeEEEEEEEeccchhhh
Confidence            35799999999999999999999999999999998632    346789999999999 89999999999865422     


Q ss_pred             --------------------------------------------------CccEEEEEeecCCChhhhcCC------CCH
Q 014406          195 --------------------------------------------------KTPSLIFEYVNSTDFKVLYPT------LTD  218 (425)
Q Consensus       195 --------------------------------------------------~~~~lv~e~~~~~~l~~~~~~------l~~  218 (425)
                                                                        ...++||||+++++|.+++..      .++
T Consensus        84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~  163 (332)
T 3qd2_B           84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH  163 (332)
T ss_dssp             HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred             hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence                                                              237899999999999988732      566


Q ss_pred             HHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCC-------------cceeeccCCCc
Q 014406          219 YDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-------------EYNVRVASRYF  285 (425)
Q Consensus       219 ~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~-------------~~~~~~~t~~y  285 (425)
                      ..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++......             ......||+.|
T Consensus       164 ~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y  242 (332)
T 3qd2_B          164 GVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMD-DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY  242 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-CCEEECCCTTCEECSCC--------------CCCSCC-CGGG
T ss_pred             HHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCC-CCEEEeecCcccccccchhhccccccccccccccccCCCcCc
Confidence            6789999999999999999999999999999999988 799999999998765432             12335789999


Q ss_pred             cCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCChhhHHHhcccC
Q 014406          286 KGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHS  365 (425)
Q Consensus       286 ~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~  365 (425)
                      +|||++.+ ..++.++|||||||++|+|++|..|+      .+....+......            ..+....       
T Consensus       243 ~aPE~~~~-~~~~~~~Di~slG~il~el~~~~~~~------~~~~~~~~~~~~~------------~~~~~~~-------  296 (332)
T 3qd2_B          243 MSPEQIHG-NNYSHKVDIFSLGLILFELLYSFSTQ------MERVRIITDVRNL------------KFPLLFT-------  296 (332)
T ss_dssp             SCHHHHHC-CCCCTHHHHHHHHHHHHHHHSCCCCH------HHHHHHHHHHHTT------------CCCHHHH-------
T ss_pred             cChHHhcC-CCCcchhhHHHHHHHHHHHHHcCCCh------hHHHHHHHHhhcc------------CCCcccc-------
Confidence            99999987 68999999999999999999987654      1111111111100            0011000       


Q ss_pred             CCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCccc
Q 014406          366 RKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV  415 (425)
Q Consensus       366 ~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~  415 (425)
                                    ..++++.+|+.+||+.||++|||++|+|+||||+++
T Consensus       297 --------------~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~~  332 (332)
T 3qd2_B          297 --------------QKYPQEHMMVQDMLSPSPTERPEATDIIENAIFENL  332 (332)
T ss_dssp             --------------HHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCCC
T ss_pred             --------------cCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhcC
Confidence                          146788999999999999999999999999999975

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.3e-48  Score=373.35  Aligned_cols=280  Identities=30%  Similarity=0.551  Sum_probs=216.6

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc--------hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCC
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~--------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (425)
                      .++|++.+.||+|+||+||+|.+..+++.||||++....        ...+.+|+.+++.+ +||||+++++++.+  ..
T Consensus         9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~   85 (346)
T 1ua2_A            9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL-SHPNIIGLLDAFGH--KS   85 (346)
T ss_dssp             ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHC-CCTTBCCEEEEECC--TT
T ss_pred             hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhC-CCCCCCeEEEEEee--CC
Confidence            578999999999999999999999999999999986422        24678999999999 89999999999954  46


Q ss_pred             ccEEEEEeecCCChhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEecccccccc
Q 014406          196 TPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (425)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~~----~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~  271 (425)
                      ..++||||+++ ++..++.    .+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus        86 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~-~~~kl~Dfg~a~~~~  163 (346)
T 1ua2_A           86 NISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDEN-GVLKLADFGLAKSFG  163 (346)
T ss_dssp             CCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-CCEEECCCGGGSTTT
T ss_pred             ceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCC-CCEEEEecccceecc
Confidence            78999999997 5555542    48899999999999999999999999999999999999988 799999999998764


Q ss_pred             CC-CcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhcc
Q 014406          272 PG-KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH  350 (425)
Q Consensus       272 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~  350 (425)
                      .. .......+|+.|+|||++.+...++.++|||||||++|+|++|..|| .+.++.+.+..+.+..+.+....+.....
T Consensus       164 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~-~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  242 (346)
T 1ua2_A          164 SPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFL-PGDSDLDQLTRIFETLGTPTEEQWPDMCS  242 (346)
T ss_dssp             SCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCCCCTTTSSSTTS
T ss_pred             CCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCC-CCCCHHHHHHHHHHHcCCCChhhhhhhcc
Confidence            32 33445678999999999977566899999999999999999998665 66677778888887777654332211111


Q ss_pred             CCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccc
Q 014406          351 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA  418 (425)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~  418 (425)
                      ...         ..................+++++++||++||+.||++|||++|+|+||||++....
T Consensus       243 ~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~~  301 (346)
T 1ua2_A          243 LPD---------YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGP  301 (346)
T ss_dssp             STT---------CCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCC
T ss_pred             Ccc---------cccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCCC
Confidence            000         00000000000001123478999999999999999999999999999999976544

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=3.5e-48  Score=373.13  Aligned_cols=257  Identities=29%  Similarity=0.471  Sum_probs=209.5

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcchHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEEEe
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEY  203 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~  203 (425)
                      .++|++.+.||+|+||+||+|.+..+++.||+|+++... ....+|++++.++.+||||+++++++.+  +...++||||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~E~~~l~~~~~hp~iv~~~~~~~~--~~~~~lv~E~   97 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK-RDPTEEIEILLRYGQHPNIITLKDVYDD--GKYVYVVTEL   97 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTT-CCCHHHHHHHHHHTTSTTBCCEEEEEEC--SSEEEEEECC
T ss_pred             cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEccc-CChHHHHHHHHHhcCCCCcCeEEEEEEc--CCEEEEEEeC
Confidence            578999999999999999999999999999999997543 3456799999988789999999999965  4788999999


Q ss_pred             ecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCC---cEEEEeccccccccCC-Ccc
Q 014406          204 VNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELR---KLRLIDWGLAEFYHPG-KEY  276 (425)
Q Consensus       204 ~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~---~~kl~Dfg~a~~~~~~-~~~  276 (425)
                      +.+++|.+++   ..+++..+..++.||+.||+|||++||+||||||+|||+..+.+   .+||+|||+++..... ...
T Consensus        98 ~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~  177 (342)
T 2qr7_A           98 MKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLL  177 (342)
T ss_dssp             CCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTCCB
T ss_pred             CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCCce
Confidence            9999998776   34899999999999999999999999999999999999855422   5999999999876543 234


Q ss_pred             eeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCC-CHH-HHHHHHHHhCCchhHHHHhhccCCCC
Q 014406          277 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD-NHD-QLVKIAKVLGTDELNAYLNKYHLELD  354 (425)
Q Consensus       277 ~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~-~~~-~~~~~~~~lg~~~~~~~~~~~~~~~~  354 (425)
                      ...++|+.|+|||++.+ ..++.++|||||||++|+|++|..||....+ ..+ .+..+..             ..... 
T Consensus       178 ~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~-------------~~~~~-  242 (342)
T 2qr7_A          178 MTPCYTANFVAPEVLER-QGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGS-------------GKFSL-  242 (342)
T ss_dssp             CCSSCCSSCCCHHHHHH-HHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHH-------------CCCCC-
T ss_pred             eccCCCccccCHHHhcC-CCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHcc-------------CCccc-
Confidence            45688999999999976 6689999999999999999999999954322 222 2222211             00000 


Q ss_pred             hhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCccccc
Q 014406          355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA  417 (425)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~  417 (425)
                                         .......+++++++||++||+.||++|||++|+++||||.+...
T Consensus       243 -------------------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~~  286 (342)
T 2qr7_A          243 -------------------SGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQ  286 (342)
T ss_dssp             -------------------CSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTGGG
T ss_pred             -------------------CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCccc
Confidence                               00112347999999999999999999999999999999976543

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=1.8e-47  Score=365.17  Aligned_cols=254  Identities=24%  Similarity=0.427  Sum_probs=211.0

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc---chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEEE
Q 014406          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE  202 (425)
Q Consensus       126 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e  202 (425)
                      .|+..+.||+|+||+||+|.+..+|+.||||++...   ..+.+.+|+.+++++ +||||+++++++...  ...++|||
T Consensus        46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~--~~~~lv~e  122 (321)
T 2c30_A           46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDY-QHFNVVEMYKSYLVG--EELWVLME  122 (321)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTC-CCTTBCCEEEEEEET--TEEEEEEC
T ss_pred             hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEEC--CEEEEEEe
Confidence            477888999999999999999999999999998643   346788999999999 999999999999764  67899999


Q ss_pred             eecCCChhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCC-cceee
Q 014406          203 YVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EYNVR  279 (425)
Q Consensus       203 ~~~~~~l~~~~~--~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~-~~~~~  279 (425)
                      |+++++|.+++.  .+++..+..++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||++....... .....
T Consensus       123 ~~~~~~L~~~l~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~-~~~kl~Dfg~~~~~~~~~~~~~~~  201 (321)
T 2c30_A          123 FLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLD-GRVKLSDFGFCAQISKDVPKRKSL  201 (321)
T ss_dssp             CCCSCBHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-CCEEECCCTTCEECCSSSCCBCCC
T ss_pred             cCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC-CcEEEeeeeeeeecccCccccccc
Confidence            999999998875  58999999999999999999999999999999999999988 789999999998765432 23456


Q ss_pred             ccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCChhhHH
Q 014406          280 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDA  359 (425)
Q Consensus       280 ~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~  359 (425)
                      .||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.. .+..+....+.... .+.                  
T Consensus       202 ~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~pf~~-~~~~~~~~~~~~~~-~~~------------------  260 (321)
T 2c30_A          202 VGTPYWMAPEVISR-SLYATEVDIWSLGIMVIEMVDGEPPYFS-DSPVQAMKRLRDSP-PPK------------------  260 (321)
T ss_dssp             CSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTT-SCHHHHHHHHHHSS-CCC------------------
T ss_pred             cCCccccCHhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhcCC-CCC------------------
Confidence            78999999999977 7799999999999999999999999843 22222222221100 000                  


Q ss_pred             HhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccch
Q 014406          360 LVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE  419 (425)
Q Consensus       360 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~~  419 (425)
                                     ......+++++.+|+.+||+.||++|||++|+++||||.+...++
T Consensus       261 ---------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~~~  305 (321)
T 2c30_A          261 ---------------LKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQTGLPE  305 (321)
T ss_dssp             ---------------CTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGCCCGG
T ss_pred             ---------------cCccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccCCCcc
Confidence                           001123688999999999999999999999999999998775443

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=3.5e-48  Score=381.94  Aligned_cols=289  Identities=25%  Similarity=0.505  Sum_probs=208.2

Q ss_pred             CCEEE-EeeeeeeCceEEEEEEEc--CCCcEEEEEEecCcc-hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEE
Q 014406          125 DDYEV-VRKVGRGKYSEVFEGINV--NTNERCIIKILKPVK-KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (425)
Q Consensus       125 ~~y~~-~~~LG~G~fg~V~~~~~~--~~~~~vavK~~~~~~-~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (425)
                      +.|++ .++||+|+||+||+|.+.  .+++.||||++.... ...+.+|+.+++++ +||||+++++++........++|
T Consensus        20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~lv   98 (405)
T 3rgf_A           20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLREL-KHPNVISLQKVFLSHADRKVWLL   98 (405)
T ss_dssp             HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHC-CCTTBCCCCEEEEETTTTEEEEE
T ss_pred             hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhc-CCCCeeeEeeEEecCCCCeEEEE
Confidence            44665 347999999999999965  578899999997543 46788999999999 89999999999987667889999


Q ss_pred             EEeecCCChhhhc-----------CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEe----cCCCCcEEEEecc
Q 014406          201 FEYVNSTDFKVLY-----------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI----DHELRKLRLIDWG  265 (425)
Q Consensus       201 ~e~~~~~~l~~~~-----------~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll----~~~~~~~kl~Dfg  265 (425)
                      |||+.++.+..+.           ..+++..++.++.||+.||+|||++||+||||||+|||+    +.+ +.+||+|||
T Consensus        99 ~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~-~~~kl~Dfg  177 (405)
T 3rgf_A           99 FDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPER-GRVKIADMG  177 (405)
T ss_dssp             EECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTT-TCEEECCTT
T ss_pred             EeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCC-CcEEEEECC
Confidence            9999875433322           138999999999999999999999999999999999999    444 789999999


Q ss_pred             ccccccCC----CcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCC--------CHHHHHHH
Q 014406          266 LAEFYHPG----KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD--------NHDQLVKI  333 (425)
Q Consensus       266 ~a~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~--------~~~~~~~~  333 (425)
                      +++.....    .......||+.|+|||++.+...++.++|||||||++|+|++|+.||.....        ..+++..+
T Consensus       178 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i  257 (405)
T 3rgf_A          178 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRI  257 (405)
T ss_dssp             CCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHH
T ss_pred             CceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHH
Confidence            99876432    2234467899999999998756699999999999999999999999854332        25788889


Q ss_pred             HHHhCCchhHHHHhhccCCCChhhHHHhcccCCCCccc----cccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcC
Q 014406          334 AKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSK----FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  409 (425)
Q Consensus       334 ~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~h  409 (425)
                      .+.+|.+....+..-........   .........+..    ..........++++.+||++||++||++|||++|+|+|
T Consensus       258 ~~~~g~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~h  334 (405)
T 3rgf_A          258 FNVMGFPADKDWEDIKKMPEHST---LMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD  334 (405)
T ss_dssp             HHHHCCCCTTTCGGGGGSTTHHH---HHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHhhCCCChhhcchhhcCcchhh---hhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            99888766443322111111111   101110000000    00011122247889999999999999999999999999


Q ss_pred             CCCcccccc
Q 014406          410 PYFAQVRAA  418 (425)
Q Consensus       410 p~~~~~~~~  418 (425)
                      |||++....
T Consensus       335 p~f~~~~~~  343 (405)
T 3rgf_A          335 PYFLEDPLP  343 (405)
T ss_dssp             GGGTSSSCC
T ss_pred             hhhccCCCC
Confidence            999986554

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=4.9e-48  Score=374.62  Aligned_cols=290  Identities=28%  Similarity=0.490  Sum_probs=217.6

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc--chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCC-----Cc
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS-----KT  196 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~-----~~  196 (425)
                      .++|++.+.||+|+||+||+|.+..+++.||||++...  ......+|+..+..+ +||||++++++|.....     ..
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~  100 (360)
T 3e3p_A           22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVL-HHPNIVQLQSYFYTLGERDRRDIY  100 (360)
T ss_dssp             HTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHH-CCTTBCCEEEEEEEECSSCTTCEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhc-CCCCcccHHHhhhcccccccccee
Confidence            47899999999999999999999999999999988543  345677888889998 99999999999965321     23


Q ss_pred             cEEEEEeecCCChhhhc------CCCCHHHHHHHHHHHHHHHHHHH--HCCceeecCCCCceEecCCCCcEEEEeccccc
Q 014406          197 PSLIFEYVNSTDFKVLY------PTLTDYDIRYYIYELLKALDYCH--SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE  268 (425)
Q Consensus       197 ~~lv~e~~~~~~l~~~~------~~l~~~~~~~i~~~i~~~L~~LH--~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~  268 (425)
                      .++||||++++.+..+.      ..+++..+..++.|++.||.|||  +.||+||||||+|||++...+.+||+|||+++
T Consensus       101 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~  180 (360)
T 3e3p_A          101 LNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAK  180 (360)
T ss_dssp             EEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTTCB
T ss_pred             EEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCCce
Confidence            78999999987544322      35889999999999999999999  99999999999999999733799999999998


Q ss_pred             cccCCCcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhh
Q 014406          269 FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK  348 (425)
Q Consensus       269 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~  348 (425)
                      ............+|+.|+|||++.+...++.++|||||||++|+|++|+.|| .+.+..+.+..+.+.++.+....+..-
T Consensus       181 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (360)
T 3e3p_A          181 KLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIF-RGDNSAGQLHEIVRVLGCPSREVLRKL  259 (360)
T ss_dssp             CCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred             ecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCc-CCCChHHHHHHHHHHcCCCCHHHHHhc
Confidence            8766666666788999999999977566899999999999999999999987 556677788888888887665443221


Q ss_pred             ccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccchh
Q 014406          349 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAES  420 (425)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~~~  420 (425)
                      ........    .......+|..... ......++++.+||.+||++||++|||+.|+|+||||+++.....
T Consensus       260 ~~~~~~~~----~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~  326 (360)
T 3e3p_A          260 NPSHTDVD----LYNSKGIPWSNVFS-DHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDPAT  326 (360)
T ss_dssp             CTTCCCGG----GGCCCCCCHHHHTT-TCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCTTC
T ss_pred             ccchhhcc----ccccccCCcccccc-hhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCccc
Confidence            11100000    00011112222111 112235789999999999999999999999999999999876554

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=8.8e-48  Score=384.87  Aligned_cols=250  Identities=24%  Similarity=0.444  Sum_probs=213.3

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCcc
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (425)
                      .++|++.+.||+|+||+||+|.+..+|+.||||+++..      ....+.+|+.+++.+ +||||+++++++...  ...
T Consensus        15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~--~~~   91 (476)
T 2y94_A           15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLF-RHPHIIKLYQVISTP--SDI   91 (476)
T ss_dssp             ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTC-CCTTBCCEEEEEECS--SEE
T ss_pred             ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEEC--CEE
Confidence            47899999999999999999999999999999999643      245788999999999 899999999999654  678


Q ss_pred             EEEEEeecCCChhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCC
Q 014406          198 SLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (425)
Q Consensus       198 ~lv~e~~~~~~l~~~~~---~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~  274 (425)
                      ++||||+++++|.+++.   .+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++......
T Consensus        92 ~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~-~~vkL~DFG~a~~~~~~~  170 (476)
T 2y94_A           92 FMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAH-MNAKIADFGLSNMMSDGE  170 (476)
T ss_dssp             EEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTT-CCEEECCCSSCEECCTTC
T ss_pred             EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecC-CCeEEEeccchhhccccc
Confidence            99999999999998873   48999999999999999999999999999999999999988 789999999998876655


Q ss_pred             cceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCC
Q 014406          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD  354 (425)
Q Consensus       275 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~  354 (425)
                      .....+||+.|+|||++.+....+.++|||||||++|+|++|+.||. +.+..+....+....                 
T Consensus       171 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~-~~~~~~~~~~i~~~~-----------------  232 (476)
T 2y94_A          171 FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFD-DDHVPTLFKKICDGI-----------------  232 (476)
T ss_dssp             CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSC-CSSSHHHHHHHHTTC-----------------
T ss_pred             cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCC-CCCHHHHHHHHhcCC-----------------
Confidence            56677899999999999874334789999999999999999999984 333333333322100                 


Q ss_pred             hhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCccc
Q 014406          355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV  415 (425)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~  415 (425)
                                          ...+..+++++.+||++||+.||++|||++|+++||||++.
T Consensus       233 --------------------~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~  273 (476)
T 2y94_A          233 --------------------FYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD  273 (476)
T ss_dssp             --------------------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred             --------------------cCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence                                00112368999999999999999999999999999999863

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=1.1e-47  Score=359.61  Aligned_cols=260  Identities=27%  Similarity=0.491  Sum_probs=211.1

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc---------chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCC
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS  194 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~---------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  194 (425)
                      .++|++.+.||+|+||+||+|.+..+++.||+|+++..         ..+.+.+|+.+++++ +||||+++++++.+.  
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~--   80 (283)
T 3bhy_A            4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI-RHPNIITLHDIFENK--   80 (283)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEEECS--
T ss_pred             hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhC-CCCCeeehhheecCC--
Confidence            35799999999999999999999999999999998643         256789999999999 899999999999654  


Q ss_pred             CccEEEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCC---CcEEEEeccccc
Q 014406          195 KTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEL---RKLRLIDWGLAE  268 (425)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~---~~~kl~Dfg~a~  268 (425)
                      ...++||||+++++|.+++   ..+++..+..++.|++.||.|||+.||+|+||||+||+++.+.   ..+||+|||++.
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~  160 (283)
T 3bhy_A           81 TDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH  160 (283)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred             CeEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccce
Confidence            6789999999999999887   4599999999999999999999999999999999999998762   179999999998


Q ss_pred             cccCCCcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhh
Q 014406          269 FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK  348 (425)
Q Consensus       269 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~  348 (425)
                      ............+++.|+|||++.+ ..++.++||||||+++|+|++|..||. +.+..+.+..+.....          
T Consensus       161 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~-~~~~~~~~~~~~~~~~----------  228 (283)
T 3bhy_A          161 KIEAGNEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFL-GETKQETLTNISAVNY----------  228 (283)
T ss_dssp             ECC--------CCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTC-CSSHHHHHHHHHTTCC----------
T ss_pred             eccCCCcccccCCCcCccCcceecC-CCCCcchhhhhHHHHHHHHHHCCCCCC-CcchHHHHHHhHhccc----------
Confidence            7765555556678999999999977 679999999999999999999999983 3333333332221100          


Q ss_pred             ccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccchhc
Q 014406          349 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAESS  421 (425)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~~~~  421 (425)
                         ....                    .....+++.+.+|+++||+.||++|||++|+++||||++++....+
T Consensus       229 ---~~~~--------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~~~  278 (283)
T 3bhy_A          229 ---DFDE--------------------EYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRNVR  278 (283)
T ss_dssp             ---CCCH--------------------HHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHCCC-
T ss_pred             ---CCcc--------------------hhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHHhhh
Confidence               0000                    0012268899999999999999999999999999999998766543

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=3.3e-47  Score=369.80  Aligned_cols=254  Identities=25%  Similarity=0.468  Sum_probs=211.5

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc-----------hHHHHHHHHHHHHhcCCCCeeeEEeEEEcC
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----------KKKIKREIKILQNLCGGPNVVKLLDIVRDQ  192 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  192 (425)
                      .++|++.+.||+|+||+||+|.+..+|+.||||++....           .+.+.+|+.+++++.+||||+++++++.. 
T Consensus        93 ~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-  171 (365)
T 2y7j_A           93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYES-  171 (365)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEB-
T ss_pred             hhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEee-
Confidence            467999999999999999999999999999999986533           34678899999998779999999999965 


Q ss_pred             CCCccEEEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEecccccc
Q 014406          193 HSKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (425)
Q Consensus       193 ~~~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~  269 (425)
                       ....++||||+.+++|.+++   ..+++..+..++.||+.||.|||+.||+|+||||+|||++.+ +.+||+|||++..
T Consensus       172 -~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~-~~ikl~DfG~~~~  249 (365)
T 2y7j_A          172 -SSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDN-MQIRLSDFGFSCH  249 (365)
T ss_dssp             -SSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-CCEEECCCTTCEE
T ss_pred             -CCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC-CCEEEEecCcccc
Confidence             46789999999999998886   469999999999999999999999999999999999999988 7999999999988


Q ss_pred             ccCCCcceeeccCCCccCcccccC-----CCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHH
Q 014406          270 YHPGKEYNVRVASRYFKGPELLVD-----LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA  344 (425)
Q Consensus       270 ~~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~  344 (425)
                      ...........||+.|+|||++.+     ...++.++|||||||++|+|++|+.||.. .+..+.+..+......     
T Consensus       250 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~-~~~~~~~~~i~~~~~~-----  323 (365)
T 2y7j_A          250 LEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWH-RRQILMLRMIMEGQYQ-----  323 (365)
T ss_dssp             CCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCC-----
T ss_pred             cCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhCCCC-----
Confidence            776666666789999999999863     13588999999999999999999999843 2222223222211000     


Q ss_pred             HHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcc
Q 014406          345 YLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ  414 (425)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~  414 (425)
                              ...                    .....++.++.+||++||+.||++|||++|+|+||||++
T Consensus       324 --------~~~--------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r  365 (365)
T 2y7j_A          324 --------FSS--------------------PEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER  365 (365)
T ss_dssp             --------CCH--------------------HHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             --------CCC--------------------cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence                    000                    001236889999999999999999999999999999974

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=5.7e-47  Score=357.42  Aligned_cols=262  Identities=26%  Similarity=0.430  Sum_probs=214.4

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc------------hHHHHHHHHHHHHhcCCCCeeeEEeEEE
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------------KKKIKREIKILQNLCGGPNVVKLLDIVR  190 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~------------~~~~~~E~~~l~~l~~h~niv~l~~~~~  190 (425)
                      ..++|++.+.||+|+||+||+|.+..+++.||||+++...            .+.+.+|+.+++++.+||||+++++++.
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (298)
T 1phk_A           15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE   94 (298)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence            4689999999999999999999999999999999996432            3457799999999956999999999996


Q ss_pred             cCCCCccEEEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEecccc
Q 014406          191 DQHSKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA  267 (425)
Q Consensus       191 ~~~~~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a  267 (425)
                      .  ....++||||+++++|.+++   ..+++..+..++.|++.||.|||+.||+|+||||+||+++.+ +.+||+|||++
T Consensus        95 ~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~-~~~kl~dfg~~  171 (298)
T 1phk_A           95 T--NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDD-MNIKLTDFGFS  171 (298)
T ss_dssp             C--SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-CCEEECCCTTC
T ss_pred             c--CCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCC-CcEEEecccch
Confidence            5  47789999999999998887   468999999999999999999999999999999999999988 78999999999


Q ss_pred             ccccCCCcceeeccCCCccCccccc-----CCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchh
Q 014406          268 EFYHPGKEYNVRVASRYFKGPELLV-----DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDEL  342 (425)
Q Consensus       268 ~~~~~~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~  342 (425)
                      .............++..|+|||++.     ....++.++||||||+++|+|++|..||.. .+..+....+....     
T Consensus       172 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~-~~~~~~~~~~~~~~-----  245 (298)
T 1phk_A          172 CQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH-RKQMLMLRMIMSGN-----  245 (298)
T ss_dssp             EECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTC-----
T ss_pred             hhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcC-ccHHHHHHHHhcCC-----
Confidence            8776665566678899999999985     235688999999999999999999999843 22222222222100     


Q ss_pred             HHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccchhc
Q 014406          343 NAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAESS  421 (425)
Q Consensus       343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~~~~  421 (425)
                              ...                    .......+++++.+|+.+||+.||++|||++|+++||||++....+.+
T Consensus       246 --------~~~--------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~~  296 (298)
T 1phk_A          246 --------YQF--------------------GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEEVR  296 (298)
T ss_dssp             --------CCC--------------------CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC-----
T ss_pred             --------ccc--------------------CcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhccchhhc
Confidence                    000                    000112368999999999999999999999999999999998776543

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=1.4e-47  Score=399.50  Aligned_cols=257  Identities=23%  Similarity=0.380  Sum_probs=218.2

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecC------cchHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCc
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP------VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~------~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (425)
                      ..++|++++.||+|+||+||+|.+..+++.||||+++.      ...+.+..|..++..+.+|+||+++++++.+  ...
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~--~~~  416 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT--MDR  416 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBC--SSE
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEe--CCE
Confidence            35789999999999999999999999999999999874      2345678899999988789999999999954  478


Q ss_pred             cEEEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEecccccccc-C
Q 014406          197 PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-P  272 (425)
Q Consensus       197 ~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~-~  272 (425)
                      +|+||||+++++|..++   ..+++..++.++.||+.||+|||++|||||||||+|||++.+ +.+||+|||+|+... .
T Consensus       417 ~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~-g~ikL~DFGla~~~~~~  495 (674)
T 3pfq_A          417 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSE-GHIKIADFGMCKENIWD  495 (674)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSS-SCEEECCCTTCEECCCT
T ss_pred             EEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCC-CcEEEeecceeeccccC
Confidence            89999999999999887   469999999999999999999999999999999999999998 799999999998643 3


Q ss_pred             CCcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCC
Q 014406          273 GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE  352 (425)
Q Consensus       273 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~  352 (425)
                      .......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||. +.+..+.+..+...             .. 
T Consensus       496 ~~~~~~~~GT~~Y~APE~l~~-~~~~~~~DvwSlGvilyelltG~~Pf~-~~~~~~~~~~i~~~-------------~~-  559 (674)
T 3pfq_A          496 GVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFE-GEDEDELFQSIMEH-------------NV-  559 (674)
T ss_dssp             TCCBCCCCSCSSSCCHHHHTC-CCBSTHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHSS-------------CC-
T ss_pred             CcccccccCCCcccCHhhhcC-CCCCccceEechHHHHHHHHcCCCCCC-CCCHHHHHHHHHhC-------------CC-
Confidence            344556789999999999987 789999999999999999999999983 33434444433210             00 


Q ss_pred             CChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCH-----HHHhcCCCCcccccchhc
Q 014406          353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA-----REAMAHPYFAQVRAAESS  421 (425)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta-----~elL~hp~~~~~~~~~~~  421 (425)
                                             ..+..+++++.+||++||+.||++|+++     +|+++||||+++.|....
T Consensus       560 -----------------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~~l~  610 (674)
T 3pfq_A          560 -----------------------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLE  610 (674)
T ss_dssp             -----------------------CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHHHHT
T ss_pred             -----------------------CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCHHHHH
Confidence                                   0112379999999999999999999997     999999999999886654

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=6.8e-48  Score=369.61  Aligned_cols=288  Identities=29%  Similarity=0.475  Sum_probs=221.7

Q ss_pred             ccCCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc-----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCC
Q 014406          120 QWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHS  194 (425)
Q Consensus       120 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  194 (425)
                      .+...++|++.+.||+|+||+||+|.+..+++.||+|++....     .+.+.+|+.+++++ +||||+++++++.+.  
T Consensus        20 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~--   96 (331)
T 4aaa_A           20 YFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQL-RHENLVNLLEVCKKK--   96 (331)
T ss_dssp             CCBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEET--
T ss_pred             hhhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhC-CCCCEeeEEEEeecC--
Confidence            3445789999999999999999999999999999999985432     34577899999999 899999999999654  


Q ss_pred             CccEEEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEecccccccc
Q 014406          195 KTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (425)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~  271 (425)
                      ...++||||++++++..+.   ..+++..+..++.|++.||+|||+.||+|+||||+|||++.+ +.+||+|||+++...
T Consensus        97 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~  175 (331)
T 4aaa_A           97 KRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQS-GVVKLCDFGFARTLA  175 (331)
T ss_dssp             TEEEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-SCEEECCCTTC----
T ss_pred             CEEEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCC-CcEEEEeCCCceeec
Confidence            6789999999999988774   569999999999999999999999999999999999999988 799999999997654


Q ss_pred             CC-CcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHH--Hhh
Q 014406          272 PG-KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAY--LNK  348 (425)
Q Consensus       272 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~--~~~  348 (425)
                      .. .......+|..|+|||++.+...++.++|||||||++|+|++|+.|| .+.++.+.+..+....+.......  ...
T Consensus       176 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (331)
T 4aaa_A          176 APGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLF-PGDSDIDQLYHIMMCLGNLIPRHQELFNK  254 (331)
T ss_dssp             --------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCSCCHHHHHHHHH
T ss_pred             CCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCC-CCCCcHHHHHHHHHHhCCCChhhhhHhhh
Confidence            32 33345678999999999987557899999999999999999999887 555666777777777765432211  111


Q ss_pred             ccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccchh
Q 014406          349 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAES  420 (425)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~~~  420 (425)
                      .....        +..................+++++.+|+.+||+.||++|||++|+|+||||+.....++
T Consensus       255 ~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~  318 (331)
T 4aaa_A          255 NPVFA--------GVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDGFAER  318 (331)
T ss_dssp             CGGGT--------TCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGGGHHHH
T ss_pred             ccccc--------cccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccCChhhh
Confidence            00000        00000000000011112247899999999999999999999999999999998765554

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=1.1e-47  Score=376.75  Aligned_cols=300  Identities=24%  Similarity=0.392  Sum_probs=223.7

Q ss_pred             CCcCCcccccCCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc--hHHHHHHHHHHHHhc-------CCCCe
Q 014406          112 WDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--KKKIKREIKILQNLC-------GGPNV  182 (425)
Q Consensus       112 ~~~~~~~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~-------~h~ni  182 (425)
                      ..+..+..+....++|++.+.||+|+||+||+|.+..+++.||||+++...  .+.+.+|+.+++.+.       +|+||
T Consensus        24 ~~~~~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~i  103 (397)
T 1wak_A           24 GGYHLVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMV  103 (397)
T ss_dssp             --CCSSCTTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGB
T ss_pred             CCceEEehhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCccee
Confidence            345555555555789999999999999999999999999999999997543  467889999999983       27889


Q ss_pred             eeEEeEEEcC--CCCccEEEEEeecCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHC-CceeecCCCCceEecCC
Q 014406          183 VKLLDIVRDQ--HSKTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHE  255 (425)
Q Consensus       183 v~l~~~~~~~--~~~~~~lv~e~~~~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~LH~~-~ivH~Dlk~~NIll~~~  255 (425)
                      +++++++...  .+...++||||+.++++..+.    ..+++..++.++.||+.||+|||++ ||+||||||+|||++.+
T Consensus       104 v~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~  183 (397)
T 1wak_A          104 VQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVN  183 (397)
T ss_dssp             CCEEEEEEEEETTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCC
T ss_pred             eeeecceeecCCCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEecc
Confidence            9999998732  446789999999776666554    3489999999999999999999998 99999999999999876


Q ss_pred             C------------------------------------------------CcEEEEeccccccccCCCcceeeccCCCccC
Q 014406          256 L------------------------------------------------RKLRLIDWGLAEFYHPGKEYNVRVASRYFKG  287 (425)
Q Consensus       256 ~------------------------------------------------~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~a  287 (425)
                      .                                                ..+||+|||+++....  ......+|..|+|
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~--~~~~~~gt~~y~a  261 (397)
T 1wak_A          184 EQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK--HFTEDIQTRQYRS  261 (397)
T ss_dssp             HHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB--CSCSCCSCGGGCC
T ss_pred             chhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc--cCccCCCCCcccC
Confidence            2                                                2799999999987543  3445678999999


Q ss_pred             cccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCC-----CHHHHHHHHHHhCCchhHHHHhh-ccCCCChhhHHHh
Q 014406          288 PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD-----NHDQLVKIAKVLGTDELNAYLNK-YHLELDPQLDALV  361 (425)
Q Consensus       288 PE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~-----~~~~~~~~~~~lg~~~~~~~~~~-~~~~~~~~~~~~~  361 (425)
                      ||++.+ ..++.++|||||||++|+|++|+.||.....     +.+.+..+.+.+|..+....... +...+........
T Consensus       262 PE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~  340 (397)
T 1wak_A          262 LEVLIG-SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLK  340 (397)
T ss_dssp             HHHHHT-SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBS
T ss_pred             ChhhcC-CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccc
Confidence            999988 6799999999999999999999999954332     34567778888887654432211 1000000000000


Q ss_pred             cccCCCCccccc----cccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcc
Q 014406          362 GRHSRKPWSKFI----NADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ  414 (425)
Q Consensus       362 ~~~~~~~~~~~~----~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~  414 (425)
                      ......+|....    ........++++.+||.+||++||++|||++|+|+||||++
T Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~  397 (397)
T 1wak_A          341 HITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS  397 (397)
T ss_dssp             SCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred             cccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence            000000110000    00111224567899999999999999999999999999974

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=2.5e-47  Score=386.23  Aligned_cols=256  Identities=27%  Similarity=0.500  Sum_probs=213.3

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc----------------chHHHHHHHHHHHHhcCCCCeeeEE
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----------------KKKKIKREIKILQNLCGGPNVVKLL  186 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~----------------~~~~~~~E~~~l~~l~~h~niv~l~  186 (425)
                      ..++|++++.||+|+||+||+|.+..+++.||+|++...                ..+.+.+|+.+++++ +||||++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~  112 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL-DHPNIIKLF  112 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTC-CCTTBCCEE
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhC-CCCCCCeEE
Confidence            367899999999999999999999999999999998642                245688999999999 899999999


Q ss_pred             eEEEcCCCCccEEEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCC--cEEE
Q 014406          187 DIVRDQHSKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELR--KLRL  261 (425)
Q Consensus       187 ~~~~~~~~~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~--~~kl  261 (425)
                      +++.+  ....++||||+++++|..++   ..+++..+..++.||+.||.|||++||+||||||+|||++.+..  .+||
T Consensus       113 ~~~~~--~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl  190 (504)
T 3q5i_A          113 DVFED--KKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKI  190 (504)
T ss_dssp             EEEEC--SSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEE
T ss_pred             EEEEc--CCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEE
Confidence            99965  47889999999999998776   56999999999999999999999999999999999999987632  6999


Q ss_pred             EeccccccccCCCcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCch
Q 014406          262 IDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDE  341 (425)
Q Consensus       262 ~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~  341 (425)
                      +|||+++............||+.|+|||++.+  .++.++||||+||++|+|++|..|| .+.+..+.+..+....-..+
T Consensus       191 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf-~~~~~~~~~~~i~~~~~~~~  267 (504)
T 3q5i_A          191 VDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPF-GGQNDQDIIKKVEKGKYYFD  267 (504)
T ss_dssp             CCCTTCEECCTTSCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHCCCCCC
T ss_pred             EECCCCEEcCCCCccccccCCcCCCCHHHhcc--CCCchHHHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHcCCCCCC
Confidence            99999988776666667789999999999864  6899999999999999999999998 34444444444332110000


Q ss_pred             hHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCccccc
Q 014406          342 LNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA  417 (425)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~  417 (425)
                      ..                                 ....+++++++||++||++||++|||++|+|+||||++...
T Consensus       268 ~~---------------------------------~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~  310 (504)
T 3q5i_A          268 FN---------------------------------DWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYAN  310 (504)
T ss_dssp             HH---------------------------------HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCC
T ss_pred             cc---------------------------------ccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchh
Confidence            00                                 01237899999999999999999999999999999987644

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=7.1e-47  Score=365.78  Aligned_cols=286  Identities=31%  Similarity=0.581  Sum_probs=220.9

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc-----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCC---
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHS---  194 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~---  194 (425)
                      ..++|.+.+.||+|+||+||+|.+..+|+.||||++....     .+.+.+|+.+++.+ +||||+++++++.....   
T Consensus        22 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~  100 (353)
T 3coi_A           22 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHM-QHENVIGLLDVFTPASSLRN  100 (353)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSSGGG
T ss_pred             cCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhc-CCCCcccHhheEeccccccc
Confidence            3578999999999999999999999999999999996432     35678999999999 89999999999975432   


Q ss_pred             -CccEEEEEeecCCChhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccC
Q 014406          195 -KTPSLIFEYVNSTDFKVLY-PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (425)
Q Consensus       195 -~~~~lv~e~~~~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~  272 (425)
                       ...++||||+++ +|..++ ..+++..+..++.||+.||+|||++||+|+||||+|||++.+ +.+||+|||+++....
T Consensus       101 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~-~~~kl~Dfg~~~~~~~  178 (353)
T 3coi_A          101 FYDFYLVMPFMQT-DLQKIMGLKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNED-CELKILDFGLARHADA  178 (353)
T ss_dssp             CCCCEEEEECCSE-EGGGTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTT-CCEEECSTTCTTC---
T ss_pred             ceeEEEEeccccC-CHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCC-CcEEEeecccccCCCC
Confidence             245899999985 666555 469999999999999999999999999999999999999988 7899999999976542


Q ss_pred             CCcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCC
Q 014406          273 GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE  352 (425)
Q Consensus       273 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~  352 (425)
                        ......+|..|+|||++.+...++.++|||||||++|+|++|+.|| .+.+..+.+..+.+..|.+...... ...  
T Consensus       179 --~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~-~~~--  252 (353)
T 3coi_A          179 --EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLF-KGKDYLDQLTQILKVTGVPGTEFVQ-KLN--  252 (353)
T ss_dssp             -------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSS-BSSCHHHHHHHHHHHHCBCCHHHHT-TCS--
T ss_pred             --CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCCHHHHH-HHh--
Confidence              2344578999999999877567899999999999999999999998 4556667788888877765533211 100  


Q ss_pred             CChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccchh
Q 014406          353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAES  420 (425)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~~~  420 (425)
                       ..................+  ......+++++.+||.+||+.||++|||++|+|+||||+.....+.
T Consensus       253 -~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~~~  317 (353)
T 3coi_A          253 -DKAAKSYIQSLPQTPRKDF--TQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEE  317 (353)
T ss_dssp             -CHHHHHHHHTSCBCSSCCT--TTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGGG
T ss_pred             -hHHHHHHHHhCcCCCCccH--HHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccCccc
Confidence             0111111111111110000  1112347899999999999999999999999999999998876543

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=9.8e-48  Score=366.55  Aligned_cols=276  Identities=18%  Similarity=0.307  Sum_probs=212.8

Q ss_pred             CCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCcc
Q 014406          122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (425)
Q Consensus       122 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (425)
                      ...++|++.+.||+|+||+||+|.+..+++.||||+++..    ..+.+.+|+.+++++ +||||+++++++........
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~   84 (319)
T 4euu_A            6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL-NHKNIVKLFAIEEETTTRHK   84 (319)
T ss_dssp             CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHC-CCTTBCCEEEEEECTTTCCE
T ss_pred             CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhc-CCCCcceEEEEeecCCCceE
Confidence            3568899999999999999999999999999999999743    346788999999999 89999999999987766788


Q ss_pred             EEEEEeecCCChhhhcCC------CCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEe----cCCCCcEEEEecccc
Q 014406          198 SLIFEYVNSTDFKVLYPT------LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI----DHELRKLRLIDWGLA  267 (425)
Q Consensus       198 ~lv~e~~~~~~l~~~~~~------l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll----~~~~~~~kl~Dfg~a  267 (425)
                      ++||||+++++|..++..      +++..++.++.|++.||+|||++||+||||||+|||+    +.+ +.+||+|||++
T Consensus        85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~-~~~kL~Dfg~a  163 (319)
T 4euu_A           85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQ-SVYKLTDFGAA  163 (319)
T ss_dssp             EEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSC-EEEEECCCTTC
T ss_pred             EEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCC-ceEEEccCCCc
Confidence            999999999999988743      8999999999999999999999999999999999998    555 67999999999


Q ss_pred             ccccCCCcceeeccCCCccCcccccC-------CCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCc
Q 014406          268 EFYHPGKEYNVRVASRYFKGPELLVD-------LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTD  340 (425)
Q Consensus       268 ~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~  340 (425)
                      +............+|..|+|||++..       ...++.++|||||||++|+|++|+.||............+.+.++..
T Consensus       164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  243 (319)
T 4euu_A          164 RELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK  243 (319)
T ss_dssp             EECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHC
T ss_pred             eecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCC
Confidence            88776666666789999999999862       26789999999999999999999999954333222222222222111


Q ss_pred             hhHHHHhhccCCCChhhHHHhcccCCCCcccccc--ccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCC
Q 014406          341 ELNAYLNKYHLELDPQLDALVGRHSRKPWSKFIN--ADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHP  410 (425)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp  410 (425)
                      +.... .......          .....|.....  ......+++.+.+|+++||++||++|||++|+|+||
T Consensus       244 p~~~~-~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~  304 (319)
T 4euu_A          244 PSGAI-SGVQKAE----------NGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET  304 (319)
T ss_dssp             CTTCC-EEEECST----------TCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred             Ccccc-hhhhccc----------CCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhcc
Confidence            10000 0000000          00000111110  011122456788999999999999999999999997

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=3.6e-47  Score=367.54  Aligned_cols=289  Identities=28%  Similarity=0.531  Sum_probs=222.2

Q ss_pred             CCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcC---CC
Q 014406          122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQ---HS  194 (425)
Q Consensus       122 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~---~~  194 (425)
                      ...++|++.+.||+|+||+||+|.+..+++.||||++....    ...+.+|+.+++++ +||||+++++++...   ..
T Consensus         8 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~   86 (353)
T 2b9h_A            8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHF-KHENIITIFNIQRPDSFENF   86 (353)
T ss_dssp             CSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSCSTTC
T ss_pred             ccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhC-cCCCcCCeeeeecccccCcc
Confidence            45789999999999999999999999999999999997433    34577999999999 899999999988643   23


Q ss_pred             CccEEEEEeecCCChhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccC
Q 014406          195 KTPSLIFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (425)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~  272 (425)
                      ...++||||+.+ +|..++  ..+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++....
T Consensus        87 ~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~-~~~kl~Dfg~a~~~~~  164 (353)
T 2b9h_A           87 NEVYIIQELMQT-DLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSN-CDLKVCDFGLARIIDE  164 (353)
T ss_dssp             CCEEEEECCCSE-EHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTT-CCEEECCCTTCEECC-
T ss_pred             ceEEEEEeccCc-cHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCC-CcEEEEeccccccccc
Confidence            578999999985 666665  469999999999999999999999999999999999999988 7899999999986643


Q ss_pred             CCc-----------ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCch
Q 014406          273 GKE-----------YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDE  341 (425)
Q Consensus       273 ~~~-----------~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~  341 (425)
                      ...           .....||..|+|||++.+...++.++|||||||++|+|++|+.|| .+.+..+.+..+....|.+.
T Consensus       165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf-~~~~~~~~~~~~~~~~~~~~  243 (353)
T 2b9h_A          165 SAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIF-PGRDYRHQLLLIFGIIGTPH  243 (353)
T ss_dssp             ---------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCCCC
T ss_pred             ccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCC-CCCCcHHHHHHHHHHhCCCc
Confidence            211           122467899999999876577999999999999999999999887 55566677777777777654


Q ss_pred             hHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccch
Q 014406          342 LNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE  419 (425)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~~  419 (425)
                      ......   .................+..  ........+++++.+||++||+.||++|||++|+++||||+......
T Consensus       244 ~~~~~~---~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~  316 (353)
T 2b9h_A          244 SDNDLR---CIESPRAREYIKSLPMYPAA--PLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPN  316 (353)
T ss_dssp             STTTTT---TCCCHHHHHHHHTSCCCCCC--CHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTT
T ss_pred             hhcccc---ccccchhhHHhhcccCCCCc--chhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCCcc
Confidence            221100   00011111111111000000  00111224789999999999999999999999999999999877654

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.1e-47  Score=369.87  Aligned_cols=258  Identities=26%  Similarity=0.477  Sum_probs=207.6

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecC--------cchHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCC
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--------VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~--------~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (425)
                      .++|++.+.||+|+||+||+|.+..+++.||+|++..        ...+.+.+|+.+++++ +||||+++++++.+  ..
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~--~~  101 (345)
T 3hko_A           25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL-HHPNIARLYEVYED--EQ  101 (345)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHC-CCTTBCCEEEEEEC--SS
T ss_pred             hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhC-CCCCcceeehhhcc--CC
Confidence            5789999999999999999999999999999999853        2346788999999999 89999999999965  46


Q ss_pred             ccEEEEEeecCCChhhhcCC-------------------------------------------CCHHHHHHHHHHHHHHH
Q 014406          196 TPSLIFEYVNSTDFKVLYPT-------------------------------------------LTDYDIRYYIYELLKAL  232 (425)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~~~-------------------------------------------l~~~~~~~i~~~i~~~L  232 (425)
                      ..++||||+++++|.+++..                                           +++..++.++.||+.||
T Consensus       102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l  181 (345)
T 3hko_A          102 YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL  181 (345)
T ss_dssp             EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHH
T ss_pred             eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence            78999999999999887731                                           25677888999999999


Q ss_pred             HHHHHCCceeecCCCCceEecCCC-CcEEEEeccccccccCCC-----cceeeccCCCccCcccccCC-CCCCCcccHHH
Q 014406          233 DYCHSQGIMHRDVKPHNVMIDHEL-RKLRLIDWGLAEFYHPGK-----EYNVRVASRYFKGPELLVDL-QDYDYSLDMWS  305 (425)
Q Consensus       233 ~~LH~~~ivH~Dlk~~NIll~~~~-~~~kl~Dfg~a~~~~~~~-----~~~~~~~t~~y~aPE~~~~~-~~~~~~~Dvws  305 (425)
                      +|||+.||+|+||||+|||++.+. ..+||+|||+++......     ......+|+.|+|||++.+. ..++.++||||
T Consensus       182 ~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diws  261 (345)
T 3hko_A          182 HYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS  261 (345)
T ss_dssp             HHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHH
T ss_pred             HHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHH
Confidence            999999999999999999998762 279999999998653221     23456789999999998642 56899999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHH
Q 014406          306 LGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEA  385 (425)
Q Consensus       306 lG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  385 (425)
                      |||++|+|++|+.||. +.+..+....+......             .                    .......+++++
T Consensus       262 lG~il~el~~g~~pf~-~~~~~~~~~~~~~~~~~-------------~--------------------~~~~~~~~~~~~  307 (345)
T 3hko_A          262 AGVLLHLLLMGAVPFP-GVNDADTISQVLNKKLC-------------F--------------------ENPNYNVLSPLA  307 (345)
T ss_dssp             HHHHHHHHHHSSCSSC-CSSHHHHHHHHHHCCCC-------------T--------------------TSGGGGGSCHHH
T ss_pred             HHHHHHHHHHCCCCCC-CCChHHHHHHHHhcccc-------------c--------------------CCcccccCCHHH
Confidence            9999999999999983 33333433333221100             0                    000111268999


Q ss_pred             HHHHHHcccCCcCCCcCHHHHhcCCCCcccccc
Q 014406          386 IDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA  418 (425)
Q Consensus       386 ~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~  418 (425)
                      .+||.+||+.||++|||+.|+|+||||++....
T Consensus       308 ~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~~~  340 (345)
T 3hko_A          308 RDLLSNLLNRNVDERFDAMRALQHPWISQFSDK  340 (345)
T ss_dssp             HHHHHHHSCSCTTTSCCHHHHHHSHHHHTTSSC
T ss_pred             HHHHHHHcCCChhHCCCHHHHhcChhhccChHh
Confidence            999999999999999999999999999988653

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=1.7e-47  Score=385.77  Aligned_cols=255  Identities=24%  Similarity=0.507  Sum_probs=212.0

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecC-----cchHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccE
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (425)
                      .++|++.+.||+|+||+||+|.+..+++.||||++..     .....+.+|+.+++++ +||||+++++++.+  ....+
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~--~~~~~   97 (486)
T 3mwu_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL-DHPNIMKLFEILED--SSSFY   97 (486)
T ss_dssp             HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHC-CCTTBCCEEEEEEC--SSEEE
T ss_pred             hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhC-CCCCcCeEEEEEEc--CCEEE
Confidence            5789999999999999999999999999999999853     3456789999999999 99999999999965  46789


Q ss_pred             EEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCC--CCcEEEEeccccccccCC
Q 014406          199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--LRKLRLIDWGLAEFYHPG  273 (425)
Q Consensus       199 lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~--~~~~kl~Dfg~a~~~~~~  273 (425)
                      +||||+.+++|.+.+   ..+++..+..++.||+.||.|||++||+||||||+|||++.+  .+.+||+|||+++.....
T Consensus        98 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~  177 (486)
T 3mwu_A           98 IVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN  177 (486)
T ss_dssp             EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC
Confidence            999999999997766   569999999999999999999999999999999999999643  257999999999877666


Q ss_pred             CcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCC
Q 014406          274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL  353 (425)
Q Consensus       274 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~  353 (425)
                      .......||+.|+|||++.+  .++.++||||+||++|+|++|..||. +.+..+.+..+........            
T Consensus       178 ~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~-~~~~~~~~~~i~~~~~~~~------------  242 (486)
T 3mwu_A          178 TKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFY-GKNEYDILKRVETGKYAFD------------  242 (486)
T ss_dssp             ----CCTTGGGGCCGGGGGS--CCCHHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHTCCCSC------------
T ss_pred             CccCCCcCCCCCCCHHHhCC--CCCchhhHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHhCCCCCC------------
Confidence            66666789999999999875  59999999999999999999999984 3343444443322100000            


Q ss_pred             ChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCccccc
Q 014406          354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA  417 (425)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~  417 (425)
                                           ......+++++++||++||+.||++|||+.|+|+||||++...
T Consensus       243 ---------------------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~  285 (486)
T 3mwu_A          243 ---------------------LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS  285 (486)
T ss_dssp             ---------------------SGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCC
T ss_pred             ---------------------CcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCcc
Confidence                                 0011237899999999999999999999999999999987654

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=9.2e-48  Score=369.32  Aligned_cols=244  Identities=26%  Similarity=0.456  Sum_probs=208.1

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----------chHHHHHHHHHHHHhcCCCCeeeEEeEEEcC
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQ  192 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  192 (425)
                      .++|++.+.||+|+||+||+|.+..+++.||||+++..           ..+.+.+|+.+++++ +||||+++++++.+ 
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~-  100 (335)
T 3dls_A           23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRV-EHANIIKVLDIFEN-  100 (335)
T ss_dssp             HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTC-CCTTBCCEEEEEEC-
T ss_pred             ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhC-CCCCEeeEEEEEee-
Confidence            46899999999999999999999999999999998753           234577899999999 99999999999965 


Q ss_pred             CCCccEEEEEeecCC-Chhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccc
Q 014406          193 HSKTPSLIFEYVNST-DFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE  268 (425)
Q Consensus       193 ~~~~~~lv~e~~~~~-~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~  268 (425)
                       ....++||||+.+| +|..++   ..+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++
T Consensus       101 -~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~-~~~kL~Dfg~a~  178 (335)
T 3dls_A          101 -QGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAED-FTIKLIDFGSAA  178 (335)
T ss_dssp             -SSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-SCEEECCCTTCE
T ss_pred             -CCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCC-CcEEEeecccce
Confidence             46789999999776 888776   358999999999999999999999999999999999999988 799999999998


Q ss_pred             cccCCCcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhh
Q 014406          269 FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK  348 (425)
Q Consensus       269 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~  348 (425)
                      ............||+.|+|||++.+...++.++|||||||++|+|++|+.||.....                   ..  
T Consensus       179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-------------------~~--  237 (335)
T 3dls_A          179 YLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE-------------------TV--  237 (335)
T ss_dssp             ECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG-------------------GT--
T ss_pred             ECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH-------------------HH--
Confidence            877666666778999999999998743348899999999999999999999932000                   00  


Q ss_pred             ccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCccc
Q 014406          349 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV  415 (425)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~  415 (425)
                                   ..          .......+++++.+||.+||+.||++|||++|+++||||++.
T Consensus       238 -------------~~----------~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~  281 (335)
T 3dls_A          238 -------------EA----------AIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQP  281 (335)
T ss_dssp             -------------TT----------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred             -------------hh----------ccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence                         00          001122378999999999999999999999999999999864

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=1.7e-47  Score=357.77  Aligned_cols=253  Identities=25%  Similarity=0.471  Sum_probs=209.1

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCc
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (425)
                      ..++|++.+.||+|+||+||+|.+..++..||+|++...      ....+.+|+.+++++ +||||+++++++.+.  ..
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~   83 (279)
T 3fdn_A            7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RHPNILRLYGYFHDA--TR   83 (279)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTC-CCTTBCCEEEEEECS--SE
T ss_pred             ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcC-CCCCCcchhheEecC--CE
Confidence            467899999999999999999999999999999998532      245688999999999 899999999999654  67


Q ss_pred             cEEEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCC
Q 014406          197 PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (425)
Q Consensus       197 ~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~  273 (425)
                      .++||||+++++|..++   ..+++..+..++.|++.||+|||+.||+|+||||+|||++.+ +.++|+|||++..... 
T Consensus        84 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~-~~~~l~Dfg~~~~~~~-  161 (279)
T 3fdn_A           84 VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSA-GELKIADFGWSVHAPS-  161 (279)
T ss_dssp             EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTT-SCEEECSCCEESCC---
T ss_pred             EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCC-CCEEEEeccccccCCc-
Confidence            89999999999998776   568999999999999999999999999999999999999988 7899999999865443 


Q ss_pred             CcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCC
Q 014406          274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL  353 (425)
Q Consensus       274 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~  353 (425)
                      .......++..|+|||.+.+ ..++.++||||||+++|+|++|..||. +.+..+....+...             .   
T Consensus       162 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~-~~~~~~~~~~~~~~-------------~---  223 (279)
T 3fdn_A          162 SRRTDLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFE-ANTYQETYKRISRV-------------E---  223 (279)
T ss_dssp             ------CCCCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCTTC-CSSHHHHHHHHHHT-------------C---
T ss_pred             ccccccCCCCCccCHhHhcc-CCCCccchhHhHHHHHHHHHHCCCCCC-CCcHHHHHHHHHhC-------------C---
Confidence            23344578999999999987 778999999999999999999999983 32322333222110             0   


Q ss_pred             ChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccch
Q 014406          354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE  419 (425)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~~  419 (425)
                                           ......+++++.+|+.+||+.||++|||++|+++||||++.....
T Consensus       224 ---------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~~~~  268 (279)
T 3fdn_A          224 ---------------------FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKP  268 (279)
T ss_dssp             ---------------------CCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHCSSC
T ss_pred             ---------------------CCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCccCc
Confidence                                 011123688999999999999999999999999999999766544

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=3.2e-47  Score=385.23  Aligned_cols=257  Identities=25%  Similarity=0.394  Sum_probs=215.0

Q ss_pred             CCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCC
Q 014406          122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (425)
Q Consensus       122 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (425)
                      ...++|++.+.||+|+||+||+|++..+++.||+|++...      ....+.+|+.+++++ +||||++++++|.+.  .
T Consensus       182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~--~  258 (543)
T 3c4z_A          182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV-HSRFIVSLAYAFETK--T  258 (543)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-CCTTBCCEEEEEECS--S
T ss_pred             CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhc-CCCCEeeEEEEEeeC--C
Confidence            3468899999999999999999999999999999999642      345688999999999 999999999999654  6


Q ss_pred             ccEEEEEeecCCChhhhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccc
Q 014406          196 TPSLIFEYVNSTDFKVLYP-------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE  268 (425)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~~-------~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~  268 (425)
                      .+|+||||++|++|..++.       .+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++
T Consensus       259 ~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~-g~vkL~DFGla~  337 (543)
T 3c4z_A          259 DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDD-GNVRISDLGLAV  337 (543)
T ss_dssp             EEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-SCEEECCCTTCE
T ss_pred             EEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCC-CCEEEeecceee
Confidence            7899999999999987752       48999999999999999999999999999999999999988 799999999998


Q ss_pred             cccCCCc-ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCC--CHHHH-HHHHHHhCCchhHH
Q 014406          269 FYHPGKE-YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD--NHDQL-VKIAKVLGTDELNA  344 (425)
Q Consensus       269 ~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~--~~~~~-~~~~~~lg~~~~~~  344 (425)
                      ....... ....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.....  ....+ ..+..         
T Consensus       338 ~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~---------  407 (543)
T 3c4z_A          338 ELKAGQTKTKGYAGTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLE---------  407 (543)
T ss_dssp             ECCTTCCCBCCCCSCTTTSCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHH---------
T ss_pred             eccCCCcccccccCCccccChhhhcC-CCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhh---------
Confidence            7654433 334589999999999987 7899999999999999999999999954322  11111 11111         


Q ss_pred             HHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcC-----HHHHhcCCCCcccccch
Q 014406          345 YLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT-----AREAMAHPYFAQVRAAE  419 (425)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpt-----a~elL~hp~~~~~~~~~  419 (425)
                          ...                        ..+..+++++.+||++||+.||++||+     ++++++||||+++.|..
T Consensus       408 ----~~~------------------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w~~  459 (543)
T 3c4z_A          408 ----QAV------------------------TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQ  459 (543)
T ss_dssp             ----CCC------------------------CCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCHHH
T ss_pred             ----ccc------------------------CCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCHHH
Confidence                000                        011237899999999999999999995     58999999999988765


Q ss_pred             h
Q 014406          420 S  420 (425)
Q Consensus       420 ~  420 (425)
                      .
T Consensus       460 l  460 (543)
T 3c4z_A          460 L  460 (543)
T ss_dssp             H
T ss_pred             H
Confidence            4

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=5.8e-47  Score=353.24  Aligned_cols=257  Identities=24%  Similarity=0.383  Sum_probs=210.6

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEE
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (425)
                      .++|++.+.||+|+||+||+|.+..+++.||+|++...    ..+.+.+|+.+++.+ +||||+++++++.+.  ...++
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~l   82 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-NHENVVKFYGHRREG--NIQYL   82 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTC-CCTTBCCEEEEEEET--TEEEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhc-CCCCceeeeeEEEcC--CEEEE
Confidence            36799999999999999999999999999999998643    246788999999999 999999999999654  67889


Q ss_pred             EEEeecCCChhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCC--
Q 014406          200 IFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK--  274 (425)
Q Consensus       200 v~e~~~~~~l~~~~~---~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~--  274 (425)
                      ||||+++++|.+++.   .+++..+..++.|++.||+|||++||+|+||||+||+++.+ +.+||+|||++.......  
T Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~-~~~kl~dfg~~~~~~~~~~~  161 (276)
T 2yex_A           83 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRE  161 (276)
T ss_dssp             EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-CCEEECCCTTCEECEETTEE
T ss_pred             EEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccC-CCEEEeeCCCccccCCCcch
Confidence            999999999988874   48999999999999999999999999999999999999988 789999999997654222  


Q ss_pred             -cceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCC
Q 014406          275 -EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL  353 (425)
Q Consensus       275 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~  353 (425)
                       ......++..|+|||.+.+...++.++||||||+++|+|++|..||.........+..+....             .. 
T Consensus       162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-------------~~-  227 (276)
T 2yex_A          162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK-------------TY-  227 (276)
T ss_dssp             CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTC-------------TT-
T ss_pred             hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcc-------------cc-
Confidence             234457899999999998744347899999999999999999999954443333222221100             00 


Q ss_pred             ChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccch
Q 014406          354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE  419 (425)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~~  419 (425)
                                           ......+++++.+|+.+||+.||++|||++|+++||||++.....
T Consensus       228 ---------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~  272 (276)
T 2yex_A          228 ---------------------LNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKG  272 (276)
T ss_dssp             ---------------------STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC--
T ss_pred             ---------------------cCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccChhhcc
Confidence                                 000123689999999999999999999999999999999875543

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=1.4e-47  Score=387.08  Aligned_cols=255  Identities=27%  Similarity=0.525  Sum_probs=210.3

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccE
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (425)
                      .++|++++.||+|+||+||+|.+..++..+|+|++...     ....+.+|+.+++.+ +||||++++++|.+.  ...+
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~--~~~~  112 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLL-DHPNIMKLYDFFEDK--RNYY  112 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTC-CCTTBCCEEEEEECS--SEEE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhC-CCCCCCeEEEEEEeC--CEEE
Confidence            45799999999999999999999999999999998643     346789999999999 999999999999654  6789


Q ss_pred             EEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCC--CCcEEEEeccccccccCC
Q 014406          199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--LRKLRLIDWGLAEFYHPG  273 (425)
Q Consensus       199 lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~--~~~~kl~Dfg~a~~~~~~  273 (425)
                      +||||+.+++|.+.+   ..+++..+..++.||+.||.|||++||+||||||+|||++.+  .+.+||+|||+++.....
T Consensus       113 lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~  192 (494)
T 3lij_A          113 LVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ  192 (494)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT
T ss_pred             EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC
Confidence            999999999997765   569999999999999999999999999999999999999764  245999999999887766


Q ss_pred             CcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCC
Q 014406          274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL  353 (425)
Q Consensus       274 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~  353 (425)
                      .......||+.|+|||++.  ..++.++||||+||++|+|++|..||. +.+..+.+..+......             .
T Consensus       193 ~~~~~~~gt~~y~aPE~l~--~~~~~~~DiwslG~il~~ll~g~~pf~-~~~~~~~~~~i~~~~~~-------------~  256 (494)
T 3lij_A          193 KKMKERLGTAYYIAPEVLR--KKYDEKCDVWSIGVILFILLAGYPPFG-GQTDQEILRKVEKGKYT-------------F  256 (494)
T ss_dssp             BCBCCCCSCTTTCCHHHHT--TCBCTHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHTCCC-------------C
T ss_pred             ccccccCCCcCeeCHHHHc--ccCCCchhHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHhCCCC-------------C
Confidence            6666778999999999985  469999999999999999999999983 33334444333221100             0


Q ss_pred             ChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCccccc
Q 014406          354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA  417 (425)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~  417 (425)
                                          .......+++++++||++||++||++|||++|+|+||||++...
T Consensus       257 --------------------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~  300 (494)
T 3lij_A          257 --------------------DSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMCS  300 (494)
T ss_dssp             --------------------CSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHHHH
T ss_pred             --------------------CchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccCcc
Confidence                                00011237899999999999999999999999999999987643

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=7.7e-47  Score=355.33  Aligned_cols=253  Identities=21%  Similarity=0.393  Sum_probs=206.5

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcC--CCCc
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQ--HSKT  196 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~--~~~~  196 (425)
                      ...|++.+.||+|+||+||+|.+..++..||+|++...     ..+.+.+|+.+++.+ +||||+++++++...  ....
T Consensus        25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~  103 (290)
T 1t4h_A           25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-QHPNIVRFYDSWESTVKGKKC  103 (290)
T ss_dssp             SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEEESSSCEE
T ss_pred             ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhC-CCCCeeeeeeeeccccCCCce
Confidence            45689999999999999999999999999999998643     235688999999999 999999999998653  3456


Q ss_pred             cEEEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--ceeecCCCCceEecCCCCcEEEEecccccccc
Q 014406          197 PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (425)
Q Consensus       197 ~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~--ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~  271 (425)
                      .++||||+++++|.+++   ..+++..++.++.|++.||.|||+.+  |+|+||||+|||++.+.+.+||+|||++....
T Consensus       104 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~  183 (290)
T 1t4h_A          104 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  183 (290)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             EEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccc
Confidence            89999999999999887   46899999999999999999999999  99999999999998444799999999997654


Q ss_pred             CCCcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccC
Q 014406          272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL  351 (425)
Q Consensus       272 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~  351 (425)
                      . .......+|+.|+|||++.+  .++.++|||||||++|+|++|+.||....+.......+.....             
T Consensus       184 ~-~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~-------------  247 (290)
T 1t4h_A          184 A-SFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK-------------  247 (290)
T ss_dssp             T-TSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC-------------
T ss_pred             c-cccccccCCcCcCCHHHHhc--cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCC-------------
Confidence            3 33445678999999998864  5899999999999999999999998433322222221111000             


Q ss_pred             CCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCccc
Q 014406          352 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV  415 (425)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~  415 (425)
                                            ........++++.+|+.+||+.||++|||++|+++||||++-
T Consensus       248 ----------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~~  289 (290)
T 1t4h_A          248 ----------------------PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE  289 (290)
T ss_dssp             ----------------------CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred             ----------------------ccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCcccccC
Confidence                                  000112257899999999999999999999999999999863

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=1.2e-47  Score=386.91  Aligned_cols=255  Identities=27%  Similarity=0.497  Sum_probs=214.4

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecC------cchHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCcc
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP------VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~------~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (425)
                      .++|++.+.||+|+||+||+|.+..+++.||||++..      ...+.+.+|+.+++++ +||||+++++++.+  ....
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~--~~~~  101 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL-DHPNIMKLYEFFED--KGYF  101 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTC-CCTTBCCEEEEEEC--SSEE
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhC-CCCCCCcEEEEEEe--CCEE
Confidence            5689999999999999999999999999999999853      2356789999999999 99999999999965  4788


Q ss_pred             EEEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecC--CCCcEEEEeccccccccC
Q 014406          198 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHP  272 (425)
Q Consensus       198 ~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~--~~~~~kl~Dfg~a~~~~~  272 (425)
                      ++||||+.+++|.+.+   ..+++..+..++.||+.||.|||++||+||||||+|||++.  +.+.+||+|||+++....
T Consensus       102 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~  181 (484)
T 3nyv_A          102 YLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA  181 (484)
T ss_dssp             EEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCC
T ss_pred             EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccc
Confidence            9999999999998776   45899999999999999999999999999999999999952  236899999999988776


Q ss_pred             CCcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCC
Q 014406          273 GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE  352 (425)
Q Consensus       273 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~  352 (425)
                      ........||+.|+|||++.+  .++.++||||+||++|+|++|..||. +.+..+.+..+......             
T Consensus       182 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~-~~~~~~~~~~i~~~~~~-------------  245 (484)
T 3nyv_A          182 SKKMKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFN-GANEYDILKKVEKGKYT-------------  245 (484)
T ss_dssp             CCSHHHHTTGGGTCCHHHHHT--CCCTHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHCCCC-------------
T ss_pred             ccccccCCCCccccCceeecC--CCCCcceeHHHHHHHHHHHHCCCCCC-CCCHHHHHHHHHcCCCC-------------
Confidence            666666789999999999875  68999999999999999999999983 44444444433221000             


Q ss_pred             CChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCccccc
Q 014406          353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA  417 (425)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~  417 (425)
                      .                    .......+++++++||++||++||++|||++|+|+||||+....
T Consensus       246 ~--------------------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~  290 (484)
T 3nyv_A          246 F--------------------ELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTK  290 (484)
T ss_dssp             C--------------------CSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC
T ss_pred             C--------------------CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhccccc
Confidence            0                    00011237899999999999999999999999999999987654

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=5.3e-47  Score=360.74  Aligned_cols=265  Identities=23%  Similarity=0.388  Sum_probs=201.6

Q ss_pred             CCCCEEEE-eeeeeeCceEEEEEEEcCCCcEEEEEEecCc---chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccE
Q 014406          123 DQDDYEVV-RKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (425)
Q Consensus       123 ~~~~y~~~-~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (425)
                      ..++|++. +.||+|+||+||+|.+..+++.||||++...   ..+.+.+|+.++.++.+||||+++++++.+.  ...+
T Consensus        10 ~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~--~~~~   87 (316)
T 2ac3_A           10 FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEE--DRFY   87 (316)
T ss_dssp             TTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEET--TEEE
T ss_pred             cceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC--CEEE
Confidence            46788885 7899999999999999999999999999643   3567899999999965899999999999764  6789


Q ss_pred             EEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCC--cEEEEeccccccccCC
Q 014406          199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELR--KLRLIDWGLAEFYHPG  273 (425)
Q Consensus       199 lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~--~~kl~Dfg~a~~~~~~  273 (425)
                      +||||+.+++|.+++   ..+++..++.++.||+.||+|||++||+||||||+|||++.+..  .+||+|||++......
T Consensus        88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~  167 (316)
T 2ac3_A           88 LVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN  167 (316)
T ss_dssp             EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-----
T ss_pred             EEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccC
Confidence            999999999998877   46899999999999999999999999999999999999987632  3999999998765322


Q ss_pred             C--------cceeeccCCCccCcccccCC----CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHH----------HHH
Q 014406          274 K--------EYNVRVASRYFKGPELLVDL----QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHD----------QLV  331 (425)
Q Consensus       274 ~--------~~~~~~~t~~y~aPE~~~~~----~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~----------~~~  331 (425)
                      .        ......+|..|+|||++.+.    ..++.++|||||||++|+|++|+.||........          ...
T Consensus       168 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  247 (316)
T 2ac3_A          168 GDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQN  247 (316)
T ss_dssp             --------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHH
T ss_pred             CccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHH
Confidence            1        12234689999999998641    3478999999999999999999999954322110          000


Q ss_pred             HHHHHhCCchhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCC
Q 014406          332 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY  411 (425)
Q Consensus       332 ~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~  411 (425)
                      .+.+         .........+.                    .....+++++++|+++||+.||++|||++|+|+|||
T Consensus       248 ~~~~---------~i~~~~~~~~~--------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~  298 (316)
T 2ac3_A          248 MLFE---------SIQEGKYEFPD--------------------KDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPW  298 (316)
T ss_dssp             HHHH---------HHHHCCCCCCH--------------------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTT
T ss_pred             HHHH---------HHhccCcccCc--------------------hhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChh
Confidence            0000         00000000000                    001236899999999999999999999999999999


Q ss_pred             Ccccccc
Q 014406          412 FAQVRAA  418 (425)
Q Consensus       412 ~~~~~~~  418 (425)
                      |++....
T Consensus       299 ~~~~~~~  305 (316)
T 2ac3_A          299 VQGCAPE  305 (316)
T ss_dssp             CC-----
T ss_pred             hcCCCCc
Confidence            9987554

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=1.1e-46  Score=359.94  Aligned_cols=283  Identities=29%  Similarity=0.542  Sum_probs=222.9

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEc-CCCcEEEEEEecCc-----chHHHHHHHHHHHHhc--CCCCeeeEEeEEEc---
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINV-NTNERCIIKILKPV-----KKKKIKREIKILQNLC--GGPNVVKLLDIVRD---  191 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~-~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~--~h~niv~l~~~~~~---  191 (425)
                      ..++|++.+.||+|+||+||+|.+. .+++.||+|++...     ....+.+|+.+++.+.  +||||+++++++..   
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            3578999999999999999999985 67899999998632     2346778888887764  79999999999862   


Q ss_pred             CCCCccEEEEEeecCCChhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccc
Q 014406          192 QHSKTPSLIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL  266 (425)
Q Consensus       192 ~~~~~~~lv~e~~~~~~l~~~~-----~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~  266 (425)
                      ......++||||+++ +|..++     ..+++..+..++.|++.||.|||+.||+|+||||+|||++.+ +.+||+|||+
T Consensus        89 ~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~-~~~kl~Dfg~  166 (326)
T 1blx_A           89 DRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSS-GQIKLADFGL  166 (326)
T ss_dssp             SSEEEEEEEEECCSC-BHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-CCEEECSCCS
T ss_pred             CCCceEEEEEecCCC-CHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCC-CCEEEecCcc
Confidence            234678999999995 777665     238999999999999999999999999999999999999988 7999999999


Q ss_pred             cccccCCCcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHH
Q 014406          267 AEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYL  346 (425)
Q Consensus       267 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~  346 (425)
                      ++............++..|+|||++.+ ..++.++|||||||++|+|++|+.|| .+.+..+.+..+.+.++.+....+.
T Consensus       167 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~  244 (326)
T 1blx_A          167 ARIYSFQMALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLF-RGSSDVDQLGKILDVIGLPGEEDWP  244 (326)
T ss_dssp             CCCCCGGGGGCCCCCCCTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCCCCGGGSC
T ss_pred             cccccCCCCccccccccceeCHHHHhc-CCCCcchhHHHHHHHHHHHHcCCCCC-CCCCHHHHHHHHHHHcCCCCcccCc
Confidence            987654444556688999999999987 67999999999999999999999997 4556667777777777765433321


Q ss_pred             hhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccch
Q 014406          347 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE  419 (425)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~~  419 (425)
                      ......  .   .........     ........+++.+.+|+.+||+.||++|||++|+++||||+++....
T Consensus       245 ~~~~~~--~---~~~~~~~~~-----~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~~  307 (326)
T 1blx_A          245 RDVALP--R---QAFHSKSAQ-----PIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCK  307 (326)
T ss_dssp             TTCSSC--G---GGSCCCCCC-----CGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCCC
T ss_pred             cccccc--h---hhhcccCcc-----hhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccchhh
Confidence            111000  0   000000000     11122344789999999999999999999999999999999987654

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=2.6e-46  Score=365.74  Aligned_cols=281  Identities=23%  Similarity=0.424  Sum_probs=215.5

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc--hHHHHHHHHHHHHhcCCC-----CeeeEEeEEEcCCCC
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--KKKIKREIKILQNLCGGP-----NVVKLLDIVRDQHSK  195 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~~h~-----niv~l~~~~~~~~~~  195 (425)
                      ..++|++.+.||+|+||+||+|.+..+++.||||+++...  ..++.+|+.+++.+..|+     +|+++++++...  .
T Consensus        52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~--~  129 (382)
T 2vx3_A           52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR--N  129 (382)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET--T
T ss_pred             eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC--C
Confidence            4689999999999999999999999999999999997543  356778999999885465     499999999654  6


Q ss_pred             ccEEEEEeecCCChhhhc-----CCCCHHHHHHHHHHHHHHHHHHH--HCCceeecCCCCceEecC-CCCcEEEEecccc
Q 014406          196 TPSLIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCH--SQGIMHRDVKPHNVMIDH-ELRKLRLIDWGLA  267 (425)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~-----~~l~~~~~~~i~~~i~~~L~~LH--~~~ivH~Dlk~~NIll~~-~~~~~kl~Dfg~a  267 (425)
                      ..++||||+++ +|.+++     ..+++..++.++.|++.||.|||  +.||+||||||+|||++. +.+.+||+|||++
T Consensus       130 ~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a  208 (382)
T 2vx3_A          130 HLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS  208 (382)
T ss_dssp             EEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred             ceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCc
Confidence            88999999976 666654     34899999999999999999999  579999999999999964 2368999999999


Q ss_pred             ccccCCCcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHh
Q 014406          268 EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLN  347 (425)
Q Consensus       268 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~  347 (425)
                      +....  ......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.|| .+.+..+.+..+.+.++.++......
T Consensus       209 ~~~~~--~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~  284 (382)
T 2vx3_A          209 CQLGQ--RIYQYIQSRFYRSPEVLLG-MPYDLAIDMWSLGCILVEMHTGEPLF-SGANEVDQMNKIVEVLGIPPAHILDQ  284 (382)
T ss_dssp             EETTC--CCCSSCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCSCCHHHHTT
T ss_pred             eeccc--ccccccCCccccChHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            87643  3345688999999999987 67999999999999999999999987 56667788888888888765433210


Q ss_pred             hccCCCChhhHHHhcccCCCCccc--------------------ccccc---------CCC----CCCHHHHHHHHHccc
Q 014406          348 KYHLELDPQLDALVGRHSRKPWSK--------------------FINAD---------NQH----LVSPEAIDFLDKLLR  394 (425)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~~--------------------~~~~~---------~~~----~~s~~~~~ll~~~L~  394 (425)
                            .+.............|..                    ....+         ...    ..++++++||++||+
T Consensus       285 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~  358 (382)
T 2vx3_A          285 ------APKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLD  358 (382)
T ss_dssp             ------CTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTC
T ss_pred             ------hHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcC
Confidence                  011111111111111100                    00000         000    011478999999999


Q ss_pred             CCcCCCcCHHHHhcCCCCcccc
Q 014406          395 YDHQDRLTAREAMAHPYFAQVR  416 (425)
Q Consensus       395 ~dP~~Rpta~elL~hp~~~~~~  416 (425)
                      +||++|||++|+|+||||++..
T Consensus       359 ~dP~~Rpta~e~L~hp~f~~~~  380 (382)
T 2vx3_A          359 YDPKTRIQPYYALQHSFFKKTA  380 (382)
T ss_dssp             SCTTTSCCHHHHTTSGGGCC--
T ss_pred             CChhhCCCHHHHhcCcccccCC
Confidence            9999999999999999998764

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=7e-47  Score=361.12  Aligned_cols=257  Identities=25%  Similarity=0.448  Sum_probs=207.6

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc-----------hHHHHHHHHHHHHhcCCCCeeeEEeEEEcC
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----------KKKIKREIKILQNLCGGPNVVKLLDIVRDQ  192 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  192 (425)
                      .++|++.+.||+|+||+||+|.+..+++.||||++....           ...+.+|+.+++++ +||||+++++++...
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~   87 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKL-NHPCIIKIKNFFDAE   87 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHC-CCTTBCCEEEEEESS
T ss_pred             hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhC-CCCCCceEeeEEcCC
Confidence            467999999999999999999999999999999986432           23578999999999 999999999999653


Q ss_pred             CCCccEEEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCC--CcEEEEecccc
Q 014406          193 HSKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEL--RKLRLIDWGLA  267 (425)
Q Consensus       193 ~~~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~--~~~kl~Dfg~a  267 (425)
                         ..++||||+.+++|.+++   ..+++..++.++.||+.||.|||++||+|+||||+|||++.+.  ..+||+|||++
T Consensus        88 ---~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~  164 (322)
T 2ycf_A           88 ---DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS  164 (322)
T ss_dssp             ---SEEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTC
T ss_pred             ---ceEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccc
Confidence               378999999999998776   3589999999999999999999999999999999999998752  24999999999


Q ss_pred             ccccCCCcceeeccCCCccCccccc--CCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHH
Q 014406          268 EFYHPGKEYNVRVASRYFKGPELLV--DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAY  345 (425)
Q Consensus       268 ~~~~~~~~~~~~~~t~~y~aPE~~~--~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~  345 (425)
                      +............+|..|+|||++.  +...++.++|||||||++|+|++|..||............+...         
T Consensus       165 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~---------  235 (322)
T 2ycf_A          165 KILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSG---------  235 (322)
T ss_dssp             EECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHT---------
T ss_pred             eecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhC---------
Confidence            8765444444567899999999974  23578999999999999999999999985433322222222110         


Q ss_pred             HhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCccccc
Q 014406          346 LNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA  417 (425)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~  417 (425)
                          .....+                    .....+++++.+|+.+||+.||++|||++|+|+||||++...
T Consensus       236 ----~~~~~~--------------------~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~~~  283 (322)
T 2ycf_A          236 ----KYNFIP--------------------EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDM  283 (322)
T ss_dssp             ----CCCCCH--------------------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCHHH
T ss_pred             ----ccccCc--------------------hhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCHHH
Confidence                000000                    001236899999999999999999999999999999987654

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=1.1e-46  Score=356.13  Aligned_cols=268  Identities=25%  Similarity=0.423  Sum_probs=211.8

Q ss_pred             CcCCcccccCCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc---chHHHHHHHHHHHHhcCCCCeeeEEeEE
Q 014406          113 DYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIV  189 (425)
Q Consensus       113 ~~~~~~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~  189 (425)
                      +|+.........++|++.+.||+|+||+||+|.+..+++.||+|++...   ..+.+.+|+.+++.+ +||||+++++++
T Consensus         7 ~~~~~~~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~   85 (302)
T 2j7t_A            7 EYEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATC-DHPYIVKLLGAY   85 (302)
T ss_dssp             ---CCBSSSCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHC-CCTTBCCEEEEE
T ss_pred             hhcccccccCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcC-CCCCEeeeeeee
Confidence            3444555556678999999999999999999999999999999998643   356788999999999 999999999999


Q ss_pred             EcCCCCccEEEEEeecCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEecc
Q 014406          190 RDQHSKTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWG  265 (425)
Q Consensus       190 ~~~~~~~~~lv~e~~~~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg  265 (425)
                      ...  ...++||||+++++|..++    ..+++..+..++.|++.||.|||+.|++|+||||+||+++.+ +.+||+|||
T Consensus        86 ~~~--~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~-~~~kl~Dfg  162 (302)
T 2j7t_A           86 YHD--GKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLE-GDIRLADFG  162 (302)
T ss_dssp             ECC---CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTT-SCEEECCCH
T ss_pred             eeC--CeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCC-CCEEEEECC
Confidence            754  6789999999999998775    459999999999999999999999999999999999999988 789999999


Q ss_pred             ccccccCC-CcceeeccCCCccCccccc----CCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCc
Q 014406          266 LAEFYHPG-KEYNVRVASRYFKGPELLV----DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTD  340 (425)
Q Consensus       266 ~a~~~~~~-~~~~~~~~t~~y~aPE~~~----~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~  340 (425)
                      ++...... .......++..|+|||++.    ....++.++|||||||++|+|++|..||. ..+..+....+...... 
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~-~~~~~~~~~~~~~~~~~-  240 (302)
T 2j7t_A          163 VSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHH-ELNPMRVLLKIAKSDPP-  240 (302)
T ss_dssp             HHHHHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTT-TSCHHHHHHHHHHSCCC-
T ss_pred             CCccccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCc-cCCHHHHHHHHhccCCc-
Confidence            87543211 1223457899999999984    23678999999999999999999999983 22222222222110000 


Q ss_pred             hhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccch
Q 014406          341 ELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE  419 (425)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~~  419 (425)
                                                       .......++.++.+|+.+||+.||++|||++|+++||||+++.+..
T Consensus       241 ---------------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~  286 (302)
T 2j7t_A          241 ---------------------------------TLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSNK  286 (302)
T ss_dssp             ---------------------------------CCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCCCCH
T ss_pred             ---------------------------------ccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhccch
Confidence                                             0011123688999999999999999999999999999999987654

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.6e-46  Score=350.81  Aligned_cols=253  Identities=23%  Similarity=0.476  Sum_probs=186.7

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCcc
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (425)
                      .++|++.+.||+|+||+||+|.+..+++.||+|++...      ..+.+.+|+.+++++ +||||+++++++.+.  ...
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~   86 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQL-KHPSILELYNYFEDS--NYV   86 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTB-CCTTBCCEEEEEECS--SEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhC-CCCCeEeEEEEEccC--CeE
Confidence            46799999999999999999999999999999999643      236788999999999 899999999999654  678


Q ss_pred             EEEEEeecCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCC
Q 014406          198 SLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (425)
Q Consensus       198 ~lv~e~~~~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~  273 (425)
                      ++||||+++++|..++    ..+++..++.++.|++.||+|||++||+|+||||+||+++.+ +.+||+|||++......
T Consensus        87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~-~~~kl~dfg~~~~~~~~  165 (278)
T 3cok_A           87 YLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRN-MNIKIADFGLATQLKMP  165 (278)
T ss_dssp             EEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTT-CCEEECCCTTCEECC--
T ss_pred             EEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCC-CCEEEEeecceeeccCC
Confidence            9999999999998876    348999999999999999999999999999999999999988 78999999999865432


Q ss_pred             -CcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCC
Q 014406          274 -KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE  352 (425)
Q Consensus       274 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~  352 (425)
                       .......+|+.|+|||.+.+ ..++.++||||||+++|+|++|+.||..... .+.+..+                   
T Consensus       166 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-~~~~~~~-------------------  224 (278)
T 3cok_A          166 HEKHYTLCGTPNYISPEIATR-SAHGLESDVWSLGCMFYTLLIGRPPFDTDTV-KNTLNKV-------------------  224 (278)
T ss_dssp             ---------------------------CTHHHHHHHHHHHHHHSSCSSCCCSC-C-----C-------------------
T ss_pred             CCcceeccCCCCcCCcchhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCChhH-HHHHHHH-------------------
Confidence             22334578999999999977 6789999999999999999999999843221 1111100                   


Q ss_pred             CChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccch
Q 014406          353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE  419 (425)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~~  419 (425)
                                  ..      .....+..++.++.+|+.+||+.||++|||++|+++||||.+.....
T Consensus       225 ------------~~------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~  273 (278)
T 3cok_A          225 ------------VL------ADYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNSSTK  273 (278)
T ss_dssp             ------------CS------SCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC------
T ss_pred             ------------hh------cccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCCCCcc
Confidence                        00      00111233789999999999999999999999999999998765443

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=3.4e-47  Score=357.41  Aligned_cols=255  Identities=22%  Similarity=0.380  Sum_probs=191.3

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcch----HHHH-HHHHHHHHhcCCCCeeeEEeEEEcCCCCcc
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK----KKIK-REIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~----~~~~-~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (425)
                      ..++|++.+.||+|+||+||+|.+..+++.||+|++.....    .+.. ++...++.+ +||||+++++++.+.  ...
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~-~h~~iv~~~~~~~~~--~~~   81 (290)
T 3fme_A            5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTV-DCPFTVTFYGALFRE--GDV   81 (290)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEECS--SSE
T ss_pred             cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhC-CCCeEEEEeeeeecc--CCE
Confidence            46789999999999999999999999999999999975321    2233 344445566 999999999999754  678


Q ss_pred             EEEEEeecCCChhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHC-CceeecCCCCceEecCCCCcEEEEecccccc
Q 014406          198 SLIFEYVNSTDFKVLY-------PTLTDYDIRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (425)
Q Consensus       198 ~lv~e~~~~~~l~~~~-------~~l~~~~~~~i~~~i~~~L~~LH~~-~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~  269 (425)
                      ++||||+++ ++..++       ..+++..++.++.|++.||+|||++ ||+|+||||+|||++.+ +.+||+|||+++.
T Consensus        82 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~  159 (290)
T 3fme_A           82 WICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINAL-GQVKMCDFGISGY  159 (290)
T ss_dssp             EEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTT-CCEEBCCC-----
T ss_pred             EEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCC-CCEEEeecCCccc
Confidence            999999986 554433       4599999999999999999999998 99999999999999988 7999999999987


Q ss_pred             ccCCCcceeeccCCCccCcccc---cCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHH
Q 014406          270 YHPGKEYNVRVASRYFKGPELL---VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYL  346 (425)
Q Consensus       270 ~~~~~~~~~~~~t~~y~aPE~~---~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~  346 (425)
                      ...........+|+.|+|||.+   .....++.++|||||||++|+|++|+.||.........+........        
T Consensus       160 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------  231 (290)
T 3fme_A          160 LVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPS--------  231 (290)
T ss_dssp             ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCC--------
T ss_pred             ccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCC--------
Confidence            7655555566899999999997   23367899999999999999999999999543333333332221100        


Q ss_pred             hhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCccccc
Q 014406          347 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA  417 (425)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~  417 (425)
                                                 .......+++++.+|+.+||+.||++|||++|+++||||+....
T Consensus       232 ---------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~~~  275 (290)
T 3fme_A          232 ---------------------------PQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHES  275 (290)
T ss_dssp             ---------------------------CCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHH
T ss_pred             ---------------------------CCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccCcc
Confidence                                       00011236899999999999999999999999999999986543

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.5e-47  Score=365.54  Aligned_cols=263  Identities=23%  Similarity=0.433  Sum_probs=211.1

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEc---CCCcEEEEEEecCc-------chHHHHHHHHHHHHhcCCCCeeeEEeEEEcC
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINV---NTNERCIIKILKPV-------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQ  192 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~---~~~~~vavK~~~~~-------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  192 (425)
                      ..++|++.+.||+|+||+||+|.+.   .+++.||||+++..       ..+.+.+|+.+++++.+||||+++++++...
T Consensus        52 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~  131 (355)
T 1vzo_A           52 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE  131 (355)
T ss_dssp             CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred             cccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeC
Confidence            3578999999999999999999884   58999999998642       3456788999999997799999999999654


Q ss_pred             CCCccEEEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEecccccc
Q 014406          193 HSKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (425)
Q Consensus       193 ~~~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~  269 (425)
                        ...++||||+++++|.+++   ..+++..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++.
T Consensus       132 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-~~~kl~DfG~a~~  208 (355)
T 1vzo_A          132 --TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSN-GHVVLTDFGLSKE  208 (355)
T ss_dssp             --TEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-SCEEESCSSEEEE
T ss_pred             --ceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC-CcEEEeeCCCCee
Confidence              6788999999999998886   469999999999999999999999999999999999999988 7999999999976


Q ss_pred             ccCCC--cceeeccCCCccCcccccCC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHH
Q 014406          270 YHPGK--EYNVRVASRYFKGPELLVDL-QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYL  346 (425)
Q Consensus       270 ~~~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~  346 (425)
                      .....  ......||+.|+|||++.+. ..++.++|||||||++|+|++|+.||......... ..+.+..        .
T Consensus       209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~-~~~~~~~--------~  279 (355)
T 1vzo_A          209 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ-AEISRRI--------L  279 (355)
T ss_dssp             CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH-HHHHHHH--------H
T ss_pred             cccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchH-HHHHHHH--------h
Confidence            53322  22345789999999999752 35789999999999999999999999543222111 1111100        0


Q ss_pred             hhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCc-----CHHHHhcCCCCcccccchhc
Q 014406          347 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYFAQVRAAESS  421 (425)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rp-----ta~elL~hp~~~~~~~~~~~  421 (425)
                       ..                        .......++..+.+||.+||+.||++||     |++|+++||||+++.+....
T Consensus       280 -~~------------------------~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~~~l~  334 (355)
T 1vzo_A          280 -KS------------------------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLA  334 (355)
T ss_dssp             -HC------------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHH
T ss_pred             -cc------------------------CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCChhHhh
Confidence             00                        0011123788999999999999999999     99999999999998876554


Q ss_pred             c
Q 014406          422 R  422 (425)
Q Consensus       422 ~  422 (425)
                      .
T Consensus       335 ~  335 (355)
T 1vzo_A          335 A  335 (355)
T ss_dssp             T
T ss_pred             h
Confidence            3

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.5e-46  Score=356.22  Aligned_cols=288  Identities=28%  Similarity=0.508  Sum_probs=213.9

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc---hHHHHHHHHHHHHhcCCCCeeeEEeEEEcC-------
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRDQ-------  192 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~-------  192 (425)
                      ..++|++.+.||+|+||+||+|.+..+++.||+|++....   .+.+.+|+.+++++ +||||+++++++...       
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~   87 (320)
T 2i6l_A            9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRL-DHDNIVKVFEILGPSGSQLTDD   87 (320)
T ss_dssp             ETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECTTSCBCCC-
T ss_pred             cCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhc-CCCCeeEEEEeccccccccccc
Confidence            4689999999999999999999999999999999987543   35688999999999 999999999998532       


Q ss_pred             -----CCCccEEEEEeecCCChhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEecc
Q 014406          193 -----HSKTPSLIFEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWG  265 (425)
Q Consensus       193 -----~~~~~~lv~e~~~~~~l~~~~~--~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg  265 (425)
                           .....++||||++ ++|..++.  .+++..++.++.|++.||+|||++||+|+||||+|||++.+.+.+||+|||
T Consensus        88 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg  166 (320)
T 2i6l_A           88 VGSLTELNSVYIVQEYME-TDLANVLEQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFG  166 (320)
T ss_dssp             ---CCSCSEEEEEEECCS-EEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCCT
T ss_pred             cccccccCceeEEeeccC-CCHHHHhhcCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccCc
Confidence                 2356899999998 47877764  489999999999999999999999999999999999998654789999999


Q ss_pred             ccccccCC----CcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCch
Q 014406          266 LAEFYHPG----KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDE  341 (425)
Q Consensus       266 ~a~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~  341 (425)
                      +++.....    .......++..|+|||.+.+...++.++|||||||++|+|++|+.|| .+.+..+.+..+.+..+...
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf-~~~~~~~~~~~~~~~~~~~~  245 (320)
T 2i6l_A          167 LARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLF-AGAHELEQMQLILESIPVVH  245 (320)
T ss_dssp             TCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHSCCCC
T ss_pred             cccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHhcCCCc
Confidence            99865432    12234467889999999876567999999999999999999999998 44455556666665554433


Q ss_pred             hHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccchh
Q 014406          342 LNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAES  420 (425)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~~~  420 (425)
                      ........ ........... .....++.     .....+++++.+|+++||+.||++|||++|+|+||||+....+..
T Consensus       246 ~~~~~~~~-~~~~~~~~~~~-~~~~~~~~-----~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p~~  317 (320)
T 2i6l_A          246 EEDRQELL-SVIPVYIRNDM-TEPHKPLT-----QLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFPMD  317 (320)
T ss_dssp             HHHHHHHH-TTSCHHHHHHT-TSCCCCHH-----HHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC---
T ss_pred             hhhhhhhh-hcCcccccccc-cCCCCChh-----HhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCccC
Confidence            22211110 01111111100 00011111     112247899999999999999999999999999999998877654

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1.9e-46  Score=349.84  Aligned_cols=251  Identities=24%  Similarity=0.409  Sum_probs=200.9

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCc
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (425)
                      ..++|++.+.||+|+||+||+|.+..+++.||+|++...      ..+.+.+|+.+++.+ +||||+++++++...  ..
T Consensus         9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~   85 (276)
T 2h6d_A            9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLF-RHPHIIKLYQVISTP--TD   85 (276)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEECS--SE
T ss_pred             eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcC-CCCCEeEEEEEEecC--Ce
Confidence            357899999999999999999999999999999998642      345788999999999 899999999999654  67


Q ss_pred             cEEEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCC
Q 014406          197 PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (425)
Q Consensus       197 ~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~  273 (425)
                      .++||||+++++|.+++   ..+++..+..++.|++.||.|||++||+|+||||+||+++.+ +.+||+|||++......
T Consensus        86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~-~~~~l~dfg~~~~~~~~  164 (276)
T 2h6d_A           86 FFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAH-MNAKIADFGLSNMMSDG  164 (276)
T ss_dssp             EEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTT-SCEEECCCCGGGCCCC-
T ss_pred             EEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCC-CCEEEeecccccccCCC
Confidence            89999999999998876   468999999999999999999999999999999999999988 78999999999877655


Q ss_pred             CcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCC
Q 014406          274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL  353 (425)
Q Consensus       274 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~  353 (425)
                      .......+++.|+|||.+.+....+.++||||||+++|+|++|..||.. .+..+....+..             ...  
T Consensus       165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~-~~~~~~~~~~~~-------------~~~--  228 (276)
T 2h6d_A          165 EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDD-EHVPTLFKKIRG-------------GVF--  228 (276)
T ss_dssp             ------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHH-------------CCC--
T ss_pred             cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCC-CcHHHHHHHhhc-------------Ccc--
Confidence            5455667899999999998743346899999999999999999999832 222222221111             000  


Q ss_pred             ChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCccc
Q 014406          354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV  415 (425)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~  415 (425)
                                            ..+..++.++.+|+.+||+.||++|||++|+++||||++.
T Consensus       229 ----------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~  268 (276)
T 2h6d_A          229 ----------------------YIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD  268 (276)
T ss_dssp             ----------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             ----------------------cCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence                                  0112368899999999999999999999999999999865

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=2.3e-46  Score=352.79  Aligned_cols=257  Identities=23%  Similarity=0.410  Sum_probs=213.7

Q ss_pred             ccCCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCC
Q 014406          120 QWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH  193 (425)
Q Consensus       120 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  193 (425)
                      .....++|++.+.||+|+||+||+|.+..+++.+|+|++...      ..+.+.+|+.+++.+ +|+||+++++++.+. 
T Consensus        10 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~-   87 (294)
T 2rku_A           10 DPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AHQHVVGFHGFFEDN-   87 (294)
T ss_dssp             ETTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEECS-
T ss_pred             CCCcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhC-CCCCEeeeeeeeccC-
Confidence            344578899999999999999999999999999999998643      245688999999999 999999999999654 


Q ss_pred             CCccEEEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccc
Q 014406          194 SKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  270 (425)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~  270 (425)
                       ...++||||+++++|.+++   ..+++.++..++.|++.||+|||+.||+|+||||+|||++.+ +.+||+|||++...
T Consensus        88 -~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~-~~~kl~dfg~~~~~  165 (294)
T 2rku_A           88 -DFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNED-LEVKIGDFGLATKV  165 (294)
T ss_dssp             -SEEEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-CCEEECCCTTCEEC
T ss_pred             -CEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCC-CCEEEEeccCceec
Confidence             6789999999999998876   468999999999999999999999999999999999999988 78999999999876


Q ss_pred             cCC-CcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhc
Q 014406          271 HPG-KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY  349 (425)
Q Consensus       271 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~  349 (425)
                      ... .......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.. ....+....+..             .
T Consensus       166 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~-~~~~~~~~~~~~-------------~  230 (294)
T 2rku_A          166 EYDGERKKVLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFET-SCLKETYLRIKK-------------N  230 (294)
T ss_dssp             CSTTCCBCCCCSCCSSCCHHHHTT-SCBCTHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHT-------------T
T ss_pred             ccCccccccccCCCCcCCcchhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhh-------------c
Confidence            432 23345678999999999977 6789999999999999999999999832 222222221110             0


Q ss_pred             cCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccch
Q 014406          350 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE  419 (425)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~~  419 (425)
                      .                        ......+++.+.+|+++||+.||++|||++|+++||||.+...+.
T Consensus       231 ~------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~~~  276 (294)
T 2rku_A          231 E------------------------YSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPA  276 (294)
T ss_dssp             C------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCCS
T ss_pred             c------------------------CCCccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecCCcCC
Confidence            0                        001123688999999999999999999999999999998765543

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=2.8e-46  Score=359.00  Aligned_cols=255  Identities=23%  Similarity=0.415  Sum_probs=213.5

Q ss_pred             cCCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCC
Q 014406          121 WGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS  194 (425)
Q Consensus       121 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  194 (425)
                      ....++|++.+.||+|+||+||++.+..+++.+|+|++...      ..+.+.+|+.+++.+ +|+||+++++++.+.  
T Consensus        37 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~--  113 (335)
T 2owb_A           37 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AHQHVVGFHGFFEDN--  113 (335)
T ss_dssp             TTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEECS--
T ss_pred             cccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEecC--
Confidence            34567899999999999999999999999999999998643      346688999999999 999999999999654  


Q ss_pred             CccEEEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEecccccccc
Q 014406          195 KTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (425)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~  271 (425)
                      ...++||||+.+++|.+++   ..+++.++..++.|++.||+|||++||+|+||||+|||++.+ +.+||+|||+++...
T Consensus       114 ~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~-~~~kl~Dfg~~~~~~  192 (335)
T 2owb_A          114 DFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNED-LEVKIGDFGLATKVE  192 (335)
T ss_dssp             SEEEEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTT-CCEEECCCTTCEECC
T ss_pred             CeEEEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCC-CCEEEeeccCceecc
Confidence            6789999999999998876   468999999999999999999999999999999999999988 789999999998764


Q ss_pred             CC-CcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhcc
Q 014406          272 PG-KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH  350 (425)
Q Consensus       272 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~  350 (425)
                      .. .......++..|+|||++.+ ..++.++|||||||++|+|++|+.||.. ....+....+..             ..
T Consensus       193 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~-~~~~~~~~~~~~-------------~~  257 (335)
T 2owb_A          193 YDGERKKVLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFET-SCLKETYLRIKK-------------NE  257 (335)
T ss_dssp             STTCCBCCCCSCCSSCCHHHHHT-SCBCTHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHH-------------TC
T ss_pred             cCcccccccCCCccccCHHHhcc-CCCCchhhHHHHHHHHHHHHHCcCCCCC-CCHHHHHHHHhc-------------CC
Confidence            32 33345678999999999987 6789999999999999999999999832 222222222211             00


Q ss_pred             CCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccc
Q 014406          351 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA  418 (425)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~  418 (425)
                      .                        .....+++++.+||++||+.||++|||++|+++||||.+....
T Consensus       258 ~------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~~~  301 (335)
T 2owb_A          258 Y------------------------SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP  301 (335)
T ss_dssp             C------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCC
T ss_pred             C------------------------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCCcc
Confidence            0                        0112368899999999999999999999999999999876543

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=3.1e-46  Score=350.13  Aligned_cols=250  Identities=23%  Similarity=0.454  Sum_probs=209.9

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCc
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (425)
                      ..++|++.+.||+|+||+||+|.+..+++.||+|++...      ..+.+.+|+.+++.+ +||||+++++++.+.  ..
T Consensus        12 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~   88 (284)
T 2vgo_A           12 TIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHL-RHPNILRMYNYFHDR--KR   88 (284)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEECS--SE
T ss_pred             hhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcC-CCCCEeeEEEEEEcC--CE
Confidence            457899999999999999999999999999999998532      346788999999999 899999999999654  67


Q ss_pred             cEEEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCC
Q 014406          197 PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (425)
Q Consensus       197 ~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~  273 (425)
                      .++||||+++++|..++   ..+++..+..++.|++.||.|||++||+|+||||+||+++.+ +.+||+|||++..... 
T Consensus        89 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~-~~~kl~Dfg~~~~~~~-  166 (284)
T 2vgo_A           89 IYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYK-GELKIADFGWSVHAPS-  166 (284)
T ss_dssp             EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTT-CCEEECCCTTCEECSS-
T ss_pred             EEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCC-CCEEEecccccccCcc-
Confidence            89999999999998776   458999999999999999999999999999999999999988 7899999999876543 


Q ss_pred             CcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCC
Q 014406          274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL  353 (425)
Q Consensus       274 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~  353 (425)
                      .......++..|+|||++.+ ..++.++||||||+++|+|++|..||.. .+..+....+..             ..   
T Consensus       167 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~-~~~~~~~~~~~~-------------~~---  228 (284)
T 2vgo_A          167 LRRRTMCGTLDYLPPEMIEG-KTHDEKVDLWCAGVLCYEFLVGMPPFDS-PSHTETHRRIVN-------------VD---  228 (284)
T ss_dssp             SCBCCCCSCGGGCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHT-------------TC---
T ss_pred             cccccccCCCCcCCHHHhcc-CCCCcccchhhHHHHHHHHHHCCCCCCC-CCHhHHHHHHhc-------------cc---
Confidence            23345678999999999987 6789999999999999999999999832 222222222111             00   


Q ss_pred             ChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccc
Q 014406          354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR  416 (425)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~  416 (425)
                                           ...+..+++++.+|+.+||+.||++|||++|+++||||++..
T Consensus       229 ---------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~  270 (284)
T 2vgo_A          229 ---------------------LKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANS  270 (284)
T ss_dssp             ---------------------CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHC
T ss_pred             ---------------------cCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhc
Confidence                                 001123689999999999999999999999999999998654

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=2e-46  Score=361.77  Aligned_cols=250  Identities=27%  Similarity=0.408  Sum_probs=204.8

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc------hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCcc
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (425)
                      .+.|++.+.||+|+||+||+|.+..+++.||||++....      .+.+.+|+.+++++ +||||+++++++.+.  ...
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~--~~~  129 (348)
T 1u5q_A           53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQYRGCYLRE--HTA  129 (348)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEET--TEE
T ss_pred             hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEEC--CeE
Confidence            356999999999999999999999999999999986432      24688999999999 899999999999764  678


Q ss_pred             EEEEEeecCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCC
Q 014406          198 SLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (425)
Q Consensus       198 ~lv~e~~~~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~  273 (425)
                      ++||||+.++ +.+++    ..+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++.... 
T Consensus       130 ~lv~e~~~g~-l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-~~~kL~DfG~a~~~~~-  206 (348)
T 1u5q_A          130 WLVMEYCLGS-ASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEP-GLVKLGDFGSASIMAP-  206 (348)
T ss_dssp             EEEEECCSEE-HHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETT-TEEEECCCTTCBSSSS-
T ss_pred             EEEEecCCCC-HHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCC-CCEEEeeccCceecCC-
Confidence            8999999864 44333    469999999999999999999999999999999999999988 7999999999986543 


Q ss_pred             CcceeeccCCCccCcccccC--CCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccC
Q 014406          274 KEYNVRVASRYFKGPELLVD--LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL  351 (425)
Q Consensus       274 ~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~  351 (425)
                        .....||+.|+|||++.+  ...++.++|||||||++|||++|+.||... +..+.+..+.....             
T Consensus       207 --~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~-~~~~~~~~~~~~~~-------------  270 (348)
T 1u5q_A          207 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-NAMSALYHIAQNES-------------  270 (348)
T ss_dssp             --BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS-CHHHHHHHHHHSCC-------------
T ss_pred             --CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHhcCC-------------
Confidence              234578999999999852  357899999999999999999999998432 22232222211000             


Q ss_pred             CCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCccccc
Q 014406          352 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA  417 (425)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~  417 (425)
                                            .......+++.+.+||.+||+.||++|||++++++||||.+...
T Consensus       271 ----------------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~~~  314 (348)
T 1u5q_A          271 ----------------------PALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERP  314 (348)
T ss_dssp             ----------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCCC
T ss_pred             ----------------------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhccCC
Confidence                                  00011236889999999999999999999999999999987654

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=3.1e-46  Score=350.02  Aligned_cols=248  Identities=18%  Similarity=0.235  Sum_probs=202.2

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccE
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (425)
                      .++|++.+.||+|+||+||+|.+..+++.||+|++...     ....+.+|+..+..+.+||||+++++++.+.  ...+
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~--~~~~   87 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAED--DHML   87 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEET--TEEE
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecC--CeEE
Confidence            46899999999999999999999999999999998743     3456788999999987899999999999654  6789


Q ss_pred             EEEEeecCCChhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCC----------------
Q 014406          199 LIFEYVNSTDFKVLY-------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE----------------  255 (425)
Q Consensus       199 lv~e~~~~~~l~~~~-------~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~----------------  255 (425)
                      +||||+++++|.+++       ..+++..++.++.||+.||+|||++||+|+||||+|||++.+                
T Consensus        88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~  167 (289)
T 1x8b_A           88 IQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWA  167 (289)
T ss_dssp             EEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC------------------
T ss_pred             EEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccccccccccc
Confidence            999999999999887       348999999999999999999999999999999999999843                


Q ss_pred             --CCcEEEEeccccccccCCCcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHH
Q 014406          256 --LRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI  333 (425)
Q Consensus       256 --~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~  333 (425)
                        ...+||+|||++......   ....+|..|+|||++.+...++.++|||||||++|+|++|..++...    +....+
T Consensus       168 ~~~~~~kl~Dfg~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~----~~~~~~  240 (289)
T 1x8b_A          168 SNKVMFKIGDLGHVTRISSP---QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG----DQWHEI  240 (289)
T ss_dssp             --CCCEEECCCTTCEETTCS---CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS----HHHHHH
T ss_pred             CCceEEEEcccccccccCCc---cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch----hHHHHH
Confidence              247899999999876532   23468999999999987446778999999999999999998766321    122111


Q ss_pred             HHHhCCchhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCc
Q 014406          334 AKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA  413 (425)
Q Consensus       334 ~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~  413 (425)
                      ..             ..                       .......+++++.+|+.+||+.||++|||++|+++||||+
T Consensus       241 ~~-------------~~-----------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~  284 (289)
T 1x8b_A          241 RQ-------------GR-----------------------LPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLL  284 (289)
T ss_dssp             HT-------------TC-----------------------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC-
T ss_pred             Hc-------------CC-----------------------CCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhh
Confidence            10             00                       0011234789999999999999999999999999999998


Q ss_pred             ccc
Q 014406          414 QVR  416 (425)
Q Consensus       414 ~~~  416 (425)
                      +..
T Consensus       285 ~~~  287 (289)
T 1x8b_A          285 SAS  287 (289)
T ss_dssp             ---
T ss_pred             hhc
Confidence            753

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=5.4e-46  Score=359.07  Aligned_cols=289  Identities=26%  Similarity=0.472  Sum_probs=219.1

Q ss_pred             CCCCCEEEEeeeeeeCceEEEEEEEcCCC-cEEEEEEecCc--chHHHHHHHHHHHHhcCCCC------eeeEEeEEEcC
Q 014406          122 GDQDDYEVVRKVGRGKYSEVFEGINVNTN-ERCIIKILKPV--KKKKIKREIKILQNLCGGPN------VVKLLDIVRDQ  192 (425)
Q Consensus       122 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~-~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~n------iv~l~~~~~~~  192 (425)
                      ...++|++.+.||+|+||+||+|.+..++ ..||+|+++..  ..+.+.+|+.+++.+ .|++      ++.+++++...
T Consensus        16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~~~~~~~~~~~~~~~~~~~~~   94 (355)
T 2eu9_A           16 WLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKI-KEKDKENKFLCVLMSDWFNFH   94 (355)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHH-HHHCTTSCSCBCCEEEEEEET
T ss_pred             eecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHH-hhcCCCCceeEEEeeeeeeeC
Confidence            34689999999999999999999998777 78999999753  346688899999998 5544      89999999654


Q ss_pred             CCCccEEEEEeecCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEe----------------
Q 014406          193 HSKTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI----------------  252 (425)
Q Consensus       193 ~~~~~~lv~e~~~~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll----------------  252 (425)
                        ...++||||++++++..+.    ..+++..++.++.||+.||+|||++||+||||||+|||+                
T Consensus        95 --~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~  172 (355)
T 2eu9_A           95 --GHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCE  172 (355)
T ss_dssp             --TEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred             --CeEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccccccc
Confidence              6889999999666655443    358999999999999999999999999999999999999                


Q ss_pred             ---cCCCCcEEEEeccccccccCCCcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHH
Q 014406          253 ---DHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQ  329 (425)
Q Consensus       253 ---~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~  329 (425)
                         +.+ +.+||+|||+++....  ......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.|| .+.+..+.
T Consensus       173 ~~~~~~-~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf-~~~~~~~~  247 (355)
T 2eu9_A          173 EKSVKN-TSIRVADFGSATFDHE--HHTTIVATRHYRPPEVILE-LGWAQPCDVWSIGCILFEYYRGFTLF-QTHENREH  247 (355)
T ss_dssp             EEEESC-CCEEECCCTTCEETTS--CCCSSCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHH
T ss_pred             ccccCC-CcEEEeecCccccccc--cccCCcCCCcccCCeeeec-CCCCCccchHHHHHHHHHHHhCCCCC-CCCCHHHH
Confidence               344 7899999999986442  3345678999999999987 68999999999999999999999998 45556677


Q ss_pred             HHHHHHHhCCchhHHHHhhcc--------CCCChhh--HHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCC
Q 014406          330 LVKIAKVLGTDELNAYLNKYH--------LELDPQL--DALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQD  399 (425)
Q Consensus       330 ~~~~~~~lg~~~~~~~~~~~~--------~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~  399 (425)
                      +..+.+.++..+.........        ..+....  ...... ...++....  ......+.++.+||++||+.||++
T Consensus       248 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~--~~~~~~~~~l~~li~~~L~~dP~~  324 (355)
T 2eu9_A          248 LVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKE-NCKPLKSYM--LQDSLEHVQLFDLMRRMLEFDPAQ  324 (355)
T ss_dssp             HHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHH-HCCCGGGGC--SCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred             HHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccc-cCCcccccc--cccchhHHHHHHHHHHHhcCChhh
Confidence            777777777654432211100        0000000  000000 000000000  111123568899999999999999


Q ss_pred             CcCHHHHhcCCCCcccccchhc
Q 014406          400 RLTAREAMAHPYFAQVRAAESS  421 (425)
Q Consensus       400 Rpta~elL~hp~~~~~~~~~~~  421 (425)
                      |||++|+|+||||+++...+.+
T Consensus       325 Rpt~~e~l~hp~f~~~~~~~~~  346 (355)
T 2eu9_A          325 RITLAEALLHPFFAGLTPEERS  346 (355)
T ss_dssp             SCCHHHHTTSGGGGGCCHHHHC
T ss_pred             CcCHHHHhcChhhcCCChhhcc
Confidence            9999999999999999876554

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=3.4e-46  Score=357.94  Aligned_cols=284  Identities=25%  Similarity=0.487  Sum_probs=216.6

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEE-cCCCcEEEEEEecCcc--hHHHHHHHHHHHHhcCCC------CeeeEEeEEEcCC
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGIN-VNTNERCIIKILKPVK--KKKIKREIKILQNLCGGP------NVVKLLDIVRDQH  193 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~-~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~~h~------niv~l~~~~~~~~  193 (425)
                      ..++|++.+.||+|+||+||+|.+ ..+++.||+|+++...  .+.+.+|+.+++.+ +|+      +++++++++... 
T Consensus        12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~~~~~~~~~~i~~~~~~~~~~-   89 (339)
T 1z57_A           12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHL-NTTDPNSTFRCVQMLEWFEHH-   89 (339)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHH-HHHCTTCTTCBCCEEEEEEET-
T ss_pred             ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHh-hhcCCCCceeeEeeecccccC-
Confidence            467999999999999999999998 5688999999997543  46788999999988 444      599999999654 


Q ss_pred             CCccEEEEEeecCCChhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCC-------------
Q 014406          194 SKTPSLIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE-------------  255 (425)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~-----~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~-------------  255 (425)
                       ...++||||+ +++|.+++     ..+++..+..++.|++.||+|||++||+||||||+|||++.+             
T Consensus        90 -~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~  167 (339)
T 1z57_A           90 -GHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRD  167 (339)
T ss_dssp             -TEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred             -CcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccccc
Confidence             6889999999 66776665     248899999999999999999999999999999999999873             


Q ss_pred             -----CCcEEEEeccccccccCCCcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHH
Q 014406          256 -----LRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL  330 (425)
Q Consensus       256 -----~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~  330 (425)
                           .+.+||+|||+++....  ......+|+.|+|||++.+ ..++.++|||||||++|+|++|..|| .+.+..+.+
T Consensus       168 ~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf-~~~~~~~~~  243 (339)
T 1z57_A          168 ERTLINPDIKVVDFGSATYDDE--HHSTLVSTRHYRAPEVILA-LGWSQPCDVWSIGCILIEYYLGFTVF-PTHDSKEHL  243 (339)
T ss_dssp             EEEESCCCEEECCCSSCEETTS--CCCSSCSCGGGCCHHHHTT-SCCCTHHHHHHHHHHHHHHHHSSCSC-CCSCHHHHH
T ss_pred             cccccCCCceEeeCcccccCcc--ccccccCCccccChHHhhC-CCCCcchhhHHHHHHHHHHHhCCCCC-CCCChHHHH
Confidence                 25799999999986442  3345678999999999987 68999999999999999999999998 455666777


Q ss_pred             HHHHHHhCCchhHHHHhhcc--------CCCChhh--HHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCC
Q 014406          331 VKIAKVLGTDELNAYLNKYH--------LELDPQL--DALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDR  400 (425)
Q Consensus       331 ~~~~~~lg~~~~~~~~~~~~--------~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R  400 (425)
                      ..+.+.++..+.........        ..+....  ....... .......  .......++++.+||++||+.||++|
T Consensus       244 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~--~~~~~~~~~~l~~li~~~L~~dP~~R  320 (339)
T 1z57_A          244 AMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRA-CKPLKEF--MLSQDVEHERLFDLIQKMLEYDPAKR  320 (339)
T ss_dssp             HHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHH-CCCGGGG--CSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred             HHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhc-Ccchhhh--cccchhhHHHHHHHHHHHhCcCcccc
Confidence            77777777654432211100        0000000  0000000 0000000  01112246789999999999999999


Q ss_pred             cCHHHHhcCCCCccccc
Q 014406          401 LTAREAMAHPYFAQVRA  417 (425)
Q Consensus       401 pta~elL~hp~~~~~~~  417 (425)
                      ||++|+++||||+.++.
T Consensus       321 pt~~ell~hp~f~~~~~  337 (339)
T 1z57_A          321 ITLREALKHPFFDLLKK  337 (339)
T ss_dssp             CCHHHHTTSGGGGGGGC
T ss_pred             cCHHHHhcCHHHHHHhc
Confidence            99999999999998754

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=4.9e-47  Score=367.85  Aligned_cols=287  Identities=21%  Similarity=0.309  Sum_probs=213.0

Q ss_pred             cCCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCc
Q 014406          121 WGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (425)
Q Consensus       121 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (425)
                      ....++|++.+.||+|+||+||+|.+..+++.||+|++....    .+.+.+|+.+++.+ +||||+++++++.+.  ..
T Consensus        29 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~--~~  105 (360)
T 3eqc_A           29 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYSD--GE  105 (360)
T ss_dssp             CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGC-CCTTBCCEEEEEEET--TE
T ss_pred             ccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHC-CCCCEEEEeEEEEEC--CE
Confidence            335688999999999999999999999999999999987542    35688999999999 999999999999764  67


Q ss_pred             cEEEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHC-CceeecCCCCceEecCCCCcEEEEeccccccccC
Q 014406          197 PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (425)
Q Consensus       197 ~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~-~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~  272 (425)
                      .++||||+++++|.+++   ..+++..+..++.|++.||.|||+. ||+|+||||+|||++.+ +.+||+|||++.....
T Consensus       106 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~  184 (360)
T 3eqc_A          106 ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSR-GEIKLCDFGVSGQLID  184 (360)
T ss_dssp             EEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTT-CCEEECCCCCCHHHHH
T ss_pred             EEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCC-CCEEEEECCCCccccc
Confidence            89999999999999887   4689999999999999999999996 99999999999999988 7899999999975532


Q ss_pred             CCcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh--CCchhHHH-Hh--
Q 014406          273 GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL--GTDELNAY-LN--  347 (425)
Q Consensus       273 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~l--g~~~~~~~-~~--  347 (425)
                      . ......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||...  +.+.+..+....  +....... ..  
T Consensus       185 ~-~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (360)
T 3eqc_A          185 S-MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPP--DAKELELMFGCQVEGDAAETPPRPRTP  260 (360)
T ss_dssp             H-C----CCCCTTCCHHHHTT-CCCSHHHHHHHHHHHHHHHHHTSCCSSCC--CHHHHHHHHC-----------------
T ss_pred             c-cccCCCCCCCeECHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHhcccccccCCCCCCCcccC
Confidence            2 2344578999999999987 68999999999999999999999999532  222222221111  10000000 00  


Q ss_pred             -----hccCCC--ChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccch
Q 014406          348 -----KYHLEL--DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE  419 (425)
Q Consensus       348 -----~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~~  419 (425)
                           ......  .............    ..........++.++.+||++||++||++|||++|+|+||||++..+.+
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~  335 (360)
T 3eqc_A          261 GRPLNKFGMDSRPPMAIFELLDYIVN----EPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEE  335 (360)
T ss_dssp             -------------CCCHHHHHHHHHH----SCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHHHSC
T ss_pred             CCcccccccCCCCcccchhhhhHHhc----cCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcchHhh
Confidence                 000000  0000000000000    0001111234788999999999999999999999999999999876544

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.2e-46  Score=356.10  Aligned_cols=259  Identities=24%  Similarity=0.411  Sum_probs=206.5

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecC--cchHHHHHHHHHHHHhcCCCCeeeEEeEEEcCC----CCc
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQH----SKT  196 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~--~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~----~~~  196 (425)
                      ..++|++.+.||+|+||+||+|.+..+++.||+|++..  ...+.+.+|+.+++++.+||||+++++++....    ...
T Consensus        22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~  101 (326)
T 2x7f_A           22 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ  101 (326)
T ss_dssp             CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCE
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccce
Confidence            57899999999999999999999999999999999864  345788999999999978999999999997643    467


Q ss_pred             cEEEEEeecCCChhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEecccccccc
Q 014406          197 PSLIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (425)
Q Consensus       197 ~~lv~e~~~~~~l~~~~-----~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~  271 (425)
                      .++||||+++++|.+++     ..+++..++.++.||+.||.|||+.||+|+||||+|||++.+ +.+||+|||++....
T Consensus       102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~-~~~kl~Dfg~~~~~~  180 (326)
T 2x7f_A          102 LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTEN-AEVKLVDFGVSAQLD  180 (326)
T ss_dssp             EEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTT-CCEEECCCTTTC---
T ss_pred             EEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCC-CCEEEeeCcCceecC
Confidence            89999999999998886     358999999999999999999999999999999999999988 789999999997654


Q ss_pred             CC-CcceeeccCCCccCcccccC----CCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHH
Q 014406          272 PG-KEYNVRVASRYFKGPELLVD----LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYL  346 (425)
Q Consensus       272 ~~-~~~~~~~~t~~y~aPE~~~~----~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~  346 (425)
                      .. .......++..|+|||++..    ...++.++|||||||++|+|++|..||. +.+..+....+... .        
T Consensus       181 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~-~~~~~~~~~~~~~~-~--------  250 (326)
T 2x7f_A          181 RTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLC-DMHPMRALFLIPRN-P--------  250 (326)
T ss_dssp             ----------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTT-TSCHHHHHHHHHHS-C--------
T ss_pred             cCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCC-CCcHHHHHHHhhcC-c--------
Confidence            32 22344578999999999862    2568899999999999999999999983 22222222211110 0        


Q ss_pred             hhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccc
Q 014406          347 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA  418 (425)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~  418 (425)
                                                ........+++.+.+||.+||+.||++|||++|+++||||++....
T Consensus       251 --------------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~~  296 (326)
T 2x7f_A          251 --------------------------APRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPNE  296 (326)
T ss_dssp             --------------------------CCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCTTH
T ss_pred             --------------------------cccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCccc
Confidence                                      0000122368999999999999999999999999999999987653

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=2.9e-46  Score=353.91  Aligned_cols=254  Identities=25%  Similarity=0.433  Sum_probs=208.7

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc---chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEE
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (425)
                      .++|++.+.||+|+||+||+|.+..+++.||+|+++..   ..+.+.+|+.+++++ +||||+++++++.+.  ...++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~lv   84 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKI-KHENIVTLEDIYEST--THYYLV   84 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHC-CCTTBCCEEEEEECS--SEEEEE
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhC-CCCCeeehhhhcccC--CEEEEE
Confidence            46899999999999999999999999999999999753   345688999999999 999999999999654  678999


Q ss_pred             EEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEe---cCCCCcEEEEeccccccccCCC
Q 014406          201 FEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI---DHELRKLRLIDWGLAEFYHPGK  274 (425)
Q Consensus       201 ~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll---~~~~~~~kl~Dfg~a~~~~~~~  274 (425)
                      |||+++++|.+++   ..+++..+..++.|++.||.|||+.||+|+||||+||++   +.+ +.+||+|||+++.... .
T Consensus        85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~-~~~kl~Dfg~~~~~~~-~  162 (304)
T 2jam_A           85 MQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEEN-SKIMITDFGLSKMEQN-G  162 (304)
T ss_dssp             ECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTT-CCEEBCSCSTTCCCCC-B
T ss_pred             EEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCC-CCEEEccCCcceecCC-C
Confidence            9999999998776   468999999999999999999999999999999999999   555 7899999999975432 2


Q ss_pred             cceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCC
Q 014406          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD  354 (425)
Q Consensus       275 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~  354 (425)
                      ......+++.|+|||++.+ ..++.++|||||||++|+|++|..||.. .+..+....+.+..             ... 
T Consensus       163 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~-~~~~~~~~~i~~~~-------------~~~-  226 (304)
T 2jam_A          163 IMSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVITYILLCGYPPFYE-ETESKLFEKIKEGY-------------YEF-  226 (304)
T ss_dssp             TTHHHHSCCCBCCTTTBSS-CSCCHHHHHHHHHHHHHHHHHSSCTTTT-SCHHHHHHHHHHCC-------------CCC-
T ss_pred             ccccccCCCCccChHHhcc-CCCCchhhHHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHcCC-------------CCC-
Confidence            3344578999999999977 6799999999999999999999999842 23233333222110             000 


Q ss_pred             hhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCccccc
Q 014406          355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA  417 (425)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~  417 (425)
                                         .......+++++.+|+.+||+.||++|||++|+++||||++...
T Consensus       227 -------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~  270 (304)
T 2jam_A          227 -------------------ESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNTA  270 (304)
T ss_dssp             -------------------CTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSCS
T ss_pred             -------------------CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCCCc
Confidence                               00111237899999999999999999999999999999987543

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=7.4e-47  Score=357.21  Aligned_cols=266  Identities=20%  Similarity=0.356  Sum_probs=189.1

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccE
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (425)
                      ..++|++.+.||+|+||+||+|.+..+++.||||++...    ..+.+.+|+.+++++ +||||+++++++...  ...+
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~   89 (303)
T 2vwi_A           13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQC-HHPNIVSYYTSFVVK--DELW   89 (303)
T ss_dssp             CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCC-CCTTBCCEEEEEESS--SCEE
T ss_pred             chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhc-CCCCEeeEEEEEeec--CCcE
Confidence            468899999999999999999998889999999998643    345678999999999 899999999999764  5788


Q ss_pred             EEEEeecCCChhhhcC-----------CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEecccc
Q 014406          199 LIFEYVNSTDFKVLYP-----------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA  267 (425)
Q Consensus       199 lv~e~~~~~~l~~~~~-----------~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a  267 (425)
                      +||||+++++|.+++.           .+++..+..++.|++.||.|||+.||+|+||||+||+++.+ +.+||+|||++
T Consensus        90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~-~~~kl~dfg~~  168 (303)
T 2vwi_A           90 LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGED-GSVQIADFGVS  168 (303)
T ss_dssp             EEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTT-CCEEECCCHHH
T ss_pred             EEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCC-CCEEEEeccch
Confidence            9999999999988763           38999999999999999999999999999999999999988 78999999999


Q ss_pred             ccccCCC------cceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCch
Q 014406          268 EFYHPGK------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDE  341 (425)
Q Consensus       268 ~~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~  341 (425)
                      .......      ......+|+.|+|||++.+...++.++|||||||++|+|++|+.||... +..+.......  +.. 
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~-~~~~~~~~~~~--~~~-  244 (303)
T 2vwi_A          169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKY-PPMKVLMLTLQ--NDP-  244 (303)
T ss_dssp             HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTS-CGGGHHHHHHT--SSC-
T ss_pred             heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccC-chhhHHHHHhc--cCC-
Confidence            7654322      1234578999999999865456899999999999999999999998432 22222211110  000 


Q ss_pred             hHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccchh
Q 014406          342 LNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAES  420 (425)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~~~  420 (425)
                                              ...............+++++.+|+.+||+.||++|||++|+++||||++....+.
T Consensus       245 ------------------------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~  299 (303)
T 2vwi_A          245 ------------------------PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNKEF  299 (303)
T ss_dssp             ------------------------CCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC--------
T ss_pred             ------------------------CccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCCCcc
Confidence                                    0000001111223347899999999999999999999999999999998876543

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=3.5e-46  Score=350.43  Aligned_cols=256  Identities=23%  Similarity=0.506  Sum_probs=211.6

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecC-----cchHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccE
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (425)
                      .++|++.+.||+|+||+||+|.+..+++.||+|++..     ...+.+.+|+.+++++ +||||+++++++.+.  ...+
T Consensus        21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~   97 (287)
T 2wei_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL-DHPNIMKLFEILEDS--SSFY   97 (287)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTC-CCTTBCCEEEEEECS--SEEE
T ss_pred             hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhc-cCCCccEEEEEEeCC--CeEE
Confidence            4689999999999999999999999999999999853     2356789999999999 999999999999654  6789


Q ss_pred             EEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCC--CcEEEEeccccccccCC
Q 014406          199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEL--RKLRLIDWGLAEFYHPG  273 (425)
Q Consensus       199 lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~--~~~kl~Dfg~a~~~~~~  273 (425)
                      +|+||+.+++|.+.+   ..+++..+..++.|++.||.|||++||+|+||||+||+++.+.  ..+||+|||++......
T Consensus        98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~  177 (287)
T 2wei_A           98 IVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN  177 (287)
T ss_dssp             EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCC
T ss_pred             EEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCC
Confidence            999999999997765   5699999999999999999999999999999999999997642  36999999999877655


Q ss_pred             CcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCC
Q 014406          274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL  353 (425)
Q Consensus       274 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~  353 (425)
                      .......++..|+|||.+.+  .++.++||||||+++|+|++|..||.. .+..+....+...             ....
T Consensus       178 ~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~-~~~~~~~~~~~~~-------------~~~~  241 (287)
T 2wei_A          178 TKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYG-KNEYDILKRVETG-------------KYAF  241 (287)
T ss_dssp             SSCSCHHHHHTTCCHHHHTT--CCCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHC-------------CCCC
T ss_pred             CccccccCcccccChHHhcC--CCCCchhhHhHHHHHHHHHhCCCCCCC-CCHHHHHHHHHcC-------------CCCC
Confidence            55555678999999999865  489999999999999999999999843 2322222222110             0000


Q ss_pred             ChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccc
Q 014406          354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA  418 (425)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~  418 (425)
                                          .......+++++.+|+++||+.||++|||++|+++||||++..+.
T Consensus       242 --------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~~  286 (287)
T 2wei_A          242 --------------------DLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSE  286 (287)
T ss_dssp             --------------------CSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHHCCC
T ss_pred             --------------------CchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhccccC
Confidence                                000112378999999999999999999999999999999877543

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1.2e-46  Score=357.78  Aligned_cols=257  Identities=21%  Similarity=0.341  Sum_probs=203.7

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc------hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCC--
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHS--  194 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~--  194 (425)
                      ..++|++.+.||+|+||+||+|.+..+++.||||++....      ...+.+|+.+++++ +||||+++++++.....  
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~   88 (311)
T 3ork_A           10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-NHPAIVAVYDTGEAETPAG   88 (311)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCC-CCTTBCCEEEEEEEEETTE
T ss_pred             ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcC-CCCCcceEEEeeeccCCCC
Confidence            3678999999999999999999999999999999997532      24678999999999 99999999999875432  


Q ss_pred             CccEEEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEecccccccc
Q 014406          195 KTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (425)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~  271 (425)
                      ...++||||+++++|.+++   ..+++.++..++.|++.||+|||++||+|+||||+|||++.+ +.+||+|||+++...
T Consensus        89 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~-~~~kl~Dfg~a~~~~  167 (311)
T 3ork_A           89 PLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISAT-NAVKVMDFGIARAIA  167 (311)
T ss_dssp             EEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETT-SCEEECCCSCC----
T ss_pred             cccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCC-CCEEEeeccCccccc
Confidence            2458999999999999886   459999999999999999999999999999999999999988 789999999998654


Q ss_pred             CCC----cceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHh
Q 014406          272 PGK----EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLN  347 (425)
Q Consensus       272 ~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~  347 (425)
                      ...    ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||. +.+..+...........+.      
T Consensus       168 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~pf~-~~~~~~~~~~~~~~~~~~~------  239 (311)
T 3ork_A          168 DSGNSVTQTAAVIGTAQYLSPEQARG-DSVDARSDVYSLGCVLYEVLTGEPPFT-GDSPVSVAYQHVREDPIPP------  239 (311)
T ss_dssp             --------------CCTTCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCSCC-CSSHHHHHHHHHHCCCCCH------
T ss_pred             ccccccccccccCcCcccCCHHHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCC-CCChHHHHHHHhcCCCCCc------
Confidence            332    2233468999999999987 689999999999999999999999983 3333332222221100000      


Q ss_pred             hccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccc
Q 014406          348 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR  416 (425)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~  416 (425)
                                                 ......+++++.+|+.+||+.||++||++.++|+|+|++...
T Consensus       240 ---------------------------~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~  281 (311)
T 3ork_A          240 ---------------------------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN  281 (311)
T ss_dssp             ---------------------------HHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHT
T ss_pred             ---------------------------ccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhc
Confidence                                       001123789999999999999999999999999999987543

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=6.1e-48  Score=376.64  Aligned_cols=252  Identities=18%  Similarity=0.248  Sum_probs=198.5

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhc--CCCCeeeEE-------e
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLC--GGPNVVKLL-------D  187 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~--~h~niv~l~-------~  187 (425)
                      ..++|++.+.||+|+||+||+|.+..+++.||||++...      ..+.+.+|+.+++.+.  +||||++++       +
T Consensus        71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~  150 (377)
T 3byv_A           71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD  150 (377)
T ss_dssp             CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred             CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence            357899999999999999999999899999999998632      2467889995554442  799999998       6


Q ss_pred             EEEcCCC----------C-----ccEEEEEeecCCChhhhcC---CCCH-------HHHHHHHHHHHHHHHHHHHCCcee
Q 014406          188 IVRDQHS----------K-----TPSLIFEYVNSTDFKVLYP---TLTD-------YDIRYYIYELLKALDYCHSQGIMH  242 (425)
Q Consensus       188 ~~~~~~~----------~-----~~~lv~e~~~~~~l~~~~~---~l~~-------~~~~~i~~~i~~~L~~LH~~~ivH  242 (425)
                      ++.+...          .     ..++||||+ +|+|.+++.   .+++       ..+..++.||+.||+|||++||+|
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH  229 (377)
T 3byv_A          151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVH  229 (377)
T ss_dssp             EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeec
Confidence            6654321          1     378999999 578888763   2444       777889999999999999999999


Q ss_pred             ecCCCCceEecCCCCcEEEEeccccccccCCCcceeeccCCCccCcccccCC----------CCCCCcccHHHHHHHHHH
Q 014406          243 RDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL----------QDYDYSLDMWSLGCMFAG  312 (425)
Q Consensus       243 ~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~----------~~~~~~~DvwslG~~l~e  312 (425)
                      |||||+|||++.+ +.+||+|||+++...  .......| +.|+|||++.+.          ..++.++|||||||++|+
T Consensus       230 rDikp~NIll~~~-~~~kL~DFG~a~~~~--~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~e  305 (377)
T 3byv_A          230 TYLRPVDIVLDQR-GGVFLTGFEHLVRDG--ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYW  305 (377)
T ss_dssp             SCCCGGGEEECTT-CCEEECCGGGCEETT--CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHH
T ss_pred             CCCCHHHEEEcCC-CCEEEEechhheecC--CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHH
Confidence            9999999999988 799999999998643  33445567 999999999872          179999999999999999


Q ss_pred             HHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHc
Q 014406          313 MIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKL  392 (425)
Q Consensus       313 lltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~  392 (425)
                      |++|+.||... +..+...                                       ..  ......+++++.+||.+|
T Consensus       306 lltg~~Pf~~~-~~~~~~~---------------------------------------~~--~~~~~~~~~~~~~li~~~  343 (377)
T 3byv_A          306 IWCADLPITKD-AALGGSE---------------------------------------WI--FRSCKNIPQPVRALLEGF  343 (377)
T ss_dssp             HHHSSCCC-------CCSG---------------------------------------GG--GSSCCCCCHHHHHHHHHH
T ss_pred             HHHCCCCCccc-ccccchh---------------------------------------hh--hhhccCCCHHHHHHHHHH
Confidence            99999998321 1000000                                       00  001124789999999999


Q ss_pred             ccCCcCCCcCHHHHhcCCCCcccccchhc
Q 014406          393 LRYDHQDRLTAREAMAHPYFAQVRAAESS  421 (425)
Q Consensus       393 L~~dP~~Rpta~elL~hp~~~~~~~~~~~  421 (425)
                      |+.||++|||+.|+++||||+++....++
T Consensus       344 L~~dp~~Rpt~~e~l~hp~f~~~~~~~~~  372 (377)
T 3byv_A          344 LRYPKEDRLLPLQAMETPEYEQLRTELSA  372 (377)
T ss_dssp             TCSSGGGCCCHHHHHTSHHHHHHHHHHHH
T ss_pred             cCCCchhCCCHHHHhhChHHHHHHHHHHH
Confidence            99999999999999999999998765544

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.6e-45  Score=350.25  Aligned_cols=257  Identities=25%  Similarity=0.415  Sum_probs=207.3

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEE
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (425)
                      ..++|++.+.||+|+||+||+|.+..+++.||+|++... ..+.+.+|+.+++.+ +||||+++++++...  ...++||
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~lv~  103 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQC-DSPHVVKYYGSYFKN--TDLWIVM  103 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTC-CCTTBCCEEEEEEET--TEEEEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhC-CCCCCccEEEEEEeC--CEEEEEe
Confidence            467899999999999999999999999999999999754 457789999999999 999999999999754  6789999


Q ss_pred             EeecCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCC-cc
Q 014406          202 EYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EY  276 (425)
Q Consensus       202 e~~~~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~-~~  276 (425)
                      ||+++++|.+++    ..+++..+..++.|++.||.|||+.||+|+||||+||+++.+ +.+||+|||++....... ..
T Consensus       104 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~-~~~kl~dfg~~~~~~~~~~~~  182 (314)
T 3com_A          104 EYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTE-GHAKLADFGVAGQLTDTMAKR  182 (314)
T ss_dssp             ECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-CCEEECCCTTCEECBTTBSCB
T ss_pred             ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCC-CCEEEeecccchhhhhhcccc
Confidence            999999998876    358999999999999999999999999999999999999988 789999999997665432 23


Q ss_pred             eeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCChh
Q 014406          277 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ  356 (425)
Q Consensus       277 ~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~  356 (425)
                      ....++..|+|||.+.+ ..++.++||||||+++|+|++|..||.. .+..+....+... ..                 
T Consensus       183 ~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~-~~~~~~~~~~~~~-~~-----------------  242 (314)
T 3com_A          183 NTVIGTPFWMAPEVIQE-IGYNCVADIWSLGITAIEMAEGKPPYAD-IHPMRAIFMIPTN-PP-----------------  242 (314)
T ss_dssp             CCCCSCGGGCCHHHHSS-SCBCTTHHHHHHHHHHHHHHHSSCTTTT-SCHHHHHHHHHHS-CC-----------------
T ss_pred             CccCCCCCccChhhcCC-CCCCccccHHHHHHHHHHHHhCCCCCCC-CChHHHHHHHhcC-CC-----------------
Confidence            44578999999999987 6789999999999999999999999842 2222211111110 00                 


Q ss_pred             hHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccch
Q 014406          357 LDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE  419 (425)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~~  419 (425)
                                .      .......+++++.+|+.+||+.||++|||+.++++||||++.....
T Consensus       243 ----------~------~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~~~~  289 (314)
T 3com_A          243 ----------P------TFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKGVS  289 (314)
T ss_dssp             ----------C------CCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCCCGG
T ss_pred             ----------c------ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCCcch
Confidence                      0      0001122688999999999999999999999999999999876543

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=4.5e-46  Score=359.16  Aligned_cols=272  Identities=22%  Similarity=0.406  Sum_probs=213.3

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcch--------------------HHHHHHHHHHHHhcCCCCee
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK--------------------KKIKREIKILQNLCGGPNVV  183 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~--------------------~~~~~E~~~l~~l~~h~niv  183 (425)
                      .++|++.+.||+|+||+||+|.+  +++.||+|++.....                    +.+.+|+.+++++ +||||+
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~  106 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDI-KNEYCL  106 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTC-CCTTBC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhC-CCCCcc
Confidence            57899999999999999999988  899999999863211                    7899999999999 899999


Q ss_pred             eEEeEEEcCCCCccEEEEEeecCCChhhh------c-----CCCCHHHHHHHHHHHHHHHHHHHH-CCceeecCCCCceE
Q 014406          184 KLLDIVRDQHSKTPSLIFEYVNSTDFKVL------Y-----PTLTDYDIRYYIYELLKALDYCHS-QGIMHRDVKPHNVM  251 (425)
Q Consensus       184 ~l~~~~~~~~~~~~~lv~e~~~~~~l~~~------~-----~~l~~~~~~~i~~~i~~~L~~LH~-~~ivH~Dlk~~NIl  251 (425)
                      ++++++.+.  ...++||||+++++|.++      +     ..+++..++.++.|++.||.|||+ .||+|+||||+||+
T Consensus       107 ~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil  184 (348)
T 2pml_X          107 TCEGIITNY--DEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNIL  184 (348)
T ss_dssp             CCSEEEESS--SEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEE
T ss_pred             eEEEEEeeC--CeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEE
Confidence            999999764  678999999999999887      4     348999999999999999999999 99999999999999


Q ss_pred             ecCCCCcEEEEeccccccccCCCcceeeccCCCccCcccccCCCCCCC-cccHHHHHHHHHHHHhCCCCCCCCCCCHHHH
Q 014406          252 IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDY-SLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL  330 (425)
Q Consensus       252 l~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~~DvwslG~~l~elltg~~pf~~~~~~~~~~  330 (425)
                      ++.+ +.+||+|||++...... ......++..|+|||++.+...++. ++|||||||++|+|++|..||.......+..
T Consensus       185 ~~~~-~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~  262 (348)
T 2pml_X          185 MDKN-GRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELF  262 (348)
T ss_dssp             ECTT-SCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHH
T ss_pred             EcCC-CcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Confidence            9988 79999999999876433 3445678999999999987435666 9999999999999999999985443334444


Q ss_pred             HHHHHHhCCchhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCC
Q 014406          331 VKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHP  410 (425)
Q Consensus       331 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp  410 (425)
                      ..+...             ....+.....     ....+...........+++++.+|+.+||+.||++|||++|+++||
T Consensus       263 ~~i~~~-------------~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp  324 (348)
T 2pml_X          263 NNIRTK-------------NIEYPLDRNH-----FLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHE  324 (348)
T ss_dssp             HHHTSC-------------CCCCCCSSSS-----STTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSG
T ss_pred             HHHhcc-------------CcCCccchhh-----hhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCc
Confidence            333211             0000000000     0000000001111244789999999999999999999999999999


Q ss_pred             CCcccccchh
Q 014406          411 YFAQVRAAES  420 (425)
Q Consensus       411 ~~~~~~~~~~  420 (425)
                      ||++..+.+.
T Consensus       325 ~f~~~~~~~~  334 (348)
T 2pml_X          325 WLADTNIEDL  334 (348)
T ss_dssp             GGTTCCHHHH
T ss_pred             cccCCCHHHH
Confidence            9999887654

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=2.9e-46  Score=366.20  Aligned_cols=252  Identities=25%  Similarity=0.448  Sum_probs=198.3

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc-----hHHHHHHHHHHHHhcC-CCCeeeEEeEEEcCCCCcc
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCG-GPNVVKLLDIVRDQHSKTP  197 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~-h~niv~l~~~~~~~~~~~~  197 (425)
                      .++|++.+.||+|+||+||+|.+.. ++.||||++....     .+.+.+|+.+++++.+ |+||+++++++...  ..+
T Consensus        55 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~--~~~  131 (390)
T 2zmd_A           55 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD--QYI  131 (390)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--SEE
T ss_pred             CCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecC--CEE
Confidence            4679999999999999999998754 8999999986432     3568899999999943 69999999999654  678


Q ss_pred             EEEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCC
Q 014406          198 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (425)
Q Consensus       198 ~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~  274 (425)
                      ++||| +.+++|.+++   ..+++.++..++.||+.||.|||++||+||||||+|||++.  +.+||+|||+++......
T Consensus       132 ~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~--~~~kl~DFG~a~~~~~~~  208 (390)
T 2zmd_A          132 YMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD--GMLKLIDFGIANQMQPDT  208 (390)
T ss_dssp             EEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEESS--SCEEECCCSSSCCC----
T ss_pred             EEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEEC--CeEEEEecCccccccCCC
Confidence            99999 5677887776   45889999999999999999999999999999999999964  579999999998765432


Q ss_pred             c---ceeeccCCCccCcccccCC----------CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCch
Q 014406          275 E---YNVRVASRYFKGPELLVDL----------QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDE  341 (425)
Q Consensus       275 ~---~~~~~~t~~y~aPE~~~~~----------~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~  341 (425)
                      .   ....+||+.|+|||++.+.          ..++.++|||||||++|+|++|+.||....+....+..+   +... 
T Consensus       209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~---~~~~-  284 (390)
T 2zmd_A          209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI---IDPN-  284 (390)
T ss_dssp             -----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHH---HCTT-
T ss_pred             ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHH---hCcc-
Confidence            2   2345799999999998651          368899999999999999999999994332222222211   1100 


Q ss_pred             hHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccc
Q 014406          342 LNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR  416 (425)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~  416 (425)
                                             .        ....+...+.++.+||++||+.||++|||+.|+|+||||+...
T Consensus       285 -----------------------~--------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~  328 (390)
T 2zmd_A          285 -----------------------H--------EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT  328 (390)
T ss_dssp             -----------------------S--------CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred             -----------------------c--------cCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccC
Confidence                                   0        0001122478899999999999999999999999999998654

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=7.4e-47  Score=368.19  Aligned_cols=265  Identities=18%  Similarity=0.204  Sum_probs=193.7

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc------hHHHHHHHHHHHHhc-CCCCeeeEE-------eEE
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLC-GGPNVVKLL-------DIV  189 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~-~h~niv~l~-------~~~  189 (425)
                      ..+|++.+.||+|+||+||+|.+..+++.||||++....      .+.+.+|+.+++.+. +||||++++       +++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            345999999999999999999999999999999998633      355778877777774 499987755       555


Q ss_pred             EcCCC---------------CccEEEEEeecCCChhhhcC----CCCHHHH------HHHHHHHHHHHHHHHHCCceeec
Q 014406          190 RDQHS---------------KTPSLIFEYVNSTDFKVLYP----TLTDYDI------RYYIYELLKALDYCHSQGIMHRD  244 (425)
Q Consensus       190 ~~~~~---------------~~~~lv~e~~~~~~l~~~~~----~l~~~~~------~~i~~~i~~~L~~LH~~~ivH~D  244 (425)
                      ..+..               ...++||||++ ++|.+++.    .+++..+      ..++.||+.||+|||++||+|||
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrD  219 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGH  219 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCc
Confidence            43321               34799999999 78888773    2444445      56779999999999999999999


Q ss_pred             CCCCceEecCCCCcEEEEeccccccccCCCcceeeccCCCccCcccccCC-CCCCCcccHHHHHHHHHHHHhCCCCCCCC
Q 014406          245 VKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL-QDYDYSLDMWSLGCMFAGMIFRKEPFFYG  323 (425)
Q Consensus       245 lk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DvwslG~~l~elltg~~pf~~~  323 (425)
                      |||+|||++.+ +.+||+|||+++....  ......+|+.|+|||++.+. ..++.++|||||||++|+|++|+.||...
T Consensus       220 ikp~NIll~~~-~~~kL~DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~  296 (371)
T 3q60_A          220 FTPDNLFIMPD-GRLMLGDVSALWKVGT--RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLV  296 (371)
T ss_dssp             CSGGGEEECTT-SCEEECCGGGEEETTC--EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBC
T ss_pred             CCHHHEEECCC-CCEEEEecceeeecCC--CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCc
Confidence            99999999988 7899999999986542  22245677999999999642 46899999999999999999999999432


Q ss_pred             CCCHHHHHHHHHHhCCchhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCH
Q 014406          324 HDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA  403 (425)
Q Consensus       324 ~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta  403 (425)
                      ......                  .+.           ...................+++++.+||.+||+.||++|||+
T Consensus       297 ~~~~~~------------------~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~  347 (371)
T 3q60_A          297 TPGIKG------------------SWK-----------RPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLP  347 (371)
T ss_dssp             CTTCTT------------------CCC-----------BCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCH
T ss_pred             Cccccc------------------chh-----------hhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCH
Confidence            111000                  000           000000000001111123579999999999999999999999


Q ss_pred             HHHhcCCCCcccccchhc
Q 014406          404 REAMAHPYFAQVRAAESS  421 (425)
Q Consensus       404 ~elL~hp~~~~~~~~~~~  421 (425)
                      +|+|+||||+++.+..++
T Consensus       348 ~e~l~hp~f~~~~~~~~~  365 (371)
T 3q60_A          348 LEAMETPEFLQLQNEISS  365 (371)
T ss_dssp             HHHTTSHHHHHHHHHHHH
T ss_pred             HHHhcCHHHHHHHHHHhh
Confidence            999999999999876543

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=3.4e-46  Score=348.73  Aligned_cols=253  Identities=25%  Similarity=0.430  Sum_probs=208.4

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccE
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (425)
                      .++|++.+.||+|+||+||+|.+..+++.||+|++...     ..+.+.+|+.+++++ +||||+++++++.+......+
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~   83 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL-KHPNIVRYYDRIIDRTNTTLY   83 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEEGGGTEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhc-CCCCCCeEEEEEecCCCceEE
Confidence            57899999999999999999999999999999999643     245688999999999 899999999998766667899


Q ss_pred             EEEEeecCCChhhhcC-------CCCHHHHHHHHHHHHHHHHHHHHCC-----ceeecCCCCceEecCCCCcEEEEeccc
Q 014406          199 LIFEYVNSTDFKVLYP-------TLTDYDIRYYIYELLKALDYCHSQG-----IMHRDVKPHNVMIDHELRKLRLIDWGL  266 (425)
Q Consensus       199 lv~e~~~~~~l~~~~~-------~l~~~~~~~i~~~i~~~L~~LH~~~-----ivH~Dlk~~NIll~~~~~~~kl~Dfg~  266 (425)
                      +||||+++++|.+++.       .+++..+..++.|++.||+|||+.+     |+|+||||+|||++.+ +.+||+|||+
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~-~~~kl~dfg~  162 (279)
T 2w5a_A           84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGK-QNVKLGDFGL  162 (279)
T ss_dssp             EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSS-SCEEECCCCH
T ss_pred             EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCC-CCEEEecCch
Confidence            9999999999988873       2899999999999999999999999     9999999999999988 7899999999


Q ss_pred             cccccCCCc-ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHH
Q 014406          267 AEFYHPGKE-YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAY  345 (425)
Q Consensus       267 a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~  345 (425)
                      ++....... .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.. .+..+....+...         
T Consensus       163 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~-~~~~~~~~~i~~~---------  231 (279)
T 2w5a_A          163 ARILNHDTSFAKTFVGTPYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTA-FSQKELAGKIREG---------  231 (279)
T ss_dssp             HHHC---CHHHHHHHSCCTTCCHHHHHC-C-CCHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHT---------
T ss_pred             heeeccccccccccCCCccccChHHhcc-CCCCchhhHHHHHHHHHHHHHCCCCCcc-cCHHHHHHHHhhc---------
Confidence            987653322 234578999999999987 6789999999999999999999999842 2222222222110         


Q ss_pred             HhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccc
Q 014406          346 LNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR  416 (425)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~  416 (425)
                          ..                       ......+++++.+++.+||+.||++|||++|+++|+|+.+-.
T Consensus       232 ----~~-----------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~  275 (279)
T 2w5a_A          232 ----KF-----------------------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHH  275 (279)
T ss_dssp             ----CC-----------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGG
T ss_pred             ----cc-----------------------ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhc
Confidence                00                       001123689999999999999999999999999999998754

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.9e-46  Score=360.10  Aligned_cols=251  Identities=25%  Similarity=0.449  Sum_probs=196.3

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc-----hHHHHHHHHHHHHhcCC--CCeeeEEeEEEcCCCC
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGG--PNVVKLLDIVRDQHSK  195 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h--~niv~l~~~~~~~~~~  195 (425)
                      ..++|++.+.||+|+||+||+|.+ .+++.||||++....     .+.+.+|+.++.++ +|  +||+++++++.+.  .
T Consensus         7 ~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~~~iv~~~~~~~~~--~   82 (343)
T 3dbq_A            7 KGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKL-QQHSDKIIRLYDYEITD--Q   82 (343)
T ss_dssp             SSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHH-TTTCTTBCCEEEEEECS--S
T ss_pred             ecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhh-hhcCCceEEEeeeEeeC--C
Confidence            467899999999999999999976 568899999986432     35688999999999 55  9999999999654  6


Q ss_pred             ccEEEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccC
Q 014406          196 TPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (425)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~  272 (425)
                      ..++||| +.+++|.+++   ..+++.++..++.||+.||+|||++||+||||||+|||++.  +.+||+|||+++....
T Consensus        83 ~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~~--~~~kl~DFG~a~~~~~  159 (343)
T 3dbq_A           83 YIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD--GMLKLIDFGIANQMQP  159 (343)
T ss_dssp             EEEEEEC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET--TEEEECCCSSSCCC--
T ss_pred             EEEEEEe-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEEC--CcEEEeecccccccCc
Confidence            8899999 5667887776   46899999999999999999999999999999999999984  5799999999987654


Q ss_pred             CCc---ceeeccCCCccCcccccC----------CCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCC
Q 014406          273 GKE---YNVRVASRYFKGPELLVD----------LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT  339 (425)
Q Consensus       273 ~~~---~~~~~~t~~y~aPE~~~~----------~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~  339 (425)
                      ...   .....||+.|+|||++.+          ...++.++|||||||++|+|++|+.||....+....+..+   +..
T Consensus       160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~---~~~  236 (343)
T 3dbq_A          160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI---IDP  236 (343)
T ss_dssp             ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHH---HCT
T ss_pred             ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHH---hcC
Confidence            322   234579999999999853          2468899999999999999999999994322222222111   110


Q ss_pred             chhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCccc
Q 014406          340 DELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV  415 (425)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~  415 (425)
                      .                        .        ........++++.+|+.+||+.||++|||++|+|+||||+..
T Consensus       237 ~------------------------~--------~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  280 (343)
T 3dbq_A          237 N------------------------H--------EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ  280 (343)
T ss_dssp             T------------------------S--------CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred             C------------------------c--------ccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccccc
Confidence            0                        0        001112257889999999999999999999999999999854

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=1.3e-45  Score=349.12  Aligned_cols=253  Identities=26%  Similarity=0.416  Sum_probs=211.3

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccE
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (425)
                      ..+.|++.+.||+|+||+||+|.+..+++.||+|++...    ..+.+.+|+.+++.+ +||||+++++++.+.  ...+
T Consensus        20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~   96 (303)
T 3a7i_A           20 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC-DSPYVTKYYGSYLKD--TKLW   96 (303)
T ss_dssp             GGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHC-CCTTBCCEEEEEEET--TEEE
T ss_pred             hHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhC-CCCCEeEEEEEEecC--CeEE
Confidence            357799999999999999999999999999999999643    347789999999999 999999999999764  6789


Q ss_pred             EEEEeecCCChhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCC-c
Q 014406          199 LIFEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-E  275 (425)
Q Consensus       199 lv~e~~~~~~l~~~~~--~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~-~  275 (425)
                      +||||+++++|.+++.  .+++..+..++.|++.||.|||+.||+|+||||+||+++.+ +.+||+|||++....... .
T Consensus        97 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~  175 (303)
T 3a7i_A           97 IIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEH-GEVKLADFGVAGQLTDTQIK  175 (303)
T ss_dssp             EEEECCTTEEHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-SCEEECCCTTCEECBTTBCC
T ss_pred             EEEEeCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCC-CCEEEeecccceecCccccc
Confidence            9999999999998874  48999999999999999999999999999999999999988 789999999997765432 2


Q ss_pred             ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCCh
Q 014406          276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP  355 (425)
Q Consensus       276 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~  355 (425)
                      .....++..|+|||++.+ ..++.++|||||||++|+|++|..||.. .+..+....+.+.             .     
T Consensus       176 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~-~~~~~~~~~~~~~-------------~-----  235 (303)
T 3a7i_A          176 RNTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELARGEPPHSE-LHPMKVLFLIPKN-------------N-----  235 (303)
T ss_dssp             BCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTT-SCHHHHHHHHHHS-------------C-----
T ss_pred             cCccCCCcCccCHHHHhc-CCCCchhhhHHHHHHHHHHccCCCCCCC-cCHHHHHHHhhcC-------------C-----
Confidence            344578999999999987 6789999999999999999999999832 2222222111110             0     


Q ss_pred             hhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCccccc
Q 014406          356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA  417 (425)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~  417 (425)
                                        .......++..+.+|+.+||+.||++|||++|+++||||.+...
T Consensus       236 ------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~  279 (303)
T 3a7i_A          236 ------------------PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAK  279 (303)
T ss_dssp             ------------------CCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHHCC
T ss_pred             ------------------CCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcCCC
Confidence                              00112237899999999999999999999999999999976543

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=9.6e-46  Score=350.17  Aligned_cols=256  Identities=26%  Similarity=0.440  Sum_probs=204.9

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-------chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCc
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (425)
                      .++|++.+.||+|+||.||+|.+..+++.+|+|+++..       ....+.+|+.+++++ +|+||+++++++.+.....
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~   82 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRL-RHKNVIQLVDVLYNEEKQK   82 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTC-CCTTBCCEEEEEECC---C
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhc-CCCCeeEEEEEEEcCCCCe
Confidence            46799999999999999999999999999999999643       346788999999999 8999999999997666678


Q ss_pred             cEEEEEeecCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccC
Q 014406          197 PSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (425)
Q Consensus       197 ~~lv~e~~~~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~  272 (425)
                      .++||||+.++....+.    ..+++..+..++.|++.||.|||++||+|+||||+|||++.+ +.+||+|||++.....
T Consensus        83 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~-~~~kl~dfg~~~~~~~  161 (305)
T 2wtk_C           83 MYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTG-GTLKISALGVAEALHP  161 (305)
T ss_dssp             EEEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-CCEEECCCTTCEECCT
T ss_pred             EEEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCC-CcEEeeccccccccCc
Confidence            89999999988333221    358999999999999999999999999999999999999988 7999999999987643


Q ss_pred             C---CcceeeccCCCccCcccccCCC-CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhh
Q 014406          273 G---KEYNVRVASRYFKGPELLVDLQ-DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK  348 (425)
Q Consensus       273 ~---~~~~~~~~t~~y~aPE~~~~~~-~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~  348 (425)
                      .   .......++..|+|||++.+.. .++.++|||||||++|+|++|+.||. +.+..+....+.+             
T Consensus       162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~-~~~~~~~~~~i~~-------------  227 (305)
T 2wtk_C          162 FAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFE-GDNIYKLFENIGK-------------  227 (305)
T ss_dssp             TCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCC-CSSHHHHHHHHHH-------------
T ss_pred             cccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCC-CchHHHHHHHHhc-------------
Confidence            2   2223457899999999987622 24779999999999999999999984 2222222222211             


Q ss_pred             ccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccch
Q 014406          349 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE  419 (425)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~~  419 (425)
                      ...                        .....+++++.+|+++||+.||++|||++|+++||||++.....
T Consensus       228 ~~~------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~  274 (305)
T 2wtk_C          228 GSY------------------------AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPA  274 (305)
T ss_dssp             CCC------------------------CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCCC-
T ss_pred             CCC------------------------CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCCCc
Confidence            000                        01123689999999999999999999999999999998776543

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=8.5e-46  Score=349.61  Aligned_cols=258  Identities=26%  Similarity=0.413  Sum_probs=201.9

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc--chHHHHHHHHHHHHhcCCCCeeeEEeEEEcC---------
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQ---------  192 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~---------  192 (425)
                      .++|++.+.||+|+||+||+|.+..+++.||||++...  ..+.+.+|+.+++++ +||||+++++++.+.         
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~   83 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASL-NHQYVVRYYAAWLERRNFVKPMTA   83 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEECCCCCC----
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhc-CchHHHHHHHHHHhhcchhhhhcc
Confidence            46799999999999999999999999999999998643  346788999999999 899999999988653         


Q ss_pred             --CCCccEEEEEeecCCChhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccc
Q 014406          193 --HSKTPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL  266 (425)
Q Consensus       193 --~~~~~~lv~e~~~~~~l~~~~~----~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~  266 (425)
                        .....++||||+++++|.+++.    .+++..+..++.|++.||+|||++||+|+||||+|||++.+ +.+||+|||+
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~-~~~kl~dfg~  162 (303)
T 1zy4_A           84 VKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDES-RNVKIGDFGL  162 (303)
T ss_dssp             --CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-SCEEECCCCC
T ss_pred             cccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCC-CCEEEeeCcc
Confidence              2356899999999999998873    37788999999999999999999999999999999999988 7899999999


Q ss_pred             cccccCC---------------CcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHH
Q 014406          267 AEFYHPG---------------KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV  331 (425)
Q Consensus       267 a~~~~~~---------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~  331 (425)
                      +......               .......++..|+|||++.+...++.++|||||||++|+|++   ||..+.+..+...
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~~  239 (303)
T 1zy4_A          163 AKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILK  239 (303)
T ss_dssp             CSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHH
T ss_pred             hhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHHH
Confidence            9765421               122345788999999999875579999999999999999998   5532221111111


Q ss_pred             HHHHHhCCchhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCC
Q 014406          332 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY  411 (425)
Q Consensus       332 ~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~  411 (425)
                      .+..             ....+                    ........++.+.+|+++||+.||++|||++|+++|||
T Consensus       240 ~~~~-------------~~~~~--------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~  286 (303)
T 1zy4_A          240 KLRS-------------VSIEF--------------------PPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGW  286 (303)
T ss_dssp             HHHS-------------TTCCC--------------------CTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSC
T ss_pred             hccc-------------ccccc--------------------CccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCC
Confidence            1110             00000                    01112236788999999999999999999999999999


Q ss_pred             Ccccccch
Q 014406          412 FAQVRAAE  419 (425)
Q Consensus       412 ~~~~~~~~  419 (425)
                      |+.....+
T Consensus       287 ~~~~~~~~  294 (303)
T 1zy4_A          287 LPVKHQDE  294 (303)
T ss_dssp             SCCCCHHH
T ss_pred             cCCCChHH
Confidence            98765544

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=1.6e-45  Score=349.78  Aligned_cols=251  Identities=18%  Similarity=0.329  Sum_probs=194.9

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc-----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCcc
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (425)
                      ..++|++.+.||+|+||+||+|.+  +++.||||++....     .+.+.+|+.+++++ +||||+++++++.+  ....
T Consensus        35 ~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~--~~~~  109 (309)
T 3p86_A           35 PWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRL-RHPNIVLFMGAVTQ--PPNL  109 (309)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECS--TTCC
T ss_pred             ChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEE--CCce
Confidence            467899999999999999999976  68899999986432     35688999999999 89999999999954  4678


Q ss_pred             EEEEEeecCCChhhhcCC------CCHHHHHHHHHHHHHHHHHHHHCC--ceeecCCCCceEecCCCCcEEEEecccccc
Q 014406          198 SLIFEYVNSTDFKVLYPT------LTDYDIRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (425)
Q Consensus       198 ~lv~e~~~~~~l~~~~~~------l~~~~~~~i~~~i~~~L~~LH~~~--ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~  269 (425)
                      ++||||+.+++|.+++..      +++..+..++.|++.||+|||+.|  |+||||||+|||++.+ +.+||+|||+++.
T Consensus       110 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~-~~~kL~Dfg~a~~  188 (309)
T 3p86_A          110 SIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKK-YTVKVCDFGLSRL  188 (309)
T ss_dssp             EEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTT-CCEEECCCC----
T ss_pred             EEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCC-CcEEECCCCCCcc
Confidence            999999999999988743      889999999999999999999999  9999999999999988 7999999999976


Q ss_pred             ccCCC-cceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhh
Q 014406          270 YHPGK-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK  348 (425)
Q Consensus       270 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~  348 (425)
                      ..... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||. +.+..+....+.....          
T Consensus       189 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~Pf~-~~~~~~~~~~~~~~~~----------  256 (309)
T 3p86_A          189 KASTFLSSKSAAGTPEWMAPEVLRD-EPSNEKSDVYSFGVILWELATLQQPWG-NLNPAQVVAAVGFKCK----------  256 (309)
T ss_dssp             -------------CCTTSCHHHHTT-CCCCTTHHHHHHHHHHHHHHHCCCTTT-TSCHHHHHHHHHHSCC----------
T ss_pred             ccccccccccCCCCccccChhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHhcCC----------
Confidence            54332 2345678999999999987 678999999999999999999999983 2222222222111000          


Q ss_pred             ccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhc--CCCCcccc
Q 014406          349 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA--HPYFAQVR  416 (425)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~--hp~~~~~~  416 (425)
                                               .......+++++.+|+++||+.||++|||++|+++  .++++...
T Consensus       257 -------------------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~  301 (309)
T 3p86_A          257 -------------------------RLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAV  301 (309)
T ss_dssp             -------------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC---
T ss_pred             -------------------------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCC
Confidence                                     01112347899999999999999999999999987  56665543

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=1.9e-45  Score=358.05  Aligned_cols=291  Identities=26%  Similarity=0.454  Sum_probs=217.1

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc--hHHHHHHHHHHHHhc----------CCCCeeeEEeEEE
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--KKKIKREIKILQNLC----------GGPNVVKLLDIVR  190 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~----------~h~niv~l~~~~~  190 (425)
                      ..++|++.+.||+|+||+||+|.+..+++.||||++....  .+.+.+|+.+++++.          +|+||+++++++.
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~   96 (373)
T 1q8y_A           17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   96 (373)
T ss_dssp             TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence            4578999999999999999999999999999999997543  466889999999883          2899999999997


Q ss_pred             cC--CCCccEEEEEeecCCChhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHC-CceeecCCCCceEecCC-----CC
Q 014406          191 DQ--HSKTPSLIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHE-----LR  257 (425)
Q Consensus       191 ~~--~~~~~~lv~e~~~~~~l~~~~-----~~l~~~~~~~i~~~i~~~L~~LH~~-~ivH~Dlk~~NIll~~~-----~~  257 (425)
                      ..  .+...++||||+ +++|..++     ..+++..+..++.||+.||+|||++ ||+||||||+|||++.+     .+
T Consensus        97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~  175 (373)
T 1q8y_A           97 HKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLI  175 (373)
T ss_dssp             EEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred             ccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcc
Confidence            54  234789999999 77777765     3489999999999999999999998 99999999999999532     24


Q ss_pred             cEEEEeccccccccCCCcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCC-----CCHHHHHH
Q 014406          258 KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH-----DNHDQLVK  332 (425)
Q Consensus       258 ~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~-----~~~~~~~~  332 (425)
                      .+||+|||+++....  ......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||....     .+.+.+..
T Consensus       176 ~~kl~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  252 (373)
T 1q8y_A          176 QIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLG-APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ  252 (373)
T ss_dssp             EEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHT-CCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHH
T ss_pred             eEEEcccccccccCC--CCCCCCCCccccCcHHHhC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHH
Confidence            799999999986543  3344578999999999987 679999999999999999999999985332     23556777


Q ss_pred             HHHHhCCchhHHHHhhccCCCChhh--HHHhcccC-CCCcc--ccc--cccCCCCCCHHHHHHHHHcccCCcCCCcCHHH
Q 014406          333 IAKVLGTDELNAYLNKYHLELDPQL--DALVGRHS-RKPWS--KFI--NADNQHLVSPEAIDFLDKLLRYDHQDRLTARE  405 (425)
Q Consensus       333 ~~~~lg~~~~~~~~~~~~~~~~~~~--~~~~~~~~-~~~~~--~~~--~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~e  405 (425)
                      +.+.+|..+....... .. ....+  ........ ...|.  ...  .......+++++.+||++||+.||++|||++|
T Consensus       253 ~~~~~~~~p~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e  330 (373)
T 1q8y_A          253 IIELLGELPSYLLRNG-KY-TRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG  330 (373)
T ss_dssp             HHHHHCSCCHHHHHHC-TT-HHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred             HHHhcCCCCHHHHhcc-ch-hhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHH
Confidence            8888886554322110 00 00000  00000000 00000  000  00111224678899999999999999999999


Q ss_pred             HhcCCCCcccccch
Q 014406          406 AMAHPYFAQVRAAE  419 (425)
Q Consensus       406 lL~hp~~~~~~~~~  419 (425)
                      +|+||||++....+
T Consensus       331 ll~hp~f~~~~~~~  344 (373)
T 1q8y_A          331 LVNHPWLKDTLGME  344 (373)
T ss_dssp             HHTCGGGTTCTTCT
T ss_pred             HhhChhhhcccCcc
Confidence            99999999875443

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=4e-45  Score=347.04  Aligned_cols=252  Identities=19%  Similarity=0.329  Sum_probs=204.9

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc---chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEE
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (425)
                      ..++|++.+.||+|+||+||+|.+..+++.||+|++...   ..+.+.+|+.+++++ +||||+++++++.+.  ...++
T Consensus         8 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~--~~~~l   84 (310)
T 3s95_A            8 RPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCL-EHPNVLKFIGVLYKD--KRLNF   84 (310)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEET--TEEEE
T ss_pred             ChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhC-CCcCcccEEEEEecC--CeeEE
Confidence            467899999999999999999999999999999998643   346788999999999 899999999999754  67899


Q ss_pred             EEEeecCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCc
Q 014406          200 IFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (425)
Q Consensus       200 v~e~~~~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~  275 (425)
                      ||||+.+++|.+++    ..+++.++..++.|++.||+|||++||+|+||||+|||++.+ +.+||+|||+++.......
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~  163 (310)
T 3s95_A           85 ITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVREN-KNVVVADFGLARLMVDEKT  163 (310)
T ss_dssp             EEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTT-SCEEECCCTTCEECC----
T ss_pred             EEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCC-CCEEEeecccceecccccc
Confidence            99999999999886    458999999999999999999999999999999999999988 7899999999986643322


Q ss_pred             c---------------eeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCc
Q 014406          276 Y---------------NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTD  340 (425)
Q Consensus       276 ~---------------~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~  340 (425)
                      .               ....||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........         
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~---------  233 (310)
T 3s95_A          164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMING-RSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFG---------  233 (310)
T ss_dssp             ----------------CCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSS---------
T ss_pred             cccccccccccccccccccCCCcceeCHHHhcC-CCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHh---------
Confidence            1               14578999999999987 7899999999999999999999988843221110000         


Q ss_pred             hhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccc
Q 014406          341 ELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR  416 (425)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~  416 (425)
                                    ...            ...........+++++.+++.+||+.||++|||++|+++  ||+++.
T Consensus       234 --------------~~~------------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~--~L~~l~  281 (310)
T 3s95_A          234 --------------LNV------------RGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH--WLETLR  281 (310)
T ss_dssp             --------------BCH------------HHHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH--HHHHHH
T ss_pred             --------------hhh------------hccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH--HHHHHH
Confidence                          000            000011112347889999999999999999999999987  565554

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.5e-45  Score=347.08  Aligned_cols=255  Identities=22%  Similarity=0.388  Sum_probs=199.0

Q ss_pred             EeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc---hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEEEeecC
Q 014406          130 VRKVGRGKYSEVFEGINVNTNERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNS  206 (425)
Q Consensus       130 ~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~  206 (425)
                      ...||+|+||+||+|.+..++..||+|.+....   .+.+.+|+.+++.+ +||||+++++++.+.  ...++||||+++
T Consensus        27 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~--~~~~lv~e~~~~  103 (295)
T 2clq_A           27 RVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHL-KHKNIVQYLGSFSEN--GFIKIFMEQVPG  103 (295)
T ss_dssp             BCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTC-CCTTBCCEEEEEEET--TEEEEEEECCSE
T ss_pred             cEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhC-CCCCEeeEeeEEEeC--CcEEEEEEeCCC
Confidence            457999999999999999999999999987532   46788999999999 999999999999654  678899999999


Q ss_pred             CChhhhcC------CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCC-cceee
Q 014406          207 TDFKVLYP------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EYNVR  279 (425)
Q Consensus       207 ~~l~~~~~------~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~-~~~~~  279 (425)
                      ++|..++.      .+++..+..++.|++.||.|||+.||+|+||||+||+++.+.+.+||+|||+++...... .....
T Consensus       104 ~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  183 (295)
T 2clq_A          104 GSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETF  183 (295)
T ss_dssp             EEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-----CCC
T ss_pred             CCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCCCccccc
Confidence            99988762      356888999999999999999999999999999999999844799999999998664322 23345


Q ss_pred             ccCCCccCcccccCC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCChhhH
Q 014406          280 VASRYFKGPELLVDL-QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLD  358 (425)
Q Consensus       280 ~~t~~y~aPE~~~~~-~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~  358 (425)
                      .++..|+|||++.+. ..++.++||||||+++|+|++|+.||............. ....                    
T Consensus       184 ~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~-~~~~--------------------  242 (295)
T 2clq_A          184 TGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKV-GMFK--------------------  242 (295)
T ss_dssp             CCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHH-HHHC--------------------
T ss_pred             CCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhh-cccc--------------------
Confidence            789999999998652 237899999999999999999999984322211111110 0000                    


Q ss_pred             HHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccchhcc
Q 014406          359 ALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAESSR  422 (425)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~~~~~  422 (425)
                                    ........+++++.+|+.+||+.||++|||++|+|+||||+........+
T Consensus       243 --------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~~~~  292 (295)
T 2clq_A          243 --------------VHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKKKKTQ  292 (295)
T ss_dssp             --------------CCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC--------
T ss_pred             --------------ccccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhccccCCCC
Confidence                          00011233789999999999999999999999999999999876555443

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=2e-45  Score=346.66  Aligned_cols=254  Identities=20%  Similarity=0.350  Sum_probs=200.2

Q ss_pred             CCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCC
Q 014406          122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (425)
Q Consensus       122 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (425)
                      ...++|++.+.||+|+||+||+|.+..+++.||+|++...      ..+.+.+|+.+++++ +||||+++++++.+  ..
T Consensus         8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~--~~   84 (294)
T 4eqm_A            8 IINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQL-SHQNIVSMIDVDEE--DD   84 (294)
T ss_dssp             CEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTC-CBTTBCCEEEEEEC--SS
T ss_pred             HhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcC-CCCCCceEEEeeee--CC
Confidence            3468999999999999999999999999999999998532      235688999999999 99999999999965  46


Q ss_pred             ccEEEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccC
Q 014406          196 TPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (425)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~  272 (425)
                      ..++||||+++++|.+++   ..+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++....
T Consensus        85 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~  163 (294)
T 4eqm_A           85 CYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSN-KTLKIFDFGIAKALSE  163 (294)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-SCEEECCCSSSTTC--
T ss_pred             eEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC-CCEEEEeCCCcccccc
Confidence            789999999999999887   458999999999999999999999999999999999999988 7899999999986643


Q ss_pred             CC--cceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhcc
Q 014406          273 GK--EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH  350 (425)
Q Consensus       273 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~  350 (425)
                      ..  ......||+.|+|||.+.+ ..++.++|||||||++|+|++|+.||. +.+..+........ ..+.         
T Consensus       164 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~pf~-~~~~~~~~~~~~~~-~~~~---------  231 (294)
T 4eqm_A          164 TSLTQTNHVLGTVQYFSPEQAKG-EATDECTDIYSIGIVLYEMLVGEPPFN-GETAVSIAIKHIQD-SVPN---------  231 (294)
T ss_dssp             -----------CCSSCCHHHHHT-CCCCTTHHHHHHHHHHHHHHHSSCSSC-SSCHHHHHHHHHSS-CCCC---------
T ss_pred             ccccccCccccCccccCHhHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCC-CCChHHHHHHHhhc-cCCC---------
Confidence            32  2234578999999999987 778999999999999999999999983 22222221111100 0000         


Q ss_pred             CCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCc
Q 014406          351 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA  413 (425)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~  413 (425)
                                            ........+++.+.+++.+||+.||++||+..+.+.+.|..
T Consensus       232 ----------------------~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~  272 (294)
T 4eqm_A          232 ----------------------VTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSS  272 (294)
T ss_dssp             ----------------------HHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHT
T ss_pred             ----------------------cchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHH
Confidence                                  00111233789999999999999999999666666665544

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=4.4e-45  Score=355.36  Aligned_cols=246  Identities=19%  Similarity=0.302  Sum_probs=200.2

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEc-------CCCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeeEEeEEEc
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINV-------NTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRD  191 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~-------~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~  191 (425)
                      ..++|++.+.||+|+||+||+|.+.       .++..||||+++...    .+.+.+|+.+++.+.+||||++++++|.+
T Consensus        79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~  158 (370)
T 2psq_A           79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ  158 (370)
T ss_dssp             CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred             cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence            3578999999999999999999875       345689999997542    35688999999999779999999999954


Q ss_pred             CCCCccEEEEEeecCCChhhhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEe
Q 014406          192 QHSKTPSLIFEYVNSTDFKVLYP-------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI  252 (425)
Q Consensus       192 ~~~~~~~lv~e~~~~~~l~~~~~-------------------~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll  252 (425)
                        ....++||||+.+++|.+++.                   .+++.++..++.||+.||+|||++||+||||||+|||+
T Consensus       159 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll  236 (370)
T 2psq_A          159 --DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV  236 (370)
T ss_dssp             --SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE
T ss_pred             --CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEE
Confidence              467899999999999988762                   37889999999999999999999999999999999999


Q ss_pred             cCCCCcEEEEeccccccccCCCc---ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHH
Q 014406          253 DHELRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHD  328 (425)
Q Consensus       253 ~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~  328 (425)
                      +.+ +.+||+|||+++.......   .....+|+.|+|||++.+ ..++.++|||||||++|||++ |+.||. +.+..+
T Consensus       237 ~~~-~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~ellt~g~~p~~-~~~~~~  313 (370)
T 2psq_A          237 TEN-NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYP-GIPVEE  313 (370)
T ss_dssp             CTT-CCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHT-CCCCHHHHHHHHHHHHHHHHTTSCCSST-TCCGGG
T ss_pred             CCC-CCEEEccccCCcccCcccceecccCCCcccceECHhHhcC-CCCCcHHHHHHHHHHHHHHHcCCCCCCC-CCCHHH
Confidence            988 7999999999986644322   223456778999999987 789999999999999999999 888873 333333


Q ss_pred             HHHHHHHHhCCchhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhc
Q 014406          329 QLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  408 (425)
Q Consensus       329 ~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~  408 (425)
                      ....+....                                    .......+++++.+|+.+||+.||++|||+.|+++
T Consensus       314 ~~~~~~~~~------------------------------------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~  357 (370)
T 2psq_A          314 LFKLLKEGH------------------------------------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE  357 (370)
T ss_dssp             HHHHHHTTC------------------------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHhcCC------------------------------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            222221100                                    00112237899999999999999999999999987


Q ss_pred             C
Q 014406          409 H  409 (425)
Q Consensus       409 h  409 (425)
                      +
T Consensus       358 ~  358 (370)
T 2psq_A          358 D  358 (370)
T ss_dssp             H
T ss_pred             H
Confidence            4

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=3.6e-45  Score=354.37  Aligned_cols=248  Identities=20%  Similarity=0.324  Sum_probs=201.7

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEE-----EcCCCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCC
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGI-----NVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQH  193 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~-----~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  193 (425)
                      ..++|++.+.||+|+||+||+|.     +..+++.||||+++...    .+.+.+|+.++.++.+||||+++++++.+. 
T Consensus        20 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~-   98 (359)
T 3vhe_A           20 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP-   98 (359)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST-
T ss_pred             cccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecC-
Confidence            46889999999999999999998     45667899999997532    346889999999997899999999999654 


Q ss_pred             CCccEEEEEeecCCChhhhcCC----------------------------------------------------------
Q 014406          194 SKTPSLIFEYVNSTDFKVLYPT----------------------------------------------------------  215 (425)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~~~----------------------------------------------------------  215 (425)
                      +...++||||+.+++|.+++..                                                          
T Consensus        99 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  178 (359)
T 3vhe_A           99 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEE  178 (359)
T ss_dssp             TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------------
T ss_pred             CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhh
Confidence            3458899999999999887621                                                          


Q ss_pred             -----------CCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCc---ceeecc
Q 014406          216 -----------LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE---YNVRVA  281 (425)
Q Consensus       216 -----------l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~  281 (425)
                                 +++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||+++.......   .....+
T Consensus       179 ~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~~  257 (359)
T 3vhe_A          179 EEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK-NVVKICDFGLARDIYKDPDYVRKGDARL  257 (359)
T ss_dssp             -----CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG-GCEEECCCGGGSCTTSCTTCEEC--CEE
T ss_pred             cccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCC-CcEEEEeccceeeecccccchhccccCC
Confidence                       8889999999999999999999999999999999999988 7899999999986543322   234567


Q ss_pred             CCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCChhhHHH
Q 014406          282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDAL  360 (425)
Q Consensus       282 t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~  360 (425)
                      |..|+|||++.+ ..++.++|||||||++|+|++ |..||............+.. -.                      
T Consensus       258 t~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~-~~----------------------  313 (359)
T 3vhe_A          258 PLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE-GT----------------------  313 (359)
T ss_dssp             CGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHH-TC----------------------
T ss_pred             CceeEChhhhcC-CCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHc-CC----------------------
Confidence            888999999987 789999999999999999998 99888433333322222211 00                      


Q ss_pred             hcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcC
Q 014406          361 VGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  409 (425)
Q Consensus       361 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~h  409 (425)
                                   .......+++++.+++.+||+.||++|||++|+++|
T Consensus       314 -------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  349 (359)
T 3vhe_A          314 -------------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  349 (359)
T ss_dssp             -------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -------------CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence                         001112368899999999999999999999999986

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=3.1e-45  Score=351.92  Aligned_cols=261  Identities=25%  Similarity=0.430  Sum_probs=184.2

Q ss_pred             CCCCEEEEe-eeeeeCceEEEEEEEcCCCcEEEEEEecCcchHHHHHHHHHHHHhcCCCCeeeEEeEEEcC--CCCccEE
Q 014406          123 DQDDYEVVR-KVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQ--HSKTPSL  199 (425)
Q Consensus       123 ~~~~y~~~~-~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~--~~~~~~l  199 (425)
                      ..++|++.+ .||+|+||+||+|.+..+++.||||++...  ....+|+..+.+..+||||+++++++...  .....++
T Consensus        26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~l  103 (336)
T 3fhr_A           26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS--PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLI  103 (336)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS--HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred             ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc--HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEE
Confidence            468899965 599999999999999999999999999753  33445555544444999999999999753  2345889


Q ss_pred             EEEeecCCChhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCC--CCcEEEEeccccccccC
Q 014406          200 IFEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--LRKLRLIDWGLAEFYHP  272 (425)
Q Consensus       200 v~e~~~~~~l~~~~~-----~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~--~~~~kl~Dfg~a~~~~~  272 (425)
                      ||||+.+++|.+++.     .+++..++.++.|++.||.|||++||+||||||+|||++.+  .+.+||+|||+++....
T Consensus       104 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~  183 (336)
T 3fhr_A          104 IMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ  183 (336)
T ss_dssp             EEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC--
T ss_pred             EEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceeccc
Confidence            999999999988872     48999999999999999999999999999999999999864  24599999999986543


Q ss_pred             CCcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCC
Q 014406          273 GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE  352 (425)
Q Consensus       273 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~  352 (425)
                       .......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||...... .....+......       ..    
T Consensus       184 -~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~-------~~----  249 (336)
T 3fhr_A          184 -NALQTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQ-AISPGMKRRIRL-------GQ----  249 (336)
T ss_dssp             ----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC--------------------------------
T ss_pred             -cccccCCCCcCccChhhhCC-CCCCchhhHHHHHHHHHHHHHCCCCCCCccch-hhhhhHHHhhhc-------cc----
Confidence             33345678999999999876 67899999999999999999999998432211 110000000000       00    


Q ss_pred             CChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCccccc
Q 014406          353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA  417 (425)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~  417 (425)
                                        ..........+++++.+|+++||+.||++|||++|+|+||||++...
T Consensus       250 ------------------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  296 (336)
T 3fhr_A          250 ------------------YGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMV  296 (336)
T ss_dssp             -------------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGGG
T ss_pred             ------------------cccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccccc
Confidence                              00001112347899999999999999999999999999999987543

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=4.1e-45  Score=348.71  Aligned_cols=252  Identities=26%  Similarity=0.414  Sum_probs=208.2

Q ss_pred             cCCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc---------hHHHHHHHHHHHHhc-CCCCeeeEEeEEE
Q 014406          121 WGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK---------KKKIKREIKILQNLC-GGPNVVKLLDIVR  190 (425)
Q Consensus       121 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~---------~~~~~~E~~~l~~l~-~h~niv~l~~~~~  190 (425)
                      ....++|++.+.||+|+||+||+|.+..+++.||||++....         .+.+.+|+.+++++. .|+||+++++++.
T Consensus        39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~  118 (320)
T 3a99_A           39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE  118 (320)
T ss_dssp             -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred             CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence            345788999999999999999999999999999999986432         245778999999994 3699999999996


Q ss_pred             cCCCCccEEEEEeecC-CChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccc
Q 014406          191 DQHSKTPSLIFEYVNS-TDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL  266 (425)
Q Consensus       191 ~~~~~~~~lv~e~~~~-~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~  266 (425)
                      ..  ...++|+||+.+ ++|.+++   ..+++..++.++.|++.||+|||+.||+||||||+|||++.+.+.+||+|||+
T Consensus       119 ~~--~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~  196 (320)
T 3a99_A          119 RP--DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGS  196 (320)
T ss_dssp             CS--SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTT
T ss_pred             cC--CcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCcc
Confidence            54  678899999976 7888776   46899999999999999999999999999999999999995447999999999


Q ss_pred             cccccCCCcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHH
Q 014406          267 AEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYL  346 (425)
Q Consensus       267 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~  346 (425)
                      ++.... .......+|..|+|||++.+...++.++|||||||++|+|++|+.||..    ...   +..           
T Consensus       197 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~----~~~---~~~-----------  257 (320)
T 3a99_A          197 GALLKD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH----DEE---IIR-----------  257 (320)
T ss_dssp             CEECCS-SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS----HHH---HHH-----------
T ss_pred             cccccc-ccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCC----hhh---hhc-----------
Confidence            987653 3334567899999999997744447889999999999999999999831    110   000           


Q ss_pred             hhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccch
Q 014406          347 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE  419 (425)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~~  419 (425)
                        ...                        .....+++++.+|+++||+.||++|||++|+++||||+++....
T Consensus       258 --~~~------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~~~  304 (320)
T 3a99_A          258 --GQV------------------------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQ  304 (320)
T ss_dssp             --CCC------------------------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCCHH
T ss_pred             --ccc------------------------cccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCccCcc
Confidence              000                        01123789999999999999999999999999999999886543

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.4e-45  Score=362.15  Aligned_cols=275  Identities=19%  Similarity=0.305  Sum_probs=209.5

Q ss_pred             CCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCcc
Q 014406          122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (425)
Q Consensus       122 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (425)
                      ...++|++.+.||+|+||+||+|.+..+++.||||+++..    ..+.+.+|+++++++ +||||+++++++.+......
T Consensus         6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~   84 (396)
T 4eut_A            6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL-NHKNIVKLFAIEEETTTRHK   84 (396)
T ss_dssp             CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHC-CCTTBCCEEEEEECTTTCCE
T ss_pred             CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhc-CCCCCCeEEEeeccCCCCee
Confidence            3567899999999999999999999999999999999743    346788999999999 89999999999987766788


Q ss_pred             EEEEEeecCCChhhhcCC------CCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEe----cCCCCcEEEEecccc
Q 014406          198 SLIFEYVNSTDFKVLYPT------LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI----DHELRKLRLIDWGLA  267 (425)
Q Consensus       198 ~lv~e~~~~~~l~~~~~~------l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll----~~~~~~~kl~Dfg~a  267 (425)
                      ++||||+.+++|.+++..      +++..++.++.||+.||+|||++||+||||||+|||+    +.+ +.+||+|||++
T Consensus        85 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~-~~~kL~DFG~a  163 (396)
T 4eut_A           85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQ-SVYKLTDFGAA  163 (396)
T ss_dssp             EEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSC-EEEEECCGGGC
T ss_pred             EEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCc-eeEEEecCCCc
Confidence            999999999999998853      8999999999999999999999999999999999998    555 67999999999


Q ss_pred             ccccCCCcceeeccCCCccCcccccCC-------CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCc
Q 014406          268 EFYHPGKEYNVRVASRYFKGPELLVDL-------QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTD  340 (425)
Q Consensus       268 ~~~~~~~~~~~~~~t~~y~aPE~~~~~-------~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~  340 (425)
                      +............||..|+|||++.+.       ..++.++|||||||++|+|++|+.||............+.+.++..
T Consensus       164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~  243 (396)
T 4eut_A          164 RELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK  243 (396)
T ss_dssp             EECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSC
T ss_pred             eEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCC
Confidence            887665555667899999999998641       3577899999999999999999999954332222222222222211


Q ss_pred             hhHHHHhhccCCCChhhHHHhcccCCCCccccccc--cCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcC
Q 014406          341 ELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINA--DNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  409 (425)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~h  409 (425)
                      +..... ......          .....|......  .....+++.+.+|+++||++||++|||+.|++++
T Consensus       244 p~~~~~-~~~~~~----------~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~  303 (396)
T 4eut_A          244 PSGAIS-GVQKAE----------NGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE  303 (396)
T ss_dssp             CTTCCE-EEECST----------TCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred             Ccccch-hheecc----------CCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence            110000 000000          000011111111  0112245678899999999999999999998543

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=5.5e-45  Score=348.55  Aligned_cols=244  Identities=16%  Similarity=0.305  Sum_probs=197.9

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCc---EEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCC
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNE---RCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~---~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (425)
                      ..++|++.+.||+|+||+||+|.+..+++   .||||+++..    ..+.+.+|+.+++++ +||||+++++++.+  +.
T Consensus        47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~  123 (325)
T 3kul_A           47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQF-DHPNIIRLEGVVTR--GR  123 (325)
T ss_dssp             CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECG--GG
T ss_pred             ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEe--CC
Confidence            46789999999999999999999886554   5999999753    235688999999999 89999999999954  46


Q ss_pred             ccEEEEEeecCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEecccccccc
Q 014406          196 TPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (425)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~  271 (425)
                      ..++||||+++++|.+++    ..+++..+..++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||+++...
T Consensus       124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~-~~~kl~Dfg~a~~~~  202 (325)
T 3kul_A          124 LAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSN-LVCKVSDFGLSRVLE  202 (325)
T ss_dssp             CCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-CCEEECCCSSCEECC
T ss_pred             ccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCC-CCEEECCCCcccccc
Confidence            788999999999999887    358999999999999999999999999999999999999988 799999999998765


Q ss_pred             CCCcc----eeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCCchhHHHH
Q 014406          272 PGKEY----NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYL  346 (425)
Q Consensus       272 ~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~  346 (425)
                      .....    ....+|..|+|||++.+ ..++.++|||||||++|+|++ |..||. +.+..+....+....         
T Consensus       203 ~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~~-~~~~~~~~~~~~~~~---------  271 (325)
T 3kul_A          203 DDPDAAYTTTGGKIPIRWTAPEAIAF-RTFSSASDVWSFGVVMWEVLAYGERPYW-NMTNRDVISSVEEGY---------  271 (325)
T ss_dssp             ----CCEECC---CCGGGSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTT-TSCHHHHHHHHHTTC---------
T ss_pred             cCccceeeccCCCCcccccCHhHhcC-CCCCcHHHHHHHHHHHHHHHcCCCCCcc-cCCHHHHHHHHHcCC---------
Confidence            43221    22345668999999977 678999999999999999999 888883 333333333221100         


Q ss_pred             hhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhc
Q 014406          347 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  408 (425)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~  408 (425)
                                                 .......+++++.+|+.+||+.||++|||++|+++
T Consensus       272 ---------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  306 (325)
T 3kul_A          272 ---------------------------RLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVS  306 (325)
T ss_dssp             ---------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---------------------------CCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                                       00112237899999999999999999999999986

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=9.9e-45  Score=341.77  Aligned_cols=262  Identities=19%  Similarity=0.350  Sum_probs=200.4

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEE----EcCCCcEEEEEEecCcch---HHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCC
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGI----NVNTNERCIIKILKPVKK---KKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~----~~~~~~~vavK~~~~~~~---~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (425)
                      ..++|++++.||+|+||+||+|.    +..+++.||||++.....   +.+.+|+.+++++ +||||+++++++......
T Consensus         8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~   86 (295)
T 3ugc_A            8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL-QHDNIVKYKGVCYSAGRR   86 (295)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECHHHHT
T ss_pred             CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEecCCCC
Confidence            46889999999999999999998    567899999999975443   5688999999999 899999999999765556


Q ss_pred             ccEEEEEeecCCChhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEecccccccc
Q 014406          196 TPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (425)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~~----~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~  271 (425)
                      ..++||||+++++|.+++.    .+++..+..++.|++.||+|||+.||+|+||||+|||++.+ +.+||+|||+++...
T Consensus        87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~-~~~kl~Dfg~~~~~~  165 (295)
T 3ugc_A           87 NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENE-NRVKIGDFGLTKVLP  165 (295)
T ss_dssp             SCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEET-TEEEECCCCSCC---
T ss_pred             ceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCC-CeEEEccCccccccc
Confidence            7899999999999998873    38999999999999999999999999999999999999988 799999999998764


Q ss_pred             CCCc----ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHh
Q 014406          272 PGKE----YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLN  347 (425)
Q Consensus       272 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~  347 (425)
                      ....    .....++..|+|||.+.+ ..++.++|||||||++|+|++|..||..   ....   ..+..+.........
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~~~~~---~~~~---~~~~~~~~~~~~~~~  238 (295)
T 3ugc_A          166 QDKEFFKVKEPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYIEKSKS---PPAE---FMRMIGNDKQGQMIV  238 (295)
T ss_dssp             ----------CTTCGGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTTCTTCS---HHHH---HHHHHCTTCCTHHHH
T ss_pred             CCcceeeeccCCCCccceeCcHHhcC-CCCChHHHHHHHHHHHHHHHhcccccCC---ChHH---HHhhhcCccccchhH
Confidence            4322    122346677999999987 6799999999999999999999998832   1111   112222211100000


Q ss_pred             hccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhc
Q 014406          348 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  408 (425)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~  408 (425)
                             ...........        .......+++++.+|+++||+.||++|||++|+++
T Consensus       239 -------~~~~~~~~~~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~  284 (295)
T 3ugc_A          239 -------FHLIELLKNNG--------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  284 (295)
T ss_dssp             -------HHHHHHHHTTC--------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             -------HHHHHHHhccC--------cCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence                   00000000000        11112347899999999999999999999999975

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=9.5e-45  Score=337.29  Aligned_cols=244  Identities=16%  Similarity=0.345  Sum_probs=200.7

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc--chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEE
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (425)
                      ..++|++.+.||+|+||+||+|.+. +++.||+|++...  ..+.+.+|+.+++++ +||||+++++++.+  ....++|
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv   83 (269)
T 4hcu_A            8 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKL-SHPKLVQLYGVCLE--QAPICLV   83 (269)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTC-CCTTBCCEEEEECS--SSSEEEE
T ss_pred             ChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCHHHHHHHHHHHHhC-CCCCEeeEEEEEec--CCceEEE
Confidence            4678999999999999999999876 5778999999754  457799999999999 89999999999955  4678999


Q ss_pred             EEeecCCChhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCC--
Q 014406          201 FEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK--  274 (425)
Q Consensus       201 ~e~~~~~~l~~~~~----~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~--  274 (425)
                      |||+++++|.+++.    .+++..+..++.|++.||+|||+.||+|+||||+||+++.+ +.+||+|||+++......  
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~  162 (269)
T 4hcu_A           84 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGEN-QVIKVSDFGMTRFVLDDQYT  162 (269)
T ss_dssp             EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGG-GCEEECCTTGGGGBCCHHHH
T ss_pred             EEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCC-CCEEeccccccccccccccc
Confidence            99999999998873    38999999999999999999999999999999999999988 789999999998654322  


Q ss_pred             cceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCC
Q 014406          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL  353 (425)
Q Consensus       275 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~  353 (425)
                      ......++..|+|||.+.+ ..++.++||||+|+++|+|++ |..|| .+.+..+....+....                
T Consensus       163 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~~g~~p~-~~~~~~~~~~~~~~~~----------------  224 (269)
T 4hcu_A          163 SSTGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPY-ENRSNSEVVEDISTGF----------------  224 (269)
T ss_dssp             STTSTTCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTT-TTCCHHHHHHHHHTTC----------------
T ss_pred             cccCcccccccCCHHHhcC-CCCCchhhhHHHHHHHHHHhcCCCCCC-CCCCHHHHHHHHhcCc----------------
Confidence            1223355678999999977 679999999999999999999 88887 3333333333221100                


Q ss_pred             ChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcC
Q 014406          354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  409 (425)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~h  409 (425)
                                          ....+..+++++.+++.+||+.||++|||++|+++|
T Consensus       225 --------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  260 (269)
T 4hcu_A          225 --------------------RLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ  260 (269)
T ss_dssp             --------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --------------------cCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence                                011122368899999999999999999999999976

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=1.3e-44  Score=344.35  Aligned_cols=256  Identities=20%  Similarity=0.319  Sum_probs=187.7

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcch----HH-HHHHHHHHHHhcCCCCeeeEEeEEEcCCCCcc
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK----KK-IKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~----~~-~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (425)
                      ..++|++.+.||+|+||+||+|.+..+++.||||++.....    .+ +.++..+++.+ +||||+++++++.+.  ...
T Consensus        23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~-~h~~i~~~~~~~~~~--~~~   99 (318)
T 2dyl_A           23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSH-DCPYIVQCFGTFITN--TDV   99 (318)
T ss_dssp             CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTT-TCTTBCCEEEEEECS--SEE
T ss_pred             hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhc-CCCceeeEEEEEecC--CcE
Confidence            35789999999999999999999999999999999975432    22 33344456666 999999999999754  678


Q ss_pred             EEEEEeecCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHC-CceeecCCCCceEecCCCCcEEEEeccccccccC
Q 014406          198 SLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (425)
Q Consensus       198 ~lv~e~~~~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~LH~~-~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~  272 (425)
                      ++||||+ ++++..+.    ..+++..+..++.|++.||.|||+. ||+|+||||+|||++.+ +.+||+|||++.....
T Consensus       100 ~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~-~~~kl~dfg~~~~~~~  177 (318)
T 2dyl_A          100 FIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDER-GQIKLCDFGISGRLVD  177 (318)
T ss_dssp             EEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTT-SCEEECCCTTC-----
T ss_pred             EEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCC-CCEEEEECCCchhccC
Confidence            9999999 44544443    4689999999999999999999995 99999999999999988 7899999999987655


Q ss_pred             CCcceeeccCCCccCcccccC----CCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhh
Q 014406          273 GKEYNVRVASRYFKGPELLVD----LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK  348 (425)
Q Consensus       273 ~~~~~~~~~t~~y~aPE~~~~----~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~  348 (425)
                      ........++..|+|||++.+    ...++.++|||||||++|+|++|+.||.....+.+.+..+.....          
T Consensus       178 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~----------  247 (318)
T 2dyl_A          178 DKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEP----------  247 (318)
T ss_dssp             ---------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCC----------
T ss_pred             CccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCC----------
Confidence            555555688999999999852    256889999999999999999999999544433333333322100          


Q ss_pred             ccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCccccc
Q 014406          349 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA  417 (425)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~  417 (425)
                                              ........+++++.+|+.+||+.||.+|||++|+++||||++...
T Consensus       248 ------------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  292 (318)
T 2dyl_A          248 ------------------------PLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYET  292 (318)
T ss_dssp             ------------------------CCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHHHH
T ss_pred             ------------------------CCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhccc
Confidence                                    000111237899999999999999999999999999999987643

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=3.5e-45  Score=355.80  Aligned_cols=250  Identities=17%  Similarity=0.280  Sum_probs=200.5

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEE-----EcCCCcEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCC
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGI-----NVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH  193 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~-----~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  193 (425)
                      ..++|++.+.||+|+||+||+|.     +..++..||||+++..    ....+.+|+.+++++ +||||+++++++.+  
T Consensus        69 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~--  145 (367)
T 3l9p_A           69 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF-NHQNIVRCIGVSLQ--  145 (367)
T ss_dssp             CGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECS--
T ss_pred             CHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhC-CCCCCCeEEEEEec--
Confidence            46789999999999999999998     4557789999999643    234688999999999 99999999999954  


Q ss_pred             CCccEEEEEeecCCChhhhcC----------CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCC--CCcEEE
Q 014406          194 SKTPSLIFEYVNSTDFKVLYP----------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--LRKLRL  261 (425)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~~----------~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~--~~~~kl  261 (425)
                      ....++||||+.+++|..++.          .+++.++..++.||+.||+|||++||+||||||+|||++.+  ...+||
T Consensus       146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL  225 (367)
T 3l9p_A          146 SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKI  225 (367)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEE
Confidence            467789999999999988862          38999999999999999999999999999999999999854  135999


Q ss_pred             EeccccccccCC---CcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHh
Q 014406          262 IDWGLAEFYHPG---KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVL  337 (425)
Q Consensus       262 ~Dfg~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~l  337 (425)
                      +|||+++.....   .......+|+.|+|||++.+ ..++.++|||||||++|||++ |..|| .+.+..+....+....
T Consensus       226 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~ellt~g~~pf-~~~~~~~~~~~i~~~~  303 (367)
T 3l9p_A          226 GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFME-GIFTSKTDTWSFGVLLWEIFSLGYMPY-PSKSNQEVLEFVTSGG  303 (367)
T ss_dssp             CCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSS-TTCCHHHHHHHHHTTC
T ss_pred             CCCccccccccccccccCCCcCCcccEECHHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCC-CCCCHHHHHHHHHcCC
Confidence            999999754221   22334567889999999987 679999999999999999998 88887 3333333332221100


Q ss_pred             CCchhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCc
Q 014406          338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA  413 (425)
Q Consensus       338 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~  413 (425)
                                                          .......+++++.+|+.+||+.||++|||++|++++.++-
T Consensus       304 ------------------------------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~  343 (367)
T 3l9p_A          304 ------------------------------------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  343 (367)
T ss_dssp             ------------------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ------------------------------------CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence                                                0011223788999999999999999999999999987654

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=6.3e-45  Score=343.76  Aligned_cols=257  Identities=23%  Similarity=0.315  Sum_probs=200.6

Q ss_pred             CCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcchHHHHHHHHHHHH--hcCCCCeeeEEeEEEcC--CCCcc
Q 014406          122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQN--LCGGPNVVKLLDIVRDQ--HSKTP  197 (425)
Q Consensus       122 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~--l~~h~niv~l~~~~~~~--~~~~~  197 (425)
                      ...++|++.+.||+|+||+||+|.+  +++.||||++.......+.+|.+++..  + +||||+++++++.+.  .....
T Consensus         5 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~l-~h~niv~~~~~~~~~~~~~~~~   81 (301)
T 3q4u_A            5 TVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRDEKSWFRETELYNTVML-RHENILGFIASDMTSRHSSTQL   81 (301)
T ss_dssp             CCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHHHTCC-CCTTBCCEEEEEEEEETTEEEE
T ss_pred             cccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccccchhhHHHHHHHHHhhc-cCcCeeeEEEeeccccCCCcee
Confidence            3568899999999999999999976  689999999988877888888888887  5 899999999987643  23568


Q ss_pred             EEEEEeecCCChhhhcC--CCCHHHHHHHHHHHHHHHHHHH--------HCCceeecCCCCceEecCCCCcEEEEecccc
Q 014406          198 SLIFEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCH--------SQGIMHRDVKPHNVMIDHELRKLRLIDWGLA  267 (425)
Q Consensus       198 ~lv~e~~~~~~l~~~~~--~l~~~~~~~i~~~i~~~L~~LH--------~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a  267 (425)
                      ++||||+++++|.+++.  .+++..+..++.|++.||+|||        +.+|+||||||+|||++.+ +.+||+|||++
T Consensus        82 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~-~~~kl~Dfg~a  160 (301)
T 3q4u_A           82 WLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKN-GQCCIADLGLA  160 (301)
T ss_dssp             EEEECCCTTCBHHHHHTTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTT-SCEEECCCTTC
T ss_pred             EEehhhccCCCHHHHHhhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCC-CCEEEeeCCCe
Confidence            89999999999999874  5899999999999999999999        9999999999999999988 79999999999


Q ss_pred             ccccCCCcc-----eeeccCCCccCcccccCCC-----CCCCcccHHHHHHHHHHHHhC----------CCCCCCCCCCH
Q 014406          268 EFYHPGKEY-----NVRVASRYFKGPELLVDLQ-----DYDYSLDMWSLGCMFAGMIFR----------KEPFFYGHDNH  327 (425)
Q Consensus       268 ~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~-----~~~~~~DvwslG~~l~elltg----------~~pf~~~~~~~  327 (425)
                      +........     ....||+.|+|||++.+..     .++.++|||||||++|||++|          ..||.......
T Consensus       161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~  240 (301)
T 3q4u_A          161 VMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPND  240 (301)
T ss_dssp             EEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             eecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCC
Confidence            765543322     2347899999999997632     344789999999999999999          78875433332


Q ss_pred             HHHHHHHHHhCCchhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHh
Q 014406          328 DQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM  407 (425)
Q Consensus       328 ~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL  407 (425)
                      .....+........                       ....   .........+++++.+|+.+||+.||++|||++|++
T Consensus       241 ~~~~~~~~~~~~~~-----------------------~~~~---~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~  294 (301)
T 3q4u_A          241 PSFEDMRKVVCVDQ-----------------------QRPN---IPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIK  294 (301)
T ss_dssp             CCHHHHHHHHTTSC-----------------------CCCC---CCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHH
T ss_pred             cchhhhhHHHhccC-----------------------CCCC---CChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHH
Confidence            22222222111000                       0000   000001112467899999999999999999999998


Q ss_pred             c
Q 014406          408 A  408 (425)
Q Consensus       408 ~  408 (425)
                      +
T Consensus       295 ~  295 (301)
T 3q4u_A          295 K  295 (301)
T ss_dssp             H
T ss_pred             H
Confidence            5

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=9.7e-45  Score=346.28  Aligned_cols=257  Identities=18%  Similarity=0.325  Sum_probs=187.5

Q ss_pred             CCCCCEEEEeeeeeeCceEEEEEEEcCCCc---EEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCC
Q 014406          122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNE---RCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH  193 (425)
Q Consensus       122 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~---~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  193 (425)
                      ...++|++.+.||+|+||+||+|.+..++.   .||||+++..     ..+.+.+|+.+++++ +||||+++++++....
T Consensus        20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~   98 (323)
T 3qup_A           20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF-DHPHVAKLVGVSLRSR   98 (323)
T ss_dssp             CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTC-CCTTBCCCCEEEECC-
T ss_pred             cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHC-CCCceehhhceeeccc
Confidence            357889999999999999999998877765   8999998643     346788999999999 9999999999997643


Q ss_pred             CC----ccEEEEEeecCCChhhhcC---------CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEE
Q 014406          194 SK----TPSLIFEYVNSTDFKVLYP---------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLR  260 (425)
Q Consensus       194 ~~----~~~lv~e~~~~~~l~~~~~---------~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~k  260 (425)
                      ..    ..++||||+.+++|..++.         .+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+|
T Consensus        99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~-~~~k  177 (323)
T 3qup_A           99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAED-MTVC  177 (323)
T ss_dssp             ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT-SCEE
T ss_pred             cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCC-CCEE
Confidence            22    2389999999999988762         48999999999999999999999999999999999999988 7999


Q ss_pred             EEeccccccccCCCcc---eeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHH
Q 014406          261 LIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKV  336 (425)
Q Consensus       261 l~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~  336 (425)
                      |+|||+++........   ....+++.|+|||.+.+ ..++.++|||||||++|+|++ |..|| .+.+..+....+...
T Consensus       178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~-~~~~~~~~~~~~~~~  255 (323)
T 3qup_A          178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLAD-NLYTVHSDVWAFGVTMWEIMTRGQTPY-AGIENAEIYNYLIGG  255 (323)
T ss_dssp             ECCCCC-----------------CCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTT-TTCCGGGHHHHHHTT
T ss_pred             EeeccccccccccccccccccccCcccccCchhhcC-CCCCCccchhhHHHHHHHHHhCCCCCc-cccChHHHHHHHhcC
Confidence            9999999866443322   23456678999999987 679999999999999999999 77777 444443333322110


Q ss_pred             hCCchhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcC-------HHHHhcC
Q 014406          337 LGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT-------AREAMAH  409 (425)
Q Consensus       337 lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpt-------a~elL~h  409 (425)
                      .                                    .......+++++.+|+.+||+.||++|||       ++++++|
T Consensus       256 ~------------------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~  299 (323)
T 3qup_A          256 N------------------------------------RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGH  299 (323)
T ss_dssp             C------------------------------------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             C------------------------------------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence            0                                    00112237899999999999999999999       8899999


Q ss_pred             CCCcccccc
Q 014406          410 PYFAQVRAA  418 (425)
Q Consensus       410 p~~~~~~~~  418 (425)
                      ||+......
T Consensus       300 ~~~~~~~~~  308 (323)
T 3qup_A          300 LSVLSTSQD  308 (323)
T ss_dssp             ---------
T ss_pred             hhhcCCCCC
Confidence            999876543

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=5.3e-44  Score=336.95  Aligned_cols=250  Identities=15%  Similarity=0.251  Sum_probs=203.7

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEE
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (425)
                      ..++|++.+.||+|+||+||+|.+..+++.||+|++... ..+.+.+|+.+++.+.+|+|++++++++.+  ....++||
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~--~~~~~lv~   85 (298)
T 1csn_A            8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQE--GLHNVLVI   85 (298)
T ss_dssp             ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEE--TTEEEEEE
T ss_pred             cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeecCC--CceeEEEE
Confidence            367899999999999999999999999999999998643 446789999999999889999999999965  46789999


Q ss_pred             EeecCCChhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCc-----EEEEeccccccccC
Q 014406          202 EYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRK-----LRLIDWGLAEFYHP  272 (425)
Q Consensus       202 e~~~~~~l~~~~~----~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~-----~kl~Dfg~a~~~~~  272 (425)
                      ||+ +++|.+++.    .+++..+..++.|++.||+|||++||+||||||+|||++.+ +.     +||+|||+++....
T Consensus        86 e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~-~~~~~~~~kl~Dfg~~~~~~~  163 (298)
T 1csn_A           86 DLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRP-NSKNANMIYVVDFGMVKFYRD  163 (298)
T ss_dssp             ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCS-SSTTTTCEEECCCTTCEESBC
T ss_pred             Eec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccC-CCCCCCeEEEEECcccccccc
Confidence            999 899988773    58999999999999999999999999999999999999876 33     99999999987654


Q ss_pred             CCc--------ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCC--CHHHHHHHHHHhCCchh
Q 014406          273 GKE--------YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD--NHDQLVKIAKVLGTDEL  342 (425)
Q Consensus       273 ~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~--~~~~~~~~~~~lg~~~~  342 (425)
                      ...        .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.....  ..+.+..+.........
T Consensus       164 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  242 (298)
T 1csn_A          164 PVTKQHIPYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL  242 (298)
T ss_dssp             TTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCH
T ss_pred             ccccccccccCccCCCCCcccCCchhhcC-CCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccH
Confidence            322        244578999999999987 6789999999999999999999999954322  12222222221100000


Q ss_pred             HHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcC
Q 014406          343 NAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  409 (425)
Q Consensus       343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~h  409 (425)
                      .                                .....+++++.+|+.+||+.||++|||++++++.
T Consensus       243 ~--------------------------------~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~  277 (298)
T 1csn_A          243 R--------------------------------ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL  277 (298)
T ss_dssp             H--------------------------------HHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred             H--------------------------------HHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            0                                0012378999999999999999999999998653

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=7.5e-45  Score=354.75  Aligned_cols=244  Identities=20%  Similarity=0.353  Sum_probs=199.2

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccE
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (425)
                      ..++|++.+.||+|+||+||+|.+..+++.||||+++...    .+.+.+|+.+++++ +||||+++++++.+  ....+
T Consensus       112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~--~~~~~  188 (377)
T 3cbl_A          112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQY-SHPNIVRLIGVCTQ--KQPIY  188 (377)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTC-CCTTBCCEEEEECS--SSSCE
T ss_pred             chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEec--CCCcE
Confidence            4678999999999999999999999999999999987542    24678999999999 99999999999954  46789


Q ss_pred             EEEEeecCCChhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCC
Q 014406          199 LIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (425)
Q Consensus       199 lv~e~~~~~~l~~~~~----~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~  274 (425)
                      +||||+++++|.+++.    .+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++......
T Consensus       189 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~-~~~kl~DfG~s~~~~~~~  267 (377)
T 3cbl_A          189 IVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEK-NVLKISDFGMSREEADGV  267 (377)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-CCEEECCGGGCEECTTSE
T ss_pred             EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCC-CcEEECcCCCceecCCCc
Confidence            9999999999988873    48999999999999999999999999999999999999988 799999999998654321


Q ss_pred             cc---eeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhcc
Q 014406          275 EY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH  350 (425)
Q Consensus       275 ~~---~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~  350 (425)
                      ..   ....++..|+|||++.+ ..++.++|||||||++|||++ |..|| .+.++.+....+..            .. 
T Consensus       268 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~t~g~~p~-~~~~~~~~~~~~~~------------~~-  332 (377)
T 3cbl_A          268 YAASGGLRQVPVKWTAPEALNY-GRYSSESDVWSFGILLWETFSLGASPY-PNLSNQQTREFVEK------------GG-  332 (377)
T ss_dssp             EECCSSCCEEEGGGSCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCSS-TTSCHHHHHHHHHT------------TC-
T ss_pred             eeecCCCCCCCcCcCCHhHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCC-CCCCHHHHHHHHHc------------CC-
Confidence            11   11234667999999976 678999999999999999998 88887 33333222221110            00 


Q ss_pred             CCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhc
Q 014406          351 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  408 (425)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~  408 (425)
                                             ....+..+++++.+|+.+||+.||++|||++++++
T Consensus       333 -----------------------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  367 (377)
T 3cbl_A          333 -----------------------RLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ  367 (377)
T ss_dssp             -----------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -----------------------CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence                                   00112237889999999999999999999999975

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=1.5e-44  Score=339.26  Aligned_cols=242  Identities=14%  Similarity=0.257  Sum_probs=200.2

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCC-------cEEEEEEecCc---chHHHHHHHHHHHHhcCCCCeeeEEeEEEcC
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTN-------ERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRDQ  192 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~-------~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  192 (425)
                      ..++|++.+.||+|+||+||+|.+..++       ..||+|++...   ..+.+.+|+.+++++ +||||+++++++.+ 
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~-   83 (289)
T 4fvq_A            6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKL-SHKHLVLNYGVCVC-   83 (289)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTS-CCTTBCCEEEEECC-
T ss_pred             chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhC-CCCCEeEEEEEEEe-
Confidence            4678999999999999999999988877       47999998643   346788999999999 89999999999965 


Q ss_pred             CCCccEEEEEeecCCChhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCc--------EE
Q 014406          193 HSKTPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRK--------LR  260 (425)
Q Consensus       193 ~~~~~~lv~e~~~~~~l~~~~~----~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~--------~k  260 (425)
                       ....++||||+.+++|.+++.    .+++..+..++.|++.||.|||++||+||||||+|||++.+ +.        +|
T Consensus        84 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~-~~~~~~~~~~~k  161 (289)
T 4fvq_A           84 -GDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIRE-EDRKTGNPPFIK  161 (289)
T ss_dssp             -TTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEEC-CBGGGTBCCEEE
T ss_pred             -CCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecC-Ccccccccceee
Confidence             467789999999999998873    28999999999999999999999999999999999999887 44        99


Q ss_pred             EEeccccccccCCCcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCc
Q 014406          261 LIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTD  340 (425)
Q Consensus       261 l~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~  340 (425)
                      |+|||++.....   .....++..|+|||++.+...++.++|||||||++|+|++|..|++...+..........   . 
T Consensus       162 l~Dfg~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~---~-  234 (289)
T 4fvq_A          162 LSDPGISITVLP---KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYED---R-  234 (289)
T ss_dssp             ECCCCSCTTTSC---HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHT---T-
T ss_pred             eccCcccccccC---ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhc---c-
Confidence            999999875432   234567889999999987567899999999999999999987777655443332221110   0 


Q ss_pred             hhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcC
Q 014406          341 ELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  409 (425)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~h  409 (425)
                                                        .......++++.+|+++||+.||++|||++|+++|
T Consensus       235 ----------------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  269 (289)
T 4fvq_A          235 ----------------------------------HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD  269 (289)
T ss_dssp             ----------------------------------CCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             ----------------------------------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence                                              00111247789999999999999999999999986

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.9e-44  Score=350.33  Aligned_cols=246  Identities=18%  Similarity=0.320  Sum_probs=201.1

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCC-------CcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeeEEeEEEc
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNT-------NERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRD  191 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~-------~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~  191 (425)
                      ..++|++.+.||+|+||+||+|.+..+       +..||+|+++...    .+.+.+|+++++++.+||||+++++++..
T Consensus        67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~  146 (382)
T 3tt0_A           67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ  146 (382)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence            467999999999999999999987543       3579999997542    25688999999999789999999999954


Q ss_pred             CCCCccEEEEEeecCCChhhhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEe
Q 014406          192 QHSKTPSLIFEYVNSTDFKVLYP-------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI  252 (425)
Q Consensus       192 ~~~~~~~lv~e~~~~~~l~~~~~-------------------~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll  252 (425)
                        ....++||||+.+++|.+++.                   .+++..++.++.||+.||+|||+.||+||||||+|||+
T Consensus       147 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll  224 (382)
T 3tt0_A          147 --DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV  224 (382)
T ss_dssp             --SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred             --CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEE
Confidence              467899999999999988762                   38999999999999999999999999999999999999


Q ss_pred             cCCCCcEEEEeccccccccCCC---cceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHH
Q 014406          253 DHELRKLRLIDWGLAEFYHPGK---EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHD  328 (425)
Q Consensus       253 ~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~  328 (425)
                      +.+ +.+||+|||+++......   ......+|..|+|||++.+ ..++.++|||||||++|+|++ |..||. +.+..+
T Consensus       225 ~~~-~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~ellt~g~~p~~-~~~~~~  301 (382)
T 3tt0_A          225 TED-NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYP-GVPVEE  301 (382)
T ss_dssp             CTT-CCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCSST-TCCHHH
T ss_pred             cCC-CcEEEcccCcccccccccccccccCCCCCcceeCHHHhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCC-CCCHHH
Confidence            988 799999999998665432   2233456788999999987 789999999999999999999 888873 333222


Q ss_pred             HHHHHHHHhCCchhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhc
Q 014406          329 QLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  408 (425)
Q Consensus       329 ~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~  408 (425)
                      ....+....                                    .......+++++.+|+++||+.||++|||++|+++
T Consensus       302 ~~~~~~~~~------------------------------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  345 (382)
T 3tt0_A          302 LFKLLKEGH------------------------------------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE  345 (382)
T ss_dssp             HHHHHHTTC------------------------------------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHcCC------------------------------------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            222211100                                    00112237899999999999999999999999997


Q ss_pred             C
Q 014406          409 H  409 (425)
Q Consensus       409 h  409 (425)
                      +
T Consensus       346 ~  346 (382)
T 3tt0_A          346 D  346 (382)
T ss_dssp             H
T ss_pred             H
Confidence            6

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=4.7e-44  Score=332.34  Aligned_cols=244  Identities=16%  Similarity=0.286  Sum_probs=199.9

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc--chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEE
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (425)
                      ..++|++.+.||+|+||+||+|.+. ++..||+|++...  ..+++.+|+.+++++ +||||+++++++.+  ....++|
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv   81 (268)
T 3sxs_A            6 KREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSEDEFFQEAQTMMKL-SHPKLVKFYGVCSK--EYPIYIV   81 (268)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCHHHHHHHHHHHHHC-CCTTBCCEEEEECS--SSSEEEE
T ss_pred             chhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcHHHHHHHHHHHHhC-CCCCEeeEEEEEcc--CCceEEE
Confidence            4678999999999999999999665 6778999999754  457789999999999 89999999999954  4678999


Q ss_pred             EEeecCCChhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCcc
Q 014406          201 FEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY  276 (425)
Q Consensus       201 ~e~~~~~~l~~~~~----~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~~  276 (425)
                      |||+++++|.+++.    .+++..+..++.|++.||+|||+.||+|+||||+||+++.+ +.+||+|||++.........
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~-~~~~l~Dfg~~~~~~~~~~~  160 (268)
T 3sxs_A           82 TEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRD-LCVKVSDFGMTRYVLDDQYV  160 (268)
T ss_dssp             EECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTT-CCEEECCTTCEEECCTTCEE
T ss_pred             EEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCC-CCEEEccCccceecchhhhh
Confidence            99999999988763    48999999999999999999999999999999999999988 79999999999866543322


Q ss_pred             --eeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCC
Q 014406          277 --NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL  353 (425)
Q Consensus       277 --~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~  353 (425)
                        ....+|..|+|||.+.+ ..++.++||||||+++|+|++ |..||. ..+..+....+....                
T Consensus       161 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~-~~~~~~~~~~~~~~~----------------  222 (268)
T 3sxs_A          161 SSVGTKFPVKWSAPEVFHY-FKYSSKSDVWAFGILMWEVFSLGKMPYD-LYTNSEVVLKVSQGH----------------  222 (268)
T ss_dssp             ECCSCCCCGGGCCHHHHHH-SEEETTHHHHHHHHHHHHHHTTTCCTTT-TSCHHHHHHHHHTTC----------------
T ss_pred             cccCCCcCcccCCHHHHhc-cCCchhhhhHHHHHHHHHHHcCCCCCcc-ccChHHHHHHHHcCC----------------
Confidence              22345567999999977 678999999999999999999 888873 333222222221100                


Q ss_pred             ChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcC
Q 014406          354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  409 (425)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~h  409 (425)
                                          .......+++++.+++.+||+.||++|||++|++++
T Consensus       223 --------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  258 (268)
T 3sxs_A          223 --------------------RLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSS  258 (268)
T ss_dssp             --------------------CCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             --------------------CCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                001112368899999999999999999999999976

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1.2e-43  Score=332.99  Aligned_cols=245  Identities=18%  Similarity=0.293  Sum_probs=199.1

Q ss_pred             CCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc----------hHHHHHHHHHHHHhcCCCCeeeEEeEEEc
Q 014406          122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----------KKKIKREIKILQNLCGGPNVVKLLDIVRD  191 (425)
Q Consensus       122 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~----------~~~~~~E~~~l~~l~~h~niv~l~~~~~~  191 (425)
                      ...++|++.+.||+|+||+||+|.+..+++.||+|++....          .+.+.+|+.+++++ +||||+++++++.+
T Consensus        16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~   94 (287)
T 4f0f_A           16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL-NHPNIVKLYGLMHN   94 (287)
T ss_dssp             CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTC-CCTTBCCEEEEETT
T ss_pred             hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhC-CCCCchhhheeecC
Confidence            35789999999999999999999999999999999985322          16788999999999 89999999999954


Q ss_pred             CCCCccEEEEEeecCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--ceeecCCCCceEecCCCCc-----EE
Q 014406          192 QHSKTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHELRK-----LR  260 (425)
Q Consensus       192 ~~~~~~~lv~e~~~~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~LH~~~--ivH~Dlk~~NIll~~~~~~-----~k  260 (425)
                      .    .++||||+.+++|...+    ..+++..+..++.|++.||+|||+.|  |+|+||||+|||++.+ +.     +|
T Consensus        95 ~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~-~~~~~~~~k  169 (287)
T 4f0f_A           95 P----PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSL-DENAPVCAK  169 (287)
T ss_dssp             T----TEEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCC-CTTCSCCEE
T ss_pred             C----CeEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEecc-CCCCceeEE
Confidence            3    26999999999997765    35899999999999999999999999  9999999999999876 44     99


Q ss_pred             EEeccccccccCCCcceeeccCCCccCcccccC-CCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCC
Q 014406          261 LIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD-LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT  339 (425)
Q Consensus       261 l~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~  339 (425)
                      |+|||+++...  .......+|..|+|||++.+ ...++.++|||||||++|+|++|+.||.................+.
T Consensus       170 l~Dfg~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  247 (287)
T 4f0f_A          170 VADFGLSQQSV--HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGL  247 (287)
T ss_dssp             ECCCTTCBCCS--SCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCC
T ss_pred             eCCCCcccccc--ccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCC
Confidence            99999997543  33445678999999999843 2457899999999999999999999995433333222221111100


Q ss_pred             chhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhc
Q 014406          340 DELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  408 (425)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~  408 (425)
                                                        .......+++++.+|+.+||+.||++|||++|+++
T Consensus       248 ----------------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  282 (287)
T 4f0f_A          248 ----------------------------------RPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK  282 (287)
T ss_dssp             ----------------------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----------------------------------CCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence                                              01112347899999999999999999999999985

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=1.1e-44  Score=338.98  Aligned_cols=246  Identities=21%  Similarity=0.332  Sum_probs=206.8

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcchHHHHHHHHHHHHhcCCCCeeeEEeEEEc------------
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRD------------  191 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~------------  191 (425)
                      .++|++.+.||+|+||+||+|.+..+++.||+|++.... +.+.+|+.+++++ +||||+++++++..            
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~~~   87 (284)
T 2a19_B           10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-EKAEREVKALAKL-DHVNIVHYNGCWDGFDYDPETSSKNS   87 (284)
T ss_dssp             HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-GGGHHHHHHHHHC-CCTTBCCEEEEEEEEEEC--------
T ss_pred             ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-HHHHHHHHHHHhC-CCCCEEEEeeeEeccccCcccccccc
Confidence            467999999999999999999999999999999997543 5678999999999 99999999998864            


Q ss_pred             --CCCCccEEEEEeecCCChhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEec
Q 014406          192 --QHSKTPSLIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDW  264 (425)
Q Consensus       192 --~~~~~~~lv~e~~~~~~l~~~~-----~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Df  264 (425)
                        ......++||||+++++|.+++     ..+++..+..++.|++.||.|||+.||+|+||||+|||++.+ +.+||+||
T Consensus        88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~-~~~kl~Df  166 (284)
T 2a19_B           88 SRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDT-KQVKIGDF  166 (284)
T ss_dssp             -CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET-TEEEECCC
T ss_pred             cccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCC-CCEEECcc
Confidence              1234578999999999999887     358999999999999999999999999999999999999988 79999999


Q ss_pred             cccccccCCCcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHH
Q 014406          265 GLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA  344 (425)
Q Consensus       265 g~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~  344 (425)
                      |++.............+++.|+|||.+.+ ..++.++|||||||++|+|++|..||+.      . ......        
T Consensus       167 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~------~-~~~~~~--------  230 (284)
T 2a19_B          167 GLVTSLKNDGKRTRSKGTLRYMSPEQISS-QDYGKEVDLYALGLILAELLHVCDTAFE------T-SKFFTD--------  230 (284)
T ss_dssp             TTCEESSCCSCCCCCCSCCTTSCHHHHHC-SCCCTHHHHHHHHHHHHHHHSCCSSHHH------H-HHHHHH--------
T ss_pred             hhheeccccccccccCCcccccChhhhcc-CCCcchhhhHHHHHHHHHHHhcCCcchh------H-HHHHHH--------
Confidence            99987766555556688999999999987 6789999999999999999999988721      0 000000        


Q ss_pred             HHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCccc
Q 014406          345 YLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV  415 (425)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~  415 (425)
                       ...                          ......++.++.+|+.+||+.||++|||+.|+++|.+.-.-
T Consensus       231 -~~~--------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~  274 (284)
T 2a19_B          231 -LRD--------------------------GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK  274 (284)
T ss_dssp             -HHT--------------------------TCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred             -hhc--------------------------ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence             000                          00112368899999999999999999999999999775543

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=3.7e-44  Score=343.51  Aligned_cols=247  Identities=19%  Similarity=0.290  Sum_probs=199.9

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEEE
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE  202 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e  202 (425)
                      .++|++.+.||+|+||+||+|.+..+++.||||++... ..+.+.+|+.+++.+.+|+||+++++++.+.  ...++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~--~~~~lv~e   85 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCG--KYNAMVLE   85 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEET--TEEEEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEecC--CccEEEEE
Confidence            57899999999999999999999999999999998743 4467899999999998899999999999664  67899999


Q ss_pred             eecCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCc-----EEEEeccccccccCC
Q 014406          203 YVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRK-----LRLIDWGLAEFYHPG  273 (425)
Q Consensus       203 ~~~~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~-----~kl~Dfg~a~~~~~~  273 (425)
                      |+ +++|.+++    ..+++..+..++.|++.||+|||+.||+||||||+|||++.+ +.     +||+|||+++.....
T Consensus        86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~-~~~~~~~~kl~DFg~a~~~~~~  163 (330)
T 2izr_A           86 LL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRP-GNKTQQVIHIIDFALAKEYIDP  163 (330)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCG-GGTCTTSEEECCCTTCEESBCT
T ss_pred             eC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccC-CCCCCceEEEEEcccceeeecC
Confidence            99 88888876    469999999999999999999999999999999999999987 55     999999999876433


Q ss_pred             Cc--------ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCC--HHHHHHHHHHhCCchhH
Q 014406          274 KE--------YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN--HDQLVKIAKVLGTDELN  343 (425)
Q Consensus       274 ~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~--~~~~~~~~~~lg~~~~~  343 (425)
                      ..        .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......  .+.+..+..........
T Consensus       164 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~  242 (330)
T 2izr_A          164 ETKKHIPYREHKSLTGTARYMSINTHLG-KEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIE  242 (330)
T ss_dssp             TTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCHH
T ss_pred             CCCccccccccCCcCCCccccChHHHcC-CCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCHH
Confidence            22        245678999999999987 77999999999999999999999998543211  11122221110000000


Q ss_pred             HHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhc
Q 014406          344 AYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  408 (425)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~  408 (425)
                      .                                ....++ ++.+|+.+||+.||.+|||++++++
T Consensus       243 ~--------------------------------~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~  274 (330)
T 2izr_A          243 V--------------------------------LCENFP-EMATYLRYVRRLDFFEKPDYDYLRK  274 (330)
T ss_dssp             H--------------------------------HTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             H--------------------------------HhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            0                                001134 8999999999999999999988876

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=1.5e-44  Score=345.74  Aligned_cols=259  Identities=20%  Similarity=0.381  Sum_probs=182.7

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc----hHHHHHHHH-HHHHhcCCCCeeeEEeEEEcCCCCcc
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIK-ILQNLCGGPNVVKLLDIVRDQHSKTP  197 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~-~l~~l~~h~niv~l~~~~~~~~~~~~  197 (425)
                      ..++|++.+.||+|+||+||+|.+..+++.||||++....    ..++..|+. +++.+ +||||+++++++.+.  ...
T Consensus        20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~-~h~niv~~~~~~~~~--~~~   96 (327)
T 3aln_A           20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSS-DCPYIVQFYGALFRE--GDC   96 (327)
T ss_dssp             CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSC-CCTTBCCEEEEEECS--SEE
T ss_pred             CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcC-CCCcEeeeeeEEEeC--Cce
Confidence            4688999999999999999999999999999999997532    234556666 44555 999999999999754  678


Q ss_pred             EEEEEeecCCChhhhc--------CCCCHHHHHHHHHHHHHHHHHHHHC-CceeecCCCCceEecCCCCcEEEEeccccc
Q 014406          198 SLIFEYVNSTDFKVLY--------PTLTDYDIRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAE  268 (425)
Q Consensus       198 ~lv~e~~~~~~l~~~~--------~~l~~~~~~~i~~~i~~~L~~LH~~-~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~  268 (425)
                      ++||||+++ +|..++        ..+++..+..++.|++.||.|||+. ||+|+||||+|||++.+ +.+||+|||+++
T Consensus        97 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~-~~~kl~Dfg~~~  174 (327)
T 3aln_A           97 WICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRS-GNIKLCDFGISG  174 (327)
T ss_dssp             EEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETT-TEEEECCCSSSC
T ss_pred             EEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCC-CCEEEccCCCce
Confidence            899999997 443332        4589999999999999999999998 99999999999999988 799999999998


Q ss_pred             cccCCCcceeeccCCCccCccccc---CCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHH
Q 014406          269 FYHPGKEYNVRVASRYFKGPELLV---DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAY  345 (425)
Q Consensus       269 ~~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~  345 (425)
                      ............+|..|+|||++.   ....++.++|||||||++|+|++|+.||.......+.+..+            
T Consensus       175 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~------------  242 (327)
T 3aln_A          175 QLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQV------------  242 (327)
T ss_dssp             C------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCC------------
T ss_pred             ecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHH------------
Confidence            765544445557899999999983   22568999999999999999999999984221111111000            


Q ss_pred             HhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccc
Q 014406          346 LNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA  418 (425)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~  418 (425)
                                         .... ...........+++++.+|+++||+.||++|||+.|+++||||.+..+.
T Consensus       243 -------------------~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~~  295 (327)
T 3aln_A          243 -------------------VKGD-PPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEER  295 (327)
T ss_dssp             -------------------CCSC-CCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHHS
T ss_pred             -------------------hcCC-CCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhHhh
Confidence                               0000 0001111123478999999999999999999999999999999876543

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6e-44  Score=343.82  Aligned_cols=248  Identities=21%  Similarity=0.346  Sum_probs=201.5

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEc-----CCCcEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCC
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINV-----NTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH  193 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~-----~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  193 (425)
                      ..++|++.+.||+|+||+||+|.+.     .++..||+|++...    ..+.+.+|+.++.++.+||||+++++++..  
T Consensus        43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~--  120 (344)
T 1rjb_A           43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL--  120 (344)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred             CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee--
Confidence            4689999999999999999999873     46678999999743    346789999999999789999999999965  


Q ss_pred             CCccEEEEEeecCCChhhhcCC--------------------------CCHHHHHHHHHHHHHHHHHHHHCCceeecCCC
Q 014406          194 SKTPSLIFEYVNSTDFKVLYPT--------------------------LTDYDIRYYIYELLKALDYCHSQGIMHRDVKP  247 (425)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~~~--------------------------l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~  247 (425)
                      ....++||||+++++|.+++..                          +++..+..++.||+.||+|||++||+|+||||
T Consensus       121 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp  200 (344)
T 1rjb_A          121 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAA  200 (344)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSG
T ss_pred             CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCh
Confidence            4678999999999999887732                          68899999999999999999999999999999


Q ss_pred             CceEecCCCCcEEEEeccccccccCCCcc---eeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCC
Q 014406          248 HNVMIDHELRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYG  323 (425)
Q Consensus       248 ~NIll~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~  323 (425)
                      +|||++.+ +.+||+|||++.........   ....+|+.|+|||.+.+ ..++.++|||||||++|+|++ |..||...
T Consensus       201 ~NIll~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~  278 (344)
T 1rjb_A          201 RNVLVTHG-KVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPYPGI  278 (344)
T ss_dssp             GGEEEETT-TEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred             hhEEEcCC-CcEEeCCCccCcccccCccceeccCccCccCccCHHHhcc-CCCChhHhHHHHHHHHHHHHcCCCCCcccC
Confidence            99999988 79999999999866443322   23456788999999977 679999999999999999998 88888433


Q ss_pred             CCCHHHHHHHHHHhCCchhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCH
Q 014406          324 HDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA  403 (425)
Q Consensus       324 ~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta  403 (425)
                       ...+.+..+...-                                   ........+++++.+|+.+||+.||++|||+
T Consensus       279 -~~~~~~~~~~~~~-----------------------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~  322 (344)
T 1rjb_A          279 -PVDANFYKLIQNG-----------------------------------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSF  322 (344)
T ss_dssp             -CCSHHHHHHHHTT-----------------------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             -CcHHHHHHHHhcC-----------------------------------CCCCCCCCCCHHHHHHHHHHcCCCchhCcCH
Confidence             3233222221100                                   0001122368999999999999999999999


Q ss_pred             HHHhcCC
Q 014406          404 REAMAHP  410 (425)
Q Consensus       404 ~elL~hp  410 (425)
                      .|+++|-
T Consensus       323 ~~l~~~l  329 (344)
T 1rjb_A          323 PNLTSFL  329 (344)
T ss_dssp             HHHHHHH
T ss_pred             HHHHHHH
Confidence            9999863

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=5e-45  Score=348.42  Aligned_cols=267  Identities=18%  Similarity=0.233  Sum_probs=198.5

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcch--HHHHHHHHHHHHhcCCCCeeeEEeEEEcCC--CCccE
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK--KKIKREIKILQNLCGGPNVVKLLDIVRDQH--SKTPS  198 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~--~~~~~E~~~l~~l~~h~niv~l~~~~~~~~--~~~~~  198 (425)
                      ..++|++.+.||+|+||+||+|.+.  ++.||||++.....  ....+|+.+++++ +||||+++++++....  ...++
T Consensus        22 ~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~~~   98 (322)
T 3soc_A           22 QSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNEYEVYSLPGM-KHENILQFIGAEKRGTSVDVDLW   98 (322)
T ss_dssp             TTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGHHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECSSSEEEE
T ss_pred             chhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCchHHHHHHHHHHHHhcC-CCCCchhhcceeccCCCCCceEE
Confidence            4678999999999999999999764  78999999975543  3456688889999 8999999999998643  23478


Q ss_pred             EEEEeecCCChhhhc--CCCCHHHHHHHHHHHHHHHHHHHHC----------CceeecCCCCceEecCCCCcEEEEeccc
Q 014406          199 LIFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQ----------GIMHRDVKPHNVMIDHELRKLRLIDWGL  266 (425)
Q Consensus       199 lv~e~~~~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~LH~~----------~ivH~Dlk~~NIll~~~~~~~kl~Dfg~  266 (425)
                      +||||+++++|.+++  ..+++..+..++.|++.||+|||+.          ||+||||||+|||++.+ +.+||+|||+
T Consensus        99 lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~-~~~kL~DFg~  177 (322)
T 3soc_A           99 LITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNN-LTACIADFGL  177 (322)
T ss_dssp             EEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTT-CCEEECCCTT
T ss_pred             EEEecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCC-CeEEEccCCc
Confidence            999999999999887  4589999999999999999999999          99999999999999988 7999999999


Q ss_pred             cccccCCCc---ceeeccCCCccCcccccCC----CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCC
Q 014406          267 AEFYHPGKE---YNVRVASRYFKGPELLVDL----QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT  339 (425)
Q Consensus       267 a~~~~~~~~---~~~~~~t~~y~aPE~~~~~----~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~  339 (425)
                      ++.......   .....+|+.|+|||++.+.    ..++.++|||||||++|+|++|+.||....+. ..........+.
T Consensus       178 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~-~~~~~~~~~~~~  256 (322)
T 3soc_A          178 ALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDE-YMLPFEEEIGQH  256 (322)
T ss_dssp             CEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCC-CCCTTHHHHCSS
T ss_pred             ccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcch-hccchhhhhccC
Confidence            977654332   2335789999999999763    24556889999999999999999998543221 111111111111


Q ss_pred             chhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhc
Q 014406          340 DELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  408 (425)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~  408 (425)
                      +........           ......+.....   .......++++.+|+++||+.||++|||++|+++
T Consensus       257 ~~~~~~~~~-----------~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  311 (322)
T 3soc_A          257 PSLEDMQEV-----------VVHKKKRPVLRD---YWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE  311 (322)
T ss_dssp             CCHHHHHHH-----------HTTSCCCCCCCG---GGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             Cchhhhhhh-----------hhcccCCCCccc---cccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            111111100           000000111110   0011113456999999999999999999999985

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=2.7e-44  Score=344.11  Aligned_cols=245  Identities=18%  Similarity=0.316  Sum_probs=194.1

Q ss_pred             CCCCCEEEEeeeeeeCceEEEEEEEcCCCcEE----EEEEecC----cchHHHHHHHHHHHHhcCCCCeeeEEeEEEcCC
Q 014406          122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERC----IIKILKP----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQH  193 (425)
Q Consensus       122 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~v----avK~~~~----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  193 (425)
                      ...++|++.+.||+|+||+||+|.+..+++.+    |+|.+..    ...+.+.+|+.+++++ +||||++++++|.+. 
T Consensus        12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~-   89 (327)
T 3poz_A           12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DNPHVCRLLGICLTS-   89 (327)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHC-CBTTBCCEEEEEESS-
T ss_pred             cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhC-CCCCEeEEEEEEecC-
Confidence            35688999999999999999999988887654    7777653    3346789999999999 999999999999763 


Q ss_pred             CCccEEEEEeecCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEecccccc
Q 014406          194 SKTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (425)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~  269 (425)
                        ..++|+||+.+++|..++    ..+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++.
T Consensus        90 --~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~-~~~kl~Dfg~a~~  166 (327)
T 3poz_A           90 --TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTP-QHVKITDFGLAKL  166 (327)
T ss_dssp             --SEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEET-TEEEECCTTHHHH
T ss_pred             --CeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCC-CCEEEccCcceeE
Confidence              477999999999998876    358999999999999999999999999999999999999988 7999999999987


Q ss_pred             ccCCCcc---eeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCCchhHHH
Q 014406          270 YHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAY  345 (425)
Q Consensus       270 ~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~lg~~~~~~~  345 (425)
                      .......   ....+|..|+|||.+.+ ..++.++|||||||++|+|++ |+.||. +.+..+....+....        
T Consensus       167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~-~~~~~~~~~~~~~~~--------  236 (327)
T 3poz_A          167 LGAEEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSILEKGE--------  236 (327)
T ss_dssp             HTTTCC-------CCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTT-TCCGGGHHHHHHTTC--------
T ss_pred             ccCCcccccccCCCccccccChHHhcc-CCCCchhhhhhhHHHHHHHHhcCCCCcc-CCCHHHHHHHHHcCC--------
Confidence            6543322   23355778999999987 789999999999999999999 888883 322222222111100        


Q ss_pred             HhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcC
Q 014406          346 LNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  409 (425)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~h  409 (425)
                                                  .......++.++.+++.+||+.||++|||+.|++++
T Consensus       237 ----------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  272 (327)
T 3poz_A          237 ----------------------------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             ----------------------------CCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred             ----------------------------CCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence                                        001122368899999999999999999999999876

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=3.7e-44  Score=335.76  Aligned_cols=244  Identities=18%  Similarity=0.313  Sum_probs=197.9

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc--chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEE
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (425)
                      ..++|++.+.||+|+||+||+|.+. ++..||+|++...  ..+.+.+|+.+++++ +|+||+++++++.+  ....++|
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv   97 (283)
T 3gen_A           22 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNL-SHEKLVQLYGVCTK--QRPIFII   97 (283)
T ss_dssp             CGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTC-CCTTBCCEEEEECS--SSSEEEE
T ss_pred             CHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCHHHHHHHHHHHhcC-CCCCEeeEEEEEec--CCCeEEE
Confidence            4678999999999999999999765 6778999999754  457799999999999 89999999999954  4678999


Q ss_pred             EEeecCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCc-
Q 014406          201 FEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-  275 (425)
Q Consensus       201 ~e~~~~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~-  275 (425)
                      |||+.+++|.+++    ..+++..+..++.|++.||.|||++||+|+||||+|||++.+ +.+||+|||+++....... 
T Consensus        98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~-~~~kl~Dfg~~~~~~~~~~~  176 (283)
T 3gen_A           98 TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQ-GVVKVSDFGLSRYVLDDEYT  176 (283)
T ss_dssp             ECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTT-SCEEECSTTGGGGBCCHHHH
T ss_pred             EeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCC-CCEEEccccccccccccccc
Confidence            9999999998887    359999999999999999999999999999999999999988 7899999999986543221 


Q ss_pred             -ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCC
Q 014406          276 -YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL  353 (425)
Q Consensus       276 -~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~  353 (425)
                       .....+|..|+|||.+.+ ..++.++||||||+++|+|++ |+.||. ..+..+....+....                
T Consensus       177 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~~l~t~g~~p~~-~~~~~~~~~~~~~~~----------------  238 (283)
T 3gen_A          177 SSVGSKFPVRWSPPEVLMY-SKFSSKSDIWAFGVLMWEIYSLGKMPYE-RFTNSETAEHIAQGL----------------  238 (283)
T ss_dssp             STTSTTSCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTTCCTTT-TSCHHHHHHHHHTTC----------------
T ss_pred             cccCCccCcccCCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCcc-ccChhHHHHHHhccc----------------
Confidence             122345677999999987 679999999999999999998 888873 333333332221110                


Q ss_pred             ChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcC
Q 014406          354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  409 (425)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~h  409 (425)
                                          .......+++.+.+|+.+||+.||++|||++|+++|
T Consensus       239 --------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  274 (283)
T 3gen_A          239 --------------------RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSN  274 (283)
T ss_dssp             --------------------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             --------------------CCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence                                001112368899999999999999999999999976

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=3.4e-44  Score=345.21  Aligned_cols=245  Identities=18%  Similarity=0.338  Sum_probs=199.5

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEc-----CCCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCC
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINV-----NTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQH  193 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~-----~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  193 (425)
                      ..++|++.+.||+|+||+||+|.+.     .+++.||+|+++...    .+.+.+|+.+++++ +||||+++++++.+  
T Consensus        45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~--  121 (343)
T 1luf_A           45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF-DNPNIVKLLGVCAV--  121 (343)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECS--
T ss_pred             cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEcc--
Confidence            4678999999999999999999987     455899999997543    35688999999999 99999999999954  


Q ss_pred             CCccEEEEEeecCCChhhhc---------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCC
Q 014406          194 SKTPSLIFEYVNSTDFKVLY---------------------------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVK  246 (425)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~---------------------------~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk  246 (425)
                      ....++||||+.+++|.+++                           ..+++.+++.++.||+.||.|||++||+|+|||
T Consensus       122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlk  201 (343)
T 1luf_A          122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLA  201 (343)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred             CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence            46789999999999998876                           348889999999999999999999999999999


Q ss_pred             CCceEecCCCCcEEEEeccccccccCCC---cceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCC
Q 014406          247 PHNVMIDHELRKLRLIDWGLAEFYHPGK---EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFY  322 (425)
Q Consensus       247 ~~NIll~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~  322 (425)
                      |+|||++.+ +.+||+|||+++......   ......+|..|+|||++.+ ..++.++|||||||++|+|++ |..||. 
T Consensus       202 p~NIl~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~-  278 (343)
T 1luf_A          202 TRNCLVGEN-MVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYY-  278 (343)
T ss_dssp             GGGEEECGG-GCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTT-
T ss_pred             cceEEECCC-CeEEEeecCCCcccccCccccccCCCcccceecChhhhcc-CCcCcccccHHHHHHHHHHHhcCCCcCC-
Confidence            999999988 789999999997654322   2234567888999999987 679999999999999999999 888884 


Q ss_pred             CCCCHHHHHHHHHHhCCchhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcC
Q 014406          323 GHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT  402 (425)
Q Consensus       323 ~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpt  402 (425)
                      +.+..+....+.+             ...                       ......+++++.+|+++||+.||++|||
T Consensus       279 ~~~~~~~~~~~~~-------------~~~-----------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps  322 (343)
T 1luf_A          279 GMAHEEVIYYVRD-------------GNI-----------------------LACPENCPLELYNLMRLCWSKLPADRPS  322 (343)
T ss_dssp             TSCHHHHHHHHHT-------------TCC-----------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred             CCChHHHHHHHhC-------------CCc-----------------------CCCCCCCCHHHHHHHHHHcccCcccCCC
Confidence            3222222222211             000                       0112237899999999999999999999


Q ss_pred             HHHHhcC
Q 014406          403 AREAMAH  409 (425)
Q Consensus       403 a~elL~h  409 (425)
                      +.+++++
T Consensus       323 ~~~~~~~  329 (343)
T 1luf_A          323 FCSIHRI  329 (343)
T ss_dssp             HHHHHHH
T ss_pred             HHHHHHH
Confidence            9999864

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=2.6e-44  Score=343.92  Aligned_cols=244  Identities=17%  Similarity=0.301  Sum_probs=196.4

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcE----EEEEEecCc----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCC
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNER----CIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS  194 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~----vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  194 (425)
                      ..++|++.+.||+|+||+||+|.+..+++.    ||+|.+...    ....+.+|+.+++++ +||||+++++++.+   
T Consensus        11 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~---   86 (325)
T 3kex_A           11 KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL-DHAHIVRLLGLCPG---   86 (325)
T ss_dssp             CTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTC-CCTTBCCEEEEECB---
T ss_pred             CHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcC-CCCCcCeEEEEEcC---
Confidence            568899999999999999999999888876    777777532    235678899999999 99999999999853   


Q ss_pred             CccEEEEEeecCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccc
Q 014406          195 KTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  270 (425)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~  270 (425)
                      ...++||||+.+++|.+++    ..+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++..
T Consensus        87 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~-~~~kl~Dfg~a~~~  165 (325)
T 3kex_A           87 SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSP-SQVQVADFGVADLL  165 (325)
T ss_dssp             SSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSS-SCEEECSCSGGGGS
T ss_pred             CccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCC-CeEEECCCCccccc
Confidence            5688999999999998876    358899999999999999999999999999999999999988 78999999999876


Q ss_pred             cCCCc---ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCCchhHHHH
Q 014406          271 HPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYL  346 (425)
Q Consensus       271 ~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~  346 (425)
                      .....   .....++..|+|||++.+ ..++.++|||||||++|+|++ |+.||. +....+....+...          
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~-~~~~~~~~~~~~~~----------  233 (325)
T 3kex_A          166 PPDDKQLLYSEAKTPIKWMALESIHF-GKYTHQSDVWSYGVTVWELMTFGAEPYA-GLRLAEVPDLLEKG----------  233 (325)
T ss_dssp             CCCTTCCC-----CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTT-TSCTTHHHHHHHTT----------
T ss_pred             CcccccccccCCCCcccccChHHhcc-CCCChhhHhHHhHHHHHHHHhCCCCCcc-ccCHHHHHHHHHcC----------
Confidence            54332   234567778999999987 679999999999999999999 999984 33222222221110          


Q ss_pred             hhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcC
Q 014406          347 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  409 (425)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~h  409 (425)
                         .                       .......++.++.+++.+||+.||++|||++|++++
T Consensus       234 ---~-----------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~  270 (325)
T 3kex_A          234 ---E-----------------------RLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANE  270 (325)
T ss_dssp             ---C-----------------------BCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred             ---C-----------------------CCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence               0                       001112257788999999999999999999999876

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=5.8e-44  Score=339.05  Aligned_cols=247  Identities=21%  Similarity=0.325  Sum_probs=201.9

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEE-----cCCCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCC
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGIN-----VNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQH  193 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~-----~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  193 (425)
                      ..++|++.+.||+|+||+||+|.+     ..+++.||+|++....    .+.+.+|+.+++++.+||||+++++++.+  
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~--   98 (313)
T 1t46_A           21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI--   98 (313)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred             ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec--
Confidence            467899999999999999999985     4577899999997543    36688999999999789999999999955  


Q ss_pred             CCccEEEEEeecCCChhhhcC---------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEe
Q 014406          194 SKTPSLIFEYVNSTDFKVLYP---------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI  252 (425)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~~---------------------~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll  252 (425)
                      ....++||||+++++|.+++.                     .+++..+..++.|++.||.|||++||+|+||||+|||+
T Consensus        99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~  178 (313)
T 1t46_A           99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL  178 (313)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred             CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEE
Confidence            467889999999999988762                     38999999999999999999999999999999999999


Q ss_pred             cCCCCcEEEEeccccccccCCCcc---eeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHH
Q 014406          253 DHELRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHD  328 (425)
Q Consensus       253 ~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~  328 (425)
                      +.+ +.+||+|||+++........   ....+|..|+|||.+.+ ..++.++|||||||++|+|++ |..||... ....
T Consensus       179 ~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~-~~~~  255 (313)
T 1t46_A          179 THG-RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGM-PVDS  255 (313)
T ss_dssp             ETT-TEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTC-CSSH
T ss_pred             cCC-CCEEEccccccccccccccceeccCCCCcceeeChHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCCCcc-cchh
Confidence            988 79999999999876544332   23456778999999987 679999999999999999999 88887433 3222


Q ss_pred             HHHHHHHHhCCchhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhc
Q 014406          329 QLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  408 (425)
Q Consensus       329 ~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~  408 (425)
                      ..........                                   .......+++++.+++.+||+.||++|||++|+++
T Consensus       256 ~~~~~~~~~~-----------------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  300 (313)
T 1t46_A          256 KFYKMIKEGF-----------------------------------RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ  300 (313)
T ss_dssp             HHHHHHHHTC-----------------------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHhccCC-----------------------------------CCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            2222211100                                   00111236899999999999999999999999987


Q ss_pred             C
Q 014406          409 H  409 (425)
Q Consensus       409 h  409 (425)
                      +
T Consensus       301 ~  301 (313)
T 1t46_A          301 L  301 (313)
T ss_dssp             H
T ss_pred             H
Confidence            5

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=8.5e-44  Score=345.66  Aligned_cols=255  Identities=14%  Similarity=0.209  Sum_probs=195.2

Q ss_pred             CCCCCEEEEeeeeeeCceEEEEEEEcCC-----CcEEEEEEecCcchHHHHHHHHH---------------HHHhcCCCC
Q 014406          122 GDQDDYEVVRKVGRGKYSEVFEGINVNT-----NERCIIKILKPVKKKKIKREIKI---------------LQNLCGGPN  181 (425)
Q Consensus       122 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~-----~~~vavK~~~~~~~~~~~~E~~~---------------l~~l~~h~n  181 (425)
                      ...++|++.+.||+|+||+||+|.+..+     ++.||||++..... .+.+|+.+               +..+ +|+|
T Consensus        32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~e~~~~~~~~~~~~~~e~~~~~~l-~h~~  109 (364)
T 3op5_A           32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNG-PLFTELKFYQRAAKPEQIQKWIRTRKL-KYLG  109 (364)
T ss_dssp             TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCH-HHHHHHHHHHHHCCHHHHHHHHHHTTC-SCCC
T ss_pred             cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccch-hHHHHHHHHHhhhhhHHHHHHHHHhhc-cCCC
Confidence            3467999999999999999999988765     58899999875432 34444444               4444 6999


Q ss_pred             eeeEEeEEEcCC--CCccEEEEEeecCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEec--
Q 014406          182 VVKLLDIVRDQH--SKTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMID--  253 (425)
Q Consensus       182 iv~l~~~~~~~~--~~~~~lv~e~~~~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~--  253 (425)
                      |+++++++....  ..+.++||||+ +++|..++    ..+++..+..++.||+.||+|||++||+||||||+|||++  
T Consensus       110 iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~  188 (364)
T 3op5_A          110 VPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYK  188 (364)
T ss_dssp             SCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESS
T ss_pred             CCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecC
Confidence            999999987542  25689999999 89998876    4599999999999999999999999999999999999998  


Q ss_pred             CCCCcEEEEeccccccccCCCc--------ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCC
Q 014406          254 HELRKLRLIDWGLAEFYHPGKE--------YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD  325 (425)
Q Consensus       254 ~~~~~~kl~Dfg~a~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~  325 (425)
                      .+ +.+||+|||+++.......        .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.....
T Consensus       189 ~~-~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~  266 (364)
T 3op5_A          189 NP-DQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNG-VAPSRRGDLEILGYCMIQWLTGHLPWEDNLK  266 (364)
T ss_dssp             CT-TCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred             CC-CeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCC-CCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence            65 7899999999976543221        123458999999999987 6799999999999999999999999954334


Q ss_pred             CHHHHHHHHHHhCCchhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHH
Q 014406          326 NHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTARE  405 (425)
Q Consensus       326 ~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~e  405 (425)
                      +............ .........+                          .....+++++.+|+..||+.||++|||+++
T Consensus       267 ~~~~~~~~~~~~~-~~~~~~~~~~--------------------------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~  319 (364)
T 3op5_A          267 DPKYVRDSKIRYR-ENIASLMDKC--------------------------FPAANAPGEIAKYMETVKLLDYTEKPLYEN  319 (364)
T ss_dssp             CHHHHHHHHHHHH-HCHHHHHHHH--------------------------SCTTCCCHHHHHHHHHHHTCCTTCCCCHHH
T ss_pred             CHHHHHHHHHHhh-hhHHHHHHHh--------------------------cccccCHHHHHHHHHHHhcCCCCCCCCHHH
Confidence            4333322221111 1111111100                          001236899999999999999999999998


Q ss_pred             Hhc
Q 014406          406 AMA  408 (425)
Q Consensus       406 lL~  408 (425)
                      +++
T Consensus       320 l~~  322 (364)
T 3op5_A          320 LRD  322 (364)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            875

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.9e-44  Score=341.28  Aligned_cols=248  Identities=24%  Similarity=0.413  Sum_probs=197.6

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc---------hHHHHHHHHHHHHhc---CCCCeeeEEeEEE
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK---------KKKIKREIKILQNLC---GGPNVVKLLDIVR  190 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~---------~~~~~~E~~~l~~l~---~h~niv~l~~~~~  190 (425)
                      ..++|++.+.||+|+||+||+|.+..+++.||+|++....         ...+.+|+.++.++.   +|+||+++++++.
T Consensus        29 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~  108 (312)
T 2iwi_A           29 FEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFE  108 (312)
T ss_dssp             ----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-
T ss_pred             hhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEe
Confidence            4678999999999999999999999999999999996432         234567999999884   6999999999996


Q ss_pred             cCCCCccEEEEEe-ecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccc
Q 014406          191 DQHSKTPSLIFEY-VNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL  266 (425)
Q Consensus       191 ~~~~~~~~lv~e~-~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~  266 (425)
                      ..  ...++|+|| +.+++|.+++   ..+++..+..++.|++.||+|||++||+|+||||+||+++.+.+.+||+|||+
T Consensus       109 ~~--~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~  186 (312)
T 2iwi_A          109 TQ--EGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGS  186 (312)
T ss_dssp             ------CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSS
T ss_pred             cC--CeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcch
Confidence            54  677899999 7889998877   35899999999999999999999999999999999999994338999999999


Q ss_pred             cccccCCCcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHH
Q 014406          267 AEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYL  346 (425)
Q Consensus       267 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~  346 (425)
                      ++.... .......++..|+|||++.+....+.++|||||||++|+|++|+.||..    ...   +..           
T Consensus       187 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~----~~~---~~~-----------  247 (312)
T 2iwi_A          187 GALLHD-EPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER----DQE---ILE-----------  247 (312)
T ss_dssp             CEECCS-SCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS----HHH---HHH-----------
T ss_pred             hhhccc-CcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCC----hHH---Hhh-----------
Confidence            987653 3344567899999999987634345689999999999999999999831    110   000           


Q ss_pred             hhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCccccc
Q 014406          347 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA  417 (425)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~  417 (425)
                        ..                        ......++.++.+|+.+||+.||++|||++|+++||||++...
T Consensus       248 --~~------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~~  292 (312)
T 2iwi_A          248 --AE------------------------LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAE  292 (312)
T ss_dssp             --TC------------------------CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC---
T ss_pred             --hc------------------------cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCchh
Confidence              00                        0011236899999999999999999999999999999998754

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=3.9e-44  Score=340.43  Aligned_cols=245  Identities=18%  Similarity=0.324  Sum_probs=199.9

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEc-----CCCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCC
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINV-----NTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQH  193 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~-----~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  193 (425)
                      ..++|++.+.||+|+||+||+|.+.     .++..||+|++....    .+.+.+|+.+++++ +||||+++++++.+  
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~--   97 (314)
T 2ivs_A           21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQV-NHPHVIKLYGACSQ--   97 (314)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECS--
T ss_pred             chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhC-CCCceeeEEEEEec--
Confidence            4688999999999999999999873     456899999997532    35688999999999 99999999999954  


Q ss_pred             CCccEEEEEeecCCChhhhcC---------------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeecCC
Q 014406          194 SKTPSLIFEYVNSTDFKVLYP---------------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVK  246 (425)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~~---------------------------~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk  246 (425)
                      ....++||||+.+++|.+++.                           .+++.++..++.||+.||.|||++||+|+|||
T Consensus        98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dik  177 (314)
T 2ivs_A           98 DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLA  177 (314)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred             CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccc
Confidence            467899999999999988863                           17889999999999999999999999999999


Q ss_pred             CCceEecCCCCcEEEEeccccccccCCCcc---eeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCC
Q 014406          247 PHNVMIDHELRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFY  322 (425)
Q Consensus       247 ~~NIll~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~  322 (425)
                      |+|||++.+ +.+||+|||+++........   ....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||. 
T Consensus       178 p~NIli~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~-  254 (314)
T 2ivs_A          178 ARNILVAEG-RKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFD-HIYTTQSDVWSFGVLLWEIVTLGGNPYP-  254 (314)
T ss_dssp             GGGEEEETT-TEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCSST-
T ss_pred             hheEEEcCC-CCEEEccccccccccccccceeccCCCCcccccChhhhcC-CCcCchhhHHHHHHHHHHHHhCCCCCCC-
Confidence            999999988 78999999999866443322   23356778999999987 678999999999999999999 888873 


Q ss_pred             CCCCHHHHHHHHHHhCCchhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcC
Q 014406          323 GHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT  402 (425)
Q Consensus       323 ~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpt  402 (425)
                      +.+..+....+....                                    .......+++++.+++.+||+.||++|||
T Consensus       255 ~~~~~~~~~~~~~~~------------------------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps  298 (314)
T 2ivs_A          255 GIPPERLFNLLKTGH------------------------------------RMERPDNCSEEMYRLMLQCWKQEPDKRPV  298 (314)
T ss_dssp             TCCGGGHHHHHHTTC------------------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred             CCCHHHHHHHhhcCC------------------------------------cCCCCccCCHHHHHHHHHHccCChhhCcC
Confidence            333222222211100                                    00112237899999999999999999999


Q ss_pred             HHHHhcC
Q 014406          403 AREAMAH  409 (425)
Q Consensus       403 a~elL~h  409 (425)
                      ++|++++
T Consensus       299 ~~~l~~~  305 (314)
T 2ivs_A          299 FADISKD  305 (314)
T ss_dssp             HHHHHHH
T ss_pred             HHHHHHH
Confidence            9999875

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=4.4e-44  Score=340.32  Aligned_cols=257  Identities=24%  Similarity=0.436  Sum_probs=196.8

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcC-CCCeeeEEeEEEcCCCCc
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCG-GPNVVKLLDIVRDQHSKT  196 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~-h~niv~l~~~~~~~~~~~  196 (425)
                      ..++|++.+.||+|+||+||+|.+. +++.||+|++...     ..+.+.+|+.++.++.+ |+||+++++++...  ..
T Consensus        26 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~--~~  102 (313)
T 3cek_A           26 KGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD--QY  102 (313)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECS--SE
T ss_pred             ccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecC--CE
Confidence            4678999999999999999999774 5889999998643     23568899999999943 69999999999654  67


Q ss_pred             cEEEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCC
Q 014406          197 PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (425)
Q Consensus       197 ~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~  273 (425)
                      .++||| +.+++|.+++   ..+++..+..++.|++.||.|||++||+|+||||+|||++.  +.+||+|||+++.....
T Consensus       103 ~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~--~~~kL~Dfg~~~~~~~~  179 (313)
T 3cek_A          103 IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD--GMLKLIDFGIANQMQPD  179 (313)
T ss_dssp             EEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET--TEEEECCCSSSCC----
T ss_pred             EEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC--CeEEEeeccccccccCc
Confidence            899999 5677887766   45899999999999999999999999999999999999975  68999999999866433


Q ss_pred             Cc---ceeeccCCCccCcccccCC----------CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCc
Q 014406          274 KE---YNVRVASRYFKGPELLVDL----------QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTD  340 (425)
Q Consensus       274 ~~---~~~~~~t~~y~aPE~~~~~----------~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~  340 (425)
                      ..   .....++..|+|||.+.+.          ..++.++|||||||++|+|++|+.||....+....+..+   +...
T Consensus       180 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~---~~~~  256 (313)
T 3cek_A          180 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI---IDPN  256 (313)
T ss_dssp             ----------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHH---HCTT
T ss_pred             cccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHH---Hhcc
Confidence            22   2345789999999998651          368889999999999999999999984332222222111   1100


Q ss_pred             hhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccchh
Q 014406          341 ELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAES  420 (425)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~~~  420 (425)
                                              .        ........++++.+|+.+||+.||++|||++|+++||||+.......
T Consensus       257 ------------------------~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~~~  304 (313)
T 3cek_A          257 ------------------------H--------EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVN  304 (313)
T ss_dssp             ------------------------S--------CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC-----
T ss_pred             ------------------------c--------ccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCCCchh
Confidence                                    0        00111225788999999999999999999999999999997765443

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=1.1e-43  Score=330.31  Aligned_cols=244  Identities=16%  Similarity=0.324  Sum_probs=190.0

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-------chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCC
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (425)
                      ..++|++.+.||+|+||+||+|.+  +++.+|||++...       ..+.+.+|+.+++.+ +||||+++++++.+  ..
T Consensus         5 ~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~   79 (271)
T 3dtc_A            5 DFAELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAML-KHPNIIALRGVCLK--EP   79 (271)
T ss_dssp             CTTSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHC-CCTTBCCEEEEECC--C-
T ss_pred             chhheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhc-CCCCEeeEEEEEec--CC
Confidence            467899999999999999999986  4889999998642       235688999999999 89999999999955  46


Q ss_pred             ccEEEEEeecCCChhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeecCCCCceEecCC-------CCcEEEEe
Q 014406          196 TPSLIFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQG---IMHRDVKPHNVMIDHE-------LRKLRLID  263 (425)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~---ivH~Dlk~~NIll~~~-------~~~~kl~D  263 (425)
                      ..++||||+++++|..++  ..+++..+..++.|++.||.|||++|   |+|+||||+|||++.+       .+.+||+|
T Consensus        80 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D  159 (271)
T 3dtc_A           80 NLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD  159 (271)
T ss_dssp             -CEEEEECCTTEEHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred             ceEEEEEcCCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence            789999999999999887  46899999999999999999999999   9999999999999862       36799999


Q ss_pred             ccccccccCCCcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhH
Q 014406          264 WGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELN  343 (425)
Q Consensus       264 fg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~  343 (425)
                      ||+++...... .....+|+.|+|||.+.+ ..++.++||||||+++|+|++|+.||.. .+.......+..  +.    
T Consensus       160 fg~~~~~~~~~-~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~-~~~~~~~~~~~~--~~----  230 (271)
T 3dtc_A          160 FGLAREWHRTT-KMSAAGAYAWMAPEVIRA-SMFSKGSDVWSYGVLLWELLTGEVPFRG-IDGLAVAYGVAM--NK----  230 (271)
T ss_dssp             CCC--------------CCGGGSCHHHHHH-CCCSHHHHHHHHHHHHHHHHHCCCTTTT-SCHHHHHHHHHT--SC----
T ss_pred             CCccccccccc-ccCCCCccceeCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHhhhc--CC----
Confidence            99998654332 234578999999999987 6799999999999999999999999842 222222111100  00    


Q ss_pred             HHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcC
Q 014406          344 AYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  409 (425)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~h  409 (425)
                                                   ........+++++.+|+.+||+.||++|||+.|++++
T Consensus       231 -----------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  267 (271)
T 3dtc_A          231 -----------------------------LALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ  267 (271)
T ss_dssp             -----------------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -----------------------------CCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence                                         0011123478999999999999999999999999874

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=4.2e-44  Score=335.15  Aligned_cols=244  Identities=22%  Similarity=0.403  Sum_probs=189.3

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCC---CcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCC
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNT---NERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~---~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (425)
                      ..++|++.+.||+|+||+||+|.+..+   +..||+|++....    .+.+.+|+.+++++ +||||+++++++.+   .
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~---~   88 (281)
T 1mp8_A           13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF-DHPHIVKLIGVITE---N   88 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECS---S
T ss_pred             ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCccceEEEEEcc---C
Confidence            467899999999999999999998654   4579999987532    35688999999999 99999999999843   5


Q ss_pred             ccEEEEEeecCCChhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEecccccccc
Q 014406          196 TPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (425)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~~----~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~  271 (425)
                      ..++||||+.+++|.+++.    .+++..+..++.|++.||+|||++||+|+||||+|||++.+ +.+||+|||+++...
T Consensus        89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~  167 (281)
T 1mp8_A           89 PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSN-DCVKLGDFGLSRYME  167 (281)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEET-TEEEECC--------
T ss_pred             ccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCC-CCEEECccccccccC
Confidence            6789999999999988873    58999999999999999999999999999999999999988 799999999998765


Q ss_pred             CCCcc--eeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhh
Q 014406          272 PGKEY--NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK  348 (425)
Q Consensus       272 ~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~  348 (425)
                      .....  ....+++.|+|||++.+ ..++.++|||||||++|+|++ |..||. +.+..+....+....           
T Consensus       168 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~ell~~g~~pf~-~~~~~~~~~~i~~~~-----------  234 (281)
T 1mp8_A          168 DSTYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQ-GVKNNDVIGRIENGE-----------  234 (281)
T ss_dssp             -----------CCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCTTT-TCCGGGHHHHHHTTC-----------
T ss_pred             cccccccccCCCcccccChhhccc-CCCCCccCchHHHHHHHHHHhcCCCCCC-cCCHHHHHHHHHcCC-----------
Confidence            43322  23455678999999976 679999999999999999997 888873 333333333221100           


Q ss_pred             ccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcC
Q 014406          349 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  409 (425)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~h  409 (425)
                                               .......+++++.+|+.+||+.||++|||+.|++++
T Consensus       235 -------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  270 (281)
T 1mp8_A          235 -------------------------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  270 (281)
T ss_dssp             -------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -------------------------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                                     001122378999999999999999999999999864

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1.1e-43  Score=335.48  Aligned_cols=261  Identities=22%  Similarity=0.356  Sum_probs=202.4

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEE----EcCCCcEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCC
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGI----NVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS  194 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~----~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  194 (425)
                      ..++|++.+.||+|+||+||+|.    +..+++.||+|++...    ..+.+.+|+.+++.+ +||||+++++++.....
T Consensus        19 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~   97 (302)
T 4e5w_A           19 EKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL-YHENIVKYKGICTEDGG   97 (302)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTC-CCTTBCCEEEEEEC---
T ss_pred             hhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhC-CCCCeeeeeeEEecCCC
Confidence            45679999999999999999998    5678999999999743    346789999999999 89999999999987766


Q ss_pred             CccEEEEEeecCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccc
Q 014406          195 KTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  270 (425)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~  270 (425)
                      ...++||||+++++|.+++    ..+++..+..++.|++.||+|||++||+|+||||+|||++.+ +.+||+|||++...
T Consensus        98 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~-~~~kl~Dfg~~~~~  176 (302)
T 4e5w_A           98 NGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESE-HQVKIGDFGLTKAI  176 (302)
T ss_dssp             CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET-TEEEECCCTTCEEC
T ss_pred             ceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCC-CCEEECcccccccc
Confidence            7789999999999999887    458999999999999999999999999999999999999988 79999999999876


Q ss_pred             cCCCc----ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHH
Q 014406          271 HPGKE----YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYL  346 (425)
Q Consensus       271 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~  346 (425)
                      .....    .....+|..|+|||++.+ ..++.++|||||||++|+|++|+.|+.      ..........+........
T Consensus       177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~------~~~~~~~~~~~~~~~~~~~  249 (302)
T 4e5w_A          177 ETDKEYYTVKDDRDSPVFWYAPECLMQ-SKFYIASDVWSFGVTLHELLTYCDSDS------SPMALFLKMIGPTHGQMTV  249 (302)
T ss_dssp             CTTCCEEECCCCTTCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGG------SHHHHHHHHHCSCCGGGHH
T ss_pred             cCCCcceeccCCCCCCccccCCeeecC-CCCCcchhHHHHHHHHHHHHHccCCCc------chhhHHhhccCCcccccCH
Confidence            54432    223456777999999987 678899999999999999999998862      1122222222221110000


Q ss_pred             hhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhc
Q 014406          347 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  408 (425)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~  408 (425)
                      .        ..........        .......+++++.+|+++||+.||++|||++|+++
T Consensus       250 ~--------~~~~~~~~~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  295 (302)
T 4e5w_A          250 T--------RLVNTLKEGK--------RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE  295 (302)
T ss_dssp             H--------HHHHHHHTTC--------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             H--------HHHHHHhccC--------CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence            0        0000000000        11122347899999999999999999999999985

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1.5e-43  Score=341.51  Aligned_cols=256  Identities=15%  Similarity=0.171  Sum_probs=196.6

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcC---CCcEEEEEEecCcc--------------hHHHHHHHHHHHHhcCCCCeeeE
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVN---TNERCIIKILKPVK--------------KKKIKREIKILQNLCGGPNVVKL  185 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~---~~~~vavK~~~~~~--------------~~~~~~E~~~l~~l~~h~niv~l  185 (425)
                      ..++|++.+.||+|+||+||+|.+..   ++..+|+|++....              ...+.+|+..++.+ +||||+++
T Consensus        35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l-~h~ni~~~  113 (345)
T 2v62_A           35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQL-DYLGIPLF  113 (345)
T ss_dssp             TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTC-SCCCCCCE
T ss_pred             cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccc-cccCccee
Confidence            46789999999999999999999987   78899999987532              12356778888888 99999999


Q ss_pred             EeEEEcC--CCCccEEEEEeecCCChhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCC--c
Q 014406          186 LDIVRDQ--HSKTPSLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELR--K  258 (425)
Q Consensus       186 ~~~~~~~--~~~~~~lv~e~~~~~~l~~~~~---~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~--~  258 (425)
                      ++++...  .....++||||+ +++|.+++.   .+++.++..++.||+.||+|||++||+||||||+|||++.+ +  .
T Consensus       114 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-~~~~  191 (345)
T 2v62_A          114 YGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYK-NPDQ  191 (345)
T ss_dssp             EEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESS-STTS
T ss_pred             ecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccC-CCCc
Confidence            9999762  246789999999 899998875   58999999999999999999999999999999999999876 4  8


Q ss_pred             EEEEeccccccccCCC--------cceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHH
Q 014406          259 LRLIDWGLAEFYHPGK--------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL  330 (425)
Q Consensus       259 ~kl~Dfg~a~~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~  330 (425)
                      +||+|||+++......        ......+|..|+|||++.+ ..++.++|||||||++|+|++|+.||.....+....
T Consensus       192 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~  270 (345)
T 2v62_A          192 VYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKG-VALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAV  270 (345)
T ss_dssp             EEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHH
T ss_pred             EEEEeCCCceecccccccccchhccccccCCCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCccccccccHHH
Confidence            9999999997654221        1134578999999999987 679999999999999999999999995444444433


Q ss_pred             HHHHHHhCCchhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcC
Q 014406          331 VKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  409 (425)
Q Consensus       331 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~h  409 (425)
                      .........            ..+.....               ......+++++.+|+.+||+.||++|||++++++.
T Consensus       271 ~~~~~~~~~------------~~~~~~~~---------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  322 (345)
T 2v62_A          271 QTAKTNLLD------------ELPQSVLK---------------WAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKI  322 (345)
T ss_dssp             HHHHHHHHH------------TTTHHHHH---------------HSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred             HHHHHhhcc------------cccHHHHh---------------hccccccHHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence            332221110            00000000               00112378999999999999999999999988753

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=2e-44  Score=357.46  Aligned_cols=256  Identities=21%  Similarity=0.337  Sum_probs=193.8

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcchHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEEE
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE  202 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e  202 (425)
                      ...+|++.+.||+|+||+||.. ...+++.||||++.......+.+|+.+++.+.+||||+++++++.+.  ...++|||
T Consensus        22 ~~~~y~~~~~LG~G~~G~V~~~-~~~~~~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~--~~~~lv~E   98 (432)
T 3p23_A           22 GKISFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKDR--QFQYIAIE   98 (432)
T ss_dssp             TTEEEEEEEEEEECGGGCEEEE-EESSSSEEEEEEECTTTEEECHHHHHHHHHSCCCTTBCCEEEEEEET--TEEEEEEE
T ss_pred             ccEEEecCCeeecCcCEEEEEE-EEeCCeEEEEEEECHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecC--CEEEEEEE
Confidence            3567999999999999997643 46788999999998776677889999999987799999999999654  67899999


Q ss_pred             eecCCChhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCC----CCcEEEEeccccccccCCC
Q 014406          203 YVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE----LRKLRLIDWGLAEFYHPGK  274 (425)
Q Consensus       203 ~~~~~~l~~~~~----~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~----~~~~kl~Dfg~a~~~~~~~  274 (425)
                      |+.+ +|.+++.    .+.+..+..++.||+.||+|||++||+||||||+|||++.+    ...+||+|||+++......
T Consensus        99 ~~~g-~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~  177 (432)
T 3p23_A           99 LCAA-TLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGR  177 (432)
T ss_dssp             CCSE-EHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC----
T ss_pred             CCCC-CHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCC
Confidence            9975 6766652    24555678899999999999999999999999999999532    2358899999998765332


Q ss_pred             ----cceeeccCCCccCcccccC--CCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCCchhHHHHh
Q 014406          275 ----EYNVRVASRYFKGPELLVD--LQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLN  347 (425)
Q Consensus       275 ----~~~~~~~t~~y~aPE~~~~--~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~  347 (425)
                          ......||+.|+|||++.+  ...++.++|||||||++|+|++ |..||. . ........+   .+.....    
T Consensus       178 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~-~-~~~~~~~~~---~~~~~~~----  248 (432)
T 3p23_A          178 HSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFG-K-SLQRQANIL---LGACSLD----  248 (432)
T ss_dssp             --------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTB-S-TTTHHHHHH---TTCCCCT----
T ss_pred             cceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcc-h-hhHHHHHHH---hccCCcc----
Confidence                2334579999999999974  2567889999999999999999 777772 2 222222111   1110000    


Q ss_pred             hccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCccccc
Q 014406          348 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA  417 (425)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~  417 (425)
                                          .      .......+..+.+||.+||+.||++|||++|+++||||..+.+
T Consensus       249 --------------------~------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~~~  292 (432)
T 3p23_A          249 --------------------C------LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEK  292 (432)
T ss_dssp             --------------------T------SCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCHHH
T ss_pred             --------------------c------cCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccChHH
Confidence                                0      0001113566899999999999999999999999999987654

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=8.8e-44  Score=340.37  Aligned_cols=263  Identities=19%  Similarity=0.311  Sum_probs=204.8

Q ss_pred             CCCCCEEEEeeeeeeCceEEEEEE----EcCCCcEEEEEEecCcc---hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCC
Q 014406          122 GDQDDYEVVRKVGRGKYSEVFEGI----NVNTNERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRDQHS  194 (425)
Q Consensus       122 ~~~~~y~~~~~LG~G~fg~V~~~~----~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  194 (425)
                      ...++|++.+.||+|+||+||+|.    +..+++.||||++....   .+.+.+|+.+++++ +|+||+++++++.....
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~   98 (327)
T 3lxl_A           20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKAL-HSDFIVKYRGVSYGPGR   98 (327)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSS
T ss_pred             hchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhc-CCCceeEEEEEEecCCC
Confidence            356899999999999999999998    46789999999997554   34588999999999 99999999999987777


Q ss_pred             CccEEEEEeecCCChhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccc
Q 014406          195 KTPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  270 (425)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~~----~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~  270 (425)
                      ...++||||+++++|.+++.    .+++..+..++.|++.||+|||+.||+|+||||+|||++.+ +.+||+|||+++..
T Consensus        99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~-~~~kl~Dfg~~~~~  177 (327)
T 3lxl_A           99 QSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESE-AHVKIADFGLAKLL  177 (327)
T ss_dssp             CEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET-TEEEECCGGGCEEC
T ss_pred             ceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCC-CCEEEcccccceec
Confidence            88999999999999998873    48999999999999999999999999999999999999988 79999999999876


Q ss_pred             cCCCcc----eeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHH
Q 014406          271 HPGKEY----NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYL  346 (425)
Q Consensus       271 ~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~  346 (425)
                      ......    ....+|..|+|||++.+ ..++.++|||||||++|+|++|+.||....  .+..................
T Consensus       178 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~  254 (327)
T 3lxl_A          178 PLDKDYYVVREPGQSPIFWYAPESLSD-NIFSRQSDVWSFGVVLYELFTYCDKSCSPS--AEFLRMMGCERDVPALSRLL  254 (327)
T ss_dssp             CTTCSEEECSSCCCSCGGGSCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGGSHH--HHHHHHCC----CCHHHHHH
T ss_pred             ccCCccceeeccCCccccccCHHHhcc-CCCChHHhHHHHHHHHHHHHhCCCCCcccc--chhhhhcccccccccHHHHH
Confidence            543322    23456777999999977 678999999999999999999999984211  11000000000000000000


Q ss_pred             hhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcC
Q 014406          347 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  409 (425)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~h  409 (425)
                                  .......        .......+++++.+|+.+||+.||++|||++|++++
T Consensus       255 ------------~~~~~~~--------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  297 (327)
T 3lxl_A          255 ------------ELLEEGQ--------RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ  297 (327)
T ss_dssp             ------------HHHHTTC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ------------HHhhccc--------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                        0000000        111123478999999999999999999999999654

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1.3e-43  Score=332.80  Aligned_cols=244  Identities=18%  Similarity=0.341  Sum_probs=202.8

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc--hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEE
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (425)
                      ..++|++.+.||+|+||+||+|.+..++..||+|++....  .+.+.+|+.+++++ +||||+++++++.+  ....++|
T Consensus        11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~--~~~~~~v   87 (288)
T 3kfa_A           11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTR--EPPFYII   87 (288)
T ss_dssp             CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHC-CCTTBCCEEEEECS--SSSEEEE
T ss_pred             cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEcc--CCCEEEE
Confidence            5788999999999999999999999999999999997543  46788999999999 89999999999954  4678999


Q ss_pred             EEeecCCChhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCc
Q 014406          201 FEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (425)
Q Consensus       201 ~e~~~~~~l~~~~~-----~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~  275 (425)
                      |||+.+++|.+++.     .+++..+..++.|++.||+|||++||+|+||||+||+++.+ +.+||+|||++........
T Consensus        88 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~-~~~~l~Dfg~~~~~~~~~~  166 (288)
T 3kfa_A           88 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGEN-HLVKVADFGLSRLMTGDTY  166 (288)
T ss_dssp             EECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGG-GCEEECCCCGGGTSCSSSS
T ss_pred             EEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCC-CCEEEccCccceeccCCcc
Confidence            99999999988872     38999999999999999999999999999999999999988 7899999999987654332


Q ss_pred             c--eeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCC
Q 014406          276 Y--NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE  352 (425)
Q Consensus       276 ~--~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~  352 (425)
                      .  ....++..|+|||.+.+ ..++.++||||||+++|+|++ |..|| .+.+..+....+...                
T Consensus       167 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~~g~~p~-~~~~~~~~~~~~~~~----------------  228 (288)
T 3kfa_A          167 TAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPY-PGIDLSQVYELLEKD----------------  228 (288)
T ss_dssp             EEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSS-TTCCGGGHHHHHHTT----------------
T ss_pred             ccccCCccccCcCChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCC-CCCCHHHHHHHHhcc----------------
Confidence            2  23456778999999987 679999999999999999999 77777 333333222222110                


Q ss_pred             CChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhc
Q 014406          353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  408 (425)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~  408 (425)
                                          ........+++++.+|+++||+.||++|||++|+++
T Consensus       229 --------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~  264 (288)
T 3kfa_A          229 --------------------YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  264 (288)
T ss_dssp             --------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --------------------CCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence                                001112347899999999999999999999999976

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1.2e-43  Score=337.28  Aligned_cols=248  Identities=20%  Similarity=0.337  Sum_probs=201.8

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEE-----cCCCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCC
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGIN-----VNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQH  193 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~-----~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  193 (425)
                      ..++|++.+.||+|+||+||+|.+     ..+++.||||++....    .+.+.+|+.++.++.+||||+++++++... 
T Consensus        25 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~-  103 (316)
T 2xir_A           25 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP-  103 (316)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT-
T ss_pred             chhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecC-
Confidence            468999999999999999999985     3567899999997542    346889999999997799999999999654 


Q ss_pred             CCccEEEEEeecCCChhhhcCC-------------------CCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecC
Q 014406          194 SKTPSLIFEYVNSTDFKVLYPT-------------------LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH  254 (425)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~~~-------------------l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~  254 (425)
                      +...++||||+++++|.+++..                   +++..+..++.|++.||.|||+.||+|+||||+||+++.
T Consensus       104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~  183 (316)
T 2xir_A          104 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE  183 (316)
T ss_dssp             TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred             CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECC
Confidence            3568999999999999888732                   788999999999999999999999999999999999998


Q ss_pred             CCCcEEEEeccccccccCCCcc---eeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHH
Q 014406          255 ELRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQL  330 (425)
Q Consensus       255 ~~~~~kl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~  330 (425)
                      + +.+||+|||+++........   ....+|..|+|||++.+ ..++.++|||||||++|+|++ |..||..........
T Consensus       184 ~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~  261 (316)
T 2xir_A          184 K-NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC  261 (316)
T ss_dssp             G-GCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHH
T ss_pred             C-CCEEECCCccccccccCccceeccCCCcceeecCchhhcc-ccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHH
Confidence            7 78999999999866443322   23466788999999987 679999999999999999998 888884333333222


Q ss_pred             HHHHHHhCCchhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcC
Q 014406          331 VKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  409 (425)
Q Consensus       331 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~h  409 (425)
                      ..+....                                    .......+++++.+++.+||+.||++|||++|+++|
T Consensus       262 ~~~~~~~------------------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  304 (316)
T 2xir_A          262 RRLKEGT------------------------------------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  304 (316)
T ss_dssp             HHHHHTC------------------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHhccCc------------------------------------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            2221100                                    001112368899999999999999999999999986

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=2.2e-43  Score=338.71  Aligned_cols=246  Identities=19%  Similarity=0.305  Sum_probs=199.0

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEc-------CCCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeeEEeEEEc
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINV-------NTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRD  191 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~-------~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~  191 (425)
                      ..++|++.+.||+|+||+||+|.+.       .++..||+|+++...    .+.+.+|+.+++.+.+||||+++++++.+
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  112 (334)
T 2pvf_A           33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ  112 (334)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence            4689999999999999999999876       457789999997542    35688999999999789999999999954


Q ss_pred             CCCCccEEEEEeecCCChhhhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEe
Q 014406          192 QHSKTPSLIFEYVNSTDFKVLYP-------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI  252 (425)
Q Consensus       192 ~~~~~~~lv~e~~~~~~l~~~~~-------------------~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll  252 (425)
                        ....++||||+.+++|.+++.                   .+++..+..++.||+.||.|||+.||+|+||||+|||+
T Consensus       113 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll  190 (334)
T 2pvf_A          113 --DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV  190 (334)
T ss_dssp             --SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred             --CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEE
Confidence              467899999999999988762                   27889999999999999999999999999999999999


Q ss_pred             cCCCCcEEEEeccccccccCCCc---ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHH
Q 014406          253 DHELRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHD  328 (425)
Q Consensus       253 ~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~  328 (425)
                      +.+ +.+||+|||+++.......   .....++..|+|||++.+ ..++.++|||||||++|+|++ |..||. +.+..+
T Consensus       191 ~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~-~~~~~~  267 (334)
T 2pvf_A          191 TEN-NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYP-GIPVEE  267 (334)
T ss_dssp             CTT-CCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCSST-TCCHHH
T ss_pred             cCC-CCEEEccccccccccccccccccCCCCcccceeChHHhcC-CCcChHHHHHHHHHHHHHHHhCCCCCcC-cCCHHH
Confidence            988 7899999999987654332   223356778999999977 678999999999999999999 888873 333222


Q ss_pred             HHHHHHHHhCCchhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhc
Q 014406          329 QLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  408 (425)
Q Consensus       329 ~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~  408 (425)
                      ....+....                                    .......++.++.+|+.+||+.||++|||++|+++
T Consensus       268 ~~~~~~~~~------------------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  311 (334)
T 2pvf_A          268 LFKLLKEGH------------------------------------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE  311 (334)
T ss_dssp             HHHHHHHTC------------------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHhcCC------------------------------------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            222221100                                    00111237899999999999999999999999987


Q ss_pred             C
Q 014406          409 H  409 (425)
Q Consensus       409 h  409 (425)
                      +
T Consensus       312 ~  312 (334)
T 2pvf_A          312 D  312 (334)
T ss_dssp             H
T ss_pred             H
Confidence            5

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=3.7e-43  Score=336.76  Aligned_cols=253  Identities=19%  Similarity=0.299  Sum_probs=203.3

Q ss_pred             CCCCCEEEEeeeeeeCceEEEEEEEcCCCc-----EEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcC
Q 014406          122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNE-----RCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQ  192 (425)
Q Consensus       122 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~-----~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  192 (425)
                      ...++|++.+.||+|+||+||+|.+..++.     .||+|++...    ..+.+.+|+.+++.+.+||||+++++++.. 
T Consensus        43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-  121 (333)
T 2i1m_A           43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH-  121 (333)
T ss_dssp             CCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred             CCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec-
Confidence            356899999999999999999999877664     7999999754    245688999999999779999999999954 


Q ss_pred             CCCccEEEEEeecCCChhhhcC-----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCC
Q 014406          193 HSKTPSLIFEYVNSTDFKVLYP-----------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE  255 (425)
Q Consensus       193 ~~~~~~lv~e~~~~~~l~~~~~-----------------~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~  255 (425)
                       ....++||||+++++|.+++.                 .+++..+..++.|++.||+|||++||+|+||||+|||++.+
T Consensus       122 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~  200 (333)
T 2i1m_A          122 -GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNG  200 (333)
T ss_dssp             -SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGG
T ss_pred             -CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCC
Confidence             467899999999999988762                 37899999999999999999999999999999999999988


Q ss_pred             CCcEEEEeccccccccCCCcc---eeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHH
Q 014406          256 LRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLV  331 (425)
Q Consensus       256 ~~~~kl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~  331 (425)
                       +.+||+|||+++........   ....+|..|+|||.+.+ ..++.++|||||||++|+|++ |..||.. ......+.
T Consensus       201 -~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~-~~~~~~~~  277 (333)
T 2i1m_A          201 -HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFD-CVYTVQSDVWSYGILLWEIFSLGLNPYPG-ILVNSKFY  277 (333)
T ss_dssp             -GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTT-CCSSHHHH
T ss_pred             -CeEEECccccccccccccceeecCCCCCCccccCHHHhcc-CCCChHHHHHHHHHHHHHHHcCCCCCCcc-cchhHHHH
Confidence             79999999999865433222   23456778999999987 679999999999999999998 8888743 33323222


Q ss_pred             HHHHHhCCchhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCC
Q 014406          332 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY  411 (425)
Q Consensus       332 ~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~  411 (425)
                      .+...-.                                   .......+++++.+++.+||+.||++|||+.|+++  +
T Consensus       278 ~~~~~~~-----------------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~--~  320 (333)
T 2i1m_A          278 KLVKDGY-----------------------------------QMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICS--F  320 (333)
T ss_dssp             HHHHHTC-----------------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--H
T ss_pred             HHHhcCC-----------------------------------CCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHH--H
Confidence            2211100                                   00111236889999999999999999999999987  3


Q ss_pred             Ccccc
Q 014406          412 FAQVR  416 (425)
Q Consensus       412 ~~~~~  416 (425)
                      |+++.
T Consensus       321 L~~~~  325 (333)
T 2i1m_A          321 LQEQA  325 (333)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            44443

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=7.8e-44  Score=359.42  Aligned_cols=244  Identities=17%  Similarity=0.340  Sum_probs=202.2

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc--chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEE
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (425)
                      ..++|++.+.||+|+||+||+|.+..++..||||+++..  ..+.+.+|+.+++++ +||||++++++|.+  ....++|
T Consensus       218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~--~~~~~lv  294 (495)
T 1opk_A          218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTR--EPPFYII  294 (495)
T ss_dssp             CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECS--SSSCEEE
T ss_pred             CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhc-CCCCEeeEEEEEec--CCcEEEE
Confidence            356899999999999999999999999999999999754  457899999999999 99999999999954  4678999


Q ss_pred             EEeecCCChhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCc
Q 014406          201 FEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (425)
Q Consensus       201 ~e~~~~~~l~~~~-----~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~  275 (425)
                      |||+.+++|.+++     ..+++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++.......
T Consensus       295 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~-~~~kl~DFG~a~~~~~~~~  373 (495)
T 1opk_A          295 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGEN-HLVKVADFGLSRLMTGDTY  373 (495)
T ss_dssp             EECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGG-GCEEECCTTCEECCTTCCE
T ss_pred             EEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCC-CcEEEeecccceeccCCce
Confidence            9999999999887     348899999999999999999999999999999999999988 7899999999987643321


Q ss_pred             c--eeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCC
Q 014406          276 Y--NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE  352 (425)
Q Consensus       276 ~--~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~  352 (425)
                      .  ....++..|+|||++.+ ..++.++|||||||++|||++ |..|| .+.+..+....+...                
T Consensus       374 ~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwSlG~~l~el~t~g~~p~-~~~~~~~~~~~~~~~----------------  435 (495)
T 1opk_A          374 TAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPY-PGIDLSQVYELLEKD----------------  435 (495)
T ss_dssp             ECCTTCCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCSS-TTCCGGGHHHHHHTT----------------
T ss_pred             eecCCCcCCcceeCHhHHhc-CCCCcHHhHHhHHHHHHHHHhCCCCCC-CCCCHHHHHHHHHcC----------------
Confidence            1  22345678999999977 679999999999999999999 77777 444433333222110                


Q ss_pred             CChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhc
Q 014406          353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  408 (425)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~  408 (425)
                                          ........+++++.+||.+||+.||++|||++++++
T Consensus       436 --------------------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~  471 (495)
T 1opk_A          436 --------------------YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  471 (495)
T ss_dssp             --------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --------------------CCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence                                001112347899999999999999999999999976

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1.6e-43  Score=337.64  Aligned_cols=258  Identities=16%  Similarity=0.250  Sum_probs=199.8

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc---hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEE
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (425)
                      ..++|++.+.||+|+||+||+|.+ .+++.||||++....   .+.+.+|+.+++.+ +||||+++++++.+  ....++
T Consensus        37 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~~~l  112 (321)
T 2qkw_B           37 ATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPESSQGIEEFETEIETLSFC-RHPHLVSLIGFCDE--RNEMIL  112 (321)
T ss_dssp             CCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCCSSHHHHHHHHHHGGGSC-CCTTBCCEEEECCC--TTCCEE
T ss_pred             HHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccChHHHHHHHHHHHHHHhC-CCCCEeeEEEEEcC--CCeEEE
Confidence            467899999999999999999975 578999999987543   46788999999999 89999999999954  467899


Q ss_pred             EEEeecCCChhhhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccC
Q 014406          200 IFEYVNSTDFKVLYP-------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (425)
Q Consensus       200 v~e~~~~~~l~~~~~-------~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~  272 (425)
                      ||||+++++|.+++.       .+++..+..++.|++.||+|||++||+|+||||+|||++.+ +.+||+|||+++....
T Consensus       113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~  191 (321)
T 2qkw_B          113 IYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDEN-FVPKITDFGISKKGTE  191 (321)
T ss_dssp             EEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTT-CCEEECCCTTCEECSS
T ss_pred             EEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCC-CCEEEeeccccccccc
Confidence            999999999998873       38899999999999999999999999999999999999988 7999999999976432


Q ss_pred             CC---cceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCH--HHHHHHHHHhCCchhHHHHh
Q 014406          273 GK---EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNH--DQLVKIAKVLGTDELNAYLN  347 (425)
Q Consensus       273 ~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~--~~~~~~~~~lg~~~~~~~~~  347 (425)
                      ..   ......||..|+|||++.+ ..++.++|||||||++|+|++|+.||.......  ..............      
T Consensus       192 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~------  264 (321)
T 2qkw_B          192 LDQTHLSTVVKGTLGYIDPEYFIK-GRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ------  264 (321)
T ss_dssp             SSCCCCBCCCEEETTTCCHHHHHH-CBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTC------
T ss_pred             ccccccccccCCCccccCHHHhcC-CCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcccccc------
Confidence            22   2234468999999999977 679999999999999999999999985432211  00000000000000      


Q ss_pred             hccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcC
Q 014406          348 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  409 (425)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~h  409 (425)
                           ..            ..............++..+.+++.+||+.||++|||++|++++
T Consensus       265 -----~~------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  309 (321)
T 2qkw_B          265 -----LE------------QIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWK  309 (321)
T ss_dssp             -----CC------------SSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -----HH------------HhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence                 00            0000000001111245678999999999999999999999976

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=3.6e-43  Score=350.67  Aligned_cols=241  Identities=17%  Similarity=0.344  Sum_probs=198.1

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEE
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (425)
                      ..++|++.+.||+|+||+||+|.+.  ++.||||+++.. ..+.+.+|+.+++++ +||||+++++++.... ...++||
T Consensus       191 ~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~-~~~~iv~  266 (450)
T 1k9a_A          191 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASVMTQL-RHSNLVQLLGVIVEEK-GGLYIVT  266 (450)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCTTSHHHHHHHHHHHTC-CCTTBCCEEEEEECTT-SCEEEEE
T ss_pred             ChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCchHHHHHHHHHHHHHhc-cCCCEEEEEEEEEcCC-CceEEEE
Confidence            4678999999999999999999764  779999999754 457799999999999 9999999999986542 4689999


Q ss_pred             EeecCCChhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCcc
Q 014406          202 EYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY  276 (425)
Q Consensus       202 e~~~~~~l~~~~~-----~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~~  276 (425)
                      ||+.+++|.+++.     .+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++.....  .
T Consensus       267 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~-~~~kl~DfG~a~~~~~~--~  343 (450)
T 1k9a_A          267 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSED-NVAKVSDFGLTKEASST--Q  343 (450)
T ss_dssp             ECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTT-SCEEECCCTTCEECC-----
T ss_pred             EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCC-CCEEEeeCCCccccccc--c
Confidence            9999999998873     27899999999999999999999999999999999999988 79999999999854322  2


Q ss_pred             eeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCCh
Q 014406          277 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP  355 (425)
Q Consensus       277 ~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~  355 (425)
                      ....++..|+|||++.+ ..++.++|||||||++|||++ |+.||. +.+..+....+.+.            .      
T Consensus       344 ~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~t~g~~P~~-~~~~~~~~~~i~~~------------~------  403 (450)
T 1k9a_A          344 DTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYP-RIPLKDVVPRVEKG------------Y------  403 (450)
T ss_dssp             ---CCCTTTSCHHHHHS-SCCCHHHHHHHHHHHHHHHHTTTCCSST-TSCTTTHHHHHHTT------------C------
T ss_pred             cCCCCCcceeCHHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCC-CCCHHHHHHHHHcC------------C------
Confidence            23466788999999987 789999999999999999998 988873 33333333322110            0      


Q ss_pred             hhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhc
Q 014406          356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  408 (425)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~  408 (425)
                                        ....+..+++++.+||.+||+.||++|||+.++++
T Consensus       404 ------------------~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~  438 (450)
T 1k9a_A          404 ------------------KMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLRE  438 (450)
T ss_dssp             ------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------------------CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                              01112347899999999999999999999999975

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=4.5e-44  Score=355.52  Aligned_cols=256  Identities=21%  Similarity=0.313  Sum_probs=192.7

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcchHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEEE
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE  202 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e  202 (425)
                      ..+.|.+.+.||+|+||+||.+ ...+|+.||||++.....+.+.+|+.++.++.+||||+++++++.+  ....++|||
T Consensus        13 l~~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~--~~~~~lv~E   89 (434)
T 2rio_A           13 LKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETT--DRFLYIALE   89 (434)
T ss_dssp             CSSCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGGGHHHHHHHHHHHHHHTTSTTBCCEEEEEEC--SSEEEEEEC
T ss_pred             hhheeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHHHHHHHHHHHHHHHhccCCCCcCeEEEEEec--CCeEEEEEe
Confidence            3566778899999999999875 4567999999999877777889999999987689999999999965  477899999


Q ss_pred             eecCCChhhhcCCC----------CHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCC------------CCcEE
Q 014406          203 YVNSTDFKVLYPTL----------TDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE------------LRKLR  260 (425)
Q Consensus       203 ~~~~~~l~~~~~~l----------~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~------------~~~~k  260 (425)
                      |++ ++|.+++...          ++..+..++.||+.||+|||++||+||||||+|||++.+            ...+|
T Consensus        90 ~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k  168 (434)
T 2rio_A           90 LCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRIL  168 (434)
T ss_dssp             CCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred             cCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEE
Confidence            996 5888776321          223456799999999999999999999999999999753            24799


Q ss_pred             EEeccccccccCCCc-----ceeeccCCCccCcccccC------CCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHH
Q 014406          261 LIDWGLAEFYHPGKE-----YNVRVASRYFKGPELLVD------LQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHD  328 (425)
Q Consensus       261 l~Dfg~a~~~~~~~~-----~~~~~~t~~y~aPE~~~~------~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~  328 (425)
                      |+|||+++.......     .....||+.|+|||++.+      ...++.++|||||||++|||++ |..||.... ..+
T Consensus       169 L~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~-~~~  247 (434)
T 2rio_A          169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY-SRE  247 (434)
T ss_dssp             ECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTT-THH
T ss_pred             EcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCch-hhH
Confidence            999999987654322     234579999999999865      2468999999999999999999 888883221 111


Q ss_pred             HHHHHHHHhCCchhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhc
Q 014406          329 QLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  408 (425)
Q Consensus       329 ~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~  408 (425)
                        ..+....             ...             ...    .......+++++.+|+.+||+.||++|||+.|+++
T Consensus       248 --~~i~~~~-------------~~~-------------~~~----~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          248 --SNIIRGI-------------FSL-------------DEM----KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             --HHHHHTC-------------CCC-------------CCC----TTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             --HHHhcCC-------------CCc-------------ccc----cccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence              1111100             000             000    00001124678999999999999999999999999


Q ss_pred             CCCCccc
Q 014406          409 HPYFAQV  415 (425)
Q Consensus       409 hp~~~~~  415 (425)
                      ||||...
T Consensus       296 hp~f~~~  302 (434)
T 2rio_A          296 HPLFWPK  302 (434)
T ss_dssp             SGGGSCH
T ss_pred             CCccCCc
Confidence            9999754

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=1.6e-44  Score=346.63  Aligned_cols=282  Identities=18%  Similarity=0.298  Sum_probs=203.3

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcchHHHHHHHHHHH--HhcCCCCeeeEEeEEEc---CCCCcc
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQ--NLCGGPNVVKLLDIVRD---QHSKTP  197 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~--~l~~h~niv~l~~~~~~---~~~~~~  197 (425)
                      ..++|++.+.||+|+||+||+|.+  +++.||||++.......+..|.+++.  .+ +|+||+++++.+..   ......
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~~-~h~~i~~~~~~~~~~~~~~~~~~   87 (336)
T 3g2f_A           11 DLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINEKNIYRVPLM-EHDNIARFIVGDERVTADGRMEY   87 (336)
T ss_dssp             CTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECTTSCEEE
T ss_pred             ChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccchhhHHHHHHHHHHHhc-cCcchhhheecccccccCCCceE
Confidence            468999999999999999999965  68999999998777777777766654  46 89999999986643   223457


Q ss_pred             EEEEEeecCCChhhhc--CCCCHHHHHHHHHHHHHHHHHHHHC---------CceeecCCCCceEecCCCCcEEEEeccc
Q 014406          198 SLIFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQ---------GIMHRDVKPHNVMIDHELRKLRLIDWGL  266 (425)
Q Consensus       198 ~lv~e~~~~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~LH~~---------~ivH~Dlk~~NIll~~~~~~~kl~Dfg~  266 (425)
                      ++||||+++++|.+++  ...++..+..++.||+.||+|||+.         ||+||||||+|||++.+ +.+||+|||+
T Consensus        88 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~-~~~kL~DFG~  166 (336)
T 3g2f_A           88 LLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKND-GTCVISDFGL  166 (336)
T ss_dssp             EEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTT-SCEEECCCTT
T ss_pred             EEEEecCCCCcHHHHHhhcccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCC-CcEEEeeccc
Confidence            8999999999999887  4578899999999999999999999         99999999999999988 7999999999


Q ss_pred             cccccCCC---------cceeeccCCCccCcccccCC------CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHH
Q 014406          267 AEFYHPGK---------EYNVRVASRYFKGPELLVDL------QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV  331 (425)
Q Consensus       267 a~~~~~~~---------~~~~~~~t~~y~aPE~~~~~------~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~  331 (425)
                      ++......         ......||..|+|||++.+.      ..++.++|||||||++|||++|+.||+.+....+...
T Consensus       167 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~  246 (336)
T 3g2f_A          167 SMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQM  246 (336)
T ss_dssp             CEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCC
T ss_pred             eeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHH
Confidence            98664321         12234689999999998752      2456789999999999999999999887665433222


Q ss_pred             HHHHHhCCchhHHHHhhccCCCChhhHHHhcccCC-CCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHH----
Q 014406          332 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSR-KPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA----  406 (425)
Q Consensus       332 ~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~el----  406 (425)
                      .+....+..+...           ........... .....  .......+++++.+||.+||+.||++|||++|+    
T Consensus       247 ~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L  313 (336)
T 3g2f_A          247 AFQTEVGNHPTFE-----------DMQVLVSREKQRPKFPE--AWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERM  313 (336)
T ss_dssp             TTHHHHCSSCCHH-----------HHHHHHTTSCCCCCCCT--TCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred             hhhcccCCCchHH-----------HHHhhhcccccCCCCCc--ccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHH
Confidence            2222222211110           00111111000 00000  001111245679999999999999999999999    


Q ss_pred             --hcCCCCcccccchhc
Q 014406          407 --MAHPYFAQVRAAESS  421 (425)
Q Consensus       407 --L~hp~~~~~~~~~~~  421 (425)
                        +.++|-++-.....+
T Consensus       314 ~~ll~~~~~~~~~~~~~  330 (336)
T 3g2f_A          314 AELMMIWERNKSVSPTA  330 (336)
T ss_dssp             HHHHHCCCC--------
T ss_pred             HHHHHHHHhcccCCCcc
Confidence              567888877665544

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=5.7e-43  Score=329.56  Aligned_cols=249  Identities=16%  Similarity=0.264  Sum_probs=198.9

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEE
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (425)
                      ..++|++.+.||+|+||+||+|.+..+++.||+|++... ..+.+.+|+.+++.+ +|++++..+..+.. .+...++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l-~~~~~i~~~~~~~~-~~~~~~lv~   84 (296)
T 3uzp_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMM-QGGVGIPTIRWCGA-EGDYNVMVM   84 (296)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHH-TTSTTCCCEEEEEE-ETTEEEEEE
T ss_pred             eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHh-hcCCCCCccccccC-CCCceEEEE
Confidence            368899999999999999999999999999999998643 446789999999999 67776666665543 246789999


Q ss_pred             EeecCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEec---CCCCcEEEEeccccccccCCC
Q 014406          202 EYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMID---HELRKLRLIDWGLAEFYHPGK  274 (425)
Q Consensus       202 e~~~~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~---~~~~~~kl~Dfg~a~~~~~~~  274 (425)
                      ||+ +++|.+++    ..+++..+..++.|++.||+|||++||+|+||||+|||++   .+ +.+||+|||+++......
T Consensus        85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~-~~~kl~Dfg~~~~~~~~~  162 (296)
T 3uzp_A           85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKG-NLVYIIDFGLAKKYRDAR  162 (296)
T ss_dssp             ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGT-TCEEECCCTTCEECBCTT
T ss_pred             Eec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCC-CeEEEeeCCCcccccccc
Confidence            999 88888776    3589999999999999999999999999999999999995   45 789999999998765433


Q ss_pred             c--------ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCC--CCHHHHHHHHHHhCCchhHH
Q 014406          275 E--------YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH--DNHDQLVKIAKVLGTDELNA  344 (425)
Q Consensus       275 ~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~--~~~~~~~~~~~~lg~~~~~~  344 (425)
                      .        .....+|..|+|||.+.+ ..++.++|||||||++|+|++|+.||....  +..+.+..+....-..+.. 
T Consensus       163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-  240 (296)
T 3uzp_A          163 THQHIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE-  240 (296)
T ss_dssp             TCCBCCCCCSCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHH-
T ss_pred             cccccccccccccccccccCChhhhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchH-
Confidence            2        244578999999999987 679999999999999999999999995322  1222233222210000000 


Q ss_pred             HHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhc
Q 014406          345 YLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  408 (425)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~  408 (425)
                                                     .....+++++.+|+.+||+.||++|||++++++
T Consensus       241 -------------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  273 (296)
T 3uzp_A          241 -------------------------------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             -------------------------------HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             -------------------------------HHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence                                           001236899999999999999999999999876

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=2.4e-43  Score=334.73  Aligned_cols=249  Identities=24%  Similarity=0.431  Sum_probs=191.9

Q ss_pred             CCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCC
Q 014406          122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (425)
Q Consensus       122 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (425)
                      ...++|++.+.||+|+||+||+|.+..+++.||+|++...      ....+.+|+.+++++ +||||+++++++...  .
T Consensus        29 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~--~  105 (310)
T 2wqm_A           29 NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-NHPNVIKYYASFIED--N  105 (310)
T ss_dssp             SSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEET--T
T ss_pred             ccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEcC--C
Confidence            3457899999999999999999999999999999998742      235688999999999 999999999999764  6


Q ss_pred             ccEEEEEeecCCChhhhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccc
Q 014406          196 TPSLIFEYVNSTDFKVLYP-------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE  268 (425)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~~-------~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~  268 (425)
                      ..++||||+.+++|.+++.       .+++..+..++.|++.||.|||+.||+|+||||+||+++.+ +.+||+|||++.
T Consensus       106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~-~~~kl~Dfg~~~  184 (310)
T 2wqm_A          106 ELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITAT-GVVKLGDLGLGR  184 (310)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-SCEEECCC----
T ss_pred             cEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCC-CCEEEEecccee
Confidence            7889999999999988763       38999999999999999999999999999999999999988 789999999997


Q ss_pred             cccCCC-cceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHh
Q 014406          269 FYHPGK-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLN  347 (425)
Q Consensus       269 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~  347 (425)
                      ...... ......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.....+...+.........+       
T Consensus       185 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-------  256 (310)
T 2wqm_A          185 FFSSKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYP-------  256 (310)
T ss_dssp             --------------CCSSCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSC-------
T ss_pred             eecCCCccccccCCCeeEeChHHhCC-CCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCC-------
Confidence            654332 2234578999999999987 6799999999999999999999999964433332222211100000       


Q ss_pred             hccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcC
Q 014406          348 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  409 (425)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~h  409 (425)
                                                 ......+++++.+|+.+||+.||++|||+++++++
T Consensus       257 ---------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~  291 (310)
T 2wqm_A          257 ---------------------------PLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDV  291 (310)
T ss_dssp             ---------------------------CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---------------------------CCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence                                       00112368999999999999999999999999863

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=3.2e-43  Score=329.11  Aligned_cols=244  Identities=23%  Similarity=0.399  Sum_probs=196.5

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcC---CCcEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCC
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVN---TNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~---~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (425)
                      ..++|++.+.||+|+||+||+|.+..   ++..||+|++...    ..+.+.+|+.+++.+ +||||+++++++.+   .
T Consensus        10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~---~   85 (281)
T 3cc6_A           10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNL-DHPHIVKLIGIIEE---E   85 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHH-CCTTBCCEEEEECS---S
T ss_pred             cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhC-CCCCcceEEEEEcC---C
Confidence            46789999999999999999998654   3446999998754    346788999999999 99999999999854   3


Q ss_pred             ccEEEEEeecCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEecccccccc
Q 014406          196 TPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (425)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~  271 (425)
                      ..++||||+.+++|.+++    ..+++..+..++.|++.||.|||++||+|+||||+|||++.+ +.+||+|||++....
T Consensus        86 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~  164 (281)
T 3cc6_A           86 PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASP-ECVKLGDFGLSRYIE  164 (281)
T ss_dssp             SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEET-TEEEECCCCGGGCC-
T ss_pred             CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCC-CcEEeCccCCCcccc
Confidence            468999999999998887    348999999999999999999999999999999999999988 799999999998665


Q ss_pred             CCCc--ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhh
Q 014406          272 PGKE--YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK  348 (425)
Q Consensus       272 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~  348 (425)
                      ....  .....++..|+|||++.+ ..++.++|||||||++|+|++ |+.||... +..+....+....           
T Consensus       165 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~llt~g~~p~~~~-~~~~~~~~~~~~~-----------  231 (281)
T 3cc6_A          165 DEDYYKASVTRLPIKWMSPESINF-RRFTTASDVWMFAVCMWEILSFGKQPFFWL-ENKDVIGVLEKGD-----------  231 (281)
T ss_dssp             --------CCCCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTS-CGGGHHHHHHHTC-----------
T ss_pred             cccccccccCCCCcceeCchhhcc-CCCCchhccHHHHHHHHHHHhCCCCCcccC-ChHHHHHHHhcCC-----------
Confidence            4322  233456778999999976 679999999999999999998 99998432 2222222221100           


Q ss_pred             ccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcC
Q 014406          349 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  409 (425)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~h  409 (425)
                                               .......+++.+.+++.+||+.||++|||+.|++++
T Consensus       232 -------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~  267 (281)
T 3cc6_A          232 -------------------------RLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS  267 (281)
T ss_dssp             -------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -------------------------CCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence                                     000112368899999999999999999999999875

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=2e-43  Score=353.02  Aligned_cols=242  Identities=15%  Similarity=0.294  Sum_probs=200.2

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc--chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEE
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (425)
                      ..++|++.+.||+|+||+||+|.+. ++..||||+++..  ..+.+.+|+.+++++ +||||+++++++.+   ...++|
T Consensus       186 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~---~~~~lv  260 (454)
T 1qcf_A          186 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTL-QHDKLVKLHAVVTK---EPIYII  260 (454)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHTTC-CCTTBCCEEEEECS---SSCEEE
T ss_pred             chHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCccHHHHHHHHHHHhhC-CCCCEeeEEEEEeC---CccEEE
Confidence            4678999999999999999999764 5778999999753  467899999999999 99999999999852   568899


Q ss_pred             EEeecCCChhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCc
Q 014406          201 FEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (425)
Q Consensus       201 ~e~~~~~~l~~~~~-----~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~  275 (425)
                      |||+.+|+|.+++.     .+++..+..++.||+.||+|||+++|+||||||+|||++.+ +.+||+|||+++.......
T Consensus       261 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~-~~~kl~DFG~a~~~~~~~~  339 (454)
T 1qcf_A          261 TEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSAS-LVCKIADFGLARVIEDNEY  339 (454)
T ss_dssp             ECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTT-CCEEECSTTGGGGBCCHHH
T ss_pred             EeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCC-CcEEEeeCCCceEcCCCce
Confidence            99999999998874     58899999999999999999999999999999999999988 7999999999987643211


Q ss_pred             --ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCC
Q 014406          276 --YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE  352 (425)
Q Consensus       276 --~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~  352 (425)
                        .....++..|+|||++.. ..++.++|||||||++|||++ |+.|| .+.+..+....+.....              
T Consensus       340 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~t~g~~P~-~~~~~~~~~~~i~~~~~--------------  403 (454)
T 1qcf_A          340 TAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLMEIVTYGRIPY-PGMSNPEVIRALERGYR--------------  403 (454)
T ss_dssp             HTTCSSSSCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSS-TTCCHHHHHHHHHHTCC--------------
T ss_pred             eccCCCcccccccCHHHhcc-CCCCcHHHHHhHHHHHHHHHhCCCCCC-CCCCHHHHHHHHHcCCC--------------
Confidence              122345678999999976 679999999999999999999 88887 34444443333322100              


Q ss_pred             CChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhc
Q 014406          353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  408 (425)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~  408 (425)
                                            ...+..+++++.+||.+||+.||++|||++++++
T Consensus       404 ----------------------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~  437 (454)
T 1qcf_A          404 ----------------------MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQS  437 (454)
T ss_dssp             ----------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----------------------CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence                                  0112237899999999999999999999999875

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=6.1e-44  Score=347.62  Aligned_cols=244  Identities=18%  Similarity=0.344  Sum_probs=187.6

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEc---CCCcEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCC
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINV---NTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~---~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (425)
                      ..++|++.+.||+|+||+||+|.+.   .++..||||+++..    ..+.+.+|+.+++++ +||||+++++++.+  ..
T Consensus        43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~--~~  119 (373)
T 2qol_A           43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF-DHPNIIRLEGVVTK--SK  119 (373)
T ss_dssp             CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECS--SS
T ss_pred             CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEee--CC
Confidence            4568999999999999999999876   46778999999753    235688999999999 99999999999954  46


Q ss_pred             ccEEEEEeecCCChhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEecccccccc
Q 014406          196 TPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (425)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~~----~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~  271 (425)
                      ..++||||+++++|.+++.    .+++.++..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus       120 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-~~~kl~Dfg~a~~~~  198 (373)
T 2qol_A          120 PVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSN-LVCKVSDFGLGRVLE  198 (373)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-CCEEECCC-------
T ss_pred             ceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCC-CCEEECcCccccccc
Confidence            7899999999999998873    48999999999999999999999999999999999999988 799999999998765


Q ss_pred             CCCcc----eeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCCchhHHHH
Q 014406          272 PGKEY----NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYL  346 (425)
Q Consensus       272 ~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~  346 (425)
                      .....    ....++..|+|||++.+ ..++.++|||||||++|||++ |+.||. +.+..+....+...          
T Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~SlG~il~ellt~g~~P~~-~~~~~~~~~~i~~~----------  266 (373)
T 2qol_A          199 DDPEAAYTTRGGKIPIRWTSPEAIAY-RKFTSASDVWSYGIVLWEVMSYGERPYW-EMSNQDVIKAVDEG----------  266 (373)
T ss_dssp             ---------------CTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTC-CTTT-TCCHHHHHHHHHTT----------
T ss_pred             cCCccceeccCCCcCCCccChhhhcc-CCcCchhcHHHHHHHHHHHHhCCCCCCC-CCCHHHHHHHHHcC----------
Confidence            33211    12234678999999987 789999999999999999998 998884 22322222221110          


Q ss_pred             hhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhc
Q 014406          347 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  408 (425)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~  408 (425)
                        .                        .......++.++.+++.+||+.||++|||++|+++
T Consensus       267 --~------------------------~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~  302 (373)
T 2qol_A          267 --Y------------------------RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS  302 (373)
T ss_dssp             --E------------------------ECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --C------------------------CCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence              0                        00111236889999999999999999999999876

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=3.1e-43  Score=326.34  Aligned_cols=244  Identities=16%  Similarity=0.330  Sum_probs=199.7

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc--chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEE
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (425)
                      ..++|++.+.||+|+||+||+|.+. ++..||+|++...  ..+.+.+|+.+++++ +||||+++++++.+  ....++|
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv   81 (267)
T 3t9t_A            6 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKL-SHPKLVQLYGVCLE--QAPICLV   81 (267)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCHHHHHHHHHHHHTC-CCTTBCCEEEEECS--SSSCEEE
T ss_pred             chhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCHHHHHHHHHHHHhC-CCCCEeeEEEEEcc--CCCeEEE
Confidence            4678999999999999999999875 6788999999754  457899999999999 89999999999965  4678999


Q ss_pred             EEeecCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCC--
Q 014406          201 FEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK--  274 (425)
Q Consensus       201 ~e~~~~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~--  274 (425)
                      |||+++++|.+++    ..+++..+..++.|++.||.|||+.||+|+||||+||+++.+ +.+||+|||+++......  
T Consensus        82 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~-~~~kl~dfg~~~~~~~~~~~  160 (267)
T 3t9t_A           82 TEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGEN-QVIKVSDFGMTRFVLDDQYT  160 (267)
T ss_dssp             ECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGG-GCEEECCTTGGGGBCCHHHH
T ss_pred             EeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCC-CCEEEccccccccccccccc
Confidence            9999999998876    348999999999999999999999999999999999999988 789999999998654321  


Q ss_pred             cceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCC
Q 014406          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL  353 (425)
Q Consensus       275 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~  353 (425)
                      ......++..|+|||++.+ ..++.++||||||+++|+|++ |..||. +.+..+....+....                
T Consensus       161 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~-~~~~~~~~~~i~~~~----------------  222 (267)
T 3t9t_A          161 SSTGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYE-NRSNSEVVEDISTGF----------------  222 (267)
T ss_dssp             STTSTTCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTT-TCCHHHHHHHHHTTC----------------
T ss_pred             ccccccccccccChhhhcC-CCccchhchhhhHHHHHHHhccCCCCCC-CCCHHHHHHHHhcCC----------------
Confidence            1123456678999999976 678999999999999999999 788873 333222222221100                


Q ss_pred             ChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcC
Q 014406          354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  409 (425)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~h  409 (425)
                                          .......+++++.+++.+||+.||++|||++|++++
T Consensus       223 --------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  258 (267)
T 3t9t_A          223 --------------------RLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ  258 (267)
T ss_dssp             --------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --------------------cCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                                001112368899999999999999999999999864

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=5.4e-43  Score=329.61  Aligned_cols=249  Identities=16%  Similarity=0.265  Sum_probs=194.4

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEE
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (425)
                      ..++|++.+.||+|+||+||+|.+..+++.||||++... ..+.+.+|+.+++.+ +|++++..+..+... ....++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l-~~~~~i~~~~~~~~~-~~~~~lv~   84 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMM-QGGVGIPTIRWCGAE-GDYNVMVM   84 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHH-TTSTTCCCEEEEEEE-TTEEEEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHh-cCCCCCCeeeeecCC-CCceEEEE
Confidence            468899999999999999999999999999999987643 346789999999999 677766666655432 46789999


Q ss_pred             EeecCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEe---cCCCCcEEEEeccccccccCCC
Q 014406          202 EYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI---DHELRKLRLIDWGLAEFYHPGK  274 (425)
Q Consensus       202 e~~~~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll---~~~~~~~kl~Dfg~a~~~~~~~  274 (425)
                      ||+ +++|.+++    ..+++..+..++.|++.||.|||++||+||||||+|||+   +.+ +.+||+|||+++......
T Consensus        85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~-~~~kL~Dfg~a~~~~~~~  162 (296)
T 4hgt_A           85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKG-NLVYIIDFGLAKKYRDAR  162 (296)
T ss_dssp             ECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGT-TCEEECCCTTCEECBCTT
T ss_pred             Ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCC-CeEEEecCccceeccCcc
Confidence            999 88888775    358999999999999999999999999999999999999   555 789999999998765432


Q ss_pred             c--------ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCC--CHHHHHHHHHHhCCchhHH
Q 014406          275 E--------YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD--NHDQLVKIAKVLGTDELNA  344 (425)
Q Consensus       275 ~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~--~~~~~~~~~~~lg~~~~~~  344 (425)
                      .        .....+|..|+|||.+.+ ..++.++|||||||++|+|++|+.||.....  ..+.+..+....-..+.  
T Consensus       163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--  239 (296)
T 4hgt_A          163 THQHIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI--  239 (296)
T ss_dssp             TCCBCCCCCSCCCCSCGGGCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH--
T ss_pred             cCccCCCCcccccCCCccccchHHhcC-CCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchh--
Confidence            2        234578999999999987 6799999999999999999999999953221  11222222111000000  


Q ss_pred             HHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhc
Q 014406          345 YLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  408 (425)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~  408 (425)
                                                    ......+++++.+|+.+||+.||++|||++++++
T Consensus       240 ------------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  273 (296)
T 4hgt_A          240 ------------------------------EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             ------------------------------HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             ------------------------------hhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence                                          0001236899999999999999999999999986

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=4.1e-43  Score=332.87  Aligned_cols=242  Identities=21%  Similarity=0.302  Sum_probs=190.9

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEE
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (425)
                      +.++|++.+.||+|+||+||+|.+  .++.||+|++... ..+.+.+|+.+++++ +||||+++++++.    ...++||
T Consensus         6 ~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~----~~~~lv~   78 (307)
T 2eva_A            6 DYKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESESERKAFIVELRQLSRV-NHPNIVKLYGACL----NPVCLVM   78 (307)
T ss_dssp             CGGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSSTTHHHHHHHHHHHHHHC-CCTTBCCEEEBCT----TTTEEEE
T ss_pred             CHhHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecChhHHHHHHHHHHHHhcC-CCCCcCeEEEEEc----CCcEEEE
Confidence            467899999999999999999976  4788999999754 356789999999999 9999999999884    3478999


Q ss_pred             EeecCCChhhhcC------CCCHHHHHHHHHHHHHHHHHHHH---CCceeecCCCCceEecCCCCcEEEEeccccccccC
Q 014406          202 EYVNSTDFKVLYP------TLTDYDIRYYIYELLKALDYCHS---QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (425)
Q Consensus       202 e~~~~~~l~~~~~------~l~~~~~~~i~~~i~~~L~~LH~---~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~  272 (425)
                      ||+++++|.+++.      .+++..+..++.|++.||+|||+   +||+||||||+|||++.+...+||+|||++.....
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~  158 (307)
T 2eva_A           79 EYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT  158 (307)
T ss_dssp             ECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC------
T ss_pred             EcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccc
Confidence            9999999998873      36888999999999999999999   89999999999999998744589999999976542


Q ss_pred             CCcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCC
Q 014406          273 GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE  352 (425)
Q Consensus       273 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~  352 (425)
                        ......+|..|+|||++.+ ..++.++|||||||++|+|++|+.||............... .+.             
T Consensus       159 --~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~-~~~-------------  221 (307)
T 2eva_A          159 --HMTNNKGSAAWMAPEVFEG-SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVH-NGT-------------  221 (307)
T ss_dssp             --------CCTTSSCHHHHTC-CCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHH-TTC-------------
T ss_pred             --ccccCCCCCceEChhhhCC-CCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHh-cCC-------------
Confidence              2334578999999999987 68999999999999999999999998533222211111100 000             


Q ss_pred             CChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcC
Q 014406          353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  409 (425)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~h  409 (425)
                                           .......+++.+.+++.+||+.||++|||++|++++
T Consensus       222 ---------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  257 (307)
T 2eva_A          222 ---------------------RPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKI  257 (307)
T ss_dssp             ---------------------CCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---------------------CCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence                                 001112378999999999999999999999999873

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=2.5e-43  Score=336.25  Aligned_cols=253  Identities=19%  Similarity=0.337  Sum_probs=203.9

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEc-----CCCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCC
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINV-----NTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQH  193 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~-----~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  193 (425)
                      ..++|++.+.||+|+||+||+|.+.     .+++.||+|++....    ...+.+|+.+++.+ +||||+++++++.+  
T Consensus        23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~--   99 (322)
T 1p4o_A           23 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF-NCHHVVRLLGVVSQ--   99 (322)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGC-CCTTBCCEEEEECS--
T ss_pred             hhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhc-CCCCEeeeEEEEcc--
Confidence            4678999999999999999999876     467899999997532    34588999999999 99999999999954  


Q ss_pred             CCccEEEEEeecCCChhhhcC-------------CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEE
Q 014406          194 SKTPSLIFEYVNSTDFKVLYP-------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLR  260 (425)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~~-------------~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~k  260 (425)
                      ....++||||+.+++|.+++.             .+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+|
T Consensus       100 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~-~~~k  178 (322)
T 1p4o_A          100 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED-FTVK  178 (322)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTT-CCEE
T ss_pred             CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCC-CeEE
Confidence            467889999999999988762             46889999999999999999999999999999999999988 7999


Q ss_pred             EEeccccccccCCCc---ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHH
Q 014406          261 LIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKV  336 (425)
Q Consensus       261 l~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~  336 (425)
                      |+|||+++.......   .....+|..|+|||++.+ ..++.++|||||||++|+|++ |..|| .+.+..+....+.. 
T Consensus       179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~-~~~~~~~~~~~~~~-  255 (322)
T 1p4o_A          179 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPY-QGLSNEQVLRFVME-  255 (322)
T ss_dssp             ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTSCCTT-TTSCHHHHHHHHHT-
T ss_pred             ECcCccccccccccccccccCCCCCCCccChhhhcc-CCCCchhhHHHHHHHHHHHHhcCCCcc-ccCCHHHHHHHHHc-
Confidence            999999976543321   123356788999999987 679999999999999999999 77776 33333222222211 


Q ss_pred             hCCchhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcC------C
Q 014406          337 LGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH------P  410 (425)
Q Consensus       337 lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~h------p  410 (425)
                                  ...                       ......+++++.+|+.+||+.||++|||+.|+++|      +
T Consensus       256 ------------~~~-----------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~  300 (322)
T 1p4o_A          256 ------------GGL-----------------------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP  300 (322)
T ss_dssp             ------------TCC-----------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred             ------------CCc-----------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhcc
Confidence                        000                       01112378999999999999999999999999987      6


Q ss_pred             CCccccc
Q 014406          411 YFAQVRA  417 (425)
Q Consensus       411 ~~~~~~~  417 (425)
                      +|+++..
T Consensus       301 ~~~~~~~  307 (322)
T 1p4o_A          301 GFREVSF  307 (322)
T ss_dssp             THHHHCS
T ss_pred             CCccccc
Confidence            6665543

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.4e-43  Score=329.11  Aligned_cols=244  Identities=20%  Similarity=0.314  Sum_probs=199.4

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCc---EEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCcc
Q 014406          125 DDYEVVRKVGRGKYSEVFEGINVNTNE---RCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (425)
Q Consensus       125 ~~y~~~~~LG~G~fg~V~~~~~~~~~~---~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (425)
                      -.|++.+.||+|+||+||+|.+..++.   .+|+|++....    .+.+.+|+.+++.+ +||||+++++++.+.. ...
T Consensus        21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~-~~~   98 (298)
T 3pls_A           21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGL-NHPNVLALIGIMLPPE-GLP   98 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTC-CCTTBCCCCEEECCSS-SCC
T ss_pred             eEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEecCC-CCc
Confidence            357778999999999999998765554   79999987533    35688999999999 9999999999996543 445


Q ss_pred             EEEEEeecCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCC
Q 014406          198 SLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (425)
Q Consensus       198 ~lv~e~~~~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~  273 (425)
                      ++||||+.+++|..++    ..+++..+..++.|++.||+|||++||+|+||||+|||++.+ +.+||+|||+++.....
T Consensus        99 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~-~~~kl~Dfg~~~~~~~~  177 (298)
T 3pls_A           99 HVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDES-FTVKVADFGLARDILDR  177 (298)
T ss_dssp             EEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT-CCEEECCTTSSCTTTTG
T ss_pred             EEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCC-CcEEeCcCCCcccccCC
Confidence            8999999999998887    348899999999999999999999999999999999999988 79999999999755432


Q ss_pred             C-----cceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhh
Q 014406          274 K-----EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK  348 (425)
Q Consensus       274 ~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~  348 (425)
                      .     ......++..|+|||.+.+ ..++.++|||||||++|+|++|..|++...+..+....+.....          
T Consensus       178 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~----------  246 (298)
T 3pls_A          178 EYYSVQQHRHARLPVKWTALESLQT-YRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRR----------  246 (298)
T ss_dssp             GGGCSCCSSCTTCGGGGSCHHHHTT-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCC----------
T ss_pred             cccccccCcCCCCCccccChhhhcc-CCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCC----------
Confidence            1     2233466788999999977 67999999999999999999988888766655444433322100          


Q ss_pred             ccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhc
Q 014406          349 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  408 (425)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~  408 (425)
                                                ......+++++.+|+.+||+.||++|||++++++
T Consensus       247 --------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  280 (298)
T 3pls_A          247 --------------------------LPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVG  280 (298)
T ss_dssp             --------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --------------------------CCCCccchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                                      0112236889999999999999999999999986

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=7.1e-43  Score=326.32  Aligned_cols=242  Identities=17%  Similarity=0.316  Sum_probs=199.0

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc--chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEE
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (425)
                      ..++|++.+.||+|+||+||+|.+. ++..||+|++...  ..+.+.+|+++++++ +||||+++++++.+   ...++|
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~---~~~~~v   85 (279)
T 1qpc_A           11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQL-QHQRLVRLYAVVTQ---EPIYII   85 (279)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECS---SSCEEE
T ss_pred             CHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcccHHHHHHHHHHHHhC-CCcCcceEEEEEcC---CCcEEE
Confidence            4578999999999999999999864 6778999999754  457899999999999 99999999999853   457899


Q ss_pred             EEeecCCChhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCc
Q 014406          201 FEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (425)
Q Consensus       201 ~e~~~~~~l~~~~~-----~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~  275 (425)
                      |||+.+++|.+++.     .+++..+..++.|++.||+|||++||+|+||||+||+++.+ +.+||+|||++........
T Consensus        86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~  164 (279)
T 1qpc_A           86 TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDT-LSCKIADFGLARLIEDNEY  164 (279)
T ss_dssp             EECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-SCEEECCCTTCEECSSSCE
T ss_pred             EecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCC-CCEEECCCcccccccCccc
Confidence            99999999999885     58999999999999999999999999999999999999988 7899999999987654322


Q ss_pred             c--eeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCC
Q 014406          276 Y--NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE  352 (425)
Q Consensus       276 ~--~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~  352 (425)
                      .  ....++..|+|||.+.+ ..++.++||||||+++|+|++ |+.|| .+.+..+....+.+..               
T Consensus       165 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~-~~~~~~~~~~~~~~~~---------------  227 (279)
T 1qpc_A          165 TAREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTHGRIPY-PGMTNPEVIQNLERGY---------------  227 (279)
T ss_dssp             ECCTTCCCCTTTSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTTCCSS-TTCCHHHHHHHHHTTC---------------
T ss_pred             ccccCCCCccCccChhhhcc-CCCCchhhhHHHHHHHHHHHhCCCCCC-cccCHHHHHHHHhccc---------------
Confidence            1  22345678999999976 678999999999999999999 88887 3333333322221100               


Q ss_pred             CChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhc
Q 014406          353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  408 (425)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~  408 (425)
                                           .......+++++.+++.+||+.||++|||++++++
T Consensus       228 ---------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  262 (279)
T 1qpc_A          228 ---------------------RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS  262 (279)
T ss_dssp             ---------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---------------------CCCCcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence                                 00112237899999999999999999999999876

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=2.2e-43  Score=331.66  Aligned_cols=247  Identities=15%  Similarity=0.312  Sum_probs=188.9

Q ss_pred             CCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCc
Q 014406          122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (425)
Q Consensus       122 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (425)
                      ...++|++.+.||+|+||+||+|.+.   ..+|+|+++..     ..+.+.+|+.+++++ +|+||+++++++..   ..
T Consensus        21 i~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~---~~   93 (289)
T 3og7_A           21 IPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT-RHVNILLFMGYSTA---PQ   93 (289)
T ss_dssp             CCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECS---SS
T ss_pred             cCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhC-CCCcEEEEEeeccC---Cc
Confidence            35788999999999999999999653   35999998643     235688999999999 89999999997633   56


Q ss_pred             cEEEEEeecCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccC
Q 014406          197 PSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (425)
Q Consensus       197 ~~lv~e~~~~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~  272 (425)
                      .++||||+.+++|..++    ..+++..+..++.|++.||.|||+.||+|+||||+|||++.+ +.+||+|||+++....
T Consensus        94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~  172 (289)
T 3og7_A           94 LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHED-NTVKIGDFGLATEKSR  172 (289)
T ss_dssp             CEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETT-TEEEECCCC-------
T ss_pred             cEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCC-CCEEEccceecccccc
Confidence            78999999999998877    348999999999999999999999999999999999999988 7999999999975542


Q ss_pred             ---CCcceeeccCCCccCcccccC--CCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHh
Q 014406          273 ---GKEYNVRVASRYFKGPELLVD--LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLN  347 (425)
Q Consensus       273 ---~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~  347 (425)
                         ........+|..|+|||++..  ...++.++|||||||++|+|++|+.||. +.++.+.+......-....      
T Consensus       173 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~-~~~~~~~~~~~~~~~~~~~------  245 (289)
T 3og7_A          173 WSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIEMVGRGSLSP------  245 (289)
T ss_dssp             -----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTS-SCCCHHHHHHHHHHTSCCC------
T ss_pred             ccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCcc-ccchHHHHHHHhcccccCc------
Confidence               122344578999999999862  2568889999999999999999999984 3344444433322110000      


Q ss_pred             hccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhc
Q 014406          348 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  408 (425)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~  408 (425)
                                          .     .......+++++.+|+.+||+.||++|||++|+++
T Consensus       246 --------------------~-----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~  281 (289)
T 3og7_A          246 --------------------D-----LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA  281 (289)
T ss_dssp             --------------------C-----TTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --------------------c-----hhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence                                0     00112237899999999999999999999999985

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=7.7e-44  Score=340.77  Aligned_cols=246  Identities=18%  Similarity=0.303  Sum_probs=198.4

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEE--EEEEecCc----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCc
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERC--IIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~v--avK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (425)
                      ..++|++.+.||+|+||+||+|.+..++..+  |+|.+...    ..+.+.+|+.+++++.+||||+++++++.+.  ..
T Consensus        23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~--~~  100 (327)
T 1fvr_A           23 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR--GY  100 (327)
T ss_dssp             CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEET--TE
T ss_pred             cHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeC--Cc
Confidence            3578999999999999999999999888865  99988642    3456889999999997899999999999654  67


Q ss_pred             cEEEEEeecCCChhhhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCC
Q 014406          197 PSLIFEYVNSTDFKVLYP-------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELR  257 (425)
Q Consensus       197 ~~lv~e~~~~~~l~~~~~-------------------~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~  257 (425)
                      .++||||+++++|.+++.                   .+++..++.++.||+.||.|||++||+|+||||+|||++.+ +
T Consensus       101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~-~  179 (327)
T 1fvr_A          101 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN-Y  179 (327)
T ss_dssp             EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGG-G
T ss_pred             eEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCC-C
Confidence            899999999999988762                   48899999999999999999999999999999999999988 7


Q ss_pred             cEEEEeccccccccCCCcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHH
Q 014406          258 KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKV  336 (425)
Q Consensus       258 ~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~  336 (425)
                      .+||+|||+++............++..|+|||++.+ ..++.++|||||||++|+|++ |+.||. +.+..+....+.. 
T Consensus       180 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~pf~-~~~~~~~~~~~~~-  256 (327)
T 1fvr_A          180 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYC-GMTCAELYEKLPQ-  256 (327)
T ss_dssp             CEEECCTTCEESSCEECCC----CCTTTCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTT-TCCHHHHHHHGGG-
T ss_pred             eEEEcccCcCccccccccccCCCCCccccChhhhcc-ccCCchhcchHHHHHHHHHHcCCCCCCC-CCcHHHHHHHhhc-
Confidence            899999999975433333344567788999999976 678999999999999999998 999883 2222222111100 


Q ss_pred             hCCchhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcC
Q 014406          337 LGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  409 (425)
Q Consensus       337 lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~h  409 (425)
                                  .                       ........+++++.+|+.+||+.||++|||++|++++
T Consensus       257 ------------~-----------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  294 (327)
T 1fvr_A          257 ------------G-----------------------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  294 (327)
T ss_dssp             ------------T-----------------------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ------------C-----------------------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                        0                       0001122368999999999999999999999999875

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=2.7e-43  Score=334.73  Aligned_cols=247  Identities=19%  Similarity=0.316  Sum_probs=191.0

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcC---CCcEEEEEEecCcc-----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCC
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVN---TNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHS  194 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~---~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  194 (425)
                      ..++|++.+.||+|+||+||+|.+..   ++..||+|+++...     .+.+.+|+.+++++ +||||+++++++.+...
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~  110 (313)
T 3brb_A           32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF-SHPNVIRLLGVCIEMSS  110 (313)
T ss_dssp             CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTC-CCTTBCCCCEEEEC---
T ss_pred             CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcC-CCCCeeeeeEEEeeccc
Confidence            56889999999999999999998765   55689999987432     35688999999999 89999999999976533


Q ss_pred             C---ccEEEEEeecCCChhhhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEE
Q 014406          195 K---TPSLIFEYVNSTDFKVLY---------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLI  262 (425)
Q Consensus       195 ~---~~~lv~e~~~~~~l~~~~---------~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~  262 (425)
                      .   ..++||||+.+++|..++         ..+++..++.++.|++.||.|||++||+|+||||+|||++.+ +.+||+
T Consensus       111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~-~~~kl~  189 (313)
T 3brb_A          111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDD-MTVCVA  189 (313)
T ss_dssp             ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTT-SCEEEC
T ss_pred             cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCC-CcEEEe
Confidence            2   458999999999998876         348999999999999999999999999999999999999988 789999


Q ss_pred             eccccccccCCCc---ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhC
Q 014406          263 DWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLG  338 (425)
Q Consensus       263 Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~lg  338 (425)
                      |||+++.......   .....++..|+|||.+.+ ..++.++|||||||++|+|++ |..|| .+.+..+....+.... 
T Consensus       190 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~-~~~~~~~~~~~~~~~~-  266 (313)
T 3brb_A          190 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIATRGMTPY-PGVQNHEMYDYLLHGH-  266 (313)
T ss_dssp             SCSCC----------------CCGGGSCHHHHHS-SCCCHHHHHHHHHHHHHHHHTTSCCSS-TTCCGGGHHHHHHTTC-
T ss_pred             ecCcceecccccccCcccccCCCccccCchhhcC-CCccchhhhHHHHHHHHHHHhcCCCCC-ccCCHHHHHHHHHcCC-
Confidence            9999986643321   233456778999999987 789999999999999999999 77676 3433333333221100 


Q ss_pred             CchhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcC
Q 014406          339 TDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  409 (425)
Q Consensus       339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~h  409 (425)
                                                         .......+++++.+|+.+||+.||++|||+.+++++
T Consensus       267 -----------------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  302 (313)
T 3brb_A          267 -----------------------------------RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ  302 (313)
T ss_dssp             -----------------------------------CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             -----------------------------------CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                               001112378999999999999999999999999864

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=5.1e-43  Score=330.46  Aligned_cols=245  Identities=20%  Similarity=0.304  Sum_probs=197.1

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCC---cEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCc
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTN---ERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~---~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (425)
                      ..+|++.+.||+|+||+||+|.+..++   ..+|+|.+....    .+.+.+|+.+++++ +||||+++++++... ...
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~-~~~  101 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLSLLGICLRS-EGS  101 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTC-CCTTBCCCCEEECCS-SSC
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhC-CCCCEeeeeeEEEcC-CCc
Confidence            456999999999999999999865433   468999987532    35688999999999 899999999997543 357


Q ss_pred             cEEEEEeecCCChhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccC
Q 014406          197 PSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (425)
Q Consensus       197 ~~lv~e~~~~~~l~~~~~----~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~  272 (425)
                      .++||||+++++|.+++.    .+++..+..++.|++.||+|||++||+|+||||+|||++.+ +.+||+|||+++....
T Consensus       102 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~-~~~kl~Dfg~a~~~~~  180 (298)
T 3f66_A          102 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEK-FTVKVADFGLARDMYD  180 (298)
T ss_dssp             CEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT-CCEEECSCGGGCCCSC
T ss_pred             eEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCC-CCEEECcccccccccc
Confidence            789999999999998873    38899999999999999999999999999999999999988 7999999999976543


Q ss_pred             CC-----cceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHh
Q 014406          273 GK-----EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLN  347 (425)
Q Consensus       273 ~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~  347 (425)
                      ..     ......+|+.|+|||.+.+ ..++.++|||||||++|+|++|..|++.+.+..+....+.....         
T Consensus       181 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~---------  250 (298)
T 3f66_A          181 KEYYSVHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR---------  250 (298)
T ss_dssp             GGGCBC-----CCBCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCC---------
T ss_pred             cchhccccccCCCCCccccChHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCC---------
Confidence            22     1233456778999999977 67999999999999999999977777666655544433321100         


Q ss_pred             hccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhc
Q 014406          348 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  408 (425)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~  408 (425)
                                                 ......+++.+.+++.+||+.||++|||++|+++
T Consensus       251 ---------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~  284 (298)
T 3f66_A          251 ---------------------------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS  284 (298)
T ss_dssp             ---------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---------------------------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                                       0011236889999999999999999999999986

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=2.2e-43  Score=327.84  Aligned_cols=241  Identities=18%  Similarity=0.279  Sum_probs=196.8

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc-----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCcc
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (425)
                      ..++|++.+.||+|+||+||+|.+.  ++.||+|++....     .+.+.+|+.+++++ +||||+++++++.+......
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~   84 (271)
T 3kmu_A            8 DFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIF-SHPNVLPVLGACQSPPAPHP   84 (271)
T ss_dssp             CGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCC-SCTTEECEEEEECTTTSSSC
T ss_pred             CHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhc-CCCchhheEEEEccCCCCCe
Confidence            4578999999999999999999874  8899999997432     35688999999999 89999999999977656788


Q ss_pred             EEEEEeecCCChhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--ceeecCCCCceEecCCCCcEEEEeccccccc
Q 014406          198 SLIFEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  270 (425)
Q Consensus       198 ~lv~e~~~~~~l~~~~~-----~l~~~~~~~i~~~i~~~L~~LH~~~--ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~  270 (425)
                      ++||||+++++|.+++.     .+++..+..++.|++.||.|||+.|  |+|+||||+|||++.+ +.++|+|||++...
T Consensus        85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~-~~~~l~~~~~~~~~  163 (271)
T 3kmu_A           85 TLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDED-MTARISMADVKFSF  163 (271)
T ss_dssp             EEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTT-SCEEEEGGGSCCTT
T ss_pred             EeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCC-cceeEEeccceeee
Confidence            99999999999998873     3899999999999999999999999  9999999999999988 78999999987543


Q ss_pred             cCCCcceeeccCCCccCcccccCCCCCC---CcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHh
Q 014406          271 HPGKEYNVRVASRYFKGPELLVDLQDYD---YSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLN  347 (425)
Q Consensus       271 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~---~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~  347 (425)
                      .    .....+|+.|+|||.+.+ ..++   .++|||||||++|+|++|+.||. +.+..+....+...-          
T Consensus       164 ~----~~~~~~t~~y~aPE~~~~-~~~~~~~~~~Di~slG~il~el~~g~~p~~-~~~~~~~~~~~~~~~----------  227 (271)
T 3kmu_A          164 Q----SPGRMYAPAWVAPEALQK-KPEDTNRRSADMWSFAVLLWELVTREVPFA-DLSNMEIGMKVALEG----------  227 (271)
T ss_dssp             S----CTTCBSCGGGSCHHHHHS-CGGGSCHHHHHHHHHHHHHHHHHHCSCTTT-TSCHHHHHHHHHHSC----------
T ss_pred             c----ccCccCCccccChhhhcc-CCCCCCCchhhHHHHHHHHHHHHhCCCCcc-ccChHHHHHHHHhcC----------
Confidence            2    233577899999999976 3333   37999999999999999999983 222222222221100          


Q ss_pred             hccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhc
Q 014406          348 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  408 (425)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~  408 (425)
                                               ........+++++.+|+.+||+.||++|||++|+++
T Consensus       228 -------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (271)
T 3kmu_A          228 -------------------------LRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP  263 (271)
T ss_dssp             -------------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -------------------------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                                     001112337899999999999999999999999985

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1.9e-43  Score=337.79  Aligned_cols=258  Identities=17%  Similarity=0.237  Sum_probs=200.1

Q ss_pred             cCCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCc
Q 014406          121 WGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (425)
Q Consensus       121 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (425)
                      ....++|++.+.||+|+||+||+|. ..+++.||||++....    ...+.+|+.+++.+ +||||+++++++..  ...
T Consensus        26 ~~~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~--~~~  101 (326)
T 3uim_A           26 QVASDNFSNKNILGRGGFGKVYKGR-LADGTLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMT--PTE  101 (326)
T ss_dssp             HTTTTSSCSTTEEECCSSSEEEEEC-CSSSCCEEEEECCC-----CCCHHHHHHHGGGTC-CCTTBCCCCEEECC--SSC
T ss_pred             HHHhhccccceeEecCCCcEEEEEE-ecCCCEEEEEEeccccCchHHHHHHHHHHHHHhc-cCCCccceEEEEec--CCc
Confidence            3457889999999999999999996 4578999999987543    23689999999999 89999999999965  467


Q ss_pred             cEEEEEeecCCChhhhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CceeecCCCCceEecCCCCcEEEEeccc
Q 014406          197 PSLIFEYVNSTDFKVLYP-------TLTDYDIRYYIYELLKALDYCHSQ---GIMHRDVKPHNVMIDHELRKLRLIDWGL  266 (425)
Q Consensus       197 ~~lv~e~~~~~~l~~~~~-------~l~~~~~~~i~~~i~~~L~~LH~~---~ivH~Dlk~~NIll~~~~~~~kl~Dfg~  266 (425)
                      .++||||+.+++|.+++.       .+++..+..++.|++.||+|||+.   ||+|+||||+|||++.+ +.+||+|||+
T Consensus       102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~-~~~kl~Dfg~  180 (326)
T 3uim_A          102 RLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEE-FEAVVGDFGL  180 (326)
T ss_dssp             CEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTT-CCEEECCCSS
T ss_pred             eEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCC-CCEEeccCcc
Confidence            789999999999988763       289999999999999999999999   99999999999999988 7999999999


Q ss_pred             cccccCCCc--ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCC----CCCCHHHHHHHHHHhCCc
Q 014406          267 AEFYHPGKE--YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY----GHDNHDQLVKIAKVLGTD  340 (425)
Q Consensus       267 a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~----~~~~~~~~~~~~~~lg~~  340 (425)
                      ++.......  .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..    ..........+...    
T Consensus       181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----  255 (326)
T 3uim_A          181 AKLMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL----  255 (326)
T ss_dssp             CEECCSSSSCEECCCCSCGGGCCHHHHHH-SEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTT----
T ss_pred             ccccCcccccccccccCCcCccCHHHhcc-CCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHH----
Confidence            987643322  233458999999999977 6789999999999999999999999831    00000000000000    


Q ss_pred             hhHHHHhhccCCCChhhHHHhcccCCCCccccccc----cCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCC
Q 014406          341 ELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINA----DNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY  411 (425)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~  411 (425)
                                             ............    ......++++.+|+.+||+.||++|||++|+++|-.
T Consensus       256 -----------------------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~  307 (326)
T 3uim_A          256 -----------------------LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE  307 (326)
T ss_dssp             -----------------------TSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred             -----------------------hhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhc
Confidence                                   000000111111    111123467899999999999999999999998854

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.2e-43  Score=328.25  Aligned_cols=245  Identities=17%  Similarity=0.329  Sum_probs=199.7

Q ss_pred             CCCCEEEEe-eeeeeCceEEEEEEEc--CCCcEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCC
Q 014406          123 DQDDYEVVR-KVGRGKYSEVFEGINV--NTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (425)
Q Consensus       123 ~~~~y~~~~-~LG~G~fg~V~~~~~~--~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (425)
                      ..++|.+.+ .||+|+||+||+|.+.  .++..||+|+++..    ..+.+.+|+.+++++ +||||+++++++..   .
T Consensus         7 ~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~---~   82 (287)
T 1u59_A            7 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-DNPYIVRLIGVCQA---E   82 (287)
T ss_dssp             CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEES---S
T ss_pred             cHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhC-CCCCEeEEEEEecC---C
Confidence            467788887 9999999999999854  46788999999753    245688999999999 99999999999943   4


Q ss_pred             ccEEEEEeecCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEecccccccc
Q 014406          196 TPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (425)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~  271 (425)
                      ..++||||+.+++|..++    ..+++..+..++.|++.||.|||+.||+|+||||+||+++.+ +.+||+|||+++...
T Consensus        83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~-~~~kl~Dfg~~~~~~  161 (287)
T 1u59_A           83 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNR-HYAKISDFGLSKALG  161 (287)
T ss_dssp             SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEET-TEEEECCCTTCEECT
T ss_pred             CcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCC-CCEEECcccceeeec
Confidence            588999999999999887    348999999999999999999999999999999999999988 799999999998765


Q ss_pred             CCCcc----eeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCCchhHHHH
Q 014406          272 PGKEY----NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYL  346 (425)
Q Consensus       272 ~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~  346 (425)
                      .....    ....+|..|+|||++.+ ..++.++|||||||++|+|++ |+.||. +.+..+....+...          
T Consensus       162 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~-~~~~~~~~~~i~~~----------  229 (287)
T 1u59_A          162 ADDSYYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYK-KMKGPEVMAFIEQG----------  229 (287)
T ss_dssp             TCSCEECCCCSSCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTT-TCCTHHHHHHHHTT----------
T ss_pred             cCcceeeccccccccccccCHHHhcc-CCCCchhhHHHHHHHHHHHHcCCCCCcc-cCCHHHHHHHHhcC----------
Confidence            43322    22345788999999976 678999999999999999998 999883 33333333222110          


Q ss_pred             hhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCC
Q 014406          347 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHP  410 (425)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp  410 (425)
                         .                       .......+++++.+++.+||+.||++|||+.|++++.
T Consensus       230 ---~-----------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l  267 (287)
T 1u59_A          230 ---K-----------------------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM  267 (287)
T ss_dssp             ---C-----------------------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred             ---C-----------------------cCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence               0                       0011223789999999999999999999999999873

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.6e-42  Score=329.13  Aligned_cols=245  Identities=20%  Similarity=0.314  Sum_probs=190.4

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc------hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCcc
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (425)
                      .++|++.+.||+|+||+||+|.+..+++.||+|++....      .+.+.+|+.+++++ +||||+++++++...  ...
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~--~~~  109 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRL-QEPHVVPIHDFGEID--GQL  109 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEET--TEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhc-CCCCeeEEEEEEeeC--CeE
Confidence            578999999999999999999999999999999997432      25688999999999 999999999999764  678


Q ss_pred             EEEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCC
Q 014406          198 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (425)
Q Consensus       198 ~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~  274 (425)
                      ++||||+++++|.+++   ..+++..+..++.|++.||+|||+.||+|+||||+|||++.+ +.+||+|||++.......
T Consensus       110 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~-~~~kl~Dfg~~~~~~~~~  188 (309)
T 2h34_A          110 YVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSAD-DFAYLVDFGIASATTDEK  188 (309)
T ss_dssp             EEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-SCEEECSCCC--------
T ss_pred             EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCC-CCEEEecCccCccccccc
Confidence            9999999999999887   459999999999999999999999999999999999999988 789999999997654332


Q ss_pred             --cceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCC
Q 014406          275 --EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE  352 (425)
Q Consensus       275 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~  352 (425)
                        ......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...  +...+.........             
T Consensus       189 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~--~~~~~~~~~~~~~~-------------  252 (309)
T 2h34_A          189 LTQLGNTVGTLYYMAPERFSE-SHATYRADIYALTCVLYECLTGSPPYQGD--QLSVMGAHINQAIP-------------  252 (309)
T ss_dssp             --------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSC--HHHHHHHHHHSCCC-------------
T ss_pred             cccccccCCCcCccCHHHHcC-CCCCchHhHHHHHHHHHHHHHCCCCCCCc--hHHHHHHHhccCCC-------------
Confidence              2234578999999999987 68899999999999999999999998321  11111111110000             


Q ss_pred             CChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCc-CHHHHhc
Q 014406          353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-TAREAMA  408 (425)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rp-ta~elL~  408 (425)
                                          ........+++++.+++.+||+.||++|| |++++++
T Consensus       253 --------------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~  289 (309)
T 2h34_A          253 --------------------RPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA  289 (309)
T ss_dssp             --------------------CGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred             --------------------CccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence                                00011234788999999999999999999 7777764

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=3.5e-43  Score=341.49  Aligned_cols=241  Identities=15%  Similarity=0.242  Sum_probs=196.1

Q ss_pred             CCCCCEEEEeeeeeeCceEEEEE-----EEcCCCcEEEEEEecCcchHHHHHHHHHHHHhcC---CCCeeeEEeEEEcCC
Q 014406          122 GDQDDYEVVRKVGRGKYSEVFEG-----INVNTNERCIIKILKPVKKKKIKREIKILQNLCG---GPNVVKLLDIVRDQH  193 (425)
Q Consensus       122 ~~~~~y~~~~~LG~G~fg~V~~~-----~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~---h~niv~l~~~~~~~~  193 (425)
                      ...++|++.+.||+|+||+||+|     .+..+++.||+|+++.....++.+|+.+++.+ +   |+||+++++++... 
T Consensus        62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~l-~~~~~~~iv~~~~~~~~~-  139 (365)
T 3e7e_A           62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERL-KPSMQHMFMKFYSAHLFQ-  139 (365)
T ss_dssp             CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCHHHHHHHHHHHHHS-CGGGGGGBCCEEEEEECS-
T ss_pred             ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCChhHHHHHHHHHHHh-hhhhhhhhhhhheeeecC-
Confidence            35688999999999999999999     46788999999999988888999999999988 5   89999999999654 


Q ss_pred             CCccEEEEEeecCCChhhhcC--------CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecC-----------
Q 014406          194 SKTPSLIFEYVNSTDFKVLYP--------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH-----------  254 (425)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~~--------~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~-----------  254 (425)
                       ...++||||+++|+|.+++.        .+++..++.++.||+.||+|||++|||||||||+|||++.           
T Consensus       140 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~  218 (365)
T 3e7e_A          140 -NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDL  218 (365)
T ss_dssp             -SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------
T ss_pred             -CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccc
Confidence             67789999999999998872        4999999999999999999999999999999999999987           


Q ss_pred             CCCcEEEEecccccccc---CCCcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHH
Q 014406          255 ELRKLRLIDWGLAEFYH---PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV  331 (425)
Q Consensus       255 ~~~~~kl~Dfg~a~~~~---~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~  331 (425)
                      + +.+||+|||+|+...   .........||..|+|||++.+ ..++.++|||||||++|||++|+.||....+....  
T Consensus       219 ~-~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~--  294 (365)
T 3e7e_A          219 S-AGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSN-KPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK--  294 (365)
T ss_dssp             C-TTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTT-CCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE--
T ss_pred             c-CCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcC-CCCCccccHHHHHHHHHHHHhCCCccccCCCCcee--
Confidence            5 789999999996543   2333455679999999999987 67999999999999999999999998432211000  


Q ss_pred             HHHHHhCCchhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcC
Q 014406          332 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  409 (425)
Q Consensus       332 ~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~h  409 (425)
                                                       .....       .....++.+.+++..||+.+|.+|++..+.+.+
T Consensus       295 ---------------------------------~~~~~-------~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~  332 (365)
T 3e7e_A          295 ---------------------------------PEGLF-------RRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQ  332 (365)
T ss_dssp             ---------------------------------ECSCC-------TTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHH
T ss_pred             ---------------------------------echhc-------cccCcHHHHHHHHHHHcCCCCCCcchHHHHHHH
Confidence                                             00000       000136678899999999999999765554443

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=4.6e-43  Score=335.55  Aligned_cols=245  Identities=18%  Similarity=0.320  Sum_probs=192.9

Q ss_pred             CCCCCEEEEeeeeeeCceEEEEEEEcCCCcEE----EEEEecC----cchHHHHHHHHHHHHhcCCCCeeeEEeEEEcCC
Q 014406          122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERC----IIKILKP----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQH  193 (425)
Q Consensus       122 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~v----avK~~~~----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  193 (425)
                      ...++|++.+.||+|+||+||+|.+..+++.+    |+|.+..    ...+.+.+|+.+++++ +||||+++++++... 
T Consensus        12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~-   89 (327)
T 3lzb_A           12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DNPHVCRLLGICLTS-   89 (327)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTC-CBTTBCCCCEEEESS-
T ss_pred             cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhC-CCCCeeEEEEEEecC-
Confidence            35789999999999999999999998888765    6666642    3457789999999999 899999999999763 


Q ss_pred             CCccEEEEEeecCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEecccccc
Q 014406          194 SKTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (425)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~  269 (425)
                        ..++|+||+.+++|.+++    ..+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||+++.
T Consensus        90 --~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~-~~~kL~DfG~a~~  166 (327)
T 3lzb_A           90 --TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTP-QHVKITDFGLAKL  166 (327)
T ss_dssp             --SEEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEET-TEEEECCTTC---
T ss_pred             --CceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCC-CCEEEccCcceeE
Confidence              478999999999998876    358999999999999999999999999999999999999988 7999999999987


Q ss_pred             ccCCCc---ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCCchhHHH
Q 014406          270 YHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAY  345 (425)
Q Consensus       270 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~lg~~~~~~~  345 (425)
                      ......   .....+|..|+|||.+.+ ..++.++|||||||++|+|++ |..||. +.+..+....+....        
T Consensus       167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~~-~~~~~~~~~~~~~~~--------  236 (327)
T 3lzb_A          167 LGAEEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSILEKGE--------  236 (327)
T ss_dssp             -------------CCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTT-TCCGGGHHHHHHTTC--------
T ss_pred             ccCccccccccCCCccccccCHHHHcC-CCCChHHHHHHHHHHHHHHHHCCCCCCC-CCCHHHHHHHHHcCC--------
Confidence            643322   223355778999999987 789999999999999999999 888873 333222222111100        


Q ss_pred             HhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcC
Q 014406          346 LNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  409 (425)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~h  409 (425)
                                                  .......++.++.+|+++||+.||++|||++|+++.
T Consensus       237 ----------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  272 (327)
T 3lzb_A          237 ----------------------------RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             ----------------------------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ----------------------------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence                                        001122368899999999999999999999999863

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.2e-43  Score=336.66  Aligned_cols=257  Identities=19%  Similarity=0.285  Sum_probs=194.9

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcchHHHHHHHHHHHHh-cCCCCeeeEEeEEEcCCC--CccEE
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNL-CGGPNVVKLLDIVRDQHS--KTPSL  199 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l-~~h~niv~l~~~~~~~~~--~~~~l  199 (425)
                      ..++|++.+.||+|+||+||+|.+.  ++.||||++.........+|.+++..+ .+||||+++++++.....  ...++
T Consensus        35 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~l  112 (337)
T 3mdy_A           35 IAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYL  112 (337)
T ss_dssp             HHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEE
T ss_pred             cccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEE
Confidence            4578999999999999999999764  899999999877777777777776654 289999999999976533  57899


Q ss_pred             EEEeecCCChhhhc--CCCCHHHHHHHHHHHHHHHHHHHHC--------CceeecCCCCceEecCCCCcEEEEecccccc
Q 014406          200 IFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQ--------GIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (425)
Q Consensus       200 v~e~~~~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~LH~~--------~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~  269 (425)
                      ||||+.+++|.+++  ..+++..+..++.|++.||+|||+.        ||+||||||+|||++.+ +.+||+|||+++.
T Consensus       113 v~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~-~~~kl~Dfg~a~~  191 (337)
T 3mdy_A          113 ITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKN-GTCCIADLGLAVK  191 (337)
T ss_dssp             EECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTT-SCEEECCCTTCEE
T ss_pred             EEeccCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCC-CCEEEEeCCCcee
Confidence            99999999999887  4689999999999999999999998        99999999999999988 7999999999976


Q ss_pred             ccCCCcc-----eeeccCCCccCcccccCCCCCCCc------ccHHHHHHHHHHHHhC----------CCCCCCCCCCHH
Q 014406          270 YHPGKEY-----NVRVASRYFKGPELLVDLQDYDYS------LDMWSLGCMFAGMIFR----------KEPFFYGHDNHD  328 (425)
Q Consensus       270 ~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~------~DvwslG~~l~elltg----------~~pf~~~~~~~~  328 (425)
                      .......     ....||+.|+|||++.+ ..++..      +|||||||++|||++|          ..||........
T Consensus       192 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~  270 (337)
T 3mdy_A          192 FISDTNEVDIPPNTRVGTKRYMPPEVLDE-SLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDP  270 (337)
T ss_dssp             CC---------CCSSCSCGGGCCHHHHTT-CCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred             eccccccccCCCCCCccCcceeChhhccc-ccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCC
Confidence            5433221     24578999999999976 444444      9999999999999999          556532221111


Q ss_pred             HHHHHHHHhCCchhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhc
Q 014406          329 QLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  408 (425)
Q Consensus       329 ~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~  408 (425)
                      ....+.......                       .......   .......+++++.+|+.+||+.||++|||++|+++
T Consensus       271 ~~~~~~~~~~~~-----------------------~~~~~~~---~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  324 (337)
T 3mdy_A          271 SYEDMREIVCIK-----------------------KLRPSFP---NRWSSDECLRQMGKLMTECWAHNPASRLTALRVKK  324 (337)
T ss_dssp             CHHHHHHHHTTS-----------------------CCCCCCC---GGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             chhhhHHHHhhh-----------------------ccCcccc---ccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHH
Confidence            111111111000                       0000000   00011125678999999999999999999999997


Q ss_pred             C
Q 014406          409 H  409 (425)
Q Consensus       409 h  409 (425)
                      |
T Consensus       325 ~  325 (337)
T 3mdy_A          325 T  325 (337)
T ss_dssp             H
T ss_pred             H
Confidence            6

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-42  Score=333.43  Aligned_cols=245  Identities=15%  Similarity=0.295  Sum_probs=192.4

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCC----cEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCC
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTN----ERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHS  194 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~----~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  194 (425)
                      ..++|++.+.||+|+||+||+|.+..++    ..||+|++....    ...+.+|+.+++++ +||||+++++++.+  .
T Consensus        42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~  118 (333)
T 1mqb_A           42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF-SHHNIIRLEGVISK--Y  118 (333)
T ss_dssp             CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECS--S
T ss_pred             ChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEec--C
Confidence            4678999999999999999999876553    459999997532    34688999999999 99999999999954  4


Q ss_pred             CccEEEEEeecCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccc
Q 014406          195 KTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  270 (425)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~  270 (425)
                      ...++||||+++++|.+++    ..+++..+..++.|++.||.|||++||+|+||||+|||++.+ +.+||+|||+++..
T Consensus       119 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~-~~~kl~Dfg~~~~~  197 (333)
T 1mqb_A          119 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSN-LVCKVSDFGLSRVL  197 (333)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-CCEEECCCCC----
T ss_pred             CCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCC-CcEEECCCCcchhh
Confidence            6789999999999999886    358999999999999999999999999999999999999988 79999999999876


Q ss_pred             cCCCc----ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCCchhHHH
Q 014406          271 HPGKE----YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAY  345 (425)
Q Consensus       271 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~lg~~~~~~~  345 (425)
                      .....    .....++..|+|||++.+ ..++.++|||||||++|+|++ |+.||. +.+..+....+.+..        
T Consensus       198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~pf~-~~~~~~~~~~~~~~~--------  267 (333)
T 1mqb_A          198 EDDPEATYTTSGGKIPIRWTAPEAISY-RKFTSASDVWSFGIVMWEVMTYGERPYW-ELSNHEVMKAINDGF--------  267 (333)
T ss_dssp             -------------CCCGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTT-TCCHHHHHHHHHTTC--------
T ss_pred             ccccccccccCCCCccccccCchhccc-CCCCchhhhHHHHHHHHHHHcCCCCCcc-cCCHHHHHHHHHCCC--------
Confidence            43321    122345678999999987 679999999999999999999 998883 223222222221100        


Q ss_pred             HhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcC
Q 014406          346 LNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  409 (425)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~h  409 (425)
                                                  .......+++++.+++.+||+.||++|||+.+++++
T Consensus       268 ----------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  303 (333)
T 1mqb_A          268 ----------------------------RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSI  303 (333)
T ss_dssp             ----------------------------CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             ----------------------------cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                        000112368899999999999999999999999874

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=2e-43  Score=337.86  Aligned_cols=250  Identities=17%  Similarity=0.290  Sum_probs=196.6

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEE-----EcCCCcEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCC
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGI-----NVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH  193 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~-----~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  193 (425)
                      ..++|++.+.||+|+||+||+|.     +..++..||||++...    ....+.+|+.+++++ +||||+++++++.+  
T Consensus        28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--  104 (327)
T 2yfx_A           28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF-NHQNIVRCIGVSLQ--  104 (327)
T ss_dssp             CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECS--
T ss_pred             ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhC-CCCCCCeEEEEEcC--
Confidence            46789999999999999999998     5567889999999643    235688999999999 99999999999965  


Q ss_pred             CCccEEEEEeecCCChhhhcC----------CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCC--CCcEEE
Q 014406          194 SKTPSLIFEYVNSTDFKVLYP----------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--LRKLRL  261 (425)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~~----------~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~--~~~~kl  261 (425)
                      ....++||||+++++|.+++.          .+++..+..++.|++.||.|||+.||+|+||||+|||++.+  ...+||
T Consensus       105 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl  184 (327)
T 2yfx_A          105 SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKI  184 (327)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEE
Confidence            467789999999999988762          38899999999999999999999999999999999999843  246999


Q ss_pred             EeccccccccCCC---cceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHh
Q 014406          262 IDWGLAEFYHPGK---EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVL  337 (425)
Q Consensus       262 ~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~l  337 (425)
                      +|||+++......   ......++..|+|||++.+ ..++.++|||||||++|+|++ |..||. +.+..+....+... 
T Consensus       185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~-~~~~~~~~~~~~~~-  261 (327)
T 2yfx_A          185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFME-GIFTSKTDTWSFGVLLWEIFSLGYMPYP-SKSNQEVLEFVTSG-  261 (327)
T ss_dssp             CCCHHHHHHHC------CCGGGSCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSST-TCCHHHHHHHHHTT-
T ss_pred             CccccccccccccccccCCCcCCCcceeCHhHhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCC-CcCHHHHHHHHhcC-
Confidence            9999997554322   2233467889999999977 679999999999999999998 888873 33322222221110 


Q ss_pred             CCchhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCc
Q 014406          338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA  413 (425)
Q Consensus       338 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~  413 (425)
                      .                                   .......+++.+.+|+.+||+.||++|||++|+++|.|+-
T Consensus       262 ~-----------------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~  302 (327)
T 2yfx_A          262 G-----------------------------------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  302 (327)
T ss_dssp             C-----------------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             C-----------------------------------CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence            0                                   0011223789999999999999999999999999997754

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=5.4e-43  Score=349.52  Aligned_cols=249  Identities=19%  Similarity=0.331  Sum_probs=198.8

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc--chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEE
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (425)
                      ..++|++.+.||+|+||+||+|.+.. +..||||+++..  ..+.+.+|+.+++++ +||||+++++++.+   ...++|
T Consensus       182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~---~~~~iv  256 (452)
T 1fmk_A          182 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYAVVSE---EPIYIV  256 (452)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECS---SSCEEE
T ss_pred             ChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCCHHHHHHHHHHHHhC-CCCCEeeEEEEEcC---CceEEE
Confidence            46789999999999999999998764 567999999753  457899999999999 99999999999854   567899


Q ss_pred             EEeecCCChhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCc
Q 014406          201 FEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (425)
Q Consensus       201 ~e~~~~~~l~~~~~-----~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~  275 (425)
                      |||+.+++|.+++.     .+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++.......
T Consensus       257 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~-~~~kl~DfG~a~~~~~~~~  335 (452)
T 1fmk_A          257 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN-LVCKVADFGLARLIEDNEY  335 (452)
T ss_dssp             ECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG-GCEEECCCCTTC-------
T ss_pred             ehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCC-CCEEECCCccceecCCCce
Confidence            99999999998874     38999999999999999999999999999999999999988 7899999999987643221


Q ss_pred             --ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCC
Q 014406          276 --YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE  352 (425)
Q Consensus       276 --~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~  352 (425)
                        .....++..|+|||++.+ ..++.++|||||||++|||++ |+.|| .+.++.+.+..+...            .   
T Consensus       336 ~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~t~g~~P~-~~~~~~~~~~~i~~~------------~---  398 (452)
T 1fmk_A          336 TARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPY-PGMVNREVLDQVERG------------Y---  398 (452)
T ss_dssp             -------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSS-TTCCHHHHHHHHHTT------------C---
T ss_pred             ecccCCcccccccCHhHHhc-CCCCccccHHhHHHHHHHHHhCCCCCC-CCCCHHHHHHHHHcC------------C---
Confidence              123355678999999987 679999999999999999999 88887 344433333322110            0   


Q ss_pred             CChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcC--CCCccc
Q 014406          353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH--PYFAQV  415 (425)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~h--p~~~~~  415 (425)
                                           ....+..+++.+.+||.+||+.||++|||++++++.  .++...
T Consensus       399 ---------------------~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~  442 (452)
T 1fmk_A          399 ---------------------RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  442 (452)
T ss_dssp             ---------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred             ---------------------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccC
Confidence                                 001122378999999999999999999999999873  555544

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=9.2e-43  Score=327.75  Aligned_cols=243  Identities=19%  Similarity=0.333  Sum_probs=195.8

Q ss_pred             CCCCEEEEe-eeeeeCceEEEEEEE--cCCCcEEEEEEecCcc-----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCC
Q 014406          123 DQDDYEVVR-KVGRGKYSEVFEGIN--VNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHS  194 (425)
Q Consensus       123 ~~~~y~~~~-~LG~G~fg~V~~~~~--~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  194 (425)
                      ..++|++.+ .||+|+||+||+|.+  ..+++.||||+++...     .+.+.+|+.+++.+ +||||+++++++..   
T Consensus        14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~---   89 (291)
T 1xbb_A           14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-DNPYIVRMIGICEA---   89 (291)
T ss_dssp             CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTC-CCTTBCCEEEEEES---
T ss_pred             cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhC-CCCCEEEEEEEECC---
Confidence            467899998 999999999999954  5677899999997432     46788999999999 89999999999943   


Q ss_pred             CccEEEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEecccccccc
Q 014406          195 KTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (425)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~  271 (425)
                      ...++||||+.+++|.+++   ..+++..+..++.|++.||+|||+.||+|+||||+|||++.+ +.+||+|||++....
T Consensus        90 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~-~~~kl~Dfg~~~~~~  168 (291)
T 1xbb_A           90 ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQ-HYAKISDFGLSKALR  168 (291)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET-TEEEECCCTTCEECC
T ss_pred             CCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCC-CcEEEccCCcceeec
Confidence            5678999999999999887   358999999999999999999999999999999999999988 799999999998765


Q ss_pred             CCCcc----eeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCCchhHHHH
Q 014406          272 PGKEY----NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYL  346 (425)
Q Consensus       272 ~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~  346 (425)
                      .....    ....++..|+|||.+.+ ..++.++||||||+++|+|++ |+.||. +.+..+....+..  +        
T Consensus       169 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~-~~~~~~~~~~~~~--~--------  236 (291)
T 1xbb_A          169 ADENYYKAQTHGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYR-GMKGSEVTAMLEK--G--------  236 (291)
T ss_dssp             TTCSEEEC----CCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCCSST-TCCHHHHHHHHHT--T--------
T ss_pred             cCCCcccccccCCCCceeeChHHhcc-CCCChhhhHHHHHHHHHHHHhcCCCCCC-CCCHHHHHHHHHc--C--------
Confidence            43322    22345678999999976 678999999999999999999 998883 2222222221110  0        


Q ss_pred             hhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhc
Q 014406          347 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  408 (425)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~  408 (425)
                         .                       .......+++++.+++.+||+.||++|||+.++++
T Consensus       237 ---~-----------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  272 (291)
T 1xbb_A          237 ---E-----------------------RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL  272 (291)
T ss_dssp             ---C-----------------------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             ---C-----------------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence               0                       00112237899999999999999999999999975

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=1.4e-42  Score=327.83  Aligned_cols=240  Identities=26%  Similarity=0.414  Sum_probs=189.1

Q ss_pred             CCCEEEE-eeeeeeCceEEEEEEEcCCCcEEEEEEecCcchHHHHHHHHHHHHhcCCCCeeeEEeEEEc--CCCCccEEE
Q 014406          124 QDDYEVV-RKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRD--QHSKTPSLI  200 (425)
Q Consensus       124 ~~~y~~~-~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~--~~~~~~~lv  200 (425)
                      .++|.+. +.||+|+||+||+|.+..+++.||+|+++.  ...+.+|+.++.++.+||||+++++++..  ......++|
T Consensus        16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv   93 (299)
T 3m2w_A           16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIV   93 (299)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC--SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred             ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc--cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEE
Confidence            4678887 779999999999999999999999999973  46778999999666699999999999865  234678999


Q ss_pred             EEeecCCChhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCC--CCcEEEEeccccccccCC
Q 014406          201 FEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--LRKLRLIDWGLAEFYHPG  273 (425)
Q Consensus       201 ~e~~~~~~l~~~~~-----~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~--~~~~kl~Dfg~a~~~~~~  273 (425)
                      |||+++++|.+++.     .+++..+..++.|++.||.|||++||+|+||||+|||++.+  .+.+||+|||++....  
T Consensus        94 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~--  171 (299)
T 3m2w_A           94 MECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT--  171 (299)
T ss_dssp             ECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT--
T ss_pred             EeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccccccc--
Confidence            99999999988762     48999999999999999999999999999999999999973  2689999999986432  


Q ss_pred             CcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCC
Q 014406          274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL  353 (425)
Q Consensus       274 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~  353 (425)
                                         + ..++.++|||||||++|+|++|+.||..... .+....+..                  
T Consensus       172 -------------------~-~~~~~~~DiwslG~il~el~tg~~pf~~~~~-~~~~~~~~~------------------  212 (299)
T 3m2w_A          172 -------------------G-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHG-LAISPGMKT------------------  212 (299)
T ss_dssp             -------------------T-CGGGGHHHHHHHHHHHHHHHHSSCSCCC--------CCSCC------------------
T ss_pred             -------------------c-ccCCchhhHHHHHHHHHHHHHCCCCCCCCcc-hhhhHHHHH------------------
Confidence                               1 4578899999999999999999999843211 100000000                  


Q ss_pred             ChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCccccc
Q 014406          354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA  417 (425)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~  417 (425)
                               ......  ..........+++++.+|+.+||+.||++|||++|+++||||++...
T Consensus       213 ---------~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~  265 (299)
T 3m2w_A          213 ---------RIRMGQ--YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK  265 (299)
T ss_dssp             ---------SSCTTC--CSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGG
T ss_pred             ---------HHhhcc--ccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhccccc
Confidence                     000000  00000011237899999999999999999999999999999987654

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=7e-43  Score=334.78  Aligned_cols=245  Identities=20%  Similarity=0.348  Sum_probs=182.0

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc---hHHHHHHHHHHHHhcCCCCeeeEEeEEEc------CC
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRD------QH  193 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~------~~  193 (425)
                      ...+|++.+.||+|+||+||+|.+..+++.||+|++....   .+.+.+|+.++.++.+||||+++++++..      ..
T Consensus        26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~  105 (337)
T 3ll6_A           26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG  105 (337)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred             cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence            3568999999999999999999999999999999985433   45688999999999569999999999952      23


Q ss_pred             CCccEEEEEeecCCChhhhc------CCCCHHHHHHHHHHHHHHHHHHHHCC--ceeecCCCCceEecCCCCcEEEEecc
Q 014406          194 SKTPSLIFEYVNSTDFKVLY------PTLTDYDIRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHELRKLRLIDWG  265 (425)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~------~~l~~~~~~~i~~~i~~~L~~LH~~~--ivH~Dlk~~NIll~~~~~~~kl~Dfg  265 (425)
                      ....++||||+++ +|.+++      ..+++..+..++.||+.||.|||+.|  |+|+||||+|||++.+ +.+||+|||
T Consensus       106 ~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~-~~~kl~Dfg  183 (337)
T 3ll6_A          106 QAEFLLLTELCKG-QLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQ-GTIKLCDFG  183 (337)
T ss_dssp             SEEEEEEEECCSE-EHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTT-SCEEBCCCT
T ss_pred             CceEEEEEEecCC-CHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCC-CCEEEecCc
Confidence            3457899999974 555544      34999999999999999999999999  9999999999999988 789999999


Q ss_pred             ccccccCCCcc-------------eeeccCCCccCccccc--CCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHH
Q 014406          266 LAEFYHPGKEY-------------NVRVASRYFKGPELLV--DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL  330 (425)
Q Consensus       266 ~a~~~~~~~~~-------------~~~~~t~~y~aPE~~~--~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~  330 (425)
                      +++........             ....+|+.|+|||++.  ....++.++|||||||++|+|++|+.||..... ....
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-~~~~  262 (337)
T 3ll6_A          184 SATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK-LRIV  262 (337)
T ss_dssp             TCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----------
T ss_pred             cceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhH-HHhh
Confidence            99876543221             1346889999999983  225688999999999999999999999832111 0000


Q ss_pred             HHHHHHhCCchhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcC
Q 014406          331 VKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  409 (425)
Q Consensus       331 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~h  409 (425)
                      .   .                                    ..........+..+.+|+++||+.||++|||++|+++|
T Consensus       263 ~---~------------------------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  302 (337)
T 3ll6_A          263 N---G------------------------------------KYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQ  302 (337)
T ss_dssp             ------------------------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             c---C------------------------------------cccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            0   0                                    00011122357789999999999999999999999987

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.6e-43  Score=342.06  Aligned_cols=246  Identities=19%  Similarity=0.300  Sum_probs=188.9

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCC---cEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCc
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTN---ERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~---~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (425)
                      ...|++.+.||+|+||+||+|.+..++   ..||+|.++..    ..+.+.+|+.+++++ +||||+++++++... ...
T Consensus        88 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~-~~~  165 (373)
T 3c1x_A           88 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLSLLGICLRS-EGS  165 (373)
T ss_dssp             TEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTC-CCTTBCCCCEEECCC-SSC
T ss_pred             hceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEcC-CCC
Confidence            346889999999999999999875433   46899998642    246788999999999 899999999987543 356


Q ss_pred             cEEEEEeecCCChhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccC
Q 014406          197 PSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (425)
Q Consensus       197 ~~lv~e~~~~~~l~~~~~----~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~  272 (425)
                      .++||||+.+++|.+++.    .+++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++....
T Consensus       166 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~-~~~kL~DFG~a~~~~~  244 (373)
T 3c1x_A          166 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEK-FTVKVADFGLARDMYD  244 (373)
T ss_dssp             CEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-CCEEECCC--------
T ss_pred             eEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCC-CCEEEeeccccccccc
Confidence            789999999999998873    47889999999999999999999999999999999999988 7999999999986543


Q ss_pred             CCc-----ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHh
Q 014406          273 GKE-----YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLN  347 (425)
Q Consensus       273 ~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~  347 (425)
                      ...     .....++..|+|||++.+ ..++.++|||||||++|||++|..|++.+.+..+....+...  .        
T Consensus       245 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~--~--------  313 (373)
T 3c1x_A          245 KEFDSVHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG--R--------  313 (373)
T ss_dssp             -------------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTT--C--------
T ss_pred             cccccccccCCCCCcccccChHHhcC-CCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcC--C--------
Confidence            221     123456778999999987 789999999999999999999655555555444333322110  0        


Q ss_pred             hccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcC
Q 014406          348 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  409 (425)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~h  409 (425)
                                                ....+..+++.+.+++.+||+.||++|||++|++++
T Consensus       314 --------------------------~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~  349 (373)
T 3c1x_A          314 --------------------------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR  349 (373)
T ss_dssp             --------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --------------------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                      000112378999999999999999999999999864

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=6.7e-43  Score=337.78  Aligned_cols=251  Identities=15%  Similarity=0.186  Sum_probs=198.6

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcC--------CCcEEEEEEecCcchHHHHHHHHHHHHhcCCCCeee-----------
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVN--------TNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVK-----------  184 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~--------~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~-----------  184 (425)
                      .++|++.+.||+|+||+||+|.+..        .++.||+|++...  +.+.+|+.+++++ +||||++           
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~  117 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--GRLFNEQNFFQRA-AKPLQVNKWKKLYSTPLL  117 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--STHHHHHHHHHHH-CCHHHHHHHHHHTTCTTC
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--chHHHHHHHHHHh-cccchhhhhhhhccCCcc
Confidence            5789999999999999999999887        4889999999754  5788999999999 8999887           


Q ss_pred             ----EEeEEEcCCCCccEEEEEeecCCChhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCC
Q 014406          185 ----LLDIVRDQHSKTPSLIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE  255 (425)
Q Consensus       185 ----l~~~~~~~~~~~~~lv~e~~~~~~l~~~~-----~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~  255 (425)
                          +++++... ....++||||+ +++|.+++     ..+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus       118 ~i~~~~~~~~~~-~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~~  195 (352)
T 2jii_A          118 AIPTCMGFGVHQ-DKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPE  195 (352)
T ss_dssp             SCCCCCEEEEET-TTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEETT
T ss_pred             CccchhhccccC-CcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcCC
Confidence                56777542 46789999999 99998886     358999999999999999999999999999999999999987


Q ss_pred             CC--cEEEEeccccccccCCC--------cceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCC
Q 014406          256 LR--KLRLIDWGLAEFYHPGK--------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD  325 (425)
Q Consensus       256 ~~--~~kl~Dfg~a~~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~  325 (425)
                       +  .+||+|||+++......        ......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.....
T Consensus       196 -~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~  273 (352)
T 2jii_A          196 -DQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKG-CGPSRRSDLQSLGYCMLKWLYGFLPWTNCLP  273 (352)
T ss_dssp             -EEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred             -CCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCcccCCc
Confidence             5  89999999997654322        1133478999999999987 6799999999999999999999999955443


Q ss_pred             CHHHHHHHHHHhCCchhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHH
Q 014406          326 NHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTARE  405 (425)
Q Consensus       326 ~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~e  405 (425)
                      +.+.+......+....         .                .  ..........+++++.+|+.+||+.||++|||+++
T Consensus       274 ~~~~~~~~~~~~~~~~---------~----------------~--~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~  326 (352)
T 2jii_A          274 NTEDIMKQKQKFVDKP---------G----------------P--FVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAM  326 (352)
T ss_dssp             CHHHHHHHHHHHHHSC---------C----------------C--EECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHH
T ss_pred             CHHHHHHHHHhccCCh---------h----------------h--hhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHH
Confidence            4444433322110000         0                0  00000011236899999999999999999999999


Q ss_pred             Hhc
Q 014406          406 AMA  408 (425)
Q Consensus       406 lL~  408 (425)
                      +++
T Consensus       327 l~~  329 (352)
T 2jii_A          327 LRN  329 (352)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            975

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=1.1e-42  Score=331.10  Aligned_cols=250  Identities=20%  Similarity=0.354  Sum_probs=196.5

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc---chHHHHHHHHHHHHhcCCCCeeeEEeEEEcC--CCCcc
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRDQ--HSKTP  197 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~--~~~~~  197 (425)
                      ..++|++.+.||+|+||+||+|.+..+++.||+|++...   ..+.+.+|+.+++.+ +||||+++++++...  .....
T Consensus        27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~  105 (317)
T 2buj_A           27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLF-NHPNILRLVAYCLRERGAKHEA  105 (317)
T ss_dssp             TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTC-CCTTBCCCCEEEEEEETTEEEE
T ss_pred             CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhc-CCCCeeeEEEEEEeccCCCcee
Confidence            568899999999999999999999999999999998543   346688999999999 999999999998743  33578


Q ss_pred             EEEEEeecCCChhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccc
Q 014406          198 SLIFEYVNSTDFKVLY-------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  270 (425)
Q Consensus       198 ~lv~e~~~~~~l~~~~-------~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~  270 (425)
                      ++||||+.+++|.+++       ..+++..+..++.|++.||.|||++||+|+||||+|||++.+ +.+||+|||++...
T Consensus       106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~-~~~kl~dfg~~~~~  184 (317)
T 2buj_A          106 WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDE-GQPVLMDLGSMNQA  184 (317)
T ss_dssp             EEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-SCEEECCCSSCEES
T ss_pred             EEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCC-CCEEEEecCcchhc
Confidence            8999999999998776       348999999999999999999999999999999999999988 78999999998754


Q ss_pred             cCCCc----------ceeeccCCCccCcccccCCC--CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC
Q 014406          271 HPGKE----------YNVRVASRYFKGPELLVDLQ--DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLG  338 (425)
Q Consensus       271 ~~~~~----------~~~~~~t~~y~aPE~~~~~~--~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg  338 (425)
                      .....          .....+|..|+|||++.+..  .++.++|||||||++|+|++|+.||......           +
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----------~  253 (317)
T 2buj_A          185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQK-----------G  253 (317)
T ss_dssp             CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHT-----------T
T ss_pred             ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcc-----------c
Confidence            32111          12235689999999986522  2689999999999999999999998210000           0


Q ss_pred             CchhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcC
Q 014406          339 TDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  409 (425)
Q Consensus       339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~h  409 (425)
                       ........              . .        ........+++++.+|+.+||+.||++|||++|++++
T Consensus       254 -~~~~~~~~--------------~-~--------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  300 (317)
T 2buj_A          254 -DSVALAVQ--------------N-Q--------LSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ  300 (317)
T ss_dssp             -SCHHHHHH--------------C-C----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -chhhHHhh--------------c-c--------CCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence             00000000              0 0        0001112368999999999999999999999999986

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=2.6e-44  Score=368.69  Aligned_cols=278  Identities=22%  Similarity=0.348  Sum_probs=207.3

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeeEEeEEEc----CCCC
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRD----QHSK  195 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~----~~~~  195 (425)
                      .++|++.+.||+|+||+||+|.+..+++.||||++...    ..+.+.+|+.+++++ +||||+++++++..    ..+.
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~v~~~~~~~~~~~   91 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKL-NHPNVVSAREVPDGLQKLAPND   91 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHC-CBTTBCCEEECCTTTCCCCTTS
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhC-CCCCCCceeeeecccccccCCC
Confidence            47899999999999999999999999999999998753    245688999999999 99999999998754    1256


Q ss_pred             ccEEEEEeecCCChhhhcC------CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCC--cEEEEecccc
Q 014406          196 TPSLIFEYVNSTDFKVLYP------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELR--KLRLIDWGLA  267 (425)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~~------~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~--~~kl~Dfg~a  267 (425)
                      ..++||||+++++|..++.      .+++..++.++.|++.||+|||+.||+|+||||+|||++.+..  .+||+|||++
T Consensus        92 ~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a  171 (676)
T 3qa8_A           92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYA  171 (676)
T ss_dssp             SCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCC
T ss_pred             eEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccccc
Confidence            7889999999999998873      4889999999999999999999999999999999999997622  4899999999


Q ss_pred             ccccCCCcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHh
Q 014406          268 EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLN  347 (425)
Q Consensus       268 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~  347 (425)
                      .............+|..|+|||++.+ ..++.++|||||||++|+|++|..||..+.. ...+.   .........    
T Consensus       172 ~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~-~~~~~---~~i~~~~~~----  242 (676)
T 3qa8_A          172 KELDQGELCTEFVGTLQYLAPELLEQ-KKYTVTVDYWSFGTLAFECITGFRPFLPNWQ-PVQWH---GKVREKSNE----  242 (676)
T ss_dssp             CBTTSCCCCCCCCSCCTTCSSCSSCC-SCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH-HHHSS---TTCC---------
T ss_pred             cccccccccccccCCcccCChHHhcc-CCCCchhHHHHHHHHHHHHHHCCCCCCcccc-hhhhh---hhhhcccch----
Confidence            88766665666789999999999987 7899999999999999999999999954321 11000   000000000    


Q ss_pred             hccCCCChhhHHHhcccCCCCccccc--cccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccch
Q 014406          348 KYHLELDPQLDALVGRHSRKPWSKFI--NADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE  419 (425)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~~  419 (425)
                      .  ......      ......+....  .......+++.+.+|+++||++||++|||++|+++||||+.+....
T Consensus       243 ~--~~~~~~------l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL  308 (676)
T 3qa8_A          243 H--IVVYDD------LTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSIL  308 (676)
T ss_dssp             ---CCSCCC------CSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHH
T ss_pred             h--hhhhhh------hccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHH
Confidence            0  000000      00000011000  0111223678899999999999999999999999999999876543

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=3.2e-42  Score=345.27  Aligned_cols=261  Identities=18%  Similarity=0.262  Sum_probs=204.5

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEE
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (425)
                      ..++|++.++||+|+||+||+|.+..+++.||||++... ...++.+|+++++.+.+++++..+..++..  ....++||
T Consensus         5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~~--~~~~~lvm   82 (483)
T 3sv0_A            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVE--GDYNVLVM   82 (483)
T ss_dssp             ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEEE--TTEEEEEE
T ss_pred             cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEee--CCEEEEEE
Confidence            357899999999999999999999999999999998743 446789999999999545666666665543  46789999


Q ss_pred             EeecCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEec---CCCCcEEEEeccccccccCCC
Q 014406          202 EYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMID---HELRKLRLIDWGLAEFYHPGK  274 (425)
Q Consensus       202 e~~~~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~---~~~~~~kl~Dfg~a~~~~~~~  274 (425)
                      ||+ +++|.+++    ..+++..++.++.||+.||+|||++|||||||||+|||++   .+ +.+||+|||+++......
T Consensus        83 e~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~-~~vkL~DFGla~~~~~~~  160 (483)
T 3sv0_A           83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRA-NQVYIIDFGLAKKYRDTS  160 (483)
T ss_dssp             ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGT-TCEEECCCTTCEECBCTT
T ss_pred             ECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCC-CeEEEEeCCcceeccCCc
Confidence            999 88888876    3599999999999999999999999999999999999994   55 789999999998765433


Q ss_pred             cc--------eeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCC--HHHHHHHHHHhCCchhHH
Q 014406          275 EY--------NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN--HDQLVKIAKVLGTDELNA  344 (425)
Q Consensus       275 ~~--------~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~--~~~~~~~~~~lg~~~~~~  344 (425)
                      ..        ....||..|+|||++.+ ..++.++|||||||++|||++|+.||......  .+.+..+....-......
T Consensus       161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~  239 (483)
T 3sv0_A          161 THQHIPYRENKNLTGTARYASVNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEA  239 (483)
T ss_dssp             TCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHH
T ss_pred             cccccccccccccCCCccccCHHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHH
Confidence            21        24578999999999987 77999999999999999999999998543221  122222211100000000


Q ss_pred             HHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhc----------CCCCcc
Q 014406          345 YLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA----------HPYFAQ  414 (425)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~----------hp~~~~  414 (425)
                                                      ....+++++.+|+.+||+.||++||+++++++          ++|+..
T Consensus       240 --------------------------------l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~~~~~~  287 (483)
T 3sv0_A          240 --------------------------------LCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQFDYV  287 (483)
T ss_dssp             --------------------------------HHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCSSC
T ss_pred             --------------------------------HhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCCCccCC
Confidence                                            00126899999999999999999999987765          677766


Q ss_pred             cccchh
Q 014406          415 VRAAES  420 (425)
Q Consensus       415 ~~~~~~  420 (425)
                      +.|...
T Consensus       288 ~dW~~~  293 (483)
T 3sv0_A          288 FDWTIL  293 (483)
T ss_dssp             CHHHHH
T ss_pred             cCchhh
Confidence            666543

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1.9e-42  Score=329.94  Aligned_cols=259  Identities=20%  Similarity=0.340  Sum_probs=199.2

Q ss_pred             CCEEEEeeeeeeCceEEEEEEE----cCCCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCc
Q 014406          125 DDYEVVRKVGRGKYSEVFEGIN----VNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (425)
Q Consensus       125 ~~y~~~~~LG~G~fg~V~~~~~----~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (425)
                      ..|++++.||+|+||+||++..    ..+++.||||+++...    .+.+.+|+.+++++ +||||+++++++.+.....
T Consensus        31 r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~  109 (318)
T 3lxp_A           31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL-YHEHIIKYKGCCEDAGAAS  109 (318)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTTTE
T ss_pred             HHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhC-CCcchhhEEEEEecCCCce
Confidence            3459999999999999988753    4578999999997543    35688999999999 8999999999998776678


Q ss_pred             cEEEEEeecCCChhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCC
Q 014406          197 PSLIFEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (425)
Q Consensus       197 ~~lv~e~~~~~~l~~~~~--~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~  274 (425)
                      .++||||+++++|.+++.  .+++..+..++.|++.||+|||+.||+|+||||+|||++.+ +.+||+|||++.......
T Consensus       110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~-~~~kl~Dfg~a~~~~~~~  188 (318)
T 3lxp_A          110 LQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDND-RLVKIGDFGLAKAVPEGH  188 (318)
T ss_dssp             EEEEECCCTTCBHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-CCEEECCGGGCEECCTTC
T ss_pred             EEEEEecccCCcHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCC-CCEEECCccccccccccc
Confidence            899999999999999874  48999999999999999999999999999999999999988 789999999998765443


Q ss_pred             c----ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhcc
Q 014406          275 E----YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH  350 (425)
Q Consensus       275 ~----~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~  350 (425)
                      .    .....++..|+|||++.+ ..++.++|||||||++|+|++|+.||...   ....   ....+........    
T Consensus       189 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~g~~p~~~~---~~~~---~~~~~~~~~~~~~----  257 (318)
T 3lxp_A          189 EYYRVREDGDSPVFWYAPECLKE-YKFYYASDVWSFGVTLYELLTHCDSSQSP---PTKF---LELIGIAQGQMTV----  257 (318)
T ss_dssp             SEEEC---CCCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGGSH---HHHH---HHHHCSCCHHHHH----
T ss_pred             cccccccCCCCCceeeChHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCccccc---chhh---hhhhcccccchhH----
Confidence            2    223456778999999987 67889999999999999999999998321   1111   1111110000000    


Q ss_pred             CCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhc
Q 014406          351 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  408 (425)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~  408 (425)
                          ...........        .......+++++.+|+++||+.||++|||++|+++
T Consensus       258 ----~~~~~~~~~~~--------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  303 (318)
T 3lxp_A          258 ----LRLTELLERGE--------RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP  303 (318)
T ss_dssp             ----HHHHHHHHTTC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----HHHHHHHhccc--------CCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence                00000000000        11122347899999999999999999999999984

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.2e-42  Score=324.81  Aligned_cols=241  Identities=16%  Similarity=0.328  Sum_probs=190.6

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEE
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (425)
                      ..++|++.+.||+|+||+||+|.+  +++.||+|+++.. ..+.+.+|+.+++++ +||||+++++++... ....++||
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~-~~~~~lv~   94 (278)
T 1byg_A           19 NMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQL-RHSNLVQLLGVIVEE-KGGLYIVT   94 (278)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC--HHHHHTHHHHTTC-CCTTBCCEEEEECCC---CCEEEE
T ss_pred             ChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchhHHHHHHHHHHHHHhC-CCCCEeeEEEEEEcC-CCceEEEE
Confidence            467899999999999999999976  4889999999754 456789999999999 899999999997543 34689999


Q ss_pred             EeecCCChhhhcCC-----CCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCcc
Q 014406          202 EYVNSTDFKVLYPT-----LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY  276 (425)
Q Consensus       202 e~~~~~~l~~~~~~-----l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~~  276 (425)
                      ||+++++|.+++..     +++..+..++.|++.||+|||++||+|+||||+||+++.+ +.+||+|||++......  .
T Consensus        95 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~-~~~~l~Dfg~~~~~~~~--~  171 (278)
T 1byg_A           95 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSED-NVAKVSDFGLTKEASST--Q  171 (278)
T ss_dssp             CCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT-SCEEECCCCC----------
T ss_pred             ecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCC-CcEEEeecccccccccc--c
Confidence            99999999888742     8899999999999999999999999999999999999988 78999999999765432  2


Q ss_pred             eeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCCh
Q 014406          277 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP  355 (425)
Q Consensus       277 ~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~  355 (425)
                      ....++..|+|||.+.+ ..++.++||||||+++|+|++ |+.||. ..+..+....+...                   
T Consensus       172 ~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~-~~~~~~~~~~~~~~-------------------  230 (278)
T 1byg_A          172 DTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYP-RIPLKDVVPRVEKG-------------------  230 (278)
T ss_dssp             ----CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCT-TSCGGGHHHHHTTT-------------------
T ss_pred             cCCCccccccCHHHhCC-CCCCchhcHHHHHHHHHHHHhCCCCCCC-CCCHHHHHHHHhcC-------------------
Confidence            33467888999999977 678999999999999999998 888873 22222222211100                   


Q ss_pred             hhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhc
Q 014406          356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  408 (425)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~  408 (425)
                                       ........+++++.+++++||+.||++|||+.|+++
T Consensus       231 -----------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  266 (278)
T 1byg_A          231 -----------------YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE  266 (278)
T ss_dssp             -----------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -----------------CCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence                             001112347899999999999999999999999985

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.2e-42  Score=329.48  Aligned_cols=262  Identities=19%  Similarity=0.363  Sum_probs=200.7

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEE----EcCCCcEEEEEEecCcc---hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCC
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGI----NVNTNERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~----~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (425)
                      ..++|++.+.||+|+||+||+|.    +..+++.||+|++....   .+.+.+|+.+++++ +||||+++++++......
T Consensus        39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~  117 (326)
T 2w1i_A           39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL-QHDNIVKYKGVCYSAGRR  117 (326)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTC-CCTTBCCEEEEECC----
T ss_pred             CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEecCCC
Confidence            45789999999999999999998    45689999999997543   35688999999999 899999999999766556


Q ss_pred             ccEEEEEeecCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEecccccccc
Q 014406          196 TPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (425)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~  271 (425)
                      ..++||||+++++|.+++    ..+++..+..++.|++.||+|||+.||+|+||||+|||++.+ +.+||+|||+++...
T Consensus       118 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~-~~~kL~Dfg~~~~~~  196 (326)
T 2w1i_A          118 NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENE-NRVKIGDFGLTKVLP  196 (326)
T ss_dssp             CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEET-TEEEECCCTTCEECC
T ss_pred             ceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCC-CcEEEecCcchhhcc
Confidence            789999999999999887    348999999999999999999999999999999999999988 799999999998765


Q ss_pred             CCCcc----eeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHh
Q 014406          272 PGKEY----NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLN  347 (425)
Q Consensus       272 ~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~  347 (425)
                      .....    ....++..|+|||.+.+ ..++.++|||||||++|+|++|..||..      ......+..+.........
T Consensus       197 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~tg~~~~~~------~~~~~~~~~~~~~~~~~~~  269 (326)
T 2w1i_A          197 QDKEYYKVKEPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYIEKSKS------PPAEFMRMIGNDKQGQMIV  269 (326)
T ss_dssp             SSCSEEECSSCCSCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHHTTCGGGS------HHHHHHHHHCTTCCTHHHH
T ss_pred             ccccccccccCCCCceeEECchhhcC-CCCCchhhHHHHHHHHHHHHhcCCCCCC------CHHHHHHhhccccchhhhH
Confidence            43321    22356677999999977 6789999999999999999999988731      1111122222211100000


Q ss_pred             hccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhc
Q 014406          348 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  408 (425)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~  408 (425)
                             ...........+        ......+++++.+|+++||+.||++|||++|+++
T Consensus       270 -------~~~~~~~~~~~~--------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~  315 (326)
T 2w1i_A          270 -------FHLIELLKNNGR--------LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  315 (326)
T ss_dssp             -------HHHHHHHHTTCC--------CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             -------HHHHHHhhcCCC--------CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                   000000000000        1112347899999999999999999999999985

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=2.5e-42  Score=332.08  Aligned_cols=258  Identities=19%  Similarity=0.243  Sum_probs=200.3

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcchHHHHHHHHHHHHh-cCCCCeeeEEeEEEcCCC--CccEE
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNL-CGGPNVVKLLDIVRDQHS--KTPSL  199 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l-~~h~niv~l~~~~~~~~~--~~~~l  199 (425)
                      ..++|++.+.||+|+||+||+|.+  +++.||||+++......+.+|.+++..+ .+||||+++++++.....  ...++
T Consensus        40 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~l  117 (342)
T 1b6c_B           40 IARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL  117 (342)
T ss_dssp             HHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEE
T ss_pred             ccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEE
Confidence            357899999999999999999977  5899999999887788889999999983 289999999999976543  37899


Q ss_pred             EEEeecCCChhhhc--CCCCHHHHHHHHHHHHHHHHHHH--------HCCceeecCCCCceEecCCCCcEEEEecccccc
Q 014406          200 IFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCH--------SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (425)
Q Consensus       200 v~e~~~~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~LH--------~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~  269 (425)
                      ||||+++++|.+++  ..+++..+..++.|++.||.|||        +.||+|+||||+|||++.+ +.+||+|||++..
T Consensus       118 v~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~-~~~kL~Dfg~~~~  196 (342)
T 1b6c_B          118 VSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN-GTCCIADLGLAVR  196 (342)
T ss_dssp             EECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTT-SCEEECCCTTCEE
T ss_pred             EEeecCCCcHHHHHhccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCC-CCEEEEECCCcee
Confidence            99999999999887  45899999999999999999999        8999999999999999988 7899999999987


Q ss_pred             ccCCCc-----ceeeccCCCccCcccccCCCC-----CCCcccHHHHHHHHHHHHhC----------CCCCCCCCCCHHH
Q 014406          270 YHPGKE-----YNVRVASRYFKGPELLVDLQD-----YDYSLDMWSLGCMFAGMIFR----------KEPFFYGHDNHDQ  329 (425)
Q Consensus       270 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~-----~~~~~DvwslG~~l~elltg----------~~pf~~~~~~~~~  329 (425)
                      ......     .....+|..|+|||++.+...     ++.++|||||||++|+|++|          ..||.........
T Consensus       197 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~  276 (342)
T 1b6c_B          197 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS  276 (342)
T ss_dssp             EETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred             ccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCccc
Confidence            654432     234578999999999976322     23689999999999999999          6787543222111


Q ss_pred             HHHHHHHhCCchhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcC
Q 014406          330 LVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  409 (425)
Q Consensus       330 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~h  409 (425)
                      ...+.+.+...                       ..+.....   ......+++.+.+|+.+||+.||++|||++|+++|
T Consensus       277 ~~~~~~~~~~~-----------------------~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~  330 (342)
T 1b6c_B          277 VEEMRKVVCEQ-----------------------KLRPNIPN---RWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  330 (342)
T ss_dssp             HHHHHHHHTTS-----------------------CCCCCCCG---GGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHH-----------------------HhCCCCcc---cccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence            11111111000                       00000000   00011135678999999999999999999999976

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=1.4e-42  Score=353.49  Aligned_cols=249  Identities=19%  Similarity=0.334  Sum_probs=202.4

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc--chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEE
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (425)
                      ..++|++.++||+|+||+||+|.+.. +..||||+++..  ..+.+.+|+.+|+++ +|+||+++++++.+   ...++|
T Consensus       265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~---~~~~lv  339 (535)
T 2h8h_A          265 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYAVVSE---EPIYIV  339 (535)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECS---SSCEEE
T ss_pred             chhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCCHHHHHHHHHHHHhC-CCCCEeeEEEEEee---ccceEe
Confidence            34679999999999999999998764 567999999753  457899999999999 99999999999854   568899


Q ss_pred             EEeecCCChhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCC-
Q 014406          201 FEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-  274 (425)
Q Consensus       201 ~e~~~~~~l~~~~~-----~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~-  274 (425)
                      |||+.+++|.+++.     .+++.++..++.||+.||+|||+++|+||||||+|||++.+ +.+||+|||+++...... 
T Consensus       340 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~-~~~kl~DFG~a~~~~~~~~  418 (535)
T 2h8h_A          340 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN-LVCKVADFGLARLIEDNEY  418 (535)
T ss_dssp             ECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG-GCEEECCTTSTTTCCCHHH
T ss_pred             eehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCC-CcEEEcccccceecCCCce
Confidence            99999999998874     38999999999999999999999999999999999999988 789999999998654321 


Q ss_pred             -cceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCC
Q 014406          275 -EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE  352 (425)
Q Consensus       275 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~  352 (425)
                       ......++..|+|||++.+ ..++.++|||||||++|||++ |+.|| .+.++.+.+..+...            +   
T Consensus       419 ~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwSlGv~l~el~t~g~~P~-~~~~~~~~~~~i~~~------------~---  481 (535)
T 2h8h_A          419 TARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPY-PGMVNREVLDQVERG------------Y---  481 (535)
T ss_dssp             HTTCSTTSCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTTCCSS-TTCCHHHHHHHHHTT------------C---
T ss_pred             ecccCCcCcccccCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCC-CCCCHHHHHHHHHcC------------C---
Confidence             1122345678999999987 679999999999999999999 88887 344433333322110            0   


Q ss_pred             CChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcC--CCCccc
Q 014406          353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH--PYFAQV  415 (425)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~h--p~~~~~  415 (425)
                                           .......+++++.+||.+||+.||++|||++++++.  .+|...
T Consensus       482 ---------------------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~  525 (535)
T 2h8h_A          482 ---------------------RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  525 (535)
T ss_dssp             ---------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCC
T ss_pred             ---------------------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhcc
Confidence                                 001122378999999999999999999999999874  555543

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=1e-41  Score=351.95  Aligned_cols=242  Identities=17%  Similarity=0.328  Sum_probs=194.8

Q ss_pred             CCCCEEEEe-eeeeeCceEEEEEEEc--CCCcEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCC
Q 014406          123 DQDDYEVVR-KVGRGKYSEVFEGINV--NTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (425)
Q Consensus       123 ~~~~y~~~~-~LG~G~fg~V~~~~~~--~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (425)
                      ..+++.+.+ .||+|+||+||+|.+.  .++..||||+++..    ..+.+.+|+.+|+++ +||||++++++|.+   .
T Consensus       333 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~---~  408 (613)
T 2ozo_A          333 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-DNPYIVRLIGVCQA---E  408 (613)
T ss_dssp             CTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTC-CCTTBCCEEEEEES---S
T ss_pred             cccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhC-CCCCEeeEEEEecc---C
Confidence            456677766 8999999999999875  35667999999753    457899999999999 99999999999965   4


Q ss_pred             ccEEEEEeecCCChhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEecccccccc
Q 014406          196 TPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (425)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~~----~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~  271 (425)
                      ..++||||+.+++|.+++.    .+++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus       409 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~-~~vkL~DFGla~~~~  487 (613)
T 2ozo_A          409 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNR-HYAKISDFGLSKALG  487 (613)
T ss_dssp             SEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEET-TEEEECCCSTTTTCC
T ss_pred             CeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCC-CcEEEeeccCccccc
Confidence            5899999999999998873    48999999999999999999999999999999999999988 799999999998764


Q ss_pred             CCCcc----eeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCCchhHHHH
Q 014406          272 PGKEY----NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYL  346 (425)
Q Consensus       272 ~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~  346 (425)
                      .....    ....++..|+|||++.+ ..++.++|||||||++|||++ |+.|| .+.+..+....+...          
T Consensus       488 ~~~~~~~~~~~~~~~~~y~APE~~~~-~~~~~~sDvwSlGv~l~ellt~G~~Pf-~~~~~~~~~~~i~~~----------  555 (613)
T 2ozo_A          488 ADDSYYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPY-KKMKGPEVMAFIEQG----------  555 (613)
T ss_dssp             --------------CCTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTT-TTCCSHHHHHHHHTT----------
T ss_pred             CCCceeeeccCCCCccceeCHhhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCC-CCCCHHHHHHHHHcC----------
Confidence            33221    22345678999999977 689999999999999999998 99888 444444443333210          


Q ss_pred             hhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHh
Q 014406          347 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM  407 (425)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL  407 (425)
                        .                        .......+++++.+||.+||+.||++|||+++++
T Consensus       556 --~------------------------~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~  590 (613)
T 2ozo_A          556 --K------------------------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVE  590 (613)
T ss_dssp             --C------------------------CCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHH
T ss_pred             --C------------------------CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence              0                        0011223789999999999999999999999885

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=3.1e-42  Score=356.88  Aligned_cols=241  Identities=17%  Similarity=0.302  Sum_probs=192.4

Q ss_pred             CCEEEE-eeeeeeCceEEEEEEE--cCCCcEEEEEEecCcc-----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCc
Q 014406          125 DDYEVV-RKVGRGKYSEVFEGIN--VNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (425)
Q Consensus       125 ~~y~~~-~~LG~G~fg~V~~~~~--~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (425)
                      ..+.+. +.||+|+||+||+|.+  ..+++.||||+++...     .+.+.+|+.+++++ +||||+++++++.+   ..
T Consensus       368 ~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~---~~  443 (635)
T 4fl3_A          368 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-DNPYIVRMIGICEA---ES  443 (635)
T ss_dssp             GGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHC-CCTTBCCEEEEEES---SS
T ss_pred             hhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEec---CC
Confidence            334443 4799999999999954  4567899999997532     46799999999999 89999999999964   35


Q ss_pred             cEEEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCC
Q 014406          197 PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (425)
Q Consensus       197 ~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~  273 (425)
                      .++||||+.+++|.+++   ..+++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++.....
T Consensus       444 ~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~-~~~kL~DFGla~~~~~~  522 (635)
T 4fl3_A          444 WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQ-HYAKISDFGLSKALRAD  522 (635)
T ss_dssp             EEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEET-TEEEECCTTHHHHTTC-
T ss_pred             EEEEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCC-CCEEEEEcCCccccccC
Confidence            78999999999999887   458999999999999999999999999999999999999988 79999999999876543


Q ss_pred             Cc----ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhh
Q 014406          274 KE----YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK  348 (425)
Q Consensus       274 ~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~  348 (425)
                      ..    .....+|..|+|||++.+ ..++.++|||||||++|||++ |+.|| .+.+..+....+....           
T Consensus       523 ~~~~~~~~~~~~t~~y~APE~~~~-~~~~~~sDvwSlGv~l~ellt~G~~Pf-~~~~~~~~~~~i~~~~-----------  589 (635)
T 4fl3_A          523 ENYYKAQTHGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPY-RGMKGSEVTAMLEKGE-----------  589 (635)
T ss_dssp             ------------CGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSS-TTCCHHHHHHHHHTTC-----------
T ss_pred             ccccccccCCCCceeeeChhhhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCC-CCCCHHHHHHHHHcCC-----------
Confidence            32    122345678999999977 789999999999999999998 99888 3333333333221100           


Q ss_pred             ccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhc
Q 014406          349 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  408 (425)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~  408 (425)
                                               .......+++++.+||.+||+.||++|||++++++
T Consensus       590 -------------------------~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~  624 (635)
T 4fl3_A          590 -------------------------RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL  624 (635)
T ss_dssp             -------------------------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             -------------------------CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence                                     00112237899999999999999999999999875

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=1.1e-41  Score=322.72  Aligned_cols=250  Identities=18%  Similarity=0.274  Sum_probs=192.6

Q ss_pred             EEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-------chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEE
Q 014406          127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (425)
Q Consensus       127 y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (425)
                      |...+.||+|+||+||+|.+  +++.||+|++...       ..+.+.+|+.+++++ +||||+++++++.+  ....++
T Consensus        33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~--~~~~~l  107 (307)
T 2nru_A           33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKC-QHENLVELLGFSSD--GDDLCL  107 (307)
T ss_dssp             TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHC-CCTTBCCEEEEECS--SSSCEE
T ss_pred             cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhc-CCCCeEEEEEEEec--CCceEE
Confidence            44457899999999999964  6889999998642       246788999999999 99999999999955  467899


Q ss_pred             EEEeecCCChhhhcC------CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCC
Q 014406          200 IFEYVNSTDFKVLYP------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (425)
Q Consensus       200 v~e~~~~~~l~~~~~------~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~  273 (425)
                      ||||+++++|.+++.      .+++..+..++.|++.||.|||+.||+|+||||+||+++.+ +.+||+|||+++.....
T Consensus       108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~-~~~kl~Dfg~~~~~~~~  186 (307)
T 2nru_A          108 VYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEA-FTAKISDFGLARASEKF  186 (307)
T ss_dssp             EEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTT-CCEEECCCTTCEECCSC
T ss_pred             EEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCC-CcEEEeecccccccccc
Confidence            999999999988763      48999999999999999999999999999999999999988 79999999999865433


Q ss_pred             Cc---ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC--CchhHHHHhh
Q 014406          274 KE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLG--TDELNAYLNK  348 (425)
Q Consensus       274 ~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg--~~~~~~~~~~  348 (425)
                      ..   .....+|..|+|||.+.+  .++.++|||||||++|+|++|..||..... .+.+..+.+.+.  ...+..+.  
T Consensus       187 ~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~--  261 (307)
T 2nru_A          187 AQTVMTSRIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLPAVDEHRE-PQLLLDIKEEIEDEEKTIEDYI--  261 (307)
T ss_dssp             SSCEECSSCCSCGGGCCHHHHTT--EECTHHHHHHHHHHHHHHHHCCCSBCTTBS-SSBTTHHHHHHHTTSCCHHHHS--
T ss_pred             cccccccccCCCcCcCChHHhcC--CCCccchhHHHHHHHHHHHHCCCCcccCcc-hHHHHHHHHHhhhhhhhhhhhc--
Confidence            22   223468999999999865  489999999999999999999999843322 222222211110  01111110  


Q ss_pred             ccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcC
Q 014406          349 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  409 (425)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~h  409 (425)
                                   ....         .......++.+.+++.+||+.||++|||+++++++
T Consensus       262 -------------~~~~---------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~  300 (307)
T 2nru_A          262 -------------DKKM---------NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL  300 (307)
T ss_dssp             -------------CSSC---------SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             -------------cccc---------cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence                         0000         00111245678999999999999999999999864

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=2.5e-42  Score=324.32  Aligned_cols=244  Identities=19%  Similarity=0.300  Sum_probs=189.1

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcC-CCc--EEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCC
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVN-TNE--RCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH  193 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~-~~~--~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  193 (425)
                      ..++|++.+.||+|+||+||+|.+.. +++  .||+|+++..      ..+.+.+|+.+++++ +||||+++++++.+. 
T Consensus        16 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~-   93 (291)
T 1u46_A           16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-DHRNLIRLYGVVLTP-   93 (291)
T ss_dssp             CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSS-
T ss_pred             chhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhC-CCCCcccEEEEEccC-
Confidence            46789999999999999999998643 333  6899998643      246788999999999 899999999999653 


Q ss_pred             CCccEEEEEeecCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEecccccc
Q 014406          194 SKTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (425)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~  269 (425)
                        ..++|+||+.+++|.+++    ..+++..+..++.|++.||.|||++||+|+||||+||+++.+ +.+||+|||++..
T Consensus        94 --~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~-~~~kl~Dfg~~~~  170 (291)
T 1u46_A           94 --PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATR-DLVKIGDFGLMRA  170 (291)
T ss_dssp             --SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEET-TEEEECCCTTCEE
T ss_pred             --CceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCC-CCEEEcccccccc
Confidence              378999999999998876    348999999999999999999999999999999999999988 7999999999987


Q ss_pred             ccCCCcc----eeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCCchhHH
Q 014406          270 YHPGKEY----NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNA  344 (425)
Q Consensus       270 ~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~lg~~~~~~  344 (425)
                      .......    ....++..|+|||++.+ ..++.++||||||+++|+|++ |..||. +.+..+....+... +      
T Consensus       171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~-~~~~~~~~~~~~~~-~------  241 (291)
T 1u46_A          171 LPQNDDHYVMQEHRKVPFAWCAPESLKT-RTFSHASDTWMFGVTLWEMFTYGQEPWI-GLNGSQILHKIDKE-G------  241 (291)
T ss_dssp             CCC-CCEEEC-----CCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCTTT-TCCHHHHHHHHHTS-C------
T ss_pred             ccccccchhhhccCCCCceeeCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCcc-cCCHHHHHHHHHcc-C------
Confidence            6543321    23456778999999977 678999999999999999999 898883 33322222222110 0      


Q ss_pred             HHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhc
Q 014406          345 YLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  408 (425)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~  408 (425)
                            .                      .......+++++.+++.+||+.||++|||+.++++
T Consensus       242 ------~----------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  277 (291)
T 1u46_A          242 ------E----------------------RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD  277 (291)
T ss_dssp             ------C----------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------C----------------------CCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence                  0                      00112237899999999999999999999999997

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=2.5e-42  Score=340.75  Aligned_cols=247  Identities=17%  Similarity=0.233  Sum_probs=185.8

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCC-CCe---------ee---
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGG-PNV---------VK---  184 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h-~ni---------v~---  184 (425)
                      ..+|...+.||+|+||+||+|.+..+++.||||++...      ..+.+.+|+.+++.+ .| +|.         +.   
T Consensus        77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l-~~~~~~~~~~~~~~~~~~~~  155 (413)
T 3dzo_A           77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLL-RGIKNQKQAKVHLRFIFPFD  155 (413)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGS-TTCCSHHHHHHHTCBCCCCE
T ss_pred             ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhh-ccCCCHHHHHHhcccccchh
Confidence            45688999999999999999999999999999998732      246788999999988 55 321         11   


Q ss_pred             ---------EEeEEEcCC---CCccEEEEEeecCCChhhhcC----------CCCHHHHHHHHHHHHHHHHHHHHCCcee
Q 014406          185 ---------LLDIVRDQH---SKTPSLIFEYVNSTDFKVLYP----------TLTDYDIRYYIYELLKALDYCHSQGIMH  242 (425)
Q Consensus       185 ---------l~~~~~~~~---~~~~~lv~e~~~~~~l~~~~~----------~l~~~~~~~i~~~i~~~L~~LH~~~ivH  242 (425)
                               +..++....   ....+++|+++ +++|.+++.          .+++..+..++.|++.||+|||++||+|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiH  234 (413)
T 3dzo_A          156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVH  234 (413)
T ss_dssp             EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence                     111111111   23455666654 466766652          2667788889999999999999999999


Q ss_pred             ecCCCCceEecCCCCcEEEEeccccccccCCCcceeeccCCCccCccccc---------CCCCCCCcccHHHHHHHHHHH
Q 014406          243 RDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV---------DLQDYDYSLDMWSLGCMFAGM  313 (425)
Q Consensus       243 ~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~---------~~~~~~~~~DvwslG~~l~el  313 (425)
                      |||||+|||++.+ +.+||+|||+++....  ......| +.|+|||++.         ....++.++|||||||++|+|
T Consensus       235 rDiKp~NILl~~~-~~~kL~DFG~a~~~~~--~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~el  310 (413)
T 3dzo_A          235 TYLRPVDIVLDQR-GGVFLTGFEHLVRDGA--SAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWI  310 (413)
T ss_dssp             SCCCGGGEEECTT-CCEEECCGGGCEETTE--EECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHH
T ss_pred             CCcccceEEEecC-CeEEEEeccceeecCC--ccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHH
Confidence            9999999999998 7899999999876542  2444567 9999999993         225688899999999999999


Q ss_pred             HhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcc
Q 014406          314 IFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLL  393 (425)
Q Consensus       314 ltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L  393 (425)
                      ++|+.||... +..+..                                       ...  ......+++++.+||.+||
T Consensus       311 ltg~~Pf~~~-~~~~~~---------------------------------------~~~--~~~~~~~~~~~~~li~~~l  348 (413)
T 3dzo_A          311 WCADLPNTDD-AALGGS---------------------------------------EWI--FRSCKNIPQPVRALLEGFL  348 (413)
T ss_dssp             HHSSCCCCTT-GGGSCS---------------------------------------GGG--GSSCCCCCHHHHHHHHHHT
T ss_pred             HHCCCCCCCc-chhhhH---------------------------------------HHH--HhhcccCCHHHHHHHHHHc
Confidence            9999998321 100000                                       000  0011237899999999999


Q ss_pred             cCCcCCCcCHHHHhcCCCCcccccc
Q 014406          394 RYDHQDRLTAREAMAHPYFAQVRAA  418 (425)
Q Consensus       394 ~~dP~~Rpta~elL~hp~~~~~~~~  418 (425)
                      +.||++|||+.|+++||||+++...
T Consensus       349 ~~dP~~Rpt~~~~l~~~~~~~~~~~  373 (413)
T 3dzo_A          349 RYPKEDRLLPLQAMETPEYEQLRTE  373 (413)
T ss_dssp             CSSGGGSCCHHHHTTSHHHHHHHHH
T ss_pred             cCChhhCcCHHHHHhCHHHHHHHHH
Confidence            9999999999999999999987543

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=2.4e-42  Score=331.69  Aligned_cols=246  Identities=19%  Similarity=0.263  Sum_probs=186.2

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc-----------hHHHHHHHHHHHHhc--------CCCCeee
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----------KKKIKREIKILQNLC--------GGPNVVK  184 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----------~~~~~~E~~~l~~l~--------~h~niv~  184 (425)
                      .++|++.+.||+|+||+||+|++  +++.||||++....           .+.+.+|+.+++.+.        +|+||++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~   96 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG   96 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred             cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence            46788899999999999999987  68999999997432           267899999999984        4888888


Q ss_pred             EEeEEEcC----------------------------CCCccEEEEEeecCCCh-hhhc-CCCCHHHHHHHHHHHHHHHHH
Q 014406          185 LLDIVRDQ----------------------------HSKTPSLIFEYVNSTDF-KVLY-PTLTDYDIRYYIYELLKALDY  234 (425)
Q Consensus       185 l~~~~~~~----------------------------~~~~~~lv~e~~~~~~l-~~~~-~~l~~~~~~~i~~~i~~~L~~  234 (425)
                      +.+.+...                            .....++||||+.+|++ ..+. ..+++..++.++.||+.||+|
T Consensus        97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~~~~~~~~~~i~~qi~~aL~~  176 (336)
T 2vuw_A           97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAV  176 (336)
T ss_dssp             EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTTCCCHHHHHHHHHHHHHHHHH
T ss_pred             hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhcCCCHHHHHHHHHHHHHHHHH
Confidence            88765311                            14789999999998854 4443 458999999999999999999


Q ss_pred             HH-HCCceeecCCCCceEecCCCC--------------------cEEEEeccccccccCCCcceeeccCCCccCcccccC
Q 014406          235 CH-SQGIMHRDVKPHNVMIDHELR--------------------KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD  293 (425)
Q Consensus       235 LH-~~~ivH~Dlk~~NIll~~~~~--------------------~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~  293 (425)
                      || ++||+||||||+|||++.+ +                    .+||+|||+|+.....    ..+||+.|+|||++.+
T Consensus       177 lH~~~~ivHrDlKp~NILl~~~-~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE~~~g  251 (336)
T 2vuw_A          177 AEASLRFEHRDLHWGNVLLKKT-SLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDEDLFTG  251 (336)
T ss_dssp             HHHHHCCBCSCCCGGGEEEEEC-SCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSGGGCC
T ss_pred             HHHhCCEeECCCCHHHEEEecc-CCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccChhhhcC
Confidence            99 9999999999999999987 4                    8999999999876532    4589999999999987


Q ss_pred             CCCCCCcccHHHHHHH-HHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCChhhHHHhcccCCCCcccc
Q 014406          294 LQDYDYSLDMWSLGCM-FAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKF  372 (425)
Q Consensus       294 ~~~~~~~~DvwslG~~-l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  372 (425)
                       .. +.++||||+|++ .+++++|..||.    +......+.+.        ........             ...    
T Consensus       252 -~~-~~~~Diwsl~~~~~~~~~~g~~p~~----~~~~~~~~~~~--------~~~~~~~~-------------~~~----  300 (336)
T 2vuw_A          252 -DG-DYQFDIYRLMKKENNNRWGEYHPYS----NVLWLHYLTDK--------MLKQMTFK-------------TKC----  300 (336)
T ss_dssp             -CS-SHHHHHHHHHHHHHTTCTTSCCTHH----HHHHHHHHHHH--------HHHTCCCS-------------SCC----
T ss_pred             -CC-ccceehhhhhCCCCcccccccCCCc----chhhhhHHHHh--------hhhhhccC-------------ccc----
Confidence             33 899999998877 677888988871    10000111100        00000000             000    


Q ss_pred             ccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHh-cCCCCc
Q 014406          373 INADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM-AHPYFA  413 (425)
Q Consensus       373 ~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL-~hp~~~  413 (425)
                       .......+++++++||++||++|     |++|+| +||||+
T Consensus       301 -~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~  336 (336)
T 2vuw_A          301 -NTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK  336 (336)
T ss_dssp             -CSHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred             -chhhhhhcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence             00001125789999999999977     999999 999995

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=6.7e-41  Score=348.11  Aligned_cols=244  Identities=22%  Similarity=0.405  Sum_probs=196.5

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCC---CcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCC
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNT---NERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~---~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (425)
                      ..++|++.+.||+|+||+||+|.+..+   +..||+|.++...    .+.+.+|+.+++++ +||||+++++++.+   .
T Consensus       388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~---~  463 (656)
T 2j0j_A          388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQF-DHPHIVKLIGVITE---N  463 (656)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECS---S
T ss_pred             ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEec---C
Confidence            457899999999999999999988653   4679999987532    36688999999999 99999999999843   4


Q ss_pred             ccEEEEEeecCCChhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEecccccccc
Q 014406          196 TPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (425)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~~----~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~  271 (425)
                      ..++||||+.+++|.+++.    .+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus       464 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~-~~vkL~DFG~a~~~~  542 (656)
T 2j0j_A          464 PVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSN-DCVKLGDFGLSRYME  542 (656)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEET-TEEEECCCCCCCSCC
T ss_pred             ceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCC-CCEEEEecCCCeecC
Confidence            5789999999999998873    48899999999999999999999999999999999999988 799999999998765


Q ss_pred             CCCcc--eeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhh
Q 014406          272 PGKEY--NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK  348 (425)
Q Consensus       272 ~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~  348 (425)
                      .....  ....++..|+|||++.+ ..++.++|||||||++|||++ |..|| .+.+..+.+..+....           
T Consensus       543 ~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~ellt~g~~Pf-~~~~~~~~~~~i~~~~-----------  609 (656)
T 2j0j_A          543 DSTYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPF-QGVKNNDVIGRIENGE-----------  609 (656)
T ss_dssp             C----------CCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTT-TTCCHHHHHHHHHHTC-----------
T ss_pred             CCcceeccCCCCCcceeCHHHhcC-CCCCchhhHHHHHHHHHHHHHcCCCCC-CCCCHHHHHHHHHcCC-----------
Confidence            43322  23455678999999977 689999999999999999997 88787 3444333333332100           


Q ss_pred             ccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcC
Q 014406          349 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  409 (425)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~h  409 (425)
                                               .......+++.+.+|+.+||+.||++|||+.|+++.
T Consensus       610 -------------------------~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~  645 (656)
T 2j0j_A          610 -------------------------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  645 (656)
T ss_dssp             -------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -------------------------CCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence                                     000122378999999999999999999999999853

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=2.3e-41  Score=322.14  Aligned_cols=242  Identities=19%  Similarity=0.315  Sum_probs=191.4

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCcc
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (425)
                      ..++|++.+.||+|+||+||+|.+..   .+|+|+++..     ..+.+.+|+.+++++ +|+||+++++++.+.  ...
T Consensus        31 ~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~--~~~  104 (319)
T 2y4i_B           31 PFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQT-RHENVVLFMGACMSP--PHL  104 (319)
T ss_dssp             CCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTC-CCTTBCCCCEEEECS--SCE
T ss_pred             CHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcC-CCCCEeEEEEEEecC--Cce
Confidence            46889999999999999999998753   4999998642     235678899999999 999999999999754  578


Q ss_pred             EEEEEeecCCChhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccC-
Q 014406          198 SLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP-  272 (425)
Q Consensus       198 ~lv~e~~~~~~l~~~~~----~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~-  272 (425)
                      ++||||+.+++|.+++.    .+++..+..++.|++.||+|||++||+|+||||+|||++ + +.+||+|||+++.... 
T Consensus       105 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~-~~~~l~Dfg~~~~~~~~  182 (319)
T 2y4i_B          105 AIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-N-GKVVITDFGLFSISGVL  182 (319)
T ss_dssp             EEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC----CCEECCCSCCC-----
T ss_pred             EEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-C-CCEEEeecCCccccccc
Confidence            99999999999998884    488999999999999999999999999999999999998 3 5899999999875432 


Q ss_pred             -----CCcceeeccCCCccCcccccC--------CCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCC
Q 014406          273 -----GKEYNVRVASRYFKGPELLVD--------LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT  339 (425)
Q Consensus       273 -----~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~  339 (425)
                           ........++..|+|||++.+        ...++.++|||||||++|+|++|+.||.. .+..+....+....  
T Consensus       183 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~-~~~~~~~~~~~~~~--  259 (319)
T 2y4i_B          183 QAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKT-QPAEAIIWQMGTGM--  259 (319)
T ss_dssp             -----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSS-CCHHHHHHHHHTTC--
T ss_pred             cccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHhccCC--
Confidence                 122334568899999999864        24578999999999999999999999832 22222222111100  


Q ss_pred             chhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhc
Q 014406          340 DELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  408 (425)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~  408 (425)
                                                .       .......++.++.+++.+||+.||++|||++++++
T Consensus       260 --------------------------~-------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  295 (319)
T 2y4i_B          260 --------------------------K-------PNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMD  295 (319)
T ss_dssp             --------------------------C-------CCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred             --------------------------C-------CCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence                                      0       00011236889999999999999999999999986

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.4e-40  Score=348.30  Aligned_cols=241  Identities=22%  Similarity=0.323  Sum_probs=196.3

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcC-CCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCC--
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVN-TNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK--  195 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~-~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~--  195 (425)
                      ..++|++.+.||+|+||+||+|.+.. +++.||||++....    ...+.+|+.+++++ +||||++++++|......  
T Consensus        78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~~  156 (681)
T 2pzi_A           78 VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEV-VHPSIVQIFNFVEHTDRHGD  156 (681)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGC-CCTTBCCEEEEEEEECTTSC
T ss_pred             eCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhc-CCCCcCeEeeeEeecCCCCC
Confidence            45899999999999999999999876 78999999986432    34678999999999 899999999999764321  


Q ss_pred             -ccEEEEEeecCCChhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCC
Q 014406          196 -TPSLIFEYVNSTDFKVLY-PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (425)
Q Consensus       196 -~~~lv~e~~~~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~  273 (425)
                       ..|+||||+++++|..++ ..+++.++..++.||+.||.|||++||+||||||+|||++.+  .+||+|||+++.....
T Consensus       157 ~~~~lv~E~~~g~~L~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~--~~kl~DFG~a~~~~~~  234 (681)
T 2pzi_A          157 PVGYIVMEYVGGQSLKRSKGQKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE--QLKLIDLGAVSRINSF  234 (681)
T ss_dssp             EEEEEEEECCCCEECC----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS--CEEECCCTTCEETTCC
T ss_pred             ceeEEEEEeCCCCcHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC--cEEEEecccchhcccC
Confidence             168999999999998876 469999999999999999999999999999999999999975  7899999999876533


Q ss_pred             CcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCC
Q 014406          274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL  353 (425)
Q Consensus       274 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~  353 (425)
                         ....||+.|+|||++.+  .++.++|||||||++|+|++|..||......           +.+.           .
T Consensus       235 ---~~~~gt~~y~aPE~~~~--~~~~~sDi~slG~~l~~l~~g~~~~~~~~~~-----------~~~~-----------~  287 (681)
T 2pzi_A          235 ---GYLYGTPGFQAPEIVRT--GPTVATDIYTVGRTLAALTLDLPTRNGRYVD-----------GLPE-----------D  287 (681)
T ss_dssp             ---SCCCCCTTTSCTTHHHH--CSCHHHHHHHHHHHHHHHHSCCCEETTEECS-----------SCCT-----------T
T ss_pred             ---CccCCCccccCHHHHcC--CCCCceehhhhHHHHHHHHhCCCCCcccccc-----------cccc-----------c
Confidence               45678999999999875  3589999999999999999998877311000           0000           0


Q ss_pred             ChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCccc
Q 014406          354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV  415 (425)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~  415 (425)
                      .+                      ....++.+.+||.+||+.||++||+..+.+.|+|+.-.
T Consensus       288 ~~----------------------~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~  327 (681)
T 2pzi_A          288 DP----------------------VLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL  327 (681)
T ss_dssp             CH----------------------HHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             cc----------------------ccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence            00                      00136789999999999999999999999999987644

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1.2e-39  Score=305.80  Aligned_cols=224  Identities=13%  Similarity=0.154  Sum_probs=178.2

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc------hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCc
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (425)
                      ..++|++.+.||+|+||+||+|.+..+++.||||++....      .+.+.+|+.++.++ +||||+++++++.+.  ..
T Consensus        29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~--~~  105 (286)
T 3uqc_A           29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRI-DKPGVARVLDVVHTR--AG  105 (286)
T ss_dssp             TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEET--TE
T ss_pred             ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcC-CCCCcceeeEEEEEC--Cc
Confidence            3578999999999999999999999999999999997542      26788999999999 999999999999764  67


Q ss_pred             cEEEEEeecCCChhhhcCC-CCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCc
Q 014406          197 PSLIFEYVNSTDFKVLYPT-LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (425)
Q Consensus       197 ~~lv~e~~~~~~l~~~~~~-l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~  275 (425)
                      .|+||||+++++|.+++.. ....++..++.|++.||+|||++||+||||||+|||++.+ +.+||+++|.         
T Consensus       106 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~-g~~kl~~~~~---------  175 (286)
T 3uqc_A          106 GLVVAEWIRGGSLQEVADTSPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSID-GDVVLAYPAT---------  175 (286)
T ss_dssp             EEEEEECCCEEEHHHHHTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETT-SCEEECSCCC---------
T ss_pred             EEEEEEecCCCCHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCC-CCEEEEeccc---------
Confidence            8999999999999988743 5667888999999999999999999999999999999988 7889885432         


Q ss_pred             ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCCh
Q 014406          276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP  355 (425)
Q Consensus       276 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~  355 (425)
                                ++        .++.++|||||||++|+|++|+.||...... +.+....+                    
T Consensus       176 ----------~~--------~~~~~~Di~slG~il~elltg~~Pf~~~~~~-~~~~~~~~--------------------  216 (286)
T 3uqc_A          176 ----------MP--------DANPQDDIRGIGASLYALLVNRWPLPEAGVR-SGLAPAER--------------------  216 (286)
T ss_dssp             ----------CT--------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBC-CCSEECCB--------------------
T ss_pred             ----------cC--------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcc-hhhHHHHH--------------------
Confidence                      22        3689999999999999999999998432211 00000000                    


Q ss_pred             hhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcC
Q 014406          356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  409 (425)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~h  409 (425)
                              .....  ..........+++++.+|+.+||+.||++| |++|+++.
T Consensus       217 --------~~~~~--~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~  259 (286)
T 3uqc_A          217 --------DTAGQ--PIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNL  259 (286)
T ss_dssp             --------CTTSC--BCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHH
T ss_pred             --------HhccC--CCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHH
Confidence                    00000  000001123478999999999999999999 99999873

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.97  E-value=4.3e-34  Score=291.92  Aligned_cols=183  Identities=20%  Similarity=0.141  Sum_probs=129.2

Q ss_pred             eeeeeCceEEEEEEEcCCCcEEEEEEecCc-------------chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccE
Q 014406          132 KVGRGKYSEVFEGINVNTNERCIIKILKPV-------------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (425)
Q Consensus       132 ~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-------------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (425)
                      .++.|++|.+..++..-.|+.+++|++...             ..+++.+|+++|+++..|+||++++++++++  ...|
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~--~~~y  318 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENA--QSGW  318 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECS--SEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEEC--CEEE
Confidence            467788888877777778999999999642             1356899999999998899999999999654  7899


Q ss_pred             EEEEeecCCChhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCC-Ccce
Q 014406          199 LIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-KEYN  277 (425)
Q Consensus       199 lv~e~~~~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~-~~~~  277 (425)
                      |||||++|++|.+++..........|+.||+.||+|||++|||||||||+|||++.+ +.+||+|||+|+..... ....
T Consensus       319 LVMEyv~G~~L~d~i~~~~~l~~~~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~d-g~vKL~DFGlAr~~~~~~~~~~  397 (569)
T 4azs_A          319 LVMEKLPGRLLSDMLAAGEEIDREKILGSLLRSLAALEKQGFWHDDVRPWNVMVDAR-QHARLIDFGSIVTTPQDCSWPT  397 (569)
T ss_dssp             EEEECCCSEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHTTCEESCCCGGGEEECTT-SCEEECCCTTEESCC---CCSH
T ss_pred             EEEecCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHCCceeccCchHhEEECCC-CCEEEeecccCeeCCCCCcccc
Confidence            999999999999988432222234589999999999999999999999999999988 79999999999876543 3345


Q ss_pred             eeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCC
Q 014406          278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEP  319 (425)
Q Consensus       278 ~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~p  319 (425)
                      ..+||+.|+|||++.+  .+..++|+||+|++++++.++..+
T Consensus       398 t~vGTp~YmAPE~l~g--~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          398 NLVQSFFVFVNELFAE--NKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             HHHHHHHHHHHHHC-------------------CCCCTTHHH
T ss_pred             CceechhhccHHHhCC--CCCCcccccccccchhhhccccch
Confidence            5689999999999975  467889999999998887665444

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.95  E-value=3.8e-28  Score=246.64  Aligned_cols=180  Identities=17%  Similarity=0.232  Sum_probs=140.3

Q ss_pred             EEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc-----------hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCc
Q 014406          128 EVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (425)
Q Consensus       128 ~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (425)
                      ...+.||+|+||+||+|  ...+..+++|......           .+.+.+|+++++++ +||||+++..++...  ..
T Consensus       339 ~~~~~LG~G~fg~Vy~~--~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~--~~  413 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRD--SYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALV-KDFGIPAPYIFDVDL--DN  413 (540)
T ss_dssp             ---------CCEEEEEE--ECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHG-GGGTCCCCCEEEEET--TT
T ss_pred             CCCCEEeeCCCEEEEEE--EECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhc-CCCCcCceEEEEEeC--Cc
Confidence            44568999999999999  4457788998864321           24478999999999 999999555544433  45


Q ss_pred             cEEEEEeecCCChhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCcc
Q 014406          197 PSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY  276 (425)
Q Consensus       197 ~~lv~e~~~~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~~  276 (425)
                      .++||||+++++|.+++..     +..++.|++.||+|||++||+||||||+|||++.   .+||+|||+++........
T Consensus       414 ~~lVmE~~~ggsL~~~l~~-----~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~---~~kL~DFGla~~~~~~~~~  485 (540)
T 3en9_A          414 KRIMMSYINGKLAKDVIED-----NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK---DLYIIDFGLGKISNLDEDK  485 (540)
T ss_dssp             TEEEEECCCSEEHHHHSTT-----CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS---SEEECCCTTCEECCCHHHH
T ss_pred             cEEEEECCCCCCHHHHHHH-----HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC---eEEEEECccCEECCCcccc
Confidence            6899999999999999876     6789999999999999999999999999999997   7999999999877543221


Q ss_pred             --------eeeccCCCccCcccccCC-CCCCCcccHHHHHHHHHHHHhCCCCC
Q 014406          277 --------NVRVASRYFKGPELLVDL-QDYDYSLDMWSLGCMFAGMIFRKEPF  320 (425)
Q Consensus       277 --------~~~~~t~~y~aPE~~~~~-~~~~~~~DvwslG~~l~elltg~~pf  320 (425)
                              ....||+.|+|||++... ..|+..+|+||..+-..+-+.++.+|
T Consensus       486 ~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          486 AVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             HHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             ccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence                    345889999999998641 34778899999999888888877666

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.92  E-value=3.5e-25  Score=206.62  Aligned_cols=143  Identities=18%  Similarity=0.243  Sum_probs=118.0

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc---------------------chHHHHHHHHHHHHhcCCCCe
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---------------------KKKKIKREIKILQNLCGGPNV  182 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~---------------------~~~~~~~E~~~l~~l~~h~ni  182 (425)
                      ...|++.+.||+|+||.||+|.+ .+++.||+|+++..                     ....+.+|+.+++++ +  | 
T Consensus        89 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l-~--~-  163 (282)
T 1zar_A           89 GKVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL-Q--G-  163 (282)
T ss_dssp             TSCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT-T--T-
T ss_pred             CeEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc-c--C-
Confidence            45677889999999999999998 88999999999632                     234588999999999 4  5 


Q ss_pred             eeEEeEEEcCCCCccEEEEEeecCCChhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEE
Q 014406          183 VKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLI  262 (425)
Q Consensus       183 v~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~  262 (425)
                      +++.+++..   ...++||||+++++|.. +.   ......++.|++.||.|||+.||+||||||+|||++ + +.+||+
T Consensus       164 ~~v~~~~~~---~~~~lvmE~~~g~~L~~-l~---~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~-~~vkl~  234 (282)
T 1zar_A          164 LAVPKVYAW---EGNAVLMELIDAKELYR-VR---VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-E-EGIWII  234 (282)
T ss_dssp             SSSCCEEEE---ETTEEEEECCCCEEGGG-CC---CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-T-TEEEEC
T ss_pred             CCcCeEEec---cceEEEEEecCCCcHHH-cc---hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-C-CcEEEE
Confidence            666666643   45689999999999988 42   233557999999999999999999999999999999 6 799999


Q ss_pred             eccccccccCCCcceeeccCCCccCccccc
Q 014406          263 DWGLAEFYHPGKEYNVRVASRYFKGPELLV  292 (425)
Q Consensus       263 Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~  292 (425)
                      |||+|+.            +..++|||++.
T Consensus       235 DFG~a~~------------~~~~~a~e~l~  252 (282)
T 1zar_A          235 DFPQSVE------------VGEEGWREILE  252 (282)
T ss_dssp             CCTTCEE------------TTSTTHHHHHH
T ss_pred             ECCCCeE------------CCCCCHHHHHH
Confidence            9999964            23467888874

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.87  E-value=4.4e-22  Score=183.31  Aligned_cols=135  Identities=18%  Similarity=0.206  Sum_probs=108.1

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcCCCcE--EEEEEecCcc---------------------------hHHHHHHHHHHHHh
Q 014406          126 DYEVVRKVGRGKYSEVFEGINVNTNER--CIIKILKPVK---------------------------KKKIKREIKILQNL  176 (425)
Q Consensus       126 ~y~~~~~LG~G~fg~V~~~~~~~~~~~--vavK~~~~~~---------------------------~~~~~~E~~~l~~l  176 (425)
                      -|++.+.||+|+||.||+|.+..+|+.  ||||+++...                           ...+.+|+.++..+
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  127 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA  127 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence            478899999999999999988778989  9999975321                           12578899999999


Q ss_pred             cCCCCe--eeEEeEEEcCCCCccEEEEEeecC-C----ChhhhcCCCCHHHHHHHHHHHHHHHHHHH-HCCceeecCCCC
Q 014406          177 CGGPNV--VKLLDIVRDQHSKTPSLIFEYVNS-T----DFKVLYPTLTDYDIRYYIYELLKALDYCH-SQGIMHRDVKPH  248 (425)
Q Consensus       177 ~~h~ni--v~l~~~~~~~~~~~~~lv~e~~~~-~----~l~~~~~~l~~~~~~~i~~~i~~~L~~LH-~~~ivH~Dlk~~  248 (425)
                       .|+++  ...++.      ...+|||||+++ |    +|.......++..+..++.|++.||.||| +.||+||||||+
T Consensus       128 -~~~~i~~p~~~~~------~~~~lVmE~~g~~g~~~~~L~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~  200 (258)
T 1zth_A          128 -KEAGVSVPQPYTY------MKNVLLMEFIGEDELPAPTLVELGRELKELDVEGIFNDVVENVKRLYQEAELVHADLSEY  200 (258)
T ss_dssp             -HHTTCCCCCEEEE------ETTEEEEECCEETTEECCBHHHHGGGGGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTT
T ss_pred             -HhCCCCCCeEEEc------CCCEEEEEecCCCCCccccHHHHhhccChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHH
Confidence             66653  344432      245799999953 3    56655444445678899999999999999 999999999999


Q ss_pred             ceEecCCCCcEEEEeccccccc
Q 014406          249 NVMIDHELRKLRLIDWGLAEFY  270 (425)
Q Consensus       249 NIll~~~~~~~kl~Dfg~a~~~  270 (425)
                      |||++.   .++|+|||+|...
T Consensus       201 NILl~~---~~~liDFG~a~~~  219 (258)
T 1zth_A          201 NIMYID---KVYFIDMGQAVTL  219 (258)
T ss_dssp             SEEESS---SEEECCCTTCEET
T ss_pred             HEEEcC---cEEEEECcccccC
Confidence            999987   6899999999754

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.73  E-value=7.5e-18  Score=161.64  Aligned_cols=134  Identities=16%  Similarity=0.241  Sum_probs=99.4

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc-----------------hHH--------HHHHHHHHHHhcCC
Q 014406          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----------------KKK--------IKREIKILQNLCGG  179 (425)
Q Consensus       125 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----------------~~~--------~~~E~~~l~~l~~h  179 (425)
                      .-|++.+.||.|+||.||+|.+ .+|+.||||+++...                 ...        ..+|...|.++ .+
T Consensus        95 ~iY~I~~~IG~Gk~a~VY~a~d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL-~~  172 (397)
T 4gyi_A           95 DVYSVGSRIGVGKESDIMIVAD-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKAL-YE  172 (397)
T ss_dssp             SCSEEEEEEEECSSEEEEEEEC-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHH-HH
T ss_pred             CEEEecCEeeeCCceEEEEEEC-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH-Hh
Confidence            3489999999999999999976 568999999975310                 011        23577777777 33


Q ss_pred             CCe--eeEEeEEEcCCCCccEEEEEeecCCChhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCC
Q 014406          180 PNV--VKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELR  257 (425)
Q Consensus       180 ~ni--v~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~  257 (425)
                      ..+  ...++..      ..+|||||++|+.+..+...   .....++.|++.+|.|||++|||||||||.|||++.+..
T Consensus       173 ~gv~vp~p~~~~------~~~LVME~i~G~~L~~l~~~---~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd  243 (397)
T 4gyi_A          173 EGFPVPEPIAQS------RHTIVMSLVDALPMRQVSSV---PDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKD  243 (397)
T ss_dssp             TTCSCCCEEEEE------TTEEEEECCSCEEGGGCCCC---SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEEC
T ss_pred             cCCCCCeeeecc------CceEEEEecCCccHhhhccc---HHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCC
Confidence            333  2222221      23699999999988766432   234567899999999999999999999999999987621


Q ss_pred             ---------cEEEEecccccc
Q 014406          258 ---------KLRLIDWGLAEF  269 (425)
Q Consensus       258 ---------~~kl~Dfg~a~~  269 (425)
                               .+.|+||+-+..
T Consensus       244 ~~d~~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          244 AEDPSSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             SSCTTSEEEEEEECCCTTCEE
T ss_pred             cccccccccceEEEEeCCccc
Confidence                     379999997654

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.45  E-value=4.5e-13  Score=123.03  Aligned_cols=137  Identities=18%  Similarity=0.237  Sum_probs=110.6

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecC---cchHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEE
Q 014406          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP---VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (425)
Q Consensus       125 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (425)
                      +.|++...+|.|+.+.||++..  .+..+++|+...   .....+.+|+.+++.+.++..+.++++++.+  ....++||
T Consensus        14 ~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~--~~~~~lv~   89 (263)
T 3tm0_A           14 EKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERH--DGWSNLLM   89 (263)
T ss_dssp             TTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE--TTEEEEEE
T ss_pred             ccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEec--CCceEEEE
Confidence            3578888899999999999853  367899999875   4456799999999999667778899998865  36788999


Q ss_pred             EeecCCChhhhcCCCCHHHHHHHHHHHHHHHHHHHH--------------------------------------------
Q 014406          202 EYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHS--------------------------------------------  237 (425)
Q Consensus       202 e~~~~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~--------------------------------------------  237 (425)
                      ||++|.++......  ......++.+++.+|..||+                                            
T Consensus        90 e~i~G~~l~~~~~~--~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (263)
T 3tm0_A           90 SEADGVLCSEEYED--EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDP  167 (263)
T ss_dssp             ECCSSEEHHHHCCT--TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSH
T ss_pred             EecCCeehhhccCC--cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCH
Confidence            99999999876432  22334678899999999998                                            


Q ss_pred             ---------------CCceeecCCCCceEecCCCCcEEEEeccccc
Q 014406          238 ---------------QGIMHRDVKPHNVMIDHELRKLRLIDWGLAE  268 (425)
Q Consensus       238 ---------------~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~  268 (425)
                                     ..++|+|+++.|||++.+ +.+.|+||+.+.
T Consensus       168 ~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~-~~~~lIDwe~a~  212 (263)
T 3tm0_A          168 RELYDFLKTEKPEEELVFSHGDLGDSNIFVKDG-KVSGFIDLGRSG  212 (263)
T ss_dssp             HHHHHHHHHCCCCCCEEEECSSCCTTSEEEETT-EEEEECCCTTCE
T ss_pred             HHHHHHHHhcCCCCCceEECCCCCcCcEEEECC-cEEEEEEchhcc
Confidence                           458999999999999865 456799998774

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.35  E-value=5.1e-12  Score=115.49  Aligned_cols=135  Identities=18%  Similarity=0.171  Sum_probs=100.4

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcchHHHHHHHHHHHHhcCCCC-eeeEEeEEEcCCCCccEEEEEee
Q 014406          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPN-VVKLLDIVRDQHSKTPSLIFEYV  204 (425)
Q Consensus       126 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~n-iv~l~~~~~~~~~~~~~lv~e~~  204 (425)
                      +|.+....+.|..+.||++. ..+|..+++|+........+.+|+.+++.+..+.- +.+++++..+.  ...++||||+
T Consensus        21 ~~~~~~~~~gg~~~~v~~~~-~~~g~~~vlK~~~~~~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~--~~~~~v~e~i   97 (264)
T 1nd4_A           21 GYDWAQQTIGCSDAAVFRLS-AQGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTEA--GRDWLLLGEV   97 (264)
T ss_dssp             TCEEEECSCTTSSCEEEEEE-CTTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEECS--SCEEEEEECC
T ss_pred             CCceEecccCCCCceEEEEe-cCCCCeEEEEeCCcccchhhhHHHHHHHHHHhCCCCCCeEEEeccCC--CCCEEEEEec
Confidence            45554444466669999984 45677899999876655678899999999954422 56688877543  5578999999


Q ss_pred             cCCChhhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---------------------------------------------
Q 014406          205 NSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQG---------------------------------------------  239 (425)
Q Consensus       205 ~~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~---------------------------------------------  239 (425)
                      +|.++.  ......   ..++.+++..|..||+..                                             
T Consensus        98 ~G~~l~--~~~~~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (264)
T 1nd4_A           98 PGQDLL--SSHLAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA  172 (264)
T ss_dssp             SSEETT--TSCCCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred             CCcccC--cCcCCH---hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHH
Confidence            999885  333332   356778888888888643                                             


Q ss_pred             -------------ceeecCCCCceEecCCCCcEEEEecccccc
Q 014406          240 -------------IMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (425)
Q Consensus       240 -------------ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~  269 (425)
                                   ++|+|++|.||+++.+ +.+.|+|||.+..
T Consensus       173 ~l~~~~~~~~~~~l~HgDl~~~Nil~~~~-~~~~liD~~~a~~  214 (264)
T 1nd4_A          173 RLKARMPDGEDLVVTHGDACLPNIMVENG-RFSGFIDCGRLGV  214 (264)
T ss_dssp             HHHHTCCSSCCEEEECSSCCGGGEEEETT-EEEEECCCTTCEE
T ss_pred             HHHHhcCCCCCeEEECCCCCCCcEEEECC-cEEEEEcchhccc
Confidence                         9999999999999876 4567999998753

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.26  E-value=3.9e-11  Score=115.40  Aligned_cols=140  Identities=20%  Similarity=0.358  Sum_probs=107.8

Q ss_pred             EeeeeeeCceEEEEEEEcCCCcEEEEEEec--Ccc----hHHHHHHHHHHHHhcC-CCCeeeEEeEEEcCCC-CccEEEE
Q 014406          130 VRKVGRGKYSEVFEGINVNTNERCIIKILK--PVK----KKKIKREIKILQNLCG-GPNVVKLLDIVRDQHS-KTPSLIF  201 (425)
Q Consensus       130 ~~~LG~G~fg~V~~~~~~~~~~~vavK~~~--~~~----~~~~~~E~~~l~~l~~-h~niv~l~~~~~~~~~-~~~~lv~  201 (425)
                      ++.|+.|.++.||+...  .+..+++|+..  ...    ...+.+|..+++.+.. +..+.+++.++.+... +..++||
T Consensus        43 ~~~l~~G~sn~~y~v~~--~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm  120 (359)
T 3dxp_A           43 VEQFKGGQSNPTFKLVT--PGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM  120 (359)
T ss_dssp             EEECCC-CCSCEEEEEC--SSCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred             EEEcCCcccceEEEEEE--CCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence            56799999999999854  34678888876  332    3578899999999943 3457889988865421 4578999


Q ss_pred             EeecCCChh-hhcCCCCHHHHHHHHHHHHHHHHHHHH-------------------------------------------
Q 014406          202 EYVNSTDFK-VLYPTLTDYDIRYYIYELLKALDYCHS-------------------------------------------  237 (425)
Q Consensus       202 e~~~~~~l~-~~~~~l~~~~~~~i~~~i~~~L~~LH~-------------------------------------------  237 (425)
                      ||++|..+. .....++..+...++.+++..|..||+                                           
T Consensus       121 e~v~G~~l~~~~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  200 (359)
T 3dxp_A          121 EFVSGRVLWDQSLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSL  200 (359)
T ss_dssp             ECCCCBCCCCTTCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHH
T ss_pred             EecCCeecCCCccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHH
Confidence            999999885 355678888899999999999999997                                           


Q ss_pred             ---------------CCceeecCCCCceEecCCCC-cEEEEecccccccc
Q 014406          238 ---------------QGIMHRDVKPHNVMIDHELR-KLRLIDWGLAEFYH  271 (425)
Q Consensus       238 ---------------~~ivH~Dlk~~NIll~~~~~-~~kl~Dfg~a~~~~  271 (425)
                                     .+++|+|+++.|||++.+.. .+.|+||+.+....
T Consensus       201 ~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g~  250 (359)
T 3dxp_A          201 MDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLGH  250 (359)
T ss_dssp             HHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEEC
T ss_pred             HHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccCC
Confidence                           35899999999999997633 35899999987543

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.13  E-value=6.4e-11  Score=111.15  Aligned_cols=185  Identities=17%  Similarity=0.229  Sum_probs=124.1

Q ss_pred             eeeeeeCceEEEEEEEcCCCcEEEEEEecCc-chHHHHHHHHHHHHhcCCCC--eeeEEeEEEcCCC-CccEEEEEeecC
Q 014406          131 RKVGRGKYSEVFEGINVNTNERCIIKILKPV-KKKKIKREIKILQNLCGGPN--VVKLLDIVRDQHS-KTPSLIFEYVNS  206 (425)
Q Consensus       131 ~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~~h~n--iv~l~~~~~~~~~-~~~~lv~e~~~~  206 (425)
                      +.++.|.++.||+..     ..+++|+.... ....+.+|..+++.+..+..  +.+.+........ ...++||++++|
T Consensus        26 ~~~~~G~~n~v~~v~-----~~~vlR~~~~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G  100 (304)
T 3sg8_A           26 EISGEGNDCIAYEIN-----RDFIFKFPKHSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKG  100 (304)
T ss_dssp             CEEEECSSEEEEEST-----TSEEEEEESSHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCC
T ss_pred             EecCCCCcceEEEEC-----CEEEEEecCCcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCC
Confidence            358999999999862     56889987644 34678899999998844333  3444444322211 245799999999


Q ss_pred             CChhh-hcCCCCHHHHHHHHHHHHHHHHHHHH------------------------------------------------
Q 014406          207 TDFKV-LYPTLTDYDIRYYIYELLKALDYCHS------------------------------------------------  237 (425)
Q Consensus       207 ~~l~~-~~~~l~~~~~~~i~~~i~~~L~~LH~------------------------------------------------  237 (425)
                      ..+.. ....++..+...++.+++..|..||+                                                
T Consensus       101 ~~l~~~~~~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  180 (304)
T 3sg8_A          101 VPLTPLLLNNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYRDI  180 (304)
T ss_dssp             EECCHHHHHTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHHHH
T ss_pred             eECCccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHHHH
Confidence            98864 44667888888899999999999986                                                


Q ss_pred             ----------CCceeecCCCCceEecCC-CCcEEEEeccccccccCCCcceeeccCCCccCcccc----cCCC-------
Q 014406          238 ----------QGIMHRDVKPHNVMIDHE-LRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL----VDLQ-------  295 (425)
Q Consensus       238 ----------~~ivH~Dlk~~NIll~~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~----~~~~-------  295 (425)
                                ..++|+|+++.||+++.+ .+.+.|+||+.+....+............-..|+..    ..+.       
T Consensus       181 l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~~~~~  260 (304)
T 3sg8_A          181 LENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHKDIPTV  260 (304)
T ss_dssp             HTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCSCHHHH
T ss_pred             HhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCCCcHHH
Confidence                      136999999999999974 256789999998765432211111000000122211    0000       


Q ss_pred             --CCCCcccHHHHHHHHHHHHhCCCCC
Q 014406          296 --DYDYSLDMWSLGCMFAGMIFRKEPF  320 (425)
Q Consensus       296 --~~~~~~DvwslG~~l~elltg~~pf  320 (425)
                        ....-.+.|++|.++|.+.+|..+|
T Consensus       261 ~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          261 LEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence              1122368999999999999998766

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.78  E-value=1.1e-07  Score=89.08  Aligned_cols=137  Identities=18%  Similarity=0.259  Sum_probs=99.1

Q ss_pred             EeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-chHHHHHHHHHHHHhcCCC--CeeeEEeEEEcCCCCccEEEEEeecC
Q 014406          130 VRKVGRGKYSEVFEGINVNTNERCIIKILKPV-KKKKIKREIKILQNLCGGP--NVVKLLDIVRDQHSKTPSLIFEYVNS  206 (425)
Q Consensus       130 ~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~~h~--niv~l~~~~~~~~~~~~~lv~e~~~~  206 (425)
                      ++.++.|....||+.     +..+++|+-... ....+.+|..+|+.+.++-  .+.+.+.+.... .+..++||||++|
T Consensus        24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~-~g~~~~v~e~i~G   97 (306)
T 3tdw_A           24 VESLGEGFRNYAILV-----NGDWVFRFPKSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRS-DGNPFVGYRKVQG   97 (306)
T ss_dssp             EEEEEECSSEEEEEE-----TTTEEEEEESSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECT-TSCEEEEEECCCS
T ss_pred             eeecCCCcceeEEEE-----CCEEEEEecCCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccC-CCceEEEEeccCC
Confidence            346889999999997     567888986432 3467889999999994431  355666666532 3567899999999


Q ss_pred             CChhh-hcCCCCHHHHHHHHHHHHHHHHHHHHC-----------------------------------------------
Q 014406          207 TDFKV-LYPTLTDYDIRYYIYELLKALDYCHSQ-----------------------------------------------  238 (425)
Q Consensus       207 ~~l~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~-----------------------------------------------  238 (425)
                      ..+.. ....++..+...++.++...|..||+.                                               
T Consensus        98 ~~l~~~~~~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~  177 (306)
T 3tdw_A           98 QILGEDGMAVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQ  177 (306)
T ss_dssp             EECHHHHHTTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHHH
T ss_pred             eECchhhhhhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHHH
Confidence            98865 345566666666777777777776642                                               


Q ss_pred             -------------CceeecCCCCceEecC---CCCcEEEEeccccccccC
Q 014406          239 -------------GIMHRDVKPHNVMIDH---ELRKLRLIDWGLAEFYHP  272 (425)
Q Consensus       239 -------------~ivH~Dlk~~NIll~~---~~~~~kl~Dfg~a~~~~~  272 (425)
                                   .++|+|+++.||+++.   +...+.|+||+.+....+
T Consensus       178 ~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~gd~  227 (306)
T 3tdw_A          178 SYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISDP  227 (306)
T ss_dssp             HHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEECG
T ss_pred             HHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCCCH
Confidence                         2499999999999987   324458999998876543

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.73  E-value=7.1e-08  Score=88.48  Aligned_cols=134  Identities=14%  Similarity=0.106  Sum_probs=96.0

Q ss_pred             eeeeeCce-EEEEEEEcCCCcEEEEEEecCcchHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEEEeecCCChh
Q 014406          132 KVGRGKYS-EVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFK  210 (425)
Q Consensus       132 ~LG~G~fg-~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~  210 (425)
                      .+..|..| +||+.....++..+++|+-.......+.+|...|+.+..+--+.++++++.+.  ...++|||+++|.++.
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~--~~~~lvme~l~G~~~~  108 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGSVANDVTDEMVRLNWLTAFMPLPTIKHFIRTP--DDAWLLTTAIPGKTAF  108 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETHHHHHHHHHHHHHHHHTTTSCCCCEEEEEEET--TEEEEEEECCCSEEHH
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCCCHhHHHHHHHHHHHhccCCCcCeEEEEEEEC--CeEEEEEEeeCCcccc
Confidence            35556655 69998777778889999988777778999999999985554567888888654  5678999999998776


Q ss_pred             hhcCCCCHHHHHHHHHHHHHHHHHHHH---------------------------------------------------C-
Q 014406          211 VLYPTLTDYDIRYYIYELLKALDYCHS---------------------------------------------------Q-  238 (425)
Q Consensus       211 ~~~~~l~~~~~~~i~~~i~~~L~~LH~---------------------------------------------------~-  238 (425)
                      ...... ......+..++...|.-||+                                                   . 
T Consensus       109 ~~~~~~-~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  187 (272)
T 4gkh_A          109 QVLEEY-PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLL  187 (272)
T ss_dssp             HHHHHC-GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTC
T ss_pred             ccccCC-HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhcc
Confidence            543221 11223344445555555542                                                   1 


Q ss_pred             ------CceeecCCCCceEecCCCCcEEEEecccccc
Q 014406          239 ------GIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (425)
Q Consensus       239 ------~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~  269 (425)
                            .++|+|+.+.|||++.+ +.+-|+||+.+..
T Consensus       188 ~~~~~~~l~HGDl~~~Nil~~~~-~~~~viDwe~a~~  223 (272)
T 4gkh_A          188 PFSPDSVVTHGDFSLDNLIFDEG-KLIGCIDVGRVGI  223 (272)
T ss_dssp             CCCCCEEEECSCCCTTSEEEETT-EEEEECCCTTCEE
T ss_pred             cccCCcEEEcCCCCCCeEEEECC-eEEEEEECccccc
Confidence                  26899999999999976 5567999998754

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.46  E-value=4.6e-07  Score=86.63  Aligned_cols=83  Identities=13%  Similarity=0.157  Sum_probs=58.6

Q ss_pred             EEEeee-eeeCceEEEEEEEc--C----CCcEEEEEEecCcc------hHHHHHHHHHHHHhcCC--CCeeeEEeEEEcC
Q 014406          128 EVVRKV-GRGKYSEVFEGINV--N----TNERCIIKILKPVK------KKKIKREIKILQNLCGG--PNVVKLLDIVRDQ  192 (425)
Q Consensus       128 ~~~~~L-G~G~fg~V~~~~~~--~----~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h--~niv~l~~~~~~~  192 (425)
                      ...+.| +.|..+.+|+....  .    ++..+++|+.....      ...+.+|..+++.+..+  -.+.+++.++.+.
T Consensus        23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~  102 (357)
T 3ats_A           23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTG  102 (357)
T ss_dssp             EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS
T ss_pred             EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC
Confidence            345678 88989999987543  0    25678999876432      35688999999988544  3567788877543


Q ss_pred             C-CCccEEEEEeecCCChh
Q 014406          193 H-SKTPSLIFEYVNSTDFK  210 (425)
Q Consensus       193 ~-~~~~~lv~e~~~~~~l~  210 (425)
                      . ....++||||++|..+.
T Consensus       103 ~~~g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          103 DVLGTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             TTTSSCEEEEECCCCBCCC
T ss_pred             CccCCceEEEEecCCCChh
Confidence            2 13467999999987765

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.20  E-value=5.8e-06  Score=80.15  Aligned_cols=74  Identities=18%  Similarity=0.213  Sum_probs=49.6

Q ss_pred             EeeeeeeCceEEEEEEEcCCCcEEEEEEecCc----------chHHHHHHHHHHHHhcCC-C-CeeeEEeEEEcCCCCcc
Q 014406          130 VRKVGRGKYSEVFEGINVNTNERCIIKILKPV----------KKKKIKREIKILQNLCGG-P-NVVKLLDIVRDQHSKTP  197 (425)
Q Consensus       130 ~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~----------~~~~~~~E~~~l~~l~~h-~-niv~l~~~~~~~~~~~~  197 (425)
                      .+.||.|.++.||++....++..+++|...+.          ..+.+..|.++++.+... + .+.+++.+.  .  ...
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~--~~~  110 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--T--EMA  110 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--T--TTT
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--C--Ccc
Confidence            45799999999999976556788999986432          234567899999987432 3 344565442  2  345


Q ss_pred             EEEEEeecCC
Q 014406          198 SLIFEYVNST  207 (425)
Q Consensus       198 ~lv~e~~~~~  207 (425)
                      ++||||+++.
T Consensus       111 ~lvmE~l~g~  120 (397)
T 2olc_A          111 VTVMEDLSHL  120 (397)
T ss_dssp             EEEECCCTTS
T ss_pred             EEEEEeCCCc
Confidence            7999999764

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.02  E-value=2.2e-05  Score=74.09  Aligned_cols=135  Identities=16%  Similarity=0.229  Sum_probs=78.6

Q ss_pred             EeeeeeeCceEEEEEEEcCCCcEEEEEEecCcchHHHHHHHHHHHHhcCC-CCeeeEEeE-----EEcCCCCccEEEEEe
Q 014406          130 VRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGG-PNVVKLLDI-----VRDQHSKTPSLIFEY  203 (425)
Q Consensus       130 ~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h-~niv~l~~~-----~~~~~~~~~~lv~e~  203 (425)
                      ++.|+.|..+.||+... .+ ..+++|+... ....+..|..+++.|..+ -.+.+++..     +. ...+..+++|+|
T Consensus        37 ~~~l~gG~~n~~~~v~~-~~-~~~vlk~~~~-~~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~-~~~~~~~~l~~~  112 (346)
T 2q83_A           37 IDVIQGNQMALVWKVHT-DS-GAVCLKRIHR-PEKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYS-KHGSFLFVVYDW  112 (346)
T ss_dssp             EEECC----CEEEEEEE-TT-EEEEEEEECS-CHHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCE-EETTEEEEEEEC
T ss_pred             eeeccccccCcEEEEEe-CC-CCEEEEecCC-CHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEE-EECCEEEEEEEe
Confidence            34577778899999854 33 3589999876 334556677777766321 133444431     11 112457899999


Q ss_pred             ecCCChhh-----h------c-------CCC-------------CHHH-------------------------------H
Q 014406          204 VNSTDFKV-----L------Y-------PTL-------------TDYD-------------------------------I  221 (425)
Q Consensus       204 ~~~~~l~~-----~------~-------~~l-------------~~~~-------------------------------~  221 (425)
                      ++|..+..     .      +       ..+             .+..                               +
T Consensus       113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  192 (346)
T 2q83_A          113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI  192 (346)
T ss_dssp             CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred             ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence            99865420     0      0       111             1110                               0


Q ss_pred             HHHHHHHHHHHHHHHH-------------CCceeecCCCCceEecCCCCcEEEEecccccc
Q 014406          222 RYYIYELLKALDYCHS-------------QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (425)
Q Consensus       222 ~~i~~~i~~~L~~LH~-------------~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~  269 (425)
                      ..+..++..++++|++             .+++|+|+++.|||++.+ +.+.|+||+.+..
T Consensus       193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~-~~~~lIDfe~a~~  252 (346)
T 2q83_A          193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGEN-EQIWVIDLDTVSF  252 (346)
T ss_dssp             HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGG-GCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCC-CcEEEEehhhccc
Confidence            1111223345666652             479999999999999766 5789999998753

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.93  E-value=8e-05  Score=69.54  Aligned_cols=76  Identities=20%  Similarity=0.186  Sum_probs=60.1

Q ss_pred             EeeeeeeCceEEEEEEEcCCCcEEEEEEecCcchHHHHHHHHHHHHhcCC--CCeeeEEeEEEcCCCCccEEEEEeecCC
Q 014406          130 VRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGG--PNVVKLLDIVRDQHSKTPSLIFEYVNST  207 (425)
Q Consensus       130 ~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h--~niv~l~~~~~~~~~~~~~lv~e~~~~~  207 (425)
                      .+.|+.|.+..+|+...  ++..+++|+........+..|...|+.|...  ..+.+.+.+....  ...++||||+++.
T Consensus        41 ~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~--g~~~lvme~l~G~  116 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLIND--EVQTVFVKINERSYRSMFRAEADQLALLAKTNSINVPLVYGIGNSQ--GHSFLLLEALNKS  116 (312)
T ss_dssp             EEEECCSSSSEEEEEES--SSCEEEEEEEEGGGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECS--SEEEEEEECCCCC
T ss_pred             eEEeCCccceeeeEEEE--CCCeEEEEeCCcccHHHHHHHHHHHHHHHhhCCCCcceEEEEeecC--CceEEEEEeccCC
Confidence            46799999999999853  4678889998766667789999999988433  5677888877543  5678999999987


Q ss_pred             Ch
Q 014406          208 DF  209 (425)
Q Consensus       208 ~l  209 (425)
                      .+
T Consensus       117 ~~  118 (312)
T 3jr1_A          117 KN  118 (312)
T ss_dssp             CC
T ss_pred             CC
Confidence            64

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.81  E-value=9.5e-05  Score=68.63  Aligned_cols=70  Identities=11%  Similarity=0.078  Sum_probs=46.0

Q ss_pred             EeeeeeeCceEEEEEEEcCCCcEEEEEEecCcch--HHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEEEee-cC
Q 014406          130 VRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK--KKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV-NS  206 (425)
Q Consensus       130 ~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~--~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~-~~  206 (425)
                      ++.|+.|....+|+.      ..+++|+......  -...+|..+++.+..+.-..+++..+  ..  .-++++||+ ++
T Consensus        23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~--~~~~v~e~i~~g   92 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHVD--PA--TGVMVTRYIAGA   92 (301)
T ss_dssp             CEEEESCSSEEEEEE------TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TT--TCCEEEECCTTC
T ss_pred             eeEcCCcccccccee------eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEEE--CC--CCEEEEeecCCC
Confidence            457899999999998      5688998865322  23467888888774333235666544  22  235899999 66


Q ss_pred             CCh
Q 014406          207 TDF  209 (425)
Q Consensus       207 ~~l  209 (425)
                      ..+
T Consensus        93 ~~l   95 (301)
T 3dxq_A           93 QTM   95 (301)
T ss_dssp             EEC
T ss_pred             ccC
Confidence            554

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.71  E-value=9.7e-05  Score=69.15  Aligned_cols=139  Identities=15%  Similarity=0.181  Sum_probs=80.9

Q ss_pred             EEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-chHHHHHHHHHHHHhcCCC-CeeeEEeEEEc----CCCCccEEEE
Q 014406          128 EVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-KKKKIKREIKILQNLCGGP-NVVKLLDIVRD----QHSKTPSLIF  201 (425)
Q Consensus       128 ~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~~h~-niv~l~~~~~~----~~~~~~~lv~  201 (425)
                      .-++.|+.|....+|+.... ++ .+++|+.... ....+..|..+++.+..+. .+.+++....+    ...+..++++
T Consensus        25 ~~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~  102 (322)
T 2ppq_A           25 TSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALI  102 (322)
T ss_dssp             EEEEEECC---EEEEEEEES-SC-CEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEE
T ss_pred             eEeeccCCCcccceEEEEeC-Cc-cEEEEEeCCCCCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEE
Confidence            34567888999999998543 33 6889998763 4567788999988884331 13333321100    0123467999


Q ss_pred             EeecCCChhhh------------------cCCC--------CHHHHHH---------------HHHHHHHHHHHHHH---
Q 014406          202 EYVNSTDFKVL------------------YPTL--------TDYDIRY---------------YIYELLKALDYCHS---  237 (425)
Q Consensus       202 e~~~~~~l~~~------------------~~~l--------~~~~~~~---------------i~~~i~~~L~~LH~---  237 (425)
                      +|++|..+...                  ...+        .......               +...+...++++.+   
T Consensus       103 ~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~  182 (322)
T 2ppq_A          103 SFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWP  182 (322)
T ss_dssp             ECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCC
T ss_pred             EeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCc
Confidence            99998654210                  0111        1111110               00123445566653   


Q ss_pred             ----CCceeecCCCCceEecCCCCcEEEEecccccc
Q 014406          238 ----QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (425)
Q Consensus       238 ----~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~  269 (425)
                          .+++|+|+.+.|||++.+ +.+.|+||+.+..
T Consensus       183 ~~~~~~liHgDl~~~Nil~~~~-~~~~lIDf~~a~~  217 (322)
T 2ppq_A          183 KDLPAGVIHADLFQDNVFFLGD-ELSGLIDFYFACN  217 (322)
T ss_dssp             CSSCEEEECSCCCGGGEEEETT-EEEEECCCTTCEE
T ss_pred             ccCCcccCCCCCCccCEEEeCC-ceEEEecchhccC
Confidence                369999999999999876 4457999998754

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.70  E-value=6.4e-05  Score=73.40  Aligned_cols=78  Identities=13%  Similarity=0.128  Sum_probs=46.7

Q ss_pred             HCCceeecCCCCceEecCCCCcEEEEeccccccccCCCcceeecc--CCCccCcccccCCC--CCCCcccHHHHHHHHHH
Q 014406          237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA--SRYFKGPELLVDLQ--DYDYSLDMWSLGCMFAG  312 (425)
Q Consensus       237 ~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~--t~~y~aPE~~~~~~--~~~~~~DvwslG~~l~e  312 (425)
                      ...++|+|+++.|||++.+ + +.|+||+.+....+.........  ...|.+|+......  .-....++.+....+|+
T Consensus       231 ~~~liHGDl~~~Nil~~~~-~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQD-S-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN  308 (420)
T ss_dssp             CCEEECSCCSGGGEEECSS-C-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred             CCeEEecCCCCCcEEEeCC-C-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence            4579999999999999977 4 89999999876543222211111  12355655443211  11123445567777777


Q ss_pred             HHhC
Q 014406          313 MIFR  316 (425)
Q Consensus       313 lltg  316 (425)
                      .+.+
T Consensus       309 ~y~~  312 (420)
T 2pyw_A          309 LFNK  312 (420)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            6654

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.68  E-value=0.00017  Score=70.60  Aligned_cols=74  Identities=15%  Similarity=0.174  Sum_probs=53.2

Q ss_pred             EeeeeeeCceEEEEEEEcC-------CCcEEEEEEecCcch-HHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEE
Q 014406          130 VRKVGRGKYSEVFEGINVN-------TNERCIIKILKPVKK-KKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (425)
Q Consensus       130 ~~~LG~G~fg~V~~~~~~~-------~~~~vavK~~~~~~~-~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (425)
                      ++.|+.|....||++....       ++..+++|+...... ..+.+|..+++.+..+.-..++++.+  .+    .+|+
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~~~~li~E~~~l~~L~~~g~~P~l~~~~--~~----g~v~  151 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIF--SG----GRLE  151 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEE--TT----EEEE
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCcHHHHHHHHHHHHHHHhCCCCCcEEEEe--CC----CEEE
Confidence            4568889999999997542       257899999854233 66778999999885444446777776  32    2899


Q ss_pred             EeecCCCh
Q 014406          202 EYVNSTDF  209 (425)
Q Consensus       202 e~~~~~~l  209 (425)
                      ||++|..+
T Consensus       152 e~l~G~~l  159 (429)
T 1nw1_A          152 EYIPSRPL  159 (429)
T ss_dssp             CCCCEEEC
T ss_pred             EEeCCccc
Confidence            99987543

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.65  E-value=0.00011  Score=69.25  Aligned_cols=136  Identities=15%  Similarity=0.139  Sum_probs=73.2

Q ss_pred             eeeeeeCceE-EEEEEEcCCCcEEEEEEecCcchHHHHHHHHHHHHhcCCC-CeeeEEeEEEcCCCCccEEEEEeecCCC
Q 014406          131 RKVGRGKYSE-VFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGP-NVVKLLDIVRDQHSKTPSLIFEYVNSTD  208 (425)
Q Consensus       131 ~~LG~G~fg~-V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~-niv~l~~~~~~~~~~~~~lv~e~~~~~~  208 (425)
                      +.|+.|+... +|+.. ..++..+++|...+.....+..|+.+++.+..+. .+.+++.+.  ...+  +++||++++..
T Consensus        24 ~~l~gg~s~~~~~r~~-~~~~~~~vlk~~~~~~~~~~~~e~~~l~~L~~~g~~vP~v~~~d--~~~g--~ll~e~l~~~~   98 (333)
T 3csv_A           24 TPLAGDASSRRYQRLR-SPTGAKAVLMDWSPEEGGDTQPFVDLAQYLRNLDISAPEIYAEE--HARG--LLLIEDLGDAL   98 (333)
T ss_dssp             CC--------CCEEEE-CTTCCEEEEEECCTTTTCCSHHHHHHHHHHHHTTCBCCCEEEEE--TTTT--EEEECCCCSCB
T ss_pred             eECCCCCCCceEEEEE-cCCCCeEEEEECCCCCCccccHHHHHHHHHHhCCCCCCceeeec--CCCC--EEEEeeCCCcc
Confidence            3566665554 66763 3335677787765443356677888888874332 355666653  2222  68999987755


Q ss_pred             hhhhc-----------------------------CCCCHHHHH-------H-HH------------HHHHHHHHHHH---
Q 014406          209 FKVLY-----------------------------PTLTDYDIR-------Y-YI------------YELLKALDYCH---  236 (425)
Q Consensus       209 l~~~~-----------------------------~~l~~~~~~-------~-i~------------~~i~~~L~~LH---  236 (425)
                      +...+                             +.+......       . +.            ..+...++.|-   
T Consensus        99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~  178 (333)
T 3csv_A           99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ  178 (333)
T ss_dssp             HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence            43211                             011111110       0 00            01112233331   


Q ss_pred             ---HCCceeecCCCCceEecCC---CCcEEEEecccccccc
Q 014406          237 ---SQGIMHRDVKPHNVMIDHE---LRKLRLIDWGLAEFYH  271 (425)
Q Consensus       237 ---~~~ivH~Dlk~~NIll~~~---~~~~kl~Dfg~a~~~~  271 (425)
                         ...++|+|+.+.|||++.+   .+.+.|+||+.+....
T Consensus       179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~  219 (333)
T 3csv_A          179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH  219 (333)
T ss_dssp             CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred             ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence               2369999999999999863   1468999999887543

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.52  E-value=0.0004  Score=66.61  Aligned_cols=133  Identities=13%  Similarity=0.192  Sum_probs=82.8

Q ss_pred             eeeeeeCceEEEEEEEcC-------CCcEEEEEEecCc--chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEE
Q 014406          131 RKVGRGKYSEVFEGINVN-------TNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (425)
Q Consensus       131 ~~LG~G~fg~V~~~~~~~-------~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (425)
                      +.|..|-...+|++....       ++..+++|+....  ......+|..+++.+..+.-..++++.+  ++    .+||
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~--~~----g~v~  129 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVF--PE----GRLE  129 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEE--TT----EEEE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEc--CC----ccEE
Confidence            357778888899986532       3578999987432  3456678999999885554456777776  32    2999


Q ss_pred             EeecCCChhhh--c-----------------------CCCC--HHHHHHHHHHHHH-------------------HHHHH
Q 014406          202 EYVNSTDFKVL--Y-----------------------PTLT--DYDIRYYIYELLK-------------------ALDYC  235 (425)
Q Consensus       202 e~~~~~~l~~~--~-----------------------~~l~--~~~~~~i~~~i~~-------------------~L~~L  235 (425)
                      ||++|..+..-  .                       ....  +.++..+..++..                   .++.|
T Consensus       130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L  209 (379)
T 3feg_A          130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL  209 (379)
T ss_dssp             ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred             EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence            99998655311  0                       0111  3445555544322                   23444


Q ss_pred             HH--------CCceeecCCCCceEecCC---CCcEEEEecccccc
Q 014406          236 HS--------QGIMHRDVKPHNVMIDHE---LRKLRLIDWGLAEF  269 (425)
Q Consensus       236 H~--------~~ivH~Dlk~~NIll~~~---~~~~kl~Dfg~a~~  269 (425)
                      .+        ..++|+|+.+.||+++.+   .+.+.++||..+..
T Consensus       210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            32        258999999999999875   35789999998854

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.49  E-value=0.0013  Score=60.51  Aligned_cols=77  Identities=14%  Similarity=0.108  Sum_probs=55.4

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc---chHHHHHHHHHHHHhcCCC--CeeeEEeEEEcCCCCccEE
Q 014406          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGP--NVVKLLDIVRDQHSKTPSL  199 (425)
Q Consensus       125 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~--niv~l~~~~~~~~~~~~~l  199 (425)
                      ....-++.+|.|..+.||+.. ..+|+.+++|+....   ....+..|...|+.|....  -+.+++++.  .    -++
T Consensus        15 ~~v~~v~~~g~G~~~~vyrv~-l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~--~----~~l   87 (288)
T 3f7w_A           15 REVAAVAERGHSHRWHLYRVE-LADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD--D----RTL   87 (288)
T ss_dssp             CCEEEEEEEEEETTEEEEEEE-ETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE--T----TEE
T ss_pred             CCeEEEEecCCCCCeEEEEEE-ECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc--C----ceE
Confidence            345667889999999999985 567889999987543   2346889999999884331  344555542  2    359


Q ss_pred             EEEeecCCC
Q 014406          200 IFEYVNSTD  208 (425)
Q Consensus       200 v~e~~~~~~  208 (425)
                      ||||+.++.
T Consensus        88 v~e~l~~~~   96 (288)
T 3f7w_A           88 AMEWVDERP   96 (288)
T ss_dssp             EEECCCCCC
T ss_pred             EEEeecccC
Confidence            999997764

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.49  E-value=0.00067  Score=66.77  Aligned_cols=74  Identities=15%  Similarity=0.216  Sum_probs=50.3

Q ss_pred             EeeeeeeCceEEEEEEEcCCCcEEEEEEecCcchH--HHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEEEeecCC
Q 014406          130 VRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKK--KIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST  207 (425)
Q Consensus       130 ~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~--~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~  207 (425)
                      ++.|+.|-...+|++....++..+++|+.......  ...+|..+++.|..+.-..++++.+  .+    .+||||++|.
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~--~~----G~v~e~I~G~  186 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFF--TN----GRIEEFMDGY  186 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEE--TT----EEEEECCCSE
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEe--CC----eEEEEeeCCc
Confidence            45788899999999976544578999998543221  1268999999995444446788877  32    2699999875


Q ss_pred             Ch
Q 014406          208 DF  209 (425)
Q Consensus       208 ~l  209 (425)
                      .+
T Consensus       187 ~l  188 (458)
T 2qg7_A          187 AL  188 (458)
T ss_dssp             EC
T ss_pred             cC
Confidence            54

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.42  E-value=0.00047  Score=64.61  Aligned_cols=133  Identities=15%  Similarity=0.165  Sum_probs=79.4

Q ss_pred             eeeeeCceEEEEEEEcCCCcEEEEEEecCc--chHHHHHHHHHHHHhcCCC-CeeeEEeEEEcC----CCCccEEEEEee
Q 014406          132 KVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGP-NVVKLLDIVRDQ----HSKTPSLIFEYV  204 (425)
Q Consensus       132 ~LG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~-niv~l~~~~~~~----~~~~~~lv~e~~  204 (425)
                      .|+ |....||+.. ..+|+.+++|+..+.  ....+..|..+++.+..+. .+.+++.. .+.    ..+..+++|+++
T Consensus        33 ~l~-g~~n~~y~v~-~~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~-~g~~~~~~~g~~~~l~~~i  109 (328)
T 1zyl_A           33 PLN-SYENRVYQFQ-DEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAF-NGQTLLNHQGFYFAVFPSV  109 (328)
T ss_dssp             EEC-CSSSEEEEEC-CTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCB-TTBSCEEETTEEEEEEECC
T ss_pred             eec-CcccceEEEE-cCCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeec-CCcEEEEECCEEEEEEEec
Confidence            466 8888999874 345667999999743  4567888999998884331 24444443 110    123457899999


Q ss_pred             cCCChhh-----h------c-------C--------CCCHHHH----HHHH---------------HHHHHHHHHHH---
Q 014406          205 NSTDFKV-----L------Y-------P--------TLTDYDI----RYYI---------------YELLKALDYCH---  236 (425)
Q Consensus       205 ~~~~l~~-----~------~-------~--------~l~~~~~----~~i~---------------~~i~~~L~~LH---  236 (425)
                      +|..+..     .      +       .        ..+....    ..++               ..+-..++.+.   
T Consensus       110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  189 (328)
T 1zyl_A          110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW  189 (328)
T ss_dssp             CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence            8865421     0      0       0        0111111    1111               01111233332   


Q ss_pred             ----HCCceeecCCCCceEecCCCCcEEEEeccccccc
Q 014406          237 ----SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  270 (425)
Q Consensus       237 ----~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~  270 (425)
                          ...++|+|+++.|||++ +  .+.|+||+.+...
T Consensus       190 ~~~~~~~l~HgD~~~~Nil~~-~--~~~lIDfe~a~~g  224 (328)
T 1zyl_A          190 REDFTVLRLHGDCHAGNILWR-D--GPMFVDLDDARNG  224 (328)
T ss_dssp             CSCSCCEECCSSCSGGGEEES-S--SEEECCCTTCCEE
T ss_pred             hhcCCeeeeeCCCCcccEeEc-C--CCEEEECCCCCcC
Confidence                23589999999999998 4  6899999987654

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.24  E-value=0.0011  Score=63.30  Aligned_cols=74  Identities=15%  Similarity=0.198  Sum_probs=46.4

Q ss_pred             EeeeeeeCceEEEEEEEcC--------CCcEEEEEEecCcchH--HHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEE
Q 014406          130 VRKVGRGKYSEVFEGINVN--------TNERCIIKILKPVKKK--KIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (425)
Q Consensus       130 ~~~LG~G~fg~V~~~~~~~--------~~~~vavK~~~~~~~~--~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (425)
                      ...|+.|....+|+.....        .+..+++|+.......  ....|..+++.+..+.-+.++++.+  .  .  ++
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~--~~  111 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF--N--G--GR  111 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--T--EE
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec--C--C--cE
Confidence            3468888889999986543        1368899987643221  2468999999884443345677654  2  2  58


Q ss_pred             EEEeecCCCh
Q 014406          200 IFEYVNSTDF  209 (425)
Q Consensus       200 v~e~~~~~~l  209 (425)
                      ||||++|..+
T Consensus       112 v~e~i~G~~l  121 (369)
T 3c5i_A          112 IEEWLYGDPL  121 (369)
T ss_dssp             EEECCCSEEC
T ss_pred             EEEEecCCcC
Confidence            9999988643

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.80  E-value=0.0059  Score=57.52  Aligned_cols=71  Identities=8%  Similarity=0.189  Sum_probs=44.4

Q ss_pred             eeeCceEEEEEEEcCCCcEEEEEEecCcchHHHHHHHHHHHHhcCC--CCeeeEEeEEEc----CCCCccEEEEEeecCC
Q 014406          134 GRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGG--PNVVKLLDIVRD----QHSKTPSLIFEYVNST  207 (425)
Q Consensus       134 G~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h--~niv~l~~~~~~----~~~~~~~lv~e~~~~~  207 (425)
                      |.|....||+.. ..+| .+++|+......   ..|+.+++.|..+  +++.+.+....+    ......+++|+|++|.
T Consensus        32 G~g~~N~vy~v~-~~~g-~~vLK~~~~~~~---~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~G~  106 (339)
T 3i1a_A           32 GADTNAFAYQAD-SESK-SYFIKLKYGYHD---EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHAP  106 (339)
T ss_dssp             TSCSSCEEEEEE-CSSC-EEEEEEEECSSC---CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCCCC
T ss_pred             cCccccceEEEE-eCCC-CEEEEEecCccc---hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccCCC
Confidence            444478999984 3445 899998875442   5677777776322  334555432111    1135678999999987


Q ss_pred             Ch
Q 014406          208 DF  209 (425)
Q Consensus       208 ~l  209 (425)
                      .+
T Consensus       107 ~~  108 (339)
T 3i1a_A          107 NG  108 (339)
T ss_dssp             BT
T ss_pred             cC
Confidence            65

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=96.56  E-value=0.023  Score=49.32  Aligned_cols=97  Identities=9%  Similarity=0.005  Sum_probs=59.8

Q ss_pred             Chhhhc----CCCCHHHHHHHHHHHHHHHHHHHH-CCceeecCCCCceEecCCCCcEEEEeccccccccCCCcceeeccC
Q 014406          208 DFKVLY----PTLTDYDIRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVAS  282 (425)
Q Consensus       208 ~l~~~~----~~l~~~~~~~i~~~i~~~L~~LH~-~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t  282 (425)
                      +|...+    ..+++++++.++.|.+.+|.-+-. ..-..+=+.|..|++..+ |.|.+.+ +.+.           ...
T Consensus        34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~d-G~V~f~~-~~s~-----------~~~  100 (229)
T 2yle_A           34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRD-GAVTLAP-AADD-----------AGE  100 (229)
T ss_dssp             EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETT-SCEEECC-C-----------------
T ss_pred             cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecC-Cceeccc-cccc-----------ccc
Confidence            455544    679999999999999998877621 111233345688888888 6765553 1110           112


Q ss_pred             CCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCC
Q 014406          283 RYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEP  319 (425)
Q Consensus       283 ~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~p  319 (425)
                      ..+.+||...  ...+.+.-|||+|+++|.-+--..|
T Consensus       101 ~~~~~pe~~~--~~~te~~~IysLG~tLY~ALDygL~  135 (229)
T 2yle_A          101 PPPVAGKLGY--SQCMETEVIESLGIIIYKALDYGLK  135 (229)
T ss_dssp             ------CCSS--SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             cCCCChhhcc--ccchHHHHHHHHHHHHHHHhhcCCC
Confidence            3456888763  3557888999999999999864444

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.41  E-value=0.0096  Score=57.79  Aligned_cols=74  Identities=16%  Similarity=0.205  Sum_probs=50.5

Q ss_pred             EeeeeeeCceEEEEEEEcCC-------CcEEEEEEecCcch--HHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEE
Q 014406          130 VRKVGRGKYSEVFEGINVNT-------NERCIIKILKPVKK--KKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (425)
Q Consensus       130 ~~~LG~G~fg~V~~~~~~~~-------~~~vavK~~~~~~~--~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (425)
                      ++.|..|-...+|+......       +..+++++......  -...+|..+++.+..+.-..++++.+  .    -++|
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~----~~~I  148 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADF--P----EGRI  148 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T----TEEE
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEc--C----CCEE
Confidence            34677788889999875421       57899999754321  23468999998885454456677654  2    2589


Q ss_pred             EEeecCCCh
Q 014406          201 FEYVNSTDF  209 (425)
Q Consensus       201 ~e~~~~~~l  209 (425)
                      +||++|..+
T Consensus       149 ~efI~G~~l  157 (424)
T 3mes_A          149 EEFIDGEPL  157 (424)
T ss_dssp             EECCCSEEC
T ss_pred             EEEeCCccC
Confidence            999998764

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=96.21  E-value=0.016  Score=55.84  Aligned_cols=30  Identities=30%  Similarity=0.556  Sum_probs=24.7

Q ss_pred             ceeecCCCCceEecC-----CCCcEEEEecccccc
Q 014406          240 IMHRDVKPHNVMIDH-----ELRKLRLIDWGLAEF  269 (425)
Q Consensus       240 ivH~Dlk~~NIll~~-----~~~~~kl~Dfg~a~~  269 (425)
                      ++|+|+.+.|||+..     +.+.+.++||.+|..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            689999999999942     336799999998864

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	425
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	1e-113
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	3e-63
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	3e-59
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	3e-57
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	5e-57
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	2e-55
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	3e-55
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	4e-55
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	9e-55
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	1e-54
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	4e-54
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-53
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-53
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	5e-53
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	1e-52
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	3e-52
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	1e-51
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	1e-51
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	1e-50
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	3e-50
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	3e-50
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	5e-49
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	3e-48
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	4e-48
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	6e-47
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	1e-45
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	6e-45
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	7e-45
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	4e-44
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	3e-43
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	8e-43
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	4e-40
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	3e-38
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	4e-38
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	4e-38
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	8e-38
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	8e-38
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	9e-37
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	1e-36
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	5e-36
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	4e-35
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	6e-35
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	7e-35
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	1e-34
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	2e-34
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	6e-34
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	7e-34
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-33
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	7e-33
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	1e-32
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	2e-32
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	2e-32
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	1e-31
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-31
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	9e-31
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	4e-30
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	8e-29
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	5e-28
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	2e-27
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	2e-27
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	4e-27
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	4e-26
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	1e-18

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  332 bits (851), Expect = e-113
 Identities = 248/325 (76%), Positives = 291/325 (89%)

Query: 92  PAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNE 151
           P  S+ARVYTDVN  RP+EYWDYES  V+WG+QDDY++VRK+GRGKYSEVFE IN+  NE
Sbjct: 2   PVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNE 61

Query: 152 RCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV 211
           + ++KILKPVKKKKIKREIKIL+NL GGPN++ L DIV+D  S+TP+L+FE+VN+TDFK 
Sbjct: 62  KVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ 121

Query: 212 LYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271
           LY TLTDYDIR+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYH
Sbjct: 122 LYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 181

Query: 272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
           PG+EYNVRVASRYFKGPELLVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHDN+DQLV
Sbjct: 182 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 241

Query: 332 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDK 391
           +IAKVLGT++L  Y++KY++ELDP+ + ++GRHSRK W +F++++NQHLVSPEA+DFLDK
Sbjct: 242 RIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDK 301

Query: 392 LLRYDHQDRLTAREAMAHPYFAQVR 416
           LLRYDHQ RLTAREAM HPYF  V 
Sbjct: 302 LLRYDHQSRLTAREAMEHPYFYTVV 326

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  205 bits (522), Expect = 3e-63
 Identities = 92/304 (30%), Positives = 146/304 (48%), Gaps = 21/304 (6%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNV 182
            +  Y   + +G G +  V++    ++ E   IK +    K+   RE++I++ L    N+
Sbjct: 18  QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-DKRFKNRELQIMRKL-DHCNI 75

Query: 183 VKLLDIVRDQHSKTPS----LIFEYVNSTDFKVL------YPTLTDYDIRYYIYELLKAL 232
           V+L         K       L+ +YV  T ++V         TL    ++ Y+Y+L ++L
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135

Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 292
            Y HS GI HRD+KP N+++D +   L+L D+G A+    G+     + SRY++ PEL+ 
Sbjct: 136 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIF 195

Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE 352
              DY  S+D+WS GC+ A ++  + P F G    DQLV+I KVLGT             
Sbjct: 196 GATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY 254

Query: 353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 412
            + +      +    PW+K           PEAI    +LL Y    RLT  EA AH +F
Sbjct: 255 TEFKFP----QIKAHPWTKVFRPR----TPPEAIALCSRLLEYTPTARLTPLEACAHSFF 306

Query: 413 AQVR 416
            ++R
Sbjct: 307 DELR 310

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (493), Expect = 3e-59
 Identities = 60/309 (19%), Positives = 117/309 (37%), Gaps = 20/309 (6%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK----PVKKKKIKREIKILQNLCGGP 180
           DD+E + ++G G    VF+  +  +      K++     P  + +I RE+++L      P
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS-P 64

Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALDYCHS 237
            +V              S+  E+++      +      + +  +      ++K L Y   
Sbjct: 65  YIVGFYGAFYSDGE--ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 122

Query: 238 Q-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
           +  IMHRDVKP N++++     ++L D+G++         N  V +R +  PE L     
Sbjct: 123 KHKIMHRDVKPSNILVNSRGE-IKLCDFGVSGQLIDSM-ANSFVGTRSYMSPERLQG-TH 179

Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT------DELNAYLNKYH 350
           Y    D+WS+G     M   + P         +L+   +V G                  
Sbjct: 180 YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSS 239

Query: 351 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHP 410
             +D +    +        ++        + S E  DF++K L  +  +R   ++ M H 
Sbjct: 240 YGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHA 299

Query: 411 YFAQVRAAE 419
           +  +  A E
Sbjct: 300 FIKRSDAEE 308

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (481), Expect = 3e-57
 Identities = 84/304 (27%), Positives = 153/304 (50%), Gaps = 21/304 (6%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK----KKIKREIKILQNLCGGP 180
             Y  +  +G G Y  V    +     R  IK + P +     ++  REIKIL       
Sbjct: 8   PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRH-E 66

Query: 181 NVVKLLDIVRD---QHSKTPSLIFEYVNSTDFKVL-YPTLTDYDIRYYIYELLKALDYCH 236
           N++ + DI+R    +  K   L+   + +  +K+L    L++  I Y++Y++L+ L Y H
Sbjct: 67  NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126

Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV----RVASRYFKGPELLV 292
           S  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE+++
Sbjct: 127 SANVLHRDLKPSNLLLNTTCD-LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 185

Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE 352
           + + Y  S+D+WS+GC+ A M+  + P F G    DQL  I  +LG+          +L+
Sbjct: 186 NSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 244

Query: 353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 412
               L + +   ++ PW++            +A+D LDK+L ++   R+   +A+AHPY 
Sbjct: 245 ARNYLLS-LPHKNKVPWNRLFPN-----ADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 298

Query: 413 AQVR 416
            Q  
Sbjct: 299 EQYY 302

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (480), Expect = 5e-57
 Identities = 88/319 (27%), Positives = 163/319 (51%), Gaps = 21/319 (6%)

Query: 111 YWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-----PVKKKK 165
           ++  E     W  +  Y  ++ VG G Y  V   ++  T  +  IK L       +  K+
Sbjct: 4   FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63

Query: 166 IKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS----LIFEYVNSTDFKVL-YPTLTDYD 220
             RE+++L+++    NV+ LLD+     +        L+  ++ +   K++ +  L +  
Sbjct: 64  AYRELRLLKHMRH-ENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDR 122

Query: 221 IRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRV 280
           I++ +Y++LK L Y H+ GI+HRD+KP N+ ++ +    +++D+GLA       E    V
Sbjct: 123 IQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCEL-KILDFGLA--RQADSEMTGYV 179

Query: 281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTD 340
            +R+++ PE++++   Y  ++D+WS+GC+ A MI  K  F  G D+ DQL +I KV GT 
Sbjct: 180 VTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLF-KGSDHLDQLKEIMKVTGTP 238

Query: 341 ELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDR 400
               ++ +   +        +    +K ++  +        SP A++ L+K+L  D + R
Sbjct: 239 PAE-FVQRLQSDEAKNYMKGLPELEKKDFASILTN-----ASPLAVNLLEKMLVLDAEQR 292

Query: 401 LTAREAMAHPYFAQVRAAE 419
           +TA EA+AHPYF  +   E
Sbjct: 293 VTAGEALAHPYFESLHDTE 311

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (467), Expect = 2e-55
 Identities = 90/307 (29%), Positives = 150/307 (48%), Gaps = 27/307 (8%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK-----IKREIKILQNLCGG 179
             YE + K+G+G + EVF+  +  T ++  +K +    +K+       REIKILQ L   
Sbjct: 10  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL-KH 68

Query: 180 PNVVKLLDIVRDQHSK------TPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLK 230
            NVV L++I R + S       +  L+F++       +L       T  +I+  +  LL 
Sbjct: 69  ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLN 128

Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-----YNVRVASRYF 285
            L Y H   I+HRD+K  NV+I  +   L+L D+GLA  +   K      Y  RV + ++
Sbjct: 129 GLYYIHRNKILHRDMKAANVLITRDGV-LKLADFGLARAFSLAKNSQPNRYTNRVVTLWY 187

Query: 286 KGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAY 345
           + PELL+  +DY   +D+W  GC+ A M  R  P   G+    QL  I+++ G+     +
Sbjct: 188 RPPELLLGERDYGPPIDLWGAGCIMAEMWTRS-PIMQGNTEQHQLALISQLCGSITPEVW 246

Query: 346 LNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTARE 405
            N  + EL  +L+ +     +    K  +    ++  P A+D +DKLL  D   R+ + +
Sbjct: 247 PNVDNYELYEKLELV-----KGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDD 301

Query: 406 AMAHPYF 412
           A+ H +F
Sbjct: 302 ALNHDFF 308

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (468), Expect = 3e-55
 Identities = 89/320 (27%), Positives = 157/320 (49%), Gaps = 22/320 (6%)

Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-----PV 161
           RP  ++  E     W   + Y+ +  VG G Y  V    +  T  R  +K L       +
Sbjct: 1   RP-TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 59

Query: 162 KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS---KTPSLIFEYVNSTDFKVLY--PTL 216
             K+  RE+++L+++    NV+ LLD+     S        +  ++   D   +     L
Sbjct: 60  HAKRTYRELRLLKHMKH-ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 118

Query: 217 TDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY 276
           TD  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +    +++D+GLA   H   E 
Sbjct: 119 TDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL-KILDFGLA--RHTDDEM 175

Query: 277 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 336
              VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +  F  G D+ DQL  I ++
Sbjct: 176 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF-PGTDHIDQLKLILRL 234

Query: 337 LGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYD 396
           +GT                 + +L         + FI        +P A+D L+K+L  D
Sbjct: 235 VGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIG------ANPLAVDLLEKMLVLD 288

Query: 397 HQDRLTAREAMAHPYFAQVR 416
              R+TA +A+AH YFAQ  
Sbjct: 289 SDKRITAAQALAHAYFAQYH 308

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  182 bits (462), Expect = 4e-55
 Identities = 89/299 (29%), Positives = 156/299 (52%), Gaps = 23/299 (7%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGG 179
           + Y  + K+G G Y  V++  N N  E   +K ++  K          REI IL+ L   
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKH- 59

Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALDYCH 236
            N+VKL D++  +      L+FE+++    K+L      L     + ++ +LL  + YCH
Sbjct: 60  SNIVKLYDVIHTKKRLV--LVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH 117

Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELLVDLQ 295
            + ++HRD+KP N++I+ E   L++ D+GLA  +  P ++Y   + + +++ P++L+  +
Sbjct: 118 DRRVLHRDLKPQNLLINREGE-LKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSK 176

Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP 355
            Y  ++D+WS+GC+FA M+    P F G    DQL++I ++LGT     + N   L   P
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGT-PLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL---P 232

Query: 356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 414
           + D     +   PW  F+       +    ID L K+L+ D   R+TA++A+ H YF +
Sbjct: 233 KYDPNFTVYEPLPWESFLKG-----LDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (460), Expect = 9e-55
 Identities = 89/302 (29%), Positives = 163/302 (53%), Gaps = 23/302 (7%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK-----IKREIKILQNLCGG 179
           ++++ V K+G G Y  V++  N  T E   +K ++   + +       REI +L+ L   
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH- 60

Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL----YPTLTDYDIRYYIYELLKALDYC 235
           PN+VKLLD++  ++     L+FE+++    K +       +    I+ Y+++LL+ L +C
Sbjct: 61  PNIVKLLDVIHTENKLY--LVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118

Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELLVDL 294
           HS  ++HRD+KP N++I+ E   ++L D+GLA  +  P + Y   V + +++ PE+L+  
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 177

Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 354
           + Y  ++D+WSLGC+FA M+ R+   F G    DQL +I + LGT +   +     +   
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRAL-FPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM--- 233

Query: 355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 414
           P       + +R+ +SK +       +  +    L ++L YD   R++A+ A+AHP+F  
Sbjct: 234 PDYKPSFPKWARQDFSKVVPP-----LDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288

Query: 415 VR 416
           V 
Sbjct: 289 VT 290

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (459), Expect = 1e-54
 Identities = 86/304 (28%), Positives = 149/304 (49%), Gaps = 26/304 (8%)

Query: 128 EVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK--------KKIKREIKILQNLCGG 179
           E +  +G G+++ V++  + NTN+   IK +K   +        +   REIK+LQ L   
Sbjct: 1   EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSH- 59

Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCH 236
           PN++ LLD     H    SL+F+++ +    ++      LT   I+ Y+   L+ L+Y H
Sbjct: 60  PNIIGLLDA--FGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH 117

Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQ 295
              I+HRD+KP+N+++D     L+L D+GLA  F  P + Y  +V +R+++ PELL   +
Sbjct: 118 QHWILHRDLKPNNLLLDENGV-LKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGAR 176

Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP 355
            Y   +DMW++GC+ A ++ R  PF  G  + DQL +I + LGT     + +   L    
Sbjct: 177 MYGVGVDMWAVGCILAELLLRV-PFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 235

Query: 356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV 415
              +  G      +S             + +D +  L  ++   R+TA +A+   YF+  
Sbjct: 236 TFKSFPGIPLHHIFSA---------AGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 286

Query: 416 RAAE 419
               
Sbjct: 287 PGPT 290

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (455), Expect = 4e-54
 Identities = 86/301 (28%), Positives = 148/301 (49%), Gaps = 21/301 (6%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK-----IKREIKILQNLCGG 179
             YE + K+G G Y  VF+  N  T+E   +K ++     +       REI +L+ L   
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKH- 60

Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCH 236
            N+V+L D++      T  L+FE+ +      F      L    ++ ++++LLK L +CH
Sbjct: 61  KNIVRLHDVLHSDKKLT--LVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH 118

Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQ 295
           S+ ++HRD+KP N++I+      +L ++GLA  F  P + Y+  V + +++ P++L   +
Sbjct: 119 SRNVLHRDLKPQNLLINRNGEL-KLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAK 177

Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP 355
            Y  S+DMWS GC+FA +     P F G+D  DQL +I ++LGT     + +   L   P
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL---P 234

Query: 356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV 415
                    +       +       ++    D L  LL+ +   R++A EA+ HPYF+  
Sbjct: 235 DYKPYPMYPATTSLVNVVPK-----LNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289

Query: 416 R 416
            
Sbjct: 290 C 290

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  180 bits (457), Expect = 2e-53
 Identities = 70/307 (22%), Positives = 137/307 (44%), Gaps = 46/307 (14%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK---PVKKKKIKREIKILQNLCGGPN 181
           D Y+++ ++G G +  V   +   T    + K +    P+ K  +K EI I+  L   P 
Sbjct: 29  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQL-HHPK 87

Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHS 237
           ++ L D   D++     LI E+++  +           +++ ++  Y+ +  + L + H 
Sbjct: 88  LINLHDAFEDKYE--MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE 145

Query: 238 QGIMHRDVKPHNVMIDH-ELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
             I+H D+KP N+M +  +   +++ID+GLA   +P +   V  A+  F  PE++ D + 
Sbjct: 146 HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIV-DREP 204

Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ 356
             +  DMW++G +   ++    P F G D+ + L  + +     + +A+ +         
Sbjct: 205 VGFYTDMWAIGVLGYVLLSGLSP-FAGEDDLETLQNVKRCDWEFDEDAFSS--------- 254

Query: 357 LDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR 416
                                   VSPEA DF+  LL+ + + RLT  +A+ HP+     
Sbjct: 255 ------------------------VSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 290

Query: 417 AAESSRT 423
           +  +SR 
Sbjct: 291 SNLTSRI 297

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  177 bits (450), Expect = 2e-53
 Identities = 70/311 (22%), Positives = 123/311 (39%), Gaps = 57/311 (18%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------------KKKIKREIK 171
            ++YE    +GRG  S V   I+  T +   +KI+                ++   +E+ 
Sbjct: 2   YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 61

Query: 172 ILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLY--PTLTDYDIRYYIYEL 228
           IL+ + G PN+++L D           L+F+ +   + F  L    TL++ + R  +  L
Sbjct: 62  ILRKVSGHPNIIQLKDTYETNTF--FFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRAL 119

Query: 229 LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 288
           L+ +   H   I+HRD+KP N+++D ++  ++L D+G +    PG++      +  +  P
Sbjct: 120 LEVICALHKLNIVHRDLKPENILLDDDMN-IKLTDFGFSCQLDPGEKLREVCGTPSYLAP 178

Query: 289 ELL-----VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELN 343
           E++      +   Y   +DMWS G +   ++    P F+       L  I          
Sbjct: 179 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP-FWHRKQMLMLRMIMS-------- 229

Query: 344 AYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA 403
                Y        D                       S    D + + L    Q R TA
Sbjct: 230 ---GNYQFGSPEWDD----------------------YSDTVKDLVSRFLVVQPQKRYTA 264

Query: 404 REAMAHPYFAQ 414
            EA+AHP+F Q
Sbjct: 265 EEALAHPFFQQ 275

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (449), Expect = 5e-53
 Identities = 86/307 (28%), Positives = 146/307 (47%), Gaps = 28/307 (9%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCI-IKILKPVK-----KKKIKREIKILQNLCG 178
             YE V ++G G Y +VF+  ++    R + +K ++             RE+ +L++L  
Sbjct: 7   QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 66

Query: 179 G--PNVVKLLDIVRDQHSKTPS---LIFEYVNSTDFKVLY----PTLTDYDIRYYIYELL 229
              PNVV+L D+     +   +   L+FE+V+      L     P +    I+  +++LL
Sbjct: 67  FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 126

Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
           + LD+ HS  ++HRD+KP N+++    +  +L D+GLA  Y         V + +++ PE
Sbjct: 127 RGLDFLHSHRVVHRDLKPQNILVTSSGQI-KLADFGLARIYSFQMALTSVVVTLWYRAPE 185

Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY 349
           +L+    Y   +D+WS+GC+FA M  RK P F G  + DQL KI  V+G      +    
Sbjct: 186 VLLQ-SSYATPVDLWSVGCIFAEMFRRK-PLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 243

Query: 350 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 409
            L             S +P  KF+       +     D L K L ++   R++A  A++H
Sbjct: 244 ALP-----RQAFHSKSAQPIEKFVTD-----IDELGKDLLLKCLTFNPAKRISAYSALSH 293

Query: 410 PYFAQVR 416
           PYF  + 
Sbjct: 294 PYFQDLE 300

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (448), Expect = 1e-52
 Identities = 66/297 (22%), Positives = 127/297 (42%), Gaps = 45/297 (15%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGPNV 182
           + Y +   +GRG++  V   +  ++ +  + K +K     +  +K+EI IL       N+
Sbjct: 5   EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIA-RHRNI 63

Query: 183 VKLLDIVRDQHSKTPSLIFEYVNSTD-FKVL---YPTLTDYDIRYYIYELLKALDYCHSQ 238
           + L +           +IFE+++  D F+ +      L + +I  Y++++ +AL + HS 
Sbjct: 64  LHLHESFESMEE--LVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH 121

Query: 239 GIMHRDVKPHNVMID-HELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDY 297
            I H D++P N++        +++I++G A    PG  + +   +  +  PE+       
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQH-DVV 180

Query: 298 DYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQL 357
             + DMWSLG +   ++    P F    N   +  I     T +  A+            
Sbjct: 181 STATDMWSLGTLVYVLLSGINP-FLAETNQQIIENIMNAEYTFDEEAFKE---------- 229

Query: 358 DALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 414
                                  +S EA+DF+D+LL  + + R+TA EA+ HP+  Q
Sbjct: 230 -----------------------ISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (443), Expect = 3e-52
 Identities = 69/313 (22%), Positives = 131/313 (41%), Gaps = 51/313 (16%)

Query: 114 YESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK---REI 170
           YE +T     +D +E++ ++G G + +V++  N  T+     K++    +++++    EI
Sbjct: 1   YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEI 60

Query: 171 KILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIY 226
            IL +    PN+VKLLD    +++    ++ E+        +       LT+  I+    
Sbjct: 61  DILASCDH-PNIVKLLDAFYYENN--LWILIEFCAGGAVDAVMLELERPLTESQIQVVCK 117

Query: 227 ELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYF 285
           + L AL+Y H   I+HRD+K  N++   +   ++L D+G++ +     +  +  + + Y+
Sbjct: 118 QTLDALNYLHDNKIIHRDLKAGNILFTLDGD-IKLADFGVSAKNTRTIQRRDSFIGTPYW 176

Query: 286 KGPELLV----DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDE 341
             PE+++      + YDY  D+WSLG     M   + P  +  +    L+KIAK      
Sbjct: 177 MAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP-HHELNPMRVLLKIAKS----- 230

Query: 342 LNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL 401
                    L    +                         S    DFL K L  +   R 
Sbjct: 231 -----EPPTLAQPSR------------------------WSSNFKDFLKKCLEKNVDARW 261

Query: 402 TAREAMAHPYFAQ 414
           T  + + HP+   
Sbjct: 262 TTSQLLQHPFVTV 274

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  175 bits (444), Expect = 1e-51
 Identities = 63/301 (20%), Positives = 121/301 (40%), Gaps = 46/301 (15%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK---KKKIKREIKILQNLCGGPN 181
           D Y++  ++G G +  V       T      K +       K+ +++EI+ +  L   P 
Sbjct: 26  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRH-PT 84

Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL----YPTLTDYDIRYYIYELLKALDYCHS 237
           +V L D   D +     +I+E+++  +        +  +++ +   Y+ ++ K L + H 
Sbjct: 85  LVNLHDAFEDDNE--MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE 142

Query: 238 QGIMHRDVKPHNVMIDHELR-KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
              +H D+KP N+M   +   +L+LID+GL     P +   V   +  F  PE+    + 
Sbjct: 143 NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEG-KP 201

Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ 356
             Y  DMWS+G +   ++    P F G ++ + L  +       + +A+           
Sbjct: 202 VGYYTDMWSVGVLSYILLSGLSP-FGGENDDETLRNVKSCDWNMDDSAFSG--------- 251

Query: 357 LDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR 416
                                   +S +  DF+ KLL  D   R+T  +A+ HP+     
Sbjct: 252 ------------------------ISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGN 287

Query: 417 A 417
           A
Sbjct: 288 A 288

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (442), Expect = 1e-51
 Identities = 70/300 (23%), Positives = 125/300 (41%), Gaps = 43/300 (14%)

Query: 125 DDYEVVRKV-GRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVV 183
           DDY+V  +V G G   +V +  N  T E+  +K+L+     K +RE+++       P++V
Sbjct: 11  DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ--DCPKARREVELHWRASQCPHIV 68

Query: 184 KLLDIVRDQHS--KTPSLIFEYVNSTDF-----KVLYPTLTDYDIRYYIYELLKALDYCH 236
           +++D+  + ++  K   ++ E ++  +             T+ +    +  + +A+ Y H
Sbjct: 69  RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 128

Query: 237 SQGIMHRDVKPHNVMIDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 294
           S  I HRDVKP N++   +     L+L D+G A+             + Y+  PE+L   
Sbjct: 129 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGP- 187

Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 354
           + YD S DMWSLG +   ++    PF Y +        +   +                 
Sbjct: 188 EKYDKSCDMWSLGVIMYILLCGYPPF-YSNHGLAISPGMKTRI----------------- 229

Query: 355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 414
                      R    +F N +    VS E    +  LL+ +   R+T  E M HP+  Q
Sbjct: 230 -----------RMGQYEFPNPEWSE-VSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 277

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (431), Expect = 1e-50
 Identities = 66/300 (22%), Positives = 117/300 (39%), Gaps = 49/300 (16%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGP 180
           +D+++V+ +G G Y EV   +N  T E   +KI+   +     + IK+EI I + L    
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-NHE 63

Query: 181 NVVKLLDIVRDQHSKTPSLIFEYV-NSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHS 237
           NVVK     R        L  EY      F  + P   + + D + + ++L+  + Y H 
Sbjct: 64  NVVKFYGHRR--EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 121

Query: 238 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDL 294
            GI HRD+KP N+++D     L++ D+GLA  +         N    +  +  PELL   
Sbjct: 122 IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 180

Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 354
           + +   +D+WS G +   M+  +   +    +  Q     K                   
Sbjct: 181 EFHAEPVDVWSCGIVLTAMLAGE-LPWDQPSDSCQEYSDWK------------------- 220

Query: 355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 414
                   +    PW K         +    +  L K+L  +   R+T  +     ++ +
Sbjct: 221 ------EKKTYLNPWKK---------IDSAPLALLHKILVENPSARITIPDIKKDRWYNK 265

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (428), Expect = 3e-50
 Identities = 65/297 (21%), Positives = 122/297 (41%), Gaps = 53/297 (17%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCG 178
           +D+E+ R +G+GK+  V+      +     +K+L   +      + +++RE++I  +L  
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALDYC 235
            PN+++L     D       LI EY                 +     YI EL  AL YC
Sbjct: 66  -PNILRLYGYFHDATR--VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 122

Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 295
           HS+ ++HRD+KP N+++      L++ D+G +  + P         +  +  PE++   +
Sbjct: 123 HSKRVIHRDIKPENLLLGSAGE-LKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEG-R 179

Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP 355
            +D  +D+WSLG +    +  K P F  +   +   +I++V  T                
Sbjct: 180 MHDEKVDLWSLGVLCYEFLVGKPP-FEANTYQETYKRISRVEFTFP-------------- 224

Query: 356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 412
                                    V+  A D + +LL+++   R   RE + HP+ 
Sbjct: 225 -----------------------DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 258

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (434), Expect = 3e-50
 Identities = 73/317 (23%), Positives = 147/317 (46%), Gaps = 18/317 (5%)

Query: 110 EYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-----PVKKK 164
           +++  E     +     Y+ ++ +G G    V    +   +    IK L          K
Sbjct: 2   QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK 61

Query: 165 KIKREIKILQNLCGGPNVVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYD 220
           +  RE+ +++ +    N++ LL++   Q +    +   L+ E +++   +V+   L    
Sbjct: 62  RAYRELVLMKCVNH-KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHER 120

Query: 221 IRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRV 280
           + Y +Y++L  + + HS GI+HRD+KP N+++  +    +++D+GLA            V
Sbjct: 121 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL-KILDFGLARTAGTSFMMTPYV 179

Query: 281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTD 340
            +RY++ PE+++    Y  ++D+WS+GC+   M+  K   F G D  DQ  K+ + LGT 
Sbjct: 180 VTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHK-ILFPGRDYIDQWNKVIEQLGTP 237

Query: 341 -----ELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRY 395
                +      + ++E  P+   L             ++++  L + +A D L K+L  
Sbjct: 238 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVI 297

Query: 396 DHQDRLTAREAMAHPYF 412
           D   R++  +A+ HPY 
Sbjct: 298 DPAKRISVDDALQHPYI 314

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (422), Expect = 5e-49
 Identities = 65/303 (21%), Positives = 121/303 (39%), Gaps = 46/303 (15%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP---VKKKKIKREIKILQNLCGGP 180
           +  Y    K+G+G    V+  ++V T +   I+ +      KK+ I  EI +++     P
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN-KNP 77

Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQ 238
           N+V  LD           ++ EY+       +     + +  I     E L+AL++ HS 
Sbjct: 78  NIVNYLDSYLVG--DELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN 135

Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDY 297
            ++HRD+K  N+++  +   ++L D+G   +      + +  V + Y+  PE++   + Y
Sbjct: 136 QVIHRDIKSDNILLGMDGS-VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-KAY 193

Query: 298 DYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQL 357
              +D+WSLG M   MI  + P +   +    L  IA                L+   +L
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPP-YLNENPLRALYLIAT----------NGTPELQNPEKL 242

Query: 358 DALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA 417
                                   S    DFL++ L  D + R +A+E + H +    + 
Sbjct: 243 ------------------------SAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKP 278

Query: 418 AES 420
             S
Sbjct: 279 LSS 281

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  164 bits (417), Expect = 3e-48
 Identities = 69/303 (22%), Positives = 121/303 (39%), Gaps = 54/303 (17%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK------KKIKREIKILQNLCG 178
             +  +R++G G +  V+   +V  +E   IK +    K      + I +E++ LQ L  
Sbjct: 15  KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74

Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYC 235
            PN ++       +H  T  L+ EY   +     +V    L + +I    +  L+ L Y 
Sbjct: 75  -PNTIQYRGCYLREH--TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYL 131

Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 295
           HS  ++HRDVK  N+++      ++L D+G A    P   +   V + Y+  PE+++ + 
Sbjct: 132 HSHNMIHRDVKAGNILLSEPGL-VKLGDFGSASIMAPANSF---VGTPYWMAPEVILAMD 187

Query: 296 D--YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 353
           +  YD  +D+WSLG     +  RK P F   +    L  IA+           N+     
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKPPLF-NMNAMSALYHIAQ-----------NESPALQ 235

Query: 354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA 413
                                       S    +F+D  L+   QDR T+   + H +  
Sbjct: 236 SGH------------------------WSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVL 271

Query: 414 QVR 416
           + R
Sbjct: 272 RER 274

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  164 bits (416), Expect = 4e-48
 Identities = 73/307 (23%), Positives = 127/307 (41%), Gaps = 47/307 (15%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP----VKKKKIKREIKILQNLCGG 179
           +D Y+    +G G +SEV    +  T +   IK +       K+  ++ EI +L  +   
Sbjct: 8   RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKI-KH 66

Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLY--PTLTDYDIRYYIYELLKALDYCH 236
           PN+V L DI          LI + V+  + F  +      T+ D    I+++L A+ Y H
Sbjct: 67  PNIVALDDIYESG--GHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLH 124

Query: 237 SQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 294
             GI+HRD+KP N++     E  K+ + D+GL++   PG   +    +  +  PE+L   
Sbjct: 125 DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQ- 183

Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 354
           + Y  ++D WS+G +   ++    P FY  ++     +I K                   
Sbjct: 184 KPYSKAVDCWSIGVIAYILLCGYPP-FYDENDAKLFEQILKA------------------ 224

Query: 355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 414
                         W           +S  A DF+  L+  D + R T  +A+ HP+ A 
Sbjct: 225 ------EYEFDSPYWDD---------ISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG 269

Query: 415 VRAAESS 421
             A + +
Sbjct: 270 DTALDKN 276

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (405), Expect = 6e-47
 Identities = 66/305 (21%), Positives = 120/305 (39%), Gaps = 58/305 (19%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-----PVKKKKIKREIKILQNLCGG 179
           +DYEV+  +G G Y    +    +  +  + K L        +K+ +  E+ +L+ L   
Sbjct: 4   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK-H 62

Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLY------PTLTDYDIRYYIYELLKAL 232
           PN+V+  D + D+ + T  ++ EY    D   V+         L +  +   + +L  AL
Sbjct: 63  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 122

Query: 233 DYCHSQG-----IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY-NVRVASRYFK 286
             CH +      ++HRD+KP NV +D +   ++L D+GLA   +    +    V + Y+ 
Sbjct: 123 KECHRRSDGGHTVLHRDLKPANVFLDGKQN-VKLGDFGLARILNHDTSFAKAFVGTPYYM 181

Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYL 346
            PE +     Y+   D+WSLGC+   +     P F      +   KI +           
Sbjct: 182 SPEQMNR-MSYNEKSDIWSLGCLLYELCALMPP-FTAFSQKELAGKIRE----------- 228

Query: 347 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA 406
                          G+  R P+            S E  + + ++L      R +  E 
Sbjct: 229 ---------------GKFRRIPYR----------YSDELNEIITRMLNLKDYHRPSVEEI 263

Query: 407 MAHPY 411
           + +P 
Sbjct: 264 LENPL 268

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (397), Expect = 1e-45
 Identities = 68/306 (22%), Positives = 130/306 (42%), Gaps = 53/306 (17%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK---------KKKIKREIKILQN 175
           D Y+   ++G G+++ V +    +T  +   K +K  +         ++ I+RE+ IL+ 
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69

Query: 176 LCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKAL 232
           +   PNV+ L ++  ++      LI E V      DF     +LT+ +   ++ ++L  +
Sbjct: 70  IQH-PNVITLHEVYENKTD--VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 126

Query: 233 DYCHSQGIMHRDVKPHNVMIDHE---LRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
            Y HS  I H D+KP N+M+        ++++ID+GLA     G E+     +  F  PE
Sbjct: 127 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 186

Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY 349
           ++ + +      DMWS+G +   ++    PF  G    + L  ++ V             
Sbjct: 187 IV-NYEPLGLEADMWSIGVITYILLSGASPF-LGDTKQETLANVSAV------------- 231

Query: 350 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 409
                            + +S           S  A DF+ +LL  D + R+T ++++ H
Sbjct: 232 -----------NYEFEDEYFSN---------TSALAKDFIRRLLVKDPKKRMTIQDSLQH 271

Query: 410 PYFAQV 415
           P+    
Sbjct: 272 PWIKPK 277

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (392), Expect = 6e-45
 Identities = 66/312 (21%), Positives = 118/312 (37%), Gaps = 61/312 (19%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK---------KKKIKREIKILQ 174
           +  Y+V   +G G +  V+ GI V+ N    IK ++  +           ++  E+ +L+
Sbjct: 3   ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 62

Query: 175 NLCGG-PNVVKLLDIVRDQHSKTPSLIFEYVNST----DFKVLYPTLTDYDIRYYIYELL 229
            +  G   V++LLD      S    LI E         DF      L +   R + +++L
Sbjct: 63  KVSSGFSGVIRLLDWFERPDSFV--LILERPEPVQDLFDFITERGALQEELARSFFWQVL 120

Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
           +A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  PE
Sbjct: 121 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD-TVYTDFDGTRVYSPPE 179

Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY 349
            +   + +  S  +WSLG +   M+    PF +  +                    + + 
Sbjct: 180 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE--------------------IIRG 219

Query: 350 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 409
            +    +                        VS E    +   L     DR T  E   H
Sbjct: 220 QVFFRQR------------------------VSSECQHLIRWCLALRPSDRPTFEEIQNH 255

Query: 410 PYFAQVRAAESS 421
           P+   V   + +
Sbjct: 256 PWMQDVLLPQET 267

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (393), Expect = 7e-45
 Identities = 71/309 (22%), Positives = 126/309 (40%), Gaps = 61/309 (19%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCG 178
           +D++  + +G G +S V     + T+    IKIL+        K   + RE  ++  L  
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67

Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTD---FKVLYPTLTDYDIRYYIYELLKALDYC 235
            P  VKL    +D           Y  + +   +     +  +   R+Y  E++ AL+Y 
Sbjct: 68  -PFFVKLYFTFQDDEK--LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYL 124

Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLV 292
           H +GI+HRD+KP N++++ ++  +++ D+G A+   P  +    N  V +  +  PELL 
Sbjct: 125 HGKGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 183

Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE 352
           + +    S D+W+LGC+   ++    P F   + +    KI K+               +
Sbjct: 184 E-KSACKSSDLWALGCIIYQLVAGLPP-FRAGNEYLIFQKIIKL-------------EYD 228

Query: 353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA------ 406
              +                          P+A D ++KLL  D   RL   E       
Sbjct: 229 FPEK------------------------FFPKARDLVEKLLVLDATKRLGCEEMEGYGPL 264

Query: 407 MAHPYFAQV 415
            AHP+F  V
Sbjct: 265 KAHPFFESV 273

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (386), Expect = 4e-44
 Identities = 55/298 (18%), Positives = 114/298 (38%), Gaps = 51/298 (17%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPN 181
            +   ++GRG +  V++G++  T        L+  K     +++ K E ++L+ L   PN
Sbjct: 11  LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQH-PN 69

Query: 182 VVKLLDIVRD--QHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALDYCH 236
           +V+  D      +  K   L+ E + S   K     +  +    +R +  ++LK L + H
Sbjct: 70  IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH 129

Query: 237 SQG--IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 294
           ++   I+HRD+K  N+ I      +++ D GLA          V + +  F  PE+    
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAV-IGTPEFMAPEMY--E 186

Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 354
           + YD S+D+++ G     M   + P+    +      ++                    D
Sbjct: 187 EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS-----------GVKPASFD 235

Query: 355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 412
                                       PE  + ++  +R +  +R + ++ + H +F
Sbjct: 236 KV------------------------AIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 269

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (384), Expect = 3e-43
 Identities = 63/302 (20%), Positives = 120/302 (39%), Gaps = 53/302 (17%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCG 178
           +D+ + + +G+G + +VF      TN+   IK LK          +    E ++L     
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALDYC 235
            P +  +    + + +     + EY+N  D                 +Y  E++  L + 
Sbjct: 62  HPFLTHMFCTFQTKEN--LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFL 119

Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDL 294
           HS+GI++RD+K  N+++D +    ++ D+G+  E      + N    +  +  PE+L+  
Sbjct: 120 HSKGIVYRDLKLDNILLDKDGHI-KIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLG- 177

Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 354
           Q Y++S+D WS G +   M+  + P F+G D  +    I                     
Sbjct: 178 QKYNHSVDWWSFGVLLYEMLIGQSP-FHGQDEEELFHSI--------------------- 215

Query: 355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAR-EAMAHPYFA 413
                   R     + +++          EA D L KL   + + RL  R +   HP F 
Sbjct: 216 --------RMDNPFYPRWL--------EKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFR 259

Query: 414 QV 415
           ++
Sbjct: 260 EI 261

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  152 bits (384), Expect = 8e-43
 Identities = 70/307 (22%), Positives = 123/307 (40%), Gaps = 55/307 (17%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCG 178
           +D+ V R +GRG + EV+     +T +   +K L   +      +     E  +L  +  
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 179 G--PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALD 233
           G  P +V +            S I + +N  D       +   ++ D+R+Y  E++  L+
Sbjct: 64  GDCPFIVCMSYAFHTPDK--LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLE 121

Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           + H++ +++RD+KP N+++D     +R+ D GLA  +   K +     +  +  PE+L  
Sbjct: 122 HMHNRFVVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHASV-GTHGYMAPEVLQK 179

Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 353
              YD S D +SLGCM   ++    P F  H   D+           E++       +EL
Sbjct: 180 GVAYDSSADWFSLGCMLFKLLRGHSP-FRQHKTKDKH----------EIDRMTLTMAVEL 228

Query: 354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT-----AREAMA 408
                                       SPE    L+ LL+ D   RL      A+E   
Sbjct: 229 PDS------------------------FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264

Query: 409 HPYFAQV 415
            P+F  +
Sbjct: 265 SPFFRSL 271

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  144 bits (364), Expect = 4e-40
 Identities = 70/328 (21%), Positives = 129/328 (39%), Gaps = 33/328 (10%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILK--PVKKKKIKREIKILQNL-------- 176
           Y +VRK+G G +S V+   ++  N    +KI++   V  +  + EIK+LQ +        
Sbjct: 15  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 74

Query: 177 --CGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDF------KVLYPTLTDYDIRYYIYEL 228
              G  +++KLLD    +      ++  +    +       K  +  +    ++    +L
Sbjct: 75  DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQL 134

Query: 229 LKALDYCH-SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVAS---RY 284
           L  LDY H   GI+H D+KP NV+++       LI   +A+  +          S   R 
Sbjct: 135 LLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTRE 194

Query: 285 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF-----FYGHDNHDQLVKIAKVLGT 339
           ++ PE+L+    +    D+WS  C+   +I     F          + D + +I ++LG 
Sbjct: 195 YRSPEVLLG-APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGE 253

Query: 340 DELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHL-----VSPEAIDFLDKLLR 394
                  N  +         L+   S+  +    +   +        + E  DFL  +L+
Sbjct: 254 LPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQ 313

Query: 395 YDHQDRLTAREAMAHPYFAQVRAAESSR 422
            D + R  A   + HP+       E  R
Sbjct: 314 LDPRKRADAGGLVNHPWLKDTLGMEEIR 341

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  138 bits (348), Expect = 3e-38
 Identities = 56/305 (18%), Positives = 113/305 (37%), Gaps = 59/305 (19%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK------PVKKKKIKREIKILQNLCG 178
            D++++R +G G +  V    + +      +K+LK        + +    E  +L  +  
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-T 62

Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYC 235
            P ++++    +D        I +Y+                +   ++Y  E+  AL+Y 
Sbjct: 63  HPFIIRMWGTFQDAQQIFM--IMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYL 120

Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 295
           HS+ I++RD+KP N+++D     +++ D+G A++            +  +  PE++   +
Sbjct: 121 HSKDIIYRDLKPENILLDKNGH-IKITDFGFAKYVP--DVTYTLCGTPDYIAPEVVST-K 176

Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP 355
            Y+ S+D WS G +   M+    P FY  +      KI                      
Sbjct: 177 PYNKSIDWWSFGILIYEMLAGYTP-FYDSNTMKTYEKILN-------------------- 215

Query: 356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHP 410
                       P+            + +  D L +L+  D   RL        +   HP
Sbjct: 216 ------AELRFPPF-----------FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHP 258

Query: 411 YFAQV 415
           +F +V
Sbjct: 259 WFKEV 263

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  137 bits (345), Expect = 4e-38
 Identities = 58/301 (19%), Positives = 104/301 (34%), Gaps = 50/301 (16%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK------PVKKKKIKREIKILQNLC 177
            D YE+   +G G  SEV    ++  +    +K+L+      P    + +RE +    L 
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL- 64

Query: 178 GGPNVVKLLDIVRDQHSKTPS--LIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKAL 232
             P +V + D    +    P   ++ EYV+    + +      +T       I +  +AL
Sbjct: 65  NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQAL 124

Query: 233 DYCHSQGIMHRDVKPHNVMIDHELR---KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
           ++ H  GI+HRDVKP N+MI            I   +A+  +   +    + +  +  PE
Sbjct: 125 NFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 184

Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY 349
                   D   D++SLGC+   ++  + P F G        +                 
Sbjct: 185 QARG-DSVDARSDVYSLGCVLYEVLTGEPP-FTGDSPVSVAYQHV--------------- 227

Query: 350 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 409
                        R    P S          +S +    + K L  + ++R      M  
Sbjct: 228 -------------REDPIPPSARHEG-----LSADLDAVVLKALAKNPENRYQTAAEMRA 269

Query: 410 P 410
            
Sbjct: 270 D 270

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (345), Expect = 4e-38
 Identities = 44/301 (14%), Positives = 111/301 (36%), Gaps = 54/301 (17%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-----PVKKKKIKREIKILQNLC 177
                 V +++G G +  V++G     +    +K+L      P + +  K E+ +L+   
Sbjct: 6   PDGQITVGQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR 62

Query: 178 GGPNVVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLY---PTLTDYDIRYYIYELLKALD 233
              N++  +           +++ ++   +  +  L+          +     +  + +D
Sbjct: 63  H-VNILLFMGYSTAPQ---LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMD 118

Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR---VASRYFKGPEL 290
           Y H++ I+HRD+K +N+ +  +L  +++ D+GLA         +       S  +  PE+
Sbjct: 119 YLHAKSIIHRDLKSNNIFLHEDLT-VKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV 177

Query: 291 LVDLQD--YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK 348
           +       Y +  D+++ G +   ++  + P +   +N DQ++ +               
Sbjct: 178 IRMQDKNPYSFQSDVYAFGIVLYELMTGQLP-YSNINNRDQIIFM--------------- 221

Query: 349 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 408
                       VGR    P    + ++            + + L+    +R    + +A
Sbjct: 222 ------------VGRGYLSPDLSKVRSN----CPKAMKRLMAECLKKKRDERPLFPQILA 265

Query: 409 H 409
            
Sbjct: 266 S 266

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (347), Expect = 8e-38
 Identities = 59/303 (19%), Positives = 109/303 (35%), Gaps = 52/303 (17%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCG 178
           +D++ ++ +G+G + +V       T     +KIL+               E ++LQN   
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 179 GPNVVKLLDIVRD-QHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHS 237
            P +  L    +                           T+   R+Y  E++ AL+Y HS
Sbjct: 65  -PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 123

Query: 238 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDY 297
           + +++RD+K  N+M+D +   +++ D+GL +                      +++  DY
Sbjct: 124 RDVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY 182

Query: 298 DYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQL 357
             ++D W LG +   M+  + P FY  D+      I                        
Sbjct: 183 GRAVDWWGLGVVMYEMMCGRLP-FYNQDHERLFELI------------------------ 217

Query: 358 DALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYF 412
                      + + +        SPEA   L  LL+ D + RL      A+E M H +F
Sbjct: 218 -----LMEEIRFPRTL--------SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264

Query: 413 AQV 415
             +
Sbjct: 265 LSI 267

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (346), Expect = 8e-38
 Identities = 58/310 (18%), Positives = 127/310 (40%), Gaps = 54/310 (17%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINV---NTNERCIIKILKPVK-------KKKIKREIKILQ 174
           +++E+++ +G G Y +VF    +   +T +   +K+LK           +  + E ++L+
Sbjct: 24  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83

Query: 175 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-YPTLTDYDIRYYIYELLKALD 233
           ++   P +V L    + +      L +         +      T+++++ Y+ E++ AL+
Sbjct: 84  HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALE 143

Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPEL 290
           + H  GI++RD+K  N+++D     + L D+GL++ +   +    Y+      Y     +
Sbjct: 144 HLHKLGIIYRDIKLENILLDSNGH-VVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIV 202

Query: 291 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH 350
                 +D ++D WSLG +   ++    P F      +   +I++ +   E         
Sbjct: 203 RGGDSGHDKAVDWWSLGVLMYELLTGASP-FTVDGEKNSQAEISRRILKSEP-------- 253

Query: 351 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TARE 405
                            P+ + +        S  A D + +LL  D + RL      A E
Sbjct: 254 -----------------PYPQEM--------SALAKDLIQRLLMKDPKKRLGCGPRDADE 288

Query: 406 AMAHPYFAQV 415
              H +F ++
Sbjct: 289 IKEHLFFQKI 298

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (339), Expect = 9e-37
 Identities = 56/349 (16%), Positives = 111/349 (31%), Gaps = 85/349 (24%)

Query: 99  VYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNER-----C 153
            Y D         W++         +++ E  + +G G + +V        ++       
Sbjct: 19  FYVDFREYEYDLKWEF--------PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQV 70

Query: 154 IIKILK----PVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTD- 208
            +K+LK      +++ +  E+K++  L    N+V LL       S    LIFEY    D 
Sbjct: 71  AVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL--SGPIYLIFEYCCYGDL 128

Query: 209 -------------------------FKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHR 243
                                     +     LT  D+  + Y++ K +++   +  +HR
Sbjct: 129 LNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHR 188

Query: 244 DVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR---VASRYFKGPELLVDLQDYDYS 300
           D+   NV++ H    +++ D+GLA        Y VR        +  PE L +   Y   
Sbjct: 189 DLAARNVLVTHGKV-VKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE-GIYTIK 246

Query: 301 LDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDAL 360
            D+WS G +   +       + G        K+ +           N + ++        
Sbjct: 247 SDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQ-----------NGFKMDQPFY---- 291

Query: 361 VGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 409
                                + E    +     +D + R +     + 
Sbjct: 292 --------------------ATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (334), Expect = 1e-36
 Identities = 39/293 (13%), Positives = 101/293 (34%), Gaps = 50/293 (17%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-PVKKKKIKREIKILQNLCGGPN 181
           +  + ++++ +G+G++ +V  G       +  +K +K     +    E  ++  L    N
Sbjct: 5   NMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRH-SN 61

Query: 182 VVKLLDIVRDQHSKTPSLIFEYV-NSTDFKVLY----PTLTDYDIRYYIYELLKALDYCH 236
           +V+LL ++ ++      ++ EY+   +    L       L    +  +  ++ +A++Y  
Sbjct: 62  LVQLLGVIVEEKGG-LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 120

Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
               +HRD+   NV++  +    ++ D+GL +     +  +       +  PE L + + 
Sbjct: 121 GNNFVHRDLAARNVLVSEDNV-AKVSDFGLTKEASSTQ--DTGKLPVKWTAPEALRE-KK 176

Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ 356
           +    D+WS G +   +       +      D + ++ K             Y ++    
Sbjct: 177 FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK------------GYKMDAPDG 224

Query: 357 LDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 409
                                     P   + +      D   R +  +    
Sbjct: 225 ------------------------CPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  133 bits (335), Expect = 5e-36
 Identities = 59/303 (19%), Positives = 114/303 (37%), Gaps = 55/303 (18%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK------REIKILQNLCG 178
           D ++ ++ +G G +  V    +  +     +KIL   K  K+K       E +ILQ +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-N 99

Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-YPTLTDYDIRYYIYELLKALDYCHS 237
            P +VKL    +D  +    + +         +      ++   R+Y  +++   +Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159

Query: 238 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDY 297
             +++RD+KP N++ID +   +++ D+G A+             +     PE+++  + Y
Sbjct: 160 LDLIYRDLKPENLLIDQQGY-IQVTDFGFAKRVKG--RTWTLCGTPEALAPEIILS-KGY 215

Query: 298 DYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQL 357
           + ++D W+LG +   M     PFF   D   Q+ +                         
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFF--ADQPIQIYEK------------------------ 249

Query: 358 DALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYF 412
              +     +  S F         S +  D L  LL+ D   R         +   H +F
Sbjct: 250 ---IVSGKVRFPSHF---------SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

Query: 413 AQV 415
           A  
Sbjct: 298 ATT 300

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (325), Expect = 4e-35
 Identities = 49/302 (16%), Positives = 104/302 (34%), Gaps = 54/302 (17%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGP 180
            ++   +  K+G+G + EV+ G    T  R  IK LKP  +  +   +E ++++ L    
Sbjct: 15  PRESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMSPEAFLQEAQVMKKLRH-E 72

Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYC 235
            +V+L  +V ++      ++ EY++               L    +     ++   + Y 
Sbjct: 73  KLVQLYAVVSEEP---IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV 129

Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY--NVRVASRYFKGPELLVD 293
                +HRD++  N+++   L   ++ D+GLA      +            +  PE  + 
Sbjct: 130 ERMNYVHRDLRAANILVGENLV-CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY 188

Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 353
              +    D+WS G +   +  +    + G  N + L ++               Y +  
Sbjct: 189 -GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV------------ERGYRMPC 235

Query: 354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTARE--AMAHPY 411
            P+                              D + +  R + ++R T     A    Y
Sbjct: 236 PPE------------------------CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 271

Query: 412 FA 413
           F 
Sbjct: 272 FT 273

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (323), Expect = 6e-35
 Identities = 43/300 (14%), Positives = 102/300 (34%), Gaps = 52/300 (17%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGP 180
            ++  ++V ++G G++ EV+ G   N + +  +K LK   +       E  +++ L    
Sbjct: 11  PRETLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQH-Q 68

Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYC 235
            +V+L  +V  +      +I EY+ +              LT   +     ++ + + + 
Sbjct: 69  RLVRLYAVVTQEP---IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 125

Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG-PELLVDL 294
             +  +HRD++  N+++   L   ++ D+GLA      +      A    K      ++ 
Sbjct: 126 EERNYIHRDLRAANILVSDTLSC-KIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY 184

Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 354
             +    D+WS G +   ++      + G  N + +  + +             Y +   
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER------------GYRMVRP 232

Query: 355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTARE--AMAHPYF 412
                                        E    +    +   +DR T     ++   +F
Sbjct: 233 DN------------------------CPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (322), Expect = 7e-35
 Identities = 42/301 (13%), Positives = 92/301 (30%), Gaps = 56/301 (18%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCI---IKILKPVK------KKKIKREIKIL 173
            + D  ++ K+G G +  V  G     + + +   +K LKP             RE+  +
Sbjct: 6   GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAM 65

Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELL 229
            +L    N+++L  +V     K   ++ E                      +  Y  ++ 
Sbjct: 66  HSLDH-RNLIRLYGVVLTPPMK---MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVA 121

Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR---VASRYFK 286
           + + Y  S+  +HRD+   N+++      +++ D+GL        ++ V        +  
Sbjct: 122 EGMGYLESKRFIHRDLAARNLLLATRDL-VKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 180

Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYL 346
                +  + + ++ D W  G     M    +  + G +    L KI K           
Sbjct: 181 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK----------- 229

Query: 347 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA 406
               L                                +  + + +   +  +DR T    
Sbjct: 230 EGERLPRPED------------------------CPQDIYNVMVQCWAHKPEDRPTFVAL 265

Query: 407 M 407
            
Sbjct: 266 R 266

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  128 bits (322), Expect = 1e-34
 Identities = 48/307 (15%), Positives = 102/307 (33%), Gaps = 50/307 (16%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-VKKKKIKREIKILQNLCGGPNVV 183
           + Y + RK+G G + +++ G ++   E   IK+     K  ++  E KI + + GG  + 
Sbjct: 7   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIP 66

Query: 184 KLLDIVRDQHSKTPSLIFEYVNSTD---FKVLYPTLTDYDIRYYIYELLKALDYCHSQGI 240
            +     +       ++ E +  +    F       +   +     +++  ++Y HS+  
Sbjct: 67  TIRWCGAEGDY--NVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNF 124

Query: 241 MHRDVKPHNVMIDHELRKLRL--IDWGLAEFYHPGKEYNVR--------VASRYFKGPEL 290
           +HRDVKP N ++    +   +  ID+GLA+ Y   + +             +  +     
Sbjct: 125 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINT 184

Query: 291 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH 350
            +   +     D+ SLG +           + G     +  K  +               
Sbjct: 185 HLG-IEQSRRDDLESLGYVLMYFNLGS-LPWQGLKAATKRQKYER--------------- 227

Query: 351 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA---REAM 407
                         S K  S  I    +     E   +L+        D+      R+  
Sbjct: 228 -------------ISEKKMSTPIEVLCKG-YPSEFATYLNFCRSLRFDDKPDYSYLRQLF 273

Query: 408 AHPYFAQ 414
            + +  Q
Sbjct: 274 RNLFHRQ 280

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (321), Expect = 2e-34
 Identities = 45/312 (14%), Positives = 95/312 (30%), Gaps = 65/312 (20%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK------PVKKKKIKREIKILQNL 176
           D +D +    +G G + +V +        R    I +          +    E+++L  L
Sbjct: 8   DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKL 67

Query: 177 CGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTD-------------------FKVLYPTLT 217
              PN++ LL     +H     L  EY    +                         TL+
Sbjct: 68  GHHPNIINLLGAC--EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 125

Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
              + ++  ++ + +DY   +  +HRD+   N+++       ++ D+GL+       +  
Sbjct: 126 SQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN-YVAKIADFGLSRGQEVYVKKT 184

Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
           +      +   E L     Y  + D+WS G +   ++      + G    +   K+    
Sbjct: 185 MGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL---- 239

Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDH 397
                      Y LE                               E  D + +  R   
Sbjct: 240 --------PQGYRLEKPLN------------------------CDDEVYDLMRQCWREKP 267

Query: 398 QDRLTAREAMAH 409
            +R +  + +  
Sbjct: 268 YERPSFAQILVS 279

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (315), Expect = 6e-34
 Identities = 47/295 (15%), Positives = 107/295 (36%), Gaps = 50/295 (16%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGP 180
           D  D   ++++G G++  V  G          IK++K   + + +   E K++ NL    
Sbjct: 2   DPKDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSH-E 59

Query: 181 NVVKLLDIVRDQHSKTPSLIFEYV-NSTDFKVLY---PTLTDYDIRYYIYELLKALDYCH 236
            +V+L  +   Q  +   +I EY+ N      L           +     ++ +A++Y  
Sbjct: 60  KLVQLYGVCTKQ--RPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE 117

Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV--RVASRYFKGPELLVDL 294
           S+  +HRD+   N +++ +   +++ D+GL+ +    +  +         +  PE+L+  
Sbjct: 118 SKQFLHRDLAARNCLVNDQGV-VKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY- 175

Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 354
             +    D+W+ G +   +    +  +    N +    IA+                   
Sbjct: 176 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ------------------- 216

Query: 355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 409
                  G    +P          HL S +    +         +R T +  +++
Sbjct: 217 -------GLRLYRP----------HLASEKVYTIMYSCWHEKADERPTFKILLSN 254

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (314), Expect = 7e-34
 Identities = 42/295 (14%), Positives = 99/295 (33%), Gaps = 50/295 (16%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGP 180
           D  +   V+++G G++  V  G  +N  ++  IK ++   + ++    E +++  L   P
Sbjct: 3   DPSELTFVQEIGSGQFGLVHLGYWLNK-DKVAIKTIREGAMSEEDFIEEAEVMMKLSH-P 60

Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTD----FKVLYPTLTDYDIRYYIYELLKALDYCH 236
            +V+L  +  +Q      L+FE++         +          +     ++ + + Y  
Sbjct: 61  KLVQLYGVCLEQAP--ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 118

Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR--VASRYFKGPELLVDL 294
              ++HRD+   N ++      +++ D+G+  F    +  +         +  PE+    
Sbjct: 119 EACVIHRDLAARNCLVGENQV-IKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF- 176

Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 354
             Y    D+WS G +   +    +  +    N + +  I+                    
Sbjct: 177 SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST------------------- 217

Query: 355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 409
                  G    KP           L S      ++   +   +DR      +  
Sbjct: 218 -------GFRLYKP----------RLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (312), Expect = 2e-33
 Identities = 53/299 (17%), Positives = 105/299 (35%), Gaps = 53/299 (17%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK-------KKIKREIKILQN 175
            ++  E+ R +G G++ +V +GI ++     +   +K  K        +K  +E   ++ 
Sbjct: 5   QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQ 64

Query: 176 LCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKA 231
               P++VKL+ ++ +       +I E     + +        +L    +  Y Y+L  A
Sbjct: 65  F-DHPHIVKLIGVITENP---VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA 120

Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV-RVASRYFKGPEL 290
           L Y  S+  +HRD+   NV++      ++L D+GL+ +      Y   +           
Sbjct: 121 LAYLESKRFVHRDIAARNVLVSSNDC-VKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE 179

Query: 291 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH 350
            ++ + +  + D+W  G     ++      F G  N+D + +I             N   
Sbjct: 180 SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI------------ENGER 227

Query: 351 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 409
           L + P                           P     + K   YD   R    E  A 
Sbjct: 228 LPMPPN------------------------CPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  123 bits (309), Expect = 7e-33
 Identities = 38/231 (16%), Positives = 90/231 (38%), Gaps = 20/231 (8%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKIL-KPVKKKKIKREIKILQNLCGGPNVVKL 185
           Y+V R++G G +  +FEG N+  N++  IK   +     +++ E +  + L G   +  +
Sbjct: 7   YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNV 66

Query: 186 LDIVRDQHSKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMH 242
                 Q      L+ + +  +   +L       +   +     ++L  +   H + +++
Sbjct: 67  YYF--GQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVY 124

Query: 243 RDVKPHNVMIDHELRK----LRLIDWGLAEFYHPG--------KEYNVRVASRYFKGPEL 290
           RD+KP N +I     K    + ++D+G+ +FY           +E      +  +     
Sbjct: 125 RDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINT 184

Query: 291 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDE 341
            +  ++     D+ +LG +F   +      + G        K  ++    +
Sbjct: 185 HLG-REQSRRDDLEALGHVFMYFLRGS-LPWQGLKAATNKQKYERIGEKKQ 233

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  122 bits (308), Expect = 1e-32
 Identities = 42/293 (14%), Positives = 104/293 (35%), Gaps = 48/293 (16%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK--PVKKKKIKREIKILQNLCGGP 180
           ++ D  +  K+G G+Y EV+EG+    +    +K LK   ++ ++  +E  +++ +   P
Sbjct: 15  ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH-P 73

Query: 181 NVVKLLDIVRDQHSKTPSLIFEYV-NSTDFKVLY----PTLTDYDIRYYIYELLKALDYC 235
           N+V+LL +   +      +I E++        L       ++   + Y   ++  A++Y 
Sbjct: 74  NLVQLLGVCTREPPFY--IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 131

Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY-NVRVASRYFKGPELLVDL 294
             +  +HRD+   N ++      +++ D+GL+          +              +  
Sbjct: 132 EKKNFIHRDLAARNCLVGENHL-VKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 190

Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 354
             +    D+W+ G +   +       + G D   Q+ ++ +             Y +E  
Sbjct: 191 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-SQVYELLE-----------KDYRMERP 238

Query: 355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
                                        +  + +    +++  DR +  E  
Sbjct: 239 EG------------------------CPEKVYELMRACWQWNPSDRPSFAEIH 267

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (308), Expect = 2e-32
 Identities = 51/317 (16%), Positives = 98/317 (30%), Gaps = 70/317 (22%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEG-----INVNTNERCIIKILKPVK----KKKIKREIKIL 173
            ++     + +G G + +V E      I  +      +K+LKP      ++ +  E+K+L
Sbjct: 21  PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVL 80

Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTD---------------------FKVL 212
             L    N+V LL            +I EY    D                      +  
Sbjct: 81  SYLGNHMNIVNLLGACTIG--GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 138

Query: 213 YPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 272
              L   D+  + Y++ K + +  S+  +HRD+   N+++ H     ++ D+GLA     
Sbjct: 139 ELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT-KICDFGLARDIKN 197

Query: 273 GKEYNVRVASRYFKG--PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL 330
              Y V+  +R          +    Y +  D+WS G     +       + G     + 
Sbjct: 198 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257

Query: 331 VKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLD 390
            K+ K             + +                                E  D + 
Sbjct: 258 YKMIK-----------EGFRMLSPEH------------------------APAEMYDIMK 282

Query: 391 KLLRYDHQDRLTAREAM 407
                D   R T ++ +
Sbjct: 283 TCWDADPLKRPTFKQIV 299

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  122 bits (307), Expect = 2e-32
 Identities = 45/303 (14%), Positives = 94/303 (31%), Gaps = 56/303 (18%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK-------KKIKREIKILQN 175
           D    ++ + +G G++ EV  G      +R I   +K +K        +    E  I+  
Sbjct: 24  DISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQ 83

Query: 176 LCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKA 231
               PNV+ L  +V         +I E++ +              T   +   +  +   
Sbjct: 84  FDH-PNVIHLEGVVTKST--PVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAG 140

Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 291
           + Y      +HRD+   N++++  L   ++ D+GL+ F           ++   K P   
Sbjct: 141 MKYLADMNYVHRDLAARNILVNSNLV-CKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRW 199

Query: 292 VD-----LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYL 346
                   + +  + D+WS G +   ++   E  ++   N D +  I +           
Sbjct: 200 TAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQ----------- 248

Query: 347 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA 406
                 L P +D                              +    + D   R    + 
Sbjct: 249 ---DYRLPPPMD----------------------CPSALHQLMLDCWQKDRNHRPKFGQI 283

Query: 407 MAH 409
           +  
Sbjct: 284 VNT 286

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (300), Expect = 1e-31
 Identities = 46/315 (14%), Positives = 105/315 (33%), Gaps = 58/315 (18%)

Query: 123 DQDDYEVV-RKVGRGKYSEVFEGINVNTNERCI--IKILKPVKKKK----IKREIKILQN 175
            +D+  +   ++G G +  V +G+     ++    IK+LK   +K     + RE +I+  
Sbjct: 6   KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQ 65

Query: 176 LCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLY---PTLTDYDIRYYIYELLKA 231
           L   P +V+L+ + + +      L+ E        K L      +   ++   ++++   
Sbjct: 66  L-DNPYIVRLIGVCQAEA---LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMG 121

Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASR---YFKGP 288
           + Y   +  +HRD+   NV++ +     ++ D+GL++       Y    ++         
Sbjct: 122 MKYLEEKNFVHRDLAARNVLLVNRH-YAKISDFGLSKALGADDSYYTARSAGKWPLKWYA 180

Query: 289 ELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK 348
              ++ + +    D+WS G      +   +  +      + +  I               
Sbjct: 181 PECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI------------EQG 228

Query: 349 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTARE--- 405
             +E  P+                          PE    +     Y  +DR        
Sbjct: 229 KRMECPPE------------------------CPPELYALMSDCWIYKWEDRPDFLTVEQ 264

Query: 406 AMAHPYFAQVRAAES 420
            M   Y++     E 
Sbjct: 265 RMRACYYSLASKVEG 279

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (301), Expect = 2e-31
 Identities = 45/301 (14%), Positives = 102/301 (33%), Gaps = 57/301 (18%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNER----CIIKILKPVKKKK----IKREIKILQN 175
           + +++ ++ +G G +  V++G+ +   E+      IK L+     K    I  E  ++ +
Sbjct: 8   ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS 67

Query: 176 LCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDY----DIRYYIYELLKA 231
           +   P+V +LL I      +   LI + +             D      +  +  ++ K 
Sbjct: 68  VDN-PHVCRLLGICLTSTVQ---LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 123

Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGP 288
           ++Y   + ++HRD+   NV++      +++ D+GLA+     ++            +   
Sbjct: 124 MNYLEDRRLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 182

Query: 289 ELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK 348
           E ++  + Y +  D+WS G     ++      + G    +    + K             
Sbjct: 183 ESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK------------G 229

Query: 349 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 408
             L   P                          + +    + K    D   R   RE + 
Sbjct: 230 ERLPQPPI------------------------CTIDVYMIMVKCWMIDADSRPKFRELII 265

Query: 409 H 409
            
Sbjct: 266 E 266

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (293), Expect = 9e-31
 Identities = 45/301 (14%), Positives = 95/301 (31%), Gaps = 58/301 (19%)

Query: 131 RKVGRGKYSEVFEGI--NVNTNERCIIKILK-----PVKKKKIKREIKILQNLCGGPNVV 183
           +++G G +  V +G        +   +KILK     P  K ++  E  ++Q L   P +V
Sbjct: 13  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDN-PYIV 71

Query: 184 KLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGI 240
           +++ I   +      L+ E                + D +I   ++++   + Y      
Sbjct: 72  RMIGICEAES---WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNF 128

Query: 241 MHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR----VASRYFKGPELLVDLQD 296
           +HRD+   NV++  +    ++ D+GL++     + Y            +  PE +     
Sbjct: 129 VHRDLAARNVLLVTQHY-AKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY-YK 186

Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ 356
           +    D+WS G +        +  + G    +    + K               +     
Sbjct: 187 FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK------------GERMGCPAG 234

Query: 357 LDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTARE--AMAHPYFAQ 414
                                      E  D ++    YD ++R            Y+  
Sbjct: 235 ------------------------CPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270

Query: 415 V 415
           V
Sbjct: 271 V 271

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  116 bits (290), Expect = 4e-30
 Identities = 47/320 (14%), Positives = 95/320 (29%), Gaps = 78/320 (24%)

Query: 124 QDDYEVVRKVGRGKYSEVFEG-----INVNTNERCIIKILKPVK----KKKIKREIKILQ 174
           +++ E VR +G G +  VF+      +         +K+LK       +   +RE  ++ 
Sbjct: 12  RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMA 71

Query: 175 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFK------------------------ 210
                PN+VKLL +      K   L+FEY+   D                          
Sbjct: 72  EFDN-PNIVKLLGV--CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRAR 128

Query: 211 ---VLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 267
                 P L+  +      ++   + Y   +  +HRD+   N ++   +  +++ D+GL+
Sbjct: 129 VSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMV-VKIADFGLS 187

Query: 268 EFYHPGKEYNV--RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD 325
              +    Y      A      P   +    Y    D+W+ G +   +       +YG  
Sbjct: 188 RNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 247

Query: 326 NHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEA 385
           + + +  +             +   L                                E 
Sbjct: 248 HEEVIYYV------------RDGNILACPEN------------------------CPLEL 271

Query: 386 IDFLDKLLRYDHQDRLTARE 405
            + +         DR +   
Sbjct: 272 YNLMRLCWSKLPADRPSFCS 291

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (282), Expect = 8e-29
 Identities = 55/327 (16%), Positives = 116/327 (35%), Gaps = 57/327 (17%)

Query: 99  VYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCI---I 155
           V+ D++ L P+     + + +             +GRG +  V+ G  ++ + + I   +
Sbjct: 2   VHIDLSALNPELVQAVQHVVIGP-SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAV 60

Query: 156 KILKPVKK----KKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV 211
           K L  +       +   E  I+++    PNV+ LL I        P ++  Y+   D + 
Sbjct: 61  KSLNRITDIGEVSQFLTEGIIMKDFSH-PNVLSLLGICLRSEGS-PLVVLPYMKHGDLRN 118

Query: 212 LY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 267
                    T  D+  +  ++ K + +  S+  +HRD+   N M+D +   +++ D+GLA
Sbjct: 119 FIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEK-FTVKVADFGLA 177

Query: 268 EFYHPGKEYNVRVASRY-----FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 322
              +  +  +V   +       +   E L   Q +    D+WS G +   ++ R  P + 
Sbjct: 178 RDMYDKEFDSVHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYP 236

Query: 323 GHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVS 382
             +  D  V + +                          GR   +P              
Sbjct: 237 DVNTFDITVYLLQ--------------------------GRRLLQP----------EYCP 260

Query: 383 PEAIDFLDKLLRYDHQDRLTAREAMAH 409
               + + K      + R +  E ++ 
Sbjct: 261 DPLYEVMLKCWHPKAEMRPSFSELVSR 287

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (274), Expect = 5e-28
 Identities = 39/302 (12%), Positives = 97/302 (32%), Gaps = 57/302 (18%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNER----CIIKILKPV----KKKKIKREIKILQ 174
                   + +G G++ EV++G+   ++ +      IK LK      ++     E  I+ 
Sbjct: 5   HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMG 64

Query: 175 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLK 230
                 N+++L  ++         +I EY+ +              +   +   +  +  
Sbjct: 65  QFSH-HNIIRLEGVISKYKPMM--IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAA 121

Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY----NVRVASRYFK 286
            + Y  +   +HRD+   N++++  L   ++ D+GL+       E     +       + 
Sbjct: 122 GMKYLANMNYVHRDLAARNILVNSNLV-CKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT 180

Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYL 346
            PE +   +    S D+WS G +   ++   E  ++   NH+ +  I             
Sbjct: 181 APEAISYRKFTSAS-DVWSFGIVMWEVMTYGERPYWELSNHEVMKAI------------N 227

Query: 347 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA 406
           + + L                                     + +  + +   R    + 
Sbjct: 228 DGFRLPTPMD------------------------CPSAIYQLMMQCWQQERARRPKFADI 263

Query: 407 MA 408
           ++
Sbjct: 264 VS 265

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (271), Expect = 2e-27
 Identities = 48/324 (14%), Positives = 104/324 (32%), Gaps = 72/324 (22%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVN-----TNERCIIKILKPVK----KKKIKREIKIL 173
            ++   + R++G+G +  V+EG+           R  IK +        + +   E  ++
Sbjct: 18  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 77

Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-------------YPTLTDYD 220
           +      +VV+LL +V     +   +I E +   D K                   +   
Sbjct: 78  KEF-NCHHVVRLLGVV--SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 134

Query: 221 IRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY---N 277
           +     E+   + Y ++   +HRD+   N M+  +   +++ D+G+    +    Y    
Sbjct: 135 MIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT-VKIGDFGMTRDIYETDYYRKGG 193

Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             +    +  PE L D   +    D+WS G +   +    E  + G  N   L  +    
Sbjct: 194 KGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV---- 248

Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDH 397
                   +    L+                                  + +    +Y+ 
Sbjct: 249 --------MEGGLLDKPDN------------------------CPDMLFELMRMCWQYNP 276

Query: 398 QDRLTAREAMA------HPYFAQV 415
           + R +  E ++       P F +V
Sbjct: 277 KMRPSFLEIISSIKEEMEPGFREV 300

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (270), Expect = 2e-27
 Identities = 47/318 (14%), Positives = 104/318 (32%), Gaps = 69/318 (21%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCI-----IKILKP----VKKKKIKREIKIL 173
            +D  ++ + +GRG + +V E      ++        +K+LK      + + +  E+KIL
Sbjct: 11  PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKIL 70

Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY------------------PT 215
            ++    NVV LL            ++           L                     
Sbjct: 71  IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 130

Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 275
           LT   +  Y +++ K +++  S+  +HRD+   N+++  +   +++ D+GLA   +   +
Sbjct: 131 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV-VKICDFGLARDIYKDPD 189

Query: 276 Y----NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
           Y    + R+  ++     +    + Y    D+WS G +   +       + G    ++  
Sbjct: 190 YVRKGDARLPLKWMAPETIF--DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 247

Query: 332 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDK 391
           +  K               +                              +PE    +  
Sbjct: 248 RRLK-----------EGTRMRAPDY------------------------TTPEMYQTMLD 272

Query: 392 LLRYDHQDRLTAREAMAH 409
               +   R T  E + H
Sbjct: 273 CWHGEPSQRPTFSELVEH 290

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  107 bits (268), Expect = 4e-27
 Identities = 43/319 (13%), Positives = 100/319 (31%), Gaps = 71/319 (22%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNE-------RCIIKILKPVKKKK----IKREIK 171
            +D   + + +G G + +V     +  ++       +  +K+LK    +K    +  E++
Sbjct: 11  PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEME 70

Query: 172 ILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL------------------- 212
           +++ +    N++ LL            +I EY +  + +                     
Sbjct: 71  MMKMIGKHKNIINLLGACTQDGP--LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 128

Query: 213 YPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 272
              L+  D+    Y++ + ++Y  S+  +HRD+   NV++  +    ++ D+GLA   H 
Sbjct: 129 EEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVM-KIADFGLARDIHH 187

Query: 273 GKEYNVRVASRYFKGPELLVDLQD--YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL 330
              Y      R          L D  Y +  D+WS G +   +       + G    +  
Sbjct: 188 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 247

Query: 331 VKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLD 390
             +               + ++                             + E    + 
Sbjct: 248 KLL------------KEGHRMDKPSN------------------------CTNELYMMMR 271

Query: 391 KLLRYDHQDRLTAREAMAH 409
                    R T ++ +  
Sbjct: 272 DCWHAVPSQRPTFKQLVED 290

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  104 bits (261), Expect = 4e-26
 Identities = 50/306 (16%), Positives = 100/306 (32%), Gaps = 42/306 (13%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQ-NLCGGPNVV 183
               +   +G+G++ EV+ G      E   +KI    +++   RE +I Q  +    N++
Sbjct: 3   RTIVLQESIGKGRFGEVWRG--KWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENIL 60

Query: 184 KLLDIVRDQHSKTPS--LIFEYVNSTD-FKVLY-PTLTDYDIRYYIYELLKALDYCHSQ- 238
             +      +       L+ +Y      F  L   T+T   +          L + H + 
Sbjct: 61  GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEI 120

Query: 239 -------GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY-----NVRVASRYFK 286
                   I HRD+K  N+++        + D GLA  +    +      N RV ++ + 
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKNGT-CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 179

Query: 287 GPELL-----VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDE 341
            PE+L     +   +     D++++G +F  +  R        D       +     + E
Sbjct: 180 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 239

Query: 342 LNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL 401
                         ++  +V     +P     N              + +    +   RL
Sbjct: 240 --------------EMRKVVCEQKLRP--NIPNRWQSCEALRVMAKIMRECWYANGAARL 283

Query: 402 TAREAM 407
           TA    
Sbjct: 284 TALRIK 289

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 81.4 bits (200), Expect = 1e-18
 Identities = 31/203 (15%), Positives = 69/203 (33%), Gaps = 34/203 (16%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP------------VKKKKIKREIKILQ 174
             + + +G GK S VF   +      C++K  K                      + I  
Sbjct: 2   DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60

Query: 175 NLCGGPNVVKLLD--IVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKAL 232
                  + KL    + +    +  +++ E +++ +   +       +    +  +L+ +
Sbjct: 61  ARNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRV----ENPDEVLDMILEEV 116

Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEY----NVRVASRYFKG 287
              + +GI+H D+  +NV++      + +ID+  + E    G       +VR    YF  
Sbjct: 117 AKFYHRGIVHGDLSQYNVLVSE--EGIWIIDFPQSVEVGEEGWREILERDVRNIITYFS- 173

Query: 288 PELLVDLQDYDYSLDMWSLGCMF 310
                  + Y    D+ S     
Sbjct: 174 -------RTYRTEKDINSAIDRI 189

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	425
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.92
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.47
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.13
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.93
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.33
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.27
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.64

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=8.8e-64  Score=477.21  Aligned_cols=326  Identities=76%  Similarity=1.301  Sum_probs=296.9

Q ss_pred             CCCccCccccccccCCCCccCCcCCcccccCCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcchHHHHHHHH
Q 014406           92 PAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIK  171 (425)
Q Consensus        92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~  171 (425)
                      |..+.++++.+.....+.++|+++...+.++..++|+++++||+|+||+||+|++..+++.||||+++....+++.+|+.
T Consensus         2 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~Ei~   81 (328)
T d3bqca1           2 PVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIK   81 (328)
T ss_dssp             CCCCCCSSSTTTTTTSCHHHHCGGGCCCCCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSCHHHHHHHHH
T ss_pred             CCCCcceeeccccccCCCccchhhhcccCCCCCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHHHHHHHHHHH
Confidence            34567788899999999999999999999999999999999999999999999999999999999999888899999999


Q ss_pred             HHHHhcCCCCeeeEEeEEEcCCCCccEEEEEeecCCChhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceE
Q 014406          172 ILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM  251 (425)
Q Consensus       172 ~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIl  251 (425)
                      +|+.+.+||||++++++|.......+++||||+.+++|..+.+.+++.+++.++.||+.||+|||++||+||||||+|||
T Consensus        82 il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NIL  161 (328)
T d3bqca1          82 ILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVM  161 (328)
T ss_dssp             HHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCCSCBGGGTTTSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred             HHHhccCCCCCcEEEEEEEecCCCceeEEEeecCCCcHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceE
Confidence            99999669999999999987777889999999999999999999999999999999999999999999999999999999


Q ss_pred             ecCCCCcEEEEeccccccccCCCcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHH
Q 014406          252 IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV  331 (425)
Q Consensus       252 l~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~  331 (425)
                      ++.+.+.+||+|||+|+............+|+.|+|||.+.+...++.++||||+||++|+|++|+.||..+.++.++..
T Consensus       162 i~~~~~~vkl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~  241 (328)
T d3bqca1         162 IDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV  241 (328)
T ss_dssp             EETTTTEEEECCGGGCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHH
T ss_pred             EcCCCCeeeecccccceeccCCCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHH
Confidence            99875679999999999887766777788999999999998866789999999999999999999999988888888899


Q ss_pred             HHHHHhCCchhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCC
Q 014406          332 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY  411 (425)
Q Consensus       332 ~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~  411 (425)
                      .+.+.+|.+....+.......................+...........++++++|||++||++||++|||++|+|+|||
T Consensus       242 ~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~  321 (328)
T d3bqca1         242 RIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY  321 (328)
T ss_dssp             HHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred             HHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence            99999998888877777777777777777777777777777777777779999999999999999999999999999999


Q ss_pred             Cccccc
Q 014406          412 FAQVRA  417 (425)
Q Consensus       412 ~~~~~~  417 (425)
                      |+.+.+
T Consensus       322 F~~v~~  327 (328)
T d3bqca1         322 FYTVVK  327 (328)
T ss_dssp             GTTSCC
T ss_pred             cCCCCC
Confidence            999865

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-59  Score=434.41  Aligned_cols=253  Identities=24%  Similarity=0.401  Sum_probs=209.9

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEE
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (425)
                      .++|++++.||+|+||+||+|++..+++.||||+++..    ..+.+.+|+.+++++ +||||+++++++.++  ...++
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~~~~~~~~~--~~~~i   80 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-NHENVVKFYGHRREG--NIQYL   80 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTC-CCTTBCCEEEEEEET--TEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhC-CCCCEeeEeeeeccC--ceeEE
Confidence            57899999999999999999999999999999998643    235688999999999 999999999999764  78899


Q ss_pred             EEEeecCCChhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCC--
Q 014406          200 IFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK--  274 (425)
Q Consensus       200 v~e~~~~~~l~~~~~---~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~--  274 (425)
                      ||||+++|+|.+++.   .+++.+++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+......  
T Consensus        81 vmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~-~~~KL~DFG~a~~~~~~~~~  159 (271)
T d1nvra_          81 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRE  159 (271)
T ss_dssp             EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTT-CCEEECCCTTCEECEETTEE
T ss_pred             EEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCC-CCEEEccchhheeeccCCcc
Confidence            999999999998874   48999999999999999999999999999999999999988 789999999998764332  


Q ss_pred             -cceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCC
Q 014406          275 -EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL  353 (425)
Q Consensus       275 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~  353 (425)
                       .....+||+.|+|||++.+...++.++||||+||++|+|++|+.||....+.......+..   ...            
T Consensus       160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~---~~~------------  224 (271)
T d1nvra_         160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE---KKT------------  224 (271)
T ss_dssp             CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHT---TCT------------
T ss_pred             ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhc---CCC------------
Confidence             2345689999999999987444568899999999999999999999544333322222211   000            


Q ss_pred             ChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCccc
Q 014406          354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV  415 (425)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~  415 (425)
                                 ..         .....+++++++||++||+.||++|||++|+|+||||++-
T Consensus       225 -----------~~---------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~  266 (271)
T d1nvra_         225 -----------YL---------NPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP  266 (271)
T ss_dssp             -----------TS---------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred             -----------CC---------CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCcC
Confidence                       00         0112378999999999999999999999999999999853

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-59  Score=429.26  Aligned_cols=247  Identities=26%  Similarity=0.492  Sum_probs=212.0

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecC------cchHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCcc
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP------VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~------~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (425)
                      .++|++.+.||+|+||+||+|++..+++.||+|++.+      ...+.+.+|+.+++++ +||||+++++++.++  ..+
T Consensus         5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~--~~~   81 (263)
T d2j4za1           5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RHPNILRLYGYFHDA--TRV   81 (263)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEECS--SEE
T ss_pred             hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhc-CCCCCCeEEEEEEEC--CEE
Confidence            4689999999999999999999999999999999863      2346788999999999 999999999999754  678


Q ss_pred             EEEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCC
Q 014406          198 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (425)
Q Consensus       198 ~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~  274 (425)
                      ++||||+++|+|..++   ..+++..++.++.||+.||+|||++|||||||||+|||++.+ +.+||+|||+|+.... .
T Consensus        82 ~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~-~~~kl~DFG~a~~~~~-~  159 (263)
T d2j4za1          82 YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSA-GELKIADFGWSVHAPS-S  159 (263)
T ss_dssp             EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-SCEEECCCCSCSCCCC-C
T ss_pred             EEEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCC-CCEeecccceeeecCC-C
Confidence            9999999999998876   569999999999999999999999999999999999999988 7899999999986653 3


Q ss_pred             cceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCC
Q 014406          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD  354 (425)
Q Consensus       275 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~  354 (425)
                      ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.|| .+.+..+.+..+.+.             ..   
T Consensus       160 ~~~~~~Gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyell~G~~Pf-~~~~~~~~~~~i~~~-------------~~---  221 (263)
T d2j4za1         160 RRTTLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRISRV-------------EF---  221 (263)
T ss_dssp             CCEETTEEGGGCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCTT-CCSSHHHHHHHHHTT-------------CC---
T ss_pred             cccccCCCCcccCHHHHcC-CCCCchhhhhhHhHHHHHHhcCCCCC-CCCCHHHHHHHHHcC-------------CC---
Confidence            4456689999999999988 78999999999999999999999998 333333333332210             00   


Q ss_pred             hhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcc
Q 014406          355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ  414 (425)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~  414 (425)
                                           ..+..+++++++||.+||+.||++|||++|+|+||||++
T Consensus       222 ---------------------~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~  260 (263)
T d2j4za1         222 ---------------------TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA  260 (263)
T ss_dssp             ---------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred             ---------------------CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence                                 011237899999999999999999999999999999974

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-59  Score=434.57  Aligned_cols=254  Identities=26%  Similarity=0.468  Sum_probs=215.3

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecC---cchHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEE
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP---VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (425)
                      .++|+++++||+|+||+||+|.+..+|+.||||+++.   ...+.+.+|+.+++++ +||||++++++|.+.  ..+|+|
T Consensus        19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~--~~~~iv   95 (293)
T d1yhwa1          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN-KNPNIVNYLDSYLVG--DELWVV   95 (293)
T ss_dssp             TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHC-CCTTBCCEEEEEEET--TEEEEE
T ss_pred             ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhC-CCCCEeeEeEEEEEC--CEEEEE
Confidence            4579999999999999999999999999999999863   3456789999999999 999999999999764  678999


Q ss_pred             EEeecCCChhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCC-cce
Q 014406          201 FEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EYN  277 (425)
Q Consensus       201 ~e~~~~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~-~~~  277 (425)
                      |||+++|+|..++  ..+++.+++.++.||+.||+|||++|||||||||+|||++.+ +.+||+|||+|+...... ...
T Consensus        96 mEy~~gg~L~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~-~~vkl~DFG~a~~~~~~~~~~~  174 (293)
T d1yhwa1          96 MEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRS  174 (293)
T ss_dssp             EECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-CCEEECCCTTCEECCSTTCCBC
T ss_pred             EEecCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCC-CcEeeccchhheeecccccccc
Confidence            9999999998876  469999999999999999999999999999999999999988 799999999998765433 345


Q ss_pred             eeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCChhh
Q 014406          278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQL  357 (425)
Q Consensus       278 ~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~  357 (425)
                      ..+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||. +.+..+.+..+... +.+                 
T Consensus       175 ~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~-~~~~~~~~~~~~~~-~~~-----------------  234 (293)
T d1yhwa1         175 TMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYL-NENPLRALYLIATN-GTP-----------------  234 (293)
T ss_dssp             CCCSCGGGCCHHHHSS-SCBCTHHHHHHHHHHHHHHHHSSCTTT-TSCHHHHHHHHHHH-CSC-----------------
T ss_pred             ccccCCCccChhhhcC-CCCCchhceehHhHHHHHHhhCCCCCC-CCCHHHHHHHHHhC-CCC-----------------
Confidence            6689999999999987 789999999999999999999999983 33333433333221 000                 


Q ss_pred             HHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCccccc
Q 014406          358 DALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA  417 (425)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~  417 (425)
                                      ....+..+++++++||++||+.||++|||++|+|+||||+....
T Consensus       235 ----------------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~~~~  278 (293)
T d1yhwa1         235 ----------------ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKP  278 (293)
T ss_dssp             ----------------CCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred             ----------------CCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCCC
Confidence                            00112237999999999999999999999999999999986543

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-58  Score=431.17  Aligned_cols=254  Identities=26%  Similarity=0.423  Sum_probs=212.0

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc---chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEE
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (425)
                      ..+.|++++.||+|+||+||+|++..+++.||||+++..   ..+.+.+|+++|+++ +||||+++++++.++  ...++
T Consensus        10 p~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~--~~~~l   86 (288)
T d2jfla1          10 PEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASC-DHPNIVKLLDAFYYE--NNLWI   86 (288)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHC-CCTTBCCEEEEEEET--TEEEE
T ss_pred             cccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEeeC--CeEEE
Confidence            356799999999999999999999999999999999643   346788999999999 999999999999764  67899


Q ss_pred             EEEeecCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCC-C
Q 014406          200 IFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-K  274 (425)
Q Consensus       200 v~e~~~~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~-~  274 (425)
                      ||||+++|+|..++    ..+++.+++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+|+..... .
T Consensus        87 vmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~-~~~Kl~DFG~a~~~~~~~~  165 (288)
T d2jfla1          87 LIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLD-GDIKLADFGVSAKNTRTIQ  165 (288)
T ss_dssp             EEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-SCEEECCCTTCEECHHHHH
T ss_pred             EEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCC-CCEEEEechhhhccCCCcc
Confidence            99999999998875    359999999999999999999999999999999999999988 78999999999765322 2


Q ss_pred             cceeeccCCCccCcccccC----CCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhcc
Q 014406          275 EYNVRVASRYFKGPELLVD----LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH  350 (425)
Q Consensus       275 ~~~~~~~t~~y~aPE~~~~----~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~  350 (425)
                      ......||+.|+|||++..    ...|+.++|||||||++|+|++|+.||. +.+..+.+..+...-.            
T Consensus       166 ~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~-~~~~~~~~~~i~~~~~------------  232 (288)
T d2jfla1         166 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHH-ELNPMRVLLKIAKSEP------------  232 (288)
T ss_dssp             HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTT-TSCGGGHHHHHHHSCC------------
T ss_pred             cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCC-CCCHHHHHHHHHcCCC------------
Confidence            2345689999999999852    2568999999999999999999999983 4444444444332100            


Q ss_pred             CCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCccc
Q 014406          351 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV  415 (425)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~  415 (425)
                                            ........+++++++||++||+.||++|||++|+|+||||+.-
T Consensus       233 ----------------------~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~~  275 (288)
T d2jfla1         233 ----------------------PTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVD  275 (288)
T ss_dssp             ----------------------CCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCCC
T ss_pred             ----------------------CCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence                                  0001112378999999999999999999999999999999753

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-59  Score=444.55  Aligned_cols=286  Identities=21%  Similarity=0.308  Sum_probs=216.8

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccE
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (425)
                      ..++|+++++||+|+||+||+|++..+|+.||+|+++..    ..+.+.+|+.+|+++ +||||++++++|.+.  ..++
T Consensus         4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~--~~~~   80 (322)
T d1s9ja_           4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYSD--GEIS   80 (322)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGC-CCTTBCCEEEEEECS--SEEE
T ss_pred             CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEEC--CEEE
Confidence            468899999999999999999999999999999998643    246788999999999 999999999999764  6789


Q ss_pred             EEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHH-CCceeecCCCCceEecCCCCcEEEEeccccccccCCC
Q 014406          199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (425)
Q Consensus       199 lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~-~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~  274 (425)
                      +||||+.+|+|..++   ..+++..++.++.|++.||.|||+ +||+||||||+|||++.+ +.+||+|||+|+..... 
T Consensus        81 iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~-~~vkl~DFGla~~~~~~-  158 (322)
T d1s9ja_          81 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDS-  158 (322)
T ss_dssp             EEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTT-CCEEECCCCCCHHHHHH-
T ss_pred             EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCC-CCEEEeeCCCccccCCC-
Confidence            999999999999887   469999999999999999999997 599999999999999988 79999999999876432 


Q ss_pred             cceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHH-hhcc---
Q 014406          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYL-NKYH---  350 (425)
Q Consensus       275 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~-~~~~---  350 (425)
                      .....+||+.|+|||++.+ ..|+.++||||+||++|||++|+.||........+........|........ ....   
T Consensus       159 ~~~~~~GT~~Y~APEvl~~-~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (322)
T d1s9ja_         159 MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL  237 (322)
T ss_dssp             TC---CCSSCCCCHHHHHC-SCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------------------
T ss_pred             ccccccCCccccCchHHcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccc
Confidence            3345689999999999998 7899999999999999999999999976655555544444433322111000 0000   


Q ss_pred             ----C--CCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccc
Q 014406          351 ----L--ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA  418 (425)
Q Consensus       351 ----~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~  418 (425)
                          .  ..................    .......+|.++++||++||++||++|||++|+|+||||++..+.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~~~  307 (322)
T d1s9ja_         238 SSYGMDSRPPMAIFELLDYIVNEPP----PKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAE  307 (322)
T ss_dssp             --------CCCCHHHHHHHHHTSCC----CCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHHHS
T ss_pred             cccccccccchhHHHHHhhhhccCC----ccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCCcc
Confidence                0  000000000000000000    011122368999999999999999999999999999999876654

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-58  Score=424.16  Aligned_cols=250  Identities=22%  Similarity=0.437  Sum_probs=206.4

Q ss_pred             CCCE-EEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcC--CCC
Q 014406          124 QDDY-EVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQ--HSK  195 (425)
Q Consensus       124 ~~~y-~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~--~~~  195 (425)
                      ..+| ++.++||+|+||+||+|.+..+++.||+|.+...     ..+.+.+|+++|+++ +||||++++++|.+.  ...
T Consensus         7 ~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~~   85 (270)
T d1t4ha_           7 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-QHPNIVRFYDSWESTVKGKK   85 (270)
T ss_dssp             TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEEESSSCE
T ss_pred             CCCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEeeccccCC
Confidence            4455 6778899999999999999999999999998643     235688999999999 899999999998753  335


Q ss_pred             ccEEEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--ceeecCCCCceEecCCCCcEEEEeccccccc
Q 014406          196 TPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  270 (425)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~--ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~  270 (425)
                      .+++||||+++|+|.+++   ..+++..++.++.||+.||+|||+++  |+||||||+|||++.+.+.+||+|||+|+..
T Consensus        86 ~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~  165 (270)
T d1t4ha_          86 CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK  165 (270)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred             EEEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceec
Confidence            689999999999999887   46999999999999999999999998  9999999999999764478999999999865


Q ss_pred             cCCCcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHH-HHHHHHhCCchhHHHHhhc
Q 014406          271 HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL-VKIAKVLGTDELNAYLNKY  349 (425)
Q Consensus       271 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~-~~~~~~lg~~~~~~~~~~~  349 (425)
                      . .......+||+.|+|||++.+  .++.++|||||||++|||++|+.||... .+.+.+ ..+..  +..+        
T Consensus       166 ~-~~~~~~~~GT~~Y~aPE~~~~--~~~~~~DIwSlGvilyel~~g~~Pf~~~-~~~~~~~~~i~~--~~~~--------  231 (270)
T d1t4ha_         166 R-ASFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSEC-QNAAQIYRRVTS--GVKP--------  231 (270)
T ss_dssp             C-TTSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTC-SSHHHHHHHHTT--TCCC--------
T ss_pred             c-CCccCCcccCccccCHHHhCC--CCCCcCchhhHHHHHHHHHHCCCCCCCc-ccHHHHHHHHHc--CCCC--------
Confidence            4 334456789999999999865  5999999999999999999999998433 333332 22211  0000        


Q ss_pred             cCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCc
Q 014406          350 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA  413 (425)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~  413 (425)
                                               ......+++++.+||++||+.||++|||++|+|+||||+
T Consensus       232 -------------------------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         232 -------------------------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             -------------------------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             -------------------------cccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence                                     001123688999999999999999999999999999996

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-58  Score=428.37  Aligned_cols=256  Identities=28%  Similarity=0.491  Sum_probs=214.1

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecC------cchHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCcc
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP------VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~------~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (425)
                      .++|++.+.||+|+||+||+|.+..+++.||||+++.      ...+.+.+|+++++++ +||||++++++|.+.  ..+
T Consensus         7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~--~~~   83 (288)
T d1uu3a_           7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVKLYFTFQDD--EKL   83 (288)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-CSTTBCCEEEEEECS--SEE
T ss_pred             CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHc-CCCCeeEEEEEEEEC--CEE
Confidence            4679999999999999999999999999999999863      2346789999999999 999999999999654  778


Q ss_pred             EEEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCC
Q 014406          198 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (425)
Q Consensus       198 ~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~  274 (425)
                      |+||||+++|+|.+++   ..+++..++.++.|++.||+|||++|||||||||+|||++.+ +.+||+|||+|+......
T Consensus        84 ~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~-~~vkl~DFG~a~~~~~~~  162 (288)
T d1uu3a_          84 YFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNED-MHIQITDFGTAKVLSPES  162 (288)
T ss_dssp             EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-SCEEECCCTTCEECC---
T ss_pred             EEEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCC-ceEEecccccceecccCC
Confidence            9999999999998776   569999999999999999999999999999999999999988 789999999998765332


Q ss_pred             ---cceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccC
Q 014406          275 ---EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL  351 (425)
Q Consensus       275 ---~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~  351 (425)
                         .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||. +.+..+.+..+.+             ...
T Consensus       163 ~~~~~~~~~GT~~Y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~-~~~~~~~~~~i~~-------------~~~  227 (288)
T d1uu3a_         163 KQARANSFVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFR-AGNEYLIFQKIIK-------------LEY  227 (288)
T ss_dssp             -------CCCCGGGCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHT-------------TCC
T ss_pred             cccccccccCCccccCceeecc-CCCCcccceehhhHHHHHHhhCCCCCC-CcCHHHHHHHHHc-------------CCC
Confidence               2344679999999999987 789999999999999999999999984 3333333333321             000


Q ss_pred             CCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHH------HhcCCCCcccccchhcc
Q 014406          352 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTARE------AMAHPYFAQVRAAESSR  422 (425)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~e------lL~hp~~~~~~~~~~~~  422 (425)
                                              ..+..+++++++||++||+.||++|||++|      +++||||++++|....+
T Consensus       228 ------------------------~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~~l~~  280 (288)
T d1uu3a_         228 ------------------------DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQ  280 (288)
T ss_dssp             ------------------------CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGGG
T ss_pred             ------------------------CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHHHhhc
Confidence                                    011237999999999999999999999987      68999999998765543

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-58  Score=425.80  Aligned_cols=249  Identities=25%  Similarity=0.435  Sum_probs=198.7

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc-----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccE
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (425)
                      .++|++++.||+|+||+||+|+++.+|+.||+|+++...     .+.+.+|+++++++ +||||+++++++.+.....++
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~~~   81 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL-KHPNIVRYYDRIIDRTNTTLY   81 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSC-CCTTBCCEEEEEEC----CEE
T ss_pred             chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHC-CCCCEeeEEEEEEeCCCCEEE
Confidence            368999999999999999999999999999999986432     35588999999999 999999999999876667889


Q ss_pred             EEEEeecCCChhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC-----ceeecCCCCceEecCCCCcEEEEeccc
Q 014406          199 LIFEYVNSTDFKVLY-------PTLTDYDIRYYIYELLKALDYCHSQG-----IMHRDVKPHNVMIDHELRKLRLIDWGL  266 (425)
Q Consensus       199 lv~e~~~~~~l~~~~-------~~l~~~~~~~i~~~i~~~L~~LH~~~-----ivH~Dlk~~NIll~~~~~~~kl~Dfg~  266 (425)
                      +||||+++|+|.+++       ..+++..++.++.||+.||+|||+.|     ||||||||+|||++.+ +.+||+|||+
T Consensus        82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~-~~vkl~DFG~  160 (269)
T d2java1          82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGK-QNVKLGDFGL  160 (269)
T ss_dssp             EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTT-SCEEECCHHH
T ss_pred             EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCC-CcEEEeeccc
Confidence            999999999999876       35999999999999999999999876     9999999999999988 7999999999


Q ss_pred             cccccCCC-cceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHH
Q 014406          267 AEFYHPGK-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAY  345 (425)
Q Consensus       267 a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~  345 (425)
                      |+...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||. +.+..+....+...         
T Consensus       161 a~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~~DIwSlGvilyel~tg~~Pf~-~~~~~~~~~~i~~~---------  229 (269)
T d2java1         161 ARILNHDTSFAKAFVGTPYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFT-AFSQKELAGKIREG---------  229 (269)
T ss_dssp             HHHC-----------CCCSCCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCC-CSSHHHHHHHHHHT---------
T ss_pred             eeecccCCCccccCCCCcccCCHHHHcC-CCCChHHHHHhhCHHHHHHhhCCCCCC-CCCHHHHHHHHHcC---------
Confidence            98775443 3345689999999999977 789999999999999999999999983 33333333332210         


Q ss_pred             HhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCC
Q 014406          346 LNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF  412 (425)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~  412 (425)
                          ..                       ...+..+|+++.+||++||+.||++|||++|+|+|||+
T Consensus       230 ----~~-----------------------~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i  269 (269)
T d2java1         230 ----KF-----------------------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI  269 (269)
T ss_dssp             ----CC-----------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             ----CC-----------------------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence                00                       00112379999999999999999999999999999995

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=2.1e-57  Score=434.69  Aligned_cols=256  Identities=24%  Similarity=0.436  Sum_probs=219.3

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc---hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEE
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (425)
                      .++|++++.||+|+||+||+|.+..+|+.||||++....   .+.+.+|+.+|+++ +||||++++++|.+.  ..+|+|
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~--~~~~iv  101 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVL-RHPTLVNLHDAFEDD--NEMVMI  101 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHT-CCTTBCCEEEEEEET--TEEEEE
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhC-CCCCCCcEEEEEEEC--CEEEEE
Confidence            468999999999999999999999999999999997543   35688999999999 899999999999764  788999


Q ss_pred             EEeecCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCC-CCcEEEEeccccccccCCCc
Q 014406          201 FEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE-LRKLRLIDWGLAEFYHPGKE  275 (425)
Q Consensus       201 ~e~~~~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~-~~~~kl~Dfg~a~~~~~~~~  275 (425)
                      |||+++|+|.+++    ..+++..++.++.||+.||+|||++|||||||||+|||++.+ .+.+||+|||+|+.......
T Consensus       102 mE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~  181 (350)
T d1koaa2         102 YEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS  181 (350)
T ss_dssp             ECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSC
T ss_pred             EEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccccc
Confidence            9999999998776    248999999999999999999999999999999999999743 36899999999998877777


Q ss_pred             ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCCh
Q 014406          276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP  355 (425)
Q Consensus       276 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~  355 (425)
                      .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||. +.+..+.+..+.......+              
T Consensus       182 ~~~~~gT~~Y~aPEv~~~-~~~~~~~DiwSlGvilyell~G~~Pf~-~~~~~~~~~~i~~~~~~~~--------------  245 (350)
T d1koaa2         182 VKVTTGTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPFG-GENDDETLRNVKSCDWNMD--------------  245 (350)
T ss_dssp             EEEECSCTTTCCHHHHHT-CCBCHHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHTCCCSC--------------
T ss_pred             cceecCcccccCHHHHcC-CCCChhHhhhhhhHHHHHHHhCCCCCC-CCCHHHHHHHHHhCCCCCC--------------
Confidence            778899999999999987 789999999999999999999999983 4455555555433211100              


Q ss_pred             hhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCccccc
Q 014406          356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA  417 (425)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~  417 (425)
                                         ......+|+++++||++||+.||++|||++|+|+||||++...
T Consensus       246 -------------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~  288 (350)
T d1koaa2         246 -------------------DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNA  288 (350)
T ss_dssp             -------------------CGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTC
T ss_pred             -------------------cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence                               0011237899999999999999999999999999999997654

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-57  Score=424.34  Aligned_cols=258  Identities=26%  Similarity=0.463  Sum_probs=215.9

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc---------chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCC
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS  194 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~---------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  194 (425)
                      .++|++.+.||+|+||+||+|++..+|+.||||+++..         ..+.+.+|+.+|+++ +||||++++++|.+.  
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~--   85 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI-QHPNVITLHEVYENK--   85 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEEECS--
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEEC--
Confidence            57899999999999999999999999999999998632         246789999999999 999999999999664  


Q ss_pred             CccEEEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCC---cEEEEeccccc
Q 014406          195 KTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELR---KLRLIDWGLAE  268 (425)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~---~~kl~Dfg~a~  268 (425)
                      ..+++||||+++|+|.+++   ..+++..++.++.|++.||+|||++||+||||||+|||++.+..   .+||+|||+|+
T Consensus        86 ~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~  165 (293)
T d1jksa_          86 TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH  165 (293)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred             CEEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhh
Confidence            7889999999999999877   46999999999999999999999999999999999999987622   59999999998


Q ss_pred             cccCCCcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhh
Q 014406          269 FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK  348 (425)
Q Consensus       269 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~  348 (425)
                      ............+|+.|+|||++.+ ..++.++||||+||++|+|++|+.||. +.+..+.+..+...-.          
T Consensus       166 ~~~~~~~~~~~~~t~~y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~-~~~~~~~~~~i~~~~~----------  233 (293)
T d1jksa_         166 KIDFGNEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANVSAVNY----------  233 (293)
T ss_dssp             ECTTSCBCSCCCCCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHTTCC----------
T ss_pred             hcCCCccccccCCCCcccCHHHHcC-CCCCCcccchhhhHHHHHHHcCCCCCC-CCCHHHHHHHHHhcCC----------
Confidence            8776666677789999999999987 789999999999999999999999984 4444444444322110          


Q ss_pred             ccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccch
Q 014406          349 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE  419 (425)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~~  419 (425)
                         ....                    .....+|+++++||++||+.||++|||++|+|+||||++..+.+
T Consensus       234 ---~~~~--------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~~  281 (293)
T d1jksa_         234 ---EFED--------------------EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQ  281 (293)
T ss_dssp             ---CCCH--------------------HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC-----
T ss_pred             ---CCCc--------------------hhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCChhH
Confidence               0000                    01123789999999999999999999999999999999876654

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.9e-57  Score=428.25  Aligned_cols=254  Identities=26%  Similarity=0.469  Sum_probs=216.8

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecC------cchHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCcc
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP------VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~------~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (425)
                      .++|++++.||+|+||+||+|++..+++.||||++++      ...+.+.+|+.+|+++ +||||++++++|.+.  ..+
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~--~~~   80 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHPFLTALKYAFQTH--DRL   80 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CCTTBCCEEEEEECS--SEE
T ss_pred             hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhC-CCCCEEEEEeeeccc--ccc
Confidence            4689999999999999999999999999999999963      2346788999999999 899999999999764  788


Q ss_pred             EEEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccC-C
Q 014406          198 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP-G  273 (425)
Q Consensus       198 ~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~-~  273 (425)
                      |+||||+++|+|..++   ..+++..++.++.||+.||+|||++|||||||||+|||++.+ +.+||+|||+|+.... .
T Consensus        81 ~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~-g~vkl~DFG~a~~~~~~~  159 (337)
T d1o6la_          81 CFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKD-GHIKITDFGLCKEGISDG  159 (337)
T ss_dssp             EEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT-SCEEECCCTTCBCSCCTT
T ss_pred             ccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCC-CCEEEeecccccccccCC
Confidence            9999999999998877   469999999999999999999999999999999999999998 7999999999987644 3


Q ss_pred             CcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCC
Q 014406          274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL  353 (425)
Q Consensus       274 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~  353 (425)
                      ......+||+.|+|||++.+ ..|+.++||||+||++|||++|+.||. +.+..+....+..             ...  
T Consensus       160 ~~~~~~~GT~~Y~aPE~~~~-~~y~~~~DiwSlGvilyeml~G~~pf~-~~~~~~~~~~i~~-------------~~~--  222 (337)
T d1o6la_         160 ATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY-NQDHERLFELILM-------------EEI--  222 (337)
T ss_dssp             CCBCCCEECGGGCCGGGGSS-SCBCTTHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHH-------------CCC--
T ss_pred             cccccceeCHHHhhhhhccC-CCCChhhcccchhhHHHHHHHCCCCCC-CcCHHHHHHHHhc-------------CCC--
Confidence            34456789999999999988 789999999999999999999999984 3333333332211             000  


Q ss_pred             ChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCc-----CHHHHhcCCCCcccccchh
Q 014406          354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYFAQVRAAES  420 (425)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rp-----ta~elL~hp~~~~~~~~~~  420 (425)
                                            ..+..+|+++++||++||++||++|+     |++|+++||||+++.+...
T Consensus       223 ----------------------~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~~~l  272 (337)
T d1o6la_         223 ----------------------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDV  272 (337)
T ss_dssp             ----------------------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHH
T ss_pred             ----------------------CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccCCHHHH
Confidence                                  11223799999999999999999999     4999999999999876543

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.3e-57  Score=429.00  Aligned_cols=254  Identities=28%  Similarity=0.472  Sum_probs=197.1

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEE
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (425)
                      .+.|++.+.||+|+||+||+|.+..+++.||||++...    ..+.+.+|+.+|+++ +||||+++++++.+.  ..+++
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~--~~~~l   84 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKI-KHPNIVALDDIYESG--GHLYL   84 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTC-CCTTBCCEEEEEECS--SEEEE
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhC-CCCCCCcEEEEEEEC--CEEEE
Confidence            57799999999999999999999999999999998743    235577999999999 999999999999654  77899


Q ss_pred             EEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecC--CCCcEEEEeccccccccCCC
Q 014406          200 IFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGK  274 (425)
Q Consensus       200 v~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~--~~~~~kl~Dfg~a~~~~~~~  274 (425)
                      ||||++||+|.+++   ..+++.+++.++.||+.||+|||++||+||||||+|||+..  +.+.+||+|||+|+......
T Consensus        85 vmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~  164 (307)
T d1a06a_          85 IMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS  164 (307)
T ss_dssp             EECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC----------
T ss_pred             EEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCC
Confidence            99999999998877   35999999999999999999999999999999999999953  23789999999998876666


Q ss_pred             cceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCC
Q 014406          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD  354 (425)
Q Consensus       275 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~  354 (425)
                      .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||. +.+..+....+.+.-             ..  
T Consensus       165 ~~~~~~GT~~y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~-~~~~~~~~~~i~~~~-------------~~--  227 (307)
T d1a06a_         165 VLSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVIAYILLCGYPPFY-DENDAKLFEQILKAE-------------YE--  227 (307)
T ss_dssp             --------CTTSCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCC-CSSHHHHHHHHHTTC-------------CC--
T ss_pred             eeeeeeeCccccCcHHHcC-CCCCcHHHhhhhhHHHHHHHhCCCCCC-CCCHHHHHHHHhccC-------------CC--
Confidence            6667789999999999987 789999999999999999999999984 333333333322100             00  


Q ss_pred             hhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCccc
Q 014406          355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV  415 (425)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~  415 (425)
                                        ........+|+++++||++||+.||++|||++|+|+||||++-
T Consensus       228 ------------------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~  270 (307)
T d1a06a_         228 ------------------FDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD  270 (307)
T ss_dssp             ------------------CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred             ------------------CCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence                              0011123479999999999999999999999999999999853

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=8.6e-57  Score=430.81  Aligned_cols=255  Identities=26%  Similarity=0.487  Sum_probs=217.7

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc---hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEE
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (425)
                      .++|++++.||+|+||+||+|.+..+|+.||||+++...   .+.+.+|+.+|+++ +||||++++++|.++  ..+++|
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~--~~~~iv  104 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQL-HHPKLINLHDAFEDK--YEMVLI  104 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTC-CSTTBCCEEEEEECS--SEEEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhC-CCCCCCcEEEEEEEC--CEEEEE
Confidence            467999999999999999999999999999999997543   35678999999999 999999999999654  788999


Q ss_pred             EEeecCCChhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecC-CCCcEEEEeccccccccCCCc
Q 014406          201 FEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH-ELRKLRLIDWGLAEFYHPGKE  275 (425)
Q Consensus       201 ~e~~~~~~l~~~~~----~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~-~~~~~kl~Dfg~a~~~~~~~~  275 (425)
                      |||+++|+|.+.+.    .+++.+++.++.||+.||+|||++|||||||||+|||++. +.+.+||+|||+|+.......
T Consensus       105 mE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~  184 (352)
T d1koba_         105 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI  184 (352)
T ss_dssp             EECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred             EEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCCc
Confidence            99999999977652    4899999999999999999999999999999999999983 337899999999998877777


Q ss_pred             ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCCh
Q 014406          276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP  355 (425)
Q Consensus       276 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~  355 (425)
                      .....+|+.|+|||++.+ ..|+.++|||||||++|+|++|+.|| .+.+..+.+..+......                
T Consensus       185 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyelltG~~Pf-~~~~~~~~~~~i~~~~~~----------------  246 (352)
T d1koba_         185 VKVTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPF-AGEDDLETLQNVKRCDWE----------------  246 (352)
T ss_dssp             EEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSS-CCSSHHHHHHHHHHCCCC----------------
T ss_pred             eeeccCcccccCHHHHcC-CCCCCccchHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHhCCCC----------------
Confidence            777899999999999987 78999999999999999999999998 444444555444331110                


Q ss_pred             hhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccc
Q 014406          356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR  416 (425)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~  416 (425)
                                       ........+++++++||++||++||++|||++|+|+||||++..
T Consensus       247 -----------------~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~  290 (352)
T d1koba_         247 -----------------FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH  290 (352)
T ss_dssp             -----------------CCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred             -----------------CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCc
Confidence                             00111234799999999999999999999999999999998643

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-57  Score=424.98  Aligned_cols=277  Identities=29%  Similarity=0.517  Sum_probs=222.1

Q ss_pred             EEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc--------hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEE
Q 014406          129 VVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (425)
Q Consensus       129 ~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~--------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (425)
                      .+++||+|+||+||+|.+..+|+.||||+++...        .+.+.+|+.+++++ +||||+++++++.+  ..++++|
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~~~~~~~~--~~~~~iv   78 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL-SHPNIIGLLDAFGH--KSNISLV   78 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHC-CCTTBCCEEEEECC--TTCCEEE
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhC-CCCCEeEEEeeecc--CCceeeh
Confidence            4678999999999999999999999999986322        24688999999999 99999999999955  4778999


Q ss_pred             EEeecCCChhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCC-cc
Q 014406          201 FEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EY  276 (425)
Q Consensus       201 ~e~~~~~~l~~~~~---~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~-~~  276 (425)
                      |||+.++++..+..   .+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+...... ..
T Consensus        79 mE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~-~~~KL~DFG~a~~~~~~~~~~  157 (299)
T d1ua2a_          79 FDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDEN-GVLKLADFGLAKSFGSPNRAY  157 (299)
T ss_dssp             EECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-CCEEECCCGGGSTTTSCCCCC
T ss_pred             hhhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCC-CccccccCccccccCCCcccc
Confidence            99999998877663   48999999999999999999999999999999999999988 799999999998765432 33


Q ss_pred             eeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCChh
Q 014406          277 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ  356 (425)
Q Consensus       277 ~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~  356 (425)
                      ...++|+.|+|||++.+...|+.++|||||||++|||++|..|| .+.++.+++..+.+.+|.+....+.......... 
T Consensus       158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf-~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~-  235 (299)
T d1ua2a_         158 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFL-PGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV-  235 (299)
T ss_dssp             CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCC-
T ss_pred             cceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCC-CCCCHHHHHHHHHHhcCCCChhhccchhccchhh-
Confidence            45689999999999987567899999999999999999998765 6777888999999988876644332111111000 


Q ss_pred             hHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccch
Q 014406          357 LDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE  419 (425)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~~  419 (425)
                              ................+++++++||++||++||++||||+|+|+||||++...+.
T Consensus       236 --------~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~p~  290 (299)
T d1ua2a_         236 --------TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPT  290 (299)
T ss_dssp             --------CCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCC
T ss_pred             --------hhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCCCC
Confidence                    0000001111111234789999999999999999999999999999999876543

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.4e-56  Score=421.97  Aligned_cols=252  Identities=22%  Similarity=0.455  Sum_probs=215.2

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecC------cchHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCcc
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP------VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~------~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (425)
                      .++|++++.||+|+||+||+|++..+|+.||||+++.      ...+.+.+|+.+++++ +||||+++++++.+.  ..+
T Consensus         3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~--~~~   79 (316)
T d1fota_           3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-THPFIIRMWGTFQDA--QQI   79 (316)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CBTTBCCEEEEEECS--SEE
T ss_pred             hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhc-cCcChhheeeeEeeC--Cee
Confidence            3679999999999999999999999999999999863      3346788999999999 999999999999654  788


Q ss_pred             EEEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCC
Q 014406          198 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (425)
Q Consensus       198 ~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~  274 (425)
                      ++||||+.||++..++   ..+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+....  
T Consensus        80 ~ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~-g~vkL~DFG~a~~~~~--  156 (316)
T d1fota_          80 FMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKN-GHIKITDFGFAKYVPD--  156 (316)
T ss_dssp             EEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTT-SCEEECCCSSCEECSS--
T ss_pred             eeEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCC-CCEEEecCccceEecc--
Confidence            9999999999988776   458899999999999999999999999999999999999988 7999999999987653  


Q ss_pred             cceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCC
Q 014406          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD  354 (425)
Q Consensus       275 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~  354 (425)
                      .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||. +.+..+....+...             ..   
T Consensus       157 ~~~~~~Gt~~Y~APE~l~~-~~y~~~~DiwSlGvilyemltG~~Pf~-~~~~~~~~~~i~~~-------------~~---  218 (316)
T d1fota_         157 VTYTLCGTPDYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFY-DSNTMKTYEKILNA-------------EL---  218 (316)
T ss_dssp             CBCCCCSCTTTCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTC-CSSHHHHHHHHHHC-------------CC---
T ss_pred             ccccccCcccccCHHHHcC-CCCCchhhccccchhHHHHHhCCCCCC-CcCHHHHHHHHHcC-------------CC---
Confidence            3345789999999999987 789999999999999999999999984 33333333333220             00   


Q ss_pred             hhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCc-----CHHHHhcCCCCcccccchh
Q 014406          355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYFAQVRAAES  420 (425)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rp-----ta~elL~hp~~~~~~~~~~  420 (425)
                                           ..+..+++++++++++||+.||++|+     |++|+++||||+++.+...
T Consensus       219 ---------------------~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~~~l  268 (316)
T d1fota_         219 ---------------------RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKL  268 (316)
T ss_dssp             ---------------------CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHHH
T ss_pred             ---------------------CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccCCHHHH
Confidence                                 01123789999999999999999996     9999999999999977643

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=7.6e-57  Score=423.81  Aligned_cols=249  Identities=27%  Similarity=0.414  Sum_probs=208.6

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc------hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccE
Q 014406          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (425)
Q Consensus       125 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (425)
                      +.|++++.||+|+||+||+|++..+++.||||+++...      .+.+.+|+.+|+++ +||||+++++++.+.  ...+
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~--~~~~   91 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQYRGCYLRE--HTAW   91 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEET--TEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHC-CCCCEeeEEEEEEEC--CEEE
Confidence            35999999999999999999999999999999986432      24688999999999 899999999999764  6789


Q ss_pred             EEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCc
Q 014406          199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (425)
Q Consensus       199 lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~  275 (425)
                      +||||+.+|++..+.   ..+++.+++.++.||+.||.|||++|||||||||+|||++.+ +.+||+|||+|+....   
T Consensus        92 iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~-~~~Kl~DFG~a~~~~~---  167 (309)
T d1u5ra_          92 LVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEP-GLVKLGDFGSASIMAP---  167 (309)
T ss_dssp             EEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETT-TEEEECCCTTCBSSSS---
T ss_pred             EEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCC-CCEEEeecccccccCC---
Confidence            999999999987654   569999999999999999999999999999999999999988 7999999999986543   


Q ss_pred             ceeeccCCCccCcccccC--CCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCC
Q 014406          276 YNVRVASRYFKGPELLVD--LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL  353 (425)
Q Consensus       276 ~~~~~~t~~y~aPE~~~~--~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~  353 (425)
                      .....||+.|+|||++.+  ...|+.++|||||||++|||++|..||. +.+..+.+..+...-.               
T Consensus       168 ~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~-~~~~~~~~~~i~~~~~---------------  231 (309)
T d1u5ra_         168 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF-NMNAMSALYHIAQNES---------------  231 (309)
T ss_dssp             BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTT-TSCHHHHHHHHHHSCC---------------
T ss_pred             CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCC-CCCHHHHHHHHHhCCC---------------
Confidence            345689999999999864  2458999999999999999999999984 3333333333322000               


Q ss_pred             ChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccc
Q 014406          354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR  416 (425)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~  416 (425)
                                          .......+|+++++||++||+.||++|||++|+|+||||.+-.
T Consensus       232 --------------------~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~~  274 (309)
T d1u5ra_         232 --------------------PALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER  274 (309)
T ss_dssp             --------------------CCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred             --------------------CCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcCCC
Confidence                                0001123789999999999999999999999999999997643

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-56  Score=418.66  Aligned_cols=280  Identities=30%  Similarity=0.600  Sum_probs=224.9

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEE
Q 014406          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (425)
Q Consensus       125 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (425)
                      ++|++++.||+|+||+||+|.+..+++.||||+++..     ..+.+.+|+++++++ +||||++++++|.+.  ...|+
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~Hp~Iv~~~~~~~~~--~~~~i   78 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-NHPNIVKLLDVIHTE--NKLYL   78 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTC-CCTTBCCEEEEEEET--TEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhC-CCCcEEEeccccccc--cceeE
Confidence            6899999999999999999999999999999998642     246788999999999 999999999999764  67899


Q ss_pred             EEEeecCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCC-C
Q 014406          200 IFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-K  274 (425)
Q Consensus       200 v~e~~~~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~-~  274 (425)
                      ||||+.++++....    ..+++..++.++.||+.||+|||++|||||||||+|||++.+ +.+||+|||+|+..... .
T Consensus        79 v~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~-~~~kl~DFG~a~~~~~~~~  157 (298)
T d1gz8a_          79 VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVR  157 (298)
T ss_dssp             EEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-SCEEECSTTHHHHHCCCSB
T ss_pred             EEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeeccc-CcceeccCCcceeccCCcc
Confidence            99999887665443    459999999999999999999999999999999999999988 78999999999876543 3


Q ss_pred             cceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCC
Q 014406          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD  354 (425)
Q Consensus       275 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~  354 (425)
                      ......||+.|+|||++.....++.++||||+||++|+|++|+.|| .+.++.+++..+....+.+....+......   
T Consensus       158 ~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~---  233 (298)
T d1gz8a_         158 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALF-PGDSEIDQLFRIFRTLGTPDEVVWPGVTSM---  233 (298)
T ss_dssp             CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCCCCTTTSTTGGGS---
T ss_pred             cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCC-CCCCHHHHHHHHHHhcCCCchhhccccccc---
Confidence            4455689999999999887566789999999999999999999998 466667788888877776543221110000   


Q ss_pred             hhhHHHhcccC-CCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccc
Q 014406          355 PQLDALVGRHS-RKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA  418 (425)
Q Consensus       355 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~  418 (425)
                            ..... ...+...........+++++++||++||+.||++|||++|+|+||||+++..+
T Consensus       234 ------~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p  292 (298)
T d1gz8a_         234 ------PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP  292 (298)
T ss_dssp             ------TTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred             ------cccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCC
Confidence                  00000 00011111111223478999999999999999999999999999999998764

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=7.2e-56  Score=410.91  Aligned_cols=254  Identities=26%  Similarity=0.449  Sum_probs=214.0

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc------------hHHHHHHHHHHHHhcCCCCeeeEEeEEEc
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------------KKKIKREIKILQNLCGGPNVVKLLDIVRD  191 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~------------~~~~~~E~~~l~~l~~h~niv~l~~~~~~  191 (425)
                      .++|++.+.||+|+||+||+|++..+++.||||+++...            .+.+.+|+.+++++..||||+++++++.+
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence            579999999999999999999999999999999986432            23578999999999559999999999965


Q ss_pred             CCCCccEEEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccc
Q 014406          192 QHSKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE  268 (425)
Q Consensus       192 ~~~~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~  268 (425)
                        .+++|+||||+++|+|.+++   ..+++.+++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++
T Consensus        82 --~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~-~~~kl~DFG~a~  158 (277)
T d1phka_          82 --NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDD-MNIKLTDFGFSC  158 (277)
T ss_dssp             --SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-CCEEECCCTTCE
T ss_pred             --CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCC-CCeEEccchhee
Confidence              47899999999999999887   469999999999999999999999999999999999999988 799999999999


Q ss_pred             cccCCCcceeeccCCCccCcccccC-----CCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhH
Q 014406          269 FYHPGKEYNVRVASRYFKGPELLVD-----LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELN  343 (425)
Q Consensus       269 ~~~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~  343 (425)
                      ............||..|+|||.+.+     ...++.++||||+||++|+|++|+.||. +.+..+....+...  .    
T Consensus       159 ~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~-~~~~~~~~~~i~~~--~----  231 (277)
T d1phka_         159 QLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW-HRKQMLMLRMIMSG--N----  231 (277)
T ss_dssp             ECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHT--C----
T ss_pred             EccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCC-CCCHHHHHHHHHhC--C----
Confidence            8776666666789999999999853     2457889999999999999999999984 33333333333221  0    


Q ss_pred             HHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcc
Q 014406          344 AYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ  414 (425)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~  414 (425)
                             ...                    .......+|+++++|+.+||+.||++|||++|+|+||||++
T Consensus       232 -------~~~--------------------~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~  275 (277)
T d1phka_         232 -------YQF--------------------GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ  275 (277)
T ss_dssp             -------CCC--------------------CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred             -------CCC--------------------CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence                   000                    00011237999999999999999999999999999999986

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-56  Score=419.20  Aligned_cols=283  Identities=29%  Similarity=0.540  Sum_probs=227.4

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCC-CcEEEEEEecCc-----chHHHHHHHHHHHHhc--CCCCeeeEEeEEEcC---
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNT-NERCIIKILKPV-----KKKKIKREIKILQNLC--GGPNVVKLLDIVRDQ---  192 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~-~~~vavK~~~~~-----~~~~~~~E~~~l~~l~--~h~niv~l~~~~~~~---  192 (425)
                      .++|+++++||+|+||+||+|++..+ ++.||||+++..     ....+.+|+.+++.+.  +||||++++++|...   
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            57999999999999999999999765 677999998632     2345778888888763  799999999998642   


Q ss_pred             CCCccEEEEEeecCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccc
Q 014406          193 HSKTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE  268 (425)
Q Consensus       193 ~~~~~~lv~e~~~~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~  268 (425)
                      .....+++|||+.++++....    ..+++..++.++.|++.||+|||++|||||||||+|||++.+ +.+||+|||+++
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~-~~~kl~dfg~~~  164 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSS-GQIKLADFGLAR  164 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-CCEEECSCCSCC
T ss_pred             cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCC-CCeeecchhhhh
Confidence            335789999999998775443    458999999999999999999999999999999999999988 789999999998


Q ss_pred             cccCCCcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhh
Q 014406          269 FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK  348 (425)
Q Consensus       269 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~  348 (425)
                      ............||+.|+|||++.+ ..|+.++||||+||++|||++|+.|| .+.++.+++..+.+.+|.+....+...
T Consensus       165 ~~~~~~~~~~~~gT~~Y~APE~~~~-~~y~~~~DiwSlG~il~ell~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~  242 (305)
T d1blxa_         165 IYSFQMALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLF-RGSSDVDQLGKILDVIGLPGEEDWPRD  242 (305)
T ss_dssp             CCCGGGGGCCCCCCCTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCCCCGGGSCTT
T ss_pred             hhcccccCCCcccChhhcCcchhcC-CCCChhehhhchHHHHHHHHHCCCCC-CCCCHHHHHHHHHHhhCCCchhccccc
Confidence            7766666677899999999999987 78999999999999999999999998 566778888889888887654432211


Q ss_pred             ccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccch
Q 014406          349 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE  419 (425)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~~  419 (425)
                      ....  ..   ........+     .......+++++++||++||++||++|||++|+|+||||+++....
T Consensus       243 ~~~~--~~---~~~~~~~~~-----~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~~k  303 (305)
T d1blxa_         243 VALP--RQ---AFHSKSAQP-----IEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCK  303 (305)
T ss_dssp             CSSC--GG---GSCCCCCCC-----GGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCCC
T ss_pred             ccch--hh---hhccccccc-----hhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCchhhC
Confidence            1100  00   000000111     1122344789999999999999999999999999999999987643

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=8e-56  Score=424.00  Aligned_cols=252  Identities=23%  Similarity=0.395  Sum_probs=215.9

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecC------cchHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCcc
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP------VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~------~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (425)
                      .++|++++.||+|+||+||+|++..+|+.||||+++.      ...+.+.+|+.+|+.+ +||||+++++++.+.  ...
T Consensus        40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~--~~~  116 (350)
T d1rdqe_          40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLEFSFKDN--SNL  116 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-CCTTBCCEEEEEECS--SEE
T ss_pred             ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHc-CCCcEeecccccccc--ccc
Confidence            4689999999999999999999999999999999863      2346688999999999 999999999999654  678


Q ss_pred             EEEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCC
Q 014406          198 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (425)
Q Consensus       198 ~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~  274 (425)
                      ++||||+.+|++..++   ..+++..++.++.||+.||.|||++|||||||||+|||++.+ +.+||+|||+|+....  
T Consensus       117 ~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~-g~ikL~DFG~a~~~~~--  193 (350)
T d1rdqe_         117 YMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVKG--  193 (350)
T ss_dssp             EEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-SCEEECCCTTCEECSS--
T ss_pred             ccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCC-CCEEeeeceeeeeccc--
Confidence            8999999999998876   569999999999999999999999999999999999999988 7999999999987653  


Q ss_pred             cceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCC
Q 014406          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD  354 (425)
Q Consensus       275 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~  354 (425)
                      ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||. +.+..+.+..+...             .    
T Consensus       194 ~~~~~~Gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~-~~~~~~~~~~i~~~-------------~----  254 (350)
T d1rdqe_         194 RTWTLCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF-ADQPIQIYEKIVSG-------------K----  254 (350)
T ss_dssp             CBCCCEECGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHC-------------C----
T ss_pred             ccccccCccccCCHHHHcC-CCCCccccccchhHHHHHHHhCCCCCC-CcCHHHHHHHHhcC-------------C----
Confidence            3345689999999999987 789999999999999999999999984 33333333333220             0    


Q ss_pred             hhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCc-----CHHHHhcCCCCcccccchh
Q 014406          355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYFAQVRAAES  420 (425)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rp-----ta~elL~hp~~~~~~~~~~  420 (425)
                                          ...+..+++++.+||++||+.||++|+     |++|+++||||+++.+...
T Consensus       255 --------------------~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~~~~  305 (350)
T d1rdqe_         255 --------------------VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAI  305 (350)
T ss_dssp             --------------------CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHH
T ss_pred             --------------------CCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCCCHHHH
Confidence                                001123799999999999999999995     9999999999999887544

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-55  Score=424.41  Aligned_cols=282  Identities=32%  Similarity=0.546  Sum_probs=229.0

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcchHHHHHHHHHHHHhcCCCCeeeEEeEEEcC----CCCccEEEE
Q 014406          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQ----HSKTPSLIF  201 (425)
Q Consensus       126 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~----~~~~~~lv~  201 (425)
                      +|+.+++||+|+||+||+|++..+|+.||||+++... ....+|+.+|+++ +|+||++++++|...    +..++++||
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~-~~~~~Ei~il~~l-~h~niv~~~~~~~~~~~~~~~~~~~lv~   98 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-RFKNRELQIMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVL   98 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-SSCCHHHHHHHHC-CCTTBCCEEEEEEEC--CCSCCEEEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccc-hHHHHHHHHHHhc-CCCCCCcEEEEEEecCccCCceEEEEEE
Confidence            6899999999999999999999999999999997543 3345899999999 999999999998642    345688999


Q ss_pred             EeecCCChhhhc------CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCc
Q 014406          202 EYVNSTDFKVLY------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (425)
Q Consensus       202 e~~~~~~l~~~~------~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~  275 (425)
                      ||++++++..+.      ..+++.+++.++.||+.||+|||++||+||||||+|||++.+...+||+|||+++.......
T Consensus        99 Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~~  178 (350)
T d1q5ka_          99 DYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP  178 (350)
T ss_dssp             ECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTSC
T ss_pred             eccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhccCCcc
Confidence            999988654432      35999999999999999999999999999999999999998756899999999988776666


Q ss_pred             ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCCh
Q 014406          276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP  355 (425)
Q Consensus       276 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~  355 (425)
                      .....||+.|+|||.+.+...++.++||||+||++|||++|+.|| .+.+..+++..+.+.+|.+..+.+..........
T Consensus       179 ~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf-~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~  257 (350)
T d1q5ka_         179 NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF-PGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF  257 (350)
T ss_dssp             CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSS-CCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CC
T ss_pred             cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCC-CCCCHHHHHHHHHHHhCCChHHhhhhhccchhhc
Confidence            677899999999999887678999999999999999999999887 5666778899999999987765543221111000


Q ss_pred             hhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccc
Q 014406          356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA  418 (425)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~  418 (425)
                      .    .......++.    ......+++++++||++||++||++||||+|+|+||||+++...
T Consensus       258 ~----~~~~~~~~~~----~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~  312 (350)
T d1q5ka_         258 K----FPQIKAHPWT----KVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDP  312 (350)
T ss_dssp             C----CCCCCCCCGG----GTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCT
T ss_pred             c----ccccccCchh----hhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccCC
Confidence            0    0000111111    12233478999999999999999999999999999999987653

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.2e-56  Score=419.05  Aligned_cols=254  Identities=25%  Similarity=0.460  Sum_probs=216.5

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcch--HHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEE
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK--KKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~--~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (425)
                      .++|++++.||+|+||+||+|.+..+++.||||+++....  ..+.+|+++|+.+ +||||++++++|.+.  ..+|+||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~--~~~~lvm   80 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIA-RHRNILHLHESFESM--EELVMIF   80 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHS-CCTTBCCEEEEEEET--TEEEEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhC-CCCCCCeEEEEEEEC--CEEEEEE
Confidence            5789999999999999999999999999999999986543  4578999999999 999999999999764  6789999


Q ss_pred             EeecCCChhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCC-CCcEEEEeccccccccCCCcc
Q 014406          202 EYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE-LRKLRLIDWGLAEFYHPGKEY  276 (425)
Q Consensus       202 e~~~~~~l~~~~~----~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~-~~~~kl~Dfg~a~~~~~~~~~  276 (425)
                      ||++|++|.+++.    .+++.+++.++.||+.||+|||++||+||||||+|||++.+ ...+||+|||+++........
T Consensus        81 E~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~  160 (321)
T d1tkia_          81 EFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF  160 (321)
T ss_dssp             CCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEE
T ss_pred             ecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCCcc
Confidence            9999999998773    48999999999999999999999999999999999999864 347999999999987766667


Q ss_pred             eeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCChh
Q 014406          277 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ  356 (425)
Q Consensus       277 ~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~  356 (425)
                      ....+|+.|+|||.+.+ ..++.++||||+||++|+|++|..|| .+.+..+.+..+.+..-..+.              
T Consensus       161 ~~~~~t~~y~ape~~~~-~~~~~~~DiWSlGvily~ll~G~~Pf-~~~~~~~~~~~i~~~~~~~~~--------------  224 (321)
T d1tkia_         161 RLLFTAPEYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGINPF-LAETNQQIIENIMNAEYTFDE--------------  224 (321)
T ss_dssp             EEEESCGGGSCHHHHTT-CEECHHHHHHHHHHHHHHHHHSSCTT-CCSSHHHHHHHHHHTCCCCCH--------------
T ss_pred             cccccccccccchhccC-CCCCchhhcccHHHHHHHHHhCCCCC-CCCCHHHHHHHHHhCCCCCCh--------------
Confidence            77889999999999987 67999999999999999999999998 344444444444331111000              


Q ss_pred             hHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCccc
Q 014406          357 LDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV  415 (425)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~  415 (425)
                                         .....+|+++++||++||+.||++|||++|+|+||||++-
T Consensus       225 -------------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~  264 (321)
T d1tkia_         225 -------------------EAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK  264 (321)
T ss_dssp             -------------------HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred             -------------------hhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence                               0011278999999999999999999999999999999753

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-55  Score=416.94  Aligned_cols=254  Identities=25%  Similarity=0.440  Sum_probs=213.9

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecC------cchHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccE
Q 014406          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP------VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (425)
Q Consensus       125 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~------~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (425)
                      ++|++++.||+|+||+||+|.+..+++.||||++++      ...+.+..|+.++.+..+||||+++++++.+.  ..+|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~--~~~y   79 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK--ENLF   79 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS--SEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccC--Ccee
Confidence            689999999999999999999999999999999963      23456777888776433999999999999664  7799


Q ss_pred             EEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCC-C
Q 014406          199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-K  274 (425)
Q Consensus       199 lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~-~  274 (425)
                      +||||+++|+|..++   ..+++.+++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++..... .
T Consensus        80 ivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~-~~~kl~DFG~a~~~~~~~~  158 (320)
T d1xjda_          80 FVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKD-GHIKIADFGMCKENMLGDA  158 (320)
T ss_dssp             EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT-SCEEECCCTTCBCCCCTTC
T ss_pred             EEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCC-Cceeccccchhhhcccccc
Confidence            999999999999887   569999999999999999999999999999999999999988 79999999999866433 3


Q ss_pred             cceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCC
Q 014406          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD  354 (425)
Q Consensus       275 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~  354 (425)
                      ......||+.|+|||++.+ ..++.++||||+||++|+|++|+.||. +.+..+.+..+..  +.+              
T Consensus       159 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyemltG~~PF~-~~~~~~~~~~i~~--~~~--------------  220 (320)
T d1xjda_         159 KTNTFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFH-GQDEEELFHSIRM--DNP--------------  220 (320)
T ss_dssp             CBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHH--CCC--------------
T ss_pred             cccccCCCCCcCCHHHHcC-CCCCchhhhhhhhHHHHHHHhCCCCCC-CCCHHHHHHHHHc--CCC--------------
Confidence            3445689999999999988 789999999999999999999999983 4443333333321  100              


Q ss_pred             hhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHH-HHhcCCCCcccccchh
Q 014406          355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAR-EAMAHPYFAQVRAAES  420 (425)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~-elL~hp~~~~~~~~~~  420 (425)
                                           ..+..+|+++++||++||+.||++|||+. |+++||||+++++.+.
T Consensus       221 ---------------------~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~~~~~l  266 (320)
T d1xjda_         221 ---------------------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWEEL  266 (320)
T ss_dssp             ---------------------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCHHHH
T ss_pred             ---------------------CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhccCCHHHH
Confidence                                 01123799999999999999999999996 8999999999876543

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.4e-55  Score=424.53  Aligned_cols=257  Identities=26%  Similarity=0.419  Sum_probs=209.9

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHH---HHHHHHhcCCCCeeeEEeEEEcCCC
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKRE---IKILQNLCGGPNVVKLLDIVRDQHS  194 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E---~~~l~~l~~h~niv~l~~~~~~~~~  194 (425)
                      .++|++++.||+|+||+||+|++..+|+.||||++...      ....+.+|   +.+++.+ +||||++++++|.+.  
T Consensus         3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~-~hpnIv~l~~~~~~~--   79 (364)
T d1omwa3           3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG-DCPFIVCMSYAFHTP--   79 (364)
T ss_dssp             STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSS-CCTTBCCEEEEEECS--
T ss_pred             HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcC-CCCcEEEEEEEEEEC--
Confidence            46899999999999999999999999999999998632      22334455   4555555 799999999999664  


Q ss_pred             CccEEEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEecccccccc
Q 014406          195 KTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (425)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~  271 (425)
                      ..+|+||||+++|+|..++   ..+++..++.++.||+.||+|||++|||||||||+|||++.+ +.+||+|||+|+...
T Consensus        80 ~~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~-g~iKl~DFGla~~~~  158 (364)
T d1omwa3          80 DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEH-GHVRISDLGLACDFS  158 (364)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-SCEEECCCTTCEECS
T ss_pred             CEEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCC-CcEEEeeeceeeecC
Confidence            6789999999999999887   458999999999999999999999999999999999999988 799999999998765


Q ss_pred             CCCcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccC
Q 014406          272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL  351 (425)
Q Consensus       272 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~  351 (425)
                      .. ......||+.|+|||++.+...|+.++|||||||++|||++|+.||..... .+... +......            
T Consensus       159 ~~-~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~-~~~~~-~~~~~~~------------  223 (364)
T d1omwa3         159 KK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT-KDKHE-IDRMTLT------------  223 (364)
T ss_dssp             SS-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCS-SCHHH-HHHHSSS------------
T ss_pred             CC-cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCH-HHHHH-HHHhccc------------
Confidence            43 345568999999999997656799999999999999999999999953222 11111 1110000            


Q ss_pred             CCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcC-----HHHHhcCCCCcccccchh
Q 014406          352 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT-----AREAMAHPYFAQVRAAES  420 (425)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpt-----a~elL~hp~~~~~~~~~~  420 (425)
                                           .....+..+++++++||.+||+.||++|||     |+|+++||||+++.|...
T Consensus       224 ---------------------~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~~~~  276 (364)
T d1omwa3         224 ---------------------MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMV  276 (364)
T ss_dssp             ---------------------CCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCHHHH
T ss_pred             ---------------------CCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCCHHHH
Confidence                                 001112347999999999999999999999     899999999999876543

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=6.8e-55  Score=407.51  Aligned_cols=276  Identities=30%  Similarity=0.573  Sum_probs=220.7

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc-----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEE
Q 014406          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (425)
Q Consensus       125 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (425)
                      ++|+++++||+|+||+||+|++. +++.||||+++...     .+.+.+|+.+|+++ +||||++++++|.++  ...++
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~--~~~~i   77 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKEL-KHSNIVKLYDVIHTK--KRLVL   77 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGC-CCTTBCCEEEEEECS--SCEEE
T ss_pred             CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhC-CCCcEEeeeeecccC--CceeE
Confidence            68999999999999999999875 78999999996432     46789999999999 899999999999654  67889


Q ss_pred             EEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCC-c
Q 014406          200 IFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-E  275 (425)
Q Consensus       200 v~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~-~  275 (425)
                      ++||+.++++..+.   ..+++..++.++.||+.||+|||++|||||||||+|||++.+ +.+||+|||.|....... .
T Consensus        78 ~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~-~~~kl~DfG~a~~~~~~~~~  156 (286)
T d1ob3a_          78 VFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINRE-GELKIADFGLARAFGIPVRK  156 (286)
T ss_dssp             EEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-SCEEECCTTHHHHHCC----
T ss_pred             EEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCC-CCEEecccccceecccCccc
Confidence            99999999887765   459999999999999999999999999999999999999998 799999999998765432 3


Q ss_pred             ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCCh
Q 014406          276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP  355 (425)
Q Consensus       276 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~  355 (425)
                      .....+++.|+|||.+.+...++.++||||+||++|||++|+.|| .+.++.+++..+.+.+|.+....+........  
T Consensus       157 ~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~--  233 (286)
T d1ob3a_         157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLF-PGVSEADQLMRIFRILGTPNSKNWPNVTELPK--  233 (286)
T ss_dssp             -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT--
T ss_pred             cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCC-CCCCHHHHHHHHHHhhCCCChhhccchhhhhh--
Confidence            345578999999999987677899999999999999999999998 56667788888888888765443321111100  


Q ss_pred             hhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcc
Q 014406          356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ  414 (425)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~  414 (425)
                       .     ..................+++++++||++||++||++|||++|+|+||||++
T Consensus       234 -~-----~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~  286 (286)
T d1ob3a_         234 -Y-----DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (286)
T ss_dssp             -C-----CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             -c-----ccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence             0     0000111111122233457899999999999999999999999999999985

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-56  Score=423.71  Aligned_cols=259  Identities=25%  Similarity=0.426  Sum_probs=209.9

Q ss_pred             CCCEEEEe-eeeeeCceEEEEEEEcCCCcEEEEEEecCcchHHHHHHHHHHHHhcCCCCeeeEEeEEEc--CCCCccEEE
Q 014406          124 QDDYEVVR-KVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRD--QHSKTPSLI  200 (425)
Q Consensus       124 ~~~y~~~~-~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~--~~~~~~~lv  200 (425)
                      .++|++++ .||+|+||+||+|.+..+++.||||+++  ..+.+.+|+.++.++.+||||++++++|.+  ....++|+|
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~--~~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~iv   87 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ--DCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIV   87 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEE--CSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEEC--CcHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEE
Confidence            46899886 5999999999999999999999999997  346788999998776689999999999975  234678999


Q ss_pred             EEeecCCChhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCC--CCcEEEEeccccccccCC
Q 014406          201 FEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--LRKLRLIDWGLAEFYHPG  273 (425)
Q Consensus       201 ~e~~~~~~l~~~~~-----~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~--~~~~kl~Dfg~a~~~~~~  273 (425)
                      |||++||+|.+++.     .+++.+++.++.||+.||+|||++||+||||||+|||++.+  .+.+||+|||+|+.....
T Consensus        88 mEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~  167 (335)
T d2ozaa1          88 MECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH  167 (335)
T ss_dssp             EECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCC
T ss_pred             EECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeeeccCC
Confidence            99999999998862     48999999999999999999999999999999999999863  357999999999987766


Q ss_pred             CcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCC
Q 014406          274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL  353 (425)
Q Consensus       274 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~  353 (425)
                      .......||+.|+|||++.+ ..|+.++|||||||++|+|+||+.||. +.+..+....+........         ..+
T Consensus       168 ~~~~~~~gt~~y~aPE~~~~-~~y~~~~DiwSlGvily~lltg~~Pf~-~~~~~~~~~~~~~~i~~~~---------~~~  236 (335)
T d2ozaa1         168 NSLTTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFY-SNHGLAISPGMKTRIRMGQ---------YEF  236 (335)
T ss_dssp             CCCCCCSCCCSSCCCCCCCG-GGGSHHHHHHHHHHHHHHHTTSSCSCE-ETTCC--------CCCSCS---------SSC
T ss_pred             CccccccCCcccCCcHHHcC-CCCCHHHHHHhhchhHHHHhhCCCCCC-CCCHHHHHHHHHHHHhcCC---------CCC
Confidence            66677899999999999987 789999999999999999999999994 3222222222211110000         000


Q ss_pred             ChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCccc
Q 014406          354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV  415 (425)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~  415 (425)
                      +                    ......+|+++++||++||++||++|||++|+|+||||++-
T Consensus       237 ~--------------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~  278 (335)
T d2ozaa1         237 P--------------------NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS  278 (335)
T ss_dssp             C--------------------TTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred             C--------------------CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCC
Confidence            0                    00011278999999999999999999999999999999754

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-54  Score=416.36  Aligned_cols=286  Identities=31%  Similarity=0.562  Sum_probs=222.6

Q ss_pred             cCCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc-----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCC--
Q 014406          121 WGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQH--  193 (425)
Q Consensus       121 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~--  193 (425)
                      +...++|+++++||+|+||+||+|.+..+|+.||||+++...     .+.+.+|+.+|+++ +||||++++++|....  
T Consensus        14 ~~~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpniv~l~~~~~~~~~~   92 (346)
T d1cm8a_          14 WEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-RHENVIGLLDVFTPDETL   92 (346)
T ss_dssp             ECCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHC-CBTTBCCCSEEECSCSST
T ss_pred             eecCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhc-CCCCeeEEEEEeccCccc
Confidence            345789999999999999999999999999999999997432     35678999999999 9999999999997542  


Q ss_pred             --CCccEEEEEeecCCChhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEecccccc
Q 014406          194 --SKTPSLIFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (425)
Q Consensus       194 --~~~~~lv~e~~~~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~  269 (425)
                        ..++|+||||+ +.++..+.  ..+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+|++|||+|+.
T Consensus        93 ~~~~~~~lv~e~~-~~~l~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~-~~~kl~Dfg~a~~  170 (346)
T d1cm8a_          93 DDFTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNED-CELKILDFGLARQ  170 (346)
T ss_dssp             TTCCCCEEEEECC-SEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-CCEEECCCTTCEE
T ss_pred             cccceEEEEEecc-cccHHHHHHhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccc-cccccccccceec
Confidence              23579999999 45565554  569999999999999999999999999999999999999998 7999999999987


Q ss_pred             ccCCCcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhc
Q 014406          270 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY  349 (425)
Q Consensus       270 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~  349 (425)
                      ..  ...+...+|+.|+|||++.+...++.++||||+||++|+|++|+.|| .+.+..+.+..+....+.++..... ..
T Consensus       171 ~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~-~~  246 (346)
T d1cm8a_         171 AD--SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLF-KGSDHLDQLKEIMKVTGTPPAEFVQ-RL  246 (346)
T ss_dssp             CC--SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCCCCHHHHH-TC
T ss_pred             cC--CccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCC-CCCChHHHHHHHHhccCCCcHHHHh-hh
Confidence            64  34456789999999999987667899999999999999999999988 5566777888888888876544321 11


Q ss_pred             cCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccc
Q 014406          350 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA  418 (425)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~  418 (425)
                      ...................+..     ....+++++++||++||++||++|||++|+|+||||+++...
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~-----~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~  310 (346)
T d1cm8a_         247 QSDEAKNYMKGLPELEKKDFAS-----ILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDT  310 (346)
T ss_dssp             SCHHHHHHHHHSCCCCCCCGGG-----TCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC--
T ss_pred             cchhhhhhhccCCcccccchHH-----hccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCc
Confidence            1111111111111122222222     223478999999999999999999999999999999987654

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-55  Score=405.02  Aligned_cols=249  Identities=26%  Similarity=0.430  Sum_probs=207.0

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc---------hHHHHHHHHHHHHhc-CCCCeeeEEeEEEcCC
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK---------KKKIKREIKILQNLC-GGPNVVKLLDIVRDQH  193 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~---------~~~~~~E~~~l~~l~-~h~niv~l~~~~~~~~  193 (425)
                      .++|++.+.||+|+||+||+|++..+++.||||+++...         ..++.+|+.+++++. .||||+++++++.++ 
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~-   81 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP-   81 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS-
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC-
Confidence            578999999999999999999999999999999986421         234678999999993 389999999999664 


Q ss_pred             CCccEEEEEeecC-CChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEecccccc
Q 014406          194 SKTPSLIFEYVNS-TDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (425)
Q Consensus       194 ~~~~~lv~e~~~~-~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~  269 (425)
                       ...++||||+.+ +++..++   ..+++.+++.++.||+.||+|||++||+||||||+|||++.+.+.+||+|||+|+.
T Consensus        82 -~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~  160 (273)
T d1xwsa_          82 -DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL  160 (273)
T ss_dssp             -SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             -CeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECcccccee
Confidence             678999999976 5665554   56999999999999999999999999999999999999997657899999999986


Q ss_pred             ccCCCcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhc
Q 014406          270 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY  349 (425)
Q Consensus       270 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~  349 (425)
                      ... .......||+.|+|||++.+...++.++||||+||++|+|++|+.||..    .+   .+.+             .
T Consensus       161 ~~~-~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~----~~---~i~~-------------~  219 (273)
T d1xwsa_         161 LKD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH----DE---EIIR-------------G  219 (273)
T ss_dssp             CCS-SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS----HH---HHHH-------------C
T ss_pred             ccc-ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCC----ch---HHhh-------------c
Confidence            543 3445678999999999998744457789999999999999999999832    11   1100             0


Q ss_pred             cCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccch
Q 014406          350 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE  419 (425)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~~  419 (425)
                      .                        ...+..+|+++++||++||+.||++|||++|+|+||||+++..++
T Consensus       220 ~------------------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~~p~  265 (273)
T d1xwsa_         220 Q------------------------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQ  265 (273)
T ss_dssp             C------------------------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCCHH
T ss_pred             c------------------------cCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCCCCC
Confidence            0                        011223799999999999999999999999999999999876533

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-54  Score=403.61  Aligned_cols=280  Identities=30%  Similarity=0.547  Sum_probs=227.2

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEE
Q 014406          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (425)
Q Consensus       125 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (425)
                      ++|+++++||+|+||+||+|++..+++.||||+++..     ...++.+|+.+++++ +||||++++++|.+.  ...++
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~--~~~~i   78 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-KHKNIVRLHDVLHSD--KKLTL   78 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTC-CCTTBCCEEEEEECS--SEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhc-CcCCEEeeccccccc--cceeE
Confidence            6899999999999999999999999999999998633     246788999999999 999999999999664  67889


Q ss_pred             EEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCC-c
Q 014406          200 IFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-E  275 (425)
Q Consensus       200 v~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~-~  275 (425)
                      ++|++.++++..+.   ..+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||.|+...... .
T Consensus        79 v~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~-~~~kl~DFG~a~~~~~~~~~  157 (292)
T d1unla_          79 VFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRN-GELKLANFGLARAFGIPVRC  157 (292)
T ss_dssp             EEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-CCEEECCCTTCEECCSCCSC
T ss_pred             EeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccC-CceeeeecchhhcccCCCcc
Confidence            99999999887765   468999999999999999999999999999999999999988 789999999998765433 3


Q ss_pred             ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCCh
Q 014406          276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP  355 (425)
Q Consensus       276 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~  355 (425)
                      .....++..|+|||++.+...++.++||||+||++|||++|+.||+.+.+..+++..+....+.+....+..........
T Consensus       158 ~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (292)
T d1unla_         158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK  237 (292)
T ss_dssp             CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred             ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccccc
Confidence            34456778899999988756689999999999999999999999998888888888888877765433221111110000


Q ss_pred             hhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccc
Q 014406          356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR  416 (425)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~  416 (425)
                             ....... ..........+++++++||++||++||++||||+|+|+||||++..
T Consensus       238 -------~~~~~~~-~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~  290 (292)
T d1unla_         238 -------PYPMYPA-TTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC  290 (292)
T ss_dssp             -------CCCCCCT-TCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCS
T ss_pred             -------ccccccc-cchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCC
Confidence                   0000000 0111222334789999999999999999999999999999998764

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-54  Score=399.33  Aligned_cols=248  Identities=16%  Similarity=0.307  Sum_probs=208.3

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc--chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEE
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (425)
                      ..++|++.+.||+|+||+||+|.+. ++..||||+++..  ..+.+.+|+.+++++ +||||++++|++.+   ...++|
T Consensus        11 ~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~---~~~~iv   85 (272)
T d1qpca_          11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQL-QHQRLVRLYAVVTQ---EPIYII   85 (272)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECS---SSCEEE
T ss_pred             CHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCCHHHHHHHHHHHHhC-CCCCEeEEEeeecc---CCeEEE
Confidence            3578999999999999999999864 6788999999753  457899999999999 99999999998854   457899


Q ss_pred             EEeecCCChhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCc
Q 014406          201 FEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (425)
Q Consensus       201 ~e~~~~~~l~~~~~-----~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~  275 (425)
                      |||+++|+|.+++.     .+++..+..++.||+.||.|||+++|+||||||+|||++.+ +.+||+|||+|+.......
T Consensus        86 ~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~-~~~Kl~DFGla~~~~~~~~  164 (272)
T d1qpca_          86 TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDT-LSCKIADFGLARLIEDNEY  164 (272)
T ss_dssp             EECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-SCEEECCCTTCEECSSSCE
T ss_pred             EEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecc-cceeeccccceEEccCCcc
Confidence            99999999988763     48999999999999999999999999999999999999988 7999999999987754332


Q ss_pred             --ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCC
Q 014406          276 --YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL  353 (425)
Q Consensus       276 --~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~  353 (425)
                        .....+|..|+|||++.+ ..++.++|||||||++|||+||+.|++...+..+.+..+....                
T Consensus       165 ~~~~~~~gt~~y~APE~~~~-~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~----------------  227 (272)
T d1qpca_         165 TAREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY----------------  227 (272)
T ss_dssp             ECCTTCCCCTTTSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC----------------
T ss_pred             ccccccCCcccccChHHHhC-CCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC----------------
Confidence              233567889999999987 6799999999999999999998888876665554444332100                


Q ss_pred             ChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhc--CCCCc
Q 014406          354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA--HPYFA  413 (425)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~--hp~~~  413 (425)
                                          ....+..+++++.+|+.+||+.||++|||++|+++  |+||.
T Consensus       228 --------------------~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft  269 (272)
T d1qpca_         228 --------------------RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT  269 (272)
T ss_dssp             --------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --------------------CCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence                                01112347899999999999999999999999998  78875

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-53  Score=394.25  Aligned_cols=249  Identities=16%  Similarity=0.327  Sum_probs=198.9

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc--chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEE
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (425)
                      +.++|++.+.||+|+||+||+|.+. +++.||||+++..  ..+++.+|+++++++ +||||++++|+|..+  ...++|
T Consensus         3 dp~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~~--~~~~lv   78 (263)
T d1sm2a_           3 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKL-SHPKLVQLYGVCLEQ--APICLV   78 (263)
T ss_dssp             CCSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECSS--SSCEEE
T ss_pred             ChHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcHHHHHHHHHHHHhc-CCCCcccccceeccC--CceEEE
Confidence            4678999999999999999999865 5678999999753  457899999999999 999999999999654  678899


Q ss_pred             EEeecCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCcc
Q 014406          201 FEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY  276 (425)
Q Consensus       201 ~e~~~~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~~  276 (425)
                      |||+++|+|.+++    ..+++..+..++.||+.||+|||+++|+||||||+|||++.+ +.+||+|||+++........
T Consensus        79 ~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~-~~~Kl~DFGla~~~~~~~~~  157 (263)
T d1sm2a_          79 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGEN-QVIKVSDFGMTRFVLDDQYT  157 (263)
T ss_dssp             EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGG-GCEEECSCC-----------
T ss_pred             EEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCC-CCeEecccchheeccCCCce
Confidence            9999999998876    348899999999999999999999999999999999999998 78999999999876543322


Q ss_pred             --eeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCC
Q 014406          277 --NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD  354 (425)
Q Consensus       277 --~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~  354 (425)
                        ....||..|+|||++.+ ..++.++|||||||++|||+|++.|++...+..+.+..+.....                
T Consensus       158 ~~~~~~gt~~y~aPE~l~~-~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~----------------  220 (263)
T d1sm2a_         158 SSTGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR----------------  220 (263)
T ss_dssp             -------CTTSCCHHHHTT-CCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCC----------------
T ss_pred             eecceecCcccCChHHhcC-CCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCC----------------
Confidence              33578899999999987 78999999999999999999987777666555444444332100                


Q ss_pred             hhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCccc
Q 014406          355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV  415 (425)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~  415 (425)
                                          ...+..+++++.+|+.+||+.||++|||++|+++|  |+++
T Consensus       221 --------------------~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~--L~~i  259 (263)
T d1sm2a_         221 --------------------LYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ--LAEI  259 (263)
T ss_dssp             --------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH--HHHH
T ss_pred             --------------------CCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHH--HHHH
Confidence                                01112368999999999999999999999999987  5444

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.9e-54  Score=401.60  Aligned_cols=245  Identities=17%  Similarity=0.325  Sum_probs=206.9

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc--chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEE
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (425)
                      ..++|++.+.||+|+||+||+|.+..+++.||||+++..  ..+++.+|+.+|+++ +||||++++++|.+  +...++|
T Consensus        15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~--~~~~~iv   91 (287)
T d1opja_          15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTR--EPPFYII   91 (287)
T ss_dssp             CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHC-CCTTBCCEEEEECS--SSSCEEE
T ss_pred             cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhC-CCCCEecCCccEee--CCeeEEE
Confidence            467899999999999999999999999999999999743  457899999999999 99999999999954  4678899


Q ss_pred             EEeecCCChhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCc
Q 014406          201 FEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (425)
Q Consensus       201 ~e~~~~~~l~~~~-----~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~  275 (425)
                      |||+++|++..++     ..+++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+.......
T Consensus        92 ~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~-~~~Kl~DFG~a~~~~~~~~  170 (287)
T d1opja_          92 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGEN-HLVKVADFGLSRLMTGDTY  170 (287)
T ss_dssp             EECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG-GCEEECCCCCTTTCCSSSS
T ss_pred             eecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCC-CcEEEccccceeecCCCCc
Confidence            9999999998876     358999999999999999999999999999999999999988 7999999999987654332


Q ss_pred             c--eeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCC
Q 014406          276 Y--NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL  353 (425)
Q Consensus       276 ~--~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~  353 (425)
                      .  ....++..|+|||++.+ ..++.++|||||||++|||++|+.||+.+.+..+....+....                
T Consensus       171 ~~~~~~~g~~~y~aPE~~~~-~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~----------------  233 (287)
T d1opja_         171 TAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY----------------  233 (287)
T ss_dssp             EEETTEEECGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC----------------
T ss_pred             eeeccccccccccChHHHcC-CCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCC----------------
Confidence            2  23457888999999987 7899999999999999999999989876655433332221100                


Q ss_pred             ChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhc
Q 014406          354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  408 (425)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~  408 (425)
                                          .......+++++.+|+.+||+.||++|||++|+++
T Consensus       234 --------------------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~  268 (287)
T d1opja_         234 --------------------RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  268 (287)
T ss_dssp             --------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --------------------CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence                                01112347899999999999999999999999976

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-53  Score=405.20  Aligned_cols=286  Identities=31%  Similarity=0.484  Sum_probs=218.6

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCC-----
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH-----  193 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~-----  193 (425)
                      -++|+++++||+|+||+||+|++..+|+.||||++...     ...++.+|+.+|+++ +|+||+++++++....     
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-~h~nii~~~~~~~~~~~~~~~   87 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL-KHENVVNLIEICRTKASPYNR   87 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHC-CCTTBCCEEEEEEC-------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHh-cCCCccceEeeeecccccccc
Confidence            47899999999999999999999999999999998532     345688999999999 8999999999986532     


Q ss_pred             -CCccEEEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEecccccc
Q 014406          194 -SKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (425)
Q Consensus       194 -~~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~  269 (425)
                       ..+.++||||+.++++....   ..+++..++.++.|++.||.|||++||+||||||+|||++.+ +.+||+|||+++.
T Consensus        88 ~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~-~~~kl~dfg~~~~  166 (318)
T d3blha1          88 CKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRD-GVLKLADFGLARA  166 (318)
T ss_dssp             ---CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-SCEEECCCTTCEE
T ss_pred             cCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCC-CcEEeeecceeee
Confidence             35689999999998877655   458999999999999999999999999999999999999998 7999999999976


Q ss_pred             ccCCC-----cceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHH
Q 014406          270 YHPGK-----EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA  344 (425)
Q Consensus       270 ~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~  344 (425)
                      .....     .....+||+.|+|||++.+...++.++||||+||++|||++|+.|| .+.++.+.+..+.+.++......
T Consensus       167 ~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~  245 (318)
T d3blha1         167 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIM-QGNTEQHQLALISQLCGSITPEV  245 (318)
T ss_dssp             CCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCCCCTTT
T ss_pred             cccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCC-CCCCHHHHHHHHHHhcCCCChhh
Confidence            54322     2233578999999999987668999999999999999999999887 56677778888888877654322


Q ss_pred             HHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCccccc
Q 014406          345 YLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA  417 (425)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~  417 (425)
                      ...........   .........  ............+++++|||.+||++||++|||++|+|+||||++-..
T Consensus       246 ~~~~~~~~~~~---~~~~~~~~~--~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~p~  313 (318)
T d3blha1         246 WPNVDNYELYE---KLELVKGQK--RKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPM  313 (318)
T ss_dssp             STTCCCC----------CCSSCC--BCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSSSC
T ss_pred             ccccchhhhhh---hhccccccc--ccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccCCC
Confidence            11100000000   000000000  000000000114778999999999999999999999999999986443

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-53  Score=409.19  Aligned_cols=283  Identities=26%  Similarity=0.490  Sum_probs=216.4

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcC----CCC
Q 014406          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQ----HSK  195 (425)
Q Consensus       125 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~----~~~  195 (425)
                      ++|+++++||+|+||+||+|.+..+|+.||||++...     ..+.+.+|+.+++++ +||||++++++|...    ...
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~~~~~f~~~~~~~~~~   95 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIISLLNVFTPQKTLEEFQ   95 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCCSTTTCC
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhc-CCCCeeEEEEEEecccccccCc
Confidence            7899999999999999999999999999999999743     234688999999999 999999999999754    346


Q ss_pred             ccEEEEEeecCCChhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCc
Q 014406          196 TPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (425)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~  275 (425)
                      ++|+||||+.++++......+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+|++|||+++.......
T Consensus        96 ~~~iv~Ey~~~~l~~~~~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~-~~~kl~df~~~~~~~~~~~  174 (355)
T d2b1pa1          96 DVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-CTLKILDFGLARTAGTSFM  174 (355)
T ss_dssp             EEEEEEECCSEEHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-CCEEECCCCC---------
T ss_pred             eeEEEEeccchHHHHhhhcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccc-cceeeechhhhhccccccc
Confidence            889999999999999888899999999999999999999999999999999999999998 7899999999987776666


Q ss_pred             ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCCh
Q 014406          276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP  355 (425)
Q Consensus       276 ~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~  355 (425)
                      .....+|+.|+|||++.+ ..++.++||||+||++++|++|+.|| .+.++..+...+...++.+....+..     ...
T Consensus       175 ~~~~~~t~~y~aPE~l~~-~~~~~~~DiwSlG~~l~ell~g~~pF-~~~~~~~~~~~i~~~~~~~~~~~~~~-----~~~  247 (355)
T d2b1pa1         175 MTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILF-PGRDYIDQWNKVIEQLGTPCPEFMKK-----LQP  247 (355)
T ss_dssp             ------CCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCCCCHHHHTT-----SCH
T ss_pred             cccccccccccChhhhcC-CCCCCCcccccccchHHHHhhCCCCC-CCCCHHHHHHHHHHhccCCCHHHHHH-----hhh
Confidence            677789999999999988 78999999999999999999999887 56677778888888777654432211     111


Q ss_pred             hhHHHhcccC---CCCcccccc-------ccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccc
Q 014406          356 QLDALVGRHS---RKPWSKFIN-------ADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR  416 (425)
Q Consensus       356 ~~~~~~~~~~---~~~~~~~~~-------~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~  416 (425)
                      ..........   ...+.....       .......++++++||++||++||++||||+|+|+||||++..
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~  318 (355)
T d2b1pa1         248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY  318 (355)
T ss_dssp             HHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred             hHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence            1111111110   011111000       001112467899999999999999999999999999998754

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-53  Score=404.50  Aligned_cols=286  Identities=28%  Similarity=0.535  Sum_probs=220.9

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCC--Cc
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHS--KT  196 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~--~~  196 (425)
                      ..++|+++++||+|+||+||+|.+..+|+.||||+++...    .+.+.+|+.+|+++ +||||+++++++.....  ..
T Consensus         6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l-~hp~iv~~~~~~~~~~~~~~~   84 (345)
T d1pmea_           6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRF-RHENIIGINDIIRAPTIEQMK   84 (345)
T ss_dssp             CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHC-CCTTBCCCCEEECCSSTTTCC
T ss_pred             cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHc-CCCCCCcEEEEEeeccccccc
Confidence            4578999999999999999999999999999999997533    34678999999999 99999999999975422  12


Q ss_pred             cEEEEEeecCCChhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCC
Q 014406          197 PSLIFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (425)
Q Consensus       197 ~~lv~e~~~~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~  274 (425)
                      .+++++|+.+++|.+++  ..+++..++.++.||+.||+|||++|||||||||+|||++.+ +.+||+|||+|+......
T Consensus        85 ~~~l~~~~~~g~L~~~l~~~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~-~~~kl~DfG~a~~~~~~~  163 (345)
T d1pmea_          85 DVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTT-CDLKICDFGLARVADPDH  163 (345)
T ss_dssp             CEEEEEECCCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-CCEEECCCTTCEECCGGG
T ss_pred             eEEEEEeecCCchhhhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCC-CCEEEcccCceeeccCCC
Confidence            34556677889998887  579999999999999999999999999999999999999988 799999999997654332


Q ss_pred             ----cceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhcc
Q 014406          275 ----EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH  350 (425)
Q Consensus       275 ----~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~  350 (425)
                          .....+||+.|+|||++.....++.++||||+||++|+|++|+.|| .+.+..++.......++.+........  
T Consensus       164 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~--  240 (345)
T d1pmea_         164 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF-PGKHYLDQLNHILGILGSPSQEDLNCI--  240 (345)
T ss_dssp             CBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCSCCHHHHHTC--
T ss_pred             ccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCC-CCCCHHHHHHHHhhhccCCChhhhhhh--
Confidence                2345678999999999877677899999999999999999999998 455566677777777766554332110  


Q ss_pred             CCCChhhHHHhcc--cCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccch
Q 014406          351 LELDPQLDALVGR--HSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE  419 (425)
Q Consensus       351 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~~  419 (425)
                       ............  ....++...     ...+++++++|+++||++||++|||++|+|+||||++.....
T Consensus       241 -~~~~~~~~~~~~~~~~~~~~~~~-----~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~~  305 (345)
T d1pmea_         241 -INLKARNYLLSLPHKNKVPWNRL-----FPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPS  305 (345)
T ss_dssp             -CCHHHHHHHHTSCCCCCCCHHHH-----CTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCGG
T ss_pred             -hhhhhhcccccCCccCCCCHHHh-----CCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCCc
Confidence             000111111111  111122111     224788999999999999999999999999999999766543

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-53  Score=395.29  Aligned_cols=246  Identities=15%  Similarity=0.312  Sum_probs=196.6

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCcc
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (425)
                      ..++|++.+.||+|+||+||+|+.   +..||||+++..     ..+.+.+|+.+++++ +||||+++++++.+   ..+
T Consensus         6 ~~~~~~~~~~lG~G~fg~Vy~~~~---~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~---~~~   78 (276)
T d1uwha_           6 PDGQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT-RHVNILLFMGYSTA---PQL   78 (276)
T ss_dssp             CTTCCCCCSEEEECSSCEEEEEES---SSEEEEEECCCSSCCTTHHHHHHHHHHHHTTC-CCTTBCCEEEEECS---SSC
T ss_pred             ccccEEEEEEEeeCCCcEEEEEEE---CCEEEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCCCEeeeeEEEec---cEE
Confidence            467889999999999999999964   235999998632     346788999999999 99999999998843   457


Q ss_pred             EEEEEeecCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCC
Q 014406          198 SLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (425)
Q Consensus       198 ~lv~e~~~~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~  273 (425)
                      ++||||+++|+|.+++    ..+++..+..++.||+.||+|||+++||||||||+|||++.+ +.+||+|||+|+.....
T Consensus        79 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~-~~~Kl~DFGla~~~~~~  157 (276)
T d1uwha_          79 AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHED-LTVKIGDFGLATVKSRW  157 (276)
T ss_dssp             EEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETT-SSEEECCCCCSCC----
T ss_pred             EEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCC-CCEEEccccceeecccc
Confidence            8999999999998876    348999999999999999999999999999999999999988 79999999999876432


Q ss_pred             C---cceeeccCCCccCcccccCC--CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh-CCchhHHHHh
Q 014406          274 K---EYNVRVASRYFKGPELLVDL--QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL-GTDELNAYLN  347 (425)
Q Consensus       274 ~---~~~~~~~t~~y~aPE~~~~~--~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~l-g~~~~~~~~~  347 (425)
                      .   ......||+.|+|||++.+.  ..|+.++|||||||++|||+||+.||. +.++.+.+......- ..+.      
T Consensus       158 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~-~~~~~~~~~~~~~~~~~~p~------  230 (276)
T d1uwha_         158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFMVGRGYLSPD------  230 (276)
T ss_dssp             --------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTT-TCCCHHHHHHHHHHTSCCCC------
T ss_pred             CCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCC-CCChHHHHHHHHhcCCCCCc------
Confidence            2   23445789999999998642  358999999999999999999999984 444444443332210 0000      


Q ss_pred             hccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcC
Q 014406          348 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  409 (425)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~h  409 (425)
                                                .......+++++.+|+.+||+.||++|||++|++++
T Consensus       231 --------------------------~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~  266 (276)
T d1uwha_         231 --------------------------LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS  266 (276)
T ss_dssp             --------------------------GGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --------------------------chhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                                      011223478999999999999999999999999976

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.2e-53  Score=399.92  Aligned_cols=247  Identities=21%  Similarity=0.377  Sum_probs=203.3

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCc-----EEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCC
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNE-----RCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH  193 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~-----~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  193 (425)
                      ..++|++.+.||+|+||+||+|++..+++     .||+|.+...    ....+.+|+.++.++.+|||||+++++|.+  
T Consensus        35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~--  112 (325)
T d1rjba_          35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL--  112 (325)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred             CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEee--
Confidence            45789999999999999999999876543     6999998542    345788999999998789999999999965  


Q ss_pred             CCccEEEEEeecCCChhhhcC--------------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCC
Q 014406          194 SKTPSLIFEYVNSTDFKVLYP--------------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKP  247 (425)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~~--------------------------~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~  247 (425)
                      ...+++||||+++|+|.+++.                          .+++..++.++.||+.||+|||+++||||||||
T Consensus       113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp  192 (325)
T d1rjba_         113 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAA  192 (325)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSG
T ss_pred             CCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCch
Confidence            467899999999999998762                          278899999999999999999999999999999


Q ss_pred             CceEecCCCCcEEEEeccccccccCCCcc---eeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCC
Q 014406          248 HNVMIDHELRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYG  323 (425)
Q Consensus       248 ~NIll~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~  323 (425)
                      +|||++.+ +.+||+|||+|+........   ....+|+.|+|||++.+ ..++.++|||||||++|||+| |+.|| .+
T Consensus       193 ~Nill~~~-~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwS~Gvil~emlt~g~~Pf-~~  269 (325)
T d1rjba_         193 RNVLVTHG-KVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPY-PG  269 (325)
T ss_dssp             GGEEEETT-TEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSS-TT
T ss_pred             hccccccC-CeEEEeeccccccccCCCceeeeccccCCCccCChHHHcC-CCCCcceeccchhHHHHHHHhCCCCCC-CC
Confidence            99999988 79999999999876544332   23567999999999987 789999999999999999998 78887 44


Q ss_pred             CCCHHHHHHHHHHhCCchhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCH
Q 014406          324 HDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA  403 (425)
Q Consensus       324 ~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta  403 (425)
                      .+..+.+..+...-           .                        ....+..+++++++||.+||+.||++|||+
T Consensus       270 ~~~~~~~~~~~~~~-----------~------------------------~~~~p~~~~~~l~~li~~cl~~dP~~RPt~  314 (325)
T d1rjba_         270 IPVDANFYKLIQNG-----------F------------------------KMDQPFYATEEIYIIMQSCWAFDSRKRPSF  314 (325)
T ss_dssp             CCCSHHHHHHHHTT-----------C------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             CCHHHHHHHHHhcC-----------C------------------------CCCCCCcCCHHHHHHHHHHcCCChhHCcCH
Confidence            44444444432210           0                        011123478999999999999999999999


Q ss_pred             HHHhcC
Q 014406          404 REAMAH  409 (425)
Q Consensus       404 ~elL~h  409 (425)
                      +|+++|
T Consensus       315 ~ei~~~  320 (325)
T d1rjba_         315 PNLTSF  320 (325)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            999976

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-52  Score=390.46  Aligned_cols=251  Identities=18%  Similarity=0.309  Sum_probs=206.0

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc--chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEE
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (425)
                      .++|++.+.||+|+||+||+|.+..+ +.||||+++..  ..+.+.+|+.+++++ +|||||+++|+|.+   ...++||
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~g~~~~---~~~~lv~   90 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYAVVSE---EPIYIVT   90 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECS---SSCEEEE
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCCHHHHHHHHHHHHhc-ccCCEeEEEEEEec---CCeEEEE
Confidence            57899999999999999999987654 57999999754  357799999999999 99999999999843   3568999


Q ss_pred             EeecCCChhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCc-
Q 014406          202 EYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-  275 (425)
Q Consensus       202 e~~~~~~l~~~~-----~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~-  275 (425)
                      ||+.+|++..++     ..+++.++..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+....... 
T Consensus        91 Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~-~~~kl~DfGla~~~~~~~~~  169 (285)
T d1fmka3          91 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN-LVCKVADFGLARLIEDNEYT  169 (285)
T ss_dssp             CCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG-GCEEECCCCTTC--------
T ss_pred             EecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCC-CcEEEcccchhhhccCCCce
Confidence            999999988776     358999999999999999999999999999999999999988 7899999999987644332 


Q ss_pred             -ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCC
Q 014406          276 -YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD  354 (425)
Q Consensus       276 -~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~  354 (425)
                       .....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||+.+....+.+..+....                 
T Consensus       170 ~~~~~~gt~~y~aPE~~~~-~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~-----------------  231 (285)
T d1fmka3         170 ARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY-----------------  231 (285)
T ss_dssp             ------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC-----------------
T ss_pred             eeccccccccccChHHHhC-CCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC-----------------
Confidence             234578999999999987 7899999999999999999999888877666555554442210                 


Q ss_pred             hhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhc--CCCCccccc
Q 014406          355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA--HPYFAQVRA  417 (425)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~--hp~~~~~~~  417 (425)
                                         .......+++++++|+.+||+.||++|||++++++  ++||.....
T Consensus       232 -------------------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p  277 (285)
T d1fmka3         232 -------------------RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP  277 (285)
T ss_dssp             -------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCC
T ss_pred             -------------------CCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCC
Confidence                               01112347899999999999999999999999988  899987643

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.6e-53  Score=392.09  Aligned_cols=249  Identities=18%  Similarity=0.350  Sum_probs=203.2

Q ss_pred             CCCCEEEEee-eeeeCceEEEEEEEcC--CCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCC
Q 014406          123 DQDDYEVVRK-VGRGKYSEVFEGINVN--TNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (425)
Q Consensus       123 ~~~~y~~~~~-LG~G~fg~V~~~~~~~--~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (425)
                      ..++|.+.+. ||+|+||+||+|.+..  ++..||||+++...    .+.+.+|+++|+++ +||||++++|++.+   .
T Consensus         6 ~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~---~   81 (285)
T d1u59a_           6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-DNPYIVRLIGVCQA---E   81 (285)
T ss_dssp             CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEES---S
T ss_pred             cccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhC-CCCCEeeEeeeecc---C
Confidence            4577888884 9999999999998754  45589999997532    35688999999999 99999999999964   3


Q ss_pred             ccEEEEEeecCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEecccccccc
Q 014406          196 TPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (425)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~  271 (425)
                      .+++||||+++|+|.+++    ..+++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+...
T Consensus        82 ~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~-~~~Kl~DFGla~~~~  160 (285)
T d1u59a_          82 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNR-HYAKISDFGLSKALG  160 (285)
T ss_dssp             SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEET-TEEEECCCTTCEECT
T ss_pred             eEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccC-Cceeeccchhhhccc
Confidence            578999999999998875    348999999999999999999999999999999999999988 799999999998775


Q ss_pred             CCCcc----eeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCCchhHHHH
Q 014406          272 PGKEY----NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYL  346 (425)
Q Consensus       272 ~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~  346 (425)
                      .....    ....+|+.|+|||++.+ ..++.++|||||||++|||+| |+.|| .+.+..+....+.+  |.       
T Consensus       161 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwS~Gv~l~E~lt~G~~Pf-~~~~~~~~~~~i~~--~~-------  229 (285)
T d1u59a_         161 ADDSYYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPY-KKMKGPEVMAFIEQ--GK-------  229 (285)
T ss_dssp             TCSCEECCCCSSCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTT-TTCCTHHHHHHHHT--TC-------
T ss_pred             ccccccccccccccCccccChHHHhC-CCCCccchhhcchHHHHHHHhCCCCCC-CCCCHHHHHHHHHc--CC-------
Confidence            44322    23467889999999987 679999999999999999998 88887 34444444433321  00       


Q ss_pred             hhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHH---hcCCCCcc
Q 014406          347 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA---MAHPYFAQ  414 (425)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~el---L~hp~~~~  414 (425)
                                                 ..+.+..+++++.+|+.+||+.||++|||+.++   |+|+|++-
T Consensus       230 ---------------------------~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~  273 (285)
T d1u59a_         230 ---------------------------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL  273 (285)
T ss_dssp             ---------------------------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             ---------------------------CCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence                                       011123478999999999999999999999887   67888753

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.2e-52  Score=393.75  Aligned_cols=245  Identities=17%  Similarity=0.295  Sum_probs=189.6

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCc---EEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCC
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNE---RCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~---~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (425)
                      ..++|++.+.||+|+||+||+|.+..+++   .||||.+...    ..+.+.+|+.+|+++ +|||||+++|+|.+  ..
T Consensus        24 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~--~~  100 (299)
T d1jpaa_          24 DISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF-DHPNVIHLEGVVTK--ST  100 (299)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECS--SS
T ss_pred             ChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhC-CCCCCccEEEEEee--CC
Confidence            35789999999999999999999876664   5889988643    235689999999999 99999999999954  46


Q ss_pred             ccEEEEEeecCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEecccccccc
Q 014406          196 TPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (425)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~  271 (425)
                      ..++||||+++|+|..++    ..+++.++..++.||+.||+|||+++|+||||||+|||++.+ +.+||+|||+|+...
T Consensus       101 ~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~-~~~Kl~DFGla~~~~  179 (299)
T d1jpaa_         101 PVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSN-LVCKVSDFGLSRFLE  179 (299)
T ss_dssp             SCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-CCEEECCC-------
T ss_pred             EEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCC-CcEEECCcccceEcc
Confidence            789999999999998865    348999999999999999999999999999999999999988 799999999998765


Q ss_pred             CCCcc------eeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCCchhHH
Q 014406          272 PGKEY------NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNA  344 (425)
Q Consensus       272 ~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~lg~~~~~~  344 (425)
                      .....      ....+|+.|+|||++.+ ..++.++|||||||++|||+| |+.|| .+.+..+.+..+....       
T Consensus       180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~el~t~g~~Pf-~~~~~~~~~~~i~~~~-------  250 (299)
T d1jpaa_         180 DDTSDPTYTSALGGKIPIRWTAPEAIQY-RKFTSASDVWSYGIVMWEVMSYGERPY-WDMTNQDVINAIEQDY-------  250 (299)
T ss_dssp             ----------------CGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTT-TTCCHHHHHHHHHTTC-------
T ss_pred             CCCCcceeeecccccCCccccCHHHHhc-CCCCcccccccchHHHHHHHhCCCCCC-CCCCHHHHHHHHHcCC-------
Confidence            43221      12356888999999987 789999999999999999998 78887 3333333333221100       


Q ss_pred             HHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcC
Q 014406          345 YLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  409 (425)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~h  409 (425)
                                                   ....+..+++++.+|+.+||+.||++|||++|++++
T Consensus       251 -----------------------------~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~  286 (299)
T d1jpaa_         251 -----------------------------RLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT  286 (299)
T ss_dssp             -----------------------------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             -----------------------------CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                                         001122378999999999999999999999999875

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-52  Score=401.65  Aligned_cols=285  Identities=29%  Similarity=0.543  Sum_probs=222.1

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc-----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCC---C
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQH---S  194 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~---~  194 (425)
                      ..++|+++++||+|+||+||+|++..+|+.||||+++...     .+.+.+|+.+|+++ +|||++++++++....   .
T Consensus        16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~h~~iv~~~~~~~~~~~~~~   94 (348)
T d2gfsa1          16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLDVFTPARSLEE   94 (348)
T ss_dssp             EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSSTTT
T ss_pred             CCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhc-CCCCeeeEEEEEeecccccc
Confidence            4688999999999999999999999999999999997432     34678999999999 9999999999996431   2


Q ss_pred             CccEEEEEeecCCChhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccC
Q 014406          195 KTPSLIFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (425)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~  272 (425)
                      ...+++++|+.+++|.+++  ..+++.+++.++.||+.||+|||++||+||||||+|||++.+ +.+|++|||++.... 
T Consensus        95 ~~~~~i~~~~~gg~L~~~~~~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~-~~~kl~dfg~a~~~~-  172 (348)
T d2gfsa1          95 FNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED-CELKILDFGLARHTD-  172 (348)
T ss_dssp             CCCCEEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-CCEEECCC----CCT-
T ss_pred             CceEEEEEeecCCchhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCcccccccc-ccccccccchhcccC-
Confidence            3345677888899999887  469999999999999999999999999999999999999998 789999999997543 


Q ss_pred             CCcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCC
Q 014406          273 GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE  352 (425)
Q Consensus       273 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~  352 (425)
                       .......|++.|+|||++.+...++.++||||+||++|+|++|+.|| .+.+.......+.+..+........    ..
T Consensus       173 -~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF-~~~~~~~~~~~i~~~~~~~~~~~~~----~~  246 (348)
T d2gfsa1         173 -DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF-PGTDHIDQLKLILRLVGTPGAELLK----KI  246 (348)
T ss_dssp             -GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCCCCHHHHT----TC
T ss_pred             -cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCC-CCCCHHHHHHHHHHhcCCCChHHhh----hc
Confidence             34455688999999999887667899999999999999999999887 5666777777777777765433221    01


Q ss_pred             CChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccccc
Q 014406          353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA  418 (425)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~~~  418 (425)
                      ...................+  ......+++++++||++||++||++|||++|+|+||||++....
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~  310 (348)
T d2gfsa1         247 SSESARNYIQSLTQMPKMNF--ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP  310 (348)
T ss_dssp             CCHHHHHHHTTSCCCCCCCH--HHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCT
T ss_pred             cchhhhhhhhhcccCCCcch--hhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCC
Confidence            11111111111111111111  11123478999999999999999999999999999999987543

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-53  Score=392.01  Aligned_cols=248  Identities=19%  Similarity=0.347  Sum_probs=197.3

Q ss_pred             EEEE-eeeeeeCceEEEEEEEc--CCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccE
Q 014406          127 YEVV-RKVGRGKYSEVFEGINV--NTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (425)
Q Consensus       127 y~~~-~~LG~G~fg~V~~~~~~--~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (425)
                      +.+. ++||+|+||+||+|.+.  .+++.||||+++..     ..+.+.+|+.+|+++ +||||++++++|.+   ...+
T Consensus         8 ~~le~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~g~~~~---~~~~   83 (277)
T d1xbba_           8 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-DNPYIVRMIGICEA---ESWM   83 (277)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTC-CCTTBCCEEEEEES---SSEE
T ss_pred             CeecCCCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhC-CCCCCceEEEEecc---CCEE
Confidence            4443 46999999999999864  45678999998643     235789999999999 99999999999964   3568


Q ss_pred             EEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCc
Q 014406          199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (425)
Q Consensus       199 lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~  275 (425)
                      +||||+++|+|.+++   ..+++..+..++.||+.||+|||+++||||||||+|||++.+ +.+||+|||+|+.......
T Consensus        84 lvmE~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~-~~~kl~DFGla~~~~~~~~  162 (277)
T d1xbba_          84 LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQ-HYAKISDFGLSKALRADEN  162 (277)
T ss_dssp             EEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET-TEEEECCCTTCEECCTTCS
T ss_pred             EEEEcCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhccccc-Ccccccchhhhhhcccccc
Confidence            999999999998876   459999999999999999999999999999999999999988 7999999999987654432


Q ss_pred             c----eeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhcc
Q 014406          276 Y----NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH  350 (425)
Q Consensus       276 ~----~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~  350 (425)
                      .    ....||+.|+|||++.+ ..++.++|||||||++|||++ |+.|| .+.+..+....+.+  |          . 
T Consensus       163 ~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDiwS~Gv~l~ellt~g~~Pf-~~~~~~~~~~~i~~--~----------~-  227 (277)
T d1xbba_         163 YYKAQTHGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPY-RGMKGSEVTAMLEK--G----------E-  227 (277)
T ss_dssp             EEEC----CCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCCSS-TTCCHHHHHHHHHT--T----------C-
T ss_pred             ccccccccCCCceecCchhhcC-CCCCchhhhccchhhhhHHhhCCCCCC-CCCCHHHHHHHHHc--C----------C-
Confidence            2    23467889999999987 679999999999999999998 78887 33333332222211  0          0 


Q ss_pred             CCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHH---hcCCCCccccc
Q 014406          351 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA---MAHPYFAQVRA  417 (425)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~el---L~hp~~~~~~~  417 (425)
                                             ....+..+++++.+|+.+||+.||++|||++++   |+|+|++-+++
T Consensus       228 -----------------------~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~~~e  274 (277)
T d1xbba_         228 -----------------------RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNE  274 (277)
T ss_dssp             -----------------------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHHH
T ss_pred             -----------------------CCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhhcCCC
Confidence                                   011123478999999999999999999999998   57777655443

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-52  Score=383.78  Aligned_cols=244  Identities=19%  Similarity=0.327  Sum_probs=203.8

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecC--cchHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEE
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~--~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (425)
                      +.++|++.++||+|+||+||+|++ .++..||||+++.  ...+++.+|+.+++++ +||||++++|+|.++  ..+++|
T Consensus         2 ~~~~~~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l-~HpnIv~~~g~~~~~--~~~~iv   77 (258)
T d1k2pa_           2 DPKDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSEDEFIEEAKVMMNL-SHEKLVQLYGVCTKQ--RPIFII   77 (258)
T ss_dssp             CCCCCCCCCCCCEETTEEEEEEEE-TTTEEEEEEEEESSSSCHHHHHHHHHHHHTC-CCTTBCCEEEEECCS--SSEEEE
T ss_pred             ChHHCEEeEEEecCCCeEEEEEEE-CCCCEEEEEEECcCcCCHHHHHHHHHHHHhc-CCCceeeEEEEEeeC--CceEEE
Confidence            357888899999999999999987 5788999999975  3457899999999999 999999999999653  678999


Q ss_pred             EEeecCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCcc
Q 014406          201 FEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY  276 (425)
Q Consensus       201 ~e~~~~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~~  276 (425)
                      |||+.+|++..++    ..+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++........
T Consensus        78 ~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~-~~~kl~DfG~a~~~~~~~~~  156 (258)
T d1k2pa_          78 TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQ-GVVKVSDFGLSRYVLDDEYT  156 (258)
T ss_dssp             EECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTT-CCEEECCCSSCCBCSSSSCC
T ss_pred             EEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCC-CcEEECcchhheeccCCCce
Confidence            9999999988774    458999999999999999999999999999999999999988 78999999999866543322


Q ss_pred             --eeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCC
Q 014406          277 --NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL  353 (425)
Q Consensus       277 --~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~  353 (425)
                        ....+|..|+|||.+.+ ..++.++|||||||++|||+| |+.|| .+.+..+....+.+..                
T Consensus       157 ~~~~~~~t~~y~aPE~~~~-~~~~~ksDiwS~G~~l~el~t~g~~Pf-~~~~~~~~~~~i~~~~----------------  218 (258)
T d1k2pa_         157 SSVGSKFPVRWSPPEVLMY-SKFSSKSDIWAFGVLMWEIYSLGKMPY-ERFTNSETAEHIAQGL----------------  218 (258)
T ss_dssp             CCCCSCCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTT-TTSCHHHHHHHHHTTC----------------
T ss_pred             eecccCCCCCcCCcHHhcC-CCCCcceeecccchhhHhHHhcCCCCC-CCCCHHHHHHHHHhCC----------------
Confidence              33568889999999987 789999999999999999998 77777 4444444333332110                


Q ss_pred             ChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcC
Q 014406          354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  409 (425)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~h  409 (425)
                                          ....+..+++++.+|+++||+.||++|||++|+++|
T Consensus       219 --------------------~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  254 (258)
T d1k2pa_         219 --------------------RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSN  254 (258)
T ss_dssp             --------------------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             --------------------CCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence                                001122378899999999999999999999999987

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=6.9e-52  Score=385.11  Aligned_cols=252  Identities=22%  Similarity=0.354  Sum_probs=198.2

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc------hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCC--C
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHS--K  195 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~--~  195 (425)
                      .++|++.+.||+|+||+||+|.+..+++.||||+++...      ...+.+|+.+++.+ +||||+++++++...+.  .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~-~hpniv~~~~~~~~~~~~~~   84 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-NHPAIVAVYDTGEAETPAGP   84 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEEECSSSE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhc-CCCCCCcccceeeeccCCCc
Confidence            578999999999999999999999999999999996432      24688999999999 99999999999976533  3


Q ss_pred             ccEEEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccC
Q 014406          196 TPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (425)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~  272 (425)
                      .+|+||||++|++|..++   ..+++.+++.++.||+.||+|||++||+||||||+|||++.+ +..+|+|||.+.....
T Consensus        85 ~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~-~~~~l~d~~~~~~~~~  163 (277)
T d1o6ya_          85 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISAT-NAVKVMDFGIARAIAD  163 (277)
T ss_dssp             EEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETT-SCEEECCCTTCEECC-
T ss_pred             eEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCcc-ccceeehhhhhhhhcc
Confidence            478999999999998776   469999999999999999999999999999999999999988 7899999999875533


Q ss_pred             CC----cceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhh
Q 014406          273 GK----EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK  348 (425)
Q Consensus       273 ~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~  348 (425)
                      ..    .....+||+.|+|||++.+ ..++.++|||||||++|+|+||+.|| .+.+..+.+..+...-..         
T Consensus       164 ~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~~DiwSlGvilyelltG~~Pf-~~~~~~~~~~~~~~~~~~---------  232 (277)
T d1o6ya_         164 SGNSVTQTAAVIGTAQYLSPEQARG-DSVDARSDVYSLGCVLYEVLTGEPPF-TGDSPVSVAYQHVREDPI---------  232 (277)
T ss_dssp             ---------------TTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHCCCC---------
T ss_pred             ccccccccccccCcccccCHHHHcC-CCCCcceecccchHHHHHHHhCCCCC-CCcCHHHHHHHHHhcCCC---------
Confidence            22    2344579999999999987 78999999999999999999999998 333333333333221000         


Q ss_pred             ccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCC
Q 014406          349 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF  412 (425)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~  412 (425)
                                              ........+|+++.+||++||+.||++||+..+.|.|+|.
T Consensus       233 ------------------------~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~  272 (277)
T d1o6ya_         233 ------------------------PPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV  272 (277)
T ss_dssp             ------------------------CGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred             ------------------------CCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHH
Confidence                                    0111223479999999999999999999954444456654

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-51  Score=384.41  Aligned_cols=245  Identities=15%  Similarity=0.282  Sum_probs=195.5

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCC----cEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCC
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTN----ERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHS  194 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~----~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  194 (425)
                      ..+.|++.+.||+|+||+||+|.+..++    ..||||+++...    ..++.+|+.+++++ +|||||+++|++.+  .
T Consensus         5 ~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~~~g~~~~--~   81 (283)
T d1mqba_           5 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF-SHHNIIRLEGVISK--Y   81 (283)
T ss_dssp             CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECS--S
T ss_pred             CHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhc-CCCCEeeeeEEEec--C
Confidence            4577999999999999999999877654    479999986432    34688999999999 89999999999954  4


Q ss_pred             CccEEEEEeecCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccc
Q 014406          195 KTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  270 (425)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~  270 (425)
                      ...++||||+.++++...+    ..+++.++..++.||+.||+|||+++|+||||||+|||++.+ +.+||+|||+|+..
T Consensus        82 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~-~~~Kl~DFGla~~~  160 (283)
T d1mqba_          82 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSN-LVCKVSDFGLSRVL  160 (283)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-CCEEECCCCC----
T ss_pred             CceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCC-CeEEEcccchhhcc
Confidence            6788999999999987765    458999999999999999999999999999999999999998 79999999999876


Q ss_pred             cCCCc----ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHH
Q 014406          271 HPGKE----YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYL  346 (425)
Q Consensus       271 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~  346 (425)
                      .....    .....||..|+|||++.+ ..++.++|||||||++|||++|+.||+.+.+..+.+..+.+..         
T Consensus       161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~---------  230 (283)
T d1mqba_         161 EDDPEATYTTSGGKIPIRWTAPEAISY-RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGF---------  230 (283)
T ss_dssp             -------------CCCGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC---------
T ss_pred             cCCCccceEeccCCCCccccCHHHHcc-CCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccC---------
Confidence            44322    123467889999999987 7899999999999999999998888876655444433322100         


Q ss_pred             hhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhc
Q 014406          347 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  408 (425)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~  408 (425)
                                                 ....+..+++++.+|+.+||+.||++|||+.|+++
T Consensus       231 ---------------------------~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~  265 (283)
T d1mqba_         231 ---------------------------RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVS  265 (283)
T ss_dssp             ---------------------------CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             ---------------------------CCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence                                       01112237889999999999999999999999987

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-51  Score=388.61  Aligned_cols=262  Identities=23%  Similarity=0.419  Sum_probs=211.5

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEc---CCCcEEEEEEecCc-------chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCC
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINV---NTNERCIIKILKPV-------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH  193 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~---~~~~~vavK~~~~~-------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  193 (425)
                      .++|++++.||+|+||+||+|.+.   .+|+.||||+++..       ..+.+.+|+.+++++.+||||+++++++.+. 
T Consensus        23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~-  101 (322)
T d1vzoa_          23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE-  101 (322)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET-
T ss_pred             hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccC-
Confidence            478999999999999999999874   46899999998632       3466889999999995558999999999765 


Q ss_pred             CCccEEEEEeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccc
Q 014406          194 SKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  270 (425)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~  270 (425)
                       ...+++|||+.+++|..++   ..+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+..
T Consensus       102 -~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~-~~vkL~DFG~a~~~  179 (322)
T d1vzoa_         102 -TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSN-GHVVLTDFGLSKEF  179 (322)
T ss_dssp             -TEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-SCEEESCSSEEEEC
T ss_pred             -CceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCC-CCEEEeeccchhhh
Confidence             6789999999999998876   568899999999999999999999999999999999999998 79999999999865


Q ss_pred             cCC--CcceeeccCCCccCcccccCCC-CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHh
Q 014406          271 HPG--KEYNVRVASRYFKGPELLVDLQ-DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLN  347 (425)
Q Consensus       271 ~~~--~~~~~~~~t~~y~aPE~~~~~~-~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~  347 (425)
                      ...  .......+++.|+|||.+.+.. .++.++|||||||+||+|++|+.||... +..+....+.+...         
T Consensus       180 ~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~-~~~~~~~~i~~~~~---------  249 (322)
T d1vzoa_         180 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVD-GEKNSQAEISRRIL---------  249 (322)
T ss_dssp             CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCT-TSCCCHHHHHHHHH---------
T ss_pred             cccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHHhcc---------
Confidence            432  2334568899999999997633 4788999999999999999999998433 22222222221100         


Q ss_pred             hccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCc-----CHHHHhcCCCCcccccchhcc
Q 014406          348 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYFAQVRAAESSR  422 (425)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rp-----ta~elL~hp~~~~~~~~~~~~  422 (425)
                      ..                        ....+..+++++++||++||++||++||     |++|+++||||+++.+....+
T Consensus       250 ~~------------------------~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~~~l~~  305 (322)
T d1vzoa_         250 KS------------------------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAA  305 (322)
T ss_dssp             HC------------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHHT
T ss_pred             cC------------------------CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCHHHHHh
Confidence            00                        0011223799999999999999999999     589999999999998765544

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-51  Score=386.35  Aligned_cols=245  Identities=18%  Similarity=0.300  Sum_probs=196.5

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCc----EEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCC
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNE----RCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS  194 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~----~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  194 (425)
                      ..++|++++.||+|+||+||+|.+..+|+    .||+|.++..    ..+++.+|+.+++++ +||||++++|+|.+   
T Consensus         7 k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~---   82 (317)
T d1xkka_           7 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DNPHVCRLLGICLT---   82 (317)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHC-CCTTBCCEEEEEES---
T ss_pred             CHHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEec---
Confidence            45789999999999999999999888876    5888887632    356799999999999 99999999999975   


Q ss_pred             CccEEEEEeecCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccc
Q 014406          195 KTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  270 (425)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~  270 (425)
                      ...++++||+.+++|.+.+    ..+++..+..++.||+.||+|||++|||||||||+|||++.+ +.+||+|||+|+..
T Consensus        83 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~-~~~kl~DFGla~~~  161 (317)
T d1xkka_          83 STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTP-QHVKITDFGLAKLL  161 (317)
T ss_dssp             SSEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEET-TEEEECCCSHHHHT
T ss_pred             CCeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCC-CCeEeeccccceec
Confidence            3467899999999887654    458999999999999999999999999999999999999988 79999999999876


Q ss_pred             cCCCcc---eeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHh
Q 014406          271 HPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLN  347 (425)
Q Consensus       271 ~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~  347 (425)
                      ......   ....||..|+|||++.+ ..++.++|||||||++|||+|++.|++.+.+..+....+.+..          
T Consensus       162 ~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~----------  230 (317)
T d1xkka_         162 GAEEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE----------  230 (317)
T ss_dssp             TTTCC--------CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTC----------
T ss_pred             ccccccccccccccCccccChHHHhc-CCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC----------
Confidence            543322   33468999999999987 7899999999999999999995444445544444333322100          


Q ss_pred             hccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcC
Q 014406          348 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  409 (425)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~h  409 (425)
                                                ....+..+++++.+|+.+||+.||++|||+.|+++|
T Consensus       231 --------------------------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  266 (317)
T d1xkka_         231 --------------------------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  266 (317)
T ss_dssp             --------------------------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --------------------------CCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence                                      001122378999999999999999999999999987

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-51  Score=384.87  Aligned_cols=249  Identities=20%  Similarity=0.320  Sum_probs=196.6

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcC-----CCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCC
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVN-----TNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQH  193 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~-----~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  193 (425)
                      ..++|++.++||+|+||+||+|.+..     +++.||||+++...    .+.+.+|..++.++.+|+||+.+++++..+ 
T Consensus        11 ~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~-   89 (299)
T d1ywna1          11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP-   89 (299)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST-
T ss_pred             cHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC-
Confidence            35789999999999999999998754     44689999987432    356778889999887899999999988654 


Q ss_pred             CCccEEEEEeecCCChhhhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecC
Q 014406          194 SKTPSLIFEYVNSTDFKVLYP-------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH  254 (425)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~~-------------------~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~  254 (425)
                      +..+++||||+++|+|.+++.                   .+++.++..++.||+.||+|||+++||||||||+|||++.
T Consensus        90 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~  169 (299)
T d1ywna1          90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE  169 (299)
T ss_dssp             TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECG
T ss_pred             CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECC
Confidence            356899999999999998862                   3789999999999999999999999999999999999998


Q ss_pred             CCCcEEEEeccccccccCCCc---ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHH
Q 014406          255 ELRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV  331 (425)
Q Consensus       255 ~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~  331 (425)
                      + +.+||+|||+|+.......   .....||+.|+|||++.+ ..++.++|||||||++|||++|..|++.+.+..+.+.
T Consensus       170 ~-~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~  247 (299)
T d1ywna1         170 K-NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC  247 (299)
T ss_dssp             G-GCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHH
T ss_pred             C-CcEEEccCcchhhccccccccccCceeeCccccchhHhhc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            8 7999999999986543322   234578999999999987 7899999999999999999998766556555544444


Q ss_pred             HHHHHhCCchhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcC
Q 014406          332 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  409 (425)
Q Consensus       332 ~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~h  409 (425)
                      .....-.                                   ....+..+++++++|+.+||+.||++|||++|+++|
T Consensus       248 ~~~~~~~-----------------------------------~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~  290 (299)
T d1ywna1         248 RRLKEGT-----------------------------------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  290 (299)
T ss_dssp             HHHHHTC-----------------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHhcCC-----------------------------------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            3322100                                   001122378999999999999999999999999987

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-51  Score=382.32  Aligned_cols=249  Identities=21%  Similarity=0.386  Sum_probs=193.0

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCC---cEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCC
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTN---ERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~---~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (425)
                      ..++|++.+.||+|+||+||+|.+..++   ..||||.++...    .+.+.+|+.+++++ +||||+++++++.+   .
T Consensus         5 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~---~   80 (273)
T d1mp8a_           5 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF-DHPHIVKLIGVITE---N   80 (273)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECS---S
T ss_pred             CHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEec---C
Confidence            3578999999999999999999886543   568899886432    35688999999999 99999999999953   5


Q ss_pred             ccEEEEEeecCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEecccccccc
Q 014406          196 TPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (425)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~  271 (425)
                      .+++||||+++|++..++    ..+++..++.++.||+.||+|||+++|+||||||+||+++.+ +.+||+|||+|+...
T Consensus        81 ~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~-~~~Kl~DfG~a~~~~  159 (273)
T d1mp8a_          81 PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSN-DCVKLGDFGLSRYME  159 (273)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEET-TEEEECC--------
T ss_pred             eEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCC-CcEEEccchhheecc
Confidence            689999999999998764    358999999999999999999999999999999999999988 799999999998765


Q ss_pred             CCCc--ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhh
Q 014406          272 PGKE--YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK  348 (425)
Q Consensus       272 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~  348 (425)
                      ....  .....+|+.|+|||++.+ ..++.++|||||||++|||++ |..|| .+.+..+....+....           
T Consensus       160 ~~~~~~~~~~~gt~~y~apE~l~~-~~~~~~~DiwSlGvil~e~lt~g~~P~-~~~~~~~~~~~i~~~~-----------  226 (273)
T d1mp8a_         160 DSTYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPF-QGVKNNDVIGRIENGE-----------  226 (273)
T ss_dssp             -----------CCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCTT-TTCCGGGHHHHHHTTC-----------
T ss_pred             CCcceeccceecCcccchhhHhcc-CCCCCccccccchHHHHHHHhcCCCCC-CCCCHHHHHHHHHcCC-----------
Confidence            4322  234567889999999987 789999999999999999998 66665 5545444444332100           


Q ss_pred             ccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccc
Q 014406          349 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR  416 (425)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~  416 (425)
                                               ....+..+++++.+||.+||+.||++|||++|+++|  |+.+.
T Consensus       227 -------------------------~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~--L~~i~  267 (273)
T d1mp8a_         227 -------------------------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ--LSTIL  267 (273)
T ss_dssp             -------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH--HHHHH
T ss_pred             -------------------------CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH--HHHHH
Confidence                                     001123479999999999999999999999999987  55543

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-51  Score=385.10  Aligned_cols=247  Identities=18%  Similarity=0.300  Sum_probs=203.3

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcE--EEEEEecCc----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCc
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNER--CIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~--vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (425)
                      +.++|++.+.||+|+||+||+|.+..++..  ||||.++..    ..+.+.+|+.+|.++.+||||++++++|.+.  ..
T Consensus         8 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~--~~   85 (309)
T d1fvra_           8 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR--GY   85 (309)
T ss_dssp             CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEET--TE
T ss_pred             CHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecC--Ce
Confidence            457899999999999999999999888874  677777532    3457899999999986799999999999754  67


Q ss_pred             cEEEEEeecCCChhhhc-------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCC
Q 014406          197 PSLIFEYVNSTDFKVLY-------------------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELR  257 (425)
Q Consensus       197 ~~lv~e~~~~~~l~~~~-------------------~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~  257 (425)
                      +++||||+++|+|.+++                   ..+++..+..++.||+.||.|||+++|+||||||+|||++.+ +
T Consensus        86 ~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~-~  164 (309)
T d1fvra_          86 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN-Y  164 (309)
T ss_dssp             EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGG-G
T ss_pred             eEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCC-C
Confidence            89999999999999886                   348999999999999999999999999999999999999998 7


Q ss_pred             cEEEEeccccccccCCCcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh
Q 014406          258 KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL  337 (425)
Q Consensus       258 ~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~l  337 (425)
                      .+||+|||+|+............+|..|+|||.+.+ ..++.++|||||||++|||++|..|++.+.+..+....+.+. 
T Consensus       165 ~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~-  242 (309)
T d1fvra_         165 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG-  242 (309)
T ss_dssp             CEEECCTTCEESSCEECCC----CCTTTCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGT-
T ss_pred             ceEEccccccccccccccccceecCCcccchHHhcc-CCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhc-
Confidence            899999999987655445556678999999999987 789999999999999999999887766655544433322110 


Q ss_pred             CCchhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcC
Q 014406          338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  409 (425)
Q Consensus       338 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~h  409 (425)
                                 .                        ..+....+++++.+||.+||+.||++|||++|+++|
T Consensus       243 -----------~------------------------~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  279 (309)
T d1fvra_         243 -----------Y------------------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  279 (309)
T ss_dssp             -----------C------------------------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -----------C------------------------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence                       0                        011123378999999999999999999999999987

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.5e-50  Score=380.39  Aligned_cols=245  Identities=18%  Similarity=0.299  Sum_probs=202.6

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEc-----CCCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCC
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINV-----NTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQH  193 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~-----~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  193 (425)
                      ..++|++++.||+|+||+||+|+..     .+++.||||+++...    .+++.+|+.+++++ +||||++++++|..  
T Consensus        11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~--   87 (301)
T d1lufa_          11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF-DNPNIVKLLGVCAV--   87 (301)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECS--
T ss_pred             CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhc-CCCCcccceeeecc--
Confidence            3678999999999999999999875     356789999997533    45689999999999 99999999999954  


Q ss_pred             CCccEEEEEeecCCChhhhcC---------------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeecCC
Q 014406          194 SKTPSLIFEYVNSTDFKVLYP---------------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVK  246 (425)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~~---------------------------~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk  246 (425)
                      ....+++|||+.+|+|.+++.                           .+++..+..++.|++.||+|||+++|||||||
T Consensus        88 ~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlK  167 (301)
T d1lufa_          88 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLA  167 (301)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred             CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEc
Confidence            467889999999999988762                           27888999999999999999999999999999


Q ss_pred             CCceEecCCCCcEEEEeccccccccCCC---cceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Q 014406          247 PHNVMIDHELRKLRLIDWGLAEFYHPGK---EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG  323 (425)
Q Consensus       247 ~~NIll~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~  323 (425)
                      |+|||+|.+ +.+||+|||+|+......   ......+++.|+|||.+.+ ..++.++|||||||++|||++|..|++.+
T Consensus       168 p~NILld~~-~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~t~ksDVwS~Gvvl~ell~~~~~p~~~  245 (301)
T d1lufa_         168 TRNCLVGEN-MVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYYG  245 (301)
T ss_dssp             GGGEEECGG-GCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             ccceEECCC-CcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHcc-CCCChhhhhccchhhHHHHHccCCCCCCC
Confidence            999999998 789999999998654332   2234578889999999987 78999999999999999999998766666


Q ss_pred             CCCHHHHHHHHHHhCCchhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCH
Q 014406          324 HDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA  403 (425)
Q Consensus       324 ~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta  403 (425)
                      .+..+....+.+..                                    ....+..+++++.+|+.+||+.||++|||+
T Consensus       246 ~~~~e~~~~v~~~~------------------------------------~~~~p~~~~~~~~~li~~cl~~~P~~RPt~  289 (301)
T d1lufa_         246 MAHEEVIYYVRDGN------------------------------------ILACPENCPLELYNLMRLCWSKLPADRPSF  289 (301)
T ss_dssp             SCHHHHHHHHHTTC------------------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             CCHHHHHHHHHcCC------------------------------------CCCCCccchHHHHHHHHHHcCCChhHCcCH
Confidence            65555544432100                                    001123478999999999999999999999


Q ss_pred             HHHhc
Q 014406          404 REAMA  408 (425)
Q Consensus       404 ~elL~  408 (425)
                      .|+++
T Consensus       290 ~ev~~  294 (301)
T d1lufa_         290 CSIHR  294 (301)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            99965

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-50  Score=371.89  Aligned_cols=248  Identities=15%  Similarity=0.313  Sum_probs=195.6

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc-hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEE
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~-~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (425)
                      ..++|++.+.||+|+||+||+|.+  .|+.||||+++... .+.+.+|+++++++ +||||++++|+|.+.. ..+++||
T Consensus         5 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~~~-~~~~lv~   80 (262)
T d1byga_           5 NMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQL-RHSNLVQLLGVIVEEK-GGLYIVT   80 (262)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC--HHHHHTHHHHTTC-CCTTBCCEEEEECCC---CCEEEE
T ss_pred             CHHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEecC-CcEEEEE
Confidence            457899999999999999999987  47889999997543 56799999999999 9999999999986432 4579999


Q ss_pred             EeecCCChhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCcc
Q 014406          202 EYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY  276 (425)
Q Consensus       202 e~~~~~~l~~~~~-----~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~~  276 (425)
                      ||+++|+|.+++.     .+++..+..++.||+.||.|||+.+|+||||||+|||++.+ +.+||+|||+++....  ..
T Consensus        81 ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~-~~~kl~dfg~s~~~~~--~~  157 (262)
T d1byga_          81 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSED-NVAKVSDFGLTKEASS--TQ  157 (262)
T ss_dssp             CCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT-SCEEECCCCC----------
T ss_pred             eccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCC-CCEeecccccceecCC--CC
Confidence            9999999998873     38999999999999999999999999999999999999998 7899999999986543  33


Q ss_pred             eeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCCChh
Q 014406          277 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ  356 (425)
Q Consensus       277 ~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~  356 (425)
                      ....++..|+|||++.+ ..++.++|||||||++|||+|++.|++...+..+....+..            .        
T Consensus       158 ~~~~~~~~y~aPE~l~~-~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~------------~--------  216 (262)
T d1byga_         158 DTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK------------G--------  216 (262)
T ss_dssp             ----CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTT------------T--------
T ss_pred             ccccccccCCChHHHhC-CCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc------------C--------
Confidence            44577889999999987 68999999999999999999954444444444443333211            0        


Q ss_pred             hHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCCCCcccc
Q 014406          357 LDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR  416 (425)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp~~~~~~  416 (425)
                                      ...+....+++++.+|+++||+.||++|||+.|++++  |++++
T Consensus       217 ----------------~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~--L~~i~  258 (262)
T d1byga_         217 ----------------YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ--LEHIK  258 (262)
T ss_dssp             ----------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH--HHHHH
T ss_pred             ----------------CCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHH--HHHHH
Confidence                            0011123478999999999999999999999999874  54443

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-49  Score=371.96  Aligned_cols=247  Identities=21%  Similarity=0.334  Sum_probs=206.9

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEc-----CCCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCC
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINV-----NTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQH  193 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~-----~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  193 (425)
                      ..++|++.+.||+|+||.||+|++.     .+++.||||+++...    ...+.+|+.++.++.+||||++++++|.+. 
T Consensus        21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~-   99 (311)
T d1t46a_          21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG-   99 (311)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-
T ss_pred             CHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC-
Confidence            4589999999999999999999863     466799999997532    356889999999997799999999999654 


Q ss_pred             CCccEEEEEeecCCChhhhcC---------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEe
Q 014406          194 SKTPSLIFEYVNSTDFKVLYP---------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI  252 (425)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~~---------------------~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll  252 (425)
                       ...++||||+++|+|..++.                     .+++..+..++.||+.||+|||+++||||||||+|||+
T Consensus       100 -~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~  178 (311)
T d1t46a_         100 -GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL  178 (311)
T ss_dssp             -SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred             -CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccc
Confidence             67889999999999988762                     48899999999999999999999999999999999999


Q ss_pred             cCCCCcEEEEeccccccccCCCcc---eeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHH
Q 014406          253 DHELRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQ  329 (425)
Q Consensus       253 ~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~  329 (425)
                      +.+ +.+|++|||+++........   ....+|+.|+|||++.+ ..++.++|||||||++|||+|++.|++.+.+..+.
T Consensus       179 ~~~-~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~  256 (311)
T d1t46a_         179 THG-RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK  256 (311)
T ss_dssp             ETT-TEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred             ccc-CcccccccchheeccCCCcceEeeecccChHHcCHHHhcC-CCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHH
Confidence            988 79999999999876543322   33578999999999987 78999999999999999999987887777766666


Q ss_pred             HHHHHHHhCCchhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhc
Q 014406          330 LVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  408 (425)
Q Consensus       330 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~  408 (425)
                      +..+.+.-                                   ........+++++.+||.+||+.||++|||++|+++
T Consensus       257 ~~~~i~~~-----------------------------------~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~  300 (311)
T d1t46a_         257 FYKMIKEG-----------------------------------FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ  300 (311)
T ss_dssp             HHHHHHHT-----------------------------------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHhcC-----------------------------------CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            55543310                                   001112236899999999999999999999999986

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-50  Score=371.08  Aligned_cols=244  Identities=18%  Similarity=0.281  Sum_probs=190.9

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCC-C--cEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCC
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNT-N--ERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH  193 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~-~--~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  193 (425)
                      +.++|++++.||+|+||+||+|+...+ +  ..||||+++..      ..+.+.+|+.+|+++ +||||++++|+|.+  
T Consensus         6 ~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~~~g~~~~--   82 (273)
T d1u46a_           6 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-DHRNLIRLYGVVLT--   82 (273)
T ss_dssp             CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHC-CCTTBCCEEEEECS--
T ss_pred             chHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEee--
Confidence            357799999999999999999986533 2  36899998642      235789999999999 99999999999954  


Q ss_pred             CCccEEEEEeecCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEecccccc
Q 014406          194 SKTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (425)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~  269 (425)
                       ...++||||++++++.+++    ..+++..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++.
T Consensus        83 -~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~-~~vkl~DfGl~~~  160 (273)
T d1u46a_          83 -PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATR-DLVKIGDFGLMRA  160 (273)
T ss_dssp             -SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEET-TEEEECCCTTCEE
T ss_pred             -cchheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccc-cceeeccchhhhh
Confidence             3568999999999988765    459999999999999999999999999999999999999998 7999999999987


Q ss_pred             ccCCCcc----eeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCCchhHH
Q 014406          270 YHPGKEY----NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNA  344 (425)
Q Consensus       270 ~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~lg~~~~~~  344 (425)
                      .......    ....++..|+|||++.+ ..++.++|||||||++|||+| |+.|| .+.+..+.+..+.+.        
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~S~Gvil~emlt~G~~Pf-~~~~~~~~~~~i~~~--------  230 (273)
T d1u46a_         161 LPQNDDHYVMQEHRKVPFAWCAPESLKT-RTFSHASDTWMFGVTLWEMFTYGQEPW-IGLNGSQILHKIDKE--------  230 (273)
T ss_dssp             CCC-CCEEEC-----CCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCTT-TTCCHHHHHHHHHTS--------
T ss_pred             cccCCCcceecCccccCcccCCHHHHhC-CCCCcchhhhhhHHHHHHHHhCCCCCC-CCcCHHHHHHHHHhC--------
Confidence            7544332    22356778999999987 789999999999999999998 78887 444444444433210        


Q ss_pred             HHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhc
Q 014406          345 YLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  408 (425)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~  408 (425)
                           .                      ...+....+++++.+|+.+||+.||++|||++|+++
T Consensus       231 -----~----------------------~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~  267 (273)
T d1u46a_         231 -----G----------------------ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD  267 (273)
T ss_dssp             -----C----------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -----C----------------------CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                 0                      001112347899999999999999999999999863

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-49  Score=375.19  Aligned_cols=252  Identities=19%  Similarity=0.314  Sum_probs=208.5

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcC-----CCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeeEEeEEEcCC
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVN-----TNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQH  193 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~-----~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  193 (425)
                      ..++|++.+.||+|+||+||+|.+..     +++.||||+++...    ...+.+|+.+++++ +||||++++++|..  
T Consensus        18 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~--   94 (308)
T d1p4oa_          18 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF-NCHHVVRLLGVVSQ--   94 (308)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGC-CCTTBCCEEEEECS--
T ss_pred             cHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHc-CCCCEeeeeeEEec--
Confidence            45899999999999999999998752     45789999997532    23588999999999 89999999999954  


Q ss_pred             CCccEEEEEeecCCChhhhc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEE
Q 014406          194 SKTPSLIFEYVNSTDFKVLY-------------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLR  260 (425)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~-------------~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~k  260 (425)
                      ....++||||+.+|+|..++             ..+++..+..++.|++.||.|||+++|+||||||+|||++.+ +.+|
T Consensus        95 ~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~-~~~K  173 (308)
T d1p4oa_          95 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED-FTVK  173 (308)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTT-CCEE
T ss_pred             CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCC-ceEE
Confidence            46788999999999998875             236888999999999999999999999999999999999988 7999


Q ss_pred             EEeccccccccCCCc---ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh
Q 014406          261 LIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL  337 (425)
Q Consensus       261 l~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~l  337 (425)
                      |+|||+|+.......   .....+|+.|+|||.+.+ ..++.++|||||||++|||+||..|++.+.+..+.+..+.+..
T Consensus       174 l~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~-~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~  252 (308)
T d1p4oa_         174 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG  252 (308)
T ss_dssp             ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTC
T ss_pred             EeecccceeccCCcceeeccceecccccCCHHHHcc-CCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCC
Confidence            999999986643322   233468899999999987 7899999999999999999999877666666555554442200


Q ss_pred             CCchhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhc------CCC
Q 014406          338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA------HPY  411 (425)
Q Consensus       338 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~------hp~  411 (425)
                                                          ....+..+++.+.++|.+||+.||++|||++|+++      +|+
T Consensus       253 ------------------------------------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~  296 (308)
T d1p4oa_         253 ------------------------------------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG  296 (308)
T ss_dssp             ------------------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTT
T ss_pred             ------------------------------------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence                                                01112237899999999999999999999999998      788


Q ss_pred             Cccc
Q 014406          412 FAQV  415 (425)
Q Consensus       412 ~~~~  415 (425)
                      |+++
T Consensus       297 ~~~~  300 (308)
T d1p4oa_         297 FREV  300 (308)
T ss_dssp             HHHH
T ss_pred             CcCC
Confidence            7754

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-49  Score=371.92  Aligned_cols=246  Identities=18%  Similarity=0.316  Sum_probs=195.5

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCC-------cEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeeEEeEEEc
Q 014406          123 DQDDYEVVRKVGRGKYSEVFEGINVNTN-------ERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRD  191 (425)
Q Consensus       123 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~-------~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~  191 (425)
                      ..++|++.+.||+|+||+||+|++..++       ..||||+++...    ..++.+|...+.++.+||||++++++|.+
T Consensus        11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~   90 (299)
T d1fgka_          11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ   90 (299)
T ss_dssp             CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence            4689999999999999999999876554       479999997543    35678899999998789999999999965


Q ss_pred             CCCCccEEEEEeecCCChhhhc-------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEe
Q 014406          192 QHSKTPSLIFEYVNSTDFKVLY-------------------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI  252 (425)
Q Consensus       192 ~~~~~~~lv~e~~~~~~l~~~~-------------------~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll  252 (425)
                        ....++||||+.+|+|.+++                   ..+++.++..++.||+.||+|||+++||||||||+|||+
T Consensus        91 --~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl  168 (299)
T d1fgka_          91 --DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV  168 (299)
T ss_dssp             --SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred             --CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceee
Confidence              46789999999999999887                   248999999999999999999999999999999999999


Q ss_pred             cCCCCcEEEEeccccccccCCCc---ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHH
Q 014406          253 DHELRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQ  329 (425)
Q Consensus       253 ~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~  329 (425)
                      +.+ +.+||+|||+++.......   .....+++.|+|||.+.+ ..|+.++|||||||++|||++++.|++.+.+..+.
T Consensus       169 ~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~-~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~  246 (299)
T d1fgka_         169 TED-NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL  246 (299)
T ss_dssp             CTT-CCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred             cCC-CCeEeccchhhccccccccccccccCCCChhhhhhhHhcC-CCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHH
Confidence            998 7899999999986654322   233578889999999987 78999999999999999999854444444443332


Q ss_pred             HHHHHHHhCCchhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhc
Q 014406          330 LVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  408 (425)
Q Consensus       330 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~  408 (425)
                      ...+..  |          .                        ....+..+++++.+||.+||+.||++|||+.|+++
T Consensus       247 ~~~i~~--~----------~------------------------~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~  289 (299)
T d1fgka_         247 FKLLKE--G----------H------------------------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE  289 (299)
T ss_dssp             HHHHHT--T----------C------------------------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHc--C----------C------------------------CCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence            222211  0          0                        01112347899999999999999999999999987

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-48  Score=368.44  Aligned_cols=240  Identities=20%  Similarity=0.332  Sum_probs=192.5

Q ss_pred             EeeeeeeCceEEEEEEEcCCC---cEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEEE
Q 014406          130 VRKVGRGKYSEVFEGINVNTN---ERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE  202 (425)
Q Consensus       130 ~~~LG~G~fg~V~~~~~~~~~---~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e  202 (425)
                      .++||+|+||+||+|.+..++   ..||||.++..    ..+++.+|+++++++ +||||++++|++... ....++|||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~~-~~~~~lv~E  109 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLSLLGICLRS-EGSPLVVLP  109 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTC-CCTTBCCCCEEEEET-TTEEEEEEE
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhC-CCCCEeEEeEEEEec-CCceEEEEE
Confidence            578999999999999986643   36899998642    235689999999999 899999999998653 356889999


Q ss_pred             eecCCChhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEeccccccccCCCc---
Q 014406          203 YVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE---  275 (425)
Q Consensus       203 ~~~~~~l~~~~~----~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~~~~~~---  275 (425)
                      |++++++.+++.    .+++..+..++.|++.||.|||+.+|+||||||+|||++.+ +.+||+|||+++.......   
T Consensus       110 ~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~-~~~kL~DFG~~~~~~~~~~~~~  188 (311)
T d1r0pa_         110 YMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEK-FTVKVADFGLARDMYDKEFDSV  188 (311)
T ss_dssp             CCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT-CCEEECSSGGGCCTTTTTCCCT
T ss_pred             EeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCC-CCEEEecccchhhccccccccc
Confidence            999999988763    46788899999999999999999999999999999999988 7999999999987643322   


Q ss_pred             --ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhhccCCC
Q 014406          276 --YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL  353 (425)
Q Consensus       276 --~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~  353 (425)
                        .....||..|+|||.+.+ ..++.++||||||+++|||++|+.||+...+..+....+..  |.              
T Consensus       189 ~~~~~~~gt~~y~aPE~~~~-~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~--g~--------------  251 (311)
T d1r0pa_         189 HNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ--GR--------------  251 (311)
T ss_dssp             TCTTCSSCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHT--TC--------------
T ss_pred             eecccccccccccChHHHhc-CCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHc--CC--------------
Confidence              223467889999999987 78999999999999999999999998655444333332211  00              


Q ss_pred             ChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcC
Q 014406          354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  409 (425)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~h  409 (425)
                                          ....+..+++++.+|+.+||+.||++|||+.|+++|
T Consensus       252 --------------------~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~  287 (311)
T d1r0pa_         252 --------------------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR  287 (311)
T ss_dssp             --------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --------------------CCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                                001122378999999999999999999999999998

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=7.7e-48  Score=371.56  Aligned_cols=291  Identities=24%  Similarity=0.382  Sum_probs=212.4

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc--hHHHHHHHHHHHHhc----------CCCCeeeEEeEEEcC
Q 014406          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--KKKIKREIKILQNLC----------GGPNVVKLLDIVRDQ  192 (425)
Q Consensus       125 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~----------~h~niv~l~~~~~~~  192 (425)
                      .+|+++++||+|+||+||+|++..+|+.||||+++...  .+.+.+|+.+++.+.          +|+||+++++++...
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~   92 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK   92 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence            56999999999999999999999999999999998653  367788999998872          358899999998765


Q ss_pred             CCCccEEEEEeecCCChhhh------cCCCCHHHHHHHHHHHHHHHHHHHH-CCceeecCCCCceEecCCCC-----cEE
Q 014406          193 HSKTPSLIFEYVNSTDFKVL------YPTLTDYDIRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHELR-----KLR  260 (425)
Q Consensus       193 ~~~~~~lv~e~~~~~~l~~~------~~~l~~~~~~~i~~~i~~~L~~LH~-~~ivH~Dlk~~NIll~~~~~-----~~k  260 (425)
                      .....+++++++..+.....      ...+++..++.++.||+.||+|||+ .||+||||||+|||++.+..     .++
T Consensus        93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~k  172 (362)
T d1q8ya_          93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIK  172 (362)
T ss_dssp             ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEE
T ss_pred             cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccceee
Confidence            55666777777755543222      1458999999999999999999998 89999999999999986522     489


Q ss_pred             EEeccccccccCCCcceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCC-----CCHHHHHHHHH
Q 014406          261 LIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH-----DNHDQLVKIAK  335 (425)
Q Consensus       261 l~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~-----~~~~~~~~~~~  335 (425)
                      ++|||.+....  .......+|+.|+|||++.+ ..++.++||||+||++++|++|+.||....     ...+.+.....
T Consensus       173 l~dfg~s~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~  249 (362)
T d1q8ya_         173 IADLGNACWYD--EHYTNSIQTREYRSPEVLLG-APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE  249 (362)
T ss_dssp             ECCCTTCEETT--BCCCSCCSCGGGCCHHHHHT-CCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHH
T ss_pred             Eeecccccccc--cccccccccccccChhhccc-cCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHH
Confidence            99999997643  33455689999999999987 789999999999999999999999985332     23456677778


Q ss_pred             HhCCchhHHHHhhccCCCChhhHHHhcccC---CCCccccc--cccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcCC
Q 014406          336 VLGTDELNAYLNKYHLELDPQLDALVGRHS---RKPWSKFI--NADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHP  410 (425)
Q Consensus       336 ~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~--~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~hp  410 (425)
                      .+|..+........................   ..++....  ........+++++|||.+||++||++||||+|+|+||
T Consensus       250 ~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp  329 (362)
T d1q8ya_         250 LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHP  329 (362)
T ss_dssp             HHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCG
T ss_pred             HhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence            888755443211000000000000000000   00000000  0011122467899999999999999999999999999


Q ss_pred             CCcccccc
Q 014406          411 YFAQVRAA  418 (425)
Q Consensus       411 ~~~~~~~~  418 (425)
                      ||++....
T Consensus       330 ~f~~~~~~  337 (362)
T d1q8ya_         330 WLKDTLGM  337 (362)
T ss_dssp             GGTTCTTC
T ss_pred             ccCCCCCc
Confidence            99976543

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-48  Score=363.27  Aligned_cols=265  Identities=18%  Similarity=0.204  Sum_probs=191.9

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcchHHHHHHHHHH--HHhcCCCCeeeEEeEEEcCCC--CccEEE
Q 014406          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKIL--QNLCGGPNVVKLLDIVRDQHS--KTPSLI  200 (425)
Q Consensus       125 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l--~~l~~h~niv~l~~~~~~~~~--~~~~lv  200 (425)
                      ++|.+.+.||+|+||+||+|+.  +|+.||||+++....+.+.+|.+++  .++ +||||+++++++.+++.  ..+++|
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~-~HpnIv~~~~~~~~~~~~~~~~~lv   79 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVML-RHENILGFIAADNKDNGTWTQLWLV   79 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhHHHHHHHHHHHhhC-CCCcCcceEEEEEeCCCcceEEEEE
Confidence            5688999999999999999975  6889999999877666666665554  466 89999999999986543  357899


Q ss_pred             EEeecCCChhhhcC--CCCHHHHHHHHHHHHHHHHHHHH--------CCceeecCCCCceEecCCCCcEEEEeccccccc
Q 014406          201 FEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHS--------QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  270 (425)
Q Consensus       201 ~e~~~~~~l~~~~~--~l~~~~~~~i~~~i~~~L~~LH~--------~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~~  270 (425)
                      |||+++|+|..++.  .+++..+..++.|++.||+|||+        +|||||||||+|||++.+ +.+||+|||+++..
T Consensus        80 ~Ey~~~g~L~~~l~~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~-~~~Kl~DFGl~~~~  158 (303)
T d1vjya_          80 SDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN-GTCCIADLGLAVRH  158 (303)
T ss_dssp             EECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTT-SCEEECCCTTCEEE
T ss_pred             EecccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCC-CCeEEEecCccccc
Confidence            99999999999884  68999999999999999999996        599999999999999988 79999999999876


Q ss_pred             cCCCc-----ceeeccCCCccCcccccCCC-----CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCc
Q 014406          271 HPGKE-----YNVRVASRYFKGPELLVDLQ-----DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTD  340 (425)
Q Consensus       271 ~~~~~-----~~~~~~t~~y~aPE~~~~~~-----~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~  340 (425)
                      .....     .....||+.|+|||++.+..     .++.++|||||||++|||+||..||............+  .....
T Consensus       159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~--~~~~~  236 (303)
T d1vjya_         159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL--VPSDP  236 (303)
T ss_dssp             ETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTT--SCSSC
T ss_pred             cCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhc--ccccc
Confidence            54332     23457899999999987622     25678999999999999999988774322211000000  00000


Q ss_pred             hhHHHHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhcC
Q 014406          341 ELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  409 (425)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~h  409 (425)
                      ......           ........+...   ............+.+|+.+||+.||++|||+.|++++
T Consensus       237 ~~~~~~-----------~~~~~~~~~p~~---~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~  291 (303)
T d1vjya_         237 SVEEMR-----------KVVCEQKLRPNI---PNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             CHHHHH-----------HHHTTSCCCCCC---CGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             hHHHHH-----------HHHhccccCCCC---CcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence            000000           000000000000   0000011123568899999999999999999999874

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.1e-46  Score=353.76  Aligned_cols=256  Identities=16%  Similarity=0.233  Sum_probs=194.2

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-chHHHHHHHHHHHHhcCCCC-eeeEEeEEEcCCCCccEEEE
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-KKKKIKREIKILQNLCGGPN-VVKLLDIVRDQHSKTPSLIF  201 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~~h~n-iv~l~~~~~~~~~~~~~lv~  201 (425)
                      .++|++.+.||+|+||+||+|++..+++.||||++... ..+++..|+++++.+ +|+| |+.+.+++.+  +...++||
T Consensus         6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l-~~~~~i~~~~~~~~~--~~~~~ivm   82 (299)
T d1ckia_           6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMM-QGGVGIPTIRWCGAE--GDYNVMVM   82 (299)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHS-TTSTTCCCEEEEEEE--TTEEEEEE
T ss_pred             CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHc-cCCCcccEEEEEEec--CCEEEEEE
Confidence            46899999999999999999999999999999998753 346788999999999 5555 5555555543  36788999


Q ss_pred             EeecCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCC--CCcEEEEeccccccccCCCc-
Q 014406          202 EYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--LRKLRLIDWGLAEFYHPGKE-  275 (425)
Q Consensus       202 e~~~~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~--~~~~kl~Dfg~a~~~~~~~~-  275 (425)
                      ||++++......   ..+++..+..++.|++.||+|||++||+||||||+|||++..  ...+||+|||+|+....... 
T Consensus        83 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~  162 (299)
T d1ckia_          83 ELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH  162 (299)
T ss_dssp             ECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTC
T ss_pred             EEcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccccc
Confidence            999776555443   469999999999999999999999999999999999998642  24699999999987654321 


Q ss_pred             -------ceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchhHHHHhh
Q 014406          276 -------YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK  348 (425)
Q Consensus       276 -------~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~lg~~~~~~~~~~  348 (425)
                             .....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||.... ..+....+...... ..      
T Consensus       163 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~el~tg~~P~~~~~-~~~~~~~~~~~~~~-~~------  233 (299)
T d1ckia_         163 QHIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLK-AATKRQKYERISEK-KM------  233 (299)
T ss_dssp             CBCCCCBCCSCCCCSSSCCHHHHTT-BCCCHHHHHHHHHHHHHHHHHSSCTTCCCC--------HHHHHHH-HH------
T ss_pred             cceeccccCCcCCCccccCHHHHhC-CCCCChhhEEecCHHHHHHHhCCCcccccc-hHHHHHHHHHhhcc-cC------
Confidence                   234579999999999987 779999999999999999999999984332 22222111110000 00      


Q ss_pred             ccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHH---HHhcCCCCc
Q 014406          349 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAR---EAMAHPYFA  413 (425)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~---elL~hp~~~  413 (425)
                       .  .                   ........+++++.+|+.+||+.||++||+++   ++|+|+|.+
T Consensus       234 -~--~-------------------~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~  279 (299)
T d1ckia_         234 -S--T-------------------PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR  279 (299)
T ss_dssp             -H--S-------------------CHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred             -C--C-------------------ChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence             0  0                   00011123789999999999999999999986   557777654

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=1e-45  Score=345.77  Aligned_cols=249  Identities=15%  Similarity=0.255  Sum_probs=197.3

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecC-cchHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEEE
Q 014406          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE  202 (425)
Q Consensus       124 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~-~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e  202 (425)
                      .++|++.+.||+|+||+||+|++..+++.||||+++. ...+.+.+|+++++.+.+|+|++.+++++..  +...++|||
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~--~~~~~~vme   81 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQE--GLHNVLVID   81 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEE--TTEEEEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEeec--CCccEEEEE
Confidence            4689999999999999999999999999999999864 3446788999999999667999999999865  467889999


Q ss_pred             eecCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCC----CCcEEEEeccccccccCCC
Q 014406          203 YVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE----LRKLRLIDWGLAEFYHPGK  274 (425)
Q Consensus       203 ~~~~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~----~~~~kl~Dfg~a~~~~~~~  274 (425)
                      |++ ++|..++    ..+++..+..++.|++.||+|||++||+||||||+|||++.+    .+.+||+|||+|+......
T Consensus        82 ~~~-~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~  160 (293)
T d1csna_          82 LLG-PSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV  160 (293)
T ss_dssp             CCC-CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTT
T ss_pred             ecC-CCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccCc
Confidence            994 6666554    458999999999999999999999999999999999999742    3679999999998764321


Q ss_pred             --------cceeeccCCCccCcccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCC--HHHHHHHHHHhCCchhHH
Q 014406          275 --------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN--HDQLVKIAKVLGTDELNA  344 (425)
Q Consensus       275 --------~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~--~~~~~~~~~~lg~~~~~~  344 (425)
                              ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......  .+....+....-..... 
T Consensus       161 ~~~~~~~~~~~~~~GT~~y~aPE~~~~-~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~-  238 (293)
T d1csna_         161 TKQHIPYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR-  238 (293)
T ss_dssp             TCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHH-
T ss_pred             cccceeecccCceEEchhhcCHHHhcC-CCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChH-
Confidence                    2234579999999999987 78999999999999999999999999432221  11222221110000000 


Q ss_pred             HHhhccCCCChhhHHHhcccCCCCccccccccCCCCCCHHHHHHHHHcccCCcCCCcCHHHHhc
Q 014406          345 YLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  408 (425)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~Rpta~elL~  408 (425)
                                                     +....+++++.+++..|++.+|++||+.+.+.+
T Consensus       239 -------------------------------~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~  271 (293)
T d1csna_         239 -------------------------------ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  271 (293)
T ss_dssp             -------------------------------HHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             -------------------------------HhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence                                           011237899999999999999999998776643

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.92  E-value=1.1e-25  Score=195.78  Aligned_cols=167  Identities=18%  Similarity=0.211  Sum_probs=121.4

Q ss_pred             EEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc---------------------hHHHHHHHHHHHHhcCCCCeeeE
Q 014406          127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK---------------------KKKIKREIKILQNLCGGPNVVKL  185 (425)
Q Consensus       127 y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~---------------------~~~~~~E~~~l~~l~~h~niv~l  185 (425)
                      +.+.++||+|+||+||+|.+. +|+.||||+++...                     .....+|...+.++ .|.+++..
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~v~~~   79 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL-QGLAVPKV   79 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT-TTSSSCCE
T ss_pred             chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHc-cCCCcceE
Confidence            457889999999999999874 68999999875211                     12345688899998 89999988


Q ss_pred             EeEEEcCCCCccEEEEEeecCCChhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCceEecCCCCcEEEEecc
Q 014406          186 LDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWG  265 (425)
Q Consensus       186 ~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~ivH~Dlk~~NIll~~~~~~~kl~Dfg  265 (425)
                      +++.  .    .+++|||+++..+..    ++......++.|++.+|.|||++||+||||||+|||++++  .++|+|||
T Consensus        80 ~~~~--~----~~lvme~~~~~~~~~----l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~--~~~liDFG  147 (191)
T d1zara2          80 YAWE--G----NAVLMELIDAKELYR----VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE--GIWIIDFP  147 (191)
T ss_dssp             EEEE--T----TEEEEECCCCEEGGG----CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT--EEEECCCT
T ss_pred             EEec--C----CEEEEEeeccccccc----hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC--CEEEEECC
Confidence            8764  1    269999999877654    3455567889999999999999999999999999999965  58999999


Q ss_pred             ccccccCCCcceeeccCCCccCcccccCCCCCCCcccHHHHHHHH
Q 014406          266 LAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMF  310 (425)
Q Consensus       266 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DvwslG~~l  310 (425)
                      .|................. .-.+.+ . ..|+.++|+||..-.+
T Consensus       148 ~a~~~~~~~~~~~l~rd~~-~~~~~f-~-r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         148 QSVEVGEEGWREILERDVR-NIITYF-S-RTYRTEKDINSAIDRI  189 (191)
T ss_dssp             TCEETTSTTHHHHHHHHHH-HHHHHH-H-HHHCCCCCHHHHHHHH
T ss_pred             CcccCCCCCcHHHHHHHHH-HHHHHH-c-CCCCCcccHHHHHHHH
Confidence            9976543221110000000 001222 2 4688999999976543

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.47  E-value=6.5e-07  Score=79.34  Aligned_cols=138  Identities=17%  Similarity=0.229  Sum_probs=89.8

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc---chHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCccEEEE
Q 014406          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (425)
Q Consensus       125 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (425)
                      +.|+..+..+.++.+.||+..  .++..+++|+....   ....+.+|...+..+..+--+.+++.+..+.  +..++||
T Consensus        14 ~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~--~~~~lv~   89 (263)
T d1j7la_          14 EKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHD--GWSNLLM   89 (263)
T ss_dssp             TTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEET--TEEEEEE
T ss_pred             hceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecC--CceEEEE
Confidence            345655555555557899873  45667788887643   2345788999999885554467788877543  6678999


Q ss_pred             EeecCCChhhhcCCCCHHHHHHHHHHHHHHHHHHH---------------------------------------------
Q 014406          202 EYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCH---------------------------------------------  236 (425)
Q Consensus       202 e~~~~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH---------------------------------------------  236 (425)
                      ++++|..+........  ....++.++...+..||                                             
T Consensus        90 ~~l~G~~~~~~~~~~~--~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (263)
T d1j7la_          90 SEADGVLCSEEYEDEQ--SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDP  167 (263)
T ss_dssp             ECCSSEEHHHHTTTCS--CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSH
T ss_pred             Eecccccccccccccc--cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHH
Confidence            9999988755432211  11112233333333333                                             


Q ss_pred             --------HC------CceeecCCCCceEecCCCCcEEEEecccccc
Q 014406          237 --------SQ------GIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (425)
Q Consensus       237 --------~~------~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~  269 (425)
                              +.      .++|+|+.|.|||++++ +.+-|+||+.+..
T Consensus       168 ~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~-~~~~lIDwe~a~~  213 (263)
T d1j7la_         168 RELYDFLKTEKPEEELVFSHGDLGDSNIFVKDG-KVSGFIDLGRSGR  213 (263)
T ss_dssp             HHHHHHHHHSCCCCCEEEECSCCCTTSEEEETT-EEEEECCCTTCEE
T ss_pred             HHHHHHHHhcCCcCCcEEEEeeccCcceeecCC-ceEEEeechhccc
Confidence                    11      37899999999999976 4556999988753

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.13  E-value=1.1e-05  Score=70.80  Aligned_cols=132  Identities=17%  Similarity=0.129  Sum_probs=85.2

Q ss_pred             eeeeeCc-eEEEEEEEcCCCcEEEEEEecCcchHHHHHHHHHHHHhcCC-CCeeeEEeEEEcCCCCccEEEEEeecCCCh
Q 014406          132 KVGRGKY-SEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGG-PNVVKLLDIVRDQHSKTPSLIFEYVNSTDF  209 (425)
Q Consensus       132 ~LG~G~f-g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h-~niv~l~~~~~~~~~~~~~lv~e~~~~~~l  209 (425)
                      .+..|.. +.||+.. ..++..+++|.........+..|...++.+..+ -.+.+++.+..++  ...++||++++|.++
T Consensus        17 ~~~~G~s~~~v~r~~-~~~~~~~vlK~~~~~~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~--~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLS-AQGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTEA--GRDWLLLGEVPGQDL   93 (255)
T ss_dssp             ECSCTTSSCEEEEEE-CTTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEECS--SCEEEEEECCSSEET
T ss_pred             EcCCcccCCeEEEEE-eCCCCEEEEEeCCccCHhHHHHHHHHHHHHHhcCCCCCceeeecccc--cceEEEEEeeecccc
Confidence            3444544 6789984 556777899998877777889999999888433 2256677776543  567899999988765


Q ss_pred             hhhcCCCCHHHHHH----HH--------------------------------------------HHHHHHHHHHHHC---
Q 014406          210 KVLYPTLTDYDIRY----YI--------------------------------------------YELLKALDYCHSQ---  238 (425)
Q Consensus       210 ~~~~~~l~~~~~~~----i~--------------------------------------------~~i~~~L~~LH~~---  238 (425)
                      ....  ........    .+                                            ......+..+.+.   
T Consensus        94 ~~~~--~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  171 (255)
T d1nd4a_          94 LSSH--LAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPD  171 (255)
T ss_dssp             TTSC--CCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCS
T ss_pred             cccc--ccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCCc
Confidence            4321  11000000    00                                            0011223444332   


Q ss_pred             ----CceeecCCCCceEecCCCCcEEEEecccccc
Q 014406          239 ----GIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (425)
Q Consensus       239 ----~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~  269 (425)
                          .++|+|+.|.|||++.+ +.+-|+||+.+..
T Consensus       172 ~~~~~liHgD~~~~Nvl~~~~-~~~~iID~~~~~~  205 (255)
T d1nd4a_         172 GEDLVVTHGDACLPNIMVENG-RFSGFIDCGRLGV  205 (255)
T ss_dssp             SCCEEEECSSCCGGGEEEETT-EEEEECCCTTCEE
T ss_pred             cCCceEEeCCCCCcceEEeCC-ceEEEEEchhccc
Confidence                37999999999999976 4567999987753

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.93  E-value=2.2e-05  Score=73.61  Aligned_cols=75  Identities=16%  Similarity=0.187  Sum_probs=49.7

Q ss_pred             EeeeeeeCceEEEEEEEcCCCcEEEEEEecC----------cchHHHHHHHHHHHHhcCC--CCeeeEEeEEEcCCCCcc
Q 014406          130 VRKVGRGKYSEVFEGINVNTNERCIIKILKP----------VKKKKIKREIKILQNLCGG--PNVVKLLDIVRDQHSKTP  197 (425)
Q Consensus       130 ~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~----------~~~~~~~~E~~~l~~l~~h--~niv~l~~~~~~~~~~~~  197 (425)
                      .+.||.|....||+..+..+++.+++|.-.+          ...++...|...|+.+..+  ..+.+++.+.  +  ...
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~--~~~  106 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--T--EMA  106 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--T--TTT
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--C--CCC
Confidence            4468999999999998777788999997542          1234566799888877433  3456666554  3  334


Q ss_pred             EEEEEeecCCC
Q 014406          198 SLIFEYVNSTD  208 (425)
Q Consensus       198 ~lv~e~~~~~~  208 (425)
                      ++|||++.+..
T Consensus       107 ~lvmE~L~~~~  117 (392)
T d2pula1         107 VTVMEDLSHLK  117 (392)
T ss_dssp             EEEECCCTTSE
T ss_pred             EEEEeccCCcc
Confidence            69999997754

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.33  E-value=0.00039  Score=64.86  Aligned_cols=78  Identities=14%  Similarity=0.184  Sum_probs=54.7

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcC-------CCcEEEEEEecC-cchHHHHHHHHHHHHhcCCCCeeeEEeEEEcCCCCc
Q 014406          125 DDYEVVRKVGRGKYSEVFEGINVN-------TNERCIIKILKP-VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (425)
Q Consensus       125 ~~y~~~~~LG~G~fg~V~~~~~~~-------~~~~vavK~~~~-~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (425)
                      +++++ +.|+.|-.-.+|++....       ..+.|++++... ...-...+|..+++.+..+.-..++++++.+     
T Consensus        43 ~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~-----  116 (395)
T d1nw1a_          43 EHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIFSG-----  116 (395)
T ss_dssp             GGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT-----
T ss_pred             cceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC-----
Confidence            34444 568889999999987543       345688888753 2334466899999988655555688888832     


Q ss_pred             cEEEEEeecCCCh
Q 014406          197 PSLIFEYVNSTDF  209 (425)
Q Consensus       197 ~~lv~e~~~~~~l  209 (425)
                       .+|+||++|..+
T Consensus       117 -g~I~efi~g~~l  128 (395)
T d1nw1a_         117 -GRLEEYIPSRPL  128 (395)
T ss_dssp             -EEEECCCCEEEC
T ss_pred             -ceEEEEeccccC
Confidence             389999987654

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.27  E-value=0.00023  Score=64.60  Aligned_cols=126  Identities=15%  Similarity=0.169  Sum_probs=75.0

Q ss_pred             ceEEEEEEEcCCCcEEEEEEecCc--chHHHHHHHHHHHHhcCCC-CeeeEEe-----EEEcCCCCccEEEEEeecCCCh
Q 014406          138 YSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGP-NVVKLLD-----IVRDQHSKTPSLIFEYVNSTDF  209 (425)
Q Consensus       138 fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~-niv~l~~-----~~~~~~~~~~~lv~e~~~~~~l  209 (425)
                      --.||++. ..+|..+++|+..+.  ..+++..|...+..|..+. -++..+.     .+  ......+.+++++.|..+
T Consensus        35 EN~vy~v~-~~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~--~~~~~~~~l~~~~~G~~~  111 (325)
T d1zyla1          35 ENRVYQFQ-DEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLL--NHQGFYFAVFPSVGGRQF  111 (325)
T ss_dssp             SSEEEEEC-CTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCE--EETTEEEEEEECCCCEEC
T ss_pred             cceeEEEE-cCCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeee--eeeeEEEEEEeecCCcCC
Confidence            35899984 467889999999865  4577899999998884221 1111111     11  123456788999887543


Q ss_pred             hhh-----------c---------------CCCCHH-------------------HHHHHHHHHHHHHHHHHH-------
Q 014406          210 KVL-----------Y---------------PTLTDY-------------------DIRYYIYELLKALDYCHS-------  237 (425)
Q Consensus       210 ~~~-----------~---------------~~l~~~-------------------~~~~i~~~i~~~L~~LH~-------  237 (425)
                      ...           +               ...+..                   ....+...+...++.+..       
T Consensus       112 ~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p  191 (325)
T d1zyla1         112 EADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFT  191 (325)
T ss_dssp             CSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSC
T ss_pred             CCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCC
Confidence            211           0               001111                   111122222233333332       


Q ss_pred             CCceeecCCCCceEecCCCCcEEEEecccccc
Q 014406          238 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (425)
Q Consensus       238 ~~ivH~Dlk~~NIll~~~~~~~kl~Dfg~a~~  269 (425)
                      .++||+|+.+.|||++++   ..++||+.+..
T Consensus       192 ~~liHgDlh~~NvL~~~~---~~~IDFdd~~~  220 (325)
T d1zyla1         192 VLRLHGDCHAGNILWRDG---PMFVDLDDARN  220 (325)
T ss_dssp             CEECCSSCSGGGEEESSS---EEECCCTTCCE
T ss_pred             ceeecCCCCcccEEEeCC---ceEEechhccc
Confidence            368999999999999754   35899998864

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.64  E-value=0.0011  Score=59.56  Aligned_cols=50  Identities=12%  Similarity=0.191  Sum_probs=32.8

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-chHHHHHHHHHHHHhc
Q 014406          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-KKKKIKREIKILQNLC  177 (425)
Q Consensus       126 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~  177 (425)
                      +..-.+.|..|---+.|+... .+| .+++|++... ..+.+..|+.++..|.
T Consensus        19 ~~~~~~~i~~G~~N~ny~v~t-~~g-~yVLri~~~~~~~~~l~~~~~~l~~L~   69 (316)
T d2ppqa1          19 SLTSYKGIAEGVENSNFLLHT-TKD-PLILTLYEKRVEKNDLPFFLGLMQHLA   69 (316)
T ss_dssp             CEEEEEEECC---EEEEEEEE-SSC-CEEEEEECC---CCHHHHHHHHHHHHH
T ss_pred             CceEeecCCCCcccCeEEEEE-CCC-cEEEEEcCCCCCHHHHHHHHHHHHhhh
Confidence            344456677888889999854 334 5899998753 4567788888888883